--
-- PostgreSQL database dump
--

-- Dumped from database version 13.5
-- Dumped by pg_dump version 13.5

SET statement_timeout = 0;
SET lock_timeout = 0;
SET idle_in_transaction_session_timeout = 0;
SET client_encoding = 'UTF8';
SET standard_conforming_strings = on;
SELECT pg_catalog.set_config('search_path', '', false);
SET check_function_bodies = false;
SET xmloption = content;
SET client_min_messages = warning;
SET row_security = off;

SET default_tablespace = '';

SET default_table_access_method = heap;

--
-- Name: area_na_link; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.area_na_link (
    id integer NOT NULL,
    input_vol double precision,
    input_amount double precision,
    area_id integer,
    nucacid_id integer,
    date timestamp with time zone,
    area_name text,
    nuc_name text
);


ALTER TABLE public.area_na_link OWNER TO borisbastian;

--
-- Name: area_na_link_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.area_na_link_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.area_na_link_id_seq OWNER TO borisbastian;

--
-- Name: area_na_link_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.area_na_link_id_seq OWNED BY public.area_na_link.id;


--
-- Name: areas; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.areas (
    ar_id integer NOT NULL,
    name character varying,
    area_type character varying,
    completion_date timestamp with time zone,
    image character varying,
    notes text,
    block integer,
    _blockname text
);


ALTER TABLE public.areas OWNER TO borisbastian;

--
-- Name: block_area_link; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.block_area_link (
    id integer NOT NULL,
    block integer,
    area integer
);


ALTER TABLE public.block_area_link OWNER TO borisbastian;

--
-- Name: block_area_link_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.block_area_link_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.block_area_link_id_seq OWNER TO borisbastian;

--
-- Name: block_area_link_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.block_area_link_id_seq OWNED BY public.block_area_link.id;


--
-- Name: blocks; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.blocks (
    bl_id integer NOT NULL,
    name character varying NOT NULL,
    age double precision,
    ulceration boolean,
    thickness double precision,
    mitoses integer,
    p_stage character varying,
    prim character varying,
    subtype character varying,
    slides integer,
    slides_left integer,
    fixation character varying,
    storage character varying,
    scan_number character varying,
    icd10 text,
    diagnosis text,
    notes text,
    micro text,
    gross text,
    clinical text,
    date_added timestamp with time zone,
    old_body_site character varying,
    collection character varying,
    path_note text,
    ip_dx text,
    body_site_id bigint,
    patient integer,
    project_id integer,
    department character varying,
    path_number character varying,
    specimen character varying,
    patient_id character varying,
    project character varying,
    patient_ip_id character varying,
    import_source character varying
);


ALTER TABLE public.blocks OWNER TO borisbastian;

--
-- Name: na_sl_link; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.na_sl_link (
    id bigint NOT NULL,
    input_vol double precision,
    input_amount double precision,
    nucacid_id integer,
    sample_lib_id bigint,
    date timestamp with time zone,
    sl_name text,
    na_name text
);


ALTER TABLE public.na_sl_link OWNER TO borisbastian;

--
-- Name: na_sl_link_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.na_sl_link_id_seq
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.na_sl_link_id_seq OWNER TO borisbastian;

--
-- Name: na_sl_link_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.na_sl_link_id_seq OWNED BY public.na_sl_link.id;


--
-- Name: nuc_acids; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.nuc_acids (
    nu_id integer NOT NULL,
    name character varying NOT NULL,
    date timestamp with time zone,
    na_type character varying,
    conc double precision,
    vol_init double precision,
    vol_remain double precision,
    notes text,
    method_id bigint
);


ALTER TABLE public.nuc_acids OWNER TO borisbastian;

--
-- Name: nuc_acids_nu_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.nuc_acids_nu_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.nuc_acids_nu_id_seq OWNER TO borisbastian;

--
-- Name: nuc_acids_nu_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.nuc_acids_nu_id_seq OWNED BY public.nuc_acids.nu_id;


--
-- Name: patients; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.patients (
    pat_id character varying(12),
    sex character varying(10),
    dob integer,
    race character varying(50),
    source character varying(20),
    blocks_temp text,
    notes text,
    pa_id integer NOT NULL,
    date_added timestamp with time zone,
    pat_ip_id character varying(12)
);


ALTER TABLE public.patients OWNER TO borisbastian;

--
-- Name: patients_pa_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.patients_pa_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.patients_pa_id_seq OWNER TO borisbastian;

--
-- Name: patients_pa_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.patients_pa_id_seq OWNED BY public.patients.pa_id;


--
-- Name: sample_lib; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.sample_lib (
    id bigint NOT NULL,
    name character varying(50) NOT NULL,
    date timestamp with time zone,
    qubit double precision,
    shear_volume double precision,
    qpcr_conc double precision,
    pcr_cycles double precision,
    amount_in double precision,
    amount_final double precision,
    vol_init double precision,
    vol_remain double precision,
    notes text,
    barcode_id text,
    method_id bigint
);


ALTER TABLE public.sample_lib OWNER TO borisbastian;

--
-- Name: sample_lib_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.sample_lib_id_seq
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.sample_lib_id_seq OWNER TO borisbastian;

--
-- Name: sample_lib_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.sample_lib_id_seq OWNED BY public.sample_lib.id;


--
-- Name: area_na_link id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.area_na_link ALTER COLUMN id SET DEFAULT nextval('public.area_na_link_id_seq'::regclass);


--
-- Name: block_area_link id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.block_area_link ALTER COLUMN id SET DEFAULT nextval('public.block_area_link_id_seq'::regclass);


--
-- Name: na_sl_link id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.na_sl_link ALTER COLUMN id SET DEFAULT nextval('public.na_sl_link_id_seq'::regclass);


--
-- Name: nuc_acids nu_id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.nuc_acids ALTER COLUMN nu_id SET DEFAULT nextval('public.nuc_acids_nu_id_seq'::regclass);


--
-- Name: patients pa_id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.patients ALTER COLUMN pa_id SET DEFAULT nextval('public.patients_pa_id_seq'::regclass);


--
-- Name: sample_lib id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.sample_lib ALTER COLUMN id SET DEFAULT nextval('public.sample_lib_id_seq'::regclass);


--
-- Data for Name: area_na_link; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.area_na_link (id, input_vol, input_amount, area_id, nucacid_id, date, area_name, nuc_name) FROM stdin;
122326	\N	\N	2136	\N	\N	2136 	\N
122327	\N	\N	2163	\N	\N	2163 	\N
122328	\N	\N	3903	\N	\N	3903 	\N
122329	\N	\N	3931	\N	\N	3931 	\N
122330	\N	\N	3932	\N	\N	3932 	\N
122331	\N	\N	3934	\N	\N	3934 	\N
122332	\N	\N	3933	\N	\N	3933 	\N
122333	\N	\N	3935	\N	\N	3935 	\N
122334	\N	\N	3937	\N	\N	3937 	\N
122335	\N	\N	3936	\N	\N	3936 	\N
122336	\N	\N	3938	\N	\N	3938 	\N
122592	\N	\N	2178	\N	\N	2178 Normal	\N
122593	\N	\N	2179	\N	\N	2179 Normal	\N
122631	\N	\N	2462	\N	\N	2462 Normal	\N
122681	\N	\N	2666	\N	\N	2666 Normal	\N
122824	\N	\N	3804	\N	\N	3804 Normal	\N
122970	\N	\N	2652	\N	\N	2652 MIS1	\N
122971	\N	\N	2659	\N	\N	2659 MIS1	\N
123003	\N	\N	2653	\N	\N	2653 MIS2	\N
123004	\N	\N	2693	\N	\N	2693 MIS2	\N
123146	\N	\N	2137	\N	\N	2137 Nevus	\N
123163	\N	\N	2239	\N	\N	2239 Nevus	\N
123057	\N	\N	798	29287	\N	798 Nevus	DNA-74
123670	\N	\N	2238	\N	\N	2238 Mel	\N
123714	\N	\N	3914	\N	\N	3914 Mel	"21\n  MEL_RNA"
123794	\N	\N	2637	\N	\N	2637 MIS	\N
123795	\N	\N	2640	\N	\N	2640 MIS	\N
123796	\N	\N	2643	\N	\N	2643 MIS	\N
123797	\N	\N	2646	\N	\N	2646 MIS	\N
123798	\N	\N	2649	\N	\N	2649 MIS	\N
123799	\N	\N	2656	\N	\N	2656 MIS	\N
123800	\N	\N	2662	\N	\N	2662 MIS	\N
123801	\N	\N	2665	\N	\N	2665 MIS	\N
123802	\N	\N	2668	\N	\N	2668 MIS	\N
123803	\N	\N	2671	\N	\N	2671 MIS	\N
123804	\N	\N	2674	\N	\N	2674 MIS	\N
123805	\N	\N	2677	\N	\N	2677 MIS	\N
123806	\N	\N	2681	\N	\N	2681 MIS	\N
124114	\N	\N	2458	\N	\N	2458 Normal 2	\N
124128	\N	\N	397	27891	\N	397 Mel 1	AM2 D-149
124503	\N	\N	2304	\N	\N	2304 Tumor	\N
124506	\N	\N	2330	\N	\N	2330 Tumor	\N
124508	\N	\N	2331	\N	\N	2331 Tumor	\N
124509	\N	\N	2332	\N	\N	2332 Tumor	\N
124510	\N	\N	2334	\N	\N	2334 Tumor	\N
124511	\N	\N	2333	\N	\N	2333 Tumor	\N
124512	\N	\N	2335	\N	\N	2335 Tumor	\N
124567	\N	\N	2767	\N	\N	2767 Tumor	\N
124584	\N	\N	2792	\N	\N	2792 Tumor	\N
124608	\N	\N	2864	\N	\N	2864 Tumor	\N
124609	\N	\N	2883	\N	\N	2883 Tumor	\N
124610	\N	\N	2884	\N	\N	2884 Tumor	\N
124611	\N	\N	2886	\N	\N	2886 Tumor	\N
124612	\N	\N	2885	\N	\N	2885 Tumor	\N
124928	\N	\N	3805	\N	\N	3805 Tumor	\N
124933	\N	\N	3842	\N	\N	3842 Tumor	\N
125061	\N	\N	2824	\N	\N	2824 MM	\N
125259	\N	\N	2018	\N	\N	2018 Invasive Melanoma	\N
125260	\N	\N	2019	\N	\N	2019 Invasive Melanoma	\N
125261	\N	\N	2020	\N	\N	2020 Invasive Melanoma	\N
125376	\N	\N	2636	\N	\N	2636 Invasive	\N
125377	\N	\N	2639	\N	\N	2639 Invasive	\N
125378	\N	\N	2642	\N	\N	2642 Invasive	\N
125379	\N	\N	2645	\N	\N	2645 Invasive	\N
125380	\N	\N	2648	\N	\N	2648 Invasive	\N
125381	\N	\N	2651	\N	\N	2651 Invasive	\N
125382	\N	\N	2655	\N	\N	2655 Invasive	\N
125383	\N	\N	2658	\N	\N	2658 Invasive	\N
125384	\N	\N	2661	\N	\N	2661 Invasive	\N
125385	\N	\N	2664	\N	\N	2664 Invasive	\N
125386	\N	\N	2667	\N	\N	2667 Invasive	\N
125387	\N	\N	2670	\N	\N	2670 Invasive	\N
125388	\N	\N	2673	\N	\N	2673 Invasive	\N
125389	\N	\N	2676	\N	\N	2676 Invasive	\N
125390	\N	\N	2680	\N	\N	2680 Invasive	\N
125391	\N	\N	2689	\N	\N	2689 Invasive	\N
125392	\N	\N	2688	\N	\N	2688 Invasive	\N
125393	\N	\N	2690	\N	\N	2690 Invasive	\N
125394	\N	\N	2691	\N	\N	2691 Invasive	\N
125395	\N	\N	2692	\N	\N	2692 Invasive	\N
125508	\N	\N	2679	\N	\N	2679  (+) Lymph Node	\N
125525	\N	\N	3448	\N	\N	3448 Waiting Process	\N
125526	\N	\N	3527	\N	\N	3527 Waiting Process	\N
125527	\N	\N	3528	\N	\N	3528 Waiting Process	\N
125528	\N	\N	3529	\N	\N	3529 Waiting Process	\N
125529	\N	\N	3530	\N	\N	3530 Waiting Process	\N
125530	\N	\N	3531	\N	\N	3531 Waiting Process	\N
125531	\N	\N	3532	\N	\N	3532 Waiting Process	\N
125532	\N	\N	3533	\N	\N	3533 Waiting Process	\N
125533	\N	\N	3534	\N	\N	3534 Waiting Process	\N
125534	\N	\N	3535	\N	\N	3535 Waiting Process	\N
125535	\N	\N	3536	\N	\N	3536 Waiting Process	\N
125536	\N	\N	3537	\N	\N	3537 Waiting Process	\N
125537	\N	\N	3538	\N	\N	3538 Waiting Process	\N
125538	\N	\N	3539	\N	\N	3539 Waiting Process	\N
125539	\N	\N	3540	\N	\N	3540 Waiting Process	\N
125540	\N	\N	3541	\N	\N	3541 Waiting Process	\N
125541	\N	\N	3542	\N	\N	3542 Waiting Process	\N
125542	\N	\N	3543	\N	\N	3543 Waiting Process	\N
125543	\N	\N	3544	\N	\N	3544 Waiting Process	\N
125544	\N	\N	3546	\N	\N	3546 Waiting Process	\N
125545	\N	\N	3545	\N	\N	3545 Waiting Process	\N
125546	\N	\N	3547	\N	\N	3547 Waiting Process	\N
125547	\N	\N	3549	\N	\N	3549 Waiting Process	\N
125548	\N	\N	3548	\N	\N	3548 Waiting Process	\N
125549	\N	\N	3551	\N	\N	3551 Waiting Process	\N
125550	\N	\N	3550	\N	\N	3550 Waiting Process	\N
125551	\N	\N	3552	\N	\N	3552 Waiting Process	\N
125552	\N	\N	3554	\N	\N	3554 Waiting Process	\N
125553	\N	\N	3553	\N	\N	3553 Waiting Process	\N
125554	\N	\N	3555	\N	\N	3555 Waiting Process	\N
125555	\N	\N	3556	\N	\N	3556 Waiting Process	\N
125556	\N	\N	3557	\N	\N	3557 Waiting Process	\N
125557	\N	\N	3558	\N	\N	3558 Waiting Process	\N
125558	\N	\N	3559	\N	\N	3559 Waiting Process	\N
125559	\N	\N	3560	\N	\N	3560 Waiting Process	\N
125560	\N	\N	3561	\N	\N	3561 Waiting Process	\N
125561	\N	\N	3562	\N	\N	3562 Waiting Process	\N
125562	\N	\N	3564	\N	\N	3564 Waiting Process	\N
125563	\N	\N	3563	\N	\N	3563 Waiting Process	\N
125564	\N	\N	3565	\N	\N	3565 Waiting Process	\N
125565	\N	\N	3566	\N	\N	3566 Waiting Process	\N
125566	\N	\N	3567	\N	\N	3567 Waiting Process	\N
125567	\N	\N	3568	\N	\N	3568 Waiting Process	\N
125568	\N	\N	3569	\N	\N	3569 Waiting Process	\N
125569	\N	\N	3570	\N	\N	3570 Waiting Process	\N
125570	\N	\N	3571	\N	\N	3571 Waiting Process	\N
125571	\N	\N	3573	\N	\N	3573 Waiting Process	\N
125572	\N	\N	3572	\N	\N	3572 Waiting Process	\N
125573	\N	\N	3574	\N	\N	3574 Waiting Process	\N
125574	\N	\N	3576	\N	\N	3576 Waiting Process	\N
125575	\N	\N	3575	\N	\N	3575 Waiting Process	\N
125576	\N	\N	3577	\N	\N	3577 Waiting Process	\N
125577	\N	\N	3578	\N	\N	3578 Waiting Process	\N
125578	\N	\N	3579	\N	\N	3579 Waiting Process	\N
125579	\N	\N	3581	\N	\N	3581 Waiting Process	\N
125580	\N	\N	3580	\N	\N	3580 Waiting Process	\N
125581	\N	\N	3582	\N	\N	3582 Waiting Process	\N
125582	\N	\N	3583	\N	\N	3583 Waiting Process	\N
125583	\N	\N	3584	\N	\N	3584 Waiting Process	\N
125584	\N	\N	3586	\N	\N	3586 Waiting Process	\N
125585	\N	\N	3585	\N	\N	3585 Waiting Process	\N
125586	\N	\N	3588	\N	\N	3588 Waiting Process	\N
125587	\N	\N	3587	\N	\N	3587 Waiting Process	\N
125588	\N	\N	3589	\N	\N	3589 Waiting Process	\N
125589	\N	\N	3590	\N	\N	3590 Waiting Process	\N
125590	\N	\N	3591	\N	\N	3591 Waiting Process	\N
125591	\N	\N	3593	\N	\N	3593 Waiting Process	\N
125592	\N	\N	3592	\N	\N	3592 Waiting Process	\N
125593	\N	\N	3594	\N	\N	3594 Waiting Process	\N
125594	\N	\N	3595	\N	\N	3595 Waiting Process	\N
125595	\N	\N	3596	\N	\N	3596 Waiting Process	\N
125596	\N	\N	3597	\N	\N	3597 Waiting Process	\N
125597	\N	\N	3598	\N	\N	3598 Waiting Process	\N
125598	\N	\N	3599	\N	\N	3599 Waiting Process	\N
125599	\N	\N	3600	\N	\N	3600 Waiting Process	\N
125600	\N	\N	3602	\N	\N	3602 Waiting Process	\N
125601	\N	\N	3601	\N	\N	3601 Waiting Process	\N
125602	\N	\N	3603	\N	\N	3603 Waiting Process	\N
125603	\N	\N	3605	\N	\N	3605 Waiting Process	\N
125604	\N	\N	3604	\N	\N	3604 Waiting Process	\N
125605	\N	\N	3607	\N	\N	3607 Waiting Process	\N
125606	\N	\N	3606	\N	\N	3606 Waiting Process	\N
125607	\N	\N	3609	\N	\N	3609 Waiting Process	\N
125608	\N	\N	3608	\N	\N	3608 Waiting Process	\N
125609	\N	\N	3610	\N	\N	3610 Waiting Process	\N
125610	\N	\N	3611	\N	\N	3611 Waiting Process	\N
125611	\N	\N	3612	\N	\N	3612 Waiting Process	\N
125612	\N	\N	3613	\N	\N	3613 Waiting Process	\N
125613	\N	\N	3615	\N	\N	3615 Waiting Process	\N
125614	\N	\N	3614	\N	\N	3614 Waiting Process	\N
125615	\N	\N	3617	\N	\N	3617 Waiting Process	\N
125616	\N	\N	3616	\N	\N	3616 Waiting Process	\N
125617	\N	\N	3618	\N	\N	3618 Waiting Process	\N
125618	\N	\N	3619	\N	\N	3619 Waiting Process	\N
125619	\N	\N	3620	\N	\N	3620 Waiting Process	\N
125620	\N	\N	3622	\N	\N	3622 Waiting Process	\N
125621	\N	\N	3621	\N	\N	3621 Waiting Process	\N
125622	\N	\N	3623	\N	\N	3623 Waiting Process	\N
125623	\N	\N	3624	\N	\N	3624 Waiting Process	\N
125624	\N	\N	3625	\N	\N	3625 Waiting Process	\N
125625	\N	\N	3627	\N	\N	3627 Waiting Process	\N
125626	\N	\N	3626	\N	\N	3626 Waiting Process	\N
125627	\N	\N	3628	\N	\N	3628 Waiting Process	\N
125628	\N	\N	3630	\N	\N	3630 Waiting Process	\N
125629	\N	\N	3629	\N	\N	3629 Waiting Process	\N
125630	\N	\N	3631	\N	\N	3631 Waiting Process	\N
125631	\N	\N	3632	\N	\N	3632 Waiting Process	\N
125632	\N	\N	3635	\N	\N	3635 Waiting Process	\N
125633	\N	\N	3633	\N	\N	3633 Waiting Process	\N
125634	\N	\N	3634	\N	\N	3634 Waiting Process	\N
125635	\N	\N	3636	\N	\N	3636 Waiting Process	\N
125636	\N	\N	3637	\N	\N	3637 Waiting Process	\N
125637	\N	\N	3639	\N	\N	3639 Waiting Process	\N
125638	\N	\N	3638	\N	\N	3638 Waiting Process	\N
125639	\N	\N	3640	\N	\N	3640 Waiting Process	\N
125640	\N	\N	3642	\N	\N	3642 Waiting Process	\N
125641	\N	\N	3641	\N	\N	3641 Waiting Process	\N
125642	\N	\N	3644	\N	\N	3644 Waiting Process	\N
125643	\N	\N	3643	\N	\N	3643 Waiting Process	\N
125644	\N	\N	3645	\N	\N	3645 Waiting Process	\N
125645	\N	\N	3646	\N	\N	3646 Waiting Process	\N
125646	\N	\N	3647	\N	\N	3647 Waiting Process	\N
125647	\N	\N	3648	\N	\N	3648 Waiting Process	\N
125648	\N	\N	3649	\N	\N	3649 Waiting Process	\N
125649	\N	\N	3650	\N	\N	3650 Waiting Process	\N
125650	\N	\N	3651	\N	\N	3651 Waiting Process	\N
125651	\N	\N	3652	\N	\N	3652 Waiting Process	\N
125652	\N	\N	3653	\N	\N	3653 Waiting Process	\N
125653	\N	\N	3654	\N	\N	3654 Waiting Process	\N
125654	\N	\N	3655	\N	\N	3655 Waiting Process	\N
125655	\N	\N	3656	\N	\N	3656 Waiting Process	\N
125656	\N	\N	3657	\N	\N	3657 Waiting Process	\N
125657	\N	\N	3659	\N	\N	3659 Waiting Process	\N
125658	\N	\N	3658	\N	\N	3658 Waiting Process	\N
125659	\N	\N	3660	\N	\N	3660 Waiting Process	\N
125660	\N	\N	3661	\N	\N	3661 Waiting Process	\N
125661	\N	\N	3662	\N	\N	3662 Waiting Process	\N
125662	\N	\N	3663	\N	\N	3663 Waiting Process	\N
125663	\N	\N	3664	\N	\N	3664 Waiting Process	\N
125664	\N	\N	3665	\N	\N	3665 Waiting Process	\N
125665	\N	\N	3666	\N	\N	3666 Waiting Process	\N
125666	\N	\N	3667	\N	\N	3667 Waiting Process	\N
125667	\N	\N	3668	\N	\N	3668 Waiting Process	\N
125668	\N	\N	3669	\N	\N	3669 Waiting Process	\N
125669	\N	\N	3670	\N	\N	3670 Waiting Process	\N
125670	\N	\N	3671	\N	\N	3671 Waiting Process	\N
125671	\N	\N	3672	\N	\N	3672 Waiting Process	\N
125672	\N	\N	3673	\N	\N	3673 Waiting Process	\N
125673	\N	\N	3674	\N	\N	3674 Waiting Process	\N
125674	\N	\N	3675	\N	\N	3675 Waiting Process	\N
125675	\N	\N	3676	\N	\N	3676 Waiting Process	\N
125676	\N	\N	3678	\N	\N	3678 Waiting Process	\N
125677	\N	\N	3677	\N	\N	3677 Waiting Process	\N
125678	\N	\N	3679	\N	\N	3679 Waiting Process	\N
125679	\N	\N	2907	\N	\N	2907 NAN	\N
125680	\N	\N	2151	\N	\N	2151 Unknown	\N
125681	\N	\N	2152	\N	\N	2152 Unknown	\N
125682	\N	\N	2164	\N	\N	2164 Unknown	\N
125683	\N	\N	2165	\N	\N	2165 Unknown	\N
125684	\N	\N	2168	\N	\N	2168 Unknown	\N
125685	\N	\N	2171	\N	\N	2171 Unknown	\N
125686	\N	\N	2172	\N	\N	2172 Unknown	\N
125687	\N	\N	2173	\N	\N	2173 Unknown	\N
125688	\N	\N	2174	\N	\N	2174 Unknown	\N
125689	\N	\N	2176	\N	\N	2176 Unknown	\N
125690	\N	\N	2177	\N	\N	2177 Unknown	\N
125692	\N	\N	2857	\N	\N	2857 Unknown	\N
125727	\N	\N	3680	\N	\N	3680 Unknown	\N
125728	\N	\N	3681	\N	\N	3681 Unknown	\N
125729	\N	\N	3902	\N	\N	3902 Unknown	\N
125730	\N	\N	2134	\N	\N	2134 Not Processed	\N
125731	\N	\N	2135	\N	\N	2135 Not Processed	\N
125732	\N	\N	2138	\N	\N	2138 Not Processed	\N
125733	\N	\N	2139	\N	\N	2139 Not Processed	\N
125734	\N	\N	2140	\N	\N	2140 Not Processed	\N
125735	\N	\N	2142	\N	\N	2142 Not Processed	\N
125736	\N	\N	2143	\N	\N	2143 Not Processed	\N
125737	\N	\N	2144	\N	\N	2144 Not Processed	\N
125738	\N	\N	2145	\N	\N	2145 Not Processed	\N
125739	\N	\N	2146	\N	\N	2146 Not Processed	\N
125740	\N	\N	2147	\N	\N	2147 Not Processed	\N
125741	\N	\N	2148	\N	\N	2148 Not Processed	\N
125742	\N	\N	2149	\N	\N	2149 Not Processed	\N
125743	\N	\N	2902	\N	\N	2902 Not Processed	\N
125745	\N	\N	3451	\N	\N	3451 Not Processed	\N
125746	\N	\N	3452	\N	\N	3452 Not Processed	\N
125747	\N	\N	3455	\N	\N	3455 Not Processed	\N
125748	\N	\N	3526	\N	\N	3526 Not Processed	\N
125749	\N	\N	3682	\N	\N	3682 Not Processed	\N
125750	\N	\N	3683	\N	\N	3683 Not Processed	\N
125751	\N	\N	3684	\N	\N	3684 Not Processed	\N
125752	\N	\N	3685	\N	\N	3685 Not Processed	\N
125753	\N	\N	3686	\N	\N	3686 Not Processed	\N
125754	\N	\N	3687	\N	\N	3687 Not Processed	\N
125755	\N	\N	3688	\N	\N	3688 Not Processed	\N
125756	\N	\N	3689	\N	\N	3689 Not Processed	\N
125757	\N	\N	3690	\N	\N	3690 Not Processed	\N
125758	\N	\N	3691	\N	\N	3691 Not Processed	\N
125759	\N	\N	3692	\N	\N	3692 Not Processed	\N
125760	\N	\N	3693	\N	\N	3693 Not Processed	\N
125761	\N	\N	3694	\N	\N	3694 Not Processed	\N
125762	\N	\N	3695	\N	\N	3695 Not Processed	\N
125763	\N	\N	3696	\N	\N	3696 Not Processed	\N
125764	\N	\N	3697	\N	\N	3697 Not Processed	\N
125765	\N	\N	3698	\N	\N	3698 Not Processed	\N
125766	\N	\N	3700	\N	\N	3700 Not Processed	\N
125767	\N	\N	3699	\N	\N	3699 Not Processed	\N
125768	\N	\N	3701	\N	\N	3701 Not Processed	\N
125769	\N	\N	3702	\N	\N	3702 Not Processed	\N
125770	\N	\N	3704	\N	\N	3704 Not Processed	\N
125771	\N	\N	3703	\N	\N	3703 Not Processed	\N
125772	\N	\N	3705	\N	\N	3705 Not Processed	\N
125773	\N	\N	3706	\N	\N	3706 Not Processed	\N
125774	\N	\N	3708	\N	\N	3708 Not Processed	\N
125775	\N	\N	3707	\N	\N	3707 Not Processed	\N
125776	\N	\N	3709	\N	\N	3709 Not Processed	\N
125777	\N	\N	3710	\N	\N	3710 Not Processed	\N
125778	\N	\N	3712	\N	\N	3712 Not Processed	\N
125779	\N	\N	3711	\N	\N	3711 Not Processed	\N
125780	\N	\N	3713	\N	\N	3713 Not Processed	\N
125781	\N	\N	3714	\N	\N	3714 Not Processed	\N
125782	\N	\N	3716	\N	\N	3716 Not Processed	\N
125783	\N	\N	3715	\N	\N	3715 Not Processed	\N
125784	\N	\N	3717	\N	\N	3717 Not Processed	\N
125785	\N	\N	3718	\N	\N	3718 Not Processed	\N
125786	\N	\N	3719	\N	\N	3719 Not Processed	\N
125787	\N	\N	3720	\N	\N	3720 Not Processed	\N
125788	\N	\N	3721	\N	\N	3721 Not Processed	\N
125789	\N	\N	3723	\N	\N	3723 Not Processed	\N
125790	\N	\N	3722	\N	\N	3722 Not Processed	\N
125791	\N	\N	3724	\N	\N	3724 Not Processed	\N
125792	\N	\N	3725	\N	\N	3725 Not Processed	\N
125793	\N	\N	3726	\N	\N	3726 Not Processed	\N
125794	\N	\N	3727	\N	\N	3727 Not Processed	\N
125795	\N	\N	3729	\N	\N	3729 Not Processed	\N
125796	\N	\N	3728	\N	\N	3728 Not Processed	\N
125797	\N	\N	3731	\N	\N	3731 Not Processed	\N
125798	\N	\N	3730	\N	\N	3730 Not Processed	\N
125799	\N	\N	3733	\N	\N	3733 Not Processed	\N
125800	\N	\N	3732	\N	\N	3732 Not Processed	\N
125801	\N	\N	3734	\N	\N	3734 Not Processed	\N
125802	\N	\N	3735	\N	\N	3735 Not Processed	\N
125803	\N	\N	3736	\N	\N	3736 Not Processed	\N
125804	\N	\N	3738	\N	\N	3738 Not Processed	\N
125805	\N	\N	3737	\N	\N	3737 Not Processed	\N
125806	\N	\N	3739	\N	\N	3739 Not Processed	\N
125807	\N	\N	3741	\N	\N	3741 Not Processed	\N
125808	\N	\N	3740	\N	\N	3740 Not Processed	\N
125809	\N	\N	3742	\N	\N	3742 Not Processed	\N
125810	\N	\N	3743	\N	\N	3743 Not Processed	\N
125811	\N	\N	3745	\N	\N	3745 Not Processed	\N
125812	\N	\N	3744	\N	\N	3744 Not Processed	\N
125813	\N	\N	3746	\N	\N	3746 Not Processed	\N
125814	\N	\N	3747	\N	\N	3747 Not Processed	\N
125815	\N	\N	3748	\N	\N	3748 Not Processed	\N
125816	\N	\N	3749	\N	\N	3749 Not Processed	\N
125817	\N	\N	3751	\N	\N	3751 Not Processed	\N
125818	\N	\N	3750	\N	\N	3750 Not Processed	\N
125819	\N	\N	3752	\N	\N	3752 Not Processed	\N
125820	\N	\N	3753	\N	\N	3753 Not Processed	\N
125821	\N	\N	3754	\N	\N	3754 Not Processed	\N
125822	\N	\N	3755	\N	\N	3755 Not Processed	\N
125823	\N	\N	3757	\N	\N	3757 Not Processed	\N
125824	\N	\N	3756	\N	\N	3756 Not Processed	\N
125825	\N	\N	3758	\N	\N	3758 Not Processed	\N
125826	\N	\N	3759	\N	\N	3759 Not Processed	\N
125827	\N	\N	3760	\N	\N	3760 Not Processed	\N
125828	\N	\N	3761	\N	\N	3761 Not Processed	\N
125829	\N	\N	3762	\N	\N	3762 Not Processed	\N
125830	\N	\N	3764	\N	\N	3764 Not Processed	\N
125831	\N	\N	3763	\N	\N	3763 Not Processed	\N
125832	\N	\N	3765	\N	\N	3765 Not Processed	\N
125833	\N	\N	3766	\N	\N	3766 Not Processed	\N
125834	\N	\N	3767	\N	\N	3767 Not Processed	\N
125835	\N	\N	3768	\N	\N	3768 Not Processed	\N
125836	\N	\N	3769	\N	\N	3769 Not Processed	\N
125837	\N	\N	3770	\N	\N	3770 Not Processed	\N
125838	\N	\N	3772	\N	\N	3772 Not Processed	\N
125839	\N	\N	3771	\N	\N	3771 Not Processed	\N
125840	\N	\N	3773	\N	\N	3773 Not Processed	\N
125841	\N	\N	3774	\N	\N	3774 Not Processed	\N
125842	\N	\N	3775	\N	\N	3775 Not Processed	\N
125843	\N	\N	3776	\N	\N	3776 Not Processed	\N
125844	\N	\N	3777	\N	\N	3777 Not Processed	\N
125845	\N	\N	3778	\N	\N	3778 Not Processed	\N
125846	\N	\N	3779	\N	\N	3779 Not Processed	\N
125847	\N	\N	3780	\N	\N	3780 Not Processed	\N
125848	\N	\N	3781	\N	\N	3781 Not Processed	\N
125849	\N	\N	3782	\N	\N	3782 Not Processed	\N
125850	\N	\N	3784	\N	\N	3784 Not Processed	\N
125851	\N	\N	3783	\N	\N	3783 Not Processed	\N
125852	\N	\N	3785	\N	\N	3785 Not Processed	\N
125853	\N	\N	3786	\N	\N	3786 Not Processed	\N
125854	\N	\N	3787	\N	\N	3787 Not Processed	\N
125855	\N	\N	3788	\N	\N	3788 Not Processed	\N
125856	\N	\N	3789	\N	\N	3789 Not Processed	\N
125857	\N	\N	3790	\N	\N	3790 Not Processed	\N
125858	\N	\N	3791	\N	\N	3791 Not Processed	\N
125859	\N	\N	3793	\N	\N	3793 Not Processed	\N
125860	\N	\N	3792	\N	\N	3792 Not Processed	\N
125861	\N	\N	3795	\N	\N	3795 Not Processed	\N
125862	\N	\N	3794	\N	\N	3794 Not Processed	\N
125863	\N	\N	3796	\N	\N	3796 Not Processed	\N
125864	\N	\N	3797	\N	\N	3797 Not Processed	\N
125865	\N	\N	3799	\N	\N	3799 Not Processed	\N
125866	\N	\N	3798	\N	\N	3798 Not Processed	\N
125867	\N	\N	3800	\N	\N	3800 Not Processed	\N
125868	\N	\N	3826	\N	\N	3826 Not Processed	\N
125869	\N	\N	3827	\N	\N	3827 Not Processed	\N
125870	\N	\N	3828	\N	\N	3828 Not Processed	\N
125871	\N	\N	3829	\N	\N	3829 Not Processed	\N
125872	\N	\N	3832	\N	\N	3832 Not Processed	\N
125873	\N	\N	3833	\N	\N	3833 Not Processed	\N
125874	\N	\N	3834	\N	\N	3834 Not Processed	\N
125875	\N	\N	3835	\N	\N	3835 Not Processed	\N
125876	\N	\N	3857	\N	\N	3857 Not Processed	\N
125889	\N	\N	3830	\N	\N	3830 Single Cell Gene Expression	\N
125890	\N	\N	3831	\N	\N	3831 Single Cell Gene Expression	\N
122430	\N	\N	1507	28014	\N	1507 Normal	AM2 D-281
127522	\N	\N	10000	32360	\N	12-6261A_Tumor	NA_12-6261A_Tumor
122337	\N	\N	1	27841	\N	1 Normal	AM2 D-100
122340	\N	\N	12	27778	\N	12 Normal	AM2 D-37
122341	\N	\N	15	27781	\N	15 Normal	AM2 D-40
122342	\N	\N	20	27786	\N	20 Normal	AM2 D-45
122343	\N	\N	22	27788	\N	22 Normal	AM2 D-47
122344	\N	\N	25	27790	\N	25 Normal	AM2 D-49
122345	\N	\N	28	27793	\N	28 Normal	AM2 D-52
122346	\N	\N	31	27796	\N	31 Normal	AM2 D-55
122347	\N	\N	35	27800	\N	35 Normal	AM2 D-59
122348	\N	\N	38	27803	\N	38 Normal	AM2 D-62
122349	\N	\N	42	27807	\N	42 Normal	AM2 D-66
122350	\N	\N	46	27811	\N	46 Normal	AM2 D-70
122351	\N	\N	49	27742	\N	49 Normal	AM2 D-01
122352	\N	\N	52	27745	\N	52 Normal	AM2 D-04
122353	\N	\N	58	27751	\N	58 Normal	AM2 D-10
122354	\N	\N	62	27755	\N	62 Normal	AM2 D-14
122357	\N	\N	72	27765	\N	72 Normal	AM2 D-24
122358	\N	\N	78	27771	\N	78 Normal	AM2 D-30
122359	\N	\N	82	27775	\N	82 Normal	AM2 D-34
122360	\N	\N	85	27815	\N	85 Normal	AM2 D-74
122361	\N	\N	89	27819	\N	89 Normal	AM2 D-78
122362	\N	\N	92	27822	\N	92 Normal	AM2 D-81
122363	\N	\N	97	27828	\N	97 Normal	AM2 D-87
122364	\N	\N	103	27834	\N	103 Normal	AM2 D-93
122374	\N	\N	729	28945	\N	729 Normal	D-NA-8691
122381	\N	\N	804	29296	\N	804 Normal	DNA-83
122382	\N	\N	883	28854	\N	883 Normal	CM D-68
122385	\N	\N	980	28855	\N	980 Normal	CM D-69
122386	\N	\N	981	28856	\N	981 Normal	CM D-70
122387	\N	\N	983	28858	\N	983 Normal	CM D-72
122388	\N	\N	984	28859	\N	984 Normal	CM D-73
122389	\N	\N	982	28857	\N	982 Normal	CM D-71
122390	\N	\N	986	28861	\N	986 Normal	CM D-75
122391	\N	\N	987	28862	\N	987 Normal	CM D-76
122392	\N	\N	985	28860	\N	985 Normal	CM D-74
122393	\N	\N	988	28863	\N	988 Normal	CM D-77
122394	\N	\N	989	28864	\N	989 Normal	CM D-78
122395	\N	\N	990	28865	\N	990 Normal	CM D-79
122396	\N	\N	991	28866	\N	991 Normal	CM D-80
122397	\N	\N	992	28867	\N	992 Normal	CM D-81
122398	\N	\N	993	28868	\N	993 Normal	CM D-82
122399	\N	\N	994	28869	\N	994 Normal	CM D-83
122400	\N	\N	995	28870	\N	995 Normal	CM D-84
122401	\N	\N	996	28871	\N	996 Normal	CM D-85
122402	\N	\N	1147	27920	\N	1147 Normal	AM2 D-178
122403	\N	\N	1243	27935	\N	1243 Normal	AM2 D-193
122405	\N	\N	1291	27944	\N	1291 Normal	AM2 D-205
122407	\N	\N	1295	27948	\N	1295 Normal	AM2 D-210
122408	\N	\N	1302	27955	\N	1302 Normal	AM2 D-217
122409	\N	\N	1305	27958	\N	1305 Normal	AM2 D-220
122438	\N	\N	1552	28056	\N	1552 Normal	AM2 D-332
122439	\N	\N	1564	28056	\N	1564 Normal	AM2 D-332
122440	\N	\N	1566	28056	\N	1566 Normal	AM2 D-332
122441	\N	\N	1569	28071	\N	1569 Normal	AM2 D-349
122442	\N	\N	1581	28089	\N	1581 Normal	AM2 D-369
122443	\N	\N	1584	28097	\N	1584 Normal	AM2 D-378
122444	\N	\N	1591	28142	\N	1591 Normal	AM2 D-437
122338	\N	\N	6	27847	\N	6 Normal	AM2 D-105
122339	\N	\N	9	27850	\N	9 Normal	AM2 D-108
122355	\N	\N	65	27758	\N	65 Normal	AM2 D-17
122356	\N	\N	68	27761	\N	68 Normal	AM2 D-20
122365	\N	\N	280	31559	\N	280 Normal	RNA-01
122366	\N	\N	286	31565	\N	286 Normal	RNA-07
122367	\N	\N	302	31581	\N	302 Normal	RNA-23
122368	\N	\N	283	31562	\N	283 Normal	RNA-04
122369	\N	\N	289	31568	\N	289 Normal	RNA-10
122370	\N	\N	304	31583	\N	304 Normal	RNA-25
122371	\N	\N	305	31584	\N	305 Normal	RNA-26
122372	\N	\N	345	31587	\N	345 Normal	RNA-29
122373	\N	\N	354	31596	\N	354 Normal	RNA-38
122375	\N	\N	778	29282	\N	778 Normal	DNA-69
122376	\N	\N	783	29286	\N	783 Normal	DNA-73
122377	\N	\N	786	29285	\N	786 Normal	DNA-72
122378	\N	\N	790	29283	\N	790 Normal	DNA-70
122379	\N	\N	792	29284	\N	792 Normal	DNA-71
122380	\N	\N	797	29281	\N	797 Normal	DNA-68
122383	\N	\N	894	29308	\N	894 Normal	DNA-96
122384	\N	\N	895	29299	\N	895 Normal	DNA-87
122404	\N	\N	1288	27941	\N	1288 Normal	AM2 D-201
122406	\N	\N	1292	27945	\N	1292 Normal	AM2 D-206
122410	\N	\N	1311	31463	\N	1311 Normal	PROG D-01
122411	\N	\N	1422	27963	\N	1422 Normal	AM2 D-225
122412	\N	\N	1425	27987	\N	1425 Normal	AM2 D-253
122413	\N	\N	1430	29310	\N	1430 Normal	DNA-98
122414	\N	\N	1431	29311	\N	1431 Normal	DNA-99
122415	\N	\N	1432	29312	\N	1432 Normal	DNA-100
122416	\N	\N	1433	29313	\N	1433 Normal	DNA-101
122417	\N	\N	1434	29309	\N	1434 Normal	DNA-97
122418	\N	\N	1438	31473	\N	1438 Normal	PROG D-11
122419	\N	\N	1446	29356	\N	1446 Normal	DNA-148
122420	\N	\N	1447	29354	\N	1447 Normal	DNA-146
122421	\N	\N	1448	29357	\N	1448 Normal	DNA-149
122422	\N	\N	1449	29358	\N	1449 Normal	DNA-150
122423	\N	\N	1450	29359	\N	1450 Normal	DNA-151
122424	\N	\N	1451	29355	\N	1451 Normal	DNA-147
122425	\N	\N	1470	27990	\N	1470 Normal	AM2 D-256
122426	\N	\N	1478	27998	\N	1478 Normal	AM2 D-264
122427	\N	\N	1490	28001	\N	1490 Normal	AM2 D-268
122428	\N	\N	1497	28008	\N	1497 Normal	AM2 D-275
122429	\N	\N	1503	28014	\N	1503 Normal	AM2 D-281
122431	\N	\N	1510	28020	\N	1510 Normal	AM2 D-288
122432	\N	\N	1521	28026	\N	1521 Normal	AM2 D-296
122433	\N	\N	1523	28028	\N	1523 Normal	AM2 D-298
122434	\N	\N	1526	28028	\N	1526 Normal	AM2 D-298
122435	\N	\N	1535	28039	\N	1535 Normal	AM2 D-314
122436	\N	\N	1541	28045	\N	1541 Normal	AM2 D-321
122437	\N	\N	1547	28051	\N	1547 Normal	AM2 D-327
127523	\N	\N	10001	32361	\N	12-6261B_Tumor	NA_12-6261B_Tumor
127524	\N	\N	10002	32362	\N	12-12366_Tumor	NA_12-12366_Tumor
127525	\N	\N	10003	32363	\N	12-12467_Tumor	NA_12-12467_Tumor
127526	\N	\N	10004	32364	\N	12-12470D_Tumor	NA_12-12470D_Tumor
127527	\N	\N	10005	32365	\N	12-562_Tumor	NA_12-562_Tumor
127528	\N	\N	10006	32366	\N	12-12647_Tumor	NA_12-12647_Tumor
127529	\N	\N	10007	32367	\N	12-12626_Tumor	NA_12-12626_Tumor
127530	\N	\N	10008	32368	\N	12-13587_Tumor	NA_12-13587_Tumor
127531	\N	\N	10009	32369	\N	12-18438A_Tumor	NA_12-18438A_Tumor
127532	\N	\N	10010	32370	\N	12-13152_Tumor	NA_12-13152_Tumor
127533	\N	\N	10011	32371	\N	12-12750B_Tumor	NA_12-12750B_Tumor
127534	\N	\N	10012	32372	\N	12-19596_Tumor	NA_12-19596_Tumor
122445	\N	\N	1593	28110	\N	1593 Normal	AM2 D-399
127535	\N	\N	10013	32373	\N	12-19187A_Tumor	NA_12-19187A_Tumor
122447	\N	\N	1608	28128	\N	1608 Normal	AM2 D-421
122448	\N	\N	1611	28136	\N	1611 Normal	AM2 D-430
122449	\N	\N	1612	28087	\N	1612 Normal	AM2 D-367
122450	\N	\N	1613	28081	\N	1613 Normal	AM2 D-360
122451	\N	\N	1614	28085	\N	1614 Normal	AM2 D-365
122452	\N	\N	1615	28144	\N	1615 Normal	AM2 D-439
122453	\N	\N	1616	28146	\N	1616 Normal	AM2 D-441
122454	\N	\N	1617	28147	\N	1617 Normal	AM2 D-443
122458	\N	\N	1656	30616	\N	1656 Normal	MMD-36
122459	\N	\N	1659	30619	\N	1659 Normal	MMD-39
122462	\N	\N	1670	30629	\N	1670 Normal	MMD-49
122464	\N	\N	1676	30681	\N	1676 Normal	MMD-103
122466	\N	\N	1683	30655	\N	1683 Normal	MMD-77
122467	\N	\N	1685	30655	\N	1685 Normal	MMD-77
122468	\N	\N	1687	30660	\N	1687 Normal	MMD-82
122469	\N	\N	1690	30665	\N	1690 Normal	MMD-87
122470	\N	\N	1696	30670	\N	1696 Normal	MMD-92
122471	\N	\N	1698	30670	\N	1698 Normal	MMD-92
122472	\N	\N	1702	30677	\N	1702 Normal	MMD-99
122479	\N	\N	1725	30707	\N	1725 Normal	MMD-130
122481	\N	\N	1730	30712	\N	1730 Normal	MMD-135
122484	\N	\N	1738	30834	\N	1738 Normal	MMD-259
122491	\N	\N	1756	30739	\N	1756 Normal	MMD-164
122492	\N	\N	1758	30741	\N	1758 Normal	MMD-166
122494	\N	\N	1763	30746	\N	1763 Normal	MMD-171
122496	\N	\N	1768	30751	\N	1768 Normal	MMD-176
122497	\N	\N	1773	30755	\N	1773 Normal	MMD-180
122498	\N	\N	1776	30758	\N	1776 Normal	MMD-183
122502	\N	\N	1785	30774	\N	1785 Normal	MMD-199
122504	\N	\N	1789	30778	\N	1789 Normal	MMD-203
122508	\N	\N	1797	30878	\N	1797 Normal	MMD-303
122509	\N	\N	1800	30881	\N	1800 Normal	MMD-306
122511	\N	\N	1804	30799	\N	1804 Normal	MMD-224
122512	\N	\N	1806	30801	\N	1806 Normal	MMD-226
122517	\N	\N	1819	30814	\N	1819 Normal	MMD-239
122520	\N	\N	1827	30818	\N	1827 Normal	MMD-243
122521	\N	\N	1829	30820	\N	1829 Normal	MMD-245
122522	\N	\N	1831	30822	\N	1831 Normal	MMD-247
122523	\N	\N	1834	30825	\N	1834 Normal	MMD-250
122524	\N	\N	1836	30827	\N	1836 Normal	MMD-252
122525	\N	\N	1838	30839	\N	1838 Normal	MMD-264
122530	\N	\N	1850	30914	\N	1850 Normal	MMD-339
122555	\N	\N	2041	31312	\N	2041 Normal	NM D-087
122556	\N	\N	2046	31316	\N	2046 Normal	NM D-091
122557	\N	\N	2050	31320	\N	2050 Normal	NM D-095
122558	\N	\N	2054	31324	\N	2054 Normal	NM D-099
122559	\N	\N	2058	28930	\N	2058 Normal	D-NA-620
122560	\N	\N	2062	28924	\N	2062 Normal	D-NA-585
122561	\N	\N	2065	28927	\N	2065 Normal	D-NA-588
122562	\N	\N	2068	28938	\N	2068 Normal	D-NA-628
122563	\N	\N	2072	28909	\N	2072 Normal	D-NA-551
122564	\N	\N	2075	28912	\N	2075 Normal	D-NA-554
122565	\N	\N	2078	28915	\N	2078 Normal	D-NA-557
122455	\N	\N	1624	28170	\N	1624 Normal	AM2 D-467
122456	\N	\N	1649	30609	\N	1649 Normal	MMD-29
122457	\N	\N	1654	30614	\N	1654 Normal	MMD-34
122460	\N	\N	1663	30623	\N	1663 Normal	MMD-43
122461	\N	\N	1668	30627	\N	1668 Normal	MMD-47
122463	\N	\N	1673	30632	\N	1673 Normal	MMD-52
122465	\N	\N	1679	30649	\N	1679 Normal	MMD-71
122473	\N	\N	1705	30690	\N	1705 Normal	MMD-113
122474	\N	\N	1709	30869	\N	1709 Normal	MMD-294
122475	\N	\N	1714	30699	\N	1714 Normal	MMD-122
122476	\N	\N	1718	30702	\N	1718 Normal	MMD-125
122477	\N	\N	1720	30702	\N	1720 Normal	MMD-125
122478	\N	\N	1722	30704	\N	1722 Normal	MMD-127
122480	\N	\N	1728	30795	\N	1728 Normal	MMD-220
122482	\N	\N	1732	30714	\N	1732 Normal	MMD-137
122483	\N	\N	1735	30717	\N	1735 Normal	MMD-142
122485	\N	\N	1739	30720	\N	1739 Normal	MMD-145
122486	\N	\N	1740	30722	\N	1740 Normal	MMD-147
122487	\N	\N	1742	30725	\N	1742 Normal	MMD-150
122488	\N	\N	1745	30727	\N	1745 Normal	MMD-152
122489	\N	\N	1748	30731	\N	1748 Normal	MMD-156
122490	\N	\N	1753	30736	\N	1753 Normal	MMD-161
122493	\N	\N	1760	30743	\N	1760 Normal	MMD-168
122495	\N	\N	1766	30749	\N	1766 Normal	MMD-174
122499	\N	\N	1778	30760	\N	1778 Normal	MMD-185
122500	\N	\N	1781	30763	\N	1781 Normal	MMD-188
122501	\N	\N	1784	30773	\N	1784 Normal	MMD-198
122503	\N	\N	1788	30777	\N	1788 Normal	MMD-202
122505	\N	\N	1791	30853	\N	1791 Normal	MMD-278
122506	\N	\N	1793	30782	\N	1793 Normal	MMD-207
122507	\N	\N	1795	30784	\N	1795 Normal	MMD-209
122510	\N	\N	1802	30797	\N	1802 Normal	MMD-222
122513	\N	\N	1809	30804	\N	1809 Normal	MMD-229
122514	\N	\N	1811	30806	\N	1811 Normal	MMD-231
122515	\N	\N	1813	30808	\N	1813 Normal	MMD-233
122516	\N	\N	1815	30810	\N	1815 Normal	MMD-235
122518	\N	\N	1821	30816	\N	1821 Normal	MMD-241
122519	\N	\N	1824	28137	\N	1824 Normal	AM2 D-431
122526	\N	\N	1840	30904	\N	1840 Normal	MMD-329
122527	\N	\N	1842	30906	\N	1842 Normal	MMD-331
122528	\N	\N	1845	30908	\N	1845 Normal	MMD-333
122529	\N	\N	1848	30912	\N	1848 Normal	MMD-337
122531	\N	\N	1852	31117	\N	1852 Normal	MMR-341
122532	\N	\N	1854	30918	\N	1854 Normal	MMD-343
122533	\N	\N	1856	31121	\N	1856 Normal	MMR-345
122534	\N	\N	1859	30923	\N	1859 Normal	MMD-348
122535	\N	\N	1862	30926	\N	1862 Normal	MMD-351
122536	\N	\N	1864	31129	\N	1864 Normal	MMR-353
122537	\N	\N	1920	29371	\N	1920 Normal	DNA-163
122538	\N	\N	1925	29376	\N	1925 Normal	DNA-168
122539	\N	\N	1929	29380	\N	1929 Normal	DNA-172
122540	\N	\N	1930	29381	\N	1930 Normal	DNA-173
122541	\N	\N	1934	29385	\N	1934 Normal	DNA-177
122542	\N	\N	1937	29388	\N	1937 Normal	DNA-180
122543	\N	\N	1940	29391	\N	1940 Normal	DNA-183
122544	\N	\N	1943	29394	\N	1943 Normal	DNA-186
122545	\N	\N	1946	29397	\N	1946 Normal	DNA-189
122546	\N	\N	1949	29400	\N	1949 Normal	DNA-192
122547	\N	\N	1950	29401	\N	1950 Normal	DNA-193
122548	\N	\N	1953	29404	\N	1953 Normal	DNA-196
122549	\N	\N	1955	29406	\N	1955 Normal	DNA-198
122550	\N	\N	1957	29467	\N	1957 Normal	DNA-261
122551	\N	\N	1956	29409	\N	1956 Normal	DNA-201
122552	\N	\N	1958	29464	\N	1958 Normal	DNA-258
122553	\N	\N	2036	29465	\N	2036 Normal	DNA-259
122554	\N	\N	2037	29466	\N	2037 Normal	DNA-260
127536	\N	\N	10014	32374	\N	12-22172_Normal	NA_12-22172_Normal
127537	\N	\N	10015	32375	\N	12-22172_Tumor	NA_12-22172_Tumor
127538	\N	\N	10016	32376	\N	12-21726A_Tumor	NA_12-21726A_Tumor
127539	\N	\N	10017	32377	\N	12-22901A_Normal	NA_12-22901A_Normal
127540	\N	\N	10018	32378	\N	12-22901A_Tumor	NA_12-22901A_Tumor
127541	\N	\N	10019	32379	\N	12-22776_Normal	NA_12-22776_Normal
127542	\N	\N	10020	32380	\N	BuffyCoat_Tumor	NA_BuffyCoat_Tumor
127543	\N	\N	10021	32381	\N	12-13587B2_Tumor	NA_12-13587B2_Tumor
122566	\N	\N	2081	28942	\N	2081 Normal	D-NA-645
122567	\N	\N	2084	28918	\N	2084 Normal	D-NA-560
127544	\N	\N	10022	32381	\N	12-13587B2_Tumor	NA_12-13587B2_Tumor
122569	\N	\N	2090	28894	\N	2090 Normal	D-NA-536
122570	\N	\N	2093	28897	\N	2093 Normal	D-NA-539
122571	\N	\N	2096	28903	\N	2096 Normal	D-NA-545
122572	\N	\N	2099	28906	\N	2099 Normal	D-NA-548
122573	\N	\N	2102	28900	\N	2102 Normal	D-NA-542
122574	\N	\N	2105	28934	\N	2105 Normal	D-NA-624
122575	\N	\N	2110	29480	\N	2110 Normal	DNA-274
122580	\N	\N	2126	29496	\N	2126 Normal	DNA-290
122581	\N	\N	2127	29508	\N	2127 Normal	DNA-302
122583	\N	\N	2150	27679	\N	2150 Normal	24-5_NA
122584	\N	\N	2153	28750	\N	2153 Normal	CGP-1481_NA
122585	\N	\N	2158	28753	\N	2158 Normal	CGP-1544_NA
122586	\N	\N	2159	28756	\N	2159 Normal	CGP-1547_NA
122587	\N	\N	2160	28762	\N	2160 Normal	CGP-1553_NA
122588	\N	\N	2161	28768	\N	2161 Normal	CGP-1559_NA
122589	\N	\N	2162	28771	\N	2162 Normal	CGP-1575_NA
122590	\N	\N	2166	28765	\N	2166 Normal	CGP-1556_NA
122591	\N	\N	2170	28759	\N	2170 Normal	CGP-1550_NA
122594	\N	\N	2183	29530	\N	2183 Normal	DNA-333
122595	\N	\N	2186	29533	\N	2186 Normal	DNA-336
122597	\N	\N	2192	29539	\N	2192 Normal	DNA-342
122598	\N	\N	2195	29542	\N	2195 Normal	DNA-347
122599	\N	\N	2199	29546	\N	2199 Normal	DNA-353
122600	\N	\N	2203	29550	\N	2203 Normal	DNA-358
122601	\N	\N	2206	29553	\N	2206 Normal	DNA-363
122602	\N	\N	2210	29557	\N	2210 Normal	DNA-367
122603	\N	\N	2214	29561	\N	2214 Normal	DNA-374
122604	\N	\N	2218	29565	\N	2218 Normal	DNA-382
122606	\N	\N	2226	29573	\N	2226 Normal	DNA-393
122609	\N	\N	2236	29583	\N	2236 Normal	DNA-407
122610	\N	\N	2240	31819	\N	2240 Normal	RNA-347
122614	\N	\N	2259	31189	\N	2259 Normal	N-1
122615	\N	\N	2261	31191	\N	2261 Normal	N-3
122616	\N	\N	2260	31190	\N	2260 Normal	N-2
122617	\N	\N	2262	31192	\N	2262 Normal	N-4
122623	\N	\N	2419	28972	\N	2419 Normal	D41_NA
122624	\N	\N	2414	28968	\N	2414 Normal	D35_NA
122625	\N	\N	2417	28970	\N	2417 Normal	D39_NA
122643	\N	\N	2508	29971	\N	2508 Normal	LMM D-027
122644	\N	\N	2511	29974	\N	2511 Normal	LMM D-030
122645	\N	\N	2514	29977	\N	2514 Normal	LMM D-033
122646	\N	\N	2517	29980	\N	2517 Normal	LMM D-036
122647	\N	\N	2520	29983	\N	2520 Normal	LMM D-039
122648	\N	\N	2523	29986	\N	2523 Normal	LMM D-042
122649	\N	\N	2526	29989	\N	2526 Normal	LMM D-045
122650	\N	\N	2527	29785	\N	2527 Normal	KA D-01
122651	\N	\N	2529	29787	\N	2529 Normal	KA D-03
122652	\N	\N	2531	29789	\N	2531 Normal	KA D-05
122653	\N	\N	2533	29791	\N	2533 Normal	KA D-07
122654	\N	\N	2535	29793	\N	2535 Normal	KA D-09
122655	\N	\N	2537	29795	\N	2537 Normal	KA D-11
122656	\N	\N	2539	29797	\N	2539 Normal	KA D-13
122657	\N	\N	2541	29799	\N	2541 Normal	KA D-15
122658	\N	\N	2543	29801	\N	2543 Normal	KA D-17
122659	\N	\N	2548	29806	\N	2548 Normal	KA D-22
122660	\N	\N	2550	29808	\N	2550 Normal	KA D-24
122661	\N	\N	2553	29811	\N	2553 Normal	KA D-27
122662	\N	\N	2555	29813	\N	2555 Normal	KA D-29
122663	\N	\N	2557	29815	\N	2557 Normal	KA D-31
122664	\N	\N	2559	29817	\N	2559 Normal	KA D-33
122665	\N	\N	2562	29820	\N	2562 Normal	KA D-36
122666	\N	\N	2600	29157	\N	2600 Normal	DMS-035N
122667	\N	\N	2603	29160	\N	2603 Normal	DMS-037N
122672	\N	\N	2638	30002	\N	2638 Normal	LMM D-060
122673	\N	\N	2641	30005	\N	2641 Normal	LMM D-063
122674	\N	\N	2644	28240	\N	2644 Normal	AM2 D-544
122675	\N	\N	2647	28241	\N	2647 Normal	AM2 D-547
122676	\N	\N	2650	28242	\N	2650 Normal	AM2 D-550
122677	\N	\N	2654	28243	\N	2654 Normal	AM2 D-554
122678	\N	\N	2657	28244	\N	2657 Normal	AM2 D-557
122679	\N	\N	2660	28245	\N	2660 Normal	AM2 D-560
122680	\N	\N	2663	28246	\N	2663 Normal	AM2 D-563
122682	\N	\N	2669	31183	\N	2669 Normal	MucM D-006
122683	\N	\N	2672	31184	\N	2672 Normal	MucM D-009
122684	\N	\N	2675	31185	\N	2675 Normal	MucM D-012
122685	\N	\N	2678	31186	\N	2678 Normal	MucM D-015
122686	\N	\N	2682	31187	\N	2682 Normal	MucM D-019
122687	\N	\N	2683	31188	\N	2683 Normal	MucM D-020
122688	\N	\N	2694	32230	\N	2694 Normal	UM38-Normal_NA
122689	\N	\N	2716	29861	\N	2716 Normal	KAM100-N
122690	\N	\N	2724	29871	\N	2724 Normal	KAM127-N
122691	\N	\N	2728	29875	\N	2728 Normal	KAM131-N
122692	\N	\N	2742	29856	\N	2742 Normal	KAM93-N-B10
122693	\N	\N	2746	29859	\N	2746 Normal	KAM99-N
122694	\N	\N	2747	29864	\N	2747 Normal	KAM111-N-A4
122695	\N	\N	2750	29842	\N	2750 Normal	KAM10-N-B7
122696	\N	\N	2751	29761	\N	2751 Normal	JBU10-Norm
122576	\N	\N	2113	29483	\N	2113 Normal	DNA-277
122577	\N	\N	2116	29486	\N	2116 Normal	DNA-280
122578	\N	\N	2120	29490	\N	2120 Normal	DNA-284
122579	\N	\N	2123	29493	\N	2123 Normal	DNA-287
122582	\N	\N	2133	29522	\N	2133 Normal	DNA-316
122596	\N	\N	2189	29536	\N	2189 Normal	DNA-339
122605	\N	\N	2222	29569	\N	2222 Normal	DNA-388
122607	\N	\N	2229	29576	\N	2229 Normal	DNA-397
122608	\N	\N	2233	29580	\N	2233 Normal	DNA-403
122611	\N	\N	2241	29585	\N	2241 Normal	DNA-418
122612	\N	\N	2242	29586	\N	2242 Normal	DNA-419
122613	\N	\N	2245	29589	\N	2245 Normal	DNA-422
122618	\N	\N	2270	31326	\N	2270 Normal	NM D-101
122619	\N	\N	2289	29593	\N	2289 Normal	DNA-426
122620	\N	\N	2293	29597	\N	2293 Normal	DNA-430
122621	\N	\N	2298	29602	\N	2298 Normal	DNA-435
122622	\N	\N	2301	29605	\N	2301 Normal	DNA-438
122626	\N	\N	2449	29612	\N	2449 Normal	DNA-445
122627	\N	\N	2446	29609	\N	2446 Normal	DNA-442
122628	\N	\N	2450	29960	\N	2450 Normal	LMM D-016
122629	\N	\N	2453	29963	\N	2453 Normal	LMM D-019
122630	\N	\N	2461	29615	\N	2461 Normal	DNA-448
122632	\N	\N	2471	29968	\N	2471 Normal	LMM D-024
122633	\N	\N	2479	29992	\N	2479 Normal	LMM D-048
122634	\N	\N	2488	30001	\N	2488 Normal	LMM D-057
122635	\N	\N	2482	29995	\N	2482 Normal	LMM D-051
122636	\N	\N	2475	28239	\N	2475 Normal	AM2 D-541
122637	\N	\N	2485	29998	\N	2485 Normal	LMM D-054
122638	\N	\N	2493	29947	\N	2493 Normal	LMM D-003
122639	\N	\N	2496	29950	\N	2496 Normal	LMM D-006
122640	\N	\N	2499	29953	\N	2499 Normal	LMM D-009
122641	\N	\N	2502	29956	\N	2502 Normal	LMM D-012
122642	\N	\N	2505	29959	\N	2505 Normal	LMM D-015
122668	\N	\N	2605	29162	\N	2605 Normal	DMS-038N
122669	\N	\N	2607	29164	\N	2607 Normal	DMS-039N
122670	\N	\N	2609	29166	\N	2609 Normal	DMS-040N
122671	\N	\N	2634	29191	\N	2634 Normal	DMS-062N
127545	\N	\N	10023	32381	\N	12-13587B2_Tumor	NA_12-13587B2_Tumor
127546	\N	\N	10024	32382	\N	BuffyCoa_Tumor	NA_BuffyCoa_Tumor
122697	\N	\N	2753	29763	\N	2753 Normal	JBU11-Norm
122698	\N	\N	2755	29757	\N	2755 Normal	JBU7-Norm
122699	\N	\N	2757	29759	\N	2757 Normal	JBU8-Norm
122700	\N	\N	2762	27658	\N	2762 Normal	21-5_NA
122701	\N	\N	2763	27679	\N	2763 Normal	24-5_NA
122702	\N	\N	2769	29634	\N	2769 Normal	DPN_8_Normal_NA
122703	\N	\N	2771	29644	\N	2771 Normal	DPN_18_Normal_NA
122704	\N	\N	2777	29630	\N	2777 Normal	DPN_5_Normal_NA
122705	\N	\N	2780	31942	\N	2780 Normal	SM_2_Normal_NA
122706	\N	\N	2783	31945	\N	2783 Normal	SM_4_Normal_NA
122707	\N	\N	2785	31947	\N	2785 Normal	SM_5_Normal_NA
122708	\N	\N	2788	31950	\N	2788 Normal	SM_7_Normal_NA
122709	\N	\N	2790	31952	\N	2790 Normal	SM_8_Normal_NA
122710	\N	\N	2793	31954	\N	2793 Normal	SM_9_Normal_NA
122711	\N	\N	2798	31959	\N	2798 Normal	SM_16_Normal_NA
122712	\N	\N	2813	29777	\N	2813 Normal	K2_4
122713	\N	\N	2815	29779	\N	2815 Normal	K2_6
122714	\N	\N	2820	29770	\N	2820 Normal	K1_19
122715	\N	\N	2822	29773	\N	2822 Normal	K1_22
122716	\N	\N	2825	31886	\N	2825 Normal	Rob-T003-Normal_NA
122717	\N	\N	2828	29750	\N	2828 Normal	JBP-6-Norm_NA
122718	\N	\N	2831	29767	\N	2831 Normal	K1_16
122719	\N	\N	2835	29000	\N	2835 Normal	D76_NA
122720	\N	\N	2849	31216	\N	2849 Normal	NGS 1-3_NA
122721	\N	\N	2854	31221	\N	2854 Normal	NGS 1-8_NA
122722	\N	\N	2862	31888	\N	2862 Normal	Rob-T005-Normal_NA
122723	\N	\N	2866	31890	\N	2866 Normal	Rob-T008-Normal_NA
122724	\N	\N	2868	31892	\N	2868 Normal	Rob-T009-Normal_NA
122725	\N	\N	2870	31894	\N	2870 Normal	Rob-T010-Normal_NA
122726	\N	\N	2901	29755	\N	2901 Normal	JBP-11Norm
122727	\N	\N	2916	27662	\N	2916 Normal	22_Normal_NA
122728	\N	\N	2927	27684	\N	2927 Normal	28-5_NA
122729	\N	\N	2936	27700	\N	2936 Normal	ALK_Cntl_NA
122730	\N	\N	2943	28502	\N	2943 Normal	BB008_HW2NC_NA
122731	\N	\N	2945	28504	\N	2945 Normal	BB008_HW8NC_NA
122732	\N	\N	2947	28506	\N	2947 Normal	BB008_HW9-NB_NA
122733	\N	\N	2964	28523	\N	2964 Normal	BB09_HW3_N_NA
122734	\N	\N	2966	28525	\N	2966 Normal	BB09_HW4_N_NA
122735	\N	\N	2968	28527	\N	2968 Normal	BB09_HW6_ND_NA
122736	\N	\N	2982	28541	\N	2982 Normal	BN_N1_NA
122737	\N	\N	2983	28542	\N	2983 Normal	BN_N2_NA
122738	\N	\N	3071	28874	\N	3071 Normal	CNS_29_Normal_NA
122739	\N	\N	3076	28879	\N	3076 Normal	CNS_34_Normal_NA
122740	\N	\N	3091	28952	\N	3091 Normal	D12_54296_Norm_NA
122741	\N	\N	3093	28954	\N	3093 Normal	D12_54992_Norm_NA
122742	\N	\N	3095	28956	\N	3095 Normal	D12_67298_Norm_NA
122743	\N	\N	3101	29005	\N	3101 Normal	DM_4_Normal_NA
122744	\N	\N	3103	29007	\N	3103 Normal	DM_6_Normal_NA
122745	\N	\N	3106	29010	\N	3106 Normal	DM_10_Normal_NA
122746	\N	\N	3112	29016	\N	3112 Normal	DM_17_Normal_NA
122747	\N	\N	3114	29018	\N	3114 Normal	DM_18_Normal_NA
122748	\N	\N	3117	29020	\N	3117 Normal	DM_22_Normal_NA
122749	\N	\N	3119	29022	\N	3119 Normal	DM_23_Normal_NA
122750	\N	\N	3121	29024	\N	3121 Normal	DM_25_Normal_NA
122751	\N	\N	3124	29027	\N	3124 Normal	DM_31_Normal_NA
122752	\N	\N	3126	29029	\N	3126 Normal	DM_36_Normal_NA
122753	\N	\N	3128	29031	\N	3128 Normal	DM_42_Normal_NA
122754	\N	\N	3130	29033	\N	3130 Normal	DM_43_Normal_NA
122755	\N	\N	3134	29037	\N	3134 Normal	DM_49_Normal_NA
122756	\N	\N	3136	29039	\N	3136 Normal	DM_58_Normal_NA
122757	\N	\N	3139	29042	\N	3139 Normal	DM_64_1_Normal_NA
122758	\N	\N	3148	29050	\N	3148 Normal	DM_93_Normal_NA
122759	\N	\N	3149	29051	\N	3149 Normal	DM_94_Normal_NA
122760	\N	\N	3152	29054	\N	3152 Normal	DM_95_Normal_NA
122761	\N	\N	3154	29056	\N	3154 Normal	DM_96_Normal_NA
122762	\N	\N	3155	29057	\N	3155 Normal	DM_98_2_Normal_NA
122763	\N	\N	3157	29059	\N	3157 Normal	DM_99_Normal_NA
122764	\N	\N	3162	29063	\N	3162 Normal	DM_101_Normal_NA
122765	\N	\N	3174	29075	\N	3174 Normal	DM1_Normal_NA
122766	\N	\N	3176	29077	\N	3176 Normal	DM2_Normal_NA
122767	\N	\N	3180	29081	\N	3180 Normal	DM7_Normal_NA
122768	\N	\N	3179	29080	\N	3179 Normal	DM5_Normal_NA
122769	\N	\N	3182	29084	\N	3182 Normal	DM11_Normal_NA
122770	\N	\N	3184	29086	\N	3184 Normal	DM12_Normal_NA
122771	\N	\N	3188	29090	\N	3188 Normal	DM14_Normal_NA
122772	\N	\N	3186	29088	\N	3186 Normal	DM13_Normal_NA
122773	\N	\N	3190	29092	\N	3190 Normal	DM16_Normal_NA
122774	\N	\N	3192	29094	\N	3192 Normal	DM21_Normal_NA
122775	\N	\N	3194	29096	\N	3194 Normal	DM26_Normal_NA
122776	\N	\N	3196	29098	\N	3196 Normal	DM28_Normal_NA
122777	\N	\N	3199	29101	\N	3199 Normal	DM29_Normal_NA
122778	\N	\N	3200	29102	\N	3200 Normal	DM34_Normal_NA
122779	\N	\N	3202	29104	\N	3202 Normal	DM37_1_Normal_NA
122780	\N	\N	3204	29106	\N	3204 Normal	DM45_Normal_NA
122781	\N	\N	3205	29108	\N	3205 Normal	DM55 Normal_NA
122782	\N	\N	3208	29111	\N	3208 Normal	DM77_Normal_NA
122783	\N	\N	3210	29113	\N	3210 Normal	DM79_Normal_NA
122784	\N	\N	3213	29118	\N	3213 Normal	DM93_Normal_NA
122785	\N	\N	3220	29636	\N	3220 Normal	DPN_9_Normal_NA
122786	\N	\N	3232	29649	\N	3232 Normal	DPN_CNN 32_NA
122787	\N	\N	3237	29667	\N	3237 Normal	DT10_63051C_NA
122788	\N	\N	3242	29680	\N	3242 Normal	G3 DP08-21965C Normal_NA
122789	\N	\N	3244	29682	\N	3244 Normal	G5 DP08-4205A Normal_NA
122790	\N	\N	3249	29687	\N	3249 Normal	HW_A1_Cntl_NA
122791	\N	\N	3251	29689	\N	3251 Normal	HW_A2_Cntl_NA
122792	\N	\N	3253	29691	\N	3253 Normal	HW_A3_Cntl_NA
122793	\N	\N	3255	29693	\N	3255 Normal	HW_A4_Cntl_NA
122794	\N	\N	3257	29695	\N	3257 Normal	HW_A5_Cntl_NA
122795	\N	\N	3259	29697	\N	3259 Normal	HW_A6_Cntl_NA
122796	\N	\N	3261	29699	\N	3261 Normal	HW_A7 Cntl_NA
122797	\N	\N	3263	29701	\N	3263 Normal	HW_A8_Cntl_NA
122798	\N	\N	3265	29703	\N	3265 Normal	HW_A9_Cntl_NA
122799	\N	\N	3267	29705	\N	3267 Normal	HW_A10_Cntl_NA
122800	\N	\N	3279	29717	\N	3279 Normal	Ivanka_9_5_NA
122801	\N	\N	3294	29732	\N	3294 Normal	Ivanka_16_5_NA
122802	\N	\N	3299	29742	\N	3299 Normal	Ivanka_22_5_NA
122803	\N	\N	3304	29781	\N	3304 Normal	K2_8
122804	\N	\N	3352	29941	\N	3352 Normal	L2-Normal_NA
122805	\N	\N	3354	29943	\N	3354 Normal	L3-Normal_NA
122806	\N	\N	3355	29944	\N	3355 Normal	L11_96096_A2_Norm_NA
122807	\N	\N	3356	30324	\N	3356 Normal	MB_161_Normal_NA
122808	\N	\N	3362	30330	\N	3362 Normal	MB_1036_Normal_NA
122809	\N	\N	3360	30328	\N	3360 Normal	MB_1028_Normal_NA
122810	\N	\N	3364	30332	\N	3364 Normal	MB_1418_Normal_NA
122811	\N	\N	3365	30333	\N	3365 Normal	MB_1454_Normal_NA
122812	\N	\N	3367	30335	\N	3367 Normal	MB1241_Norm_NA
122813	\N	\N	3366	30334	\N	3366 Normal	MB_1609_Normal_NA
122814	\N	\N	3369	30337	\N	3369 Normal	MB1421_Norm_NA
122815	\N	\N	3370	30338	\N	3370 Normal	MB1423_Norm_NA
122816	\N	\N	3373	30341	\N	3373 Normal	MB1428_Norm_NA
122817	\N	\N	3378	30568	\N	3378 Normal	MIN_3_NA
122818	\N	\N	3381	30571	\N	3381 Normal	MIN_6_NA
122819	\N	\N	3388	31198	\N	3388 Normal	N3_6_NA
122820	\N	\N	3390	31200	\N	3390 Normal	N3_8_NA
122821	\N	\N	3392	31202	\N	3392 Normal	N3_10_NA
122822	\N	\N	3423	31455	\N	3423 Normal	P57-Normal_NA_3423-Normal
122823	\N	\N	3424	31456	\N	3424 Normal	P57-Normal_NA_3424-Normal
122825	\N	\N	3810	29737	\N	3810 Normal	Ivanka_20_5_NA
122826	\N	\N	3852	31209	\N	3852 Normal	NA_CP1_Normal
122827	\N	\N	3859	31884	\N	3859 Normal	Rob-T001-Normal_NA
122828	\N	\N	2	27842	\N	2 Mel1	AM2 D-101
122831	\N	\N	14	27780	\N	14 Mel1	AM2 D-39
122832	\N	\N	17	27783	\N	17 Mel1	AM2 D-42
122833	\N	\N	21	27787	\N	21 Mel1	AM2 D-46
122834	\N	\N	23	27789	\N	23 Mel1	AM2 D-48
122835	\N	\N	27	27792	\N	27 Mel1	AM2 D-51
122836	\N	\N	30	27795	\N	30 Mel1	AM2 D-54
122837	\N	\N	34	27799	\N	34 Mel1	AM2 D-58
122838	\N	\N	37	27802	\N	37 Mel1	AM2 D-61
122839	\N	\N	41	27806	\N	41 Mel1	AM2 D-65
122840	\N	\N	45	27810	\N	45 Mel1	AM2 D-69
122841	\N	\N	48	27814	\N	48 Mel1	AM2 D-73
122842	\N	\N	51	27744	\N	51 Mel1	AM2 D-03
122843	\N	\N	57	27750	\N	57 Mel1	AM2 D-09
122844	\N	\N	61	27754	\N	61 Mel1	AM2 D-13
122845	\N	\N	64	27757	\N	64 Mel1	AM2 D-16
122849	\N	\N	81	27774	\N	81 Mel1	AM2 D-33
122850	\N	\N	88	27818	\N	88 Mel1	AM2 D-77
122851	\N	\N	91	27821	\N	91 Mel1	AM2 D-80
122852	\N	\N	95	27825	\N	95 Mel1	AM2 D-84
122854	\N	\N	106	27837	\N	106 Mel1	AM2 D-96
122855	\N	\N	422	27916	\N	422 Mel1	AM2 D-174
122856	\N	\N	363	27857	\N	363 Mel1	AM2 D-115
122857	\N	\N	371	27864	\N	371 Mel1	AM2 D-122
122859	\N	\N	423	27917	\N	423 Mel1	AM2 D-175
122860	\N	\N	384	27877	\N	384 Mel1	AM2 D-135
122861	\N	\N	378	27871	\N	378 Mel1	AM2 D-129
122862	\N	\N	393	27885	\N	393 Mel1	AM2 D-143
122863	\N	\N	410	27904	\N	410 Mel1	AM2 D-162
122865	\N	\N	406	27900	\N	406 Mel1	AM2 D-158
122866	\N	\N	418	27912	\N	418 Mel1	AM2 D-170
122867	\N	\N	367	27860	\N	367 Mel1	AM2 D-118
122868	\N	\N	389	27882	\N	389 Mel1	AM2 D-140
122870	\N	\N	1145	27918	\N	1145 Mel1	AM2 D-176
122871	\N	\N	1293	27946	\N	1293 Mel1	AM2 D-207
122872	\N	\N	1298	27951	\N	1298 Mel1	AM2 D-213
122873	\N	\N	1303	27956	\N	1303 Mel1	AM2 D-218
122874	\N	\N	1306	27959	\N	1306 Mel1	AM2 D-221
122875	\N	\N	1309	27962	\N	1309 Mel1	AM2 D-224
122888	\N	\N	2107	28936	\N	2107 Mel1	D-NA-626
122892	\N	\N	96	27826	\N	96 Mel2	AM2 D-85
122893	\N	\N	107	27838	\N	107 Mel2	AM2 D-97
122894	\N	\N	368	27861	\N	368 Mel2	AM2 D-119
122897	\N	\N	1289	27942	\N	1289 Mel2	AM2 D-202
122898	\N	\N	1299	27952	\N	1299 Mel2	AM2 D-214
122908	\N	\N	2061	28933	\N	2061 Mel2	D-NA-623
122909	\N	\N	2108	28937	\N	2108 Mel2	D-NA-627
122914	\N	\N	13	27779	\N	13 MIS1	AM2 D-38
122915	\N	\N	16	27782	\N	16 MIS1	AM2 D-41
122916	\N	\N	18	27784	\N	18 MIS1	AM2 D-43
122917	\N	\N	24	27827	\N	24 MIS1	AM2 D-86
122918	\N	\N	26	27791	\N	26 MIS1	AM2 D-50
122919	\N	\N	29	27794	\N	29 MIS1	AM2 D-53
122920	\N	\N	36	27801	\N	36 MIS1	AM2 D-60
122921	\N	\N	39	27804	\N	39 MIS1	AM2 D-63
122922	\N	\N	43	27808	\N	43 MIS1	AM2 D-67
122923	\N	\N	47	27812	\N	47 MIS1	AM2 D-71
122924	\N	\N	50	27743	\N	50 MIS1	AM2 D-02
122925	\N	\N	54	27747	\N	54 MIS1	AM2 D-06
122926	\N	\N	59	27752	\N	59 MIS1	AM2 D-11
122927	\N	\N	63	27756	\N	63 MIS1	AM2 D-15
122930	\N	\N	73	27766	\N	73 MIS1	AM2 D-25
122931	\N	\N	79	27772	\N	79 MIS1	AM2 D-31
122932	\N	\N	83	27776	\N	83 MIS1	AM2 D-35
122933	\N	\N	86	27816	\N	86 MIS1	AM2 D-75
122934	\N	\N	90	27820	\N	90 MIS1	AM2 D-79
122935	\N	\N	93	27823	\N	93 MIS1	AM2 D-82
122937	\N	\N	104	27835	\N	104 MIS1	AM2 D-94
122938	\N	\N	382	27875	\N	382 MIS1	AM2 D-133
122829	\N	\N	4	27844	\N	4 Mel1	AM2 D-103
122830	\N	\N	10	27851	\N	10 Mel1	AM2 D-109
122846	\N	\N	67	27760	\N	67 Mel1	AM2 D-19
122847	\N	\N	71	27764	\N	71 Mel1	AM2 D-23
122848	\N	\N	76	27769	\N	76 Mel1	AM2 D-28
122853	\N	\N	100	27831	\N	100 Mel1	AM2 D-90
122858	\N	\N	414	27908	\N	414 Mel1	AM2 D-166
122864	\N	\N	375	27868	\N	375 Mel1	AM2 D-126
122869	\N	\N	401	27895	\N	401 Mel1	AM2 D-153
122876	\N	\N	1471	27991	\N	1471 Mel1	AM2 D-257
122877	\N	\N	1475	27995	\N	1475 Mel1	AM2 D-261
122878	\N	\N	1491	28002	\N	1491 Mel1	AM2 D-269
122879	\N	\N	1494	28005	\N	1494 Mel1	AM2 D-272
122880	\N	\N	1502	28013	\N	1502 Mel1	AM2 D-280
122881	\N	\N	1515	28023	\N	1515 Mel1	AM2 D-293
122882	\N	\N	1524	28029	\N	1524 Mel1	AM2 D-299
122883	\N	\N	1529	28033	\N	1529 Mel1	AM2 D-308
122884	\N	\N	1548	28052	\N	1548 Mel1	AM2 D-328
122885	\N	\N	1553	28057	\N	1553 Mel1	AM2 D-333
122886	\N	\N	1570	28072	\N	1570 Mel1	AM2 D-350
122887	\N	\N	2060	28932	\N	2060 Mel1	D-NA-622
122889	\N	\N	2180	29527	\N	2180 Mel1	DNA-330
122890	\N	\N	2223	29570	\N	2223 Mel1	DNA-390
122891	\N	\N	77	27770	\N	77 Mel2	AM2 D-29
122895	\N	\N	402	27896	\N	402 Mel2	AM2 D-154
122896	\N	\N	1286	27939	\N	1286 Mel2	AM2 D-199
122899	\N	\N	1476	27996	\N	1476 Mel2	AM2 D-262
122900	\N	\N	1492	28003	\N	1492 Mel2	AM2 D-270
122901	\N	\N	1495	28006	\N	1495 Mel2	AM2 D-273
122902	\N	\N	1516	28077	\N	1516 Mel2	AM2 D-355
122903	\N	\N	1530	28034	\N	1530 Mel2	AM2 D-309
122904	\N	\N	1549	28053	\N	1549 Mel2	AM2 D-329
122905	\N	\N	1554	28058	\N	1554 Mel2	AM2 D-334
122906	\N	\N	1571	28073	\N	1571 Mel2	AM2 D-351
122907	\N	\N	1622	28156	\N	1622 Mel2	AM2 D-453
122910	\N	\N	2181	29528	\N	2181 Mel2	DNA-331
122911	\N	\N	2224	29571	\N	2224 Mel2	DNA-391
122912	\N	\N	2246	28477	\N	2246 Mel2	AM2 R-517
122913	\N	\N	7	27848	\N	7 MIS1	AM2 D-106
122928	\N	\N	66	27759	\N	66 MIS1	AM2 D-18
122929	\N	\N	69	27762	\N	69 MIS1	AM2 D-21
122936	\N	\N	99	27830	\N	99 MIS1	AM2 D-89
127547	\N	\N	10025	32383	\N	12-22775_Tumor	NA_12-22775_Tumor
127548	\N	\N	10026	32384	\N	12-22794A_Tumor	NA_12-22794A_Tumor
127549	\N	\N	10027	32385	\N	12-22573_Tumor	NA_12-22573_Tumor
127550	\N	\N	10028	32386	\N	12-22582A_Tumor	NA_12-22582A_Tumor
127551	\N	\N	10029	32387	\N	12-22587_Tumor	NA_12-22587_Tumor
127552	\N	\N	10030	32388	\N	12-22592_Tumor	NA_12-22592_Tumor
127553	\N	\N	10031	32389	\N	12-22597_Tumor	NA_12-22597_Tumor
127554	\N	\N	10032	32390	\N	12-22602A_Tumor	NA_12-22602A_Tumor
127555	\N	\N	10033	32391	\N	12-22602B_Tumor	NA_12-22602B_Tumor
127772	\N	\N	10250	32585	\N	DM96_Tumor	NA_DM96_Tumor
127556	\N	\N	10034	32392	\N	12-22603_Tumor	NA_12-22603_Tumor
122940	\N	\N	365	27858	\N	365 MIS1	AM2 D-116
122942	\N	\N	361	27855	\N	361 MIS1	AM2 D-113
122944	\N	\N	408	27902	\N	408 MIS1	AM2 D-160
122945	\N	\N	405	27899	\N	405 MIS1	AM2 D-157
122946	\N	\N	396	27890	\N	396 MIS1	AM2 D-148
122947	\N	\N	377	27870	\N	377 MIS1	AM2 D-128
122948	\N	\N	416	27910	\N	416 MIS1	AM2 D-168
122949	\N	\N	386	27879	\N	386 MIS1	AM2 D-137
122950	\N	\N	392	27884	\N	392 MIS1	AM2 D-142
122951	\N	\N	370	27863	\N	370 MIS1	AM2 D-121
122952	\N	\N	412	27906	\N	412 MIS1	AM2 D-164
122954	\N	\N	1296	27949	\N	1296 MIS1	AM2 D-211
122972	\N	\N	19	27785	\N	19 MIS2	AM2 D-44
122973	\N	\N	40	27805	\N	40 MIS2	AM2 D-64
122974	\N	\N	44	27809	\N	44 MIS2	AM2 D-68
122975	\N	\N	55	27748	\N	55 MIS2	AM2 D-07
122976	\N	\N	60	27753	\N	60 MIS2	AM2 D-12
122979	\N	\N	80	27773	\N	80 MIS2	AM2 D-32
122980	\N	\N	87	27817	\N	87 MIS2	AM2 D-76
122981	\N	\N	94	27824	\N	94 MIS2	AM2 D-83
122982	\N	\N	105	27836	\N	105 MIS2	AM2 D-95
122984	\N	\N	417	27911	\N	417 MIS2	AM2 D-169
122985	\N	\N	374	27867	\N	374 MIS2	AM2 D-125
122986	\N	\N	400	27894	\N	400 MIS2	AM2 D-152
122987	\N	\N	362	27856	\N	362 MIS2	AM2 D-114
122988	\N	\N	366	27859	\N	366 MIS2	AM2 D-117
122989	\N	\N	387	27880	\N	387 MIS2	AM2 D-138
122990	\N	\N	409	27903	\N	409 MIS2	AM2 D-161
122991	\N	\N	383	27876	\N	383 MIS2	AM2 D-134
122993	\N	\N	1240	27932	\N	1240 MIS2	AM2 D-190
122995	\N	\N	1297	27950	\N	1297 MIS2	AM2 D-212
123005	\N	\N	3	27843	\N	3 Met1	AM2 D-102
123007	\N	\N	8	27849	\N	8 Met1	AM2 D-107
123010	\N	\N	108	27839	\N	108 Met1	AM2 D-98
123011	\N	\N	1152	27925	\N	1152 Met1	AM2 D-183
123012	\N	\N	1285	27938	\N	1285 Met1	AM2 D-196
123020	\N	\N	2817	29765	\N	2817 Met1	K1_14
123021	\N	\N	102	27833	\N	102 Met2	AM2 D-92
123022	\N	\N	109	27840	\N	109 Met2	AM2 D-99
123023	\N	\N	1151	27924	\N	1151 Met2	AM2 D-182
123024	\N	\N	1287	27940	\N	1287 Met2	AM2 D-200
123029	\N	\N	2033	28204	\N	2033 Met2	AM2 D-503
123031	\N	\N	2818	29766	\N	2818 Met2	K1_15
123032	\N	\N	2819	29764	\N	2819 Met2	K1_13
123033	\N	\N	53	27746	\N	53 Nevus	AM2 D-05
122941	\N	\N	399	27893	\N	399 MIS1	AM2 D-151
122943	\N	\N	373	27866	\N	373 MIS1	AM2 D-124
122953	\N	\N	1244	27936	\N	1244 MIS1	AM2 D-194
122955	\N	\N	1428	31468	\N	1428 MIS1	PROG D-06
122956	\N	\N	1441	29331	\N	1441 MIS1	DNA-124
122957	\N	\N	1442	29320	\N	1442 MIS1	DNA-113
122958	\N	\N	1472	27992	\N	1472 MIS1	AM2 D-258
122959	\N	\N	1508	28018	\N	1508 MIS1	AM2 D-286
122960	\N	\N	1525	28030	\N	1525 MIS1	AM2 D-300
122961	\N	\N	1533	28037	\N	1533 MIS1	AM2 D-312
122962	\N	\N	1539	28043	\N	1539 MIS1	AM2 D-319
122963	\N	\N	1550	28054	\N	1550 MIS1	AM2 D-330
122964	\N	\N	1555	28059	\N	1555 MIS1	AM2 D-335
122965	\N	\N	1572	28074	\N	1572 MIS1	AM2 D-352
122966	\N	\N	1587	28138	\N	1587 MIS1	AM2 D-433
122967	\N	\N	1594	28111	\N	1594 MIS1	AM2 D-400
122968	\N	\N	1597	28107	\N	1597 MIS1	AM2 D-393
122969	\N	\N	1600	28114	\N	1600 MIS1	AM2 D-403
122977	\N	\N	70	27763	\N	70 MIS2	AM2 D-22
122978	\N	\N	74	27767	\N	74 MIS2	AM2 D-26
122983	\N	\N	421	27915	\N	421 MIS2	AM2 D-173
122992	\N	\N	413	27907	\N	413 MIS2	AM2 D-165
122994	\N	\N	1245	27937	\N	1245 MIS2	AM2 D-195
122996	\N	\N	1443	29321	\N	1443 MIS2	DNA-114
122997	\N	\N	1444	29332	\N	1444 MIS2	DNA-125
122998	\N	\N	1540	28044	\N	1540 MIS2	AM2 D-320
122999	\N	\N	1556	28060	\N	1556 MIS2	AM2 D-336
123000	\N	\N	1573	28075	\N	1573 MIS2	AM2 D-353
123001	\N	\N	1588	28139	\N	1588 MIS2	AM2 D-434
123002	\N	\N	2034	28200	\N	2034 MIS2	AM2 D-498
123006	\N	\N	5	27845	\N	5 Met1	AM2 D-104
123008	\N	\N	11	27852	\N	11 Met1	AM2 D-110
123009	\N	\N	101	27832	\N	101 Met1	AM2 D-91
123013	\N	\N	1312	31464	\N	1312 Met1	PROG D-02
123014	\N	\N	1474	27994	\N	1474 Met1	AM2 D-260
123015	\N	\N	1504	28015	\N	1504 Met1	AM2 D-282
123016	\N	\N	1509	28019	\N	1509 Met1	AM2 D-287
123017	\N	\N	1577	28102	\N	1577 Met1	AM2 D-383
123018	\N	\N	1579	28122	\N	1579 Met1	AM2 D-412
123019	\N	\N	2268	31325	\N	2268 Met1	NM D-100
123025	\N	\N	1313	31465	\N	1313 Met2	PROG D-03
123026	\N	\N	1500	28011	\N	1500 Met2	AM2 D-278
123027	\N	\N	1505	28016	\N	1505 Met2	AM2 D-283
123028	\N	\N	1520	28025	\N	1520 Met2	AM2 D-295
123030	\N	\N	2269	31325	\N	2269 Met2	NM D-100
123034	\N	\N	290	31569	\N	290 Nevus	RNA-11
123035	\N	\N	296	31575	\N	296 Nevus	RNA-17
123036	\N	\N	300	31579	\N	300 Nevus	RNA-21
123037	\N	\N	294	31573	\N	294 Nevus	RNA-15
123038	\N	\N	287	31566	\N	287 Nevus	RNA-08
123039	\N	\N	298	31577	\N	298 Nevus	RNA-19
123040	\N	\N	292	31571	\N	292 Nevus	RNA-13
123041	\N	\N	284	31563	\N	284 Nevus	RNA-05
123042	\N	\N	281	31560	\N	281 Nevus	RNA-02
123043	\N	\N	352	31594	\N	352 Nevus	RNA-36
123044	\N	\N	346	31588	\N	346 Nevus	RNA-30
123045	\N	\N	350	31592	\N	350 Nevus	RNA-34
123046	\N	\N	348	31590	\N	348 Nevus	RNA-32
123047	\N	\N	773	29262	\N	773 Nevus	DNA-44
123048	\N	\N	775	29264	\N	775 Nevus	DNA-46
123049	\N	\N	777	29268	\N	777 Nevus	DNA-50
123050	\N	\N	780	29275	\N	780 Nevus	DNA-56
123051	\N	\N	782	29279	\N	782 Nevus	DNA-62
123052	\N	\N	785	29294	\N	785 Nevus	DNA-81
123053	\N	\N	788	29288	\N	788 Nevus	DNA-75
123054	\N	\N	789	29269	\N	789 Nevus	DNA-52
127557	\N	\N	10035	32393	\N	12-22604_Tumor	NA_12-22604_Tumor
127558	\N	\N	10036	32394	\N	12-22720A_Tumor	NA_12-22720A_Tumor
127559	\N	\N	10037	32395	\N	12-22868_Tumor	NA_12-22868_Tumor
127560	\N	\N	10038	32396	\N	12-22884C_Tumor	NA_12-22884C_Tumor
127561	\N	\N	10039	32397	\N	12-22884D_Tumor	NA_12-22884D_Tumor
127562	\N	\N	10040	32398	\N	12-22886_Tumor	NA_12-22886_Tumor
127563	\N	\N	10041	32399	\N	12-22894B_Tumor	NA_12-22894B_Tumor
127564	\N	\N	10042	32400	\N	12-22898_Tumor	NA_12-22898_Tumor
127565	\N	\N	10043	32401	\N	12-22900_Tumor	NA_12-22900_Tumor
127566	\N	\N	10044	32389	\N	12-22597_Tumor	NA_12-22597_Tumor
127567	\N	\N	10045	32389	\N	12-22597_Tumor	NA_12-22597_Tumor
127568	\N	\N	10046	32389	\N	12-22597_Tumor	NA_12-22597_Tumor
127773	\N	\N	10251	32586	\N	DM96_Normal	NA_DM96_Normal
127569	\N	\N	10047	32389	\N	12-22597_Tumor	NA_12-22597_Tumor
123062	\N	\N	1134	28749	\N	1134 Nevus	CGH19-097_2
123092	\N	\N	1664	30841	\N	1664 Nevus	MMD-266
123122	\N	\N	2059	28931	\N	2059 Nevus	D-NA-621
123123	\N	\N	2063	28925	\N	2063 Nevus	D-NA-586
123124	\N	\N	2066	28928	\N	2066 Nevus	D-NA-589
123129	\N	\N	2082	28943	\N	2082 Nevus	D-NA-646
123130	\N	\N	2085	28919	\N	2085 Nevus	D-NA-561
123133	\N	\N	2094	28898	\N	2094 Nevus	D-NA-540
123134	\N	\N	2097	28904	\N	2097 Nevus	D-NA-546
123135	\N	\N	2100	28907	\N	2100 Nevus	D-NA-549
123136	\N	\N	2103	28901	\N	2103 Nevus	D-NA-543
123137	\N	\N	2106	28935	\N	2106 Nevus	D-NA-625
123056	\N	\N	796	29266	\N	796 Nevus	DNA-48
123058	\N	\N	800	29291	\N	800 Nevus	DNA-78
123059	\N	\N	801	29292	\N	801 Nevus	DNA-79
123060	\N	\N	803	29295	\N	803 Nevus	DNA-82
123061	\N	\N	893	29307	\N	893 Nevus	DNA-95
123063	\N	\N	1445	31973	\N	1445 Nevus	SND-01
123064	\N	\N	1452	31974	\N	1452 Nevus	SND-02
123065	\N	\N	1453	31975	\N	1453 Nevus	SND-03
123066	\N	\N	1454	31976	\N	1454 Nevus	SND-04
123067	\N	\N	1455	31977	\N	1455 Nevus	SND-05
123068	\N	\N	1458	31980	\N	1458 Nevus	SND-08
123069	\N	\N	1457	31979	\N	1457 Nevus	SND-07
123070	\N	\N	1456	31978	\N	1456 Nevus	SND-06
123071	\N	\N	1462	31984	\N	1462 Nevus	SND-12
123072	\N	\N	1461	31983	\N	1461 Nevus	SND-11
123073	\N	\N	1460	31982	\N	1460 Nevus	SND-10
123074	\N	\N	1463	31985	\N	1463 Nevus	SND-13
123075	\N	\N	1459	31981	\N	1459 Nevus	SND-09
123076	\N	\N	1464	31986	\N	1464 Nevus	SND-14
123077	\N	\N	1465	31987	\N	1465 Nevus	SND-15
123078	\N	\N	1466	31988	\N	1466 Nevus	SND-16
123079	\N	\N	1468	31990	\N	1468 Nevus	SND-18
123080	\N	\N	1467	31989	\N	1467 Nevus	SND-17
123081	\N	\N	1469	31991	\N	1469 Nevus	SND-19
123082	\N	\N	1480	31992	\N	1480 Nevus	SND-20
123083	\N	\N	1481	31993	\N	1481 Nevus	SND-21
123084	\N	\N	1483	31995	\N	1483 Nevus	SND-23
123085	\N	\N	1482	31994	\N	1482 Nevus	SND-22
123086	\N	\N	1484	31996	\N	1484 Nevus	SND-24
123087	\N	\N	1485	31997	\N	1485 Nevus	SND-25
123088	\N	\N	1486	31998	\N	1486 Nevus	SND-26
123089	\N	\N	1487	31999	\N	1487 Nevus	SND-27
123090	\N	\N	1488	32000	\N	1488 Nevus	SND-28
123091	\N	\N	1642	30953	\N	1642 Nevus	MMR-17
123093	\N	\N	1779	31053	\N	1779 Nevus	MMR-186
123094	\N	\N	1817	30812	\N	1817 Nevus	MMD-237
123095	\N	\N	1876	30125	\N	1876 Nevus	LN D-070
123096	\N	\N	1881	30130	\N	1881 Nevus	LN D-075
123097	\N	\N	1883	30132	\N	1883 Nevus	LN D-077
123098	\N	\N	1885	30134	\N	1885 Nevus	LN D-079
123099	\N	\N	1886	30135	\N	1886 Nevus	LN D-080
123100	\N	\N	1888	30136	\N	1888 Nevus	LN D-082
123101	\N	\N	1894	30141	\N	1894 Nevus	LN D-087
123102	\N	\N	1896	30143	\N	1896 Nevus	LN D-090
123103	\N	\N	1897	30144	\N	1897 Nevus	LN D-091
123104	\N	\N	1899	30146	\N	1899 Nevus	LN D-093
123105	\N	\N	1900	30147	\N	1900 Nevus	LN D-094
123106	\N	\N	1902	30162	\N	1902 Nevus	LN D-109
123107	\N	\N	1904	30166	\N	1904 Nevus	LN D-113
123108	\N	\N	1911	30160	\N	1911 Nevus	LN D-107
123109	\N	\N	1912	30185	\N	1912 Nevus	LN D-132
123110	\N	\N	1919	29370	\N	1919 Nevus	DNA-162
123111	\N	\N	1922	29373	\N	1922 Nevus	DNA-165
123112	\N	\N	1924	29375	\N	1924 Nevus	DNA-167
123113	\N	\N	1928	29379	\N	1928 Nevus	DNA-171
123114	\N	\N	1933	29384	\N	1933 Nevus	DNA-176
123115	\N	\N	1936	29387	\N	1936 Nevus	DNA-179
123116	\N	\N	1939	29390	\N	1939 Nevus	DNA-182
123117	\N	\N	1942	29393	\N	1942 Nevus	DNA-185
123118	\N	\N	1945	29396	\N	1945 Nevus	DNA-188
123119	\N	\N	1948	29399	\N	1948 Nevus	DNA-191
123120	\N	\N	1952	29403	\N	1952 Nevus	DNA-195
123121	\N	\N	2042	29478	\N	2042 Nevus	DNA-272
123125	\N	\N	2069	28939	\N	2069 Nevus	D-NA-629
123126	\N	\N	2073	28910	\N	2073 Nevus	D-NA-552
123127	\N	\N	2076	28913	\N	2076 Nevus	D-NA-555
123128	\N	\N	2079	28916	\N	2079 Nevus	D-NA-558
123131	\N	\N	2088	28922	\N	2088 Nevus	D-NA-564
123132	\N	\N	2091	28895	\N	2091 Nevus	D-NA-537
123138	\N	\N	2112	29482	\N	2112 Nevus	DNA-276
123139	\N	\N	2115	29485	\N	2115 Nevus	DNA-279
123140	\N	\N	2118	29488	\N	2118 Nevus	DNA-282
123141	\N	\N	2121	29491	\N	2121 Nevus	DNA-285
123142	\N	\N	2125	29495	\N	2125 Nevus	DNA-289
123143	\N	\N	2128	29517	\N	2128 Nevus	DNA-311
123144	\N	\N	2130	29519	\N	2130 Nevus	DNA-313
123145	\N	\N	2132	29521	\N	2132 Nevus	DNA-315
123147	\N	\N	2182	29529	\N	2182 Nevus	DNA-332
123148	\N	\N	2185	29532	\N	2185 Nevus	DNA-335
123149	\N	\N	2188	29535	\N	2188 Nevus	DNA-338
123150	\N	\N	2191	29538	\N	2191 Nevus	DNA-341
123151	\N	\N	2194	29541	\N	2194 Nevus	DNA-346
123152	\N	\N	2198	29545	\N	2198 Nevus	DNA-351
123153	\N	\N	2202	29549	\N	2202 Nevus	DNA-357
123154	\N	\N	2205	29552	\N	2205 Nevus	DNA-361
123155	\N	\N	2208	29555	\N	2208 Nevus	DNA-365
123156	\N	\N	2213	29560	\N	2213 Nevus	DNA-373
123157	\N	\N	2216	29563	\N	2216 Nevus	DNA-379
123158	\N	\N	2221	29568	\N	2221 Nevus	DNA-387
123159	\N	\N	2225	29572	\N	2225 Nevus	DNA-392
123160	\N	\N	2228	29575	\N	2228 Nevus	DNA-396
123161	\N	\N	2232	29579	\N	2232 Nevus	DNA-402
123162	\N	\N	2235	29582	\N	2235 Nevus	DNA-405
123164	\N	\N	2244	29526	\N	2244 Nevus	DNA-320
127570	\N	\N	10048	32402	\N	WP11_Tumor	NA_WP11_Tumor
127571	\N	\N	10049	32403	\N	WP23_Tumor	NA_WP23_Tumor
127572	\N	\N	10050	32404	\N	WP29_Tumor	NA_WP29_Tumor
127573	\N	\N	10051	32405	\N	PG8_Tumor	NA_PG8_Tumor
127574	\N	\N	10052	32406	\N	KIT37_Tumor	NA_KIT37_Tumor
127575	\N	\N	10053	32407	\N	KIT62_Tumor	NA_KIT62_Tumor
127576	\N	\N	10054	32408	\N	KIT118_Tumor	NA_KIT118_Tumor
127577	\N	\N	10055	32409	\N	KIT181_Tumor	NA_KIT181_Tumor
127578	\N	\N	10056	32410	\N	KIT227_Tumor	NA_KIT227_Tumor
127579	\N	\N	10057	32411	\N	KIT275_Tumor	NA_KIT275_Tumor
127580	\N	\N	10058	32412	\N	Bivona-L1_Tumor	NA_Bivona-L1_Tumor
127581	\N	\N	10059	32413	\N	Bivona-L2_Tumor	NA_Bivona-L2_Tumor
127582	\N	\N	10060	32414	\N	Bivona-L3_Tumor	NA_Bivona-L3_Tumor
127583	\N	\N	10061	32415	\N	Bivona-L4_Tumor	NA_Bivona-L4_Tumor
127584	\N	\N	10062	32416	\N	Bivona-L5_Tumor	NA_Bivona-L5_Tumor
127585	\N	\N	10063	32417	\N	Bivona-L6_Tumor	NA_Bivona-L6_Tumor
123165	\N	\N	2272	28760	\N	2272 Nevus	CGP-1551_NA
123166	\N	\N	2274	28754	\N	2274 Nevus	CGP-1545_NA
123167	\N	\N	2276	28757	\N	2276 Nevus	CGP-1548_NA
123168	\N	\N	2278	28763	\N	2278 Nevus	CGP-1554_NA
123169	\N	\N	2280	28766	\N	2280 Nevus	CGP-1557_NA
123170	\N	\N	2282	28769	\N	2282 Nevus	CGP-1560_NA
123171	\N	\N	2284	28772	\N	2284 Nevus	CGP-1576_NA
123172	\N	\N	2286	28751	\N	2286 Nevus	CGP-1482_NA
127586	\N	\N	10064	32418	\N	10-41439_Melanoma	NA_10-41439_Melanoma
123179	\N	\N	2861	31887	\N	2861 Nevus	Rob-T005-Nev_NA
123180	\N	\N	2865	31889	\N	2865 Nevus	Rob-T008-Nev_NA
123181	\N	\N	2867	31891	\N	2867 Nevus	Rob-T009-Nev_NA
123182	\N	\N	2869	31893	\N	2869 Nevus	Rob-T010-Nev_NA
123183	\N	\N	2912	27657	\N	2912 Nevus	21-4_NA
123184	\N	\N	2911	27656	\N	2911 Nevus	21-3_NA
123185	\N	\N	2915	27661	\N	2915 Nevus	22_Nevus_NA
123186	\N	\N	2921	27677	\N	2921 Nevus	24-3_NA
123187	\N	\N	2922	27678	\N	2922 Nevus	24-4_NA
123188	\N	\N	2926	27683	\N	2926 Nevus	28-4_NA
123189	\N	\N	2925	28965	\N	2925 Nevus	D28-3_NA
123190	\N	\N	3277	29715	\N	3277 Nevus	Ivanka_9_3_NA
123191	\N	\N	3278	29716	\N	3278 Nevus	Ivanka_9_4_NA
123192	\N	\N	3292	29730	\N	3292 Nevus	Ivanka_16_3_NA
123193	\N	\N	3293	29731	\N	3293 Nevus	Ivanka_16_4_NA
123194	\N	\N	3298	29741	\N	3298 Nevus	Ivanka_22_4_NA
123195	\N	\N	3297	29740	\N	3297 Nevus	Ivanka_22_3_NA
123196	\N	\N	3377	30567	\N	3377 Nevus	MIN_2_NA
123197	\N	\N	3380	30570	\N	3380 Nevus	MIN_5_NA
123198	\N	\N	3808	29735	\N	3808 Nevus	Ivanka_20_3_NA
123199	\N	\N	3809	29736	\N	3809 Nevus	Ivanka_20_4_NA
123200	\N	\N	3905	32334	\N	3905 Nevus	10 NEV_RNA
123201	\N	\N	3907	32336	\N	3907 Nevus	12 NEV_RNA
123202	\N	\N	3909	32338	\N	3909 Nevus	18 NEV_RNA
123203	\N	\N	3911	32340	\N	3911 Nevus	19 NEV_RNA
123204	\N	\N	3913	32342	\N	3913 Nevus	20 NEV_RNA
123205	\N	\N	3915	32347	\N	3915 Nevus	21 NEV_RNA
123206	\N	\N	3917	32349	\N	3917 Nevus	22 NEV_RNA
123207	\N	\N	3919	32351	\N	3919 Nevus	23 NEV_RNA
123208	\N	\N	3921	32353	\N	3921 Nevus	25 NEV_RNA
123209	\N	\N	3923	32355	\N	3923 Nevus	26 NEV_RNA
123210	\N	\N	3925	32357	\N	3925 Nevus	27 NEV_RNA
123211	\N	\N	3927	32359	\N	3927 Nevus	28 NEV_RNA
123212	\N	\N	3928	32343	\N	3928 Nevus	3 NEV_RNA
123213	\N	\N	3930	32345	\N	3930 Nevus	5 NEV_RNA
123214	\N	\N	56	27749	\N	56 MIS3	AM2 D-08
123216	\N	\N	388	27881	\N	388 MIS3	AM2 D-139
123217	\N	\N	1239	27931	\N	1239 MIS3	AM2 D-189
123218	\N	\N	1241	27933	\N	1241 MIS3	AM2 D-191
123223	\N	\N	372	27865	\N	372 Normal1	AM2 D-123
123224	\N	\N	369	27862	\N	369 Normal1	AM2 D-120
123225	\N	\N	376	27869	\N	376 Normal1	AM2 D-127
123226	\N	\N	98	27829	\N	98 Normal2	AM2 D-88
123227	\N	\N	1242	27934	\N	1242 Normal2	AM2 D-192
123228	\N	\N	84	27777	\N	84 Mel	AM2 D-36
123245	\N	\N	618	30379	\N	618 Mel	MDD-36
123246	\N	\N	629	30382	\N	629 Mel	MDD-39
123247	\N	\N	627	30380	\N	627 Mel	MDD-37
123248	\N	\N	628	30381	\N	628 Mel	MDD-38
123249	\N	\N	631	30384	\N	631 Mel	MDD-41
123250	\N	\N	630	30383	\N	630 Mel	MDD-40
123251	\N	\N	632	30344	\N	632 Mel	MDD-01
123252	\N	\N	661	30373	\N	661 Mel	MDD-30
123253	\N	\N	660	30372	\N	660 Mel	MDD-29
123254	\N	\N	639	30351	\N	639 Mel	MDD-08
123255	\N	\N	635	30347	\N	635 Mel	MDD-04
123257	\N	\N	662	30374	\N	662 Mel	MDD-31
123258	\N	\N	652	30364	\N	652 Mel	MDD-21
123259	\N	\N	658	30370	\N	658 Mel	MDD-27
123261	\N	\N	663	30375	\N	663 Mel	MDD-32
123262	\N	\N	653	30365	\N	653 Mel	MDD-22
123263	\N	\N	664	30376	\N	664 Mel	MDD-33
123264	\N	\N	643	30355	\N	643 Mel	MDD-12
123265	\N	\N	648	30360	\N	648 Mel	MDD-17
123266	\N	\N	642	30354	\N	642 Mel	MDD-11
123267	\N	\N	665	30377	\N	665 Mel	MDD-34
123268	\N	\N	656	30368	\N	656 Mel	MDD-25
123269	\N	\N	666	30378	\N	666 Mel	MDD-35
123270	\N	\N	659	30371	\N	659 Mel	MDD-28
123271	\N	\N	633	30345	\N	633 Mel	MDD-02
123273	\N	\N	637	30349	\N	637 Mel	MDD-06
123275	\N	\N	641	30353	\N	641 Mel	MDD-10
123276	\N	\N	655	30367	\N	655 Mel	MDD-24
123277	\N	\N	657	30369	\N	657 Mel	MDD-26
123278	\N	\N	649	30361	\N	649 Mel	MDD-18
123279	\N	\N	654	30366	\N	654 Mel	MDD-23
123281	\N	\N	636	30348	\N	636 Mel	MDD-05
123282	\N	\N	640	30352	\N	640 Mel	MDD-09
123283	\N	\N	645	30357	\N	645 Mel	MDD-14
123284	\N	\N	634	30346	\N	634 Mel	MDD-03
123285	\N	\N	644	30356	\N	644 Mel	MDD-13
123291	\N	\N	784	29280	\N	784 Mel	DNA-65
123174	\N	\N	2296	29600	\N	2296 Nevus	DNA-433
123175	\N	\N	2300	29604	\N	2300 Nevus	DNA-437
123176	\N	\N	2445	29608	\N	2445 Nevus	DNA-441
123177	\N	\N	2448	29611	\N	2448 Nevus	DNA-444
123178	\N	\N	2460	29614	\N	2460 Nevus	DNA-447
123215	\N	\N	75	27768	\N	75 MIS3	AM2 D-27
123219	\N	\N	1557	28061	\N	1557 MIS3	AM2 D-337
123220	\N	\N	1618	28154	\N	1618 MIS3	AM2 D-451
123221	\N	\N	1620	28412	\N	1620 MIS3	AM2 R-445
123222	\N	\N	2035	28201	\N	2035 MIS3	AM2 D-499
123229	\N	\N	293	31572	\N	293 Mel	RNA-14
123230	\N	\N	282	31561	\N	282 Mel	RNA-03
123231	\N	\N	291	31570	\N	291 Mel	RNA-12
123232	\N	\N	288	31567	\N	288 Mel	RNA-09
123233	\N	\N	303	31582	\N	303 Mel	RNA-24
123234	\N	\N	285	31564	\N	285 Mel	RNA-06
123235	\N	\N	297	31576	\N	297 Mel	RNA-18
123236	\N	\N	299	31578	\N	299 Mel	RNA-20
123237	\N	\N	295	31574	\N	295 Mel	RNA-16
123238	\N	\N	301	31580	\N	301 Mel	RNA-22
123239	\N	\N	344	31586	\N	344 Mel	RNA-28
123240	\N	\N	349	31591	\N	349 Mel	RNA-33
123241	\N	\N	353	31595	\N	353 Mel	RNA-37
123242	\N	\N	351	31593	\N	351 Mel	RNA-35
123243	\N	\N	356	31598	\N	356 Mel	RNA-40
123244	\N	\N	347	31589	\N	347 Mel	RNA-31
123256	\N	\N	646	30358	\N	646 Mel	MDD-15
123260	\N	\N	638	30350	\N	638 Mel	MDD-07
123272	\N	\N	650	30362	\N	650 Mel	MDD-19
123274	\N	\N	647	30359	\N	647 Mel	MDD-16
123280	\N	\N	651	30363	\N	651 Mel	MDD-20
123286	\N	\N	772	29261	\N	772 Mel	DNA-43
123287	\N	\N	774	29263	\N	774 Mel	DNA-45
123288	\N	\N	776	29267	\N	776 Mel	DNA-49
123289	\N	\N	779	29274	\N	779 Mel	DNA-55
123290	\N	\N	781	29278	\N	781 Mel	DNA-61
123292	\N	\N	791	29289	\N	791 Mel	DNA-76
123293	\N	\N	794	29270	\N	794 Mel	DNA-53
123294	\N	\N	795	29265	\N	795 Mel	DNA-47
123295	\N	\N	799	29290	\N	799 Mel	DNA-77
123296	\N	\N	802	29293	\N	802 Mel	DNA-80
123297	\N	\N	805	29276	\N	805 Mel	DNA-59
127587	\N	\N	10065	32418	\N	10-41439_Melanoma	NA_10-41439_Melanoma
127588	\N	\N	10066	32419	\N	10-41439_Nevus	NA_10-41439_Nevus
127589	\N	\N	10067	32419	\N	10-41439_Nevus	NA_10-41439_Nevus
127590	\N	\N	10068	32420	\N	10-41439_Normal	NA_10-41439_Normal
127591	\N	\N	10069	32421	\N	11-23681_Melanoma	NA_11-23681_Melanoma
127592	\N	\N	10070	32421	\N	11-23681_Melanoma	NA_11-23681_Melanoma
127593	\N	\N	10071	32422	\N	11-23681_Nevus	NA_11-23681_Nevus
123299	\N	\N	896	31635	\N	896 Mel	RNA-101 (Mel_1)
123300	\N	\N	897	31636	\N	897 Mel	RNA-102 (Mel_2)
123301	\N	\N	898	31637	\N	898 Mel	RNA-103 (Mel_3)
123302	\N	\N	899	31638	\N	899 Mel	RNA-104 (Mel_4)
123303	\N	\N	901	31640	\N	901 Mel	RNA-106 (Mel_6)
123304	\N	\N	900	31639	\N	900 Mel	RNA-105 (Mel_5)
123305	\N	\N	912	30385	\N	912 Mel	MDD-42
123306	\N	\N	913	30386	\N	913 Mel	MDD-43
123307	\N	\N	914	30387	\N	914 Mel	MDD-44
123308	\N	\N	915	30388	\N	915 Mel	MDD-45
123309	\N	\N	961	30434	\N	961 Mel	MDD-91
123310	\N	\N	920	30393	\N	920 Mel	MDD-50
123311	\N	\N	962	30435	\N	962 Mel	MDD-92
123312	\N	\N	930	30403	\N	930 Mel	MDD-60
123313	\N	\N	945	30418	\N	945 Mel	MDD-75
123314	\N	\N	959	30432	\N	959 Mel	MDD-89
123315	\N	\N	916	30389	\N	916 Mel	MDD-46
123316	\N	\N	944	30417	\N	944 Mel	MDD-74
123317	\N	\N	973	30446	\N	973 Mel	MDD-103
123318	\N	\N	933	30406	\N	933 Mel	MDD-63
123319	\N	\N	918	30391	\N	918 Mel	MDD-48
123320	\N	\N	926	30399	\N	926 Mel	MDD-56
123321	\N	\N	949	30422	\N	949 Mel	MDD-79
123322	\N	\N	979	30452	\N	979 Mel	MDD-109
123323	\N	\N	919	30392	\N	919 Mel	MDD-49
123324	\N	\N	931	30404	\N	931 Mel	MDD-61
123325	\N	\N	974	30447	\N	974 Mel	MDD-104
123326	\N	\N	942	30415	\N	942 Mel	MDD-72
123327	\N	\N	964	30437	\N	964 Mel	MDD-94
123328	\N	\N	978	30451	\N	978 Mel	MDD-108
123329	\N	\N	951	30424	\N	951 Mel	MDD-81
123330	\N	\N	947	30420	\N	947 Mel	MDD-77
123331	\N	\N	957	30430	\N	957 Mel	MDD-87
123332	\N	\N	929	30402	\N	929 Mel	MDD-59
123333	\N	\N	948	30421	\N	948 Mel	MDD-78
123334	\N	\N	971	30444	\N	971 Mel	MDD-101
123335	\N	\N	975	30448	\N	975 Mel	MDD-105
123336	\N	\N	921	30394	\N	921 Mel	MDD-51
123337	\N	\N	936	30409	\N	936 Mel	MDD-66
123338	\N	\N	924	30397	\N	924 Mel	MDD-54
123339	\N	\N	953	30426	\N	953 Mel	MDD-83
123340	\N	\N	927	30400	\N	927 Mel	MDD-57
123341	\N	\N	946	30419	\N	946 Mel	MDD-76
123342	\N	\N	977	30450	\N	977 Mel	MDD-107
123343	\N	\N	923	30396	\N	923 Mel	MDD-53
123344	\N	\N	939	30412	\N	939 Mel	MDD-69
123345	\N	\N	940	30413	\N	940 Mel	MDD-70
123346	\N	\N	934	30407	\N	934 Mel	MDD-64
123347	\N	\N	965	30438	\N	965 Mel	MDD-95
123348	\N	\N	928	30401	\N	928 Mel	MDD-58
123349	\N	\N	917	30390	\N	917 Mel	MDD-47
123350	\N	\N	935	30408	\N	935 Mel	MDD-65
123351	\N	\N	925	30398	\N	925 Mel	MDD-55
123352	\N	\N	967	30440	\N	967 Mel	MDD-97
123353	\N	\N	956	30429	\N	956 Mel	MDD-86
123354	\N	\N	943	30416	\N	943 Mel	MDD-73
123355	\N	\N	972	30445	\N	972 Mel	MDD-102
123356	\N	\N	976	30449	\N	976 Mel	MDD-106
123357	\N	\N	950	30423	\N	950 Mel	MDD-80
123358	\N	\N	970	30443	\N	970 Mel	MDD-100
123359	\N	\N	969	30442	\N	969 Mel	MDD-99
123360	\N	\N	922	30395	\N	922 Mel	MDD-52
123361	\N	\N	955	30428	\N	955 Mel	MDD-85
123362	\N	\N	963	30436	\N	963 Mel	MDD-93
123363	\N	\N	960	30433	\N	960 Mel	MDD-90
123364	\N	\N	938	30411	\N	938 Mel	MDD-68
123365	\N	\N	932	30405	\N	932 Mel	MDD-62
123366	\N	\N	941	30414	\N	941 Mel	MDD-71
123367	\N	\N	954	30427	\N	954 Mel	MDD-84
123368	\N	\N	966	30439	\N	966 Mel	MDD-96
123369	\N	\N	937	30410	\N	937 Mel	MDD-67
123370	\N	\N	952	30425	\N	952 Mel	MDD-82
123371	\N	\N	968	30441	\N	968 Mel	MDD-98
123372	\N	\N	958	30431	\N	958 Mel	MDD-88
123373	\N	\N	1022	30453	\N	1022 Mel	MDD-110
123374	\N	\N	1023	30454	\N	1023 Mel	MDD-111
123375	\N	\N	1024	30455	\N	1024 Mel	MDD-112
123376	\N	\N	1025	30456	\N	1025 Mel	MDD-113
123377	\N	\N	1091	30522	\N	1091 Mel	MDD-179
123378	\N	\N	1026	30457	\N	1026 Mel	MDD-114
123379	\N	\N	1095	30526	\N	1095 Mel	MDD-183
123380	\N	\N	1048	30479	\N	1048 Mel	MDD-136
123381	\N	\N	1074	30505	\N	1074 Mel	MDD-162
123382	\N	\N	1082	30513	\N	1082 Mel	MDD-170
123383	\N	\N	1071	30502	\N	1071 Mel	MDD-159
123384	\N	\N	1088	30519	\N	1088 Mel	MDD-176
123385	\N	\N	1064	30495	\N	1064 Mel	MDD-152
123386	\N	\N	1062	30493	\N	1062 Mel	MDD-150
123387	\N	\N	1053	30484	\N	1053 Mel	MDD-141
123388	\N	\N	1033	30464	\N	1033 Mel	MDD-121
123389	\N	\N	1037	30468	\N	1037 Mel	MDD-125
123390	\N	\N	1083	30514	\N	1083 Mel	MDD-171
123391	\N	\N	1106	30537	\N	1106 Mel	MDD-194
123392	\N	\N	1087	30518	\N	1087 Mel	MDD-175
123393	\N	\N	1114	30545	\N	1114 Mel	MDD-202
123394	\N	\N	1099	30530	\N	1099 Mel	MDD-187
123395	\N	\N	1056	30487	\N	1056 Mel	MDD-144
123396	\N	\N	1060	30491	\N	1060 Mel	MDD-148
123397	\N	\N	1126	30557	\N	1126 Mel	MDD-214
123398	\N	\N	1128	30559	\N	1128 Mel	MDD-216
123399	\N	\N	1118	30549	\N	1118 Mel	MDD-206
123400	\N	\N	1108	30539	\N	1108 Mel	MDD-196
123401	\N	\N	1044	30475	\N	1044 Mel	MDD-132
123402	\N	\N	1057	30488	\N	1057 Mel	MDD-145
123403	\N	\N	1052	30483	\N	1052 Mel	MDD-140
123404	\N	\N	1073	30504	\N	1073 Mel	MDD-161
123405	\N	\N	1089	30520	\N	1089 Mel	MDD-177
123406	\N	\N	1032	30463	\N	1032 Mel	MDD-120
123407	\N	\N	1113	30544	\N	1113 Mel	MDD-201
123408	\N	\N	1065	30496	\N	1065 Mel	MDD-153
123409	\N	\N	1054	30485	\N	1054 Mel	MDD-142
123410	\N	\N	1067	30498	\N	1067 Mel	MDD-155
123411	\N	\N	1079	30510	\N	1079 Mel	MDD-167
123412	\N	\N	1116	30547	\N	1116 Mel	MDD-204
123413	\N	\N	1101	30532	\N	1101 Mel	MDD-189
123414	\N	\N	1103	30534	\N	1103 Mel	MDD-191
123415	\N	\N	1132	30563	\N	1132 Mel	MDD-220
123416	\N	\N	1077	30508	\N	1077 Mel	MDD-165
123417	\N	\N	1107	30538	\N	1107 Mel	MDD-195
123418	\N	\N	1097	30528	\N	1097 Mel	MDD-185
123419	\N	\N	1085	30516	\N	1085 Mel	MDD-173
123420	\N	\N	1045	30476	\N	1045 Mel	MDD-133
123421	\N	\N	1036	30467	\N	1036 Mel	MDD-124
123422	\N	\N	1049	30480	\N	1049 Mel	MDD-137
123423	\N	\N	1115	30546	\N	1115 Mel	MDD-203
123424	\N	\N	1119	30550	\N	1119 Mel	MDD-207
123425	\N	\N	1046	30477	\N	1046 Mel	MDD-134
123426	\N	\N	1125	30556	\N	1125 Mel	MDD-213
123427	\N	\N	1061	30492	\N	1061 Mel	MDD-149
123428	\N	\N	1100	30531	\N	1100 Mel	MDD-188
123429	\N	\N	1080	30511	\N	1080 Mel	MDD-168
123430	\N	\N	1111	30542	\N	1111 Mel	MDD-199
123431	\N	\N	1039	30470	\N	1039 Mel	MDD-127
123432	\N	\N	1117	30548	\N	1117 Mel	MDD-205
123433	\N	\N	1058	30489	\N	1058 Mel	MDD-146
123434	\N	\N	1059	30490	\N	1059 Mel	MDD-147
123435	\N	\N	1055	30486	\N	1055 Mel	MDD-143
123436	\N	\N	1063	30494	\N	1063 Mel	MDD-151
123437	\N	\N	1104	30535	\N	1104 Mel	MDD-192
123438	\N	\N	1086	30517	\N	1086 Mel	MDD-174
123439	\N	\N	1031	30462	\N	1031 Mel	MDD-119
123440	\N	\N	1094	30525	\N	1094 Mel	MDD-182
123441	\N	\N	1109	30540	\N	1109 Mel	MDD-197
123442	\N	\N	1090	30521	\N	1090 Mel	MDD-178
123443	\N	\N	1130	30561	\N	1130 Mel	MDD-218
123444	\N	\N	1105	30536	\N	1105 Mel	MDD-193
123445	\N	\N	1051	30482	\N	1051 Mel	MDD-139
123446	\N	\N	1035	30466	\N	1035 Mel	MDD-123
123447	\N	\N	1043	30474	\N	1043 Mel	MDD-131
123448	\N	\N	1093	30524	\N	1093 Mel	MDD-181
123449	\N	\N	1121	30552	\N	1121 Mel	MDD-209
123450	\N	\N	1110	30541	\N	1110 Mel	MDD-198
123451	\N	\N	1034	30465	\N	1034 Mel	MDD-122
123452	\N	\N	1096	30527	\N	1096 Mel	MDD-184
123453	\N	\N	1078	30509	\N	1078 Mel	MDD-166
123454	\N	\N	1127	30558	\N	1127 Mel	MDD-215
123455	\N	\N	1081	30512	\N	1081 Mel	MDD-169
123456	\N	\N	1124	30555	\N	1124 Mel	MDD-212
123457	\N	\N	1066	30497	\N	1066 Mel	MDD-154
123458	\N	\N	1069	30500	\N	1069 Mel	MDD-157
123459	\N	\N	1084	30515	\N	1084 Mel	MDD-172
123460	\N	\N	1092	30523	\N	1092 Mel	MDD-180
123461	\N	\N	1042	30473	\N	1042 Mel	MDD-130
123462	\N	\N	1041	30472	\N	1041 Mel	MDD-129
123463	\N	\N	1102	30533	\N	1102 Mel	MDD-190
123464	\N	\N	1120	30551	\N	1120 Mel	MDD-208
123465	\N	\N	1075	30506	\N	1075 Mel	MDD-163
123466	\N	\N	1122	30553	\N	1122 Mel	MDD-210
123467	\N	\N	1070	30501	\N	1070 Mel	MDD-158
123468	\N	\N	1098	30529	\N	1098 Mel	MDD-186
123469	\N	\N	1028	30459	\N	1028 Mel	MDD-116
123470	\N	\N	1050	30481	\N	1050 Mel	MDD-138
123471	\N	\N	1129	30560	\N	1129 Mel	MDD-217
123472	\N	\N	1133	30564	\N	1133 Mel	MDD-221
123473	\N	\N	1027	30458	\N	1027 Mel	MDD-115
123474	\N	\N	1068	30499	\N	1068 Mel	MDD-156
123475	\N	\N	1131	30562	\N	1131 Mel	MDD-219
123476	\N	\N	1072	30503	\N	1072 Mel	MDD-160
123477	\N	\N	1123	30554	\N	1123 Mel	MDD-211
123478	\N	\N	1076	30507	\N	1076 Mel	MDD-164
123479	\N	\N	1112	30543	\N	1112 Mel	MDD-200
123480	\N	\N	1310	31599	\N	1310 Mel	RNA-41
127594	\N	\N	10072	32422	\N	11-23681_Nevus	NA_11-23681_Nevus
123518	\N	\N	1675	30680	\N	1675 Mel	MMD-102
123521	\N	\N	1680	30650	\N	1680 Mel	MMD-72
123482	\N	\N	1627	30582	\N	1627 Mel	MMD-02
123483	\N	\N	1628	30583	\N	1628 Mel	MMD-03
123484	\N	\N	1630	30585	\N	1630 Mel	MMD-05
123485	\N	\N	1629	30584	\N	1629 Mel	MMD-04
123486	\N	\N	1631	30586	\N	1631 Mel	MMD-06
123487	\N	\N	1633	30588	\N	1633 Mel	MMD-08
123488	\N	\N	1632	30587	\N	1632 Mel	MMD-07
123489	\N	\N	1634	30589	\N	1634 Mel	MMD-09
123490	\N	\N	1635	30590	\N	1635 Mel	MMD-10
123491	\N	\N	1636	30947	\N	1636 Mel	MMR-11
123492	\N	\N	1637	30948	\N	1637 Mel	MMR-12
123493	\N	\N	1639	30950	\N	1639 Mel	MMR-14
123494	\N	\N	1638	30949	\N	1638 Mel	MMR-13
123495	\N	\N	1640	30951	\N	1640 Mel	MMR-15
123496	\N	\N	1641	30952	\N	1641 Mel	MMR-16
123497	\N	\N	1643	30598	\N	1643 Mel	MMD-18
123498	\N	\N	1644	30599	\N	1644 Mel	MMD-19
123499	\N	\N	1645	30600	\N	1645 Mel	MMD-20
123500	\N	\N	1646	30601	\N	1646 Mel	MMD-21
123501	\N	\N	1647	30602	\N	1647 Mel	MMD-22
123502	\N	\N	1648	30608	\N	1648 Mel	MMD-28
123503	\N	\N	1650	30610	\N	1650 Mel	MMD-30
123504	\N	\N	1651	30967	\N	1651 Mel	MMR-31
123505	\N	\N	1652	30612	\N	1652 Mel	MMD-32
123506	\N	\N	1653	30613	\N	1653 Mel	MMD-33
123507	\N	\N	1655	30615	\N	1655 Mel	MMD-35
123508	\N	\N	1657	30617	\N	1657 Mel	MMD-37
123509	\N	\N	1658	30618	\N	1658 Mel	MMD-38
123510	\N	\N	1660	30620	\N	1660 Mel	MMD-40
123511	\N	\N	1661	30621	\N	1661 Mel	MMD-41
123512	\N	\N	1662	30622	\N	1662 Mel	MMD-42
123513	\N	\N	1665	30977	\N	1665 Mel	MMR-44
123514	\N	\N	1666	30625	\N	1666 Mel	MMD-45
123515	\N	\N	1667	30979	\N	1667 Mel	MMR-46
123516	\N	\N	1669	30628	\N	1669 Mel	MMD-48
123517	\N	\N	1672	30631	\N	1672 Mel	MMD-51
123519	\N	\N	1677	30645	\N	1677 Mel	MMD-67
123520	\N	\N	1678	30648	\N	1678 Mel	MMD-70
123522	\N	\N	1681	30651	\N	1681 Mel	MMD-73
123523	\N	\N	1682	30654	\N	1682 Mel	MMD-76
123524	\N	\N	1684	30656	\N	1684 Mel	MMD-78
123525	\N	\N	1686	30659	\N	1686 Mel	MMD-81
123526	\N	\N	1688	30661	\N	1688 Mel	MMD-83
123527	\N	\N	1689	30664	\N	1689 Mel	MMD-86
123528	\N	\N	1691	30664	\N	1691 Mel	MMD-86
123529	\N	\N	1693	30998	\N	1693 Mel	MMR-89
123530	\N	\N	1695	30669	\N	1695 Mel	MMD-91
123531	\N	\N	1697	30669	\N	1697 Mel	MMD-91
123532	\N	\N	1699	30674	\N	1699 Mel	MMD-96
123533	\N	\N	1700	31005	\N	1700 Mel	MMR-97
123534	\N	\N	1701	31006	\N	1701 Mel	MMR-98
123535	\N	\N	1704	30689	\N	1704 Mel	MMD-112
123536	\N	\N	1707	30692	\N	1707 Mel	MMD-115
123537	\N	\N	1708	30693	\N	1708 Mel	MMD-116
123538	\N	\N	1712	30696	\N	1712 Mel	MMD-119
123539	\N	\N	1713	31015	\N	1713 Mel	MMR-120
123540	\N	\N	1715	30698	\N	1715 Mel	MMD-121
123541	\N	\N	1717	30701	\N	1717 Mel	MMD-124
123542	\N	\N	1719	30701	\N	1719 Mel	MMD-124
123543	\N	\N	1721	30703	\N	1721 Mel	MMD-126
123544	\N	\N	1724	30706	\N	1724 Mel	MMD-129
123545	\N	\N	1727	30794	\N	1727 Mel	MMD-219
123546	\N	\N	1729	30711	\N	1729 Mel	MMD-134
123547	\N	\N	1731	30713	\N	1731 Mel	MMD-136
123548	\N	\N	1733	31026	\N	1733 Mel	MMR-140
123549	\N	\N	1734	30716	\N	1734 Mel	MMD-141
123550	\N	\N	1736	30718	\N	1736 Mel	MMD-143
123551	\N	\N	1741	30724	\N	1741 Mel	MMD-149
123552	\N	\N	1743	30726	\N	1743 Mel	MMD-151
123553	\N	\N	1744	30726	\N	1744 Mel	MMD-151
123554	\N	\N	1747	30730	\N	1747 Mel	MMD-155
123555	\N	\N	1749	31034	\N	1749 Mel	MMR-157
123556	\N	\N	1750	30733	\N	1750 Mel	MMD-158
123557	\N	\N	1752	30735	\N	1752 Mel	MMD-160
123558	\N	\N	1754	30737	\N	1754 Mel	MMD-162
123559	\N	\N	1755	30738	\N	1755 Mel	MMD-163
123560	\N	\N	1757	30740	\N	1757 Mel	MMD-165
123561	\N	\N	1759	30742	\N	1759 Mel	MMD-167
123562	\N	\N	1762	30745	\N	1762 Mel	MMD-170
123563	\N	\N	1764	31044	\N	1764 Mel	MMR-172
127595	\N	\N	10073	32423	\N	11-23681_Normal	NA_11-23681_Normal
127596	\N	\N	10074	32424	\N	11-37533_Melanoma	NA_11-37533_Melanoma
127597	\N	\N	10075	32424	\N	11-37533_Melanoma	NA_11-37533_Melanoma
127598	\N	\N	10076	32425	\N	11-37533_Nevus	NA_11-37533_Nevus
127599	\N	\N	10077	32425	\N	11-37533_Nevus	NA_11-37533_Nevus
127600	\N	\N	10078	32426	\N	11-37533_Normal	NA_11-37533_Normal
127601	\N	\N	10079	32427	\N	KIT262_Tumor	NA_KIT262_Tumor
127602	\N	\N	10080	32428	\N	Dog12_Tumor	NA_Dog12_Tumor
127603	\N	\N	10081	32429	\N	Dog24_Tumor	NA_Dog24_Tumor
127604	\N	\N	10082	32430	\N	Dog43_Tumor	NA_Dog43_Tumor
127605	\N	\N	10083	32431	\N	Dog55_Tumor	NA_Dog55_Tumor
127606	\N	\N	10084	32432	\N	HW3_Tumor	NA_HW3_Tumor
127607	\N	\N	10085	32433	\N	HW3_Normal	NA_HW3_Normal
127608	\N	\N	10086	32434	\N	HW4_Tumor	NA_HW4_Tumor
123588	\N	\N	1818	30813	\N	1818 Mel	MMD-238
123595	\N	\N	1837	30838	\N	1837 Mel	MMD-263
123619	\N	\N	1975	31346	\N	1975 Mel	OM D-44.2
123623	\N	\N	1989	31360	\N	1989 Mel	OM D-57
123624	\N	\N	2038	31309	\N	2038 Mel	NM D-084
123625	\N	\N	2039	31310	\N	2039 Mel	NM D-085
123626	\N	\N	2040	31311	\N	2040 Mel	NM D-086
123627	\N	\N	2044	31314	\N	2044 Mel	NM D-089
123628	\N	\N	2043	31313	\N	2043 Mel	NM D-088
123629	\N	\N	2045	31315	\N	2045 Mel	NM D-090
123630	\N	\N	2047	31317	\N	2047 Mel	NM D-092
123631	\N	\N	2048	31318	\N	2048 Mel	NM D-093
123632	\N	\N	2049	31319	\N	2049 Mel	NM D-094
123633	\N	\N	2051	31321	\N	2051 Mel	NM D-096
123634	\N	\N	2053	31323	\N	2053 Mel	NM D-098
123635	\N	\N	2052	31322	\N	2052 Mel	NM D-097
123636	\N	\N	2064	28926	\N	2064 Mel	D-NA-587
123637	\N	\N	2067	28929	\N	2067 Mel	D-NA-590
123642	\N	\N	2083	28944	\N	2083 Mel	D-NA-647
123643	\N	\N	2086	28920	\N	2086 Mel	D-NA-562
123646	\N	\N	2095	28899	\N	2095 Mel	D-NA-541
123647	\N	\N	2098	28905	\N	2098 Mel	D-NA-547
123648	\N	\N	2101	28908	\N	2101 Mel	D-NA-550
123649	\N	\N	2104	28902	\N	2104 Mel	D-NA-544
123671	\N	\N	2271	28761	\N	2271 Mel	CGP-1552_NA
123672	\N	\N	2273	28755	\N	2273 Mel	CGP-1546_NA
123673	\N	\N	2275	28758	\N	2275 Mel	CGP-1549_NA
123674	\N	\N	2277	28764	\N	2277 Mel	CGP-1555_NA
123675	\N	\N	2279	28767	\N	2279 Mel	CGP-1558_NA
123676	\N	\N	2281	28770	\N	2281 Mel	CGP-1561_NA
123677	\N	\N	2283	28773	\N	2283 Mel	CGP-1577_NA
123678	\N	\N	2285	28752	\N	2285 Mel	CGP-1483_NA
123565	\N	\N	1767	30750	\N	1767 Mel	MMD-175
123566	\N	\N	1769	31047	\N	1769 Mel	MMR-177
123567	\N	\N	1770	30753	\N	1770 Mel	MMD-178
123568	\N	\N	1771	30753	\N	1771 Mel	MMD-178
123569	\N	\N	1774	30756	\N	1774 Mel	MMD-181
123570	\N	\N	1775	30757	\N	1775 Mel	MMD-182
123571	\N	\N	1777	31052	\N	1777 Mel	MMR-184
123572	\N	\N	1780	31054	\N	1780 Mel	MMR-187
123573	\N	\N	1782	30771	\N	1782 Mel	MMD-196
123574	\N	\N	1783	30772	\N	1783 Mel	MMD-197
123575	\N	\N	1786	31060	\N	1786 Mel	MMR-200
123576	\N	\N	1787	30776	\N	1787 Mel	MMD-201
123577	\N	\N	1790	30852	\N	1790 Mel	MMD-277
123578	\N	\N	1792	30781	\N	1792 Mel	MMD-206
123579	\N	\N	1796	30877	\N	1796 Mel	MMD-302
123580	\N	\N	1799	31096	\N	1799 Mel	MMR-305
123581	\N	\N	1801	30796	\N	1801 Mel	MMD-221
123582	\N	\N	1803	30798	\N	1803 Mel	MMD-223
123583	\N	\N	1805	30800	\N	1805 Mel	MMD-225
123584	\N	\N	1808	30803	\N	1808 Mel	MMD-228
123585	\N	\N	1810	30805	\N	1810 Mel	MMD-230
123586	\N	\N	1812	30807	\N	1812 Mel	MMD-232
123587	\N	\N	1814	30809	\N	1814 Mel	MMD-234
123589	\N	\N	1820	30815	\N	1820 Mel	MMD-240
123590	\N	\N	1826	30817	\N	1826 Mel	MMD-242
123591	\N	\N	1828	31080	\N	1828 Mel	MMR-244
123592	\N	\N	1830	30821	\N	1830 Mel	MMD-246
123593	\N	\N	1833	31083	\N	1833 Mel	MMR-249
123594	\N	\N	1835	30826	\N	1835 Mel	MMD-251
123596	\N	\N	1839	30903	\N	1839 Mel	MMD-328
123597	\N	\N	1841	30905	\N	1841 Mel	MMD-330
123598	\N	\N	1843	30907	\N	1843 Mel	MMD-332
123599	\N	\N	1846	30910	\N	1846 Mel	MMD-335
123600	\N	\N	1847	30911	\N	1847 Mel	MMD-336
123601	\N	\N	1849	30913	\N	1849 Mel	MMD-338
123602	\N	\N	1851	30915	\N	1851 Mel	MMD-340
123603	\N	\N	1853	31118	\N	1853 Mel	MMR-342
123604	\N	\N	1855	31120	\N	1855 Mel	MMR-344
123605	\N	\N	1858	31123	\N	1858 Mel	MMR-347
123606	\N	\N	1861	31126	\N	1861 Mel	MMR-350
123607	\N	\N	1863	31128	\N	1863 Mel	MMR-352
123608	\N	\N	1884	30133	\N	1884 Mel	LN D-078
123609	\N	\N	1889	30137	\N	1889 Mel	LN D-083
123610	\N	\N	1917	29368	\N	1917 Mel	DNA-160
123611	\N	\N	1921	29372	\N	1921 Mel	DNA-164
123612	\N	\N	1923	29374	\N	1923 Mel	DNA-166
123613	\N	\N	1926	29377	\N	1926 Mel	DNA-169
123614	\N	\N	1931	29382	\N	1931 Mel	DNA-174
123615	\N	\N	1935	29386	\N	1935 Mel	DNA-178
123616	\N	\N	1941	29392	\N	1941 Mel	DNA-184
123617	\N	\N	1944	29395	\N	1944 Mel	DNA-187
123618	\N	\N	1951	29402	\N	1951 Mel	DNA-194
123620	\N	\N	1977	31348	\N	1977 Mel	OM D-45
123621	\N	\N	1978	31349	\N	1978 Mel	OM D-46
123622	\N	\N	1979	31350	\N	1979 Mel	OM D-47
123638	\N	\N	2071	28941	\N	2071 Mel	D-NA-631
123639	\N	\N	2074	28911	\N	2074 Mel	D-NA-553
123640	\N	\N	2077	28914	\N	2077 Mel	D-NA-556
123641	\N	\N	2080	28917	\N	2080 Mel	D-NA-559
123644	\N	\N	2089	28923	\N	2089 Mel	D-NA-565
123645	\N	\N	2092	28896	\N	2092 Mel	D-NA-538
123650	\N	\N	2109	29479	\N	2109 Mel	DNA-273
123651	\N	\N	2111	29481	\N	2111 Mel	DNA-275
123652	\N	\N	2114	29484	\N	2114 Mel	DNA-278
123653	\N	\N	2117	29487	\N	2117 Mel	DNA-281
123654	\N	\N	2124	29494	\N	2124 Mel	DNA-288
123655	\N	\N	2129	29518	\N	2129 Mel	DNA-312
123656	\N	\N	2131	29520	\N	2131 Mel	DNA-314
123657	\N	\N	2184	29531	\N	2184 Mel	DNA-334
123658	\N	\N	2187	29534	\N	2187 Mel	DNA-337
123659	\N	\N	2190	29537	\N	2190 Mel	DNA-340
123660	\N	\N	2193	29540	\N	2193 Mel	DNA-344
123661	\N	\N	2196	29543	\N	2196 Mel	DNA-348
123662	\N	\N	2200	29547	\N	2200 Mel	DNA-355
123663	\N	\N	2204	29551	\N	2204 Mel	DNA-359
123664	\N	\N	2211	29558	\N	2211 Mel	DNA-369
123665	\N	\N	2215	29562	\N	2215 Mel	DNA-377
123666	\N	\N	2219	29566	\N	2219 Mel	DNA-383
123667	\N	\N	2227	29574	\N	2227 Mel	DNA-394
123668	\N	\N	2230	29577	\N	2230 Mel	DNA-399
123669	\N	\N	2234	29581	\N	2234 Mel	DNA-404
123679	\N	\N	2287	29591	\N	2287 Mel	DNA-424
123680	\N	\N	2290	29594	\N	2290 Mel	DNA-427
123681	\N	\N	2292	29596	\N	2292 Mel	DNA-429
127609	\N	\N	10087	32435	\N	HW4_Normal	NA_HW4_Normal
127610	\N	\N	10088	32436	\N	HW6_Tumor	NA_HW6_Tumor
127611	\N	\N	10089	32437	\N	HW6_Normal	NA_HW6_Normal
127612	\N	\N	10090	32438	\N	10-86469_Tumor	NA_10-86469_Tumor
127613	\N	\N	10091	32439	\N	11-12273_Tumor	NA_11-12273_Tumor
127614	\N	\N	10092	32440	\N	11-23710_Tumor	NA_11-23710_Tumor
127615	\N	\N	10093	32441	\N	11-30426_Tumor	NA_11-30426_Tumor
127616	\N	\N	10094	32442	\N	11-31904_Tumor	NA_11-31904_Tumor
127617	\N	\N	10095	32443	\N	11-47644_Tumor	NA_11-47644_Tumor
127618	\N	\N	10096	32444	\N	MB_161_Tumor	NA_MB_161_Tumor
127619	\N	\N	10097	32445	\N	MB_161_Normal	NA_MB_161_Normal
123685	\N	\N	2425	28978	\N	2425 Mel	D47_NA
123689	\N	\N	2803	29897	\N	2803 Mel	Kit_227_Acral_WT_NA
123690	\N	\N	2860	31885	\N	2860 Mel	Rob-T003-Mel_NA
123691	\N	\N	2909	28962	\N	2909 Mel	D21-1_NA
123692	\N	\N	2910	27655	\N	2910 Mel	21-2_NA
123693	\N	\N	2914	27660	\N	2914 Mel	22_Melanoma_NA
123694	\N	\N	2919	27675	\N	2919 Mel	24-1_NA
123695	\N	\N	2920	27676	\N	2920 Mel	24-2_NA
123696	\N	\N	2923	28963	\N	2923 Mel	D28-1_NA
123697	\N	\N	2924	28964	\N	2924 Mel	D28-2_NA
123698	\N	\N	3275	29713	\N	3275 Mel	Ivanka_9_1_NA
123699	\N	\N	3276	29714	\N	3276 Mel	Ivanka_9_2_NA
123700	\N	\N	3291	29729	\N	3291 Mel	Ivanka_16_2_NA
123701	\N	\N	3290	29728	\N	3290 Mel	Ivanka_16_1_NA
123702	\N	\N	3296	29739	\N	3296 Mel	Ivanka_22_2_NA
123703	\N	\N	3295	29738	\N	3295 Mel	Ivanka_22_1_NA
123704	\N	\N	3376	30566	\N	3376 Mel	MIN_1_NA
123705	\N	\N	3379	30569	\N	3379 Mel	MIN_4_NA
123706	\N	\N	3806	29733	\N	3806 Mel	Ivanka_20_1_NA
123707	\N	\N	3807	29734	\N	3807 Mel	Ivanka_20_2_NA
123708	\N	\N	3858	31883	\N	3858 Mel	Rob-T001-Mel_NA
123709	\N	\N	3904	32333	\N	3904 Mel	10 MEL_RNA
123710	\N	\N	3906	32335	\N	3906 Mel	12 MEL_RNA
123711	\N	\N	3908	32337	\N	3908 Mel	18 MEL_RNA
123712	\N	\N	3910	32339	\N	3910 Mel	19 MEL_RNA
123713	\N	\N	3912	32341	\N	3912 Mel	20 MEL_RNA
123715	\N	\N	3916	32348	\N	3916 Mel	22 MEL_RNA
123716	\N	\N	3918	32350	\N	3918 Mel	23 MEL_RNA
123717	\N	\N	3920	32352	\N	3920 Mel	25 MEL_RNA
123718	\N	\N	3922	32354	\N	3922 Mel	26 MEL_RNA
123719	\N	\N	3924	32356	\N	3924 Mel	27 MEL_RNA
123720	\N	\N	3926	32358	\N	3926 Mel	28 MEL_RNA
123721	\N	\N	3929	32344	\N	3929 Mel	5 MEL_RNA
123722	\N	\N	32	27797	\N	32 MIS	AM2 D-56
123723	\N	\N	33	27798	\N	33 MIS	AM2 D-57
123726	\N	\N	787	29260	\N	787 MIS	DNA-41
123727	\N	\N	884	29297	\N	884 MIS	DNA-85
123729	\N	\N	1146	27919	\N	1146 MIS	AM2 D-177
123683	\N	\N	2297	29601	\N	2297 Mel	DNA-434
123684	\N	\N	2299	29603	\N	2299 Mel	DNA-436
123686	\N	\N	2443	29606	\N	2443 Mel	DNA-439
123687	\N	\N	2447	29610	\N	2447 Mel	DNA-443
123688	\N	\N	2476	27663	\N	2476 Mel	22-44183B-DNA
123724	\N	\N	355	31597	\N	355 MIS	RNA-39
123725	\N	\N	343	31585	\N	343 MIS	RNA-27
123728	\N	\N	885	29298	\N	885 MIS	DNA-86
123730	\N	\N	1498	28009	\N	1498 MIS	AM2 D-276
123731	\N	\N	1671	30630	\N	1671 MIS	MMD-50
123732	\N	\N	1674	30679	\N	1674 MIS	MMD-101
123733	\N	\N	1692	30666	\N	1692 MIS	MMD-88
123734	\N	\N	1694	30999	\N	1694 MIS	MMR-90
123735	\N	\N	1703	31007	\N	1703 MIS	MMR-100
123736	\N	\N	1706	30691	\N	1706 MIS	MMD-114
123737	\N	\N	1710	30695	\N	1710 MIS	MMD-118
123738	\N	\N	1711	30695	\N	1711 MIS	MMD-118
123739	\N	\N	1716	30700	\N	1716 MIS	MMD-123
123740	\N	\N	1723	30705	\N	1723 MIS	MMD-128
123741	\N	\N	1726	30708	\N	1726 MIS	MMD-131
123742	\N	\N	1737	30719	\N	1737 MIS	MMD-144
123743	\N	\N	1746	31032	\N	1746 MIS	MMR-153
123744	\N	\N	1751	30734	\N	1751 MIS	MMD-159
123745	\N	\N	1761	30744	\N	1761 MIS	MMD-169
123746	\N	\N	1772	30754	\N	1772 MIS	MMD-179
123747	\N	\N	1794	30783	\N	1794 MIS	MMD-208
123748	\N	\N	1798	30879	\N	1798 MIS	MMD-304
123749	\N	\N	1807	30802	\N	1807 MIS	MMD-227
123750	\N	\N	1816	30811	\N	1816 MIS	MMD-236
123751	\N	\N	1832	30823	\N	1832 MIS	MMD-248
123752	\N	\N	1844	30909	\N	1844 MIS	MMD-334
123753	\N	\N	1857	31122	\N	1857 MIS	MMR-346
123754	\N	\N	1860	31125	\N	1860 MIS	MMR-349
123755	\N	\N	1918	29369	\N	1918 MIS	DNA-161
123756	\N	\N	1927	29378	\N	1927 MIS	DNA-170
123757	\N	\N	1932	29383	\N	1932 MIS	DNA-175
123758	\N	\N	1938	29389	\N	1938 MIS	DNA-181
123759	\N	\N	1954	31731	\N	1954 MIS	RNA-197
123760	\N	\N	2119	29489	\N	2119 MIS	DNA-283
123761	\N	\N	2122	29492	\N	2122 MIS	DNA-286
123762	\N	\N	2197	29544	\N	2197 MIS	DNA-350
123763	\N	\N	2201	29548	\N	2201 MIS	DNA-356
123764	\N	\N	2207	29554	\N	2207 MIS	DNA-364
123765	\N	\N	2212	29559	\N	2212 MIS	DNA-372
123766	\N	\N	2220	29567	\N	2220 MIS	DNA-385
123767	\N	\N	2231	29578	\N	2231 MIS	DNA-401
123768	\N	\N	2237	29584	\N	2237 MIS	DNA-417
123769	\N	\N	2243	29588	\N	2243 MIS	DNA-421
123770	\N	\N	2295	29599	\N	2295 MIS	DNA-432
123771	\N	\N	2444	29607	\N	2444 MIS	DNA-440
123772	\N	\N	2451	29961	\N	2451 MIS	LMM D-017
123773	\N	\N	2459	29613	\N	2459 MIS	DNA-446
123774	\N	\N	2454	29964	\N	2454 MIS	LMM D-020
123775	\N	\N	2470	29967	\N	2470 MIS	LMM D-023
123776	\N	\N	2487	30000	\N	2487 MIS	LMM D-056
123777	\N	\N	2473	28237	\N	2473 MIS	AM2 D-539
123778	\N	\N	2484	29997	\N	2484 MIS	LMM D-053
123779	\N	\N	2481	29994	\N	2481 MIS	LMM D-050
123780	\N	\N	2474	28238	\N	2474 MIS	AM2 D-540
123781	\N	\N	2478	29991	\N	2478 MIS	LMM D-047
123782	\N	\N	2492	29946	\N	2492 MIS	LMM D-002
123783	\N	\N	2495	29949	\N	2495 MIS	LMM D-005
123784	\N	\N	2498	29952	\N	2498 MIS	LMM D-008
123785	\N	\N	2501	29955	\N	2501 MIS	LMM D-011
123786	\N	\N	2504	29958	\N	2504 MIS	LMM D-014
123787	\N	\N	2507	30031	\N	2507 MIS	LMM R-026
123788	\N	\N	2510	30033	\N	2510 MIS	LMM R-029
123789	\N	\N	2513	30035	\N	2513 MIS	LMM R-032
123790	\N	\N	2516	30037	\N	2516 MIS	LMM R-035
123791	\N	\N	2519	30039	\N	2519 MIS	LMM R-038
123792	\N	\N	2522	30041	\N	2522 MIS	LMM R-041
123793	\N	\N	2525	30043	\N	2525 MIS	LMM R-044
127620	\N	\N	10098	32446	\N	MB_327_Tumor	NA_MB_327_Tumor
127621	\N	\N	10099	32447	\N	MB_1454_Normal	NA_MB_1454_Normal
127622	\N	\N	10100	32448	\N	MB_760_Tumor	NA_MB_760_Tumor
127623	\N	\N	10101	32449	\N	MB_1418_Normal	NA_MB_1418_Normal
127624	\N	\N	10102	32450	\N	MB_1029_Tumor	NA_MB_1029_Tumor
127625	\N	\N	10103	32451	\N	MB_1028_Normal	NA_MB_1028_Normal
127626	\N	\N	10104	32452	\N	MB_1046_Tumor	NA_MB_1046_Tumor
127627	\N	\N	10105	32453	\N	MB_1036_Normal	NA_MB_1036_Normal
127628	\N	\N	10106	32454	\N	Bivona-L17_Tumor	NA_Bivona-L17_Tumor
123807	\N	\N	110	32169	\N	110 DN	TPP_3-01
123808	\N	\N	111	32170	\N	111 DN	TPP_3-02
123809	\N	\N	112	32171	\N	112 DN	TPP_3-03
123810	\N	\N	113	32172	\N	113 DN	TPP_3-04
123811	\N	\N	114	32173	\N	114 DN	TPP_3-05
123812	\N	\N	115	32174	\N	115 DN	TPP_3-06
123813	\N	\N	116	32175	\N	116 DN	TPP_3-07
123814	\N	\N	117	32176	\N	117 DN	TPP_3-08
123815	\N	\N	118	32177	\N	118 DN	TPP_3-09
123816	\N	\N	119	32178	\N	119 DN	TPP_3-10
123817	\N	\N	120	32179	\N	120 DN	TPP_3-11
123818	\N	\N	121	32180	\N	121 DN	TPP_3-12
123819	\N	\N	122	32181	\N	122 DN	TPP_3-13
123820	\N	\N	123	32182	\N	123 DN	TPP_3-14
123821	\N	\N	124	32183	\N	124 DN	TPP_3-15
123822	\N	\N	125	32184	\N	125 DN	TPP_3-16
123823	\N	\N	126	32185	\N	126 DN	TPP_3-17
123824	\N	\N	127	32186	\N	127 DN	TPP_3-18
123825	\N	\N	128	32187	\N	128 DN	TPP_3-19
123826	\N	\N	129	32188	\N	129 DN	TPP_3-20
123827	\N	\N	130	32189	\N	130 DN	TPP_3-21
123828	\N	\N	131	32190	\N	131 DN	TPP_3-22
123829	\N	\N	132	32191	\N	132 DN	TPP_3-23
123830	\N	\N	133	32192	\N	133 DN	TPP_3-24
123831	\N	\N	134	32193	\N	134 DN	TPP_3-25
123832	\N	\N	136	32195	\N	136 DN	TPP_3-27
123833	\N	\N	135	32194	\N	135 DN	TPP_3-26
123834	\N	\N	137	32196	\N	137 DN	TPP_3-28
123835	\N	\N	138	32197	\N	138 DN	TPP_3-29
123836	\N	\N	139	32198	\N	139 DN	TPP_3-30
123837	\N	\N	140	32199	\N	140 DN	TPP_3-31
123838	\N	\N	141	32200	\N	141 DN	TPP_3-32
123839	\N	\N	142	32201	\N	142 DN	TPP_3-33
123840	\N	\N	143	32202	\N	143 DN	TPP_3-34
123841	\N	\N	144	32203	\N	144 DN	TPP_3-35
123842	\N	\N	145	32204	\N	145 DN	TPP_3-36
123843	\N	\N	146	32205	\N	146 DN	TPP_3-37
123844	\N	\N	147	32206	\N	147 DN	TPP_3-38
123845	\N	\N	148	32207	\N	148 DN	TPP_3-39
123846	\N	\N	150	32209	\N	150 DN	TPP_3-41
123847	\N	\N	151	32210	\N	151 DN	TPP_3-42
123848	\N	\N	149	32208	\N	149 DN	TPP_3-40
123849	\N	\N	153	32212	\N	153 DN	TPP_3-44
123850	\N	\N	152	32211	\N	152 DN	TPP_3-43
123851	\N	\N	154	32213	\N	154 DN	TPP_3-45
123852	\N	\N	156	32215	\N	156 DN	TPP_3-47
123853	\N	\N	155	32214	\N	155 DN	TPP_3-46
123854	\N	\N	157	32216	\N	157 DN	TPP_3-48
123855	\N	\N	158	32217	\N	158 DN	TPP_3-49
123856	\N	\N	159	32218	\N	159 DN	TPP_3-50
123857	\N	\N	160	32219	\N	160 DN	TPP_3-51
123858	\N	\N	162	32221	\N	162 DN	TPP_3-53
123859	\N	\N	161	32220	\N	161 DN	TPP_3-52
123860	\N	\N	165	32054	\N	165 DN	TPP 1_1
123861	\N	\N	163	32222	\N	163 DN	TPP_3-54
123862	\N	\N	164	32223	\N	164 DN	TPP_3-55
123863	\N	\N	166	32055	\N	166 DN	TPP 1_2
123864	\N	\N	168	32057	\N	168 DN	TPP 1_4
123865	\N	\N	167	32056	\N	167 DN	TPP 1_3
123866	\N	\N	171	32060	\N	171 DN	TPP 1_7
123867	\N	\N	172	32061	\N	172 DN	TPP 1_8
123868	\N	\N	170	32059	\N	170 DN	TPP 1_6
123869	\N	\N	169	32058	\N	169 DN	TPP 1_5
123870	\N	\N	174	32063	\N	174 DN	TPP 1_10
123871	\N	\N	176	32065	\N	176 DN	TPP 1_12
123872	\N	\N	175	32064	\N	175 DN	TPP 1_11
123873	\N	\N	173	32062	\N	173 DN	TPP 1_9
123874	\N	\N	177	32066	\N	177 DN	TPP 1_13
123875	\N	\N	179	32068	\N	179 DN	TPP 1_15
123876	\N	\N	178	32067	\N	178 DN	TPP 1_14
123877	\N	\N	180	32069	\N	180 DN	TPP 1_16
123878	\N	\N	181	32070	\N	181 DN	TPP 1_17
123879	\N	\N	182	32071	\N	182 DN	TPP 1_18
123880	\N	\N	183	32072	\N	183 DN	TPP 1_19
123881	\N	\N	184	32073	\N	184 DN	TPP 1_20
123882	\N	\N	185	32074	\N	185 DN	TPP 1_21
123883	\N	\N	186	32075	\N	186 DN	TPP 1_22
123884	\N	\N	187	32076	\N	187 DN	TPP 1_23
123885	\N	\N	188	32077	\N	188 DN	TPP 1_24
123886	\N	\N	189	32078	\N	189 DN	TPP 1_25
123887	\N	\N	191	32080	\N	191 DN	TPP 1_27
123888	\N	\N	190	32079	\N	190 DN	TPP 1_26
123889	\N	\N	193	32082	\N	193 DN	TPP 2_2
123890	\N	\N	192	32081	\N	192 DN	TPP 2_1
123891	\N	\N	194	32083	\N	194 DN	TPP 2_3
123892	\N	\N	195	32084	\N	195 DN	TPP 2_4
123893	\N	\N	196	32085	\N	196 DN	TPP 2_5
123894	\N	\N	197	32086	\N	197 DN	TPP 2_6
123895	\N	\N	198	32087	\N	198 DN	TPP 2_7
123896	\N	\N	199	32088	\N	199 DN	TPP 2_8
123897	\N	\N	200	32089	\N	200 DN	TPP 2_9
123898	\N	\N	201	32090	\N	201 DN	TPP 2_10
123899	\N	\N	202	32091	\N	202 DN	TPP 2_11
123900	\N	\N	203	32092	\N	203 DN	TPP 2_12
123901	\N	\N	204	32093	\N	204 DN	TPP 2_13
123902	\N	\N	205	32094	\N	205 DN	TPP 2_14
123903	\N	\N	237	32126	\N	237 DN	TPP 2_46
123904	\N	\N	252	32141	\N	252 DN	TPP 2_61
123905	\N	\N	220	32109	\N	220 DN	TPP 2_29
123906	\N	\N	218	32107	\N	218 DN	TPP 2_27
123907	\N	\N	240	32129	\N	240 DN	TPP 2_49
123908	\N	\N	208	32097	\N	208 DN	TPP 2_17
123909	\N	\N	259	32148	\N	259 DN	TPP 2_68
123910	\N	\N	207	32096	\N	207 DN	TPP 2_16
123911	\N	\N	276	32165	\N	276 DN	TPP 2_85
123912	\N	\N	256	32145	\N	256 DN	TPP 2_65
123913	\N	\N	278	32167	\N	278 DN	TPP 2_87
123914	\N	\N	231	32120	\N	231 DN	TPP 2_40
123915	\N	\N	254	32143	\N	254 DN	TPP 2_63
123916	\N	\N	275	32164	\N	275 DN	TPP 2_84
123917	\N	\N	263	32152	\N	263 DN	TPP 2_72
123918	\N	\N	261	32150	\N	261 DN	TPP 2_70
123919	\N	\N	269	32158	\N	269 DN	TPP 2_78
123920	\N	\N	215	32104	\N	215 DN	TPP 2_24
123921	\N	\N	232	32121	\N	232 DN	TPP 2_41
123922	\N	\N	247	32136	\N	247 DN	TPP 2_56
123923	\N	\N	243	32132	\N	243 DN	TPP 2_52
123924	\N	\N	253	32142	\N	253 DN	TPP 2_62
123925	\N	\N	241	32130	\N	241 DN	TPP 2_50
123926	\N	\N	223	32112	\N	223 DN	TPP 2_32
123927	\N	\N	219	32108	\N	219 DN	TPP 2_28
123928	\N	\N	250	32139	\N	250 DN	TPP 2_59
123929	\N	\N	248	32137	\N	248 DN	TPP 2_57
123930	\N	\N	228	32117	\N	228 DN	TPP 2_37
123931	\N	\N	273	32162	\N	273 DN	TPP 2_82
123932	\N	\N	210	32099	\N	210 DN	TPP 2_19
123933	\N	\N	249	32138	\N	249 DN	TPP 2_58
123934	\N	\N	222	32111	\N	222 DN	TPP 2_31
123935	\N	\N	260	32149	\N	260 DN	TPP 2_69
123936	\N	\N	239	32128	\N	239 DN	TPP 2_48
123937	\N	\N	234	32123	\N	234 DN	TPP 2_43
123938	\N	\N	221	32110	\N	221 DN	TPP 2_30
123939	\N	\N	224	32113	\N	224 DN	TPP 2_33
123940	\N	\N	235	32124	\N	235 DN	TPP 2_44
123941	\N	\N	226	32115	\N	226 DN	TPP 2_35
123942	\N	\N	266	32155	\N	266 DN	TPP 2_75
123943	\N	\N	267	32156	\N	267 DN	TPP 2_76
123944	\N	\N	268	32157	\N	268 DN	TPP 2_77
123945	\N	\N	214	32103	\N	214 DN	TPP 2_23
123946	\N	\N	213	32102	\N	213 DN	TPP 2_22
123947	\N	\N	216	32105	\N	216 DN	TPP 2_25
123948	\N	\N	262	32151	\N	262 DN	TPP 2_71
123949	\N	\N	230	32119	\N	230 DN	TPP 2_39
123950	\N	\N	209	32098	\N	209 DN	TPP 2_18
123951	\N	\N	271	32160	\N	271 DN	TPP 2_80
123952	\N	\N	279	32168	\N	279 DN	TPP 2_88
123953	\N	\N	211	32100	\N	211 DN	TPP 2_20
123954	\N	\N	246	32135	\N	246 DN	TPP 2_55
123955	\N	\N	212	32101	\N	212 DN	TPP 2_21
123956	\N	\N	258	32147	\N	258 DN	TPP 2_67
123957	\N	\N	225	32114	\N	225 DN	TPP 2_34
123958	\N	\N	257	32146	\N	257 DN	TPP 2_66
123959	\N	\N	244	32133	\N	244 DN	TPP 2_53
123960	\N	\N	272	32161	\N	272 DN	TPP 2_81
123961	\N	\N	242	32131	\N	242 DN	TPP 2_51
123962	\N	\N	206	32095	\N	206 DN	TPP 2_15
123963	\N	\N	227	32116	\N	227 DN	TPP 2_36
123964	\N	\N	251	32140	\N	251 DN	TPP 2_60
123965	\N	\N	245	32134	\N	245 DN	TPP 2_54
123966	\N	\N	217	32106	\N	217 DN	TPP 2_26
123967	\N	\N	274	32163	\N	274 DN	TPP 2_83
123968	\N	\N	238	32127	\N	238 DN	TPP 2_47
123969	\N	\N	233	32122	\N	233 DN	TPP 2_42
123970	\N	\N	236	32125	\N	236 DN	TPP 2_45
123971	\N	\N	277	32166	\N	277 DN	TPP 2_86
123972	\N	\N	270	32159	\N	270 DN	TPP 2_79
123973	\N	\N	255	32144	\N	255 DN	TPP 2_64
123974	\N	\N	229	32118	\N	229 DN	TPP 2_38
123975	\N	\N	265	32154	\N	265 DN	TPP 2_74
123976	\N	\N	264	32153	\N	264 DN	TPP 2_73
123977	\N	\N	687	31140	\N	687 DN	MR-001
123978	\N	\N	707	31160	\N	707 DN	MR-030
123979	\N	\N	722	31175	\N	722 DN	MR-045
123980	\N	\N	692	31145	\N	692 DN	MR-006
123981	\N	\N	726	31179	\N	726 DN	MR-049
123982	\N	\N	725	31178	\N	725 DN	MR-048
123983	\N	\N	720	31173	\N	720 DN	MR-043
123984	\N	\N	704	31157	\N	704 DN	MR-026
123985	\N	\N	709	31162	\N	709 DN	MR-032
123986	\N	\N	713	31166	\N	713 DN	MR-036
123987	\N	\N	699	31152	\N	699 DN	MR-017
123988	\N	\N	708	31161	\N	708 DN	MR-031
123989	\N	\N	700	31153	\N	700 DN	MR-020
123990	\N	\N	712	31165	\N	712 DN	MR-035
123991	\N	\N	727	31180	\N	727 DN	MR-050
123992	\N	\N	711	31164	\N	711 DN	MR-034
123993	\N	\N	718	31171	\N	718 DN	MR-041
123994	\N	\N	702	31155	\N	702 DN	MR-024
123995	\N	\N	696	31149	\N	696 DN	MR-011
123996	\N	\N	703	31156	\N	703 DN	MR-025
123997	\N	\N	728	31181	\N	728 DN	MR-051
123998	\N	\N	705	31158	\N	705 DN	MR-027
123999	\N	\N	688	31141	\N	688 DN	MR-002
124000	\N	\N	721	31174	\N	721 DN	MR-044
124001	\N	\N	690	31143	\N	690 DN	MR-004
124002	\N	\N	719	31172	\N	719 DN	MR-042
124003	\N	\N	695	31148	\N	695 DN	MR-010
124004	\N	\N	716	31169	\N	716 DN	MR-039
124005	\N	\N	715	31168	\N	715 DN	MR-038
124006	\N	\N	693	31146	\N	693 DN	MR-008
124007	\N	\N	723	31176	\N	723 DN	MR-046
124008	\N	\N	724	31177	\N	724 DN	MR-047
124009	\N	\N	710	31163	\N	710 DN	MR-033
124010	\N	\N	717	31170	\N	717 DN	MR-040
124011	\N	\N	706	31159	\N	706 DN	MR-029
124012	\N	\N	698	31151	\N	698 DN	MR-015
124013	\N	\N	714	31167	\N	714 DN	MR-037
124014	\N	\N	689	31142	\N	689 DN	MR-003
124015	\N	\N	691	31144	\N	691 DN	MR-005
124016	\N	\N	697	31150	\N	697 DN	MR-012
124017	\N	\N	694	31147	\N	694 DN	MR-009
124018	\N	\N	701	31154	\N	701 DN	MR-021
124019	\N	\N	1249	29193	\N	1249 DN	DN-052
124020	\N	\N	1284	29228	\N	1284 DN	DN-087
124021	\N	\N	1271	29215	\N	1271 DN	DN-074
124022	\N	\N	1250	29194	\N	1250 DN	DN-053
124023	\N	\N	1255	29199	\N	1255 DN	DN-058
124024	\N	\N	1259	29203	\N	1259 DN	DN-062
124025	\N	\N	1276	29220	\N	1276 DN	DN-079
124026	\N	\N	1265	29209	\N	1265 DN	DN-068
124027	\N	\N	1275	29219	\N	1275 DN	DN-078
124028	\N	\N	1256	29200	\N	1256 DN	DN-059
124029	\N	\N	1262	29206	\N	1262 DN	DN-065
124030	\N	\N	1279	29223	\N	1279 DN	DN-082
124031	\N	\N	1282	29226	\N	1282 DN	DN-085
124032	\N	\N	1252	29196	\N	1252 DN	DN-055
124033	\N	\N	1261	29205	\N	1261 DN	DN-064
124034	\N	\N	1272	29216	\N	1272 DN	DN-075
124035	\N	\N	1264	29208	\N	1264 DN	DN-067
124036	\N	\N	1278	29222	\N	1278 DN	DN-081
124037	\N	\N	1251	29195	\N	1251 DN	DN-054
124038	\N	\N	1280	29224	\N	1280 DN	DN-083
124039	\N	\N	1260	29204	\N	1260 DN	DN-063
124040	\N	\N	1283	29227	\N	1283 DN	DN-086
124041	\N	\N	1270	29214	\N	1270 DN	DN-073
124042	\N	\N	1258	29202	\N	1258 DN	DN-061
124043	\N	\N	1253	29197	\N	1253 DN	DN-056
124044	\N	\N	1277	29221	\N	1277 DN	DN-080
124045	\N	\N	1273	29217	\N	1273 DN	DN-076
124046	\N	\N	1268	29212	\N	1268 DN	DN-071
124047	\N	\N	1263	29207	\N	1263 DN	DN-066
124048	\N	\N	1281	29225	\N	1281 DN	DN-084
124049	\N	\N	1257	29201	\N	1257 DN	DN-060
124050	\N	\N	1267	29211	\N	1267 DN	DN-070
124051	\N	\N	1274	29218	\N	1274 DN	DN-077
124052	\N	\N	1254	29198	\N	1254 DN	DN-057
124053	\N	\N	1266	29210	\N	1266 DN	DN-069
124054	\N	\N	1269	29213	\N	1269 DN	DN-072
124055	\N	\N	3484	31140	\N	3484 DN	MR-001
124056	\N	\N	3485	31141	\N	3485 DN	MR-002
124057	\N	\N	3486	31142	\N	3486 DN	MR-003
124058	\N	\N	3487	31143	\N	3487 DN	MR-004
124059	\N	\N	3488	31144	\N	3488 DN	MR-005
124060	\N	\N	3489	31145	\N	3489 DN	MR-006
124061	\N	\N	3490	31146	\N	3490 DN	MR-008
124062	\N	\N	3491	31147	\N	3491 DN	MR-009
124063	\N	\N	3492	31148	\N	3492 DN	MR-010
124064	\N	\N	3493	31149	\N	3493 DN	MR-011
124065	\N	\N	3494	31150	\N	3494 DN	MR-012
124066	\N	\N	3495	31151	\N	3495 DN	MR-015
124067	\N	\N	3496	31152	\N	3496 DN	MR-017
124068	\N	\N	3497	31153	\N	3497 DN	MR-020
124069	\N	\N	3498	31154	\N	3498 DN	MR-021
124070	\N	\N	3500	31156	\N	3500 DN	MR-025
124071	\N	\N	3499	31155	\N	3499 DN	MR-024
124072	\N	\N	3502	31158	\N	3502 DN	MR-027
124073	\N	\N	3501	31157	\N	3501 DN	MR-026
124074	\N	\N	3503	31159	\N	3503 DN	MR-029
124075	\N	\N	3504	31160	\N	3504 DN	MR-030
124076	\N	\N	3505	31161	\N	3505 DN	MR-031
124077	\N	\N	3507	31163	\N	3507 DN	MR-033
124078	\N	\N	3506	31162	\N	3506 DN	MR-032
124079	\N	\N	3508	31164	\N	3508 DN	MR-034
124080	\N	\N	3509	31165	\N	3509 DN	MR-035
124081	\N	\N	3510	31166	\N	3510 DN	MR-036
124082	\N	\N	3511	31167	\N	3511 DN	MR-037
124083	\N	\N	3513	31169	\N	3513 DN	MR-039
124084	\N	\N	3512	31168	\N	3512 DN	MR-038
124085	\N	\N	3514	31170	\N	3514 DN	MR-040
124086	\N	\N	3515	31171	\N	3515 DN	MR-041
124087	\N	\N	3517	31173	\N	3517 DN	MR-043
124088	\N	\N	3516	31172	\N	3516 DN	MR-042
124089	\N	\N	3518	31174	\N	3518 DN	MR-044
124090	\N	\N	3519	31175	\N	3519 DN	MR-045
124091	\N	\N	3520	31176	\N	3520 DN	MR-046
124092	\N	\N	3522	31178	\N	3522 DN	MR-048
124093	\N	\N	3521	31177	\N	3521 DN	MR-047
124094	\N	\N	3525	31181	\N	3525 DN	MR-051
124095	\N	\N	3523	31179	\N	3523 DN	MR-049
124096	\N	\N	3524	31180	\N	3524 DN	MR-050
124097	\N	\N	359	27853	\N	359 Normal 1	AM2 D-111
124098	\N	\N	380	27873	\N	380 Normal 1	AM2 D-131
124099	\N	\N	390	27886	\N	390 Normal 1	AM2 D-144
124100	\N	\N	419	27913	\N	419 Normal 1	AM2 D-171
124101	\N	\N	403	27897	\N	403 Normal 1	AM2 D-155
124102	\N	\N	415	27909	\N	415 Normal 1	AM2 D-167
124103	\N	\N	395	27889	\N	395 Normal 1	AM2 D-147
124104	\N	\N	411	27905	\N	411 Normal 1	AM2 D-163
124105	\N	\N	407	27901	\N	407 Normal 1	AM2 D-159
124106	\N	\N	394	27888	\N	394 Normal 1	AM2 D-146
124107	\N	\N	391	27883	\N	391 Normal 1	AM2 D-141
124108	\N	\N	404	27898	\N	404 Normal 1	AM2 D-156
124109	\N	\N	398	27892	\N	398 Normal 1	AM2 D-150
124110	\N	\N	364	27887	\N	364 Normal 1	AM2 D-145
124111	\N	\N	360	27854	\N	360 Normal 2	AM2 D-112
124112	\N	\N	381	27874	\N	381 Normal 2	AM2 D-132
127774	\N	\N	10252	32587	\N	KIT8_Tumor	NA_KIT8_Tumor
127629	\N	\N	10107	32455	\N	Bivona-L18_Tumor	NA_Bivona-L18_Tumor
124116	\N	\N	379	27872	\N	379 LN Met 1	AM2 D-130
124117	\N	\N	1154	27927	\N	1154 LN Met 1	AM2 D-185
124118	\N	\N	1148	27921	\N	1148 LN Met 1	AM2 D-179
124119	\N	\N	1307	27960	\N	1307 LN Met 1	AM2 D-222
124129	\N	\N	424	31916	\N	424 Blue + spitz	SM D-01
124130	\N	\N	425	31917	\N	425 Blue + spitz	SM D-02
124131	\N	\N	428	31920	\N	428 blue nevus+ cellular+  DF like	SM D-05
124132	\N	\N	427	31919	\N	427 blue nevus+ cellular+  DF like	SM D-04
124133	\N	\N	426	31918	\N	426 blue nevus+ cellular+  DF like	SM D-03
124134	\N	\N	432	31924	\N	432 common + blue	SM D-09
124135	\N	\N	430	31922	\N	430 common + blue	SM D-07
124136	\N	\N	431	31923	\N	431 common + blue	SM D-08
124137	\N	\N	433	31925	\N	433 common + blue	SM D-10
124138	\N	\N	434	31926	\N	434 common + blue	SM D-11
124139	\N	\N	435	31927	\N	435 common + blue	SM D-12
124140	\N	\N	429	31921	\N	429 common + blue	SM D-06
124141	\N	\N	439	31931	\N	439 common+ sclerotic dermal component 	SM D-16
124142	\N	\N	445	31937	\N	445 common+ sclerotic dermal component 	SM D-22
124143	\N	\N	443	31935	\N	443 common+ sclerotic dermal component 	SM D-20
124144	\N	\N	437	31929	\N	437 common+ sclerotic dermal component 	SM D-14
124145	\N	\N	440	31932	\N	440 common+ sclerotic dermal component 	SM D-17
124146	\N	\N	436	31928	\N	436 common+ sclerotic dermal component 	SM D-13
124147	\N	\N	441	31933	\N	441 common+ sclerotic dermal component 	SM D-18
124148	\N	\N	438	31930	\N	438 common+ sclerotic dermal component 	SM D-15
124149	\N	\N	442	31934	\N	442 compound meloncytic nevus 	SM D-19
124150	\N	\N	444	31936	\N	444 blue nevus+ cellular 	SM D-21
124151	\N	\N	446	31938	\N	446 DPN+ pure	SM D-23
124152	\N	\N	447	31939	\N	447 balloon cell nevus	SM D-24
124153	\N	\N	448	31940	\N	448 common & balloon	SM D-25
124154	\N	\N	1999	31371	\N	1999 blue nevus with ovoid melanocytes	OM D-65
124155	\N	\N	452	31963	\N	452 Spitz mel	SMPR2
124156	\N	\N	454	31964	\N	454 Spitz mel	SMPR4
124157	\N	\N	458	31968	\N	458 Spitz mel	SMPR48
124158	\N	\N	460	31970	\N	460 Spitz mel	SMPR56
124159	\N	\N	459	31969	\N	459 Spitz mel	SMPR55
124160	\N	\N	462	31972	\N	462 Spitz mel	SMPR58B
124161	\N	\N	456	31966	\N	456 Spitz mel	SMPR12
124162	\N	\N	457	31967	\N	457 Spitz mel	SMPR20
124163	\N	\N	461	31971	\N	461 Spitz mel	SMPR58A
124164	\N	\N	455	31965	\N	455 Spitz mel	SMPR11
124165	\N	\N	463	28543	\N	463 cellular blue nevus	BND-001
124166	\N	\N	464	28544	\N	464 cellular blue nevus	BND-002
124167	\N	\N	467	28547	\N	467 cellular blue nevus	BND-005
124168	\N	\N	474	28554	\N	474 cellular blue nevus	BND-012
124169	\N	\N	466	28546	\N	466 cellular blue nevus	BND-004
124170	\N	\N	472	28552	\N	472 cellular blue nevus	BND-010
124171	\N	\N	468	28548	\N	468 cellular blue nevus	BND-006
124172	\N	\N	469	28549	\N	469 cellular blue nevus	BND-007
124173	\N	\N	465	28545	\N	465 cellular blue nevus	BND-003
124174	\N	\N	473	28553	\N	473 cellular blue nevus	BND-011
124175	\N	\N	471	28551	\N	471 cellular blue nevus	BND-009
124176	\N	\N	470	28550	\N	470 cellular blue nevus	BND-008
124177	\N	\N	477	31226	\N	477 nevus or nevus like	NLD-013
124178	\N	\N	481	31230	\N	481 nevus or nevus like	NLD-017
124179	\N	\N	486	31235	\N	486 nevus or nevus like	NLD-022
124180	\N	\N	492	28671	\N	492 nevus or nevus like	CGH14-145
124181	\N	\N	494	28719	\N	494 nevus or nevus like	CGH16-200
124182	\N	\N	491	28649	\N	491 nevus or nevus like	CGH12-280
124183	\N	\N	487	31236	\N	487 nevus or nevus like	NLD-023
124184	\N	\N	479	31228	\N	479 nevus or nevus like	NLD-015
124185	\N	\N	497	28744	\N	497 nevus or nevus like	CGH17-240
124186	\N	\N	490	28645	\N	490 nevus or nevus like	CGH12-109
124187	\N	\N	483	31232	\N	483 nevus or nevus like	NLD-019
124188	\N	\N	485	31234	\N	485 nevus or nevus like	NLD-021
124189	\N	\N	478	31227	\N	478 nevus or nevus like	NLD-014
124190	\N	\N	480	31229	\N	480 nevus or nevus like	NLD-016
124191	\N	\N	493	28678	\N	493 nevus or nevus like	CGH14-348
124192	\N	\N	489	31238	\N	489 nevus or nevus like	NLD-025
124193	\N	\N	482	31231	\N	482 nevus or nevus like	NLD-018
124194	\N	\N	488	31237	\N	488 nevus or nevus like	NLD-024
124195	\N	\N	496	28747	\N	496 nevus or nevus like	CGH18-139
124196	\N	\N	484	31233	\N	484 nevus or nevus like	NLD-020
124197	\N	\N	495	28743	\N	495 nevus or nevus like	CGH17-135
124198	\N	\N	502	30077	\N	502 Junctional	LN D-022 (LN-022)
124199	\N	\N	503	30078	\N	503 Junctional	LN D-023 (LN-023)
124200	\N	\N	505	30080	\N	505 Junctional	LN D-025 (LN-025)
124201	\N	\N	506	30081	\N	506 Junctional	LN D-026 (LN-026)
124202	\N	\N	518	30093	\N	518 Junctional	LN D-038 (LN-038)
124203	\N	\N	512	30087	\N	512 Junctional	LN D-032 (LN-032)
124204	\N	\N	509	30084	\N	509 Junctional	LN D-029 (LN-029)
124205	\N	\N	521	30096	\N	521 Junctional	LN D-041 (LN-041)
124206	\N	\N	508	30083	\N	508 Junctional	LN D-028 (LN-028)
124207	\N	\N	513	30088	\N	513 Junctional	LN D-033 (LN-033)
124208	\N	\N	520	30095	\N	520 Junctional	LN D-040 (LN-040)
124209	\N	\N	510	30085	\N	510 Junctional	LN D-030 (LN-030)
124210	\N	\N	507	30082	\N	507 Junctional	LN D-027 (LN-027)
124211	\N	\N	517	30092	\N	517 Junctional	LN D-037 (LN-037)
124212	\N	\N	519	30094	\N	519 Junctional	LN D-039 (LN-039)
124213	\N	\N	514	30089	\N	514 Junctional	LN D-034 (LN-034)
124214	\N	\N	515	30090	\N	515 Junctional	LN D-035 (LN-035)
124215	\N	\N	516	30091	\N	516 Junctional	LN D-036 (LN-036)
124216	\N	\N	504	30079	\N	504 Junctional	LN D-024 (LN-024)
124217	\N	\N	511	30086	\N	511 Junctional	LN D-031 (LN-031)
124218	\N	\N	675	30057	\N	675 Junctional	LN D-02 (LN-02)
124219	\N	\N	680	30062	\N	680 Junctional	LN D-07 (LN-07)
124220	\N	\N	676	30058	\N	676 Junctional	LN D-03 (LN-03)
124221	\N	\N	679	30061	\N	679 Junctional	LN D-06 (LN-06)
124222	\N	\N	677	30059	\N	677 Junctional	LN D-04 (LN-04)
124223	\N	\N	681	30063	\N	681 Junctional	LN D-08 (LN-08)
124224	\N	\N	678	30060	\N	678 Junctional	LN D-05 (LN-05)
124225	\N	\N	682	30064	\N	682 Junctional	LN D-09 (LN-09)
124226	\N	\N	1865	30056	\N	1865 Junctional	LN D-01 (LN-01)
124227	\N	\N	1866	30065	\N	1866 Junctional	LN D-10 (LN-10)
124120	\N	\N	1423	27981	\N	1423 LN Met 1	AM2 D-247
124121	\N	\N	1479	27999	\N	1479 LN Met 1	AM2 D-265
124122	\N	\N	1499	28010	\N	1499 LN Met 1	AM2 D-277
124123	\N	\N	1519	28024	\N	1519 LN Met 1	AM2 D-294
124124	\N	\N	1527	28031	\N	1527 LN Met 1	AM2 D-303
124125	\N	\N	1558	28062	\N	1558 LN Met 1	AM2 D-338
124126	\N	\N	1574	28076	\N	1574 LN Met 1	AM2 D-354
124127	\N	\N	1609	28129	\N	1609 LN Met 1	AM2 D-422
127630	\N	\N	10108	32456	\N	Bivona-L19_Tumor	NA_Bivona-L19_Tumor
127631	\N	\N	10109	32410	\N	KIT227_Tumor	NA_KIT227_Tumor
124228	\N	\N	527	30102	\N	527 Congenital superficial	LN D-047 (LN-047)
124229	\N	\N	526	30101	\N	526 Congenital superficial	LN D-046 (LN-046)
124230	\N	\N	524	30099	\N	524 Congenital superficial	LN D-044 (LN-044)
124231	\N	\N	525	30100	\N	525 Congenital superficial	LN D-045 (LN-045)
124232	\N	\N	523	30098	\N	523 Congenital superficial	LN D-043 (LN-043)
124233	\N	\N	548	30123	\N	548 Congenital superficial	LN D-068 (LN-068)
124234	\N	\N	522	30097	\N	522 Congenital superficial	LN D-042 LN-042)
124235	\N	\N	541	30116	\N	541 Compound	LN D-061 (LN-061)
124236	\N	\N	538	30113	\N	538 Compound	LN D-058 (LN-058)
124237	\N	\N	530	30105	\N	530 Compound	LN D-050 (LN-050)
124238	\N	\N	546	30121	\N	546 Compound	LN D-066 (LN-066)
124239	\N	\N	545	30120	\N	545 Compound	LN D-065 (LN-065)
124240	\N	\N	537	30112	\N	537 Compound	LN D-057 (LN-057)
124241	\N	\N	536	30111	\N	536 Compound	LN D-056 (LN-056)
124242	\N	\N	544	30119	\N	544 Compound	LN D-064 (LN-064)
124243	\N	\N	542	30117	\N	542 Compound	LN D-062 (LN-062)
124244	\N	\N	547	30122	\N	547 Compound	LN D-067 (LN-067)
124245	\N	\N	540	30115	\N	540 Compound	LN D-060 (LN-060)
124246	\N	\N	533	30108	\N	533 Compound	LN D-053 (LN-053)
124247	\N	\N	531	30106	\N	531 Compound	LN D-051 (LN-051)
124248	\N	\N	529	30104	\N	529 Compound	LN D-049 (LN-049)
124249	\N	\N	543	30118	\N	543 Compound	LN D-063 (LN-063)
124250	\N	\N	539	30114	\N	539 Compound	LN D-059 (LN-059)
124251	\N	\N	535	30110	\N	535 Compound	LN D-055 (LN-055)
124252	\N	\N	534	30109	\N	534 Compound	LN D-054 (LN-054)
124253	\N	\N	532	30107	\N	532 Compound	LN D-052 (LN-052)
124254	\N	\N	528	30103	\N	528 Compound	LN D-048 (LN-048)
124255	\N	\N	685	30075	\N	685 Compound	LN D-20 (LN-20)
124256	\N	\N	684	30073	\N	684 Compound	LN D-18 (LN-18)
124257	\N	\N	683	30069	\N	683 Compound	LN D-14 (LN-14)
124258	\N	\N	1867	30066	\N	1867 Compound	LN D-11 (LN-11)
124259	\N	\N	1868	30067	\N	1868 Compound	LN D-12 (LN-12)
124260	\N	\N	1869	30068	\N	1869 Compound	LN D-13 (LN-13)
124261	\N	\N	1870	30070	\N	1870 Compound	LN D-15 (LN-15)
124262	\N	\N	1871	30071	\N	1871 Compound	LN D-16 (LN-16)
124263	\N	\N	1872	30072	\N	1872 Compound	LN D-17 (LN-17)
124264	\N	\N	1873	30074	\N	1873 Compound	LN D-19 (LN-19)
124265	\N	\N	1874	30076	\N	1874 Compound	LN D-21 (LN-21)
124266	\N	\N	551	31239	\N	551 Nodular Mel	NM D-01
124267	\N	\N	556	31244	\N	556 Nodular Mel	NM D-06
124268	\N	\N	601	31289	\N	601 Nodular Mel	NM D-064
124269	\N	\N	591	31279	\N	591 Nodular Mel	NM D-051
124270	\N	\N	552	31240	\N	552 Nodular Mel	NM D-02
124271	\N	\N	587	31275	\N	587 Nodular Mel	NM D-047
124272	\N	\N	593	31281	\N	593 Nodular Mel	NM D-053
124273	\N	\N	565	31253	\N	565 Nodular Mel	NM D-15
124274	\N	\N	589	31277	\N	589 Nodular Mel	NM D-049
124275	\N	\N	600	31288	\N	600 Nodular Mel	NM D-063
124276	\N	\N	599	31287	\N	599 Nodular Mel	NM D-061
124277	\N	\N	558	31246	\N	558 Nodular Mel	NM D-08
124278	\N	\N	579	31267	\N	579 Nodular Mel	NM D-038
124279	\N	\N	576	31264	\N	576 Nodular Mel	NM D-035
124280	\N	\N	590	31278	\N	590 Nodular Mel	NM D-050
124281	\N	\N	602	31290	\N	602 Nodular Mel	NM D-065
124282	\N	\N	566	31254	\N	566 Nodular Mel	NM D-16
124283	\N	\N	588	31276	\N	588 Nodular Mel	NM D-048
124284	\N	\N	571	31259	\N	571 Nodular Mel	NM D-29
124285	\N	\N	572	31260	\N	572 Nodular Mel	NM D-31
124286	\N	\N	582	31270	\N	582 Nodular Mel	NM D-041
124287	\N	\N	559	31247	\N	559 Nodular Mel	NM D-09
124288	\N	\N	553	31241	\N	553 Nodular Mel	NM D-03
124289	\N	\N	596	31284	\N	596 Nodular Mel	NM D-058
124290	\N	\N	561	31249	\N	561 Nodular Mel	NM D-11
124291	\N	\N	560	31248	\N	560 Nodular Mel	NM D-10
124292	\N	\N	567	31255	\N	567 Nodular Mel	NM D-17
124293	\N	\N	581	31269	\N	581 Nodular Mel	NM D-040
124294	\N	\N	573	31261	\N	573 Nodular Mel	NM D-32
124295	\N	\N	554	31242	\N	554 Nodular Mel	NM D-04
124296	\N	\N	562	31250	\N	562 Nodular Mel	NM D-12
124297	\N	\N	585	31273	\N	585 Nodular Mel	NM D-045
124298	\N	\N	557	31245	\N	557 Nodular Mel	NM D-07
124299	\N	\N	555	31243	\N	555 Nodular Mel	NM D-05
124300	\N	\N	583	31271	\N	583 Nodular Mel	NM D-043
124301	\N	\N	564	31252	\N	564 Nodular Mel	NM D-14
124302	\N	\N	577	31265	\N	577 Nodular Mel	NM D-036
124303	\N	\N	569	31257	\N	569 Nodular Mel	NM D-19
124304	\N	\N	584	31272	\N	584 Nodular Mel	NM D-044
124305	\N	\N	570	31258	\N	570 Nodular Mel	NM D-27
124306	\N	\N	598	31286	\N	598 Nodular Mel	NM D-060
124307	\N	\N	574	31262	\N	574 Nodular Mel	NM D-033
124308	\N	\N	563	31251	\N	563 Nodular Mel	NM D-13
124309	\N	\N	597	31285	\N	597 Nodular Mel	NM D-059
124310	\N	\N	580	31268	\N	580 Nodular Mel	NM D-039
124311	\N	\N	594	31282	\N	594 Nodular Mel	NM D-054
124312	\N	\N	568	31256	\N	568 Nodular Mel	NM D-18
124313	\N	\N	578	31266	\N	578 Nodular Mel	NM D-037
124314	\N	\N	575	31263	\N	575 Nodular Mel	NM D-034
124315	\N	\N	586	31274	\N	586 Nodular Mel	NM D-046
124316	\N	\N	595	31283	\N	595 Nodular Mel	NM D-055
124317	\N	\N	592	31280	\N	592 Nodular Mel	NM D-052
124318	\N	\N	1004	31291	\N	1004 Nodular Mel	NM D-066
124319	\N	\N	1005	31292	\N	1005 Nodular Mel	NM D-067
124320	\N	\N	1006	31293	\N	1006 Nodular Mel	NM D-068
124321	\N	\N	1008	31295	\N	1008 Nodular Mel	NM D-070
124322	\N	\N	1007	31294	\N	1007 Nodular Mel	NM D-069
124323	\N	\N	1009	31296	\N	1009 Nodular Mel	NM D-071
124324	\N	\N	1010	31297	\N	1010 Nodular Mel	NM D-072
124325	\N	\N	1011	31298	\N	1011 Nodular Mel	NM D-073
124326	\N	\N	1012	31299	\N	1012 Nodular Mel	NM D-074
124327	\N	\N	1013	31300	\N	1013 Nodular Mel	NM D-075
124328	\N	\N	1014	31301	\N	1014 Nodular Mel	NM D-076
124329	\N	\N	1015	31302	\N	1015 Nodular Mel	NM D-077
124330	\N	\N	1016	31303	\N	1016 Nodular Mel	NM D-078
124331	\N	\N	1017	31304	\N	1017 Nodular Mel	NM D-079
124332	\N	\N	1018	31305	\N	1018 Nodular Mel	NM D-080
124333	\N	\N	1020	31307	\N	1020 Nodular Mel	NM D-082
124334	\N	\N	1019	31306	\N	1019 Nodular Mel	NM D-081
124335	\N	\N	1021	31308	\N	1021 Nodular Mel	NM D-083
124336	\N	\N	604	30323	\N	604 Acral Melanoma Cells	MaMel  152aI (AMC-01)
124337	\N	\N	605	30321	\N	605 Acral Melanoma Cells	M100118 (AMC-02)
124338	\N	\N	606	30576	\N	606 Acral Melanoma Cells	MM100511 (AMC-03)
124339	\N	\N	607	30577	\N	607 Acral Melanoma Cells	MM100512 (AMC-03)
124340	\N	\N	608	30578	\N	608 Acral Melanoma Cells	MM100513 (AMC-03)
124341	\N	\N	609	30579	\N	609 Acral Melanoma Cells	MM100916 (AMC-03)
124342	\N	\N	610	30315	\N	610 Acral Melanoma Cells	M040204 (AMC-07)
124343	\N	\N	611	30317	\N	611 Acral Melanoma Cells	M040415 (AMC-08)
124344	\N	\N	612	30318	\N	612 Acral Melanoma Cells	M040416 (AMC-08)
124345	\N	\N	613	30319	\N	613 Acral Melanoma Cells	M040418 (AMC-08)
124346	\N	\N	614	30320	\N	614 Acral Melanoma Cells	M040419A (AMC-08)
124347	\N	\N	615	30580	\N	615 Acral Melanoma Cells	MM160113 (AMC-12)
124348	\N	\N	616	30322	\N	616 Acral Melanoma Cells	M180322 (AMC-13)
124349	\N	\N	1246	31907	\N	1246 Acral Melanoma Cells	SKMel 1107B Dec2019 (MC-02)
124350	\N	\N	1247	31909	\N	1247 Acral Melanoma Cells	SKMel 1121B Dec2019 (MC-03)
124351	\N	\N	1248	30316	\N	1248 Acral Melanoma Cells	M040204 Dec2019 (AMC-07)
124352	\N	\N	1316	31905	\N	1316 Acral Melanoma Cells	SKMEL 1023A
124353	\N	\N	1317	31906	\N	1317 Acral Melanoma Cells	SKMEL 1107B
124354	\N	\N	1318	31908	\N	1318 Acral Melanoma Cells	SKMEL 1121B
124355	\N	\N	1319	30565	\N	1319 Acral Melanoma Cells	Mel290
124356	\N	\N	2836	32240	\N	2836 Acral Melanoma Cells	WM8_NA
124357	\N	\N	2837	32241	\N	2837 Acral Melanoma Cells	WM51_NA
124358	\N	\N	2838	32242	\N	2838 Acral Melanoma Cells	WM1963_NA
124359	\N	\N	2839	32243	\N	2839 Acral Melanoma Cells	WM3622_NA
124360	\N	\N	2840	32244	\N	2840 Acral Melanoma Cells	WM3912_NA
124361	\N	\N	2841	32245	\N	2841 Acral Melanoma Cells	WM3918_NA
124362	\N	\N	621	28643	\N	621 Nevus?	CGH12-092-D
124363	\N	\N	625	28684	\N	625 Nevus?	CGH15-109-D
124364	\N	\N	619	28640	\N	619 Nevus?	CGH12-056-D
124365	\N	\N	622	28668	\N	622 Nevus?	CGH14-083-D
124366	\N	\N	620	28637	\N	620 Nevus?	CGH12-039-D
124367	\N	\N	624	28745	\N	624 Nevus?	CGH18-012-D
124368	\N	\N	623	28677	\N	623 Nevus?	CGH14-341-D
124369	\N	\N	673	31138	\N	673 Uveal Mel	MP41-D
124370	\N	\N	674	31139	\N	674 Uveal Mel	MP41-YM-R1-D
124371	\N	\N	2760	32224	\N	2760 Uveal Mel	UM1_NA
124372	\N	\N	2761	32225	\N	2761 Uveal Mel	UM2_NA
124373	\N	\N	3838	32226	\N	3838 Uveal Mel	UM23_NA
124374	\N	\N	3839	32227	\N	3839 Uveal Mel	UM24_NA
124375	\N	\N	3840	32228	\N	3840 Uveal Mel	UM25_NA
124376	\N	\N	3841	32229	\N	3841 Uveal Mel	UM26_NA
124377	\N	\N	617	28600	\N	617 Tumor	CGH11-098-D
124378	\N	\N	730	28946	\N	730 Tumor	D-NA-8692
124379	\N	\N	997	28641	\N	997 Tumor	CGH12-058
124380	\N	\N	998	28650	\N	998 Tumor	CGH12-301
124381	\N	\N	999	28666	\N	999 Tumor	CGH14-050
124382	\N	\N	1000	28694	\N	1000 Tumor	CGH15-249
124383	\N	\N	1001	28672	\N	1001 Tumor	CGH14-147
124384	\N	\N	1002	28642	\N	1002 Tumor	CGH12-067
124385	\N	\N	1003	28748	\N	1003 Tumor	CGH19-097_1.00
124386	\N	\N	1144	29918	\N	1144 Tumor	KIT-11
124387	\N	\N	1136	29910	\N	1136 Tumor	KIT-03
124388	\N	\N	1137	29911	\N	1137 Tumor	KIT-04
124389	\N	\N	1141	29915	\N	1141 Tumor	KIT-08
124390	\N	\N	1140	29914	\N	1140 Tumor	KIT-07
124391	\N	\N	1139	29913	\N	1139 Tumor	KIT-06
124392	\N	\N	1135	29909	\N	1135 Tumor	KIT-02
124393	\N	\N	1142	29916	\N	1142 Tumor	KIT-09
124394	\N	\N	1138	29912	\N	1138 Tumor	KIT-05
124395	\N	\N	1143	29917	\N	1143 Tumor	KIT-10
124396	\N	\N	1315	29672	\N	1315 Tumor	Fusion-01
124397	\N	\N	1320	29673	\N	1320 Tumor	Fusion-02
124398	\N	\N	1321	29674	\N	1321 Tumor	Fusion-05
124399	\N	\N	1322	29675	\N	1322 Tumor	Fusion-06
124400	\N	\N	1323	29676	\N	1323 Tumor	Fusion-08
124401	\N	\N	1324	29677	\N	1324 Tumor	Fusion-09
124402	\N	\N	1325	29678	\N	1325 Tumor	Fusion-10
124403	\N	\N	1328	29908	\N	1328 Tumor	KIT-01
124404	\N	\N	1329	29919	\N	1329 Tumor	KIT-12
124405	\N	\N	1330	29920	\N	1330 Tumor	KIT-13
124406	\N	\N	1331	29921	\N	1331 Tumor	KIT-14
124407	\N	\N	1332	29922	\N	1332 Tumor	KIT-15
124408	\N	\N	1333	29923	\N	1333 Tumor	KIT-16
124409	\N	\N	1334	29924	\N	1334 Tumor	KIT-17
124410	\N	\N	1335	29925	\N	1335 Tumor	KIT-18
124411	\N	\N	1336	28594	\N	1336 Tumor	CGH11-045_NA
124412	\N	\N	1345	28647	\N	1345 Tumor	CGH12-191
124413	\N	\N	1339	28617	\N	1339 Tumor	CGH11-282
124414	\N	\N	1337	28599	\N	1337 Tumor	CGH11-092
124415	\N	\N	1344	28639	\N	1344 Tumor	CGH12-055
124416	\N	\N	1341	28621	\N	1341 Tumor	CGH11-386_DNA
124417	\N	\N	1342	28622	\N	1342 Tumor	CGH11-399
124418	\N	\N	1343	28623	\N	1343 Tumor	CGH11-402
124419	\N	\N	1346	28648	\N	1346 Tumor	CGH12-273
124420	\N	\N	1340	28618	\N	1340 Tumor	CGH11-294
124421	\N	\N	1338	28615	\N	1338 Tumor	CGH11-268
124422	\N	\N	1347	28662	\N	1347 Tumor	CGH13-159
124423	\N	\N	1416	28741	\N	1416 Tumor	CGH17-097
124424	\N	\N	1365	28688	\N	1365 Tumor	CGH15-163
124425	\N	\N	1411	28736	\N	1411 Tumor	CGH17-052
124426	\N	\N	1363	28686	\N	1363 Tumor	CGH15-139
124427	\N	\N	1407	28732	\N	1407 Tumor	CGH17-026
124428	\N	\N	1401	28726	\N	1401 Tumor	CGH17-003
124429	\N	\N	1372	28696	\N	1372 Tumor	CGH15-263
124430	\N	\N	1392	28716	\N	1392 Tumor	CGH16-172-2
124431	\N	\N	1397	28722	\N	1397 Tumor	CGH16-222
124432	\N	\N	1403	28728	\N	1403 Tumor	CGH17-015
124433	\N	\N	1387	28711	\N	1387 Tumor	CGH16-105
124434	\N	\N	1398	28723	\N	1398 Tumor	CGH16-250
124435	\N	\N	1362	28685	\N	1362 Tumor	CGH15-115
124436	\N	\N	1368	28691	\N	1368 Tumor	CGH15-210
124437	\N	\N	1402	28727	\N	1402 Tumor	CGH17-008
124438	\N	\N	1394	28718	\N	1394 Tumor	CGH16-198
124439	\N	\N	1379	28703	\N	1379 Tumor	CGH16-053
124440	\N	\N	1350	28665	\N	1350 Tumor	CGH14-032
124441	\N	\N	1378	28702	\N	1378 Tumor	CGH16-038
124442	\N	\N	1351	28669	\N	1351 Tumor	CGH14-119
124443	\N	\N	1404	28729	\N	1404 Tumor	CGH17-017
124444	\N	\N	1391	28715	\N	1391 Tumor	CGH16-136
124445	\N	\N	1367	28690	\N	1367 Tumor	CGH15-206
124446	\N	\N	1388	28712	\N	1388 Tumor	CGH16-117
124447	\N	\N	1369	28692	\N	1369 Tumor	CGH15-211
124448	\N	\N	1354	28674	\N	1354 Tumor	CGH14-286
124449	\N	\N	1405	28730	\N	1405 Tumor	CGH17-021
124450	\N	\N	1353	28673	\N	1353 Tumor	CGH14-181
124451	\N	\N	1382	28706	\N	1382 Tumor	CGH16-071
124452	\N	\N	1370	28693	\N	1370 Tumor	CGH15-246
124453	\N	\N	1360	28682	\N	1360 Tumor	CGH15-082
124454	\N	\N	1395	28720	\N	1395 Tumor	CGH16-209
124455	\N	\N	1377	28701	\N	1377 Tumor	CGH16-035
124456	\N	\N	1366	28689	\N	1366 Tumor	CGH15-176
124457	\N	\N	1380	28704	\N	1380 Tumor	CGH16-054
124458	\N	\N	1361	28683	\N	1361 Tumor	CGH15-090
124459	\N	\N	1364	28687	\N	1364 Tumor	CGH15-151
124460	\N	\N	1384	28708	\N	1384 Tumor	CGH16-089
124461	\N	\N	1385	28709	\N	1385 Tumor	CGH16-093
124462	\N	\N	1348	28663	\N	1348 Tumor	CGH13-321
124463	\N	\N	1414	28739	\N	1414 Tumor	CGH17-083
124464	\N	\N	1352	28670	\N	1352 Tumor	CGH14-144
124465	\N	\N	1412	28737	\N	1412 Tumor	CGH17-058
124466	\N	\N	1355	28675	\N	1355 Tumor	CGH14-293
124467	\N	\N	1390	28714	\N	1390 Tumor	CGH16-130
124468	\N	\N	1373	28697	\N	1373 Tumor	CGH16-002
124469	\N	\N	1393	28717	\N	1393 Tumor	CGH16-179
124470	\N	\N	1413	28738	\N	1413 Tumor	CGH17-076
124471	\N	\N	1371	28695	\N	1371 Tumor	CGH15-253
124472	\N	\N	1400	28725	\N	1400 Tumor	CGH17-001
124473	\N	\N	1389	28713	\N	1389 Tumor	CGH16-123
124474	\N	\N	1383	28707	\N	1383 Tumor	CGH16-087
124475	\N	\N	1357	28679	\N	1357 Tumor	CGH15-043
124476	\N	\N	1349	28664	\N	1349 Tumor	CGH13-340
124477	\N	\N	1399	28724	\N	1399 Tumor	CGH16-254
124478	\N	\N	1415	28740	\N	1415 Tumor	CGH17-095
124479	\N	\N	1417	28742	\N	1417 Tumor	CGH17-104
124480	\N	\N	1381	28705	\N	1381 Tumor	CGH16-062
124481	\N	\N	1409	28734	\N	1409 Tumor	CGH17-033
124482	\N	\N	1356	28676	\N	1356 Tumor	CGH14-328
124483	\N	\N	1376	28700	\N	1376 Tumor	CGH16-032
124484	\N	\N	1410	28735	\N	1410 Tumor	CGH17-039
124485	\N	\N	1375	28699	\N	1375 Tumor	CGH16-025
124486	\N	\N	1359	28681	\N	1359 Tumor	CGH15-081
124487	\N	\N	1408	28733	\N	1408 Tumor	CGH17-031
124488	\N	\N	1396	28721	\N	1396 Tumor	CGH16-215
124489	\N	\N	1374	28698	\N	1374 Tumor	CGH16-023
124490	\N	\N	1358	28680	\N	1358 Tumor	CGH15-064
124491	\N	\N	1406	28731	\N	1406 Tumor	CGH17-024
124492	\N	\N	1386	28710	\N	1386 Tumor	CGH16-097
124493	\N	\N	2250	29679	\N	2250 Tumor	Fusion-11
124494	\N	\N	2251	30572	\N	2251 Tumor	MM-1
124495	\N	\N	2252	30573	\N	2252 Tumor	MM-2
124496	\N	\N	2253	30574	\N	2253 Tumor	MM-3
124497	\N	\N	2254	30575	\N	2254 Tumor	MM-4
124498	\N	\N	2256	31460	\N	2256 Tumor	PM-2
124499	\N	\N	2255	31459	\N	2255 Tumor	PM-1
124500	\N	\N	2258	31462	\N	2258 Tumor	PM-4
124501	\N	\N	2257	31461	\N	2257 Tumor	PM-3
127632	\N	\N	10110	32457	\N	KIT53_Tumor	NA_KIT53_Tumor
124504	\N	\N	2321	28630	\N	2321 Tumor	CGH12_056_NA
124505	\N	\N	2322	28627	\N	2322 Tumor	CGH12_039_NA
124507	\N	\N	2328	28631	\N	2328 Tumor	CGH12_058_NA
124513	\N	\N	2418	28971	\N	2418 Tumor	D40_NA
124516	\N	\N	2695	32231	\N	2695 Tumor	UM38-Tumor_NA
124517	\N	\N	2696	29626	\N	2696 Tumor	DPN 49
124536	\N	\N	2715	29843	\N	2715 Tumor	KAM10-T
124537	\N	\N	2717	29862	\N	2717 Tumor	KAM100-T-11
124538	\N	\N	2718	29863	\N	2718 Tumor	KAM102-T-B
124539	\N	\N	2719	29867	\N	2719 Tumor	KAM113-T-H
124540	\N	\N	2720	29868	\N	2720 Tumor	KAM116-T
124541	\N	\N	2721	29844	\N	2721 Tumor	KAM12-T
124542	\N	\N	2722	29869	\N	2722 Tumor	KAM122-T-A
124543	\N	\N	2723	29870	\N	2723 Tumor	KAM123-T
124544	\N	\N	2725	29872	\N	2725 Tumor	KAM127-T
124545	\N	\N	2726	29873	\N	2726 Tumor	KAM128-T
124546	\N	\N	2727	29874	\N	2727 Tumor	KAM130-T
124547	\N	\N	2729	29876	\N	2729 Tumor	KAM131-T
124548	\N	\N	2730	29845	\N	2730 Tumor	KAM14-T
124549	\N	\N	2731	29846	\N	2731 Tumor	KAM26-T
124550	\N	\N	2732	29841	\N	2732 Tumor	KAM3-T-A
124551	\N	\N	2733	29847	\N	2733 Tumor	KAM34-T
124552	\N	\N	2734	29848	\N	2734 Tumor	KAM37-T
124553	\N	\N	2735	29849	\N	2735 Tumor	KAM43-T
124554	\N	\N	2736	29850	\N	2736 Tumor	KAM48-T
124555	\N	\N	2737	29851	\N	2737 Tumor	KAM62-T
124556	\N	\N	2738	29852	\N	2738 Tumor	KAM65-T
124557	\N	\N	2739	29853	\N	2739 Tumor	KAM71-T
124558	\N	\N	2740	29854	\N	2740 Tumor	KAM75-T
124559	\N	\N	2741	29855	\N	2741 Tumor	KAM79-T
124560	\N	\N	2743	29857	\N	2743 Tumor	KAM93-T
124561	\N	\N	2744	29858	\N	2744 Tumor	KAM95-T-B1
124562	\N	\N	2745	29860	\N	2745 Tumor	KAM99-T
124563	\N	\N	2748	29865	\N	2748 Tumor	KAM111-T-A1
124564	\N	\N	2749	29866	\N	2749 Tumor	KAM111-T-A2
124565	\N	\N	2764	27680	\N	2764 Tumor	26_NA
124568	\N	\N	2768	28580	\N	2768 Tumor	CGH11_109_NA
124569	\N	\N	2770	29635	\N	2770 Tumor	DPN_8_Tumor_NA
124570	\N	\N	2772	27703	\N	2772 Tumor	AM_11_Tumor_NA
124571	\N	\N	2773	27704	\N	2773 Tumor	AM_13_Tumor_NA
124572	\N	\N	2774	27705	\N	2774 Tumor	AM_14_Tumor_NA
124573	\N	\N	2775	27701	\N	2775 Tumor	AM_7_Tumor_NA
124574	\N	\N	2776	27702	\N	2776 Tumor	AM_9_Tumor_NA
124575	\N	\N	2778	29633	\N	2778 Tumor	DPN_7_Tumor_NA
124576	\N	\N	2779	31941	\N	2779 Tumor	SM_1_Tumor_NA
124577	\N	\N	2781	31943	\N	2781 Tumor	SM_2_Tumor_NA
124578	\N	\N	2782	31944	\N	2782 Tumor	SM_3_Tumor_NA
124579	\N	\N	2784	31946	\N	2784 Tumor	SM_4_Tumor_NA
124581	\N	\N	2787	31949	\N	2787 Tumor	SM_6_Tumor_NA
124583	\N	\N	2791	31953	\N	2791 Tumor	SM_8_Tumor_NA
124586	\N	\N	2795	31956	\N	2795 Tumor	SM_10_Tumor_NA
124587	\N	\N	2796	31957	\N	2796 Tumor	SM_11_Tumor_NA
124588	\N	\N	2797	31958	\N	2797 Tumor	SM_12_Tumor_NA
124589	\N	\N	2799	31960	\N	2799 Tumor	SM_16_Tumor_NA
124590	\N	\N	2800	31961	\N	2800 Tumor	SM_18_Tumor_NA
124591	\N	\N	2802	31962	\N	2802 Tumor	SM7_Tumor_NA
124592	\N	\N	2804	29881	\N	2804 Tumor	Kit_53_Acral_NRAS_NA
124593	\N	\N	2805	32249	\N	2805 Tumor	WTMM-17-Tumor_NA
124594	\N	\N	2807	32251	\N	2807 Tumor	WTMM-19-Tumor_NA
124595	\N	\N	2806	32250	\N	2806 Tumor	WTMM-18-Tumor_NA
124596	\N	\N	2808	32252	\N	2808 Tumor	WTMM-20-Tumor_NA
124597	\N	\N	2809	32253	\N	2809 Tumor	WTMM-21-Tumor_NA
124598	\N	\N	2810	32254	\N	2810 Tumor	WTMM-22-Tumor_NA
124599	\N	\N	2811	32255	\N	2811 Tumor	WTMM-23-Tumor_NA
124600	\N	\N	2812	32256	\N	2812 Tumor	WTMM-24-Tumor_NA
124601	\N	\N	2814	29778	\N	2814 Tumor	K2_5
124602	\N	\N	2816	29780	\N	2816 Tumor	K2_7
124514	\N	\N	2457	27669	\N	2457 Tumor	22-104389C-DNA
124515	\N	\N	2456	27665	\N	2456 Tumor	22-104389A2-DNA
124518	\N	\N	2697	27706	\N	2697 Tumor	AM-15-Tumor
124519	\N	\N	2698	27708	\N	2698 Tumor	AM-16-Tumor
124520	\N	\N	2703	27718	\N	2703 Tumor	AM-21-Tumor
124521	\N	\N	2711	27734	\N	2711 Tumor	AM-29-Tumor
124522	\N	\N	2709	27730	\N	2709 Tumor	AM-27-Tumor
124523	\N	\N	2699	27710	\N	2699 Tumor	AM-17-Tumor
124524	\N	\N	2712	27736	\N	2712 Tumor	AM-30-Tumor
124525	\N	\N	2714	27740	\N	2714 Tumor	AM-32-Tumor
124526	\N	\N	2710	27732	\N	2710 Tumor	AM-28-Tumor
124527	\N	\N	2700	27712	\N	2700 Tumor	AM-18-Tumor
124528	\N	\N	2705	27722	\N	2705 Tumor	AM-23-Tumor
124529	\N	\N	2707	27726	\N	2707 Tumor	AM-25-Tumor
124530	\N	\N	2706	27724	\N	2706 Tumor	AM-24-Tumor
124531	\N	\N	2708	27728	\N	2708 Tumor	AM-26-Tumor
124532	\N	\N	2702	27716	\N	2702 Tumor	AM-20-Tumor
124533	\N	\N	2704	27720	\N	2704 Tumor	AM-22-Tumor
124534	\N	\N	2713	27738	\N	2713 Tumor	AM-31-Tumor
124535	\N	\N	2701	27714	\N	2701 Tumor	AM-19-Tumor
124566	\N	\N	2766	29743	\N	2766 Tumor	Ivanka_23_1_NA
124580	\N	\N	2786	31949	\N	2786 Tumor	SM_6_Tumor_NA
124582	\N	\N	2789	31953	\N	2789 Tumor	SM_8_Tumor_NA
124585	\N	\N	2794	31956	\N	2794 Tumor	SM_10_Tumor_NA
127633	\N	\N	10111	32458	\N	KIT313_Tumor	NA_KIT313_Tumor
127634	\N	\N	10112	32459	\N	HW2_Normal	NA_HW2_Normal
127635	\N	\N	10113	32460	\N	HW2_Tumor	NA_HW2_Tumor
127636	\N	\N	10114	32461	\N	HW8_Normal	NA_HW8_Normal
127637	\N	\N	10115	32462	\N	HW8_Tumor	NA_HW8_Tumor
124603	\N	\N	2848	31215	\N	2848 Tumor	NGS 1-1_NA
124604	\N	\N	2852	31219	\N	2852 Tumor	NGS 1-6_NA
124605	\N	\N	2850	31217	\N	2850 Tumor	NGS 1-4_NA
124606	\N	\N	2853	31220	\N	2853 Tumor	NGS 1-7_NA
124607	\N	\N	2851	31218	\N	2851 Tumor	NGS 1-5_NA
124613	\N	\N	2913	27659	\N	2913 Tumor	22_IS_NA
124614	\N	\N	2928	27685	\N	2928 Tumor	35_M_NA
124615	\N	\N	2929	27687	\N	2929 Tumor	49_M_NA
124616	\N	\N	2934	27698	\N	2934 Tumor	AF13_212_NA
124617	\N	\N	2935	27699	\N	2935 Tumor	Algazi_Tumor_NA
124618	\N	\N	2938	28497	\N	2938 Tumor	BB008_CGH10-013_NA
124619	\N	\N	2939	28498	\N	2939 Tumor	BB008_CGH11-036_NA
124620	\N	\N	2940	28499	\N	2940 Tumor	BB008_CGH11-153_NA
124621	\N	\N	2941	28500	\N	2941 Tumor	BB008_CGH11-386_NA
124622	\N	\N	2942	28501	\N	2942 Tumor	BB008_CGH12-047_NA
124623	\N	\N	2944	28503	\N	2944 Tumor	BB008_HW2TC_NA
124624	\N	\N	2946	28505	\N	2946 Tumor	BB008_HW8TC_NA
124625	\N	\N	2948	28507	\N	2948 Tumor	BB008_HW9TC_NA
124626	\N	\N	2949	28508	\N	2949 Tumor	BB008_Kit 227 Acral WT_NA
124627	\N	\N	2960	28519	\N	2960 Tumor	BB09_CGH11_045_NA
124628	\N	\N	2959	28518	\N	2959 Tumor	BB09_CGH11_029_NA
124629	\N	\N	2962	28521	\N	2962 Tumor	BB09_CGH11_125_NA
124630	\N	\N	2961	28520	\N	2961 Tumor	BB09_CGH11_092_NA
124631	\N	\N	2963	28522	\N	2963 Tumor	BB09_CGH11_194_NA
124632	\N	\N	2965	28524	\N	2965 Tumor	BB09_HW3_T_NA
124633	\N	\N	2967	28526	\N	2967 Tumor	BB09_HW4_T_NA
124634	\N	\N	2969	28528	\N	2969 Tumor	BB09_HW6_TD_NA
124635	\N	\N	2980	28539	\N	2980 Tumor	BN_M1_NA
124636	\N	\N	2979	28538	\N	2979 Tumor	bMV_10_0206_NA
124637	\N	\N	2981	28540	\N	2981 Tumor	BN_M2_NA
124638	\N	\N	2988	28559	\N	2988 Tumor	CGH_11_361_NA
124639	\N	\N	2991	28562	\N	2991 Tumor	CGH_11_388_NA
124640	\N	\N	2989	28560	\N	2989 Tumor	CGH_11_366_NA
124641	\N	\N	2990	28561	\N	2990 Tumor	CGH_11_376_NA
124642	\N	\N	2993	28564	\N	2993 Tumor	CGH_12_016_NA
124643	\N	\N	2992	28563	\N	2992 Tumor	CGH_11_422_NA
124644	\N	\N	2996	28567	\N	2996 Tumor	CGH10_020_NA
124645	\N	\N	2995	28566	\N	2995 Tumor	CGH10_17_NA
124646	\N	\N	2994	28565	\N	2994 Tumor	CGH10_16_NA
124647	\N	\N	2998	28569	\N	2998 Tumor	CGH10_058_NA
124648	\N	\N	2997	28568	\N	2997 Tumor	CGH10_049_NA
124649	\N	\N	2999	28570	\N	2999 Tumor	CGH10-028_NA
124650	\N	\N	3000	28571	\N	3000 Tumor	CGH10-045_NA
124651	\N	\N	3002	28573	\N	3002 Tumor	CGH10-062_NA
124652	\N	\N	3003	28574	\N	3003 Tumor	CGH11_020_NA
124653	\N	\N	3001	28572	\N	3001 Tumor	CGH10-058_NA
124654	\N	\N	3004	28575	\N	3004 Tumor	CGH11_035_NA
124655	\N	\N	3005	28576	\N	3005 Tumor	CGH11_60_NA
124656	\N	\N	3006	28577	\N	3006 Tumor	CGH11_078_NA
124657	\N	\N	3007	28578	\N	3007 Tumor	CGH11_080_NA
124658	\N	\N	3008	28579	\N	3008 Tumor	CGH11_091_NA
124659	\N	\N	3009	28581	\N	3009 Tumor	CGH11_252_NA
124660	\N	\N	3011	28583	\N	3011 Tumor	CGH11_283_NA
124661	\N	\N	3012	28584	\N	3012 Tumor	CGH11_292_NA
124662	\N	\N	3010	28582	\N	3010 Tumor	CGH11_281_NA
124663	\N	\N	3013	28585	\N	3013 Tumor	CGH11_305_NA
124664	\N	\N	3014	28586	\N	3014 Tumor	CGH11_310_NA
124665	\N	\N	3015	28587	\N	3015 Tumor	CGH11_319_NA
124666	\N	\N	3016	28588	\N	3016 Tumor	CGH11_343_NA
124667	\N	\N	3018	28590	\N	3018 Tumor	CGH11_410_NA
124668	\N	\N	3017	28589	\N	3017 Tumor	CGH11_348_NA
124669	\N	\N	3019	28591	\N	3019 Tumor	CGH11_424_NA
124670	\N	\N	3020	28592	\N	3020 Tumor	CGH11-011_NA
124671	\N	\N	3021	28593	\N	3021 Tumor	CGH11-035_NA
124672	\N	\N	3022	28596	\N	3022 Tumor	CGH11-072_NA
124673	\N	\N	3023	28597	\N	3023 Tumor	CGH11-087_NA
124674	\N	\N	3024	28598	\N	3024 Tumor	CGH11-089_NA
124675	\N	\N	3025	28601	\N	3025 Tumor	CGH11-115_NA
124676	\N	\N	3026	28602	\N	3026 Tumor	CGH11-147_NA
124677	\N	\N	3028	28604	\N	3028 Tumor	CGH11-166_NA
124678	\N	\N	3027	28603	\N	3027 Tumor	CGH11-158_NA
124679	\N	\N	3031	28607	\N	3031 Tumor	CGH11-194_NA
124680	\N	\N	3029	28605	\N	3029 Tumor	CGH11-172_NA
124681	\N	\N	3030	28606	\N	3030 Tumor	CGH11-184_NA
124682	\N	\N	3032	28608	\N	3032 Tumor	CGH11-224_NA
124683	\N	\N	3033	28609	\N	3033 Tumor	CGH11-229_NA
124684	\N	\N	3034	28610	\N	3034 Tumor	CGH11-231_NA
124685	\N	\N	3035	28611	\N	3035 Tumor	CGH11-232_NA
124686	\N	\N	3036	28612	\N	3036 Tumor	CGH11-237_NA
124687	\N	\N	3037	28613	\N	3037 Tumor	CGH11-252_NA
124688	\N	\N	3039	28619	\N	3039 Tumor	CGH11-315_NA
124689	\N	\N	3038	28614	\N	3038 Tumor	CGH11-259_NA
124690	\N	\N	3041	28624	\N	3041 Tumor	CGH11-404_NA
124691	\N	\N	3040	28620	\N	3040 Tumor	CGH11-339_NA
124692	\N	\N	3042	28625	\N	3042 Tumor	CGH11-409_NA
124693	\N	\N	3043	28626	\N	3043 Tumor	CGH12_026_NA
124694	\N	\N	3045	28628	\N	3045 Tumor	CGH12_040_NA
124695	\N	\N	3046	28629	\N	3046 Tumor	CGH12_053_NA
124696	\N	\N	3049	28632	\N	3049 Tumor	CGH12_135_NA
124697	\N	\N	3050	28633	\N	3050 Tumor	CGH12_161_NA
124698	\N	\N	3052	28635	\N	3052 Tumor	CGH12_317_NA
124699	\N	\N	3051	28634	\N	3051 Tumor	CGH12_224_NA
124700	\N	\N	3053	28636	\N	3053 Tumor	CGH12_343_NA
124701	\N	\N	3055	28644	\N	3055 Tumor	CGH12-104_NA
124702	\N	\N	3054	28638	\N	3054 Tumor	CGH12-043_NA
124703	\N	\N	3056	28646	\N	3056 Tumor	CGH12-124_NA
124704	\N	\N	3057	28651	\N	3057 Tumor	CGH12-345_NA
124705	\N	\N	3058	28652	\N	3058 Tumor	CGH12-347_NA
124706	\N	\N	3059	28653	\N	3059 Tumor	CGH13-003_NA
124707	\N	\N	3061	28655	\N	3061 Tumor	CGH13-011_NA
124708	\N	\N	3060	28654	\N	3060 Tumor	CGH13-009_NA
124709	\N	\N	3063	28657	\N	3063 Tumor	CGH13-034_NA
124710	\N	\N	3062	28656	\N	3062 Tumor	CGH13-033_NA
124711	\N	\N	3064	28658	\N	3064 Tumor	CGH13-041_NA
124712	\N	\N	3066	28660	\N	3066 Tumor	CGH13-046_NA
124713	\N	\N	3065	28659	\N	3065 Tumor	CGH13-044_NA
124714	\N	\N	3067	28661	\N	3067 Tumor	CGH13-058_NA
124715	\N	\N	3070	28776	\N	3070 Tumor	CHG12-335_NA
124716	\N	\N	3069	28774	\N	3069 Tumor	CHG11-402_NA
124717	\N	\N	3068	28667	\N	3068 Tumor	CGH14-059_NA
124718	\N	\N	3073	28876	\N	3073 Tumor	CNS_30_Tumor_NA
124719	\N	\N	3072	28875	\N	3072 Tumor	CNS_29_Tumor_NA
124720	\N	\N	3075	28878	\N	3075 Tumor	CNS_33_Tumor_NA
124721	\N	\N	3074	28877	\N	3074 Tumor	CNS_31_Tumor_NA
124722	\N	\N	3078	28881	\N	3078 Tumor	CNS_35_Tumor_NA
124723	\N	\N	3077	28880	\N	3077 Tumor	CNS_34_Tumor_NA
124724	\N	\N	3079	28882	\N	3079 Tumor	CNS_36_Tumor_NA
124725	\N	\N	3080	28883	\N	3080 Tumor	CNS_37_Tumor_NA
124726	\N	\N	3081	28884	\N	3081 Tumor	CNS_38_Tumor_NA
124727	\N	\N	3083	28886	\N	3083 Tumor	CNS_40_Tumor_NA
124728	\N	\N	3082	28885	\N	3082 Tumor	CNS_39_Tumor_NA
124729	\N	\N	3085	28888	\N	3085 Tumor	CNS_42_Tumor_NA
124730	\N	\N	3084	28887	\N	3084 Tumor	CNS_41_Tumor_NA
124731	\N	\N	3087	28890	\N	3087 Tumor	CNS_44_Tumor_NA
124732	\N	\N	3086	28889	\N	3086 Tumor	CNS_43_Tumor_NA
124733	\N	\N	3088	28891	\N	3088 Tumor	CNS_48_Tumor_NA
124734	\N	\N	3089	28892	\N	3089 Tumor	CNS_49_Tumor_NA
124735	\N	\N	3090	28893	\N	3090 Tumor	CNS_50_Tumor_NA
124736	\N	\N	3092	28953	\N	3092 Tumor	D12_54296_Tumor_NA
124737	\N	\N	3094	28955	\N	3094 Tumor	D12_54992_Tumor_NA
124738	\N	\N	3096	28957	\N	3096 Tumor	D12_67298_Tumor_NA
124739	\N	\N	3099	29003	\N	3099 Tumor	DM_2_NA
124740	\N	\N	3100	29004	\N	3100 Tumor	DM_2_Tumor_NA
124741	\N	\N	3102	29006	\N	3102 Tumor	DM_4_Tumor_NA
124742	\N	\N	3104	29008	\N	3104 Tumor	DM_6_Tumor_NA
124743	\N	\N	3105	29009	\N	3105 Tumor	DM_8_Tumor_NA
124744	\N	\N	3107	29011	\N	3107 Tumor	DM_10_Tumor_NA
124745	\N	\N	3109	29014	\N	3109 Tumor	DM_13_Tumor_NA
124746	\N	\N	3110	29013	\N	3110 Tumor	DM_13_2_Tumor_NA
124747	\N	\N	3111	29015	\N	3111 Tumor	DM_14_Tumor_NA
124748	\N	\N	3113	29017	\N	3113 Tumor	DM_17_Tumor_NA
124749	\N	\N	3115	29019	\N	3115 Tumor	DM_18_Tumor_NA
124750	\N	\N	3116	29019	\N	3116 Tumor	DM_18_Tumor_NA
124751	\N	\N	3118	29021	\N	3118 Tumor	DM_22_Tumor_NA
124752	\N	\N	3120	29023	\N	3120 Tumor	DM_23_Tumor_NA
124753	\N	\N	3122	29025	\N	3122 Tumor	DM_25_Tumor_NA
124754	\N	\N	3123	29026	\N	3123 Tumor	DM_31_2_Tumor_NA
124755	\N	\N	3125	29028	\N	3125 Tumor	DM_36_2_Tumor_NA
124756	\N	\N	3127	29030	\N	3127 Tumor	DM_37_Tumor_NA
124757	\N	\N	3129	29032	\N	3129 Tumor	DM_42_Tumor_NA
124758	\N	\N	3132	29035	\N	3132 Tumor	DM_48_Tumor_NA
124759	\N	\N	3131	29034	\N	3131 Tumor	DM_43_Tumor_NA
124760	\N	\N	3133	29036	\N	3133 Tumor	DM_49_2_Tumor_NA
124761	\N	\N	3135	29038	\N	3135 Tumor	DM_51_Tumor_NA
124762	\N	\N	3137	29040	\N	3137 Tumor	DM_58_Tumor_NA
124763	\N	\N	3138	29041	\N	3138 Tumor	DM_59_Tumor_NA
124764	\N	\N	3140	29043	\N	3140 Tumor	DM_64_Tumor_NA
124765	\N	\N	3142	29045	\N	3142 Tumor	DM_68_Tumor_NA
124766	\N	\N	3141	29044	\N	3141 Tumor	DM_65_2_Tumor_NA
124767	\N	\N	3144	29047	\N	3144 Tumor	DM_74_2_Tumor_NA
124768	\N	\N	3143	29046	\N	3143 Tumor	DM_74_1_Tumor_NA
124769	\N	\N	3146	29048	\N	3146 Tumor	DM_93_3_Tumor_NA
124770	\N	\N	3145	29047	\N	3145 Tumor	DM_74_2_Tumor_NA
124771	\N	\N	3147	29049	\N	3147 Tumor	DM_93_cgn_NA
124772	\N	\N	3150	29052	\N	3150 Tumor	DM_94_Tumor_NA
124773	\N	\N	3151	29053	\N	3151 Tumor	DM_95_2_Tumor_NA
124774	\N	\N	3153	29055	\N	3153 Tumor	DM_96_2_Tumor_NA
124775	\N	\N	3156	29058	\N	3156 Tumor	DM_98_Tumor_NA
124776	\N	\N	3158	29060	\N	3158 Tumor	DM_99_Tumor_NA
124777	\N	\N	3159	29060	\N	3159 Tumor	DM_99_Tumor_NA
124778	\N	\N	3160	29061	\N	3160 Tumor	DM_100_Tumor_Pool_NA
124779	\N	\N	3163	29064	\N	3163 Tumor	DM_101_Tumor_NA
124780	\N	\N	3164	29065	\N	3164 Tumor	DM_102_Tumor_NA
124781	\N	\N	3165	29066	\N	3165 Tumor	DM-60-Tumor_NA
124782	\N	\N	3166	29067	\N	3166 Tumor	DM-61-Tumor_NA
124783	\N	\N	3167	29068	\N	3167 Tumor	DM-62-Tumor_NA
124784	\N	\N	3169	29070	\N	3169 Tumor	DM-66-Tumor_NA
124785	\N	\N	3168	29069	\N	3168 Tumor	DM-63-Tumor_NA
124786	\N	\N	3171	29072	\N	3171 Tumor	DM-69-Tumor_NA
124787	\N	\N	3170	29071	\N	3170 Tumor	DM-67-Tumor_NA
124788	\N	\N	3172	29073	\N	3172 Tumor	DM-70-Tumor_NA
124789	\N	\N	3173	29074	\N	3173 Tumor	DM-81-Tumor_NA
124790	\N	\N	3175	29076	\N	3175 Tumor	DM1_Tumor_NA
124791	\N	\N	3177	29078	\N	3177 Tumor	DM2_Tumor_NA
124792	\N	\N	3178	29079	\N	3178 Tumor	DM5 _Tumor_NA
124793	\N	\N	3181	29082	\N	3181 Tumor	DM7_Tumor_NA
124794	\N	\N	3183	29085	\N	3183 Tumor	DM11_Tumor_NA
124795	\N	\N	3185	29087	\N	3185 Tumor	DM12_Tumor_NA
124796	\N	\N	3187	29089	\N	3187 Tumor	DM13_Tumor_NA
124797	\N	\N	3189	29091	\N	3189 Tumor	DM14_Tumor_NA
124798	\N	\N	3191	29093	\N	3191 Tumor	DM16_Tumor_NA
124799	\N	\N	3193	29095	\N	3193 Tumor	DM21_Tumor_NA
124800	\N	\N	3195	29097	\N	3195 Tumor	DM26_Tumor_NA
124801	\N	\N	3198	29100	\N	3198 Tumor	DM29_2_Tumor_NA
124802	\N	\N	3197	29099	\N	3197 Tumor	DM28_Tumor_NA
124803	\N	\N	3201	29103	\N	3201 Tumor	DM34_Tumor_NA
124804	\N	\N	3203	29105	\N	3203 Tumor	DM45_2_Tumor_NA
124805	\N	\N	3206	29109	\N	3206 Tumor	DM55_Tumor_NA
124806	\N	\N	3207	29110	\N	3207 Tumor	DM77_2_Tumor_NA
124807	\N	\N	3209	29112	\N	3209 Tumor	DM79_2_Tumor_NA
124808	\N	\N	3211	29115	\N	3211 Tumor	DM93_2_Tumor_NA
124809	\N	\N	3212	29116	\N	3212 Tumor	DM93_CGN_NA
124810	\N	\N	3214	29625	\N	3214 Tumor	DP12_200_NA
124811	\N	\N	3216	29628	\N	3216 Tumor	DPN_3_Tumor_NA
124812	\N	\N	3215	29627	\N	3215 Tumor	DPN_1_Tumor_NA
124813	\N	\N	3217	29629	\N	3217 Tumor	DPN_4_Tumor_NA
124814	\N	\N	3219	29632	\N	3219 Tumor	DPN_6_Tumor_NA
124815	\N	\N	3218	29631	\N	3218 Tumor	DPN_5_Tumor_NA
124816	\N	\N	3223	29639	\N	3223 Tumor	DPN_11_Tumor_NA
124817	\N	\N	3222	29638	\N	3222 Tumor	DPN_10_Tumor_NA
124818	\N	\N	3221	29637	\N	3221 Tumor	DPN_9_Tumor_NA
124819	\N	\N	3224	29640	\N	3224 Tumor	DPN_12_Tumor_NA
124820	\N	\N	3225	29641	\N	3225 Tumor	DPN_14_Tumor_NA
124821	\N	\N	3226	29642	\N	3226 Tumor	DPN_16_Tumor_NA
124822	\N	\N	3227	29643	\N	3227 Tumor	DPN_17_Tumor_NA
124823	\N	\N	3228	29645	\N	3228 Tumor	DPN_18_Tumor_NA
124824	\N	\N	3229	29646	\N	3229 Tumor	DPN_19_Tumor_NA
124825	\N	\N	3231	29648	\N	3231 Tumor	DPN_CNN 30_NA
124826	\N	\N	3230	29647	\N	3230 Tumor	DPN_35_NA
124827	\N	\N	3233	29650	\N	3233 Tumor	DPN_Conv_35_NA
124828	\N	\N	3234	29651	\N	3234 Tumor	DPN_MM 20_NA
124829	\N	\N	3236	29653	\N	3236 Tumor	DPN_MM 22_NA
124830	\N	\N	3235	29652	\N	3235 Tumor	DPN_MM 21_NA
124831	\N	\N	3243	29681	\N	3243 Tumor	G3 DP08-21965C Tumor_NA
124832	\N	\N	3245	29683	\N	3245 Tumor	G5 DP08-4205A Tumor_NA
124833	\N	\N	3247	29685	\N	3247 Tumor	HW_3_Tumor_NA
124834	\N	\N	3246	29684	\N	3246 Tumor	HW_2_Tumor Dissect_NA
124835	\N	\N	3250	29688	\N	3250 Tumor	HW_A1_Tumor_NA
124836	\N	\N	3248	29686	\N	3248 Tumor	HW_8_Mucosal_Tumor_NA
124837	\N	\N	3252	29690	\N	3252 Tumor	HW_A2_Tumor_NA
124838	\N	\N	3254	29692	\N	3254 Tumor	HW_A3_Tumor_NA
124839	\N	\N	3256	29694	\N	3256 Tumor	HW_A4_Tumor_NA
124840	\N	\N	3258	29696	\N	3258 Tumor	HW_A5_Tumor_NA
124841	\N	\N	3260	29698	\N	3260 Tumor	HW_A6_Tumor_NA
124842	\N	\N	3262	29700	\N	3262 Tumor	HW_A7_Tumor_NA
124843	\N	\N	3264	29702	\N	3264 Tumor	HW_A8_Tumor_NA
124844	\N	\N	3266	29704	\N	3266 Tumor	HW_A9_Tumor_NA
124845	\N	\N	3269	29707	\N	3269 Tumor	HW_Acral_#8_Tumor_NA
124846	\N	\N	3268	29706	\N	3268 Tumor	HW_A10_Tumor_NA
124847	\N	\N	3300	29772	\N	3300 Tumor	K1_21
124848	\N	\N	3302	29775	\N	3302 Tumor	K2_2_NA
124849	\N	\N	3301	29774	\N	3301 Tumor	K2_1_NA
124850	\N	\N	3306	29783	\N	3306 Tumor	K2_10
124851	\N	\N	3305	29782	\N	3305 Tumor	K2_9
124852	\N	\N	3307	29784	\N	3307 Tumor	K2_11_NA
124853	\N	\N	3308	29877	\N	3308 Tumor	Kit 262_NA
124854	\N	\N	3310	29879	\N	3310 Tumor	Kit_21_NA
124855	\N	\N	3311	29880	\N	3311 Tumor	Kit_37_Acral_NRAS_NA
124856	\N	\N	3309	29878	\N	3309 Tumor	Kit_8_NA
124857	\N	\N	3313	29883	\N	3313 Tumor	Kit_62__Acral_NRAS_NA
124858	\N	\N	3312	29882	\N	3312 Tumor	Kit_55_NA
124859	\N	\N	3314	29884	\N	3314 Tumor	Kit_76_NA
124860	\N	\N	3315	29885	\N	3315 Tumor	Kit_118_Muc_NRAS_NA
124861	\N	\N	3316	29886	\N	3316 Tumor	KIT_134_NA
127638	\N	\N	10116	32463	\N	HW9_Normal	NA_HW9_Normal
124863	\N	\N	3321	29891	\N	3321 Tumor	Kit_203_NA
124864	\N	\N	3319	29889	\N	3319 Tumor	KIT_191_NA
124865	\N	\N	3320	29890	\N	3320 Tumor	Kit_192_NA
124866	\N	\N	3322	29892	\N	3322 Tumor	KIT_205_NA
124867	\N	\N	3324	29894	\N	3324 Tumor	KIT_210_NA
124868	\N	\N	3325	29895	\N	3325 Tumor	KIT_217_NA
124869	\N	\N	3323	29893	\N	3323 Tumor	KIT_206_NA
124870	\N	\N	3326	29896	\N	3326 Tumor	KIT_225_NA
124871	\N	\N	3327	29898	\N	3327 Tumor	KIT_230_NA
124872	\N	\N	3329	29900	\N	3329 Tumor	KIT_260_NA
124873	\N	\N	3328	29899	\N	3328 Tumor	KIT_244_NA
124874	\N	\N	3330	29901	\N	3330 Tumor	KIT_273_NA
124875	\N	\N	3332	29903	\N	3332 Tumor	KIT_295_NA
124876	\N	\N	3331	29902	\N	3331 Tumor	Kit_275_Muc_BRAF_NA
124877	\N	\N	3333	29904	\N	3333 Tumor	KIT_297_NA
124878	\N	\N	3335	29906	\N	3335 Tumor	Kit_313_Mucosal_NA
124879	\N	\N	3334	29905	\N	3334 Tumor	KIT_302_NA
124880	\N	\N	3336	29907	\N	3336 Tumor	KIT_316_NA
124881	\N	\N	3337	29926	\N	3337 Tumor	KR_8_NA
124882	\N	\N	3338	29927	\N	3338 Tumor	KR_150_NA
124883	\N	\N	3339	29928	\N	3339 Tumor	KR_166_NA
124884	\N	\N	3340	29929	\N	3340 Tumor	KR_177_NA
124885	\N	\N	3342	29931	\N	3342 Tumor	KR_229_NA
124886	\N	\N	3341	29930	\N	3341 Tumor	KR_203_NA
124887	\N	\N	3344	29933	\N	3344 Tumor	KR_2064_NA
124888	\N	\N	3343	29932	\N	3343 Tumor	KR_2030_NA
124889	\N	\N	3347	29936	\N	3347 Tumor	KR_RMK0137C_NA
124890	\N	\N	3345	29934	\N	3345 Tumor	KR_5233_NA
124891	\N	\N	3346	29935	\N	3346 Tumor	KR_RMK0091B_NA
124892	\N	\N	3349	29938	\N	3349 Tumor	KR_RMK0168C_NA
124893	\N	\N	3348	29937	\N	3348 Tumor	KR_RMK0162C_NA
124894	\N	\N	3350	29939	\N	3350 Tumor	KR_RMK0194C_NA
124895	\N	\N	3359	30327	\N	3359 Tumor	MB_760_Tumor_NA
124896	\N	\N	3358	30326	\N	3358 Tumor	MB_327_Tumor_NA
124897	\N	\N	3357	30325	\N	3357 Tumor	MB_161_Tumor_NA
124898	\N	\N	3361	30329	\N	3361 Tumor	MB_1029_Tumor_NA
124899	\N	\N	3363	30331	\N	3363 Tumor	MB_1046_Tumor_NA
124900	\N	\N	3368	30336	\N	3368 Tumor	MB1242_Tumor_NA
124901	\N	\N	3371	30339	\N	3371 Tumor	MB1423_Tumor_NA
124902	\N	\N	3372	30340	\N	3372 Tumor	MB1424 _Tumor_NA
124903	\N	\N	3374	30342	\N	3374 Tumor	MB1429_Tumor_NA
124904	\N	\N	3375	30343	\N	3375 Tumor	MB1617_Tumor_NA
124905	\N	\N	3382	31182	\N	3382 Tumor	MS_1_Tumor_NA
124906	\N	\N	3384	31194	\N	3384 Tumor	N3_2_NA
124907	\N	\N	3383	31193	\N	3383 Tumor	N3_1_NA
124908	\N	\N	3385	31195	\N	3385 Tumor	N3_3_NA
124909	\N	\N	3386	31196	\N	3386 Tumor	N3_4_NA
124910	\N	\N	3387	31197	\N	3387 Tumor	N3_5_NA
124911	\N	\N	3391	31201	\N	3391 Tumor	N3_9_NA
124912	\N	\N	3389	31199	\N	3389 Tumor	N3_7_NA
124913	\N	\N	3394	31204	\N	3394 Tumor	N3_12_NA
124914	\N	\N	3393	31203	\N	3393 Tumor	N3_11_NA
124915	\N	\N	3395	31205	\N	3395 Tumor	N3_13_NA
124916	\N	\N	3396	31206	\N	3396 Tumor	N3_14_NA
124917	\N	\N	3398	31208	\N	3398 Tumor	N3_16_NA
124918	\N	\N	3397	31207	\N	3397 Tumor	N3_15_NA
124919	\N	\N	3427	31896	\N	3427 Tumor	S12_20321_A2_Tumor_NA
124920	\N	\N	3426	31895	\N	3426 Tumor	RPA_09_0209_NA
124921	\N	\N	3428	31899	\N	3428 Tumor	Seider_Roe_NA
124922	\N	\N	3429	31900	\N	3429 Tumor	Seider_Uveal Melanoma_NA
124923	\N	\N	3435	32246	\N	3435 Tumor	WP_11_NA
124924	\N	\N	3437	32248	\N	3437 Tumor	WP_29_NA
124925	\N	\N	3436	32247	\N	3436 Tumor	WP_23_NA
124926	\N	\N	3442	28775	\N	3442 Tumor	CHG11-409_NA
124927	\N	\N	3447	30312	\N	3447 Tumor	Luping_ROS 1_NA
124929	\N	\N	3824	28531	\N	3824 Tumor	Bivona_L_18_NA
124930	\N	\N	3825	28532	\N	3825 Tumor	Bivona_L_19_NA
124931	\N	\N	3836	32050	\N	3836 Tumor	TCR-Beta-1_NA
124932	\N	\N	3837	32051	\N	3837 Tumor	TCR-Beta-2_NA
124934	\N	\N	3845	31458	\N	3845 Tumor	PG8_NA
124935	\N	\N	3847	31210	\N	3847 Tumor	NA_CP1-5_Tumor
124936	\N	\N	3848	31211	\N	3848 Tumor	NA_CP1-10_Tumor
124937	\N	\N	3849	31212	\N	3849 Tumor	NA_CP1-20_Tumor
124938	\N	\N	3850	31213	\N	3850 Tumor	NA_CP1-40_Tumor
124939	\N	\N	3851	31214	\N	3851 Tumor	NA_CP1-80_Tumor
124940	\N	\N	3853	29107	\N	3853 Tumor	DM45_Tumor_NA
124941	\N	\N	3854	29114	\N	3854 Tumor	DM79_Tumor_NA
124942	\N	\N	3855	29117	\N	3855 Tumor	DM93_NFKBIE_NA
124943	\N	\N	3856	29119	\N	3856 Tumor	DM93_Tumor_NA
124944	\N	\N	3860	29654	\N	3860 Tumor	DPN50-Tumor_NA
124945	\N	\N	3861	29655	\N	3861 Tumor	DPN51-Tumor_NA
124946	\N	\N	3862	29656	\N	3862 Tumor	DPN52-Tumor_NA
124947	\N	\N	3863	29657	\N	3863 Tumor	DPN53-Tumor_NA
124948	\N	\N	3864	29658	\N	3864 Tumor	DPN54-Tumor_NA
124949	\N	\N	3865	29659	\N	3865 Tumor	DPN55-Tumor_NA
124950	\N	\N	3866	29660	\N	3866 Tumor	DPN56-Tumor_NA
124951	\N	\N	3867	29661	\N	3867 Tumor	DPN57-Tumor_NA
124952	\N	\N	3868	29662	\N	3868 Tumor	DPN58-Tumor_NA
124953	\N	\N	3869	29663	\N	3869 Tumor	DPN59-Tumor_NA
124954	\N	\N	3870	29664	\N	3870 Tumor	DPN60-Tumor_NA
124955	\N	\N	3871	29665	\N	3871 Tumor	DPN61-Tumor_NA
124956	\N	\N	3872	29666	\N	3872 Tumor	DPN62-Tumor_NA
124957	\N	\N	3901	29083	\N	3901 Tumor	DM8TumorCrest_NA
124958	\N	\N	806	28872	\N	806 MELANOMA	CMD-01
124959	\N	\N	819	28800	\N	819 MELANOMA	CM D-14
124960	\N	\N	811	28792	\N	811 MELANOMA	CM D-06
124961	\N	\N	818	28799	\N	818 MELANOMA	CM D-13
124962	\N	\N	815	28796	\N	815 MELANOMA	CM D-10
124963	\N	\N	831	28811	\N	831 MELANOMA	CM D-25
124964	\N	\N	838	28817	\N	838 MELANOMA	CM D-31
124965	\N	\N	816	28797	\N	816 MELANOMA	CM D-11
124966	\N	\N	814	28795	\N	814 MELANOMA	CM D-09
124967	\N	\N	828	28808	\N	828 MELANOMA	CM D-22
124968	\N	\N	830	28810	\N	830 MELANOMA	CM D-24
124969	\N	\N	808	28789	\N	808 MELANOMA	CM D-03
124970	\N	\N	822	28803	\N	822 MELANOMA	CM D-17
124971	\N	\N	829	28809	\N	829 MELANOMA	CM D-23
124972	\N	\N	846	28825	\N	846 MELANOMA	CM D-39
124973	\N	\N	821	28802	\N	821 MELANOMA	CM D-16
124974	\N	\N	833	28813	\N	833 MELANOMA	CM D-27
124975	\N	\N	835	28815	\N	835 MELANOMA	CM D-29
124976	\N	\N	845	28824	\N	845 MELANOMA	CM D-38
124977	\N	\N	837	28816	\N	837 MELANOMA	CM D-30
124978	\N	\N	842	28821	\N	842 MELANOMA	CM D-35
124979	\N	\N	847	28826	\N	847 MELANOMA	CM D-40
124980	\N	\N	843	28822	\N	843 MELANOMA	CM D-36
124981	\N	\N	812	28793	\N	812 MELANOMA	CM D-07
124982	\N	\N	827	28807	\N	827 MELANOMA	CM D-21
124983	\N	\N	825	28805	\N	825 MELANOMA	CM D-19
124984	\N	\N	813	28794	\N	813 MELANOMA	CM D-08
124985	\N	\N	839	28818	\N	839 MELANOMA	CM D-32
124986	\N	\N	844	28823	\N	844 MELANOMA	CM D-37
124987	\N	\N	809	28790	\N	809 MELANOMA	CM D-04
124988	\N	\N	3270	29708	\N	3270 MELANOMA	Ivanka_5_1_NA
124989	\N	\N	3272	29710	\N	3272 MELANOMA	Ivanka_5_3_NA
124990	\N	\N	3273	29711	\N	3273 MELANOMA	Ivanka_5_4_NA
124991	\N	\N	3271	29709	\N	3271 MELANOMA	Ivanka_5_2_NA
124992	\N	\N	3274	29712	\N	3274 MELANOMA	Ivanka_5_5_NA
124993	\N	\N	3281	29719	\N	3281 MELANOMA	Ivanka_10_2_NA
124994	\N	\N	3282	29720	\N	3282 MELANOMA	Ivanka_10_3_NA
124995	\N	\N	3280	29718	\N	3280 MELANOMA	Ivanka_10_1_NA
124996	\N	\N	3283	29721	\N	3283 MELANOMA	Ivanka_10_4_NA
124997	\N	\N	3285	29723	\N	3285 MELANOMA	Ivanka_12_1_NA
124998	\N	\N	3286	29724	\N	3286 MELANOMA	Ivanka_12_2_NA
124999	\N	\N	3284	29722	\N	3284 MELANOMA	Ivanka_10_5_NA
125000	\N	\N	3288	29726	\N	3288 MELANOMA	Ivanka_12_4_NA
125001	\N	\N	3289	29727	\N	3289 MELANOMA	Ivanka_12_5_NA
125002	\N	\N	3287	29725	\N	3287 MELANOMA	Ivanka_12_3_NA
125003	\N	\N	810	28791	\N	810 NORMAL	CM D-05
125004	\N	\N	820	28801	\N	820 NORMAL	CM D-15
125005	\N	\N	823	28804	\N	823 NORMAL	CM D-18
125006	\N	\N	866	28843	\N	866 NORMAL	CM D-57
125007	\N	\N	834	28814	\N	834 NORMAL	CM D-28
125008	\N	\N	870	28847	\N	870 NORMAL	CM D-61
125009	\N	\N	864	28841	\N	864 NORMAL	CM D-55
125010	\N	\N	848	28827	\N	848 NORMAL	CM D-41
125011	\N	\N	832	28812	\N	832 NORMAL	CM D-26
125012	\N	\N	841	28820	\N	841 NORMAL	CM D-34
125013	\N	\N	826	28806	\N	826 NORMAL	CM D-20
125014	\N	\N	874	28851	\N	874 PAM	CM D-65
125015	\N	\N	871	28848	\N	871 PAM	CM D-62
125016	\N	\N	868	28845	\N	868 PAM	CM D-59
125017	\N	\N	873	28850	\N	873 PAM	CM D-64
125018	\N	\N	875	28852	\N	875 PAM	CM D-66
125019	\N	\N	865	28842	\N	865 PAM	CM D-56
125020	\N	\N	863	28840	\N	863 PAM	CM D-54
125021	\N	\N	807	28873	\N	807 PAM	CMD-02
125022	\N	\N	867	28844	\N	867 PAM	CM D-58
125023	\N	\N	872	28849	\N	872 PAM	CM D-63
125024	\N	\N	869	28846	\N	869 PAM	CM D-60
125025	\N	\N	877	28853	\N	877 PAM	CM D-67
125026	\N	\N	840	28819	\N	840 PAM	CM D-33
125027	\N	\N	817	28798	\N	817 PAM	CM D-12
125028	\N	\N	855	28833	\N	855 NEVUS	CM D-47
125029	\N	\N	854	28832	\N	854 NEVUS	CM D-46
125030	\N	\N	857	28835	\N	857 NEVUS	CM D-49
125031	\N	\N	852	28830	\N	852 NEVUS	CM D-44
125032	\N	\N	856	28834	\N	856 NEVUS	CM D-48
125033	\N	\N	851	28829	\N	851 NEVUS	CM D-43
125034	\N	\N	861	28839	\N	861 NEVUS	CM D-53
125035	\N	\N	859	28837	\N	859 NEVUS	CM D-51
125036	\N	\N	858	28836	\N	858 NEVUS	CM D-50
125037	\N	\N	853	28831	\N	853 NEVUS	CM D-45
125038	\N	\N	850	28828	\N	850 NEVUS	CM D-42
125039	\N	\N	860	28838	\N	860 NEVUS	CM D-52
125040	\N	\N	1235	29624	\N	1235 NEVUS	DNPD-09
125041	\N	\N	1420	29620	\N	1420 NEVUS	DNPD-05
125042	\N	\N	1421	29621	\N	1421 NEVUS	DNPD-06
125043	\N	\N	1153	27926	\N	1153 LN Met 2	AM2 D-184
125047	\N	\N	1149	27922	\N	1149 Mel3	AM2 D-180
125052	\N	\N	1150	27923	\N	1150 Normal3	AM2 D-181
125053	\N	\N	498	28746	\N	498 DPN-mm	CGH18-137
125054	\N	\N	878	29616	\N	878 DPN-mm	DNPD-01
125055	\N	\N	879	29617	\N	879 DPN-mm	DNPD-02
125056	\N	\N	880	29623	\N	880 DPN-mm	DNPD-08
125057	\N	\N	882	29618	\N	882 DPN-mm	DNPD-03
125058	\N	\N	911	29619	\N	911 DPN-mm	DNPD-04
125059	\N	\N	881	29622	\N	881 MM	DNPD-07
125060	\N	\N	2821	29771	\N	2821 MM	K1_20
125062	\N	\N	2827	29752	\N	2827 MM	JBP-9MM_NA
125063	\N	\N	2829	29749	\N	2829 MM	JBP-6-MM_NA
125064	\N	\N	2832	29768	\N	2832 MM	K1_17
125065	\N	\N	2833	29768	\N	2833 MM	K1_17
125066	\N	\N	2900	29754	\N	2900 MM	JBP-11MM
125067	\N	\N	1236	27928	\N	1236 LN Met 4	AM2 D-186
125070	\N	\N	1237	27929	\N	1237 LN Met 3	AM2 D-187
125073	\N	\N	1238	27930	\N	1238 MIS4	AM2 D-188
125076	\N	\N	1290	27943	\N	1290 LN Met	AM2 D-203
125077	\N	\N	1294	27947	\N	1294 LN Met	AM2 D-208
125078	\N	\N	1300	27953	\N	1300 LN Met	AM2 D-215
125080	\N	\N	1301	27954	\N	1301 Cutaneous Metastasis	AM2 D-216
125082	\N	\N	1304	27957	\N	1304 Subcutaneous Metastasis	AM2 D-219
125083	\N	\N	1308	27961	\N	1308 Bladder Metastasis	AM2 D-223
125084	\N	\N	886	29300	\N	886 Blue Nevus	DNA-88
125085	\N	\N	887	29301	\N	887 Blue Nevus	DNA-89
125086	\N	\N	888	29302	\N	888 Blue Nevus	DNA-90
125087	\N	\N	889	29303	\N	889 Blue Nevus	DNA-91
125088	\N	\N	890	29304	\N	890 Blue Nevus	DNA-92
125089	\N	\N	891	29305	\N	891 Blue Nevus	DNA-93
125090	\N	\N	2016	31429	\N	2016 Blue Nevus	OM-16D
125092	\N	\N	2572	29129	\N	2572 Blue Nevus	DMS-008
125093	\N	\N	2573	29130	\N	2573 Blue Nevus	DMS-009
125094	\N	\N	2575	29132	\N	2575 Blue Nevus	DMS-011
125095	\N	\N	2577	29134	\N	2577 Blue Nevus	DMS-013
125096	\N	\N	2576	29133	\N	2576 Blue Nevus	DMS-012
125097	\N	\N	2578	29135	\N	2578 Blue Nevus	DMS-014
125098	\N	\N	2581	29138	\N	2581 Blue Nevus	DMS-017
125099	\N	\N	2579	29136	\N	2579 Blue Nevus	DMS-015
125100	\N	\N	2580	29137	\N	2580 Blue Nevus	DMS-016
125102	\N	\N	2586	29143	\N	2586 Blue Nevus	DMS-022
125103	\N	\N	2590	29147	\N	2590 Blue Nevus	DMS-026
125104	\N	\N	2594	29151	\N	2594 Blue Nevus	DMS-030
125105	\N	\N	2595	29152	\N	2595 Blue Nevus	DMS-031
125106	\N	\N	2588	29145	\N	2588 Blue Nevus	DMS-024
125108	\N	\N	2593	29150	\N	2593 Blue Nevus	DMS-029
125109	\N	\N	2589	29146	\N	2589 Blue Nevus	DMS-025
125110	\N	\N	2587	29144	\N	2587 Blue Nevus	DMS-023
125111	\N	\N	2592	29149	\N	2592 Blue Nevus	DMS-028
125112	\N	\N	2591	29148	\N	2591 Blue Nevus	DMS-027
125044	\N	\N	1489	28000	\N	1489 LN Met 2	AM2 D-266
125045	\N	\N	1528	28032	\N	1528 LN Met 2	AM2 D-304
125046	\N	\N	1559	28063	\N	1559 LN Met 2	AM2 D-339
125048	\N	\N	1477	27997	\N	1477 Mel3	AM2 D-263
125049	\N	\N	1496	28007	\N	1496 Mel3	AM2 D-274
125050	\N	\N	1517	28078	\N	1517 Mel3	AM2 D-356
125051	\N	\N	1531	28035	\N	1531 Mel3	AM2 D-310
125068	\N	\N	1545	28049	\N	1545 LN Met 4	AM2 D-325
125069	\N	\N	1561	28065	\N	1561 LN Met 4	AM2 D-341
125071	\N	\N	1544	28048	\N	1544 LN Met 3	AM2 D-324
125072	\N	\N	1560	28064	\N	1560 LN Met 3	AM2 D-340
125074	\N	\N	1619	28155	\N	1619 MIS4	AM2 D-452
125075	\N	\N	1621	28150	\N	1621 MIS4	AM2 D-446
125079	\N	\N	1586	28099	\N	1586 LN Met	AM2 D-380
125081	\N	\N	1424	27982	\N	1424 Cutaneous Metastasis	AM2 D-248
125091	\N	\N	2025	31443	\N	2025 Blue Nevus	OM-26D
125101	\N	\N	2582	29139	\N	2582 Blue Nevus	DMS-018
125107	\N	\N	2596	29153	\N	2596 Blue Nevus	DMS-032
127639	\N	\N	10117	32464	\N	HW9_Tumor	NA_HW9_Tumor
127640	\N	\N	10118	32465	\N	12-6981_Tumor	NA_12-6981_Tumor
127641	\N	\N	10119	32466	\N	10-55707_Tumor	NA_10-55707_Tumor
127642	\N	\N	10120	32467	\N	11-34950_Tumor	NA_11-34950_Tumor
127643	\N	\N	10121	32468	\N	11-8228_Tumor	NA_11-8228_Tumor
125114	\N	\N	2826	29751	\N	2826 Met	JBP-9Met_NA
125115	\N	\N	2830	29748	\N	2830 Met	JBP-6-Met_NA
125116	\N	\N	2834	29769	\N	2834 Met	K1_18
125117	\N	\N	2899	29753	\N	2899 Met	JBP-11Met
125160	\N	\N	1976	31347	\N	1976 Invasive Mel 1	OM D-44.3
125199	\N	\N	1959	31329	\N	1959 Typical Melanotic Macule	OM D-30
125202	\N	\N	1963	31333	\N	1963 Typical Melanotic Macule	OM D-33A
125118	\N	\N	1314	31466	\N	1314 Met3	PROG D-04
125119	\N	\N	1501	28012	\N	1501 Met3	AM2 D-279
125120	\N	\N	1506	28017	\N	1506 Met3	AM2 D-284
125121	\N	\N	1512	28021	\N	1512 Met3	AM2 D-289
125122	\N	\N	1426	31467	\N	1426 Met4	PROG D-05
125123	\N	\N	1429	31469	\N	1429 Invasive 1	PROG D-07
125124	\N	\N	2302	31482	\N	2302 Invasive 1	PROG D-20
125125	\N	\N	1435	31470	\N	1435 Invasive 2	PROG D-08
125126	\N	\N	1436	31471	\N	1436 Invasive 3	PROG D-09
125127	\N	\N	1437	31472	\N	1437 Invasive 4	PROG D-10
125128	\N	\N	1439	31474	\N	1439 Invasive 5	PROG D-12
125129	\N	\N	1440	31475	\N	1440 Invasive 6	PROG D-13
125130	\N	\N	1473	27993	\N	1473 Recurrence 1	AM2 D-259
125131	\N	\N	1493	28004	\N	1493 Lung Met 1	AM2 D-271
125132	\N	\N	1511	28021	\N	1511 Intestine Met 2	AM2 D-289
125133	\N	\N	1513	28022	\N	1513 Brain Met 4	AM2 D-291
125134	\N	\N	1514	28022	\N	1514 Met5	AM2 D-291
125135	\N	\N	2305	31483	\N	2305 Met5	PROG D-21
125136	\N	\N	1518	28079	\N	1518 Mel4	AM2 D-357
125137	\N	\N	1532	28036	\N	1532 Mel4	AM2 D-311
125138	\N	\N	1522	28027	\N	1522 Mel5	AM2 D-297
125139	\N	\N	1534	28038	\N	1534 Skin Met1	AM2 D-313
125140	\N	\N	1542	28046	\N	1542 Skin Met1	AM2 D-322
125141	\N	\N	1536	28040	\N	1536 Skin Met2	AM2 D-316
125142	\N	\N	1537	28041	\N	1537 Skin Met4	AM2 D-317
125143	\N	\N	1538	28042	\N	1538 Skin Met3	AM2 D-318
125144	\N	\N	1543	28047	\N	1543 Brain Met2	AM2 D-323
125145	\N	\N	1546	28050	\N	1546 LN Met5	AM2 D-326
125146	\N	\N	1551	28055	\N	1551 Salivary Met1	AM2 D-331
125147	\N	\N	1562	28066	\N	1562 Brain Met 5	AM2 D-342
125148	\N	\N	1563	28067	\N	1563 Brain Met 6	AM2 D-343
125149	\N	\N	1565	28068	\N	1565 LN Met 9	AM2 D-345
125150	\N	\N	1567	28069	\N	1567 LN Met 7	AM2 D-347
125151	\N	\N	1568	28070	\N	1568 LN Met 8	AM2 D-348
125152	\N	\N	1576	28092	\N	1576 Subcutaneous Met 2	AM2 D-372
125153	\N	\N	1578	28131	\N	1578 Local Recurrent-Met2	AM2 D-425
125154	\N	\N	1580	28124	\N	1580 Local Recurrent-Met3	AM2 D-414
125155	\N	\N	1582	28090	\N	1582 Invasive Mel 1	AM2 D-370
125156	\N	\N	1585	28098	\N	1585 Invasive Mel 1	AM2 D-379
125157	\N	\N	1598	28108	\N	1598 Invasive Mel 1	AM2 D-394
125158	\N	\N	1623	28157	\N	1623 Invasive Mel 1	AM2 D-454
125159	\N	\N	1822	28100	\N	1822 Invasive Mel 1	AM2 D-381
125161	\N	\N	1583	28091	\N	1583 Invasive Mel 2	AM2 D-371
125162	\N	\N	1599	28109	\N	1599 Invasive Mel 2	AM2 D-395
125163	\N	\N	1823	28101	\N	1823 Invasive Mel 2	AM2 D-382
125164	\N	\N	1589	28140	\N	1589 Primary Mel 1	AM2 D-435
125165	\N	\N	1590	28141	\N	1590 Primary Mel 2	AM2 D-436
125166	\N	\N	1592	28143	\N	1592 In Transit Met	AM2 D-438
125167	\N	\N	1595	28112	\N	1595 Invasive Primary Mel 1	AM2 D-401
125168	\N	\N	1606	28126	\N	1606 Invasive Primary Mel 1	AM2 D-419
125169	\N	\N	1596	28113	\N	1596 Invasive Primary Mel 2	AM2 D-402
125170	\N	\N	1607	28127	\N	1607 Invasive Primary Mel 2	AM2 D-420
125171	\N	\N	1601	28115	\N	1601 Invasive Primary Mel	AM2 D-404
125172	\N	\N	1610	28130	\N	1610 Invasive Primary Mel	AM2 D-423
125173	\N	\N	1602	28116	\N	1602 Metastatic Mel 2	AM2 D-405
125174	\N	\N	1605	28119	\N	1605 Metastatic Mel 1	AM2 D-408
125175	\N	\N	1625	28176	\N	1625 MIS2 In situ	AM2 D-474
125176	\N	\N	1877	30126	\N	1877 Lentigo Simplex	LN D-071
125177	\N	\N	1879	30128	\N	1879 Lentigo Simplex	LN D-073
125178	\N	\N	1882	30131	\N	1882 Lentigo Simplex	LN D-076
125179	\N	\N	1890	30138	\N	1890 Lentigo Simplex	LN D-084
125180	\N	\N	1892	30140	\N	1892 Lentigo Simplex	LN D-086
125181	\N	\N	1895	30142	\N	1895 Lentigo Simplex	LN D-089
125182	\N	\N	1898	30145	\N	1898 Lentigo Simplex	LN D-092
125183	\N	\N	1901	30161	\N	1901 Lentigo Simplex	LN D-108
125184	\N	\N	1903	30165	\N	1903 Lentigo Simplex	LN D-112
125185	\N	\N	1905	30158	\N	1905 Lentigo Simplex	LN D-105
125186	\N	\N	1907	30163	\N	1907 Lentigo Simplex	LN D-110
125187	\N	\N	1913	30186	\N	1913 Lentigo Simplex	LN D-133
125188	\N	\N	1914	30187	\N	1914 Lentigo Simplex	LN D-134
125189	\N	\N	1875	30124	\N	1875 Compound Melanocytic Nevus	LN D-069
125190	\N	\N	1909	30167	\N	1909 Compound Melanocytic Nevus	LN D-114
125191	\N	\N	1910	30168	\N	1910 Compound Melanocytic Nevus	LN D-115
125192	\N	\N	1878	30127	\N	1878 Junctional Melanocytic Nevus	LN D-072
125193	\N	\N	1880	30129	\N	1880 Junctional Melanocytic Nevus	LN D-074
125194	\N	\N	1891	30139	\N	1891 Seborrheic Keratosis	LN D-085
125195	\N	\N	1906	30159	\N	1906 Junctional Nevus	LN D-106
125196	\N	\N	1908	30164	\N	1908 Junctional Nevus	LN D-111
125197	\N	\N	1947	29398	\N	1947 Melanocytoma	DNA-190
125198	\N	\N	2288	29592	\N	2288 Melanocytoma	DNA-425
125200	\N	\N	1960	31330	\N	1960 Typical Melanotic Macule	OM D-31
125201	\N	\N	1961	31331	\N	1961 Typical Melanotic Macule	OM D-32
127644	\N	\N	10122	32469	\N	11-84681_Tumor	NA_11-84681_Tumor
127645	\N	\N	10123	32410	\N	KIT227_Tumor	NA_KIT227_Tumor
127646	\N	\N	10124	32470	\N	WM3211_Tumor	NA_WM3211_Tumor
127647	\N	\N	10125	32471	\N	NB2107_Tumor	NA_NB2107_Tumor
127648	\N	\N	10126	32472	\N	London-L1_Tumor	NA_London-L1_Tumor
127649	\N	\N	10127	32473	\N	London-L2_Tumor	NA_London-L2_Tumor
127650	\N	\N	10128	32474	\N	Bivona-L7_Tumor	NA_Bivona-L7_Tumor
127651	\N	\N	10129	32475	\N	Bivona-L8_Tumor	NA_Bivona-L8_Tumor
127652	\N	\N	10130	32476	\N	Bivona-L9_Tumor	NA_Bivona-L9_Tumor
127653	\N	\N	10131	32477	\N	Bivona-L10_Tumor	NA_Bivona-L10_Tumor
127654	\N	\N	10132	32432	\N	HW3_Tumor	NA_HW3_Tumor
127655	\N	\N	10133	32433	\N	HW3_Normal	NA_HW3_Normal
127656	\N	\N	10134	32434	\N	HW4_Tumor	NA_HW4_Tumor
127657	\N	\N	10135	32435	\N	HW4_Normal	NA_HW4_Normal
127658	\N	\N	10136	32436	\N	HW6_Tumor	NA_HW6_Tumor
127659	\N	\N	10137	32437	\N	HW6_Normal	NA_HW6_Normal
127660	\N	\N	10138	32438	\N	10-86469_Tumor	NA_10-86469_Tumor
127661	\N	\N	10139	32439	\N	11-12273_Tumor	NA_11-12273_Tumor
127662	\N	\N	10140	32440	\N	11-23710_Tumor	NA_11-23710_Tumor
127663	\N	\N	10141	32441	\N	11-30426_Tumor	NA_11-30426_Tumor
127664	\N	\N	10142	32442	\N	11-31904_Tumor	NA_11-31904_Tumor
127665	\N	\N	10143	32478	\N	Bivona-L11_Tumor	NA_Bivona-L11_Tumor
127666	\N	\N	10144	32479	\N	HWA1_Tumor	NA_HWA1_Tumor
127667	\N	\N	10145	32480	\N	HWA1_Normal	NA_HWA1_Normal
125213	\N	\N	1980	31351	\N	1980 Typical Melanotic Macule	OM D-48
125214	\N	\N	1982	31353	\N	1982 Typical Melanotic Macule	OM D-50
125215	\N	\N	1981	31352	\N	1981 Typical Melanotic Macule	OM D-49
125216	\N	\N	1983	31354	\N	1983 Typical Melanotic Macule	OM D-51
125217	\N	\N	1984	31355	\N	1984 Typical Melanotic Macule	OM D-52
125218	\N	\N	1985	31356	\N	1985 Typical Melanotic Macule	OM D-53
125219	\N	\N	1986	31357	\N	1986 Typical Melanotic Macule	OM D-54
125220	\N	\N	1987	31358	\N	1987 Typical Melanotic Macule	OM D-55
125221	\N	\N	1988	31359	\N	1988 Typical Melanotic Macule	OM D-56
125222	\N	\N	1993	31365	\N	1993 Typical Melanotic Macule	OM D-60
125223	\N	\N	1994	31366	\N	1994 Typical Melanotic Macule	OM D-61
125224	\N	\N	1995	31367	\N	1995 Typical Melanotic Macule	OM D-62A
125225	\N	\N	1996	31368	\N	1996 Typical Melanotic Macule	OM D-62B
125226	\N	\N	2000	31372	\N	2000 Typical Melanotic Macule	OM D-66.1
125227	\N	\N	2001	31373	\N	2001 Typical Melanotic Macule	OM D-66.2
125228	\N	\N	2004	31363	\N	2004 Typical Melanotic Macule	OM D-58.3
125229	\N	\N	2005	31375	\N	2005 Typical Melanotic Macule	OM D-67
125230	\N	\N	2006	31376	\N	2006 Typical Melanotic Macule	OM D-68.1
125231	\N	\N	2009	31379	\N	2009 Typical Melanotic Macule	OM D-69
125232	\N	\N	2010	31380	\N	2010 Typical Melanotic Macule	OM D-70
125233	\N	\N	2011	31381	\N	2011 Typical Melanotic Macule	OM D-71
125234	\N	\N	1970	31340	\N	1970 Intramucosal Nevus	OM D-40.1
125235	\N	\N	1992	31364	\N	1992 Intramucosal Nevus	OM D-59
125236	\N	\N	1998	31370	\N	1998 Intramucosal Nevus	OM D-64
125237	\N	\N	2003	31341	\N	2003 Intramucosal Nevus	OM D-40.2
125238	\N	\N	2014	31424	\N	2014 Intramucosal Nevus	OM-13D
125239	\N	\N	2015	31425	\N	2015 Intramucosal Nevus	OM-14D
125245	\N	\N	1974	31345	\N	1974 Superficial Melanoma	OM D-44.1
125246	\N	\N	1990	31361	\N	1990 Atypical Melanocytic Proliferation	OM D-58.1
125247	\N	\N	1991	31362	\N	1991 Atypical Melanocytic Proliferation	OM D-58.2
125248	\N	\N	2002	31374	\N	2002 Atypical Melanocytic Proliferation	OM D-66.3
125249	\N	\N	2007	31377	\N	2007 Atypical Melanocytic Proliferation	OM D-68.2
125250	\N	\N	2008	31378	\N	2008 Atypical Melanocytic Proliferation	OM D-68.3
125255	\N	\N	1997	31369	\N	1997 Lentiginous junctional melanocytic nevus	OM D-63
125257	\N	\N	2013	31421	\N	2013 Intramucosal Melanocytic Nevus	OM-11D (P040_11C)
125265	\N	\N	2154	32232	\N	2154 Capture Area A1	VS-01_NA
125266	\N	\N	2684	32236	\N	2684 Capture Area A1	VS-05_NA
125267	\N	\N	2155	32233	\N	2155 Capture Area B1	VS-02_NA
125268	\N	\N	2685	32237	\N	2685 Capture Area B1	VS-06_NA
125269	\N	\N	2156	32234	\N	2156 Capture Area C1	VS-03_NA
125270	\N	\N	2686	32238	\N	2686 Capture Area C1	VS-07_NA
125271	\N	\N	2157	32235	\N	2157 Capture Area D1	VS-04_NA
125272	\N	\N	2687	32239	\N	2687 Capture Area D1	VS-08_NA
125275	\N	\N	2336	32257	\N	2336 Cell Line	Xu-1
125276	\N	\N	2338	32259	\N	2338 Cell Line	Xu-3
125277	\N	\N	2337	32258	\N	2337 Cell Line	Xu-2
125278	\N	\N	2339	32260	\N	2339 Cell Line	Xu-4
125279	\N	\N	2341	32262	\N	2341 Cell Line	Xu-6
125280	\N	\N	2340	32261	\N	2340 Cell Line	Xu-5
125281	\N	\N	2342	32263	\N	2342 Cell Line	Xu-7
125282	\N	\N	2343	32264	\N	2343 Cell Line	Xu-8
125283	\N	\N	2345	32266	\N	2345 Cell Line	Xu-10
125284	\N	\N	2344	32265	\N	2344 Cell Line	Xu-9
125285	\N	\N	2346	32267	\N	2346 Cell Line	Xu-11
125286	\N	\N	2347	32268	\N	2347 Cell Line	Xu-12
125287	\N	\N	2348	32269	\N	2348 Cell Line	Xu-13
125288	\N	\N	2349	32270	\N	2349 Cell Line	Xu-14
125289	\N	\N	2350	32271	\N	2350 Cell Line	Xu-015
125290	\N	\N	2351	32272	\N	2351 Cell Line	Xu-016
125291	\N	\N	2352	32273	\N	2352 Cell Line	Xu-017
125292	\N	\N	2356	32277	\N	2356 Cell Line	Xu-021
125293	\N	\N	2354	32275	\N	2354 Cell Line	Xu-019
125294	\N	\N	2355	32276	\N	2355 Cell Line	Xu-020
125295	\N	\N	2353	32274	\N	2353 Cell Line	Xu-018
125296	\N	\N	2357	32278	\N	2357 Cell Line	Xu-022
125297	\N	\N	2358	32279	\N	2358 Cell Line	Xu-023
125298	\N	\N	2359	32280	\N	2359 Cell Line	Xu-024
125299	\N	\N	2360	32281	\N	2360 Cell Line	Xu-025
125300	\N	\N	2361	32282	\N	2361 Cell Line	Xu-026
125301	\N	\N	2363	32284	\N	2363 Cell Line	Xu-028
125302	\N	\N	2362	32283	\N	2362 Cell Line	Xu-027
125303	\N	\N	2364	32285	\N	2364 Cell Line	Xu-029
125304	\N	\N	2366	32287	\N	2366 Cell Line	Xu-031
125305	\N	\N	2365	32286	\N	2365 Cell Line	Xu-030
125306	\N	\N	2367	32288	\N	2367 Cell Line	Xu-032
125307	\N	\N	2368	32289	\N	2368 Cell Line	Xu-033
125308	\N	\N	2370	32291	\N	2370 Cell Line	Xu-035
125309	\N	\N	2369	32290	\N	2369 Cell Line	Xu-034
125310	\N	\N	2371	32292	\N	2371 Cell Line	Xu-036
125311	\N	\N	2373	32294	\N	2373 Cell Line	Xu-038
125312	\N	\N	2372	32293	\N	2372 Cell Line	Xu-037
125313	\N	\N	2374	32295	\N	2374 Cell Line	Xu-039
125314	\N	\N	2375	32296	\N	2375 Cell Line	Xu-040
125315	\N	\N	2376	32297	\N	2376 Cell Line	Xu-041
125204	\N	\N	1964	31334	\N	1964 Typical Melanotic Macule	OM D-34
125205	\N	\N	1965	31335	\N	1965 Typical Melanotic Macule	OM D-35
125206	\N	\N	1966	31336	\N	1966 Typical Melanotic Macule	OM D-36
125207	\N	\N	1967	31337	\N	1967 Typical Melanotic Macule	OM D-37
125208	\N	\N	1968	31338	\N	1968 Typical Melanotic Macule	OM D-38
125209	\N	\N	1969	31339	\N	1969 Typical Melanotic Macule	OM D-39
125210	\N	\N	1971	31342	\N	1971 Typical Melanotic Macule	OM D-41
125211	\N	\N	1972	31343	\N	1972 Typical Melanotic Macule	OM D-42
125212	\N	\N	1973	31344	\N	1973 Typical Melanotic Macule	OM D-43
125240	\N	\N	2023	31439	\N	2023 Intramucosal Nevus	OM-24D
125241	\N	\N	2024	31441	\N	2024 Intramucosal Nevus	OM-25D
125242	\N	\N	2026	31445	\N	2026 Intramucosal Nevus	OM-27D
125243	\N	\N	2027	31447	\N	2027 Intramucosal Nevus	OM-28D
125244	\N	\N	2028	31449	\N	2028 Intramucosal Nevus	OM-29D
125251	\N	\N	2029	31398	\N	2029 Atypical Melanocytic Proliferation	OM-1D-2
125252	\N	\N	2030	31404	\N	2030 Atypical Melanocytic Proliferation	OM-4D-2
125253	\N	\N	2031	31408	\N	2031 Atypical Melanocytic Proliferation	OM-5D-2
125254	\N	\N	2032	31412	\N	2032 Atypical Melanocytic Proliferation	OM-6D-2
125256	\N	\N	2012	31417	\N	2012 Intramucosal Melanocytic Nevus	OM-10D (P040_11B)
125258	\N	\N	2017	31426	\N	2017 Invasive Melanoma	OM-15D (P040_11D)
125262	\N	\N	2021	31435	\N	2021 Lentiginous Juntional Melanocytic Nevus	OM-22D
125263	\N	\N	2022	31437	\N	2022 Compound Nevus	OM-23D
125264	\N	\N	2070	28940	\N	2070 AMB	D-NA-630
125273	\N	\N	2209	29556	\N	2209 PRAME-positive Nevus	DNA-366
125274	\N	\N	2217	29564	\N	2217 Regressed Area	DNA-381
127668	\N	\N	10146	32481	\N	HWA2_Tumor	NA_HWA2_Tumor
127669	\N	\N	10147	32482	\N	HWA2_Normal	NA_HWA2_Normal
125316	\N	\N	2377	32298	\N	2377 Cell Line	Xu-042
125317	\N	\N	2378	32299	\N	2378 Cell Line	Xu-043
125318	\N	\N	2379	32300	\N	2379 Cell Line	Xu-044
125319	\N	\N	2380	32301	\N	2380 Cell Line	Xu-045
125320	\N	\N	2381	32302	\N	2381 Cell Line	Xu-046
125321	\N	\N	2382	32303	\N	2382 Cell Line	Xu-047
125322	\N	\N	2383	32304	\N	2383 Cell Line	Xu-048
125323	\N	\N	2384	32305	\N	2384 Cell Line	Xu-049
125324	\N	\N	2385	32306	\N	2385 Cell Line	Xu-050
125325	\N	\N	2386	32307	\N	2386 Cell Line	Xu-051
125326	\N	\N	2388	32309	\N	2388 Cell Line	Xu-053
125327	\N	\N	2387	32308	\N	2387 Cell Line	Xu-052
125328	\N	\N	2389	32310	\N	2389 Cell Line	Xu-054
125329	\N	\N	2390	32311	\N	2390 Cell Line	Xu-055
125330	\N	\N	2391	32312	\N	2391 Cell Line	Xu-056
125331	\N	\N	2392	32313	\N	2392 Cell Line	Xu-057
125332	\N	\N	2394	32315	\N	2394 Cell Line	Xu-059
125333	\N	\N	2393	32314	\N	2393 Cell Line	Xu-058
125334	\N	\N	2395	32316	\N	2395 Cell Line	Xu-060
125335	\N	\N	2396	32317	\N	2396 Cell Line	Xu-061
125336	\N	\N	2397	32318	\N	2397 Cell Line	Xu-062
125337	\N	\N	2399	32320	\N	2399 Cell Line	Xu-064
125338	\N	\N	2398	32319	\N	2398 Cell Line	Xu-063
125339	\N	\N	2466	27690	\N	2466 Cell Line	230 WT
125340	\N	\N	2465	27689	\N	2465 Cell Line	144aI WT
125341	\N	\N	2759	32053	\N	2759 Cell Line	Thomas_SK_Mel23
125342	\N	\N	2842	31913	\N	2842 Cell Line	SKMEL28-1_NA
125343	\N	\N	2843	31914	\N	2843 Cell Line	SKMEL28-2_NA
125344	\N	\N	2844	31915	\N	2844 Cell Line	SKMEL28-3_NA
125345	\N	\N	2845	31910	\N	2845 Cell Line	SKMEL5-1_NA
125346	\N	\N	2847	31912	\N	2847 Cell Line	SKMEL5-3_NA
125347	\N	\N	2846	31911	\N	2846 Cell Line	SKMEL5-2_NA
125348	\N	\N	2951	28510	\N	2951 Cell Line	BB008_LAL-L2_NA
125349	\N	\N	2950	28509	\N	2950 Cell Line	BB008_LAL-L1_NA
125350	\N	\N	2952	28511	\N	2952 Cell Line	BB008_NB2107_NA
125351	\N	\N	2953	28512	\N	2953 Cell Line	BB008_WM3211_NA
125352	\N	\N	3434	32052	\N	3434 Cell Line	Thomas_SK_MEL_23_NA
125353	\N	\N	3801	27691	\N	3801 Cell Line	1205lu-1_NA
125354	\N	\N	3802	27692	\N	3802 Cell Line	1205lu-2_NA
125355	\N	\N	3803	27693	\N	3803 Cell Line	1205LU-3_NA
127670	\N	\N	10148	32483	\N	HWA3_Tumor	NA_HWA3_Tumor
125401	\N	\N	2400	28947	\N	2400 Melanocytic Nevus	D1_NA
125402	\N	\N	2401	28948	\N	2401 Melanocytic Nevus	D2_NA
125403	\N	\N	2403	28950	\N	2403 Melanocytic Nevus	D7_NA
125404	\N	\N	2406	28960	\N	2406 Melanocytic Nevus	D15_NA
125405	\N	\N	2410	27681	\N	2410 Melanocytic Nevus	27_NA
125406	\N	\N	2426	28979	\N	2426 Melanocytic Nevus	D48_NA
125407	\N	\N	2427	28980	\N	2427 Melanocytic Nevus	D49_NA
125408	\N	\N	2428	28981	\N	2428 Melanocytic Nevus	D51_NA
125409	\N	\N	2431	28984	\N	2431 Melanocytic Nevus	D58_NA
125410	\N	\N	2437	28990	\N	2437 Melanocytic Nevus	D65_NA
125411	\N	\N	2439	28992	\N	2439 Melanocytic Nevus	D67_NA
125412	\N	\N	2436	28989	\N	2436 Melanocytic Nevus	D64_NA
125413	\N	\N	2440	28993	\N	2440 Melanocytic Nevus	D68_NA
125414	\N	\N	2432	28985	\N	2432 Melanocytic Nevus	D59_NA
125415	\N	\N	2438	28991	\N	2438 Melanocytic Nevus	D66_NA
125416	\N	\N	2441	28994	\N	2441 Melanocytic Nevus	D70_NA
125417	\N	\N	2402	28949	\N	2402 SCC	D6_NA
125418	\N	\N	2408	27673	\N	2408 SCC	23_NA
125419	\N	\N	2411	27682	\N	2411 SCC	28_NA
125420	\N	\N	2421	28975	\N	2421 SCC	D44_NA
125421	\N	\N	2422	28976	\N	2422 SCC	D45_NA
125422	\N	\N	2423	28977	\N	2423 SCC	D46_NA
125423	\N	\N	2424	28974	\N	2424 SCC	D43_NA_SCC
125424	\N	\N	2442	28995	\N	2442 SCC	D71_NA
125425	\N	\N	2404	28951	\N	2404 BCC	D11_NA
125427	\N	\N	2434	28987	\N	2434 BCC	D61_NA
125428	\N	\N	2407	28961	\N	2407 Cellular Dermatofibroma 	D20_NA
125429	\N	\N	2409	27674	\N	2409 SCC+ in situ	24_NA
125430	\N	\N	2415	28969	\N	2415 SCC+ in situ	D36_NA
125431	\N	\N	2412	28966	\N	2412 SCC+ in situ	D29_NA
125432	\N	\N	2413	28967	\N	2413 Dermatofibroma	D31_NA
125433	\N	\N	2416	27686	\N	2416 Dermatofibroma	38_NA
125434	\N	\N	2420	28973	\N	2420 Buffy Coat DNA	D43_NA_BC
125435	\N	\N	2429	28982	\N	2429 Keratosis	D55_NA
125436	\N	\N	2433	28986	\N	2433 Pilomatricoma+ cystic	D60_NA
125437	\N	\N	2435	28988	\N	2435 Leiomyoma	D62_NA
125438	\N	\N	2468	30314	\N	2468 Melanoma Cell Line	M230 Imat A3
125439	\N	\N	2464	27688	\N	2464 Melanoma Cell Line	144 Imat B15-2
125440	\N	\N	2463	29352	\N	2463 Melanoma Cell Line	DNA-144 Imat B15
125441	\N	\N	2467	30313	\N	2467 Melanoma Cell Line	M230 Imat A2
125357	\N	\N	2455	29965	\N	2455 Invasive	LMM D-021
125358	\N	\N	2469	29966	\N	2469 Invasive	LMM D-022
125359	\N	\N	2486	29999	\N	2486 Invasive	LMM D-055
125360	\N	\N	2483	29996	\N	2483 Invasive	LMM D-052
125361	\N	\N	2477	29990	\N	2477 Invasive	LMM D-046
125362	\N	\N	2472	28236	\N	2472 Invasive	AM2 D-538
125363	\N	\N	2480	29993	\N	2480 Invasive	LMM D-049
125364	\N	\N	2491	29945	\N	2491 Invasive	LMM D-001
125365	\N	\N	2494	29948	\N	2494 Invasive	LMM D-004
125366	\N	\N	2497	29951	\N	2497 Invasive	LMM D-007
125367	\N	\N	2500	29954	\N	2500 Invasive	LMM D-010
125368	\N	\N	2503	29957	\N	2503 Invasive	LMM D-013
125369	\N	\N	2506	30030	\N	2506 Invasive	LMM R-025
125370	\N	\N	2509	30032	\N	2509 Invasive	LMM R-028
125371	\N	\N	2512	30034	\N	2512 Invasive	LMM R-031
125372	\N	\N	2515	30036	\N	2515 Invasive	LMM R-034
125373	\N	\N	2518	30038	\N	2518 Invasive	LMM R-037
125374	\N	\N	2521	30040	\N	2521 Invasive	LMM R-040
125375	\N	\N	2524	30042	\N	2524 Invasive	LMM R-043
125396	\N	\N	2306	31484	\N	2306 Met6	PROG D-22
125397	\N	\N	2307	31485	\N	2307 Met7	PROG D-23
125398	\N	\N	2308	31486	\N	2308 Met8	PROG D-24
125399	\N	\N	2309	31487	\N	2309 Met9	PROG D-25
125400	\N	\N	2310	31488	\N	2310 Met10	PROG D-26
125426	\N	\N	2430	28983	\N	2430 BCC	D56_NA
127671	\N	\N	10149	32484	\N	HWA3_Normal	NA_HWA3_Normal
127672	\N	\N	10150	32485	\N	HWA4_Tumor	NA_HWA4_Tumor
127673	\N	\N	10151	32486	\N	HWA4_Normal	NA_HWA4_Normal
127674	\N	\N	10152	32487	\N	11-5482_Tumor	NA_11-5482_Tumor
127775	\N	\N	10253	32588	\N	KIT21_Tumor	NA_KIT21_Tumor
127675	\N	\N	10153	32488	\N	11-79158_Tumor	NA_11-79158_Tumor
125445	\N	\N	2566	29123	\N	2566 Congenital Nevus	DMS-002
125446	\N	\N	2567	29124	\N	2567 Congenital Nevus	DMS-003
125447	\N	\N	2568	29125	\N	2568 Congenital Nevus	DMS-004
125448	\N	\N	2570	29127	\N	2570 Congenital Nevus	DMS-006
125449	\N	\N	2571	29128	\N	2571 Congenital Nevus	DMS-007
125464	\N	\N	2569	29126	\N	2569 Spitz Nevus	DMS-005
125465	\N	\N	2574	29131	\N	2574 Spitz Nevus	DMS-010
125476	\N	\N	2611	29168	\N	2611 Spitz Nevus	DMS-042
125509	\N	\N	2752	29760	\N	2752 MVP	JBU10-MVP
125510	\N	\N	2754	29762	\N	2754 MVP	JBU11-MVP
125511	\N	\N	2756	29756	\N	2756 MVP	JBU7-MVP
125512	\N	\N	2758	29758	\N	2758 MVP	JBU8-MVP
125513	\N	\N	2887	28777	\N	2887 Cell Line - Control	ChIP1_1_NA
125514	\N	\N	2888	28778	\N	2888 Cell Line - Control	ChIP1_2_NA
125515	\N	\N	2889	28779	\N	2889 Cell Line - Control	ChIP1_3_NA
125516	\N	\N	2893	28783	\N	2893 Cell Line - Control	ChIP1_7_NA
125517	\N	\N	2895	28785	\N	2895 Cell Line - Control	ChIP1_9_NA
125518	\N	\N	2894	28784	\N	2894 Cell Line - Control	ChIP1_8_NA
125519	\N	\N	2890	28780	\N	2890 Cell Line - Knockdown	ChIP1_4_NA
125520	\N	\N	2891	28781	\N	2891 Cell Line - Knockdown	ChIP1_5_NA
125521	\N	\N	2892	28782	\N	2892 Cell Line - Knockdown	ChIP1_6_NA
125522	\N	\N	2896	28786	\N	2896 Cell Line - Knockdown	ChIP1_10_NA
125523	\N	\N	2897	28787	\N	2897 Cell Line - Knockdown	ChIP1_11_NA
125524	\N	\N	2898	28788	\N	2898 Cell Line - Knockdown	ChIP1_12_NA
125443	\N	\N	2564	29121	\N	2564 Congenital Nevus	DMS-001B
125444	\N	\N	2565	29122	\N	2565 Congenital Nevus	DMS-001C
125450	\N	\N	2583	29140	\N	2583 Congenital Nevus	DMS-019
125451	\N	\N	2585	29142	\N	2585 Congenital Nevus	DMS-021
125452	\N	\N	2584	29141	\N	2584 Congenital Nevus	DMS-020
125453	\N	\N	2624	29181	\N	2624 Congenital Nevus	DMS-054
125454	\N	\N	2625	29182	\N	2625 Congenital Nevus	DMS-055
125455	\N	\N	2626	29183	\N	2626 Congenital Nevus	DMS-056
125456	\N	\N	2627	29184	\N	2627 Congenital Nevus	DMS-057
125457	\N	\N	2629	29186	\N	2629 Congenital Nevus	DMS-059A
125458	\N	\N	2628	29185	\N	2628 Congenital Nevus	DMS-058
125459	\N	\N	2630	29187	\N	2630 Congenital Nevus	DMS-059B
125460	\N	\N	2631	29188	\N	2631 Congenital Nevus	DMS-060
125461	\N	\N	2633	29190	\N	2633 Congenital Nevus	DMS-062
125462	\N	\N	2632	29189	\N	2632 Congenital Nevus	DMS-061
125463	\N	\N	2635	29192	\N	2635 Congenital Nevus	DMS-063
125466	\N	\N	2598	29155	\N	2598 Spitz Nevus	DMS-034
125467	\N	\N	2597	29154	\N	2597 Spitz Nevus	DMS-033
125468	\N	\N	2599	29156	\N	2599 Spitz Nevus	DMS-035
125469	\N	\N	2601	29158	\N	2601 Spitz Nevus	DMS-036
125470	\N	\N	2602	29159	\N	2602 Spitz Nevus	DMS-037
125471	\N	\N	2604	29161	\N	2604 Spitz Nevus	DMS-038
125472	\N	\N	2606	29163	\N	2606 Spitz Nevus	DMS-039
125473	\N	\N	2608	29165	\N	2608 Spitz Nevus	DMS-040
125474	\N	\N	2612	29169	\N	2612 Spitz Nevus	DMS-043
125475	\N	\N	2610	29167	\N	2610 Spitz Nevus	DMS-041
125477	\N	\N	2613	29170	\N	2613 Spitz Nevus	DMS-044
125478	\N	\N	2614	29171	\N	2614 Spitz Nevus	DMS-045
125479	\N	\N	2615	29172	\N	2615 Spitz Nevus	DMS-046
125480	\N	\N	2616	29173	\N	2616 Spitz Nevus	DMS-047
125481	\N	\N	2617	29174	\N	2617 Spitz Nevus	DMS-048
125482	\N	\N	2618	29175	\N	2618 Spitz Nevus	DMS-049
125483	\N	\N	2619	29176	\N	2619 Spitz Nevus	DMS-050
125484	\N	\N	2620	29177	\N	2620 Spitz Nevus	DMS-051
125485	\N	\N	2621	29178	\N	2621 Spitz Nevus	DMS-052 A
125486	\N	\N	2623	29180	\N	2623 Spitz Nevus	DMS-053
125487	\N	\N	2622	29179	\N	2622 Spitz Nevus	DMS-052 B
125488	\N	\N	2528	29786	\N	2528 Keratoacanthoma	KA D-02
125489	\N	\N	2530	29788	\N	2530 Keratoacanthoma	KA D-04
125490	\N	\N	2532	29790	\N	2532 Keratoacanthoma	KA D-06
125491	\N	\N	2534	29792	\N	2534 Keratoacanthoma	KA D-08
125492	\N	\N	2536	29794	\N	2536 Keratoacanthoma	KA D-10
125493	\N	\N	2538	29796	\N	2538 Keratoacanthoma	KA D-12
125494	\N	\N	2540	29798	\N	2540 Keratoacanthoma	KA D-14
125495	\N	\N	2542	29800	\N	2542 Keratoacanthoma	KA D-16
125496	\N	\N	2544	29802	\N	2544 Keratoacanthoma	KA D-18
125497	\N	\N	2545	29803	\N	2545 Keratoacanthoma	KA D-19
125498	\N	\N	2546	29804	\N	2546 Keratoacanthoma	KA D-20
125499	\N	\N	2547	29805	\N	2547 Keratoacanthoma	KA D-21
125500	\N	\N	2549	29807	\N	2549 Keratoacanthoma	KA D-23
125501	\N	\N	2551	29809	\N	2551 Keratoacanthoma	KA D-25
125502	\N	\N	2552	29810	\N	2552 Keratoacanthoma	KA D-26
125503	\N	\N	2554	29812	\N	2554 Keratoacanthoma	KA D-28
125504	\N	\N	2556	29814	\N	2556 Keratoacanthoma	KA D-30
125505	\N	\N	2558	29816	\N	2558 Keratoacanthoma	KA D-32
125506	\N	\N	2560	29818	\N	2560 Keratoacanthoma	KA D-34
125507	\N	\N	2561	29819	\N	2561 Keratoacanthoma	KA D-35
127676	\N	\N	10154	32489	\N	DP12-200_Tumor	NA_DP12-200_Tumor
127677	\N	\N	10155	32490	\N	TissueCoreALKControl_Normal	NA_TissueCoreALKControl_Normal
127678	\N	\N	10156	32491	\N	10-59344_Tumor	NA_10-59344_Tumor
125691	\N	\N	2405	28959	\N	2405 Unknown	D13_NA
125693	\N	\N	2908	28958	\N	2908 Unknown	D12_M_NA
125694	\N	\N	2918	27668	\N	2918 Unknown	22-104389A4-RNA
125695	\N	\N	2917	27667	\N	2917 Unknown	22-104389A4-DNA
125696	\N	\N	3161	29062	\N	3161 Unknown	DM_101_IS_NA
125697	\N	\N	3303	29776	\N	3303 Unknown	K2_3_NA
125698	\N	\N	3400	31400	\N	3400 Unknown	OM-1R (P040_05A)
125699	\N	\N	3399	31397	\N	3399 Unknown	OM-1D (P040_09A)
125700	\N	\N	3401	31401	\N	3401 Unknown	OM-3D (P040_09B)
125701	\N	\N	3402	31402	\N	3402 Unknown	OM-3R (P040_05B)
125702	\N	\N	3405	31407	\N	3405 Unknown	OM-5D (P040_09D)
125703	\N	\N	3403	31403	\N	3403 Unknown	OM-4D (P040_09C)
125704	\N	\N	3404	31406	\N	3404 Unknown	OM-4R (P040_05C)
125705	\N	\N	3408	31415	\N	3408 Unknown	OM-8R (P040_07A)
125706	\N	\N	3406	31410	\N	3406 Unknown	OM-5R (P040_05D)
125707	\N	\N	3407	31414	\N	3407 Unknown	OM-8D (P040_11A)
125708	\N	\N	3409	31416	\N	3409 Unknown	OM-9D
125709	\N	\N	3410	31420	\N	3410 Unknown	OM-10R (P040_07B)
125710	\N	\N	3412	31423	\N	3412 Unknown	OM-12D
125711	\N	\N	3411	31422	\N	3411 Unknown	OM-11R (P040_07C)
125712	\N	\N	3414	31430	\N	3414 Unknown	OM-17D
125713	\N	\N	3413	31428	\N	3413 Unknown	OM-15R (P040_07D)
125714	\N	\N	3415	31431	\N	3415 Unknown	OM-18D
125715	\N	\N	3417	31433	\N	3417 Unknown	OM-18D3
125716	\N	\N	3416	31432	\N	3416 Unknown	OM-18D2
125717	\N	\N	3418	31434	\N	3418 Unknown	OM-18D4
125718	\N	\N	3425	31457	\N	3425 Unknown	PG_8_NA
125719	\N	\N	3438	30003	\N	3438 Unknown	LMM D-061
125720	\N	\N	3439	30004	\N	3439 Unknown	LMM D-062
125721	\N	\N	3440	28595	\N	3440 Unknown	CGH11-051
125722	\N	\N	3441	28616	\N	3441 Unknown	CGH11-275
125723	\N	\N	3443	31222	\N	3443 Unknown	NGS 1-9_NA
125724	\N	\N	3445	31224	\N	3445 Unknown	NGS 1-13_NA
125725	\N	\N	3444	31223	\N	3444 Unknown	NGS 1-10_NA
125726	\N	\N	3446	31225	\N	3446 Unknown	NGS 1-14_NA
125744	\N	\N	2937	27813	\N	2937 Not Processed	AM2 D-72
125877	\N	\N	3811	28516	\N	3811 Lung Cell Line	BB09_Bivona_L10_NA
125878	\N	\N	3812	28517	\N	3812 Lung Cell Line	BB09_Bivona_L11_NA
125879	\N	\N	3819	28513	\N	3819 Lung Cell Line	BB09_Bivona_L7_NA
125880	\N	\N	3820	28514	\N	3820 Lung Cell Line	BB09_Bivona_L8_NA
125881	\N	\N	3821	28515	\N	3821 Lung Cell Line	BB09_Bivona_L9_NA
125882	\N	\N	3823	28530	\N	3823 Lung Cell Line	Bivona_L_17_NA
125883	\N	\N	3813	28529	\N	3813 Lung Cells	Bivona_L_1_NA
125884	\N	\N	3814	28533	\N	3814 Lung Cells	Bivona_L2_NA
125885	\N	\N	3815	28534	\N	3815 Lung Cells	Bivona_L3_NA
125886	\N	\N	3816	28535	\N	3816 Lung Cells	Bivona_L4_NA
125887	\N	\N	3817	28536	\N	3817 Lung Cells	Bivona_L5_NA
125888	\N	\N	3818	28537	\N	3818 Lung Cells	Bivona_L6_NA
125891	\N	\N	3351	29940	\N	3351 Intermediate	L2-HGD_NA
125892	\N	\N	3353	29942	\N	3353 Intermediate	L3-HGD_NA
125893	\N	\N	3419	31451	\N	3419 Cadaver Skin	P57-A-1.0mm_NA
125894	\N	\N	3420	31452	\N	3420 Cadaver Skin	P57-A-2.0mm_NA
125895	\N	\N	3422	31454	\N	3422 Cadaver Skin	P57-B-2.0mm_NA
125896	\N	\N	3421	31453	\N	3421 Cadaver Skin	P57-B-1.0mm_NA
125897	\N	\N	2930	27694	\N	2930 Human Cadaver Skin - Acral	ACL01
125898	\N	\N	2931	27695	\N	2931 Human Cadaver Skin - Acral	ACL03
125899	\N	\N	2932	27696	\N	2932 Human Cadaver Skin - Acral	ACL05
125900	\N	\N	2933	27697	\N	2933 Human Cadaver Skin - Acral	ACL06
125901	\N	\N	2984	28555	\N	2984 Human Cadaver Skin - Buttocks	BTK01
125902	\N	\N	2985	28556	\N	2985 Human Cadaver Skin - Buttocks	BTK03
125903	\N	\N	2986	28557	\N	2986 Human Cadaver Skin - Buttocks	BTK05
125904	\N	\N	2987	28558	\N	2987 Human Cadaver Skin - Buttocks	BTK06
125905	\N	\N	3238	29668	\N	3238 Human Cadaver Skin - Face	FAC01
125906	\N	\N	3239	29669	\N	3239 Human Cadaver Skin - Face	FAC03
125907	\N	\N	3240	29670	\N	3240 Human Cadaver Skin - Face	FAC05
125908	\N	\N	3241	29671	\N	3241 Human Cadaver Skin - Face	FAC06
125909	\N	\N	3431	31902	\N	3431 Human Cadaver Skin - Shoulder	SHR03
125910	\N	\N	3430	31901	\N	3430 Human Cadaver Skin - Shoulder	SHR01
125911	\N	\N	3433	31904	\N	3433 Human Cadaver Skin - Shoulder	SHR06
125912	\N	\N	3432	31903	\N	3432 Human Cadaver Skin - Shoulder	SHR05
127679	\N	\N	10157	32492	\N	11-16253_Tumor	NA_11-16253_Tumor
125914	\N	\N	1575	28362	\N	\N	AM2 R-358
122325	\N	\N	1575	28080	\N	1575 	AM2 D-358
125915	\N	\N	6	27983	\N	\N	AM2 D-249
125916	\N	\N	6	28267	\N	\N	AM2 R-249
125917	\N	\N	9	27970	\N	\N	AM2 D-236
125918	\N	\N	9	28254	\N	\N	AM2 R-236
125919	\N	\N	65	27973	\N	\N	AM2 D-239
125920	\N	\N	65	28257	\N	\N	AM2 R-239
125921	\N	\N	65	28145	\N	\N	AM2 D-440
125922	\N	\N	68	27977	\N	\N	AM2 D-243
125923	\N	\N	68	28261	\N	\N	AM2 R-243
125924	\N	\N	280	29229	\N	\N	DNA-01
125925	\N	\N	280	29230	\N	\N	DNA-01_REPEAT
125926	\N	\N	280	29503	\N	\N	DNA-297
125927	\N	\N	280	29514	\N	\N	DNA-308
125928	\N	\N	286	29236	\N	\N	DNA-07
125929	\N	\N	302	29250	\N	\N	DNA-23
125930	\N	\N	302	29322	\N	\N	DNA-115
125931	\N	\N	302	31649	\N	\N	RNA-115
125932	\N	\N	302	29353	\N	\N	DNA-145
125933	\N	\N	302	31679	\N	\N	RNA-145
125934	\N	\N	283	29233	\N	\N	DNA-04
125935	\N	\N	289	29239	\N	\N	DNA-10
125936	\N	\N	289	29314	\N	\N	DNA-107
125937	\N	\N	289	31641	\N	\N	RNA-107
125938	\N	\N	304	29252	\N	\N	DNA-25
125939	\N	\N	305	29253	\N	\N	DNA-26
125940	\N	\N	345	29256	\N	\N	DNA-29
125941	\N	\N	354	29259	\N	\N	DNA-38
125942	\N	\N	354	29333	\N	\N	DNA-126
125943	\N	\N	354	31660	\N	\N	RNA-126
125944	\N	\N	354	31673	\N	\N	RNA-139
125945	\N	\N	354	29346	\N	\N	DNA-139
125946	\N	\N	778	31625	\N	\N	RNA-72
125947	\N	\N	783	31626	\N	\N	RNA-73
125948	\N	\N	783	29335	\N	\N	DNA-128
125949	\N	\N	783	31662	\N	\N	RNA-128
125950	\N	\N	786	29336	\N	\N	DNA-129
125951	\N	\N	786	31663	\N	\N	RNA-129
125952	\N	\N	790	31628	\N	\N	RNA-75
125953	\N	\N	792	31627	\N	\N	RNA-74
125954	\N	\N	797	31629	\N	\N	RNA-76
125955	\N	\N	894	29338	\N	\N	DNA-131
125956	\N	\N	894	31665	\N	\N	RNA-131
125957	\N	\N	894	29473	\N	\N	DNA-267
125958	\N	\N	894	29476	\N	\N	DNA-270
125959	\N	\N	894	29477	\N	\N	DNA-271
125960	\N	\N	895	29317	\N	\N	DNA-110
125961	\N	\N	895	31644	\N	\N	RNA-110
125962	\N	\N	895	31668	\N	\N	RNA-134
125963	\N	\N	895	29341	\N	\N	DNA-134
125964	\N	\N	1288	28148	\N	\N	AM2 D-444
125965	\N	\N	1292	27986	\N	\N	AM2 D-252
125966	\N	\N	1292	28270	\N	\N	AM2 R-252
125967	\N	\N	1311	31489	\N	\N	PROG R-01
125968	\N	\N	1311	31477	\N	\N	PROG D-15
125969	\N	\N	1311	31503	\N	\N	PROG R-15
125970	\N	\N	1422	28247	\N	\N	AM2 R-225
125971	\N	\N	1425	28271	\N	\N	AM2 R-253
125972	\N	\N	1430	31631	\N	\N	RNA-98
125973	\N	\N	1431	31632	\N	\N	RNA-99
125974	\N	\N	1432	31633	\N	\N	RNA-100
125975	\N	\N	1432	31675	\N	\N	RNA-141
125976	\N	\N	1432	29348	\N	\N	DNA-141
125977	\N	\N	1433	31634	\N	\N	RNA-101
125978	\N	\N	1434	31630	\N	\N	RNA-97
125979	\N	\N	1434	31669	\N	\N	RNA-135
125980	\N	\N	1434	29342	\N	\N	DNA-135
125981	\N	\N	1438	31499	\N	\N	PROG R-11
125982	\N	\N	1438	31476	\N	\N	PROG D-14
125983	\N	\N	1438	31502	\N	\N	PROG R-14
125984	\N	\N	1438	31481	\N	\N	PROG D-19
125985	\N	\N	1438	31507	\N	\N	PROG R-19
125986	\N	\N	1446	31682	\N	\N	RNA-148
125987	\N	\N	1446	29361	\N	\N	DNA-153
125988	\N	\N	1446	31687	\N	\N	RNA-153
125989	\N	\N	1447	31680	\N	\N	RNA-146
125990	\N	\N	1448	31683	\N	\N	RNA-149
125991	\N	\N	1448	29362	\N	\N	DNA-154
125992	\N	\N	1448	31688	\N	\N	RNA-154
125993	\N	\N	1448	29366	\N	\N	DNA-158
125994	\N	\N	1448	31692	\N	\N	RNA-158
125995	\N	\N	1449	31684	\N	\N	RNA-150
125996	\N	\N	1449	29363	\N	\N	DNA-155
125997	\N	\N	1449	31689	\N	\N	RNA-155
125998	\N	\N	1450	31685	\N	\N	RNA-151
125999	\N	\N	1450	29364	\N	\N	DNA-156
126000	\N	\N	1450	31690	\N	\N	RNA-156
126001	\N	\N	1450	29367	\N	\N	DNA-159
126002	\N	\N	1450	31693	\N	\N	RNA-159
126003	\N	\N	1451	31681	\N	\N	RNA-147
126004	\N	\N	1451	29360	\N	\N	DNA-152
126005	\N	\N	1451	31686	\N	\N	RNA-152
126006	\N	\N	1451	29365	\N	\N	DNA-157
126007	\N	\N	1451	31691	\N	\N	RNA-157
126008	\N	\N	1470	28274	\N	\N	AM2 R-256
126009	\N	\N	1470	28170	\N	\N	AM2 D-467
126010	\N	\N	1470	28433	\N	\N	AM2 R-467
126011	\N	\N	1478	28282	\N	\N	AM2 R-264
126012	\N	\N	1478	28191	\N	\N	AM2 D-488
126013	\N	\N	1478	28192	\N	\N	AM2 D-489
126014	\N	\N	1478	28451	\N	\N	AM2 R-488
126015	\N	\N	1478	28452	\N	\N	AM2 R-489
126016	\N	\N	1490	28285	\N	\N	AM2 R-268
126017	\N	\N	1490	28088	\N	\N	AM2 D-368
126018	\N	\N	1497	28292	\N	\N	AM2 R-275
126019	\N	\N	1503	28298	\N	\N	AM2 R-281
126020	\N	\N	1507	28298	\N	\N	AM2 R-281
126021	\N	\N	1510	28304	\N	\N	AM2 R-288
126022	\N	\N	1510	28219	\N	\N	AM2 D-519
126023	\N	\N	1510	28479	\N	\N	AM2 R-519
126024	\N	\N	1521	28310	\N	\N	AM2 R-296
126025	\N	\N	1521	28086	\N	\N	AM2 D-366
126026	\N	\N	1523	28312	\N	\N	AM2 R-298
126027	\N	\N	1526	28312	\N	\N	AM2 R-298
126028	\N	\N	1526	28228	\N	\N	AM2 D-528
126029	\N	\N	1526	28488	\N	\N	AM2 R-528
126030	\N	\N	1535	28323	\N	\N	AM2 R-314
126031	\N	\N	1535	28120	\N	\N	AM2 D-410
126032	\N	\N	1535	28121	\N	\N	AM2 D-411
126033	\N	\N	1535	28391	\N	\N	AM2 R-410
126034	\N	\N	1535	28392	\N	\N	AM2 R-411
126035	\N	\N	1541	28329	\N	\N	AM2 R-321
126036	\N	\N	1541	28083	\N	\N	AM2 D-362
126037	\N	\N	1541	28173	\N	\N	AM2 D-471
126038	\N	\N	1541	28436	\N	\N	AM2 R-471
126039	\N	\N	1547	28335	\N	\N	AM2 R-327
126040	\N	\N	1604	28178	\N	\N	AM2 D-476
126041	\N	\N	1604	28441	\N	\N	AM2 R-476
122446	\N	\N	1604	28118	\N	1604 Normal	AM2 D-407
126042	\N	\N	1624	28433	\N	\N	AM2 R-467
126043	\N	\N	1649	30965	\N	\N	MMR-29
126044	\N	\N	1649	30688	\N	\N	MMD-111
126045	\N	\N	1654	30970	\N	\N	MMR-34
126046	\N	\N	1654	30685	\N	\N	MMD-107
126047	\N	\N	1654	30768	\N	\N	MMD-193
126048	\N	\N	1663	30687	\N	\N	MMD-109
126049	\N	\N	1663	30770	\N	\N	MMD-195
126050	\N	\N	1663	31057	\N	\N	MMR-195
126051	\N	\N	1663	30842	\N	\N	MMD-267
126052	\N	\N	1663	31088	\N	\N	MMR-267
126053	\N	\N	1668	30683	\N	\N	MMD-105
126054	\N	\N	1668	30843	\N	\N	MMD-268
126055	\N	\N	1673	30681	\N	\N	MMD-103
126056	\N	\N	1679	30765	\N	\N	MMD-190
126057	\N	\N	1679	30849	\N	\N	MMD-274
126058	\N	\N	1679	30930	\N	\N	MMD-355 (P041_01A)
126059	\N	\N	1679	31131	\N	\N	MMR-355
126060	\N	\N	1705	30866	\N	\N	MMD-291
126061	\N	\N	1705	30787	\N	\N	MMD-212
126062	\N	\N	1709	30694	\N	\N	MMD-117
126063	\N	\N	1714	30871	\N	\N	MMD-296
126064	\N	\N	1718	30874	\N	\N	MMD-299
126065	\N	\N	1720	30874	\N	\N	MMD-299
126066	\N	\N	1722	30790	\N	\N	MMD-215
126067	\N	\N	1722	30875	\N	\N	MMD-300
126068	\N	\N	1728	30710	\N	\N	MMD-133
126069	\N	\N	1732	30829	\N	\N	MMD-254
126070	\N	\N	1732	30932	\N	\N	MMD-357 (P041_01C)
126071	\N	\N	1732	31133	\N	\N	MMR-357
126072	\N	\N	1735	30832	\N	\N	MMD-257
126073	\N	\N	1739	30721	\N	\N	MMD-146
126074	\N	\N	1740	30723	\N	\N	MMD-148
126075	\N	\N	1742	30887	\N	\N	MMD-312
126076	\N	\N	1745	30729	\N	\N	MMD-154
126077	\N	\N	1745	30836	\N	\N	MMD-261
126078	\N	\N	1745	30935	\N	\N	MMD-360
126079	\N	\N	1745	31136	\N	\N	MMR-360
126080	\N	\N	1748	30889	\N	\N	MMD-314
126081	\N	\N	1753	30840	\N	\N	MMD-265
126082	\N	\N	1760	30845	\N	\N	MMD-270
126083	\N	\N	1766	30891	\N	\N	MMD-316
126084	\N	\N	1778	30882	\N	\N	MMD-307
126085	\N	\N	1781	30885	\N	\N	MMD-310
126086	\N	\N	1784	30893	\N	\N	MMD-318
126087	\N	\N	1788	30895	\N	\N	MMD-320
126088	\N	\N	1791	30780	\N	\N	MMD-205
126089	\N	\N	1793	30897	\N	\N	MMD-322
126090	\N	\N	1795	30785	\N	\N	MMD-210
126091	\N	\N	1802	30855	\N	\N	MMD-280
126092	\N	\N	1809	30900	\N	\N	MMD-325
126093	\N	\N	1809	31102	\N	\N	MMR-325
126094	\N	\N	1811	30859	\N	\N	MMD-284
126095	\N	\N	1813	30902	\N	\N	MMD-327
126096	\N	\N	1813	31104	\N	\N	MMR-327
126097	\N	\N	1815	30861	\N	\N	MMD-286
126098	\N	\N	1821	30865	\N	\N	MMD-290
126099	\N	\N	1824	28406	\N	\N	AM2 R-431
126100	\N	\N	1840	31106	\N	\N	MMR-329
126101	\N	\N	1842	31108	\N	\N	MMR-331
126102	\N	\N	1845	31110	\N	\N	MMR-333
126103	\N	\N	1848	31114	\N	\N	MMR-337
126104	\N	\N	1852	30916	\N	\N	MMD-341
126105	\N	\N	1854	31119	\N	\N	MMR-343
126106	\N	\N	1856	30920	\N	\N	MMD-345
126107	\N	\N	1859	31124	\N	\N	MMR-348
126108	\N	\N	1862	31127	\N	\N	MMR-351
126109	\N	\N	1864	30928	\N	\N	MMD-353
126110	\N	\N	1920	31697	\N	\N	RNA-163
126111	\N	\N	1920	29414	\N	\N	DNA-206
126112	\N	\N	1925	31702	\N	\N	RNA-168
126113	\N	\N	1925	29419	\N	\N	DNA-211
126114	\N	\N	1929	31706	\N	\N	RNA-172
126115	\N	\N	1929	29423	\N	\N	DNA-215
126116	\N	\N	1930	31707	\N	\N	RNA-173
126117	\N	\N	1930	29424	\N	\N	DNA-216
126118	\N	\N	1934	31711	\N	\N	RNA-177
126119	\N	\N	1934	29428	\N	\N	DNA-220
126120	\N	\N	1937	31714	\N	\N	RNA-180
126121	\N	\N	1937	29431	\N	\N	DNA-223
126122	\N	\N	1940	31717	\N	\N	RNA-183
126123	\N	\N	1940	29434	\N	\N	DNA-226
126124	\N	\N	1943	31720	\N	\N	RNA-186
126125	\N	\N	1943	29437	\N	\N	DNA-229
126126	\N	\N	1946	31723	\N	\N	RNA-189
126127	\N	\N	1946	29440	\N	\N	DNA-232
126128	\N	\N	1949	31726	\N	\N	RNA-192
126129	\N	\N	1949	29444	\N	\N	DNA-236
126130	\N	\N	1950	31727	\N	\N	RNA-193
126131	\N	\N	1950	29410	\N	\N	DNA-202
126132	\N	\N	1950	29445	\N	\N	DNA-237
126133	\N	\N	1950	29456	\N	\N	DNA-248
126134	\N	\N	1953	31730	\N	\N	RNA-196
126135	\N	\N	1953	29448	\N	\N	DNA-240
126136	\N	\N	1955	29449	\N	\N	DNA-241
126137	\N	\N	1955	29462	\N	\N	DNA-256
126138	\N	\N	1955	29463	\N	\N	DNA-257
126139	\N	\N	1957	29468	\N	\N	DNA-262
126140	\N	\N	1956	29452	\N	\N	DNA-244
126141	\N	\N	1956	31762	\N	\N	RNA-244
126142	\N	\N	1956	29461	\N	\N	DNA-255
126143	\N	\N	1958	29469	\N	\N	DNA-263
126144	\N	\N	2036	29470	\N	\N	DNA-264
126145	\N	\N	2037	29471	\N	\N	DNA-265
126146	\N	\N	2087	29502	\N	\N	DNA-296
122568	\N	\N	2087	28921	\N	2087 Normal	D-NA-563
126147	\N	\N	2113	29497	\N	\N	DNA-291
126148	\N	\N	2116	29498	\N	\N	DNA-292
126149	\N	\N	2120	31782	\N	\N	RNA-284
126150	\N	\N	2120	29499	\N	\N	DNA-293
126151	\N	\N	2123	29525	\N	\N	DNA-319
126152	\N	\N	2133	29523	\N	\N	DNA-317
126153	\N	\N	2189	31814	\N	\N	RNA-339
126154	\N	\N	2222	29590	\N	\N	DNA-423
126155	\N	\N	2222	31857	\N	\N	RNA-423
126156	\N	\N	2222	31854	\N	\N	RNA-420
126157	\N	\N	2229	29587	\N	\N	DNA-420
126158	\N	\N	2233	31848	\N	\N	RNA-403
126159	\N	\N	2241	31852	\N	\N	RNA-418
126160	\N	\N	2242	31853	\N	\N	RNA-419
126161	\N	\N	2245	31856	\N	\N	RNA-422
126162	\N	\N	2270	31328	\N	\N	NM R-101
126163	\N	\N	2289	31860	\N	\N	RNA-426
126164	\N	\N	2293	31864	\N	\N	RNA-430
126165	\N	\N	2298	31869	\N	\N	RNA-435
126166	\N	\N	2301	31872	\N	\N	RNA-438
126167	\N	\N	2449	31879	\N	\N	RNA-445
126168	\N	\N	2446	31876	\N	\N	RNA-442
126169	\N	\N	2450	30021	\N	\N	LMM R-016
126170	\N	\N	2453	30024	\N	\N	LMM R-019
126171	\N	\N	2461	31882	\N	\N	RNA-448
126172	\N	\N	2471	30029	\N	\N	LMM R-024
126173	\N	\N	2479	30046	\N	\N	LMM R-048
126174	\N	\N	2488	30055	\N	\N	LMM R-057
126175	\N	\N	2482	30049	\N	\N	LMM R-051
126176	\N	\N	2475	28496	\N	\N	AM2 R-541
126177	\N	\N	2485	30052	\N	\N	LMM R-054
126178	\N	\N	2493	30008	\N	\N	LMM R-003
126179	\N	\N	2496	30011	\N	\N	LMM R-006
126180	\N	\N	2499	30014	\N	\N	LMM R-009
126181	\N	\N	2502	30017	\N	\N	LMM R-012
126182	\N	\N	2505	30020	\N	\N	LMM R-015
126183	\N	\N	2605	31529	\N	\N	RMS-038N
126184	\N	\N	2607	31531	\N	\N	RMS-039N
126185	\N	\N	2609	31533	\N	\N	RMS-040N
126186	\N	\N	2634	31557	\N	\N	RMS-062N
126187	\N	\N	4	27968	\N	\N	AM2 D-232
126188	\N	\N	4	28252	\N	\N	AM2 R-232
126189	\N	\N	10	27971	\N	\N	AM2 D-237
126190	\N	\N	10	28255	\N	\N	AM2 R-237
126191	\N	\N	67	27975	\N	\N	AM2 D-241
126192	\N	\N	67	28259	\N	\N	AM2 R-241
126193	\N	\N	71	27980	\N	\N	AM2 D-246
126194	\N	\N	71	28264	\N	\N	AM2 R-246
126195	\N	\N	71	27988	\N	\N	AM2 D-254
126196	\N	\N	71	28272	\N	\N	AM2 R-254
126197	\N	\N	76	27966	\N	\N	AM2 D-228
126198	\N	\N	76	28250	\N	\N	AM2 R-228
126199	\N	\N	100	28234	\N	\N	AM2 D-536
126200	\N	\N	100	28491	\N	\N	AM2 R-536
126201	\N	\N	414	28194	\N	\N	AM2 D-491
126202	\N	\N	414	28454	\N	\N	AM2 R-491
126203	\N	\N	375	28186	\N	\N	AM2 D-484
126204	\N	\N	375	28446	\N	\N	AM2 R-484
126205	\N	\N	375	28190	\N	\N	AM2 D-487
126206	\N	\N	375	28450	\N	\N	AM2 R-487
126207	\N	\N	401	28235	\N	\N	AM2 D-537
126208	\N	\N	401	28492	\N	\N	AM2 R-537
126209	\N	\N	1471	28275	\N	\N	AM2 R-257
126210	\N	\N	1471	28172	\N	\N	AM2 D-470
126211	\N	\N	1471	28435	\N	\N	AM2 R-470
126212	\N	\N	1475	28279	\N	\N	AM2 R-261
126213	\N	\N	1475	28084	\N	\N	AM2 D-363
126214	\N	\N	1475	28364	\N	\N	AM2 R-363
126215	\N	\N	1475	28187	\N	\N	AM2 D-485
126216	\N	\N	1475	28447	\N	\N	AM2 R-485
126217	\N	\N	1491	28286	\N	\N	AM2 R-269
126218	\N	\N	1491	28214	\N	\N	AM2 D-513
126219	\N	\N	1491	28474	\N	\N	AM2 R-513
126220	\N	\N	1494	28289	\N	\N	AM2 R-272
126221	\N	\N	1494	28231	\N	\N	AM2 D-533
126222	\N	\N	1502	28297	\N	\N	AM2 R-280
126223	\N	\N	1515	28307	\N	\N	AM2 R-293
126224	\N	\N	1515	28158	\N	\N	AM2 D-455
126225	\N	\N	1515	28421	\N	\N	AM2 R-455
126226	\N	\N	1524	28313	\N	\N	AM2 R-299
126227	\N	\N	1524	28485	\N	\N	AM2 R-525
126228	\N	\N	1524	28225	\N	\N	AM2 D-525
126229	\N	\N	1529	28317	\N	\N	AM2 R-308
126230	\N	\N	1529	28160	\N	\N	AM2 D-457
126231	\N	\N	1529	28423	\N	\N	AM2 R-457
126232	\N	\N	1548	28336	\N	\N	AM2 R-328
126233	\N	\N	1548	28163	\N	\N	AM2 D-460
126234	\N	\N	1548	28426	\N	\N	AM2 R-460
126235	\N	\N	1553	28340	\N	\N	AM2 R-333
126236	\N	\N	1553	28167	\N	\N	AM2 D-464
126237	\N	\N	1553	28430	\N	\N	AM2 R-464
126238	\N	\N	1570	28354	\N	\N	AM2 R-350
126239	\N	\N	2060	32323	\N	\N	3 MEL_RNA
126240	\N	\N	2180	31807	\N	\N	RNA-330
126241	\N	\N	2223	31840	\N	\N	RNA-390
126242	\N	\N	77	27967	\N	\N	AM2 D-229
126243	\N	\N	77	28251	\N	\N	AM2 R-229
126244	\N	\N	402	28466	\N	\N	AM2 R-505
126245	\N	\N	402	28206	\N	\N	AM2 D-505
126246	\N	\N	1286	27969	\N	\N	AM2 D-233
126247	\N	\N	1286	28253	\N	\N	AM2 R-233
126248	\N	\N	1476	28280	\N	\N	AM2 R-262
126249	\N	\N	1476	28184	\N	\N	AM2 D-482 (P041_03C)
126250	\N	\N	1492	28287	\N	\N	AM2 R-270
126251	\N	\N	1492	28215	\N	\N	AM2 D-514
126252	\N	\N	1492	28475	\N	\N	AM2 R-514
126253	\N	\N	1495	28290	\N	\N	AM2 R-273
126254	\N	\N	1495	28232	\N	\N	AM2 D-534
126255	\N	\N	1516	28359	\N	\N	AM2 R-355
126256	\N	\N	1516	28185	\N	\N	AM2 D-483 (P041_03D)
126257	\N	\N	1530	28318	\N	\N	AM2 R-309
126258	\N	\N	1549	28337	\N	\N	AM2 R-329
126259	\N	\N	1549	28164	\N	\N	AM2 D-461
126260	\N	\N	1549	28427	\N	\N	AM2 R-461
126261	\N	\N	1554	28341	\N	\N	AM2 R-334
126262	\N	\N	1554	28168	\N	\N	AM2 D-465
126263	\N	\N	1554	28431	\N	\N	AM2 R-465
126264	\N	\N	1571	28355	\N	\N	AM2 R-351
126265	\N	\N	1622	28419	\N	\N	AM2 R-453
126266	\N	\N	2181	31808	\N	\N	RNA-331
126267	\N	\N	2224	31841	\N	\N	RNA-391
126268	\N	\N	2246	28217	\N	\N	AM2 D-517
126269	\N	\N	7	27984	\N	\N	AM2 D-250
126270	\N	\N	7	28268	\N	\N	AM2 R-250
126271	\N	\N	66	27974	\N	\N	AM2 D-240
126272	\N	\N	66	28258	\N	\N	AM2 R-240
126273	\N	\N	69	27978	\N	\N	AM2 D-244
126274	\N	\N	69	28262	\N	\N	AM2 R-244
126275	\N	\N	99	28463	\N	\N	AM2 R-501
126276	\N	\N	99	28203	\N	\N	AM2 D-501
126277	\N	\N	420	28416	\N	\N	AM2 R-450
126278	\N	\N	420	28153	\N	\N	AM2 D-450
126279	\N	\N	420	27936	\N	\N	AM2 D-194
126280	\N	\N	420	28195	\N	\N	AM2 D-492
126281	\N	\N	420	28455	\N	\N	AM2 R-492
122939	\N	\N	420	27914	\N	420 MIS1	AM2 D-172
126282	\N	\N	399	28465	\N	\N	AM2 R-504
126283	\N	\N	399	28205	\N	\N	AM2 D-504
126284	\N	\N	373	28151	\N	\N	AM2 D-447
126285	\N	\N	373	28414	\N	\N	AM2 R-447
126286	\N	\N	1244	28195	\N	\N	AM2 D-492
126287	\N	\N	1244	28455	\N	\N	AM2 R-492
126288	\N	\N	1428	31494	\N	\N	PROG R-06
126289	\N	\N	1441	31658	\N	\N	RNA-124
126290	\N	\N	1441	31672	\N	\N	RNA-138
126291	\N	\N	1441	29345	\N	\N	DNA-138
126292	\N	\N	1442	31647	\N	\N	RNA-113
126293	\N	\N	1442	29349	\N	\N	DNA-142
126294	\N	\N	1442	31676	\N	\N	RNA-142
126295	\N	\N	1472	28276	\N	\N	AM2 R-258
126296	\N	\N	1472	28183	\N	\N	AM2 D-481 (P041_03B)
126297	\N	\N	1508	28302	\N	\N	AM2 R-286
126298	\N	\N	1508	28220	\N	\N	AM2 D-520
126299	\N	\N	1508	28480	\N	\N	AM2 R-520
126300	\N	\N	1525	28314	\N	\N	AM2 R-300
126301	\N	\N	1525	28486	\N	\N	AM2 R-526
126302	\N	\N	1525	28226	\N	\N	AM2 D-526
126303	\N	\N	1533	28321	\N	\N	AM2 R-312
126304	\N	\N	1539	28327	\N	\N	AM2 R-319
126305	\N	\N	1539	28175	\N	\N	AM2 D-473
126306	\N	\N	1539	28438	\N	\N	AM2 R-473
126307	\N	\N	1550	28338	\N	\N	AM2 R-330
126308	\N	\N	1555	28342	\N	\N	AM2 R-335
126309	\N	\N	1572	28356	\N	\N	AM2 R-352
126310	\N	\N	1587	28407	\N	\N	AM2 R-433
126311	\N	\N	1594	28384	\N	\N	AM2 R-400
126312	\N	\N	1597	28381	\N	\N	AM2 R-393
126313	\N	\N	1600	28387	\N	\N	AM2 R-403
126314	\N	\N	1600	28181	\N	\N	AM2 D-479
126315	\N	\N	1600	28444	\N	\N	AM2 R-479
126316	\N	\N	70	27979	\N	\N	AM2 D-245
126317	\N	\N	70	28263	\N	\N	AM2 R-245
126318	\N	\N	74	27964	\N	\N	AM2 D-226
126319	\N	\N	74	28248	\N	\N	AM2 R-226
126320	\N	\N	421	28196	\N	\N	AM2 D-493
126321	\N	\N	421	28456	\N	\N	AM2 R-493
126322	\N	\N	413	28152	\N	\N	AM2 D-448
126323	\N	\N	413	28415	\N	\N	AM2 R-448
126324	\N	\N	413	28193	\N	\N	AM2 D-490
126325	\N	\N	413	28453	\N	\N	AM2 R-490
126326	\N	\N	1245	28196	\N	\N	AM2 D-493
126327	\N	\N	1245	28456	\N	\N	AM2 R-493
126328	\N	\N	1443	31648	\N	\N	RNA-114
126329	\N	\N	1443	29350	\N	\N	DNA-143
126330	\N	\N	1443	31677	\N	\N	RNA-143
126331	\N	\N	1444	31659	\N	\N	RNA-125
126332	\N	\N	1444	29351	\N	\N	DNA-144
126333	\N	\N	1444	31678	\N	\N	RNA-144
126334	\N	\N	1540	28328	\N	\N	AM2 R-320
126335	\N	\N	1540	28082	\N	\N	AM2 D-361
126336	\N	\N	1540	28363	\N	\N	AM2 R-361
126337	\N	\N	1540	28176	\N	\N	AM2 D-474
126338	\N	\N	1540	28439	\N	\N	AM2 R-474
126339	\N	\N	1540	28468	\N	\N	AM2 R-507
126340	\N	\N	1540	28208	\N	\N	AM2 D-507
126341	\N	\N	1556	28343	\N	\N	AM2 R-336
126342	\N	\N	1573	28357	\N	\N	AM2 R-353
126343	\N	\N	1588	28408	\N	\N	AM2 R-434
126344	\N	\N	1588	28177	\N	\N	AM2 D-475
126345	\N	\N	1588	28440	\N	\N	AM2 R-475
126346	\N	\N	2034	28460	\N	\N	AM2 R-498
126347	\N	\N	5	27846	\N	\N	AM2 D-104-1
126348	\N	\N	5	28218	\N	\N	AM2 D-518
126349	\N	\N	5	28478	\N	\N	AM2 R-518
126350	\N	\N	11	27972	\N	\N	AM2 D-238
126351	\N	\N	11	28256	\N	\N	AM2 R-238
126352	\N	\N	11	28462	\N	\N	AM2 R-500
126353	\N	\N	11	28202	\N	\N	AM2 D-500
126354	\N	\N	11	28473	\N	\N	AM2 R-512
126355	\N	\N	11	28213	\N	\N	AM2 D-512
126356	\N	\N	101	28476	\N	\N	AM2 R-516
126357	\N	\N	101	28216	\N	\N	AM2 D-516
126358	\N	\N	1312	31490	\N	\N	PROG R-02
126359	\N	\N	1312	31478	\N	\N	PROG D-16
126360	\N	\N	1312	31504	\N	\N	PROG R-16
126361	\N	\N	1474	28278	\N	\N	AM2 R-260
126362	\N	\N	1504	28299	\N	\N	AM2 R-282
126363	\N	\N	1509	28303	\N	\N	AM2 R-287
126364	\N	\N	1509	28221	\N	\N	AM2 D-521
126365	\N	\N	1509	28481	\N	\N	AM2 R-521
126366	\N	\N	1577	28103	\N	\N	AM2 D-384
126367	\N	\N	1577	28104	\N	\N	AM2 D-385
126368	\N	\N	1577	28105	\N	\N	AM2 D-386
126369	\N	\N	1577	28376	\N	\N	AM2 R-383
126370	\N	\N	1577	28377	\N	\N	AM2 R-384
126371	\N	\N	1577	28378	\N	\N	AM2 R-385
126372	\N	\N	1577	28379	\N	\N	AM2 R-386
126373	\N	\N	1577	28380	\N	\N	AM2 R-387
126374	\N	\N	1577	28106	\N	\N	AM2 D-387
126375	\N	\N	1579	28123	\N	\N	AM2 D-413
126376	\N	\N	1579	28393	\N	\N	AM2 R-412
126377	\N	\N	1579	28394	\N	\N	AM2 R-413
126378	\N	\N	2268	31327	\N	\N	NM R-100
126379	\N	\N	1313	31491	\N	\N	PROG R-03
126380	\N	\N	1313	31478	\N	\N	PROG D-16
126381	\N	\N	1313	31504	\N	\N	PROG R-16
126382	\N	\N	1500	28295	\N	\N	AM2 R-278
126383	\N	\N	1505	28300	\N	\N	AM2 R-283
126384	\N	\N	1520	28309	\N	\N	AM2 R-295
126385	\N	\N	1520	28484	\N	\N	AM2 R-524
126386	\N	\N	1520	28224	\N	\N	AM2 D-524
126387	\N	\N	2269	31327	\N	\N	NM R-100
126388	\N	\N	290	29240	\N	\N	DNA-11
126389	\N	\N	296	29244	\N	\N	DNA-17
126390	\N	\N	300	29248	\N	\N	DNA-21
126391	\N	\N	294	29242	\N	\N	DNA-15
126392	\N	\N	294	29319	\N	\N	DNA-112
126393	\N	\N	294	31646	\N	\N	RNA-112
126394	\N	\N	287	29237	\N	\N	DNA-08
126395	\N	\N	298	29246	\N	\N	DNA-19
126396	\N	\N	292	29316	\N	\N	DNA-109
126397	\N	\N	292	31643	\N	\N	RNA-109
126398	\N	\N	284	29234	\N	\N	DNA-05
126399	\N	\N	281	29231	\N	\N	DNA-02
126400	\N	\N	281	29504	\N	\N	DNA-298
126401	\N	\N	281	31789	\N	\N	RNA-298
126402	\N	\N	281	29515	\N	\N	DNA-309
126403	\N	\N	281	31798	\N	\N	RNA-309
126404	\N	\N	352	29330	\N	\N	DNA-123
126405	\N	\N	352	31657	\N	\N	RNA-123
126406	\N	\N	352	31671	\N	\N	RNA-137
126407	\N	\N	352	29344	\N	\N	DNA-137
126408	\N	\N	346	29257	\N	\N	DNA-30
126409	\N	\N	350	29328	\N	\N	DNA-121
126410	\N	\N	350	31655	\N	\N	RNA-121
126411	\N	\N	348	29326	\N	\N	DNA-119
126412	\N	\N	348	31653	\N	\N	RNA-119
126413	\N	\N	348	31670	\N	\N	RNA-136
126414	\N	\N	348	29343	\N	\N	DNA-136
126415	\N	\N	348	29506	\N	\N	DNA-300
126416	\N	\N	348	31791	\N	\N	RNA-300
126417	\N	\N	773	31602	\N	\N	RNA-44
126418	\N	\N	773	29510	\N	\N	DNA-304
126419	\N	\N	773	31794	\N	\N	RNA-304
126420	\N	\N	775	31604	\N	\N	RNA-46
126421	\N	\N	777	31608	\N	\N	RNA-50
126422	\N	\N	780	31614	\N	\N	RNA-56
126423	\N	\N	782	31620	\N	\N	RNA-62
126424	\N	\N	782	29513	\N	\N	DNA-307
126425	\N	\N	782	31797	\N	\N	RNA-307
126426	\N	\N	785	31624	\N	\N	RNA-66
126427	\N	\N	788	31600	\N	\N	RNA-42
126428	\N	\N	789	31610	\N	\N	RNA-52
126429	\N	\N	793	31612	\N	\N	RNA-54
126430	\N	\N	793	29273	\N	\N	DNA-54_REPEAT
123055	\N	\N	793	29272	\N	793 Nevus	DNA-54
126431	\N	\N	796	31606	\N	\N	RNA-48
126432	\N	\N	800	31616	\N	\N	RNA-58
126433	\N	\N	801	31622	\N	\N	RNA-64
126434	\N	\N	803	31618	\N	\N	RNA-60
126435	\N	\N	803	29324	\N	\N	DNA-117
126436	\N	\N	803	31651	\N	\N	RNA-117
126437	\N	\N	893	29340	\N	\N	DNA-133
126438	\N	\N	893	31667	\N	\N	RNA-133
126439	\N	\N	1445	32016	\N	\N	SNR-01
126440	\N	\N	1452	32017	\N	\N	SNR-02
126441	\N	\N	1453	32018	\N	\N	SNR-03
126442	\N	\N	1453	32001	\N	\N	SND-29
126443	\N	\N	1453	32044	\N	\N	SNR-29
126444	\N	\N	1453	32007	\N	\N	SND-35
126445	\N	\N	1454	32019	\N	\N	SNR-04
126446	\N	\N	1454	32011	\N	\N	SND-39
126447	\N	\N	1455	32020	\N	\N	SNR-05
126448	\N	\N	1455	32012	\N	\N	SND-40
126449	\N	\N	1458	32023	\N	\N	SNR-08
126450	\N	\N	1458	32002	\N	\N	SND-30
126451	\N	\N	1458	32045	\N	\N	SNR-30
126452	\N	\N	1458	32008	\N	\N	SND-36
126453	\N	\N	1457	32022	\N	\N	SNR-07
126454	\N	\N	1456	32021	\N	\N	SNR-06
126455	\N	\N	1456	32013	\N	\N	SND-41
126456	\N	\N	1462	32027	\N	\N	SNR-12
126457	\N	\N	1462	32004	\N	\N	SND-32
126458	\N	\N	1462	32047	\N	\N	SNR-32
126459	\N	\N	1462	32014	\N	\N	SND-42
126460	\N	\N	1461	32026	\N	\N	SNR-11
126461	\N	\N	1461	32003	\N	\N	SND-31
126462	\N	\N	1461	32046	\N	\N	SNR-31
126463	\N	\N	1461	32015	\N	\N	SND-43
126464	\N	\N	1460	32025	\N	\N	SNR-10
126465	\N	\N	1463	32028	\N	\N	SNR-13
126466	\N	\N	1459	32024	\N	\N	SNR-09
126467	\N	\N	1464	32029	\N	\N	SNR-14
126468	\N	\N	1465	32030	\N	\N	SNR-15
126469	\N	\N	1466	32031	\N	\N	SNR-16
126470	\N	\N	1466	32005	\N	\N	SND-33
126471	\N	\N	1466	32048	\N	\N	SNR-33
126472	\N	\N	1468	32033	\N	\N	SNR-18
126473	\N	\N	1468	32006	\N	\N	SND-34
126474	\N	\N	1468	32049	\N	\N	SNR-34
126475	\N	\N	1468	32009	\N	\N	SND-37
126476	\N	\N	1467	32032	\N	\N	SNR-17
126477	\N	\N	1469	32034	\N	\N	SNR-19
126478	\N	\N	1480	32035	\N	\N	SNR-20
126479	\N	\N	1481	32036	\N	\N	SNR-21
126480	\N	\N	1483	32038	\N	\N	SNR-23
126481	\N	\N	1482	32037	\N	\N	SNR-22
126482	\N	\N	1484	32039	\N	\N	SNR-24
126483	\N	\N	1485	32040	\N	\N	SNR-25
126484	\N	\N	1486	32041	\N	\N	SNR-26
126485	\N	\N	1486	32010	\N	\N	SND-38
126486	\N	\N	1487	32042	\N	\N	SNR-27
126487	\N	\N	1488	32043	\N	\N	SNR-28
126488	\N	\N	1642	30597	\N	\N	MMD-17
126489	\N	\N	1642	29408	\N	\N	DNA-200
126490	\N	\N	1642	29451	\N	\N	DNA-243
126491	\N	\N	1642	31761	\N	\N	RNA-243
126492	\N	\N	1642	31733	\N	\N	RNA-200
126493	\N	\N	1642	29460	\N	\N	DNA-254
126494	\N	\N	1642	31769	\N	\N	RNA-254
126495	\N	\N	1779	30761	\N	\N	MMD-186
126496	\N	\N	1779	30883	\N	\N	MMD-308
126497	\N	\N	1779	31097	\N	\N	MMR-308
126498	\N	\N	1817	30863	\N	\N	MMD-288
126499	\N	\N	1817	31077	\N	\N	MMR-237
126500	\N	\N	1817	31091	\N	\N	MMR-288
126501	\N	\N	1876	30219	\N	\N	LN R-070
126502	\N	\N	1876	30170	\N	\N	LN D-117
126503	\N	\N	1876	30264	\N	\N	LN R-117
126504	\N	\N	1881	30224	\N	\N	LN R-075
126505	\N	\N	1881	30152	\N	\N	LN D-099
126506	\N	\N	1881	30246	\N	\N	LN R-099
126507	\N	\N	1881	30204	\N	\N	LN D-151
126508	\N	\N	1881	30298	\N	\N	LN R-151
126509	\N	\N	1883	30226	\N	\N	LN R-077
126510	\N	\N	1883	30266	\N	\N	LN R-119
126511	\N	\N	1883	30172	\N	\N	LN D-119
126512	\N	\N	1885	30228	\N	\N	LN R-079
126513	\N	\N	1885	30153	\N	\N	LN D-100
126514	\N	\N	1885	30247	\N	\N	LN R-100
126515	\N	\N	1885	30205	\N	\N	LN D-152
126516	\N	\N	1885	30299	\N	\N	LN R-152
126517	\N	\N	1886	30229	\N	\N	LN R-080
126518	\N	\N	1886	30174	\N	\N	LN D-121
126519	\N	\N	1886	30268	\N	\N	LN R-121
126520	\N	\N	1886	30206	\N	\N	LN D-153
126521	\N	\N	1886	30300	\N	\N	LN R-153
126522	\N	\N	1888	30230	\N	\N	LN R-082
126523	\N	\N	1888	30154	\N	\N	LN D-101
126524	\N	\N	1888	30248	\N	\N	LN R-101
126525	\N	\N	1888	30207	\N	\N	LN D-154
126526	\N	\N	1888	30301	\N	\N	LN R-154
126527	\N	\N	1894	30235	\N	\N	LN R-087
126528	\N	\N	1894	30270	\N	\N	LN R-123
126529	\N	\N	1894	30176	\N	\N	LN D-123
126530	\N	\N	1896	30237	\N	\N	LN R-090
126531	\N	\N	1896	30178	\N	\N	LN D-125
126532	\N	\N	1896	30272	\N	\N	LN R-125
126533	\N	\N	1897	30238	\N	\N	LN R-091
126534	\N	\N	1897	30179	\N	\N	LN D-126
126535	\N	\N	1897	30273	\N	\N	LN R-126
126536	\N	\N	1899	30240	\N	\N	LN R-093
126537	\N	\N	1899	30275	\N	\N	LN R-128
126538	\N	\N	1899	30181	\N	\N	LN D-128
126539	\N	\N	1899	30213	\N	\N	LN D-160
126540	\N	\N	1899	30307	\N	\N	LN R-160
126541	\N	\N	1900	30241	\N	\N	LN R-094
126542	\N	\N	1900	30182	\N	\N	LN D-129
126543	\N	\N	1900	30276	\N	\N	LN R-129
126544	\N	\N	1902	30256	\N	\N	LN R-109
126545	\N	\N	1902	30193	\N	\N	LN D-140
126546	\N	\N	1902	30287	\N	\N	LN R-140
126547	\N	\N	1904	30260	\N	\N	LN R-113
126548	\N	\N	1904	30197	\N	\N	LN D-144
126549	\N	\N	1904	30291	\N	\N	LN R-144
126550	\N	\N	1904	30217	\N	\N	LN D-164
126551	\N	\N	1904	30311	\N	\N	LN R-164
126552	\N	\N	1911	30254	\N	\N	LN R-107
126553	\N	\N	1911	30282	\N	\N	LN R-135
126554	\N	\N	1911	30188	\N	\N	LN D-135
126555	\N	\N	1912	30279	\N	\N	LN R-132
126556	\N	\N	1912	30283	\N	\N	LN R-136
126557	\N	\N	1912	30189	\N	\N	LN D-136
126558	\N	\N	1919	31696	\N	\N	RNA-162
126559	\N	\N	1919	29413	\N	\N	DNA-205
126560	\N	\N	1919	31736	\N	\N	RNA-205
126561	\N	\N	1922	31699	\N	\N	RNA-165
126562	\N	\N	1922	29416	\N	\N	DNA-208
126563	\N	\N	1922	31738	\N	\N	RNA-208
126564	\N	\N	1924	31701	\N	\N	RNA-167
126565	\N	\N	1924	29418	\N	\N	DNA-210
126566	\N	\N	1924	31740	\N	\N	RNA-210
126567	\N	\N	1924	29457	\N	\N	DNA-251
126568	\N	\N	1924	31766	\N	\N	RNA-251
126569	\N	\N	1928	31705	\N	\N	RNA-171
126570	\N	\N	1928	29422	\N	\N	DNA-214
126571	\N	\N	1928	31743	\N	\N	RNA-214
126572	\N	\N	1933	31710	\N	\N	RNA-176
126573	\N	\N	1933	29427	\N	\N	DNA-219
126574	\N	\N	1933	31746	\N	\N	RNA-219
126575	\N	\N	1933	29458	\N	\N	DNA-252
126576	\N	\N	1933	31767	\N	\N	RNA-252
126577	\N	\N	1936	31713	\N	\N	RNA-179
126578	\N	\N	1936	29430	\N	\N	DNA-222
126579	\N	\N	1936	31748	\N	\N	RNA-222
126580	\N	\N	1939	31716	\N	\N	RNA-182
126581	\N	\N	1939	29433	\N	\N	DNA-225
126582	\N	\N	1939	31750	\N	\N	RNA-225
126583	\N	\N	1939	29459	\N	\N	DNA-253
126584	\N	\N	1939	31768	\N	\N	RNA-253
126585	\N	\N	1942	31719	\N	\N	RNA-185
126586	\N	\N	1942	29436	\N	\N	DNA-228
126587	\N	\N	1942	31752	\N	\N	RNA-228
126588	\N	\N	1945	31722	\N	\N	RNA-188
126589	\N	\N	1945	29439	\N	\N	DNA-231
126590	\N	\N	1945	31754	\N	\N	RNA-231
126591	\N	\N	1948	31725	\N	\N	RNA-191
126592	\N	\N	1948	29443	\N	\N	DNA-235
126593	\N	\N	1948	31757	\N	\N	RNA-235
126594	\N	\N	1952	31729	\N	\N	RNA-195
126595	\N	\N	1952	29447	\N	\N	DNA-239
126596	\N	\N	1952	31759	\N	\N	RNA-239
126597	\N	\N	2042	31773	\N	\N	RNA-272
126598	\N	\N	2069	32324	\N	\N	13 NEV_RNA
126599	\N	\N	2073	32327	\N	\N	14 NEV_RNA
126600	\N	\N	2076	32329	\N	\N	16 NEV_RNA
126601	\N	\N	2079	32331	\N	\N	17 NEV_RNA
126602	\N	\N	2088	29501	\N	\N	DNA-295
126603	\N	\N	2088	31788	\N	\N	RNA-295
126604	\N	\N	2091	32321	\N	\N	1 NEV_RNA
126605	\N	\N	2112	31776	\N	\N	RNA-276
126606	\N	\N	2115	31778	\N	\N	RNA-279
126607	\N	\N	2118	31780	\N	\N	RNA-282
126608	\N	\N	2121	31783	\N	\N	RNA-285
126609	\N	\N	2121	29524	\N	\N	DNA-318
126610	\N	\N	2121	31805	\N	\N	RNA-318
126611	\N	\N	2125	31786	\N	\N	RNA-289
126612	\N	\N	2128	31800	\N	\N	RNA-311
126613	\N	\N	2130	31802	\N	\N	RNA-313
126614	\N	\N	2132	31804	\N	\N	RNA-315
126615	\N	\N	2182	31809	\N	\N	RNA-332
126616	\N	\N	2185	31811	\N	\N	RNA-335
126617	\N	\N	2188	31813	\N	\N	RNA-338
126618	\N	\N	2191	31816	\N	\N	RNA-341
126619	\N	\N	2194	31818	\N	\N	RNA-346
126620	\N	\N	2198	31822	\N	\N	RNA-351
126621	\N	\N	2202	31825	\N	\N	RNA-357
126622	\N	\N	2205	31827	\N	\N	RNA-361
126623	\N	\N	2208	31829	\N	\N	RNA-365
126624	\N	\N	2213	31833	\N	\N	RNA-373
126625	\N	\N	2216	31835	\N	\N	RNA-379
126626	\N	\N	2221	31839	\N	\N	RNA-387
126627	\N	\N	2225	31842	\N	\N	RNA-392
126628	\N	\N	2228	31844	\N	\N	RNA-396
126629	\N	\N	2232	31847	\N	\N	RNA-402
126630	\N	\N	2235	31850	\N	\N	RNA-405
126631	\N	\N	2244	31806	\N	\N	RNA-320
126632	\N	\N	2291	31862	\N	\N	RNA-428
123173	\N	\N	2291	29595	\N	2291 Nevus	DNA-428
126633	\N	\N	2296	31867	\N	\N	RNA-433
126634	\N	\N	2300	31871	\N	\N	RNA-437
126635	\N	\N	2445	31875	\N	\N	RNA-441
126636	\N	\N	2448	31878	\N	\N	RNA-444
126637	\N	\N	2460	31881	\N	\N	RNA-447
126638	\N	\N	75	27965	\N	\N	AM2 D-227
126639	\N	\N	75	28249	\N	\N	AM2 R-227
126640	\N	\N	1557	28344	\N	\N	AM2 R-337
126641	\N	\N	1557	28169	\N	\N	AM2 D-466
126642	\N	\N	1557	28432	\N	\N	AM2 R-466
126643	\N	\N	1557	28469	\N	\N	AM2 R-508
126644	\N	\N	1557	28209	\N	\N	AM2 D-508
126645	\N	\N	1618	28417	\N	\N	AM2 R-451
126646	\N	\N	1618	28197	\N	\N	AM2 D-494
126647	\N	\N	1618	28457	\N	\N	AM2 R-494
126648	\N	\N	1620	28149	\N	\N	AM2 D-445
126649	\N	\N	2035	28461	\N	\N	AM2 R-499
126650	\N	\N	293	29315	\N	\N	DNA-108
126651	\N	\N	293	31642	\N	\N	RNA-108
126652	\N	\N	282	29232	\N	\N	DNA-03
126653	\N	\N	282	29505	\N	\N	DNA-299
126654	\N	\N	282	31790	\N	\N	RNA-299
126655	\N	\N	282	29516	\N	\N	DNA-310
126656	\N	\N	282	31799	\N	\N	RNA-310
126657	\N	\N	291	29241	\N	\N	DNA-12
126658	\N	\N	288	29238	\N	\N	DNA-09
126659	\N	\N	303	29251	\N	\N	DNA-24
126660	\N	\N	303	29323	\N	\N	DNA-116
126661	\N	\N	303	31650	\N	\N	RNA-116
126662	\N	\N	285	29235	\N	\N	DNA-06
126663	\N	\N	297	29245	\N	\N	DNA-18
126664	\N	\N	299	29247	\N	\N	DNA-20
126665	\N	\N	295	29243	\N	\N	DNA-16
126666	\N	\N	295	29318	\N	\N	DNA-111
126667	\N	\N	295	31645	\N	\N	RNA-111
126668	\N	\N	301	29249	\N	\N	DNA-22
126669	\N	\N	344	29255	\N	\N	DNA-28
126670	\N	\N	349	29325	\N	\N	DNA-118
126671	\N	\N	349	31652	\N	\N	RNA-118
126672	\N	\N	349	29507	\N	\N	DNA-301
126673	\N	\N	349	31792	\N	\N	RNA-301
126674	\N	\N	353	29329	\N	\N	DNA-122
126675	\N	\N	353	31656	\N	\N	RNA-122
126676	\N	\N	351	29327	\N	\N	DNA-120
126677	\N	\N	351	31654	\N	\N	RNA-120
126678	\N	\N	356	31674	\N	\N	RNA-140
126679	\N	\N	347	29258	\N	\N	DNA-31
126680	\N	\N	646	30471	\N	\N	MDD-128
126681	\N	\N	638	30478	\N	\N	MDD-135
126682	\N	\N	650	30460	\N	\N	MDD-117
126683	\N	\N	647	30469	\N	\N	MDD-126
126684	\N	\N	651	30461	\N	\N	MDD-118
126685	\N	\N	772	31601	\N	\N	RNA-43
126686	\N	\N	772	29509	\N	\N	DNA-303
126687	\N	\N	772	31793	\N	\N	RNA-303
126688	\N	\N	774	31603	\N	\N	RNA-45
126689	\N	\N	776	31607	\N	\N	RNA-49
126690	\N	\N	776	29511	\N	\N	DNA-305
126691	\N	\N	776	31795	\N	\N	RNA-305
126692	\N	\N	779	31613	\N	\N	RNA-55
126693	\N	\N	781	31619	\N	\N	RNA-61
126694	\N	\N	781	29512	\N	\N	DNA-306
126695	\N	\N	781	31796	\N	\N	RNA-306
126696	\N	\N	791	31609	\N	\N	RNA-51
126697	\N	\N	794	31611	\N	\N	RNA-53
126698	\N	\N	794	29271	\N	\N	DNA-53_REPEAT
126699	\N	\N	795	31605	\N	\N	RNA-47
126700	\N	\N	799	31615	\N	\N	RNA-57
126701	\N	\N	802	31621	\N	\N	RNA-63
126702	\N	\N	805	31617	\N	\N	RNA-59
126703	\N	\N	805	29277	\N	\N	DNA-59_REPEAT
126704	\N	\N	892	29339	\N	\N	DNA-132
126705	\N	\N	892	31666	\N	\N	RNA-132
126706	\N	\N	892	29472	\N	\N	DNA-266
126707	\N	\N	892	31770	\N	\N	RNA-266
123298	\N	\N	892	29306	\N	892 Mel	DNA-94
126708	\N	\N	1626	30937	\N	\N	MMR-01
123481	\N	\N	1626	30581	\N	1626 Mel	MMD-01
126709	\N	\N	1627	30938	\N	\N	MMR-02
126710	\N	\N	1628	30939	\N	\N	MMR-03
126711	\N	\N	1630	30941	\N	\N	MMR-05
126712	\N	\N	1630	30634	\N	\N	MMD-54
126713	\N	\N	1630	30984	\N	\N	MMR-54
126714	\N	\N	1630	30646	\N	\N	MMD-68
126715	\N	\N	1629	30940	\N	\N	MMR-04
126716	\N	\N	1631	30942	\N	\N	MMR-06
126717	\N	\N	1633	30944	\N	\N	MMR-08
126718	\N	\N	1632	30943	\N	\N	MMR-07
126719	\N	\N	1634	30945	\N	\N	MMR-09
126720	\N	\N	1634	30635	\N	\N	MMD-55
126721	\N	\N	1634	30985	\N	\N	MMR-55
126722	\N	\N	1634	30647	\N	\N	MMD-69
126723	\N	\N	1635	30946	\N	\N	MMR-10
126724	\N	\N	1636	30591	\N	\N	MMD-11
126725	\N	\N	1637	30592	\N	\N	MMD-12
126726	\N	\N	1639	30594	\N	\N	MMD-14
126727	\N	\N	1639	30603	\N	\N	MMD-23
126728	\N	\N	1639	30959	\N	\N	MMR-23
126729	\N	\N	1638	30593	\N	\N	MMD-13
126730	\N	\N	1640	30595	\N	\N	MMD-15
126731	\N	\N	1641	30596	\N	\N	MMD-16
126732	\N	\N	1641	30604	\N	\N	MMD-24
126733	\N	\N	1641	30960	\N	\N	MMR-24
126734	\N	\N	1641	29407	\N	\N	DNA-199
126735	\N	\N	1641	29450	\N	\N	DNA-242
126736	\N	\N	1641	31760	\N	\N	RNA-242
126737	\N	\N	1641	31732	\N	\N	RNA-199
126738	\N	\N	1643	30954	\N	\N	MMR-18
126739	\N	\N	1644	30955	\N	\N	MMR-19
126740	\N	\N	1644	30605	\N	\N	MMD-25
126741	\N	\N	1644	30961	\N	\N	MMR-25
126742	\N	\N	1645	30956	\N	\N	MMR-20
126743	\N	\N	1646	30606	\N	\N	MMD-26
126744	\N	\N	1646	30957	\N	\N	MMR-21
126745	\N	\N	1646	30962	\N	\N	MMR-26
126746	\N	\N	1647	30607	\N	\N	MMD-27
126747	\N	\N	1647	30958	\N	\N	MMR-22
126748	\N	\N	1647	30963	\N	\N	MMR-27
126749	\N	\N	1648	30964	\N	\N	MMR-28
126750	\N	\N	1648	30637	\N	\N	MMD-59
126751	\N	\N	1650	30966	\N	\N	MMR-30
126752	\N	\N	1651	30611	\N	\N	MMD-31
126753	\N	\N	1651	30638	\N	\N	MMD-60
126754	\N	\N	1652	30968	\N	\N	MMR-32
126755	\N	\N	1652	30639	\N	\N	MMD-61
126756	\N	\N	1653	30969	\N	\N	MMR-33
126757	\N	\N	1653	30640	\N	\N	MMD-62
126758	\N	\N	1653	30684	\N	\N	MMD-106
126759	\N	\N	1655	30971	\N	\N	MMR-35
126760	\N	\N	1657	30972	\N	\N	MMR-37
126761	\N	\N	1658	30973	\N	\N	MMR-38
126762	\N	\N	1660	30636	\N	\N	MMD-56
126763	\N	\N	1660	30986	\N	\N	MMR-56
126764	\N	\N	1660	30974	\N	\N	MMR-40
126765	\N	\N	1661	30975	\N	\N	MMR-41
126766	\N	\N	1662	30976	\N	\N	MMR-42
126767	\N	\N	1662	30686	\N	\N	MMD-108
126768	\N	\N	1662	30769	\N	\N	MMD-194
126769	\N	\N	1665	30641	\N	\N	MMD-63
126770	\N	\N	1665	30624	\N	\N	MMD-44
126771	\N	\N	1666	30978	\N	\N	MMR-45
126772	\N	\N	1667	30626	\N	\N	MMD-46
126773	\N	\N	1667	30642	\N	\N	MMD-64
126774	\N	\N	1667	30682	\N	\N	MMD-104
126775	\N	\N	1669	30643	\N	\N	MMD-65
126776	\N	\N	1669	30980	\N	\N	MMR-48
126777	\N	\N	1672	30982	\N	\N	MMR-51
126778	\N	\N	1672	30680	\N	\N	MMD-102
126779	\N	\N	1677	30633	\N	\N	MMD-53
126780	\N	\N	1677	30983	\N	\N	MMR-53
126781	\N	\N	1678	30987	\N	\N	MMR-70
126782	\N	\N	1678	30764	\N	\N	MMD-189
126783	\N	\N	1678	30848	\N	\N	MMD-273
126784	\N	\N	1678	30929	\N	\N	MMD-354
126785	\N	\N	1678	31130	\N	\N	MMR-354
126786	\N	\N	1681	30652	\N	\N	MMD-74
126787	\N	\N	1681	30653	\N	\N	MMD-75
126788	\N	\N	1681	30671	\N	\N	MMD-93
126789	\N	\N	1681	30988	\N	\N	MMR-73
126790	\N	\N	1681	30989	\N	\N	MMR-74
126791	\N	\N	1681	31001	\N	\N	MMR-93
126792	\N	\N	1682	30990	\N	\N	MMR-76
126793	\N	\N	1684	30657	\N	\N	MMD-79
126794	\N	\N	1684	30658	\N	\N	MMD-80
126795	\N	\N	1684	30991	\N	\N	MMR-78
126796	\N	\N	1684	30992	\N	\N	MMR-79
126797	\N	\N	1684	30672	\N	\N	MMD-94
126798	\N	\N	1684	31002	\N	\N	MMR-94
126799	\N	\N	1686	30993	\N	\N	MMR-81
126800	\N	\N	1688	30662	\N	\N	MMD-84
126801	\N	\N	1688	30663	\N	\N	MMD-85
126802	\N	\N	1688	30673	\N	\N	MMD-95
126803	\N	\N	1688	30994	\N	\N	MMR-83
126804	\N	\N	1688	30995	\N	\N	MMR-84
126805	\N	\N	1688	31003	\N	\N	MMR-95
126806	\N	\N	1689	30996	\N	\N	MMR-86
126807	\N	\N	1691	30996	\N	\N	MMR-86
126808	\N	\N	1691	31055	\N	\N	MMR-191
126809	\N	\N	1691	30766	\N	\N	MMD-191
126810	\N	\N	1693	30667	\N	\N	MMD-89
126811	\N	\N	1695	31000	\N	\N	MMR-91
126812	\N	\N	1697	31000	\N	\N	MMR-91
126813	\N	\N	1699	31004	\N	\N	MMR-96
126814	\N	\N	1700	30675	\N	\N	MMD-97
126815	\N	\N	1701	30676	\N	\N	MMD-98
126816	\N	\N	1704	31009	\N	\N	MMR-112
126817	\N	\N	1704	30867	\N	\N	MMD-292
126818	\N	\N	1704	30786	\N	\N	MMD-211
126819	\N	\N	1707	31011	\N	\N	MMR-115
126820	\N	\N	1708	31012	\N	\N	MMR-116
126821	\N	\N	1712	31014	\N	\N	MMR-119
126822	\N	\N	1713	30697	\N	\N	MMD-120
126823	\N	\N	1715	31016	\N	\N	MMR-121
126824	\N	\N	1717	31018	\N	\N	MMR-124
126825	\N	\N	1717	30873	\N	\N	MMD-298
126826	\N	\N	1719	31018	\N	\N	MMR-124
126827	\N	\N	1719	30873	\N	\N	MMD-298
126828	\N	\N	1721	31019	\N	\N	MMR-126
126829	\N	\N	1724	31021	\N	\N	MMR-129
126830	\N	\N	1724	30792	\N	\N	MMD-217
126831	\N	\N	1727	30709	\N	\N	MMD-132
126832	\N	\N	1727	31023	\N	\N	MMR-132
126833	\N	\N	1729	31024	\N	\N	MMR-134
126834	\N	\N	1731	31025	\N	\N	MMR-136
126835	\N	\N	1731	30828	\N	\N	MMD-253
126836	\N	\N	1731	31085	\N	\N	MMR-253
126837	\N	\N	1731	30931	\N	\N	MMD-356 (P041_01B)
126838	\N	\N	1731	31132	\N	\N	MMR-356
126839	\N	\N	1733	30715	\N	\N	MMD-140
126840	\N	\N	1733	31086	\N	\N	MMR-255
126841	\N	\N	1733	30830	\N	\N	MMD-255
126842	\N	\N	1734	31027	\N	\N	MMR-141
126843	\N	\N	1734	30831	\N	\N	MMD-256
126844	\N	\N	1736	31028	\N	\N	MMR-143
126845	\N	\N	1736	30833	\N	\N	MMD-258
126846	\N	\N	1736	30933	\N	\N	MMD-358
126847	\N	\N	1736	31134	\N	\N	MMR-358
126848	\N	\N	1741	31030	\N	\N	MMR-149
126849	\N	\N	1741	30886	\N	\N	MMD-311
126850	\N	\N	1743	31031	\N	\N	MMR-151
126851	\N	\N	1744	31031	\N	\N	MMR-151
126852	\N	\N	1744	30835	\N	\N	MMD-260
126853	\N	\N	1747	30888	\N	\N	MMD-313
126854	\N	\N	1747	31033	\N	\N	MMR-155
126855	\N	\N	1747	31098	\N	\N	MMR-313
126856	\N	\N	1749	30732	\N	\N	MMD-157
126857	\N	\N	1750	31035	\N	\N	MMR-158
126858	\N	\N	1752	31037	\N	\N	MMR-160
126859	\N	\N	1754	31038	\N	\N	MMR-162
126860	\N	\N	1755	31039	\N	\N	MMR-163
126861	\N	\N	1757	31040	\N	\N	MMR-165
126862	\N	\N	1759	30844	\N	\N	MMD-269
126863	\N	\N	1759	31041	\N	\N	MMR-167
126864	\N	\N	1762	31043	\N	\N	MMR-170
126865	\N	\N	1764	30747	\N	\N	MMD-172
126866	\N	\N	1765	31045	\N	\N	MMR-173
126867	\N	\N	1765	30890	\N	\N	MMD-315
123564	\N	\N	1765	30748	\N	1765 Mel	MMD-173
126868	\N	\N	1767	31046	\N	\N	MMR-175
126869	\N	\N	1769	30752	\N	\N	MMD-177
126870	\N	\N	1770	31048	\N	\N	MMR-178
126871	\N	\N	1771	31048	\N	\N	MMR-178
126872	\N	\N	1774	31050	\N	\N	MMR-181
126873	\N	\N	1775	31051	\N	\N	MMR-182
126874	\N	\N	1777	30759	\N	\N	MMD-184
126875	\N	\N	1780	30762	\N	\N	MMD-187
126876	\N	\N	1780	30884	\N	\N	MMD-309
126877	\N	\N	1782	31058	\N	\N	MMR-196
126878	\N	\N	1782	30851	\N	\N	MMD-276
126879	\N	\N	1783	30892	\N	\N	MMD-317
126880	\N	\N	1783	31059	\N	\N	MMR-197
126881	\N	\N	1786	30775	\N	\N	MMD-200
126882	\N	\N	1787	31061	\N	\N	MMR-201
126883	\N	\N	1787	30894	\N	\N	MMD-319
126884	\N	\N	1790	30779	\N	\N	MMD-204
126885	\N	\N	1790	31062	\N	\N	MMR-204
126886	\N	\N	1792	31063	\N	\N	MMR-206
126887	\N	\N	1792	30896	\N	\N	MMD-321
126888	\N	\N	1792	31099	\N	\N	MMR-321
126889	\N	\N	1796	31094	\N	\N	MMR-302
126890	\N	\N	1799	30880	\N	\N	MMD-305
126891	\N	\N	1801	30854	\N	\N	MMD-279
126892	\N	\N	1801	31068	\N	\N	MMR-221
126893	\N	\N	1801	31090	\N	\N	MMR-279
126894	\N	\N	1803	31069	\N	\N	MMR-223
126895	\N	\N	1805	31070	\N	\N	MMR-225
126896	\N	\N	1805	30856	\N	\N	MMD-281
126897	\N	\N	1808	31072	\N	\N	MMR-228
126898	\N	\N	1808	30899	\N	\N	MMD-324
126899	\N	\N	1808	31101	\N	\N	MMR-324
126900	\N	\N	1810	31073	\N	\N	MMR-230
126901	\N	\N	1810	30858	\N	\N	MMD-283
126902	\N	\N	1812	30901	\N	\N	MMD-326
126903	\N	\N	1812	31074	\N	\N	MMR-232
126904	\N	\N	1812	31103	\N	\N	MMR-326
126905	\N	\N	1814	30860	\N	\N	MMD-285
126906	\N	\N	1814	31075	\N	\N	MMR-234
126907	\N	\N	1820	30864	\N	\N	MMD-289
126908	\N	\N	1820	31078	\N	\N	MMR-240
126909	\N	\N	1826	31079	\N	\N	MMR-242
126910	\N	\N	1828	30819	\N	\N	MMD-244
126911	\N	\N	1830	31081	\N	\N	MMR-246
126912	\N	\N	1833	30824	\N	\N	MMD-249
126913	\N	\N	1835	31084	\N	\N	MMR-251
126914	\N	\N	1839	31105	\N	\N	MMR-328
126915	\N	\N	1841	31107	\N	\N	MMR-330
126916	\N	\N	1843	31109	\N	\N	MMR-332
126917	\N	\N	1846	31112	\N	\N	MMR-335
126918	\N	\N	1847	31113	\N	\N	MMR-336
126919	\N	\N	1849	31115	\N	\N	MMR-338
126920	\N	\N	1851	31116	\N	\N	MMR-340
126921	\N	\N	1853	30917	\N	\N	MMD-342
126922	\N	\N	1855	30919	\N	\N	MMD-344
126923	\N	\N	1858	30922	\N	\N	MMD-347
126924	\N	\N	1861	30925	\N	\N	MMD-350
126925	\N	\N	1863	30927	\N	\N	MMD-352
126926	\N	\N	1884	30227	\N	\N	LN R-078
126927	\N	\N	1884	30267	\N	\N	LN R-120
126928	\N	\N	1884	30173	\N	\N	LN D-120
126929	\N	\N	1889	30231	\N	\N	LN R-083
126930	\N	\N	1889	30155	\N	\N	LN D-102
126931	\N	\N	1889	30249	\N	\N	LN R-102
126932	\N	\N	1889	30208	\N	\N	LN D-155
126933	\N	\N	1889	30302	\N	\N	LN R-155
126934	\N	\N	1917	31694	\N	\N	RNA-160
126935	\N	\N	1917	29411	\N	\N	DNA-203
126936	\N	\N	1917	31734	\N	\N	RNA-203
126937	\N	\N	1921	31698	\N	\N	RNA-164
126938	\N	\N	1921	29415	\N	\N	DNA-207
126939	\N	\N	1921	29453	\N	\N	DNA-245
126940	\N	\N	1921	31737	\N	\N	RNA-207
126941	\N	\N	1921	31763	\N	\N	RNA-245
126942	\N	\N	1923	31700	\N	\N	RNA-166
126943	\N	\N	1923	29417	\N	\N	DNA-209
126944	\N	\N	1923	29454	\N	\N	DNA-246
126945	\N	\N	1923	31739	\N	\N	RNA-209
126946	\N	\N	1923	31764	\N	\N	RNA-246
126947	\N	\N	1926	31703	\N	\N	RNA-169
126948	\N	\N	1926	29420	\N	\N	DNA-212
126949	\N	\N	1926	31741	\N	\N	RNA-212
126950	\N	\N	1931	31708	\N	\N	RNA-174
126951	\N	\N	1931	29425	\N	\N	DNA-217
126952	\N	\N	1931	31744	\N	\N	RNA-217
126953	\N	\N	1935	31712	\N	\N	RNA-178
126954	\N	\N	1935	29429	\N	\N	DNA-221
126955	\N	\N	1935	31747	\N	\N	RNA-221
126956	\N	\N	1941	31718	\N	\N	RNA-184
126957	\N	\N	1941	29435	\N	\N	DNA-227
126958	\N	\N	1941	31751	\N	\N	RNA-227
126959	\N	\N	1944	31721	\N	\N	RNA-187
126960	\N	\N	1944	29438	\N	\N	DNA-230
126961	\N	\N	1944	31753	\N	\N	RNA-230
126962	\N	\N	1951	31728	\N	\N	RNA-194
126963	\N	\N	1951	29446	\N	\N	DNA-238
126964	\N	\N	1951	31758	\N	\N	RNA-238
126965	\N	\N	1951	31771	\N	\N	RNA-268
126966	\N	\N	1951	29474	\N	\N	DNA-268
126967	\N	\N	1951	31772	\N	\N	RNA-269
126968	\N	\N	1951	29475	\N	\N	DNA-269
126969	\N	\N	1977	31394	\N	\N	OM R-45
126970	\N	\N	1978	31395	\N	\N	OM R-46
126971	\N	\N	1979	31396	\N	\N	OM R-47
126972	\N	\N	2071	32326	\N	\N	13 MEL_RNA
126973	\N	\N	2074	32328	\N	\N	14 MEL_RNA
126974	\N	\N	2077	32330	\N	\N	16 MEL_RNA
126975	\N	\N	2080	32332	\N	\N	17 MEL_RNA
126976	\N	\N	2089	29500	\N	\N	DNA-294
126977	\N	\N	2089	31787	\N	\N	RNA-294
126978	\N	\N	2092	32322	\N	\N	1 MEL_RNA
126979	\N	\N	2109	31774	\N	\N	RNA-273
126980	\N	\N	2111	31775	\N	\N	RNA-275
126981	\N	\N	2114	31777	\N	\N	RNA-278
126982	\N	\N	2117	31779	\N	\N	RNA-281
126983	\N	\N	2124	31785	\N	\N	RNA-288
126984	\N	\N	2129	31801	\N	\N	RNA-312
126985	\N	\N	2131	31803	\N	\N	RNA-314
126986	\N	\N	2184	31810	\N	\N	RNA-334
126987	\N	\N	2187	31812	\N	\N	RNA-337
126988	\N	\N	2190	31815	\N	\N	RNA-340
126989	\N	\N	2193	31817	\N	\N	RNA-344
126990	\N	\N	2196	31820	\N	\N	RNA-348
126991	\N	\N	2200	31823	\N	\N	RNA-355
126992	\N	\N	2204	31826	\N	\N	RNA-359
126993	\N	\N	2211	31831	\N	\N	RNA-369
126994	\N	\N	2215	31834	\N	\N	RNA-377
126995	\N	\N	2219	31837	\N	\N	RNA-383
126996	\N	\N	2227	31843	\N	\N	RNA-394
126997	\N	\N	2230	31845	\N	\N	RNA-399
126998	\N	\N	2234	31849	\N	\N	RNA-404
126999	\N	\N	2287	31858	\N	\N	RNA-424
127000	\N	\N	2290	31861	\N	\N	RNA-427
127001	\N	\N	2292	31863	\N	\N	RNA-429
127002	\N	\N	2294	31865	\N	\N	RNA-431
123682	\N	\N	2294	29598	\N	2294 Mel	DNA-431
127003	\N	\N	2297	31868	\N	\N	RNA-434
127004	\N	\N	2299	31870	\N	\N	RNA-436
127005	\N	\N	2443	31873	\N	\N	RNA-439
127006	\N	\N	2447	31877	\N	\N	RNA-443
127007	\N	\N	2476	27664	\N	\N	22-44183B-RNA
127008	\N	\N	355	29334	\N	\N	DNA-127
127009	\N	\N	355	31661	\N	\N	RNA-127
127010	\N	\N	355	29347	\N	\N	DNA-140
127011	\N	\N	343	29254	\N	\N	DNA-27
127012	\N	\N	885	31623	\N	\N	RNA-65
127013	\N	\N	885	29337	\N	\N	DNA-130
127014	\N	\N	885	31664	\N	\N	RNA-130
127015	\N	\N	1498	28293	\N	\N	AM2 R-276
127016	\N	\N	1671	30644	\N	\N	MMD-66
127017	\N	\N	1671	30981	\N	\N	MMR-50
127018	\N	\N	1674	31008	\N	\N	MMR-101
127019	\N	\N	1692	30997	\N	\N	MMR-88
127020	\N	\N	1692	30767	\N	\N	MMD-192
127021	\N	\N	1692	31056	\N	\N	MMR-192
127022	\N	\N	1692	30847	\N	\N	MMD-272
127023	\N	\N	1694	30668	\N	\N	MMD-90
127024	\N	\N	1703	30678	\N	\N	MMD-100
127025	\N	\N	1706	31010	\N	\N	MMR-114
127026	\N	\N	1706	30868	\N	\N	MMD-293
127027	\N	\N	1706	31092	\N	\N	MMR-293
127028	\N	\N	1706	30788	\N	\N	MMD-213
127029	\N	\N	1706	31065	\N	\N	MMR-213
127030	\N	\N	1710	31013	\N	\N	MMR-118
127031	\N	\N	1710	31066	\N	\N	MMR-214
127032	\N	\N	1710	30870	\N	\N	MMD-295
127033	\N	\N	1710	30789	\N	\N	MMD-214
127034	\N	\N	1711	31013	\N	\N	MMR-118
127035	\N	\N	1711	31066	\N	\N	MMR-214
127036	\N	\N	1711	30870	\N	\N	MMD-295
127037	\N	\N	1711	30789	\N	\N	MMD-214
127038	\N	\N	1716	31017	\N	\N	MMR-123
127039	\N	\N	1716	30872	\N	\N	MMD-297
127040	\N	\N	1723	31020	\N	\N	MMR-128
127041	\N	\N	1723	30791	\N	\N	MMD-216
127042	\N	\N	1723	31067	\N	\N	MMR-216
127043	\N	\N	1723	30876	\N	\N	MMD-301
127044	\N	\N	1723	31093	\N	\N	MMR-301
127045	\N	\N	1726	31022	\N	\N	MMR-131
127046	\N	\N	1726	30793	\N	\N	MMD-218
127047	\N	\N	1737	31029	\N	\N	MMR-144
127048	\N	\N	1737	30934	\N	\N	MMD-359 (P041_01D)
127049	\N	\N	1737	31135	\N	\N	MMR-359
127050	\N	\N	1746	30728	\N	\N	MMD-153
127051	\N	\N	1746	30837	\N	\N	MMD-262
127052	\N	\N	1746	31087	\N	\N	MMR-262
127053	\N	\N	1746	30936	\N	\N	MMD-361 (P041_03A)
127054	\N	\N	1746	31137	\N	\N	MMR-361
127055	\N	\N	1751	31036	\N	\N	MMR-159
127056	\N	\N	1751	31089	\N	\N	MMR-275
127057	\N	\N	1751	30850	\N	\N	MMD-275
127058	\N	\N	1761	30846	\N	\N	MMD-271
127059	\N	\N	1761	31042	\N	\N	MMR-169
127060	\N	\N	1772	31049	\N	\N	MMR-179
127061	\N	\N	1794	31064	\N	\N	MMR-208
127062	\N	\N	1794	30898	\N	\N	MMD-323
127063	\N	\N	1794	31100	\N	\N	MMR-323
127064	\N	\N	1798	31095	\N	\N	MMR-304
127065	\N	\N	1807	31071	\N	\N	MMR-227
127066	\N	\N	1807	30857	\N	\N	MMD-282
127067	\N	\N	1816	30862	\N	\N	MMD-287
127068	\N	\N	1816	31076	\N	\N	MMR-236
127069	\N	\N	1832	31082	\N	\N	MMR-248
127070	\N	\N	1844	31111	\N	\N	MMR-334
127071	\N	\N	1857	30921	\N	\N	MMD-346
127072	\N	\N	1860	30924	\N	\N	MMD-349
127073	\N	\N	1918	31695	\N	\N	RNA-161
127074	\N	\N	1918	29412	\N	\N	DNA-204
127075	\N	\N	1918	31735	\N	\N	RNA-204
127076	\N	\N	1927	31704	\N	\N	RNA-170
127077	\N	\N	1927	29421	\N	\N	DNA-213
127078	\N	\N	1927	31742	\N	\N	RNA-213
127079	\N	\N	1932	31709	\N	\N	RNA-175
127080	\N	\N	1932	29426	\N	\N	DNA-218
127081	\N	\N	1932	31745	\N	\N	RNA-218
127082	\N	\N	1938	31715	\N	\N	RNA-181
127083	\N	\N	1938	29432	\N	\N	DNA-224
127084	\N	\N	1938	31749	\N	\N	RNA-224
127085	\N	\N	1954	29405	\N	\N	DNA-197
127086	\N	\N	1954	29441	\N	\N	DNA-233
127087	\N	\N	1954	31755	\N	\N	RNA-233
127088	\N	\N	2119	31781	\N	\N	RNA-283
127089	\N	\N	2122	31784	\N	\N	RNA-286
127090	\N	\N	2197	31821	\N	\N	RNA-350
127091	\N	\N	2201	31824	\N	\N	RNA-356
127092	\N	\N	2207	31828	\N	\N	RNA-364
127093	\N	\N	2212	31832	\N	\N	RNA-372
127094	\N	\N	2220	31838	\N	\N	RNA-385
127095	\N	\N	2231	31846	\N	\N	RNA-401
127096	\N	\N	2237	31851	\N	\N	RNA-417
127097	\N	\N	2243	31855	\N	\N	RNA-421
127098	\N	\N	2295	31866	\N	\N	RNA-432
127099	\N	\N	2444	31874	\N	\N	RNA-440
127100	\N	\N	2451	30022	\N	\N	LMM R-017
127101	\N	\N	2459	31880	\N	\N	RNA-446
127102	\N	\N	2454	30025	\N	\N	LMM R-020
127103	\N	\N	2470	30028	\N	\N	LMM R-023
127104	\N	\N	2487	30054	\N	\N	LMM R-056
127105	\N	\N	2473	28494	\N	\N	AM2 R-539
127106	\N	\N	2484	30051	\N	\N	LMM R-053
127107	\N	\N	2481	30048	\N	\N	LMM R-050
127108	\N	\N	2474	28495	\N	\N	AM2 R-540
127109	\N	\N	2478	30045	\N	\N	LMM R-047
127110	\N	\N	2492	30007	\N	\N	LMM R-002
127111	\N	\N	2495	30010	\N	\N	LMM R-005
127112	\N	\N	2498	30013	\N	\N	LMM R-008
127113	\N	\N	2501	30016	\N	\N	LMM R-011
127114	\N	\N	2504	30019	\N	\N	LMM R-014
127115	\N	\N	2507	29970	\N	\N	LMM D-026
127116	\N	\N	2510	29973	\N	\N	LMM D-029
127117	\N	\N	2513	29976	\N	\N	LMM D-032
127118	\N	\N	2516	29979	\N	\N	LMM D-035
127119	\N	\N	2519	29982	\N	\N	LMM D-038
127120	\N	\N	2522	29985	\N	\N	LMM D-041
127121	\N	\N	2525	29988	\N	\N	LMM D-044
127122	\N	\N	1603	28178	\N	\N	AM2 D-476
127123	\N	\N	1603	28441	\N	\N	AM2 R-476
124113	\N	\N	1603	28117	\N	1603 Normal 2	AM2 D-406
127124	\N	\N	385	28464	\N	\N	AM2 R-503
124115	\N	\N	385	27878	\N	385 LN Met 1	AM2 D-136
127125	\N	\N	1423	27985	\N	\N	AM2 D-251
127126	\N	\N	1423	28265	\N	\N	AM2 R-247
127127	\N	\N	1423	28269	\N	\N	AM2 R-251
127128	\N	\N	1479	28283	\N	\N	AM2 R-265
127129	\N	\N	1479	28188	\N	\N	AM2 D-486-1
127130	\N	\N	1479	28448	\N	\N	AM2 R-486-1
127131	\N	\N	1499	28294	\N	\N	AM2 R-277
127132	\N	\N	1519	28308	\N	\N	AM2 R-294
127133	\N	\N	1519	28483	\N	\N	AM2 R-523
127134	\N	\N	1519	28223	\N	\N	AM2 D-523
127135	\N	\N	1527	28315	\N	\N	AM2 R-303
127136	\N	\N	1558	28345	\N	\N	AM2 R-338
127137	\N	\N	1574	28358	\N	\N	AM2 R-354
127138	\N	\N	1609	28399	\N	\N	AM2 R-422
127139	\N	\N	2303	31898	\N	\N	SCH R-01
124502	\N	\N	2303	31897	\N	2303 Tumor	SCH D-01
127140	\N	\N	2457	27670	\N	\N	22-104389C-RNA
127141	\N	\N	2456	27666	\N	\N	22-104389A2-RNA
127142	\N	\N	2697	27706	\N	\N	AM-15-Tumor
127143	\N	\N	2698	27708	\N	\N	AM-16-Tumor
127144	\N	\N	2703	27718	\N	\N	AM-21-Tumor
127145	\N	\N	2711	27734	\N	\N	AM-29-Tumor
127146	\N	\N	2709	27730	\N	\N	AM-27-Tumor
127147	\N	\N	2699	27710	\N	\N	AM-17-Tumor
127148	\N	\N	2712	27736	\N	\N	AM-30-Tumor
127149	\N	\N	2714	27740	\N	\N	AM-32-Tumor
127150	\N	\N	2710	27732	\N	\N	AM-28-Tumor
127151	\N	\N	2700	27712	\N	\N	AM-18-Tumor
127152	\N	\N	2705	27722	\N	\N	AM-23-Tumor
127153	\N	\N	2707	27726	\N	\N	AM-25-Tumor
127154	\N	\N	2706	27724	\N	\N	AM-24-Tumor
127155	\N	\N	2708	27728	\N	\N	AM-26-Tumor
127156	\N	\N	2702	27716	\N	\N	AM-20-Tumor
127157	\N	\N	2704	27720	\N	\N	AM-22-Tumor
127158	\N	\N	2713	27738	\N	\N	AM-31-Tumor
127159	\N	\N	2701	27714	\N	\N	AM-19-Tumor
127160	\N	\N	2766	29744	\N	\N	Ivanka_23_2_NA
127161	\N	\N	2766	29745	\N	\N	Ivanka_23_3_NA
127162	\N	\N	2766	29746	\N	\N	Ivanka_23_4_NA
127163	\N	\N	2766	29747	\N	\N	Ivanka_23_5_NA
127164	\N	\N	2786	31948	\N	\N	SM_5_Tumor_NA
127165	\N	\N	2789	31951	\N	\N	SM_7_Tumor_NA
127166	\N	\N	2794	31955	\N	\N	SM_9_Tumor_NA
127167	\N	\N	3318	29887	\N	\N	Kit_181_Muc BRAF_NA
124862	\N	\N	3318	29888	\N	3318 Tumor	Kit_181_Muc_BRAF_NA
127168	\N	\N	1489	28284	\N	\N	AM2 R-266
127169	\N	\N	1489	28189	\N	\N	AM2 D-486-2
127170	\N	\N	1489	28449	\N	\N	AM2 R-486-2
127171	\N	\N	1528	28316	\N	\N	AM2 R-304
127172	\N	\N	1528	28487	\N	\N	AM2 R-527
127173	\N	\N	1528	28227	\N	\N	AM2 D-527
127174	\N	\N	1559	28346	\N	\N	AM2 R-339
127175	\N	\N	1477	28281	\N	\N	AM2 R-263
127176	\N	\N	1496	28291	\N	\N	AM2 R-274
127177	\N	\N	1496	28233	\N	\N	AM2 D-535
127178	\N	\N	1517	28360	\N	\N	AM2 R-356
127179	\N	\N	1517	28467	\N	\N	AM2 R-506
127180	\N	\N	1517	28207	\N	\N	AM2 D-506
127181	\N	\N	1531	28319	\N	\N	AM2 R-310
127182	\N	\N	1531	28229	\N	\N	AM2 D-531
127183	\N	\N	1531	28489	\N	\N	AM2 R-531
127184	\N	\N	1545	28333	\N	\N	AM2 R-325
127185	\N	\N	1561	28348	\N	\N	AM2 R-341
127186	\N	\N	1544	28332	\N	\N	AM2 R-324
127187	\N	\N	1560	28347	\N	\N	AM2 R-340
127188	\N	\N	1619	28418	\N	\N	AM2 R-452
127189	\N	\N	1619	28198	\N	\N	AM2 D-495
127190	\N	\N	1619	28458	\N	\N	AM2 R-495
127191	\N	\N	1621	28413	\N	\N	AM2 R-446
127192	\N	\N	1586	28373	\N	\N	AM2 R-380
127193	\N	\N	1424	28266	\N	\N	AM2 R-248
127194	\N	\N	1424	27989	\N	\N	AM2 D-255
127195	\N	\N	1424	28273	\N	\N	AM2 R-255
127196	\N	\N	2025	31444	\N	\N	OM-26D-2
127197	\N	\N	2582	31518	\N	\N	RMS-018
127198	\N	\N	2596	31522	\N	\N	RMS-032
127199	\N	\N	1427	28260	\N	\N	AM2 R-242
125113	\N	\N	1427	27976	\N	1427 Lung Metastasis	AM2 D-242
127200	\N	\N	1314	31492	\N	\N	PROG R-04
127201	\N	\N	1314	31479	\N	\N	PROG D-17
127202	\N	\N	1314	31505	\N	\N	PROG R-17
127203	\N	\N	1501	28296	\N	\N	AM2 R-279
127204	\N	\N	1506	28301	\N	\N	AM2 R-284
127205	\N	\N	1512	28305	\N	\N	AM2 R-289
127206	\N	\N	1512	28222	\N	\N	AM2 D-522
127207	\N	\N	1512	28482	\N	\N	AM2 R-522
127208	\N	\N	1426	31493	\N	\N	PROG R-05
127209	\N	\N	1429	31495	\N	\N	PROG R-07
127210	\N	\N	2302	31508	\N	\N	PROG R-20
127211	\N	\N	1435	31496	\N	\N	PROG R-08
127212	\N	\N	1436	31497	\N	\N	PROG R-09
127213	\N	\N	1437	31498	\N	\N	PROG R-10
127214	\N	\N	1439	31500	\N	\N	PROG R-12
127215	\N	\N	1439	31480	\N	\N	PROG D-18
127216	\N	\N	1439	31506	\N	\N	PROG R-18
127217	\N	\N	1440	31501	\N	\N	PROG R-13
127218	\N	\N	1473	28277	\N	\N	AM2 R-259
127219	\N	\N	1473	28171	\N	\N	AM2 D-468
127220	\N	\N	1473	28434	\N	\N	AM2 R-468
127221	\N	\N	1493	28288	\N	\N	AM2 R-271
127222	\N	\N	1511	28305	\N	\N	AM2 R-289
127223	\N	\N	1511	28222	\N	\N	AM2 D-522
127224	\N	\N	1511	28482	\N	\N	AM2 R-522
127225	\N	\N	1513	28306	\N	\N	AM2 R-291
127226	\N	\N	1514	28306	\N	\N	AM2 R-291
127227	\N	\N	2305	31509	\N	\N	PROG R-21
127228	\N	\N	1518	28361	\N	\N	AM2 R-357
127229	\N	\N	1518	28159	\N	\N	AM2 D-456
127230	\N	\N	1518	28422	\N	\N	AM2 R-456
127231	\N	\N	1532	28320	\N	\N	AM2 R-311
127232	\N	\N	1532	28161	\N	\N	AM2 D-458
127233	\N	\N	1532	28424	\N	\N	AM2 R-458
127234	\N	\N	1522	28311	\N	\N	AM2 R-297
127235	\N	\N	1534	28322	\N	\N	AM2 R-313
127236	\N	\N	1534	28162	\N	\N	AM2 D-459
127237	\N	\N	1534	28425	\N	\N	AM2 R-459
127238	\N	\N	1542	28330	\N	\N	AM2 R-322
127239	\N	\N	1542	28174	\N	\N	AM2 D-472
127240	\N	\N	1542	28437	\N	\N	AM2 R-472
127241	\N	\N	1542	28199	\N	\N	AM2 D-496
127242	\N	\N	1542	28459	\N	\N	AM2 R-496
127243	\N	\N	1536	28324	\N	\N	AM2 R-316
127244	\N	\N	1537	28325	\N	\N	AM2 R-317
127245	\N	\N	1538	28326	\N	\N	AM2 R-318
127246	\N	\N	1543	28331	\N	\N	AM2 R-323
127247	\N	\N	1543	28230	\N	\N	AM2 D-532
127248	\N	\N	1543	28490	\N	\N	AM2 R-532
127249	\N	\N	1546	28334	\N	\N	AM2 R-326
127250	\N	\N	1551	28339	\N	\N	AM2 R-331
127251	\N	\N	1562	28349	\N	\N	AM2 R-342
127252	\N	\N	1562	28165	\N	\N	AM2 D-462
127253	\N	\N	1562	28428	\N	\N	AM2 R-462
127254	\N	\N	1563	28350	\N	\N	AM2 R-343
127255	\N	\N	1563	28166	\N	\N	AM2 D-463
127256	\N	\N	1563	28429	\N	\N	AM2 R-463
127257	\N	\N	1565	28351	\N	\N	AM2 R-345
127258	\N	\N	1567	28352	\N	\N	AM2 R-347
127259	\N	\N	1568	28353	\N	\N	AM2 R-348
127260	\N	\N	1576	28094	\N	\N	AM2 D-374
127261	\N	\N	1576	28093	\N	\N	AM2 D-373
127262	\N	\N	1576	28095	\N	\N	AM2 D-375
127263	\N	\N	1576	28096	\N	\N	AM2 D-376
127264	\N	\N	1576	28367	\N	\N	AM2 R-372
127265	\N	\N	1576	28368	\N	\N	AM2 R-373
127266	\N	\N	1576	28369	\N	\N	AM2 R-374
127267	\N	\N	1576	28370	\N	\N	AM2 R-375
127268	\N	\N	1576	28371	\N	\N	AM2 R-376
127269	\N	\N	1578	28132	\N	\N	AM2 D-426
127270	\N	\N	1578	28133	\N	\N	AM2 D-427
127271	\N	\N	1578	28134	\N	\N	AM2 D-428
127272	\N	\N	1578	28135	\N	\N	AM2 D-429
127273	\N	\N	1578	28401	\N	\N	AM2 R-425
127274	\N	\N	1578	28402	\N	\N	AM2 R-426
127275	\N	\N	1578	28403	\N	\N	AM2 R-427
127276	\N	\N	1578	28404	\N	\N	AM2 R-428
127277	\N	\N	1578	28405	\N	\N	AM2 R-429
127278	\N	\N	1580	28125	\N	\N	AM2 D-415
127279	\N	\N	1580	28395	\N	\N	AM2 R-414
127280	\N	\N	1580	28396	\N	\N	AM2 R-415
127281	\N	\N	1582	28365	\N	\N	AM2 R-370
127282	\N	\N	1585	28372	\N	\N	AM2 R-379
127283	\N	\N	1598	28382	\N	\N	AM2 R-394
127284	\N	\N	1623	28420	\N	\N	AM2 R-454
127285	\N	\N	1822	28374	\N	\N	AM2 R-381
127286	\N	\N	1583	28366	\N	\N	AM2 R-371
127287	\N	\N	1599	28383	\N	\N	AM2 R-395
127288	\N	\N	1823	28375	\N	\N	AM2 R-382
127289	\N	\N	1589	28409	\N	\N	AM2 R-435
127290	\N	\N	1589	28470	\N	\N	AM2 R-509
127291	\N	\N	1589	28210	\N	\N	AM2 D-509
127292	\N	\N	1590	28410	\N	\N	AM2 R-436
127293	\N	\N	1592	28411	\N	\N	AM2 R-438
127294	\N	\N	1595	28385	\N	\N	AM2 R-401
127295	\N	\N	1606	28397	\N	\N	AM2 R-419
127296	\N	\N	1606	28471	\N	\N	AM2 R-510
127297	\N	\N	1606	28211	\N	\N	AM2 D-510
127298	\N	\N	1596	28386	\N	\N	AM2 R-402
127299	\N	\N	1607	28398	\N	\N	AM2 R-420
127300	\N	\N	1607	28472	\N	\N	AM2 R-511
127301	\N	\N	1607	28212	\N	\N	AM2 D-511
127302	\N	\N	1601	28388	\N	\N	AM2 R-404
127303	\N	\N	1601	28182	\N	\N	AM2 D-480
127304	\N	\N	1601	28445	\N	\N	AM2 R-480
127305	\N	\N	1610	28400	\N	\N	AM2 R-423
127306	\N	\N	1602	28389	\N	\N	AM2 R-405
127307	\N	\N	1602	28180	\N	\N	AM2 D-478
127308	\N	\N	1602	28443	\N	\N	AM2 R-478
127309	\N	\N	1605	28390	\N	\N	AM2 R-408
127310	\N	\N	1605	28179	\N	\N	AM2 D-477
127311	\N	\N	1605	28442	\N	\N	AM2 R-477
127312	\N	\N	1625	28439	\N	\N	AM2 R-474
127313	\N	\N	1877	30220	\N	\N	LN R-071
127314	\N	\N	1877	30148	\N	\N	LN D-095
127315	\N	\N	1877	30242	\N	\N	LN R-095
127316	\N	\N	1877	30200	\N	\N	LN D-147
127317	\N	\N	1877	30294	\N	\N	LN R-147
127318	\N	\N	1879	30222	\N	\N	LN R-073
127319	\N	\N	1879	30150	\N	\N	LN D-097
127320	\N	\N	1879	30244	\N	\N	LN R-097
127321	\N	\N	1879	30202	\N	\N	LN D-149
127322	\N	\N	1879	30296	\N	\N	LN R-149
127323	\N	\N	1882	30225	\N	\N	LN R-076
127324	\N	\N	1882	30265	\N	\N	LN R-118
127325	\N	\N	1882	30171	\N	\N	LN D-118
127326	\N	\N	1890	30232	\N	\N	LN R-084
127327	\N	\N	1890	30156	\N	\N	LN D-103
127328	\N	\N	1890	30250	\N	\N	LN R-103
127329	\N	\N	1890	30209	\N	\N	LN D-156
127330	\N	\N	1890	30303	\N	\N	LN R-156
127331	\N	\N	1892	30234	\N	\N	LN R-086
127332	\N	\N	1892	30175	\N	\N	LN D-122
127333	\N	\N	1892	30269	\N	\N	LN R-122
127334	\N	\N	1892	30211	\N	\N	LN D-158
127335	\N	\N	1892	30305	\N	\N	LN R-158
127336	\N	\N	1895	30236	\N	\N	LN R-089
127337	\N	\N	1895	30177	\N	\N	LN D-124
127338	\N	\N	1895	30271	\N	\N	LN R-124
127339	\N	\N	1898	30239	\N	\N	LN R-092
127340	\N	\N	1898	30274	\N	\N	LN R-127
127341	\N	\N	1898	30180	\N	\N	LN D-127
127342	\N	\N	1898	30212	\N	\N	LN D-159
127343	\N	\N	1898	30306	\N	\N	LN R-159
127344	\N	\N	1901	30255	\N	\N	LN R-108
127345	\N	\N	1901	30192	\N	\N	LN D-139
127346	\N	\N	1901	30286	\N	\N	LN R-139
127347	\N	\N	1903	30259	\N	\N	LN R-112
127348	\N	\N	1903	30196	\N	\N	LN D-143
127349	\N	\N	1903	30290	\N	\N	LN R-143
127350	\N	\N	1903	30216	\N	\N	LN D-163
127351	\N	\N	1903	30310	\N	\N	LN R-163
127352	\N	\N	1905	30252	\N	\N	LN R-105
127353	\N	\N	1905	30277	\N	\N	LN R-130
127354	\N	\N	1905	30183	\N	\N	LN D-130
127355	\N	\N	1905	30214	\N	\N	LN D-161
127356	\N	\N	1905	30308	\N	\N	LN R-161
127357	\N	\N	1907	30257	\N	\N	LN R-110
127358	\N	\N	1907	30288	\N	\N	LN R-141
127359	\N	\N	1907	30194	\N	\N	LN D-141
127360	\N	\N	1913	30280	\N	\N	LN R-133
127361	\N	\N	1913	30284	\N	\N	LN R-137
127362	\N	\N	1913	30190	\N	\N	LN D-137
127363	\N	\N	1914	30281	\N	\N	LN R-134
127364	\N	\N	1914	30285	\N	\N	LN R-138
127365	\N	\N	1914	30191	\N	\N	LN D-138
127366	\N	\N	1875	30218	\N	\N	LN R-069
127367	\N	\N	1875	30169	\N	\N	LN D-116
127368	\N	\N	1875	30263	\N	\N	LN R-116
127369	\N	\N	1909	30261	\N	\N	LN R-114
127370	\N	\N	1909	30292	\N	\N	LN R-145
127371	\N	\N	1909	30198	\N	\N	LN D-145
127372	\N	\N	1910	30262	\N	\N	LN R-115
127373	\N	\N	1910	30293	\N	\N	LN R-146
127374	\N	\N	1910	30199	\N	\N	LN D-146
127375	\N	\N	1878	30221	\N	\N	LN R-072
127376	\N	\N	1878	30149	\N	\N	LN D-096
127377	\N	\N	1878	30243	\N	\N	LN R-096
127378	\N	\N	1878	30201	\N	\N	LN D-148
127379	\N	\N	1878	30295	\N	\N	LN R-148
127380	\N	\N	1880	30223	\N	\N	LN R-074
127381	\N	\N	1880	30151	\N	\N	LN D-098
127382	\N	\N	1880	30245	\N	\N	LN R-098
127383	\N	\N	1880	30203	\N	\N	LN D-150
127384	\N	\N	1880	30297	\N	\N	LN R-150
127385	\N	\N	1891	30233	\N	\N	LN R-085
127386	\N	\N	1891	30157	\N	\N	LN D-104
127387	\N	\N	1891	30251	\N	\N	LN R-104
127388	\N	\N	1891	30210	\N	\N	LN D-157
127389	\N	\N	1891	30304	\N	\N	LN R-157
127390	\N	\N	1906	30253	\N	\N	LN R-106
127391	\N	\N	1906	30278	\N	\N	LN R-131
127392	\N	\N	1906	30184	\N	\N	LN D-131
127393	\N	\N	1906	30215	\N	\N	LN D-162
127394	\N	\N	1906	30309	\N	\N	LN R-162
127395	\N	\N	1908	30258	\N	\N	LN R-111
127396	\N	\N	1908	30289	\N	\N	LN R-142
127397	\N	\N	1908	30195	\N	\N	LN D-142
127398	\N	\N	1947	31724	\N	\N	RNA-190
127399	\N	\N	1947	29442	\N	\N	DNA-234
127400	\N	\N	1947	29455	\N	\N	DNA-247
127401	\N	\N	1947	31756	\N	\N	RNA-234
127402	\N	\N	1947	31765	\N	\N	RNA-247
127403	\N	\N	2288	31859	\N	\N	RNA-425
127404	\N	\N	1960	31382	\N	\N	OM R-31
127405	\N	\N	1961	31383	\N	\N	OM R-32
127406	\N	\N	1962	31384	\N	\N	OM R-33
125203	\N	\N	1962	31332	\N	1962 Typical Melanotic Macule	OM D-33
127407	\N	\N	1964	31385	\N	\N	OM R-34
127408	\N	\N	1965	31386	\N	\N	OM R-35
127409	\N	\N	1966	31387	\N	\N	OM R-36
127410	\N	\N	1967	31388	\N	\N	OM R-37
127411	\N	\N	1968	31389	\N	\N	OM R-38
127412	\N	\N	1969	31390	\N	\N	OM R-39
127413	\N	\N	1971	31391	\N	\N	OM R-41
127414	\N	\N	1972	31392	\N	\N	OM R-42
127415	\N	\N	1973	31393	\N	\N	OM R-43
127416	\N	\N	2023	31440	\N	\N	OM-24D-2
127417	\N	\N	2024	31442	\N	\N	OM-25D-2
127418	\N	\N	2026	31446	\N	\N	OM-27D-2
127419	\N	\N	2027	31448	\N	\N	OM-28D-2
127420	\N	\N	2028	31450	\N	\N	OM-29D-2
127421	\N	\N	2029	31399	\N	\N	OM-1D-3
127422	\N	\N	2030	31405	\N	\N	OM-4D-3
127423	\N	\N	2031	31409	\N	\N	OM-5D-3
127424	\N	\N	2032	31413	\N	\N	OM-6D-3
127425	\N	\N	2012	31418	\N	\N	OM-10D-2
127426	\N	\N	2012	31419	\N	\N	OM-10D-3
127427	\N	\N	2017	31411	\N	\N	OM-6D
127428	\N	\N	2017	31427	\N	\N	OM-15D-2
127429	\N	\N	2021	31436	\N	\N	OM-22D-2
127430	\N	\N	2022	31438	\N	\N	OM-23D-2
127431	\N	\N	2070	32325	\N	\N	13 AMB_RNA
127432	\N	\N	2209	31830	\N	\N	RNA-366
127433	\N	\N	2217	31836	\N	\N	RNA-381
127434	\N	\N	2452	30023	\N	\N	LMM R-018
125356	\N	\N	2452	29962	\N	2452 Invasive	LMM D-018
127435	\N	\N	2455	30026	\N	\N	LMM R-021
127436	\N	\N	2469	30027	\N	\N	LMM R-022
127437	\N	\N	2486	30053	\N	\N	LMM R-055
127438	\N	\N	2483	30050	\N	\N	LMM R-052
127439	\N	\N	2477	30044	\N	\N	LMM R-046
127440	\N	\N	2472	28493	\N	\N	AM2 R-538
127441	\N	\N	2480	30047	\N	\N	LMM R-049
127442	\N	\N	2491	30006	\N	\N	LMM R-001
127443	\N	\N	2494	30009	\N	\N	LMM R-004
127444	\N	\N	2497	30012	\N	\N	LMM R-007
127445	\N	\N	2500	30015	\N	\N	LMM R-010
127446	\N	\N	2503	30018	\N	\N	LMM R-013
127447	\N	\N	2506	29969	\N	\N	LMM D-025
127448	\N	\N	2509	29972	\N	\N	LMM D-028
127449	\N	\N	2512	29975	\N	\N	LMM D-031
127450	\N	\N	2515	29978	\N	\N	LMM D-034
127451	\N	\N	2518	29981	\N	\N	LMM D-037
127452	\N	\N	2521	29984	\N	\N	LMM D-040
127453	\N	\N	2524	29987	\N	\N	LMM D-043
127454	\N	\N	2306	31510	\N	\N	PROG R-22
127455	\N	\N	2307	31511	\N	\N	PROG R-23
127456	\N	\N	2308	31512	\N	\N	PROG R-24
127457	\N	\N	2309	31513	\N	\N	PROG R-25
127458	\N	\N	2310	31514	\N	\N	PROG R-26
127459	\N	\N	2430	28996	\N	\N	D72_NA
127460	\N	\N	2430	28997	\N	\N	D73_NA
127461	\N	\N	2430	28998	\N	\N	D74_NA
127462	\N	\N	2430	28999	\N	\N	D75_NA
127463	\N	\N	2563	31515	\N	\N	RMS-001A
125442	\N	\N	2563	29120	\N	2563 Congenital Nevus	DMS-001A
127464	\N	\N	2564	31516	\N	\N	RMS-001B
127465	\N	\N	2565	31517	\N	\N	RMS-001C
127466	\N	\N	2583	31519	\N	\N	RMS-019
127467	\N	\N	2585	31521	\N	\N	RMS-021
127468	\N	\N	2584	31520	\N	\N	RMS-020
127469	\N	\N	2624	31547	\N	\N	RMS-054
127470	\N	\N	2625	31548	\N	\N	RMS-055
127471	\N	\N	2626	31549	\N	\N	RMS-056
127472	\N	\N	2627	31550	\N	\N	RMS-057
127473	\N	\N	2629	31552	\N	\N	RMS-059A
127474	\N	\N	2628	31551	\N	\N	RMS-058
127475	\N	\N	2630	31553	\N	\N	RMS-059B
127476	\N	\N	2631	31554	\N	\N	RMS-060
127477	\N	\N	2633	31556	\N	\N	RMS-062
127478	\N	\N	2632	31555	\N	\N	RMS-061
127479	\N	\N	2635	31558	\N	\N	RMS-063
127480	\N	\N	2598	31524	\N	\N	RMS-034
127481	\N	\N	2597	31523	\N	\N	RMS-033
127482	\N	\N	2599	31525	\N	\N	RMS-035
127483	\N	\N	2601	31526	\N	\N	RMS-036
127484	\N	\N	2602	31527	\N	\N	RMS-037
127485	\N	\N	2604	31528	\N	\N	RMS-038
127486	\N	\N	2606	31530	\N	\N	RMS-039
127487	\N	\N	2608	31532	\N	\N	RMS-040
127488	\N	\N	2612	31535	\N	\N	RMS-043
127489	\N	\N	2610	31534	\N	\N	RMS-041
127490	\N	\N	2613	31536	\N	\N	RMS-044
127491	\N	\N	2614	31537	\N	\N	RMS-045
127492	\N	\N	2615	31538	\N	\N	RMS-046
127493	\N	\N	2616	31539	\N	\N	RMS-047
127494	\N	\N	2617	31540	\N	\N	RMS-048
127495	\N	\N	2618	31541	\N	\N	RMS-049
127496	\N	\N	2619	31542	\N	\N	RMS-050
127497	\N	\N	2620	31543	\N	\N	RMS-051
127498	\N	\N	2621	31544	\N	\N	RMS-052A
127499	\N	\N	2623	31546	\N	\N	RMS-053
127500	\N	\N	2622	31545	\N	\N	RMS-052B
127501	\N	\N	2528	29821	\N	\N	KA R-02
127502	\N	\N	2530	29822	\N	\N	KA R-04
127503	\N	\N	2532	29823	\N	\N	KA R-06
127504	\N	\N	2534	29824	\N	\N	KA R-08
127505	\N	\N	2536	29825	\N	\N	KA R-10
127506	\N	\N	2538	29826	\N	\N	KA R-12
127507	\N	\N	2540	29827	\N	\N	KA R-14
127508	\N	\N	2542	29828	\N	\N	KA R-16
127509	\N	\N	2544	29829	\N	\N	KA R-18
127510	\N	\N	2545	29830	\N	\N	KA R-19
127511	\N	\N	2546	29831	\N	\N	KA R-20
127512	\N	\N	2547	29832	\N	\N	KA R-21
127513	\N	\N	2549	29833	\N	\N	KA R-23
127514	\N	\N	2551	29834	\N	\N	KA R-25
127515	\N	\N	2552	29835	\N	\N	KA R-26
127516	\N	\N	2554	29836	\N	\N	KA R-28
127517	\N	\N	2556	29837	\N	\N	KA R-30
127518	\N	\N	2558	29838	\N	\N	KA R-32
127519	\N	\N	2560	29839	\N	\N	KA R-34
127520	\N	\N	2561	29840	\N	\N	KA R-35
127521	\N	\N	2247	27671	\N	\N	22-125373-DNA
125913	\N	\N	2247	27672	\N	2247 tum	22-125373-RNA
127680	\N	\N	10158	32493	\N	11-61046_Tumor	NA_11-61046_Tumor
127681	\N	\N	10159	32494	\N	10-56047_Tumor	NA_10-56047_Tumor
127682	\N	\N	10160	32495	\N	12-67298_Tumor	NA_12-67298_Tumor
127683	\N	\N	10161	32496	\N	12-67298_Normal	NA_12-67298_Normal
127684	\N	\N	10162	32497	\N	12-20321_Tumor	NA_12-20321_Tumor
127685	\N	\N	10163	32498	\N	11-96096_Normal	NA_11-96096_Normal
127686	\N	\N	10164	32499	\N	MB1242_Tumor	NA_MB1242_Tumor
127687	\N	\N	10165	32500	\N	MB1241_Normal	NA_MB1241_Normal
127688	\N	\N	10166	32501	\N	MB1423_Tumor	NA_MB1423_Tumor
127689	\N	\N	10167	32502	\N	MB1423_Normal	NA_MB1423_Normal
127690	\N	\N	10168	32503	\N	MB1424__Tumor	NA_MB1424__Tumor
127691	\N	\N	10169	32504	\N	MB1421_Normal	NA_MB1421_Normal
127692	\N	\N	10170	32505	\N	MB1429_Tumor	NA_MB1429_Tumor
127693	\N	\N	10171	32506	\N	MB1428_Normal	NA_MB1428_Normal
127694	\N	\N	10172	32507	\N	12-71679_Tumor	NA_12-71679_Tumor
127695	\N	\N	10173	32508	\N	12-80985B_Tumor	NA_12-80985B_Tumor
127696	\N	\N	10174	32509	\N	12-31996_Tumor	NA_12-31996_Tumor
127697	\N	\N	10175	32510	\N	12-39632_Tumor	NA_12-39632_Tumor
127698	\N	\N	10176	32511	\N	HWA5_Tumor	NA_HWA5_Tumor
127699	\N	\N	10177	32512	\N	HWA5_Normal	NA_HWA5_Normal
127700	\N	\N	10178	32513	\N	HWA6_Tumor	NA_HWA6_Tumor
127701	\N	\N	10179	32514	\N	HWA6_Normal	NA_HWA6_Normal
127702	\N	\N	10180	32515	\N	HWA7_Tumor	NA_HWA7_Tumor
127703	\N	\N	10181	32516	\N	HWA7_Normal	NA_HWA7_Normal
127704	\N	\N	10182	32517	\N	HWA8_Tumor	NA_HWA8_Tumor
127705	\N	\N	10183	32518	\N	HWA8_Normal	NA_HWA8_Normal
127706	\N	\N	10184	32519	\N	HWA9_Tumor	NA_HWA9_Tumor
127707	\N	\N	10185	32520	\N	HWA9_Normal	NA_HWA9_Normal
127708	\N	\N	10186	32521	\N	HWA10_Tumor	NA_HWA10_Tumor
127709	\N	\N	10187	32522	\N	HWA10_Normal	NA_HWA10_Normal
127710	\N	\N	10188	32523	\N	MB1617_Tumor	NA_MB1617_Tumor
127711	\N	\N	10189	32524	\N	MB1609_Normal	NA_MB1609_Normal
127712	\N	\N	10190	32525	\N	WM51_Tumor	NA_WM51_Tumor
127713	\N	\N	10191	32526	\N	wm3918_Tumor	NA_wm3918_Tumor
127714	\N	\N	10192	32527	\N	DM1_Normal	NA_DM1_Normal
127715	\N	\N	10193	32528	\N	DM1_Tumor	NA_DM1_Tumor
127716	\N	\N	10194	32529	\N	DM2_Normal	NA_DM2_Normal
127717	\N	\N	10195	32530	\N	DM2_Tumor	NA_DM2_Tumor
127718	\N	\N	10196	32531	\N	DM5_Normal	NA_DM5_Normal
127719	\N	\N	10197	32532	\N	DM5_Tumor	NA_DM5_Tumor
127720	\N	\N	10198	32533	\N	DM7_Normal	NA_DM7_Normal
127721	\N	\N	10199	32534	\N	DM7_Tumor	NA_DM7_Tumor
127722	\N	\N	10200	32535	\N	DM12_Normal	NA_DM12_Normal
127723	\N	\N	10201	32536	\N	DM12_Tumor	NA_DM12_Tumor
127724	\N	\N	10202	32537	\N	DM13_Normal	NA_DM13_Normal
127725	\N	\N	10203	32538	\N	DM13_Tumor	NA_DM13_Tumor
127726	\N	\N	10204	32539	\N	DM21_Normal	NA_DM21_Normal
127727	\N	\N	10205	32540	\N	DM21_Tumor	NA_DM21_Tumor
127728	\N	\N	10206	32541	\N	DM93_Normal	NA_DM93_Normal
127729	\N	\N	10207	32542	\N	DM93_Tumor	NA_DM93_Tumor
127730	\N	\N	10208	32543	\N	11-20375_Tumor	NA_11-20375_Tumor
127731	\N	\N	10209	32544	\N	11-21491_Tumor	NA_11-21491_Tumor
127732	\N	\N	10210	32545	\N	11-65778_Tumor	NA_11-65778_Tumor
127733	\N	\N	10211	32546	\N	10-88482_Tumor	NA_10-88482_Tumor
127734	\N	\N	10212	32547	\N	11-63178_Tumor	NA_11-63178_Tumor
127735	\N	\N	10213	32548	\N	10-71761_Tumor	NA_10-71761_Tumor
127736	\N	\N	10214	32549	\N	10-84478_Tumor	NA_10-84478_Tumor
127737	\N	\N	10215	32550	\N	10-88475_Tumor	NA_10-88475_Tumor
127738	\N	\N	10216	32551	\N	12-54296_Normal	NA_12-54296_Normal
127739	\N	\N	10217	32552	\N	12-54296_Tumor	NA_12-54296_Tumor
127740	\N	\N	10218	32553	\N	12-54992_Normal	NA_12-54992_Normal
127741	\N	\N	10219	32554	\N	12-54992_Tumor	NA_12-54992_Tumor
127742	\N	\N	10220	32555	\N	WM3622_Tumor	NA_WM3622_Tumor
127743	\N	\N	10221	32556	\N	WM1963_Tumor	NA_WM1963_Tumor
127744	\N	\N	10222	32557	\N	WM8_Tumor	NA_WM8_Tumor
127745	\N	\N	10223	32558	\N	WM3912_Tumor	NA_WM3912_Tumor
127746	\N	\N	10224	32559	\N	DM11_Tumor	NA_DM11_Tumor
127747	\N	\N	10225	32560	\N	DM11_Normal	NA_DM11_Normal
127748	\N	\N	10226	32561	\N	DM14_Tumor	NA_DM14_Tumor
127749	\N	\N	10227	32562	\N	DM14_Normal	NA_DM14_Normal
127750	\N	\N	10228	32563	\N	DM26_Tumor	NA_DM26_Tumor
127751	\N	\N	10229	32564	\N	DM26_Normal	NA_DM26_Normal
127752	\N	\N	10230	32565	\N	DM28_Tumor	NA_DM28_Tumor
127753	\N	\N	10231	32566	\N	DM28_Normal	NA_DM28_Normal
127754	\N	\N	10232	32567	\N	DM29_Tumor	NA_DM29_Tumor
127755	\N	\N	10233	32568	\N	DM29_Normal	NA_DM29_Normal
127756	\N	\N	10234	32569	\N	DM34_Tumor	NA_DM34_Tumor
127757	\N	\N	10235	32570	\N	DM34_Normal	NA_DM34_Normal
127758	\N	\N	10236	32571	\N	DM55_Tumor	NA_DM55_Tumor
127759	\N	\N	10237	32572	\N	DM55_Normal	NA_DM55_Normal
127760	\N	\N	10238	32573	\N	DM79_Tumor	NA_DM79_Tumor
127761	\N	\N	10239	32574	\N	DM79_Normal	NA_DM79_Normal
127762	\N	\N	10240	32575	\N	11-78845_Tumor	NA_11-78845_Tumor
127763	\N	\N	10241	32576	\N	11-81405_Tumor	NA_11-81405_Tumor
127764	\N	\N	10242	32577	\N	11-85075_Tumor	NA_11-85075_Tumor
127765	\N	\N	10243	32578	\N	11-83908_Tumor	NA_11-83908_Tumor
127766	\N	\N	10244	32579	\N	11-85859_Tumor	NA_11-85859_Tumor
127767	\N	\N	10245	32580	\N	11-95663_Tumor	NA_11-95663_Tumor
127768	\N	\N	10246	32581	\N	DM4_Tumor	NA_DM4_Tumor
127769	\N	\N	10247	32582	\N	DM4_Normal	NA_DM4_Normal
127770	\N	\N	10248	32583	\N	DM95_Tumor	NA_DM95_Tumor
127771	\N	\N	10249	32584	\N	DM95_Normal	NA_DM95_Normal
127776	\N	\N	10254	32589	\N	KIT55_Tumor	NA_KIT55_Tumor
127777	\N	\N	10255	32590	\N	KIT76_Tumor	NA_KIT76_Tumor
127778	\N	\N	10256	32591	\N	W09-1121_Tumor	NA_W09-1121_Tumor
127779	\N	\N	10257	32592	\N	W09-1121_Normal	NA_W09-1121_Normal
127780	\N	\N	10258	32593	\N	W10-143_Tumor	NA_W10-143_Tumor
127781	\N	\N	10259	32594	\N	S94-31062_Tumor	NA_S94-31062_Tumor
127782	\N	\N	10260	32595	\N	S02-23636A02_Tumor	NA_S02-23636A02_Tumor
127783	\N	\N	10261	32596	\N	S02-33818A03_Tumor	NA_S02-33818A03_Tumor
127784	\N	\N	10262	32597	\N	S02-33818A03_Normal	NA_S02-33818A03_Normal
127785	\N	\N	10263	32598	\N	S05-7439A12_Tumor	NA_S05-7439A12_Tumor
127786	\N	\N	10264	32599	\N	S05-41924_Tumor	NA_S05-41924_Tumor
127787	\N	\N	10265	32600	\N	S06-47079A02_Tumor	NA_S06-47079A02_Tumor
127788	\N	\N	10266	32601	\N	S08-4544A03_Tumor	NA_S08-4544A03_Tumor
127789	\N	\N	10267	32602	\N	S10-26316A2_Tumor	NA_S10-26316A2_Tumor
127790	\N	\N	10268	32603	\N	S10-44069A4_Tumor	NA_S10-44069A4_Tumor
127791	\N	\N	10269	32604	\N	S11-38910A2_Tumor	NA_S11-38910A2_Tumor
127792	\N	\N	10270	32605	\N	KIT192_Tumor	NA_KIT192_Tumor
127793	\N	\N	10271	32606	\N	KIT203_Tumor	NA_KIT203_Tumor
127794	\N	\N	10272	32607	\N	KR_166_Tumor	NA_KR_166_Tumor
127795	\N	\N	10273	32608	\N	KR_2064_Tumor	NA_KR_2064_Tumor
127796	\N	\N	10274	32609	\N	KR_2030_Tumor	NA_KR_2030_Tumor
127797	\N	\N	10275	32610	\N	KR_177_Tumor	NA_KR_177_Tumor
127798	\N	\N	10276	32611	\N	KR_150_Tumor	NA_KR_150_Tumor
127799	\N	\N	10277	32612	\N	KR_229_Tumor	NA_KR_229_Tumor
127800	\N	\N	10278	32613	\N	KR_203_Tumor	NA_KR_203_Tumor
127801	\N	\N	10279	32614	\N	KR_8_Tumor	NA_KR_8_Tumor
127802	\N	\N	10280	32615	\N	KR_5233_Tumor	NA_KR_5233_Tumor
127803	\N	\N	10281	32616	\N	KR_RMK0091B_Tumor	NA_KR_RMK0091B_Tumor
127804	\N	\N	10282	32617	\N	KR_RMK0194C_Tumor	NA_KR_RMK0194C_Tumor
127805	\N	\N	10283	32618	\N	KR_RMK0137C_Tumor	NA_KR_RMK0137C_Tumor
127806	\N	\N	10284	32619	\N	KR_RMK0162C_Tumor	NA_KR_RMK0162C_Tumor
127807	\N	\N	10285	32620	\N	KR_RMK0168C_Tumor	NA_KR_RMK0168C_Tumor
127808	\N	\N	10286	32420	\N	10-41439_Normal	NA_10-41439_Normal
127809	\N	\N	10287	32621	\N	11-23681A+C_Normal	NA_11-23681A+C_Normal
127810	\N	\N	10288	32622	\N	DM10_Tumor	NA_DM10_Tumor
127811	\N	\N	10289	32623	\N	DM10_Normal	NA_DM10_Normal
127812	\N	\N	10290	32624	\N	DM17_Tumor	NA_DM17_Tumor
127813	\N	\N	10291	32625	\N	DM17_Normal	NA_DM17_Normal
127814	\N	\N	10292	32626	\N	DM18_Tumor	NA_DM18_Tumor
127815	\N	\N	10293	32627	\N	DM18_Normal	NA_DM18_Normal
127816	\N	\N	10294	32628	\N	DM22_Tumor	NA_DM22_Tumor
127817	\N	\N	10295	32629	\N	DM22_Normal	NA_DM22_Normal
127818	\N	\N	10296	32630	\N	DM23_Tumor	NA_DM23_Tumor
127819	\N	\N	10297	32631	\N	DM23_Normal	NA_DM23_Normal
127820	\N	\N	10298	32632	\N	DM25_Tumor	NA_DM25_Tumor
127821	\N	\N	10299	32633	\N	DM25_Normal	NA_DM25_Normal
127822	\N	\N	10300	32634	\N	DM6_Tumor	NA_DM6_Tumor
127823	\N	\N	10301	32635	\N	DM37_Tumor	NA_DM37_Tumor
127824	\N	\N	10302	32541	\N	DM93_Normal	NA_DM93_Normal
127825	\N	\N	10303	32542	\N	DM93_Tumor	NA_DM93_Tumor
127826	\N	\N	10304	32636	\N	SM_1_Tumor	NA_SM_1_Tumor
127827	\N	\N	10305	32637	\N	SM_3_Tumor	NA_SM_3_Tumor
127828	\N	\N	10306	32638	\N	SM_4_Tumor	NA_SM_4_Tumor
127829	\N	\N	10307	32639	\N	SM_4_Normal	NA_SM_4_Normal
127830	\N	\N	10308	32640	\N	SM_5_Tumor	NA_SM_5_Tumor
127831	\N	\N	10309	32641	\N	SM_5_Normal	NA_SM_5_Normal
127832	\N	\N	10310	32642	\N	SM7_Tumor	NA_SM7_Tumor
127833	\N	\N	10311	32643	\N	SM_8_Tumor	NA_SM_8_Tumor
127834	\N	\N	10312	32644	\N	SM_11_Tumor	NA_SM_11_Tumor
127835	\N	\N	10313	32645	\N	SM_12_Tumor	NA_SM_12_Tumor
127836	\N	\N	10314	32646	\N	SM_16_Tumor	NA_SM_16_Tumor
127837	\N	\N	10315	32647	\N	SM_16_Normal	NA_SM_16_Normal
127838	\N	\N	10316	32648	\N	SM_18_Tumor	NA_SM_18_Tumor
127839	\N	\N	10317	32649	\N	DM42_Tumor	NA_DM42_Tumor
127840	\N	\N	10318	32650	\N	DM43_Tumor	NA_DM43_Tumor
127841	\N	\N	10319	32651	\N	DM48_Tumor	NA_DM48_Tumor
127842	\N	\N	10320	32652	\N	11-64496_Tumor	NA_11-64496_Tumor
127843	\N	\N	10321	32653	\N	11-71491_Tumor	NA_11-71491_Tumor
127844	\N	\N	10322	32654	\N	11-65756_Tumor	NA_11-65756_Tumor
127845	\N	\N	10323	32655	\N	11-74100_Tumor	NA_11-74100_Tumor
127846	\N	\N	10324	32656	\N	11-74517_Tumor	NA_11-74517_Tumor
127847	\N	\N	10325	32657	\N	10-74513_Tumor	NA_10-74513_Tumor
127848	\N	\N	10326	32658	\N	10-80009_Tumor	NA_10-80009_Tumor
127849	\N	\N	10327	32659	\N	10-91484_Tumor	NA_10-91484_Tumor
127850	\N	\N	10328	32660	\N	11-699_Tumor	NA_11-699_Tumor
127851	\N	\N	10329	32661	\N	11-18560_Tumor	NA_11-18560_Tumor
127852	\N	\N	10330	32662	\N	11-20772_Tumor	NA_11-20772_Tumor
127853	\N	\N	10331	32663	\N	11-19877_Tumor	NA_11-19877_Tumor
127854	\N	\N	10332	32664	\N	11-35616_Tumor	NA_11-35616_Tumor
127855	\N	\N	10333	32665	\N	11-33856_Tumor	NA_11-33856_Tumor
127856	\N	\N	10334	32666	\N	11-38771_Tumor	NA_11-38771_Tumor
127857	\N	\N	10335	32667	\N	11-39639_Tumor	NA_11-39639_Tumor
127858	\N	\N	10336	32546	\N	10-88482_Tumor	NA_10-88482_Tumor
127859	\N	\N	10337	32487	\N	11-5482_Tumor	NA_11-5482_Tumor
127860	\N	\N	10338	32442	\N	11-31904_Tumor	NA_11-31904_Tumor
127861	\N	\N	10339	32493	\N	11-61046_Tumor	NA_11-61046_Tumor
127862	\N	\N	10340	32668	\N	08-27590_Tumor	NA_08-27590_Tumor
127863	\N	\N	10341	32669	\N	08-27590_Normal	NA_08-27590_Normal
127864	\N	\N	10342	32670	\N	06-32942_Tumor	NA_06-32942_Tumor
127865	\N	\N	10343	32671	\N	06-52508_Tumor	NA_06-52508_Tumor
127866	\N	\N	10344	32672	\N	06-52508_Normal	NA_06-52508_Normal
127867	\N	\N	10345	32673	\N	07-04365_Tumor	NA_07-04365_Tumor
127868	\N	\N	10346	32674	\N	07-04365_Normal	NA_07-04365_Normal
127869	\N	\N	10347	32675	\N	07-14044A_Tumor	NA_07-14044A_Tumor
127870	\N	\N	10348	32676	\N	07-14044A_Normal	NA_07-14044A_Normal
127871	\N	\N	10349	32677	\N	07-26247_Tumor	NA_07-26247_Tumor
127872	\N	\N	10350	32678	\N	09-37302_Tumor	NA_09-37302_Tumor
127873	\N	\N	10351	32679	\N	12-79358_Tumor	NA_12-79358_Tumor
127874	\N	\N	10352	32680	\N	12-81302_Tumor	NA_12-81302_Tumor
127875	\N	\N	10353	32681	\N	12-81749_Tumor	NA_12-81749_Tumor
127876	\N	\N	10354	32682	\N	12-97031_Tumor	NA_12-97031_Tumor
127877	\N	\N	10355	32683	\N	12-98736_Tumor	NA_12-98736_Tumor
127878	\N	\N	10356	32684	\N	13-3874_Tumor	NA_13-3874_Tumor
127879	\N	\N	10357	32685	\N	13-3732_Tumor	NA_13-3732_Tumor
127880	\N	\N	10358	32686	\N	13-3889_Tumor	NA_13-3889_Tumor
127881	\N	\N	10359	32687	\N	13-4090B_Tumor	NA_13-4090B_Tumor
127882	\N	\N	10360	32688	\N	13-4136_Tumor	NA_13-4136_Tumor
127883	\N	\N	10361	32689	\N	13-7186_Tumor	NA_13-7186_Tumor
127884	\N	\N	10362	32690	\N	13-25A_Tumor	NA_13-25A_Tumor
127885	\N	\N	10363	32691	\N	11-71241_Tumor	NA_11-71241_Tumor
127886	\N	\N	10364	32692	\N	11-26903_Tumor	NA_11-26903_Tumor
127887	\N	\N	10365	32693	\N	11-28912B_Tumor	NA_11-28912B_Tumor
127888	\N	\N	10366	32694	\N	11-5210D_Tumor	NA_11-5210D_Tumor
127889	\N	\N	10367	32695	\N	10-83193_Tumor	NA_10-83193_Tumor
127890	\N	\N	10368	32696	\N	11-95856_Tumor	NA_11-95856_Tumor
127891	\N	\N	10369	32697	\N	10-23569A_Tumor	NA_10-23569A_Tumor
127892	\N	\N	10370	32698	\N	09-92749_Tumor	NA_09-92749_Tumor
127893	\N	\N	10371	32699	\N	09-72944_Tumor	NA_09-72944_Tumor
127894	\N	\N	10372	32700	\N	10-46536_Tumor	NA_10-46536_Tumor
127895	\N	\N	10373	32701	\N	10-83613A_Tumor	NA_10-83613A_Tumor
127896	\N	\N	10374	32702	\N	K1_1_Tumor	NA_K1_1_Tumor
127897	\N	\N	10375	32703	\N	K1_2_Tumor	NA_K1_2_Tumor
127898	\N	\N	10376	32704	\N	K1_3_Tumor	NA_K1_3_Tumor
127899	\N	\N	10377	32705	\N	London-L20_Melanoma	NA_London-L20_Melanoma
127900	\N	\N	10378	32706	\N	London-L20_Normal	NA_London-L20_Normal
127901	\N	\N	10379	32707	\N	London-L20_Nevus	NA_London-L20_Nevus
127902	\N	\N	10380	32708	\N	London-L15_Normal	NA_London-L15_Normal
127903	\N	\N	10381	32709	\N	London-L23C_Nevus	NA_London-L23C_Nevus
127904	\N	\N	10382	32710	\N	K1_9_Tumor	NA_K1_9_Tumor
127905	\N	\N	10383	32711	\N	K1_10_Tumor	NA_K1_10_Tumor
127906	\N	\N	10384	32712	\N	K1_11_Tumor	NA_K1_11_Tumor
127907	\N	\N	10385	32713	\N	K1_12_Tumor	NA_K1_12_Tumor
127908	\N	\N	10386	32714	\N	K1_13_Tumor	NA_K1_13_Tumor
127909	\N	\N	10387	32715	\N	K1_14_Tumor	NA_K1_14_Tumor
127910	\N	\N	10388	32716	\N	K1_15_Tumor	NA_K1_15_Tumor
127911	\N	\N	10389	32717	\N	K1_16_Tumor	NA_K1_16_Tumor
127912	\N	\N	10390	32718	\N	K1_17_Tumor	NA_K1_17_Tumor
127913	\N	\N	10391	32719	\N	K1_18_Tumor	NA_K1_18_Tumor
127914	\N	\N	10392	32720	\N	K1_19_Tumor	NA_K1_19_Tumor
127915	\N	\N	10393	32721	\N	K1_20_Tumor	NA_K1_20_Tumor
127916	\N	\N	10394	32722	\N	10-32987_Tumor	NA_10-32987_Tumor
127917	\N	\N	10395	32723	\N	06-08042_Tumor	NA_06-08042_Tumor
127918	\N	\N	10396	32724	\N	06-00911_Tumor	NA_06-00911_Tumor
127919	\N	\N	10397	32725	\N	06-21363_Tumor	NA_06-21363_Tumor
127920	\N	\N	10398	32726	\N	06-47334_Tumor	NA_06-47334_Tumor
127921	\N	\N	10399	32727	\N	S12-6332A5_Tumor	NA_S12-6332A5_Tumor
127922	\N	\N	10400	32728	\N	S11-032523A1_Tumor	NA_S11-032523A1_Tumor
127923	\N	\N	10401	32729	\N	S08-1463A2_Tumor	NA_S08-1463A2_Tumor
127924	\N	\N	10402	32730	\N	S12-7093NG176-1_Tumor	NA_S12-7093NG176-1_Tumor
127925	\N	\N	10403	32731	\N	S10-7937B2_Tumor	NA_S10-7937B2_Tumor
127926	\N	\N	10404	32732	\N	S11-21025B1_Tumor	NA_S11-21025B1_Tumor
127927	\N	\N	10405	32733	\N	10-58663_Melanoma	NA_10-58663_Melanoma
127928	\N	\N	10406	32733	\N	10-58663_Melanoma	NA_10-58663_Melanoma
127929	\N	\N	10407	32734	\N	10-58663_Nevus	NA_10-58663_Nevus
127930	\N	\N	10408	32734	\N	10-58663_Nevus	NA_10-58663_Nevus
127931	\N	\N	10409	32735	\N	10-58663_Normal	NA_10-58663_Normal
127932	\N	\N	10410	32736	\N	08-52519_Melanoma	NA_08-52519_Melanoma
127933	\N	\N	10411	32736	\N	08-52519_Melanoma	NA_08-52519_Melanoma
127934	\N	\N	10412	32737	\N	08-52519_Nevus	NA_08-52519_Nevus
127935	\N	\N	10413	32737	\N	08-52519_Nevus	NA_08-52519_Nevus
127936	\N	\N	10414	32738	\N	08-52519_Normal	NA_08-52519_Normal
127937	\N	\N	10415	32739	\N	09-8165_Melanoma	NA_09-8165_Melanoma
127938	\N	\N	10416	32739	\N	09-8165_Melanoma	NA_09-8165_Melanoma
127939	\N	\N	10417	32740	\N	09-8165_Nevus	NA_09-8165_Nevus
127940	\N	\N	10418	32740	\N	09-8165_Nevus	NA_09-8165_Nevus
127941	\N	\N	10419	32741	\N	09-8165_Normal	NA_09-8165_Normal
127942	\N	\N	10420	32742	\N	08-46462_Melanoma	NA_08-46462_Melanoma
127943	\N	\N	10421	32742	\N	08-46462_Melanoma	NA_08-46462_Melanoma
127944	\N	\N	10422	32743	\N	08-46462_Nevus	NA_08-46462_Nevus
127945	\N	\N	10423	32743	\N	08-46462_Nevus	NA_08-46462_Nevus
127946	\N	\N	10424	32744	\N	08-46462_Normal	NA_08-46462_Normal
127947	\N	\N	10425	32745	\N	11-25808_Tumor	NA_11-25808_Tumor
127948	\N	\N	10426	32746	\N	11-42027_Tumor	NA_11-42027_Tumor
127949	\N	\N	10427	32747	\N	12-7775_Tumor	NA_12-7775_Tumor
127950	\N	\N	10428	32542	\N	DM93_Tumor	NA_DM93_Tumor
127951	\N	\N	10429	32748	\N	DM37_Normal	NA_DM37_Normal
127952	\N	\N	10430	32749	\N	DM45_Tumor	NA_DM45_Tumor
127953	\N	\N	10431	32750	\N	DM45_Normal	NA_DM45_Normal
127954	\N	\N	10432	32751	\N	DM16_Tumor	NA_DM16_Tumor
127955	\N	\N	10433	32752	\N	DM16_Normal	NA_DM16_Normal
127956	\N	\N	10434	32753	\N	DM77_Tumor	NA_DM77_Tumor
127957	\N	\N	10435	32754	\N	DM77_Normal	NA_DM77_Normal
127958	\N	\N	10436	32432	\N	HW3_Tumor	NA_HW3_Tumor
127959	\N	\N	10437	32460	\N	HW2_Tumor	NA_HW2_Tumor
127960	\N	\N	10438	32755	\N	HWAcr_Tumor	NA_HWAcr_Tumor
127961	\N	\N	10439	32409	\N	KIT181_Tumor	NA_KIT181_Tumor
127962	\N	\N	10440	32538	\N	DM13_Tumor	NA_DM13_Tumor
127963	\N	\N	10441	32756	\N	DM94_Tumor	NA_DM94_Tumor
127964	\N	\N	10442	32757	\N	DM94_Normal	NA_DM94_Normal
127965	\N	\N	10443	32758	\N	DM98_Tumor	NA_DM98_Tumor
127966	\N	\N	10444	32759	\N	DM98_Normal	NA_DM98_Normal
127967	\N	\N	10445	32760	\N	DM99_Tumor	NA_DM99_Tumor
127968	\N	\N	10446	32761	\N	DM99_Normal	NA_DM99_Normal
127969	\N	\N	10447	32762	\N	DM64_Tumor	NA_DM64_Tumor
127970	\N	\N	10448	32763	\N	DM64_Normal	NA_DM64_Normal
127971	\N	\N	10449	32764	\N	DM51_Tumor	NA_DM51_Tumor
127972	\N	\N	10450	32765	\N	DM58_Tumor	NA_DM58_Tumor
127973	\N	\N	10451	32766	\N	DM59_Tumor	NA_DM59_Tumor
127974	\N	\N	10452	32767	\N	DM31_Tumor	NA_DM31_Tumor
127975	\N	\N	10453	32768	\N	DM36_Tumor	NA_DM36_Tumor
127976	\N	\N	10454	32769	\N	DM74_Tumor	NA_DM74_Tumor
127977	\N	\N	10455	32622	\N	DM10_Tumor	NA_DM10_Tumor
127978	\N	\N	10456	32626	\N	DM18_Tumor	NA_DM18_Tumor
127979	\N	\N	10457	32462	\N	HW8_Tumor	NA_HW8_Tumor
127980	\N	\N	10458	32770	\N	08-43264_Melanoma	NA_08-43264_Melanoma
127981	\N	\N	10459	32770	\N	08-43264_Melanoma	NA_08-43264_Melanoma
127982	\N	\N	10460	32771	\N	08-43264_Nevus	NA_08-43264_Nevus
127983	\N	\N	10461	32771	\N	08-43264_Nevus	NA_08-43264_Nevus
127984	\N	\N	10462	32772	\N	08-43264_Normal	NA_08-43264_Normal
127985	\N	\N	10463	32773	\N	08-51219_Melanoma	NA_08-51219_Melanoma
127986	\N	\N	10464	32773	\N	08-51219_Melanoma	NA_08-51219_Melanoma
127987	\N	\N	10465	32774	\N	08-51219_Nevus	NA_08-51219_Nevus
127988	\N	\N	10466	32774	\N	08-51219_Nevus	NA_08-51219_Nevus
127989	\N	\N	10467	32775	\N	08-51219_Normal	NA_08-51219_Normal
127990	\N	\N	10468	32776	\N	S12-18826_Tumor	NA_S12-18826_Tumor
127991	\N	\N	10469	32777	\N	11-81851_Melanoma	NA_11-81851_Melanoma
127992	\N	\N	10470	32777	\N	11-81851_Melanoma	NA_11-81851_Melanoma
127993	\N	\N	10471	32778	\N	11-81851_Nevus	NA_11-81851_Nevus
127994	\N	\N	10472	32778	\N	11-81851_Nevus	NA_11-81851_Nevus
127995	\N	\N	10473	32779	\N	11-81851_Normal	NA_11-81851_Normal
127996	\N	\N	10474	32780	\N	10-73024_Melanoma	NA_10-73024_Melanoma
127997	\N	\N	10475	32780	\N	10-73024_Melanoma	NA_10-73024_Melanoma
127998	\N	\N	10476	32781	\N	10-73024_Nevus	NA_10-73024_Nevus
127999	\N	\N	10477	32781	\N	10-73024_Nevus	NA_10-73024_Nevus
128000	\N	\N	10478	32782	\N	10-73024_Normal	NA_10-73024_Normal
128001	\N	\N	10479	32783	\N	12_M_Tumor	NA_12_M_Tumor
128002	\N	\N	10480	32784	\N	35_M_Tumor	NA_35_M_Tumor
128003	\N	\N	10481	32785	\N	49_M_Tumor	NA_49_M_Tumor
128004	\N	\N	10482	32530	\N	DM2_Tumor	NA_DM2_Tumor
128005	\N	\N	10483	32786	\N	10-0206_Tumor	NA_10-0206_Tumor
128006	\N	\N	10484	32787	\N	09-0209_Tumor	NA_09-0209_Tumor
128007	\N	\N	10485	32788	\N	13-25110A1_Melanoma	NA_13-25110A1_Melanoma
128008	\N	\N	10486	32789	\N	13-25110A1_Nevus	NA_13-25110A1_Nevus
128009	\N	\N	10487	32790	\N	13-25110A1_Normal	NA_13-25110A1_Normal
128010	\N	\N	10488	32791	\N	13-45163_Melanoma	NA_13-45163_Melanoma
128011	\N	\N	10489	32792	\N	13-45163_Nevus	NA_13-45163_Nevus
128012	\N	\N	10490	32793	\N	13-45163_Normal	NA_13-45163_Normal
128013	\N	\N	10491	32794	\N	DM49_Tumor	NA_DM49_Tumor
128014	\N	\N	10492	32795	\N	DP08-21965C_Tumor	NA_DP08-21965C_Tumor
128015	\N	\N	10493	32796	\N	DP08-21965C_Normal	NA_DP08-21965C_Normal
128016	\N	\N	10494	32797	\N	DP08-4205A_Tumor	NA_DP08-4205A_Tumor
128017	\N	\N	10495	32798	\N	DP08-4205A_Normal	NA_DP08-4205A_Normal
128018	\N	\N	10496	32799	\N	11-50182_Tumor	NA_11-50182_Tumor
128019	\N	\N	10497	32800	\N	11-51553_Tumor	NA_11-51553_Tumor
128020	\N	\N	10498	32801	\N	11-52339_Tumor	NA_11-52339_Tumor
128021	\N	\N	10499	32802	\N	11-55993_Tumor	NA_11-55993_Tumor
128022	\N	\N	10500	32803	\N	11-57051_Tumor	NA_11-57051_Tumor
128023	\N	\N	10501	32804	\N	11-71006_Tumor	NA_11-71006_Tumor
128024	\N	\N	10502	32805	\N	11-76464_Tumor	NA_11-76464_Tumor
128025	\N	\N	10503	32806	\N	11-88431_Tumor	NA_11-88431_Tumor
128026	\N	\N	10504	32807	\N	11-88432_Tumor	NA_11-88432_Tumor
128027	\N	\N	10505	32808	\N	11-88209_Tumor	NA_11-88209_Tumor
128028	\N	\N	10506	32809	\N	Thomas_SK_MEL_23_Tumor	NA_Thomas_SK_MEL_23_Tumor
128029	\N	\N	10507	32810	\N	KIT134_Tumor	NA_KIT134_Tumor
128030	\N	\N	10508	32811	\N	KIT191_Tumor	NA_KIT191_Tumor
128031	\N	\N	10509	32812	\N	KIT205_Tumor	NA_KIT205_Tumor
128032	\N	\N	10510	32813	\N	KIT206_Tumor	NA_KIT206_Tumor
128033	\N	\N	10511	32814	\N	KIT210_Tumor	NA_KIT210_Tumor
128034	\N	\N	10512	32815	\N	KIT217_Tumor	NA_KIT217_Tumor
128035	\N	\N	10513	32816	\N	KIT225_Tumor	NA_KIT225_Tumor
128036	\N	\N	10514	32817	\N	KIT244_Tumor	NA_KIT244_Tumor
128037	\N	\N	10515	32818	\N	KIT260_Tumor	NA_KIT260_Tumor
128038	\N	\N	10516	32819	\N	KIT273_Tumor	NA_KIT273_Tumor
128039	\N	\N	10517	32820	\N	KIT295_Tumor	NA_KIT295_Tumor
128040	\N	\N	10518	32821	\N	11-23878_Tumor	NA_11-23878_Tumor
128041	\N	\N	10519	32822	\N	12-11041_Tumor	NA_12-11041_Tumor
128042	\N	\N	10520	32823	\N	12-55584_Tumor	NA_12-55584_Tumor
128043	\N	\N	10521	32824	\N	11-85416_Tumor	NA_11-85416_Tumor
128044	\N	\N	10522	32825	\N	11-94134_Tumor	NA_11-94134_Tumor
128045	\N	\N	10523	32826	\N	12-2898_Tumor	NA_12-2898_Tumor
128046	\N	\N	10524	32827	\N	12-1782_Tumor	NA_12-1782_Tumor
128047	\N	\N	10525	32828	\N	12-4251_Tumor	NA_12-4251_Tumor
128048	\N	\N	10526	32829	\N	12-8171_Tumor	NA_12-8171_Tumor
128049	\N	\N	10527	32830	\N	12-10777_Tumor	NA_12-10777_Tumor
128050	\N	\N	10528	32831	\N	10_63051C_Normal	NA_10_63051C_Normal
128051	\N	\N	10529	32832	\N	DPN8_Normal	NA_DPN8_Normal
128052	\N	\N	10530	32833	\N	DPN9_Normal	NA_DPN9_Normal
128053	\N	\N	10531	32834	\N	DPN18_Normal	NA_DPN18_Normal
128054	\N	\N	10532	32835	\N	11-21178_Tumor	NA_11-21178_Tumor
128055	\N	\N	10533	32836	\N	13-212_Tumor	NA_13-212_Tumor
128056	\N	\N	10534	32769	\N	DM74_Tumor	NA_DM74_Tumor
128057	\N	\N	10535	32760	\N	DM99_Tumor	NA_DM99_Tumor
128058	\N	\N	10536	32837	\N	KIT230_Tumor	NA_KIT230_Tumor
128059	\N	\N	10537	32838	\N	KIT297_Tumor	NA_KIT297_Tumor
128060	\N	\N	10538	32839	\N	KIT302_Tumor	NA_KIT302_Tumor
128061	\N	\N	10539	32840	\N	KIT316_Tumor	NA_KIT316_Tumor
128062	\N	\N	10540	32841	\N	DM6_Normal	NA_DM6_Normal
128063	\N	\N	10541	32842	\N	DM31_Normal	NA_DM31_Normal
128064	\N	\N	10542	32843	\N	DM36_Normal	NA_DM36_Normal
128065	\N	\N	10543	32844	\N	DM42_Normal	NA_DM42_Normal
128066	\N	\N	10544	32845	\N	DM68_Tumor	NA_DM68_Tumor
128067	\N	\N	10545	32622	\N	DM10_Tumor	NA_DM10_Tumor
128068	\N	\N	10546	32623	\N	DM10_Normal	NA_DM10_Normal
128069	\N	\N	10547	32622	\N	DM10_Tumor	NA_DM10_Tumor
128070	\N	\N	10548	32846	\N	11-50270_Tumor	NA_11-50270_Tumor
128071	\N	\N	10549	32847	\N	12-23578_Tumor	NA_12-23578_Tumor
128072	\N	\N	10550	32848	\N	12-31421_Tumor	NA_12-31421_Tumor
128073	\N	\N	10551	32849	\N	11-13661_Tumor	NA_11-13661_Tumor
128074	\N	\N	10552	32850	\N	RC11-001_Tumor	NA_RC11-001_Tumor
128075	\N	\N	10553	32851	\N	RC11-002_Tumor	NA_RC11-002_Tumor
128076	\N	\N	10554	32852	\N	RC11-003_Tumor	NA_RC11-003_Tumor
128077	\N	\N	10555	32853	\N	RC11-004_Tumor	NA_RC11-004_Tumor
128078	\N	\N	10556	32854	\N	RC11-005_Tumor	NA_RC11-005_Tumor
128079	\N	\N	10557	32855	\N	RC11-021_Tumor	NA_RC11-021_Tumor
128080	\N	\N	10558	32856	\N	RC11-022_Tumor	NA_RC11-022_Tumor
128081	\N	\N	10559	32857	\N	RC11-023_Tumor	NA_RC11-023_Tumor
128082	\N	\N	10560	32858	\N	RC11-024_Tumor	NA_RC11-024_Tumor
128083	\N	\N	10561	32859	\N	Kit298_Tumor	NA_Kit298_Tumor
128084	\N	\N	10562	32860	\N	08-46462_Tumor	NA_08-46462_Tumor
128085	\N	\N	10563	32743	\N	08-46462_Nevus	NA_08-46462_Nevus
128086	\N	\N	10564	32860	\N	08-46462_Tumor	NA_08-46462_Tumor
128087	\N	\N	10565	32744	\N	08-46462_Normal	NA_08-46462_Normal
128088	\N	\N	10566	32861	\N	BN_N1_Tumor	NA_BN_N1_Tumor
128089	\N	\N	10567	32862	\N	BN_N2_Tumor	NA_BN_N2_Tumor
128090	\N	\N	10568	32863	\N	BN_M1_Tumor	NA_BN_M1_Tumor
128091	\N	\N	10569	32864	\N	BN_M2_Tumor	NA_BN_M2_Tumor
128092	\N	\N	10570	32769	\N	DM74_Tumor	NA_DM74_Tumor
128093	\N	\N	10571	32622	\N	DM10_Tumor	NA_DM10_Tumor
128094	\N	\N	10572	32865	\N	SQ13-8208B_Tumor	NA_SQ13-8208B_Tumor
128095	\N	\N	10573	32866	\N	98-18400a_Tumor	NA_98-18400a_Tumor
128096	\N	\N	10574	32867	\N	12-11406A_Tumor	NA_12-11406A_Tumor
128097	\N	\N	10575	32868	\N	08-70283a_Tumor	NA_08-70283a_Tumor
128098	\N	\N	10576	32869	\N	03-34051A1_Tumor	NA_03-34051A1_Tumor
128099	\N	\N	10577	32870	\N	02-42436_Tumor	NA_02-42436_Tumor
128100	\N	\N	10578	32871	\N	11-38149_Normal	NA_11-38149_Normal
128101	\N	\N	10579	32872	\N	13-2939B_Tumor	NA_13-2939B_Tumor
128102	\N	\N	10580	32873	\N	L13-48798_Tumor	NA_L13-48798_Tumor
128103	\N	\N	10581	32874	\N	13-51115A_Tumor	NA_13-51115A_Tumor
128104	\N	\N	10582	32875	\N	11-73238A_Normal	NA_11-73238A_Normal
128105	\N	\N	10583	32876	\N	11-73999_Normal	NA_11-73999_Normal
128106	\N	\N	10584	32877	\N	DM43_Normal	NA_DM43_Normal
128107	\N	\N	10585	32878	\N	DM49_Normal	NA_DM49_Normal
128108	\N	\N	10586	32879	\N	DM58_Normal	NA_DM58_Normal
128109	\N	\N	10587	32880	\N	DM65_Tumor	NA_DM65_Tumor
128110	\N	\N	10588	32542	\N	DM93_Tumor	NA_DM93_Tumor
128111	\N	\N	10589	32622	\N	DM10_Tumor	NA_DM10_Tumor
128112	\N	\N	10590	32881	\N	13-59840_Tumor	NA_13-59840_Tumor
128113	\N	\N	10591	32881	\N	13-59840_Tumor	NA_13-59840_Tumor
128114	\N	\N	10592	32882	\N	Seider_Uveal_Tumor	NA_Seider_Uveal_Tumor
128115	\N	\N	10593	32883	\N	Luping_ROS_1_Tumor	NA_Luping_ROS_1_Tumor
128116	\N	\N	10594	32884	\N	Seider_Roe_Tumor	NA_Seider_Roe_Tumor
128117	\N	\N	10595	32795	\N	DP08-21965C_Tumor	NA_DP08-21965C_Tumor
128118	\N	\N	10596	32626	\N	DM18_Tumor	NA_DM18_Tumor
128119	\N	\N	10597	32799	\N	11-50182_Tumor	NA_11-50182_Tumor
128120	\N	\N	10598	32885	\N	11-41004_Tumor	NA_11-41004_Tumor
128121	\N	\N	10599	32886	\N	11-51223_Tumor	NA_11-51223_Tumor
128122	\N	\N	10600	32887	\N	12-22542_Tumor	NA_12-22542_Tumor
128123	\N	\N	10601	32888	\N	12-42406_Tumor	NA_12-42406_Tumor
128124	\N	\N	10602	32889	\N	12-55875_Tumor	NA_12-55875_Tumor
128125	\N	\N	10603	32890	\N	12-88454_Tumor	NA_12-88454_Tumor
128126	\N	\N	10604	32891	\N	12-98328_Tumor	NA_12-98328_Tumor
128127	\N	\N	10605	32690	\N	13-25A_Tumor	NA_13-25A_Tumor
128128	\N	\N	10606	32892	\N	12-762B_Normal	NA_12-762B_Normal
128129	\N	\N	10607	32893	\N	12-168B_Normal	NA_12-168B_Normal
128130	\N	\N	10608	32894	\N	11-75173_Normal	NA_11-75173_Normal
128131	\N	\N	10609	32895	\N	12-167B_Normal	NA_12-167B_Normal
128132	\N	\N	10610	32896	\N	13-47668_Tumor	NA_13-47668_Tumor
128133	\N	\N	10611	32896	\N	13-47668_Tumor	NA_13-47668_Tumor
128134	\N	\N	10612	32897	\N	12-66661_Tumor	NA_12-66661_Tumor
128135	\N	\N	10613	32898	\N	13-47621_Tumor	NA_13-47621_Tumor
128136	\N	\N	10614	32898	\N	13-47621_Tumor	NA_13-47621_Tumor
128137	\N	\N	10615	32899	\N	13-37371_Tumor	NA_13-37371_Tumor
128138	\N	\N	10616	32899	\N	13-37371_Tumor	NA_13-37371_Tumor
128139	\N	\N	10617	32559	\N	DM11_Tumor	NA_DM11_Tumor
128140	\N	\N	10618	32561	\N	DM14_Tumor	NA_DM14_Tumor
128141	\N	\N	10619	32788	\N	13-25110A1_Melanoma	NA_13-25110A1_Melanoma
128142	\N	\N	10620	32790	\N	13-25110A1_Normal	NA_13-25110A1_Normal
128143	\N	\N	10621	32793	\N	13-45163_Normal	NA_13-45163_Normal
128144	\N	\N	10622	32900	\N	Acral-11_Tumor	NA_Acral-11_Tumor
128145	\N	\N	10623	32901	\N	Acral-11_Normal	NA_Acral-11_Normal
128146	\N	\N	10624	32902	\N	Acral-12_Tumor	NA_Acral-12_Tumor
128147	\N	\N	10625	32903	\N	Acral-12_Normal	NA_Acral-12_Normal
128148	\N	\N	10626	32904	\N	02-2599_Tumor	NA_02-2599_Tumor
128149	\N	\N	10627	32904	\N	02-2599_Tumor	NA_02-2599_Tumor
128150	\N	\N	10628	32905	\N	02-2599C_Tumor	NA_02-2599C_Tumor
128151	\N	\N	10629	32904	\N	02-2599_Tumor	NA_02-2599_Tumor
128152	\N	\N	10630	32906	\N	DM48_Normal	NA_DM48_Normal
128153	\N	\N	10631	32907	\N	DM59_Normal	NA_DM59_Normal
128154	\N	\N	10632	32908	\N	DM68_Normal	NA_DM68_Normal
128155	\N	\N	10633	32583	\N	DM95_Tumor	NA_DM95_Tumor
128156	\N	\N	10634	32743	\N	08-46462_Nevus	NA_08-46462_Nevus
128157	\N	\N	10635	32909	\N	08-46462_MIS	NA_08-46462_MIS
128158	\N	\N	10636	32744	\N	08-46462_Normal	NA_08-46462_Normal
128159	\N	\N	10637	32742	\N	08-46462_Melanoma	NA_08-46462_Melanoma
128160	\N	\N	10638	32910	\N	T07-1120_Tumor	NA_T07-1120_Tumor
128161	\N	\N	10639	32911	\N	T09-8069_Tumor	NA_T09-8069_Tumor
128162	\N	\N	10640	32912	\N	T02-16195_Tumor	NA_T02-16195_Tumor
128163	\N	\N	10641	32913	\N	T00-12011_Tumor	NA_T00-12011_Tumor
128164	\N	\N	10642	32914	\N	T06-6855_Tumor	NA_T06-6855_Tumor
128165	\N	\N	10643	32915	\N	12-18832AA_Tumor	NA_12-18832AA_Tumor
128166	\N	\N	10644	32916	\N	CNS52_Tumor	NA_CNS52_Tumor
128167	\N	\N	10645	32917	\N	CNS53_Tumor	NA_CNS53_Tumor
128168	\N	\N	10646	32918	\N	CNS54_Tumor	NA_CNS54_Tumor
128169	\N	\N	10647	32919	\N	CNS57_Tumor	NA_CNS57_Tumor
128170	\N	\N	10648	32920	\N	CNS57_Normal	NA_CNS57_Normal
128171	\N	\N	10649	32921	\N	BN-N1-Tert_Tumor	NA_BN-N1-Tert_Tumor
128172	\N	\N	10650	32922	\N	BN-N2-Tert_Tumor	NA_BN-N2-Tert_Tumor
128173	\N	\N	10651	32923	\N	BN-M1-Tert_Tumor	NA_BN-M1-Tert_Tumor
128174	\N	\N	10652	32771	\N	08-43264_Nevus	NA_08-43264_Nevus
128175	\N	\N	10653	32733	\N	10-58663_Melanoma	NA_10-58663_Melanoma
128176	\N	\N	10654	32924	\N	12-12039B_Tumor	NA_12-12039B_Tumor
128177	\N	\N	10655	32925	\N	12-22776B3_Tumor	NA_12-22776B3_Tumor
128178	\N	\N	10656	32926	\N	99-29482_Tumor	NA_99-29482_Tumor
128179	\N	\N	10657	32927	\N	99-15313_Tumor	NA_99-15313_Tumor
128180	\N	\N	10658	32928	\N	99-885_Tumor	NA_99-885_Tumor
128181	\N	\N	10659	32929	\N	98-37643_Tumor	NA_98-37643_Tumor
128182	\N	\N	10660	32930	\N	13-25288_Tumor	NA_13-25288_Tumor
128183	\N	\N	10661	32931	\N	09-29997_Tumor	NA_09-29997_Tumor
128184	\N	\N	10662	32932	\N	04-11158_Tumor	NA_04-11158_Tumor
128185	\N	\N	10663	32933	\N	UM4_Tumor	NA_UM4_Tumor
128186	\N	\N	10664	32934	\N	UM5_Tumor	NA_UM5_Tumor
128187	\N	\N	10665	32935	\N	08-84352_Melanoma	NA_08-84352_Melanoma
128188	\N	\N	10666	32935	\N	08-84352_Melanoma	NA_08-84352_Melanoma
128189	\N	\N	10667	32936	\N	08-84352_Nevus	NA_08-84352_Nevus
128190	\N	\N	10668	32937	\N	08-84352_Normal	NA_08-84352_Normal
128191	\N	\N	10669	32938	\N	11-88792_Melanoma	NA_11-88792_Melanoma
128192	\N	\N	10670	32938	\N	11-88792_Melanoma	NA_11-88792_Melanoma
128193	\N	\N	10671	32939	\N	11-88792_Nevus	NA_11-88792_Nevus
128194	\N	\N	10672	32939	\N	11-88792_Nevus	NA_11-88792_Nevus
128195	\N	\N	10673	32940	\N	11-88792_Normal	NA_11-88792_Normal
128196	\N	\N	10674	32941	\N	13-74952_Tumor	NA_13-74952_Tumor
128197	\N	\N	10675	32942	\N	13-75067_Tumor	NA_13-75067_Tumor
128198	\N	\N	10676	32943	\N	Spitz_M1_Tumor	NA_Spitz_M1_Tumor
128199	\N	\N	10677	32944	\N	Spitz_M2_(?)_Tumor	NA_Spitz_M2_(?)_Tumor
128200	\N	\N	10678	32945	\N	Spitz_N1_Tumor	NA_Spitz_N1_Tumor
128201	\N	\N	10679	32946	\N	Spitz_N2_Tumor	NA_Spitz_N2_Tumor
128202	\N	\N	10680	32947	\N	Spitz_N3_Tumor	NA_Spitz_N3_Tumor
128203	\N	\N	10681	32948	\N	BN_Normal	NA_BN_Normal
128204	\N	\N	10682	32949	\N	13-159_Tumor	NA_13-159_Tumor
128205	\N	\N	10683	32950	\N	12-43016_Tumor	NA_12-43016_Tumor
128206	\N	\N	10684	32951	\N	13-34291_Tumor	NA_13-34291_Tumor
128207	\N	\N	10685	32952	\N	GAK_DNA_Tumor	NA_GAK_DNA_Tumor
128208	\N	\N	10686	32953	\N	Yurif_DNA_Tumor	NA_Yurif_DNA_Tumor
128209	\N	\N	10687	32900	\N	Acral-11_Tumor	NA_Acral-11_Tumor
128210	\N	\N	10688	32901	\N	Acral-11_Normal	NA_Acral-11_Normal
128211	\N	\N	10689	32954	\N	DPN26_Tumor	NA_DPN26_Tumor
128212	\N	\N	10690	32896	\N	13-47668_Tumor	NA_13-47668_Tumor
128213	\N	\N	10691	32896	\N	13-47668_Tumor	NA_13-47668_Tumor
128214	\N	\N	10692	32898	\N	13-47621_Tumor	NA_13-47621_Tumor
128215	\N	\N	10693	32898	\N	13-47621_Tumor	NA_13-47621_Tumor
128216	\N	\N	10694	32899	\N	13-37371_Tumor	NA_13-37371_Tumor
128217	\N	\N	10695	32899	\N	13-37371_Tumor	NA_13-37371_Tumor
128218	\N	\N	10696	32749	\N	DM45_Tumor	NA_DM45_Tumor
128219	\N	\N	10697	32765	\N	DM58_Tumor	NA_DM58_Tumor
128220	\N	\N	10698	32528	\N	DM1_Tumor	NA_DM1_Tumor
128221	\N	\N	10699	32530	\N	DM2_Tumor	NA_DM2_Tumor
128222	\N	\N	10700	32749	\N	DM45_Tumor	NA_DM45_Tumor
128223	\N	\N	10701	32573	\N	DM79_Tumor	NA_DM79_Tumor
128224	\N	\N	10702	32542	\N	DM93_Tumor	NA_DM93_Tumor
128225	\N	\N	10703	32872	\N	13-2939B_Tumor	NA_13-2939B_Tumor
128226	\N	\N	10704	32955	\N	11-73238A_Tumor	NA_11-73238A_Tumor
128227	\N	\N	10705	32926	\N	99-29482_Tumor	NA_99-29482_Tumor
128228	\N	\N	10706	32930	\N	13-25288_Tumor	NA_13-25288_Tumor
128229	\N	\N	10707	32932	\N	04-11158_Tumor	NA_04-11158_Tumor
128230	\N	\N	10708	32466	\N	10-55707_Tumor	NA_10-55707_Tumor
128231	\N	\N	10709	32467	\N	11-34950_Tumor	NA_11-34950_Tumor
128232	\N	\N	10710	32468	\N	11-8228_Tumor	NA_11-8228_Tumor
128233	\N	\N	10711	32469	\N	11-84681_Tumor	NA_11-84681_Tumor
128234	\N	\N	10712	32799	\N	11-50182_Tumor	NA_11-50182_Tumor
128235	\N	\N	10713	32956	\N	MIN_7_Normal	NA_MIN_7_Normal
128236	\N	\N	10714	32957	\N	MIN_7_Nevus	NA_MIN_7_Nevus
128237	\N	\N	10715	32958	\N	MIN_7_Tumor	NA_MIN_7_Tumor
128238	\N	\N	10716	32959	\N	MIN_8_Normal	NA_MIN_8_Normal
128239	\N	\N	10717	32960	\N	MIN_8_Nevus	NA_MIN_8_Nevus
128240	\N	\N	10718	32961	\N	MIN_8_Tumor	NA_MIN_8_Tumor
128241	\N	\N	10719	32962	\N	501_Mel_Tumor	NA_501_Mel_Tumor
128242	\N	\N	10720	32963	\N	Sk_Mel_1_Tumor	NA_Sk_Mel_1_Tumor
128243	\N	\N	10721	32964	\N	DPN24_Tumor	NA_DPN24_Tumor
128244	\N	\N	10722	32965	\N	DPN28_Tumor	NA_DPN28_Tumor
128245	\N	\N	10723	32966	\N	DPN29_Tumor	NA_DPN29_Tumor
128246	\N	\N	10724	32967	\N	DPN31_Tumor	NA_DPN31_Tumor
128247	\N	\N	10725	32968	\N	DPN33_Tumor	NA_DPN33_Tumor
128248	\N	\N	10726	32969	\N	DPN40_Tumor	NA_DPN40_Tumor
128249	\N	\N	10727	32969	\N	DPN40_Tumor	NA_DPN40_Tumor
128250	\N	\N	10728	32970	\N	DPN41_Tumor	NA_DPN41_Tumor
128251	\N	\N	10729	32971	\N	DPN42_Tumor	NA_DPN42_Tumor
128252	\N	\N	10730	32972	\N	DPN44_Tumor	NA_DPN44_Tumor
128253	\N	\N	10731	32973	\N	DPN45_Tumor	NA_DPN45_Tumor
128254	\N	\N	10732	32974	\N	DPN46_Tumor	NA_DPN46_Tumor
128255	\N	\N	10733	32975	\N	UM_6_Tumor	NA_UM_6_Tumor
128256	\N	\N	10734	32976	\N	Birt_Hogg_Dube_Tumor	NA_Birt_Hogg_Dube_Tumor
128257	\N	\N	10735	32977	\N	13-1939_Tumor	NA_13-1939_Tumor
128258	\N	\N	10736	32978	\N	13-51657_Tumor	NA_13-51657_Tumor
128259	\N	\N	10737	32979	\N	13-89069_Tumor	NA_13-89069_Tumor
128260	\N	\N	10738	32980	\N	11-1051A_Tumor	NA_11-1051A_Tumor
128261	\N	\N	10739	32981	\N	11-5480_Tumor	NA_11-5480_Tumor
128262	\N	\N	10740	32982	\N	10-73024_Tumor	NA_10-73024_Tumor
128263	\N	\N	10741	32782	\N	10-73024_Normal	NA_10-73024_Normal
128264	\N	\N	10742	32983	\N	09-33283_Melanoma	NA_09-33283_Melanoma
128265	\N	\N	10743	32983	\N	09-33283_Melanoma	NA_09-33283_Melanoma
128266	\N	\N	10744	32984	\N	09-33283_Nevus	NA_09-33283_Nevus
128267	\N	\N	10745	32984	\N	09-33283_Nevus	NA_09-33283_Nevus
128268	\N	\N	10746	32985	\N	09-31895_Melanoma	NA_09-31895_Melanoma
128269	\N	\N	10747	32985	\N	09-31895_Melanoma	NA_09-31895_Melanoma
128270	\N	\N	10748	32986	\N	09-31895_Nevus	NA_09-31895_Nevus
128271	\N	\N	10749	32986	\N	09-31895_Nevus	NA_09-31895_Nevus
128272	\N	\N	10750	32987	\N	09-31895_Normal	NA_09-31895_Normal
128273	\N	\N	10751	32988	\N	R29032-05_Tumor	NA_R29032-05_Tumor
128274	\N	\N	10752	32989	\N	R29032-05_Normal	NA_R29032-05_Normal
128275	\N	\N	10753	32990	\N	01-8297_Tumor	NA_01-8297_Tumor
128276	\N	\N	10754	32991	\N	01-8297_Normal	NA_01-8297_Normal
128277	\N	\N	10755	32992	\N	8298-01_Tumor	NA_8298-01_Tumor
128278	\N	\N	10756	32993	\N	8298-01_Normal	NA_8298-01_Normal
128279	\N	\N	10757	32994	\N	08-53951_Melanoma	NA_08-53951_Melanoma
128280	\N	\N	10758	32994	\N	08-53951_Melanoma	NA_08-53951_Melanoma
128281	\N	\N	10759	32995	\N	08-53951_Nevus	NA_08-53951_Nevus
128282	\N	\N	10760	32995	\N	08-53951_Nevus	NA_08-53951_Nevus
128283	\N	\N	10761	32996	\N	13000212_Tumor	NA_13000212_Tumor
128284	\N	\N	10762	32997	\N	8528-05_Tumor	NA_8528-05_Tumor
128285	\N	\N	10763	32998	\N	1286184b_Tumor	NA_1286184b_Tumor
128286	\N	\N	10764	32999	\N	1286184b_Normal	NA_1286184b_Normal
128287	\N	\N	10765	33000	\N	206436_Tumor	NA_206436_Tumor
128288	\N	\N	10766	33001	\N	35942-04_Tumor	NA_35942-04_Tumor
128289	\N	\N	10767	33002	\N	15329-03_Normal	NA_15329-03_Normal
128290	\N	\N	10768	33003	\N	Z1188-03_Tumor	NA_Z1188-03_Tumor
128291	\N	\N	10769	33004	\N	1185-03_Normal	NA_1185-03_Normal
128292	\N	\N	10770	33005	\N	14514-02_Tumor	NA_14514-02_Tumor
128293	\N	\N	10771	33006	\N	15102-02_Normal	NA_15102-02_Normal
128294	\N	\N	10772	33007	\N	9116-05_Tumor	NA_9116-05_Tumor
128295	\N	\N	10773	33008	\N	24516-06_Tumor	NA_24516-06_Tumor
128296	\N	\N	10774	33009	\N	24516-06_Normal	NA_24516-06_Normal
128297	\N	\N	10775	33010	\N	07-3078_Tumor	NA_07-3078_Tumor
128298	\N	\N	10776	33011	\N	B06-37358_Tumor	NA_B06-37358_Tumor
128299	\N	\N	10777	33012	\N	21590_Tumor	NA_21590_Tumor
128300	\N	\N	10778	33013	\N	21590_Normal	NA_21590_Normal
128301	\N	\N	10779	33014	\N	A2A79@_Tumor	NA_A2A79@_Tumor
128302	\N	\N	10780	33015	\N	356A3-075_Tumor	NA_356A3-075_Tumor
128303	\N	\N	10781	33016	\N	20847-09_Normal	NA_20847-09_Normal
128304	\N	\N	10782	33017	\N	525_Tumor	NA_525_Tumor
128305	\N	\N	10783	33018	\N	PMM_23_Tumor	NA_PMM_23_Tumor
128306	\N	\N	10784	33019	\N	PMM_23_Normal	NA_PMM_23_Normal
128307	\N	\N	10785	33020	\N	UM7_Tumor	NA_UM7_Tumor
128308	\N	\N	10786	33021	\N	UM8_Tumor	NA_UM8_Tumor
128309	\N	\N	10787	33022	\N	UM9_Tumor	NA_UM9_Tumor
128310	\N	\N	10788	33023	\N	UM10_Tumor	NA_UM10_Tumor
128311	\N	\N	10789	33024	\N	UM11_Tumor	NA_UM11_Tumor
128312	\N	\N	10790	33025	\N	Xanthoma_Disseminatum_Tumor	NA_Xanthoma_Disseminatum_Tumor
128313	\N	\N	10791	32927	\N	99-15313_Tumor	NA_99-15313_Tumor
128314	\N	\N	10792	32929	\N	98-37643_Tumor	NA_98-37643_Tumor
128315	\N	\N	10793	32931	\N	09-29997_Tumor	NA_09-29997_Tumor
128316	\N	\N	10794	33026	\N	13-94981_Tumor	NA_13-94981_Tumor
128317	\N	\N	10795	33027	\N	13-99411A_Tumor	NA_13-99411A_Tumor
128318	\N	\N	10796	33028	\N	13-94484_Tumor	NA_13-94484_Tumor
128319	\N	\N	10797	33029	\N	DM27_Tumor	NA_DM27_Tumor
128320	\N	\N	10798	33030	\N	DM32_Tumor	NA_DM32_Tumor
128321	\N	\N	10799	33031	\N	DM35_Tumor	NA_DM35_Tumor
128322	\N	\N	10800	33032	\N	DM40_Tumor	NA_DM40_Tumor
128323	\N	\N	10801	32421	\N	11-23681_Melanoma	NA_11-23681_Melanoma
128324	\N	\N	10802	32421	\N	11-23681_Melanoma	NA_11-23681_Melanoma
128325	\N	\N	10803	33033	\N	H01.10457/II_Primary	NA_H01.10457/II_Primary
128326	\N	\N	10804	33034	\N	H01.10457/II_Normal	NA_H01.10457/II_Normal
128327	\N	\N	10805	33035	\N	14.20/II_Met1	NA_14.20/II_Met1
128328	\N	\N	10806	33036	\N	HS14.18/I_Met2	NA_HS14.18/I_Met2
128329	\N	\N	10807	33037	\N	HS14.19/D_Primary	NA_HS14.19/D_Primary
128330	\N	\N	10808	33038	\N	HS14.19/D_Nevus	NA_HS14.19/D_Nevus
128331	\N	\N	10809	33039	\N	HS2014.15/7_Met1	NA_HS2014.15/7_Met1
128332	\N	\N	10810	33040	\N	HS2014.15/7_Normal	NA_HS2014.15/7_Normal
128333	\N	\N	10811	33041	\N	HS14.16_Primary	NA_HS14.16_Primary
128334	\N	\N	10812	33042	\N	HS14.16_Normal	NA_HS14.16_Normal
128335	\N	\N	10813	33043	\N	HS14.17/I_Met1	NA_HS14.17/I_Met1
128336	\N	\N	10814	33044	\N	Long-TN1_Normal	NA_Long-TN1_Normal
128337	\N	\N	10815	33045	\N	Long-TN1_Tumor	NA_Long-TN1_Tumor
128338	\N	\N	10816	33046	\N	Long-TN2_Normal	NA_Long-TN2_Normal
128339	\N	\N	10817	33047	\N	Long-TN2_Tumor	NA_Long-TN2_Tumor
128340	\N	\N	10818	33048	\N	D326_Tumor	NA_D326_Tumor
128341	\N	\N	10819	33048	\N	D326_Tumor	NA_D326_Tumor
128342	\N	\N	10820	33049	\N	D366_Tumor	NA_D366_Tumor
128343	\N	\N	10821	33049	\N	D366_Tumor	NA_D366_Tumor
128344	\N	\N	10822	33050	\N	DPN48_Tumor	NA_DPN48_Tumor
128345	\N	\N	10823	33051	\N	11-2532_Tumor	NA_11-2532_Tumor
128346	\N	\N	10824	33052	\N	AST-1_Tumor	NA_AST-1_Tumor
128347	\N	\N	10825	33053	\N	08-18595B_Tumor	NA_08-18595B_Tumor
128348	\N	\N	10826	33054	\N	13-60273_Tumor	NA_13-60273_Tumor
128349	\N	\N	10827	33055	\N	12-52454_Tumor	NA_12-52454_Tumor
128350	\N	\N	10828	33056	\N	12-75125_Tumor	NA_12-75125_Tumor
128351	\N	\N	10829	33057	\N	12-98235A_Tumor	NA_12-98235A_Tumor
128352	\N	\N	10830	33058	\N	13-3619B_Tumor	NA_13-3619B_Tumor
128353	\N	\N	10831	33059	\N	13-67500AL_Normal	NA_13-67500AL_Normal
128354	\N	\N	10832	33060	\N	13-19205_Tumor	NA_13-19205_Tumor
128355	\N	\N	10833	33061	\N	13-48330_Tumor	NA_13-48330_Tumor
128356	\N	\N	10834	33062	\N	13-11086_Tumor	NA_13-11086_Tumor
128357	\N	\N	10835	33063	\N	13-15966_Tumor	NA_13-15966_Tumor
128358	\N	\N	10836	33064	\N	13-39228_Tumor	NA_13-39228_Tumor
128359	\N	\N	10837	33065	\N	13-45942_Tumor	NA_13-45942_Tumor
128360	\N	\N	10838	33066	\N	13-49600_Tumor	NA_13-49600_Tumor
128361	\N	\N	10839	33067	\N	13-59640_Tumor	NA_13-59640_Tumor
128362	\N	\N	10840	33068	\N	13-67817_Tumor	NA_13-67817_Tumor
128363	\N	\N	10841	33069	\N	SP-12-5612(1K)_Normal	NA_SP-12-5612(1K)_Normal
128364	\N	\N	10842	33070	\N	SP-13-14992(1A)_Tumor	NA_SP-13-14992(1A)_Tumor
128365	\N	\N	10843	33071	\N	SP-12-2294-2(2A)_Normal	NA_SP-12-2294-2(2A)_Normal
128366	\N	\N	10844	33072	\N	SP-13-17075(1B)_Tumor	NA_SP-13-17075(1B)_Tumor
128367	\N	\N	10845	33073	\N	SP-42-10361(1A)_Normal	NA_SP-42-10361(1A)_Normal
128368	\N	\N	10846	33074	\N	SP-13-1038(1A)_Tumor	NA_SP-13-1038(1A)_Tumor
128470	\N	\N	10948	33163	\N	DM66_Tumor	NA_DM66_Tumor
128369	\N	\N	10847	33075	\N	S13-13286A6_Tumor	NA_S13-13286A6_Tumor
128370	\N	\N	10848	33076	\N	S13-13286A6_Normal	NA_S13-13286A6_Normal
128371	\N	\N	10849	33077	\N	S11-20884A-A1_Tumor	NA_S11-20884A-A1_Tumor
128372	\N	\N	10850	33078	\N	S11-20884A-A1_Normal	NA_S11-20884A-A1_Normal
128373	\N	\N	10851	33079	\N	S12-6218A-D3_Tumor	NA_S12-6218A-D3_Tumor
128374	\N	\N	10852	33080	\N	S12-6218A-D3_Normal	NA_S12-6218A-D3_Normal
128375	\N	\N	10853	33081	\N	ZS06-11249A-C2_Tumor	NA_ZS06-11249A-C2_Tumor
128376	\N	\N	10854	33082	\N	S12-26125A2_Tumor	NA_S12-26125A2_Tumor
128377	\N	\N	10855	33083	\N	S12-28585A6_Tumor	NA_S12-28585A6_Tumor
128378	\N	\N	10856	33084	\N	S11-2018B5_Tumor	NA_S11-2018B5_Tumor
128379	\N	\N	10857	33085	\N	S13-11748F5_Tumor	NA_S13-11748F5_Tumor
128380	\N	\N	10858	33086	\N	S12-7250E3_Tumor	NA_S12-7250E3_Tumor
128381	\N	\N	10859	33087	\N	S13-3401B3_Tumor	NA_S13-3401B3_Tumor
128382	\N	\N	10860	33088	\N	S13-12947A2_Tumor	NA_S13-12947A2_Tumor
128383	\N	\N	10861	33089	\N	S13-18444A16_Tumor	NA_S13-18444A16_Tumor
128384	\N	\N	10862	33090	\N	ZS07-1210F6_Tumor	NA_ZS07-1210F6_Tumor
128385	\N	\N	10863	33091	\N	ZS10-11930B12_Tumor	NA_ZS10-11930B12_Tumor
128386	\N	\N	10864	33092	\N	S12-28988_Tumor	NA_S12-28988_Tumor
128387	\N	\N	10865	33093	\N	SSS13-1652B2_Tumor	NA_SSS13-1652B2_Tumor
128388	\N	\N	10866	33094	\N	S13-5249_Tumor	NA_S13-5249_Tumor
128389	\N	\N	10867	33015	\N	356A3-075_Tumor	NA_356A3-075_Tumor
128390	\N	\N	10868	33016	\N	20847-09_Normal	NA_20847-09_Normal
128391	\N	\N	10869	33095	\N	London-L1_Normal	NA_London-L1_Normal
128392	\N	\N	10870	33096	\N	London-L1_Nevus	NA_London-L1_Nevus
128393	\N	\N	10871	33097	\N	London-L1_MIS	NA_London-L1_MIS
128394	\N	\N	10872	33098	\N	London-L1_Melanoma	NA_London-L1_Melanoma
128395	\N	\N	10873	33099	\N	London-L14_Normal	NA_London-L14_Normal
128396	\N	\N	10874	33100	\N	London-L14_Nevus	NA_London-L14_Nevus
128397	\N	\N	10875	33100	\N	London-L14_Nevus	NA_London-L14_Nevus
128398	\N	\N	10876	33101	\N	London-L14_Melanoma	NA_London-L14_Melanoma
128399	\N	\N	10877	33101	\N	London-L14_Melanoma	NA_London-L14_Melanoma
128400	\N	\N	10878	33101	\N	London-L14_Melanoma	NA_London-L14_Melanoma
128401	\N	\N	10879	33102	\N	London-L14C_Normal	NA_London-L14C_Normal
128402	\N	\N	10880	33103	\N	London-L14C_Intermediate	NA_London-L14C_Intermediate
128403	\N	\N	10881	33104	\N	08-79358_Melanoma	NA_08-79358_Melanoma
128404	\N	\N	10882	33104	\N	08-79358_Melanoma	NA_08-79358_Melanoma
128405	\N	\N	10883	33105	\N	08-79358_Nevus	NA_08-79358_Nevus
128406	\N	\N	10884	33106	\N	08-79358_Normal	NA_08-79358_Normal
128407	\N	\N	10885	33107	\N	09-45509_Melanoma	NA_09-45509_Melanoma
128408	\N	\N	10886	33107	\N	09-45509_Melanoma	NA_09-45509_Melanoma
128409	\N	\N	10887	33108	\N	09-45509_Nevus	NA_09-45509_Nevus
128410	\N	\N	10888	33109	\N	09-45509_Normal	NA_09-45509_Normal
128411	\N	\N	10889	33110	\N	DM50_Tumor	NA_DM50_Tumor
128412	\N	\N	10890	33111	\N	DM56_Tumor	NA_DM56_Tumor
128413	\N	\N	10891	33112	\N	11-94204_Melanoma	NA_11-94204_Melanoma
128414	\N	\N	10892	33113	\N	11-94204_Nevus	NA_11-94204_Nevus
128415	\N	\N	10893	33114	\N	11-94204_Normal	NA_11-94204_Normal
128416	\N	\N	10894	33115	\N	London-L10_Normal	NA_London-L10_Normal
128417	\N	\N	10895	33116	\N	London-L10_MIS	NA_London-L10_MIS
128418	\N	\N	10896	33117	\N	London-L10_Melanoma	NA_London-L10_Melanoma
128419	\N	\N	10897	33118	\N	London-L10_Intermediate	NA_London-L10_Intermediate
128420	\N	\N	10898	33119	\N	London-L12_Normal	NA_London-L12_Normal
128421	\N	\N	10899	33120	\N	London-L12_Nevus	NA_London-L12_Nevus
128422	\N	\N	10900	33121	\N	London-L12_Intermediate	NA_London-L12_Intermediate
128423	\N	\N	10901	33122	\N	London-L16_Nevus	NA_London-L16_Nevus
128424	\N	\N	10902	33123	\N	London-L16_Melanoma	NA_London-L16_Melanoma
128425	\N	\N	10903	33124	\N	London-L16A_Normal	NA_London-L16A_Normal
128426	\N	\N	10904	33125	\N	London-L16A_Nevus	NA_London-L16A_Nevus
128427	\N	\N	10905	33126	\N	London-L16A_Melanoma	NA_London-L16A_Melanoma
128428	\N	\N	10906	33127	\N	London-L16B_Intermediate	NA_London-L16B_Intermediate
128429	\N	\N	10907	33127	\N	London-L16B_Intermediate	NA_London-L16B_Intermediate
128430	\N	\N	10908	33128	\N	London-L16B_Normal	NA_London-L16B_Normal
128431	\N	\N	10909	33129	\N	DM15_Tumor	NA_DM15_Tumor
128432	\N	\N	10910	33130	\N	DM19_Tumor	NA_DM19_Tumor
128433	\N	\N	10911	33130	\N	DM19_Tumor	NA_DM19_Tumor
128434	\N	\N	10912	33131	\N	DM46_Tumor	NA_DM46_Tumor
128435	\N	\N	10913	33132	\N	140038340_Tumor	NA_140038340_Tumor
128436	\N	\N	10914	33133	\N	140092090_Normal	NA_140092090_Normal
128437	\N	\N	10915	33134	\N	UM13_Tumor	NA_UM13_Tumor
128438	\N	\N	10916	33135	\N	UM14_Tumor	NA_UM14_Tumor
128439	\N	\N	10917	33136	\N	UM16_Tumor	NA_UM16_Tumor
128440	\N	\N	10918	33137	\N	London-L17_Normal	NA_London-L17_Normal
128441	\N	\N	10919	33138	\N	London-L17_Nevus	NA_London-L17_Nevus
128442	\N	\N	10920	33138	\N	London-L17_Nevus	NA_London-L17_Nevus
128443	\N	\N	10921	33139	\N	London-L17_Melanoma	NA_London-L17_Melanoma
128444	\N	\N	10922	33139	\N	London-L17_Melanoma	NA_London-L17_Melanoma
128445	\N	\N	10923	33140	\N	GAK_Tumor	NA_GAK_Tumor
128446	\N	\N	10924	33141	\N	Yurif_Tumor	NA_Yurif_Tumor
128447	\N	\N	10925	32995	\N	08-53951_Nevus	NA_08-53951_Nevus
128448	\N	\N	10926	33142	\N	08-53951_M1	NA_08-53951_M1
128449	\N	\N	10927	33143	\N	08-53951_M2	NA_08-53951_M2
128450	\N	\N	10928	33144	\N	London-L18_Normal	NA_London-L18_Normal
128451	\N	\N	10929	33145	\N	London-L18_Nevus	NA_London-L18_Nevus
128452	\N	\N	10930	33146	\N	London-L18_Melanoma	NA_London-L18_Melanoma
128453	\N	\N	10931	33146	\N	London-L18_Melanoma	NA_London-L18_Melanoma
128454	\N	\N	10932	33147	\N	London-L21_MIS	NA_London-L21_MIS
128455	\N	\N	10933	33148	\N	London-L21_Intermediate	NA_London-L21_Intermediate
128456	\N	\N	10934	33149	\N	London-L21_Normal	NA_London-L21_Normal
128457	\N	\N	10935	33150	\N	14-16247_Tumor	NA_14-16247_Tumor
128458	\N	\N	10936	33151	\N	13-35959_Tumor	NA_13-35959_Tumor
128459	\N	\N	10937	33152	\N	13-102610_Tumor	NA_13-102610_Tumor
128460	\N	\N	10938	33153	\N	13-99417_Tumor	NA_13-99417_Tumor
128461	\N	\N	10939	33154	\N	13-98534_Tumor	NA_13-98534_Tumor
128462	\N	\N	10940	33155	\N	13-32982A_Tumor	NA_13-32982A_Tumor
128463	\N	\N	10941	33156	\N	13-9916_Tumor	NA_13-9916_Tumor
128464	\N	\N	10942	33157	\N	11-44609F_Tumor	NA_11-44609F_Tumor
128465	\N	\N	10943	33158	\N	12-98575A1_Tumor	NA_12-98575A1_Tumor
128466	\N	\N	10944	33159	\N	DM60_Tumor	NA_DM60_Tumor
128467	\N	\N	10945	33160	\N	DM61_Tumor	NA_DM61_Tumor
128468	\N	\N	10946	33161	\N	DM62_Tumor	NA_DM62_Tumor
128469	\N	\N	10947	33162	\N	DM63_Tumor	NA_DM63_Tumor
128471	\N	\N	10949	33164	\N	DM67_Tumor	NA_DM67_Tumor
128472	\N	\N	10950	33165	\N	DM69_Tumor	NA_DM69_Tumor
128473	\N	\N	10951	33166	\N	DM70_Tumor	NA_DM70_Tumor
128474	\N	\N	10952	33167	\N	DM81_Tumor	NA_DM81_Tumor
128475	\N	\N	10953	33168	\N	London-L2_Normal	NA_London-L2_Normal
128476	\N	\N	10954	33169	\N	London-L2_Intermediate	NA_London-L2_Intermediate
128477	\N	\N	10955	33170	\N	London-L3_Normal	NA_London-L3_Normal
128478	\N	\N	10956	33171	\N	London-L3_Intermediate	NA_London-L3_Intermediate
128479	\N	\N	10957	33172	\N	S12-27617B9_Normal	NA_S12-27617B9_Normal
128480	\N	\N	10958	33173	\N	S12-25164A_Tumor	NA_S12-25164A_Tumor
128481	\N	\N	10959	33174	\N	S12-25164C1_Tumor	NA_S12-25164C1_Tumor
128482	\N	\N	10960	33175	\N	London-L19_Normal	NA_London-L19_Normal
128483	\N	\N	10961	33176	\N	London-L19_Nevus	NA_London-L19_Nevus
128484	\N	\N	10962	33177	\N	London-L19_Melanoma	NA_London-L19_Melanoma
128485	\N	\N	10963	33178	\N	London-L19E_Normal	NA_London-L19E_Normal
128486	\N	\N	10964	33179	\N	London-L19E_Nevus	NA_London-L19E_Nevus
128487	\N	\N	10965	33180	\N	London-L19E_Melanoma	NA_London-L19E_Melanoma
128488	\N	\N	10966	33181	\N	London-L22_MIS	NA_London-L22_MIS
128489	\N	\N	10967	33182	\N	London-L22_Melanoma	NA_London-L22_Melanoma
128490	\N	\N	10968	33183	\N	London-L22_Normal	NA_London-L22_Normal
128491	\N	\N	10969	33184	\N	London-L23_Melanoma	NA_London-L23_Melanoma
128492	\N	\N	10970	33185	\N	London-L23C_Normal	NA_London-L23C_Normal
128493	\N	\N	10971	33186	\N	London-L23C_Melanoma	NA_London-L23C_Melanoma
128494	\N	\N	10972	33187	\N	London-L23D_Normal	NA_London-L23D_Normal
128495	\N	\N	10973	33188	\N	London-L23D_Intermediate	NA_London-L23D_Intermediate
128496	\N	\N	10974	33189	\N	London-L6_Normal	NA_London-L6_Normal
128497	\N	\N	10975	33190	\N	London-L6_Nevus	NA_London-L6_Nevus
128498	\N	\N	10976	33190	\N	London-L6_Nevus	NA_London-L6_Nevus
128499	\N	\N	10977	33191	\N	XD-2_Tumor	NA_XD-2_Tumor
128500	\N	\N	10978	33192	\N	XD-2_Normal	NA_XD-2_Normal
128501	\N	\N	10979	33193	\N	SP-13-006364_Normal	NA_SP-13-006364_Normal
128502	\N	\N	10980	33194	\N	SP-14-001249_Tumor	NA_SP-14-001249_Tumor
128503	\N	\N	10981	33195	\N	SP-13-0185993A_Normal	NA_SP-13-0185993A_Normal
128504	\N	\N	10982	33196	\N	SP-13-0185992B_Tumor	NA_SP-13-0185992B_Tumor
128505	\N	\N	10983	33197	\N	SP-12-003309B_Normal	NA_SP-12-003309B_Normal
128506	\N	\N	10984	33198	\N	SP-13-0212981A_Tumor	NA_SP-13-0212981A_Tumor
128507	\N	\N	10985	33199	\N	SP-13-0068754A_Normal	NA_SP-13-0068754A_Normal
128508	\N	\N	10986	33200	\N	SP-13-0068751C_Tumor	NA_SP-13-0068751C_Tumor
128509	\N	\N	10987	33201	\N	SP-07-0116602_Normal	NA_SP-07-0116602_Normal
128510	\N	\N	10988	33202	\N	12GS-2466_Tumor	NA_12GS-2466_Tumor
128511	\N	\N	10989	33203	\N	SP-09-0150202A_Normal	NA_SP-09-0150202A_Normal
128512	\N	\N	10990	33204	\N	SP-13-006535C_Tumor	NA_SP-13-006535C_Tumor
128513	\N	\N	10991	33205	\N	SP-10-003167A_Normal	NA_SP-10-003167A_Normal
128514	\N	\N	10992	33206	\N	SP-13-009897_Tumor	NA_SP-13-009897_Tumor
128515	\N	\N	10993	33207	\N	SP-12-0087723B_Normal	NA_SP-12-0087723B_Normal
128516	\N	\N	10994	33208	\N	SP-12-020017C_Tumor	NA_SP-12-020017C_Tumor
128517	\N	\N	10995	33209	\N	SP-12-0032671A_Normal	NA_SP-12-0032671A_Normal
128518	\N	\N	10996	33210	\N	SP-13-006337A_Tumor	NA_SP-13-006337A_Tumor
128519	\N	\N	10997	33211	\N	SP-12-0228802A_Normal	NA_SP-12-0228802A_Normal
128520	\N	\N	10998	33212	\N	SP-12-0228801A_Tumor	NA_SP-12-0228801A_Tumor
128521	\N	\N	10999	33213	\N	SP-12-0146612A_Normal	NA_SP-12-0146612A_Normal
128522	\N	\N	11000	33214	\N	SP-12-01466111A_Tumor	NA_SP-12-01466111A_Tumor
128523	\N	\N	11001	33215	\N	SP-10-004335_Normal	NA_SP-10-004335_Normal
128524	\N	\N	11002	33216	\N	SP-13-000848_Tumor	NA_SP-13-000848_Tumor
128525	\N	\N	11003	33217	\N	M230_Tumor	NA_M230_Tumor
128526	\N	\N	11004	33218	\N	M257_Tumor	NA_M257_Tumor
128527	\N	\N	11005	33219	\N	M285_Tumor	NA_M285_Tumor
128528	\N	\N	11006	33220	\N	M368_Tumor	NA_M368_Tumor
128529	\N	\N	11007	33221	\N	M375_Tumor	NA_M375_Tumor
128530	\N	\N	11008	33222	\N	M418_Tumor	NA_M418_Tumor
128531	\N	\N	11009	33223	\N	C8161_Tumor	NA_C8161_Tumor
128532	\N	\N	11010	33224	\N	London-L4_Normal	NA_London-L4_Normal
128533	\N	\N	11011	33225	\N	London-L4_Nevus	NA_London-L4_Nevus
128534	\N	\N	11012	33226	\N	London-L5_Normal	NA_London-L5_Normal
128535	\N	\N	11013	33227	\N	London-L5_Nevus	NA_London-L5_Nevus
128536	\N	\N	11014	33228	\N	London-L8_Normal	NA_London-L8_Normal
128537	\N	\N	11015	33229	\N	London-L8_Nevus	NA_London-L8_Nevus
128538	\N	\N	11016	33230	\N	London-L9_Normal	NA_London-L9_Normal
128539	\N	\N	11017	33231	\N	London-L9_Intermediate	NA_London-L9_Intermediate
128540	\N	\N	11018	33232	\N	London-L13_Normal	NA_London-L13_Normal
128541	\N	\N	11019	33233	\N	London-L13_Intermediate	NA_London-L13_Intermediate
128542	\N	\N	11020	33233	\N	London-L13_Intermediate	NA_London-L13_Intermediate
128543	\N	\N	11021	33234	\N	London-L15_Nevus	NA_London-L15_Nevus
128544	\N	\N	11022	33235	\N	London-L15_Melanoma	NA_London-L15_Melanoma
128545	\N	\N	11023	33236	\N	1212_Tumor	NA_1212_Tumor
128546	\N	\N	11024	33237	\N	1213_Tumor	NA_1213_Tumor
128547	\N	\N	11025	33238	\N	1214_Tumor	NA_1214_Tumor
128548	\N	\N	11026	33239	\N	3860_Tumor	NA_3860_Tumor
128549	\N	\N	11027	32988	\N	R29032-05_Tumor	NA_R29032-05_Tumor
128550	\N	\N	11028	32990	\N	01-8297_Tumor	NA_01-8297_Tumor
128551	\N	\N	11029	32992	\N	8298-01_Tumor	NA_8298-01_Tumor
128552	\N	\N	11030	33003	\N	Z1188-03_Tumor	NA_Z1188-03_Tumor
128553	\N	\N	11031	33008	\N	24516-06_Tumor	NA_24516-06_Tumor
128554	\N	\N	11032	33240	\N	UM17_Tumor	NA_UM17_Tumor
128555	\N	\N	11033	33241	\N	S12-23475A6_Normal	NA_S12-23475A6_Normal
128556	\N	\N	11034	33242	\N	S12-23475A4_Tumor	NA_S12-23475A4_Tumor
128557	\N	\N	11035	33243	\N	S12-23475C1_Tumor	NA_S12-23475C1_Tumor
128558	\N	\N	11036	33244	\N	13-21725_Normal	NA_13-21725_Normal
128559	\N	\N	11037	33245	\N	SP-14-68521D_Tumor	NA_SP-14-68521D_Tumor
128560	\N	\N	11038	33246	\N	SP-13-208365A_Normal	NA_SP-13-208365A_Normal
128561	\N	\N	11039	33247	\N	SP-14-36134A_Tumor	NA_SP-14-36134A_Tumor
128562	\N	\N	11040	33248	\N	SP-14-73676A_Normal	NA_SP-14-73676A_Normal
128563	\N	\N	11041	33249	\N	SP-14-73671M_Tumor	NA_SP-14-73671M_Tumor
128564	\N	\N	11042	33250	\N	SP-14-7691A_Normal	NA_SP-14-7691A_Normal
128565	\N	\N	11043	33251	\N	SP-14-7691A_Tumor	NA_SP-14-7691A_Tumor
128566	\N	\N	11044	33252	\N	WM3928F_Tumor	NA_WM3928F_Tumor
128567	\N	\N	11045	33253	\N	C037_Tumor	NA_C037_Tumor
128568	\N	\N	11046	33254	\N	C022_Tumor	NA_C022_Tumor
128569	\N	\N	11047	32705	\N	London-L20_Melanoma	NA_London-L20_Melanoma
128570	\N	\N	11048	32706	\N	London-L20_Normal	NA_London-L20_Normal
128571	\N	\N	11049	32707	\N	London-L20_Nevus	NA_London-L20_Nevus
128572	\N	\N	11050	32708	\N	London-L15_Normal	NA_London-L15_Normal
128573	\N	\N	11051	32709	\N	London-L23C_Nevus	NA_London-L23C_Nevus
128574	\N	\N	11052	33255	\N	UM15_Tumor	NA_UM15_Tumor
128575	\N	\N	11053	33256	\N	UM19_Tumor	NA_UM19_Tumor
128576	\N	\N	11054	33257	\N	UM20_Tumor	NA_UM20_Tumor
128577	\N	\N	11055	33258	\N	CP-1_Tumor	NA_CP-1_Tumor
128578	\N	\N	11056	33259	\N	CP-2_Tumor	NA_CP-2_Tumor
128579	\N	\N	11057	33260	\N	CP-3_Tumor	NA_CP-3_Tumor
128580	\N	\N	11058	33261	\N	CP-4_Tumor	NA_CP-4_Tumor
128581	\N	\N	11059	33262	\N	CP-5_Tumor	NA_CP-5_Tumor
128582	\N	\N	11060	33263	\N	CP-6_Tumor	NA_CP-6_Tumor
128583	\N	\N	11061	33264	\N	14-18_Tumor	NA_14-18_Tumor
128584	\N	\N	11062	33265	\N	14-19_Tumor	NA_14-19_Tumor
128585	\N	\N	11063	33266	\N	14-21_Tumor	NA_14-21_Tumor
128586	\N	\N	11064	33267	\N	XD-1_Tumor	NA_XD-1_Tumor
128587	\N	\N	11065	33268	\N	XD-1.1_Tumor	NA_XD-1.1_Tumor
128588	\N	\N	11066	33269	\N	PMM-8_Tumor	NA_PMM-8_Tumor
128589	\N	\N	11067	33270	\N	Long-TN10_Normal	NA_Long-TN10_Normal
128590	\N	\N	11068	33271	\N	Long-TN10_Tumor	NA_Long-TN10_Tumor
128591	\N	\N	11069	33272	\N	Long-TN11_Normal	NA_Long-TN11_Normal
128592	\N	\N	11070	33273	\N	Long-TN11_Tumor	NA_Long-TN11_Tumor
128593	\N	\N	11071	33274	\N	JBP-3_Normal	NA_JBP-3_Normal
128594	\N	\N	11072	33275	\N	JBP-3-MM_Tumor	NA_JBP-3-MM_Tumor
128595	\N	\N	11073	33276	\N	JBP-3-Met1_Tumor	NA_JBP-3-Met1_Tumor
128596	\N	\N	11074	33277	\N	S12-15765B3_Tumor	NA_S12-15765B3_Tumor
128597	\N	\N	11075	33278	\N	S12-4365A8_Normal	NA_S12-4365A8_Normal
128598	\N	\N	11076	33279	\N	S12-4365A7_Tumor	NA_S12-4365A7_Tumor
128599	\N	\N	11077	33280	\N	S12-4365B1_Tumor	NA_S12-4365B1_Tumor
128600	\N	\N	11078	33281	\N	S12-4365C1_Tumor	NA_S12-4365C1_Tumor
128601	\N	\N	11079	33282	\N	S12-9606C4_Normal	NA_S12-9606C4_Normal
128602	\N	\N	11080	33283	\N	S12-9606EE_Tumor	NA_S12-9606EE_Tumor
128603	\N	\N	11081	33284	\N	S12-9606A2_Tumor	NA_S12-9606A2_Tumor
128604	\N	\N	11082	33285	\N	ZS10-972C2_Normal	NA_ZS10-972C2_Normal
128605	\N	\N	11083	33286	\N	ZS10-972A9_Tumor	NA_ZS10-972A9_Tumor
128606	\N	\N	11084	33287	\N	JBP-7-Met_Tumor	NA_JBP-7-Met_Tumor
128607	\N	\N	11085	33288	\N	ZS10-1843A5_Normal	NA_ZS10-1843A5_Normal
128608	\N	\N	11086	33289	\N	ZS10-8439A4_Tumor	NA_ZS10-8439A4_Tumor
128609	\N	\N	11087	33290	\N	ZS10-1843A4_Tumor	NA_ZS10-1843A4_Tumor
128610	\N	\N	11088	33291	\N	ZS10-10558B1_Normal	NA_ZS10-10558B1_Normal
128611	\N	\N	11089	33292	\N	ZS10-10558A10_Tumor	NA_ZS10-10558A10_Tumor
128612	\N	\N	11090	33293	\N	ZS10-10558C1_Tumor	NA_ZS10-10558C1_Tumor
128613	\N	\N	11091	33294	\N	ZS10-3560F1_Normal	NA_ZS10-3560F1_Normal
128614	\N	\N	11092	33295	\N	ZS10-3560A3_Tumor	NA_ZS10-3560A3_Tumor
128615	\N	\N	11093	33296	\N	ZS10-3560C1_Tumor	NA_ZS10-3560C1_Tumor
128616	\N	\N	11094	33297	\N	UM23_Tumor	NA_UM23_Tumor
128617	\N	\N	11095	33298	\N	UM24_Tumor	NA_UM24_Tumor
128618	\N	\N	11096	33299	\N	UM25_Tumor	NA_UM25_Tumor
128619	\N	\N	11097	33300	\N	UM26_Tumor	NA_UM26_Tumor
128620	\N	\N	11098	33301	\N	TCR-Beta-1_Tumor	NA_TCR-Beta-1_Tumor
128621	\N	\N	11099	33302	\N	TCR-Beta-2_Tumor	NA_TCR-Beta-2_Tumor
128622	\N	\N	11100	31214	\N	CP1-80_Tumor	NA_CP1-80_Tumor
128623	\N	\N	11101	31213	\N	CP1-40_Tumor	NA_CP1-40_Tumor
128624	\N	\N	11102	31212	\N	CP1-20_Tumor	NA_CP1-20_Tumor
128625	\N	\N	11103	31211	\N	CP1-10_Tumor	NA_CP1-10_Tumor
128626	\N	\N	11104	31210	\N	CP1-5_Tumor	NA_CP1-5_Tumor
128627	\N	\N	11105	31209	\N	CP1_Normal	NA_CP1_Normal
128628	\N	\N	11106	33303	\N	SMU10-0457_Tumor	NA_SMU10-0457_Tumor
128629	\N	\N	11107	33304	\N	SMU10-0206_Tumor	NA_SMU10-0206_Tumor
128630	\N	\N	11108	33305	\N	SMU10-0240_Tumor	NA_SMU10-0240_Tumor
128631	\N	\N	11109	33306	\N	SCC10-0092_Tumor	NA_SCC10-0092_Tumor
128632	\N	\N	11110	33307	\N	MASCRI-432_Tumor	NA_MASCRI-432_Tumor
128633	\N	\N	11111	33308	\N	RPA08-0209_Tumor	NA_RPA08-0209_Tumor
128634	\N	\N	11112	33309	\N	RPA08-0315_Tumor	NA_RPA08-0315_Tumor
128635	\N	\N	11113	33310	\N	NZM52_Tumor	NA_NZM52_Tumor
128636	\N	\N	11114	33311	\N	NZM40_Tumor	NA_NZM40_Tumor
128637	\N	\N	11115	33312	\N	NZM91_Tumor	NA_NZM91_Tumor
128638	\N	\N	11116	33313	\N	SP-13-198211A_Tumor	NA_SP-13-198211A_Tumor
128639	\N	\N	11117	33314	\N	RNS11P15316B1_Normal	NA_RNS11P15316B1_Normal
128640	\N	\N	11118	33315	\N	9246581-A3_Tumor	NA_9246581-A3_Tumor
128641	\N	\N	11119	33316	\N	9246581-A6_Normal	NA_9246581-A6_Normal
128642	\N	\N	11120	33317	\N	DHM4855-14MP_Tumor	NA_DHM4855-14MP_Tumor
128643	\N	\N	11121	33318	\N	SNPN08289D_Normal	NA_SNPN08289D_Normal
128644	\N	\N	11122	33319	\N	SP-10-143551E_Tumor	NA_SP-10-143551E_Tumor
128645	\N	\N	11123	33320	\N	SP-10-143552A_Normal	NA_SP-10-143552A_Normal
128646	\N	\N	11124	33321	\N	04-SW-12-31366B1_Tumor	NA_04-SW-12-31366B1_Tumor
128647	\N	\N	11125	33322	\N	04-SW-12-31366B6_Normal	NA_04-SW-12-31366B6_Normal
128648	\N	\N	11126	33323	\N	SP-13-63011A_Tumor	NA_SP-13-63011A_Tumor
128649	\N	\N	11127	33324	\N	SP-11-160493A_Normal	NA_SP-11-160493A_Normal
128650	\N	\N	11128	33325	\N	SP-13-87981B_Tumor	NA_SP-13-87981B_Tumor
128651	\N	\N	11129	33326	\N	SP-11-40641B_Normal	NA_SP-11-40641B_Normal
128652	\N	\N	11130	33327	\N	SP-14-125801B_Tumor	NA_SP-14-125801B_Tumor
128653	\N	\N	11131	33328	\N	SP-14-125802A_Normal	NA_SP-14-125802A_Normal
128654	\N	\N	11132	33329	\N	WCRS97-025628_Tumor	NA_WCRS97-025628_Tumor
128655	\N	\N	11133	33330	\N	SCHS10-026422_Tumor	NA_SCHS10-026422_Tumor
128656	\N	\N	11134	33331	\N	SROS12-001198_Tumor	NA_SROS12-001198_Tumor
128657	\N	\N	11135	33332	\N	SROS09-001574_Tumor	NA_SROS09-001574_Tumor
128658	\N	\N	11136	33333	\N	SCHS09-005840-B5_Tumor	NA_SCHS09-005840-B5_Tumor
128659	\N	\N	11137	33334	\N	SACS05-011507_Tumor	NA_SACS05-011507_Tumor
128660	\N	\N	11138	33335	\N	FRSS09-009402-A1_Tumor	NA_FRSS09-009402-A1_Tumor
128661	\N	\N	11139	33336	\N	RCHS07-000380-B1_Tumor	NA_RCHS07-000380-B1_Tumor
128662	\N	\N	11140	33337	\N	SROS11-005030_Tumor	NA_SROS11-005030_Tumor
128663	\N	\N	11141	33338	\N	VALS09-000266_Tumor	NA_VALS09-000266_Tumor
128664	\N	\N	11142	33339	\N	SFOS09-007093_Tumor	NA_SFOS09-007093_Tumor
128665	\N	\N	11143	33340	\N	FRSS09-008805_Tumor	NA_FRSS09-008805_Tumor
128666	\N	\N	11144	33341	\N	RCHS06-004567_Tumor	NA_RCHS06-004567_Tumor
128667	\N	\N	11145	33342	\N	VALS05-014946-E_Tumor	NA_VALS05-014946-E_Tumor
128668	\N	\N	11146	33343	\N	SCHS08-007754_Tumor	NA_SCHS08-007754_Tumor
128669	\N	\N	11147	33344	\N	SFOS12-018173_Tumor	NA_SFOS12-018173_Tumor
128670	\N	\N	11148	33345	\N	SROS00-001103_Tumor	NA_SROS00-001103_Tumor
128671	\N	\N	11149	33346	\N	MTZS94-007340_Tumor	NA_MTZS94-007340_Tumor
128672	\N	\N	11150	33347	\N	SFOS94-003116_Tumor	NA_SFOS94-003116_Tumor
128673	\N	\N	11151	33348	\N	SACS93-027850_Tumor	NA_SACS93-027850_Tumor
128674	\N	\N	11152	33349	\N	SCLS91-006557_Tumor	NA_SCLS91-006557_Tumor
128675	\N	\N	11153	33350	\N	OAKS90-012369_Tumor	NA_OAKS90-012369_Tumor
128676	\N	\N	11154	33351	\N	HAYS02-005731_Tumor	NA_HAYS02-005731_Tumor
128677	\N	\N	11155	33352	\N	SRFS97-002805_Tumor	NA_SRFS97-002805_Tumor
128678	\N	\N	11156	33353	\N	VALS03-019832_Tumor	NA_VALS03-019832_Tumor
128679	\N	\N	11157	33354	\N	SSCS03-014369_Tumor	NA_SSCS03-014369_Tumor
128680	\N	\N	11158	33355	\N	RCHS01-003684_Tumor	NA_RCHS01-003684_Tumor
128681	\N	\N	11159	33356	\N	WCRS99-012800_Tumor	NA_WCRS99-012800_Tumor
128682	\N	\N	11160	33357	\N	HAYS90-005154_Tumor	NA_HAYS90-005154_Tumor
128683	\N	\N	11161	33358	\N	SFOS00-016989_Tumor	NA_SFOS00-016989_Tumor
128684	\N	\N	11162	33359	\N	VALS03-007457_Tumor	NA_VALS03-007457_Tumor
128685	\N	\N	11163	33360	\N	SFO93-005184_Tumor	NA_SFO93-005184_Tumor
128686	\N	\N	11164	33361	\N	DHM50691-14MP5C_Tumor	NA_DHM50691-14MP5C_Tumor
128687	\N	\N	11165	33362	\N	DHM50691-14MP3_Normal	NA_DHM50691-14MP3_Normal
128688	\N	\N	11166	33363	\N	RNS14P13907B1_Tumor	NA_RNS14P13907B1_Tumor
128689	\N	\N	11167	33364	\N	SP-10-197431A_Normal	NA_SP-10-197431A_Normal
128690	\N	\N	11168	33365	\N	DHM57444-14MP_Tumor	NA_DHM57444-14MP_Tumor
128691	\N	\N	11169	33366	\N	SP-12-177322A_Normal	NA_SP-12-177322A_Normal
128692	\N	\N	11170	33367	\N	DHM94457-13SK_Tumor	NA_DHM94457-13SK_Tumor
128693	\N	\N	11171	33368	\N	DHM48742-12MPE_Normal	NA_DHM48742-12MPE_Normal
128694	\N	\N	11172	33369	\N	Laverty13-88354_Tumor	NA_Laverty13-88354_Tumor
128695	\N	\N	11173	33370	\N	ICPMR19684.13A11_Normal	NA_ICPMR19684.13A11_Normal
128696	\N	\N	11174	33371	\N	SP-13-15691B_Tumor	NA_SP-13-15691B_Tumor
128697	\N	\N	11175	33372	\N	SP-13-15691D_Normal	NA_SP-13-15691D_Normal
128698	\N	\N	11176	33373	\N	57059699_Tumor	NA_57059699_Tumor
128699	\N	\N	11177	33374	\N	57269600_Tumor	NA_57269600_Tumor
128700	\N	\N	11178	33375	\N	57213442_Tumor	NA_57213442_Tumor
128701	\N	\N	11179	33376	\N	57346060_Tumor	NA_57346060_Tumor
128702	\N	\N	11180	33377	\N	SROS10-009251_Tumor	NA_SROS10-009251_Tumor
128703	\N	\N	11181	33378	\N	FRSS99-007026_Tumor	NA_FRSS99-007026_Tumor
128704	\N	\N	11182	33379	\N	SCLS04-001045_Tumor	NA_SCLS04-001045_Tumor
128705	\N	\N	11183	33380	\N	OAKS96-014392-G_Tumor	NA_OAKS96-014392-G_Tumor
128706	\N	\N	11184	33381	\N	OAKS96-022398_Tumor	NA_OAKS96-022398_Tumor
128707	\N	\N	11185	33382	\N	OAK84-008979-B_Tumor	NA_OAK84-008979-B_Tumor
128708	\N	\N	11186	33383	\N	ROSS09-022626-A1_Tumor	NA_ROSS09-022626-A1_Tumor
128709	\N	\N	11187	33384	\N	SCHS11-018842-A1_Tumor	NA_SCHS11-018842-A1_Tumor
128710	\N	\N	11188	33385	\N	SSCS03-004945_Tumor	NA_SSCS03-004945_Tumor
128711	\N	\N	11189	33386	\N	WCRS02-022688_Tumor	NA_WCRS02-022688_Tumor
128712	\N	\N	11190	33387	\N	SACS02-020334_Tumor	NA_SACS02-020334_Tumor
128713	\N	\N	11191	33388	\N	HAYS98-001046_Tumor	NA_HAYS98-001046_Tumor
128714	\N	\N	11192	33389	\N	SACS88-019073_Tumor	NA_SACS88-019073_Tumor
128715	\N	\N	11193	33390	\N	SACS87-010145_Tumor	NA_SACS87-010145_Tumor
128716	\N	\N	11194	33391	\N	STRS91-006237_Tumor	NA_STRS91-006237_Tumor
128717	\N	\N	11195	33392	\N	SSCS92-009981_Tumor	NA_SSCS92-009981_Tumor
128718	\N	\N	11196	33393	\N	14-59304A_Normal	NA_14-59304A_Normal
128719	\N	\N	11197	33394	\N	14-59304A_Nevus	NA_14-59304A_Nevus
128720	\N	\N	11198	33395	\N	13-48020_Normal	NA_13-48020_Normal
128721	\N	\N	11199	33396	\N	13-48020_Nevus	NA_13-48020_Nevus
128722	\N	\N	11200	33397	\N	14-13499_Normal	NA_14-13499_Normal
128723	\N	\N	11201	33398	\N	14-13499_Nevus	NA_14-13499_Nevus
128724	\N	\N	11202	33399	\N	13-64515B_Normal	NA_13-64515B_Normal
128725	\N	\N	11203	33400	\N	13-64515B_Nevus	NA_13-64515B_Nevus
128726	\N	\N	11204	33401	\N	13-64515B_Tumor	NA_13-64515B_Tumor
128727	\N	\N	11205	33402	\N	14-22939_Nevus	NA_14-22939_Nevus
128728	\N	\N	11206	33403	\N	14-22939_Tumor	NA_14-22939_Tumor
128729	\N	\N	11207	33404	\N	13-61146_Normal	NA_13-61146_Normal
128730	\N	\N	11208	33405	\N	13-61146_Nevus	NA_13-61146_Nevus
128731	\N	\N	11209	33406	\N	13-61146_Tumor	NA_13-61146_Tumor
128732	\N	\N	11210	33407	\N	57001550_Tumor	NA_57001550_Tumor
128733	\N	\N	11211	33408	\N	57291680_Tumor	NA_57291680_Tumor
128734	\N	\N	11212	33409	\N	London-L3_Tumor	NA_London-L3_Tumor
128735	\N	\N	11213	33410	\N	London-L13_Tumor	NA_London-L13_Tumor
128736	\N	\N	11214	33409	\N	London-L3_Tumor	NA_London-L3_Tumor
128737	\N	\N	11215	33409	\N	London-L3_Tumor	NA_London-L3_Tumor
128738	\N	\N	11216	33409	\N	London-L3_Tumor	NA_London-L3_Tumor
128739	\N	\N	11217	33409	\N	London-L3_Tumor	NA_London-L3_Tumor
128740	\N	\N	11218	33410	\N	London-L13_Tumor	NA_London-L13_Tumor
128741	\N	\N	11219	33410	\N	London-L13_Tumor	NA_London-L13_Tumor
128742	\N	\N	11220	33411	\N	UM33_Tumor	NA_UM33_Tumor
128743	\N	\N	11221	33412	\N	UM35_A_Tumor	NA_UM35_A_Tumor
128744	\N	\N	11222	33413	\N	UM39_Tumor	NA_UM39_Tumor
128745	\N	\N	11223	33414	\N	UM40_Tumor	NA_UM40_Tumor
128746	\N	\N	11224	33415	\N	UM41_Tumor	NA_UM41_Tumor
128747	\N	\N	11225	33416	\N	UM36_Tumor	NA_UM36_Tumor
128748	\N	\N	11226	33417	\N	UM37_Tumor	NA_UM37_Tumor
128749	\N	\N	11227	33410	\N	London-L13_Tumor	NA_London-L13_Tumor
128750	\N	\N	11228	33418	\N	57715138_Tumor	NA_57715138_Tumor
128751	\N	\N	11229	33418	\N	57715138_Tumor	NA_57715138_Tumor
128752	\N	\N	11230	33419	\N	332771_Tumor	NA_332771_Tumor
128753	\N	\N	11231	33420	\N	57723220_Tumor	NA_57723220_Tumor
128754	\N	\N	11232	33421	\N	55875588_Tumor	NA_55875588_Tumor
128755	\N	\N	11233	33422	\N	57714581_Tumor	NA_57714581_Tumor
128756	\N	\N	11234	33423	\N	UM47_Tumor	NA_UM47_Tumor
128757	\N	\N	11235	33424	\N	UM47_Normal	NA_UM47_Normal
128758	\N	\N	11236	33425	\N	Sample_KAM1-T_Tumor	NA_Sample_KAM1-T_Tumor
128759	\N	\N	11237	33426	\N	Sample_KAM106-T_Tumor	NA_Sample_KAM106-T_Tumor
128760	\N	\N	11238	33427	\N	Sample_KAM12-T_Tumor	NA_Sample_KAM12-T_Tumor
128761	\N	\N	11239	33428	\N	Sample_KAM121-T-B_Tumor	NA_Sample_KAM121-T-B_Tumor
128762	\N	\N	11240	33429	\N	Sample_KAM20-T_Tumor	NA_Sample_KAM20-T_Tumor
128763	\N	\N	11241	33430	\N	Sample_KAM3-T-A_Tumor	NA_Sample_KAM3-T-A_Tumor
128764	\N	\N	11242	33431	\N	Sample_KAM35-T_Tumor	NA_Sample_KAM35-T_Tumor
128765	\N	\N	11243	33432	\N	Sample_KAM38-T-B_Tumor	NA_Sample_KAM38-T-B_Tumor
128766	\N	\N	11244	33433	\N	Sample_KAM53-T_Tumor	NA_Sample_KAM53-T_Tumor
128767	\N	\N	11245	33434	\N	Sample_KAM61-T_Tumor	NA_Sample_KAM61-T_Tumor
128768	\N	\N	11246	33435	\N	Sample_KAM7-T_Tumor	NA_Sample_KAM7-T_Tumor
128769	\N	\N	11247	33436	\N	Sample_KAM78-T-III_Tumor	NA_Sample_KAM78-T-III_Tumor
128770	\N	\N	11248	33437	\N	Sample_KAM82-T-B8_Tumor	NA_Sample_KAM82-T-B8_Tumor
128771	\N	\N	11249	33438	\N	Sample_KAM84-T_Tumor	NA_Sample_KAM84-T_Tumor
128772	\N	\N	11250	33439	\N	Sample_KAM94-T_Tumor	NA_Sample_KAM94-T_Tumor
128773	\N	\N	11251	33440	\N	Sample_KAM96-T_Tumor	NA_Sample_KAM96-T_Tumor
\.


--
-- Data for Name: areas; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.areas (ar_id, name, area_type, completion_date, image, notes, block, _blockname) FROM stdin;
1575	1575 	\N	\N	\N	Do NOT use these nucleic acids, Mel1 and Mel2 were pooled by error.	\N	K8-B
2136	2136 	\N	\N	\N	\N	\N	18-97419C
2163	2163 	\N	\N	\N	Progression Cases.	\N	11-49127
3903	3903 	\N	\N	\N	\N	\N	\N
3931	3931 	\N	\N	\N	\N	\N	\N
3932	3932 	\N	\N	\N	\N	\N	\N
3934	3934 	\N	\N	\N	\N	\N	\N
3933	3933 	\N	\N	\N	\N	\N	\N
3935	3935 	\N	\N	\N	\N	\N	\N
3937	3937 	\N	\N	\N	\N	\N	\N
3936	3936 	\N	\N	\N	\N	\N	\N
3938	3938 	\N	\N	\N	\N	\N	\N
1	1 Normal	Normal	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H09.22183/1
6	6 Normal	Normal	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H14.26934/2
9	9 Normal	Normal	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H15.19121/7
12	12 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86502b
15	15 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	78821-1c
20	20 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	also on block 534-1-11.3	\N	534-1-11.2
22	22 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86541-2c
25	25 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79447-d
28	28 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	also on block 79049-2a	\N	79049-1a
31	31 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	352-1-15.1
35	35 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	2686-1-13.1
38	38 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	1586-2-13-C
42	42 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	385/14
46	46 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	4070/2/13.1
49	49 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	501950A3
52	52 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
58	58 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	604076
62	62 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	488836A
65	65 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.660
68	68 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.215/5
72	72 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/3
78	78 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K1-D
82	82 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K2-D
85	85 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	19111/14.2
89	89 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	21159 G2
92	92 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
97	97 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-C
103	103 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-D
280	280 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22139,25172	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-109659A4
286	286 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=930	\N	\N	17-26457
302	302 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22154	\N	\N	17-68446
283	283 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22140	\N	\N	16-84820
289	289 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24928	\N	\N	16-106975
304	304 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22138	\N	\N	16-107007
305	305 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22147	\N	\N	17-33401C
345	345 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22144	\N	\N	17-130286
354	354 Normal	Normal	\N	\N	\N	\N	16-101803B
729	729 Normal	Normal	\N	\N	\N	\N	18-68921A
778	778 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-61310
783	783 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-43703
786	786 Normal	Normal	\N	\N	\N	\N	17-32863B
790	790 Normal	Normal	\N	\N	\N	\N	17-31440
792	792 Normal	Normal	\N	\N	\N	\N	17-36409
797	797 Normal	Normal	\N	\N	\N	\N	17-61108
804	804 Normal	Normal	\N	\N	\N	\N	16-88453A
883	883 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.14.04
894	894 Normal	Normal	\N	\N	\N	\N	17-125030
895	895 Normal	Normal	\N	\N	\N	\N	17-88262
980	980 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.08.05
981	981 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.13.04
983	983 Normal	Normal	\N	\N	\N	\N	19Rig750007.02.03.03
984	984 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.02.05
982	982 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.15.03
986	986 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.07.05
987	987 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.08.05
985	985 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.04.03
988	988 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.11.03
989	989 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.12.05
990	990 Normal	Normal	\N	\N	\N	\N	19Rig750007.04.07.09
991	991 Normal	Normal	\N	\N	\N	\N	19Rig750007.04.12.08
992	992 Normal	Normal	\N	\N	\N	\N	19Rig750007.04.13.08
993	993 Normal	Normal	\N	\N	\N	\N	19Rig750007.05.05.08
994	994 Normal	Normal	\N	\N	\N	\N	19Rig750007.05.06.10
995	995 Normal	Normal	\N	\N	\N	\N	19Rig750007.05.13.09
996	996 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.07.03
1147	1147 Normal	Normal	\N	\N	\N	\N	501950A3
1243	1243 Normal	Normal	\N	\N	\N	\N	K23-D
1288	1288 Normal	Normal	\N	\N	\N	\N	H18.7977
1291	1291 Normal	Normal	\N	\N	\N	\N	2686-1-13.2
1292	1292 Normal	Normal	\N	\N	\N	\N	H13.10897/2
1295	1295 Normal	Normal	\N	\N	\N	\N	H13.21587/1
1302	1302 Normal	Normal	\N	\N	\N	\N	H12.27716/7
1305	1305 Normal	Normal	\N	\N	\N	\N	H2007.4636/9
1311	1311 Normal	Normal	\N	\N	\N	\N	07-2104
1422	1422 Normal	Normal	\N	\N	\N	\N	B2007.998/2
1425	1425 Normal	Normal	\N	\N	\N	\N	B2007.15494/1
1430	1430 Normal	Normal	\N	\N	\N	\N	16-105218C
1431	1431 Normal	Normal	\N	\N	\N	\N	19-135629A
1432	1432 Normal	Normal	\N	\N	\N	\N	17-27224
1433	1433 Normal	Normal	\N	\N	\N	\N	17-62026B
1434	1434 Normal	Normal	\N	\N	\N	\N	17-55182C
1438	1438 Normal	Normal	\N	\N	\N	\N	12-3277
1446	1446 Normal	Normal	\N	\N	\N	\N	06-72820A
1447	1447 Normal	Normal	\N	\N	\N	\N	17-99365
1448	1448 Normal	Normal	\N	\N	\N	\N	16-108259C
1449	1449 Normal	Normal	\N	\N	\N	\N	16-104614H
1450	1450 Normal	Normal	\N	\N	\N	\N	17-83378D
1451	1451 Normal	Normal	\N	\N	\N	\N	17-95052A
1470	1470 Normal	Normal	\N	\N	\N	\N	13-30315A3
1478	1478 Normal	Normal	\N	\N	15-17010C, 15-17010A2	\N	15-17010C1
1490	1490 Normal	Normal	\N	\N	\N	\N	12-24189A1
1497	1497 Normal	Normal	\N	\N	\N	\N	11-36301A5
1503	1503 Normal	Normal	\N	\N	\N	\N	10-18253B
1507	1507 Normal	Normal	\N	\N	\N	\N	10-17734
1510	1510 Normal	Normal	\N	\N	\N	\N	10-13619
1521	1521 Normal	Normal	\N	\N	\N	\N	15-3736C5
1523	1523 Normal	Normal	\N	\N	Merge: AM2-097-1, and AM2-097-2	\N	15-4505A1
1526	1526 Normal	Normal	\N	\N	Merge: AM2-097-1, and AM2-097-2	\N	15-4505B
1535	1535 Normal	Normal	\N	\N	Merge:  Both Normal from AM2-099-3	\N	14-37577A5
1541	1541 Normal	Normal	\N	\N	\N	\N	15-48543A1
1547	1547 Normal	Normal	\N	\N	\N	\N	15-26253A1
1552	1552 Normal	Normal	\N	\N	Merge: AM2-102-1, AM2-102-5-2, AM2-102-5-1	\N	16-552A7
1564	1564 Normal	Normal	\N	\N	Merge: AM2-102-1, AM2-102-5-2, AM2-102-5-1	\N	17-14203A1
1566	1566 Normal	Normal	\N	\N	Merge: AM2-102-1, AM2-102-5-2, AM2-102-5-1	\N	17-14203A2
1569	1569 Normal	Normal	\N	\N	\N	\N	16-10035A3
1581	1581 Normal	Normal	\N	\N	\N	\N	18-22781A1
1584	1584 Normal	Normal	\N	\N	\N	\N	18-35014A1
1591	1591 Normal	Normal	\N	\N	\N	\N	19-44348A1
1593	1593 Normal	Normal	\N	\N	\N	\N	19-52004A1
1604	1604 Normal	Normal	\N	\N	\N	\N	20-28721A1
1608	1608 Normal	Normal	\N	\N	\N	\N	16-35844B2
1611	1611 Normal	Normal	\N	\N	\N	\N	20-26269A1
1612	1612 Normal	Normal	\N	\N	\N	\N	15-3736C1
1613	1613 Normal	Normal	\N	\N	\N	\N	16-21256
1614	1614 Normal	Normal	\N	\N	\N	\N	18-28886
1615	1615 Normal	Normal	\N	\N	\N	\N	B62056/15
1616	1616 Normal	Normal	\N	\N	\N	\N	B2008.3067/5
1617	1617 Normal	Normal	\N	\N	\N	\N	H16.5818/2
1624	1624 Normal	Normal	\N	\N	\N	\N	14-31886
1649	1649 Normal	Normal	\N	\N	\N	\N	99-14477
1654	1654 Normal	Normal	\N	\N	\N	\N	08-51663
1656	1656 Normal	Normal	\N	\N	\N	\N	05-66206A
1659	1659 Normal	Normal	\N	\N	\N	\N	06-4069
1663	1663 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1668	1668 Normal	Normal	\N	\N	\N	\N	95-5908
1670	1670 Normal	Normal	\N	\N	\N	\N	04-31313A
1673	1673 Normal	Normal	\N	\N	\N	\N	09-23922A
1676	1676 Normal	Normal	\N	\N	\N	\N	09-23922B
1679	1679 Normal	Normal	\N	\N	\N	\N	13-14077
1683	1683 Normal	Normal	\N	\N	\N	\N	08-1851A
1685	1685 Normal	Normal	\N	\N	\N	\N	08-1851C
1687	1687 Normal	Normal	\N	\N	\N	\N	07-67657A
1690	1690 Normal	Normal	\N	\N	\N	\N	13-32289A
1696	1696 Normal	Normal	\N	\N	\N	\N	03-57585A
1698	1698 Normal	Normal	\N	\N	\N	\N	03-57585E
1702	1702 Normal	Normal	\N	\N	\N	\N	04-6689B
1705	1705 Normal	Normal	\N	\N	\N	\N	96-3842
1709	1709 Normal	Normal	\N	\N	\N	\N	96-18458A
1714	1714 Normal	Normal	\N	\N	\N	\N	03-16497A
1718	1718 Normal	Normal	\N	\N	\N	\N	04-25639A
1720	1720 Normal	Normal	\N	\N	\N	\N	04-25639B
1722	1722 Normal	Normal	\N	\N	\N	\N	03-39293
1725	1725 Normal	Normal	\N	\N	\N	\N	02-20619B
1728	1728 Normal	Normal	\N	\N	\N	\N	08-25654
1730	1730 Normal	Normal	\N	\N	\N	\N	94-7602A
1732	1732 Normal	Normal	\N	\N	\N	\N	11-80898
1735	1735 Normal	Normal	\N	\N	\N	\N	04-50387
1738	1738 Normal	Normal	\N	\N	\N	\N	10-23548
1739	1739 Normal	Normal	\N	\N	\N	\N	10-25517A
1740	1740 Normal	Normal	\N	\N	\N	\N	10-25517E
1742	1742 Normal	Normal	\N	\N	04-14908A, 04-14908	\N	04-14908
1745	1745 Normal	Normal	\N	\N	\N	\N	08-8920B
1748	1748 Normal	Normal	\N	\N	\N	\N	07-37090
1753	1753 Normal	Normal	\N	\N	\N	\N	08-44748
1756	1756 Normal	Normal	\N	\N	\N	\N	05-58791
1758	1758 Normal	Normal	\N	\N	\N	\N	06-5249
1760	1760 Normal	Normal	\N	\N	\N	\N	98-11545
1763	1763 Normal	Normal	\N	\N	\N	\N	99-3122A
1766	1766 Normal	Normal	\N	\N	\N	\N	01-6748
1768	1768 Normal	Normal	\N	\N	\N	\N	00-26584A1
1773	1773 Normal	Normal	\N	\N	\N	\N	03-3075A
1776	1776 Normal	Normal	\N	\N	\N	\N	05-27756B
1778	1778 Normal	Normal	\N	\N	\N	\N	98-9595B
1781	1781 Normal	Normal	\N	\N	\N	\N	98-21806
1784	1784 Normal	Normal	\N	\N	\N	\N	06-17933A
1785	1785 Normal	Normal	\N	\N	\N	\N	06-17933A
1788	1788 Normal	Normal	\N	\N	\N	\N	95-21392
1789	1789 Normal	Normal	\N	\N	\N	\N	95-21392
1791	1791 Normal	Normal	\N	\N	\N	\N	98-13466
1793	1793 Normal	Normal	\N	\N	\N	\N	93-13675B
1795	1795 Normal	Normal	\N	\N	\N	\N	93-13675A
1797	1797 Normal	Normal	\N	\N	\N	\N	05-5976A
1800	1800 Normal	Normal	\N	\N	\N	\N	06-21115B
1802	1802 Normal	Normal	\N	\N	\N	\N	98-6161B
1804	1804 Normal	Normal	\N	\N	\N	\N	01-11378A2
1806	1806 Normal	Normal	\N	\N	\N	\N	07-76799A
1809	1809 Normal	Normal	\N	\N	\N	\N	98-1556
1811	1811 Normal	Normal	\N	\N	\N	\N	99-19410B
1813	1813 Normal	Normal	\N	\N	\N	\N	06-22923
1815	1815 Normal	Normal	\N	\N	http://64.54.108.147/eSlideTray.php?ImageIds=1003 , 05-37586A1, 05-37586A3	\N	05-37586A3
1819	1819 Normal	Normal	\N	\N	\N	\N	04-57347A
1821	1821 Normal	Normal	\N	\N	\N	\N	00-5989A2
1824	1824 Normal	Normal	\N	\N	\N	\N	19-43366G
1827	1827 Normal	Normal	\N	\N	\N	\N	03-24651
1829	1829 Normal	Normal	\N	\N	\N	\N	98-10389
1831	1831 Normal	Normal	\N	\N	\N	\N	99-4387
1834	1834 Normal	Normal	\N	\N	\N	\N	97-13166G
1836	1836 Normal	Normal	\N	\N	\N	\N	06-73878A
1838	1838 Normal	Normal	\N	\N	\N	\N	99-3122A
1840	1840 Normal	Normal	\N	\N	\N	\N	92-5109
1842	1842 Normal	Normal	\N	\N	\N	\N	92-1608A
1845	1845 Normal	Normal	\N	\N	\N	\N	06-11151F
1848	1848 Normal	Normal	\N	\N	\N	\N	00-4845
1850	1850 Normal	Normal	\N	\N	\N	\N	04-12137A
1852	1852 Normal	Normal	\N	\N	\N	\N	01-34127B
1854	1854 Normal	Normal	\N	\N	\N	\N	03-29330A
1856	1856 Normal	Normal	\N	\N	\N	\N	00-556A
1859	1859 Normal	Normal	\N	\N	\N	\N	03-30961B
1862	1862 Normal	Normal	\N	\N	\N	\N	97-23367
1864	1864 Normal	Normal	\N	\N	\N	\N	99-23502A
1920	1920 Normal	Normal	\N	\N	\N	\N	08-48442
1925	1925 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1929	1929 Normal	Normal	\N	\N	\N	\N	05-27460
1930	1930 Normal	Normal	\N	\N	\N	\N	05-37586A1
1934	1934 Normal	Normal	\N	\N	\N	\N	05-37586A3
1937	1937 Normal	Normal	\N	\N	\N	\N	99-32835
1940	1940 Normal	Normal	\N	\N	\N	\N	06-10811
1943	1943 Normal	Normal	\N	\N	\N	\N	98-9595B
1946	1946 Normal	Normal	\N	\N	\N	\N	03-57215B
1949	1949 Normal	Normal	\N	\N	\N	\N	01-10896
1950	1950 Normal	Normal	\N	\N	\N	\N	06-23240A
1953	1953 Normal	Normal	\N	\N	\N	\N	22-17043
1955	1955 Normal	Normal	\N	\N	\N	\N	07-85201
1957	1957 Normal	Normal	\N	\N	\N	\N	05-29484A
1956	1956 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	02-7356
1958	1958 Normal	Normal	\N	\N	\N	\N	08-65412A
2036	2036 Normal	Normal	\N	\N	\N	\N	11-89154A6
2037	2037 Normal	Normal	\N	\N	\N	\N	07-41091A
2041	2041 Normal	Normal	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	22-51092
2046	2046 Normal	Normal	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-106642A
2050	2050 Normal	Normal	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-91914A
2054	2054 Normal	Normal	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-60974B
2058	2058 Normal	Normal	\N	\N	Progression Cases. Comments:  normal sample has granulation tissue and fat necrosis, copy number data for all samples looks dirty. Hunter has already sequenced this case before. \tbastianlab2\\HiSeqData_Hunter\\AperioScansForEvaluation\\22_2. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS3\\H&E\n	\N	11-37533B
2062	2062 Normal	Normal	\N	\N	Comments:  good normal, copy number data looks dirty. Hunter has already sequenced this case before. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS5\n	\N	11-94204
2065	2065 Normal	Normal	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS12. Comments:  good normal, copy number data looks dirty	\N	12-93589A
2068	2068 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS13	\N	13-2138C
2072	2072 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS14	\N	13-98648
2075	2075 Normal	Normal	\N	\N	Progression Cases.\tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS16	\N	14-64047
2078	2078 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS17	\N	14-33100
2081	2081 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS18	\N	14-47962
2084	2084 Normal	Normal	\N	\N	Progression Cases.	\N	14-73175B
2087	2087 Normal	Normal	\N	\N	Progression Cases. Block is missing (08/15/22) and there are no other blocks to get Normal tissue from.	\N	14-78242
2090	2090 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS1\\H&E	\N	11-23681B
2093	2093 Normal	Normal	\N	\N	Progression Cases, 12-67568A, 12-67568B	\N	12-67568A
2096	2096 Normal	Normal	\N	\N	\N	\N	12-12684
2099	2099 Normal	Normal	\N	\N	12-21993C, 12-21993I	\N	12-21993C
2102	2102 Normal	Normal	\N	\N	\N	\N	12-79097B
2105	2105 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS11w , 12-57349C, 12-57349E	\N	12-57349E
2110	2110 Normal	Normal	\N	\N	\N	\N	17-68780C
2113	2113 Normal	Normal	\N	\N	Progression Cases.	\N	14-73175B
2116	2116 Normal	Normal	\N	\N	\N	\N	17-38404A2
2120	2120 Normal	Normal	\N	\N	\N	\N	16-109052C
2123	2123 Normal	Normal	\N	\N	\N	\N	17-23681
2126	2126 Normal	Normal	\N	\N	\N	\N	14-50051
2127	2127 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	16-103438
2133	2133 Normal	Normal	\N	\N	\N	\N	17-100072A
2150	2150 Normal	Normal	\N	\N	Progression Cases	\N	11-23681A
2153	2153 Normal	Normal	\N	\N	Progression Cases.	\N	15-98263
2158	2158 Normal	Normal	\N	\N	Progression Cases.	\N	15-22411
2159	2159 Normal	Normal	\N	\N	Progression Cases.	\N	15-50051
2160	2160 Normal	Normal	\N	\N	Progression Cases.	\N	15-12964B
2161	2161 Normal	Normal	\N	\N	Progression Cases.	\N	15-85517
2162	2162 Normal	Normal	\N	\N	Progression Cases.	\N	15-21741
2166	2166 Normal	Normal	\N	\N	Progression Cases.; 15-14665B, 15-14665C	\N	15-14665B
2170	2170 Normal	Normal	\N	\N	\N	\N	15-48134
2178	2178 Normal	Normal	\N	\N	\N	\N	17-68780A
2179	2179 Normal	Normal	\N	\N	\N	\N	17-68780B
2183	2183 Normal	Normal	\N	\N	\N	\N	16-17132B
2186	2186 Normal	Normal	\N	\N	\N	\N	16-35900
2189	2189 Normal	Normal	\N	\N	\N	\N	18-139329
2192	2192 Normal	Normal	\N	\N	\N	\N	18-75585B
2195	2195 Normal	Normal	\N	\N	\N	\N	19-36210A
2199	2199 Normal	Normal	\N	\N	\N	\N	19-5916
2203	2203 Normal	Normal	\N	\N	\N	\N	20-31447
2206	2206 Normal	Normal	\N	\N	\N	\N	20-43011
2210	2210 Normal	Normal	\N	\N	\N	\N	20-53075B
2214	2214 Normal	Normal	\N	\N	\N	\N	20-79197A
2218	2218 Normal	Normal	\N	\N	\N	\N	21-118604
2222	2222 Normal	Normal	\N	\N	\N	\N	21-131828
2226	2226 Normal	Normal	\N	\N	\N	\N	21-2141
2229	2229 Normal	Normal	\N	\N	\N	\N	21-41149
2233	2233 Normal	Normal	\N	\N	\N	\N	21-1134A
2236	2236 Normal	Normal	\N	\N	\N	\N	22-102809
2240	2240 Normal	Normal	\N	\N	\N	\N	19-36210A
2241	2241 Normal	Normal	\N	\N	\N	\N	18-67239
2242	2242 Normal	Normal	\N	\N	\N	\N	21-16708A
2245	2245 Normal	Normal	\N	\N	\N	\N	16-99265
2259	2259 Normal	Normal	2019-07-19 00:00:00-07	\N	Normal	\N	05-605A2
2261	2261 Normal	Normal	2019-07-19 00:00:00-07	\N	Normal	\N	08-6790A
2260	2260 Normal	Normal	2019-07-19 00:00:00-07	\N	Normal	\N	04-35102A
2262	2262 Normal	Normal	2019-07-19 00:00:00-07	\N	Normal	\N	96-4039
2270	2270 Normal	Normal	2023-03-29 00:00:00-07	\N	\N	\N	22-81852B
2289	2289 Normal	Normal	\N	\N	\N	\N	22-114059B
2293	2293 Normal	Normal	\N	\N	\N	\N	23-11588A
2298	2298 Normal	Normal	\N	\N	\N	\N	22-80319A2
2301	2301 Normal	Normal	\N	\N	\N	\N	22-104652
2419	2419 Normal	Normal	2015-07-31 00:00:00-07	\N	\N	\N	12-22776B5
2414	2414 Normal	Normal	2015-07-31 00:00:00-07	\N	\N	\N	12-22172
2417	2417 Normal	Normal	2015-07-31 00:00:00-07	\N	\N	\N	12-22901A
2449	2449 Normal	Normal	\N	\N	\N	\N	23-47727
2446	2446 Normal	Normal	\N	\N	\N	\N	23-47967
2450	2450 Normal	Normal	2023-05-19 00:00:00-07	\N	\N	\N	23-37003
2453	2453 Normal	Normal	2023-05-19 00:00:00-07	\N	\N	\N	22-29280
2461	2461 Normal	Normal	\N	\N	\N	\N	23-49347
2462	2462 Normal	Normal	\N	\N	\N	\N	22-104389A4
2471	2471 Normal	Normal	\N	\N	\N	\N	17-77365
2479	2479 Normal	Normal	\N	\N	\N	\N	22-102807-4
2488	2488 Normal	Normal	\N	\N	\N	\N	23-1012A2
2482	2482 Normal	Normal	\N	\N	\N	\N	22-15594-4
2475	2475 Normal	Normal	\N	\N	\N	\N	23-51956A3
2485	2485 Normal	Normal	\N	\N	\N	\N	17-81380B
2493	2493 Normal	Normal	\N	\N	\N	\N	20-81257A\n
2496	2496 Normal	Normal	\N	\N	\N	\N	21-7055B1
2499	2499 Normal	Normal	\N	\N	\N	\N	21-25546B2
2502	2502 Normal	Normal	\N	\N	\N	\N	21-35943A
2505	2505 Normal	Normal	\N	\N	\N	\N	22-91699A7
2508	2508 Normal	Normal	\N	\N	\N	\N	20-11796D
2511	2511 Normal	Normal	\N	\N	\N	\N	19-75051
2514	2514 Normal	Normal	\N	\N	\N	\N	18-12160F
2517	2517 Normal	Normal	\N	\N	\N	\N	22-94741
2520	2520 Normal	Normal	\N	\N	\N	\N	21-62764
2523	2523 Normal	Normal	\N	\N	\N	\N	20-18383B2
2526	2526 Normal	Normal	\N	\N	\N	\N	22-76519A
2527	2527 Normal	Normal	\N	\N	\N	\N	21-89776A
2529	2529 Normal	Normal	\N	\N	\N	\N	21-89776B
2531	2531 Normal	Normal	\N	\N	\N	\N	20-91483A
2533	2533 Normal	Normal	\N	\N	\N	\N	20-91483B
2535	2535 Normal	Normal	\N	\N	\N	\N	22-52528-1
2537	2537 Normal	Normal	\N	\N	\N	\N	22-52528-2
2539	2539 Normal	Normal	\N	\N	\N	\N	22-105120-1
2541	2541 Normal	Normal	\N	\N	\N	\N	22-105120-2
2543	2543 Normal	Normal	\N	\N	\N	\N	20-82651A
2548	2548 Normal	Normal	\N	\N	\N	\N	20-82651E
2550	2550 Normal	Normal	\N	\N	\N	\N	21-96446A1
2553	2553 Normal	Normal	\N	\N	\N	\N	20-104213A
2555	2555 Normal	Normal	\N	\N	\N	\N	20-104213B
2557	2557 Normal	Normal	\N	\N	\N	\N	20-18514A
2559	2559 Normal	Normal	\N	\N	\N	\N	20-98774A
2562	2562 Normal	Normal	\N	\N	\N	\N	20-98774D
2600	2600 Normal	Normal	\N	\N	\N	\N	20-14475
2603	2603 Normal	Normal	\N	\N	\N	\N	20-31361
2605	2605 Normal	Normal	\N	\N	\N	\N	20-35177
2607	2607 Normal	Normal	\N	\N	\N	\N	20-43970
2609	2609 Normal	Normal	\N	\N	\N	\N	20-5264
2634	2634 Normal	Normal	\N	\N	\N	\N	22-93578
2638	2638 Normal	Normal	\N	\N	\N	\N	17-122697A
2641	2641 Normal	Normal	\N	\N	\N	\N	23-12491
2644	2644 Normal	Normal	\N	\N	\N	\N	18-51740B2
2647	2647 Normal	Normal	\N	\N	\N	\N	21-4449B2
2650	2650 Normal	Normal	\N	\N	\N	\N	19-360A2
2654	2654 Normal	Normal	\N	\N	\N	\N	20-113547C2
2657	2657 Normal	Normal	\N	\N	\N	\N	20-37211I
2660	2660 Normal	Normal	\N	\N	\N	\N	20-83082B
2663	2663 Normal	Normal	\N	\N	\N	\N	20-8536D
2666	2666 Normal	Normal	\N	\N	\N	\N	22-34510B1
2669	2669 Normal	Normal	\N	\N	\N	\N	20-10245F1
2672	2672 Normal	Normal	\N	\N	\N	\N	17-33973A1
2675	2675 Normal	Normal	\N	\N	\N	\N	20-16903A2
2678	2678 Normal	Normal	\N	\N	\N	\N	13-17186A21
2682	2682 Normal	Normal	\N	\N	\N	\N	14-12190L4
2683	2683 Normal	Normal	\N	\N	\N	\N	14-12190A1
2694	2694 Normal	Normal	\N	\N	\N	\N	09-80101A-2
2716	2716 Normal	Normal	\N	\N	\N	\N	02-012396A
2724	2724 Normal	Normal	\N	\N	\N	\N	13-17202C4
2728	2728 Normal	Normal	\N	\N	\N	\N	14-4989D3
2742	2742 Normal	Normal	\N	\N	\N	\N	09-005840
2746	2746 Normal	Normal	\N	\N	\N	\N	05-015408
2747	2747 Normal	Normal	\N	\N	\N	\N	99-012800
2750	2750 Normal	Normal	\N	\N	\N	\N	00-001103B7
2751	2751 Normal	Normal	\N	\N	\N	\N	X06-6624D1
2753	2753 Normal	Normal	\N	\N	\N	\N	03-1978B3
2755	2755 Normal	Normal	\N	\N	\N	\N	02-5203G2
2757	2757 Normal	Normal	\N	\N	\N	\N	X98-1056
2762	2762 Normal	Normal	\N	\N	\N	\N	10-41439
2763	2763 Normal	Normal	\N	\N	\N	\N	11-23681C
2769	2769 Normal	Normal	\N	\N	\N	\N	10-23569A
2771	2771 Normal	Normal	\N	\N	\N	\N	06-21363
2777	2777 Normal	Normal	\N	\N	\N	\N	11-38149
2780	2780 Normal	Normal	\N	\N	\N	\N	08-27590
2783	2783 Normal	Normal	\N	\N	\N	\N	SM_4
2785	2785 Normal	Normal	\N	\N	\N	\N	SM_5
2788	2788 Normal	Normal	\N	\N	\N	\N	06-52508
2790	2790 Normal	Normal	\N	\N	\N	\N	07-04365
2793	2793 Normal	Normal	\N	\N	\N	\N	07-14044A
2798	2798 Normal	Normal	\N	\N	\N	\N	SM_16
2813	2813 Normal	Normal	\N	\N	\N	\N	07-011660-2
2815	2815 Normal	Normal	\N	\N	\N	\N	09-015020-2A
2820	2820 Normal	Normal	\N	\N	\N	\N	10-972C2
2822	2822 Normal	Normal	\N	\N	\N	\N	10-1843A5
2825	2825 Normal	Normal	\N	\N	\N	\N	14-61299
2828	2828 Normal	Normal	\N	\N	\N	\N	ZS10-10558B1
2831	2831 Normal	Normal	\N	\N	\N	\N	S12-9606C4
2835	2835 Normal	Normal	\N	\N	\N	\N	12-4365A8
2849	2849 Normal	Normal	\N	\N	\N	\N	CGH13-034
2854	2854 Normal	Normal	\N	\N	\N	\N	10-42241
2862	2862 Normal	Normal	\N	\N	\N	\N	14-59332
2866	2866 Normal	Normal	\N	\N	\N	\N	14-61835
2868	2868 Normal	Normal	\N	\N	\N	\N	14-58667
2870	2870 Normal	Normal	\N	\N	\N	\N	14-59304A
2901	2901 Normal	Normal	\N	\N	\N	\N	ZS10-3560F1
2916	2916 Normal	Normal	\N	\N	\N	\N	08-46462
2927	2927 Normal	Normal	\N	\N	\N	\N	11-37533
2936	2936 Normal	Normal	\N	\N	\N	\N	TissueCoreALKControl
2943	2943 Normal	Normal	\N	\N	\N	\N	HW2- Normal Curls
2945	2945 Normal	Normal	\N	\N	\N	\N	HW8- Normal Curls
2947	2947 Normal	Normal	\N	\N	\N	\N	HW9- Normal gDNA from Blood (129920)
2964	2964 Normal	Normal	\N	\N	\N	\N	HW3-Normal
2966	2966 Normal	Normal	\N	\N	\N	\N	HW4-Normal
2968	2968 Normal	Normal	\N	\N	\N	\N	HW6-NormalDissect
2982	2982 Normal	Normal	\N	\N	\N	\N	BN_N1
2983	2983 Normal	Normal	\N	\N	\N	\N	BN_N2
3071	3071 Normal	Normal	\N	\N	\N	\N	09-1121
3076	3076 Normal	Normal	\N	\N	\N	\N	02-33818A-03
3091	3091 Normal	Normal	\N	\N	\N	\N	12-54296
3093	3093 Normal	Normal	\N	\N	\N	\N	12-54992
3095	3095 Normal	Normal	\N	\N	\N	\N	12-67298
3101	3101 Normal	Normal	\N	\N	\N	\N	DM4
3103	3103 Normal	Normal	\N	\N	\N	\N	DM6
3106	3106 Normal	Normal	\N	\N	\N	\N	DM10
3112	3112 Normal	Normal	\N	\N	\N	\N	DM17
3114	3114 Normal	Normal	\N	\N	\N	\N	DM18
3117	3117 Normal	Normal	\N	\N	\N	\N	DM22
3119	3119 Normal	Normal	\N	\N	\N	\N	DM23
3121	3121 Normal	Normal	\N	\N	\N	\N	DM25
3124	3124 Normal	Normal	\N	\N	\N	\N	DM31
3126	3126 Normal	Normal	\N	\N	\N	\N	DM36
3128	3128 Normal	Normal	\N	\N	\N	\N	DM42
3130	3130 Normal	Normal	\N	\N	\N	\N	DM43
3134	3134 Normal	Normal	\N	\N	\N	\N	DM49
3136	3136 Normal	Normal	\N	\N	\N	\N	DM58
3139	3139 Normal	Normal	\N	\N	\N	\N	DM64
3148	3148 Normal	Normal	\N	\N	\N	\N	DM93
3149	3149 Normal	Normal	\N	\N	\N	\N	DM94
3152	3152 Normal	Normal	\N	\N	\N	\N	DM95
3154	3154 Normal	Normal	\N	\N	\N	\N	DM96
3155	3155 Normal	Normal	\N	\N	\N	\N	DM98
3157	3157 Normal	Normal	\N	\N	\N	\N	DM99
3162	3162 Normal	Normal	\N	\N	\N	\N	DM101
3174	3174 Normal	Normal	\N	\N	\N	\N	DM1
3176	3176 Normal	Normal	\N	\N	\N	\N	DM2
3180	3180 Normal	Normal	\N	\N	\N	\N	DM7
3179	3179 Normal	Normal	\N	\N	\N	\N	DM5
3182	3182 Normal	Normal	\N	\N	\N	\N	DM11
3184	3184 Normal	Normal	\N	\N	\N	\N	DM12
3188	3188 Normal	Normal	\N	\N	\N	\N	DM14
3186	3186 Normal	Normal	\N	\N	\N	\N	DM13
3190	3190 Normal	Normal	\N	\N	\N	\N	DM16
3192	3192 Normal	Normal	\N	\N	\N	\N	DM21
3194	3194 Normal	Normal	\N	\N	\N	\N	DM26
3196	3196 Normal	Normal	\N	\N	\N	\N	DM28
3199	3199 Normal	Normal	\N	\N	\N	\N	DM29
3200	3200 Normal	Normal	\N	\N	\N	\N	DM34
3202	3202 Normal	Normal	\N	\N	\N	\N	DM37
3204	3204 Normal	Normal	\N	\N	\N	\N	DM45
3205	3205 Normal	Normal	\N	\N	\N	\N	DM55
3208	3208 Normal	Normal	\N	\N	\N	\N	DM77
3210	3210 Normal	Normal	\N	\N	\N	\N	DM79
3213	3213 Normal	Normal	\N	\N	\N	\N	DM93
3220	3220 Normal	Normal	\N	\N	\N	\N	09-92749
3232	3232 Normal	Normal	\N	\N	\N	\N	11-73999
3237	3237 Normal	Normal	\N	\N	Ivanka Normal (for #9)	\N	10-63051C
3242	3242 Normal	Normal	\N	\N	\N	\N	08-21965C
3244	3244 Normal	Normal	\N	\N	\N	\N	08-4205A
3249	3249 Normal	Normal	\N	\N	\N	\N	HW Acral #1 Cntl
3251	3251 Normal	Normal	\N	\N	\N	\N	HW Acral #2 Cntl
3253	3253 Normal	Normal	\N	\N	\N	\N	HW Acral #3 Cntl
3255	3255 Normal	Normal	\N	\N	\N	\N	HW Acral #4 Cntl
3257	3257 Normal	Normal	\N	\N	\N	\N	HW Acral #5 Cntl
3259	3259 Normal	Normal	\N	\N	\N	\N	HW Acral #6 Cntl
3261	3261 Normal	Normal	\N	\N	\N	\N	HW Acral #7 Cntl
3263	3263 Normal	Normal	\N	\N	\N	\N	HW Acral #8 Cntl
3265	3265 Normal	Normal	\N	\N	\N	\N	HW Acral #9 Cntl
3267	3267 Normal	Normal	\N	\N	\N	\N	HW Acral #10 Cntl
3279	3279 Normal	Normal	\N	\N	\N	\N	10-58663
3294	3294 Normal	Normal	\N	\N	\N	\N	09-8165
3299	3299 Normal	Normal	\N	\N	\N	\N	08-46462
3304	3304 Normal	Normal	\N	\N	\N	\N	JBP-3
3352	3352 Normal	Normal	\N	\N	\N	\N	London-L2
3354	3354 Normal	Normal	\N	\N	\N	\N	London-L3
3355	3355 Normal	Normal	\N	\N	\N	\N	11-96096
3356	3356 Normal	Normal	\N	\N	\N	\N	MB_161
3362	3362 Normal	Normal	\N	\N	\N	\N	MB_1036
3360	3360 Normal	Normal	\N	\N	\N	\N	MB_1028
3364	3364 Normal	Normal	\N	\N	\N	\N	MB_1418
3365	3365 Normal	Normal	\N	\N	\N	\N	MB_1454
3367	3367 Normal	Normal	\N	\N	\N	\N	MB1241
3366	3366 Normal	Normal	\N	\N	\N	\N	MB1609
3369	3369 Normal	Normal	\N	\N	\N	\N	MB1421
3370	3370 Normal	Normal	\N	\N	\N	\N	MB1423
3373	3373 Normal	Normal	\N	\N	\N	\N	MB1428
3378	3378 Normal	Normal	\N	\N	\N	\N	13-25110A1
3381	3381 Normal	Normal	\N	\N	\N	\N	13-45163
3388	3388 Normal	Normal	\N	\N	\N	\N	HW3-Normal
3390	3390 Normal	Normal	\N	\N	\N	\N	HW4-Normal
3392	3392 Normal	Normal	\N	\N	\N	\N	HW6-NormalDissect
3423	3423 Normal	Normal	\N	\N	\N	\N	P57
3424	3424 Normal	Normal	\N	\N	\N	\N	P57
3804	3804 Normal	Normal	\N	\N	\N	\N	08-21965C
3810	3810 Normal	Normal	\N	\N	\N	\N	11-81851
3852	3852 Normal	Normal	\N	\N	\N	\N	CP1
3859	3859 Normal	Normal	\N	\N	\N	\N	14-58566
2	2 Mel1	Mel1	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H09.22183/1
4	4 Mel1	Mel1	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H15.5120/1
10	10 Mel1	Mel1	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H15.19121/7
14	14 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86502b
17	17 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	78821-1c
21	21 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	534-1-11.2
23	23 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86541-1E
27	27 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79447-c
30	30 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79049-1c
34	34 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	352-1-15.1
37	37 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	2686-1-13.1
41	41 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	1586-2-13-C
45	45 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	385/14
48	48 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	AM2 D-72 not circled on the image, no DNA extracted	\N	4070/2/13.1
51	51 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	501950A3
57	57 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
61	61 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	604076
64	64 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	488836A
67	67 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.660
71	71 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.215/5
76	76 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/1
81	81 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	info from Shanshan's list, some of the images can't be found	\N	K1-B
88	88 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	19111/14.3
91	91 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	21159 A5
95	95 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
100	100 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-A-B
106	106 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-B
422	422 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K23-A-B
363	363 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-A-B
371	371 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K7-B
925	925 Mel	Mel	\N	\N	\N	\N	95-01141-1 M1
414	414 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K21-A-B
423	423 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K24-A-B
384	384 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-B
378	378 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K9-A-B
393	393 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K12-B
410	410 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K20-A-B
375	375 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K8-B
406	406 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K17-B
418	418 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K22-A-B
367	367 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-B
389	389 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-B
401	401 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-A-B
1145	1145 Mel1	Mel1	\N	\N	\N	\N	501950A3
1293	1293 Mel1	Mel1	\N	\N	\N	\N	H13.10897/11
1298	1298 Mel1	Mel1	\N	\N	\N	\N	B06.41962/5
1303	1303 Mel1	Mel1	\N	\N	\N	\N	H12.27716/7
1306	1306 Mel1	Mel1	\N	\N	\N	\N	H2007.4636/9
1309	1309 Mel1	Mel1	\N	\N	\N	\N	H13.3143 
1471	1471 Mel1	Mel1	\N	\N	\N	\N	13-30315A3
1475	1475 Mel1	Mel1	\N	\N	\N	\N	15-17010A1
1491	1491 Mel1	Mel1	\N	\N	\N	\N	12-24189A1
1494	1494 Mel1	Mel1	\N	\N	\N	\N	11-36301A1
1502	1502 Mel1	Mel1	\N	\N	\N	\N	10-15411B
1515	1515 Mel1	Mel1	\N	\N	\N	\N	15-3736C1
1524	1524 Mel1	Mel1	\N	\N	\N	\N	15-4505A1
1529	1529 Mel1	Mel1	\N	\N	\N	\N	13-23696A5
1548	1548 Mel1	Mel1	\N	\N	\N	\N	15-26253A1
1553	1553 Mel1	Mel1	\N	\N	\N	\N	16-552A7
1570	1570 Mel1	Mel1	\N	\N	\N	\N	16-10035A3
2060	2060 Mel1	Mel1	\N	\N	Progression Cases. Hunter has already sequenced this case before. \tbastianlab2\\HiSeqData_Hunter\\AperioScansForEvaluation\\22_2. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS3\\H&E	\N	11-37533B
2107	2107 Mel1	Mel1	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS11w , 12-57349C, 12-57349E	\N	12-57349C
2180	2180 Mel1	Mel1	\N	\N	\N	\N	16-17132B
2223	2223 Mel1	Mel1	\N	\N	\N	\N	21-2141
77	77 Mel2	Mel2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/1
96	96 Mel2	Mel2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
107	107 Mel2	Mel2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-B
368	368 Mel2	Mel2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-B
402	402 Mel2	Mel2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-A-B
1286	1286 Mel2	Mel2	\N	\N	\N	\N	H15.5120/1
1289	1289 Mel2	Mel2	\N	\N	\N	\N	86541-1g
1299	1299 Mel2	Mel2	\N	\N	\N	\N	B06.41962/5
1476	1476 Mel2	Mel2	\N	\N	\N	\N	15-17010A1
1492	1492 Mel2	Mel2	\N	\N	\N	\N	12-24189A1
1495	1495 Mel2	Mel2	\N	\N	\N	\N	11-36301A1
1516	1516 Mel2	Mel2	\N	\N	\N	\N	15-3736C1
1530	1530 Mel2	Mel2	\N	\N	\N	\N	13-23696A5
1549	1549 Mel2	Mel2	\N	\N	\N	\N	15-26253A1
1554	1554 Mel2	Mel2	\N	\N	\N	\N	16-552A7
1571	1571 Mel2	Mel2	\N	\N	\N	\N	16-10035A3
1622	1622 Mel2	Mel2	\N	\N	\N	\N	K8-B
2061	2061 Mel2	Mel2	\N	\N	Progression Cases. Hunter has already sequenced this case before. \tbastianlab2\\HiSeqData_Hunter\\AperioScansForEvaluation\\22_2. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS3\\H&E	\N	11-37533B
2108	2108 Mel2	Mel2	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS11w , 12-57349C, 12-57349E	\N	12-57349C
2181	2181 Mel2	Mel2	\N	\N	\N	\N	16-17132B
2224	2224 Mel2	Mel2	\N	\N	\N	\N	21-2141
2246	2246 Mel2	Mel2	\N	\N	\N	\N	K3-A-B
7	7 MIS1	MIS1	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H14.26934/2
13	13 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86502b
16	16 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	78821-1c
18	18 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	also on block 534-1-11.3	\N	534-1-11.2
24	24 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86541-1g
26	26 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79447-c
29	29 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79049-1c
36	36 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	2686-1-13.1
39	39 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	1586-2-13-C
43	43 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	385/14
47	47 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	4070/2/13.1
50	50 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	501950A3
54	54 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
59	59 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	604076
63	63 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	488836A
66	66 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.660
69	69 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.215/5
73	73 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/3
79	79 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	info from Shanshan's list, some of the images can't be found	\N	K1-A
83	83 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K2-B
86	86 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	19111/14.3
90	90 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	21159 A5
93	93 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
99	99 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-A-B
104	104 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-B
967	967 Mel	Mel	\N	\N	\N	\N	96-07395C M1
382	382 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-B
420	420 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K23-A-B
365	365 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-B
399	399 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-A-B
361	361 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-A-B
373	373 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K8-B
408	408 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K20-A-B
405	405 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K17-B
396	396 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K14-A
377	377 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K9-A-B
416	416 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K22-A-B
386	386 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-B
392	392 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K12-A
370	370 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K7-B
412	412 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K21-A-B
1244	1244 MIS1	MIS1	\N	\N	\N	\N	K23-A-B
1296	1296 MIS1	MIS1	\N	\N	\N	\N	B06.41962/3
1428	1428 MIS1	MIS1	\N	\N	\N	\N	11-1973
1441	1441 MIS1	MIS1	\N	\N	\N	\N	17-83378B
1442	1442 MIS1	MIS1	\N	\N	\N	\N	17-88262
1472	1472 MIS1	MIS1	\N	\N	\N	\N	13-30315A3
1508	1508 MIS1	MIS1	\N	\N	\N	\N	10-14390
1525	1525 MIS1	MIS1	\N	\N	\N	\N	15-4505A1
1533	1533 MIS1	MIS1	\N	\N	\N	\N	13-23696A5
1539	1539 MIS1	MIS1	\N	\N	\N	\N	14-51352
1550	1550 MIS1	MIS1	\N	\N	\N	\N	15-26253A1
1555	1555 MIS1	MIS1	\N	\N	\N	\N	16-552A7
1572	1572 MIS1	MIS1	\N	\N	\N	\N	16-10035A3
1587	1587 MIS1	MIS1	\N	\N	\N	\N	19-44348A1
1594	1594 MIS1	MIS1	\N	\N	\N	\N	19-52004A1
1597	1597 MIS1	MIS1	\N	\N	\N	\N	19-44987A1
1600	1600 MIS1	MIS1	\N	\N	\N	\N	08-35719A1
2652	2652 MIS1	MIS1	\N	\N	\N	\N	20-113547A2
2659	2659 MIS1	MIS1	\N	\N	\N	\N	20-83082A3
19	19 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	also on block 534-1-11.3	\N	534-1-11.2
40	40 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	1586-2-13-C
44	44 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	385/14
55	55 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
60	60 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	604076
70	70 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.215/5
74	74 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/1
80	80 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	info from Shanshan's list, some of the images can't be found	\N	K1-A
87	87 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	19111/14.3
94	94 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
105	105 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-A
421	421 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K23-A-B
417	417 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K22-A-B
374	374 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K8-A
400	400 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-A-B
362	362 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-A-B
366	366 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-B
387	387 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-B
409	409 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K20-A-B
383	383 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-A
413	413 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K21-A-B
1240	1240 MIS2	MIS2	\N	\N	\N	\N	K7-A
1245	1245 MIS2	MIS2	\N	\N	\N	\N	K23-A-B
1297	1297 MIS2	MIS2	\N	\N	\N	\N	B06.41962/5
1443	1443 MIS2	MIS2	\N	\N	\N	\N	17-88262
1444	1444 MIS2	MIS2	\N	\N	\N	\N	17-83378B
1540	1540 MIS2	MIS2	\N	\N	\N	\N	14-51352
1556	1556 MIS2	MIS2	\N	\N	\N	\N	16-552A7
1573	1573 MIS2	MIS2	\N	\N	\N	\N	16-10035A3
1588	1588 MIS2	MIS2	\N	\N	\N	\N	19-44348A1
2034	2034 MIS2	MIS2	\N	\N	\N	\N	K2-A
2653	2653 MIS2	MIS2	\N	\N	\N	\N	20-113547A3
2693	2693 MIS2	MIS2	\N	\N	\N	\N	20-83082A3
3	3 Met1	Met1	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H13.5620/1
5	5 Met1	Met1	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.5818/2
8	8 Met1	Met1	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	HS17.35/2
11	11 Met1	Met1	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.872/2
101	101 Met1	Met1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-C
108	108 Met1	Met1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-C
1152	1152 Met1	Met1	\N	\N	\N	\N	K2-C
1285	1285 Met1	Met1	\N	\N	\N	\N	38637-16.2
1312	1312 Met1	Met1	\N	\N	\N	\N	07-2104
1474	1474 Met1	Met1	\N	\N	\N	\N	15-29364A1
1504	1504 Met1	Met1	\N	\N	\N	\N	10-18253B
1509	1509 Met1	Met1	\N	\N	\N	\N	10-14100
1577	1577 Met1	Met1	\N	\N	\N	\N	20-33334A1
1579	1579 Met1	Met1	\N	\N	\N	\N	20-09338A1
2268	2268 Met1	Met1	2023-03-29 00:00:00-07	\N	Met1 and Met2 merged	\N	22-81852A
2817	2817 Met1	Met1	\N	\N	\N	\N	12-4365B1
102	102 Met2	Met2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-C
109	109 Met2	Met2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-C
1151	1151 Met2	Met2	\N	\N	\N	\N	H13.5620/1
1287	1287 Met2	Met2	\N	\N	\N	\N	H18.7977
1313	1313 Met2	Met2	\N	\N	\N	\N	07-2104
1500	1500 Met2	Met2	\N	\N	\N	\N	11-36301C1
1505	1505 Met2	Met2	\N	\N	\N	\N	10-39146A1
1520	1520 Met2	Met2	\N	\N	\N	\N	15-18463
2033	2033 Met2	Met2	\N	\N	\N	\N	K10-C
2269	2269 Met2	Met2	2023-03-29 00:00:00-07	\N	Met1 and Met2 merged	\N	22-81852A
2818	2818 Met2	Met2	\N	\N	\N	\N	12-4365C1
2819	2819 Met2	Met2	\N	\N	\N	\N	12-4365C2
53	53 Nevus	Nevus	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
290	290 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24928	\N	\N	16-106975
296	296 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22138	\N	\N	16-107007
300	300 Nevus	Nevus	\N	\N	\N	\N	16-110683
294	294 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22157	\N	\N	17-88262
287	287 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=930	\N	\N	17-26457
298	298 Nevus	Nevus	\N	\N	\N	\N	16-88453A
292	292 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22142	\N	\N	17-12444
284	284 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22140	\N	\N	16-84820
281	281 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22139,25172	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-109659A4
352	352 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22156	\N	\N	17-83378B
346	346 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22144	\N	\N	17-130286
350	350 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22141,25173	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-99265
348	348 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24932,25176	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	16-103438
773	773 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-103071
775	775 Nevus	Nevus	\N	\N	(new HE recut on 5/5/2022)	\N	17-82793A
777	777 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-61310
780	780 Nevus	Nevus	\N	\N	\N	\N	17-56506
782	782 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-43703
785	785 Nevus	Nevus	\N	\N	\N	\N	17-32863B
788	788 Nevus	Nevus	\N	\N	\N	\N	17-13334
789	789 Nevus	Nevus	\N	\N	\N	\N	17-31440
793	793 Nevus	Nevus	\N	\N	\N	\N	17-36409
796	796 Nevus	Nevus	\N	\N	\N	\N	17-61108
798	798 Nevus	Nevus	\N	\N	\N	\N	17-68446
800	800 Nevus	Nevus	\N	\N	\N	\N	17-88895
801	801 Nevus	Nevus	\N	\N	\N	\N	17-43712
803	803 Nevus	Nevus	\N	\N	\N	\N	17-55182D
893	893 Nevus	Nevus	\N	\N	\N	\N	17-125030
1134	1134 Nevus	Nevus	\N	\N	Atypical Spitz tumor-nevus	\N	19-44904
1445	1445 Nevus	Nevus	\N	\N	\N	\N	19-53945B
1452	1452 Nevus	Nevus	\N	\N	\N	\N	19-69103
1453	1453 Nevus	Nevus	\N	\N	\N	\N	19-104449D
1454	1454 Nevus	Nevus	\N	\N	\N	\N	19-103058B
1455	1455 Nevus	Nevus	\N	\N	\N	\N	15-102927
1458	1458 Nevus	Nevus	\N	\N	\N	\N	19-97163
1457	1457 Nevus	Nevus	\N	\N	\N	\N	19-117270
1456	1456 Nevus	Nevus	\N	\N	\N	\N	19-115700A
1462	1462 Nevus	Nevus	\N	\N	\N	\N	19-80535A
1461	1461 Nevus	Nevus	\N	\N	\N	\N	19-79825
1460	1460 Nevus	Nevus	\N	\N	\N	\N	19-43600A
1463	1463 Nevus	Nevus	\N	\N	\N	\N	19-43600B
1459	1459 Nevus	Nevus	\N	\N	\N	\N	19-59869A
1464	1464 Nevus	Nevus	\N	\N	\N	\N	19-78038
1465	1465 Nevus	Nevus	\N	\N	\N	\N	19-89855A
1466	1466 Nevus	Nevus	\N	\N	\N	\N	19-105255
1468	1468 Nevus	Nevus	\N	\N	\N	\N	19-9438B
1467	1467 Nevus	Nevus	\N	\N	\N	\N	19-21355B
1469	1469 Nevus	Nevus	\N	\N	\N	\N	20-25263A
1480	1480 Nevus	Nevus	\N	\N	\N	\N	20-36120
1481	1481 Nevus	Nevus	\N	\N	\N	\N	20-92494
1483	1483 Nevus	Nevus	\N	\N	\N	\N	19-117072A
1482	1482 Nevus	Nevus	\N	\N	\N	\N	20-43801
1484	1484 Nevus	Nevus	\N	\N	\N	\N	20-36500A
1485	1485 Nevus	Nevus	\N	\N	\N	\N	20-48338A
1486	1486 Nevus	Nevus	\N	\N	\N	\N	20-48331
1487	1487 Nevus	Nevus	\N	\N	\N	\N	20-57308
1488	1488 Nevus	Nevus	\N	\N	\N	\N	20-34915
1642	1642 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. http://64.54.108.147/eSlideTray.php?ImageIds=22989,22990,22991,22992  http://64.54.108.147/eSlideTray.php?ImageIds=21403\n	\N	02-7356
1664	1664 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1779	1779 Nevus	Nevus	\N	\N	\N	\N	98-9595B
1817	1817 Nevus	Nevus	\N	\N	\N	\N	05-37586A3
1876	1876 Nevus	Nevus	\N	\N	\N	\N	21-52881
1881	1881 Nevus	Nevus	\N	\N	COMPOUND MELANOCYTIC NEVUS	\N	21-63579A
1883	1883 Nevus	Nevus	\N	\N	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	\N	21-59993A
1885	1885 Nevus	Nevus	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	21-98047
1886	1886 Nevus	Nevus	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	21-98013A
1888	1888 Nevus	Nevus	\N	\N	MELANOMA, AT LEAST IN SITU, WITH SUPERIMPOSED CHANGES OF REGRESSION	\N	21-63575B
1894	1894 Nevus	Nevus	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-110504
1896	1896 Nevus	Nevus	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	\N	21-110027B
1897	1897 Nevus	Nevus	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	\N	21-110027B
1899	1899 Nevus	Nevus	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-110012A
1900	1900 Nevus	Nevus	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE	\N	21-110009A
1902	1902 Nevus	Nevus	\N	\N	\N	\N	21-112195B
1904	1904 Nevus	Nevus	\N	\N	\N	\N	21-112321A
1911	1911 Nevus	Nevus	\N	\N	\N	\N	21-112298
1912	1912 Nevus	Nevus	\N	\N	\N	\N	21-112298
1919	1919 Nevus	Nevus	\N	\N	\N	\N	08-48442
1922	1922 Nevus	Nevus	\N	\N	\N	\N	04-34117
1924	1924 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1928	1928 Nevus	Nevus	\N	\N	\N	\N	05-27460
1933	1933 Nevus	Nevus	\N	\N	\N	\N	05-37586A3
1936	1936 Nevus	Nevus	\N	\N	\N	\N	99-32835
1939	1939 Nevus	Nevus	\N	\N	\N	\N	06-10811
1942	1942 Nevus	Nevus	\N	\N	\N	\N	98-9595B
1945	1945 Nevus	Nevus	\N	\N	\N	\N	03-57215B
1948	1948 Nevus	Nevus	\N	\N	\N	\N	01-10896
1952	1952 Nevus	Nevus	\N	\N	\N	\N	22-17043
2042	2042 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	07-37378
293	293 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22142	\N	\N	17-12444
956	956 Mel	Mel	\N	\N	\N	\N	10-20397-3 M1
943	943 Mel	Mel	\N	\N	\N	\N	03-04925E M1
2059	2059 Nevus	Nevus	\N	\N	Progression Cases. Hunter has already sequenced this case before. \tbastianlab2\\HiSeqData_Hunter\\AperioScansForEvaluation\\22_2. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS3\\H&E	\N	11-37533B
2063	2063 Nevus	Nevus	\N	\N	Hunter has already sequenced this case before. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS5	\N	11-94204
2066	2066 Nevus	Nevus	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS12.	\N	12-93589A
2069	2069 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS13	\N	13-2138C
2073	2073 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS14	\N	13-98648
2076	2076 Nevus	Nevus	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS16	\N	14-64047
2079	2079 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS17	\N	14-33100
2082	2082 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS18	\N	14-47962
2085	2085 Nevus	Nevus	\N	\N	Progression Cases.	\N	14-73175B
2088	2088 Nevus	Nevus	\N	\N	Progression Cases. Block is missing (08/15/22) and there are no other blocks to get Normal tissue from.	\N	14-78242
2091	2091 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS1\\H&E	\N	11-23681B
2094	2094 Nevus	Nevus	\N	\N	Progression Cases, 12-67568A, 12-67568B	\N	12-67568B
2097	2097 Nevus	Nevus	\N	\N	\N	\N	12-12684
2100	2100 Nevus	Nevus	\N	\N	12-21993C, 12-21993I	\N	12-21993I
2103	2103 Nevus	Nevus	\N	\N	\N	\N	12-79097B
2106	2106 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS11w , 12-57349C, 12-57349E	\N	12-57349C
2112	2112 Nevus	Nevus	\N	\N	Progression Cases.	\N	14-73175B
2115	2115 Nevus	Nevus	\N	\N	\N	\N	17-38404A2
2118	2118 Nevus	Nevus	\N	\N	\N	\N	16-109052C
2121	2121 Nevus	Nevus	\N	\N	\N	\N	17-23681
2125	2125 Nevus	Nevus	\N	\N	\N	\N	14-50051
2128	2128 Nevus	Nevus	\N	\N	\N	\N	17-68780C
2130	2130 Nevus	Nevus	\N	\N	\N	\N	14-73175B
2132	2132 Nevus	Nevus	\N	\N	\N	\N	17-100072A
2137	2137 Nevus	Nevus	\N	\N	\N	\N	17-89239A
2182	2182 Nevus	Nevus	\N	\N	\N	\N	16-17132B
2185	2185 Nevus	Nevus	\N	\N	\N	\N	16-35900
2188	2188 Nevus	Nevus	\N	\N	\N	\N	18-139329
2191	2191 Nevus	Nevus	\N	\N	\N	\N	18-75585B
2194	2194 Nevus	Nevus	\N	\N	\N	\N	19-36210A
2198	2198 Nevus	Nevus	\N	\N	\N	\N	19-5916
2202	2202 Nevus	Nevus	\N	\N	\N	\N	20-31447
2205	2205 Nevus	Nevus	\N	\N	\N	\N	20-43011
2208	2208 Nevus	Nevus	\N	\N	\N	\N	20-53075B
2213	2213 Nevus	Nevus	\N	\N	\N	\N	20-79197A
2216	2216 Nevus	Nevus	\N	\N	\N	\N	21-118604
2221	2221 Nevus	Nevus	\N	\N	\N	\N	21-131828
2225	2225 Nevus	Nevus	\N	\N	\N	\N	21-2141
2228	2228 Nevus	Nevus	\N	\N	\N	\N	21-41149
2232	2232 Nevus	Nevus	\N	\N	\N	\N	21-44171
2235	2235 Nevus	Nevus	\N	\N	\N	\N	22-102809
2239	2239 Nevus	Nevus	\N	\N	\N	\N	19-36210A
2244	2244 Nevus	Nevus	\N	\N	\N	\N	16-99265
2272	2272 Nevus	Nevus	\N	\N	\N	\N	15-48134
2274	2274 Nevus	Nevus	\N	\N	\N	\N	15-22411
2276	2276 Nevus	Nevus	\N	\N	\N	\N	15-50051
2278	2278 Nevus	Nevus	\N	\N	\N	\N	15-12964B
2280	2280 Nevus	Nevus	\N	\N	15-14665B, 15-14665C	\N	15-14665B
2282	2282 Nevus	Nevus	\N	\N	\N	\N	15-85517
2284	2284 Nevus	Nevus	\N	\N	\N	\N	15-21741
2286	2286 Nevus	Nevus	\N	\N	\N	\N	15-98263
2291	2291 Nevus	Nevus	\N	\N	\N	\N	23-2718 (block 1)
2296	2296 Nevus	Nevus	\N	\N	\N	\N	22-80319A1
2300	2300 Nevus	Nevus	\N	\N	\N	\N	22-104652
2445	2445 Nevus	Nevus	\N	\N	\N	\N	23-47967
2448	2448 Nevus	Nevus	\N	\N	\N	\N	23-47727
2460	2460 Nevus	Nevus	\N	\N	\N	\N	23-49347
2861	2861 Nevus	Nevus	\N	\N	\N	\N	14-59332
2865	2865 Nevus	Nevus	\N	\N	\N	\N	14-61835
2867	2867 Nevus	Nevus	\N	\N	\N	\N	14-58667
2869	2869 Nevus	Nevus	\N	\N	\N	\N	14-59304A
2912	2912 Nevus	Nevus	\N	\N	\N	\N	10-41439
2911	2911 Nevus	Nevus	\N	\N	\N	\N	10-41439
2915	2915 Nevus	Nevus	\N	\N	\N	\N	08-46462
2921	2921 Nevus	Nevus	\N	\N	\N	\N	11-23681
2922	2922 Nevus	Nevus	\N	\N	\N	\N	11-23681
2926	2926 Nevus	Nevus	\N	\N	\N	\N	11-37533
2925	2925 Nevus	Nevus	\N	\N	\N	\N	11-37533
3277	3277 Nevus	Nevus	\N	\N	\N	\N	10-58663
3278	3278 Nevus	Nevus	\N	\N	\N	\N	10-58663
3292	3292 Nevus	Nevus	\N	\N	\N	\N	09-8165
3293	3293 Nevus	Nevus	\N	\N	\N	\N	09-8165
3298	3298 Nevus	Nevus	\N	\N	\N	\N	08-46462
3297	3297 Nevus	Nevus	\N	\N	\N	\N	08-46462
3377	3377 Nevus	Nevus	\N	\N	\N	\N	13-25110A1
3380	3380 Nevus	Nevus	\N	\N	\N	\N	13-45163
3808	3808 Nevus	Nevus	\N	\N	\N	\N	11-81851
3809	3809 Nevus	Nevus	\N	\N	\N	\N	11-81851
3905	3905 Nevus	Nevus	\N	\N	\N	\N	\N
3907	3907 Nevus	Nevus	\N	\N	\N	\N	12-93589A
3909	3909 Nevus	Nevus	\N	\N	\N	\N	14-47962
3911	3911 Nevus	Nevus	\N	\N	\N	\N	14-73175B
3913	3913 Nevus	Nevus	\N	\N	\N	\N	14-78242
3915	3915 Nevus	Nevus	\N	\N	\N	\N	15-98263
3917	3917 Nevus	Nevus	\N	\N	\N	\N	\N
3919	3919 Nevus	Nevus	\N	\N	\N	\N	15-50051
3921	3921 Nevus	Nevus	\N	\N	\N	\N	15-12964B
3923	3923 Nevus	Nevus	\N	\N	\N	\N	15-14665B
3925	3925 Nevus	Nevus	\N	\N	\N	\N	15-85517
3927	3927 Nevus	Nevus	\N	\N	\N	\N	15-21741
3928	3928 Nevus	Nevus	\N	\N	\N	\N	11-37533B
3930	3930 Nevus	Nevus	\N	\N	\N	\N	11-94204
56	56 MIS3	MIS3	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
75	75 MIS3	MIS3	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/1
388	388 MIS3	MIS3	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-A
1239	1239 MIS3	MIS3	\N	\N	\N	\N	K7-B-2
1241	1241 MIS3	MIS3	\N	\N	\N	\N	K22-D
1557	1557 MIS3	MIS3	\N	\N	\N	\N	16-552A7
1618	1618 MIS3	MIS3	\N	\N	\N	\N	K23-D
1620	1620 MIS3	MIS3	\N	\N	\N	\N	K1-A.2
2035	2035 MIS3	MIS3	\N	\N	\N	\N	K2-A
372	372 Normal1	Normal1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K8-A
369	369 Normal1	Normal1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K7-B
376	376 Normal1	Normal1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K9-D
98	98 Normal2	Normal2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-D
1242	1242 Normal2	Normal2	\N	\N	\N	\N	K22-D
84	84 Mel	Mel	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K2-B
282	282 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22139,25172	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-109659A4
291	291 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24928	\N	\N	16-106975
288	288 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=930	\N	\N	17-26457
303	303 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22154	\N	\N	17-68446
285	285 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22140	\N	\N	16-84820
297	297 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22138	\N	\N	16-107007
299	299 Mel	Mel	\N	\N	\N	\N	16-88453A
295	295 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22157	\N	\N	17-88262
301	301 Mel	Mel	\N	\N	\N	\N	16-110683
344	344 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22147	\N	\N	17-33401C
349	349 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24932,25176	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	16-103438
353	353 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22156	\N	\N	17-83378B
351	351 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22141,25173	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-99265
356	356 Mel	Mel	\N	\N	\N	\N	16-101803B
347	347 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22144	\N	\N	17-130286
618	618 Mel	Mel	\N	\N	\N	\N	15-32174 T2
629	629 Mel	Mel	\N	\N	\N	\N	06-08092 T3
627	627 Mel	Mel	\N	\N	\N	\N	16-31317 T4
628	628 Mel	Mel	\N	\N	\N	\N	05-01411 T4
631	631 Mel	Mel	\N	\N	\N	\N	13-24372B T1
630	630 Mel	Mel	\N	\N	\N	\N	06-14812E T2
632	632 Mel	Mel	\N	\N	\N	\N	00-21551 T3
661	661 Mel	Mel	\N	\N	\N	\N	12-12352 T3
660	660 Mel	Mel	\N	\N	\N	\N	12-05858 T3
639	639 Mel	Mel	\N	\N	\N	\N	04-01809 T4
635	635 Mel	Mel	\N	\N	\N	\N	01-20248 T3
646	646 Mel	Mel	\N	\N	\N	\N	06-04915 T2
662	662 Mel	Mel	\N	\N	\N	\N	13-24372A T1
652	652 Mel	Mel	\N	\N	\N	\N	06-23587 T1
658	658 Mel	Mel	\N	\N	\N	\N	11-03286 T3
638	638 Mel	Mel	\N	\N	\N	\N	04-28824 T2
663	663 Mel	Mel	\N	\N	\N	\N	13-26846 T4
653	653 Mel	Mel	\N	\N	\N	\N	06-16759 T1
664	664 Mel	Mel	\N	\N	\N	\N	14-03473 T3
643	643 Mel	Mel	\N	\N	\N	\N	05-29322 T3
648	648 Mel	Mel	\N	\N	\N	\N	06-17441 T2
642	642 Mel	Mel	\N	\N	\N	\N	05-14988 T3
665	665 Mel	Mel	\N	\N	\N	\N	15-02416 T2
656	656 Mel	Mel	\N	\N	\N	\N	09-21320 T2
666	666 Mel	Mel	\N	\N	\N	\N	15-22166 T4
659	659 Mel	Mel	\N	\N	\N	\N	11-27846 T3
633	633 Mel	Mel	\N	\N	\N	\N	01-00027 T1
650	650 Mel	Mel	\N	\N	\N	\N	06-23345 T1
637	637 Mel	Mel	\N	\N	\N	\N	03-26518 T1
647	647 Mel	Mel	\N	\N	\N	\N	06-14812D T2
641	641 Mel	Mel	\N	\N	\N	\N	05-23001 T4
655	655 Mel	Mel	\N	\N	\N	\N	08-21729 T2
657	657 Mel	Mel	\N	\N	\N	\N	10-10275 T2
649	649 Mel	Mel	\N	\N	\N	\N	06-25697 T1
654	654 Mel	Mel	\N	\N	\N	\N	07-25593 T2
651	651 Mel	Mel	\N	\N	\N	\N	06-27633 T1
636	636 Mel	Mel	\N	\N	\N	\N	02-05776 T1
640	640 Mel	Mel	\N	\N	\N	\N	04-05355 T4
645	645 Mel	Mel	\N	\N	\N	\N	06-01845 T4
634	634 Mel	Mel	\N	\N	\N	\N	01-07957 T4
644	644 Mel	Mel	\N	\N	\N	\N	06-05518 T4
772	772 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-103071
774	774 Mel	Mel	\N	\N	(new HE recut on 5/5/2022)	\N	17-82793A
776	776 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-61310
779	779 Mel	Mel	\N	\N	\N	\N	17-56506
781	781 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-43703
784	784 Mel	Mel	\N	\N	\N	\N	17-32863B
791	791 Mel	Mel	\N	\N	\N	\N	17-31440
794	794 Mel	Mel	\N	\N	\N	\N	17-36409
795	795 Mel	Mel	\N	\N	\N	\N	17-61108
799	799 Mel	Mel	\N	\N	\N	\N	17-88895
802	802 Mel	Mel	\N	\N	\N	\N	17-43712
805	805 Mel	Mel	\N	\N	\N	\N	17-55182D
892	892 Mel	Mel	\N	\N	\N	\N	17-125030
896	896 Mel	Mel	\N	\N	\N	\N	MEL202_DMSO
897	897 Mel	Mel	\N	\N	\N	\N	MEL202_DMSO
898	898 Mel	Mel	\N	\N	\N	\N	MEL202_DMSO
899	899 Mel	Mel	\N	\N	\N	\N	MEL202_Vemu
901	901 Mel	Mel	\N	\N	\N	\N	MEL202_Vemu
900	900 Mel	Mel	\N	\N	\N	\N	MEL202_Vemu
912	912 Mel	Mel	\N	\N	\N	\N	05-12693C M1
913	913 Mel	Mel	\N	\N	\N	\N	05-27343A M1
914	914 Mel	Mel	\N	\N	\N	\N	06-03046F N1
915	915 Mel	Mel	\N	\N	\N	\N	06-06325 M1
961	961 Mel	Mel	\N	\N	\N	\N	11-27846-2 N1
920	920 Mel	Mel	\N	\N	\N	\N	94-00143-2 N1
962	962 Mel	Mel	\N	\N	\N	\N	12-05858A3 M1
930	930 Mel	Mel	\N	\N	\N	\N	97-01837E M1
945	945 Mel	Mel	\N	\N	\N	\N	04-00065-6 M1
959	959 Mel	Mel	\N	\N	\N	\N	11-03286-4 M1
916	916 Mel	Mel	\N	\N	\N	\N	06-16008-1
944	944 Mel	Mel	\N	\N	\N	\N	03-16198-1C M1
973	973 Mel	Mel	\N	\N	\N	\N	02-16797C M1
933	933 Mel	Mel	\N	\N	\N	\N	98-05054 N1
918	918 Mel	Mel	\N	\N	\N	\N	12-05089-3
926	926 Mel	Mel	\N	\N	\N	\N	95-05724-1 M1
949	949 Mel	Mel	\N	\N	\N	\N	05-21257 M1
979	979 Mel	Mel	\N	\N	\N	\N	06-12646D M1
919	919 Mel	Mel	\N	\N	\N	\N	94-00669 N1
931	931 Mel	Mel	\N	\N	\N	\N	98-02267-5 M1
974	974 Mel	Mel	\N	\N	\N	\N	02-00594E M1
942	942 Mel	Mel	\N	\N	\N	\N	02-16325B M1
964	964 Mel	Mel	\N	\N	\N	\N	14-04359A2 N1
978	978 Mel	Mel	\N	\N	\N	\N	05-14728C M1
951	951 Mel	Mel	\N	\N	\N	\N	09-15598 M1
947	947 Mel	Mel	\N	\N	\N	\N	04-21305-4 M1
957	957 Mel	Mel	\N	\N	\N	\N	10-30890-5 N1
929	929 Mel	Mel	\N	\N	\N	\N	96-18967-1 M1
948	948 Mel	Mel	\N	\N	\N	\N	05-01411C N1
971	971 Mel	Mel	\N	\N	\N	\N	01-00467B N1
975	975 Mel	Mel	\N	\N	\N	\N	06-11147 N1
921	921 Mel	Mel	\N	\N	\N	\N	93-06269-4 N1
936	936 Mel	Mel	\N	\N	\N	\N	00-09653C M1
924	924 Mel	Mel	\N	\N	\N	\N	85-01186
953	953 Mel	Mel	\N	\N	\N	\N	09-13370-2G N1
927	927 Mel	Mel	\N	\N	\N	\N	96-06832D M1
946	946 Mel	Mel	\N	\N	\N	\N	04-01241G M1
977	977 Mel	Mel	\N	\N	\N	\N	04-20471E M1
923	923 Mel	Mel	\N	\N	\N	\N	89-10432A M1
939	939 Mel	Mel	\N	\N	\N	\N	02-11468D M1
940	940 Mel	Mel	\N	\N	\N	\N	02-22843 M1
934	934 Mel	Mel	\N	\N	\N	\N	99-16633E N1
965	965 Mel	Mel	\N	\N	\N	\N	14-17085A2 M1
928	928 Mel	Mel	\N	\N	\N	\N	91-16318 M1
917	917 Mel	Mel	\N	\N	\N	\N	10-10942A2 M1
935	935 Mel	Mel	\N	\N	\N	\N	99-27534 M1
972	972 Mel	Mel	\N	\N	\N	\N	00-27758D M1
976	976 Mel	Mel	\N	\N	\N	\N	03-26518B M1
950	950 Mel	Mel	\N	\N	\N	\N	08-21729-2 M1
970	970 Mel	Mel	\N	\N	\N	\N	98-23221F M1
969	969 Mel	Mel	\N	\N	\N	\N	96-23601-4 M1
922	922 Mel	Mel	\N	\N	\N	\N	95-05959 M1
955	955 Mel	Mel	\N	\N	\N	\N	10-10275D13 M1
963	963 Mel	Mel	\N	\N	\N	\N	13-26846A1 N1
960	960 Mel	Mel	\N	\N	\N	\N	13-24372B CONSULTA
938	938 Mel	Mel	\N	\N	\N	\N	00-15034-1B M1
932	932 Mel	Mel	\N	\N	\N	\N	98-03336-8 M1
941	941 Mel	Mel	\N	\N	\N	\N	02-22662B M1
954	954 Mel	Mel	\N	\N	\N	\N	09-21320A3 N1-M1
966	966 Mel	Mel	\N	\N	\N	\N	94-21132 M1
937	937 Mel	Mel	\N	\N	\N	\N	00-11793E M1
952	952 Mel	Mel	\N	\N	\N	\N	09-13370-1M N1
968	968 Mel	Mel	\N	\N	\N	\N	96-13701 M1
958	958 Mel	Mel	\N	\N	\N	\N	10-30525-4 M1
1022	1022 Mel	Mel	\N	\N	\N	\N	03-19132B T1
1023	1023 Mel	Mel	\N	\N	\N	\N	02-05776D T1
1024	1024 Mel	Mel	\N	\N	\N	\N	06-25697-1 T1
1025	1025 Mel	Mel	\N	\N	\N	\N	06-01845E T4
1091	1091 Mel	Mel	\N	\N	\N	\N	02-17209C T2
1026	1026 Mel	Mel	\N	\N	\N	\N	95-14690F T1
1095	1095 Mel	Mel	\N	\N	\N	\N	01-1112 T2
1048	1048 Mel	Mel	\N	\N	\N	\N	05-29322B T3
1074	1074 Mel	Mel	\N	\N	\N	\N	04-05355B T4
1082	1082 Mel	Mel	\N	\N	\N	\N	99-19998 T2
1071	1071 Mel	Mel	\N	\N	\N	\N	04-13607 T1
1088	1088 Mel	Mel	\N	\N	\N	\N	03-08311E T2
1064	1064 Mel	Mel	\N	\N	\N	\N	04-14677 T1
1062	1062 Mel	Mel	\N	\N	\N	\N	05-04949-1C T1
1053	1053 Mel	Mel	\N	\N	\N	\N	01-15780R T1
1033	1033 Mel	Mel	\N	\N	\N	\N	00-23160D T1
1037	1037 Mel	Mel	\N	\N	\N	\N	06-16759A T1
1083	1083 Mel	Mel	\N	\N	\N	\N	03-21273-1G T1
1106	1106 Mel	Mel	\N	\N	\N	\N	98-06203-3 T2
1087	1087 Mel	Mel	\N	\N	\N	\N	03-24659-2 T2
1114	1114 Mel	Mel	\N	\N	\N	\N	95-14297-5 T2
1099	1099 Mel	Mel	\N	\N	\N	\N	00-12952-3 T2
1056	1056 Mel	Mel	\N	\N	\N	\N	05-17080 T2
1060	1060 Mel	Mel	\N	\N	\N	\N	04-08148D T1
1126	1126 Mel	Mel	\N	\N	\N	\N	91-09968E T3
1128	1128 Mel	Mel	\N	\N	\N	\N	94-18018-2 T3
1118	1118 Mel	Mel	\N	\N	\N	\N	87-14087B T2
1108	1108 Mel	Mel	\N	\N	\N	\N	95-02325-1 T3
1044	1044 Mel	Mel	\N	\N	\N	\N	06-01846D T1
1057	1057 Mel	Mel	\N	\N	\N	\N	05-23001E T4
1052	1052 Mel	Mel	\N	\N	\N	\N	05-26627-1B T1
1073	1073 Mel	Mel	\N	\N	\N	\N	04-03547G T1
1089	1089 Mel	Mel	\N	\N	\N	\N	02-26442 T4
1032	1032 Mel	Mel	\N	\N	\N	\N	06-24998B T2
1113	1113 Mel	Mel	\N	\N	\N	\N	91-08026A T2
1065	1065 Mel	Mel	\N	\N	\N	\N	04-00122C T1
1054	1054 Mel	Mel	\N	\N	\N	\N	05-20065-4 T1
1067	1067 Mel	Mel	\N	\N	\N	\N	04-14508C T1
1079	1079 Mel	Mel	\N	\N	\N	\N	03-19132B T1
1116	1116 Mel	Mel	\N	\N	\N	\N	95-16013B T3
1101	1101 Mel	Mel	\N	\N	\N	\N	99-15953D T2
1103	1103 Mel	Mel	\N	\N	\N	\N	99-09753 T2
1132	1132 Mel	Mel	\N	\N	\N	\N	93-13951 T2
1077	1077 Mel	Mel	\N	\N	\N	\N	04-02031D T1
1107	1107 Mel	Mel	\N	\N	\N	\N	97-8417 T2
1097	1097 Mel	Mel	\N	\N	\N	\N	00-24216D T4
1085	1085 Mel	Mel	\N	\N	\N	\N	03-15183D T1
1045	1045 Mel	Mel	\N	\N	\N	\N	06-06053B T1
1036	1036 Mel	Mel	\N	\N	\N	\N	06-20661-2 T1
1049	1049 Mel	Mel	\N	\N	\N	\N	05-26408 T1
1115	1115 Mel	Mel	\N	\N	\N	\N	96-02480 T3
1119	1119 Mel	Mel	\N	\N	\N	\N	88-6851-2 T3
1046	1046 Mel	Mel	\N	\N	\N	\N	96-24948 T1
1125	1125 Mel	Mel	\N	\N	\N	\N	93-12428-1 T2
1061	1061 Mel	Mel	\N	\N	\N	\N	04-22191D T1
1100	1100 Mel	Mel	\N	\N	\N	\N	00-15364 T2
1080	1080 Mel	Mel	\N	\N	\N	\N	03-22623A T1
1111	1111 Mel	Mel	\N	\N	\N	\N	93-21060-4 T2
1039	1039 Mel	Mel	\N	\N	\N	\N	06-17562-2 T1
1117	1117 Mel	Mel	\N	\N	\N	\N	92-18572E T3
1058	1058 Mel	Mel	\N	\N	\N	\N	05-04841C T2
1059	1059 Mel	Mel	\N	\N	\N	\N	05-14988B T3
1055	1055 Mel	Mel	\N	\N	\N	\N	05-13894C T2
1063	1063 Mel	Mel	\N	\N	\N	\N	04-18775B T1
1104	1104 Mel	Mel	\N	\N	\N	\N	99-16706 T2
1086	1086 Mel	Mel	\N	\N	\N	\N	03-17395J T2
1031	1031 Mel	Mel	\N	\N	\N	\N	06-23587B T1
1094	1094 Mel	Mel	\N	\N	\N	\N	01-26615B T2
1109	1109 Mel	Mel	\N	\N	\N	\N	90-07958-1 T2
1090	1090 Mel	Mel	\N	\N	\N	\N	02-20732 T2
1130	1130 Mel	Mel	\N	\N	\N	\N	94-23180 T4
1105	1105 Mel	Mel	\N	\N	\N	\N	98-21389A T2
1051	1051 Mel	Mel	\N	\N	\N	\N	05-24184C T1
1035	1035 Mel	Mel	\N	\N	\N	\N	06-21073E T3
1043	1043 Mel	Mel	\N	\N	\N	\N	06-05518B T4
1093	1093 Mel	Mel	\N	\N	\N	\N	02-20495B T2
1121	1121 Mel	Mel	\N	\N	\N	\N	94-19725B T3
1110	1110 Mel	Mel	\N	\N	\N	\N	96-20650-1A T3
1034	1034 Mel	Mel	\N	\N	\N	\N	06-17441-2 T2
1096	1096 Mel	Mel	\N	\N	\N	\N	01-17200 T3
1078	1078 Mel	Mel	\N	\N	\N	\N	04-01809E T4
1127	1127 Mel	Mel	\N	\N	\N	\N	89-13569-1 T2
1081	1081 Mel	Mel	\N	\N	\N	\N	03-23238B T2
1124	1124 Mel	Mel	\N	\N	\N	\N	86-04906-2 T2
1066	1066 Mel	Mel	\N	\N	\N	\N	04-11144C T1
1069	1069 Mel	Mel	\N	\N	\N	\N	04-17745B T1
1084	1084 Mel	Mel	\N	\N	\N	\N	03-19080C T1
1092	1092 Mel	Mel	\N	\N	\N	\N	02-28682 T4
1042	1042 Mel	Mel	\N	\N	\N	\N	06-10522-2B T1
1041	1041 Mel	Mel	\N	\N	\N	\N	06-15453C T1
1102	1102 Mel	Mel	\N	\N	\N	\N	99-24969F T4
1120	1120 Mel	Mel	\N	\N	\N	\N	92-14752-1 T2
1075	1075 Mel	Mel	\N	\N	\N	\N	04-03311H T2
1122	1122 Mel	Mel	\N	\N	\N	\N	92-06469A T2
1070	1070 Mel	Mel	\N	\N	\N	\N	04-15689C T1
1098	1098 Mel	Mel	\N	\N	\N	\N	00-06521B T3
1028	1028 Mel	Mel	\N	\N	\N	\N	99-13402-3 T1
1050	1050 Mel	Mel	\N	\N	\N	\N	07-25593-2 T2
1129	1129 Mel	Mel	\N	\N	\N	\N	94-12246 T3
1133	1133 Mel	Mel	\N	\N	\N	\N	89-10450-1 T2
1027	1027 Mel	Mel	\N	\N	\N	\N	00-16651B T1
1068	1068 Mel	Mel	\N	\N	\N	\N	04-15616C T2
1131	1131 Mel	Mel	\N	\N	\N	\N	94-08318-1 T2
1072	1072 Mel	Mel	\N	\N	\N	\N	04-13171C T1
1123	1123 Mel	Mel	\N	\N	\N	\N	94-01469-2 T3
1076	1076 Mel	Mel	\N	\N	\N	\N	01-10208A T1
1112	1112 Mel	Mel	\N	\N	\N	\N	92-03953C T2
1310	1310 Mel	Mel	\N	\N	\N	\N	17-13334
1626	1626 Mel	Mel	\N	\N	\N	\N	09-48136A
1627	1627 Mel	Mel	\N	\N	\N	\N	06-70035C
1628	1628 Mel	Mel	\N	\N	\N	\N	12-85105A
1630	1630 Mel	Mel	\N	\N	\N	\N	06-28087
1629	1629 Mel	Mel	\N	\N	\N	\N	05-28152B
1631	1631 Mel	Mel	\N	\N	\N	\N	98-16285A2
1633	1633 Mel	Mel	\N	\N	\N	\N	06-8729
1632	1632 Mel	Mel	\N	\N	\N	\N	04-18467
1634	1634 Mel	Mel	\N	\N	\N	\N	14-34758
1635	1635 Mel	Mel	\N	\N	\N	\N	99-18307
1636	1636 Mel	Mel	\N	\N	\N	\N	99-30301
1637	1637 Mel	Mel	\N	\N	\N	\N	04-38345
1639	1639 Mel	Mel	\N	\N	\N	\N	04-15284
1638	1638 Mel	Mel	\N	\N	\N	\N	06-47809B
1640	1640 Mel	Mel	\N	\N	\N	\N	04-59140B
1641	1641 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. http://64.54.108.147/eSlideTray.php?ImageIds=22989,22990,22991,22992  http://64.54.108.147/eSlideTray.php?ImageIds=21403\n	\N	02-7356
1643	1643 Mel	Mel	\N	\N	\N	\N	05-19406
1644	1644 Mel	Mel	\N	\N	\N	\N	09-90221
1645	1645 Mel	Mel	\N	\N	\N	\N	00-14127B
1646	1646 Mel	Mel	\N	\N	\N	\N	02-8746A
1647	1647 Mel	Mel	\N	\N	\N	\N	02-8746B
1648	1648 Mel	Mel	\N	\N	\N	\N	99-14477
1650	1650 Mel	Mel	\N	\N	\N	\N	05-46869B
1651	1651 Mel	Mel	\N	\N	\N	\N	06-18321
1652	1652 Mel	Mel	\N	\N	\N	\N	02-5600A
1653	1653 Mel	Mel	\N	\N	\N	\N	08-51663
1655	1655 Mel	Mel	\N	\N	\N	\N	05-66206A
1657	1657 Mel	Mel	\N	\N	\N	\N	01-18107A
1658	1658 Mel	Mel	\N	\N	\N	\N	06-4069
1660	1660 Mel	Mel	\N	\N	\N	\N	02-49261
1661	1661 Mel	Mel	\N	\N	\N	\N	06-64692B
1662	1662 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1665	1665 Mel	Mel	\N	\N	\N	\N	02-17626
1666	1666 Mel	Mel	\N	\N	\N	\N	02-28807
1667	1667 Mel	Mel	\N	\N	\N	\N	95-5908
1669	1669 Mel	Mel	\N	\N	\N	\N	04-31313A
1672	1672 Mel	Mel	\N	\N	\N	\N	09-23922A
1675	1675 Mel	Mel	\N	\N	\N	\N	09-23922B
1677	1677 Mel	Mel	\N	\N	\N	\N	06-68314
1678	1678 Mel	Mel	\N	\N	\N	\N	13-14077
1680	1680 Mel	Mel	\N	\N	\N	\N	09-31608
1681	1681 Mel	Mel	\N	\N	\N	\N	15-43069A
1682	1682 Mel	Mel	\N	\N	\N	\N	08-1851A
1684	1684 Mel	Mel	\N	\N	\N	\N	08-1851B
1686	1686 Mel	Mel	\N	\N	\N	\N	07-67657A
1688	1688 Mel	Mel	\N	\N	\N	\N	07-67657B
1689	1689 Mel	Mel	\N	\N	\N	\N	13-32289A
1691	1691 Mel	Mel	\N	\N	\N	\N	13-32289B
1693	1693 Mel	Mel	\N	\N	\N	\N	01-16263
1695	1695 Mel	Mel	\N	\N	\N	\N	03-57585A
1697	1697 Mel	Mel	\N	\N	\N	\N	03-57585C
1699	1699 Mel	Mel	\N	\N	\N	\N	96-12193
1700	1700 Mel	Mel	\N	\N	\N	\N	06-65105
1701	1701 Mel	Mel	\N	\N	\N	\N	04-6689B
1704	1704 Mel	Mel	\N	\N	\N	\N	96-3842
1707	1707 Mel	Mel	\N	\N	\N	\N	03-47623B
1708	1708 Mel	Mel	\N	\N	\N	\N	96-18458E
1712	1712 Mel	Mel	\N	\N	\N	\N	04-28340
1713	1713 Mel	Mel	\N	\N	\N	\N	03-44586
1715	1715 Mel	Mel	\N	\N	\N	\N	03-16497B
1717	1717 Mel	Mel	\N	\N	\N	\N	04-25639A
1719	1719 Mel	Mel	\N	\N	\N	\N	04-25639B
1721	1721 Mel	Mel	\N	\N	\N	\N	03-39293
1724	1724 Mel	Mel	\N	\N	\N	\N	02-20619B
1727	1727 Mel	Mel	\N	\N	\N	\N	08-25654
1729	1729 Mel	Mel	\N	\N	\N	\N	94-7602A
1731	1731 Mel	Mel	\N	\N	\N	\N	11-80898
1733	1733 Mel	Mel	\N	\N	\N	\N	11-37100B
1734	1734 Mel	Mel	\N	\N	\N	\N	04-50387
1736	1736 Mel	Mel	\N	\N	\N	\N	10-23548
1741	1741 Mel	Mel	\N	\N	04-14908A, 04-14908	\N	04-14908A
1743	1743 Mel	Mel	\N	\N	\N	\N	08-8920A
1744	1744 Mel	Mel	\N	\N	\N	\N	08-8920B
1747	1747 Mel	Mel	\N	\N	\N	\N	07-37090
1749	1749 Mel	Mel	\N	\N	\N	\N	07-77608
1750	1750 Mel	Mel	\N	\N	\N	\N	07-42908
1752	1752 Mel	Mel	\N	\N	\N	\N	08-44748
1754	1754 Mel	Mel	\N	\N	\N	\N	09-16836
1755	1755 Mel	Mel	\N	\N	\N	\N	05-58791
1757	1757 Mel	Mel	\N	\N	\N	\N	06-5249
1759	1759 Mel	Mel	\N	\N	\N	\N	98-11545
1762	1762 Mel	Mel	\N	\N	\N	\N	99-3122A
1764	1764 Mel	Mel	\N	\N	\N	\N	07-55149
1765	1765 Mel	Mel	\N	\N	\N	\N	01-6748
1767	1767 Mel	Mel	\N	\N	\N	\N	00-26584A1
1769	1769 Mel	Mel	\N	\N	\N	\N	00-7684A2
1770	1770 Mel	Mel	\N	\N	\N	\N	03-3075A
1771	1771 Mel	Mel	\N	\N	\N	\N	03-3075B
1774	1774 Mel	Mel	\N	\N	Light Blue	\N	05-27756A
1775	1775 Mel	Mel	\N	\N	Nevoid Melanoma	\N	05-27756B
1777	1777 Mel	Mel	\N	\N	\N	\N	98-9595B
1780	1780 Mel	Mel	\N	\N	\N	\N	98-21806
1782	1782 Mel	Mel	\N	\N	\N	\N	07-40241A
1783	1783 Mel	Mel	\N	\N	\N	\N	06-17933B
1786	1786 Mel	Mel	\N	\N	\N	\N	07-7626
1787	1787 Mel	Mel	\N	\N	\N	\N	95-21392
1790	1790 Mel	Mel	\N	\N	\N	\N	98-13466
1792	1792 Mel	Mel	\N	\N	\N	\N	93-13675B
1796	1796 Mel	Mel	\N	\N	http://64.54.108.147/eSlideTray.php?ImageIds=1021 , 05-5976B, 05-5976C	\N	05-5976B
1799	1799 Mel	Mel	\N	\N	http://64.54.108.147/eSlideTray.php?ImageIds=1408 , 06-21115A, 06-21115B	\N	06-21115A
1801	1801 Mel	Mel	\N	\N	\N	\N	98-6161B
1803	1803 Mel	Mel	\N	\N	\N	\N	01-11378A2
1805	1805 Mel	Mel	\N	\N	\N	\N	07-76799A
1808	1808 Mel	Mel	\N	\N	\N	\N	98-1556
1810	1810 Mel	Mel	\N	\N	http://64.54.108.147/eSlideTray.php?ImageIds=1002 , 99-19410B, 99-19410A	\N	99-19410A
1812	1812 Mel	Mel	\N	\N	\N	\N	06-22923
1814	1814 Mel	Mel	\N	\N	\N	\N	05-37586A3
1818	1818 Mel	Mel	\N	\N	\N	\N	04-57347A
1820	1820 Mel	Mel	\N	\N	\N	\N	00-5989A2
1826	1826 Mel	Mel	\N	\N	\N	\N	03-24651
1828	1828 Mel	Mel	\N	\N	\N	\N	98-10389
1830	1830 Mel	Mel	\N	\N	\N	\N	99-4387
1833	1833 Mel	Mel	\N	\N	\N	\N	97-13166G
1835	1835 Mel	Mel	\N	\N	http://64.54.108.1/eSlideTray.php?ImageIds=1404 , 06-73878C, 06-73878D	\N	06-73878C
1837	1837 Mel	Mel	\N	\N	\N	\N	99-3122A
1839	1839 Mel	Mel	\N	\N	\N	\N	92-5109
1841	1841 Mel	Mel	\N	\N	\N	\N	92-1608B
1843	1843 Mel	Mel	\N	\N	\N	\N	06-11151C
1846	1846 Mel	Mel	\N	\N	\N	\N	10-43330
1847	1847 Mel	Mel	\N	\N	\N	\N	00-4845
1849	1849 Mel	Mel	\N	\N	04-12137D, 04-12137E	\N	04-12137D,04-12137E
1851	1851 Mel	Mel	\N	\N	\N	\N	01-34127A
1853	1853 Mel	Mel	\N	\N	\N	\N	03-29330B
1855	1855 Mel	Mel	\N	\N	\N	\N	00-556B
1858	1858 Mel	Mel	\N	\N	\N	\N	03-30961B
1861	1861 Mel	Mel	\N	\N	\N	\N	97-23367
1863	1863 Mel	Mel	\N	\N	\N	\N	99-23502C
1884	1884 Mel	Mel	\N	\N	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	\N	21-59993A
1889	1889 Mel	Mel	\N	\N	MELANOMA, AT LEAST IN SITU, WITH SUPERIMPOSED CHANGES OF REGRESSION	\N	21-63575B
1917	1917 Mel	Mel	\N	\N	\N	\N	08-48442
1921	1921 Mel	Mel	\N	\N	\N	\N	04-34117
1923	1923 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1926	1926 Mel	Mel	\N	\N	\N	\N	05-27460
1931	1931 Mel	Mel	\N	\N	\N	\N	05-37586A3
1935	1935 Mel	Mel	\N	\N	\N	\N	99-32835
1941	1941 Mel	Mel	\N	\N	\N	\N	98-9595B
1944	1944 Mel	Mel	\N	\N	\N	\N	03-57215B
1951	1951 Mel	Mel	\N	\N	\N	\N	22-17043
1975	1975 Mel	Mel	\N	\N	\N	\N	17-116120
1977	1977 Mel	Mel	\N	\N	\N	\N	18-44728A
1978	1978 Mel	Mel	\N	\N	\N	\N	18-88579
1979	1979 Mel	Mel	\N	\N	\N	\N	18-90413
1989	1989 Mel	Mel	\N	\N	\N	\N	16-37928A
2038	2038 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	22-51092
2039	2039 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	22-51092
2040	2040 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	22-51092
2044	2044 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-106642A
2043	2043 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-106642A
2045	2045 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-106642A
2047	2047 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-91914A
2048	2048 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-91914A
2049	2049 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-91914A
2051	2051 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-60974B
2053	2053 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-60974B
2052	2052 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-60974B
2064	2064 Mel	Mel	\N	\N	Hunter has already sequenced this case before. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS5	\N	11-94204
2067	2067 Mel	Mel	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS12.	\N	12-93589A
2071	2071 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS13	\N	13-2138C
2074	2074 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS14	\N	13-98648
2077	2077 Mel	Mel	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS16	\N	14-64047
2080	2080 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS17	\N	14-33100
2083	2083 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS18	\N	14-47962
2086	2086 Mel	Mel	\N	\N	Progression Cases.	\N	14-73175B
2089	2089 Mel	Mel	\N	\N	Progression Cases. Block is missing (08/15/22) and there are no other blocks to get Normal tissue from.	\N	14-78242
2092	2092 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS1\\H&E	\N	11-23681B
2095	2095 Mel	Mel	\N	\N	Progression Cases, 12-67568A, 12-67568B	\N	12-67568B
2098	2098 Mel	Mel	\N	\N	\N	\N	12-12684
2101	2101 Mel	Mel	\N	\N	12-21993C, 12-21993I	\N	12-21993I
2104	2104 Mel	Mel	\N	\N	\N	\N	12-79097B
2109	2109 Mel	Mel	\N	\N	\N	\N	17-68780C
2111	2111 Mel	Mel	\N	\N	Progression Cases.	\N	14-73175B
2114	2114 Mel	Mel	\N	\N	\N	\N	17-38404A2
2117	2117 Mel	Mel	\N	\N	\N	\N	16-109052C
2124	2124 Mel	Mel	\N	\N	\N	\N	14-50051
2129	2129 Mel	Mel	\N	\N	\N	\N	17-68780C
2131	2131 Mel	Mel	\N	\N	\N	\N	17-100072A
2184	2184 Mel	Mel	\N	\N	\N	\N	16-35900
2187	2187 Mel	Mel	\N	\N	\N	\N	18-139329
2190	2190 Mel	Mel	\N	\N	\N	\N	18-75585B
2193	2193 Mel	Mel	\N	\N	\N	\N	19-36210A
2196	2196 Mel	Mel	\N	\N	\N	\N	19-5916
2200	2200 Mel	Mel	\N	\N	\N	\N	20-31447
2204	2204 Mel	Mel	\N	\N	\N	\N	20-43011
2211	2211 Mel	Mel	\N	\N	\N	\N	20-79197A
2215	2215 Mel	Mel	\N	\N	\N	\N	21-118604
2219	2219 Mel	Mel	\N	\N	\N	\N	21-131828
2227	2227 Mel	Mel	\N	\N	\N	\N	21-41149
2230	2230 Mel	Mel	\N	\N	\N	\N	21-44171
2234	2234 Mel	Mel	\N	\N	\N	\N	22-102809
2238	2238 Mel	Mel	\N	\N	\N	\N	19-36210A
2271	2271 Mel	Mel	\N	\N	\N	\N	15-48134
2273	2273 Mel	Mel	\N	\N	\N	\N	15-22411
2275	2275 Mel	Mel	\N	\N	\N	\N	15-50051
2277	2277 Mel	Mel	\N	\N	\N	\N	15-12964B
2279	2279 Mel	Mel	\N	\N	15-14665B, 15-14665C	\N	15-14665C
2281	2281 Mel	Mel	\N	\N	\N	\N	15-85517
2283	2283 Mel	Mel	\N	\N	\N	\N	15-21741
2285	2285 Mel	Mel	\N	\N	\N	\N	15-98263
2287	2287 Mel	Mel	\N	\N	\N	\N	22-101809
2290	2290 Mel	Mel	\N	\N	\N	\N	23-2718 (block 1)
2292	2292 Mel	Mel	\N	\N	\N	\N	23-2718 (block 2)
2294	2294 Mel	Mel	\N	\N	\N	\N	22-80319A1
2297	2297 Mel	Mel	\N	\N	\N	\N	22-80319A2
2299	2299 Mel	Mel	\N	\N	\N	\N	22-104652
2425	2425 Mel	Mel	2015-07-31 00:00:00-07	\N	\N	\N	12-22794A
2443	2443 Mel	Mel	\N	\N	\N	\N	23-47967
2447	2447 Mel	Mel	\N	\N	\N	\N	23-34755
2476	2476 Mel	Mel	\N	\N	\N	\N	22-44813B
2803	2803 Mel	Mel	\N	\N	\N	\N	96-6536
2860	2860 Mel	Mel	\N	\N	\N	\N	14-61299
2909	2909 Mel	Mel	\N	\N	\N	\N	10-41439
2910	2910 Mel	Mel	\N	\N	\N	\N	10-41439
2914	2914 Mel	Mel	\N	\N	\N	\N	08-46462
2919	2919 Mel	Mel	\N	\N	\N	\N	11-23681
2920	2920 Mel	Mel	\N	\N	\N	\N	11-23681
2923	2923 Mel	Mel	\N	\N	\N	\N	11-37533
2924	2924 Mel	Mel	\N	\N	\N	\N	11-37533
3275	3275 Mel	Mel	\N	\N	\N	\N	10-58663
3276	3276 Mel	Mel	\N	\N	\N	\N	10-58663
3291	3291 Mel	Mel	\N	\N	\N	\N	09-8165
3290	3290 Mel	Mel	\N	\N	\N	\N	09-8165
3296	3296 Mel	Mel	\N	\N	\N	\N	08-46462
3295	3295 Mel	Mel	\N	\N	\N	\N	08-46462
3376	3376 Mel	Mel	\N	\N	\N	\N	13-25110A1
3379	3379 Mel	Mel	\N	\N	\N	\N	13-45163
3806	3806 Mel	Mel	\N	\N	\N	\N	11-81851
3807	3807 Mel	Mel	\N	\N	\N	\N	11-81851
3858	3858 Mel	Mel	\N	\N	\N	\N	14-58566
3904	3904 Mel	Mel	\N	\N	\N	\N	\N
3906	3906 Mel	Mel	\N	\N	\N	\N	12-93589A
3908	3908 Mel	Mel	\N	\N	\N	\N	14-47962
3910	3910 Mel	Mel	\N	\N	\N	\N	14-73175B
3912	3912 Mel	Mel	\N	\N	\N	\N	14-78242
3914	3914 Mel	Mel	\N	\N	\N	\N	15-98263
3916	3916 Mel	Mel	\N	\N	\N	\N	\N
3918	3918 Mel	Mel	\N	\N	\N	\N	15-50051
3920	3920 Mel	Mel	\N	\N	\N	\N	15-12964B
3922	3922 Mel	Mel	\N	\N	\N	\N	15-14665B
3924	3924 Mel	Mel	\N	\N	\N	\N	15-85517
3926	3926 Mel	Mel	\N	\N	\N	\N	15-21741
3929	3929 Mel	Mel	\N	\N	\N	\N	11-94204
32	32 MIS	MIS	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	352-1-15.1
33	33 MIS	MIS	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	352-1-15.1
355	355 MIS	MIS	\N	\N	\N	\N	16-101803B
343	343 MIS	MIS	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22147	\N	\N	17-33401C
787	787 MIS	MIS	\N	\N	\N	\N	17-13334
884	884 MIS	MIS	\N	\N	\N	\N	16-88453A
885	885 MIS	MIS	\N	\N	\N	\N	17-32863B
1146	1146 MIS	MIS	\N	\N	\N	\N	501950A3
1498	1498 MIS	MIS	\N	\N	\N	\N	11-36301A5
1671	1671 MIS	MIS	\N	\N	\N	\N	04-31313A
1674	1674 MIS	MIS	\N	\N	\N	\N	09-23922B
1692	1692 MIS	MIS	\N	\N	\N	\N	13-32289B
1694	1694 MIS	MIS	\N	\N	\N	\N	01-16263
1703	1703 MIS	MIS	\N	\N	\N	\N	04-6689B
1706	1706 MIS	MIS	\N	\N	\N	\N	96-3842
1710	1710 MIS	MIS	\N	\N	\N	\N	96-18458C
1711	1711 MIS	MIS	\N	\N	\N	\N	96-18458F
1716	1716 MIS	MIS	\N	\N	\N	\N	03-16497B
1723	1723 MIS	MIS	\N	\N	\N	\N	03-39293
1726	1726 MIS	MIS	\N	\N	\N	\N	02-20619B
1737	1737 MIS	MIS	\N	\N	\N	\N	10-23548
1746	1746 MIS	MIS	\N	\N	\N	\N	08-8920B
1751	1751 MIS	MIS	\N	\N	\N	\N	07-42908
1761	1761 MIS	MIS	\N	\N	\N	\N	98-11545
1772	1772 MIS	MIS	\N	\N	\N	\N	03-3075B
1794	1794 MIS	MIS	\N	\N	\N	\N	93-13675B
1798	1798 MIS	MIS	\N	\N	\N	\N	05-5976A
1807	1807 MIS	MIS	\N	\N	\N	\N	07-76799A
1816	1816 MIS	MIS	\N	\N	\N	\N	05-37586A3
1832	1832 MIS	MIS	\N	\N	\N	\N	99-4387
1844	1844 MIS	MIS	\N	\N	\N	\N	06-11151C
1857	1857 MIS	MIS	\N	\N	\N	\N	00-556B
1860	1860 MIS	MIS	\N	\N	\N	\N	03-30961A
1918	1918 MIS	MIS	\N	\N	\N	\N	08-48442
1927	1927 MIS	MIS	\N	\N	\N	\N	05-27460
1932	1932 MIS	MIS	\N	\N	\N	\N	05-37586A3
1938	1938 MIS	MIS	\N	\N	\N	\N	06-10811
1954	1954 MIS	MIS	\N	\N	\N	\N	03-57215B
2119	2119 MIS	MIS	\N	\N	\N	\N	16-109052C
2122	2122 MIS	MIS	\N	\N	\N	\N	17-23681
2197	2197 MIS	MIS	\N	\N	\N	\N	19-5916
2201	2201 MIS	MIS	\N	\N	\N	\N	20-31447
2207	2207 MIS	MIS	\N	\N	\N	\N	20-53075B
2212	2212 MIS	MIS	\N	\N	\N	\N	20-79197A
2220	2220 MIS	MIS	\N	\N	\N	\N	21-131828
2231	2231 MIS	MIS	\N	\N	\N	\N	21-44171
2237	2237 MIS	MIS	\N	\N	\N	\N	21-118604
2243	2243 MIS	MIS	\N	\N	\N	\N	16-99265
2295	2295 MIS	MIS	\N	\N	\N	\N	22-80319A1
2444	2444 MIS	MIS	\N	\N	\N	\N	23-47967
2451	2451 MIS	MIS	2023-05-19 00:00:00-07	\N	\N	\N	23-37003
2459	2459 MIS	MIS	\N	\N	\N	\N	23-49347
2454	2454 MIS	MIS	2023-05-19 00:00:00-07	\N	\N	\N	21-135927
2470	2470 MIS	MIS	\N	\N	\N	\N	20-102366B1
2487	2487 MIS	MIS	\N	\N	\N	\N	22-38234B
2473	2473 MIS	MIS	\N	\N	\N	\N	23-51956B14
2484	2484 MIS	MIS	\N	\N	\N	\N	16-74494
2481	2481 MIS	MIS	\N	\N	\N	\N	22-7578
2474	2474 MIS	MIS	\N	\N	\N	\N	23-51956B16
2478	2478 MIS	MIS	\N	\N	\N	\N	22-102807-2
2492	2492 MIS	MIS	\N	\N	\N	\N	20-81257B
2495	2495 MIS	MIS	\N	\N	\N	\N	21-7055B6
2498	2498 MIS	MIS	\N	\N	\N	\N	21-457B
2501	2501 MIS	MIS	\N	\N	\N	\N	21-21304A1
2504	2504 MIS	MIS	\N	\N	\N	\N	22-91699A1
2507	2507 MIS	MIS	\N	\N	\N	\N	20-6751
2510	2510 MIS	MIS	\N	\N	\N	\N	18-83370A
2513	2513 MIS	MIS	\N	\N	\N	\N	18-12160E
2516	2516 MIS	MIS	\N	\N	\N	\N	21-83029B
2519	2519 MIS	MIS	\N	\N	\N	\N	21-62764
2522	2522 MIS	MIS	\N	\N	\N	\N	20-18383A1
2525	2525 MIS	MIS	\N	\N	\N	\N	21-79845
2637	2637 MIS	MIS	\N	\N	\N	\N	17-111862B
2640	2640 MIS	MIS	\N	\N	\N	\N	23-3314
2643	2643 MIS	MIS	\N	\N	\N	\N	18-51740C6
2646	2646 MIS	MIS	\N	\N	\N	\N	21-4449A3
2649	2649 MIS	MIS	\N	\N	\N	\N	19-360A1
2656	2656 MIS	MIS	\N	\N	\N	\N	20-37211A
2662	2662 MIS	MIS	\N	\N	\N	\N	20-8536E
2665	2665 MIS	MIS	\N	\N	\N	\N	22-34510A3
2668	2668 MIS	MIS	\N	\N	\N	\N	20-10245D1
2671	2671 MIS	MIS	\N	\N	\N	\N	17-33973C4
2674	2674 MIS	MIS	\N	\N	\N	\N	20-16903C1
2677	2677 MIS	MIS	\N	\N	\N	\N	13-17186A14
2681	2681 MIS	MIS	\N	\N	\N	\N	14-12190L4
110	110 DN	DN	\N	\N	\N	\N	16-119467B
111	111 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10819	\N	\N	16-118019
112	112 DN	DN	\N	\N	\N	\N	17-20908
113	113 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10878	\N	\N	17-62534
114	114 DN	DN	\N	\N	\N	\N	16-125177
115	115 DN	DN	\N	\N	\N	\N	17-65315B
116	116 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10832	\N	\N	16-97347
117	117 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10835	\N	\N	16-98123
118	118 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10868	\N	\N	17-36614
119	119 DN	DN	\N	\N	\N	\N	17-27830B
120	120 DN	DN	\N	\N	\N	\N	16-119311
121	121 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10855	\N	\N	17-28040A
122	122 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10818	\N	\N	16-117695A
123	123 DN	DN	\N	\N	\N	\N	16-126284A
124	124 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10846	\N	\N	17-21476B
125	125 DN	DN	\N	\N	\N	\N	17-21066B
126	126 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10825	\N	\N	16-125611
127	127 DN	DN	\N	\N	\N	\N	17-27833
128	128 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10834	\N	\N	16-98055B
129	129 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10871	\N	\N	17-3829B
130	130 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10822	\N	\N	16-119467D
131	131 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10833	\N	\N	16-98043
132	132 DN	DN	\N	\N	\N	\N	17-26447
133	133 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10836	\N	\N	16-98328A
134	134 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10852	\N	\N	17-26432B
136	136 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10853	\N	\N	17-27000
135	135 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10870	\N	\N	17-3731
137	137 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10844	\N	\N	17-21049
138	138 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10826	\N	\N	16-125621
139	139 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10839	\N	\N	16-98735
140	140 DN	DN	\N	\N	\N	\N	17-20501C
141	141 DN	DN	\N	\N	\N	\N	17-27380
142	142 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10841	\N	\N	17-20244B
143	143 DN	DN	\N	\N	\N	\N	16-118014
144	144 DN	DN	\N	\N	\N	\N	17-20497A
145	145 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10829	\N	\N	16-126714
146	146 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10856	\N	\N	17-34432B
147	147 DN	DN	\N	\N	\N	\N	17-34432C
148	148 DN	DN	\N	\N	\N	\N	17-34432D
150	150 DN	DN	\N	\N	\N	\N	17-35917A
151	151 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10863	\N	\N	17-35859A
149	149 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10859	\N	\N	17-35486A
153	153 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10857	\N	\N	17-34464A
152	152 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10865	\N	\N	17-35859C
154	154 DN	DN	\N	\N	\N	\N	17-34464B
156	156 DN	DN	\N	\N	\N	\N	17-64032
155	155 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10883	\N	\N	17-63837
157	157 DN	DN	\N	\N	\N	\N	17-65020B
158	158 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10876	\N	\N	17-62502A
159	159 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10877	\N	\N	17-62502B
160	160 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10886	\N	\N	17-65263C
162	162 DN	DN	\N	\N	\N	\N	17-65218B
161	161 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10879	\N	\N	17-62813A
165	165 DN	DN	\N	\N	\N	\N	16-12574
163	163 DN	DN	\N	\N	\N	\N	17-3739
164	164 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10849	\N	\N	17-26289G
166	166 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10823	\N	\N	16-119468
168	168 DN	DN	\N	\N	\N	\N	16-125177
167	167 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10845	\N	\N	17-21285
171	171 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10824	\N	\N	16-125609
172	172 DN	DN	\N	\N	\N	\N	17-27830B
170	170 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10832	\N	\N	16-97347
169	169 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10850	\N	\N	17-26400
174	174 DN	DN	\N	\N	\N	\N	16-119063
176	176 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10828	\N	\N	16-126258A
175	175 DN	DN	\N	\N	\N	\N	17-26455B
173	173 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10818	\N	\N	16-117695A
177	177 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10848	\N	\N	17-2270A
179	179 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10855	\N	\N	17-28040A
178	178 DN	DN	\N	\N	\N	\N	16-119311
180	180 DN	DN	\N	\N	\N	\N	16-125177
181	181 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10850	\N	\N	17-26400
182	182 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10832	\N	\N	16-97347
183	183 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10824	\N	\N	16-125609
184	184 DN	DN	\N	\N	\N	\N	17-27830B
185	185 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10818	\N	\N	16-117695A
186	186 DN	DN	\N	\N	\N	\N	16-119063
187	187 DN	DN	\N	\N	\N	\N	17-26455B
188	188 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10828	\N	\N	16-126258A
189	189 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10848	\N	\N	17-2270A
191	191 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10855	\N	\N	17-28040A
190	190 DN	DN	\N	\N	\N	\N	16-119311
193	193 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10842	\N	\N	17-20901
192	192 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10823	\N	\N	16-119468
194	194 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10845	\N	\N	17-21285
195	195 DN	DN	\N	\N	\N	\N	16-126284A
196	196 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10846	\N	\N	17-21476B
197	197 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10835	\N	\N	16-98123
198	198 DN	DN	\N	\N	\N	\N	17-21066B
199	199 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10827	\N	\N	16-125754
200	200 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10825	\N	\N	16-125611
201	201 DN	DN	\N	\N	\N	\N	17-27833
202	202 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10838	\N	\N	16-98733
203	203 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10837	\N	\N	16-98528A
204	204 DN	DN	\N	\N	\N	\N	16-98055A
205	205 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10834	\N	\N	16-98055B
237	237 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10829	\N	\N	16-126714
252	252 DN	DN	\N	\N	\N	\N	17-34448
220	220 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10820	\N	\N	16-119333
218	218 DN	DN	\N	\N	\N	\N	17-26969
240	240 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10856	\N	\N	17-34432B
208	208 DN	DN	\N	\N	\N	\N	16-119467C
259	259 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10874	\N	\N	17-62447A
207	207 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10821	\N	\N	16-119467B
276	276 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10873	\N	\N	17-62251
256	256 DN	DN	\N	\N	\N	\N	17-36682
278	278 DN	DN	\N	\N	\N	\N	17-63890C
231	231 DN	DN	\N	\N	\N	\N	17-20501C
254	254 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10857	\N	\N	17-34464A
275	275 DN	DN	\N	\N	\N	\N	17-63163
263	263 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10885	\N	\N	17-65201A
261	261 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10880	\N	\N	17-62828A
269	269 DN	DN	\N	\N	\N	\N	17-65000
215	215 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10851	\N	\N	17-26432A
232	232 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10854	\N	\N	17-27403
247	247 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10863	\N	\N	17-35859A
243	243 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10859	\N	\N	17-35486A
253	253 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10858	\N	\N	17-34977
241	241 DN	DN	\N	\N	\N	\N	17-34432C
223	223 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10830	\N	\N	16-126879A
219	219 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10870	\N	\N	17-3731
250	250 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10860	\N	\N	17-35502A
248	248 DN	DN	\N	\N	\N	\N	17-35859B
228	228 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10826	\N	\N	16-125621
273	273 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10879	\N	\N	17-62813A
210	210 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10833	\N	\N	16-98043
249	249 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10865	\N	\N	17-35859C
222	222 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10844	\N	\N	17-21049
260	260 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10875	\N	\N	17-62447B
239	239 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10866	\N	\N	17-35916B
234	234 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10841	\N	\N	17-20244B
221	221 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10853	\N	\N	17-27000
224	224 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10819	\N	\N	16-118019
235	235 DN	DN	\N	\N	\N	\N	16-118014
226	226 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10847	\N	\N	17-2241
266	266 DN	DN	\N	\N	\N	\N	17-64032
267	267 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10882	\N	\N	17-63503
268	268 DN	DN	\N	\N	\N	\N	17-65020B
214	214 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10836	\N	\N	16-98328A
213	213 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10849	\N	\N	17-26289G
216	216 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10852	\N	\N	17-26432B
262	262 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10881	\N	\N	17-62828B
230	230 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10839	\N	\N	16-98735
209	209 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10822	\N	\N	16-119467D
271	271 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10877	\N	\N	17-62502B
279	279 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10884	\N	\N	17-65160B
211	211 DN	DN	\N	\N	\N	\N	17-3739
246	246 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10867	\N	\N	17-35917B
212	212 DN	DN	\N	\N	\N	\N	17-26447
258	258 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10868	\N	\N	17-36614
225	225 DN	DN	\N	\N	\N	\N	17-20900B
257	257 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10872	\N	\N	17-48595B
244	244 DN	DN	\N	\N	\N	\N	17-35486B
272	272 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10886	\N	\N	17-65263C
242	242 DN	DN	\N	\N	\N	\N	17-34432D
206	206 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10871	\N	\N	17-3829B
227	227 DN	DN	\N	\N	\N	\N	16-98130
251	251 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10861	\N	\N	17-35502B
245	245 DN	DN	\N	\N	\N	\N	17-35917A
217	217 DN	DN	\N	\N	\N	\N	17-20908
274	274 DN	DN	\N	\N	\N	\N	17-65218B
238	238 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10862	\N	\N	17-35589
233	233 DN	DN	\N	\N	\N	\N	17-27380
236	236 DN	DN	\N	\N	\N	\N	17-20497A
277	277 DN	DN	\N	\N	\N	\N	17-65315B
270	270 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10876	\N	\N	17-62502A
255	255 DN	DN	\N	\N	\N	\N	17-34464B
229	229 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10831	\N	\N	16-48776B
265	265 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10883	\N	\N	17-63837
264	264 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10878	\N	\N	17-62534
687	687 DN	DN	\N	\N	\N	\N	18-96989
707	707 DN	DN	\N	\N	\N	\N	17-74882B
722	722 DN	DN	\N	\N	\N	\N	17-117666
692	692 DN	DN	\N	\N	\N	\N	17-82365B
726	726 DN	DN	\N	\N	\N	\N	17-112631B
725	725 DN	DN	\N	\N	\N	\N	17-81609B
720	720 DN	DN	\N	\N	\N	\N	17-81767C
704	704 DN	DN	\N	\N	\N	\N	17-85037
709	709 DN	DN	\N	\N	\N	\N	17-125335
713	713 DN	DN	\N	\N	\N	\N	17-112277
699	699 DN	DN	\N	\N	\N	\N	18-120593B
708	708 DN	DN	\N	\N	\N	\N	17-74282
700	700 DN	DN	\N	\N	\N	\N	18-90550
712	712 DN	DN	\N	\N	\N	\N	18-121415
727	727 DN	DN	\N	\N	\N	\N	18-65038B
711	711 DN	DN	\N	\N	\N	\N	18-54612
718	718 DN	DN	\N	\N	\N	\N	18-120587
702	702 DN	DN	\N	\N	\N	\N	17-72563
696	696 DN	DN	\N	\N	\N	\N	18-96108
703	703 DN	DN	\N	\N	\N	\N	17-92405
728	728 DN	DN	\N	\N	\N	\N	17-93920
705	705 DN	DN	\N	\N	\N	\N	17-74152D
688	688 DN	DN	\N	\N	\N	\N	17-72585B
721	721 DN	DN	\N	\N	\N	\N	17-81767B
690	690 DN	DN	\N	\N	\N	\N	17-72585C
719	719 DN	DN	\N	\N	\N	\N	17-82806
695	695 DN	DN	\N	\N	\N	\N	17-91889
716	716 DN	DN	\N	\N	\N	\N	17-92850
715	715 DN	DN	\N	\N	\N	\N	18-52908
693	693 DN	DN	\N	\N	\N	\N	17-72429A
723	723 DN	DN	\N	\N	\N	\N	17-117775B
724	724 DN	DN	\N	\N	\N	\N	17-49739B
710	710 DN	DN	\N	\N	\N	\N	17-93961A
717	717 DN	DN	\N	\N	\N	\N	18-120470
706	706 DN	DN	\N	\N	\N	\N	17-74882A
698	698 DN	DN	\N	\N	\N	\N	18-119369B
714	714 DN	DN	\N	\N	\N	\N	18-121006
689	689 DN	DN	\N	\N	\N	\N	17-72585A
691	691 DN	DN	\N	\N	\N	\N	17-93945C
697	697 DN	DN	\N	\N	\N	\N	18-121403A
694	694 DN	DN	\N	\N	\N	\N	18-119366A
701	701 DN	DN	\N	\N	\N	\N	17-72580
1249	1249 DN	DN	\N	\N	\N	\N	18-135600
1284	1284 DN	DN	\N	\N	\N	\N	19-37607D
1271	1271 DN	DN	\N	\N	\N	\N	19-29433C
1250	1250 DN	DN	\N	\N	\N	\N	18-135492
1255	1255 DN	DN	\N	\N	\N	\N	19-7686A
1259	1259 DN	DN	\N	\N	\N	\N	18-137340A
1276	1276 DN	DN	\N	\N	\N	\N	19-37607E
1265	1265 DN	DN	\N	\N	\N	\N	19-7357A
1275	1275 DN	DN	\N	\N	\N	\N	19-30025B
1256	1256 DN	DN	\N	\N	\N	\N	18-135485
1262	1262 DN	DN	\N	\N	\N	\N	18-137809B
1279	1279 DN	DN	\N	\N	\N	\N	19-37607F
1282	1282 DN	DN	\N	\N	\N	\N	19-38090
1252	1252 DN	DN	\N	\N	\N	\N	18-136721
1261	1261 DN	DN	\N	\N	\N	\N	18-137857
1272	1272 DN	DN	\N	\N	\N	\N	19-15130
1264	1264 DN	DN	\N	\N	\N	\N	19-7344
1278	1278 DN	DN	\N	\N	\N	\N	19-15378
1251	1251 DN	DN	\N	\N	\N	\N	18-135488
1280	1280 DN	DN	\N	\N	\N	\N	19-37409B
1260	1260 DN	DN	\N	\N	\N	\N	18-137854C
1283	1283 DN	DN	\N	\N	\N	\N	19-15442
1270	1270 DN	DN	\N	\N	\N	\N	19-7669
1258	1258 DN	DN	\N	\N	\N	\N	18-136800B
1253	1253 DN	DN	\N	\N	\N	\N	18-136716B
1277	1277 DN	DN	\N	\N	\N	\N	19-38447
1273	1273 DN	DN	\N	\N	\N	\N	19-37609
1268	1268 DN	DN	\N	\N	\N	\N	19-7600
1263	1263 DN	DN	\N	\N	\N	\N	19-7126B
1281	1281 DN	DN	\N	\N	\N	\N	19-30079A
1257	1257 DN	DN	\N	\N	\N	\N	18-136484
1267	1267 DN	DN	\N	\N	\N	\N	19-7596C
1274	1274 DN	DN	\N	\N	\N	\N	19-29129
1254	1254 DN	DN	\N	\N	\N	\N	18-136800A
1266	1266 DN	DN	\N	\N	\N	\N	19-7357B
1269	1269 DN	DN	\N	\N	\N	\N	19-7601
3484	3484 DN	DN	\N	\N	\N	\N	18-96989
3485	3485 DN	DN	\N	\N	\N	\N	17-72585B
3486	3486 DN	DN	\N	\N	\N	\N	17-72585A
3487	3487 DN	DN	\N	\N	\N	\N	17-72585C
3488	3488 DN	DN	\N	\N	\N	\N	17-93945C
3489	3489 DN	DN	\N	\N	\N	\N	17-82365B
3490	3490 DN	DN	\N	\N	\N	\N	17-72429A
3491	3491 DN	DN	\N	\N	\N	\N	18-119366A
3492	3492 DN	DN	\N	\N	\N	\N	17-91889
3493	3493 DN	DN	\N	\N	\N	\N	18-96108
3494	3494 DN	DN	\N	\N	\N	\N	18-121403A
3495	3495 DN	DN	\N	\N	\N	\N	18-121403A
3496	3496 DN	DN	\N	\N	\N	\N	18-119369B
3497	3497 DN	DN	\N	\N	\N	\N	18-120593B
3498	3498 DN	DN	\N	\N	\N	\N	18-90550
3500	3500 DN	DN	\N	\N	\N	\N	17-72563
3499	3499 DN	DN	\N	\N	\N	\N	17-72580
3502	3502 DN	DN	\N	\N	\N	\N	17-85037
3501	3501 DN	DN	\N	\N	\N	\N	17-92405
3503	3503 DN	DN	\N	\N	\N	\N	17-74152D
3504	3504 DN	DN	\N	\N	\N	\N	17-74882A
3505	3505 DN	DN	\N	\N	\N	\N	17-74882B
3507	3507 DN	DN	\N	\N	\N	\N	17-125335
3506	3506 DN	DN	\N	\N	\N	\N	17-74282
3508	3508 DN	DN	\N	\N	\N	\N	17-93961A
3509	3509 DN	DN	\N	\N	\N	\N	18-54612
3510	3510 DN	DN	\N	\N	\N	\N	18-121415
3511	3511 DN	DN	\N	\N	\N	\N	17-112277
3513	3513 DN	DN	\N	\N	\N	\N	18-52908
3512	3512 DN	DN	\N	\N	\N	\N	18-121006
3514	3514 DN	DN	\N	\N	\N	\N	17-92850
3515	3515 DN	DN	\N	\N	\N	\N	18-120587
3517	3517 DN	DN	\N	\N	\N	\N	17-81767C
3516	3516 DN	DN	\N	\N	\N	\N	17-82806
3518	3518 DN	DN	\N	\N	\N	\N	17-81767B
3519	3519 DN	DN	\N	\N	\N	\N	17-117666
3520	3520 DN	DN	\N	\N	\N	\N	17-117775B
3522	3522 DN	DN	\N	\N	\N	\N	17-81609B
3521	3521 DN	DN	\N	\N	\N	\N	17-49739B
3525	3525 DN	DN	\N	\N	\N	\N	17-93920
3523	3523 DN	DN	\N	\N	\N	\N	17-112631B
3524	3524 DN	DN	\N	\N	\N	\N	18-65038B
359	359 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-A-B
380	380 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-A
390	390 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-D
419	419 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K23-A-B
403	403 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K16-D
415	415 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K22-A-B
395	395 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K14-D
411	411 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K21-A-B
407	407 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K20-A-B
394	394 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K13-D
391	391 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K12-D
404	404 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K17-D
398	398 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-D
364	364 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-A-D
360	360 Normal 2	Normal 2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-D
381	381 Normal 2	Normal 2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-C
1603	1603 Normal 2	Normal 2	\N	\N	\N	\N	19-51759
2458	2458 Normal 2	Normal 2	\N	\N	\N	\N	12-3277
385	385 LN Met 1	LN Met 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-C
379	379 LN Met 1	LN Met 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K9-C
1154	1154 LN Met 1	LN Met 1	\N	\N	\N	\N	K1-C
1148	1148 LN Met 1	LN Met 1	\N	\N	\N	\N	B2007.998/2
1307	1307 LN Met 1	LN Met 1	\N	\N	\N	\N	B2007.15494/1
1423	1423 LN Met 1	LN Met 1	\N	\N	\N	\N	B2008.3067/5
1479	1479 LN Met 1	LN Met 1	\N	\N	\N	\N	15-17010C1
1499	1499 LN Met 1	LN Met 1	\N	\N	\N	\N	11-36301C1
1519	1519 LN Met 1	LN Met 1	\N	\N	\N	\N	15-3736A1
1527	1527 LN Met 1	LN Met 1	\N	\N	\N	\N	15-4505C
1558	1558 LN Met 1	LN Met 1	\N	\N	\N	\N	17-9337A1
1574	1574 LN Met 1	LN Met 1	\N	\N	\N	\N	16-10035C
1609	1609 LN Met 1	LN Met 1	\N	\N	\N	\N	16-35844B2
397	397 Mel 1	Mel 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K14-B
424	424 Blue + spitz	Blue + spitz	\N	\N	\N	\N	15-21302
425	425 Blue + spitz	Blue + spitz	\N	\N	\N	\N	11-53065
428	428 blue nevus+ cellular+  DF like	blue nevus, cellular,  DF like	\N	\N	\N	\N	17-120984
427	427 blue nevus+ cellular+  DF like	blue nevus, cellular,  DF like	\N	\N	\N	\N	16-33907
426	426 blue nevus+ cellular+  DF like	blue nevus, cellular,  DF like	\N	\N	\N	\N	06-2345
432	432 common + blue	common + blue	\N	\N	\N	\N	17-90774B
430	430 common + blue	common + blue	\N	\N	\N	\N	15-72350
431	431 common + blue	common + blue	\N	\N	\N	\N	17-82364B
433	433 common + blue	common + blue	\N	\N	\N	\N	17-106118B
434	434 common + blue	common + blue	\N	\N	\N	\N	17-106118C
435	435 common + blue	common + blue	\N	\N	\N	\N	17-115105
429	429 common + blue	common + blue	\N	\N	\N	\N	12-51532
439	439 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	17-21788B
445	445 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	18-113402B
443	443 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	18-59376
437	437 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	15-118245A
440	440 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	17-52720
436	436 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	15-16261
441	441 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	17-120487A
536	536 Compound	Compound	\N	\N	\N	\N	18-18111B
438	438 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	17-10753
442	442 compound meloncytic nevus 	compound meloncytic nevus 	\N	\N	\N	\N	18-24908
444	444 blue nevus+ cellular 	blue nevus, cellular 	\N	\N	\N	\N	18-76281
446	446 DPN+ pure	DPN, pure	\N	\N	\N	\N	12-16974C
447	447 balloon cell nevus	balloon cell nevus	\N	\N	\N	\N	17-128346A
448	448 common & balloon	common & balloon	\N	\N	\N	\N	18-85718
1999	1999 blue nevus with ovoid melanocytes	blue nevus with ovoid melanocytes	\N	\N	\N	\N	20-026598
452	452 Spitz mel	Spitz mel	\N	\N	\N	\N	14-39393
454	454 Spitz mel	Spitz mel	\N	\N	\N	\N	14-59414
458	458 Spitz mel	Spitz mel	\N	\N	\N	\N	15-52921B
460	460 Spitz mel	Spitz mel	\N	\N	\N	\N	11-7028
459	459 Spitz mel	Spitz mel	\N	\N	\N	\N	11-1044
462	462 Spitz mel	Spitz mel	\N	\N	\N	\N	14-115431C
456	456 Spitz mel	Spitz mel	\N	\N	\N	\N	13-105024A
457	457 Spitz mel	Spitz mel	\N	\N	\N	\N	12-91942
461	461 Spitz mel	Spitz mel	\N	\N	\N	\N	14-115431A
455	455 Spitz mel	Spitz mel	\N	\N	\N	\N	12-24027C
463	463 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-37217
464	464 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-52736
467	467 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-20144
474	474 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-43354
466	466 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-6550
472	472 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	10-83193
468	468 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-32138
469	469 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-47908
465	465 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-97918
473	473 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-19048
471	471 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-85008
470	470 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-59209
477	477 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	12-16974B
481	481 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-121943A
486	486 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	14-113821
492	492 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	14-48102
494	494 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	16-83056
491	491 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	12-67286
487	487 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-34960
479	479 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	19-1978C
497	497 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	17-112474
490	490 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	12-26470
483	483 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-121973
485	485 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	15-101715
478	478 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-129422
480	480 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	19-2264A
493	493 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	14-96361
489	489 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-122972
482	482 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-121971A
488	488 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-122476
496	496 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-95537
484	484 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-121986
495	495 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	17-61001
502	502 Junctional	Junctional	\N	\N	\N	\N	17-111004B
503	503 Junctional	Junctional	\N	\N	\N	\N	17-112365B
505	505 Junctional	Junctional	\N	\N	\N	\N	17-115572A
506	506 Junctional	Junctional	\N	\N	\N	\N	17-115588
518	518 Junctional	Junctional	\N	\N	\N	\N	17-115571C
512	512 Junctional	Junctional	\N	\N	\N	\N	18-18111A
509	509 Junctional	Junctional	\N	\N	\N	\N	17-111657B
521	521 Junctional	Junctional	\N	\N	\N	\N	17-112588B
508	508 Junctional	Junctional	\N	\N	\N	\N	17-111657A
513	513 Junctional	Junctional	\N	\N	\N	\N	17-112653
520	520 Junctional	Junctional	\N	\N	\N	\N	17-112365A
510	510 Junctional	Junctional	\N	\N	\N	\N	17-111279
507	507 Junctional	Junctional	\N	\N	\N	\N	17-115635
517	517 Junctional	Junctional	\N	\N	\N	\N	17-111038B
519	519 Junctional	Junctional	\N	\N	\N	\N	17-115571D
514	514 Junctional	Junctional	\N	\N	\N	\N	17-115568B
515	515 Junctional	Junctional	\N	\N	\N	\N	17-114505
516	516 Junctional	Junctional	\N	\N	\N	\N	17-115149A
504	504 Junctional	Junctional	\N	\N	\N	\N	17-111571
511	511 Junctional	Junctional	\N	\N	\N	\N	18-61924A
675	675 Junctional	Junctional	\N	\N	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS	\N	17-118831C
680	680 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-119302B
676	676 Junctional	Junctional	\N	\N	LENTIGINOUS INTRAEPIDERMAL PROLIFERATION OF MELANOCYTES, WITH EXTENSION CLOSE TO THE PERIPHERY OF THE BIOPSY	\N	17-109907D
679	679 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-119445
677	677 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-120049C
681	681 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-118980
678	678 Junctional	Junctional	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	17-119013
682	682 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-120790
1865	1865 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-119570C
1866	1866 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-119451
527	527 Congenital superficial	Congenital superficial	\N	\N	\N	\N	18-81165B
526	526 Congenital superficial	Congenital superficial	\N	\N	\N	\N	17-111004C
524	524 Congenital superficial	Congenital superficial	\N	\N	\N	\N	18-35802B
525	525 Congenital superficial	Congenital superficial	\N	\N	\N	\N	17-111004A
523	523 Congenital superficial	Congenital superficial	\N	\N	\N	\N	18-27178B
548	548 Congenital superficial	Congenital superficial	\N	\N	\N	\N	18-44465
522	522 Congenital superficial	Congenital superficial	\N	\N	\N	\N	17-111040A
541	541 Compound	Compound	\N	\N	\N	\N	18-19195A
538	538 Compound	Compound	\N	\N	\N	\N	18-57977B
530	530 Compound	Compound	\N	\N	\N	\N	18-27178A
546	546 Compound	Compound	\N	\N	\N	\N	18-69862B
545	545 Compound	Compound	\N	\N	\N	\N	18-69862A
537	537 Compound	Compound	\N	\N	\N	\N	18-18111C
544	544 Compound	Compound	\N	\N	\N	\N	18-44464
542	542 Compound	Compound	\N	\N	\N	\N	18-44463B
547	547 Compound	Compound	\N	\N	\N	\N	18-76615
540	540 Compound	Compound	\N	\N	\N	\N	18-65957A
533	533 Compound	Compound	\N	\N	\N	\N	18-17957
531	531 Compound	Compound	\N	\N	\N	\N	17-111324
529	529 Compound	Compound	\N	\N	\N	\N	17-114552
543	543 Compound	Compound	\N	\N	\N	\N	18-44463C
539	539 Compound	Compound	\N	\N	\N	\N	18-65460
535	535 Compound	Compound	\N	\N	\N	\N	17-111704B
534	534 Compound	Compound	\N	\N	\N	\N	17-111704A
532	532 Compound	Compound	\N	\N	\N	\N	17-113511
528	528 Compound	Compound	\N	\N	\N	\N	18-136508B
685	685 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17460	\N	18-15803
684	684 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17455	\N	18-15165
683	683 Compound	Compound	\N	\N	JUNCTIONAL PROLIFERATION OF MELANOCYTES, FAVOR A LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-110828C
1867	1867 Compound	Compound	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-120839
1868	1868 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	17-120280
1869	1869 Compound	Compound	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-120276
1870	1870 Compound	Compound	\N	\N	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17446	\N	17-118904B
1871	1871 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17448	\N	17-119079A
1872	1872 Compound	Compound	\N	\N	http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17451	\N	17-99294B
1873	1873 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17458	\N	18-15028
1874	1874 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	18-15487B
551	551 Nodular Mel	Nodular Mel	\N	\N	\N	\N	5890/08
556	556 Nodular Mel	Nodular Mel	\N	\N	\N	\N	07B2313 (eppendorf)
601	601 Nodular Mel	Nodular Mel	\N	\N	\N	\N	17-1468II-2
591	591 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B215962
552	552 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1485/15 (1485/15 slide)
587	587 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B224228/2
593	593 Nodular Mel	Nodular Mel	\N	\N	\N	\N	351/10 2 (HBD)
565	565 Nodular Mel	Nodular Mel	\N	\N	\N	\N	14B1910 (eppendorf)
589	589 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B236709/ 1B
600	600 Nodular Mel	Nodular Mel	\N	\N	\N	\N	176323
599	599 Nodular Mel	Nodular Mel	\N	\N	\N	\N	15356/1 (H08.15356/1 slide)
558	558 Nodular Mel	Nodular Mel	\N	\N	\N	\N	14B13985 (eppendorf)
579	579 Nodular Mel	Nodular Mel	\N	\N	\N	\N	4890/15 8
576	576 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1283/14
590	590 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B206739
602	602 Nodular Mel	Nodular Mel	\N	\N	\N	\N	17-1741I
566	566 Nodular Mel	Nodular Mel	\N	\N	\N	\N	13B10486 (eppendorf)
588	588 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B205907 III
571	571 Nodular Mel	Nodular Mel	\N	\N	\N	\N	16053/12 wy (16053/12 slide)
572	572 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2227/14 4
582	582 Nodular Mel	Nodular Mel	\N	\N	\N	\N	5698.3 (14.5698.3 slide)
559	559 Nodular Mel	Nodular Mel	\N	\N	\N	\N	10B18943 (eppendorf)
553	553 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2997/11
596	596 Nodular Mel	Nodular Mel	\N	\N	\N	\N	N-ID 2225
561	561 Nodular Mel	Nodular Mel	\N	\N	\N	\N	08B8345 (eppendorf)
560	560 Nodular Mel	Nodular Mel	\N	\N	\N	\N	08B9531 (eppendorf)
567	567 Nodular Mel	Nodular Mel	\N	\N	\N	\N	11B9724 (eppendorf)
581	581 Nodular Mel	Nodular Mel	\N	\N	\N	\N	11649.2 (15.11649.2 slide)
573	573 Nodular Mel	Nodular Mel	\N	\N	\N	\N	150/17
554	554 Nodular Mel	Nodular Mel	\N	\N	\N	\N	5696/15
562	562 Nodular Mel	Nodular Mel	\N	\N	\N	\N	10B339 (eppendorf)
585	585 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B246205/ 1BI
557	557 Nodular Mel	Nodular Mel	\N	\N	\N	\N	16B10343 (eppendorf)
555	555 Nodular Mel	Nodular Mel	\N	\N	\N	\N	03B12175 (eppendorf)
583	583 Nodular Mel	Nodular Mel	\N	\N	\N	\N	12410/09
564	564 Nodular Mel	Nodular Mel	\N	\N	\N	\N	16B8849 (eppendorf)
577	577 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1205/17
569	569 Nodular Mel	Nodular Mel	\N	\N	\N	\N	11522/18
584	584 Nodular Mel	Nodular Mel	\N	\N	\N	\N	17890/18 (HBD)
570	570 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2065/12 (2065/117 slide)
598	598 Nodular Mel	Nodular Mel	\N	\N	\N	\N	3188/18
574	574 Nodular Mel	Nodular Mel	\N	\N	\N	\N	4136/16
563	563 Nodular Mel	Nodular Mel	\N	\N	\N	\N	10B7952 (eppendorf)
597	597 Nodular Mel	Nodular Mel	\N	\N	\N	\N	N-ID 1941
580	580 Nodular Mel	Nodular Mel	\N	\N	\N	\N	6172.3 (14.6172.3 slide)
594	594 Nodular Mel	Nodular Mel	\N	\N	\N	\N	351/10 4 (HBD)
568	568 Nodular Mel	Nodular Mel	\N	\N	\N	\N	11B2562 (eppendorf)
578	578 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1813/15 3
575	575 Nodular Mel	Nodular Mel	\N	\N	\N	\N	4449/16 (4449/16 3 slide)
586	586 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B247206/ 1Bl
595	595 Nodular Mel	Nodular Mel	\N	\N	\N	\N	467/10  1
592	592 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B167003/1B  I
1004	1004 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1135/19
1005	1005 Nodular Mel	Nodular Mel	\N	\N	\N	\N	59/15
1006	1006 Nodular Mel	Nodular Mel	\N	\N	\N	\N	718/12a
1008	1008 Nodular Mel	Nodular Mel	\N	\N	\N	\N	46976B
1007	1007 Nodular Mel	Nodular Mel	\N	\N	\N	\N	115016
1009	1009 Nodular Mel	Nodular Mel	\N	\N	\N	\N	6258/2015
1010	1010 Nodular Mel	Nodular Mel	\N	\N	\N	\N	21831/14
1011	1011 Nodular Mel	Nodular Mel	\N	\N	\N	\N	156/13
1012	1012 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2017-19575
1013	1013 Nodular Mel	Nodular Mel	\N	\N	\N	\N	K3920/19 A1
1014	1014 Nodular Mel	Nodular Mel	\N	\N	\N	\N	10226 2
1015	1015 Nodular Mel	Nodular Mel	\N	\N	\N	\N	M32727/18 A1
1016	1016 Nodular Mel	Nodular Mel	\N	\N	\N	\N	M21326/18 A1
1017	1017 Nodular Mel	Nodular Mel	\N	\N	\N	\N	14531/14
1018	1018 Nodular Mel	Nodular Mel	\N	\N	\N	\N	8716/2016
1020	1020 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2017-07184
1019	1019 Nodular Mel	Nodular Mel	\N	\N	\N	\N	M31513/18
1021	1021 Nodular Mel	Nodular Mel	\N	\N	\N	\N	15864 3
604	604 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MaMel 152aI
605	605 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M100118
1366	1366 Tumor	Tumor	\N	\N	\N	\N	15-71393
606	606 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM100511
607	607 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM100512
608	608 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM100513
609	609 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM100916
610	610 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040204
611	611 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040415
612	612 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040416
613	613 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040418
614	614 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040419A
615	615 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM160113
616	616 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M180322
1246	1246 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMel 1107B Dec2019
1247	1247 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMel 1121B Dec2019
1248	1248 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040204 Dec2019
1316	1316 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMEL 1023A
1317	1317 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMEL 1107B
1318	1318 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMEL 1121B
1319	1319 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	Mel290
2836	2836 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM8
2837	2837 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM51
2838	2838 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM1963
2839	2839 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM3622
2840	2840 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM3912
2841	2841 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM3918
621	621 Nevus?	Nevus?	\N	\N	\N	\N	12-24226
625	625 Nevus?	Nevus?	\N	\N	\N	\N	15-42060
619	619 Nevus?	Nevus?	\N	\N	\N	\N	12-10777
622	622 Nevus?	Nevus?	\N	\N	\N	\N	14-29390
620	620 Nevus?	Nevus?	\N	\N	\N	\N	12-1782
624	624 Nevus?	Nevus?	\N	\N	\N	\N	17-132120
623	623 Nevus?	Nevus?	\N	\N	\N	\N	14-90528
673	673 Uveal Mel	Uveal Mel	\N	\N	\N	\N	MP41
674	674 Uveal Mel	Uveal Mel	\N	\N	\N	\N	MP41-YM-R1
2760	2760 Uveal Mel	Uveal Mel	\N	\N	Uveal Melanoma, Dr. Seider	\N	UM1_UvealMel
2761	2761 Uveal Mel	Uveal Mel	\N	\N	Uveal Melanoma, Dr. Seider	\N	UM2_UvealMel
3838	3838 Uveal Mel	Uveal Mel	\N	\N	\N	\N	UM23
3839	3839 Uveal Mel	Uveal Mel	\N	\N	\N	\N	UM24
3840	3840 Uveal Mel	Uveal Mel	\N	\N	\N	\N	UM25
3841	3841 Uveal Mel	Uveal Mel	\N	\N	\N	\N	UM26
617	617 Tumor	Tumor	\N	\N	\N	\N	11-13665
730	730 Tumor	Tumor	\N	\N	\N	\N	18-28169
997	997 Tumor	Tumor	\N	\N	PRKC fused cases	\N	12-11041
998	998 Tumor	Tumor	\N	\N	PRKC fused cases	\N	12-70514
999	999 Tumor	Tumor	\N	\N	PRKC fused cases	\N	14-15427
1000	1000 Tumor	Tumor	\N	\N	NRAS sequencing	\N	15-101612
1001	1001 Tumor	Tumor	\N	\N	NRAS sequencing	\N	14-43805
1002	1002 Tumor	Tumor	\N	\N	NRAS sequencing	\N	10-75211
1003	1003 Tumor	Tumor	\N	\N	Atypical Spitz tumor-nodule	\N	19-44904
1144	1144 Tumor	Tumor	\N	\N	\N	\N	12-169
1136	1136 Tumor	Tumor	\N	\N	\N	\N	13-140
1137	1137 Tumor	Tumor	\N	\N	\N	\N	13-129
1141	1141 Tumor	Tumor	\N	\N	\N	\N	12-073
1140	1140 Tumor	Tumor	\N	\N	\N	\N	13-028
1139	1139 Tumor	Tumor	\N	\N	\N	\N	13-074
1135	1135 Tumor	Tumor	\N	\N	\N	\N	13-207
1142	1142 Tumor	Tumor	\N	\N	\N	\N	12-095
1138	1138 Tumor	Tumor	\N	\N	\N	\N	13-122
1143	1143 Tumor	Tumor	\N	\N	\N	\N	12-122
1315	1315 Tumor	Tumor	\N	\N	\N	\N	12-4251
1320	1320 Tumor	Tumor	\N	\N	\N	\N	11-31904
1321	1321 Tumor	Tumor	\N	\N	\N	\N	11-5482
1322	1322 Tumor	Tumor	\N	\N	\N	\N	12-11041
1323	1323 Tumor	Tumor	\N	\N	\N	\N	11-23710,11-61046
1324	1324 Tumor	Tumor	\N	\N	\N	\N	11-23710
1325	1325 Tumor	Tumor	\N	\N	\N	\N	Lung cancer with ALK fusion
1328	1328 Tumor	Tumor	\N	\N	\N	\N	14-077
1329	1329 Tumor	Tumor	\N	\N	\N	\N	12-200
1330	1330 Tumor	Tumor	\N	\N	\N	\N	11-072
1331	1331 Tumor	Tumor	\N	\N	\N	\N	11-091
1332	1332 Tumor	Tumor	\N	\N	\N	\N	11-133
1333	1333 Tumor	Tumor	\N	\N	\N	\N	11-154
1334	1334 Tumor	Tumor	\N	\N	\N	\N	11-172
1335	1335 Tumor	Tumor	\N	\N	\N	\N	11-256
1336	1336 Tumor	Tumor	\N	\N	\N	\N	11-12273
1345	1345 Tumor	Tumor	\N	\N	\N	\N	12-48249
1339	1339 Tumor	Tumor	\N	\N	\N	\N	11-65284
1337	1337 Tumor	Tumor	\N	\N	\N	\N	11-23710
1344	1344 Tumor	Tumor	\N	\N	\N	\N	12-9397B
1341	1341 Tumor	Tumor	\N	\N	\N	\N	11-84681
1342	1342 Tumor	Tumor	\N	\N	\N	\N	11-87412
1343	1343 Tumor	Tumor	\N	\N	\N	\N	11-88431
1346	1346 Tumor	Tumor	\N	\N	\N	\N	12-64897
1340	1340 Tumor	Tumor	\N	\N	\N	\N	11-66564
1338	1338 Tumor	Tumor	\N	\N	\N	\N	11-63724
1347	1347 Tumor	Tumor	\N	\N	\N	\N	13-32039
1416	1416 Tumor	Tumor	\N	\N	\N	\N	17-49361
1365	1365 Tumor	Tumor	\N	\N	\N	\N	15-61456
1411	1411 Tumor	Tumor	\N	\N	\N	\N	17-26078
1363	1363 Tumor	Tumor	\N	\N	\N	\N	15-52489
1407	1407 Tumor	Tumor	\N	\N	\N	\N	17-8968
1401	1401 Tumor	Tumor	\N	\N	\N	\N	16-92011
1372	1372 Tumor	Tumor	\N	\N	\N	\N	15-117186
1392	1392 Tumor	Tumor	\N	\N	\N	\N	16-77392
1397	1397 Tumor	Tumor	\N	\N	\N	\N	16-96276
1403	1403 Tumor	Tumor	\N	\N	\N	\N	17-2869
1387	1387 Tumor	Tumor	\N	\N	\N	\N	16-42062
1398	1398 Tumor	Tumor	\N	\N	\N	\N	16-105648
1362	1362 Tumor	Tumor	\N	\N	\N	\N	15-41815
1368	1368 Tumor	Tumor	\N	\N	\N	\N	15-92618
1402	1402 Tumor	Tumor	\N	\N	\N	\N	16-125975
1394	1394 Tumor	Tumor	\N	\N	\N	\N	16-89926
1379	1379 Tumor	Tumor	\N	\N	\N	\N	16-25723
1350	1350 Tumor	Tumor	\N	\N	\N	\N	14-11769
1378	1378 Tumor	Tumor	\N	\N	\N	\N	16-18320A
1351	1351 Tumor	Tumor	\N	\N	\N	\N	14-42631
1404	1404 Tumor	Tumor	\N	\N	\N	\N	17-2120
1391	1391 Tumor	Tumor	\N	\N	\N	\N	16-63804
1367	1367 Tumor	Tumor	\N	\N	\N	\N	15-88900
1388	1388 Tumor	Tumor	\N	\N	\N	\N	16-55411
1369	1369 Tumor	Tumor	\N	\N	\N	\N	15-87833
1354	1354 Tumor	Tumor	\N	\N	\N	\N	14-83928
1405	1405 Tumor	Tumor	\N	\N	\N	\N	17-6351
1353	1353 Tumor	Tumor	\N	\N	\N	\N	14-57552
1382	1382 Tumor	Tumor	\N	\N	\N	\N	16-31382
1370	1370 Tumor	Tumor	\N	\N	\N	\N	15-110181
1360	1360 Tumor	Tumor	\N	\N	\N	\N	07-55184
1395	1395 Tumor	Tumor	\N	\N	\N	\N	16-90917
1377	1377 Tumor	Tumor	\N	\N	\N	\N	16-20360
1380	1380 Tumor	Tumor	\N	\N	\N	\N	16-30292
1361	1361 Tumor	Tumor	\N	\N	\N	\N	15-33496
1364	1364 Tumor	Tumor	\N	\N	\N	\N	15-60391
1384	1384 Tumor	Tumor	\N	\N	\N	\N	16-42657
1385	1385 Tumor	Tumor	\N	\N	\N	\N	16-27084
1348	1348 Tumor	Tumor	\N	\N	\N	\N	13-73582
1414	1414 Tumor	Tumor	\N	\N	\N	\N	17-42757
1352	1352 Tumor	Tumor	\N	\N	\N	\N	14-46549
1412	1412 Tumor	Tumor	\N	\N	\N	\N	17-29457B
1355	1355 Tumor	Tumor	\N	\N	\N	\N	14-82758
1390	1390 Tumor	Tumor	\N	\N	\N	\N	16-42198
1373	1373 Tumor	Tumor	\N	\N	\N	\N	15-123058
1393	1393 Tumor	Tumor	\N	\N	\N	\N	16-80354
1413	1413 Tumor	Tumor	\N	\N	\N	\N	17-13205
1371	1371 Tumor	Tumor	\N	\N	\N	\N	15-116253
1400	1400 Tumor	Tumor	\N	\N	\N	\N	16-127388
1389	1389 Tumor	Tumor	\N	\N	\N	\N	16-56300
1383	1383 Tumor	Tumor	\N	\N	\N	\N	16-41709
1357	1357 Tumor	Tumor	\N	\N	\N	\N	15-10108
1349	1349 Tumor	Tumor	\N	\N	\N	\N	13-75788B
1399	1399 Tumor	Tumor	\N	\N	\N	\N	16-97391
1415	1415 Tumor	Tumor	\N	\N	\N	\N	17-48219
1417	1417 Tumor	Tumor	\N	\N	\N	\N	17-50829
1381	1381 Tumor	Tumor	\N	\N	\N	\N	16-26672
1409	1409 Tumor	Tumor	\N	\N	\N	\N	17-10585
1356	1356 Tumor	Tumor	\N	\N	\N	\N	14-95595
1376	1376 Tumor	Tumor	\N	\N	\N	\N	16-19895
1410	1410 Tumor	Tumor	\N	\N	\N	\N	17-14313
1375	1375 Tumor	Tumor	\N	\N	\N	\N	16-10466
1359	1359 Tumor	Tumor	\N	\N	\N	\N	15-25818
1408	1408 Tumor	Tumor	\N	\N	\N	\N	17-9550
1396	1396 Tumor	Tumor	\N	\N	\N	\N	16-94655
1374	1374 Tumor	Tumor	\N	\N	\N	\N	16-13909
1358	1358 Tumor	Tumor	\N	\N	\N	\N	15-16907A
1406	1406 Tumor	Tumor	\N	\N	\N	\N	17-6368
1386	1386 Tumor	Tumor	\N	\N	\N	\N	16-19890
2250	2250 Tumor	Tumor	\N	\N	\N	\N	12-11041
2251	2251 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Metastatic	\N	05-605A2
2252	2252 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Metastatic	\N	06-521B2
2253	2253 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Metastatic	\N	11-19653B2
2254	2254 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Metastatic	\N	02-1274B1
2256	2256 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Primary Tumor	\N	04-35102A
2255	2255 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Primary Tumor	\N	02-49261
2258	2258 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Primary Tumor	\N	96-14850
2257	2257 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Primary Tumor	\N	08-6790B
2303	2303 Tumor	Tumor	\N	\N	\N	\N	20-30367
2304	2304 Tumor	Tumor	\N	\N	\N	\N	21-21351
2321	2321 Tumor	Tumor	\N	\N	\N	\N	12-10777
2322	2322 Tumor	Tumor	\N	\N	\N	\N	12-1782
2330	2330 Tumor	Tumor	\N	\N	\N	\N	CGH14-050
2328	2328 Tumor	Tumor	\N	\N	\N	\N	12-11041
2331	2331 Tumor	Tumor	\N	\N	\N	\N	CGH15-249
2332	2332 Tumor	Tumor	\N	\N	\N	\N	CGH14-147
2334	2334 Tumor	Tumor	\N	\N	\N	\N	CGH19-097
2333	2333 Tumor	Tumor	\N	\N	\N	\N	CGH12-067
2335	2335 Tumor	Tumor	\N	\N	\N	\N	CGH19-097
2418	2418 Tumor	Tumor	2015-07-31 00:00:00-07	\N	\N	\N	12-22901A
2457	2457 Tumor	Tumor	2023-05-19 00:00:00-07	\N	\N	\N	22-104389C
2456	2456 Tumor	Tumor	2023-05-19 00:00:00-07	\N	\N	\N	22-104389A2
2695	2695 Tumor	Tumor	\N	\N	\N	\N	09-80101A-2
2696	2696 Tumor	Tumor	\N	\N	\N	\N	61000/00 (LN)
2697	2697 Tumor	Tumor	\N	\N	\N	\N	14-102015A
2698	2698 Tumor	Tumor	\N	\N	\N	\N	15-45455F
2703	2703 Tumor	Tumor	\N	\N	\N	\N	14-37911A
2711	2711 Tumor	Tumor	\N	\N	\N	\N	15-16543B
2709	2709 Tumor	Tumor	\N	\N	\N	\N	14-118975
2699	2699 Tumor	Tumor	\N	\N	\N	\N	13-61266A
2712	2712 Tumor	Tumor	\N	\N	\N	\N	13-46194
2714	2714 Tumor	Tumor	\N	\N	\N	\N	13-62943
2710	2710 Tumor	Tumor	\N	\N	\N	\N	14-88685
2700	2700 Tumor	Tumor	\N	\N	\N	\N	14-13830
2705	2705 Tumor	Tumor	\N	\N	\N	\N	14-83646
2707	2707 Tumor	Tumor	\N	\N	\N	\N	15-3641
2706	2706 Tumor	Tumor	\N	\N	\N	\N	14-99831
2708	2708 Tumor	Tumor	\N	\N	\N	\N	13-90988
2702	2702 Tumor	Tumor	\N	\N	\N	\N	14-32353
2704	2704 Tumor	Tumor	\N	\N	\N	\N	14-66686B
2713	2713 Tumor	Tumor	\N	\N	\N	\N	13-69386B
2701	2701 Tumor	Tumor	\N	\N	\N	\N	14-3598
2715	2715 Tumor	Tumor	\N	\N	\N	\N	00-001103
2717	2717 Tumor	Tumor	\N	\N	\N	\N	02-020334-11
2718	2718 Tumor	Tumor	\N	\N	\N	\N	90-012097B
2719	2719 Tumor	Tumor	\N	\N	\N	\N	92-003527H
2720	2720 Tumor	Tumor	\N	\N	\N	\N	91-017419
2721	2721 Tumor	Tumor	\N	\N	\N	\N	09-008704
2722	2722 Tumor	Tumor	\N	\N	\N	\N	04-003736A
2723	2723 Tumor	Tumor	\N	\N	\N	\N	02-008514
2725	2725 Tumor	Tumor	\N	\N	\N	\N	13-17202A11
2726	2726 Tumor	Tumor	\N	\N	\N	\N	13-10776A1
2727	2727 Tumor	Tumor	\N	\N	\N	\N	14-159A2
2729	2729 Tumor	Tumor	\N	\N	\N	\N	14-4989D3
2730	2730 Tumor	Tumor	\N	\N	\N	\N	01-003845
2731	2731 Tumor	Tumor	\N	\N	\N	\N	94-016368
2732	2732 Tumor	Tumor	\N	\N	\N	\N	02-000540
2733	2733 Tumor	Tumor	\N	\N	\N	\N	10-006275
2734	2734 Tumor	Tumor	\N	\N	\N	\N	95-007992
2735	2735 Tumor	Tumor	\N	\N	\N	\N	98-019394
2736	2736 Tumor	Tumor	\N	\N	\N	\N	08-018003
2737	2737 Tumor	Tumor	\N	\N	\N	\N	99-005681
2738	2738 Tumor	Tumor	\N	\N	\N	\N	05-006815
2739	2739 Tumor	Tumor	\N	\N	\N	\N	06-018998
2740	2740 Tumor	Tumor	\N	\N	\N	\N	98-001046
2741	2741 Tumor	Tumor	\N	\N	\N	\N	03-007239
2743	2743 Tumor	Tumor	\N	\N	\N	\N	09-005840
2744	2744 Tumor	Tumor	\N	\N	\N	\N	07-012236B1
2745	2745 Tumor	Tumor	\N	\N	\N	\N	05-011507
2748	2748 Tumor	Tumor	\N	\N	\N	\N	10-008371A1
2749	2749 Tumor	Tumor	\N	\N	\N	\N	99-012800-2
2764	2764 Tumor	Tumor	\N	\N	\N	\N	12-19018B
2766	2766 Tumor	Tumor	\N	\N	\N	\N	10-73024
2767	2767 Tumor	Tumor	\N	\N	\N	\N	08-46462
2768	2768 Tumor	Tumor	\N	\N	\N	\N	11-21178
2770	2770 Tumor	Tumor	\N	\N	\N	\N	10-23569A
2772	2772 Tumor	Tumor	\N	\N	\N	\N	08-70283a
2773	2773 Tumor	Tumor	\N	\N	\N	\N	03-34051A1
2774	2774 Tumor	Tumor	\N	\N	\N	\N	02-42436
2775	2775 Tumor	Tumor	\N	\N	\N	\N	98-18400a
2776	2776 Tumor	Tumor	\N	\N	\N	\N	12-11406A
2778	2778 Tumor	Tumor	\N	\N	\N	\N	11-95856
2779	2779 Tumor	Tumor	\N	\N	\N	\N	08-27590
2781	2781 Tumor	Tumor	\N	\N	\N	\N	SM_2_Tumor
2782	2782 Tumor	Tumor	\N	\N	\N	\N	SM_3
2784	2784 Tumor	Tumor	\N	\N	\N	\N	SM_4
2786	2786 Tumor	Tumor	\N	\N	\N	\N	06-32942
2787	2787 Tumor	Tumor	\N	\N	\N	\N	06-52508
2789	2789 Tumor	Tumor	\N	\N	\N	\N	07-04365
2791	2791 Tumor	Tumor	\N	\N	\N	\N	07-04365
2792	2792 Tumor	Tumor	\N	\N	\N	\N	07-14044A
2794	2794 Tumor	Tumor	\N	\N	\N	\N	07-26247
2795	2795 Tumor	Tumor	\N	\N	\N	\N	SM_10_Tumor
2796	2796 Tumor	Tumor	\N	\N	\N	\N	SM_11
2797	2797 Tumor	Tumor	\N	\N	\N	\N	SM_12
2799	2799 Tumor	Tumor	\N	\N	\N	\N	SM_16
2800	2800 Tumor	Tumor	\N	\N	\N	\N	09-37302
2802	2802 Tumor	Tumor	\N	\N	\N	\N	SM7
2804	2804 Tumor	Tumor	\N	\N	\N	\N	07-20501
2805	2805 Tumor	Tumor	\N	\N	\N	\N	13-35959
2807	2807 Tumor	Tumor	\N	\N	\N	\N	13-99417
2806	2806 Tumor	Tumor	\N	\N	\N	\N	13-102610
2808	2808 Tumor	Tumor	\N	\N	\N	\N	13-98534
2809	2809 Tumor	Tumor	\N	\N	\N	\N	13-32982A
2810	2810 Tumor	Tumor	\N	\N	\N	\N	13-9916
2811	2811 Tumor	Tumor	\N	\N	\N	\N	11-44609F
2812	2812 Tumor	Tumor	\N	\N	\N	\N	12-98575A1
2814	2814 Tumor	Tumor	\N	\N	\N	\N	12-004374B
2816	2816 Tumor	Tumor	\N	\N	\N	\N	13-006535C
2848	2848 Tumor	Tumor	\N	\N	\N	\N	CGH12-146
2852	2852 Tumor	Tumor	\N	\N	\N	\N	13-9682
2850	2850 Tumor	Tumor	\N	\N	\N	\N	CGH13-026
2853	2853 Tumor	Tumor	\N	\N	\N	\N	13-2054
2851	2851 Tumor	Tumor	\N	\N	\N	\N	CGH13-014
2864	2864 Tumor	Tumor	\N	\N	\N	\N	10-83193
2883	2883 Tumor	Tumor	\N	\N	\N	\N	13-12947A2
2884	2884 Tumor	Tumor	\N	\N	\N	\N	13-18444A16
2886	2886 Tumor	Tumor	\N	\N	\N	\N	10-11930B12
2885	2885 Tumor	Tumor	\N	\N	\N	\N	07-1210F6
2913	2913 Tumor	Tumor	\N	\N	\N	\N	08-46462
2928	2928 Tumor	Tumor	\N	\N	\N	\N	35_M
2929	2929 Tumor	Tumor	\N	\N	\N	\N	49_M
2934	2934 Tumor	Tumor	\N	\N	\N	\N	13-212
2935	2935 Tumor	Tumor	\N	\N	\N	\N	12-18826
2938	2938 Tumor	Tumor	\N	\N	\N	\N	10-55707
2939	2939 Tumor	Tumor	\N	\N	\N	\N	11-8228
2940	2940 Tumor	Tumor	\N	\N	\N	\N	11-34950
2941	2941 Tumor	Tumor	\N	\N	\N	\N	11-84681
2942	2942 Tumor	Tumor	\N	\N	\N	\N	12-6981
2944	2944 Tumor	Tumor	\N	\N	\N	\N	HW2- Tumor Dissect
2946	2946 Tumor	Tumor	\N	\N	\N	\N	HW8- Tumor Curls
2948	2948 Tumor	Tumor	\N	\N	\N	\N	HW9- Tumor Curls
2949	2949 Tumor	Tumor	\N	\N	\N	\N	KIT227
2960	2960 Tumor	Tumor	\N	\N	\N	\N	11-12273
2959	2959 Tumor	Tumor	\N	\N	\N	\N	10-86469
2962	2962 Tumor	Tumor	\N	\N	\N	\N	11-30426
2961	2961 Tumor	Tumor	\N	\N	\N	\N	11-23710
2963	2963 Tumor	Tumor	\N	\N	\N	\N	11-31904
2965	2965 Tumor	Tumor	\N	\N	\N	\N	HW3-Tumor
2967	2967 Tumor	Tumor	\N	\N	\N	\N	HW4-Tumor
2969	2969 Tumor	Tumor	\N	\N	\N	\N	HW6-TumorDissect
2980	2980 Tumor	Tumor	\N	\N	\N	\N	BN_M1
2979	2979 Tumor	Tumor	\N	\N	\N	\N	10-0206
2981	2981 Tumor	Tumor	\N	\N	\N	\N	BN_M2
2988	2988 Tumor	Tumor	\N	\N	\N	\N	11-78845
2991	2991 Tumor	Tumor	\N	\N	\N	\N	11-83908
2989	2989 Tumor	Tumor	\N	\N	\N	\N	11-81405
2990	2990 Tumor	Tumor	\N	\N	\N	\N	11-85075
2993	2993 Tumor	Tumor	\N	\N	\N	\N	11-95663
2992	2992 Tumor	Tumor	\N	\N	\N	\N	11-85859
2996	2996 Tumor	Tumor	\N	\N	\N	\N	10-71761
2995	2995 Tumor	Tumor	\N	\N	\N	\N	10-56047
2994	2994 Tumor	Tumor	\N	\N	\N	\N	10-59344
2998	2998 Tumor	Tumor	\N	\N	\N	\N	10-88482
2997	2997 Tumor	Tumor	\N	\N	\N	\N	10-84478
2999	2999 Tumor	Tumor	\N	\N	\N	\N	10-74513
3000	3000 Tumor	Tumor	\N	\N	\N	\N	10-80009
3002	3002 Tumor	Tumor	\N	\N	\N	\N	10-91484
3003	3003 Tumor	Tumor	\N	\N	\N	\N	10-88475
3001	3001 Tumor	Tumor	\N	\N	\N	\N	10-88482
3004	3004 Tumor	Tumor	\N	\N	\N	\N	11-5482
3005	3005 Tumor	Tumor	\N	\N	\N	\N	11-16253
3006	3006 Tumor	Tumor	\N	\N	\N	\N	11-20375
3007	3007 Tumor	Tumor	\N	\N	\N	\N	11-21491
3008	3008 Tumor	Tumor	\N	\N	\N	\N	11-21178
3009	3009 Tumor	Tumor	\N	\N	\N	\N	11-61046
3011	3011 Tumor	Tumor	\N	\N	\N	\N	11-63178
3012	3012 Tumor	Tumor	\N	\N	\N	\N	11-64496
3010	3010 Tumor	Tumor	\N	\N	\N	\N	11-65778
3013	3013 Tumor	Tumor	\N	\N	\N	\N	11-71491
3014	3014 Tumor	Tumor	\N	\N	\N	\N	11-65756
3015	3015 Tumor	Tumor	\N	\N	\N	\N	11-74100
3016	3016 Tumor	Tumor	\N	\N	\N	\N	11-79158
3018	3018 Tumor	Tumor	\N	\N	\N	\N	11-85416
3017	3017 Tumor	Tumor	\N	\N	\N	\N	11-74517
3019	3019 Tumor	Tumor	\N	\N	\N	\N	11-94134
3020	3020 Tumor	Tumor	\N	\N	\N	\N	11-699
3021	3021 Tumor	Tumor	\N	\N	\N	\N	11-5482
3022	3022 Tumor	Tumor	\N	\N	\N	\N	11-18560
3023	3023 Tumor	Tumor	\N	\N	\N	\N	11-20772
3024	3024 Tumor	Tumor	\N	\N	\N	\N	11-19877
3025	3025 Tumor	Tumor	\N	\N	\N	\N	11-25808
3026	3026 Tumor	Tumor	\N	\N	\N	\N	11-35616
3028	3028 Tumor	Tumor	\N	\N	\N	\N	11-38771
3027	3027 Tumor	Tumor	\N	\N	\N	\N	11-33856
3031	3031 Tumor	Tumor	\N	\N	\N	\N	11-31904
3029	3029 Tumor	Tumor	\N	\N	\N	\N	11-39639
3030	3030 Tumor	Tumor	\N	\N	\N	\N	11-42027
3032	3032 Tumor	Tumor	\N	\N	\N	\N	11-50270
3033	3033 Tumor	Tumor	\N	\N	\N	\N	11-50182
3034	3034 Tumor	Tumor	\N	\N	\N	\N	11-51553
3035	3035 Tumor	Tumor	\N	\N	\N	\N	11-52339
3036	3036 Tumor	Tumor	\N	\N	\N	\N	11-55993
3037	3037 Tumor	Tumor	\N	\N	\N	\N	11-61046
3039	3039 Tumor	Tumor	\N	\N	\N	\N	11-71006
3038	3038 Tumor	Tumor	\N	\N	\N	\N	11-57051
3041	3041 Tumor	Tumor	\N	\N	\N	\N	11-88432
3040	3040 Tumor	Tumor	\N	\N	\N	\N	11-76464
3042	3042 Tumor	Tumor	\N	\N	\N	\N	11-88209
3043	3043 Tumor	Tumor	\N	\N	\N	\N	12-2898
3045	3045 Tumor	Tumor	\N	\N	\N	\N	12-4251
3046	3046 Tumor	Tumor	\N	\N	\N	\N	12-8171
3049	3049 Tumor	Tumor	\N	\N	\N	\N	12-31996
3050	3050 Tumor	Tumor	\N	\N	\N	\N	12-39632
3052	3052 Tumor	Tumor	\N	\N	\N	\N	12-71679
3051	3051 Tumor	Tumor	\N	\N	\N	\N	12-55584
3053	3053 Tumor	Tumor	\N	\N	\N	\N	12-80985B
3055	3055 Tumor	Tumor	\N	\N	\N	\N	12-23578
3054	3054 Tumor	Tumor	\N	\N	\N	\N	12-7775
3056	3056 Tumor	Tumor	\N	\N	\N	\N	12-31421
3057	3057 Tumor	Tumor	\N	\N	\N	\N	12-81302
3058	3058 Tumor	Tumor	\N	\N	\N	\N	12-81749
3059	3059 Tumor	Tumor	\N	\N	\N	\N	12-97031
3061	3061 Tumor	Tumor	\N	\N	\N	\N	13-25A
3060	3060 Tumor	Tumor	\N	\N	\N	\N	12-98736
3063	3063 Tumor	Tumor	\N	\N	\N	\N	13-3732
3062	3062 Tumor	Tumor	\N	\N	\N	\N	13-3874
3064	3064 Tumor	Tumor	\N	\N	\N	\N	13-3889
3066	3066 Tumor	Tumor	\N	\N	\N	\N	13-4136
3065	3065 Tumor	Tumor	\N	\N	\N	\N	13-4090B
3067	3067 Tumor	Tumor	\N	\N	\N	\N	13-7186
3070	3070 Tumor	Tumor	\N	\N	\N	\N	12-79358
3069	3069 Tumor	Tumor	\N	\N	\N	\N	11-88431
3068	3068 Tumor	Tumor	\N	\N	\N	\N	14-16247
3073	3073 Tumor	Tumor	\N	\N	\N	\N	10-143
3072	3072 Tumor	Tumor	\N	\N	\N	\N	09-1121
3075	3075 Tumor	Tumor	\N	\N	\N	\N	02-23636A-02
3074	3074 Tumor	Tumor	\N	\N	\N	\N	94-31062  
3078	3078 Tumor	Tumor	\N	\N	\N	\N	05-7439A12
3077	3077 Tumor	Tumor	\N	\N	\N	\N	02-33818A-03
3079	3079 Tumor	Tumor	\N	\N	\N	\N	05-41924
3080	3080 Tumor	Tumor	\N	\N	\N	\N	06-47079A02
3081	3081 Tumor	Tumor	\N	\N	\N	\N	08-4544A03
3083	3083 Tumor	Tumor	\N	\N	\N	\N	10-44069A4
3082	3082 Tumor	Tumor	\N	\N	\N	\N	10-26316A2
3085	3085 Tumor	Tumor	\N	\N	\N	\N	12-6332A5
3084	3084 Tumor	Tumor	\N	\N	\N	\N	11-38910A2
3087	3087 Tumor	Tumor	\N	\N	\N	\N	08-1463A2
3086	3086 Tumor	Tumor	\N	\N	\N	\N	11-032523A1
3088	3088 Tumor	Tumor	\N	\N	\N	\N	12-7093NG176-1
3089	3089 Tumor	Tumor	\N	\N	\N	\N	10-7937B2
3090	3090 Tumor	Tumor	\N	\N	\N	\N	11-21025B1
3092	3092 Tumor	Tumor	\N	\N	\N	\N	12_54296,12-54296
3094	3094 Tumor	Tumor	\N	\N	\N	\N	12-54992
3096	3096 Tumor	Tumor	\N	\N	\N	\N	12-67298
3099	3099 Tumor	Tumor	\N	\N	\N	\N	DM2
3100	3100 Tumor	Tumor	\N	\N	\N	\N	DM2
3102	3102 Tumor	Tumor	\N	\N	\N	\N	DM4
3104	3104 Tumor	Tumor	\N	\N	\N	\N	DM6
3105	3105 Tumor	Tumor	\N	\N	\N	\N	DM8
3107	3107 Tumor	Tumor	\N	\N	\N	\N	DM10
3109	3109 Tumor	Tumor	\N	\N	\N	\N	DM13
3110	3110 Tumor	Tumor	\N	\N	\N	\N	DM13
3111	3111 Tumor	Tumor	\N	\N	\N	\N	DM14
3113	3113 Tumor	Tumor	\N	\N	\N	\N	DM17
3115	3115 Tumor	Tumor	\N	\N	\N	\N	DM18
3116	3116 Tumor	Tumor	\N	\N	\N	\N	DM18
3118	3118 Tumor	Tumor	\N	\N	\N	\N	DM22
3120	3120 Tumor	Tumor	\N	\N	\N	\N	DM23
3122	3122 Tumor	Tumor	\N	\N	\N	\N	DM25
3123	3123 Tumor	Tumor	\N	\N	\N	\N	DM31
3125	3125 Tumor	Tumor	\N	\N	\N	\N	DM36
3127	3127 Tumor	Tumor	\N	\N	\N	\N	DM37
3129	3129 Tumor	Tumor	\N	\N	\N	\N	DM42
3132	3132 Tumor	Tumor	\N	\N	\N	\N	DM48
3131	3131 Tumor	Tumor	\N	\N	\N	\N	DM43
3133	3133 Tumor	Tumor	\N	\N	\N	\N	DM49
3135	3135 Tumor	Tumor	\N	\N	\N	\N	DM51
3137	3137 Tumor	Tumor	\N	\N	\N	\N	DM58
3138	3138 Tumor	Tumor	\N	\N	\N	\N	DM59
3140	3140 Tumor	Tumor	\N	\N	\N	\N	DM64
3142	3142 Tumor	Tumor	\N	\N	\N	\N	DM68
3141	3141 Tumor	Tumor	\N	\N	\N	\N	DM65
3144	3144 Tumor	Tumor	\N	\N	\N	\N	DM74
3143	3143 Tumor	Tumor	\N	\N	\N	\N	DM74
3146	3146 Tumor	Tumor	\N	\N	\N	\N	DM93
3145	3145 Tumor	Tumor	\N	\N	\N	\N	DM74
3147	3147 Tumor	Tumor	\N	\N	\N	\N	DM93
3150	3150 Tumor	Tumor	\N	\N	\N	\N	DM94
3151	3151 Tumor	Tumor	\N	\N	\N	\N	DM95
3153	3153 Tumor	Tumor	\N	\N	\N	\N	DM96
3156	3156 Tumor	Tumor	\N	\N	\N	\N	DM98
3158	3158 Tumor	Tumor	\N	\N	\N	\N	DM99
3159	3159 Tumor	Tumor	\N	\N	\N	\N	DM99
3160	3160 Tumor	Tumor	\N	\N	\N	\N	DM100
3163	3163 Tumor	Tumor	\N	\N	\N	\N	DM101
3164	3164 Tumor	Tumor	\N	\N	\N	\N	DM102
3165	3165 Tumor	Tumor	\N	\N	\N	\N	DM60
3166	3166 Tumor	Tumor	\N	\N	\N	\N	DM61
3167	3167 Tumor	Tumor	\N	\N	\N	\N	DM62
3169	3169 Tumor	Tumor	\N	\N	\N	\N	DM66
3168	3168 Tumor	Tumor	\N	\N	\N	\N	DM63
3171	3171 Tumor	Tumor	\N	\N	\N	\N	DM69
3170	3170 Tumor	Tumor	\N	\N	\N	\N	DM67
3172	3172 Tumor	Tumor	\N	\N	\N	\N	DM70
3173	3173 Tumor	Tumor	\N	\N	\N	\N	DM81
3175	3175 Tumor	Tumor	\N	\N	\N	\N	DM1
3177	3177 Tumor	Tumor	\N	\N	\N	\N	DM2
3178	3178 Tumor	Tumor	\N	\N	\N	\N	DM5
3181	3181 Tumor	Tumor	\N	\N	\N	\N	DM7
3183	3183 Tumor	Tumor	\N	\N	\N	\N	DM11
3185	3185 Tumor	Tumor	\N	\N	\N	\N	DM12
3187	3187 Tumor	Tumor	\N	\N	\N	\N	DM13
3189	3189 Tumor	Tumor	\N	\N	\N	\N	DM14
3191	3191 Tumor	Tumor	\N	\N	\N	\N	DM16
3193	3193 Tumor	Tumor	\N	\N	\N	\N	DM21
3195	3195 Tumor	Tumor	\N	\N	\N	\N	DM26
3198	3198 Tumor	Tumor	\N	\N	\N	\N	DM29
3197	3197 Tumor	Tumor	\N	\N	\N	\N	DM28
3201	3201 Tumor	Tumor	\N	\N	\N	\N	DM34
3203	3203 Tumor	Tumor	\N	\N	\N	\N	DM45
3206	3206 Tumor	Tumor	\N	\N	\N	\N	DM55
3207	3207 Tumor	Tumor	\N	\N	\N	\N	DM77
3209	3209 Tumor	Tumor	\N	\N	\N	\N	DM79
3211	3211 Tumor	Tumor	\N	\N	\N	\N	DM93
3212	3212 Tumor	Tumor	\N	\N	\N	\N	DM93
3214	3214 Tumor	Tumor	\N	\N	\N	\N	DP12-200 
3216	3216 Tumor	Tumor	\N	\N	\N	\N	11-26903
3215	3215 Tumor	Tumor	\N	\N	\N	\N	11-71241
3217	3217 Tumor	Tumor	\N	\N	\N	\N	11-28912B
3219	3219 Tumor	Tumor	\N	\N	\N	\N	10-83193
3218	3218 Tumor	Tumor	\N	\N	\N	\N	11-5210D
3223	3223 Tumor	Tumor	\N	\N	\N	\N	10-46536
3222	3222 Tumor	Tumor	\N	\N	\N	\N	09-72944
3221	3221 Tumor	Tumor	\N	\N	\N	\N	09-92749
3224	3224 Tumor	Tumor	\N	\N	\N	\N	10-83613A
3225	3225 Tumor	Tumor	\N	\N	\N	\N	10-32987
3226	3226 Tumor	Tumor	\N	\N	\N	\N	06-08042
3227	3227 Tumor	Tumor	\N	\N	\N	\N	06-00911
3228	3228 Tumor	Tumor	\N	\N	\N	\N	06-21363
3229	3229 Tumor	Tumor	\N	\N	\N	\N	06-47334
3231	3231 Tumor	Tumor	\N	\N	\N	\N	11-73238A
3230	3230 Tumor	Tumor	\N	\N	\N	\N	13-59840
3233	3233 Tumor	Tumor	\N	\N	\N	\N	13-59840
3234	3234 Tumor	Tumor	\N	\N	\N	\N	13-2939B
3236	3236 Tumor	Tumor	\N	\N	\N	\N	13-51115A
3235	3235 Tumor	Tumor	\N	\N	\N	\N	13-48798
3243	3243 Tumor	Tumor	\N	\N	\N	\N	08-21965C
3245	3245 Tumor	Tumor	\N	\N	\N	\N	08-4205A
3247	3247 Tumor	Tumor	\N	\N	\N	\N	HW3-Tumor
3246	3246 Tumor	Tumor	\N	\N	\N	\N	HW2- Tumor Dissect
3250	3250 Tumor	Tumor	\N	\N	\N	\N	HW Acral #1 Tumor
3248	3248 Tumor	Tumor	\N	\N	\N	\N	HW8- Tumor Curls
3252	3252 Tumor	Tumor	\N	\N	\N	\N	HW Acral #2 Tumor
3254	3254 Tumor	Tumor	\N	\N	\N	\N	HW Acral #3 Tumor
3256	3256 Tumor	Tumor	\N	\N	\N	\N	HW Acral #4 Tumor
3258	3258 Tumor	Tumor	\N	\N	\N	\N	HW Acral #5 Tumor
3260	3260 Tumor	Tumor	\N	\N	\N	\N	HW Acral #6 Tumor
3262	3262 Tumor	Tumor	\N	\N	\N	\N	HW Acral #7 Tumor
3264	3264 Tumor	Tumor	\N	\N	\N	\N	HW Acral #8 Tumor
3266	3266 Tumor	Tumor	\N	\N	\N	\N	HW Acral #9 Tumor
3269	3269 Tumor	Tumor	\N	\N	\N	\N	HW Acral #8 Tumor
3268	3268 Tumor	Tumor	\N	\N	\N	\N	HW Acral #10 Tumor
3300	3300 Tumor	Tumor	\N	\N	\N	\N	JBP-7-Met
3302	3302 Tumor	Tumor	\N	\N	\N	\N	XD-1.1
3301	3301 Tumor	Tumor	\N	\N	\N	\N	XD-1
3306	3306 Tumor	Tumor	\N	\N	\N	\N	JBP-3-Met1
3305	3305 Tumor	Tumor	\N	\N	\N	\N	JBP-3-MM
3307	3307 Tumor	Tumor	\N	\N	\N	\N	12-15765B3
3308	3308 Tumor	Tumor	\N	\N	\N	\N	KIT262
3310	3310 Tumor	Tumor	\N	\N	\N	\N	KIT21
3311	3311 Tumor	Tumor	\N	\N	\N	\N	KIT37
3309	3309 Tumor	Tumor	\N	\N	\N	\N	KIT8
3313	3313 Tumor	Tumor	\N	\N	\N	\N	KIT62
3312	3312 Tumor	Tumor	\N	\N	\N	\N	KIT55
3314	3314 Tumor	Tumor	\N	\N	\N	\N	KIT76
3315	3315 Tumor	Tumor	\N	\N	\N	\N	KIT118
3316	3316 Tumor	Tumor	\N	\N	\N	\N	KIT134
3318	3318 Tumor	Tumor	\N	\N	\N	\N	KIT181
3321	3321 Tumor	Tumor	\N	\N	\N	\N	KIT203
3319	3319 Tumor	Tumor	\N	\N	\N	\N	KIT191
3320	3320 Tumor	Tumor	\N	\N	\N	\N	KIT192
3322	3322 Tumor	Tumor	\N	\N	\N	\N	KIT205
3324	3324 Tumor	Tumor	\N	\N	\N	\N	KIT210
3325	3325 Tumor	Tumor	\N	\N	\N	\N	KIT217
3323	3323 Tumor	Tumor	\N	\N	\N	\N	KIT206
3326	3326 Tumor	Tumor	\N	\N	\N	\N	KIT225
3327	3327 Tumor	Tumor	\N	\N	\N	\N	KIT230
3329	3329 Tumor	Tumor	\N	\N	\N	\N	KIT260
3328	3328 Tumor	Tumor	\N	\N	\N	\N	KIT244
3330	3330 Tumor	Tumor	\N	\N	\N	\N	KIT273
3332	3332 Tumor	Tumor	\N	\N	\N	\N	KIT295
3331	3331 Tumor	Tumor	\N	\N	\N	\N	KIT275
3333	3333 Tumor	Tumor	\N	\N	\N	\N	KIT297
3335	3335 Tumor	Tumor	\N	\N	\N	\N	KIT313
3334	3334 Tumor	Tumor	\N	\N	\N	\N	KIT302
3336	3336 Tumor	Tumor	\N	\N	\N	\N	KIT316
3337	3337 Tumor	Tumor	\N	\N	\N	\N	KR_8
3338	3338 Tumor	Tumor	\N	\N	\N	\N	KR_150
3339	3339 Tumor	Tumor	\N	\N	\N	\N	KR_166
3340	3340 Tumor	Tumor	\N	\N	\N	\N	KR_177
3342	3342 Tumor	Tumor	\N	\N	\N	\N	KR_229
3341	3341 Tumor	Tumor	\N	\N	\N	\N	KR_203
3344	3344 Tumor	Tumor	\N	\N	\N	\N	KR_2064
3343	3343 Tumor	Tumor	\N	\N	\N	\N	KR_2030
3347	3347 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0137C
3345	3345 Tumor	Tumor	\N	\N	\N	\N	KR_5233
3346	3346 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0091B
3349	3349 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0168C
3348	3348 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0162C
3350	3350 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0194C
3359	3359 Tumor	Tumor	\N	\N	\N	\N	MB_760
3358	3358 Tumor	Tumor	\N	\N	\N	\N	MB_327
3357	3357 Tumor	Tumor	\N	\N	\N	\N	MB_161
3361	3361 Tumor	Tumor	\N	\N	\N	\N	MB_1029
3363	3363 Tumor	Tumor	\N	\N	\N	\N	MB_1046
3368	3368 Tumor	Tumor	\N	\N	\N	\N	MB1242
3371	3371 Tumor	Tumor	\N	\N	\N	\N	MB1423
3372	3372 Tumor	Tumor	\N	\N	\N	\N	MB1424
3374	3374 Tumor	Tumor	\N	\N	\N	\N	MB1429
3375	3375 Tumor	Tumor	\N	\N	\N	\N	MB1617
3382	3382 Tumor	Tumor	\N	\N	\N	\N	13-8208B
3384	3384 Tumor	Tumor	\N	\N	\N	\N	Dog24
3383	3383 Tumor	Tumor	\N	\N	\N	\N	Dog12
3385	3385 Tumor	Tumor	\N	\N	\N	\N	Dog43
3386	3386 Tumor	Tumor	\N	\N	\N	\N	Dog55
3387	3387 Tumor	Tumor	\N	\N	\N	\N	HW3-Tumor
3391	3391 Tumor	Tumor	\N	\N	\N	\N	HW6-TumorDissect
3389	3389 Tumor	Tumor	\N	\N	\N	\N	HW4-Tumor
3394	3394 Tumor	Tumor	\N	\N	\N	\N	11-12273
3393	3393 Tumor	Tumor	\N	\N	\N	\N	10-86469
3395	3395 Tumor	Tumor	\N	\N	\N	\N	11-23710
3396	3396 Tumor	Tumor	\N	\N	\N	\N	11-30426
3398	3398 Tumor	Tumor	\N	\N	\N	\N	11-47644
3397	3397 Tumor	Tumor	\N	\N	\N	\N	11-31904
3427	3427 Tumor	Tumor	\N	\N	\N	\N	12_20321A2
3426	3426 Tumor	Tumor	\N	\N	\N	\N	09-0209
3428	3428 Tumor	Tumor	\N	\N	\N	\N	Seider_Roe
3429	3429 Tumor	Tumor	\N	\N	\N	\N	Seider_Uveal
3435	3435 Tumor	Tumor	\N	\N	\N	\N	WP 11
3437	3437 Tumor	Tumor	\N	\N	\N	\N	WP 29
3436	3436 Tumor	Tumor	\N	\N	\N	\N	WP 23
3442	3442 Tumor	Tumor	\N	\N	\N	\N	11-88209
3447	3447 Tumor	Tumor	\N	\N	\N	\N	Luping_ROS_1
3805	3805 Tumor	Tumor	\N	\N	\N	\N	08-21965C
3824	3824 Tumor	Tumor	\N	\N	\N	\N	Bivona-L18
3825	3825 Tumor	Tumor	\N	\N	\N	\N	Bivona-L19
3836	3836 Tumor	Tumor	\N	\N	\N	\N	TCR-Beta-1
3837	3837 Tumor	Tumor	\N	\N	\N	\N	TCR-Beta-2
3842	3842 Tumor	Tumor	\N	\N	\N	\N	12-22582C
3845	3845 Tumor	Tumor	\N	\N	\N	\N	PG8
3847	3847 Tumor	Tumor	\N	\N	\N	\N	CP1-5
3848	3848 Tumor	Tumor	\N	\N	\N	\N	CP1-10
3849	3849 Tumor	Tumor	\N	\N	\N	\N	CP1-20
3850	3850 Tumor	Tumor	\N	\N	\N	\N	CP1-40
3851	3851 Tumor	Tumor	\N	\N	\N	\N	CP1-80
3853	3853 Tumor	Tumor	\N	\N	\N	\N	DM45
3854	3854 Tumor	Tumor	\N	\N	\N	\N	DM79
3855	3855 Tumor	Tumor	\N	\N	\N	\N	DM93
3856	3856 Tumor	Tumor	\N	\N	\N	\N	DM93
3860	3860 Tumor	Tumor	\N	\N	\N	\N	14-106005
3861	3861 Tumor	Tumor	\N	\N	\N	\N	14-94217A
3862	3862 Tumor	Tumor	\N	\N	\N	\N	14-74770
3863	3863 Tumor	Tumor	\N	\N	\N	\N	14-80165
3864	3864 Tumor	Tumor	\N	\N	\N	\N	14-59956
3865	3865 Tumor	Tumor	\N	\N	\N	\N	14-96795
3866	3866 Tumor	Tumor	\N	\N	\N	\N	14-62335
3867	3867 Tumor	Tumor	\N	\N	\N	\N	15-6952
3868	3868 Tumor	Tumor	\N	\N	\N	\N	14-113574
3869	3869 Tumor	Tumor	\N	\N	\N	\N	04-9498
3870	3870 Tumor	Tumor	\N	\N	\N	\N	15-8321
3871	3871 Tumor	Tumor	\N	\N	\N	\N	02-20629
3872	3872 Tumor	Tumor	\N	\N	\N	\N	04-37400
3901	3901 Tumor	Tumor	\N	\N	\N	\N	DM8
806	806 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.01.02
819	819 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.16.02
811	811 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.07.02
818	818 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.15.01
815	815 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.12.02
831	831 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.09.02
838	838 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.02.03
816	816 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.13.03
814	814 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.11.02
828	828 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.04.02
830	830 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.08.02
808	808 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.04.02
822	822 MELANOMA	MELANOMA	\N	\N	\N	\N	19rig75000701.18.01
829	829 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.05.03
846	846 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.11.02
821	821 MELANOMA	MELANOMA	\N	\N	\N	\N	19rig750007.01.17.01
833	833 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.10.01
835	835 MELANOMA	MELANOMA	\N	\N	\N	\N	19rig750007.02.11.01
845	845 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.08.03
837	837 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.01.03
842	842 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.04.02
847	847 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.12.02
843	843 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.05.02
812	812 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.08.03
827	827 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.03.02
825	825 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.02.03
813	813 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.10.03
839	839 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.03.03
844	844 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.07.03
809	809 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.05.02
3270	3270 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43264
3272	3272 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43266
3273	3273 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43267
3271	3271 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43265
3274	3274 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43268
3281	3281 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51220
3282	3282 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51221
3280	3280 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51219
3283	3283 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51222
3285	3285 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
3286	3286 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
3284	3284 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51223
3288	3288 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
3289	3289 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
3287	3287 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
810	810 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.01.05.03
820	820 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.01.16.03
823	823 NORMAL	NORMAL	\N	\N	\N	\N	19rig75000701.18.02
866	866 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.05.02.04
834	834 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.02.10.02
870	870 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.05.06.04
864	864 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.05.01.04
848	848 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.03.12.03
832	832 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.02.09.03
841	841 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.03.03.05
826	826 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.02.02.04
874	874 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.15.03
871	871 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.07.03
868	868 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.05.03
873	873 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.14.03
875	875 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.16.01
865	865 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.02.03
863	863 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.01.03
807	807 PAM	PAM	\N	\N	\N	\N	19Rig750007.01.01.03
867	867 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.04.03
872	872 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.13.03
869	869 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.06.03
877	877 PAM	PAM	\N	\N	\N	\N	19Rig750007.06.01
840	840 PAM	PAM	\N	\N	\N	\N	19Rig750007.03.03.04
817	817 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.11.03
855	855 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.06.03
854	854 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.05.03
857	857 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.09.03
852	852 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.03.03
856	856 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.07.03
851	851 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.02.03
861	861 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.15.03
859	859 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.12.03
858	858 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.10.03
853	853 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.04.03
850	850 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.01.03
860	860 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.13.03
1235	1235 NEVUS	NEVUS	\N	\N	\N	\N	10-57426
1420	1420 NEVUS	NEVUS	\N	\N	\N	\N	19-135490
1421	1421 NEVUS	NEVUS	\N	\N	\N	\N	19-28178
1153	1153 LN Met 2	LN Met 2	\N	\N	\N	\N	K1-C
1489	1489 LN Met 2	LN Met 2	\N	\N	\N	\N	15-17010C1
1528	1528 LN Met 2	LN Met 2	\N	\N	\N	\N	15-4505C
1559	1559 LN Met 2	LN Met 2	\N	\N	\N	\N	17-9337A1
1149	1149 Mel3	Mel3	\N	\N	\N	\N	H09.22183/1
1477	1477 Mel3	Mel3	\N	\N	\N	\N	15-17010A1
1496	1496 Mel3	Mel3	\N	\N	\N	\N	11-36301A1
1517	1517 Mel3	Mel3	\N	\N	\N	\N	15-3736C1
1531	1531 Mel3	Mel3	\N	\N	\N	\N	13-23696A5
1150	1150 Normal3	Normal3	\N	\N	\N	\N	H13.5620/1
498	498 DPN-mm	DPN-mm	\N	\N	\N	\N	18-95536
878	878 DPN-mm	DPN-mm	\N	\N	\N	\N	19-88385
879	879 DPN-mm	DPN-mm	\N	\N	\N	\N	19-109646
880	880 DPN-mm	DPN-mm	\N	\N	\N	\N	12-051311
882	882 DPN-mm	DPN-mm	\N	\N	\N	\N	18-31431
911	911 DPN-mm	DPN-mm	\N	\N	\N	\N	10-57426
881	881 MM	MM	\N	\N	\N	\N	12-051311
2821	2821 MM	MM	\N	\N	10-972A9, 10-972A10, 10-972A17	\N	10-972A17,10-972A9
2824	2824 MM	MM	\N	\N	10-3560A3, 10-3560A4, 10-3560A10	\N	ZS10-3560A10
2827	2827 MM	MM	\N	\N	\N	\N	10-8439A4
2829	2829 MM	MM	\N	\N	\N	\N	ZS10-10558A10
2832	2832 MM	MM	\N	\N	\N	\N	S12-9606E4
2833	2833 MM	MM	\N	\N	\N	\N	S12-9606E9
2900	2900 MM	MM	\N	\N	10-3560A3, 10-3560A4, 10-3560A10	\N	ZS10-3560A3,ZS10-3560A4
1236	1236 LN Met 4	LN Met 4	\N	\N	\N	\N	K4-C-2
1545	1545 LN Met 4	LN Met 4	\N	\N	\N	\N	15-0176A1
1561	1561 LN Met 4	LN Met 4	\N	\N	\N	\N	17-9337A2
1237	1237 LN Met 3	LN Met 3	\N	\N	\N	\N	K4-C-2
1544	1544 LN Met 3	LN Met 3	\N	\N	\N	\N	15-0176A1
1560	1560 LN Met 3	LN Met 3	\N	\N	\N	\N	17-9337A1
1238	1238 MIS4	MIS4	\N	\N	\N	\N	K7-B-2
1619	1619 MIS4	MIS4	\N	\N	\N	\N	K23-D
1621	1621 MIS4	MIS4	\N	\N	\N	\N	K1-A.2
1290	1290 LN Met	LN Met	\N	\N	also on block 86541-2b	\N	86541-2a
1294	1294 LN Met	LN Met	\N	\N	\N	\N	B13.26332/1
1300	1300 LN Met	LN Met	\N	\N	\N	\N	B14.2561/12
1586	1586 LN Met	LN Met	\N	\N	\N	\N	18-35014A1
1301	1301 Cutaneous Metastasis	Cutaneous Metastasis	\N	\N	\N	\N	H13.21587/1
1424	1424 Cutaneous Metastasis	Cutaneous Metastasis	\N	\N	\N	\N	H 2008.8956/1
1304	1304 Subcutaneous Metastasis	Subcutaneous Metastasis	\N	\N	\N	\N	H15.2058/1
1308	1308 Bladder Metastasis	Bladder Metastasis	\N	\N	\N	\N	B2008.24393/1
886	886 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-2710
887	887 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-4879
888	888 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-2118
889	889 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-488
890	890 Blue Nevus	Blue Nevus	\N	\N	\N	\N	16-1675
891	891 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-596B
2016	2016 Blue Nevus	Blue Nevus	\N	\N	\N	\N	21-21341
2025	2025 Blue Nevus	Blue Nevus	\N	\N	\N	\N	20-28273
2572	2572 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-122015
2573	2573 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-115763
2575	2575 Blue Nevus	Blue Nevus	\N	\N	\N	\N	23-5230
2577	2577 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-127365
2576	2576 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-114644
2578	2578 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-127490
2581	2581 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-83883
2680	2680 Invasive	Invasive	\N	\N	\N	\N	14-12190L4
2579	2579 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-128532
2580	2580 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-128941
2582	2582 Blue Nevus	Blue Nevus	\N	\N	\N	\N	23-293
2586	2586 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-8115
2590	2590 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-85528
2594	2594 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-94507
2595	2595 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-95858
2588	2588 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-83760
2596	2596 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-99877
2593	2593 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-91591
2589	2589 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-854
2587	2587 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-81230
2592	2592 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-90430
2591	2591 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-88969
1427	1427 Lung Metastasis	Lung Metastasis	\N	\N	\N	\N	B15.28523/11
2826	2826 Met	Met	\N	\N	\N	\N	10-1843A4
2830	2830 Met	Met	\N	\N	\N	\N	ZS10-10558C1
2834	2834 Met	Met	\N	\N	\N	\N	S12-9606A2
2899	2899 Met	Met	\N	\N	\N	\N	ZS10-3560C1\n
1314	1314 Met3	Met3	\N	\N	\N	\N	07-3001
1501	1501 Met3	Met3	\N	\N	\N	\N	11-36301C1
1506	1506 Met3	Met3	\N	\N	\N	\N	10-39146A2
1512	1512 Met3	Met3	\N	\N	Merged: Met 2 and Met 3	\N	10-13619
1426	1426 Met4	Met4	\N	\N	\N	\N	07-3001
1429	1429 Invasive 1	Invasive 1	\N	\N	\N	\N	11-1973
2302	2302 Invasive 1	Invasive 1	\N	\N	\N	\N	11-1969-F
1435	1435 Invasive 2	Invasive 2	\N	\N	\N	\N	11-1973
1436	1436 Invasive 3	Invasive 3	\N	\N	\N	\N	11-1973
1437	1437 Invasive 4	Invasive 4	\N	\N	\N	\N	11-1973
1439	1439 Invasive 5	Invasive 5	\N	\N	\N	\N	12-3277
1440	1440 Invasive 6	Invasive 6	\N	\N	\N	\N	12-3277
1473	1473 Recurrence 1	Recurrence 1	\N	\N	\N	\N	14-31886
1493	1493 Lung Met 1	Lung Met 1	\N	\N	\N	\N	12-24455
1511	1511 Intestine Met 2	Intestine Met 2	\N	\N	Merged: Met 2 and Met 3	\N	10-13619
1513	1513 Brain Met 4	Brain Met 4	\N	\N	Merged: Met 4 and Met 5	\N	10-15514A2
1514	1514 Met5	Met5	\N	\N	Merged: Met 4 and Met 5	\N	10-15514A2
2305	2305 Met5	Met5	\N	\N	\N	\N	07-2479-1 
1518	1518 Mel4	Mel4	\N	\N	\N	\N	15-3736C1
1532	1532 Mel4	Mel4	\N	\N	\N	\N	13-23696A5
1522	1522 Mel5	Mel5	\N	\N	\N	\N	15-3736C5
1534	1534 Skin Met1	Skin Met1	\N	\N	\N	\N	14-35086A
1542	1542 Skin Met1	Skin Met1	\N	\N	\N	\N	15-48543A1
1536	1536 Skin Met2	Skin Met2	\N	\N	\N	\N	14-37577A5
1537	1537 Skin Met4	Skin Met4	\N	\N	\N	\N	16-9204
1538	1538 Skin Met3	Skin Met3	\N	\N	\N	\N	16-21256
1543	1543 Brain Met2	Brain Met2	\N	\N	\N	\N	17-21835A3
1546	1546 LN Met5	LN Met5	\N	\N	\N	\N	15-00176S2
1551	1551 Salivary Met1	Salivary Met1	\N	\N	\N	\N	18-28886
1562	1562 Brain Met 5	Brain Met 5	\N	\N	\N	\N	19-19590
1563	1563 Brain Met 6	Brain Met 6	\N	\N	\N	\N	19-19590
1565	1565 LN Met 9	LN Met 9	\N	\N	\N	\N	17-14203A1
1567	1567 LN Met 7	LN Met 7	\N	\N	\N	\N	17-14203A2
1568	1568 LN Met 8	LN Met 8	\N	\N	\N	\N	17-14203A2
1576	1576 Subcutaneous Met 2	Subcutaneous Met 2	\N	\N	Used to compare CELLDATA and QIAGEN's Kits	\N	20-21458A1
1578	1578 Local Recurrent-Met2	Local Recurrent-Met2	\N	\N	\N	\N	20-26269A1
1580	1580 Local Recurrent-Met3	Local Recurrent-Met3	\N	\N	\N	\N	20-26269A1
1582	1582 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	18-22781A1
1585	1585 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	18-35014A1
1598	1598 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	19-44987A1
1623	1623 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	H2007.4636/9
1822	1822 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	19-43366A1
1976	1976 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	17-116120
1583	1583 Invasive Mel 2	Invasive Mel 2	\N	\N	\N	\N	18-22781A1
1599	1599 Invasive Mel 2	Invasive Mel 2	\N	\N	\N	\N	19-44987A1
1823	1823 Invasive Mel 2	Invasive Mel 2	\N	\N	\N	\N	19-43366A1
1589	1589 Primary Mel 1	Primary Mel 1	\N	\N	\N	\N	19-44348A1
1590	1590 Primary Mel 2	Primary Mel 2	\N	\N	\N	\N	19-44348A1
1592	1592 In Transit Met	In Transit Met	\N	\N	\N	\N	19-44348A1
1595	1595 Invasive Primary Mel 1	Invasive Primary Mel 1	\N	\N	\N	\N	19-52004A1
1606	1606 Invasive Primary Mel 1	Invasive Primary Mel 1	\N	\N	\N	\N	16-32182
1596	1596 Invasive Primary Mel 2	Invasive Primary Mel 2	\N	\N	\N	\N	19-52004A1
1607	1607 Invasive Primary Mel 2	Invasive Primary Mel 2	\N	\N	\N	\N	16-32182
1601	1601 Invasive Primary Mel	Invasive Primary Mel	\N	\N	\N	\N	08-35719A1
1610	1610 Invasive Primary Mel	Invasive Primary Mel	\N	\N	\N	\N	15-24753A1
1602	1602 Metastatic Mel 2	Metastatic Mel 2	\N	\N	\N	\N	19-51759
1605	1605 Metastatic Mel 1	Metastatic Mel 1	\N	\N	\N	\N	20-28721A1
1625	1625 MIS2 In situ	MIS2 In situ	\N	\N	\N	\N	14-51352
1877	1877 Lentigo Simplex	Lentigo Simplex	\N	\N	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXCISED IN PLANES OF SECTION EXAMINED	\N	20-60575
1879	1879 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-61821
1882	1882 Lentigo Simplex	Lentigo Simplex	\N	\N	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	\N	21-59993A
1890	1890 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGO SIMPLEX	\N	21-61319
1892	1892 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGO SIMPLEX	\N	21-96630
1895	1895 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	\N	21-110027B
1898	1898 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-110012A
1901	1901 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112195B
1903	1903 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112321A
1905	1905 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112103B
1907	1907 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112195D
1913	1913 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112298
1914	1914 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112298
1875	1875 Compound Melanocytic Nevus	Compound Melanocytic Nevus	\N	\N	COMPOUND MELANOCYTIC NEVUS	\N	21-52881
1909	1909 Compound Melanocytic Nevus	Compound Melanocytic Nevus	\N	\N	\N	\N	21-62140A
1910	1910 Compound Melanocytic Nevus	Compound Melanocytic Nevus	\N	\N	\N	\N	21-62140A
1878	1878 Junctional Melanocytic Nevus	Junctional Melanocytic Nevus	\N	\N	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXCISED IN PLANES OF SECTION EXAMINED	\N	20-60575
1880	1880 Junctional Melanocytic Nevus	Junctional Melanocytic Nevus	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-61821
1891	1891 Seborrheic Keratosis	Seborrheic Keratosis	\N	\N	SEBORRHEIC KERATOSIS	\N	21-61319
1906	1906 Junctional Nevus	Junctional Nevus	\N	\N	\N	\N	21-112103B
1908	1908 Junctional Nevus	Junctional Nevus	\N	\N	\N	\N	21-112195D
1947	1947 Melanocytoma	Melanocytoma	\N	\N	\N	\N	01-10896
2288	2288 Melanocytoma	Melanocytoma	\N	\N	\N	\N	22-101809
1959	1959 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	11-48013
1960	1960 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-48
1961	1961 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-11936
1963	1963 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-51506A
1962	1962 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-51506B
1964	1964 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	14-70636
1965	1965 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	14-14773
1966	1966 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-30226
1967	1967 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-99261C
1968	1968 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-102731B
1969	1969 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-122774
1971	1971 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-77557
1972	1972 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-70204
1973	1973 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-24139
1980	1980 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	10-86269
1982	1982 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-86891
1981	1981 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-55769
1983	1983 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-43382
1984	1984 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-74487
1985	1985 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-96473
1986	1986 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-53528
1987	1987 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-55930
1988	1988 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-8674
1993	1993 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-108474
1994	1994 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-118278
1995	1995 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-3165A
1996	1996 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-3165B
2000	2000 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	07-74058B
2001	2001 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	07-74058B
2004	2004 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-44627
2005	2005 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	14-01007
2006	2006 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	14-4953
2009	2009 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-122795
2010	2010 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-85059
2011	2011 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-91629
1970	1970 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	16-2833
1992	1992 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	16-76143
1998	1998 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	16-24795
2003	2003 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	16-2833
2014	2014 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-21338
2015	2015 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-21336
2023	2023 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	19-122139
2024	2024 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	20-16705
2026	2026 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-59477
2027	2027 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-59483
2028	2028 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-93208
1974	1974 Superficial Melanoma	Superficial Melanoma	\N	\N	\N	\N	17-116120
1990	1990 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	16-44627
1991	1991 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	16-44627
2002	2002 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	07-74058B
2007	2007 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	14-4953
2008	2008 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	14-4953
2029	2029 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	07-74058A
2030	2030 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	13-68674
2031	2031 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	13-107061
2032	2032 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	15-1495
1997	1997 Lentiginous junctional melanocytic nevus	Lentiginous junctional melanocytic nevus	\N	\N	\N	\N	19-94975
2012	2012 Intramucosal Melanocytic Nevus	Intramucosal Melanocytic Nevus	\N	\N	\N	\N	21-21342
2013	2013 Intramucosal Melanocytic Nevus	Intramucosal Melanocytic Nevus	\N	\N	\N	\N	21-21334
2017	2017 Invasive Melanoma	Invasive Melanoma	\N	\N	\N	\N	21-21351
2018	2018 Invasive Melanoma	Invasive Melanoma	\N	\N	\N	\N	21-21316
2019	2019 Invasive Melanoma	Invasive Melanoma	\N	\N	\N	\N	21-21314
2020	2020 Invasive Melanoma	Invasive Melanoma	\N	\N	Invasive Melanoma, in situ melanoma, intraepidermal proliferation of atypical melanocytes, Normal	\N	21-21315C
2021	2021 Lentiginous Juntional Melanocytic Nevus	Lentiginous Juntional Melanocytic Nevus	\N	\N	\N	\N	18-00192
2022	2022 Compound Nevus	Compound Nevus	\N	\N	\N	\N	19-72316
2070	2070 AMB	AMB	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS13	\N	13-2138C
2154	2154 Capture Area A1	Capture Area A1	\N	\N	\N	\N	11-14908C
2684	2684 Capture Area A1	Capture Area A1	\N	\N	\N	\N	22-75050A2
2155	2155 Capture Area B1	Capture Area B1	\N	\N	\N	\N	20-30233
2685	2685 Capture Area B1	Capture Area B1	\N	\N	\N	\N	22-124532-2
2156	2156 Capture Area C1	Capture Area C1	\N	\N	\N	\N	19-10031
2686	2686 Capture Area C1	Capture Area C1	\N	\N	\N	\N	22-119466
2157	2157 Capture Area D1	Capture Area D1	\N	\N	\N	\N	15-22411
2687	2687 Capture Area D1	Capture Area D1	\N	\N	\N	\N	22-73345B
2209	2209 PRAME-positive Nevus	PRAME-positive Nevus	\N	\N	\N	\N	20-53075B
2217	2217 Regressed Area	Regressed Area	\N	\N	\N	\N	21-118604
2336	2336 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-1
2338	2338 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-3
2337	2337 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-2
2339	2339 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-4
2341	2341 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-6
2340	2340 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-5
2342	2342 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-7
2343	2343 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-8
2345	2345 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-10
2344	2344 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-9
2346	2346 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-11
2347	2347 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-12
2348	2348 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-13
2349	2349 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-14
2350	2350 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-15
2351	2351 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-16
2352	2352 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-17
2356	2356 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-21
2354	2354 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-19
2355	2355 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-20
2353	2353 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-18
2357	2357 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-22
2358	2358 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-23
2359	2359 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-24
2360	2360 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-25
2361	2361 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-26
2363	2363 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-28
2362	2362 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-27
2364	2364 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-29
2366	2366 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-31
2365	2365 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-30
2367	2367 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-32
2368	2368 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-33
2370	2370 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-35
2369	2369 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-34
2371	2371 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-36
2373	2373 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-38
2372	2372 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-37
2374	2374 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-39
2375	2375 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-40
2376	2376 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-41
2377	2377 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-42
2378	2378 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-43
2379	2379 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-44
2380	2380 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-45
2381	2381 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-46
2382	2382 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-47
2383	2383 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-48
2384	2384 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-49
2385	2385 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-50
2386	2386 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-51
2388	2388 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-53
2387	2387 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-52
2389	2389 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-54
2390	2390 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-55
2391	2391 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-56
2392	2392 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-57
2394	2394 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-59
2393	2393 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-58
2395	2395 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-60
2396	2396 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-61
2397	2397 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-62
2399	2399 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-64
2398	2398 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-63
2466	2466 Cell Line	Cell Line	\N	\N	\N	\N	230 WT
2465	2465 Cell Line	Cell Line	\N	\N	\N	\N	144aI WT
2759	2759 Cell Line	Cell Line	\N	\N	\N	\N	Thomas_SK_Mel23
2842	2842 Cell Line	Cell Line	\N	\N	SKMEL28-1	\N	SKMEL28-1
2843	2843 Cell Line	Cell Line	\N	\N	SKMEL28-2	\N	SKMEL28-2
2844	2844 Cell Line	Cell Line	\N	\N	SKMEL28-3	\N	SKMEL28-3
2845	2845 Cell Line	Cell Line	\N	\N	SKMEL5-1	\N	SKMEL5-1
2847	2847 Cell Line	Cell Line	\N	\N	SKMEL5-3	\N	SKMEL5-3
2846	2846 Cell Line	Cell Line	\N	\N	SKMEL5-2	\N	SKMEL5-2
2951	2951 Cell Line	Cell Line	\N	\N	\N	\N	LAL-L Cells
2950	2950 Cell Line	Cell Line	\N	\N	\N	\N	LAL-L Cells
2952	2952 Cell Line	Cell Line	\N	\N	\N	\N	NB2107
2953	2953 Cell Line	Cell Line	\N	\N	\N	\N	WM3211
3434	3434 Cell Line	Cell Line	\N	\N	\N	\N	Thomas_SK_MEL_23
3801	3801 Cell Line	Cell Line	\N	\N	\N	\N	1205lu-1
3802	3802 Cell Line	Cell Line	\N	\N	\N	\N	1205lu-2
3803	3803 Cell Line	Cell Line	\N	\N	\N	\N	1205LU-3
2452	2452 Invasive	Invasive	2023-05-19 00:00:00-07	\N	\N	\N	23-37003
2455	2455 Invasive	Invasive	2023-05-19 00:00:00-07	\N	\N	\N	21-135927
2469	2469 Invasive	Invasive	\N	\N	\N	\N	20-102366B2
2486	2486 Invasive	Invasive	\N	\N	\N	\N	22-38234B
2483	2483 Invasive	Invasive	\N	\N	\N	\N	16-74494
2477	2477 Invasive	Invasive	\N	\N	\N	\N	22-102807-2
2472	2472 Invasive	Invasive	\N	\N	\N	\N	23-51956B17
2480	2480 Invasive	Invasive	\N	\N	\N	\N	22-7578
2491	2491 Invasive	Invasive	\N	\N	\N	\N	20-81257B
2494	2494 Invasive	Invasive	\N	\N	\N	\N	21-7055B4
2497	2497 Invasive	Invasive	\N	\N	\N	\N	21-457C
2500	2500 Invasive	Invasive	\N	\N	\N	\N	21-21304A10
2503	2503 Invasive	Invasive	\N	\N	\N	\N	22-91699A4
2506	2506 Invasive	Invasive	\N	\N	\N	\N	20-6751
2509	2509 Invasive	Invasive	\N	\N	\N	\N	18-83370B
2512	2512 Invasive	Invasive	\N	\N	\N	\N	18-12160D
2515	2515 Invasive	Invasive	\N	\N	\N	\N	21-83029A
2518	2518 Invasive	Invasive	\N	\N	\N	\N	21-62764
2521	2521 Invasive	Invasive	\N	\N	\N	\N	20-18383A1
2524	2524 Invasive	Invasive	\N	\N	\N	\N	21-79845
2636	2636 Invasive	Invasive	\N	\N	\N	\N	17-111862A
2639	2639 Invasive	Invasive	\N	\N	\N	\N	23-3314
2642	2642 Invasive	Invasive	\N	\N	\N	\N	18-51740C7
2645	2645 Invasive	Invasive	\N	\N	\N	\N	21-4449A5
2648	2648 Invasive	Invasive	\N	\N	\N	\N	19-360A1
2651	2651 Invasive	Invasive	\N	\N	\N	\N	20-113547A2
2655	2655 Invasive	Invasive	\N	\N	\N	\N	20-37211A
2658	2658 Invasive	Invasive	\N	\N	\N	\N	20-83082A3
2661	2661 Invasive	Invasive	\N	\N	\N	\N	20-8536E
2664	2664 Invasive	Invasive	\N	\N	\N	\N	22-34510A3
2667	2667 Invasive	Invasive	\N	\N	\N	\N	20-10245H3
2670	2670 Invasive	Invasive	\N	\N	\N	\N	17-33973D3
2673	2673 Invasive	Invasive	\N	\N	\N	\N	20-16903C4
2676	2676 Invasive	Invasive	\N	\N	\N	\N	13-17186A16
2689	2689 Invasive	Invasive	\N	\N	\N	\N	23-51956B14
2688	2688 Invasive	Invasive	\N	\N	\N	\N	23-51956B17
2690	2690 Invasive	Invasive	\N	\N	\N	\N	19-360A2
2691	2691 Invasive	Invasive	\N	\N	20-113547A2, 20-113547A3	\N	20-113547A2
2692	2692 Invasive	Invasive	\N	\N	20-113547A2, 20-113547A3	\N	20-113547A3
2306	2306 Met6	Met6	\N	\N	\N	\N	07-2479-2
2307	2307 Met7	Met7	\N	\N	\N	\N	07-2889-1 
2308	2308 Met8	Met8	\N	\N	\N	\N	07-2889-2
2309	2309 Met9	Met9	\N	\N	\N	\N	07-1791
2310	2310 Met10	Met10	\N	\N	\N	\N	07-1841
2400	2400 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-6261A
2401	2401 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-6261B
2403	2403 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-12467
2406	2406 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-12647
2410	2410 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-13152
2426	2426 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22573
2427	2427 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22582A
2428	2428 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22587
2431	2431 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22602A
2437	2437 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22884C
2439	2439 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22886
2436	2436 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22868
2440	2440 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22894B
2432	2432 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22602B
2438	2438 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22884D
2441	2441 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22898
2402	2402 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-12366
2408	2408 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-13587B2
2411	2411 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-12750B
2421	2421 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-13587B2
2422	2422 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-13587B2
2423	2423 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-13587B2
2424	2424 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-22775
2442	2442 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-22900
2404	2404 BCC	BCC	2015-07-31 00:00:00-07	\N	\N	\N	12-12470D
2430	2430 BCC	BCC	2015-07-31 00:00:00-07	\N	\N	\N	12-22597
2434	2434 BCC	BCC	2015-07-31 00:00:00-07	\N	\N	\N	12-22604
2407	2407 Cellular Dermatofibroma 	Cellular Dermatofibroma 	2015-07-31 00:00:00-07	\N	\N	\N	12-12626
2409	2409 SCC+ in situ	SCC, in situ	2015-07-31 00:00:00-07	\N	\N	\N	12-18438A
2415	2415 SCC+ in situ	SCC, in situ	2015-07-31 00:00:00-07	\N	\N	\N	12-22172
2412	2412 SCC+ in situ	SCC, in situ	2015-07-31 00:00:00-07	\N	\N	\N	12-19596
2413	2413 Dermatofibroma	Dermatofibroma	2015-07-31 00:00:00-07	\N	\N	\N	12-19187A
2416	2416 Dermatofibroma	Dermatofibroma	2015-07-31 00:00:00-07	\N	\N	\N	12-21726A
2420	2420 Buffy Coat DNA	Buffy Coat DNA	2015-07-31 00:00:00-07	\N	\N	\N	Buffy Coat
2429	2429 Keratosis	Keratosis	2015-07-31 00:00:00-07	\N	\N	\N	12-22592
2433	2433 Pilomatricoma+ cystic	Pilomatricoma, cystic	2015-07-31 00:00:00-07	\N	\N	\N	12-22603
2435	2435 Leiomyoma	Leiomyoma	2015-07-31 00:00:00-07	\N	\N	\N	12-22720A1
2468	2468 Melanoma Cell Line	Melanoma Cell Line	\N	\N	\N	\N	M230 Imat A3
2464	2464 Melanoma Cell Line	Melanoma Cell Line	\N	\N	\N	\N	144 Imat B15-2
2463	2463 Melanoma Cell Line	Melanoma Cell Line	\N	\N	\N	\N	144 Imat B15
2467	2467 Melanoma Cell Line	Melanoma Cell Line	\N	\N	\N	\N	M230 Imat A2
2563	2563 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-7246A 
2564	2564 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-7246B
2565	2565 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-7246C
2566	2566 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4594
2567	2567 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4595
2568	2568 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-5236
2570	2570 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4742
2571	2571 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4604
2583	2583 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4720
2585	2585 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-3020
2584	2584 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-115140
2624	2624 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-46448
2625	2625 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-47776
2626	2626 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-51687
2627	2627 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-53879
2629	2629 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-67443
2628	2628 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-61674
2630	2630 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-67443
2631	2631 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-84696
2633	2633 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-93578
2632	2632 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-88291
2635	2635 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-95643
2569	2569 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	22-35051
2574	2574 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	22-59468
2598	2598 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-103041
2597	2597 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	19-111428
2599	2599 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-14475
2601	2601 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-23650
2602	2602 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-31361
2604	2604 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-35177
2606	2606 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-43970
2608	2608 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-5264
2612	2612 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	23-7509
2610	2610 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-57917
2611	2611 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-64178
2613	2613 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	23-14412
2614	2614 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	23-37594
2615	2615 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	23-42323
2616	2616 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-102266
2617	2617 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-113038
2618	2618 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-130985
2619	2619 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-48914
2620	2620 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-75346
2621	2621 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-91856A
2623	2623 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-94254
2622	2622 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-91856B
2528	2528 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	21-89776A
2530	2530 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	21-89776B
2532	2532 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-91483A
2534	2534 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-91483B
2536	2536 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	22-52528-1
2538	2538 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	22-52528-2
2540	2540 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	22-105120-1
2542	2542 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	22-105120-2
2544	2544 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651A
2545	2545 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651B
2546	2546 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651C
2547	2547 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651D
2549	2549 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651E
2551	2551 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	21-96446A1
2552	2552 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	21-96446A2
2554	2554 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-104213A
2556	2556 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-104213B
2558	2558 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-18514B
2560	2560 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-98774A
2561	2561 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-98774B
2679	2679  (+) Lymph Node	 (+) Lymph Node	\N	\N	\N	\N	13-17186A20
2752	2752 MVP	MVP	\N	\N	\N	\N	X06-6624A7
2754	2754 MVP	MVP	\N	\N	\N	\N	03-197B2
2756	2756 MVP	MVP	\N	\N	\N	\N	02-5203B2
2758	2758 MVP	MVP	\N	\N	\N	\N	X98-1056A9
2887	2887 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-Input
2888	2888 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-H3K4
2889	2889 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-H3K27
2893	2893 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-Input
2895	2895 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-H3K27
2894	2894 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-H3K4
2890	2890 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-Input
2891	2891 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-H3K4
2892	2892 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-H3K27
2896	2896 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-Input
2897	2897 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-H3K4
2898	2898 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-H3K27
3448	3448 Waiting Process	Waiting Process	\N	\N	\N	\N	20-00698
3527	3527 Waiting Process	Waiting Process	\N	\N	\N	\N	16-00657-2
3528	3528 Waiting Process	Waiting Process	\N	\N	\N	\N	16-03460-1
3529	3529 Waiting Process	Waiting Process	\N	\N	\N	\N	16-04805-2
3530	3530 Waiting Process	Waiting Process	\N	\N	\N	\N	16-05265-2
3531	3531 Waiting Process	Waiting Process	\N	\N	\N	\N	16-05548-2
3532	3532 Waiting Process	Waiting Process	\N	\N	\N	\N	16-05958-2
3533	3533 Waiting Process	Waiting Process	\N	\N	\N	\N	16-06126-2
3534	3534 Waiting Process	Waiting Process	\N	\N	\N	\N	16-06348-2
3535	3535 Waiting Process	Waiting Process	\N	\N	\N	\N	16-06590-2
3536	3536 Waiting Process	Waiting Process	\N	\N	\N	\N	16-06994-1
3537	3537 Waiting Process	Waiting Process	\N	\N	\N	\N	16-09944-2
3538	3538 Waiting Process	Waiting Process	\N	\N	\N	\N	16-10560-1
3539	3539 Waiting Process	Waiting Process	\N	\N	\N	\N	16-10561-3
3540	3540 Waiting Process	Waiting Process	\N	\N	\N	\N	13-32637
3541	3541 Waiting Process	Waiting Process	\N	\N	\N	\N	13-33924
3542	3542 Waiting Process	Waiting Process	\N	\N	\N	\N	13-50059
3543	3543 Waiting Process	Waiting Process	\N	\N	\N	\N	14-31325
3544	3544 Waiting Process	Waiting Process	\N	\N	\N	\N	15-05771-4
3546	3546 Waiting Process	Waiting Process	\N	\N	\N	\N	15-07035-1
3545	3545 Waiting Process	Waiting Process	\N	\N	\N	\N	15-06395-3
3547	3547 Waiting Process	Waiting Process	\N	\N	\N	\N	15-08075-5
3549	3549 Waiting Process	Waiting Process	\N	\N	\N	\N	15-08727-2
3548	3548 Waiting Process	Waiting Process	\N	\N	\N	\N	15-08126-3
3551	3551 Waiting Process	Waiting Process	\N	\N	\N	\N	15-11029-1
3550	3550 Waiting Process	Waiting Process	\N	\N	\N	\N	15-10294-1
3552	3552 Waiting Process	Waiting Process	\N	\N	\N	\N	15-13150A1
3554	3554 Waiting Process	Waiting Process	\N	\N	\N	\N	15-36675
3553	3553 Waiting Process	Waiting Process	\N	\N	\N	\N	15-36291
3555	3555 Waiting Process	Waiting Process	\N	\N	\N	\N	15-49595
3556	3556 Waiting Process	Waiting Process	\N	\N	\N	\N	15-49595A1
3557	3557 Waiting Process	Waiting Process	\N	\N	\N	\N	16-32627A1
3558	3558 Waiting Process	Waiting Process	\N	\N	\N	\N	16-37564A1
3559	3559 Waiting Process	Waiting Process	\N	\N	\N	\N	16-53749A1
3560	3560 Waiting Process	Waiting Process	\N	\N	\N	\N	16-53749A2
3561	3561 Waiting Process	Waiting Process	\N	\N	\N	\N	17-00730-3
3562	3562 Waiting Process	Waiting Process	\N	\N	\N	\N	17-00731-3
3564	3564 Waiting Process	Waiting Process	\N	\N	\N	\N	17-03472-1
3563	3563 Waiting Process	Waiting Process	\N	\N	\N	\N	17-00792
3565	3565 Waiting Process	Waiting Process	\N	\N	\N	\N	17-08581-5
3566	3566 Waiting Process	Waiting Process	\N	\N	\N	\N	17-09063-1
3567	3567 Waiting Process	Waiting Process	\N	\N	\N	\N	17-09063-N1
3568	3568 Waiting Process	Waiting Process	\N	\N	\N	\N	17-10231-5
3569	3569 Waiting Process	Waiting Process	\N	\N	\N	\N	17-10987-6
3570	3570 Waiting Process	Waiting Process	\N	\N	\N	\N	17-10987-N2
3571	3571 Waiting Process	Waiting Process	\N	\N	\N	\N	17-11087-5
3573	3573 Waiting Process	Waiting Process	\N	\N	\N	\N	17-37055
3572	3572 Waiting Process	Waiting Process	\N	\N	\N	\N	17-11446-5
3574	3574 Waiting Process	Waiting Process	\N	\N	\N	\N	17-55712A1
3576	3576 Waiting Process	Waiting Process	\N	\N	\N	\N	18-00447-2
3575	3575 Waiting Process	Waiting Process	\N	\N	\N	\N	17-55712A2
3577	3577 Waiting Process	Waiting Process	\N	\N	\N	\N	18-00447N1
3578	3578 Waiting Process	Waiting Process	\N	\N	\N	\N	18-02303-1
3579	3579 Waiting Process	Waiting Process	\N	\N	\N	\N	18-05067
3581	3581 Waiting Process	Waiting Process	\N	\N	\N	\N	18-09671-4
3580	3580 Waiting Process	Waiting Process	\N	\N	\N	\N	18-08429-4
3582	3582 Waiting Process	Waiting Process	\N	\N	\N	\N	18-09671N1
3583	3583 Waiting Process	Waiting Process	\N	\N	\N	\N	18-31426A
3584	3584 Waiting Process	Waiting Process	\N	\N	\N	\N	19-01043-1
3586	3586 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03114-6
3585	3585 Waiting Process	Waiting Process	\N	\N	\N	\N	19-01043N2
3588	3588 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03361-3
3587	3587 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03114N1
3589	3589 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03736
3590	3590 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03800-4
3591	3591 Waiting Process	Waiting Process	\N	\N	\N	\N	19-05094-9
3593	3593 Waiting Process	Waiting Process	\N	\N	\N	\N	19-05268N1
3592	3592 Waiting Process	Waiting Process	\N	\N	\N	\N	19-05268-9
3594	3594 Waiting Process	Waiting Process	\N	\N	\N	\N	19-05307-8
3595	3595 Waiting Process	Waiting Process	\N	\N	\N	\N	19-08527-2
3596	3596 Waiting Process	Waiting Process	\N	\N	\N	\N	19-08527N1
3597	3597 Waiting Process	Waiting Process	\N	\N	\N	\N	19-09700-4
3598	3598 Waiting Process	Waiting Process	\N	\N	\N	\N	19-17484
3599	3599 Waiting Process	Waiting Process	\N	\N	\N	\N	19-25808
3600	3600 Waiting Process	Waiting Process	\N	\N	\N	\N	19-33672A1
3602	3602 Waiting Process	Waiting Process	\N	\N	\N	\N	20-00548-10
3601	3601 Waiting Process	Waiting Process	\N	\N	\N	\N	19-44938
3603	3603 Waiting Process	Waiting Process	\N	\N	\N	\N	20-00782N3
3605	3605 Waiting Process	Waiting Process	\N	\N	\N	\N	20-01665-3
3604	3604 Waiting Process	Waiting Process	\N	\N	\N	\N	20-01244-2
3607	3607 Waiting Process	Waiting Process	\N	\N	\N	\N	20-03009-7
3606	3606 Waiting Process	Waiting Process	\N	\N	\N	\N	20-02956-5
3609	3609 Waiting Process	Waiting Process	\N	\N	\N	\N	20-04152-8
3608	3608 Waiting Process	Waiting Process	\N	\N	\N	\N	20-03009N1
3610	3610 Waiting Process	Waiting Process	\N	\N	\N	\N	20-04546-3
3611	3611 Waiting Process	Waiting Process	\N	\N	\N	\N	20-05671-2
3612	3612 Waiting Process	Waiting Process	\N	\N	\N	\N	20-06242
3613	3613 Waiting Process	Waiting Process	\N	\N	\N	\N	20-7562\t
3615	3615 Waiting Process	Waiting Process	\N	\N	\N	\N	20-13577A1
3614	3614 Waiting Process	Waiting Process	\N	\N	\N	\N	20-08679-5
3617	3617 Waiting Process	Waiting Process	\N	\N	\N	\N	20-50565A1
3616	3616 Waiting Process	Waiting Process	\N	\N	\N	\N	20-24373A1
3618	3618 Waiting Process	Waiting Process	\N	\N	\N	\N	20-50565B1
3619	3619 Waiting Process	Waiting Process	\N	\N	\N	\N	20-52125A1
3620	3620 Waiting Process	Waiting Process	\N	\N	\N	\N	20-54923B1
3622	3622 Waiting Process	Waiting Process	\N	\N	\N	\N	20-56832A1
3621	3621 Waiting Process	Waiting Process	\N	\N	\N	\N	20-56532
3623	3623 Waiting Process	Waiting Process	\N	\N	\N	\N	21-03240
3624	3624 Waiting Process	Waiting Process	\N	\N	\N	\N	21-04018
3625	3625 Waiting Process	Waiting Process	\N	\N	\N	\N	21-04690-3
3627	3627 Waiting Process	Waiting Process	\N	\N	\N	\N	21-08944-3
3626	3626 Waiting Process	Waiting Process	\N	\N	\N	\N	21-06796-5
3628	3628 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09097A1
3630	3630 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09119-4
3629	3629 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09119-2
3631	3631 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09119N2
3632	3632 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09543-1
3635	3635 Waiting Process	Waiting Process	\N	\N	\N	\N	21-10478-2
3633	3633 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09543-2
3634	3634 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09545-2
3636	3636 Waiting Process	Waiting Process	\N	\N	\N	\N	21-13595A1
3637	3637 Waiting Process	Waiting Process	\N	\N	\N	\N	21-13595C1
3639	3639 Waiting Process	Waiting Process	\N	\N	\N	\N	21-17351
3638	3638 Waiting Process	Waiting Process	\N	\N	\N	\N	21-15959
3640	3640 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20002A1
3642	3642 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20367A1
3641	3641 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20305A1
3644	3644 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20368A3
3643	3643 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20368A1
3645	3645 Waiting Process	Waiting Process	\N	\N	\N	\N	21-21081
3646	3646 Waiting Process	Waiting Process	\N	\N	\N	\N	21-30633A1
3647	3647 Waiting Process	Waiting Process	\N	\N	\N	\N	21-32669B1
3648	3648 Waiting Process	Waiting Process	\N	\N	\N	\N	21-37814A1
3649	3649 Waiting Process	Waiting Process	\N	\N	\N	\N	22-00847N5
3650	3650 Waiting Process	Waiting Process	\N	\N	\N	\N	22-00892-16
3651	3651 Waiting Process	Waiting Process	\N	\N	\N	\N	22-01164-2
3652	3652 Waiting Process	Waiting Process	\N	\N	\N	\N	22-03790
3653	3653 Waiting Process	Waiting Process	\N	\N	\N	\N	22-04201-6
3654	3654 Waiting Process	Waiting Process	\N	\N	\N	\N	22-04201N2
3655	3655 Waiting Process	Waiting Process	\N	\N	\N	\N	22-05287-15
3656	3656 Waiting Process	Waiting Process	\N	\N	\N	\N	22-05287N2
3657	3657 Waiting Process	Waiting Process	\N	\N	\N	\N	22-06500-1
3659	3659 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A1
3658	3658 Waiting Process	Waiting Process	\N	\N	\N	\N	22-07164-1
3660	3660 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A2
3661	3661 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A3
3662	3662 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A4
3663	3663 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A5
3664	3664 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21031A1
3665	3665 Waiting Process	Waiting Process	\N	\N	\N	\N	22-25709C1
3666	3666 Waiting Process	Waiting Process	\N	\N	\N	\N	22-34951
3667	3667 Waiting Process	Waiting Process	\N	\N	\N	\N	22-42722B1
3668	3668 Waiting Process	Waiting Process	\N	\N	\N	\N	23-01133
3669	3669 Waiting Process	Waiting Process	\N	\N	\N	\N	23-01329-1
3670	3670 Waiting Process	Waiting Process	\N	\N	\N	\N	23-02692-3
3671	3671 Waiting Process	Waiting Process	\N	\N	\N	\N	23-03515-1
3672	3672 Waiting Process	Waiting Process	\N	\N	\N	\N	23-03529-3
3673	3673 Waiting Process	Waiting Process	\N	\N	\N	\N	23-04628-5
3674	3674 Waiting Process	Waiting Process	\N	\N	\N	\N	23-04707-7
3675	3675 Waiting Process	Waiting Process	\N	\N	\N	\N	23-05091-4
3676	3676 Waiting Process	Waiting Process	\N	\N	\N	\N	23-05782-2
3678	3678 Waiting Process	Waiting Process	\N	\N	\N	\N	23-07186-13
3677	3677 Waiting Process	Waiting Process	\N	\N	\N	\N	23-06001-12
3679	3679 Waiting Process	Waiting Process	\N	\N	\N	\N	23-09618
2907	2907 NAN	NAN	\N	\N	\N	\N	21-108509B
2151	2151 Unknown	Unknown	\N	\N	Progression Cases.	\N	14-2508
2152	2152 Unknown	Unknown	\N	\N	Progression Cases.	\N	11-29719
2164	2164 Unknown	Unknown	\N	\N	Progression Cases.	\N	12-21933I
2165	2165 Unknown	Unknown	\N	\N	Progression Cases.	\N	12-57797
2168	2168 Unknown	Unknown	\N	\N	\N	\N	14-53094\t
2171	2171 Unknown	Unknown	\N	\N	\N	\N	14-44611
2172	2172 Unknown	Unknown	\N	\N	\N	\N	14-53375
2173	2173 Unknown	Unknown	\N	\N	\N	\N	14-58586
2174	2174 Unknown	Unknown	\N	\N	\N	\N	14-61297
2176	2176 Unknown	Unknown	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\T\\T3	\N	14-53894B
2177	2177 Unknown	Unknown	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\T\\T5	\N	14-58579
2405	2405 Unknown	Unknown	2015-07-31 00:00:00-07	\N	\N	\N	12-562
2857	2857 Unknown	Unknown	\N	\N	\N	\N	\N
2908	2908 Unknown	Unknown	\N	\N	\N	\N	D12_M
2918	2918 Unknown	Unknown	\N	\N	\N	\N	22-104389A4
2917	2917 Unknown	Unknown	\N	\N	\N	\N	22-104389A4
3161	3161 Unknown	Unknown	\N	\N	\N	\N	DM101
3303	3303 Unknown	Unknown	\N	\N	\N	\N	PMM-8
3400	3400 Unknown	Unknown	\N	\N	\N	\N	07-74058A
3399	3399 Unknown	Unknown	\N	\N	\N	\N	07-74058A
3401	3401 Unknown	Unknown	\N	\N	\N	\N	09-88536
3402	3402 Unknown	Unknown	\N	\N	\N	\N	09-88536
3405	3405 Unknown	Unknown	\N	\N	\N	\N	13-107061
3403	3403 Unknown	Unknown	\N	\N	\N	\N	13-68674
3404	3404 Unknown	Unknown	\N	\N	\N	\N	13-68674
3408	3408 Unknown	Unknown	\N	\N	\N	\N	18-91716
3406	3406 Unknown	Unknown	\N	\N	\N	\N	13-107061
3407	3407 Unknown	Unknown	\N	\N	\N	\N	18-91716
3409	3409 Unknown	Unknown	\N	\N	\N	\N	15-1495
3410	3410 Unknown	Unknown	\N	\N	\N	\N	21-21342
3412	3412 Unknown	Unknown	\N	\N	\N	\N	19-126110
3411	3411 Unknown	Unknown	\N	\N	\N	\N	21-21334
3414	3414 Unknown	Unknown	\N	\N	\N	\N	21-21316
3413	3413 Unknown	Unknown	\N	\N	\N	\N	21-21351
3415	3415 Unknown	Unknown	\N	\N	\N	\N	21-21324
3417	3417 Unknown	Unknown	\N	\N	\N	\N	21-21315C
3416	3416 Unknown	Unknown	\N	\N	\N	\N	21-21315C
3418	3418 Unknown	Unknown	\N	\N	\N	\N	21-21315C
3425	3425 Unknown	Unknown	\N	\N	\N	\N	PG_8
3438	3438 Unknown	Unknown	\N	\N	\N	\N	23-3314
3439	3439 Unknown	Unknown	\N	\N	\N	\N	23-3314
3440	3440 Unknown	Unknown	\N	\N	\N	\N	11-13661
3441	3441 Unknown	Unknown	\N	\N	\N	\N	11-62022
3443	3443 Unknown	Unknown	\N	\N	\N	\N	CGH13-008
3445	3445 Unknown	Unknown	\N	\N	\N	\N	CGH13-026
3444	3444 Unknown	Unknown	\N	\N	\N	\N	CGH13-010
3446	3446 Unknown	Unknown	\N	\N	\N	\N	CGH13-094
3680	3680 Unknown	Unknown	\N	\N	\N	\N	18-103965B
3681	3681 Unknown	Unknown	\N	\N	\N	\N	08-16770
3902	3902 Unknown	Unknown	\N	\N	\N	\N	DPN9
2134	2134 Not Processed	Not Processed	\N	\N	\N	\N	09-36483
2135	2135 Not Processed	Not Processed	\N	\N	\N	\N	17-43707
2138	2138 Not Processed	Not Processed	\N	\N	\N	\N	08-65412B
2139	2139 Not Processed	Not Processed	\N	\N	\N	\N	07-13061
2140	2140 Not Processed	Not Processed	\N	\N	\N	\N	05-29484B
2142	2142 Not Processed	Not Processed	\N	\N	\N	\N	05-29484C
2143	2143 Not Processed	Not Processed	\N	\N	\N	\N	05-29484D
2144	2144 Not Processed	Not Processed	\N	\N	\N	\N	05-29484E
2145	2145 Not Processed	Not Processed	\N	\N	\N	\N	05-29484F
2146	2146 Not Processed	Not Processed	\N	\N	\N	\N	07-41091B
2147	2147 Not Processed	Not Processed	\N	\N	\N	\N	09-22513A
2148	2148 Not Processed	Not Processed	\N	\N	\N	\N	10-4769A
2149	2149 Not Processed	Not Processed	\N	\N	\N	\N	11-89154A7
2902	2902 Not Processed	Not Processed	\N	\N	\N	\N	21-108510A
2937	2937 Not Processed	Not Processed	\N	\N	\N	\N	AM2_D-72
3451	3451 Not Processed	Not Processed	\N	\N	\N	\N	03-57215A
3452	3452 Not Processed	Not Processed	\N	\N	\N	\N	05-5976C
3455	3455 Not Processed	Not Processed	\N	\N	\N	\N	06-11151D
3526	3526 Not Processed	Not Processed	\N	\N	\N	\N	06-73878D
3682	3682 Not Processed	Not Processed	\N	\N	\N	\N	10-22013
3683	3683 Not Processed	Not Processed	\N	\N	\N	\N	10-22319
3684	3684 Not Processed	Not Processed	\N	\N	\N	\N	10-38178A1
3685	3685 Not Processed	Not Processed	\N	\N	\N	\N	11-35367
3686	3686 Not Processed	Not Processed	\N	\N	\N	\N	12-1450
3687	3687 Not Processed	Not Processed	\N	\N	\N	\N	12-24502A1
3688	3688 Not Processed	Not Processed	\N	\N	\N	\N	K7-D
3689	3689 Not Processed	Not Processed	\N	\N	\N	\N	K10-D
3690	3690 Not Processed	Not Processed	\N	\N	\N	\N	K13-A
3691	3691 Not Processed	Not Processed	\N	\N	\N	\N	K13-B
3692	3692 Not Processed	Not Processed	\N	\N	\N	\N	K16-A-B
3693	3693 Not Processed	Not Processed	\N	\N	\N	\N	K17-A
3694	3694 Not Processed	Not Processed	\N	\N	\N	\N	K18-A-B
3695	3695 Not Processed	Not Processed	\N	\N	\N	\N	K19-A-B
3696	3696 Not Processed	Not Processed	\N	\N	\N	\N	12-24502B
3697	3697 Not Processed	Not Processed	\N	\N	\N	\N	12-41833E1
3698	3698 Not Processed	Not Processed	\N	\N	\N	\N	13-37513
3700	3700 Not Processed	Not Processed	\N	\N	\N	\N	15-17010A2
3699	3699 Not Processed	Not Processed	\N	\N	\N	\N	15-14674
3701	3701 Not Processed	Not Processed	\N	\N	\N	\N	17-21588
3702	3702 Not Processed	Not Processed	\N	\N	\N	\N	17-34742
3704	3704 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A1
3703	3703 Not Processed	Not Processed	\N	\N	\N	\N	18-12734
3705	3705 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A2
3706	3706 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A3
3708	3708 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A5
3707	3707 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A4
3709	3709 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A6
3710	3710 Not Processed	Not Processed	\N	\N	\N	\N	18-35014B2
3712	3712 Not Processed	Not Processed	\N	\N	\N	\N	19-6410A2
3711	3711 Not Processed	Not Processed	\N	\N	\N	\N	19-6410A1
3713	3713 Not Processed	Not Processed	\N	\N	\N	\N	19-20141
3714	3714 Not Processed	Not Processed	\N	\N	\N	\N	19-23613C4
3716	3716 Not Processed	Not Processed	\N	\N	\N	\N	19-34937S1
3715	3715 Not Processed	Not Processed	\N	\N	\N	\N	19-34937A2
3717	3717 Not Processed	Not Processed	\N	\N	\N	\N	19-43366F
3718	3718 Not Processed	Not Processed	\N	\N	\N	\N	19-44348A4
3719	3719 Not Processed	Not Processed	\N	\N	\N	\N	19-44987C1
3720	3720 Not Processed	Not Processed	\N	\N	\N	\N	19-52004B1
3721	3721 Not Processed	Not Processed	\N	\N	\N	\N	20-12501A1
3723	3723 Not Processed	Not Processed	\N	\N	\N	\N	20-21458A2
3722	3722 Not Processed	Not Processed	\N	\N	\N	\N	20-12501E1
3724	3724 Not Processed	Not Processed	\N	\N	\N	\N	20-59076A1
3725	3725 Not Processed	Not Processed	\N	\N	\N	\N	21-961A
3726	3726 Not Processed	Not Processed	\N	\N	\N	\N	21-13227A
3727	3727 Not Processed	Not Processed	\N	\N	\N	\N	21-26009A1
3729	3729 Not Processed	Not Processed	\N	\N	\N	\N	21-108508B
3728	3728 Not Processed	Not Processed	\N	\N	\N	\N	21-108508A
3731	3731 Not Processed	Not Processed	\N	\N	\N	\N	21-108509C
3730	3730 Not Processed	Not Processed	\N	\N	\N	\N	21-108509A
3733	3733 Not Processed	Not Processed	\N	\N	\N	\N	21-108509E
3732	3732 Not Processed	Not Processed	\N	\N	\N	\N	21-108509D
3734	3734 Not Processed	Not Processed	\N	\N	\N	\N	21-108510B
3735	3735 Not Processed	Not Processed	\N	\N	\N	\N	21-108510C
3736	3736 Not Processed	Not Processed	\N	\N	\N	\N	22-9055A1
3738	3738 Not Processed	Not Processed	\N	\N	\N	\N	22-25497A1
3737	3737 Not Processed	Not Processed	\N	\N	\N	\N	22-9055C1
3739	3739 Not Processed	Not Processed	\N	\N	\N	\N	22-25497A2
3741	3741 Not Processed	Not Processed	\N	\N	\N	\N	22-44747A2
3740	3740 Not Processed	Not Processed	\N	\N	\N	\N	22-44747A1
3742	3742 Not Processed	Not Processed	\N	\N	\N	\N	22-510407A1
3743	3743 Not Processed	Not Processed	\N	\N	\N	\N	23-6349A1
3745	3745 Not Processed	Not Processed	\N	\N	\N	\N	23-6349A3
3744	3744 Not Processed	Not Processed	\N	\N	\N	\N	23-6349A2
3746	3746 Not Processed	Not Processed	\N	\N	\N	\N	352-1-15.2
3747	3747 Not Processed	Not Processed	\N	\N	\N	\N	352-1-15.3
3748	3748 Not Processed	Not Processed	\N	\N	\N	\N	534-1-11.1
3749	3749 Not Processed	Not Processed	\N	\N	\N	\N	534-1-11.3
3751	3751 Not Processed	Not Processed	\N	\N	\N	\N	1586-2-13-B
3750	3750 Not Processed	Not Processed	\N	\N	\N	\N	1586-2-13-A
3752	3752 Not Processed	Not Processed	\N	\N	\N	\N	4070/2/13.2
3753	3753 Not Processed	Not Processed	\N	\N	\N	\N	4070/2/13.3
3754	3754 Not Processed	Not Processed	\N	\N	\N	\N	4070/3/13.1
3755	3755 Not Processed	Not Processed	\N	\N	\N	\N	4070/3/13.2
3757	3757 Not Processed	Not Processed	\N	\N	\N	\N	19111/14.1\n
3756	3756 Not Processed	Not Processed	\N	\N	\N	\N	4070/3/13.3
3758	3758 Not Processed	Not Processed	\N	\N	\N	\N	19111/14.4
3759	3759 Not Processed	Not Processed	\N	\N	\N	\N	19111/14.5
3760	3760 Not Processed	Not Processed	\N	\N	\N	\N	21159 A6
3761	3761 Not Processed	Not Processed	\N	\N	\N	\N	21159 G5
3762	3762 Not Processed	Not Processed	\N	\N	\N	\N	38637-16.3
3764	3764 Not Processed	Not Processed	\N	\N	\N	\N	78821-1b
3763	3763 Not Processed	Not Processed	\N	\N	\N	\N	78821-1a\n
3765	3765 Not Processed	Not Processed	\N	\N	\N	\N	78821-2a
3766	3766 Not Processed	Not Processed	\N	\N	\N	\N	78821-2b
3767	3767 Not Processed	Not Processed	\N	\N	\N	\N	79049-1b
3768	3768 Not Processed	Not Processed	\N	\N	\N	\N	79049-1d
3769	3769 Not Processed	Not Processed	\N	\N	\N	\N	79049-2a
3770	3770 Not Processed	Not Processed	\N	\N	\N	\N	79049-2b
3772	3772 Not Processed	Not Processed	\N	\N	\N	\N	79447-b
3771	3771 Not Processed	Not Processed	\N	\N	\N	\N	79447-a\n
3773	3773 Not Processed	Not Processed	\N	\N	\N	\N	86502c
3774	3774 Not Processed	Not Processed	\N	\N	\N	\N	86502d
3775	3775 Not Processed	Not Processed	\N	\N	\N	\N	86502f
3776	3776 Not Processed	Not Processed	\N	\N	\N	\N	86541-1f
3777	3777 Not Processed	Not Processed	\N	\N	\N	\N	86541-2b
3778	3778 Not Processed	Not Processed	\N	\N	\N	\N	501950C
3779	3779 Not Processed	Not Processed	\N	\N	\N	\N	610186B\n
3780	3780 Not Processed	Not Processed	\N	\N	\N	\N	610186C
3781	3781 Not Processed	Not Processed	\N	\N	\N	\N	610186D
3782	3782 Not Processed	Not Processed	\N	\N	\N	\N	B2015.54040
3784	3784 Not Processed	Not Processed	\N	\N	\N	\N	B17.80125 
3783	3783 Not Processed	Not Processed	\N	\N	\N	\N	B14. 951 
3785	3785 Not Processed	Not Processed	\N	\N	\N	\N	H 2015.1871
3786	3786 Not Processed	Not Processed	\N	\N	\N	\N	14-5893
3787	3787 Not Processed	Not Processed	\N	\N	\N	\N	14-40331B
3788	3788 Not Processed	Not Processed	\N	\N	\N	\N	17-8769A
3789	3789 Not Processed	Not Processed	\N	\N	\N	\N	17-51847B
3790	3790 Not Processed	Not Processed	\N	\N	\N	\N	19-94061
3791	3791 Not Processed	Not Processed	\N	\N	\N	\N	19-117072A2
3793	3793 Not Processed	Not Processed	\N	\N	\N	\N	22-95643B
3792	3792 Not Processed	Not Processed	\N	\N	\N	\N	21-3841E1
3795	3795 Not Processed	Not Processed	\N	\N	\N	\N	22-152373
3794	3794 Not Processed	Not Processed	\N	\N	\N	\N	22-115635C4
3796	3796 Not Processed	Not Processed	\N	\N	\N	\N	23-83099
3797	3797 Not Processed	Not Processed	\N	\N	\N	\N	23-97273
3799	3799 Not Processed	Not Processed	\N	\N	\N	\N	96-4039A5
3798	3798 Not Processed	Not Processed	\N	\N	\N	\N	23-107334C2
3800	3800 Not Processed	Not Processed	\N	\N	\N	\N	96-4039A7
3826	3826 Not Processed	Not Processed	\N	\N	\N	\N	17-27410
3827	3827 Not Processed	Not Processed	\N	\N	\N	\N	17-27410
3828	3828 Not Processed	Not Processed	\N	\N	\N	\N	17-34979
3829	3829 Not Processed	Not Processed	\N	\N	\N	\N	17-83378C
3832	3832 Not Processed	Not Processed	\N	\N	\N	\N	22-80980
3833	3833 Not Processed	Not Processed	\N	\N	\N	\N	22-83923A
3834	3834 Not Processed	Not Processed	\N	\N	\N	\N	22-107614
3835	3835 Not Processed	Not Processed	\N	\N	\N	\N	23-18865
3857	3857 Not Processed	Not Processed	\N	\N	\N	\N	11-91034
3811	3811 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L10
3812	3812 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L11
3819	3819 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L7
3820	3820 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L8
3821	3821 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L9
3823	3823 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona-L17
3813	3813 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L1
3814	3814 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L2
3815	3815 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L3
3816	3816 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L4
3817	3817 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L5
3818	3818 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L6
3830	3830 Single Cell Gene Expression	Single Cell Gene Expression	\N	\N	\N	\N	19-10031-2
3831	3831 Single Cell Gene Expression	Single Cell Gene Expression	\N	\N	\N	\N	20-30233-2
3351	3351 Intermediate	Intermediate	\N	\N	\N	\N	London-L2
3353	3353 Intermediate	Intermediate	\N	\N	\N	\N	London-L3
3419	3419 Cadaver Skin	Cadaver Skin	\N	\N	\N	\N	P57-A-1.0mm
3420	3420 Cadaver Skin	Cadaver Skin	\N	\N	\N	\N	P57-A-2.0mm
3422	3422 Cadaver Skin	Cadaver Skin	\N	\N	\N	\N	P57-B-2.0mm
3421	3421 Cadaver Skin	Cadaver Skin	\N	\N	\N	\N	P57-B-1.0mm
2930	2930 Human Cadaver Skin - Acral	Human Cadaver Skin - Acral	\N	\N	\N	\N	UCSF-23-041_Biopsy
2931	2931 Human Cadaver Skin - Acral	Human Cadaver Skin - Acral	\N	\N	\N	\N	UCSF-23-041_Biopsy
2932	2932 Human Cadaver Skin - Acral	Human Cadaver Skin - Acral	\N	\N	\N	\N	UCSF-23-041_Biopsy
2933	2933 Human Cadaver Skin - Acral	Human Cadaver Skin - Acral	\N	\N	\N	\N	UCSF-23-041_Biopsy
2984	2984 Human Cadaver Skin - Buttocks	Human Cadaver Skin - Buttocks	\N	\N	\N	\N	UCSF-23-041_Biopsy
2985	2985 Human Cadaver Skin - Buttocks	Human Cadaver Skin - Buttocks	\N	\N	\N	\N	UCSF-23-041_Biopsy
2986	2986 Human Cadaver Skin - Buttocks	Human Cadaver Skin - Buttocks	\N	\N	\N	\N	UCSF-23-041_Biopsy
2987	2987 Human Cadaver Skin - Buttocks	Human Cadaver Skin - Buttocks	\N	\N	\N	\N	UCSF-23-041_Biopsy
3238	3238 Human Cadaver Skin - Face	Human Cadaver Skin - Face	\N	\N	\N	\N	UCSF-23-041_Biopsy
3239	3239 Human Cadaver Skin - Face	Human Cadaver Skin - Face	\N	\N	\N	\N	UCSF-23-041_Biopsy
3240	3240 Human Cadaver Skin - Face	Human Cadaver Skin - Face	\N	\N	\N	\N	UCSF-23-041_Biopsy
3241	3241 Human Cadaver Skin - Face	Human Cadaver Skin - Face	\N	\N	\N	\N	UCSF-23-041_Biopsy
3431	3431 Human Cadaver Skin - Shoulder	Human Cadaver Skin - Shoulder	\N	\N	\N	\N	UCSF-23-041_Biopsy
3430	3430 Human Cadaver Skin - Shoulder	Human Cadaver Skin - Shoulder	\N	\N	\N	\N	UCSF-23-041_Biopsy
3433	3433 Human Cadaver Skin - Shoulder	Human Cadaver Skin - Shoulder	\N	\N	\N	\N	UCSF-23-041_Biopsy
3432	3432 Human Cadaver Skin - Shoulder	Human Cadaver Skin - Shoulder	\N	\N	\N	\N	UCSF-23-041_Biopsy
2247	2247 tum	tum	\N	\N	\N	\N	22-125373
10000	12-6261A_Tumor	Tumor	\N	\N	\N	\N	12-6261A
10001	12-6261B_Tumor	Tumor	\N	\N	\N	\N	12-6261B
10002	12-12366_Tumor	Tumor	\N	\N	\N	\N	12-12366
10003	12-12467_Tumor	Tumor	\N	\N	\N	\N	12-12467
10004	12-12470D_Tumor	Tumor	\N	\N	\N	\N	12-12470D
10005	12-562_Tumor	Tumor	\N	\N	\N	\N	12-562
10006	12-12647_Tumor	Tumor	\N	\N	\N	\N	12-12647
10007	12-12626_Tumor	Tumor	\N	\N	\N	\N	12-12626
10008	12-13587_Tumor	Tumor	\N	\N	\N	\N	12-13587
10009	12-18438A_Tumor	Tumor	\N	\N	\N	\N	12-18438A
10010	12-13152_Tumor	Tumor	\N	\N	\N	\N	12-13152
10011	12-12750B_Tumor	Tumor	\N	\N	\N	\N	12-12750B
10012	12-19596_Tumor	Tumor	\N	\N	\N	\N	12-19596
10013	12-19187A_Tumor	Tumor	\N	\N	\N	\N	12-19187A
10014	12-22172_Normal	Normal	\N	\N	\N	\N	12-22172
10015	12-22172_Tumor	Tumor	\N	\N	\N	\N	12-22172
10016	12-21726A_Tumor	Tumor	\N	\N	\N	\N	12-21726A
10017	12-22901A_Normal	Normal	\N	\N	\N	\N	12-22901A
10018	12-22901A_Tumor	Tumor	\N	\N	\N	\N	12-22901A
10019	12-22776_Normal	Normal	\N	\N	\N	\N	12-22776
10020	BuffyCoat_Tumor	Tumor	\N	\N	\N	\N	BuffyCoat
10021	12-13587B2_Tumor	Tumor	\N	\N	\N	\N	12-13587B2
10022	12-13587B2_Tumor	Tumor	\N	\N	\N	\N	12-13587B2
10023	12-13587B2_Tumor	Tumor	\N	\N	\N	\N	12-13587B2
10024	BuffyCoa_Tumor	Tumor	\N	\N	\N	\N	BuffyCoa
10025	12-22775_Tumor	Tumor	\N	\N	\N	\N	12-22775
10026	12-22794A_Tumor	Tumor	\N	\N	\N	\N	12-22794A
10027	12-22573_Tumor	Tumor	\N	\N	\N	\N	12-22573
10028	12-22582A_Tumor	Tumor	\N	\N	\N	\N	12-22582A
10029	12-22587_Tumor	Tumor	\N	\N	\N	\N	12-22587
10030	12-22592_Tumor	Tumor	\N	\N	\N	\N	12-22592
10031	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10032	12-22602A_Tumor	Tumor	\N	\N	\N	\N	12-22602A
10033	12-22602B_Tumor	Tumor	\N	\N	\N	\N	12-22602B
10034	12-22603_Tumor	Tumor	\N	\N	\N	\N	12-22603
10035	12-22604_Tumor	Tumor	\N	\N	\N	\N	12-22604
10036	12-22720A_Tumor	Tumor	\N	\N	\N	\N	12-22720A
10037	12-22868_Tumor	Tumor	\N	\N	\N	\N	12-22868
10038	12-22884C_Tumor	Tumor	\N	\N	\N	\N	12-22884C
10039	12-22884D_Tumor	Tumor	\N	\N	\N	\N	12-22884D
10040	12-22886_Tumor	Tumor	\N	\N	\N	\N	12-22886
10041	12-22894B_Tumor	Tumor	\N	\N	\N	\N	12-22894B
10042	12-22898_Tumor	Tumor	\N	\N	\N	\N	12-22898
10043	12-22900_Tumor	Tumor	\N	\N	\N	\N	12-22900
10044	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10045	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10046	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10047	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10048	WP11_Tumor	Tumor	\N	\N	\N	\N	WP11
10049	WP23_Tumor	Tumor	\N	\N	\N	\N	WP23
10050	WP29_Tumor	Tumor	\N	\N	\N	\N	WP29
10051	PG8_Tumor	Tumor	\N	\N	\N	\N	PG8
10052	KIT37_Tumor	Tumor	\N	\N	\N	\N	KIT37
10053	KIT62_Tumor	Tumor	\N	\N	\N	\N	KIT62
10054	KIT118_Tumor	Tumor	\N	\N	\N	\N	KIT118
10055	KIT181_Tumor	Tumor	\N	\N	\N	\N	KIT181
10056	KIT227_Tumor	Tumor	\N	\N	\N	\N	KIT227
10057	KIT275_Tumor	Tumor	\N	\N	\N	\N	KIT275
10058	Bivona-L1_Tumor	Tumor	\N	\N	\N	\N	Bivona-L1
10059	Bivona-L2_Tumor	Tumor	\N	\N	\N	\N	Bivona-L2
10060	Bivona-L3_Tumor	Tumor	\N	\N	\N	\N	Bivona-L3
10061	Bivona-L4_Tumor	Tumor	\N	\N	\N	\N	Bivona-L4
10062	Bivona-L5_Tumor	Tumor	\N	\N	\N	\N	Bivona-L5
10063	Bivona-L6_Tumor	Tumor	\N	\N	\N	\N	Bivona-L6
10064	10-41439_Melanoma	Melanoma	\N	\N	\N	\N	10-41439
10065	10-41439_Melanoma	Melanoma	\N	\N	\N	\N	10-41439
10066	10-41439_Nevus	Nevus	\N	\N	\N	\N	10-41439
10067	10-41439_Nevus	Nevus	\N	\N	\N	\N	10-41439
10068	10-41439_Normal	Normal	\N	\N	\N	\N	10-41439
10069	11-23681_Melanoma	Melanoma	\N	\N	\N	\N	11-23681
10070	11-23681_Melanoma	Melanoma	\N	\N	\N	\N	11-23681
10071	11-23681_Nevus	Nevus	\N	\N	\N	\N	11-23681
10072	11-23681_Nevus	Nevus	\N	\N	\N	\N	11-23681
10073	11-23681_Normal	Normal	\N	\N	\N	\N	11-23681
10074	11-37533_Melanoma	Melanoma	\N	\N	\N	\N	11-37533
10075	11-37533_Melanoma	Melanoma	\N	\N	\N	\N	11-37533
10076	11-37533_Nevus	Nevus	\N	\N	\N	\N	11-37533
10077	11-37533_Nevus	Nevus	\N	\N	\N	\N	11-37533
10078	11-37533_Normal	Normal	\N	\N	\N	\N	11-37533
10079	KIT262_Tumor	Tumor	\N	\N	\N	\N	KIT262
10080	Dog12_Tumor	Tumor	\N	\N	\N	\N	Dog12
10081	Dog24_Tumor	Tumor	\N	\N	\N	\N	Dog24
10082	Dog43_Tumor	Tumor	\N	\N	\N	\N	Dog43
10083	Dog55_Tumor	Tumor	\N	\N	\N	\N	Dog55
10084	HW3_Tumor	Tumor	\N	\N	\N	\N	HW3
10085	HW3_Normal	Normal	\N	\N	\N	\N	HW3
10086	HW4_Tumor	Tumor	\N	\N	\N	\N	HW4
10087	HW4_Normal	Normal	\N	\N	\N	\N	HW4
10088	HW6_Tumor	Tumor	\N	\N	\N	\N	HW6
10089	HW6_Normal	Normal	\N	\N	\N	\N	HW6
10090	10-86469_Tumor	Tumor	\N	\N	\N	\N	10-86469
10091	11-12273_Tumor	Tumor	\N	\N	\N	\N	11-12273
10092	11-23710_Tumor	Tumor	\N	\N	\N	\N	11-23710
10093	11-30426_Tumor	Tumor	\N	\N	\N	\N	11-30426
10094	11-31904_Tumor	Tumor	\N	\N	\N	\N	11-31904
10095	11-47644_Tumor	Tumor	\N	\N	\N	\N	11-47644
10096	MB_161_Tumor	Tumor	\N	\N	\N	\N	MB_161
10097	MB_161_Normal	Normal	\N	\N	\N	\N	MB_161
10098	MB_327_Tumor	Tumor	\N	\N	\N	\N	MB_327
10099	MB_1454_Normal	Normal	\N	\N	\N	\N	MB_1454
10100	MB_760_Tumor	Tumor	\N	\N	\N	\N	MB_760
10101	MB_1418_Normal	Normal	\N	\N	\N	\N	MB_1418
10102	MB_1029_Tumor	Tumor	\N	\N	\N	\N	MB_1029
10103	MB_1028_Normal	Normal	\N	\N	\N	\N	MB_1028
10104	MB_1046_Tumor	Tumor	\N	\N	\N	\N	MB_1046
10105	MB_1036_Normal	Normal	\N	\N	\N	\N	MB_1036
10106	Bivona-L17_Tumor	Tumor	\N	\N	\N	\N	Bivona-L17
10107	Bivona-L18_Tumor	Tumor	\N	\N	\N	\N	Bivona-L18
10108	Bivona-L19_Tumor	Tumor	\N	\N	\N	\N	Bivona-L19
10109	KIT227_Tumor	Tumor	\N	\N	\N	\N	KIT227
10110	KIT53_Tumor	Tumor	\N	\N	\N	\N	KIT53
10111	KIT313_Tumor	Tumor	\N	\N	\N	\N	KIT313
10112	HW2_Normal	Normal	\N	\N	\N	\N	HW2
10113	HW2_Tumor	Tumor	\N	\N	\N	\N	HW2
10114	HW8_Normal	Normal	\N	\N	\N	\N	HW8
10115	HW8_Tumor	Tumor	\N	\N	\N	\N	HW8
10116	HW9_Normal	Normal	\N	\N	\N	\N	HW9
10117	HW9_Tumor	Tumor	\N	\N	\N	\N	HW9
10118	12-6981_Tumor	Tumor	\N	\N	\N	\N	12-6981
10119	10-55707_Tumor	Tumor	\N	\N	\N	\N	10-55707
10120	11-34950_Tumor	Tumor	\N	\N	\N	\N	11-34950
10121	11-8228_Tumor	Tumor	\N	\N	\N	\N	11-8228
10122	11-84681_Tumor	Tumor	\N	\N	\N	\N	11-84681
10123	KIT227_Tumor	Tumor	\N	\N	\N	\N	KIT227
10124	WM3211_Tumor	Tumor	\N	\N	\N	\N	WM3211
10125	NB2107_Tumor	Tumor	\N	\N	\N	\N	NB2107
10126	London-L1_Tumor	Tumor	\N	\N	\N	\N	London-L1
10127	London-L2_Tumor	Tumor	\N	\N	\N	\N	London-L2
10128	Bivona-L7_Tumor	Tumor	\N	\N	\N	\N	Bivona-L7
10129	Bivona-L8_Tumor	Tumor	\N	\N	\N	\N	Bivona-L8
10130	Bivona-L9_Tumor	Tumor	\N	\N	\N	\N	Bivona-L9
10131	Bivona-L10_Tumor	Tumor	\N	\N	\N	\N	Bivona-L10
10132	HW3_Tumor	Tumor	\N	\N	\N	\N	HW3
10133	HW3_Normal	Normal	\N	\N	\N	\N	HW3
10134	HW4_Tumor	Tumor	\N	\N	\N	\N	HW4
10135	HW4_Normal	Normal	\N	\N	\N	\N	HW4
10136	HW6_Tumor	Tumor	\N	\N	\N	\N	HW6
10137	HW6_Normal	Normal	\N	\N	\N	\N	HW6
10138	10-86469_Tumor	Tumor	\N	\N	\N	\N	10-86469
10139	11-12273_Tumor	Tumor	\N	\N	\N	\N	11-12273
10140	11-23710_Tumor	Tumor	\N	\N	\N	\N	11-23710
10141	11-30426_Tumor	Tumor	\N	\N	\N	\N	11-30426
10142	11-31904_Tumor	Tumor	\N	\N	\N	\N	11-31904
10143	Bivona-L11_Tumor	Tumor	\N	\N	\N	\N	Bivona-L11
10144	HWA1_Tumor	Tumor	\N	\N	\N	\N	HWA1
10145	HWA1_Normal	Normal	\N	\N	\N	\N	HWA1
10146	HWA2_Tumor	Tumor	\N	\N	\N	\N	HWA2
10147	HWA2_Normal	Normal	\N	\N	\N	\N	HWA2
10148	HWA3_Tumor	Tumor	\N	\N	\N	\N	HWA3
10149	HWA3_Normal	Normal	\N	\N	\N	\N	HWA3
10150	HWA4_Tumor	Tumor	\N	\N	\N	\N	HWA4
10151	HWA4_Normal	Normal	\N	\N	\N	\N	HWA4
10152	11-5482_Tumor	Tumor	\N	\N	\N	\N	11-5482
10153	11-79158_Tumor	Tumor	\N	\N	\N	\N	11-79158
10154	DP12-200_Tumor	Tumor	\N	\N	\N	\N	DP12-200
10155	TissueCoreALKControl_Normal	Normal	\N	\N	\N	\N	TissueCoreALKControl
10156	10-59344_Tumor	Tumor	\N	\N	\N	\N	10-59344
10157	11-16253_Tumor	Tumor	\N	\N	\N	\N	11-16253
10158	11-61046_Tumor	Tumor	\N	\N	\N	\N	11-61046
10159	10-56047_Tumor	Tumor	\N	\N	\N	\N	10-56047
10160	12-67298_Tumor	Tumor	\N	\N	\N	\N	12-67298
10161	12-67298_Normal	Normal	\N	\N	\N	\N	12-67298
10162	12-20321_Tumor	Tumor	\N	\N	\N	\N	12-20321
10163	11-96096_Normal	Normal	\N	\N	\N	\N	11-96096
10164	MB1242_Tumor	Tumor	\N	\N	\N	\N	MB1242
10165	MB1241_Normal	Normal	\N	\N	\N	\N	MB1241
10166	MB1423_Tumor	Tumor	\N	\N	\N	\N	MB1423
10167	MB1423_Normal	Normal	\N	\N	\N	\N	MB1423
10168	MB1424__Tumor	Tumor	\N	\N	\N	\N	MB1424_
10169	MB1421_Normal	Normal	\N	\N	\N	\N	MB1421
10170	MB1429_Tumor	Tumor	\N	\N	\N	\N	MB1429
10171	MB1428_Normal	Normal	\N	\N	\N	\N	MB1428
10172	12-71679_Tumor	Tumor	\N	\N	\N	\N	12-71679
10173	12-80985B_Tumor	Tumor	\N	\N	\N	\N	12-80985B
10174	12-31996_Tumor	Tumor	\N	\N	\N	\N	12-31996
10175	12-39632_Tumor	Tumor	\N	\N	\N	\N	12-39632
10176	HWA5_Tumor	Tumor	\N	\N	\N	\N	HWA5
10177	HWA5_Normal	Normal	\N	\N	\N	\N	HWA5
10178	HWA6_Tumor	Tumor	\N	\N	\N	\N	HWA6
10179	HWA6_Normal	Normal	\N	\N	\N	\N	HWA6
10180	HWA7_Tumor	Tumor	\N	\N	\N	\N	HWA7
10181	HWA7_Normal	Normal	\N	\N	\N	\N	HWA7
10182	HWA8_Tumor	Tumor	\N	\N	\N	\N	HWA8
10183	HWA8_Normal	Normal	\N	\N	\N	\N	HWA8
10184	HWA9_Tumor	Tumor	\N	\N	\N	\N	HWA9
10185	HWA9_Normal	Normal	\N	\N	\N	\N	HWA9
10186	HWA10_Tumor	Tumor	\N	\N	\N	\N	HWA10
10187	HWA10_Normal	Normal	\N	\N	\N	\N	HWA10
10188	MB1617_Tumor	Tumor	\N	\N	\N	\N	MB1617
10189	MB1609_Normal	Normal	\N	\N	\N	\N	MB1609
10190	WM51_Tumor	Tumor	\N	\N	\N	\N	WM51
10191	wm3918_Tumor	Tumor	\N	\N	\N	\N	wm3918
10192	DM1_Normal	Normal	\N	\N	\N	\N	DM1
10193	DM1_Tumor	Tumor	\N	\N	\N	\N	DM1
10194	DM2_Normal	Normal	\N	\N	\N	\N	DM2
10195	DM2_Tumor	Tumor	\N	\N	\N	\N	DM2
10196	DM5_Normal	Normal	\N	\N	\N	\N	DM5
10197	DM5_Tumor	Tumor	\N	\N	\N	\N	DM5
10198	DM7_Normal	Normal	\N	\N	\N	\N	DM7
10199	DM7_Tumor	Tumor	\N	\N	\N	\N	DM7
10200	DM12_Normal	Normal	\N	\N	\N	\N	DM12
10201	DM12_Tumor	Tumor	\N	\N	\N	\N	DM12
10202	DM13_Normal	Normal	\N	\N	\N	\N	DM13
10203	DM13_Tumor	Tumor	\N	\N	\N	\N	DM13
10204	DM21_Normal	Normal	\N	\N	\N	\N	DM21
10205	DM21_Tumor	Tumor	\N	\N	\N	\N	DM21
10206	DM93_Normal	Normal	\N	\N	\N	\N	DM93
10207	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10208	11-20375_Tumor	Tumor	\N	\N	\N	\N	11-20375
10209	11-21491_Tumor	Tumor	\N	\N	\N	\N	11-21491
10210	11-65778_Tumor	Tumor	\N	\N	\N	\N	11-65778
10211	10-88482_Tumor	Tumor	\N	\N	\N	\N	10-88482
10212	11-63178_Tumor	Tumor	\N	\N	\N	\N	11-63178
10213	10-71761_Tumor	Tumor	\N	\N	\N	\N	10-71761
10214	10-84478_Tumor	Tumor	\N	\N	\N	\N	10-84478
10215	10-88475_Tumor	Tumor	\N	\N	\N	\N	10-88475
10216	12-54296_Normal	Normal	\N	\N	\N	\N	12-54296
10217	12-54296_Tumor	Tumor	\N	\N	\N	\N	12-54296
10218	12-54992_Normal	Normal	\N	\N	\N	\N	12-54992
10219	12-54992_Tumor	Tumor	\N	\N	\N	\N	12-54992
10220	WM3622_Tumor	Tumor	\N	\N	\N	\N	WM3622
10221	WM1963_Tumor	Tumor	\N	\N	\N	\N	WM1963
10222	WM8_Tumor	Tumor	\N	\N	\N	\N	WM8
10223	WM3912_Tumor	Tumor	\N	\N	\N	\N	WM3912
10224	DM11_Tumor	Tumor	\N	\N	\N	\N	DM11
10225	DM11_Normal	Normal	\N	\N	\N	\N	DM11
10226	DM14_Tumor	Tumor	\N	\N	\N	\N	DM14
10227	DM14_Normal	Normal	\N	\N	\N	\N	DM14
10228	DM26_Tumor	Tumor	\N	\N	\N	\N	DM26
10229	DM26_Normal	Normal	\N	\N	\N	\N	DM26
10230	DM28_Tumor	Tumor	\N	\N	\N	\N	DM28
10231	DM28_Normal	Normal	\N	\N	\N	\N	DM28
10232	DM29_Tumor	Tumor	\N	\N	\N	\N	DM29
10233	DM29_Normal	Normal	\N	\N	\N	\N	DM29
10234	DM34_Tumor	Tumor	\N	\N	\N	\N	DM34
10235	DM34_Normal	Normal	\N	\N	\N	\N	DM34
10236	DM55_Tumor	Tumor	\N	\N	\N	\N	DM55
10237	DM55_Normal	Normal	\N	\N	\N	\N	DM55
10238	DM79_Tumor	Tumor	\N	\N	\N	\N	DM79
10239	DM79_Normal	Normal	\N	\N	\N	\N	DM79
10240	11-78845_Tumor	Tumor	\N	\N	\N	\N	11-78845
10241	11-81405_Tumor	Tumor	\N	\N	\N	\N	11-81405
10242	11-85075_Tumor	Tumor	\N	\N	\N	\N	11-85075
10243	11-83908_Tumor	Tumor	\N	\N	\N	\N	11-83908
10244	11-85859_Tumor	Tumor	\N	\N	\N	\N	11-85859
10245	11-95663_Tumor	Tumor	\N	\N	\N	\N	11-95663
10246	DM4_Tumor	Tumor	\N	\N	\N	\N	DM4
10247	DM4_Normal	Normal	\N	\N	\N	\N	DM4
10248	DM95_Tumor	Tumor	\N	\N	\N	\N	DM95
10249	DM95_Normal	Normal	\N	\N	\N	\N	DM95
10250	DM96_Tumor	Tumor	\N	\N	\N	\N	DM96
10251	DM96_Normal	Normal	\N	\N	\N	\N	DM96
10252	KIT8_Tumor	Tumor	\N	\N	\N	\N	KIT8
10253	KIT21_Tumor	Tumor	\N	\N	\N	\N	KIT21
10254	KIT55_Tumor	Tumor	\N	\N	\N	\N	KIT55
10255	KIT76_Tumor	Tumor	\N	\N	\N	\N	KIT76
10256	W09-1121_Tumor	Tumor	\N	\N	\N	\N	W09-1121
10257	W09-1121_Normal	Normal	\N	\N	\N	\N	W09-1121
10258	W10-143_Tumor	Tumor	\N	\N	\N	\N	W10-143
10259	S94-31062_Tumor	Tumor	\N	\N	\N	\N	S94-31062
10260	S02-23636A02_Tumor	Tumor	\N	\N	\N	\N	S02-23636A02
10261	S02-33818A03_Tumor	Tumor	\N	\N	\N	\N	S02-33818A03
10262	S02-33818A03_Normal	Normal	\N	\N	\N	\N	S02-33818A03
10263	S05-7439A12_Tumor	Tumor	\N	\N	\N	\N	S05-7439A12
10264	S05-41924_Tumor	Tumor	\N	\N	\N	\N	S05-41924
10265	S06-47079A02_Tumor	Tumor	\N	\N	\N	\N	S06-47079A02
10266	S08-4544A03_Tumor	Tumor	\N	\N	\N	\N	S08-4544A03
10267	S10-26316A2_Tumor	Tumor	\N	\N	\N	\N	S10-26316A2
10268	S10-44069A4_Tumor	Tumor	\N	\N	\N	\N	S10-44069A4
10269	S11-38910A2_Tumor	Tumor	\N	\N	\N	\N	S11-38910A2
10270	KIT192_Tumor	Tumor	\N	\N	\N	\N	KIT192
10271	KIT203_Tumor	Tumor	\N	\N	\N	\N	KIT203
10272	KR_166_Tumor	Tumor	\N	\N	\N	\N	KR_166
10273	KR_2064_Tumor	Tumor	\N	\N	\N	\N	KR_2064
10274	KR_2030_Tumor	Tumor	\N	\N	\N	\N	KR_2030
10275	KR_177_Tumor	Tumor	\N	\N	\N	\N	KR_177
10276	KR_150_Tumor	Tumor	\N	\N	\N	\N	KR_150
10277	KR_229_Tumor	Tumor	\N	\N	\N	\N	KR_229
10278	KR_203_Tumor	Tumor	\N	\N	\N	\N	KR_203
10279	KR_8_Tumor	Tumor	\N	\N	\N	\N	KR_8
10280	KR_5233_Tumor	Tumor	\N	\N	\N	\N	KR_5233
10281	KR_RMK0091B_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0091B
10282	KR_RMK0194C_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0194C
10283	KR_RMK0137C_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0137C
10284	KR_RMK0162C_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0162C
10285	KR_RMK0168C_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0168C
10286	10-41439_Normal	Normal	\N	\N	\N	\N	10-41439
10287	11-23681A+C_Normal	Normal	\N	\N	\N	\N	11-23681A+C
10288	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10289	DM10_Normal	Normal	\N	\N	\N	\N	DM10
10290	DM17_Tumor	Tumor	\N	\N	\N	\N	DM17
10291	DM17_Normal	Normal	\N	\N	\N	\N	DM17
10292	DM18_Tumor	Tumor	\N	\N	\N	\N	DM18
10293	DM18_Normal	Normal	\N	\N	\N	\N	DM18
10294	DM22_Tumor	Tumor	\N	\N	\N	\N	DM22
10295	DM22_Normal	Normal	\N	\N	\N	\N	DM22
10296	DM23_Tumor	Tumor	\N	\N	\N	\N	DM23
10297	DM23_Normal	Normal	\N	\N	\N	\N	DM23
10298	DM25_Tumor	Tumor	\N	\N	\N	\N	DM25
10299	DM25_Normal	Normal	\N	\N	\N	\N	DM25
10300	DM6_Tumor	Tumor	\N	\N	\N	\N	DM6
10301	DM37_Tumor	Tumor	\N	\N	\N	\N	DM37
10302	DM93_Normal	Normal	\N	\N	\N	\N	DM93
10303	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10304	SM_1_Tumor	Tumor	\N	\N	\N	\N	SM_1
10305	SM_3_Tumor	Tumor	\N	\N	\N	\N	SM_3
10306	SM_4_Tumor	Tumor	\N	\N	\N	\N	SM_4
10307	SM_4_Normal	Normal	\N	\N	\N	\N	SM_4
10308	SM_5_Tumor	Tumor	\N	\N	\N	\N	SM_5
10309	SM_5_Normal	Normal	\N	\N	\N	\N	SM_5
10310	SM7_Tumor	Tumor	\N	\N	\N	\N	SM7
10311	SM_8_Tumor	Tumor	\N	\N	\N	\N	SM_8
10312	SM_11_Tumor	Tumor	\N	\N	\N	\N	SM_11
10313	SM_12_Tumor	Tumor	\N	\N	\N	\N	SM_12
10314	SM_16_Tumor	Tumor	\N	\N	\N	\N	SM_16
10315	SM_16_Normal	Normal	\N	\N	\N	\N	SM_16
10316	SM_18_Tumor	Tumor	\N	\N	\N	\N	SM_18
10317	DM42_Tumor	Tumor	\N	\N	\N	\N	DM42
10318	DM43_Tumor	Tumor	\N	\N	\N	\N	DM43
10319	DM48_Tumor	Tumor	\N	\N	\N	\N	DM48
10320	11-64496_Tumor	Tumor	\N	\N	\N	\N	11-64496
10321	11-71491_Tumor	Tumor	\N	\N	\N	\N	11-71491
10322	11-65756_Tumor	Tumor	\N	\N	\N	\N	11-65756
10323	11-74100_Tumor	Tumor	\N	\N	\N	\N	11-74100
10324	11-74517_Tumor	Tumor	\N	\N	\N	\N	11-74517
10325	10-74513_Tumor	Tumor	\N	\N	\N	\N	10-74513
10326	10-80009_Tumor	Tumor	\N	\N	\N	\N	10-80009
10327	10-91484_Tumor	Tumor	\N	\N	\N	\N	10-91484
10328	11-699_Tumor	Tumor	\N	\N	\N	\N	11-699
10329	11-18560_Tumor	Tumor	\N	\N	\N	\N	11-18560
10330	11-20772_Tumor	Tumor	\N	\N	\N	\N	11-20772
10331	11-19877_Tumor	Tumor	\N	\N	\N	\N	11-19877
10332	11-35616_Tumor	Tumor	\N	\N	\N	\N	11-35616
10333	11-33856_Tumor	Tumor	\N	\N	\N	\N	11-33856
10334	11-38771_Tumor	Tumor	\N	\N	\N	\N	11-38771
10335	11-39639_Tumor	Tumor	\N	\N	\N	\N	11-39639
10336	10-88482_Tumor	Tumor	\N	\N	\N	\N	10-88482
10337	11-5482_Tumor	Tumor	\N	\N	\N	\N	11-5482
10338	11-31904_Tumor	Tumor	\N	\N	\N	\N	11-31904
10339	11-61046_Tumor	Tumor	\N	\N	\N	\N	11-61046
10340	08-27590_Tumor	Tumor	\N	\N	\N	\N	08-27590
10341	08-27590_Normal	Normal	\N	\N	\N	\N	08-27590
10342	06-32942_Tumor	Tumor	\N	\N	\N	\N	06-32942
10343	06-52508_Tumor	Tumor	\N	\N	\N	\N	06-52508
10344	06-52508_Normal	Normal	\N	\N	\N	\N	06-52508
10345	07-04365_Tumor	Tumor	\N	\N	\N	\N	07-04365
10346	07-04365_Normal	Normal	\N	\N	\N	\N	07-04365
10347	07-14044A_Tumor	Tumor	\N	\N	\N	\N	07-14044A
10348	07-14044A_Normal	Normal	\N	\N	\N	\N	07-14044A
10349	07-26247_Tumor	Tumor	\N	\N	\N	\N	07-26247
10350	09-37302_Tumor	Tumor	\N	\N	\N	\N	09-37302
10351	12-79358_Tumor	Tumor	\N	\N	\N	\N	12-79358
10352	12-81302_Tumor	Tumor	\N	\N	\N	\N	12-81302
10353	12-81749_Tumor	Tumor	\N	\N	\N	\N	12-81749
10354	12-97031_Tumor	Tumor	\N	\N	\N	\N	12-97031
10355	12-98736_Tumor	Tumor	\N	\N	\N	\N	12-98736
10356	13-3874_Tumor	Tumor	\N	\N	\N	\N	13-3874
10357	13-3732_Tumor	Tumor	\N	\N	\N	\N	13-3732
10358	13-3889_Tumor	Tumor	\N	\N	\N	\N	13-3889
10359	13-4090B_Tumor	Tumor	\N	\N	\N	\N	13-4090B
10360	13-4136_Tumor	Tumor	\N	\N	\N	\N	13-4136
10361	13-7186_Tumor	Tumor	\N	\N	\N	\N	13-7186
10362	13-25A_Tumor	Tumor	\N	\N	\N	\N	13-25A
10363	11-71241_Tumor	Tumor	\N	\N	\N	\N	11-71241
10364	11-26903_Tumor	Tumor	\N	\N	\N	\N	11-26903
10365	11-28912B_Tumor	Tumor	\N	\N	\N	\N	11-28912B
10366	11-5210D_Tumor	Tumor	\N	\N	\N	\N	11-5210D
10367	10-83193_Tumor	Tumor	\N	\N	\N	\N	10-83193
10368	11-95856_Tumor	Tumor	\N	\N	\N	\N	11-95856
10369	10-23569A_Tumor	Tumor	\N	\N	\N	\N	10-23569A
10370	09-92749_Tumor	Tumor	\N	\N	\N	\N	09-92749
10371	09-72944_Tumor	Tumor	\N	\N	\N	\N	09-72944
10372	10-46536_Tumor	Tumor	\N	\N	\N	\N	10-46536
10373	10-83613A_Tumor	Tumor	\N	\N	\N	\N	10-83613A
10374	K1_1_Tumor	Tumor	\N	\N	\N	\N	K1_1
10375	K1_2_Tumor	Tumor	\N	\N	\N	\N	K1_2
10376	K1_3_Tumor	Tumor	\N	\N	\N	\N	K1_3
10377	London-L20_Melanoma	Melanoma	\N	\N	\N	\N	London-L20
10378	London-L20_Normal	Normal	\N	\N	\N	\N	London-L20
10379	London-L20_Nevus	Nevus	\N	\N	\N	\N	London-L20
10380	London-L15_Normal	Normal	\N	\N	\N	\N	London-L15
10381	London-L23C_Nevus	Nevus	\N	\N	\N	\N	London-L23C
10382	K1_9_Tumor	Tumor	\N	\N	\N	\N	K1_9
10383	K1_10_Tumor	Tumor	\N	\N	\N	\N	K1_10
10384	K1_11_Tumor	Tumor	\N	\N	\N	\N	K1_11
10385	K1_12_Tumor	Tumor	\N	\N	\N	\N	K1_12
10386	K1_13_Tumor	Tumor	\N	\N	\N	\N	K1_13
10387	K1_14_Tumor	Tumor	\N	\N	\N	\N	K1_14
10388	K1_15_Tumor	Tumor	\N	\N	\N	\N	K1_15
10389	K1_16_Tumor	Tumor	\N	\N	\N	\N	K1_16
10390	K1_17_Tumor	Tumor	\N	\N	\N	\N	K1_17
10391	K1_18_Tumor	Tumor	\N	\N	\N	\N	K1_18
10392	K1_19_Tumor	Tumor	\N	\N	\N	\N	K1_19
10393	K1_20_Tumor	Tumor	\N	\N	\N	\N	K1_20
10394	10-32987_Tumor	Tumor	\N	\N	\N	\N	10-32987
10395	06-08042_Tumor	Tumor	\N	\N	\N	\N	06-08042
10396	06-00911_Tumor	Tumor	\N	\N	\N	\N	06-00911
10397	06-21363_Tumor	Tumor	\N	\N	\N	\N	06-21363
10398	06-47334_Tumor	Tumor	\N	\N	\N	\N	06-47334
10399	S12-6332A5_Tumor	Tumor	\N	\N	\N	\N	S12-6332A5
10400	S11-032523A1_Tumor	Tumor	\N	\N	\N	\N	S11-032523A1
10401	S08-1463A2_Tumor	Tumor	\N	\N	\N	\N	S08-1463A2
10402	S12-7093NG176-1_Tumor	Tumor	\N	\N	\N	\N	S12-7093NG176-1
10403	S10-7937B2_Tumor	Tumor	\N	\N	\N	\N	S10-7937B2
10404	S11-21025B1_Tumor	Tumor	\N	\N	\N	\N	S11-21025B1
10405	10-58663_Melanoma	Melanoma	\N	\N	\N	\N	10-58663
10406	10-58663_Melanoma	Melanoma	\N	\N	\N	\N	10-58663
10407	10-58663_Nevus	Nevus	\N	\N	\N	\N	10-58663
10408	10-58663_Nevus	Nevus	\N	\N	\N	\N	10-58663
10409	10-58663_Normal	Normal	\N	\N	\N	\N	10-58663
10410	08-52519_Melanoma	Melanoma	\N	\N	\N	\N	08-52519
10411	08-52519_Melanoma	Melanoma	\N	\N	\N	\N	08-52519
10412	08-52519_Nevus	Nevus	\N	\N	\N	\N	08-52519
10413	08-52519_Nevus	Nevus	\N	\N	\N	\N	08-52519
10414	08-52519_Normal	Normal	\N	\N	\N	\N	08-52519
10415	09-8165_Melanoma	Melanoma	\N	\N	\N	\N	09-8165
10416	09-8165_Melanoma	Melanoma	\N	\N	\N	\N	09-8165
10417	09-8165_Nevus	Nevus	\N	\N	\N	\N	09-8165
10418	09-8165_Nevus	Nevus	\N	\N	\N	\N	09-8165
10419	09-8165_Normal	Normal	\N	\N	\N	\N	09-8165
10420	08-46462_Melanoma	Melanoma	\N	\N	\N	\N	08-46462
10421	08-46462_Melanoma	Melanoma	\N	\N	\N	\N	08-46462
10422	08-46462_Nevus	Nevus	\N	\N	\N	\N	08-46462
10423	08-46462_Nevus	Nevus	\N	\N	\N	\N	08-46462
10424	08-46462_Normal	Normal	\N	\N	\N	\N	08-46462
10425	11-25808_Tumor	Tumor	\N	\N	\N	\N	11-25808
10426	11-42027_Tumor	Tumor	\N	\N	\N	\N	11-42027
10427	12-7775_Tumor	Tumor	\N	\N	\N	\N	12-7775
10428	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10429	DM37_Normal	Normal	\N	\N	\N	\N	DM37
10430	DM45_Tumor	Tumor	\N	\N	\N	\N	DM45
10431	DM45_Normal	Normal	\N	\N	\N	\N	DM45
10432	DM16_Tumor	Tumor	\N	\N	\N	\N	DM16
10433	DM16_Normal	Normal	\N	\N	\N	\N	DM16
10434	DM77_Tumor	Tumor	\N	\N	\N	\N	DM77
10435	DM77_Normal	Normal	\N	\N	\N	\N	DM77
10436	HW3_Tumor	Tumor	\N	\N	\N	\N	HW3
10437	HW2_Tumor	Tumor	\N	\N	\N	\N	HW2
10438	HWAcr_Tumor	Tumor	\N	\N	\N	\N	HWAcr
10439	KIT181_Tumor	Tumor	\N	\N	\N	\N	KIT181
10440	DM13_Tumor	Tumor	\N	\N	\N	\N	DM13
10441	DM94_Tumor	Tumor	\N	\N	\N	\N	DM94
10442	DM94_Normal	Normal	\N	\N	\N	\N	DM94
10443	DM98_Tumor	Tumor	\N	\N	\N	\N	DM98
10444	DM98_Normal	Normal	\N	\N	\N	\N	DM98
10445	DM99_Tumor	Tumor	\N	\N	\N	\N	DM99
10446	DM99_Normal	Normal	\N	\N	\N	\N	DM99
10447	DM64_Tumor	Tumor	\N	\N	\N	\N	DM64
10448	DM64_Normal	Normal	\N	\N	\N	\N	DM64
10449	DM51_Tumor	Tumor	\N	\N	\N	\N	DM51
10450	DM58_Tumor	Tumor	\N	\N	\N	\N	DM58
10451	DM59_Tumor	Tumor	\N	\N	\N	\N	DM59
10452	DM31_Tumor	Tumor	\N	\N	\N	\N	DM31
10453	DM36_Tumor	Tumor	\N	\N	\N	\N	DM36
10454	DM74_Tumor	Tumor	\N	\N	\N	\N	DM74
10455	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10456	DM18_Tumor	Tumor	\N	\N	\N	\N	DM18
10457	HW8_Tumor	Tumor	\N	\N	\N	\N	HW8
10458	08-43264_Melanoma	Melanoma	\N	\N	\N	\N	08-43264
10459	08-43264_Melanoma	Melanoma	\N	\N	\N	\N	08-43264
10460	08-43264_Nevus	Nevus	\N	\N	\N	\N	08-43264
10461	08-43264_Nevus	Nevus	\N	\N	\N	\N	08-43264
10462	08-43264_Normal	Normal	\N	\N	\N	\N	08-43264
10463	08-51219_Melanoma	Melanoma	\N	\N	\N	\N	08-51219
10464	08-51219_Melanoma	Melanoma	\N	\N	\N	\N	08-51219
10465	08-51219_Nevus	Nevus	\N	\N	\N	\N	08-51219
10466	08-51219_Nevus	Nevus	\N	\N	\N	\N	08-51219
10467	08-51219_Normal	Normal	\N	\N	\N	\N	08-51219
10468	S12-18826_Tumor	Tumor	\N	\N	\N	\N	S12-18826
10469	11-81851_Melanoma	Melanoma	\N	\N	\N	\N	11-81851
10470	11-81851_Melanoma	Melanoma	\N	\N	\N	\N	11-81851
10471	11-81851_Nevus	Nevus	\N	\N	\N	\N	11-81851
10472	11-81851_Nevus	Nevus	\N	\N	\N	\N	11-81851
10473	11-81851_Normal	Normal	\N	\N	\N	\N	11-81851
10474	10-73024_Melanoma	Melanoma	\N	\N	\N	\N	10-73024
10475	10-73024_Melanoma	Melanoma	\N	\N	\N	\N	10-73024
10476	10-73024_Nevus	Nevus	\N	\N	\N	\N	10-73024
10477	10-73024_Nevus	Nevus	\N	\N	\N	\N	10-73024
10478	10-73024_Normal	Normal	\N	\N	\N	\N	10-73024
10479	12_M_Tumor	Tumor	\N	\N	\N	\N	12_M
10480	35_M_Tumor	Tumor	\N	\N	\N	\N	35_M
10481	49_M_Tumor	Tumor	\N	\N	\N	\N	49_M
10482	DM2_Tumor	Tumor	\N	\N	\N	\N	DM2
10483	10-0206_Tumor	Tumor	\N	\N	\N	\N	10-0206
10484	09-0209_Tumor	Tumor	\N	\N	\N	\N	09-0209
10485	13-25110A1_Melanoma	Melanoma	\N	\N	\N	\N	13-25110A1
10486	13-25110A1_Nevus	Nevus	\N	\N	\N	\N	13-25110A1
10487	13-25110A1_Normal	Normal	\N	\N	\N	\N	13-25110A1
10488	13-45163_Melanoma	Melanoma	\N	\N	\N	\N	13-45163
10489	13-45163_Nevus	Nevus	\N	\N	\N	\N	13-45163
10490	13-45163_Normal	Normal	\N	\N	\N	\N	13-45163
10491	DM49_Tumor	Tumor	\N	\N	\N	\N	DM49
10492	DP08-21965C_Tumor	Tumor	\N	\N	\N	\N	DP08-21965C
10493	DP08-21965C_Normal	Normal	\N	\N	\N	\N	DP08-21965C
10494	DP08-4205A_Tumor	Tumor	\N	\N	\N	\N	DP08-4205A
10495	DP08-4205A_Normal	Normal	\N	\N	\N	\N	DP08-4205A
10496	11-50182_Tumor	Tumor	\N	\N	\N	\N	11-50182
10497	11-51553_Tumor	Tumor	\N	\N	\N	\N	11-51553
10498	11-52339_Tumor	Tumor	\N	\N	\N	\N	11-52339
10499	11-55993_Tumor	Tumor	\N	\N	\N	\N	11-55993
10500	11-57051_Tumor	Tumor	\N	\N	\N	\N	11-57051
10501	11-71006_Tumor	Tumor	\N	\N	\N	\N	11-71006
10502	11-76464_Tumor	Tumor	\N	\N	\N	\N	11-76464
10503	11-88431_Tumor	Tumor	\N	\N	\N	\N	11-88431
10504	11-88432_Tumor	Tumor	\N	\N	\N	\N	11-88432
10505	11-88209_Tumor	Tumor	\N	\N	\N	\N	11-88209
10506	Thomas_SK_MEL_23_Tumor	Tumor	\N	\N	\N	\N	Thomas_SK_MEL_23
10507	KIT134_Tumor	Tumor	\N	\N	\N	\N	KIT134
10508	KIT191_Tumor	Tumor	\N	\N	\N	\N	KIT191
10509	KIT205_Tumor	Tumor	\N	\N	\N	\N	KIT205
10510	KIT206_Tumor	Tumor	\N	\N	\N	\N	KIT206
10511	KIT210_Tumor	Tumor	\N	\N	\N	\N	KIT210
10512	KIT217_Tumor	Tumor	\N	\N	\N	\N	KIT217
10513	KIT225_Tumor	Tumor	\N	\N	\N	\N	KIT225
10514	KIT244_Tumor	Tumor	\N	\N	\N	\N	KIT244
10515	KIT260_Tumor	Tumor	\N	\N	\N	\N	KIT260
10516	KIT273_Tumor	Tumor	\N	\N	\N	\N	KIT273
10517	KIT295_Tumor	Tumor	\N	\N	\N	\N	KIT295
10518	11-23878_Tumor	Tumor	\N	\N	\N	\N	11-23878
10519	12-11041_Tumor	Tumor	\N	\N	\N	\N	12-11041
10520	12-55584_Tumor	Tumor	\N	\N	\N	\N	12-55584
10521	11-85416_Tumor	Tumor	\N	\N	\N	\N	11-85416
10522	11-94134_Tumor	Tumor	\N	\N	\N	\N	11-94134
10523	12-2898_Tumor	Tumor	\N	\N	\N	\N	12-2898
10524	12-1782_Tumor	Tumor	\N	\N	\N	\N	12-1782
10525	12-4251_Tumor	Tumor	\N	\N	\N	\N	12-4251
10526	12-8171_Tumor	Tumor	\N	\N	\N	\N	12-8171
10527	12-10777_Tumor	Tumor	\N	\N	\N	\N	12-10777
10528	10_63051C_Normal	Normal	\N	\N	\N	\N	10_63051C
10529	DPN8_Normal	Normal	\N	\N	\N	\N	DPN8
10530	DPN9_Normal	Normal	\N	\N	\N	\N	DPN9
10531	DPN18_Normal	Normal	\N	\N	\N	\N	DPN18
10532	11-21178_Tumor	Tumor	\N	\N	\N	\N	11-21178
10533	13-212_Tumor	Tumor	\N	\N	\N	\N	13-212
10534	DM74_Tumor	Tumor	\N	\N	\N	\N	DM74
10535	DM99_Tumor	Tumor	\N	\N	\N	\N	DM99
10536	KIT230_Tumor	Tumor	\N	\N	\N	\N	KIT230
10537	KIT297_Tumor	Tumor	\N	\N	\N	\N	KIT297
10538	KIT302_Tumor	Tumor	\N	\N	\N	\N	KIT302
10539	KIT316_Tumor	Tumor	\N	\N	\N	\N	KIT316
10540	DM6_Normal	Normal	\N	\N	\N	\N	DM6
10541	DM31_Normal	Normal	\N	\N	\N	\N	DM31
10542	DM36_Normal	Normal	\N	\N	\N	\N	DM36
10543	DM42_Normal	Normal	\N	\N	\N	\N	DM42
10544	DM68_Tumor	Tumor	\N	\N	\N	\N	DM68
10545	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10546	DM10_Normal	Normal	\N	\N	\N	\N	DM10
10547	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10548	11-50270_Tumor	Tumor	\N	\N	\N	\N	11-50270
10549	12-23578_Tumor	Tumor	\N	\N	\N	\N	12-23578
10550	12-31421_Tumor	Tumor	\N	\N	\N	\N	12-31421
10551	11-13661_Tumor	Tumor	\N	\N	\N	\N	11-13661
10552	RC11-001_Tumor	Tumor	\N	\N	\N	\N	RC11-001
10553	RC11-002_Tumor	Tumor	\N	\N	\N	\N	RC11-002
10554	RC11-003_Tumor	Tumor	\N	\N	\N	\N	RC11-003
10555	RC11-004_Tumor	Tumor	\N	\N	\N	\N	RC11-004
10556	RC11-005_Tumor	Tumor	\N	\N	\N	\N	RC11-005
10557	RC11-021_Tumor	Tumor	\N	\N	\N	\N	RC11-021
10558	RC11-022_Tumor	Tumor	\N	\N	\N	\N	RC11-022
10559	RC11-023_Tumor	Tumor	\N	\N	\N	\N	RC11-023
10560	RC11-024_Tumor	Tumor	\N	\N	\N	\N	RC11-024
10561	Kit298_Tumor	Tumor	\N	\N	\N	\N	Kit298
10562	08-46462_Tumor	Tumor	\N	\N	\N	\N	08-46462
10563	08-46462_Nevus	Nevus	\N	\N	\N	\N	08-46462
10564	08-46462_Tumor	Tumor	\N	\N	\N	\N	08-46462
10565	08-46462_Normal	Normal	\N	\N	\N	\N	08-46462
10566	BN_N1_Tumor	Tumor	\N	\N	\N	\N	BN_N1
10567	BN_N2_Tumor	Tumor	\N	\N	\N	\N	BN_N2
10568	BN_M1_Tumor	Tumor	\N	\N	\N	\N	BN_M1
10569	BN_M2_Tumor	Tumor	\N	\N	\N	\N	BN_M2
10570	DM74_Tumor	Tumor	\N	\N	\N	\N	DM74
10571	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10572	SQ13-8208B_Tumor	Tumor	\N	\N	\N	\N	SQ13-8208B
10573	98-18400a_Tumor	Tumor	\N	\N	\N	\N	98-18400a
10574	12-11406A_Tumor	Tumor	\N	\N	\N	\N	12-11406A
10575	08-70283a_Tumor	Tumor	\N	\N	\N	\N	08-70283a
10576	03-34051A1_Tumor	Tumor	\N	\N	\N	\N	03-34051A1
10577	02-42436_Tumor	Tumor	\N	\N	\N	\N	02-42436
10578	11-38149_Normal	Normal	\N	\N	\N	\N	11-38149
10579	13-2939B_Tumor	Tumor	\N	\N	\N	\N	13-2939B
10580	L13-48798_Tumor	Tumor	\N	\N	\N	\N	L13-48798
10581	13-51115A_Tumor	Tumor	\N	\N	\N	\N	13-51115A
10582	11-73238A_Normal	Normal	\N	\N	\N	\N	11-73238A
10583	11-73999_Normal	Normal	\N	\N	\N	\N	11-73999
10584	DM43_Normal	Normal	\N	\N	\N	\N	DM43
10585	DM49_Normal	Normal	\N	\N	\N	\N	DM49
10586	DM58_Normal	Normal	\N	\N	\N	\N	DM58
10587	DM65_Tumor	Tumor	\N	\N	\N	\N	DM65
10588	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10589	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10590	13-59840_Tumor	Tumor	\N	\N	\N	\N	13-59840
10591	13-59840_Tumor	Tumor	\N	\N	\N	\N	13-59840
10592	Seider_Uveal_Tumor	Tumor	\N	\N	\N	\N	Seider_Uveal
10593	Luping_ROS_1_Tumor	Tumor	\N	\N	\N	\N	Luping_ROS_1
10594	Seider_Roe_Tumor	Tumor	\N	\N	\N	\N	Seider_Roe
10595	DP08-21965C_Tumor	Tumor	\N	\N	\N	\N	DP08-21965C
10596	DM18_Tumor	Tumor	\N	\N	\N	\N	DM18
10597	11-50182_Tumor	Tumor	\N	\N	\N	\N	11-50182
10598	11-41004_Tumor	Tumor	\N	\N	\N	\N	11-41004
10599	11-51223_Tumor	Tumor	\N	\N	\N	\N	11-51223
10600	12-22542_Tumor	Tumor	\N	\N	\N	\N	12-22542
10601	12-42406_Tumor	Tumor	\N	\N	\N	\N	12-42406
10602	12-55875_Tumor	Tumor	\N	\N	\N	\N	12-55875
10603	12-88454_Tumor	Tumor	\N	\N	\N	\N	12-88454
10604	12-98328_Tumor	Tumor	\N	\N	\N	\N	12-98328
10605	13-25A_Tumor	Tumor	\N	\N	\N	\N	13-25A
10606	12-762B_Normal	Normal	\N	\N	\N	\N	12-762B
10607	12-168B_Normal	Normal	\N	\N	\N	\N	12-168B
10608	11-75173_Normal	Normal	\N	\N	\N	\N	11-75173
10609	12-167B_Normal	Normal	\N	\N	\N	\N	12-167B
10610	13-47668_Tumor	Tumor	\N	\N	\N	\N	13-47668
10611	13-47668_Tumor	Tumor	\N	\N	\N	\N	13-47668
10612	12-66661_Tumor	Tumor	\N	\N	\N	\N	12-66661
10613	13-47621_Tumor	Tumor	\N	\N	\N	\N	13-47621
10614	13-47621_Tumor	Tumor	\N	\N	\N	\N	13-47621
10615	13-37371_Tumor	Tumor	\N	\N	\N	\N	13-37371
10616	13-37371_Tumor	Tumor	\N	\N	\N	\N	13-37371
10617	DM11_Tumor	Tumor	\N	\N	\N	\N	DM11
10618	DM14_Tumor	Tumor	\N	\N	\N	\N	DM14
10619	13-25110A1_Melanoma	Melanoma	\N	\N	\N	\N	13-25110A1
10620	13-25110A1_Normal	Normal	\N	\N	\N	\N	13-25110A1
10621	13-45163_Normal	Normal	\N	\N	\N	\N	13-45163
10622	Acral-11_Tumor	Tumor	\N	\N	\N	\N	Acral-11
10623	Acral-11_Normal	Normal	\N	\N	\N	\N	Acral-11
10624	Acral-12_Tumor	Tumor	\N	\N	\N	\N	Acral-12
10625	Acral-12_Normal	Normal	\N	\N	\N	\N	Acral-12
10626	02-2599_Tumor	Tumor	\N	\N	\N	\N	02-2599
10627	02-2599_Tumor	Tumor	\N	\N	\N	\N	02-2599
10628	02-2599C_Tumor	Tumor	\N	\N	\N	\N	02-2599C
10629	02-2599_Tumor	Tumor	\N	\N	\N	\N	02-2599
10630	DM48_Normal	Normal	\N	\N	\N	\N	DM48
10631	DM59_Normal	Normal	\N	\N	\N	\N	DM59
10632	DM68_Normal	Normal	\N	\N	\N	\N	DM68
10633	DM95_Tumor	Tumor	\N	\N	\N	\N	DM95
10634	08-46462_Nevus	Nevus	\N	\N	\N	\N	08-46462
10635	08-46462_MIS	MIS	\N	\N	\N	\N	08-46462
10636	08-46462_Normal	Normal	\N	\N	\N	\N	08-46462
10637	08-46462_Melanoma	Melanoma	\N	\N	\N	\N	08-46462
10638	T07-1120_Tumor	Tumor	\N	\N	\N	\N	T07-1120
10639	T09-8069_Tumor	Tumor	\N	\N	\N	\N	T09-8069
10640	T02-16195_Tumor	Tumor	\N	\N	\N	\N	T02-16195
10641	T00-12011_Tumor	Tumor	\N	\N	\N	\N	T00-12011
10642	T06-6855_Tumor	Tumor	\N	\N	\N	\N	T06-6855
10643	12-18832AA_Tumor	Tumor	\N	\N	\N	\N	12-18832AA
10644	CNS52_Tumor	Tumor	\N	\N	\N	\N	CNS52
10645	CNS53_Tumor	Tumor	\N	\N	\N	\N	CNS53
10646	CNS54_Tumor	Tumor	\N	\N	\N	\N	CNS54
10647	CNS57_Tumor	Tumor	\N	\N	\N	\N	CNS57
10648	CNS57_Normal	Normal	\N	\N	\N	\N	CNS57
10649	BN-N1-Tert_Tumor	Tumor	\N	\N	\N	\N	BN-N1-Tert
10650	BN-N2-Tert_Tumor	Tumor	\N	\N	\N	\N	BN-N2-Tert
10651	BN-M1-Tert_Tumor	Tumor	\N	\N	\N	\N	BN-M1-Tert
10652	08-43264_Nevus	Nevus	\N	\N	\N	\N	08-43264
10653	10-58663_Melanoma	Melanoma	\N	\N	\N	\N	10-58663
10654	12-12039B_Tumor	Tumor	\N	\N	\N	\N	12-12039B
10655	12-22776B3_Tumor	Tumor	\N	\N	\N	\N	12-22776B3
10656	99-29482_Tumor	Tumor	\N	\N	\N	\N	99-29482
10657	99-15313_Tumor	Tumor	\N	\N	\N	\N	99-15313
10658	99-885_Tumor	Tumor	\N	\N	\N	\N	99-885
10659	98-37643_Tumor	Tumor	\N	\N	\N	\N	98-37643
10660	13-25288_Tumor	Tumor	\N	\N	\N	\N	13-25288
10661	09-29997_Tumor	Tumor	\N	\N	\N	\N	09-29997
10662	04-11158_Tumor	Tumor	\N	\N	\N	\N	04-11158
10663	UM4_Tumor	Tumor	\N	\N	\N	\N	UM4
10664	UM5_Tumor	Tumor	\N	\N	\N	\N	UM5
10665	08-84352_Melanoma	Melanoma	\N	\N	\N	\N	08-84352
10666	08-84352_Melanoma	Melanoma	\N	\N	\N	\N	08-84352
10667	08-84352_Nevus	Nevus	\N	\N	\N	\N	08-84352
10668	08-84352_Normal	Normal	\N	\N	\N	\N	08-84352
10669	11-88792_Melanoma	Melanoma	\N	\N	\N	\N	11-88792
10670	11-88792_Melanoma	Melanoma	\N	\N	\N	\N	11-88792
10671	11-88792_Nevus	Nevus	\N	\N	\N	\N	11-88792
10672	11-88792_Nevus	Nevus	\N	\N	\N	\N	11-88792
10673	11-88792_Normal	Normal	\N	\N	\N	\N	11-88792
10674	13-74952_Tumor	Tumor	\N	\N	\N	\N	13-74952
10675	13-75067_Tumor	Tumor	\N	\N	\N	\N	13-75067
10676	Spitz_M1_Tumor	Tumor	\N	\N	\N	\N	Spitz_M1
10677	Spitz_M2_(?)_Tumor	Tumor	\N	\N	\N	\N	Spitz_M2_(?)
10678	Spitz_N1_Tumor	Tumor	\N	\N	\N	\N	Spitz_N1
10679	Spitz_N2_Tumor	Tumor	\N	\N	\N	\N	Spitz_N2
10680	Spitz_N3_Tumor	Tumor	\N	\N	\N	\N	Spitz_N3
10681	BN_Normal	Normal	\N	\N	\N	\N	BN
10682	13-159_Tumor	Tumor	\N	\N	\N	\N	13-159
10683	12-43016_Tumor	Tumor	\N	\N	\N	\N	12-43016
10684	13-34291_Tumor	Tumor	\N	\N	\N	\N	13-34291
10685	GAK_DNA_Tumor	Tumor	\N	\N	\N	\N	GAK_DNA
10686	Yurif_DNA_Tumor	Tumor	\N	\N	\N	\N	Yurif_DNA
10687	Acral-11_Tumor	Tumor	\N	\N	\N	\N	Acral-11
10688	Acral-11_Normal	Normal	\N	\N	\N	\N	Acral-11
10689	DPN26_Tumor	Tumor	\N	\N	\N	\N	DPN26
10690	13-47668_Tumor	Tumor	\N	\N	\N	\N	13-47668
10691	13-47668_Tumor	Tumor	\N	\N	\N	\N	13-47668
10692	13-47621_Tumor	Tumor	\N	\N	\N	\N	13-47621
10693	13-47621_Tumor	Tumor	\N	\N	\N	\N	13-47621
10694	13-37371_Tumor	Tumor	\N	\N	\N	\N	13-37371
10695	13-37371_Tumor	Tumor	\N	\N	\N	\N	13-37371
10696	DM45_Tumor	Tumor	\N	\N	\N	\N	DM45
10697	DM58_Tumor	Tumor	\N	\N	\N	\N	DM58
10698	DM1_Tumor	Tumor	\N	\N	\N	\N	DM1
10699	DM2_Tumor	Tumor	\N	\N	\N	\N	DM2
10700	DM45_Tumor	Tumor	\N	\N	\N	\N	DM45
10701	DM79_Tumor	Tumor	\N	\N	\N	\N	DM79
10702	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10703	13-2939B_Tumor	Tumor	\N	\N	\N	\N	13-2939B
10704	11-73238A_Tumor	Tumor	\N	\N	\N	\N	11-73238A
10705	99-29482_Tumor	Tumor	\N	\N	\N	\N	99-29482
10706	13-25288_Tumor	Tumor	\N	\N	\N	\N	13-25288
10707	04-11158_Tumor	Tumor	\N	\N	\N	\N	04-11158
10708	10-55707_Tumor	Tumor	\N	\N	\N	\N	10-55707
10709	11-34950_Tumor	Tumor	\N	\N	\N	\N	11-34950
10710	11-8228_Tumor	Tumor	\N	\N	\N	\N	11-8228
10711	11-84681_Tumor	Tumor	\N	\N	\N	\N	11-84681
10712	11-50182_Tumor	Tumor	\N	\N	\N	\N	11-50182
10713	MIN_7_Normal	Normal	\N	\N	\N	\N	MIN_7
10714	MIN_7_Nevus	Nevus	\N	\N	\N	\N	MIN_7
10715	MIN_7_Tumor	Tumor	\N	\N	\N	\N	MIN_7
10716	MIN_8_Normal	Normal	\N	\N	\N	\N	MIN_8
10717	MIN_8_Nevus	Nevus	\N	\N	\N	\N	MIN_8
10718	MIN_8_Tumor	Tumor	\N	\N	\N	\N	MIN_8
10719	501_Mel_Tumor	Tumor	\N	\N	\N	\N	501_Mel
10720	Sk_Mel_1_Tumor	Tumor	\N	\N	\N	\N	Sk_Mel_1
10721	DPN24_Tumor	Tumor	\N	\N	\N	\N	DPN24
10722	DPN28_Tumor	Tumor	\N	\N	\N	\N	DPN28
10723	DPN29_Tumor	Tumor	\N	\N	\N	\N	DPN29
10724	DPN31_Tumor	Tumor	\N	\N	\N	\N	DPN31
10725	DPN33_Tumor	Tumor	\N	\N	\N	\N	DPN33
10726	DPN40_Tumor	Tumor	\N	\N	\N	\N	DPN40
10727	DPN40_Tumor	Tumor	\N	\N	\N	\N	DPN40
10728	DPN41_Tumor	Tumor	\N	\N	\N	\N	DPN41
10729	DPN42_Tumor	Tumor	\N	\N	\N	\N	DPN42
10730	DPN44_Tumor	Tumor	\N	\N	\N	\N	DPN44
10731	DPN45_Tumor	Tumor	\N	\N	\N	\N	DPN45
10732	DPN46_Tumor	Tumor	\N	\N	\N	\N	DPN46
10733	UM_6_Tumor	Tumor	\N	\N	\N	\N	UM_6
10734	Birt_Hogg_Dube_Tumor	Tumor	\N	\N	\N	\N	Birt_Hogg_Dube
10735	13-1939_Tumor	Tumor	\N	\N	\N	\N	13-1939
10736	13-51657_Tumor	Tumor	\N	\N	\N	\N	13-51657
10737	13-89069_Tumor	Tumor	\N	\N	\N	\N	13-89069
10738	11-1051A_Tumor	Tumor	\N	\N	\N	\N	11-1051A
10739	11-5480_Tumor	Tumor	\N	\N	\N	\N	11-5480
10740	10-73024_Tumor	Tumor	\N	\N	\N	\N	10-73024
10741	10-73024_Normal	Normal	\N	\N	\N	\N	10-73024
10742	09-33283_Melanoma	Melanoma	\N	\N	\N	\N	09-33283
10743	09-33283_Melanoma	Melanoma	\N	\N	\N	\N	09-33283
10744	09-33283_Nevus	Nevus	\N	\N	\N	\N	09-33283
10745	09-33283_Nevus	Nevus	\N	\N	\N	\N	09-33283
10746	09-31895_Melanoma	Melanoma	\N	\N	\N	\N	09-31895
10747	09-31895_Melanoma	Melanoma	\N	\N	\N	\N	09-31895
10748	09-31895_Nevus	Nevus	\N	\N	\N	\N	09-31895
10749	09-31895_Nevus	Nevus	\N	\N	\N	\N	09-31895
10750	09-31895_Normal	Normal	\N	\N	\N	\N	09-31895
10751	R29032-05_Tumor	Tumor	\N	\N	\N	\N	R29032-05
10752	R29032-05_Normal	Normal	\N	\N	\N	\N	R29032-05
10753	01-8297_Tumor	Tumor	\N	\N	\N	\N	01-8297
10754	01-8297_Normal	Normal	\N	\N	\N	\N	01-8297
10755	8298-01_Tumor	Tumor	\N	\N	\N	\N	8298-01
10756	8298-01_Normal	Normal	\N	\N	\N	\N	8298-01
10757	08-53951_Melanoma	Melanoma	\N	\N	\N	\N	08-53951
10758	08-53951_Melanoma	Melanoma	\N	\N	\N	\N	08-53951
10759	08-53951_Nevus	Nevus	\N	\N	\N	\N	08-53951
10760	08-53951_Nevus	Nevus	\N	\N	\N	\N	08-53951
10761	13000212_Tumor	Tumor	\N	\N	\N	\N	13000212
10762	8528-05_Tumor	Tumor	\N	\N	\N	\N	8528-05
10763	1286184b_Tumor	Tumor	\N	\N	\N	\N	1286184b
10764	1286184b_Normal	Normal	\N	\N	\N	\N	1286184b
10765	206436_Tumor	Tumor	\N	\N	\N	\N	206436
10766	35942-04_Tumor	Tumor	\N	\N	\N	\N	35942-04
10767	15329-03_Normal	Normal	\N	\N	\N	\N	15329-03
10768	Z1188-03_Tumor	Tumor	\N	\N	\N	\N	Z1188-03
10769	1185-03_Normal	Normal	\N	\N	\N	\N	1185-03
10770	14514-02_Tumor	Tumor	\N	\N	\N	\N	14514-02
10771	15102-02_Normal	Normal	\N	\N	\N	\N	15102-02
10772	9116-05_Tumor	Tumor	\N	\N	\N	\N	9116-05
10773	24516-06_Tumor	Tumor	\N	\N	\N	\N	24516-06
10774	24516-06_Normal	Normal	\N	\N	\N	\N	24516-06
10775	07-3078_Tumor	Tumor	\N	\N	\N	\N	07-3078
10776	B06-37358_Tumor	Tumor	\N	\N	\N	\N	B06-37358
10777	21590_Tumor	Tumor	\N	\N	\N	\N	21590
10778	21590_Normal	Normal	\N	\N	\N	\N	21590
10779	A2A79@_Tumor	Tumor	\N	\N	\N	\N	A2A79@
10780	356A3-075_Tumor	Tumor	\N	\N	\N	\N	356A3-075
10781	20847-09_Normal	Normal	\N	\N	\N	\N	20847-09
10782	525_Tumor	Tumor	\N	\N	\N	\N	525
10783	PMM_23_Tumor	Tumor	\N	\N	\N	\N	PMM_23
10784	PMM_23_Normal	Normal	\N	\N	\N	\N	PMM_23
10785	UM7_Tumor	Tumor	\N	\N	\N	\N	UM7
10786	UM8_Tumor	Tumor	\N	\N	\N	\N	UM8
10787	UM9_Tumor	Tumor	\N	\N	\N	\N	UM9
10788	UM10_Tumor	Tumor	\N	\N	\N	\N	UM10
10789	UM11_Tumor	Tumor	\N	\N	\N	\N	UM11
10790	Xanthoma_Disseminatum_Tumor	Tumor	\N	\N	\N	\N	Xanthoma_Disseminatum
10791	99-15313_Tumor	Tumor	\N	\N	\N	\N	99-15313
10792	98-37643_Tumor	Tumor	\N	\N	\N	\N	98-37643
10793	09-29997_Tumor	Tumor	\N	\N	\N	\N	09-29997
10794	13-94981_Tumor	Tumor	\N	\N	\N	\N	13-94981
10795	13-99411A_Tumor	Tumor	\N	\N	\N	\N	13-99411A
10796	13-94484_Tumor	Tumor	\N	\N	\N	\N	13-94484
10797	DM27_Tumor	Tumor	\N	\N	\N	\N	DM27
10798	DM32_Tumor	Tumor	\N	\N	\N	\N	DM32
10799	DM35_Tumor	Tumor	\N	\N	\N	\N	DM35
10800	DM40_Tumor	Tumor	\N	\N	\N	\N	DM40
10801	11-23681_Melanoma	Melanoma	\N	\N	\N	\N	11-23681
10802	11-23681_Melanoma	Melanoma	\N	\N	\N	\N	11-23681
10803	H01.10457/II_Primary	Primary	\N	\N	\N	\N	Dummer-KF1-Primary
10804	H01.10457/II_Normal	Normal	\N	\N	\N	\N	Dummer-KF1
10805	14.20/II_Met1	Met1	\N	\N	\N	\N	Dummer-KF1-Met1
10806	HS14.18/I_Met2	Met2	\N	\N	\N	\N	Dummer-KF1-Met2
10807	HS14.19/D_Primary	Primary	\N	\N	\N	\N	Dummer-KF2-Primary
10808	HS14.19/D_Nevus	Nevus	\N	\N	\N	\N	Dummer-KF2
10809	HS2014.15/7_Met1	Met1	\N	\N	\N	\N	Dummer-KF2-Met1
10810	HS2014.15/7_Normal	Normal	\N	\N	\N	\N	Dummer-KF2
10811	HS14.16_Primary	Primary	\N	\N	\N	\N	Dummer-KF3-Primary
10812	HS14.16_Normal	Normal	\N	\N	\N	\N	Dummer-KF3
10813	HS14.17/I_Met1	Met1	\N	\N	\N	\N	Dummer-KF3-Met1
10814	Long-TN1_Normal	Normal	\N	\N	\N	\N	Long-TN1
10815	Long-TN1_Tumor	Tumor	\N	\N	\N	\N	Long-TN1
10816	Long-TN2_Normal	Normal	\N	\N	\N	\N	Long-TN2
10817	Long-TN2_Tumor	Tumor	\N	\N	\N	\N	Long-TN2
10818	D326_Tumor	Tumor	\N	\N	\N	\N	D326
10819	D326_Tumor	Tumor	\N	\N	\N	\N	D326
10820	D366_Tumor	Tumor	\N	\N	\N	\N	D366
10821	D366_Tumor	Tumor	\N	\N	\N	\N	D366
10822	DPN48_Tumor	Tumor	\N	\N	\N	\N	DPN48
10823	11-2532_Tumor	Tumor	\N	\N	\N	\N	11-2532
10824	AST-1_Tumor	Tumor	\N	\N	\N	\N	AST-1
10825	08-18595B_Tumor	Tumor	\N	\N	\N	\N	08-18595B
10826	13-60273_Tumor	Tumor	\N	\N	\N	\N	13-60273
10827	12-52454_Tumor	Tumor	\N	\N	\N	\N	12-52454
10828	12-75125_Tumor	Tumor	\N	\N	\N	\N	12-75125
10829	12-98235A_Tumor	Tumor	\N	\N	\N	\N	12-98235A
10830	13-3619B_Tumor	Tumor	\N	\N	\N	\N	13-3619B
10831	13-67500AL_Normal	Normal	\N	\N	\N	\N	13-67500AL
10832	13-19205_Tumor	Tumor	\N	\N	\N	\N	13-19205
10833	13-48330_Tumor	Tumor	\N	\N	\N	\N	13-48330
10834	13-11086_Tumor	Tumor	\N	\N	\N	\N	13-11086
10835	13-15966_Tumor	Tumor	\N	\N	\N	\N	13-15966
10836	13-39228_Tumor	Tumor	\N	\N	\N	\N	13-39228
10837	13-45942_Tumor	Tumor	\N	\N	\N	\N	13-45942
10838	13-49600_Tumor	Tumor	\N	\N	\N	\N	13-49600
10839	13-59640_Tumor	Tumor	\N	\N	\N	\N	13-59640
10840	13-67817_Tumor	Tumor	\N	\N	\N	\N	13-67817
10841	SP-12-5612(1K)_Normal	Normal	\N	\N	\N	\N	SP-12-5612(1K)
10842	SP-13-14992(1A)_Tumor	Tumor	\N	\N	\N	\N	SP-13-14992(1A)
10843	SP-12-2294-2(2A)_Normal	Normal	\N	\N	\N	\N	SP-12-2294-2(2A)
10844	SP-13-17075(1B)_Tumor	Tumor	\N	\N	\N	\N	SP-13-17075(1B)
10845	SP-42-10361(1A)_Normal	Normal	\N	\N	\N	\N	SP-42-10361(1A)
10846	SP-13-1038(1A)_Tumor	Tumor	\N	\N	\N	\N	SP-13-1038(1A)
10847	S13-13286A6_Tumor	Tumor	\N	\N	\N	\N	S13-13286A6
10848	S13-13286A6_Normal	Normal	\N	\N	\N	\N	S13-13286A6
10849	S11-20884A-A1_Tumor	Tumor	\N	\N	\N	\N	S11-20884A-A1
10850	S11-20884A-A1_Normal	Normal	\N	\N	\N	\N	S11-20884A-A1
10851	S12-6218A-D3_Tumor	Tumor	\N	\N	\N	\N	S12-6218A-D3
10852	S12-6218A-D3_Normal	Normal	\N	\N	\N	\N	S12-6218A-D3
10853	ZS06-11249A-C2_Tumor	Tumor	\N	\N	\N	\N	ZS06-11249A-C2
10854	S12-26125A2_Tumor	Tumor	\N	\N	\N	\N	S12-26125A2
10855	S12-28585A6_Tumor	Tumor	\N	\N	\N	\N	S12-28585A6
10856	S11-2018B5_Tumor	Tumor	\N	\N	\N	\N	S11-2018B5
10857	S13-11748F5_Tumor	Tumor	\N	\N	\N	\N	S13-11748F5
10858	S12-7250E3_Tumor	Tumor	\N	\N	\N	\N	S12-7250E3
10859	S13-3401B3_Tumor	Tumor	\N	\N	\N	\N	S13-3401B3
10860	S13-12947A2_Tumor	Tumor	\N	\N	\N	\N	S13-12947A2
10861	S13-18444A16_Tumor	Tumor	\N	\N	\N	\N	S13-18444A16
10862	ZS07-1210F6_Tumor	Tumor	\N	\N	\N	\N	ZS07-1210F6
10863	ZS10-11930B12_Tumor	Tumor	\N	\N	\N	\N	ZS10-11930B12
10864	S12-28988_Tumor	Tumor	\N	\N	\N	\N	S12-28988
10865	SSS13-1652B2_Tumor	Tumor	\N	\N	\N	\N	SSS13-1652B2
10866	S13-5249_Tumor	Tumor	\N	\N	\N	\N	S13-5249
10867	356A3-075_Tumor	Tumor	\N	\N	\N	\N	356A3-075
10868	20847-09_Normal	Normal	\N	\N	\N	\N	20847-09
10869	London-L1_Normal	Normal	\N	\N	\N	\N	London-L1
10870	London-L1_Nevus	Nevus	\N	\N	\N	\N	London-L1
10871	London-L1_MIS	MIS	\N	\N	\N	\N	London-L1
10872	London-L1_Melanoma	Melanoma	\N	\N	\N	\N	London-L1
10873	London-L14_Normal	Normal	\N	\N	\N	\N	London-L14
10874	London-L14_Nevus	Nevus	\N	\N	\N	\N	London-L14
10875	London-L14_Nevus	Nevus	\N	\N	\N	\N	London-L14
10876	London-L14_Melanoma	Melanoma	\N	\N	\N	\N	London-L14
10877	London-L14_Melanoma	Melanoma	\N	\N	\N	\N	London-L14
10878	London-L14_Melanoma	Melanoma	\N	\N	\N	\N	London-L14
10879	London-L14C_Normal	Normal	\N	\N	\N	\N	London-L14C
10880	London-L14C_Intermediate	Intermediate	\N	\N	\N	\N	London-L14C
10881	08-79358_Melanoma	Melanoma	\N	\N	\N	\N	08-79358
10882	08-79358_Melanoma	Melanoma	\N	\N	\N	\N	08-79358
10883	08-79358_Nevus	Nevus	\N	\N	\N	\N	08-79358
10884	08-79358_Normal	Normal	\N	\N	\N	\N	08-79358
10885	09-45509_Melanoma	Melanoma	\N	\N	\N	\N	09-45509
10886	09-45509_Melanoma	Melanoma	\N	\N	\N	\N	09-45509
10887	09-45509_Nevus	Nevus	\N	\N	\N	\N	09-45509
10888	09-45509_Normal	Normal	\N	\N	\N	\N	09-45509
10889	DM50_Tumor	Tumor	\N	\N	\N	\N	DM50
10890	DM56_Tumor	Tumor	\N	\N	\N	\N	DM56
10891	11-94204_Melanoma	Melanoma	\N	\N	\N	\N	11-94204
10892	11-94204_Nevus	Nevus	\N	\N	\N	\N	11-94204
10893	11-94204_Normal	Normal	\N	\N	\N	\N	11-94204
10894	London-L10_Normal	Normal	\N	\N	\N	\N	London-L10
10895	London-L10_MIS	MIS	\N	\N	\N	\N	London-L10
10896	London-L10_Melanoma	Melanoma	\N	\N	\N	\N	London-L10
10897	London-L10_Intermediate	Intermediate	\N	\N	\N	\N	London-L10
10898	London-L12_Normal	Normal	\N	\N	\N	\N	London-L12
10899	London-L12_Nevus	Nevus	\N	\N	\N	\N	London-L12
10900	London-L12_Intermediate	Intermediate	\N	\N	\N	\N	London-L12
10901	London-L16_Nevus	Nevus	\N	\N	\N	\N	London-L16
10902	London-L16_Melanoma	Melanoma	\N	\N	\N	\N	London-L16
10903	London-L16A_Normal	Normal	\N	\N	\N	\N	London-L16A
10904	London-L16A_Nevus	Nevus	\N	\N	\N	\N	London-L16A
10905	London-L16A_Melanoma	Melanoma	\N	\N	\N	\N	London-L16A
10906	London-L16B_Intermediate	Intermediate	\N	\N	\N	\N	London-L16B
10907	London-L16B_Intermediate	Intermediate	\N	\N	\N	\N	London-L16B
10908	London-L16B_Normal	Normal	\N	\N	\N	\N	London-L16B
10909	DM15_Tumor	Tumor	\N	\N	\N	\N	DM15
10910	DM19_Tumor	Tumor	\N	\N	\N	\N	DM19
10911	DM19_Tumor	Tumor	\N	\N	\N	\N	DM19
10912	DM46_Tumor	Tumor	\N	\N	\N	\N	DM46
10913	140038340_Tumor	Tumor	\N	\N	\N	\N	140038340
10914	140092090_Normal	Normal	\N	\N	\N	\N	140092090
10915	UM13_Tumor	Tumor	\N	\N	\N	\N	UM13
10916	UM14_Tumor	Tumor	\N	\N	\N	\N	UM14
10917	UM16_Tumor	Tumor	\N	\N	\N	\N	UM16
10918	London-L17_Normal	Normal	\N	\N	\N	\N	London-L17
10919	London-L17_Nevus	Nevus	\N	\N	\N	\N	London-L17
10920	London-L17_Nevus	Nevus	\N	\N	\N	\N	London-L17
10921	London-L17_Melanoma	Melanoma	\N	\N	\N	\N	London-L17
10922	London-L17_Melanoma	Melanoma	\N	\N	\N	\N	London-L17
10923	GAK_Tumor	Tumor	\N	\N	\N	\N	GAK
10924	Yurif_Tumor	Tumor	\N	\N	\N	\N	Yurif
10925	08-53951_Nevus	Nevus	\N	\N	\N	\N	08-53951
10926	08-53951_M1	M1	\N	\N	\N	\N	08-53951
10927	08-53951_M2	M2	\N	\N	\N	\N	08-53951
10928	London-L18_Normal	Normal	\N	\N	\N	\N	London-L18
10929	London-L18_Nevus	Nevus	\N	\N	\N	\N	London-L18
10930	London-L18_Melanoma	Melanoma	\N	\N	\N	\N	London-L18
10931	London-L18_Melanoma	Melanoma	\N	\N	\N	\N	London-L18
10932	London-L21_MIS	MIS	\N	\N	\N	\N	London-L21
10933	London-L21_Intermediate	Intermediate	\N	\N	\N	\N	London-L21
10934	London-L21_Normal	Normal	\N	\N	\N	\N	London-L21
10935	14-16247_Tumor	Tumor	\N	\N	\N	\N	14-16247
10936	13-35959_Tumor	Tumor	\N	\N	\N	\N	13-35959
10937	13-102610_Tumor	Tumor	\N	\N	\N	\N	13-102610
10938	13-99417_Tumor	Tumor	\N	\N	\N	\N	13-99417
10939	13-98534_Tumor	Tumor	\N	\N	\N	\N	13-98534
10940	13-32982A_Tumor	Tumor	\N	\N	\N	\N	13-32982A
10941	13-9916_Tumor	Tumor	\N	\N	\N	\N	13-9916
10942	11-44609F_Tumor	Tumor	\N	\N	\N	\N	11-44609F
10943	12-98575A1_Tumor	Tumor	\N	\N	\N	\N	12-98575A1
10944	DM60_Tumor	Tumor	\N	\N	\N	\N	DM60
10945	DM61_Tumor	Tumor	\N	\N	\N	\N	DM61
10946	DM62_Tumor	Tumor	\N	\N	\N	\N	DM62
10947	DM63_Tumor	Tumor	\N	\N	\N	\N	DM63
10948	DM66_Tumor	Tumor	\N	\N	\N	\N	DM66
10949	DM67_Tumor	Tumor	\N	\N	\N	\N	DM67
10950	DM69_Tumor	Tumor	\N	\N	\N	\N	DM69
10951	DM70_Tumor	Tumor	\N	\N	\N	\N	DM70
10952	DM81_Tumor	Tumor	\N	\N	\N	\N	DM81
10953	London-L2_Normal	Normal	\N	\N	\N	\N	London-L2
10954	London-L2_Intermediate	Intermediate	\N	\N	\N	\N	London-L2
10955	London-L3_Normal	Normal	\N	\N	\N	\N	London-L3
10956	London-L3_Intermediate	Intermediate	\N	\N	\N	\N	London-L3
10957	S12-27617B9_Normal	Normal	\N	\N	\N	\N	S12-27617B9
10958	S12-25164A_Tumor	Tumor	\N	\N	\N	\N	S12-25164A
10959	S12-25164C1_Tumor	Tumor	\N	\N	\N	\N	S12-25164C1
10960	London-L19_Normal	Normal	\N	\N	\N	\N	London-L19
10961	London-L19_Nevus	Nevus	\N	\N	\N	\N	London-L19
10962	London-L19_Melanoma	Melanoma	\N	\N	\N	\N	London-L19
10963	London-L19E_Normal	Normal	\N	\N	\N	\N	London-L19E
10964	London-L19E_Nevus	Nevus	\N	\N	\N	\N	London-L19E
10965	London-L19E_Melanoma	Melanoma	\N	\N	\N	\N	London-L19E
10966	London-L22_MIS	MIS	\N	\N	\N	\N	London-L22
10967	London-L22_Melanoma	Melanoma	\N	\N	\N	\N	London-L22
10968	London-L22_Normal	Normal	\N	\N	\N	\N	London-L22
10969	London-L23_Melanoma	Melanoma	\N	\N	\N	\N	London-L23
10970	London-L23C_Normal	Normal	\N	\N	\N	\N	London-L23C
10971	London-L23C_Melanoma	Melanoma	\N	\N	\N	\N	London-L23C
10972	London-L23D_Normal	Normal	\N	\N	\N	\N	London-L23D
10973	London-L23D_Intermediate	Intermediate	\N	\N	\N	\N	London-L23D
10974	London-L6_Normal	Normal	\N	\N	\N	\N	London-L6
10975	London-L6_Nevus	Nevus	\N	\N	\N	\N	London-L6
10976	London-L6_Nevus	Nevus	\N	\N	\N	\N	London-L6
10977	XD-2_Tumor	Tumor	\N	\N	\N	\N	XD-2
10978	XD-2_Normal	Normal	\N	\N	\N	\N	XD-2
10979	SP-13-006364_Normal	Normal	\N	\N	\N	\N	SP-13-006364
10980	SP-14-001249_Tumor	Tumor	\N	\N	\N	\N	SP-14-001249
10981	SP-13-0185993A_Normal	Normal	\N	\N	\N	\N	SP-13-0185993A
10982	SP-13-0185992B_Tumor	Tumor	\N	\N	\N	\N	SP-13-0185992B
10983	SP-12-003309B_Normal	Normal	\N	\N	\N	\N	SP-12-003309B
10984	SP-13-0212981A_Tumor	Tumor	\N	\N	\N	\N	SP-13-0212981A
10985	SP-13-0068754A_Normal	Normal	\N	\N	\N	\N	SP-13-0068754A
10986	SP-13-0068751C_Tumor	Tumor	\N	\N	\N	\N	SP-13-0068751C
10987	SP-07-0116602_Normal	Normal	\N	\N	\N	\N	SP-07-0116602
10988	12GS-2466_Tumor	Tumor	\N	\N	\N	\N	12GS-2466
10989	SP-09-0150202A_Normal	Normal	\N	\N	\N	\N	SP-09-0150202A
10990	SP-13-006535C_Tumor	Tumor	\N	\N	\N	\N	SP-13-006535C
10991	SP-10-003167A_Normal	Normal	\N	\N	\N	\N	SP-10-003167A
10992	SP-13-009897_Tumor	Tumor	\N	\N	\N	\N	SP-13-009897
10993	SP-12-0087723B_Normal	Normal	\N	\N	\N	\N	SP-12-0087723B
10994	SP-12-020017C_Tumor	Tumor	\N	\N	\N	\N	SP-12-020017C
10995	SP-12-0032671A_Normal	Normal	\N	\N	\N	\N	SP-12-0032671A
10996	SP-13-006337A_Tumor	Tumor	\N	\N	\N	\N	SP-13-006337A
10997	SP-12-0228802A_Normal	Normal	\N	\N	\N	\N	SP-12-0228802A
10998	SP-12-0228801A_Tumor	Tumor	\N	\N	\N	\N	SP-12-0228801A
10999	SP-12-0146612A_Normal	Normal	\N	\N	\N	\N	SP-12-0146612A
11000	SP-12-01466111A_Tumor	Tumor	\N	\N	\N	\N	SP-12-01466111A
11001	SP-10-004335_Normal	Normal	\N	\N	\N	\N	SP-10-004335
11002	SP-13-000848_Tumor	Tumor	\N	\N	\N	\N	SP-13-000848
11003	M230_Tumor	Tumor	\N	\N	\N	\N	M230
11004	M257_Tumor	Tumor	\N	\N	\N	\N	M257
11005	M285_Tumor	Tumor	\N	\N	\N	\N	M285
11006	M368_Tumor	Tumor	\N	\N	\N	\N	M368
11007	M375_Tumor	Tumor	\N	\N	\N	\N	M375
11008	M418_Tumor	Tumor	\N	\N	\N	\N	M418
11009	C8161_Tumor	Tumor	\N	\N	\N	\N	C8161
11010	London-L4_Normal	Normal	\N	\N	\N	\N	London-L4
11011	London-L4_Nevus	Nevus	\N	\N	\N	\N	London-L4
11012	London-L5_Normal	Normal	\N	\N	\N	\N	London-L5
11013	London-L5_Nevus	Nevus	\N	\N	\N	\N	London-L5
11014	London-L8_Normal	Normal	\N	\N	\N	\N	London-L8
11015	London-L8_Nevus	Nevus	\N	\N	\N	\N	London-L8
11016	London-L9_Normal	Normal	\N	\N	\N	\N	London-L9
11017	London-L9_Intermediate	Intermediate	\N	\N	\N	\N	London-L9
11018	London-L13_Normal	Normal	\N	\N	\N	\N	London-L13
11019	London-L13_Intermediate	Intermediate	\N	\N	\N	\N	London-L13
11020	London-L13_Intermediate	Intermediate	\N	\N	\N	\N	London-L13
11021	London-L15_Nevus	Nevus	\N	\N	\N	\N	London-L15
11022	London-L15_Melanoma	Melanoma	\N	\N	\N	\N	London-L15
11023	1212_Tumor	Tumor	\N	\N	\N	\N	1212
11024	1213_Tumor	Tumor	\N	\N	\N	\N	1213
11025	1214_Tumor	Tumor	\N	\N	\N	\N	1214
11026	3860_Tumor	Tumor	\N	\N	\N	\N	3860
11027	R29032-05_Tumor	Tumor	\N	\N	\N	\N	R29032-05
11028	01-8297_Tumor	Tumor	\N	\N	\N	\N	01-8297
11029	8298-01_Tumor	Tumor	\N	\N	\N	\N	8298-01
11030	Z1188-03_Tumor	Tumor	\N	\N	\N	\N	Z1188-03
11031	24516-06_Tumor	Tumor	\N	\N	\N	\N	24516-06
11032	UM17_Tumor	Tumor	\N	\N	\N	\N	UM17
11033	S12-23475A6_Normal	Normal	\N	\N	\N	\N	S12-23475A6
11034	S12-23475A4_Tumor	Tumor	\N	\N	\N	\N	S12-23475A4
11035	S12-23475C1_Tumor	Tumor	\N	\N	\N	\N	S12-23475C1
11036	13-21725_Normal	Normal	\N	\N	\N	\N	13-21725
11037	SP-14-68521D_Tumor	Tumor	\N	\N	\N	\N	SP-14-68521D
11038	SP-13-208365A_Normal	Normal	\N	\N	\N	\N	SP-13-208365A
11039	SP-14-36134A_Tumor	Tumor	\N	\N	\N	\N	SP-14-36134A
11040	SP-14-73676A_Normal	Normal	\N	\N	\N	\N	SP-14-73676A
11041	SP-14-73671M_Tumor	Tumor	\N	\N	\N	\N	SP-14-73671M
11042	SP-14-7691A_Normal	Normal	\N	\N	\N	\N	SP-14-7691A
11043	SP-14-7691A_Tumor	Tumor	\N	\N	\N	\N	SP-14-7691A
11044	WM3928F_Tumor	Tumor	\N	\N	\N	\N	WM3928F
11045	C037_Tumor	Tumor	\N	\N	\N	\N	C037
11046	C022_Tumor	Tumor	\N	\N	\N	\N	C022
11047	London-L20_Melanoma	Melanoma	\N	\N	\N	\N	London-L20
11048	London-L20_Normal	Normal	\N	\N	\N	\N	London-L20
11049	London-L20_Nevus	Nevus	\N	\N	\N	\N	London-L20
11050	London-L15_Normal	Normal	\N	\N	\N	\N	London-L15
11051	London-L23C_Nevus	Nevus	\N	\N	\N	\N	London-L23C
11052	UM15_Tumor	Tumor	\N	\N	\N	\N	UM15
11053	UM19_Tumor	Tumor	\N	\N	\N	\N	UM19
11054	UM20_Tumor	Tumor	\N	\N	\N	\N	UM20
11055	CP-1_Tumor	Tumor	\N	\N	\N	\N	CP-1
11056	CP-2_Tumor	Tumor	\N	\N	\N	\N	CP-2
11057	CP-3_Tumor	Tumor	\N	\N	\N	\N	CP-3
11058	CP-4_Tumor	Tumor	\N	\N	\N	\N	CP-4
11059	CP-5_Tumor	Tumor	\N	\N	\N	\N	CP-5
11060	CP-6_Tumor	Tumor	\N	\N	\N	\N	CP-6
11061	14-18_Tumor	Tumor	\N	\N	\N	\N	14-18
11062	14-19_Tumor	Tumor	\N	\N	\N	\N	14-19
11063	14-21_Tumor	Tumor	\N	\N	\N	\N	14-21
11064	XD-1_Tumor	Tumor	\N	\N	\N	\N	XD-1
11065	XD-1.1_Tumor	Tumor	\N	\N	\N	\N	XD-1.1
11066	PMM-8_Tumor	Tumor	\N	\N	\N	\N	PMM-8
11067	Long-TN10_Normal	Normal	\N	\N	\N	\N	Long-TN10
11068	Long-TN10_Tumor	Tumor	\N	\N	\N	\N	Long-TN10
11069	Long-TN11_Normal	Normal	\N	\N	\N	\N	Long-TN11
11070	Long-TN11_Tumor	Tumor	\N	\N	\N	\N	Long-TN11
11071	JBP-3_Normal	Normal	\N	\N	\N	\N	JBP-3
11072	JBP-3-MM_Tumor	Tumor	\N	\N	\N	\N	JBP-3-MM
11073	JBP-3-Met1_Tumor	Tumor	\N	\N	\N	\N	JBP-3-Met1
11074	S12-15765B3_Tumor	Tumor	\N	\N	\N	\N	S12-15765B3
11075	S12-4365A8_Normal	Normal	\N	\N	\N	\N	S12-4365A8
11076	S12-4365A7_Tumor	Tumor	\N	\N	\N	\N	S12-4365A7
11077	S12-4365B1_Tumor	Tumor	\N	\N	\N	\N	S12-4365B1
11078	S12-4365C1_Tumor	Tumor	\N	\N	\N	\N	S12-4365C1
11079	S12-9606C4_Normal	Normal	\N	\N	\N	\N	S12-9606C4
11080	S12-9606EE_Tumor	Tumor	\N	\N	\N	\N	S12-9606EE
11081	S12-9606A2_Tumor	Tumor	\N	\N	\N	\N	S12-9606A2
11082	ZS10-972C2_Normal	Normal	\N	\N	\N	\N	ZS10-972C2
11083	ZS10-972A9_Tumor	Tumor	\N	\N	\N	\N	ZS10-972A9
11084	JBP-7-Met_Tumor	Tumor	\N	\N	\N	\N	JBP-7-Met
11085	ZS10-1843A5_Normal	Normal	\N	\N	\N	\N	ZS10-1843A5
11086	ZS10-8439A4_Tumor	Tumor	\N	\N	\N	\N	ZS10-8439A4
11087	ZS10-1843A4_Tumor	Tumor	\N	\N	\N	\N	ZS10-1843A4
11088	ZS10-10558B1_Normal	Normal	\N	\N	\N	\N	ZS10-10558B1
11089	ZS10-10558A10_Tumor	Tumor	\N	\N	\N	\N	ZS10-10558A10
11090	ZS10-10558C1_Tumor	Tumor	\N	\N	\N	\N	ZS10-10558C1
11091	ZS10-3560F1_Normal	Normal	\N	\N	\N	\N	ZS10-3560F1
11092	ZS10-3560A3_Tumor	Tumor	\N	\N	\N	\N	ZS10-3560A3
11093	ZS10-3560C1_Tumor	Tumor	\N	\N	\N	\N	ZS10-3560C1
11094	UM23_Tumor	Tumor	\N	\N	\N	\N	UM23
11095	UM24_Tumor	Tumor	\N	\N	\N	\N	UM24
11096	UM25_Tumor	Tumor	\N	\N	\N	\N	UM25
11097	UM26_Tumor	Tumor	\N	\N	\N	\N	UM26
11098	TCR-Beta-1_Tumor	Tumor	\N	\N	\N	\N	TCR-Beta-1
11099	TCR-Beta-2_Tumor	Tumor	\N	\N	\N	\N	TCR-Beta-2
11100	CP1-80_Tumor	Tumor	\N	\N	\N	\N	CP1-80
11101	CP1-40_Tumor	Tumor	\N	\N	\N	\N	CP1-40
11102	CP1-20_Tumor	Tumor	\N	\N	\N	\N	CP1-20
11103	CP1-10_Tumor	Tumor	\N	\N	\N	\N	CP1-10
11104	CP1-5_Tumor	Tumor	\N	\N	\N	\N	CP1-5
11105	CP1_Normal	Normal	\N	\N	\N	\N	CP1
11106	SMU10-0457_Tumor	Tumor	\N	\N	\N	\N	SMU10-0457
11107	SMU10-0206_Tumor	Tumor	\N	\N	\N	\N	SMU10-0206
11108	SMU10-0240_Tumor	Tumor	\N	\N	\N	\N	SMU10-0240
11109	SCC10-0092_Tumor	Tumor	\N	\N	\N	\N	SCC10-0092
11110	MASCRI-432_Tumor	Tumor	\N	\N	\N	\N	MASCRI-432
11111	RPA08-0209_Tumor	Tumor	\N	\N	\N	\N	RPA08-0209
11112	RPA08-0315_Tumor	Tumor	\N	\N	\N	\N	RPA08-0315
11113	NZM52_Tumor	Tumor	\N	\N	\N	\N	NZM52
11114	NZM40_Tumor	Tumor	\N	\N	\N	\N	NZM40
11115	NZM91_Tumor	Tumor	\N	\N	\N	\N	NZM91
11116	SP-13-198211A_Tumor	Tumor	\N	\N	\N	\N	SP-13-198211A
11117	RNS11P15316B1_Normal	Normal	\N	\N	\N	\N	RNS11P15316B1
11118	9246581-A3_Tumor	Tumor	\N	\N	\N	\N	9246581-A3
11119	9246581-A6_Normal	Normal	\N	\N	\N	\N	9246581-A6
11120	DHM4855-14MP_Tumor	Tumor	\N	\N	\N	\N	DHM4855-14MP
11121	SNPN08289D_Normal	Normal	\N	\N	\N	\N	SNPN08289D
11122	SP-10-143551E_Tumor	Tumor	\N	\N	\N	\N	SP-10-143551E
11123	SP-10-143552A_Normal	Normal	\N	\N	\N	\N	SP-10-143552A
11124	04-SW-12-31366B1_Tumor	Tumor	\N	\N	\N	\N	04-SW-12-31366B1
11125	04-SW-12-31366B6_Normal	Normal	\N	\N	\N	\N	04-SW-12-31366B6
11126	SP-13-63011A_Tumor	Tumor	\N	\N	\N	\N	SP-13-63011A
11127	SP-11-160493A_Normal	Normal	\N	\N	\N	\N	SP-11-160493A
11128	SP-13-87981B_Tumor	Tumor	\N	\N	\N	\N	SP-13-87981B
11129	SP-11-40641B_Normal	Normal	\N	\N	\N	\N	SP-11-40641B
11130	SP-14-125801B_Tumor	Tumor	\N	\N	\N	\N	SP-14-125801B
11131	SP-14-125802A_Normal	Normal	\N	\N	\N	\N	SP-14-125802A
11132	WCRS97-025628_Tumor	Tumor	\N	\N	\N	\N	WCRS97-025628
11133	SCHS10-026422_Tumor	Tumor	\N	\N	\N	\N	SCHS10-026422
11134	SROS12-001198_Tumor	Tumor	\N	\N	\N	\N	SROS12-001198
11135	SROS09-001574_Tumor	Tumor	\N	\N	\N	\N	SROS09-001574
11136	SCHS09-005840-B5_Tumor	Tumor	\N	\N	\N	\N	SCHS09-005840-B5
11137	SACS05-011507_Tumor	Tumor	\N	\N	\N	\N	SACS05-011507
11138	FRSS09-009402-A1_Tumor	Tumor	\N	\N	\N	\N	FRSS09-009402-A1
11139	RCHS07-000380-B1_Tumor	Tumor	\N	\N	\N	\N	RCHS07-000380-B1
11140	SROS11-005030_Tumor	Tumor	\N	\N	\N	\N	SROS11-005030
11141	VALS09-000266_Tumor	Tumor	\N	\N	\N	\N	VALS09-000266
11142	SFOS09-007093_Tumor	Tumor	\N	\N	\N	\N	SFOS09-007093
11143	FRSS09-008805_Tumor	Tumor	\N	\N	\N	\N	FRSS09-008805
11144	RCHS06-004567_Tumor	Tumor	\N	\N	\N	\N	RCHS06-004567
11145	VALS05-014946-E_Tumor	Tumor	\N	\N	\N	\N	VALS05-014946-E
11146	SCHS08-007754_Tumor	Tumor	\N	\N	\N	\N	SCHS08-007754
11147	SFOS12-018173_Tumor	Tumor	\N	\N	\N	\N	SFOS12-018173
11148	SROS00-001103_Tumor	Tumor	\N	\N	\N	\N	SROS00-001103
11149	MTZS94-007340_Tumor	Tumor	\N	\N	\N	\N	MTZS94-007340
11150	SFOS94-003116_Tumor	Tumor	\N	\N	\N	\N	SFOS94-003116
11151	SACS93-027850_Tumor	Tumor	\N	\N	\N	\N	SACS93-027850
11152	SCLS91-006557_Tumor	Tumor	\N	\N	\N	\N	SCLS91-006557
11153	OAKS90-012369_Tumor	Tumor	\N	\N	\N	\N	OAKS90-012369
11154	HAYS02-005731_Tumor	Tumor	\N	\N	\N	\N	HAYS02-005731
11155	SRFS97-002805_Tumor	Tumor	\N	\N	\N	\N	SRFS97-002805
11156	VALS03-019832_Tumor	Tumor	\N	\N	\N	\N	VALS03-019832
11157	SSCS03-014369_Tumor	Tumor	\N	\N	\N	\N	SSCS03-014369
11158	RCHS01-003684_Tumor	Tumor	\N	\N	\N	\N	RCHS01-003684
11159	WCRS99-012800_Tumor	Tumor	\N	\N	\N	\N	WCRS99-012800
11160	HAYS90-005154_Tumor	Tumor	\N	\N	\N	\N	HAYS90-005154
11161	SFOS00-016989_Tumor	Tumor	\N	\N	\N	\N	SFOS00-016989
11162	VALS03-007457_Tumor	Tumor	\N	\N	\N	\N	VALS03-007457
11163	SFO93-005184_Tumor	Tumor	\N	\N	\N	\N	SFO93-005184
11164	DHM50691-14MP5C_Tumor	Tumor	\N	\N	\N	\N	DHM50691-14MP5C
11165	DHM50691-14MP3_Normal	Normal	\N	\N	\N	\N	DHM50691-14MP3
11166	RNS14P13907B1_Tumor	Tumor	\N	\N	\N	\N	RNS14P13907B1
11167	SP-10-197431A_Normal	Normal	\N	\N	\N	\N	SP-10-197431A
11168	DHM57444-14MP_Tumor	Tumor	\N	\N	\N	\N	DHM57444-14MP
11169	SP-12-177322A_Normal	Normal	\N	\N	\N	\N	SP-12-177322A
11170	DHM94457-13SK_Tumor	Tumor	\N	\N	\N	\N	DHM94457-13SK
11171	DHM48742-12MPE_Normal	Normal	\N	\N	\N	\N	DHM48742-12MPE
11172	Laverty13-88354_Tumor	Tumor	\N	\N	\N	\N	Laverty13-88354
11173	ICPMR19684.13A11_Normal	Normal	\N	\N	\N	\N	ICPMR19684.13A11
11174	SP-13-15691B_Tumor	Tumor	\N	\N	\N	\N	SP-13-15691B
11175	SP-13-15691D_Normal	Normal	\N	\N	\N	\N	SP-13-15691D
11176	57059699_Tumor	Tumor	\N	\N	\N	\N	57059699
11177	57269600_Tumor	Tumor	\N	\N	\N	\N	57269600
11178	57213442_Tumor	Tumor	\N	\N	\N	\N	57213442
11179	57346060_Tumor	Tumor	\N	\N	\N	\N	57346060
11180	SROS10-009251_Tumor	Tumor	\N	\N	\N	\N	SROS10-009251
11181	FRSS99-007026_Tumor	Tumor	\N	\N	\N	\N	FRSS99-007026
11182	SCLS04-001045_Tumor	Tumor	\N	\N	\N	\N	SCLS04-001045
11183	OAKS96-014392-G_Tumor	Tumor	\N	\N	\N	\N	OAKS96-014392-G
11184	OAKS96-022398_Tumor	Tumor	\N	\N	\N	\N	OAKS96-022398
11185	OAK84-008979-B_Tumor	Tumor	\N	\N	\N	\N	OAK84-008979-B
11186	ROSS09-022626-A1_Tumor	Tumor	\N	\N	\N	\N	ROSS09-022626-A1
11187	SCHS11-018842-A1_Tumor	Tumor	\N	\N	\N	\N	SCHS11-018842-A1
11188	SSCS03-004945_Tumor	Tumor	\N	\N	\N	\N	SSCS03-004945
11189	WCRS02-022688_Tumor	Tumor	\N	\N	\N	\N	WCRS02-022688
11190	SACS02-020334_Tumor	Tumor	\N	\N	\N	\N	SACS02-020334
11191	HAYS98-001046_Tumor	Tumor	\N	\N	\N	\N	HAYS98-001046
11192	SACS88-019073_Tumor	Tumor	\N	\N	\N	\N	SACS88-019073
11193	SACS87-010145_Tumor	Tumor	\N	\N	\N	\N	SACS87-010145
11194	STRS91-006237_Tumor	Tumor	\N	\N	\N	\N	STRS91-006237
11195	SSCS92-009981_Tumor	Tumor	\N	\N	\N	\N	SSCS92-009981
11196	14-59304A_Normal	Normal	\N	\N	\N	\N	14-59304A
11197	14-59304A_Nevus	Nevus	\N	\N	\N	\N	14-59304A
11198	13-48020_Normal	Normal	\N	\N	\N	\N	13-48020
11199	13-48020_Nevus	Nevus	\N	\N	\N	\N	13-48020
11200	14-13499_Normal	Normal	\N	\N	\N	\N	14-13499
11201	14-13499_Nevus	Nevus	\N	\N	\N	\N	14-13499
11202	13-64515B_Normal	Normal	\N	\N	\N	\N	13-64515B
11203	13-64515B_Nevus	Nevus	\N	\N	\N	\N	13-64515B
11204	13-64515B_Tumor	Tumor	\N	\N	\N	\N	13-64515B
11205	14-22939_Nevus	Nevus	\N	\N	\N	\N	14-22939
11206	14-22939_Tumor	Tumor	\N	\N	\N	\N	14-22939
11207	13-61146_Normal	Normal	\N	\N	\N	\N	13-61146
11208	13-61146_Nevus	Nevus	\N	\N	\N	\N	13-61146
11209	13-61146_Tumor	Tumor	\N	\N	\N	\N	13-61146
11210	57001550_Tumor	Tumor	\N	\N	\N	\N	57001550
11211	57291680_Tumor	Tumor	\N	\N	\N	\N	57291680
11212	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11213	London-L13_Tumor	Tumor	\N	\N	\N	\N	London-L13
11214	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11215	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11216	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11217	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11218	London-L13_Tumor	Tumor	\N	\N	\N	\N	London-L13
11219	London-L13_Tumor	Tumor	\N	\N	\N	\N	London-L13
11220	UM33_Tumor	Tumor	\N	\N	\N	\N	UM33
11221	UM35_A_Tumor	Tumor	\N	\N	\N	\N	UM35_A
11222	UM39_Tumor	Tumor	\N	\N	\N	\N	UM39
11223	UM40_Tumor	Tumor	\N	\N	\N	\N	UM40
11224	UM41_Tumor	Tumor	\N	\N	\N	\N	UM41
11225	UM36_Tumor	Tumor	\N	\N	\N	\N	UM36
11226	UM37_Tumor	Tumor	\N	\N	\N	\N	UM37
11227	London-L13_Tumor	Tumor	\N	\N	\N	\N	London-L13
11228	57715138_Tumor	Tumor	\N	\N	\N	\N	57715138
11229	57715138_Tumor	Tumor	\N	\N	\N	\N	57715138
11230	332771_Tumor	Tumor	\N	\N	\N	\N	332771
11231	57723220_Tumor	Tumor	\N	\N	\N	\N	57723220
11232	55875588_Tumor	Tumor	\N	\N	\N	\N	55875588
11233	57714581_Tumor	Tumor	\N	\N	\N	\N	57714581
11234	UM47_Tumor	Tumor	\N	\N	\N	\N	UM47
11235	UM47_Normal	Normal	\N	\N	\N	\N	UM47
11236	Sample_KAM1-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM1-T
11237	Sample_KAM106-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM106-T
11238	Sample_KAM12-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM12-T
11239	Sample_KAM121-T-B_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM121-T-B
11240	Sample_KAM20-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM20-T
11241	Sample_KAM3-T-A_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM3-T-A
11242	Sample_KAM35-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM35-T
11243	Sample_KAM38-T-B_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM38-T-B
11244	Sample_KAM53-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM53-T
11245	Sample_KAM61-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM61-T
11246	Sample_KAM7-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM7-T
11247	Sample_KAM78-T-III_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM78-T-III
11248	Sample_KAM82-T-B8_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM82-T-B8
11249	Sample_KAM84-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM84-T
11250	Sample_KAM94-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM94-T
11251	Sample_KAM96-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM96-T
\.


--
-- Data for Name: block_area_link; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.block_area_link (id, block, area) FROM stdin;
54978	3411	1575
54979	2341	2136
54980	1485	2163
54981	3329	1
54982	3336	6
54983	3339	9
54984	3115	12
54985	3102	15
54986	3039	20
54987	3124	22
54988	3114	25
54989	3105	28
54990	3033	31
54991	3057	35
54992	3051	38
54993	3036	42
54994	3061	46
54995	3128	49
54996	3131	52
54997	3130	58
54998	3127	62
54999	3340	65
55000	3344	68
55001	3346	72
55002	3389	78
55003	3393	82
55004	3086	85
55005	3092	89
55006	3095	92
55007	3395	97
55008	3401	103
55009	1986	280
55010	2072	286
55011	2156	302
55012	1955	283
55013	1981	289
55014	1982	304
55015	2085	305
55016	2264	345
55017	1975	354
55018	2323	729
55019	2133	778
55020	2115	783
55021	2084	786
55022	2083	790
55023	2109	792
55024	2132	797
55025	1957	804
55026	2491	883
55027	2261	894
55028	2185	895
55029	2485	980
55030	2490	981
55031	2500	983
55032	2511	984
55033	2493	982
55034	2519	986
55035	2521	987
55036	2516	985
55037	2523	988
55038	2526	989
55039	2534	990
55040	2538	991
55041	2540	992
55042	2548	993
55043	2551	994
55044	2555	995
55045	2483	996
55046	3128	1147
55047	3445	1243
55048	3343	1288
55049	3058	1291
55050	3333	1292
55051	3335	1295
55052	3330	1302
55053	3347	1305
55054	1262	1311
55055	3143	1422
55056	3144	1425
55057	1979	1430
55058	2476	1431
55059	2075	1432
55060	2134	1433
55061	2126	1434
55062	1547	1438
55063	1255	1446
55064	2201	1447
55065	1983	1448
55066	1978	1449
55067	2183	1450
55068	2199	1451
55069	1698	1470
55070	1842	1478
55071	1617	1490
55072	1470	1497
55073	1379	1503
55074	1378	1507
55075	1373	1510
55076	1817	1521
55077	1818	1523
55078	1819	1526
55079	1755	1535
55080	1863	1541
55081	1850	1547
55082	1893	1552
55083	2047	1564
55084	2048	1566
55085	1909	1569
55086	2294	1581
55087	2303	1584
55088	2442	1591
55089	2449	1593
55090	2605	1604
55091	1932	1608
55092	2602	1611
55093	1816	1612
55094	1921	1613
55095	2299	1614
55096	3148	1615
55097	3145	1616
55098	3342	1617
55099	1750	1624
55100	3011	1649
55101	1326	1654
55102	1193	1656
55103	1201	1659
55104	1278	1663
55105	2957	1668
55106	1141	1670
55107	1346	1673
55108	1347	1676
55109	1683	1679
55110	1296	1683
55111	1298	1685
55112	1287	1687
55113	1700	1690
55114	1100	1696
55115	1102	1698
55116	1115	1702
55117	2965	1705
55118	2975	1709
55119	1078	1714
55120	1137	1718
55121	1138	1720
55122	1095	1722
55123	1057	1725
55124	1310	1728
55125	2945	1730
55126	1513	1732
55127	1146	1735
55128	1383	1738
55129	1385	1739
55130	1386	1740
55131	1126	1742
55132	1304	1745
55133	1279	1748
55134	1318	1753
55135	1192	1756
55136	1203	1758
55137	2996	1760
55138	3004	1763
55139	1024	1766
55140	1018	1768
55141	1071	1773
55142	1178	1776
55143	2994	1778
55144	3002	1781
55145	1227	1784
55146	1227	1785
55147	2963	1788
55148	2963	1789
55149	2997	1791
55150	2939	1793
55151	2938	1795
55152	1154	1797
55153	1234	1800
55154	2992	1802
55155	1028	1804
55156	1291	1806
55157	2988	1809
55158	3017	1811
55159	1236	1813
55160	1189	1815
55161	1147	1819
55162	1005	1821
55163	2439	1824
55164	1086	1827
55165	2995	1829
55166	3005	1831
55167	2985	1834
55168	1256	1836
55169	3004	1838
55170	2932	1840
55171	2928	1842
55172	1216	1845
55173	1004	1848
55174	1119	1850
55175	1036	1852
55176	1090	1854
55177	1000	1856
55178	1093	1859
55179	2986	1862
55180	3019	1864
55181	1320	1920
55182	1278	1925
55183	1176	1929
55184	1188	1930
55185	1189	1934
55186	3024	1937
55187	1212	1940
55188	2994	1943
55189	1099	1946
55190	1027	1949
55191	1237	1950
55192	2778	1953
55193	1293	1955
55194	1182	1957
55195	1045	1956
55196	1328	1958
55197	1526	2036
55198	1282	2037
55199	2800	2041
55200	2658	2046
55201	2648	2050
55202	2634	2054
55203	1474	2058
55204	1530	2062
55205	1653	2065
55206	1668	2068
55207	1724	2072
55208	1783	2075
55209	1752	2078
55210	1763	2081
55211	1786	2084
55212	1789	2087
55213	1453	2090
55214	1642	2093
55215	1575	2096
55216	1590	2099
55217	1646	2102
55218	1637	2105
55219	2159	2110
55220	1786	2113
55221	2113	2116
55222	1985	2120
55223	2063	2123
55224	1765	2126
55225	1977	2127
55226	2202	2133
55227	1452	2150
55228	1880	2153
55229	1847	2158
55230	1866	2159
55231	1832	2160
55232	1874	2161
55233	1845	2162
55234	1834	2166
55235	1862	2170
55236	2157	2178
55237	2158	2179
55238	1916	2183
55239	1933	2186
55240	2373	2189
55241	2326	2192
55242	2429	2195
55243	2394	2199
55244	2610	2203
55245	2618	2206
55246	2626	2210
55247	2636	2214
55248	2759	2218
55249	2760	2222
55250	2666	2226
55251	2717	2229
55252	2665	2233
55253	2839	2236
55254	2429	2240
55255	2322	2241
55256	2691	2242
55257	1974	2245
55258	1149	2259
55259	1301	2261
55260	1143	2260
55261	2966	2262
55262	2816	2270
55263	2847	2289
55264	2894	2293
55265	2812	2298
55266	2843	2301
55267	1605	2419
55268	1592	2414
55269	1614	2417
55270	2902	2449
55271	2903	2446
55272	2899	2450
55273	2788	2453
55274	2904	2461
55275	2841	2462
55276	2172	2471
55277	2838	2479
55278	2863	2488
55279	2777	2482
55280	2905	2475
55281	2173	2485
55282	2637	2493
55283	2675	2496
55284	2711	2499
55285	2715	2502
55286	2828	2505
55287	2584	2508
55288	2455	2511
55289	2277	2514
55290	2831	2517
55291	2726	2520
55292	2594	2523
55293	2810	2526
55294	2732	2527
55295	2733	2529
55296	2646	2531
55297	2647	2533
55298	2802	2535
55299	2803	2537
55300	2844	2539
55301	2845	2541
55302	2639	2543
55303	2643	2548
55304	2735	2550
55305	2656	2553
55306	2657	2555
55307	2595	2557
55308	2650	2559
55309	2652	2562
55310	2588	2600
55311	2609	2603
55312	2613	2605
55313	2620	2607
55314	2572	2609
55315	2829	2634
55316	2260	2638
55317	2895	2641
55318	2311	2644
55319	2672	2647
55320	2375	2650
55321	2661	2654
55322	2617	2657
55323	2645	2660
55324	2577	2663
55325	2790	2666
55326	2582	2669
55327	2086	2672
55328	2590	2675
55329	1687	2678
55330	1742	2682
55331	1741	2683
55332	1353	2694
55333	1050	2716
55334	1689	2724
55335	1738	2728
55336	1335	2742
55337	1165	2746
55338	3008	2747
55339	1003	2750
55340	3601	2751
55341	1070	2753
55342	1041	2755
55343	3602	2757
55344	1394	2762
55345	1454	2763
55346	1384	2769
55347	1235	2771
55348	1475	2777
55349	1311	2780
55350	3571	2783
55351	3572	2785
55352	1250	2788
55353	1268	2790
55354	1273	2793
55355	3576	2798
55356	1270	2813
55357	1340	2815
55358	1361	2820
55359	1363	2822
55360	1780	2825
55361	3612	2828
55362	3550	2831
55363	1549	2835
55364	3246	2849
55365	1395	2854
55366	1776	2862
55367	1781	2866
55368	1774	2868
55369	1775	2870
55370	3610	2901
55371	1319	2916
55372	1473	2927
55373	3582	2936
55374	3369	2943
55375	3377	2945
55376	3379	2947
55377	3371	2964
55378	3373	2966
55379	3375	2968
55380	3173	2982
55381	3174	2983
55382	1334	3071
55383	1066	3076
55384	1633	3091
55385	1634	3093
55386	1641	3095
55387	3264	3101
55388	3266	3103
55389	3269	3106
55390	3275	3112
55391	3276	3114
55392	3278	3117
55393	3279	3119
55394	3280	3121
55395	3284	3124
55396	3286	3126
55397	3288	3128
55398	3289	3130
55399	3292	3134
55400	3295	3136
55401	3301	3139
55402	3312	3148
55403	3313	3149
55404	3314	3152
55405	3315	3154
55406	3316	3155
55407	3317	3157
55408	3319	3162
55409	3262	3174
55410	3263	3176
55411	3267	3180
55412	3265	3179
55413	3270	3182
55414	3271	3184
55415	3273	3188
55416	3272	3186
55417	3274	3190
55418	3277	3192
55419	3281	3194
55420	3282	3196
55421	3283	3199
55422	3285	3200
55423	3287	3202
55424	3290	3204
55425	3294	3205
55426	3309	3208
55427	3310	3210
55428	3312	3213
55429	1356	3220
55430	1507	3232
55431	1404	3237
55432	1309	3242
55433	1299	3244
55434	3349	3249
55435	3351	3251
55436	3353	3253
55437	3355	3255
55438	3357	3257
55439	3359	3259
55440	3361	3261
55441	3363	3263
55442	3365	3265
55443	3367	3267
55444	1402	3279
55445	1336	3294
55446	1319	3299
55447	3381	3304
55448	3492	3352
55449	3493	3354
55450	1533	3355
55451	3510	3356
55452	3515	3362
55453	3513	3360
55454	3517	3364
55455	3518	3365
55456	3519	3367
55457	3526	3366
55458	3521	3369
55459	3522	3370
55460	3524	3373
55461	1695	3378
55462	1707	3381
55463	3371	3388
55464	3373	3390
55465	3375	3392
55466	3541	3423
55467	3541	3424
55468	1309	3804
55469	1515	3810
55470	3252	3852
55471	1771	3859
55472	3329	2
55473	3338	4
55474	3339	10
55475	3115	14
55476	3102	17
55477	3039	21
55478	3119	23
55479	3113	27
55480	3107	30
55481	3033	34
55482	3057	37
55483	3051	41
55484	3036	45
55485	3061	48
55486	3128	51
55487	3131	57
55488	3130	61
55489	3127	64
55490	3340	67
55491	3344	71
55492	3345	76
55493	3387	81
55494	3087	88
55495	3090	91
55496	3095	95
55497	3394	100
55498	3398	106
55499	3444	422
55500	3402	363
55501	3407	371
55502	2954	925
55503	3441	414
55504	3446	423
55505	3416	384
55506	3412	378
55507	3423	393
55508	3440	410
55509	3411	375
55510	3436	406
55511	3442	418
55512	3405	367
55513	3420	389
55514	3431	401
55515	3128	1145
55516	3334	1293
55517	3137	1298
55518	3330	1303
55519	3347	1306
55520	3331	1309
55521	1698	1471
55522	1840	1475
55523	1617	1491
55524	1469	1494
55525	1376	1502
55526	1816	1515
55527	1818	1524
55528	1691	1529
55529	1850	1548
55530	1893	1553
55531	1909	1570
55532	1474	2060
55533	1636	2107
55534	1916	2180
55535	2666	2223
55536	3345	77
55537	3095	96
55538	3398	107
55539	3405	368
55540	3431	402
55541	3338	1286
55542	3121	1289
55543	3137	1299
55544	1840	1476
55545	1617	1492
55546	1469	1495
55547	1816	1516
55548	1691	1530
55549	1850	1549
55550	1893	1554
55551	1909	1571
55552	3411	1622
55553	1474	2061
55554	1636	2108
55555	1916	2181
55556	2666	2224
55557	3394	2246
55558	3336	7
55559	3115	13
55560	3102	16
55561	3039	18
55562	3121	24
55563	3113	26
55564	3107	29
55565	3057	36
55566	3051	39
55567	3036	43
55568	3061	47
55569	3128	50
55570	3131	54
55571	3130	59
55572	3127	63
55573	3340	66
55574	3344	69
55575	3346	73
55576	3385	79
55577	3391	83
55578	3087	86
55579	3090	90
55580	3095	93
55581	3394	99
55582	3398	104
55583	2971	967
55584	3416	382
55585	3444	420
55586	3405	365
55587	3431	399
55588	3402	361
55589	3411	373
55590	3440	408
55591	3436	405
55592	3428	396
55593	3412	377
55594	3442	416
55595	3420	386
55596	3422	392
55597	3407	370
55598	3441	412
55599	3444	1244
55600	3136	1296
55601	1430	1428
55602	2181	1441
55603	2185	1442
55604	1698	1472
55605	1375	1508
55606	1818	1525
55607	1691	1533
55608	1766	1539
55609	1850	1550
55610	1893	1555
55611	1909	1572
55612	2442	1587
55613	2449	1594
55614	2446	1597
55615	1312	1600
55616	2659	2652
55617	2644	2659
55618	3039	19
55619	3051	40
55620	3036	44
55621	3131	55
55622	3130	60
55623	3344	70
55624	3345	74
55625	3385	80
55626	3087	87
55627	3095	94
55628	3397	105
55629	3444	421
55630	3442	417
55631	3410	374
55632	3431	400
55633	3402	362
55634	3405	366
55635	3420	387
55636	3440	409
55637	3415	383
55638	3441	413
55639	3406	1240
55640	3444	1245
55641	3137	1297
55642	2185	1443
55643	2181	1444
55644	1766	1540
55645	1893	1556
55646	1909	1573
55647	2442	1588
55648	3390	2034
55649	2660	2653
55650	2644	2693
55651	3332	3
55652	3342	5
55653	3348	8
55654	3341	11
55655	3395	101
55656	3399	108
55657	3392	1152
55658	3096	1285
55659	1262	1312
55660	1851	1474
55661	1379	1504
55662	1374	1509
55663	2611	1577
55664	2580	1579
55665	2815	2268
55666	1550	2817
55667	3395	102
55668	3399	109
55669	3332	1151
55670	3343	1287
55671	1262	1313
55672	1471	1500
55673	1392	1505
55674	1843	1520
55675	3417	2033
55676	2815	2269
55677	1551	2818
55678	1552	2819
55679	3131	53
55680	1981	290
55681	1982	296
55682	1987	300
55683	2185	294
55684	2072	287
55685	1957	298
55686	2044	292
55687	1955	284
55688	1986	281
55689	2181	352
55690	2264	346
55691	1974	350
55692	1977	348
55693	1976	773
55694	2179	775
55695	2133	777
55696	2130	780
55697	2115	782
55698	2084	785
55699	2046	788
55700	2083	789
55701	2109	793
55702	2132	796
55703	2156	798
55704	2186	800
55705	2117	801
55706	2127	803
55707	2261	893
55708	2444	1134
55709	2451	1445
55710	2453	1452
55711	2465	1453
55712	2464	1454
55713	1885	1455
55714	2463	1458
55715	2472	1457
55716	2469	1456
55717	2458	1462
55718	2457	1461
55719	2440	1460
55720	2441	1463
55721	2452	1459
55722	2456	1464
55723	2460	1465
55724	2466	1466
55725	2408	1468
55726	2418	1467
55727	2601	1469
55728	2614	1480
55729	2649	1481
55730	2470	1483
55731	2619	1482
55732	2615	1484
55733	2622	1485
55734	2621	1486
55735	2630	1487
55736	2612	1488
55737	1045	1642
55738	1278	1664
55739	2994	1779
55740	1189	1817
55741	2719	1876
55742	2728	1881
55743	2722	1883
55744	2739	1885
55745	2738	1886
55746	2727	1888
55747	2753	1894
55748	2752	1896
55749	2752	1897
55750	2751	1899
55751	2750	1900
55752	2755	1902
55753	2758	1904
55754	2757	1911
55755	2757	1912
55756	1320	1919
55757	1142	1922
55758	1278	1924
55759	1176	1928
55760	1189	1933
55761	3024	1936
55762	1212	1939
55763	2994	1942
55764	1099	1945
55765	1027	1948
55766	2778	1952
55767	1280	2042
55768	2044	293
55769	1380	956
55770	1073	943
55771	1474	2059
55772	1530	2063
55773	1653	2066
55774	1668	2069
55775	1724	2073
55776	1783	2076
55777	1752	2079
55778	1763	2082
55779	1786	2085
55780	1789	2088
55781	1453	2091
55782	1643	2094
55783	1575	2097
55784	1591	2100
55785	1646	2103
55786	1636	2106
55787	1786	2112
55788	2113	2115
55789	1985	2118
55790	2063	2121
55791	1765	2125
55792	2159	2128
55793	1786	2130
55794	2202	2132
55795	2187	2137
55796	1916	2182
55797	1933	2185
55798	2373	2188
55799	2326	2191
55800	2429	2194
55801	2394	2198
55802	2610	2202
55803	2618	2205
55804	2626	2208
55805	2636	2213
55806	2759	2216
55807	2760	2221
55808	2666	2225
55809	2717	2228
55810	2718	2232
55811	2839	2235
55812	2429	2239
55813	1974	2244
55814	1862	2272
55815	1847	2274
55816	1866	2276
55817	1832	2278
55818	1834	2280
55819	1874	2282
55820	1845	2284
55821	1880	2286
55822	2867	2291
55823	2811	2296
55824	2843	2300
55825	2903	2445
55826	2902	2448
55827	2904	2460
55828	1776	2861
55829	1781	2865
55830	1774	2867
55831	1775	2869
55832	1394	2912
55833	1394	2911
55834	1319	2915
55835	1451	2921
55836	1451	2922
55837	1473	2926
55838	1473	2925
55839	1402	3277
55840	1402	3278
55841	1336	3292
55842	1336	3293
55843	1319	3298
55844	1319	3297
55845	1695	3377
55846	1707	3380
55847	1515	3808
55848	1515	3809
55849	1653	3907
55850	1763	3909
55851	1786	3911
55852	1789	3913
55853	1880	3915
55854	1866	3919
55855	1832	3921
55856	1834	3923
55857	1874	3925
55858	1845	3927
55859	1474	3928
55860	1530	3930
55861	3131	56
55862	3345	75
55863	3419	388
55864	3408	1239
55865	3443	1241
55866	1893	1557
55867	3445	1618
55868	3386	1620
55869	3390	2035
55870	3410	372
55871	3407	369
55872	3414	376
55873	3396	98
55874	3443	1242
55875	3391	84
55876	1986	282
55877	1981	291
55878	2072	288
55879	2156	303
55880	1955	285
55881	1982	297
55882	1957	299
55883	2185	295
55884	1987	301
55885	2085	344
55886	1977	349
55887	2181	353
55888	1974	351
55889	1975	356
55890	2264	347
55891	1853	618
55892	1209	629
55893	1927	627
55894	1150	628
55895	1694	631
55896	1219	630
55897	1015	632
55898	1569	661
55899	1555	660
55900	1107	639
55901	1033	635
55902	1202	646
55903	1692	662
55904	1239	652
55905	1431	658
55906	1140	638
55907	1696	663
55908	1222	653
55909	1734	664
55910	1180	643
55911	1224	648
55912	1163	642
55913	1813	665
55914	1343	656
55915	1846	666
55916	1458	659
55917	1020	633
55918	1238	650
55919	1088	637
55920	1218	647
55921	1170	641
55922	1307	655
55923	1369	657
55924	1242	649
55925	1275	654
55926	1244	651
55927	1043	636
55928	1113	640
55929	1196	645
55930	1025	634
55931	1204	644
55932	1976	772
55933	2179	774
55934	2133	776
55935	2130	779
55936	2115	781
55937	2084	784
55938	2083	791
55939	2109	794
55940	2132	795
55941	2186	799
55942	2117	802
55943	2127	805
55944	2261	892
55945	3528	896
55946	3528	897
55947	3528	898
55948	3529	899
55949	3529	901
55950	3529	900
55951	1160	912
55952	1175	913
55953	1200	914
55954	1207	915
55955	1459	961
55956	2942	920
55957	1556	962
55958	2983	930
55959	1104	945
55960	1432	959
55961	1221	916
55962	1077	944
55963	1052	973
55964	2991	933
55965	1554	918
55966	2956	926
55967	1169	949
55968	1217	979
55969	2943	919
55970	2989	931
55971	1038	974
55972	1051	942
55973	1736	964
55974	1162	978
55975	1341	951
55976	1135	947
55977	1389	957
55978	2979	929
55979	1151	948
55980	1021	971
55981	1213	975
55982	2936	921
55983	1008	936
55984	2915	924
55985	1339	953
55986	2970	927
55987	1106	946
55988	1134	977
55989	2919	923
55990	1049	939
55991	1061	940
55992	3013	934
55993	1747	965
55994	2926	928
55995	1371	917
55996	3022	935
55997	1019	972
55998	1089	976
55999	1308	950
56000	3003	970
56001	2981	969
56002	2958	922
56003	1370	955
56004	1697	963
56005	1693	960
56006	1012	938
56007	2990	932
56008	1060	941
56009	1344	954
56010	2951	966
56011	1009	937
56012	1338	952
56013	2973	968
56014	1388	958
56015	1082	1022
56016	1044	1023
56017	1243	1024
56018	1197	1025
56019	1053	1091
56020	2961	1026
56021	1022	1095
56022	1181	1048
56023	1114	1074
56024	3018	1082
56025	1123	1071
56026	1075	1088
56027	1125	1064
56028	1153	1062
56029	1029	1053
56030	1016	1033
56031	1223	1037
56032	1083	1083
56033	2993	1106
56034	1087	1087
56035	2960	1114
56036	1010	1099
56037	1166	1056
56038	1116	1060
56039	2925	1126
56040	2949	1128
56041	2917	1118
56042	2955	1108
56043	1198	1044
56044	1171	1057
56045	1174	1052
56046	1111	1073
56047	1063	1089
56048	1241	1032
56049	2924	1113
56050	1105	1065
56051	1168	1054
56052	1124	1067
56053	1082	1079
56054	2962	1116
56055	3012	1101
56056	3007	1103
56057	2940	1132
56058	1109	1077
56059	2984	1107
56060	1017	1097
56061	1076	1085
56062	1206	1045
56063	1231	1036
56064	1173	1049
56065	2964	1115
56066	2918	1119
56067	2982	1046
56068	2937	1125
56069	1136	1061
56070	1013	1100
56071	1084	1080
56072	2941	1111
56073	1226	1039
56074	2935	1117
56075	1152	1058
56076	1164	1059
56077	1161	1055
56078	1133	1063
56079	3014	1104
56080	1080	1086
56081	1240	1031
56082	1034	1094
56083	2922	1109
56084	1059	1090
56085	2952	1130
56086	3001	1105
56087	1172	1051
56088	1232	1035
56089	1205	1043
56090	1056	1093
56091	2950	1121
56092	2980	1110
56093	1225	1034
56094	1031	1096
56095	1108	1078
56096	2921	1127
56097	1085	1081
56098	2916	1124
56099	1118	1066
56100	1131	1069
56101	1081	1084
56102	1064	1092
56103	1211	1042
56104	1220	1041
56105	3021	1102
56106	2934	1120
56107	1110	1075
56108	2933	1122
56109	1130	1070
56110	1006	1098
56111	3010	1028
56112	1276	1050
56113	2947	1129
56114	2920	1133
56115	1014	1027
56116	1129	1068
56117	2946	1131
56118	1122	1072
56119	2944	1123
56120	1026	1076
56121	2931	1112
56122	2046	1310
56123	1351	1626
56124	1254	1627
56125	1651	1628
56126	1245	1630
56127	1179	1629
56128	2998	1631
56129	1210	1633
56130	1132	1632
56131	1753	1634
56132	3015	1635
56133	3023	1636
56134	1145	1637
56135	1128	1639
56136	1249	1638
56137	1148	1640
56138	1045	1641
56139	1167	1643
56140	1355	1644
56141	1011	1645
56142	1047	1646
56143	1048	1647
56144	3011	1648
56145	1191	1650
56146	1229	1651
56147	1042	1652
56148	1326	1653
56149	1193	1655
56150	1032	1657
56151	1201	1658
56152	1068	1660
56153	1251	1661
56154	1278	1662
56155	1054	1665
56156	1065	1666
56157	2957	1667
56158	1141	1669
56159	1346	1672
56160	1347	1675
56161	1253	1677
56162	1683	1678
56163	1348	1680
56164	1859	1681
56165	1296	1682
56166	1297	1684
56167	1287	1686
56168	1288	1688
56169	1700	1689
56170	1701	1691
56171	1030	1693
56172	1100	1695
56173	1101	1697
56174	2972	1699
56175	1252	1700
56176	1115	1701
56177	2965	1704
56178	1097	1707
56179	2977	1708
56180	1139	1712
56181	1096	1713
56182	1079	1715
56183	1137	1717
56184	1138	1719
56185	1095	1721
56186	1057	1724
56187	1310	1727
56188	2945	1729
56189	1513	1731
56190	1472	1733
56191	1146	1734
56192	1383	1736
56193	1127	1741
56194	1303	1743
56195	1304	1744
56196	1279	1747
56197	1292	1749
56198	1284	1750
56199	1318	1752
56200	1342	1754
56201	1192	1755
56202	1203	1757
56203	2996	1759
56204	3004	1762
56205	1285	1764
56206	1024	1765
56207	1018	1767
56208	1007	1769
56209	1071	1770
56210	1072	1771
56211	1177	1774
56212	1178	1775
56213	2994	1777
56214	3002	1780
56215	1281	1782
56216	1228	1783
56217	1269	1786
56218	2963	1787
56219	2997	1790
56220	2939	1792
56221	1155	1796
56222	1233	1799
56223	2992	1801
56224	1028	1803
56225	1291	1805
56226	2988	1808
56227	3016	1810
56228	1236	1812
56229	1189	1814
56230	1147	1818
56231	1005	1820
56232	1086	1826
56233	2995	1828
56234	3005	1830
56235	2985	1833
56236	1257	1835
56237	3004	1837
56238	2932	1839
56239	2929	1841
56240	1214	1843
56241	1396	1846
56242	1004	1847
56243	1035	1851
56244	1091	1853
56245	1001	1855
56246	1093	1858
56247	2986	1861
56248	3020	1863
56249	2722	1884
56250	2727	1889
56251	1320	1917
56252	1142	1921
56253	1278	1923
56254	1176	1926
56255	1189	1931
56256	3024	1935
56257	2994	1941
56258	1099	1944
56259	2778	1951
56260	2241	1975
56261	2310	1977
56262	2333	1978
56263	2334	1979
56264	1935	1989
56265	2800	2038
56266	2800	2039
56267	2800	2040
56268	2658	2044
56269	2658	2043
56270	2658	2045
56271	2648	2047
56272	2648	2048
56273	2648	2049
56274	2634	2051
56275	2634	2053
56276	2634	2052
56277	1530	2064
56278	1653	2067
56279	1668	2071
56280	1724	2074
56281	1783	2077
56282	1752	2080
56283	1763	2083
56284	1786	2086
56285	1789	2089
56286	1453	2092
56287	1643	2095
56288	1575	2098
56289	1591	2101
56290	1646	2104
56291	2159	2109
56292	1786	2111
56293	2113	2114
56294	1985	2117
56295	1765	2124
56296	2159	2129
56297	2202	2131
56298	1933	2184
56299	2373	2187
56300	2326	2190
56301	2429	2193
56302	2394	2196
56303	2610	2200
56304	2618	2204
56305	2636	2211
56306	2759	2215
56307	2760	2219
56308	2717	2227
56309	2718	2230
56310	2839	2234
56311	2429	2238
56312	1862	2271
56313	1847	2273
56314	1866	2275
56315	1832	2277
56316	1835	2279
56317	1874	2281
56318	1845	2283
56319	1880	2285
56320	2836	2287
56321	2867	2290
56322	2868	2292
56323	2811	2294
56324	2812	2297
56325	2843	2299
56326	1606	2425
56327	2903	2443
56328	2898	2447
56329	2797	2476
56330	2969	2803
56331	1780	2860
56332	1394	2909
56333	1394	2910
56334	1319	2914
56335	1451	2919
56336	1451	2920
56337	1473	2923
56338	1473	2924
56339	1402	3275
56340	1402	3276
56341	1336	3291
56342	1336	3290
56343	1319	3296
56344	1319	3295
56345	1695	3376
56346	1707	3379
56347	1515	3806
56348	1515	3807
56349	1771	3858
56350	1653	3906
56351	1763	3908
56352	1786	3910
56353	1789	3912
56354	1880	3914
56355	1866	3918
56356	1832	3920
56357	1834	3922
56358	1874	3924
56359	1845	3926
56360	1530	3929
56361	3033	32
56362	3033	33
56363	1975	355
56364	2085	343
56365	2046	787
56366	1957	884
56367	2084	885
56368	3128	1146
56369	1470	1498
56370	1141	1671
56371	1347	1674
56372	1701	1692
56373	1030	1694
56374	1115	1703
56375	2965	1706
56376	2976	1710
56377	2978	1711
56378	1079	1716
56379	1095	1723
56380	1057	1726
56381	1383	1737
56382	1304	1746
56383	1284	1751
56384	2996	1761
56385	1072	1772
56386	2939	1794
56387	1154	1798
56388	1291	1807
56389	1189	1816
56390	3005	1832
56391	1214	1844
56392	1001	1857
56393	1092	1860
56394	1320	1918
56395	1176	1927
56396	1189	1932
56397	1212	1938
56398	1099	1954
56399	1985	2119
56400	2063	2122
56401	2394	2197
56402	2610	2201
56403	2626	2207
56404	2636	2212
56405	2760	2220
56406	2718	2231
56407	2759	2237
56408	1974	2243
56409	2811	2295
56410	2903	2444
56411	2899	2451
56412	2904	2459
56413	2761	2454
56414	2653	2470
56415	2793	2487
56416	2906	2473
56417	1949	2484
56418	2773	2481
56419	2907	2474
56420	2837	2478
56421	2638	2492
56422	2677	2495
56423	2662	2498
56424	2699	2501
56425	2826	2504
56426	2575	2507
56427	2330	2510
56428	2276	2513
56429	2731	2516
56430	2726	2519
56431	2593	2522
56432	2729	2525
56433	2221	2637
56434	2870	2640
56435	2312	2643
56436	2670	2646
56437	2374	2649
56438	2616	2656
56439	2578	2662
56440	2789	2665
56441	2581	2668
56442	2087	2671
56443	2591	2674
56444	1684	2677
56445	1742	2681
56446	1995	110
56447	1990	111
56448	2055	112
56449	2140	113
56450	1999	114
56451	2155	115
56452	1963	116
56453	1968	117
56454	2110	118
56455	2079	119
56456	1993	120
56457	2081	121
56458	1988	122
56459	2006	123
56460	2059	124
56461	2057	125
56462	2001	126
56463	2080	127
56464	1967	128
56465	2026	129
56466	1997	130
56467	1965	131
56468	2070	132
56469	1970	133
56470	2069	134
56471	2074	136
56472	2024	135
56473	2056	137
56474	2002	138
56475	1973	139
56476	2052	140
56477	2076	141
56478	2050	142
56479	1989	143
56480	2051	144
56481	2007	145
56482	2089	146
56483	2090	147
56484	2091	148
56485	2107	150
56486	2103	151
56487	2098	149
56488	2093	153
56489	2105	152
56490	2094	154
56491	2148	156
56492	2146	155
56493	2150	157
56494	2138	158
56495	2139	159
56496	2154	160
56497	2153	162
56498	2141	161
56499	1914	165
56500	2025	163
56501	2066	164
56502	1998	166
56503	1999	168
56504	2058	167
56505	2000	171
56506	2079	172
56507	1963	170
56508	2067	169
56509	1992	174
56510	2005	176
56511	2071	175
56512	1988	173
56513	2019	177
56514	2081	179
56515	1993	178
56516	1999	180
56517	2067	181
56518	1963	182
56519	2000	183
56520	2079	184
56521	1988	185
56522	1992	186
56523	2071	187
56524	2005	188
56525	2019	189
56526	2081	191
56527	1993	190
56528	2054	193
56529	1998	192
56530	2058	194
56531	2006	195
56532	2059	196
56533	1968	197
56534	2057	198
56535	2003	199
56536	2001	200
56537	2080	201
56538	1972	202
56539	1971	203
56540	1966	204
56541	1967	205
56542	2007	237
56543	2092	252
56544	1994	220
56545	2073	218
56546	2089	240
56547	1996	208
56548	2136	259
56549	1995	207
56550	2135	276
56551	2111	256
56552	2147	278
56553	2052	231
56554	2093	254
56555	2144	275
56556	2152	263
56557	2142	261
56558	2149	269
56559	2068	215
56560	2077	232
56561	2103	247
56562	2098	243
56563	2096	253
56564	2090	241
56565	2008	223
56566	2024	219
56567	2100	250
56568	2104	248
56569	2002	228
56570	2141	273
56571	1965	210
56572	2105	249
56573	2056	222
56574	2137	260
56575	2106	239
56576	2050	234
56577	2074	221
56578	1990	224
56579	1989	235
56580	2018	226
56581	2148	266
56582	2145	267
56583	2150	268
56584	1970	214
56585	2066	213
56586	2069	216
56587	2143	262
56588	1973	230
56589	1997	209
56590	2139	271
56591	2151	279
56592	2025	211
56593	2108	246
56594	2070	212
56595	2110	258
56596	2053	225
56597	2119	257
56598	2099	244
56599	2154	272
56600	2091	242
56601	2026	206
56602	1969	227
56603	2101	251
56604	2107	245
56605	2055	217
56606	2153	274
56607	2102	238
56608	2076	233
56609	2051	236
56610	2155	277
56611	2138	270
56612	2094	255
56613	1941	229
56614	2146	265
56615	2140	264
56616	2340	687
56617	2170	707
56618	2242	722
56619	2178	692
56620	2227	726
56621	2174	725
56622	2176	720
56623	2184	704
56624	2262	709
56625	2222	713
56626	2348	699
56627	2168	708
56628	2335	700
56629	2351	712
56630	2319	727
56631	2315	711
56632	2347	718
56633	2162	702
56634	2339	696
56635	2193	703
56636	2195	728
56637	2167	705
56638	2165	688
56639	2175	721
56640	2166	690
56641	2180	719
56642	2192	695
56643	2194	716
56644	2314	715
56645	2161	693
56646	2243	723
56647	2122	724
56648	2197	710
56649	2346	717
56650	2169	706
56651	2345	698
56652	2349	714
56653	2164	689
56654	2196	691
56655	2350	697
56656	2344	694
56657	2163	701
56658	2362	1249
56659	2431	1284
56660	2423	1271
56661	2361	1250
56662	2405	1255
56663	2369	1259
56664	2432	1276
56665	2399	1265
56666	2424	1275
56667	2359	1256
56668	2370	1262
56669	2433	1279
56670	2435	1282
56671	2366	1252
56672	2372	1261
56673	2412	1272
56674	2398	1264
56675	2413	1278
56676	2360	1251
56677	2430	1280
56678	2371	1260
56679	2414	1283
56680	2404	1270
56681	2368	1258
56682	2365	1253
56683	2436	1277
56684	2434	1273
56685	2402	1268
56686	2397	1263
56687	2425	1281
56688	2363	1257
56689	2401	1267
56690	2422	1274
56691	2367	1254
56692	2400	1266
56693	2403	1269
56694	2340	3484
56695	2165	3485
56696	2164	3486
56697	2166	3487
56698	2196	3488
56699	2178	3489
56700	2161	3490
56701	2344	3491
56702	2192	3492
56703	2339	3493
56704	2350	3494
56705	2350	3495
56706	2345	3496
56707	2348	3497
56708	2335	3498
56709	2162	3500
56710	2163	3499
56711	2184	3502
56712	2193	3501
56713	2167	3503
56714	2169	3504
56715	2170	3505
56716	2262	3507
56717	2168	3506
56718	2197	3508
56719	2315	3509
56720	2351	3510
56721	2222	3511
56722	2314	3513
56723	2349	3512
56724	2194	3514
56725	2347	3515
56726	2176	3517
56727	2180	3516
56728	2175	3518
56729	2242	3519
56730	2243	3520
56731	2174	3522
56732	2122	3521
56733	2195	3525
56734	2227	3523
56735	2319	3524
56736	3402	359
56737	3415	380
56738	3421	390
56739	3444	419
56740	3434	403
56741	3442	415
56742	3430	395
56743	3441	411
56744	3440	407
56745	3427	394
56746	3424	391
56747	3437	404
56748	3432	398
56749	3404	364
56750	3403	360
56751	3417	381
56752	2448	1603
56753	1547	2458
56754	3417	385
56755	3413	379
56756	3388	1154
56757	3143	1148
56758	3144	1307
56759	3145	1423
56760	1842	1479
56761	1471	1499
56762	1815	1519
56763	1820	1527
56764	2034	1558
56765	1910	1574
56766	1932	1609
56767	3429	397
56768	1844	424
56769	1490	425
56770	2259	428
56771	1931	427
56772	1199	426
56773	2188	432
56774	1872	430
56775	2177	431
56776	2204	433
56777	2205	434
56778	2233	435
56779	1631	429
56780	2061	439
56781	2343	445
56782	2317	443
56783	1889	437
56784	2125	440
56785	1837	436
56786	2256	441
56787	2291	536
56788	2039	438
56789	2295	442
56790	2327	444
56791	1581	446
56792	2263	447
56793	2332	448
56794	2603	1999
56795	1757	452
56796	1777	454
56797	1868	458
56798	1435	460
56799	1428	459
56800	1806	462
56801	1727	456
56802	1652	457
56803	1805	461
56804	1616	455
56805	1626	463
56806	1632	464
56807	1587	467
56808	1480	474
56809	1560	466
56810	1410	472
56811	1625	468
56812	1483	469
56813	1655	465
56814	1443	473
56815	1518	471
56816	1493	470
56817	1580	477
56818	2352	481
56819	1804	486
56820	1764	492
56821	1954	494
56822	1640	491
56823	2302	487
56824	2380	479
56825	2225	497
56826	1622	490
56827	2354	483
56828	1883	485
56829	2358	478
56830	2382	480
56831	1798	493
56832	2357	489
56833	2353	482
56834	2356	488
56835	2338	496
56836	2355	484
56837	2131	495
56838	2209	502
56839	2224	503
56840	2238	505
56841	2239	506
56842	2236	518
56843	2290	512
56844	2217	509
56845	2226	521
56846	2216	508
56847	2228	513
56848	2223	520
56849	2213	510
56850	2240	507
56851	2211	517
56852	2237	519
56853	2235	514
56854	2231	515
56855	2234	516
56856	2215	504
56857	2318	511
56858	2244	675
56859	2249	680
56860	2206	676
56861	2250	679
56862	2253	677
56863	2246	681
56864	2247	678
56865	2257	682
56866	2252	1865
56867	2251	1866
56868	2329	527
56869	2210	526
56870	2305	524
56871	2208	525
56872	2297	523
56873	2309	548
56874	2212	522
56875	2293	541
56876	2316	538
56877	2296	530
56878	2325	546
56879	2324	545
56880	2292	537
56881	2308	544
56882	2306	542
56883	2328	547
56884	2321	540
56885	2289	533
56886	2214	531
56887	2232	529
56888	2307	543
56889	2320	539
56890	2219	535
56891	2218	534
56892	2230	532
56893	2364	528
56894	2288	685
56895	2280	684
56896	2207	683
56897	2258	1867
56898	2255	1868
56899	2254	1869
56900	2245	1870
56901	2248	1871
56902	2200	1872
56903	2279	1873
56904	2287	1874
56905	3072	551
56906	1294	556
56907	2015	601
56908	3152	591
56909	3048	552
56910	3153	587
56911	3031	593
56912	1808	565
56913	3154	589
56914	3126	600
56915	3081	599
56916	1809	558
56917	3069	579
56918	3047	576
56919	3151	590
56920	2016	602
56921	1729	566
56922	3150	588
56923	3083	571
56924	3056	572
56925	3071	582
56926	1420	559
56927	3059	553
56928	3539	596
56929	1331	561
56930	1332	560
56931	1535	567
56932	3078	581
56933	3028	573
56934	3070	554
56935	1418	562
56936	3155	585
56937	2011	557
56938	1103	555
56939	3079	583
56940	2010	564
56941	3043	577
56942	3077	569
56943	3084	584
56944	3055	570
56945	3060	598
56946	3067	574
56947	1419	563
56948	3538	597
56949	3073	580
56950	3032	594
56951	1534	568
56952	3052	578
56953	3068	575
56954	3156	586
56955	3037	595
56956	3149	592
56957	3042	1004
56958	2914	1005
56959	3041	1006
56960	3098	1008
56961	3125	1007
56962	3074	1009
56963	3094	1010
56964	3029	1011
56965	3054	1012
56966	3447	1013
56967	3076	1014
56968	3500	1015
56969	3498	1016
56970	3080	1017
56971	3075	1018
56972	3053	1020
56973	3499	1019
56974	3082	1021
56975	3509	604
56976	3507	605
56977	1871	1366
56978	3531	606
56979	3532	607
56980	3533	608
56981	3534	609
56982	3501	610
56983	3503	611
56984	3504	612
56985	3505	613
56986	3506	614
56987	3535	615
56988	3508	616
56989	3560	1246
56990	3562	1247
56991	3502	1248
56992	3558	1316
56993	3559	1317
56994	3561	1318
56995	3530	1319
56996	3590	2836
56997	3591	2837
56998	3592	2838
56999	3594	2839
57000	3595	2840
57001	3596	2841
57002	1618	621
57003	1858	625
57004	1566	619
57005	1748	622
57006	1545	620
57007	2266	624
57008	1795	623
57009	3536	673
57010	3537	674
57011	3584	2760
57012	3585	2761
57013	3586	3838
57014	3587	3839
57015	3588	3840
57016	3589	3841
57017	1439	617
57018	2298	730
57019	1567	997
57020	1644	998
57021	1745	999
57022	1882	1000
57023	1760	1001
57024	1408	1002
57025	2444	1003
57026	1541	1144
57027	1664	1136
57028	1663	1137
57029	1538	1141
57030	1659	1140
57031	1661	1139
57032	1665	1135
57033	1539	1142
57034	1662	1138
57035	1540	1143
57036	1548	1315
57037	1463	1320
57038	1434	1321
57039	1567	1322
57040	1455	1324
57041	3494	1325
57042	1730	1328
57043	1542	1329
57044	1421	1330
57045	1422	1331
57046	1423	1332
57047	1424	1333
57048	1425	1334
57049	1426	1335
57050	1437	1336
57051	1629	1345
57052	1499	1339
57053	1455	1337
57054	1565	1344
57055	1517	1341
57056	1522	1342
57057	1524	1343
57058	1639	1346
57059	1502	1340
57060	1497	1338
57061	1699	1347
57062	2121	1416
57063	1870	1365
57064	2065	1411
57065	1867	1363
57066	2031	1407
57067	1960	1401
57068	1888	1372
57069	1951	1392
57070	1962	1397
57071	2020	1403
57072	1937	1387
57073	1980	1398
57074	1857	1362
57075	1878	1368
57076	2004	1402
57077	1958	1394
57078	1923	1379
57079	1740	1350
57080	1917	1378
57081	1759	1351
57082	2017	1404
57083	1948	1391
57084	1877	1367
57085	1945	1388
57086	1876	1369
57087	1793	1354
57088	2027	1405
57089	1770	1353
57090	1928	1382
57091	1886	1370
57092	1286	1360
57093	1959	1395
57094	1920	1377
57095	1926	1380
57096	1854	1361
57097	1869	1364
57098	1939	1384
57099	1925	1385
57100	1720	1348
57101	2114	1414
57102	1762	1352
57103	2082	1412
57104	1791	1355
57105	1938	1390
57106	1892	1373
57107	1953	1393
57108	2045	1413
57109	1887	1371
57110	2009	1400
57111	1947	1389
57112	1936	1383
57113	1829	1357
57114	1721	1349
57115	1964	1399
57116	2118	1415
57117	2123	1417
57118	1924	1381
57119	2038	1409
57120	1797	1356
57121	1919	1376
57122	2049	1410
57123	1911	1375
57124	1849	1359
57125	2036	1408
57126	1961	1396
57127	1915	1374
57128	1839	1358
57129	2028	1406
57130	1918	1386
57131	1567	2250
57132	1149	2251
57133	1194	2252
57134	1444	2253
57135	1039	2254
57136	1143	2256
57137	1068	2255
57138	2974	2258
57139	1302	2257
57140	2608	2303
57141	2710	2304
57142	1566	2321
57143	1545	2322
57144	3248	2330
57145	1567	2328
57146	3250	2331
57147	3249	2332
57148	3251	2334
57149	3240	2333
57150	3251	2335
57151	1614	2418
57152	2842	2457
57153	2840	2456
57154	1353	2695
57155	3099	2696
57156	1801	2697
57157	1861	2698
57158	1756	2703
57159	1838	2711
57160	1807	2709
57161	1716	2699
57162	1708	2712
57163	1717	2714
57164	1794	2710
57165	1743	2700
57166	1792	2705
57167	1814	2707
57168	1800	2706
57169	1722	2708
57170	1751	2702
57171	1784	2704
57172	1719	2713
57173	1735	2701
57174	1002	2715
57175	1055	2717
57176	2923	2718
57177	2930	2719
57178	2927	2720
57179	1337	2721
57180	1112	2722
57181	1046	2723
57182	1688	2725
57183	1680	2726
57184	1731	2727
57185	1738	2729
57186	1023	2730
57187	2948	2731
57188	1037	2732
57189	1365	2733
57190	2959	2734
57191	3000	2735
57192	1306	2736
57193	3006	2737
57194	1157	2738
57195	1230	2739
57196	2987	2740
57197	1074	2741
57198	1335	2743
57199	1271	2744
57200	1159	2745
57201	1367	2748
57202	3009	2749
57203	1584	2764
57204	1406	2766
57205	1319	2767
57206	1449	2768
57207	1384	2770
57208	1330	2772
57209	1094	2773
57210	1067	2774
57211	2999	2775
57212	1568	2776
57213	1532	2778
57214	1311	2779
57215	3569	2781
57216	3570	2782
57217	3571	2784
57218	1246	2786
57219	1250	2787
57220	1268	2789
57221	1268	2791
57222	1273	2792
57223	1277	2794
57224	3573	2795
57225	3574	2796
57226	3575	2797
57227	3576	2799
57228	1350	2800
57229	3577	2802
57230	1274	2804
57231	1705	2805
57232	1725	2807
57233	1726	2806
57234	1723	2808
57235	1703	2809
57236	1679	2810
57237	1481	2811
57238	1656	2812
57239	1553	2814
57240	1675	2816
57241	3241	2848
57242	1678	2852
57243	3245	2850
57244	1667	2853
57245	3244	2851
57246	1410	2864
57247	1682	2883
57248	1690	2884
57249	1372	2886
57250	1259	2885
57251	1319	2913
57252	2912	2928
57253	2913	2929
57254	1666	2934
57255	1583	2935
57256	1399	2938
57257	1436	2939
57258	1466	2940
57259	1517	2941
57260	1561	2942
57261	3370	2944
57262	3378	2946
57263	3380	2948
57264	3465	2949
57265	1437	2960
57266	1414	2959
57267	1462	2962
57268	1455	2961
57269	1463	2963
57270	3372	2965
57271	3374	2967
57272	3376	2969
57273	3171	2980
57274	1358	2979
57275	3172	2981
57276	1511	2988
57277	1516	2991
57278	1514	2989
57279	1519	2990
57280	1531	2993
57281	1521	2992
57282	1405	2996
57283	1400	2995
57284	1403	2994
57285	1416	2998
57286	1412	2997
57287	1407	2999
57288	1409	3000
57289	1417	3002
57290	1415	3003
57291	1416	3001
57292	1434	3004
57293	1441	3005
57294	1446	3006
57295	1450	3007
57296	1449	3008
57297	1494	3009
57298	1496	3011
57299	1498	3012
57300	1501	3010
57301	1505	3013
57302	1500	3014
57303	1508	3015
57304	1512	3016
57305	1520	3018
57306	1509	3017
57307	1529	3019
57308	1427	3020
57309	1434	3021
57310	1442	3022
57311	1447	3023
57312	1445	3024
57313	1456	3025
57314	1468	3026
57315	1476	3028
57316	1465	3027
57317	1463	3031
57318	1478	3029
57319	1479	3030
57320	1487	3032
57321	1486	3033
57322	1488	3034
57323	1489	3035
57324	1491	3036
57325	1494	3037
57326	1503	3039
57327	1492	3038
57328	1525	3041
57329	1510	3040
57330	1523	3042
57331	1546	3043
57332	1548	3045
57333	1564	3046
57334	1624	3049
57335	1627	3050
57336	1645	3052
57337	1635	3051
57338	1648	3053
57339	1615	3055
57340	1563	3054
57341	1623	3056
57342	1649	3057
57343	1650	3058
57344	1654	3059
57345	1658	3061
57346	1657	3060
57347	1670	3063
57348	1671	3062
57349	1672	3064
57350	1674	3066
57351	1673	3065
57352	1676	3067
57353	1647	3070
57354	1524	3069
57355	1746	3068
57356	1357	3073
57357	1334	3072
57358	1062	3075
57359	2953	3074
57360	1158	3078
57361	1066	3077
57362	1190	3079
57363	1247	3080
57364	1300	3081
57365	1397	3083
57366	1387	3082
57367	1559	3085
57368	1477	3084
57369	1295	3087
57370	1464	3086
57371	1562	3088
57372	1366	3089
57373	1448	3090
57374	1634	3094
57375	1641	3096
57376	3263	3099
57377	3263	3100
57378	3264	3102
57379	3266	3104
57380	3268	3105
57381	3269	3107
57382	3272	3109
57383	3272	3110
57384	3273	3111
57385	3275	3113
57386	3276	3115
57387	3276	3116
57388	3278	3118
57389	3279	3120
57390	3280	3122
57391	3284	3123
57392	3286	3125
57393	3287	3127
57394	3288	3129
57395	3291	3132
57396	3289	3131
57397	3292	3133
57398	3293	3135
57399	3295	3137
57400	3296	3138
57401	3301	3140
57402	3305	3142
57403	3302	3141
57404	3308	3144
57405	3308	3143
57406	3312	3146
57407	3308	3145
57408	3312	3147
57409	3313	3150
57410	3314	3151
57411	3315	3153
57412	3316	3156
57413	3317	3158
57414	3317	3159
57415	3318	3160
57416	3319	3163
57417	3320	3164
57418	3297	3165
57419	3298	3166
57420	3299	3167
57421	3303	3169
57422	3300	3168
57423	3306	3171
57424	3304	3170
57425	3307	3172
57426	3311	3173
57427	3262	3175
57428	3263	3177
57429	3265	3178
57430	3267	3181
57431	3270	3183
57432	3271	3185
57433	3272	3187
57434	3273	3189
57435	3274	3191
57436	3277	3193
57437	3281	3195
57438	3283	3198
57439	3282	3197
57440	3285	3201
57441	3290	3203
57442	3294	3206
57443	3309	3207
57444	3310	3209
57445	3312	3211
57446	3312	3212
57447	3325	3214
57448	1457	3216
57449	1504	3215
57450	1460	3217
57451	1410	3219
57452	1433	3218
57453	1398	3223
57454	1352	3222
57455	1356	3221
57456	1411	3224
57457	1390	3225
57458	1208	3226
57459	1195	3227
57460	1235	3228
57461	1248	3229
57462	1506	3231
57463	1715	3230
57464	1715	3233
57465	1669	3234
57466	1711	3236
57467	1709	3235
57468	1309	3243
57469	1299	3245
57470	3372	3247
57471	3370	3246
57472	3350	3250
57473	3378	3248
57474	3352	3252
57475	3354	3254
57476	3356	3256
57477	3358	3258
57478	3360	3260
57479	3362	3262
57480	3364	3264
57481	3366	3266
57482	3364	3269
57483	3368	3268
57484	3384	3300
57485	3605	3302
57486	3604	3301
57487	3382	3306
57488	3383	3305
57489	1579	3307
57490	3469	3308
57491	3449	3310
57492	3450	3311
57493	3448	3309
57494	3452	3313
57495	3451	3312
57496	3453	3314
57497	3454	3315
57498	3455	3316
57499	3456	3318
57500	3459	3321
57501	3457	3319
57502	3458	3320
57503	3460	3322
57504	3462	3324
57505	3463	3325
57506	3461	3323
57507	3464	3326
57508	3466	3327
57509	3468	3329
57510	3467	3328
57511	3470	3330
57512	3472	3332
57513	3471	3331
57514	3473	3333
57515	3475	3335
57516	3474	3334
57517	3476	3336
57518	3477	3337
57519	3478	3338
57520	3479	3339
57521	3480	3340
57522	3482	3342
57523	3481	3341
57524	3484	3344
57525	3483	3343
57526	3487	3347
57527	3485	3345
57528	3486	3346
57529	3489	3349
57530	3488	3348
57531	3490	3350
57532	3512	3359
57533	3511	3358
57534	3510	3357
57535	3514	3361
57536	3516	3363
57537	3520	3368
57538	3522	3371
57539	3523	3372
57540	3525	3374
57541	3527	3375
57542	1677	3382
57543	3322	3384
57544	3321	3383
57545	3323	3385
57546	3324	3386
57547	3372	3387
57548	3376	3391
57549	3374	3389
57550	1437	3394
57551	1414	3393
57552	1455	3395
57553	1462	3396
57554	1482	3398
57555	1463	3397
57556	1536	3427
57557	1333	3426
57558	3553	3428
57559	3554	3429
57560	3597	3435
57561	3599	3437
57562	3598	3436
57563	1523	3442
57564	3495	3447
57565	1309	3805
57566	3169	3824
57567	3170	3825
57568	3578	3836
57569	3579	3837
57570	1595	3842
57571	3547	3845
57572	3253	3847
57573	3254	3848
57574	3255	3849
57575	3256	3850
57576	3257	3851
57577	3290	3853
57578	3310	3854
57579	3312	3855
57580	3312	3856
57581	1802	3860
57582	1796	3861
57583	1788	3862
57584	1790	3863
57585	1778	3864
57586	1799	3865
57587	1782	3866
57588	1823	3867
57589	1803	3868
57590	1117	3869
57591	1827	3870
57592	1058	3871
57593	1144	3872
57594	3268	3901
57595	2477	806
57596	2494	819
57597	2482	811
57598	2492	818
57599	2488	815
57600	2504	831
57601	2510	838
57602	2489	816
57603	2487	814
57604	2501	828
57605	2503	830
57606	2479	808
57607	2560	822
57608	2502	829
57609	2522	846
57610	2496	821
57611	2506	833
57612	2508	835
57613	2520	845
57614	2509	837
57615	2515	842
57616	2524	847
57617	2517	843
57618	2484	812
57619	2499	827
57620	2497	825
57621	2486	813
57622	2512	839
57623	2518	844
57624	2480	809
57625	1313	3270
57626	1315	3272
57627	1316	3273
57628	1314	3271
57629	1317	3274
57630	1322	3281
57631	1323	3282
57632	1321	3280
57633	1324	3283
57634	1327	3285
57635	1327	3286
57636	1325	3284
57637	1327	3288
57638	1327	3289
57639	1327	3287
57640	2481	810
57641	2495	820
57642	2561	823
57643	2545	866
57644	2507	834
57645	2550	870
57646	2543	864
57647	2525	848
57648	2505	832
57649	2514	841
57650	2498	826
57651	2557	874
57652	2552	871
57653	2547	868
57654	2556	873
57655	2558	875
57656	2544	865
57657	2542	863
57658	2478	807
57659	2546	867
57660	2554	872
57661	2549	869
57662	2559	877
57663	2513	840
57664	2553	817
57665	2532	855
57666	2531	854
57667	2535	857
57668	2529	852
57669	2533	856
57670	2528	851
57671	2541	861
57672	2537	859
57673	2536	858
57674	2530	853
57675	2527	850
57676	2539	860
57677	1401	1235
57678	2475	1420
57679	2421	1421
57680	3388	1153
57681	1842	1489
57682	1820	1528
57683	2034	1559
57684	3329	1149
57685	1840	1477
57686	1469	1496
57687	1816	1517
57688	1691	1531
57689	3332	1150
57690	2337	498
57691	2459	878
57692	2467	879
57693	1630	880
57694	2301	882
57695	1401	911
57696	1630	881
57697	3608	2824
57698	1368	2827
57699	3611	2829
57700	3551	2832
57701	3552	2833
57702	3400	1236
57703	1810	1545
57704	2035	1561
57705	3400	1237
57706	1810	1544
57707	2034	1560
57708	3408	1238
57709	3445	1619
57710	3386	1621
57711	3122	1290
57712	3138	1294
57713	3140	1300
57714	2303	1586
57715	3335	1301
57716	3327	1424
57717	3337	1304
57718	3146	1308
57719	2383	886
57720	2389	887
57721	2381	888
57722	2376	889
57723	1895	890
57724	2377	891
57725	2708	2016
57726	2604	2025
57727	2853	2572
57728	2851	2573
57729	2881	2575
57730	2856	2577
57731	2848	2576
57732	2857	2578
57733	2818	2581
57734	1742	2680
57735	2858	2579
57736	2859	2580
57737	2862	2582
57738	2774	2586
57739	2821	2590
57740	2830	2594
57741	2834	2595
57742	2817	2588
57743	2835	2596
57744	2825	2593
57745	2763	2589
57746	2814	2587
57747	2824	2592
57748	2823	2591
57749	3141	1427
57750	1362	2826
57751	3613	2830
57752	3549	2834
57753	3609	2899
57754	1267	1314
57755	1471	1501
57756	1393	1506
57757	1373	1512
57758	1267	1426
57759	1430	1429
57760	1429	2302
57761	1430	1435
57762	1430	1436
57763	1430	1437
57764	1547	1439
57765	1547	1440
57766	1750	1473
57767	1619	1493
57768	1373	1511
57769	1377	1513
57770	1377	1514
57771	1263	2305
57772	1816	1518
57773	1691	1532
57774	1817	1522
57775	1754	1534
57776	1863	1542
57777	1755	1536
57778	1907	1537
57779	1921	1538
57780	2062	1543
57781	1811	1546
57782	2299	1551
57783	2416	1562
57784	2416	1563
57785	2047	1565
57786	2048	1567
57787	2048	1568
57788	2597	1576
57789	2602	1578
57790	2602	1580
57791	2294	1582
57792	2303	1585
57793	2446	1598
57794	3347	1623
57795	2437	1822
57796	2241	1976
57797	2294	1583
57798	2446	1599
57799	2437	1823
57800	2442	1589
57801	2442	1590
57802	2442	1592
57803	2449	1595
57804	1929	1606
57805	2449	1596
57806	1929	1607
57807	1312	1601
57808	1848	1610
57809	2448	1602
57810	2605	1605
57811	1766	1625
57812	2633	1877
57813	2724	1879
57814	2722	1882
57815	2723	1890
57816	2737	1892
57817	2752	1895
57818	2751	1898
57819	2755	1901
57820	2758	1903
57821	2754	1905
57822	2756	1907
57823	2757	1913
57824	2757	1914
57825	2719	1875
57826	2725	1909
57827	2725	1910
57828	2633	1878
57829	2724	1880
57830	2723	1891
57831	2754	1906
57832	2756	1908
57833	1027	1947
57834	2836	2288
57835	1484	1959
57836	1660	1960
57837	1681	1961
57838	1712	1963
57839	1713	1962
57840	1785	1964
57841	1744	1965
57842	1852	1966
57843	1881	1967
57844	1884	1968
57845	1890	1969
57846	1952	1971
57847	2160	1972
57848	2064	1973
57849	1413	1980
57850	1875	1982
57851	1714	1981
57852	1860	1983
57853	1873	1984
57854	1879	1985
57855	1942	1986
57856	1946	1987
57857	1906	1988
57858	1984	1993
57859	1991	1994
57860	2021	1995
57861	2022	1996
57862	1290	2000
57863	1290	2001
57864	1940	2004
57865	1732	2005
57866	1737	2006
57867	1891	2009
57868	1956	2010
57869	2189	2011
57870	1896	1970
57871	1950	1992
57872	1922	1998
57873	1896	2003
57874	2707	2014
57875	2706	2015
57876	2473	2023
57877	2589	2024
57878	2720	2026
57879	2721	2027
57880	2734	2028
57881	2241	1974
57882	1940	1990
57883	1940	1991
57884	1290	2002
57885	1737	2007
57886	1737	2008
57887	1289	2029
57888	1718	2030
57889	1728	2031
57890	1812	2032
57891	2462	1997
57892	2709	2012
57893	2705	2013
57894	2710	2017
57895	2703	2018
57896	2701	2019
57897	2702	2020
57898	2267	2021
57899	2454	2022
57900	1668	2070
57901	1440	2154
57902	2809	2684
57903	2606	2155
57904	2854	2685
57905	2410	2156
57906	2852	2686
57907	1847	2157
57908	2808	2687
57909	2626	2209
57910	2759	2217
57911	3176	2336
57912	3178	2338
57913	3177	2337
57914	3179	2339
57915	3181	2341
57916	3180	2340
57917	3182	2342
57918	3183	2343
57919	3185	2345
57920	3184	2344
57921	3186	2346
57922	3187	2347
57923	3188	2348
57924	3189	2349
57925	3190	2350
57926	3191	2351
57927	3192	2352
57928	3196	2356
57929	3194	2354
57930	3195	2355
57931	3193	2353
57932	3197	2357
57933	3198	2358
57934	3199	2359
57935	3200	2360
57936	3201	2361
57937	3203	2363
57938	3202	2362
57939	3204	2364
57940	3206	2366
57941	3205	2365
57942	3207	2367
57943	3208	2368
57944	3210	2370
57945	3209	2369
57946	3211	2371
57947	3213	2373
57948	3212	2372
57949	3214	2374
57950	3215	2375
57951	3216	2376
57952	3217	2377
57953	3218	2378
57954	3219	2379
57955	3220	2380
57956	3221	2381
57957	3222	2382
57958	3223	2383
57959	3224	2384
57960	3225	2385
57961	3226	2386
57962	3228	2388
57963	3227	2387
57964	3229	2389
57965	3230	2390
57966	3231	2391
57967	3232	2392
57968	3234	2394
57969	3233	2393
57970	3235	2395
57971	3236	2396
57972	3237	2397
57973	3239	2399
57974	3238	2398
57975	3030	2466
57976	3027	2465
57977	3581	2759
57978	3566	2842
57979	3567	2843
57980	3568	2844
57981	3563	2845
57982	3565	2847
57983	3564	2846
57984	3491	2951
57985	3491	2950
57986	3540	2952
57987	3593	2953
57988	3580	3434
57989	3044	3801
57990	3045	3802
57991	3046	3803
57992	2899	2452
57993	2761	2455
57994	2654	2469
57995	2793	2486
57996	1949	2483
57997	2837	2477
57998	2908	2472
57999	2773	2480
58000	2638	2491
58001	2676	2494
58002	2663	2497
58003	2700	2500
58004	2827	2503
58005	2575	2506
58006	2331	2509
58007	2275	2512
58008	2730	2515
58009	2726	2518
58010	2593	2521
58011	2729	2524
58012	2220	2636
58013	2870	2639
58014	2313	2642
58015	2671	2645
58016	2374	2648
58017	2659	2651
58018	2616	2655
58019	2644	2658
58020	2578	2661
58021	2789	2664
58022	2583	2667
58023	2088	2670
58024	2592	2673
58025	1685	2676
58026	2906	2689
58027	2908	2688
58028	2375	2690
58029	2659	2691
58030	2660	2692
58031	1264	2306
58032	1265	2307
58033	1266	2308
58034	1260	2309
58035	1261	2310
58036	1557	2400
58037	1558	2401
58038	1571	2403
58039	1574	2406
58040	1577	2410
58041	1593	2426
58042	1594	2427
58043	1596	2428
58044	1599	2431
58045	1608	2437
58046	1610	2439
58047	1607	2436
58048	1611	2440
58049	1600	2432
58050	1609	2438
58051	1612	2441
58052	1570	2402
58053	1578	2408
58054	1576	2411
58055	1578	2421
58056	1578	2422
58057	1578	2423
58058	1604	2424
58059	1613	2442
58060	1572	2404
58061	1598	2430
58062	1602	2434
58063	1573	2407
58064	1582	2409
58065	1592	2415
58066	1586	2412
58067	1585	2413
58068	1588	2416
58069	3175	2420
58070	1597	2429
58071	1601	2433
58072	1603	2435
58073	3497	2468
58074	3026	2464
58075	3025	2463
58076	3496	2467
58077	2889	2563
58078	2890	2564
58079	2891	2565
58080	2873	2566
58081	2874	2567
58082	2882	2568
58083	2879	2570
58084	2875	2571
58085	2878	2583
58086	2869	2585
58087	2849	2584
58088	2798	2624
58089	2799	2625
58090	2801	2626
58091	2804	2627
58092	2807	2629
58093	2806	2628
58094	2807	2630
58095	2820	2631
58096	2829	2633
58097	2822	2632
58098	2832	2635
58099	2792	2569
58100	2805	2574
58101	2655	2598
58102	2468	2597
58103	2588	2599
58104	2599	2601
58105	2609	2602
58106	2613	2604
58107	2620	2606
58108	2572	2608
58109	2892	2612
58110	2631	2610
58111	2635	2611
58112	2896	2613
58113	2900	2614
58114	2901	2615
58115	2203	2616
58116	2229	2617
58117	2265	2618
58118	2120	2619
58119	2171	2620
58120	2190	2621
58121	2198	2623
58122	2191	2622
58123	2732	2528
58124	2733	2530
58125	2646	2532
58126	2647	2534
58127	2802	2536
58128	2803	2538
58129	2844	2540
58130	2845	2542
58131	2639	2544
58132	2640	2545
58133	2641	2546
58134	2642	2547
58135	2643	2549
58136	2735	2551
58137	2736	2552
58138	2656	2554
58139	2657	2556
58140	2596	2558
58141	2650	2560
58142	2651	2561
58143	1686	2679
58144	3600	2752
58145	1069	2754
58146	1040	2756
58147	3603	2758
58148	3260	2887
58149	3258	2888
58150	3259	2889
58151	3260	2893
58152	3259	2895
58153	3258	2894
58154	3557	2890
58155	3555	2891
58156	3556	2892
58157	3557	2896
58158	3555	2897
58159	3556	2898
58160	2563	3448
58161	1894	3527
58162	1897	3528
58163	1898	3529
58164	1899	3530
58165	1900	3531
58166	1901	3532
58167	1902	3533
58168	1903	3534
58169	1904	3535
58170	1905	3536
58171	1908	3537
58172	1912	3538
58173	1913	3539
58174	1702	3540
58175	1704	3541
58176	1749	3543
58177	1821	3544
58178	1824	3546
58179	1822	3545
58180	1825	3547
58181	1828	3549
58182	1826	3548
58183	1831	3551
58184	1830	3550
58185	1833	3552
58186	1856	3554
58187	1855	3553
58188	1864	3555
58189	1865	3556
58190	1930	3557
58191	1934	3558
58192	1943	3559
58193	1944	3560
58194	2012	3561
58195	2013	3562
58196	2023	3564
58197	2014	3563
58198	2029	3565
58199	2032	3566
58200	2033	3567
58201	2037	3568
58202	2040	3569
58203	2041	3570
58204	2042	3571
58205	2112	3573
58206	2043	3572
58207	2128	3574
58208	2268	3576
58209	2129	3575
58210	2269	3577
58211	2270	3578
58212	2271	3579
58213	2273	3581
58214	2272	3580
58215	2274	3582
58216	2300	3583
58217	2378	3584
58218	2384	3586
58219	2379	3585
58220	2386	3588
58221	2385	3587
58222	2387	3589
58223	2388	3590
58224	2390	3591
58225	2392	3593
58226	2391	3592
58227	2393	3594
58228	2406	3595
58229	2407	3596
58230	2409	3597
58231	2415	3598
58232	2420	3599
58233	2426	3600
58234	2562	3602
58235	2445	3601
58236	2564	3603
58237	2566	3605
58238	2565	3604
58239	2568	3607
58240	2567	3606
58241	2570	3609
58242	2569	3608
58243	2571	3610
58244	2573	3611
58245	2574	3612
58246	2576	3613
58247	2587	3615
58248	2579	3614
58249	2623	3617
58250	2600	3616
58251	2624	3618
58252	2625	3619
58253	2627	3620
58254	2629	3622
58255	2628	3621
58256	2667	3623
58257	2669	3624
58258	2673	3625
58259	2678	3627
58260	2674	3626
58261	2679	3628
58262	2681	3630
58263	2680	3629
58264	2682	3631
58265	2683	3632
58266	2686	3635
58267	2684	3633
58268	2685	3634
58269	2688	3636
58270	2689	3637
58271	2692	3639
58272	2690	3638
58273	2693	3640
58274	2695	3642
58275	2694	3641
58276	2697	3644
58277	2696	3643
58278	2698	3645
58279	2713	3646
58280	2714	3647
58281	2716	3648
58282	2762	3649
58283	2764	3650
58284	2765	3651
58285	2766	3652
58286	2767	3653
58287	2768	3654
58288	2769	3655
58289	2770	3656
58290	2771	3657
58291	2779	3659
58292	2772	3658
58293	2780	3660
58294	2781	3661
58295	2782	3662
58296	2783	3663
58297	2784	3664
58298	2787	3665
58299	2791	3666
58300	2794	3667
58301	2864	3668
58302	2865	3669
58303	2866	3670
58304	2871	3671
58305	2872	3672
58306	2876	3673
58307	2877	3674
58308	2880	3675
58309	2883	3676
58310	2888	3678
58311	2884	3677
58312	2893	3679
58313	2743	2907
58314	1733	2151
58315	1461	2152
58316	1589	2164
58317	1638	2165
58318	1767	2168
58319	1761	2171
58320	1768	2172
58321	1773	2173
58322	1779	2174
58323	1769	2176
58324	1772	2177
58325	1543	2405
58326	3261	2908
58327	2841	2918
58328	2841	2917
58329	3319	3161
58330	3548	3303
58331	1289	3400
58332	1289	3399
58333	1354	3401
58334	1354	3402
58335	1728	3405
58336	1718	3403
58337	1718	3404
58338	2336	3408
58339	1728	3406
58340	2336	3407
58341	1812	3409
58342	2709	3410
58343	2474	3412
58344	2705	3411
58345	2703	3414
58346	2710	3413
58347	2704	3415
58348	2702	3417
58349	2702	3416
58350	2702	3418
58351	3546	3425
58352	2870	3438
58353	2870	3439
58354	1438	3440
58355	1495	3441
58356	3242	3443
58357	3245	3445
58358	3243	3444
58359	3247	3446
58360	2342	3680
58361	1305	3681
58362	3326	3902
58363	1349	2134
58364	2116	2135
58365	1329	2138
58366	1272	2139
58367	1183	2140
58368	1184	2142
58369	1185	2143
58370	1186	2144
58371	1187	2145
58372	1283	2146
58373	1345	2147
58374	1364	2148
58375	1527	2149
58376	2747	2902
58377	3135	2937
58378	1098	3451
58379	1156	3452
58380	1215	3455
58381	1258	3526
58382	1381	3682
58383	1382	3683
58384	1391	3684
58385	1467	3685
58386	1544	3686
58387	1620	3687
58388	3409	3688
58389	3418	3689
58390	3425	3690
58391	3426	3691
58392	3433	3692
58393	3435	3693
58394	3438	3694
58395	3439	3695
58396	1621	3696
58397	1628	3697
58398	1706	3698
58399	1841	3700
58400	1836	3699
58401	2060	3701
58402	2095	3702
58403	2281	3704
58404	2278	3703
58405	2282	3705
58406	2283	3706
58407	2285	3708
58408	2284	3707
58409	2286	3709
58410	2304	3710
58411	2396	3712
58412	2395	3711
58413	2417	3713
58414	2419	3714
58415	2428	3716
58416	2427	3715
58417	2438	3717
58418	2443	3718
58419	2447	3719
58420	2450	3720
58421	2585	3721
58422	2598	3723
58423	2586	3722
58424	2632	3724
58425	2664	3725
58426	2687	3726
58427	2712	3727
58428	2741	3729
58429	2740	3728
58430	2744	3731
58431	2742	3730
58432	2746	3733
58433	2745	3732
58434	2748	3734
58435	2749	3735
58436	2775	3736
58437	2785	3738
58438	2776	3737
58439	2786	3739
58440	2796	3741
58441	2795	3740
58442	2861	3742
58443	2885	3743
58444	2887	3745
58445	2886	3744
58446	3034	3746
58447	3035	3747
58448	3038	3748
58449	3040	3749
58450	3050	3751
58451	3049	3750
58452	3062	3752
58453	3063	3753
58454	3064	3754
58455	3065	3755
58456	3085	3757
58457	3066	3756
58458	3088	3758
58459	3089	3759
58460	3091	3760
58461	3093	3761
58462	3097	3762
58463	3101	3764
58464	3100	3763
58465	3103	3765
58466	3104	3766
58467	3106	3767
58468	3108	3768
58469	3109	3769
58470	3110	3770
58471	3112	3772
58472	3111	3771
58473	3116	3773
58474	3117	3774
58475	3118	3775
58476	3120	3776
58477	3123	3777
58478	3129	3778
58479	3132	3779
58480	3133	3780
58481	3134	3781
58482	3147	3782
58483	3142	3784
58484	3139	3783
58485	3328	3785
58486	1739	3786
58487	1758	3787
58488	2030	3788
58489	2124	3789
58490	2461	3790
58491	2471	3791
58492	2833	3793
58493	2668	3792
58494	2860	3795
58495	2850	3794
58496	2909	3796
58497	2910	3797
58498	2967	3799
58499	2911	3798
58500	2968	3800
58501	2078	3826
58502	2078	3827
58503	2097	3828
58504	2182	3829
58505	2813	3832
58506	2819	3833
58507	2846	3834
58508	2897	3835
58509	1528	3857
58510	3166	3811
58511	3167	3812
58512	3163	3819
58513	3164	3820
58514	3165	3821
58515	3168	3823
58516	3157	3813
58517	3158	3814
58518	3159	3815
58519	3160	3816
58520	3161	3817
58521	3162	3818
58522	2411	3830
58523	2607	3831
58524	3492	3351
58525	3493	3353
58526	3542	3419
58527	3543	3420
58528	3545	3422
58529	3544	3421
58530	3583	2930
58531	3583	2931
58532	3583	2932
58533	3583	2933
58534	3583	2984
58535	3583	2985
58536	3583	2986
58537	3583	2987
58538	3583	3238
58539	3583	3239
58540	3583	3240
58541	3583	3241
58542	3583	3431
58543	3583	3430
58544	3583	3433
58545	3583	3432
58546	2855	2247
58547	1557	10000
58548	1558	10001
58549	1570	10002
58550	1571	10003
58551	1572	10004
58552	1543	10005
58553	1574	10006
58554	1573	10007
58555	10008	10008
58556	1582	10009
58557	1577	10010
58558	1576	10011
58559	1586	10012
58560	1585	10013
58561	1592	10014
58562	1592	10015
58563	1588	10016
58564	1614	10017
58565	1614	10018
58566	10019	10019
58567	10020	10020
58568	1578	10021
58569	1578	10022
58570	1578	10023
58571	10024	10024
58572	1604	10025
58573	1606	10026
58574	1593	10027
58575	1594	10028
58576	1596	10029
58577	1597	10030
58578	1598	10031
58579	1599	10032
58580	1600	10033
58581	1601	10034
58582	1602	10035
58583	10036	10036
58584	1607	10037
58585	1608	10038
58586	1609	10039
58587	1610	10040
58588	1611	10041
58589	1612	10042
58590	1613	10043
58591	1598	10044
58592	1598	10045
58593	1598	10046
58594	1598	10047
58595	10048	10048
58596	10049	10049
58597	10050	10050
58598	3547	10051
58599	3450	10052
58600	3452	10053
58601	3454	10054
58602	3456	10055
58603	3465	10056
58604	3471	10057
58605	10058	10058
58606	10059	10059
58607	10060	10060
58608	10061	10061
58609	10062	10062
58610	10063	10063
58611	1394	10064
58612	1394	10065
58613	1394	10066
58614	1394	10067
58615	1394	10068
58616	1451	10069
58617	1451	10070
58618	1451	10071
58619	1451	10072
58620	1451	10073
58621	1473	10074
58622	1473	10075
58623	1473	10076
58624	1473	10077
58625	1473	10078
58626	3469	10079
58627	3321	10080
58628	3322	10081
58629	3323	10082
58630	3324	10083
58631	10084	10084
58632	10084	10085
58633	10086	10086
58634	10086	10087
58635	10088	10088
58636	10088	10089
58637	1414	10090
58638	1437	10091
58639	1455	10092
58640	1462	10093
58641	1463	10094
58642	1482	10095
58643	3510	10096
58644	3510	10097
58645	3511	10098
58646	3518	10099
58647	3512	10100
58648	3517	10101
58649	3514	10102
58650	3513	10103
58651	3516	10104
58652	3515	10105
58653	3168	10106
58654	3169	10107
58655	3170	10108
58656	3465	10109
58657	10110	10110
58658	3475	10111
58659	10112	10112
58660	10112	10113
58661	10114	10114
58662	10114	10115
58663	10116	10116
58664	10116	10117
58665	1561	10118
58666	1399	10119
58667	1466	10120
58668	1436	10121
58669	1517	10122
58670	3465	10123
58671	3593	10124
58672	3540	10125
58673	10126	10126
58674	3492	10127
58675	10128	10128
58676	10129	10129
58677	10130	10130
58678	10131	10131
58679	10084	10132
58680	10084	10133
58681	10086	10134
58682	10086	10135
58683	10088	10136
58684	10088	10137
58685	1414	10138
58686	1437	10139
58687	1455	10140
58688	1462	10141
58689	1463	10142
58690	10143	10143
58691	10144	10144
58692	10144	10145
58693	10146	10146
58694	10146	10147
58695	10148	10148
58696	10148	10149
58697	10150	10150
58698	10150	10151
58699	1434	10152
58700	1512	10153
58701	10154	10154
58702	3582	10155
58703	1403	10156
58704	1441	10157
58705	1494	10158
58706	1400	10159
58707	1641	10160
58708	1641	10161
58709	10162	10162
58710	1533	10163
58711	3520	10164
58712	3519	10165
58713	3522	10166
58714	3522	10167
58715	10168	10168
58716	3521	10169
58717	3525	10170
58718	3524	10171
58719	1645	10172
58720	1648	10173
58721	1624	10174
58722	1627	10175
58723	10176	10176
58724	10176	10177
58725	10178	10178
58726	10178	10179
58727	10180	10180
58728	10180	10181
58729	10182	10182
58730	10182	10183
58731	10184	10184
58732	10184	10185
58733	10186	10186
58734	10186	10187
58735	3527	10188
58736	3526	10189
58737	3591	10190
58738	10191	10191
58739	3262	10192
58740	3262	10193
58741	3263	10194
58742	3263	10195
58743	3265	10196
58744	3265	10197
58745	3267	10198
58746	3267	10199
58747	3271	10200
58748	3271	10201
58749	3272	10202
58750	3272	10203
58751	3277	10204
58752	3277	10205
58753	3312	10206
58754	3312	10207
58755	1446	10208
58756	1450	10209
58757	1501	10210
58758	1416	10211
58759	1496	10212
58760	1405	10213
58761	1412	10214
58762	1415	10215
58763	1633	10216
58764	1633	10217
58765	1634	10218
58766	1634	10219
58767	3594	10220
58768	3592	10221
58769	3590	10222
58770	3595	10223
58771	3270	10224
58772	3270	10225
58773	3273	10226
58774	3273	10227
58775	3281	10228
58776	3281	10229
58777	3282	10230
58778	3282	10231
58779	3283	10232
58780	3283	10233
58781	3285	10234
58782	3285	10235
58783	3294	10236
58784	3294	10237
58785	3310	10238
58786	3310	10239
58787	1511	10240
58788	1514	10241
58789	1519	10242
58790	1516	10243
58791	1521	10244
58792	1531	10245
58793	3264	10246
58794	3264	10247
58795	3314	10248
58796	3314	10249
58797	3315	10250
58798	3315	10251
58799	3448	10252
58800	3449	10253
58801	3451	10254
58802	3453	10255
58803	10256	10256
58804	10256	10257
58805	10258	10258
58806	10259	10259
58807	10260	10260
58808	10261	10261
58809	10261	10262
58810	10263	10263
58811	10264	10264
58812	10265	10265
58813	10266	10266
58814	10267	10267
58815	10268	10268
58816	10269	10269
58817	3458	10270
58818	3459	10271
58819	3479	10272
58820	3484	10273
58821	3483	10274
58822	3480	10275
58823	3478	10276
58824	3482	10277
58825	3481	10278
58826	3477	10279
58827	3485	10280
58828	3486	10281
58829	3490	10282
58830	3487	10283
58831	3488	10284
58832	3489	10285
58833	1394	10286
58834	10287	10287
58835	3269	10288
58836	3269	10289
58837	3275	10290
58838	3275	10291
58839	3276	10292
58840	3276	10293
58841	3278	10294
58842	3278	10295
58843	3279	10296
58844	3279	10297
58845	3280	10298
58846	3280	10299
58847	3266	10300
58848	3287	10301
58849	3312	10302
58850	3312	10303
58851	10304	10304
58852	3570	10305
58853	3571	10306
58854	3571	10307
58855	3572	10308
58856	3572	10309
58857	3577	10310
58858	10311	10311
58859	3574	10312
58860	3575	10313
58861	3576	10314
58862	3576	10315
58863	10316	10316
58864	3288	10317
58865	3289	10318
58866	3291	10319
58867	1498	10320
58868	1505	10321
58869	1500	10322
58870	1508	10323
58871	1509	10324
58872	1407	10325
58873	1409	10326
58874	1417	10327
58875	1427	10328
58876	1442	10329
58877	1447	10330
58878	1445	10331
58879	1468	10332
58880	1465	10333
58881	1476	10334
58882	1478	10335
58883	1416	10336
58884	1434	10337
58885	1463	10338
58886	1494	10339
58887	1311	10340
58888	1311	10341
58889	1246	10342
58890	1250	10343
58891	1250	10344
58892	1268	10345
58893	1268	10346
58894	1273	10347
58895	1273	10348
58896	1277	10349
58897	1350	10350
58898	1647	10351
58899	1649	10352
58900	1650	10353
58901	1654	10354
58902	1657	10355
58903	1671	10356
58904	1670	10357
58905	1672	10358
58906	1673	10359
58907	1674	10360
58908	1676	10361
58909	1658	10362
58910	1504	10363
58911	1457	10364
58912	1460	10365
58913	1433	10366
58914	1410	10367
58915	1532	10368
58916	1384	10369
58917	1356	10370
58918	1352	10371
58919	1398	10372
58920	1411	10373
58921	10374	10374
58922	10375	10375
58923	10376	10376
58924	10377	10377
58925	10377	10378
58926	10377	10379
58927	10380	10380
58928	10381	10381
58929	10382	10382
58930	10383	10383
58931	10384	10384
58932	10385	10385
58933	10386	10386
58934	10387	10387
58935	10388	10388
58936	10389	10389
58937	10390	10390
58938	10391	10391
58939	10392	10392
58940	10393	10393
58941	1390	10394
58942	1208	10395
58943	1195	10396
58944	1235	10397
58945	1248	10398
58946	10399	10399
58947	10400	10400
58948	10401	10401
58949	10402	10402
58950	10403	10403
58951	10404	10404
58952	1402	10405
58953	1402	10406
58954	1402	10407
58955	1402	10408
58956	1402	10409
58957	1327	10410
58958	1327	10411
58959	1327	10412
58960	1327	10413
58961	1327	10414
58962	1336	10415
58963	1336	10416
58964	1336	10417
58965	1336	10418
58966	1336	10419
58967	1319	10420
58968	1319	10421
58969	1319	10422
58970	1319	10423
58971	1319	10424
58972	1456	10425
58973	1479	10426
58974	1563	10427
58975	3312	10428
58976	3287	10429
58977	3290	10430
58978	3290	10431
58979	3274	10432
58980	3274	10433
58981	3309	10434
58982	3309	10435
58983	10084	10436
58984	10112	10437
58985	10438	10438
58986	3456	10439
58987	3272	10440
58988	3313	10441
58989	3313	10442
58990	3316	10443
58991	3316	10444
58992	3317	10445
58993	3317	10446
58994	3301	10447
58995	3301	10448
58996	3293	10449
58997	3295	10450
58998	3296	10451
58999	3284	10452
59000	3286	10453
59001	3308	10454
59002	3269	10455
59003	3276	10456
59004	10114	10457
59005	1313	10458
59006	1313	10459
59007	1313	10460
59008	1313	10461
59009	1313	10462
59010	1321	10463
59011	1321	10464
59012	1321	10465
59013	1321	10466
59014	1321	10467
59015	10468	10468
59016	1515	10469
59017	1515	10470
59018	1515	10471
59019	1515	10472
59020	1515	10473
59021	1406	10474
59022	1406	10475
59023	1406	10476
59024	1406	10477
59025	1406	10478
59026	10479	10479
59027	2912	10480
59028	2913	10481
59029	3263	10482
59030	1358	10483
59031	1333	10484
59032	1695	10485
59033	1695	10486
59034	1695	10487
59035	1707	10488
59036	1707	10489
59037	1707	10490
59038	3292	10491
59039	10492	10492
59040	10492	10493
59041	10494	10494
59042	10494	10495
59043	1486	10496
59044	1488	10497
59045	1489	10498
59046	1491	10499
59047	1492	10500
59048	1503	10501
59049	1510	10502
59050	1524	10503
59051	1525	10504
59052	1523	10505
59053	3580	10506
59054	3455	10507
59055	3457	10508
59056	3460	10509
59057	3461	10510
59058	3462	10511
59059	3463	10512
59060	3464	10513
59061	3467	10514
59062	3468	10515
59063	3470	10516
59064	3472	10517
59065	10518	10518
59066	1567	10519
59067	1635	10520
59068	1520	10521
59069	1529	10522
59070	1546	10523
59071	1545	10524
59072	1548	10525
59073	1564	10526
59074	1566	10527
59075	10528	10528
59076	10529	10529
59077	3326	10530
59078	10531	10531
59079	1449	10532
59080	1666	10533
59081	3308	10534
59082	3317	10535
59083	3466	10536
59084	3473	10537
59085	3474	10538
59086	3476	10539
59087	3266	10540
59088	3284	10541
59089	3286	10542
59090	3288	10543
59091	3305	10544
59092	3269	10545
59093	3269	10546
59094	3269	10547
59095	1487	10548
59096	1615	10549
59097	1623	10550
59098	1438	10551
59099	10552	10552
59100	10553	10553
59101	10554	10554
59102	10555	10555
59103	10556	10556
59104	10557	10557
59105	10558	10558
59106	10559	10559
59107	10560	10560
59108	10561	10561
59109	1319	10562
59110	1319	10563
59111	1319	10564
59112	1319	10565
59113	3173	10566
59114	3174	10567
59115	3171	10568
59116	3172	10569
59117	3308	10570
59118	3269	10571
59119	10572	10572
59120	2999	10573
59121	1568	10574
59122	1330	10575
59123	1094	10576
59124	1067	10577
59125	1475	10578
59126	1669	10579
59127	10580	10580
59128	1711	10581
59129	1506	10582
59130	1507	10583
59131	3289	10584
59132	3292	10585
59133	3295	10586
59134	3302	10587
59135	3312	10588
59136	3269	10589
59137	1715	10590
59138	1715	10591
59139	3554	10592
59140	3495	10593
59141	3553	10594
59142	10492	10595
59143	3276	10596
59144	1486	10597
59145	10598	10598
59146	10599	10599
59147	10600	10600
59148	10601	10601
59149	10602	10602
59150	10603	10603
59151	10604	10604
59152	1658	10605
59153	10606	10606
59154	10607	10607
59155	10608	10608
59156	10609	10609
59157	10610	10610
59158	10610	10611
59159	10612	10612
59160	10613	10613
59161	10613	10614
59162	10615	10615
59163	10615	10616
59164	3270	10617
59165	3273	10618
59166	1695	10619
59167	1695	10620
59168	1707	10621
59169	10622	10622
59170	10622	10623
59171	10624	10624
59172	10624	10625
59173	10626	10626
59174	10626	10627
59175	10628	10628
59176	10626	10629
59177	3291	10630
59178	3296	10631
59179	3305	10632
59180	3314	10633
59181	1319	10634
59182	1319	10635
59183	1319	10636
59184	1319	10637
59185	10638	10638
59186	10639	10639
59187	10640	10640
59188	10641	10641
59189	10642	10642
59190	10643	10643
59191	10644	10644
59192	10645	10645
59193	10646	10646
59194	10647	10647
59195	10647	10648
59196	10649	10649
59197	10650	10650
59198	10651	10651
59199	1313	10652
59200	1402	10653
59201	10654	10654
59202	10655	10655
59203	10656	10656
59204	10657	10657
59205	10658	10658
59206	10659	10659
59207	10660	10660
59208	10661	10661
59209	10662	10662
59210	10663	10663
59211	10664	10664
59212	10665	10665
59213	10665	10666
59214	10665	10667
59215	10665	10668
59216	10669	10669
59217	10669	10670
59218	10669	10671
59219	10669	10672
59220	10669	10673
59221	10674	10674
59222	10675	10675
59223	10676	10676
59224	10677	10677
59225	10678	10678
59226	10679	10679
59227	10680	10680
59228	10681	10681
59229	10682	10682
59230	10683	10683
59231	10684	10684
59232	10685	10685
59233	10686	10686
59234	10622	10687
59235	10622	10688
59236	10689	10689
59237	10610	10690
59238	10610	10691
59239	10613	10692
59240	10613	10693
59241	10615	10694
59242	10615	10695
59243	3290	10696
59244	3295	10697
59245	3262	10698
59246	3263	10699
59247	3290	10700
59248	3310	10701
59249	3312	10702
59250	1669	10703
59251	1506	10704
59252	10656	10705
59253	10660	10706
59254	10662	10707
59255	1399	10708
59256	1466	10709
59257	1436	10710
59258	1517	10711
59259	1486	10712
59260	10713	10713
59261	10713	10714
59262	10713	10715
59263	10716	10716
59264	10716	10717
59265	10716	10718
59266	10719	10719
59267	10720	10720
59268	10721	10721
59269	10722	10722
59270	10723	10723
59271	10724	10724
59272	10725	10725
59273	10726	10726
59274	10726	10727
59275	10728	10728
59276	10729	10729
59277	10730	10730
59278	10731	10731
59279	10732	10732
59280	10733	10733
59281	10734	10734
59282	10735	10735
59283	10736	10736
59284	10737	10737
59285	10738	10738
59286	10739	10739
59287	1406	10740
59288	1406	10741
59289	10742	10742
59290	10742	10743
59291	10742	10744
59292	10742	10745
59293	10746	10746
59294	10746	10747
59295	10746	10748
59296	10746	10749
59297	10746	10750
59298	10751	10751
59299	10751	10752
59300	10753	10753
59301	10753	10754
59302	10755	10755
59303	10755	10756
59304	10757	10757
59305	10757	10758
59306	10757	10759
59307	10757	10760
59308	10761	10761
59309	10762	10762
59310	10763	10763
59311	10763	10764
59312	10765	10765
59313	10766	10766
59314	10767	10767
59315	10768	10768
59316	10769	10769
59317	10770	10770
59318	10771	10771
59319	10772	10772
59320	10773	10773
59321	10773	10774
59322	10775	10775
59323	10776	10776
59324	10777	10777
59325	10777	10778
59326	10779	10779
59327	10780	10780
59328	10781	10781
59329	10782	10782
59330	10783	10783
59331	10783	10784
59332	10785	10785
59333	10786	10786
59334	10787	10787
59335	10788	10788
59336	10789	10789
59337	10790	10790
59338	10657	10791
59339	10659	10792
59340	10661	10793
59341	10794	10794
59342	10795	10795
59343	10796	10796
59344	10797	10797
59345	10798	10798
59346	10799	10799
59347	10800	10800
59348	1451	10801
59349	1451	10802
59350	10803	10803
59351	10804	10804
59352	10805	10805
59353	10806	10806
59354	10807	10807
59355	10808	10808
59356	10809	10809
59357	10808	10810
59358	10811	10811
59359	10812	10812
59360	10813	10813
59361	10814	10814
59362	10814	10815
59363	10816	10816
59364	10816	10817
59365	10818	10818
59366	10818	10819
59367	10820	10820
59368	10820	10821
59369	10822	10822
59370	10823	10823
59371	10824	10824
59372	10825	10825
59373	10826	10826
59374	10827	10827
59375	10828	10828
59376	10829	10829
59377	10830	10830
59378	10831	10831
59379	10832	10832
59380	10833	10833
59381	10834	10834
59382	10835	10835
59383	10836	10836
59384	10837	10837
59385	10838	10838
59386	10839	10839
59387	10840	10840
59388	10841	10841
59389	10842	10842
59390	10843	10843
59391	10844	10844
59392	10845	10845
59393	10846	10846
59394	10847	10847
59395	10847	10848
59396	10849	10849
59397	10849	10850
59398	10851	10851
59399	10851	10852
59400	10853	10853
59401	10854	10854
59402	10855	10855
59403	10856	10856
59404	10857	10857
59405	10858	10858
59406	10859	10859
59407	10860	10860
59408	10861	10861
59409	10862	10862
59410	10863	10863
59411	10864	10864
59412	10865	10865
59413	10866	10866
59414	10780	10867
59415	10781	10868
59416	10126	10869
59417	10126	10870
59418	10126	10871
59419	10126	10872
59420	10873	10873
59421	10873	10874
59422	10873	10875
59423	10873	10876
59424	10873	10877
59425	10873	10878
59426	10879	10879
59427	10879	10880
59428	10881	10881
59429	10881	10882
59430	10881	10883
59431	10881	10884
59432	10885	10885
59433	10885	10886
59434	10885	10887
59435	10885	10888
59436	10889	10889
59437	10890	10890
59438	1530	10891
59439	1530	10892
59440	1530	10893
59441	10894	10894
59442	10894	10895
59443	10894	10896
59444	10894	10897
59445	10898	10898
59446	10898	10899
59447	10898	10900
59448	10901	10901
59449	10901	10902
59450	10903	10903
59451	10903	10904
59452	10903	10905
59453	10906	10906
59454	10906	10907
59455	10906	10908
59456	10909	10909
59457	10910	10910
59458	10910	10911
59459	10912	10912
59460	10913	10913
59461	10914	10914
59462	10915	10915
59463	10916	10916
59464	10917	10917
59465	10918	10918
59466	10918	10919
59467	10918	10920
59468	10918	10921
59469	10918	10922
59470	10923	10923
59471	10924	10924
59472	10757	10925
59473	10757	10926
59474	10757	10927
59475	10928	10928
59476	10928	10929
59477	10928	10930
59478	10928	10931
59479	10932	10932
59480	10932	10933
59481	10932	10934
59482	1746	10935
59483	1705	10936
59484	1726	10937
59485	1725	10938
59486	1723	10939
59487	1703	10940
59488	1679	10941
59489	1481	10942
59490	1656	10943
59491	3297	10944
59492	3298	10945
59493	3299	10946
59494	3300	10947
59495	3303	10948
59496	3304	10949
59497	3306	10950
59498	3307	10951
59499	3311	10952
59500	3492	10953
59501	3492	10954
59502	3493	10955
59503	3493	10956
59504	10957	10957
59505	10958	10958
59506	10959	10959
59507	10960	10960
59508	10960	10961
59509	10960	10962
59510	10963	10963
59511	10963	10964
59512	10963	10965
59513	10966	10966
59514	10966	10967
59515	10966	10968
59516	10969	10969
59517	10381	10970
59518	10381	10971
59519	10972	10972
59520	10972	10973
59521	10974	10974
59522	10974	10975
59523	10974	10976
59524	10977	10977
59525	10977	10978
59526	10979	10979
59527	10980	10980
59528	10981	10981
59529	10982	10982
59530	10983	10983
59531	10984	10984
59532	10985	10985
59533	10986	10986
59534	10987	10987
59535	10988	10988
59536	10989	10989
59537	10990	10990
59538	10991	10991
59539	10992	10992
59540	10993	10993
59541	10994	10994
59542	10995	10995
59543	10996	10996
59544	10997	10997
59545	10998	10998
59546	10999	10999
59547	11000	11000
59548	11001	11001
59549	11002	11002
59550	11003	11003
59551	11004	11004
59552	11005	11005
59553	11006	11006
59554	11007	11007
59555	11008	11008
59556	11009	11009
59557	11010	11010
59558	11010	11011
59559	11012	11012
59560	11012	11013
59561	11014	11014
59562	11014	11015
59563	11016	11016
59564	11016	11017
59565	11018	11018
59566	11018	11019
59567	11018	11020
59568	10380	11021
59569	10380	11022
59570	11023	11023
59571	11024	11024
59572	11025	11025
59573	11026	11026
59574	10751	11027
59575	10753	11028
59576	10755	11029
59577	10768	11030
59578	10773	11031
59579	11032	11032
59580	11033	11033
59581	11034	11034
59582	11035	11035
59583	11036	11036
59584	11037	11037
59585	11038	11038
59586	11039	11039
59587	11040	11040
59588	11041	11041
59589	11042	11042
59590	11042	11043
59591	11044	11044
59592	11045	11045
59593	11046	11046
59594	10377	11047
59595	10377	11048
59596	10377	11049
59597	10380	11050
59598	10381	11051
59599	11052	11052
59600	11053	11053
59601	11054	11054
59602	11055	11055
59603	11056	11056
59604	11057	11057
59605	11058	11058
59606	11059	11059
59607	11060	11060
59608	11061	11061
59609	11062	11062
59610	11063	11063
59611	3604	11064
59612	3605	11065
59613	3548	11066
59614	11067	11067
59615	11067	11068
59616	11069	11069
59617	11069	11070
59618	3381	11071
59619	3383	11072
59620	3382	11073
59621	11074	11074
59622	11075	11075
59623	11076	11076
59624	11077	11077
59625	11078	11078
59626	3550	11079
59627	11080	11080
59628	3549	11081
59629	11082	11082
59630	11083	11083
59631	3384	11084
59632	11085	11085
59633	11086	11086
59634	11087	11087
59635	3612	11088
59636	3611	11089
59637	3613	11090
59638	3610	11091
59639	3606	11092
59640	11093	11093
59641	3586	11094
59642	3587	11095
59643	3588	11096
59644	3589	11097
59645	3578	11098
59646	3579	11099
59647	3257	11100
59648	3256	11101
59649	3255	11102
59650	3254	11103
59651	3253	11104
59652	3252	11105
59653	11106	11106
59654	11107	11107
59655	11108	11108
59656	11109	11109
59657	11110	11110
59658	11111	11111
59659	11112	11112
59660	11113	11113
59661	11114	11114
59662	11115	11115
59663	11116	11116
59664	11117	11117
59665	11118	11118
59666	11119	11119
59667	11120	11120
59668	11121	11121
59669	11122	11122
59670	11123	11123
59671	11124	11124
59672	11125	11125
59673	11126	11126
59674	11127	11127
59675	11128	11128
59676	11129	11129
59677	11130	11130
59678	11131	11131
59679	11132	11132
59680	11133	11133
59681	11134	11134
59682	11135	11135
59683	11136	11136
59684	11137	11137
59685	11138	11138
59686	11139	11139
59687	11140	11140
59688	11141	11141
59689	11142	11142
59690	11143	11143
59691	11144	11144
59692	11145	11145
59693	11146	11146
59694	11147	11147
59695	11148	11148
59696	11149	11149
59697	11150	11150
59698	11151	11151
59699	11152	11152
59700	11153	11153
59701	11154	11154
59702	11155	11155
59703	11156	11156
59704	11157	11157
59705	11158	11158
59706	11159	11159
59707	11160	11160
59708	11161	11161
59709	11162	11162
59710	11163	11163
59711	11164	11164
59712	11165	11165
59713	11166	11166
59714	11167	11167
59715	11168	11168
59716	11169	11169
59717	11170	11170
59718	11171	11171
59719	11172	11172
59720	11173	11173
59721	11174	11174
59722	11175	11175
59723	11176	11176
59724	11177	11177
59725	11178	11178
59726	11179	11179
59727	11180	11180
59728	11181	11181
59729	11182	11182
59730	11183	11183
59731	11184	11184
59732	11185	11185
59733	11186	11186
59734	11187	11187
59735	11188	11188
59736	11189	11189
59737	11190	11190
59738	11191	11191
59739	11192	11192
59740	11193	11193
59741	11194	11194
59742	11195	11195
59743	1775	11196
59744	1775	11197
59745	11198	11198
59746	11198	11199
59747	11200	11200
59748	11200	11201
59749	11207	11207
59750	11207	11208
59751	11207	11209
59752	11210	11210
59753	11211	11211
59754	3493	11212
59755	11018	11213
59756	3493	11214
59757	3493	11215
59758	3493	11216
59759	3493	11217
59760	11018	11218
59761	11018	11219
59762	11220	11220
59763	11221	11221
59764	11222	11222
59765	11223	11223
59766	11224	11224
59767	11225	11225
59768	11226	11226
59769	11018	11227
59770	11228	11228
59771	11228	11229
59772	11230	11230
59773	11231	11231
59774	11232	11232
59775	11233	11233
59776	11234	11234
59777	11234	11235
59778	11236	11236
59779	11237	11237
59780	11238	11238
59781	11239	11239
59782	11240	11240
59783	11241	11241
59784	11242	11242
59785	11243	11243
59786	11244	11244
59787	11245	11245
59788	11246	11246
59789	11247	11247
59790	11248	11248
59791	11249	11249
59792	11250	11250
59793	11251	11251
\.


--
-- Data for Name: blocks; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.blocks (bl_id, name, age, ulceration, thickness, mitoses, p_stage, prim, subtype, slides, slides_left, fixation, storage, scan_number, icd10, diagnosis, notes, micro, gross, clinical, date_added, old_body_site, collection, path_note, ip_dx, body_site_id, patient, project_id, department, path_number, specimen, patient_id, project, patient_ip_id, import_source) FROM stdin;
1002	00-001103	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	00-1103	\N	SYNAT1	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1003	00-001103B7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	00-1103	B7	SYNAT1	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1023	01-003845	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	01-3845	\N	SYNAT2	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1353	09-80101A-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT3	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1037	02-000540	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	02-540	\N	SYNAT4	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1040	02-5203B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	02-5203	B2	SYNAT5	2010-2017	\N	AirTable blocks_with_IP_info.csv
1041	02-5203G2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	02-5203	G2	SYNAT5	2010-2017	\N	AirTable blocks_with_IP_info.csv
1046	02-008514	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	02-8514	\N	SYNAT6	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1050	02-012396A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	02-12396	A	SYNAT7	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1055	02-020334-11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT8	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1058	02-20629	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of spindled melanocytes with pigmented cytoplasms, surrounded by melanophages.  Collagen bundles are thickened.  The melanocytes extend deeply throughout the reticular dermis and in bulbous fashion into the superficial subcutis.  In one area, an eccrine unit is completely enveloped by the melanocytic proliferation.	Cylindrical skin segment, 0.7 cm in diameter and 0.5 cm in thickness,\ntrisected and totally submitted.	RECURRENT BLUE NEVUS	\N	\N	\N	This lesion shows many features observed in so-called deep penetrating nevus, with deep extension abutting upon the superficial subcutis in one focus.  There are subtle changes of superficial scar in the superficial dermis, which I deduce from the submitted clinical information must stem from a prior biopsy from this site.  If you would like us to retrieve and review the prior specimen, please let us know additional information about its location.	CELLULAR BLUE NEVUS WITH SPINDLED CELLS AND SCLEROSIS	173613	\N	\N	\N	02-20629	\N	SYNAT9	Dysplastic Nevi	IP325354	AirTable blocks_with_IP_info.csv
1062	02-23636A-02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT10	2010-2017	\N	AirTable blocks_with_IP_info.csv
1066	02-33818A-03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT11	2010-2017	\N	AirTable blocks_with_IP_info.csv
1069	03-197B2	77	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	707.9	\N	\N	Sections show squamous mucosa and salivary gland epithelium, with a sharply circumscribed zone of ulceration and infiltrates of neutrophils.	Two outside slides labeled S02-4228 A1 and A2.	\N	\N	\N	\N	There is no evidence of carcinoma.  The is no clue as to the cause of the ulcer in these sections.  At the time that I evaluated these sections, we had not yet received any clinical information, other than that on the report from Forensic Medical Group.  Please contact us  if your clinical impression does not fit well with our diagnosis.	ULCERATION AND REACTIVE CHANGES	100065	\N	\N	\N	03-197	B2	SYNAT12	2010-2017	IP358509	AirTable blocks_with_IP_info.csv
1070	03-1978B3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	03-1978	B3	SYNAT13	2010-2017	\N	AirTable blocks_with_IP_info.csv
1074	03-007239	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	03-7239	\N	SYNAT14	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1187	05-29484F	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22981	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	\N	\N	\N	05-29484	F	SYNAT15	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1112	04-003736A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	04-3736	A	SYNAT16	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1117	04-9498	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a propensity for nests to surround adnexal structures or vessels.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and pleomorphic nuclei.  They are associated with many melanophages.	Ellipse measuring 1.5 x 1.0 x 1.3 cm, margins inked blue, serially sectioned and entirely submitted with five sections in one cassette.	A) R/O MM, B) ATYPICAL PIGMENTED LESION	\N	\N	\N	Deep penetrating nevus is either a form of blue nevus or closely related to it.  Its name derives from the tendency of its cells to extend into the subcutaneous fat along the paths of adnexa, especially hair follicles. The excision appears to be complete.	DEEP PENETRATING NEVUS	173539	\N	\N	\N	04-9498	\N	SYNAT17	Dysplastic Nevi	IP425897	AirTable blocks_with_IP_info.csv
1144	04-37400	18	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes with abundant vacuolated cytoplasm, which extends deeply in the reticular dermis as nests and fascicles.  There are also a few large junctional nests.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are many interspersed melanophages.	Ellipse measuring 1.3 x 0.8 x 0.7 cm, including 0.7 x 0.6 cm central dark pigmented area, margins inked blue, serially sectioned and entirely submitted with five sections in one cassette.	ATYPICAL NEVUS	\N	\N	\N	None	DEEP PENETRATING NEVUS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOCYTIC NEVUS)	173620	\N	\N	\N	04-37400	\N	SYNAT18	Dysplastic Nevi	IP453803	AirTable blocks_with_IP_info.csv
1157	05-006815	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	05-6815	\N	SYNAT19	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1158	05-7439A12	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	Sections show a proliferation of basosquamoid keratinocytes arrayed in an interanastomosing pattern, with strikingly thickened rete. There are many incorporated squamous eddies as well as focal spongiosis and a sparse infiltrate.	One outside slide, CT05-19314 (05-4297).	4 X 4 WARTY KERATOSIS, R/O INFLAMED BCC	\N	\N	\N	\N	IRRITATED SEBORRHEIC KERATOSIS	300335	\N	\N	\N	05-7439	A12	SYNAT20	2010-2017	IP484151	AirTable blocks_with_IP_info.csv
1159	05-011507	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	05-11507	\N	SYNAT21	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1165	05-015408	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	05-15408	\N	SYNAT22	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1186	05-29484E	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22980	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	\N	\N	\N	05-29484	E	SYNAT15	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
10732	DPN46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1891	\N	\N	\N	\N	SYNX488	\N	\N	Consolidated_data_final.csv
1182	05-29484A	26	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22976	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	\N	\N	\N	05-29484	A	SYNAT15	Melanoma Epigenetics	IP504172	AirTable blocks_with_IP_info.csv
1183	05-29484B	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22977	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	\N	\N	\N	05-29484	B	SYNAT15	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1184	05-29484C	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22978	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	\N	\N	\N	05-29484	C	SYNAT15	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1185	05-29484D	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22979	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	\N	\N	\N	05-29484	D	SYNAT15	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1190	05-41924	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	05-41924	\N	SYNAT23	2010-2017	\N	AirTable blocks_with_IP_info.csv
1213	06-11147 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	999	\N	\N	None	\N	MD-103	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1230	06-018998	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	06-18998	\N	SYNAT24	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1322	08-51220	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a proliferation of small melanocytes with ovoid nuclei, arrayed as nests and syncytia in a domed configuration in the dermis. There is diminishment in melanocyte size with descent in the dermis, and some deep melanocytes are positioned around vascular and adnexal structures. There is an incidental associated sparse perifollicular lymphohistiocytic infiltrate.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted.	4 MM SKIN-COLORED PAPULE INCREASING IN SIZE; IDN, COMPOUND NEVUS	\N	\N	\N	None	INTRADERMAL MELANOCYTIC NEVUS (MIESCHER'S NEVUS)	173313	\N	\N	\N	08-51220	\N	SYNAT25	2010-2017	IP759861	AirTable blocks_with_IP_info.csv
1323	08-51221	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	08-51221	\N	SYNAT26	2010-2017	\N	AirTable blocks_with_IP_info.csv
1247	06-47079A02	60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of melanocytes with lightly pigmented cytoplasm situated as large round nests and singly along the dermo-epidermal junction.  The melanocytes have relatively monomorphous nuclei.	Ellipse, 0.8 x 0.5 x 0.3 cm, including a central dark brown 0.5 x 0.4 cm pigmented spot.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.	HISTORY OF MELANOMA, DARKENING LESION	\N	\N	\N	The neoplasm extends to within 1 mm. of the edge of the specimen. There are no worrisome features, however.	JUNCTIONAL MELANOCYTIC NEVUS	173792	\N	\N	\N	06-47079	A02	SYNAT27	2010-2017	IP586773	AirTable blocks_with_IP_info.csv
1324	08-51222	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis. There is little diminishment in melanocyte size with descent in the dermis. The nodule is composed of coalescing nests and fascicles that do not mature with descent. Many cells are evident in mitosis. There is a flanking lymphohistiocytic infiltrate and diffuse surface ulceration.	One outside slide, S08-9388.	UCSF MELANOMA CLINIC PATIENT	\N	\N	\N	This specimen shows an extensively ulcerated nodular melanoma with invasion limited to the papillary dermis (Clark's level III). I do not see any evidence of associated regression, vascular invasion, or neurotropism in the present sections. There is a great deal of fragmentation, and thus my thickness measurement can only be listed as an approximation.	MELANOMA OF APPROXIMATELY 1.5 MM IN THICKNESS	173619	\N	\N	\N	08-51222	\N	SYNAT28	2010-2017	IP759863	AirTable blocks_with_IP_info.csv
1259	07-1210F6	82	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.4	\N	\N	There are large angulated nests of basaloid cells in inflamed fibrotic stroma within the dermis, focally separated from that stroma by clefts. Peripheral palisading is focally evident.	One outside slide, 7-6.	DEBULKING LAYER AT TIME OF MOHS' SURGERY OF LESION OF DT06-74049, MORE TISSUE TO RE-DEFINE DIAGNOSIS, THIS SITS OVER TAIL OF PAROTID, BUT DID NOT EXTEND INTO THE PAROTID, I TOOK OF THE DEBULKING LAYER THEN TOOK A SECTION - THE CENTER AND DID H&E FROZEN SECTION ON IT, THE TWO OTHER ENDS CALL THE RESIDUAL TISSUE WHICH HAD BEEN FROZEN WAS PUT IN FORMALIN AND SENT TO YOU WITH THE SLIDE	\N	\N	\N	The neoplasm extends to the base of the specimen.	BASAL CELL CARCINOMA, INFILTRATIVE PATTERN	173404	\N	\N	\N	07-1210	F6	SYNAT29	2010-2017	IP614870	AirTable blocks_with_IP_info.csv
1270	07-011660-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT30	Long-Triple Negative Metastatic Melanoma	\N	AirTable blocks_with_IP_info.csv
1271	07-012236B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	07-12236	B1	SYNAT31	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1272	07-13061	27	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22975	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and the superficialmost dermis. There are single melanocytes and nests arrayed along the sides and bases of rete, and some of these cells have vacuolated and pigmented cytoplasm and assume an epithelioid configuration. The papillary dermis is expanded by slight fibroplasia and a sparse patchy lymphohistiocytic infiltrate.	Ellipse, 0.9 x 0.5 x 0.8 cm, including a central brown 0.7 x 0.4 cm area.  With margins inked blue, the specimen is serially trisected perpendicular to the long axis and entirely submitted.	DYSPLASTIC NEVUS, R/O MM	\N	\N	\N	This report was reissued on April 7, 2011, to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173527	\N	\N	\N	07-13061	\N	SYNAT32	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1274	07-20501	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	07-20501	\N	SYNAT33	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1282	07-41091A	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22987	172.3	\N	\N	Sections show inflammation and granulation tissue, with no evidence of an atypical melanocytic proliferation.	Oriented ellipse, 3.5 x 1.5 x 0.7 cm, including a central 1.0 x 1.0 cm defect per MD.  With the orienting sutured tip placed to the left and designated suture @ superior by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with four sections each in cassettes A and B, tips returned to container.\n	R/O MM	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA	102304	\N	\N	\N	07-41091	A	SYNAT34	Melanoma Epigenetics	IP659911	AirTable blocks_with_IP_info.csv
1283	07-41091B	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22988	172.3	\N	\N	Sections show inflammation and granulation tissue, with no evidence of an atypical melanocytic proliferation.	Oriented ellipse, 3.5 x 1.5 x 0.7 cm, including a central 1.0 x 1.0 cm defect per MD.  With the orienting sutured tip placed to the left and designated suture @ superior by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with four sections each in cassettes A and B, tips returned to container.\n	R/O MM	\N	\N	\N	None	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA	102304	\N	\N	\N	07-41091	B	SYNAT34	Melanoma Epigenetics	IP659911	AirTable blocks_with_IP_info.csv
1325	08-51223	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of large atypical melanocytes in large nodules with zones of necrosis. There are atypical mitotic figures. There are surrounding areas with second population of smaller, hyperpigmented melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Seventeen outside slides, S08-2691:A1, A2, A3, and three corresponding blocks.	REFERRAL FOR CGH	\N	\N	\N	Comparative genomic hybridization performed on DNA extracted from the specimen revealed several chromosomal aberrations that are frequently seen in melanoma: loss of the short arm of chromosome 1, gain of the short arm of chromosome 6, and loss of the long arm of chromosome 6. These findings confirm the diagnosis above.	MELANOMA, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS OF THE CONGENITAL TYPE	174523	\N	\N	\N	08-51223	\N	SYNAT35	2010-2017	IP692531	AirTable blocks_with_IP_info.csv
1295	08-1463A2	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a proliferation of spindled and stellate cells, with intervening thickened collagen bundles and thin-walled vascular spaces.	Skin segment measuring 0.3 x 0.2 x 0.1 cm, bisected and entirely submitted.	3 MM FLESH SHINY PAP; FIBROUS PAP; R/O BCC	\N	\N	\N	\N	ANGIOFIBROMA, ALSO KNOWN AS FIBROUS PAPULE	102370	\N	\N	\N	08-1463	A2	SYNAT36	2010-2017	IP475429	AirTable blocks_with_IP_info.csv
1299	08-4205A	43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show irregular epidermal hyperplasia with fibrosing granulation tissue, but no evidence of an atypical melanocytic proliferation.	Ellipse, 2.2 x 0.8 x 0.2 cm, including a central tan brown 0.7 x 0.6 cm irregular bordered lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	ATYPICAL NEVUS (DT07-78376)	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF A RESIDUAL MELANOCYTIC NEOPLASM	102734	\N	\N	\N	08-4205	A	SYNAT37	2010-2017	IP700910	AirTable blocks_with_IP_info.csv
1300	08-4544A03	91	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	709.09	\N	\N	There are elongated, rounded rete ridges and hyperpigmentation of the basal layer of the epidermis, and there is solar elastosis within the subjacent dermis. There are many melanophages clustered in the papillary dermis in part of the lesion.	Ellipse,1.6 x 0.8 x 0.3 cm, including a central 0.9 x 0.4 cm dark pigment.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	R/O MM/LK/REGRESSION	\N	\N	\N	\N	SOLAR LENTIGO	173404	\N	\N	\N	08-4544	A03	SYNAT38	2010-2017	IP424543	AirTable blocks_with_IP_info.csv
1306	08-018003	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	08-18003	\N	SYNAT39	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1309	08-21965C	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a central stellate zone of extensive post-surgical fibrosis with an associated lymphohistiocytic and granulomatous infiltrate (including scattered siderophages), spanning the reticular dermis and extending into subjacent subcutis and skeletal muscle. Within this stellate area, there is a background of coarse fibroplasia that probably is strictly post-surgical in nature, but there are also clusters of smaller spindled and stellate cells enmeshed in a myxoid background in storiform fashion. There are also deep areas in which small spindled cells and a fibrous matrix extend into underlying skeletal muscle. Superficially in the skeletal muscle, a giant cell reaction is appreciable.	Four outside slides and accompanying blocks, J08-1072 A-D (M0-257-#1).	SPINDLE CELL CA	\N	\N	\N	A limited immunoperoxidase assessment (with no associated fee) utilizing CD34 was completed. The CD34 stain shows avid labeling of many normal dendritic cells within the dermis and subcutis but does not show CD34 immunopositivity within or in proximity to the zone of post-surgical scarring. I interpret the CD34 immunostaining as lending support to the conclusion that there is no residual sarcoma at this site.	EXTENSIVE POST-SURGICAL FIBROPLASIA, WITH NO CLEAR EVIDENCE OF RESIDUAL SARCOMA	173301	\N	\N	\N	08-21965	C	SYNAT40	2010-2017	IP730606	AirTable blocks_with_IP_info.csv
1314	08-43265	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	08-43265	\N	SYNAT41	2010-2017	\N	AirTable blocks_with_IP_info.csv
1315	08-43266	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show marked solar elastosis, club-shaped rete ridges with basilar hyperpigmentation, and an area in which there are increased numbers of melanocytes both singly and in small nests, mainly in the basal layer of the epidermis. The lesional melanocytes have abundant, pale cytoplasm.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted.	LENTIGO VS. MM IN SITU	\N	\N	\N	The melanocytic proliferation extends to the peripheral edge of the specimen. Its differential diagnosis includes both evolving melanoma in situ and the junctional component of a so-called Miescher's nevus (the wedge shaped nevus found in facial skin, the surface of which can simulate melanoma in situ). This was not clarified by levels.	JUNCTIONAL PROLIFERATION OF MELANOCYTES AND A SOLAR LENTIGO	173307	\N	\N	\N	08-43266	\N	SYNAT42	2010-2017	IP751907	AirTable blocks_with_IP_info.csv
1316	08-43267	39	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a mostly endophytic, lobular proliferation of keratinocytes with pallid cytoplasms and small, monomorphous nuclei. There are patchy infiltrates of lymphocytes.	Skin segment measuring 0.3 x 0.3 x 0.1 cm.	R/O BCC	\N	\N	\N	There is no evidence of carcinoma in level sections.	TRICHILEMMOMA	173305	\N	\N	\N	08-43267	\N	SYNAT43	2010-2017	IP751908	AirTable blocks_with_IP_info.csv
1317	08-43268	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	08-43268	\N	SYNAT44	2010-2017	\N	AirTable blocks_with_IP_info.csv
1328	08-65412A	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22973	216.6	\N	\N	Sections show relatively circumscribed proliferation of spindled and stellate cells in the dermis, arrayed amongst thickened collagen bundles. Peripherally and deeply, some collagen bundles are markedly thickened (colloquially, collagen balls). There is also focal reticular dermal sclerosis. The superjacent epidermis is slightly acanthotic with basal pigmentation.	Ellipse measuring 1.6 x 0.7 x 0.5 cm, serially sectioned perpendicular to the long axis and entirely submitted with six sections in cassette A.	A-B) DERMATOFIBROMAS	\N	\N	\N	\N	DERMATOFIBROMA, EXCISED IN PLANES OF SECTION EXAMINED	173602	\N	\N	\N	08-65412	A	SYNAT45	Melanoma Epigenetics	IP504172	AirTable blocks_with_IP_info.csv
1329	08-65412B	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22974	216.7	\N	\N	Sections show a nodular proliferation of spindled and stellate cells arrayed amongst thickened collagen bundles in the reticular dermis, set beneath an epidermis that is acanthotic with broad, flattened rete.	Ellipse measuring 1.3 x 0.6 x 0.7 cm, serially quadrisected perpendicular to the long axis and entirely submitted in cassette B.\n	A-B) DERMATOFIBROMAS	\N	\N	\N	\N	DERMATOFIBROMA, EXCISED IN PLANES OF SECTION EXAMINED	173702	\N	\N	\N	08-65412	B	SYNAT45	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1334	09-1121	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	09-1121	\N	SYNAT46	2010-2017	\N	AirTable blocks_with_IP_info.csv
1335	09-005840	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	09-5840	\N	SYNAT47	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1337	09-008704	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	09-8704	\N	SYNAT48	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1340	09-015020-2A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT49	Long-Triple Negative Metastatic Melanoma	\N	AirTable blocks_with_IP_info.csv
1345	09-22513A	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23271,23272	172.5	\N	\N	There is a well circumscribed, slightly asymmetric compound proliferation of melanocytes that abuts a focally thinned epidermis, and is partially encompassed by epithelial collarettes. There are confluent aggregations of cells with large, vesicular nuclei and central, prominent nucleoli. Some cells have abundant amphophilic cytoplasm, but in many areas of the lesion, cytoplasm is scant and nuclei appear to overlap. Little maturation with descent is evident. The accompanying Ki-67 stained slide shows that there is a moderately elevated (roughly 5%) proliferation rate even in the lower part of the lesion.	Thirteen outside slides, 069-322-0920-0, D09-2956, DJ9005911:1 (Including five unstained slides).	SECOND OPINION, DIFFERENCE OF OPINION OUTLINED IN COVER LETTER, SPITZ'S NEVUS VS. MELANOMA	\N	\N	\N	The neoplasm extends to within a millimeter or so of the peripheral margin. This is a difficult case in which expert dermatopathologists could have differences of opinions. For me, findings against a Spitz's nevus include a thinned rather than thickened epidermis, the presence of epithelial collarettes, and at least in the bulbous portion of the lesion that extends to the deep reticular dermis, very little maturation. The cells are not classic Spitz cells, lacking sufficient amounts of cytoplasm, and their cytoplasm is pale and vacuolated. This having been said, my instinct is that this is not a conventional melanoma, either. It has the silhouette more typically seen in spitzoid melanomas in children and adolescent patients. This patient is obviously older than that age group, but the lesion may be similar. Among such lesions, sentinel lymph nodes are often involved, but distant metastases are rare. Hence, I would be reluctant to tell this patient that their prognosis is that of a 2.3 mm, level IV melanoma. If you or the treating clinician would like us to, we can perform additional testing (analysis for a b-raf mutation, which would not be present in a Spitz's nevus or in a spitzoid melanoma of childhood type, and either fluorescence in situ hybridization or comparative genomic hybridization). I would be happy to discuss these options with you.	MELANOMA, 2.3 MM IN THICKNESS	173508	\N	\N	\N	09-22513	A	SYNAT50	2010-2017	IP823276	AirTable blocks_with_IP_info.csv
1349	09-36483	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22972	216.6	\N	\N	Sections show a melanocytic proliferation composed of nests of melanocytes along the junction, with clusters of similar cells in the subjacent dermis.  Many neoplastic cells have pigmented cytoplasm.	Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted.	H/O MELANOMA, IRREGULARLY SHAPED MACULE; R/O MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, WITH MANY HYPERPIGMENTED MELANOCYTES	173688	\N	\N	\N	09-36483	\N	SYNAT51	California Cancer Registry	IP757083	AirTable blocks_with_IP_info.csv
1357	10-143	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	10-143	\N	SYNAT52	2010-2017	\N	AirTable blocks_with_IP_info.csv
1359	10-972A9	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of small melanocytes with round to oval nuclei, the junctional component of which consists of nested and solitary melanocytes arrayed along the sides and bases of elongated rete.  There are similar melanocytes within the underlying papillary and reticular dermis, with melanocytes splayed amongst collagen bundles, largely in the upper half of the reticular dermis.	Cylindrical skin segment, 0.8 cm in diameter and 0.3 cm in thickness, trisected and entirely submitted in cassette A.	A-B) R/O DN	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173504	\N	\N	\N	10-972	A9	SYNAT53	Long-Triple Negative Metastatic Melanoma	IP895542	AirTable blocks_with_IP_info.csv
1360	10-972A17	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of small melanocytes with round to oval nuclei, the junctional component of which consists of nested and solitary melanocytes arrayed along the sides and bases of elongated rete.  There are similar melanocytes within the underlying papillary and reticular dermis, with melanocytes splayed amongst collagen bundles, largely in the upper half of the reticular dermis.	Cylindrical skin segment, 0.8 cm in diameter and 0.3 cm in thickness, trisected and entirely submitted in cassette A.	A-B) R/O DN	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173504	\N	\N	\N	10-972	A17	SYNAT53	Long-Triple Negative Metastatic Melanoma	IP895542	AirTable blocks_with_IP_info.csv
1361	10-972C2	54	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of small melanocytes with round to oval nuclei, the junctional component of which consists of nested and solitary melanocytes arrayed along the sides and bases of elongated rete.  There are similar melanocytes within the underlying papillary and reticular dermis, with melanocytes splayed amongst collagen bundles, largely in the upper half of the reticular dermis.	Cylindrical skin segment, 0.8 cm in diameter and 0.3 cm in thickness, trisected and entirely submitted in cassette A.	A-B) R/O DN	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173504	\N	\N	\N	10-972	C2	SYNAT53	Long-Triple Negative Metastatic Melanoma	IP895542	AirTable blocks_with_IP_info.csv
1362	10-1843A4	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles.	One outside slide, M10-38.	NEVUS, R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	529699	\N	\N	\N	10-1843	A4	SYNAT54	2010-2017	IP896413	AirTable blocks_with_IP_info.csv
1363	10-1843A5	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles.	One outside slide, M10-38.	NEVUS, R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	529699	\N	\N	\N	10-1843	A5	SYNAT54	Long-Triple Negative Metastatic Melanoma	IP896413	AirTable blocks_with_IP_info.csv
1364	10-4769A	61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23273	238.2	\N	\N	Sections show superficial shave specimen with digitate epidermal hyperplasia with collections of large, atypical, acantholytic keratinocytes in the lower epidermis confined largely to the interadnexal epidermis, with overlying parakeratosis and focal parakeratosis with serum and neutrophils.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted.	0.6 CM PEARLY PAPULE	\N	\N	\N	The atypical acantholytic keratinocytes extend to the base of the specimen and squamous cell carcinoma cannot be ruled out.  Deeper biopsy or additional treatment measures are recommended.	ACANTHOTIC SOLAR KERATOSIS WITH ACANTHOLYSIS, TRANSECTED AT THE DEEP BIOPSY MARGIN	193399	\N	\N	\N	10-4769	A	SYNAT55	2010-2017	IP852443	AirTable blocks_with_IP_info.csv
1365	10-006275	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	10-6275	\N	SYNAT56	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1366	10-7937B2	82	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	232.6	\N	\N	Sections show irregular epidermal hyperplasia with inflamed granulation tissue, but no evidence of an atypical melanocytic proliferation.	Oriented ellipse, 4.0 x 2.2 x 0.8 cm, including a central 1.7 x 1.4 cm lesion area.  With the orienting sutured tip placed to the left and designated suture at medial tip by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with two sections in cassette B1, one section each in cassettes B2 through B5 and two sections in cassette B6, tips returned to container.\n	A) BCC PER DT09-80352:A, B) MIS PER DT09-80352:B	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA IN SITU	106677	\N	\N	\N	10-7937	B2	SYNAT57	2010-2017	IP164592	AirTable blocks_with_IP_info.csv
1367	10-008371A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	10-8371	A1	SYNAT58	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1368	10-8439A4	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer.	Skin segment measuring 0.4 x 0.3 x 0.1 cm.	ATYPICAL NEVUS	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	187724	\N	\N	\N	10-8439	A4	SYNAT59	2010-2017	IP903012	AirTable blocks_with_IP_info.csv
1372	10-11930B12	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.3	\N	\N	Sections show both rounded and angulated aggregations of atypical, peripherally palisaded basaloid cells in the dermis alongside fibromyxoid stroma. Clefts between the epithelium and stroma of the neoplasm are present.  Centrally there is a cystic space.  There is an associated lymphocytic infiltrate.	One outside slide, Q15927. One corresponding block received 3-4-10.	ADNEXAL VS. DILATED PORE	\N	\N	\N	Centrally this carcinoma shows a dilated cystic space.  Multiple level sections were examined and the carcinoma is visualized on the additional sections.  The initial section are non-diagnostic.	NODULAR/INFILTRATIVE BASAL CELL CARCINOMA	173305	\N	\N	\N	10-11930	B12	SYNAT60	2010-2017	IP906503	AirTable blocks_with_IP_info.csv
1387	10-26316A2	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	709.09	\N	\N	Sections show skin with bulbous rete ridges, basilar hyperpigmentation, some large nuclei among keratinocytes in the lower half of the epidermis, and maturation of the epidermis through a granular layer.  The dermis contains elastotic fibers.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, serially sectioned and entirely submitted with five sections.	1 CM BROWN IRREGULAR NEVUS	\N	\N	\N	Large cell acanthoma is a variant of solar lentigo in which keratinocytes have abnormally enlarged nuclei, especially in the lower half of the epidermis. Despite the resemblance to solar keratosis or Bowen's disease that some lesions show, large cell acanthoma is not associated with squamous cell carcinoma.	LARGE CELL ACANTHOMA	173620	\N	\N	\N	10-26316	A2	SYNAT62	2010-2017	IP666578	AirTable blocks_with_IP_info.csv
1395	10-42241	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mac Millain	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	10-42241	\N	SYNAT63	2010-2017	\N	AirTable blocks_with_IP_info.csv
1397	10-44069A4	38	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show central fibrosing granulation tissue and early scar with an associated lymphohistiocytic infiltrate, stemming from past biopsy/surgery, and no residual melanocytic lesion is in evidence.	Ellipse, 1.7 x 0.7 x 0.5 cm, including a central 0.5 x 0.4 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections, tips retained.	SEE PREVIOUS: DT10-34472	\N	\N	\N	\N	POST-BIOPSY SCARRING, WITH NO RESIDUUM	173619	\N	\N	\N	10-44069	A4	SYNAT64	2010-2017	IP929046	AirTable blocks_with_IP_info.csv
1404	10-63051C	52	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show central fibrosing granulation tissue and early scar coupled with a mixed infiltrate below an ulcer, and no evidence of an atypical melanocytic proliferation remains in contiguity with this. There are inflamed parakeratosis and exudate above the ulcer base.	Oriented ellipse, 7.1 x 3.0 x 1.0 cm, including a central 2.1 x 2.0 cm lesion, and a satellite dark pigment measuring 1.0 x 0.5 cm. With the orienting superior edge pre-inked red, the near margin is inked yellow during grossing. The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with two sections in cassette A, one section each in cassettes B-K, two sections in L, and three sections in cassette M; tips in vial.	MELANOMA EXC	\N	\N	\N	None	POST-SURGICAL ULCERATION, INFLAMMATION, AND SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	139524	\N	\N	\N	10-63051	C	SYNAT65	2010-2017	IP953239	AirTable blocks_with_IP_info.csv
1448	11-21025B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	11-21025	B1	SYNAT66	2010-2017	\N	AirTable blocks_with_IP_info.csv
1464	11-032523A1	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.11	\N	\N	Sections show an epidermal proliferation of small keratinocytes arrayed as thickened or interconnecting rete in a specimen with a papillated profile. In addition, there is a band-like lymphohistiocytic infiltrate juxtaposed upon the epidermal-dermal junction, with areas of vacuolar alteration with necrotic keratinocytes.  There is also an area in the mid-dermis in which there is fibrosis along with keloidal collagen.	Skin segment measuring 0.9 x 0.4 x 0.1 cm, bisected and entirely submitted.	R/O BCC	\N	\N	\N	A scar is present in the mid-dermis, and some of the inflammation present in the dermis probably is due to the scarring reaction. I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	SEBORRHEIC KERATOSIS WITH AN ADJACENT LICHEN PLANUS-LIKE KERATOSIS	173527	\N	\N	\N	11-32523	A1	SYNAT67	2010-2017	IP939446	AirTable blocks_with_IP_info.csv
1477	11-38910A2	53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a relatively circumscribed proliferation of dendritic melanocytes and melanophages in the dermis.	Cylindrical skin segment, 0.4 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted.	INCREASING SIZE BR GREY MAC; R/O BLUE NEVUS	\N	\N	\N	\N	BLUE NEVUS	373301	\N	\N	\N	11-38910	A2	SYNAT68	2010-2017	IP1028349	AirTable blocks_with_IP_info.csv
1495	11-62022	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a domed segment of skin with nests of small, round melanocytes in the dermis.  Some melanocytes are multinucleated.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette B.	A) 2 MO AGO TINY FRECKLE, RAISED UP, IRREG COLOR, 7 MM PAPULE, EXT SUN EXPOSURE; R/O MELANOMA, B) TENDER PAPULE	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173530	\N	\N	\N	11-62022	\N	SYNAT69	2010-2017	IP948784	AirTable blocks_with_IP_info.csv
1536	12_20321A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT70	2010-2017	\N	AirTable blocks_with_IP_info.csv
1537	12_54296	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT71	2010-2017	\N	AirTable blocks_with_IP_info.csv
1549	12-4365A8	73	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show small rounded and angulate aggregations of atypical basaloid keratinocytes associated with scant inflamed stroma in the dermis, and the surface of the biopsy is ulcerated, with exudate and crust residing above it.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted.	? FIBROMA/IDN	\N	\N	\N	\N	ULCERATED INFILTRATIVE BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173313	\N	\N	\N	12-4365	A8	SYNAT72	2010-2017	IP39574	AirTable blocks_with_IP_info.csv
1550	12-4365B1	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show small rounded and angulate aggregations of atypical basaloid keratinocytes associated with scant inflamed stroma in the dermis, and the surface of the biopsy is ulcerated, with exudate and crust residing above it.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted.	? FIBROMA/IDN	\N	\N	\N	None	ULCERATED INFILTRATIVE BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173313	\N	\N	\N	12-4365	B1	SYNAT72	Long-Triple Negative Metastatic Melanoma	IP39574	AirTable blocks_with_IP_info.csv
1551	12-4365C1	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show small rounded and angulate aggregations of atypical basaloid keratinocytes associated with scant inflamed stroma in the dermis, and the surface of the biopsy is ulcerated, with exudate and crust residing above it.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted.	? FIBROMA/IDN	\N	\N	\N	None	ULCERATED INFILTRATIVE BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173313	\N	\N	\N	12-4365	C1	SYNAT72	Long-Triple Negative Metastatic Melanoma	IP39574	AirTable blocks_with_IP_info.csv
1552	12-4365C2	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show small rounded and angulate aggregations of atypical basaloid keratinocytes associated with scant inflamed stroma in the dermis, and the surface of the biopsy is ulcerated, with exudate and crust residing above it.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted.	? FIBROMA/IDN	\N	\N	\N	None	ULCERATED INFILTRATIVE BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173313	\N	\N	\N	12-4365	C2	SYNAT72	Long-Triple Negative Metastatic Melanoma	IP39574	AirTable blocks_with_IP_info.csv
1553	12-004374B	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show acral skin with melanocytes singly and in large nests at the dermo-epidermal junction, and within the subjacent superficial dermis.  The dermal component matures with descent.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted.	4 MM PIGMENTED PAPULE THAT HAS INCREASED IN SIZE IN THE LAST 2 YEARS; NEVUS, R/O CHANGE	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	273766	\N	\N	\N	12-4374	B	SYNAT73	Long-Triple Negative Metastatic Melanoma	IP222047	AirTable blocks_with_IP_info.csv
1562	12-7093NG176-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT74	2010-2017	\N	AirTable blocks_with_IP_info.csv
1579	12-15765B3	78	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a proliferation of melanocytes along the dermo-epidermal junction, with small nests and horizontally oriented single cells disposed mostly at the sides and bases of elongated rete ridges above an altered papillary dermis. Many of the melanocytes have large, hyperchromatic nuclei and scant cytoplasm. The bases of some adjacent rete ridges are fused, with subjacent fibroplasia.	Skin segment measuring 1.2 x 1.1 x 0.1 cm, serially sectioned and entirely submitted with five sections.	1 CM HYPERPIGMENTED PATCH; R/O ATYPIA	\N	\N	\N	The neoplasm diminishes in cellularity toward, but extends to the periphery of the specimen. Given the degree of non-spitzoid cytologic atypia, I would consider a narrow re-excision of this site.	JUNCTIONAL MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE	333504	\N	\N	\N	12-15765	B3	SYNAT75	2010-2017	IP1101581	AirTable blocks_with_IP_info.csv
1583	12-18826	75	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a proliferation of melanocytes arrayed as single cells in lentiginous fashion along the sides and bases of pigmented rete. The dermis deep to this shows elastosis and considerable fibrosis. Scattered perijunctional lymphocytes and melanophages are also apparent.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette A.	A-B) HISTORY OF MELANOMA, 3 X 3 MM BR PAPULES	\N	\N	\N	SOX-10 immunostaining and level sections demonstrate a small lesion with only a slight increase in melanocytes at the junction, and this configuration points to interpretation as a lentigo.	LENTIGO SIMPLEX, APPARENTLY EXCISED IN THE AVAILABLE PLANES OF SECTION	333433	\N	\N	\N	12-18826	\N	SYNAT76	2010-2017	IP535712	AirTable blocks_with_IP_info.csv
1584	12-19018B	61	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show an apparently circumscribed, multinodular proliferation of epithelial cells, many of which are polygonal and have abundant pallid eosinophilic cytoplasms.  Ductular differentiation is apparent.	Oriented elliptical excision, 2.0 x 1.3 x 0.8 cm, including a central 1.0 x 1.0 cm pink tan and raised area.  With the orienting suture designated 12:00, posterior tip by the surgeon, the 12:00-6:00 margin is inked blue and the 6:00-12:00 margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12:00 to 6:00 tips and entirely submitted with five sections each in cassette A and B.\n	DOME-SHAPED PINK-TAN NODULE WITH POSITIVE DIMPLE SIGN; DERMATOFIBROMA VS. HYPERTROPHIC SCAR, PLEASE CHECK MARGINS	\N	\N	\N	None	CLEAR CELL HIDRADENOMA	101544	\N	\N	\N	12-19018	B	SYNAT77	2010-2017	IP1104835	AirTable blocks_with_IP_info.csv
1589	12-21933I	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26324	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	12-21933	I	SYNAT78	Melanoma Evolution	\N	AirTable blocks_with_IP_info.csv
1595	12-22582C	16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Melanocytic Nevus	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. Clusters of similar melanocytes are present in the dermis. There are melanophages in the dermis.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, submitted intact in cassette C.	A) NEOP VS. ATYP POLYP NEVUS, B) NEOP VS. ATYP NEVUS, C) 0.2 X 0.3 CM; NEOP VS. DYSPL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	107787	\N	\N	\N	12-22582	C	SYNAT79	Melanocytic Nevus	IP1108400	AirTable blocks_with_IP_info.csv
1603	12-22720A1	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Leiomyoma	\N	Sections show a fascicled dermal proliferation of spindled cells with blunt-ended nuclei and eosinophilic cytoplasm situated in the superficial reticular dermis.  Mitotic figures are inconspicuous.	Ellipse, 1.8 x 0.7 x 0.8 cm, including 0.5 x 0.4 cm central raised area. With the peripheral and deep margins inked blue, the specimen is serially sectioned left to right perpendicular to the long axis and entirely submitted with four sections in cassette A1, three sections in cassette A2.	A) 0.6 X 0.6 CM IRREGULARLY PIGMENTED PAPULE; R/O MALIGNANCY MELANOMA VS. LEIOMYOMA VS. NEVUS, B) 0.5 CM X 0.8 CM PAINFUL ERYTHEMATOUS PLAQUE; R/O LEIOMYOMA	\N	Upper back	\N	\N	LEIOMYOMA, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	174533	\N	\N	\N	12-22720	A1	SYNAT80	2010-2017	IP118827	AirTable blocks_with_IP_info.csv
1605	12-22776B5	36	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.9	Acral melanoma	\N	Sections show a biopsy site on acral skin with an adjacent, broad proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells extending broadly into the dermis. There is a dense lichenoid lymphocytic infiltrate. In some areas melanocytes are present in pagetoid array within the epidermis.	Oriented skin excision with curled and twisted appearance, 3.2 x 2.6 x 0.5 cm, including a nearly central 2.3 x 1.6 cm gray-brown area. With the orienting suture at one end placed to the left and designated proximal edge by the surgeon, the far margin is inked blue and the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from proximal to distal and entirely submitted with three sections each in cassettes B1 and B2, two sections each in cassettes B3 through B5, and three sections in cassette B6.	A-B) 172.7: TELEPHONE 3-2384 (SURGICENTER)	\N	Biopsy site w/residual Acral,Toe web	\N	We do not have a record of a prior biopsy on this site. Can you please forward a copy of the previous pathology report to our office. Histopathologic features of possible prognostic importance include:  Level: IV Vascular or lymphatic invasion: absent Dermal mitotic rate: rare mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: not detected Stage: pT2a	BIOPSY SITE WITH RESIDUAL ACRAL MELANOMA, 1.5 MM IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	666955	\N	\N	\N	12-22776	B5	SYNAT81	2010-2017	IP1096148	AirTable blocks_with_IP_info.csv
3221	Cell-Line_Xu-46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT82	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3222	Cell-Line_Xu-47	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT83	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1731	14-159A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-159	A2	SYNAT84	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3085	19111/14.1\n	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-051_1.1	\N	\N	\N	\N	right heel	\N	\N	\N	\N	\N	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1667	13-2054	5	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a dome-shaped segment of skin in which there is a compound proliferation of melanocytes, many of which have copious eosinophilic cytoplasm and large nuclei, partially obscured by a dense lymphocytic infiltrate.  Some of the melanocytes within the dermis are quite large and 1 mitotic figure among the mid-dermal melanocytes is identifiable. Dull pink globules are present within the epidermis. The melanocytes within the epidermis are generally smaller than those within the dermis.	Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted.  PL/PL	4 MM PINK PAPULE X 2 YEARS WITH OCCASIONAL BLEEDING; DISCRETE OVAL PINK PAPULE; R/O SPITZ, 4 MM PUNCH ENTIRE LESION	\N	\N	\N	Some of the lesional cells are quite large. Therefore, to further evaluate this lesion, I performed immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown). The stain shows a relatively low proliferation rate of approximately 15% among the lesional cells.  I also considered the possibility of performing comparative genomic hybridization (CGH) on this section. However, it is technically not possible to do this testing on this lesion due to the dense admixed inflammatory infiltrate, since this infiltrate would skew the results.  Therefore, coupling the findings on the routinely stained hematoxylin and eosin section with the low proliferation rate mentioned above, I favor a nevus. Nonetheless, due to the presence of these large cells, in addition to an identifiable mitotic figure within the dermis, a conservative re-excision at this site is warranted. I have also shared this case with my colleagues, Drs. Philip LeBoit and Boris Bastian, who agrees with this diagnosis and assessment.	SPITZ'S NEVUS, COMPOUND TYPE, WITH HALO REACTION, EXTENDING TO THE TISSUE EDGES	103327	\N	\N	\N	13-2054	\N	SYNAT85	2010-2017	IP1186796	AirTable blocks_with_IP_info.csv
1716	13-61266A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	13-61266	A	SYNAT86	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1675	13-006535C	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a mostly dermal proliferation of bland variably pigmented melanocytes which involves the superficial reticular and adventitial dermis. There are scattered melanophages.	Skin segment measuring 0.7 x 0.5 x 0.2 cm, bisected and entirely submitted in cassette A.   CF/CF	A-B) BROWN/PINK PAPULE; R/O CANCER	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, SUPERFICIAL CONGENITAL PATTERN, VARIABLY PIGMENTED	100444	\N	\N	\N	13-6535	C	SYNAT87	Long-Triple Negative Metastatic Melanoma	IP1191278	AirTable blocks_with_IP_info.csv
1677	13-8208B	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.51	\N	\N	The features are similar to those in (A).	Skin segment measuring 0.5 x 0.3 x 0.2 cm, submitted intact in cassette B.  RS/RS	A-B) R/O BCC	\N	\N	\N	\N	BASAL CELL CARCINOMA, SUPERFICIAL AND NODULAR PATTERNS, EXTENDING TO THE EDGE AND BASE OF THE SPECIMEN	101505	\N	\N	\N	13-8208	B	SYNAT88	2010-2017	IP1192951	AirTable blocks_with_IP_info.csv
1678	13-9682	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	13-9682	\N	SYNAT89	2010-2017	\N	AirTable blocks_with_IP_info.csv
1680	13-10776A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	13-10776	A1	SYNAT90	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1682	13-12947A2	26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show nested and solitary melanocytes scattered along the dermal-epidermal junction, and the constituent melanocytes have ample finely melanized cytoplasm. The dermis below this is diffusely fibrotic and holds a superficial lymphohistiocytic infiltrate with admixed melanophages.	Two skin segments received in one specimen bottle. The first skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. The second skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted. Both submitted in A. RS/RS	A) R/O RECURRING NEVUS, B) R/O NEVUS	\N	\N	\N	Thank you for assisting us in the retrieval of the original biopsy from this site, which has now been reviewed as our specimen DS13-16516. The prior biopsy demonstrates a compound melanocytic nevus, and by extension the population of melanocytes seen here can be interpreted as representing a persistent melanocytic nevus. There is no evidence of malignancy. Please note that the persistent lesion extends close to the edge of the biopsy in the available sections.	PERSISTENT JUNCTIONAL MELANOCYTIC NEVUS	173527	\N	\N	\N	13-12947	A2	SYNAT91	2010-2017	IP1197690	AirTable blocks_with_IP_info.csv
1717	13-62943	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	13-62943	\N	SYNAT92	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1688	13-17202A11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	13-17202	A11	SYNAT93	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1689	13-17202C4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	13-17202	C4	SYNAT93	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1690	13-18444A16	88	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	709.01	\N	\N	Sections show absence of melanocytes along the junction.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) VITILIGINOUS SKIN - DEPIGMENTED; R/O CTCL, B) NORMAL SKIN; TELEPHONE: 810-5563 (SHARLENE-DAUGHTER/LM)	\N	\N	\N	A Melan-A stain shows absence of melanocytes at the dermo-epidermal junction a finding of late stage vitiligo.  Neither biopsy shows any significant amount of inflammation.  There is no evidence of a lymphoproliferative disorder.	VITILIGO	173405	\N	\N	\N	13-18444	A16	SYNAT94	Unknown	IP1203187	AirTable blocks_with_IP_info.csv
1708	13-46194	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	13-46194	\N	SYNAT95	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1709	13-48798	82	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly and focally somewhat confluently along the junction. In the dermis and upper subcutis below this, there is a population of enlarged fusiform melanocytes with finely melanized cytoplasm coupled with a permeative lymphohistiocytic infiltrate with admixed melanophages and extensive dermal fibroplasia.	Six outside slides, DN13-21643, and one corresponding block.	HISTORY OF MELANOMA (1981), 1.5 X 3 CM LESION GREW IN 2 YEARS; MELANOMA? PRIMARY OR METASTATIC?	\N	\N	\N	Given the overall histopathologic configuration and the presence of melanoma in situ involving the epidermis and focally involving adnexa, I believe this biopsy demonstrates a primary blue nevus-like melanoma rather than metastatic melanoma. SOX-10 staining was included in our assessment and demonstrates avid labeling of the component of melanoma in situ and also demonstrates strong positive labeling of a population of atypical melanocytes in the dermis, thereby confirming that a component of invasive melanoma is present. There is also extensive partial regression in the dermis. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration. Therefore, it represents melanoma of stage pT2a (2009 AJCC Guidelines). (Since the thickness of the zone of regression extends to a thickness of 2.9 mm, one could also also make a case that AJCC stage pT3a would be appropriate.) The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	MELANOMA OF AT 1.85 MM IN THICKNESS, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173620	\N	\N	\N	13-48798	\N	SYNAT96	2010-2017	IP1290801	AirTable blocks_with_IP_info.csv
1719	13-69386B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	13-69386	B	SYNAT97	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1722	13-90988	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	13-90988	\N	SYNAT98	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1735	14-3598	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-3598	\N	SYNAT99	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1738	14-4989D3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-4989	D3	SYNAT100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1739	14-5893	82	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.52	\N	\N	Sections show a small cyst in the superficial dermis lined by squamous epithelium that forms laminated keratin via a granular layer, with fibrosis of the adjacent dermis and an infiltrate of plasma cells.	Ellipse, 1.6 x 0.6 x 0.7 cm, with a central 0.9 x 0.4 cm area of variegated color and texture. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections. RS/RS	SEE DT13-59530	\N	\N	\N	None	POST-BIOPSY SCAR, WITH NO EVIDENCE OF RESIDUAL SQUAMOUS CELL CARCINOMA	173566	\N	\N	\N	14-5893	\N	SYNAT101	Melanoma Epigenetics	IP370740	AirTable blocks_with_IP_info.csv
1743	14-13830	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-13830	\N	SYNAT102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1751	14-32353	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-32353	\N	SYNAT103	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1756	14-37911A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-37911	A	SYNAT104	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1771	14-58566	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-58566	\N	SYNAT105	2010-2017	\N	AirTable blocks_with_IP_info.csv
1758	14-40331B	76	\N	0.45	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a vertically oriented zone of inflamed, fibrosing granulation tissue, flanked by a proliferation of enlarged melanocytes distributed at irregular intervals along the dermo-epidermal junction in a broad and poorly circumscribed manner, with some small nests of similar cells in the superficial dermis. There are also a few clusters of small, round melanocytes in the superficial dermis near one of the margins. The subjacent dermis is altered by severe solar elastosis.	Ellipse, 3.1 x 1.1 x 0.8 cm, including a central 2.5 x 0.3 cm linear scar. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with six sections each in A-B. HD/HD	MALIGNANT MELANOMA RESIDUAL, CHECK MARGINS FINAL LENGTH (REFER TO DT14-36406)	\N	\N	\N	Melanoma in situ extends to one of the peripheral margins, where an incidental intradermal melanocytic nevus is also present. The neoplasm in this specimen is 0.45 mm. in thickness, less than that in the initial biopsy. The AJCC stage of pT1b remains unchanged.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, SEE NOTE RE THICKNESS	123388	\N	\N	\N	14-40331	B	SYNAT106	Melanoma Epigenetics	IP1380659	AirTable blocks_with_IP_info.csv
1761	14-44611	72	\N	\N	1	T1b	Primary	Superficial spreading	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26343,26344	172.6	\N	\N	Sections show a broad and poorly circumscribed compound proliferation of melanocytes. Within the epidermis many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Many of the lesional melanocytes contain abundant dusty melanin within their cytoplasm. There are nests, cords and strands of similar melanocytes in the dermis and the size of the melanocytes generally does not diminish with descent. In addition, there are numerous mitotic figures evident among the dermal melanocytes. The melanocytes in the dermis are present within fibrosis which overlies solar elastosis.  A surrounding lymphohistiocytic infiltrate is present as well.  There is also a domed/papillated proliferation of keratinocytes with uniform nuclei arrayed as interanastomosing rete that expand the epidermis. Small pseudocystic spaces are focally entrapped by the interconnecting rete.	Ellipse, 1.4 x 1.0 x 0.5 cm, with a central 0.8 x 0.7 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. RS/RS	8 MM TAN, BROWN, BLK IRREGULAR PAPULE, EXCISED; R/O MM	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: Procedure: Punch biopsy Microscopic tumor type: Superficial spreading Breslow thickness: 0.7 mm Ulceration: not present Margins, peripheral and deep: Intraepidermal melanoma extends to within 0.8 millimeters of the peripheral edge of the specimen. The deep margin is free. Mitotic index: > 1/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1bNxMx  Further treatment at this site is warranted.	MELANOMA, 0.7 MILLIMETERS IN THICKNESS, WITH CLOSE EXTENSION TO THE SPECIMEN PERIPHERY	173611	\N	\N	\N	14-44611	\N	SYNAT107	2010-2017	IP1394545	AirTable blocks_with_IP_info.csv
1772	14-58579	33	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26351,26352	216.6	\N	\N	Sections show skin with a compound proliferation of small round melanocytes arranged as nests at the junction, and as nests, cords and strands within the dermis beneath an epidermis that features interconnected rete ridges, horn pseudocysts and a papillated surface. Part of the dermal component surrounds adnexa or lies as strands between reticular dermal collagen bundles. The lesion has a wedge shaped base.	Ellipse measuring 1.5 x 1.0 x 0.7 cm, including a central 0.6 x 0.5 cm brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. RS/KC	R/O DYSPLASTIC NEVUS	\N	\N	\N	The excision appears complete.  There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173649	\N	\N	\N	14-58579	\N	SYNAT108	2010-2017	IP1408520	AirTable blocks_with_IP_info.csv
1767	14-53094\t	80	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26338	172.7	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of melanocytes involving the epidermis and superficial dermis. There are foci in which single melanocytes predominate along the junction, with some of them scattered above the basal layer. Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  The lesional melanocytes have moderately abundant pale cytoplasm and variably large nuclei at the dermo-epidermal junction with areas in which the dermal component contains aggregates of similar but smaller cells, and a focally dense lymphocytic infiltrate. Several mitotic figures are present in the upper part of the dermal component.	Skin segment measuring 1.5 x 1.5 x 0.2 cm, serially sectioned and entirely submitted with five sections. PL/PL	1.2 X 1.1 CM; R/O MM	\N	\N	\N	The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. While the lesion is not ulcerated, the presence of several melanocytes in mitosis in the dermis qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma. Some of the smaller melanocytes in the superficial dermis may be those of a pre-existent melanocytic nevus. Re-excision of this site is of course appropriate.	MELANOMA, 0.9 MM. IN THICKNESS	173710	\N	\N	\N	14-53094	\N	SYNAT109	Melanoma Evolution	IP1403032	AirTable blocks_with_IP_info.csv
1768	14-53375	68	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26345	172.6	\N	\N	Sections show an asymmetric proliferation of melanocytes distributed singly and as variably sized nests along the junction and within the subjacent dermis. Scattered melanocytes are also present above the basal layer. Nests of melanocytes focally extend along adnexal epithelium. Nuclear pleomorphism and hyperchromasia are noted. The dermis is elastotic.	Skin segment, 1.5 x 0.7 x 0.1 cm, trisected and entirely submitted. PL/CL	15 X 9 MM, NEW HYPERPIGMENTED PATCH WITH SUPERIOR ERYTHEMATOUS SENSITIVE-TO-TOUCH PATCH; R/O DN VS. MM VS. INFLAM AK	\N	\N	\N	With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its small invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	MELANOMA OF 0.5 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173688	\N	\N	\N	14-53375	\N	SYNAT110	2010-2017	IP1403313	AirTable blocks_with_IP_info.csv
3206	Cell-Line_Xu-31	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT112	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1773	14-58586	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26346	216.5	\N	\N	Sections show a broad-based proliferation of melanocytes involving the epidermis and mostly, the superficial dermis. There are increased single melanocytes at the dermo-epidermal junction, and some small nests of them, in part positioned at the sides and bases of elongated rete ridges. The surface is papillated, with interconnecting rete ridges that enclose horn pseudocysts. There is basilar hyperpigmentation in the affected area.  Within the dermis are nests, cords and strands of small, round melanocytes.  These cells mature with descent, and lie in part around adnexal structures.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. HD/KC	A) CONGENITAL NEVUS VS. DYSPLASTIC NEVUS. VARIEGATED BROWN PAPULE.	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	273562	\N	\N	\N	14-58586	\N	SYNAT113	2010-2017	IP1408527	AirTable blocks_with_IP_info.csv
1774	14-58667	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show acral skin with a well circumscribed proliferation of melanocytes mostly in nests at the dermo-epidermal junction, and within the subjacent superficial dermis.  The junctional melanocytes are plump, oval cells with monomorphous nuclei and the dermal component matures with descent.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. CF/KC	R/O ATYPIA	\N	\N	\N	The margins appear clear in the planes of section examined. There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS	173717	\N	\N	\N	14-58667	\N	SYNAT114	2010-2017	IP1304478	AirTable blocks_with_IP_info.csv
1782	14-62335	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a dome surfaced proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the superficial reticular dermis, in part around folliculo-sebaceous units. There are evenly distributed melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness, bisected and totally submitted. RS/RS	B'D DURING PREGNANCY; ATYPICAL NEVUS VS. MELANOMA	\N	\N	\N	I obtained a few stains to rule out a deep penetrating nevus-like melanoma. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product, a reassuring finding. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate. The term deep penetrating nevus refers to a specific melanocytic proliferation that resembles blue nevus clinically and in some histopathologic aspects, but is genomically distinct from it. The neoplasm extends to the peripheral edge of the specimen at the level of the superficial reticular dermis, very focally. There are no microscopic findings that suggest a need for re-excision, however.	DEEP PENETRATING NEVUS	173620	\N	\N	\N	14-62335	\N	SYNAT121	Dysplastic Nevi	IP1412277	AirTable blocks_with_IP_info.csv
1784	14-66686B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-66686	B	SYNAT122	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1788	14-74770	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a wedge-shaped proliferation of medium-sized oval melanocytes with monomorphic nuclei and amphophilic cytoplasm, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.	Cylindrical skin segment, 0.3 cm in diameter and 0.5 cm in thickness. Submitted intact. HD/KC	BLACK 4 MM PAPULE; NEVUS, R/O ATYPIA (TELEPHONE: 510-508-8632, OK TO MSG)	\N	\N	\N	This melanocytic nevus has mixed features of a deep penetrating nevus and a congenital pattern nevus. No evidence of melanoma or significant atypicality was detected.	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173304	\N	\N	\N	14-74770	\N	SYNAT123	Dysplastic Nevi	IP1424729	AirTable blocks_with_IP_info.csv
1790	14-80165	61	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a neoplasm composed of melanocytes, involving the superficial and deep dermis, with a propensity to aggregate around adnexal structures or vessels.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and slightly pleomorphic nuclei.  They are associated with many melanophages.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, quadrisected and entirely submitted. CF/KC	1 CM DARK PAPULE, NEW; R/O MM	\N	\N	\N	A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows that there are no melanocytes in mitosis, which is a findings that supports the diagnosis of a melanocytic nevus. Please note that this unusual nevus extends to the specimen edge and base such that it may persist if not re-excised. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this assessment.	DEEP PENETRATING NEVUS	173702	\N	\N	\N	14-80165	\N	SYNAT124	Dysplastic Nevi	IP1430130	AirTable blocks_with_IP_info.csv
1792	14-83646	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-83646	\N	SYNAT125	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1794	14-88685	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-88685	\N	SYNAT126	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1796	14-94217A	36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.8 cm in thickness, bisected and entirely submitted in A. KC/KC	A) DEEP PENETRATING NEVUS, R/O OTHER, B) NEVUS, R/O ATYPIA (TELEPHONE: 806-6123, MSG OK)	\N	\N	\N	\N	DEEP PENETRATING NEVUS	173507	\N	\N	\N	14-94217	A	SYNAT127	Dysplastic Nevi	IP1444208	AirTable blocks_with_IP_info.csv
1800	14-99831	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-99831	\N	SYNAT128	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1801	14-102015A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-102015	A	SYNAT129	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1802	14-106005	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages. There are also superficial lymphocytic infiltrates with spongiosis of the overlying epidermis and focal parakeratosis. some parafollicular .	Cylindrical skin segment, 0.3 cm in diameter and 0.5 cm in thickness. Submitted intact. RS/RS	BLUE NEVUS, R/O MELANOMA	\N	\N	\N	Deep penetrating nevus is a variant of blue nevus. The dermatitis could reflect eczematous or seborrheic dermatitis, depending on the clinical context.	DEEP PENETRATING NEVUS, WITH OVERLYING SUBACUTE SPONGIOTIC DERMATITIS	173305	\N	\N	\N	14-106005	\N	SYNAT130	Dysplastic Nevi	IP1456016	AirTable blocks_with_IP_info.csv
1803	14-113574	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a wedge-shaped neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a propensity for nests to surround adnexal structures or vessels.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and pleomorphic nuclei.  They are associated with melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.9 cm in thickness, bisected and entirely submitted. RS/RS	5 MM, NEVUS, CHANGING - GREY, DARK BROWN, R/O BLUE NEVUS / MM	\N	\N	\N	Deep penetrating nevus is either a form of blue nevus or closely related to it.  Its name derives from the tendency of its cells to extend into the subcutaneous fat along the paths of adnexa, especially hair follicles.  Alone among variants of blue nevi, it can feature an intraepidermal component, and its large, ovoid and pale cells are often found in combination with other types of melanocytes in combined nevi (Seab JA, Graham JH, Helwig EB. Deep penetrating nevus.  Am. J. Surg. Pathol. 1989; 13:39; Cooper PH. J. Cutan. Pathol. 1991;19:172-180).	DEEP PENETRATING NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	173610	\N	\N	\N	14-113574	\N	SYNAT131	Dysplastic Nevi	IP1463605	AirTable blocks_with_IP_info.csv
1807	14-118975	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	14-118975	\N	SYNAT132	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1814	15-3641	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	15-3641	\N	SYNAT133	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1823	15-6952	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show two tissue fragments that both contain a proliferation composed of fascicles of melanocytes, involving the superficial and deep dermis and adnexal structures.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and pleomorphic nuclei.  They are associated with many melanophages.	Two specimens received in one specimen bottle. One cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. One skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. RS/RS	6 MM PIGMENTED PAPULE; R/O MM, TWO PIECES (BISECTED)	\N	\N	\N	I did not find phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) positive nuclei in the lesional melanocytes, a finding that supports the benign interpretation of a deep penetrating nevus. The nevus extends to the base and edge of the specimen in the deeper tissue segment. Therefore, this nevus is likely to persist if re-excision is not performed. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis and assessment.	DEEP PENETRATING NEVUS, EXTENDING TO THE BASE AND PERIPHERAL ASPECT OF THE SPECIMEN	139522	\N	\N	\N	15-6952	\N	SYNAT134	Dysplastic Nevi	IP1477972	AirTable blocks_with_IP_info.csv
1827	15-8321	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Beneath a superficial zone of fibrosing granulation tissue is a proliferation of large oval melanocytes with monomorphous small, oval nuclei and abundant pale vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the deep reticular dermis, with a tendency of aggregations to be positioned next to adnexa or small vessels. There are clusters of melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. RS/RS	4 MM PUNCH, SEE PATH DT14-98210	\N	\N	\N	The findings in the residuum are those of a fairly prototypical deep penetrating nevus, with nuclear pleomorphism well within the range of that seen in this entity, and a scarcity of mitotic figures. The deep reticular dermal margins are involved. The term deep penetrating nevus refers to a specific melanocytic proliferation that resembles blue nevus clinically and in some histopathologic aspects, but is genomically distinct from it.	BIOPSY SITE AND SUBJACENT DEEP PENETRATING NEVUS	100388	\N	\N	\N	15-8321	\N	SYNAT135	Dysplastic Nevi	IP1448202	AirTable blocks_with_IP_info.csv
1838	15-16543B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	15-16543	B	SYNAT136	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1861	15-45455F	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	15-45455	F	SYNAT137	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3207	Cell-Line_Xu-32	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT138	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3208	Cell-Line_Xu-33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT139	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
2030	17-8769A	53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a zone of inflammation and granulation tissue, representing a prior biopsy or surgical site, with no evidence of a melanocytic proliferation.	Oriented ellipse, 2.3 x 1.1 x 0.3 cm, including a central 0.5 x 0.4 cm crusted area. With the orienting notched tip placed to the left and designated as 9 o'clock by the grosser, the 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections each in A-B. HD/HD	EXC MELANO PROLIF, DT17-6212	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF A RESIDUAL MELANOCYTIC NEOPLASM	273693	\N	\N	\N	17-8769	A	SYNAT140	Melanoma Epigenetics	IP1576568	AirTable blocks_with_IP_info.csv
3209	Cell-Line_Xu-34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT141	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
2116	17-43707	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22437	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	17-43707	\N	SYNAT142	2010-2017	\N	AirTable blocks_with_IP_info.csv
3210	Cell-Line_Xu-35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT143	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3211	Cell-Line_Xu-36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT144	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3212	Cell-Line_Xu-37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT145	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3213	Cell-Line_Xu-38	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT146	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3214	Cell-Line_Xu-39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT147	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3215	Cell-Line_Xu-40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT148	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3099	61000/00 (LN)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT149	Dysplastic Nevi	\N	AirTable blocks_with_IP_info.csv
3100	78821-1a\n	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-002_1.1	\N	\N	\N	\N	Left Hallux	\N	\N	\N	\N	\N	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2461	19-94061	87	\N	\N	0	T2a	Primary	acral melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show acral skin with a proliferation of melanocytes with large hyperchromatic nuclei and scant cytoplasm singly and in small nests along and above the dermo-epidermal junction, and in inflamed fibrotic stroma in the superficial dermis in the center of the specimen.	Ellipse, 1.3 x 0.6 x 0.4 cm, including a central 0.8 x 0.3 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with five sections. HD/HD	PREVIOUS PATH DT12-23088 (3/28/12)	\N	\N	\N	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: incisional biopsy Microscopic tumor type: acral melanoma Breslow thickness: 1.3 mm. Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear by < 2 mm. Mitotic index: 0/mm2 Microsatellitosis: to be determined following complete excision Vascular Invasion: to be determined following complete excision Perineural invasion: to be determined following complete excision Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.3 MM. IN THICKNESS	173732	\N	\N	\N	19-94061	\N	SYNAT150	Melanoma Epigenetics	IP370740	AirTable blocks_with_IP_info.csv
3216	Cell-Line_Xu-41	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT151	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3111	79447-a\n	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-007_1.1	\N	\N	\N	\N	Skin	\N	\N	\N	\N	\N	\N	\N	None	\N	AM2-007	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2637	20-81257A\n	90	t	\N	2	T3b	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29789,29790,29791,29792,29793,29794,29795,29796	172.6	\N	\N	Sections show fibrosing granulation tissue stemming from previous biopsy/surgery within a backdrop of marked solar elastosis. There is a residual array of atypical melanocytes, distributed in the lowermost epidermis and in the underlying dermis.	Oriented ellipse measuring 4.8 x 1.3 x 0.5 cm, including a central 3.9 x 1.3 cm area of variegated color/texture. The orienting short suture located at the mid-point of one edge is indicated 12 o'clock on the requisition and is placed toward 12 o'clock, and the long suture indicated 3 o'clock is placed toward the 3 o'clock. The grosser inked 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with six sections each in A-C. CF/CF	LEFT ARM WIDE EXCISION FOR MELANOMA	\N	\N	\N	Invasive and in situ melanoma extensively involve the blue inked and yellow inked peripheral margins.  As per the gross description, this would correspond to variable positivity along the approximate 11-3 o'clock and 3-7 o'clock peripheral margins. Coupling the findings in the original biopsy with the features in this re-excision specimen, the final parameters for reporting per the guidelines of the College of American Pathologists for this melanoma include the following:  Procedure: excision Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 2.5 mm. Ulceration: present Margins, peripheral: involved by invasive and melanoma in situ (see above); Margins, deep: negative for in situ and invasive melanoma Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3b pNX	RESIDUAL MELANOMA, BRESLOW THICKNESS 1.9 MM; INVASIVE AND IN SITU MELANOMA IN SITU EXTENDS TO THE INKED PERIPHERAL MARGINS; DEEP MARGINS FREE OF MELANOMA.  SEE NOTE.	173601	\N	\N	\N	20-81257	A	LMM-01	Lentigo Maligna Melanoma	IP1127057	AirTable blocks_with_IP_info.csv
3217	Cell-Line_Xu-42	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT152	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3218	Cell-Line_Xu-43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT153	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
2668	21-3841E1	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	There are nests, cords and strands of small, round melanocytes that mature with descent into the dermis.	Skin segment measuring 0.4 x 0.2 x 0.1 cm. Submitted intact in A. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. BASAL CELL CARCINOMA VS. ANGIOFIBROMA. FLESH-COLORED PAPULE. PRE OP SIZE: 0.2 CM. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. BASAL CELL CARCINOMA VS. ANGIOFIBROMA. FLESH-COLORED PAPULE. PRE OP SIZE: 0.2 CM.	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	192355	\N	\N	\N	21-3841	E1	SYNAT154	Melanoma Epigenetics	IP1199808	AirTable blocks_with_IP_info.csv
3219	Cell-Line_Xu-44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT155	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
2701	21-21314	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	B11-01	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	\N	\N	\N	21-21314	\N	SYNAT156	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2704	21-21324	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	21-21324	\N	SYNAT157	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2969	96-6536	84	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.4	\N	\N	Sections show a proliferation composed of small nodular aggregations of basaloid cells positioned between collagen bundles in the dermis.	One slide, GG96-361.	NEW GROWTH OF UNKNOWN DURATION, SLIGHTLY TENDER, 8 MM SMOOTH GRAY NODULE; CLINICAL DIAGNOSIS - BASAL CELL CARCINOMA	\N	\N	\N	In general, examples of BCC with a micronodular pattern display greater local invasiveness than neoplasms with a conventional nodular pattern.	BASAL CELL CARCINOMA, MICRONODULAR PATTERN, EXCORIATED, EXTENDING TO THE DEEP MARGIN	173416	\N	\N	\N	96-6536	\N	SYNAT158	Mucosal Melanoma	IP77652	AirTable blocks_with_IP_info.csv
3132	610186B\n	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	AM2-029_2	\N	\N	\N	\N	LN	\N	\N	\N	\N	\N	\N	\N	None	\N	AM2-029	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2813	22-80980	78	t	\N	2	T4b	Primary	High chronic sun-damage	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30858	172.4	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis which form an expansile nodule. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 2.0 x 1.5 x 0.6 cm, serially sectioned and entirely submitted with five sections plus fragments. CF/CF	BLACK TO GREY NODULE; MELANOMA VS. LESS LIKELY ATYPICAL NEVUS	\N	\N	\N	Diagnostic features of note include: Procedure: Biopsy Tumor site: Scalp Microscopic tumor type: High chronic sun-damage Breslow thickness: 6.0 mm at least Ulceration: Present Margins, peripheral and deep: Involved Mitotic index: 2/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT4b	MELANOMA, AT LEAST 6.0 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102485	\N	\N	\N	22-80980	\N	SYNAT159	Melanoma Epigenetics	IP2482899	AirTable blocks_with_IP_info.csv
2819	22-83923A	45	f	\N	\N	T2a	Primary	low cumulative sun damage (WHO)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30859,30860,30861	172.5	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have increased pale grey cytoplasm and enlarged irregular nuclei with a central nucleolus. These melanocytes are irregularly distributed along the dermal-epidermal junction as single cells and irregular, expansile nests. There are areas of confluence and pagetoid scatter. Similar melanocytes are present in the subjacent dermis. In the dermis, there is a second population of smaller melanocytes with cytologically bland nuclei (melanocytic nevus). There is a separate dermal proliferation of spindled and stellate cells arrayed amongst thickened collagen bundles in the reticular dermis (incidental dermatofibroma).	Ellipse, 3.0 x 1.4 x 0.9 cm, including a central 1.9 x 1.3 cm dark brown elevated area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis, and submitted with four sections each in A1-A2 and three sections in A3. Tips reserved. HD/HD	A) 2 X 1.5 CM IRREGULAR BLACK / BROWN / PINK PLAQUE; MELANOMA VS. SK, B) 0.8 X 0.6 CM IRREGULAR BROWN PAPULE; R/O MELANOMA	\N	\N	\N	There is also an incidental dermatofibroma captured herein. Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Tumor site: upper midline back Microscopic tumor type: low cumulative sun damage (WHO) Breslow thickness: 1.2 mm Ulceration: absent Margins, peripheral and deep: melanoma in situ present at inked peripheral margin; deep margin free Mitotic index (per square millimeter): 1 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2a pNX	MELANOMA, BRESLOW THICKNESS 1.2 mm, NON-ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	172599	\N	\N	\N	22-83923	A	SYNAT160	2010-2017	IP2060770	AirTable blocks_with_IP_info.csv
3135	AM2_D-72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT161	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3220	Cell-Line_Xu-45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT162	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
2846	22-107614	76	\N	\N	\N	T4b	Primary	low cumulative sun damage (WHO)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30870,30871,30872,30873,30874,30875,30876	172.5	\N	\N	Sections show a polypoid proliferation of cytologically malignant epithelioid melanocytes forming an expansile nodule in the dermis. These melanocytes contain increased amphophilic cytoplasm and enlarged oval-irregular nuclei with conspicuous nucleoli and are associated with a delicate lymphocytic infiltrate. The overlying epidermis shows a polypoid architecture and there is focal ulceration present. There is a dense lichenoid lymphohistiocytic inflammatory infiltrate with numerous melanophages and fibrosis aligned along the adjacent epidermis. Towards one edge of the biopsy, there is an adjacent lentiginous compound proliferation of smaller cytologically bland melanocytes (lentiginous compound melanocytic nevus).	Two skin segments received in vial. Skin segment one measuring 1.3 x 0.9 x 0.2 cm, two representative sections submitted. Skin segment two measuring 1.5 x 1.4 x 1.3 cm, two representative sections submitted. KB/ES	4 X 2 CM BLACK PATCH WITH SATELLITE PAPULES AND CENTRAL CRUST; POSSIBLE MELANOMA	\N	\N	\N	Immunostains for SOX-10 highlight the epithelioid tumor cells and the adjacent melanocytic nevus while Melan-A highlights only the compound melanocytic nevus. The tumor cells are negative for p40. BAP-1 shows preserved nuclear expression throughout. I have shared this case with my colleague, Dr. Thaddeus Mully, who agrees with the diagnosis and assessment. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: deep shave biopsy Tumor site: right chest Microscopic tumor type: low cumulative sun damage (WHO) Breslow thickness: 7 mm Ulceration: present Margins, peripheral and deep: changes of regression present at the peripheral and focally the deep tissue edge; nevus present at the peripheral and deep tissue edge Mitotic index (per square millimeter): 1 Microsatellitosis: to be determined in the resection specimen Vascular Invasion: not identified Perineural invasion: not identified Regression: present, extensive Pathologic Staging (pTNM): pT4b pNX	MELANOMA, BRESLOW THICKNESS 7.0 mm, WITH ULCERATION AND REGRESSION	173526	\N	\N	\N	22-107614	\N	SYNAT163	2010-2017	IP2509746	AirTable blocks_with_IP_info.csv
2850	22-115635C4	55	\N	\N	2	T4a	Primary	\N	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes within the nail matrix and nail bed epithelium. A broad area features increased numbers of single melanocytes with large and irregularly shaped nuclei and scant cytoplasm positioned at irregular intervals, with a nodular proliferation of cells with even larger nuclei in the proximal nail bed, without evidence of maturation and dispersion with descent.	Oriented distal phalanx measuring 2.7 x 3.2 x 1.6 cm, including a central 2.1 x 1.7 cm area of variegated color and texture. With the midpoint of the dorsal proximal margin designated 12 o'clock by the grosser, the grosser inked the 9-12 o'clock margin black and the 12-3 o'clock margin blue. An approximately 0.3 cm intact crescent (9 to 3 o'clock) is removed parallel to the plane of amputation. This crescent is submitted intact in C1 for en-face sections with the true margin embedded down. From the remaining portion, eight central representative sections are submitted with two sections each in C2-C5. The bone and the remaining tissue are reserved. CF/CF	A) RIGHT INGUINAL SENTINEL LYMPH NODE # 1 HOT AND BLUE PROXIMAL BELOW SAPHENOUS VEIN EX VIVO 5500, B) RIGHT INGUINAL SENTINEL LYMPH NODE # 2 HOT AND BLUE SUPERFICIAL SAPHENOUS VEIN EX VIVO 4900, C) RIGHT GREATER TOE WITH SUBUNGUAL MELANOMA, D) ADDITIONAL POSTERIOR FLAP RIGHT GREATER TOE MARGIN, E) ADDITIONAL POSTERIOR FLAT RIGHT GREATER TOE MARGIN # 2, A-E) MELANOMA	\N	\N	\N	Features suggested for reporting per the guidelines of the College of American Pathologists, updated from the report of the prior biopsy include: Procedure: re-excision Microscopic tumor type: acral Ulceration: no Margins, peripheral and deep: both clear Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX  The proximal margin was evaluated with en face sections.	MELANOMA, 5 MM IN THICKNESS	176788	\N	\N	\N	22-115635	C4	SYNAT164	Melanoma Epigenetics	IP908318	AirTable blocks_with_IP_info.csv
2860	22-152373	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	22-152373	\N	SYNAT165	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
2927	91-017419	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	91-17419	\N	SYNAT166	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2897	23-18865	42	t	\N	3	T3b	Primary	High chronic sun-damage	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30878	172.4	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Two skin segments measuring 0.9 x 0.9 x 0.3 cm in aggregate. With the larger skin segment quadrisected, a total of five sections is entirely submitted. HD/HD	7 MM BRIGHT PINK SHINY PAPULE WITH DARK BROWN BORDER; R/O PIGMENTED BCC VS. OTHER	\N	\N	\N	Diagnostic features of note include: Procedure: Shave Tumor site: Scalp Microscopic tumor type: High chronic sun-damage Breslow thickness: 2.4 mm at least Ulceration: Present Margins, peripheral and deep: Involved Mitotic index: 3/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT3b at least	MELANOMA, AT LEAST 2.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102499	\N	\N	\N	23-18865	\N	SYNAT167	Melanoma Epigenetics	IP2557030	AirTable blocks_with_IP_info.csv
2909	23-83099	51	f	\N	0	T1b	Primary	melanoma on skin with low cumulative sun-induced damage (low CSD melanoma)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=34332,34333,34334	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus).	Ellipse, 4.2 x 1.7 x 0.7 cm, including a central 2.0 x 1.3 cm black-white area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in 1-3. Tips reserved. BY/BY	15 X 24 MM, MM - CHECK MARGINS	\N	\N	\N	Diagnostic features of note include: Procedure: excision Tumor site: shoulder Microscopic tumor type: melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Breslow thickness: 0.9 mm Ulceration: absent Margins, peripheral and deep: not involved Mitotic index: 0/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: present Pathologic Staging (pTNM): pT1b pNX	MELANOMA, 0.9 mm IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	529699	\N	\N	\N	23-83099	\N	SYNAT168	Melanoma Epigenetics	IP2621535	AirTable blocks_with_IP_info.csv
2910	23-97273	46	\N	\N	0	T1a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Extending from the proximal nail matrix distally into the nail bed epithelium in the slides from blocks 4 and 5 is a proliferation of melanocytes with variably enlarged, hyperchromatic or vesicular nuclei, distributed singly or in small nests, in a nearly confluent manner.  There are foci which these cells infiltrate the superficial onychodermis, with dense infiltrates of plasma cells and fibrosis.  Poorly circumscribed basilar proliferation of atypical melanocytes extends along the junctional zone in parts of the en face sections from the medial and lateral peripheral margins.	Oriented fingernail excision measuring 2.6 x 2.1 x 0.4 cm. There is a suture at the midpoint of the distal tip as indicated on the requisition. The surgeon pre-inked the ulnar margin green and the radial margin yellow. The grosser inked the proximal margin blue. An approximately 4 mm strip of the margin is removed with the resulting edges inked orange by the grosser. The peripheral margin is entirely submitted for en face sections in 1-3. The yellow-inked radial margin is submitted in 1, the green-inked ulnar margin is submitted in 2, and the blue-inked proximal margin is submitted in 3. The poles indicating the midpoint of the distal margin is inked black for the radial and ulnar margins (blocks 1-2). The radial pole of the proximal margin (block 3) is inked black. The remaining central portion is serially sectioned from the radial to ulnar direction and entirely submitted with three sections each in 4-5. PL/PL	BIOPSY CONFIRMED MELANOMA IN SITU OF NAIL UNIT, EN BLOC EXCISION OF NAIL UNIT, PLEASE EVALUATE MARGINS AND FOR INVASION COMPONENT, GREEN ON ULNAR SIDE, YELLOW ON RADIAL SIDE (TELEPHONE: 415-845-0515, MSG OK)	\N	\N	\N	Unlike the case in the initial biopsy, an invasive component is present. The thickness is listed as an approximation because the tissue in the area of the thickness melanoma was disrupted by the previous biopsy. Portions of the en face margins are involved.  A specimen diagram will be sent to Dr. Klufas by email, and uploaded to Apex.  Of these areas is on the radial side of the specimen, proximally and the other is on the ulnar side distally.  In both areas, increased numbers of SOX-10 positive cells with PRAME positive nuclei are present.  The deepest extent of the melanoma is its in situ portion, in the proximal part of the nail matrix, where it is less than 1 mm from the deep margin.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: biopsy Microscopic tumor type: Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 0/mm2 Microsatellitosis: to be determined following re-excision Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, APPROXIMATELY 0.7 MM IN THICKNESS	173632	\N	\N	\N	23-97273	\N	SYNAT169	Melanoma Epigenetics	IP2626851	AirTable blocks_with_IP_info.csv
2923	90-012097B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	90-12097	B	SYNAT171	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2912	35_M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1734	\N	\N	None	\N	SYNAT172	2010-2017	\N	AirTable blocks_with_IP_info.csv
2930	92-003527H	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	92-3527	H	SYNAT173	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2948	94-016368	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	94-16368	\N	SYNAT174	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2953	94-31062  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	94-31062	\N	SYNAT175	2010-2017	\N	AirTable blocks_with_IP_info.csv
2959	95-007992	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	95-7992	\N	SYNAT176	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2987	98-001046	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	98-1046	\N	SYNAT177	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3000	98-019394	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	98-19394	\N	SYNAT178	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3006	99-005681	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	99-5681	\N	SYNAT179	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3008	99-012800	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	99-12800	\N	SYNAT180	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3009	99-012800-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT180	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3025	144 Imat B15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT181	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3026	144 Imat B15-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT182	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3027	144aI WT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT183	Cell Line	\N	AirTable blocks_with_IP_info.csv
3030	230 WT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT184	Cell Line	\N	AirTable blocks_with_IP_info.csv
3044	1205lu-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT185	Cell Line	\N	AirTable blocks_with_IP_info.csv
3045	1205lu-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT186	Cell Line	\N	AirTable blocks_with_IP_info.csv
3046	1205LU-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT187	Cell Line	\N	AirTable blocks_with_IP_info.csv
3157	Bivona L1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT188	2010-2017	\N	AirTable blocks_with_IP_info.csv
3158	Bivona L2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT189	2010-2017	\N	AirTable blocks_with_IP_info.csv
3159	Bivona L3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT190	2010-2017	\N	AirTable blocks_with_IP_info.csv
3160	Bivona L4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT191	2010-2017	\N	AirTable blocks_with_IP_info.csv
3161	Bivona L5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT192	2010-2017	\N	AirTable blocks_with_IP_info.csv
3162	Bivona L6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT193	2010-2017	\N	AirTable blocks_with_IP_info.csv
3163	Bivona L7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT194	2010-2017	\N	AirTable blocks_with_IP_info.csv
3164	Bivona L8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT195	2010-2017	\N	AirTable blocks_with_IP_info.csv
3165	Bivona L9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT196	2010-2017	\N	AirTable blocks_with_IP_info.csv
3166	Bivona L10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT197	2010-2017	\N	AirTable blocks_with_IP_info.csv
3167	Bivona L11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT198	2010-2017	\N	AirTable blocks_with_IP_info.csv
3175	Buffy Coat	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Buffy Coat:  This is DNA that was derived from the Buffy Coat layer of a patient sample with a strong family history of Melanoma. 	\N	\N	\N	\N	Family History (9 members) have melanoma	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT199	2010-2017	\N	AirTable blocks_with_IP_info.csv
3176	Cell-Line_Xu-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT200	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3177	Cell-Line_Xu-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT201	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3178	Cell-Line_Xu-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT202	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3179	Cell-Line_Xu-4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT203	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3180	Cell-Line_Xu-5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT204	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3181	Cell-Line_Xu-6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT205	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3182	Cell-Line_Xu-7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT206	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3183	Cell-Line_Xu-8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT207	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3184	Cell-Line_Xu-9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT208	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3185	Cell-Line_Xu-10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT209	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3223	Cell-Line_Xu-48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT230	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3224	Cell-Line_Xu-49	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT231	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3225	Cell-Line_Xu-50	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT232	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3226	Cell-Line_Xu-51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT233	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3227	Cell-Line_Xu-52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT234	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3228	Cell-Line_Xu-53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT235	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3229	Cell-Line_Xu-54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT236	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3249	CGH14-147	11	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. The span of the junctional component exceeds that of the dermal portion. The lesional melanocytes include many cells with large, irregularly shaped hyperchromatic nuclei and scant cytoplasm. Some have abundant, pale cytoplasm. Nests of melanocytes predominate over those distributed singly along the junctional zone, and some of those nests are confluent. Some areas show maturation and dispersion with descent.	One outside slide, D-2147-14 (LX-14-01265 A-1). One corresponding block received 6-9-14.	COMPOUND NEVUS; ATYPICAL MELANOCYTIC PROLIFERATION	\N	\N	\N	Along with the slides was a report from Barr Dermatopathology suggesting comparative genomic hybridization; per a message from your institution we proceeded with that testing. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include a gain involving chr. 1q, loss of 2p with areas of gain involving 2q but a gain involving the terminal portion of that chromosome, loss involving 4q, and loss involving 9p. Several of these aberrations are commonly found in melanoma.  While formally, this is an AJCC stage pT1a lesion, the prognosis is in a group of cases of this type is even more favorable than in a group of adult patients with conventional AJCC stage pT1a lesions. Spitzoid melanomas in children have a considerably lower rate of extranodal disease. This lesion is well circumscribed and has a margin of about 1 mm. As local recurrence from incomplete excision is rare in lesions of this type, I would suggest a narrow re-excision to achieve 5 mm. margins. Sentinel lymph node biopsy is controversial in this type of case, with childhood spitzoid melanomas having a high rate of nodal involvment, but a much lower rate of extranodal spread. Hence, the prognostic value of the procedure is much less than in an adult patient, and the procedure can lead to overtreatment.	MELANOMA, 0.85 MM. IN THICKNESS	273588	\N	\N	L	14-43805	A	SYNAT257	2010-2017	IP1393739	AirTable blocks_with_IP_info.csv
3250	CGH15-249	16	\N	\N	1	T2a	Primary	spitzoid melanoma	\N	\N	\N	\N	\N	172.6	\N	\N	A broad shave biopsy demonstrates a compound proliferation of enlarged fusiform and epithelioid melanocytes. The background epidermis is acanthotic and harbors these melanocytes distributed in pagetoid fashion, and scattered well-formed pink globules are present concurrently. In fibrotic inflamed dermis below this, maturing nests, cords, and fascicles of similar melanocytes are noted. These melanocytes mature to form small compact nests at the base of the proliferation.	Four outside slides, S-15-28819-B1. One corresponding block received 10/23/15.	IMPRESSION WAS INFLAMED SEBORRHEIC KERATOSIS VS. R/O SCC	\N	\N	\N	Your submitted immunoperoxidase stains demonstrate that the Ki-67 cell proliferation index is low and that expression of p16 is not detectable. To further assess the nature of this proliferation, we first repeated p16 immunohistochemistry and additionally completed NTRK-1 immunostaining. The repeat p16 stain was again negative, while the NTRK-1 immunostain demonstrated significant positivity, and thus underlying NTRK-1 gene fusion may be present. Given the histopathologic findings and the above immunostaining results, the differential diagnosis included a so-called 'atypical Spitz tumor' and spitzoid melanoma. To enable full characterization, we next completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in proximal chromosome 1p as well as loss in chromosomes 9 and 14q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of melanoma. In short, the molecular findings we have defined are incompatible with interpretation as a melanocytic nevus. Additionally, the loss of chromosome 9 that has been defined via aCGH explains the loss of p16 expression, as the CDKN2A locus is encoded within chromosome 9p.  In summary, the combination of results derived from conventional microscopy coupled with aCGH support interpretation as a thin spitzoid melanoma. This biopsy is only partial in nature and thus reexcision remains indicated, if that has not yet been accomplished. Synoptic melanoma reporting is included below.  Procedure: shave biopsy Microscopic tumor type: spitzoid melanoma Breslow thickness: 1.05 mm Ulceration: not detected Margin: involved Mitotic index: 1/square mm Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): pT2aNxMx  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	SPITZOID MELANOMA OF 1.05 MM IN THICKNESS, FOCALLY INVOLVING THE DEEP EDGE OF THE BIOPSY	173619	\N	\N	L	15-101612	A	SYNAT258	2010-2017	IP1573327	AirTable blocks_with_IP_info.csv
3258	ct-H3K4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT260	2010-2017	\N	AirTable blocks_with_IP_info.csv
3259	ct-H3K27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT261	2010-2017	\N	AirTable blocks_with_IP_info.csv
3260	ct-Input	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT262	2010-2017	\N	AirTable blocks_with_IP_info.csv
3318	DM100	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT265	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3319	DM101	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT266	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3320	DM102	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT267	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3325	DP12-200 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	DP	12-200	\N	SYNAT268	2010-2017	\N	AirTable blocks_with_IP_info.csv
3349	HW Acral #1 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT269	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3350	HW Acral #1 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT270	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3351	HW Acral #2 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT271	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3352	HW Acral #2 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT272	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3353	HW Acral #3 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT273	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3354	HW Acral #3 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT274	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3355	HW Acral #4 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT275	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3356	HW Acral #4 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT276	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3357	HW Acral #5 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT277	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3358	HW Acral #5 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT278	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3359	HW Acral #6 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT279	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3360	HW Acral #6 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT280	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3361	HW Acral #7 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT281	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3362	HW Acral #7 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT282	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3363	HW Acral #8 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT283	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3364	HW Acral #8 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT284	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3365	HW Acral #9 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT285	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3366	HW Acral #9 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT286	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3367	HW Acral #10 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect | Barcode mismatch comment in note	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT287	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3368	HW Acral #10 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT288	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3369	HW2- Normal Curls	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, vulva, Hong Wu	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT289	2010-2017	\N	AirTable blocks_with_IP_info.csv
3370	HW2- Tumor Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, vulva, Hong Wu	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT290	2010-2017	\N	AirTable blocks_with_IP_info.csv
3371	HW3-Normal	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| Normal Melanoma, Mucosal nasal sinus	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT291	2010-2017	\N	AirTable blocks_with_IP_info.csv
3372	HW3-Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| TUMOR Mucosal Melanoma, nasal sinus	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT292	2010-2017	\N	AirTable blocks_with_IP_info.csv
3373	HW4-Normal	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| Normal Melanoma, Mucosal nasal sinus	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT293	2010-2017	\N	AirTable blocks_with_IP_info.csv
3374	HW4-Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| TUMOR Melanoma, Mucosal nasal sinus	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT294	2010-2017	\N	AirTable blocks_with_IP_info.csv
3375	HW6-NormalDissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| Normal Melanoma, Mucosal vulva	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT295	2010-2017	\N	AirTable blocks_with_IP_info.csv
3376	HW6-TumorDissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| Tumor Melanoma, Mucosal vulva	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT296	2010-2017	\N	AirTable blocks_with_IP_info.csv
3377	HW8- Normal Curls	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Urethra, Hong Wu	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT297	2010-2017	\N	AirTable blocks_with_IP_info.csv
3378	HW8- Tumor Curls	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Urethra, Hong Wu	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT298	2010-2017	\N	AirTable blocks_with_IP_info.csv
3379	HW9- Normal gDNA from Blood (129920)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Blood, Hong Wu	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT299	2010-2017	\N	AirTable blocks_with_IP_info.csv
3380	HW9- Tumor Curls	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosla Melanoma, vulva, Hong Wu	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT300	2010-2017	\N	AirTable blocks_with_IP_info.csv
3491	LAL-L Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas 	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT301	2010-2017	\N	AirTable blocks_with_IP_info.csv
3496	M230 Imat A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT302	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3497	M230 Imat A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT303	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3523	MB1424	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT304	2010-2017	\N	AirTable blocks_with_IP_info.csv
3541	P57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT305	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
3542	P57-A-1.0mm	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT306	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
3543	P57-A-2.0mm	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT307	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
3544	P57-B-1.0mm	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT308	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
3545	P57-B-2.0mm	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT309	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
3551	S12-9606E4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	S	12-9606	E4	SYNAT310	2010-2017	\N	AirTable blocks_with_IP_info.csv
3552	S12-9606E9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	S	12-9606	E9	SYNAT310	2010-2017	\N	AirTable blocks_with_IP_info.csv
3555	sh-H3K4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT311	2010-2017	\N	AirTable blocks_with_IP_info.csv
3556	sh-H3K27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT312	2010-2017	\N	AirTable blocks_with_IP_info.csv
3557	sh-Input	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT313	2010-2017	\N	AirTable blocks_with_IP_info.csv
3563	SKMEL5-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT314	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
3564	SKMEL5-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT315	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
3565	SKMEL5-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT316	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
3566	SKMEL28-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT317	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
3567	SKMEL28-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT318	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
3568	SKMEL28-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT319	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
3569	SM_2_Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT320	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
3573	SM_10_Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT321	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
3581	Thomas_SK_Mel23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT322	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3583	UCSF-23-041_Biopsy	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT323	Mutation Burden in Normal Skin,Willed Body Program	\N	AirTable blocks_with_IP_info.csv
3584	UM1_UvealMel	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT324	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
3585	UM2_UvealMel	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT325	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
3596	WM3918	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	wt/wt Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT326	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3597	WP 11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT327	2010-2017	\N	AirTable blocks_with_IP_info.csv
3598	WP 23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT328	2010-2017	\N	AirTable blocks_with_IP_info.csv
3599	WP 29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT329	2010-2017	\N	AirTable blocks_with_IP_info.csv
3600	X06-6624A7	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	The epidermis is thickened by a proliferation of keratinocytes with small, monomorphous nuclei that form bulbous rete ridges.  There is basilar hyperpigmentation.	Deep skin segment, 1.0 x 0.8 x 0.3 cm, margins inked blue, serially sectioned and entirely submitted with five sections.	PIGMENTED LESION	\N	\N	\N	\N	SEBORRHEIC KERATOSIS	173601	\N	\N	X	06-6624	A7	SYNAT330	2010-2017	IP227601	AirTable blocks_with_IP_info.csv
3601	X06-6624D1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	X	06-6624	D1	SYNAT330	2010-2017	\N	AirTable blocks_with_IP_info.csv
3602	X98-1056	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	X	98-1056	\N	SYNAT331	2010-2017	\N	AirTable blocks_with_IP_info.csv
3603	X98-1056A9	38	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	Sections show a proliferation of small basaloid keratinocytes,\narrayed as interanastomosing rete.  There are horn pseudocysts.	Skin segment measuring 0.8 x 0.5 x 0.3 cm, bisected and entirely\nsubmitted.	CLINICAL DIAGNOSIS - R/O NEVUS	\N	\N	\N	\N	SEBORRHEIC KERATOSIS	101499	\N	\N	X	98-1056	A9	SYNAT331	2010-2017	IP138629	AirTable blocks_with_IP_info.csv
3607	ZS10-3560A4	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.0	\N	\N	Sections show zones of the epidermis that contain a proliferation of keratinocytes with atypical nuclei, and parakeratosis containing inflammatory cells is present in the overlying cornified layer.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.1 cm in thickness.	H/O SCC, BCC, PERSISTENT SCALY PATCH, PRIOR TX X2 LN02	\N	\N	\N	\N	CRUSTED SOLAR KERATOSIS	123144	\N	\N	ZS	10-3560	A4	SYNAT332	2010-2017	IP773046	AirTable blocks_with_IP_info.csv
3608	ZS10-3560A10	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.0	\N	\N	Sections show zones of the epidermis that contain a proliferation of keratinocytes with atypical nuclei, and parakeratosis containing inflammatory cells is present in the overlying cornified layer.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.1 cm in thickness.	H/O SCC, BCC, PERSISTENT SCALY PATCH, PRIOR TX X2 LN02	\N	\N	\N	\N	CRUSTED SOLAR KERATOSIS	123144	\N	\N	ZS	10-3560	A10	SYNAT332	2010-2017	IP773046	AirTable blocks_with_IP_info.csv
3609	ZS10-3560C1\n	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	ZS	10-3560	C1	SYNAT332	2010-2017	\N	AirTable blocks_with_IP_info.csv
3536	MP41	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1392	\N	\N	None	\N	UV-01	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1311	08-27590	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	See above.	Two outside slides, 6110/08 and one corresponding block.	CLINICALLY ANGIOMA OR A FIBROMA SUSPECTED	\N	\N	\N	Both Dr. McCalmont and I favor melanoma over a Spitz's nevus; neither of can rule out melanoma arising in a Spitz's nevus (this diagnosis can be difficult to prove!). The central portion of the lesion is ulcerated, has a thin epidermis, is surrounded by epithelial collarettes and contains melanocytes with striking nuclear atypia, even in the lower half of the lesion. The nests in this area are strikingly confluent. The peripheral part of the lesion resembles a Spitz's nevus, with smaller cells in discrete nests along the dermo-epidermal junction, and some Kamino bodies (highlighted in the PAS stain). The thickness of 3.8 mm. may have been established on examination of a different slide from this one.	MELANOMA, ABOUT 3 MILLIMETERS IN THICKNESS IN THESE SECTIONS	173740	1648	\N	\N	08-27590	\N	SYNAT333	Spitzoid Melanoma	IP736231	AirTable blocks_with_IP_info.csv
1568	12-11406A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1806	\N	\N	12-11406	A	SYNAT334	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3117	86502d	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-001_1.2	\N	\N	\N	\N	Right sole	\N	\N	\N	\N	1	\N	\N	None	\N	AM2-001	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3116	86502c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-001_1.3	\N	\N	\N	\N	Right sole	\N	\N	\N	\N	1	\N	\N	None	\N	AM2-001	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3120	86541-1f	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-006_1.2	\N	\N	\N	\N	Heel	\N	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1655	12-97918	36	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show a proliferation of spindled and dendritic melanocytes that is relatively well-circumscribed.  There are interspersed melanophages.  In the most cellular areas, clusters of polygonal melanocytes with pallid cytoplasm are arrayed in a pattern that vaguely resembles nerve fascicles.	Oval brown skin excision, 1.0 x 0.9 x 0.5 cm, margins inked blue, serially sectioned perpendicular to the long axis and entirely submitted with five sections.   SL/SL	ATYPICAL NEVUS, R/O MELANOMA	\N	\N	Scraping	None	CELLULAR BLUE NEVUS, SO-CALLED MASSON'S BLUE NEURONEVUS PATTERN	173507	107	\N	\N	12-97918	\N	BN-003	Nevus Library	IP1183735	AirTable blocks_with_IP_info.csv
2414	19-15442	56	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 1.3 x 1.0 x 0.2 cm, with the based inked, quadrisected and entirely submitted. CF/CF	0.9 X 0.6 CM DARK BROWN PAP WITH IRREGULAR BORDERS ON RIGHT MID LAT BACK	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139524	636	\N	\N	19-15442	\N	DN-161	Dysplastic Nevi	IP2019543	AirTable blocks_with_IP_info.csv
2431	19-37607D	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in D. KC/KC	A) 7 MM X 5 MM DARK BROWN IRREGULAR MACULE ADJACENT TO SK; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 2.5 CM X 2 CM DARK BROWN HYPERKERATOTIC PLAQUE; PROBABLE SK, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, C) 4 MM X 4 MM VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, D) 5 MM X 6 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, E) 4 MM X 4 MM DARK BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, F) 3 X 4 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173530	637	\N	\N	19-37607	D	DN-162	Dysplastic Nevi	IP2041843	AirTable blocks_with_IP_info.csv
1080	03-17395J T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1048	\N	\N	None	\N	MD-171	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1087	03-24659-2 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1049	\N	\N	None	\N	MD-172	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1075	03-08311E T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1050	\N	\N	None	\N	MD-173	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1063	02-26442 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1051	\N	\N	None	\N	MD-174	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1748	14-29390	60	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.9	\N	from Swapna	See UCSF Surgical Pathology report S14-7672.	One outside slide, S14-7672 (14N-7254:2B), and one corresponding block.	REFERRAL FOR MOLECULAR TESTING	\N	\N	\N	The comparative genomic hybridization array graph shows a baseline shift, but there are clear losses of 1, 2, 5q, 14q, 17p, 18, 21, 22 and chromothripsis in 5p. A detailed look at chr. 3p shows no bap-1 loss. The multiple aberrations and presence of chromothripsis, in the context of a lesion with this degree of atypicality favor a melanoma. We did not find aberrations in b-raf, gnaq or gna-11. BRAF exon 15: wild-type. GNAQ exons 4 and 5: wild-type. GNA11 exons 4 and 5: wild-type.	MELANOMA	666955	642	\N	\N	14-29390	\N	DP-05	Possible TERT Fusion	IP1379315	AirTable blocks_with_IP_info.csv
1059	02-20732 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1052	\N	\N	None	\N	MD-175	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1882	15-101612	16	\N	\N	1	T2a	Primary	spitzoid melanoma	\N	\N	\N	\N	\N	172.6	\N	from Swapna	A broad shave biopsy demonstrates a compound proliferation of enlarged fusiform and epithelioid melanocytes. The background epidermis is acanthotic and harbors these melanocytes distributed in pagetoid fashion, and scattered well-formed pink globules are present concurrently. In fibrotic inflamed dermis below this, maturing nests, cords, and fascicles of similar melanocytes are noted. These melanocytes mature to form small compact nests at the base of the proliferation.	Four outside slides, S-15-28819-B1. One corresponding block received 10/23/15.	IMPRESSION WAS INFLAMED SEBORRHEIC KERATOSIS VS. R/O SCC	\N	\N	\N	Your submitted immunoperoxidase stains demonstrate that the Ki-67 cell proliferation index is low and that expression of p16 is not detectable. To further assess the nature of this proliferation, we first repeated p16 immunohistochemistry and additionally completed NTRK-1 immunostaining. The repeat p16 stain was again negative, while the NTRK-1 immunostain demonstrated significant positivity, and thus underlying NTRK-1 gene fusion may be present. Given the histopathologic findings and the above immunostaining results, the differential diagnosis included a so-called 'atypical Spitz tumor' and spitzoid melanoma. To enable full characterization, we next completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in proximal chromosome 1p as well as loss in chromosomes 9 and 14q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of melanoma. In short, the molecular findings we have defined are incompatible with interpretation as a melanocytic nevus. Additionally, the loss of chromosome 9 that has been defined via aCGH explains the loss of p16 expression, as the CDKN2A locus is encoded within chromosome 9p.  In summary, the combination of results derived from conventional microscopy coupled with aCGH support interpretation as a thin spitzoid melanoma. This biopsy is only partial in nature and thus reexcision remains indicated, if that has not yet been accomplished. Synoptic melanoma reporting is included below.  Procedure: shave biopsy Microscopic tumor type: spitzoid melanoma Breslow thickness: 1.05 mm Ulceration: not detected Margin: involved Mitotic index: 1/square mm Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): pT2aNxMx  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	SPITZOID MELANOMA OF 1.05 MM IN THICKNESS, FOCALLY INVOLVING THE DEEP EDGE OF THE BIOPSY	173619	649	\N	\N	15-101612	\N	DP-12	NRAS Amplified	IP1573327	AirTable blocks_with_IP_info.csv
1064	02-28682 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1054	\N	\N	None	\N	MD-177	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1497	11-63724	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show large, irregularly shaped areas of subcutaneous tissue and dermis in which there are poorly circumscribed masses of plump oval to spindled cells with pale amphophilic cytoplasm, and distinct cytoplasmic borders and oval, vesicular nuclei that have small nucleoli. The latter are irregular in shape, but not strikingly atypical. Mitotic figures are very few. The enclosed immunoperoxidase-stained sections demonstrate that the proliferation is S100 and Melan-A positive.	Eleven outside slides, SD11-6824:1-11 and one corresponding block (SD11-6824:5). Three additional slides received 12/27/18.	EXCISIONAL BIOPSY OF SR09-1700/DL09-34832	\N	\N	\N	The recurrent lesion has areas of striking cellularity, but these are not overtly malignant. Comparative genomic hybridization shows a similar loss of 5pter and 5qter as was present in 2009. There is a small peri-centromeric deletion, and we are reviewing the 2009 data (done by a different method- we currently use array CGH and at that time we were using metaphase CGH) to see if was present then. This set of mutations has not been linked to melanoma. I would regard this as a low grade neoplasm that will probably grow slowly. The risk of overt malignancy may be tempered by the loss involving 5pter, which contains the catalytic subunit of telomerase, but this is speculative. My colleague Dr. Boris Bastian also reviewed the CGH data. Mutational analysis for two genes mutated in most blue nevus was also performed.  GNAQ exon 5: wild-type. GNA11 exon 5: wild-type.  If local control of this unusual lesion becomes an issue, we can perform analyses for b-raf and other genes linked to initiation in melanocytic lesions.	BLUE NEVUS-LIKE MELANOCYTIC PROLIFERATION	173311	655	\N	\N	11-63724	\N	DP-18	CGH Validation	IP835595	AirTable blocks_with_IP_info.csv
1699	13-32039	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a dome shaped segment of skin with an intradermal proliferation of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei containing moderately enlarged nucleoli. The lesional melanocytes are distributed singly or in small collections. The enclosed immunoperoxidase stains show that there is a relatively low proliferation rate and that there is retention of p16 tumor suppressor protein staining.	Five outside slides, S13-02977 (REB13-3963). One corresponding block received 5-1-13.	EXOPHYTIC SMOOTH BROWN NODULE, ABOUT 10 X 18 MM; POSSIBLE NEVUS, R/O MALIGNANCY  (SEE CLINICAL IMAGES)	\N	\N	\N	Thank you for sending the clinical image of this patient's lesion. The neoplasm extends to the base of the specimen across a broad front. Comparative genomic hybridization shows several genomic aberrations. These include gains involving chromosomes 5 and 17, and a complex rearrangement involving chromosome 7. The latter includes an amplification of the promoter region of b-raf, with loss of most the rest of that gene. Our group has identified similar b-raf fusions as a driver in cases in which b-raf mutation is absent (abstract ASCO, 2013). My colleague, Dr. Boris Bastian has also reviewed the comparative genomic hybridization data and agrees with this interpretation of it.  Based on the findings by conventional histopathology and by comparative genomic hybridization, I would assess this as a atypical Spitz tumor- a proliferation of melanocytes with features intermediate between Spitz's nevus and spitzoid melanoma. Lesions of this type often involve local lymph nodes, but seldom have distant metastases. Because of the lack of predictive value, sentinel lymph node biopsy can lead to over-treatment. If there were to be distant metastasis in the future, treatment with a b-raf inhibitor might be indicated, as lesions with b-raf fusions like this one can respond to agents targeting b-raf, despite the absence of driver mutations.	MOSTLY INTRADERMAL PROLIFERATION OF LARGE SPITZOID MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR	17722	664	\N	\N	13-32039	\N	DP-27	CGH Validation	IP1216784	AirTable blocks_with_IP_info.csv
2280	18-15165	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18197	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/PL	ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139522	838	\N	\N	18-15165	\N	LN-18	Lentiginous Nevi 	IP1878752	AirTable blocks_with_IP_info.csv
1031	01-17200 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1058	\N	\N	None	\N	MD-181	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1308	08-21729-2 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	930	\N	\N	None	\N	MD-24	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2301	18-31431	32	f	\N	0	T4a	Primary	Melanoma, NOS	\N	\N	FFPE	\N	\N	172.5	DPN-mm	\N	Sections show a compound proliferation of atypical melanocytes. Within the epidermis there are melanocytes configured as nests and single cells. THe melanocytes that are single cells ar arranged irregularly, with some above the basal layer of the epidermis.  There are sheets of similar melanocytes in the dermis. Many of the dermal melanocytes have large and hyperchromatic nuclei and the melanocytes do not diminish in size with descent into the dermis. In addition, there are numerous admixed melanophages.	Cylindrical skin segment, 0.3 cm in diameter and 0.4 cm in thickness, submitted intact. CF/CF	ENLARGING VASCULAR NODULE	\N	\N	Scraping	There is nearly complete loss of p16 staining among most of the melanocytes in the reticular dermis, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. Coupling this loss of p16 staining with the presence of markedly atypical melanocytes with nuclear pleomorphism in the dermis, the features in this biopsy represent melanoma. Synoptic melanoma reporting is included below: Procedure: Punch biopsy Microscopic tumor type: Melanoma, NOS Breslow thickness: 4.7 mm Ulceration: Absent Margins: + Base; + Peripheral Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT4aNxMx  I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this assessment.	MELANOMA, 4.7 MILLIMETERS IN THICKNESS, EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	173531	738	\N	\N	18-31431	\N	DPN-05	Deep Penetrating Melanoma	IP1895153	AirTable blocks_with_IP_info.csv
1474	11-37533B	74	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26293,26318,26319	172.7	\N	\N	Sections show a zone of fibrosis and inflammation consistent with prior biopsy and a residual compound proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly and in poorly circumscribed fashion within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the fibrotic superficial dermis, along with some smaller but still atypical melanocytes.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. There is a focal epidermal defect and subjacent fibrosis consistent with prior biopsy.	Ellipse, 3.0 x 1.5 x 0.8 cm, including a central 2.0 x 1.5 cm variegated brown and textured area.  With the peripheral margins and base inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections with fragment (at cut-in) in cassette A, three sections in cassette B, three sections with fragment (at cut-in) in cassette C, and three sections in cassette D.	R/O MELANOMA	\N	\N	FFPE	The residual neoplasm contains diagnostic areas of melanoma, including some smaller cells in a nevoid melanoma pattern, as well as a pre-existent nevus. Histopathologic features of possible prognostic importance include the following. The thickness of the tumor in the re-excision is greater than that in the original biopsy. Dermal mitotic rate has supplanted Clark's levels with respect to staging of melanoma less than 1 mm in thickness in the current AJCC classification. Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: not evident AJCC stage: T1a	RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	897777	742	\N	\N	11-37533	B	JJS3	Melanoma Evolution	IP1021763	AirTable blocks_with_IP_info.csv
1555	12-05858 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	935	\N	\N	None	\N	MD-29	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1646	12-79097B	81	\N	\N	\N	T1a	Primary	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26322	172.6	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus).  The second population consists of nested and solitary melanocytes, some of which display atypical nuclei, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis within fibrosis over elastosis. There is an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted in cassette B.    SL/SL	A) 4 X 4 MM PEARLY PAPULE; R/O BCC, B) 8 X 5 MM HYPOPIGMENTED TAN IRREGULAR MACULE; NEVUS, R/O ATYPIA, C) 8 X 8 MM ERYTHEMATOUS SLIGHTLY HYPERKERATOTIC PAPULE; LPLK, R/O SCC, D) 4 X 4 MM INDURATED HYPERKERATOTIC PAPULE; IRRITATED SK, R/O SCC	\N	\N	FFPE	The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma. Complete re-excision of this site is of course warranted.	MELANOMA, 0.85 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING INTRAEPIDERMALLY WITHIN 2 MM OF THE SPECIMEN PERIPHERY	173649	745	\N	\N	12-79097	B	JJS6	Melanoma Evolution	IP504932	AirTable blocks_with_IP_info.csv
2651	20-98774B	51	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33790	173.62	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Oriented ellipse, 4.5 x 1.8 x 1.4 cm, including a central 1.5 x 1.5 cm elevated area. The orienting notched tip is indicated superior on the requisition and is designated 12 o'clock by the grosser. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, two sections each in B-C, and three sections in D. Tips reserved. HD/KB	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH CENTRAL KERATIN PLUG, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173620	775	\N	\N	20-98774	B	KA-09	Keratoacanthoma	IP2246722	AirTable blocks_with_IP_info.csv
2650	20-98774A	51	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33789	173.62	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Oriented ellipse, 4.5 x 1.8 x 1.4 cm, including a central 1.5 x 1.5 cm elevated area. The orienting notched tip is indicated superior on the requisition and is designated 12 o'clock by the grosser. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, two sections each in B-C, and three sections in D. Tips reserved. HD/KB	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH CENTRAL KERATIN PLUG, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173620	775	\N	\N	20-98774	A	KA-09	Keratoacanthoma	IP2246722	AirTable blocks_with_IP_info.csv
1541	12-169	67	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show nodular aggregations of atypical and peripherally palisaded basaloid cells with clefting from surrounding fibromyxoid stroma.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted.	R/O SEB HYPERPLASIA VS. BCC	\N	\N	\N	None	BASAL CELL CARCINOMA, NODULAR PATTERN, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173316	792	\N	\N	12-169	\N	KIT-11	Kit mutants	IP1080700	AirTable blocks_with_IP_info.csv
3494	Lung cancer with ALK fusion	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	780	\N	\N	None	\N	KF-10	Fusion RNA	\N	AirTable blocks_with_IP_info.csv
1730	14-077	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component comprised of single cells and small pigmented nests arrayed along the sides and bases of pigmented rete. Small nests of similar melanocytes are positioned in the subjacent superficial dermis, where scattered lymphocytes and melanophages are also evident.	Cylindrical skin segment, 0.4 cm in diameter and 1.3 cm in thickness, bisected and entirely submitted. RS/RS	3 MM BROWN BLACK MACULE WITH IRREGULAR BORDERS; R/O DYSPLASTIC NEVUS	\N	\N	\N	This is not a dysplastic nevus. There is no evidence of melanoma.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	17733	782	\N	\N	14-77	\N	KIT-01	Kit mutants	IP1349996	AirTable blocks_with_IP_info.csv
1665	13-207	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	783	\N	\N	13-207	\N	KIT-02	Kit mutants	\N	AirTable blocks_with_IP_info.csv
1664	13-140	31	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	There is a zone of granulation tissue with a subjacent rectangular area containing a proliferation of melanocytes with cytologic features similar to those in (A). There is little maturation with descent. A mitotic figure is evident in a superficial melanocyte. About 5-10% of the melanocytic nuclei appear to be Ki-67 positive.	Three outside slides, S12-95328 / A1-A2.	A) SOFT-TISSUE MASS, B) SECOND EXCISION, COMPLETE AS RECOMMENDED; R/O MELANOMA	\N	\N	\N	The findings in (A) are not diagnostic. Putting them together with those in (B), given the degree of nuclear pleomorphism, the high nuclear/cytoplasmic ratio in many of the lesional cells, the presence of at least one mitotic figure in a dermal melanocyte, and the lack of maturation with descent, I believe that a spitzoid melanoma is the best diagnosis here, rather than an atypical Spitz tumor. We would be happy to perform comparative genomic hybridization as an ancillary test.  The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. While the lesion is not ulcerated, the presence of melanocytes in mitosis in the dermis qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, 0.95 MM. IN THICKNESS	173602	784	\N	\N	13-140	\N	KIT-03	Kit mutants	IP1184882	AirTable blocks_with_IP_info.csv
1663	13-129	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	785	\N	\N	13-129	\N	KIT-04	Kit mutants	\N	AirTable blocks_with_IP_info.csv
1542	12-200	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	793	\N	\N	12-200	\N	KIT-12	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2943	94-00669 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	953	\N	\N	None	\N	MD-47	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2942	94-00143-2 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	954	\N	\N	None	\N	MD-48	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2936	93-06269-4 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	955	\N	\N	None	\N	MD-49	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2958	95-05959 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	956	\N	\N	None	\N	MD-50	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
10020	BuffyCoat	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1421	\N	\N	\N	\N	SYNX18	\N	\N	Consolidated_data_final.csv
10178	HWA6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1531	\N	\N	\N	\N	SYNX128	\N	\N	Consolidated_data_final.csv
10382	K1_9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1684	\N	\N	\N	\N	SYNX281	\N	\N	Consolidated_data_final.csv
10529	DPN8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1776	\N	\N	\N	\N	SYNX373	\N	\N	Consolidated_data_final.csv
10685	GAK_DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1874	\N	\N	\N	\N	SYNX471	\N	\N	Consolidated_data_final.csv
1559	12-6332A5	8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a papillated epidermis with a symmetric melanocytic proliferation composed of nests of small melanocytes along the junction, with clusters of similar cells in the subjacent dermis.  Many neoplastic cells have pigmented cytoplasm, and there are also surrounding melanophages in the center of the lesion.  Melanocytes in the reticular dermis surround adnexal structures.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.3 cm in thickness. Submitted intact in cassette A.	A) PINK PAPULE WITH DARKLY HYPERPIGMENTED MACULE IN CENTER; SPITZ, PSCN (4 MM PUNCH OF 4 MM LESION), B) 2 MM TAN PAPULE; CMN	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN, WITH MANY MELANOPHAGES	105524	\N	\N	\N	12-6332	A5	SYNAT61	2010-2017	IP1092148	AirTable blocks_with_IP_info.csv
1769	14-53894B	53	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26349,26350	172.6	\N	\N	Sections show an asymmetric irregularly nested proliferation of somewhat spindled melanocytes irregularly distributed along the dermo-epidermal junction and within the papillary dermis. Solar elastosis is noted.	Ellipse, 1.9 x 0.9 x 0.5 cm, including a central 0.6 x 0.5 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections in B. Tips reserved. PL/PL	A) MELANOMA, B) ATYPICAL NEVUS	\N	\N	\N	Melanoma in situ is present to within a millimeter of the peripheral margins.  I have examined additional sections.  Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferative rate of the lesional melanocytes but highlights the asymmetric architecture of this lesion.  I had originally considered the possibility that this was an unusual melanocytic nevus, but due to the asymmetry, irregular nesting, and pagetoid spread of melanocytes highlighted with the immunostain, I think that this lesion is best regarded as a thin melanoma.  I have reviewed this case with Dr. McCalmont who concurs with this assessment.  In terms of staging this is a non-ulcerated lesion and no dermal mitotic figures are noted.  It should be regarded as a pT1a lesion.	MELANOMA, 0.55 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED	222689	\N	\N	\N	14-53894	B	SYNAT111	2010-2017	IP1403832	AirTable blocks_with_IP_info.csv
1776	14-59332	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There are nests of melanocytes at the dermo-epidermal junction, in part extending to the side of a dermal component in which there are nests, cords and strands of melanocytes.  These cells mature with descent into the superficial reticular dermis, and lie in part around adnexal structures.	Skin segment measuring 1.5 x 1.1 x 0.2 cm, quadrisected and entirely submitted. PL/KC	1.2 X 1.1 TAN / BROWN COLOR PATCH; R/O ATYP	\N	\N	\N	There are junctional nests lateral to the dermal component, which may have imparted a macular edge to the clinical appearance of this lesion, but no worrisome features are present.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	528599	\N	\N	\N	14-59332	\N	SYNAT115	2010-2017	IP988413	AirTable blocks_with_IP_info.csv
3115	86502b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	Mel 1	Aperio file AM2-001_1.1\n	\N	\N	\N	\N	Right sole	Punch	\N	\N	\N	1	\N	\N	None	\N	AM2-001	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1778	14-59956	69	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a deep dermal nested and syncytial proliferation of melanocytes with pale pigmented cytoplasm. Interstitial melanophages are noted. Above this, the dermis is fibrotic, and a lymphohistiocytic infiltrate is apparent concurrently.	Cylindrical skin segment, 0.3 cm in diameter and 0.3 cm in thickness, submitted intact. HD/HD	DARK MACULE, PATIENT TREATED SITE RECENTLY WITH VINEGAR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS, R/O MELANOMA-IN-SITU VS. OTHER	\N	\N	\N	The pigmentation seen here stems from a deep penetrating nevus. The scarring noted concurrently at this site was apparently incited by topical application of acetic acid. There is no evidence of melanoma in situ.	DEEP PENETRATING MELANOCYTIC NEVUS WITH AN OVERLYING INFLAMED SCAR	173304	\N	\N	\N	14-59956	\N	SYNAT116	Dysplastic Nevi	IP1409897	AirTable blocks_with_IP_info.csv
1779	14-61297	27	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26347	216.5	\N	\N	There are nests, cords and strands of cytologically bland melanocytes that extend from the junctional zone into the superficial reticular dermis.  The dermal component matures with descent.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/KC	R/O ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	139524	\N	\N	\N	14-61297	\N	SYNAT117	2010-2017	IP1411239	AirTable blocks_with_IP_info.csv
1780	14-61299	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26348	216.5	\N	\N	There are nests, cords and strands of cytologically bland melanocytes that extend from the junctional zone into the superficial reticular dermis.  The dermal component matures with descent.	Skin segment measuring 1.3 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/KC	R/O ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173539	\N	\N	\N	14-61299	\N	SYNAT118	2010-2017	IP1411241	AirTable blocks_with_IP_info.csv
1781	14-61835	21	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There are nests, cords and strands of cytologically bland melanocytes that extend from the junctional zone into the superficial reticular dermis.  The dermal component matures with descent.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. RS/RS	7 MM X 6 MM WITH 2.3 CENTRAL DARK PIGMENTATION, IPIS; NEVUS VS. OTHER	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	139522	\N	\N	\N	14-61835	\N	SYNAT119	2010-2017	IP1411777	AirTable blocks_with_IP_info.csv
1799	14-96795	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show an inverted wedge-shaped proliferation of spindled and fusiform melanocytes with pale pigmented cytoplasm that extends relatively deeply in the reticular dermis. Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous. Many fascicles are noted. There are interspersed melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.7 cm in thickness, bisected and entirely submitted. PL/KC	SUSPICIOUS IRREGULAR MULTI-COLORED MACULE; MELANOMA VS. BLUE NEVUS	\N	\N	\N	This biopsy demonstrates a deep penetrating nevus rather than a blue nevus. There is no evidence of melanoma.	DEEP PENETRATING NEVUS	17733	\N	\N	\N	14-96795	\N	SYNAT120	Dysplastic Nevi	IP1069336	AirTable blocks_with_IP_info.csv
2911	23-107334C2	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show lymph nodes without evidence of metastatic melanoma.	Tissue segment measuring 3.4 x 1.5 x 0.9 cm, serially sectioned perpendicular to the long axis and entirely submitted with four sections in C1 and six sections in C2. Entire node is submitted. ES/ES	A) RIGHT MIDDLE FINGER DISTAL PHALANGE- PROXIMAL LEFT CORNER PREVIOUS MELANOMA IN SITU, B) VOLAR FLAP MARGIN, C) RIGHT AXILLARY SENTINEL LYMPH NODE, D) RIGHT AXILLARY SENTINEL LYMPH NODE #2	\N	\N	\N	There is no evidence of metastatic melanoma in either the routinely-stained section or sections stained with SOX-10 and pan-melanin.	LYMPH NODES, WITH NO EVIDENCE OF METASTATIC MELANOMA	222922	\N	\N	\N	23-107334	C2	SYNAT170	Melanoma Epigenetics	IP2626851	AirTable blocks_with_IP_info.csv
3186	Cell-Line_Xu-11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT210	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3187	Cell-Line_Xu-12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT211	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3188	Cell-Line_Xu-13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT212	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3189	Cell-Line_Xu-14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT213	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3190	Cell-Line_Xu-15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT214	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3191	Cell-Line_Xu-16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT215	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3192	Cell-Line_Xu-17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT216	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3193	Cell-Line_Xu-18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT217	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3194	Cell-Line_Xu-19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT218	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3195	Cell-Line_Xu-20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT219	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3196	Cell-Line_Xu-21	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT220	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3197	Cell-Line_Xu-22	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT221	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3198	Cell-Line_Xu-23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT222	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3199	Cell-Line_Xu-24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT223	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3200	Cell-Line_Xu-25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT224	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3201	Cell-Line_Xu-26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT225	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3202	Cell-Line_Xu-27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT226	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3203	Cell-Line_Xu-28	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT227	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3204	Cell-Line_Xu-29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT228	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3205	Cell-Line_Xu-30	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT229	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3230	Cell-Line_Xu-55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT237	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3231	Cell-Line_Xu-56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT238	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3232	Cell-Line_Xu-57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT239	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3233	Cell-Line_Xu-58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT240	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3234	Cell-Line_Xu-59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT241	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3235	Cell-Line_Xu-60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT242	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3236	Cell-Line_Xu-61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT243	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3237	Cell-Line_Xu-62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT244	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3238	Cell-Line_Xu-63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT245	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3239	Cell-Line_Xu-64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT246	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3503	M040415	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	102	\N	\N	None	\N	AMC-08	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3240	CGH12-067	34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show fibrosing granulation tissue stemming from prior biopsy with a residual array of melanocytes with in the deeper dermis characterized by medium to large melanocytes with abundant amphophilic cytoplasm and pleomorphic nuclei arranged in fascicles and nests.	Ellipse, 1.3 x 0.5 x 0.2 cm, including a central 1.1 x 0.5 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	BX PROVEN PROLIFERATION OF ENLARGED MELANOCYTES, 0.4 CM PINK SCAR	\N	\N	\N	ADDENDUM, March 20, 2012: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system: We continue to favor a melanocytic nevus as the most likely diagnosis.  Comparative genomic hybridization shows no loss or gain of chromosomal material. This favors a benign interpretation, or a low grade neoplasm with limited metastatic potential. About 95% of conventional melanomas show detectable losses or gains with this technique. Nonetheless, the melanocytic proliferation is unusual and has not been removed by this procedure, and further excision to ensure its complete removal is recommended.	RESIDUAL INTRADERMAL PROLIFERATION OF MELANOCYTES, EXTENDING TO BOTH EDGES AND CLOSELY TO THE BASE OF THE SPECIMEN	123298	\N	\N	T	10-75211	A	SYNAT247	2010-2017	IP963226	AirTable blocks_with_IP_info.csv
3241	CGH12-146	14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is an ulcerated compound proliferation of melanocytes accompanied by pseudocarcinomatous epithelial hyperplasia. Situated at, or just beneath the junctional zone are nests of large fusiform melanocytes with relatively monomorphous oval vesicular nuclei and abundant amphophilic cytoplasm. A very high mitotic rate is evident, with some microscopic fields that contain four or five mitotic figures. Maturation with descent, coupled by a diminution in the sizes of aggregations and in the number of mitotic figures is evident toward the base of the lesion.	Six outside slides, PC12-135434-HD:A1,A2 and one corresponding block (A2).	HEMANGIOMA	\N	\N	\N	The mitotic rate in the upper part of the lesion, and the Ki-67 proliferation rate are both remarkable. The differential diagnosis includes a so-called atypical Spitz tumor and a spitzoid melanoma. The findings exceed those seen in a conventional Spitz's nevus. Comparative genomic hybridization did not show chromosomal gains or losses. Based on these findings, I favor a atypical Spitz tumor, i.e. a lesion with very limited metastatic capability. I would obtain a complete excision, if this has not already been done. The literature on sentinel lymph node biopsy and atypical Spitz tumor suggests a very low rate of involvement beyond local lymph nodes, and casts doubt on the utility of this technique in this setting.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	173701	\N	\N	L	12-35761	A	SYNAT248	2010-2017	IP1121579	AirTable blocks_with_IP_info.csv
3242	CGH13-008	20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is a proliferation of large, oval and fusiform melanocytes with a domed surface, marked epidermal hyperplasia with blunt rete ridges, and dermal fascicles and nests of melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei containing large nucleoli. Some mature with descent is evident. The enclosed Ki-67 stain is difficult to evaluate, as many nuclei in the dermis are positive but some may be those of infiltrating lymphocytes.	Seven outside slides, B12-200322 (S12-12868). One corresponding block received 12-3-12.	NO SPECIFIC CLINICAL INFORMATION GIVEN, MANY FEATURES IN COMMON WITH SPITZ'S NEVUS NOTED IN COVER LETTER, AS WELL AS LESS CHARACTERISTIC FEATURES	\N	\N	\N	A focus of lymphatic invasion is present in the superficial portion of the the scout section (the hematoxylin and eosin stained recut that we obtain at the time that sections are cut for immunoperoxidase stains). A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a very low proliferation rate in the dermal component, with only scattered melanocytes staining for the MART-1/tyrosinase component. The base of the specimen is focally involved. Comparative genomic hybridization shows loss of chromosome 14 q, and a gain of 22q. These chromosomal aberrations have been seen in melanoma, but are uncommon. In the face of the other findings and the young age of the patient I would not regard it as sufficient for a diagnosis of spitzoid melanoma. I would regard this lesion as equivalent to an atypical Spitz tumor; many series of such cases have shown only rare involvement beyond local nodes. The base of the specimen is focally involved.  My colleague, Dr. Boris Bastian has reviewed the comparative genomic hybridization data and agrees with this interpretation of it.	MOSTLY INTRADERMAL PROLIFERATION OF LARGE SPITZOID MELANOCYTES, BEST CONSIDERED AS AN ATYPICAL SPITZ TUMOR	173202	\N	\N	L	12-89621	A	SYNAT249	2010-2017	IP1175438	AirTable blocks_with_IP_info.csv
3243	CGH13-010	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a proliferation of melanocytes arrayed singly and in nests, irregularly within the basal layer of the epidermis, in large part at the sides and bases of elongated rete ridges. Most of the junctional component overlies a zone of paucicellular fibrosis. There are discrete nests of small, round melanocytes in the superficial dermis in some foci, with slightly larger cells in dyscohesive nests in another area, bordering a focally dense lymphocytic infiltrate. A few dermal melanocytes have large, hyperchromatic nuclei. In the mid-reticular dermis near one edge of the specimen are small nests, cords and strands of small, round melanocytes, in a partially perivascular pattern.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, trisected and entirely submitted.  PL/PL	6 MM DARK BROWN IRREGULAR MOLE, PROBABLY MELANOMA, ADJACENT TO OLD BIOPSY SCAR, BUT I AM NOT CONVINCED THEY ARE RELATED (DT08-18690)	\N	\N	\N	ADDENDUM, January 25, 2013: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: The lesion overlies a scar, making it likely that it is related to DT08-18690. Portions of the dermal component with small cells in the current case resemble those in the prior one as well. While some features of the current lesion raise the possibility of melanoma, little pagetoid scatter is present and the lesional melanocytes are largely small and monomorphous (with rare cells having large nuclei). Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows many Ki-67 positive melanocytes in the junctional zone and only a few in the dermis. There is a remnant of an unequivocally benign intradermal melanocytic nevus as well.  Given these findings, I re-examined the sections from the 2008 biopsy, and obtained a similar two-color immunoperoxidase stain on it. There are a few single melanocytes above the basal layer, with a low proliferation rate in both junctional and dermal components. The features still favor a dysplastic (Clark's) nevus rather than melanoma with respect to the initial lesion.  On the basis of morphology, I favor a thin melanoma over a dysplastic (Clark's) nevus in regard to the current persistent/recurrent lesion. A re-excision is certainly appropriate, as the lesion is less than 1 mm. from the margin. We performed comparative genomic hybridization to see if unequivocal findings of melanoma were present. There were several low level aberrations (this may indicate aberrations in a minority of cells, with the effect in in our array graph muted by the presence of other melanocytes without these copy number changes). The aberrations are in areas not typically affected in melanoma, including gains in chr. 2p and 7q, and a loss in 3q. Given these idiosyncratic findings, I asked my colleague and the director of our molecular lab, Dr. Boris Bastian to review the comparative genomic hybridization data. He stated that he would be unable to make a diagnosis of melanoma based on the data alone.  In sum, this is a difficult and borderline recurrent lesion whose differential diagnosis includes a thin melanoma, but falls short of being unequivocal diagnostic, either morphologically, with immunoperoxidase stains or molecular methods.	SCAR AND PERSISTENT COMPOUND PROLIFERATION OF MELANOCYTES WITH ATYPICAL FEATURES	173505	\N	\N	T	12-97432	A	SYNAT250	2010-2017	IP300725	AirTable blocks_with_IP_info.csv
3244	CGH13-014	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show an intradermal proliferation of enlarged epithelioid and fusiform melanocytes. These cells are distributed as nests, cords, and fascicles within reticular dermal sclerosis, and a rare dermal melanocyte in mitosis can be found. A modest juxtaposed lymphocytic infiltrate is also noted. In the background, substantial solar elastosis is appreciable.	One outside slide, S12-49334 A-1 (MR# 30392441) and one corresponding block.	PINK PAPULE 3-4 MM X MONTHS; ? FOLLICULAR CYST VS. BASAL CELL CARCINOMA, WITH DISTANT HISTORY OF MELANOMA - MOLECULAR STUDIES??	\N	\N	\N	I believe this partial biopsy demonstrates a desmoplastic Spitz nevus. To assess primary spitzoid melanoma and metastatic melanoma as additional possibilities in the differential diagnosis, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number abnormalities, as can be seen in association with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 11p with no other chromosomal gains or losses. Gain in chromosome 11p as a monoaberration has been documented in a subset of Spitz nevi that also harbor HRAS mutation. This genomic aberration has not been demonstrated to be present in association with melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, we have confirmed that this melanocytic nevus represents a Spitz nevus variant with associated gain in chromosome 11p, which implies that HRAS mutation is present. As this is only a partial biopsy, conservative complete reexcision of this site can be considered if the patient is interested in complete removal of any residuum and the prevention of persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5. (Please note that this paper describes a tumor with genomic findings similar to those seen in this case.)	DESMOPLASTIC INTRADERMAL SPITZ NEVUS	173305	\N	\N	L	13-788	A	SYNAT251	2010-2017	IP1185530	AirTable blocks_with_IP_info.csv
3118	86502f	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-001_1.4	\N	\N	\N	\N	Right sole	\N	\N	\N	\N	1	\N	\N	None	\N	AM2-001	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3101	78821-1b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-002_1.2	\N	\N	\N	\N	Left Hallux	\N	\N	\N	\N	2	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3102	78821-1c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-002_1.3	\N	\N	\N	\N	Left Hallux	Punch	\N	\N	\N	2	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3103	78821-2a	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-002_2.1	\N	\N	\N	\N	Sentinel node	\N	\N	\N	\N	2	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3104	78821-2b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-002_2.2	\N	\N	\N	\N	Sentinel node	\N	\N	\N	\N	2	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3038	534-1-11.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-004_1.1	\N	\N	\N	\N	left plantar skin	\N	\N	\N	\N	3	\N	\N	None	\N	AM2-004	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3245	CGH13-026	3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. The surface is coarsely papillated. Nests of melanocytes predominate over those distributed singly along the junctional zone, with subtle suprabasilar scatter of single cells in small foci. The overlying epidermis is thinned in the center of the lesion, where very large nests of melanocytes are evident superficially. Smaller ones are seen in the lower part of the lesion.	One outside slide, SCD-12-35582:A, and one corresponding block.	7 X 5 MM TAN OVAL PAPULE X 1 YR W/ RECENT HX RAPID GROWTH AND BLEEDING CENTRALLY, FRIABLE PINK RED RAISED CENTRAL PAPULE; UNUSUAL VV, PYOGENIC GRANULOMA, R/O MM	\N	\N	\N	A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows scattered mitotic figures in dermal melanocytes, mostly in the upper part of the lesion. Comparative genomic hybridization shows discrete areas of losses involving chromosome 1p, and to a lesser extent, chromosome 1q. While losses involving chromosome 1p can be seen in melanoma, this is seldom an isolated finding. Under the circumstances, and given the age of the patient I would prefer to regard this lesion as equivalent to a so-called atypical Spitz tumor, rather than assign a diagnosis of spitzoid melanoma. Despite the surgically difficult location, a narrow reexcision to obtain histopathologically clear margins seems warranted. Given the low predictive value of sentinel lymph node positivity in this setting, I do not advise it.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173208	\N	\N	L	13-479	A	SYNAT252	2010-2017	IP1185221	AirTable blocks_with_IP_info.csv
3246	CGH13-034	36	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show melanocytes arrayed in largely dermal fashion. Superficially, there are large nests and syncytia of enlarged epithelioid melanocytes in the upper dermis, and these melanocytes have finely melanized cytoplasm. In a recut section, some of these melanocytes appear spitzoid. More deeply, there are fusiform and dendritic melanocytes that are much smaller residing in the reticular dermis, and interstitial melanophages can be seen.	Four outside slides, CSI-13-225, and one corresponding block.	4 MM BROWN FIRM PAPULE, (+) PIGMENTED AT BASE, ONSET 2 YEARS AGO, INCREASING IN SIZE + COLOR CHANGES X 1 YEAR, 2 SECTIONS IN BOTTLE, PROCESS ALL FRAGMENTS; SK, RULE OUT MM	\N	\N	\N	ADDENDUM, February 8, 2013: As I reported previously, my differential diagnosis included a variant of cellular blue nevus, a combined melanocytic nevus, and melanoma ex blue nevus. Your submitted immunostains demonstrate avid expression of HMB-45, as would be expected with a blue nevus or blue nevus-like melanoma. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show slightly elevated nuclear expression of Ki-67, thus implying that cellular proliferation is elevated, which is of potential concern. A p16 immunostain demonstrates preservation of expression, which implies that an underlying anomaly in chromosome 9p is not present. This is the type of challenging case for which array-based comparative genomic hybridization (aCGH) can be applied to screen for genomic copy number anomalies, as can be seen with melanoma. Per your request and approval, completed molecular assessment. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 7, 8, and 22q. The identification of multiple chromosomal copy number aberrations indicates genomic instability, as is stereotypical of malignancies such as melanoma. The aCGH profile that we have defined is incompatible with a benign interpretation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH demonstrates that this atypical melanocytic tumor represents melanoma that has developed secondarily in a blue nevus. This entity can be referred to as 'blue nevus-like melanoma'. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration in the current sections. Therefore, it provisionally represents melanoma of stage pT2a (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.  This report was reissued on April 24, 2014, to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF AT LEAST 1.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A BLUE NEVUS	100678	\N	\N	L	13-3732	A	SYNAT253	2010-2017	IP1188475	AirTable blocks_with_IP_info.csv
3247	CGH13-094	23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is a large polypoid segment of modified skin within which there is a relatively well-circumscribed oval mass composed of densely fibrotic stroma, and relatively small round aggregations of large polygonal and oval melanocytes. The latter have abundant homogeneous-appearing eosinophilic cytoplasm and strikingly pleomorphic, vesicular nuclei with large nucleoli. Mitotic figures are rare. The enclosed Ki-67 stain shows a proliferation rate estimated at 5 percent.	Twelve outside slides, 13-SUH-5219 (1A-1B) and corresponding block 1A.	BIOPSY ORIGINATES FROM A 23 YEAR OLD WOMAN WHO PRESENT AT CESAREAN SECTION WITH A PERIANAL MASS, BENIGN LOOKING EXOPHYTIC PERIANAL MASS	\N	\N	\N	Comparative genomic hybridization shows a gain involving chromosome 7q. Isolated gains of 7q can be seen in some Spitz's nevi. In this case, a rearrangement involving the b-raf locus is also present, a finding that we have not encountered in this group. I would regard this lesion as equivalent to an atypical Spitz tumor rather than a Spitz's nevus or spitzoid melanoma. A narrow re-excision despite the difficult site would be prudent. My colleague, Dr. Boris Bastian has reviewed the comparative genomic hybridization data and agrees with this interpretation of it. Atypical Spitz tumors have a high rate of local nodal involvement, as assessed by sentinel lymph node biopsy. However, distant metastasis is very rare, making it unlikely that such biopsies, let alone completion lymphadenectomy based on them are of benefit.	INTRADERMAL PROLIFERATION OF LARGE SPITZOID MELANOCYTES, WITH UNUSUAL GENOMIC FEATURES	173521	\N	\N	L	13-18243	A	SYNAT254	2010-2017	IP1202986	AirTable blocks_with_IP_info.csv
3248	CGH14-050	34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a roughly oval mass of melanocytes within fibrofatty tissue. At the periphery of the mass are cords and strands of small, round cells with relatively scant pale cytoplasm and monomorphous oval nuclei containing small nucleoli. These cells are separated by thickened collagen bundles in some areas, with a few melanophages. The center of the lesion is more cellular. There are sheets of cells with inconspicuous pale cytoplasm and considerably larger, vesicular nuclei with moderately enlarged reddish nucleoli. Several mitotic figures are evident (but usually 1-2 per mm square). There are occasional multinucleated cells, as well as pseudovascular spaces within the masses of melanocytes. The enclosed immunostains include positive S100 and Melan-A stains, as well as an HMB-45 stain which marks both the smaller and larger melanocytes.	Twelve outside slides, SC14-637:A/1,A/2, XPS-14-931:B/1,B/2 (including five unstained slides cut from block A/1) and two corresponding blocks.	THIRD OPINION, NO HISTORY OF MELANOMA, PRESENT FOR YEARS AND HAD POSSIBLY BEEN INCREASING IN SIZE SLIGHTLY, INTRAOPERATIVELY IT SHELLED OUT EASILY AND DID NOT APPEAR TO BE CONNECTED OR INVOLVING THE OVERLYING EPIDERMIS; THROMBOSED VESSEL	\N	\N	\N	The HMB-45 staining of both components of the lesion is in keeping with both populations deriving from a blue nevus, probably a cellular blue nevus (the quotation marks reflect my unhappiness with the common/cellular dichotomy). The more cellular population lacks the typical nested, or lobular peninsula-like architecture of a cellular blue nevus, nuclei are somewhat enlarged and crowded, and the mitotic rate is higher than in most such lesions. However, the striking cytologic atypia, necrosis and lymphocytic infiltrate seen in some melanomas arising in blue nevi are not evident here. Some would term the current changes atypical blue nevus, a term I am not fond of but may have some applicability in this case. In keeping with this borderline character, comparative genomic hybridization shows an aberration not typically seen in melanoma. There is a gain involving chr. 9, which is often lost in melanoma. A re-excision of this area seems appropriate. In the reference below, the number of aberrations seen in blue nevus-like melanoma was higher than in atypical blue nevi or in conventional cellular blue nevi; with one aberration, and that one not typically associated with melanoma, this intermediate category seems best.  Reference:  Maize JC Jr, McCalmont TH, Carlson JA, Busam KJ, Kutzner H, Bastian BC. Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol. 2005 Sep;29(9):1214-20.	ATYPICAL MELANOCYTIC PROLIFERATION ARISING IN A CELLULAR BLUE NEVUS	173788	\N	\N	L	14-15427	A	SYNAT255	2010-2017	IP1365348	AirTable blocks_with_IP_info.csv
3546	PG_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT256	2010-2017	\N	AirTable blocks_with_IP_info.csv
3251	CGH19-097	3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a dome shaped skin segment with an effaced epidermis that contains occasional nests of spindled and epithelioid melanocytes. Within the dermis there are nests of large epithelioid melanocytes, with occasional large multinucleate melanocytes. The proliferation has a wedge-shaped profile and in the reticular dermis melanocytes are positioned between thickened collagen bundles. There is a sparse lymphocytic infiltrate.	Eleven outside slides, 19/CH18523, including 10 unstained slides. One corresponding block received 6/24/19.	ATYPICAL - LOOKS LIKE MELANOMA BUT 3 Y/O? CGH USEFUL	\N	\N	\N	ADDENDUM, July 19, 2019: Dear Dr. Hitchcock,  Thank you for sending this case in consultation. I agree with you that this spitzoid proliferation is unusual and has a slightly asymmetric architecture. However it does mature and the FISH findings are reassuring. We performed array comparative genomic hybridization specifically on the superficial nodular area within the tumor that shows greater cytomorphologic atypia and mitotic activity. This demonstrated loss of chromosome 9 but no other significant copy number alterations. p16 immunohistochemistry demonstrates strong staining in the majority of the tumor, but no staining in the area that we tested by aCGH. I believe this case represents an atypical Spitz tumor arising in a Spitz nevus due to loss of CDKN2A (on chromosome 9p). The aCGH findings do not support a diagnosis of melanoma.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173602	\N	\N	N	19-44904	A	SYNAT259	2010-2017	IP2049186	AirTable blocks_with_IP_info.csv
3261	D12_M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT263	2010-2017	\N	AirTable blocks_with_IP_info.csv
3268	DM8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	None	\N	SYNAT264	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3040	534-1-11.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	MIS2	AM2-004_1.3	\N	\N	\N	\N	left plantar skin	Punch	\N	\N	\N	3	\N	\N	None	\N	AM2-004	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3039	534-1-11.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-004_1.2	\N	\N	\N	\N	left plantar skin	Punch	\N	\N	\N	3	\N	\N	None	\N	AM2-004	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3123	86541-2b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-006_2.2	\N	\N	\N	\N	Right inguinal	\N	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3121	86541-1g	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	MIS1	AM2-006_1.3	\N	\N	\N	\N	Heel	Punch	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3122	86541-2a	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-006_2.1	\N	\N	\N	\N	Right inguinal	\N	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3124	86541-2c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Normal	AM2-006_2.3	\N	\N	\N	\N	Right inguinal	Punch	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3119	86541-1E	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-006_1.1	\N	\N	\N	\N	Heel	Punch	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3113	79447-c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-007_1.3	\N	\N	\N	\N	Skin	Punch	\N	\N	\N	5	\N	\N	None	\N	AM2-007	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3114	79447-d	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-007_1.4	\N	\N	\N	\N	Skin	Punch	\N	\N	\N	5	\N	\N	None	\N	AM2-007	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3112	79447-b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-007_1.2	\N	\N	\N	\N	Skin	\N	\N	\N	\N	5	\N	\N	None	\N	AM2-007	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3105	79049-1a	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-008_1.1	\N	\N	\N	\N	Right hallux	Punch	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3107	79049-1c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-008_1.3	\N	\N	\N	\N	Right hallux	Punch	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3109	79049-2a	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-008_2.1	\N	\N	\N	\N	Sentinel node	Punch	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3110	79049-2b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-008_2.2	\N	\N	\N	\N	Sentinel node	\N	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3108	79049-1d	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-008_1.4	\N	\N	\N	\N	Right hallux	\N	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3106	79049-1b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-008_1.2	\N	\N	\N	\N	Right hallux	\N	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3033	352-1-15.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	\N	\N	\N	\N	\N	Left heel	Punch	\N	\N	\N	7	\N	\N	None	\N	AM2-012	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3035	352-1-15.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	Left heel	\N	\N	\N	\N	7	\N	\N	None	\N	AM2-012	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3034	352-1-15.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	4/5 involved	\N	\N	\N	\N	Inguinal lymph node	\N	\N	\N	\N	7	\N	\N	None	\N	AM2-012	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3057	2686-1-13.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-014_1.1	\N	\N	\N	\N	Finger	Punch	\N	\N	\N	8	\N	\N	None	\N	AM2-014	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3058	2686-1-13.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-014_1.2	\N	\N	\N	\N	Finger	\N	\N	\N	\N	8	\N	\N	None	\N	AM2-014	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3050	1586-2-13-B	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-018_1.2, 4 small areas	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	9	\N	\N	None	\N	AM2-018	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3049	1586-2-13-A	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-018_1.1	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	9	\N	\N	None	\N	AM2-018	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3051	1586-2-13-C	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-018_1.3	\N	\N	\N	\N	Hallux	Punch	\N	\N	\N	9	\N	\N	None	\N	AM2-018	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3036	385/14	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-019_1.1	\N	\N	\N	\N	Left foot	Punch	\N	\N	\N	10	\N	\N	None	\N	AM2-019	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3064	4070/3/13.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.4, met in 1/17	\N	\N	\N	\N	axillary LN	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3066	4070/3/13.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.6, met in 1/17	\N	\N	\N	\N	axillary LN	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3061	4070/2/13.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-022_1.1	\N	\N	\N	\N	finger	Punch	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3065	4070/3/13.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.5, met in 1/17	\N	\N	\N	\N	axillary LN	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3063	4070/2/13.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.3	\N	\N	\N	\N	finger	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3062	4070/2/13.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.2	\N	\N	\N	\N	finger	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3128	501950A3	\N	\N	\N	\N	\N	\N	\N	12	\N	FFPE	\N	\N	\N	Mel 1	AM2-027_1	\N	\N	\N	\N	Sole	Scraping	\N	\N	\N	12	\N	\N	None	\N	AM2-027	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3129	501950C	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	AM2-027_2	\N	\N	\N	\N	LN	\N	\N	\N	\N	12	\N	\N	None	\N	AM2-027	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3134	610186D	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	AM2-029_4, Met	\N	\N	\N	\N	\N	\N	\N	\N	\N	13	\N	\N	None	\N	AM2-029	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3131	610186A	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	Mel 1	AM2-029_1	\N	\N	\N	\N	Left Heel	Scraping	\N	\N	\N	13	\N	\N	None	\N	AM2-029	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3133	610186C	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	AM2-029_3, Met	\N	\N	\N	\N	\N	\N	\N	\N	\N	13	\N	\N	None	\N	AM2-029	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3130	604076	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	Mel 1	AM2-030_1	\N	\N	\N	\N	Right Heel	Scraping	\N	\N	\N	14	\N	\N	None	\N	AM2-030	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3127	488836A	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	Mel 1	AM2-039_1	\N	\N	\N	\N	Ungueal	Scraping	\N	\N	\N	15	\N	\N	None	\N	AM2-039	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3334	H13.10897/11	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-040_1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	16	\N	\N	None	\N	AM2-040	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3138	B13.26332/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-040_4	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	16	\N	\N	None	\N	AM2-040	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3333	H13.10897/2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-040_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	16	\N	\N	None	\N	AM2-040	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3136	B06.41962/3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-041_1	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	17	\N	\N	None	\N	AM2-041	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3140	B14.2561/12	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-041_5	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	17	\N	\N	None	\N	AM2-041	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3335	H13.21587/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-041_4	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	17	\N	\N	None	\N	AM2-041	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3137	B06.41962/5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-041_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	17	\N	\N	None	\N	AM2-041	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3148	B62056/15	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	MIS2	AM2-042_1	\N	\N	\N	\N	Primary tumor (Punch)	\N	\N	\N	\N	18	\N	\N	None	\N	AM2-042	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3340	H16.660	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	Mel 1	AM2-042_2	\N	\N	\N	\N	Primary tumor	Scraping	\N	\N	\N	18	\N	\N	None	\N	AM2-042	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3141	B15.28523/11	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	Metastasis	 AM2-042_3, image not shown	\N	\N	\N	\N	Lung Metastasis	Scraping	\N	\N	\N	18	\N	\N	None	\N	AM2-042	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3337	H15.2058/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-043_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	19	\N	\N	None	\N	AM2-043	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3330	H12.27716/7	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-043_1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	19	\N	\N	None	\N	AM2-043	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3145	B2008.3067/5	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-045_2	\N	\N	\N	\N	Lymph Node Met	\N	\N	\N	\N	20	\N	\N	None	\N	AM2-045	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3344	H2007.215/5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-045_1	\N	\N	\N	\N	Primary tumor	\N	\N	\N	\N	20	\N	\N	None	\N	AM2-045	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3327	H 2008.8956/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-045_3, two small areas	\N	\N	\N	\N	Dermal Met	\N	\N	\N	\N	20	\N	\N	None	\N	AM2-045	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3146	B2008.24393/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-046_3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	21	\N	\N	None	\N	AM2-046	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3347	H2007.4636/9	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-046_1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	21	\N	\N	None	\N	AM2-046	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3144	B2007.15494/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-046_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	21	\N	\N	None	\N	AM2-046	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3346	H2007.358/3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	MIS1	AM2-048_2	\N	\N	\N	\N	Primary tumor	\N	\N	\N	\N	22	\N	\N	None	\N	AM2-048	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3345	H2007.358/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-048_1	\N	\N	\N	\N	Primary tumor	\N	\N	\N	\N	22	\N	\N	None	\N	AM2-048	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3143	B2007.998/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-048_3	\N	\N	\N	\N	Met	\N	\N	\N	\N	22	\N	\N	None	\N	AM2-048	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3385	K1-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	MIS	AM2-049_1.1; AM2-049_1.2	\N	\N	\N	\N	in situ (radial growth phase)	Scraping	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3387	K1-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Mel 1	AM2-049_2	\N	\N	\N	\N	invasive (vertical growth phase)	Scraping	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3386	K1-A.2	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3389	K1-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Normal	AM2-049_4.1; AM2-049_4.2	\N	\N	\N	\N	normal	Scraping	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3388	K1-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-049_3.1;AM2-049_3.2	\N	\N	\N	\N	metastasis	\N	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3390	K2-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	MIS	AM2-050_1.1; AM2-050_1.2	\N	\N	\N	\N	in situ (radial growth phase)	\N	\N	\N	\N	24	\N	\N	None	\N	AM2-050	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3392	K2-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-050_3.1; AM2-050_3.2	\N	\N	\N	\N	metastasis	\N	\N	\N	\N	24	\N	\N	None	\N	AM2-050	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3393	K2-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Normal	AM2-050_4.1; AM2-050_4.2	\N	\N	\N	\N	normal	Scraping	\N	\N	\N	24	\N	\N	None	\N	AM2-050	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3391	K2-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Mel	AM2-050_2.1; AM2-050_2.2	\N	\N	\N	\N	invasive (vertical growth phase)	Scraping	\N	\N	\N	24	\N	\N	None	\N	AM2-050	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3089	19111/14.5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-051_1.5	\N	\N	\N	\N	Right heel	\N	\N	\N	\N	25	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3086	19111/14.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Normal	AM2-051_1.2, No metastasis identified	\N	\N	\N	\N	Inguinal lymph node	Punch	\N	\N	\N	25	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3088	19111/14.4	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-051_1.4	\N	\N	\N	\N	right heel	\N	\N	\N	\N	25	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3087	19111/14.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-051_1.3	\N	\N	\N	\N	right heel	Punch	\N	\N	\N	25	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3090	21159 A5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-053_1.1	\N	\N	\N	\N	Left foot	Punch	\N	\N	\N	26	\N	\N	None	\N	AM2-053	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3093	21159 G5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-053_1.4, No metastasis identified	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	26	\N	\N	None	\N	AM2-053	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3091	21159 A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-053_1.2	\N	\N	\N	\N	Left foot	\N	\N	\N	\N	26	\N	\N	None	\N	AM2-053	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3092	21159 G2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Normal	AM2-053_1.3, No metastasis identified	\N	\N	\N	\N	inguinal lymph node	Punch	\N	\N	\N	26	\N	\N	None	\N	AM2-053	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3097	38637-16.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-055_1.3, also looks LN met	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	27	\N	\N	None	\N	AM2-055	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3096	38637-16.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-055_1.2	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	27	\N	\N	None	\N	AM2-055	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3095	38637-16.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-055_1.1	\N	\N	\N	\N	Heel	Punch	\N	\N	\N	27	\N	\N	None	\N	AM2-055	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3332	H13.5620/1	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-057_2	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	28	\N	\N	None	\N	AM2-057	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3329	H09.22183/1	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Primary tumor	AM2-057_1	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	28	\N	\N	None	\N	AM2-057	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3343	H18.7977	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-058_3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	29	\N	\N	None	\N	AM2-058	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3342	H16.5818/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-058_2	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	29	\N	\N	None	\N	AM2-058	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3338	H15.5120/1	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Primary tumor	AM2-058_1, no matched normal	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	29	\N	\N	None	\N	AM2-058	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3336	H14.26934/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Primary tumor	AM2-059_1	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	30	\N	\N	None	\N	AM2-059	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3348	HS17.35/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-059_2	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	30	\N	\N	None	\N	AM2-059	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3339	H15.19121/7	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Primary tumor	AM2-060_1	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	31	\N	\N	None	\N	AM2-060	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3341	H16.872/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-060_2	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	31	\N	\N	None	\N	AM2-060	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3396	K3-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Normal	AM2-061_1	\N	\N	\N	\N	Normal lymphocyte	Scraping	\N	\N	\N	32	\N	\N	None	\N	AM2-061	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3395	K3-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-061_3, microdissected	\N	\N	\N	\N	Lymph node metastasis	Scraping	\N	\N	\N	32	\N	\N	None	\N	AM2-061	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3394	K3-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Mel 1	AM2-061_2	\N	\N	\N	\N	Melanoma in-situ and invasive melanoma components	Scraping	\N	\N	\N	32	\N	\N	None	\N	AM2-061	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3399	K4-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-062_4, microdissected	\N	\N	\N	\N	Metastasis, unknown location. Necrotic and ulcerated	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3401	K4-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Normal	AM2-062_1	\N	\N	\N	\N	Normal skin	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3397	K4-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	MIS2	AM2-062_2	\N	\N	\N	\N	Melanoma in-situ	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3400	K4-C-2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	AM2-062-5	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3398	K4-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Mel 2	AM2-062_3	\N	\N	\N	\N	Invasive primary	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3402	K5-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-063_1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	34	\N	\N	None	\N	AM2-063	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3403	K5-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-063_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	34	\N	\N	None	\N	AM2-063	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3404	K6-A-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-065-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	35	\N	\N	None	\N	AM2-065	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3405	K6-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-065-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	35	\N	\N	None	\N	AM2-065	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3409	K7-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-066-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	36	\N	\N	None	\N	AM2-066	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3406	K7-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-066-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	36	\N	\N	None	\N	AM2-066	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3407	K7-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-066-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	36	\N	\N	None	\N	AM2-066	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3408	K7-B-2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	AM2-066-4	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	36	\N	\N	None	\N	AM2-066	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3410	K8-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-067-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	37	\N	\N	None	\N	AM2-067	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3411	K8-B	\N	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	\N	\N	AM2-067-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	37	\N	\N	None	\N	AM2-067	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3414	K9-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-068-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	38	\N	\N	None	\N	AM2-068	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3412	K9-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-068-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	38	\N	\N	None	\N	AM2-068	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3413	K9-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-068-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	38	\N	\N	None	\N	AM2-068	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3415	K10-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-069-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	39	\N	\N	None	\N	AM2-069	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3417	K10-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-069-4	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	39	\N	\N	None	\N	AM2-069	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3418	K10-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-069-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	39	\N	\N	None	\N	AM2-069	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3416	K10-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-069-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	39	\N	\N	None	\N	AM2-069	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3421	K11-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-070-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	40	\N	\N	None	\N	AM2-070	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3420	K11-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-070-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	40	\N	\N	None	\N	AM2-070	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3419	K11-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-070-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	40	\N	\N	None	\N	AM2-070	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3422	K12-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-071-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	41	\N	\N	None	\N	AM2-071	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3423	K12-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-071-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	41	\N	\N	None	\N	AM2-071	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3424	K12-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-071-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	41	\N	\N	None	\N	AM2-071	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3427	K13-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-072-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	42	\N	\N	None	\N	AM2-072	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3426	K13-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-072-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	42	\N	\N	None	\N	AM2-072	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3425	K13-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-072-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	42	\N	\N	None	\N	AM2-072	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3429	K14-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-073-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	43	\N	\N	None	\N	AM2-073	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3430	K14-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-073-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	43	\N	\N	None	\N	AM2-073	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3428	K14-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-073-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	43	\N	\N	None	\N	AM2-073	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3431	K15-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	BLACK BOX 1	\N	\N	\N	AM2-074-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	44	\N	\N	None	\N	AM2-074	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3432	K15-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-074-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	44	\N	\N	None	\N	AM2-074	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3434	K16-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-075-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	45	\N	\N	None	\N	AM2-075	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3433	K16-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-075-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	45	\N	\N	None	\N	AM2-075	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3435	K17-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-076-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	46	\N	\N	None	\N	AM2-076	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3437	K17-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-076-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	46	\N	\N	None	\N	AM2-076	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3436	K17-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-076-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	46	\N	\N	None	\N	AM2-076	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3438	K18-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-077	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	47	\N	\N	None	\N	AM2-077	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3439	K19-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-078	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	48	\N	\N	None	\N	AM2-078	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3440	K20-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-079	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	49	\N	\N	None	\N	AM2-079	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3441	K21-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-080	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	50	\N	\N	None	\N	AM2-080	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3442	K22-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-081	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	51	\N	\N	None	\N	AM2-081	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3443	K22-D	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	AM2-081-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	51	\N	\N	None	\N	AM2-081	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3445	K23-D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-082-2; AM2-082-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	52	\N	\N	None	\N	AM2-082	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3444	K23-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-082	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	52	\N	\N	None	\N	AM2-082	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3446	K24-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-083	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	53	\N	\N	None	\N	AM2-083	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3328	H 2015.1871	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-084-1, Didn't receive slides	\N	\N	\N	\N	\N	\N	\N	\N	\N	54	\N	\N	None	\N	AM2-084	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3142	B17.80125 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Metastasis	AM2-084-3, dermal/subcutaneous metastasis, stage III A	\N	\N	\N	\N	left groin	\N	\N	\N	\N	54	\N	\N	None	\N	AM2-084	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3147	B2015.54040	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-084-2, Didn't receive slides	\N	\N	\N	\N	\N	\N	\N	\N	\N	54	\N	\N	None	\N	AM2-084	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3331	H13.3143 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-085-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	55	\N	\N	None	\N	AM2-085	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3139	B14. 951 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-085-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	55	\N	\N	None	\N	AM2-085	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1851	15-29364A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2	\N	\N	Metastasis	AM2-086-3	\N	\N	\N	\N	right inguinal lymph node	Scraping	\N	\N	\N	56	\N	\N	15-29364	A1	AM2-086	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1750	14-31886	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-4; BOX-12	\N	\N	Acrolentiginous melanoma	AM2-086-2, recurrent	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	56	\N	\N	14-31886	\N	AM2-086	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1698	13-30315A3	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-9; BOX-13	\N	\N	Acrolentiginous melanoma	 AM2-086-1, wide excision, pT4bN0	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	56	\N	\N	13-30315	A3	AM2-086	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1382	10-22319	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-087-1, subtotal amputation, stage IIA at least	\N	\N	\N	\N	left thumb	Scraping	\N	\N	\N	57	\N	\N	10-22319	\N	AM2-087	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1836	15-14674	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Metastasis	AM2-087-2, Soft tissue, echo-guided biopsy	\N	\N	\N	\N	left axillary	Scraping	\N	\N	\N	57	\N	\N	15-14674	\N	AM2-087	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3501	M040204	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	101	\N	\N	None	\N	AMC-07	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1840	15-17010A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-8; BOX-13	\N	\N	Acral melanoma	AM2-088-1, wide excision	\N	\N	\N	\N	left sole	Scraping	\N	\N	\N	58	\N	\N	15-17010	A1	AM2-088	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1841	15-17010A2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	non-tumor	FFPE	\N	\N	\N	58	\N	\N	15-17010	A2	AM2-088	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1842	15-17010C1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-8	\N	\N	Metastasis	AM2-088-2, metastatic melanoma (2/6)	\N	\N	\N	\N	left  inguinal and femoral lymph node	Scraping	\N	\N	\N	58	\N	\N	15-17010	C1	AM2-088	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1620	12-24502A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-089-1	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	59	\N	\N	12-24502	A1	AM2-089	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1621	12-24502B	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Metastasis	AM2-089-2, labeled as 2, lymphadenectomy, 	\N	\N	\N	\N	right inguinal lymph node	Scraping	\N	\N	\N	59	\N	\N	12-24502	B	AM2-089	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1617	12-24189A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-12	\N	\N	Acrolentiginous melanoma	AM2-090-1, amputation	\N	\N	\N	\N	right 4-5th toe 	Scraping	\N	\N	\N	60	\N	\N	12-24189	A1	AM2-090	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1619	12-24455	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3	\N	\N	Metastasis	AM2-090-2, bronchoscopic biopsy	\N	\N	\N	\N	right lower lobe lung	Scraping	\N	\N	\N	60	\N	\N	12-24455	\N	AM2-090	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1470	11-36301A5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	non-tumor and melanoma in situ	FFPE	\N	\N	\N	61	\N	\N	11-36301	A5	AM2-091	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1467	11-35367	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-091-1, AM2-091-2, labeled as "A", wide excision, Stage IIIC	\N	\N	\N	\N	left heel	Scraping	\N	\N	\N	61	\N	\N	11-35367	\N	AM2-091	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1469	11-36301A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	tumor	FFPE	\N	\N	\N	61	\N	\N	11-36301	A1	AM2-091	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1471	11-36301C1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	groin metastatic lymph node	FFPE	\N	\N	\N	61	\N	\N	11-36301	C1	AM2-091	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1391	10-38178A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-092-1, amputation, pT1aN0	\N	\N	\N	\N	left great toe	Scraping	\N	\N	\N	62	\N	\N	10-38178	A1	AM2-092	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1628	12-41833E1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Metastasis	AM2-092-2, malignant melanoma, metastatic (3/6)	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	62	\N	\N	12-41833	E1	AM2-092	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1706	13-37513	\N	\N	\N	\N	\N	\N	\N	0	\N	\N	\N	\N	\N	Metastasis	AM2-093-2, No slides were sent from TW, ultrasound-guided biopsy, malignant melanoma, metastatic	\N	\N	\N	\N	right subpleural lung	\N	\N	\N	\N	63	\N	\N	13-37513	\N	AM2-093	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1381	10-22013	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-093-1, pT4b	\N	\N	\N	\N	left sole	Scraping	\N	\N	\N	63	\N	\N	10-22013	\N	AM2-093	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1379	10-18253B	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3	\N	\N	Metastasis	AM2-094-2, lymphadenectomy, malignant melanoma, metastatic (1/1)	\N	\N	\N	\N	lower left inguinal sentinel lymph node	Scraping	\N	\N	\N	64	\N	\N	10-18253	B	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1388	10-30525-4 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	987	\N	\N	None	\N	MD-86	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1378	10-17734	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	left ankle , basal hyperpigmentation	FFPE	\N	\N	\N	64	\N	\N	10-17734	\N	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1376	10-15411B	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3	\N	\N	Acrolentiginous melanoma	AM2-094-1, incisional biopsy, clark level V (5.5 mm in depth), at least stage IIB	\N	\N	\N	\N	left ankle	Scraping	\N	\N	\N	64	\N	\N	10-15411	B	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1392	10-39146A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4	\N	\N	\N	\N	\N	\N	\N	\N	Skin, lower leg, left, excision, malignant melanoma, metastatic	FFPE	\N	\N	\N	64	\N	\N	10-39146	A1	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1393	10-39146A2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4	\N	\N	\N	\N	\N	\N	\N	\N	Skin, lower leg, left, excision, malignant melanoma, metastatic	FFPE	\N	\N	\N	64	\N	\N	10-39146	A2	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1375	10-14390	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-11	\N	\N	MIS	AM2-095-1	\N	\N	\N	\N	left heel	Scraping	\N	\N	\N	65	\N	\N	10-14390	\N	AM2-095	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1374	10-14100	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5; BOX-9	\N	\N	Metastasis	AM2-095-2	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	65	\N	\N	10-14100	\N	AM2-095	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1377	10-15514A2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-9; BOX-16	\N	\N	Metastasis	AM2-095-4	\N	\N	\N	\N	left cerebellum	Scraping	\N	\N	\N	65	\N	\N	10-15514	A2	AM2-095	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1373	10-13619	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4; BOX-9	\N	\N	Metastasis	AM2-095-3, endoscopic biopsy	\N	\N	\N	\N	duodenum	Scraping	\N	\N	\N	65	\N	\N	10-13619	\N	AM2-095	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1817	15-3736C5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	non-tumor and tumor	FFPE	\N	\N	\N	66	\N	\N	15-3736	C5	AM2-096	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1843	15-18463	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5; BOX-11	\N	\N	MELANOMA	AM2-096-1, soft tissue, excision	\N	\N	\N	\N	Soft tissue, groin, left, excision, malignant melanoma; left groin	Scraping	\N	\N	\N	66	\N	\N	15-18463	\N	AM2-096	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1816	15-3736C1	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-2; BOX-11	\N	\N	Acrolentiginous melanoma	AM2-096-1, wide excision	\N	\N	\N	\N	left sole 	Scraping	\N	\N	\N	66	\N	\N	15-3736	C1	AM2-096	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1815	15-3736A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-11	\N	\N	Metastasis	AM2-096-2	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	66	\N	\N	15-3736	A1	AM2-096	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2887	23-6349A3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32814	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	23-6349	A3	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1819	15-4505B	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4	\N	\N	Metastasis	AM2-097-2, lymphadenectomy, melanoma, metastatic (1/1)	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	67	\N	\N	15-4505	B	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2785	22-25497A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32819	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	22-25497	A1	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2795	22-44747A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32816	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	22-44747	A1	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2786	22-25497A2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32815	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	22-25497	A2	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2796	22-44747A2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32817	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	22-44747	A2	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2886	23-6349A2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32813	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	23-6349	A2	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1818	15-4505A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-10	\N	\N	Acral melanoma	AM2-097-1, wide excision	\N	\N	\N	\N	left heel 	Scraping	\N	\N	\N	67	\N	\N	15-4505	A1	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2885	23-6349A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32818	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	23-6349	A1	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1820	15-4505C	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5; BOX-10	\N	\N	Metastasis	AM2-097-3, lymphadenectomy, melanoma, metastatic (1/1)	\N	\N	\N	\N	left popliteal fossa lymph node	Scraping	\N	\N	\N	67	\N	\N	15-4505	C	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2281	18-15332A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-9; BOX-10; BOX-13	\N	\N	MIS	AM2-098-1, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	Skin, heel, right, status post excisional biopsy, wide excision, melanoma in situ, residual; right heel	FFPE	\N	\N	\N	68	\N	\N	18-15332	A1	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2283	18-15332A3	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	MIS	AM2-098-3, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A3	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2282	18-15332A2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4	\N	\N	MIS	AM2-098-2, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A2	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2286	18-15332A6	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1	\N	\N	MIS	AM2-098-6, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A6	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2285	18-15332A5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	MIS	AM2-098-5, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A5	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2419	19-23613C4	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	MELANOMA	AM2-098-7, wide excision (1) melanoma, recurrent; (2) verrucous hyperplasia	\N	\N	\N	\N	right posterior heel	Scraping	\N	\N	\N	68	\N	\N	19-23613	C4	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2417	19-20141	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-9; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, heel, right, biopsy, melanoma, recurrent	FFPE	\N	\N	\N	68	\N	\N	19-20141	\N	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2284	18-15332A4	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	MIS	AM2-098-4, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A4	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1907	16-9204	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1	\N	\N	Metastasis	AM2-099-4, biopsy	\N	\N	\N	\N	left posterior leg	Scraping	\N	\N	\N	69	\N	\N	16-9204	\N	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1921	16-21256	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1; BOX-10	\N	\N	Metastasis	AM2-099-5, biopsy	\N	\N	\N	\N	left leg	Scraping	\N	\N	\N	69	\N	\N	16-21256	\N	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1755	14-37577A5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	Metastasis	AM2-099-3, larger specimen, wide excision	\N	\N	\N	\N	left lateral lower leg	Scraping	\N	\N	\N	69	\N	\N	14-37577	A5	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1691	13-23696A5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-9	\N	\N	Acrolentiginous melanoma	AM2-099-1, wide excision	\N	\N	\N	\N	left sole	Scraping	\N	\N	\N	69	\N	\N	13-23696	A5	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1754	14-35086A	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1; BOX-9	\N	\N	Metastasis	AM2-099-2, biopsy	\N	\N	\N	\N	left lower ankle	Scraping	\N	\N	\N	69	\N	\N	14-35086	A	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2062	17-21835A3	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-12	\N	\N	Metastasis	AM2-100-4	\N	\N	\N	\N	Brain, site not stated	Scraping	\N	\N	\N	70	\N	\N	17-21835	A3	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1810	15-0176A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0; BOX-11	\N	\N	\N	\N	\N	\N	\N	\N	metastatic lymph node	FFPE	\N	\N	\N	70	\N	\N	15-176	A1	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1811	15-00176S2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	70	\N	\N	15-176	S2	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2095	17-34742	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Metastasis	AM2-100-5	\N	\N	\N	\N	right inguinal area	Scraping	\N	\N	\N	70	\N	\N	17-34742	\N	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1766	14-51352	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1; BOX-11	\N	\N	Acral melanoma	AM2-100-1, wide excision; AM2-100-2, lymphadenectomy, melanoma, metastatic (1/2),  but only one set of slides was sent with the ID# 14-51352. No lymph node in the sample provided. 	\N	\N	\N	\N	right third and fourth toe	Scraping	\N	\N	\N	70	\N	\N	14-51352	\N	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1863	15-48543A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-12	\N	\N	Metastasis	AM2-100-3, wide excision	\N	\N	\N	\N	right dorsal foot 	Scraping	\N	\N	\N	70	\N	\N	15-48543	A1	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2299	18-28886	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX 3	\N	\N	Metastasis	AM2-101-2, excision	\N	\N	\N	\N	left neck minor salivary gland 	Scraping	\N	\N	\N	71	\N	\N	18-28886	\N	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2395	19-6410A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32810	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	71	\N	\N	19-6410	A1	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2396	19-6410A2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32811	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	71	\N	\N	19-6410	A2	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1850	15-26253A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-9	\N	\N	Acrolentiginous melanoma	AM2-101-1, amputation	\N	\N	\N	\N	right great toe	Scraping	\N	\N	\N	71	\N	\N	15-26253	A1	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2278	18-12734	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32812	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	71	\N	\N	18-12734	\N	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2047	17-14203A1	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	Skin, ankle, left, excision, verrucous hyperplasia	FFPE	\N	\N	\N	72	\N	\N	17-14203	A1	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2048	17-14203A2	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	72	\N	\N	17-14203	A2	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1893	16-552A7	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-10	\N	\N	Acrolentiginous melanoma	AM2-102-1, wide excision	\N	\N	\N	\N	left lateral heel	Scraping	\N	\N	\N	72	\N	\N	16-552	A7	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2035	17-9337A2	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-5	\N	\N	Metastasis	AM2-102-3, excision	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	72	\N	\N	17-9337	A2	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2416	19-19590	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-5; BOX-9	\N	\N	Metastasis	AM2-102-4, craniotomy and excision	\N	\N	\N	\N	left posterior frontal lobe of cerebrum	Scraping	\N	\N	\N	72	\N	\N	19-19590	\N	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2034	17-9337A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	Metastasis	AM2-102-2, excision	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	72	\N	\N	17-9337	A1	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2060	17-21588	\N	\N	\N	\N	\N	\N	\N	0	\N	FFPE	\N	\N	\N	Metastasis	AM2-103-3, No slides were sent from TW 	\N	\N	\N	\N	left parietal lobe, cerebrum	\N	\N	\N	\N	73	\N	\N	17-21588	\N	AM2-103	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1910	16-10035C	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	\N	AM2-103-2	\N	\N	\N	\N	Lymph node, sentinel, inguinal, right, dissection, melanoma, metastatic (1/1)	\N	\N	\N	\N	73	\N	\N	16-10035	C	AM2-103	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1909	16-10035A3	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	Acrolentiginous melanoma	AM2-103-1, amputation, vertical growth phase  amputation, acral lentiginous melanoma, vertical growth phase  	\N	\N	\N	\N	right hallux subungual 	\N	\N	\N	\N	73	\N	\N	16-10035	A3	AM2-103	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2580	20-09338A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, groin, lower part, right, dissection, melanoma, metastatic	FFPE	\N	\N	\N	74	\N	\N	20-9338	A1	AM2-104	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3502	M040204 Dec2019	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	101	\N	\N	None	\N	AMC-07	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2294	18-22781A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-8	\N	\N	\N	\N	\N	\N	\N	\N	Skin, great toe, subungual, right, amputation, ALM	FFPE	\N	\N	\N	74	\N	\N	18-22781	A1	AM2-104	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2303	18-35014A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Microscopically, sections A1-6 show a cellular spindle cell tumor with hyperchromatic spindle cells arranged in a fascicular pattern. The stroma is collagenous. Focally small nests of more epithelioid cells are noted. Immunohistochemically, the tumor cells (including the more epithelioid cells) are positive for SOX-10 but negative for HMB-45 and Melan-A. A small focus of atypical lentiginous proliferation of melanocytes is noted in the epidermis, suggesting the in situ component. An acral lentiginous melanoma with a nearly pure desmoplastic melanoma component is considered.	FFPE	\N	\N	\N	75	\N	\N	18-35014	A1	AM2-105	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2597	20-21458A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-7	\N	\N	\N	\N	\N	\N	\N	\N	Soft tissue, inguinal area, left, excision, desmoplastic melanoma, metastatic/recurrent	FFPE	\N	\N	\N	75	\N	\N	20-21458	A1	AM2-105	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2304	18-35014B2	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	a lymph node with tumor metastasis. 	FFPE	\N	\N	\N	75	\N	\N	18-35014	B2	AM2-105	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2598	20-21458A2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	75	\N	\N	20-21458	A2	AM2-105	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2428	19-34937S1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-8; BOX-9	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, inguinal, right, sentinel lymph node biopsy, melanoma, metastatic (1/1)	FFPE	\N	\N	\N	76	\N	\N	19-34937	S1	AM2-106	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2427	19-34937A2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-8; BOX-9; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, heel, right, status post biopsy, wide excision, acral lentiginous melanoma	FFPE	\N	\N	\N	76	\N	\N	19-34937	A2	AM2-106	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2439	19-43366G	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-7; BOX-16	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, sentinel, biopsy, melanoma, metastatic (1/1)	FFPE	\N	\N	\N	77	\N	\N	19-43366	G	AM2-107	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2438	19-43366F	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	SLIDE BOX-16	\N	\N	\N	6703137,  (Y21-108507)	\N	\N	\N	\N	\N	\N	\N	\N	\N	77	\N	\N	19-43366	F	AM2-107	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2437	19-43366A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-8	\N	\N	\N	\N	\N	\N	\N	\N	Skin, index finger, right, amputation, acral lentiginous melanoma	FFPE	\N	\N	\N	77	\N	\N	19-43366	A1	AM2-107	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2443	19-44348A4	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	Skin, foot and leg, right, wide excision, melanoma, satellite and in-transit metastasis, multiple	FFPE	\N	\N	\N	78	\N	\N	19-44348	A4	AM2-108	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2632	20-59076A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32809	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	78	\N	\N	20-59076	A1	AM2-108	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2442	19-44348A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-8; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, foot, right, wide excision, acral lentiginous melanoma	FFPE	\N	\N	\N	78	\N	\N	19-44348	A1	AM2-108	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2446	19-44987A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Skin, thumb, left, amputation, acral lentiginous melanoma	FFPE	\N	\N	\N	79	\N	\N	19-44987	A1	AM2-109	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2447	19-44987C1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-8	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, axillary, left, lymphadenectomy, melanoma, metastatic (2/5)	FFPE	\N	\N	\N	79	\N	\N	19-44987	C1	AM2-109	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2611	20-33334A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Skin, forearm, left, tumor excision, melanoma, metastatic	FFPE	\N	\N	\N	79	\N	\N	20-33334	A1	AM2-109	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2449	19-52004A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Skin, thumb, right, amputation, acral lentiginous melanoma	FFPE	\N	\N	\N	80	\N	\N	19-52004	A1	AM2-110	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2450	19-52004B1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-9	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, axillary, right, sentinel, biopsy, melanoma, metastatic (1/1)	FFPE	\N	\N	\N	80	\N	\N	19-52004	B1	AM2-110	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1191	05-46869B	37	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=314	172.6	\N	\N	Sections show skin with a broad and poorly circumscribed proliferation of melanocytes.  Nests of melanocytes are distributed at irregular intervals, and are focally confluent.  There are foci in which single melanocytes predominate as well.  \nThere are some melanocytes scattered above the basal layer in such areas.  There is a domed area, in which large, oval melanocytes with large, pleomorphic vesicular nuclei form sheets in the papillary dermis. A minor population of melanocytes with small, monomorphous nuclei are clustered around a pilosebaceous unit at the base of the lesion.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, trisected and entirely submitted in cassette B.	A) ANGIOMA; B) 10 X 6 MM; IDN	\N	\N	Scraping	Melanoma in situ extends to the periphery of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, 1.0 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS OF THE CONGENITAL TYPE	173610	185	\N	\N	05-46869	B	CCR-205	California Cancer Registry	IP523582	AirTable blocks_with_IP_info.csv
2605	20-28721A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6; BOX-9	\N	\N	\N	\N	\N	\N	\N	\N	Skin, leg, lower, left, excision, melanoma, metastatic	FFPE	\N	\N	\N	81	\N	\N	20-28721	A1	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2448	19-51759	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-8; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, lower leg, left, biopsy, melanoma, metastatic	FFPE	\N	\N	\N	81	\N	\N	19-51759	\N	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2664	21-961A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32808	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	81	\N	\N	21-961	A	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1312	08-35719A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-7; BOX-11	\N	\N	\N	\N	\N	\N	\N	\N	Skin, great toe, left, excision, subungual malignant melanoma	FFPE	\N	\N	\N	81	\N	\N	08-35719	A1	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2712	21-26009A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32806	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	81	\N	\N	21-26009	A1	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2687	21-13227A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32807	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	81	\N	\N	21-13227	A	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2586	20-12501E1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	ymph node, groin, left, biopsy, melanoma, metastatic (number examined: 2; number involved: 2)	FFPE	\N	\N	\N	82	\N	\N	20-12501	E1	AM2-112	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2585	20-12501A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-7; BOX-8	\N	\N	\N	\N	\N	\N	\N	\N	Skin, heel, left, wide excision, acral lentiginous melanoma	FFPE	\N	\N	\N	82	\N	\N	20-12501	A1	AM2-112	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1932	16-35844B2	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-8; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, axillary (sentinel), biopsy, melanoma, metastatic	FFPE	\N	\N	\N	83	\N	\N	16-35844	B2	AM2-113	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1929	16-32182	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-7; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, palm, lateral side, right, excision, acral melanoma, in vertical growth phase	FFPE	\N	\N	\N	83	\N	\N	16-32182	\N	AM2-113	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1848	15-24753A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-7	\N	\N	\N	\N	\N	\N	\N	\N	Skin, heel, right, wide excision, acral lentiginous melanoma	FFPE	\N	\N	\N	84	\N	\N	15-24753	A1	AM2-114	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2602	20-26269A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-7	\N	\N	\N	\N	\N	\N	\N	\N	Skin, medial foot, right, wide excision, acral lentiginous melanoma, recurrent	FFPE	\N	\N	\N	84	\N	\N	20-26269	A1	AM2-114	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2741	21-108508B	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-16	\N	\N	\N	6828093; 21-14158B1	\N	\N	\N	\N	Lymph node, sentinel, inguinal, right, lymphadenectomy, melanoma, metastatic(1/1)	\N	\N	\N	\N	85	\N	\N	21-108508	B	AM2-115	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2740	21-108508A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-16	\N	\N	\N	6828093; 21-14158A1	\N	\N	\N	\N	Skin, second, third and great toe, right, amputation, acral lentiginous melanoma	\N	\N	\N	\N	85	\N	\N	21-108508	A	AM2-115	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2742	21-108509A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-14	\N	\N	\N	5383991; 12-06252A2, 12-06252A1, 12-06252A3 (BOX-15)	\N	\N	\N	\N	Brain, site not stated, craniotomy and excision, melanoma, metastatic	\N	\N	\N	\N	86	\N	\N	21-108509	A	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2745	21-108509D	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	5383991; 08-40286A (BOX-16)	\N	\N	\N	\N	Digit, thumb, left, amputation, malignant melanoma	\N	\N	\N	\N	86	\N	\N	21-108509	D	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2743	21-108509B	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	5383991; 11-15420J1 (BOX-15)	\N	\N	\N	\N	Soft tissue, back, left, tumor resection, malignant melanoma, metastatic	\N	\N	\N	\N	86	\N	\N	21-108509	B	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2744	21-108509C	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-16	\N	\N	\N	5383991; 11-15420E1	\N	\N	\N	\N	Lymph node, segmental, right, lymphadenectomy, malignant melanoma, metastatic (1/5)	\N	\N	\N	\N	86	\N	\N	21-108509	C	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2746	21-108509E	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	5383991; 08-40286C	\N	\N	\N	\N	Lymph node, axillary, labeled as C, lymphadenectomy, melanoma, metastatic 	\N	\N	\N	\N	86	\N	\N	21-108509	E	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2747	21-108510A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	3876570; 11-38925C	\N	\N	\N	\N	Soft tissue, subcutaneous, tumor excision, melanoma, metastatic	\N	\N	\N	\N	87	\N	\N	21-108510	A	AM2-117	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2748	21-108510B	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-14	\N	\N	\N	3876570; 11-11698A1; 11-11698A2	\N	\N	\N	\N	Soft tissue, leg, right, excisional biopsy, melanoma, metastatic	\N	\N	\N	\N	87	\N	\N	21-108510	B	AM2-117	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2749	21-108510C	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	3876570; 09-38374 (BOX-15)	\N	\N	\N	\N	Skin, sole, right, biopsy, acrolentiginous melanoma	\N	\N	\N	\N	87	\N	\N	21-108510	C	AM2-117	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2775	22-9055A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-20	http://64.54.108.121/eSlideTray.php?ImageIds=32803	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	88	\N	\N	22-9055	A1	AM2-118	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2776	22-9055C1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-20	http://64.54.108.121/eSlideTray.php?ImageIds=32804	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	88	\N	\N	22-9055	C1	AM2-118	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2861	22-510407A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-20	http://64.54.108.121/eSlideTray.php?ImageIds=32805	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	88	\N	\N	22-510407	A1	AM2-118	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1736	14-04359A2 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	988	\N	\N	None	\N	MD-92	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2905	23-51956A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32561,32562,32563,32564,32565,32566,32567,32568,32569,32570,32571,32572,32573,32574,32575,32576,32577,32578,32579,32580,32581,32582,32583,32610,32611,32584,32585,32586,32612,32613,32587,32588,32589	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	89	\N	\N	23-51956	A3	AM2-119	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2906	23-51956B14	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32561,32562,32563,32564,32565,32566,32567,32568,32569,32570,32571,32572,32573,32574,32575,32576,32577,32578,32579,32580,32581,32582,32583,32610,32611,32584,32585,32586,32612,32613,32587,32588,32589	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	89	\N	\N	23-51956	B14	AM2-119	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2907	23-51956B16	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32561,32562,32563,32564,32565,32566,32567,32568,32569,32570,32571,32572,32573,32574,32575,32576,32577,32578,32579,32580,32581,32582,32583,32610,32611,32584,32585,32586,32612,32613,32587,32588,32589	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	89	\N	\N	23-51956	B16	AM2-119	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2908	23-51956B17	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32561,32562,32563,32564,32565,32566,32567,32568,32569,32570,32571,32572,32573,32574,32575,32576,32577,32578,32579,32580,32581,32582,32583,32610,32611,32584,32585,32586,32612,32613,32587,32588,32589	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	89	\N	\N	23-51956	B17	AM2-119	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2311	18-51740B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	90	\N	\N	18-51740	B2	AM2-120	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2312	18-51740C6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	90	\N	\N	18-51740	C6	AM2-120	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2313	18-51740C7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	90	\N	\N	18-51740	C7	AM2-120	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2672	21-4449B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	91	\N	\N	21-4449	B2	AM2-121	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2670	21-4449A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	91	\N	\N	21-4449	A3	AM2-121	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2671	21-4449A5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	91	\N	\N	21-4449	A5	AM2-121	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2375	19-360A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	92	\N	\N	19-360	A2	AM2-122	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2374	19-360A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	92	\N	\N	19-360	A1	AM2-122	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2661	20-113547C2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	93	\N	\N	20-113547	C2	AM2-123	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2659	20-113547A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	93	\N	\N	20-113547	A2	AM2-123	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2660	20-113547A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	93	\N	\N	20-113547	A3	AM2-123	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2616	20-37211A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	94	\N	\N	20-37211	A	AM2-124	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2617	20-37211I	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	94	\N	\N	20-37211	I	AM2-124	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2644	20-83082A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	95	\N	\N	20-83082	A3	AM2-125	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2645	20-83082B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	95	\N	\N	20-83082	B	AM2-125	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2577	20-8536D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	96	\N	\N	20-8536	D	AM2-126	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2578	20-8536E	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	96	\N	\N	20-8536	E	AM2-126	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3509	MaMel 152aI	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	98	\N	\N	None	\N	AMC-01	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3507	M100118	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	99	\N	\N	None	\N	AMC-02	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3531	MM100511	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	100	\N	\N	None	\N	AMC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3532	MM100512	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	100	\N	\N	None	\N	AMC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3533	MM100513	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	100	\N	\N	None	\N	AMC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3534	MM100916	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	100	\N	\N	None	\N	AMC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3504	M040416	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	102	\N	\N	None	\N	AMC-08	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3506	M040419A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	102	\N	\N	None	\N	AMC-08	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3505	M040418	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	102	\N	\N	None	\N	AMC-08	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3535	MM160113	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	103	\N	\N	None	\N	AMC-12	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3508	M180322	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	104	\N	\N	None	\N	AMC-13	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1626	12-37217	65	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.3	cellular blue nevus	\N	Sections show a proliferation of spindled melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Ellipse, 0.8 x 0.8 x 0.3 cm, including a central 0.7 x 0.7 cm pink tan and raised area.  With the peripheral and deep margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.	ATYPICAL PIGMENTED LESION	\N	\N	Scraping	This blue nevus appears narrowly excised in the available planes of section. There is no evidence of melanoma or atypicality. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation.	CELLULAR BLUE NEVUS	173315	105	\N	\N	12-37217	\N	BN-001	Nevus Library	IP1120977	AirTable blocks_with_IP_info.csv
1632	12-52736	12	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show a dermal and subcutaneous proliferation consisting in part of slender spindled melanocytes with monomorphous nuclei arranged in fascicles with encompassing areas displaying fibrosis and sclerosis and containing melanophages. Peripherally, there are many dendritic melanocytes with similar background changes.	Oval skin excision, 1.1 x 0.9 x 0.9 cm, including a central 1.0 x 0.8 cm dark brown area. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections each in cassettes A and B.   SL/SL	0.7 X 1.0 CM BLACK PAPULE; R/O BLUE NEVUS VS. MM	\N	\N	Scraping	There is no evidence of melanoma.	CELLULAR BLUE NEVUS	173516	106	\N	\N	12-52736	\N	BN-002	Nevus Library	IP1138549	AirTable blocks_with_IP_info.csv
1527	11-89154A7	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23313	198.2	\N	\N	\N	Two blocks S11-13013:A6 and A7.	MELANOMA SUBMITTED FOR BRAF & NRAS MUTATION ANALYSIS	\N	\N	\N	The histopathological assessment of this melanoma has been documented in UCSF Surgical Pathology report S11-13013. Using this metastatic tumor, we completed KIT and BRAF mutation analysis via Sanger sequencing. The following results were obtained: BRAF exon 15: V600E mutation. NRAS exons 1 and 2: wild-type (non-mutated).	SUBCUTANEOUS METASTATIC MELANOMA	112208	127	\N	\N	11-89154	A7	CCR-011	2010-2017	IP757083	AirTable blocks_with_IP_info.csv
1560	12-6550	59	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	cellular blue nevus	\N	Sections show a superficial zone of dermal fibrosis consistent with a biopsy site with a subjacent proliferation of spindled melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles. The proliferation has a round, pushing border into the subcutis. There are many stromal melanophages.	Ellipse, 1.6 x 1.0 x 0.7 cm, including 1.1 x 0.6 cm central variegated color and texture area. With the deep and peripheral margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A, three sections in cassette B.\n	DL11-82358	\N	\N	Scraping	The nevus appears to have been narrowly excised. There is no evidence of melanoma. I have shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation.	BIOPSY SCAR AND RESIDUAL BLUE NEVUS, CELLULAR TYPE, WITH A MIXED PATTERN (SPINDLE CELLS IN FASCICLES AND WITHIN SCLEROSIS)	173416	108	\N	\N	12-6550	\N	BN-004	Nevus Library	IP1071806	AirTable blocks_with_IP_info.csv
1587	12-20144	17	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	cellular blue nevus	\N	Sections show a proliferation of ovoid melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.  The proliferation extends from the papillary dermis  into the deep dermis with arrangement around adnexal structures and a slightly bulbous configuration in the deep portion.	Two specimens received in the same container. The first specimen is a skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. The second specimen is a cylindrical skin segment, 0.6 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. A total of four pieces entirely submitted in a single cassette.	DARKENING NEVUS; R/O CONGENITAL NEVUS VS. MELANOMA	\N	\N	Scraping	None	BLUE NEVUS, CELLULAR TYPE	173602	109	\N	\N	12-20144	\N	BN-005	Nevus Library	IP1105962	AirTable blocks_with_IP_info.csv
1625	12-32138	12	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	cellular blue nevus	\N	Sections show a dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles with intervening areas displaying fibrosis and sclerosis and containing melanophages. Some areas of increased basilar single melanocytes along the dermo-epidermal junction are noted.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted.	4 M; R/O ATYPICAL NEVUS	\N	\N	Scraping	The proliferation appears very narrowly excised in the available planes of section. There is no evidence of melanoma. I have shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation.	CELLULAR BLUE NEVUS	173425	110	\N	\N	12-32138	\N	BN-006	Nevus Library	IP1117956	AirTable blocks_with_IP_info.csv
1483	11-47908	16	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	cellular blue nevus	\N	Sections show a proliferation of spindled to ovoid variably pigmented melanocytes, with areas composed of compact fascicles and sheets, and a bulbous deep aspect, and other areas in which spindled and dendritic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Oriented ellipse measuring 1.5 x 1.0 x 0.6 cm, with a central 0.8 x 0.7 cm brown area. With the orienting suture placed to the left and designated superior by the surgeon, the far margin is inked blue and the near margin is inked yellow. Serially sectioned from left to right perpendicular to the long axis and entirely submitted with three sections each in cassettes A and B.	RULE OUT DYSPLASTIC NEVUS, CHECK MARGINS	\N	\N	Scraping	None	BLUE NEVUS, CELLULAR TYPE, WITH A MIXED PATTERN, EXTENDING CLOSE TO THE SPECIMEN BASE	173602	111	\N	\N	11-47908	\N	BN-007	Nevus Library	IP1037347	AirTable blocks_with_IP_info.csv
1493	11-59209	54	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show an area of dermal fibrosis adjacent to which there are clusters and large lobules of spindled melanocytes with many melanophages, with some interstitial melanocytes and associated fibrosis.	Cylindrical skin segment, 0.8 cm in diameter and 0.2 cm in thickness. The peripheral edge and base is inked blue. The specimen specimen is serially sectioned and entirely submitted with three sections.	6 MM SOFT GREY BLUE PAPULE S/P PREVIOUS MOLE SHAVE REMOVAL 3 YRS AGO	\N	\N	Scraping	None	DERMAL SCAR AND PERSISTENT CELLULAR BLUE NEVUS, EXTENDING TO THE SPECIMEN BASE	173508	112	\N	\N	11-59209	\N	BN-008	Nevus Library	IP740593	AirTable blocks_with_IP_info.csv
1518	11-85008	7	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show a dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles with intervening areas displaying fibrosis and sclerosis and containing melanophages.	Oriented ellipse, 3.5 x 2.0 x 1.0 cm, including a central 0.8 x 0.6 x 0.1 cm raised dark-brown area. With the orienting suture at one tip placed to the left, the far margin is inked blue and the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from left to right and submitted with two sections each in cassettes A through F, tips returned to container.\n\n	1.0 CM JET BLACK PAPULE; R/O MELANOMA, R/O BLUE NEVUS, R/O SPITZ	\N	\N	Scraping	None	BLUE NEVUS, CELLULAR (BLUE NEVUS WITH SPINDLE CELLS IN FASCICLES), COMPLETELY EXCISED	121523	113	\N	\N	11-85008	\N	BN-009	Nevus Library	IP1074456	AirTable blocks_with_IP_info.csv
1526	11-89154A6	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23311	198.2	\N	\N	\N	Two blocks S11-13013:A6 and A7.	MELANOMA SUBMITTED FOR BRAF & NRAS MUTATION ANALYSIS	\N	\N	\N	The histopathological assessment of this melanoma has been documented in UCSF Surgical Pathology report S11-13013. Using this metastatic tumor, we completed KIT and BRAF mutation analysis via Sanger sequencing. The following results were obtained: BRAF exon 15: V600E mutation. NRAS exons 1 and 2: wild-type (non-mutated).	SUBCUTANEOUS METASTATIC MELANOMA	112208	127	\N	\N	11-89154	A6	CCR-011	2010-2017	IP757083	AirTable blocks_with_IP_info.csv
1443	11-19048	48	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	cellular blue nevus	\N	Sections show a proliferation of spindled and dendritic melanocytes within fibrosis that is relatively well-circumscribed.  There are interspersed melanophages.  In the most cellular areas, clusters of polygonal melanocytes with pallid cytoplasm are arrayed in a pattern that vaguely resembles nerve fascicles. There is ulceration with scale-crust formation.	Ellipse measuring 2.1 x 1.0 x 0.5 cm.  With the aspect inked blue, four central representative sections are submitted, remainder returned to container.	R/O CYST	\N	\N	Scraping	There is superficial ulceration. Did a biopsy occur here recently? Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation index within constituent melanocytes which is reassuring. Thank you for your patience as this staining needed to be repeated.	BLUE NEVUS, WITH SOME AREAS CONTAINING SO-CALLED MASSON'S BLUE NEURONEVUS PATTERN, TRAUMATIZED	173417	115	\N	\N	11-19048	\N	BN-011	Nevus Library	IP1008486	AirTable blocks_with_IP_info.csv
1480	11-43354	13	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show a proliferation of spindled to dendritic to epithelioid pigmented melanocytes, with areas composed of sheets and compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Ellipse measuring 1.0 x 0.7 x 0.5 cm. With margins inked blue, quadrisected perpendicular to the long axis and entirely submitted.	TATTOO FROM LEAD PENCIL AT AGE 7	\N	\N	Scraping	There is no evidence of a traumatic tattoo. This large blue nevus contains some epithelioid blue nevus-type melanocytes. The patient should thus be examined for lentigines which could in turn suggest the possibility of Carney's complex.	BLUE NEVUS, WITH EPITHELIOID FEATURES	105539	116	\N	\N	11-43354	\N	BN-012	Nevus Library	IP1032793	AirTable blocks_with_IP_info.csv
2323	18-68921A	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	Normal	\N	Sections show a zone of fibrosis, representing a prior biopsy or surgical site, flanked by a proliferation of atypical basaloid keratinocytes.	Ellipse, 2.9 x 1.3 x 0.7 cm, including a central 1.3 x 1.0 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections in A and five sections in B. One tip reserved. RS/RS	EXCISION OF PROVEN MICRO NOD BCC (TELEPHONE: 408-896-4280 OK LM)	\N	\N	\N	\N	SCAR, WITH RESIDUAL BASAL CELL CARCINOMA, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	174523	117	\N	\N	18-68921	A	CCGL-2973	Clinical Cases-BCC	IP1757569	AirTable blocks_with_IP_info.csv
2298	18-28169	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.51	BCC	\N	Sections show a proliferation of atypical and peripherally palisaded basaloid cells, arrayed as clusters near the junctional zone and as nodular aggregations in the dermis. Some aggregations are pigmented.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted with two sections and fragment in D. RS/PL	A) PT WITH HISTORY OF MULTIPLE BCC'S BROWN ERODED PAPULE; R/O PIGMENTED BCC, B) STUCK ON APPEARING VERRUCOUS PAPULE; IRRITATED SK VS. BCC, C) PINK/BROWN EXCORIATED PAPULE; R/O BCC, D) BROWN EXCORIATED PAPULE; R/O BCC (TELEPHONE: 408-896-4280 MSG OK)	\N	\N	\N	None	PIGMENTED BASAL CELL CARCINOMA, SUPERFICIAL AND NODULAR PATTERNS, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	115502	117	\N	\N	18-28169	\N	CCGL-2973	Clinical Cases-BCC	IP1757569	AirTable blocks_with_IP_info.csv
1128	04-15284	52	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.7	\N	\N	There is a proliferation of small and large melanocytes arranged as irregularly shaped and focally confluent nests along the junction, with some pagetoid scatter of single cells.  A dense band-like infiltrate of lymphocytes and melanophages obscures the junctional zone and thickens the papillary dermis.  Occasional large cells reside within the infiltrate.	Skin segment, 1.0 x 0.8 x 0.2 cm, trisected and totally submitted.	CHANGING PIGMENTED LESION; ?DERMAL NEVUS, ?KERATOSIS, R/O MELANOMA	\N	\N	Scraping	Immunoperoxidase staining with Melan-A and S100 protein show that the there are occasional large, positively stained cells within the papillary dermis.  Although the thickness of this neoplasm is nominally 0.4 mm, the tumor volume is less than is usual for this thickness, and this may be a positive prognostic attribute.	MELANOMA. 0.4 MM IN THICKNESS	562711	118	\N	\N	04-15284	\N	CCR-	California Cancer Registry	IP431683	AirTable blocks_with_IP_info.csv
3004	99-3122A	76	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3512	172.4	\N	\N	Sections show a compound proliferation of melanocytes, with an\nintraepidermal component consisting predominantly of nests of\nmelanocytes in irregular array.  Irregular clusters of similar\nmelanocytes are also present in the dermis.	Ellipse, measuring 1.0 x 0.5 x 0.2 cm, trisected and entirely\nsubmitted, margins inked blue.	A - TAN BROWN IRREGULARLY PIGMENTED PLAQUE WITH IRREGULAR BORDERS, B - C - BROWN GRAY NODULES; CLINICAL DIAGNOSIS - A) R/O MM, SK, B) - C) R/O MM, SATELLITE NODULE VS SK, REMAINING DATA ON FILE	\N	\N	\N	\N	MELANOMA, 0.8 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	100440	119	\N	\N	99-3122	A	CCR-001	California Cancer Registry	IP178655	AirTable blocks_with_IP_info.csv
2551	19Rig750007.05.06.10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	295	\N	\N	None	\N	CM-62	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2549	19Rig750007.05.06.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	295	\N	\N	None	\N	CM-62	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2552	19Rig750007.05.07.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	296	\N	\N	None	\N	CM-63	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2554	19Rig750007.05.13.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	297	\N	\N	None	\N	CM-69	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2555	19Rig750007.05.13.09	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	297	\N	\N	None	\N	CM-69	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1753	14-34758	49	\N	\N	1	T1a	Primary	Superficial spreading	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes, some with atypical nuclei, arranged in some areas as nests along the sides and bases of elongated rete ridges, with fibroplasia of the papillary dermis.  In other areas, a more irregular distribution of melanocytes is present within the epidermis, and single melanocytes predominate over nests in some areas while scattered intraspinous melanocytes are apparent in some foci as well. Nests of melanocytes are present in the dermis as well, and some of the dermal melanocytes are large and have hyperchromatic nuclei. There are also areas in which the dermis is thickened and fibrotic, with a patchy bandlike lymphohistiocytic infiltrate that includes numerous melanophages and diminished numbers of melanocytes in such areas, when compared to the remainder of the lesion.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness, bisected and totally submitted. PL/PL	SOFT TISSUE MASS, NOS, 6 MM PUNCH BX, 2 CM HYPERKER IRREGULAR PIG LESION	\N	\N	Scraping	The melanoma extends only to one peripheral edge of this biopsy such that it gave the initial impression that the lesion might be small and partially captured in this specimen. However, I discussed the case by telephone with Dr. Dasilva who confirmed that the lesion indeed measured  2 cm in diameter and that only the edge of the lesion was captured in this biopsy. In light of this additional information, the microscopic features in this specimen are in keeping with melanoma. A synoptic report of potential prognostic factors is listed below:  Procedure: Punch biopsy Microscopic tumor type: Superficial spreading Breslow thickness:  0.95 mm Ulceration: Not present Margins, peripheral and deep: + peripheral; 5 millimeters from deep Mitotic index: < 1/mm2 Microsatellitosis: not evident Vascular invasion: None identified in a section stained with D2-40 Regression: Partial Pathologic staging (pTNM): pT1a, should no more adverse findings be evident on complete excision  My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this assessment.	MELANOMA, 0.95 MILLIMETERS IN THICKNESS AND WITH PARTIAL REGRESSION, EXTENDING TO THE PERIPHERAL EDGE OF THE SPECIMEN	139524	120	\N	\N	14-34758	\N	CCR-003	California Cancer Registry	IP1384692	AirTable blocks_with_IP_info.csv
1285	07-55149	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2735	172.6	\N	\N	Sections show a compound proliferation of melanocytes, arrayed singly and in small clusters within the epidermis, with a lack of clear circumscription. There are similar cells singly and in small irregular clusters within the superficial dermis, which also displays fibroplasia and a permeative lymphohistiocytic infiltrate with admixed melanophages. There is elastosis evident more deeply.	Cylindrical skin segment, 0.8 cm in diameter and 0.6 cm in thickness, quadrisected and entirely submitted.	IRREGULAR PIGMENTED PLAQUE; 1 1/2 X 1 CM; R/O MELANOMA	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion limited to the papillary dermis (Clark's level III). There is no evidence of associated vascular invasion or neurotropism. In light of the changes of regression, the microstage measurement listed above may underestimate the prognostic impact of this lesion. However, I believe that the microstage thickness listed above is reasonably representative. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.6 MM IN THICKNESS, WITH ASSOCIATED CHANGES OF PARTIAL REGRESSION	529699	121	\N	\N	07-55149	\N	CCR-004	California Cancer Registry	IP677682	AirTable blocks_with_IP_info.csv
3011	99-14477	41	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=313	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a multinodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis.	Ellipse measuring 0.6 x 0.6 x 0.6 cm, trisected and entirely\nsubmitted, margins inked blue.	6.0 MM MELANOMA	\N	\N	Scraping	Melanocytes extend to a greater depth in the perifollicular adventitial dermis, but these are not conventionally measured to determine thickness.	MELANOMA, 1.0 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173601	122	\N	\N	99-14477	\N	CCR-005	California Cancer Registry	IP190010	AirTable blocks_with_IP_info.csv
1011	00-14127B	33	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation\nof atypical melanocytes, arranged irregularly within the epidermis,\nflanking a multinodular proliferation of similar melanocytes that\ndo not mature (diminish in size) with descent into the dermis.\nThere are many mitotic figures the dermal component.  There is\nbuckshot scatter of melanocytes in the epidermis at the edges of\nthe specimen.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness,\nbisected and totally submitted in block B.	A - 5 X 4 MM RED RAISED OVAL SHAPED W/LIGHT GRAY STREAK WITHIN, B - 8 X 7 MM RAISED BROWN MOLE SUPERIOR ASPECT OVERLAPPING LIGHT BROWN PATCH, ASYMMETRICAL TWO-TONED BROWN AND DARK BROWN	\N	\N	Scraping	\N	MELANOMA, 1.85 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	321533	123	\N	\N	00-14127	B	CCR-007	California Cancer Registry	IP229230	AirTable blocks_with_IP_info.csv
1045	02-7356	45	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=21403,22649,22992	172.5	\N	\N	Sections show an extensively ulcerated proliferation of large atypical melanocytes in irregular array within the epidermis and dermis, with foci of pagetoid spread, failure to mature and mitoses among dermal melanocytes, as well as a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the superficial reticular dermis and around adnexal structures.	Ellipse measuring 1.6 x 0.8 x 0.5 cm including central black-brown\n0.7 x 0.5 cm pigmented area.  With margins inked blue, five central\nrepresentative sections are submitted, tips returned to container.	? MELANOMA	\N	\N	Scraping	The nevus, but not the melanoma extends to the periphery of the specimen.  There is extensive ulceration, a finding associated with adverse prognostic influence in many studies, and one that makes it difficult to determine an exact thickness.	MELANOMA, APPROXIMATELY 1.4 MM. IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS OF THE CONGENITAL TYPE	173528	124	\N	\N	02-7356	\N	CCR-008	California Cancer Registry	IP267299	AirTable blocks_with_IP_info.csv
1027	01-10896	45	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=5929	216.5	\N	\N	Sections show a predominantly intradermal proliferation of small melanocytes in the superficial and mid-dermis, with cells clustered around appendages or arranged as syncytia or strands within the reticular dermis.  There is a second population of melanocytes with abundant pale to vacuolated cytoplasm and finely divided melanin pigment, accompanied by melanophages.  These latter cells are arrayed in a stroma that shows telangiectasia and focal sclerosis.	Skin segment, 1.0 x 0.8 x 0.5 cm, trisected and totally submitted.	ID NEVUS	\N	\N	FFPE	There is no evidence of melanoma in this biopsy.	COMBINED MELANOCYTIC NEVUS, WITH PIGMENTED EPITHELIOID MELANOCYTES IN THE DERMIS OF A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	173502	124	\N	\N	01-10896	\N	CCR-008	Melanoma Epigenetics	IP267299	AirTable blocks_with_IP_info.csv
1229	06-18321	67	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=315	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly and confluently within the epidermis, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes arrayed densely in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. There is elastosis more deeply.	Ellipse measuring 0.8 x 0.5 x 0.3 cm.  With margins inked blue, the specimen is serially trisected perpendicular to the long axis and entirely submitted.	IRRIT SEB KERATOSIS; R/O DYSPLASIA	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or regression in these sections. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.2 MM IN THICKNESS, TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	105539	125	\N	\N	06-18321	\N	CCR-009	California Cancer Registry	IP563387	AirTable blocks_with_IP_info.csv
2556	19Rig750007.05.14.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	298	\N	\N	None	\N	CM-70	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1167	05-19406	87	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.6	\N	\N	There is a proliferation of melanocytes with abundant, pale cytoplasm and dusty appearing melanin in apposition to a thinned epidermis, flanked on one side by a small zone with some pagetoid scatter, and on the other by a thickened and fibrotic papillary dermis, loss of rete ridges and diminished numbers of melanocytes.	Skin segment measuring 1.9 x 1.4 x 0.2 cm, entirely submitted in five sections.	1 YR H/O DK IRREG BLACK PLAQUE; R/O MELANOMA	\N	\N	Scraping	Melanoma in situ is present less than 1 mm. from the peripheral margin. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: present, over 50% in some sections Microsatellite metastasis: absent	MELANOMA, 1.5 MM  IN THICKNESS	173619	126	\N	\N	05-19406	\N	CCR-010	California Cancer Registry	IP496118	AirTable blocks_with_IP_info.csv
1320	08-48442	48	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=7265	172.2	\N	\N	Sections show an asymmetrical biphasic compound proliferation of melanocytes. One population consists of enlarged epithelioid melanocytes with amphophilic or finely pigmented cytoplasm, and these cells are distributed singly and in nests along the epidermal-dermal junction in erratic fashion and also reside in the upper dermis. In one central domed nodular area, large atypical melanocytes are arrayed as coalescing nests and fascicles without clear maturation with descent, and these cells are encompassed by dermal fibroplasia. A sparse scattering of melanophages is also evident in the dermis in this area. A second population of melanocytes consists of much smaller cells, mostly dermal in location, consisting of nests and cords that mature with descent.	Skin segment measuring 0.8 x 0.8 x 0.4 cm, trisected and entirely submitted with fragment.	BROWN MACULE WITH CENTRAL, BLACK NODULAR COMPONENT; R/O MELANOMA	\N	\N	FFPE	Our differential diagnosis included an unusual combined melanocytic nevus on one hand, and melanoma arising in association with a melanocytic nevus on the other. To definitively address the differential via molecular means, we completed fluorescence in situ hybridization (FISH) analysis, utilizing a panel of 4 DNA probes (to loci on 6p, 6q, 6cent and 11q) developed by Dr. Boris Bastian of our group. FISH analysis demonstrates an imbalance in chromosome 6q and gain in chromosome 6p, a molecular combination supporting classification as melanoma. In short, based upon the combination of both conventional microscopy and FISH analysis, we believe this lesion represents melanoma and not an unusual melanocytic nevus. In terms of staging, this is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). There is no evidence of associated vascular invasion, neurotropism, or regression. Further excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 2.0 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	112208	127	\N	\N	08-48442	\N	CCR-011	Melanoma Epigenetics	IP757083	AirTable blocks_with_IP_info.csv
2515	19Rig750007.03.04.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	273	\N	\N	None	\N	CM-33	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2516	19Rig750007.03.04.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	273	\N	\N	None	\N	CM-33	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1355	09-90221	65	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.3	\N	\N	There is a broad, asymmetric and poorly circumscribed atypical melanocytic neoplasm characterized by large nests and sheets of melanocytes along an atrophic epidermis and throughout the papillary and reticular dermis. In some areas, there are small nests and individual melanocytes in the spinous and granular layers of the epidermis. There is focal fibrosis with melanophages. The melanocytes vary greatly in size from small to large with nuclear pleomorphism and many atypical mitoses.  Two of the sections have ulceration without crust and melanocytes throughout the dermis.	Two skin segments, one measuring 0.9 x 0.5 x 0.1 cm, bisected (fragmented upon cutting), and the other measuring, 0.8 x 0.5 x 0.1 cm, bisected, all entirely submitted.	PIGMENTED NEOPLASM	\N	\N	Scraping	The melanoma extends to at least a Clark level IV and is broadly transected.  The thickness measurement was taken from the thickest shave specimen. There is an additional separate shave specimen with melanoma throughout the dermis and extending to the base, measuring 0.4 millimeters in thickness.  It is unclear exactly how the two specimens are oriented relative to each other, but it is possible that the two measurements should be considered additive and the melanoma thickness may be considered up to at least 1.3 millimeters.  The excisional specimen will be necessary to further characterize the melanoma and its prognostic factors. The melanoma also extends to the peripheral edge of the biopsy and complete excision to ensure its complete removal is, of course, warranted.  Dr. Beth Ruben has reviewed this case and agrees with the diagnosis. ADDENDUM, July 17, 2011: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system:  This report was re-issued after the medical record number was added to the case record.	MELANOMA, MEASURING AT LEAST 0.9 MILLIMETERS IN THICKNESS, TRANSECTED, NON-ULCERATED	173307	128	\N	\N	09-90221	\N	CCR-014	California Cancer Registry	IP890987	AirTable blocks_with_IP_info.csv
1326	08-51663	50	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2743	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed in part of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with focal associated suprabasal scatter. In one cross section, there is an unusual configuration with coalescing nests and fascicles of pale melanocytes that penetrate into the upper reticular dermis. Many of these dermal melanocytes have slightly spindled morphology.	Cylindrical skin segment, 0.8 cm in diameter and 1.0 cm in thickness, trisected and entirely submitted.	PROB MELANOMA	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). There is no evidence of associated vascular invasion, neurotropism, or regression. Further excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.4 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY NEAR TO THE PERIPHERY OF THE SPECIMEN	273588	129	\N	\N	08-51663	\N	CCR-015	California Cancer Registry	IP760304	AirTable blocks_with_IP_info.csv
1318	08-44748	75	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2370	172.4	\N	\N	Sections show a cellular proliferation of elongated spindled cells with atypical and pleomorphic nuclei, arrayed in a vaguely fascicular configuration in a myxoid and highly vascular stroma. Many malignant cells are captured in mitosis. Neither cytoplasmic pigmentation nor keratinization is clearly evident. There is surface ulceration with superjacent exudate and crust.	Skin segment measuring 1.2 x 1.1 x 0.2 cm, quadrisected and entirely submitted.	PINK NODULAR CRUSTED PLAQUE; BCC VS. OTHER NEOPLASM	\N	\N	\N	The lineage of this malignancy was evaluated via immunoperoxidase staining. There is avid diffuse expression of both S100 protein and p75, substantiating melanocytic lineage. A keratin stain is completely negative, excluding carcinoma from the differential diagnosis. There is weak expression of actin with a lack of expression of desmin, and thus there is no support for leiomyosarcoma as  potential consideration. A procollagen stain shows weak reactivity while a CD10 stain is completely negative, and thus there is also no support for pleomorphic sarcoma (atypical fibroxanthoma). In terms of staging, this is an extensively ulcerated melanoma with invasion of the reticular dermis (at least Clark's level IV). Full microstaging cannot be completed because of the partial nature of the biopsy. Further extirpation is warranted, both to eradicate this malignancy locally and to enable full microstage analysis to be completed.	SPINDLED MELANOMA OF AT LEAST 3.0 MM IN THICKNESS	147408	130	\N	\N	08-44748	\N	CCR-020	California Cancer Registry	IP753389	AirTable blocks_with_IP_info.csv
1651	12-85105A	67	\N	\N	\N	T4a	Primary	\N	3	\N	FFPE	\N	\N	172.6	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in the dermis.  Many melanocytes have pigmented cytoplasms.  There are numerous mitotic figures.  No connection to the epidermis is noted, but there are numerous melanophages, dermal fibrosis, and epidermal thinning.	Cylindrical skin segment, 0.7 cm in diameter and 0.6 cm in thickness, trisected and totally submitted in cassette A.    SL/SL	A) 4.8 X 2.6 CM LARGE BLUE PLAQUE; SUSPECT MELANOMA, B) 1.2 X 0.8 CM PINK FIRM SUBQ NODULE; SUSPECT SQ MELANOMA MET	\N	\N	Scraping	Melanoma extends to the base of the biopsy and therefore the the above measurement represents a minimal thickness.  I fail to note any epidermal connection which raises the possibility of a metastatic lesion.  There are numerous melanophages in the papillary dermis which could indicate regression of a pre-existing junctional component.  Perhaps additional diagnostic information will be apparent in the complete excision specimen.  This lesion is not ulcerated and should be regarded as a pT4a melanoma.	MELANOMA, AT LEAST 5.5 MILLIMETERS IN THICKNESS	173649	136	\N	\N	12-85105	A	CCR-034	California Cancer Registry	IP1170922	AirTable blocks_with_IP_info.csv
1142	04-34117	43	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=7270	172.4	\N	\N	Sections show nodular aggregations of melanocytes with atypical nuclei in the dermis, lack of maturation of these cells with descent, and their arrangement in irregularly shaped aggregations. Scattered intraepidermal melanocytes are also present.   Patchy inflammation is present mainly surrounding the tumor.  Slight parakeratotic scale-crust and hyperkeratosis is present, but no ulceration is evident.  Lymphovascular invasion is present.  A second population of small round melanocytes arranged in discrete collections is also present.  There is a dilated follicular infundibulum centrally, and there is moderate fibrosis and slight telangiectasia.	Skin segment, 1.5 x 1.0 x 0.5 cm, quadrisected and entirely submitted.	HEMANGIOMA VS NEVI	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level IV: Tumor infiltrating lymphocytes: absent Vascular or lymphatic invasion: present Mitotic rate: 4 per 6 high powered fields (moderate) Perineural invasion: absent Ulceration:  absent Regression: absent Microsatellite metastasis: absent  This is a high risk lesion, given its thickness and the presence of vascular invasion.	MELANOMA, 4.00 MILLIMETERS IN THICKNESS, WITH VASCULAR INVASION, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO PERIPHERAL AND DEEP BIOPSY MARGINS	173417	131	\N	\N	04-34117	\N	CCR-021	Melanoma Epigenetics	IP450519	AirTable blocks_with_IP_info.csv
1293	07-85201	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=21405	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	131	\N	\N	07-85201	\N	CCR-021	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
1210	06-8729	50	\N	\N	\N	None	None	None	4	\N	FFPE	\N	\N	173.5	\N	\N	Sections show a broad asymmetrical compound proliferation of melanocytes, some with atypical nuclei, arranged in some areas as single cells and nests along the sides and bases of elongated rete ridges, with fibroplasia of the papillary dermis. There is extensive subjacent dermal fibroplasia with a superficial infiltrate of lymphocytes and melanophages. In a central area, nodular array of strikingly atypical epithelioid melanocytes is evident in partial continuity with the epidermal-dermal junction, and some of these larger cells are captured in mitosis.	Skin segment, 2.6 x 1.5 x 0.4 cm, including a 0.9 x 0.7 cm raised area, serially sectioned perpendicular to the long axis and entirely submitted with seven sections.	PT WITH VIOLACEOUS PAPULE WITH ADJACENT TAN-BROWN PATCH; NEVUS, R/O ATYPIA	\N	\N	Scraping	This is an extraordinarily broad melanoma with a central nodular invasive component and with extensive associated partial and complete regression. In light of the changes of regression, the microstage measurement listed above may underestimate the prognostic impact of this lesion. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an strikingly expanded papillary dermis (Clark's level III). There is no evidence of associated vascular invasion, perineural extension or microsatellitosis in these sections. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF AT LEAST 2.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	173502	132	\N	\N	06-8729	\N	CCR-024	California Cancer Registry	IP553795	AirTable blocks_with_IP_info.csv
2517	19Rig750007.03.05.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	274	\N	\N	None	\N	CM-34	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2518	19Rig750007.03.07.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	275	\N	\N	None	\N	CM-36	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1747	14-17085A2 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	989	\N	\N	None	\N	MD-93	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1032	01-18107A	80	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=319	172.7	\N	\N	Sections show a proliferation of cells with atypical nuclei and ample\ncytoplasm, arrayed as confluent nests and sheets in the dermis, with\nextensive overlying ulceration.  There are many mitotic figures.\nThere are many single melanocytes in the basal layer of an\nirregularly hyperplastic epidermis.	Skin segment, 1.0 x 0.6 x 0.3 cm, bisected and totally submitted.	A) 8 X 5 MM ERYTHEMATOUS PAPULE; R/O MELANOMA VS VERRUCA, B) 1 CM BLACK MACULE; R/O MEL	\N	\N	Scraping	\N	MELANOMA, AT LEAST 3.0 MM. IN THICKNESS, ULCERATED, EXTENDING TO THE DEEP MARGIN	173713	133	\N	\N	01-18107	A	CCR-029	California Cancer Registry	IP129670	AirTable blocks_with_IP_info.csv
1342	09-16836	85	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2371	172.7	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis which is markedly thinned.  There is little diminishment in melanocyte size with descent in the dermis and mitotic figures are apparent.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted.	RECENT PAPULE; R/O SCC	\N	\N	\N	S100 and Melan-A immunostains label the neoplastic cells, confirming the melanocytic lineage of this lesion. Keratin stain is by contrast negative. In terms of staging, this is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). Definitive assessment of these and other prognostic features should be deferred to the excision specimen, as these changes extend to biopsy margins.	AMELANOTIC MELANOMA, AT LEAST 2.2 MM IN THICKNESS, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173741	134	\N	\N	09-16836	\N	CCR-031	California Cancer Registry	IP371067	AirTable blocks_with_IP_info.csv
1278	07-28805	37	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=323,22991	172.6	\N	\N	Sections show an asymmetrical proliferation of large melanocytes with abundant cytoplasm, which fail to mature with descent in the dermis. Mitotic figures are identifiable within the dermal component, including near the base of the lesion. Within the epidermis, melanocytes are arrayed as nests and single cells somewhat irregularly, and there are foci of suprabasal scatter. Within the dermis, melanocytes are arrayed mainly in syncytia and occasional small clusters. They fail to mature with descent. Many have prominent nucleoli. The base of these changes is irregular. Some melanocytes are present adjacent to small nerve twigs. There is an adjacent population of small bland melanocytes arrayed as clusters and syncytia in the superficial reticular dermis (melanocytic nevus). There is slight solar elastosis.	Ellipse measuring 1.0 x 0.5 x 0.6 cm.  With margins inked blue, the specimen is serially quadrisected perpendicular to the long axis and entirely submitted.\n	6 X 7 MM SENSITIVE INFLAMED PAPULE X 8 MONTHS; ? INFLAMED NEVUS	\N	\N	Scraping	Because of the unusual nature of this tumor, I have also shared this case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with this diagnosis. Although there are some cytologic features reminiscent of a Spitz's nevus, there is a predominantly sheet-like arrangement of melanocytes which are atypical, and mitotic figures are identifiable within the dermal component, including within deeper aspects of it. There is also a degree of suprabasal scatter of melanocytes within the epidermis, and together, these features are diagnostic of melanoma. There is an associated melanocytic nevus, of superficial congenital pattern. In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level IV, with significant involvement of the reticular dermis. There is no evidence of vascular invasion, or regression. Tumor lies adjacent to small nerve twigs. It is difficult to know if this merely reflects diffuse involvement of the dermis in such areas, which I favor, rather than true neurotropism.  Complete excision of this site is of course warranted. The patient may also be a candidate for sentinel node sampling, based on the guidelines used in many institutions.	MELANOMA, 2.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING VERY CLOSE TO THE PERIPHERAL MARGIN, WITH NEVUS PRESENT AT THE PERIPHERAL MARGIN	173688	135	\N	\N	07-28805	\N	CCR-032	California Cancer Registry,Melanoma Epigenetics	IP651337	AirTable blocks_with_IP_info.csv
2557	19Rig750007.05.15.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	299	\N	\N	None	\N	CM-71	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2558	19Rig750007.05.16.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	300	\N	\N	None	\N	CM-72	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2559	19Rig750007.06.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 6 PAM without sun exposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	301	\N	\N	None	\N	CM-73	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2508	19rig750007.02.11.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	302	\N	\N	None	\N	CM-76	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1785	14-70636	\N	\N	\N	\N	\N	\N	\N	22	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	acral mel macule	FFPE	\N	\N	\N	1292	\N	\N	14-70636	\N	OM-34	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1351	09-48136A	56	\N	\N	\N	\N	\N	\N	3	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of malignant cells with strikingly atypical nuclei and ample amphophilic cytoplasm arrayed as coalescing nests and sheets, and extensive overlying ulceration is apparent. In some areas of viable epidermis, cells in pagetoid array can be found. The subjacent dermis is fibrotic and inflamed.	Gross description recorded by digital image.	3 CM EXOPHYTIC SESSILE PLAQUE, PURPURIC; R/O PYOGENIC GRANULOMA	\N	\N	Scraping	In light of the gravity of this diagnosis, immunoperoxidase staining to verify lineage was included in our assessment. This malignancy shows avid diffuse expression of both S100 protein and Melan-A, thereby confirming its melanocytic nature. A D2-40 immunostain, which represents a lymphatic endothelial marker, was also completed. There are collections of melanoma cells in the dermis that are fully encircled by D2-40 positive cells, thus suggesting that vascular invasion may have occurred. In terms of staging, this is an extensive ulcerated melanoma with associated Clark's level IV invasion. Although vascular invasion may have occurred, there is no evidence of associated regression or perineural invasion. Further excision is warranted to ensure that local eradication has been accomplished.	ULCERATED MELANOMA OF APPROXIMATELY 9.5 MM IN THICKNESS, EXTENSIVELY TRANSECTED AT THE DEEP EDGE OF THE BIOPSY	423789	137	\N	\N	09-48136	A	CCR-035	California Cancer Registry	IP848899	AirTable blocks_with_IP_info.csv
1280	07-37378	25	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=7279	172.3	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern. One population consists of melanocytes, some of which have atypical nuclei, with abundant dusty cytoplasmic melanin, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. There are defects in circumscription, and the intraepidermal component is quite broad. There is adnexal extension. Similar melanocytes are present in the subjacent dermis, including the adventitial dermis. Rare mitotic figures are evident in this dermal component. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). This population demonstrates maturation with melanocytic descent. There is slight solar elastosis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted.	R/O MM	\N	\N	FFPE	Because of the unusual nature of this lesion, and the relatively young age of the patient, this case was also presented at our Peer Consensus Conference, and my colleague, Dr. Timothy McCalmont, also agrees with this interpretation. In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level at least III. It is somewhat difficult to assess the Clark's level in that there is extensive periadnexal involvement, and it is difficult to assess if there is any genuine involvement of the superficial reticular dermis. As these changes are transected, definitive assessment of thickness, and other such prognostic factors should also be deferred to the complete excision specimen. There is no evidence of vascular invasion, neurotropism, or regression.	MELANOMA, AT LEAST 0.65 MILLIMETER IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO THE DEEP MARGIN, AND WITH MELANOMA IN SITU EXTENDING TO PERIPHERAL MARGINS	102304	138	\N	\N	07-37378	\N	CCR-040	California Cancer Registry	IP659911	AirTable blocks_with_IP_info.csv
3015	99-18307	38	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.4	\N	\N	There is a multinodular proliferation of melanocytes with atypical nuclei beneath a thinned epidermis.  There is little diminishment in melanocyte size with descent in the dermis.  There is marked fibrosis and there are many melanophages.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, trisected and entirely\nsubmitted.	CLINICAL DIAGNOSIS - R/O BLUE NEVUS	\N	\N	Scraping	The lesion measures at least 2.2 mm in thickness, but final thickness awaits complete excision.	MELANOMA, EXTENDING TO THE DEEP MARGIN	102499	148	\N	\N	99-18307	\N	CCR-058	California Cancer Registry	IP193840	AirTable blocks_with_IP_info.csv
1065	02-28807	79	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=325	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes in predominance in many areas. There are clusters of similar cells in the superficial dermis, also above elastosis, and some nests that permeate adnexal epithelium	Skin segment measuring 0.4 x 0.3 x 0.1 cm, bisected and entirely submitted.	R/O KER VS NEVUS	\N	\N	Scraping	This is a non-ulcerated primary melanoma with invasion confined to the papillary dermis (Clark's level II). There is no evidence of vascular or perineural invasion. In short, this is a thin, low-risk primary melanoma. This report was reissued on 1/13/2005 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF 0.4 MILLIMETERS IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173441	139	\N	\N	02-28807	\N	CCR-041	California Cancer Registry	IP333561	AirTable blocks_with_IP_info.csv
2957	95-5908	34	\N	\N	\N	None	None	None	25	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2742	172.7	\N	\N	There is irregular epidermal hyperplasia with hyperkeratosis, overlying a compound proliferation of melanocytes with abundant pale, finely vacuolated cytoplasm and dusty melanin pigment.  Pagetoid upward spread of individual melanocytes is evident at one edge of the specimen.	Cylindrical skin segment, 4 mm in diameter, 3 mm in depth.	12 X 10 MM TAN/BROWN IRREGULAR BORDER NEVUS SINCE CHILDHOOD, DEVELOPED DARK BLACK PAPULE IN IT RECENTLY DURING PREGNANCY; CLINICAL DIAGNOSIS - CONGENITAL NEVUS WITH PROBABLE MELANOMA	\N	\N	Scraping	The thickness measurement is preliminary, pending complete excision.  It is somewhat exaggerated by the presence of irregular epidermal hyperplasia over the lesion, and, should this be the deepest area, the prognosis may be somewhat better than implied by this thickness.	MALIGNANT MELANOMA, 1.0 MM IN THICKNESS	173727	140	\N	\N	95-5908	\N	CCR-042	California Cancer Registry	IP60334	AirTable blocks_with_IP_info.csv
1192	05-58791	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2373	172.5	\N	\N	There is a broad-based proliferation of melanocytes, most of which have abundant pale cytoplasm and large, pleomorphic, vesicular nuclei. The epidermis is thinned across a broad area, with confluence of junctional nests, and large nests of similar melanocytes amidst a dense lymphocytic infiltrate. There are foci of pagetoid spread. One edge of the specimen features a thickened, fibrotic papillary dermis with few neoplastic melanocytes and a thinned epidermis.	Deep skin segment, 1.5 x 1.3 x 0.3 cm, margins inked blue, serially sectioned and entirely submitted with six sections.	1 CM PEARLY PAPULE WITH BLACK PIGMENT; BCC VS NEVUS, R/O ATYPIA	\N	\N	\N	The neoplasm extends to the edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: present* Microsatellite metastasis: absent  *Extensive regression is currently considered an adverse prognostic factor. As the regressed area extends to the edge of the specimen, it is impossible to tell the proportion of this lesion that is affected by regression (this may be more easily determined after completer excision).	MELANOMA. 0.95 MILLIMETERS IN THICKNESS	173502	141	\N	\N	05-58791	\N	CCR-046	California Cancer Registry	IP535505	AirTable blocks_with_IP_info.csv
2694	21-20305A1	37	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32751	216.6	\N	2895628	Sections show acral skin with a mostly nested proliferation of melanocytes.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	NEW DARK 1-2 MM MACULE; R/O ACRAL NEVUS VS. OTHER	\N	Skin, arm, right, excision, melanoma, metastatic	FFPE	\N	JUNCTIONAL MELANOCYTIC NEVUS	173617	303	\N	\N	21-20305	A1	CME-001	Cutaneous Melanoma Ethnicities	IP2282778	AirTable blocks_with_IP_info.csv
1864	15-49595	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32779	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	316	\N	\N	15-49595	\N	CME-014	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1347	09-23922B	64	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=330	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis. Many of the melanocytes have pagetoid cytologic features,  i.e., abundant pale cytoplasm that is finely vacuolated, with dusty melanin pigment.	Gross description recorded by digital image.	PREVIOUS HISTORY OF BCC'S, BUT NO ABNORMAL PIGMENTED LESIONS, PRESENTS TODAY FOR SEMI ANNUAL EXAM, HE HAS AN ABNORMAL PIGMENTED COMPLEXION ON HIS LEFT FLANK THAT HAS A BLACK NODULE AND IRREGULAR PIGMENTED MACULES, THE WHOLE 2 CM COMPLEX IS EXCISED	\N	\N	Scraping	Histopathologic features of possible prognostic importance include: Level: III Tumor infiltrating lymphocytes: low Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: mild	MELANOMA, 1.0 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY	173544	142	\N	\N	09-23922	B	CCR-048	California Cancer Registry	IP824685	AirTable blocks_with_IP_info.csv
1346	09-23922A	64	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=329	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis. Many of the melanocytes have pagetoid cytologic features,  i.e., abundant pale cytoplasm that is finely vacuolated, with dusty melanin pigment.	Gross description recorded by digital image.	PREVIOUS HISTORY OF BCC'S, BUT NO ABNORMAL PIGMENTED LESIONS, PRESENTS TODAY FOR SEMI ANNUAL EXAM, HE HAS AN ABNORMAL PIGMENTED COMPLEXION ON HIS LEFT FLANK THAT HAS A BLACK NODULE AND IRREGULAR PIGMENTED MACULES, THE WHOLE 2 CM COMPLEX IS EXCISED	\N	\N	Scraping	Histopathologic features of possible prognostic importance include: Level: III Tumor infiltrating lymphocytes: low Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: mild	MELANOMA, 1.0 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY	173544	142	\N	\N	09-23922	A	CCR-048	California Cancer Registry	IP824685	AirTable blocks_with_IP_info.csv
2996	98-11545	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2374	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.	Cylindrical skin segment, 0.9 cm in diameter and 0.5 cm in thickness,\ntrisected and entirely submitted.	PIGMENTED LESION; CLINICAL DIAGNOSIS - R/O MALIGNANT MELANOMA	\N	\N	\N	None	MELANOMA, 1.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173406	143	\N	\N	98-11545	\N	CCR-049	California Cancer Registry	IP149118	AirTable blocks_with_IP_info.csv
1954	16-83056	11	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	There is an ulcerated, mostly intradermal proliferation of large, oval and fusiform melanocytes with abundant pale cytoplasm and large, vesicular nuclei. These cells are present in confluent fascicles and sheets, with scattered relatively deep mitotic figures and little maturation or dispersion with descent. There is retention of p16 staining.	Nine outside slides, S16-27822 (A1-A2), including three unstained slides (A2), and one corresponding block (A2).	LESION, HISTORY OF BLEEDING, TREATMENT FOR WART AND PRESUMED KELOID (INTRALESIONAL STEROID INJECTION); ATYPICAL SPITZ TUMOR VS. SPITZOID MELANOMA	\N	\N	Scraping	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. It is unclear from the history if the ulceration is spontaneous, or due to treatment or trauma. Given the degree of nuclear pleomorphism and the sheet-like growth pattern, I proposed that molecular testing would be advantageous to see if chromosomal copy number changes, as seen in melanoma are present here. I had also proposed hTERT promoter mutation analysis, but my understanding is that insurance has denied coverage for this test. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows losses involving chr. 9, 13 and 18q, and a possible loss of the peri-centromeric area on chr. 10p. Losses involving chromosomes 9 and 10 are common in melanoma. The loss involving chr. 9 was not accentuated in the area of 9p that contains CDKN2A, making it unlikely that there is a homozygous deletion. This correlates with the preservation of p16 staining by immunohistochemistry.  Given the ulceration, histopathologic findings and the results of comparative genomic hybridization, I would regard this as a relatively high risk atypical Spitz tumor, if not spitzoid melanoma. It would be advantageous to also have the results of hTERT promoter testing.	ATYPICAL SPITZ TUMOR, ULCERATED, WITH SEVERAL CHROMOSOMAL COPY NUMBER CHANGES	173201	244	\N	\N	16-83056	\N	CGH16-200	Nevus Library	IP1682818	AirTable blocks_with_IP_info.csv
1859	15-43069A	62	\N	\N	1	T4b	Primary	nodular	8	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=343	172.6	\N	\N	There is a multi-nodular proliferation of large, oval melanocytes in partial apposition to a thinned and focally ulcerated epidermis. The lesional cells have abundant, pale cytoplasm and dusty appearing melanin and large, oval vesicular nuclei with large, central nucleoli. Maturation with descent is absent. There are a few mitotic figures within dermal melanocytes.	Skin segment measuring 2.2 x 1.8 x 0.5 cm, serially sectioned, and entirely submitted with four sections each in A-B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA. 2.3 X 2.5 CM FUNGATING MASS ON L FOREARM. NO SATELLITE LESIONS. NO OLECRANON LAN. NO L AXILLARY LAN	\N	\N	Scraping	The neoplasm extends to the base of the specimen across a broad front. The final thickness measurement should be made after complete excision. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: biopsy Tumor site: as above Microscopic tumor type: nodular Breslow thickness: as above Ulceration: yes Margins, peripheral and deep: both involved Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4b pNX	MELANOMA, AT LEAST 5 MM. IN THICKNESS	173610	144	\N	\N	15-43069	A	CCR-051	California Cancer Registry	IP116836	AirTable blocks_with_IP_info.csv
1700	13-32289A	63	\N	\N	\N	T3a	Primary	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=350	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes involving the epidermis and in a domed area in the center of the lesion, the papillary, and superficial reticular dermis.  In the peripheral portion, nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent, with subjacent lymphocytic infiltrates.  The domed portion features a thinned epidermis and sheets of melanocytes, with a predominance of cells with large, vesicular nuclei and enlarged nucleoli, and abundant, pale cytoplasm in some areas. There is defective maturation with descent, and mitotic figures are apparent among these cells.	Oriented ellipse measuring 3.3 x 1.7 x 0.7 cm, including a central 1.5 x 1.3 cm raised area. With the orienting sutured tip placed to the left and arbitrarily designated as 12:00 by the grosser, the 12:00-6:00 margin is inked blue and the 6:00-12:00 margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and four sections each in B and C. HD/HD	R/O MEL PROCESS VS. CONG NEVUS WITH SK	\N	\N	Scraping	The neoplasm extends to within 2 mm. of the peripheral edge of the specimen. The lesion is not ulcerated, and is therefore stage pT3a per the 2009 AJCC staging schema for melanoma.	MELANOMA, 2.5 MM. IN THICKNESS	273588	145	\N	\N	13-32289	A	CCR-054	California Cancer Registry	IP1217034	AirTable blocks_with_IP_info.csv
2688	21-13595A1	40	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32749	216.3	\N	2895628	Sections show a predominantly dermal proliferation of small melanocytes which diminish in size with descent in the dermis.  There is surrounding elastosis and scattered thin walled vessels.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, trisected and entirely submitted. BY/KB	IRRITATED NEVUS	\N	Skin, thigh, right, wide excision, nodular melanoma	FFPE	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173304	303	\N	\N	21-13595	A1	CME-001	Cutaneous Melanoma Ethnicities	IP2276005	AirTable blocks_with_IP_info.csv
1701	13-32289B	63	\N	\N	\N	T3a	Primary	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2740	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes involving the epidermis and in a domed area in the center of the lesion, the papillary, and superficial reticular dermis.  In the peripheral portion, nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent, with subjacent lymphocytic infiltrates.  The domed portion features a thinned epidermis and sheets of melanocytes, with a predominance of cells with large, vesicular nuclei and enlarged nucleoli, and abundant, pale cytoplasm in some areas. There is defective maturation with descent, and mitotic figures are apparent among these cells.	Oriented ellipse measuring 3.3 x 1.7 x 0.7 cm, including a central 1.5 x 1.3 cm raised area. With the orienting sutured tip placed to the left and arbitrarily designated as 12:00 by the grosser, the 12:00-6:00 margin is inked blue and the 6:00-12:00 margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and four sections each in B and C. HD/HD	R/O MEL PROCESS VS. CONG NEVUS WITH SK	\N	\N	Scraping	The neoplasm extends to within 2 mm. of the peripheral edge of the specimen. The lesion is not ulcerated, and is therefore stage pT3a per the 2009 AJCC staging schema for melanoma.	MELANOMA, 2.5 MM. IN THICKNESS	273588	145	\N	\N	13-32289	B	CCR-054	California Cancer Registry	IP1217034	AirTable blocks_with_IP_info.csv
1683	13-14077	66	\N	\N	\N	T2a	Primary	None	15	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2739	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed compound proliferation of melanocytes. Melanocytes are arranged as irregular single cells and nests within the epidermis and single melanocytes predominate over nests in some foci. In addition, scattered melanocytes are present in the spinous layer. In addition, there are nests and sheets of atypical melanocytes in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis. Solar elastosis is present in the dermis as well. Scattered mitotic figures are present amid dermal melanocytes as well.	Cylindrical skin segment, 0.3 cm in diameter and 0.4 cm in thickness, submitted intact. HD/HD	BCC	\N	\N	Scraping	A SOX-10 immunoperoxidase stain avidly labels the lesional cells, confirming the diagnosis of melanoma. The melanoma is between 1 and 2 mm in thickness, and is not ulcerated. Therefore,  should no more adverse findings be evident on complete excision, it would be classified as pT2a per the 2009 revision of the AJCC staging system for melanoma. Further treatment at this site is warranted.	MELANOMA, 1.1 MILLIMETERS IN THICKNESS, EXTENDING TO THE LATERAL ASPECTS OF THE SPECIMEN	173526	146	\N	\N	13-14077	\N	CCR-055	California Cancer Registry	IP1198820	AirTable blocks_with_IP_info.csv
1115	04-6689B	67	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.6	\N	\N	Sections show a broad, asymmetrical and poorly circumscribed proliferation of large melanocytes, present in a pagetoid pattern within the epidermis in some of the flat areas of the neoplasm.  In others, a dense band-like lymphocytic infiltrate is present, obscuring the junction and causing the rete ridge, dermal papilla pattern to nearly disappear.  Toward the center, a crust overlies a dome-shaped area within which there are sheets of large melanocytes with pleomorphic, vesicular nuclei.  Melanocytes in this area fail to mature with descent and mitotic figures are present in number.  Beneath this area, nests of melanocytes are seen adjacent to an eccrine sweat coil, and in slide B, around a small nerve.	Oriented ellipse measuring 5.5 x 2.2 x 1.2 cm, with central lesion measuring 1.7 x 1.5 cm. The far aspect of the specimen is preinked in blue. The far aspect of specimen is inked in red and the near half of specimen is inked in yellow. The specimen is serially sectioned perpendicular to the long axis from the left to the right and submitted with four sections each in cassettes A and B; tips returned to container\n	RED 2 CM PLAQUE WITH ULCER AT 1/28 BX SITE, NO PRIOR H/O ULCER, NO PIGMENTATION; AMELANOTIC MELANOMA, EXCISIONAL BX WITH 3 MM MARGINS FOR PROGNOSIS	\N	\N	Scraping	Melanoma cells extend around a nerve and into eccrine sweat coils beneath the main part of the lesion.  I did not include these nests in the thickness measurement, as they appear to have extended along adnexal and vascular structures.  There appears to be a recently healed ulcer, but this may reflect the previous biopsy rather than indicate tumor ulceration (which if present, is an unfavorable sign).  There is a moderate mitotic rate. While the excision appears complete, melanoma in situ extends sufficiently close to the edges of the specimen that further surgery seems advisable.  In addition, perineural invasion is present sufficiently close to the base of the specimen that a reexcision that extends to fascia, if present, would be worthwhile.	MELANOMA, AT LEAST 2 MM IN THICKNESS	173605	147	\N	\N	04-6689	B	CCR-057	California Cancer Registry	IP423088	AirTable blocks_with_IP_info.csv
2519	19Rig750007.03.07.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	275	\N	\N	None	\N	CM-36	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2971	96-07395C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	991	\N	\N	None	\N	MD-95	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1348	09-31608	66	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=386	172.4	\N	\N	Sections show a proliferation of spindled cells with hyperchromatic nuclei positioned between thickened collagen bundles in the upper dermis. A vaguely fascicular configuration is focally apparent. There is no increase in cellularity at the junction. A sparse and patchy lymphocytic infiltrate is also present.	Two skin segments measuring 0.8 x 0.7 x 0.1 cm, trisected, and 0.6 x 0.5 x 0.1 cm, bisected, entirely submitted.	FIBROMA VS. SCLEROSING BCC?	\N	\N	Scraping	There is no evidence of carcinoma. Rather, this biopsy shows early desmoplastic melanoma. We utilized immunoperoxidase staining to confirm lineage. There is avid expression of S100 protein, constituting a staining result that is strongly supportive of the above interpretation. There is general lack of expression of CD10 and procollagen by lesional cells, and thus it is clear that this proliferation is not of fibrous lineage. In terms of staging, this is a non-ulcerated melanoma with Clark's level IV invasion but without associated vascular invasion, perineural invasion, or regression. Further excision is warranted to ensure that local eradication has been accomplished. A call to Dr. Jacoby's cell phone regarding this diagnosis was placed at the time this report was issued, per request.	DESMOPLASTIC MELANOMA OF 1.0 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173410	149	\N	\N	09-31608	\N	CCR-066	California Cancer Registry	IP832371	AirTable blocks_with_IP_info.csv
1100	03-57585A	83	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=425	172.5	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclear features, in irregular array along the epidermal-dermal junction.  Similar melanocytes are present in clusters in the underlying dermis.	Oriented ellipse measuring 4.2 x 3.0 x 1.3 cm, central lesion measuring 3.1 x 1.8 cm, pigmented, with the suture at 12 o'clock, the far aspect of specimen is inked in blue and the near half of specimen is inked in yellow.  The specimen is serially sectioned and submitted with three sections each in cassettes A and E and two sections each in cassettes B through D	R/O MELANOMA	\N	\N	Scraping	There is extensive lymphatic invasion. Histopathologic features of possible prognostic importance include:  Level:  IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: present Mitotic rate: moderate Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, ABOUT 2.2 MM  IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139522	154	\N	\N	03-57585	A	CCR-090	California Cancer Registry	IP415901	AirTable blocks_with_IP_info.csv
2562	20-00548-10	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36029	\N	\N	\N	\N	\N	\N	\N	H20-00548 (right cheek) #10	FFPE	\N	\N	\N	360	\N	\N	None	\N	CME-058	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1310	08-25654	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=387	172.7	\N	\N	Sections show acral skin with a proliferation of melanocytes that extends into the deep reticular dermis. There are large nests positioned at, or just beneath the dermal-epidermal junction, composed of cells with abundant amphophilic cytoplasm and large, pleomorphic, vesicular nuclei that contain large nucleoli. Situated in the upper dermis are slightly smaller, but focally confluent nests of similar cells in which there are occasional mitotic figures. The nuclei in some of these nests appear to overlap. Smaller nests of small, round melanocytes, again with overlapping nuclei extend further into the dermis. There are patchy lymphocytic infiltrates, superficially joined by melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted.	R/O ATYPICAL NEVUS	\N	\N	\N	The thickness is listed as an estimate, as there are small cells near the base of the lesion that could represent either small melanoma cells or those of a pre-existent nevus. I favor the former, in which case the thickness would be closer to 3.0 mm. No ulceration is present, but there is an area in which the papillary dermis is thickened, fibrotic and inflamed that could represent regression. This may be clarified on complete excision. Additionally, the deep dermis is fibrotic. This may be a reaction to chronic inflammation, or could reflect a previous procedure or trauma at this site.	MELANOMA, AT LEAST 2.0 MM IN THICKNESS	173713	150	\N	\N	08-25654	\N	CCR-067	California Cancer Registry	IP734295	AirTable blocks_with_IP_info.csv
1297	08-1851B	58	\N	\N	\N	None	None	None	6	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=395	172.5	\N	\N	There is a proliferation of melanocytes with abundant pale cytoplasm, dusty melanin and striking nuclear pleomorphism that extends from the epidermis into the subcutis at the base of the specimen. Single cells predominate in portions of the lesion, with pagetoid spread; there is no maturation with descent into the dermis and subcutis. Mitoses are easily identified. There are large zones of necrosis, and others in which melanophages predominate over melanocytes.	Oriented excision, 2.3 x 1.5 x 1.0 cm, including a central 1.8 x 1.2 cm dark pigment.  With the orienting sutured end placed to the left and designated suture at 12:00 by the surgeon, the 12 to 3 to 6 o'clock (far) margin is inked blue and the 6 to 9 to 12 o'clock (near) margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12 o'clock to 6 o'clock ends (left to right) and entirely submitted with four sections in cassette A, two sections in cassette B, and three sections in cassette C.	R/O MELANOMA	\N	\N	Scraping	This neoplasm extends deeply into the subcutis (level V), has a high mitotic rate and features necrosis en masse. Ulceration is not evident, however. Deeply pigmented melanomas with a peri-appendageal pattern of this type have been called animal-type melanoma. However, the analogy to eccrine melanotic disease is flawed, and there is little evidence that this type of melanoma behaves differently in humans from other forms of melanoma.	MELANOMA, AT LEAST 9 MM IN THICKNESS	173568	151	\N	\N	08-1851	B	CCR-074	California Cancer Registry	IP710492	AirTable blocks_with_IP_info.csv
1298	08-1851C	58	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=396	172.5	\N	\N	There is a proliferation of melanocytes with abundant pale cytoplasm, dusty melanin and striking nuclear pleomorphism that extends from the epidermis into the subcutis at the base of the specimen. Single cells predominate in portions of the lesion, with pagetoid spread; there is no maturation with descent into the dermis and subcutis. Mitoses are easily identified. There are large zones of necrosis, and others in which melanophages predominate over melanocytes.	Oriented excision, 2.3 x 1.5 x 1.0 cm, including a central 1.8 x 1.2 cm dark pigment.  With the orienting sutured end placed to the left and designated suture at 12:00 by the surgeon, the 12 to 3 to 6 o'clock (far) margin is inked blue and the 6 to 9 to 12 o'clock (near) margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12 o'clock to 6 o'clock ends (left to right) and entirely submitted with four sections in cassette A, two sections in cassette B, and three sections in cassette C.	R/O MELANOMA	\N	\N	Scraping	This neoplasm extends deeply into the subcutis (level V), has a high mitotic rate and features necrosis en masse. Ulceration is not evident, however. Deeply pigmented melanomas with a peri-appendageal pattern of this type have been called animal-type melanoma. However, the analogy to eccrine melanotic disease is flawed, and there is little evidence that this type of melanoma behaves differently in humans from other forms of melanoma.	MELANOMA, AT LEAST 9 MM IN THICKNESS	173568	151	\N	\N	08-1851	C	CCR-074	California Cancer Registry	IP710492	AirTable blocks_with_IP_info.csv
1101	03-57585C	83	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=427	172.5	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclear features, in irregular array along the epidermal-dermal junction.  Similar melanocytes are present in clusters in the underlying dermis.	Oriented ellipse measuring 4.2 x 3.0 x 1.3 cm, central lesion measuring 3.1 x 1.8 cm, pigmented, with the suture at 12 o'clock, the far aspect of specimen is inked in blue and the near half of specimen is inked in yellow.  The specimen is serially sectioned and submitted with three sections each in cassettes A and E and two sections each in cassettes B through D	R/O MELANOMA	\N	\N	Scraping	There is extensive lymphatic invasion. Histopathologic features of possible prognostic importance include:  Level:  IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: present Mitotic rate: moderate Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, ABOUT 2.2 MM  IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139522	154	\N	\N	03-57585	C	CCR-090	California Cancer Registry	IP415901	AirTable blocks_with_IP_info.csv
1513	11-80898	84	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=952	172.4	\N	\N	Sections show a compound proliferation of melanocytes with vacuolated pale cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, and conspicuous associated suprabasal scatter is apparent. There are also nests of similar melanocytes in fibrotic upper dermis, where a lymphohistiocytic infiltrate also resides. Part of the background epidermis is atypical and is capped by parakeratosis.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, trisected and entirely submitted.	ATP BR PATCH; R/O PIG AK/SCC IN SITU/MIS/OTHER	\N	\N	\N	This melanoma has occurred in collision with a solar keratosis. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.55 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE SPECIMEN PERIPHERY	173406	155	\N	\N	11-80898	\N	CCR-097	California Cancer Registry	IP61385	AirTable blocks_with_IP_info.csv
2566	20-01665-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36030	\N	\N	\N	\N	\N	\N	\N	H20-01665 (lower right eyelid) #3	FFPE	\N	\N	\N	361	\N	\N	None	\N	CME-059	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3254	CP1-10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2150	\N	\N	None	\N	SYNAT670	2010-2017	\N	AirTable blocks_with_IP_info.csv
1296	08-1851A	58	\N	\N	\N	\N	\N	\N	12	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=394	172.5	\N	\N	There is a proliferation of melanocytes with abundant pale cytoplasm, dusty melanin and striking nuclear pleomorphism that extends from the epidermis into the subcutis at the base of the specimen. Single cells predominate in portions of the lesion, with pagetoid spread; there is no maturation with descent into the dermis and subcutis. Mitoses are easily identified. There are large zones of necrosis, and others in which melanophages predominate over melanocytes.	Oriented excision, 2.3 x 1.5 x 1.0 cm, including a central 1.8 x 1.2 cm dark pigment.  With the orienting sutured end placed to the left and designated suture at 12:00 by the surgeon, the 12 to 3 to 6 o'clock (far) margin is inked blue and the 6 to 9 to 12 o'clock (near) margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12 o'clock to 6 o'clock ends (left to right) and entirely submitted with four sections in cassette A, two sections in cassette B, and three sections in cassette C.	R/O MELANOMA	\N	\N	Scraping	This neoplasm extends deeply into the subcutis (level V), has a high mitotic rate and features necrosis en masse. Ulceration is not evident, however. Deeply pigmented melanomas with a peri-appendageal pattern of this type have been called animal-type melanoma. However, the analogy to eccrine melanotic disease is flawed, and there is little evidence that this type of melanoma behaves differently in humans from other forms of melanoma.	MELANOMA, AT LEAST 9 MM IN THICKNESS	173568	151	\N	\N	08-1851	A	CCR-074	California Cancer Registry	IP710492	AirTable blocks_with_IP_info.csv
1288	07-67657B	70	\N	\N	\N	None	None	None	4	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=415	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei, mitotic figures and abundant pigmentation, in partial contiguity with the epidermis.  There is a permeative infiltrate of lymphocytes, as well as a patchy infiltrate and fibrosis at the periphery. Melanocytes lie in close apposition to small nerve twigs.	Oriented ellipse, 2.1 x 1.4 x 0.7 cm, including a central violaceous 1.1 x 1.0 cm nodule.  With the orienting sutured tip placed to the left, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right tips and entirely submitted with three sections each in cassettes A and B, and four sections in cassette C.	9 X 7 MM BLACK NODULE; PROBABLE MELANOMA	\N	\N	Scraping	This is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). There is focal regression, and perineural invasion involving small nerve twigs. There is no evidence of vascular invasion. Tumor extends within 2 mm of peripheral margins, and changes of regression are present at some peripheral margins. Additional excision is warranted.	MELANOMA, 4.0 MM IN THICKNESS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERAL MARGIN	173526	152	\N	\N	07-67657	B	CCR-083	California Cancer Registry	IP690191	AirTable blocks_with_IP_info.csv
1287	07-67657A	70	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=414	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei, mitotic figures and abundant pigmentation, in partial contiguity with the epidermis.  There is a permeative infiltrate of lymphocytes, as well as a patchy infiltrate and fibrosis at the periphery. Melanocytes lie in close apposition to small nerve twigs.	Oriented ellipse, 2.1 x 1.4 x 0.7 cm, including a central violaceous 1.1 x 1.0 cm nodule.  With the orienting sutured tip placed to the left, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right tips and entirely submitted with three sections each in cassettes A and B, and four sections in cassette C.	9 X 7 MM BLACK NODULE; PROBABLE MELANOMA	\N	\N	Scraping	This is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). There is focal regression, and perineural invasion involving small nerve twigs. There is no evidence of vascular invasion. Tumor extends within 2 mm of peripheral margins, and changes of regression are present at some peripheral margins. Additional excision is warranted.	MELANOMA, 4.0 MM IN THICKNESS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERAL MARGIN	173526	152	\N	\N	07-67657	A	CCR-083	California Cancer Registry	IP690191	AirTable blocks_with_IP_info.csv
1030	01-16263	58	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2741	172.5	\N	\N	Sections show a compound proliferation of melanocytes arrayed as irregular nests along the epidermal-dermal junction, with nests and sheets of atypical melanocytes in the underlying dermis.  Most of the melanocytes have atypical nuclei and ample vacuolated and pigmented cytoplasm, and a few dermal mitotic figures are appreciable.  There is an substantial lymphocytic infiltrate in the papillary dermis.	Oval-shaped excision, 1.8 x 1.5 x 1.0 cm, with margins inked blue,\nthree central sections submitted, incorporating the central pigmented\nzone, with tips returned to container.	13 X 11 MM PLAQUE; R/O MM	\N	\N	Scraping	The in situ component of this lesion is arranged in a predominantly nested fashion, resembling the configuration of a dysplastic nevus.  Indeed, it is possible that this melanoma evolved from a dysplastic nevus.  There are changes of regression present, but I doubt that the regressive alteration has significantly influenced the above microstage measurement.  There is no evidence of vascular or perineural invasion, and there is also no evidence of ulceration.  The tip margins of this specimen were not grossed for microscopic assessment, and as it appears that this site will be excised further, I intend to defer further assessment of the specimen tips.  If you prefer for the tips to be examined, please give me a call.	MELANOMA, 1.6 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 1 MM OF THE PERIPHERAL BIOPSY MARGIN	528522	153	\N	\N	01-16263	\N	CCR-086	California Cancer Registry	IP272666	AirTable blocks_with_IP_info.csv
1102	03-57585E	83	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=429	172.5	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclear features, in irregular array along the epidermal-dermal junction.  Similar melanocytes are present in clusters in the underlying dermis.	Oriented ellipse measuring 4.2 x 3.0 x 1.3 cm, central lesion measuring 3.1 x 1.8 cm, pigmented, with the suture at 12 o'clock, the far aspect of specimen is inked in blue and the near half of specimen is inked in yellow.  The specimen is serially sectioned and submitted with three sections each in cassettes A and E and two sections each in cassettes B through D	R/O MELANOMA	\N	\N	Scraping	There is extensive lymphatic invasion. Histopathologic features of possible prognostic importance include:  Level:  IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: present Mitotic rate: moderate Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, ABOUT 2.2 MM  IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139522	154	\N	\N	03-57585	E	CCR-090	California Cancer Registry	IP415901	AirTable blocks_with_IP_info.csv
2521	19Rig750007.03.08.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	276	\N	\N	None	\N	CM-37	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2520	19Rig750007.03.08.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	276	\N	\N	None	\N	CM-37	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1472	11-37100B	65	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=970	172.5	\N	\N	Sections show a proliferation of melanocytes distributed as single cells and nests along the sides and bases of elongated pigmented rete. The dermis below this shows considerable elastosis and also superficial fibrosis. There is a sparse superficial dermal lymphohistiocytic infiltrate with admixed melanophages. Near the junction, dermal nests and cords of melanocytes can also be seen.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected and entirely submitted in cassette B.	A) R/O MELANOMA WITH ERYTHEMA, B) SL, R/O MELANOMA	\N	\N	\N	With respect to staging, this melanoma is also of stage T1a. As for the specimen above, further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.45 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE SPECIMEN PERIPHERY	139522	156	\N	\N	11-37100	B	CCR-099	California Cancer Registry	IP1026539	AirTable blocks_with_IP_info.csv
1385	10-25517A	91	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=972	172.6	\N	Re-excision path number for T10-23548	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.	Ellipse, 7.5 x 3.0 x 1.2 cm, including a central black 1.5 x 1.0 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections in cassette A, one section each in cassettes B through H, and two sections in cassette I.	WLE MM	\N	\N	\N	In light of the increased thickness of the residual lesion, this melanoma should now be regarded as a pT2a lesion.  No lymphatic or perineural invasion is noted.  There is no evidence of regression.  Microsatellites are not identified.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, APPROXIMATELY 1.25 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED	173619	157	\N	\N	10-25517	A	CCR-102	California Cancer Registry	IP918121	AirTable blocks_with_IP_info.csv
1386	10-25517E	91	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=976	172.6	\N	Re-excision path number for T10-23548	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.	Ellipse, 7.5 x 3.0 x 1.2 cm, including a central black 1.5 x 1.0 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections in cassette A, one section each in cassettes B through H, and two sections in cassette I.	WLE MM	\N	\N	\N	In light of the increased thickness of the residual lesion, this melanoma should now be regarded as a pT2a lesion.  No lymphatic or perineural invasion is noted.  There is no evidence of regression.  Microsatellites are not identified.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, APPROXIMATELY 1.25 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED	173619	157	\N	\N	10-25517	E	CCR-102	California Cancer Registry	IP918121	AirTable blocks_with_IP_info.csv
1383	10-23548	91	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=971	172.6	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes involving the epidermis and dermis. It is composed largely of cells with ample vacuolated and pigmented cytoplasm and atypical nuclei. Single cells and nests are arrayed irregularly within the epidermis, with prominent foci of suprabasal scatter. There are clusters of similar melanocytes in the fibrotic superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. Scattered mitoses are seen. There is solar elastosis as well.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected and entirely submitted.	PARTIAL BX 2 CM RED, BROWN, BLUE PATCH; MELANOCYTIC VS. BCC PIG	\N	\N	\N	Histopathologic features of possible prognostic importance include (but definitive assessment should be performed on the re-excision): Level: III/IV Tumor infiltrating lymphocytes: few, non-brisk Vascular or lymphatic invasion: not identified Mitotic rate: 1 per square mm Perineural invasion: not identified Ulceration: not identified Regression: not identified Microsatellite metastasis: not identified	MELANOMA, AT LEAST 0.4 MM IN THICKNESS, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173619	157	\N	\N	10-23548	\N	CCR-102	California Cancer Registry	IP918121	AirTable blocks_with_IP_info.csv
3024	99-32835	39	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.5	\N	\N	Partially encompassed by epithelial collarettes is a proliferation of relatively small melanocytes, with hyperchromatic nuclei, focally in pagetoid array within the epidermis and in compact nests within the papillary dermis.  There is an infiltrate of lymphocytes and melanophages.  To one side are small, round melanocytes arranged as cords and strands within edematous stroma.	Skin segment measuring 0.7 x 0.5 x 0.2 cm, trisected and entirely\nsubmitted.	5 X 3 MM PIGMENTED PAPULE	\N	\N	FFPE	This is a very small melanoma, with an unusual pattern.  It is composed of small nevoid cells.  It extends close to the base of the specimen.	MELANOMA, 0.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173533	173	\N	\N	99-32835	\N	CCR-151	Melanoma Epigenetics	IP208368	AirTable blocks_with_IP_info.csv
1304	08-8920B	61	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=983	172.4	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis including within adnexa, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages.	Ellipse, 2.4 x 1.2 x 0.5 cm, including a central dark brown 1.3 x 0.8 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	R/O MELANOMA	\N	\N	\N	This is a non-ulcerated primary melanoma with invasion limited to the papillary dermis (Clark's level III). The measurement of thickness does not include a periadventitial focus present at a deeper aspect, as such areas should not be included in this measurement. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is warrranted to ensure that this lesion has been removed completely.	MELANOMA, 0.7 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 1 MILLIMETER OF THE PERIPHERAL MARGIN	173404	158	\N	\N	08-8920	B	CCR-107	California Cancer Registry	IP717561	AirTable blocks_with_IP_info.csv
2985	97-13166G	68	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1015	172.5	\N	\N	Sections show a proliferation of atypical melanocytes, arranged irregularly as single cells and nests at the epidermal-dermal junction, and in the dermis without diminishment in size.  There are areas in which the papillary dermis is thickened and fibrotic, with a lichenoid infiltrate of lymphocytes, as well as diminished numbers of melanocytes in comparison to the remainder of the lesion.	Ellipse, 7.0 x 4.3 x 1.3 cm, serially sectioned and submitted with\none section each in blocks A through I and two sections in block J,\nmargins inked blue, tips returned to container.	BLACK LESION; CLINICAL DIAGNOSIS - MELANOMA, REMAINING DATA ON FILE	\N	\N	\N	Regression is currently believed to be an adverse prognostic factor in patients with melanoma.	MELANOMA, 0.4 MM IN THICKNESS, WITH AREAS OF REGRESSION, COMPLETELY EXCISED, WITH MARGINS FREE OF NEOPLASM	139523	171	\N	\N	97-13166	G	CCR-147	California Cancer Registry	IP115935	AirTable blocks_with_IP_info.csv
1303	08-8920A	61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=982	172.4	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis including within adnexa, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages.	Ellipse, 2.4 x 1.2 x 0.5 cm, including a central dark brown 1.3 x 0.8 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	R/O MELANOMA	\N	\N	\N	This is a non-ulcerated primary melanoma with invasion limited to the papillary dermis (Clark's level III). The measurement of thickness does not include a periadventitial focus present at a deeper aspect, as such areas should not be included in this measurement. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is warrranted to ensure that this lesion has been removed completely.	MELANOMA, 0.7 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 1 MILLIMETER OF THE PERIPHERAL MARGIN	173404	158	\N	\N	08-8920	A	CCR-107	California Cancer Registry	IP717561	AirTable blocks_with_IP_info.csv
1292	07-77608	85	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=984	172.6	\N	\N	Sections show a proliferation of melanocytes in the epidermis and dermis of a dome shaped segment of skin.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The papillary dermis is expanded by large aggregates of similar cells, with little maturation, and areas in which many mitotic figures are found. There are many plasma cells in the adjacent stroma.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted.	CLEAR CELL ACANTHOMA, R/O BCC	\N	\N	\N	The final thickness measurement and a comprehensive evaluation of risk factors should be made after complete excision of this amelanotic lesion. The mitotic rate is high, there is no ulceration and although the interface between the papillary and reticular dermis is obscured, it is likely that this is a level IV lesion.	MELANOMA, AT LEAST 1.6 MM  IN THICKNESS	173611	159	\N	\N	07-77608	\N	CCR-109	California Cancer Registry	IP31137	AirTable blocks_with_IP_info.csv
1284	07-42908	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=985	172.6	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also densely juxtaposed clusters of similar melanocytes in the dermis, jointly with an infiltrate of lymphocytes and melanophages. The dermal melanocytes show little maturation with descent. The flanking reticular dermis is strikingly elastotic.	Skin segment measuring 1.1 x 0.9 x 0.3 cm, trisected and entirely submitted.	R/O SEB K	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion of the superficial reticular dermis (Clark's level IV). There is no evidence of associated vascular invasion, neurotropism, or regression. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF AT LEAST 1.3 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173601	160	\N	\N	07-42908	\N	CCR-112	California Cancer Registry	IP665441	AirTable blocks_with_IP_info.csv
1281	07-40241A	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=986	173.5	\N	\N	Sections show a compound proliferation of melanocytes, some with atypical nuclei, with nests along the sides and bases of elongated rete ridges, with fibroplasia of the papillary dermis.  In areas, a more irregular distribution of melanocytes is present within the epidermis, with many single melanocytes scattered above the basal layer. Small nests of similar melanocytes are present in the papillary dermis.	Skin segment measuring 1.7 x 1.1 x 0.1 cm, including a central black 0.6 x 0.5 cm pigment, serially sectioned and entirely submitted with four sections in cassette A and three sections in cassette B.	ATYPICAL PIGMENTED LESION; R/O MM VS OTHER	\N	\N	\N	The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. Portions of this lesion resemble a dysplastic (Clark's) nevus.  It is difficult to tell whether this is due to the cells of this melanoma being arranged in a pattern that simulates such a nevus, or whether one was pre-existent in this site. There is no evidence of ulceration, regression or other findings that would adversely affect the prognosis of this thin level II lesion.	MELANOMA, 0.3 MM  IN THICKNESS	273588	161	\N	\N	07-40241	A	CCR-113	California Cancer Registry	IP662774	AirTable blocks_with_IP_info.csv
2998	98-16285A2	37	\N	\N	\N	\N	\N	\N	3	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes arrayed as\nirregular nests along the epidermal-dermal junction, with nests and\nsheets of atypical melanocytes in the underlying dermis.  There is a\nbandlike infiltrate of lymphocytes in the papillary dermis.	Ellipse, 3.5 x 1.7 x 1.2 cm, serially sectioned and submitted, tips\nreturned to container.	CLINICAL DIAGNOSIS - VIOLACEOUS NODULE, R/O MELANOMA	\N	\N	Scraping	The melanoma extends near to the periphery of the specimen.  In light of the changes of regression, the microstage measurement listed above may underestimate the prognostic risk of this lesion.	MELANOMA, 3.2 MM IN THICKNESS, WITH SUPERIMPOSED LICHENOID LYMPHOCYTIC INFILTRATE AND CHANGES OF REGRESSION	139524	195	\N	\N	98-16285	A2	CCR-217	California Cancer Registry	IP153858	AirTable blocks_with_IP_info.csv
2522	19Rig750007.03.11.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	277	\N	\N	None	\N	CM-40	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2973	96-13701 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	992	\N	\N	None	\N	MD-96	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1269	07-7626	54	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=988	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes.  Nests of melanocytes are distributed at irregular intervals, and are focally confluent.  The papillary dermis is distended by aggregates of similar cells.  The papillary dermis is in one focus thickened and fibrotic, with a patchy bandlike lymphocytic infiltrate and diminished numbers of melanocytes in such areas, when compared to the remainder of the lesion.	Skin segment measuring 1.5 x 1.3 x 0.2 cm, quadrisected and entirely submitted.	MOLE TURNING PINK X 2 YEARS, 1.5 CM TAN, PINK IRRITATED PAPULE > 2 YEARS; R/O IRRITATED SK VS BCC VS MIS	\N	\N	\N	The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: present* Microsatellite metastasis: absent, but should be re-evaluated after complete excision  * This is less than 50% of two cross sections.  Some studies show regression is an adverse prognostic finding, but only when greater than that amount.	MELANOMA, 1.0 MM  IN THICKNESS	273588	162	\N	\N	07-7626	\N	CCR-114	California Cancer Registry	IP630157	AirTable blocks_with_IP_info.csv
2997	98-13466	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=991	172.5	\N	\N	Sections show melanocytes in irregular array within the epidermis above a zone of scar, and irregular clusters of melanocytes are present in the underlying dermis.	Skin segment, 1.0 x 1.0 x 0.4 cm, quadrisected longitudinally and\nentirely submitted.	CLINICAL DIAGNOSIS - R/O MM	\N	\N	\N	7/31/98:  Please provide my thanks to your staff for clarifying that a prior biopsy from this patient does exist.  We attempted to retrieve the earlier biopsy from this site, but the outside office that we contacted had no record of this patient.  If the earlier biopsy from this patient can be located in the future, I would like to have an opportunity to review the specimen as part of this consultation.   5/19/98:  There is a clear-cut scar underlying this lesion, implying that it was biopsied previously. Please verify with the patient whether any prior biopsies from this site have been obtained, as any earlier specimens from this site should be re-evaluated to see if they hold any implications for the microstage measurement listed above.  In any event, further re-excision of this lesion is warranted, as the changes of intraepidermal melanoma extend nearly to the periphery of the specimen.	MELANOMA, 0.75 MM IN THICKNESS, PRESENT ABOVE SCAR AND EXTENDING NEAR TO THE PERIPHERAL MARGIN	173502	163	\N	\N	98-13466	\N	CCR-124	California Cancer Registry	IP151039	AirTable blocks_with_IP_info.csv
2992	98-6161B	73	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=993	172.5	\N	\N	Sections show nested and solitary melanocytes, some with atypical\nnuclei, arrayed irregularly within the epidermis as both single\ncells and as laterally confluent nests.  In the underlying dermis,\nthere are irregularly-shaped, horizontally-oriented clusters of\nsimilar but slightly smaller melanocytes, which are surrounded by\nfibrosis.  These changes are present above elastosis.  There is a\nbandlike infiltrate of lymphocytes in the papillary dermis.\nMultinucleated melanocytes are present in both the junctional and\nintradermal components.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.3 cm in\nthickness.	B - ERYTHEMATOUS PAPULE, 4X4 MM WITH RING OF PIGMENT, B - AMELANOCYTIC PAPULE IN CENTER OF EVENLY PIGMENTED MACULE; CLINICAL DIAGNOSIS - A) R/O BCC, B) R/O MM, C ) R/O MM, REMAINING DATA ON FILE	\N	\N	\N	Melanomas in which small, round cells predominate in the dermal component have been termed nevoid melanoma, or minimal deviation melanoma. Several studies have suggested that there is no prognostic difference between this form and conventional melanoma.	MELANOMA, MEASURING 0.35 MM IN THICKNESS.	152589	164	\N	\N	98-6161	B	CCR-125	California Cancer Registry	IP136586	AirTable blocks_with_IP_info.csv
1291	07-76799A	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=994	172.4	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed of cells with scant vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter and with scattered gargantuan nests at the junction. There are also irregular clusters of similar melanocytes in the superficial dermis, jointly with subjunctional fibrosis and a patchy dermal lymphohistiocytic infiltrate. The deeper dermis shows a mix of elastosis and fibrosis. Many lesional melanocytes permeate adnexa.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in cassette A.	A) 1.5 X 1.1 CM PINK TAN SHINY PLAQUE; SK, R/O ATYPIA; B) 3 X 3 MM PEARLY PAPULE; R/O BCC	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion limited to the papillary dermis (Clark's level III). There is no evidence of associated vascular invasion, neurotropism, or regression. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.8 MM IN THICKNESS, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173445	165	\N	\N	07-76799	A	CCR-130	California Cancer Registry	IP641150	AirTable blocks_with_IP_info.csv
3016	99-19410A	78	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1001	172.6	\N	\N	Sections show a compound proliferation of melanocytes, the junctional\ncomponent of which consists of nested and solitary melanocytes\narrayed irregularly along the junction.  Clusters of similar cells\nare present in the superficial dermis.  In some areas, the density of\nthe melanocytic proliferation along the junctional zone is markedly\ndiminished, and the subjacent papillary dermis is expanded by\nfibrosis accompanied by lymphocytes and melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness,\nbisected and entirely submitted.	A - 3.7 X 2.3 CM IRREGULARLY SHAPED PIGMENTED PLAQUE, HYPERPIGMENTATION, ? REGRESSION, WITH A SUPERFICIAL ULCERATION, B - DARKEST THICKEST AREA; CLINICAL DIAGNOSIS - A) - B) - SUPERFICIAL SPREADING MELANOMA	\N	\N	\N	In light of the extensive changes of regression, the microstage measurement listed above may underestimate the prognostic risk of this lesion.  Final microstage measurements should be deferred until this lesion has been completely reexcised.	MELANOMA, AT LEAST 0.35 MM IN THICKNESS, WITH AREAS OF PARTIAL AND COMPLETE REGRESSION, AND WITH INVOLVEMENT OF THE PERIPHERAL BIOPSY MARGIN	173619	166	\N	\N	99-19410	A	CCR-134	California Cancer Registry	IP194943	AirTable blocks_with_IP_info.csv
3017	99-19410B	78	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1002	232.6	\N	\N	Sections show nested and solitary melanocytes in irregular array\nwithin the epidermis, including some melanocytes arrayed above the\nbasal zone.  There is a permeative lymphocytic infiltrate in the\nsubjacent papillary dermis.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness,\nbisected and entirely submitted.	A - 3.7 X 2.3 CM IRREGULARLY SHAPED PIGMENTED PLAQUE, HYPERPIGMENTATION, ? REGRESSION, WITH A SUPERFICIAL ULCERATION, B - DARKEST THICKEST AREA; CLINICAL DIAGNOSIS - A) - B) - SUPERFICIAL SPREADING MELANOMA	\N	\N	\N	\N	MELANOMA IN SITU, WITH SUPERIMPOSED LICHENOID INFLAMMATORY REACTION, EXTENDING TO THE PERIPHERAL MARGIN	173619	166	\N	\N	99-19410	B	CCR-134	California Cancer Registry	IP194943	AirTable blocks_with_IP_info.csv
2523	19Rig750007.03.11.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	277	\N	\N	None	\N	CM-40	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2995	98-10389	78	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1008	172.5	\N	\N	Sections show a mostly dermal proliferation of atypical melanocytes.  There are a few nested and solitary melanocytes, some with atypical nuclei, arrayed irregularly within the epidermis.  In the underlying dermis, there are irregularly-shaped, horizontally-oriented clusters of similar but slightly smaller melanocytes, which are surrounded by fibrosis.  Maturation is defective, in that cells with large nuclei and eosinophilic nucleoli are present near the base of the neoplasm. These changes are present above elastosis and many small dilated venules.	Skin segment measuring 0.9 x 0.5 x 0.2 cm, bisected and entirely\nsubmitted.	BROWN RED AND BLACK LESION; CLINICAL DIAGNOSIS - R/O MELANOMA, R/O IRRITATED SEBORRHEIC KERATOSIS	\N	\N	\N	Melanomas in which small, round cells predominate in the dermal component have been termed nevoid melanoma, or minimal deviation melanoma. Several studies have suggested that there is no prognostic difference between this form and conventional melanoma.	MELANOMA, 0.85 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173539	170	\N	\N	98-10389	\N	CCR-146	California Cancer Registry	IP147962	AirTable blocks_with_IP_info.csv
10168	MB1424_	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Tumor, Thumb, Frozen Tissue DNA extracted by Denver	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1522	\N	\N	\N	\N	SYNX119	\N	\N	Consolidated_data_final.csv
1188	05-37586A1	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1003	172.6	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern. One population consists of small melanocytes with small oval or spindled nuclei, positioned in the dermis and accompanied by foci of adipocytic metaplasia(melanocytic nevus).  The second population consists of nested and solitary melanocytes, some of which display atypical nuclei and most with ample vacuolated and pigmented cytoplasm, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis. The dermal melanocytes are mostly arrayed in a central nodular focus with confluence of nests. There is a variable upper dermal infiltrate of lymphocytes and melanophages.	Ellipse, 4.6 x 1.9 x 1.6 cm, including a central 1.5 x 1.5 cm brown pigmented bump and an off-center 0.3 x 0.2 cm brown area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A1, two sections each in cassette A2 and A3, and six sections in cassette A4.	IRREG PIGMENTED LESION WITH RAISED AREA; R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with a central nodular invasive component that involves the upper reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or regression in these sections, and I do not see any evidence of microsatellites in this excisional specimen. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 3.0 MM IN THICKNESS, PRESENT IN CONTINUITY WITH A MELANOCYTIC NEVUS AND EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL MARGIN	173649	167	\N	\N	05-37586	A1	CCR-141	California Cancer Registry	IP514299	AirTable blocks_with_IP_info.csv
1189	05-37586A3	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22989	172.6	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern. One population consists of small melanocytes with small oval or spindled nuclei, positioned in the dermis and accompanied by foci of adipocytic metaplasia(melanocytic nevus).  The second population consists of nested and solitary melanocytes, some of which display atypical nuclei and most with ample vacuolated and pigmented cytoplasm, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis. The dermal melanocytes are mostly arrayed in a central nodular focus with confluence of nests. There is a variable upper dermal infiltrate of lymphocytes and melanophages.	Ellipse, 4.6 x 1.9 x 1.6 cm, including a central 1.5 x 1.5 cm brown pigmented bump and an off-center 0.3 x 0.2 cm brown area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A1, two sections each in cassette A2 and A3, and six sections in cassette A4.	IRREG PIGMENTED LESION WITH RAISED AREA; R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with a central nodular invasive component that involves the upper reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or regression in these sections, and I do not see any evidence of microsatellites in this excisional specimen. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 3.0 MM IN THICKNESS, PRESENT IN CONTINUITY WITH A MELANOCYTIC NEVUS AND EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL MARGIN	173649	167	\N	\N	05-37586	A3	CCR-141	California Cancer Registry	IP514299	AirTable blocks_with_IP_info.csv
1176	05-27460	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus). These melanocytes demonstrate maturation with melanocytic descent in the dermis. The second population consists of nested and solitary melanocytes, most of which display atypical nuclei, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters of similar melanocytes filling the papillary dermis. Many of these melanocytes are large, and contain abundant dusty cytoplasmic melanin (so-called pagetoid melanocytes), and some are more epithelioid, with abundant pink cytoplasm. This latter population does not demonstrate appreciable maturation, or a significant mitotic rate. There is slight solar elastosis.	Ellipse, 1.3 x 0.7 x 0.1 cm, including a central dark brown-black 0.7 x 0.5 cm pigmented lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections, one tip returned to container.	R/O MALIGNANT MELANOMA	\N	\N	FFPE	In terms of staging, this a non-ulcerated primary melanoma of Clark's anatomic level III. It appears to have arisen in association with a melanocytic nevus as noted. There is no evidence of regression, or vascular or perineural invasion in these sections. Complete reexcision is of course warranted.	MELANOMA, 0.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, WITH INTRAEPIDERMAL MELANOMA EXTENDING TO WITHIN 1 MM OF PERIPHERAL BIOPSY MARGINS	173502	168	\N	\N	05-27460	\N	CCR-142	Melanoma Epigenetics	IP504172	AirTable blocks_with_IP_info.csv
1005	00-5989A2	26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1007	172.5	\N	\N	Sections show a proliferation of small melanocytes with round to oval\nnuclei arranged in irregular fashion within the epidermis as well as\nin the subjacent dermis.  The epidermal component consists largely\nof nests, but areas in which cells with ample vacuolated cytoplasm\nare arrayed at all epidermal levels can be found without difficulty,\nincluding at the leading edges of the proliferation.  In the\nunderlying dermis, nests and sheets of compact cells with\nhyperchromatic nuclei and cytoplasmic pigmentation are noted.  A\ndistinct population of melanocytes with somewhat smaller\nnuclei is also present in the dermis.	Oriented ellipse, 2.5 x 1.0 x 0.6 cm, serially sectioned and\nsubmitted with four sections each in blocks A1 and A2, with tip\nmarked by suture placed to the left, superior half of specimen is\ninked in blue, and inferior half of specimen is inked in yellow.	A - 8 X 6 MM TWO TONED DARK BROWN AND ERYTHEMATOUS MILD BROWN MACULE WITH IRREGULAR BORDERS, B - IRREGULAR SHAPED 5 MM LITE BROWN MACULE, "CROSS" PATTERN; CLINICAL DIAGNOSIS - A) R/O ATYPIA VS IDN-B, B) R/O ATYPIA, REMAINING DATA ON FILE	\N	\N	\N	This lesion could be interpreted as a form of nevoid melanoma, in which the melanoma cells are arrayed in a pattern that vaguely resembles that of a melanocytic nevus.  There have been several studies that have demonstrated that the prognosis of nevoid melanoma is similar to that of conventional melanoma.	MELANOMA, 0.85 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED, WITH MARGINS FREE OF NEOPLASM	173536	169	\N	\N	00-5989	A2	CCR-144	California Cancer Registry	IP221092	AirTable blocks_with_IP_info.csv
2131	17-61001	6	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Two outside slides, D17-58 (A-B), and one corresponding block (1B).	CHANGING DARK PAPULE LEFT BUTTOCK; HEMOSIDEROTIC DX, SPITZ, BLUE NEVUS/CELLULAR	\N	\N	Scraping	Much of the lesion has a composition of classic Spitz cells, with a portion (including bulbous aggregations that protrude into the deep reticular dermis) that are composed of pulverocytes*. The latter raises the possibility of additional transformation, vs. the presence of a combined deep penetrating nevic component. This is not supported by a beta catenin immunostain, which shows only cytoplasmic membranous staining, and not nuclear staining, as we have seen in a proportion of deep penetrating nevi (manuscript in press, Nature Genetics). There is nearly complete loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma.  A phosphohistone H3/MART-1/tyrosinase two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows at least one deep mitotic figure and several superficial melanocytes with positive nuclei.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a loss involving chr. 9, but not in a pattern that would correlate with homozygous loss of CDKN2A, which encodes p16. There are near-threshold gains and losses around the centromere of chr. 10. These do not have breakpoints around known melanoma-associated genes. Dr. Boris Bastian also viewed the chr. 10 results, and would not make a diagnosis of melanoma based on them.  Following the same microdissection and DNA extraction for CGH, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Given these findings, an atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. The value of the latter is questionable, especially given the results of the multi-center trial just reported in N. Engl. J. Med. 2017 Jun 8;376(23):2211-2222.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.    *This term is introduced in Massi G, LeBoit P. Histologic Diagnosis of Nevi and Melanoma, 2nd Edition, Springer-Verlag, Berlin Heidelberg, 2014 p. 57, and refers to cells with abundant, pale cytoplasm and dusty appearing melanin, deriving from the Latin term for dust; such cells are only unusually present in Spitz's nevi	ATYPICAL SPITZ TUMOR	173507	245	\N	\N	17-61001	\N	CGH17-135	Nevus Library	IP1790788	AirTable blocks_with_IP_info.csv
2981	96-23601-4 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	993	\N	\N	None	\N	MD-97	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1156	05-5976C	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections demonstrate a central zone of scar, corresponding to the site of the previous biopsy.  There is a broad and poorly circumscribed proliferation of melanocytes within the epidermis adjacent to the scar, with extensive pagetoid scatter of single cells.  The papillary dermis is markedly thickened and fibrotic.  There are areas in which cords of melanocytes with relatively small, monomorphous nuclei are arranged as horizontally oriented strands beneath a thinned epidermis.  These cells merge with slightly smaller, subjacent ones that are arranged discretely around small vessels and nerve fibers in the upper reticular dermis.	Ellipse measuring 5.9 x 2.7 x 0.7 cm, including 1.8 x 1.1 cm central raised dark pigmented area. With margins inked blue the specimen is serially sectioned perpendicular to the long axis with two central sections each submitted in cassettes A, B, C, D, remainder returned to container.	RE EXCISION MM CHECK MARGINS	\N	\N	\N	There is extensive residual melanoma, both in situ and invasive.  The invasive component consists of small, round or nevoid melanoma cells that merge with the cells of a preexistent nevus near the base of the neoplasm.  The thickness appears slightly greater than in the initial biopsy.  There are no adverse histopathologic findings, such as ulceration, vascular invasion or significant zones of regression (some small ones are present).  The excision appears complete with adequate margins.	SCAR, WITH RESIDUAL MELANOMA, APPROXIMATELY 0.8 MM IN THICKNESS	139522	172	\N	\N	05-5976	C	CCR-148	California Cancer Registry	IP476117	AirTable blocks_with_IP_info.csv
1154	05-5976A	53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1019	172.5	\N	\N	Sections demonstrate a central zone of scar, corresponding to the site of the previous biopsy.  There is a broad and poorly circumscribed proliferation of melanocytes within the epidermis adjacent to the scar, with extensive pagetoid scatter of single cells.  The papillary dermis is markedly thickened and fibrotic.  There are areas in which cords of melanocytes with relatively small, monomorphous nuclei are arranged as horizontally oriented strands beneath a thinned epidermis.  These cells merge with slightly smaller, subjacent ones that are arranged discretely around small vessels and nerve fibers in the upper reticular dermis.	Ellipse measuring 5.9 x 2.7 x 0.7 cm, including 1.8 x 1.1 cm central raised dark pigmented area. With margins inked blue the specimen is serially sectioned perpendicular to the long axis with two central sections each submitted in cassettes A, B, C, D, remainder returned to container.	RE EXCISION MM CHECK MARGINS	\N	\N	\N	There is extensive residual melanoma, both in situ and invasive.  The invasive component consists of small, round or nevoid melanoma cells that merge with the cells of a preexistent nevus near the base of the neoplasm.  The thickness appears slightly greater than in the initial biopsy.  There are no adverse histopathologic findings, such as ulceration, vascular invasion or significant zones of regression (some small ones are present).  The excision appears complete with adequate margins.	SCAR, WITH RESIDUAL MELANOMA, APPROXIMATELY 0.8 MM IN THICKNESS	139522	172	\N	\N	05-5976	A	CCR-148	California Cancer Registry	IP476117	AirTable blocks_with_IP_info.csv
1155	05-5976B	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1020	172.5	\N	\N	Sections demonstrate a central zone of scar, corresponding to the site of the previous biopsy.  There is a broad and poorly circumscribed proliferation of melanocytes within the epidermis adjacent to the scar, with extensive pagetoid scatter of single cells.  The papillary dermis is markedly thickened and fibrotic.  There are areas in which cords of melanocytes with relatively small, monomorphous nuclei are arranged as horizontally oriented strands beneath a thinned epidermis.  These cells merge with slightly smaller, subjacent ones that are arranged discretely around small vessels and nerve fibers in the upper reticular dermis.	Ellipse measuring 5.9 x 2.7 x 0.7 cm, including 1.8 x 1.1 cm central raised dark pigmented area. With margins inked blue the specimen is serially sectioned perpendicular to the long axis with two central sections each submitted in cassettes A, B, C, D, remainder returned to container.	RE EXCISION MM CHECK MARGINS	\N	\N	\N	There is extensive residual melanoma, both in situ and invasive.  The invasive component consists of small, round or nevoid melanoma cells that merge with the cells of a preexistent nevus near the base of the neoplasm.  The thickness appears slightly greater than in the initial biopsy.  There are no adverse histopathologic findings, such as ulceration, vascular invasion or significant zones of regression (some small ones are present).  The excision appears complete with adequate margins.	SCAR, WITH RESIDUAL MELANOMA, APPROXIMATELY 0.8 MM IN THICKNESS	139522	172	\N	\N	05-5976	B	CCR-148	California Cancer Registry	IP476117	AirTable blocks_with_IP_info.csv
2524	19Rig750007.03.12.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	278	\N	\N	None	\N	CM-41	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2526	19Rig750007.03.12.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	278	\N	\N	None	\N	CM-41	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2525	19Rig750007.03.12.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	278	\N	\N	None	\N	CM-41	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2932	92-5109	64	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1027	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes.  Most of the junctional component consists of individual cells and a few nests located along the bases of rete, but in some areas the melanocytes confluently replace the basal zone.  These melanocytes have atypical nuclei, prominent eosinophilic nucleoli, and finely dusty melanin in their cytoplasm (pagetoid cells), and are seen scattered throughout all zones of the epidermis including the granular layer.  In the subjacent dermis there are similar atypical pagetoid melanocytes with mitotic figures readily identified. Similar cells also infiltrate the fibrous tract of a hair follicle. Below this zone of pagetoid melanocytes there are nests and strands of small nevus cells. There is prominent angiogenesis, but vascular invasion is not apparent.	Cylindrical skin segment, 0.6 cm in diameter, 0.2 cm in depth,\nbisected.	2.3 X 2.8 CM IRREGULAR BORDERED, IRREGULAR PIGMENTED PLAQUE; PATIENT STATES LESION PRESENT ALL HIS LIFE AND HAS ONLY CHANGED IN PAST FEW WEEKS, BUT NO INCREASING IN SIZE; CLINICAL DIAGNOSIS - MELANOMA	\N	\N	\N	The thickness is 1.4 mm, however, final microstage measurements are pending re-excision.	MALIGNANT MELANOMA, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS, SEE NOTE	173528	174	\N	\N	92-5109	\N	CCR-154	California Cancer Registry	IP14859	AirTable blocks_with_IP_info.csv
2689	21-13595C1	40	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32750	216.3	\N	2895628	Sections show a predominantly dermal proliferation of small melanocytes which diminish in size with descent in the dermis.  There is surrounding elastosis and scattered thin walled vessels.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, trisected and entirely submitted. BY/KB	IRRITATED NEVUS	\N	Lymph node, sentinel, inguinal, right, biopsy, melanoma, metastatic (Involved: 4; Examined: 5)	FFPE	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173304	303	\N	\N	21-13595	C1	CME-001	Cutaneous Melanoma Ethnicities	IP2276005	AirTable blocks_with_IP_info.csv
3521	MB1421	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1523	\N	\N	None	\N	SYNAT420	2010-2017	\N	AirTable blocks_with_IP_info.csv
2929	92-1608B	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad, asymmetrical proliferation of melanocytes with extensive areas of partial and complete regression, the latter evidenced by a thickened and fibrotic papillary dermis, diminished rete ridge pattern, and numerous melanophages.  In section C there are clusters of melanocytes with atypical nuclei and abundant cytoplasm that contain dusty melanin pigment, both at the d-e junction and within the superficial dermis.  Beneath the band of melanophages is the residuum of a melanocytic nevus, with small round and s-shaped spindled melanocytes.	Ellipse, 4 x 1.9 x 0.8 cm, with surface showing  1 x 1.3 cm irregular\nblack-brown macular patch, tips returned to container, sections\nadjacent to tip embedded in block A, remainder serially sectioned\nwith two sectioned each embedded in blocks B-C, margins inked green.	IRREGULAR BORDERS AND PIGMENTATION OF A MOLE ON UPPER BACK.  MEASURING 1.6 CM IN DIAMETER.  PRESENT FOR MANY YEARS, BUT NO CHANGE IN SIZE, COLOR ON BORDER. CLINICAL DIAGNOSIS - MALIGNANT MELANOMA	\N	\N	\N	None	MALIGNANT MELANOMA, SUPERFICIAL SPREADING TYPE, 0.5 MM IN THICKNESS, ARISING IN A PRE-EXISTANT MELANOCYTIC NEVUS AND SHOWING LARGE AREAS OF COMPLETE REGRESSION	333504	175	\N	\N	92-1608	B	CCR-155	California Cancer Registry	IP11358	AirTable blocks_with_IP_info.csv
2928	92-1608A	43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad, asymmetrical proliferation of melanocytes with\nextensive areas of partial and complete regression, the latter\nevidenced by a thickened and fibrotic papillary dermis, diminished\nrete ridge pattern, and numerous melanophages.  In section C there\nare clusters of melanocytes with atypical nuclei and abundant\ncytoplasm that contain dusty melanin pigment, both at the d-e\njunction and within the superficial dermis.  Beneath the band of\nmelanophages is the residuum of a melanocytic nevus, with small round\nand s-shaped spindled melanocytes.	Ellipse, 4 x 1.9 x 0.8 cm, with surface showing  1 x 1.3 cm irregular\nblack-brown macular patch, tips returned to container, sections\nadjacent to tip embedded in block A, remainder serially sectioned\nwith two sectioned each embedded in blocks B-C, margins inked green.	IRREGULAR BORDERS AND PIGMENTATION OF A MOLE ON UPPER BACK.  MEASURING 1.6 CM IN DIAMETER.  PRESENT FOR MANY YEARS, BUT NO CHANGE IN SIZE, COLOR ON BORDER. CLINICAL DIAGNOSIS - MALIGNANT MELANOMA	\N	\N	\N	\N	MALIGNANT MELANOMA, SUPERFICIAL SPREADING TYPE, 0.5 MM IN THICKNESS, ARISING IN A PRE-EXISTANT MELANOCYTIC NEVUS AND SHOWING LARGE AREAS OF COMPLETE REGRESSION	333504	175	\N	\N	92-1608	A	CCR-155	California Cancer Registry	IP11358	AirTable blocks_with_IP_info.csv
1396	10-43330	104	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1258	172.6	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis. There is little diminishment in melanocyte size with descent in the dermis. Within the epidermis, single cells and nests are scattered broadly, and cells in pagetoid array can be found. In the dermis, the non-maturing melanocytes show central juxtaposed hemorrhage and are commonly found in mitosis.	Ellipse, 1.0 x 1.0 x 0.3 cm, including a central salmon pink 0.7 x 0.7 cm raised lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections.	PROBABLE NODULAR MELANOMA	\N	\N	\N	This narrow excision contains a nodular non-ulcerated melanoma with associated Clark's level IV invasion. There is no evidence of associated vascular invasion, perineural invasion, or regression. The mitotic index of the invasive component exceeds 10/square mm. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 3.9 MM IN THICKNESS	173610	176	\N	\N	10-43330	\N	CCR-157	California Cancer Registry	IP937906	AirTable blocks_with_IP_info.csv
1119	04-12137A	86	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1259	172.5	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.  The epidermal component consists of single cells and nests arrayed broadly and confluently within the epithelium, with considerable suprabasal scatter of melanocytes.  There are irregular nests in the papillary and reticular dermis below these areas of intraepidermal involvement, and many of the dermal nests are enveloped by considerable fibrosis.  In some areas, a lichenoid lymphocytic infiltrate expands the papillary dermis, and in other areas, the papillary dermis is fibrotic.	Oriented ellipse 7.5 x 4.5 x 1.5 cm. The far left margin is preinked black. The far right margin is preinked green. The near left margin is preinked red. The near right margin is preinked blue. The intersection of the black and green is labeled as s. The intersection of the the red and blue is labeled as i. The intersection of the black and red is labeled as med. The intersection of the green and blue is labeled as lat. The specimen is bisected along the long axis. The two equal sections of the specimen are serially sectioned perpendicular to the long axis from the left to the right and entirely submitted with 3 sections each in cassettes A, H, and I and 2 sections each in cassettes B, C, D, E, F, G, J, K, L, M, N, O, P, and Q	RE-EXC MM	\N	\N	\N	Upon complete excision, the residual melanoma in this reexcision specimen shows findings identical to those noted in the initial partial biopsy.  In addition, there are focal changes of partial and complete regression in these sections, but I believe that the microstage measurement above is fully representative of the prognosis of this melanoma.  Final surgical margins are uninvolved. This report was reissued on 3/29/2004 to forward a copy to Dr. Malani's office.	RESIDUAL MELANOMA OF 2.3 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173527	177	\N	\N	04-12137	A	CCR-158	California Cancer Registry	IP426119	AirTable blocks_with_IP_info.csv
2527	19Rig750007.04.01.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	279	\N	\N	None	\N	CM-42	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2528	19Rig750007.04.02.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	280	\N	\N	None	\N	CM-43	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2529	19Rig750007.04.03.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	281	\N	\N	None	\N	CM-44	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2530	19Rig750007.04.04.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	282	\N	\N	None	\N	CM-45	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1093	03-30961B	47	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1285	172.5	\N	\N	Sections show a broad, compound proliferation of melanocytes.  In most of the lesion, single cells and small nests are present at the sides and bases of elongated rete ridges.  Centrally, there are some small, round melanocytes in the papillary dermis, but (best seen in slide B) there is a zone in which the surface is elevated, and the papillary dermis is thickened by melanocytes with striking nuclear pleomorphism.  Many of the cells have large, vesicular nuclei, large (and sometimes multiple) eosinophilic nucleoli, show little maturation with descent and contain mitotic figures.  There is some pagetoid spread of similar melanocytes in the epidermis in this small, papular area.	Ellipse measuring 2.5 x 1.4 x 0.5 cm, with irregular border brown pigment measuring 1.5 x 1.0 cm. The margin is inked blue. The specimen is serially sectioned and submitted with four sections each in cassettes A and B.	15 X 9 MM IRREGULAR LESION WITH CENTRAL PAPULAR COMPONENT; MIS, R/O MELANOMA	\N	\N	\N	This lesion apparently arose in the center of a Clark's or dysplastic nevus.  This is an unusual event, as most melanomas that arise in such nevi do so toward one side or the other.	MELANOMA, 0.7 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS OF THE CLARK'S OR DYSPLASTIC TYPE	173528	179	\N	\N	03-30961	B	CCR-162	California Cancer Registry	IP389274	AirTable blocks_with_IP_info.csv
1120	04-12137D	86	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1262	172.5	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.  The epidermal component consists of single cells and nests arrayed broadly and confluently within the epithelium, with considerable suprabasal scatter of melanocytes.  There are irregular nests in the papillary and reticular dermis below these areas of intraepidermal involvement, and many of the dermal nests are enveloped by considerable fibrosis.  In some areas, a lichenoid lymphocytic infiltrate expands the papillary dermis, and in other areas, the papillary dermis is fibrotic.	Oriented ellipse 7.5 x 4.5 x 1.5 cm. The far left margin is preinked black. The far right margin is preinked green. The near left margin is preinked red. The near right margin is preinked blue. The intersection of the black and green is labeled as s. The intersection of the the red and blue is labeled as i. The intersection of the black and red is labeled as med. The intersection of the green and blue is labeled as lat. The specimen is bisected along the long axis. The two equal sections of the specimen are serially sectioned perpendicular to the long axis from the left to the right and entirely submitted with 3 sections each in cassettes A, H, and I and 2 sections each in cassettes B, C, D, E, F, G, J, K, L, M, N, O, P, and Q	RE-EXC MM	\N	\N	\N	Upon complete excision, the residual melanoma in this reexcision specimen shows findings identical to those noted in the initial partial biopsy.  In addition, there are focal changes of partial and complete regression in these sections, but I believe that the microstage measurement above is fully representative of the prognosis of this melanoma.  Final surgical margins are uninvolved. This report was reissued on 3/29/2004 to forward a copy to Dr. Malani's office.	RESIDUAL MELANOMA OF 2.3 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173527	177	\N	\N	04-12137	D	CCR-158	California Cancer Registry	IP426119	AirTable blocks_with_IP_info.csv
1121	04-12137E	86	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1263	172.5	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.  The epidermal component consists of single cells and nests arrayed broadly and confluently within the epithelium, with considerable suprabasal scatter of melanocytes.  There are irregular nests in the papillary and reticular dermis below these areas of intraepidermal involvement, and many of the dermal nests are enveloped by considerable fibrosis.  In some areas, a lichenoid lymphocytic infiltrate expands the papillary dermis, and in other areas, the papillary dermis is fibrotic.	Oriented ellipse 7.5 x 4.5 x 1.5 cm. The far left margin is preinked black. The far right margin is preinked green. The near left margin is preinked red. The near right margin is preinked blue. The intersection of the black and green is labeled as s. The intersection of the the red and blue is labeled as i. The intersection of the black and red is labeled as med. The intersection of the green and blue is labeled as lat. The specimen is bisected along the long axis. The two equal sections of the specimen are serially sectioned perpendicular to the long axis from the left to the right and entirely submitted with 3 sections each in cassettes A, H, and I and 2 sections each in cassettes B, C, D, E, F, G, J, K, L, M, N, O, P, and Q	RE-EXC MM	\N	\N	\N	Upon complete excision, the residual melanoma in this reexcision specimen shows findings identical to those noted in the initial partial biopsy.  In addition, there are focal changes of partial and complete regression in these sections, but I believe that the microstage measurement above is fully representative of the prognosis of this melanoma.  Final surgical margins are uninvolved. This report was reissued on 3/29/2004 to forward a copy to Dr. Malani's office.	RESIDUAL MELANOMA OF 2.3 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173527	177	\N	\N	04-12137	E	CCR-158	California Cancer Registry	IP426119	AirTable blocks_with_IP_info.csv
1091	03-29330B	83	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1277	172.6	\N	\N	Sections show a broad and poorly circumscribed proliferation of atypical melanocytes, arranged as single cells within the basal layer of the epidermis, flanking a compact, multinodular proliferation of larger melanocytes that do not mature (diminish in size) with descent into the dermis.  The epidermis over the nodule is thinned.  There are some melanocytes scattered above the basal layer just to the side of the nodule.	Oval excision, 5.8 x 2.3 x 1.4 cm (including fat) and 3.0 x 2.5 x 1.4 cm (area with epidermis), including central 2.5 x 2.0 cm dark brown pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A, B and D, and one section each in cassettes C, E and F, remainder returned to container.	2.2 X 2.7 IRREGULAR BLACK PIGMENTED MACULE EXCISED WITH 5 MM MARGIN, MELANOMA WITH CENTRAL PAPULE WITHIN A LESION	\N	\N	\N	Melanoma in situ extends to within 2 mm. of the periphery of the specimen.   There are no microscopic findings other than a high mitotic rate (see below) that would substantially change the prognosis indicated by the tumor thickness listed above.  The epidermis, while strikingly thinned, is not truly ulcerated. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: absent Vascular or lymphatic invasion: absent Mitotic rate: high Perineural invasion: absent Ulceration: absent (see above comment) Regression: absent Microsatellite metastasis: absent	MELANOMA, 1.7 MM  IN THICKNESS	173601	178	\N	\N	03-29330	B	CCR-159	California Cancer Registry	IP387643	AirTable blocks_with_IP_info.csv
1090	03-29330A	83	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1276	172.6	\N	\N	Sections show a broad and poorly circumscribed proliferation of atypical melanocytes, arranged as single cells within the basal layer of the epidermis, flanking a compact, multinodular proliferation of larger melanocytes that do not mature (diminish in size) with descent into the dermis.  The epidermis over the nodule is thinned.  There are some melanocytes scattered above the basal layer just to the side of the nodule.	Oval excision, 5.8 x 2.3 x 1.4 cm (including fat) and 3.0 x 2.5 x 1.4 cm (area with epidermis), including central 2.5 x 2.0 cm dark brown pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A, B and D, and one section each in cassettes C, E and F, remainder returned to container.	2.2 X 2.7 IRREGULAR BLACK PIGMENTED MACULE EXCISED WITH 5 MM MARGIN, MELANOMA WITH CENTRAL PAPULE WITHIN A LESION	\N	\N	\N	Melanoma in situ extends to within 2 mm. of the periphery of the specimen.   There are no microscopic findings other than a high mitotic rate (see below) that would substantially change the prognosis indicated by the tumor thickness listed above.  The epidermis, while strikingly thinned, is not truly ulcerated. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: absent Vascular or lymphatic invasion: absent Mitotic rate: high Perineural invasion: absent Ulceration: absent (see above comment) Regression: absent Microsatellite metastasis: absent	MELANOMA, 1.7 MM  IN THICKNESS	173601	178	\N	\N	03-29330	A	CCR-159	California Cancer Registry	IP387643	AirTable blocks_with_IP_info.csv
2531	19Rig750007.04.05.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	283	\N	\N	None	\N	CM-46	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2532	19Rig750007.04.06.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	284	\N	\N	None	\N	CM-47	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2533	19Rig750007.04.07.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	285	\N	\N	None	\N	CM-48	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2534	19Rig750007.04.07.09	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	285	\N	\N	None	\N	CM-48	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1092	03-30961A	47	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1284	172.5	\N	\N	Sections show a broad, compound proliferation of melanocytes.  In most of the lesion, single cells and small nests are present at the sides and bases of elongated rete ridges.  Centrally, there are some small, round melanocytes in the papillary dermis, but (best seen in slide B) there is a zone in which the surface is elevated, and the papillary dermis is thickened by melanocytes with striking nuclear pleomorphism.  Many of the cells have large, vesicular nuclei, large (and sometimes multiple) eosinophilic nucleoli, show little maturation with descent and contain mitotic figures.  There is some pagetoid spread of similar melanocytes in the epidermis in this small, papular area.	Ellipse measuring 2.5 x 1.4 x 0.5 cm, with irregular border brown pigment measuring 1.5 x 1.0 cm. The margin is inked blue. The specimen is serially sectioned and submitted with four sections each in cassettes A and B.	15 X 9 MM IRREGULAR LESION WITH CENTRAL PAPULAR COMPONENT; MIS, R/O MELANOMA	\N	\N	\N	This lesion apparently arose in the center of a Clark's or dysplastic nevus.  This is an unusual event, as most melanomas that arise in such nevi do so toward one side or the other.	MELANOMA, 0.7 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS OF THE CLARK'S OR DYSPLASTIC TYPE	173528	179	\N	\N	03-30961	A	CCR-162	California Cancer Registry	IP389274	AirTable blocks_with_IP_info.csv
3020	99-23502C	64	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1289	172.6	\N	\N	Sections show skin with severe solar elastosis, and a broad, asymmetrical and poorly circumscribed proliferation of atypical melanocytes, focally in a pagetoid pattern within the epidermis and forming a plaque - like mass in the papillary dermis without evidence of maturation.	Ellipse, measuring 5..0 x 2.0 x 0.8 cm, serially sectioned and\nsubmitted with four sections in block A, three sections each in\nblocks B and C, and six sections in block D, margins pre-inked in\nblack.	1.1 X 0.9 CM BLACK BARELY PALPABLE PLAQUE, MOLE AT SITE X BIRTH OR EARLY CHILDHOOD, MOLE STARTED TO CHANGE X EARLY THIS YEAR, LESION EXCISED WITH 1CM MARGIN	\N	\N	\N	I saw no evidence of a congenital nevus in these sections, but it is possible that the melanoma destroyed a superficial nevus.	MELANOMA, 1.1 MM IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173601	180	\N	\N	99-23502	C	CCR-163	California Cancer Registry	IP199035	AirTable blocks_with_IP_info.csv
3019	99-23502A	64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1287	172.6	\N	\N	Sections show skin with severe solar elastosis, and a broad,\nasymmetrical and poorly circumscribed proliferation of atypical\nmelanocytes, focally in a pagetoid pattern within the epidermis and\nforming a plaque - like mass in the papillary dermis without\nevidence of maturation.	Ellipse, measuring 5..0 x 2.0 x 0.8 cm, serially sectioned and\nsubmitted with four sections in block A, three sections each in\nblocks B and C, and six sections in block D, margins pre-inked in\nblack.	1.1 X 0.9 CM BLACK BARELY PALPABLE PLAQUE, MOLE AT SITE X BIRTH OR EARLY CHILDHOOD, MOLE STARTED TO CHANGE X EARLY THIS YEAR, LESION EXCISED WITH 1CM MARGIN	\N	\N	\N	I saw no evidence of a congenital nevus in these sections, but it is possible that the melanoma destroyed a superficial nevus.	MELANOMA, 1.1 MM IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173601	180	\N	\N	99-23502	A	CCR-163	California Cancer Registry	IP199035	AirTable blocks_with_IP_info.csv
3023	99-30301	71	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.4	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in contiguity with the epidermis.  There is little diminishment in melanocyte size with descent in the dermis, and there are scattered dermal mitotic figures.	Skin segment measuring 0.7 x 0.5 x 0.2 cm, bisected and entirely\nsubmitted.	PURPLE PAPULE; HEMANGIOMA, MALIGNANCY	\N	\N	Scraping	In the clinical context, these findings probably represent a nodular primary melanoma, but I did consider the possibility that this lesion could represent a metastatic deposit (because of its nodular pathologic appearance). A total skin examination would thus be appropriate. This patient is a candidate for sentinel node evaluation. Please notify me if you would like to receive additional information regarding this technique.	MELANOMA, AT LEAST 2.0 MM IN THICKNESS, EXTENDING TO THE DEEP BIOPSY MARGIN	173406	181	\N	\N	99-30301	\N	CCR-201	California Cancer Registry	IP58570	AirTable blocks_with_IP_info.csv
2965	96-3842	65	\N	\N	\N	None	None	None	15	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1295	172.4	\N	\N	Sections show a proliferation of nested and solitary melanocytes, some of which have atypical nuclei, irregularly distributed above elastosis.  There is pronounced involvement of adnexal epithelium. Clusters of similar melanocytes are present in the adventitial dermis.	Cylindrical skin segment, 5 mm in diameter, 6 mm in depth, bisected.	IRREGULAR BLACK PAPULE ON VERTEX SCALP, CLINICAL DIAGNOSIS - R/O MELANOMA	\N	\N	Scraping	The reexcision specimen from this site did not reveal any residual neoplasm, so I returned to this original biopsy to obtain a thickness measurement.  Please note that much of the invasive melanoma is present within the adventitial dermis around follicular structures, and thus the microstage measurement listed above probably overestimates the prognostic risk of this lesion.	MELANOMA, APPROXIMATELY 1.0 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL BIOPSY MARGIN (MICROSTAGE MEASUREMENT REVISED 3/27/96)	173406	182	\N	\N	96-3842	\N	CCR-202	California Cancer Registry	IP80606	AirTable blocks_with_IP_info.csv
2535	19Rig750007.04.09.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	286	\N	\N	None	\N	CM-50	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2536	19Rig750007.04.10.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	287	\N	\N	None	\N	CM-51	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2538	19Rig750007.04.12.08	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	288	\N	\N	None	\N	CM-53	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2537	19Rig750007.04.12.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	288	\N	\N	None	\N	CM-53	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1042	02-5600A	63	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=316	172.6	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei\nin partial contiguity with the epidermis.  There is little\ndiminishment in melanocyte size with descent in the dermis.  The\nconstituent melanocytes have ample vacuolated and pigmented\ncytoplasm, and there are many intervening melanophages as well.  A\nfew scattered single necrotic melanocytes are identifiable, although\nthe number of mitotic figures is not striking.  There is a permeative\nlymphocytic infiltrate near the base of the process, and deeper in\nthe dermis elastosis is evident.	Oriented ellipse measuring 2.1 x 1.0 x 0.4 cm including central 0.8 x\n0.6 cm black lesion.  With the superior margin preinked black and the\ninferior half preinked yellow, three central representative sections\nare submitted in cassette A and two sections in cassette B, tips\nreturned to container.in aggregate	R/O MM	\N	\N	Scraping	This is a non-ulcerated primary melanoma with a nodular pattern.  There is a subtle concurrent element of regression, but I doubt that these findings are sufficiently developed to be of clinical significance. There is no evidence of vascular or perineural invasion in this specimen.	MELANOMA, 1.1 MM IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173688	188	\N	\N	02-5600	A	CCR-208	California Cancer Registry	IP76569	AirTable blocks_with_IP_info.csv
1145	04-38345	48	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There are also clusters of similar melanocytes in the superficial dermis.  The clusters in the dermis are enveloped by a complex fibrosing inflammatory reaction, with an infiltrate of lymphocytes and melanophages that varies in density.  In some areas, there is a marked reduction in the number of melanocytes, with an underlying fibrotic papillary dermis that contains a sparse infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, trisected and entirely submitted.	IRREGULAR PIGMENTED LESION	\N	\N	Scraping	This is a non-ulcerated primary melanoma with invasion confined to a strikingly expanded papillary dermis (Clark's level III). There is a prominent associated component of partial and focal complete regression, and thus the microstage measurement listed above may underestimate the prognostic impact of this lesion. There is no evidence of associated vascular invasion or perineural extension in these sections. Further reexcision of this site is warranted to be certain that local eradication of this melanoma has been accomplished.	MELANOMA OF 1.0 MILLIMETER IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	222533	183	\N	\N	04-38345	\N	CCR-203	California Cancer Registry	IP454748	AirTable blocks_with_IP_info.csv
1245	06-28087	59	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.6	\N	\N	Sections show skin with a moderate degree of solar elastosis. There is a moderately broad but poorly circumscribed proliferation of melanocytes, arranged singly and as both small and large nests along the junction, with areas in which junctional nests are confluent. There is a central area in which rete ridges are lost, the papillary dermis is fibrotic, and there are small nests of melanocytes within it accompanied by lymphocytes and melanophages.	Excision measuring 1.0 x 0.8 x 0.3 cm, including central 0.8 x 0.7 cm pigmented area.  With margins inked blue, the specimen is serially quadrisected and entirely submitted.	R/O MELANOMA	\N	\N	Scraping	The intraepidermal portion of this lesion extends to within less than 1 mm of the edges of the specimen. The lesion is unusual, in that most of the constituent melanocytes are not strikingly atypical on a cytologic basis. There is no evidence of ulceration or of other microscopic findings that would have an adverse prognostic influence. Histopathologic features of possible prognostic importance include:  Level: II Tumor infiltrating lymphocytes: moderate Vascular or lymphatic invasion: absent Mitotic rate: n/a Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, 0.4 MM IN THICKNESS	173620	184	\N	\N	06-28087	\N	CCR-204	California Cancer Registry	IP573155	AirTable blocks_with_IP_info.csv
1048	02-8746B	49	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a broad, asymmetrical compound proliferation of melanocytes featuring a broad area in which the papillary dermis is strikingly fibrotic, with a diminished rete ridge pattern.  Compact nests of relatively small melanocytes are present throughout this zone, and several contain mitotic figures.  At the other side of the lesion is a dome shaped area with spindled melanocytes superficially and small, round ones in the deep portion.  Again, some superficial melanocytes are in mitosis.  Maturation with descent appears to be present in this area.  Melanocytes at the base of this zone are present as strands between reticular dermal collagen bundles or around small vessels.  A small focus of pagetoid spread is evident at one edge, with not fibrosis underneath it (as would be present in a persistent nevus).	Ellipse measuring 3.2 x 1.2 x 0.4 cm including central dark brown and\nbrown 1.3 x 1.1 cm pigmented area.  With margins inked blue, five\ncentral representative sections are submitted in cassette A and four\nsections in cassette B, tips returned to container.	DYSPLASTIC NEVUS; MELANOMA	\N	\N	Scraping	3/12/2002:  Per my telephone conversation with Dr. Denny Tuffanelli yesterday, there is no history of a previous biopsy or trauma.  In spending more time with these sections today and yesterday, and in reviewing them with my associate, Dr. Timothy McCalmont, I think that this is an unusual melanoma.  There may be evidence of a pre-existent congenital nevus at the base of the specimen, and I did not measure the cells that I believe represent the nevus.  The fibrosis may reflect regression.  I have updated the microscopic description below to incorporate new observations.   3/4/2002:  Some features suggest that this is a persistent nevus, in which the papillary dermis has been altered by a shave biopsy or trauma.  We have a record of a previous nevus from the torso but are unsure as to whether it is from the same site.  Could you kindly inform us whether this is the case, and if not, whether there could be a previous biopsy at this site? If there is none in your files, could you ask the patient?	MELANOMA, 1.05 MM. IN THICKNESS	173570	186	\N	\N	02-8746	B	CCR-206	California Cancer Registry	IP172758	AirTable blocks_with_IP_info.csv
1047	02-8746A	49	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a broad, asymmetrical compound proliferation of\nmelanocytes featuring a broad area in which the papillary dermis is\nstrikingly fibrotic, with a diminished rete ridge pattern.  Compact\nnests of relatively small melanocytes are present throughout this\nzone, and several contain mitotic figures.  At the other side of the\nlesion is a dome shaped area with spindled melanocytes superficially\nand small, round ones in the deep portion.  Again, some superficial\nmelanocytes are in mitosis.  Maturation with descent appears to be\npresent in this area.  Melanocytes at the base of this zone are\npresent as strands between reticular dermal collagen bundles or\naround small vessels.  A small focus of pagetoid spread is evident at\none edge, with not fibrosis underneath it (as would be present in a\npersistent nevus).	Ellipse measuring 3.2 x 1.2 x 0.4 cm including central dark brown and\nbrown 1.3 x 1.1 cm pigmented area.  With margins inked blue, five\ncentral representative sections are submitted in cassette A and four\nsections in cassette B, tips returned to container.	DYSPLASTIC NEVUS; MELANOMA	\N	\N	Scraping	3/12/2002:  Per my telephone conversation with Dr. Denny Tuffanelli yesterday, there is no history of a previous biopsy or trauma.  In spending more time with these sections today and yesterday, and in reviewing them with my associate, Dr. Timothy McCalmont, I think that this is an unusual melanoma.  There may be evidence of a pre-existent congenital nevus at the base of the specimen, and I did not measure the cells that I believe represent the nevus.  The fibrosis may reflect regression.  I have updated the microscopic description below to incorporate new observations.   3/4/2002:  Some features suggest that this is a persistent nevus, in which the papillary dermis has been altered by a shave biopsy or trauma.  We have a record of a previous nevus from the torso but are unsure as to whether it is from the same site.  Could you kindly inform us whether this is the case, and if not, whether there could be a previous biopsy at this site? If there is none in your files, could you ask the patient?	MELANOMA, 1.05 MM. IN THICKNESS	173570	186	\N	\N	02-8746	A	CCR-206	California Cancer Registry	IP172758	AirTable blocks_with_IP_info.csv
1148	04-59140B	47	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.5	\N	\N	There is an ulcerated neoplasm of melanocytes that extensively involves the epidermis, with a central, raised area in which neoplastic cells extend into the superficial reticular dermis.  Striking cytologic atypia, scattered mitotic figures and failure to mature with descent are all evident.  Plasma cells are present at the base of the specimen.	Skin segment, 1.4 x 1.2 x 0.4 cm, with the specimen noted by the surgeon and preinked as follows: superior margin preinked red, the left-inferior margin preinked yellow, the right-inferior margin preinked blue. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections each in cassettes A and B.	R/O MM	\N	\N	Scraping	Melanoma in situ extends to the peripheral margin. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent	MELANOMA, 1.8 MM  IN THICKNESS	173507	187	\N	\N	04-59140	B	CCR-207	California Cancer Registry	IP475548	AirTable blocks_with_IP_info.csv
3002	98-21806	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2738	172.6	\N	\N	Sections show sheets and fascicles of spindled neoplastic cells with clear cytoplasm.  There is a subtle overlying component of nested melanocytes in the epidermis.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness,\nbisected and entirely submitted.	4MM PEARLY PAPULE AROSE FEW MOS. AGO IN AREA OF 1.6 X 2CM BROWN MACULE, RED HAIR; CLINICAL DIAGNOSIS - BASAL CELL CARCINOMA IN LENTIGO VS MM	\N	\N	\N	None	MELANOMA, FOCALLY DESMOPLASTIC IN PATTERN, 1.8 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173611	222	\N	\N	98-21806	\N	CCR-272	California Cancer Registry	IP159379	AirTable blocks_with_IP_info.csv
2540	19Rig750007.04.13.08	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	289	\N	\N	None	\N	CM-54	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1237	06-23240A	67	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=5995	238.2	\N	\N	Sections show a zone of lymphohistiocytic inflammation and fibrosing granulation tissue, representing a prior biopsy or surgical site, with no evidence of an atypical melanocytic proliferation.	Oriented ellipse measuring 2.9 x 1.3 x 0.7 cm, including central 0.6 x 0.6 cm white area. With 9-3 o'clock edge preinked black, the far margin is inked blue the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in cassette A and B, tips returned to container.	LENTIGINOUS PROLIFERATION OF MELANOCYTES (DT06-18879)	\N	\N	FFPE	The atypical melanocytic lesion that once resided her has been completely eradicated. There is an incidental small lentiginous melanocytic nevus within this reexcision specimen.	POST-SURGICAL CHANGES, WITH NO EVIDENCE OF RESIDUAL MELANOCYTIC NEOPLASM	173688	189	\N	\N	06-23240	A	CCR-209	Melanoma Epigenetics	IP76569	AirTable blocks_with_IP_info.csv
1212	06-10811	77	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22990	172.6	\N	\N	Sections show a broad asymmetrical compound proliferation of melanocytes, with single cells and nests arrayed irregularly along the epidermal-dermal junction and with many single melanocytes in pagetoid array. The underlying dermis contains small melanocytes with hyperchromatic nuclei arrayed in clusters and strands above modest elastosis, enmeshed in part within a central broad zone of exaggerated dermal fibroplasia. Some deep dermal melanocytes have plasmacytoid or oncocytic cytomorphology.	Skin segment, 1.5 x 1.4 x 0.3 cm, serially sectioned and entirely submitted with five sections.	ATYPICAL PIGMENTED LESION	\N	\N	FFPE	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the superficialmost reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or significant regression in these sections. As some of the deep dermal melanocytes in this biopsy have compact cytomorphology, I considered the possibility that there might be a precursor melanocytic nevus at this site. However, I tend to believe this is not the case, and that the entirety of this lesion represents melanoma. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	173601	189	\N	\N	06-10811	\N	CCR-209	Melanoma Epigenetics	IP443105	AirTable blocks_with_IP_info.csv
1097	03-47623B	50	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1296	172.4	\N	\N	Sections show a proliferation of atypical melanocytes in nodular array within the epidermis and dermis, as well as a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.  The atypical melanocytes have epithelioid cytomorphology and ample vacuolated and pigmented cytoplasm, and are arrayed as irregular nests along the epidermal-dermal junction, with nests and sheets of atypical melanocytes in the papillary and reticular dermis.  There is a dense permeative lymphocytic infiltrate with many melanophages, and there are areas of dermal fibrosis.	Skin segment measuring 1.1 x 1.0 x 0.3 cm, quadrisected and entirely submitted.	ATYPICAL NEVI	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension.  There is an element of associated partial regression, and thus the microstage measurement listed above may slightly underestimate the prognostic impact of this melanoma.  Regressive changes abut the peripheral margin of this biopsy, and thus further excision of this site will be necessary to ensure local control.	MELANOMA OF 1.6 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS OF CONGENITAL TYPE	173439	190	\N	\N	03-47623	B	CCR-211	California Cancer Registry	IP405938	AirTable blocks_with_IP_info.csv
1132	04-18467	85	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.3	\N	\N	Sections show sheets and fascicles of spindled neoplastic cells, many of which have atypical nuclei or were captured in mitosis.  There are nests and fascicles of melanocytes scattered along the epidermal-dermal junction at the periphery of the biopsy, with lateral extension above elastosis.  There is a sparse dermal infiltrate with lymphocytes and melanophages.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted.	BLACK 6 MM NODULE; IRR SK, R/O MELANOMA IN SITU COMPOUND	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension or regression in this initial partial biopsy.  Final microstage assessment must of course be deferred until this  lesion has been completely reexcised.	MELANOMA OF 1.6 MILLIMETERS IN THICKNESS, TRANSECTED AT THE DEEP BIOPSY MARGIN	100333	191	\N	\N	04-18467	\N	CCR-212	California Cancer Registry	IP434866	AirTable blocks_with_IP_info.csv
1258	06-73878D	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1404	173.6	\N	\N	Sections show rounded nests of peripherally palisaded basaloid cells accompanied by fibromyxoid stroma from which they are separated by clefts.  Some aggregations have small round spaces between their epithelial cells, containing mucin.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette D.	A) IRREGULAR 8-10 MM MACULE; R/O MELANOMA, B) 2 WK HX OF RAPIDLY GROWING PAPULE; R/O SK, C-D) R/O BCC	\N	\N	\N	\N	BASAL CELL CARCINOMA, NODULAR (ADENOID) PATTERN, TRANSECTED AT THE DEEP BIOPSY EDGE	522697	232	\N	\N	06-73878	D	CCR-301	California Cancer Registry	IP89612	AirTable blocks_with_IP_info.csv
2539	19Rig750007.04.13.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	289	\N	\N	None	\N	CM-54	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2541	19Rig750007.04.15.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	290	\N	\N	None	\N	CM-56	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1201	06-4069	76	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=320	172.7	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, with foci of pagetoid spread, flanking an ulcerated nodular proliferation of large oval melanocytes that do not mature with descent into the dermis. The latter cells have abundant, pale eosinophilic cytoplasm and large, pleomorphic vesicular nuclei and some are in mitosis.	Ellipse, 1.8 x 1.0 x 0.8 cm, including a central 0.6 x 0.6 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.	R/O PYOGENIC GRANULOMA	\N	\N	Scraping	Melanoma in situ extends to the periphery of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  The lesion is hypomelanotic, reflecting your clinical impression.	MELANOMA, 3 MM  IN THICKNESS	154799	196	\N	\N	06-4069	\N	CCR-219	California Cancer Registry	IP549135	AirTable blocks_with_IP_info.csv
2029	17-08581-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36090	\N	\N	\N	\N	\N	\N	\N	H17-08581 #5 (right shoulder)	FFPE	\N	\N	\N	406	\N	\N	None	\N	CME-104	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1193	05-66206A	46	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=318	172.5	\N	\N	Sections show melanocytes arrayed mostly in nests, irregularly and in pagetoid fashion within the epidermis. In the underlying dermis, there are irregularly-shaped, (sometimes) horizontally-oriented clusters of similar but slightly smaller melanocytes, which are enveloped by fibroplasia. In another cross-section, there are melanocytes with ample pale vacuolated and pigmented cytoplasm, arrayed as irregular nests in the dermis and also focally in pagetoid array within the epidermis. The upper dermis shows areas of coarse fibroplasia. There are foci in which the epidermis is missing, which in one area is related to electrocautery. There is also a patchy infiltrate of lymphocytes and melanophages at the base of the proliferation.	Ellipse , 2.3 x 1.6 x 0.6 cm, including a central 1.5 x 1.0 cm lesion with to left of center 0.7 x 0.3 cm depression.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A and four sections plus fragment (0.6 x 0.4 x 0.2 cm) in cassette B.	R/O MELANOMA VS PIGMENTED BASAL CELL CA	\N	\N	Scraping	In terms of staging, this melanoma invades the superficial reticular dermis (Clark's level IV). I do not see any evidence of vascular invasion, perineural extension, or regression in these sections. It is impossible to determine whether or not ulceration is present, as portions of the epidermis are missing from these sections ( including one area in which the epidermis has been destroyed by electrocautery).	MELANOMA OF 2.0 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	139522	192	\N	\N	05-66206	A	CCR-213	California Cancer Registry	IP542950	AirTable blocks_with_IP_info.csv
1249	06-47809B	39	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections demonstrate an asymmetric compound proliferation of melanocytes at and above the dermal-epidermal junction and within the dermis. There are irregularly arrayed nests and single cells within the epidermis with areas of confluence of melanocytic nests, and with many melanocytes in pagetoid array. There is a dermal inflammatory reaction with lymphocytes and melanophages at the base of the melanocytic proliferation and areas of fibroplasia (with reduction in melanocyte density) adjacent to the proliferation.	Ellipse, 3.3 x 1.8 x 0.8 cm, including a central brown 1.5 x 1.0 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with three sections each in cassettes A, B and C, tips returned to container.	OVER APPROXIMATELY ONE YEAR, CHANGES IN SHAPE, COLOR & SIZE HAVE OCCURRED WITH ITCHING AND INFLAMMATION (INFLAMED IN CONCAVITY OF SHAPE); INFLAMED SSM VS DN	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the superficialmost reticular dermis (Clark's level IV). There is no evidence of vascular invasion or neurotropism. There are considerable associate changes of complete regression accompanying and flanking this melanoma; in light of the changes of regression, the microstage measurement listed above may underestimate the prognostic impact of this lesion.	MELANOMA OF 1.1 MM IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA)	173544	193	\N	\N	06-47809	B	CCR-214	California Cancer Registry	IP592878	AirTable blocks_with_IP_info.csv
2977	96-18458E	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1301	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.  There are sheets of atypical melanocytes in the superficial dermis.	Ellipse, 6 x 2.8 x 1 cm, central portion serially sectioned and\nsubmitted with one section each in blocks A through H, margins inked\nblue, tips returned to container.	BLEEDING FRIABLE NODULE; CLINICAL DIAGNOSIS - MELANOMA, DATA ON FILE	\N	\N	\N	This is a high risk primary lesion.  As there is extensive ulceration, the microstage measurment probably underestimates the prognostic risk of this lesion.	MELANOMA, AT LEAST 3.5 MM IN THICKNESS, WITH INTRAEPIDERMAL MELANOMA EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	104444	194	\N	\N	96-18458	E	CCR-215	California Cancer Registry	IP95222	AirTable blocks_with_IP_info.csv
2976	96-18458C	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1299	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.  There are sheets of atypical melanocytes in the superficial dermis.	Ellipse, 6 x 2.8 x 1 cm, central portion serially sectioned and\nsubmitted with one section each in blocks A through H, margins inked\nblue, tips returned to container.	BLEEDING FRIABLE NODULE; CLINICAL DIAGNOSIS - MELANOMA, DATA ON FILE	\N	\N	\N	This is a high risk primary lesion.  As there is extensive ulceration, the microstage measurment probably underestimates the prognostic risk of this lesion.	MELANOMA, AT LEAST 3.5 MM IN THICKNESS, WITH INTRAEPIDERMAL MELANOMA EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	104444	194	\N	\N	96-18458	C	CCR-215	California Cancer Registry	IP95222	AirTable blocks_with_IP_info.csv
2978	96-18458F	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1302	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.  There are sheets of atypical melanocytes in the superficial dermis.	Ellipse, 6 x 2.8 x 1 cm, central portion serially sectioned and\nsubmitted with one section each in blocks A through H, margins inked\nblue, tips returned to container.	BLEEDING FRIABLE NODULE; CLINICAL DIAGNOSIS - MELANOMA, DATA ON FILE	\N	\N	\N	This is a high risk primary lesion.  As there is extensive ulceration, the microstage measurment probably underestimates the prognostic risk of this lesion.	MELANOMA, AT LEAST 3.5 MM IN THICKNESS, WITH INTRAEPIDERMAL MELANOMA EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	104444	194	\N	\N	96-18458	F	CCR-215	California Cancer Registry	IP95222	AirTable blocks_with_IP_info.csv
2975	96-18458A	59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1297	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly\nwithin the epidermis, with foci of pagetoid upward scatter.  Some\nmelanocytes have atypical nuclei.  Aggregations of similar\nmelanocytes are present in the dermis.  There are sheets of atypical\nmelanocytes in the superficial dermis.	Ellipse, 6 x 2.8 x 1 cm, central portion serially sectioned and\nsubmitted with one section each in blocks A through H, margins inked\nblue, tips returned to container.	BLEEDING FRIABLE NODULE; CLINICAL DIAGNOSIS - MELANOMA, DATA ON FILE	\N	\N	\N	This is a high risk primary lesion.  As there is extensive ulceration, the microstage measurment probably underestimates the prognostic risk of this lesion.	MELANOMA, AT LEAST 3.5 MM IN THICKNESS, WITH INTRAEPIDERMAL MELANOMA EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	104444	194	\N	\N	96-18458	A	CCR-215	California Cancer Registry	IP95222	AirTable blocks_with_IP_info.csv
2542	19Rig750007.05.01.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	291	\N	\N	None	\N	CM-57	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
3003	98-23221F M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	994	\N	\N	None	\N	MD-98	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1251	06-64692B	58	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=322	172.5	\N	\N	Sections show sheets and fascicles of spindled malignant cells, many of which have atypical nuclei or were captured in mitosis and many of which have pigmented cytoplasm. There is no maturation with descent. A few similar cells are scattered within the epidermis. There is a background of dermal fibroplasia with a variable infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.2 x 1.0 x 0.7 cm, quadrisected and entirely submitted in cassette B.	A) TWO-TONED NEVUS, B-C) MELANOMA	\N	\N	Scraping	The present partial biopsy shows a non-ulcerated melanoma with invasion of the reticular dermis (Clark's level IV). There is no evidence of vascular invasion, neurotropism, or regression, but these attributes should be reassessed upon complete extirpation.	MELANOMA OF AT LEAST 3.8 MM IN THICKNESS, EXTENSIVELY TRANSECTED AT THE DEEP BIOPSY MARGIN	528599	197	\N	\N	06-64692	B	CCR-220	California Cancer Registry	IP609761	AirTable blocks_with_IP_info.csv
1203	06-5249	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2372	172.7	\N	\N	Sections show a sizable asymmetrical compound proliferation of atypical melanocytes, composed largely of cells with vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. In some central cross sections, strikingly atypical melanocytes extend deeply into the dermis, as sizable sheets of cells.	Oval excision, 1.7 x 1.5 x 0.8 cm, including a central raised brown 0.6 x 0.5 x 0.2 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with five central sections, tips returned to container.	R/O MELANOMA	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that extensively involves the reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or regression in these sections, and I do not see any associated microsatellites. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished. This report was reissued on 3/7/2006 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF 2.4 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	563789	198	\N	\N	06-5249	\N	CCR-221	California Cancer Registry	IP550315	AirTable blocks_with_IP_info.csv
1054	02-17626	53	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=324	172.6	\N	\N	Sections show a thick compound proliferation of melanocytes, with single cells and nests arrayed irregularly and focally in near confluence along the epidermal-dermal junction.  The underlying dermis contains sheets and confluent nests of small melanocytes with irregularly shaped hyperchromatic nuclei and scant cytoplasm, embedded in densely fibrotic stroma, overlying a dermis altered by severe solar elastosis.  Scattered melanocytes with pyknotic nuclei are present, as are rare mitotic figures in melanocytes.  There are some areas with small, round melanocytes in discrete nests as well.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness,\nbisected and totally submitted.	R/O DYSPLASTIC NEVUS	\N	\N	Scraping	This is an unusual form of melanoma with small cells resembling those of a nevus (nevoid melanoma).  There is no reproducible difference in prognosis between this form, and conventional melanoma, however, taking standard prognostic variables into account.  There are areas that could represent a pre-existent nevus that has been colonized by the proliferation.	MELANOMA, 2.4 MM. IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173611	199	\N	\N	02-17626	\N	CCR-222	California Cancer Registry	IP322353	AirTable blocks_with_IP_info.csv
1179	05-28152B	58	\N	\N	\N	None	None	None	3	\N	FFPE	\N	\N	172.6	\N	\N	There is an asymmetrical nodular array composed of confluently disposed nests melanocytes with atypical nuclei and vacuolated and pigmented cytoplasm, in partial contiguity with the epidermis. There is little diminishment in melanocyte size with descent in the dermis. Some melanocytes course deeply in the reticular dermis and adventitial dermis, and some reach the subcutis. There is focal necrosis en masse. At least one cluster is present in a vascular channel.	Ellipse, 2.0 x 1.6 x 1.0 cm, including a central raised 1.3 x 1.2 x 0.3 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.	NINE MONTH HISTORY OF GRAY PINK KERATOTIC TUMOR; R/O MM	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with a nodular invasive component that extends to the superficial subcutis (Clark's level V). There is no evidence of perineural extension or regression in these sections. An obvious focus of vascular invasion is present, but microsatellitosis is not identifiable in the present specimen. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 7.5 MILLIMETERS IN THICKNESS, FOCALLY ABUTTING THE DEEP BIOPSY MARGIN	173605	200	\N	\N	05-28152	B	CCR-224	California Cancer Registry	IP504864	AirTable blocks_with_IP_info.csv
2340	18-96989	9	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10817	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O ATYPIA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173509	564	\N	\N	18-96989	\N	DN-089	Dysplastic Nevi	IP1960988	AirTable blocks_with_IP_info.csv
2491	19Rig750007.01.14.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	258	\N	\N	None	\N	CM-14	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1021	01-00467B N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	995	\N	\N	None	\N	MD-99	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1177	05-27756A	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1354	172.5	\N	\N	Sections show sheets of melanocytes beneath a thin epidermis, with one part of the lesion having oval cells with large, vesicular nuclei and the other small, monomorphous nuclei, the latter cells positioned between thickened collagen bundles and in myxoid stroma.	Ellipse, 2.2 x 1.5 x 0.9 cm, including a central 1.4 x 1.3 cm bump.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.	10 X 20 MM DOME SHAPED PLAQUE WITH 2 DARKER PLAQUES WITH VARIEGATED BROWN/RED COLOR; ? MELANOMA, ? NEVUS	\N	\N	\N	The neoplasm extends to within 1 mm. of the edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  This is an usual lesion, with a desmoplastic component- but with small round rather than spindled melanocytes.	MELANOMA, 3.4 MM  IN THICKNESS	528599	214	\N	\N	05-27756	A	CCR-256	California Cancer Registry	IP504468	AirTable blocks_with_IP_info.csv
1254	06-70035C	66	\N	\N	\N	None	None	None	3	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a polypoid proliferation of melanocytes with marked nuclear atypia, markedly expanding the papillary dermis, invading the reticular dermis and impinging upon the subcutaneous fat. There is an adjacent asymmetrical junctional component with confluence of atypical cells as nests and single cells. Maturation is not present, and many mitotic figures are present in the dermal melanocytic population. There is surface ulceration. Tumor islands are present within and adherent to the endothelial surface of vascular spaces.	Oval excision, 2.2 x 2.0 x 1.4 cm, including a central 1.8 x 1.3 cm bump.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections in cassette A, one section each in cassettes B through D, and four sections in cassette E.	2 X 2 CM EXOPHYTIC BEEFY RED PIGMENTED NODULE PRESENT 3-4 MONTHS; R/O MELANOMA; TELEPHONE: 925-287-1586	\N	\N	Scraping	possible prognostic factors include: thickness: 7.15 mm Clark's level: IV (the melanoma impinges upon but does not invade into the underlying subcutaneous fat) ulceration: present microsatellite metastases: not seen lymphovascular invasion: present margins: uninvolved with narrow peripheral epidermal margin of approximately 2 mm mitoses: >15 per sq. mm. regression: absent lymphocytic infiltrate: present and non-brisk  Several studies confirm that a polypoid configuration is not an independent prognostic variable in patients with melanoma.	POLYPOID INVASIVE MELANOMA, 7.15 mm THICK, ULCERATED,  NOT PRESENT AT BIOPSY EDGES (NARROWLY EXCISED)	173701	201	\N	\N	06-70035	C	CCR-225	California Cancer Registry	IP615104	AirTable blocks_with_IP_info.csv
1141	04-31313A	31	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of melanocytes with round to oval nuclei arranged in irregular nested and pagetoid fashion within the epidermis as well as in large and confluent nests in the subjacent papillary dermis.  A focally dense lymphocytic infiltrate is present at the base of some, but not all of this population. A distinct population of melanocytes with somewhat smaller nuclei is also present in the dermis, arranged as small, discrete nests.	Oriented ellipse, 3.0 x 1.5 x 0.7 cm, including central slightly elevated tan and brown 1.0 x 0.9 cm pigmented lesion.  With the orienting sutured tip placed to the left, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from the sutured tip to the opposite tip (left to right) and submitted with four sections each in cassettes A and B, tips returned to container.\n	15 X 12 MM PINK/BROWN PLAQUE; R/O MELANOCYTIC PROCESS	\N	\N	Scraping	The excision appears to be complete, but the margins are clear by only 2-3 millimeters. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  Please note that the dermal portion of this melanoma is partially nevoid, e.g. consists of small round melanocytes.  Several studies show little difference in prognosis with conventional melanoma.	MELANOMA, 0.85 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173710	202	\N	\N	04-31313	A	CCR-228	California Cancer Registry	IP446906	AirTable blocks_with_IP_info.csv
1139	04-28340	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1305	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There are also clusters of similar melanocytes arrayed densely in the superficial dermis, including the reticular dermis. Some atypical clusters are present in vascular channels.  There are smaller melanocytes to the side of these atypical cells, both along the epidermal-dermal junction and in the dermis.	Skin segment measuring 0.9 x 0.7 x 0.2 cm, trisected and entirely submitted.	4 X 10 MM IRREGULAR PIGMENTED PAPULE; MM	\N	\N	\N	This is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV). There is also underlying vascular invasion.  There is no evidence of perineural extension or regression.  Further re-excision of this site is warranted to ensure that local control has been established; this patient is also a candidate for sentinel node evaluation,  based upon criteria currently employed by the UCSF Melanoma Center.	MELANOMA OF 0.8 MILLIMETERS IN THICKNESS, PRESENT IN ASSOCIATION WITH A COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE AND TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	173526	203	\N	\N	04-28340	\N	CCR-231	California Cancer Registry	IP444742	AirTable blocks_with_IP_info.csv
1253	06-68314	71	\N	\N	\N	None	None	None	10	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a domed, asymmetrical compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and faintly pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, forming a central nodule. There is a patchy lymphohistiocytic infiltrate accompanying the dermal melanocytes.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted.	NEW PINK PAPULE; BCC, DF, NF, OTHER	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with invasion of the superficial reticular dermis (Clark's level IV). There is no evidence of vascular invasion, neurotropism, or regression. Further re-excision of this site is warranted to ensure that local eradication has been accomplished. This report was reissued on 12/19/2006 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF 0.85 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173524	204	\N	\N	06-68314	\N	CCR-233	California Cancer Registry	IP613383	AirTable blocks_with_IP_info.csv
1096	03-44586	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1306	172.4	\N	\N	Sections show a compound proliferation of melanocytes arrayed as large irregular nests along the epidermal-dermal junction, with nests and sheets of atypical melanocytes in the underlying dermis.  Mitotic figures are not difficult to identify in dermal nests.  Pigmentation is scant.	Skin segment measuring 0.8 x 0.8 x 0.3 cm, trisected and entirely submitted.	RED 4 MM NODULE; NEVUS, R/O BCC	\N	\N	\N	In terms of staging, this is a non-ulcerated nodular primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  The lesion appears largely amelanotic.  There is no evidence of vascular invasion or perineural extension or regression.  Complete excision will be necessary for complete staging parameters to be procured.  This patient is a candidate for sentinel node evaluation,  based upon criteria currently employed by the UCSF Melanoma Center.  Further re-excision of this site is of course warranted to ensure local control.	MELANOMA OF AT LEAST 1.5 MILLIMETERS IN THICKNESS	173499	205	\N	\N	03-44586	\N	CCR-234	California Cancer Registry	IP402900	AirTable blocks_with_IP_info.csv
2493	19Rig750007.01.15.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	259	\N	\N	None	\N	CM-15	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2492	19Rig750007.01.15.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	259	\N	\N	None	\N	CM-15	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1252	06-65105	84	\N	\N	\N	None	None	None	4	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1691	172.5	\N	\N	Sections show a proliferation of large melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm.  There is an intraepidermal component, and a massive, nodular dermal one. Nests of melanocytes are distributed at irregular intervals along the dermo-epidermal junction, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermal component is dominate by a large oval mass in which mitoses are easily found, with no maturation toward the base of the lesion. The papillary dermis is thickened and fibrotic at one the edge of the specimen, with fewer lesional melanocytes than in the rest of the specimen.	Ellipse, 1.5 x 1.1 x 1.0 cm, including a central 1.2 x 1.0 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.	RAPIDLY GROWING FIRM NODULAR LESION; MELANOMA, ? FIBROMA/ SARCOMA, ? LIPOMA, ?	\N	\N	Scraping	Histopathologic features of possible prognostic importance include: Level: V Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: high Perineural invasion: absent Ulceration: present Regression: present* Microsatellite metastasis: absent**  *The extent of regression cannot be evaluated after complete excision (some regard the extent, rather than the mere presence of regression as important for prognosis, but this is already a high risk lesion **This finding is best evaluated after complete excision	MELANOMA, 7.3 MM  IN THICKNESS	173540	206	\N	\N	06-65105	\N	CCR-235	California Cancer Registry	IP592825	AirTable blocks_with_IP_info.csv
1079	03-16497B	58	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1307	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, with foci of pagetoid scatter, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the superficial reticular dermis.  Mitoses are present in areas of the latter component.	Ellipse, 2.5 x 1.3 x 1.0 cm, including central raised tan and brown 1.5 x 1.0 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in cassettes A and B, tips returned to container.	R/O SCC AND BCC	\N	\N	\N	Melanoma in situ extends to the periphery of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above.	MELANOMA, 2.3 MM  IN THICKNESS	173610	207	\N	\N	03-16497	B	CCR-237	California Cancer Registry	IP374810	AirTable blocks_with_IP_info.csv
1078	03-16497A	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1307	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, with foci of pagetoid scatter, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the superficial reticular dermis.  Mitoses are present in areas of the latter component.	Ellipse, 2.5 x 1.3 x 1.0 cm, including central raised tan and brown 1.5 x 1.0 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in cassettes A and B, tips returned to container.	R/O SCC AND BCC	\N	\N	\N	Melanoma in situ extends to the periphery of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above.	MELANOMA, 2.3 MM  IN THICKNESS	173610	207	\N	\N	03-16497	A	CCR-237	California Cancer Registry	IP374810	AirTable blocks_with_IP_info.csv
1138	04-25639B	56	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1310	172.5	\N	\N	Sections show a strikingly asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There are also large irregular clusters of similar melanocytes in the dermis, enveloped by an infiltrate of lymphocytes and melanophages.	Oriented ellipse measuring 2.0 x 1.0 x 1.0 cm, central lesion measuring 0.9 x 0.8 cm, with superior margins preinked black and inferior margins preinked blue. The specimen is serially sectioned and submitted with three sections each in cassettes A and B.	R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the superficial reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension or regression.  Further re-excision of this site is of course warranted to ensure that local control has been established.	MELANOMA OF 1.1 MILLIMETERS IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173531	208	\N	\N	04-25639	B	CCR-238	California Cancer Registry	IP441707	AirTable blocks_with_IP_info.csv
1137	04-25639A	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1309	172.5	\N	\N	Sections show a strikingly asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There are also large irregular clusters of similar melanocytes in the dermis, enveloped by an infiltrate of lymphocytes and melanophages.	Oriented ellipse measuring 2.0 x 1.0 x 1.0 cm, central lesion measuring 0.9 x 0.8 cm, with superior margins preinked black and inferior margins preinked blue. The specimen is serially sectioned and submitted with three sections each in cassettes A and B.	R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the superficial reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension or regression.  Further re-excision of this site is of course warranted to ensure that local control has been established.	MELANOMA OF 1.1 MILLIMETERS IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173531	208	\N	\N	04-25639	A	CCR-238	California Cancer Registry	IP441707	AirTable blocks_with_IP_info.csv
1622	12-26470	4	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show an asymmetrical compound proliferation of fusiform and epithelioid melanocytes that are enlarged. Within the epidermis, which is centrally thinned, single melanocytes and nests are distributed erratically, and some scatter above the junction can be seen. In fibrotic dermis below this, two zones of melanocytes can be seen. In a superficial area, slightly fibrotic dermis holds non-maturing nests and syncytia of large epithelioid melanocytes, several of which can be found in mitosis. A patchy juxtaposed lymphocytic infiltrate is present concurrently. In a subjacent sclerotic zone, similar melanocytes are distributed interstitially as cords and thin fascicles.	Two outside slides, WCRS12-8356/DRMC12-2194 (MR:13117741). One corresponding block received 4-20-12.	RAPIDLY GROWING 9 MM RED PAPULE WITH A DARK BROWN PINPOINT MACULE; SPITZ'S NEVUS VS. MELANOMA VS. SPITZOID MELANOMA OF CHILDHOOD	\N	\N	Scraping	ADDENDUM, May 18, 2012: As I reported previously, the differential diagnosis includes a highly unconventional Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. Based solely upon conventional microscopical parameters, an unequivocal diagnosis is not possible. This is the type of challenging case for which comparative genomic hybridization (CGH) can be of value, and we proceeded with CGH analysis, as per your request. After extraction of tumoral DNA from the tissue block, application of aCGH revealed small segmental areas of gain and loss in chromosome 11q but other significant chromosomal gains or losses are lacking. Interestingly, these areas of anomalous genomic copy number do not involve the location of the CCND1 (cyclin-D1) gene, as might be seen in association with melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has yielded an ambiguous result. We have not identified microscopic findings or molecular aberrations that are conclusively diagnostic of childhood-type melanoma. Summing all of the available information, I favor an unconventional Spitz nevus as the best overall classification for this case. Complete reexcision of this site will be necessary in follow-up, but no other surgical intervention is indicated once local clearance has been achieved.  Dr. Denianke, I would be happy to discuss this case with you by telephone.	ATYPICAL COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, TRANSECTED AT THE SPECIMEN PERIPHERY	424655	240	\N	\N	12-26470	\N	CGH12-109	Nevus Library	IP1112288	AirTable blocks_with_IP_info.csv
1095	03-39293	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1311	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, as single cells and nests with an area of pagetoid spread, flanking a nodular proliferation of large melanocytes that do not mature (diminish in size) with descent into the dermis, but are associated with a dense lymphocytic infiltrate.  Between the nodule and the intraepidermal component, the papillary dermis is thickened and fibrotic, with a patchy bandlike lymphocytic infiltrate and diminished numbers of melanocytes.	Ellipse measuring 2.0 x 0.8 x 0.3 cm, multiple raised skins measuring 0.7 x 0.5 cm, with margins inked blue, the specimen is serially sections and submitted in six sections.	NODULAR GROWTH WITHIN A PRE-EXISTING PLAQUE; R/O MELANOMA VS PIGMENTED BCC	\N	\N	\N	9/5/2003:  The thickness is listed above.  Aside from regression and a dense infiltrate of tumor infiltrating lymphocytes, there are no other findings of prognostic import.  Melanoma in situ extends almost to the periphery of the specimen. 9/3/2003:  I will be back in the office on 9/5 and will send a final report with a thickness measurement.  The microscope I am currently at does not have a micrometer.  This appears to be an intermediate risk primary melanoma (level III with regression).	MELANOMA, 1.4 MM  IN THICKNESS	529698	209	\N	\N	03-39293	\N	CCR-240	California Cancer Registry	IP397607	AirTable blocks_with_IP_info.csv
1057	02-20619B	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1313	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes in predominance in many areas.  Many of the constituent melanocytes have ample vacuolated and pigmented cytoplasm, and some melanocytes have slightly spindled cytomorphology.  There are clusters of similar cells in the superficial dermis, also above elastosis.  In a central area there are nodular collections of these melanocytes, forming an array that extends through the reticular dermis to the level of the superficial subcutis.  There is also an upper dermal infiltrate of lymphocytes and melanophages scattered throughout this lesion.	Oval-shaped oriented excision measuring 3.0 x 2.2 x 0.8 cm, with tip\nmarked by a single suture at 9 o'clock margin and two notable\nsutures placed at 12 o'clock margin, superior half of specimen is\ninked in blue, and inferior half of specimen is inked in yellow,\nserially sectioned and submitted with four sections each in cassettes\nA and C, three sections in cassette B.	FLAT BLACK NEVUS OF ? DURATION; SSM	\N	\N	\N	This is a non-ulcerated primary melanoma with a central nodular invasive focus that is prognostically worrisome based upon its thickness, and also based upon the fact that the invasive cells extend through the reticular dermis and abut upon the superficial subcutis (thus existing at the Clark's IV/V interface).  I do not see any clear evidence of vascular invasion or perineural extension in these sections.	MELANOMA OF 3.1 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 1 MM OF BOTH PERIPHERAL BIOPSY MARGINS	173410	210	\N	\N	02-20619	B	CCR-241	California Cancer Registry	IP325344	AirTable blocks_with_IP_info.csv
1024	01-6748	76	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1316	172.4	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclei, in irregular array along the epidermal-dermal junction.  Similar melanocytes are present in clusters in the underlying dermis, along with some melanocytes with nearly clear appearing vacuolated cytoplasm.  There are many melanophages in the papillary dermis.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely\nsubmitted.	R/O MELANOMA	\N	\N	\N	3/5/2001:  The thickness is now listed above.  2/27/2001:  Measurement of this specimen will be delayed as I do not have access to a micrometer at this moment, but I estimate the thickness at less than 1.0 mm.  While the configuration suggests that this specimen will provide the thickness of record, that judgment should be made following complete excision.	MELANOMA, 0.8 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173406	211	\N	\N	01-6748	\N	CCR-247	California Cancer Registry	IP263151	AirTable blocks_with_IP_info.csv
1018	00-26584A1	36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a proliferation of atypical melanocytes, arranged\nirregularly as single cells and nests at the epidermal-dermal\njunction, and in a central area in the dermis without diminishment in\nsize, where sheets and nodular aggregates are present.  There are\nareas in which the papillary dermis is thickened and fibrotic, with a\nlichenoid infiltrate of lymphocytes and melanophages, as well as\ndiminished numbers of melanocytes in comparison to the remainder of\nthe lesion.	Ellipse, measuring 2.9 x 1.8 x 0.7 cm, serially sectioned and\nsubmitted with three sections in blocks A1 and A2, and two sections\nin block A3, margins inked blue.	CLINICAL DIAGNOSIS - MELANOMA; TELEPHONE: 415-664-8630	\N	\N	\N	Regression is currently believed to be an adverse prognostic factor in patients with melanoma.	MELANOMA, 2.5 MM IN THICKNESS, WITH AREAS OF REGRESSION, EXTENDING TO WITHIN 2 MM OF THE PERIPHERAL BIOPSY MARGIN	172733	212	\N	\N	00-26584	A1	CCR-248	California Cancer Registry	IP241687	AirTable blocks_with_IP_info.csv
1007	00-7684A2	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1318	173.5	\N	\N	Sections show a compound proliferation of polygonal neoplastic cells\narrayed as irregular sheets of cells along the epidermal-dermal\njunction, with nests and sheets of similar cells in the underlying\ndermis.  There is extensive necrosis.	Oval-shaped excision measuring 4.0 x 4.0 x 1.5 cm, serially sectioned\nand submitted with two sections each in blocks A1, A10 and A11, one\nsection each in blocks A2, A3, A4, A5, A6, A7, A8, and A9, margins\ninked blue.	A) 4.0 X 3.5 CM BLEEDING FUNGATING NODULE WHICH IS 1.0 X 1.5 CM THICK, B) 2.0 X 3.0/4.0 CM PEARLY ERODED RED PLAQUE; CLINICAL DIAGNOSIS - A) PG VS NODULAR MELANOMA VS BCC, B) BCC	\N	\N	\N	3/29/2000:  An S100 immunostain is positive in the neoplastic cells, confirming the melanocytic lineage of this lesion.  This is a high-risk primary melanoma, based upon lesional thickness.  Consideration could be given to sentinel node evaluation.  Please contact me if you would like additional information regarding this technique.   3/19/2000:  This lesion is likely a melanoma of 12 mm in thickness.	MELANOMA, AT LEAST 12 MM IN THICKNESS, BROADLY TRANSECTED AT THE DEEP BIOPSY MARGIN	273588	213	\N	\N	00-7684	A2	CCR-250	California Cancer Registry	IP222787	AirTable blocks_with_IP_info.csv
1640	12-67286	18	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	There is a compound proliferation melanocytes with a junctional component including nests of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. These bridge adjacent rete ridges and in the center of the lesion are in apposition to a thinned epidermis. Smaller melanocytes with pigmented cytoplasm are present in the papillary dermis, along with a patchy lymphocytic infiltrate joined by melanophages.	Six outside slides, S12-39988 (CD12-103252) including 5 unstained slides.	MELANOCYTIC LESION	\N	\N	Scraping	Comparative genomic hybridization shows an isolated gain involving chromosome 10p. This is not a locus typically gained in melanoma. I would view this as an idiosyncratic aberration, in keeping with the low level of genetic instability seen in atypical Spitz tumors and similar lesions.	COMPOUND PROLIFERATION MELANOCYTES WITH A JUNCTIONAL COMPONENT OF LARGE SPITZOID CELLS	173528	241	\N	\N	12-67286	\N	CGH12-280	Nevus Library	IP1153102	AirTable blocks_with_IP_info.csv
1178	05-27756B	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1355	172.5	\N	\N	Sections show sheets of melanocytes beneath a thin epidermis, with one part of the lesion having oval cells with large, vesicular nuclei and the other small, monomorphous nuclei, the latter cells positioned between thickened collagen bundles and in myxoid stroma.	Ellipse, 2.2 x 1.5 x 0.9 cm, including a central 1.4 x 1.3 cm bump.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.	10 X 20 MM DOME SHAPED PLAQUE WITH 2 DARKER PLAQUES WITH VARIEGATED BROWN/RED COLOR; ? MELANOMA, ? NEVUS	\N	\N	\N	The neoplasm extends to within 1 mm. of the edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  This is an usual lesion, with a desmoplastic component- but with small round rather than spindled melanocytes.	MELANOMA, 3.4 MM  IN THICKNESS	528599	214	\N	\N	05-27756	B	CCR-256	California Cancer Registry	IP504468	AirTable blocks_with_IP_info.csv
2945	94-7602A	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1356	172.5	\N	\N	Sections show a compound proliferation of melanocytes, many of which\nhave atypical nuclei.  Nested and solitary melanocytes are arrayed at\nall epidermal levels, and aggregates and sheets of similar\nmelanocytes extend into the underlying dermis, to a maximum depth of\n1.6 mm.  A few melanocytes may extend more deeply, but only in areas\nof the adventitial dermis, where measurement is not utilized by\nconvention.  There are patchy lymphocytic infiltrates that permeate\nthe neoplasm, and there are areas of surrounding fibrosis.	Unoriented ellipse, 5.5 x 1.6 x 0.7 cm, serially sectioned with\nthree sections each submitted in blocks A and C, and two sections\neach in blocks B and D, tips returned to container, margins inked.\nSurface shows irregular brown macule, 1.9 x 0.9 cm.	LARGE IRREGULAR PIGMENTED PLAQUE; CLINICAL DIAGNOSIS - R/O MM	\N	\N	\N	There are broad zones of remote scar in the dermis underlying this neoplasm.  Was any prior surgery performed at this site, or was this a site of prior trauma?  If any prior surgical specimens exist, I would be happy to review them as part of this consultation.   The original report contained an erroneous microstage measurement, which may have been due to a transcription error.  This report contains corrected information (7/19/94).	MALIGNANT MELANOMA, SUPERFICIAL SPREADING TYPE, 1.6 MM IN THICKNESS, CLARK'S LEVEL III, EXCISED	173502	215	\N	\N	94-7602	A	CCR-257	California Cancer Registry	IP43096	AirTable blocks_with_IP_info.csv
2972	96-12193	44	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1690	172.5	\N	\N	Sections show nested and solitary melanocytes, some with atypical nuclear features, in irregular array along the dermo-epidermal junction.  Aggregates of similar melanocytes are present in the underlying dermis.	Skin segment measuring 8 x 5 x 1 mm, bisected longitudinally.	A - 2 X 3 CM PLAQUE; CLINICAL DIAGNOSIS - R/O BCC	\N	\N	Scraping	None	MELANOMA, AT LEAST 0.4 MM IN THICKNESS, EXTENDING TO THE DEEP BIOPSY MARGIN, FINAL MICROSTAGING PENDING COMPLETE REEXCISION	173525	216	\N	\N	96-12193	\N	CCR-258	California Cancer Registry	IP88957	AirTable blocks_with_IP_info.csv
1071	03-3075A	71	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1361	172.4	\N	\N	Sections show nested melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes that vary in size and shape.  There are clusters and nests and sheets of similar cells in the dermis, also above elastosis, jointly with an infiltrate of lymphocytes and melanophages and fibrosis, some of which could stem from a prior biopsy.	Ellipse measuring 1.8 x 0.7 x 0.3 cm, margins inked blue serially sectioned and submitted with four segments each in cassettes A and B.	6 MONTH HX OF GROWING IRREGULAR PLAQUE, BX'D BY ANOTHER MD WITH REPORT READ AS ATYPICAL NEVUS, DX:MELANOMA; R/O MELANOMA, EXCISION BX NO ULCERATION	\N	\N	\N	This is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension.  There is evidence of partial regression, and thus the microstage measurement listed above may underestimate the prognostic risk of this lesion.  This patient is a candidate for sentinel node evaluation,  based upon criteria currently employed by the UCSF Melanoma Center.  Further re-excision of this lesion is also warranted to be certain local control has been established. The prior biopsy should be reviewed to see if it holds prognostic importance.  Please forward a report or additional details to my attention and I will make the necessary arrangements.	MELANOMA OF 1.6 MM IN THICKNESS, WITH EXTENSION NEAR TO THE PERIPHERAL BIOPSY MARGIN	173406	217	\N	\N	03-3075	A	CCR-261	California Cancer Registry	IP361387	AirTable blocks_with_IP_info.csv
1764	14-48102	26	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.7	\N	\N	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei and large, central nucleoli, some eosinophilic. The lesion is raised, and nearly pedunculated. There is irregular epidermal hyperplasia overlying large confluent nests of the above-mentioned cells, with areas in nests are confluent both in the upper and lower parts of the lesion. Many admixed melanophages are present.	One outside slide, S12235/14 / A2, and one corresponding block.	PT PREGNANT 26 WEEKS, RAPIDLY GROWING LESION; ? PYOGENIC GRANULOMA, BUT EXCLUDE MELANOMA, DIFFERENTIAL IS ATYPICAL SPITZ TUMOUR VS. SPITZOID MELANOMA	\N	\N	Scraping	Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in Spitz nevi. These include gains of 1q, a gain involving the distal part of 5q, a gain of 6p and a loss of 6q, a low level gain of chr. 7, a loss of chr. 9p, an amplification involving chr. 10p, loss of chr. 11, and loss of chr. 14.	MELANOMA, 2.5 MM. IN THICKNESS	101721	242	\N	\N	14-48102	\N	CGH14-145	Nevus Library	IP1398038	AirTable blocks_with_IP_info.csv
1019	00-27758D M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	996	\N	\N	None	\N	MD-100	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2543	19Rig750007.05.01.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	291	\N	\N	None	\N	CM-57	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2545	19Rig750007.05.02.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	292	\N	\N	None	\N	CM-58	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2544	19Rig750007.05.02.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	292	\N	\N	None	\N	CM-58	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2546	19Rig750007.05.04.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	293	\N	\N	None	\N	CM-60	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2547	19Rig750007.05.05.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	294	\N	\N	None	\N	CM-61	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2548	19Rig750007.05.05.08	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	294	\N	\N	None	\N	CM-61	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2550	19Rig750007.05.06.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	295	\N	\N	None	\N	CM-62	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1072	03-3075B	71	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1362	172.4	\N	\N	Sections show nested melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes that vary in size and shape.  There are clusters and nests and sheets of similar cells in the dermis, also above elastosis, jointly with an infiltrate of lymphocytes and melanophages and fibrosis, some of which could stem from a prior biopsy.	Ellipse measuring 1.8 x 0.7 x 0.3 cm, margins inked blue serially sectioned and submitted with four segments each in cassettes A and B.	6 MONTH HX OF GROWING IRREGULAR PLAQUE, BX'D BY ANOTHER MD WITH REPORT READ AS ATYPICAL NEVUS, DX:MELANOMA; R/O MELANOMA, EXCISION BX NO ULCERATION	\N	\N	\N	This is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension.  There is evidence of partial regression, and thus the microstage measurement listed above may underestimate the prognostic risk of this lesion.  This patient is a candidate for sentinel node evaluation,  based upon criteria currently employed by the UCSF Melanoma Center.  Further re-excision of this lesion is also warranted to be certain local control has been established. The prior biopsy should be reviewed to see if it holds prognostic importance.  Please forward a report or additional details to my attention and I will make the necessary arrangements.	MELANOMA OF 1.6 MM IN THICKNESS, WITH EXTENSION NEAR TO THE PERIPHERAL BIOPSY MARGIN	173406	217	\N	\N	03-3075	B	CCR-261	California Cancer Registry	IP361387	AirTable blocks_with_IP_info.csv
1146	04-50387	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1364	173.5	\N	\N	Sections show a broad and extremely poorly circumscribed compound proliferation of melanocytes, some with atypical nuclei, arranged above fibroplasia of the papillary dermis. There are single cells and nests arrayed broadly in somewhat lentiginous fashion, with many single melanocytes in pagetoid array. The dermis holds horizontal aggregations of melanocytes enveloped by fibrosis, with a sparse infiltrate of lymphocytes and melanophages also evident, and with elastosis more deeply.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted.	LARGE IRREGULAR PIGMENTED LESION	\N	\N	\N	Although this lesion shows some dysplastic nevus-like attributes, it is extremely broad and asymmetrical and includes melanocytes in pagetoid array within the epidermis, a combination that favors the above diagnosis. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion or perineural extension or regression. Further re-excision of this site is warranted to ensure that local control has been established.	MELANOMA OF 0.35 MILLIMETERS IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173582	218	\N	\N	04-50387	\N	CCR-263	California Cancer Registry	IP466795	AirTable blocks_with_IP_info.csv
1126	04-14908	80	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the superficial reticular dermis.	Ellipse measuring 2.2 x 1.2 x 0.3 cm, margins inked blue, serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.\n	ATYPICAL	\N	\N	\N	Melanoma in situ extends to the periphery of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  ADDENDUM, 4/12/2004:  The thickness has now been added to the diagnosis line.	MELANOMA, 1.35 MM  IN THICKNESS	173610	219	\N	\N	04-14908	\N	CCR-264	California Cancer Registry	IP431307	AirTable blocks_with_IP_info.csv
1127	04-14908A	80	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1365	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the superficial reticular dermis.	Ellipse measuring 2.2 x 1.2 x 0.3 cm, margins inked blue, serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.\n	ATYPICAL	\N	\N	\N	Melanoma in situ extends to the periphery of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  ADDENDUM, 4/12/2004:  The thickness has now been added to the diagnosis line.	MELANOMA, 1.35 MM  IN THICKNESS	173610	219	\N	\N	04-14908	A	CCR-264	California Cancer Registry	IP431307	AirTable blocks_with_IP_info.csv
1279	07-37090	86	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1377	172.4	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclear features, in irregular array along the epidermal-dermal junction.  Many melanocytes are scattered above the basal layer.  The epidermis is focally hyperplastic. Similar melanocytes are present in clusters in the underlying dermis, within a zone of fibrosis, occurring over marked elastosis.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted.	R/O ATYPIA	\N	\N	\N	Level sections were helpful in demonstrating an invasive component, which was also suggested an initial sections.  In terms of staging, this is a nonulcerated primary melanoma of Clark's anatomic level II, with melanocytes abutting the reticular dermal interface, within a zone of fibrosis. There is no evidence of vascular invasion, neurotropism, or regression. Definitive assessment of thickness and other prognostic factors should be deferred to complete excision of this neoplasm, as I assume this is a small sample of a larger lesion.	MELANOMA, 0.5 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGINS	173405	220	\N	\N	07-37090	\N	CCR-268	California Cancer Registry	IP659623	AirTable blocks_with_IP_info.csv
2994	98-9595B	61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22648	172.5	\N	\N	Sections show a compound proliferation of melanocytes arrayed as\nirregular nests along the epidermal-dermal junction, with nests and\nsheets of atypical melanocytes in the underlying dermis.  Smaller\nmelanocytes are present in one peripheral focus (representing\nmelanocytic nevus).	Ellipse, 2.0 x 2.0 x 1.0 cm, serially sectioned and submitted with\nsix pieces in block A1, margins inked blue.	CLINICAL DIAGNOSIS - R/O MELANOMA VS BCC X 2	\N	\N	\N	In one of the cross sections of this biopsy, small melanocytes, which appear to represent remnants of a precursor melanocytic nevus, are present in the superficial dermis.  Further reexcision of this site is warranted.	MELANOMA, 1.6 MM IN THICKNESS, EXTENDING NEAR TO THE PERIPHERAL MARGIN	433599	221	\N	\N	98-9595	B	CCR-269	California Cancer Registry	IP146596	AirTable blocks_with_IP_info.csv
2495	19Rig750007.01.16.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	260	\N	\N	None	\N	CM-16	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1227	06-17933A	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1381	172.5	\N	\N	Sections show a broad compound proliferation of atypical melanocytes, composed largely of cells with scant vacuolated and/or pigmented cytoplasm. Single cells and nests are arrayed broadly and in lentiginous fashion within the epidermis, with conspicuous associated suprabasal scatter. There are also tiny clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. In some areas of the proliferation, somewhat smaller melanocytes are present in broad and lentiginous array.	Ellipse, 3.0 x 1.3 x 1.1 cm, including a central 1.3 x 1.0 cm dark pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	R/O DYSPLASIA	\N	\N	\N	Part of this broad lesion includes atypical melanocytes in pagetoid array, a configuration suggesting melanoma, while part consists of somewhat smaller melanocytes arrayed in lentiginous fashion, a configuration that may represent a preceding melanocytic nevus. In terms of staging, I believe this is a non-ulcerated primary melanoma with invasion confined to the papillary dermis (Clark's level II). There is no evidence of vascular invasion, neurotropism, or regression in these sections. In essence, this is a very thin, minimal-risk primary melanoma. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.3 MM IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE NARROWLY FREE OF INTRAEPIDERMAL MELANOMA)	273588	223	\N	\N	06-17933	A	CCR-273	California Cancer Registry	IP562999	AirTable blocks_with_IP_info.csv
1228	06-17933B	58	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1382	172.5	\N	\N	Sections show a broad compound proliferation of atypical melanocytes, composed largely of cells with scant vacuolated and/or pigmented cytoplasm. Single cells and nests are arrayed broadly and in lentiginous fashion within the epidermis, with conspicuous associated suprabasal scatter. There are also tiny clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. In some areas of the proliferation, somewhat smaller melanocytes are present in broad and lentiginous array.	Ellipse, 3.0 x 1.3 x 1.1 cm, including a central 1.3 x 1.0 cm dark pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	R/O DYSPLASIA	\N	\N	\N	Part of this broad lesion includes atypical melanocytes in pagetoid array, a configuration suggesting melanoma, while part consists of somewhat smaller melanocytes arrayed in lentiginous fashion, a configuration that may represent a preceding melanocytic nevus. In terms of staging, I believe this is a non-ulcerated primary melanoma with invasion confined to the papillary dermis (Clark's level II). There is no evidence of vascular invasion, neurotropism, or regression in these sections. In essence, this is a very thin, minimal-risk primary melanoma. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.3 MM IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE NARROWLY FREE OF INTRAEPIDERMAL MELANOMA)	273588	223	\N	\N	06-17933	B	CCR-273	California Cancer Registry	IP562999	AirTable blocks_with_IP_info.csv
2963	95-21392	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1383	172.5	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.	Cylindrical skin segment, 7 mm in diameter, 6 mm in depth, bisected.	GROWING MOLE 5 X 6 MM, BLACK WITH FAINT ERYTHEMA. CLINICAL DIAGNOSIS - R/O MELANOMA	\N	\N	\N	A few small and bland melanocytes are present at the base of this proliferation, and these changes probably represent a precursor melanocytic nevus.  The bulk of the present lesion consists of melanoma.	MELANOMA, 0.95 MM IN THICKNESS, EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	173527	224	\N	\N	95-21392	\N	CCR-274	California Cancer Registry	IP51560	AirTable blocks_with_IP_info.csv
2938	93-13675A	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1387	172.5	\N	\N	Sections show an incompletely circumscribed compound proliferation of\natypical melanocytes, with areas in which single cells predominate\nover nests along the junction.  There is prominent upward scatter of\nmelanocytes, and melanocytes with atypical nuclei extend in\naggregates of variable size into the dermis.  There is slight\nsurrounding fibrosis, and there is a patchy lymphoid reaction at the\nbase.	Ellipse, 2.5 x 1.3 x 0.8 cm.  Surface shows a brown macule, 0.6 x 0.6\ncm.  Two sections lateral to tumor submitted as A, central portion of\nellipse submitted as three sections in B.  Tips returned to\ncontainer.	WF WITH CHANGING MOLE 1.5 CM WITH BLACK AREA NEAR TAN AREA X 1-1/2 YEARS; CLINICAL DIAGNOSIS - R/O SS MELANOMA	\N	\N	\N	\N	MALIGNANT MELANOMA, 0.7 MM IN THICKNESS, CLARK'S LEVEL III, SUPERFICIAL SPREADING TYPE, WITH THE IN SITU COMPONENT EXTENDING NEAR TO LATERAL BIOPSY MARGINS	173502	225	\N	\N	93-13675	A	CCR-281	California Cancer Registry	IP35049	AirTable blocks_with_IP_info.csv
2939	93-13675B	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1388	172.5	\N	\N	Sections show an incompletely circumscribed compound proliferation of atypical melanocytes, with areas in which single cells predominate over nests along the junction.  There is prominent upward scatter of melanocytes, and melanocytes with atypical nuclei extend in aggregates of variable size into the dermis.  There is slight surrounding fibrosis, and there is a patchy lymphoid reaction at the base.	Ellipse, 2.5 x 1.3 x 0.8 cm.  Surface shows a brown macule, 0.6 x 0.6\ncm.  Two sections lateral to tumor submitted as A, central portion of\nellipse submitted as three sections in B.  Tips returned to\ncontainer.	WF WITH CHANGING MOLE 1.5 CM WITH BLACK AREA NEAR TAN AREA X 1-1/2 YEARS; CLINICAL DIAGNOSIS - R/O SS MELANOMA	\N	\N	\N	None	MALIGNANT MELANOMA, 0.7 MM IN THICKNESS, CLARK'S LEVEL III, SUPERFICIAL SPREADING TYPE, WITH THE IN SITU COMPONENT EXTENDING NEAR TO LATERAL BIOPSY MARGINS	173502	225	\N	\N	93-13675	B	CCR-281	California Cancer Registry	IP35049	AirTable blocks_with_IP_info.csv
2494	19Rig750007.01.16.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	260	\N	\N	None	\N	CM-16	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2496	19rig750007.01.17.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	261	\N	\N	None	\N	CM-17	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2561	19rig75000701.18.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	262	\N	\N	None	\N	CM-18	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2560	19rig75000701.18.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	262	\N	\N	None	\N	CM-18	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2498	19Rig750007.02.02.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	263	\N	\N	None	\N	CM-21	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2497	19Rig750007.02.02.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	263	\N	\N	None	\N	CM-21	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2500	19Rig750007.02.03.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	264	\N	\N	None	\N	CM-22	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1028	01-11378A2	79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1392	172.5	\N	\N	Sections show an area of inflammation and fibrosis, representing the\naftermath of a prior biopsy or surgery, flanked by a proliferation\nof melanocytes arrayed as irregular clusters in the epidermis and\ndermis.  The junctional melanocytes are arrayed in predominantly\nnested but confluent fashion, and only rare underlying dermal\nmelanocytes are evident.  The papillary dermis is also expanded by\nfibrosis and an infiltrate of lymphocytes and melanophages.	Ellipse, measuring 5.7 x 2.5 x 0.5 cm, margins inked blue, serially\nsectioned and submitted with three sections in block A1 and two\nsections in block A2, remainder returned to container.	H/O MELANOMA; MELANOMA, 0.25; TELEPHONE:  284-0559	\N	\N	\N	Unfortunately, a full cross section of one of the segments of tissue from this specimen could not be visualized, due to aberrations in the gross sectioning of this specimen.  Based upon all other profiles, it appears that this lesion has been completely excised with a wide margin.  Thus, I believe that surgical margins are negative, despite the fact that there are some limitations in the interpretation of the margins of this excisional specimen.	RESIDUAL MELANOMA OF 0.35MM IN THICKNESS, APPARENTLY COMPLETELY EXCISED (FINAL SURGICAL MARGINS APPEAR FREE OF MELANOMA CELLS)	136563	226	\N	\N	01-11378	A2	CCR-282	California Cancer Registry	IP129632	AirTable blocks_with_IP_info.csv
2988	98-1556	80	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1394	172.4	\N	\N	Sections show a compound proliferation of melanocytes arrayed as irregular nests along the epidermal-dermal junction, with nests and sheets of atypical melanocytes in the underlying dermis.  There is elastosis.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness,\nbisected and entirely submitted.	CLINICAL DIAGNOSIS - R/O BCE	\N	\N	\N	Final microstage measurements have been deferred until this lesion has been completely reexcised.	MELANOMA, 0.95 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173403	227	\N	\N	98-1556	\N	CCR-287	California Cancer Registry	IP17286	AirTable blocks_with_IP_info.csv
1236	06-22923	72	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1397	172.6	\N	\N	Sections show nested and solitary melanocytes arrayed broadly and irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes in predominance. There are clusters of similar cells in the superficial dermis, also above elastosis and accompanied by considerable subjunctional fibroplasia.	Skin segment measuring 1.2 x 0.8 x 0.2 cm, quadrisected and entirely submitted.	IRREGULAR BROWN MACULE; R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion, neurotropism, or regression in these sections. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.4 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173610	228	\N	\N	06-22923	\N	CCR-290	California Cancer Registry	IP334006	AirTable blocks_with_IP_info.csv
1147	04-57347A	59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1398	172.6	\N	\N	Sections show a high-domed area with a proliferation of pleomorphic spindled cells with variably hyperchromatic vesicular nuclei, positioned in areas of dense lymphocytic infiltrates and between thickened collagen bundles in the reticular dermis. There are adjacent zones in which there are increased single melanocytes in the basal layer, some with hyperchromatic nuclei.  There is marked solar elastosis.	Ellipse measuring 4.0 x 1.0 x 1.2 cm, with central lesion, margins inked blue, serially sectioned perpendicular to the long axis and submitted with four sections each in cassettes A and B; tips returned to container.\n	R/O MM	\N	\N	\N	An S100 stain is positive in both very large pleomorphic cells and in smaller spindled ones in areas of fibrosis. Please note that melanoma in situ extends to within 2 mm. of the edge of the specimen.  I did not detect perineural invasion, but a re-excision should be considered, as the margins are more narrow than those usually considered adequate for this neoplasm.  Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: many Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  Please note that conventional staging may not be applicable to desmoplastic melanoma, which seems to metastasize systemically less than conventional melanomas of similar thickness.	DESMOPLASTIC MELANOMA, 2.2 MM  IN THICKNESS	173601	229	\N	\N	04-57347	A	CCR-296	California Cancer Registry	IP473755	AirTable blocks_with_IP_info.csv
1086	03-24651	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1399	172.5	\N	\N	Sections show a cellular asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly and nearly confluently within the epidermis, with foci of suprabasal scatter.  There are also clusters of similar melanocytes in the upper dermis, which contains a relatively dense infiltrate of lymphocytes and melanophages.	Ellipse, 1.5 x 0.9 x 0.6 cm, including central light and dark brown 0.8 x 0.5 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections, one tip returned to container.	PIG LESION	\N	\N	\N	This is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III).  There is no evidence of vascular invasion or perineural extension, and there is also no significant evidence of regression.  There are some small melanocytes at the periphery of this melanoma, and thus I believe it developed in association with a melanocytic nevus.  Further re-excision of this site is warranted to ensure local control of this malignancy.	MELANOMA OF 0.9 MILLIMETERS IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS NEAR TO THE PERIPHERAL MARGIN	173509	230	\N	\N	03-24651	\N	CCR-298	California Cancer Registry	IP382964	AirTable blocks_with_IP_info.csv
3005	99-4387	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1400	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, focally in a pagetoid pattern, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis.	Ellipse measuring 1.1 x 0.9 x 0.4 cm, quadrisected and entirely\nsubmitted, margins inked blue.	8.0 X 9.0 MM IRREGULAR MACULE SINCE 12/98; CLINICAL DIAGNOSIS - LENTIGO VS LENTIGO MALIGNA VS NEVUS, R/O MELANOMA	\N	\N	\N	None	MELANOMA, 0.8 MM IN THICKNESS, EXTENDING TO WITHIN 1 MM OF THE PERIPHERAL BIOPSY MARGIN	576544	231	\N	\N	99-4387	\N	CCR-300	California Cancer Registry	IP179920	AirTable blocks_with_IP_info.csv
2499	19Rig750007.02.03.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	264	\N	\N	None	\N	CM-22	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2501	19Rig750007.02.04.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	265	\N	\N	None	\N	CM-23	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2502	19Rig750007.02.05.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	266	\N	\N	None	\N	CM-24	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2503	19Rig750007.02.08.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	267	\N	\N	None	\N	CM-27	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1256	06-73878A	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1401	172.5	\N	\N	Sections show an irregular proliferation of atypical melanocytes with nests of melanocytes that are distributed at irregular intervals, and are focally confluent.  There are foci in which single melanocytes predominate as well.  The dermis contains aggregates of similar cells and there is solar elastosis.	Cylindrical skin segment measuring 0.4 cm in diameter x 0.9 cm in thickness, bisected and entirely submitted in cassette A.	A) IRREGULAR 8-10 MM MACULE; R/O MELANOMA, B) 2 WK HX OF RAPIDLY GROWING PAPULE; R/O SK, C-D) R/O BCC	\N	\N	\N	ADDENDUM, 5/15/2007: This appears to be a small biopsy from a larger lesion and shows a thin invasive melanoma without ulceration, microsatellites, or vascular invasion. The final pathologic staging should await examination of the completely excised lesion. This case was originally reported by Dr. Richard Kasper, who provided the note above. Drs. Yu and Fu have asked for a comment regarding the Clark's level, and whether regression is evident, as it was in the excision specimen. I have reviewed this slide only. The Clark's level is II, and there is evidence of regression, affecting much of this small punch biopsy specimen.  Its extent is thus better estimated with respect to the lesion upon excision, as reported by me separately.	INVASIVE MELANOMA, 0.35 mm THICK, NON-ULCERATED, WITH INTRAEPIDERMAL COMPONENT PRESENT AT BIOPSY EDGE	173536	232	\N	\N	06-73878	A	CCR-301	California Cancer Registry	IP89612	AirTable blocks_with_IP_info.csv
1257	06-73878C	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1403	173.2	\N	\N	Sections show a nodular proliferation of peripherally palisaded basaloid cells with some neoplastic cells in mitosis, others in necrosis, and an area of surface ulceration.	Skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette C.	A) IRREGULAR 8-10 MM MACULE; R/O MELANOMA, B) 2 WK HX OF RAPIDLY GROWING PAPULE; R/O SK, C-D) R/O BCC	\N	\N	\N	\N	NODULAR BASAL CELL CARCINOMA, ULCERATED LESION, TRANSECTED AT THE DEEP BIOPSY EDGE	112210	232	\N	\N	06-73878	C	CCR-301	California Cancer Registry	IP89612	AirTable blocks_with_IP_info.csv
1099	03-57215B	31	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1406	172.5	\N	\N	Sections show a large cellular asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There is focal ulceration with overlying purulent crust.  There are also clusters of similar melanocytes in the upper dermis, and these cells meld into clusters and tracts of cells with hyperchromatic nuclei that jut into the reticular dermis.  At one edge of the specimen, smaller melanocytes reside in the dermis.	Ellipse, 3.0 x 1.5 x 0.9 cm, including central elevated tan and gray 1.5 x 1.0 cm pigmented lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four central sections in cassette A and three central sections in cassette B, tips returned to container.	R/O MM	\N	\N	FFPE	In terms of staging, this is an ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  The melanoma arose in association with a nevus of superficial congenital type, a remnant of which is also apparent in these sections.  There is no evidence of vascular invasion or perineural extension or regression.  Further re-excision of this site is warranted to ensure that local control has been established.	MELANOMA OF 1.7 MILLIMETERS IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE NARROWLY FREE OF MELANOMA CELLS)	100556	233	\N	\N	03-57215	B	CCR-302	Melanoma Epigenetics	IP415531	AirTable blocks_with_IP_info.csv
1098	03-57215A	31	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a large cellular asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There is focal ulceration with overlying purulent crust.  There are also clusters of similar melanocytes in the upper dermis, and these cells meld into clusters and tracts of cells with hyperchromatic nuclei that jut into the reticular dermis.  At one edge of the specimen, smaller melanocytes reside in the dermis.	Ellipse, 3.0 x 1.5 x 0.9 cm, including central elevated tan and gray 1.5 x 1.0 cm pigmented lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four central sections in cassette A and three central sections in cassette B, tips returned to container.	R/O MM	\N	\N	\N	In terms of staging, this is an ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  The melanoma arose in association with a nevus of superficial congenital type, a remnant of which is also apparent in these sections.  There is no evidence of vascular invasion or perineural extension or regression.  Further re-excision of this site is warranted to ensure that local control has been established.	MELANOMA OF 1.7 MILLIMETERS IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE NARROWLY FREE OF MELANOMA CELLS)	100556	233	\N	\N	03-57215	A	CCR-302	Melanoma Epigenetics	IP415531	AirTable blocks_with_IP_info.csv
1233	06-21115A	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1407	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with a dense infiltrate of lymphocytes and melanophages. In some areas where the infiltrate is densest, superficial dermal fibroplasia is appreciable. There may also be a reduction in density of melanocytes in some dermal areas.	Oriented ellipse, 1.7 x 1.0 x 0.3 cm, including a central dark brown and brown-black 1.3 x 0.9 cm pigmented area.  With the orienting slit placed to the left, the far margin is inked blue and the near margin is inked green (yellow over blue).  The specimen is serially sectioned perpendicular to the long axis from left to right and entirely submitted with four sections each in cassettes A (3 pieces embedded) and B.	10 X 13 MM BLACK FLAT BUT PALPABLE SLIGHTLY IRREGULAR BORDER GETTING LARGER PAST 4 YEARS, ADVISED BY GYN OVER 1 YEAR AGO TO HAVE IT REMOVED PROMPTLY, INGUINAL LYMPH NODES NOT PALPABLE	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to a strikingly expanded papillary dermis (Clark's level III). There is no evidence of associated vascular invasion or neurotropism in these sections. There are inflammatory changes that could represent an element of evolving partial regression, and thus the microstage measurement listed above may slightly underestimate the prognostic impact of this lesion. However, I suspect that the present microstage thickness is reasonably representative. Further reexcision of this site is of course warranted to be certain that local eradication has been accomplished.	MELANOMA OF 0.85 MM IN THICKNESS, TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	100556	234	\N	\N	06-21115	A	CCR-303	California Cancer Registry	IP566181	AirTable blocks_with_IP_info.csv
2505	19Rig750007.02.09.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	268	\N	\N	None	\N	CM-28	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2504	19Rig750007.02.09.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	268	\N	\N	None	\N	CM-28	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2507	19Rig750007.02.10.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	269	\N	\N	None	\N	CM-29	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2506	19Rig750007.02.10.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	269	\N	\N	None	\N	CM-29	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2509	19Rig750007.03.01.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	270	\N	\N	None	\N	CM-30	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1234	06-21115B	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	https://64.54.108.121/app/WebViewer/view/image/1408	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with a dense infiltrate of lymphocytes and melanophages. In some areas where the infiltrate is densest, superficial dermal fibroplasia is appreciable. There may also be a reduction in density of melanocytes in some dermal areas.	Oriented ellipse, 1.7 x 1.0 x 0.3 cm, including a central dark brown and brown-black 1.3 x 0.9 cm pigmented area.  With the orienting slit placed to the left, the far margin is inked blue and the near margin is inked green (yellow over blue).  The specimen is serially sectioned perpendicular to the long axis from left to right and entirely submitted with four sections each in cassettes A (3 pieces embedded) and B.	10 X 13 MM BLACK FLAT BUT PALPABLE SLIGHTLY IRREGULAR BORDER GETTING LARGER PAST 4 YEARS, ADVISED BY GYN OVER 1 YEAR AGO TO HAVE IT REMOVED PROMPTLY, INGUINAL LYMPH NODES NOT PALPABLE	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to a strikingly expanded papillary dermis (Clark's level III). There is no evidence of associated vascular invasion or neurotropism in these sections. There are inflammatory changes that could represent an element of evolving partial regression, and thus the microstage measurement listed above may slightly underestimate the prognostic impact of this lesion. However, I suspect that the present microstage thickness is reasonably representative. Further reexcision of this site is of course warranted to be certain that local eradication has been accomplished.	MELANOMA OF 0.85 MM IN THICKNESS, TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	100556	234	\N	\N	06-21115	B	CCR-303	California Cancer Registry	IP566181	AirTable blocks_with_IP_info.csv
1216	06-11151F	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1417	172.5	\N	\N	Sections show a densely cellular compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated or pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages and enveloping superficial dermal fibroplasia. There is also deeper scarring stemming from prior biopsy/surgery at this site.	Oriented ellipse, 5.2 x 2.0 x 0.7 cm, including a central brown 0.8 x 0.7 cm pigmented area.  With the orienting sutured tip placed to the left and designated stitch at superior tip by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right pseudotips and submitted with three sections in cassette A and two sections each in cassettes B through F, tips returned to container.	1.2 X 1.2 CM IRREG PIG PLAQUE; MIS; EXCISION MIS (SEE PREV PATH DS06-6467); TELEPHONE: 241-0686	\N	\N	\N	Upon complete excision, it is clear that this lesion represents melanoma. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion or perineural extension or regression in these sections.	RESIDUAL MELANOMA OF 0.5 MM IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS APPEAR FREE OF MELANOMA)	173536	235	\N	\N	06-11151	F	CCR-310	California Cancer Registry	IP551533	AirTable blocks_with_IP_info.csv
1215	06-11151D	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a densely cellular compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated or pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages and enveloping superficial dermal fibroplasia. There is also deeper scarring stemming from prior biopsy/surgery at this site.	Oriented ellipse, 5.2 x 2.0 x 0.7 cm, including a central brown 0.8 x 0.7 cm pigmented area.  With the orienting sutured tip placed to the left and designated stitch at superior tip by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right pseudotips and submitted with three sections in cassette A and two sections each in cassettes B through F, tips returned to container.	1.2 X 1.2 CM IRREG PIG PLAQUE; MIS; EXCISION MIS (SEE PREV PATH DS06-6467); TELEPHONE: 241-0686	\N	\N	\N	Upon complete excision, it is clear that this lesion represents melanoma. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion or perineural extension or regression in these sections.	RESIDUAL MELANOMA OF 0.5 MM IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS APPEAR FREE OF MELANOMA)	173536	235	\N	\N	06-11151	D	CCR-310	California Cancer Registry	IP551533	AirTable blocks_with_IP_info.csv
1214	06-11151C	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1414	172.5	\N	\N	Sections show a densely cellular compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated or pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages and enveloping superficial dermal fibroplasia. There is also deeper scarring stemming from prior biopsy/surgery at this site.	Oriented ellipse, 5.2 x 2.0 x 0.7 cm, including a central brown 0.8 x 0.7 cm pigmented area.  With the orienting sutured tip placed to the left and designated stitch at superior tip by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right pseudotips and submitted with three sections in cassette A and two sections each in cassettes B through F, tips returned to container.	1.2 X 1.2 CM IRREG PIG PLAQUE; MIS; EXCISION MIS (SEE PREV PATH DS06-6467); TELEPHONE: 241-0686	\N	\N	\N	Upon complete excision, it is clear that this lesion represents melanoma. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion or perineural extension or regression in these sections.	RESIDUAL MELANOMA OF 0.5 MM IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS APPEAR FREE OF MELANOMA)	173536	235	\N	\N	06-11151	C	CCR-310	California Cancer Registry	IP551533	AirTable blocks_with_IP_info.csv
1798	14-96361	37	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show a segment of acral skin with a compound melanocytic proliferation.  There are large polygonal, ovoid, and spindled melanocytes in nests separated by clefts from the overlying hyperplastic epidermis, and similar cells are present in collections in the dermis.  Within the epidermis, some of the melanocytes are within the spinous layer. In the dermis, some of the melanocytes contain abundant eosinophilic cytoplasm, but the size of the melanocytes appears to diminish with descent. The melanocytes extend into the reticular dermis.	Ovoid excision measuring 1.0 x 1.0 x 0.2 cm, including a central 0.8 x 0.7 cm pink-brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections. HD/KC	0.7 X 0.9 CM TWO-TONED PLAQUE W/ DARK EDGES, HISTORY OF RAPID GROWTH; ACRAL NEVUS, R/O ATYPIA / MELANOMA VS. DERMATOFIBROMA VS. OTHER	\N	\N	Scraping	ADDENDUM, November 16, 2014: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: The junctional component is unusual since melanocytes are arranged in a somewhat irregular array, since many of these melanocytes are large and contain abundant eosinophilic cytoplasm and since there are foci in which single melanocytes predominate over nests. There are clusters of similar melanocytes in the underlying dermis.  Due to these unusual features, I sought to further evaluate this specimen via immunoperoxidase staining. Staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions). By contrast, there was loss of p16 staining among a subset of the junctional and dermal melanocytes, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasms, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located.  Given the features on the routinely stained hematoxylin and eosin section, in concert with the partial loss of p16, a definitive diagnosis could not be reached based on these data. Therefore, after receiving authorization to proceed with comparative genomic hybridization (CGH) testing, following microdissection and DNA extraction, we performed CGH to further evaluate this proliferation.  The testing revealed gains of chromosome 7q and 10p. Otherwise, no significant abnormalities were detected. Interestingly, there were no abnormalities of chromosome 9p and thus the loss of p16 staining probably is not significant. The chromosomal abnormalities detected by the CGH study can be seen in atypical Spitz tumors, which is the category into which I would classify this lesion. The CGH results do not support the diagnosis of melanoma, since, in melanoma, there are usually many chromosomal abnormalities detected. Given that this atypical Spitz tumor has been narrow excised, I think that the site could be clinically monitored or a narrow re-excision could be performed. Both Drs. Boris Bastian and Philip LeBoit have reviewed this case and agree with this assessment.	COMPOUND MELANOCYTIC PROLIFERATION, EXTENDING TO WITHIN 0.3 MILLIMETERS OF THE PERIPHERAL INKED MARGIN	672655	243	\N	\N	14-96361	\N	CGH14-348	Nevus Library	IP1446353	AirTable blocks_with_IP_info.csv
1004	00-4845	83	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1424	172.6	\N	\N	Sections show fibrosis of the papillary dermis, in conjunction with a focally lichenoid papillary dermal lymphocytic infiltrate.  Clusters of melanophages are also present in the dermis.  There are also slightly hyperchromatic spindled cells arrayed in association with sclerosis throughout the superficial reticular dermis, with a sparse infiltrate of surrounding lymphocytes near the deepest of the spindled cells.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness,\nbisected and totally submitted.	IRREG HYPERPIGMENTED MACULE ADJACENT TO PALE PINK PAPULE; CLINICAL DIAGNOSIS - R/O MELANOMA VS PIGMENTED BCC	\N	\N	\N	3/2/2000: A repeat S100 immunostain avidly labels the nests of malignant cells in the dermis, confirming melanocytic lineage and thereby supporting the diagnosis listed above.   2/29/2000:  Level sections clearly show clusters of malignant cells subjacent to the zone of regression, and these changes, in the context of the biopsy, appear to represent melanoma.  However, as overt or specific evidence of melanocytic lineage is not present, a second S100 immunostain will be obtained to confirm the diagnosis.  This stain will be completed later this week.  Please note that this patient is a candidate for sentinel node evaluation, and a decision regarding the application of this technique should be made before a definitive reexcision is performed.   2/28/2000:  An S100 immunostain has been completed, and only scattered dendritic cells show positive labeling.  This staining reaction highlights the presence of non-neoplastic cells, and thus the staining result lends no support to the possibility of a component of desmoplastic melanoma in this lesion. However, these changes may represent regression of conventional melanoma in which no viable neoplasm remains.  Level sections to seek any remaining viable neoplasm have been requested and should be completed shortly, thereby permitting finalization of this report.   2/18/2000:  This pattern is worrisome for regression of a melanocytic neoplasm, and these changes may represent partial regression of a superficial desmoplastic melanoma.	MELANOMA, 2.2 MM IN THICKNESS, WITH EXTENSIVE REGRESSION AND EXTENSION TO THE PERIPHERAL MARGIN	173649	236	\N	\N	00-4845	\N	CCR-311	California Cancer Registry	IP219948	AirTable blocks_with_IP_info.csv
1036	01-34127B	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1426	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis.  There is suprabasal scatter of melanocytes in several foci.  There is little diminishment in melanocyte size with descent in the dermis, and dermal melanocytes contain many mitotic figures.  There is marked angiogenesis at the base of the lesion, but no evidence of vascular invasion.	Ellipse measuring 4.6 x 2.3 x 0.7 cm including central raised\nbrown-gray 0.9 x 0.7 x 0.2 cm area.  With margins preinked black,\nthree central representative sections are submitted in cassette A\nand two sections in cassette B, tips returned to container.	8 X 9 X 3 MM VARIEGATED BLUE-BLACK NODULE, PT HAS NOTED THIS HAS BEEN PRESENT SINCE CHILDHOOD, REMOVED WITH 1 CM MARGINS	\N	\N	\N	None	MELANOMA, 2.4 MM. IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173536	237	\N	\N	01-34127	B	CCR-312	California Cancer Registry	IP290530	AirTable blocks_with_IP_info.csv
1035	01-34127A	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1425	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei\nin partial contiguity with the epidermis.  There is suprabasal\nscatter of melanocytes in several foci.  There is little diminishment\nin melanocyte size with descent in the dermis, and dermal melanocytes\ncontain many mitotic figures.  There is marked angiogenesis at the\nbase of the lesion, but no evidence of vascular invasion.	Ellipse measuring 4.6 x 2.3 x 0.7 cm including central raised\nbrown-gray 0.9 x 0.7 x 0.2 cm area.  With margins preinked black,\nthree central representative sections are submitted in cassette A\nand two sections in cassette B, tips returned to container.	8 X 9 X 3 MM VARIEGATED BLUE-BLACK NODULE, PT HAS NOTED THIS HAS BEEN PRESENT SINCE CHILDHOOD, REMOVED WITH 1 CM MARGINS	\N	\N	\N	\N	MELANOMA, 2.4 MM. IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173536	237	\N	\N	01-34127	A	CCR-312	California Cancer Registry	IP290530	AirTable blocks_with_IP_info.csv
1000	00-556A	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1427	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation\nof atypical melanocytes, arranged irregularly within the epidermis,\nflanking a nodular proliferation of similar melanocytes that do not\nmature (diminish in size) with descent into the dermis.  There are\ndense lymphocytic infiltrates, dilated vessels, and fibrosis,\noverlying severe elastosis.	Oriented ellipse measuring 4.5 x 2.5 x 1.0 cm.  With the sutured tip\nto the left, the superior half of the specimen is inked blue and the\ninferior half is inked yellow.  The specimen is serially sectioned\nand submitted with four sections each in blocks A and C, and three\nsections in block B.	EXCISION OF MELANOMA, SUTURE AT PROXIMAL END; CLINICAL DIAGNOSIS - R/O MELANOMA	\N	\N	\N	\N	MELANOMA, 1.4 MM IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173611	238	\N	\N	00-556	A	CCR-313	California Cancer Registry	IP215659	AirTable blocks_with_IP_info.csv
1001	00-556B	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1428	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis.  There are dense lymphocytic infiltrates, dilated vessels, and fibrosis, overlying severe elastosis.	Oriented ellipse measuring 4.5 x 2.5 x 1.0 cm.  With the sutured tip\nto the left, the superior half of the specimen is inked blue and the\ninferior half is inked yellow.  The specimen is serially sectioned\nand submitted with four sections each in blocks A and C, and three\nsections in block B.	EXCISION OF MELANOMA, SUTURE AT PROXIMAL END; CLINICAL DIAGNOSIS - R/O MELANOMA	\N	\N	\N	None	MELANOMA, 1.4 MM IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173611	238	\N	\N	00-556	B	CCR-313	California Cancer Registry	IP215659	AirTable blocks_with_IP_info.csv
2986	97-23367	56	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1430	172.6	\N	\N	Sections show nested and solitary melanocytes, some with atypical nuclei, arrayed irregularly within the epidermis.  In the underlying dermis, there are irregularly-shaped, horizontally-oriented clusters of similar but slightly smaller melanocytes, which are surrounded by fibrosis.  These changes are present above elastosis.  There is pagetoid upward spread.  Large spindled melanocytes are seen at the base of the lesion.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely\nsubmitted.	CLINICAL DIAGNOSIS - R/O MELANOMA, R/O BCC	\N	\N	\N	Melanomas in which small, round cells predominate in the dermal component have been termed nevoid melanoma, or minimal deviation melanoma. Several studies have suggested that there is no prognostic difference between this form and conventional melanoma.	MELANOMA, 1.2 MM IN THICKNESS, EXTENDING TO THE DEEP MARGIN	173601	239	\N	\N	97-23367	\N	CCR-316	California Cancer Registry	IP126136	AirTable blocks_with_IP_info.csv
2510	19Rig750007.03.02.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	271	\N	\N	None	\N	CM-31	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2511	19Rig750007.03.02.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	271	\N	\N	None	\N	CM-31	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2514	19Rig750007.03.03.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	272	\N	\N	None	\N	CM-32	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2512	19Rig750007.03.03.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	272	\N	\N	None	\N	CM-32	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2225	17-112474	67	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.5	\N	\N	None	Block DL17-76060 (S17-8234), received 11-16-17.	ORIGINALLY READ AS DL17-76060; REACCESSIONED FOR CGH TESTING	\N	\N	Scraping	Following microdissection and DNA extraction, we performed comparative genomic hybridization. The hybridization shows gain of chr. 6p, and a loss involving an area on chr. 6q with the ARID1B gene near its breakpoint. Gain of 6p and loss of 6q are commonly found together in melanoma, and the finding of a breakpoint at a gene important in melanomagenesis further supports that diagnosis. The biopsy and re-excision from this lesion correlate for an approximate thickness of 6 mm. A beta-catenin immunostain labels not only the cytoplasm of the lesional melanocytes but also their nuclei. This supports the assessment of a deep penetrating nevic lineage, per a recent study from our group. This lineage includes deep penetrating nevus, indeterminate lesions, and deep penetrating nevus-like melanoma.  In the re-excision, the neoplasm was a fraction of a mm. from the deep margin near the center of the specimen, and a further excision (still deeper, but not necessary wider) seems warranted.  The comparative genomic hybridization data was also reviewed by my colleague, Dr. Boris Bastian who agrees with this interpretation of it.  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la FouchardiËre A. Combined activation of MAP kinase pathway and ﬂ-catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644. doi: 10.1038/s41467-017-00758-3. PubMed PMID: 28935960; PubMed Central PMCID: PMC5608693.	MELANOMA, WITH DEEP PENETRATING NEVUS-LIKE FEATURES, 6  MM. IN THICKNESS	273588	246	\N	\N	17-112474	\N	CGH17-240	Nevus Library	IP1806028	AirTable blocks_with_IP_info.csv
2337	18-95536	47	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.7	DPN-mm	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Seven outside slides, S-18-32980 A1 / HST18-053114 / HST18-055181, and one corresponding block.	18 X 13 MM BLACK PLAQUE; ATYPICAL NEVUS VS. MELANOMA	\N	\N	Scraping	The strong nuclear beta-catenin positivity favors this being in the deep penetrating nevic series, rather than in the classic blue nevic one. The focus of necrosis, and high proliferation rate were features worrisome for a deep penetrating nevus-like melanoma. This diagnosis has been confirmed by molecular studies. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows loss of chr. 10, which is a highly characteristic chromosomal copy number change seen in melanoma, with gains in both chr. 11p and 11q (the gain in chr. 11p is of higher amplitude). The former hints at an h-ras mutation. While h-ras mutated Spitz's nevi have isolated chr. 11p gains, and behave benignly, the presence of additional changes in this case means that its presence does not favor benignity. There is also a loss involving chr. 13q.  My colleague, Dr. Iwei Yeh also viewed the comparative genomic hybridization results, and the sections and agreed with this diagnosis. One of the deep penetrating nevus-like melanomas in our study had an h-ras mutation.  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la FouchardiËre A. Combined activation of MAP kinase pathway and ﬂ-catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644. doi: 10.1038/s41467-017-00758-3. PubMed PMID: 28935960; PubMed Central PMCID:PMC5608693.	MELANOMA, 2.2 MM. IN THICKNESS	173727	247	\N	\N	18-95536	\N	CGH18-137	Deep Penetrating Melanoma	IP1959535	AirTable blocks_with_IP_info.csv
2338	18-95537	28	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.7	\N	\N	The microscopic findings are essentially as described in the accompanying pathology reports and in the note above.	Three outside slides, S-18-33098 A1, and one corresponding block.	ATYPICAL NEVUS VS. LESS LIKELY ATYP SK, R/O PIGMENTED TUMOR	\N	\N	Scraping	This unusual spitzoid neoplasm features strikingly confluent junctional nests and nearly, consumption of the epidermis. Paradoxically, there is a very low proliferation rate in the multiplex stain. Following microdissection and DNA extraction, we performed comparative genomic hybridization. It shows several gains of different amplitudes near the terminal portion of chr. 5p, in a pattern suggestive of a TRIO-TERT fusion. Such fusions are seen in pediatric sarcomas, and in the context of a melanocytic neoplasm point toward melanoma. Another area of amplification is present on 20qter.  My colleague, Dr. Iwei Yeh also viewed the comparative genomic hybridization data and slides, and agress with this interpretation.	MELANOMA, 0.7 MM. IN THICKNESS	173723	248	\N	\N	18-95537	\N	CGH18-139	Nevus Library	IP1959536	AirTable blocks_with_IP_info.csv
2477	19Rig750007.01.01.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	249	\N	\N	None	\N	CM-01	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2478	19Rig750007.01.01.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	249	\N	\N	None	\N	CM-01	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2479	19Rig750007.01.04.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	250	\N	\N	None	\N	CM-04	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2480	19Rig750007.01.05.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	251	\N	\N	None	\N	CM-05	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2481	19Rig750007.01.05.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	251	\N	\N	None	\N	CM-05	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2483	19Rig750007.01.07.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	252	\N	\N	None	\N	CM-07	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2482	19Rig750007.01.07.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	252	\N	\N	None	\N	CM-07	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2484	19Rig750007.01.08.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	253	\N	\N	None	\N	CM-08	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2485	19Rig750007.01.08.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	253	\N	\N	None	\N	CM-08	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2486	19Rig750007.01.10.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	254	\N	\N	None	\N	CM-10	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2487	19Rig750007.01.11.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	255	\N	\N	None	\N	CM-11	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2488	19Rig750007.01.12.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	256	\N	\N	None	\N	CM-12	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2490	19Rig750007.01.13.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	257	\N	\N	None	\N	CM-13	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2553	19Rig750007.05.11.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	257	\N	\N	None	\N	CM-13	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2489	19Rig750007.01.13.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	257	\N	\N	None	\N	CM-13	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2513	19Rig750007.03.03.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	272	\N	\N	None	\N	CM-32	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
1052	02-16797C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	997	\N	\N	None	\N	MD-101	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2679	21-09097A1	48	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32748	216.3	\N	2895628	Sections show nests, cords and strands of small, round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures. These melanocytes mature and disperse with descent.	Two skin segments measuring 0.8 x 0.7 x 0.3 cm in aggregate, both bisected and entirely submitted in A. HD/BY	A) IRRITATED NEVUS. . .. B) IRRITATED NEVUS. . ..	\N	2389	FFPE	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	192356	303	\N	\N	21-9097	A1	CME-001	Cutaneous Melanoma Ethnicities	IP2271470	AirTable blocks_with_IP_info.csv
2693	21-20002A1	66	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32752	216.5	\N	6840768	Sections show a compound proliferation of melanocytes with a flat profile.  Nested and solitary melanocytes are relatively evenly arrayed along the epidermal-dermal junction, and there is slight fibrosis of the papillary dermis.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MMIS. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MMIS. PAPULE.	\N	Skin, foot, lateral, left, biopsy, melanoma	FFPE	This lesion shows some of the microscopic features of a so-called Clark's or dysplastic nevus. A p16 immunostain shows preserved expression, and a PRAME immunostain shows only partial expression in the lesional melanocytes. These are overall reassuring results that support the above interpretation.	COMPOUND MELANOCYTIC NEVUS, EXTENDING TO THE PERIPHERAL BIOPSY MARGIN	528522	304	\N	\N	21-20002	A1	CME-002	Cutaneous Melanoma Ethnicities	IP2282472	AirTable blocks_with_IP_info.csv
2696	21-20368A1	49	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32753	173.41	\N	6840768	There are nests of peripherally palisaded basaloid cells attached to the undersurface of the epidermis, along with a thickened and fibrotic papillary dermis. Angulated nests of similar cells are also present within this stroma.	Skin segment measuring 0.8 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	PEARLY DEPRESSED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA	\N	Skin, foot, left, wide excision, superficial spreading melanoma, Satellite: present, Stage IIIC	FFPE	\N	BASAL CELL CARCINOMA, SUPERFICIAL AND INFILTRATIVE PATTERNS, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	333433	304	\N	\N	21-20368	A1	CME-002	Cutaneous Melanoma Ethnicities	IP1869479	AirTable blocks_with_IP_info.csv
1826	15-08126-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36066	\N	\N	\N	\N	\N	\N	\N	H15-08126 #3 (left back)	FFPE	\N	\N	\N	385	\N	\N	None	\N	CME-083	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1038	02-00594E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	998	\N	\N	None	\N	MD-102	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2697	21-20368A3	49	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32754	173.41	\N	6840768	There are nests of peripherally palisaded basaloid cells attached to the undersurface of the epidermis, along with a thickened and fibrotic papillary dermis. Angulated nests of similar cells are also present within this stroma.	Skin segment measuring 0.8 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	PEARLY DEPRESSED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA	\N	Skin, foot, left, wide excision, superficial spreading melanoma, Satellite: present, Stage IIIC	FFPE	\N	BASAL CELL CARCINOMA, SUPERFICIAL AND INFILTRATIVE PATTERNS, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	333433	304	\N	\N	21-20368	A3	CME-002	Cutaneous Melanoma Ethnicities	IP1869479	AirTable blocks_with_IP_info.csv
2625	20-52125A1	46	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32755	692.9	\N	6799901	Sections show a superficial perivascular infiltrate of lymphocytes and eosinophils, hypergranulosis, psoriasiform epidermal hyperplasia, and a thickened cornified layer.  There is slight spongiosis and considerable papillary dermal fibrosis.	Cylindrical skin segment, 0.3 cm in diameter and 0.2 cm in thickness. Submitted intact. BY/BY	DDX: RASH UNSPECIFIED, NOTES: R/O TRIGEMINAL TROPHIC SYNDROME VS. DLE VS. LSC (PHOTO)	\N	Skin, buttock, left, tumor excision, superficial spreading melanoma	FFPE	There is no evidence of lupus erythematosus in this specimen. Rather, the differential diagnosis for these features includes 1) chronic and lichenified spongiotic dermatitis such as allergic contact dermatitis or nummular dermatitis and 2) inflamed lichen simplex chronicus. Thank you for submitting a clinical photograph which, to my eye, demonstrates features that could be in keeping with either chronic and lichenified spongiotic dermatitis or inflamed lichen simplex chronicus.	EPIDERMAL ACANTHOSIS WITH HYPERGRANULOSIS, DERMAL FIBROSIS AND DERMATITIS WITH A FEW EOSINOPHILS	222322	305	\N	\N	20-52125	A1	CME-003	Cutaneous Melanoma Ethnicities	IP2199853	AirTable blocks_with_IP_info.csv
2794	22-42722B1	72	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32757	216.5	\N	6799901	Sections show a proliferation of spindled and stellate cells, separated in some areas by thickened collagen bundles.  The overlying epidermis is thickened, and also displays a proliferation of basaloid cells that protrude from the undersurface of the epidermis, accompanied by the formation of incompletely formed hair papillae. In addition, in some areas, there are nests, cords and strands of small and cytologically bland round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KB/KB	A) 0.4 IRPM, B) 0.6; R/O DN, C) 0.7; R/O LM	\N	Lung, upper lobe, right, wedge resection, melanoma, metastatic	FFPE	With regard to biopsy (B), this specimen captures both a dermatofibroma and an intradermal melanocytic nevus.	DERMATOFIBROMA WITH INTRADERMAL MELANOCYTIC NEVUS	133559	305	\N	\N	22-42722	B1	CME-003	Cutaneous Melanoma Ethnicities	IP2231041	AirTable blocks_with_IP_info.csv
2627	20-54923B1	53	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32756	216.3	\N	6799901	Sections show a dome surfaced segment of skin with enlarged but normally-formed sebaceous lobules attached to a cystically dilated follicular infundibulum, above which the epidermal surface is slightly depressed.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, submitted intact. KB/HD	R/O NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN, MELANOCYTIC NEVUS, DYSPLASTIC NEVUS OF SKIN, HYPERPIGMENTED PAPULE	\N	Lymph node, inguinal, left, biopsy, melanoma, metastatic (positive/total: 1/1)	FFPE	None	SEBACEOUS HYPERPLASIA	173304	305	\N	\N	20-54923	B1	CME-003	Cutaneous Melanoma Ethnicities	IP2202665	AirTable blocks_with_IP_info.csv
2713	21-30633A1	82	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32763	702.0	\N	3340573	Zones of the surface epidermis are replaced by atypical keratinocytes with superjacent parakeratosis. Adnexal ostia are generally spared. There are bud-like rete.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BB/BB	A) PINK SCALY PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA, B) NEOPLASM OF UNCERTAIN BEHAVIOR LPLK VS. LM	\N	Melanoma, morphologically consistent with superficial spreading type, arising in chronically sun-damaged skin	FFPE	\N	ACTINIC KERATOSIS	173305	307	\N	\N	21-30633	A1	CME-005	Cutaneous Melanoma Ethnicities	IP1814167	AirTable blocks_with_IP_info.csv
2624	20-50565B1	59	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32760	216.7	\N	6668726	There are superimposed changes resembling prurigo nodularis. A small portion of subjacent dermis in which small spindled and stellate cells are positioned between thickened collagen bundles. At the bases of some rete ridges are nubbins of palisaded basaloid cells and collections of fibroblasts, simulating embryonic follicular germs and papillae.	Two outside slides, PU20-000278 (A1).	R/O LSC	\N	Skin, scalp, frontal, left, biopsy, no evidence of malignancy	FFPE	There are superimposed changes resembling prurigo nodularis. There are nubbins of peripherally palisaded basaloid cells attached to the undersurface of the epidermis above the lesion, representing follicular induction (follicular germs and papillae), simulating basal cell carcinoma.	SURFACE OF A DERMATOFIBROMA	173788	306	\N	\N	20-50565	B1	CME-004	Cutaneous Melanoma Ethnicities	IP2198283	AirTable blocks_with_IP_info.csv
2629	20-56832A1	34	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32761	210.4	\N	6668726	There is a lobulated fibrous proliferation associated with the formation of mineralized tissues surfaced by hyperplastic and inflamed squamous epithelium that is ulcerated.  The fibroblastic component is cellular especially around areas of mineralization that consists of bone, cementum-like material and dystrophic calcifications.  The bone is both woven and trabecular type with some trabeculae of unmineralized osteoid.  Dystrophic calcifications are characterized by variably sized globules of basophilic mineralized material.  A few multinucleated giant cells  are identified in association with the mineralized product. The overlying epithelium is ulcerated.	Excision measuring 0.8 x 0.5 x 0.2 cm, bisected and entirely submitted. BB/BB	FIBROTIC OVERGROWN LESION NOTED BY PT, ~5 MONTHS AGO, PT OTHERWISE ASYMPTOMATIC; PYOGENIC GRANULOMA	\N	Lymph node, peri-parotid, left, dissection, melanoma, metastatic (1/3)	FFPE	There is no evidence of malignancy.  Peripheral ossifying fibroma is an inflammatory hyperplasia thought to be derived from pluripotent cells of the periodontal ligament. Excision is typically curative although recurrences are recognized.	PERIPHERAL OSSIFYING FIBROMA, ULCERATED	100003	306	\N	\N	20-56832	A1	CME-004	Cutaneous Melanoma Ethnicities	IP2204580	AirTable blocks_with_IP_info.csv
2716	21-37814A1	71	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32762	216.7	\N	6668726	Sections show an array of nested and solitary melanocytes with relatively small nuclei positioned along the sides and bases of elongated rete subjacent to a compact cornified layer that contains melanin. The superficial dermis contains similar cells in small clusters, and also displays an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted. BB/BB	0.5 CM IRREGULAR BROWN MACULE (PERSONAL HISTORY MELANOMA ELSEWHERE IN PAST)	\N	Salivary gland, parotid, right, parotidectomy, melanoma, metastatic 	FFPE	The lesion was broad and the melanocytes showed nuclear enlargement, so I performed immunostains as a precaution. SOX-10 highlights discontinuous junctional melanocytes without significant pagetoid scatter along with a rare cluster of dermal melanocytes. PRAME highlights a rare subset of the junctional melanocytes, but is mostly negative. These are together reassuring results that support the above diagnosis.  The nevus is excised in planes of section examined.	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	187724	306	\N	\N	21-37814	A1	CME-004	Cutaneous Melanoma Ethnicities	IP1826289	AirTable blocks_with_IP_info.csv
2420	19-25808	67	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32758	173.31	\N	6668726	Sections show aggregates of peripherally palisaded basaloid keratinocytes attached to the undersurface of the epidermis and a patchy lymphocytic infiltrate.	Rectangular excision measuring 0.7 x 0.5 x 0.3 cm. With the margins inked, the specimen is trisected perpendicular to the long axis and entirely submitted with one section each in A-C. The poles are submitted in A and C. PL/PL	R/O BCC, NO PREV BX, CHECK MARGINS	\N	Skin, scalp, temporal, right, excision, nodular melanoma (see comment)	FFPE	None	BASAL CELL CARCINOMA, SUPERFICIAL PATTERN, EXTENDING TO THE TISSUE EDGES	212322	306	\N	\N	19-25808	\N	CME-004	Cutaneous Melanoma Ethnicities	IP1669040	AirTable blocks_with_IP_info.csv
2623	20-50565A1	59	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32759	216.7	\N	6668726	There are superimposed changes resembling prurigo nodularis. A small portion of subjacent dermis in which small spindled and stellate cells are positioned between thickened collagen bundles. At the bases of some rete ridges are nubbins of palisaded basaloid cells and collections of fibroblasts, simulating embryonic follicular germs and papillae.	Two outside slides, PU20-000278 (A1).	R/O LSC	\N	 Microscopically, section A1 shows a nodule of pigmented ovoid to epithelioid melanocytes with hyperchromatic nuclei in the subcutis. It is consistent with a recurrent or in transit metastatic melanoma. Please correlate with clinical findings.	FFPE	There are superimposed changes resembling prurigo nodularis. There are nubbins of peripherally palisaded basaloid cells attached to the undersurface of the epidermis above the lesion, representing follicular induction (follicular germs and papillae), simulating basal cell carcinoma.	SURFACE OF A DERMATOFIBROMA	173788	306	\N	\N	20-50565	A1	CME-004	Cutaneous Melanoma Ethnicities	IP2198283	AirTable blocks_with_IP_info.csv
2781	22-21012A3	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32767	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (＞3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A3	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
2043	17-11446-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36091	\N	\N	\N	\N	\N	\N	\N	H17-11446 (left popliteal) #5	FFPE	\N	\N	\N	407	\N	\N	None	\N	CME-105	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2783	22-21012A5	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32769	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (＞3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A5	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
1749	14-31325	69	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32773	238.2	\N	5926196	Sections show a proliferation of atypical cells in within the follicular epithelium.  Some of the atypical cells have pallid cytoplasm with scattered mitoses. The epidermis is ulcerated.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.1 cm in thickness. Submitted intact. PL/PL	R/O SCC	\N	Skin, flank, left, biopsy, melanoma	FFPE	The epidermis is nearly entirely ulcerated. There are markedly atypical cells with pagetoid cytomorphology in the follicular epithelium that are concerning for adnexal extension of squamous cell carcinoma in situ. A SOX-10 immunoperoxidase stain did not show evidence of melanoma in situ. Additional biopsy of the periphery of the lesion is recommended. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation.	ULCERATED ATYPICAL KERATINOCYTIC PROLIFERATION, WORRISOME FOR ULCERATED SQUAMOUS CELL CARCINOMA IN SITU	100222	311	\N	\N	14-31325	\N	CME-009	Cutaneous Melanoma Ethnicities	IP787867	AirTable blocks_with_IP_info.csv
1828	15-08727-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36067	\N	\N	\N	\N	\N	\N	\N	H15-08727 #2 (right flank)	FFPE	\N	\N	\N	386	\N	\N	None	\N	CME-084	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1134	04-20471E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1000	\N	\N	None	\N	MD-105	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2780	22-21012A2	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32766	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (＞3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A2	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
2714	21-32669B1	43	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32764	216.5	\N	3340573	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels. A perifollicular lymphohistiocytic infiltrate is also noted.	Cylindrical skin segment, 0.7 cm in diameter and 0.4 cm in thickness, trisected and entirely submitted. BB/BB	RECENTLY ENLARGED & INCONSISTENTLY PIGMENTED MACULE; R/O DMN	\N	Lymph node, pre-auricular, right, lymphadenectomy, melanoma, metastatic (1/1)	FFPE	There is no evidence of melanocytic dysplasia.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	131544	307	\N	\N	21-32669	B1	CME-005	Cutaneous Melanoma Ethnicities	IP1021720	AirTable blocks_with_IP_info.csv
1855	15-36291	90	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32777	173.72	\N	5908581	Sections show a fragmented papillated to crateriform proliferation of atypical keratinocytes with central and overlying ortho- and parakeratosis. Keratinocytes with atypical nuclei are scattered throughout the proliferation.	One skin segment and multiple tissue fragments received in one specimen bottle. Skin segment measuring 1.1 x 1.0 x 0.2 cm, quadrisected. Multiple tissue fragments measuring 1.3 x 0.8 x 0.3 cm in aggregate. All entirely submitted in A. CF/CF	A) SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS VS. ACTINIC KERATOSIS VS. KERATOACANTHOMA. PINK HYPERKERATOTIC PAPULES. PRE OP SIZE: 1.2CM. FRAGMENTED. B) SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS VS. ACTINIC KERATOSIS VS. KERATOACANTHOMA. PINK HYPERKERATOTIC PAPULES. PRE OP SIZE: 0.8CM. C) SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS VS. ACTINIC KERATOSIS VS. KERATOACANTHOMA. PINK HYPERKERATOTIC PAPULES. PRE OP SIZE: 1.0CM. FRAGMENTED. D) SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS VS. ACTINIC KERATOSIS VS. KERATOACANTHOMA. PINK HYPERKERATOTIC PAPULES. PRE OP SIZE: 0.7CM.	\N	Skin, posterior thigh, right, status post-biopsy, wide excision, melanoma in situ, residual	FFPE	None	CRATERIFORM SQUAMOUS CELL CARCINOMA, CURETTAGE FRAGMENTS	173720	315	\N	\N	15-36291	\N	CME-013	Cutaneous Melanoma Ethnicities	IP1176627	AirTable blocks_with_IP_info.csv
2681	21-09119-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36046,36047,36048,36110	\N	\N	\N	\N	\N	\N	\N	H21-09119 #4 (satellite lesion)	FFPE	\N	\N	\N	371	\N	\N	None	\N	CME-069	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2779	22-21012A1	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32765	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (＞3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A1	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
2782	22-21012A4	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32768	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (＞3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A4	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
1702	13-32637	74	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32770	173.62	\N	4611431	Sections show ulceration attributable to recent curettage. There is no evidence of residual carcinoma. There are fibroplasia and a lymphohistiocytic infiltrate below the iatrogenic ulcer. Focally, the flanking epidermis is replaced by atypical keratinocytes.	Ellipse, 5.0 x 1.2 x 0.5 cm, with a central 1.3 x 0.9 cm depression. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections each in C1-C2, and five sections in C3. Tips reserved. RS/RS	A-B) LONG-STANDING RASH; NEOPLASM OF UNCERTAIN BEHAVIOR, C) ERYTHEMATOUS TENDER NODULE WITH HYPERKERATOTIC SCALE; SQUAMOUS CELL CARCINOMA, PLEASE CHECK MARGINS	\N	Skin, chest, right, biopsy, consistent with superficial spreading malignant melanoma	FFPE	Incidental solar keratosis is included in this reexcision specimen.	ULCERATION, WITH NO EVIDENCE OF RESIDUAL SQUAMOUS CELL CARCINOMA	113601	308	\N	\N	13-32637	\N	CME-006	Cutaneous Melanoma Ethnicities	IP818391	AirTable blocks_with_IP_info.csv
1704	13-33924	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32771	\N	\N	2875342	\N	\N	\N	\N	Skin, scalp, frontal, right, incision, malignant melanoma	FFPE	\N	\N	\N	309	\N	\N	13-33924	\N	CME-007	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1930	16-32627A1	76	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32774	232.7	\N	6205395	Sections show an area of post-surgical fibrosing granulation tissue with an associated lymphohistiocytic infiltrate, with no evidence of residual intraepidermal carcinoma.	Ellipse, 1.8 x 1.0 x 0.3 cm, including a central 0.8 x 0.7 cm area of variegated color. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with eight sections in A. RS/RS	A-B) PINK MACULE; SQUAMOUS CELL CARCINOMA IN SITU, EXCISION BASAL CELL CARCINOMA, ADJACENT LENTIGINES	\N	Skin, scalp, right, bottle 1, wide excision, malignant melanoma with vertical growth phase	FFPE	\N	POST-SURGICAL CHANGES, WITH NO EVIDENCE OF RESIDUAL BOWEN'S DISEASE	173710	312	\N	\N	16-32627	A1	CME-010	Cutaneous Melanoma Ethnicities	IP108396	AirTable blocks_with_IP_info.csv
1833	15-13150A1	40	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32775	228.1	\N	3469335	Sections show a well-circumscribed proliferation composed of dilated vascular spaces with monomorphous cuboidal and polygonal cells with small, round to oval nuclei, forming ribbons surrounding thin-walled vessels.	Ellipse measuring 0.7 x 0.5 x 0.6 cm. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . PLEASE CHECK MARGINS..	\N	Skin, thigh, inner, left, wide excision, superficial spreading melanoma	FFPE	The proliferation extends to the margins. There are no particularly concerning findings that would compel a reexcision.	GLOMANGIOMA (GLOMUVENOUS MALFORMATION)	523659	313	\N	\N	15-13150	A1	CME-011	Cutaneous Melanoma Ethnicities	IP628748	AirTable blocks_with_IP_info.csv
1856	15-36675	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32776	\N	\N	4377899	\N	\N	\N	\N	Skin, thigh, lateral, left, wide excision, superficial spreading melanoma	FFPE	\N	\N	\N	314	\N	\N	15-36675	\N	CME-012	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1865	15-49595A1	39	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32778	215.9	\N	6294524	A nodule of dense fibrous tissue is surfaced by stratified squamous epithelium.	Tissue segment measuring 0.8 x 0.4 x 0.3 cm, bisected, and entirely submitted. HD/HD	SESSILE SOFT TISSUE MASS, MEAS 5 MM X 3 MM, NT, NONULCERATIVE; CONSISTENT WITH FIBROMA (TRAUMATIC)	\N	Skin, upper arm, right, status post excision, wide excision, malignant melanoma, residual	FFPE	There is no evidence of dysplasia or malignancy. The changes are consistent with chronic trauma.	FOCAL FIBROUS HYPERPLASIA (IRRITATION FIBROMA)	101037	316	\N	\N	15-49595	A1	CME-014	Cutaneous Melanoma Ethnicities	IP1520923	AirTable blocks_with_IP_info.csv
1944	16-53749A2	55	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32781	698.3	\N	\N	There is a dome shaped segment of skin with psoriasiform epidermal hyperplasia, a thick granular layer and compact hyperkeratosis.  The papillary dermis is fibrotic.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, submitted intact with one fragment. RS/RS	PINK KERATOTIC PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. SEBACEOUS ADENOMA VS. ACTINIC KERATOSIS	\N	\N	FFPE	There are a few sebaceous lobules but no evidence of a bona fide sebaceous adenoma.  No carcinoma is present either.	PRURIGO NODULARIS	173305	317	\N	\N	16-53749	A2	CME-015	Cutaneous Melanoma Ethnicities	IP1653163	AirTable blocks_with_IP_info.csv
1943	16-53749A1	55	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32780	698.3	\N	5483587	There is a dome shaped segment of skin with psoriasiform epidermal hyperplasia, a thick granular layer and compact hyperkeratosis.  The papillary dermis is fibrotic.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, submitted intact with one fragment. RS/RS	PINK KERATOTIC PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. SEBACEOUS ADENOMA VS. ACTINIC KERATOSIS	\N	Skin, pubic, excision, melanoma, superficial spreading	FFPE	There are a few sebaceous lobules but no evidence of a bona fide sebaceous adenoma.  No carcinoma is present either.	PRURIGO NODULARIS	173305	317	\N	\N	16-53749	A1	CME-015	Cutaneous Melanoma Ethnicities	IP1653163	AirTable blocks_with_IP_info.csv
2112	17-37055	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32782	\N	\N	4457955	\N	\N	\N	\N	Skin, shin, right, wide excision, melanoma, arising from nevus	FFPE	\N	\N	\N	318	\N	\N	17-37055	\N	CME-016	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2128	17-55712A1	79	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32783	526.4	\N	5762876	Cyst is formed by inflamed fibrous tissue and lined by stratified squamous non-keratinized epithelium.   Some bacteria are also present.	Multiple soft tissue segment and tooth fragments received in biopsy bottle. Soft tissue segments measuring 1.4 x 0.7 x 0.5 cm in aggregate, sectioned and entirely submitted. Tooth fragments measuring 0.8 x 0.7 x 0.4 cm in aggregate, reserved. PL/PL	#19 VERTICAL FRACTURE OF MESIAL ROOT SURROUNDED BY SOFT TISSUE	\N	Skin, back, right side, biopsy, malignant melanoma, superficial spreading type	FFPE	There is no evidence of malignancy in the sections. The specimen could represent either periodontal disease or a radicular cyst depending on the periodontal findings and whether tooth #19 was vital or nonvital.  Radiographic and clinical correlation is recommended	INFLAMED GRANULATION TISSUE FAVOR RADICULAR (PERIAPICAL) CYST	100065	319	\N	\N	17-55712	A1	CME-017	Cutaneous Melanoma Ethnicities	IP1268632	AirTable blocks_with_IP_info.csv
2865	23-01329-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36061	\N	\N	\N	\N	\N	\N	\N	H23-01329 (lower right leg) #1	FFPE	\N	\N	\N	380	\N	\N	None	\N	CME-078	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2129	17-55712A2	79	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32784	526.4	\N	\N	Cyst is formed by inflamed fibrous tissue and lined by stratified squamous non-keratinized epithelium.   Some bacteria are also present.	Multiple soft tissue segment and tooth fragments received in biopsy bottle. Soft tissue segments measuring 1.4 x 0.7 x 0.5 cm in aggregate, sectioned and entirely submitted. Tooth fragments measuring 0.8 x 0.7 x 0.4 cm in aggregate, reserved. PL/PL	#19 VERTICAL FRACTURE OF MESIAL ROOT SURROUNDED BY SOFT TISSUE	\N	\N	FFPE	There is no evidence of malignancy in the sections. The specimen could represent either periodontal disease or a radicular cyst depending on the periodontal findings and whether tooth #19 was vital or nonvital.  Radiographic and clinical correlation is recommended	INFLAMED GRANULATION TISSUE FAVOR RADICULAR (PERIAPICAL) CYST	100065	319	\N	\N	17-55712	A2	CME-017	Cutaneous Melanoma Ethnicities	IP1268632	AirTable blocks_with_IP_info.csv
2271	18-05067	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32785	\N	\N	6535383	\N	\N	\N	\N	Skin, thigh, right, biopsy, melanoma (see descriptions)	FFPE	\N	\N	\N	320	\N	\N	18-5067	\N	CME-018	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2415	19-17484	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32786	\N	\N	2244268	\N	\N	\N	\N	Skin, temporal, left, biopsy, melanoma	FFPE	\N	\N	\N	321	\N	\N	19-17484	\N	CME-019	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2426	19-33672A1	34	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32787	238.2	\N	6685202	Sections show a compound proliferation of melanocytes arrayed at the junction in lentiginous fashion and in nests, singly above the junction, and in maturing fashion in the perijunctional or upper dermis as nests, cords, and small syncytia. Focal adnexal extension and slight perijunctional fibrosis are noted. There is parakeratosis in orthohyperkeratosis in a muted epidermis.	Three outside slides, S19-010230 3A and one block.	NUB, R/O DN	\N	Skin, back, right, wide excision, superficial spreading melanoma	FFPE	This biopsy demonstrates mixed features of a congenital melanocytic nevus and a 'melanocytic nevus of special site', and an atypical intraepidermal distribution -- with slight scatter above the junction -- is noted and may have been triggered by irritation. Immunostaining for p16 was completed here in San Francisco and demonstrates retained positivity, and this finding lends additional support to the diagnosis of melanocytic nevus. As the edge of the biopsy is involved, either timely clinical follow-up of the biopsy site (to observe for persistence) or narrow additional removal (to mitigate persistence) can be considered as a management strategy.	COMPOUND MELANOCYTIC NEVUS, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173508	322	\N	\N	19-33672	A1	CME-020	Cutaneous Melanoma Ethnicities	IP2037885	AirTable blocks_with_IP_info.csv
2445	19-44938	82	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32788	172.5	\N	5910996	Sections show an intraepidermal proliferation of melanocytes in which single melanocytes predominate, with neoplastic cells in irregular and near-continuous array along the epidermal-dermal junction.	One outside slide, BD19-01269, and one corresponding block.	22 X 15 MM TAN BROWN PATCH OF UNCERTAIN DURATION; R/O LENTIGO MALIGNA (PHOTOS)	\N	Skin, foot, dorsal, right, wide excision, superficial spreading melanoma, with spitzoid features	FFPE	None	MELANOMA IN SITU, EXTENDING TO THE TISSUE EDGES	173525	323	\N	\N	19-44938	\N	CME-021	Cutaneous Melanoma Ethnicities	IP2049220	AirTable blocks_with_IP_info.csv
2576	20-7562\t	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32789	\N	\N	6739663	\N	\N	\N	\N	Skin, nipple, right, wide excision, superficial spreading melanoma	FFPE	\N	\N	\N	324	\N	\N	20-7562	\N	CME-022	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2684	21-09543-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36049,36050	\N	\N	\N	\N	\N	\N	\N	H21-09543 #2 (metastasis in right neck)	FFPE	\N	\N	\N	372	\N	\N	None	\N	CME-070	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2683	21-09543-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36049,36050	\N	\N	\N	\N	\N	\N	\N	H21-09543 #1 (right thigh)	FFPE	\N	\N	\N	372	\N	\N	None	\N	CME-070	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3525	MB1429	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1524	\N	\N	None	\N	SYNAT421	2010-2017	\N	AirTable blocks_with_IP_info.csv
2587	20-13577A1	76	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32790	216.3	\N	1951217	Sections show enlarged but normally-formed sebaceous lobules in the vicinity of a follicular infundibulum. Inflammation and erosion are noted.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) 0.4 CM PINK-YELLOW FIRM PAPULE; BCC VS. SCC VS. SEBACEOUS CA VS. SEBACEOUS HYPERPLASIA, B) 1.2 CM PINK SCALY THIN PLAQUE; BCC VS. SCC VS. AK, C) 1.2 CM PINK SCALY THIN PLAQUE; BCC VS. SCC VS. AK, D) 0.8 CM PINK-BROWN PATCH	\N	Skin, scalp, site not specified, biopsy, nodular melanoma	FFPE	\N	SEBACEOUS GLAND HYPERPLASIA	562311	325	\N	\N	20-13577	A1	CME-023	Cutaneous Melanoma Ethnicities	IP1191988	AirTable blocks_with_IP_info.csv
2628	20-56532	84	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32791	173.61	\N	6805784	Sections show fibrosing granulation tissue, stemming from recent surgery/biopsy, with a contiguous residual proliferation composed of nodular clusters of atypical basaloid cells and there inflamed fibromyxoid stroma.	Oriented ellipse measuring 3.0 x 0.9 x 0.2 cm, including a central 0.5 x 0.3 cm pearly area. The orienting long suture located at the mid-point of one edge is indicated 12:00 on the requisition is placed toward 12 o'clock, and the short suture indicated 3:00 on the requisition is placed toward 3 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with six sections in A and five in B. KB/CF	EXCISION OF BCC WITH 3 MM MARGINS, DT20-26498	\N	Skin, umbilicus, tumor biopsy, superficial spreading melanoma	FFPE	The involved margin is in the 12-3 o'clock quadrant of the specimen.	RESIDUAL NODULAR BASAL CELL CARCINOMA, FOCALLY ABUTTING THE INKED PERIPHERAL MARGIN	113604	326	\N	\N	20-56532	\N	CME-024	Cutaneous Melanoma Ethnicities	IP2174045	AirTable blocks_with_IP_info.csv
2695	21-20367A1	37	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32792	173.21	\N	6169532	There are angulated nests of basaloid cells in fibrotic stroma within the dermis, focally separated from that stroma by clefts.	Skin segment measuring 0.3 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	CRUSTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ACTINIC KERATOSIS VS. R/O NMSC	\N	Skin, forearm, left, wide excision, superficial spreading melanoma	FFPE	\N	BASAL CELL CARCINOMA, INFILTRATIVE PATTERN, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	102270	327	\N	\N	21-20367	A1	CME-025	Cutaneous Melanoma Ethnicities	IP2282840	AirTable blocks_with_IP_info.csv
2690	21-15959	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32793	\N	\N	5839734	\N	\N	\N	\N	Skin, thigh, lateral, right, tumor biopsy, melanoma in situ, at least (see description)	FFPE	\N	\N	\N	328	\N	\N	21-15959	\N	CME-026	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2692	21-17351	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32794	\N	\N	4085044	\N	\N	\N	\N	Skin, forearm, left, incisional biopsy, superficial spreading melanoma	FFPE	\N	\N	\N	329	\N	\N	21-17351	\N	CME-027	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1821	15-05771-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36062	\N	\N	\N	\N	\N	\N	\N	H15-05771 #4 (upper left arm)	FFPE	\N	\N	\N	381	\N	\N	None	\N	CME-079	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1162	05-14728C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1001	\N	\N	None	\N	MD-106	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2600	20-24373A1	30	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32795	706.2	\N	6478917	Sections show skin with a deep dermal cyst lined by keratinocytes that mature via a granular layer, forming orthokeratotic material centrally.	Cylindrical skin segment, 0.5 cm in diameter and 1.4 cm in thickness, bisected and entirely submitted. CF/CF	1 CM, ILL DEFINED SUBCUTANEOUS NODULE	\N	Skin,thigh,left lateral,excision,nodular melanoma 	FFPE	\N	INFUNDIBULAR FOLLICULAR CYST	173509	330	\N	\N	20-24373	A1	CME-028	Cutaneous Melanoma Ethnicities	IP2171911	AirTable blocks_with_IP_info.csv
1934	16-37564A1	82	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32796	54.9	\N	2086921	Sections show dermal infiltrates of lymphocytes and intraepidermal vesiculation bordered by necrotic keratinocytes. Some keratinocytes have margination of chromatin and moulded, multiple nuclei.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. HD/HD	INFLAMED, PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. HERPETIC ERUPTION, RECURRENT	\N	Skin, scalp, frontal, right, wide excision, melanoma in situ	FFPE	The viral cytopathic changes in this tissue could stem from infection by either herpes simplex or varicella zoster virus.  We have immunostains that can distinguish between the two.  Please inform me if you would like me to pursue this staining.	HERPETIC VESICULAR DERMATITIS	173508	331	\N	\N	16-37564	A1	CME-029	Cutaneous Melanoma Ethnicities	IP1636840	AirTable blocks_with_IP_info.csv
2300	18-31426A	41	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32797	202.1	\N	6583945	Sections show a dense bandlike infiltrate of (mostly small) lymphocytes in a thickened papillary dermis beneath a psoriasiform epidermis. Lymphocytes, some of which have slightly enlarged and convoluted nuclei, are present in a discrete collection within the epidermis.	Cylindrical skin segment, 0.4 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted in A. CF/CF	PREVIOUSLY BX'D WITH DX'D OF T-CELL LYMPHOPROLIFERATIVE DX, RE-BX TODAY, A) ERYTHEMATOUS PATCHES, B) FLAT ERYTHEMATOUS PATCHES, C) PREVIOUSLY BX'D AREA WITH ERYTHEMATOUS PLAQUE	\N	Skin, scalp, frontal, left, main lesion, biopsy, melanoma 	FFPE	\N	MYCOSIS FUNGOIDES, LATE PATCH STAGE LESION	173505	332	\N	\N	18-31426	A	CME-030	Cutaneous Melanoma Ethnicities	IP1876253	AirTable blocks_with_IP_info.csv
2698	21-21081	83	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32798	173.32	\N	3631303	Sections show a proliferation of keratinocytes with atypical nuclei and abundant eosinophilic cytoplasm that thickens the epidermis and forms lobules in part attached to the undersurface of the epidermis and within the dermis. Mitotic figures are easily identifiable within the proliferation. In the surrounding dermis, there is marked solar elastosis. The epidermis is ulcerated.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. KB/KB	? BCC	\N	Skin, forehead, left, biopsy, lentigo maligna melanoma	FFPE	None	SQUAMOUS CELL CARCINOMA, EXTENDING TO THE BASE OF THE SPECIMEN	173304	333	\N	\N	21-21081	\N	CME-031	Cutaneous Melanoma Ethnicities	IP613067	AirTable blocks_with_IP_info.csv
2791	22-34951	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32799	\N	\N	3902497	\N	\N	\N	\N	Skin, buttock, right, biopsy, superficial spreading melanoma	FFPE	\N	\N	\N	334	\N	\N	22-34951	\N	CME-032	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2013	17-00731-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36086	\N	\N	\N	\N	\N	\N	\N	H17-00731 #3 (right thigh)	FFPE	\N	\N	\N	403	\N	\N	None	\N	CME-101	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2023	17-03472-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36087,36112	\N	\N	\N	\N	\N	\N	\N	H17-03472 #1 (left anterior chest, in situ)	FFPE	\N	\N	\N	404	\N	\N	None	\N	CME-102	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2784	22-21031A1	71	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32800	216.7	\N	6336181	Sections show a compound proliferation of melanocytes. Within the epidermis, there are melanocytes configured as nests and single cells. Many of the superficial melanocytes contain abundant pigment within their cytoplasm. There are a few melanocytes above the basal layer of the epidermis. Within the dermis, there are spindled and epithelioid melanocytes positioned between thickened collagen bundles in the dermis. There are a few melanocytes above the basal layer of the epidermis.	One outside slide, 2FMC-22-01318, and one corresponding block.	RULE OUT DN, CHECK MARGINS	\N	Skin, chest left, wide excision, mixed superficial spreading and desmoplastic melanoma	FFPE	Dr. Careccia, thank you for sending this case in consultation. I agree with your analysis that these microscopic features represent a compound melanocytes nevus with desmplastic features. There are a few melanocytes above the basal layer of the epidermis, and these are likely due to trauma given that this biopsy was taken from the knee, which is a common site of trauma.	COMPOUND MELANOCYTIC NEVUS WITH DESMOPLASTIC FEATURES	121790	335	\N	\N	22-21031	A1	CME-033	Cutaneous Melanoma Ethnicities	IP2422603	AirTable blocks_with_IP_info.csv
2787	22-25709C1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32801	\N	\N	5489820	\N	\N	\N	\N	Skin, labia majora, tumor biopsy, melanoma	FFPE	\N	\N	\N	336	\N	\N	22-25709	C1	CME-034	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2893	23-09618	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32802	\N	\N	3396383	\N	\N	\N	\N	Skin, back, right side, excision, superficial spreading melanoma	FFPE	\N	\N	\N	337	\N	\N	23-9618	\N	CME-035	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2866	23-02692-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/35999	\N	\N	\N	\N	\N	\N	\N	H23-02692 #3 (lower right leg)	FFPE	\N	\N	\N	338	\N	\N	None	\N	CME-036	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2872	23-03529-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36000	\N	\N	\N	\N	\N	\N	\N	H23-03529 #3 (left cheek, in situ)	FFPE	\N	\N	\N	339	\N	\N	None	\N	CME-037	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2877	23-04707-7	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36001	\N	\N	\N	\N	\N	\N	\N	H23-04707 #7 (lower right leg)	FFPE	\N	\N	\N	340	\N	\N	None	\N	CME-038	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2880	23-05091-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36002	\N	\N	\N	\N	\N	\N	\N	H23-05091 #4 (right cheek)	FFPE	\N	\N	\N	341	\N	\N	None	\N	CME-039	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2876	23-04628-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36003	\N	\N	\N	\N	\N	\N	\N	H23-04628 #5 (left cheek)	FFPE	\N	\N	\N	342	\N	\N	None	\N	CME-040	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2883	23-05782-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36004	\N	\N	\N	\N	\N	\N	\N	H23-05782 #2 (nose, in situ)	FFPE	\N	\N	\N	343	\N	\N	None	\N	CME-041	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2884	23-06001-12	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36005	\N	\N	\N	\N	\N	\N	\N	H23-06001 #12 (upper right thigh)	FFPE	\N	\N	\N	344	\N	\N	None	\N	CME-042	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2888	23-07186-13	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36006	\N	\N	\N	\N	\N	\N	\N	H23-07186 #13 (lower left leg)	FFPE	\N	\N	\N	345	\N	\N	None	\N	CME-043	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1822	15-06395-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36063	\N	\N	\N	\N	\N	\N	\N	H15-06395 #3 (back)	FFPE	\N	\N	\N	382	\N	\N	None	\N	CME-080	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1217	06-12646D M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1002	\N	\N	None	\N	MD-107	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2269	18-00447N1	79	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36007,36008,36106	238.2	\N	\N	Sections show central post-procedural fibrosing inflammatory alterations, and no contiguous residual tumor remains in association with this. A cap of inflamed parakeratosis and exudate is above all this.	Ellipse, 2.3 x 1.1 x 0.7 cm, including a central 1.0 x 0.6 cm crusted area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with seven sections. Tips reserved. KC/KC	IRREGULAR BROWN PAPULE AND 4 X 4; ATYPICAL NEVUS, PLEASE CHECK MARGINS	\N	H18-00447 N1 (right axilla)	FFPE	None	POST-BIOPSY SCARRING, WITH NO RESIDUUM	115516	346	\N	\N	18-447	N1	CME-044	Cutaneous Melanoma Ethnicities	IP1430577	AirTable blocks_with_IP_info.csv
2268	18-00447-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36007,36008,36106	\N	\N	\N	\N	\N	\N	\N	H18-00447 #2 (upper right chest)	FFPE	\N	\N	\N	346	\N	\N	None	\N	CME-044	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2270	18-02303-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36009	\N	\N	\N	\N	\N	\N	\N	H18-02303 #1 (left shoulder, in situ)	FFPE	\N	\N	\N	347	\N	\N	None	\N	CME-045	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2272	18-08429-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36010	\N	\N	\N	\N	\N	\N	\N	H18-08429 #4 (right cheek)	FFPE	\N	\N	\N	348	\N	\N	None	\N	CME-046	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2274	18-09671N1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36011,36012,36013,36107	\N	\N	\N	\N	\N	\N	\N	H18-09671 N1 (right inguinal sentinel)	FFPE	\N	\N	\N	349	\N	\N	18-9671	N1	CME-047	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2273	18-09671-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36011,36012,36013,36107	\N	\N	\N	\N	\N	\N	\N	H18-09671 #4 (waist)	FFPE	\N	\N	\N	349	\N	\N	None	\N	CME-047	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2564	20-00782N3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36011,36012,36013,36107	\N	\N	\N	\N	\N	\N	\N	H20-00782 N3 (inguinal lymphadenectomy 2 years later)	FFPE	\N	\N	\N	349	\N	\N	20-782	N3	CME-047	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2387	19-03736	57	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36014,36015,36016,36108	173.31	\N	\N	Sections show nodular aggregations of atypical and peripherally palisaded basaloid cells. There is solar elastosis.	Skin segment measuring 0.3 x 0.2 x 0.1 cm, submitted intact. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. HAK. CRUSTED PAPULE.	\N	H19-03736 (back, metastasis)	FFPE	None	BASAL CELL CARCINOMA, NODULAR PATTERN, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	193355	350	\N	\N	19-3736	\N	CME-048	Cutaneous Melanoma Ethnicities	IP2007776	AirTable blocks_with_IP_info.csv
2033	17-09063-N1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36088,36089	\N	\N	\N	\N	\N	\N	\N	H17-09063 N1 (axillary sentinel lymph node)	FFPE	\N	\N	\N	405	\N	\N	None	\N	CME-103	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2032	17-09063-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36088,36089	\N	\N	\N	\N	\N	\N	\N	H17-09063 #1 (right forearm)	FFPE	\N	\N	\N	405	\N	\N	None	\N	CME-103	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2379	19-01043N2	26	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36014,36015,36016,36108	173.31	\N	\N	Sections show nodular aggregations of atypical and peripherally palisaded basaloid cells. Necrosis en masse is present. Clefts between the epithelium and stroma of the neoplasm are present. The adjacent dermis shows solar elastosis.	Skin segment measuring 1.1 x 1.0 x 0.2 cm, with the base inked, quadrisected and entirely submitted. CF/CF	9 X 7 MM WAXY PL WITH TELANGIECTATIC; R/O BCC	\N	H19-01043 N2(left axillary sentinel lymph node)	FFPE	None	BASAL CELL CARCINOMA, NODULAR PATTERN, EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	173305	350	\N	\N	19-1043	N2	CME-048	Cutaneous Melanoma Ethnicities	IP2005069	AirTable blocks_with_IP_info.csv
2378	19-01043-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36014,36015,36016,36108	\N	\N	\N	\N	\N	\N	\N	H19-01043 #1 (left back)	FFPE	\N	\N	\N	350	\N	\N	None	\N	CME-048	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2384	19-03114-6	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36096,36097	\N	\N	\N	\N	\N	\N	\N	H19-03114 #6 (head)	FFPE	\N	\N	\N	351	\N	\N	None	\N	CME-049	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2385	19-03114N1	34	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36096,36097	238.2	\N	\N	Sections show a compound proliferation of melanocytes involving the junctional zone and papillary dermis.  Some of the melanocytes are large and spindled, with abundant cytoplasm and oval nuclei.  They are mostly arranged as nests along the sides and bases of elongated rete ridges, some of which are fused. The papillary dermis is altered by fibroplasia. The dermal component matures with descent. Kamino bodies are present. Pagetoid scatter is present.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. PL/PL	CYT19-56, 9 MM FLAT BROWN MACULE WITH DARK PIGMENT; R/O ATYPICAL NEVUS	\N	H19-03114 N1 (sentinel cervical lymph node: accessory nerve area)	FFPE	Spitzoid Clark's nevi have the architectural features of a Clark's or dysplastic nevus, with melanocytes whose cytologic features resemble those of a Spitz's nevus. In this case, there are also areas of pagetoid scatter, so I would recommend conservative re-excision to prevent local persistence.	ATYPICAL COMPOUND SPITZOID CLARK'S (DYSPLASTIC) NEVUS, EXTENDING TO THE SPECIMEN PERIPHERY	273588	351	\N	\N	19-3114	N1	CME-049	Cutaneous Melanoma Ethnicities	IP1615172	AirTable blocks_with_IP_info.csv
2388	19-03800-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36017	\N	\N	\N	\N	\N	\N	\N	H19-03800 #4 (right cheek)	FFPE	\N	\N	\N	352	\N	\N	None	\N	CME-050	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2567	20-02956-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36018,36019,36020	\N	\N	\N	\N	\N	\N	\N	H20-02956 #5 (recurrence after 1 year, upper right arm, in situ)	FFPE	\N	\N	\N	353	\N	\N	None	\N	CME-051	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2386	19-03361-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36018,36019,36020	\N	\N	\N	\N	\N	\N	\N	H19-03361 #3 (upper right arm)	FFPE	\N	\N	\N	353	\N	\N	None	\N	CME-051	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2563	20-00698	35	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36018,36019,36020	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a central focus featuring nests, cords and strands of melanocytes that mature with descent. Some lie adjacent to adnexal structures in the reticular dermis.  There are junctional nests of melanocytes with pale vacuolated cytoplasm and small, monomorphous nuclei at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused, with subjacent fibroplasia. There are also areas featuring evenly elongated rete ridges with fused bases and subjacent fibroplasia, with a paucity of melanocytes along the junction.	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	R/O NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN, IRREGULAR NEW / GROWING MOLE	\N	H20-00698	FFPE	The changes at the periphery of the nevus resemble those seen in Clark's or dysplastic nevi and would account for a clinically atypical appearance. The base of the specimen is focally involved. There are no microscopic findings that suggest a need for re-excision.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173529	353	\N	\N	20-698	\N	CME-051	Cutaneous Melanoma Ethnicities	IP2148155	AirTable blocks_with_IP_info.csv
2392	19-05268N1	75	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36021,36114,36109	216.6	\N	\N	There is a dermal proliferation of small, s-shaped spindled cells arranged in thin, wavy fascicles separated by clefts that appear to contain mucin and scattered mast cells.	Ellipse, 0.9 x 0.6 x 0.3 cm, including a central 0.6 x 0.4 cm pink beige area. With the margins inked, the specimen is quadrisected perpendicular to the long axis, and entirely submitted. HD/HD	8 MM PINK SMOOTH NEW PAPULE WITH POORLY DEFINED BORDER; RULE OUT AMELANOTIC MELANOMA, MERKEL CELL, BASAL CELL	\N	H19-05268 N1 (sentinel inguinal lymph node)	FFPE	None	NEUROFIBROMA	173610	354	\N	\N	19-5268	N1	CME-052	Cutaneous Melanoma Ethnicities	IP2009315	AirTable blocks_with_IP_info.csv
2391	19-05268-9	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36021,36114,36109	\N	\N	\N	\N	\N	\N	\N	H19-05268 #9 (lower right leg)	FFPE	\N	\N	\N	354	\N	\N	None	\N	CME-052	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2390	19-05094-9	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36023	\N	\N	\N	\N	\N	\N	\N	19-05094-9 (right cheek)	FFPE	\N	\N	\N	355	\N	\N	None	\N	CME-053	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2393	19-05307-8	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36024	\N	\N	\N	\N	\N	\N	\N	H19-05307 #8 (right forearm, in situ)	FFPE	\N	\N	\N	356	\N	\N	None	\N	CME-054	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2406	19-08527-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36025,36026	\N	\N	\N	\N	\N	\N	\N	H19-08527 (upper left back) #2	FFPE	\N	\N	\N	357	\N	\N	None	\N	CME-055	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2407	19-08527N1	57	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36025,36026	216.3	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages. There is solar elastosis.	One outside slide, LIN19-0152 1A / 7101961.	A) PATIENT PRESENTS WITH PIGMENTED LESION ON L CHEEK OF "A FEW MONTHS" DURATION, ASYMPTOMATIC, B) PATIENT PRESENTS WITH PIGMENTED LESION ON L CHIN OF UNKNOWN DURATION, INCIDENTAL FINDING ON SKIN EXAM	\N	H19-08527-N1 (left axillary sentinel lymph node)	FFPE	None	BLUE NEVUS	123334	357	\N	\N	19-8527	N1	CME-055	Cutaneous Melanoma Ethnicities	IP2012587	AirTable blocks_with_IP_info.csv
2409	19-09700-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36027	\N	\N	\N	\N	\N	\N	\N	H19-09700 (mid-abdomen) #4	FFPE	\N	\N	\N	358	\N	\N	None	\N	CME-056	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2565	20-01244-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36028	\N	\N	\N	\N	\N	\N	\N	H20-01244 (right cheek, in situ) #2	FFPE	\N	\N	\N	359	\N	\N	None	\N	CME-057	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2569	20-03009N1	71	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36031,36032	238.2	\N	\N	Sections show a proliferation with melanocytes arrayed in compound fashion. There is a lentiginous intraepidermal distribution with dermal involvment in small nests with fibrosis and a lymphohistiocytic infiltrate with admixed melanophages. The melanocytes of interest are large with finely pigmented cytoplasm.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. BY/BY	5 MM PIGMENTED MACULE AT MIS EXCISION SITE; R/O MIS	\N	H20-03009-N1 (sentinel parotid lymph node)	FFPE	The context is worrisome for persistent melanoma, but the histopathologic pattern favors interpretation as a distorted atypical melanocytic nevus. PRAME immunohistochemistry was included in our assessment and demonstrates incomplete partial positivity, and this finding supports the conclusion that frank melanoma is not present here. Ongoing follow-up of the biopsy site and the surgical scar is recommended.	COMPOUND PROLIFERATION OF ATYPICAL MELANOCYTES WITH ASSOCIATED SCAR, CONSISTENT WITH AN ATYPICAL COMPOUND MELANOCYTIC NEVUS	528522	362	\N	\N	20-3009	N1	CME-060	Cutaneous Melanoma Ethnicities	IP2105806	AirTable blocks_with_IP_info.csv
2568	20-03009-7	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36031,36032	\N	\N	\N	\N	\N	\N	\N	H20-03009 (right cheek) #7	FFPE	\N	\N	\N	362	\N	\N	None	\N	CME-060	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2570	20-04152-8	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36033	\N	\N	\N	\N	\N	\N	\N	H20-04152 (right cheek) #8	FFPE	\N	\N	\N	363	\N	\N	None	\N	CME-061	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2772	22-07164-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36034,36035,36036	\N	\N	\N	\N	\N	\N	\N	H22-07164 (subcutaneous metastasis in right forearm 2 years later) #1	FFPE	\N	\N	\N	364	\N	\N	None	\N	CME-062	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2571	20-04546-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36034,36035,36036	\N	\N	\N	\N	\N	\N	\N	H20-04546 (dorsum of right hand, with satellite lesion) #3	FFPE	\N	\N	\N	364	\N	\N	None	\N	CME-062	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2667	21-03240	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36034,36035,36036	\N	\N	\N	\N	\N	\N	\N	H21-03240 (subcutaneous metastasis in right upper arm 1 year later)	FFPE	\N	\N	\N	364	\N	\N	21-3240	\N	CME-062	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2579	20-08679-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36037	\N	\N	\N	\N	\N	\N	\N	H20-08679 (lower left leg, in situ) #5	FFPE	\N	\N	\N	365	\N	\N	None	\N	CME-063	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2574	20-06242	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36038	\N	\N	\N	\N	\N	\N	\N	H20-06242 (back)	FFPE	\N	\N	\N	366	\N	\N	20-6242	\N	CME-064	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2669	21-04018	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36039,36040,36041	\N	\N	\N	\N	\N	\N	\N	H21-04018 (subcutaneous metastasis in head 1 year later)	FFPE	\N	\N	\N	367	\N	\N	21-4018	\N	CME-065	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2573	20-05671-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36039,36040,36041	\N	\N	\N	\N	\N	\N	\N	H20-05671 #2 (head)	FFPE	\N	\N	\N	367	\N	\N	None	\N	CME-065	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1824	15-07035-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36064	\N	\N	\N	\N	\N	\N	\N	H15-07035 #1 (lower left leg)	FFPE	\N	\N	\N	383	\N	\N	None	\N	CME-081	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1825	15-08075-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36065	\N	\N	\N	\N	\N	\N	\N	H15-08075 #5 (left buttock)	FFPE	\N	\N	\N	384	\N	\N	None	\N	CME-082	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1082	03-19132B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1003	\N	\N	None	\N	MD-108	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2766	22-03790	72	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36039,36040,36041	173.61	\N	\N	Sections show a focus of fibrosing granulation tissue corresponding to the site of a previous biopsy, with a proliferation of atypical, peripherally palisaded basaloid cells arranged in part as small nodules in the dermis.	Ellipse, 1.7 x 1.2 x 0.4 cm, including a central 0.9 x 0.6 cm tan beige area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. BB/BB	SEE PREVIOUS PATH # DT21-127294-A, HEALING SITE; NODULAR BASAL CELL CARCINOMA, EXCISION OF NODULAR BASAL CELL CARCINOMA	\N	H22-03790 (subcutaneous metastasis in cheek)	FFPE	None	HEALING BIOPSY SITE, WITH RESIDUAL BASAL CELL CARCINOMA, MICRONODULAR PATTERN, COMPLETELY EXCISED, WITH MARGINS FREE OF NEOPLASM	102611	367	\N	\N	22-3790	\N	CME-065	Cutaneous Melanoma Ethnicities	IP927085	AirTable blocks_with_IP_info.csv
2871	23-03515-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36042,36043	\N	\N	\N	\N	\N	\N	\N	H23-03515 (recurrence 2 years later in right flank) #1	FFPE	\N	\N	\N	368	\N	\N	None	\N	CME-066	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2673	21-04690-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36042,36043	\N	\N	\N	\N	\N	\N	\N	H21-04690 (right flank) #3	FFPE	\N	\N	\N	368	\N	\N	None	\N	CME-066	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2674	21-06796-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36044	\N	\N	\N	\N	\N	\N	\N	H21-06796 (right upper back) #5	FFPE	\N	\N	\N	369	\N	\N	None	\N	CME-067	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2678	21-08944-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36045	\N	\N	\N	\N	\N	\N	\N	H21-08944 (left cheek) #3	FFPE	\N	\N	\N	370	\N	\N	None	\N	CME-068	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2682	21-09119N2	64	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36046,36047,36048,36110	173.51	\N	\N	There is a superficial zone of fibrosing granulation tissue, flanked by rounded aggregates of basaloid epithelial cells attached to the undersurface of the epidermis.	Oriented ellipse, 6.0 x 2.4 x 1.2 cm, including a peripheral 0.4 x 0.4 cm slightly raised white-gray area and a central 1.6 x 1.5 cm white-pink area. The orienting blunted pole is indicated 3 o'clock on the requisition and is placed toward 3 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four representative sections in A (white-gray area), one representative section each in B-G, and two representative sections each in H-I. CF/BY	A) MIXED SUPERFICIAL AND NODULAR BASAL CELL CARCINOMA. PSORIASIFORM PATCH. PLEASE CHECK MARGINS.. REFER TO PATH DT21-681. BLUNTED AT 3 "0" CLOCK.	\N	H21-09119 N2 occipital lymph node	FFPE	None	HEALING BIOPSY SITE, WITH RESIDUAL BASAL CELL CARCINOMA, SUPERFICIAL PATTERN, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	263566	371	\N	\N	21-9119	N2	CME-069	Cutaneous Melanoma Ethnicities	IP2262988	AirTable blocks_with_IP_info.csv
2680	21-09119-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36046,36047,36048,36110	\N	\N	\N	\N	\N	\N	\N	H21-09119 #2 (left occiput)	FFPE	\N	\N	\N	371	\N	\N	None	\N	CME-069	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2762	22-00847N5	52	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36051,36052	173.31	\N	\N	There are rounded nests of peripherally palisaded basaloid cells in the dermis, accompanied by fibromyxoid stroma from which they are separated by clefts.	Skin segment measuring 0.4 x 0.3 x 0.1 cm. Submitted intact. BB/BB	NEOPLASM OF UNCERTAIN BEHAVIOR. BCC.	\N	H22-00847 (left axillary lymph node) N5	FFPE	The neoplasm extends to the base of the specimen.	NODULAR BASAL CELL CARCINOMA	173304	373	\N	\N	22-847	N5	CME-071	Cutaneous Melanoma Ethnicities	IP2064455	AirTable blocks_with_IP_info.csv
2685	21-09545-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36051,36052	\N	\N	\N	\N	\N	\N	\N	H21-09545 #2 (left axilla)	FFPE	\N	\N	\N	373	\N	\N	None	\N	CME-071	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2764	22-00892-16	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36053	\N	\N	\N	\N	\N	\N	\N	H22-00892 (right head) #16	FFPE	\N	\N	\N	374	\N	\N	None	\N	CME-072	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2765	22-01164-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36054	\N	\N	\N	\N	\N	\N	\N	H22-01164 (left back) #2	FFPE	\N	\N	\N	375	\N	\N	None	\N	CME-073	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2768	22-04201N2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36055,36056	\N	\N	\N	\N	\N	\N	\N	H22-04201 (right inguinal lymph node) N2	FFPE	\N	\N	\N	376	\N	\N	22-4201	N2	CME-074	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2767	22-04201-6	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36055,36056	\N	\N	\N	\N	\N	\N	\N	H22-04201 (lower right leg) #6	FFPE	\N	\N	\N	376	\N	\N	None	\N	CME-074	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2770	22-05287N2	63	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36057,36058	173.21	\N	\N	Sections show both rounded and angulated aggregations of atypical, peripherally palisaded basaloid cells in the dermis alongside fibromyxoid stroma. Clefts between the epithelium and stroma of the neoplasm are present.	Two skin segments measuring 0.9 x 0.8 x 0.1 cm in aggregate, each bisected and all entirely submitted. BB/BB	A) BASAL CELL CARCINOMA. . ..	\N	H22-05287 (right axillary lymph node) N2	FFPE	None	BASAL CELL CARCINOMA, NODULAR AND INFILTRATIVE PATTERNS, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	100223	377	\N	\N	22-5287	N2	CME-075	Cutaneous Melanoma Ethnicities	IP2406736	AirTable blocks_with_IP_info.csv
2769	22-05287-15	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36057,36058	\N	\N	\N	\N	\N	\N	\N	H22-05287 (upper right arm) #15	FFPE	\N	\N	\N	377	\N	\N	None	\N	CME-075	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2771	22-06500-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36059,36111	\N	\N	\N	\N	\N	\N	\N	H22-06500 (right chest) #1	FFPE	\N	\N	\N	378	\N	\N	None	\N	CME-076	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2864	23-01133	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36060	\N	\N	\N	\N	\N	\N	\N	H23-01133 (right cheek)	FFPE	\N	\N	\N	379	\N	\N	23-1133	\N	CME-077	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1830	15-10294-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36068	\N	\N	\N	\N	\N	\N	\N	H15-10294 #1 (lower left abdomen)	FFPE	\N	\N	\N	387	\N	\N	None	\N	CME-085	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1831	15-11029-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36069	\N	\N	\N	\N	\N	\N	\N	H15-11029 #1 (upper right chest)	FFPE	\N	\N	\N	388	\N	\N	None	\N	CME-086	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1894	16-00657-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36070	\N	\N	\N	\N	\N	\N	\N	H16-00657 #2 (left back)	FFPE	\N	\N	\N	389	\N	\N	None	\N	CME-087	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1897	16-03460-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36071	\N	\N	\N	\N	\N	\N	\N	H16-03460 #1 (lower right limb)	FFPE	\N	\N	\N	390	\N	\N	None	\N	CME-088	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2014	17-00792	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36072,36073	\N	\N	\N	\N	\N	\N	\N	H17-00792 (chest metastasis after 6 months)	FFPE	\N	\N	\N	391	\N	\N	17-792	\N	CME-089	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1898	16-04805-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36072,36073	\N	\N	\N	\N	\N	\N	\N	H16-04805 #2 (abdomen)	FFPE	\N	\N	\N	391	\N	\N	None	\N	CME-089	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1899	16-05265-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36074	\N	\N	\N	\N	\N	\N	\N	H16-05265 #2 (left hip)	FFPE	\N	\N	\N	392	\N	\N	None	\N	CME-090	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1900	16-05548-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36075	\N	\N	\N	\N	\N	\N	\N	H16-05548 #2 (right cheek)	FFPE	\N	\N	\N	393	\N	\N	None	\N	CME-091	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2686	21-10478-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36076,36077	\N	\N	\N	\N	\N	\N	\N	H21-10478 (December 2021 right upper back) #2	FFPE	\N	\N	\N	394	\N	\N	None	\N	CME-092	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1901	16-05958-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36076,36077	\N	\N	\N	\N	\N	\N	\N	H16-05958 #2 (right thoracic side)	FFPE	\N	\N	\N	394	\N	\N	None	\N	CME-092	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1902	16-06126-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36078	\N	\N	\N	\N	\N	\N	\N	H16-06126 #2 (left cheek)	FFPE	\N	\N	\N	395	\N	\N	None	\N	CME-093	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1903	16-06348-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36079	\N	\N	\N	\N	\N	\N	\N	H16-06348 #2 (lower right leg)	FFPE	\N	\N	\N	396	\N	\N	None	\N	CME-094	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1904	16-06590-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36080	\N	\N	\N	\N	\N	\N	\N	H16-06590 #2 (left back)	FFPE	\N	\N	\N	397	\N	\N	None	\N	CME-095	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1905	16-06994-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36081	\N	\N	\N	\N	\N	\N	\N	H16-06994 #1 (left hip)	FFPE	\N	\N	\N	398	\N	\N	None	\N	CME-096	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1908	16-09944-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36082	\N	\N	\N	\N	\N	\N	\N	H16-09944 (left cheek, in situ) #2	FFPE	\N	\N	\N	399	\N	\N	None	\N	CME-097	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1913	16-10561-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36083	\N	\N	\N	\N	\N	\N	\N	H16-10561 (left forearm, in situ) #3	FFPE	\N	\N	\N	400	\N	\N	None	\N	CME-098	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
1912	16-10560-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36084	\N	\N	\N	\N	\N	\N	\N	H16-10560 (right shoulder) #1	FFPE	\N	\N	\N	401	\N	\N	None	\N	CME-099	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2012	17-00730-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36085	\N	\N	\N	\N	\N	\N	\N	H17-00730 #3 (left nasal ala)	FFPE	\N	\N	\N	402	\N	\N	None	\N	CME-100	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2041	17-10987-N2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-39	https://64.54.108.121/app/WebViewer/view/image/36092,36093	\N	\N	\N	\N	\N	\N	\N	H17-10987 N2 (axillary lymph node)	FFPE	\N	\N	\N	408	\N	\N	None	\N	CME-106	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2040	17-10987-6	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36092,36093,36113	\N	\N	\N	\N	\N	\N	\N	H17-10987 #6 (back)	FFPE	\N	\N	\N	408	\N	\N	None	\N	CME-106	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2042	17-11087-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-39	https://64.54.108.121/app/WebViewer/view/image/36094	\N	\N	\N	\N	\N	\N	\N	H17-11087 #5 (right auricle, in situ)	FFPE	\N	\N	\N	409	\N	\N	None	\N	CME-107	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2037	17-10231-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-39	https://64.54.108.121/app/WebViewer/view/image/36095	\N	\N	\N	\N	\N	\N	\N	H17-10231 #5 (right cheek)	FFPE	\N	\N	\N	410	\N	\N	None	\N	CME-108	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2873	23-4594	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.2	\N	\N	Sections show a compound proliferation of melanocytes with a domed profile. There are melanocytes scattered singly and in nests along the epidermal-dermal junction, and maturing nests, cords, and syncytia of similar melanocytes are distributed in the underlying reticular dermis, extending deeply.	Skin segment measuring 0.6 x 0.5 x 0.3 cm, bisected and entirely submitted. KB/ES	A) NEOPLASM OF UNCERTAIN BEHAVIOR. PAPULE.	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	173202	414	\N	\N	23-4594	\N	DMS-002	Superficial Congenital Nevi	IP2542680	AirTable blocks_with_IP_info.csv
2961	95-14690F T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1004	\N	\N	None	\N	MD-112	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1014	00-16651B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1005	\N	\N	None	\N	MD-113	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2841	22-104389A4	2	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28255,28256,28257,28258,28260,28261,28262,28263	238.2	Normal	\N	Sections show melanocytes arrayed singly and in clusters irregularly within the epidermis, with a zone of scar that also encompasses similar clusters of cells. Some cells have moderately large spindled nuclei with abundant, pale amphophilic cytoplasm and interspersed melanophages.	Oriented irregular shaped excision, 4.4 x 1.9 x 0.6 cm, including a central 0.9 x 0.7 cm crusted area and generalized brown spots ranging from 0.2 x 0.2 cm to 0.3 x 0.2 cm. The orienting sutured tip is indicated as superior adjacent to lateral campus on the requisition form, designated as 12 o'clock by the grosser, and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock and 6-9-12 o'clock edges, blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with five sections in A1, four sections in A2, five sections in A3, and six sections and fragment in A4. HD/HD	WIDE LOCAL EXCISION MALIGNANT LESIONS RIGHT FACE X4	\N	Right Cheek	FFPE	The residuum is broad and composed of a heterogenous population of melanocytes including some small melanocytes and some large cells. The largest, nodular zone of melanocytes with the most atypical features appears completely excised. There are multi-focal areas of the melanocytoma that are present at the peripheral margins. After reviewing the clinical images, this is not surprising given the large pigmented patch from which these nodular lesions are arising.	SCAR AND RESIDUAL WNT-ACTIVATED/DEEP PENETRATING MELANOCYTOMA, SEE NOTES	173305	411	\N	\N	22-104389	A4	CS-01	Clinical Cases	IP2435904	AirTable blocks_with_IP_info.csv
2840	22-104389A2	2	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28255,28256,28257,28258,28260,28261,28262,28263	238.2	Tumor	\N	Sections show melanocytes arrayed singly and in clusters irregularly within the epidermis, with a zone of scar that also encompasses similar clusters of cells. Some cells have moderately large spindled nuclei with abundant, pale amphophilic cytoplasm and interspersed melanophages.	Oriented irregular shaped excision, 4.4 x 1.9 x 0.6 cm, including a central 0.9 x 0.7 cm crusted area and generalized brown spots ranging from 0.2 x 0.2 cm to 0.3 x 0.2 cm. The orienting sutured tip is indicated as superior adjacent to lateral campus on the requisition form, designated as 12 o'clock by the grosser, and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock and 6-9-12 o'clock edges, blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with five sections in A1, four sections in A2, five sections in A3, and six sections and fragment in A4. HD/HD	WIDE LOCAL EXCISION MALIGNANT LESIONS RIGHT FACE X4	\N	Right Cheek	FFPE	The residuum is broad and composed of a heterogenous population of melanocytes including some small melanocytes and some large cells. The largest, nodular zone of melanocytes with the most atypical features appears completely excised. There are multi-focal areas of the melanocytoma that are present at the peripheral margins. After reviewing the clinical images, this is not surprising given the large pigmented patch from which these nodular lesions are arising.	SCAR AND RESIDUAL WNT-ACTIVATED/DEEP PENETRATING MELANOCYTOMA, SEE NOTES	173305	411	\N	\N	22-104389	A2	CS-01	Clinical Cases	IP2435904	AirTable blocks_with_IP_info.csv
2842	22-104389C	2	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28255,28256,28257,28258,28260,28261,28262,28263	238.2	Tumor	\N	The histopathology is generally similar to that described for specimen A.	Ellipse, 1.1 x 0.4 x 0.3 cm, including a central 0.4 x 0.3 cm elevated area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in C. HD/HD	WIDE LOCAL EXCISION MALIGNANT LESIONS RIGHT FACE X4	\N	Right Cheek	FFPE	\N	WNT-ACTIVATED/DEEP PENETRATING MELANOCYTOMA, EXTENDING TO THE PERIPHERAL MARGIN	110003	411	\N	\N	22-104389	C	CS-01	Clinical Cases	IP2435904	AirTable blocks_with_IP_info.csv
2797	22-44813B	23	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31083,31084,31085,31086,31087,31088	238.2	\N	\N	The features are similar to those in (A), except that the proliferation is larger, with an exophytic profile and extension through the depth of the reticular dermis with a wedge-shaped lower profile. There is overlying parakeratosis Dermal mitotic figures are present including near the base of the biopsy. Slight maturation is present. Small melanocytes are present in the flanking epidermis on both sides of the larger melanocytes.	One outside slide, DP22-01833 (B1), and one corresponding block.	A-D) NO HISTORY PROVIDED, EXCISION; CONGENITAL NEVUS VS. OTHER	\N	\N	FFPE	\N	WNT-ACTIVATED MELANOCYTOMA	173105	411	\N	\N	22-44813	B	CS-01	Clinical Cases	IP2435904	AirTable blocks_with_IP_info.csv
2855	22-125373	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29100,29101,29102,29103,29104,29105,29106,29107,29108,29109,29110	\N	Primary tumor	(ST22-7809-A2)	\N	\N	\N	\N	\N	\N	\N	\N	\N	412	\N	\N	22-125373	\N	CS-02	\N	\N	AirTable blocks_with_IP_info.csv
2825	22-91591	84	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. CF/CF\n	IRREGULAR GREY BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL PIGMENTED LESION	\N	\N	\N	None	BLUE NEVUS, SPINDLE CELL/SCLEROTIC TYPE	139700	441	\N	\N	22-91591	\N	DMS-029	Superficial Congenital Nevi	IP302644	AirTable blocks_with_IP_info.csv
2889	23-7246A 	39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a sessile polypoid skin segment containing a dermal proliferation of melanocytes, arrayed as nests, cords and syncytia that diminish in size with descent in the dermis. Small melanocytes are arrayed in the reticular and adventitial dermis in the deepest parts of the lesion. The epidermal surface is acanthotic in a papillated and seborrheic keratosis-like configuration, with nests and syncytia present within the resultant widened papillae.	Skin segment measuring 0.5 x 0.4 x 0.2 cm, bisected and entirely submitted in A. BY/BY	A) IRRITATED NEVUS. 5 MM PINK PAPULE. B) IRRITATED NEVUS. 7 MM PINK PAPULE. C) IRRITATED NEVUS. 1 CM PINK PAPULE.	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	173404	413	\N	\N	23-7246	A	DMS-001	Superficial Congenital Nevi	IP2511339	AirTable blocks_with_IP_info.csv
2891	23-7246C	39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. Most of the lesion consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels. The dermal melanocytes show maturation with dermal descent.	Skin segment measuring 0.9 x 0.7 x 0.2 cm, trisected and entirely submitted in C. BY/BY	A) IRRITATED NEVUS. 5 MM PINK PAPULE. B) IRRITATED NEVUS. 7 MM PINK PAPULE. C) IRRITATED NEVUS. 1 CM PINK PAPULE.	\N	\N	\N	\N	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	139522	413	\N	\N	23-7246	C	DMS-001	Superficial Congenital Nevi	IP2511339	AirTable blocks_with_IP_info.csv
2890	23-7246B	39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a sessile polypoid skin segment containing a dermal proliferation of melanocytes, arrayed as nests, cords and syncytia that diminish in size with descent in the dermis. Small melanocytes are arrayed in the reticular and adventitial dermis in the deepest parts of the lesion. The epidermal surface is acanthotic in a papillated and seborrheic keratosis-like configuration, with nests and syncytia present within the resultant widened papillae.	Skin segment measuring 0.8 x 0.4 x 0.2 cm, bisected and entirely submitted in B. BY/BY	A) IRRITATED NEVUS. 5 MM PINK PAPULE. B) IRRITATED NEVUS. 7 MM PINK PAPULE. C) IRRITATED NEVUS. 1 CM PINK PAPULE.	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	173578	413	\N	\N	23-7246	B	DMS-001	Superficial Congenital Nevi	IP2511339	AirTable blocks_with_IP_info.csv
2874	23-4595	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a mostly dermal proliferation of melanocytes, arrayed as nests and strands and syncytia that diminish in size with descent in the dermis.  Small melanocytes are splayed between collagen bundles in the superficial reticular dermis.	Skin segment, 1.0 x 0.6 x 0.4 cm, bisected and totally submitted. KB/ES	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS. PAPULE.	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	273562	415	\N	\N	23-4595	\N	DMS-003	Superficial Congenital Nevi	IP2542681	AirTable blocks_with_IP_info.csv
2882	23-5236	50	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a mostly dermal proliferation of melanocytes, arrayed as nests and strands and syncytia that diminish in size with descent in the dermis.  Small melanocytes are splayed between collagen bundles in the superficial reticular dermis.	Skin segment measuring 0.6 x 0.6 x 0.2 cm, bisected and entirely submitted. CF/CF	9 MM PINK CAULIFLOWER-LIKE PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. CONDYLOMA ACUMINATA	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	532525	416	\N	\N	23-5236	\N	DMS-004	Superficial Congenital Nevi	IP2543326	AirTable blocks_with_IP_info.csv
2792	22-35051	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. Kamino bodies are present.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. HD/HD	R/O SK	\N	\N	\N	The neoplastic melanocytes in the biopsy have spitzoid cytomorphology with large, vesicular nuclei, prominent nucleoli, and abundant homogeneous appearing cytoplasm with clefts delineating cells from each other. There is associated epidermal hyperplasia and Kamino body formation. These findings support a diagnosis of a Spitz nevus. The proliferation extends to the specimen edge. Either conservative re-excision or clinical follow up to monitor for recurrence are both reasonable treatment options.	COMPOUND SPITZ NEVUS, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	173719	417	\N	\N	22-35051	\N	DMS-005	Superficial Congenital Nevi	IP2436715	AirTable blocks_with_IP_info.csv
2879	23-4742	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show skin with hyperpigmentation of the basal layer.  There are slightly elongated, rounded rete ridges.  There is solar elastosis of the subjacent dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, trisected and entirely submitted with fragment in B. BB/BB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. BASAL CELL CARCINOMA VS. NEVUS VS. IRRITATED SEBORRHEIC KERATOSIS. RED SHINY PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. MELANOMA VS. SOLAR LENTIGO. BROWN IRREGULAR MACULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. SEBORRHEIC KERATOSIS, ANGIOFIBROMA, SCAR. WHITE PAPULE.	\N	\N	\N	None	SOLAR LENTIGO	173624	418	\N	\N	23-4742	\N	DMS-006	Superficial Congenital Nevi	IP1019455	AirTable blocks_with_IP_info.csv
2875	23-4604	51	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a mostly dermal proliferation of melanocytes, arrayed as nests and strands and syncytia that diminish in size with descent in the dermis.  Small melanocytes are splayed between collagen bundles in the superficial reticular dermis.	Skin segment measuring 1.1 x 1.0 x 0.4 cm, quadrisected and entirely submitted. KB/ES	R/O DYSPLASTIC NEVUS	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	528599	419	\N	\N	23-4604	\N	DMS-007	Superficial Congenital Nevi	IP2100566	AirTable blocks_with_IP_info.csv
2853	22-122015	64	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a dermal proliferation of oval melanocytes with small, monomorphous nuclei and abundant, pale cytoplasm, arranged as discrete collections, and accompanied by lesser numbers of bipolar dendritic melanocytes and by melanophages.	Cylindrical skin segment, 0.7 cm in diameter and 0.8 cm in thickness, trisected and entirely submitted. BY/BY	4 MM AR2CP; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	BLUE NEVUS	139524	420	\N	\N	22-122015	\N	DMS-008	Superficial Congenital Nevi	IP2524217	AirTable blocks_with_IP_info.csv
2851	22-115763	67	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. KB/KB	6 X 6 MM SUBCUTANEOUS NODULE; PILAR CYST (TELEPHONE: 415-346-6927, MSG OK)	\N	\N	\N	None	BLUE NEVUS, SPINDLE CELL/SCLEROTIC TYPE	173406	421	\N	\N	22-115763	\N	DMS-009	Superficial Congenital Nevi	IP1982053	AirTable blocks_with_IP_info.csv
1744	14-14773	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	acral mel macule	FFPE	\N	\N	\N	1293	\N	\N	14-14773	\N	OM-35	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3524	MB1428	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1525	\N	\N	None	\N	SYNAT422	2010-2017	\N	AirTable blocks_with_IP_info.csv
2805	22-59468	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.1	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Skin segment measuring 0.6 x 0.5 x 0.2 cm, bisected and entirely submitted. HD/HD	7 MM DOME SHAPED REDDISH PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR, JXG VS. SPITZ NEVUS VS. DOUBT VERRUCA VULGARIS (PHOTOS)	\N	\N	\N	Thank you for sending the clinical images of this patient's lesion. The biopsy shows a compound proliferation of large spitzoid melanocytes that was transected at the shave specimen base. The proliferation has a symmetrical appearance with uniform appearance of the melanocytes and rare mitotic figures. Given some vertically oriented fascicles of melanocytes in the biopsy, I obtained an ALK immunoperoxidase stain. The ALK gene can be involved in a gene fusion, with resultant overexpression in a subset of Spitz nevi with this morphologic finding. The stain is negative in this case, however. There is a mosaic pattern of staining for p16, sufficient to exclude the possibility of a bi-allelic deletion of the CDKN2A gene which encodes that tumor suppressor protein. PRAME staining is negative. These findings support a diagnosis of a Spitz nevus.	COMPOUND SPITZ NEVUS, TRANSECTED ACROSS THE SPECIMEN BASE	173115	422	\N	\N	22-59468	\N	DMS-010	Superficial Congenital Nevi	IP2461249	AirTable blocks_with_IP_info.csv
2881	23-5230	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a relatively circumscribed proliferation of dendritic melanocytes and melanophages in the dermis.	Cylindrical skin segment, 0.2 cm in diameter and 0.3 cm in thickness, submitted intact in B. CF/CF	A) 4 X 4 MM TWO TONED MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOCYTIC ATYPIA, B) 2 X 2 MM BLUE BLACK MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS VS. MELANOCYTIC ATYPIA	\N	\N	\N	None	BLUE NEVUS	733602	423	\N	\N	23-5230	\N	DMS-011	Superficial Congenital Nevi	IP2543320	AirTable blocks_with_IP_info.csv
2099	17-35486B	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in B. KC/KC	A-B) NEVUS, R/O ATYPIA	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173531	491	\N	\N	17-35486	B	DN-016	Dysplastic Nevi	IP1764932	AirTable blocks_with_IP_info.csv
2848	22-114644	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Ellipse, 1.5 x 0.6 x 0.4 cm, including a central 0.5 x 0.4 cm crusted area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. BY/BY	C/W NEVUS	\N	\N	\N	None	BLUE NEVUS, COMPLETELY EXCISED (MARGINS FREE OF TUMOR)	173305	424	\N	\N	22-114644	\N	DMS-012	Superficial Congenital Nevi	IP2516809	AirTable blocks_with_IP_info.csv
2856	22-127365	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There are compactly arranged, intensely pigmented, bipolar dendritic melanocytes in the dermis, accompanied by numerous melanophages.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, trisected and entirely submitted. BB/BB	8 MM BLUE / BLACK PAPULE; BLUE NEVUS, ENLARGING, R/O ATYPIA	\N	\N	\N	The dermal melanocytes show strong diffuse positivity for both HMB-45 and p16 and also show retained expression of protein kinase regulatory subunit 1A (PRKAR1a; against the consideration of a pigmented epithelioid melanocytoma). These are together reassuring results that support the above diagnosis	BLUE NEVUS	173788	425	\N	\N	22-127365	\N	DMS-013	Superficial Congenital Nevi	IP2529583	AirTable blocks_with_IP_info.csv
2857	22-127490	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages and by thickened collagen bundles. Pigmentation and cellularity are accentuated around adnexal structures.	Oriented ellipse, 1.4 x 0.6 x 0.3 cm, including a central 0.4 x 0.4 cm light-gray area. The orienting sutured tip is indicated ulnar on the requisition. This tip is designated 12 o'clock by the grosser and is placed toward 12 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections each in 1-2. BY/BY	0.5 X 0.4 CM BLUE PAPULE ON R DORSAL HAND; BLUE NEVUS, R/O ATYPIA	\N	\N	\N	None	BLUE NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173614	426	\N	\N	22-127490	\N	DMS-014	Superficial Congenital Nevi	IP2529712	AirTable blocks_with_IP_info.csv
2858	22-128532	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages.	Two specimens received in vial. Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. Skin segment measuring 0.4 x 0.2 x 0.1 cm and submitted intact. BY/BY	ATYPICAL BROWN GREY MACULE WITH ADJACENT LIGHT BROWN MACULE; BLUE NEVUS	\N	\N	\N	None	BLUE NEVUS	17723	427	\N	\N	22-128532	\N	DMS-015	Superficial Congenital Nevi	IP2530754	AirTable blocks_with_IP_info.csv
2859	22-128941	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Cylindrical skin segment measuring 0.5 cm in diameter and 0.8 cm in thickness, with the margins inked blue by the grosser, bisected and entirely submitted. CF/CF	SLATE-BLUE PAPULE; BLUE NEVUS VS. ATYPICAL NEVUS	\N	\N	\N	No evidence of melanoma or significant atypia was detected.	BLUE NEVUS	173625	428	\N	\N	22-128941	\N	DMS-016	Superficial Congenital Nevi	IP758536	AirTable blocks_with_IP_info.csv
2818	22-83883	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a dermal proliferation of moderately sized spindled melanocytes with monomorphous thin oval nuclei and tiny nucleoli, positioned between thickened collagen bundles and accompanied by melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. HD/HD	5 X 5 MM DARK BROWN PAPULE; BLUE NEVUS (TELEPHONE: 443-223-4442, MSG OK)	\N	\N	\N	The neoplasm extends to the peripheral edges of the specimen and focally to its base. There are no worrisome features, however.	BLUE NEVUS	173676	429	\N	\N	22-83883	\N	DMS-017	Superficial Congenital Nevi	IP2485829	AirTable blocks_with_IP_info.csv
2862	23-293	74	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted. KB/KB	0.5 X 0.5 CM SUSPICIOUS IRREGULAR MULTI-COLORED MACULE; MELANOMA VS. DYSPLASTIC NEVUS VS. ATYPICAL SEBORRHEIC KERATOSIS VS. PIGMENTED BASAL CELL CARCINOMA	\N	\N	\N	No evidence of melanoma or significant atypia was detected.	BLUE NEVUS	143499	430	\N	\N	23-293	\N	DMS-018	Superficial Congenital Nevi	IP2538345	AirTable blocks_with_IP_info.csv
2878	23-4720	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of single and nested cells positioned along the epidermal-dermal junction, with similar cells in clusters and syncytia in the underlying dermis, with some cells arrayed in the superficial reticular and adventitial dermis.  The junctional melanocytes extend far lateral to those in the dermis.	Skin segment measuring 1.4 x 0.7 x 0.1 cm, trisected, and entirely submitted. HD/HD	R/O DYSPLASTIC NEVUS	\N	\N	\N	None	COMPOUND SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH LATERAL EXTENSION OF THE JUNCTIONAL COMPONENT	173556	431	\N	\N	23-4720	\N	DMS-019	Superficial Congenital Nevi	IP2542807	AirTable blocks_with_IP_info.csv
2849	22-115140	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with nested and solitary melanocytes scattered along the junction. There are maturing nests, cords, and syncytia of small melanocytes in the reticular dermis below this.	Cylindrical skin segment, 0.4 cm in diameter and 0.7 cm in thickness, bisected and entirely submitted. BB/BB	4.5 MM ASYMMETRICAL PIGMENTED PAPULE, CHANGING; R/O DYSPLASTIC NEVUS (TELEPHONE: 818-726-3130, MSG YES)	\N	\N	\N	A PRAME immunoperoxidase stain does not label the lesional melanocytes and a SOX-10 immunoperoxidase stain highlights that most of the junctional melanocytes are within the basal layer of the epidermis. These results support that this proliferation represents a compound melanocytic nevus with superficial congenital features.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173784	432	\N	\N	22-115140	\N	DMS-020	Superficial Congenital Nevi	IP2517308	AirTable blocks_with_IP_info.csv
2869	23-3020	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels. Melanocytes with spindled shapes form neuroid structures in some areas.	Skin segment measuring 0.8 x 0.8 x 0.2 cm, trisected and entirely submitted. HD/ES	A) ATYPICAL NEVUS VS. INTRADERMAL NEVUS. IRREGULAR BROWN MACULE.	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	17722	433	\N	\N	23-3020	\N	DMS-021	Superficial Congenital Nevi	IP2541093	AirTable blocks_with_IP_info.csv
3010	99-13402-3 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1006	\N	\N	None	\N	MD-114	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1241	06-24998B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1007	\N	\N	None	\N	MD-118	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1016	00-23160D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1008	\N	\N	None	\N	MD-119	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2774	22-8115	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a proliferation of spindled melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Excision measuring 0.8 x 0.7 x 0.7 cm, trisected perpendicular to the long axis and entirely submitted. Bottle contents filtered upon grossing. CF/CF	CYST	\N	\N	\N	There is no evidence of a cyst. The biopsy shows a cellular blue nevus with prominent dermal sclerosis.	CELLULAR BLUE NEVUS WITH SCLEROSIS	173508	434	\N	\N	22-8115	\N	DMS-022	Superficial Congenital Nevi	IP2406658	AirTable blocks_with_IP_info.csv
2814	22-81230	33	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show rounded masses formed by a dermal proliferation of pigmented bipolar dendritic melanocytes distributed between thickened collagen bundles and accompanied by melanophages. One of them is perifollicular.	Ellipse, 1.6 x 0.7 x 0.7 cm, including a central 1.0 x 0.5 cm gray-tan area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. CF/CF	BROWN BLUE BLACK IRREGULAR PLAQUE; R/O PILOMATRICOMA VS. ATYPICAL NEVUS	\N	\N	\N	There are no worrisome features. A lobule of this benign proliferation abuts the subcutaneous margin.	BLUE NEVUS	173509	435	\N	\N	22-81230	\N	DMS-023	Superficial Congenital Nevi	IP1381937	AirTable blocks_with_IP_info.csv
2817	22-83760	79	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a wedge based proliferation of thin spindled and pigmented, bipolar dendritic melanocytes.  There are closely apposed collagen bundles and interspersed melanophages.  The cellularity and pigmentation of the proliferation is accentuated around adnexal structures.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS R/O MALIGNANT. BLUE GRAY MACULE.	\N	\N	\N	The neoplasm extends to the peripheral edges of the specimen at the level of the deep reticular dermis. There are no worrisome features, however.	BLUE NEVUS	147407	436	\N	\N	22-83760	\N	DMS-024	Superficial Congenital Nevi	IP2477312	AirTable blocks_with_IP_info.csv
2763	22-854	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a wedge based proliferation of thin spindled and pigmented, bipolar dendritic melanocytes.  There are closely apposed collagen bundles and interspersed melanophages.  The cellularity and pigmentation of the proliferation is accentuated around adnexal structures.	Excision measuring 0.7 x 0.6 x 0.7 cm, including a central 0.4 x 0.4 cm brown area. With the margins inked by the grosser, the specimen is trisected perpendicular to the long axis and entirely submitted. BB/BB	R/O BLUE NEVUS	\N	\N	\N	The neoplasm diminishes in cellularity, but extends to a peripheral margin at the level of the mid-reticular dermis. There are no worrisome features, however.	BLUE NEVUS	173602	437	\N	\N	22-854	\N	DMS-025	Superficial Congenital Nevi	IP2402256	AirTable blocks_with_IP_info.csv
2821	22-85528	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a wedge based proliferation of thin spindled and pigmented, bipolar dendritic melanocytes.  There are closely apposed collagen bundles and interspersed melanophages.  The cellularity and pigmentation of the proliferation is accentuated around adnexal structures.	Two skin segments measuring 1.2 x 0.8 x 0.2 cm and 0.5 x 0.5 x 0.1 cm. The specimens are serially sectioned and entirely submitted with five sections. HD/HD	R/O CONGENITAL NEVUS VS. MNM VS. OTHER (2 SHAVES SUPERFICIAL & DEEP IN SAME BOTTLE) (PHOTO)	\N	\N	\N	None	BLUE NEVUS	173788	438	\N	\N	22-85528	\N	DMS-026	Superficial Congenital Nevi	IP2487493	AirTable blocks_with_IP_info.csv
2823	22-88969	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a mid-dermal proliferation of moderately sized oval melanocytes with small, monomorphous nuclei and abundant, pale cytoplasm, arranged in a web shaped mass and accompanied by melanophages.	Cylindrical skin segment, 0.3 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. HD/HD	BLUE NEVUS VS. OTHER	\N	\N	\N	None	BLUE NEVUS	106677	439	\N	\N	22-88969	\N	DMS-027	Superficial Congenital Nevi	IP2490960	AirTable blocks_with_IP_info.csv
2824	22-90430	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of thin spindled and a few pigmented bipolar dendritic melanocytes in a mass adjacent to a follicular unit.	Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. KB/KB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS. GREY PAPULE.	\N	\N	\N	None	BLUE NEVUS	173619	440	\N	\N	22-90430	\N	DMS-028	Superficial Congenital Nevi	IP2492438	AirTable blocks_with_IP_info.csv
3315	DM96	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1578	\N	\N	None	\N	SYNAT461	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
2830	22-94507	40	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a nearly pan-dermal proliferation bipolar dendritic melanocytes and thickened collagen bundles. The cellularity of the lesion is more marked in the lower, than in the upper part of the lesion, where poorly formed fascicles of small, oval cells with lightly pigmented cytoplasm are present, along with many interspersed melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. BY/BY	A) BLUE NEVUS VS. RULE OUT MALIGNANCY. BLUE-BROWN PAPULE, NO BLACK AREAS OR SUSPICIOUS FEATURES ON DERMOSCOPY, AND NO SUSPICIOUS FEATURES ON DERMOSCOPY. LESION SIZE:  4.5 MM; 5 MM PUNCH PERFORMED.	\N	\N	\N	None	BLUE NEVUS	173676	442	\N	\N	22-94507	\N	DMS-030	Superficial Congenital Nevi	IP2496535	AirTable blocks_with_IP_info.csv
2834	22-95858	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages and by thickened collagen bundles.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. KB/KB	PT WITH HISTORY OF MELANOMA AND BLUE - BLACK MACULE; R/O BLUE NEVUS / DMN	\N	\N	\N	None	BLUE NEVUS	173610	443	\N	\N	22-95858	\N	DMS-031	Superficial Congenital Nevi	IP633741	AirTable blocks_with_IP_info.csv
2835	22-99877	86	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a dermal proliferation of spindled melanocytes with bland nuclei, and bipolar dendritic melanocytes with pigmented cytoplasm. These cells are accompanied by fibrosis and melanophages.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted in E. No additional tissue noted in vial. BB/PL	A) BASAL CELL CARCINOMA. SHINY PAPULE. B) BASAL CELL CARCINOMA. SHINY PAPULE. C) DYSPLASTIC NEVUS. IRREGULAR BROWN PAPULE. D) DYSPLASTIC NEVUS. IRREGULAR BROWN PAPULE. E) CYST. SUBCUTANEOUS CYST.	\N	\N	\N	None	BLUE NEVUS	173610	444	\N	\N	22-99877	\N	DMS-032	Superficial Congenital Nevi	IP2501946	AirTable blocks_with_IP_info.csv
1232	06-21073E T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1009	\N	\N	None	\N	MD-121	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1231	06-20661-2 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1010	\N	\N	None	\N	MD-122	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2468	19-111428	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.2	\N	\N	Sections show a compound proliferation of large spindled melanocytes, arrayed as nests and fascicles along the junctional zone and as smaller nests and fascicles in the underlying dermis.  The overlying epidermis is acanthotic, and there are foci of perimelanocytic clefting.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. BY/BY	TRAUMATIZED NEVUS	\N	\N	\N	The lesional cells are positive for p16 and negative for ALK.	SPITZ'S NEVUS, COMPOUND TYPE	173207	445	\N	\N	19-111428	\N	DMS-033	Superficial Congenital Nevi	IP2116153	AirTable blocks_with_IP_info.csv
2655	20-103041	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a well-circumscribed, wedge-shaped, symmetric, compound proliferation of large fusiform and epithelioid melanocytes arrayed as expansile nests and fascicles along and above the junctional zone and as smaller nests and fascicles in the underlying dermis. The background epidermis is acanthotic with hyperkeratosis, and pale eosinophilic globules are evident within the epidermis and among the junctional nests. A symmetric lymphohistiocytic infiltrate with scattered melanophages is noted.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, trisected and entirely submitted. BY/BY	CHANGING PIGMENTED; COMPOUND NEVUS	\N	\N	\N	A p16 immunoperoxidase stain shows strong diffuse expression of p16 in the melanocytes.  This is a reassuring result aand supports the above diagnosis.  The lesion is narrowly excised in planes of section examined. Clinical follow up to monitor for recurrence is recommended. I shared this case with my colleague, Dr. Thaddeus Mully, who agrees with the diagnosis and assessment.	SPITZ'S NEVUS, COMPOUND TYPE, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	173713	446	\N	\N	20-103041	\N	DMS-034	Superficial Congenital Nevi	IP2251026	AirTable blocks_with_IP_info.csv
2588	20-14475	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a compound proliferation of large fusiform melanocytes arrayed as nests and fascicles along the junctional zone and as smaller or maturing nests and fascicles in the underlying dermis. The background epidermis is partially acanthotic. A lymphohistiocytic infiltrate is noted. Centrally, perijunctional post-procedural fibrosing inflammatory alterations are also prominent.	Ellipse, 2.3 x 1.8 x 0.6 cm, including a central 1.3 x 1.0 cm variegated textured area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and submitted with four sections each in A-B. One tip reserved. HD/HD	EXCISION / DL19-142230 (PHOTOS)	\N	\N	\N	The prominently fascicular configuration seen in this reexcision specimen suggests a Spitz nevus induced by kinase gene fusion. Immunostaining for ALK is negative (identical to what was defined in conjunction with the original biopsy from this site), and thus ALK gene fusion has been excluded. By contrast, ROS1 staining demonstrates diffuse positivity, which suggests that ROS1 gene fusion is present. Importantly, expression of p16 is maintained, indicating that concomitant CDKN2A deletion has not occurred. In summary, the combined results derived from conventional microscopy and immunohistochemistry support the diagnosis of fascicular Spitz nevus. This relatively large (plaque-like) example has now been excised with a free margin.	RESIDUAL FASCICULAR COMPOUND SPITZ NEVUS INDUCED BY ROS1 GENE FUSION, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE)	173313	447	\N	\N	20-14475	\N	DMS-035	Superficial Congenital Nevi	IP2147133	AirTable blocks_with_IP_info.csv
2599	20-23650	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a well-circumscribed compound proliferation of large spindled melanocytes, arrayed as nests and fascicles along the junctional zone and as smaller nests and fascicles in the underlying dermis.  The overlying epidermis is acanthotic, and there are foci of perimelanocytic clefting.	Cylindrical skin segment, 0.6 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. KC/KC	5 MM ERYTHEMATOUS - BROWN WELL CIRCUMSCRIBED DOME SHAPED PAPULE; BENIGN ADNEXAL TUMOR VS. BCC DOUBT MASTOCYTOMA	\N	\N	\N	This biopsy shows a well-circumscribed proliferation of moderately large melanocytes with epithelioid to spindled nuclei and abundant, pale amphophilic cytoplasm with associated acanthosis. Mitotic activity is limited to the superficial portion of the neoplasm, and there is dermal maturation with descent. The findings are consistent with a compound Spitz nevus.	COMPOUND SPITZ NEVUS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173649	448	\N	\N	20-23650	\N	DMS-036	Superficial Congenital Nevi	IP2171186	AirTable blocks_with_IP_info.csv
2801	22-51687	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in C. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. . B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. . C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. .	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	139512	468	\N	\N	22-51687	\N	DMS-056	Superficial Congenital Nevi	IP699795	AirTable blocks_with_IP_info.csv
2609	20-31361	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of spindled and polygonal melanocytes, some with enlarged nuclei. The background epidermis is acanthotic and hyperkeratotic.  There are eosinophilic globules in the epidermis in some areas.	Skin segment measuring 0.4 x 0.4 x 0.3 cm, bisected and entirely submitted. HD/HD	MORPHOLOGY: PINK CAULIFLOWER-LIKE PAPULES, DDX: VERRUCA VULGARIS, NOTES: COULD JUST BE A WART, NEW, SOLITARY FIRM PINK PAPULE GROWING ON UPPER ARM, DDX IF MOLLUSCUM, SPITZ, ETC	\N	\N	\N	A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product. Combining this staining result with the findings on the routinely-stained section, the features in this biopsy are those of a compound Spitz's nevus. The nevus focally extends to the specimen base.	SPITZ'S NEVUS, COMPOUND TYPE	523654	449	\N	\N	20-31361	\N	DMS-037	Superficial Congenital Nevi	IP2178947	AirTable blocks_with_IP_info.csv
2613	20-35177	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of spindled and polygonal melanocytes, some with enlarged nuclei. The background epidermis is acanthotic and hyperkeratotic. There are eosinophilic globules in the epidermis in some areas. The melanocytes in the dermis mature in size with descent.	Cylindrical skin segment and one-half cylindrical skin segment received. Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected. One-half cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, intact. All entirely submitted. KC/KC	2 PIECES; ATYPICAL NEVUS, R/O MELANOMA	\N	\N	\N	I performed a few select immunoperoxidase stains to further evaluate this Spitzoid melanocytic proliferation. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product among the lesional melanocytes. This excludes a bi-allelic loss of chr. 9p. In addition, the melanocytes do not label with a PRAME immunoperoxidase stain. Coupling these staining results with the features on the routinely-stained section, the findings in this biopsy represent a compound Spitz's nevus. The nevus focally extends to the peripheral edge of the specimen. I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	SPITZ'S NEVUS, COMPOUND TYPE	173620	450	\N	\N	20-35177	\N	DMS-038	Superficial Congenital Nevi	IP2182787	AirTable blocks_with_IP_info.csv
2105	17-35859C	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10865	216.5	DN	\N	The features are similar to those in (B).	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in C. PL/PL	A) JC17-152, R/O 6 MM ATYPICAL MOLE, B) JC17-153, R/O 6 MM ATYPICAL MOLE, C) JC17-154, R/O 3 MM ATYPICAL MOLE	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	173543	497	\N	\N	17-35859	C	DN-022	Dysplastic Nevi	IP1082132	AirTable blocks_with_IP_info.csv
1226	06-17562-2 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1011	\N	\N	None	\N	MD-125	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1220	06-15453C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1012	\N	\N	None	\N	MD-127	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2620	20-43970	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a well-circumscribed proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. CF/HD	4 MM DARK BROWN PAPULE W/ SLIGHT CENTRAL BLUE-GRAY VEIL ON DERMOSCOPY - NEW NEVUS; CMN VS. PIGMENTED SPITZ, R/O DN / MM	\N	\N	\N	None	COMPOUND SPITZ NEVUS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	139523	451	\N	\N	20-43970	\N	DMS-039	Superficial Congenital Nevi	IP2191651	AirTable blocks_with_IP_info.csv
2572	20-5264	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of large fusiform melanocytes arrayed as nests and fascicles along and above the junctional zone and as maturing nests and fascicles in the underlying dermis. The background epidermis is acanthotic. A lymphohistiocytic infiltrate is focally noted.	Skin segment measuring 0.6 x 0.3 x 0.2 cm. Submitted intact. BY/BY	R/O SPITZ NEVUS	\N	\N	\N	This biopsy demonstrates a Spitz/Reed nevus, and thus your clinical diagnosis is exactly correct. Immunohistochemistry demonstrates that expression of p16 is retained, and this finding lends additional support to the diagnosis of melanocytic nevus.	FASCICULAR COMPOUND SPITZ NEVUS	100578	452	\N	\N	20-5264	\N	DMS-040	Superficial Congenital Nevi	IP2152745	AirTable blocks_with_IP_info.csv
2631	20-57917	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. BY/BY	ATYPICAL NEVUS	\N	\N	\N	None	SPITZ'S NEVUS, COMPOUND TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	453	\N	\N	20-57917	\N	DMS-041	Superficial Congenital Nevi	IP2205671	AirTable blocks_with_IP_info.csv
2635	20-64178	10	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	There is a well circumscribed proliferation of moderately enlarged melanocytes, arranged mostly as nests along the dermo-epidermal junction. The junctional melanocytes have scant, pigmented cytoplasm and monomorphous oval nuclei. There is epidermal hyperplasia overlying the lesion. Smaller cells are present in the subjacent papillary dermis. Kamino bodies are present. There is pigmentation of the basal layer and in subjacent melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. BB/CF	R/O NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN, MELANOCYTIC NEVUS, MELANOMA OF SKIN, DYSPLASTIC NEVUS OF SKIN, BLUE NEVUS OF SKIN, 6 MM PUNCH, HYPERPIGMENTED PAPULE, 6 MM PUNCH DONE WHICH REMOVED ALL OF THE LESION	\N	\N	\N	The margins appear clear in the planes of section examined. There are no microscopic findings that suggest a need for re-excision.	PIGMENTED SPINDLE CELL (REED'S) NEVUS, COMPOUND	173450	454	\N	\N	20-64178	\N	DMS-042	Superficial Congenital Nevi	IP2211971	AirTable blocks_with_IP_info.csv
2798	22-46448	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels. The superficial dermal melanocytes are pigmented and associated with scattered melanophages. In the most cellular areas of the lesion, there are irregular clefts between melanocytes, creating a pattern that resembles a vascular neoplasm.	Skin segment measuring 0.8 x 0.8 x 0.2 cm, trisected and entirely submitted. KB/KB	REGULAR, SYMMETRICAL, EVENLY-COLORED BROWN MACULE; BENIGN NEVUS	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	173531	466	\N	\N	22-46448	\N	DMS-054	Superficial Congenital Nevi	IP2448183	AirTable blocks_with_IP_info.csv
2892	23-7509	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. HD/ES	A) ATYPICAL NEVI. 6 MM RUBBERY PINK/RED PAPULE WITH DARKENED CENTER. COMPLETE READ.	\N	\N	\N	The biopsy shows a compound proliferation of spitzoid melanocytes with a relatively symmetrical growth pattern. The cells of interest are strongly positive with an ALK stain. ALK gene fusions and subsequent over-expression of ALK protein has been identified in a subset of Spitz nevi, atypical Spitz tumors and Spitz melanomas. The length of some of the fascicles with vertical orientation is the morphologic clue that is associated with this genetic event. A p16 immunoperoxidase stain is positive indicating there is no loss of that tumor suppressor gene product, and PRAME staining is negative. These results support a diagnosis of a Spitz nevus over Spitz melanocytoma or Spitz melanoma.	COMPOUND SPITZ NEVUS WITH AN ALK GENE FUSION, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	592733	455	\N	\N	23-7509	\N	DMS-043	Superficial Congenital Nevi	IP2545623	AirTable blocks_with_IP_info.csv
2896	23-14412	3	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Skin segment measuring 0.6 x 0.6 x 0.3 cm, bisected and entirely submitted. BY/BY	A) PYOGENIC GRANULOMA VS. SPITZ NEVUS.	\N	\N	\N	The biopsy shows a compound proliferation of spitzoid melanocytes with associated epidermal hyperplasia and Kamino body formation. p16 staining is positive, and PRAME staining is negative. The neoplasm has a symmetrical growth pattern with evidence of dermal maturation. These findings support a benign diagnosis of a Spitz nevus.	COMPOUND SPITZ NEVUS, EXTENDING TO THE SPECIMEN PERIPHERY	173741	456	\N	\N	23-14412	\N	DMS-044	Superficial Congenital Nevi	IP2552547	AirTable blocks_with_IP_info.csv
2900	23-37594	3	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Small keratinizing cysts are present in the superficial dermis and there is overlying parakeratosis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes form fascicular nests in the dermis and mature with descent with the sizes of their aggregations also diminishing with descent.	Skin segment measuring 0.6 x 0.6 x 0.2 cm, bisected and entirely submitted. HD/KB	PINK CAULIFLOWER - LIKE PAPULES; WART VS. MOLLUSCUM	\N	\N	\N	None	COMPOUND SPITZ NEVUS	173613	457	\N	\N	23-37594	\N	DMS-045	Superficial Congenital Nevi	IP2575828	AirTable blocks_with_IP_info.csv
1989	16-118014	84	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	DN	\N	Sections show a compound proliferation of melanocytes with round to oval nuclei and scant cytoplasm, arrayed as nests along the epidermal-dermal junction and as small clusters in the subjacent dermis. There is solar elastosis.	Skin segment measuring 1.1 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. BENIGN NEVUS. MACULE.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS	112610	561	\N	\N	16-118014	\N	DN-086	Dysplastic Nevi	IP1647593	AirTable blocks_with_IP_info.csv
2901	23-42323	3	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly symmetrical compound melanocytic proliferation with a domed surface.  The overlying epidermis is thickened, with hyperplasia of the spinous layer, hypergranulosis and compact hyperkeratosis. Situated at the epidermal-dermal junction are nests of slightly enlarged but monomorphous oval melanocytes, some of which are separated from the epidermis by clefts.  The junctional melanocytes have abundant pale cytoplasm monomorphous vesicular nuclei containing small nucleoli. Kamino bodies (dull pink globules) are present. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. ES/ES	4 MM ERYTHEMATOUS PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ANGIOMA VS. SPITZ NEVUS VS. WART VS. AMELANOTIC MELANOMA	\N	\N	\N	The neoplasm extends to the peripheral edge of the specimen. There are absolutely no worrisome features.	COMPOUND SPITZ'S NEVUS	523659	458	\N	\N	23-42323	\N	DMS-046	Superficial Congenital Nevi	IP2580588	AirTable blocks_with_IP_info.csv
2203	17-102266	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale pigmented cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. There are multiple Kamino bodies in the epidermis and rare pagetoid scatter is limited to the central portion of the lesion. Nests of similar melanocytes are present in the dermis and the sizes of their aggregations also diminish with descent. There is a focally dense lymphocytic infiltrate.	Skin segment measuring 1.1 x 0.7 x 0.3 cm, trisected and entirely submitted. KC/KC	SPITZ NEVUS VS. ATYPICAL NEVUS, PLEASE CHECK MARGINS (SEE PHOTO)	\N	\N	\N	Thank you for sending a clinical photograph. The nevus is excised in planes of section examined.	COMPOUND SPITZ'S NEVUS, INFLAMED	121790	459	\N	\N	17-102266	\N	DMS-047	Superficial Congenital Nevi	IP1832595	AirTable blocks_with_IP_info.csv
2229	17-113038	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of large fusiform melanocytes arrayed as nests and fascicles along and above the junctional zone and as smaller nests and fascicles in the underlying dermis, where a florid lymphohistiocytic infiltrate with admixed melanophages is noted. The background epidermis is acanthotic. There are many pigmented pink globules. The cells of interest are also finely pigmented.	Cylindrical skin segment, 0.6 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. HD/HD	4 X 7 MM PIGMENTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SPITZ NEVUS	\N	\N	\N	The melanocytic nevus appears excised in the available planes of section.	INTRAEPIDERMAL PIGMENTED SPITZ (PIGMENTED SPINDLE CELL) NEVUS	173784	460	\N	\N	17-113038	\N	DMS-048	Superficial Congenital Nevi	IP1843519	AirTable blocks_with_IP_info.csv
2799	22-47776	13	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment, 1.0 x 0.6 x 0.2 cm, bisected and entirely submitted. KB/KB	PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR, R/O NEVUS VS. CLARK'S NEVUS VS. MELANOMA	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	104401	467	\N	\N	22-47776	\N	DMS-055	Superficial Congenital Nevi	IP2449513	AirTable blocks_with_IP_info.csv
2265	17-130985	30	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a well circumscribed and roughly symmetrical compound melanocytic proliferation with a domed surface.  The overlying epidermis is thickened, with hyperplasia of the spinous layer, hypergranulosis and compact hyperkeratosis. Situated at the epidermal-dermal junction are nests of large oval melanocytes, some of which are separated from the epidermis by clefts.  The junctional melanocytes have abundant cytoplasm and large, monomorphous vesicular nuclei. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent, forming a flat base in the superficial dermis.	Skin segment measuring 1.0 x 0.9 x 0.2 cm, quadrisected and entirely submitted. RS/RS	R/O MM VS. ATYPICAL NEVUS	\N	\N	\N	The margins appear clear in the planes of section examined. There are no microscopic findings that suggest a need for re-excision.	SPITZ'S NEVUS, COMPOUND	173799	461	\N	\N	17-130985	\N	DMS-049	Superficial Congenital Nevi	IP1861634	AirTable blocks_with_IP_info.csv
2120	17-48914	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a zone of fibrosing granulation tissue corresponding to the site of a previous biopsy. In addition, there is a compound proliferation of spindled and polygonal melanocytes, some with enlarged nuclei in a somewhat wedge shape. The background epidermis is acanthotic and hyperkeratotic.	Ellipse measuring 1.0 x 0.6 x 0.2 cm, with the margins inked, quadrisected perpendicular to the long axis and entirely submitted. PL/PL	CHECK MARGINS, SEE PATH DT17-35380	\N	\N	\N	I reviewed the prior biopsy at this site (17-35380). Coupling the features in that biopsy with the findings in this re-excision specimen, it is now clear that this neoplasm represents a compound Spitz's nevus. I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	RESIDUAL COMPOUND SPITZ'S NEVUS, NARROWLY EXCISED	273699	462	\N	\N	17-48914	\N	DMS-050	Superficial Congenital Nevi	IP1764826	AirTable blocks_with_IP_info.csv
2171	17-75346	26	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a symmetric proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale pigmented and amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Small Kamino bodies are present in the epidermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. The papillary dermis contains melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. HD/PL	IRREGULARLY PIGMENTED PAPULE OF 8 MONTHS DURATION	\N	\N	\N	This Spitz nevus abuts the edge of the biopsy. Clinical monitoring of the site or removal of residual pigmented lesion is recommended.	COMPOUND SPITZ'S NEVUS	173605	463	\N	\N	17-75346	\N	DMS-051	Superficial Congenital Nevi	IP1805306	AirTable blocks_with_IP_info.csv
2190	17-91856A	23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of large spindled melanocytes, arrayed as nests and fascicles along the junctional zone and as smaller nests and fascicles in the underlying superficial dermis.  The overlying epidermis is acanthotic, and there are foci of perimelanocytic clefting.	Oriented ellipse, 1.9 x 0.9 x 0.5 cm, including a central 0.8 x 0.8 cm brown area. With the notched tip placed to the left, this tip is indicated medial on the requisition and is designated 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections in A and four sections in B. KC/KC	R/O MM VS. DN, CHECK MARGINS	\N	\N	\N	The tumor cells are positive for ALK, indicating a Spitz nevus with an ALK fusion. Reference: Busam KJ, Kutzner H, Cerroni L, Wiesner T. Clinical and Pathologic Findings of Spitz Nevi and Atypical Spitz Tumors With ALK Fusions. Am J Surg Pathol. 2014 Apr 2. PubMed PMID: 24698967.  With your notch at 9 o'clock the compromised margin is at the 6 o'clock quadrant.	SPITZ'S NEVUS, COMPOUND TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173765	464	\N	\N	17-91856	A	DMS-052	Superficial Congenital Nevi	IP1817495	AirTable blocks_with_IP_info.csv
1211	06-10522-2B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1013	\N	\N	None	\N	MD-128	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1198	06-01846D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1014	\N	\N	None	\N	MD-130	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1206	06-06053B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1015	\N	\N	None	\N	MD-131	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2191	17-91856B	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of large spindled melanocytes, arrayed as nests and fascicles along the junctional zone and as smaller nests and fascicles in the underlying superficial dermis.  The overlying epidermis is acanthotic, and there are foci of perimelanocytic clefting.	Oriented ellipse, 1.9 x 0.9 x 0.5 cm, including a central 0.8 x 0.8 cm brown area. With the notched tip placed to the left, this tip is indicated medial on the requisition and is designated 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections in A and four sections in B. KC/KC	R/O MM VS. DN, CHECK MARGINS	\N	\N	\N	The tumor cells are positive for ALK, indicating a Spitz nevus with an ALK fusion. Reference: Busam KJ, Kutzner H, Cerroni L, Wiesner T. Clinical and Pathologic Findings of Spitz Nevi and Atypical Spitz Tumors With ALK Fusions. Am J Surg Pathol. 2014 Apr 2. PubMed PMID: 24698967.  With your notch at 9 o'clock the compromised margin is at the 6 o'clock quadrant.	SPITZ'S NEVUS, COMPOUND TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173765	464	\N	\N	17-91856	B	DMS-052	Superficial Congenital Nevi	IP1817495	AirTable blocks_with_IP_info.csv
2198	17-94254	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a broad proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Skin segment measuring 1.5 x 1.0 x 0.2 cm, quadrisected and entirely submitted. KC/KC	A) INTRADERMAL NEVUS VS. SPITS NEVUS VS DERMATOFIBROMA. DOME SHAPED REGULAR PAPULE.	\N	\N	\N	The neoplasm was broadly transected. Mitotic figures are rare and dermal maturation is evident. p16 staining does not show loss of that tumor suppressor protein. Overall the findings are consistent with a Spitz's nevus. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation.	IRRITATED COMPOUND SPITZ'S NEVUS, TRANSECTED ACROSS THE SPECIMEN BASE	173508	465	\N	\N	17-94254	\N	DMS-053	Superficial Congenital Nevi	IP1824484	AirTable blocks_with_IP_info.csv
1852	15-30226	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1294	\N	\N	15-30226	\N	OM-36	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3448	KIT8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1579	\N	\N	None	\N	SYNAT462	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3449	KIT21	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1580	\N	\N	None	\N	SYNAT463	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3451	KIT55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1581	\N	\N	None	\N	SYNAT464	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
2804	22-53879	47	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in C. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. . B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. . C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. .	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	110501	469	\N	\N	22-53879	\N	DMS-057	Superficial Congenital Nevi	IP2455638	AirTable blocks_with_IP_info.csv
2806	22-61674	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes featuring a central area in which there are nests, cords and strands of melanocytes that mature with descent; some lie adjacent to adnexal structures in the reticular dermis.  At the periphery of the neoplasm, there are nests of, and increased numbers of single melanocytes along the sides and bases of elongated rete ridges.  The bases of some adjacent rete ridges are fused, and the papillary dermis beneath them is fibrotic.	Skin segment measuring 1.2 x 1.0 x 0.3 cm, quadrisected and entirely submitted in A. BY/BY	A) 1.2 X 0.9 CM IRREGULAR BROWN PLAQUE, CHANGING; CLARK'S NEVUS VS. BENIGN MELANOCYTIC NEVUS, B) 0.8 X 0.5 CM BROWN PAPULE, TRAUMATIZED; TRAUMATIZED BENIGN MELANOCYTIC NEVUS, C) 0.5 X 0.3 CM SOFT BROWN PAPULE; BENIGN MELANOCYTIC NEVUS (TELEPHONE: 628-225-9082, MSG OK)	\N	\N	\N	With regard to specimen (A), the findings in the junctional component of the nevus resemble those seen in low grade Clark's or dysplastic nevi and would correspond to a macular peripheral area.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	133559	470	\N	\N	22-61674	\N	DMS-058	Superficial Congenital Nevi	IP2458098	AirTable blocks_with_IP_info.csv
2807	22-67443	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a domed segment of skin containing a compound proliferation of melanocytes with a junctional component of occasional single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.6 x 0.5 x 0.2 cm, bisected and entirely submitted in B. BY/BY	A-B) REGULAR, SYMMETRICAL, EVENLY-COLORED BROWN MACULE; BENIGN NEVUS	\N	\N	\N	None	LENTIGINOUS COMPOUND SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	139523	471	\N	\N	22-67443	\N	DMS-059	Superficial Congenital Nevi	IP794446	AirTable blocks_with_IP_info.csv
2820	22-84696	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a domed-papillated segment of skin containing a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. Most of the lesion consists of a dermal proliferation of mostly small melanocytes arranged as nests, cords, and syncytia arrayed in the reticular dermis around small vascular channels and extending deeply along follicular epithelium. The dermal melanocytes show maturation with dermal descent.	Skin segment measuring 0.9 x 0.7 x 0.4 cm, trisected and entirely submitted. PL/PL	ATYPICAL NEVUS. IRREGULAR BROWN MACULE.	\N	\N	\N	None	LENTIGINOUS COMPOUND SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	444599	472	\N	\N	22-84696	\N	DMS-060	Superficial Congenital Nevi	IP2486650	AirTable blocks_with_IP_info.csv
2822	22-88291	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes featuring a central area in which there are nests, cords and strands of melanocytes that mature with descent; some lie adjacent to adnexal structures in the reticular dermis.  At the periphery of the neoplasm, there are nests of, and increased numbers of single melanocytes along the sides and bases of elongated rete ridges.  The bases of some adjacent rete ridges are fused, and the papillary dermis beneath them is fibrotic.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, trisected and entirely submitted in B. BB/BY	A) 9 X 6 MM, B) 6 X 5 MM; A-B) R/O DYSPLASTIC NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	12522	473	\N	\N	22-88291	\N	DMS-061	Superficial Congenital Nevi	IP576759	AirTable blocks_with_IP_info.csv
2829	22-93578	26	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes featuring a central area in which there are nests, cords and strands of melanocytes that mature with descent; some lie adjacent to adnexal structures in the reticular dermis.  At the periphery of the neoplasm, there are nests of, and increased numbers of single melanocytes along the sides and bases of elongated rete ridges.  The bases of some adjacent rete ridges are fused, and the papillary dermis beneath them is fibrotic.  Some of the junctional nests are large and are composed of melanocytes with abundant dusty melanin within their cytoplasm.	Skin segment measuring 1.1 x 1.0 x 0.3 cm, quadrisected and entirely submitted. CF/BB	12 X 10 MM IRREGULAR PIGMENTED MACULE / PAPULE; R/O DYSPLASTIC NEVUS VS. OTHER	\N	\N	\N	The findings in the junctional component of the nevus resemble those seen in so-called Clark's or dysplastic nevi.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173530	474	\N	\N	22-93578	\N	DMS-062	Superficial Congenital Nevi	IP2495605	AirTable blocks_with_IP_info.csv
2833	22-95643B	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of variably pigmented rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted in B. KB/KB	A) PEARLY TELANGIECTATIC PAPULE; RULE-OUT BASAL CELL CARCINOMA, B) RULE-OUT ATYPICAL MELANOCYTIC PROCESS	\N	\N	\N	\N	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	173726	475	\N	\N	22-95643	B	DMS-063	DNA Methylation Study	IP1973500	AirTable blocks_with_IP_info.csv
2832	22-95643	51	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of variably pigmented rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted in B. KB/KB	A) PEARLY TELANGIECTATIC PAPULE; RULE-OUT BASAL CELL CARCINOMA, B) RULE-OUT ATYPICAL MELANOCYTIC PROCESS	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	173726	475	\N	\N	22-95643	\N	DMS-063	Superficial Congenital Nevi	IP1973500	AirTable blocks_with_IP_info.csv
1998	16-119468	15	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10823	216.4	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and papillary dermis, with a partially raised surface, and extension of junctional nests to the side of the dermal component.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. KC/KC	A) ATYPICAL NEVUS VS. MELANOMA VS. BENIGN NEVUS. 0.6 CM, IRREGULAR BORDERS. CC DENISE O'RIORDAN, MD.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	100449	476	\N	\N	16-119468	\N	DN-001	Dysplastic Nevi	IP1458214	AirTable blocks_with_IP_info.csv
2054	17-20901	18	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10842	216.5	\N	\N	Section show a broad compound proliferation of melanocytes arrayed in mostly nested fashion mostly along the junction and within a thickened and fibrotic papillary dermis.  There is a dense superficial dermal infiltrate of lymphocytes.	Skin segment measuring 1.9 x 0.6 x 0.1 cm, bisected and entirely submitted plus one fragment. RS/RS	R/O ATYPICAL NEVUS	\N	\N	\N	The lesion is broad and extends to the edges. Conservative re-excision of this site is recommended to prevent re-growth and/or evolution towards melanoma.	COMPOUND MELANOCYTIC NEVUS, CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO PERIPHERAL MARGINS	528599	477	\N	\N	17-20901	\N	DN-002	Dysplastic Nevi	IP1750156	AirTable blocks_with_IP_info.csv
2102	17-35589	18	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10862	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis.	Oriented ellipse, 4.7 x 1.7 x 0.8 cm, including a central 1.8 x 1.2 cm brown area. With the sutured tip placed to the left, this tip is indicated as laterally at 12 o'clock on the requisition. The 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with three sections each in A-D. Tips reserved. RS/RS	1.6 X 1.4 CM TAN PATCH, PROBABLE CONGENITAL NEVUS, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	110501	478	\N	\N	17-35589	\N	DN-003	Dysplastic Nevi	IP1765035	AirTable blocks_with_IP_info.csv
2137	17-62447B	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10875	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in B. HD/HD	A) 9 X 8 MM ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS, B) 8 MM ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	528522	485	\N	\N	17-62447	B	DN-010	Dysplastic Nevi	IP1792269	AirTable blocks_with_IP_info.csv
2058	17-21285	23	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10845	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages. The papillary dermis is fibrotic.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR. BLACK MACULE.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173528	479	\N	\N	17-21285	\N	DN-004	Dysplastic Nevi	IP1750551	AirTable blocks_with_IP_info.csv
2001	16-125611	25	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10825	216.5	DN	\N	Sections show a zone of inflammation and granulation tissue, representing the aftermath of a prior biopsy, with an adjacent compound proliferation of melanocytes limited to the epidermal-dermal junction and the superficial dermis.	Oriented ellipse, 1.9 x 1.0 x 0.6 cm, including a central 1.0 x 0.9 cm variegated brown area. With the orienting sutured tip placed to the left and indicated as 12 o'clock, medial tip on the requisition form, the 12-3-6 o'clock and 6-9-12 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and four sections in B. HD/HD	A) COMPOUND NEVUS WITH MODERATE ATYPIA. APPROPRIATELY HEALING BIOPSY SITE. PREVIOUS ACCESSION #: DT16-113705. PLEASE CHECK MARGINS. SUTURE PLACED AT 12 O'CLOCK MEDIAL TIP..	\N	\N	Scraping	None	HEALING BIOPSY SITE WITH RESIDUAL COMPOUND CLARK'S (DYSPLASTIC) NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173544	480	\N	\N	16-125611	\N	DN-005	Dysplastic Nevi	IP1713848	AirTable blocks_with_IP_info.csv
2006	16-126284A	24	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration in one area in the center.	Skin segment, 1.1 x 0.9 x 0.2 cm, trisected and totally submitted in A. CF/CF	A) 9 MM PINK / BROWN PAPULE WITH CENTRAL BROWN / BLACK DOT; DYSPLASTIC NEVUS, R/O MM, B) PINK ERODED PAPULE; EXCORIATED FOLLICULITIS, R/O NMSC	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	174533	481	\N	\N	16-126284	A	DN-006	Dysplastic Nevi	IP1726527	AirTable blocks_with_IP_info.csv
2057	17-21066B	26	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages. Some of melanocytes are spindled or epithelioid.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer. There are areas with slight spongiosis and parakeratosis.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) RED BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR, ENLARGING NEVUS, PT WITH SIGNIFICANT HISTORY OF ATYPICAL NEVI, B) RED PAPULE WITH BROWN EDGE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. As it extends close to the edge of the biopsy, a re-excision is warranted.	IRRITATED COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173726	482	\N	\N	17-21066	B	DN-007	Dysplastic Nevi	IP711299	AirTable blocks_with_IP_info.csv
1999	16-125177	28	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O SCABIES	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173524	483	\N	\N	16-125177	\N	DN-008	Dysplastic Nevi	IP1660916	AirTable blocks_with_IP_info.csv
1950	16-76143	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1317	\N	\N	16-76143	\N	OM-59	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2106	17-35916B	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10866	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages. There is focal parakeratosis.	Cylindrical skin segment, 0.6 cm in diameter and 1.4 cm in thickness, bisected and entirely submitted in B. CF/CF	A) RULE-OUT ATYPICAL MELANOCYTIC PROCESS. HEART-SHAPED BROWN MACULE WITH + UGLY DUCKLING SIGN, AND WITH COLORED OF BROWN, GRAY, RED AND PERIPHERAL DARK BLOTCH (ROSETTE?) ON DERMOSCOPY. LESION SIZE 6 MM; 6 MM P PERFORMED. B) JUNCTIONAL MELANOCYTIC NEVUS VS. RULE OUT ATYPICAL MELANOCYTIC PROCESS. DARK BROWN MACULE WITH IRREGULAR BORDER & + UGLY DUCKLING SIGN WITH COLORS OF BLACK, BROWN, RED. LESION SIZE 7 MM; 8 MM P PERFORMED.	\N	\N	\N	Similar as in (A), there are no signs that compel a re-excision.	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	345533	484	\N	\N	17-35916	B	DN-009	Dysplastic Nevi	IP1765367	AirTable blocks_with_IP_info.csv
2136	17-62447A	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10874	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of single and nested cells positioned along the epidermal-dermal junction, with similar cells in clusters and syncytia in the underlying dermis, with some cells arrayed in the superficial reticular and adventitial dermis.  The junctional melanocytes extend far lateral to those in the dermis. Bridging of adjacent rete ridges by nests of melanocytes is present in these areas.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected, and entirely submitted in A. HD/HD	A) 9 X 8 MM ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS, B) 8 MM ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS	\N	\N	\N	This lesion is atypical in that it shows irregular architectural features and a junctional component that extends considerably lateral of the dermal component. Conservative re-excision of this site is warranted to ensure complete removal and further progression of this lesion.	SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, COMPOUND TYPE, WITH LATERAL EXTENSION OF THE JUNCTIONAL COMPONENT, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173527	485	\N	\N	17-62447	A	DN-010	Dysplastic Nevi	IP1792269	AirTable blocks_with_IP_info.csv
2982	96-24948 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1016	\N	\N	None	\N	MD-132	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1173	05-26408 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1017	\N	\N	None	\N	MD-135	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1172	05-24184C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1018	\N	\N	None	\N	MD-137	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2059	17-21476B	30	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10846	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and a few are present above the basal layer. Scattered melanocytes have enlarged nuclei. There is a papular dermal component composed largely of small melanocytes, which mature with descent into the dermis. There is a bandlike infiltrate of lymphocytes in the papillary dermis, which focally obscures the dermo-epidermal junction.	Ellipse, 2.9 x 1.1 x 0.8 cm, including a central 1.0 x 0.8 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections in A and four sections in B. Tips reserved. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . PLEASE CHECK MARGINS..	\N	\N	Scraping	This lesion is atypical in that it displays significant architectural and cytologic atypia, representing the high end of dysplastic nevus.	INFLAMED COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	423566	486	\N	\N	17-21476	B	DN-011	Dysplastic Nevi	IP1745878	AirTable blocks_with_IP_info.csv
2003	16-125754	30	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10827	216.5	\N	\N	Sections show a circumscribed and symmetrical compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Ellipse, 1.6 x 0.7 x 0.6 cm, including a central 0.5 x 0.5 cm brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. KC/KC	6 MM DEEPLY PIGMENTED PAPULE WITH IRREG BORDER, BLONDE HAIRED, BLUE EYES, SURFER	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	528599	487	\N	\N	16-125754	\N	DN-012	Dysplastic Nevi	IP1725994	AirTable blocks_with_IP_info.csv
2143	17-62828B	31	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10881	216.5	\N	\N	The features are similar to those in (A).	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in B. KC/KC	A-B) IRREGULAR BROWN MACULE; DYSPLASTIC NEVUS VS. MIS	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	239512	488	\N	\N	17-62828	B	DN-013	Dysplastic Nevi	IP1792659	AirTable blocks_with_IP_info.csv
2142	17-62828A	31	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10880	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted in A. KC/KC	A-B) IRREGULAR BROWN MACULE; DYSPLASTIC NEVUS VS. MIS	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	102539	488	\N	\N	17-62828	A	DN-013	Dysplastic Nevi	IP1792659	AirTable blocks_with_IP_info.csv
1968	16-98123	32	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10835	216.5	DN	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows fibrosis, some in a lamellar configuration.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected and entirely submitted. CF/CF	9 MM BROWN NEVUS; R/O MM	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	333504	489	\N	\N	16-98123	\N	DN-014	Dysplastic Nevi	IP1698042	AirTable blocks_with_IP_info.csv
1984	16-108474	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1318	\N	\N	16-108474	\N	OM-60	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1991	16-118278	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1319	\N	\N	16-118278	\N	OM-61	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2091	17-34432D	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	DN	\N	Sections show a junctional proliferation of melanocytes without striking nuclear variability.  The proliferation has a flat configuration, when viewed from scanning magnification.  There is fibrosis of the papillary dermis.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in D. KC/KC	A-D) R/O DN, HISTORY OF CLARK'S, DYSPLASTIC NEVUS	\N	\N	Scraping	\N	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173710	490	\N	\N	17-34432	D	DN-015	Dysplastic Nevi	IP1697427	AirTable blocks_with_IP_info.csv
2089	17-34432B	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10856	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A-D) R/O DN, HISTORY OF CLARK'S, DYSPLASTIC NEVUS	\N	\N	Scraping	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE BASE OF THE SPECIMEN	100578	490	\N	\N	17-34432	B	DN-015	Dysplastic Nevi	IP1697427	AirTable blocks_with_IP_info.csv
2090	17-34432C	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	DN	\N	Sections show a proliferation of melanocytes in which nested and single cells are arrayed along the junction, above a papillary dermis that shows fibrosis, some of which is lamellar in pattern.  Single melanocytes are increased in number in some areas, with some melanocytes present above the basal zone.	Skin segment measuring 0.9 x 0.5 x 0.1 cm, bisected and entirely submitted in C. KC/KC	A-D) R/O DN, HISTORY OF CLARK'S, DYSPLASTIC NEVUS	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	173610	490	\N	\N	17-34432	C	DN-015	Dysplastic Nevi	IP1697427	AirTable blocks_with_IP_info.csv
2098	17-35486A	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10859	216.5	DN	\N	Sections show a compound proliferation of melanocytes with round to oval nuclei and scant cytoplasm, arrayed as nests along the epidermal-dermal junction and as small clusters in the subjacent dermis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in A. KC/KC	A-B) NEVUS, R/O ATYPIA	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	173530	491	\N	\N	17-35486	A	DN-016	Dysplastic Nevi	IP1764932	AirTable blocks_with_IP_info.csv
1174	05-26627-1B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1019	\N	\N	None	\N	MD-138	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1029	01-15780R T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1020	\N	\N	None	\N	MD-139	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2152	17-65201A	33	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10885	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted plus one fragment in A. RS/RS	A) 6 MM HYPERPIGMENTED MACULE W/ UNDERLYING ASYMMETRIC PIGMENT + ERYTHEMA; MELANOCYTIC NEVUS VS. OTHER W/ ATYPIA, B) 6 MM TAN-BROWN SOFT PAPULE, CONSTANTLY IRRITATED DUE TO LOCATION; IDN VS. OTHER MELANOCYTIC NEVUS, C) 8 MM HYPERPIGMENTED SOFT PAPULE, CONSTANTLY IRRITATED DUE TO LOCATION; IDN VS. OTHER MELANOCYTIC NEVUS	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	333504	492	\N	\N	17-65201	A	DN-017	Dysplastic Nevi	IP1795054	AirTable blocks_with_IP_info.csv
2108	17-35917B	34	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10867	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	One cylindrical skin segment and one tissue segment received in one specimen vial. Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness, bisected. Tissue segment measuring 0.5 x 0.2 x 0.2 cm, intact. All entirely submitted in B. CF/CF	A) JUNCTIONAL MELANOCYTIC NEVUS VS. RULE OUT ATYPICAL MELANOCYTIC PROCESS. SOMEWHAT TRIANGULARLY-SHAPED BROWN MACULE WITH PERIPHERAL DOTS ALONG ONE PERIPHERAL EDGE, BUT NOT ALONG THE REST OF THE LESION'S EDGE. LESION SIZE 4 MM; 4 MM P PERFORMED. B) JUNCTIONAL MELANOCYTIC NEVUS VS. SPITZ NEVUS, RULE OUT ATYPICAL MELANOCYTIC PROCESS. REGULAR, SYMMETRIC BROWN MACULE WITH SUBTLE PSEUDOPODS ALL AROUND PERIPHERY. LESION SIZE 2 MM; 3 MM P PERFORMED.	\N	\N	\N	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	101523	493	\N	\N	17-35917	B	DN-018	Dysplastic Nevi	IP1765368	AirTable blocks_with_IP_info.csv
2107	17-35917A	34	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes arrayed largely as nests along the epidermal-dermal junction and in the subjacent superficial dermis, and some neoplastic melanocytes have ample vacuolated and pigmented cytoplasm.  The superficial dermis also contains a permeative infiltrate of lymphocytes.	Cylindrical skin segment, 0.3 cm in diameter and 0.4 cm in thickness, submitted intact in A. CF/CF	A) JUNCTIONAL MELANOCYTIC NEVUS VS. RULE OUT ATYPICAL MELANOCYTIC PROCESS. SOMEWHAT TRIANGULARLY-SHAPED BROWN MACULE WITH PERIPHERAL DOTS ALONG ONE PERIPHERAL EDGE, BUT NOT ALONG THE REST OF THE LESION'S EDGE. LESION SIZE 4 MM; 4 MM P PERFORMED. B) JUNCTIONAL MELANOCYTIC NEVUS VS. SPITZ NEVUS, RULE OUT ATYPICAL MELANOCYTIC PROCESS. REGULAR, SYMMETRIC BROWN MACULE WITH SUBTLE PSEUDOPODS ALL AROUND PERIPHERY. LESION SIZE 2 MM; 3 MM P PERFORMED.	\N	\N	Scraping	April 27, 2017: There is no need for a re-excision.	COMPOUND MELANOCYTIC NEVUS, INFLAMED	239512	493	\N	\N	17-35917	A	DN-018	Dysplastic Nevi	IP1765368	AirTable blocks_with_IP_info.csv
2067	17-26400	35	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10850	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. KC/KC	TAN MACULE W/ FOCAL AREA OF DARK PIG CHANGING NEVUS; POSS MM	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	172541	494	\N	\N	17-26400	\N	DN-019	Dysplastic Nevi	IP1755718	AirTable blocks_with_IP_info.csv
3453	KIT76	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1582	\N	\N	None	\N	SYNAT465	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
10256	W09-1121	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	1583	\N	\N	\N	\N	SYNX180	\N	\N	Consolidated_data_final.csv
2140	17-62534	35	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10878	216.5	DN	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.3 x 1.0 x 0.1 cm, quadrisected and entirely submitted. PL/PL	1.2 CM X 8 MM BROWN PATCH WITH HYPERPIGMENTED BORDER NEVUS; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	495	\N	\N	17-62534	\N	DN-020	Dysplastic Nevi	IP1792363	AirTable blocks_with_IP_info.csv
2005	16-126258A	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10828	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in A. PL/PL	A) 8 MM IRREGULAR DARK / BROWN MACULE; NEVUS, R/O MM, B) APPROX 6 MM SCAR AT SITE OF LIKELY PRIOR NEVUS BIOPSY NOW WITH 3 MM BLACK DOT CENTRALLY, INITIAL PATH NOT AVAILABLE; REPIGMENTATION, R/O MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173527	496	\N	\N	16-126258	A	DN-021	Dysplastic Nevi	IP1726501	AirTable blocks_with_IP_info.csv
2104	17-35859B	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction.  Similar but slightly smaller cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in B. PL/PL	A) JC17-152, R/O 6 MM ATYPICAL MOLE, B) JC17-153, R/O 6 MM ATYPICAL MOLE, C) JC17-154, R/O 3 MM ATYPICAL MOLE	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	173529	497	\N	\N	17-35859	B	DN-022	Dysplastic Nevi	IP1082132	AirTable blocks_with_IP_info.csv
2103	17-35859A	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10863	216.5	DN	\N	Sections show a compound proliferation of melanocytes, arrayed in lentiginous and nested fashion along the epidermal-dermal junction and as clusters and syncytia of similar but smaller cells in the subjacent papillary and superficial reticular dermis. Some junctional melanocytes have abundant vacuolated cytoplasm and show fine cytoplasmic pigmentation. There is  lateral extension of junctional melanocytes beyond the last dermal cluster to one side, above slight papillary dermal fibrosis and a sparse infiltrate.	Skin segment measuring 1.1 x 0.8 x 0.2 cm, trisected and entirely submitted in A. PL/PL	A) JC17-152, R/O 6 MM ATYPICAL MOLE, B) JC17-153, R/O 6 MM ATYPICAL MOLE, C) JC17-154, R/O 3 MM ATYPICAL MOLE	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE	175566	497	\N	\N	17-35859	A	DN-022	Dysplastic Nevi	IP1082132	AirTable blocks_with_IP_info.csv
1168	05-20065-4 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1021	\N	\N	None	\N	MD-140	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1161	05-13894C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1022	\N	\N	None	\N	MD-141	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1992	16-119063	37	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis is fibrotic and contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	7 X 6 MM IRREGULAR MACULE; R/O MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	273588	498	\N	\N	16-119063	\N	DN-023	Dysplastic Nevi	IP1719254	AirTable blocks_with_IP_info.csv
2000	16-125609	38	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10824	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Cylindrical skin segment measuring 0.8 cm in diameter and 1.0 cm in thickness. With the margins inked, the specimen is trisected, and entirely submitted. HD/HD	PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	273588	499	\N	\N	16-125609	\N	DN-024	Dysplastic Nevi	IP1408533	AirTable blocks_with_IP_info.csv
1971	16-98528A	39	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10837	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. The superficial melanocytes have finely vacuolated and pigmented cytoplasm,  where as the ones underneath are small with almost no cytoplasm.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. NEVUS. MACULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. NEVUS. MACULE.	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	129522	500	\N	\N	16-98528	A	DN-025	Dysplastic Nevi	IP1698449	AirTable blocks_with_IP_info.csv
1963	16-97347	41	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10832	216.6	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	1 CM, ATYPICAL PIGMENTED LESION, AND IRREGULAR BROWN MACULE; ATYPICAL NEVUS VS. MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	529698	501	\N	\N	16-97347	\N	DN-026	Dysplastic Nevi	IP438654	AirTable blocks_with_IP_info.csv
1988	16-117695A	42	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10818	216.5	\N	\N	Sections show a compound proliferation of melanocytes in which nested and solitary cells are arrayed relatively evenly above a papillary dermis that displays nests of similar melanocytes, fibrosis, and a lymphocytic infiltrate.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected, and entirely submitted in A. HD/HD	A) 6 MM DARK BROWN W/ IRREGULAR PIGMENT; ATYPICAL NEVUS POSS MM, B) 4 MM DARK BROWN W/ IRREGULAR PIGMENT; ATYPICAL NEVUS POSS MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXTENDING TO THE EDGE OF THE SPECIMEN	102537	502	\N	\N	16-117695	A	DN-027	Dysplastic Nevi	IP1717875	AirTable blocks_with_IP_info.csv
10258	W10-143	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_3	\N	\N	\N	\N	\N	\N	\N	\N	\N	1584	\N	\N	\N	\N	SYNX181	\N	\N	Consolidated_data_final.csv
10259	S94-31062	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_4	\N	\N	\N	\N	\N	\N	\N	\N	\N	1585	\N	\N	\N	\N	SYNX182	\N	\N	Consolidated_data_final.csv
10260	S02-23636A02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_5	\N	\N	\N	\N	\N	\N	\N	\N	\N	1586	\N	\N	\N	\N	SYNX183	\N	\N	Consolidated_data_final.csv
2146	17-63837	42	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10883	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. KC/KC	JC17-264, 4 MM; R/O ATYPICAL, PINK MACULE WITH BROWN EDGE	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	503	\N	\N	17-63837	\N	DN-028	Dysplastic Nevi	IP342191	AirTable blocks_with_IP_info.csv
2079	17-27830B	43	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction.  Similar but slightly smaller cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted in B. PL/PL	A-B) NEVUS, R/O ATYPIA	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	139523	504	\N	\N	17-27830	B	DN-029	Dysplastic Nevi	IP709271	AirTable blocks_with_IP_info.csv
1967	16-98055B	43	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10834	216.6	DN	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A-C) NEOP UNC VS. DYSPLASTIC NEVUS	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173620	505	\N	\N	16-98055	B	DN-030	Dysplastic Nevi	IP834471	AirTable blocks_with_IP_info.csv
1966	16-98055A	43	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in A. RS/RS	A-C) NEOP UNC VS. DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGES OF THE SPECIMEN	152589	505	\N	\N	16-98055	A	DN-030	Dysplastic Nevi	IP834471	AirTable blocks_with_IP_info.csv
2148	17-64032	43	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	0.7 CM PIGMENTED PAPULE, STANDS OUT; R/O ATYPICAL NEVUS	\N	\N	Scraping	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	528599	506	\N	\N	17-64032	\N	DN-031	Dysplastic Nevi	IP1793874	AirTable blocks_with_IP_info.csv
1166	05-17080 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1023	\N	\N	None	\N	MD-142	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2080	17-27833	44	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned in areas along the junction, above a papillary dermis that is expanded by slight fibrosis, with areas where only fibrosis and no nests of melanocytes are present.	Skin segment measuring 1.4 x 1.0 x 0.1 cm, quadrisected and entirely submitted. PL/PL	11 X 7 MM IRREGULARLY PIGMENTED PATCH	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AREAS OF REGRESSION,  EXCISED IN PLANES OF SECTION EXAMINED	173527	507	\N	\N	17-27833	\N	DN-032	Dysplastic Nevi	IP1757164	AirTable blocks_with_IP_info.csv
1972	16-98733	44	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10838	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Oval excision measuring 1.2 x 1.1 x 0.7 cm, including a central 0.7 x 0.7 cm brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections. KC/KC	8 X 6 MM BR TAN PINK OVAL MAC; R/O DN, PLEASE CHECK MARGINS	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE PERIPHERAL MARGIN	173507	508	\N	\N	16-98733	\N	DN-033	Dysplastic Nevi	IP1494176	AirTable blocks_with_IP_info.csv
2071	17-26455B	44	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) 6 MM PINK PALUP; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BENIGN NEVUS, B) BROWN AND TAN PAPULE AND 6 X 4 MM; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. INTRADERMAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173556	509	\N	\N	17-26455	B	DN-034	Dysplastic Nevi	IP1755773	AirTable blocks_with_IP_info.csv
2101	17-35502B	44	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10861	216.5	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) IRREG 8 MM MACULE; R/O DYSPL CN VS. OTHER, B) HAZY 7 MM MACULE; R/O DYSPL CN VS. OTHER	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	105525	510	\N	\N	17-35502	B	DN-035	Dysplastic Nevi	IP1764948	AirTable blocks_with_IP_info.csv
2138	17-62502A	49	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10876	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.2 x 0.7 x 0.1 cm, trisected, and entirely submitted in A. HD/HD	A-B) CHANGING MELANOCYTIC NEVUS	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE	173544	519	\N	\N	17-62502	A	DN-044	Dysplastic Nevi	IP1792328	AirTable blocks_with_IP_info.csv
2100	17-35502A	44	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10860	216.6	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis. There is focal parakeratosis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) IRREG 8 MM MACULE; R/O DYSPL CN VS. OTHER, B) HAZY 7 MM MACULE; R/O DYSPL CN VS. OTHER	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	733602	510	\N	\N	17-35502	A	DN-035	Dysplastic Nevi	IP1764948	AirTable blocks_with_IP_info.csv
2097	17-34979	45	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	no tissue extracted	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. HD/HD	0.6 CM DARKER BROWN MACULE	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528599	511	\N	\N	17-34979	\N	DN-036	Dysplastic Nevi	IP1689367	AirTable blocks_with_IP_info.csv
2145	17-63503	45	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10882	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. HD/HD	IRREGULAR MACULE; R/O ATYPIA	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	102537	512	\N	\N	17-63503	\N	DN-037	Dysplastic Nevi	IP1793343	AirTable blocks_with_IP_info.csv
2019	17-2270A	46	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10848	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges in some areas, and are accompanied by lamellar fibrosis.	Ellipse, 1.0 x 0.7 x 0.2 cm, including a central 0.7 x 0.5 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with five sections in A. HD/HD	A-B) R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	173539	513	\N	\N	17-2270	A	DN-038	Dysplastic Nevi	IP1731355	AirTable blocks_with_IP_info.csv
1993	16-119311	46	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction and within the papillary dermis, with elongated and hyperpigmented rete which bear both nested and solitary melanocytes. The papillary dermis shows fibrosis, some of which is lamellar in configuration, and a sparse infiltrate.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, trisected and entirely submitted. KC/KC	PIGMENTED NEOPLASM; R/O ATYPIA	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139524	514	\N	\N	16-119311	\N	DN-039	Dysplastic Nevi	IP1719503	AirTable blocks_with_IP_info.csv
2193	17-92405	54	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O DN, MM	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	273588	578	\N	\N	17-92405	\N	DN-103	Dysplastic Nevi	IP1822602	AirTable blocks_with_IP_info.csv
2150	17-65020B	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.6	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) CYT17-933, R/O BCC, PEARLY PATCH, LESION SIZE 6 MM, B) CYT17-934, R/O ATYPIA, PINK BROWN PAPULE WITH IRREGULAR BORDER, LESION SIZE 7 X 4 MM, C) CYT17-935, R/O ATYPIA, PINK BROWN PAPULE WITH IRREGULAR BORDERS, LESION SIZE 6 X 5 MM	\N	\N	Scraping	July 17, 2017: There are no worrisome features that would compel a re-excision.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	529698	515	\N	\N	17-65020	B	DN-040	Dysplastic Nevi	IP87016	AirTable blocks_with_IP_info.csv
2149	17-65000	68	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show basilar pigmentation of plump elongated rete ridges above elastosis, with no significant increase in the number of junctional melanocytes.  There are clusters of melanophages in the superficial dermis.	Skin segment measuring 1.2 x 1.0 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	UNEVENLY PIGMENTED MACULE; R/O MALIGNANCY (1 X 1 CM)	\N	\N	\N	None	SOLAR LENTIGO, WITH SUPERIMPOSED POST-INFLAMMATORY PIGMENTARY ALTERATION	139522	516	\N	\N	17-65000	\N	DN-041	Dysplastic Nevi	IP1794850	AirTable blocks_with_IP_info.csv
2081	17-28040A	46	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10855	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Cylindrical skin segment, 1.1 cm in diameter and 0.6 cm in thickness, with the margins inked, serially sectioned and entirely submitted with five sections in A. RS/RS	A) 7 MM REDDISH BROWN MACULE IRREG PIGMENT NEW SINCE 2014; R/O ATYP NEVUS VS. MEL, B) 9 MM IRREG BROWN MACULE CHANGED SINCE 2014; R/O ATYP NEVUS (TELEPHONE: 646-243-7108 MSG OK)	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	100556	517	\N	\N	17-28040	A	DN-042	Dysplastic Nevi	IP884112	AirTable blocks_with_IP_info.csv
2025	17-3739	49	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. PL/PL	SOFT HAZY TAN PAPULE; R/O COMP NEVUS VS. OTHER	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173536	518	\N	\N	17-3739	\N	DN-043	Dysplastic Nevi	IP891221	AirTable blocks_with_IP_info.csv
10261	S02-33818A03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_6	\N	\N	\N	\N	\N	\N	\N	\N	\N	1587	\N	\N	\N	\N	SYNX184	\N	\N	Consolidated_data_final.csv
2139	17-62502B	49	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10877	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.5 x 1.0 x 0.1 cm, quadrisected, and entirely submitted in B. HD/HD	A-B) CHANGING MELANOCYTIC NEVUS	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT	139524	519	\N	\N	17-62502	B	DN-044	Dysplastic Nevi	IP1792328	AirTable blocks_with_IP_info.csv
2078	17-27410	50	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	no tissue extracted	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 1.2 x 1.0 x 0.3 cm, quadrisected longitudinally and entirely submitted. RS/RS	ERYTHEMATOUS PATCH WITH BROWN EDGE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA, PLEASE SECTION LONGITUDINALLY, BROWN PIGMENT IS AT ONE EDGE OF THE ELLIPTICAL LESION	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	173505	520	\N	\N	17-27410	\N	DN-045	Dysplastic Nevi	IP465995	AirTable blocks_with_IP_info.csv
1965	16-98043	50	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10833	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a focally dense infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate. Scattered melanocytes have enlarged nuclei.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/RS	ITCHY 5 MM PAPULE WITH PINK AREA; ? MM VS. OTHER	\N	\N	Scraping	This lesion is atypical in that it appears poorly circumscribed and has areas in which single melanocytes predominate. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	273588	521	\N	\N	16-98043	\N	DN-046	Dysplastic Nevi	IP1697959	AirTable blocks_with_IP_info.csv
2026	17-3829B	51	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10871	216.5	DN	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction and within the papillary dermis, with elongated and hyperpigmented rete which bear both nested and solitary melanocytes. The papillary dermis shows fibrosis, some of which is lamellar in configuration, and a sparse infiltrate.	Skin segment measuring 1.1 x 1.1 x 0.1 cm, serially sectioned and entirely submitted with five sections in B. KC/KC	A) BASAL CELL CARCINOMA VS. ACTINIC KERATOSIS. SHINY PATCH, 0.4 CM. CC STEVEN DAGG, MD. B) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. UNEVENLY PIGMENTED GROWTH, 0.9 CM DIAMETER.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139510	522	\N	\N	17-3829	B	DN-047	Dysplastic Nevi	IP1732930	AirTable blocks_with_IP_info.csv
1152	05-04841C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1024	\N	\N	None	\N	MD-144	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1995	16-119467B	52	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10821	216.5	DN	\N	Sections show a compound proliferation of melanocytes in which nested and solitary cells are arrayed relatively evenly above a papillary dermis that displays nests of similar melanocytes, fibrosis, and a lymphocytic infiltrate. There is focal spongiosis.	Skin segment measuring 1.4 x 1.0 x 0.2 cm, quadrisected and entirely submitted in B. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR. 9MM2 HK TAN PINK R/O SK VS. SCC. B) NEOPLASM OF UNCERTAIN BEHAVIOR. 1.2X0.8CM SPECKLED TAN BROWN PATCH, NEVUS R/O ATYPIA. C) NEOPLASM OF UNCERTAIN BEHAVIOR. 5X6MM TAN PINK MACULE, NEVUS R/O ATYPIA. PLEASE CC DR. CYNTHIA STEPHENSEN IN WALNUT CREEK (DDS). D) NEOPLASM OF UNCERTAIN BEHAVIOR. 8MM2 DARK BROWN MACULE, NEVUS R/O ATYPIA.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXTENDING TO THE EDGE OF THE SPECIMEN	528599	523	\N	\N	16-119467	B	DN-048	Dysplastic Nevi	IP1719660	AirTable blocks_with_IP_info.csv
1997	16-119467D	52	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10822	216.5	DN	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in D. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR. 9MM2 HK TAN PINK R/O SK VS. SCC. B) NEOPLASM OF UNCERTAIN BEHAVIOR. 1.2X0.8CM SPECKLED TAN BROWN PATCH, NEVUS R/O ATYPIA. C) NEOPLASM OF UNCERTAIN BEHAVIOR. 5X6MM TAN PINK MACULE, NEVUS R/O ATYPIA. PLEASE CC DR. CYNTHIA STEPHENSEN IN WALNUT CREEK (DDS). D) NEOPLASM OF UNCERTAIN BEHAVIOR. 8MM2 DARK BROWN MACULE, NEVUS R/O ATYPIA.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173539	523	\N	\N	16-119467	D	DN-048	Dysplastic Nevi	IP1719660	AirTable blocks_with_IP_info.csv
1996	16-119467C	52	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in C. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR. 9MM2 HK TAN PINK R/O SK VS. SCC. B) NEOPLASM OF UNCERTAIN BEHAVIOR. 1.2X0.8CM SPECKLED TAN BROWN PATCH, NEVUS R/O ATYPIA. C) NEOPLASM OF UNCERTAIN BEHAVIOR. 5X6MM TAN PINK MACULE, NEVUS R/O ATYPIA. PLEASE CC DR. CYNTHIA STEPHENSEN IN WALNUT CREEK (DDS). D) NEOPLASM OF UNCERTAIN BEHAVIOR. 8MM2 DARK BROWN MACULE, NEVUS R/O ATYPIA.	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	173531	523	\N	\N	16-119467	C	DN-048	Dysplastic Nevi	IP1719660	AirTable blocks_with_IP_info.csv
2024	17-3731	60	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10870	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	NEVUS, R/O ATYPIA	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	531	\N	\N	17-3731	\N	DN-056	Dysplastic Nevi	IP28684	AirTable blocks_with_IP_info.csv
1970	16-98328A	55	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10836	238.2	DN	\N	Sections show a circumscribed compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and a few are present above the basal layer in some areas. There are patchy infiltrates of lymphocytes.	Ellipse, 1.8 x 1.1 x 0.8 cm, including a central 1.1 x 0.8 cm brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections in A. KC/KC	A) SUSPECT MELANOMA EXCISIONAL BX, B) SUSPECT NMSC (TELEPHONE: 415-531-1244 MSG OK)	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, INFLAMED, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173531	524	\N	\N	16-98328	A	DN-049	Dysplastic Nevi	IP1698249	AirTable blocks_with_IP_info.csv
2070	17-26447	56	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis. Scattered melanocytes have enlarged nuclei.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	IRREGULARLY PIGMENTED MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173533	525	\N	\N	17-26447	\N	DN-050	Dysplastic Nevi	IP1755765	AirTable blocks_with_IP_info.csv
2073	17-26969	57	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction and on one side scattered melanocytes have enlarged nuclei.	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/RS	PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	This lesion is atypical in that it is asymmetrical, with a area of larger melanocytes towards one edge. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	173539	526	\N	\N	17-26969	\N	DN-051	Dysplastic Nevi	IP313644	AirTable blocks_with_IP_info.csv
2092	17-34448	58	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 0.8 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	8 MM IRP WITH NEW HYPERPIGMENTATION; R/O ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	139523	527	\N	\N	17-34448	\N	DN-052	Dysplastic Nevi	IP1572932	AirTable blocks_with_IP_info.csv
2096	17-34977	59	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10858	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.7 x 0.2 cm, trisected and entirely submitted. HD/HD	0.6 CM SLIGHTLY IRREGULAR BROWN MACULE	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	172599	528	\N	\N	17-34977	\N	DN-053	Dysplastic Nevi	IP1764420	AirTable blocks_with_IP_info.csv
1116	04-08148D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1025	\N	\N	None	\N	MD-146	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1136	04-22191D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1026	\N	\N	None	\N	MD-147	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1153	05-04949-1C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1027	\N	\N	None	\N	MD-148	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2154	17-65263C	59	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10886	216.5	DN	\N	There is a compound proliferation of melanocytes in which junctional nests are inconspicuous.  There are slightly elongated rete and papillary dermal fibrosis, some of which is lamellar.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted in C. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. PIGMENTED MACULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. PAPULE AND PIGMENTED MACULE.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, WITH INVOLUTIONAL CHANGES, EXCISED IN PLANES OF SECTION EXAMINED	139523	529	\N	\N	17-65263	C	DN-054	Dysplastic Nevi	IP1662759	AirTable blocks_with_IP_info.csv
2068	17-26432A	60	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10851	172.6	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which consists of nested and solitary melanocytes in irregular array within the epidermis. Scattered melanocytes have enlarged nuclei and/or a positional above the basal layer.  In some areas with the epidermis, a relatively orderly pattern of nesting is apparent. A few nest of may be in the underlying papillary dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) ATYPICAL BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, B) ATYPICAL BROWN PATCH; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	\N	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA IN SITU, ARISING IN A COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	529699	530	\N	\N	17-26432	A	DN-055	Dysplastic Nevi	IP99195	AirTable blocks_with_IP_info.csv
2069	17-26432B	60	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10852	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.1 x 1.0 x 0.2 cm, quadrisected and entirely submitted in B. PL/PL	A) ATYPICAL BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, B) ATYPICAL BROWN PATCH; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXCISED IN PLANES OF SECTION EXAMINED	139522	530	\N	\N	17-26432	B	DN-055	Dysplastic Nevi	IP99195	AirTable blocks_with_IP_info.csv
10263	S05-7439A12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	1588	\N	\N	\N	\N	SYNX185	\N	\N	Consolidated_data_final.csv
10264	S05-41924	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_9	\N	\N	\N	\N	\N	\N	\N	\N	\N	1589	\N	\N	\N	\N	SYNX186	\N	\N	Consolidated_data_final.csv
10265	S06-47079A02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_10	\N	\N	\N	\N	\N	\N	\N	\N	\N	1590	\N	\N	\N	\N	SYNX187	\N	\N	Consolidated_data_final.csv
2056	17-21049	60	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10844	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	IRREGULAR BROWN PAPULE; ATYPICAL NEVUS	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	345533	532	\N	\N	17-21049	\N	DN-057	Dysplastic Nevi	IP899509	AirTable blocks_with_IP_info.csv
2066	17-26289G	61	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10849	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in G. RS/RS	A) 6 X 5 MM VARIEG BRN TAN MAC; R/O DYSPLASTIC NEVUS, B) 10 X 8 MM VARIEG BRN MAC; CMN, R/O ATYPIA, C) 11 X 7 MM VARIEG TAN MAC, D) 4 X 3 MM VARIEG BRN MAC; CMN, R/O DYSPLASTIC NEVUS, E) 7 X 8 MM VARIEG BRN MAC; CMN, R/O ATYPIA, F) 3 X 3 MM BRN MAC INLINE WITH #1.2; CMN, R/O ATYPIA, G) 11 X 7 MM PINK TAN PAP; CMN, R/O ATYPIA, H) 5 X 4 MM BRN IRREG PAP; CMN, R/O ATYPIA, I) 8 X 4 MM PINK PAP; R/O BCC, J) 1 CM X 8 MM PINK PAP; R/O BCC, K) 1 CM X 8 MM PINK PATCH; R/O BOWEN'S	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	173527	533	\N	\N	17-26289	G	DN-058	Dysplastic Nevi	IP1691692	AirTable blocks_with_IP_info.csv
2141	17-62813A	61	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10879	238.2	DN	\N	Sections show a melanocytic proliferation with nested and solitary melanocytes arrayed along the sides and bases of elongated rete and also occasionally above the junction, with lymphocytes and melanophages in the superficial dermis.	Oriented ellipse measuring 2.0 x 0.9 x 0.3 cm, including a central 0.6 x 0.6 cm brown area. With the blue dyed tip placed to the left and indicated as upper pole on the requisition form, this pole is designated as 12 o'clock by the grosser. The 12-3-6 o'clock margin is inked red and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in A and three in B. CF/CF	SUSPICOUS IRREGULAR MULTI-COLORED MACULE; MALIGNANT MELANOMA IN SITU VS. CA, 6 MM, MIS, CAN, EXCISION	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS WITH ATYPICAL FEATURES, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173777	534	\N	\N	17-62813	A	DN-059	Dysplastic Nevi	IP1275465	AirTable blocks_with_IP_info.csv
2074	17-27000	62	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10853	216.5	DN	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction.  Similar but slightly smaller cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O DN	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS WITH PIGMENTED EPITHELIOID MELANOCYTES	122533	535	\N	\N	17-27000	\N	DN-060	Dysplastic Nevi	IP1756322	AirTable blocks_with_IP_info.csv
1133	04-18775B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1028	\N	\N	None	\N	MD-149	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1125	04-14677 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1029	\N	\N	None	\N	MD-150	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1105	04-00122C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1030	\N	\N	None	\N	MD-151	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2093	17-34464A	62	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10857	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected and entirely submitted in A. CF/CF	A-B) PT WITH HISTORY OF MM, R/O MM	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139523	536	\N	\N	17-34464	A	DN-061	Dysplastic Nevi	IP1725842	AirTable blocks_with_IP_info.csv
2094	17-34464B	62	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	DN	\N	The features are similar to those in (A).	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in B. CF/CF	A-B) PT WITH HISTORY OF MM, R/O MM	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139523	536	\N	\N	17-34464	B	DN-061	Dysplastic Nevi	IP1725842	AirTable blocks_with_IP_info.csv
2153	17-65218B	62	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in B. KC/KC	A-B) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	This lesion is atypical in that it displays areas where melanocytes are arranged as single cells along the basal layer. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	239512	537	\N	\N	17-65218	B	DN-062	Dysplastic Nevi	IP464470	AirTable blocks_with_IP_info.csv
2055	17-20908	64	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile. There is abundant melanin in the cornified layer.	Skin segment measuring 1.2 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	RETICULATED SK VS. MELANOCYTIC NEOPLASM	\N	\N	Scraping	This lesion is quite broad and a re-excision may be prudent to prevent regrowth and possible evolution towards melanoma.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173556	538	\N	\N	17-20908	\N	DN-063	Dysplastic Nevi	IP1750163	AirTable blocks_with_IP_info.csv
1990	16-118019	65	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10819	216.7	DN	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis. There is solar elastosis.	Skin segment measuring 1.1 x 1.0 x 0.1 cm, quadrisected and entirely submitted. KC/KC	A) MELANOMA VS. NEVUS. SUSPICIOUS IRREGULAR MULTI-COLORED MACULE.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173710	539	\N	\N	16-118019	\N	DN-064	Dysplastic Nevi	IP1034557	AirTable blocks_with_IP_info.csv
1994	16-119333	67	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10820	216.6	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/RS	9 MM IRREGULAR PIG PAP	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173619	540	\N	\N	16-119333	\N	DN-065	Dysplastic Nevi	IP529433	AirTable blocks_with_IP_info.csv
2111	17-36682	67	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show a proliferation of melanocytes in which nested and single cells are arrayed along the junction, above a papillary dermis that shows fibrosis, some of which is lamellar in pattern.  Single melanocytes are increased in number in some areas, with some melanocytes present above the basal zone.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	5 MM BROWN AND PINK MACULE	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes, so that I cannot rule out an evolving melanoma in situ. Conservative re-excision of this site is warranted.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	273588	541	\N	\N	17-36682	\N	DN-066	Dysplastic Nevi	IP1766150	AirTable blocks_with_IP_info.csv
2008	16-126879A	68	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10830	216.7	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted in A. CF/CF	A-C) 0.6 X 0.6; R/O DYSP NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	122777	542	\N	\N	16-126879	A	DN-067	Dysplastic Nevi	IP1705946	AirTable blocks_with_IP_info.csv
2002	16-125621	68	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10826	216.5	DN	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	A) MELANOMA VS. NEVUS. SUSPICIOUS IRREGULAR MULTI-COLORED MACULE.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	345542	543	\N	\N	16-125621	\N	DN-068	Dysplastic Nevi	IP1725860	AirTable blocks_with_IP_info.csv
2053	17-20900B	69	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in B. RS/RS	A) R/O SK, B) R/O NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173724	544	\N	\N	17-20900	B	DN-069	Dysplastic Nevi	IP83591	AirTable blocks_with_IP_info.csv
1118	04-11144C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1031	\N	\N	None	\N	MD-152	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1124	04-14508C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1032	\N	\N	None	\N	MD-153	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1129	04-15616C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1033	\N	\N	None	\N	MD-154	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1131	04-17745B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1034	\N	\N	None	\N	MD-155	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1973	16-98735	69	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10839	216.5	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 1.1 x 0.9 x 0.1 cm, quadrisected and entirely submitted. KC/KC	IRREGULAR PIGMENTED PAPULE	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	173529	545	\N	\N	16-98735	\N	DN-070	Dysplastic Nevi	IP1698660	AirTable blocks_with_IP_info.csv
2052	17-20501C	69	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	DN	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component that extends lateral to the small underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  Scattered melanocytes have enlarged nuclei. There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment plus one fragment measuring 1.3 x 1.3 x 0.3 cm in aggregate. The skin segment is serially sectioned and entirely submitted with five sections. All submitted in C. RS/RS	A) 6 X 7 MM TAN REGULAR MACULE; FAVOR LENTIGO, B) PINK KERATOTIC 6 X 6 MM PAPULE; HAK, R/O NMSC, C) 1 X 6 MM TAN PAPULE WITH AMORPHOUS PIGMENT AND GREY DOT AT PERIPHERY WITH BACKGROUND ERYTHEMA; ? ATYPIA (TELEPHONE: 707-648-3733 MSG OK)	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Re-excision of this site is warranted to assure that the lesion is removed to prevent regrowth or progression to melanoma.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGES OF THE SPECIMEN	333504	546	\N	\N	17-20501	C	DN-071	Dysplastic Nevi	IP183716	AirTable blocks_with_IP_info.csv
2144	17-63163	69	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.4 x 0.1 cm, bisected and entirely submitted. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. PIGMENTED MACULE.	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528599	547	\N	\N	17-63163	\N	DN-072	Dysplastic Nevi	IP1572575	AirTable blocks_with_IP_info.csv
2076	17-27380	75	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.7	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	5 MM ASYMMETRICAL BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	234789	548	\N	\N	17-27380	\N	DN-073	Dysplastic Nevi	IP1756705	AirTable blocks_with_IP_info.csv
2135	17-62251	70	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	64.54.108.121/eSlideTray.php?ImageIds=10873	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.1 x 0.9 x 0.1 cm, quadrisected and entirely submitted plus fragments. RS/RS	IRREG BROWN PATCH, NEOPLASM NOS L UPPER BACK; R/O MM, SHAVE BX AFTER CONSTANT W.C - SPECKLED, ISK #1 LN2 / W.C (+) COMPONENT LSC + STOP ___ (SEE PHOTO)	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted to ensure complete removal and prevent progression to melanoma.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173530	549	\N	\N	17-62251	\N	DN-074	Dysplastic Nevi	IP1792072	AirTable blocks_with_IP_info.csv
1969	16-98130	71	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	\N	\N	Sections show a predominantly intradermal proliferation of small melanocytes with round to oval nuclei that mature (diminish in size) with descent in the dermis.  The overlying epidermis shows elongated rete that intertwine.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. CF/CF	4 X 4 MM BROWN PAP; SK VS. CMN R/O ATYPIA	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	106678	550	\N	\N	16-98130	\N	DN-075	Dysplastic Nevi	IP166471	AirTable blocks_with_IP_info.csv
2155	17-65315B	71	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	DN	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) ASYMMETRICAL 7 MM BROWN MACULE; POSS ATYPICAL NEVUS, B) 6 MM BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	897777	551	\N	\N	17-65315	B	DN-076	Dysplastic Nevi	IP1795170	AirTable blocks_with_IP_info.csv
2151	17-65160B	73	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10884	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) 6 MM X 5 MM ROUND, VERY UNEVEN PAPULE; CMN, R/O ATYPIA, B) 6 MM X 7 MM ROUND, DARK UNEVEN PIGMENTED MACULE; CMN, R/O ATYPIA	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	876543	552	\N	\N	17-65160	B	DN-077	Dysplastic Nevi	IP1795010	AirTable blocks_with_IP_info.csv
2349	18-121006	64	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10891	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/PL	6 X 5 MM, HISTORY MM X 2, IRREG CHANGING MACULE; DN VS. MM	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	105539	588	\N	\N	18-121006	\N	DN-113	Dysplastic Nevi	IP556850	AirTable blocks_with_IP_info.csv
1941	16-48776B	73	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10831	216.5	\N	\N	Sections show a compound proliferation of melanocytes in which both single cells and small nests are present along the sides and bases of elongated rete, extending well beyond a papillary dermal component of similar small melanocytes.  There is papillary dermal fibrosis, some of which is lamellar in configuration. There is an infiltrate of lymphocytes and melanophages in the superficial dermis.	Skin segment measuring 1.4 x 0.7 x 0.1 cm, trisected, wrapped, and entirely submitted in B. HD/HD	A) 7 X 4 MM PIGMENTED MACULE WITH IRREGULAR GREY COLOR, 8 MM PUNCH; NEVUS, MELANOMA, B) ABDOMEN 1.1 X 0.7 DARK BROWN MACULE WITH ___ OF IRREGULAR PIGMENTATION; NEVUS, MELANOMA, C) 3 X 3 FLAT PEARLY PAPULE; BCC, SK (TELEPHONE:  415-982-6614 MSG OK)	\N	\N	\N	Broad-based lentiginous Clark's or dysplastic nevi are often present on the backs of older (especially male) patients. These lesions are an exception to the rule that predominantly junctional melanocytic lesions in older patients are melanomas.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173528	553	\N	\N	16-48776	B	DN-078	Dysplastic Nevi	IP546	AirTable blocks_with_IP_info.csv
2147	17-63890C	72	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, in which only a few junctional nests lie above a papillary dermis that shows marked fibrosis.  Clusters of cytologically bland melanocytes are present in the papillary dermis.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, trisected and entirely submitted in C. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. ACTINIC KERATOSIS VS. BASAL CELL CARCINOMA. PAPULE. C) MELANOMA VS. NEVUS VS. PIGMENTED SEBORRHEIC KERATOSIS. SUSPICIOUS IRREGULAR MULTI-COLORED PAPULE.	\N	\N	\N	The architectural features of this lesion suggest that this is a so-called dysplastic or Clark's nevus in which much of the junctional component has involuted.	COMPOUND MELANOCYTIC NEVUS, WITH INVOLUTIONAL CHANGES	139512	554	\N	\N	17-63890	C	DN-079	Dysplastic Nevi	IP1793730	AirTable blocks_with_IP_info.csv
2018	17-2241	74	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10847	238.2	\N	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying small dermal component. There is a broad zone of papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted. KC/KC	13 X 11 MM; R/O LM VS. MM VS. MIS	\N	\N	\N	This lesion is atypical in that it displays areas in which single cells predominate and a limited degree of intraepithelial scatter of melanocytes.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGES OF THE SPECIMEN	102538	555	\N	\N	17-2241	\N	DN-080	Dysplastic Nevi	IP1731326	AirTable blocks_with_IP_info.csv
10266	S08-4544A03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_11	\N	\N	\N	\N	\N	\N	\N	\N	\N	1591	\N	\N	\N	\N	SYNX188	\N	\N	Consolidated_data_final.csv
10267	S10-26316A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_12	\N	\N	\N	\N	\N	\N	\N	\N	\N	1592	\N	\N	\N	\N	SYNX189	\N	\N	Consolidated_data_final.csv
10268	S10-44069A4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_13	\N	\N	\N	\N	\N	\N	\N	\N	\N	1593	\N	\N	\N	\N	SYNX190	\N	\N	Consolidated_data_final.csv
2051	17-20497A	75	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.6	DN	\N	Sections show nested and solitary melanocytes arrayed along the sides and bases of elongated and pigmented rete. There are many melanophages within the underlying superficial dermis. There is a bandlike infiltrate of lymphocytes in the papillary dermis. There is a focus with keratinous debris engulfed by macrophages, some of which are multinucleate and some of which display clefts within their cytoplasm.	Cylindrical skin segment, 0.6 cm in diameter and 0.9 cm in thickness, bisected and entirely submitted in A. RS/RS	A) 4 MM DARK BROWN MACULE; LENTIGO VS. MELANOMA, B) 2 X 1 CM SCAR LIKE NODULE, PT DENIES TRAUMA OR PROCEDURE; R/O SCAR ? DFSP (TELEPHONE: 650-755-7521 RUSSIAN)	\N	\N	Scraping	There is an incidental keratin granuloma.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS WITH MANY SUPERFICIAL DERMAL MELANOPHAGES	173619	556	\N	\N	17-20497	A	DN-081	Dysplastic Nevi	IP898098	AirTable blocks_with_IP_info.csv
2077	17-27403	76	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10854	216.6	\N	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction and within the papillary dermis, with elongated and hyperpigmented rete which bear both nested and solitary melanocytes. The papillary dermis shows fibrosis, some of which is lamellar in configuration, and a sparse infiltrate. There is solar elastosis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. RS/RS	ATYPICAL RED BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173611	557	\N	\N	17-27403	\N	DN-082	Dysplastic Nevi	IP111660	AirTable blocks_with_IP_info.csv
2119	17-48595B	78	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10872	238.2	\N	\N	Sections show a broad, compound melanocytic neoplasm in which junctional nests extends to either side of a central dermal component.  The junctional nests are located both at the sides and bases of elongated rete ridges, and contain a proportion of cytologically atypical cells.  Pagetoid upward migration is not present to a significant degree.  The papillary dermis shows marked fibrosis in the center and contains some melanocytes similar to those in the junctional zone, as well as smaller cells.	Skin segment measuring 1.2 x 1.0 x 0.1 cm, quadrisected and entirely submitted in B. PL/PL	A) TRANSLUCENT PG; R/O HIDROCYSTOMA VS. BCC, B) R/O DN, C) R/O AK / SCC	\N	\N	\N	This lesion is atypical in that it displays lack of maturation of dermal melanocytes. Conservative re-excision of this site is warranted to prevent the lesion to persist and evolve towards melanoma.	COMPOUND MELANOCYTIC NEVUS, WITH SEVERE DYSPLASIA AND PARTIAL REGRESSION, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	529698	558	\N	\N	17-48595	B	DN-083	Dysplastic Nevi	IP1567816	AirTable blocks_with_IP_info.csv
2110	17-36614	80	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10868	216.5	DN	\N	Sections show a junctional proliferation of melanocytes without striking nuclear variability.  The proliferation has a flat configuration, when viewed from scanning magnification.  There is fibrosis of the papillary dermis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. PL/PL	7 MM ASYMMETRICAL BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	None	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173531	559	\N	\N	17-36614	\N	DN-084	Dysplastic Nevi	IP1766078	AirTable blocks_with_IP_info.csv
2050	17-20244B	84	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10841	216.5	DN	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Two skin fragments measuring 0.9 x 0.7 x 0.1 cm in aggregate, one is bisected and all entirely submitted in B. CF/CF	A-B) R/O IRRITATED ID NEVUS, 0.6 X 0.6 CM	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139523	560	\N	\N	17-20244	B	DN-085	Dysplastic Nevi	IP1164464	AirTable blocks_with_IP_info.csv
1130	04-15689C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1035	\N	\N	None	\N	MD-156	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1123	04-13607 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1036	\N	\N	None	\N	MD-157	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2007	16-126714	87	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10829	216.5	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 1.4 x 0.9 x 0.1 cm, trisected and entirely submitted. PL/PL	7 MM IRREGULAR BROWN PATCH; R/O MELANOMA	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	105575	562	\N	\N	16-126714	\N	DN-087	Dysplastic Nevi	IP1683560	AirTable blocks_with_IP_info.csv
1914	16-12574	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	563	\N	\N	16-12574	\N	DN-088	Dysplastic Nevi	\N	AirTable blocks_with_IP_info.csv
2164	17-72585A	16	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show a proliferation of enlarged melanocytes in irregular array within the epidermis and dermis amidst fibrosis, flanked by a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in A. The contents of the specimen bottle filtered. RS/RS	A) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS WITH POSSIBLE CYST, B) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOTIC NEVUS, C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS	\N	\N	\N	This lesion is atypical in that it contains an area with enlarged melanocytes in irregular array at the dermo-epidermal junction and in the dermis, extending to the base. I performed immunoperoxidase staining in order to further evaluate this lesion. The cells in the area described above are strongly positive for p16 and show no labeling with a Ki-67 stain, supporting the notion that this is not melanoma. I have also shared this case with my colleagues, Dr. Philip LeBoit and Dr. McCalmont, who agree with these findings. Conservative re-excision of this site is warranted.	ATYPICAL COMPOUND MELANOCYTIC PROLIFERATION ARISING WITHIN A COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN, EXTENDING TO THE BASE OF THE SPECIMEN	529698	565	\N	\N	17-72585	A	DN-090	Dysplastic Nevi	IP1177975	AirTable blocks_with_IP_info.csv
2165	17-72585B	16	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.4	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis.	Skin segment measuring 0.8 x 0.6 x 0.2 cm, bisected and entirely submitted in B. RS/RS	A) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS WITH POSSIBLE CYST, B) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOTIC NEVUS, C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173404	565	\N	\N	17-72585	B	DN-090	Dysplastic Nevi	IP1177975	AirTable blocks_with_IP_info.csv
2166	17-72585C	16	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability, arrayed as nests along the junctional zone and within the underlying dermis.  The overlying epidermis is papillated and hyperkeratotic.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, trisected and entirely submitted in C. RS/RS	A) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS WITH POSSIBLE CYST, B) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOTIC NEVUS, C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	17723	565	\N	\N	17-72585	C	DN-090	Dysplastic Nevi	IP1177975	AirTable blocks_with_IP_info.csv
2196	17-93945C	17	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of single and nested cells positioned along the epidermal-dermal junction, with similar cells in clusters and syncytia in the underlying dermis, with some cells arrayed in the superficial reticular and adventitial dermis.  Scattered melanocytes have enlarged nuclei. The junctional melanocytes extend lateral to those in the dermis.	Skin segment measuring 1.1 x 0.8 x 0.2 cm, trisected and entirely submitted in C. CF/CF	A) 5 MM 2 TONED ASYM BROWN PAPULE; R/O ATYPICAL NEVUS VS. MM, B) 4 MM 2 TONED ASYM BROWN PAPULE; R/O ATYPICAL NEVUS VS. MM, C) 7 MM 2 TONED ASYM BROWN PAPULE; R/O ATYPICAL NEVUS VS. MM	\N	\N	\N	This lesion shows some attributes of a so-called Clark's or dysplastic nevus.	SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, COMPOUND TYPE, WITH LATERAL EXTENSION OF THE JUNCTIONAL COMPONENT, EXCISED IN PLANES OF SECTION EXAMINED	138523	566	\N	\N	17-93945	C	DN-091	Dysplastic Nevi	IP1824168	AirTable blocks_with_IP_info.csv
2178	17-82365B	20	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. Clusters of similar melanocytes are present in the dermis.	Skin segment measuring 0.8 x 0.6 x 0.2 cm, bisected and entirely submitted in B. RS/RS	A) 4 MM SOFT BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS, B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED COMPOUND NEVUS VS. CLARK'S NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	528599	567	\N	\N	17-82365	B	DN-092	Dysplastic Nevi	IP1812422	AirTable blocks_with_IP_info.csv
2161	17-72429A	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction of an epidermis with elongated rete ridges, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in A. CF/CF	A-B) IRREGULAR BROWN MACULE; R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173522	568	\N	\N	17-72429	A	DN-093	Dysplastic Nevi	IP1802357	AirTable blocks_with_IP_info.csv
2344	18-119366A	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction.  Similar but slightly smaller cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in A. HD/PL	A-C) COLOR VARIEGATION AND BORDER IRREGULARLY; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	101532	569	\N	\N	18-119366	A	DN-094	Dysplastic Nevi	IP1908323	AirTable blocks_with_IP_info.csv
2314	18-52908	63	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/PL	R/O DN, PARTIAL LESION	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	291511	589	\N	\N	18-52908	\N	DN-114	Dysplastic Nevi	IP1916757	AirTable blocks_with_IP_info.csv
1122	04-13171C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1037	\N	\N	None	\N	MD-158	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2192	17-91889	35	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of single and nested cells positioned along the epidermal-dermal junction, with similar cells in clusters and syncytia in the underlying dermis, with some cells arrayed in the superficial reticular and adventitial dermis.  The junctional melanocytes and superficial dermal melanocytes extend far lateral to one side to those in the deeper dermis.	Skin segment measuring 1.0 x 0.9 x 0.3 cm, quadrisected, and entirely submitted. HD/HD	7 X 5 MM PINK / TAN DOME SHAPED PAP WITH BROWN PIGMENTATION EXTENDING BEYOND THE BORDER; ATYPICAL NEVUS, R/O DYSPLASIA	\N	\N	\N	This lesion is atypical in that it displays a one-sided significant extension of its superficial component, which is that of a dysplastic nevus. As this portion extends to the tissue edges, I recommend further excision to ensure complete removal.	SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, COMPOUND TYPE, WITH ASYMMETRICAL LATERAL EXTENSION OF THE JUNCTIONAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	173502	570	\N	\N	17-91889	\N	DN-095	Dysplastic Nevi	IP1822073	AirTable blocks_with_IP_info.csv
2339	18-96108	39	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10897	216.5	\N	\N	Sections show a circumscribed compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 1.5 x 0.9 x 0.2 cm, quadrisected and entirely submitted. RS/RS	1.3 CM HAZY BROWN PATCH; R/O DYSPL CN VS. OTHER	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	101532	571	\N	\N	18-96108	\N	DN-096	Dysplastic Nevi	IP720723	AirTable blocks_with_IP_info.csv
2350	18-121403A	39	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10892	216.5	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A-B) R/O DYSPLASIA	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139512	572	\N	\N	18-121403	A	DN-097	Dysplastic Nevi	IP1312981	AirTable blocks_with_IP_info.csv
2345	18-119369B	40	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10888	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 1.1 x 0.9 x 0.1 cm, quadrisected and entirely submitted with four sections and fragment in B. HD/PL	A-C) ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	131544	573	\N	\N	18-119369	B	DN-098	Dysplastic Nevi	IP1983455	AirTable blocks_with_IP_info.csv
10269	S11-38910A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_14	\N	\N	\N	\N	\N	\N	\N	\N	\N	1594	\N	\N	\N	\N	SYNX191	\N	\N	Consolidated_data_final.csv
2348	18-120593B	41	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10890	216.5	\N	\N	Sections show a broad, circumscribed compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted in B. CF/PL	A) 5 M WAXY PAPULE; SK, PIGMENTED BCC, MM, B) 8 M TELANGIECTATIC NEVUS R/O MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	101532	574	\N	\N	18-120593	B	DN-099	Dysplastic Nevi	IP1984680	AirTable blocks_with_IP_info.csv
2335	18-90550	48	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10895	238.2	\N	\N	Sections show a broad but relatively symmetrical compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, with melanocytes showing random nuclear atypia and spindled configurations, where as the cells underneath are small and round.	Oriented ellipse, 4.3 x 1.8 x 0.8 cm, including a central 1.7 x 1.4 cm brown area. The orienting sutured tip is indicated medially on the requisition. This tip is designated 3 o'clock by the grosser and is placed toward 3 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four sections in A, three sections in B, and five sections in C. Tips reserved. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR. 2.0 X 1.1 CM IRREGULAR BROWN PAPULE WITH H/O SIGNIFICANT GROWTH, NEVUS R/O ATYPIA. SUTURE PLACED MEDIALLY, PLEASE CHECK MARGINS.. CC: DR. TRICIA YEAP, (PCP IN WALNUT CREEK).	\N	\N	\N	This lesion shows an atypical junctional and superficial dermal component. It has been adequately removed.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	528522	575	\N	\N	18-90550	\N	DN-100	Dysplastic Nevi	IP605933	AirTable blocks_with_IP_info.csv
2163	17-72580	48	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a circumscribed and symmetrical compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages. Some melanocytes are present above the basal layer.	Skin segment measuring 1.1 x 0.6 x 0.1 cm, with the margins inked, serially sectioned and entirely submitted with five sections. RS/RS	6 X 4 MM DARK BROWN TO BLACK IRREGULAR MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR, PLEASE CHECK MARGINS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	345533	576	\N	\N	17-72580	\N	DN-101	Dysplastic Nevi	IP698516	AirTable blocks_with_IP_info.csv
2162	17-72563	51	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted. CF/CF	R/O ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	433599	577	\N	\N	17-72563	\N	DN-102	Dysplastic Nevi	IP1350209	AirTable blocks_with_IP_info.csv
1111	04-03547G T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1038	\N	\N	None	\N	MD-159	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1110	04-03311H T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1039	\N	\N	None	\N	MD-161	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1026	01-10208A T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1040	\N	\N	None	\N	MD-162	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1109	04-02031D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1041	\N	\N	None	\N	MD-163	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2184	17-85037	54	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10887	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	R/O DYSPLASIA	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	173530	579	\N	\N	17-85037	\N	DN-104	Dysplastic Nevi	IP373264	AirTable blocks_with_IP_info.csv
2167	17-74152D	55	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.7 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with five sections in D. RS/PL	A) NEOP UNC VS. DYSPLASTIC NEVUS, 0.6 X 0.6, B-C) NEOP UNC VS. LENTIGO, 0.6 X 0.6, D-E) NEOP UNC VS. DYSPLASTIC NEVUS, 1.1 X 1.1, F) NEOP UNC VS. DYSPLASTIC NEVUS, 0.6 X 0.6	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528522	580	\N	\N	17-74152	D	DN-105	Dysplastic Nevi	IP255809	AirTable blocks_with_IP_info.csv
2170	17-74882B	58	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	The features are similar to those in (A).	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected and entirely submitted in B. CF/PL	A) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 0.8 CM, UNEVEN COLOR. CC LEENA KAMAT, MD. B) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 1.0 CM, UNEVEN COLOR.	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE BASE OF THE SPECIMEN	172541	581	\N	\N	17-74882	B	DN-106	Dysplastic Nevi	IP1804838	AirTable blocks_with_IP_info.csv
2319	18-65038B	84	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10893	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A) PINK PAPULE; BASAL CELL CARCINOMA, B) ATYPICAL BROWN MACULE; ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	174566	600	\N	\N	18-65038	B	DN-125	Dysplastic Nevi	IP439323	AirTable blocks_with_IP_info.csv
3458	KIT192	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1595	\N	\N	None	\N	SYNAT466	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
2169	17-74882A	58	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted in A. CF/PL	A) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 0.8 CM, UNEVEN COLOR. CC LEENA KAMAT, MD. B) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 1.0 CM, UNEVEN COLOR.	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139510	581	\N	\N	17-74882	A	DN-106	Dysplastic Nevi	IP1804838	AirTable blocks_with_IP_info.csv
2168	17-74282	58	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted. HD/PL	MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	152589	582	\N	\N	17-74282	\N	DN-107	Dysplastic Nevi	IP1804228	AirTable blocks_with_IP_info.csv
2262	17-125335	60	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a small, roughly wedge-shaped proliferation composed of small melanocytes with round or ovoid nuclei that diminish in size with descent in the dermis. In level sections, a separate tissue section shows a symmetric junctional melanocytic proliferation arrayed along the sides and bases of hyperpigmented rete above many papillary dermal melanophages.	Cylindrical skin segment, 0.8 cm in diameter and 0.4 cm in thickness, with the margins inked, trisected and entirely submitted. PL/PL	PT WITH CHURG STRAUSS ON IMMUNE SUPPRESSION WHO PRESENTS WITH A 6 MM IRREGULAR NEVUS WITH A LATERAL FLESH COLORED PAPULE AND MEDIAL IRREGULAR BROWN MACULE; ATYPICAL NEVUS, MIS, CONGENITAL NEVUS WITH ATYPIA (TELEPHONE: 707-799-2405 MSG OK)	\N	\N	\N	In level sections, a second nevus is identified.	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS AND ADJACENT LENTIGINOUS JUNCTIONAL NEVUS	273588	583	\N	\N	17-125335	\N	DN-108	Dysplastic Nevi	IP1855930	AirTable blocks_with_IP_info.csv
2197	17-93961A	61	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows broad zones of fibrosis, some in a lamellar configuration.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected, and entirely submitted in A. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. MELANOMA. PAPULE. B) MELANOMA IN SITU. SUSPICIOUS IRREGULAR MULTI-COLORED MACULE. MELANOMA IN SITU (DT17-75711), NOW EXCISED WITH 1 CM MARGINS.  PLEASE CHECK MARGINS..	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	222566	584	\N	\N	17-93961	A	DN-109	Dysplastic Nevi	IP1805672	AirTable blocks_with_IP_info.csv
2315	18-54612	61	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend far lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows fibrosis, some in a lamellar configuration.	Skin segment measuring 1.5 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. TWO TONED DARK BROWN PATCH.	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173529	585	\N	\N	18-54612	\N	DN-110	Dysplastic Nevi	IP650724	AirTable blocks_with_IP_info.csv
2351	18-121415	62	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction and within the papillary dermis, with elongated and hyperpigmented rete which bear both nested and solitary melanocytes. The papillary dermis shows fibrosis, some of which is lamellar in configuration, and a sparse infiltrate.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	R/O MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139522	586	\N	\N	18-121415	\N	DN-111	Dysplastic Nevi	IP1985504	AirTable blocks_with_IP_info.csv
2222	17-112277	64	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. RS/RS	4 X 4 MM SLIGHTLY IRREGULAR TAN BROWN PAPULE; NEVUS, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	529699	587	\N	\N	17-112277	\N	DN-112	Dysplastic Nevi	IP781920	AirTable blocks_with_IP_info.csv
2194	17-92850	68	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.4	\N	\N	Sections show nested and solitary melanocytes in irregular array within the epidermis, including some melanocytes arrayed above the basal zone.  There is a permeative lymphocytic infiltrate in the subjacent papillary dermis, which is focally fibrotic.	Skin segment measuring 1.1 x 1.1 x 0.1 cm, serially sectioned, and entirely submitted with five sections. HD/HD	A) ATYPICAL MELANOCYTIC PROLIFERATION. . PLEASE CHECK MARGINS. SEE PHOTO.	\N	\N	\N	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA IN SITU, WITH SUPERIMPOSED LICHENOID INFLAMMATORY REACTION, EXTENDING TO THE EDGE OF THE SPECIMEN	524456	590	\N	\N	17-92850	\N	DN-115	Dysplastic Nevi	IP1596350	AirTable blocks_with_IP_info.csv
2346	18-120470	69	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes arrayed mostly as nests at the sides and bases of elongated rete ridges, with marked fibrosis of the papillary dermis and a sparse infiltrate. There are similar melanocytes, in nests and diffusely in the underlying superficial dermis. The epidermis is thickened, with interconnecting rete ridges and horn pseudocysts towards one edge.	Skin segment measuring 1.4 x 1.0 x 0.1 cm, quadrisected and entirely submitted. BY/PL	ATYPICAL PIGMENTED PAPULE; R/O DYSPLASTIC NEVUS	\N	\N	\N	There is an incidental seborrheic keratosis.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	273588	591	\N	\N	18-120470	\N	DN-116	Dysplastic Nevi	IP1984557	AirTable blocks_with_IP_info.csv
2347	18-120587	69	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10889	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/PL	PIGMENTED NEOPLASM	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173581	592	\N	\N	18-120587	\N	DN-117	Dysplastic Nevi	IP1779775	AirTable blocks_with_IP_info.csv
2180	17-82806	70	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show a proliferation of melanocytes in which nested and single cells are arrayed along the junction, above a papillary dermis that shows fibrosis, some of which is lamellar in pattern.  Single melanocytes are increased in number in some areas, with some melanocytes present above the basal zone.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	R/O DN	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	273588	593	\N	\N	17-82806	\N	DN-118	Dysplastic Nevi	IP877561	AirTable blocks_with_IP_info.csv
2175	17-81767B	72	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis. In one area there is marked fibrosis of the superficial dermis with melanocytes intercalated between thickened collagen bundles.	Skin segment measuring 1.3 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with six sections in B. RS/RS	A) POSSIBLE BASAL CELL, B-C) GROWING LESIONS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES WITH AREAS OF FIBROSIS	152589	594	\N	\N	17-81767	B	DN-119	Dysplastic Nevi	IP339970	AirTable blocks_with_IP_info.csv
2176	17-81767C	72	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted in C. RS/RS	A) POSSIBLE BASAL CELL, B-C) GROWING LESIONS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	101532	594	\N	\N	17-81767	C	DN-119	Dysplastic Nevi	IP339970	AirTable blocks_with_IP_info.csv
2242	17-117666	75	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10840	238.2	\N	\N	Sections show a proliferation of melanocytes in which nested and single cells are arrayed along the junction, above a papillary dermis that shows marked fibrosis, some of which is lamellar in pattern.  Bridging of adjacent rete ridges by nests of melanocytes is present. Single melanocytes are increased in number in some areas, with some melanocytes present above the basal zone.	Skin segment measuring 1.6 x 1.3 x 0.1 cm, serially sectioned and entirely submitted with five sections. CF/CF	1.1 CM BROWN IRREGULAR PATCH; NEOPLASM OF UNCERTAIN BEHAVIOR VS. INDLAMED SOLAR LENTIGO, R/O MIS, PLEASE CHECK MARGINS (SEE PHOTO)	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is recommended.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	529698	595	\N	\N	17-117666	\N	DN-120	Dysplastic Nevi	IP1588836	AirTable blocks_with_IP_info.csv
2243	17-117775B	77	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a predominantly intradermal proliferation of small melanocytes that progressively diminish in size with descent in the dermis.  There are areas in which small melanocytes are spindled in shape and embedded in fibrillar matrix.	Skin segment measuring 0.8 x 0.7 x 0.3 cm, trisected and entirely submitted in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. SEBACEOUS GLAND HYPERPLASIA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. INTRADERMAL NEVUS. PAPULE.	\N	\N	\N	\N	INTRADERMAL MELANOCYTIC NEVUS, WITH NEUROTIZATION, A SENESCENT CHANGE	273588	596	\N	\N	17-117775	B	DN-121	Dysplastic Nevi	IP1499470	AirTable blocks_with_IP_info.csv
2122	17-49739B	78	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a symmetrical and circumscribed compound proliferation of melanocytes, with single cells and nests arrayed along the sides and bases of elongated rete ridges and with some nests positioned within the papillary dermis. Some of the junctional melanocytes are pigmented and spindled in configuration and are separated from adjacent structures by small clefts. There is solar elastosis.	Skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR. ATYPICAL BROWN PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR. ATYPICAL BROWN MACULE.	\N	\N	\N	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH SOME FEATURES OF PIGMENTED SPINDLE CELL NEVUS (A VARIANT OF SPITZ'S NEVUS), EXCISED IN PLANES OF SECTION EXAMINED	139524	597	\N	\N	17-49739	B	DN-122	Dysplastic Nevi	IP302644	AirTable blocks_with_IP_info.csv
1084	03-22623A T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1042	\N	\N	None	\N	MD-165	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1085	03-23238B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1043	\N	\N	None	\N	MD-166	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3018	99-19998 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1044	\N	\N	None	\N	MD-167	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2174	17-81609B	80	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows fibrosis, some in a lamellar configuration.	Skin segment measuring 1.4 x 0.8 x 0.1 cm, trisected, and entirely submitted in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR. EROSION. 4 MONTH HISTORY OF SLOWLY EXPANDING EROSION ON THE RIGHT POSTERIOR SHOULDER. THE EROSION IS PAINLESS AND THE PATIENT ADAMANTLY DENIES PICKING AT THE LESION; R/O BASAL CELL CARCINOMA VS. EXCORIATION VS. INFECTION. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED SEBORRHEIC KERATOSIS VS. MELANOMA VS. NEVUS. PAPULE.	\N	\N	\N	This lesion is atypical in that it is quite broad and, because it extends to the edges of the biopsy, its circumscription cannot be assessed. Conservative re-excision of this site is warranted to ensure complete removal.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	110501	598	\N	\N	17-81609	B	DN-123	Dysplastic Nevi	IP1811650	AirTable blocks_with_IP_info.csv
2227	17-112631B	82	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a mostly dermal proliferation of melanocytes, arrayed as nests and strands and syncytia that diminish in size with descent in the dermis.  Small melanocytes are splayed between collagen bundles in the superficial reticular dermis.	Multiple skin segments measuring 0.9 x 0.8 x 0.2 cm in aggregate, sectioned and entirely submitted in B. PL/PL	A) 3 MM X 2 MM BLUE BLACK MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS VS. ATYPICAL PIGMENTED LESION, NOTES #1, B) 7 MM X 5 MM PINK BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SYMPTOMATIC IDN, NOTES #2	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	876543	599	\N	\N	17-112631	B	DN-124	Dysplastic Nevi	IP1843109	AirTable blocks_with_IP_info.csv
3459	KIT203	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1596	\N	\N	None	\N	SYNAT467	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3479	KR_166	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1597	\N	\N	None	\N	SYNAT468	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
3484	KR_2064	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1598	\N	\N	None	\N	SYNAT469	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
2195	17-93920	82	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.6	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which consists of nested and solitary melanocytes in irregular array within the epidermis.  In some areas with the epidermis, a more orderly pattern of nesting is apparent. There is solar elastosis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. PL/PL	6 X 5 MM CHANGING PIGMENTED MACULE; DN VS. MM	\N	\N	\N	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA IN SITU, ARISING IN A COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	113603	601	\N	\N	17-93920	\N	DN-126	Dysplastic Nevi	IP749893	AirTable blocks_with_IP_info.csv
2362	18-135600	60	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. BY/BY	ATYPICAL RED / BROWN PATCH; ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	101544	602	\N	\N	18-135600	\N	DN-127	Dysplastic Nevi	IP777076	AirTable blocks_with_IP_info.csv
2361	18-135492	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a circumscribed compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis. Bridging of adjacent rete ridges by nests of melanocytes is present. There are bland melanocytes in the subjacent dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. BY/BY	1 X 0.7 CM IRREGULAR TAN BROWN PATCH; NEVUS, R/O ATYPIA, NUB	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE BASE OF THE SPECIMEN	529698	603	\N	\N	18-135492	\N	DN-128	Dysplastic Nevi	IP1697627	AirTable blocks_with_IP_info.csv
2360	18-135488	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability. Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis and nests of similar melanocytes are present in the superficial dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. BY/BY	6 X 4 MM MEDIUM BROWN IRREGULAR MACULE WITH DARK BROWN CENTER; R/O ATYPICAL NEVUS, NUB	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED \t	273578	604	\N	\N	18-135488	\N	DN-129	Dysplastic Nevi	IP681488	AirTable blocks_with_IP_info.csv
2366	18-136721	50	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173530	605	\N	\N	18-136721	\N	DN-130	Dysplastic Nevi	IP2000868	AirTable blocks_with_IP_info.csv
2365	18-136716B	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a proliferation composed predominantly of nests of melanocytes arrayed along the junctional zone, above a papillary dermis that is expanded by fibrosis.  There is an infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in B. BY/BY	A) ATYPICAL RED BROWN PAPULE; ATYPICAL NEVUS, B) ATYPICAL GRAY BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS WITH REGRESSION	\N	\N	\N	December 21, 2018: The lesion appears adequately treated and no further re-excision seems necessary on histopathologic grounds.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH SUPERIMPOSED CHANGES OF REGRESSION, EXCISED IN PLANES OF SECTION EXAMINED	174566	606	\N	\N	18-136716	B	DN-131	Dysplastic Nevi	IP126817	AirTable blocks_with_IP_info.csv
2367	18-136800A	52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in A. KC/KC	A) 6 MM DARK LENTIGINOUS NEVUS; ATYPICAL NEVUS, R/O MM, B) 1.1 CM PINK BROWN LENTIGINOUS NEVUS; ATYPICAL NEVUS, R/O MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173536	607	\N	\N	18-136800	A	DN-132	Dysplastic Nevi	IP1417678	AirTable blocks_with_IP_info.csv
2405	19-7686A	59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of melanocytes with a flat profile from scanning magnification.  The junctional component consists largely of nests of epithelioid melanocytes, some of which have enlarged nuclei and are separated from each other by small clefts.  Clusters of similar melanocytes are also present in the subjacent superficial dermis, where lamellar fibrosis is apparent. There is solar elastosis.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) R/O BCC, B) FAVOR IRRIT SK, R/O PIG BCC (TELEPHONE: 415-317-6230 MSG OK)	\N	\N	\N	This lesion is atypical in that it displays larger melanocytes with irregularly sized nuclei. Conservative re-excision of this site is warranted.	COMPOUND CLARK'S OR DYSPLASTIC NEVUS WITH EPITHELIOID MELANOCYTES, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173620	608	\N	\N	19-7686	A	DN-133	Dysplastic Nevi	IP881926	AirTable blocks_with_IP_info.csv
2359	18-135485	40	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	6 X 5 MM DARK BROWN SLIGHTLY IRREGULAR MACULE DARKEST LESION ON FULL BODY SKIN CHECK; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	345543	609	\N	\N	18-135485	\N	DN-134	Dysplastic Nevi	IP1658571	AirTable blocks_with_IP_info.csv
2363	18-136484	54	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	IRREGULAR PIGMENTED MACULE, ~1 CM	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173526	610	\N	\N	18-136484	\N	DN-135	Dysplastic Nevi	IP2000624	AirTable blocks_with_IP_info.csv
3483	KR_2030	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1599	\N	\N	None	\N	SYNAT470	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
3480	KR_177	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1600	\N	\N	None	\N	SYNAT471	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
2368	18-136800B	52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 1.5 x 0.9 x 0.1 cm, quadrisected and entirely submitted in B. KC/KC	A) 6 MM DARK LENTIGINOUS NEVUS; ATYPICAL NEVUS, R/O MM, B) 1.1 CM PINK BROWN LENTIGINOUS NEVUS; ATYPICAL NEVUS, R/O MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	101532	611	\N	\N	18-136800	B	DN-136	Dysplastic Nevi	IP1417678	AirTable blocks_with_IP_info.csv
2369	18-137340A	44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with round to oval nuclei and scant cytoplasm, arrayed as nests along the epidermal-dermal junction and as small clusters in the subjacent dermis.	Skin segment measuring 0.9 x 0.9 x 0.1 cm, quadrisected and entirely submitted in A. KC/KC	A) CHANGING IN SIZE AND 5.2 CM; ATYPICAL NEVUS, B) 3 MM AND ASYMMETRICAL NEVUS; ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	273588	612	\N	\N	18-137340	A	DN-137	Dysplastic Nevi	IP1431131	AirTable blocks_with_IP_info.csv
2371	18-137854C	77	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted in C. HD/HD	A) R/O AK / SK, B) 6 MM; R/O DN, C) 9; R/O DN	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	222533	613	\N	\N	18-137854	C	DN-138	Dysplastic Nevi	IP477134	AirTable blocks_with_IP_info.csv
2372	18-137857	75	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.9 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173530	614	\N	\N	18-137857	\N	DN-139	Dysplastic Nevi	IP2002013	AirTable blocks_with_IP_info.csv
2370	18-137809B	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. BY/BY	A) ATYPICAL NEVUS VS. MELANOMA VS. BENIGN NEVUS. BROWN PATCH IRREGULAR BORDERS 0.6 CM. CC: MARGO ESTRIN, MD AND SALLY DAVIS, MD. B) ATYPICAL NEVUS VS. MELANOMA VS. BENIGN NEVUS. BICOLORED PIGMENTED PATCH 0.7 CM.	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173711	615	\N	\N	18-137809	B	DN-140	Dysplastic Nevi	IP171892	AirTable blocks_with_IP_info.csv
2397	19-7126B	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.6 x 0.2 cm, bisected and entirely submitted in B. PL/PL	A-C) R/O MELANOMA	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	133559	616	\N	\N	19-7126	B	DN-141	Dysplastic Nevi	IP2011182	AirTable blocks_with_IP_info.csv
2398	19-7344	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a broad compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis. Bridging of adjacent rete ridges by nests of melanocytes is present. There is an encompassing lymphocytic infiltrate.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	LICHENOID KERATOSIS VS. BCC	\N	\N	\N	This lesion is broad and has irregular architectural features. Conservative re-excision of this site is warranted to ensure complete removal.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	100589	617	\N	\N	19-7344	\N	DN-142	Dysplastic Nevi	IP266145	AirTable blocks_with_IP_info.csv
2399	19-7357A	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. A few small clusters of similar melanocytes are present in the dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A-B) R/O DN	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	173611	618	\N	\N	19-7357	A	DN-143	Dysplastic Nevi	IP2011413	AirTable blocks_with_IP_info.csv
2400	19-7357B	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted with one fragment in B. CF/CF	A-B) R/O DN	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173502	619	\N	\N	19-7357	B	DN-144	Dysplastic Nevi	IP2011413	AirTable blocks_with_IP_info.csv
2401	19-7596C	76	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in C. KC/KC	A) RULE-OUT ATYPICAL MELANOCYTIC PROCESS. SUSPICOUS IRREGULAR MULTI-COLORED MACULE. B) RULE-OUT ATYPICAL MELANOCYTIC PROCESS. SUSPICOUS IRREGULAR MULTI-COLORED MACULE. C) RULE-OUT DYSPLASTIC NEVUS. IRREGULAR BROWN MACULE.	\N	\N	\N	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	239512	620	\N	\N	19-7596	C	DN-145	Dysplastic Nevi	IP2011652	AirTable blocks_with_IP_info.csv
2402	19-7600	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes, arrayed largely as nests and accompanied by papillary dermal fibrosis and partially obscured by a permeative lymphocytic infiltrate.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	5 X 5 MM, ATYPICAL MACULE; R/O DYSPLASTIC NEVUS VS. MM	\N	\N	\N	None	PREDOMINANTLY JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, ACCOMPANIED BY A HALO REACTION, EXCISED IN PLANES OF SECTION EXAMINED	333504	621	\N	\N	19-7600	\N	DN-146	Dysplastic Nevi	IP2011656	AirTable blocks_with_IP_info.csv
3478	KR_150	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1601	\N	\N	None	\N	SYNAT472	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
2403	19-7601	72	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes arranged singly or as small nests in the basal layer above papillary dermal fibroplasia. A perijunctional lymphohistiocytic infiltrate with admixed melanophages is also present. There is solar elastosis.	Skin segment measuring 1.4 x 1.4 x 0.1 cm, serially sectioned and entirely submitted with five sections. KC/KC	1.5 CM X 8 MM ASYMMETRICALLY PIGMENTED PATCH; POSS MM	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139522	622	\N	\N	19-7601	\N	DN-147	Dysplastic Nevi	IP2011657	AirTable blocks_with_IP_info.csv
2404	19-7669	79	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/CF	R/O DYSPLASTIC NEVUS, 0.6 X 0.6 CM	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528599	623	\N	\N	19-7669	\N	DN-148	Dysplastic Nevi	IP11027	AirTable blocks_with_IP_info.csv
2423	19-29433C	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected, and entirely submitted in C. HD/HD	A) CYT19-446, R/O ATYPICAL, DARK MACULE WITH IRREGULAR BORDERS, LESION SIZE 0.6 X 0.5 CM, B) CYT19-447, R/O ATYPICAL, PINK BROWN MACULE IRREGULAR COLOR DISTRIBUTION, LESION SIZE 1.2 X 1.1 CM, C) CYT19-448, R/O ATYPICAL, PINK BROWN WITH IRREGULAR COLOR DISTRIBUTION, LESION SIZE 1.1 X 0.5 CM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139524	624	\N	\N	19-29433	C	DN-149	Dysplastic Nevi	IP630209	AirTable blocks_with_IP_info.csv
2412	19-15130	48	f	\N	0	T1a	Primary	melanoma on skin with low cumulative sun-induced damage (WHO: low CSD melanoma); SSM	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a broad compound proliferation of atypical melanocytes composed largely of cells with vacuolated and finely pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, jointly with a dense infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.6 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with five sections. CF/CF	R/O DYSPLASTIC NEVUS VS. MM, 2 X 1 CM	\N	\N	\N	Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows much more pagetoid scatter than could be discerned in the hematoxylin and eosin stained sections. A p16 immunoperoxidase shows retention of expression. Diagnostic features of note include:  Procedure: shave biopsy Tumor site: abdomen Microscopic tumor type: melanoma on skin with low cumulative sun-induced damage (WHO: low CSD melanoma); SSM Breslow thickness: 0.6 mm Ulceration: absent Margins, peripheral and deep: narrowly clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX  My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis.	MELANOMA, 0.6 MM IN THICKNESS, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	222533	625	\N	\N	19-15130	\N	DN-150	Dysplastic Nevi	IP2019231	AirTable blocks_with_IP_info.csv
2434	19-37609	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	7 MM X 5 MM REDDISH PINK VARIEGATED MACULAR; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	The lesion is broad and not well circumscribed. A conservative re-excision may be prudent.	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139511	626	\N	\N	19-37609	\N	DN-151	Dysplastic Nevi	IP2041845	AirTable blocks_with_IP_info.csv
1421	11-072	85	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	The epidermis shows many pigmented bud-like rete that emanate from the junctional zone above elastosis, and single melanocytes are detectable along the junction but are not significantly increased in density. There is woven orthohyperkeratosis above this.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette A.	A) R/O MELANOMA IN SITU, B) R/O BASAL CELL CARCINOMA, C) R/O MELANOMA IN SITU	\N	\N	\N	There is no evidence of intraepidermal melanoma.	HYPERKERATOTIC SOLAR LENTIGO	103327	794	\N	\N	11-72	\N	KIT-13	Kit mutants	IP842527	AirTable blocks_with_IP_info.csv
1422	11-091	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	795	\N	\N	11-91	\N	KIT-14	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2422	19-29129	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate. Scattered melanocytes have enlarged nuclei.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	R/O DN	\N	\N	\N	This lesion is atypical in that it displays scattered atypical melanocytes. Conservative re-excision of this site is recommended.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT	139524	627	\N	\N	19-29129	\N	DN-152	Dysplastic Nevi	IP1663236	AirTable blocks_with_IP_info.csv
2424	19-30025B	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a melanocytic proliferation in which single melanocytes and melanocytes in small nests are positioned along the sides and bases of elongated and pigmented rete ridges, above a fibrotic papillary dermis.	Skin segment measuring 1.1 x 0.6 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) R/O BOWEN'S VS. SUP BCC, B) ATYPICAL NEVUS, R/O SSM	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	628	\N	\N	19-30025	B	DN-153	Dysplastic Nevi	IP143268	AirTable blocks_with_IP_info.csv
2254	17-120276	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18183	216.5	\N	\N	Sections show a proliferation of solitary melanocytes and small nests of them arrayed along the sides and bases of elongated and pigmented rete ridges. There are many melanophages within the underlying superficial dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	6 MM HYPERPIGMENTED MACULE; R/O MELANOMA	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173526	833	\N	\N	17-120276	\N	LN-13	Lentiginous Nevi 	IP1850825	AirTable blocks_with_IP_info.csv
3482	KR_229	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1602	\N	\N	None	\N	SYNAT473	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
3481	KR_203	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1603	\N	\N	None	\N	SYNAT474	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
2432	19-37607E	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in E. KC/KC	A) 7 MM X 5 MM DARK BROWN IRREGULAR MACULE ADJACENT TO SK; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 2.5 CM X 2 CM DARK BROWN HYPERKERATOTIC PLAQUE; PROBABLE SK, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, C) 4 MM X 4 MM VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, D) 5 MM X 6 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, E) 4 MM X 4 MM DARK BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, F) 3 X 4 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139524	629	\N	\N	19-37607	E	DN-154	Dysplastic Nevi	IP2041843	AirTable blocks_with_IP_info.csv
2436	19-38447	79	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a melanocytic proliferation in which single cells predominate, in irregular array within the epidermis.  There are foci of pagetoid scatter.  There is a bandlike infiltrate of lymphocytes in the papillary dermis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/CF	ATYPICAL NEVUS	\N	\N	\N	An immunoperoxidase for SOX-10 shows poor circumscription and broad zones of pagetoid scatter. This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	102537	630	\N	\N	19-38447	\N	DN-155	Dysplastic Nevi	IP2042685	AirTable blocks_with_IP_info.csv
2413	19-15378	47	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of melanocytes, with solitary and nested melanocytes arrayed along the junctional zone above a papillary dermis that contains melanocytes jointly with lamellar fibrosis and melanophages.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/CF	5 MM, COLOR VARIEGATION; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, AMP	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	102611	631	\N	\N	19-15378	\N	DN-156	Dysplastic Nevi	IP2019479	AirTable blocks_with_IP_info.csv
2433	19-37607F	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in F. KC/KC	A) 7 MM X 5 MM DARK BROWN IRREGULAR MACULE ADJACENT TO SK; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 2.5 CM X 2 CM DARK BROWN HYPERKERATOTIC PLAQUE; PROBABLE SK, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, C) 4 MM X 4 MM VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, D) 5 MM X 6 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, E) 4 MM X 4 MM DARK BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, F) 3 X 4 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173529	632	\N	\N	19-37607	F	DN-157	Dysplastic Nevi	IP2041843	AirTable blocks_with_IP_info.csv
2430	19-37409B	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in B. KC/KC	A-B) R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139524	633	\N	\N	19-37409	B	DN-158	Dysplastic Nevi	IP2041641	AirTable blocks_with_IP_info.csv
2425	19-30079A	60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) ATYPICAL NEVUS VS. SEBORRHEIC KERATOSIS VS. MELANOMA VS. BENIGN NEVUS. DARKLY PIGMENTED LINEAR MACULE, 0.6 CM. CC: NATHALIE MICHAUD, MD. B) IRRITATED NEVUS VS. ATYPICAL NEVUS. 0.4 CM, ERYTHEMATOUS TAN PAPULE.	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, FOCALLY EXTENDING TO THE BASE OF THE SPECIMEN	139522	634	\N	\N	19-30079	A	DN-159	Dysplastic Nevi	IP1858202	AirTable blocks_with_IP_info.csv
2435	19-38090	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.5 x 1.3 x 0.1 cm, serially sectioned and entirely submitted with five sections. CF/CF	A) ATYPICAL NEVUS. 12 X 10 MM OVAL BROWN PAPULE WITH SLIGHT ASYMMETRY OF PIGMENTATION. PLEASE CHECK MARGINS. PHOTO.	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528599	635	\N	\N	19-38090	\N	DN-160	Dysplastic Nevi	IP2042328	AirTable blocks_with_IP_info.csv
1423	11-133	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	796	\N	\N	11-133	\N	KIT-15	Kit mutants	\N	AirTable blocks_with_IP_info.csv
1083	03-21273-1G T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1045	\N	\N	None	\N	MD-168	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1081	03-19080C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1046	\N	\N	None	\N	MD-169	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1076	03-15183D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1047	\N	\N	None	\N	MD-170	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1745	14-15427	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	Sections show a roughly oval mass of melanocytes within fibrofatty tissue. At the periphery of the mass are cords and strands of small, round cells with relatively scant pale cytoplasm and monomorphous oval nuclei containing small nucleoli. These cells are separated by thickened collagen bundles in some areas, with a few melanophages. The center of the lesion is more cellular. There are sheets of cells with inconspicuous pale cytoplasm and considerably larger, vesicular nuclei with moderately enlarged reddish nucleoli. Several mitotic figures are evident (but usually 1-2 per mm square). There are occasional multinucleated cells, as well as pseudovascular spaces within the masses of melanocytes. The enclosed immunostains include positive S100 and Melan-A stains, as well as an HMB-45 stain which marks both the smaller and larger melanocytes.	Twelve outside slides, SC14-637:A/1,A/2, XPS-14-931:B/1,B/2 (including five unstained slides cut from block A/1) and two corresponding blocks.	THIRD OPINION, NO HISTORY OF MELANOMA, PRESENT FOR YEARS AND HAD POSSIBLY BEEN INCREASING IN SIZE SLIGHTLY, INTRAOPERATIVELY IT SHELLED OUT EASILY AND DID NOT APPEAR TO BE CONNECTED OR INVOLVING THE OVERLYING EPIDERMIS; THROMBOSED VESSEL	\N	\N	\N	The HMB-45 staining of both components of the lesion is in keeping with both populations deriving from a blue nevus, probably a cellular blue nevus (the quotation marks reflect my unhappiness with the common/cellular dichotomy). The more cellular population lacks the typical nested, or lobular peninsula-like architecture of a cellular blue nevus, nuclei are somewhat enlarged and crowded, and the mitotic rate is higher than in most such lesions. However, the striking cytologic atypia, necrosis and lymphocytic infiltrate seen in some melanomas arising in blue nevi are not evident here. Some would term the current changes atypical blue nevus, a term I am not fond of but may have some applicability in this case. In keeping with this borderline character, comparative genomic hybridization shows an aberration not typically seen in melanoma. There is a gain involving chr. 9, which is often lost in melanoma. A re-excision of this area seems appropriate. In the reference below, the number of aberrations seen in blue nevus-like melanoma was higher than in atypical blue nevi or in conventional cellular blue nevi; with one aberration, and that one not typically associated with melanoma, this intermediate category seems best.  Reference:  Maize JC Jr, McCalmont TH, Carlson JA, Busam KJ, Kutzner H, Bastian BC. Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol. 2005 Sep;29(9):1214-20.	ATYPICAL MELANOCYTIC PROLIFERATION ARISING IN A CELLULAR BLUE NEVUS	173788	648	\N	\N	14-15427	\N	DP-11	PRKC Fused Cases	IP1365348	AirTable blocks_with_IP_info.csv
1439	11-13665	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	from Swapna	Sections show a polypoid segment of anal mucosa with a large, multinodular proliferation of neoplastic cells with amphophilic cytoplasm and large, pleomorphic vesicular nuclei. Foci of necrosis, many mitotic figures and clusters of melanophages are present. The enclosed immunoperoxidase stains show that the neoplastic cells are positive for HMB45 and Melan-A. Some areas feature enlarged single melanocytes colonizing the basal layer of the epithelium.	Seven outside slides, SROS11-255: A1,A2,A3. One corresponding block (A1) received 4/5/11.	UCSF MELANOMA CLINIC PATIENT	\N	\N	\N	ADDENDUM, April 29, 2011: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system: The neoplasm extends to the edges of some of the sections, but whether these are true margins or not cannot be determined. There is a significant intraepithelial component, which led to my original supposition that this was a primary melanoma.  Given the findings on re-examination of a previous case in our files, 00-33973, we performed comparative genomic hybridization on both specimens. This specimen showed many genomic aberrations, including some commonly found in melanoma. These included a gain involving 1q, gains and losses in small areas on 5p, a loss on 5q, a gain of 6p and a loss of 6q, a loss of 8p and a gain of 8q, a gain near the end of 10q, a loss of 11q and a gain of 18p with a loss involving 18q. The quality of this hybridization was excellent, while the 2000 hybridization was not as good. However, there are clear aberrations in the 2000 hybridization shared by this one, including those involving 6p and 6q, and 8q. Also, there are clear inflections in the array of the 2000 case at most of the other sites that have aberrations in the current material. This strongly suggests that the current anal lesion is a metastasis from the 2000 cutaneous lesion and not a new primary tumor.	MELANOMA, 12 MM. IN THICKNESS	173521	638	\N	\N	11-13665	\N	DP-01	Possible TERT Fusion	IP249076	AirTable blocks_with_IP_info.csv
1618	12-24226	43	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	from Swapna	Sections show a broad, asymmetrical, and badly circumscribed compound proliferation of enlarged epithelioid melanocytes. There are single melanocytes and nests distributed along the junction, and subtle areas of suprabasal scatter can be found. In the perijunctional dermis, some cross sections show non-maturing nests and cords of cytologically similar melanocytes. Other areas show a patchy perijunctional infiltrate of lymphocytes and melanophages. Very focally, the epidermal surface has overlying parakeratosis, suggesting trauma or irritation.	Three outside slides, D12-10741 and one corresponding block.	SHAVE BIOPSY IN TWO PIECES; R/O MELANOMA	\N	\N	\N	The differential diagnosis included a thin melanoma on one hand and an unconventional melanocytic nevus on the other, and the former possibility proves to represent the best interpretation for this atypical melanocytic proliferation. To fully substantiate the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 4p, 5p, and 7p as well as loss in chromosomes 6p, 9p, and 12p. The identification of multiple chromosomal copy number aberrations suggests genomic instability, as is typical of malignancies such as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to a diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.6 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE SPECIMEN PERIPHERY	528522	641	\N	\N	12-24226	\N	DP-04	Possible TERT Fusion	IP1110044	AirTable blocks_with_IP_info.csv
1795	14-90528	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	Sections show a domed compound proliferation of melanocytes with single cells and nests arrayed along the junction. The junctional melanocytes are pale and have heavily pigmented cytoplasm, and pigmented hyperkeratosis is above them. In the dermis, there are maturing nests, cords, and small syncytia of similar melanocytes, and those superficially are heavily pigmented, while those more deeply exhibit limited neural differentiation in a central focus. There are some superficial dermal or perijunctional melanocytes in mitosis. Many superficial dermal melanophages are also noted.	Five outside slides, SD-14-32477 (A1). One corresponding block received 10-28-14.	SECOND OPINION	\N	\N	\N	Given the small overall size, good lateral demarcation, gradient of maturation, and deep neural differentiation that are apparent in association with this tumor, I believe it represents melanocytic nevus and not melanoma. There are several perijunctional melanocytes in mitosis, which is unconventional and of some concern. That said, I do not see how a microscopic diagnosis of melanoma could be easily rendered, given the characteristics mentioned in the first sentence of this paragraph. Per a clinical request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies as an ancillary means of assessment. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 15q as a monoaberration (and also subthreshold gain in chromosome 20q) with no other associated chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. Gain in 15q is an anomaly that we have identified in a subset of melanocytic nevi with spitzoid features.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our analysis has identified an uncommon monoaberration that we have identified in a subset of Spitz nevi or partially transformed Spitz tumors. In the available sections, this melanocytic proliferation appears narrowly excised. Clinical monitoring of the biopsy site can be utilized to verify that no persistence ensues. Given the complexity of this assessment, conservative complete reexcision of this site could also be considered as follow-up management.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF HEAVILY PIGMENTED MELANOCYTES, CONSISTENT WITH A COMPOUND MELANOCYTIC NEVUS	897777	643	\N	\N	14-90528	\N	DP-06	Possible TERT Fusion	IP1440512	AirTable blocks_with_IP_info.csv
2266	17-132120	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	The lesion has a domed surface and a flat base. I has large polygonal and fusiform melanocytes with abundant, pale cytoplasm and dusty appearing melanin and enlarged nuclei superficially and smaller cells more deeply. Areas feature a syncytial arrangement, rather than discrete aggregations. I did not encounter mitotic figures in dermal melanocytes.	One outside slide, S-90406. One corresponding block received 1/10/18.	BIOPSY LEFT FOREARM	\N	\N	\N	The differential diagnosis posed by these sections includes a Spitz's nevus, an atypical Spitz tumor and spitzoid melanoma. The asymmetry of the lesion and presence of many cells with abundant, pale cytoplasm and dusty appearing melanin is against a Spitz's nevus and favors one of the other two categories. A phosphohistone H3/MART-1/tyrosinase two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows several positive nuclei in the upper or mid-part of the lesion.  While only a small minority of the melanocytes are p16 positive, I did not find extensive areas completely lacking p16 positive cells, as can be seen with bi-allelic loss of CDKN2A. Such areas can in some cases indicate melanoma.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. Comparative genomic hybridization shows no significant chromosomal copy number changes. An idiosyncratic finding- a loss of a small pericentromeric area in chr. 9q was present. This area does not contain any tumor suppressor genes known to play a role in melanomagenesis. About 95% of conventional melanomas show significant losses or gains with this technique.  Using the DNA extracted for CGH, we also performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  An atypical Spitz tumor seems to be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. As the the base of the specimen is involved, conservative re-excision of this site is warranted.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	ATYPICAL SPITZ TUMOR	173610	644	\N	\N	17-132120	\N	DP-07	Possible TERT Fusion	IP1862784	AirTable blocks_with_IP_info.csv
1858	15-42060	48	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	from Swapna	There is a compound proliferation of melanocytes featuring a predominant population of large round to oval cells with abundant pale cytoplasm and dusty melanin, and moderately enlarged round nuclei. These are arranged as large and confluent nests at the junction, in some cases bridging adjacent ridges, and encased within dense fibrotic stroma in the center of the lesion (with a much less prominent junctional component in this area). The cells contrast with cords and strands of small round melanocytes in a looser configuration in one focus.	Five outside slides, USP(DP)15-13953 A1 and one corresponding block.	CHANGING NEVUS, R/O DYSPLASTIC NEVUS, CHECK MARGINS	\N	\N	\N	The differential diagnosis included a nevus of special site, and melanoma arising in a pre-existent nevus with superficial congenital features. Based on the findings seen in the hematoxylin and eosin stained sections, I was quite concerned re the possibility of melanoma. Both entities can have confluent junctional nests composed of melanocytes with abundant, pale, vacuolated cytoplasm, but in this case, the confluent nests extend above dermal papillae, and are accompanied a dermal component encased in sclerotic stroma. The enclosed immunostains are not decisive. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include loss involving chr. 3, loss involving chr. 5p with small gains in the peri-centromeric area of 5p, areas of gain and loss involving chr. 7p in a pattern suggesting chromothripsis, gain of 7q, loss of 8p, loss of 11q, and gains and losses of 21q. While the the individual loci are not stereotypically altered in melanoma, taken together the findings strongly favor that diagnosis, including the presence of chromothripsis.  The neoplasm extends to the base of the specimen.	MELANOMA, 1.2 MM. IN THICKNESS	105586	645	\N	\N	15-42060	\N	DP-08	Possible TERT Fusion	IP1513334	AirTable blocks_with_IP_info.csv
1644	12-70514	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.4	\N	from Swapna	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. The lesion has a domed surface and a wedge shaped base. Cohesive aggregations of melanocytes are present within the superficial subcutis, without much dispersion or maturation. There are scattered mitotic figures in both the superficial and deep dermal parts of the lesion.	One hematoxylin and eosin-stained section prepared from outside block labeled L12-8883.	SPITZ; REFERRED FOR CGH OR FISH TESTING	\N	\N	\N	Comparative genomic hybridization shows multiple chromosomal aberrations indicative of melanoma. These include gains involving chromosomes 1p, 8q, and 11q, with losses involving chromosome 9, and a portion of 17q. Many of these are frequent aberrations in melanoma. Currently, I use the term Spitzoid melanoma, childhood type, for an emerging class of lesions that usually but not exclusively occur in children and teens, often lack b-raf mutations (which are present in most melanomas in adults) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. These are findings that would support conservative treatment. Most lesions of this type are deeper, but usually not much wider than their exophytic portions, and even when they are, are well circumscribed. While sentinel nodes are often positive, this positivity has much less predictive value for systemic spread than is the case with adult melanoma.  The lesion is nominally 4.2 mm in thickness, but as implied above, the prognosis in cases of this type is considerably better than in adult melanomas of comparable thickness.	SPITZOID MELANOMA, CHILDHOOD TYPE	104444	647	\N	\N	12-70514	\N	DP-10	PRKC Fused Cases	IP1156331	AirTable blocks_with_IP_info.csv
1053	02-17209C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1053	\N	\N	None	\N	MD-176	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2931	92-03953C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1074	\N	\N	None	\N	MD-197	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2924	91-08026A T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1075	\N	\N	None	\N	MD-198	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2960	95-14297-5 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1076	\N	\N	None	\N	MD-199	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2964	96-02480 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1077	\N	\N	None	\N	MD-200	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2962	95-16013B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1078	\N	\N	None	\N	MD-201	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2935	92-18572E T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1079	\N	\N	None	\N	MD-202	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1760	14-43805	11	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	from Swapna	Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. The span of the junctional component exceeds that of the dermal portion. The lesional melanocytes include many cells with large, irregularly shaped hyperchromatic nuclei and scant cytoplasm. Some have abundant, pale cytoplasm. Nests of melanocytes predominate over those distributed singly along the junctional zone, and some of those nests are confluent. Some areas show maturation and dispersion with descent.	One outside slide, D-2147-14 (LX-14-01265 A-1). One corresponding block received 6-9-14.	COMPOUND NEVUS; ATYPICAL MELANOCYTIC PROLIFERATION	\N	\N	\N	Along with the slides was a report from Barr Dermatopathology suggesting comparative genomic hybridization; per a message from your institution we proceeded with that testing. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include a gain involving chr. 1q, loss of 2p with areas of gain involving 2q but a gain involving the terminal portion of that chromosome, loss involving 4q, and loss involving 9p. Several of these aberrations are commonly found in melanoma.  While formally, this is an AJCC stage pT1a lesion, the prognosis is in a group of cases of this type is even more favorable than in a group of adult patients with conventional AJCC stage pT1a lesions. Spitzoid melanomas in children have a considerably lower rate of extranodal disease. This lesion is well circumscribed and has a margin of about 1 mm. As local recurrence from incomplete excision is rare in lesions of this type, I would suggest a narrow re-excision to achieve 5 mm. margins. Sentinel lymph node biopsy is controversial in this type of case, with childhood spitzoid melanomas having a high rate of nodal involvment, but a much lower rate of extranodal spread. Hence, the prognostic value of the procedure is much less than in an adult patient, and the procedure can lead to overtreatment.	MELANOMA, 0.85 MM. IN THICKNESS	273588	650	\N	\N	14-43805	\N	DP-13	NRAS Amplified	IP1393739	AirTable blocks_with_IP_info.csv
1408	10-75211	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	Sections show fibrosing granulation tissue stemming from prior biopsy with a residual array of melanocytes with in the deeper dermis characterized by medium to large melanocytes with abundant amphophilic cytoplasm and pleomorphic nuclei arranged in fascicles and nests.	Ellipse, 1.3 x 0.5 x 0.2 cm, including a central 1.1 x 0.5 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	BX PROVEN PROLIFERATION OF ENLARGED MELANOCYTES, 0.4 CM PINK SCAR	\N	\N	\N	ADDENDUM, March 20, 2012: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system: We continue to favor a melanocytic nevus as the most likely diagnosis.  Comparative genomic hybridization shows no loss or gain of chromosomal material. This favors a benign interpretation, or a low grade neoplasm with limited metastatic potential. About 95% of conventional melanomas show detectable losses or gains with this technique. Nonetheless, the melanocytic proliferation is unusual and has not been removed by this procedure, and further excision to ensure its complete removal is recommended.	RESIDUAL INTRADERMAL PROLIFERATION OF MELANOCYTES, EXTENDING TO BOTH EDGES AND CLOSELY TO THE BASE OF THE SPECIMEN	123298	651	\N	\N	10-75211	\N	DP-14	NRAS Amplified	IP963226	AirTable blocks_with_IP_info.csv
2444	19-44904	3	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	Sections show a dome shaped skin segment with an effaced epidermis that contains occasional nests of spindled and epithelioid melanocytes. Within the dermis there are nests of large epithelioid melanocytes, with occasional large multinucleate melanocytes. The proliferation has a wedge-shaped profile and in the reticular dermis melanocytes are positioned between thickened collagen bundles. There is a sparse lymphocytic infiltrate.	Eleven outside slides, 19/CH18523, including 10 unstained slides. One corresponding block received 6/24/19.	ATYPICAL - LOOKS LIKE MELANOMA BUT 3 Y/O? CGH USEFUL	\N	\N	\N	ADDENDUM, July 19, 2019: Dear Dr. Hitchcock,  Thank you for sending this case in consultation. I agree with you that this spitzoid proliferation is unusual and has a slightly asymmetric architecture. However it does mature and the FISH findings are reassuring. We performed array comparative genomic hybridization specifically on the superficial nodular area within the tumor that shows greater cytomorphologic atypia and mitotic activity. This demonstrated loss of chromosome 9 but no other significant copy number alterations. p16 immunohistochemistry demonstrates strong staining in the majority of the tumor, but no staining in the area that we tested by aCGH. I believe this case represents an atypical Spitz tumor arising in a Spitz nevus due to loss of CDKN2A (on chromosome 9p). The aCGH findings do not support a diagnosis of melanoma.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173602	652	\N	\N	19-44904	\N	DP-15	Atypical Spitz Progression	IP2049186	AirTable blocks_with_IP_info.csv
1499	11-65284	26	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes that is relatively symmetrical, has good lateral demarcation, but is biphasic or multiphasic in its composition. Along the junction, there are single melanocytes and nests distributed at the sides and bases of rete ridges, and most of these melanocytes are relatively small. Many of them have finely melanized cytoplasm. In perijunctional dermis below this, a wedge-shaped array of maturing nests, cords, and syncytia of similar melanocytes can be seen. Centrally, additional melanocyte morphologies are noted. In some areas, there are enlarged epithelioid melanocytes with finely vacuolated cytoplasm. In other areas, there are enlarged epithelioid melanocytes positioned singly and in cords between thickened collagen bundles. A juxtaposed sparse infiltrate of lymphocytes and melanophages is noted.	Five outside slides, 11-RSC-17793:1A,1B. One corresponding block (1B) received 9-8-11.	MOLE	\N	\N	\N	I believe this proliferation represents a combined melanocytic nevus. It includes the commingling of conventional melanocytic nevus, balloon cell nevus, and desmoplastic Spitz nevus. I do not believe that melanoma is present. However, as there has been diagnostic variability with respect to the interpretation of this proliferation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a small segmental gain in chromosome 3p and also focal loss in chromosome 3p; no other chromosomal copy number aberrations were found. Loss of chromosome 3p occurred at the location of the BAP-1 gene and has been correlated with mutations in the BAP-1 gene (further explanation is included below). As you probably know, the vast majority of melanomas analyzed via aCGH contain multiple chromosomal copy number gains and/or losses, while virtually all melanocytic nevi lack associated copy number gains or losses. The identification of focal aberrations limited to chromosome 3p has been documented within melanocytic nevi and is not considered to represent molecular support for a diagnosis of melanoma.  Mutations in the BAP-1 gene can be seen in epithelioid melanocytic nevi that occur in familial fashion. A link to some ocular melanomas has also been established. If epithelioid melanocytic nevus are noted in this patient or in other family members, additional molecular assessment of such lesions may be indicated. Reference: Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rutten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011 Aug 28. doi: 10.1038/ng.910. [Epub ahead of print] PubMed PMID: 21874003.	BIPHASIC COMPOUND PROLIFERATION OF MELANOCYTES, CONSISTENT WITH A COMBINED MELANOCYTIC NEVUS	173619	656	\N	\N	11-65284	\N	DP-19	CGH Validation	IP1054727	AirTable blocks_with_IP_info.csv
1502	11-66564	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show an asymmetrical compound proliferation of melanocytes. Within the epidermis, there are large melanocytes with abundant dusty cytoplasmic melanin as well as some smaller ones, and in some areas there is marked confluence of large nests, and these nests include a combination of both melanocytic phenotypes within them. The intraepidermal component extends asymmetrically lateral to a dermal component of similar large cells, many of them in clusters and short fascicles. An encompassing lymphohistiocytic infiltrate with admixed melanophages is also noted. A number of dermal mitotic figures are evident, including some at the very base of the proliferation.	One outside slide, MKS-11-008738 A1-1 and one corresponding block.	MOLE INCREASING IN SIZE AND CHANGING IN COLOR OVER PREVIOUS 2 MONTHS	\N	\N	\N	ADDENDUM, October 10, 2011: Our differential diagnosis for this atypical melanocytic proliferation included melanoma on one hand and a highly atypical melanocytic nevus on the other. To more fully address this differential diagnosis via molecular means, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gains in chromosomes 7p, 13q, and 20, and losses in chromosomes 9, 11p (segmental), and 11q were also noted. The presence of multiple chromosomal copy number aberrations indicates the presence of genomic instability, and this molecular finding points directly to classification as melanoma. In short, the molecular results we have demonstrated are incompatible with any type of melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with has provided clear evidence in support of a diagnosis of melanoma. This melanoma is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished, if that has not yet been accomplished.	MELANOMA OF 1.6 MM IN THICKNESS, TRANSECTED AT THE SPECIMEN PERIPHERY	173602	657	\N	\N	11-66564	\N	DP-20	CGH Validation	IP1056007	AirTable blocks_with_IP_info.csv
1056	02-20495B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1055	\N	\N	None	\N	MD-178	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1034	01-26615B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1056	\N	\N	None	\N	MD-179	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1022	01-1112 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1057	\N	\N	None	\N	MD-180	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1694	13-24372B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	937	\N	\N	None	\N	MD-31	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2917	87-14087B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1080	\N	\N	None	\N	MD-203	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2918	88-6851-2 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1081	\N	\N	None	\N	MD-204	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2934	92-14752-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1082	\N	\N	None	\N	MD-205	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1522	11-87412	85	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a segment of severely sun-damaged skin with a wedge-shaped, somewhat asymmetrical proliferation of large oval and spindled melanocytes in the superficial dermis. These are compactly arranged in the upper part of the lesion, with smaller aggregations of somewhat smaller cells dispersed between thickened collagen bundles toward the lower portion of it.	Three outside slides, SW11-6722-A:1-1, A:2-1, and A:3-1, and one corresponding block, A:3.	SPINDLE CELL PROLIFERATION, SEE DL11-77917	\N	\N	\N	Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate in the upper part of the lesion and a near zero proliferation rate in the lower part. A phosphohistone H3 immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows only rare positive nuclei in the upper part of the lesion. Comparative genomic hybridization shows multiple chromosomal gains and losses diagnostic of melanoma. There are losses involving chromosomes 1q, 7p, 9 and a small portion of 12q. There are gains involving 6q, 7q and 8. Several of these aberrations are commonly found in melanoma, and the large number of aberrations is strong evidence favoring that diagnosis.  I have listed the thickness as at least 1.6 mm. as there was a initial biopsy with a melanocytic proliferation that measures 1 mm in thickness. I cannot tell the exact area in which the intial biopsy overlay the specimen, but it is likely that the thickness was over 2 mm and hence that this was a T3a melanoma.	MELANOMA, AT LEAST 1.6 MM. IN THICKNESS	562711	659	\N	\N	11-87412	\N	DP-22	CGH Validation	IP1076860	AirTable blocks_with_IP_info.csv
1565	12-9397B	20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a broad based and asymmetrical proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. There is a mostly junctional flatter area featuring discrete nests of melanocytes with abundant, pale lightly pigmented cytoplasm and small, monomorphous nuclei, and intervening basilar hyperpigmentation. The raised area features large, compact nests of melanocytes with small round to oval nuclei, small nucleoli and scattered mitotic figures. Some mature with descent is present, and smaller cells lie in between collagen bundles in the superficial reticular dermis and around blood vascular and lymphatic vessels.	Three outside slides, S08-851. One corresponding block received 2-14-12.	2ND OPINION, A) POSTERIOR NECK LESION, B) PIGMENTED IRREGULAR LESION; R/O ATYPIA, C) REEXCISION OF PIGMENTED IRREGULAR LESION, D) BOWEL INTUSSUSCEPTION, POSSIBLE MELANOMA	\N	\N	\N	This lesion has many features of the superficial form of compound congenital nevus. The nests in the more raised area of the lesion are compactly arranged, and melanocytes in mitosis are readily found. The sections are somewhat thick, which may exaggerate the cellularity in the larger nests. The differential diagnosis included a nevus with some unusual features, including mitotic figures (which can occur in benign nevi), and an unusual nevoid melanoma. Per my discussion with Dr. Spitler, we requested the blocks from the skin lesion (this part of the case) and from (D) for comparative genomic hybridization. This was to see if chromosomal aberrations typical of melanoma are present in the skin lesion, and if so, if they are the same ones as are present in the intestinal metastasis.  Comparative genomic hybridization shows findings indicative of melanoma in this unusual case. There are multiple chromosomal gains and losses, some of them involving areas that are frequently aberrant in melanoma. The aberrations in this case include a loss involving 5q, a loss of 6qtr, chromosome 9, a complex rearrangement involving 11q with multiple gains and losses, a loss of 12p and a gain of 13. The pattern seen here overlaps with that found in a separate CGH reaction from DNA extracted from the bowel metastasis (see part D, below).	MELANOMA, 1.0 MM IN THICKNESS	173619	661	\N	\N	12-9397	B	DP-24	CGH Validation	IP1095213	AirTable blocks_with_IP_info.csv
1629	12-48249	54	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a compound proliferation of melanocytes involving the epidermis and superficial dermis. The lesion is broad, has a slightly domed surface, and where it can be ascertained, appears well circumscribed. There are evenly elongated, round-based rete ridges, some of which are bridged by oval nests of large oval melanocytes that have abundant pale cytoplasm and slightly enlarged nuclei. Single melanocytes with scant cytoplasm are also present in the basal layer of the epidermis in between the ridges, and very focally above them. Within the superficial dermis, especially in the center of the lesion are poorly formed fascicles of spindled melanocytes with scant cytoplasm and variably sized, hyperchromatic nuclei. Toward one edge of the specimen, the dermis contains vertically oriented vessels and closely apposed, thin collagen bundles.	Five outside slides, D12-18979:1 and 2. Two corresponding blocks received 7-5-12.	R/O RECURRENT DYSPLASTIC NEVUS	\N	\N	\N	ADDENDUM, July  5, 2012: The following note has been modified from that in the original report, a copy of which is on file as a .pdf in our computer system: The neoplasm extends to the peripheral edge of the specimen.  The melanocytic proliferation has the overall architectural features of a dysplastic nevus, but has very large and confluent junctional nests, and a dermal component with some desmoplastic features. The differential diagnosis included an unusual dysplastic (Clark's) nevus and a dysplastic nevus-like pattern of melanoma.  Comparative genomic hybridization shows many chromosomal gains and losses, indicative of a level of genomic instability seen in melanoma and not in nevi. These included losses involving chromosome 3q, 8p, and 9p, and multiple areas of gains and losses on chromosome 11q. Losses of 9p are the most common aberrations in melanoma, and while not specific, when associated with other abnormalities point to that diagnosis.  The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 0.45 MM. IN THICKNESS	173532	662	\N	\N	12-48249	\N	DP-25	CGH Validation	IP1134062	AirTable blocks_with_IP_info.csv
1639	12-64897	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	There is a multinodular dermal proliferation of large, oval melanocytes with abundant, amphophilic cytoplasm and large, vesicular or hyperchromatic nuclei in the dermis, sparing the epidermis. Occasional melanocytes have abundant, pale cytoplasm and dusty appearing melanin. There is a lack of maturation or dispersion with descent. There are admixed lymphocytic infiltrates.	One hematoxylin and eosin-stained section prepared from outside block labeled Y12-2899 A1. Three additional corresponding slides (A1 and A2) received 8-31-12.	SPITZ	\N	\N	\N	Comparative genomic hybridization shows several chromosomal aberrations indicative of melanoma. There are losses involving chromosomes 4, 9, 11 and 14 with gains involving chromosomes 19p and 20q. Chromosome 9 is the most commonly lost chromosome in melanoma, and when present along with other multiple other aberrations supports the diagnosis of melanoma. Given the age of the patient and spitzoid morphology, the prognosis may be more favorable than the thickness would indicate. The margin is focally involved at the level of the deep reticular dermis.	MELANOMA, 3.4 MM. IN THICKNESS	173602	663	\N	\N	12-64897	\N	DP-26	CGH Validation	IP1150713	AirTable blocks_with_IP_info.csv
1720	13-73582	18	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a compound proliferation of large oval melanocytes that extends from the junctional zone to the base of the specimen in the mid-reticular dermis. The center of the lesion features irregular epidermal hyperplasia and parakeratotic scale-crust, with subepidermal fibrin deposits. In the upper part of the lesion, there are large confluent nests of melanocytes with indistinct cell borders, pale vacuolated cytoplasm and pleomorphic nuclei. More discrete aggregations of slightly smaller cells are positioned between collagen bundles toward the base of the lesion. The enclosed Ki-67 stain shows a moderate proliferation rate among the lesional melanocytes.	Three outside slides, DC13-489, SCC13-2099, DT13-4756 and one corresponding block.	SPITZ NEVUS, R/O MELANOMA	\N	\N	\N	The mode of biopsy precluded an evaluation of some architectural features. Comparative genomic hybridization shows an amplification involving chromosome 7q. Isolated gains involving this area have been seen in Spitz's nevi, with several different morphologies. High level copy number gains or amplifications involving 7q can occur in such lesions when there are gene fusions involving b-raf, where the fusion partner is within 7q. The subject of spitzoid lesions with b-raf fusions is discussed in the paper below. Given the findings seen here, and this genomic result, I believe that a conventional melanoma can be excluded. The most likely possibility is that this is a Spitz's nevus with a b-RAF fusion, and some unusual morphologic features. Ideally, complete excision with a narrow margin of uninvolved skin would be attained. It is difficult to make a suggestion regarding complete removal without knowing what this would entail at this site.  Reference:  Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, Leboit PE, Burton EA, Bollag G, Ballotti R,  Bastian BC. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res. 2013 Jul 24. doi: 10.1111/pcmr.12148. [Epub ahead of print] PubMed PMID: 23890088.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH GENOMIC FEATURES FAVORING AN UNUSUAL SPITZ'S NEVUS	172340	665	\N	\N	13-73582	\N	DP-28	CGH Validation	IP1315587	AirTable blocks_with_IP_info.csv
1426	11-256	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.2	\N	\N	There are nests of melanocytes at the dermo-epidermal junction, and nests, cords and strands of plump, oval to small round melanocytes within the subjacent dermis. Some of the superficial nests are composed of melanocytes that have lightly pigmented cytoplasm. Some of these nests are large and horizontally oriented. These cells mature with descent, and lie in part around adnexal structures.	One outside slide, Q80255.	SPITZ NEVUS, R/O ATYPIA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	102270	799	\N	\N	11-256	\N	KIT-18	Kit mutants	IP989693	AirTable blocks_with_IP_info.csv
1721	13-75788B	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	\N	\N	Sections show nodular aggregations of large, epithelioid cells similar to those in (A), with more nuclear pleomorphism and hyperchromasia. There is variably intense staining with low molecular weight, and pan-keratin.	Seven outside slides, 12SSH7050 (1A - 1A3) and one corresponding block (1A), received 9-25-13.	PT WITH METASTATIC MELANOMA TO THE LYMPH NODES, NO PRIMARY EVER FOUND, HALO NEVUS ENLARGING (POSSIBLE CGH)	\N	\N	\N	The findings in the hematoxylin and eosin-stained sections in (A)suggested a Spitz's nevus with a halo reaction. While the morphology suggested a BAP-1 mutation, staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions). One can occasionally see retention of immunohistochemical staining with BAP-1 mutations, however. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively low proliferation rate in the dermal melanocytes. Given the keratin positivity in (B) I also obtaining a keratin stain in (A), but it is negative.  A Fontana stain shows complete loss of melanin from the basal layer of the epidermis, in keeping with the history of a halo. Comparative genomic hybridization in (A) did not show chromosomal gains or losses, a finding that is strongly against melanoma.  We also reviewed the sections from the metastasis, see part (B) below. Staining for BAP-1 in (B) shows no loss of that protein (the same result as in (A). Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. While the hybridization was of low quality (probably due to the presence of necrosis en masse), there were gains in 3q, 5p, 6p, 8q and 10p, and losses in 6q, 9 and 10p, among others.  In sum, the findings point to the two lesions as being unrelated.	METASTATIC MELANOMA	173541	666	\N	\N	13-75788	B	DP-29	CGH Validation	IP1317793	AirTable blocks_with_IP_info.csv
1740	14-11769	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged fusiform melanocytes arrayed irregularly within the epidermis and dermis in large fascicles that are centrally maturing, an melanocytes in mitosis are easily found in the upper dermis. The background epidermis is acanthotic and verrucous, and the fibrotic encompassing dermis holds a lymphohistiocytic infiltrate and ectatic vessels.	Two outside slides, EFG17-14 (1-2) and one corresponding block Jo-13-1-20651-2.	FOR 2 MONTHS HAD SOMETIMES BLEEDING LESION; NEVUS, HEMANGIOMA, R/O MELANOMA	\N	\N	\N	My differential diagnosis included a hyperproliferative polypoid Spitz nevus, an HRAS-mutated Spitz nevus, and spitzoid melanoma. Based solely upon the examination of microscopic sections, I initially favored either of the former two possibilities as most likely, but I cannot fully exclude melanoma based solely upon histopathologic parameters. (An HRAS-mutated Spitz nevus has now been excluded from the differential diagnosis on molecular grounds, as is discussed further in the sentences that follow.) Per your request, we completed comparative genomic hybridization (CGH) as part of our assessment. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in distal chromosome 6q with no other associated chromosomal gains or losses. Loss in chromosome 6q can be seen in association with melanoma but typically involves the MYB gene; in this instance, the loss of 6q may fall distal to the MYB gene locus. There is not gain in chromosome 11p present, and thus an HRAS-mutated Spitz nevus can be excluded from diagnostic consideration.  In summary, the combination of results derived from conventional microscopy coupled with CGH has not produced an entirely straightforward result. The differential diagnosis lies between an atypical Spitz nevus/tumor with associated distal chromosome 6q loss on one hand and spitzoid melanoma of 3.4 mm in thickness on the other. As melanoma cannot be excluded from the differential diagnosis, I believe that melanoma should be considered the functional diagnosis for this case.  If staged as melanoma, this non-ulcerated tumor is between 2-4 mm and thus represents stage pT3a (2009 AJCC Guidelines). Complete local removal has already been achieved.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	POLYPOID COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, 3.4 MM IN THICKNESS, EXCISED IN THE AVAILABLE PLANES OF SECTION	123298	667	\N	\N	14-11769	\N	DP-30	CGH Validation	IP1361690	AirTable blocks_with_IP_info.csv
1759	14-42631	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a roughly symmetrical compound melanocytic proliferation with a domed surface.  The overlying epidermis is thickened, with hyperplasia of the spinous layer, hypergranulosis and compact hyperkeratosis. Situated at the epidermal-dermal junction are nests of large oval melanocytes, some of which are separated from the epidermis by clefts.  The junctional melanocytes have abundant cytoplasm and large vesicular nuclei. Kamino bodies (dull pink globules) are present. Many melanocytes have abundant, pale cytoplasm and dusty appearing melanin and strikingly large, pleomorphic vesicular nuclei.	One outside slide, JS-14-25671 / A1, and one corresponding block.	DARK IRREGULARLY PIGMENTED PLAQUE, PT HAS A COUPLE OF OTHER SMALLER LIGHTER NEVI ON BUTTOCKS ALSO; NEOPLASM OF UNCERTAIN BEHAVIOR VS. COMPOUND NEVUS, R/O ATYPIA OR DYSPLASIA	\N	\N	\N	Per your cover letter, we performed comparative genomic hybridization. This unusual lesion has the silhouette of a Spitz's nevus, and has many Kamino bodies. However, many of the lesional melanocytes are pulverocytes* and some nuclei near the base of the specimen have strikingly atypical nuclei. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. There is a small interstitial deletion in chr. 4q of unknown significance. Areas of loss involving chr. 9q are present. Losses involving chr. 9 or 9p are the most common aberrations in melanoma; losses of 9q with preservation of 9p are less common and seem less significant. A small interstitial gain within chr. 10q is present. The most important aberration is a cluster of high level amplifications and losses involving chr. 12q. These include an amplification that my colleague, Dr. Iwei Yeh pointed out to me includes the CDK4 locus. In past work from our group, gains of CDK4 were seen in melanomas that were wild type for b-raf and n-ras.  Given the above findings, a spitzoid melanoma rather than a spitzoid melanoma is the best interpretation for this neoplasm, despite the presence of Kamino bodies.  *This term is introduced in Massi G, LeBoit P. Histologic Diagnosis of Nevi and Melanoma, 2nd Edition, Springer-Verlag, Berlin Heidelberg, 2014 p. 57, and refers to cells with abundant, pale cytoplasm and dusty appearing melanin, deriving from the Latin term for dust; such cells, referred to by the late Dr. A. Bernard Ackerman as pagetoid melanocytes (a confusing term, as it can be used for cells with pagetoid scatter) are unusual in Spitz's nevus.	MELANOMA, 0.95 MM. IN THICKNESS	173507	668	\N	\N	14-42631	\N	DP-31	CGH Validation	IP1392565	AirTable blocks_with_IP_info.csv
1762	14-46549	36	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show melanocytes arrayed in compound fashion in a sessile specimen. There are large fusiform, epithelioid, and plasmacytoid melanocytes that are distributed in some very large nests and in collagenous dermal stroma. Cells in mitosis can be found in the perijunctional zone.	Three outside slides, COV14-697 A1 and one corresponding block.	MOLE REMOVAL	\N	\N	\N	Per your approval, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma, at a reduced fee. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 1q, 8q, 20q, and 21q with gain and loss in chromosome 3q and with loss of distal chromosome 6q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of melanoma. The aCGH profile that we have defined is essentially incompatible with a benign interpretation. With respect to staging, this non-ulcerated melanoma is between 2-4 mm and thus represents melanoma of stage pT3a (2009 AJCC Guidelines). Further excision is warranted to ensure that local control has been established.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MELANOMA OF 3.8 MM IN THICKNESS, FOCALLY INVOLVING THE DEEP EDGE OF THE BIOPSY	173727	669	\N	\N	14-46549	\N	DP-32	CGH Validation	IP1396485	AirTable blocks_with_IP_info.csv
1770	14-57552	36	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	A partially circumscribed, hypercellular compound proliferation of enlarged fusiform and epithelioid melanocytes has associated epithelial hyperplasia with areas of thinning. In this background epidermis, melanocytes are distributed confluently and sometimes in pagetoid fashion. There is limited extension of these melanocytes along adnexal epithelium and into the perijunctional dermis, where a lymphohistiocytic infiltrate with admixed melanophages is noted.	Two outside slides, ES14-26948 (A1), and one corresponding block.	HISTORY OF NEVUS FOR A LONG TIME BUT WHICH IS CURRENTLY CHANGING IN COLOR AND COMPOSITION, IRREGULAR DARK BROWN TO BLACK MOLE WITH HALO EFFECT; ABNORMAL NEVUS	\N	\N	\N	My differential diagnosis included both minimally invasive melanoma on one hand and an unusual inflamed Spitz nevus on the other, and after the completion of the assessment that is delineated in the sentences that follow, the former possibility has been substantiated as the best overall diagnosis for this case. Immunostaining with p16 demonstrates diffuse preserved expression, and this staining result implies that the loss of CDKN2A function (and loss of p16 expression) that can be seen n association with many examples of melanoma is not apparent here (this finding was borne out by molecular assessment, as is discussed in the paragraph that follows). Given the unusual and challenging histomorphology, we proceed with array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma and as per your approval. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosomes 8p, 10, and 11q, and additionally there was a focused gain in chromosome 11q at the location of the CCND1 gene. The identification of multiple copy number abnormalities indicates genomic instability, as is stereotypical of melanoma, and in particular the finding of CCND1 gain is associated with the diagnosis of melanoma. As was alluded to in the paragraph above, chromosome 9 was found to be without aberrations, and thus the preserved expression of p16 that has been documented is appropriate, even in the context of a diagnosis of melanoma.  In summary, based upon the analysis of both histopathologic and molecular attributes, we have confirmed a diagnosis of spitzoid melanoma. This melanoma is only minimally invasive, and its overall microstage thickness has been inflated by associated acanthosis. With respect to staging, this non-ulcerated tumor is between 1-2 mm in thickness and thus is technically staged as a melanoma of stage pT2a (2009 AJCC Guidelines), although I suspect stage pT1a is more reflective of the situation, since the dermal involvement seen here is minimal.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MELANOMA OF 1.1 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173528	670	\N	\N	14-57552	\N	DP-33	CGH Validation	IP1407492	AirTable blocks_with_IP_info.csv
2279	18-15028	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18202	216.4	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/PL	R/O DYSPLASTIC NEVUS VS. LENTIGO	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173477	839	\N	\N	18-15028	\N	LN-19	Lentiginous Nevi 	IP260019	AirTable blocks_with_IP_info.csv
1017	00-24216D T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1059	\N	\N	None	\N	MD-182	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1793	14-83928	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a large pan-dermal population of atypical spindle cells that completely lacks maturation. These cells are arrayed in coalescing fascicles within the larger nodule, and cells and mytosis are commonly found.  Some of the cells of interest form rounded, lumen-like spaces.  The encompassing dermis is fibrotic and highly vascular with congested vessels.  Accompanying immunostains demonstrate expression of SOX-10 and S100 protein, Patchy expression of MelanA and HMB-45, and preserved nuclear expression of INI-1.	Twenty-one outside slides, DC14-03059 (A-C) (GLC-14-03777), and one corresponding block (C).	R/O CYST VS. LIPOMA VS. JXG	\N	\N	\N	Our differential diagnosis included melanoma and so-called paraganglioma-like dermal melanocytic tumor, and the observed degree of cytologic atypicality and the elevated mitotic index associated are concerning for the former possibility. A detailed molecular analysis of the latter entity has not yet been completed, but chromosomal copy number abnormalities would likely be infrequent in that context (given that it is said to be a low-risk tumor). To attempt to clarify the diagnosis, we additionally completed comparative genomic hybridization (CGH) to screen for chromosomal copy number abnormalities, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed a focused deletion involving chromosome 5q as a monoaberration with no other associated chromosomal gains or losses. (The deletion in chromosome 5q includes the APC gene, which is part of the WNT signaling pathway.) As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from aCGH has not produced confirmation of a molecular diagnosis of melanoma. Although it is impossible to exclude melanoma on histopathologic grounds, the molecular result that has been obtained suggests that this tumor may be of ambiguous or low-grade biologic potential. In short, classification as a paraganglioma-like melanocytic tumor (or as a similar form of low-grade tumor) can be considered plausible from a molecular standpoint. Dr. Boris Bastian has reviewed the molecular data for this case and agrees that the molecular result should not be viewed as being confirmatory of a diagnosis of melanoma.  This tumor is 7.9 mm in thickness and is non-ulcerated. It has not yet been adequately excised.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	PLEOMORPHIC SPINDLE CELL TUMOR WITH S100-IMMUNOPOSITIVITY AND A LACK OF SIGNIFICANT GENOMIC COPY NUMBER ABERRATIONS	173604	671	\N	\N	14-83928	\N	DP-34	CGH Validation	IP1433898	AirTable blocks_with_IP_info.csv
2950	94-19725B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1083	\N	\N	None	\N	MD-206	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1791	14-82758	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a pedunculated segment of skin with a mostly papillary dermal proliferation of large, oval melanocytes with homogeneous appearing eosinophilic cytoplasm and markedly pleomorphic and heterochromatic vesicular nuclei, some with large, central nucleoli. Some maturation with descent is evident. Several mitotic figures are present. A patchy lymphocytic infiltrate is also seen.	Six outside slides, D-14-00845 (A1) (HR14-31395-A), and one corresponding block.	PATIENT WITH A FIVE-MONTH HISTORY OF A GROWTH ON HIS LEFT HAND, DIGIT FOUR, THE LESION WAS FROZEN A FEW WEEKS AGO AND TURNED RED BUT DID NOT GO AWAY, WHEN HE PRESENTED TO ME, HE HAD A PINK DOME-SHAPED PAPULE ON THE DORSAL ASPECT OF THE DIGIT, 0.5 CM PAPULE; R/O PYOGENIC GRANULOMA	\N	\N	\N	ADDENDUM, October  5, 2014 The following note has been modified from that in the original report and preceding addenda, copies of which are on file as .pdfs in our computer system; the new material is bracketed with asterisks: The differential diagnosis includes an atypical Spitz tumor and spitzoid melanoma.  *** Comparative genomic hybridization shows no significant chromosomal gains or losses. This is a reassuring finding, and could signify that the chromosomal copy number changes seen in fluorescence in situ hybridization might reflect changes in a minor population. I would regard this as an atypical Spitz tumor, and obtain a re-excision (given the configuration, not much wider, but deeper). ***	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, BEST VIEWED AS AN ATYPICAL SPITZ TUMOR	173613	672	\N	\N	14-82758	\N	DP-35	CGH Validation	IP1432726	AirTable blocks_with_IP_info.csv
1797	14-95595	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	A broad shave biopsy demonstrates a compound proliferation of enlarged fusiform and epithelioid melanocytes. The background epidermis is partially acanthotic but also significantly thinned, and melanocytes are in pagetoid array within it. There are non-maturing melanocytes distributed diffusely within the dermis below this, where occasional melanocytes in mitosis can be found. The melanocytes are distributed somewhat syncytially and permeate superficial skeletal muscle. The Ki-67 cell proliferation index is elevated.	Four outside slides, SD14-7940 (A1), and one corresponding block.	5 MM YELLOW PAPULE; IMPRESSION INCLUDED JUVENILE XANTHOGRANULOMA, VERRUCA, OTHER	\N	\N	\N	Based upon the observed histopathologic findings coupled with the elevated Ki-67 cell proliferation index and the loss of p16 expression that you demonstrated, I found this tumor worrisome for childhood spitzoid melanoma. To further explore the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) analysis to screen for genomic copy number anomalies. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in distal chromosome 7q as a monoaberration with no other associated chromosomal gains or losses. The area of gain includes the BRAF gene, but there is no indication of a BRAF gene fusion. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of monoaberrations is generally considered non-supportive of the diagnosis of melanoma. Additionally, the aCGH tracing does not demonstrate loss in chromosome 9p, thus indicating that the loss of p16 expression that has been demonstrated is likely epigenetic in nature. After completion of aCGH, BAP-1 immunohistochemistry was additionally completed. Strong expression was observed, indicating that loss of this tumor suppressor protein has not occurred (this corroborates the normal result observed with respect to chromosome 3p in the aCGH tracing). In summary, the interpretation of this tumor is not straightforward. Summing all of the available findings, we have defined a spitzoid melanocytic tumor that has epigenetic loss of p16 expression and that has an associated genomic monoaberration involving distal chromosome 7q. This combination suggests that this tumor does not represent childhood spitzoid melanoma but rather represents a partially transformed Spitz tumor ('atypical Spitz tumor'). Since the current biopsy is only partial in nature, reexcision of the remainder of this tumor will be necessary as follow-up care.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.  This report was reissued on December 10, 2014, after correcting a typographical error. (A dropped word was inserted.)	ATYPICAL COMPOUND PROLIFERATION OF MELANOCYTES, INVOLVING THE DEEP EDGE OF THE BIOPSY	101044	673	\N	\N	14-95595	\N	DP-36	CGH Validation	IP1445586	AirTable blocks_with_IP_info.csv
1829	15-10108	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed irregularly along the junction.  There are clusters and syncytia of melanocytes arrayed irregularly in the superficial dermis, which is fibrotic, and some melanocytes are larger.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis, but some are larger as well. The epidermis is largely folded in initial sections.	One outside slide, N15-33-GB (15-DM-462-1). One corresponding block received 2/6/15.	STRONG FAMILY HISTORY OF MELANOMA, NEW PINK LESION ON BACK	\N	\N	\N	ADDENDUM, March 13, 2015: While there are some features suggesting a Spitz's nevus, there is an irregular distribution of melanocytes and incomplete maturation. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively low proliferation index. A p16 immunoperoxidase stain shows partial retention of that tumor suppressor gene product. BAP-1 staining is also preserved (this can be lost in a subset of Spitzoid proliferations). To assess whether this may reflect an emerging class of Spitzoid neoplasms with genetic fusion events, I also examined ALK and NTRK-1 which are not overexpressed. For further assessment of this proliferation, to exclude the possibility of Spitzoid melanoma, I was interested in obtaining comparative genomic hybridization on this case. This is a technique that assesses chromosomal gains or losses, which (with the exception of a gain of 11p, and few other specific, less common aberrations) are found in melanoma and not in Spitz's nevus. Dr. Timothy McCalmont, also reviewed these sections and agreed with this assessment.  We subsequently received your message authorizing comparative genomic hybridization and this has now been completed. The results are unusual but do not support a diagnosis of melanoma, nor is there an 11p gain as in some Spitz's nevi. I asked my colleagues Drs. Bastian and Yeh, of our molecular unit, to analyze these findings further. There are a complex array of small gains and losses involving a portion of chromosome 7q mainly, and a loss of a portion of 12p. Such anomalies have not been characterized or associated with a specific melanocytic entity to date. Thus, an atypical nevus is likely. However, as there are aberrations and unusual histologic features, as above, re-excision of this site is warranted as noted in the initial report.	COMPOUND MELANOCYTIC PROLIFERATION, WITH SPITZOID FEATURES, EXTENDING TO THE EDGE AND BASE OF THE SPECIMEN	173530	674	\N	\N	15-10108	\N	DP-37	CGH Validation	IP1481138	AirTable blocks_with_IP_info.csv
1839	15-16907A	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There are large, pan-dermal and superficial subcutaneous masses of melanocytes with eccentric nuclei and a somewhat plasmacytoid appearance. The nuclei are moderately enlarged and oval, with relatively small nucleoli. It is difficult to find mitotic figures. Occasional pyknotic nuclei are present. The epidermis is uninvolved. The deep subcutis is replaced by dense, paucicellular fibrosis.	Two outside slides, DRVS15-1294-A1. One corresponding block received 3/3/15.	PATIENT WITH HISTORY OF MELANOCYTIC PROLIFERATION IN 2007 ON RIGHT SCALP, ORIGINALLY READ AS 3.2 MM MELANOMA NEVOID TYPE BT STANFORD PATHOLOGY, THE READ AS COMBINED MELANOCYTIC NEVUS BY UCSF, PATIENT PRESENTING WITH TWO LESIONS OF CONCERN, A) 4 MM PINK MACULE ON THE SURGICAL SCAR, B) 1 CM PINK/PURPLE ON A 5 MM STALK NOT TOUCHING THE SCAR LINE (SEE PHOTOS)	\N	\N	\N	\N	INTRADERMAL MELANOCYTIC PROLIFERATION ABOVE A SCAR, WITH IMMUNOHISTOCHEMICAL EVIDENCE OF BAP-1 LOSS, AND MULTIPLE CHROMOSOMAL COPY NUMBER CHANGES, SEE NOTE (B)	143499	675	\N	\N	15-16907	A	DP-38	CGH Validation	IP677717	AirTable blocks_with_IP_info.csv
1849	15-25818	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a mostly intradermal proliferation of large, oval melanocytes with abundant pale cytoplasm and large, vesicular nuclei. The lesion has a pedunculated contour. There are elongated rete ridges with basilar hyperpigmentation and increased numbers of single melanocytes toward the edge of the lesion. In its core, there are strands of large, oval melanocytes with fibrotic stroma.	Seven outside slides, NF-15-3476-ND, including six unstained slides. One corresponding block received 4-3-15.	0.9 CM SHAVE, APL	\N	\N	\N	ADDENDUM, April 24, 2015: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: The differential diagnosis included an atypical Spitz tumor and a spitzoid melanoma.  A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. However, an A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows several mitotic figures in the lower part of the lesion including one marginal mitosis. Given this, I suggested obtaining comparative genomic hybridization. This showed an interstitial loss involving chr. 3p, as well as a loss involving the terminal part of chr. 19p. The interstitial area in 3p includes the BAP-1 gene. The loss of chr. 19p is not one associated with melanoma.  The morphology is not stereotypic for a spitzoid lesion with BAP-1 loss. However, there is a predominant population of epithelioid melanocytes with pale cytoplasm, so it seems compatible.  Please also note that the junctional component of this lesion is at a margin, and that the lesional thickness is 4 mm. Local control with atypical Spitz tumor and spitzoid melanomas can be achieved with more narrow margins than conventional melanoma, and the metastatic risk is much less than that of a conventional melanoma of comparable thickness.	ATYPICAL SPITZ TUMOR	102537	676	\N	\N	15-25818	\N	DP-39	CGH Validation	IP1496980	AirTable blocks_with_IP_info.csv
1006	00-06521B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1060	\N	\N	None	\N	MD-183	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1010	00-12952-3 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1061	\N	\N	None	\N	MD-184	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1013	00-15364 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1062	\N	\N	None	\N	MD-185	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3012	99-15953D T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1063	\N	\N	None	\N	MD-186	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3021	99-24969F T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1064	\N	\N	None	\N	MD-187	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2257	17-120790	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18175	216.7	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/CF	R/O ATYPIA	\N	\N	\N	The benign diagnosis listed above is based in part upon the presumption that nearly the entirety of this lesion has been captured by this biopsy, indicating that the lesion at hand is small. If this is instead a partial biopsy of a larger lesion, then the present histopathology may not be fully representative.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	17722	829	\N	\N	17-120790	\N	LN-09	Lentiginous Nevi 	IP1851350	AirTable blocks_with_IP_info.csv
1286	07-55184	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed and partially polypoid proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of relatively small cells with scant or amphophilic cytoplasm, arrayed as dermal nests, cords, and syncytia. A small number of these melanocytes have more abundant vacuolated cytoplasm and are multinucleate. The second population consists of large epithelioid melanocytes with enlarged nuclei and ample eosinophilic cytoplasm, arrayed singly and in small clusters, partially commingling with the first population. There is permeative lymphohistiocytic infiltrate, mostly associated with the large epithelioid melanocytes. Subsequently, in three additional slides received, occasional dermal melanocytes in mitosis are evident.	Two outside slides, S07-26466 (MSUR-07-03218).  Three additional slides received 09/05/07.  Three additional immunoperoxidase stained slides, IP07-3648 (S07-26466) received 9/11/07. One corresponding block (M07-3218) received 3-23-15.	UCSF MELANOMA CLINIC PATIENT	\N	\N	\N	Dr. Denianke, we have completed comparative genomic hybridization (CGH) of this 2007 specimen, and results will incorporated into the final reporting of other reports for this patient. Please refer to reports 15-16907 and 15-27070 for additional information. My addendum commentary regarding this specimen, from 2007, follows below. ADDENDUM, September 14, 2007: After my original interpretation of this case as a combined melanocytic nevus, I received 3 additional slides of this tissue from Dr. Sundram. The new slides highlight occasional dermal melanocytes in mitosis. I also received HMB-45 and Ki-67 stains completed at Stanford Pathology. The HMB-45 stain is completely non-reactive, while the Ki-67 stain shows scattered positively-labeled nuclei, with a low overall labeling rate. I interpret the Ki-67 immunostaining results as supportive of a benign diagnosis and I continue to favor a diagnosis of combined melanocytic nevus (with the commingling of both conventional melanocytic nevus and epithelioid Spitz's nevus).  Dr. Philip LeBoit reviewed this case independently (including review of the 3 additional slides and the immunoperoxidase stains) and came to an identical diagnosis. We do not believe this lesion should be considered to represent melanoma.	MELANOCYTIC TUMOR, HISTORICALLY INTERPRETED AS A COMBINED MELANOCYTIC NEVUS	173406	677	\N	\N	07-55184	\N	DP-40	CGH Validation	IP677717	AirTable blocks_with_IP_info.csv
1854	15-33496	48	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a compound proliferation of melanocytes that is slightly asymmetrical. Along the junction, single melanocytes and large fascicles of finely pigmented melanocytes are noted, and these fascicles are noteworthy for the presence of ample myxoid change. In the dermis below this, partially maturing nests, cords, and syncytia of similar melanocytes are noted. In some areas in the dermis, the melanocytes become epithelioid or spindled in configuration, and a flanking infiltrate of lymphocytes and melanophages is noted. Scattered melanophages are present concurrently (Microscopic description by Dr. Timothy McCalmont).	Five outside slides, SLNS15-5627 (A1). One corresponding block received 4/24/15.	6 MM PIGMENTED LESION RECENTLY CHANGING WITH SOME IRREGULAR DERMOSCOPIC FEATURES, NO PHOTO AVAILABLE; R/O PIGMENTED SEBORRHEIC KERATOSIS VS. ATYPICAL NEVUS VS. MELANOMA	\N	\N	\N	ADDENDUM, May 11, 2015: Dr. Timothy McCalmont's initial note read:  The differential diagnosis lies between myxoid melanoma on one hand and a myxoid melanocytic nevus on the other. On balance, I favor the former possibility as most likely, but I do not believe that an utterly definitive diagnosis is possible based solely on histopathologic parameters. Given the extremely unusual configuration of this tumor, molecular analysis has been recommended.  We are just in receipt of the tissue block and will proceed with array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. A diagnostic delay of approximately 3 weeks will ensue while molecular testing is completed.  Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include a gain of chr. 5p, loss of 5q, loss of 6qter, loss of 9, loss of a pericentromeric area of 12, loss of 17 and losses and gains in a complex pattern in chr. 22. This melanoma has myxoid stroma, a finding of histopathologic interest, but not relevant to clinical behavior. A superficial dermal margin is involved.	MELANOMA, 1.2 MM IN THICKNESS	173688	678	\N	\N	15-33496	\N	DP-41	CGH Validation	IP1030082	AirTable blocks_with_IP_info.csv
1857	15-41815	68	f	\N	1	T2a	Primary	nevoid melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	There are nests, cords and strands of round melanocytes within the superficial dermis, which exhibit some degree of maturation with descent. There are also portions of the proliferation with clusters of larger melanocytes, some with vacuolated cytoplasm and medium-sized to large nuclei. Scattered mitoses are noted and there are epithelial collarettes present.	Cylindrical skin segment, 0.6 cm in diameter and 1.0 cm in thickness, bisected and entirely submitted. CF/CF	FIRM PAPULE W/ IRREGULAR PIGMENTATION; ? NEVUS VS. DF (TELEPHONE: 415-863-4204 - NEED RUSSIAN INTERPRETER, OK TO LMSG)	\N	\N	\N	Immunostaining using Ki-67 shows an elevated proliferation rate of the melanocytes in some areas (>10%), and p16 staining shows complete loss of staining in the larger population of atypical melanocytes with retained staining in the benign nevus portion. Given these concerning features, additional testing was performed with fluorescent in situ hybridization (FISH) using four probes (to loci on 6p, 6q, 6cent and 11q) and two probes to chromosome 9 (cep9 and 9p21) to assess for CDKN2A loss. The four probe cocktail showed polyploidy which is an ambiguous result that can be seen in both melanomas and some Spitz nevi, while the chromosome 9 probes showed homozygous loss of 9p21. The latter finding in the context of the other findings in this case supports a diagnosis of melanoma. I have shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation. A synoptic report of potential prognostic factors is listed below: Procedure: punch biopsy Microscopic tumor type: nevoid melanoma Breslow thickness: 1.5 mm Ulceration: absent Margins, peripheral and deep: peripheral positive for nevus, melanoma within 0.5 mm, deep neg Mitotic index: 1 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.5 MM IN THICKNESS, NON-ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173701	679	\N	\N	15-41815	\N	DP-42	CGH Validation	IP1513088	AirTable blocks_with_IP_info.csv
1867	15-52489	16	\N	\N	0	T1a	Primary	nevoid melanoma ex 'BAPoma'	\N	\N	\N	\N	\N	172.5	\N	\N	A broad shave biopsy contains a broad compound proliferation of melanocytes that is biphasic or triphasic in its composition. Within the epidermis, large fusiform and epithelioid melanocytes are distributed confluently, and the cells extend into the stratum spinosum, the stratum granulosum, and adnexal epithelium. In the dermis below this, a polymorphous melanocytic population is noted. There are large melanocytes in the upper dermis that are similar to those seen intraepidermally, while smaller hyperchromatic melanocytes are present more deeply in the dermis. Scattered only occasionally, there are also extremely large epithelioid melanocytes with ample cytoplasm. Much of the dermis appear fibrotic, and a scattered infiltrate of lymphocytes and eosinophils is also noted.	Four outside slides, 15-AD-26995-1A, and one corresponding block.	IMPRESSION WAS R/O R/O DYSPLASTIC NEVUS	\N	\N	\N	Array-based comparative genomic hybridization (aCGH) has been completed as per payor authorization. My previously-reported histopathologic analysis of this tumor remains in this report and is included in full below the line of asterisks that has been inserted (below). With respect to molecular assessment, after microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed segmental loss of chromosome 3p as a monoaberration with no other associated chromosomal gains or losses. As background for understanding this result, note that many melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of chromosome 3p loss confirms that BAP-1 genomic loss has occurred in this tumor. There are a number of reasons why aCGH analysis could fail to identify additional copy number change in a component of melanoma, including an inherent lack of copy number change in the given tumor, the effects of contaminating normal cells, or sampling error. In summary, the combination of results derived from conventional microscopy coupled with aCGH has confirmed the presence of BAP-1 genomic loss. Analysis by aCGH has not demonstrated a molecular footprint that is diagnostic of melanoma, but I still believe a component of melanoma is present on histopathologic grounds.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.  *************************************************************************************************************************** Objectively, I believe the histomorphology in your submitted slides point to a diagnosis of nevoid melanoma ex melanocytic nevus. Your submitted phosphohistone immunostain labels melanocytes in mitosis, most of which appear to be intraepidermal in distribution. We additionally completed p16 and BAP-1 immunostains as part of our assessment. The p16 stain demonstrates partial loss of expression, and thus hemizygous loss of chromosome 9p may be present in this tumor. The BAP-1 stain demonstrates loss of nuclear positivity in a subset of large epithelioid cells within this polymorphic tumor, and this labeling result indicates that BAP-1 genomic loss has occurred. In short, I believe this biopsy demonstrates melanoma ex 'BAPoma'.  Deletions (or loss) in BAP-1 can be detected by comparative genomic hybridization (CGH), and the presence of genomic loss can also be inferred by the identification of loss of nuclear BAP-1 expression by immunoperoxidase staining, as has been demonstrated here. Loss of BAP-1 can be accompanied by mutations in the remaining BAP-1 allele, which can be somatically acquired or inherited (germline). Inherited mutations of BAP-1 have recently been associated with a new cancer susceptibility syndrome, which is characterized by the occurrence of multiple skin-colored papules in affected individuals, only a minority of which develop uveal or cutaneous melanoma. Affected family members have had many (5 to >50) of the clinically innocuous yet histopathologically distinct melanocytic tumors, whereas there were few melanomas, suggesting that malignant potential is very low. Independently, germline mutations of BAP-1 have also been reported to be associated with familial mesothelioma.  The significance of this tumor in this patient needs to be judged in the larger familial context. If this is a solitary papule in a patient with no other similar lesions, then the BAP-1 alteration may be sporadic. If this patient has multiple similar papules or if there are similar papules in other family members, then the possibility of an underlying syndrome (with germline mutation) may be deserving of further consideration. If there is clinical interest in further corroborating the above diagnosis by means of comparative genomic hybridization (CGH), please let me know and we can proceed once authorization has been received.  Synoptic melanoma reporting is included below.  Procedure: shave removal Microscopic tumor type: nevoid melanoma ex 'BAPoma' Breslow thickness: 0.65 mm Ulceration: not detected Margin: deep edge involved Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1aNxMx	POLYMORPHOUS COMPOUND PROLIFERATION OF MELANOCYTES, INCLUDING BOTH MELANOMA OF 0.65 MM IN THICKNESS AND AN ATYPICAL COMBINED MELANOCYTIC NEVUS WITH ASSOCIATED BAP-1 GENOMIC LOSS	173568	680	\N	\N	15-52489	\N	DP-43	CGH Validation	IP1523838	AirTable blocks_with_IP_info.csv
1869	15-60391	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	The available tissue sections demonstrate a segment of acral skin harboring a broad, asymmetrical, and compound proliferation of large fusiform and epithelioid melanocytes. These cells are distributed in pagetoid and lentiginous fashion within the epidermis, and conspicuous extension down eccrine epithelium is noted. In one cross section, an area of erosion and reactive acanthosis is noted. In the perijunctional dermis and also the reticular dermis, there is a relatively diffuse array of fusiform melanocytes that extend through collagenous tissue into the upper subcutis. Cells in mitosis can occasionally be found. Much of the distribution of melanocytes in the dermis is fascicular, but a sheet-like pattern is focally apparent.	One outside slide, PCS-15-2278-A1, and one corresponding block.	SECOND OPINION	\N	\N	\N	I believe that the conventional histopathologic findings support a diagnosis of spitzoid melanoma. We completed p16 immunohistochemistry as an initial step in assessment, and significant diffuse partial positivity is apparent. This is prognostically significant, as it implies that biallelic loss of chromosome 9p, which represents a negative prognostic indicator, is unlikely to be present. Comparative genomic hybridization (CGH) was also included in our assessment. The application of CGH permits screening for genomic copy number anomalies. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 7p, gain and loss in 7q and 10p, and gain in 11q. The identification of multiple chromosomal copy number gains and losses indicates genomic instability, as would be expected with melanoma, and can be considered confirmatory of the above diagnosis.  This tumor is ulcerated and its full thickness can be reassessed upon complete excision. Please note that the conventional staging parameters associated with melanoma in adulthood are not known to be predictive of prognosis in the pediatric setting.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	SPITZOID MELANOMA OF AT LEAST 2.9 MM IN THICKNESS, INCOMPLETELY EXCISED	173716	681	\N	\N	15-60391	\N	DP-44	CGH Validation	IP1531774	AirTable blocks_with_IP_info.csv
1870	15-61456	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed as many large fascicles in the epidermis with acanthosis, and good lateral demarcation is noted. There are maturing fascicles in the perijunctional dermis jointly with slight myxoid change and a lymphohistiocytic infiltrate.	One outside slide, DE-15-009578 and one corresponding block\nSeven outside slides, DE-12-013912 A1.	6 MM RED-BROWN SYMMETRIC PLUMP PAPULE, FATHER DIED AT AGE 62 OF METASTATIC MELANOMA IN 2012, THREE MONTHS AFTER BEING DIAGNOSED, ALSO INCLUDED FOR REFERENCE IS AN EARLIER BIOPSY OF ANOTHER LESION (LEFT INNER CALF) BIOPSIED IN 2012	\N	\N	\N	This addendum report has been issued to comprehensively document the date of service. Molecular assessment (the results of which are discussed below) was initiated on July 29, 2015. Data became available during the subsequent week, and my final interpretation of the molecular data was completed on August 7, 2015. As I have discussed with you, this biopsy demonstrates a configuration that fits with a diagnosis of 'NTRK1-oma', namely a Spitz nevus/tumor with associated NTRK1 gene fusion. NTRK1 immunohistochemistry has been completed and demonstrates remarkable positivity, and this labeling result implies that underlying NTRK1 gene fusion has occurred. Gene fusion is merely a mechanism of tumor development and does not provide information regarding clinical behavior, but my impression, based upon histopathologic characteristics, is that this tumor is only partially transformed and thus holds no adverse clinical implications.  Given the high clinical concern, we completed ancillary assessment to further substantiate the nature of this tumor. This was completed by array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, I believe this tumor is unusual but essentially equivalent to a melanocytic nevus. Dr. Rosenman should follow the site to verify that no persistence ensues, if no reexcision is planned.  Please note that I have also retrospectively reviewed a 2012 biopsy from this patient as part of my evaluation. My retrospective diagnosis for the prior specimen is that it demonstrates a 'pagetoid' pigmented spindle cell nevus. Some tumors within the spectrum of pigmented spindle cell nevus are induced by NTRK1 gene fusion, and thus it is conceivable that this patient's prior tumor and current tumor are mechanistically related. We understand that the old tissue block has been exhausted, and thus no further testing in that regard will be possible.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND SPITZ TUMOR/NEVUS WITH ASSOCIATED NTRK1 GENE FUSION, EXCISED IN THE AVAILABLE PLANES OF SECTION	105575	682	\N	\N	15-61456	\N	DP-45	CGH Validation	IP1532843	AirTable blocks_with_IP_info.csv
1871	15-71393	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a compound proliferation of melanocytes with a domed surface, epidermal hyperplasia, a few moderately sized nests at the dermo-epidermal junction and nests, cords and strands in a peri-adnexal pattern in the dermis. The superficial melanocytes have moderately large amounts of cytoplasm and enlarged nuclei, with small, round melanocytes predominating toward the base of the lesion.	Eight outside slides, P15-16595-A1, including five unstained slides. One corresponding block received 8/5/15.	NEW FIRM HYPERPIG NODULE; R/O ATYPIA	\N	\N	\N	The features seemed in part to be a mixture of those of a Spitz's nevus and those of a superficial congenital nevus, but some raised the possibility of a nevoid melanoma, necessitating additional studies. As some Spitz's nevi with cells that have less cytoplasm than usual have NTRK1 gene fusions, I obtained that immunostain, but the strong staining seen in that situation is not present. A p16 immunostain shows that this tumor suppressor protein is retained only in a minority of cells, but these are distributed evenly, and not in a pattern suggesting loss of p16 in a clonal population, as could reflect bi-allelic loss of CDKN2A as would favor melanoma. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) has now been repeated (the first try resulted in a slide in which much of the tissue had fallen off), and shows a marginal mitosis as well as one in the mid-portion of the lesion.  Marginal mitoses are mentioned in the reference below as a finding favoring melanoma over Spitz's nevus, and also emerged in the results of an expert panel in 2008 evaluating melanocytic neoplasms of unknown malignant potential.  Given this finding, I suggested comparative genomic hybridization, which has now been completed. It shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include loss of chr. 1p, chr. 2, gain of 4q, loss of 5, gain of 6p and loss of 6q, gains of 7 and 8, losses of 9 and 10, loss of 13, gain of 15, loss of 16 and gain of 19. Many of these are copy number changes often found in melanoma.  A recent study from St. Jude's Medical Center, referenced below suggests that hTERT mutation analysis is more important than chromosomal copy number changes in determining the potential for childhood spitzoid melanomas to spread beyond local nodes. In this case, this may not be as important, as the morphology is more nevoid than spitzoid. This testing is not commercially available, but we hope to have it set up in our lab in several months time. In the interim, it is available at St. Jude's, but only for patients being seen there clinically.  References:  Crotty KA. Spitz naevus: histological features and distinction from malignant melanoma. Australas J Dermatol. 1997 Jun;38 Suppl 1:S49-53.  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	MELANOMA, 2.3 MM. IN THICKNESS	173719	683	\N	\N	15-71393	\N	DP-46	CGH Validation	IP1542843	AirTable blocks_with_IP_info.csv
1877	15-88900	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a large, oval dermal mass of plasmacytoid cells similar to the population in part of the nodule in (A), with adjacent fibrosis, and elongated rete ridges with basilar hyperpigmentation and increased numbers of basilar melanocytes.	One hematoxylin and eosin-stained section prepared from outside block labeled SP15-9506 D5.	A-B) GIANT CONGENITAL NEVUS, BILATERAL AXILLARY ADENOPATHY, MULTIPLE PROLIFERATIVE NODULES	\N	\N	\N	None	SAME AS (A)	101532	684	\N	\N	15-88900	\N	DP-47	CGH Validation	IP1528823	AirTable blocks_with_IP_info.csv
3007	99-09753 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1065	\N	\N	None	\N	MD-188	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1878	15-92618	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections from PS09-5773 show a dome surfaced and wedge-based, predominantly dermal proliferation of plump, oval to small round melanocytes in severely sun damaged skin. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.   Sections from 13-1009 show a similar lesion with more spindled and pigmented dendritic cells in one part of the lesion, and some cells with large, oval vesicular nuclei.   Sections from 15-5372 shows a large, nodular proliferation of large, oval melanocytes with marked nuclear pleomorphism, and variable proportions of pigmented, bipolar dendritic melanocytes and melanophages. Areas that are more cytologically bland are also present. A junctional component is evident to the side of the nodule, with small nests of cytologically bland melanocytes bridging adjacent ridges, and basilar hyperpigmentation. A broad zone of paucicellular fibrosis is present to the side of the nodule.	Six outside slides, PS09-5773 (A-B) (13-1009, 184965-JDI) (DC15-4002) (15A-5372, 15B-5372), and three corresponding blocks.	RECURRENT DOUBLE NEVUS (SEE COVER LETTER)	\N	\N	\N	This persistent/recurrent lesion had prior biopsies with considerably less worrisome features. Given this, and the resemblance in areas to a cellular blue nevus we obtained comparative genomic hybridization. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include gains of chrs. 2, 4q, 15q, 18p and parts of 22, and losses involving 3p, 5qter, 9p, 10q, 11q, 19 and part of 22. The interstitial loss on chr. 3p flanks the BAP-1 locus, which can be lost in some blue nevus-like melanomas. The loss involving chr. 9p has a step-down around CDKN2A, which codes for p16, indicating a bi-allelic deletion.  The prior biopsies show a progression of increasingly atypical changes leading to the current lesion. This can occur with lesions in the cellular blue nevus spectrum. The excision appears to be complete in the current sections.	MELANOMA, 4.1 MM. IN THICKNESS	173610	685	\N	\N	15-92618	\N	DP-48	CGH Validation	IP1564268	AirTable blocks_with_IP_info.csv
1876	15-87833	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of spitzoid melanocytes. Along the junction, there are melanocytes arranged as nests and single cells mostly within the lower epidermis. Many of the melanocytes are epithelioid and contain abundant eosinophilic cytoplasm, while some are more spindled. The overlying epidermis is acanthotic and hypergranulotic. Within the dermis, there are nests and some near sheets of similar melanocytes. Scattered dermal mitotic figures are apparent among dermal melanocytes, including some in the deep dermis. In some areas, there is diminishment in the size of melanocytes with descent into the dermis, while in other foci, large epithelioid melanocytes are present in the lower portion of the proliferation.	One hematoxylin and eosin-stained section prepared from outside block labeled 15-6056-A.	SECOND OPINION, R/O WART (SEE PHOTO)	\N	\N	\N	In the initial routine section, there were two populations of Spitzoid melanocytes. One population was composed of relatively small epithelioid melanocytes that diminished in size with descent and that were located mostly at the periphery of the proliferation. The other population was composed of large epithelioid melanocytes, many with atypical nuclei and some in mitosis, that formed large nests and near sheets within the central aspect of the specimen. This central population of melanocytes was concerning for Spitzoid melanoma while the peripheal population was suggestive of a Spitz nevus. In order to further evaluate this neoplasm, I performed immunoperoxidase staining. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) demonstrates a non-trivial number of melanocytes in mitosis within the dermal component of this proliferation.  Staining with p16 demonstrates significant loss of p16 staining among melanocytes within the central aspect of the proliferation (i.e. those concerning for Spitzoid melanoma) but no loss in the peripheral melanocytes. This loss can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16, is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma. Nonetheless, detection of this loss within the morphologically atypical melanocytes is concerning. While I favored a Spitzoid melanoma arising in a Spitz nevus for the above mentioned reasons, I did not think that an unequivocal diagnosis could be rendered based on the above data. Therefore, after receiving authorization from the clinical team, I (1) completed FISH analysis for chromosome 9p in order to determine if the loss of p16 staining mentioned above represented an authentic mutation in this genetic locus of an epigenetic phenomenon and (2) completed array-based comparative genomic hybridization (aCGH) since FISH analysis only tests for one genetic locus.  The FISH testing did not show homozygous loss of chromosome 9p and thus the loss of p16 appears to be an epigenetic phenomenon.  The aCGH reveals a small sub-centromeric gain on chromosome 1q, a loss on chromosome 6q and a gain of chromosome 21q. The loss on chromosome 1 is bordered by TPM3, which is a gene involved in a range of fusions, and thus it is possible that a fusion has occurred. While the presence of these three abnormalities detected on the aCGH is worrisome, it is not sufficiently atypical to render an unequivocal diagnosis of Spitzoid melanoma. I think it is best to regard this lesion as representing an atypical Spitz tumor, which is a Spitzoid neoplasm that shows more atypicality than a conventional Spitz tumor but is not sufficiently atypical to warrant an unequivocal diagnosis of Spitzoid melanoma. Fusions occur relatively frequently in atypical Spitz tumors, which might have been the case herein.  Given that this proliferation extends to the base and peripheral aspect of the specimen, I think that it should be re-excised with a few millimeters of a margin.  My colleagues, Dr. Timothy McCalmont and Boris Bastian, also reviewed these sections and agree with this assessment.	BIPHASIC ATYPICAL SPITZOID TUMOR, EXTENDING TO THE BASE AND PERIPHERAL ASPECT OF THE SPECIMEN	132799	686	\N	\N	15-87833	\N	DP-49	CGH Validation	IP1559454	AirTable blocks_with_IP_info.csv
1886	15-110181	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a well circumscribed compound proliferation of moderately large, oval melanocytes. The lesion has a domed surface and a flat base. The lesional melanocytes have small amounts of pale amphophilic cytoplasm and monomorphous vesicular nuclei. Please see note above for additional details.	Two outside slides, D15-40415. One corresponding block received 11/20/15.	PIGMENTED LESION OF UNCERTAIN DURATION	\N	\N	\N	The cells are smaller than classic Spitz cells, but a Spitz's nevus may yet prove to be the best designation here. There are some poorly formed Kamino bodies, supporting this. The inter-retial epidermis is relatively thin for a Spitz's nevus, and the mitotic figures are cautionary. I would consider obtaining fluorescence in situ or comparative genomic hybridization, although based on this material alone, I would favor a Spitz's nevus. ADDENDUM, November 17, 2015:  Per our telephone discussion today, the patient would like us to perform comparative genomic hybridization.  ADDENDUM, December 18, 2015:  Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include losses of the peri-terminal areas of chr. 5p and 5q, 6q, an interstitial area on 9p (not including CDKN2A) and 22q and evidence of a complex rearrangement involving chrs. 7 and 8. Of these, chr. 6q loss is common in melanoma, and given the other aberrations, melanoma is the best interpretation of this data (as opposed to an atypical Spitz tumor).	MELANOMA, 1.3 MM. IN THICKNESS	173727	687	\N	\N	15-110181	\N	DP-50	CGH Validation	IP1581959	AirTable blocks_with_IP_info.csv
1887	15-116253	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	A biopsy from 2009 demonstrates a compound proliferation of melanocytes with single melanocytes and small pigmented nests distributed in lentiginous fashion at the junction. There is slight perijunctional fibrosis below this, and nests and cords of melanocytes are present in the perijunctional dermis as well. More deeply, elastosis is noted. A biopsy from the current year demonstrates a broad compound proliferation of melanocytes distributed in conjunction with upper dermal fibrosis that is apparently post-procedural. There are single melanocytes and nests distributed relatively confluently along the junction, and some nests and melanocytes are large. Scatter of melanocytes above the junction and in adnexa can also be seen. The fibrotic perijunctional dermis contains nests and cords of cytologically similar melanocytes jointly with an infiltrate of lymphocytes and melanophages.	One outside slide, D09-11415-B. Seven outside slides, D15-43009-A1, and one corresponding block; said to be from the same general location as the 2009 specimen.	1.2 CM BROWN, IRREGULAR PATCH; R/O MELANOMA	\N	\N	\N	Like you, I believe the 2015 specimen from this patient represents a thin invasive melanoma. To clarify the nature of this tumor, we completed comparative genomic hybridization (CGH) to screen for chromosomal copy number abnormalities, as would be expected in association with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 6p and 7q as well as small losses in distal chromosomes 4p and 6q. The areas of gain include the RREB1 and BRAF genes and the area of loss within chromosome 6q includes the MYB gene, and all of these loci are known to be instrumental in the pathogenesis of melanoma. In short, the molecular findings are supportive of a diagnosis of melanoma. The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL COMPOUND PROLIFERATION OF MELANOCYTES, CONSISTENT WITH MELANOMA OF 0.5 MM IN THICKNESS	173536	688	\N	\N	15-116253	\N	DP-51	CGH Validation	IP1588055	AirTable blocks_with_IP_info.csv
1888	15-117186	21	\N	\N	2	T3a	Primary	spitzoid or deep penetrating melanoma	\N	\N	\N	\N	\N	172.2	\N	\N	Sections show melanocytes arrayed irregularly within the epidermis, and incompletely maturing nests, cords, and fascicles of similar melanocytes are in the dermis below this. The tumor is relatively large in size. The cells of interest are often fusiform and are enlarged. Pale pigmented cytoplasm is noted. Cells in mitosis can be found.	One outside slide, DN15-48616, and one corresponding block.	FLESH-COLORED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS	\N	\N	\N	This biopsy demonstrates an atypical melanocytic tumor with a differential diagnosis including a mitotically-active deep penetrating nevus on one hand and spitzoid or deep penetrating melanoma on the other. Immunostaining with p16 demonstrates significant loss of expression in over 50% of the tumor, which was of concern. In my original version of this report, I indicated that melanoma could not be excluded from the differential diagnosis based strictly upon microscopic and immunohistochemical findings, and the subsequent molecular evaluation that has now been completed (and that is discussed further below) has confirmed the diagnosis of melanoma. To clarify the nature of this proliferation, molecular assessment was completed (with appropriate payor authorization) via array-based comparative genomic hybridization (aCGH). After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 8q; loss in chromosomes 2p, 3, 5p, 9, and 11p; and segmental gain and loss in chromosomes 1 and 7q. The identification of multiple areas with copy number gain and loss indicates genomic instability, as is stereotypical of melanoma. In short, the molecular findings we have identified are incompatible with a benign interpretation and favor instead a diagnosis of melanoma.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.  Synoptic melanoma reporting has now been included below.  Procedure: shave removal Microscopic tumor type: spitzoid or deep penetrating melanoma Breslow thickness: at least 2.3 mm Ulceration: not detected Margin: deep edge involved by melanoma Mitotic index: 2-3/square mm Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): pT3aNxMx	MELANOMA OF AT LEAST 2.3 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	102270	689	\N	\N	15-117186	\N	DP-52	CGH Validation	IP1588995	AirTable blocks_with_IP_info.csv
1892	15-123058	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Key features include a compound distribution, a small intraepidermal component, a substantial and deep dermal component that is peripherally infiltrative, and a number of melanocytes in mitosis. The cells of interest are fusiform and finely pigmented. Some have large nuclei.	Four outside slides, ES15-58684-A1. One corresponding block received 12/29/15.	0.5 X 0.5 CM LESION	\N	\N	\N	The conventional histopathologic findings are suggestive of a mitotically-active spitzoid deep penetrating nevus. Your submitted immunostains demonstrate that p16 expression is generally preserved, which is in keeping with interpretation as a melanocytic nevus. That said, given the presence of deep mitotic figures in this tumor, we found it difficult to fully exclude pediatric melanoma from the differential diagnosis on strictly histopathologic grounds. In light of this, I recommended molecular analysis via either comparative genomic hybridization or fluorescence in situ hybridization (FISH) to screen for genomic copy number anomalies, as would be expected with melanoma. After receipt of payor authorization, we proceed with array-based comparative genomic hybridization (aCGH). After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss of distal chromosome 5q as a monoaberration with no other associated chromosomal gains or losses (there is also equivocal gain in chromosome 7p, but this is a distinctly subthreshold finding). As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of a monoaberration, and in particular a monoaberration involving chromosome 5q, does not provide support for a molecular diagnosis of melanoma.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a molecular diagnosis of melanoma. Rather, our combined histopathologic and molecular findings support interpretation as an atypical melanocytic nevus (or as a 'partially transformed' tumor). As this biopsy is only partial in nature, reexcision of this site is indicated as follow-up management, if that has not yet been done. The intent of reexcision is simply to ensure complete removal and verify that persistence with additional transformation cannot ensue.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MITOTICALLY-ACTIVE COMPOUND PROLIFERATION OF ENLARGED MELANOCYTES, WITH LOSS OF DISTAL CHROMOSOME 5q DOCUMENTED VIA COMPARATIVE GENOMIC HYBRIDIZATION	173711	690	\N	\N	15-123058	\N	DP-53	CGH Validation	IP1594906	AirTable blocks_with_IP_info.csv
2288	18-15803	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18205	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis along with scattered melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. CF/PL	R/O MM, 6 MM LESION	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173530	840	\N	\N	18-15803	\N	LN-20	Lentiginous Nevi 	IP1879395	AirTable blocks_with_IP_info.csv
3014	99-16706 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1066	\N	\N	None	\N	MD-189	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1915	16-13909	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	See report 15-95056 for histopathologic details.	Block DL15-92056 (DPR15-08971:A1).	SEE DL15-92056; FOR CGH TESTING	\N	\N	\N	The diagnosis of melanoma has been based in large part on the results of array-based comparative genomic hybridization (aCGH) analysis. Please refer to my addendum report of case 15-92056 for the full interpretation of this tumor. With respect to aCGH analysis, after microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosomes 1q, 9, and 17p. There is also subthreshold loss in chromosomes 19 and 22q. The significance of these findings is discussed further in the addendum report to case 15-92056. The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL COMPOUND PROLIFERATION OF MELANOCYTES, CONSISTENT WITH MELANOMA OF 1.65 MM IN THICKNESS	173549	691	\N	\N	16-13909	\N	DP-54	CGH Validation	IP1563705	AirTable blocks_with_IP_info.csv
1911	16-10466	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed in compound fashion with a mostly nested configuration and good lateral demarcation. There are many large nests and fascicles of melanocytes at the junction, and maturing nests, cords, and fascicles of similar melanocytes are in the perijunctional dermis with a lymphohistiocytic infiltrate. Focal adnexal extension is noted. There are occasional pink globules.	Three outside slides, S16-2862-A1, and one corresponding block.	10 X 6 MM PINK/BROWN OVAL WELL-CIRCUMSCRIBED PLAQUE	\N	\N	\N	This specimen does not demonstrate melanoma. Rather, this specimen contains a Spitz nevus (or Spitz tumor) with associated NTRK1 gene fusion. Immunohistochemistry was included in our assessment to more fully characterize the tumor. The cells of interest avidly express NTRK1, and this labeling result corroborates that NTRK1 gene fusion has occurred. ALK immunostaining is negative, and thus there is no indication of ALK gene fusion. A p16 immunostain demonstrates mosaic immunopositivity, and thus biallelic loss of chromosome 9p has not occurred. As you probably know, total loss of p16 expression can be considered a concerning immunohistochemical finding, but that is not present here. Kinase gene fusion, including ALK and NTRK1 gene fusion, represents a not uncommon mechanism of induction of Spitz nevi. Such tumors are only partially transformed and thus are self limited in behavior.  Per request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in distal chromosome 11q as a monoaberration with no other associated chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The monoaberration involving chromosome 11q that has been defined represents a direct consequence of NTRK1 fusion, as the area of loss initiates in the vicinity of the NTRK1 gene.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our histopathologic, immunohistochemical, and molecular results are confirmatory of the diagnosis of Spitz nevus with associated NTRK1 gene fusion.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND SPITZ NEVUS WITH ASSOCIATED NTRK1 GENE FUSION	139524	692	\N	\N	16-10466	\N	DP-55	CGH Validation	IP1609493	AirTable blocks_with_IP_info.csv
1919	16-19895	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed in compound fashion with acanthosis. The cells are generally fusiform and finely pigmented. There are large nests and fascicles of melanocytes in the epidermis, and maturing nests, cords, and fascicles of similar melanocytes are in the dermis and also in adnexa. A lymphohistiocytic infiltrate with admixed melanophages is also noted. Some pink globules can be found in the intraepidermal, although they are incompletely formed.	Five outside slides, AID16-01165 A (CN16-374) and one corresponding block.	IMPRESSION WAS PINK PAPULE; REQUEST FOR MOLECULAR ANALYSIS	\N	\N	\N	This biopsy does not demonstrate melanoma. Rather, it demonstrates characteristics that are typical of a variant of Spitz nevus, namely a Spitz nevus with underlying NTRK1 gene fusion. Immunostaining with NTRK1 has been completed and demonstrates avid positivity, and this labeling result corroborates that NTRK1 gene fusion is present. We additionally completed array-based comparative genomic hybridization (aCGH) to screen for copy number loss as a means to fully exclude melanoma from the differential diagnosis. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed a slightly noisy tracing (with possible/equivocal subthreshold loss in chromosome 19) with no significant chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. There is a small segmental loss in chromosome 1q at the location of the NTRK1 gene, and it seems likely that this is a consequence of gene fusion. The gene fusion partner cannot be identified by means of the aCGH technique.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our results substantiate the diagnosis of Spitz nevus with underlying kinase gene fusion. Please note that this melanocytic tumor involves the edge of the biopsy, and thus conservative complete reexcision of this site can be considered as follow-up management. The intent of reexcision is simply to ensure complete removal and verify that persistence with additional transformation cannot ensue.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND SPITZ NEVUS WITH ASSOCIATED NTRK1 GENE FUSION, FOCALLY TRANSECTED AT THE PERIPHERY OF THE BIOPSY	273578	693	\N	\N	16-19895	\N	DP-56	CGH Validation	IP1619022	AirTable blocks_with_IP_info.csv
1920	16-20360	46	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report.	Six outside slides, SH-16-9238-A1, and one corresponding block.	ERYTHEMA, RAISED, ABOUT 1.2 CM DIAMETER, LOOKS INFLAMED, ITCHY	\N	\N	\N	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations.  Following the above DNA extraction, we performed comparative genomic hybridization, and found losses involving chrs. 9 and 10. These are commonly found in melanoma. The chr. 9 loss appears to be heterozygous, as p16 is preserved by immunohistochemistry. Putting this all together, the maturation and dispersion with descent, and absence of hTERT promoter mutation are against a fully malignant neoplasm while the comparative genomic hybridization result somewhat favors melanoma, but not as much as if there was a homozygous chr. 9 or 9p loss.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, FAVOR AN ATYPICAL SPITZ TUMOR	173649	694	\N	\N	16-20360	\N	DP-57	CGH Validation	IP1619491	AirTable blocks_with_IP_info.csv
1917	16-18320A	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is a well-circumscribed oval mass composed of spindled cells with monomorphous nuclei and inconspicuous cytoplasm disposed as relatively closely apposed fascicles.	Tissue segment measuring 1.2 x 0.9 x 0.6 cm, trisected and entirely submitted in A. PL/PL	A) CYST. SUBCUTANEOUS PAPULE. PLEASE CHECK MARGINS.. PLEASE CHECK MARGINS.. B) NEUROFIBROMA VS. SCHWANNOMA VS LEIOMYOMA. . PLEASE CHECK MARGINS..	\N	\N	\N	The configuration initially suggested a schwannoma. The cells of interest are positive with S100 protein, in keeping with a schwannoma, but an epithelial membrane antigen positive capsule is not present with that stain. Also, there are no cellular (Antoni A) and myxoid, less cellular (Antoni B) areas, and a small focus features melanophages. Neurofilament protein immunostaining is negative, unlike the case in palisaded and encapsulated neuroma (which should also have an EMA positive capsule). There is focal positivity with two melanocytic markers, Melan-A and HMB45. The latter is positive in fewer cells than would be expected in a cellular blue nevus. A p16 stain shows large areas with only a few positive cells, and some with none, worrisome for melanoma. A focally elevated Ki-67 cell proliferation index is present. ALK was obtained, given the long fascicles, but is negative (unlike the case in spitzoid melanocytic neoplasms with ALK gene fusions). A p53 immunoperoxidase stain does not show aberrant expression. Mutation of TP53 and overexpression of p53 is uncommon in primary melanomas in general, but occurs in many desmoplastic melanomas, which some aspects of this case raised.  Comparative genomic hybridization shows multiple aberrations, including a gain involving chr. 2q, gains involving chr. 4p, gains and losses involving chr. 9, and a gain involving chr. 15q. The loss involving chr. 9 includes two levels in the CDKN2A area, suggesting a homozygous loss, worrisome for melanoma; there may also be a rearrangement involving NTRK3. The genomic data were also reviewed by my colleague, Dr. Iwei Yeh.  Given these results, I believe that this neoplasm should be treated in a manner adequate for a low grade melanoma/melanocytic tumor of unknown malignant potential, with complete excision (the lesion in these sections is an oval mass with essentially positive margins around much of it.	SPINDLE CELL MELANOCYTIC NEOPLASM WITH ATYPICAL FEATURES, SEE COMMENT	173604	695	\N	\N	16-18320	A	DP-58	CGH Validation	IP1617429	AirTable blocks_with_IP_info.csv
1923	16-25723	30	f	\N	0	T2a	Primary	spitzoid	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show melanocytes arrayed irregularly and focally confluently within the epidermis, with clusters of similar cells within the subjacent dermis with extensive fibrosis. Many of the melanocytes have spindled cytomorphology with large vesicular nuclei.	One outside slide, OJ16-233. One corresponding block received 3/22/16.	PATIENT WITH A 1.1 CM IRREG PIGMENTED LESION; ? SPITZOID NEVUS	\N	\N	\N	There is marked confluence and asymmetry in the junctional component of this proliferation and prominent fibrosis associated with the dermal melanocytes. Most of the melanocytes have spindled nuclei with amphophilic cytoplasm. Given the long, vertically oriented fascicles in the dermis, I obtained NTRK-1 and ALK immunoperoxidase stains. These genes can be involved in a gene fusion, with resultant overexpression in a subset of Spitz's nevi with this morphologic finding. The stains are negative in this case, however. The differential diagnosis includes an atypical pigmented spindle cell nevus or plexiform spindle cell nevus, atypical Spitz tumor, and spitzoid melanoma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) does not show significant pagetoid scatter in the MART-1 component beyond what was evident in the hematoxylin and eosin stained sections, and the Ki-67 proliferation rate of the lesional melanocytes is around 5%. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. Given the ambiguous findings in the routine sections and immunoperoxidase workup, I obtained comparative genomic hybridization to assess for melanoma associated chromosomal abnormalities. This showed multiple chromosomal gains and losses including 1p and 8q loss, 7p and 15q gain, a complex pattern of both gains and losses on 7q including findings that suggest a BRAF fusion event, and an isolated interstitial deletion involving a portion of chromosome 3p containing the BAP-1 gene. Analysis for a tert promoter mutation was negative.  Given the genetic findings of multiple chromosomal gains and losses, including regions frequently seen in melanoma, I believe the best diagnosis for this case is a spitzoid melanoma and not an atypical Spitz tumor. I shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation.  A synoptic report of potential prognostic factors is listed below:  Procedure: shave biopsy Microscopic tumor type: spitzoid Breslow thickness: at least 1.3 mm Ulceration: absent Margins, peripheral and deep: both + Mitotic index: 0 mm/2 Microsatellitosis: cannot assess Vascular invasion: not identified Regression: not identified Perineural invasion: not identified Pathologic staging (pTNM): at least pT2a	MELANOMA, AT LEAST 1.3 MM IN THICKNESS, TRANSECTED ACROSS THE SPECIMEN BASE	123724	696	\N	\N	16-25723	\N	DP-59	CGH Validation	IP1624894	AirTable blocks_with_IP_info.csv
1926	16-30292	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a mostly intradermal proliferation of large, oval and polygonal melanocytes with abundant homogeneous appearing cytoplasm and large, pleomorphic vesicular nuclei, singly and in small nests in the dermis without much maturation and dispersion with descent.	Seven outside slides, S16-4576-A1, and one corresponding block.	MOLE; R/O CANCER	\N	\N	\N	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. There is nearly complete loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a gain involving chr. 2, and losses involving chrs. 6q and 9. The depression in the CGH array graph suggests heterozygous rather than homozygous chr. 9 loss. Losses of chrs. 6q and 9 are common aberrations seen in atypical Spitz tumors and in melanoma, but not in conventional Spitz's nevi.  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations.  Based on these findings, I favor an atypical Spitz tumor. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. The lesion is broadly transected, and a re-excision (not much wider- I would suggest 5 mm. or so around the prior biopsy site or any residuum), but deeper)  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, FAVOR AN ATYPICAL SPITZ TUMOR	173207	697	\N	\N	16-30292	\N	DP-60	CGH Validation	IP1629500	AirTable blocks_with_IP_info.csv
1924	16-26672	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a dome surfaced compound proliferation of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. The lesion has a domed surface and an irregular but partly wedge shaped base. Nests of melanocytes predominate over single cells along the junction .Many of the superficial melanocytes have abundant, pale cytoplasm and dusty appearing melanin and a few are in mitosis. Melanocytes mature with descent within the dermis in some but not all areas, and the sizes of their aggregations also diminish with descent. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. The enclosed two-color immunostain shows that there is a low proliferation rate among the lesional melanocytes.	Four outside slides, 16-6675.S (1A), and one corresponding block.	PEARLY TELANGIECTATIC PAPULE WITH BEADS OF PIGMENTATION; R/O SPITZ NEVUS VS. SPITZOID MELANOMA	\N	\N	\N	The differential diagnosis posed by these sections includes a Spitz's nevus, an atypical Spitz tumor and spitzoid melanoma. Some unusual features present here include many pulverocytes* in the upper part of the lesion, and several mitotic figures in the mid-dermal portion, as well as a notched lesional undersurface. While I favored an atypical Spitz tumor, I wanted to obtain comparative genomic hybridization to assess chromosomal copy number changes. This was approved by the insurance carrier.  A recent study (see reference below) suggests that hTERT promoter mutation status may be even more predictive of aggressive behavior in atypical spitzoid neoplasms than are chromosomal copy number changes.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows only a gain on chromosome 7q, with an area of loss of the terminal part of 7q. The breakpoint for the 7q gain is at the braf locus, as can be seen in lesions with wild type b-raf, but a gene fusion involving b-raf and another partner. b-raf gene fusions can occur in both some Spitz's nevi and atypical Spitz tumors and in some melanomas. Most melanomas with these fusions have other aberrations as well, which are absent here.  I favor an atypical Spitz tumor with a b-raf fusion, but would still favor obtaining a study to determine hTERT promoter status.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, FAVOR ATYPICAL SPITZ TUMOR, SEE COMMENT	173641	698	\N	\N	16-26672	\N	DP-61	CGH Validation	IP1625850	AirTable blocks_with_IP_info.csv
2933	92-06469A T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1084	\N	\N	None	\N	MD-207	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2944	94-01469-2 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1085	\N	\N	None	\N	MD-208	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1928	16-31382	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Eight outside slides, DP-16-5687. One corresponding block received 4/21/16.	R/O SK (CLINICAL INFORMATION FROM ENCLOSED OUTSIDE PATHOLOGY REPORT)	\N	\N	\N	The lower part of the lesion appears to be a nevus with congenital features. The upper part has, as you note, very large and confluent nests of somewhat larger cells, raising the possibility of so-called nevoid verrucous melanoma. Findings that held me back from that diagnosis included: - a scarcity of mitotic figures in dermal nests. Most of the cells in the phosphohistone H3 stain are keratinocytes or are melanocytes in junctional nests. - the larger melanocytes do not stuff the papillations, as they can in nevoid verrucous melanoma - areas of transition, where the larger cells appear to mature with descent - a lack of a lymphocytic infiltrate beneath the larger cells  Following microdissection and DNA extraction, we performed comparative genomic hybridization. It showed a gain involving chr. 6p and a loss involving chr. 6q. These are both common aberrations in melanoma. A loss of chr. 16q (of uncertain significance) was also found. Given these results, I have measured the larger nests in the dermis to establish the thickness above.	MELANOMA, 1.3 MM. IN THICKNESS	139524	699	\N	\N	16-31382	\N	DP-62	CGH Validation	IP1630595	AirTable blocks_with_IP_info.csv
1936	16-41709	80	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show acral skin with large, oval nests of large, oval melanocytes with abundant, pale cytoplasm and monomorphous oval vesicular nuclei, within fibrotic stroma and with relatively evenly distributed melanophages.	Four outside slides, ES-16-7020 (A1-A4), and one corresponding block (A1).	THICK ERYTH PAPULE AND PIGMENTED PAPULE; NUB VS. MELANOMA	\N	\N	\N	A BAP-1 immunostain shows no loss of nuclear staining. The stain was performed as some blue nevus-like melanoma show BAP-1 loss due to mutation in one allele and loss of part or all of chromosome 3p or chr. 3. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma).  I did not find mitotic figures in dermal melanocytes in a phosphohistone H3/Melan-A two color immunostain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle), a finding against melanoma. The stain did show a minor junctional component and a few melanocytes scattered singly above the junction, against a cellular blue nevus.  Given this latter finding, I favor an unusually mitotically quiescent melanoma, and advise re-excision on that basis, despite the difficulties at this site. The thickness in these sections is problematic, given that only a tiny portion of epidermis is included, and the pieces are not optimally oriented. I estimate the thickness as about 2 mm.  If a definitive diagnosis is needed before additional surgery, we could perform comparative genomic hybridization (this is an authorized service if the patient's insurance is via Medicare, as our lab has a Z code from MolDx).  ADDENDUM, May  9, 2016:  We will proceed with comparative genomic hybridization, per your message.  ADDENDUM, May 31, 2016:  Following microdissection and DNA extraction, we performed comparative genomic hybridization. It shows an interesting array of aberrations, including evidence of a complex pattern of chromosomal fragmentation and re-jointing of chr. 7q, a loss involving chr. 10p and the pericentromeric area of 10q, two narrow areas of gain on chr 15 within the TRPM1 and MYO5A genes, respectively, a loss involving chr. 21q, and gain involving the pericentromeric area of chr. 22p with a breakpoint at the MAPK1 gene. Of these, chr. 10 loss if often found in melanoma, and complex chromosomal rearrangments like the one involving chr. 7q also point to melanoma. MAPK1 gain is present in only 1.5% of melanomas, with an unknown percentage having a focussed gain involving a narrow area around the gene. Whether the gains involving TRPM1 and MYO5A, both of which are involved in melanocytic tumor progression are significant or not is unknown.  The reporting of this case was delayed, as I wanted to go over the comparative genomic hybridization data with my colleagues, Dr. Boris Bastian and Iwei Yeh.	MELANOMA, AT LEAST 2.5 MM. IN THICKNESS	582721	700	\N	\N	16-41709	\N	DP-63	CGH Validation	IP1641025	AirTable blocks_with_IP_info.csv
1939	16-42657	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei, set in severely sun damaged skin. There is irregular epidermal hyperplasia with focal ulceration, a patchy lymphocytic infiltrate and a distribution of melanocytes detailed in the note above.	Eleven outside slides, DC16-2805 (A1-A2), and one corresponding block (A2).	SOLITARY TUMOR, THE TUMOR HAS BEEN REPORTEDLY PRESENT FOR FOUR MONTHS, AND A RAPID INCREASE IN SIZE WAS ALSO DOCUMENTED; DERMATOFIBROMA VS. BCC RAPID INCREASE IN SIZE	\N	\N	\N	This new addendum report has been simplified for ease in readability. Please refer to preceding versions of this report for the detailed information that Dr. LeBoit previously included. All prior versions of this report are on file in our unit in .pdf fashion and can be supplied to you upon request. Our prior comparative genomic hybridization (CGH) analysis established this tumor as an HRAS-mutated Spitz nevus. TERT promoter analysis was additionally initiated by Dr. LeBoit and has now been completed. The TERT promoter region was found to be of wild-type.  HRAS-mutated Spitz nevi are not known to hold any adverse potential. The confirmation that no TERT promoter mutation is present is concordant with that.	SPITZ NEVUS, PREDOMINANTLY INTRADERMAL (HRAS-MUTATED SPITZ NEVUS)	173602	701	\N	\N	16-42657	\N	DP-64	CGH Validation	IP1641978	AirTable blocks_with_IP_info.csv
1925	16-27084	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a partially polypoid intradermal proliferation of enlarged epithelioid melanocytes. These cells are distributed as nests, cords, and sheets in the upper dermis, and encompassing collagenous stroma is noted. A number of the cells are multinucleated. More deeply in the dermis, similar melanocytes are distributed as large lobules with a flanking lymphohistiocytic infiltrate. In slide A3, areas of dermal fibrosis that may represent scar are concurrently apparent.	Three outside slides, DPP-16-4718 (A1-A3), and one corresponding block (A2).	PATIENT WITH ATYPICAL INTRADERMAL MELANOCYTIC PROLIFERATION	\N	\N	\N	Immunohistochemistry to further assess the nature of this proliferation was included in our assessment. Phosphohistone-H3 staining demonstrates that the mitotic index is significantly elevated (4 per square millimeter). BAP-1 expression is preserved, and thus a so-called 'BAPoma' has been excluded from the differential diagnosis. Immunostaining with p16 demonstrates partial mosaic immunopositivity; since there is significant loss of expression in a superficial nodular area, we additionally completed fluorescence in situ hybridization (FISH) to better assess the copy number status of the CDKN2A locus. No copy number loss was identified in the CDKN2A FISH assessment, and this implies that the loss of p16 expression documented by immunohistochemistry is probably epigenetic in nature (and thus it cannot be taken as being diagnostically meaningful). Given the elevated mitotic index, my differential diagnosis included an ambiguous/indeterminate Spitz tumor on one hand and pediatric spitzoid melanoma on the other. The best current means to comprehensively evaluate the nature of a proliferation such as this one is to complete array-based comparative genomic hybridization (aCGH) to screen for copy number anomalies throughout the genome. After receipt of payor authorization, we thus initiated aCGH assessment. This consisted of microdissection of tumor followed by extraction of tumoral DNA from the tissue block and application of aCGH, which demonstrated gain in chromosome 4p as well as loss in chromosomes 4q, 5q, 9q, 16q, and 22q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of melanoma.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has provided support for a diagnosis of pediatric spitzoid melanoma. The AJCC staging parameters that are applied to the assessment of adult melanoma are not known to be reflective of prognosis in the pediatric setting. With that said, for the sake of completeness, please note that this relatively thick tumor is non-ulcerated. As noted above, the mitotic index is 4 per square millimeter. The margin of excision is narrow in the available sections.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	POLYPOID INTRADERMAL PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, CONSISTENT WITH SPITZOID MELANOMA OF 8.2 MM IN THICKNESS	139522	702	\N	\N	16-27084	\N	DP-65	CGH Validation	IP1626264	AirTable blocks_with_IP_info.csv
1918	16-19890	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Three outside slides, 16S-01754 1A1-1B2. Three additional slides (ALK-1 & p16 stains for A1) received 3/14/16. Three additional slides (ALK-1 & p16 stains for 1B) received 3/18/16. One corresponding block (1B) received 3/30/16.	2ND OPINION, NEVUS; NUB	\N	\N	\N	This proliferation of spitzoid cells shows large bulbous aggregations extending into the subcutis, as can be seen both in atypical Spitz tumors and spitzoid melanoma. There are mitotic figures in the deep portion of the lesion, including some so-called marginal mitoses. As there are thin, pointed ridges and long, vertically oriented fascicles, I suggested an ALK immunostain (along with p16). The stained sections have now been received. The ALK stain is negative, excluding that variant of spitzoid neoplasm. There is a mosaic pattern of staining for p16, sufficient to exclude the possibility of a bi-allelic deletion of chr. 9p, which can be found in melanoma (the absence of which does not exclude the diagnosis, however).  The differential diagnosis included an atypical Spitz tumor and spitzoid melanoma.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These included gains involving chromosomes 2p, 3p, 4p, and 8q and losses involving 3q and 4q. C-myc is on chr. 8q, and gains of this chromosome are a repeatable aberration in melanoma, while many of the other aberrations are not.  Currently, I use the term spitzoid melanoma, childhood type, for an emerging class of lesions that usually but not exclusively occur in children and teens, lack b-raf mutations (which are present in most melanomas in adults) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. These are findings that would support conservative treatment. Most lesions of this type are deeper, but usually not much wider than their exophytic portions, and even when they are, are well circumscribed. While sentinel nodes are often positive, this positivity has much less predictive value for systemic spread than is the case with adult melanoma.  We will contact you if testing for hTERT promoter mutations again becomes available in our lab.  ADDENDUM, June 29, 2016:  Per my discussion with Dr. Dohil, we will be performing hTERT promoter mutation analysis; please expect results in 2-3 weeks.  ADDENDUM, July 13, 2016:  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Hence, even though the designation spitzoid melanoma may be apt morphologically, the prognosis would be expected to be better than in conventional melanomas of this thickness.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	SPITZOID MELANOMA, 3.5 MM. IN THICKNESS	173305	703	\N	\N	16-19890	\N	DP-66	CGH Validation	IP1619017	AirTable blocks_with_IP_info.csv
1937	16-42062	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a coarsely papillated, mostly intradermal proliferation of large, oval melanocytes with abundant pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei. Large nests are present superficially with confluent tracts of cells in sclerotic stroma deeper in the lesion, with limited maturation with descent.	Skin segment measuring 2.3 x 1.5 x 0.8 cm. With the base inked, the specimen is serially sectioned and entirely submitted with three sections each in A and B. CF/CF	2.5 X 2 CM PIGMENTED PLAQUE WITH 1.5 X 2 CM CENTRAL PEDUNCULATED PORTION	\N	\N	\N	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma).  Given the prominent fascicles, I obtained an ALK immunoperoxidase stain. The ALK gene can be involved in a gene fusion, with resultant overexpression in a subset of Spitz's nevi with this morphologic finding. The stain is negative in this case, however.  Staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions).  A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows scattered positive nuclei, some well within the lesion.  Given that the lesion is broad and does not have a typical pattern for either a conventional Spitz's nevus or one identifiable as associated with a common spitzoid gene fusion, I obtained comparative genomic hybridization, and Medi-Cal authorized this testing. Following microdissection and DNA extraction, we performed CGH. which showed a high level gain of chr. 7q. An interstitial gain involving a gene, CDH19 was also identified. We have seen gains of 7q, which contains braf in some Spitz's nevi and atypical Spitz tumors.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. If there is a significant residuum on re-excision, I would appreciate a chance to see the sections. Please let me know as well if you have an available pre-biopsy clinical image.	ATYPICAL SPITZ TUMOR	173534	704	\N	\N	16-42062	\N	DP-67	CGH Validation	IP1641378	AirTable blocks_with_IP_info.csv
1945	16-55411	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	There is a mostly intradermal proliferation of melanocytes in part composed of large, oval and fusiform cells with abundant pale homogeneous appearing cytoplasm and large, vesicular nuclei, in a background of smaller cells. There is nearly complete loss of p16, except in small, round cells near the base of the specimen. A Ki-67 stain shows positive nuclei in number only just beneath the epidermis.	Eleven outside slides, S16-17518-1A (000675315-AM), and one corresponding block.	MELANOCYTIC NEVUS OF NECK	\N	\N	\N	The differential diagnosis included a combined lesion with banal nevus and an atypical Spitz tumor and a spitzoid melanoma arising in a nevus. The nearly complete loss of p16 was of concern. Following microdissection and DNA extraction, we performed comparative genomic hybridization. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include losses involving chr. 1q, a gain involving the terminal end of 7q, a loss involving chr. 9p with a pattern suggesting that the loss of CDKN2A is homozygous, and correlating with the negative p16 stain, and losses involving chr. 17. The findings are unusual in that the smaller cells have cytological features resembling those of a conventional nevus and the larger ones, resembling those of a Spitz's nevus.  The neoplasm extends to the base of the specimen. The final thickness measurement should be made after complete excision.  ADDENDUM, June 30, 2016:  Staining for the protein product of the V600e mutation of b-raf is positive. I obtained this stain out of interest, as Spitz's nevi with chr. 7q gain usually have gene fusions involving b-raf, but the b-raf gene is wild type (not mutated). The result implies that the chr. 7q gain seen here is not due to a b-raf fusion. There is no fee for the stain, but it may be relevant for treatment if there is metastatic disease in the future.	MELANOMA, 2.1 MM. IN THICKNESS	173405	705	\N	\N	16-55411	\N	DP-68	CGH Validation	IP1654849	AirTable blocks_with_IP_info.csv
1344	09-21320A3 N1-M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	931	\N	\N	None	\N	MD-25	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1343	09-21320 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	931	\N	\N	None	\N	MD-25	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1370	10-10275D13 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	932	\N	\N	None	\N	MD-26	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1947	16-56300	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show acral skin with a mostly intradermal proliferation of large oval cells that form sheets in the superficial dermis with a more discrete fascicular pattern toward the base of the specimen, where similar but smaller cells predominate.	One hematoxylin and eosin-stained section prepared from outside block labeled W16-1703 1A.	12 MM FIRM FLESH COLORED PAPULE/NODULE OVER THE DISTAL PROXIMAL NAIL FOLD, NO NAIL DYSTROPHY; R/O NEUROFIBROMA VS. ACQUIRED DIGITAL FIBROMA KERATOMA	\N	\N	\N	The enclosed records indicate that immunostains were done at the Univ. of Utah, including one showing a low (1%) proliferation rate, and that the Myriad MyPath score favored benignity (-7.7). The reports also indicate a deep mitotic figure. Staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions).  There is nearly complete loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma.  The findings made a nevoid melanoma a strong consideration. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This showed a loss involving chr. 9, with at step down in the CGH array graph surrounding the CDKN2A locus, in keeping with homozygous loss of this gene. This, in my opinion, favors melanoma. The final thickness measurement should be made after complete excision.	MELANOMA, 3.1 MM. IN THICKNESS	333788	706	\N	\N	16-56300	\N	DP-69	CGH Validation	IP1655740	AirTable blocks_with_IP_info.csv
1938	16-42198	48	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	There is a dome surfaced, wedge shaped proliferation of large oval and fusiform melanocytes with abundant pale cytoplasm and large, moderately pleomorphic vesicular nuclei that mature and disperse evenly with descent, with preservation of p16 staining.	Nine outside slides, MS16-8430-1A. One corresponding block received 6/3/16.	RUA SKIN LESION	\N	\N	\N	The accompanying cover letter detailing fluorescence in situ hybridization studies mentions hemizygous deletions of all four chromosomal loci that were tested. I have not encountered this, and asked my colleague, Dr. Boris Bastian, who developed the FISH test for melanoma, for his comments. He was skeptical of this result, and suggested that the testing was done on sections that were too thin. Otherwise, the findings appear to be those of a Spitz's nevus with a characteristic domed surface, wedge shaped base and diminishing cellularity toward the base of the lesion. The retention of p16 is a reassuring finding. A zone of granulation tissue implying a prior biopsy site is present, with a limitation of this evaluation being that if so, the sections from the biopsy are not included.  The margins appear clear in the planes of section examined.  We then tried to verify or refute the presence of chromosomal copy number changes by comparative genomic hybridization, per your message.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. It shows an isolated gain involving chromosome 11p, but no other aberrations, implying that the impression of hemizygous deletions was artifactual. Isolated 11p gain usually corresponds to two copies of 11p joined by a centromere, and has not been seen to date in melanoma. Spitz's nevi with this aberration are likely to have a mutation involving h-ras, and to deeply infiltrate the reticular dermis as single cells, findings that are present here.  References:  van Engen-van Grunsven AC, van Dijk MC, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WA. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. Am J Surg Pathol. 2010 Oct;34(10):1436-41.  Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000 Sep;157(3):967-72.	SPITZ'S NEVUS, PREDOMINANTLY INTRADERMAL	173688	707	\N	\N	16-42198	\N	DP-70	CGH Validation	IP1641515	AirTable blocks_with_IP_info.csv
1948	16-63804	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes arrayed as a few small nests along the epidermal-dermal junction, and as nests, cords and strands that extend into the superficial reticular dermis and are distributed around adnexa. Markedly fibrotic stroma is present in some areas, and there are dermal melanocytes with abundant, pale cytoplasm.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. HD/HD	IRREGULAR BROWN PAPULE AND 3 SHADE COLOR; ATYPICAL NEVUS	\N	\N	\N	The overall findings favor a nevus with congenital features, but some peculiar features are present, including some larger cells in the dermal component and fibrotic stroma. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma).  Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively low proliferation rate in the junctional component and a moderately elevated proliferation rate in a mid-portion of the dermal component. The MART-1/tyrosinase component does not reveal more suprabasilar scatter than could be seen in the hematoxylin and eosin stained sections.  The findings are peculiar, and in another setting, I would consider complete excision. There may be a role for adjunctive testing, and follow up rather than excision if the results point to a benign lesion. I would be happy to discuss this with you.  ADDENDUM, July  6, 2016:  Per your message, we will proceed with comparative genomic hybridization. Results are usually available in 3-4 weeks.  ADDENDUM #2, July 30, 2016:  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a gain involving an area on distal chr. 7q, with a breakpoint within the b-raf gene. We have seen this pattern in Spitz nevi with braf gene fusions (e.g. fusions of b-raf with another partner on the same chromosome). These fusions activate b-raf transcription, and are much rarer than are b-raf mutations. While b-raf gene fusions can occasionally occur in melanoma, these are very rare and would be expected to be accompanied by other chromosomal copy number changes. Also, the morphology of some of these cases has had single melanocytes permeating the deep reticular dermis similar to the appearance here.  The neoplasm extends to the base of the specimen. Given this result by comparative genomic hybridization, I favor an unusual nevus with some spitzoid features. I believe that the site could be periodically followed.	COMPOUND MELANOCYTIC NEVUS WITH SOME UNUSUAL FEATURES, SEE COMMENT	128529	708	\N	\N	16-63804	\N	DP-71	CGH Validation	IP1663322	AirTable blocks_with_IP_info.csv
1951	16-77392	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	A shave biopsy demonstrates a compound proliferation of large epithelioid and fusiform melanocytes with pale pigmented cytoplasm. These cells are distributed in giant nests and fascicles that are stuffed in dermal papillae below a thinned epidermis, and interstitial cords and fascicles of similar melanocytes extend in badly-circumscribed fashion in the dermis below this. A patchy infiltrate of lymphocytes and melanophages is present concurrently. Scattered cells in mitosis are identifiable, and some of these have been marked within the submitted slides.	One outside slide, JS-16-43216-A1. One block received 8-18-16.	IMPRESSION WAS DERMATOFIBROMA VS. VASCULAR VS. ATYPICAL NEVUS	\N	\N	\N	As has been clear from prior reporting of this case, this specimen does not contain any type of conventional melanocytic nevus. Rather, this tumor shows many histopathologic features that were considered worrisome for nevoid melanoma with pseudomaturation. The gargantuan nests of melanocytes that are present superficially and the elevated mitotic index are both features that were considered to be of concern. I additionally considered the possibility of an epidermotropic metastasis of melanoma in my differential diagnosis. However, that would only be germane in the context of a patient with an existing history of melanoma and thus can be excluded in the interpretation of this specimen. To add additional diagnostic information, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss, as can be seen in association with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 11p as well as loss in chromone 22q with no other associated genomic gains or losses. Loss in chromosome 22q is a rare molecular finding and is likely of no larger significance. Gain in chromosome 11p has been identified in a subset of Spitz tumors and is highly correlated with underlying HRAS mutation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH suggests that this proliferation represents an HRAS-mutated Spitz tumor rather than a frank melanoma. What is unusual about this case is that the microscopic findings are quite different from most examples of that entity. With that said, the molecular findings seem clear cut. Long-term follow-up studies of HRAS-mutated Spitz tumors suggests that they are functionally benign and thus are of no larger clinical significance. As the deep edge of this biopsy is involved, conservative reexcision is recommended to be certain that full local removal has been accomplished.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5. Please note that this citation includes a discussion of an HRAS-mutated tumor with histopathologic findings that are more conventional of this entity, in contrast to the findings seen here.	COMPOUND MELANOCYTIC TUMOR WITH ASSOCIATED GENOMIC GAIN IN CHROMOSOME 11p, FOCALLY INVOLVING THE DEEP EDGE OF THE BIOPSY	173628	709	\N	\N	16-77392	\N	DP-72	CGH Validation	IP1677083	AirTable blocks_with_IP_info.csv
1953	16-80354	56	\N	\N	1	T2a	Primary	melanoma NOS	\N	\N	\N	\N	\N	172.7	\N	\N	An excisional specimen demonstrates a compound proliferation of enlarged fusiform melanocytes with finely pigmented cytoplasm. There are single melanocytes and nests and fascicles of melanocytes present within the epidermis, and limited suprajunctional scatter can be seen. In the dermis below this, the fusiform melanocytes mature as coalescing nests, fascicles, and syncytia, and a scattered infiltrate of lymphocytes and melanophages can be seen. The dermis is elastotic.	Three outside slides, DPR-16-8373-A1, and one corresponding block.	6 MM DEEP BROWN PAPULE WITH ECCENTRIC RED BORDER; DYSPLASTIC NEVUS VS. MELANOMA	\N	\N	\N	My differential diagnosis included a deep penetrating nevus (plexiform spindle cell nevus), a variant of Spitz nevus, and melanoma. Your submitted immunostain for p16 shows partial loss of expression, and this finding is diagnostically inconclusive (although a loss of chromosome 9 was ultimately confirmed to be present, as is discussed in the paragraph that follows). To further evaluate this tumor, we completed phosphohistone-H3 immunostaining to assess the mitotic index. In the resultant immunostain, rather dramatic maturation is apparent, and only a small number of perijunctional melanocytes in mitosis can be identified. To clarify the differential diagnosis, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 12p and 15q as well as loss in chromosomes 1p, 2p, centromeric 7p, 9, centromeric 12q, 13q, 17, and 18. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is typical of melanoma. In short, the aCGH result confirms the diagnosis of melanoma and excludes any type of melanocytic nevus from the differential diagnosis.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.  Synoptic melanoma reporting is included below.  Procedure: narrow excision Microscopic tumor type: melanoma NOS Breslow thickness: 1.05 mm Ulceration: not detected Margin: narrow / equivocal Mitotic index: 1 per square mm Vascular invasion: not detected Regression: not significant Pathologic staging (pTNM): pT2aNxMx	MELANOMA OF 1.05 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173726	710	\N	\N	16-80354	\N	DP-73	CGH Validation	IP1680083	AirTable blocks_with_IP_info.csv
1958	16-89926	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed focally in the epidermis with acanthosis, and partially maturing nests, cords, and fascicles of melanocytes are in collagenous dermis below this. The cells of interest are enlarged and often fusiform. A lymphohistiocytic infiltrate is noted.	Five outside slides, ST16-4992-A1, and one corresponding block.	NO HISTORY OF PREVIOUS MELANOMA	\N	\N	\N	My differential diagnosis included a large desmoplastic Spitz nevus, an HRAS-mutated Spitz nevus, and a kinase fusion Spitz nevus. Immunostaining demonstrated mosaic expression of p16, and thus biallelic loss in CDKN2A is not present in association with this tumor (the fact that there is not CDKN2A loss at all was subsequently documented by molecular methods, as is discussed in the paragraph that follows). An ALK stain is negative, and thus underlying ALK gene fusion is not present. My residual differential included an HRAS-mutated desmoplastic Spitz nevus, and array-based comparative genomic hybridization (aCGH) was completed to fully clarify the diagnosis. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 11p as a monoaberration with no other associated chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of gain in chromosome 11p is highly correlated with HRAS mutation, and this finding corroborates the diagnosis of HRAS-mutated Spitz nevus.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our analysis confirms that this represents a variant of Spitz nevus, namely a Spitz nevus with HRAS mutation and gain. With respect to management, the inked edge of the specimen is focally involved, and thus conservative complete reexcision can be considered as a means to prevent persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5. Please note that this reference includes discussion of a tumor with characteristics similar to this one.	HRAS-MUTATED DESMOPLASTIC SPITZ NEVUS	173450	711	\N	\N	16-89926	\N	DP-74	CGH Validation	IP1689756	AirTable blocks_with_IP_info.csv
2596	20-18514B	80	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33787	173.62	\N	\N	Sections show a lobular and crateriform proliferation of keratinocytes, in large part composed of cells with abundant pale pink cytoplasm. Elastotic fibers are evident between the keratinocytes near the periphery. Nuclear atypicality is most pronounced in the most peripheral keratinocytes. There is a surrounding infiltrate of lymphocytes and granulocytes.	Elliptical excision, 3.6 x 1.7 x 1.1 cm, including a central 2.1 x 1.5 cm raised area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, three in B, and five in C. CF/CF	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH HYPERKERATOTIC SCALE, DDX: SQUAMOUS CELL CARCINOMA	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173622	774	\N	\N	20-18514	B	KA-08	Keratoacanthoma	IP2166036	AirTable blocks_with_IP_info.csv
1959	16-90917	40	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Seven outside slides, KA16-20753 (A1-A2), and one corresponding block (A2).	IRREGULAR BROWN MACULE; DYSPLASTIC NEVUS	\N	\N	\N	The majority of features in the submitted slides favored an atypical Spitz tumor over spitzoid melanoma. The lesional melanocytes have monomorphous nuclei, and in most of the lesion nests are moderately sized superficially, and quite small along the base of the lesion. However, there were some areas in which disproportionately large nests are present toward the lesional base. Given this feature, I obtained comparative genomic hybridization. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. There are losses involving chromosomes 1p, 3p, 6q, 8p, 12p and 17q and a gain involving 8q. There are sub-threshold, possible aberrations as well- possible loss of 14 and possible gains of 1q and 6p. Some of the above chromosomal copy number changes are typical ones seen in melanoma.  Given these findings, I favor treating this lesion as melanoma, despite the findings by morphology and immunohistochemistry.	MELANOMA, 2.2 MM. IN THICKNESS	173507	712	\N	\N	16-90917	\N	DP-75	CGH Validation	IP1690755	AirTable blocks_with_IP_info.csv
1961	16-94655	73	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a very broad-based compound proliferation of melanocytes involving the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges, and are accompanied by lamellar fibroplasia.  The center of the lesion has a different pattern.  The normal pattern of rete ridges and dermal papillae has been lost in two closely apposed areas, and junctional melanocytes are far fewer than at the periphery. The subjacent papillary dermis in this area has more marked fibrosis than is present at the periphery.  The dermal component consists of compactly arranged cords and strands of melanocytes with coarse chromatin set in dense fibrotic stroma.	Six outside slides, SW16-6248 (A1-A2) (TC16-59816-A). Two corresponding blocks received 9/29/16.	ATYPICAL NEVUS VS. MELANOMA	\N	\N	\N	The differential diagnosis included a dysplastic (Clark's) nevus and a melanoma simulating one. The architectural features are similar to those of some dysplastic nevi as described in the papers cited below. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This found a gain of chr. 6p, and an interstitial deletion involving chr. 15q. Chr. 6p gain is a common aberration in melanoma. While the 15q loss is not, its presence shows additional chromosomal instability.  Given the absence of ulceration or of mitotic figures in the dermal component, I would assess this as a AJCC stage pT1a melanoma. The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen.	MELANOMA, 0.75 MM. IN THICKNESS	173508	713	\N	\N	16-94655	\N	DP-76	CGH Validation	IP1694537	AirTable blocks_with_IP_info.csv
1962	16-96276	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a pedunculated segment of skin with a compound proliferation of large, and small oval melanocytes with the large cells having homogeneous appearing abundant, pale amphophilic cytoplasm and large, vesicular nuclei, and the smaller ones scant cytoplasm and smaller nuclei with coarse chromatin. A permeative lymphocytic infiltrate is present.	One outside slide, S16-19348-A1, and one corresponding block.	HISTORY OF MELANOMA (RIGHT ARM), RIGHT THIGH IRRITATED SKIN LESION, 4-PROBE FISH FOR ATYPICAL SPITZ LESION	\N	\N	\N	Our preferred technique for spitzoid neoplasm that are over 0.4 mm. thick is comparative genomic hybridization rather than fluorescence in situ hybridization, as this interrogates sites spanning the genome, rather than a few loci. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows losses involving chromosomes 9 and 10, which are among the most common chromosomal aberrations in melanoma. While isolated chr. 9 loss can be seen in some atypical Spitz tumors, the addition of clear-cut chr. 10 loss makes that unlikely.	MELANOMA, 2.2 MM. IN THICKNESS	173727	714	\N	\N	16-96276	\N	DP-77	CGH Validation	IP1696172	AirTable blocks_with_IP_info.csv
1980	16-105648	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a pedunculated compound proliferation of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei. The overlying epidermis is relatively thin. Large nests predominate throughout the expanded papillary dermis with small nests of smaller cells in the subjacent superficial reticular dermis.	Two outside slides, S16-38422-A1, and one corresponding block.	LESION HAS BEEN PRESENT FOR SEVERAL MONTHS, IT ITCHES AND HAS BLED IF SCRATCHED OR INJURED, HE HAS NO HISTORY OF ATYPICAL NEVI OR MELANOMA, IT IS DESCRIBED AS A 3 MM ERYTHEMATOUS ROUND PAPULE; POSSIBLE PYOGENIC GRANULOMA	\N	\N	\N	A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma). A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows a few mitotic figures in the upper part of the lesion and one near its base, the latter a worrisome finding.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows losses involving chromosomes 9 and 14. While chromosomes 9 loss is common in melanoma, it can be seen as an isolated finding, or along with chromosomal copy number changes affecting less significant sites in some partially transformed lesions. Chr. 14 loss is not characteristic of melanoma.  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Taking these findings into account together with the histopathologic findings, an atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. The neoplasm extends to the base of the specimen, and a narrow re-excision still seems warranted.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, FAVOR AN ATYPICAL SPITZ TUMOR	173305	715	\N	\N	16-105648	\N	DP-78	CGH Validation	IP1705676	AirTable blocks_with_IP_info.csv
1964	16-97391	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a proliferation of large, oval melanocytes with abundant, pale cytoplasm and large, pleomorphic vesicular nuclei that has a bosselated surface. There are prominent junctional nests at the edges of the lesion and a thin epidermis with fewer junctional nests centrally. Other features are as noted above.	Seven outside slides, RWCS16-10413-A1. One corresponding block received 11/9/16.	LESION	\N	\N	\N	I note the area mentioned in your cover letter as showing diminished p16 immunostaining. There are enough interspersed cells still present that I doubt that this represents a focus in which there is homozygous CDKN2A loss. While the overall size and cellularity of this lesion are daunting, the maturation and dispersion with descent, and flat base are reassuring findings. Despite the difficult site, a re-excision would be wise. We can provide additional confirmation by hTERT promoter mutation analysis, comparative genomic hybridization or both. ADDENDUM, November 11, 2016:  Per Dr. Rao's request, we will proceed with testing.  ADDENDUM, December  1, 2016:  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a gain and an loss on chr. 7q, and a loss involving chromosome 9. While chromosomes 9 loss is common in melanoma, it can be seen as an isolated finding, or along with chromosomal copy number changes affecting less significant sites in some partially transformed lesions. The changes on chr. 7q signify a b-raf rearrangement (not mutation, but fusion of the wild type gene) as can be seen in a subset of spitzoid lesions.  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Taking these findings into account together with the histopathologic findings, an atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. A narrow re-excision still seems warranted.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	ATYPICAL SPITZ TUMOR, SEE COMMENT	100222	716	\N	\N	16-97391	\N	DP-79	CGH Validation	IP1697302	AirTable blocks_with_IP_info.csv
2009	16-127388	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	A domed compound proliferation of strikingly large and variable melanocytes has a wedge-shaped profile with deep folliculocentricity. At the junction, there are irregular large nests and fascicles of melanocytes distributed irregularly, and focal thinning of the otherwise acanthotic epidermis is noted. Focal extension above the junction can be found. Similar large epithelioid and fusiform melanocytes are arrayed in collagenous dermis below this, where partial pigmentation and incomplete maturation are noted. There is an infiltrate of lymphocytes and melanophages as well.	Four outside slides, SK16-24757-A1, and one block.	IMPRESSION WAS 'HEMANGIOMA?'	\N	\N	\N	Your submitted p16 immunostain demonstrates near-total loss of expression, which was of concern as a potential indicator of chromosome 9 loss (more narrowly as an indicator of CDKN2A genomic loss). To fully delineate the genomic profile of this atypical proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss throughout the genome. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed subthreshold loss in chromosome 9p coupled with low amplitude loss in chromosome 6q and low amplitude gain in chromosome 15q. As all of the molecular findings are of low amplitude, the observed results do not support interpretation as frank spitzoid melanoma. The most significant finding is loss in chromosome 9; this can be seen in melanoma as well as in histopathologically ambiguous proliferations within the spectrum of 'atypical Spitz tumor'. I believe the latter categorization represents the best classification for this proliferation. The low amplitude changes observed within chromosomes 6q and 15q may be an indication of partial transformation by a subpopulation of melanocytes.  In summary, the combination of results derived from conventional microscopy coupled with aCGH do not support interpretation as frank spitzoid melanoma. Rather, I believe this histopathologically ambiguous proliferation is best categorized as an atypical Spitz tumor. The removal at present is equivocally narrow, and additional excision is indicated to ensure that local removal has been accomplished.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF ENLARGED ATYPICAL SPITZOID MELANOCYTES, FOCALLY ABUTTING THE INKED SPECIMEN MARGIN	17723	717	\N	\N	16-127388	\N	DP-80	CGH Validation	IP1727647	AirTable blocks_with_IP_info.csv
1661	13-074	83	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.62	\N	\N	Sections show a proliferation of atypical keratinocytes that extends as clusters into the superficial dermis.	Oriented ellipse, measuring 2.1 x 0.9 x 0.4 cm. With the orienting suture at 12 o'clock position and designated mid superior border 12 o'clock by the surgeon, the 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with four sections in cassette B1, and three sections each in cassettes B2 and B3.   SL/SL	A) R/O BCC, B-C) NO PREVIOUS PATH	\N	\N	\N	None	SUPERFICIALLY INVASIVE SQUAMOUS CELL CARCINOMA, COMPLETELY EXCISED	173649	787	\N	\N	13-74	\N	KIT-06	Kit mutants	IP715566	AirTable blocks_with_IP_info.csv
1659	13-028	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	788	\N	\N	13-28	\N	KIT-07	Kit mutants	\N	AirTable blocks_with_IP_info.csv
1960	16-92011	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show melanocytes arrayed in compound fashion in each of two specimens. In an initial partial biopsy, there are melanocytes arrayed in lentiginous fashion and in limited pagetoid fashion and also in adnexa, and below this there are both large melanocytes with pale pigmented cytoplasm as well as smaller melanocytes with lesser pigmentation. The reexcision specimen demonstrates a limited residuum that is partially similar and that is obscured by a permeative lymphohistiocytic infiltrate with admixed melanophages.	One outside slide, D16-11636-A. Nine additional slides (levels and eight unstained) and one corresponding block received 1/5/17.\nThree outside slides, HD16-699 (A3-A4), and two blocks.	PATIENT WHO HAD A MOLE THAT HAD BEEN RECENTLY CHANGING	\N	\N	\N	Both an initial biopsy and a subsequent excision have been evaluated jointly as the basis for this consultation, and the findings in the two are generally similar. I agree with Dr. Sigal that the microscopic findings are worrisome for nevoid melanoma, and that diagnosis has now been substantiated by molecular means, as is discussed in the paragraph that follows. After receiving authorization to complete molecular testing, we applied array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss, as can be seen with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in telomeric chromosome 9 as well as subthreshold gain in chromosome 15q and in telomeric 13q. Additionally, we found loss in chromosomes 1, 2p, 9p, 10p, and centromeric 10q. There was subthreshold loss in telomeric chromosome 11q as well. The identification of multiple chromosomal gains and losses can be taken as being confirmatory of the diagnosis of melanoma.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	NEVOID MELANOMA OF 1.1 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	123398	718	\N	\N	16-92011	\N	DP-81	CGH Validation	IP1691865	AirTable blocks_with_IP_info.csv
2004	16-125975	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed irregularly within the epidermis, which is strikingly thinned, and ovoid melanocytes are arrayed syncytially in a swath of the upper dermis below this. Deeper yet, there are fusiform melanocytes in fascicles. Some melanocytes are heavily pigmented, and melanophages are noted as well. A reexcision specimen consists largely of the fusiform component below central ulcerative fibrosing inflammatory alterations that are post-procedural.	Three outside slides, DPR-16-14154-A1; block received 1/5/17.\nEight outside slides, DPR-16-14772 (A1-A5), and one block (A4).	IRREG PIGMENTED LESION	\N	\N	\N	Both an initial biopsy and a subsequent excision have been evaluated jointly as the basis for this consultation, and the findings in both are generally similar and complementary. Based upon the findings in both, my differential diagnosis included a cellular blue nevus with perijunctional hypercellularity, an atypical cellular blue nevus, and blue nevus-like melanoma. Please note that the most atypical portion of the entire process is the hypercellularity seen in the perijunctional zone in the initial biopsy. Your p16 stain demonstrates generally preserved expression. Immunostaining for BAP-1 and phosphohistone-H3 was additionally completed, and the BAP-1 stain demonstrates preserved nuclear expression while the phosphohistone-H3 stain demonstrates that the mitotic index is low (<1 per square mm). These immunoperoxidase findings do not provide clear support to interpretation as melanoma and fit better with interpretation as an atypical melanocytic nevus.  Molecular assessment via array-based comparative genomic hybridization (aCGH) was recommended and has now been completed. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed a focused loss in chromosome 4q and subthreshold gain in telomeric chromosome 9q with no other additional chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The two tiny aberrations that we have identified are not of diagnostic significance and are not known to be associated with blue nevus-like melanoma.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our analysis fits with interpretation as an atypical cellular blue nevus. The tumor has been excised by means of the second specimen in this sequence, an no additional surgery at this site is recommended.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL CELLULAR BLUE NEVUS, FULLY EXCISED (THE FINAL MARGIN APPEARS UNINVOLVED)	100589	719	\N	\N	16-125975	\N	DP-82	CGH Validation	IP1726217	AirTable blocks_with_IP_info.csv
2020	17-2869	14	\N	\N	3	T2b	Primary	spitzoid	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a focally ulcerated proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Large nests of similar melanocytes are present in the papillary dermis and melanocytes in mitosis are observed. There is uneven maturation of melanocytes with descent within the dermis and nests of melanocytes with small hyperchromatic nuclei and scant cytoplasm admixed with melanocytes with abundant amphophilic cytoplasm and vesicular nuclei. There is a patchy lymphocytic infiltrate.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted. KC/KC	EXCORIATED RED PAP 5 - 6 MM; ADNEXAL VS. NEVUS	\N	\N	\N	This ulcerated spitzoid melanoma demonstrates uneven maturation of melanocytes and dermal mitoses. The tumor is negative for p16, indicating loss of this tumor suppressor. The initiating oncogene in this tumor remains unknown as it is negative for ALK and only moderately positive for NTRK1, indicating the absence of ALK or NTRK1 fusion. In this challenging case, additional molecular studies were performed. By array comparative genomic hybridization, the tumor demonstrates loss of chromosome 6q and chromosome 9. These findings support a diagnosis of spitzoid melanoma. A TERT promoter mutation is not identified.  While the prognostic features used for melanoma in adults may have different implications for pediatric patients, they are provided below:  Microscopic tumor type: spitzoid Breslow thickness: at least 1.2 mm Ulceration: yes Margins, peripheral and deep: both involved Mitotic index: 3 per square mm Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2b  The clinical utility of sentinel node biopsy in pediatric patients, particularly those with spitzoid melanoma is controversial.  References: 1. Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	SPITZOID MELANOMA, EXTENDING TO THE EDGE AND BASE OF THE BIOPSY	123644	720	\N	\N	17-2869	\N	DP-83	CGH Validation	IP1731960	AirTable blocks_with_IP_info.csv
2017	17-2120	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	A sequence of level sections demonstrates a compound proliferation of enlarged epithelioid and fusiform melanocytes distributed in association with post-procedural scarring and a lymphohistiocytic infiltrate. In the available level sections, small numbers of melanocytes are positioned at the junction and along the junction of adnexal epithelium to the dermis, but most melanocytes are intradermal in distribution. Some of the constituent cells are extremely large with plasmacytoid or epithelioid morphology. In a sequence of slides labeled WP16-2671-A1, a more orderly configuration is apparent, and melanocytes are distributed in compound fashion with maturing nests, cords, and fascicles in the dermis . A series of three unrelated slides (16-2671-B1) shows a congenital melanocytic nevus of the face as an incidental additional finding.	Twenty-two slides, WP16-2671 (A1-A2) (HI16-1471, A1-A2), and two blocks.\nThree slides, WP16-2671 (B1-B2), and two blocks.	REEXCISION OF LEFT POSTERIOR THIGH MELANOCYTIC LESION; CONCERNED FOR AN ATYPICAL SPITZ TUMOR VS. SPITZ OR MELANOMA; PREVIOUS BIOPSY DIAGNOSED ELSEWHERE AS INTRADERMAL SPITZ NEVUS WITH MODERATE CYTOLOGIC ATYPIA	\N	\N	\N	The original immunoperoxidase stains that were received demonstrate that p16 expression is preserved and additionally demonstrate that the Ki-67 cell proliferation index is only modestly elevated, and these two findings suggest that frank pediatric spitzoid melanoma is unlikely. After the examination of recut sections, it became clear that only one of the two submitted blocks was exhausted of tissue. A BAP-1 immunostain of the viable tissue block demonstrates preserved nuclear positivity, and thus BAP-1 genomic loss has not occurred in this tumor. A repeat p16 stain demonstrates loss of positivity in a small population of enlarged melanocytes, and this fits with an emerging clone of atypical spitzoid tumor cells. Per your authorization, array-based comparative genomic hybridization (aCGH) was also applied to screen for chromosomal copy number gain or loss throughout the genome. After microdissection of the key area of the tumor followed by extraction of tumoral DNA from the tissue block, the application of aCGH revealed gain in centromeric chromosome 1p, loss in telomeric chromosome 1q, gain and loss in chromosome 7q with associated chromothripsis, and loss in chromosome 9. A marked focal gain in chromosome 7q is apparent at the location of BRAF, and this is probably an indicator of BRAF gene fusion.  In summary, the combination of results derived from conventional microscopy coupled with immunohistochemistry and aCGH suggests that frank spitzoid melanoma is not present here. Rather, we have identified an emerging spitzoid clone characterized by loss in CDKN2A and BRAF gene fusion. The secondary clone is best categorized as an 'atypical Spitz tumor', and the case as a whole can be viewed as an 'atypical Spitz tumor' arising focally within a Spitz nevus. With respect to management, the tumor appears narrowly excised in the current planes of section. Clinical follow-up of the surgical site is warranted, at a minimum (to verify that no persistence ensues), and additional excision can also be considered to ensure local removal.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	RESIDUAL COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES; LIMITED GENOMIC ABERRATIONS HAVE BEEN IDENTIFIED BY MOLECULAR ANALYSIS	173726	721	\N	\N	17-2120	\N	DP-84	CGH Validation	IP1731205	AirTable blocks_with_IP_info.csv
2027	17-6351	21	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a polypoid segment of skin with a mostly intradermal proliferation of large, oval melanocytes with abundant pale homogeneous appearing cytoplasm and large, oval vesicular nuclei with relatively small nucleoli. These cells are arranged as closely apposed small aggregations with intervening lymphocytes.	One outside slide, 17-013-P82-0021-0 A1 and one corresponding block.	MOLE REMOVAL	\N	\N	\N	The differential diagnosis included an atypical Spitz tumor and a spitzoid melanoma. A BAP-1 immunostain labels the nuclei of keratinocytes in the overlying epidermis, those of lymphocytes and those of the smaller melanocytes, but not the larger, spitzoid ones. This is consistent with BAP-1 loss in the larger spitzoid cells. This loss can be due to mutation in one allele and loss of the other, or to epigenetic mechanisms.  A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma). As loss of p16 can follow BAP-1 loss in multi-step progression toward melanoma, this is a reassuring finding.  A phosphohistone H3/MART-1/tyrosinase two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows up to four mitotic figures in dermal melanocytes/section.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows only an interstitial loss in chr. 3p around the area of the BAP-1 gene, and no other gains or losses. This is against progression toward melanoma.  Using the DNA extracted for this procedure, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  In sum, the findings are those of an atypical Spitz tumor with BAP-1 loss, but not progression toward a BAP-1 deficient spitzoid melanoma. A narrow re-excision of this site would still be prudent, as lesions with BAP-1 loss may convert to melanoma at a higher rate than other spitzoid neoplasms.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	ATYPICAL SPITZ TUMOR WITH BAP-1 LOSS	173500	722	\N	\N	17-6351	\N	DP-85	CGH Validation	IP1735471	AirTable blocks_with_IP_info.csv
2028	17-6368	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	723	\N	\N	17-6368	\N	DP-86	CGH Validation	\N	AirTable blocks_with_IP_info.csv
2031	17-8968	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Ten outside slides, P17-146-A1, and one corresponding block.	LESION	\N	\N	\N	While I favored a Spitz's nevus based on the submitted slides, the proliferation rate is, as you note very high. Following microdissection and DNA extraction, we performed comparative genomic hybridization. We found losses involving chr 6q, 9p and 13q. The first two are commonly found in melanoma.  As the CGH findings were unexpected, we performed sequencing to see if there was a mutation in the hTERT promoter gene. A recent study (see reference below) suggests that hTERT promoter mutation status is closely linked to aggressive behavior in atypical spitzoid neoplasms than are chromosomal copy number changes. Using the DNA extracted for CGH, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Given these findings, I would obtain a complete re-excision, but I would not regard this lesion as melanoma. It fits into the broad category of atypical Spitz tumors, with more genomic than histopathologic aberrancy.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, SEE COMMENT	129522	724	\N	\N	17-8968	\N	DP-87	CGH Validation	IP1738128	AirTable blocks_with_IP_info.csv
2036	17-9550	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show an asymmetrical compound proliferation of hyperchromatic melanocytes. Within the epidermis, which is partially thinned, there is single melanocytes and nests distributed nearly confluently, and associated pagetoid scatter is noted. In the dermis below this, incompletely maturing nests, cords, fascicles, and small syncytia of finely pigmented melanocytes are noted, and interstitial melanophages are also apparent. Pigmentation by melanocytes is retained through all of the thickness of the dermal component. Reevaluation of the intraepidermal component in a recut section, after the receipt of the molecular result, affirms that much of it is composed of fusiform melanocytes in fascicles.	Three outside slides, CT17-1057, and one block.	NEVUS ON THE RIGHT DORSAL FOOT OF PATIENT, THE PATIENT BELIEVES IT HAS BEEN PRESENT FOR MANY YEARS, ALTHOUGH THE DERMATOLOGIST QUESTIONS HIS ACCURACY AS A HISTORIAN, ATYPICAL NEVUS, NEVOID MM	\N	\N	\N	My differential diagnosis included an atypical melanocytic nevus on one hand and nevoid melanoma on the other, and based upon the analysis delineated in the sentences that follow, it becomes clear that the former possibility represents the best overall categorization. Your submitted phosphohistone-H3 immunostain demonstrates that the mitotic index is low, but this finding is of little diagnostic comfort, as the mitotic rate in many examples of nevoid melanoma approaches zero. Immunohistochemistry for p16 was additionally completed and demonstrates mosaic positivity, and this implies that biallelic loss in CDKN2A is not apparent in this tumor. (If biallelic loss was present, it would compellingly favor the diagnosis of melanoma.) The defined findings were certainly plausible as an atypical melanocytic nevus, but I did not feel that nevoid melanoma of 0.75 mm in thickness could be excluded on histopathologic grounds. In light of this and as per your authorization, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss, as would be expected in association with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 7q with loss of telomeric chromosome 6q (not involving the MYB gene) with no other associated gains or losses. The gain in chromosome 7q includes a spike in the vicinity of 7q34, and this finding suggests that BRAF gene fusion has occurred. As background for fully understanding the molecular result, note that most melanomas analyzed via aCGH demonstrate multiple associated significant chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations or show a monoaberration, as is apparent here (the loss of telomeric 6q is trivial and is not of larger diagnostic significance, and thus the gain in 7q qualifies as a monoaberration).  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced confirmation of a diagnosis of nevoid melanoma. Rather, I believe the proliferation represents a partially transformed melanocytic nevus with underlying BRAF gene fusion. Returning to the slide after analyzing the molecular findings, there are subtle spitzoid characteristics that I did not fully appreciate in my prior evaluation. Based upon these findings coupled with the molecular result, I believe this melanocytic nevus is best categorized within the spectrum of Spitz nevus.  Gene fusion, including BRAF gene fusion, represents a not uncommon mechanism of induction of Spitz nevi and Spitz tumors. Such tumors are only minimally or partially transformed and typically hold no larger clinical potential. With that said, as this biopsy is only partial in nature, conservative complete reexcision can be considered as follow-up management. The intent of reexcision is simply to ensure complete removal and verify that persistence with additional transformation cannot ensue.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL COMPOUND SPITZ NEVUS WITH BRAF GENE FUSION, INVOLVING THE DEEP EDGE OF THE BIOPSY	173788	725	\N	\N	17-9550	\N	DP-88	CGH Validation	IP1738711	AirTable blocks_with_IP_info.csv
2038	17-10585	39	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	There is a dome shaped segment of skin. There are small, round melanocytes arranged as compact nests, separated from one another by clefts in some areas, and large, oval cells with pleomorphic, irregularly shaped and heterochromatic nuclei in others.	Seven outside slides, SH-17-3220-A1, and one corresponding block.	MELANOCYTIC LESION	\N	\N	\N	The differential diagnosis includes a combined atypical Spitz tumor and a spitzoid melanoma arising in a nevus. Staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions). However, there is nearly complete loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma.  Following microdissection and DNA extraction, we performed comparative genomic hybridization.  It shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. The chromosomal copy number changes that we found include loss of chr. 1p, loss involving much of chr. 4, gain of 8q, loss of 9p, loss of 10, loss of 22. Many of these are classic aberrations seen in melanoma. The loss of chr. 9p correlates with the absence of p16 by immunohistochemistry. The neoplasm extends to the base of the specimen.	MELANOMA, AT LEAST 1.6 MM. IN THICKNESS	173403	726	\N	\N	17-10585	\N	DP-89	CGH Validation	IP1739754	AirTable blocks_with_IP_info.csv
2049	17-14313	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed in compound fashion in a partial incisional specimen. The cells of interest are large and fusiform or epithelioid. There are large junctional or perijunctional nests, and maturing nests, cords, and fascicles of similar melanocytes are in collagenous dermis below this. There are perijunctional fibrosing inflammatory alterations that are probably due to a prior biopsy, and entrapped cystic folliculosebaceous units are noted.	Six outside slides, S17-957 (A1-A2). One block (A2) received 2-24-17.	PATIENT WITH SPITZ NEVUS	\N	\N	\N	This apparent reexcision specimen demonstrates the substantial residuum of a Spitz tumor. My differential diagnosis included a large desmoplastic Spitz nevus, a so-called HRAS-mutated Spitz nevus, and an 'atypical Spitz tumor'. As is discussed in the paragraphs that follow, the diagnosis of HRAS-mutated Spitz nevus has now been confirmed. Ancillary analysis was recommended and has been completed, as per your authorization. Immunohistochemistry for p16 was completed to assess (or infer) the copy number status of CDKN2A, and mosaic immunopositivity has been demonstrated; this implies that significant genomic loss in CDKN2A has not occurred. Array-based comparative genomic hybridization (aCGH) was additionally completed to screen for chromosomal copy number gain or loss throughout the genome. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed isolated gain in chromosome 11p as a monoaberration with no additional chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of isolated gain in chromosome 11p corresponds to mutation in HRAS and can be considered confirmatory of the above diagnosis.  In summary, the combination of results derived from conventional microscopy coupled with aCGH confirms the diagnosis of HRAS-mutated Spitz nevus. The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5. Please note that this citation discusses a case with molecular findings identical to this tumor.	(RESIDUAL) HRAS-MUTATED DESMOPLASTIC SPITZ NEVUS	173306	727	\N	\N	17-14313	\N	DP-90	CGH Validation	IP1743507	AirTable blocks_with_IP_info.csv
2065	17-26078	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a zone of fibrosing granulation tissue, adjacent to which is a vertically oriented compound pan-dermal and superificial subcutaneous proliferation of large, oval melanocytes. These cells of interest form very large nests associated with irregular epidermal hyperplasia, foci of erosion, some suprabasilar scatter, some dispersion in the deep reticular dermis, and a large vertically oriented oval mass in the subcutis. Many mitotic figures are present superficially and a few more deeply.	Two outside slides, P17-1100 (A-B). One corresponding block (B) received 3/27/17.	NEVUS	\N	\N	\N	The very large size of the superficial nests, the number of mitotic figures within them, and the large bulbous mass that protrudes into the superficial subcutis are features that lie beyond those of a Spitz's nevus and make the differential diagnosis between that of an atypical Spitz tumor and a spitzoid melanoma. Some relatively deep mitotic figures are present as well. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a complex pattern of gains and losses on chr. 3p including an amplification of an area around MiTF. While the area of loss encompassed the BAP-1 gene on chr. 3p, no loss of BAP-1 was seen by immunohistochemistry, making it unlikely that a BAP-1 mutation was present. MiTF amplifications are usually found in high grade melanomas, and seldom in spitzoid lesions in children. There is a loss of chr. 6q, and a gain of chr. 7. A gain of part of chr. X is also present. The chr. 6q loss has a copy number transition around ROS1, which can point to a ROS gene fusion.  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  In sum, while the hTERT promoter gene was wild type, the findings by CGH included MiTF amplification, which in addition to the other chromosomal copy number changes favors melanoma. My colleague Dr. Iwei Yei also reviewed the sections and CGH data, and agree with this interpretation. I would note that spitzoid melanomas in children have a much better prognosis than conventional ones of the same thickness in adults. The neoplasm extends to the base of the specimen.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	MELANOMA, 4.5 MM. IN THICKNESS	173701	728	\N	\N	17-26078	\N	DP-91	CGH Validation	IP1755396	AirTable blocks_with_IP_info.csv
2082	17-29457B	56	\N	\N	0	T2a	Primary	\N	\N	\N	\N	\N	\N	172.5	\N	\N	There is a mostly intradermal proliferation of large, oval melanocytes in which particularly large cells with abundant, pale cytoplasm and irregularly shaped nuclei predominate superficially. Some of these nuclei are very large.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) 3 X 4 MM SCALY PAPULE; AK VS. SCC, B) 4 X 4 MM RED PAPULE; IDN VS. BCC, C) 8 X 5 MM BROWN MACULE; NEVUS, POSS ATYPIA, D) POSSIBLE GA	\N	\N	\N	A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma). I did not find mitotic figures in dermal melanocytes in a phosphohistone H3/Melan-A two color immunostain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle), a finding against melanoma.  Given the degree of nuclear pleomorphism, without other findings strongly favoring melanoma, I obtain comparative genomic hybridization.  Following microdissection and DNA extraction, we performed this study. The findings include losses involving chromosomes 3, 9, and 16q, with the chr. 9 loss a common one found in melanoma. Other subthreshold losses include chromosomes 5q and 7p.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: biopsy Microscopic tumor type: nodular Ulceration: no Margins, peripheral: clear by < 1 mm. and deep: involved Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, AT LEAST 1.1 MM. IN THICKNESS	102538	729	\N	\N	17-29457	B	DP-92	CGH Validation	IP80460	AirTable blocks_with_IP_info.csv
2045	17-13205	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Three outside slides, SU17-1576-1 (AX17-96), and one corresponding block.	SECOND OPINION, REQUEST FOR GENETIC STUDIES IN COVER LETTER FOLLOWING DISCUSSION WITH CLINICIAN	\N	\N	\N	As you note, the differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. The findings are more atypical than those of a Spitz's nevus. The worrisome aspects include variable cellularity at the same stratum of the dermis, the degree of nuclear pleomorphism and heterochromasia, and mitotic figures relatively deep in the lesion. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows losses involving chromosomes 9, 13 and 14, and a gain involving chr. 15. While chromosome 9 loss is common in melanoma, it can occur as an isolated finding in benign spitzoid neoplasms. In this case, it is not accompanied by other common chromosomal copy number changes seen in melanoma, but by two relatively idiosyncratic ones (loss of chrs. 13 and 14) and by an intermediate frequency one.  Following the same microdissection and DNA extraction, we also performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Given these findings, I favor an atypical Spitz tumor with a low risk of extranodal spread, but a higher one that if the CGH profile had been negative. My colleague, Dr. Boris Bastian also viewed the CGH array data and agrees with this interpretation of it. If it has not yet been done, a narrow re-excision of this site seems prudent.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, SEE COMMENT	173719	730	\N	\N	17-13205	\N	DP-93	CGH Validation	IP1742388	AirTable blocks_with_IP_info.csv
2114	17-42757	43	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	There is a narrowly based proliferation of large oval melanocytes with abundant pale cytoplasm and from small and monomorphous to large and pleomorphic nuclei. The latter diminish toward the base of the specimen, with some dispersion.	Five outside slides, SFS17-14484-1A, and one corresponding block.	PATIENT HAS A HISTORY OF DYSPLASTIC NEVI AND SCCIS, ERYTHEMATOUS HYPERKERATOTIC PAPULE (SEE PHOTO)	\N	\N	\N	This lesion has more strikingly pleomorphism than most desmoplastic Spitz's nevi have, and is in the setting of dyschromic skin with other atypical appearing pigmented lesions. p16 is entirely negative, raising the possibility of a homozygous deletion of chromosome 9p/CDKN2A. Following microdissection and DNA extraction, we performed comparative genomic hybridization. It shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi in adult patients. The aberrations include loss of the pericentromeric area of chr. 1p and loss of 1q, loss of the distal part of chr. 6q, loss of chr. 9, and loss of chr. 17. Losses of chr. 6q and 9 are common in melanoma, although usually the entire arm of chr. 6q is lost. Gains of 1p are common in melanoma rather than losses of it. However, taking into account the atypical histopathologic features and these aberrations, I favor the diagnosis above.  Given the absence of ulceration or of mitotic figures in the dermal component, I would assess this as a AJCC stage pT1a melanoma, pending re-excision (which could show deeper lesional melanocytes).	MELANOMA, AT LEAST 0.9 MM. IN THICKNESS	173619	731	\N	\N	17-42757	\N	DP-94	CGH Validation	IP1772311	AirTable blocks_with_IP_info.csv
1369	10-10275 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	932	\N	\N	None	\N	MD-26	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1432	11-03286-4 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	933	\N	\N	None	\N	MD-27	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1431	11-03286 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	933	\N	\N	None	\N	MD-27	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1458	11-27846 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	934	\N	\N	None	\N	MD-28	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1459	11-27846-2 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	934	\N	\N	None	\N	MD-28	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2118	17-48219	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a proliferation of melanocytes with two separate cellular components (a biphasic pattern). There are both small conventional melanocytes in nests and syncytia as well as large fusiform and ovoid melanocytes with finely pigmented cytoplasm. The latter cells are arrayed in coalescing nests, cords, fascicles, and syncytia throughout the upper and lower reticular dermis and also in the adventitial dermis without clear circumscription. In the upper dermis, some fusiform melanocytes are enlarged. A robust deep lymphohistiocytic infiltrate with admixed melanophages is also noted -- and this includes some lymphoid follicles. There are also fascicles that encompass peripheral nerves.	21 slides, CE-17-001314 A1 & A2 (17-3142 A & B) and two blocks.	? SPITZ NEVUS, R/O DYSPLASTIC NEVUS, ? DERMATOFIBROMA	\N	\N	\N	The discussion that follows has been modified to integrate molecular results. This unusual tumor includes both conventional melanocytic nevus and a secondary component resembling a deep penetrating nevus, and the latter component exhibits associated neurotropism and adnexotropism. Your immunoperoxidase stains demonstrate that expression of p16 is generally preserved and that the Ki-67 cell proliferation index is low, and both of these labeling results are as would be expected with a melanocytic nevus, or at least do not provide clear support to interpretation as melanoma. Immunostaining for beta catenin was included in our evaluation and is negative. Some but not all examples of deep penetrating nevus exhibit nuclear positivity with beta catenin immunohistochemistry, as activating mutations in beta catenin are common to their pathogenesis.  In terms of potential considerations in the differential diagnosis, I found myself unable to render a diagnosis of neurotropic melanoma (arising in conjunction with a melanocytic nevus) on histopathologic grounds, but obviously the finding of marked neurotropism is extreme and unusual. To clarify the diagnosis, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss, as per your authorization. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 1p, focal loss in telomeric chromosome 2q, and gain in telomeric chromosome 7q, including the region where BRAF is encoded. This unusual molecular result with multiple small aberrations does not provide support to interpretation as frank melanoma but also indicates that this proliferation does not represent any form of conventional melanocytic nevus. In short, these combined histopathologic and molecular results suggest a partially transformed tumor; the findings we have defined are roughly equivalent to what is often termed 'atypical Spitz tumor'. My colleague, Dr. Iwei Yeh, also reviewed the molecular results for this case and is in agreement that the defined findings do not support interpretation as melanoma.  The neurotropic component of this unusual tumor extends focally to the inked specimen margin. Reexcision to obtain a free margin is recommended.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL COMBINED DEEP PENETRATING NEVUS-LIKE MELANOCYTIC PROLIFERATION WITH ASSOCIATED NEUROTROPISM	173526	732	\N	\N	17-48219	\N	DP-95	CGH Validation	IP1777827	AirTable blocks_with_IP_info.csv
2121	17-49361	81	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a dome surfaced compound proliferation of melanocytes with a thin overlying epidermis. Many small Kamino bodies are present. Nests of small fusiform melanocytes are present irregularly along the dermo-epidermal junction, and compact nests of small, oval melanocytes are embedded in fibrotic stroma in the dermis.	One outside slide, 17-02845 A (H-70147). One corresponding block received 5/23/17.	R/O BCC (SEE PHOTO)	\N	\N	\N	Many features favored a Spitz's nevus, although the patient is considerably older than most with that diagnosis. Given the setting, we obtained comparative genomic hybridization to see if chromosomal copy number changes as occur in melanoma but not in Spitz's nevus were present. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These included several that are typical of melanoma, including a gain involving chr. 6p and a loss involving chr. 9. A subthreshold loss of chr. 6q was also present (indicating that this may be in a subset of cells).  The final thickness measurement should be made after complete excision.	MELANOMA, AT LEAST 0.6 MM. IN THICKNESS	128547	733	\N	\N	17-49361	\N	DP-96	CGH Validation	IP655827	AirTable blocks_with_IP_info.csv
2123	17-50829	57	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Eighteen outside slides, S17-28577 (A1-A2), and two corresponding blocks.	1.4 CM IRREGULARLY PIGMENTED PLAQUE-MELANOMA FAVORED (SEE PHOTOS)	\N	\N	\N	I agree that the differential diagnosis includes both a nevoid melanoma resembling a dysplastic nevus, and a lesion at the upper end of the spectrum for dysplastic nevus. While the peripheral component is mostly nested, featuring bridging and fibroplasia, there is more pagetoid scatter in the Mart-1 immunostains than could be appreciated in the hematoxylin eosin-stained sections. Also, as you note there is compression of the elastic fiber network, and although the dermal melanocytes are relatively small they have slightly more cytoplasm than in most dysplastic nevi. Given the difficulties of this case, I obtained comparative genomic hybridization to see if chromosomal copy number changes as found in melanoma were present or not. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This showed a gain involving the terminal portion of chr. 2q, and one involving chr. 6p. While the number of chromosomal copy number changes is limited, gain of chr. 6p is highly characteristic of melanoma and in the context of the microscopic findings is, in my opinion, sufficient for a diagnosis of melanoma. I included the larger of the dermal cells in the thickness, but not the small, round melanocytes loosely arranged at the base of the papillary dermis (which may be those of a pre-existent nevus).  Given the absence of ulceration or of mitotic figures in the dermal component, I would assess this as a AJCC stage pT1a melanoma.	MELANOMA, 0.6 MM. IN THICKNESS	273588	734	\N	\N	17-50829	\N	DP-97	CGH Validation	IP1780487	AirTable blocks_with_IP_info.csv
2459	19-88385	74	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.7	DPN-mm	\N	The microscopic findings are essentially as described in the accompanying cover letter, enclosed pathology report, and in the note above.	Eight outside slides, D19-365 (1-2) and one corresponding block (2).	R/O SUBCORNEAL HEMORRHAGE/HEMATOMA VS. CYST VS. MASSON'S TUMOR VS. OTHER NEO	\N	\N	Scraping	The differential diagnosis included a combined deep penetrating nevus, or more likely, a deep penetrating nevus-like melanoma arising in a nevus, or a conventional melanoma arising in one. The the scout section (the hematoxylin and eosin stained recut that we obtain at the time that sections are cut for immunoperoxidase stains) shows two mitotic figures in the large, pale melanocytes, one of them a marginal mitosis. Some strikingly large and irregularly shaped nuclei are present in these cells. The sizes of the nests are larger than in most deep penetrating nevi.  A beta-catenin immunostain labels not only the cytoplasm of the large, pale melanocytes but also their nuclei. This supports the assessment of a deep penetrating nevic lineage, per a recent study from our group. This lineage includes deep penetrating nevus, indeterminate lesions, and deep penetrating nevus-like melanoma.  A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product in either population. A PRAME immunostain is negative. Strong, uniform staining of the nuclei of the lesional melanocytes would have favored melanoma.  Based on the findings in the hematoxylin and eosin stained sections, I favor the large cells representing deep penetrating nevus-like melanoma rather than a deep penetrating nevus.  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la FouchardiËre A. Combined activation of MAP kinase pathway and ﬂ-catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644. doi: 10.1038/s41467-017-00758-3. PubMed PMID: 28935960; PubMed Central PMCID: PMC5608693.	MELANOMA, 1.0 MM. IN THICKNESS, ARISING IN A NEVUS	17733	735	\N	\N	19-88385	\N	DPN-01	Deep Penetrating Melanoma	IP2092941	AirTable blocks_with_IP_info.csv
2467	19-109646	16	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	DPN-mm	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Six outside slides, D19-08803 1A. One corresponding block received 10/9/19.	NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	Scraping	This lesion has a plexiform pattern and cells that are similar to those seen in deep penetrating nevus, and also to some cellular blue nevi and blue nevus-like melanomas. The melanophages usually present in that condition are scant, and there is a zone of verrucous epidermal hyperplasia over it, which is not usually the case. The percentage of cells with Ki-67 positivity is of concern. A beta-catenin immunostain labels not only the cytoplasm of the lesional melanocytes but also a few of their nuclei. This supports the assessment of a deep penetrating nevic lineage, per a recent study from our group. This lineage includes deep penetrating nevus, indeterminate lesions, and deep penetrating nevus-like melanoma.  A high percentage of the nuclei of the lesional melanocytes have from faint to marked positivity for p53. This is of concern for a deep penetrating nevus-like melanoma. One of the cases of that entity in the reference below had a TP53 mutation.  Ideally, we would confirm the diagnosis of a deep penetrating nevus-like melanoma with next generation sequencing, or comparative genomic hybridization coupled with hTERT promoter sequencing. I will in touch re such testing. In its absence, re-excision and follow-up appropriate for a melanoma of at least 2.1 mm. thickness. Please note that deep penetrating nevus-like melanomas are usually well circumscribed and that relatively narrow (e.g. 1 cm) excision margins suffice in the large majority of cases.  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la FouchardiËre A. Combined activation of MAP kinase pathway and ﬂ-catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644. doi: 10.1038/s41467-017-00758-3. PubMed PMID: 28935960; PubMed Central PMCID: PMC5608693.	PREDOMINANTLY INTRADERMAL MELANOCYTIC PROLIFERATION WITH ATYPICAL FEATURES, FAVOR A DEEP PENETRATING NEVUS-LIKE MELANOMA	173531	736	\N	\N	19-109646	\N	DPN-02	Deep Penetrating Melanoma	IP2114353	AirTable blocks_with_IP_info.csv
1630	12-051311	57	\N	\N	\N	T3a	Primary	None	\N	\N	FFPE	\N	\N	172.6	DPN-mm	\N	There is a relatively narrowly based, well circumscribed but asymmetrical nodular proliferation of large, atypical melanocytes in partial apposition to a thinned epidermis. The lesional melanocytes have abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei. Maturation with descent is faulty, with some of the deepest cells having pigmented cytoplasm and large nuclei. There are a few mitotic figures within dermal melanocytes.	Cylindrical skin segment, 0.6 cm in diameter and 0.8 cm in thickness, bisected, and entirely submitted.   HD/HD	5 MM BROWN PAPULE WITH DARK BROWN EDGE; ATYPICAL NEVUS VS. MELANOMA (EXCISION IF +)	\N	\N	Scraping	The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. The lesion is non-ulcerated, and is thus AJCC stage T3a. There are melanocytes slightly deeper than the stated thickness, but these are in a pattern suggesting that they are along the axis of an adnexal structure.	MELANOMA, 2.2 MM. IN THICKNESS	173619	737	\N	\N	12-51311	\N	DPN-03	Deep Penetrating Melanoma	IP683438	AirTable blocks_with_IP_info.csv
1401	10-57426	52	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.7	DPN-mm	\N	Sections show an asymmetrical proliferation of melanocytes arranged as nests and cords predominantly in the dermis. In the upper part of the dermis, the melanocytes form large nests. These collections are arranged amidst a sclerotic stroma. There is a lack of maturation with descent into the dermis and a few mitotic figures are identified within the collections in the deep dermis.	Skin segment measuring 0.9 x 0.9 x 0.4 cm, quadrisected and entirely submitted.	H/O MM L CHEEK, HAD A GROWTH ON R LEG THAT HAS INCREASED IN SIZE, 6 X 6 MM VIOLACEOUS FIRM NODULE; DF, VS. LESS LIKELY DFSP	\N	\N	Scraping	The microstaging of this melanoma is as follows: Level: IV Tumor infiltrating lymphocytes:  None identified Vascular or lymphatic invasion: Not identified in D2-40 stain Dermal mitotic rate: 1/square mm Perineural invasion: Not identified Ulceration: Not identified Regression: Not identified Microsatellite metastasis: Not identified  The final thickness determination and microstaging of this melanoma will be determined in the final excision.  This case was reviewed by Drs. McCalmont, LeBoit, Ruben, and Mully who agree with the diagnosis of melanoma.	MELANOMA, AT LEAST 3.3 MM IN THICKNESS, TRANSECTED AT THE BASE OF THE BIOPSY	173702	739	\N	\N	10-57426	\N	DPN-06	Deep Penetrating Melanoma	IP522472	AirTable blocks_with_IP_info.csv
1454	11-23681C	58	\N	\N	3	T4b	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	LARGE PG OR ANGIOSARCOMA/FIBROMA?, SEE PHOTO	\N	\N	\N	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	740	\N	\N	11-23681	C	JJS1	2010-2017	IP1013119	AirTable blocks_with_IP_info.csv
1453	11-23681B	58	\N	\N	3	T4b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26308,26292	172.5	\N	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	LARGE PG OR ANGIOSARCOMA/FIBROMA?, SEE PHOTO	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	740	\N	\N	11-23681	B	JJS1	Melanoma Evolution	IP1013119	AirTable blocks_with_IP_info.csv
2916	86-04906-2 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1086	\N	\N	None	\N	MD-209	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2937	93-12428-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1087	\N	\N	None	\N	MD-210	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2925	91-09968E T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1088	\N	\N	None	\N	MD-211	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2921	89-13569-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1089	\N	\N	None	\N	MD-212	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2949	94-18018-2 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1090	\N	\N	None	\N	MD-213	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1452	11-23681A	58	\N	\N	3	T4b	Primary	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26294	172.5	\N	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	LARGE PG OR ANGIOSARCOMA/FIBROMA?, SEE PHOTO	\N	\N	\N	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	740	\N	\N	11-23681	A	JJS1	2010-2017	IP1013119	AirTable blocks_with_IP_info.csv
1461	11-29719	34	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26309	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of large, pleomorphic melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with many melanocytes present above the basal zone.  A few large atypical melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus) that are arranged in small nests along the junction and within the papillary dermis extending between collagen bundles and around adnexal structures.	Ellipse, 1.6 x 0.9 x 0.6 cm, including a central 0.5 x 0.3 cm dark brown area.  With the margin inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	9 MM 2-COLOR DARK BROWN PAPULE X 6 MTH; ? MELANOMA	\N	\N	FFPE	The melanoma extends to a Clark level II of the dermis.  Features of regression are not present and mitoses are not apparent in the dermal component of the melanoma.  The melanoma fits the criteria for stage T1a according the the 2009 AJCC melanoma staging criteria. Excision to ensure its complete removal is warranted.	MELANOMA, MEASURING 0.70 MILLIMETERS IN THICKNESS, NON-ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO THE EDGE OF THE SPECIMEN	529699	741	\N	\N	11-29719	\N	JJS2	Melanoma Evolution	IP1019157	AirTable blocks_with_IP_info.csv
1485	11-49127	31	\N	\N	\N	T1b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26320	172.6	\N	\N	Sections show a proliferation of melanocytes involving the junctional zone and superficial dermis. The lesion has a domed surface and a flat base. Within the upper part of the lesion, oval melanocytes with moderately enlarged vesicular nuclei containing small nuclei form confluent nests and sheets, among which some mitotic figures are present. Smaller melanocytes are evident at the base of the lesion.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted.	R/O ATYPICAL NEVUS	\N	\N	FFPE	This lesion features a population of large, atypical melanocytes overlying nests of smaller ones. The large, atypical cells show more intense staining with MART-1 than the smaller ones do in a MART-1/tyrosinase - red, Ki-67 - brown double stain. These cells also have a higher proliferative rate than the smaller ones do. The large cells are p16 negative, while the small ones are p16 positive. Some of the large, but not the small melanocytes are positive with phosphohistone H3, a marker of cells in or near mitosis. Hence, I believe that the large cells represent melanoma and the smaller ones a pre-existent nevus. The larger cells have a mitotic rate of 1 per square millimeter, making this a T1b primary melanoma. The intraepidermal component of the lesion extends to within a millimeter of the peripheral margin.	MELANOMA, 0.6 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173688	743	\N	\N	11-49127	\N	JJS4	Melanoma Evolution	IP1038566	AirTable blocks_with_IP_info.csv
1575	12-12684	34	\N	\N	\N	T3a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26342	172.5	\N	\N	Sections show a broad based and asymmetrical proliferation of melanocytes involving the junctional zone, superficial dermis and more deeply, the perifollicular adventitial dermis. On one side, there are nests, cords and strands of small, round melanocytes that mature with descent. On the other, there are confluent aggregations of melanocytes with abundant, pale cytoplasm and larger nuclei. Several mitotic figures are evident in the upper part of the lesion.	Skin segment measuring 1.0 x 0.6 x 0.2 cm, bisected and entirely submitted.	ASYMMETRIC BROWN PAPULE, PT NOTICES THIS HAS CHANGED OVER THE LAST YEAR; APPEARS TO BE A NEVUS AND SK THAT ARE CONTIGUOUS BUT CANNOT RULE OUT MELANOMA UNDER DERMOSCOPY	\N	\N	FFPE	The differential diagnosis included a melanoma arising in a nevus with congenital features. A p16 immunoperoxidase stain shows that the smaller cells mentioned in the first part of the microscopic description stain strongly, while there is total loss of staining in the larger cells mentioned later in the description. While the perifollicular distribution of these cells at the base of the lesion initially made me believe that even if there was melanoma, the base was benign, the p16 stain shows loss of this protein even in these deeper cells. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows no labeling of nuclei in the portion that I now believe is nevus, with diminished Melan-A staining intensity and scattered phosphohistone immunopositive cells throughout the entire thickness of the lesion, including one positive nucleus near the base. Among the phosphohistone positive nuclei are some that appear to be mitotic figures. Given these findings, a combined nevus can be excluded. The lesion is over 2 mm in thickness, and not ulcerated (and is hence stage T3a per the 2009 revised AJCC guidelines. The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis.	MELANOMA, 2.1 MM. IN THICKNESS, ARISING ADJACENT TO A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	528522	746	\N	\N	12-12684	\N	JJS7	Melanoma Evolution	IP1098500	AirTable blocks_with_IP_info.csv
1591	12-21993I	68	\N	\N	\N	T1b	Primary	None	\N	0	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population of melanocytes is arrayed in poorly circumscribed fashion along the junction, as irregular nests and single cells, filling the papillary dermis and surrounded by a dense lymphocytic infiltrate. The melanocytes are large and have prominent nucleoli. Scattered mitotic figures are present. The second population of melanocytes consists of nests of slightly smaller cells arrayed along the junction and in the papillary dermis (melanocytic nevus). There is a zone of inflammation and granulation tissue corresponding to the prior biopsy site.	Ellipse measuring 8.4 x 3.9 x 1.1 cm, with a central 2.5 x 2.6 cm raised area. The margins of the specimen are inked blue. Fifteen representative sections are submitted, with one section each in cassettes A and B, and one section, bisected into two halves, each in cassettes C thru O. Remainder returned to container.	RE-EXCISION OF MELANOMA, 10 CM ELLIPTICAL EXCISION WITH 1 CM LATERAL MARGINS	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level:III Tumor infiltrating lymphocytes:brisk Vascular or lymphatic invasion: absent Dermal mitotic rate: scattered mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: low Stage: pT1b	MELANOMA, 0.9 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS OF THE CLARK'S OR DYSPLASTIC TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139524	747	\N	\N	12-21993	I	JJS8	Melanoma Evolution	IP1102243	AirTable blocks_with_IP_info.csv
1556	12-05858A3 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	935	\N	\N	None	\N	MD-29	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1569	12-12352 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	936	\N	\N	None	\N	MD-30	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1693	13-24372B CONSULTA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	937	\N	\N	None	\N	MD-31	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1590	12-21993C	68	\N	\N	\N	T1b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26323	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population of melanocytes is arrayed in poorly circumscribed fashion along the junction, as irregular nests and single cells, filling the papillary dermis and surrounded by a dense lymphocytic infiltrate. The melanocytes are large and have prominent nucleoli. Scattered mitotic figures are present. The second population of melanocytes consists of nests of slightly smaller cells arrayed along the junction and in the papillary dermis (melanocytic nevus). There is a zone of inflammation and granulation tissue corresponding to the prior biopsy site.	Ellipse measuring 8.4 x 3.9 x 1.1 cm, with a central 2.5 x 2.6 cm raised area. The margins of the specimen are inked blue. Fifteen representative sections are submitted, with one section each in cassettes A and B, and one section, bisected into two halves, each in cassettes C thru O. Remainder returned to container.	RE-EXCISION OF MELANOMA, 10 CM ELLIPTICAL EXCISION WITH 1 CM LATERAL MARGINS	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level:III Tumor infiltrating lymphocytes:brisk Vascular or lymphatic invasion: absent Dermal mitotic rate: scattered mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: low Stage: pT1b	MELANOMA, 0.9 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS OF THE CLARK'S OR DYSPLASTIC TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139524	747	\N	\N	12-21993	C	JJS8	Melanoma Evolution	IP1102243	AirTable blocks_with_IP_info.csv
1638	12-57797	36	\N	\N	\N	T3b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26325	172.5	\N	\N	Sections show a focally ulcerated polypoid skin segment containing a compound melanocytic proliferation with with a biphasic pattern.  The major population consists of nested and solitary large melanocytes, which display atypical nuclei, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters and syncytia of similar melanocytes within the superficial dermis. Mitotic figures are readily identifiable in the dermal component. This component does not mature with descent. A minor population consists of small melanocytes with round to oval nuclei, positioned in the deeper dermis (melanocytic nevus).	Ellipse, 1.2 x 0.7 x 0.5 cm, including a central 0.8 x 0.6 cm raised area.  With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections.   RS/PL	IRRITATED NEVUS	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: 2/square mm Perineural invasion: not evident Ulceration: present Regression: not evident Microsatellite metastasis: not evident AJCC stage: T3b	MELANOMA, 2.4 MM IN THICKNESS, ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING INTRAEPIDERMALLY WITHIN 1MM OF THE SPECIMEN PERIPHERY	173540	748	\N	\N	12-57797	\N	JJS9	Melanoma Evolution	IP1143612	AirTable blocks_with_IP_info.csv
1642	12-67568A	59	\N	\N	\N	T2b	Primary	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26295,26296	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of markedly atypical melanocytes. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis that form expansile nodules. Ulceration is noted.  There are also broad zones of fibrosis and ample dermal melanophages.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 2.5 x 1.3 x 0.4 cm, longitudinally sectioned and entirely submitted with three sections in cassette A, two sections in cassette B.  DM/DM	R/O MM VS. IRRITATED IDN VS. ISK VS. HEMANGIOMA	\N	\N	FFPE	Melanoma in situ extends along a follicle to the base.  The melanoma in ulcerated.  There are broad zones of regression characterized by dermal fibrosis, ample melanophages and a paucity of melanocytes.  Based on the 2009 AJCC melanoma staging system, this is a pT2b lesion.	MELANOMA, APPROXIMATELY 2.0 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102537	749	\N	\N	12-67568	A	JJS10	Melanoma Evolution	IP1153384	AirTable blocks_with_IP_info.csv
1643	12-67568B	59	\N	\N	\N	T2b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26295,26296	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of markedly atypical melanocytes. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis that form expansile nodules. Ulceration is noted.  There are also broad zones of fibrosis and ample dermal melanophages.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 2.5 x 1.3 x 0.4 cm, longitudinally sectioned and entirely submitted with three sections in cassette A, two sections in cassette B.  DM/DM	R/O MM VS. IRRITATED IDN VS. ISK VS. HEMANGIOMA	\N	\N	FFPE	Melanoma in situ extends along a follicle to the base.  The melanoma in ulcerated.  There are broad zones of regression characterized by dermal fibrosis, ample melanophages and a paucity of melanocytes.  Based on the 2009 AJCC melanoma staging system, this is a pT2b lesion.	MELANOMA, APPROXIMATELY 2.0 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102537	749	\N	\N	12-67568	B	JJS10	Melanoma Evolution	IP1153384	AirTable blocks_with_IP_info.csv
1636	12-57349C	57	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26297,26326	172.5	\N	\N	Sections show a scar and a residual compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus). The dermal component matures with descent.  The second population consists of a broad proliferation of nested and solitary melanocytes which display atypical nuclei, arrayed irregularly and in poorly circumscribed and pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis. The papillary dermis is thickened and fibrotic, with a patchy bandlike lymphocytic infiltrate and diminished numbers of melanocytes in such areas, when compared to the remainder of the lesion.	Ellipse measuring 2.7 x 1.9 x 1.2 cm, including a central 1.4 x 1.4 cm area of variegated color and texture. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections each in cassettes A through G.  RS/RS	2.2 X 1.8 CM; COMPOUND MELANOCYTIC PROLIFERATION CONCERNING FOR MELANOMA: TELEPHONE 209-968-1322 (CELL), 209-522-4074 (HOME, OK TO LM)	\N	\N	FFPE	The residuum proves to be biphasic, with indisputable melanoma with regression, along with a melanocytic nevus with superficial congenital features. I reviewed the original biopsy for prognostic features. The thickness is similar, and there are no other salient features in that small specimen. Histopathologic features of possible prognostic importance include the following. Complete re-excision of this site is of course warranted.  Level: II Tumor infiltrating lymphocytes: moderate Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: present, moderate Microsatellite metastasis:  not evident AJCC stage: T1a	RESIDUAL MELANOMA, 0.6 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	173536	750	\N	\N	12-57349	C	JJS11	Melanoma Evolution	IP1142084	AirTable blocks_with_IP_info.csv
1692	13-24372A T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	937	\N	\N	None	\N	MD-31	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1696	13-26846 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	938	\N	\N	None	\N	MD-32	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1637	12-57349E	57	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26297,26326	172.5	\N	\N	Sections show a scar and a residual compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus). The dermal component matures with descent.  The second population consists of a broad proliferation of nested and solitary melanocytes which display atypical nuclei, arrayed irregularly and in poorly circumscribed and pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis. The papillary dermis is thickened and fibrotic, with a patchy bandlike lymphocytic infiltrate and diminished numbers of melanocytes in such areas, when compared to the remainder of the lesion.	Ellipse measuring 2.7 x 1.9 x 1.2 cm, including a central 1.4 x 1.4 cm area of variegated color and texture. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections each in cassettes A through G.  RS/RS	2.2 X 1.8 CM; COMPOUND MELANOCYTIC PROLIFERATION CONCERNING FOR MELANOMA: TELEPHONE 209-968-1322 (CELL), 209-522-4074 (HOME, OK TO LM)	\N	\N	FFPE	The residuum proves to be biphasic, with indisputable melanoma with regression, along with a melanocytic nevus with superficial congenital features. I reviewed the original biopsy for prognostic features. The thickness is similar, and there are no other salient features in that small specimen. Histopathologic features of possible prognostic importance include the following. Complete re-excision of this site is of course warranted.  Level: II Tumor infiltrating lymphocytes: moderate Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: present, moderate Microsatellite metastasis:  not evident AJCC stage: T1a	RESIDUAL MELANOMA, 0.6 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	173536	750	\N	\N	12-57349	E	JJS11	Melanoma Evolution	IP1142084	AirTable blocks_with_IP_info.csv
1653	12-93589A	27	\N	\N	\N	T3a	Primary	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26298	172.4	\N	\N	Sections show a broad based and asymmetrical proliferation of melanocytes with two components. One population of melanocytes consists of cells with abundant pale vacuolated cytoplasm and finely divided melanin pigment. These cells are positioned singly and as small but confluent nests at the edges of the lesion, bridging adjacent rete ridges. Centrally, there is a protuberant nodule in which large, confluent nests and sheets of large, oval melanocytes are present, with some cells of similar appearance, and others with more homogeneous appearing amphophilic cytoplasm. Many mitotic figures are present in melanocytes in the dermis.  In another area, small, round melanocytes and s-shaped spindled ones forming tactoid bodies are interspersed with adipocytes is a partially peri-adnexal pattern.	Ellipse, 2.1 x 1.0 x 0.7 cm, including a central 1.1 x 0.7 cm variegated raised area.  With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A and four sections in cassette B.   DM/PL	1.3 CM X 9 MM TRI-TONE PINK/BROWN ASYMMETRICAL PLAQUE; NEVUS, MELANOMA	\N	\N	FFPE	I note the age of the patient, but the histopathologic findings are unequivocal. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is not ulcerated, making it AJCC stage T3a. The pre-existent melanocytic nevus has congenital features. Melanoma cells in the perifollicular adventitial dermis or involving adnexa extend to a slightly greater thickness than that listed above. However, such adnexal extension is not utilized for determination of thickness for prognostic purposes, by convention.	MELANOMA, 2.05 MM. IN THICKNESS, ARISING IN PRE-EXISTENT NEVUS	172438	751	\N	\N	12-93589	A	JJS12	Melanoma Evolution	IP1179406	AirTable blocks_with_IP_info.csv
1668	13-2138C	48	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26299	172.6	\N	\N	Sections show a broad proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  Most of the lesion consists of bland melanocytes arranged as single units and as nests at the dermo-epidermal junction and as nests and cords in the dermis.  More centrally the melanocytes are more atypical with hyperchromatic nuclei and more apparent cytoplasm.  There is increased confluence of these melanocytes and some are present above the dermo-epidermal junction as well as in the papillary dermis.  There is an associated dense band like lymphocytic infiltrate in this area.  Broad zones of old scarring fibrosis are identified.  In addition a more recent biopsy site is present.	Oriented elliptical excision, 6.3 x 2.5 x 0.9 cm, including a central 2.5 x 1.5 cm pearly pink brown and raised area.  With the orienting sutured edge arbitrarily designated 11:00 by the grosser, the 12:00-6:00 margin is inked blue and the 6:00-12:00 margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12:00 to 6:00 tips and submitted with three sections each in cassettes A through D and four sections in cassette E. Tips are returned to container.   HD/HD	7 X 5 CM FOCALLY PIGMENTED PLAQUE W/RECENT BX = ATYPICAL COMPD NEVUS, 2 PREVIOUS BX = CONGENITAL NEVUS	\N	\N	FFPE	This is a large lesion that extends to margins.  Much of it looks like a congenital melanocytic nevus.  Other foci show more worrisome features including irregularity of the melanocytic nesting pattern and melanocytes above the dermo-epidermal junction. Due to the presence of extensive scarring both old and recent and the history of prior biopsies I considered the possibility that these more atypical areas could represent a recurrent nevus phenomenon which has in the past been termed pseudomelanoma.  I retrieved two prior biopsies from this area (reviewed as DS13-3590).  The most recent of these biopsies (from 2012) shows a portion of a melanocytic nevus with an unusual intraepidermal component.   The more remote biopsy (from 2004) shows a bland compound melanocytic nevus.  After reviewing this material it became apparent to me that the changes in the excision specimen were more atypical than those present in the biopsies with greater cytologic atypia of the consistent melanocytes and greater architectural atypia than could be explained by a recurrent nevus phenomenon especially since the more atypical areas extended beyond the biopsy site scars.  I think therefore that this patient has a thin melanoma that has arisen in association with a congenital pattern melanocytic nevus.  I have reviewed this case with Dr. LeBoit who also concurs with this interpretation.  The melanoma portion of this lesion has been excised but the melanocytic nevus extends to nearly all of the lateral margins of the specimen.  The melanoma is not ulcerated and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.	MELANOMA, APPROXIMATELY 0.55 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH A CONGENITAL PATTERN	173649	752	\N	\N	13-2138	C	JJS13	Melanoma Evolution	IP1186880	AirTable blocks_with_IP_info.csv
1724	13-98648	83	\N	\N	\N	T2a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26300,26301	172.4	\N	\N	Sections show a bi-domed proliferation of melanocytes mostly in the superficial dermis. There are nests, cords and strands of plump, oval to small, round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures. Some multinucleated melanocytes are present superficially. There is a nodular area in which larger melanocytes including cells in mitosis are present. The melanocytes in this area have slightly larger and more vesicular nuclei, and more pigmented cytoplasm.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, quadrisected and entirely submitted. CF/CF	SMOOTH PEARLY PAPULES, SOME PIGMENTED	\N	\N	FFPE	This melanoma lacks an intraepidermal component, and has arisen in a nevus that is quite cellular for the age of the patient. The lesion is between 1 and 2 mm in thickness, and is not ulcerated. Therefore it should be classified as T2a per the 2009 revision of the AJCC staging system for melanoma. The melanoma nearly reaches the base of the specimen and the nevus is broadly transected.	MELANOMA, 1.7 MM. IN THICKNESS, ARISING IN A PRE-EXISTENT NEVUS WITH CONGENITAL FEATURES	173404	753	\N	\N	13-98648	\N	JJS14	Melanoma Evolution	IP1340664	AirTable blocks_with_IP_info.csv
2639	20-82651A	97	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33775	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	\N	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	A	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
1697	13-26846A1 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	938	\N	\N	None	\N	MD-32	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1734	14-03473 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	939	\N	\N	None	\N	MD-33	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1813	15-02416 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	940	\N	\N	None	\N	MD-34	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1733	14-2508	49	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26302	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are a few similar melanocytes in the subjacent papillary dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  A zone of dermal fibrosis with an overlying paucity of melanocytes is identified.	Skin segment measuring 1.3 x 0.9 x 0.2 cm, trisected and entirely submitted. PL/PL	1 CM IRREGULAR PIGMENTED PATCH; R/O MM	\N	\N	FFPE	Melanoma in situ extends along a follicle to the base of the biopsy.  I have examined additional sections and a Melan-A stain.  The immunostain highlights areas of  increased confluence of junctional melanocytes, melanocytes above the dermo-epidermal junction, and a few irregular aggregates of melanocytes in the papillary dermis.  There is also a larger proliferation of bland dermal melanocytes. A central zone of fibrosis which could represent a focus of partial regression is also noted.  This is a non-ulcerated melanoma and no dermal mitotic figures are identified.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.  I have also reviewed this case with Dr. LeBoit who concurs with the diagnosis.	MELANOMA, 0.23 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	423566	754	\N	\N	14-2508	\N	JJS15	Melanoma Evolution	IP594605	AirTable blocks_with_IP_info.csv
1783	14-64047	53	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26303,26327	172.5	\N	\N	Sections show a proliferation of large atypical melanocytes with ample pigmented cytoplasm distributed singly and as large nests in irregular fashion within the epidermis and dermis.  Many melanocytes are scattered in the upper layers of the epidermis.  Dermal nests are present in fibrosis and surrounded by a lymphocytic infiltrate.  There is also a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis, with intermixed elastotic fibers, demonstrating maturation with descent.	Skin segment measuring 1.6 x 1.3 x 0.2 cm, serially sectioned and entirely submitted with six sections. HD/KC	A) MELANOMA. SUSPICOUS IRREGULAR MULTI-COLORED PAPULE.	\N	\N	FFPE	The lesion is less than 1 mm in thickness, is not ulcerated, and I did not detect mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.  This melanoma extends to within < 1 mm of the specimen periphery in sections examined.  Additional treatment at this site is warranted.	MELANOMA OF 0.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS WITH CONGENITAL FEATURES	239512	755	\N	\N	14-64047	\N	JJS16	Melanoma Evolution	IP1413990	AirTable blocks_with_IP_info.csv
1752	14-33100	39	\N	\N	\N	T2a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26304,26305	172.5	\N	\N	Sections show a melanocytic proliferation with a biphasic configuration in a polyp. There is a population of small melanocytes arrayed as maturing nests, cords, and syncytia, representing melanocytic nevus, and more distally in the polyp there is a population of large atypical melanocytes, some of which are multinucleate or in mitosis, and no maturation is apparent. There is also marked vascular ectasia.	Skin segment measuring 0.6 x 0.6 x 0.3 cm, bisected and entirely submitted. RS/RS	PATCH; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	FFPE	This specimen demonstrates the unusual occurrence of a melanoma arising secondarily within what appears to be a partially polypoid congenital melanocytic nevus. The enlarged melanocytes seen here are quite strikingly atypical and there are dermal melanocytes in mitosis, and thus the diagnosis of melanoma has a solid foundation. With respect to staging, this non-ulcerated tumor is between 1-2 mm in thickness and thus represents melanoma of stage pT2a (2009 AJCC Guidelines). Further excision is warranted to ensure that local control has been established.	MELANOMA OF 1.3 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	139524	756	\N	\N	14-33100	\N	JJS17	Melanoma Evolution	IP1383034	AirTable blocks_with_IP_info.csv
1763	14-47962	69	\N	\N	\N	T2a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26306,26339	172.5	\N	\N	Sections show a broad-based and asymmetrical proliferation of melanocytes involving the epidermis and dermis flanking a polypoid area. Within the latter are small nests, cords and strands of small, round melanocytes. The remainder of the lesion features melanocytes with abundant, pale, vacuolated cytoplasm and enlarged nuclei arranged irregularly as single cells and large nests positioned at irregular intervals along the dermo-epidermal junction and in the subjacent dermis, intruding into the area of small, round melanocytes and undermining it.	Skin segment measuring 1.4 x 0.7 x 0.7 cm, trisected and entirely submitted. RS/RS	? SK, R/O MM	\N	\N	FFPE	Most of the exophytic part of the lesion is a polypoid nevus, and most of the flat portion is a relatively thin melanoma, with a thicker area in the dermis undermining the pre-existent nevus. Melanoma extends to the base of the specimen beneath the polypoid nevus. As there is no ulceration, given the configuration of the dermal component the AJCC stage will most likely be pT2a. The thickness is listed as an approximation because of the unusual configuration of the area of invasive melanoma.	MELANOMA, 1.5 MM. IN APPROXIMATE THICKNESS, ARISING IN A PRE-EXISTENT, POLYPOID NEVUS	173526	757	\N	\N	14-47962	\N	JJS18	Melanoma Evolution	IP1397898	AirTable blocks_with_IP_info.csv
1787	14-73175B	44	\N	\N	1	T2a	Primary	Melanoma, NOS, arising in association with a melanocytic nevus with congenital features 3.	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26307,26202,26340	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  The overlying epidermis is thinned and there is overlying parakeratosis that contains serum and inflammatory cells. Similar melanocytes are present in the subjacent dermis, and, in some foci, these melanocytes aggregate around adnexa. There are mitotic figures evident among the dermal melanocytes. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). These melanocytes are located within the deep reticular dermis subjacent to the population of atypical melanocytes.	Ellipse measuring 3.9 x 1.4 x 0.7 cm, including a central 1.2 x 0.8 cm raised area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. RS/KC	PRESUMED ULCERATED MM EXC	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: 1. Procedure: Excisional biopsy 2. Microscopic tumor type: Melanoma, NOS, arising in association with a melanocytic nevus with congenital features 3. Breslow thickness: 1.45 millimeters 4. Ulceration: Microscopic evidence of ulceration is not apparent. The clinical impression of ulceration was probably due to the presence of crust in the stratum corneum. 5. Margins: The melanoma extends to within 3 millimeters of the peripheral inked margin within the central aspect of the specimen. The melanoma is 4 millimeters from the inked margin at the specimen base. 6. Mitotic index: > 1/mm2 7. Microsatellitosis: Not identified 8. Vascular invasion: Not identified 9. Regression: Not identified 10. Pathologic staging (pTNM): pT2aNxMx	MELANOMA, 1.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS AND EXTENDING CLOSELY TO THE PERIPHERAL INKED MARGINS	529698	758	\N	\N	14-73175	B	JJS19	Melanoma Epigenetics	IP1423133	AirTable blocks_with_IP_info.csv
2251	17-119451	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18177	216.7	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. RS/RS	6 X 5 MM NOTCHED IRREGULARLY PIGMENTED MACULE; R/O MELANOMA	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173711	830	\N	\N	17-119451	\N	LN-10	Lentiginous Nevi 	IP1849990	AirTable blocks_with_IP_info.csv
1786	14-73175B	44	\N	\N	1	T2a	Primary	Melanoma, NOS, arising in association with a melanocytic nevus with congenital features 3.	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26307,26202,26340	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  The overlying epidermis is thinned and there is overlying parakeratosis that contains serum and inflammatory cells. Similar melanocytes are present in the subjacent dermis, and, in some foci, these melanocytes aggregate around adnexa. There are mitotic figures evident among the dermal melanocytes. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). These melanocytes are located within the deep reticular dermis subjacent to the population of atypical melanocytes.	Ellipse measuring 3.9 x 1.4 x 0.7 cm, including a central 1.2 x 0.8 cm raised area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. RS/KC	PRESUMED ULCERATED MM EXC	\N	\N	FFPE	A synoptic report of potential prognostic factors is listed below: 1. Procedure: Excisional biopsy 2. Microscopic tumor type: Melanoma, NOS, arising in association with a melanocytic nevus with congenital features 3. Breslow thickness: 1.45 millimeters 4. Ulceration: Microscopic evidence of ulceration is not apparent. The clinical impression of ulceration was probably due to the presence of crust in the stratum corneum. 5. Margins: The melanoma extends to within 3 millimeters of the peripheral inked margin within the central aspect of the specimen. The melanoma is 4 millimeters from the inked margin at the specimen base. 6. Mitotic index: > 1/mm2 7. Microsatellitosis: Not identified 8. Vascular invasion: Not identified 9. Regression: Not identified 10. Pathologic staging (pTNM): pT2aNxMx	MELANOMA, 1.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS AND EXTENDING CLOSELY TO THE PERIPHERAL INKED MARGINS	529698	758	\N	\N	14-73175	B	JJS19	Melanoma Evolution	IP1423133	AirTable blocks_with_IP_info.csv
1846	15-22166 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	941	\N	\N	None	\N	MD-35	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1853	15-32174 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	942	\N	\N	None	\N	MD-36	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1927	16-31317 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	943	\N	\N	None	\N	MD-37	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1150	05-01411 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	944	\N	\N	None	\N	MD-38	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1151	05-01411C N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	944	\N	\N	None	\N	MD-38	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1789	14-78242	78	\N	\N	\N	T2b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26310,26311, 26195	172.4	\N	Smallish nevus but good\n	Sections show a polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis arranged as cellular nests and sheets. Near the ulcer dermal edema is present. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.0 x 0.9 x 0.7 cm, quadrisected and entirely submitted. RS/KC	NEVUS, R/O MALIGNANCY	\N	\N	FFPE	Melanoma in situ extends to the edge of the specimen.  The lesion is ulcerated and dermal edema is present near the ulcer which complicates measurement somewhat. I took the above measurement in the best oriented and least edematous area.  This lesion would be staged as a pT2b melanoma based on the 2009 AJCC melanoma staging system.	MELANOMA, APPROXIMATELY 1.55 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102485	759	\N	\N	14-78242	\N	JJS20	Melanoma Evolution,Melanoma Epigenetics	IP1428205	AirTable blocks_with_IP_info.csv
1880	15-98263	52	f	1.5	1	T2a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26312	172.6	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population consists of a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis.  In fact, some of the dermal melanocytes contain abundant dusty melanin with their cytoplasm. In addition, mitotic figures are present amid dermal melanocytes. The other population is composed of maturing nests, cords, and syncytia of small melanocytes that extend into the reticular dermis and around adnexa.	Skin segment measuring 1.2 x 1.1 x 0.3 cm, serially sectioned, and entirely submitted with five sections. HD/HD	NODULAR, PIGMENTED CHANGING LESION	\N	\N	FFPE	This specimen captures a melanoma of 1.5 millimeters in thickness that appears to have developed within a melanocytic nevus with superficial congenital features. This is in keeping with the clinical history of a changing pigmented lesion. Synoptic melanoma reporting is included below:  Procedure: Deep shave biopsy Tumor site: Right posterior shoulder Microscopic tumor type: Superficial spreading Breslow thickness: 1.5 millimeters Ulceration: Absent Margins: Intraepidermal melanoma extends to within 1 millimeter of the peripheral edge of the specimen Mitotic index: 1/10 hpf Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2aNxMx  Further treatment is warranted.	MELANOMA, 1.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND EXTENDING CLOSELY TO THE SPECIMEN EDGE	529699	760	\N	\N	15-98263	\N	JJS21	Melanoma Evolution	IP1569950	AirTable blocks_with_IP_info.csv
1866	15-50051	68	\N	\N	3	T1b	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26314	172.5	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis. Within the epidermis, there are melanocytes in pagetoid scatter and single melanocytes predominate over nests. Thera ear clusters of similar melanocytes in the dermis and the size of the melanocytes does not diminish with descent. In addition, there are mitotic figures present among the dermal melanocytes. A dense surrounding lymphohistiocytic is present and there is solar elastosis in the subjacent dermis. There is as a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures. There are also nests of similar melanocytes within the lower epidermis.	Skin segment measuring 1.2 x 0.7 x 0.2 cm, trisected and entirely submitted. CF/CF	PINK BROWN PAPULE; BCC VS. ATYPICAL NEVUS VS. MELANOMA VS. IRRITATED SK	\N	\N	FFPE	This melanoma is juxtaposed to a melanocytic nevus with superficial congenital features, suggesting that the melanoma arose within the nevus. Is there a history of a changing pigmented lesion? Synoptic melanoma reporting is included below. Procedure: Scoop shave biopsy Microscopic tumor type: Superficial spreading Breslow thickness: 0.9 millimeters Ulceration: Not present Margins: + peripheral, close to deep Mitotic index: 3/mm2 Microsatellitosis: not identified Vascular invasion: not identified Regression: not identified Pathologic staging (pTNM): pT1bNxMx  Further treatment at this site is warranted.	MELANOMA, 0.9 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173527	761	\N	\N	15-50051	\N	JJS23	Melanoma Evolution	IP796072	AirTable blocks_with_IP_info.csv
2258	17-120839	67	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18179	216.4	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O LENTIGO, HISTORY OF MELANOMA IN SITU	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173406	831	\N	\N	17-120839	\N	LN-11	Lentiginous Nevi 	IP1562416	AirTable blocks_with_IP_info.csv
2947	94-12246 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1091	\N	\N	None	\N	MD-214	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1862	15-48134	76	f	\N	0	T1a	Primary	SSM, non-CSD	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26341	172.7	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus).	Cylindrical skin segment, 0.8 cm in diameter and 0.6 cm in thickness, with margins inked, trisected and entirely submitted. KC/KC	PT WITH 20 YEAR HISTORY OF RED / BROWN NEVUS AT RIGHT THIGH WITH CHANGES IN COLOR FOR YEARS, NO HISTORY OF SKIN CANCER; R/O MELANOMA (PHOTOS)	\N	\N	FFPE	There appears to be an associated nevus. Diagnostic features of note include:  Procedure: punch Tumor site: leg Microscopic tumor type: SSM, non-CSD Breslow thickness: 0.95 mm Ulceration: absent Margins, peripheral and deep: both peripheral involved Mitotic index: 0 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a	MELANOMA, 0.95 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO THE EDGES OF THE SPECIMEN	562711	762	\N	\N	15-48134	\N	JJS24	Melanoma Evolution	IP1519455	AirTable blocks_with_IP_info.csv
2641	20-82651C	97	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33777	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	None	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	C	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
1209	06-08092 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	945	\N	\N	None	\N	MD-39	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1160	05-12693C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	946	\N	\N	None	\N	MD-40	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1832	15-12964B	68	f	\N	0	T2a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26315	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent fibrotic dermis. Prominent adnexal involvement is present in foci.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Oriented ellipse, 2.4 x 1.2 x 0.7 cm, including a central 1.6 x 1.0 cm area of variegated color. With the sutured tip placed to the left, this tip is indicated as 9 o'clock medial margin on the requisition. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and six sections in B. RS/RS	HISTORY OF NMSC AND MELANOMA, BROWN PLAQUE NEW X FEW YEARS, PINK + BROWN 1.1 X 1.8 CM, NARROWLY EXCISED; MELANOMA VS. INFLAMED NEVUS VS. BCC (TELEPHONE: 415-717-8833)	\N	\N	FFPE	With the suture designated as 9 o'clock, melanoma in situ extends to the peripheral margin from approximately the 6-9 o'clock position. Diagnostic features of note include:  Procedure: Excisional biopsy Tumor site: Abdomen Microscopic tumor type: Superficial spreading Breslow thickness: 1.32 millimeters Ulceration: Absent Margins, peripheral and deep: Peripheral involved by melanoma in situ, deep free (see above) Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.32 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	100555	763	\N	\N	15-12964	B	JJS25	Melanoma Evolution	IP267123	AirTable blocks_with_IP_info.csv
1834	15-14665B	54	f	\N	0	T1a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26328,26329	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  A patchy lymphocytic infiltrate with associated dermal fibrosis is noted.	Ellipse, 3.8 x 1.7 x 0.9 cm, including a central 2.3 x 1.3 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, three sections each in B-D, and four sections in E. RS/RS	PT WITH MANY YEAR HX/O PIGMENTED LESION OF BACK, SLOWLY CHANGING; R/O MM	\N	\N	FFPE	Melanoma in situ is present <2 millimeters from the closest lateral margin. Diagnostic features of note include:  Procedure: Excision Tumor site: Back Microscopic tumor type: Superficial spreading Breslow thickness: 0.72 millimeters Ulceration: Absent Margins, peripheral and deep: Free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Present, focal Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.72 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173531	764	\N	\N	15-14665	B	JJS26	Melanoma Evolution	IP1485712	AirTable blocks_with_IP_info.csv
1835	15-14665C	54	f	\N	0	T1a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26328,26329	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  A patchy lymphocytic infiltrate with associated dermal fibrosis is noted.	Ellipse, 3.8 x 1.7 x 0.9 cm, including a central 2.3 x 1.3 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, three sections each in B-D, and four sections in E. RS/RS	PT WITH MANY YEAR HX/O PIGMENTED LESION OF BACK, SLOWLY CHANGING; R/O MM	\N	\N	FFPE	Melanoma in situ is present <2 millimeters from the closest lateral margin. Diagnostic features of note include:  Procedure: Excision Tumor site: Back Microscopic tumor type: Superficial spreading Breslow thickness: 0.72 millimeters Ulceration: Absent Margins, peripheral and deep: Free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Present, focal Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.72 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173531	764	\N	\N	15-14665	C	JJS26	Melanoma Evolution	IP1485712	AirTable blocks_with_IP_info.csv
2952	94-23180 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1092	\N	\N	None	\N	MD-215	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1874	15-85517	49	\N	\N	0	T1a	Primary	superficial spreading melanoma	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26316	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and most of which have pale cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer, especially near the edges of the lesion.  There are similar melanocytes in dense fibrotic stroma in the subjacent dermis in the center of the lesion. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei, positioned toward one edge.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted. KC/KC	11 MM ERYTH DARK BROWN PATCH; R/O ATYPIA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: right mid-back Microscopic tumor type: superficial spreading melanoma Breslow thickness: 0.9 mm. Ulceration: no Margins, peripheral: involved, and deep: clear by 0.1 mm. Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.9 MM. IN THICKNESS, ARISING IN A PRE-EXISTENT NEVUS	139524	765	\N	\N	15-85517	\N	JJS27	Melanoma Evolution	IP1557118	AirTable blocks_with_IP_info.csv
2643	20-82651E	97	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33779	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	None	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	E	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
1175	05-27343A M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	947	\N	\N	None	\N	MD-41	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1200	06-03046F N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	948	\N	\N	None	\N	MD-42	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1207	06-06325 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	949	\N	\N	None	\N	MD-43	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1845	15-21741	37	\N	\N	1	T2a	Primary	superficial spreading and nodular	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26317	172.5	\N	\N	Sections show a partly sessile/polypoid compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus).  The second population consists of nested and solitary large epithelioid melanocytes with dusty cytoplasmic melanin, which display atypical nuclei, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters and syncytia of similar melanocytes within the dermis. There is a patchy infiltrate of lymphocytes.	Skin segment measuring 1.5 x 1.0 x 0.3 cm, quadrisected and entirely submitted. KC/KC	12 MM VARIEGATED BROWN MACULE WITH ECCENTRIC RAISED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA EVOLVING FROM COMPOUND NEVUS	\N	\N	FFPE	A synoptic report of potential prognostic factors is listed below: Procedure: shave biopsy Microscopic tumor type: superficial spreading and nodular Breslow thickness:  1.65 mm Ulceration: none Margins, peripheral and deep: both narrow Mitotic index: 1/square mm Microsatellitosis: not evident Vascular invasion: not evident Regression: not evident Perineural invasion: not evident Pathologic staging (pTNM): pT2a	MELANOMA, 1. 65 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173541	766	\N	\N	15-21741	\N	JJS28	Melanoma Evolution	IP1492837	AirTable blocks_with_IP_info.csv
2733	21-89776B	87	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33797	173.52	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Oriented ellipse, 2.9 x 1.3 x 0.7 cm, including a central 0.8 x 0.6 cm raised area. The orienting sutured tip is indicated lateral on the requisition. The orienting sutured tip is designated 9 o'clock by the grosser and is placed toward 9 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with five sections in A and three sections in B. Tips reserved. BY/BY	1 CM X 1 CM HYPERKERATOTIC RED CRUSTED PAPULE; R/O SCC	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	174529	767	\N	\N	21-89776	B	KA-01	Keratoacanthoma	IP2352756	AirTable blocks_with_IP_info.csv
2732	21-89776A	87	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33796	173.52	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Oriented ellipse, 2.9 x 1.3 x 0.7 cm, including a central 0.8 x 0.6 cm raised area. The orienting sutured tip is indicated lateral on the requisition. The orienting sutured tip is designated 9 o'clock by the grosser and is placed toward 9 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with five sections in A and three sections in B. Tips reserved. BY/BY	1 CM X 1 CM HYPERKERATOTIC RED CRUSTED PAPULE; R/O SCC	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	174529	767	\N	\N	21-89776	A	KA-01	Keratoacanthoma	IP2352756	AirTable blocks_with_IP_info.csv
2255	17-120280	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18181	216.5	\N	\N	Sections show a symmetric compound melanocytic proliferation. There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges.  There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis and mature with descent.	Skin segment measuring 1.1 x 0.9 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	6 MM BLACK MACULE; R/O MM	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	333504	832	\N	\N	17-120280	\N	LN-12	Lentiginous Nevi 	IP1850829	AirTable blocks_with_IP_info.csv
2946	94-08318-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1093	\N	\N	None	\N	MD-216	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2647	20-91483B	79	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33799	173.72	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Ellipse, 3.4 x 1.5 x 0.6 cm, including a central 1.3 x 1.3 cm elevated area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis, and submitted with five sections in A and four sections in B. Tips reserved. HD/HD	MORPHOLOGY: SMOOTH PINK NODULE WITH CENTRAL ROUGH AREA, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	123746	768	\N	\N	20-91483	B	KA-02	Keratoacanthoma	IP2239395	AirTable blocks_with_IP_info.csv
2646	20-91483A	79	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33798	173.72	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Ellipse, 3.4 x 1.5 x 0.6 cm, including a central 1.3 x 1.3 cm elevated area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis, and submitted with five sections in A and four sections in B. Tips reserved. HD/HD	MORPHOLOGY: SMOOTH PINK NODULE WITH CENTRAL ROUGH AREA, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	123746	768	\N	\N	20-91483	A	KA-02	Keratoacanthoma	IP2239395	AirTable blocks_with_IP_info.csv
2802	22-52528-1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33800	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	769	\N	\N	None	\N	KA-03	Keratoacanthoma	\N	AirTable blocks_with_IP_info.csv
2803	22-52528-2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33801	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	769	\N	\N	None	\N	KA-03	Keratoacanthoma	\N	AirTable blocks_with_IP_info.csv
2844	22-105120-1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33802	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	770	\N	\N	None	\N	KA-04	Keratoacanthoma	\N	AirTable blocks_with_IP_info.csv
2845	22-105120-2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33803	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	770	\N	\N	None	\N	KA-04	Keratoacanthoma	\N	AirTable blocks_with_IP_info.csv
1538	12-073	87	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.72	\N	\N	There is a densely inflamed keratinocytic proliferation with atypical keratinocytes, and there is a contiguous proliferation of atypical keratinocytes throughout the lower epidermis and focally extending from the epidermal-dermal junction in small collections within the subjacent dermis.  The keratinocytes are large with atypical mitoses and focal dyskeratosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted.	SCALY RED PATCH; R/O SCCIS VS. BCC VS. AK	\N	\N	\N	None	SQUAMOUS CELL CARCINOMA AND CONTIGUOUS SOLAR KERATOSIS, EXTENDING TO THE SPECIMEN BASE	173724	789	\N	\N	12-73	\N	KIT-08	Kit mutants	IP761084	AirTable blocks_with_IP_info.csv
1221	06-16008-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	950	\N	\N	None	\N	MD-44	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2642	20-82651D	97	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33778	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	None	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	D	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
2640	20-82651B	97	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33776	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	None	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	B	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
2736	21-96446A2	78	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33781	173.62	\N	\N	Sections show a papillated to crateriform proliferation of atypical keratinocytes, some of which have ample pallid cytoplasm. Orthokeratotic material predominates centrally, and nuclear variability is most pronounced at the lesion's periphery.  The peripheral margins of the specimen are not involved by neoplasm.	Oriented ellipse, 4.9 x 2.2 x 1.0 cm, including a central 1.7 x 1.6 cm raised area. The orienting sutured tip is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four sections in A1, two sections each in A2-A3, and four sections in A4. Tips reserved. BY/BY	A) PROBABLE KERATOACANTHOMA, B) BCCA	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	106678	772	\N	\N	21-96446	A2	KA-06	Keratoacanthoma	IP2359460	AirTable blocks_with_IP_info.csv
2735	21-96446A1	78	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33780	173.62	\N	\N	Sections show a papillated to crateriform proliferation of atypical keratinocytes, some of which have ample pallid cytoplasm. Orthokeratotic material predominates centrally, and nuclear variability is most pronounced at the lesion's periphery.  The peripheral margins of the specimen are not involved by neoplasm.	Oriented ellipse, 4.9 x 2.2 x 1.0 cm, including a central 1.7 x 1.6 cm raised area. The orienting sutured tip is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four sections in A1, two sections each in A2-A3, and four sections in A4. Tips reserved. BY/BY	A) PROBABLE KERATOACANTHOMA, B) BCCA	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	106678	772	\N	\N	21-96446	A1	KA-06	Keratoacanthoma	IP2359460	AirTable blocks_with_IP_info.csv
2657	20-104213B	72	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33785	173.72	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Ellipse, 4.2 x 1.7 x 0.7 cm, including a central 1.4 x 1.2 cm raised crusted area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. CF/BB	KERATOTIC NODULE	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173711	773	\N	\N	20-104213	B	KA-07	Keratoacanthoma	IP2252203	AirTable blocks_with_IP_info.csv
2656	20-104213A	72	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33784	173.72	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Ellipse, 4.2 x 1.7 x 0.7 cm, including a central 1.4 x 1.2 cm raised crusted area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. CF/BB	KERATOTIC NODULE	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173711	773	\N	\N	20-104213	A	KA-07	Keratoacanthoma	IP2252203	AirTable blocks_with_IP_info.csv
2595	20-18514A	80	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33786	173.62	\N	\N	Sections show a lobular and crateriform proliferation of keratinocytes, in large part composed of cells with abundant pale pink cytoplasm. Elastotic fibers are evident between the keratinocytes near the periphery. Nuclear atypicality is most pronounced in the most peripheral keratinocytes. There is a surrounding infiltrate of lymphocytes and granulocytes.	Elliptical excision, 3.6 x 1.7 x 1.1 cm, including a central 2.1 x 1.5 cm raised area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, three in B, and five in C. CF/CF	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH HYPERKERATOTIC SCALE, DDX: SQUAMOUS CELL CARCINOMA	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173622	774	\N	\N	20-18514	A	KA-08	Keratoacanthoma	IP2166036	AirTable blocks_with_IP_info.csv
1539	12-095	46	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of dendritic melanocytes arrayed between thickened collagen bundles.  Scattered melanophages are present.	Skin segment measuring 0.6 x 0.3 x 0.1 cm.  Submitted intact.	4 MM TOTAL SIZE LESION BIOPSY; R/O ATYPICAL	\N	\N	\N	None	BLUE NEVUS	173688	790	\N	\N	12-95	\N	KIT-09	Kit mutants	IP1085911	AirTable blocks_with_IP_info.csv
1540	12-122	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	791	\N	\N	12-122	\N	KIT-10	Kit mutants	\N	AirTable blocks_with_IP_info.csv
1371	10-10942A2 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	951	\N	\N	None	\N	MD-45	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1554	12-05089-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	952	\N	\N	None	\N	MD-46	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2652	20-98774D	51	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33792	173.62	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Oriented ellipse, 4.5 x 1.8 x 1.4 cm, including a central 1.5 x 1.5 cm elevated area. The orienting notched tip is indicated superior on the requisition and is designated 12 o'clock by the grosser. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, two sections each in B-C, and three sections in D. Tips reserved. HD/KB	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH CENTRAL KERATIN PLUG, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173620	775	\N	\N	20-98774	D	KA-09	Keratoacanthoma	IP2246722	AirTable blocks_with_IP_info.csv
1662	13-122	77	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	There are large, irregularly shaped and rounded masses of cells in the dermis beneath an ulcer.  The neoplastic cells have scant cytoplasm and large round to oval nuclei, with coarse chromatin and inconspicuous nucleoli.  Many cells are in mitosis, and many single cells are necrotic, in addition to necrosis en masse. The enclosed immunoperoxidase stains show that the cells of interest are positive for cytokeratin 20 with most cells having diffuse cytoplasmic positivity, and only a few perinuclear punctate positivity. There is strong staining for neuron specific enolase. Scattered single cells are synaptophysin or chromogranin positive.	Six outside slides, U12-16181 (12-D3272 A) and one corresponding block.	RIGHT HAND LESION; R/O METASTATIC CARCINOMA VS. MERKEL CELL CA VS. OTHER	\N	\N	\N	A keratin immunoperoxidase stain performed in our laboratory shows both staining of entire cells, and paranuclear dot-like positivity, the latter typical of Merkel cell carcinoma. However, there is no staining for Merkel cell polyomavirus large T antigen, and neurofilament protein is negative (in our hands, it is positive more often than cytokeratin 20). There is spotty staining for p63 (done as a prognostic marker, should the result have backed Merkel cell carcinoma). A thyroid transcription factor-1 stain is positive in the nuclei of small groups of cells. This does not support Merkel cell carcinoma, and raises the possibility of a metastasis from a small cell lung carcinoma.	SMALL CELL MALIGNANT NEOPLASM WITH NEUROENDOCRINE FEATURES, WORRISOME FOR A METASTASIS TO THE SKIN	173614	786	\N	\N	13-122	\N	KIT-05	Kit mutants	IP1184864	AirTable blocks_with_IP_info.csv
1424	11-154	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of melanocytes, with a predominance of nests along the at the sides and bases of elongated rete ridges, fusion of the bases of rete ridges and small nests of similar or smaller cells in the papillary dermis toward the center of the lesion. Most of the junctional melanocytes have finely distributed pigment and abundant vacuolated cytoplasm. Scattered melanocytes have enlarged nuclei. There is subjacent fibroplasia and a patchy lymphocytic infiltrate.	Skin segment measuring 1.0 x 0.7 x 0.2 cm, trisected and entirely submitted.	R/O AN	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173620	797	\N	\N	11-154	\N	KIT-16	Kit mutants	IP965940	AirTable blocks_with_IP_info.csv
1425	11-172	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	798	\N	\N	11-172	\N	KIT-17	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2940	93-13951 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1094	\N	\N	None	\N	MD-217	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2920	89-10450-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1095	\N	\N	None	\N	MD-218	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2638	20-81257B	90	t	\N	2	T3b	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29789,29790,29791,29792,29793,29794,29795,29796	172.6	\N	\N	Sections show fibrosing granulation tissue stemming from previous biopsy/surgery within a backdrop of marked solar elastosis. There is a residual array of atypical melanocytes, distributed in the lowermost epidermis and in the underlying dermis.	Oriented ellipse measuring 4.8 x 1.3 x 0.5 cm, including a central 3.9 x 1.3 cm area of variegated color/texture. The orienting short suture located at the mid-point of one edge is indicated 12 o'clock on the requisition and is placed toward 12 o'clock, and the long suture indicated 3 o'clock is placed toward the 3 o'clock. The grosser inked 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with six sections each in A-C. CF/CF	LEFT ARM WIDE EXCISION FOR MELANOMA	\N	\N	\N	Invasive and in situ melanoma extensively involve the blue inked and yellow inked peripheral margins.  As per the gross description, this would correspond to variable positivity along the approximate 11-3 o'clock and 3-7 o'clock peripheral margins. Coupling the findings in the original biopsy with the features in this re-excision specimen, the final parameters for reporting per the guidelines of the College of American Pathologists for this melanoma include the following:  Procedure: excision Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 2.5 mm. Ulceration: present Margins, peripheral: involved by invasive and melanoma in situ (see above); Margins, deep: negative for in situ and invasive melanoma Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3b pNX	RESIDUAL MELANOMA, BRESLOW THICKNESS 1.9 MM; INVASIVE AND IN SITU MELANOMA IN SITU EXTENDS TO THE INKED PERIPHERAL MARGINS; DEEP MARGINS FREE OF MELANOMA.  SEE NOTE.	173601	800	\N	\N	20-81257	B	LMM-01	Lentigo Maligna Melanoma	IP1127057	AirTable blocks_with_IP_info.csv
2675	21-7055B1	87	t	\N	7	T3b	Primary	lentigo maligna melanoma with nodular invasion Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29797,29798,29799,29800,29801,29802,29803,29804,29805,29806,29807,29808,29809,29810,29811	172.4	\N	\N	\N	Oriented oval excision measuring 8.5 x 4.8 x 1.4 cm, including a central 1.6 x 1.4 cm depressed area and a peripheral 5.0 x 4.5 cm pink-brown area. The orienting single staple at one pole is indicated 12:00 on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with a total of fifteen representative sections with one in B1, two each (bisected in halves) in B2-B14, and one (bisected) in B15. HD/CF	A) LEFT NECK NON-SENTINEL LYMPH NODES, B) POSTERIOR SCALP LESION, C) LEFT NECK SENTINEL LYMPH NODE #1, A-C) MELANOMA OF SCALP	\N	\N	\N	Dr. George, this case has been extensively discussed with Dr. Saylor of Dermatology. Dr. Saylor, as I discussed with you, upon re-review of prior specimen 20-110140-A, I believe focal melanoma in situ is apparent, and extensive in situ melanoma is also apparent in this new tissue. In short, it becomes fully clear that this tumor represents primary melanoma and not a metastasis. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma with nodular invasion Final Breslow thickness: 3.7 mm Ulceration: present Peripheral margin: narrow (2 mm) in the 12-3 o'clock quadrant Deep margin: centrally narrow (2 mm or so) Mitotic index: 7 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT3bN0Mx	RESIDUAL MELANOMA OF 3.7 MM IN THICKNESS	173439	801	\N	\N	21-7055	B1	LMM-02	Lentigo Maligna Melanoma	IP554241	AirTable blocks_with_IP_info.csv
2677	21-7055B6	87	t	\N	7	T3b	Primary	lentigo maligna melanoma with nodular invasion Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29797,29798,29799,29800,29801,29802,29803,29804,29805,29806,29807,29808,29809,29810,29811	172.4	\N	\N	\N	Oriented oval excision measuring 8.5 x 4.8 x 1.4 cm, including a central 1.6 x 1.4 cm depressed area and a peripheral 5.0 x 4.5 cm pink-brown area. The orienting single staple at one pole is indicated 12:00 on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with a total of fifteen representative sections with one in B1, two each (bisected in halves) in B2-B14, and one (bisected) in B15. HD/CF	A) LEFT NECK NON-SENTINEL LYMPH NODES, B) POSTERIOR SCALP LESION, C) LEFT NECK SENTINEL LYMPH NODE #1, A-C) MELANOMA OF SCALP	\N	\N	\N	Dr. George, this case has been extensively discussed with Dr. Saylor of Dermatology. Dr. Saylor, as I discussed with you, upon re-review of prior specimen 20-110140-A, I believe focal melanoma in situ is apparent, and extensive in situ melanoma is also apparent in this new tissue. In short, it becomes fully clear that this tumor represents primary melanoma and not a metastasis. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma with nodular invasion Final Breslow thickness: 3.7 mm Ulceration: present Peripheral margin: narrow (2 mm) in the 12-3 o'clock quadrant Deep margin: centrally narrow (2 mm or so) Mitotic index: 7 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT3bN0Mx	RESIDUAL MELANOMA OF 3.7 MM IN THICKNESS	173439	801	\N	\N	21-7055	B6	LMM-02	Lentigo Maligna Melanoma	IP554241	AirTable blocks_with_IP_info.csv
2773	22-7578	74	f	\N	2	T1b	Primary	high cumulative sun damaged skin	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with a few small nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei. There are nests of similar melanocytes in the dermis.	Skin segment measuring 1.8 x 1.2 x 0.2 cm, serially sectioned and entirely submitted with five sections. KB/KB	MELANOMA VS. SK	\N	\N	\N	Procedure: shave biopsy Microscopic tumor type: high cumulative sun damaged skin Breslow thickness: 0.9 mm Ulceration: absent Margin: peripheral and deep edges of the specimen involved by melanoma in situ (deep edge via adnexal extension), edges are uninvolved by invasive melanoma Mitotic index: 2/mm2 Vascular invasion: absent Regression: absent Pathologic staging (pTNM): pT1b	MELANOMA, 0.9 MM IN THICKNESS	173410	816	\N	\N	22-7578	\N	LMM-17	Lentigo Maligna Melanoma	IP150179	AirTable blocks_with_IP_info.csv
2331	18-83370B	55	\N	\N	0	T2a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with a few large nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are rounded nests of similar melanocytes in the superficial and mid- dermis.	Oriented ellipse, 2.0 x 0.8 x 0.5 cm, including a central 1.0 x 0.6 cm brown patch. The orienting sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with four sections each in A-B. BY/BY	A) IRREGULAR TAN, GREYISH BROWN AND PINK CM PATCH WITH SUPERIOR MORE SEBORRHEIC KERATOSIS LIKE WAXY TAN PAPULE WITH HORN CYSTS. POSSIBLE COLLISION TUMOR CONSTITUTED BY SEBORRHEIC KERATOSIS AND MALIGNANT MELANOMA. PATIENT WITH STRONG FAMILY HISTORY OF MALIGNANT MELANOMA, INCLUDING YOUNG ONSET STAGE III MELANOMA IN HIS MOTHER; MALIGNANT MELANOMA SUTURE TAGGED 12 O'CLOCK, SUPERIOR ASPECT.	\N	\N	FFPE	Areas of melanoma in situ either extend to the margins, or to within less than 1 mm. of the margins flanking the biopsy site. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.3 mm. Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.3 MM. IN THICKNESS	172438	809	\N	\N	18-83370	B	LMM-10	Lentigo Maligna Melanoma	IP1469433	AirTable blocks_with_IP_info.csv
3477	KR_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1604	\N	\N	None	\N	SYNAT475	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
2676	21-7055B4	87	t	\N	7	T3b	Primary	lentigo maligna melanoma with nodular invasion Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29797,29798,29799,29800,29801,29802,29803,29804,29805,29806,29807,29808,29809,29810,29811	172.4	\N	\N	\N	Oriented oval excision measuring 8.5 x 4.8 x 1.4 cm, including a central 1.6 x 1.4 cm depressed area and a peripheral 5.0 x 4.5 cm pink-brown area. The orienting single staple at one pole is indicated 12:00 on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with a total of fifteen representative sections with one in B1, two each (bisected in halves) in B2-B14, and one (bisected) in B15. HD/CF	A) LEFT NECK NON-SENTINEL LYMPH NODES, B) POSTERIOR SCALP LESION, C) LEFT NECK SENTINEL LYMPH NODE #1, A-C) MELANOMA OF SCALP	\N	\N	\N	Dr. George, this case has been extensively discussed with Dr. Saylor of Dermatology. Dr. Saylor, as I discussed with you, upon re-review of prior specimen 20-110140-A, I believe focal melanoma in situ is apparent, and extensive in situ melanoma is also apparent in this new tissue. In short, it becomes fully clear that this tumor represents primary melanoma and not a metastasis. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma with nodular invasion Final Breslow thickness: 3.7 mm Ulceration: present Peripheral margin: narrow (2 mm) in the 12-3 o'clock quadrant Deep margin: centrally narrow (2 mm or so) Mitotic index: 7 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT3bN0Mx	RESIDUAL MELANOMA OF 3.7 MM IN THICKNESS	173439	801	\N	\N	21-7055	B4	LMM-02	Lentigo Maligna Melanoma	IP554241	AirTable blocks_with_IP_info.csv
2662	21-457B	75	\N	\N	1	T1a	Primary	lentigo maligna melanoma Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28275,28276,28277,28278,28279,28280,30985	172.6	\N	\N	Sections show post-procedural fibrosing inflammatory alterations coupled with a broad and confluent population of atypical melanocytes, some of which are fusiform. A lymphohistiocytic infiltrate is noted in the perijunctional zone. The background epidermis is thinned or muted. Old fibrosis is also noted.	Oriented oval, 4.2 x 3.1 x 0.9 cm, including a central 1.9 x 1.3 cm variegated brown area. The orienting yellow-green pole is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The submitting office pre-inked the 9-12 o'clock margin red, the 12-3 o'clock margin red, the 3-6 o'clock margin blue, and the 6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with two sections each in A-E and one section in F. 3 o'clock pole reserved. BY/BY	MALIGNANT MELANOMA. PLEASE CHECK MARGINS.	\N	\N	\N	Upon wider excision, it becomes clear that this melanoma is of the lentigo maligna subtype. There is old scar in part of the dermis, and thus a preceding biopsy from some time ago may have been obtained. The final margin is free but is extremely narrow (1 mm or so) in the 3-6 and 6-9 o'clock quadrants. An updated brief synoptic is included below.  Procedure: wide excision Microscopic tumor type: lentigo maligna melanoma Final Breslow thickness: 0.6 mm Ulceration: not detected Peripheral margin: narrow in 3-6 and 6-9 o'clock quadrants Deep margin: widely free Mitotic index: 1 per square mm Regression: not significant Vascular invasion: not detected Perineural invasion: not detected Pathologic staging (pTNM): pT1a	RESIDUAL MELANOMA OF 0.6 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE BUT IS FOCALLY NARROW)	173611	802	\N	\N	21-457	B	LMM-03	Lentigo Maligna Melanoma	IP2011798	AirTable blocks_with_IP_info.csv
2663	21-457C	75	\N	\N	1	T1a	Primary	lentigo maligna melanoma Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28275,28276,28277,28278,28279,28280,30985	172.6	\N	\N	Sections show post-procedural fibrosing inflammatory alterations coupled with a broad and confluent population of atypical melanocytes, some of which are fusiform. A lymphohistiocytic infiltrate is noted in the perijunctional zone. The background epidermis is thinned or muted. Old fibrosis is also noted.	Oriented oval, 4.2 x 3.1 x 0.9 cm, including a central 1.9 x 1.3 cm variegated brown area. The orienting yellow-green pole is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The submitting office pre-inked the 9-12 o'clock margin red, the 12-3 o'clock margin red, the 3-6 o'clock margin blue, and the 6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with two sections each in A-E and one section in F. 3 o'clock pole reserved. BY/BY	MALIGNANT MELANOMA. PLEASE CHECK MARGINS.	\N	\N	\N	Upon wider excision, it becomes clear that this melanoma is of the lentigo maligna subtype. There is old scar in part of the dermis, and thus a preceding biopsy from some time ago may have been obtained. The final margin is free but is extremely narrow (1 mm or so) in the 3-6 and 6-9 o'clock quadrants. An updated brief synoptic is included below.  Procedure: wide excision Microscopic tumor type: lentigo maligna melanoma Final Breslow thickness: 0.6 mm Ulceration: not detected Peripheral margin: narrow in 3-6 and 6-9 o'clock quadrants Deep margin: widely free Mitotic index: 1 per square mm Regression: not significant Vascular invasion: not detected Perineural invasion: not detected Pathologic staging (pTNM): pT1a	RESIDUAL MELANOMA OF 0.6 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE BUT IS FOCALLY NARROW)	173611	802	\N	\N	21-457	C	LMM-03	Lentigo Maligna Melanoma	IP2011798	AirTable blocks_with_IP_info.csv
2715	21-35943A	75	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show granulation tissue and inflammation, with no evidence of an atypical melanocytic proliferation.	Ellipse measuring 5.7 x 1.1 x 0.6 cm, including a central 4.1 x 0.3 cm scar. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in A-B. Tips reserved. BB/BB	A) MALIGNANT MELANOMA. PLEASE CHECK MARGINS. RE-EXCISION FROM 1/4/21, DT21-457	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA IN SITU	173611	802	\N	\N	21-35943	A	LMM-03	Lentigo Maligna Melanoma	IP2011798	AirTable blocks_with_IP_info.csv
2729	21-79845	84	\N	\N	7	T3b	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a proliferation of cells with atypical nuclei and ample cytoplasm arrayed in nodular fashion below a crusted ulceration. There is poor maturation with an uptick in the mitotic index. To the side, there is superficial compound involvement by smaller melanocytes with pagetoid scatter, adnexal extension, and a lymphohistiocytic infiltrate with admixed melanophages.	Skin segment measuring 2.1 x 1.7 x 0.7 cm. Three sections submitted. BY/BY	ULCERATED 2 CM IRREGULAR NODULE / PLAQUE; CANCER FORM  (TELEPHONE: 415-391-7597, MSG OK)	\N	\N	\N	This tissue contain a significantly invasive melanoma with prominent associated adnexal extension. A brief synoptic is included below. Procedure: narrow excision Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 2.7 mm Ulceration: prominent Margin: narrow Mitotic index: 7 per square mm Vascular invasion: not detected Microsatellitosis: not detected Perineural invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT3b	MELANOMA OF 2.7 MM IN THICKNESS	173619	814	\N	\N	21-79845	\N	LMM-15	Lentigo Maligna Melanoma	IP49555	AirTable blocks_with_IP_info.csv
2777	22-15594-4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	816	\N	\N	None	\N	LMM-17	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
2700	21-21304A10	88	\N	\N	2	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29812,29813,29814,29815,29816,29817,29818,29819,29820,29821,29822,30986,30987	172.3	\N	\N	Sections show post-procedural fibrosing inflammatory alterations coupled with a broad compound residuum with focal epidermal effacement, deep multifocal adnexal involvement, and a patchy perijunctional lymphohistiocytic infiltrate.	Oriented oval, 4.3 x 3.1 x 0.8 cm, including a central 2.4 x 1.1 cm raised area of variegated color. The orienting single stapled pole is indicated as 12 o'clock on the requisition and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirey submitted with three sections in A1, one section each in A2-A9, and two sections each in A10-A11. BB/BB	A) RIGHT CHEEK LESION - PERMANENT, B) SENTINEL TISSUE - PERMANENT	\N	\N	\N	A broad residuum of lentigo maligna melanoma is apparent in this reexcision specimen, and the final inked margin is involved by melanoma in situ between 1-5 o'clock and again between 7-11 o'clock. The deep margin is free. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.7 mm Ulceration: not detected Peripheral margin: involved Deep margin: free Mitotic index: 2 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: not significant Pathologic staging (pTNM): pT2aN0Mx	EXTENSIVE RESIDUAL MELANOMA OF 1.7 MM IN THICKNESS, PROMINENTLY INVOLVING THE INKED PERIPHERAL SURGICAL MARGIN	173305	803	\N	\N	21-21304	A10	LMM-04	Lentigo Maligna Melanoma	IP2283785	AirTable blocks_with_IP_info.csv
2699	21-21304A1	88	\N	\N	2	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29812,29813,29814,29815,29816,29817,29818,29819,29820,29821,29822,30986,30987	172.3	\N	\N	Sections show post-procedural fibrosing inflammatory alterations coupled with a broad compound residuum with focal epidermal effacement, deep multifocal adnexal involvement, and a patchy perijunctional lymphohistiocytic infiltrate.	Oriented oval, 4.3 x 3.1 x 0.8 cm, including a central 2.4 x 1.1 cm raised area of variegated color. The orienting single stapled pole is indicated as 12 o'clock on the requisition and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirey submitted with three sections in A1, one section each in A2-A9, and two sections each in A10-A11. BB/BB	A) RIGHT CHEEK LESION - PERMANENT, B) SENTINEL TISSUE - PERMANENT	\N	\N	\N	A broad residuum of lentigo maligna melanoma is apparent in this reexcision specimen, and the final inked margin is involved by melanoma in situ between 1-5 o'clock and again between 7-11 o'clock. The deep margin is free. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.7 mm Ulceration: not detected Peripheral margin: involved Deep margin: free Mitotic index: 2 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: not significant Pathologic staging (pTNM): pT2aN0Mx	EXTENSIVE RESIDUAL MELANOMA OF 1.7 MM IN THICKNESS, PROMINENTLY INVOLVING THE INKED PERIPHERAL SURGICAL MARGIN	173305	803	\N	\N	21-21304	A1	LMM-04	Lentigo Maligna Melanoma	IP2283785	AirTable blocks_with_IP_info.csv
2711	21-25546B2	88	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show central fibrosing granulation tissue and early scar coupled with a lymphohistiocytic infiltrate, and no evidence of an atypical melanocytic proliferation remains in contiguity with this.	Oriented oval measuring 4.2 x 0.5 x 0.6 cm. The orienting pre-inked blue edge is indicated true margin on the requisition and is placed toward 12-3-6 o'clock. The submitting clinician pre-inked the 12-3-6 o'clock margin blue and the grosser inked 6-9-12 o'clock edge yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with seven sections each in B1-B2 and six sections in B3. BY/BY	A) RIGHT CHEEK LESION, SUPERIOR MEDIAL MARGIN, TRUE MARGIN IS INKED (PERMANENT), B) RIGHT CHEEK LESION, INFERIOR MEDIAL MARGIN, TRUE MARGIN IS INKED (PERMANENT), C) RIGHT CHEEK LESION, INFERIOR LATERAL MARGIN, TRUE MARGIN IS INKED (PERMANENT), D) RIGHT CHEEK LESION, SUPERIOR LATERAL MARGIN, TRUE MARGIN IS INKED (PERMANENT)	\N	\N	\N	\N	POST-BIOPSY SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173305	803	\N	\N	21-25546	B2	LMM-04	Lentigo Maligna Melanoma	IP2283785	AirTable blocks_with_IP_info.csv
2828	22-91699A7	94	t	\N	2	T4b	Primary	high-CSD melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28283,28284,28285,28286,28287,28288,28289	172.6	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone. Centrally, the epidermis is effaced above a nodular proliferation of atypical melanocytes. The dermis displays marked solar elastosis.	Oriented ellipse, 5.7 x 2.4 x 1.1 cm, including a central 1.2 x 1.2 cm raised area. The orienting short sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with two sections in A1, one section each in A2-A5, and two sections in A6. Subsequently, the 12 o'clock tip is serially sectioned and four sections, adjacent to those in block A1, are submitted in A7. Tips reserved. KB/KB	A) LEFT ARM WIDE EXCISION MELANOMA - PERMANENT, B) LEFT UPPER ARM SKIN LESION - PERMANENT, C) LEFT ARM WIDE EXCISION; R/O SQUAMOUS CELL CARCINOMA - PERMANENT	\N	\N	\N	In this excisional biopsy, there is a component of lentiginous melanoma in situ. Procedure: excision Microscopic tumor type: high-CSD melanoma Breslow thickness: 4.9 mm Ulceration: present Margins, peripheral and deep: free Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4b	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA OF 4.9 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	173601	804	\N	\N	22-91699	A7	LMM-05	Lentigo Maligna Melanoma	IP1692985	AirTable blocks_with_IP_info.csv
2810	22-76519A	85	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show irregular epidermal hyperplasia with inflamed granulation tissue, but no evidence of an atypical melanocytic proliferation.	Excision measuring 1.8 x 1.2 x 0.4 cm. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections in A. KB/KB	A) BX PROVEN MIS, THIS IS A DEBULKING SPECIMEN, PERIPHERAL MARGINS TO BE CLEARED WITH MOHS; PLEASE R/O INVASIVE COMPONENT, B) HEMORRHAGIC CRUSTED PAPULE X SEVERAL MONTHS (0.8 X 0.8 CM); SCC VS. ISK VS. MELANOMA VS. PYOGENIC GRANULOMA	\N	\N	\N	Biopsy site changes extend to the edge of this Mohs debulk specimen.	HEALING BIOPSY SITE, WITH NO EVIDENCE OF INVASIVE MELANOMA	173416	814	\N	\N	22-76519	A	LMM-15	Lentigo Maligna Melanoma	IP49555	AirTable blocks_with_IP_info.csv
2837	22-102807-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	815	\N	\N	None	\N	LMM-16	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
2838	22-102807-4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	815	\N	\N	None	\N	LMM-16	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
2919	89-10432A M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	957	\N	\N	None	\N	MD-51	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2827	22-91699A4	94	t	\N	2	T4b	Primary	high-CSD melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28283,28284,28285,28286,28287,28288,28289	172.6	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone. Centrally, the epidermis is effaced above a nodular proliferation of atypical melanocytes. The dermis displays marked solar elastosis.	Oriented ellipse, 5.7 x 2.4 x 1.1 cm, including a central 1.2 x 1.2 cm raised area. The orienting short sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with two sections in A1, one section each in A2-A5, and two sections in A6. Subsequently, the 12 o'clock tip is serially sectioned and four sections, adjacent to those in block A1, are submitted in A7. Tips reserved. KB/KB	A) LEFT ARM WIDE EXCISION MELANOMA - PERMANENT, B) LEFT UPPER ARM SKIN LESION - PERMANENT, C) LEFT ARM WIDE EXCISION; R/O SQUAMOUS CELL CARCINOMA - PERMANENT	\N	\N	\N	In this excisional biopsy, there is a component of lentiginous melanoma in situ. Procedure: excision Microscopic tumor type: high-CSD melanoma Breslow thickness: 4.9 mm Ulceration: present Margins, peripheral and deep: free Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4b	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA OF 4.9 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	173601	804	\N	\N	22-91699	A4	LMM-05	Lentigo Maligna Melanoma	IP1692985	AirTable blocks_with_IP_info.csv
2826	22-91699A1	94	t	\N	2	T4b	Primary	high-CSD melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28283,28284,28285,28286,28287,28288,28289	172.6	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone. Centrally, the epidermis is effaced above a nodular proliferation of atypical melanocytes. The dermis displays marked solar elastosis.	Oriented ellipse, 5.7 x 2.4 x 1.1 cm, including a central 1.2 x 1.2 cm raised area. The orienting short sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with two sections in A1, one section each in A2-A5, and two sections in A6. Subsequently, the 12 o'clock tip is serially sectioned and four sections, adjacent to those in block A1, are submitted in A7. Tips reserved. KB/KB	A) LEFT ARM WIDE EXCISION MELANOMA - PERMANENT, B) LEFT UPPER ARM SKIN LESION - PERMANENT, C) LEFT ARM WIDE EXCISION; R/O SQUAMOUS CELL CARCINOMA - PERMANENT	\N	\N	\N	In this excisional biopsy, there is a component of lentiginous melanoma in situ. Procedure: excision Microscopic tumor type: high-CSD melanoma Breslow thickness: 4.9 mm Ulceration: present Margins, peripheral and deep: free Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4b	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA OF 4.9 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	173601	804	\N	\N	22-91699	A1	LMM-05	Lentigo Maligna Melanoma	IP1692985	AirTable blocks_with_IP_info.csv
2899	23-37003	73	\N	\N	2	T2a	Primary	high cumulative sun-damage melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31834,31835,31836,31837,31838,31839,31840	172.3	\N	 (prior bx T23-31171)	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and as nests in the dermis. The dermal melanocytes do not show significant maturation and mitotic figures are present.	Oriented ellipse, 2.1 x 1.1 x 0.3 cm, including a central 1.0 x 0.9 cm white-tan area. The orienting notch is located at the midpoint of one edge. This notch is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with four sections each in 1-2. KB/KB	MM EXCISION, REFER TO SLIDE, #DT23-31171	\N	\N	\N	There is a residuum of invasive melanoma, which when measured away from adnexal structures has a Breslow depth greater than observed in the prior biopsy. A brief synoptic is included below.  Procedure: excision Microscopic tumor type: high cumulative sun-damage melanoma Breslow thickness: 1.3 mm Ulceration: not detected Margin: melanoma in situ extends to within 1 mm of both peripheral margins in the central portions of the ellipse Mitotic index: 2 per square mm Regression: not detected Pathologic staging (pTNM): pT2a	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, 1.3 mm IN THICKNESS	321300	805	\N	\N	23-37003	\N	LMM-06	Lentigo Maligna Melanoma	IP2569388	AirTable blocks_with_IP_info.csv
2761	21-135927	60	f	\N	\N	T1a	Primary	low cumulative sun-damaged skin (WHO)	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a proliferation of nested and solitary melanocytes, some of which have atypical nuclei, irregularly distributed above elastosis.  Clusters of similar melanocytes are present in the dermis.	Skin segment measuring 1.2 x 1.0 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	EVOLVING 8 CM IRREGULAR PAPULE RETICULAR & ERYTHEMATOUS PAPULE; R/O ATYPIA, HISTORY OF MM (TELEPHONE: 415-867-0936, MSG OK)	\N	\N	\N	Procedure: shave biopsy Microscopic tumor type: low cumulative sun-damaged skin (WHO) Breslow thickness: 0.6 mm Ulceration: absent Margins, peripheral and deep: melanoma in situ within 1 mm of the peripheral tissue edge; deep tissue edge free Mitotic index (per square millimeter): 0 Vascular invasion: not identified Regression: not identified Pathologic staging (pTNM): pT1a	INVASIVE MELANOMA, BRESLOW THICKNESS 0.6 mm, NON-ULCERATED	187724	806	\N	\N	21-135927	\N	LMM-07	Lentigo Maligna Melanoma	IP2399198	AirTable blocks_with_IP_info.csv
2788	22-29280	60	f	\N	\N	T1a	Primary	low cumulative sun-damaged skin (WHO)	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show central iatrogenic fibrosing inflammatory alterations stemming from a procedure, and no evidence of an atypical melanocytic proliferation remains in contiguity with this.	Ellipse, 7.9 x 2.4 x 0.8 cm, including a central 1.0 x 0.8 cm pink area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in 1-4. Tips reserved. BY/BY	0.9 X 1.0 MACULE PREVIOUSLY BIOPSIED & CONSISTENT WITH MELANOMA, 0.6 MM BRESLOW, HER FOR EXCISION, PLEASE CHECK MARGINS (TELEPHONE: 415-867-0936)	\N	\N	\N	Final synoptic melanoma reporting, including information derived from the earlier specimen from this site, is included below. Procedure: excision Microscopic tumor type: low cumulative sun-damaged skin (WHO) Breslow thickness: 0.6 mm Ulceration: absent Margins, peripheral and deep: negative for melanoma Mitotic index (per square millimeter): 0 Vascular invasion: not identified Regression: not identified Pathologic staging (pTNM): pT1a pNX	POST-BIOPSY SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173532	806	\N	\N	22-29280	\N	LMM-07	Lentigo Maligna Melanoma	IP2399198	AirTable blocks_with_IP_info.csv
2915	85-01186	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	958	\N	\N	85-1186	\N	MD-52	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2954	95-01141-1 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	959	\N	\N	None	\N	MD-53	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2653	20-102366B1	95	\N	\N	\N	T4a	Primary	high cumulative sun damage	\N	\N	FFPE	\N	\N	172.4	\N	\N	Sections show a proliferation of nested and solitary melanocytes, which have atypical enlarged nuclei with conspicuous nucleoli, irregularly distributed above elastosis with melanin pigmentation.  Sheets of similar melanocytes efface the underlying dermis.	Two oval excisions received in vial. One measures 2.5 x 1.6 x 0.4 cm, including a central 1.4 x 1.0 cm raised area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections each in B1-B2. The other measures 1.3 x 0.8 x 0.2 cm. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections in B3. BY/CF	A-B) SKIN CANCER	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Tumor site: right frontal scalp Microscopic tumor type: high cumulative sun damage Breslow thickness: at least 4.7 mm Ulceration: not identified Margins, peripheral and deep: invasive melanoma present peripheral and deep tissue edge; melanoma in situ extends to the peripheral tissue edge Mitotic index (per square millimeter): 17 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4a pNX	INVASIVE MELANOMA, BRESLOW THICKNESS AT LEAST 4.7 mm, NON-ULCERATED; INVASIVE MELANOMA PRESENT AT DEEP AND PERIPHERAL TISSUE EDGES	146466	807	\N	\N	20-102366	B1	LMM-08	Lentigo Maligna Melanoma	IP115267	AirTable blocks_with_IP_info.csv
2654	20-102366B2	95	\N	\N	\N	T4a	Primary	high cumulative sun damage	\N	\N	FFPE	\N	\N	172.4	\N	\N	Sections show a proliferation of nested and solitary melanocytes, which have atypical enlarged nuclei with conspicuous nucleoli, irregularly distributed above elastosis with melanin pigmentation.  Sheets of similar melanocytes efface the underlying dermis.	Two oval excisions received in vial. One measures 2.5 x 1.6 x 0.4 cm, including a central 1.4 x 1.0 cm raised area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections each in B1-B2. The other measures 1.3 x 0.8 x 0.2 cm. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections in B3. BY/CF	A-B) SKIN CANCER	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Tumor site: right frontal scalp Microscopic tumor type: high cumulative sun damage Breslow thickness: at least 4.7 mm Ulceration: not identified Margins, peripheral and deep: invasive melanoma present peripheral and deep tissue edge; melanoma in situ extends to the peripheral tissue edge Mitotic index (per square millimeter): 17 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4a pNX	INVASIVE MELANOMA, BRESLOW THICKNESS AT LEAST 4.7 mm, NON-ULCERATED; INVASIVE MELANOMA PRESENT AT DEEP AND PERIPHERAL TISSUE EDGES	146466	807	\N	\N	20-102366	B2	LMM-08	Lentigo Maligna Melanoma	IP115267	AirTable blocks_with_IP_info.csv
2172	17-77365	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	807	\N	\N	17-77365	\N	LMM-08	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
2584	20-11796D	90	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.3	\N	\N	Sections show a zone of fibrosing granulation tissue, representing a prior biopsy site, with a subtle proliferation composed mostly of enlarged single melanocytes in irregular array along the epidermal-dermal junction in a narrowly based but poorly circumscribed area. There is a dense infiltrate of neutrophils in a cavity in the dermis.	Elliptical excision, 6.1 x 1.3 x 0.4 cm, including a central 5.3 x 0.3 cm scar. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections in A and six each in B-D. CF/CF	A) MELANOMA IN SITU. . PLEASE CHECK MARGINS..(PHOTO)	\N	\N	FFPE	None	HEALING BIOPSY SITE, WITH SUBTLE RESIDUAL MELANOMA IN SITU, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173304	808	\N	\N	20-11796	D	LMM-09	Lentigo Maligna Melanoma	IP2097439	AirTable blocks_with_IP_info.csv
2575	20-6751	90	\N	\N	4	T2a	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	0	FFPE	\N	\N	172.3	\N	\N	Sections show a broad and poorly circumscribed proliferation melanocytes, with a peripheral portion composed of mostly solitary melanocytes, with a few small nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are progressively larger and more confluent junctional nests toward the center of the lesion. There are large nests of similar melanocytes in the dermis, with mitotic figures among their cells, and little maturation and dispersion with descent.	Oriented ellipse, 4.8 x 1.1 x 0.2 cm, including a central 0.7 x 0.6 cm crusted area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with eight sections. Tips reserved. BY/BY	A) MALIGNANT MELANOMA IN SITU. . PLEASE CHECK MARGINS (PHOTO)	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 1.4 mm. Ulceration: no Margins, peripheral: involved, and deep: clear by < 1 mm. Mitotic index: 4/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.4 MM. IN THICKNESS	173304	808	\N	\N	20-6751	\N	LMM-09	Lentigo Maligna Melanoma	IP2097439	AirTable blocks_with_IP_info.csv
2330	18-83370A	55	\N	\N	0	T2a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with a few large nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are rounded nests of similar melanocytes in the superficial and mid- dermis.	Oriented ellipse, 2.0 x 0.8 x 0.5 cm, including a central 1.0 x 0.6 cm brown patch. The orienting sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with four sections each in A-B. BY/BY	A) IRREGULAR TAN, GREYISH BROWN AND PINK CM PATCH WITH SUPERIOR MORE SEBORRHEIC KERATOSIS LIKE WAXY TAN PAPULE WITH HORN CYSTS. POSSIBLE COLLISION TUMOR CONSTITUTED BY SEBORRHEIC KERATOSIS AND MALIGNANT MELANOMA. PATIENT WITH STRONG FAMILY HISTORY OF MALIGNANT MELANOMA, INCLUDING YOUNG ONSET STAGE III MELANOMA IN HIS MOTHER; MALIGNANT MELANOMA SUTURE TAGGED 12 O'CLOCK, SUPERIOR ASPECT.	\N	\N	FFPE	Areas of melanoma in situ either extend to the margins, or to within less than 1 mm. of the margins flanking the biopsy site. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.3 mm. Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.3 MM. IN THICKNESS	172438	809	\N	\N	18-83370	A	LMM-10	Lentigo Maligna Melanoma	IP1469433	AirTable blocks_with_IP_info.csv
2455	19-75051	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	809	\N	\N	19-75051	\N	LMM-10	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
2956	95-05724-1 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	960	\N	\N	None	\N	MD-54	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2970	96-06832D M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	961	\N	\N	None	\N	MD-55	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2276	18-12160E	76	\N	\N	10	T4a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of solitary melanocytes, with small but variably confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some intraepidermal melanocytes have atypical nuclei. There are very large masses of melanocytes with a greater degree of nuclear pleomorphism in the dermis and subcutis, with a high mitotic rate and a lack of maturation and dispersion with descent.	Oriented ellipse, 4.9 x 2.3 x 0.9 cm, including a central 3.0 x 2.2 cm variegated black-blue area. With the orienting sutured tip placed to the left and designated 12 o'clock by the grosser, the 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with four sections in A and two sections each in B-F. Tips reserved. HD/PL	PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SEBORRHEIC KERATOSIS, SEVERAL MONTH H/O GROWING BLACK/BLUE IRREGULAR 2.7 X 2.0 CM PLAQUE, SUBMITTED NOW AS EXCISIONAL BIOPSY, R/O MELANOMA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 6.8 mm. Ulceration: no Margins, peripheral: clear by < 1 mm., and deep: clear by 2 mm. Mitotic index: 10/mm2 Microsatellitosis: present Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX  A very large microsatellite is present and included in the thickness measurement.	MELANOMA, 6.8 MM. IN THICKNESS	173410	810	\N	\N	18-12160	E	LMM-11	Lentigo Maligna Melanoma	IP1875716	AirTable blocks_with_IP_info.csv
2277	18-12160F	76	\N	\N	10	T4a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of solitary melanocytes, with small but variably confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some intraepidermal melanocytes have atypical nuclei. There are very large masses of melanocytes with a greater degree of nuclear pleomorphism in the dermis and subcutis, with a high mitotic rate and a lack of maturation and dispersion with descent.	Oriented ellipse, 4.9 x 2.3 x 0.9 cm, including a central 3.0 x 2.2 cm variegated black-blue area. With the orienting sutured tip placed to the left and designated 12 o'clock by the grosser, the 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with four sections in A and two sections each in B-F. Tips reserved. HD/PL	PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SEBORRHEIC KERATOSIS, SEVERAL MONTH H/O GROWING BLACK/BLUE IRREGULAR 2.7 X 2.0 CM PLAQUE, SUBMITTED NOW AS EXCISIONAL BIOPSY, R/O MELANOMA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 6.8 mm. Ulceration: no Margins, peripheral: clear by < 1 mm., and deep: clear by 2 mm. Mitotic index: 10/mm2 Microsatellitosis: present Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX  A very large microsatellite is present and included in the thickness measurement.	MELANOMA, 6.8 MM. IN THICKNESS	173410	810	\N	\N	18-12160	F	LMM-11	Lentigo Maligna Melanoma	IP1875716	AirTable blocks_with_IP_info.csv
2275	18-12160D	76	\N	\N	10	T4a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of solitary melanocytes, with small but variably confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some intraepidermal melanocytes have atypical nuclei. There are very large masses of melanocytes with a greater degree of nuclear pleomorphism in the dermis and subcutis, with a high mitotic rate and a lack of maturation and dispersion with descent.	Oriented ellipse, 4.9 x 2.3 x 0.9 cm, including a central 3.0 x 2.2 cm variegated black-blue area. With the orienting sutured tip placed to the left and designated 12 o'clock by the grosser, the 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with four sections in A and two sections each in B-F. Tips reserved. HD/PL	PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SEBORRHEIC KERATOSIS, SEVERAL MONTH H/O GROWING BLACK/BLUE IRREGULAR 2.7 X 2.0 CM PLAQUE, SUBMITTED NOW AS EXCISIONAL BIOPSY, R/O MELANOMA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 6.8 mm. Ulceration: no Margins, peripheral: clear by < 1 mm., and deep: clear by 2 mm. Mitotic index: 10/mm2 Microsatellitosis: present Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX  A very large microsatellite is present and included in the thickness measurement.	MELANOMA, 6.8 MM. IN THICKNESS	173410	810	\N	\N	18-12160	D	LMM-11	Lentigo Maligna Melanoma	IP1875716	AirTable blocks_with_IP_info.csv
2250	17-119445	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18169	216.7	\N	\N	Sections show acral skin with a proliferation of small melanocytes with round to oval nuclei, positioned singly and as small nests at the epidermal-dermal junction with accompanying epidermal pigmentation. There are papillary dermal melanophages and columns of pigment in the stratum corneum.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	NEW 2 - 3 MM PIGMENTED ACRAL NEVUS	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173788	826	\N	\N	17-119445	\N	LN-06	Lentiginous Nevi 	IP1849984	AirTable blocks_with_IP_info.csv
2926	91-16318 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	962	\N	\N	None	\N	MD-56	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1949	16-74494	89	f	\N	1	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermis contains aggregates of similar cells displacing solar elastosis.	Skin segment measuring 1.7 x 1.4 x 0.2 cm, serially sectioned and entirely submitted with six sections. RS/RS	NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED SEBORRHEIC KERATOSIS VS. MMIS	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: Procedure: shave biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.6 mm Ulceration: absent Margins, peripheral and deep: deep focally positive, peripheral positive Mitotic index: 1 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.6 MM IN THICKNESS, NON-ULCERATED	173710	817	\N	\N	16-74494	\N	LMM-18	Lentigo Maligna Melanoma	IP1674137	AirTable blocks_with_IP_info.csv
3485	KR_5233	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1605	\N	\N	None	\N	SYNAT476	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
3486	KR_RMK0091B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1606	\N	\N	None	\N	SYNAT477	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
2731	21-83029B	83	\N	2.5	1	T3a	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	0	FFPE	\N	\N	172.0	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with some confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are sheets of similar melanocytes in the dermis in several areas, without appropriate maturation and dispersion with descent.	Oval excision measuring 2.0 x 1.7 x 0.7 cm, including a central 0.8 x 0.8 cm white-gray area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in A-B. CF/KB	MELANOMA, PLEASE CHECK MARGINS	\N	\N	FFPE	ADDENDUM, August 17, 2021: Per our telephone discussion, I had not realized that this is a re-excision of a prior biopsy that showed a melanoma that was 2.5 mm in thickness. That thickness is significantly greater than the thickness seen in the residuum. I have revised the diagnosis above to reflect this, and amended the synoptic data below, after reviewing the previous report, and re-reviewing the slides.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: re-excision Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 2.5 mm Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	BIOPSY SITE AND RESIDUAL MELANOMA, SEE COMMENT RE THICKNESS	101038	811	\N	\N	21-83029	B	LMM-12	Lentigo Maligna Melanoma	IP1380659	AirTable blocks_with_IP_info.csv
2730	21-83029A	83	\N	2.5	1	T3a	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	0	FFPE	\N	\N	172.0	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with some confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are sheets of similar melanocytes in the dermis in several areas, without appropriate maturation and dispersion with descent.	Oval excision measuring 2.0 x 1.7 x 0.7 cm, including a central 0.8 x 0.8 cm white-gray area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in A-B. CF/KB	MELANOMA, PLEASE CHECK MARGINS	\N	\N	FFPE	ADDENDUM, August 17, 2021: Per our telephone discussion, I had not realized that this is a re-excision of a prior biopsy that showed a melanoma that was 2.5 mm in thickness. That thickness is significantly greater than the thickness seen in the residuum. I have revised the diagnosis above to reflect this, and amended the synoptic data below, after reviewing the previous report, and re-reviewing the slides.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: re-excision Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 2.5 mm Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	BIOPSY SITE AND RESIDUAL MELANOMA, SEE COMMENT RE THICKNESS	101038	811	\N	\N	21-83029	A	LMM-12	Lentigo Maligna Melanoma	IP1380659	AirTable blocks_with_IP_info.csv
2831	22-94741	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	811	\N	\N	22-94741	\N	LMM-12	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
2726	21-62764	64	f	\N	1	T1a	Primary	high cumulative sun damage (WHO)	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a proliferation of nested and solitary melanocytes, some of which have atypical nuclei, irregularly distributed above marked elastosis.  Clusters of similar melanocytes are present in the dermis amidst a variable lymphohistiocytic  inflammatory infiltrate.	Skin segment measuring 1.5 x 1.1 x 0.1 cm, serially sectioned, and entirely submitted with five sections. HD/HD	JUNCTIONAL NEVUS, 11 X 8 MM; R/O MM	\N	\N	\N	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: Tumor site: right proximal forearm Microscopic tumor type: high cumulative sun damage (WHO) Breslow thickness: 0.6 mm Ulceration: absent Margins, peripheral and deep: melanoma in situ extends close to the peripheral tissue edge; deep tissue edge free Mitotic index: 1 Microsatellitosis: not identified Vascular Invasion:  not identified Perineural invasion: not identified Regression: present, focal Pathologic Staging (pTNM): pT1a pNX	INVASIVE MELANOMA, BRESLOW THICKNESS 0.6 mm, NON-ULCERATED	113605	812	\N	\N	21-62764	\N	LMM-13	Lentigo Maligna Melanoma	IP2325554	AirTable blocks_with_IP_info.csv
2594	20-18383B2	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.62	\N	\N	Sections show ulceration. There are slight fibroplasia and a subtle lymphohistiocytic infiltrate below the ulcer. No contiguous residual carcinoma is noted.	Oriented ellipse, 1.3 x 1.0 x 0.2 cm, including a central 0.5 x 0.5 cm depressed area. The orienting sutured edge is indicated as 12 o'clock on the requisition form and placed toward 12 o'clock. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections in B1 and two sections in B2. HD/HD	A) R/O MM VS. SEB K, B) PROVEN INVASIVE SCC, WELL DIFF, CHECK MARGINS	\N	\N	\N	No residuum is apparent, and the final margin is now free.	ULCERATION, WITH NO EVIDENCE OF RESIDUAL SQUAMOUS CELL CARCINOMA	173614	813	\N	\N	20-18383	B2	LMM-14	Lentigo Maligna Melanoma	IP2165905	AirTable blocks_with_IP_info.csv
2593	20-18383A1	70	\N	\N	1	T1b	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show nested and solitary melanocytes with atypical nuclear features in irregular array along and above the epidermal-dermal junction. Similar melanocytes are present in irregular large nests in the underlying dermis. A lymphohistiocytic infiltrate with admixed melanophages is noted, and maturing melanocytes are focally noted as well.	Oriented ovoid, 2.3 x 1.7 x 0.7 cm, including a central 1.3 x 1.0 cm brown area. The orienting sutured pole is indicated as 12 o'clock on the requisition form and placed toward 12 o'clock. The 12-3-6 o'clock and 6-9-12 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with four sections each in A1-A2. HD/HD	A) R/O MM VS. SEB K, B) PROVEN INVASIVE SCC, WELL DIFF, CHECK MARGINS	\N	\N	\N	Incidental melanocytic nevus, actinic keratosis, and seborrheic keratosis are also noted in this tissue. A brief synoptic is included below. Procedure: narrow excision Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 0.8 mm Ulceration: not detected Margin: periphery involved, deep free Mitotic index: 1 per square millimeter Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): pT1b	MELANOMA OF 0.8 MM THICKNESS, WITH IN SITU MELANOMA ABUTTING THE INKED PERIPHERAL SURGICAL MARGIN	173404	813	\N	\N	20-18383	A1	LMM-14	Lentigo Maligna Melanoma	IP2165905	AirTable blocks_with_IP_info.csv
2979	96-18967-1 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	963	\N	\N	None	\N	MD-57	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
10731	DPN45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1890	\N	\N	\N	\N	SYNX487	\N	\N	Consolidated_data_final.csv
2173	17-81380B	90	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.62	\N	\N	Sections show a focus of fibrosing granulation tissue and an adjacent crateriform, exo-endophytic proliferation of keratinocytes, with a central mass of cornified cells. One part of the lining is composed of cytologically bland keratinocytes that mature through a granular layer. There is fibrosis beneath this portion. Other areas have lobules of keratinocytes with large, vesicular nuclei and abundant, pale eosinophilic cytoplasm.	Ellipse, 3.5 x 1.3 x 0.8 cm, including a central 1.5 x 1.0 m white area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with eight sections in A and seven sections in B. KC/KC	HEALING BX SITE, DDX KERATOACANTHOMA, PLEASE CHECK MARGINS	\N	\N	\N	The neoplasm extends to the base of the specimen. In my opinion, keratoacanthoma is a form of squamous cell carcinoma that involutes in the majority of cases. In this case, part of the lesion shows signs of involution, but part does not. Persistence of a lesion thought to be a keratoacanthoma should trigger re-evaluation.	BIOPSY SITE AND RESIDUAL KERATOACANTHOMA, PARTIALLY INVOLUTED, WITH A RESIDUAL PROLIFERATIVE AREA, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173611	817	\N	\N	17-81380	B	LMM-18	Lentigo Maligna Melanoma	IP1674137	AirTable blocks_with_IP_info.csv
2793	22-38234B	84	\N	\N	0	T1a	Primary	high-CSD melanoma	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermis contains large irregular aggregates of similar melanocytes within inflamed fibrosis. There is a scar in the dermis below, centrally.	Skin segment measuring 1.4 x 0.9 x 0.2 cm, trisected and entirely submitted in B. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED SEBORRHEIC KERATOSIS VS. MELANOMA. PAPULE.	\N	\N	\N	A brief synoptic is included below. Procedure: biopsy Microscopic tumor type: high-CSD melanoma Breslow thickness: 0.5 mm Ulceration: not detected Margin: intraepidermal melanoma extends to the periphery of the biopsy Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	MELANOMA OF 0.5 mm IN THICKNESS	139522	818	\N	\N	22-38234	B	LMM-19	Lentigo Maligna Melanoma	IP2376091	AirTable blocks_with_IP_info.csv
2863	23-1012A2	85	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.62	\N	\N	Sections show central post-procedural fibrosing inflammatory alterations, and no residual atypical keratinocytic proliferation remains in the dermis in contiguity with this. There is solar elastosis.	Ellipse, 3.6 x 1.6 x 0.2 cm, including a central 1.0 x 1.0 cm pink beige area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A1-A2. Tips reserved. HD/HD	A) SQUAMOUS CELL CARCINOMA. HEALING BX SITE. PLEASE CHECK MARGINS. B) SQUAMOUS CELL CARCINOMA. HEALING BX SITE. PLEASE CHECK MARGINS.	\N	\N	\N	\N	POST-BIOPSY SCARRING, WITH NO EVIDENCE OF RESIDUAL CARCINOMA	113605	818	\N	\N	23-1012	A2	LMM-19	Lentigo Maligna Melanoma	IP2376091	AirTable blocks_with_IP_info.csv
2221	17-111862B	64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.1	\N	\N	Sections show increased numbers of solitary melanocytes and some small nests of them, irregularly distributed within the epidermis above a dermis with severe solar elastosis.  Some melanocytes have large, hyperchromatic nuclei.	Oriented excision measuring 1.3 x 0.5 x 0.2 cm. With the orienting pre-inked green margin placed distally to the grosser, the edge toward the grosser is inked yellow. The specimen is submitted intact for en face sections in B. PL/PL	A) SLOW MOHS OF PATH #DT17-84030 ENFACE, B-H) PERIPHERAL MARGINS INKED IN GREEN (SEE PHOTO)	\N	\N	\N	This lesion shows the lentigo maligna pattern of melanoma in situ.	MELANOMA IN SITU	101109	819	\N	\N	17-111862	B	LMM-20	Lentigo Maligna Melanoma	IP1814097	AirTable blocks_with_IP_info.csv
2220	17-111862A	64	\N	\N	3	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.1	\N	\N	There is a zone of fibrosing granulation tissue, corresponding to the site of a previous biopsy. There is a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with a few small nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There is a narrowly based, dome surfaced area in which similar cells are present in irregularly sized nests in the dermis, with some large nuclei deeply, and scattered mitotic figures among them.	Excision measuring 2.7 x 1.8 x 0.5 cm, six representative sections submitted in A. PL/PL	A) SLOW MOHS OF PATH #DT17-84030 ENFACE, B-H) PERIPHERAL MARGINS INKED IN GREEN (SEE PHOTO)	\N	\N	\N	Most of the surface of this piece is covered by melanoma in situ, with a small area (which would have been a papule, clinically) in which there is invasive melanoma. Features suggested for reporting per the guidelines of the College of American Pathologists, updated from the report of the prior biopsy include:  Procedure: re-excision, with slow Mohs' method Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.2 mm. Ulceration: no Margins, peripheral: involved by melanoma in situ, see B and C below, and deep: clear by 4 mm. Mitotic index: 3/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	BIOPSY SITE AND ADJACENT MELANOMA, 1.2 MM. IN THICKNESS	101109	819	\N	\N	17-111862	A	LMM-20	Lentigo Maligna Melanoma	IP1814097	AirTable blocks_with_IP_info.csv
2249	17-119302B	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18171	216.7	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges. Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages are present in the papillary dermis.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in B. CF/CF	A-B) R/O DN, C) R/O BCC	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173798	827	\N	\N	17-119302	B	LN-07	Lentiginous Nevi 	IP1849840	AirTable blocks_with_IP_info.csv
2983	97-01837E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	964	\N	\N	None	\N	MD-58	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2246	17-118980	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18173	216.6	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. PL/PL	R/O DYSPLASTIC NEVUS VS. MM	\N	\N	\N	Melan-a immunohistochemistry demonstrates that the lentiginous junctional melanocytic proliferation is limited to the biopsy. Melanocytes are also limited to the lower epidermis and spare suprapapillary plates.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	222612	828	\N	\N	17-118980	\N	LN-08	Lentiginous Nevi 	IP1629847	AirTable blocks_with_IP_info.csv
3490	KR_RMK0194C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1607	\N	\N	None	\N	SYNAT478	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
3487	KR_RMK0137C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1608	\N	\N	None	\N	SYNAT479	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
3488	KR_RMK0162C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1609	\N	\N	None	\N	SYNAT480	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
2260	17-122697A	64	\N	\N	3	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.1	\N	\N	Sections show skin without evidence of a proliferation of melanocytes along the dermo-epidermal junction.	Oriented excision measuring 1.1 x 0.4 x 0.4 cm. The green pre-inked edge is placed distally to the grosser and indicated as peripheral margin on the requisition form. At grossing, the left half of the peripheral margin is re-inked blue and the right half is re-inked red. The opposite surgical margin is inked black. The specimen is submitted intact in A for en-face sectioning. CF/CF	A-B) SLOW MOHS OF PATH DT17-121515 (SEE PHOTO)	\N	\N	\N	There is no evidence of the melanoma in situ seen at the edge of one of the previous margins. Procedure: re-excision, with slow Mohs' method Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.2 mm. Ulceration: no Margins, peripheral: clear, distance not known (best estimated by the clinician, as slow Mohs was performed), and deep: clear by 4 mm. Mitotic index: 3/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	PERIPHERAL MARGIN, NO MELANOMA IN SITU IDENTIFIED	173101	819	\N	\N	17-122697	A	LMM-20	Lentigo Maligna Melanoma	IP1814097	AirTable blocks_with_IP_info.csv
2895	23-12491	97	\N	\N	0	T2a	Primary	High cumulative sun-damaged skin	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a zone of fibrosis with an associated lymphohistiocytic infiltrate, representing a prior biopsy/surgical site, flanked by a proliferation of melanocytes in irregular array within the contiguous epidermis.	Oriented oval, 1.7 x 1.5 x 0.3 cm, including a central 0.8 x 0.8 cm scaly area. The orienting pre-inked blue edge is indicated 6-12 and is placed toward 6-9-12 o'clock. The submitting office pre-inked the 6-9-12 o'clock margin blue and the 12-3-6 o'clock margin green. The grosser inked the 3-6-9 o'clock margin black. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections each in 1-2. BY/BY	MALIGNANT MELANOMA, PLEASE CHECK MARGINS	\N	\N	\N	No residual invasive melanoma was identified. The staging remains the same as reported previously. A synoptic report with information incorporated from the original biopsy is below. There is an incidental seborrheic keratosis. Procedure: re-excision Microscopic tumor type: High cumulative sun-damaged skin Breslow thickness:  1.3 millimeters Ulceration: Not identified Margins: clear Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2aNxMx	SCAR, WITH RESIDUAL MELANOMA IN SITU, COMPLETELY EXCISED (MARGINS ARE FREE OF MELANOMA)	173316	820	\N	\N	23-12491	\N	LMM-21	Lentigo Maligna Melanoma	IP746083	AirTable blocks_with_IP_info.csv
2870	23-3314	97	\N	\N	0	T2a	Primary	High cumulative sun-damaged skin	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis. Solar elastosis is present in the underlying dermis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. HD/HD	R/O MELANOMA VS. SK	\N	\N	\N	Preliminary synoptic melanoma reporting, based on this partial biopsy, is included below: Procedure: Shave biopsy Microscopic tumor type: High cumulative sun-damaged skin Breslow thickness:  1.3 millimeters, at least Ulceration: Not identified Margins: The melanoma extends to the base and peripheral edge of the specimen Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2aNxMx	MELANOMA, AT LEAST 1.3 MILLIMETERS IN THICKNESS, EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	173316	820	\N	\N	23-3314	\N	LMM-21	Lentigo Maligna Melanoma	IP746083	AirTable blocks_with_IP_info.csv
2252	17-119570C	59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18159	216.7	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in C. HD/HD	A-B) 6 MM; R/O IRRITATED NEVUS, C) 6 MM; R/O MELANOMA	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173727	821	\N	\N	17-119570	C	LN-01	Lentiginous Nevi 	IP1817562	AirTable blocks_with_IP_info.csv
2244	17-118831C	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18161	216.6	\N	\N	Sections show a small and symmetric proliferation with increased numbers of single melanocytes and small nests of them positioned at the sides and bases of elongated rete ridges. There is abundant melanin the cornified layer, in the subjacent epidermis and within melanophages in the papillary dermis beneath the lesion. There is solar elastosis.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in C. CF/CF	A-B) R/O BCC, C) R/O MM	\N	\N	\N	\N	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS	173619	822	\N	\N	17-118831	C	LN-02	Lentiginous Nevi 	IP842282	AirTable blocks_with_IP_info.csv
2206	17-109907D	33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18163	238.2	\N	\N	Sections show a proliferation of melanocytes arrayed as single cells and pigmented nests in lentiginous fashion along the sides and bases of pigmented rete. Some intraspinous melanocytes are noted. The dermis deep to this shows elastosis. Slight subjunctional fibroplasia and scattered perijunctional lymphocytes and melanophages are also apparent.	Cylindrical skin segment, 0.8 cm in diameter and 0.4 cm in thickness, with the margins inked, trisected and entirely submitted. RS/RS	A-B) CHANGING NEVUS, PROB IDN, C-D) R/O MELANOMA	\N	\N	\N	The differential diagnosis lies between a lentiginous melanocytic nevus occurring within dermatoheliotic skin on one hand and early lentiginous melanoma in situ on the other. While I favor an atypical melanocytic nevus as most likely, early melanoma in situ cannot be excluded, and thus reexcision is recommended as follow-up management.	LENTIGINOUS INTRAEPIDERMAL PROLIFERATION OF MELANOCYTES, WITH EXTENSION CLOSE TO THE PERIPHERY OF THE BIOPSY	173610	823	\N	\N	17-109907	D	LN-03	Lentiginous Nevi 	IP1840351	AirTable blocks_with_IP_info.csv
2253	17-120049C	49	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18165	216.5	\N	\N	The features are similar to those in (B).	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in C. KC/KC	A-C) 0.6 X 0.6 CM; R/O DYSP	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	273588	824	\N	\N	17-120049	C	LN-04	Lentiginous Nevi 	IP932194	AirTable blocks_with_IP_info.csv
2247	17-119013	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18167	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges.  There is basilar hyperpigmentation in the affected area.  Small clusters of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	ATYPICAL DARK BROWN MACULE; ATYPICAL NEVUS VS. LENTIGINOUS NEVUS	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	273588	825	\N	\N	17-119013	\N	LN-05	Lentiginous Nevi 	IP1849540	AirTable blocks_with_IP_info.csv
2989	98-02267-5 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	965	\N	\N	None	\N	MD-59	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2990	98-03336-8 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	966	\N	\N	None	\N	MD-60	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2207	17-110828C	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18185	238.2	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer. There is solar elastosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in C. HD/HD	A) 4 MM SCALY PAPULE; AK VS. SCC, B) 7 MM SCALY PAPULE; AK VS. SCC, C) 4 MM BROWN MACULE; NEVUS, POSS ATYPIA, D) 6 MM BROWN PAPULE; NEVUS, POSS ATYPIA	\N	\N	\N	The proliferation in (C) has a lentiginous pattern and occurs in sun damaged skin with close extension to the specimen periphery. Given the histopathologic overlap of early lentigo maligna melanoma in situ and lentiginous nevi, either conservative re-excision or clinical follow up to monitor for recurrence is recommended.	JUNCTIONAL PROLIFERATION OF MELANOCYTES, FAVOR A LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173610	834	\N	\N	17-110828	C	LN-14	Lentiginous Nevi 	IP1614923	AirTable blocks_with_IP_info.csv
2245	17-118904B	89	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18187	216.6	\N	\N	There are increased numbers of single melanocytes and small nests of them positioned along the sides and bases of elongated rete ridges. Small, round melanocytes are present in small collections in the subjacent papillary dermis. There are flecks of melanin within lamellar hyperkeratosis above the lesion, hyperpigmentation of the lesional epidermis, and a subjacent infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted in B. CF/CF	A) R/O MALIGNANCY, B) NEVUS, R/O ATYPIA	\N	\N	\N	\N	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173602	835	\N	\N	17-118904	B	LN-15	Lentiginous Nevi 	IP1849428	AirTable blocks_with_IP_info.csv
2248	17-119079A	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18189	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in A. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . SCC. B) NEOPLASM OF UNCERTAIN BEHAVIOR. . SCC. C) NEOPLASM OF UNCERTAIN BEHAVIOR. . SCC.	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	273588	836	\N	\N	17-119079	A	LN-16	Lentiginous Nevi 	IP1692384	AirTable blocks_with_IP_info.csv
2200	17-99294B	22	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18192	216.5	\N	\N	Sections show a proliferation of melanocytes with a biphasic pattern (arrayed as 2 populations of cells).  One population consists of small melanocytes with ovoid nuclei, arrayed in a lentiginous pattern along the epidermal-dermal junction (with single cells and nests along the sides and bases of rete) and as small clusters in the superficial dermis.  The second population consists of melanocytes that exhibit finely pigmented cytoplasm, and there are intervening melanophages.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) CYT17-1556, R/O ATYPICAL, PINK BROWN MACULE WITH IRREGULAR BORDERS, LESION SIZE: 5 MM, B) CYT17-1557, R/O ATYPICAL, DARK BACK MACULE, LESION SIZE: 3 MM	\N	\N	\N	\N	COMBINED MELANOCYTIC NEVUS	528522	837	\N	\N	17-99294	B	LN-17	Lentiginous Nevi 	IP1154787	AirTable blocks_with_IP_info.csv
2287	18-15487B	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18209	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component comprised of single cells and small pigmented nests arrayed along the sides and bases of pigmented rete. Small nests and cords of similar melanocytes are positioned in the subjacent superficial dermis, where scattered melanophages are also evident.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 0.6 CM UNEVEN PIGMENT. CC: ANDREA ASHBY, MD. B) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. UNEVENLY PIGMENTED MACULE 0.5 CM.	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	592733	841	\N	\N	18-15487	B	LN-21	Lentiginous Nevi 	IP1078920	AirTable blocks_with_IP_info.csv
2209	17-111004B	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37592	216.7	\N	\N	There are increased numbers of single melanocytes and small nests of them positioned at the sides and bases of elongated rete ridges. There is abundant melanin the cornified layer, in the subjacent epidermis and within melanophages in the papillary dermis beneath the lesion.	Cylindrical skin segment, 0.5 cm in diameter and 1.0 cm in thickness, bisected and entirely submitted plus one fragment in B. RS/RS	A-C) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	\N	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS	173727	842	\N	\N	17-111004	B	LN-022	Lentiginous Nevi 	IP366882	AirTable blocks_with_IP_info.csv
2224	17-112365B	47	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37593	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A-B) 4 MM BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	139524	843	\N	\N	17-112365	B	LN-023	Lentiginous Nevi 	IP1842838	AirTable blocks_with_IP_info.csv
2215	17-111571	37	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37594	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	JC17-520, 5 MM; R/O ATYPICAL	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	273588	844	\N	\N	17-111571	\N	LN-024	Lentiginous Nevi 	IP1767762	AirTable blocks_with_IP_info.csv
2238	17-115572A	60	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37595	216.4	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer. There is solar elastosis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) R/O LENTIGO, 0.6 X 0.6, B) NEOP UNC VS. SCAR VS. BCC, 0.6 X 0.6	\N	\N	Scraping	The proliferation has a lentiginous pattern and occurs in heavily sun damaged skin. The above interpretation is based on the assumption that this biopsy represents the entire lesion. If this is a partial biopsy of a larger lesion, conservative excision is recommended so that the entire proliferation can be assessed.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173404	845	\N	\N	17-115572	A	LN-025	Lentiginous Nevi 	IP1846067	AirTable blocks_with_IP_info.csv
2021	17-3165A	44	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	216.5	\N	\N	Sections show an increased number of individual melanocytes, arrayed along the sides and bases of elongated, hyperpigmented rete ridges.	Skin segment measuring 0.6 x 0.2 x 0.1 cm, submitted intact in A. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. PIGMENTED SCC INSITU VS LENTIGO. 2MMX3MM BROWN MACULE. #1 SUPERIOR. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. PIGMENTED SCC INSITU VS LENTIGO. 3MMX2MM BROWN MACULE. #2 INFERIOR.	\N	genital mucosa	FFPE	\N	LENTIGO SIMPLEX	135578	1320	\N	\N	17-3165	A	OM-62	Oral Mucosa Lesions	IP1729294	AirTable blocks_with_IP_info.csv
2239	17-115588	41	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37596	216.5	\N	\N	There are increased numbers of single melanocytes and small nests of them positioned at the sides and bases of elongated rete ridges. There is abundant melanin the cornified layer, in the subjacent epidermis and within melanophages in the papillary dermis beneath the lesion. Some melanocytes have fusiform nuclei.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. PL/PL	SIZE 0.4 CM, IRREGULAR BROWN MACULE; ATYPICAL NEVUS	\N	\N	Scraping	This lesion shows some features of a pigmented spindle cell nevus, which most observers consider a variant of Spitz's nevus. No evidence of melanoma or significant atypia was detected.	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	273588	846	\N	\N	17-115588	\N	LN-026	Lentiginous Nevi 	IP1846085	AirTable blocks_with_IP_info.csv
2240	17-115635	62	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37597	216.5	\N	\N	There are increased numbers of single melanocytes and small nests of them positioned at the sides and bases of elongated rete ridges. There is abundant melanin the cornified layer, in the subjacent epidermis and within melanophages in the papillary dermis beneath the lesion. There is solar elastosis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/CF	DARK BROWN MACULE, NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. NEVUS	\N	\N	Scraping	None	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS	128547	847	\N	\N	17-115635	\N	LN-027	Lentiginous Nevi 	IP1463681	AirTable blocks_with_IP_info.csv
2216	17-111657A	74	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37598	172.5	\N	\N	Sections show a proliferation of nested and solitary melanocytes that are irregularly distributed within the epidermis. Some melanocytes have atypical nuclei. The dermis contains solar elastosis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) 0.6 X 0.6 CM; R/O DYSP VS. MM, B) 0.6 X 0.6 CM; R/O DYSP VS. MM, C) 0.6 X 0.6 CM; R/O DYSP VS. MM, D) 0.6 X 0.6 CM; R/O DYSP VS. MM, E) 0.6 X 0.6 CM; R/O DYSP VS. MM	\N	\N	Scraping	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	139522	848	\N	\N	17-111657	A	LN-028	Lentiginous Nevi 	IP531322	AirTable blocks_with_IP_info.csv
2217	17-111657B	74	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37607	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) 0.6 X 0.6 CM; R/O DYSP VS. MM, B) 0.6 X 0.6 CM; R/O DYSP VS. MM, C) 0.6 X 0.6 CM; R/O DYSP VS. MM, D) 0.6 X 0.6 CM; R/O DYSP VS. MM, E) 0.6 X 0.6 CM; R/O DYSP VS. MM	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	433599	848	\N	\N	17-111657	B	LN-028	Lentiginous Nevi 	IP531322	AirTable blocks_with_IP_info.csv
2213	17-111279	46	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37599	216.5	\N	\N	Sections show a proliferation of solitary melanocytes and small nests of them arrayed along the sides and bases of elongated and pigmented rete ridges. There are many melanophages within the underlying superficial dermis.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/CF	R/O DN	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173568	849	\N	\N	17-111279	\N	LN-030	Lentiginous Nevi 	IP1841740	AirTable blocks_with_IP_info.csv
2991	98-05054 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	967	\N	\N	None	\N	MD-61	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3013	99-16633E N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	968	\N	\N	None	\N	MD-62	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2318	18-61924A	25	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37600	216.7	\N	\N	Sections show nested and solitary melanocytes arrayed along the sides and bases of elongated and pigmented rete, and the stratum corneum above them is laced with melanin. Scattered lymphocytes and melanophages are present in the perijunctional dermis.	Skin segment measuring 0.5 x 0.2 x 0.1 cm. Submitted intact in A. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS.	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, INFLAMED	173798	850	\N	\N	18-61924	A	LN-031	Lentiginous Nevi 	IP1791157	AirTable blocks_with_IP_info.csv
2290	18-18111A	58	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37601	216.5	\N	\N	Sections show an excision specimen of skin with a well-circumscribed small junctional proliferation of melanocytes distributed predominantly in small nests and single cells along the sides and the bases of the rete ridges. Melanocytes are focally present above the junction in the center of the lesion. There are melanophages in the superficial dermis and minimal solar elastosis.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BY/PL	R/O ATYPICAL NEVI	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	105539	851	\N	\N	18-18111	A	LN-032	Lentiginous Nevi 	IP683601	AirTable blocks_with_IP_info.csv
2228	17-112653	71	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37602	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion. The specimen is partially tangentially sectioned. There is solar elastosis in the dermis.	Cylindrical skin segment measuring 0.8 cm in diameter and 0.5 cm in thickness, with the margins inked, trisected and entirely submitted. CF/CF	UNKNOWN DURATION OF IRREGULAR DARK - BROWN MACULE; R/O DYSPLASIA APPROX EQUAL TO 6 MM DIAMETER	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173765	852	\N	\N	17-112653	\N	LN-033	Lentiginous Nevi 	IP512135	AirTable blocks_with_IP_info.csv
2235	17-115568B	59	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37603	216.5	\N	\N	There is a compound proliferation of melanocytes mostly involving the junctional zone and a thickened papillary dermis.  Nests of, and increased numbers of single melanocytes are situated at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused.  Toward the center of the lesion, smaller melanocytes reside in the papillary dermis. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A-D) R/O DYSP NEVUS, 0.6 X 0.6	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173539	853	\N	\N	17-115568	B	LN-034	Lentiginous Nevi 	IP185229	AirTable blocks_with_IP_info.csv
2354	18-121973	50	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show acral skin with nested and solitary melanocytes arrayed at the epidermal-dermal junction, with clusters of similar but smaller melanocytes in the superficial dermis.  Most prominently centrally, there are melanocytes above the basal layer, but these are not cytologically atypical.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. HD/PL	ATYPICAL DARK BROWN MACULE; ATYPICAL NEVUS	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS	224789	1181	\N	\N	18-121973	\N	NL-019	Nevus Library	IP828094	AirTable blocks_with_IP_info.csv
2231	17-114505	54	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37604	216.5	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. RS/RS	IRREGULAR BROWN PAPULE; ATYPICAL NEVUS VS. BENIGN NEVUS	\N	\N	Scraping	As the lesion is in sun-damaged skin and its circumscription was difficult to evaluate in the hematoxylin and eosin stained sections, I obtained a SOX-10 immunostain. It shows no suprabasilar scatter, and in the stain, the lesion appears well circumscribed. Given these results, I do not believe that re-excision is necessary.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	575533	854	\N	\N	17-114505	\N	LN-035	Lentiginous Nevi 	IP1812345	AirTable blocks_with_IP_info.csv
2234	17-115149A	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37605	216.7	\N	\N	Sections show a proliferation of solitary melanocytes and small nests of them arrayed along the sides and bases of elongated and pigmented rete ridges. There are many melanophages within the underlying superficial dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in A. PL/PL	A) IRREGULAR BROWN PAPULE; ATYPICAL NEVUS, B) INFLAMED PIGMENTED PAPULE WITH HEMORRHAGIC CRUSTING; IRRITATED NEVUS VS. VV	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173727	855	\N	\N	17-115149	A	LN-036	Lentiginous Nevi 	IP1845642	AirTable blocks_with_IP_info.csv
2211	17-111038B	74	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37606	216.5	\N	\N	The microscopic features are similar to those of (A).	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in B. CF/CF	A-B) R/O DYSP VS. COMP N, C) R/O BCC	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173529	856	\N	\N	17-111038	B	LN-037	Lentiginous Nevi 	IP1772327	AirTable blocks_with_IP_info.csv
2237	17-115571D	39	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37609	216.7	\N	\N	The histopathology is generally similar to that described for specimen A.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in D. HD/HD	A) R/O LENTIGO, 0.6 X 0.6, B-E) R/O COMPOUND NEVUS, 0.6 X 0.6,	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173799	857	\N	\N	17-115571	D	LN-038	Lentiginous Nevi 	IP1840629	AirTable blocks_with_IP_info.csv
2236	17-115571C	39	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37608	216.7	\N	\N	The histopathology is generally similar to that described for specimen A.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in C. HD/HD	A) R/O LENTIGO, 0.6 X 0.6, B-E) R/O COMPOUND NEVUS, 0.6 X 0.6,	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	17723	857	\N	\N	17-115571	C	LN-038	Lentiginous Nevi 	IP1840629	AirTable blocks_with_IP_info.csv
2223	17-112365A	47	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37610	216.5	\N	\N	Sections show skin with hyperpigmentation of the basal layer.  There are slightly elongated, rounded rete ridges. There are scattered melanophages in a band-like array in the papillary dermis. There is solar elastosis of the subjacent dermis.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in A. KC/KC	A-B) 4 MM BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	\N	SOLAR LENTIGO WITH POST-INFLAMMATORY PIGMENTARY ALTERATION	528522	858	\N	\N	17-112365	A	LN-040	Lentiginous Nevi 	IP1842838	AirTable blocks_with_IP_info.csv
2226	17-112588B	75	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37611	216.5	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in B. HD/HD	A) CYT17-1735, R/O BCC, 5 MM, B) CYT17-1736, R/O ATYPIA, 6 MM	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	122533	859	\N	\N	17-112588	B	LN-041	Lentiginous Nevi 	IP1843066	AirTable blocks_with_IP_info.csv
3022	99-27534 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	969	\N	\N	None	\N	MD-63	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1008	00-09653C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	970	\N	\N	None	\N	MD-64	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2212	17-111040A	70	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37612	216.5	\N	\N	There are increased numbers of single melanocytes and there are some small nests of them positioned at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the area of the proliferation. Nests of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 1.2 x 0.9 x 0.1 cm, quadrisected and entirely submitted in A. CF/CF	A-B) R/O DYSP VS. COMP N	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	528523	860	\N	\N	17-111040	A	LN-042	Lentiginous Nevi 	IP1841501	AirTable blocks_with_IP_info.csv
2297	18-27178B	66	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37613	216.5	\N	\N	Sections show a compound proliferation of melanocytes with single cells and nests arrayed along the sides and bases of elongated, pigmented rete, and maturing nests, cords, and fascicles of similar cells are present in the upper dermis, which also harbors scattered melanophages. Many lesional melanocytes have finely melanized cytoplasm. Some are fusiform.	Skin segment measuring 1.0 x 0.9 x 0.3 cm, quadrisected and entirely submitted in B. RS/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . B) NEOPLASM OF UNCERTAIN BEHAVIOR. .	\N	\N	Scraping	This broad melanocytic nevus exhibits mixed features of a lentiginous melanocytic nevus and a deep penetrating nevus. Partial balloon cell change is noted.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	528522	861	\N	\N	18-27178	B	LN-043	Lentiginous Nevi 	IP401538	AirTable blocks_with_IP_info.csv
2305	18-35802B	55	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37614	216.5	\N	\N	Sections show a compound proliferation of melanocytes with single melanocytes and nests arrayed along the sides and bases of pigmented rete, and many nests, cords, and small syncytia are below this. Some melanocytes have pale pigmented cytoplasm. There are scattered lymphocytes and melanophages.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) COLOR VARIEGATION and BRODER IRREGULARITY; NEOPLASM OF UNCERTAIN BEHAVIOR VS. CHANGING SK VS. AMP, SIZE 1.3 MM, B) TWO-TINED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, SIZE 0.5 MM	\N	\N	Scraping	This melanocytic nevus is deeply pigmented but otherwise unremarkable. There is no evidence of melanoma or a dysplastic nevus.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	567566	862	\N	\N	18-35802	B	LN-044	Lentiginous Nevi 	IP1899554	AirTable blocks_with_IP_info.csv
2355	18-121986	57	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	There are increased single melanocytes along the sides and bases of elongated rete ridges, and small, round melanocytes in the subjacent papillary dermis. There is basilar hyperpigmentation in the affected area.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. HD/PL	6 MM IRREGULAR BROWN MACULE; R/O MM	\N	\N	Scraping	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	528522	1182	\N	\N	18-121986	\N	NL-020	Nevus Library	IP1986075	AirTable blocks_with_IP_info.csv
2208	17-111004A	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37615	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component arrayed largely as single melanocytes along the sides and bases of rete.  There are also small melanocytes within the dermis, some of which are positioned in the adventitial and reticular dermis. There is melanin pigment in the stratum corneum.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted in A. RS/RS	A-C) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	132788	863	\N	\N	17-111004	A	LN-045	Lentiginous Nevi 	IP366882	AirTable blocks_with_IP_info.csv
2210	17-111004C	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37616	216.7	\N	\N	The histopathology is generally similar to that described for specimen A.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in C. RS/RS	A-C) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	No evidence of melanoma or significant atypicality was detected in any of the three specimens.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	173710	863	\N	\N	17-111004	C	LN-045	Lentiginous Nevi 	IP366882	AirTable blocks_with_IP_info.csv
2329	18-81165B	51	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37617	216.5	\N	\N	Sections show skin with clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles. A few dermal melanocytes have balloon cell change to their cytoplasms and artifactual clefts separate a few nuclei and nests. There is tattoo pigment within the adjacent dermis and macrophages in these areas.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, trisected and entirely submitted in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. SCCIS. PATCH. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. NEVUS. PAPULE. 0.5 X 0.5 CM	\N	\N	Scraping	Tattoo pigment is present in the dermis in specimen (B). I presume that this biopsy was taken from within a decorative tattoo.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	273588	864	\N	\N	18-81165	B	LN-047	Lentiginous Nevi 	IP1945117	AirTable blocks_with_IP_info.csv
2364	18-136508B	26	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37624	216.6	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, submitted intact in B. PL/PL	A-C) R/O DYSPLASTIC NEVI VS. MM	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173610	865	\N	\N	18-136508	B	LN-048	Lentiginous Nevi 	IP1911688	AirTable blocks_with_IP_info.csv
2232	17-114552	46	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37625	216.5	\N	\N	None	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted. RS/RS	PIGMENTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS	\N	\N	Scraping	This small and heavily pigmented melanocytic nevus is of the 'hypermelanotic' type. There is no evidence of melanoma or a dysplastic nevus.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173504	866	\N	\N	17-114552	\N	LN-049	Lentiginous Nevi 	IP630078	AirTable blocks_with_IP_info.csv
2296	18-27178A	66	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37618	216.5	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which is composed of single cells and small nests arrayed along the sides and bases of pigmented rete. There are nests and cords of similar melanocytes in the superficial dermis, where scattered melanophages are also in residence. The superjacent stratum corneum is orthokeratotic with admixed melanin.	Skin segment measuring 1.2 x 1.0 x 0.2 cm, quadrisected and entirely submitted in A. RS/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . B) NEOPLASM OF UNCERTAIN BEHAVIOR. .	\N	\N	Scraping	There appear to be two melanocytic nevi apparent in side-by-side fashion in this biopsy.	LENTIGINOUS COMPOUND MELANOCYTIC NEVI, EXCISED IN THE AVAILABLE PLANES OF SECTION	139511	867	\N	\N	18-27178	A	LN-050	Lentiginous Nevi 	IP401538	AirTable blocks_with_IP_info.csv
2214	17-111324	78	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37619	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted. HD/HD	6 MM VARIEGATED MACULE; R/O ATYPIA	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	100589	868	\N	\N	17-111324	\N	LN-051	Lentiginous Nevi 	IP403180	AirTable blocks_with_IP_info.csv
2230	17-113511	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37622	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	869	\N	\N	17-113511	\N	LN-052	Lentiginous Nevi 	\N	AirTable blocks_with_IP_info.csv
2289	18-17957	51	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37623	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of  single and nested melanocytes arrayed along the epidermal-dermal  junction, positioned along the sides and bases of pigmented, elongated rete ridges.  There are similar melanocytes in the subjacent dermis. There is a focal dense infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. RED BROWN MACULE.	\N	\N	Scraping	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	155566	870	\N	\N	18-17957	\N	LN-053	Lentiginous Nevi 	IP825795	AirTable blocks_with_IP_info.csv
2219	17-111704B	70	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37627	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.4 x 0.2 x 0.1 cm, submitted intact in B. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. ATYPICAL BROWN PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. ATYPICAL BROWN MACULE.	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173714	871	\N	\N	17-111704	B	LN-054	Lentiginous Nevi 	IP327995	AirTable blocks_with_IP_info.csv
2218	17-111704A	70	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37626	216.7	\N	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. Clusters of similar melanocytes are present in the dermis.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, submitted intact in A. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. ATYPICAL BROWN PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. ATYPICAL BROWN MACULE.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	173710	871	\N	\N	17-111704	A	LN-054	Lentiginous Nevi 	IP327995	AirTable blocks_with_IP_info.csv
1484	11-48013	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1288	\N	\N	11-48013	\N	OM-30	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1660	13-48	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1289	\N	\N	13-48	\N	OM-31	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2292	18-18111C	58	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37629	216.5	\N	\N	Sections show an excision specimen of skin with a well-circumscribed small compound proliferation of melanocytes. Within the epidermis, lesional melanocytes are distributed predominantly in small nests and single cells along the sides and the bases of the thin rete ridges. In the dermis, the melanocytes are organized into small nests and cords that exhibit maturation with decent. Melanophages ar scattered in the superficial dermis and there is minimal solar elastosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, quadrisected and entirely submitted in C. BY/PL	R/O ATYPICAL NEVI	\N	\N	Scraping	These biopsies all show similar features and appear to represent the patient's signature nevus. There are some features of a Clark's or dysplastic nevus. No evidence of melanoma or significant atypia was detected.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS WITH ASSOCIATED MELANOPHAGES	623544	872	\N	\N	18-18111	C	LN-056	Lentiginous Nevi 	IP683601	AirTable blocks_with_IP_info.csv
2291	18-18111B	58	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37628	216.5	\N	\N	Sections show an excision specimen of skin with a well-circumscribed small junctional proliferation of melanocytes distributed predominantly in small nests and single cells along the sides and the bases of the rete ridges. There are melanophages in the superficial dermis and minimal solar elastosis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in B. BY/PL	R/O ATYPICAL NEVI	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	139524	872	\N	\N	18-18111	B	LN-056	Lentiginous Nevi 	IP683601	AirTable blocks_with_IP_info.csv
2316	18-57977B	57	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37630	216.5	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which is composed of single cells and small nests arrayed along the sides and bases of pigmented rete. There are nests and cords of similar melanocytes in the superficial dermis, where scattered melanophages are also in residence. The superjacent stratum corneum is orthokeratotic with admixed melanin.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) 3 X 3 MM DARK BROWN MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 4 X 4 MM DARK BROWN MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	Scraping	This second melanocytic nevus is of the 'hypermelanotic' type. There is no evidence of malignancy or atypicality.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	291511	873	\N	\N	18-57977	B	LN-058	Lentiginous Nevi 	IP1921853	AirTable blocks_with_IP_info.csv
2320	18-65460	11	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37631	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion. There are nests of small and cytologically bland melanocytes in the dermis.  There are a few small melanocytes above the basal layer of the epidermis.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted. KC/KC	1.0 CM IRREGULAR PIGMENTED PAPULE	\N	\N	Scraping	A SOX-10 immunoperoxidase stain highlights that most of the intraepidermal melanocytes are within the basal layer of the epidermis. This staining result, in concert with the findings on the routinely-stained section, supports that the features in this biopsy represent a lentiginous compound melanocytic nevus. The SOX-10 stain does show a few melanocytes above the basal layer of the epidermis, but since these melanocytes are small and cytologically bland and since this proliferation was taken from the anterior shin, these suprabasilar melanocytes most likely due to trauma/irritation. I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173741	874	\N	\N	18-65460	\N	LN-059	Lentiginous Nevi 	IP1929354	AirTable blocks_with_IP_info.csv
2321	18-65957A	51	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37632	216.5	\N	\N	Sections show a compound proliferation of small melanocytes with round to oval nuclei, the junctional component of which consists of nested and solitary melanocytes arrayed along the sides and bases of elongated rete.  There are similar melanocytes within the underlying papillary and reticular dermis, with melanocytes splayed amongst collagen bundles, largely in the upper half of the reticular dermis.	Skin segment measuring 0.9 x 0.9 x 0.1 cm, quadrisected and entirely submitted in A. RS/RS	A) CYT18-1117, 7 MM; R/O ATYPICAL VS. SK, B) CYT18-1118, 1 CM X 5 MM; R/O ATYPICAL	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE	173525	875	\N	\N	18-65957	A	LN-060	Lentiginous Nevi 	IP1929851	AirTable blocks_with_IP_info.csv
1009	00-11793E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	971	\N	\N	None	\N	MD-65	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1012	00-15034-1B M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	972	\N	\N	None	\N	MD-66	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1049	02-11468D M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	973	\N	\N	None	\N	MD-67	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1061	02-22843 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	974	\N	\N	None	\N	MD-68	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1060	02-22662B M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	975	\N	\N	None	\N	MD-69	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1051	02-16325B M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	976	\N	\N	None	\N	MD-70	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2293	18-19195A	74	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37633	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges.  There is basilar hyperpigmentation in the affected area.  Clusters of small, round melanocytes reside in the subjacent dermis. There are superficial dermal melanophages.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in A. RS/PL	A) CYT18-236, BROWN MACULE WITH IRRITATED BASE, LESION SIZE 5 MM; R/O ATYPICAL, B) CYT18-237, LESION SIZE 3 MM, FIRM BLACK PAPULE; R/O INTERACTED HEMANGIOMA VS. ATYPICAL	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	528522	876	\N	\N	18-19195	A	LN-061	Lentiginous Nevi 	IP1487591	AirTable blocks_with_IP_info.csv
2307	18-44463C	61	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37635	216.5	\N	\N	Sections show skin with a compound proliferation of bland melanocytes arranged in predominantly single cells and small nests within the sides and bases of elongated rete ridges. There is focal bridging of these rete ridges. Within the dermis, similar melanocytes are arranged in maturing nests, cords, and single cells amidst melanophages. There are rare flecks of melanin pigment in the overlying stratum corneum.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in C. HD/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. HEMANGIOMA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE.	\N	\N	Scraping	There is a focus of acantholytic dyskeratosis, which could be incidental, or indicative of Grover's disease, depending on the clinical context.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139511	877	\N	\N	18-44463	C	LN-062	Lentiginous Nevi 	IP1908257	AirTable blocks_with_IP_info.csv
1681	13-11936	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1290	\N	\N	13-11936	\N	OM-32	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2306	18-44463B	61	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37634	216.5	\N	\N	Sections show skin with a compound proliferation of bland melanocytes. Within the epidermis, heavily pigmented melanocytes are arranged in predominantly single cells within the basilar layer of the epidermis. There is overlying lamellar hyperkertosis with flecks of melanin pigment within the stratum corneum. There is focal bridging of elongated rete ridges. Within the dermis, similar melanocytes are arranged in maturing nests and cords within a fibrotic dermis that holds melanophages and few lymphocytes. There is perijunctional lamellar fibroplasia.	Two skin segments measuring 0.8 x 0.5 x 0.1 cm in aggregate, sectioned and entirely submitted with three sections in B. HD/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. HEMANGIOMA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE.	\N	\N	Scraping	\N	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	239512	877	\N	\N	18-44463	B	LN-062	Lentiginous Nevi 	IP1908257	AirTable blocks_with_IP_info.csv
2308	18-44464	41	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37636	216.5	\N	\N	Sections show skin with a compound proliferation of bland melanocytes arranged in predominantly single cells and small nests within the sides and bases of elongated rete ridges. Within the dermis, similar melanocytes are arranged in maturing nests, cords, and single cells amidst melanophages.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected and entirely submitted. HD/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE.	\N	\N	Scraping	In the junctional component, there are nests that extend to the specimen periphery that are separated from the remainder of the neoplasm that appear to represent a second melanocytic nevus. Given this focus of irregular junctional distribution, clinical follow-up is recommended.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, SEE NOTES	139512	878	\N	\N	18-44464	\N	LN-064	Lentiginous Nevi 	IP1908258	AirTable blocks_with_IP_info.csv
2324	18-69862A	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37637	216.5	\N	\N	Sections show a compound proliferation of melanocytes with single cells and nests arrayed along the junction at the sides and bases of slender elongated rete. There are similar melanocytes arrayed as nests and cords in the dermis below this. There is solar elastosis in the dermis.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) ATYPICAL NEVUS. IRREGULAR BROWN MACULE. ATYPICAL LESION, APPEARS SLIGHTLY LARGER COMPARED WITH PREVIOUS PHOTO. B) ATYPICAL NEVUS. IRREGULAR BROWN MACULE.	\N	\N	Scraping	In specimen (A), a SOX-10 immunoperoxidase stain highlights that most of the intraepidermal melanocytes are within the basal layer of the epidermis. Coupling this staining result with the findings on the routinely-stained section, I think that the findings in this biopsy represent a lentiginous compound melanocytic nevus. Nonetheless, this benign listed is based in part upon the presumption that the entirety or near entirety of this lesion has been captured by this biopsy, indicating that the lesion at hand is small with good lateral demarcation. If this is instead a partial biopsy of a larger lesion, then the present histopathology may not be fully representative.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173527	879	\N	\N	18-69862	A	LN-065	Lentiginous Nevi 	IP128042	AirTable blocks_with_IP_info.csv
2325	18-69862B	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37638	216.5	\N	\N	Sections show an array of nested and solitary melanocytes with relatively small nuclei positioned along the sides and bases of elongated rete subjacent to a compact cornified layer that contains melanin. The superficial dermis contains similar cells in small clusters, and also displays an infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) ATYPICAL NEVUS. IRREGULAR BROWN MACULE. ATYPICAL LESION, APPEARS SLIGHTLY LARGER COMPARED WITH PREVIOUS PHOTO. B) ATYPICAL NEVUS. IRREGULAR BROWN MACULE.	\N	\N	Scraping	Similar to specimen (A), in specimen (B), a SOX-10 immunoperoxidase stain confirms that most of the intraepidermal melanocytes are within the basal layer of the epidermis. Coupling this staining result with the findings on the routinely-stained section, the features in this biopsy are those of a hypermelanotic lentiginous compound melanocytic nevus.	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	102588	879	\N	\N	18-69862	B	LN-065	Lentiginous Nevi 	IP128042	AirTable blocks_with_IP_info.csv
2328	18-76615	40	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37639	216.5	\N	\N	Sections show a compound proliferation of melanocytes with single cells and nests arrayed along the sides and bases of elongated, pigmented rete, and maturing nests and cords of similar cells are present in the upper dermis, which also harbors scattered lymphocytes and melanophages. Many lesional melanocytes have finely melanized cytoplasm.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. BY/BY	6 MM IRREG BROWN PAPULE; R/O DYSPL CN VS. OTHER	\N	\N	Scraping	There is partial balloon cell change or oncocytic metaplasia associated with this deeply pigmented melanocytic nevus. There is no evidence of malignancy or atypicality.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	273588	880	\N	\N	18-76615	\N	LN-067	Lentiginous Nevi 	IP109853	AirTable blocks_with_IP_info.csv
1073	03-04925E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	977	\N	\N	None	\N	MD-71	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2309	18-44465	31	\N	\N	\N	None	None	None	\N	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/37640	216.7	\N	\N	Sections show skin with a compound proliferation of bland melanocytes arranged in predominantly single cells and small nests within the sides and bases of elongated rete ridges amidst darkly pigmented keratinocytes.Within the dermis, melanocytes are arranged in both medium-sized and small nests and single cells. In some foci, melanocytes are arranged adjacent to dermal blood vessels There are rare flecks of melanin pigment in the overlying stratum corneum.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. MELANOMA VS. DYSPLASTIC NEVUS. MACULE.	\N	\N	FFPE	None	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	17733	881	\N	\N	18-44465	\N	LN-068	Lentiginous Nevi 	IP1908259	AirTable blocks_with_IP_info.csv
2719	21-52881	32	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18348	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/CF	3.5 DARK MOLE RAISED IRREGULAR BROWN MAC; R/O ATYPIA	\N	\N	FFPE	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173507	882	\N	\N	21-52881	\N	LN-069	Lentiginous Nevi 	IP2315596	AirTable blocks_with_IP_info.csv
3489	KR_RMK0168C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1610	\N	\N	None	\N	SYNAT481	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
10988	12GS-2466	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2056	\N	\N	\N	\N	SYNX653	\N	\N	Consolidated_data_final.csv
3253	CP1-5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2151	\N	\N	None	\N	SYNAT671	2010-2017	\N	AirTable blocks_with_IP_info.csv
2633	20-60575	68	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18347	216.5	\N	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction, with single cells and nests arrayed along the sides and bases of elongated, hyperpigmented rete.  The underlying papillary dermis is expanded by fibrosis and contains a permeative lymphocytic infiltrate.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. BY/KB	A) DYSPLASTIC NEVUS VS. MELANOMA IN SITU. DARK BROWN IRREGULAR 5MM X 5MM MACULE WITH IRREGULAR PIGMENT NETWORK ON DERMOSCOPY.	\N	\N	FFPE	None	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXCISED IN PLANES OF SECTION EXAMINED	173504	883	\N	\N	20-60575	\N	LN-070	Lentiginous Nevi 	IP1156616	AirTable blocks_with_IP_info.csv
2724	21-61821	63	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18338	216.6	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion. There are elongated rete ridges with hyperpigmentation of the basal layer. The dermis is altered by solar elastosis.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted. KB/CF	TWO COLORS IRREGULAR COLOR AND BORDER; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH	\N	\N	FFPE	There is a background of solar lentigo.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	202612	884	\N	\N	21-61821	\N	LN-071	Lentiginous Nevi 	IP1860574	AirTable blocks_with_IP_info.csv
2728	21-63579A	66	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18339	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) 4 MM X 2 MM IRREGULARLY PIGMENTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O ATYPICAL NEVUS, PLEASE CHECK MARGINS, B) 7 MM X 5 MM IRREGULAR BROWN PATCH WITH HOMOGENEOUS, GLOBULAR AND FINGERPRINT NETWORKS; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SOLAR LENTIGO, R/O MELANOMA IN SITU, PLEASE CHECK MARGINS, C) PINK SCALY VERRUCOUS PAPULE WITH FOCAL PINPOINT THROMBOSED CAPILLARIES; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED SEBORRHEIC KERATOSIS VS. INFLAMED VERRUCA VULGARIS VS. SQUAMOUS CELL CARCINOMA	\N	\N	FFPE	\N	COMPOUND MELANOCYTIC NEVUS	101532	885	\N	\N	21-63579	A	LN-072	Lentiginous Nevi 	IP2326379	AirTable blocks_with_IP_info.csv
2722	21-59993A	88	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18340	172.5	\N	\N	Sections show an asymmetrical, poorly circumscribed melanocytic proliferation in which single cells predominate, in irregular array within the epidermis.  There is solar elastosis.	Skin segment measuring 1.3 x 0.9 x 0.1 cm, trisected and entirely submitted in A. BB/BB	A) CYT21-469, 1.0 X 1.2 CM; BROWN UNEVEN PIGMENT, B) CYT21-470, 0.2 X 0.2 CM DARK MACULE; A-B) R/O ATYPICAL	\N	\N	FFPE	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	139522	886	\N	\N	21-59993	A	LN-073	Lentiginous Nevi 	IP1020374	AirTable blocks_with_IP_info.csv
2739	21-98047	45	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18341	216.4	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. BY/BY	4 MM IRREGULAR BROWN MACULE WITH CENTRAL CLEARING; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. SL VS. MIS	\N	\N	FFPE	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173441	887	\N	\N	21-98047	\N	LN-074	Lentiginous Nevi 	IP558857	AirTable blocks_with_IP_info.csv
2738	21-98013A	68	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18342	216.7	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A-B) R/O DN	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	154799	888	\N	\N	21-98013	A	LN-075	Lentiginous Nevi 	IP2361035	AirTable blocks_with_IP_info.csv
2725	21-62140A	72	\N	\N	\N	\N	\N	\N	30	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18343	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Two skin segments measuring 1.1 x 0.8 x 0.1 cm in aggregate, each sectioned and all entirely submitted with five sections in A. KB/KB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL PIGMENTED LESION. IRREGULAR BROWN MACULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL PIGMENTED LESION. IRREGULAR BROWN MACULE.	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173531	889	\N	\N	21-62140	A	LN-076	Lentiginous Nevi 	IP225884	AirTable blocks_with_IP_info.csv
1077	03-16198-1C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	978	\N	\N	None	\N	MD-72	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1104	04-00065-6 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	979	\N	\N	None	\N	MD-73	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1106	04-01241G M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	980	\N	\N	None	\N	MD-74	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1135	04-21305-4 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	981	\N	\N	None	\N	MD-75	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1169	05-21257 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	982	\N	\N	None	\N	MD-77	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2727	21-63575B	89	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18344	172.5	\N	\N	Sections show atypical melanocytes arranged singly and in nests within the epidermis.  In some areas, there are diminished numbers of melanocytes in concert with a thickened and fibrotic papillary dermis that contains lymphocytes and melanophages.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in B. CF/CF	A) KERATOTIC PINK PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O KERATOACANTHOMA SQUAMOUS CELL CARCINOMA, B) IRREGULAR BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O ATN VS. SOLAR LENTIGO, PLEASE CHECK MARGINS, C) IRREGULAR BROWN PATCH WITH THUMBPRINT HOMOGENEOUS PIGMENT PATTERN; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O SOLAR LENTIGO VS. MELANOMA IN SITU, PLEASE CHECK MARGINS, D) ILL-DEFINED BROWN PATCH WITH THUMBPRINT HOMOGENOUS PIGMENT PATTERN; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SO;AR LENTIGO'S, MELANOMA IN SITU, PLEASE CHECK MARGINS, E) KERATOTIC PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O SQUAMOUS CELL CARCINOMA, PLEASE CHECK MARGINS	\N	\N	FFPE	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA, AT LEAST IN SITU, WITH SUPERIMPOSED CHANGES OF REGRESSION	173525	890	\N	\N	21-63575	B	LN-077	Lentiginous Nevi 	IP2326375	AirTable blocks_with_IP_info.csv
10989	SP-09-0150202A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2057	\N	\N	\N	\N	SYNX654	\N	\N	Consolidated_data_final.csv
2723	21-61319	74	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18345	216.5	\N	\N	There is a narrowly based lesion in which there are thin, elongated rete ridges with increased numbers of melanocytes arranged as single cells along their sides and bases. The basal layer is hyperpigmented.  There are infiltrates of lymphocytes and melanophages in the subjacent papillary dermis. The epidermis is focally thickened, with interconnecting rete ridges and horn pseudocysts.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected and entirely submitted. KB/KB	DARK BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. LMN VS. LENTIGO / EVOLVING SEBORRHEIC KERATOSIS VS. MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental seborrheic keratosis.	LENTIGO SIMPLEX	173529	891	\N	\N	21-61319	\N	LN-078	Lentiginous Nevi 	IP278814	AirTable blocks_with_IP_info.csv
2737	21-96630	74	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18346	216.7	\N	\N	There is a narrowly based lesion in which there are thin, elongated rete ridges with increased numbers of melanocytes arranged as single cells along their sides and bases. The basal layer is hyperpigmented.  There are infiltrates of lymphocytes and melanophages in the subjacent papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. BY/BY	NEVUS, R/O ATYPIA	\N	\N	FFPE	None	LENTIGO SIMPLEX	173765	892	\N	\N	21-96630	\N	LN-079	Lentiginous Nevi 	IP968238	AirTable blocks_with_IP_info.csv
2753	21-110504	61	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18349	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. BY/BY	ATYPICAL MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	FFPE	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173711	893	\N	\N	21-110504	\N	LN-080	Lentiginous Nevi 	IP2373605	AirTable blocks_with_IP_info.csv
2752	21-110027B	79	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18350	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the junctional component show areas in which melanocytes are arrayed singly along the sides and bases of elongated rete ridges.  The small melanocytes that constitute the dermal component are surrounded by a permeative infiltrate of lymphocytes.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. KB/KB	A-B) R/O ATYPICAL MELANOCYTIC PROCESS	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	528599	894	\N	\N	21-110027	B	LN-081	Lentiginous Nevi 	IP981802	AirTable blocks_with_IP_info.csv
2751	21-110012A	75	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18351	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) TWO COLOR, IRREGULAR BORDERS; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, B) 4 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	101523	895	\N	\N	21-110012	A	LN-082	Lentiginous Nevi 	IP2281905	AirTable blocks_with_IP_info.csv
2750	21-110009A	68	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18352	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) 6 MM, 2 COLORS; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, B) 7 MM, WAXY, 2 COLORS; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE	129588	896	\N	\N	21-110009	A	LN-083	Lentiginous Nevi 	IP2373107	AirTable blocks_with_IP_info.csv
2754	21-112103B	75	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18353	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. BY/BY	A) 0.7; R/O BCC, B) 0.7; R/O SK VS. DN, C) 3 MM; R/O BCC	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	433599	897	\N	\N	21-112103	B	LN-084	Lentiginous Nevi 	IP1386399	AirTable blocks_with_IP_info.csv
2757	21-112298	52	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18354	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/CF	SIM; R/O ATYPIA	\N	\N	FFPE	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	101532	898	\N	\N	21-112298	\N	LN-085	Lentiginous Nevi 	IP1358879	AirTable blocks_with_IP_info.csv
2951	94-21132 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	990	\N	\N	None	\N	MD-94	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1341	09-15598 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	983	\N	\N	None	\N	MD-79	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1339	09-13370-2G N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	984	\N	\N	None	\N	MD-80	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1338	09-13370-1M N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	984	\N	\N	None	\N	MD-80	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1380	10-20397-3 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	985	\N	\N	None	\N	MD-84	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1389	10-30890-5 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	986	\N	\N	None	\N	MD-85	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2755	21-112195B	65	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18355	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KB/KB	A) 1 CM, WAXY; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA, B-C) 6 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, D) 7 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139512	899	\N	\N	21-112195	B	LN-086	Lentiginous Nevi 	IP2375313	AirTable blocks_with_IP_info.csv
1598	12-22597	87	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.41	BCC	\N	Sections show a proliferation of small nodular collections of basaloid keratinocytes in poorly-circumscribed array.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted.	SIZE 1.6 X 1.4 CM, C&D DONE AT SAME TIME AS BX; R/O BCC	\N	Micronodular, neck	\N	None	BASAL CELL CARCINOMA, MICRONODULAR PATTERN, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173450	1429	\N	\N	12-22597	\N	SYNAT363	2010-2017	IP575947	AirTable blocks_with_IP_info.csv
2756	21-112195D	65	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18356	216.6	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in D. KB/KB	A) 1 CM, WAXY; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA, B-C) 6 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, D) 7 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	102611	900	\N	\N	21-112195	D	LN-087	Lentiginous Nevi 	IP2375313	AirTable blocks_with_IP_info.csv
2758	21-112321A	80	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18357	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in A. KB/KB	A) ATYPICAL BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR, B) ATYPICAL BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL PIGMENTED LESION VS. PIGMENTED SEBORRHEIC KERATOSIS	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173714	901	\N	\N	21-112321	A	LN-088	Lentiginous Nevi 	IP847876	AirTable blocks_with_IP_info.csv
3558	SKMEL 1023A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	903	\N	\N	None	\N	MC-01	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3560	SKMel 1107B Dec2019	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	904	\N	\N	None	\N	MC-02	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3559	SKMEL 1107B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	904	\N	\N	None	\N	MC-02	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3561	SKMEL 1121B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	905	\N	\N	None	\N	MC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3562	SKMel 1121B Dec2019	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	905	\N	\N	None	\N	MC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3530	Mel290	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	906	\N	\N	None	\N	MC-04	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1015	00-21551 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	907	\N	\N	None	\N	MD-01	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1020	01-00027 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	908	\N	\N	None	\N	MD-02	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1025	01-07957 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	909	\N	\N	None	\N	MD-03	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1033	01-20248 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	910	\N	\N	None	\N	MD-04	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1044	02-05776D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	911	\N	\N	None	\N	MD-05	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1043	02-05776 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	911	\N	\N	None	\N	MD-05	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1089	03-26518B M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	912	\N	\N	None	\N	MD-06	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1088	03-26518 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	912	\N	\N	None	\N	MD-06	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1140	04-28824 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	913	\N	\N	None	\N	MD-07	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1107	04-01809 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	914	\N	\N	None	\N	MD-08	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1108	04-01809E T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	914	\N	\N	None	\N	MD-08	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1113	04-05355 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	915	\N	\N	None	\N	MD-09	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1114	04-05355B T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	915	\N	\N	None	\N	MD-09	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1170	05-23001 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	916	\N	\N	None	\N	MD-10	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1171	05-23001E T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	916	\N	\N	None	\N	MD-10	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1164	05-14988B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	917	\N	\N	None	\N	MD-11	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1163	05-14988 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	917	\N	\N	None	\N	MD-11	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1181	05-29322B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	918	\N	\N	None	\N	MD-12	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1180	05-29322 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	918	\N	\N	None	\N	MD-12	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1204	06-05518 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	919	\N	\N	None	\N	MD-13	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1205	06-05518B T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	919	\N	\N	None	\N	MD-13	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1197	06-01845E T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	920	\N	\N	None	\N	MD-14	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1196	06-01845 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	920	\N	\N	None	\N	MD-14	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1202	06-04915 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	921	\N	\N	None	\N	MD-15	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1218	06-14812D T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	922	\N	\N	None	\N	MD-16	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1219	06-14812E T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	922	\N	\N	None	\N	MD-16	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1224	06-17441 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	923	\N	\N	None	\N	MD-17	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1225	06-17441-2 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	923	\N	\N	None	\N	MD-17	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1243	06-25697-1 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	924	\N	\N	None	\N	MD-18	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1242	06-25697 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	924	\N	\N	None	\N	MD-18	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1238	06-23345 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	925	\N	\N	None	\N	MD-19	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1244	06-27633 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	926	\N	\N	None	\N	MD-20	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1239	06-23587 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	927	\N	\N	None	\N	MD-21	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1240	06-23587B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	927	\N	\N	None	\N	MD-21	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1223	06-16759A T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	928	\N	\N	None	\N	MD-22	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1222	06-16759 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	928	\N	\N	None	\N	MD-22	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1275	07-25593 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	929	\N	\N	None	\N	MD-23	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1276	07-25593-2 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	929	\N	\N	None	\N	MD-23	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1307	08-21729 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	930	\N	\N	None	\N	MD-24	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3001	98-21389A T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1067	\N	\N	None	\N	MD-190	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2993	98-06203-3 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1068	\N	\N	None	\N	MD-191	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2984	97-8417 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1069	\N	\N	None	\N	MD-192	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2955	95-02325-1 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1070	\N	\N	None	\N	MD-193	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2922	90-07958-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1071	\N	\N	None	\N	MD-194	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2980	96-20650-1A T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1072	\N	\N	None	\N	MD-195	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2941	93-21060-4 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1073	\N	\N	None	\N	MD-196	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1986	16-109659A4	67	\N	\N	2	T4a	Primary	Nevoid	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22139,25172	172.4	\N	\N	Sections show a very local multilobular proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, with atypical nuclei. These cells for expansile nests.  Separate nodular foci are present and a collection of these cells is noted in a blood vessel. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  Biopsy site changes are noted.	Oriented oval excision, 5.8 x 5.5 x 2.0 cm, including a central 2.7 x 2.0 cm raised area. With the orienting single suture located at the midpoint of one edge and placed distally to the grosser, the single suture is indicated 12 o'clock on the requisition. There are double sutures at 3 o'clock, triple sutures at 6 o'clock and quadruple sutures at 9 o'clock as indicated on the requisition. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. Six representative sections submitted with two half-sections (one section) in A1, one-half section each in A2-A9 and two half sections (one section) in A10. PL/PL	A) RIGHT PARIETAL SCALP MELANOMA, B) RIGHT NECK SENTINEL LYMPH NODE #1 EXVIVO 1780, C) RIGHT NECK SENTINEL LYMPH NODE #2 EXVIVO 1000, D) RIGHT NECK SENTINEL LYMPH NODE #3 EXVIVO 400, E) RIGHT NECK SENTINEL LYMPH NODE #4 EXVIVO 500, F) RIGHT NECK SENTINEL LYMPH NODE #5 EXVIVO 5000	\N	\N	Scraping	This excision specimen demonstrates a very thick melanoma that has arisen in association with a congenital melanocytic nevus.  Microsatellite metastases are noted and a focus of vascular invasion is present. Diagnostic features of note include:  Procedure: Excision Tumor site: Scalp Microscopic tumor type: Nevoid Breslow thickness: 12.0 millimeters Ulceration: Present (I assume this is from the prior biopsies) Margins, peripheral and deep: Free Mitotic index: 2/mm2 Microsatellitosis: Present Vascular invasion: Present Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT4a (as initial biopsy was not reported as ulcerated)N2c	MELANOMA, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, APPROXIMATELY 12.0 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED	172438	1096	\N	\N	16-109659	A4	ME-01	Melanoma Epigenetics	IP1687145	AirTable blocks_with_IP_info.csv
1955	16-84820	62	\N	\N	1	T2a	Primary	superficial spreading melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22140	172.6	\N	\N	Sections show a proliferation of melanocytes with a dome surfaced and a flattish portion. The domed area features large, oval melanocytes with abundant, pale cytoplasm and dusty appearing melanin and enlarged nuclei in a pagetoid pattern in the epidermis and as large nests in fibrotic stroma in the superficial dermis. To the side of these changes, there are plump, oval to small round melanocytes in discrete nests in the papillary dermis.	Cylindrical skin segment measuring 0.9 cm in diameter and 0.6 cm in thickness, with the margins inked, quadrisected and entirely submitted. CF/CF	IRREGULAR BROWN PAPULE; MELANOMA	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: right arm Microscopic tumor type: superficial spreading melanoma Breslow thickness: 1.2 mm. Ulceration: no Margins, peripheral: clear by 2 mm. of melanoma, involved by nevus, and deep: unequivocal clear Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.2 MM. IN THICKNESS, ARISING IN A NEVUS	273699	1097	\N	\N	16-84820	\N	ME-02	Melanoma Epigenetics	IP1684607	AirTable blocks_with_IP_info.csv
2072	17-26457	60	f	\N	1	T3a	Primary	SSM with a desmoplastic component, melanoma on non-chronically sun-damaged skin (non-CSD)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=930	172.5	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis, with some cells having a spindled shape with surrounding fibrosis. There is also a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Skin segment measuring 1.2 x 1.2 x 0.4 cm, serially sectioned and entirely submitted with five sections. RS/RS	SUSPICIOUS IRREGULAR MULTI-COLORED PAPULE; MALIGNANT MELANOMA VS. DYSPLASTIC NEVUS, RULE OUT MELANOMA ARISING IN AN IDN, SOFT PINK PAPULE WITH ADJACENT SPREADING AREA OF PIGMENTATION	\N	\N	Scraping	Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows focal significant pagetoid scatter in the MART-1 component. MART-1 expression is significantly reduced in the invasive melanoma component. The Ki-67 proliferation rate of the dermal melanocytes in the nevus component is very  low (<1%). p16 immunoreactivity is strong in the nevus, and completely absent in most of the dermal component of the melanoma. Diagnostic features of note include:  Procedure: shave biopsy Tumor site: back Microscopic tumor type: SSM with a desmoplastic component, melanoma on non-chronically sun-damaged skin (non-CSD) Breslow thickness: 2.2 mm Ulceration: absent Margins, peripheral and deep: deep and peripheral margin focally involved by nevus Mitotic index: 1/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	MELANOMA, 2.2 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE SPECIMEN BASE AND EDGE	291511	1098	\N	\N	17-26457	\N	ME-03	Melanoma Epigenetics	IP1755775	AirTable blocks_with_IP_info.csv
3539	N-ID 2225	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1233	\N	\N	None	\N	NM-58	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3538	N-ID 1941	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1234	\N	\N	None	\N	NM-59	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3060	3188/18	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1235	\N	\N	None	\N	NM-60	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1981	16-106975	49	\N	\N	2	T2a	Primary	nodular	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24928	172.5	\N	\N	Sections show large, oval melanocytes with abundant, pale cytoplasm and large, pleomorphic vesicular nuclei in a nodular mass apposed to the undersurface of the epidermis. Adjacent to this, there are nests, cords and strands of small, round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures.	Skin segment measuring 1.3 x 0.7 x 0.2 cm, trisected and entirely submitted. CF/CF	R/O MALIGNANCY	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: left back Microscopic tumor type: nodular Breslow thickness: 1.5 mm. Ulceration: no Margins, peripheral: clear by < 1mm., and deep: clear by < 0.5 mm. Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.5 MM. IN THICKNESS, ARISING IN A NEVUS WITH CONGENITAL FEATURES	173530	1099	\N	\N	16-106975	\N	ME-04	Melanoma Epigenetics	IP822002	AirTable blocks_with_IP_info.csv
2044	17-12444	64	\N	\N	10	T3b	Primary	nodular melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22142	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes, with a flattish periphery and protuberant, ulcerated center. It features, in the flattish part:  • small nests of plump, oval melanocytes at the sides and bases of elongated rete ridges  • the bases of some adjacent rete ridges are fused, with subjacent fibroplasia • small, round melanocytes in discrete nests in the papillary dermis   In the raised part:  • sheets of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei with large nucleoli  • many mitotic figures  • no maturation and dispersion with descent	Skin segment measuring 1.4 x 1.0 x 0.4 cm, quadrisected and entirely submitted. PL/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA VS. MELANOMA. PAPULE.	\N	\N	Scraping	This amelanotic neoplasm is a high risk lesion and extends to the base of the specimen across a broad front. The final thickness measurement, and pressmen of AJCC stage should be made after complete excision. It seems to have arisen in a dysplastic nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: biopsy Tumor site: right chest Microscopic tumor type: nodular melanoma Breslow thickness: >2.7 mm. Ulceration: yes Margins, peripheral: involved by melanoma in situ, and deep: transected Mitotic index: 10/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): at least pT3b pNX	MELANOMA, AT LEAST 2.7 MM. IN THICKNESS	173529	1100	\N	\N	17-12444	\N	ME-05	Melanoma Epigenetics	IP1741621	AirTable blocks_with_IP_info.csv
2201	17-99365	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24929	\N	\N	\N	\N	\N	\N	\N	\N	Punch	\N	\N	\N	1100	\N	\N	17-99365	\N	ME-05	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
3515	MB_1036	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1481	\N	\N	None	\N	SYNAT395	2010-2017	\N	AirTable blocks_with_IP_info.csv
3168	Bivona-L17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1482	\N	\N	None	\N	SYNAT396	2010-2017	\N	AirTable blocks_with_IP_info.csv
3169	Bivona-L18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1483	\N	\N	None	\N	SYNAT397	2010-2017	\N	AirTable blocks_with_IP_info.csv
2185	17-88262	66	f	\N	0	T1a	Primary	Melanoma, arising in association with a melanocytic nevus with superfical congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22157	172.5	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis. There is also a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Skin segment measuring 1.8 x 1.5 x 0.1 cm, serially secitoned, and entirely submitted with six sections. HD/HD	VARIEGATED PLAQUE; WORRISOME FOR MM, 15 X 13 MM	\N	\N	Scraping	Synoptic melanoma reporting is included below: Procedure: Shave biopsy Microscopic tumor type: Melanoma, arising in association with a melanocytic nevus with superfical congenital features Breslow thickness: 0.6 mm Ulceration: Absent Margins: + base; + peripheral Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.6 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	433599	1101	\N	\N	17-88262	\N	ME-06	Melanoma Epigenetics	IP1818404	AirTable blocks_with_IP_info.csv
2199	17-95052A	66	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24930	232.5	\N	\N	Sections show a zone of granulation tissue representing the residuum of a prior biopsy site, flanked by a proliferation of single and nested melanocytes in irregular array along the epidermal-dermal junction.  A compound proliferation of bland melanocytes is also noted.	Oriented ellipse measuring 5.5 x 2.5 x 1.3 cm, including a central 1.8 x 1.1 cm crusted area. With the orienting notch located at the midpoint of one edge placed distally to the grosser, the notch is indicated as superior edge on the requisition form. With the notch designated as 12 o'clock by the grosser, the 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in A-F. Tips reserved. CF/CF	MM EXC SEE PATH DT17-88262	\N	\N	Punch	A lentiginous melanocytic nevus is also present.  It too has been completely excised.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA IN SITU, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF MALIGNANCY)	433599	1101	\N	\N	17-95052	A	ME-06	Melanoma Epigenetics	IP1818404	AirTable blocks_with_IP_info.csv
1982	16-107007	67	\N	\N	1	T1b	Primary	melanoma, NOS	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22138	172.6	\N	\N	Sections show an irregularly distributed proliferation of enlarged atypical pigmented melanocytes. Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermis contains aggregates of similar cells with defective maturation that are surrounded by a brisk lymphocytic infiltrate. To the side of these changes, there are small melanocytes with round to oval nuclei in the superficial dermis. The dermis displays marked solar elastosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. HD/HD	RED, SCALY PAPULE; ? MM VS. ISK	\N	\N	Scraping	This melanoma is present adjacent to a common nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: shave biopsy Microscopic tumor type: melanoma, NOS Breslow thickness: 0.75 mm Ulceration: no Margins, peripheral and deep: melanoma is present near the peripheral and deep edges of the biopsy Mitotic index: 1 per square mm Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Tumor-infiltrating lymphocytes: brisk Pathologic Staging (pTNM): pT1b pNX	MELANOMA, 0.75 MM IN THICKNESS	422655	1102	\N	\N	16-107007	\N	ME-07	Melanoma Epigenetics	IP1707061	AirTable blocks_with_IP_info.csv
3081	15356/1 (H08.15356/1 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1236	\N	\N	None	\N	NM-61	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3126	176323	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1237	\N	\N	None	\N	NM-63	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1957	16-88453A	67	f	\N	0	T1a	Primary	Nevoid	\N	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent fibrotic dermis. Zones of epidermal atrophy are noted. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.4 x 1.0 x 0.2 cm, quadrisected and entirely submitted in A. CF/CF	A-B) R/O MM	\N	\N	Scraping	Diagnostic features of note include: Procedure: Shave Tumor site: Back Microscopic tumor type: Nevoid Breslow thickness: 0.84 millimeters Ulceration: Absent Margins, peripheral and deep: Peripheral involved by melanoma in situ, deep free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT1a	MELANOMA, 0.84 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	139522	1103	\N	\N	16-88453	A	ME-08	Melanoma Epigenetics	IP1688270	AirTable blocks_with_IP_info.csv
1987	16-110683	62	f	\N	2	T2a	Primary	Nevoid	\N	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. KC/KC	NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA	\N	\N	Scraping	The melanoma is transected at the base of the biopsy and therefore the above measurement represents a minimum thickness.  Based on the findings here the following microstaging parameters apply: Diagnostic features of note include:  Procedure: Shave Tumor site: Foot Microscopic tumor type: Nevoid Breslow thickness: 1.4 millimeters at least Ulceration: Absent Margins, peripheral and deep: Involved Mitotic index: 2/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a at least	MELANOMA, AT LEAST 1.4 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	101721	1104	\N	\N	16-110683	\N	ME-09	Melanoma Epigenetics	IP1710779	AirTable blocks_with_IP_info.csv
3170	Bivona-L19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1484	\N	\N	None	\N	SYNAT398	2010-2017	\N	AirTable blocks_with_IP_info.csv
10110	KIT53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Melanoma, Heel	_Acral_NRAS	\N	\N	\N	\N	\N	\N	\N	\N	\N	1485	\N	\N	\N	\N	SYNX82	\N	\N	Consolidated_data_final.csv
3475	KIT313	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1486	\N	\N	None	\N	SYNAT399	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
2156	17-68446	63	f	\N	0	T1a	Primary	Melanoma, NOS, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22154	172.7	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis. Within the epidermis, there are melanocytes arranged as nests and single cells. In some areas, there are melanocytes above the basal layer of the epidermis and there are areas in which melanocytes are configured as single cells in confluence. There are nests of similar melanocytes in the dermis. There is a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Cylindrical skin segment, 0.6 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. HD/HD	PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. MELANOMA VS. DYSPLASTIC NEVUS VS. IRRITATED SEBORRHEIC KERATOSIS	\N	\N	Scraping	Synoptic melanoma reporting is included below: Procedure: Punch biopsy Microscopic tumor type: Melanoma, NOS, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.6 mm Ulceration: Absent Margins: Intraepidermal melanoma extends to the peripheral edge of the specimen Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.6 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND EXTENDING INTRAEPIDERMALLY TO THE PERIPHERAL EDGE OF THE SPECIMEN	17733	1105	\N	\N	17-68446	\N	ME-10	Melanoma Epigenetics	IP524944	AirTable blocks_with_IP_info.csv
1255	06-72820A	52	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=,24931	216.5	\N	\N	Sections show an area of lymphohistiocytic inflammation and fibrosing granulation tissue due to earlier surgery, with no evidence of residual melanocytic neoplasm.	Ellipse, 3.5 x 1.0 x 0.5 cm, including a central white 0.5 x 0.3 cm area with 1.2 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections each in cassettes A and B, tips returned to container.	R/O CLARK'S OR DYSPLASTIC NEVUS, CHECK MARGINS	\N	\N	Punch	\N	POST-SURGICAL CHANGES, WITH NO EVIDENCE OF RESIDUAL MELANOCYTIC NEVUS	173532	1105	\N	\N	06-72820	A	ME-10	Melanoma Epigenetics	IP524944	AirTable blocks_with_IP_info.csv
2126	17-55182C	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22438	216.5	\N	\N	Sections show a array of delicate, wavy spindled cells with perijunctional fibrosis due to irritation.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in C. CF/CF	A) SKIN TAG VS. NEVUS VS. OTHER. 2.5 MM PINK PAPULE. COMPLETE READ. B) SKIN TAG VS. NEVUS VS OTHER. 2.5 CM PINK PAPULE. COMPLETE READ. C) SKIN TAG VS. NEVUS VS OTHER. 4 MM PINKISH PAPULE. COMPLETE READ. D) NEOPLASM OF UNCERTAIN BEHAVIOR. 6 - 7 MM PINK PAPULE WITHIN CONGENITAL NEVUS. COMPLETE READ.	\N	\N	\N	\N	NEUROFIBROMA	172541	1106	\N	\N	17-55182	C	ME-11	Melanoma Epigenetics	IP1784912	AirTable blocks_with_IP_info.csv
1977	16-103438	71	\N	\N	0	T1a	Primary	superficial spreading melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=25176,24932,27427	172.5	\N	REMOVED: ME-14 : Both Nevus and Melanoma have low VAF (BRAF.V600E).	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei, abundant, pale cytoplasm and dusty appearing melanin or both. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer, and some markedly confluent nests.  There are similar or smaller melanocytes in the subjacent dermis, along with fibrosis and a patchy lymphocytic infiltrate. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected and entirely submitted. KC/KC	5 X 7 CM BLACK RECTANGULAR PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O MELANOMA, SEEP SHAVE REMOVAL	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: left upper back Microscopic tumor type: superficial spreading melanoma Breslow thickness: 0.5 mm. Ulceration: no Margins, peripheral: clear by 1 mm., and deep: clear by 0.4 mm. Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.5 MM. IN THICKNESS, ARISING IN A NEVUS	273588	1109	\N	\N	16-103438	\N	ME-14	Melanoma Epigenetics	IP1703438	AirTable blocks_with_IP_info.csv
2015	17-1468II-2	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1238	\N	\N	None	\N	NM-64	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2127	17-55182D	51	\N	\N	5	T2a	Primary	nodular melanoma (ex melanocytic nevus)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22150	172.5	\N	\N	There is a nodular proliferation of histiocytoid cells with atypical enlarged nuclei in partial contiguity with the epidermis. Some cells are wholly intraepidermal. There is little diminishment in cell size with descent in the dermis. Centrally, there is reticular dermal fibrosis as well. To the side, maturing small melanocytes are in nests, cords, and syncytia.	Skin segment measuring 0.8 x 0.5 x 0.2 cm, bisected and entirely submitted in D. CF/CF	A) SKIN TAG VS. NEVUS VS. OTHER. 2.5 MM PINK PAPULE. COMPLETE READ. B) SKIN TAG VS. NEVUS VS OTHER. 2.5 CM PINK PAPULE. COMPLETE READ. C) SKIN TAG VS. NEVUS VS OTHER. 4 MM PINKISH PAPULE. COMPLETE READ. D) NEOPLASM OF UNCERTAIN BEHAVIOR. 6 - 7 MM PINK PAPULE WITHIN CONGENITAL NEVUS. COMPLETE READ.	\N	\N	Scraping	This biopsy demonstrates nodular melanoma ex congenital melanocytic nevus. Immunostaining with SOX-10 and Melan-A demonstrates intense positivity, and thus melanocytic lineage has been confirmed. Some of the atypical melanocytes have reniform nuclei and histiocytoid morphology, and thus I additionally completed a CD1a immunostain, but the stain is completely negative, and thus the remote possibility of an atypical Langerhans cell infiltrate has been excluded. A synoptic is included below.  Procedure: shave biopsy Microscopic tumor type: nodular melanoma (ex melanocytic nevus) Breslow thickness: at least 1.9 mm Ulceration: not detected Margin: deep edge involved Mitotic index: 5 per square mm Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): at least pT2a	NODULAR MELANOMA OF AT LEAST 1.9 MM IN THICKNESS, ARISING WITHIN A CONGENITAL MELANOCYTIC NEVUS AND INVOLVING THE DEEP EDGE OF THE BIOPSY	139510	1106	\N	\N	17-55182	D	ME-11	Melanoma Epigenetics	IP1784912	AirTable blocks_with_IP_info.csv
2790	22-34510B1	79	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.62	\N	\N	There is a domed surface with psoriasiform epidermal hyperplasia with a thick granular and a compact cornified layer. The center of the specimen shows a proliferation of keratinocytes with atypical nuclei and abundant pale cytoplasm that thicken the epidermis, which has a papillated surface, and forms lobules in part attached to its undersurface.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, quadrisected and entirely submitted. BB/BB	A) SQUAMOUS CELL CARCINOMA. 7 MM PINK SCALY PAPULE.	\N	\N	\N	There are superimposed changes resembling prurigo nodularis. The margins appear clear in the planes of section examined.	SQUAMOUS CELL CARCINOMA	113602	1169	\N	\N	22-34510	B1	MucM-01	Mucosal Melanoma	IP2436172	AirTable blocks_with_IP_info.csv
3252	CP1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2152	\N	\N	None	\N	SYNAT672	2010-2017	\N	AirTable blocks_with_IP_info.csv
2085	17-33401C	85	\N	\N	2	T3b	Primary	NOS, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22147	172.5	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis.  Centrally, there is a large sheet of atypical melanocytes, some of which have an epithelioid morphology and within which mitotic figures are evident. These melanocytes do not diminish in size with descent into the dermis. The epidermis overlying this focus is ulcerated. There is also proliferation of cytologically bland melanocytes in the dermis that diminish in size with descent into the reticular dermis. There is solar elastosis in the dermis.	Oriented ellipse, 7.0 x 3.0 x 0.7 cm, including a central 2.0 x 2.3 cm brown area. With the orienting notch located at the midpoint of one edge and placed distally to the grosser, the notch is indicated as 12 o'clock on the requisition. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with three sections each in A-D and two sections in E. Tips reserved. RS/RS	PRESUMED MM EXC	\N	\N	Scraping	Synoptic melanoma reporting is included below: Procedure: Excision Microscopic tumor type: NOS, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 3.5 mm Ulceration: Present Margins: With the orienting suture placed by the surgeon designated as the 12 o'clock position, residual intraepidermal melanoma extends to within 3 millimeters of the peripheral inked margin at approximately the 12-2 and 7-8 o'clock positions Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT3bNxMx	ULCERATED MELANOMA, 3.5 MILLIMETERS IN THICKNESS, NARROWLY EXCISED	333504	1107	\N	\N	17-33401	C	ME-12	Melanoma Epigenetics	IP1762801	AirTable blocks_with_IP_info.csv
2264	17-130286	17	f	\N	1	T2a	Primary	Nodular	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22144	172.3	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis that form expansile nests. Scattered dermal mitotic figures are noted. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Ellipse, 1.1 x 0.6 x 0.5 cm, including a central 0.8 x 0.5 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections. RS/RS	TWO-TONED PIGMENTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. DYSPLASTIC NEVUS VS. SPITZ NEVUS, ATYPICAL APPEARING MELANOCYTIC LESION, EXCISIONAL BIOPSY	\N	\N	Scraping	I have reviewed this case with Dr. McCalmont who concurs with this diagnosis. Diagnostic features of note include:  Procedure: Excision biopsy Tumor site: Cheek Microscopic tumor type: Nodular Breslow thickness: 1.19 millimeters Ulceration: Absent Margins, peripheral and deep: Free, narrow Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.19 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	123311	1108	\N	\N	17-130286	\N	ME-13	Melanoma Epigenetics	IP1860925	AirTable blocks_with_IP_info.csv
1983	16-108259C	71	\N	\N	0	T1a	Primary	superficial spreading melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24933	172.5	\N	\N	Sections show no evidence of a residual atypical melanocytic lesion along the junctional zone. Central ulcerative fibrosing inflammatory alterations that are post-procedural are noted.	Oriented ellipse, 6.0 x 2.4 x 0.6 cm, including a central 1.0 x 0.9 cm tan area. With the orienting sutured tip placed to the left and designated 9 o'clock by the grosser, the 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with three sections in A, four sections in B and three sections in C. Tips reserved. PL/PL	HEALING BIOPSY SITE; MALIGNANT MELANOMA, PLEASE CHECK MARGINS	\N	\N	Punch	No residuum is apparent, and the final margin is free. An updated melanoma synoptic is included below. Procedure: wide excision Microscopic tumor type: superficial spreading melanoma Breslow thickness: 0.5 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	FREE OF RESIDUAL MELANOMA	273588	1109	\N	\N	16-108259	C	ME-14	Melanoma Epigenetics	IP1703438	AirTable blocks_with_IP_info.csv
2778	22-17043	64	f	\N	1	T1b	Primary	melanoma on skin with high cumulative sun-induced damage (WHO: high CSD melanoma)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=20994,20995,20996	172.4	\N	\N	Sections show a bi-phasic proliferation of melanocytes. With larger, epithelioid melanocytes in the superficial dermis and small monomorphous melanocytes underneath.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. PIGMENTED BCC. PAPULE.	\N	\N	FFPE	The superficial component of larger melanocytes is PRAME positive and p16 negative, whereas the small melanocytes at the base (representing the nevus) are negative. Diagnostic features of note include:  Procedure: shave biopsy Microscopic tumor type: melanoma on skin with high cumulative sun-induced damage (WHO: high CSD melanoma) Breslow thickness: 0.9 mm (measured to the deepest PRAME positive/p16 negative cell) Ulceration: absent Margins, peripheral and deep: narrow. Deep margin involved by nevus Mitotic index: 1/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1b pNX	MELANOMA, 0.9 mm IN THICKNESS, ARISING IN A PREDOMINANTLY INTRADERMAL NEVUS	445440	1132	\N	\N	22-17043	\N	ME-37	Melanoma Epigenetics	IP1179175	AirTable blocks_with_IP_info.csv
3098	46976B	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1244	\N	\N	None	\N	NM-70	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1974	16-99265	37	f	\N	0	T1a	Primary	SSM, non-CSD	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22141,25173	172.5	\N	\N	Sections show a proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. In one area there are delicate spindle cells in the dermis along with histiocytes, likely representing a an area of scar.	Skin segment measuring 1.4 x 1.0 x 0.4 cm, quadrisected and entirely submitted. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SEBORRHEIC KERATOSIS. 1.4 X 1.1 CM BLACK VERRUCOUS PLAQUE. (SEE PHOTO)	\N	\N	Scraping	I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with these findings. Diagnostic features of note include:  Procedure: excision Tumor site: back Microscopic tumor type: SSM, non-CSD Breslow thickness: 0.65 mm Ulceration: absent Margins, peripheral and deep: clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular invasion:  absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.65 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	138523	1110	\N	\N	16-99265	\N	ME-15	Melanoma Epigenetics	IP1699195	AirTable blocks_with_IP_info.csv
10112	HW2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, vulva, Hong Wu	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1487	\N	\N	\N	\N	SYNX84	\N	\N	Consolidated_data_final.csv
1978	16-104614H	37	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24934	172.5	\N	\N	Sections show no evidence of a residual atypical melanocytic lesion along the junctional zone. Central ulcerative fibrosing inflammatory alterations that are post-procedural are noted.	Ellipse, 9.7 x 3.4 x 1.2 cm, including a central 1.8 x 1.5 cm depression. In addition, there is a peripherally located 0.3 x 0.3 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections in A, one section each in B-C, one section (bisected) each in D-H, and one section each in I-K. The section in K is a representative section through the peripheral brown area. Tips reserved. RS/RS	MALIGNANT MELANOMA, PLEASE CHECK MARGINS	\N	\N	Punch	No residuum is apparent, and the final margin is free. An incidental lentiginous junctional melanocytic nevus is noted. An updated melanoma synoptic is included below. Procedure: wide excision Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.65 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	FREE OF RESIDUAL MELANOMA	139522	1110	\N	\N	16-104614	H	ME-15	Melanoma Epigenetics	IP1699195	AirTable blocks_with_IP_info.csv
2181	17-83378B	62	\N	\N	1	T3a	Primary	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22156	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of melanocytes with a broad-based flat area and a dome surfaced and flat based nodular one. The flat area features rete ridges whose bases are fused by a proliferation of small fusiform cells with monomorphous oval nuclei and scant cytoplasm. There is subjacent fibroplasia. The nodular area features a thin epidermis and sheets of large, oval melanocytes with abundant, pale cytoplasm and dusty melanin, and large, pleomorphic vesicular nuclei. There is failure of maturation and dispersion with descent and scattered mitotic figures are present.	Ellipse, 2.5 x 1.7 x 1.3 cm, including a central 2.0 x 1.5 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with three sections in A, two sections each in B-C, and three sections in D. HD/HD	MELANOMA	\N	\N	Scraping	The neoplasm may have arisen in a dysplastic nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: clear by 1 mm., and deep: clear by 7 mm. Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	MELANOMA, 2.5 MM. IN THICKNESS	173525	1111	\N	\N	17-83378	B	ME-16	Melanoma Epigenetics	IP1813443	AirTable blocks_with_IP_info.csv
2182	17-83378C	62	\N	\N	1	T3a	Primary	None	\N	\N	FFPE	\N	\N	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of melanocytes with a broad-based flat area and a dome surfaced and flat based nodular one. The flat area features rete ridges whose bases are fused by a proliferation of small fusiform cells with monomorphous oval nuclei and scant cytoplasm. There is subjacent fibroplasia. The nodular area features a thin epidermis and sheets of large, oval melanocytes with abundant, pale cytoplasm and dusty melanin, and large, pleomorphic vesicular nuclei. There is failure of maturation and dispersion with descent and scattered mitotic figures are present.	Ellipse, 2.5 x 1.7 x 1.3 cm, including a central 2.0 x 1.5 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with three sections in A, two sections each in B-C, and three sections in D. HD/HD	MELANOMA	\N	\N	FFPE	The neoplasm may have arisen in a dysplastic nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: clear by 1 mm., and deep: clear by 7 mm. Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	MELANOMA, 2.5 MM. IN THICKNESS	173525	1111	\N	\N	17-83378	C	ME-16	Melanoma Epigenetics	IP1813443	AirTable blocks_with_IP_info.csv
2183	17-83378D	62	\N	\N	1	T3a	Primary	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22440	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of melanocytes with a broad-based flat area and a dome surfaced and flat based nodular one. The flat area features rete ridges whose bases are fused by a proliferation of small fusiform cells with monomorphous oval nuclei and scant cytoplasm. There is subjacent fibroplasia. The nodular area features a thin epidermis and sheets of large, oval melanocytes with abundant, pale cytoplasm and dusty melanin, and large, pleomorphic vesicular nuclei. There is failure of maturation and dispersion with descent and scattered mitotic figures are present.	Ellipse, 2.5 x 1.7 x 1.3 cm, including a central 2.0 x 1.5 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with three sections in A, two sections each in B-C, and three sections in D. HD/HD	MELANOMA	\N	\N	Punch	The neoplasm may have arisen in a dysplastic nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: clear by 1 mm., and deep: clear by 7 mm. Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	MELANOMA, 2.5 MM. IN THICKNESS	173525	1111	\N	\N	17-83378	D	ME-16	Melanoma Epigenetics	IP1813443	AirTable blocks_with_IP_info.csv
1975	16-101803B	66	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	\N	172.3	\N	\N	There are melanocytes distributed singly and in small nests in lentiginous fashion at the junction, and some suprajunctional scatter of melanocytes is noted. The perijunctional dermis contains a lymphohistiocytic infiltrate with admixed melanophages, and elastosis is present more deeply. In subjunctional fibrosis, plump nests of melanocytes are noted. To the side of this, a large population of small syncytial maturing melanocytes is noted.	Skin segment measuring 1.9 x 1.3 x 0.3 cm, serially sectioned and entirely submitted with five sections in B. RS/RS	A) 12 X 7 MM RED SCALY PLAQUE; POSS NMSC, B) 14 X 11 MM DARK BROWN PLAQUE NEVUS; POSS ATYPIA, C) 4 X 3 MM BROWN MACULE; NEVUS POSS ATYPIA, D) 6 X 5 MM BROWN DARK MACULE; ATYPICAL NEVUS POSS MM	\N	\N	Scraping	A large congenital melanocytic nevus occupies about half of the middle of this specimen. To one side of the melanocytic nevus, there is a second population of atypical melanocytes, and I believe these cells represent a thin invasive melanoma with a mostly nested pattern. Synoptic parameters for this melanoma are listed below. Procedure: shave removal Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.65 mm Ulceration: not detected Margin: periphery involved by melanoma in situ Mitotic index: 0 Regression: not significant; inflammation is present Pathologic staging (pTNM): pT1a	MELANOMA OF 0.65 MM IN THICKNESS, CONTIGUOUS WITH A CONGENITAL MELANOCYTIC NEVUS	173316	1112	\N	\N	16-101803	B	ME-17	Melanoma Epigenetics	IP1701781	AirTable blocks_with_IP_info.csv
1976	16-103071	85	\N	\N	0	T1a	Primary	melanoma NOS (melanoma ex melanocytic nevus)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22137,25177	172.6	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes in predominance in many areas, and marked epidermal thinning is noted. There are irregular clusters of similar cells in the superficial dermis, also above elastosis, and no maturation is apparent. A lymphohistiocytic infiltrate with admixed melanophages is present as well. Focally, maturing melanocytes are noted in the subjacent reticular dermis.	Cylindrical skin segment, 0.8 cm in diameter and 0.5 cm in thickness, with the margins inked, trisected and entirely submitted. RS/RS	ATYPICAL PIGMENTED MACULE; R/O MM	\N	\N	Scraping	This biopsy demonstrates melanoma overlying a longstanding melanocytic nevus. Synoptic parameters are included below. Procedure: subtotal excision Microscopic tumor type: melanoma NOS (melanoma ex melanocytic nevus) Breslow thickness: 0.55 mm Ulceration: not detected Margin: periphery involved Mitotic index: 0 Regression: present; partial Pathologic staging (pTNM): pT1a	MELANOMA OF 0.55 MM IN THICKNESS, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173602	1113	\N	\N	16-103071	\N	ME-18	Melanoma Epigenetics	IP1174641	AirTable blocks_with_IP_info.csv
1979	16-105218C	85	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22435	172.6	\N	\N	Sections show post-surgical disruption flanked by a proliferation of melanocytes arrayed erratically within the epidermis and dermis. There are cords of hyperchromatic melanocytes in the dermal component.	Ellipse, 7.4 x 2.8 x 1.8 cm, including a central 0.7 x 0.9 cm depression. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with one section each in A-I. Tips reserved. RS/RS	PRIOR BX MM, CHECK MARGINS PLS	\N	\N	Scraping	An updated melanoma synoptic is included below. Procedure: wide excision Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.55 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	RESIDUAL MELANOMA OF 0.55 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	173602	1113	\N	\N	16-105218	C	ME-18	Melanoma Epigenetics	IP1174641	AirTable blocks_with_IP_info.csv
2179	17-82793A	52	\N	\N	0	T1a	Primary	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23367	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and abundant, pale cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and small nests, with some present above the basal layer. The epidermis is thickened in the involved area There are melanocytes in the subjacent dermis with  large and irregularly shaped and hyperchromatic nuclei and scant cytoplasm. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei in a separate dome surfaced area, with a partially peri-adnexal pattern in the superficial reticular dermis.	Skin segment measuring 1.0 x 0.9 x 0.5 cm, quadrisected, and entirely submitted in A. HD/HD	A) PINK PAPULE WITH PERIPHERAL MACULAR BROWN PIGMENTATION, ATYPICAL NEVUS VS. OTHER; B) FIRM PINK PAPULE, DERMATOFIBROMA VS. OTHER.	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists, updated from the report of the prior biopsy include: Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: clear by 1 mm. and deep: clear by < 2 mm. Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.95 MM. IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173688	1114	\N	\N	17-82793	A	ME-19	Melanoma Epigenetics	IP1812855	AirTable blocks_with_IP_info.csv
2476	19-135629A	55	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22441	380.0	\N	\N	Sections show a focally hypergranulotic and hyperkeratotic epidermis beneath which there is an increase in spindled cells and small blood vessels.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) EROSION WITH SURROUNDING ERYTHEMA TO R ANTIHELIX; FAVOR CNH, B) SMALL VARIEGATED MACULE; FAVOR NEVUS VS. R/O MELANOMA, C) IRREGULAR DARK BROWN MACULE; FAVOR NEVUS	\N	\N	Scraping	\N	CHONDRODERMATITIS NODULARIS HELICIS	100223	1114	\N	\N	19-135629	A	ME-19	Melanoma Epigenetics	IP1812855	AirTable blocks_with_IP_info.csv
2133	17-61310	35	f	\N	0	T1a	Primary	Superficial spreading	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=25174,22153	172.6	\N	\N	Sections show a broad proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Oval excision measuring 1.4 x 1.3 x 0.3 cm, including a brown surface. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections. KC/KC	IRREGULARLY PIGMENTED PLAQUE; R/O MELANOMA VS. SK VS. NEVUS	\N	\N	Scraping	I have examined additional sections and a Melan-A stain which highlights the markedly irregular and confluent distribution of junctional melanocytes as well as clusters of similar melanocytes in the upper dermis. In additional there is also a proliferation of bland dermal melanocytes that mature with descent. The measurement of this lesion is complicated by large areas in which the epidermis has become detached. I think that this is post excisional biopsy phenomenon and not reflective of clinical ulceration. Diagnostic features of note include:  Procedure: Excisional biopsy Tumor site: Arm Microscopic tumor type: Superficial spreading Breslow thickness: 0.7 millimeters Ulceration: Absent Margins, peripheral and deep: Peripheral involved by melanoma in situ, deep free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT1a	MELANOMA, APPROXIMATELY 0.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173688	1115	\N	\N	17-61310	\N	ME-20	Melanoma Epigenetics	IP1791101	AirTable blocks_with_IP_info.csv
2016	17-1741I	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1239	\N	\N	17-1741	I	NM-65	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2130	17-56506	56	f	\N	2	T2a	Primary	NOS, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis. Within the epidermis, there are numerous melanocytes in irregular pagetoid array and there are nests of similar melanocytes in the dermis. There is also a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures. There are melanocytes that extend into adnexal epithelium as single cells as well.	Skin segment measuring 2.2 x 2.0 x 0.4 cm, with base inked blue, the specimen is serially sectioned and entirely submitted with ten sections. KC/KC	R/O MM	\N	\N	Scraping	Synoptic melanoma reporting based on this partial biopsy is included below. Procedure: Deep shave biopsy Tumor site: Left lower leg Microscopic tumor type: NOS, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 1.5 millimeters, at least Ulceration: Absent Margins: + base; + peripheral Mitotic index: 2/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2aNxMx	MELANOMA, AT LEAST 1.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173741	1116	\N	\N	17-56506	\N	ME-21	Melanoma Epigenetics	IP1786249	AirTable blocks_with_IP_info.csv
10990	SP-13-006535C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2058	\N	\N	\N	\N	SYNX655	\N	\N	Consolidated_data_final.csv
2115	17-43703	41	\N	\N	1	T1b	Primary	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23270,25079,25175	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and abundant, pale cytoplasm and dusty appearing melanin. These cells form both small and large nests in the papillar dermis, with foci in which single cells colonize the basal layer of the epidermis with a small amount of suprabasal scatter. In some areas, junctional melanocytes are present at the sides and bases of rete ridges, with bridging and fibroplasia. There is a dense infiltrate of lymphocytes and melanophages and beneath it, discrete aggregations of small round melanocytes.	Oval excision, 1.1 x 0.7 x 0.5 cm, including a central 0.7 x 0.6 cm dark-brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections. CF/CF	BLACK PAPULE WITH IRREGULARLY PIGMENTED EXTENSION; R/O MM (SEE PHOTO)	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1b pNX	MELANOMA, 0.7 MM. IN THICKNESS, ARISING IN A NEVUS	529699	1117	\N	\N	17-43703	\N	ME-22	Melanoma Epigenetics	IP1773263	AirTable blocks_with_IP_info.csv
2084	17-32863B	50	f	\N	0	T1a	Primary	superficial spreading melanoma, non-chronically sun damaged (non-CSD) skin	\N	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis with a lymphohistiocytic inflammatory infiltrate. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.1 x 1.1 x 0.1 cm, serially sectioned, and entirely submitted with five sections in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. BASAL CELL CARCINOMA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA. PAPULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA. PAPULE. BCC VS. ACROANGIODERMATITIS. D) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. ACROANGIODERMATITIS. PAPULE.	\N	\N	Scraping	A synoptic report of potential prognostic factors is listed below: Procedure: shave biopsy Microscopic tumor type: superficial spreading melanoma, non-chronically sun damaged (non-CSD) skin Breslow thickness: 0.5 mm Ulceration: absent Margins, peripheral and deep: deep negative, peripheral focally positive Mitotic index: 0 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.5 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173777	1118	\N	\N	17-32863	B	ME-23	Melanoma Epigenetics	IP1762252	AirTable blocks_with_IP_info.csv
2046	17-13334	71	f	\N	0	T1a	Primary	Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22145	172.5	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and these melanocytes are within fibrosis that overlies solar elastosis. There are also collections of small and cytologically bland melanocytes in the dermis that diminish in size with descent and are present within solar elastosis.	Skin segment measuring 1.3 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	1.2 CM PEARLY PATCH	\N	\N	Scraping	There is a background of a melanocytic nevus with superficial congenital features and thus this melanoma most likely arose within a background of a melanocytic nevus. The melanoma is largely not pigmented, which helps to explain why it was clinically perceived as a pearly patch. Synoptic melanoma reporting is included below:  Procedure: Shave biopsy Microscopic tumor type: Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.55 mm Ulceration: Absent Margins: + base; + periphery Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.55 MILLIMETERS IN THICKNESS, EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	139522	1119	\N	\N	17-13334	\N	ME-24	Melanoma Epigenetics	IP1732209	AirTable blocks_with_IP_info.csv
2075	17-27224	71	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22436	216.5	\N	\N	There is a compound proliferation of melanocytes mostly involving the junctional zone and a thickened papillary dermis.  Nests of, and increased numbers of single melanocytes are situated at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused.  Toward the center of the lesion, smaller melanocytes reside in the papillary dermis.	Skin segment measuring 1.3 x 1.0 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	0.6 CM BROWN MACULE (PERSONAL HISTORY OF MELANOMA)	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, EXCISED IN THE AVAILABLE PLANES OF SECTION	139522	1119	\N	\N	17-27224	\N	ME-24	Melanoma Epigenetics	IP1732209	AirTable blocks_with_IP_info.csv
3042	1135/19	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1240	\N	\N	None	\N	NM-66	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2914	59/15	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1241	\N	\N	None	\N	NM-67	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2187	17-89239A	63	f	\N	0	T1a	Primary	melanoma ex nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26688	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population of melanocytes is arrayed in poorly circumscribed fashion along the junction, as irregular nests and single cells, with some cells in pagetoid array.  The second population of melanocytes consists of nests of slightly smaller cells arrayed along the junction and in the papillary dermis (melanocytic nevus).	Skin segment measuring 1.2 x 0.7 x 0.2 cm, trisected and entirely submitted in A. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA. ASYMMETRIC PIGMENTED LESION. PLEASE CHECK MARGINS.. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA. ASYMMETRIC PIGMENTED LESION. PLEASE CHECK MARGINS..	\N	\N	FFPE	This melanoma appears to have arisen within a Clark's/dysplastic nevus. A synoptic report of potential prognostic factors is listed below: Procedure: saucerization biopsy Microscopic tumor type: melanoma ex nevus Breslow thickness: 0.75 mm Ulceration: absent Margins, peripheral and deep: deep <0.5 mm, peripheral positive Mitotic index: 0 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.75 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS	173532	1141	\N	\N	17-89239	A	ME-46	Melanoma Epigenetics	IP850037	AirTable blocks_with_IP_info.csv
2083	17-31440	55	f	\N	0	T1a	Primary	Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22146	172.5	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis. Within the epidermis, there are areas in which melanocytes are present above the basal layer of the epidermis and other areas in which they are configured as single cells in confluence. There are nests of similar melanocytes in the dermis. In addition, there is a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures. There is solar elastosis in the dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. HD/HD	PATIENT WITH A HISTORY OF METASTATIC MELANOMA, WHO P/W A CHANGING MOLE ON THE BACK, 5 X 6 MM BROWN PAPULE; R/O DYSPLASTIC NEVUS VS. NEOPLASM	\N	\N	Scraping	Synoptic melanoma reporting is included below: Procedure: Shave biopsy Microscopic tumor type: Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.5 mm Ulceration: Absent Margins: Intraepidermal melanoma extends to the peripheral edge of the specimen Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	273588	1120	\N	\N	17-31440	\N	ME-25	Melanoma Epigenetics	IP266136	AirTable blocks_with_IP_info.csv
2109	17-36409	45	f	\N	1	T2a	Primary	Nevoid	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22148	172.7	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and as large elongate nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Cylindrical skin segment, 0.7 cm in diameter and 0.8 cm in thickness, bisected and entirely submitted. KC/KC	PT WITH > 100 NEVI, NOW WITH DARK BLACK / BLUE NODULE; R/O MM VS. PIGMENTED BASAL CELL VS. ATYPICAL NEVUS	\N	\N	Scraping	Diagnostic features of note include: Procedure: Punch Tumor site: Thigh Microscopic tumor type: Nevoid Breslow thickness: 1.28 millimeters Ulceration: Absent Margins, peripheral and deep: Involved by invasive and in situ melanoma Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.28 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173777	1121	\N	\N	17-36409	\N	ME-26	Melanoma Epigenetics	IP1765868	AirTable blocks_with_IP_info.csv
2132	17-61108	74	f	0.85	2	T1b	Primary	Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22152	172.5	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters and sheets in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis.  In addition, mitotic figures are present amid dermal melanocytes. There is a heavy surrounding inflammatory infiltrate. There is also a second population of smaller melanocytes that diminish in size with descent in the dermis and that intercalate with solar elastosis (melanocytic nevus).	Skin segment measuring 1.2 x 1.0 x 0.1 cm, quadrisected and entirely submitted. CF/CF	R/O PIG BCC / INFL SK / DN	\N	\N	Scraping	The findings in this biopsy are in keeping with a melanoma of 0.85 millimeters in thickness arising in association with a melanocytic nevus with superficial congenital features. Is there a history of a changing pigmented lesion? Synoptic melanoma reporting is included below:  Procedure: Shave biopsy Microscopic tumor type: Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.85 mm Ulceration: Absent Margins: + base; abuts periphery Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1bNxMx	MELANOMA, 0.85 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTES NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	433599	1122	\N	\N	17-61108	\N	ME-27	Melanoma Epigenetics	IP983876	AirTable blocks_with_IP_info.csv
2117	17-43712	47	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22149	172.5	\N	\N	Sections show a compound proliferation of melanocytes with vacuolated and finely pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, and associated suprabasal scatter is focally apparent. There are also nests of similar melanocytes in the upper dermis, where a lymphohistiocytic infiltrate with admixed melanophages resides with fibrosis.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	R/O APL	\N	\N	Scraping	This biopsy demonstrates a thin invasive melanoma that has developed in conjunction with a small congenital melanocytic nevus, a remnant of which is included subjacent to the melanoma. A brief synoptic is included below. Procedure: shave removal Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.65 mm Ulceration: not detected Margin: focally involved by melanoma in situ Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	MELANOMA OF 0.65 MM IN THICKNESS, FOCALLY TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173539	1123	\N	\N	17-43712	\N	ME-28	Melanoma Epigenetics	IP741233	AirTable blocks_with_IP_info.csv
2134	17-62026B	47	\N	\N	0	T1a	Primary	melanoma NOS	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22439	172.5	\N	\N	Sections show central iatrogenic fibrosing inflammatory alterations stemming from a procedure, and no evidence of an atypical melanocytic proliferation remains in contiguity with this.	Oriented ellipse, 4.7 x 1.7 x 1.2 cm, including a central 1.0 x 0.5 cm brown area. With the orienting sutured tip placed to the left and indicated medial on the requisition, the sutured tip is designated 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in A-D. Tips reserved. PL/PL	MM EXCISION, RE-EXC DT17-43712	\N	\N	Scraping	No residuum is apparent, and the final margin is now free. An updated brief synoptic is included below. Procedure: wide excision Microscopic tumor type: melanoma NOS Breslow thickness: 0.65 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	POST-PROCEDURAL SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173539	1123	\N	\N	17-62026	B	ME-28	Melanoma Epigenetics	IP741233	AirTable blocks_with_IP_info.csv
3041	718/12a	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1242	\N	\N	None	\N	NM-68	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3125	115016	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1243	\N	\N	None	\N	NM-69	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2261	17-125030	72	\N	\N	2	T4a	Primary	nodular ex nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22143	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  There are:  • A peripheral papillated portion in which nests of moderately enlarged melanocytes bridges adjacent rete ridges, with subjacent fibroplasia  • small, round melanocytes in the subjacent dermis in that area • a central nodule in which there are sheets of large, oval melanocytes with abundant, pale cytoplasm and large, pleomorphic vesicular nuclei with large, central nucleoli  • mitotic figures among the larger cells, which do no mature with descent	Skin segment measuring 2.8 x 1.8 x 0.7 cm. Three representative sections submitted. RS/RS	3 CM BRN TO PINK NODULE; POSS SK VS. MM	\N	\N	Scraping	The central, exophytic nodule is melanoma. It arose in a flattish but papillated pre-existent nevus, whose contour resembles that of a seborrheic keratosis, accounting for your observation. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: nodular ex nevus Breslow thickness: 5.0 mm. Ulceration: no Margins, peripheral: involved by pre-existent dysplastic nevus, and deep: focally involved Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX	MELANOMA, 5 MM. IN THICKNESS, ARISING IN A NEVUS	528599	1124	\N	\N	17-125030	\N	ME-29	Melanoma Epigenetics	IP1855625	AirTable blocks_with_IP_info.csv
2389	19-4879	78	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.4	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Skin segment measuring 1.0 x 0.7 x 0.2 cm, trisected and entirely submitted. HD/HD	BLUE NEVUS; R/O MELANOMA	\N	\N	Scraping	None	BLUE NEVUS, SPINDLE CELL/SCLEROTIC TYPE	423456	1125	\N	\N	19-4879	\N	ME-30	Melanoma Epigenetics	IP935967	AirTable blocks_with_IP_info.csv
2381	19-2118	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.  A superficial scar is present.	Elliptical excision, 2.2 x 0.9 x 0.3 cm, including a central 0.7 x 0.6 cm white-gray area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with eight sections. CF/CF	BLUE-GREY PAPULE, WHITE CYSTIC COMPONENT AT LATERAL EDGE (AT SITE OF RECURRENT BLUE NEVUS); BLUE NEVUS, R/O ATYPIA	\N	\N	Scraping	None	BLUE NEVUS, SPINDLE CELL/SCLEROTIC TYPE, COMPLETELY EXCISED	173663	1126	\N	\N	19-2118	\N	ME-31	Melanoma Epigenetics	IP2001940	AirTable blocks_with_IP_info.csv
2376	19-488	51	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages and by thickened collagen bundles.	Cylindrical skin segment and skin segment received. Cylindrical skin segment, 0.5 cm in diameter and 0.2 cm in thickness. Skin segment measuring 0.5 x 0.4 x 0.1 cm. Each bisected and all entirely submitted. KC/KC	4 MM BLACK PAPULE THAT IS GETTING BIGGER AND DARKER; R/O ATYPIA	\N	\N	Scraping	None	BLUE NEVUS	173676	1127	\N	\N	19-488	\N	ME-32	Melanoma Epigenetics	IP2004512	AirTable blocks_with_IP_info.csv
1895	16-1675	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	1128	\N	\N	16-1675	\N	ME-33	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
2377	19-596B	56	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	\N	\N	Sections show a proliferation of spindled and dendritic melanocytes enmeshed in thickened, sclerotic collagen. The lesional cells show considerable cytoplasmic pigmentation and scattered accompanying melanophages are appreciable as well.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) PATCH AND MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS, B) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. DERMATOFIBROMA	\N	\N	Scraping	There is no evidence of melanoma or a dysplastic nevus.	DESMOPLASTIC BLUE NEVUS	123747	1129	\N	\N	19-596	B	ME-34	Melanoma Epigenetics	IP2004620	AirTable blocks_with_IP_info.csv
2383	19-2710	25	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a wedge shaped area in the superficial and deep dermis with sparse bipolar dendritic melanocytes, thickened collagen bundles and melanophages.	Ellipse measuring 1.4 x 0.8 x 0.7 cm, serially sectioned perpendicular to the long axis and entirely submitted with six sections. The specimen vial was examined for additional tissue. PL/PL	LESION ON LEFT BACK - EPIDERMAL CYST	\N	\N	Scraping	The neoplasm extends to the base of the specimen. There are no worrisome features, however.	BLUE NEVUS	173530	1130	\N	\N	19-2710	\N	ME-35	Melanoma Epigenetics	IP2006742	AirTable blocks_with_IP_info.csv
2186	17-88895	69	f	\N	0	T1a	Primary	Melanoma, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	\N	172.4	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis.  Some of the dermal melanocytes are within fibrosis overlying solar elastosis. There is a second population of smaller melanocytes arranged as cords and strands between collagen bundles and elastotic fibers in the reticular dermis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted with two sections and one fragment. PL/PL	PIGMENTED PAPULE, HISTORY OF MM	\N	\N	Scraping	Preliminary synoptic melanoma reporting, based on this partial biopsy, is included below: Procedure: Shave biopsy Microscopic tumor type: Melanoma, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.8 mm Ulceration: Absent Margins: + base; + peripheral Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, AT LEAST 0.8 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	173405	1131	\N	\N	17-88895	\N	ME-36	Melanoma Epigenetics	IP979333	AirTable blocks_with_IP_info.csv
1149	05-605A2	44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.11	\N	\N	Sections show an epidermis expanded by a proliferation of keratinocytes arrayed as broad interconnected rete.  Some keratinocytes are deeply pigmented, and melanophages are present in the papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in cassette A.	R/O BCC	\N	\N	\N	\N	HYPERPIGMENTED SEBORRHEIC KERATOSIS	173536	1165	\N	\N	05-605	A2	MP-01	Hockemeyer Melanoma Progression	IP401771	AirTable blocks_with_IP_info.csv
2382	19-2264A	60	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles with intervening areas displaying fibrosis and sclerosis and containing melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted in A. KC/KC	A) 3 MM BLACK / TAN MACULE; R/O MM, B) 5 MM IRREGULARLY BORDERED BROWN / BLACK MACULE; R/O MM	\N	\N	Scraping	\N	BLUE NEVUS	100444	1178	\N	\N	19-2264	A	NL-016	Nevus Library	IP1955064	AirTable blocks_with_IP_info.csv
2341	18-97419C	74	f	\N	0	T2a	Primary	SSM, melanoma on skin with low cumulative sun-induced damage (low CSD melanoma)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26193	172.5	\N	definite MIS with sclerotic nevus/melanoma component	Sections show a zone of granulation tissue representing the residuum of a prior biopsy site, flanked by a proliferation of atypical melanocytes in irregular array along the junctional zone and in the underlying dermis, with cords of neoplastic melanocytes stacked horizontally between fibrosis. There are small melanocytes with round to oval nuclei in the dermis in one area.	Oriented ellipse, 5.2 x 1.7 x 0.4 cm, including a central 3.0 x 14 cm pink brown area. The orienting notched edge is indicated as medial superior on the requisition form, designated as 12 o'clock, and placed toward 12 o'clock. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with submitted with six sections in A, four sections in B, and six sections in C. Tips reserved. HD/HD	EXC OF COMPOUND MELANOCYTIC PROLIFERATION - SEE PATH DT18-70644	\N	chest	FFPE	There is a substantial residuum, which in some areas shows unequivocal features of melanoma. There is also an associated nevus. Diagnostic features of note include:  Procedure: re-excision Tumor site: chest Microscopic tumor type: SSM, melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Breslow thickness: 1.4mm Ulceration: absent Margins, peripheral and deep: clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, 1.4 MM IN THICKNESS, COMPLETELY EXCISED, WITH MARGINS FREE OF NEOPLASM	573535	1133	\N	\N	18-97419	C	ME-38	Melanoma Epigenetics	IP1934546	AirTable blocks_with_IP_info.csv
2124	17-51847B	70	f	\N	1	T2a	Primary	Nevoid	\N	\N	FFPE	\N	\N	172.5	\N	Good case	Sections show a very broad proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are hyperchromatic melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei that tend to mature with descent.	Ellipse, 3.2 x 2.5 x 0.6 cm, including a central 2.0 x 1.6 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, four sections in B, and five sections in C. RS/RS	1.7 X 1.6 CM BROWN PATCH W/ IRREGULAR BORDERS AND COLOR; R/O MELANOMA (TELEPHONE: 415-902-7635 OK TO LM)	\N	right axilla	FFPE	Diagnostic features of note include: Procedure: Excision Tumor site: Axilla Microscopic tumor type: Nevoid Breslow thickness: 1.33 millimeters Ulceration: Absent Margins, peripheral and deep: Free Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.33 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, COMPLETELY EXCISED	173540	1134	\N	\N	17-51847	B	ME-39	Melanoma Epigenetics	IP524148	AirTable blocks_with_IP_info.csv
2202	17-100072A	69	\N	\N	1	T2a	Primary	Melanoma, NOS, arising in association with a melanocytic nevus with superfical congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26196	172.6	\N	Good case	Sections show a broad proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, some of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis. The dermal melanocytes are located within fibrosis overlying solar elastosis. There are melanocytes distributed irregularly in the epidermis overlying solar elastosis in some areas as well.  Centrally, in some areas there are melanocytes that mature with descent into the dermis and which extend around adnexal epithelium.  An artifactual rift is present within the epidermis.	Oriented blunted ellipse, 2.2 x 1.3 x 0.7 cm, including a central 1.3 x 0.8 cm brown area. The blunted tip is placed to the left and designated as 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and four in B. CF/CF	R/O ATYPICAL NEVUS	\N	left posterior shoulder	FFPE	The microscopic findings in this specimen are in keeping with a melanoma arising in association with a melanocytic nevus with superfical congenital features. Synoptic melanoma reporting is included below: Procedure: Excisional biopsy Microscopic tumor type: Melanoma, NOS, arising in association with a melanocytic nevus with superfical congenital features Breslow thickness: 1.2 mm Ulceration: Absent Margins: Intraepidermal melanoma extends to within 1-2 millimeters of most of the peripheral inked margins Mitotic index: 1/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2aNxMx	MELANOMA, 1.2 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND WITH CLOSE EXTENSION TO THE PERIPHERAL INKED MARGINS	529698	1135	\N	\N	17-100072	A	ME-40	Melanoma Epigenetics	IP1830366	AirTable blocks_with_IP_info.csv
2063	17-23681	73	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26197	172.5	\N	Small nevus	Sections show a broad compound proliferation of melanocytes with vacuolated and finely pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, and conspicuous associated suprabasal scatter is also apparent. There are also nests and cords of similar melanocytes in the upper dermis, where a lymphohistiocytic infiltrate with admixed melanophages resides jointly with fibroplasia. More deeply, there are maturing melanocytes in nests, cords, and small syncytia.	Skin segment measuring 1.8 x 1.6 x 0.2 cm, serially sectioned and entirely submitted with eight sections. RS/RS	2.0 CM IRREGULAR RED / BLACK PAPULE; ? MM	\N	midline mid lower back	FFPE	This biopsy demonstrates a thin invasive melanoma with associated partial regression that developed overlying a remnant of a small congenital melanocytic nevus. A synoptic is included below. Procedure: shave removal Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.5 mm Ulceration: not detected Margin: periphery involved by melanoma in situ Mitotic index: 0 Regression: present; extensive partial Pathologic staging (pTNM): pT1a	MELANOMA OF 0.5 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE PERIPHERY OF THE BIOPSY	291511	1136	\N	\N	17-23681	\N	ME-41	Melanoma Epigenetics	IP802036	AirTable blocks_with_IP_info.csv
2839	22-102809	82	f	\N	1	T2a	Primary	melanoma on skin with low cumulative sun-induced damage (low CSD melanoma)	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=27911	172.5	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis, as well as a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Skin segment measuring 1.4 x 1.1 x 0.2 cm, serially sectioned and enrtirely submitted with five sections. BB/BB	ISK - TX'D, NOW WITH SCAR, PIH VS. MELANOCYTIC PROCESS, 15 X 9 MM	\N	\N	FFPE	Diagnostic features of note include: Procedure: shave biopsy Microscopic tumor type: melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Breslow thickness: 1.8 mm Ulceration: absent Margins, peripheral and deep: both narrow Mitotic index: 1/mm2 Microsatellitosis: not detected Vascular invasion: not detected Perineural invasion: not detected Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.8 mm IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE SPECIMEN BASE AND EDGE	139523	1157	\N	\N	22-102809	\N	ME-62	Melanoma Epigenetics	IP642510	AirTable blocks_with_IP_info.csv
3153	B224228/2	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1224	\N	\N	None	\N	NM-47	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1985	16-109052C	70	f	\N	0	T1a	Primary	Nevoid	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26198	172.5	\N	Small nevus area	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  A band like infiltrate of lymphocytes is present and a scar from a prior biopsy is identified.	Ellipse, 7.5 x 2.8 x 1.1 cm, including a central 1.6 x 1.2 cm variegated brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in A-B, three sections each in C-D, and two sections each in E-F. Tips reserved. KC/KC	MALIGNANT MELANOMA, PLEASE CHECK MARGINS	\N	right mid upper back	FFPE	I did not review the prior biopsy.  Based on the findings in the excision specimen the following microstaging parameters apply: Procedure: Excision Tumor site: Back Microscopic tumor type: Nevoid Breslow thickness: 0.62 millimeters Ulceration: Absent Margins, peripheral and deep: Free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Present Pathologic Staging (pTNM): pT1a	SCAR AND RESIDUAL MELANOMA, 0.62 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED	139524	1137	\N	\N	16-109052	C	ME-42	Melanoma Epigenetics	IP1709134	AirTable blocks_with_IP_info.csv
2113	17-38404A2	72	\N	\N	1	T2a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26199,37568	172.5	\N	OK, but nevus blends with melanoma	Sections show a proliferation of melanocytes that involves the epidermis and dermis with two populations of cells. One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer, and there are similar melanocytes in subjacent fibrotic inflamed dermis as well. The second population consists of deep small melanocytes in nests, cords, and syncytia. There is also an intermediate population of finely pigmented melanocytes that are small and that are accompanied by melanophages.	Oriented ellipse, 2.7 x 1.6 x 0.4 cm, including a central 1.4 x 0.7 cm variegated brown area. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, indicated as superior on the requisition form, and designated as 12 o'clock by the grosser. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections each in A1-A2. HD/HD	A) ? MELANOMA, B-C) VASCULAR LESION, BEING WORKED UP FOR FABRY'S SYNDROME; R/O ANGIOKERATOMA?	\N	right lateral chest	FFPE	At the request of Dr. Silver, this specimen was intended for evaluation by me. I have reissued this report to oblige that request. The previously-issued report contained similar diagnostic content. Please contact me if you have any questions. A synoptic for this melanoma is included below. Procedure: wide excision Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 1.4 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 1 per square mm Vascular invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT2a	MELANOMA OF 1.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173578	1138	\N	\N	17-38404	A2	ME-43	Melanoma Epigenetics	IP1767896	AirTable blocks_with_IP_info.csv
2158	17-68780B	68	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=27426	216.5	\N	\N	Sections show a compound melanocytic proliferation of cytologically bland melanocytes arrayed as large nests and single cells at the sides and bases of elongated and hyperpigmented rete ridges. Clusters of melanocytes mature with descent in the superficial dermis. There is some papillary dermal fibrosis.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in B. CF/CF	A) PINK PEARLY PIGMENTED PAPULE; BASAL CELL CARCINOMA, B-C) ATYPICAL BROWN MACULE; ATYPICAL NEVUS	\N	\N	FFPE	This nevus has large junctional nests and papillary dermal fibrosis which are features of nevi on the breast.	COMPOUND MELANOCYTIC NEVUS	173505	1139	\N	\N	17-68780	B	ME-44	Melanoma Epigenetics	IP543552	AirTable blocks_with_IP_info.csv
2159	17-68780C	68	\N	\N	0	T1a	Primary	nevoid melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26200	172.5	\N	EXCLUDED. \n0.7 mm with adjacent Clark. OK but nevus a bit paucicellular	Sections show a compound proliferation of nested melanocytes, both at the junction and within a papillary dermis that is strikingly thickened by lamellar fibroplasia in multiple areas. Some nests of melanocytes within the areas of fibroplasia are disposed horizontally and the melanocytes have small darkly staining nuclei. To the side of these fibrotic areas are a distinct population of small round melanocytes.	Skin segment measuring 1.1 x 0.6 x 0.1 cm, bisected and entirely submitted in C. CF/CF	A) PINK PEARLY PIGMENTED PAPULE; BASAL CELL CARCINOMA, B-C) ATYPICAL BROWN MACULE; ATYPICAL NEVUS	\N	right trunk	FFPE	Melan-a immunohistochemistry demonstrates pagetoid scatter of melanocytes within the epidermis and areas of confluence. There is an associated nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: shave biopsy Microscopic tumor type: nevoid melanoma Breslow thickness: 0.7 mm Ulceration: no Margins, peripheral and deep: peripheral involved, deep free Mitotic index: 0 per square mm Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT1a	MELANOMA, 0.7 MM IN THICKNESS	101544	1139	\N	\N	17-68780	C	ME-44	Melanoma Epigenetics	IP543552	AirTable blocks_with_IP_info.csv
2157	17-68780A	68	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=27425	173.51	\N	\N	Sections show a proliferation of atypical and peripherally palisaded basaloid cells, arrayed as rounded nests attached to the undersurface of the epidermis and as rounded aggregations in the dermis. Foci of keratinization are present and sclerotic collagen bundles are positioned between neoplastic keratinocytes.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) PINK PEARLY PIGMENTED PAPULE; BASAL CELL CARCINOMA, B-C) ATYPICAL BROWN MACULE; ATYPICAL NEVUS	\N	\N	FFPE	\N	SUPERFICIAL/NODULAR BASAL CELL CARCINOMA, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	139523	1139	\N	\N	17-68780	A	ME-44	Melanoma Epigenetics	IP543552	AirTable blocks_with_IP_info.csv
1765	14-50051	45	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26201	173.31	\N	\N	Beneath an ulcer are rounded nests of peripherally palisaded basaloid cells in the dermis, accompanied by fibromyxoid stroma from which they are separated by clefts.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted in A. RS/RS	A) NON HEALING LESION; S/P 5FU, B) NODULAR NEOPLASM	\N	\N	FFPE	The neoplasm extends to the base of the specimen.	NODULAR BASAL CELL CARCINOMA	173311	1140	\N	\N	14-50051	\N	ME-45	Melanoma Epigenetics	IP988468	AirTable blocks_with_IP_info.csv
2847	22-114059B	79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31605,31606,31607,31608,31609	238.2	\N	\N	Sections show lymph node without evidence of metastatic melanoma.	Tissue segment measuring 2.5 x 1.5 x 1.2 cm is serially sectioned perpendicular to the long axis and submitted with four representative sections in B. BY/BY	A) WIDE EXCISION FOR MELANOMA, B) SENTINEL LYMPH NODE #1 EX VIVO 920 - PERM, C) SENTINEL LYMPH NODE #2 EX VIVO 1100 - PERM, D) SENTINEL LYMPH NODE #1 EX VIVO 2895 - PERM, E) SENTINEL LYMPH NODE #2 EX VIVO 6100 - PERM	\N	\N	\N	Level sections, SOX-10 and Pan-melanocytic cocktail immunostains were examined and do not reveal metastatic melanoma.	LYMPH NODE, WITH NO EVIDENCE OF METASTATIC MELANOMA	173540	1158	\N	\N	22-114059	B	ME-63	Melanoma Epigenetics	IP2503898	AirTable blocks_with_IP_info.csv
1916	16-17132B	79	t	\N	4	T4b	Primary	Nodular	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26405,26406	172.6	\N	\N	Sections show an ulcerated nodular proliferation of markedly atypical melanocytes.  In the deeper dermal a second population of smaller melanocytes is noted.  Patchy band like infiltrates of lymphocytes and melanophages are present and no proliferation of melanocytes is noted along the dermo-epidermal junction.	Oriented oval excision, 2.3 x 2.2 x 0.7 cm, including a central 2.0 x 1.5 cm raised area. With the orienting notch placed to the left and designated 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in A, three sections in B and three sections plus one fragment in C. PL/PL	2.2 X 1.2 CM BLUE / PINK ERODED NODULE; MELANOMA VS. OTHER MALIGNANCY	\N	MELANOMA, APPROXIMATELY 4.6 MILLIMETERS IN THICKNESS	FFPE	I confirmed with melanocytic lineage of this lesion with a positive Melan-A stain.  This stain demonstrates loss of junctional melanocytes compatible with complete regression of the junctional component of this lesion.  The dermal component consist of large nodules of markedly pleomorphic melanocytes.  In the deeper dermis there are clusters of smaller melanocytes indicating a melanocytic nevus.  The large nodular area of melanoma has been completely excised.  Changes of regression extends to all peripheral margins. Diagnostic features of note include:  Procedure: Excision Tumor site: Arm Microscopic tumor type: Nodular Breslow thickness: 4.6 millimeters Ulceration: Present, extensive Margins, peripheral and deep: See above Mitotic index: 4/10 hpf Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Present Pathologic Staging (pTNM): pT4b	MELANOMA, APPROXIMATELY 4.6 MILLIMETERS IN THICKNESS	173688	1142	\N	\N	16-17132	B	ME-47	Melanoma Epigenetics	IP1616233	AirTable blocks_with_IP_info.csv
1933	16-35900	68	\N	\N	8	T3a	Primary	melanoma NOS arising in a nevus	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26407	172.2	\N	\N	Sections show a large, poorly circumscribed proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. Smaller foci of these atypical melanocytes are present distinctly separated from the main tumor body. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Two specimens received in one specimen bottle. One skin segment, 1.3 x 1.0 x 0.4 cm, quadrisected and entirely submitted. One tissue segment, 0.6 x 0.5 x 0.2 cm, bisected and entirely submitted. RS/RS	12 X 16 MM, BLACK NODULE WITH SURROUNDING DARK (BLUE), 1 MM MACULAR, 2 PIECES, SECOND SMALLER PIECE MOST MEDIAL; WORRISOME FOR MM WITH MICRO METASTASIS, R/O MALIGNANCY (SEE PHOTOS)	\N	MELANOMA, 2.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Thank you for sending the clinical image of this patient's lesion. A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type: melanoma NOS arising in a nevus Breslow thickness: 2.4 mm Ulceration: not identified Margins, peripheral and deep: peripheral negative, deep focally positive Mitotic index: 8 mm/2 Microsatellitosis: present Vascular invasion: not identified Regression: not identified Perineural invasion: not identified Pathologic staging (pTNM): pT3a	MELANOMA, 2.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173201	1143	\N	\N	16-35900	\N	ME-48	Melanoma Epigenetics	IP1635170	AirTable blocks_with_IP_info.csv
2373	18-139329	40	f	\N	2	T2a	Primary	Nevoid	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26411	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as cellular nests and sheets in the subjacent dermis. Mitotic figures are readily identified.  An atypical mitosis is also noted.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.5 x 1.0 x 0.2 cm, quadrisected and entirely submitted. BY/BY	R/O ATYPICAL NEVUS	\N	MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Diagnostic features of note include: Procedure: Deep shave Tumor site: Abdomen Microscopic tumor type: Nevoid Breslow thickness: 1.7 millimeters Ulceration: Absent Margins, peripheral and deep: Free, narrow Mitotic index: 2/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173539	1144	\N	\N	18-139329	\N	ME-49	Melanoma Epigenetics	IP2003493	AirTable blocks_with_IP_info.csv
2326	18-75585B	57	\N	\N	2	T2a	Primary	melanoma ex melanocytic nevus	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26413	172.5	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern, as small melanocytes are also present deep to the atypical melanocytes. A lymphohistiocytic infiltrate with admixed melanophages is also noted.	Oriented ellipse, 1.8 x 1.1 x 0.7 cm, including a central 0.8 x 0.6 cm variegated area. The orienting sutured tip is indicated medial on the requisition. This sutured tip is designated 3 o'clock by the grosser and is placed toward 3 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections each in A-B. BY/BY	6 X 16 MM DARK BROWN TO BLACK PAPULE WITH IRREGULAR ERYTHEMA, BLUE WHITE VEIL, ATYPICAL PIGMENT NETWORK, MEDIAL ASPECT TAGGED; R/O MELANOMA	\N	MELANOMA OF 2.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE INKED PERIPHERAL MARGIN	FFPE	This specimen demonstrates melanoma overlying a remnant of congenital melanocytic nevus. A brief synoptic is included below. Procedure: subtotal excision Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 2.3 mm Ulceration: not detected Margin: involved by melanoma in situ Mitotic index: 2 per square mm Vascular invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT2a	MELANOMA OF 2.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE INKED PERIPHERAL MARGIN	102538	1145	\N	\N	18-75585	B	ME-50	Melanoma Epigenetics	IP844686	AirTable blocks_with_IP_info.csv
2429	19-36210A	49	f	\N	0	T2a	Primary	Nevoid	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26508	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.3 x 1.0 x 0.1 cm, quadrisected, and entirely submitted in A. HD/HD	A) PT WITH FAMILY HISTORY MM WITH TWO TONE NODULE WITH RAPID GROWTH; MM VS. ATYPICAL NEVUS VS. PIGMENTED BCC, B) IRREGULAR NEVUS VS. MM VS. CONGENITAL NEVUS	\N	A- MELANOMA, 1.1 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Diagnostic features of note include: Procedure: Excisional biopsy Tumor site: Back Microscopic tumor type: Nevoid Breslow thickness: 1.1 millimeters Ulceration: Absent Margins, peripheral and deep: Involved Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.1 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	1146	\N	\N	19-36210	A	ME-51	Melanoma Epigenetics	IP2040437	AirTable blocks_with_IP_info.csv
2394	19-5916	81	f	\N	2	T3a	Primary	superficial spreading melanoma	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26423	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.1 x 1.0 x 0.8 cm, with the base inked, quadrisected and entirely submitted. CF/CF	R/O MM	\N	MELANOMA, 2.2 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	ADDENDUM, January 25, 2019: This report is being reissued to correct the anatomic site of the biopsy.  A synoptic report of potential prognostic factors is listed below:  Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Breslow thickness: 2.2 mm Ulceration: absent Margins, peripheral and deep: both narrow Mitotic index: 2 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT3a	MELANOMA, 2.2 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173620	1147	\N	\N	19-5916	\N	ME-52	Melanoma Epigenetics	IP1359612	AirTable blocks_with_IP_info.csv
2610	20-31447	43	\N	1.8	4	T2a	Primary	superficial spreading melanoma (WHO classification: low cumulative sun damage)	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26427,26428	172.4	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.8 x 1.4 x 0.1 cm is serially sectioned and entirely submitted with five sections. BY/BY	14 X 12 MM, TAN / BROWN MACULE WITH CENTRAL PAPULES, SOMEWHAT IRREGULARLY DISTRIBUTED PIGMENT; R/O DYSPLASIA VS. MM	\N	MELANOMA, 1.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	This melanoma measures at least 1.8 mm in thickness and was focally transected at the specimen base. An associated melanocytic nevus is present. A synoptic report of potential prognostic factors is listed below: Procedure: saucerization biopsy Microscopic tumor type: superficial spreading melanoma (WHO classification: low cumulative sun damage) Breslow thickness: at least 1.8 mm Ulceration: absent Margins, peripheral and deep: deep involved by invasive melanoma, peripheral involved by melanoma in situ Mitotic index: 4 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173450	1148	\N	\N	20-31447	\N	ME-53	Melanoma Epigenetics	IP2179033	AirTable blocks_with_IP_info.csv
2322	18-67239	74	\N	\N	\N	None	None	None	3	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26429,26430,37573,37574	238.2	\N	\N	Sections show a superficial area of fibrosing granulation tissue, but no evidence of an atypical melanocytic proliferation.	Ellipse, 3.0 x 1.3 x 0.9 cm, including a central 0.9 x 0.4 cm pearly area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. KC/KC	A) DYSPLASTIC NEVUS. HEALING BX. PLEASE CHECK MARGINS..	\N	\N	FFPE	None	HEALING BIOPSY SITE, WITH NO EVIDENCE OF A RESIDUAL MELANOCYTIC NEOPLASM	333504	1149	\N	\N	18-67239	\N	ME-54	Melanoma Epigenetics	IP1919209	AirTable blocks_with_IP_info.csv
2618	20-43011	76	f	\N	4	T3a	Primary	None	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26429,26430,37573,37574	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests.  There are similar melanocytes in the subjacent dermis in nests and strands with scattered mitoses. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.3 x 0.9 x 0.3 cm, quadrisected and entirely submitted. KB/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. DYSPLASTIC NEVUS. PAPULE.	\N	MELANOMA, 2.2 MM IN THICKNESS, NON-ULCERATED	FFPE	The Melan-A component of a PRAME/Melan-A multiplex immunostain highlights the irregular distribution of melanocytes, and PRAME is positive in the melanocytes as well, supporting a diagnosis of melanoma. There are some areas with smaller melanocytes with less PRAME expression that could represent a precursor nevus. Some of the larger cells have a plasmacytoid epithelioid appearance, but BAP-1 staining did not show loss of nuclear expression to indicate possible BAP-1 mutation. There is loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanomas, namely bi-allelic loss of chromosome 9p21 where the CDKN2A gene that encodes p16 is located. This loss is not entirely specific for melanoma, but is another concerning finding that supports melanoma. A synoptic report of potential prognostic factors is listed below: Procedure: saucerization biopsy Microscopic tumor type, WHO classification: low cumulative sun damage Breslow thickness: 2.2 mm Ulceration: absent Margins, peripheral and deep: deep focally involved by invasive melanoma, peripheral involved by invasive melanoma Mitotic index: 4 mm/2 Regression: partial regression present Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT3a	MELANOMA, 2.2 MM IN THICKNESS, NON-ULCERATED	529699	1149	\N	\N	20-43011	\N	ME-54	Melanoma Epigenetics	IP1919209	AirTable blocks_with_IP_info.csv
1068	02-49261	76	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=321	172.5	\N	\N	Sections show a proliferation of melanocytes, largely as single cells or small nests within the epidermis, with foci of pagetoid spread.  The papillary dermis is relatively uninvolved.  The reticular dermis has both large and small nodules of strikingly atypical melanocytes that show little maturation with descent, and contain mitotic figures.	Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness,\nbisected and entirely submitted.	R/O MM, SEE CHART NOTES	\N	\N	\N	This melanoma has an unusual configuration, with extensive melanoma in situ and scattered nests throughout the reticular dermis.  While I suspect that it is a primary melanoma rather than an epidermotropic metastasis, this determination would best be made after complete excision.  If this is a primary melanoma, it measures at least 4 mm. in thickness, and possibly has microsatellite metastases.  I would appreciate a chance to see sections from the re-excision.	MELANOMA	273588	1165	\N	\N	02-49261	\N	MP-01	Hockemeyer Melanoma Progression	IP353896	AirTable blocks_with_IP_info.csv
2626	20-53075B	38	f	\N	0	T2a	Primary	nevoid melanoma (WHO classification: low cumulative sun damage)	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26431,26432,26433	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Oriented ellipse, 2.5 x 1.2 x 0.7 cm, including a central 1.4 x 1.0 cm variegated brown area. The orienting sutured tip is indicated as 3 o'clock on the requisition form and placed toward 3 o'clock. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four sections each in A-B. The 9 o'clock tip is reserved. HD/HD	NEVUS, R/O ATYPIA	\N	MELANOMA, 1.1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product, but PRAME staining highlights two distinct populations of melanocytes. PRAME staining is positive in much of the junctional component and is positive in the population of slightly larger melanocytes in the dermis. The findings are consistent with melanoma arising in a pre-existing nevus. A synoptic report of potential prognostic factors is listed below. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation. Procedure: excisional biopsy Microscopic tumor type: nevoid melanoma (WHO classification: low cumulative sun damage) Breslow thickness: 1.1 mm Ulceration: absent Margins, peripheral and deep: deep negative, peripheral <1mm Mitotic index: 0 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	528599	1150	\N	\N	20-53075	B	ME-55	Melanoma Epigenetics	IP1769161	AirTable blocks_with_IP_info.csv
2636	20-79197A	57	f	\N	1	T2a	Primary	Nevoid	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26437,37575	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis arranged as expansile nests. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.1 x 0.9 x 0.4 cm, quadrisected, and entirely submitted in A. KB/HD	A) MORPHOLOGY: IRREGULAR BROWN PAPULE, SIZE: 1 CM, DDX: ATYPICAL NEVUS, B) MORPHOLOGY: IRREGULAR BROWN MACULE, SIZE: 0.4 CM, DDX: ATYPICAL NEVUS, C) MORPHOLOGY: IRREGULAR BROWN MACULE, SIZE: 0.2 CM, DDX: ATYPICAL NEVUS	\N	A- MELANOMA, 1.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Diagnostic features of note include: Procedure: Excisional biopsy Tumor site: Arm Microscopic tumor type: Nevoid Breslow thickness: 1.5 millimeters Ulceration: Absent Margins, peripheral and deep: Peripheral narrow, deep free Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	523654	1151	\N	\N	20-79197	A	ME-56	Melanoma Epigenetics	IP264110	AirTable blocks_with_IP_info.csv
2759	21-118604	65	t	\N	12	T3b	Primary	melanoma ex nevus (WHO classification: low cumulative sun damage)	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26438	172.5	\N	\N	Sections show an ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 2.1 x 1.5 x 0.4 cm, serially sectioned and submitted with five representative sections. BB/BB	2.0 X 1.8 CM ULCERATED BLACK / BROWN PLAQUE, EVALUATE FOR MELANOMA	\N	MELANOMA, 2.9 mm BRESLOW THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type: melanoma ex nevus (WHO classification: low cumulative sun damage) Breslow thickness: 2.9 mm Ulceration: present Margins, peripheral and deep: both <1 mm Mitotic index: 12 per square mm Regression: present Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT3b	MELANOMA, 2.9 mm BRESLOW THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	139522	1152	\N	\N	21-118604	\N	ME-57	Melanoma Epigenetics	IP2381778	AirTable blocks_with_IP_info.csv
2760	21-131828	73	\N	\N	\N	T2b	Primary	low cumulative sun damage (WHO)	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26440,37576	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have enlarged oval nuclei (some eccentrically placed) and increased cytoplasm. These melanocytes are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis forming an expansile nodule beneath an ulcerated epidermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). There is an ulcer.	Ellipse measuring 0.8 x 0.7 x 0.5 cm, including a central 0.5 x 0.4 cm raised brown area. With the margins inked by the grosser, the specimen is trisected perpendicular to the long axis and entirely submitted. BB/CF	MELANOMA	\N	INVASIVE MELANOMA, BRESLOW THICKNESS 1.4 mm, ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: Tumor site: right posterior shoulder Microscopic tumor type: low cumulative sun damage (WHO) Breslow thickness: 1.4 mm Ulceration: present Margins, peripheral and deep: melanoma in situ and nevus present at  peripheral tissue edge; deep tissue edge free Mitotic index (per square millimeter): 15 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2b pNX	INVASIVE MELANOMA, BRESLOW THICKNESS 1.4 mm, ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	529699	1153	\N	\N	21-131828	\N	ME-58	Melanoma Epigenetics	IP2395063	AirTable blocks_with_IP_info.csv
2836	22-101809	79	f	\N	\N	T2a	Primary	BAP-1 inactivated	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30863,30864,30865,30866,30867,30868	172.5	\N	\N	Sections show a predominantly intradermal melanocytic proliferation with a triphasic pattern.  There is a peripheral proliferation of small nevoid melanocytes with round nuclei, and these are well spaced from one another. Centrally, there is a proliferation of epithelioid melanocytes with increased cytoplasm and enlarged oval nuclei. These are associated with a delicate infiltrate of lymphocytes. Finally, there is a proliferation of markedly atypical epithelioid melanocytes forming a densely cellular expansile nodule in the deep dermis. These melanocytes show enlarged oval nuclei and increased pale grey cytoplasm.	Two skin segments measuring 1.1 x 0.8 x 0.2 cm in aggregate are serially sectioned and entirely submitted with five sections. No additional tissue noted in vial. BY/BY	8 MM FLESHY PINK PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEUROFIBROMA VS. PIGMENTED BCC VS. CYST VS. COLLISION LESION WITH NEUROFIBROMA AND CYST VS. COLLISION NEVUS NEUROFIBROMA AND MELANOCYTIC NEVUS	\N	\N	\N	Immunostains were helpful to characterize the melanocytes. BAP-1 shows loss of nuclear expression in the epithelioid melanocytes but is preserved in the smaller nevoid forms. PRAME shows strong nuclear expression in the most atypical epithelioid melanocytes. A cocktail (MART-1 red, PHH3 brown) highlights mitotic figures in the most atypical dermal melanocytes. p16 shows diffuse expression. These results together support the diagnosis of BAP-1 inactivated melanoma arising in association with a combined BAP-1 inactivated melanocytic nevus. I have shared this case with my colleagues, Dr. Philip LeBoit and Dr. Iwei Yeh, who agree with the diagnosis and assessment.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: shave biopsy Tumor site: superior lumbar spine Microscopic tumor type: BAP-1 inactivated Breslow thickness: at least 2.0 mm Ulceration: absent Margins, peripheral and deep: melanoma present at deep tissue edge Mitotic index (per square millimeter): 2 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): at least pT2a pNX	BAP-1 INACTIVATED MELANOMA, BRESLOW THICKNESS AT LEAST 2.0 mm, NON-ULCERATED, ARISING IN ASSOCIATION WITH A BAP-1 INACTIVATED MELANOCYTIC NEVUS	100523	1158	\N	\N	22-101809	\N	ME-63	Melanoma Epigenetics	IP2503898	AirTable blocks_with_IP_info.csv
3150	B205907 III	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1225	\N	\N	None	\N	NM-48	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2789	22-34510A3	79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.62	\N	\N	There is a domed surface with psoriasiform epidermal hyperplasia with a thick granular and a compact cornified layer. The center of the specimen shows a proliferation of keratinocytes with atypical nuclei and abundant pale cytoplasm that thicken the epidermis, which has a papillated surface, and forms lobules in part attached to its undersurface.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, quadrisected and entirely submitted. BB/BB	A) SQUAMOUS CELL CARCINOMA. 7 MM PINK SCALY PAPULE.	\N	\N	\N	There are superimposed changes resembling prurigo nodularis. The margins appear clear in the planes of section examined.	SQUAMOUS CELL CARCINOMA	113602	1169	\N	\N	22-34510	A3	MucM-01	Mucosal Melanoma	IP2436172	AirTable blocks_with_IP_info.csv
2353	18-121971A	61	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show acral skin with nested and solitary melanocytes arrayed at the epidermal-dermal junction, with clusters of similar but smaller melanocytes in the superficial dermis centrally.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, trisected and entirely submitted in A. HD/PL	A) ATYPICAL NEVUS. ATYPICAL RED BROWN MACULE. B) BASAL CELL CARCINOMA. EXCORIATED PAPULE.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	173733	1180	\N	\N	18-121971	A	NL-018	Nevus Library	IP599761	AirTable blocks_with_IP_info.csv
11106	SMU10-0457	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2153	\N	\N	\N	\N	SYNX750	\N	\N	Consolidated_data_final.csv
2666	21-2141	54	\N	\N	4	T2b	Primary	None	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26441	172.5	\N	\N	Sections show an ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.2 x 1.2 x 0.2 cm, serially sectioned and entirely submitted with five sections. KB/KB	11 X 11 MM, ERYTHEMATOUS WEEPING PAPULE WITH BLACK DOTS UNEVENLY DISTRIBUTED; R/O PIGMENTED BCC VS. MM	\N	ULCERATED MELANOMA, 1.1 mm IN THICKNESS, WITH AN ASSOCIATED MELANOCYTIC NEVUS	FFPE	A synoptic report of potential prognostic factors is listed below: Procedure: saucerization biopsy Microscopic tumor type WHO classification: low cumulative sun damage Breslow thickness: 1.1 mm Ulceration: present Margins, peripheral and deep: deep focally involved by invasive melanoma, peripheral involved by invasive melanoma Mitotic index: 4 per square mm Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2b	ULCERATED MELANOMA, 1.1 mm IN THICKNESS, WITH AN ASSOCIATED MELANOCYTIC NEVUS	133559	1154	\N	\N	21-2141	\N	ME-59	Melanoma Epigenetics	IP2267514	AirTable blocks_with_IP_info.csv
2691	21-16708A	54	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/26441,37577,37578	229.0	\N	\N	\N	Tissue segment, 2.5 x 0.8 x 0.5 cm, serially sectioned perpendicular to the long axis and submitted with four representative sections in A. KB/KB	A) RIGHT SUPRACLAVICULAR SENTINEL LYMPH NODE, COUNT 5500, PERMANENT, B) RIGHT AXILLARY SENTINEL LYMPH NODE #1, COUNT 1755, PERMANENT	\N	\N	FFPE	This first lymph node does not contain detectable metastatic melanoma as assessed by conventional microscopy supplemented by Melan-A and SOX-10 immunohistochemistry.	FREE OF MELANOMA	555556	1154	\N	\N	21-16708	A	ME-59	Melanoma Epigenetics	IP2267514	AirTable blocks_with_IP_info.csv
2717	21-41149	52	f	\N	\N	T2a	Primary	low cumulative sun damage	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26442	172.5	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have slightly enlarged oval nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. Similar melanocytes are present in the subjacent dermis as expansile, densely cellular nests. Scattered mitotic figures are evident. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus), and these are situated in the deeper aspects of the dermis. There is a patchy lymphocytic infiltrate mostly associated with the enlarged cells and expansile nests.	Cylindrical skin segment, 0.8 cm in diameter and 1.3 cm in thickness, trisected and entirely submitted. HD/CF	1 CM WHITE PLAQUE AND 2 CM ILL-DEFINED BLACK BROWN PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR, MM	\N	INVASIVE MELANOMA, BRESLOW THICKNESS 2.0 mm, NON-ULCERATED ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: punch biopsy Tumor site: left middle thoracic back Microscopic tumor type: low cumulative sun damage Breslow thickness: 2.0 mm Ulceration: absent Margins, peripheral and deep: invasive melanoma present at peripheral biopsy margin; deep biopsy margin free Mitotic index (per square millimeter): 1 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2a pNX	INVASIVE MELANOMA, BRESLOW THICKNESS 2.0 mm, NON-ULCERATED ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	528522	1155	\N	\N	21-41149	\N	ME-60	Melanoma Epigenetics	IP2303774	AirTable blocks_with_IP_info.csv
2665	21-1134A	54	\N	\N	\N	\N	\N	\N	3	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/26443,37569,37570	728.79	\N	\N	Sections show a proliferation composed of fascicles of elongated spindled cells with intervening compact collagen bundles.  Mitotic figures are inconspicuous, and there is not pronounced nuclear variability, even in cellular areas.	Excision measuring 4.0 x 2.6 x 1.0 cm, two representative sections submitted in A. KB/KB	A-C) JOINT CYSTIC MASS	\N	\N	FFPE	As a precaution, I performed immunostains.  Beta-catenin shows scattered nuclear positivity among the spindle cells, while the spindle cells show strong diffuse positivity for smooth muscle actin and Cyclin D1 (the latter is considered a surrogate for beta-catenin activation).  The morphology of the tumor cells is similar to those seen in parts B and C. These findings support the above interpretation. I have shared this case with my colleague, Dr. Timothy McCalmont, who agrees with the diagnosis and assessment.	FIBROMATOSIS, CELLULAR PHASE	173616	1156	\N	\N	21-1134	A	ME-61	Melanoma Epigenetics	IP426984	AirTable blocks_with_IP_info.csv
2718	21-44171	54	f	\N	0	T2a	Primary	Low CSD	20	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/26443,37569,37570	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  Numerous melanophages are noted.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted with fragment. BB/BB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA. DROWN BROWN IRREGULAR PAPULE.	\N	MELANOMA, 1.1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Diagnostic features of note include: Procedure: Shave Tumor site: Back Microscopic tumor type: Low CSD Breslow thickness: 1.1 mm Ulceration: Absent Margins, peripheral and deep: Involved Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	155566	1156	\N	\N	21-44171	\N	ME-61	Melanoma Epigenetics	IP426984	AirTable blocks_with_IP_info.csv
2894	23-11588A	75	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31601,31602,31603,31604	238.2	\N	\N	Sections show lymph nodes without evidence of metastatic melanoma.	Tissue segment measuring 2.0 x 1.6 x 0.7 cm, three representative sections submitted in A. Lymph node entirely submitted. KB/KB	A) LEFT INGUINAL SENTINEL LYMPH NODE #1, EXVIVO 2600 PERMANENT, B) RIGHT GROIN SENTINEL LYMPH NODE #1 EXVIVO 1200 PERMANENT, C) LEFT GROIN SENTINEL LYMPH NODE #2, EXVIVO 1200 PERMANENT, D) WIDE ABDOMEN MELANOMA - PERMANENT	\N	\N	\N	There is no evidence of metastatic melanoma in either the routinely-stained section or sections stained with SOX-10 and pan-melanin.	LYMPH NODE, WITH NO EVIDENCE OF METASTATIC MELANOMA	105586	1159	\N	\N	23-11588	A	ME-64	Melanoma Epigenetics	IP347366	AirTable blocks_with_IP_info.csv
2867	23-2718 (block 1)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30854	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1159	\N	\N	None	\N	ME-64	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
2868	23-2718 (block 2)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30855	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1159	\N	\N	None	\N	ME-64	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
2812	22-80319A2	54	f	\N	2	T2a	Primary	superficial spreading melanoma (WHO classification: low cumulative sun damage)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30856,30857	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 3.5 x 1.4 x 0.4 cm, serially sectioned and entirely submitted with three sections each in 1-2. CF/CF	DYSPLASTIC NEVUS VS. MELANOMA. IRREGULAR BROWN MACULE.	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma (WHO classification: low cumulative sun damage) Breslow thickness: 1.1 mm Ulceration: absent Margins, peripheral and deep: deep clear, peripheral involved Mitotic index: 2 per square mm Regression: partial regression present Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.1 mm BRESLOW THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	1160	\N	\N	22-80319	A2	ME-65	Melanoma Epigenetics	IP2482233	AirTable blocks_with_IP_info.csv
2811	22-80319A1	54	f	\N	2	T2a	Primary	superficial spreading melanoma (WHO classification: low cumulative sun damage)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30856	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 3.5 x 1.4 x 0.4 cm, serially sectioned and entirely submitted with three sections each in 1-2. CF/CF	DYSPLASTIC NEVUS VS. MELANOMA. IRREGULAR BROWN MACULE.	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma (WHO classification: low cumulative sun damage) Breslow thickness: 1.1 mm Ulceration: absent Margins, peripheral and deep: deep clear, peripheral involved Mitotic index: 2 per square mm Regression: partial regression present Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.1 mm BRESLOW THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	1160	\N	\N	22-80319	A1	ME-65	Melanoma Epigenetics	IP2482233	AirTable blocks_with_IP_info.csv
2843	22-104652	63	t	\N	1	T2b	Primary	Low chronic sun-damage	\N	\N	\N	\N	https://64.54.108.121/app/WebViewer/view/image/30869,37571	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.9 x 1.5 x 0.3 cm, serially sectioned and entirely submitted with six sections. BB/ES	17 MM PLAQUE; POSS MM	\N	\N	\N	Diagnostic features of note include: Procedure: Shave Tumor site: Back Microscopic tumor type: Low chronic sun-damage Breslow thickness: 1.6 mm Ulceration: Present Margins, peripheral and deep: Narrow Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2b	MELANOMA, 1.6 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	898589	1161	\N	\N	22-104652	\N	ME-66	Melanoma Epigenetics	IP2506763	AirTable blocks_with_IP_info.csv
2903	23-47967	76	f	\N	1	T2a	Primary	lowcsd	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32288	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population of melanocytes is arrayed in poorly circumscribed fashion along the junction, as irregular nests and single cells, with some cells in pagetoid array. There is a larger nodule of atypical epithelioid melanocytes extending throughout the dermis, in one area. The second population of junctional melanocytes consists of nests of slightly smaller cells arrayed along the junction and in the papillary dermis (melanocytic nevus).	Skin segment measuring 1.3 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with five sections. BB/KB	BCC VS. MELANOCYTIC NEOPLASM	\N	\N	\N	There is an associated nevus. Diagnostic features of note include: Procedure: shave biopsy Tumor site: back Microscopic tumor type: lowcsd Breslow thickness: at least 1.4 mm Ulceration: absent Margins, peripheral and deep: broadly transected at the base, melanoma in situ extending to the periphery Mitotic index: 1/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): at least pT2a pNX	MELANOMA, AT LEAST 1.4 mm IN THICKNESS, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173530	1162	\N	\N	23-47967	\N	ME-67	Melanoma Epigenetics	IP2586261	AirTable blocks_with_IP_info.csv
2902	23-47727	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32275,32276,32277,32278,32279	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1163	\N	\N	23-47727	\N	ME-68	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
2898	23-34755	76	\N	0.6	0	T1a	Primary	Melanoma, arising in association with a melanocytic nevus	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32270,32271,32272,32273,32274	172.5	\N	\N	Sections show melanocytes arrayed irregularly within the epidermis, including some above the basal layer. Many of the melanocytes have somewhat large and hyperchromatic nuclei. In addition, there are similar melanocytes in the dermis, including some configured as nests and cords. There is inflamed fibrosis in the dermis as well. There are nests and cords of cytologically bland melanocytes in the dermis as well.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	SUSPICIOUS IRREGULAR MULTI-COLORED MACULE; MELANOMA IN SITU, RULE OUT RECURRENCE	\N	\N	\N	I performed immunoperoxidase staining to further evaluate these microscopic features. The melanocytes do not label with a PRAME stain and a p16 stain labels most of the melanocytes. Despite these staining results, I think that the findings in this biopsy represent a melanoma of 0.6 millimeters in thickness since there are numerous melanocytes in above the basal layer of the epidermis in pagetoid array and since some of the melanocytes have somewhat large and hyperchromatic nuclei. A melanocytic nevus with superficial congenital features is captured in this specimen as well. Synoptic melanoma reporting is included below: Procedure: Shave biopsy Microscopic tumor type: Melanoma, arising in association with a melanocytic nevus Breslow thickness: 0.6 millimeters Ulceration: Absent Margins: The melanoma extends to the base and peripheral edge of the specimen Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a  I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	MELANOMA, 0.6 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS AND EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	139523	1163	\N	\N	23-34755	\N	ME-68	Melanoma Epigenetics	IP1372960	AirTable blocks_with_IP_info.csv
2904	23-49347	56	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32371,37572	172.4	\N	\N	Sections show a poorly-circumscribed proliferation of nested and solitary melanocytes, some of which have atypical nuclei, distributed irregularly within the epidermis.  There are also clusters of cytologically bland melanocytes in the dermis.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/KB	MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA	\N	\N	\N	None	MELANOMA IN SITU, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173404	1164	\N	\N	23-49347	\N	ME-69	Melanoma Epigenetics	IP434922	AirTable blocks_with_IP_info.csv
1143	04-35102A	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a multinodular neoplasm of melanocytes that extends from the undersurface of the epidermis to the deep reticular dermis.  In the upper portion of the lesion, there are large and confluent nests of large plump oval melanocytes with vesicular nuclei and pale, vacuolated cytoplasm.  Mitotic figures are easily identified among this population, which does not mature.  At the base of the proliferation in the reticular dermis are interconnecting cords of spindled melanocytes associated with melanophages (which are nearly absent from the upper part of the lesion).  In one tip are nests, cords and strands of smaller, round melanocytes with monomorphous nuclei that aggregate around adnexal structures.	Oriented ellipse measuring 1.8 x 1.0 x 0.7 cm, including 0.7 x 0.7 cm raised central lesion, with tip marked by suture noted by surgeon as the superior pole placed to the left and arbitrarily designated the 12:00 pole, the right tip arbitrarily designated the 6:00 pole. The far aspect of specimen (12:00-3:00-6:00 margin) is inked in blue and the near half of specimen (6:00-9:00-12:00 margin) is inked in yellow. The specimen is serially sectioned and entirely submitted with four sections each in cassettes A and B.	ONE WEEK H/O CHANGE IN PIGMENTED NEVUS-BLEEDING; MELANOMA-NODULAR?	\N	\N	\N	Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: high Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  The excision appears narrow but complete.	MELANOMA, 2.5 MM IN THICKNESS	173316	1166	\N	\N	04-35102	A	MP-02	Hockemeyer Melanoma Progression	IP451504	AirTable blocks_with_IP_info.csv
1194	06-521B2	24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a sessile polypoid segment of skin, containing a largely dermal proliferation of small melanocytes, arrayed as nests and syncytia and strands of cells within the papillary and superficial reticular dermis.  There is slight diminishment in melanocyte size with dermal descent.	Cylindrical skin segment, 0.7 cm in diameter and 0.4 cm in thickness, trisected and totally submitted in cassette B.	A) IDN VS MELANOMA IN SITU, B) IDN	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE	173305	1166	\N	\N	06-521	B2	MP-02	Hockemeyer Melanoma Progression	IP545586	AirTable blocks_with_IP_info.csv
1301	08-6790A	52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad-based and poorly circumscribed proliferation of melanocytes with a flattish periphery and a raised, ulcerated center. The central component features sheets of large oval and spindled melanocytes with strikingly pleomorphic, heterochromatic nuclei, with scattered cells in mitosis. Little maturation with descent to the level of the superficial reticular dermis is evident. The periphery of the lesion features single cells and small nests distributed along the sides and bases of elongated rete ridges in an irregular pattern.	Ellipse measuring 3.5 x 1.3 x 1.0 cm, including two possible notches place to the left and a central pink-red 1.4 x 1.0 cm irregular bordered nodule.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections each in cassettes B and C, tips returned to container.	R/O MM	\N	\N	\N	The intraepidermal component extends to within less than one millimeter of the periphery of the specimen. The neoplasm is ulcerated, has a moderate mitotic rate, and extends into the upper reticular dermis (level IV). Otherwise, there are no findings that would significantly affect prognosis.	MELANOMA, 3.0 MM IN THICKNESS	105543	1167	\N	\N	08-6790	A	MP-03	Hockemeyer Melanoma Progression	IP715431	AirTable blocks_with_IP_info.csv
1302	08-6790B	52	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad-based and poorly circumscribed proliferation of melanocytes with a flattish periphery and a raised, ulcerated center. The central component features sheets of large oval and spindled melanocytes with strikingly pleomorphic, heterochromatic nuclei, with scattered cells in mitosis. Little maturation with descent to the level of the superficial reticular dermis is evident. The periphery of the lesion features single cells and small nests distributed along the sides and bases of elongated rete ridges in an irregular pattern.	Ellipse measuring 3.5 x 1.3 x 1.0 cm, including two possible notches place to the left and a central pink-red 1.4 x 1.0 cm irregular bordered nodule.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections each in cassettes B and C, tips returned to container.	R/O MM	\N	\N	\N	The intraepidermal component extends to within less than one millimeter of the periphery of the specimen. The neoplasm is ulcerated, has a moderate mitotic rate, and extends into the upper reticular dermis (level IV). Otherwise, there are no findings that would significantly affect prognosis.	MELANOMA, 3.0 MM IN THICKNESS	105543	1167	\N	\N	08-6790	B	MP-03	Hockemeyer Melanoma Progression	IP715431	AirTable blocks_with_IP_info.csv
1444	11-19653B2	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which is composed of single cells and nests arrayed along the sides and bases of elongated pigmented rete. There are small nests and cords of similar melanocytes in the perijunctional dermis, where a lymphohistiocytic infiltrate with admixed melanophages also resides. The superjacent stratum corneum is orthokeratotic with admixed melanin.	Two outside slides, 5011044/311 2973 and one corresponding block.	LESION PRESENT FOR YEARS, TWO TO THREE TONE BROWN WITH IRREGULAR BORDER; COMPOUND NEVUS	\N	\N	\N	There is no evidence of malignancy.	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	100556	1167	\N	\N	11-19653	B2	MP-03	Hockemeyer Melanoma Progression	IP1009091	AirTable blocks_with_IP_info.csv
2974	96-14850	60	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a polypoid proliferation of melanocytes with marked nuclear atypia, markedly expanding the papillary dermis. Maturation is not present, and mitotic figures are present in the dermal melanocytic population.	Skin segment measuring 11 x 10 x 4 mm, bisected.	CLINICAL DIAGNOSIS - PYOGENIC GRANULOMA	\N	\N	\N	Several studies confirm that a polypoid configuration is not an independent prognostic variable in patients with melanoma.	MELANOMA, 2.0 MM IN THICKNESS, POLYPOID	173604	1168	\N	\N	96-14850	\N	MP-04	Hockemeyer Melanoma Progression	IP91614	AirTable blocks_with_IP_info.csv
1039	02-1274B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1168	\N	\N	02-1274	B1	MP-04	Hockemeyer Melanoma Progression	\N	AirTable blocks_with_IP_info.csv
2967	96-4039A5	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	698.3	\N	\N	Level sections show psoriasiform epidermal hyperplasia and overlying\nhyperkeratosis.  The papillary dermis is fibrotic.  There is solar\nelastosis.	Two skin segments measuring 4 x 3 x 2 mm and 4 x 4 x 4 mm.	1 CM CRUSTED NON-HEALING PLAQUE X 1 YR; CLINICAL DIAGNOSIS - R/O MALIGNANCY	\N	\N	\N	\N	\N	173614	1168	\N	\N	96-4039	A5	MP-04	Melanoma Epigenetics	IP80712	AirTable blocks_with_IP_info.csv
2968	96-4039A7	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	698.3	\N	\N	Level sections show psoriasiform epidermal hyperplasia and overlying\nhyperkeratosis.  The papillary dermis is fibrotic.  There is solar\nelastosis.	Two skin segments measuring 4 x 3 x 2 mm and 4 x 4 x 4 mm.	1 CM CRUSTED NON-HEALING PLAQUE X 1 YR; CLINICAL DIAGNOSIS - R/O MALIGNANCY	\N	\N	\N	\N	\N	173614	1168	\N	\N	96-4039	A7	MP-04	Melanoma Epigenetics	IP80712	AirTable blocks_with_IP_info.csv
2966	96-4039	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1168	\N	\N	96-4039	\N	MP-04	Hockemeyer Melanoma Progression	\N	AirTable blocks_with_IP_info.csv
2582	20-10245F1	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	Sections show an area of dermal fibrosis, with no evidence of residual invasive carcinoma.	Oriented ellipse, 3.5 x 1.4 x 0.3 cm, including a central 1.1 x 1.0 cm white-gray area. The orienting notched tip is indicated posterior tip on the requisition and is placed toward 9 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with seven sections in A and six in B. CF/CF	HISTORY OF BCC, EXC PLS CHECK MARGINS	\N	\N	\N	None	SCAR, WITH NO EVIDENCE OF RESIDUAL BASAL CELL CARCINOMA	113605	1170	\N	\N	20-10245	F1	MucM-02	Mucosal Melanoma	IP2148195	AirTable blocks_with_IP_info.csv
2583	20-10245H3	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	Sections show an area of dermal fibrosis, with no evidence of residual invasive carcinoma.	Oriented ellipse, 3.5 x 1.4 x 0.3 cm, including a central 1.1 x 1.0 cm white-gray area. The orienting notched tip is indicated posterior tip on the requisition and is placed toward 9 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with seven sections in A and six in B. CF/CF	HISTORY OF BCC, EXC PLS CHECK MARGINS	\N	\N	\N	None	SCAR, WITH NO EVIDENCE OF RESIDUAL BASAL CELL CARCINOMA	113605	1170	\N	\N	20-10245	H3	MucM-02	Mucosal Melanoma	IP2148195	AirTable blocks_with_IP_info.csv
2581	20-10245D1	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	Sections show an area of dermal fibrosis, with no evidence of residual invasive carcinoma.	Oriented ellipse, 3.5 x 1.4 x 0.3 cm, including a central 1.1 x 1.0 cm white-gray area. The orienting notched tip is indicated posterior tip on the requisition and is placed toward 9 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with seven sections in A and six in B. CF/CF	HISTORY OF BCC, EXC PLS CHECK MARGINS	\N	\N	\N	None	SCAR, WITH NO EVIDENCE OF RESIDUAL BASAL CELL CARCINOMA	113605	1170	\N	\N	20-10245	D1	MucM-02	Mucosal Melanoma	IP2148195	AirTable blocks_with_IP_info.csv
2088	17-33973D3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1171	\N	\N	17-33973	D3	MucM-03	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
2087	17-33973C4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1171	\N	\N	17-33973	C4	MucM-03	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
2086	17-33973A1	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	Sections show a domed/papillated proliferation of keratinocytes with uniform nuclei arrayed as interanastomosing rete that expand the epidermis. Small pseudocystic spaces are focally entrapped by the interconnecting rete.	Skin segment measuring 1.2 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	SK VS. NEVUS, R/O MM	\N	\N	\N	\N	SEBORRHEIC KERATOSIS	273588	1171	\N	\N	17-33973	A1	MucM-03	Mucosal Melanoma	IP1763381	AirTable blocks_with_IP_info.csv
2592	20-16903C4	76	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a lesion formed by plump, oval melanocytes in singly and in nests at the dermo-epidermal junction, with smaller cells in the subjacent dermis.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in B. HD/HD	A) 3 MM BROWN MACULE, B) 4 MM DARK BROWN MACULE	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	173720	1172	\N	\N	20-16903	C4	MucM-04	Mucosal Melanoma	IP1108900	AirTable blocks_with_IP_info.csv
2590	20-16903A2	76	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	There are elongated rete ridges that bear increased numbers of single melanocytes at their sides and bases.  There are nests, cords and strands of small, round melanocytes that mature with descent into the subjacent dermis.	Cylindrical skin segment, 0.3 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted in A. HD/HD	A) 3 MM BROWN MACULE, B) 4 MM DARK BROWN MACULE	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173710	1172	\N	\N	20-16903	A2	MucM-04	Mucosal Melanoma	IP1108900	AirTable blocks_with_IP_info.csv
2591	20-16903C1	76	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a lesion formed by plump, oval melanocytes in singly and in nests at the dermo-epidermal junction, with smaller cells in the subjacent dermis.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in B. HD/HD	A) 3 MM BROWN MACULE, B) 4 MM DARK BROWN MACULE	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	173720	1172	\N	\N	20-16903	C1	MucM-04	Mucosal Melanoma	IP1108900	AirTable blocks_with_IP_info.csv
1687	13-17186A21	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	\N	\N	Sections show ulceration consistent with recent curettage. In an adjacent area, there is residual neoplasm composed of clusters of atypical keratinocytes with abundant eosinophilic cytoplasm. To the side of these changes, there are elongated rete ridges with hyperpigmentation of the basal layer and foci of acantholytic dyskeratosis.	Oriented ellipse measuring 2.0 x 1.2 x 0.3 cm. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, and arbitrarily designated 12:00 by the grosser. The 9:00-3:00 margin is inked blue and the 3:00-9:00 margin is inked yellow.  With the 9:00 tip placed to the left, the specimen is serially sectioned perpendicular to the long axis, entirely submitted with four sections in A and five sections in B. HD/HD	SCC, PLEASE SEE PATH DT13-15696	\N	\N	\N	\N	CURETTAGE SITE, WITH RESIDUAL SQUAMOUS CELL CARCINOMA, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF CARCINOMA)	177522	1173	\N	\N	13-17186	A21	MucM-05	Mucosal Melanoma	IP26960	AirTable blocks_with_IP_info.csv
3154	B236709/ 1B	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1226	\N	\N	None	\N	NM-49	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3151	B206739	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1227	\N	\N	None	\N	NM-50	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3152	B215962	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1228	\N	\N	None	\N	NM-51	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3149	B167003/1B  I	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1229	\N	\N	None	\N	NM-52	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1686	13-17186A20	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	\N	\N	Sections show ulceration consistent with recent curettage. In an adjacent area, there is residual neoplasm composed of clusters of atypical keratinocytes with abundant eosinophilic cytoplasm. To the side of these changes, there are elongated rete ridges with hyperpigmentation of the basal layer and foci of acantholytic dyskeratosis.	Oriented ellipse measuring 2.0 x 1.2 x 0.3 cm. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, and arbitrarily designated 12:00 by the grosser. The 9:00-3:00 margin is inked blue and the 3:00-9:00 margin is inked yellow.  With the 9:00 tip placed to the left, the specimen is serially sectioned perpendicular to the long axis, entirely submitted with four sections in A and five sections in B. HD/HD	SCC, PLEASE SEE PATH DT13-15696	\N	\N	\N	\N	CURETTAGE SITE, WITH RESIDUAL SQUAMOUS CELL CARCINOMA, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF CARCINOMA)	177522	1173	\N	\N	13-17186	A20	MucM-05	Mucosal Melanoma	IP26960	AirTable blocks_with_IP_info.csv
10114	HW8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Urethra, Hong Wu	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1488	\N	\N	\N	\N	SYNX85	\N	\N	Consolidated_data_final.csv
3314	DM95	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1577	\N	\N	None	\N	SYNAT400	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
10991	SP-10-003167A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2059	\N	\N	\N	\N	SYNX656	\N	\N	Consolidated_data_final.csv
1684	13-17186A14	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	\N	\N	Sections show ulceration consistent with recent curettage. In an adjacent area, there is residual neoplasm composed of clusters of atypical keratinocytes with abundant eosinophilic cytoplasm. To the side of these changes, there are elongated rete ridges with hyperpigmentation of the basal layer and foci of acantholytic dyskeratosis.	Oriented ellipse measuring 2.0 x 1.2 x 0.3 cm. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, and arbitrarily designated 12:00 by the grosser. The 9:00-3:00 margin is inked blue and the 3:00-9:00 margin is inked yellow.  With the 9:00 tip placed to the left, the specimen is serially sectioned perpendicular to the long axis, entirely submitted with four sections in A and five sections in B. HD/HD	SCC, PLEASE SEE PATH DT13-15696	\N	\N	\N	\N	CURETTAGE SITE, WITH RESIDUAL SQUAMOUS CELL CARCINOMA, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF CARCINOMA)	177522	1173	\N	\N	13-17186	A14	MucM-05	Mucosal Melanoma	IP26960	AirTable blocks_with_IP_info.csv
1685	13-17186A16	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	\N	\N	Sections show ulceration consistent with recent curettage. In an adjacent area, there is residual neoplasm composed of clusters of atypical keratinocytes with abundant eosinophilic cytoplasm. To the side of these changes, there are elongated rete ridges with hyperpigmentation of the basal layer and foci of acantholytic dyskeratosis.	Oriented ellipse measuring 2.0 x 1.2 x 0.3 cm. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, and arbitrarily designated 12:00 by the grosser. The 9:00-3:00 margin is inked blue and the 3:00-9:00 margin is inked yellow.  With the 9:00 tip placed to the left, the specimen is serially sectioned perpendicular to the long axis, entirely submitted with four sections in A and five sections in B. HD/HD	SCC, PLEASE SEE PATH DT13-15696	\N	\N	\N	\N	CURETTAGE SITE, WITH RESIDUAL SQUAMOUS CELL CARCINOMA, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF CARCINOMA)	177522	1173	\N	\N	13-17186	A16	MucM-05	Mucosal Melanoma	IP26960	AirTable blocks_with_IP_info.csv
1742	14-12190L4	33	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes featuring a central area in which there are nests, cords and strands of melanocytes that mature with descent; some lie adjacent to adnexal structures in the reticular dermis.  At the periphery of the neoplasm, there are nests of, and increased numbers of single melanocytes along the sides and bases of elongated rete ridges.  The bases of some adjacent rete ridges are fused, and the papillary dermis beneath them is fibrotic.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted with three sections and one fragment in B. PL/PL	A) ~ 3 MM ATYP RED BR PAP, B) ~ 1 CM ATYP RED BR PATCH	\N	\N	\N	In (B), the changes at the periphery of the nevus resemble those seen in Clark's or dysplastic nevi and would account for a clinically atypical appearance.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173532	1174	\N	\N	14-12190	L4	MucM-06	Mucosal Melanoma	IP650361	AirTable blocks_with_IP_info.csv
1741	14-12190A1	33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	There is a compound proliferation of melanocytes mostly involving the junctional zone and a thickened papillary dermis.  Nests of, and increased numbers of single melanocytes are situated at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused.  Toward the center of the lesion, smaller melanocytes reside in the papillary dermis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) ~ 3 MM ATYP RED BR PAP, B) ~ 1 CM ATYP RED BR PATCH	\N	\N	\N	The proliferation extends to the specimen edge so circumscription cannot be fully assessed, but appears well-nested without significant pagetoid scatter or cytologic atypia.	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, EXTENDING TO THE SPECIMEN PERIPHERY	173531	1174	\N	\N	14-12190	A1	MucM-06	Mucosal Melanoma	IP650361	AirTable blocks_with_IP_info.csv
1580	12-16974B	33	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a circumscribed compound melanocytic proliferation with a multiphasic pattern.  Some of the melanocytes have round to oval nuclei, while others have abundant dusty cytoplasmic melanin and are surrounded by melanophages.  Focally, there are larger polygonal melanocytes with ample eosinophilic cytoplasm (Spitz's nevus cells).	Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted in cassette B.	A-C) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	\N	TRIPHASIC COMBINED MELANOCYTIC NEVUS, WITH ORDINARY, BLUE (PIGMENTED EPITHELIOID), AND SPITZ'S NEVUS ELEMENTS	173711	1175	\N	\N	12-16974	B	NL-013	Nevus Library	IP1102790	AirTable blocks_with_IP_info.csv
2358	18-129422	34	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a nodular dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles with intervening areas displaying fibrosis and sclerosis and containing melanophages.	Cylindrical skin segment measuring 0.7 cm in diameter and 0.3 cm in thickness. With the margins inked, the specimen is trisected, and entirely submitted. HD/HD	RAPIDLY ENLARGING BLACK PAPULE, PRESENT X 6 YRS WITH RAPID ENLARGEMENT X 2 YRS; BLUE NEVUS, R/O MELANOMA	\N	\N	Scraping	None	BLUE NEVUS	173663	1176	\N	\N	18-129422	\N	NL-014	Nevus Library	IP1993538	AirTable blocks_with_IP_info.csv
2380	19-1978C	76	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.3	\N	\N	Sections show a well circumscribed dermal proliferation of S-shaped spindled cells with small, monomorphous oval or elliptical nuclei and inconspicuous cytoplasm, apposed to thin collagen bundles, forming compactly arranged fascicles separated from one another by thin clefts.	Skin segment measuring 1.0 x 0.6 x 0.2 cm, bisected and entirely submitted in C. BY/BY	A) SQUAMOUS CELL CARCINOMA VS. VERRUCA VULGARIS VS. KA. ERYTHEMATOUS TENDER NODULE WITH HYPERKERATOTIC SCALE. B) SUPERFICIAL BASAL CELL CARCINOMA VS. BOWEN'S DISEASE. PSORIASIFORM PATCH. C) BASAL CELL CARCINOMA VS. DERMAL NEVUS. PEARLY TELANGIECTATIC PAPULE.	\N	\N	Scraping	This lesion is also called palisaded and encapsulated neuroma. It is a benign neoplasm composed of Schwann cells (as is schwannoma) but differs in that many axons are also present.	SOLITARY, CIRCUMSCRIBED NEUROMA	173304	1177	\N	\N	19-1978	C	NL-015	Nevus Library	IP2006010	AirTable blocks_with_IP_info.csv
3031	351/10 2 (HBD)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1230	\N	\N	None	\N	NM-53	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3032	351/10 4 (HBD)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1231	\N	\N	None	\N	NM-54	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2352	18-121943A	32	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component comprised of single cells and small pigmented nests arrayed along the sides and bases of pigmented rete. Small nests and cords of similar melanocytes are positioned in the subjacent superficial dermis, where scattered melanophages are also evident.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) 0.8 CM, COLOR VARIEGATION; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, B) 1.8 CM, BROWN VERRUCOUS PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SK VS. PIGMENTED SCCIS VS. CONDYLOMATA	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	110501	1179	\N	\N	18-121943	A	NL-017	Nevus Library	IP1986032	AirTable blocks_with_IP_info.csv
10992	SP-13-009897	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2060	\N	\N	\N	\N	SYNX657	\N	\N	Consolidated_data_final.csv
11107	SMU10-0206	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2154	\N	\N	\N	\N	SYNX751	\N	\N	Consolidated_data_final.csv
1883	15-101715	89	\N	\N	4	T4b	Primary	melanoma, not otherwise classified	\N	0	FFPE	\N	\N	172.2	\N	\N	Sections show a compound melanocytic proliferation. Within the dermis, a nodule composed of closely positioned nests of atypical melanocytes with abundant cytoplasm and enlarged nuclei is present. There is little maturation with descent and mitotic figures are present within lesional melanocytes. The neoplastic melanocytes are pigmented and in fascicular array in areas. There is patchy inflammation with scattered melanophages. The surrounding dermis harbors a lymphocytic infiltrate with eosinophils and plasma cells. The epidermis is focally ulcerated.	Three skin segments received in one specimen bottle. The first skin segment, 1.2 x 0.9 x 0.5 cm, with the edges inked blue, quadrisected and entirely submitted. The second skin segment, 1.2 x 0.6 x 0.3 cm, with the edges inked yellow, bisected and entirely submitted. The third skin segment, 1.1 x 0.5 x 0.2 cm, bisected and entirely submitted. RS/RS	MM VS. ANGIOMA, MELANOMA LIKELY - LARGEST PIECE IS TOP OF LESION,2 ND LARGEST PIECE WAS SHAVED WHEN PIGMENT STILL PRESENT AT BASE, SMALLEST PIECE WAS FROM AN EDGE	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: left ear Microscopic tumor type: melanoma, not otherwise classified Breslow thickness: at least 4.6 mm Ulceration: yes Margins, peripheral and deep: peripheral narrow, deep involved Mitotic index: 4 per square mm Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4b pNX	MELANOMA, AT LEAST 4.6 MM IN THICKNESS, EXTENDING TO THE BASE OF THE BIOPSY	173201	1183	\N	\N	15-101715	\N	NL-021	Nevus Library	IP1573430	AirTable blocks_with_IP_info.csv
1528	11-91034	10	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Desmoplastic spits nevus	\N	Sections show a dermal proliferation of large, oval melanocytes with abundant, pale amphophilic cytoplasm and monomorphous oval vesicular nuclei, distributed as small nests in the upper part of the lesion and as smaller nests and singly in the lower part. The lesion has a relatively flat base in the mid-reticular dermis.	Cylindrical skin segment measuring 0.25 cm in diameter and 0.3 cm in thickness. Submitted intact.	CHILD WITH LARGE CALM AROUND ARM & (R) UPPER TRUNK WITH TNTC SMALL DARK BROWN NEVI WITHIN IT, THIS IS A NEW, ROUND, URTICARIAL IN APPEARANCE PLAQUE JUST POSTERIOR TO THE CALM	\N	\N	Scraping	The neoplasm extends to the peripheral edge of the specimen. There are no particularly worrisome findings. Given your description, this could be an agminated Spitz's nevus. A clinical photograph would be gratefully received (it could be sent to me as an email attachment: philip.leboit@ucsf.edu).	SPITZ'S NEVUS, PREDOMINANTLY INTRADERMAL	173688	1184	\N	\N	11-91034	\N	NL-022	Cafe au Lait	IP1080482	AirTable blocks_with_IP_info.csv
1804	14-113821	13	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a compound proliferation of spindled and spindled melanocytes with enlarged nuclei. The overlying epidermis is hyperkeratotic. In the dermis, single and fascicular melanocytes are positioned amongst collagen bundles, which are thickened.	Cylindrical skin segment, 0.3 cm in diameter and 0.3 cm in thickness. Submitted intact. RS/RS	BORN WITH LARGE CALM...DEVELOPING TNTC DARK NEVI WITHIN IT...AND THESE SMOOTH TAN BROWN PLAQUES (PHOTOS)	\N	\N	Scraping	This biopsy demonstrates a desmoplastic Spitz nevus arising secondarily within a cafe-au-lait macule. An agminated presentation of Spitz nevus or eruptive Spitz nevi is/are intriguing as a potential classification. Immunostaining with ALK demonstrates a lack of positivity, and thus underlying ALK gene fusion has not occurred. In contrast, NTRK1 immunostaining demonstrates considerable cytoplasmic positivity, and thus this Spitz nevus may have been induced by NTRK1 gene fusion. As you know, this biopsy is partial in nature.	DESMOPLASTIC COMPOUND SPITZ NEVUS	173602	1184	\N	\N	14-113821	\N	NL-022	Cafe au Lait	IP1080482	AirTable blocks_with_IP_info.csv
2421	19-28178	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Desmoplastic spits nevus	\N	There is papillated acanthosis. There are vertically or diagonally oriented fascicles of large pale melanocytes with abundant cytoplasm and monomorphous vesicular nuclei that contain small nucleoli. Maturation and dispersion toward the base of the lesion is present.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted. BY/BY	HISTORY OF LARGE SPECKLED LENTIGINOUS NEVUS WITH AGMINATED DESMOPLASTIC SPITZ WITHIN IT, THIS BIOPSY LESION TODAY IS MORE ATYPICAL THAN HER OTHERS	\N	\N	Scraping	The findings, like those in the previous two biopsies are consistent with Spitz's nevus. The lower part of this lesion is desmoplastic. Given the clinical setting (I reviewed the image that we received with the 2014 biopsy) I do not see features that would require re-excision.	DESMOPLASTIC SPITZ'S NEVUS, COMPOUND	523651	1184	\N	\N	19-28178	\N	NL-022	Cafe au Lait	IP1080482	AirTable blocks_with_IP_info.csv
3037	467/10  1	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1232	\N	\N	None	\N	NM-55	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2475	19-135490	18	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Compound melanocytic nevus(conventional)	\N	There are nests, cords and strands of cytologically bland melanocytes that extend from the junctional zone into the superficial reticular dermis. The dermal component matures with descent. There are scattered melanophages in the superficial aspect.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	BROWN MACULE	\N	\N	Scraping	This nevus does not demonstrate any features of Spitz nevus, but rather has a common acquired morphology.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	101623	1184	\N	\N	19-135490	\N	NL-022	Cafe au Lait	IP1080482	AirTable blocks_with_IP_info.csv
2302	18-34960	63	f	\N	1	T2a	Primary	Superficial spreading and deep penetrating nevus-like features	\N	0	FFPE	\N	\N	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of large, epithelioid melanocytes with abundant dusty cytoplasm.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermis contains aggregates of spindled to epithelioid melanocytes arranged in fascicles between collagen bundles.  The melanocytes show abundant pigmentation.	Skin segment measuring 1.2 x 1.0 x 0.2 cm, quadrisected and entirely submitted. RS/PL	PATIENT WITH A HISTORY OF MELANOMA (EXCISED 3 YRS AGO), 1.1 CM BROWN PLAQUE WITH VARIEGATED PIGMENT, ASYMMETRY AND AN IRREGULAR BORDER; MM VS. DYSPLASTIC NEVUS VS. OTHER	\N	\N	Scraping	An immunohistochemical stain for p16 demonstrated loss of this tumor suppressor protein in the entire lesion.  A Beta-catenin stain highlights nuclear staining in the deep penetrating nevus-like portion of the melanoma, and only membranous staining in the junctional and superficial portions. This findings suggests an acquired activating mutation in the Beta-catenin gene (see reference), which may account for the deep penetrating nature of the dermal component. Dr. McCalmont has also reviewed this case and agrees with the diagnosis.  A synoptic report of potential prognostic factors is listed below:  Procedure: Shave biopsy Microscopic tumor type: Superficial spreading and deep penetrating nevus-like features Breslow thickness: 1.7 mm Ulceration: absent Margins: peripheral negative and deep positive for invasive component Mitotic index: 1 mm/2 Microsatellitosis: not identified Vascular invasion: not identified Regression: absent Perineural invasion: not identified Pathologic staging (pTNM): pT2a  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la FouchardiËre A. Combined activation of MAP kinase pathway and ﬂ-catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644.	MELANOMA, 1.7 MM THICKNESS, NON-ULCERATED	152589	1185	\N	\N	18-34960	\N	NL-023	Nevus Library	IP1898705	AirTable blocks_with_IP_info.csv
2356	18-122476	70	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a proliferation of dendritic melanocytes and melanophages in the superficial dermis. Some melanocytes appear ovoid with pigmented cytoplasm.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/PL	IRREGULAR BROWN MACULE; ATYPICAL NEVUS VS. MELANOMA	\N	\N	Scraping	None	BLUE NEVUS, WITH DENDRITIC MELANOCYTES	103431	1186	\N	\N	18-122476	\N	NL-024	Nevus Library	IP594622	AirTable blocks_with_IP_info.csv
10993	SP-12-0087723B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2061	\N	\N	\N	\N	SYNX658	\N	\N	Consolidated_data_final.csv
11108	SMU10-0240	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2155	\N	\N	\N	\N	SYNX752	\N	\N	Consolidated_data_final.csv
2357	18-122972	25	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show acral skin with a small and symmetric proliferation of small melanocytes with round to oval nuclei, positioned singly and as small nests at the epidermal-dermal junction or above it, with accompanying epidermal pigmentation.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/PL	A) ATYPICAL NEVUS. 2MM  AND PIGMENT SEEMS TO BE LOCATED IN THE FURROWS AND NOT ON THE RIDGE UNDER DERMATOSCOPY ALTHOUGH SOME AREAS ARE UNCLEAR.	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	172710	1187	\N	\N	18-122972	\N	NL-025	Nevus Library	IP1987073	AirTable blocks_with_IP_info.csv
3072	5890/08	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1188	\N	\N	None	\N	NM-001	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3048	1485/15 (1485/15 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1189	\N	\N	None	\N	NM-002	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3059	2997/11	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1190	\N	\N	None	\N	NM-003	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3070	5696/15	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1191	\N	\N	None	\N	NM-004	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1103	03B12175 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1192	\N	\N	None	\N	NM-005	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1294	07B2313 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1193	\N	\N	None	\N	NM-006	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2011	16B10343 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1194	\N	\N	None	\N	NM-007	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1809	14B13985 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1195	\N	\N	None	\N	NM-008	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1420	10B18943 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1196	\N	\N	None	\N	NM-009	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1332	08B9531 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1197	\N	\N	None	\N	NM-010	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1331	08B8345 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1198	\N	\N	None	\N	NM-011	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1418	10B339 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1199	\N	\N	None	\N	NM-012	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1419	10B7952 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1200	\N	\N	None	\N	NM-013	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2010	16B8849 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1201	\N	\N	None	\N	NM-014	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1808	14B1910 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1202	\N	\N	None	\N	NM-015	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1729	13B10486 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1203	\N	\N	None	\N	NM-016	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1535	11B9724 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1204	\N	\N	None	\N	NM-017	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1534	11B2562 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1205	\N	\N	None	\N	NM-018	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3077	11522/18	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1206	\N	\N	None	\N	NM-019	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3055	2065/12 (2065/117 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1207	\N	\N	None	\N	NM-027	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3083	16053/12 wy (16053/12 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1208	\N	\N	None	\N	NM-029	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3056	2227/14 4	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1209	\N	\N	None	\N	NM-031	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3028	150/17	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1210	\N	\N	None	\N	NM-032	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3067	4136/16	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1211	\N	\N	None	\N	NM-33	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3068	4449/16 (4449/16 3 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1212	\N	\N	None	\N	NM-34	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3047	1283/14	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1213	\N	\N	None	\N	NM-35	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3043	1205/17	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1214	\N	\N	None	\N	NM-36	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3052	1813/15 3	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1215	\N	\N	None	\N	NM-37	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3069	4890/15 8	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1216	\N	\N	None	\N	NM-38	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3073	6172.3 (14.6172.3 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1217	\N	\N	None	\N	NM-39	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3078	11649.2 (15.11649.2 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1218	\N	\N	None	\N	NM-40	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3071	5698.3 (14.5698.3 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1219	\N	\N	None	\N	NM-41	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3079	12410/09	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1220	\N	\N	None	\N	NM-43	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3084	17890/18 (HBD)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1221	\N	\N	None	\N	NM-44	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3155	B246205/ 1BI	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1222	\N	\N	None	\N	NM-45	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3156	B247206/ 1Bl	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1223	\N	\N	None	\N	NM-46	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3074	6258/2015	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1245	\N	\N	None	\N	NM-71	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3094	21831/14	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1246	\N	\N	None	\N	NM-72	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3029	156/13	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1247	\N	\N	None	\N	NM-73	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3054	2017-19575	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1248	\N	\N	None	\N	NM-74	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3447	K3920/19 A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1249	\N	\N	None	\N	NM-75	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3076	10226 2	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1250	\N	\N	None	\N	NM-76	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3500	M32727/18 A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1251	\N	\N	None	\N	NM-77	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3498	M21326/18 A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1252	\N	\N	None	\N	NM-78	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3080	14531/14	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1253	\N	\N	None	\N	NM-79	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3075	8716/2016	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1254	\N	\N	None	\N	NM-80	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3499	M31513/18	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1255	\N	\N	None	\N	NM-81	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3053	2017-07184	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1256	\N	\N	None	\N	NM-82	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3082	15864 3	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1257	\N	\N	None	\N	NM-83	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1713	13-51506B	33	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	709.09	Typical melanotic macule	\N	The microscopic features are similar to those of (A).	Three skin segments ranging in measurement from 0.4 x 0.2 x 0.1 cm to 1.0 x 0.5 x 0.1 cm, with the largest segment bisected and the remainder intact, all entirely submitted in B. PL/PL	A-B) R/O LENTIGO MALIGNA	\N	genital mucosa	FFPE	Melanotic macules occur at a variety of sites, and consist of basilar hyperpigmentation without a significantly increased number of melanocytes.	MELANOTIC MACULE	135577	1291	\N	\N	13-51506	B	OM-33	Oral Mucosa Lesions	IP1293509	AirTable blocks_with_IP_info.csv
2815	22-81852A	63	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/30414,30415,30416,30417	198.2	\N	\N	Sections show nodal parenchyma that contains clusters of atypical melanocytes and melanophages, with focal necrosis.	Tissue segment measuring 2.4 x 1.6 x 1.3 cm, serially sectioned perpendicular to the long axis and submitted with seven representative sections in A. BB/BB	A) RIGHT INGUINAL SENTINEL LYMPH NODE (HOT AND BLUE), FRESH, B) EXCISION OF RIGHT THIGH MELANOMA, PERMANENT	\N	\N	FFPE	There are deposits of neoplastic cells that are strongly and uniformly positive for with SOX-10 and pan-melanoma immunostains, measuring up to 5 mm.	METASTATIC MELANOMA, PRESENT IN A LYMPH NODE	173518	1258	\N	\N	22-81852	A	NM-84	Nodular Melanoma	IP2452836	AirTable blocks_with_IP_info.csv
2800	22-51092	63	t	\N	20	T4b	Primary	melanoma on skin with low cumulative sun-induced damage (low CSD melanoma)	20	10	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24190	172.7	\N	\N	There is a polypoid nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis.  There is little diminishment in melanocyte size with descent in the dermis. There are numerous mitoses. The surface of the lesion is focally ulcerated.	Skin segment measuring 1.2 x 1.0 x 0.5 cm, quadrisected and entirely submitted. BY/BY	R/O PG VS. MM, 12 X 12 MM	\N	\N	FFPE	Diagnostic features of note include: Procedure: shave biopsy Tumor site: leg Microscopic tumor type: melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Breslow thickness: 4.4 mm Ulceration: present Margins, peripheral and deep: abutting the base and focally extending to the periphery Mitotic index: 20/mm2 Microsatellitosis: not observed Vascular invasion: not observed Perineural invasion: not observed Regression: not observed Pathologic Staging (pTNM): pT4b pNX	MELANOMA, 4.4 mm, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	17723	1258	\N	\N	22-51092	\N	NM-84	Nodular Melanoma	IP2452836	AirTable blocks_with_IP_info.csv
2816	22-81852B	63	t	\N	20	T4b	Primary	melanoma in skin with low cumulative sun damage (WHO classification)	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30418,30419,30420,30421,30422,30423,30424,30425,30426,30427,30428,30429	172.7	\N	\N	Sections show a zone of fibrosing granulation tissue representing the residuum of a prior biopsy site, flanked by a proliferation of atypical melanocytes in irregularly shaped masses in the adjacent dermis, with some intervening areas of uninvolved dermis.	Oriented ellipse, 8.6 x 3.3 x 1.8 cm, including a central 1.0 x 1.0 cm pearly area. The orienting short sutured tip is indicated as superior 12 o'clock on the requisition and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with one-half section each in B1-B12. Tips reserved. BB/BB	A) RIGHT INGUINAL SENTINEL LYMPH NODE (HOT AND BLUE), FRESH, B) EXCISION OF RIGHT THIGH MELANOMA, PERMANENT	\N	\N	FFPE	The residual invasive melanoma in this specimen is not as thick (as in the initial biopsy), which remains the overall thickness of record. Features suggested for reporting per the guidelines of the College of American Pathologists, updated from the report of the prior biopsy include:  Procedure: re-excision Microscopic tumor type: melanoma in skin with low cumulative sun damage (WHO classification) Breslow thickness: 4.4 mm Ulceration: present Margins, peripheral and deep: both clear Mitotic index: 20/mm2 Microsatellitosis: present Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4b	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173727	1258	\N	\N	22-81852	B	NM-84	Nodular Melanoma	IP2452836	AirTable blocks_with_IP_info.csv
2658	20-106642A	78	\N	\N	9	T4b	Primary	\N	10	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22687	172.6	\N	\N	There is an ulcerated nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis.  There is little diminishment in melanocyte size with descent in the dermis.	Elliptical excision, 4.3 x 1.8 x 0.7 cm, including a central 1.3 x 1.3 cm raised area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A and B. Tips reserved. CF/CF	DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SQUAMOUS CELL CARCINOMA VS. BASAL CELL CARCINOMA, NOTES: PLEASE CHECK MARGINS (PHOTO)	\N	\N	FFPE	A Melan-A immunostain is positive, confirming melanocytic lineage in the malignancy, and also highlights areas of regression. A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type, WHO classification: high cumulative sun damage Breslow thickness: 4.5 mm Ulceration: present Margins, peripheral and deep: peripheral involved by melanoma in situ, deep narrow Mitotic index: 9 per square mm Microsatellitosis: not identified Vascular invasion: not identified Regression: partial present Perineural invasion: not identified Pathologic staging (pTNM): pT4b	MELANOMA, 4.5 MM IN THICKNESS, ULCERATED	173611	1259	\N	\N	20-106642	A	NM-85	Nodular Melanoma	IP279875	AirTable blocks_with_IP_info.csv
2708	21-21341	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3580	\N	\N	56-18	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	1277	\N	\N	21-21341	\N	OM-16	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2703	21-21316	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	18-19	\N	\N	\N	\N	gingiva	\N	\N	\N	\N	1278	\N	\N	21-21316	\N	OM-17	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2702	21-21315C	0	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	B15-01O	\N	One outside slide, B15-01-O, and one corresponding block.\nUpdate: Two of five pieces from original block (1) re-embedded into new block (2).	MUCOSA PROJECT, DX: IN SITU MELANOMA	\N	upper gingiva and palate	\N	\N	\N	101006	1279	\N	\N	21-21315	C	OM-18	Oral Mucosa Lesions	IP2283796	AirTable blocks_with_IP_info.csv
2648	20-91914A	74	\N	\N	13	T4b	Primary	melanoma in skin with low cumulative sun damage (WHO classification)	10	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22686	172.5	\N	\N	There is a pedunculated, ulcerated multi-nodular proliferation of large, atypical melanocytes in partial apposition to the epidermis. Maturation with descent is faulty. There are many mitotic figures within dermal melanocytes.	Skin segment measuring 1.7 x 1.5 x 0.6 cm, serially sectioned and submitted with three representative sections in A. BB/BB	A) MORPHOLOGY: PEARLY TELANGIECTATIC PAPULE, DDX: BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA, B) MORPHOLOGY: SUSPICIOUS IRREGULAR MULTI-COLORED MACULE, DDX: MELANOMA IN SITU VS. DYSPLASTIC NEVUS, C) MORPHOLOGY: WELL-DEMARCATED ERYTHEMATOUS SCALY THIN PLAQUE, DDX: BOWEN'S DISEASE VS. SUPERFICIAL BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Microscopic tumor type: melanoma in skin with low cumulative sun damage (WHO classification) Breslow thickness: 5.5 mm Ulceration: yes Margins, peripheral: clear by 1 mm., and deep: clear by 1 mm. Mitotic index: 13/mm2 Microsatellitosis: to be determined following re-excision Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4b pNX	MELANOMA, 5.5 MM. IN THICKNESS	173524	1260	\N	\N	20-91914	A	NM-86	Nodular Melanoma	IP918535	AirTable blocks_with_IP_info.csv
10994	SP-12-020017C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2062	\N	\N	\N	\N	SYNX659	\N	\N	Consolidated_data_final.csv
2634	20-60974B	87	\N	\N	1	T3b	Primary	Nodular melanoma	10	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22654	172.7	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis.  There is little diminishment in melanocyte size with descent in the dermis. The surface of the lesion is ulcerated.	Skin segment measuring 1.1 x 1.0 x 0.4 cm, quadrisected and entirely submitted in B. KB/BY	A) BCC?, B) R/O MM	\N	\N	FFPE	Diagnostic features of note include: Procedure: biopsy Tumor site: melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Microscopic tumor type: Nodular melanoma Breslow thickness: 2.6 mm Ulceration: present Margins, peripheral and deep: peripheral involved, deep narrow Mitotic index: 1/mm2 Microsatellitosis: not detected Vascular invasion: not detected Perineural invasion: not detected Regression: not detected Pathologic Staging (pTNM): pT3b pNX	MELANOMA, 2.6 MM IN THICKNESS, WITH ULCERATION, EXTENDING TO THE EDGE OF THE SPECIMEN	173702	1261	\N	\N	20-60974	B	NM-87	Nodular Melanoma	IP284614	AirTable blocks_with_IP_info.csv
1289	07-74058A	28	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show a mucosal segment with basilar hyperpigmentation and normal numbers of melanocytes along the epithelial-submucosal junction. Parts of the submucosa appear fibrotic and contain melanophages. There is also a focus of vacuolar change with scattered necrotic keratinocytes at the junction. In level sections, scattered enlarged atypical melanocytes are found along the junction toward one edge of the biopsy.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in cassette A.	2 BROWN MACULES	\N	right lower lip lateral	\N	Level sections show a population of melanocytes with enlarged atypical nuclei focally present within this biopsy. I believe these cells represent a subtle manifestation of the intraepidermal melanoma that is evident in the other biopsy from this patient.	SUBTLE INTRAEPIDERMAL PROLIFERATION OF ENLARGED ATYPICAL MELANOCYTES, PRESENT CONCURRENTLY WITH A MELANOTIC MACULE	101044	1262	\N	\N	07-74058	A	OM-01	Oral Mucosa Lesions	IP696592	AirTable blocks_with_IP_info.csv
1290	07-74058B	28	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	232.9	\N	\N	Sections show squamous mucosa with an intraepithelial proliferation of melanocytes. The lesional melanocytes have strikingly large and hyperchromatic nuclei and are scattered erratically in the lower half of the epithelium. There is also submucosal elastosis with scattered melanophages. A contiguous area shows basal pigmentation, submucosal fibrosis, and muting of rete with vacuolar changes.	Skin segment measuring 1.3 x 0.6 x 0.1 cm, bisected and entirely submitted in cassette B.	2 BROWN MACULES	\N	oral mucosa	FFPE	There is also a concurrent/contiguous melanotic macule in this biopsy as well.	MELANOMA IN SITU, FOCALLY TRANSECTED AT THE PERIPHERY OF THE BIOPSY	101044	1262	\N	\N	07-74058	B	OM-01	Oral Mucosa Lesions	IP696592	AirTable blocks_with_IP_info.csv
1305	08-16770	32	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show an increased number of individual melanocytes, arrayed along the sides and bases of elongated, hyperpigmented rete. Only a rare melanocyte shows nuclear enlargement. There may be rare tiny admixed nests present. A few lesional melanocytes are present in the lowermost stratum spinosum.	Skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted.	LABIAL MELANOSIS	\N	left labia minora	\N	There is no evidence of a genital melanotic macule, as the degree of cellularity along the junction is greater than what is stereotypically associated with that entity. Does this biopsy include the entire clinical pigmented lesion? If so, then the differential diagnosis lies between a lentigo simplex on one hand, and an evolving lentiginous junctional melanocytic nevus on the other. Is this instead a partial biopsy of a larger pigmented lesion? If so, then the present findings are somewhat more worrisome, as circumscription cannot be fully ascertained, and thus ongoing close clinical follow-up or conservative complete reexcision of this site should be considered. We apologize for the brief delay in reporting. Level sections were not immediately ordered because of an oversight in the laboratory. Again, we apologize for any inconvenience caused.	INTRAEPIDERMAL PROLIFERATION OF MELANOCYTES WITH A LENTIGO SIMPLEX-LIKE CONFIGURATION	205552	1263	\N	\N	08-16770	\N	OM-02	Oral Mucosa Lesions	IP725411	AirTable blocks_with_IP_info.csv
1354	09-88536	47	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show vacuolar alteration and an increase in cellularity along the epidermal-dermal junction, where scattered necrotic keratinocytes are apparent. The fibrotic submucosa below this holds a lymphohistiocytic infiltrate with admixed melanophages.	Cylindrical skin segment (rc'd in 2 pcs) measuring 0.3 cm in diameter and 0.4 cm in thickness in aggregate (head=0.3 cm in diameter and 0.1 cm in thickness, stem=0.2 cm in diameter and 0.4 cm in thickness); all submitted.	NEVUS, R/O ATYPIA VS. LABIAL MACULE	\N	left labia	\N	My differential diagnosis included a lichenoid form of vulvitis as well as an inflamed pigmented lesion, such as an inflamed melanotic macule, and I favor the former possibility as most likely. Melan-A and MiTF immunostains were both completed as part of our assessment and both show a normal (or perhaps slightly elevated) density of melanocytes, thereby suggesting that there is not a melanocytic lesion at this site. An elastic tissue (EVG) stain shows a loss of fine elastic fibrils in the perijunctional zone, which, when coupled with the lichenoid infiltrate observed in conventional sections, raises lichen sclerosus et atrophicus as a potential consideration. A PAS-D stain was completed as well and shows focal slight accentuation of the perijunctional basement membrane, as can also be seen with lichen sclerosus. Is there any indication of lichen sclerosus from a clinical perspective?	LICHENOID MUCOSITIS WITH ASSOCIATED POST-INFLAMMATORY HYPERPIGMENTATION	104587	1264	\N	\N	09-88536	\N	OM-03	Oral Mucosa Lesions	IP840903	AirTable blocks_with_IP_info.csv
2267	18-00192	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	palate	FFPE	\N	\N	\N	1280	\N	\N	18-192	\N	OM-22	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1718	13-68674	60	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show basilar hyperpigmentation of a hyperplastic mucosal epithelium with an increase of small melanocytes in the basal layer. Melanophages are scattered in the submucosa.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, bisected and entirely submitted. RS/RS	DEEPLY PIGMENTED MACULE; R/O MM	\N	right labia minora	\N	In level sections and with SOX-10 immunohistochemistry, the increase in small melanocytes with small nuclei in the basal layer is more apparent than in initial sections. This increase in melanocyte density is not typically observed in melanotic macule. If the clinical lesion is small, a conservative re-excision would be reasonable. I would be happy to review any available clinical photos. Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis and assessment.	MELANOTIC MACULE WITH INCREASED EPIDERMAL MELANOCYTES, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	205551	1265	\N	\N	13-68674	\N	OM-04	Oral Mucosa Lesions	IP475265	AirTable blocks_with_IP_info.csv
1712	13-51506A	33	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	709.09	Typical melanotic macule	\N	Sections show basilar hyperpigmentation without evidence of a proliferation of melanocytes.	Seven skin segments ranging in measurement from 0.2 x 0.1 x 0.1 cm to 0.8 x 0.4 x 0.1 cm, with the largest segment bisected, all entirely submitted in A. PL/PL	A-B) R/O LENTIGO MALIGNA	\N	genital mucosa	FFPE	\N	MELANOTIC MACULE	205551	1291	\N	\N	13-51506	A	OM-33	Oral Mucosa Lesions	IP1293509	AirTable blocks_with_IP_info.csv
1728	13-107061	40	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show labial epithelium with lymphocytes and melanophages in the submucosa, slight spongiosis and enlarged single melanocytes in small numbers along the junctional zone. Some of these have slightly enlarged, hyperchromatic nuclei.	Cylindrical skin segment measuring 0.2 cm in diameter and 0.2 cm in thickness, submitted intact. HD/HD	Melanoma vs. Labial Lentigo Brown macule PRE OP SIZE: 0.4 CM	\N	left inferior vermillion lip	\N	Both a Sox-10 immunostain and levels highlight that the lesional melanocytes have more enlarged nuclei than usual for a labial melanotic macule, and the melanocytes are more unevenly distributed. I would consider additional sampling, or complete removal with margins sufficient to assess circumscription.	SPARSELY CELLULAR JUNCTIONAL PROLIFERATION OF MELANOCYTES	122031	1266	\N	\N	13-107061	\N	OM-05	Oral Mucosa Lesions	IP1349079	AirTable blocks_with_IP_info.csv
1812	15-1495	65	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	There are elongated rete ridges with basilar hyperpigmentation and increased numbers of single melanocytes in the basal layer, with scant cytoplasm and small, round nuclei; a patchy lymphocytic infiltrate with melanophages is present in the subjacent lamina propria.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	DARK MACULE; R/O DARK LABIAL LENTIGO VS. OTHER	\N	letf labia majora	\N	Per my telephone discussion with Dr. Ferzli today, the specimen included the entire clinically evident pigmented lesion, which was of recent onset. While melanocytes are sparse, their number is still greater than that usually present in genital melanotic macules, and a few are present in the lamina propria. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate among the junctional melanocytes, and does not show suprabasilar scatter. In addition, rare single melanocytes are present in the lamina propria, with a zero proliferation rate. A SOX-10 stain shows that the nuclei of the junctional melanocytes are clustered near the bases of elongated rete ridges and also does not show suprabasilar scatter.  I favor a partially transformed lesion that might progress if not fully excised, and given a chance to recur. A narrow re-excision of a few mms. to assure removal seems warranted.	SPARSELY CELLULAR PROLIFERATION OF MELANOCYTES	135577	1267	\N	\N	15-1495	\N	OM-06	Oral Mucosa Lesions	IP1472484	AirTable blocks_with_IP_info.csv
2342	18-103965B	63	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show basilar pigmentation with submucosal melanophages. There is solar elastosis in the subepithelial zone as well.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A) IRREGULAR BROWN MACULE; ATYPICAL JUNCTIONAL MELANOCYTIC HYPERPLASIA, IRREGULAR PIGM, MACULES ON LOWER LIP OF RECENT ONSET, ATYPICAL MELANOCYTIC PROLIFERATION, R/O LM, B) SUSPICIOUS IRREGULAR PIGMENTED PATCH ON SUN EXPOSED SKIN; LENTIGO MALIGNA, 6 MM IRREGULARLY PIGM, MACULE ON L LOWER LIP OF RECENT ONSET, LM VS. ATYPICAL MELANOCYTIC PROLIFERATION	\N	left lower lip	\N	With regard to specimen (B), a SOX-10 immunoperoxidase stain also reveals a normal number and distribution of junctional melanocytes, supporting the diagnosis of a labial melanotic macule.	LABIAL MELANOTIC MACULE	201098	1268	\N	\N	18-103965	B	OM-07	Oral Mucosa Lesions	IP1386790	AirTable blocks_with_IP_info.csv
2336	18-91716	37	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly along the dermal-epidermal junction.	Tiny skin segment measuring 0.2 x 0.2 x 0.1 cm, submitted intact. The specimen vial is examined for additional tissue. CF/CF	6 M BROWN MACULE; BOWEN'S, MELANOTIC MACULE, OTHER	\N	gland penis	\N	This lesion has an increased number of junctional melanocytes, which rules out a melanotic macule. However, the cells are regularly distributed and not atypical, rendering melanoma in situ unlikely. I would thus classify this as a borderline lesion and, given its small size, recommend narrow but complete removal to avoid further enlargement and possible progression.	JUNCTIONAL MELANOCYTIC PROLIFERATION, EXTENDING TO THE EDGES OF THE SPECIMEN	115524	1269	\N	\N	18-91716	\N	OM-08	Oral Mucosa Lesions	IP1955698	AirTable blocks_with_IP_info.csv
2709	21-21342	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3581	\N	\N	78-18	\N	\N	\N	\N	gingiva	\N	\N	\N	\N	1271	\N	\N	21-21342	\N	OM-10	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2705	21-21334	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3316	\N	\N	B01-322	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	1272	\N	\N	21-21334	\N	OM-11	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2474	19-126110	73	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show a zone of scar, and the epidermis above the scar contains prominent single melanocytes. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Excision and ellipse received in biopsy bottle. Excision measuring 0.6 x 0.3 x 0.3 cm with the margins inked yellow and ellipse measuring 0.8 x 0.2 x 0.2 cm with the margins inked blue, both trisected perpendicular to the long axis and entirely submitted. PL/PL	A) SCAR VS. MM. VIOLACEOUS SCAR. PLEASE CHECK MARGINS.. HISTORY OF URETHRAL MELANOMA R/O SCAR VS MM. CC: DR. ENBE (HANFORD) AND STANFORD GYN (DR. DAUD).	\N	left labium majus	\N	A SOX-10 immunoperoxidase stain and level sections show single melanocytes at the junction with foci of basilar hyperpigmentation, but they do not show definitive evidence of a persistent melanocytic neoplasm. A PRAME immunostain is negative as well. Positive PRAME staining of the nuclei of the melanocytes would have favored persistent melanoma. These findings are within the spectrum of a genital melanotic macule over a scar. I have shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation.	SCAR WITH BASILAR HYPERPIGMENTATION, SEE NOTES	135577	1273	\N	\N	19-126110	\N	OM-12	Oral Mucosa Lesions	IP1847018	AirTable blocks_with_IP_info.csv
2707	21-21338	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3320	\N	\N	B13-164	\N	\N	\N	\N	soft palate	\N	\N	\N	\N	1274	\N	\N	21-21338	\N	OM-13	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2706	21-21336	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3318	\N	\N	B11-073	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	1275	\N	\N	21-21336	\N	OM-14	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2710	21-21351	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3590	\N	\N	10-21	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	1276	\N	\N	21-21351	\N	OM-15	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3282	DM28	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1565	\N	\N	None	\N	SYNAT335	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
2454	19-72316	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	lip	FFPE	\N	\N	\N	1281	\N	\N	19-72316	\N	OM-23	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2473	19-122139	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	gingiva	FFPE	\N	\N	\N	1282	\N	\N	19-122139	\N	OM-24	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2589	20-16705	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	buccal	FFPE	\N	\N	\N	1283	\N	\N	20-16705	\N	OM-25	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2604	20-28273	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	lip	FFPE	\N	\N	\N	1284	\N	\N	20-28273	\N	OM-26	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2720	21-59477	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	buccal	FFPE	\N	\N	\N	1285	\N	\N	21-59477	\N	OM-27	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2721	21-59483	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	buccal	FFPE	\N	\N	\N	1286	\N	\N	21-59483	\N	OM-28	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2734	21-93208	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	buccal	FFPE	\N	\N	\N	1287	\N	\N	21-93208	\N	OM-29	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1881	15-99261C	34	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	709.09	Typical melanotic macule	\N	Sections show basilar hyperpigmentation without evidence of a proliferation of melanocytes.	Skin segment measuring 1.0 x 0.7 x 0.3 cm, trisected and entirely submitted in C. KC/KC	A) CLINICALLY BENIGN PAPULE WITH MULTIPLE EPISODES OF BLEEDING, B) PROJECTING PAPULE NOTED A FEW DAYS AGO AT THE SITE OF WHAT PT BELIEVES IS A LONGSTANDING "MOLE", C) PIGMENTED LESION THAT APPEARED 1 YEAR AGO, D) PIGMENTED LESION THAT APPEARED 1 YEAR AGO	\N	acral mel macule	FFPE	Melanotic macules occur at a variety of sites, and consist of basilar hyperpigmentation without a significantly increased number of melanocytes.	MELANOTIC MACULE	173714	1295	\N	\N	15-99261	C	OM-37	Oral Mucosa Lesions	IP1570965	AirTable blocks_with_IP_info.csv
1884	15-102731B	67	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	709.09	Typical melanotic macule	\N	Sections show acral skin with basilar hyperpigmentation without evidence of a proliferation of melanocytes. Within the deep dermis there is an area of fibrosis with an increase in small nerve bundles, suggesting a traumatic neuroma.	Cylindrical skin segment, 0.3 cm in diameter and 0.5 cm in thickness, submitted intact in B. KC/KC	R/O MELANOMA W/ HUTCHINSON'S FRECKLE, SEE PATH DT15-95455	\N	hand/foot	FFPE	Melan-a immunohistochemistry demonstrates single melanocytes at the dermo-epidermal junction, in keeping with the above diagnosis. Melanotic macules occur at a variety of sites, and consist of basilar hyperpigmentation without a significantly increased number of melanocytes. Within the dermis, there are findings suggestive of scar or traumatic neuroma. Perhaps there was a prior injury at this site which would correspond with the hyperpigmentation?	MELANOTIC MACULE	325678	1296	\N	\N	15-102731	B	OM-38	Oral Mucosa Lesions	IP1567130	AirTable blocks_with_IP_info.csv
1890	15-122774	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1297	\N	\N	15-122774	\N	OM-39	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1896	16-2833	\N	\N	\N	\N	\N	\N	\N	16	0	FFPE	\N	\N	\N	Intramucosal nevus	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1298	\N	\N	16-2833	\N	OM-40	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1952	16-77557	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1299	\N	\N	16-77557	\N	OM-41	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2160	17-70204	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1300	\N	\N	17-70204	\N	OM-42	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2064	17-24139	\N	\N	\N	\N	\N	\N	\N	16	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1301	\N	\N	17-24139	\N	OM-43	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2241	17-116120	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1302	\N	\N	17-116120	\N	OM-44	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2310	18-44728A	80	\N	\N	\N	\N	\N	\N	16	0	FFPE	\N	\N	198.5	Mel	\N	Rounded large and small islands and of poorly differentiated epithelial cells infiltrate inflamed connective tissue. Tumor cells are pleomorphic and atypical with large hyperchromatic nuclei but only rare mitoses. Comedo-type necrosis is seen.	Multiple soft tissue fragments and multiple teeth fragments received in one vial. Multiple soft tissue fragments measuring 2.2 x 1.7 x 0.3 cm in aggregate, all entirely submitted with multiple fragments each in A-B. Multiple teeth fragments ranging in measurements from 0.5 x 0.4 x 0.5 cm to 0.7 x 0.7 x 2.2 cm, not run and all reserved. CF/CF	ANTERIOR MANDIBULAR LESION WITH TEETH #23 - #27	\N	oral mucosa	FFPE	This is a poorly differentiated dyscohesive malignancy requiring immunostains to further classify and the results are as follows: S-100: diffusely and strongly positive, supports a diagnosis of melanoma SOX-10: diffusely and strongly positive, supports a diagnosis of melanoma Melan-A: negative BRAF V600E: negative CD138: negative, against a plasma cell malignancy CD3: positive in small lymphocytes, tumor cells are negative, against a T-cell lymphoma CD20: negative, against a B-cell lymphoma keratin: negative, against a carcinoma p63: negative, against a carcinoma  Given the history in 2010 and 2016 of cutaneous melanoma reported to involve the left chest, the findings here are consistent with a metastatic melanoma.  The positive S-100 and SOX-10 stains coupled with the negative keratin and p63 immunostains suggest that this tumor is unlikely to be a squamous cell carcinoma.  The patient is reported to have had a dermatofibroma protuberans (DFSP) involving the right neck in 2014 but there are no features here to support that diagnosis. Dr. J. North, Dr. T. Mully and Dr. P. LeBoit also reviewed this case and concur with the diagnosis.  I showed selected sections to Dr. T. McCalmont who concurs. I notified Dr. Patel of the results on May 2, 2018.	POORLY DIFFERENTIATED MALIGNANCY MOST CONSISTENT WITH METASTATIC MELANOMA	175344	1303	\N	\N	18-44728	A	OM-45	Oral Mucosa Lesions	IP1510187	AirTable blocks_with_IP_info.csv
2333	18-88579	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Mel	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1304	\N	\N	18-88579	\N	OM-46	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2334	18-90413	\N	\N	\N	\N	\N	\N	\N	16	0	FFPE	\N	\N	\N	Mel	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1305	\N	\N	18-90413	\N	OM-47	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1413	10-86269	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1306	\N	\N	10-86269	\N	OM-48	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1714	13-55769	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1307	\N	\N	13-55769	\N	OM-49	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1875	15-86891	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1308	\N	\N	15-86891	\N	OM-50	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1860	15-43382	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1309	\N	\N	15-43382	\N	OM-51	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1873	15-74487	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1310	\N	\N	15-74487	\N	OM-52	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1879	15-96473	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1311	\N	\N	15-96473	\N	OM-53	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1942	16-53528	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1312	\N	\N	16-53528	\N	OM-54	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1946	16-55930	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1313	\N	\N	16-55930	\N	OM-55	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1906	16-8674	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1314	\N	\N	16-8674	\N	OM-56	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1935	16-37928A	49	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	172.0	\N	\N	There is an epithiotropic poorly circumscribed proliferation of atypical melanocytes, with a few small nests, irregularly distributed within the lamina propria and extending into the basal layer of the epithelium.  Some melanocytes have atypical nuclei.	Three outside slides, CS-16-003019 A1.	SUBSEQUENT EXCISIONS OF THE AREA SURROUNDING THE ORIGINAL EXCISION SITE (SEE DJ16-31388); MELANOMA	\N	oral mucosa	FFPE	Many thanks for asking me to review this case. I agree with your diagnosis that this lesion is a melanoma that shows epitheliotropic and angiotropic features.  The depth of invasion is 1.3 mm measured from the epithelial surface.  This diagnosis is supported by the MART-1 immunostain showing that the tumor cells are positive. Tumor is transected at the deep and one peripheral specimen margin.  Since tumor is present at the specimen margins, staging of the patient followed by wider excision to achieve clear margins by a clinician experienced in this disease would be an appropriate treatment option.  I also shared this H&E sections of this case with Dr. P. LeBoit who concurs.  I spoke to Dr. Peterson about this case on April 22, 2015.	MELANOMA TRANSECTED AT THE DEEP AND ONE PERIPHERAL SPECIMEN MARGIN	101005	1315	\N	\N	16-37928	A	OM-57	Oral Mucosa Lesions	IP1630601	AirTable blocks_with_IP_info.csv
1940	16-44627	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1316	\N	\N	16-44627	\N	OM-58	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2022	17-3165B	44	\N	\N	\N	\N	\N	\N	4	\N	FFPE	\N	\N	709.09	\N	\N	Sections show basilar hyperpigmentation without evidence of a proliferation of melanocytes.  The epidermis is acanthotic and hypergranulotic and there is an underlying patchy lymphohistiocytic infiltrate and a few perijunctional necrotic keratinocytes.	Skin segment measuring 0.7 x 0.3 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. PIGMENTED SCC INSITU VS LENTIGO. 2MMX3MM BROWN MACULE. #1 SUPERIOR. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. PIGMENTED SCC INSITU VS LENTIGO. 3MMX2MM BROWN MACULE. #2 INFERIOR.	\N	genital mucosa	FFPE	\N	MELANOTIC MACULE, INFLAMED	135578	1320	\N	\N	17-3165	B	OM-62	Oral Mucosa Lesions	IP1729294	AirTable blocks_with_IP_info.csv
2462	19-94975	38	\N	\N	\N	None	None	None	6	\N	FFPE	\N	\N	216.0	\N	\N	There is a proliferation of melanocytes, mostly at the epithelial-connective tissue junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer.	Tissue segment, 0.5 x 0.5 x 0.1 cm, bisected, and entirely submitted. HD/HD	SLIGHTLY IRREGULAR BORDER - SLIGHT RAISED PAPULE, BROWN	\N	oral mucosa	FFPE	There is no evidence of malignancy in the sections. I showed this case to my colleague Dr. I. Yeh who agrees with the above diagnosis.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	100009	1321	\N	\N	19-94975	\N	OM-63	Oral Mucosa Lesions	IP2099586	AirTable blocks_with_IP_info.csv
1922	16-24795	\N	\N	\N	\N	\N	\N	\N	4	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1322	\N	\N	16-24795	\N	OM-64	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2603	20-026598	\N	\N	\N	\N	\N	\N	\N	4	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1323	\N	\N	20-26598	\N	OM-65	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1732	14-01007	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1324	\N	\N	14-1007	\N	OM-67	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1737	14-4953	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1325	\N	\N	14-4953	\N	OM-68	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1891	15-122795	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1326	\N	\N	15-122795	\N	OM-69	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1956	16-85059	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1327	\N	\N	16-85059	\N	OM-70	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
2189	17-91629	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1328	\N	\N	17-91629	\N	OM-71	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3528	MEL202_DMSO	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Melanoma cell line, treated with DMSO	\N	\N	\N	\N	\N	\N	\N	\N	\N	1329	\N	\N	None	\N	P_MEL202	Melanoma Epigenetics,Cell Line	\N	AirTable blocks_with_IP_info.csv
3529	MEL202_Vemu	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Melanoma cell line, treated with 100ng vemurafenib	\N	\N	\N	\N	\N	\N	\N	\N	\N	1329	\N	\N	None	\N	P_MEL202	Melanoma Epigenetics,Cell Line	\N	AirTable blocks_with_IP_info.csv
2177	17-82364B	37	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a biphasic melanocytic proliferation.  One population of melanocytes consists of small cells with round to oval nuclei. There is a focus where there are also melanocytes with spindled configurations, which display cytoplasmic pigmentation and surrounding melanophages.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) ATYPICAL NEVUS. ATYPICAL RED BROWN PAPULE. B) ATYPICAL NEVUS. IRREGULAR BROWN PAPULE.	\N	left hairline	Scraping	\N	COMBINED MELANOCYTIC NEVUS, WITH BOTH ORDINARY NEVUS AND SPINDLED BLUE NEVUS ELEMENTS	102422	1338	\N	\N	17-82364	B	SM-008	Nevus Library	IP650361	AirTable blocks_with_IP_info.csv
2608	20-30367	14	\N	\N	\N	None	None	None	10	0	FFPE	\N	\N	216.3	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges.  There is basilar hyperpigmentation in the affected area.  Clusters of small, round melanocytes reside in the subjacent dermis.	Four outside slides, D20-012267 (A1), and one corresponding block.	R/O MIS	\N	\N	FFPE	I favor a compound nevus with aberrant PRAME expression, but am obtained a few more stains to further evaluate this lesion. A p16 immunoperoxidase stain shows adequate expression of tumor suppressor gene product (nearly complete or complete absence of staining in a defined zone is worrisome for melanoma). An elastic van Gieson stain no longer contains more than rare papillary dermal cells, precluding a determination as to whether these cells displace the dermal component, as would favor a dysplastic nevus-like melanoma. Given that this lesion is on the forehead of a child, and in my opinion, is more likely to have an immunohistochemical aberration than represent melanoma in situ arising in a nevus, I would follow the site clinically.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS WITH AN ATYPICAL IMMUNOHISTOCHEMICAL FINDING, SEE COMMENT	102388	1330	\N	\N	20-30367	\N	SCH-01	Seattle Children's Hospital -GENOMICS OF CUTANEOUS NEVI AND HEMANGIOMAS IN RING CHROMOSOME 7	IP2177946	AirTable blocks_with_IP_info.csv
1844	15-21302	46	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a dermal proliferation of melanocytes, some of which are large with abundant cytoplasm and ovoid nuclei, and others of which are slender and dendritic and are associated with melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. PL/PL	ATYPICAL BROWN GREY BARELY ELEVATED PAPULE; ATYPICAL NEVUS VS. BLUE NEVUS VS. MELANOMA VS. NEVUS	\N	right upper arm 	Scraping	Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation index. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. These findings are reassuring, but the proliferation remains unusual, such that conservative re-excision of this site seems warranted.	COMBINED MELANOCYTIC NEVUS, WITH SPITZ'S NEVUS AND BLUE NEVUS ELEMENTS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173688	1331	\N	\N	15-21302	\N	SM-001	Nevus Library	IP488197	AirTable blocks_with_IP_info.csv
1490	11-53065	60	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show lentiginous elongation and hyperpigmentation of rete, without a definite junctional component. The dermis contains a wedge-shaped proliferation of spindled or epithelioid melanocytes interspersed between sclerotic collagen bundles. To one side, the cells have a more rounded nevoid appearance and are nested superficially. Overall, there is good maturation and symmetry to both components. A few scattered dendritic cells are present.	Skin segment measuring 0.5 x 0.4 x 0.2 cm, bisected and entirely submitted.	R/O ATYPICAL	\N	right lower arm 	Scraping	Despite its occurrence in severely elastotic skin, the lesion has an orderly growth pattern and appears benign. It has combined features, but the dominant pattern is of desmoplastic Spitz nevus. The case has been reviewed with concurrence by Drs. LeBoit and Mully.	TRIPHASIC COMBINED MELANOCYTIC NEVUS, WITH ORDINARY, BLUE, AND SPITZ'S NEVUS ELEMENTS, EXCISED IN PLANES OF SECTION EXAMINED	529611	1332	\N	\N	11-53065	\N	SM-002	Nevus Library	IP1042505	AirTable blocks_with_IP_info.csv
1885	15-102927	61	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a dermal proliferation of small melanocytes with round to oval nuclei, coupled with spindled cells associated with thickened collagen. There is solar elastosis in the dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. RS/RS	A) RULE-OUT ATYPICAL MELANOCYTIC PROCESS. PINK SCALY PAPULE WITH PERIPHERAL BROWN PIGMENTATION AND BROWN DOTS AND CLODS AT PERIPHERY. PMH MMIS.	\N	\N	FFPE	None	COMBINED MELANOCYTIC NEVUS, WITH ORDINARY (CONGENITAL) AND BLUE NEVUS COMPONENTS	173688	1368	\N	\N	15-102927	\N	SN-05	Sclerotic Nevi	IP1374483	AirTable blocks_with_IP_info.csv
1199	06-2345	40	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a deep and partially wedge-shaped proliferation of slightly spindled and ovoid melanocytes, some with vacuolated and pigmented cytoplasm, which extends deeply in the reticular and adventitial dermis. Some deep melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous. There are many interspersed melanophages. Superficially, these cells meld with a population of heavily pigmented spindled melanocytes enmeshed in sclerosis.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted.	4 X 3 MM BLUISH PAPULE; ?RECURRENT BLUE NEVUS, R/O ATYPICAL PIGMENTED LESION	\N	left scalp	Scraping	This lesion could also be interpreted as a combined melanocytic nevus, with an admixture of deep penetrating nevus and conventional blue nevus. There is no evidence of melanoma.	CELLULAR BLUE NEVUS	173417	1333	\N	\N	06-2345	\N	SM-003	Nevus Library	IP395583	AirTable blocks_with_IP_info.csv
1931	16-33907	67	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of spindled and dendritic melanocytes enmeshed in thickened, sclerotic collagen. The lesional cells show considerable cytoplasmic pigmentation and scattered accompanying melanophages are appreciable as well. Focal post-traumatic ulceration is noted.	Skin segment measuring 1.0 x 0.9 x 0.3 cm, quadrisected and entirely submitted. RS/RS	R/O DF	\N	left upper lateral back 	Scraping	This biopsy demonstrates a lightly pigmented blue nevus rather than a dermatofibroma.	DESMOPLASTIC BLUE NEVUS	273588	1334	\N	\N	16-33907	\N	SM-004	Nevus Library	IP1633163	AirTable blocks_with_IP_info.csv
2259	17-120984	16	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a wedge shaped proliferation of spindled melanocytes with monomorphous nuclei, positioned between thickened collagen bundles and accompanied by melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. RS/RS	R/O DYSPLASTIC NEVUS	\N	right dorsal hand	Scraping	None	BLUE NEVUS	173663	1335	\N	\N	17-120984	\N	SM-005	Nevus Library	IP1851544	AirTable blocks_with_IP_info.csv
1631	12-51532	42	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.2	\N	\N	Sections show a predominantly dermal proliferation of small melanocytes with round to oval nuclei, coupled with larger spindled cells associated with thickened collagen bundles and melanophages. There is increased cellularity near adnexal structures. In addition, spongiosis of the overlying epidermis is apparent.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted.  SL/SL	? ATYPIA	\N	left ear 	Scraping	This nevus has features of both a blue nevus and of a intradermal melanocytic nevus with congenital features.	COMBINED MELANOCYTIC NEVUS	173201	1336	\N	\N	12-51532	\N	SM-006	Nevus Library	IP368502	AirTable blocks_with_IP_info.csv
1872	15-72350	20	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show dermal proliferation of small melanocytes with round to oval nuclei, coupled with larger ovoid and spindled melanocytes associated with melanophages. The melanocytes extend into the reticular dermis.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR. DARKLY PIGMENTED MACULE. DARKLY PIGMENTED MACULE; FAVOR BENIGN NEVUS BUT GETTING DARKER..	\N	left medial clavicle 	Scraping	None	COMBINED MELANOCYTIC NEVUS, WITH SUPERFICIAL CONGENITAL AND BLUE NEVUS COMPONENTS	105525	1337	\N	\N	15-72350	\N	SM-007	Nevus Library	IP495959	AirTable blocks_with_IP_info.csv
1608	12-22884C	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a predominantly dermal proliferation of melanocytes that diminish in size with descent in the dermis.  Mitotic figures are inconspicuous.  Some small melanocytes are situated between reticular dermal collagen bundles.	Skin segment measuring 0.8 x 0.6 x 0.2 cm, bisected and entirely submitted in cassette C.	A-C) SK, D) IDN	\N	Intradermal, congenital pattern, back	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, CONGENITAL PATTERN	173502	1435	\N	\N	12-22884	C	SYNAT336	Melanocytic Nevus	IP1108702	AirTable blocks_with_IP_info.csv
2188	17-90774B	78	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a biphasic melanocytic proliferation. There are both conventional melanocytes and dendritic or spindled melanocytes jointly with lymphocytes and melanophages.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR. B) NEOPLASM OF UNCERTAIN BEHAVIOR.	\N	right anterior shoulder	Scraping	This biphasic melanocytic nevus includes the commingling of conventional melanocytic nevus with dendritic blue nevus.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	102611	1339	\N	\N	17-90774	B	SM-009	Nevus Library	IP1314381	AirTable blocks_with_IP_info.csv
2205	17-106118C	66	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a domed skin segment harboring a dermal proliferation of melanocytes arrayed as coalescing and maturing nests, cords, and small syncytia with deep neural differentiation in the reticular dermis, which is elastotic.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in C. KC/KC	A-D) R/O DYSP VS. COMP N	\N	left posterior neck	Scraping	As for the specimen above, this melanocytic nevus is heavily pigmented and is accompanied in the biopsy by actinic (solar) lentigo.	INTRADERMAL MELANOCYTIC NEVUS	173404	1340	\N	\N	17-106118	C	SM-010	Nevus Library	IP1836502	AirTable blocks_with_IP_info.csv
2204	17-106118B	66	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a domed skin segment harboring a dermal proliferation of melanocytes arrayed as coalescing and maturing nests, cords, and syncytia in the reticular dermis. There is prominent perijunctional hyperpigmentation. Bud-like rete are above this.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A-D) R/O DYSP VS. COMP N	\N	right posterior neck 	Scraping	\N	INTRADERMAL MELANOCYTIC NEVUS WITH COINCIDENTAL OVERLYING ACTINIC LENTIGO	173477	1340	\N	\N	17-106118	B	SM-010	Nevus Library	IP1836502	AirTable blocks_with_IP_info.csv
2233	17-115105	31	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.0	\N	\N	Sections show a melanocytic proliferation composed of cells with two distinct cytologic appearances. There may also be a third in the form of dendritic cells. There are melanophages scattered in the upper dermis as well.	Skin segment measuring 0.5 x 0.5 x 0.2 cm, bisected and entirely submitted. HD/HD	SHAVE REMOVAL OF 0.5 X 0.6 CMN DARK BROWN PAPULE; COMPOUND NEVUS, R/O MM	\N	right upper lip	Scraping	This biphasic melanocytic nevus includes the commingling of conventional melanocytic nevus with blue nevus. I considered the possibility that deep penetrating nevus might be present as well, but bcl-1 staining is negative, which suggests this is not the case.	COMBINED MELANOCYTIC NEVUS	100031	1341	\N	\N	17-115105	\N	SM-012	Nevus Library	IP1271461	AirTable blocks_with_IP_info.csv
2469	19-115700A	48	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.6	\N	GNAQ	Sections show conventional melanocytes and deeply pigmented fusiform melanocytes that commingle.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) R/O MIS VS. HYPERMELANOTIC, B) R/O DN, HISTORY OF CLARK'S	\N	\N	FFPE	This papular melanocytic nevus exhibits the commingling of conventional lentiginous melanocytic nevus with deeply pigmented melanocytic nevus resembling a blue nevus.	COMBINED MELANOCYTIC NEVUS	173620	1369	\N	\N	19-115700	A	SN-06	Sclerotic Nevi	IP2120444	AirTable blocks_with_IP_info.csv
11109	SCC10-0092	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2156	\N	\N	\N	\N	SYNX753	\N	\N	Consolidated_data_final.csv
1837	15-16261	59	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show nests, cords and strands of mostly small, round melanocytes extending into the superficial reticular dermis and around a folliculo-sebaceous unit. In the superficial reticular dermis are thickened collagen bundles, with some of the melanocytes in this area that are large, oval cells with pale cytoplasm and slightly enlarged vesicular nuclei.	Cylindrical skin segment, 0.5 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. CF/CF	R/O PIGMENTED BCC	\N	right proximal flexor forearm 	Scraping	This lesion has a minor, but not worrisome-appearing desmoplastic spitzoid component. A dermal margin is involved, but in my opinion, re-excision is not needed.	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	113605	1342	\N	\N	15-16261	\N	SM-013	Nevus Library	IP1487321	AirTable blocks_with_IP_info.csv
1889	15-118245A	28	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with nested and solitary melanocytes scattered along the junction. There are maturing nests, cords, and syncytia of small melanocytes in the reticular dermis below this. A perifollicular keratin granuloma is present as well.	Cylindrical skin segment, 0.4 cm in diameter and 0.7 cm in thickness, bisected and entirely submitted in A. PL/PL	A) 5 X 4 MM TAN PAPULE; CMN, R/O ATYPIA, B) 5 X 4 MM BROWN PAPULE; DYSPLASTIC CMN, R/O ATYPIA, C) 6 X 4 MM VARIEGATED BROWN PAPULE; CMN, R/O ATYPIA , D) 8 X 5 MM VARIEGATED BROWN PAPULE; CMN, R/O ATYPIA, E) 5 X 5 MM PINK PAPULE; CMN VS. SCAR	\N	right deltoid 	Scraping	\N	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	105539	1343	\N	\N	15-118245	A	SM-014	Nevus Library	IP1590062	AirTable blocks_with_IP_info.csv
2039	17-10753	28	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a dome shaped segment of skin with a proliferation of melanocytes with two types of cells. One population consists of clusters of small melanocytes with round to oval monomorphous nuclei. A second population consists of collections of oval and spindled melanocytes with large oval nuclei embedded in between thickened collagen bundles as single cells and as small nests.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	LM VS. MM VS. MIS, 8 X 8 MM	\N	right lateral antecubital 	Scraping	There are no worrisome features.	COMBINED MELANOCYTIC NEVUS, WITH PREDOMINANTLY INTRADERMAL (ORDINARY) AND DESMOPLASTIC SPITZ'S NEVUS COMPONENTS	100689	1344	\N	\N	17-10753	\N	SM-015	Nevus Library	IP1739922	AirTable blocks_with_IP_info.csv
2061	17-21788B	62	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a symmetric compound proliferation of melanocytes. Small nests of small round melanocytes and single melanocytes are arrayed at the sides and bases of elongated rete. Within the dermis, there are nests of melanocytes, and some have abundant amphophilic cytoplasm. Dermal melanocytes mature and disperse to single cells within fibrotic collagen with a wedge shaped lower border.	Oriented ellipse, 2.0 x 0.9 x 0.5 cm, including a central 0.8 x 0.5 cm brown area. With the orienting pre-inked blue tip placed to the left and indicated L pole 9 o'clock on the requisition, the 9-12-3 o'clock margin is inked black and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in A and five sections in B. PL/PL	MALIGNANT MELANOMA VS. CAN, 7 MM IRR BRN PAPULE, MM, CAN, EXCISION	\N	left buttock	Scraping	This nevus has small round melanocytes as well as melanocytes with abundant cytoplasm similar to those in Spitz nevus. The lower portion of the nevus is set within desmoplastic stroma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively low proliferation rate in the junctional component and a near zero proliferation rate in the dermal component. The MART-1/tyrosinase component does not reveal more suprabasilar scatter than could be seen in the hematoxylin and eosin stained sections. p16 staining is strong in a subset of the lesional melanocytes, supporting a benign diagnosis. Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis and assessment. The nevus is completely excised.	COMPOUND MELANOCYTIC NEVUS	173507	1345	\N	\N	17-21788	B	SM-016	Nevus Library	IP1747915	AirTable blocks_with_IP_info.csv
1610	12-22886	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show nests, cords and strands of small round melanocytes in the dermis.  These cells mature with descent.  There are admixed adipocytes.	Skin segment measuring 0.4 x 0.4 x 0.2 cm, bisected and entirely submitted.	IDN	\N	Lipoid Metaplasia, right neck	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH LIPOID METAPLASIA (A SENESCENT CHANGE)	173405	1436	\N	\N	12-22886	\N	SYNAT337	Melanocytic Nevus	IP337537	AirTable blocks_with_IP_info.csv
2125	17-52720	31	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.2	\N	\N	Sections show a proliferation of melanocytes involving the epidermis and mostly, the superficial dermis. There are increased single melanocytes at the dermo-epidermal junction, and some small nests of them, in part positioned at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area.  Within the dermis are nests, cords and strands of small, round melanocytes.  These cells mature with descent, and lie in part around adnexal structures. Deeper in the dermis is a sclerotic, pauci-cellular area in which there are thin spindled cells and mucin deposition.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. KC/KC	NEVUS WITH CYST, R/O ATYPIA, 5 MM	\N	left posterior earlobe	Scraping	ADDENDUM, June 12, 2017: The dermal and subcutaneous margins are involved, per you inquiry.  Original note:  This unusual lesion has a lower portion that raised the possibility of desmoplastic melanoma arising beneath a nevus, which is a very rare occurrence. The markedly fibrotic area in question has S100+ spindled cells within it, many of which are thin, and long. These also stain with WT-1. Neither stain shows significantly thick fascicles, as would favor desmoplastic melanoma and the nuclei of the cells in question are not markedly atypical. Staining with CD34 shows some foci with a whorled pattern, as can be seen in perineuriomas, and some dendritic processes are positive with epithelial membrane antigen, as can be seen in perineurioma.  In sum, the fibrosing spindle cell area has mixed features of neurofibroma and perineurioma, and the findings do not support a component of desmoplastic melanoma. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis. We do not believe that re-excision is necessary.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES, WITH A SUBJACENT AREA FEATURING SCHWANNIAN AND PERINEURIOMATOUS DIFFERENTIATION	173222	1346	\N	\N	17-52720	\N	SM-017	Nevus Library	IP1782404	AirTable blocks_with_IP_info.csv
2256	17-120487A	48	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a symmetric predominantly dermal proliferation of melanocytes with nests of small round melanocytes in the superficial dermis. Below, melanocytes are positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis with a wedge-shaped profile.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in A. KC/KC	A) 4 X 4 MM BROWN ERYTHEMATOUS PAPULE; NEVUS, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 4 X 4 MM SLIGHTLY IRREGULAR TAN BROWN MACULE; NEVUS, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	left anterior upper arm	Scraping	\N	PREDOMINANTLY INTRADERMAL NEVUS	173649	1347	\N	\N	17-120487	A	SM-018	Nevus Library	IP349912	AirTable blocks_with_IP_info.csv
2295	18-24908	25	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a wedge-shaped profile. Pigmented melanocytes are present along the sides and bases of elongated and hyperpigmented rete. The melanocytes are evenly distributed and mature with descent in the reticular dermis arrayed as single cells and cords between thickened collagen bundles at the base of the biopsy.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. HD/PL	R/O NEOPLASM OF UNCERTAIN BEHAVIOR, DYSPLASTIC NEVUS, MALIGNANT MELANOMA, 0.4 CM DARK BROWN PAPULE	\N	left scapular back	Scraping	This benign lesion shares a fibrotic dermal reaction with desmoplastic Spitz's nevus, but lacks the large melanocytes seen in that condition.	COMPOUND MELANOCYTIC NEVUS	173530	1348	\N	\N	18-24908	\N	SM-019	Nevus Library	IP1888575	AirTable blocks_with_IP_info.csv
11110	MASCRI-432	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2157	\N	\N	\N	\N	SYNX754	\N	\N	Consolidated_data_final.csv
2317	18-59376	49	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a symmetric compound proliferation of melanocytes. Small round melanocytes with round or ovoid nuclei and scant cytoplasm are arrayed as nests and single cells along the sides and bases or elongated rete. In the dermis below, nests of melanocytes mature to single cells between desmoplastic collagen bundles with a wedge-shaped profile.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. KC/KC	3 MM IRREGULAR BROWN MACULE; ATYPICAL NEVUS	\N	left lower thigh 	Scraping	In areas, this nevus has features of a blue nevus, perhaps accounting for the clinical appearance.	COMPOUND MELANOCYTIC NEVUS	173726	1349	\N	\N	18-59376	\N	SM-020	Nevus Library	IP1491105	AirTable blocks_with_IP_info.csv
2327	18-76281	78	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a dermal proliferation of spindled melanocytes with bland nuclei, and bipolar dendritic melanocytes with pigmented cytoplasm. These cells are accompanied by fibrosis and melanophages.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	0.2 CM GREYISH PAPULE	\N	left mid lateral forearm 	Scraping	None	BLUE NEVUS	177611	1350	\N	\N	18-76281	\N	SM-021	Nevus Library	IP1940225	AirTable blocks_with_IP_info.csv
2343	18-113402B	30	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show nested and solitary melanocytes arrayed along the epidermal-dermal junction and in the superficial dermis. There is also a second population of spindled and dendritic melanocytes that are associated with melanophages and sclerosis.	Oriented ellipse, 1.7 x 0.7 x 0.6 cm, including a central 1.0 x 0.6 cm brown area. The orienting notched edge is indicated as 12 o'clock on the requisition form and placed toward 12 o'clock. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections each in A-B. HD/HD	1 CM SYMMETRICAL IRREGULAR PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA, PLEASE CHECK MARGINS	\N	mid lower back 	Scraping	This biphasic melanocytic nevus includes the commingling of conventional lentiginous melanocytic nevus and desmoplastic nevus. There is no evidence of melanoma.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	102537	1351	\N	\N	18-113402	B	SM-022	Nevus Library	IP1977457	AirTable blocks_with_IP_info.csv
1581	12-16974C	33	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends within the reticular dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages.	Cylindrical skin segment measuring 0.6 cm in diameter and 0.6 cm in thickness. The specimen is bisected (fragmented while cutting), and entirely submitted with two sections and fragment in cassette C.	A-C) R/O DYSPLASTIC NEVUS	\N	right knee lateral	Scraping	\N	DEEP PENETRATING NEVUS (PIGMENTED EPITHELIOID MELANOCYTIC NEVUS), SUPERFICIAL TYPE, A VARIANT OF BLUE NEVUS	102733	1352	\N	\N	12-16974	C	SM-023	Nevus Library	IP1102790	AirTable blocks_with_IP_info.csv
2263	17-128346A	27	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a predominantly dermal proliferation of melanocytes that diminish in size with descent in the dermis.  There are nests and syncytia of relatively small melanocytes superficially, with nests and strands of similar cells deeper in the specimen.  The overlying epidermis displays elongated rete that intertwine. Some melanocytes have vacuolated cytoplasm.	Cylindrical skin segment, 0.5 cm in diameter and 0.9 cm in thickness, bisected and entirely submitted in A. RS/RS	A-B) 4 MM BROWN PAPULE; CPD NEVUS, C) 3 MM BROWN PAPULE; CPD NEVUS, D) 4 MM BROWN PAPULE; CPD NEVUS, E) 3.5 MM BROWN PAPULE; CPD NEVUS, F) 2.5 MM BROWN PAPULE; CPD NEVUS, G) 6 X 8 MM BROWN PAPULE; CPD NEVUS, H) 5 MM BROWN PAPULE; CPD NEVUS, I) 3 MM BROWN PAPULE; CPD NEVUS	\N	left upper arm 	Scraping	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173649	1353	\N	\N	17-128346	A	SM-024	Nevus Library	IP1787557	AirTable blocks_with_IP_info.csv
2332	18-85718	9	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	\N	\N	There is a proliferation of cytologically bland melanocytes that is in part nested at the dermo-epidermal junction, also involving the superficial dermis. In one half of the specimen, the deep dermal melanocytes demonstrate prominent pale and vacuolated cytoplasm.	Skin segment measuring 0.6 x 0.4 x 0.2 cm, bisected and entirely submitted. KC/KC	4 MM X 4 MM FLESH COLORED PINK PAPULE, HISTORY OF CHANGE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	left lower neck 	Scraping	This nevus displays prominent balloon cell change.	COMPOUND MELANOCYTIC NEVUS	139498	1354	\N	\N	18-85718	\N	SM-025	Nevus Library	IP1949687	AirTable blocks_with_IP_info.csv
1757	14-39393	70	f	\N	0	T1a	Primary	Superficial spreading melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show an asymmetrical, compound proliferation of melanocytes, many of which have atypical nuclei.  There is prominent pagetoid scatter. There are irregular clusters of similar melanocytes in the underlying superficial dermis.  The overlying epidermis is thickened with focal parakeratosis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, quadrisected and entirely submitted with four sections plus one fragment. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. ATYPICAL PIGMENTED LESION. PATCH. 8MMX6MM BLACK PATCH WITH DARK DOTS.	\N	\N	\N	With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its small invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). The proliferation extends to the specimen periphery. Additional treatment to ensure complete removal would be prudent. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation. A synoptic report of potential prognostic factors is listed below: Procedure: shave biopsy Microscopic tumor type: Superficial spreading melanoma Breslow thickness: 0.32 mm Ulceration: absent Margins, peripheral and deep: peripheral positive, deep negative Mitotic index: 0 mm/2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.32 MM IN THICKNESS, NON-ULCERATED	17733	1355	\N	\N	14-39393	\N	SMP2	Spitz Melanoma	IP1389327	AirTable blocks_with_IP_info.csv
2472	19-117270	34	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a wedge shaped dermal proliferation of melanocytes of two types, both positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis. There are cells with slightly enlarged round or ovoid nuclei, and scant cytoplasm, as well as typical Spitz cells, large, oval melanocytes with abundant, pale cytoplasm and monomorphous oval vesicular nuclei.	Ellipse, 2.0 x 0.9 x 0.3 cm, including a central 0.5 x 0.5 cm white area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with nine sections. PL/PL	DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. PROBABLE COMBINED NEVUS (SEE PATH), UNCERTAIN BEHAVIOR, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	The excision is complete. The residual lesion seen here has the wedge shaped, dense fibrous stroma, and and some large oval cells as would be typical for a desmoplastic Spitz's nevus, but also has some cells with small nuclei and scant cytoplasm. The excision is complete, and there are no particularly worrisome features.	BIOPSY SITE CHANGES AND RESIDUAL DESMOPLASTIC NEVUS	273692	1370	\N	\N	19-117270	\N	SN-07	Sclerotic Nevi	IP2115907	AirTable blocks_with_IP_info.csv
1777	14-59414	27	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show melanocytes arrayed irregularly and in pagetoid fashion in the epidermis and as partially maturing nests, cords, and fascicles in the dermis. The constituent melanocytes are fusiform and enlarged with pale pigmented cytoplasm. Scattered dermal lymphocytes and melanophages are noted.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. RS/RS	NEVUS, R/O ATYPIA	\N	\N	\N	My differential diagnosis included an unconventional Spitz nevus/tumor and melanoma, and I believe the latter possibility represents the best categorization for this tumor. Selected immunostains were included in our analysis. Immunostaining for p16, which represents the gene product of the CDKN2A gene, demonstrates a significant loss of reactivity, as is common in association with melanoma. Phosphohistone-H3 immunostaining (in combination with Melan-A) confirms that relatively florid pagetoid scatter of melanocytes is present, and the phosphohistone-H3 component of the combined immunostain fails to demonstrate any dermal melanocytes in mitosis. With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its invasive component, as was corroborated by phosphohistone-H3 immunostaining. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Further excision is warranted to ensure that local control has been established.	MELANOMA OF 0.6 MM IN THICKNESS, FOCALLY TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173508	1356	\N	\N	14-59414	\N	SMP4	Spitz Melanoma	IP1313107	AirTable blocks_with_IP_info.csv
1616	12-24027C	13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a large segment of skin in which there is a superficial scar. In addition, there is an intradermal proliferation of large melanocytes arranged as nodular aggregations of varying sizes. Many of the lesional melanocytes contain abundant eosinophilic cytoplasm and some have eccentrically located nuclei. In addition, many of the lesional melanocytes contain prominent nucleoli. The size of the melanocytes generally does not diminish with descent into the dermis. Lesional melanocytes aggregate around nerves in the deep aspect of the specimen. Mitotic figures are present within the proliferation.	Oriented ellipse measuring 1.8 x 1.3 x 0.9 cm, including a central 1.2 x 1.2 cm pearly pink and raised area.  The orienting short suture is designated superior by the surgeon and arbitrarily designated 12:00 by the grosser. The orienting long suture is designated lateral by the surgeon and arbitrarily designated 3:00 by the grosser. The 12:00-3:00 margin is inked blue, the 3:00-6:00 margin is inked red, and the the 6:00-12:00 margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 12:00 to 6:00 tips and entirely submitted with two sections each in cassettes C1 and C2 and one section each in cassettes C3 through C7.	A-C) LESION	\N	\N	\N	The findings in this current specimen were similar to those in the prior biopsy from this site (12-18611). Thus, the differential diagnosis was between a spitzoid melanoma and an unusual Spitz's nevus. To further evaluate for this differential diagnosis, we performed comparative genomic hybridization (CGH) on this tissue. The CGH data shows a small abnormality on the proximal portion of chromosome 5p, but it is very subtle and of uncertain significance. Therefore, our interpretation of the CGH data is that it does not show any meaningful chromosomal gains or losses.  Despite the normal CGH, given that numerous mitotic figures are present among lesional melanocytes, that many of the melanocytes have large, hyperchromatic nuclei, and the melanocytes are arranged as sheets, we are still quite concerned that the findings in this biopsy represent those of a spitzoid melanoma. If a melanoma has chromosomal aberrations that are copy number neutral, CGH will not show any aberrations, which could explain the normal CGH data in this case. If this lesion does represent a melanoma, it is 8.5 millimeters in thickness. However, as you know, spitzoid melanomas in children tend to behave in a less aggressive fashion compared with conventional melanomas of equivalent thickness. Therefore, the thickness measurement mentioned above should be interpreted in this context.  The residual melanoma present in this specimen is located at least 6 millimeters from all of the inked margins.  My colleagues, Drs. Timothy McCalmont, Philip LeBoit and Boris Bastian have seen these sections and agree with this assessment.	SCAR AND RESIDUAL INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, CONCERNING FOR SPITZOID MELANOMA	173304	1357	\N	\N	12-24027	C	SMP11	Spitz Melanoma	IP1104428	AirTable blocks_with_IP_info.csv
1727	13-105024A	11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.9	\N	\N	There is a proliferation of large oval and fusiform melanocytes that are predominantly situated in the dermis, forming large confluent nests at the junction of an irregularly hyperplastic epidermis with a domed surface. There is marked nuclear pleomorphism, with many of the cells having scant cytoplasm, resulting in an appearance where nuclei appear to overlap. Many of these nuclei are vesicular, with large nucleoli. Maturation with descent is faulty. Large aggregates are present at the base of the lesion. There is a dense lymphocytic infiltrate underlying the lesion.	One hematoxylin and eosin-stained section prepared from outside blocks labeled 67397 (A-B).	NOT PROVIDED	\N	\N	\N	While the scanning microscopic appearance raises the possibility of a Spitz's nevus, the degree of confluence of junctional nests, the high nuclear to cytoplasmic ratio, the large nucleoli and the failure to mature uniformly with descent are all findings that favor a spitzoid melanoma over a Spitz's nevus. Additionally, while the lesion appears to have a flat base at scanning magnification, that base is provided by lymphocytes. When one looks at the contour of the melanocytic proliferation itself, it is quite uneven. A p16 immunostain performed in our laboratory shows a near absence of staining. This can correlate with bi-allelic loss of chr. 9p. or chr. 9, but is not as strong evidence for the genomic loss as would be fluorescence in situ hybridization or comparative genomic hybridization testing. Currently, I use the term Spitzoid melanoma, childhood type, for an emerging class of lesions that usually but not exclusively occur in children and teens, usually lack b-raf mutations (which are present in most melanomas in adults) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. These are findings that would support conservative treatment. Most lesions of this type are deeper, but usually not much wider than their exophytic portions, and even when they are, are well circumscribed. While sentinel nodes are often positive, this positivity has much less predictive value for systemic spread than is the case with adult melanoma. Hence, the thickness of 2.1 mm would result in a prognosis that is much more grim than a lesion such as this one would ordinarily have. A narrow re-excision and clinical follow-up is preferable to more aggressive treatment.	SPITZOID MELANOMA, CHILDHOOD TYPE	666955	1358	\N	\N	13-105024	A	SMP12	Spitz Melanoma	IP1347042	AirTable blocks_with_IP_info.csv
1652	12-91942	49	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a roughly symmetrical compound melanocytic proliferation with a domed surface and a flattish base.  The overlying epidermis is thickened, with hyperplasia of the spinous layer, hypergranulosis and compact hyperkeratosis. Situated at the epidermal-dermal junction are nests of large oval melanocytes, some of which are separated from the epidermis by clefts.  The junctional melanocytes have abundant pale vacuolated and lightly pigmented cytoplasm and large, pleomorphic vesicular nuclei. Kamino bodies (dull pink globules) are present. Melanocytes mature with descent within the dermis in some areas but not others, and the sizes of their aggregations also diminish with descent.	Ellipse, 1.3 x 0.6 x 0.3 cm, including 0.6 x 0.6 cm central brown area. With the deep and peripheral margin inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections in one cassette.  DM/DM	ATYPICAL NEVUS	\N	\N	\N	The differential diagnosis included a Spitz's nevus and a spitzoid melanoma. Favoring a Spitz's nevus were the architectural features of the lesion and the presence of many Kamino bodies. Favoring melanoma are the character of the cytoplasm of the lesional melanocytes and the degree of nuclear pleomorphism of both epidermal and dermal melanocytes. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate in the dermal component. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows some mitotic figures in the junctional component but not in the dermal component. Both of these are reassuring findings. A p16 immunoperoxidase stain shows nearly complete loss of that tumor suppressor gene product. Comparative genomic hybridization shows multiple chromosomal aberrations pointing to melanoma. There is a gain involving chromosome 1q, and losses involving chromosomes 9, 10 and the distal portion of 11q. The first three are common occurrences in melanoma. The low amplitude of the deviations from the baseline on the comparative genomic hybridization array graph probably reflects normal cell contamination, as the epidermis in the area that was used for comparative genomic hybridization is quite thick (DNA from normal keratinocytes and lymphocytes diluted the DNA from the lesional melanocytes).  The neoplasm extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 0.65 MM. IN THICKNESS	173740	1359	\N	\N	12-91942	\N	SMP20	Spitz Melanoma	IP1177759	AirTable blocks_with_IP_info.csv
2465	19-104449D	68	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	216.5	\N	GNAQ	Sections show a proliferation of melanocytes with a biphasic pattern (arrayed as 2 populations of cells).  One population consists of small conventional melanocytes, while the second consists of deeply pigmented fusiform melanocytes with melanophages.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in D. HD/HD	A) R/O DYSP VS. COMP N VS. LPLK, B-E) R/O DYSP VS. COMP N, F) R/O BCC	\N	\N	FFPE	Conventional lentiginous melanocytic nevus is mixed with deeply pigmented spindled melanocytes in this small proliferation.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	139523	1366	\N	\N	19-104449	D	SN-03	Sclerotic Nevi	IP2109117	AirTable blocks_with_IP_info.csv
2464	19-103058B	66	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	GNAQ	Sections show conventional melanocytes overlying deeply pigmented fusiform melanocytes.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) 3 MM DARK BROWN PAPULE WITH NO PIGMENT NETWORK; R/O ATYPIA VS. NEVUS, B) CONTIGUOUS WITH SK, 4 MM DARK BROWN TO BLACK PAPULE; R/O SK	\N	\N	FFPE	This biopsy contains a combined spindle cell deep penetrating nevus. There is no evidence of malignancy or atypicality.	COMBINED MELANOCYTIC NEVUS	273588	1367	\N	\N	19-103058	B	SN-04	Sclerotic Nevi	IP2107719	AirTable blocks_with_IP_info.csv
2463	19-97163	50	\N	\N	\N	None	None	None	10	0	FFPE	\N	\N	216.4	\N	GNAQ	There are nests, cords and strands of small, round melanocytes that mature with descent into the dermis, and a second population of bipolar dendritic melanocytes accompanied by melanophages. The proliferation in part surrounds adnexal structures.	Skin segment measuring 0.2 x 0.1 x 0.1 cm. Submitted intact. BY/BY	1 MM; R/O ATYPICAL NEVUS	\N	\N	FFPE	No evidence of melanoma or significant atypia was detected.	COMBINED MELANOCYTIC NEVUS, WITH BOTH SUPERFICIAL CONGENITAL AND BLUE NEVUS ELEMENTS	173405	1371	\N	\N	19-97163	\N	SN-08	Sclerotic Nevi	IP679852	AirTable blocks_with_IP_info.csv
2601	20-25263A	66	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	MAP2K1	Sections show clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. 3MM PINK PAPULE WITH BROWN CENTER. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. MMIS. 1.5 MM BLACK MACULE.	\N	\N	FFPE	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	273588	1382	\N	\N	20-25263	A	SN-19	Sclerotic Nevi	IP1865438	AirTable blocks_with_IP_info.csv
10995	SP-12-0032671A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2063	\N	\N	\N	\N	SYNX660	\N	\N	Consolidated_data_final.csv
1868	15-52921B	61	\N	\N	2	T2a	Primary	melanoma NOS	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a compound proliferation of melanocytes with vacuolated and finely pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, and conspicuous associated suprabasal scatter is apparent, yet there are also nested and fascicular areas with fusiform melanocytes. There are also nests and fascicles of similar melanocytes in the upper dermis, where a lymphohistiocytic infiltrate with admixed melanophages resides. Zones have lost melanocytes and have fibrosis instead.	Oriented ellipse measuring 2.5 x 1.5 x 0.4 cm, including a central 1.8 x 1.0 cm pink brown area. With the orienting notched tip placed to the left and designated as 9 o'clock by the grosser, the 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in B1 and five sections in B2. HD/HD	A) AK VS. SCC, B) MM	\N	\N	\N	This melanoma is associated with extensive partial and complete regression. In light of the associated regression, the microstage measurement listed above may underestimate the prognostic impact of this melanoma. Synoptic melanoma reporting is included below. Procedure: narrow excision Microscopic tumor type: melanoma NOS Breslow thickness: 1.2 mm Ulceration: not detected Margins, peripheral and deep: free of melanoma Mitotic index: 2/square mm Microsatellitosis: not detected Vascular invasion: not detected Regression: present; partial and complete Pathologic staging (pTNM): pT2aNxMx with regression	MELANOMA OF 1.2 MM IN THICKNESS, NARROWLY BUT FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA BY 1-2 MM OR SO)	173727	1360	\N	\N	15-52921	B	SMP48	Spitz Melanoma	IP1524271	AirTable blocks_with_IP_info.csv
1428	11-1044	39	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a polypoid, largely dermal proliferation of large atypical melanocytes, with prominent nucleoli, and some intranuclear inclusions, as well as some multinucleate cells, arrayed as clusters and sheets within the dermis, without demonstrating adequate maturation with melanocytic descent. Mitotic activity is not conspicuous. There is a patchy lymphocytic infiltrate. Similar melanocytes are present within the overlying epidermis, which is slightly hyperplastic, mainly in single array, within the lower epidermis. There is slight epidermal hyperplasia, as well as hypergranulosis and hyperkeratosis. The constituent cells label with S100, and variably with HMB45 and MART-1, with no significant staining with CD68 or high molecular weight cytokeratin. The Ki-67 stain may be suboptimal, with inadequate internal controls, that is, a lack of uniform strong staining of the basal keratinocytes. Thus, it cannot be interpreted readily. There is no significant labeling rate within dermal melanocytes, however.	Eight outside slides, OPD 10STX109022-A-2-1.  One corresponding block received 1/11/11.	POLYPOID LESION	\N	\N	\N	This spitzoid melanocytic proliferation contains remarkably large melanocytes, some of which are multinucleate, and fails to demonstrate adequate maturation with melanocytic descent. It also contains a somewhat syncytial arrangement of dermal melanocytes. It did not thus display features of a conventional Spitz's nevus by any means. As the differential diagnosis included spitzoid melanoma, such lesions often prompt analysis by comparative genomic hybridization, a molecular technique that uses lesional tissue from the paraffin block. It is based on the presence of chromosomal gains and losses in about 95% of melanomas, but with the exception of a gain of 11p, a lack of them in Spitz's nevi. A reference on this technique and its applicability to this differential diagnosis is listed below. This testing has now been completed, and shows multiple chromosomal aberrations. There is a complete loss of chromosome 9, a finding which on its own may not be of particular significance, but in combination with the other aberrations noted, supports a diagnosis of melanoma. There is a loss of chromosome 1p, as well as losses of part of chromosome 17 and 19p as well. These findings, along with the atypical histologic features noted, confirm the diagnosis of melanoma. In terms of staging, pertinent prognostic features summarized below. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis.  Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: low Perineural invasion: not evident Ulceration: not evident Regression: not evident Microsatellite metastasis: not evident AJCC stage: T3a  Reference: Bastian BC, Wesselmann U, Pinkel D, LeBoit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999 Dec;113(6):1065-9.	POLYPOID MELANOMA WITH LARGE SPITZOID MELANOCYTES, 3.5 MM IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173727	1361	\N	\N	11-1044	\N	SMP55	Spitz Melanoma	IP990481	AirTable blocks_with_IP_info.csv
1435	11-7028	26	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a proliferation of melanocytes with a domed surface, a flat base, and a much more cellular component on one side of the lesion than on the other. The lesional melanocytes are large and oval, many with a high nuclear-to-cytoplasmic ratio, large vesicular nuclei and prominent nucleoli. The more sparsely cellular area has markedly thickened collagen bundles. I did not encounter mitotic figures in dermal melanocytes. The enclosed immunoperoxidase-stained sections infer a very low proliferative rate amongst lesional melanocytes, but the overlying epidermis also has a very low rate, indicating that this may not be reliable.	Three outside slides, D10-49200 A (11-1438) and one corresponding block.	FAMILY HX OF MELANOMA, 0.7 CM CHANGING PAPULE; R/O MELANOMA	\N	\N	\N	To further substantiate the nature of this atypical melanocytic proliferation, we completed array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, aCGH assessment demonstrated losses in chromosomes 6q, 9, 10q, 12q, 13, 14q, and 18. The documentation of multiple chromosomal gains and losses is not known to occur in association with melanocytic nevi, including Spitz nevi, and instead points to interpretation as melanoma. This is a non-ulcerated melanoma with associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.3 MM IN THICKNESS, EXCISED IN THE AVAILABLE PLANES OF SECTION	173710	1362	\N	\N	11-7028	\N	SMP56	Spitz Melanoma	IP996465	AirTable blocks_with_IP_info.csv
1806	14-115431C	4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	\N	\N	The microscopic changes are similar to those in (B), but are more extensive.	Six outside slides, DC14-6132 (C1-C2), two corresponding blocks received 12/23/14.	A) MELANOMA, B) SENTINEL LYMPH NODE PLACEMENT, C) LYMPH NODE	\N	\N	\N	The area of involvement in (C) is discontinuous, but ranges up to 7 mm. Extracapsular involvement is not present. My estimate is that less than 10% of the nodal cross sectional area is involved in (B), and about 10% is involved in (A). Nodal involvement in this context does not have the same implications as in conventional melanoma in adults.	SAME AS (B)	173702	1363	\N	\N	14-115431	C	SMP58	Spitz Melanoma	IP1428103	AirTable blocks_with_IP_info.csv
1805	14-115431A	4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.7	\N	\N	There is a proliferation of large oval melanocytes with markedly pleomorphic vesicular nuclei with a raised surface, irregular epidermal hyperplasia and a multinodular dermal component, with little maturation with descent and some dee mitotic figures. A few pulverocytes are present. There is an admixed lymphocytic infiltrate.	Nine outside slides, DC14-6132 (A1-A9), nine corresponding blocks received 12/23/14.	A) MELANOMA, B) SENTINEL LYMPH NODE PLACEMENT, C) LYMPH NODE	\N	\N	\N	Re the nature of this neoplasm, please see my note in the report on the initial biopsy. The lesional thickness is 6 mm. in these sections. This should not be used for prognosis in the manner that thickness in conventional melanoma in adults is.	RESIDUAL SPITZOID MELANOMA, CHILDHOOD TYPE	192711	1363	\N	\N	14-115431	A	SMP58	Spitz Melanoma	IP1428103	AirTable blocks_with_IP_info.csv
2451	19-53945B	48	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	MAP2K1	Sections show a dermal proliferation of melanocytes with slightly enlarged round or ovoid nuclei, and scant cytoplasm. The cells are positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A-B) MORPHOLOGY: PAPULE, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. DERMATOFIBROMA	\N	\N	FFPE	This lesion has dense fibrotic stroma, and cells that are on average smaller than those in a classic Spitz's nevus, but larger than those of a common nevus. Some melanocytes express p16, in keeping with a nevus.	DESMOPLASTIC NEVUS	173528	1364	\N	\N	19-53945	B	SN-01	Sclerotic Nevi	IP2058294	AirTable blocks_with_IP_info.csv
2453	19-69103	72	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	There are nests, cords and strands of small, round melanocytes that mature with descent into the dermis. In the lower portion of the dermis, melanocytes have a spindled configuration. Some superficial melanocytes are pigmented.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	5 MM DARK PAPULE; R/O DARK SK VS. ATYPIA	\N	\N	FFPE	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173620	1365	\N	\N	19-69103	\N	SN-02	Sclerotic Nevi	IP316729	AirTable blocks_with_IP_info.csv
2452	19-59869A	45	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.4	\N	MAP2K1	Sections show a compound proliferation of melanocytes with mostly single melanocytes at the dermo-epidermal junction and oval and spindled melanocytes positioned between thickened collagen bundles in the dermis.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) R/O BASAL CELL CARCINOMA - PRIMARY, SEBACEOUS GLAND HYPERPLASIA, PINK TRANSLUCENT PEARLY PAPULE WITH ARBORIZING TELANGIECTASIA, B-C) R/O NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN, COMPOUND NEVUS OF SKIN, DYSPLASTIC NEVUS OF SKIN, VARIEGATED TAN, BROWN AND ERYTHEMATOUS LESION	\N	\N	FFPE	This benign lesion shares a fibrotic dermal reaction with desmoplastic Spitz nevus, but lacks the large melanocytes seen in that condition.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS WITH DESMOPLASTIC FEATURES	173441	1372	\N	\N	19-59869	A	SN-09	Sclerotic Nevi	IP2064255	AirTable blocks_with_IP_info.csv
2440	19-43600A	78	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.6	\N	GNAQ	Sections show a melanocytic proliferation with two types of cells.  One population of melanocytes consists of small round cells with scant cytoplasm and monomorphous round to oval nuclei. Beneath them are dendritic, pigmented melanocytes with inconspicuous nuclei and variable cytoplasmic pigmentation, accompanied by melanophages.	Four skin fragments measuring 1.2 x 0.7 x 0.1 cm in aggregate, one is bisected and all entirely submitted in A. CF/CF	A) 5 MM; R/O ATYP, B) 6 MM; R/O ATYP	\N	\N	FFPE	\N	COMBINED MELANOCYTIC NEVUS, WITH ORDINARY AND BLUE NEVUS ELEMENTS	173619	1373	\N	\N	19-43600	A	SN-10	Sclerotic Nevi	IP1927911	AirTable blocks_with_IP_info.csv
2457	19-79825	50	\N	\N	\N	None	None	None	10	0	FFPE	\N	\N	216.5	\N	MAP2K1	There are increased single melanocytes and small nests of them along the sides and bases of elongated rete ridges. Small, round melanocytes in the subjacent papillary dermis mature to spindled melanocytes. There is basilar hyperpigmentation in the affected area.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. BY/BY	MORPHOLOGY: COLOR VARIEGATION AND BORDER IRREGULARITY AND 3 MM, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	FFPE	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	345533	1374	\N	\N	19-79825	\N	SN-11	Sclerotic Nevi	IP1933035	AirTable blocks_with_IP_info.csv
2458	19-80535A	41	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	216.5	\N	MAP2K1	There are increased single melanocytes along the sides and bases of elongated rete ridges, and small, round melanocytes that mature to spindled cells in the subjacent dermis. There is basilar hyperpigmentation in the affected area.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) PINK ON THE EDGES, BROWN ON THE CENTER; R/O ATYPIA, B) 5 X 4 MM THIN BROWN PAP; R/O ATYPIA	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	155568	1375	\N	\N	19-80535	A	SN-12	Sclerotic Nevi	IP2085042	AirTable blocks_with_IP_info.csv
2441	19-43600B	78	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	GNAQ	The microscopic features are similar to those of (A), with the addition of a few junctional nests.	Three skin fragments measuring 0.7 x 0.6 x 0.1 cm in aggregate, one is bisected and all entirely submitted in B. CF/CF	A) 5 MM; R/O ATYP, B) 6 MM; R/O ATYP	\N	\N	FFPE	\N	COMBINED MELANOCYTIC NEVUS, WITH ORDINARY AND BLUE NEVUS ELEMENTS	111501	1376	\N	\N	19-43600	B	SN-13	Sclerotic Nevi	IP1927911	AirTable blocks_with_IP_info.csv
2456	19-78038	74	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a compound proliferation of melanocytes with spindled melanocytes positioned between thickened collagen bundles in the dermis.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. KC/KC	MORPHOLOGY: FIRM PINK / BROWN PAPULE, DDX: CONGENITAL NEVUS VS. SPITZ VS. OTHER	\N	\N	FFPE	This benign lesion shares a fibrotic dermal reaction with desmoplastic Spitz's nevus, but lacks the large melanocytes seen in that condition.	COMPOUND MELANOCYTIC NEVUS WITH DESMOPLASTIC FEATURES	424655	1377	\N	\N	19-78038	\N	SN-14	Sclerotic Nevi	IP144115	AirTable blocks_with_IP_info.csv
2607	20-30233-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	https://64.54.108.121/app/WebViewer/view/image/34969	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1395	\N	\N	None	\N	VS-02	Chromium Single Cell Gene Expression Flex	\N	AirTable blocks_with_IP_info.csv
10088	HW6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanaoma| Tumor Melanoma, Mucosal vulva	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1466	\N	\N	\N	\N	SYNX63	\N	\N	Consolidated_data_final.csv
3283	DM29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1566	\N	\N	None	\N	SYNAT338	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
2460	19-89855A	44	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	MAP2K1	Sections show a compound proliferation of melanocytes with spindled melanocytes positioned between thickened collagen bundles in the dermis. There are scattered pigmented melanophages in the dermis.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) MORPHOLOGY: IRREGULAR BROWN MACULE, DDX: ATYPICAL NEVUS, SIZE 0.4 CM, B) MORPHOLOGY: DOME-SHAPED PINK-TAN NODULE WITH POSITIVE DIMPLE SIGN, DDX: DERMATOFIBROMA, SIZE 0.8 CM	\N	\N	FFPE	This benign lesion has some features of a deep penetrating nevus in a the background of a fibrotic stroma. Dr. McCalmont has also reviewed this case and agrees with the diagnosis.	COMPOUND MELANOCYTIC NEVUS WITH DESMOPLASTIC FEATURES	173536	1378	\N	\N	19-89855	A	SN-15	Sclerotic Nevi	IP2094427	AirTable blocks_with_IP_info.csv
2466	19-105255	57	\N	\N	\N	None	None	None	10	0	FFPE	\N	\N	216.7	\N	GNAQ	Sections show a melanocytic proliferation with two types of cells.  One population of melanocytes consists of small round cells with scant cytoplasm and monomorphous round to oval nuclei. Next to them are dendritic, pigmented melanocytes with inconspicuous nuclei and variable cytoplasmic pigmentation, accompanied by melanophages.	Skin segment measuring 0.4 x 0.3 x 0.1 cm. Submitted intact. BY/BY	A) COMPOUND NEVUS VS. BLUE NEVUS VS DYSPLASTIC NEVUS. 0.2 CM X 0.1 CM TWO-TONED BROWN PAPULE WITH IRREGULAR PIGMENT NETWORK ON DERMOSCOPY.	\N	\N	FFPE	None	COMBINED MELANOCYTIC NEVUS, WITH ORDINARY AND BLUE NEVUS ELEMENTS	173710	1379	\N	\N	19-105255	\N	SN-16	Sclerotic Nevi	IP162083	AirTable blocks_with_IP_info.csv
2418	19-21355B	63	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a dermal proliferation of melanocytes with slightly enlarged round or ovoid nuclei, and scant cytoplasm. The cells are positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in B. PL/PL	A) R/O LENTIGO VS. LM VS. OTHER, B) R/O DF VS. R/O ATYPIA	\N	\N	FFPE	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH A SCLEROTIC STROMA	173601	1380	\N	\N	19-21355	B	SN-17	Sclerotic Nevi	IP90936	AirTable blocks_with_IP_info.csv
2408	19-9438B	84	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a dermal proliferation of melanocytes with slightly enlarged round or ovoid nuclei, and scant cytoplasm. The cells are positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A) PINK PEARLY PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA, B) RED BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	FFPE	\N	INTRADERMAL MELANOCYTIC NEVUS	529698	1381	\N	\N	19-9438	B	SN-18	Sclerotic Nevi	IP182592	AirTable blocks_with_IP_info.csv
10996	SP-13-006337A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2064	\N	\N	\N	\N	SYNX661	\N	\N	Consolidated_data_final.csv
10997	SP-12-0228802A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2065	\N	\N	\N	\N	SYNX662	\N	\N	Consolidated_data_final.csv
2614	20-36120	47	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.5	\N	\N	Sections show a broad but symmetric intradermal proliferation of melanocytes. In the central and superficial aspect of the proliferation, there are balloon melanocytes arrayed as nests that become smaller in size and disperse with depth in the dermis. Admixed, there are also melanocytes with round nuclei and scant vacuolated cytoplasm. Surrounding this population of melanocytes are dendritic and spindled melanocytes dispersed between thickened collagen bundles. Melanophages are scattered throughout the proliferation.	Six outside slides, SS20-12875 / S-20-1791 A1, and one corresponding block.	RECURRENT NEVUS	\N	\N	FFPE	This appears to be a blue nevus with balloon cell change, and this is supported by the diffuse positivity for HMB45 demonstrated in your immunostain. Given the breadth of the lesion, I further evaluated BAP-1, p16 and PRAME immunochemistry to screen for changes associated with melanoma. BAP-1 is retained and p16 demonstrates mosaic positivity, including in some ballooned melanocytes. The melanocytes are negative for PRAME overexpression. The immunohistochemical results support the above benign diagnosis.	BLUE NEVUS WITH BALLOON CELL CHANGE	173507	1383	\N	\N	20-36120	\N	SN-20	Sclerotic Nevi	IP2183737	AirTable blocks_with_IP_info.csv
2649	20-92494	42	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.5	\N	\N	Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.	Cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. KB/KB	MORPHOLOGY: TWO-TONED BROWN MACULE, DDX: ATYPICAL NEVUS	\N	\N	FFPE	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	139523	1384	\N	\N	20-92494	\N	SN-21	Sclerotic Nevi	IP2240410	AirTable blocks_with_IP_info.csv
2619	20-43801	43	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	\N	Sections show a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature to spindled melanocytes as they extend into the reticular dermis. Some of the dermal melanocytes are pigmented. The overlying epidermis displays elongated, hyperpigmented rete ridges.	Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. CF/HD	R/O DYSPLASTIC NEVUS VS. MM	\N	\N	FFPE	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173641	1385	\N	\N	20-43801	\N	SN-22	Sclerotic Nevi	IP2191480	AirTable blocks_with_IP_info.csv
2470	19-117072A	38	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	\N	There is a bi-phasic, dome-shaped proliferation of melanocytes, mostly within the dermis. There are discrete nests of plump, oval to small round melanocytes in the superficial dermis, and beneath them, collections of larger cells with abundant, vacuolated cytoplasm and some neurotization. This second population contains multinucleated melanocytes set in a fibrotic stroma.	Ellipse, 1.8 x 1.1 x 0.9 cm, including a central 1.1 x 1.0 cm elevated area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with four sections in A1 and three sections in A2. HD/HD	A) MORPHOLOGY: 1.6 TAN DOME ITCHY AND INCREASE IN SIZE AND TENDER, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR, NOTES: PLEASE CHECK MARGINS, B) MORPHOLOGY: 5 MM, IRREGULAR BORDER AND COLOR, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	This is a biphasic melanocytic tumor with both a conventional nevus seen superficially and a second population of larger melanocytes with abundant cytoplasm set in a sclerotic dermis. To further evaluate this second population, p16 and BAP-1 immunohistochemical stains were performed. The BAP-1 stain demonstrated retention of this nuclear protein, excluding the possibility of a BAP-1 inactivated melanocytoma. The p16 stain was also strongly retained in both populations, confirming that biallelic loss of CDKN2A has not occurred. We additionally performed staining for cilia, which has been shown to be lost in conventional melanoma and retained in nevi. This stain also demonstrated a reassuring pattern of cilia retention in both populations (ref). Overall, the histopathologic pattern seen in this lesion is not classic for any known underlying mechanisms, but has some features of a combined desmoplastic nevus with both conventional and deep penetrating nevus components. The lesion appears focally transected at the periphery and clear at the deep edge. As this lesion is unconventional, reexcision of this site to define a free margin and prevent further persistence is recommended as follow-up management. Dr. McCalmont has also reviewed this case and agrees with the diagnosis.  References: Lang UE, Love NR, Cheung C, McCalmont TH, Kim J. Use of the Ciliation Index to Distinguish Invasive Melanoma From Associated Conventional Melanocytic Nevi. Am J Dermatopathol. 2019 May 22.	COMBINED DESMOPLASTIC AND CONVENTIONAL MELANOCYTIC NEVUS	528599	1386	\N	\N	19-117072	A	SN-23	Sclerotic Nevi	IP2121822	AirTable blocks_with_IP_info.csv
1582	12-18438A	81	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	232.5	SCC, in situ	\N	The epidermis is thickened, with widened rete ridges and keratinocytes that confluently have large, atypical nuclei.  Keratinocytes in the basal layer have smaller nuclei than do the cells above them in some areas.  There are patchy infiltrates of lymphocytes.	Skin segment measuring 1.0 x 0.5 x 0.1 cm, bisected and entirely submitted.	? BOWEN'S DISEASE	\N	\N	\N	The neoplasm extends to the edge of the specimen.	SQUAMOUS CELL CARCINOMA IN SITU (BOWEN'S DISEASE)	102538	1412	\N	\N	12-18438	A	SYNAT339	2010-2017	IP1104255	AirTable blocks_with_IP_info.csv
2471	19-117072A2	38	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	There is a bi-phasic, dome-shaped proliferation of melanocytes, mostly within the dermis. There are discrete nests of plump, oval to small round melanocytes in the superficial dermis, and beneath them, collections of larger cells with abundant, vacuolated cytoplasm and some neurotization. This second population contains multinucleated melanocytes set in a fibrotic stroma.	Ellipse, 1.8 x 1.1 x 0.9 cm, including a central 1.1 x 1.0 cm elevated area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with four sections in A1 and three sections in A2. HD/HD	A) MORPHOLOGY: 1.6 TAN DOME ITCHY AND INCREASE IN SIZE AND TENDER, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR, NOTES: PLEASE CHECK MARGINS, B) MORPHOLOGY: 5 MM, IRREGULAR BORDER AND COLOR, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, NOTES: PLEASE CHECK MARGINS	\N	\N	\N	This is a biphasic melanocytic tumor with both a conventional nevus seen superficially and a second population of larger melanocytes with abundant cytoplasm set in a sclerotic dermis. To further evaluate this second population, p16 and BAP-1 immunohistochemical stains were performed. The BAP-1 stain demonstrated retention of this nuclear protein, excluding the possibility of a BAP-1 inactivated melanocytoma. The p16 stain was also strongly retained in both populations, confirming that biallelic loss of CDKN2A has not occurred. We additionally performed staining for cilia, which has been shown to be lost in conventional melanoma and retained in nevi. This stain also demonstrated a reassuring pattern of cilia retention in both populations (ref). Overall, the histopathologic pattern seen in this lesion is not classic for any known underlying mechanisms, but has some features of a combined desmoplastic nevus with both conventional and deep penetrating nevus components. The lesion appears focally transected at the periphery and clear at the deep edge. As this lesion is unconventional, reexcision of this site to define a free margin and prevent further persistence is recommended as follow-up management. Dr. McCalmont has also reviewed this case and agrees with the diagnosis.  References: Lang UE, Love NR, Cheung C, McCalmont TH, Kim J. Use of the Ciliation Index to Distinguish Invasive Melanoma From Associated Conventional Melanocytic Nevi. Am J Dermatopathol. 2019 May 22.	COMBINED DESMOPLASTIC AND CONVENTIONAL MELANOCYTIC NEVUS	528599	1386	\N	\N	19-117072	A2	SN-23	Melanoma Epigenetics	IP2121822	AirTable blocks_with_IP_info.csv
2615	20-36500A	32	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	\N	Sections show a predominantly intradermal proliferation of melanocytes with a wedge shaped profile. Nests of melanocytes with round nuclei and scant cytoplasm are present in the superficial dermis. They mature to single melanocytes and cords of them positioned between thickened collagen bundles in the dermis below.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) 3 X 3 MM, B) 2 X 3 MM, A-B) MORPHOLOGY: SUSPICIOUS IRREGULAR MULTI-COLORED MACULE AND 3 X 3 MM, DDX: MELANOMA VS. PIGMENTED BASAL CELL CARCINOMA VS. DYSPLASTIC NEVUS VS. ATYPICAL NEVUS	\N	\N	FFPE	This benign lesion shares a fibrotic dermal reaction with desmoplastic Spitz's nevus, but lacks the large melanocytes seen in that condition.	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	273588	1387	\N	\N	20-36500	A	SN-24	Sclerotic Nevi	IP2184119	AirTable blocks_with_IP_info.csv
2622	20-48338A	56	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.2	\N	\N	Sections show a dome shaped skin segment with a compound proliferation of melanocytes with spindled melanocytes evenly positioned between slightly thickened collagen bundles in the dermis. The dermal component matures with descent.	Skin segment measuring 0.4 x 0.2 x 0.1 cm. Submitted intact with fragment in A. BB/BB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA. ERYTHEMATOUS SCALY PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA. ERYTHEMATOUS SCALY PAPULE.	\N	\N	FFPE	\N	COMPOUND MELANOCYTIC NEVUS	173230	1388	\N	\N	20-48338	A	SN-25	Sclerotic Nevi	IP515987	AirTable blocks_with_IP_info.csv
2621	20-48331	35	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	\N	Sections show a small dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles and as single cells with intervening areas displaying fibrosis and sclerosis and containing melanophages.	Skin segment measuring 0.3 x 0.2 x 0.1 cm, submitted intact. HD/HD	FAVOR NEVUS	\N	\N	FFPE	None	BLUE NEVUS	173649	1389	\N	\N	20-48331	\N	SN-26	Sclerotic Nevi	IP2196043	AirTable blocks_with_IP_info.csv
10998	SP-12-0228801A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2066	\N	\N	\N	\N	SYNX663	\N	\N	Consolidated_data_final.csv
10999	SP-12-0146612A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2067	\N	\N	\N	\N	SYNX664	\N	\N	Consolidated_data_final.csv
2630	20-57308	27	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.7	\N	\N	Sections show a compound proliferation of medium-sized melanocytes, many of which are finely pigmented. There are nests, cords, fascicles, and small syncytia in the dermis, with very focal palisading of cellularity, and the superjacent epidermis contains a prominent component with many nests and fascicles and limited epidermal consumption. Adnexal extension and melanophages are noted. Expression of p16 is avid. The Ki-67 cell proliferation index is low. In one area of deeper dermal extension, the encompassing stroma appears hyalinized.	Seven outside slides, DD20-09516 (A1). Six unstained received 7/24/20.	PRESENT AT LEAST 15 YEARS, RECENTLY DOUBLED IN 6 MONTHS, AND DARKER IN THE CENTER, OCCASIONALLY ITCHY; IMPRESSION WAS R/O DN VS. MELANOMA VS. CONGENITAL NEVUS	\N	\N	FFPE	I fully agree that the histomorphology within these slides closely resembles that of a congenital melanocytic nevus. With that having been noted, please additionally note that I do not believe this tumor is of conventional lineage, meaning that I do not believe that an underlying BRAF or NRAS mutation served as the molecular starting point. Rather, to my eye the histopathologic pattern suggests a small cell Spitz nevus induced by kinase gene fusion. More narrowly, I suspect a Spitz nevus induced by MYO5A/NTRK3 gene fusion. As my diagnosis implies, I believe there is only one population of melanocytes in these sections. There are some large nests that probably correlate with the recent enlargement observed clinically, and there is also stromal hyalinization as an apparent indicator of longevity. There is no evidence of malignancy, and there is also no indication of atypicality, at least not in the conventional sense of that term.  Thank you for providing unstained slides. I will provide additional information regarding molecular findings at a later point in time.	PIGMENTED FASCICULAR COMPOUND SPITZ NEVUS	173733	1390	\N	\N	20-57308	\N	SN-27	Sclerotic Nevi	IP2205057	AirTable blocks_with_IP_info.csv
2612	20-34915	26	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	\N	Sections show a proliferation of melanocytes arrayed as maturing nests, cords, and syncytia with multinucleation, and deeply the melanocytes transition to fusiform cells in collagenous hypervascular stroma with an associated lymphohistiocytic infiltrate. The cells of interest have a low Ki-67 cell proliferation index. Expression of p16 is retained	Six outside slides, DF0222362 Jar 1, Bk 4. Four unstained received 5/13/20.	IMPRESSION WAS ATYPICAL NEVUS	\N	\N	FFPE	This represents a so-called perineuriomatous melanocytic nevus. Melanoma is not present here.	DESMOPLASTIC MELANOCYTIC NEVUS WITH ASSOCIATED DEEP NERVE SHEATH DIFFERENTIATION	173688	1391	\N	\N	20-34915	\N	SN-28	Sclerotic Nevi	IP2182521	AirTable blocks_with_IP_info.csv
3537	MP41-YM-R1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1393	\N	\N	None	\N	UV-02	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1440	11-14908C	34	\N	\N	\N	T1a	Primary	None	\N	\N	FFPE	\N	\N	172.6	\N	\N	Sections show melanocytes arrayed in biphasic and compound fashion. One population consists of maturing nests and cords of smallish melanocytes arrayed toward one edge of the specimen. The second larger population includes slightly spindled and epithelioid melanocytes with ample finely melanized cytoplasm. These cells are arrayed as large nests and single cells along the junction with limited intraspinous scatter, and nests of similar melanocytes reside in the perijunctional dermis jointly with an obscuring lymphohistiocytic infiltrate with admixed melanophages.	Ellipse, 2.4 x 1.3 x 0.8 cm, including a central 0.8 x 0.7 cm brown area. With the edges inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in A through C.  Subsequently, the wax block C was melted down, three sections were submitted in C1 and one section submitted in C2.	R/O MELANOMA	\N	\N	FFPE	Our differential diagnosis included melanoma ex melanocytic nevus on one hand and a peculiar combined melanocytic nevus on the other, and it is now clear that the former possibility represents the correct interpretation of this melanocytic proliferation. To further assess the nature of this proliferation via molecular means, we completed fluorescence in situ hybridization (FISH) analysis to screen for melanoma-associated genomic anomalies. FISH analysis was fulfilled utilizing a panel of 4 DNA probes (to loci on 6p, 6q, 6cent and 11q) and demonstrated an imbalance in chromosome 6q at the location of the MYB gene as well as gain in chromosome 11q at the location of the CCND1 (cyclin-D1) gene. Both of these genomic anomalies are highly associated with the diagnosis of melanoma and are thus confirmatory of the above diagnosis. This melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage T1a per the 2009 revision of the AJCC staging system. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.65 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173688	1394	\N	\N	11-14908	C	VS-01	Spatial Gene Expression	IP1004345	AirTable blocks_with_IP_info.csv
2606	20-30233	34	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show nests and syncytia of small melanocytes with round to oval nuclei in the upper reticular dermis, jointly with a second population of melanocytes with large nuclei and ample eosinophilic cytoplasm. The proliferation has a protuberant contour.	Skin segment measuring 0.7 x 0.6 x 0.4 cm, bisected and entirely submitted. BY/BY  Subsequently, the wax block was melted down and one section each was submitted in 1 and 2. DM	6 MM DARK TAN PAPULE, PATIENT DARKEST LESION; R/O ATYPIA	\N	\N	FFPE	This biopsy demonstrates an exophytic proliferation that includes a dominant component of conventional/congenital melanocytic nevus as well as a secondary component of BAP-1 inactivated melanocytoma. BAP-1 immunohistochemistry demonstrates a lack of nuclear positivity in the subset of enlarged melanocytes, thereby corroborating that BAP-1 inactivation has occurred in those cells. Expression of p16 is maintained throughout, and thus concomitant CDKN2A deletion has not occurred. Given that the proliferation extends to the base and edge of the specimen, either timely clinical follow-up of the biopsy site (to observe for persistence) or narrow additional removal (to mitigate persistence) can be considered as a management approach.	COMBINED BAP-1 INACTIVATED MELANOCYTOMA (BAP-1 INACTIVATED MELANOCYTIC NEVUS), EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	273588	1395	\N	\N	20-30233	\N	VS-02	Spatial Gene Expression	IP2177811	AirTable blocks_with_IP_info.csv
2410	19-10031	30	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.4	\N	\N	Sections show a proliferation of melanocytes mostly in the dermis beneath an epidermis that is papillated, with interconnecting rete ridges and horn pseudocysts. Nests, cords and strands of melanocytes that diminish in size with descent lie between reticular dermal collagen bundles and surround adnexal structures. There are sebaceous lobules at the bases of some elongated rete ridges. In the center of the lesion is a large, oval area in which there are small discrete aggregations of large, oval melanocytes with abundant, pale cytoplasm and dusty appearing melanin and moderately enlarged nuclei, with interspersed melanophages.	Skin segment measuring 1.0 x 0.8 x 0.6 cm, trisected and entirely submitted. PL/PL Subsequently, the wax block was melted down and two sections were submitted in 1 and one section in 2. DM	1 CM BROWN NODULE INCREASING IN SIZE; R/O DYSPLASIA	\N	\N	FFPE	A beta catenin immunostain labels the nuclei of many of the lesional cells in the center of the lesion, in keeping with the diagnosis of deep penetrating nevus for this component. A recent study from our group shows activation of the beta catenin pathway is a common finding in this entity, and is distinct from the molecular changes in blue nevi, which the entity has some clinical and pathologic features in common with. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma).  There are only scattered Ki-67 positive nuclei in this component. As some deep penetrating nevus-like melanomas have had mutations in TP53, we obtained a p53 immunostain which is negative.  In sum, the larger melanocytes with more pigmentation in the the center of the lesion represent a rare type of melanocytic proliferation, deep penetrating nevus but not deep penetrating nevus-like melanoma. The deep penetrating nevic component is within 0.3 mm. of the base of the specimen, but lacks findings that could compel re-excision.	COMBINED MELANOCYTIC NEVUS, WITH SUPERFICIAL CONGENITAL FEATURES AND A DEEP PENETRATING NEVIC COMPONENT	173476	1396	\N	\N	19-10031	\N	VS-03	Spatial Gene Expression	IP561112	AirTable blocks_with_IP_info.csv
2411	19-10031-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	https://64.54.108.121/app/WebViewer/view/image/34968	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1396	\N	\N	None	\N	VS-03	Chromium Single Cell Gene Expression Flex	\N	AirTable blocks_with_IP_info.csv
1260	07-1791	64	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31873	173.6	\N	(5-82-149-7)	Sections show an exoendophytic proliferation of keratinocytes arranged in lobules, with many cells having abundant eosinophilic cytoplasm, and some cells having atypical nuclei. There is verrucous epidermal hyperplasia.	Skin segment measuring 1.0 x 0.9 x 0.2 cm, trisected and entirely submitted.	SCC (KA TYPE)	\N	Liver	\N	Not enough of this neoplasm is visible to determine if this lesion is a keratoacanthoma (which I regard as a form of squamous cell carcinoma which involutes in the majority of cases) or a conventional squamous cell carcinoma.	EXOENDOPHYTIC PROLIFERATION OF ATYPICAL KERATINOCYTES, EXTENDING TO THE DEEP MARGIN	113601	1403	\N	\N	07-1791	\N	WS-02	Werner Syndrome	IP624320	AirTable blocks_with_IP_info.csv
1262	07-2104	\N	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31404	\N	\N	Tissue was mounted on LCM slides. Circled images are kept in the server.	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1403	\N	\N	07-2104	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
1847	15-22411	63	f	\N	0	T1a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26313	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population consists of melanocytes with variable nuclei that are arrayed irregularly along the epidermal-dermal junction and within the dermis. Within the epidermis, there are numerous melanocytes in pagetoid scatter and single epithelioid melanocytes predominate over nests in some foci. There are nests of similar melanocytes in the underlying dermis. There is also a second population of smaller and cytologically melanocytes that diminish in size with descent in the dermis and extend into the reticular dermis.	Skin segment measuring 1.0 x 0.7 x 0.2 cm, trisected, and entirely submitted. HD/HD	DARK PAPULE, SLIGHTLY IRREGULAR ATYPICAL NEVUS VS. SK, DOUBT MELANOMA	\N	\N	FFPE	In addition to the melanoma, there is a melanocytic nevus with superficial congenital features that intermingles with the melanoma that is present in this specimen. Therefore, it is most likely that the melanoma arose within a melanocytic nevus. Is there a clinical history of a changing pigmented lesion? Synoptic melanoma reporting is included below:  Procedure: Scoop shave biopsy Microscopic tumor type: Superficial spreading Breslow thickness:  0.8 mm Ulceration: absent Margins: Intraepidermal melanoma extends to within 1 millimeter of the specimen edge Mitotic index: 0 mm/2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a  Further treatment at this site is warranted to ensure that local eradication has been accomplished.	MELANOMA, 0.8 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173531	1397	\N	\N	15-22411	\N	VS-04_JJS22	Melanoma Evolution,Spatial Gene Expression	IP1199550	AirTable blocks_with_IP_info.csv
2809	22-75050A2	71	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/34970	238.2	\N	\N	Sections show skin with marked elastosis. Centrally, there is a dermal proliferation of melanocytes with small round nuclei and scant cytoplasm that mature with descent in the dermis. Deep and to the sides of this is a second population of melanocytes with expanded pigmented cytoplasm and oval nuclei with open chromatin arrayed as nests. There are scattered melanophages alongside thickened collagen bundles.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in A. BY/BY Subsequently, the wax block was melted down and entirely resubmitted with one section in A1 and two sections in A2. JC	A) SUSPICIOUS IRREGULAR MULTI-COLORED PAPULE; ATYPICAL PIGMENTED LESION, B) PEARLY TELANGIECTATIC PAPULE; BASAL CELL CARCINOMA VS. SEBACEOUS HYPERPLASIA	\N	\N	FFPE	Wnt-activated melanocytomas were previously known as deep penetrating nevi. This example retains p16 expression and does not express PRAME, arguing against melanoma. They typically harbor activating mutations of CTNNB1 and are considered low-grade melanocytic neoplasms with benign behavior. The melanocytoma broadly extends to the base of the biopsy. A re-excision of the site is recommended to ensure complete removal. Reference: Combined activation of MAP kinase pathway and ﬂ-catenin signaling cause deep penetrating nevi. Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la FouchardiËre A. Nat Commun. 2017 Sep 21;8(1):644.	WNT-ACTIVATED MELANOCYTOMA ARISING WITH ASSOCIATED PRECURSOR MELANOCYTIC NEVUS	173727	1398	\N	\N	22-75050	A2	VS-05	Spatial Gene Expression	IP2476934	AirTable blocks_with_IP_info.csv
2854	22-124532-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/34971	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1399	\N	\N	None	\N	VS-06	Spatial Gene Expression	\N	AirTable blocks_with_IP_info.csv
2852	22-119466	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/34972	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1400	\N	\N	22-119466	\N	VS-07	Spatial Gene Expression	\N	AirTable blocks_with_IP_info.csv
2808	22-73345B	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/34973	216.3	\N	\N	\N	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KB/KB	A-B) R/O DN	\N	\N	FFPE	A portion of this lesion had small to medium-sized epithelioid cells, an appearance suggesting a population that had undergone inactivation of the tumor suppressor gene, BAP-1. This was confirmed by an immunostain performed in our laboratory, and other stains do not support additional neoplastic transformation. The neoplasm extends to the base of the specimen. A narrow re-excision of this site would still be prudent, as lesions with BAP-1 loss may convert to melanoma at a higher rate than other nevi. Most spitzoid neoplasms with BAP-1 loss are sporadic. Toward making sure that this patient does not have a germline mutation in BAP-1, the clinician should undertake a full body skin exam to see if other lesions clinically similar to this one or to the ones depicted in the reference below might be present. Also, the absence of a family history of similar lesions, and both cutaneous and uveal melanoma, or mesothelioma should be confirmed.  Additionally, I would consider obtaining testing for a germline mutation in BAP-1. This appears to be present in a significant percentage of patients with BAP-1 inactivated spitzoid lesions, and is available through several sources (we do not do it in our laboratory, but see Invitae.com and GeneDx.com).  Reference:  Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, R¸tten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. Germline mutations in BAP-1 predispose to melanocytic tumors. Nat Genet. 2011 Aug 28;43(10):1018-21. doi: 10.1038/ng.910. PubMed PMID: 21874003.	COMBINED MELANOCYTIC NEVUS WITH CONVENTIONAL AND BAP-1 INACTIVATED COMPONENTS	173304	1401	\N	\N	22-73345	B	VS-08	Spatial Gene Expression	IP2475216	AirTable blocks_with_IP_info.csv
1429	11-1969-F	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Tissue was mounted on LCM slides.	\N	\N	\N	\N	\N	\N	\N	\N	\N	1402	\N	\N	None	\N	WS-01	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
1544	12-1450	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31867	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction. Similar cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Ellipse measuring 0.8 x 0.5 x 0.5 cm, with a central 0.7 x 0.5 cm brown area. With the margins inked blue, trisected perpendicular to the long axis and entirely submitted in cassette A.	A-B) IRREG NEVUS	\N	Right nasal cavity	\N	I have shared this case with my colleague Dr. Thad Mully who agrees with this interpretation.	COMPOUND MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	115516	1402	\N	\N	12-1450	\N	WS-01	Werner Syndrome	IP326919	AirTable blocks_with_IP_info.csv
3285	DM34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1567	\N	\N	None	\N	SYNAT340	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3294	DM55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1568	\N	\N	None	\N	SYNAT341	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1547	12-3277	53	\N	\N	\N	None	None	None	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31407	172.5	\N	Tissue was mounted on LCM slides. Circled images are kept in the server.	Sections show central iatrogenic fibrosing inflammatory alterations stemming from a procedure, and no evidence of an atypical melanocytic proliferation remains in contiguity with this.	Ellipse measuring 4.3 x 1.6 x 1.0 cm, with a central 0.8 x 0.7 cm pink area. With the margins inked blue, serially sectioned perpendicular to the long axis and submitted with three sections in cassette A and two sections each in cassettes B thru E. Tips returned to container.	PREVIOUS DIAGNOSED/BIOPSIED MM AT LEAST 0.5 MM, DT11-94203, EXCISED 0.5 CM MARGIN MINIMUM	\N	\N	FFPE	As there is no residuum, the provisional thickness and staging, as listed in our original report DT11-94203, now become the final figures for this melanoma.	POST-PROCEDURAL SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173526	1402	\N	\N	12-3277	\N	WS-01	Werner Syndrome	IP1083651	AirTable blocks_with_IP_info.csv
1430	11-1973	\N	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31406	\N	\N	Tissue was mounted on LCM slides. Circled images are kept in the server.	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1402	\N	\N	11-1973	\N	WS-01	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
1263	07-2479-1 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31868	\N	\N	\N	\N	\N	\N	\N	Right forearm	\N	\N	\N	\N	1403	\N	\N	None	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
1267	07-3001	\N	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31405	\N	\N	Tissue was mounted on LCM slides. Circled images are kept in the server.	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1403	\N	\N	07-3001	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
1266	07-2889-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31871	\N	\N	\N	\N	\N	\N	\N	Waist	\N	\N	\N	\N	1403	\N	\N	None	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
1265	07-2889-1 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31870	\N	\N	\N	\N	\N	\N	\N	Waist	\N	\N	\N	\N	1403	\N	\N	None	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
1261	07-1841	74	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31872	238.2	\N	(D01-44-2)	Sections show solitary melanocytes and small nests arrayed within the basal epidermis along the sides and bases of rete, above areas of solar elastosis and adjacent to dermal scar.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, bisected and entirely submitted in cassette A.	A) PREV H/O LENTIGO, RECURRENCE; B) CLARK'S NEVUS	\N	Liver	\N	None	LENTIGINOUS INTRAEPIDERMAL PROLIFERATION OF MELANOCYTES WITH SUBJACENT SCAR AND ELASTOSIS	173527	1403	\N	\N	07-1841	\N	WS-02	Werner Syndrome	IP624370	AirTable blocks_with_IP_info.csv
1264	07-2479-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31869	\N	\N	\N	\N	\N	\N	\N	Right forearm	\N	\N	\N	\N	1403	\N	\N	None	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
1557	12-6261A	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Melanocytic Nevus	\N	Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, quadrisected, and entirely submitted in cassette A.	A-B) NEVUS	\N	Cheek	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173304	1404	\N	\N	12-6261	A	SYNAT342	2010-2017	IP1092077	AirTable blocks_with_IP_info.csv
1558	12-6261B	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine.	Skin segment, 0.5 x 0.4 x 0.4 cm, bisected and entirely submitted in cassette B.	A-B) NEVUS	\N	Neck	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173403	1404	\N	\N	12-6261	B	SYNAT342	2010-2017	IP1092077	AirTable blocks_with_IP_info.csv
1570	12-12366	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	SCC	\N	\N	\N	\N	\N	Associated with Solar Keratosis, rt cheek	\N	\N	\N	\N	1405	\N	\N	12-12366	\N	SYNAT343	2010-2017	\N	AirTable blocks_with_IP_info.csv
1571	12-12467	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis.	Skin segment measuring 0.4 x 0.3 x 0.2 cm, submitted intact in cassette B.	A) 0.7 X 0.6 CM; NEOP VS. ID NEVUS, B) 0.5 X 0.5 CM; NEOP VS. ID NEVUS, C) 0.7 X 0.6 CM; NEOP VS. DYSP NEVUS, D) 0.7 X 0.7 CM; NEOP VS. ID NEVUS	\N	Predominately intradermal, rt breast	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	101581	1406	\N	\N	12-12467	\N	SYNAT344	2010-2017	IP1098283	AirTable blocks_with_IP_info.csv
1572	12-12470D	98	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.61	BCC	\N	Sections show nodular aggregations of atypical, peripherally palisaded basaloid cells. In some areas, angulate aggregations of similar cells are apparent in infiltrative array. There is enveloping cellular stroma. There is crush artifact.	Multiple tissue segments measuring 1.0 x 0.9 x 0.2 cm in aggregate.  The specimen is filtered, serially sectioned, wrapped and entirely submitted in cassette D.	(+) HISTORY OF MM, A) 0.7 X 0.5 CM, B) 0.9 X 1.0 CM, C) 1.4 X 0.8 CM, D) 1.3 X 0.7 CM; A-D) NEOP VS. BCC (C&D DONE AT TIME OF BX)	\N	Nodular/Infiltrative, upper anterior forearm	\N	The neoplasm extends to the edges of the specimen.	NODULAR/INFILTRATIVE BASAL CELL CARCINOMA	423654	1407	\N	\N	12-12470	D	SYNAT345	2010-2017	IP192328	AirTable blocks_with_IP_info.csv
1543	12-562	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1408	\N	\N	12-562	\N	SYNAT346	2010-2017	\N	AirTable blocks_with_IP_info.csv
1574	12-12647	52	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.51	Melanocytic Nevus	\N	Sections show a neoplastic proliferation of atypical, peripherally palisaded basaloid cells arranged as aggregations attached to the undersurface of the epidermis and as nodules within the dermis.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, trisected and entirely submitted with one additional fragment.	R/O SCC: TELEPHONE 925-212-5590	\N	Intradermal, right breast	\N	None	BASAL CELL CARCINOMA, SUPERFICIAL AND NODULAR PATTERNS, EXTENDING TO THE DEEP MARGIN	333504	1409	\N	\N	12-12647	\N	SYNAT347	2010-2017	IP858006	AirTable blocks_with_IP_info.csv
1573	12-12626	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Cellular Dermatofibroma 	\N	Sections show a cellular proliferation of spindled and stellate cells, arranged amongst thickened collagen bundles in some areas. The overlying epidermis is acanthotic.	Cylindrical skin segment, 0.8 cm in diameter and 0.5 cm in thickness, trisected and totally submitted.	DF	\N	Right Arm	\N	None	CELLULAR DERMATOFIBROMA	173602	1410	\N	\N	12-12626	\N	SYNAT348	2010-2017	IP1098442	AirTable blocks_with_IP_info.csv
3310	DM79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1569	\N	\N	None	\N	SYNAT349	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1577	12-13152	71	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows fibrosis, some in a lamellar configuration.	Skin segment measuring 1.3 x 1.2 x 0.1 cm, quadrisected and entirely submitted.	UNKNOWN DURATION OF 7 MM, WELL-DEMARCATED, 1/2 TAN, 1/2 BROWN MACULE; R/O DYSPLASTIC NEVUS	\N	Compound, Clarks or Dysplastic type, back	\N	The neoplasm extends to the base of the specimen in one small focus but is widely excised towards the periphery. The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE	273588	1413	\N	\N	12-13152	\N	SYNAT350	2010-2017	IP1098968	AirTable blocks_with_IP_info.csv
1576	12-12750B	91	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.32	SCC	\N	Sections show a proliferation composed of atypical keratinocytes, arrayed as irregular nests that infiltrate the dermis.  There are keratotic whorls and pale keratinocytes. The mitotic rate is high.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted in cassette B.	A) ? LARGE ACTINIC KERATOSIS OR IRRITATED SEBORRHEIC KERATOSIS, R/O SQ CELL CA (2 PIECES), B) ? IRRITATED SEBORRHEIC KERATOSIS, R/O BASAL OR SQ CELL CA	\N	Forehead	\N	\N	SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP BIOPSY MARGIN	123398	1414	\N	\N	12-12750	B	SYNAT351	2010-2017	IP114451	AirTable blocks_with_IP_info.csv
1586	12-19596	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	SCC, in situ	\N	\N	\N	\N	\N	Bowen's Disease, pagetoid	\N	\N	\N	\N	1415	\N	\N	12-19596	\N	SYNAT352	2010-2017	\N	AirTable blocks_with_IP_info.csv
1585	12-19187A	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Dermatofibroma	\N	There is a dermal proliferation of spindled cells, arranged as interconnecting fascicles. These are more compactly arranged in the center of the lesion than at its periphery, where these cells progressively are interspersed between reticular dermal collagen bundles. The overlying epidermis is thickened.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in cassette A.	A) INDURATED PAPULE; FAVOR DF, B) SKIN-COLORED TRANSLUCENT PAPULE; FAVOR NF VS. NEVUS	\N	Shin	\N	\N	DERMATOFIBROMA	187724	1416	\N	\N	12-19187	A	SYNAT353	2010-2017	IP1105004	AirTable blocks_with_IP_info.csv
1592	12-22172	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.1	SCC, in situ	\N	Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.	Ellipse, 0.9 x 0.5 x 0.4 cm, including a central 0.6 x 0.4 cm tan-brown area. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in one cassette.	6 MM GROWING PAPULE; R/O IDN VS. OTHER	\N	Bowen's Disease,Left lateral back	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	123122	1417	\N	\N	12-22172	\N	SYNAT354	2010-2017	IP1107990	AirTable blocks_with_IP_info.csv
1588	12-21726A	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Dermatofibroma	\N	Sections show a dome shaped, cellular proliferation of spindled and stellate cells, arranged amongst thickened collagen bundles in some areas. The overlying epidermis is acanthotic.	Ellipse, 1.7 x 1.0 x 0.4 cm, including a central 0.8 x 0.7 cm pearly pink and raised area.  With the peripheral and deep margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in cassettes A and B.	POSSIBLE IDN, R/O MELANOTIC MELANOMA	\N	A Melan-A stain (-), leg	\N	A Melan-A stain is negative.	CELLULAR DERMATOFIBROMA	173740	1418	\N	\N	12-21726	A	SYNAT355	2010-2017	IP1107544	AirTable blocks_with_IP_info.csv
1614	12-22901A	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Melanocytic Nevus	\N	Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.	Ellipse, 1.1 x 0.6 x 0.35 cm, including a central 0.7 x 0.5 cm white-tan raised area.  With the margins inked blue, the specimen is serially sectioned and entirely submitted with three sections each in cassettes A and B.	NEVUS	\N	Intradermal, forehead	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	123398	1419	\N	\N	12-22901	A	SYNAT356	Melanocytic Nevus	IP1108719	AirTable blocks_with_IP_info.csv
1578	12-13587B2	84	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.72	SCC	\N	There is an exo-endophytic proliferation of keratinocytes.  Some areas have lobules composed of cells with abundant pale cytoplasm and central foci of abrupt keratinization, while others are composed of cells with a high nuclear to cytoplasmic ratio, and atypical nuclei. The flanking epidermis shows atypical keratinocytes that in several areas involve the entire thickness of the epithelium.	Skin segment measuring 2.3 x 1.6 x 0.6 cm, with a central 1.6 x 1.0 cm raised area. With the peripheral edges and base inked blue, serially sectioned and entirely submitted with two sections each in cassettes B1 thru B3.	A-B) R/O KA	\N	Ext deep margins, leg	\N	While there are some features of keratoacanthoma, the preponderance of atypical keratinocytes and broad zones of squamous cell carcinoma in situ involving the flanking epidermis rules out this possibility.	SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP MARGIN	173740	1411	\N	\N	12-13587	B2	SYNAT357	2010-2017	IP502329	AirTable blocks_with_IP_info.csv
10008	12-13587	84	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	686.0	SCC	\N	Sections show a dense and diffuse infiltrate of neutrophils. There are a few islands of epithelial cells within the infiltrate that I interpret as squamous metaplasia of eccrine ductular epithelium. There are also fragments of keratin as seen in ruptured epidermal inclusion cysts.	Skin segment measuring 2.3 x 1.5 x 0.6 cm, with a central 1.6 x 1.4 cm brown area. With the peripheral edges and base inked blue, serially sectioned, with the specimen fragmenting upon sectioning, and entirely submitted with two sections in cassette A1, two sections plus one fragment in cassette A2, and two sections plus three fragments in cassette A3.	\N	\N	\N	\N	A PAS-D stain is negative for fungi, and a Brown-Brenn (Gram) and Fite stain do not reveal bacteria. The differential diagnosis includes a suppurative reaction to a ruptured (and fully digested) cyst or an infectious process not captured in the studies performed. There is no evidence of a neoplasm.	SOLAR KERATOSIS WITH UNDERLYING SUPPURATIVE DERMATITIS	173741	1411	\N	\N	12-13587	A	SYNX8	\N	IP502329	Consolidated_data_final.csv
10024	BuffyCoa	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Family History (9 members) have melanoma	Collaborated with Robert Nussbaum to get this blood	\N	\N	\N	\N	\N	\N	\N	\N	\N	1422	\N	\N	\N	\N	SYNX19	\N	\N	Consolidated_data_final.csv
1604	12-22775	69	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.52	SCC	\N	Sections show a papillated to crateriform proliferation of atypical keratinocytes with central and overlying ortho- and parakeratosis. Keratinocytes with atypical nuclei are scattered throughout the proliferation.	Skin segment measuring 1.0 x 0.8 x 0.3 cm, trisected and entirely submitted.	0.8 X 1 CM DOME-SHAPED HYPERKERATOTIC PAPULE; KA VS. SCC: TELEPHONE 650-465-3946 (CELL)	\N	Crateriform, chest	\N	None	CRATERIFORM SQUAMOUS CELL CARCINOMA, EXTENDING TO THE BASE OF THE SPECIMEN	173527	1423	\N	\N	12-22775	\N	SYNAT358	2010-2017	IP249102	AirTable blocks_with_IP_info.csv
10822	DPN48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	DPN-like Melanoma: MSK 13-53190-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1952	\N	\N	\N	\N	SYNX549	\N	\N	Consolidated_data_final.csv
10980	SP-14-001249	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2048	\N	\N	\N	\N	SYNX645	\N	\N	Consolidated_data_final.csv
1606	12-22794A	49	\N	\N	\N	T1b	Primary	\N	\N	\N	\N	\N	\N	172.6	Mel	\N	Sections show an asymmetrical proliferation of nested and solitary melanocytes with atypical nuclear features, and dusty cytoplasms. They are arrayed irregularly within the epidermis, with foci of suprabasal scatter of cells.  Larger clusters of similar melanocytes are present in the dermis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in cassette A.	A) R/O PIGMENTED BCC, B) R/O BCC: TELEPHONE 530-365-9295 (OK TO LM)	\N	Level III, right shoulder	\N	Histopathologic features of possible prognostic importance include: Level:III Tumor infiltrating lymphocytes: absent Vascular or lymphatic invasion: not detected Dermal mitotic rate: 1/ HPF Perineural invasion: not detected Ulceration: not detected Regression: not detected Microsatellite metastasis: not detected Solar elastosis: moderate Stage: pT1b	MELANOMA, 0.80 MM IN THICKNESS, EXTENDING TO THE PERIPHERY OF THE BIOPSY	173620	1424	\N	\N	12-22794	A	SYNAT359	2010-2017	IP454633	AirTable blocks_with_IP_info.csv
1593	12-22573	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine. There are numerous horn pseudocysts.	Skin segment measuring 1.1 x 1.0 x 0.5 cm, quadrisected and entirely submitted.	BROWN PAPULE WITH A BLACK DOT; R/O MIS	\N	Intradermal, breast	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	192588	1425	\N	\N	12-22573	\N	SYNAT360	2010-2017	IP1108391	AirTable blocks_with_IP_info.csv
1594	12-22582A	16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a proliferation of melanocytes arrayed singly and as nests along the epidermal-dermal junction, with clusters and strands of similar cells in the underlying dermis.  In some areas within dermal clusters, melanocytes are separated by clefts, in a pattern that resembles vascular channels.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette A.	A) NEOP VS. ATYP POLYP NEVUS, B) NEOP VS. ATYP NEVUS, C) 0.2 X 0.3 CM; NEOP VS. DYSPL NEVUS	\N	Compound,  Neck	\N	\N	COMPOUND MELANOCYTIC NEVUS	173441	1426	\N	\N	12-22582	A	SYNAT79	2010-2017	IP1108400	AirTable blocks_with_IP_info.csv
1596	12-22587	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a melanocytic proliferation composed of nests of melanocytes along the junction, with clusters of similar cells in the subjacent dermis.  Many superficial melanocytes have pigmented cytoplasm, and there are also surrounding melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness, bisected and totally submitted.	DARK 4 MM PAP; R/O MM	\N	Compound, hyperpigmented melanocytes,neck	\N	None	COMPOUND MELANOCYTIC NEVUS, WITH HYPERPIGMENTED MELANOCYTES	173477	1427	\N	\N	12-22587	\N	SYNAT361	2010-2017	IP1108405	AirTable blocks_with_IP_info.csv
1597	12-22592	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Keratosis, Atrophic Solar 	\N	\N	\N	\N	\N	Scalp	\N	\N	\N	\N	1428	\N	\N	12-22592	\N	SYNAT362	2010-2017	\N	AirTable blocks_with_IP_info.csv
1600	12-22602B	37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine.	Skin segment measuring 0.6 x 0.5 x 0.3 cm, bisected and entirely submitted in cassette B.	A-B) COSMETIC SHAVE REMOVAL IDN	\N	Intradermal,posteriolateral neck	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173477	1430	\N	\N	12-22602	B	SYNAT364	Melanocytic Nevus	IP1081809	AirTable blocks_with_IP_info.csv
1599	12-22602A	37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a predominantly intradermal proliferation of small melanocytes with round to oval nuclei that mature (diminish in size) with descent in the dermis.  The overlying epidermis shows elongated rete that intertwine.	Skin segment measuring 0.5 x 0.5 x 0.3 cm, bisected, wrapped with a fragment and entirely submitted in cassette A.	A-B) COSMETIC SHAVE REMOVAL IDN	\N	Intradermal, anterolateral neck	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	123455	1430	\N	\N	12-22602	A	SYNAT364	Melanocytic Nevus	IP1081809	AirTable blocks_with_IP_info.csv
1601	12-22603	69	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	Pilomatricoma, cystic	\N	There is a cystic space lined in part by matrical (basaloid) cells, and shadow cells are also apparent.	Two cystic fragments, one measuring 0.7 x 0.6 x 0.2 cm and the other 0.6 x 0.35 x 0.3 cm. The larger is bisected and the smaller is intact, all wrapped with a fragment and entirely submitted.	VARIEGATED ERYTHEM PAPULOCYSTIC LESION; FAVOR FOLLIC CYST VS. CYSTIC BCC VS. PILOMATRIXOMA	\N	Forehead	\N	None	CYSTIC PILOMATRICOMA	123398	1431	\N	\N	12-22603	\N	SYNAT365	2010-2017	IP1108421	AirTable blocks_with_IP_info.csv
1602	12-22604	83	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	BCC	\N	Sections show a neoplastic proliferation of atypical basaloid keratinocytes arrayed as jagged aggregates in infiltrative array, and the surrounding stroma displays evidence of coarse fibrosis in the form of thickened (keloidal) collagen bundles.	Skin segment measuring 0.4 x 0.25 x 0.1 cm. Submitted intact.	PEARLY TELANGIECTATIC PAPULE; R/O BCC	\N	Infiltrative, Keloidal stroma, nasal bridge	\N	None	INFILTRATIVE BASAL CELL CARCINOMA, WITH KELOIDAL STROMA, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	103341	1432	\N	\N	12-22604	\N	SYNAT366	2010-2017	IP1108422	AirTable blocks_with_IP_info.csv
10036	12-22720A	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Leiomyoma	Upper back	Sections show a fascicled dermal proliferation of spindled cells with blunt-ended nuclei and eosinophilic cytoplasm situated in the superficial reticular dermis.  Mitotic figures are inconspicuous.	Ellipse, 1.8 x 0.7 x 0.8 cm, including 0.5 x 0.4 cm central raised area. With the peripheral and deep margins inked blue, the specimen is serially sectioned left to right perpendicular to the long axis and entirely submitted with four sections in cassette A1, three sections in cassette A2.	\N	\N	\N	\N	\N	LEIOMYOMA, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	174533	1433	\N	\N	12-22720	A	SYNX30	\N	IP118827	Consolidated_data_final.csv
1607	12-22868	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine.	Skin segment measuring 0.9 x 0.8 x 0.6 cm, trisected and entirely submitted.	R/O TRAUMATIZED NEVUS	\N	Intradermal, back	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173532	1434	\N	\N	12-22868	\N	SYNAT367	Melanocytic Nevus	IP1108686	AirTable blocks_with_IP_info.csv
1609	12-22884D	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.0	Melanocytic Nevus	\N	Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, submitted intact in cassette D.	A-C) SK, D) IDN	\N	Intradermal, left lower lip	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	201098	1435	\N	\N	12-22884	D	SYNAT336	Melanocytic Nevus	IP1108702	AirTable blocks_with_IP_info.csv
1611	12-22894B	32	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles.	Skin segment measuring 1.2 x 0.8 x 0.3 cm, trisected and entirely submitted in cassette B.	A) 0.2 X 0.2 CM PINK-YELLOW PAPULE; R/O IRRITATED SEBACEOUS HYPERPLASIA VS. NEVUS, B) 1.1 X 0.5 CM HYPERPIGMENTED PATCH W/ VARIEGATED PIGMENTATION; R/O DMN VS. MIS S/P DEEP SHAVE BX	\N	Compound, congenital pattern, neck	\N	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173450	1437	\N	\N	12-22894	B	SYNAT368	Melanocytic Nevus	IP1108712	AirTable blocks_with_IP_info.csv
1612	12-22898	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Melanocytic Nevus	\N	Sections show a predominantly intradermal proliferation of small melanocytes with round to oval nuclei that mature (diminish in size) with descent in the dermis.  The overlying epidermis shows elongated rete that intertwine.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted.	CONGENITAL NEVUS	\N	Intradermal, rt upper arm	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173688	1438	\N	\N	12-22898	\N	SYNAT369	Melanocytic Nevus	IP445158	AirTable blocks_with_IP_info.csv
1613	12-22900	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.32	SCC	\N	Sections show a proliferation composed of atypical keratinocytes, arrayed as irregular nests that infiltrate the dermis.  Foci of keratinization are apparent.	Skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted.	R/O BCC	\N	Eyebrow	\N	None	SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP BIOPSY MARGIN	102345	1439	\N	\N	12-22900	\N	SYNAT370	2010-2017	IP2427054	AirTable blocks_with_IP_info.csv
10048	WP11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1440	\N	\N	\N	\N	SYNX37	\N	\N	Consolidated_data_final.csv
10049	WP23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1441	\N	\N	\N	\N	SYNX38	\N	\N	Consolidated_data_final.csv
10050	WP29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1442	\N	\N	\N	\N	SYNX39	\N	\N	Consolidated_data_final.csv
3547	PG8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	1443	\N	\N	None	\N	SYNAT371	2010-2017	\N	AirTable blocks_with_IP_info.csv
3450	KIT37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	1444	\N	\N	None	\N	SYNAT372	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3452	KIT62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	1445	\N	\N	None	\N	SYNAT373	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3454	KIT118	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	1446	\N	\N	None	\N	SYNAT374	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3456	KIT181	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	1447	\N	\N	None	\N	SYNAT375	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3465	KIT227	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1448	\N	\N	None	\N	SYNAT376	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3471	KIT275	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	1449	\N	\N	None	\N	SYNAT377	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
10058	Bivona-L1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1450	\N	\N	\N	\N	SYNX47	\N	\N	Consolidated_data_final.csv
10059	Bivona-L2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1451	\N	\N	\N	\N	SYNX48	\N	\N	Consolidated_data_final.csv
10060	Bivona-L3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1452	\N	\N	\N	\N	SYNX49	\N	\N	Consolidated_data_final.csv
10061	Bivona-L4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1453	\N	\N	\N	\N	SYNX50	\N	\N	Consolidated_data_final.csv
10062	Bivona-L5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1454	\N	\N	\N	\N	SYNX51	\N	\N	Consolidated_data_final.csv
10063	Bivona-L6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1455	\N	\N	\N	\N	SYNX52	\N	\N	Consolidated_data_final.csv
1394	10-41439	67	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, forming confluent nests, with no maturation and a mitotic figure among the dermal melanocytes.  Beneath this is a zone of paucicellular fibrosis, with horizontally oriented, closely apposed collagen bundles. Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis, in part around epithelial adnexal structures.	Ellipse, 1.2 x 1.0 x 0.1 cm, including a central pink-tan 0.9 x 0.8 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections plus a fragment.	R/O MELANOMA	\N	 MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS	\N	The nevus has a congenital pattern. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, but has a mitotic figures in its dermal component. Therefore it should be classified as T1b per the 2009 revision of the AJCC staging system for melanoma. A superficial scar is also present. If this area was previously biopsied (we do not know of any in our files), the slides from it should be reviewed to make sure that the prognostic information above is correct.	MELANOMA, 0.65 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS	139524	1456	\N	\N	10-41439	\N	SYNAT378	2010-2017	IP936014	AirTable blocks_with_IP_info.csv
1473	11-37533	74	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a zone of fibrosis and inflammation consistent with prior biopsy and a residual compound proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly and in poorly circumscribed fashion within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the fibrotic superficial dermis, along with some smaller but still atypical melanocytes.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. There is a focal epidermal defect and subjacent fibrosis consistent with prior biopsy.	Ellipse, 3.0 x 1.5 x 0.8 cm, including a central 2.0 x 1.5 cm variegated brown and textured area.  With the peripheral margins and base inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections with fragment (at cut-in) in cassette A, three sections in cassette B, three sections with fragment (at cut-in) in cassette C, and three sections in cassette D.	R/O MELANOMA	\N	 RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	\N	The residual neoplasm contains diagnostic areas of melanoma, including some smaller cells in a nevoid melanoma pattern, as well as a pre-existent nevus. Histopathologic features of possible prognostic importance include the following. The thickness of the tumor in the re-excision is greater than that in the original biopsy. Dermal mitotic rate has supplanted Clark's levels with respect to staging of melanoma less than 1 mm in thickness in the current AJCC classification. Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: not evident AJCC stage: T1a	RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	897777	1458	\N	\N	11-37533	\N	JJS3	2010-2017	IP1021763	AirTable blocks_with_IP_info.csv
3469	KIT262	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1459	\N	\N	None	\N	SYNAT379	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3321	Dog12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka, Dog Melanoma| mucosal melanoma +EIN	\N	\N	\N	\N	1460	\N	\N	None	\N	SYNAT380	2010-2017	\N	AirTable blocks_with_IP_info.csv
3322	Dog24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka, Dog Melanoma| mucosal melanomas-non-pigmented	\N	\N	\N	\N	1461	\N	\N	None	\N	SYNAT381	2010-2017	\N	AirTable blocks_with_IP_info.csv
3323	Dog43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka, Dog Melanoma| melanocytoma	\N	\N	\N	\N	1462	\N	\N	None	\N	SYNAT382	2010-2017	\N	AirTable blocks_with_IP_info.csv
3324	Dog55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka, Dog Melanoma| acral melanoma	\N	\N	\N	\N	1463	\N	\N	None	\N	SYNAT383	2010-2017	\N	AirTable blocks_with_IP_info.csv
10084	HW3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanaoma| TUMOR Mucosal Melanoma, nasal sinus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1464	\N	\N	\N	\N	SYNX61	\N	\N	Consolidated_data_final.csv
10086	HW4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanaoma| TUMOR Melanoma, Mucosal nasal sinus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1465	\N	\N	\N	\N	SYNX62	\N	\N	Consolidated_data_final.csv
1414	10-86469	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show an ulcerated proliferation of large oval and fusiform melanocytes with a domed surface. The epidermis is irregularly hyperplastic in some areas, and relatively thinned in others. There are large, confluent nests of cells with abundant amphophilic cytoplasm and large, vesicular nuclei superficially, with smaller aggregations of somewhat smaller cells toward the base of the lesion. Scattered mitotic figures are present. The enclosed immunoperoxidase-stained sections show retention of p16 staining by most of the nuclei, and a relatively high proliferation rate.	Six outside slides, GHS-10-7835, D10-9413:A. One corresponding block received 1/26/2011.	EXCORIATED COMPOUND MELANOCYTIC PROLIFERATION	\N	Iwei, CGH Array run| NTRK3 Translocation case	\N	This proliferation shows conflicting criteria, including some attributes (large confluent nests, a high proliferation index, easily-identifiable dermal mitotic figures, a thinned epidermis, and focal ulceration) that raised the possibility of spitzoid melanoma as a potential consideration in the differential diagnosis. The differential diagnosis also includes a traumatized cellular Spitz nevus. We received the tissue block and utilized it to pursue array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you probably know, genomic gains and losses can be identified in the vast majority of melanomas, including proliferations within the spectrum of so-called childhood-type spitzoid melanoma. In short, the lack of demonstrable genomic anomalies in this specimen does not provide direct support for a diagnosis of spitzoid melanoma. I recommend complete excision of this site in follow-up. If the resultant reexcision specimen does not contain any residuum, then I view a traumatized hypercellular Spitz nevus as the most likely diagnostic possibility. If a nodular residuum is found below the site of the present biopsy, then it should be reassessed jointly with this specimen.	ULCERATED COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, INVOLVING THE DEEP EDGE OF THE BIOPSY	173701	1467	\N	\N	10-86469	\N	SYNAT384	2010-2017	IP981048	AirTable blocks_with_IP_info.csv
10019	12-22776	36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Melanoma, Acral	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. Clusters of similar melanocytes are present in the dermis.	Oriented ellipse, 1.6 x 0.9 x 0.3 cm, including a central 0.4 x 0.3 cm brown area. With the orienting suture at one tip placed to the left and designated proximal by the surgeon, the far margin is inked blue and the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from proximal to distal and entirely submitted with four sections each in cassettes A1 and A2.	\N	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS ON ACRAL SKIN, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	107722	1420	\N	\N	12-22776	A	SYNX17	\N	IP1096148	Consolidated_data_final.csv
11000	SP-12-01466111A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2068	\N	\N	\N	\N	SYNX665	\N	\N	Consolidated_data_final.csv
11001	SP-10-004335	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2069	\N	\N	\N	\N	SYNX666	\N	\N	Consolidated_data_final.csv
11002	SP-13-000848	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2070	\N	\N	\N	\N	SYNX667	\N	\N	Consolidated_data_final.csv
11003	M230	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2071	\N	\N	\N	\N	SYNX668	\N	\N	Consolidated_data_final.csv
1437	11-12273	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.2	\N	\N	Sections show a cellular, exophytic, polypoid compound proliferation of melanocytes. Within the background epidermis, which is thin, there are single melanocytes and nests distributed erratically, and cells above the junction can be found. The dermis below this contains large and irregular nests of similar melanocytes that lack maturation with descent in the dermis. An increase in dermal vascularity is appreciable. Dermal melanocytes in mitosis are easily found.	Seven outside slides, S10-40898 A1 (DC11-357, DEE-12580) and one corresponding block.	LARGE PEARLY PAPULE ON L PINNA FOR 2-3 WEEKS; FAVOR PYOGENIC GRANULOMA	\N	Iwei, CGH Array run| ROS1 Translocation case	\N	Our differential diagnosis included childhood-type spitzoid melanoma on one hand and a peculiar cellular Spitz nevus on the other. To address this differential, we completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 1q and loss of chromosome 6q. The identification of multiple chromosomal gains and losses is not known to occur in Spitz nevi and favors instead the above interpretation. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This proliferation has not been adequately excised. Further excision is warranted to ensure that local eradication has been accomplished.	CHILDHOOD-TYPE SPITZOID MELANOMA OF 2.9 MM IN THICKNESS	102270	1468	\N	\N	11-12273	\N	DP-16	CGH Validation	IP1001710	AirTable blocks_with_IP_info.csv
1455	11-23710	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	KF-09, AND DP-17 are the same patient	Sections show enlarged spindled and fusiform melanocytes arrayed in nests and fascicles in compound fashion. Large nests and fascicles are apparent at the junction in concert with acanthosis (and also central erosion), and many coalescing fascicles reside in the dermis and upper subcutis below that in concert with a lymphohistiocytic infiltrate. There is only partial maturation with descent. Dermal melanocytes in mitosis can be found, especially in the upper half of the proliferation.	Five outside slides, S11-11651 and one corresponding block.	PYOGENIC GRANULOMA	\N	Iwei, CGH Array run| ROS1 Translocation case	\N	As you note in your correspondence regarding this case, this proliferation does not represent a conventional Spitz nevus. The lesion is ulcerated, has a high overall cellularity and has a nodular component in the subcutis. Comparative genomic hybridization shows loss of chromosome 6q, an aberration that is common in melanoma. There is also a gain of a small area in the distal part of 5q. Given these findings, I believe that this is best assessed as a spitzoid melanoma of childhood. I use this term for an emerging class of lesions that usually lack b-raf mutations (which are present in most melanomas) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma.  While the thickness is approximately 4.5 mm., it would be a mistake to use prognostic data from adult melanoma cases in this setting. The prognosis is far better. As the lesion extends to a dermal margins, a narrow re-excision is reasonable. Lesions of this type are usually well circumscribed, and I have not seen regrowth when narrow but clear margins have been obtained. The role of sentinel lymph nodes is debatable, as sentinel lymph node involvement is common, but distant metastasis is rare.	SPITZOID MELANOMA, CHILDHOOD TYPE	173307	1469	\N	\N	11-23710	\N	DP-17	CGH Validation,Fusion RNA	IP1013148	AirTable blocks_with_IP_info.csv
1462	11-30426	18	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a proliferation of large melanocytes with a domed surface and a wedge-shaped base. Large nests predominate superficially, and are composed of cells with abundant pale vacuolated cytoplasm and dusty melanin, and large pleomorphic vesicular nuclei. The sizes of the aggregations and of the cells that comprise them diminish with descent, and the cytoplasm in the underlying dermis is less vacuolated and less pigmented.	One outside slide, S11-16547-2, SHD11-79642:A6 and one corresponding block.	SPITZOID MELANOCYTIC PROLIFERATION SUBMITTED FOR CGH ANALYSIS	\N	Iwei, CGH Array run| NTRK3 Translocation case	\N	Comparative genomic hybridization shows losses involving 6p and 16q. 6p gain is common in melanoma, but 6p loss is unusual. 16q loss is infrequent, but a repeatable event in melanoma. Given the combination of these features and the findings in the hematoxylin and eosin-stained sections, I believe that melanoma is the most appropriate diagnosis here. The base of the specimen is focally involved. The final thickness measurement should be made after complete excision.	MELANOMA, 2.3 MM. IN THICKNESS	173727	1470	\N	\N	11-30426	\N	SYNAT385	2010-2017	IP1019864	AirTable blocks_with_IP_info.csv
1463	11-31904	39	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad-based  proliferation of melanocytes involving the epidermis and papillary dermis. There is irregular epidermal hyperplasia with a thick granular and a compact cornified layer. Situated along the junction are confluent nests of large oval melanocytes with pleomorphic, vesicular nuclei. Some pagetoid scatter is present, largely in the center of the lesion. Smaller aggregates of smaller cells are evident in the subjacent dermis. There are rare mitotic figures, one in a melanocyte at the lower edge of the lesion (a so-called marginal mitosis). There are focally dense lymphocytic infiltrates.	Six outside slides, DC11-7871:1A and one corresponding block.	PIGMENTED LESION; R/O DYSPLASTIC NEVUS	\N	\N	\N	While the pattern at scanning magnification suggested a Spitz's nevus, there were several worrisome morphologic features, including striking confluence of junctional nests, some pagetoid scatter and a so-called marginal mitosis (see microscopic description below). We therefore performed comparative genomic hybridization. This shows a gain involving a discrete area of 7p near its terminal end, a loss involving part of 7q and a gain involving the terminal end of 7q. Gains and losses within the same chromosome reflect severe genetic damage, and in this context favor melanoma. Furthermore, gains involving all, or part of chromosome 7 are common in melanoma.  Given the lack of ulceration, this is a T3a primary lesion in the 2009 AJCC staging schema for melanoma.	MELANOMA, 2.65 MM. IN THICKNESS	139522	1471	\N	\N	11-31904	\N	KF-02	Fusion RNA	IP1021342	AirTable blocks_with_IP_info.csv
10853	ZS06-11249A-C2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma (Hunter Extraction)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1980	\N	\N	\N	\N	SYNX577	\N	\N	Consolidated_data_final.csv
10854	S12-26125A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1981	\N	\N	\N	\N	SYNX578	\N	\N	Consolidated_data_final.csv
1482	11-47644	13	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a compound proliferation of enlarged epithelioid and spindled melanocytes with finely yet heavily pigmented cytoplasm. Single melanocytes and nests are distributed relatively confluently along the junction, and in some areas the background epithelium is slightly thinned. Limited scatter of melanocytes above the junction can be seen. In fibrotic perijunctional dermis below this, non-maturing or partially-maturing nests, fascicles, and cords of similar melanocytes can be seen. A patchy associated infiltrate of lymphocytes and melanophages is also noted.	Two outside slides, D11-6279:A1 and A2. Two corresponding blocks received 7-7-11.	COMPOUND SPITZ NEVUS, REEXCISION	\N	Iwei, CGH Array run| BRAF Translocation case	\N	This atypical melanocytic proliferation does not represent a conventional Spitz nevus. Rather, our differential diagnosis included an atypical Spitz nevus on one hand and melanoma on the other. To more fully assess this differential, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosomes 2, 7q, 11q, 12, 13, 15, and 19. A segmental gain in chromosome 11p was also documented. As you probably know, the identification of multiple chromosomal gains or losses can be documented in most melanomas. In contrast, chromosomal gain/loss is not known to occur in melanocytic nevi. In summary, the combination of results derived from conventional microscopy coupled with aCGH points clearly to a diagnosis of melanoma. With respect to staging, this melanoma is non-ulcerated and shows Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.  Based upon the above clinical synopsis, we presume that a prior biopsy from this site was obtained. We have not reviewed that earlier specimen.	MELANOMA OF 1.3 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	373719	1472	\N	\N	11-47644	\N	SYNAT386	2010-2017	IP1037083	AirTable blocks_with_IP_info.csv
3510	MB_161	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1473	\N	\N	None	\N	SYNAT387	2010-2017	\N	AirTable blocks_with_IP_info.csv
3511	MB_327	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1474	\N	\N	None	\N	SYNAT388	2010-2017	\N	AirTable blocks_with_IP_info.csv
3518	MB_1454	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1475	\N	\N	None	\N	SYNAT389	2010-2017	\N	AirTable blocks_with_IP_info.csv
3512	MB_760	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1476	\N	\N	None	\N	SYNAT390	2010-2017	\N	AirTable blocks_with_IP_info.csv
3517	MB_1418	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1477	\N	\N	None	\N	SYNAT391	2010-2017	\N	AirTable blocks_with_IP_info.csv
3514	MB_1029	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1478	\N	\N	None	\N	SYNAT392	2010-2017	\N	AirTable blocks_with_IP_info.csv
3513	MB_1028	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1479	\N	\N	None	\N	SYNAT393	2010-2017	\N	AirTable blocks_with_IP_info.csv
3516	MB_1046	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1480	\N	\N	None	\N	SYNAT394	2010-2017	\N	AirTable blocks_with_IP_info.csv
10655	12-22776B3	36	f	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.9	Iwei Acral Melanoma	\N	Sections show a biopsy site on acral skin with an adjacent, broad proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells extending broadly into the dermis. There is a dense lichenoid lymphocytic infiltrate. In some areas melanocytes are present in pagetoid array within the epidermis.	Oriented skin excision with curled and twisted appearance, 3.2 x 2.6 x 0.5 cm, including a nearly central 2.3 x 1.6 cm gray-brown area. With the orienting suture at one end placed to the left and designated proximal edge by the surgeon, the far margin is inked blue and the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from proximal to distal and entirely submitted with three sections each in cassettes B1 and B2, two sections each in cassettes B3 through B5, and three sections in cassette B6.	\N	\N	\N	\N	We do not have a record of a prior biopsy on this site. Can you please forward a copy of the previous pathology report to our office. Histopathologic features of possible prognostic importance include:  Level: IV Vascular or lymphatic invasion: absent Dermal mitotic rate: rare mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: not detected Stage: pT2a	BIOPSY SITE WITH RESIDUAL ACRAL MELANOMA, 1.5 MM IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	666955	1420	\N	\N	12-22776	B	SYNX17	\N	IP1096148	Consolidated_data_final.csv
10116	HW9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Blood, Hong Wu	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1489	\N	\N	\N	\N	SYNX86	\N	\N	Consolidated_data_final.csv
1561	12-6981	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes with features as noted in Dr. Gottlieb's consultation report.	One outside slide, HD12-9831 A.  One corresponding block received 2-6-12.	R/O BCC, R/O MERKEL CELL	\N	NTRK3, Iwei Translocations	\N	I agree with the considerations in Dr. Gottlieb's report. Comparative genomic hybridization did not show chromosomal gains or losses, a finding that is strongly against melanoma and favors a unusual Spitz's nevus. Any lesion this controversial and needed molecular testing for diagnosis should be fully excised, but the findings do not support additional measures beyond that.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	17733	1490	\N	\N	12-6981	\N	SYNAT401	2010-2017	IP1092797	AirTable blocks_with_IP_info.csv
1399	10-55707	21	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a domed, cellular, laterally demarcated compound proliferation of enlarged epithelioid melanocytes. The background epidermis is acanthotic but is also focally thinned. Within the epidermis and along the junction, there are single melanocytes and nests distributed relatively densely, and some of the junctional nests are sizable. In the dermis below this, nests and cords of coalescing and partially-maturing melanocytes extend relatively deeply, where a flanking lymphohistiocytic infiltrate can also be seen.	Nine outside slides, SN10-2916-1, and one corresponding block.	LESION	\N	ALK, Iwei Translocations	\N	ADDENDUM, November 10, 2010: Per a clinical request, we completed comparative genomic hybridization (CGH) analysis of this tumor. Genomic analysis revealed loss in chromosomes 2p, 6q, 8p, and 12q, and loss of the entirety of chromosome 18 is also apparent. The presence of multiple genomic anomalies points to spitzoid melanoma as the best interpretation. Please note that childhood-type spitzoid melanoma represents an emerging entity that we believe is distinct from conventional adult melanoma. Cases reported in the literature as malignant Spitz nevus probably represent the same entity. With respect to clinical behavior, there is a risk for extension to regional lymph nodes, but our experience to date suggests that the risk for seeding of widespread metastatic disease is low. This proliferation is narrowly excised in the available sections. Further excision remains warranted to ensure that local eradication has been accomplished.  As we reported previously, our differential diagnosis included a cellular epithelioid Spitz nevus on one hand and so-called childhood-type spitzoid melanoma on the other. The latter has now been proven as the diagnosis for this case based upon the results of aCGH analysis. We also completed immunoperoxidase staining utilizing a two-color development system (with MART-1 labeled red and Ki-67 labeled brown) was included in our evaluation. By this staining method, we found diffuse MART-1 reactivity. Although the overall labeling index is modest, the MART-positive cells show focally increased nuclear expression of Ki-67, especially in the upper half of the proliferation, thus implying that cellular proliferation is focally elevated. This staining result is diagnostically inconclusive.	CHILDHOOD-TYPE SPITZOID MELANOMA OF 2.9 MM IN THICKNESS	173300	1491	\N	\N	10-55707	\N	SYNAT402	2010-2017	IP950283	AirTable blocks_with_IP_info.csv
1433	11-5210D	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.8 cm in thickness, bisected and totally submitted in cassette D.	A-C) IRREGULARLY SHAPED COLORED MACULE; R/O CLARK'S, D) BLACK NODULE; R/O NEVUS VS. MELANOMA	\N	\N	\N	\N	DEEP PENETRATING NEVUS	173726	1670	\N	\N	11-5210	D	SYNAT403	Deep Penetrating Nevus	IP873475	AirTable blocks_with_IP_info.csv
1466	11-34950	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed compound proliferation of enlarged slightly spindled melanocytes that is somewhat asymmetrical. The background epidermis is acanthotic and hyperkeratotic, and a rare large nest can be found at the junction. In fibrotic dermis below this, there are nests, cords, and fascicles of similar melanocytes that mature with descent in the dermis. One peripheral edge of the specimen lacks clears circumscription, and an increase in vasculature can be found around the proliferation as well. Rare superficial dermal melanocytes in mitosis can be seen. There is also a juxtaposed patchy lymphocytic infiltrate.	One outside slide, S-11-10561 / 1-A-2, and one corresponding block.	2-MO H/O PAINFUL PERSISTENT PAPULE, 0.9 X 0.5 CM; PROBABLE KELOID, R/O PSEUDOLYMPHOMA, SPITZ NEVUS	\N	ALK, Iwei Translocations	\N	I believe this proliferation represents an unusual compound desmoplastic Spitz nevus. To further assess spitzoid melanoma as a potential consideration in the differential diagnosis, we pursued array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you probably know, the identification of genomic gain or loss is common to the vast majority of melanomas. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as a desmoplastic Spitz nevus rather than melanoma. This proliferation is focally present at the periphery of this biopsy. Further excision can be considered to ensure that local eradication has been accomplished and that persistence does not ensue.	DESMOPLASTIC COMPOUND SPITZOID NEOPLASM, CONSISTENT WITH A DESMOPLASTIC COMPOUND SPITZ NEVUS	173625	1492	\N	\N	11-34950	\N	SYNAT404	2010-2017	IP1024388	AirTable blocks_with_IP_info.csv
1436	11-8228	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show an asymmetrical and focally ulcerated compound proliferation of slender spindled melanocytes with heavily melanized cytoplasm. There is a small junctional component jointly with marked acanthosis, and below this coalescing fascicles of non-maturing melanocytes reside in the dermis, where many interstitial melanophages are apparent.	One outside slide, S11-3178 and one corresponding block.	AFRICAN-AMERICAN BOY WITH A BROWN-BLACK PAPULE	\N	ALK, Iwei Translocations	\N	Our differential diagnosis included an unusual hypermelanotic spindled melanocytic nevus on one hand and childhood-type melanoma on the other. To more fully assess this differential, array-based comparative genomic hybridization (aCGH) was utilized to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis did not demonstrate chromosomal gains or losses. GNAQ and GNA11 gene sequencing was also completed, and GNAQ exon 5 and GNA11 exon 5 were both found to be wild-type (non-mutated). Based upon the results derived from conventional microscopy and molecular assessment, I offer the following conclusions:  1. The lack of genomic aberrations, as demonstrated by aCGH analysis, speaks against melanoma as a possibility and favors interpretation as a peculiar melanocytic nevus. I do not believe this lesion should be interpreted as a pigmented epithelioid melanocytoma (with respect to that diagnostic term, this proliferation is composed of melanocytes that have distinctly spindled cytomorphology).  2. The lack of mutation in GNAQ or GNA11 suggests that this proliferation fits better on the spectrum of pigmented spindle cell nevus or plexiform spindle cell nevus rather than blue nevus.  3. The proliferation is unusual and involves the deep edge of this biopsy. Further excision is thus warranted to ensure that local eradication has been accomplished and that persistence cannot ensue.	ULCERATED COMPOUND PROLIFERATION OF STRIKINGLY HYPERPIGMENTED/SPINDLED MELANOCYTES	173417	1493	\N	\N	11-8228	\N	SYNAT405	2010-2017	IP997665	AirTable blocks_with_IP_info.csv
1403	10-59344	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a proliferation of melanocytes with a domed surface and a wedge-shaped base. The overlying epidermis is alternatively thinned and irregularly thickened. There are large, confluent nests of cells with relatively monomorphous oval vesicular nuclei and abundant pale amphophilic cytoplasm. Many mitotic figures are present both in the upper and lower parts of the lesion. Both maturation, and dispersion to smaller aggregations toward the inferior edge of the specimen is evident.	Six outside slides, D10-9923 (1&2) and one corresponding block (1).	BX PROVEN ATYPICAL NEVUS, UNUSUAL MELANOCYTIC NEOPLASM, FAVOR SPITZ'S NEVUS, CHECK MARGINS	\N	\N	\N	This lesion has some features that make a conventional Spitz's nevus unlikely, including a thinned epidermis, the extent of confluence of nests and the number of mitotic figures, some of them in the lower half of the lesion. The more striking cytologic atypia seen in the lesions that I term spitzoid melanoma of childhood is not evident. Similar lesions to this one have been reported under a variety of names, including atypical Spitz tumor. They tend to involve local (and sentinel) lymph nodes at a relatively high rate, but distant metastasis is unlikely. Given the sharp circumscription of the lesion, one could consider a re-excision of this site, but I have not seen lesions of this type recur when excised by even a few millimeters. With regard to sentinel lymph node biopsy, there is little prognostic information as there is such a disparity between a percent of patients with nodal involvement and distant metastases. Comparative genomic hybridization does not show clear-cut evidence of chromosomal gains or losses. Because deflections were present in the plotted CGH data, we consulted with our former colleague, Dr. Boris Bastian (now chairman of Pathology at Memorial Sloan-Kettering Medical Center, New York) who agrees that no definite aberrations are present. The lack of aberrations does not exclude the possibility of melanoma, but makes it less likely (aberrations, especially multiple ones in loci characteristic of conventional melanomas would have resulted in an outright diagnosis of melanoma in this case). If one is looking for a more specific name for a lesion like this one, atypical Spitz tumor may be apt.  Please note that a margin of about a millimeter or so is present between the neoplasm and the peripheral margin. Lesions of this type are usually well circumscribed, and do not recur even with narrow excision margins, if the excision margins are histopathologically proven. Hence, I believe that this site could be treated with a reexcision of only a few more millimeters.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173304	1512	\N	\N	10-59344	\N	SYNAT411	2010-2017	IP953920	AirTable blocks_with_IP_info.csv
11004	M257	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2072	\N	\N	\N	\N	SYNX669	\N	\N	Consolidated_data_final.csv
11005	M285	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2073	\N	\N	\N	\N	SYNX670	\N	\N	Consolidated_data_final.csv
1517	11-84681	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.7	\N	\N	There is a broad-based, dome-surfaced proliferation of large oval melanocytes coupled with irregular epidermal hyperplasia, compact hyperkeratosis and a proliferation of melanocytes that is broadly transected at the base of the specimen in the superficial reticular dermis. The lesional cells are large, fusiform or polygonal, and have large, pleomorphic heterochromatic nuclei, some with prominent intranuclear inclusions.	One outside slide, S11-21609:A/1.	6 MM FLAT PINK AND BROWN VERRUCOUS PAPULE PRESENT FOR APPROXIMATELY ONE YEAR, BROWN/PINK/HEMORRHAGIC PAPULE; LIKELY WART, R/O NEVUS WITH ATYPIA; DESPITE THE PATIENT'S YOUNG AGE, THE ASYMMETRIC DISTRIBUTION OF MELANOCYTES, PROMINENT SPINOUS LAYER INVOLVEMENT, AND MELANOCYTE NUCLEAR PLEOMORPHISM ARE VERY CONCERNING FOR A MELANOMA	\N	ROS1, Iwei Translocations	\N	Comparative genomic hybridization shows losses involving chromosomes 6q, 10q and 12q. Loss of 6q and involving chromosome 10 are among the most common aberrations in melanoma. The final thickness measurement should be made after complete excision. The portion of the lesion seen in these sections is just over 1 mm in thickness, but not ulcerated. The final thickness measurement should be made after complete excision. In determining re-excision margins, please keep in mind that most spitzoid melanomas in children are well circumscribed and recurrence at the biopsy site due to residual neoplastic melanocytes is rare, regardless of thickness, even with very narrow (e.g. 5 mm) margins. Also, involvement of sentinel lymph nodes is more common than in adult melanoma, but distant metastasis is much less frequent. Therefore, the role of sentinel lymph node biopsy is questionable.	MELANOMA WITH SPITZOID FEATURES	987777	1494	\N	\N	11-84681	\N	DP-21	CGH Validation	IP1074129	AirTable blocks_with_IP_info.csv
3593	WM3211	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Wistar Cell Lines, passage 61, wt/wt	\N	\N	\N	\N	1495	\N	\N	None	\N	SYNAT406	Cell Line	\N	AirTable blocks_with_IP_info.csv
3540	NB2107	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Wistar Cell Lines, passage 5, wt/wt	\N	\N	\N	\N	1496	\N	\N	None	\N	SYNAT407	2010-2017	\N	AirTable blocks_with_IP_info.csv
10126	London-L1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas 	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N	\N	\N	\N	\N	\N	\N	\N	\N	1497	\N	\N	\N	\N	SYNX94	\N	\N	Consolidated_data_final.csv
3492	London-L2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1498	\N	\N	None	\N	SYNAT408	2010-2017	\N	AirTable blocks_with_IP_info.csv
10128	Bivona-L7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1499	\N	\N	\N	\N	SYNX96	\N	\N	Consolidated_data_final.csv
10129	Bivona-L8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1500	\N	\N	\N	\N	SYNX97	\N	\N	Consolidated_data_final.csv
10130	Bivona-L9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1501	\N	\N	\N	\N	SYNX98	\N	\N	Consolidated_data_final.csv
10131	Bivona-L10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1502	\N	\N	\N	\N	SYNX99	\N	\N	Consolidated_data_final.csv
10143	Bivona-L11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1503	\N	\N	\N	\N	SYNX100	\N	\N	Consolidated_data_final.csv
10144	HWA1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, FFPE Curls	Hong Wu	\N	\N	\N	\N	\N	\N	\N	\N	\N	1504	\N	\N	\N	\N	SYNX101	\N	\N	Consolidated_data_final.csv
10146	HWA2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, FFPE Curls	Hong Wu	\N	\N	\N	\N	\N	\N	\N	\N	\N	1505	\N	\N	\N	\N	SYNX102	\N	\N	Consolidated_data_final.csv
10148	HWA3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, FFPE Curls	Hong Wu	\N	\N	\N	\N	\N	\N	\N	\N	\N	1506	\N	\N	\N	\N	SYNX103	\N	\N	Consolidated_data_final.csv
10150	HWA4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	 Acral Melanoma, FFPE Curls	Hong Wu	\N	\N	\N	\N	\N	\N	\N	\N	\N	1507	\N	\N	\N	\N	SYNX104	\N	\N	Consolidated_data_final.csv
1434	11-5482	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show an exophytic, eroded compound proliferation of enlarged spindled and epithelioid melanocytes. Intraepidermally, these cells are distributed in concert with marked epidermal hyperplasia. At the junction, there are cellular nests and fascicles of melanocytes that often hold a vertical orientation, and some large nests show central necrosis en masse within them. There are cellular fascicles, cords, and nests of cytologically similar melanocytes that descend into the dermis below this, where partial maturation with descent is appreciable. Dermal melanocytes in mitosis or single necrotic melanocytes are easily found. A juxtaposed sparse lymphohistiocytic infiltrate is apparent within fibrotic peritumoral dermis.	One outside slide, HS11-1031.  Twenty-one additional slides (20 unstained) received 2-3-11.	1.0 CM ERYTHEMATOUS CRUSTED TENDER PAPULE, RECENT CHANGE IN SIZE, AND BLEEDING	\N	\N	\N	I believe this proliferation represents childhood-type spitzoid melanoma not a peculiar or atypical Spitz nevus. To further substantiate this interpretation, we completed comparative genomic hybridization via array methodology (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis revealed gain in chromosomes 7q and 12p. The presence of multiple chromosomal gains is not known to occur in Spitz nevi and favors instead the above interpretation. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This tumor is transected at the deep edge of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.	CHILDHOOD-TYPE SPITZOID MELANOMA OF AT LEAST 4.0 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	192799	1508	\N	\N	11-5482	\N	KF-05	Fusion RNA	IP994919	AirTable blocks_with_IP_info.csv
10607	12-168B	71	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Iwei DPN (Control Normal Nevus)	\N	Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis, in part in a peri-adnexal pattern.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in cassette B.	\N	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173340	1828	\N	\N	12-168	B	SYNX425	\N	IP1080712	Consolidated_data_final.csv
1512	11-79158	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged epithelioid and slightly spindled melanocytes arrayed asymmetrically in epidermis and dermis. Within the epidermis, there are single melanocytes and nests distributed centrally, and thinning of the epidermis is noted. In the dermis, there are nests, fascicles, syncytia, and sheets of melanocytes, and encompassing sclerosis is focally apparent. There is a deep nodular focus in which a bulbous extension of melanocytes extends through most of the reticular dermis.	Six outside slides (five unstained), S11-50264 (CD11-155069).	REQUEST FOR CGH ANALYSIS OF MELANOCYTIC TUMOR	\N	\N	\N	The differential diagnosis includes an unconventional deep penetrating nevus or combined melanocytic nevus as well as low-grade melanoma. To further address this differential, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies, as per your request. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in distal chromosome 1q as well as focal gain and focal loss in distal chromosome 15q. This represents an ambiguous aCGH result. We have observed 15q gain in association with Spitz nevi, but the fact that multiple chromosomal gains and losses have been identified indicates that the interpretation is less than straightforward. In summary, the combination of results derived from conventional microscopy coupled with aCGH has yielded an ambiguous result. Based solely upon conventional microscopy, I favor a peculiar melanocytic nevus as most likely. The proliferation extends quite close to the inked margins of excision. Further excision is warranted to ensure that local eradication has been accomplished.	NODULAR COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES	173676	1509	\N	\N	11-79158	\N	SYNAT409	2010-2017	IP1068606	AirTable blocks_with_IP_info.csv
10154	DP12-200	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	RT, Upper Arm, Polypoid Pyogenic Granuloma (Lobular Capillary Hemangioma)	Dr. Lutzky's Case	\N	\N	\N	\N	\N	\N	\N	\N	\N	1510	\N	\N	\N	\N	SYNX107	\N	\N	Consolidated_data_final.csv
3582	TissueCoreALKControl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1511	\N	\N	None	\N	SYNAT410	2010-2017	\N	AirTable blocks_with_IP_info.csv
1533	11-96096	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show inflammation and granulation tissue, with no evidence of an atypical melanocytic proliferation.	Eighteen outside slides, DI08-6824:C1 through C18.	UCSF MELANOMA CLINIC PATIENT; SUBMITTED FOR CONSULT AND FOR BRAF & NRAS MUTATION ANALYSIS	\N	\N	\N	None	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173701	1518	\N	\N	11-96096	\N	SYNAT416	2010-2017	IP1085544	AirTable blocks_with_IP_info.csv
1441	11-16253	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a sessile, exophytic, compound proliferation of enlarged melanocytes. Within the epidermis, which is acanthotic and hyperkeratotic, there are single melanocytes and nests and fascicles of melanocytes distributed somewhat unevenly. Some collections of melanocytes extend above the junction. In dermis below this, there are nests and fascicles of melanocytes that are encompassed by fibrotic dermis. Very large and coalescing fascicles are present in the subjunctional zone, but maturation into smaller nests, cords, and fascicles is apparent more deeply. Part of the proliferation encompasses a folliculosebaceous unit. Dermal melanocytes in mitosis can be found but are uncommon.	One outside slide, CS11-1999. One corresponding block received 3-8-11.	AMELANOTIC MELANOMA VS. DFSP, FAVOR SPITZ NEVUS, ? ATYPIA	\N	\N	\N	This proliferation does not represent a conventional Spitz nevus. Rather, our differential diagnosis included a hypercellular Spitz nevus on one hand and so-called childhood-type spitzoid melanoma on the other. To further address this differential, we pursued array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated loss of a small segment of distal chromosome 7q and gain in the proximal portion of chromosome 11p. Chromosome 11p gain can be seen in association with Spitz nevi, especially, large and cellular Spitz nevi, and this molecular aberration is not common to melanoma. The segment of chromosomal loss in 7q is quite small and is not believed to be diagnostically significant. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as a cellular Spitz nevus. We have not demonstrated molecular anomalies via aCGH that are supportive of a diagnosis of childhood-type spitzoid melanoma. This proliferation has been fully excised by means of this specimen, and I do not believe that further surgery at this site is indicated.	CELLULAR COMPOUND SPITZOID NEOPLASM, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173508	1513	\N	\N	11-16253	\N	SYNAT412	2010-2017	IP1005690	AirTable blocks_with_IP_info.csv
1494	11-61046	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a proliferation of large spindled melanocytes arrayed in the dermis as coalescing fascicles that form a larger sessile nodule. There is partial maturation with descent. Many of the constituent melanocytes have finely melanized cytoplasm. Superficially, there is perijunctional fibrosis. The superjacent epidermis is thinned. There are melanophages scattered in the upper dermis as well.	Skin segment measuring 0.9 x 0.6 x 0.2 cm, bisected and entirely submitted.	? NEW CONG NEVUS	\N	\N	\N	We believe this proliferation falls on the spectrum of a pigmented spindle cell nevus (or plexiform spindle cell nevus). To further assess its nature, we completed immunoperoxidase staining. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show low nuclear expression of Ki-67, thus implying that cellular proliferation is very low, which is reassuring but not definitive. There is also general preservation of p16 expression, which also lends support to a benign interpretation. To definitively assess the nature of this tumor, we also completed array-based comparative genomic hybridization (aCGH), with your approval. This approach was utilized to screen this tumor tissue for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a small segmental loss of chromosome 15q and a small segmental gain in chromosome 19p. Neither of these small aberrations is known to be associated with melanoma. Most melanomas demonstrate multiple chromosomal copy number gains and losses when assessed via aCGH, and this was not apparent in this instance.  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as an unconventional pigmented spindle cell nevus. This is a most unusual melanocytic proliferation, and we utilized sophisticated techniques to evaluate its nature. Further excision is recommended ensure that local eradication has been accomplished and that persistence cannot ensue.	INTRADERMAL PROLIFERATION OF ENLARGED SPINDLED MELANOCYTES	173439	1514	\N	\N	11-61046	\N	KF-08	Fusion RNA	IP1050489	AirTable blocks_with_IP_info.csv
1624	12-31996	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed compound proliferation of enlarged melanocytes, and the epidermis above these cells is thinned. There are very large nests and fascicles of melanocytes just below the junction, and a few central nests are noted above this. In dermis below this, partially-maturing nests, fascicles, and cords of similar melanocytes can be seen, and a number of dermal melanocytes in mitosis can be identified.	Three outside slides, STRS12-7480 A1 (DRMC12-2648, MR# 12546629). One additional outside slide, STRS12-7480:A1-2 (12546629), received 05/07/12.  One corresponding block received 5-11-12.	LESION PRESENT APPROX 6 MONTHS; HEMANGIOMA VS. SPITZ NEVUS	\N	\N	\N	ADDENDUM, June 7, 2012: Our differential diagnosis included an unconventional Spitz nevus on one hand and so-called childhood-type spitzoid melanoma. Thank you for arranging for p16 immunostaining to be completed in your laboratory; relatively avid expression of p16 was documented. We also received a clinical request for us to complete array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 9 with no other chromosomal gains or losses. Loss in chromosome 9 represents a relatively common aberration in childhood spitzoid melanoma, but we do not consider it sufficient to be fully decisive from a diagnostic standpoint (most melanomas have multiple genomic aberrations). In summary, the combination of results derived from conventional microscopy coupled with aCGH raises childhood-type spitzoid melanoma as a possibility, but these molecular findings are not decisively diagnostic. This atypical melanocytic proliferation is 2.1 mm in thickness and involves the deep edge of the current specimen. Complete reexcision of this site is warranted in follow-up. My personal opinion is that nodal assessment is not beneficial in this context, as any results found do not correlate with prognosis, in contrast to experience with adult melanoma.	ATYPICAL COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, WITH LOSS OF CHROMOSOME 9 DEMONSTRATED BY MOLECULAR ASSESSMENT	173507	1528	\N	\N	12-31996	\N	SYNAT413	2010-2017	IP1148421	AirTable blocks_with_IP_info.csv
1400	10-56047	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a moderately narrow, relatively symmetrical proliferation of large oval melanocytes involving the superficial dermis. The lesional cells have abundant amphophilic cytoplasm and moderately pleomorphic, vesicular nuclei. Relatively small nests are present, with even smaller aggregations toward the base of the lesion. A sparse lymphocytic infiltrate is present.	Two outside slides, D10-5276, and one corresponding block.	ENLARGING LESION	\N	\N	\N	The enclosed Ki-67 stain is difficult to interpret, as many lymphocytes are present. A few mitotic figures are present, including one in the lower half of the lesion. Immunoperoxidase staining performed in our laboratory using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) to more specifically evaluate the proliferation rate in melanocytes shows a very low labeling rate, although a few positive nuclei are present near the base of the lesion. A p16 stain labels only rare cells (less than 5%). My initial assessment of this lesion was that it is not a conventional Spitz's nevus, but a lesion with low metastatic potential (referred to as atypical Spitz tumor in some studies). However, comparative genomic hybridization shows a loss of chromosome 9, and a gain involving most of chromosome 7. The chromosome 9 loss corroborates the near-total absence of staining for p16, as the gene is located on 9p. Gains involving chromosome 7 and losses involving chromosome 9 are common aberrations in melanoma.  Hence, I believe an outright diagnosis of melanoma is more apt.  The lesion appears to have been narrowly excised.	MELANOMA, 1.7 MM IN THICKNESS	173508	1515	\N	\N	10-56047	\N	SYNAT414	2010-2017	IP950623	AirTable blocks_with_IP_info.csv
1641	12-67298	75	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	None	One block #DT12-55826.	MALIGNANT S-100 POSITIVE SPINDLE CELL NEOPLASM SUBMITTED FOR BRAF MUTATION ANALYSIS	\N	\N	\N	The histopathological diagnosis was established by our previous pathology report DT12-55826. Sanger sequencing of exon 15 of BRAF revealed a V600E mutation.	MALIGNANT S-100 POSITIVE SPINDLE CELL NEOPLASM, BRAF V600E MUTATION DETECTED	100711	1516	\N	\N	12-67298	\N	SYNAT415	2010-2017	IP960004	AirTable blocks_with_IP_info.csv
10162	12-20321	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	Brain, right frontal, biopsy: Glioblastoma, WHO Grade IV 	\N	Sections show a polypoid segment of skin with a papillated surface, and the epidermis is expanded by a proliferation of keratinocytes arrayed as interanastomosing rete.	Skin segment, 1.0 x 0.4 x 0.4 cm, bisected and entirely submitted.	\N	\N	\N	\N	\N	POLYPOID SEBORRHEIC KERATOSIS	173404	1517	\N	\N	12-20321	A	SYNX114	\N	IP1102231	Consolidated_data_final.csv
3520	MB1242	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1519	\N	\N	None	\N	SYNAT417	2010-2017	\N	AirTable blocks_with_IP_info.csv
3519	MB1241	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1520	\N	\N	None	\N	SYNAT418	2010-2017	\N	AirTable blocks_with_IP_info.csv
3522	MB1423	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1521	\N	\N	None	\N	SYNAT419	2010-2017	\N	AirTable blocks_with_IP_info.csv
1645	12-71679	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a broad-based compound proliferation of melanocytes in which the junctional component outflanks the centrally positioned intradermal one. There are closely apposed nests of moderately enlarged fusiform melanocytes with monomorphous oval nuclei and pale, lightly pigmented cytoplasm at the junction, extending into the upper portions of folliculosebaceous units. A few incipient Kamino bodies are present. There is a central focus in which nests of progressively smaller cells are embedded within fibrotic stroma. I did not detect mitotic figures in the dermal component. The enclosed two-color immunoperoxidase-stained sections show a moderate proliferation rate in melanocytes in the papillary dermis, with considerably less staining toward the base of the lesion.	Four outside slides, KC12-1201 2A. One corresponding block received 9-28-12.	R/O HEMANGIOMA VS. DYSPLASTIC NEVUS	\N	\N	\N	Comparative genomic hybridization has been performed, and while not technically optimal, shows no chromosomal aberrations. Especially given this result, I favor an unusual nevus in the Spitz/pigmented spindle cell nevus spectrum. As the junctional nests are closely apposed, resulting in a hypercellular appearance, a spitzoid melanoma is also in the differential diagnosis, albeit less likely. In any case that is at this level of difficulty, a narrow reexcision is appropriate.	COMPOUND PROLIFERATION OF LARGE SOMEWHAT SPITZOID MELANOCYTES	105536	1526	\N	\N	12-71679	\N	SYNAT423	2010-2017	IP1157496	AirTable blocks_with_IP_info.csv
1648	12-80985B	7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a residual dermal proliferation of enlarged fusiform melanocytes arrayed as a wedge-shaped nodule of coalescing fascicles in the reticular dermis. There is a juxtaposed sparse permeative lymphohistiocytic infiltrate, and a swath of post-procedural fibrosing inflammatory alterations sits above this. There is no ulceration. Combining both specimens, a tumor thickness of 1.4 mm is appreciable.	One outside slide, 12-050491 and one corresponding block.	BIOPSY AND REEXCISION OF COMPOUND ATYPICAL SPITZOID MELANOCYTIC PROLIFERATION (FOR CGH)	\N	\N	\N	Our differential diagnosis included both an unconventional Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. Per your request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen in association with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 8p as well as segmental loss of chromosome 12q and loss of distal chromosome 15q. The identification of multiple chromosomal copy number abnormalities provides confirmation that this tumor does not represent a conventional Spitz nevus. However, the several small segmental genomic aberrations we have identified are not specifically diagnostic of melanoma, either. Thus, this tumor can be considered an example of 'atypical Spitz tumor or 'Spitz tumor of ambiguous potential'. Dr. Boris Bastian has reviewed the molecular results and is in agreement with this interpretation.  The small residuum seen here is non-ulcerated and appears excised in the available planes of section.	RESIDUAL ATYPICAL COMPOUND SPITZOID NEOPLASM, EXCISED IN THE AVAILABLE PLANES OF SECTION	173305	1527	\N	\N	12-80985	B	SYNAT424	2010-2017	IP1166802	AirTable blocks_with_IP_info.csv
10855	S12-28585A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1982	\N	\N	\N	\N	SYNX579	\N	\N	Consolidated_data_final.csv
10856	S11-2018B5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1983	\N	\N	\N	\N	SYNX580	\N	\N	Consolidated_data_final.csv
10857	S13-11748F5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1984	\N	\N	\N	\N	SYNX581	\N	\N	Consolidated_data_final.csv
10858	S12-7250E3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1985	\N	\N	\N	\N	SYNX582	\N	\N	Consolidated_data_final.csv
10859	S13-3401B3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1986	\N	\N	\N	\N	SYNX583	\N	\N	Consolidated_data_final.csv
1627	12-39632	5	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of large spindled and epithelioid melanocytes, the junctional component of which is arrayed with the lowermost sections of an epithelium that is acanthotic and hyperkeratotic, with thinning of the epidermis over some large nests. Some single melanocytes are scattered above the basal layer. Rare small Kamino bodies are present. In the dermis, melanocytes are arrayed as nests and syncytia. There is some maturation, but some larger melanocytes persist at the base. There is deep adnexal extension. The stroma is focally myxoid.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted.	HIGHLY IRREGULAR APPEARING LESION	\N	\N	\N	ADDENDUM, June 29, 2012: While there are features in common with a Spitz's nevus, there are also unusual features, including deep adnexal extension, marked thinning of the epidermis over some junctional nests, and a lack of complete maturation of the dermal component. We were interested in performing comparative genomic hybridization. This is a molecular technique that uses lesional tissue from the paraffin block. It is based on the presence of chromosomal gains and losses in about 95% of melanomas, but with the exception of a gain of 11p, a lack of them in Spitz's nevi. A reference on this technique and its applicability to this differential diagnosis is listed below. Thank you for informing us that we could proceed with this testing. This shows no significant loss or gain of chromosomal material. This favors a benign interpretation. About 95% of conventional melanomas show detectable losses or gains with this technique. Because of the unusual findings noted, however, complete re-excision of this site is of course warranted.  Reference:  Bastian BC, Wassermann U, Pinkel D, LeBoit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999 Dec;113(6):1065-9.	COMPOUND PROLIFERATION OF LARGE SPINDLED AND EPITHELIOID MELANOCYTES, PROBABLY AN UNUSUAL SPITZ'S NEVUS, EXTENDING TO THE EDGE OF THE SPECIMEN	173508	1529	\N	\N	12-39632	\N	SYNAT425	2010-2017	IP1125450	AirTable blocks_with_IP_info.csv
10176	HWA5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1530	\N	\N	\N	\N	SYNX127	\N	\N	Consolidated_data_final.csv
10180	HWA7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1532	\N	\N	\N	\N	SYNX129	\N	\N	Consolidated_data_final.csv
10182	HWA8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1533	\N	\N	\N	\N	SYNX130	\N	\N	Consolidated_data_final.csv
10184	HWA9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1534	\N	\N	\N	\N	SYNX131	\N	\N	Consolidated_data_final.csv
10186	HWA10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1535	\N	\N	\N	\N	SYNX132	\N	\N	Consolidated_data_final.csv
3527	MB1617	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma | Barcode mismatch comment in note	\N	\N	\N	\N	1536	\N	\N	None	\N	SYNAT426	2010-2017	\N	AirTable blocks_with_IP_info.csv
3526	MB1609	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma	\N	\N	\N	\N	1537	\N	\N	None	\N	SYNAT427	2010-2017	\N	AirTable blocks_with_IP_info.csv
3591	WM51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	wt/wt Cell Line DNA	\N	\N	\N	\N	1538	\N	\N	None	\N	SYNAT428	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
10191	wm3918	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	wt/wt Cell Line DNA	Wistar	\N	\N	\N	\N	\N	\N	\N	\N	\N	1539	\N	\N	\N	\N	SYNX136	\N	\N	Consolidated_data_final.csv
3262	DM1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	1540	\N	\N	None	\N	SYNAT429	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3263	DM2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	1541	\N	\N	None	\N	SYNAT430	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3265	DM5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	1542	\N	\N	None	\N	SYNAT431	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3267	DM7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	1543	\N	\N	None	\N	SYNAT432	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3271	DM12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	1544	\N	\N	None	\N	SYNAT433	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3272	DM13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	1545	\N	\N	None	\N	SYNAT434	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3277	DM21	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	1546	\N	\N	None	\N	SYNAT435	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3312	DM93	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	1547	\N	\N	None	\N	SYNAT436	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
11006	M368	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2074	\N	\N	\N	\N	SYNX671	\N	\N	Consolidated_data_final.csv
11007	M375	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2075	\N	\N	\N	\N	SYNX672	\N	\N	Consolidated_data_final.csv
11008	M418	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2076	\N	\N	\N	\N	SYNX673	\N	\N	Consolidated_data_final.csv
11009	C8161	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2077	\N	\N	\N	\N	SYNX674	\N	\N	Consolidated_data_final.csv
11010	London-L4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2078	\N	\N	\N	\N	SYNX675	\N	\N	Consolidated_data_final.csv
11012	London-L5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2079	\N	\N	\N	\N	SYNX676	\N	\N	Consolidated_data_final.csv
1446	11-20375	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes that assumes a domed profile. In some areas, the background epidermis is acanthotic, and in other areas the background epithelium is thinned. In areas where the epithelium is expanded, there are single melanocytes and nests distributed within the epidermis at all levels, and large and well-formed pink globules (Kamino bodies) can be found above dermal papillae. Below this, there are nests and cords of melanocytes that in some areas mature with descent. In areas where the epithelium is thin, a nodular array of non-maturing melanocytes is appreciable. These cells are slightly spindled and epithelioid in morphology and have amphophilic or finely melanized cytoplasm. Within these nodules, melanocytes in mitosis are relatively easily found. A juxtaposed sparse infiltrate of lymphocytes is apparent as well.	One outside slide, 11-051610, and one corresponding block.	7 X 5 MM RED PAPULE THAT HAD BEEN PRESENT FOR ONE YEAR AND OVER THE LAST 1-2 MONTHS HAD BECOME "MORE PAPULAR", SHE HAS AN ADJACENT CONGENITAL NEVUS, CLINICAL DDX WAS PYOGENIC GRANULOMA VS. MOLLUSCUM CONTAGIOSUM VS. JUVENILE XANTHOGRANULOMA, NO FAMILY HISTORY OF MELANOMA, NEGATIVE FISH STUDY, WE WOULD APPRECIATE YOUR EVALUATION FOR COMPARATIVE GENOMIC HYBRIDIZATION	\N	\N	\N	Based upon conventional microscopy, the dominant nodule within this specimen shows a configuration that is worrisome for childhood-type spitzoid melanoma. This nodular proliferation developed secondarily within a preexistent Spitz nevus. I also understand that an adjacent congenital melanocytic nevus was noted clinically. To further assess the nature of this proliferation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, completion of aCGH analysis demonstrated loss in chromosomal 1p with no other associated chromosomal gains or losses. We have observed anomalies involving chromosome 1 in other examples of spitzoid melanoma. In summary, my interpretation of the the combination of results derived from conventional microscopy coupled with aCGH analysis is that a nodule of childhood-type spitzoid melanoma has developed secondarily within a preexistent Spitz nevus. The nodular population of melanocytes within this specimen is 1.6 mm in thickness. Please note that the negative prior analysis via fluorescence in situ hybridization (FISH) is unsurprising, as FISH testing only evaluates loci on chromosomes 6 and 11. To state it differently, the chromosomal anomaly that we have detected could not be identified via FISH.  The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination. The proliferation in this specimen involves the deep edge of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.	BIPHASIC COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, INCLUDING A NODULAR POPULATION OF ATYPICAL MELANOCYTES WITH CHROMOSOME 1p LOSS	101624	1548	\N	\N	11-20375	\N	SYNAT437	2010-2017	IP1009813	AirTable blocks_with_IP_info.csv
1450	11-21491	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged melanocytes arrayed as gargantuan nests and fascicles in compound fashion in concert with acanthosis in a sessile polypoid skin segment. The acanthotic epidermis is focally eroded. In the dermis, non-maturing and coalescing fascicles of melanocytes are coupled with a sparse encompassing lymphohistiocytic infiltrate, and cells in mitosis are relatively easily found.	Four outside slides, S11-10002:1A,1B and one corresponding block (1A).	REFERRED FOR EXCISION, RAISED PEDUNCULATED IRRITATED NEVUS, ONSET THREE MONTHS AGO, ALSO HAS LESIONS ON LOWER ABDOMEN, PURPLISH, ? HEMANGIOMA	\N	\N	\N	The cellularity of this process raised concern for the possibility of childhood-type spitzoid melanoma as a potential alternative i the differential diagnosis. The best means to assess or refute this possibility is to complete array-based comparative genomic hybridization (aCGH) analysis, which we pursued. After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you know, the vast majority of melanomas, including childhood-type melanomas, harbor various genomic anomalies. In summary, the combination of results derived from conventional microscopy coupled with aCGH does not provide support for a diagnosis of melanoma. I believe this unusual proliferation represents a hypercellular Spitz nevus. The process appears excised in the available planes of section.	HYPERCELLULAR COMPOUND PROLIFERATION OF MELANOCYTES, CONSISTENT WITH A HYPERCELLULAR SPITZ NEVUS	173502	1549	\N	\N	11-21491	\N	SYNAT438	2010-2017	IP1010929	AirTable blocks_with_IP_info.csv
1415	10-88475	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a well-circumscribed, dome-surfaced proliferation of melanocytes involving the junctional zone and superficial dermis. The base of the lesion is relatively flat, except in a central area where melanocytes extend along the access of an eccrine duct. The overlying epidermis is irregularly hyperplastic, with jagged rete ridges and a thick spinous layer. There are large, confluent nests of large oval melanocytes along the junction. These cells have monomorphous oval vesicular nuclei, small nucleoli and abundant pale eosinophilic cytoplasm. Many mitotic figures are present, both in the superficial and deep portions of the lesion. There is some maturation with descent, and in the central, peri-adnexal area, some myxoid stroma is present.	Four outside slides, B8538/10. One corresponding block received 1-14-11.	PIGMENTED PAPULE	\N	\N	\N	ADDENDUM, February 14, 2011: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system: While the architectural features of this lesion favor a Spitz's nevus, some of the cytologic features are of concern (many cells have less cytoplasm than classic Spitz cells typically do), and many more mitotic figures are present than in most Spitz nevi. Additionally, the striking confluence of junctional nests is of concern.  Comparative genomic hybridization shows no chromosomal gains or losses. Given these findings, I am unable to render a diagnosis of spitzoid melanoma, and favor a unusual Spitz's nevus. The lesion appears to have been removed with a margin of about 3 mm on one side. It is very well circumscribed, and lesions of this type seldom recur in the scar from the previous biopsy. Also, it is very common for spitzoid lesions of all types (including benign Spitz nevi) to have small clusters of spitzoid melanocytes in a sentinel lymph node. The predictive value of this finding is very low, and I, for this reason, would not endorse this approach.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	173727	1555	\N	\N	10-88475	\N	SYNAT439	2010-2017	IP983054	AirTable blocks_with_IP_info.csv
1633	12-54296	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1556	\N	\N	12-54296	\N	SYNAT440	2010-2017	\N	AirTable blocks_with_IP_info.csv
1634	12-54992	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1557	\N	\N	12-54992	\N	SYNAT441	2010-2017	\N	AirTable blocks_with_IP_info.csv
3594	WM3622	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1558	\N	\N	None	\N	SYNAT442	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1501	11-65778	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound, wedge-shaped, slightly asymmetrical proliferation of spindled and epithelioid melanocytes arrayed as nests and fascicles which are vertically oriented in the dermis and focally along the junction of an epidermis that is acanthotic. Within the dermis, similar melanocytes are present in clusters, fascicles, and interstitially. Mitotic figures are evident very focally within the dermal component, including within deeper aspects of it. There is a patchy juxtaposed lymphocytic infiltrate.	One outside slide, S11-29473 A1 and one corresponding block.	ATYPICAL MELANOCYTIC NEVUS	\N	\N	\N	Our differential diagnosis for this spitzoid tumor included an unconventional Spitz nevus on one hand and spitzoid melanoma on the other. To further assess this differential via molecular means, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss of chromosome 7p as well as focal gain in chromosome 7q. No other chromosomal copy number aberrations were identified. As background, please note that chromosomal copy number aberrations involving multiple chromosomes can be identified in the vast majority of melanomas evaluated via aCGH, while most melanocytic nevi lack such aberrations. A subset of Spitz nevi demonstrate aberrations involving a single chromosome, including chromosomes 7, 11, and 15. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced clear support for a diagnosis of melanoma. Rather, I believe this proliferation represents an unconventional Spitz nevus with associated gain in chromosome 7q. My colleague, Dr. Boris Bastian, reviewed the aCGH tracing for this case and is in agreement with my diagnostic interpretation.  We recommend complete reexcision of this site in follow-up to be certain there is not possibility of local persistence.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, FOCALLY ABUTTING THE INKED SPECIMEN PERIPHERY	333504	1550	\N	\N	11-65778	\N	SYNAT443	2010-2017	IP1055221	AirTable blocks_with_IP_info.csv
1384	10-23569A	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages. Mitoses are not readily identified.	Ellipse, 1.4 x 0.4 x 0.3 cm, including a central raised 0.7 x 0.4 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections in cassette A.	A) R/O ATYPICAL BLUE NEVUS VS. SPITZ NEVUS, B) DYSPLASTIC NEVUS	\N	\N	\N	Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferative rate thereby supporting the above interpretation.	DEEP PENETRATING NEVUS, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	174526	1673	\N	\N	10-23569	A	SYNAT504	Deep Penetrating Nevus	IP918142	AirTable blocks_with_IP_info.csv
11014	London-L8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2080	\N	\N	\N	\N	SYNX677	\N	\N	Consolidated_data_final.csv
11016	London-L9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2081	\N	\N	\N	\N	SYNX678	\N	\N	Consolidated_data_final.csv
11018	London-L13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2082	\N	\N	\N	\N	SYNX679	\N	\N	Consolidated_data_final.csv
1416	10-88482	74	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show markedly sun-damaged skin with a well-circumscribed, wedge-shaped to somewhat rectangular proliferation of melanocytes that mostly involves the dermis. Most of the proliferation is embedded in markedly fibrotic stroma, which displaces the elastotic material. There are large nests of large oval melanocytes superficially. These cells have pale amphophilic cytoplasm with large, relatively monomorphous vesicular nuclei. The aggregates, the cells themselves and the sizes of their nuclei diminish with descent. Although the enclosed Ki-67 double-stained sections show a very low proliferative rate, a mitotic figure is present within a high power field of the base of the specimen.	Seven outside slides, OS10-24774. One corresponding block received 12-14-10.	SPITZ NEVUS VS. MELANOCYTIC TUMOR OF UNCERTAIN MALIGNANT POTENTIAL VS. SPITZOID MELANOMA	\N	\N	\N	There are conflicting findings, as noted in your cover letter. The architectural features of the lesion could well be those of a Spitz's nevus, but the setting, in an older patient, in severely sun-damaged skin with, and presence of deep mitotic figures is worrisome. A p16 stain is positive in about 30% of lesional nuclei. Testing with comparative genomic hybridization shows a gain involving much of the long arm of chromosome 15 (15q), and one involving 22q. Although these are not among the very most commonly affected loci in melanoma, gains in both of these areas are seen in a proportion of typical melanomas.  The lesion extends to within 1 mm of the margin in the reticular dermis. It is not ulcerated, and hence is a T3a primary melanoma in the 2009 AJCC staging schema for melanoma.	DESMOPLASTIC MELANOMA, 3.8 MM. IN THICKNESS	173610	1551	\N	\N	10-88482	\N	SYNAT444	2010-2017	IP983061	AirTable blocks_with_IP_info.csv
1496	11-63178	41	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a slightly asymmetrical, compound proliferation of melanocytes, many of which have abundant dusty cytoplasmic melanin, and some of which are slightly spindled. These are arrayed irregularly within the epidermis as nests and single cells with focal suprabasal scatter. Within the dermis, similar melanocytes are arrayed in clusters and small fascicles or syncytia, and these do not mature with descent. A single dermal melanocyte in mitosis is apparent in a recut section. There is periadnexal extension. There are numerous admixed melanophages, and a patchy lymphocytic infiltrate. There is solar elastosis appreciable.	Two outside slides, P11-01555 / B. One corresponding block received 9-9-11.	A) 2 MM BROWN MACULE, B) 4 MM DARK-BLUE/BLACK PAPULE	\N	\N	\N	Our differential diagnosis included a peculiar deep penetrating melanocytic nevus on one hand and melanoma on the other, and we did not believe this differential could be conclusively resolved based solely upon conventional microscopy. Per your request, we thus completed array-based comparative genomic hybridization (aCGH) to screen this tumor for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed copy number loss in chromosomes 3, 9, and 10. The identification of multiple chromosomal copy number aberrations is indicative of genomic instability and is confirmatory of a diagnosis of melanoma. Please note that melanocytic nevi do not have associated chromosomal copy number aberrations involving multiple chromosomes. In essence, the aCGH result has proven that this proliferation cannot represent a melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH is confirmatory of a diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness and lacks associated ulceration, yet melanocytes in mitosis are detectable in its invasive component. Therefore, this represents melanoma of stage pT1b (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.9 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173649	1552	\N	\N	11-63178	\N	SYNAT445	2010-2017	IP1052621	AirTable blocks_with_IP_info.csv
1405	10-71761	33	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There are increased single melanocytes and nests of them along the dermo-epidermal junction, with nests of small, round melanocytes in the papillary dermis as well.	One outside slide, DK10-19623:B.	SECOND OPINION, A) ANGIOMA, B) NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	528522	1553	\N	\N	10-71761	\N	SYNAT446	2010-2017	IP966340	AirTable blocks_with_IP_info.csv
10733	UM_6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dr. Seider Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1892	\N	\N	\N	\N	SYNX489	\N	\N	Consolidated_data_final.csv
1412	10-84478	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed, cellular and somewhat asymmetrical compound proliferation of enlarged spindled and epithelioid melanocytes. Within the epidermis, which is markedly acanthotic, there are strikingly enlarged nests and fascicles of melanocytes distributed somewhat unevenly, and centrally an area of erosion is capped by neutrophilic exudate. There are large nests and fascicles of similar melanocytes in the underlying dermis, and partial maturation with descent in the dermis is appreciable. In the deepest extent of the lesion, the lesional melanocytes extend amongst adnexal structures. A patchy dermal lymphocytic infiltrate is present concurrently. A number of dermal melanocytes in mitosis can be found.	Two outside slides, 1032157 01B. Two corresponding blocks received 11/24/10 (01A & 01B).	RULE OUT BASAL CELL CARCINOMA	\N	\N	\N	ADDENDUM, January 14, 2011: As noted previously, my differential diagnosis includes a hypercellular Spitz nevus on one hand and childhood-type spitzoid melanoma on the other, and I favor the former possibility as most likely. As this differential diagnosis is best addressed by inclusion of the results of molecular analysis, we pursued comparative genomic hybridization analysis via tissue array methodology (aCGH). After extraction of tumoral DNA, aCGH assessment demonstrated gain in chromosome 7q and no other genomic aberrations. Chromosome 7q gain as a monoaberration does not presently have defined significance. We have observed it in melanocytic tumors interpreted ambiguously. A monoaberration in chromosome 7q is not sufficient to warrant interpretation as childhood-type spitzoid melanoma. In summary, based upon the combination of conventional microscopy coupled with aCGH results, I continue to favor a hypercellular Spitz nevus as most likely. As this interpretation is not unequivocal, further excision of this site is warranted to ensure that local eradication has been accomplished and that persistence cannot ensue.	COMPOUND SPITZOID NEOPLASM, FOCALLY ABUTTING THE PERIPHERY OF THE BIOPSY	173649	1554	\N	\N	10-84478	\N	SYNAT447	2010-2017	IP979057	AirTable blocks_with_IP_info.csv
3592	WM1963	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1559	\N	\N	None	\N	SYNAT448	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3590	WM8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1560	\N	\N	None	\N	SYNAT449	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3595	WM3912	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1561	\N	\N	None	\N	SYNAT450	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3270	DM11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1562	\N	\N	None	\N	SYNAT451	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3273	DM14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1563	\N	\N	None	\N	SYNAT452	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3281	DM26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1564	\N	\N	None	\N	SYNAT453	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1511	11-78845	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged epithelioid melanocytes arranged as large nests at the dermo-epidermal junction and as irregular large and small nests in the dermis.  Some of the dermal melanocytes are smaller.  Scattered mitotic figures are noted near the surface of the lesion and one is atypical.  The overlying epidermis shows focal crusting.	Skin segment measuring 0.4 x 0.3 x 0.1 cm. Submitted intact.	R/O HEMANGIOMA	\N	\N	\N	Array chromosomal genomic hybridization studies were performed on this case.  They reveal a gain of chromosome 13q.  This finding, while unusual, is not known to be associated with melanoma.  The overall histopathology of this case including enlarged melanocytes and scattered mitotic figures, one of which is atypical remains worrisome however, and the exact biologic potential of this lesion cannot be completely predicted.  Most larger series of this rare diagnostic category indicate that most patients are alive and well after treatment, which includes excision, and can include sentinel lymph node biopsy, (which may show metastatic foci).  Rare patients succumb to metastatic disease.  In this case, since the lesion extends to the edges of the specimen, a full thickness re-excision with a minimum of 5 millimeter margins is recommended.  I have reviewed this case with Dr. LeBoit who concurs with the diagnosis and treatment recommendationl.  The reference below represents one of the larger series related to this entity. Ludgate MW et al The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2009 Feb 1;115(3):631-41.	ATYPICAL SPITZ TUMOR, EXTENDING TO THE TISSUE EDGES	173530	1570	\N	\N	11-78845	\N	SYNAT454	2010-2017	IP1068293	AirTable blocks_with_IP_info.csv
1514	11-81405	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a pedunculated proliferation of large oval melanocytes seen beneath an irregularly hyperplastic and focally atrophic epidermis, encompassed by epithelial collarettes. Extending from the junctional zone to the flat base of the lesion in the upper reticular dermis is a proliferation of large oval melanocytes with relatively monomorphous oval vesicular nuclei that contain small nucleoli. These cells have moderate amounts of eosinophilic cytoplasm. Scattered mitotic figures are present in both the upper and lower portions of the proliferation.	One outside slide, K15783-11 and one corresponding block.	RED EXOPHYTIC LESION; HEMANGIOMA?	\N	\N	\N	The architectural features of this lesion differ from those of a classic Spitz's nevus by virtue of having epithelial collarettes and a focally thinned epidermis. The dermal component features striking confluence of nests, and a mitotic rate higher than that in most Spitz's nevi. For these reasons, we performed comparative genomic hybridization. No chromosomal gains or losses were detected. In the context of the histopathologic findings, I favor an unusual Spitz's nevus. The lesion appears to have been narrowly removed.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH FEATURES FAVORING AN UNUSUAL SPITZ'S NEVUS	713789	1571	\N	\N	11-81405	\N	SYNAT455	2010-2017	IP1070853	AirTable blocks_with_IP_info.csv
1519	11-85075	20	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a broad, slightly asymmetrical and compound proliferation of enlarged slightly spindled and epithelioid melanocytes. Within the epidermis, single melanocytes and nests are distributed along the sides and bases of elongated rete, and in one focus there is scatter of melanocytes above the junction. In fibrotic and sclerotic reticular dermis below this, there are partially maturing nests, cords, and fascicles of similar melanocytes distributed broadly, and extension to the inked edges of the specimen is noted. A multifocal juxtaposed lymphocytic infiltrate is present concurrently. The melanocytes in the dermis show avid expression of p16 and have a low Ki-67 cell proliferation index. Dermal melanocytes in mitosis are not easily found.	Nine outside slides, SP11-6973:A, and B, and one corresponding block, B.	LESION WITH CONFLICTING CRITERIA, WITH FEATURES THAT SUGGEST ATYPICAL SPITZ NEVUS VS. SPITZOID MELANOMA	\N	\N	\N	As discussed in your correspondence, the differential diagnosis includes an unconventional desmoplastic Spitz nevus on one hand and spitzoid melanoma on the other, and I believe the former possibility represents the correct interpretation for this case. To further substantiate the nature of this proliferation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated chromosomal copy number aberrations. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a tiny segmental gain in chromosome 7q with no other associated chromosomal gains or losses. This is an aberration that we have identified in association with a small number of desmoplastic Spitz nevi. As you know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. (Importantly, only a small segmental aberration involving a single chromosome was identified in association with this proliferation, and thus the aCGH profile is not suggestive of melanoma.) In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. I believe this proliferation represents an unusual desmoplastic Spitz nevus. As this biopsy is only partial in nature, further excision is recommended to ensure that local eradication has been accomplished.	DESMOPLASTIC COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, CONSISTENT WITH A DESMOPLASTIC SPITZ NEVUS	173727	1572	\N	\N	11-85075	\N	SYNAT456	2010-2017	IP1074523	AirTable blocks_with_IP_info.csv
1516	11-83908	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged melanocytes arrayed in compound fashion within a sessile, protuberant skin segment. There are single melanocytes and nests and fascicles of melanocytes within the epidermis, which is thinned, and in the dermis there are partially-maturing nests and sheets of melanocytes coupled with a lymphohistiocytic infiltrate.	One hematoxylin and eosin-stained section prepared from outside block labeled  S11-3281.	ELEVATED INTRADERMAL NEVUS, FAST GROWING	\N	\N	\N	This proliferation does not represent a conventional Spitz nevus. Rather, our differential diagnosis included an atypical Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show modestly elevated nuclear expression of Ki-67, thus implying that cellular proliferation is elevated. This staining result is of concern but is not specifically diagnostic. To more fully assess the nature of this proliferation, we also completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed equivocal segmental loss in distal chromosome 8p with no other chromosomal gains or losses. As you probably know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The aCGH profile that we have defined here is not specific.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced clear support for a diagnosis of melanoma. Rather, I favor an unconventional (or atypical) Spitz nevus as most likely. The proliferation abuts the specimen periphery in the available sections. In light of this, conservative complete reexcision of this site represents a follow-up step worthy of consideration. If there is no apparent residuum, then close clinical monitoring of the biopsy site could also be considered as a possibility.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION	173305	1573	\N	\N	11-83908	\N	SYNAT457	2010-2017	IP1073356	AirTable blocks_with_IP_info.csv
1521	11-85859	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	The submitted level sections demonstrate a sessile skin segment that harbors a dermal proliferation of melanocytes arrayed in nested, fascicular, and syncytial fashion. Near the junctional zone, epithelioid melanocytes with pale or finely melanized cytoplasm are arrayed in coalescing fashion, and subjacent to this there are coalescing fascicles of slightly spindled melanocytes with similar cytoplasmic qualities. As one extends more deeply in the dermis, the melanocytes become smaller with descent and occasionally are wrapped around tiny peripheral nerves or abut vascular channels. Extension into the subjacent reticular dermis is coupled with a marked diminishment in cell size and an interstitial distribution. Dermal melanocytes in mitosis are not easily found, and the Ki-67 cell proliferation index appears to be relatively low.	Eleven outside slides, 11-31668:A1-1 through A1-11, and one corresponding block, A1.	MELANOCYTIC LESION, DESCRIBED AS A "SUSPICIOUS MOLE	\N	\N	\N	ADDENDUM, January 10, 2012: As I reported previously, some of the constituent melanocytes have enlarged nuclei, this proliferation could also be interpreted as a spitzoid deep penetrating nevus (or perhaps as a Spitz nevus). Per your request, we completed array-based comparative genomic hybridization (aCGH) assessment of this tumor to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 9 with equivocal segmental loss in chromosomes 7p and 8p. The identification of chromosome 9 loss represents an ambiguous aCGH result. We have identified chromosome 9 loss as a monoaberration in some melanomas, but we have also found chromosome 9 loss in proliferations in which the best expert microscopic interpretation was as a melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced an unequivocal diagnosis. Based solely upon conventional microscopy, I favor an unconventional deep penetrating melanocytic nevus as most likely. The results of our aCGH analysis have additionally raised melanoma of 1.6 mm in thickness as a diagnostic possibility. The proliferation appears excised in the available planes of section in the current specimen. Additional excision and ongoing clinical follow-up will be necessary in light of the fact that melanoma has now been raised as a distinct possibility in the differential diagnosis.	INTRADERMAL PROLIFERATION OF MELANOCYTES, WITH MANY ATTRIBUTES OF A DEEP PENETRATING MELANOCYTIC NEVUS	173508	1574	\N	\N	11-85859	\N	SYNAT458	2010-2017	IP1075307	AirTable blocks_with_IP_info.csv
10860	S13-12947A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1987	\N	\N	\N	\N	SYNX584	\N	\N	Consolidated_data_final.csv
10861	S13-18444A16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1988	\N	\N	\N	\N	SYNX585	\N	\N	Consolidated_data_final.csv
1531	11-95663	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a proliferation of large fusiform and oval melanocytes involving the superficial, mid and focally the deep reticular dermis. There are fascicles of cells with large vesicular or diffusely hyperchromatic nuclei and relatively small nucleoli, some positioned along the axes of folliculosebaceous units. There is dispersion from large to smaller groups in the interstitial reticular dermis. I did not detect expansile-appearing aggregations of melanocytes or melanocytes in mitosis.	One outside slide, S11-12286:A1. One corresponding block received 1-3-12.	A) DERMATOFIBROMA, B) 4 MM NEVUS	\N	\N	\N	The differential diagnosis includes an unusual Spitz's nevus, as well as a low-grade spitzoid melanoma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate (my estimate is between 1 and 3%). A phosphohistone H3 immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows positive nuclei among the large, spindled melanocytes. Comparative genomic hybridization shows gains and losses in portions of both the short and long arms of chromosome 7, and and area of loss near the terminal portion of chromosome 16q. While chromosome 7q gains can occur in some Spitz's nevi, the mixture of gains and losses within the same chromosome seen here favors a spitzoid melanoma. If the lesion has been re-excised, I would prefer to issue a final report after seeing the residuum.	INTRADERMAL PROLIFERATION OF LARGE SOMEWHAT SPITZOID MELANOCYTES, WITH GENOMIC FINDINGS WORRISOME FOR MELANOMA	173406	1575	\N	\N	11-95663	\N	SYNAT459	2010-2017	IP1085111	AirTable blocks_with_IP_info.csv
3264	DM4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1576	\N	\N	None	\N	SYNAT460	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1451	11-23681	58	\N	\N	3	T4b	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	LARGE PG OR ANGIOSARCOMA/FIBROMA?, SEE PHOTO	\N	 MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	\N	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	1457	\N	\N	11-23681	\N	JJS1	2010-2017	IP1013119	AirTable blocks_with_IP_info.csv
1410	10-83193	17	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	cellular blue nevus	\N	Sections show a proliferation of spindled melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Ellipse, 0.8 x 0.7 x 0.2 cm, including a central 0.6 x 0.5 cm lesion.  With margins inked blue, the specimen is serially quadrisected perpendicular to the long axis and entirely submitted.	ATYPICAL NEVUS	\N	\N	Scraping	None	BLUE NEVUS, COMPLETELY EXCISED	173688	1671	\N	\N	10-83193	\N	BN-010	Nevus Library	IP977772	AirTable blocks_with_IP_info.csv
10287	11-23681A+C	58	t	\N	3	T4b	Primary	\N	\N	\N	\N	\N	\N	172.5	Ivanka Normal Resequencing	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	\N	\N	\N	\N	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	1457	\N	\N	11-23681	A	SYNX54	\N	IP1013119	Consolidated_data_final.csv
3269	DM10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1611	\N	\N	None	\N	SYNAT482	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3275	DM17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1612	\N	\N	None	\N	SYNAT483	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3276	DM18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1613	\N	\N	None	\N	SYNAT484	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3278	DM22	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1614	\N	\N	None	\N	SYNAT485	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3279	DM23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1615	\N	\N	None	\N	SYNAT486	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3280	DM25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1616	\N	\N	None	\N	SYNAT487	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3266	DM6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1617	\N	\N	None	\N	SYNAT488	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3287	DM37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1618	\N	\N	None	\N	SYNAT489	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
10304	SM_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Spitzoid Melanoma Maria	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1619	\N	\N	\N	\N	SYNX216	\N	\N	Consolidated_data_final.csv
3570	SM_3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1620	\N	\N	None	\N	SYNAT490	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
3571	SM_4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1621	\N	\N	None	\N	SYNAT491	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
3572	SM_5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1622	\N	\N	None	\N	SYNAT492	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
3577	SM7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1623	\N	\N	None	\N	SYNAT493	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
10311	SM_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Spitzoid Melanoma Maria	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1624	\N	\N	\N	\N	SYNX221	\N	\N	Consolidated_data_final.csv
3574	SM_11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1625	\N	\N	None	\N	SYNAT494	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
3575	SM_12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1626	\N	\N	None	\N	SYNAT495	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
3576	SM_16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1627	\N	\N	None	\N	SYNAT496	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
10316	SM_18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Spitzoid Melanoma Maria	| Barcode mismatch comment in note	\N	\N	\N	\N	\N	\N	\N	\N	\N	1628	\N	\N	\N	\N	SYNX225	\N	\N	Consolidated_data_final.csv
3288	DM42	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1629	\N	\N	None	\N	SYNAT497	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3289	DM43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1630	\N	\N	None	\N	SYNAT498	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3291	DM48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1631	\N	\N	None	\N	SYNAT499	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1356	09-92749	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.  Thickened collagen bundles are noted within and adjacent to the melanocytic proliferation.	Cylindrical skin segment, 0.8 cm in diameter and 1.3 cm in thickness, quadrisected and entirely submitted.	1 CM BLACK NODULE VERY FIRM; R/O NEVUS VS. MELANOMA VS. DF	\N	\N	\N	There are thickened, sclerotic collagen bundles associated with this nevus.	DEEP PENETRATING NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	173539	1674	\N	\N	09-92749	\N	SYNAT505	Deep Penetrating Nevus	IP893515	AirTable blocks_with_IP_info.csv
11023	1212	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2083	\N	\N	\N	\N	SYNX680	\N	\N	Consolidated_data_final.csv
11024	1213	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2084	\N	\N	\N	\N	SYNX681	\N	\N	Consolidated_data_final.csv
11025	1214	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2085	\N	\N	\N	\N	SYNX682	\N	\N	Consolidated_data_final.csv
11026	3860	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2086	\N	\N	\N	\N	SYNX683	\N	\N	Consolidated_data_final.csv
11032	UM17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2087	\N	\N	\N	\N	SYNX684	\N	\N	Consolidated_data_final.csv
1498	11-64496	5	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a dome-surfaced, somewhat wedge-shaped proliferation of large fusiform melanocytes that extends from the junctional zone into the subcutis. The cellularity of the lesion is densest toward the base. The overlying epidermis has jagged rete ridges, is moderately thickened and contains foci in which there are increased numbers of single melanocytes, some above the basal layer, but is mostly uninvolved. Within the dermis, fascicles of cells with abundant eosinophilic cytoplasm and large, pleomorphic, vesicular nuclei that contain large nucleoli are present within fibrotic stroma. Clefts demarcate adjacent melanocytes from one another. Mitotic figures are rare, but at least one is present a short distance from the base of the lesion. The enclosed immunoperoxidase-stained sections include S100 and Melan-A stains that highlight the fascicular structure of the lesion, and HMB45 stain that shows some positivity throughout the entire thickness of the lesion, and a Ki-67 stain showing what appears to be an elevated proliferation rate (this is difficult to judge, as there are admixed lymphocytes).	Thirteen outside slides, CS11-1847 (including six unstained slides).  One corresponding block received 9-7-11.	RECENTLY ENLARGING LESION	\N	\N	\N	The findings are equivalent to those published in the literature as atypical Spitz tumor. Lesions of this type are generally well circumscribed. In this case, the dermal and subcutaneous margins appear involved, and a narrow reexcision should be performed to prevent regrowth. My experience is that lesions of this type seldom recur with 5 mm margins. Involvement of local lymph nodes is common, but distant metastasis is rare. We obtained comparative genomic hybridization on this case. There is a clear cut loss involving chromosome 1p, without other aberrations. Certain chromosomal gains and losses are typical of melanoma, but this is not one of them. Idiosyncratic ones such as those seen here may occur in so-called atypical Spitz tumors. In general, Spitz's nevi have gains of 11p alone, 7q alone, or no aberrations. Hence, the results are intermediate, and although abnormal are not interpretable as melanoma.  Dr. Boris Bastian, my colleague who developed diagnostic comparative genomic hybridization also reviewed the results of this test and agrees with this interpretation of it.	MOSTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	123289	1632	\N	\N	11-64496	\N	SYNAT500	2010-2017	IP1053939	AirTable blocks_with_IP_info.csv
1505	11-71491	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged slightly spindled and epithelioid melanocytes arrayed in compound fashion. There is good lateral demarcation and slight asymmetry. Single melanocytes and nests and fascicles of melanocytes are apparent along the junction in concert with epidermal hyperplasia, and some junctional fascicles have encompassing myxoid stroma. There are partially-maturing nests and cords of epithelioid melanocytes in the dermis below this, and cells in mitosis can occasionally be found. A sparse and patchy juxtaposed lymphocytic infiltrate is also noted.	Nine outside slides, D11-35107 / 1-2, and two corresponding blocks.	ENLARGING LESION X 3 MONTHS, SMALL, WELL CIRCUMSCRIBED, SYMMETRICAL, MELANOCYTIC; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	This melanocytic proliferation shows some Spitz nevus-like attributes but also some unconventional features, including partial loss of p16 expression and occasional dermal melanocytes in mitosis. In light of this, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies as an additional step in assessment. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal copy number gains or losses. The vast majority of melanomas analyzed by aCGH have associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack demonstrable aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. I continue to favor an unconventional Spitz nevus as the best interpretation of this tumor, which appears excised in the available planes of section.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, CONSISTENT WITH A COMPOUND SPITZ NEVUS	173531	1633	\N	\N	11-71491	\N	SYNAT501	2010-2017	IP1060934	AirTable blocks_with_IP_info.csv
10862	ZS07-1210F6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1989	\N	\N	\N	\N	SYNX586	\N	\N	Consolidated_data_final.csv
10863	ZS10-11930B12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1990	\N	\N	\N	\N	SYNX587	\N	\N	Consolidated_data_final.csv
10864	S12-28988	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1991	\N	\N	\N	\N	SYNX588	\N	\N	Consolidated_data_final.csv
10865	SSS13-1652B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1992	\N	\N	\N	\N	SYNX589	\N	\N	Consolidated_data_final.csv
10866	S13-5249	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1993	\N	\N	\N	\N	SYNX590	\N	\N	Consolidated_data_final.csv
1500	11-65756	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a somewhat asymmetrical, dome-surfaced proliferation of melanocytes with irregular epidermal hyperplasia in some areas and a relatively thin epidermis in others. Jagged rete ridges, hypergranulosis and a mixture of lamellar hyperkeratosis and compact hyperkeratosis are present. Extending from the junctional zone to the base of the specimen in the superficial reticular dermis are variably confluent nests of large oval melanocytes with striking nuclear pleomorphism. Both large vesicular nuclei with large central nucleoli and hyperchromatic nuclei are present. Some maturation with descent is evident, and the aggregations near the base of the specimen are considerably smaller than those situated more superficially. Many multinucleated melanocytes are also seen. The accompanying immunoperoxidase-stained sections include a p16 stain in which most of the cells fail to react. Among the minority which are positive, a disproportionate number are multinucleated.	Eight outside slides, SD-11-27155:A1,A2 and one corresponding block (A1).	SECOND OPINION, FLESH-COLORED PAPULE WITH TELANGIECTASIA; PYOGENIC GRANULOMA VS. WART VS. JXG	\N	\N	\N	I agree with the considerations noted in your report. Given the clinical setting, we obtained comparative genomic hybridization. This shows multiple chromosomal aberrations, which in concert with the histopathologic findings favor interpretation as a spitzoid melanoma rather than as an unusual Spitz's nevus. These aberrations include losses involving most of chromosome 2 (with a gain of a smaller focus in the same chromosome), and gains involving chromosome 7q, 9p, 17q and 19p. Finding gains and losses in the same chromosome, as in chromosome 2 in this case is particularly suggestive of melanoma, as is the sheer number of aberrations; both point to a high degree of genomic instability. Some of the aberrations seen in this case are idiosyncratic (such as the gain in 9p; 9p is usually lost in melanoma) while others are characteristic of melanomas in adults (such as the gain in 7q). The lesion measures 2.2 mm in thickness, and may prove to be thicker on complete excision. Lesions of this type often involve sentinel lymph nodes, but the predictive value vis-a-vis extranodal metastatic spread is limited. If there are interesting or unusual findings in the reexcision specimen, I would be interested in viewing the sections as part of this consultation.	SPITZOID MELANOMA	173649	1634	\N	\N	11-65756	\N	SYNAT502	2010-2017	IP1055199	AirTable blocks_with_IP_info.csv
1508	11-74100	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged slightly spindled and epithelioid melanocytes arrayed in compound fashion. There are single melanocytes and nests and fascicles of melanocytes within the epidermis, which is partially acanthotic and hyperkeratotic, and limited intraspinous scatter is noted. There are also many small pink globules within the epidermis. The dermis below this holds maturing nests and fascicles in concert with fibrosis, and a juxtaposed sparse lymphohistiocytic infiltrate is also  noted.	Three outside slides, D11-38152, and one corresponding block.	SHAVE BIOPSY OF A 0.8 CM CRESCENT-SHAPED, PINK AND BROWN PAPULE; NEVUS, RULE OUT ATYPIA	\N	\N	\N	Based upon conventional microscopical attributes, I favored interpretation as an unconventional Spitz nevus occurring in adulthood, although I understand that your group viewed this possibility as improbable. In light of this ambiguous diagnostic situation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As you know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced clear support for a diagnosis of melanoma. Rather, I believe this melanocytic proliferation represents an unconventional melanocytic nevus. This process is transected at the periphery of the current specimen. In light of this, further excision is recommended to ensure that local eradication has been accomplished.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, CONSISTENT WITH AN UNCONVENTIONAL COMPOUND SPITZ NEVUS	133559	1635	\N	\N	11-74100	\N	SYNAT503	2010-2017	IP1063547	AirTable blocks_with_IP_info.csv
10401	S08-1463A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1703	\N	\N	\N	\N	SYNX300	\N	\N	Consolidated_data_final.csv
10402	S12-7093NG176-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1704	\N	\N	\N	\N	SYNX301	\N	\N	Consolidated_data_final.csv
10403	S10-7937B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1705	\N	\N	\N	\N	SYNX302	\N	\N	Consolidated_data_final.csv
10404	S11-21025B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1706	\N	\N	\N	\N	SYNX303	\N	\N	Consolidated_data_final.csv
11033	S12-23475A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Lymph Node Metastasis	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2088	\N	\N	\N	\N	SYNX685	\N	\N	Consolidated_data_final.csv
11034	S12-23475A4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Lymph Node Metastasis	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2089	\N	\N	\N	\N	SYNX686	\N	\N	Consolidated_data_final.csv
1509	11-74517	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.3	\N	\N	There is a dome-surfaced proliferation of large oval melanocytes involving both the junctional zone of a thinned epidermis and the superficial dermis beneath it. Nests predominate over single cells along the junction. The lesional cells have abundant amphophilic cytoplasm and large oval vesicular nuclei with relatively small nucleoli. Many superficial dermal nests are extensively confluent or oddly shaped, and many mitotic figures are present, some of them atypical. Smaller nests composed of more mature-appearing and less mitotically active cells are evident toward the base of the lesion.	One outside slide, SCD-11-37655:A1. One corresponding block received 10/14/11.	SPITZOID MELANOCYTIC NEOPLASM; PYOGENIC GRANULOMA VS. ATYPICAL SPITZ NEVUS	\N	\N	\N	The findings are not those of a conventional Spitz's nevus. The thinned epidermis, mitotic rate and large, confluent nests in the superficial part of the lesion are all worrisome features. Comparative genomic hybridization shows multiple chromosomal losses including 8p, 9, 14 and 16. Several of these, most notably 8p and 9 are commonly lost in melanoma. Given these findings, despite the age of the patient, I believe that this lesion is best viewed as a spitzoid melanoma of childhood. I use this term for an emerging class of lesions that have a spitzoid morphology and a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. This makes sentinel lymph node biopsy less predictive than in adult melanoma. The thickness in this case is at least 1.8 mm as the lesion is transected. Thickness and prognosis are also not coupled in the same manner as in adult melanoma and the prognosis is also considerably better than with an adult lesion of the same thickness. Also, lesions of this type tend to be well circumscribed and excision margins can be considerably less.	SPITZOID MELANOMA, CHILDHOOD TYPE	173304	1636	\N	\N	11-74517	\N	SYNAT506	2010-2017	IP1063964	AirTable blocks_with_IP_info.csv
1442	11-18560	60	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a broad, incompletely circumscribed compound proliferation of melanocytes. Within the epidermis, which is psoriasiform in some areas and thinned in others, there are single melanocytes and nests distributed broadly. Many of these melanocytes are arrayed in lentiginous fashion along the sides and bases of rete ridges, and limited scatter of melanocytes into the stratum spinosum can also be seen. In fibrotic perijunctional dermis below this, there are partially-maturing nests, cords, and fascicles of similar melanocytes. Many melanocytes, both epidermal and dermal, have scant finely melanized cytoplasm. In the upper dermis, scattered melanophages can be seen. There is also an element of reticular dermal elastosis.	Four outside slides, 11DP1358:A.  One corresponding block received 3-17-11.	R/O MELANOMA	\N	\N	\N	Our differential diagnosis included a fibrotic dysplastic nevus on one hand and nevoid melanoma on the other, and based solely upon conventional microscopy I favored the latter possibility as most likely. In an effort to provide a more definitive analysis of this proliferation, we completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 6p and loss in chromosome 7q. The gain in chromosome 6p includes the location of the RREB1 gene, and mutations in RREB1 are common to melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has confirmed a diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage T1a per the 2009 revision of the AJCC staging system. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.7 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	133596	1641	\N	\N	11-18560	\N	SYNAT507	2010-2017	IP1007998	AirTable blocks_with_IP_info.csv
10657	99-15313	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Iwei Acral Melanoma	\N	There is a proliferation of atypical melanocytes, arranged as\nconfluent nests at the junctions with focal pagetoid spread, with\nextension of smaller but cytologically atypical melanocytes into the\nsubjacent dermis.  Squamatization of eccrine ducts in prominent.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.3 cm in\nthickness.	\N	\N	\N	\N	A PAS-D stain ordered at the time that this specimen was grossed in does not reveal dermatophytes.	MELANOMA, INVOLVING ACRAL SKIN, 2.0 MM IN THICKNESS; FINAL THICKNESS TO AWAIT COMPLETE EXCISION	173622	1853	\N	\N	99-15313	A	SYNX450	\N	IP190846	Consolidated_data_final.csv
1407	10-74513	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a domed, hypercellular compound proliferation of slender spindled melanocytes distributed as irregular fascicles in compound fashion. The background epidermis is acanthotic in irregular fashion. Toward one edge of the specimen, vertically-oriented and incompletely-maturing fascicles of said melanocytes can be seen, and the dermis encompassing them is coarse and vascularized. Within large fascicles, occasional juxtaposed neutrophils, occasional single necrotic melanocytes, and occasional melanocytes in mitosis can be found. Toward one edge of the specimen, there is an area of lesser cellularity that shows a greater degree of maturation with descent.	Seven outside slides, DN10-034669 and one corresponding block.	DF/NEVUS	\N	\N	\N	Our differential diagnosis included a hypercellular Spitz nevus on one hand and spitzoid melanoma on the other, and the latter possibility proves to represent the correct classification for this tumor. To more fully establish the nature of this process, we completed comparative genomic hybridization via an array methodology (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gains in chromosomes 1q, 6p, 7, and 19, and losses in chromosomes 6q, 9, and 16q were also apparent. The documentation of multiple chromosomal anomalies is strongly supportive of the above diagnosis of melanoma. The above microstage thickness measurement is provisional and should be revised once complete excision has been accomplished. This melanoma is nonulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF AT LEAST 1.4 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173508	1637	\N	\N	10-74513	\N	SYNAT508	2010-2017	IP969092	AirTable blocks_with_IP_info.csv
1409	10-80009	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a dome-surfaced proliferation of large oval melanocytes involving the junctional zone, a thickened papillary dermis and the upper portion of the reticular dermis centered around a folliculosebaceous unit. The lesion is relatively symmetrical, and well circumscribed. Only a few junctional nests are present, with slightly increased numbers of single melanocytes, mostly over the apex of the lesion. The superficial dermal portion of the proliferation consists of cells with abundant amphophilic cytoplasm and pleomorphic, vesicular nuclei, some of which have large and/or multiple nucleoli. Somewhat smaller cells are seen in smaller aggregations toward the base of the lesion. Several deep mitotic figures are evident, including one within a high power microscopic field of the deep edge of the lesion (a so-called marginal mitosis).	Three outside slides, DE-10-012089:A1.	SPITZ NEVUS	\N	\N	\N	The enclosed images appear to show a relatively low Ki-67 labeling rate in a two-color immunoperoxidase stain (some positive nuclei are present in the enclosed Ki-67 stain, but it is difficult to evaluate how many are in melanocytes). I agree that this lesion has several features that push the limits for the diagnosis of Spitz's nevus, including a relatively thin epidermis, above-average nuclear pleomorphism and the presence of several deep mitotic figures. There are many dermatopathologists who would classify this as a so-called atypical Spitz tumor, a diagnostic term that is, unfortunately, used in different ways by different observers. However, it captures the sense that the lesion does not conform to the standard features of a Spitz's nevus, but does not have sufficiently atypical findings for an outright diagnosis of melanoma. Comparative genomic hybridization with an array based method shows an isolated gain involving the terminal end of 7q. This aberration, when seen without other gains or losses usually occurs in benign lesions (similar to gains of 11p). Hence, an unusual Spitz's nevus is the most likely finding. A narrow re-excision would still be appropriate.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	173525	1638	\N	\N	10-80009	\N	SYNAT509	2010-2017	IP974588	AirTable blocks_with_IP_info.csv
1417	10-91484	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show an asymmetrical, incompletely circumscribed, compound proliferation of enlarged spindled and epithelioid melanocytes with finely melanized cytoplasm. Within the background epidermis, which is slightly acanthotic, there are single melanocytes and nests distributed nearly confluently, and prominent suprabasal scatter is appreciable. In the dermis below this, there are partially-maturing nests, cords, and syncytia of cytologically similar melanocytes, and scattered dermal melanophages and lymphocytes can also be seen.	Two outside slides, S-10-29362:1A and one corresponding block.	CLAIMS HAS NOTICED FOR 1 1/2 YEARS AND IS INCREASING IN SIZE; NEVUS	\N	\N	\N	My differential diagnosis included a peculiar melanocytic nevus on one hand and melanoma on the other, and I believe the latter possibility represents the best interpretation of this atypical melanocytic proliferation. To more fully evaluate this tumor, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated clear loss of chromosome 9 with possible gain in chromosomes 5 and 7. (Because of a technical shortcoming, we repeated the molecular analysis; I apologize for the delay this provoked.) Loss in chromosome 9 is a common molecular event in association with melanoma and lends support to the above interpretation. This melanoma is non-ulcerated and displays associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.1 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173765	1639	\N	\N	10-91484	\N	SYNAT510	2010-2017	IP986063	AirTable blocks_with_IP_info.csv
10393	K1_20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1695	\N	\N	\N	\N	SYNX292	\N	\N	Consolidated_data_final.csv
3172	BN_M2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1803	\N	\N	None	\N	SYNAT587	2010-2017	\N	AirTable blocks_with_IP_info.csv
1390	10-32987	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular and adventitial dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages, and the stroma is focally sclerotic.	Cylindrical skin segment measuring 0.6 cm in diameter x 0.6 cm in thickness, bisected and entirely submitted.	4 MM BLUE PAPULE; BLUE NEVUS, R/O MELANOMA	\N	\N	\N	None	DEEP PENETRATING NEVUS (A VARIANT OF BLUE NEVUS)	173611	1696	\N	\N	10-32987	\N	SYNAT511	Deep Penetrating Nevus	IP927561	AirTable blocks_with_IP_info.csv
1208	06-08042	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a nodular and somewhat wedge-shaped proliferation of slightly spindled and epithelioid melanocytes, most of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis in bulbous fashion. Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous. There are interspersed melanophages in large numbers.	Cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted.	DARK BLUE NODULE; ANGIOMA, BLUE NEVUS, R/O ATYPIA	\N	\N	\N	This lesion could also be interpreted as an epithelioid blue nevus.	DEEP PENETRATING NEVUS	173611	1697	\N	\N	06-8042	\N	SYNAT512	Deep Penetrating Nevus	IP553108	AirTable blocks_with_IP_info.csv
1427	11-699	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show acral skin with a deep dermal and subcutaneous fibrotic mass containing nests of melanocytes with abundant amphophilic cytoplasm and moderately enlarged oval vesicular nuclei, some of which are diffusely hyperchromatic. There are scattered pyknotic nuclei. Mitotic figures appear rare.	Eleven outside slides (ten unstained), S10-55992 (S10-2413).	MELANOCYTIC TUMOR SUBMITTED FOR COMPARATIVE GENOMIC HYBRIDIZATION, LINEAGE ESTABLISHED AS MELANOCYTIC BY IMMUNOPEROXIDASE STAINS AT SLOAN-KETTERING	\N	\N	\N	Comparative genomic hybridization shows an area of loss involving the long arm of chromosome 7, with a gain of the distal portion of the long arm of chromosome 7. The data from this case has been forwarded to Dr. Boris Bastian to try to determine where the breakpoint in this aberrant area is. There is also an area of loss in the terminal portion of chromosome 16q. The findings favor classification as melanoma. Given the monomorphous nuclei and the age of the patient, this may represent a variant with a prognosis different from that which would be inferred by the lesional thickness.	INTRADERMAL PROLIFERATION OF LARGE, SOMEWHAT SPITZOID MELANOCYTES	174789	1640	\N	\N	11-699	\N	SYNAT513	2010-2017	IP990136	AirTable blocks_with_IP_info.csv
1447	11-20772	29	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a sessile polypoid compound proliferation of large spindled and epithelioid melanocytes, the sparse junctional component of which is arrayed with the lowermost sections of an epithelium that is slightly acanthotic and hyperkeratotic. The dermal component contains similar melanocytes in clusters and sheets. There are rare mitotic figures. The papillary dermis is edematous.	Six outside slides, D11-10315 and one corresponding block.	R/O PYOGENIC GRANULOMA	\N	\N	\N	Thank you for your kind accompanying letter. I agree with you that while a Spitz's nevus seemed possible in initial sections, there are some unconventional features, and rare mitoses are evident in the dermal component, raising the possibility of Spitzoid melanoma. The enclosed Ki-67 immunoperoxidase stains indicates a low proliferation index, however. As you suggested, we performed comparative genomic hybridization to determine whether this tumor contains clonal DNA copy number changes that may be of value in the differential diagnosis. This reveals multiple aberrations, including losses or gains affecting nearly all of chromosomes 7, 8, and 9, and gains on chromosome 5. These results strongly support a diagnosis of melanoma. Of note is that none of these aberrations would have been detected via fluorescence in situ hybridization, and these aberrations are not those associated with spitzoid melanoma of childhood. I have shared this case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with this diagnosis. Histopathologic features of possible prognostic importance include the following. Definitive assessment of prognostic features should be deferred to the excision specimen.  Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: greater than 1/sq mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: cannot assess AJCC stage: T3a preliminary	COMPOUND PROLIFERATION OF LARGE SPINDLED AND EPITHELIOID MELANOCYTES, GENOMICALLY MELANOMA, AT LEAST 3.9 MM IN THICKNESS, EXTENDING TO THE SPECIMEN BASE	173719	1642	\N	\N	11-20772	\N	SYNAT514	2010-2017	IP1010210	AirTable blocks_with_IP_info.csv
1445	11-19877	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a predominantly dermal proliferation of melanocytes partially encompassed by epithelial collarettes, with a protuberant configuration. The lesional melanocytes are arranged in discrete nests, cords and strands. Most are plump, oval to small round melanocytes that mature with descent, with a minor population of melanocytes with large, oval vesicular nuclei and more prominent nucleoli.	One outside slide, K05-13644.	SECOND OPINION, "RECURRENT NEVUS	\N	\N	\N	None	MELANOMA, 1.1 MM IN THICKNESS	173688	1643	\N	\N	11-19877	\N	SYNAT515	2010-2017	IP1009315	AirTable blocks_with_IP_info.csv
1468	11-35616	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a sizable, deeply-situated, multinodular dermal and subcutaneous proliferation of enlarged slightly spindled and epithelioid melanocytes, some of which have finely melanized cytoplasm. Others have amphophilic cytoplasm. Gargantuan collections of cells are enmeshed in a sclerotic backdrop in concert with a juxtaposed lymphohistiocytic infiltrate, and melanocytes in mitosis can be found.	Six outside slides, S11-16670 (including 5 unstained slides).	BULKY MELANOCYTIC TUMOR	\N	\N	\N	We completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies, per your request. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrates possible loss in distal chromosome 4p and loss in chromosomes 7q and 11 (in actual fact, there are both gains and losses in chromosome 7q; the observed pattern is quite exceptional). There is gain in chromosomes 5p, 8, 9p, 14p, and 20. The presence of multiple chromosomal copy number changes corroborates the above diagnosis of melanoma. Given the number and diversity of the chromosomal aberrations that have been found, the more favorable prognosis that is associated with so-called childhood-type spitzoid melanoma cannot be expected here. I do not have the full thickness of this melanoma apparent in the sections available to me, and thus the above thickness measurement is provisional. This melanoma invades deep into the subcutis and approaches superficial skeletal muscle.	SPITZOID MELANOMA EXCEEDING 6 MM IN THICKNESS	173712	1644	\N	\N	11-35616	\N	SYNAT516	2010-2017	IP1025054	AirTable blocks_with_IP_info.csv
1465	11-33856	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a broad, somewhat asymmetrical, and incompletely circumscribed compound proliferation of enlarged slightly spindled and epithelioid melanocytes. Only small numbers of melanocytes are distributed along the junction. Within the dermis, there are nests, cords, and fascicles of melanocytes that are similar to those seen intraepidermally, and these cells are entrapped in a coarse collagenous matrix. In some areas, a subjacent lymphohistiocytic infiltrate can be seen, and some of the dermal melanocytes have fine cytoplasmic melanization. Only an occasional melanocyte in mitosis can be found.	One outside slide, S-11-12116:A1-1. One corresponding block received 5-23-11.	LESION RECENTLY CHANGING IN COLOR AND SIZE	\N	\N	\N	Our differential diagnosis for this proliferation included an unconventional Spitz nevus on one hand and melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show increased nuclear expression of Ki-67, especially in the upper dermis, thus implying that cellular proliferation is elevated. This staining result was of potential concern but is not diagnostically decisive. In light of diagnostic ambiguity, we next pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 11p. A small segmental loss in chromosome 14q was also noted. Gain in chromosome 11p is commonly found as an aberration in desmoplastic Spitz tumors with associated HRAS mutation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH analysis points to interpretation as an unconventional (HRAS-mutated) Spitz nevus. This proliferation is focally transected at the periphery of the current specimen. Further excision is recommended to ensure that local eradication has been accomplished.  A pertinent reference can be found at the following citation: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND SPITZOID NEOPLASM, CONSISTENT WITH A DESMOPLASTIC COMPOUND SPITZ NEVUS	173600	1645	\N	\N	11-33856	\N	SYNAT517	2010-2017	IP1023294	AirTable blocks_with_IP_info.csv
10806	Dummer-KF1-Met2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.18/I 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1941	\N	\N	\N	\N	SYNX538	\N	\N	Consolidated_data_final.csv
11035	S12-23475C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Lymph Node Metastasis	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2090	\N	\N	\N	\N	SYNX687	\N	\N	Consolidated_data_final.csv
11036	13-21725	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	Sections show an area of inflammation and granulation tissue, with no evidence of a lymphoma.	Ellipse measuring 2.2 x 0.9 x 0.2 cm, including a central 0.5 x 0.5 cm pink tan area.  With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with ten sections. HD/HD	\N	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL LYMPHOMA	173620	2091	\N	\N	13-21725	A	SYNX688	\N	IP1175186	Consolidated_data_final.csv
1476	11-38771	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show enlarged epithelioid melanocytes arrayed in compound fashion. Within the acanthotic epidermis, single melanocytes and nests that vary in size can be seen. Non-maturing nests, small syncytia, and cords can be seen in fibrotic upper dermis, and some of these melanocytes are captured in mitosis. The background epidermis, while generally acanthotic, is focally thinned.	One outside slide, BT11-09846 (DC11-2858), and one corresponding block, BT11-09846.	TRAUMATIZED MELANOCYTIC NEOPLASM FROM THE FOOT	\N	\N	\N	Based upon conventional microscopy, I believe this proliferation represents melanoma. Per your request, we completed array-based comparative genomic hybridization (aCGH) to screen this tissue for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated focal gain in chromosome 1p, gain in chromosome 7q, and losses in chromosomes 1p, distal 1q, 2p, and 14q. As you know, the identification of multiple genomic gains and losses is incompatible with a diagnosis of melanocytic nevus and points squarely to a diagnosis of melanoma. Given the number of aberrations that are present here, I believe this malignancy represents conventional melanoma and not a form of childhood-type melanoma. This melanoma is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.75 MM IN THICKNESS, FOCALLY TRANSECTED AT THE SPECIMEN PERIPHERY	173713	1646	\N	\N	11-38771	\N	SYNAT518	2010-2017	IP1028210	AirTable blocks_with_IP_info.csv
1478	11-39639	11	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a dome shaped segment of skin with a few well formed junctional nests of melanocytes with abundant, pale cytoplasm and pleomorphic, heterochromatic nuclei, and irregularly shaped aggregations of similar cells, as well as ones with scant cytoplasm in the subjacent dermis. These are positioned between collagen bundles in the superficial reticular dermis toward the base of the lesion. The nuclei are crowded together in some foci. The enclosed immunoperoxidase stains show that no melanocytic nuclei are positive for the mitotic marker, phosphohistone H3.	Three outside slides, D11-18326 A and one corresponding block.	PINK PAPULE; SPITZ NEVUS	\N	\N	\N	The neoplasm extends to the base of the specimen. Comparative genomic hybridization shows losses involving chromosomes 7p and 9q. Such focused gains or losses, involving only parts of chromosomes rather than whole ones are not seen in so-called proliferating nodules in congenital nevi. Chromosome 9 losses are common in melanoma. The small size of the cells indicates that this is a nevoid or small cell melanoma. The latter is one of the few forms of melanoma that can occur in children. The configuration suggests that this lesion will be (after complete excision) less than 2 mms, and is most likely T2a in the 2009 AJCC staging schema for melanoma.	MELANOMA, 1.2 MM. IN THICKNESS	173721	1647	\N	\N	11-39639	\N	SYNAT519	2010-2017	IP1029078	AirTable blocks_with_IP_info.csv
10608	11-75173	52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Iwei DPN (Control Normal Nevus)	\N	Sections show a compound proliferation of melanocytes composed of single cells and nests along the sides and bases of elongated rete ridges. Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the superficial reticular dermis.  Overlying rete ridges are elongated and interanastomosing.	Skin segment measuring 1.0 x 0.6 x 0.4 cm, bisected and entirely submitted.\n	\N	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173525	1829	\N	\N	11-75173	A	SYNX426	\N	IP1064620	Consolidated_data_final.csv
1246	06-32942	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a broad, asymmetrical, compound proliferation of large and strikingly atypical spindled melanocytes, extensively involving both epidermis and dermis. Along the junction, there are nests and fascicles of melanocytes disposed erratically and somewhat confluently, and many intraepidermal nests are large and irregular. There are confluent nests and fascicles of melanocytes distributed throughout the upper reticular dermis, with little maturation with dermal descent and with dermal mitotic figures readily identifiable. The background epidermis is acanthotic and hyperkeratotic and is centrally partially ablated by ulceration, with superjacent exudate and crust.	Skin segment measuring 1.2 x 0.9 x 0.4 cm, trisected and entirely submitted.	MELANOMA	\N	\N	\N	In terms of staging, this is a focally ulcerated melanoma with a nodular invasive component, with extensive involvement of the reticular dermis (Clark's level IV). I do not see any evidence of vascular invasion, perineural extension, or regression. Further re-excision of this site is of course warranted to be certain that local eradication has been accomplished.	MELANOMA OF 3.3 MM IN THICKNESS, FOCALLY TRANSECTED AT THE DEEP BIOPSY MARGIN	222533	1649	\N	\N	06-32942	\N	SYNAT520	Spitzoid Melanoma	IP578011	AirTable blocks_with_IP_info.csv
1250	06-52508	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show an asymmetrical, compound proliferation of melanocytes, many of which have atypical nuclei, many of them with a spindled configuration. There is adnexal extension, focal confluence of junctional melanocytes, and also, adnexal extension. Suprabasal scatter of melanocytes is also present. There are irregular clusters of similar melanocytes in the underlying dermis. There is a bandlike infiltrate of lymphocytes in the papillary dermis. The overlying epidermis is thickened and hyperkeratotic.	Skin segment measuring 0.8 x 0.8 x 0.4 cm, margins inked blue, trisected and entirely submitted.	SINGLE PPP X 3 MONTHS	\N	\N	\N	This neoplasm has some cytologic and architectural features in common with a Spitz's nevus. However, atypical melanocytes are focally confluent, there is significant adnexal extension, as well as significant suprabasal scatter of melanocytes. These changes are in keeping with melanoma. In addition, it appears in slightly sun-damaged skin. In terms of staging, this is a thin primary melanoma, non-ulcerated, of Clark's anatomic level II. The dermis is partially obscured by a dense lichenoid infiltrate, and the thickness above is my best judgment in this context. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Complete reexcision is of course warranted. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with the diagnosis of melanoma.	MELANOMA, APPROXIMATELY 0.5 MM IN THICKNESS, WITH MELANOMA IN SITU EXTENDING CLOSE TO PERIPHERAL MARGINS	173536	1650	\N	\N	06-52508	\N	SYNAT521	Spitzoid Melanoma	IP597577	AirTable blocks_with_IP_info.csv
10560	RC11-024	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1798	\N	\N	\N	\N	SYNX395	\N	\N	Consolidated_data_final.csv
10612	12-66661	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.1	Iwei DPN  	\N	Sections show a melanocytic proliferation composed of cells with two distinct cytologic appearances.  One population is composed of cells with abundant pale cytoplasm, arranged in small clusters accompanied by melanophages. The other consists of small melanocytes with round to oval nuclei, arranged in nests and cords.	Two skin segments, one measuring 0.45 x 0.3 x 0.1 cm and the other 0.35 x 0.2 x 0.1 cm, both submitted intact.   SL/SL	\N	\N	\N	\N	The nevus has combined components, the deep penetrating nevus portion of which may account for a darker portion clinically. This is a benign variant that has also been given other names such as clonal nevus and others.	COMBINED MELANOCYTIC NEVUS, WITH COMPONENTS OF ORDINARY MELANOCYTIC NEVUS AND DEEP PENETRATING NEVUS	173121	1832	\N	\N	12-66661	A	SYNX429	\N	IP1152477	Consolidated_data_final.csv
1268	07-04365	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show an asymmetrical, compound proliferation of melanocytes, many of which have atypical nuclei. Many of the junctional melanocytes have spindled or epithelioid cytology, and there are some perimelanocytic clefts. There are many melanocytes present above the basal layer. The epidermis is thinned overlying some of the junctional nests. Small Kamino bodies are evident. There are irregular clusters of similar melanocytes in the underlying dermis, and also, a subtle population of perhaps slightly smaller melanocytes towards the base. These are in continuity with larger melanocytes in general, however. The overlying epidermis is thickened and hyperkeratotic, and there are also areas of thinning of the epidermis as noted. The proliferation is fairly well-circumscribed, although there are minor defects in lateral circumscription noted. There is surrounding slight solar elastosis, and a patchy lymphocytic infiltrate. The papillary dermis is focally fibrotic.	Slightly irregular ellipse, 1.7 x 1.1 x 0.3 cm, including a central brown 0.7 x 0.5 cm area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	R/O MELANOMA	\N	\N	\N	This example of melanoma has a pattern reminiscent of that seen in a Spitz's nevus. However, it is broad, markedly asymmetrical, and demonstrates focal defects in circumscription. There are even occasional Kamino bodies, which are relatively small but well formed, a feature also seen in Spitz's nevi. There is a population of somewhat smaller cells in some areas as well. Thus, although this would be an unusual occurrence, we cannot completely exclude the possibility of melanoma arising in a background of Spitz's nevus. I have also shared this case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with these findings. In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level at least III, filling and expanding the papillary dermis. I cannot completely exclude the possibility of superficial involvement of the reticular dermis, as the interface is obscured by the tumor and by a lymphocytic infiltrate. There is no evidence of vascular invasion, neurotropism, or regression. There are also no microsatellites noted. Complete excision is of course warranted.	MELANOMA, WITH SPITZOID FEATURES, 0.8 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 2 MM OF THE PERIPHERAL MARGIN	173701	1651	\N	\N	07-4365	\N	SYNAT522	Spitzoid Melanoma	IP617346	AirTable blocks_with_IP_info.csv
1273	07-14044A	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show an asymmetrical, poorly circumscribed, compound proliferation of melanocytes, many of which have atypical nuclei. There are irregular clusters of similar melanocytes in the underlying dermis. Many of the melanocytes are spindled or epithelioid, and some perimelanocytic clefts are evident. Melanocytes are scattered above the basal layer. Mitotic figures are evident within the dermal component which fails to mature with descent in the dermis. The overlying epidermis is thickened and hyperkeratotic. There is focal hemorrhagic crust.	Oval excision, 1.1 x 0.8 x 0.3 cm, including a central 0.7 x 0.5 cm lesion.  With margins inked blue, the specimen is serially quadrisected perpendicular to the long axis and entirely submitted.	R/O MELANOMA	\N	\N	\N	Although there are some features reminiscent of a Spitz's nevus, this is a markedly asymmetrical and poorly circumscribed neoplasm. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level IV, expanding the papillary dermis and involving the superficial reticular dermis. There is no evidence of vascular invasion, neurotropism, or regression. Complete excision is of course warranted.	MELANOMA, 1.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS CLOSE TO THE PERIPHERAL MARGIN	173601	1652	\N	\N	07-14044	A	SYNAT523	Spitzoid Melanoma	IP636575	AirTable blocks_with_IP_info.csv
1277	07-26247	46	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a compound proliferation of large spindled and epithelioid melanocytes, the junctional component of which is arrayed with the lowermost sections of an epithelium that is slightly acanthotic and hyperkeratotic. The junctional component is asymmetrical, and extends far lateral to the dermal component at one edge.  Rare melanocytes are positioned above the basal layer, and there is focal crust and serum.  The dermal component is also asymmetrical.  It consists of large and small clusters and syncytia of similar melanocytes, with slight dispersion of the base, but with little diminishment in size with the dermal descent.  Many mitotic figures are identifiable within the dermal component, in the superficial and mid dermal components mainly. Minimal solar elastosis is evident.	Skin segment measuring 1.2 x 0.7 x 0.3 cm, bisected (fragmented upon embedding into 3 pieces) and entirely submitted.	HAD RED SPOT BELOW RT PATELLA 5 MONTHS AGO, CENTER TURNED BLACK, HAS BLED TWICE AFTER CUT IT SHAVING HER LEG, THE GROWTH IS 8 X 12 MM WITH 6 MM BLACK PAPULE IN CENTER - FLESH AREA, SUPERIORLY IS REDDISH, FLAT AREA BELOW IT IS LIGHT BROWN	\N	\N	\N	We have examined this problematic lesion on several occasions since its receipt. Although there are some features similar to those seen in a Spitz's nevus, and in fact, we considered an unusual Spitz's nevus as an alternative diagnosis, this proliferation is markedly asymmetrical.  In addition, mitotic figures are readily evident within the dermal component.  I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees that melanoma is a more appropriate diagnosis based on these findings. In terms of staging, this is a nonulcerated primary melanoma of Clark's anatomic level at least IV. There is no evidence of vascular invasion, neurotropism, or regression. Definitive assessment of thickness as well as other prognostic factors should also be deferred to the complete excision specimen.	MELANOMA, AT LEAST 2.3 MM IN THICKNESS, EXTENDING TO THE EDGES AND BASE OF THE SPECIMEN	32765	1653	\N	\N	07-26247	\N	SYNAT524	Spitzoid Melanoma	IP208441	AirTable blocks_with_IP_info.csv
1670	13-3732	36	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show melanocytes arrayed in largely dermal fashion. Superficially, there are large nests and syncytia of enlarged epithelioid melanocytes in the upper dermis, and these melanocytes have finely melanized cytoplasm. In a recut section, some of these melanocytes appear spitzoid. More deeply, there are fusiform and dendritic melanocytes that are much smaller residing in the reticular dermis, and interstitial melanophages can be seen.	Four outside slides, CSI-13-225, and one corresponding block.	4 MM BROWN FIRM PAPULE, (+) PIGMENTED AT BASE, ONSET 2 YEARS AGO, INCREASING IN SIZE + COLOR CHANGES X 1 YEAR, 2 SECTIONS IN BOTTLE, PROCESS ALL FRAGMENTS; SK, RULE OUT MM	\N	\N	\N	ADDENDUM, February 8, 2013: As I reported previously, my differential diagnosis included a variant of cellular blue nevus, a combined melanocytic nevus, and melanoma ex blue nevus. Your submitted immunostains demonstrate avid expression of HMB-45, as would be expected with a blue nevus or blue nevus-like melanoma. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show slightly elevated nuclear expression of Ki-67, thus implying that cellular proliferation is elevated, which is of potential concern. A p16 immunostain demonstrates preservation of expression, which implies that an underlying anomaly in chromosome 9p is not present. This is the type of challenging case for which array-based comparative genomic hybridization (aCGH) can be applied to screen for genomic copy number anomalies, as can be seen with melanoma. Per your request and approval, completed molecular assessment. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 7, 8, and 22q. The identification of multiple chromosomal copy number aberrations indicates genomic instability, as is stereotypical of malignancies such as melanoma. The aCGH profile that we have defined is incompatible with a benign interpretation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH demonstrates that this atypical melanocytic tumor represents melanoma that has developed secondarily in a blue nevus. This entity can be referred to as 'blue nevus-like melanoma'. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration in the current sections. Therefore, it provisionally represents melanoma of stage pT2a (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.  This report was reissued on April 24, 2014, to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF AT LEAST 1.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A BLUE NEVUS	100678	1661	\N	\N	13-3732	\N	SYNAT525	2010-2017	IP1188475	AirTable blocks_with_IP_info.csv
10798	DM32	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1935	\N	\N	\N	\N	SYNX532	\N	\N	Consolidated_data_final.csv
1350	09-37302	66	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed, compound proliferation of spindled to epithelioid melanocytes, many of which have atypical nuclei, arrayed as irregular nests and single melanocytes within the epidermis, with adnexal extension, and areas of suprabasal scatter.  There are irregular clusters of similar melanocytes in the underlying papillary dermis along with some slightly smaller ones.  The overlying epidermis is thickened, with intertwining rete. There is a patchy infiltrate of lymphocytes.	Ellipse, 1.0 x 0.7 x 0.5 cm. With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.\n	IRRITATED SK VS. OTHER	\N	\N	\N	This is a non-ulcerated melanoma with associated Clark's level II invasion. The measurement of thickness may be a slight overestimate, as there is epidermal hyperplasia. There is no evidence of associated vascular invasion, perineural invasion, or regression.	MELANOMA, 0.8 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE PERIPHERY OF THE BIOPSY	529698	1654	\N	\N	09-37302	\N	SYNAT526	Spitzoid Melanoma	IP838065	AirTable blocks_with_IP_info.csv
1647	12-79358	25	\N	\N	1	T1b	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	There is a compound proliferation of melanocytes mostly involving the superficial dermis. The surface is slightly domed and slightly papillated. The predominant population consists of large oval melanocytes with pale, variably vacuolated and lightly pigmented cytoplasm with relatively monomorphous oval vesicular nuclei that contain small nucleoli. There are large aggregations of these cells within dermal papillae, and progressively smaller ones, with cytologic maturation toward the upper reticular dermis. Additionally, discrete nests of small round melanocytes are present.	One outside slide, PD903226 / A, and one corresponding block.	DYSPLASTIC NEVUS VS. IRRITATED NEVUS	\N	\N	\N	The differential diagnosis included a combined (deep penetrating or Spitz) and superficial congenital nevus, and melanoma arising in a nevus. Comparative genomic hybridization shows losses involving chromosomes 9p, areas of both 10 p and q and 14. Losses involving chromosomes 9p and 10 are among the most commonly seen in melanoma. While the lesion is not ulcerated, the presence of a melanocytes in mitosis in the dermis (low mitotic rate, 1 per mm2) qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma. A pre-existent melanocytic nevus with congenital features is also present.	MELANOMA, 0.7 MM. IN THICKNESS	173611	1655	\N	\N	12-79358	\N	SYNAT527	2010-2017	IP1165175	AirTable blocks_with_IP_info.csv
10808	Dummer-KF2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.19/D 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1943	\N	\N	\N	\N	SYNX540	\N	\N	Consolidated_data_final.csv
10681	BN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Blue Nevus Normal	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1870	\N	\N	\N	\N	SYNX467	\N	\N	Consolidated_data_final.csv
1649	12-81302	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	A shave biopsy has been removed in multiple layers. In the superficial portions of the specimen, there is the surface of a compound proliferation of melanocytes, and central ulceration is prominent. To the side of the ulceration, single melanocytes and nests are sparsely distributed within the epidermis. In the dermis below this, non-maturing nests and sheets of similar melanocytes are apparent. In deeper segments of tissue, there are also similar non-maturing nests and large aggregations. Many of the constituent melanocytes in the dermis have amphophilic or finely melanized cytoplasm, and a juxtaposed infiltrate of lymphocytes and melanophages is also noted.	Three outside slides, WCS-12-06587 (R12-21441/DC12-5467).  One corresponding block received 10-29-12.	RIGHT DORSAL FOOT LESION; REFERRAL FOR POSSIBLE CGH TESTING	\N	\N	\N	Based upon attributes evaluated by conventional microscopy, I believe this tumor represents melanoma. Per your request, we additionally completed array-based comparative genomic hybridization (aCGH) to screen this tumor for chromosomal copy number abnormalities, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 1q and loss in chromosomes 1p and 9. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is typical of malignancies such as melanoma. This melanoma is probably best considered to represents an example of 'childhood-type spitzoid melanoma'. This designation refers to an emerging entity that we believe may be prognostically distinct from conventional adult melanoma. Such tumors commonly lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination (in comparison to conventional adult melanoma).  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. This tumor is ulcerated, but the mother has reported to me that pressure from distance running shoes may have been contributory to surface erosion. The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	MELANOMA OF AT LEAST 1.8 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173788	1656	\N	\N	12-81302	\N	SYNAT528	2010-2017	IP1167119	AirTable blocks_with_IP_info.csv
1650	12-81749	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a small excisional specimen that harbors a compound proliferation of enlarged fusiform and epithelioid melanocytes. A modest number of giant fascicles of these melanocytes are distributed asymmetrically along the junction, and portions of the background epidermis show irregular acanthosis. In fibrotic dermis below this, there are large nests, cords, and fascicles of similar melanocytes that extend through the reticular dermis into the upper subcutis. The melanocytes diminish slightly in size with descent in the dermis, but many melanocytes in mitosis can be found, including mitotic figures within deep melanocytic aggregates. The fibroplasia that is present stems, in part, from a prior biopsy in this region.	Six outside slides, S12-41686 / 1 (RS12-11612 / B), including five unstained slides.	R/O MELANOMA, REVIEW AND CGH ANALYSIS	\N	\N	\N	Our differential diagnosis included a highly unconventional Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. As per your request, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number abnormalities, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As you know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, the results of our assessment favor interpretation as an unconventional melanocytic nevus. Please note that this melanocytic proliferation focally involves the deep edge of the current specimen. Reexcision may be necessary to ensure that local eradication has been accomplished. Close clinical follow-up of the specimen site is warranted at a minimum.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, CONSISTENT WITH AN UNCONVENTIONAL COMPOUND SPITZ NEVUS	173201	1657	\N	\N	12-81749	\N	SYNAT529	2010-2017	IP1167566	AirTable blocks_with_IP_info.csv
1654	12-97031	48	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a domed dermal proliferation of melanocytes arrayed as partially-maturing nests, cords, and small syncytia. The background epidermis is slightly acanthotic and is capped focally by parakeratosis. In the dermis, some perijunctional melanocytes are enlarged and epithelioid.	Four outside slides, DS12-132130 / A1, and one corresponding block. One additional slide (DS12-132130-A1 DC1) received 12/28/12.	R/O BASAL CELL CARCINOMA	\N	\N	\N	ADDENDUM, January 18, 2013: As I indicated previously, cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. Similar to what was seen in your special stain, the MART-positive cells show low nuclear expression of Ki-67, thus implying that cellular proliferation is very low. This finding can be seen in association with melanocytic nevi but is not definitively diagnostic (a low cell proliferation index can also be seen in the context of nevoid melanoma). One of your original slides demonstrates multiple melanocytes in mitosis, and this finding proved to be worrisome for melanoma. To further clarify the nature of this tumor, we completed comparative genomic hybridization (CGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 1q and 7 as well as loss in chromosomes 9, 10q, and 22q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of malignancies such as melanoma. The genomic profile that we have defined excludes a melanocytic nevus from the differential diagnosis.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has confirmed the diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness and lacks associated ulceration, yet melanocytes in mitosis are detectable in its invasive component. Therefore, this provisionally represents melanoma of stage pT1b (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	NEVOID MELANOMA OF AT LEAST 0.8 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173702	1658	\N	\N	12-97031	\N	SYNAT530	2010-2017	IP1182848	AirTable blocks_with_IP_info.csv
1657	12-98736	68	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show enlarged epithelioid and fusiform melanocytes arrayed in compound fashion with lateral extension of the intraepidermal component. There are single melanocytes and nests and fascicles of melanocytes in acanthotic epidermis, and some scatter in the stratum spinosum is appreciable. Rare small pink globules are noted. In the dermis, there are nests, cords, and small syncytia of similar melanocytes, and some melanocytes seem to have granular cytoplasm. Partial maturation is noted.	Three outside slides, PC12-352427-HD and one corresponding block.	LESION IS SAID TO HAVE BEEN PRESENT FOR QUITE SOME TIME	\N	\N	\N	ADDENDUM, January 25, 2013: As I reported previously, our differential diagnosis included an unconventional Spitz nevus and nevoid/spitzoid melanoma. Your Ki-67 immunostain shows a low cell proliferation index, which is reassuring but not definitive. We also completed a p16 immunostain and demonstrated retention of positive expression, as can be seen with melanocytic nevi. Per your approval, we pursued array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 5q, 7, and 15q. The identification of multiple genomic copy number abnormalities suggests genomic instability and favors melanoma as most likely. However, some of the genomic aberrations that have been identified, such as gain in chromosome 15q, are not anomalies that are specific to melanoma (it can also be seen in some Spitz tumors).  In summary, the combination of results derived from conventional microscopy coupled with aCGH favors a diagnosis melanoma. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration. Therefore, it represents melanoma of stage pT2a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MELANOMA OF 1.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE SPECIMEN PERIPHERY	173628	1659	\N	\N	12-98736	\N	SYNAT531	2010-2017	IP1184553	AirTable blocks_with_IP_info.csv
1671	13-3874	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a protuberant compound proliferation of enlarged melanocytes with a partially polypoid profile. There are single melanocytes and nests and fascicles of melanocytes arrayed relatively confluently along the junction of a hyperkeratotic epidermis, and partially maturing nests, cords, and fascicles of melanocytes reside in the dermis below this, extending deeply. An element of superficial dermal edema is also noted.	One outside slide, DPR-12-11014:A1, and one corresponding block, DP12-11014:A1.	5 X 6 MM PINK PAPULE; SPITZ'S NEVUS VS. JXG	\N	\N	\N	Our differential diagnosis included an unconventional (and hypercellular) Spitz nevus and spitzoid melanoma. To more fully assess this differential diagnosis, per your request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As background for understanding this result, please note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our histopathologic and molecular assessment points to interpretation as a Spitz nevus. This melanocytic tumor appears narrowly excised in the available planes of section.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	PARTIALLY POLYPOID COMPOUND PROLIFERATION OF ENLARGED MELANOCYTES, CONSISTENT WITH A POLYPOID COMPOUND SPITZ NEVUS	173304	1660	\N	\N	13-3874	\N	SYNAT532	2010-2017	IP1188617	AirTable blocks_with_IP_info.csv
10609	12-167B	32	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Iwei DPN (Control Normal Nevus)	\N	Sections show nests, cords and strands of small, round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted in cassette B.	\N	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	333504	1830	\N	\N	12-167	B	SYNX427	\N	IP671051	Consolidated_data_final.csv
10799	DM35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1936	\N	\N	\N	\N	SYNX533	\N	\N	Consolidated_data_final.csv
1672	13-3889	27	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a broad-based proliferation of melanocytes extending from the junctional zone to the deep reticular dermis. The undersurface of the lesion has a jagged border. The epidermis is hyperplastic, with nests of small fusiform cells with lightly pigmented cytoplasm. The most striking findings are in the dermis, where thin fascicles and singly dispersed cells with large, diffusely hyperchromatic nuclei are present between thin but closely apposed collagen bundles. Maturation with descent is imperfect. Neither expansile-appearing aggregations nor mitotic figures in dermal melanocytes are evident. The enclosed immunoperoxidase-stained sections show an absence of HMB45 staining and a very low proliferative rate.	Ten outside slides, SH-12-0057700 A.1-A.2  Two corresponding blocks received 1-25-13.	FIRM PINK/BROWN PAPULE WITH AN ATYPICAL AREA OF PIGMENTATION; R/O DERMATOFIBROMA	\N	\N	\N	This unusual lesion has some features of a desmoplastic Spitz's nevus, but more nuclei are hyperchromatic than vesicular, and many, even toward the base of the lesion are quite large. Also, the undersurface is more irregular than in most desmoplastic Spitz nevi. For these reasons, we obtained comparative genomic hybridization on this challenging case. This showed a loss of chr. 7p, and a gain involving chr. 15q. Gains, rather than losses of chr. 7p are common in melanoma. Gains of 15q can be seen in melanoma, but usually in concert with other aberrations. Hence, the findings do not provide unequivocal support for melanoma, but do indicate copy number changes not seen in routine Spitz's nevi. I would re-excision this site, and consider this as a lesion with some metastatic potential. I would expect the behavior of a group of lesions with similar findings to these to be better than that of a group of melanomas of comparable thickness.	COMPOUND PROLIFERATION OF LARGE, ATYPICAL MELANOCYTES	173620	1662	\N	\N	13-3889	\N	SYNAT533	2010-2017	IP1188632	AirTable blocks_with_IP_info.csv
1673	13-4090B	50	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes that is well-circumscribed and symmetric. Large nests of melanocytes with moderately large nuclei and moderate amounts of pale cytoplasm are present at the size and bases of elongated rete ridges. Some adjacent rete ridges are fused at their bases and the underlying papillary dermis is fibrotic.  Centrally, the epidermis is effaced with large nests of melanocytes within sclerotic collagen below. There is a focal patchy lymphocytic infiltrate with scattered melanophages throughout the lesion.  The proliferation demonstrates even maturation with descent into the reticular dermis and there is a periadnexal distribution. One dermal mitosis is noted which may be within a melanocyte.	Ellipse, 2.2 x 1.3 x 0.8 cm, including a central 1.4 x 0.7 cm brown area. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections in cassette A, two sections each in cassettes B and C, and three sections in cassette D.  SL/SL	13 X 7 MM PURPLE BLACK CHANGING (LESION X 10 YRS), LAST MEASURED 3/2011 10 X 5 MM	\N	\N	\N	ADDENDUM, February 21, 2013: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) does not demonstrate mitoses within melanocytes, and only rare cells have nuclear phosphohistone H3 staining.  Comparative genomic hybridization shows gains of chromosome 1q, 6, and 15.  The presence of genomic aberrations in this melanocytic neoplasm argues that this represents melanoma and not a severely atypical dysplastic nevus. The lesion is greater than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T2a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 1.1 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	100556	1663	\N	\N	13-4090	B	SYNAT534	2010-2017	IP1188833	AirTable blocks_with_IP_info.csv
11037	SP-14-68521D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2092	\N	\N	\N	\N	SYNX689	\N	\N	Consolidated_data_final.csv
1674	13-4136	5	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a roughly wedge-shaped proliferation of large oval and fusiform melanocytes with abundant pale cytoplasm and large oval vesicular nuclei with prominent and sometimes multiple, large central nucleoli. A few mitotic figures are seen amongst the lesional cells. There are some melanocytes with scant cytoplasm and others whose nuclei appear to overlap. The overlying epidermis is irregularly hyperplastic, and subepidermal granulation tissue is focally evident.	Three outside slides, D13-556 / 1-3.  Three corresponding blocks received 1-28-13.	REEXCISION (SEE L12-93693).	\N	\N	\N	The residuum has some worrisome features. The changes in the initial biopsy suggested a minor population of cells with copy number aberrations involving whole chromosomes, a pattern usually seen in proliferative nodules rather than in atypical Spitz tumors or spitzoid melanomas. The same findings were seen in the repeat testing, indicating that the copy number aberrations are in a significant portion of the lesion, and not just in a minor component. I favor regarding this lesion as an atypical Spitz tumor and not just as a Spitz's nevus. The removal appears complete. While lesions of this type have a high probability of involving a sentinel lymph node, the predictive value of this for distant metastasis is very low.	HEALING BIOPSY SITE AND RESIDUAL INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	173305	1664	\N	\N	13-4136	\N	SYNAT535	2010-2017	IP1179510	AirTable blocks_with_IP_info.csv
1676	13-7186	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a broad, asymmetrical, and incompletely circumscribed compound proliferation of enlarged fusiform and epithelioid melanocytes. These cells are distributed singly and in nests and fascicles along the junction, and areas of thinning are noted. In the dermis below this, the constituent cells mature to form nests, sheets, and syncytia that fill and expand the papillary and superficial reticular dermis. The constituent melanocytes have amphophilic cytoplasm that is sometimes finely melanized, and scattered accompanying melanophages are noted. Only rare dermal mitotic figures can be found. The tumor thickness is 2.2 mm.	Four outside slides, SH-13-2468 (B1-B2) and corresponding block B2.	CHANGING MOLE X 10 YRS	\N	\N	\N	ADDENDUM, March 14, 2013: As I reported previously, my differential diagnosis included an unconventional melanocytic nevus and nevoid melanoma. Your submitted immunoperoxidase stains included a Ki-67 stain that demonstrates a low cell proliferation index. We additionally completed p16 and BAP-1 immunostains in our assessment. There is a marked loss of p16 expression, which implied that underlying loss in chromosome 9p might be present (this proved not to be the case, as is discussed further below). There is preservation of BAP-1 expression, and thus there is not an underlying anomaly in chromosome 3p. Per your approval, we pursued array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed several contiguous areas of gain within chromosome 15q with no other associated chromosomal gains or losses. (With specific reference to chromosome 9, no gain or loss was found.) We have observed gain in chromosome 15q as a monoaberration in a series of atypical Spitz (or pigmented spindle cell) nevi, and this genomic anomaly is not believed to be indicative of a diagnosis of melanoma. Rather, we believe the gain is a consequence of NTRK3 gene rearrangement.  In summary, although I had reservations regarding the possibility of nevoid melanoma based upon conventional histopathologic findings, the combination of results derived from conventional microscopy coupled with aCGH favors instead interpretation as an unconventional melanocytic nevus (or unconventional Spitz/Reed nevus). My colleague, Dr. Boris Bastian, has reviewed the molecular findings for this case and is in agreement with my diagnosis. Given the complexity of this case, it would certainly be reasonable to complete reexcision of this site in follow-up.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	HYPERCELLULAR COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, FOCALLY TRANSECTED AT THE SPECIMEN PERIPHERY	173727	1665	\N	\N	13-7186	\N	SYNAT536	2010-2017	IP1191929	AirTable blocks_with_IP_info.csv
1658	13-25A	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a relatively narrowly based lesion in which a thickened epidermis with rounded rete ridges overlies a dermal proliferation of melanocytes, with moderate amphophilic cytoplasm and enlarged nuclei, some hyperchromatic, distributed singly or in small collections in the dermis. There is elastotic stroma. The enclosed two-color immunostain shows that there is a low proliferation rate among the lesional melanocytes.	Three outside slides, D12-48401, and one corresponding block.	A) ERYTHEMATOUS NODULE; DF, B) EXCISION WITH 1 CM MARGINS OF DERMAL MELANOCYTIC PROLIFERATION	\N	\N	\N	\N	MELANOMA, 1.2 MM. IN THICKNESS	173602	1666	\N	\N	13-25	A	SYNAT537	2010-2017	IP1184767	AirTable blocks_with_IP_info.csv
1504	11-71241	10	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a predominantly intradermal proliferation of melanocytes with abundant, pale, vacuolated, amphophilic cytoplasm with melanin and medium-sized, oval vesicular nuclei with small nucleoli arranged as nests and fascicles with interspersed melanophages in the upper dermis. There is extension of these melanocytes into the deep dermis along adnexae and neurovascular bundles. A focally dense, lymphohistiocytic inflammatory infiltrate is present concurrently. Mitotic figures are rare.	Skin excision, 0.6 x 0.5 x 0.4 cm, including a central 0.5 x 0.4 cm brown area. With the margins inked blue, the specimen is trisected and entirely submitted.	6 X 4 MM NEVOID NODULE, 2 YEAR HX; SPITZ? CONGENITAL?	\N	\N	\N	There is no evidence of melanoma or atypicality. I have shared this case with my colleague Dr. Beth Ruben who agrees with this interpretation.	DEEP PENETRATING NEVUS	273588	1667	\N	\N	11-71241	\N	SYNAT538	2010-2017	IP1060684	AirTable blocks_with_IP_info.csv
1457	11-26903	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted.	BLUE NEVUS VS. PIGMENTED BCC	\N	\N	\N	The lesion has characteristic features of deep penetrating nevus, a benign lesion some consider a variant of blue nevus. It appears excised in planes of section examined. Case reviewed with concurrence by Drs. McCalmont, Ruben and Mully.	DEEP PENETRATING NEVUS	139523	1668	\N	\N	11-26903	\N	SYNAT539	2010-2017	IP1016341	AirTable blocks_with_IP_info.csv
10800	DM40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1937	\N	\N	\N	\N	SYNX534	\N	\N	Consolidated_data_final.csv
10873	London-L14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1994	\N	\N	\N	\N	SYNX591	\N	\N	Consolidated_data_final.csv
1532	11-95856	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a relatively symmetric and well-circumscribed, roughly wedge-shaped proliferation of spindled and polygonal large melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis around a follicle.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed densely pigmented melanophages.	Cylindrical skin segment plus fragments, 0.7 cm in diameter and 0.4 cm in thickness in aggregate, trisected and totally submitted.	R/O NEW BLACK NEVUS	\N	\N	\N	While the findings are diagnostic of deep penetrating nevus, the melanocytes are large and conservative excision is recommended.  The excision should extend to the subcutaneous fat, as the lesion is broadly transected at the base of the punch specimen, and only needs to be slightly wider than the biopsy, as the lesion extends focally to the peripheral edge of the specimen. Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis and assessment.	DEEP PENETRATING NEVUS, EXTENDING FOCALLY TO THE EDGE AND BASE OF THE SPECIMEN	173719	1672	\N	\N	11-95856	\N	SYNAT540	2010-2017	IP1085304	AirTable blocks_with_IP_info.csv
1352	09-72944	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted.	3 MM BLACK MACULE; PROB BLUE NEVUS	\N	\N	\N	None	DEEP PENETRATING NEVUS, EXTENDING TO THE TISSUE EDGE	107705	1675	\N	\N	09-72944	\N	SYNAT541	Deep Penetrating Nevus	IP563362	AirTable blocks_with_IP_info.csv
11038	SP-13-208365A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2093	\N	\N	\N	\N	SYNX690	\N	\N	Consolidated_data_final.csv
11039	SP-14-36134A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2094	\N	\N	\N	\N	SYNX691	\N	\N	Consolidated_data_final.csv
11040	SP-14-73676A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2095	\N	\N	\N	\N	SYNX692	\N	\N	Consolidated_data_final.csv
1398	10-46536	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a propensity for nests to surround adnexal structures.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and pleomorphic nuclei.  At the periphery of the neoplasm small collections of melanocytes interweave with thickened collagen bundles. They are associated with many melanophages.  There are lymphocytes throughout the neoplasm.   There is also vacuolar interface change with dyskeratotic keratinocytes.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted.	PT WITH NEUROBLASTOMA & 3 X 3 MM BLUISH PAPULE WITH SURROUNDING HALO; R/O BLUE NEVUS VS. CONGENITAL MELANOCYTIC NEVUS VS. METS FROM NEUROBLASTOMA: TELEPHONE 559-589-1501	\N	\N	\N	There is also vacuolar interface change with dyskeratotic keratinocytes.  The epidermal changes and the inflammation surrounding the melanocytic nevus may be related to this patient's recent radio-therapy.  Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis.	BLUE NEVUS WITH FEATURES OF DEEP PENETRATING NEVUS, INFLAMED, EXTENDING TO THE EDGE OF THE SPECIMEN	273588	1676	\N	\N	10-46536	\N	SYNAT542	Deep Penetrating Nevus	IP941112	AirTable blocks_with_IP_info.csv
1411	10-83613A	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a two stage biopsy of a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the mid reticular dermis, with a couple of clusters in the lower reticular dermis/subcutis interface.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages.	Two skin segments, one measuring 1.2 x 0.9 x 0.2 cm, quadrisected, and the other measuring 1.4 x 1.2 x 0.4 cm, serially sectioned, all entirely submitted with four sections in cassette A and five sections in cassette B.	BROWN NODULE, I SHAVE IT FLUSH WITH SKIN INITIALLY, BUT THEN WAS PIGMENT AT THE BASE SO I DID A DEEPER SHAVE OF THE SAME SPOT, ONLY SP. B WAS SUBMITTED TO UCSF	\N	\N	\N	The lesion appears excised in planes of section examined. The lesion is broad, but mitotic activity is not prominent. A Ki-67/Melan A stain was obtained to evaluate proliferative activity and it is very low, consistent with the H and E impression of a benign nevus. The case (except Ki-67 stain) was reviewed with concurrence by Dr. McCalmont.	DEEP PENETRATING NEVUS	101624	1677	\N	\N	10-83613	A	SYNAT543	Deep Penetrating Nevus	IP978192	AirTable blocks_with_IP_info.csv
10374	K1_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1678	\N	\N	\N	\N	SYNX275	\N	\N	Consolidated_data_final.csv
10375	K1_2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1679	\N	\N	\N	\N	SYNX276	\N	\N	Consolidated_data_final.csv
10376	K1_3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1680	\N	\N	\N	\N	SYNX277	\N	\N	Consolidated_data_final.csv
10377	London-L20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Dysplastic Nevus	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1681	\N	\N	\N	\N	SYNX278	\N	\N	Consolidated_data_final.csv
10380	London-L15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Dysplastic Nevus	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1682	\N	\N	\N	\N	SYNX279	\N	\N	Consolidated_data_final.csv
10381	London-L23C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Dysplastic Nevus	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1683	\N	\N	\N	\N	SYNX280	\N	\N	Consolidated_data_final.csv
10383	K1_10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1685	\N	\N	\N	\N	SYNX282	\N	\N	Consolidated_data_final.csv
10384	K1_11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1686	\N	\N	\N	\N	SYNX283	\N	\N	Consolidated_data_final.csv
10385	K1_12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1687	\N	\N	\N	\N	SYNX284	\N	\N	Consolidated_data_final.csv
10386	K1_13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1688	\N	\N	\N	\N	SYNX285	\N	\N	Consolidated_data_final.csv
10387	K1_14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1689	\N	\N	\N	\N	SYNX286	\N	\N	Consolidated_data_final.csv
10388	K1_15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1690	\N	\N	\N	\N	SYNX287	\N	\N	Consolidated_data_final.csv
10389	K1_16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1691	\N	\N	\N	\N	SYNX288	\N	\N	Consolidated_data_final.csv
10390	K1_17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1692	\N	\N	\N	\N	SYNX289	\N	\N	Consolidated_data_final.csv
10391	K1_18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1693	\N	\N	\N	\N	SYNX290	\N	\N	Consolidated_data_final.csv
10392	K1_19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1694	\N	\N	\N	\N	SYNX291	\N	\N	Consolidated_data_final.csv
1195	06-00911	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis and also in the adventitial dermis around a folliculosebaceous unit. Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous. There are interspersed melanophages.	Cylindrical skin excision, 0.4 cm in diameter and 0.6 cm in thickness, margins inked blue, bisected and entirely submitted.	ODD 4 MM DARK PAPULE; MOLE VS NODULAR MM	\N	\N	\N	None	DEEP PENETRATING NEVUS	173610	1698	\N	\N	06-911	\N	SYNAT544	Deep Penetrating Nevus	IP545976	AirTable blocks_with_IP_info.csv
10803	Dummer-KF1-Primary	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, H01.10457/II 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1938	\N	\N	\N	\N	SYNX535	\N	\N	Consolidated_data_final.csv
1235	06-21363	20	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly wedge-shaped infiltrate of spindled and polygonal melanocytes, some of which have ample vacuolated and pigmented cytoplasm, positioned in the superficial dermis and along the epidermal-dermal junction, where rare nests can be found. Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are hard to find. There are interspersed melanophages and also scattered interstitial lymphocytes and histiocytes.	Cylindrical skin excision, 0.6 cm in diameter and 0.9 cm in thickness, including a central gray-brown 0.4 cm pigmented spot.  With margins inked blue, the specimen is serially bisected perpendicular to the short axis and totally submitted.	R/O MELANOMA	\N	\N	\N	This lesion represents a bit of a hybrid, showing some features of a desmoplastic pigmented Spitz's nevus and also some features of a so-called deep penetrating nevus. I do not believe these changes signify melanoma.	HEAVILY PIGMENTED COMPOUND MELANOCYTIC NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	529698	1699	\N	\N	06-21363	\N	SYNAT545	Deep Penetrating Nevus	IP566429	AirTable blocks_with_IP_info.csv
1248	06-47334	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a dome surfaced, roughly wedge-shaped proliferation of large oval melanocytes, most of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis.  Some melanocyte nuclei are modestly enlarged.  There are interspersed melanophages.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted.	PT IS 6 MONTHS PREGNANT, CHANGING MOLE	\N	\N	\N	The base of the specimen is focally involved. There are no worrisome features, however.	DEEP PENETRATING NEVUS	173601	1700	\N	\N	06-47334	\N	SYNAT546	Deep Penetrating Nevus	IP454219	AirTable blocks_with_IP_info.csv
10399	S12-6332A5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1701	\N	\N	\N	\N	SYNX298	\N	\N	Consolidated_data_final.csv
10400	S11-032523A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1702	\N	\N	\N	\N	SYNX299	\N	\N	Consolidated_data_final.csv
1402	10-58663	52	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	Melanoma with nevus	Sections show a broad-based proliferation of melanocytes with a markedly asymmetric configuration, involving the epidermis and superficial dermis. One part of the lesion features interconnecting rete ridges with subjacent nests, cords and strands of small round melanocytes, with clusters of adipocytes admixed with them. The other portion features a thickened epidermis with a relatively flat rete ridge pattern, a basal layer sparsely colonized by melanocytes with large, hyperchromatic nuclei, and a fibrotic stroma containing nests of similar cells, some with scant and some with abundant pale cytoplasm. There is little maturation with descent.	Skin segment measuring 1.7 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with five sections.	ATYPICAL PIGMENTED SK; R/O MM	\N	\N	\N	The lesion is not ulcerated, and hence this is a T2a primary melanoma in the 2009 AJCC staging classification. The mitotic rate is low, and I did not encounter other features that would have a significant prognostic impact.	MELANOMA, 1.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS	139524	1707	\N	\N	10-58663	\N	SYNAT547	2010-2017	IP953239	AirTable blocks_with_IP_info.csv
1327	08-52519	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	Melanoma with nevus	Sections show a bilobed, somewhat polypoid proliferation of melanocytes in a biphasic pattern. The smaller lobe contains an intradermal proliferation of bland melanocytes, which demonstrate a degree of neural differentiation (melanocytic nevus). In the other more polypoid zone, there is a markedly asymmetrical proliferation of atypical melanocytes, which are morphologically heterogeneous, arrayed as irregular clusters and syncytia. In many areas, these fail to mature with descent. Mitotic figures are evident within the dermal component. In areas near the base, there is also a population of smaller melanocytes. Some are in continuity with some of the larger ones overlying them, while others are somewhat bland and may demonstrate a degree of maturation with melanocytic descent. There is fibrosis, and a patchy lymphocytic infiltrate, as well as dilated lymphovascular spaces.	Skin segment measuring 0.7 x 0.5 x 0.4 cm, bisected and entirely submitted.	SINGLE PINK PAPULE WITH BROWN APICAL PORTION; R/O MIS	\N	\N	\N	In one area, there is a neurotized intradermal nevus. In the larger more polypoid zone adjacent to this, there is a markedly asymmetrical proliferation of more atypical melanocytes, with mitotic figures evident within the dermal component, compatible with melanoma. There is also a population of somewhat smaller melanocytes near the base of this proliferation. Some of these probably represent small cells of melanoma, while there may some nevus present there as well. The measurement of thickness is thus based on my best judgment as to what represents the component of melanoma. In terms of other staging parameters, this is a non-ulcerated primary melanoma of Clark's anatomic level IV. There are no other features which would have a significant impact on prognosis. Complete re-excision is of course warranted. I have also shared this unusual case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with these findings.	MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173399	1708	\N	\N	08-52519	\N	SYNAT548	2010-2017	IP761160	AirTable blocks_with_IP_info.csv
1336	09-8165	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	Melanoma with nevus	Sections show a markedly atypical, compound proliferation of melanocytes, with a subtly biphasic pattern. Within the epidermis, there are atypical melanocytes, arrayed as nests, single cells, and in zones of near confluence, with an area in which the epidermis is disrupted. Similar melanocytes are present in clusters and syncytia within the papillary dermis, filling it, and extending to the reticular dermal interface. Near the base of the specimen, there is another population of somewhat smaller bland melanocytes, arrayed as clusters and syncytia, and these demonstrate maturation with melanocytic descent (melanocytic nevus). There is a patchy lymphocytic infiltrate, and scattered melanophages.	Ellipse, 2.2 x 1.1 x 0.9 cm, including a central 1.0 x 0.8 cm dark pigmentation.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with six central sections, tips returned to container.	R/O MM VS. PIGMENTED SK VS. CONGENITAL NEVUS	\N	\N	\N	In terms of staging, this is a probably non-ulcerated, primary melanoma of Clark's anatomic level III/IV, extending to and possibly involving the papillary dermal-superficial reticular dermal interface. Measurement of thickness is an approximation, as the epidermis is disrupted overlying the thickest portion of the neoplasm. While there is near confluence of melanocytes in this zone, it is difficult to know whether ulceration has occurred. I suspect that it has not. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Additional excision is warranted to achieve standard margins for a tumor of these staging parameters. This case was reissued on April 20, 2009 to add the patient's UCSF medical record number.	MELANOMA, APPROXIMATELY 1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERY OF THE EXCISION	173568	1709	\N	\N	09-8165	\N	SYNAT549	2010-2017	IP458841	AirTable blocks_with_IP_info.csv
1319	08-46462	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	Melanoma with nevus	There are nests of melanocytes at the dermo-epidermal junction, and nests, cords and strands of melanocytes within the subjacent dermis.  These cells mature with descent, and lie in part around adnexal structures.	Cylindrical skin segment measuring 0.7 cm in diameter x 0.7 cm in thickness, trisected and entirely submitted in cassette B.	A) 1.4 CM X 1.2 CM RED/BLACK ULCERATED PLAQUE; MELANOMA, B) 7 MM TWO-TONED BROWN PAPULE; NEVUS, MELANOMA	\N	\N	\N	The excision is complete.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	273588	1710	\N	\N	08-46462	\N	SYNAT550	2010-2017	IP755103	AirTable blocks_with_IP_info.csv
1545	12-1782	37	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.4	\N	from Swapna	There is a broad-based melanocytic proliferation with a flat peripheral area and a raised central one. The peripheral portion features discrete nests of small round melanocytes. The raised portion has a relatively thin epidermis, large irregularly shaped and focally confluent nests of large oval and fusiform melanocytes superficially, and smaller ones embedded in a dense lymphocytic infiltrate more deeply. The larger melanocytes include some cells with very large, hyperchromatic nuclei, prominent nuclear pseudoinclusions, or large nucleoli. A few mitotic figures are present, mainly in melanocytes in the upper part of the lesion.	Four outside slides, TT12-7000012-(1&2) and two corresponding blocks.	EXCISION SCALP LESION	\N	Iwei CGH, 7Q Gain 	\N	Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively high proliferation rate in the superficial part of the lesion but a low one in the deeper portions. This finding is not decisive. A p16 stain shows a complete loss of expression in the larger cells, while some smaller melanocytes near the edge of the specimen retain expression. This finding is worrisome for melanoma arising in a nevus. As the changes were somewhat equivocal, we obtained comparative genomic hybridization. This shows set of chromosomal gains and loss diagnostic of melanoma, including a gain involving 3q, complex rearrangements involving chromosomes 5p and 7p, loss of 7qter and 8p, a gain of 8q, a loss involving 9p, and a loss involving 21q. The loss involving 9p correslates with the negative p16 immunoperoxidase stain noted above.  The nevus extends to a peripheral margin, and the melanomatous component to within less than 1 mm of it. The lesion is not ulcerated, making it stage T2a in the 2009 AJCC staging schema for melanoma.	MELANOMA, 1.4 MM. IN THICKNESS	173406	1771	\N	\N	12-1782	\N	DP-03	Possible TERT Fusion	IP1087598	AirTable blocks_with_IP_info.csv
10879	London-L14C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1995	\N	\N	\N	\N	SYNX592	\N	\N	Consolidated_data_final.csv
1456	11-25808	41	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a broad-based proliferation of melanocytes involving the epidermis and superficial dermis. The epidermis is hyperplastic, and there are increased numbers of single melanocytes and both small and large nests of them positioned at irregular intervals along the junction. Some branching rete ridges are evident, with subjacent fibrosis. There are nests, cords and strands of plump oval to small round melanocytes in the subjacent dermis, with some tendency to cluster around the upper parts of adnexal structures.	One outside slide, ND11-734. One corresponding block received 4/15/11.	RULE OUT ATYPIA	\N	\N	\N	The neoplasm extends to the peripheral edge of the specimen. While the distribution of melanocytes within the epidermis is irregular, and some of the cells in the dermis are moderately enlarged, other features raise the possibility of an unusual congenital nevus. The dermal component matures with descent in areas, and mostly has discrete aggregations of cells. As nevoid melanoma is in the differential diagnosis, I obtained immunoperoxidase stains. These include an HMB45 stain, strongly positive at the dermo-epidermal junction and weakly positive within only the superficial-most melanocytes. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a near zero proliferation rate in the dermal melanocytes.  A scout section (the hematoxylin and eosin stained recut that we obtain at the time that sections are cut for immunoperoxidase stains) contained several melanocytes in mitosis. B  Comparative genomic hybridization shows a gain involving chromosome 7, a loss of chromosome 9, and a gain of most of chromosome 14. This combination of features indicates melanoma. Whether a component of nevus is also present could not be determined.  While the lesion is not ulcerated, the presence of melanocytes in mitosis in the dermis qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma.	MELANOMA, 0.7 MM. IN THICKNESS	173726	1711	\N	\N	11-25808	\N	SYNAT551	2010-2017	IP1015246	AirTable blocks_with_IP_info.csv
1479	11-42027	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1712	\N	\N	11-42027	\N	SYNAT552	2010-2017	\N	AirTable blocks_with_IP_info.csv
11041	SP-14-73671M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2096	\N	\N	\N	\N	SYNX693	\N	\N	Consolidated_data_final.csv
11042	SP-14-7691A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2097	\N	\N	\N	\N	SYNX694	\N	\N	Consolidated_data_final.csv
11044	WM3928F	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2098	\N	\N	\N	\N	SYNX695	\N	\N	Consolidated_data_final.csv
11045	C037	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2099	\N	\N	\N	\N	SYNX696	\N	\N	Consolidated_data_final.csv
1563	12-7775	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a broad based proliferation of large, oval and fusiform melanocytes, positioned as nests along the undersurface of an irregularly hyperplastic epidermis, and as smaller aggregations in a fibrotic superficial dermis. There are clefts between melanocytes and between them and  the adjacent epidermis. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. Several mitotic figures are present, including some near the base of the specimen.	Three outside slides, D12-8697 and one corresponding block.	SEBORRHEIC KERATOSIS, R/O ATYPIA, CHECK MARGINS CLINICALLY; CONCERN RE SPITZIOD MELANOMA ON PATHOLOGIC EXAMINATION; REQUEST FOR CONSULTATION AND COMPARATIVE GENOMIC HYBRIDIZATION IN COVER LETTER	\N	\N	\N	Comparative genomic hybridization shows a narrow gain involving an area of chromosome 7q and a narrow gain with higher amplitude involving a second area of 7q. Isolated gains involving chromosome 7q can occur in Spitz's nevus. My colleague, Dr. Boris Bastian examined the comparative genomic hybridization examined the comparative genomic hybridization data and notes that the larger gain includes the MET locus. This finding has been seen previously in Spitz's nevus. Given that the changes are less straightforward than the finding of no gains or losses, or of an isolated gain of 11p or of the entire 7q arm, I would like to leave the diagnosis somewhat ambiguous, but favoring a Spitz's nevus. The neoplasm extends to the base of the specimen across a broad front, and if there is a significant residuum on re-excision, I would be interested in viewing the sections.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH FINDINGS FAVORING AN UNUSUAL SPITZ'S NEVUS	173508	1713	\N	\N	12-7775	\N	SYNAT553	2010-2017	IP1093591	AirTable blocks_with_IP_info.csv
3290	DM45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1714	\N	\N	None	\N	SYNAT554	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3274	DM16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1715	\N	\N	None	\N	SYNAT555	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3309	DM77	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1716	\N	\N	None	\N	SYNAT556	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
10438	HWAcr	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, FCCC, Dissect, Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1717	\N	\N	\N	\N	SYNX314	\N	\N	Consolidated_data_final.csv
3313	DM94	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1718	\N	\N	None	\N	SYNAT557	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3316	DM98	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1719	\N	\N	None	\N	SYNAT558	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3317	DM99	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1720	\N	\N	None	\N	SYNAT559	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3301	DM64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1721	\N	\N	None	\N	SYNAT560	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3293	DM51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1722	\N	\N	None	\N	SYNAT561	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3295	DM58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1723	\N	\N	None	\N	SYNAT562	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3296	DM59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1724	\N	\N	None	\N	SYNAT563	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3284	DM31	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1725	\N	\N	None	\N	SYNAT564	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3286	DM36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1726	\N	\N	None	\N	SYNAT565	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3308	DM74	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1727	\N	\N	None	\N	SYNAT566	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1313	08-43264	50	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. A large portion of the lesion is a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature as they extend into the superficial reticular dermis.  Near the periphery, there are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in some areas. A few similar cells reside in the subjacent papillary dermis.	Ellipse, 2.2 x 1.0 x 0.3 cm, including a central brown 0.6 x 0.4 cm macule.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with five central sections, tips returned to container.\n	ATYPICAL PIGMENTED LESION	\N	\N	\N	The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above. The lesion is not ulcerated, and only involves a portion of the papillary dermis (level II).	MELANOMA, 0.5 MM  IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173529	1728	\N	\N	08-43264	\N	SYNAT567	2010-2017	IP179649	AirTable blocks_with_IP_info.csv
1321	08-51219	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	The histopathology is generally similar to that described for specimen DH08-51219B, with a greater degree of subjunctional fibroplasia apparent.	Ellipse, 2.0 x 0.9 x 0.6 cm, including a central variegated brown 1.5 x 0.8 cm plaque.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections each in cassettes C1 and C2.	A-C) LONG-TIME ATYPICAL NEVI; A) 8 MM TRANSVERSE; B) 4 MM LONG X 1.1 CM; C) 6 MM LONG X 1.4 CM TRANSVERSE; A-C) R/O ATYPICAL NEVI	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to the papillary dermis (Clark's level III). Further excision of this site is warranted.	MELANOMA OF 0.55 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS AND EXTENDING NEAR TO THE PERIPHERY OF THE SPECIMEN	173539	1729	\N	\N	08-51219	\N	SYNAT568	2010-2017	IP754897	AirTable blocks_with_IP_info.csv
10468	S12-18826	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Alain Algazi	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1730	\N	\N	\N	\N	SYNX327	\N	\N	Consolidated_data_final.csv
3305	DM68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1785	\N	\N	None	\N	SYNAT569	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1515	11-81851	67	\N	\N	5	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show nodular aggregations of melanocytes with atypical nuclei in the dermis, lack of maturation of these cells with descent, and their arrangement in irregularly shaped aggregations. There is a flanking intraepidermal component with pagetoid growth pattern.  A second population of small round melanocytes arranged in discrete collections is also present. Some of these melanocytes show neuroid differentiation.	Skin segment measuring 0.7 x 0.5 x 0.5 cm, bisected and entirely submitted.	R/O INFLAMED NEVUS, PYOGENIC GRANULOMA	\N	\N	\N	The melanoma arose in continuity with an intradermal melanocytic nevus. Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: non-brisk Vascular or lymphatic invasion: non detected Dermal mitotic rate:  5/mm2 Perineural invasion: not detected Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: moderate (non-CSD) WHO type: superficial spreading melanoma	MELANOMA, 1.9 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY	173404	1731	\N	\N	11-81851	\N	SYNAT570	2010-2017	IP1071299	AirTable blocks_with_IP_info.csv
11046	C022	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2100	\N	\N	\N	\N	SYNX697	\N	\N	Consolidated_data_final.csv
11053	UM19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2102	\N	\N	\N	\N	SYNX699	\N	\N	Consolidated_data_final.csv
11054	UM20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2103	\N	\N	\N	\N	SYNX700	\N	\N	Consolidated_data_final.csv
11055	CP-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2104	\N	\N	\N	\N	SYNX701	\N	\N	Consolidated_data_final.csv
1406	10-73024	55	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  There is an associated dense band like lymphocytic infiltrate with numerous melanophages.  There are foci of epidermal atrophy with an associated paucity of melanocytes.	Oriented ellipse, 2.8 x 1.5 x 0.5 cm, including a central 0.5 x 0.5 cm lesion and a smaller lesion measuring 0.8 x 1.2 cm.  With the orienting notch placed to the left, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right tips and entirely submitted with five sections each in cassettes A and B.	SPLIT IS PROXIMAL CLUSTER OF BLACK PAPULES, H/O OF PREV NEVUS, CHANGED OVER THE LAST FEW YRS; R/O MELANOMA	\N	\N	\N	Melan-A stains were done and they highlight a broad proliferation of atypical melanocytes at the dermoepidermal junction and above it.  A few nests of atypical melanocytes are also noted in the dermis.  These were difficult to detect on routine staining due to the associated dense band like infiltrate of lymphocytes and melanophages.  The lesion has been completely, but narrowly excised.  Melanoma in situ is present to within 1 millimeter of the 9 o'clock position with the orienting notch designated as 12 o'clock.  In terms of staging this is a thin non-ulcerated melanoma with foci of regression.  No dermal mitotic figures are noted within the small dermal component.  It should be regarded as a pT1a lesion based on the 2009 AJCC melanoma staging system.	MELANOMA, 0.32 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED	173611	1732	\N	\N	10-73024	\N	SYNAT571	2010-2017	IP967603	AirTable blocks_with_IP_info.csv
10479	12_M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter, Desmoplastic Melanoma Amplicon Sequence	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1733	\N	\N	\N	\N	SYNX330	\N	\N	Consolidated_data_final.csv
2913	49_M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1735	\N	\N	None	\N	SYNAT572	2010-2017	\N	AirTable blocks_with_IP_info.csv
1358	10-0206	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.3	\N	\N	Sections show irregular aggregations of atypical basaloid to squamoid keratinocytes, with focal epithelial-stromal clefting.	Four outside slides, CPP-09-35739:A1.	REVIEW OF OUTSIDE SLIDES PRIOR TO MICROGRAPHIC SURGERY	\N	\N	\N	I favor basal cell carcinoma over squamous cell carcinoma. Ber-EP4 and keratin immunoperoxidase stains were attempted by the referring laboratory, but no tumor remains in those sections. The pattern of tumor is not fully classifiable as little is present.	INVASIVE CARCINOMA, FAVOR BASAL CELL CARCINOMA, EXTENDING TO THE SPECIMEN BASE	373314	1736	\N	\N	10-206	\N	SYNAT573	2010-2017	IP894776	AirTable blocks_with_IP_info.csv
1333	09-0209	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1737	\N	\N	09-209	\N	SYNAT574	2010-2017	\N	AirTable blocks_with_IP_info.csv
1695	13-25110A1	29	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.7	\N	\N	There is a proliferation of melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm, arranged in an irregular pattern along the junction and within the dermis.  Suprabasal scatter of melanocytes is prominent in some areas.  In other areas the melanocytes are bland and mature with descent in the dermis.  There is an infiltrate of lymphocytes and melanophages.	Elliptical excision, 2.8 x 1.3 x 0.9 cm, including a central 1.3 x 1.1 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A1 and A2. Tips reserved. CF/CF	A) 1.4 X 1.6 CM IRREGULAR/ASYMMETRIC BLACK-PIGMENTED PAPULE WITH RAISED CENTER; MELANOMA, NARROW EXCISIONAL BIOPSY (2 MM MARGIN), B) 0.5 X 0.5 CM ERYTHEMATOUS PAPULE; PYOGENIC GRANULOMA, POSSIBLE ANGIOMA	\N	\N	\N	Melanoma in situ is present < 1 millimeter from the edge of the specimen.  This is a non-ulcerated melanoma.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.	MELANOMA, 1.2 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED	122741	1738	\N	\N	13-25110	A1	SYNAT575	2010-2017	IP1209855	AirTable blocks_with_IP_info.csv
1707	13-45163	58	\N	\N	\N	T1a	Primary	melanoma on non-chronically sun-damaged skin, SSM	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei arranged in wedge-shaped array  (melanocytic nevus).	Ellipse, 1.8 x 0.9 x 0.3 cm, including a central 0.9 x 0.7 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with eight sections. PL/PL	1 CM BROWN/BLACK ROUND MACULE	\N	\N	\N	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excision Tumor site: back Microscopic tumor type: melanoma on non-chronically sun-damaged skin, SSM Breslow thickness: 0.4 Ulceration: no Margins, peripheral and deep: Intraepidermal component extending close to the peripheral margin Mitotic index: none detected Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX Solar elastosis: mild	MELANOMA, 0.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY	139524	1739	\N	\N	13-45163	\N	SYNAT576	2010-2017	IP468757	AirTable blocks_with_IP_info.csv
3292	DM49	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1740	\N	\N	None	\N	SYNAT577	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
10492	DP08-21965C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1741	\N	\N	\N	\N	SYNX338	\N	\N	Consolidated_data_final.csv
10494	DP08-4205A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1742	\N	\N	\N	\N	SYNX339	\N	\N	Consolidated_data_final.csv
1486	11-50182	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a domed segment of skin with a dermal proliferation of enlarged fusiform melanocytes with abundant, pale cytoplasm and dusty appearing melanin. These melanocytes are arranged as thick and thin interconnecting fascicles with interspersed melanophages. The aggregations are more closely apposed in the upper part of the lesion than near the base of the specimen. Mitoses are present (around 1 per 5 400x fields). Some melanocytes have large, hyperchromatic nuclei.	Two outside slides, D11-10392. One corresponding block received 7/25/11.	TWO-TONED CHANGING LESION; REQUEST FOR CGH FROM DR VENNA	\N	\N	\N	ADDENDUM, August 18, 2011: Our differential diagnosis included an atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity and a low Ki-67 cell proliferation index. We also completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue bock, application of aCGH demonstrated segmental gain in chromosome 7q and loss of chromosome 9q. The presence of multiple chromosomal losses suggests genomic instability and favors interpretation as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as blue nevus-like (or deep penetrating nevus-like) melanoma. With respect to staging, this tumor is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to permit further microstage assessment and to ensure that local eradication has been accomplished.	ATYPICAL INTRADERMAL PROLIFERATION OF ENLARGED SPINDLED MELANOCYTES, CONSISTENT WITH MELANOMA OF 1.9 MM IN THICKNESS	173502	1743	\N	\N	11-50182	\N	SYNAT578	2010-2017	IP1039621	AirTable blocks_with_IP_info.csv
10561	Kit298	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1799	\N	\N	\N	\N	SYNX396	\N	\N	Consolidated_data_final.csv
3173	BN_N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1800	\N	\N	None	\N	SYNAT579	2010-2017	\N	AirTable blocks_with_IP_info.csv
10598	11-41004	8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Iwei 7Q Gain	CGH11-202 	Sections show a predominantly dermal proliferation of large melanocytes, with a domed surface and a wedge shaped base. The lesional melanocytes are fusiform, with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular and heterochromatic nuclei, some with large nucleoli. A few mitotic figures are present in melanocytes well within the dermis. While there is a greater degree of cellularity in the upper than in the lower part of the lesion, some of the aggregations toward the base of the lesion are substantial. The enclosed immunoperoxidase stains show that many nuclei are Ki-67 positive, but many of these may be those of lymphocytes.	Seven outside slides, SC11-2567.	\N	\N	\N	\N	The neoplasm extends to the peripheral dermal edge of the specimen. Many features favor a Spitz's nevus, but there are large aggregations deep in the lesion, a few mitotic figures at the level of the mid-reticular dermis and the melanocytic nuclei are more pleomorphic than usual. Complete excision, despite the cosmetically sensitive area is warranted.  Comparative genomic hybridization shows a gain involving chromosome 11p, and also one involving 7q. Isolated 11p gain usually corresponds to the formation of an isochromosome (two copies of 11p joined by a centromere), and has not been seen to date in melanoma. Spitz's nevi with this aberration are likely to have a mutation involving h-ras, and to deeply infiltrate the reticular dermis as single cells, findings that are present here. In this case, the 11p gain is not isolated but is associated by a gain of 7q. I consulted with Dr. Boris Bastian, at Sloan-Kettering Cancer Center, New York, a colleague whose laboratory developed diagnostic comparative genomic hybridization when he was here at UCSF. He has not seen these two aberrations together, and heretofore regarded them as mutually exclusive. He believes that the current CGH picture still favors Spitz's nevus, even though the 11p aberration is not an isolated one.  References:  van Engen-van Grunsven AC, van Dijk MC, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WA. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. Am J Surg Pathol. 2010 Oct;34(10):1436-41.  Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000 Sep;157(3):967-72.	PREDOMINANTLY INTRADERMAL SPITZ'S NEVUS WITH SOME UNUSUAL FEATURES	102353	1820	\N	\N	11-41004	A	SYNX417	\N	IP1030443	Consolidated_data_final.csv
11056	CP-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2105	\N	\N	\N	\N	SYNX702	\N	\N	Consolidated_data_final.csv
11057	CP-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2106	\N	\N	\N	\N	SYNX703	\N	\N	Consolidated_data_final.csv
1488	11-51553	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	There is a compound proliferation of melanocytes that extends into the deep reticular dermis. The epidermis overlying the proliferation is thinned. There are nests and single melanocytes along the junction, and most have abundant pale, vacuolated cytoplasm and some have enlarged oval vesicular nuclei. A limited degree of pagetoid scatter is present. Within the subjacent dermis there are coalescing nests, cords, and small syncytia of similar-appearing cells, some of which have even more abundant cytoplasm or larger and more hyperchromatic nuclei. Interspersed amidst these cells are foci in which melanocytes with smaller and more monomorphous nuclei predominate. Near the base of the proliferation are lymphoid nodules. A permeative component to the infiltrate in the reticular dermis is also noted.	One outside slide, D11-25135 and one corresponding block.	CHANGING MOLE WHICH BLEEDS OCCASIONALLY AND HAS BEEN PRESENT FOR ONE AND A HALF YEARS	\N	\N	\N	The findings are not those of a conventional congenital, Spitz or deep penetrating melanocytic nevus. Immunoperoxidase staining using two colors (with MART-1/tyrosinase labeled red and Ki-67 labeled brown) shows a relatively low cell proliferation index. However, some positively-labeled nuclei are apparent even in the deep dermis, which is of concern. We also completed array-based comparative genomic hybridization (aCGH) to further address the differential diagnosis between melanocytic nevus and melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed segmental gain in chromosome 7p and also in 7q. The presence of multiple chromosomal copy number aberrations indicates genomic instability and favors interpretation as melanoma. We have not observed gain in chromosome 7 in melanocytic nevi of any type.  In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as an unconventional melanoma occurring in childhood. We refer to tumors within this spectrum as childhood-type melanomas. The designation childhood-type melanoma refers to an emerging tumor category that we believe is distinct from conventional (or adult-type) melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This tumor is 4.2 mm in thickness and is non-ulcerated. Further excision is warranted to ensure that local eradication has been accomplished. I have received a call from Dr. Saadia Raza and will be returning her call to discuss the case.	ATYPICAL COMPOUND PROLIFERATION OF MELANOCYTES; GAIN IN CHROMOSOMES 7p AND 7q APPARENT VIA COMPARATIVE GENOMIC HYBRIDIZATION	173304	1744	\N	\N	11-51553	\N	SYNAT580	2010-2017	IP1040993	AirTable blocks_with_IP_info.csv
1489	11-52339	31	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a domed and flattish yet asymmetrical proliferation of large ovoid and spindled melanocytes involving the epidermis and dermis. The epidermis overlying the proliferation has a slightly elevated surface and is acanthotic with a thickened granular layer and a thin but partially compact cornified layer. Situated at the junction and focally above the junction are large melanocytes with abundant pale amphophilic cytoplasm and pleomorphic, vesicular and heterochromatic nuclei. Smaller aggregations of similar cells disperse and partially mature toward the base of the lesion. A few mitotic figures are evident in junctional melanocytes and rarely in dermal melanocytes. A juxtaposed lymphohistiocytic infiltrate is present concurrently.	Three outside slides, PANS11-14530 A1. One corresponding block received 7-25-11.	HX OF MELANOMA IN SITU ON THE LEFT FOREARM DIAGNOSED IN 2002 AND AN ATYPICAL MELANOCYTIC LESION ON THE LEFT LOWER BACK AT LEFT UPPER ARM, NOW WITH 7 MM PINK PAPULE; MELANOMA?	\N	\N	\N	To assess a differential diagnosis between an unconventional Spitz nevus on one hand and melanoma on the other, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 1p, segmental loss of chromosome 1q, loss in chromosome 2p, 2 segmental gains in chromosome 7q, and loss of chromosome 9. The identification of multiple chromosomal copy number aberrations indicates genomic instability and points to interpretation as melanoma. The identification of multiple chromosomal gains and losses is incompatible with any form of Spitz nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH confirm that this proliferation represents melanoma and not a Spitz nevus. With respect to staging, this melanoma is less than 1 mm in thickness and lacks associated ulceration, yet melanocytes in mitosis are detectable in its dermal component. Therefore, this represents melanoma of stage pT1b (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.85 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173727	1745	\N	\N	11-52339	\N	SYNAT581	2010-2017	IP1041779	AirTable blocks_with_IP_info.csv
1491	11-55993	48	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a partial biopsy that contains a compound proliferation of enlarged melanocytes that are slightly spindled or epithelioid in morphology. Within the epidermis, nests and fascicles of enlarged melanocytes are positioned at the junction in concert with acanthosis, and clefts separate some melanocytic fascicles from the epithelium. In the dermis below this, there are maturing nests, cords, and small syncytia of similar melanocytes, and a juxtaposed permeative lymphohistiocytic infiltrate is also noted. An element of reticular dermal elastosis can be seen.	Three outside slides, D11-27883 and one corresponding block.	1.5 CM PINK PLAQUE WITH DARKER MACULE ON THE UPPER ASPECT ON THE LEFT THIGH POSTERIOR; NEVUS VS. MELANOMA	\N	\N	\N	This partial biopsy raised a differential diagnosis between the center of a Spitz nevus on one hand and melanoma on the other. To more fully address this differential, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 4, gain in distal chromosome 7q, loss of chromosome 9, and gain in chromosome 15q. The identification of multiple genomic gains and losses confirms the presence of genomic instability, which is confirmatory of a diagnosis of melanoma. As you probably know, the aCGH profile that has been demonstrated is incompatible with a diagnosis of melanocytic nevus. Please note that this melanoma would not be diagnosable via application of fluorescence in situ hybridization (FISH). The current FISH approach that is utilized analyzes (and thus potentially demonstrates) aberrations involving only chromosomes 6 and 11. This melanoma, which has multiple aberrations involving other chromosomes, would have a normal FISH profile. (This is not uncommon in spitzoid melanomas.)  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. This is a non-ulcerated melanoma with associated Clark's level IV invasion. The final microstage parameters should be reassessed once this melanoma has been fully extirpated.	MELANOMA OF 0.95 MM IN THICKNESS	173765	1746	\N	\N	11-55993	\N	SYNAT582	2010-2017	IP1045436	AirTable blocks_with_IP_info.csv
1492	11-57051	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a broad-based and asymmetrical proliferation of melanocytes mostly involving the epidermis (chiefly the junctional zone within it) and the superficial dermis. There are elongated rete ridges, with increased numbers of single melanocytes at the sides and bases of a few, and nests of them toward the bases of more. Toward one end of the specimen, junctional nests are particularly confluent and crowded together. Toward the center of the lesion, nests of plump oval to small round melanocytes lie within fibrotic stroma. The epidermis above this central area is more markedly thickened and has a thick granular and a partially compact cornified layer.	One outside slide, CB11-3582-2. One corresponding block received 8/25/11.	2ND OPINION, INITIAL BIOPSY AND EXCISION OF RIGHT CALF LESION; R/O DN (ALSO INCLUDED WAS A FOREHEAD BIOPSY; R/O BCC)	\N	\N	\N	The differential diagnosis was between a thin melanoma and an unusual nevus. A slight degree of pagetoid scatter is present, which may be due to irritation (this is suggested by the findings of lichen simplex chronicus in the overlying epidermis). We performed comparative genomic hybridization, which shows a gain involving chromosome 7q. We have noted isolated gains of 7q in Spitz nevi, but not melanoma. Given this result, I favor a benign interpretation, specifically a nevus in which there are the architectural features of a dysplastic (Clark's) nevus and (only well developed in some nests) the cytologic features of a Spitz's nevus. Given the unusual nature of the lesion, and its proximity to the peripheral margins, I would consider a narrow re-excision of the site.	SPITZOID CLARK'S NEVUS, COMPOUND	173711	1747	\N	\N	11-57051	\N	SYNAT583	2010-2017	IP1046494	AirTable blocks_with_IP_info.csv
1503	11-71006	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a dome shaped segment of skin with irregular epidermal hyperplasia, and confluent nests of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei within the dermis. Many necrotic melanocytes are evident. The enclosed immunoperoxidase stains show that there is strong staining for cyclin D1 throughout the thickness of the lesion. There is negligible staining with HMB45.	Ten outside slides, S-11-10063:A-1-2, 1-3, 1-5 through 1-9, 1-11, 1-14 and 1-16 (S-2130-11), and one corresponding block, 2130-11.	CAUTERY REMOVAL; SPITZOID LESION (SEE DETAILED LETTER AND REPORT)	\N	\N	\N	As there were some findings worrisome for a spitzoid melanoma rather than a Spitz's nevus. I proposed obtaining comparative genomic hybridization on this case. This showed an isolated gain of 7q, an aberration that when unaccompanied by others favors a Spitz's nevus. Given the worrisome histopathologic findings, I would still obtain a re-excision if it has not been done, even though the base may have been cauterized. I reviewed the comparative genomic hybridization data with Dr. Boris Bastian, who agreed regarding the implications of this finding.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, PROBABLY AN UNUSUAL SPITZ'S NEVUS	192799	1748	\N	\N	11-71006	\N	SYNAT584	2010-2017	IP1060449	AirTable blocks_with_IP_info.csv
3174	BN_N2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1801	\N	\N	None	\N	SYNAT585	2010-2017	\N	AirTable blocks_with_IP_info.csv
3171	BN_M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1802	\N	\N	None	\N	SYNAT586	2010-2017	\N	AirTable blocks_with_IP_info.csv
1510	11-76464	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a well-circumscribed but asymmetrical compound proliferation of melanocytes involving the junctional zone and the superficial dermis, extending within a pilosebaceous unit to the level of the deep reticular dermis in one focus. An aggregate of melanocytes abuts a lymphatic space at the same level. Nests predominate over single cells along the junction, and are in part composed of cells with polygonal outlines, abundant pale, vacuolated cytoplasm, dusty melanin and large but monomorphous vesicular nuclei that contain moderately sized nucleoli. These cells merge with melanocytes that have moderate-sized nuclei and scant cytoplasm toward the base of the lesion. Several mitotic figures are seen in the more pale-appearing melanocytes in the upper part of the proliferation.	Ten outside slides, SSL11-8420:A1, including nine unstained slides.  One corresponding block received 10-20-11.	RULE OUT COMPOUND NEVUS VS. SPITZ NEVUS (CLINICAL INFORMATION FROM ENCLOSED OUTSIDE PATHOLOGY REPORT)	\N	\N	\N	Comparative genomic hybridization shows a gain involving chromosome 7q. Isolated 7q gains (such as that seen here) are present in a small group of Spitz's nevus, and we have not yet encountered isolated 7q gains in melanoma. There is diminished binding of the lesional DNA to probes representing chromosome 19, but this is a common artifactual problem due to high GC content. The lesion extends to within 1 mm. of the peripheral edge of the specimen. I would consider a very narrow re-excision to achieve 5 mm margins, but the findings seen here do not, in my opinion, support more than that.	SPITZ'S NEVUS, COMPOUND	554434	1749	\N	\N	11-76464	\N	SYNAT588	2010-2017	IP1065911	AirTable blocks_with_IP_info.csv
1524	11-88431	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show enlarged melanocytes arrayed irregularly within the epidermis, which is acanthotic, and non-maturing melanocytes in nests and fascicles are positioned in fibrotic dermis below this. The constituent melanocytes are generally spindled. Some are strikingly nucleomegalic. Dermal melanocytes in mitosis can be found. There is parakeratosis within orthohyperkeratosis above this.	Four outside slides, ES11-15479 (DC11-6719) and one corresponding block.	ONE YEAR HISTORY OF WARTY EXPANDING LESION, AREA SURROUNDING DARKLY PIGMENTED BUT SUPERFICIAL, NOT IN PROXIMITY TO ANY NAIL OR NAIL BED REGION, NO PERSONAL HX OF MELANOMA BUT PATIENT'S MOTHER DIED SOME YEARS AGO FROM METASTATIC MELANOMA	\N	\N	\N	Based upon results derived from conventional microscopy, I favored melanoma over an unconventional Spitz nevus as most likely. To further substantiate this diagnosis, analysis via array-based comparative genomic hybridization (aCGH) was completed to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 12q, 18q, 20q, and 22q as well as loss in chromosomes 3q, 8p, 9p, 12q, 15p, and 16q. The identification of multiple genomic aberrations confirms the presence of genomic instability, as is stereotypical of melanoma. Please note that the aCGH profile that we have defined is incompatible with interpretation as any type of melanocytic nevus. In short, a benign interpretation has been excluded from the differential diagnosis by means of our molecular results. In summary, the combination of results derived from conventional microscopy coupled with has demonstrated that this atypical melanocytic proliferation represents spitzoid melanoma. This melanoma is non-ulcerated and shows Clark's level IV invasion. The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	MELANOMA OF AT LEAST 2.3 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173622	1750	\N	\N	11-88431	\N	DP-23	CGH Validation	IP1077879	AirTable blocks_with_IP_info.csv
1525	11-88432	20	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show enlarged slightly spindled and epithelioid melanocytes arrayed in compound fashion within a sessile and partially polypoid skin segment. There are very large nests and fascicles of melanocytes intraepidermally, and similar melanocytes are arrayed in partially maturing fashion in dermis below this. The constituent melanocytes have finely melanized or amphophilic cytoplasm. It is not difficult to identify dermal melanocytes in mitosis.	One outside slide, RMC11-519 (DC11-5529) and one corresponding block.	HAS "TRIPLED IN SIZE IN THE LAST YEAR", RED BROWN AND CRUSTED	\N	\N	\N	My differential diagnosis included a highly unconventional Spitz nevus on one hand and spitzoid melanoma on the other, and after completion of our analysis of this tumor, the latter possibility proves to represent the best diagnosis for this case. To more fully evaluate the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 7q as well as loss in chromosomes 1q, 5q, 7q, 9, 10q, 13p, 14q, and 16q. The identification of multiple genomic aberrations indicates genomic instability, as is stereotypical of melanoma. Please note that the aCGH profile that we have defined is incompatible with interpretation as any type of melanocytic nevus. In short, an atypical Spitz nevus has been excluded from the differential diagnosis by means of our molecular results. In summary, the combination of results derived from conventional microscopy coupled with has demonstrated that this atypical melanocytic proliferation represents spitzoid melanoma. This melanoma is non-ulcerated and shows Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 2.5 MM IN THICKNESS, FOCALLY INVOLVING THE DEEP EDGE OF THE SPECIMEN	139523	1751	\N	\N	11-88432	\N	SYNAT589	2010-2017	IP1077880	AirTable blocks_with_IP_info.csv
1523	11-88209	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.4	\N	\N	Sections show a papillated segment of skin with a predominantly dermal proliferation of melanocytes, most of which have abundant, pale cytoplasm and large, oval vesicular nuclei. The overlying epidermis is focally hyperplastic. A few junctional nests are present. The dermal aggregations are variably confluent. The cells toward the base of the specimen are smaller, and have smaller and more monomorphous nuclei than those superficially. It is difficult to find mitotic figures. The enclosed immunoperoxidase stains show that the junctional melanocytes and some superficial dermal ones stain with HMB-45 and that the Ki-67 labeling rate is up to 5% or so in some areas.	Six outside slides, FT11-71845 (AX11-1474/RSS11-18539).  Fifteen corresponding (unstained) slides received 12-5-11.	ORIGINAL BIOPSY OF PATH DL11-81921	\N	\N	\N	Comparative genomic hybridization shows multiple chromosomal aberrations indicative of melanoma. These include a loss involving chromosome 6p, a partial loss of 6q, an amplification (high level copy number gain) of 7q, a loss of 9p and a loss of 9qter. Losses involving 6q and 9p are particularly common in melanoma. While isolated gains involving chromosome 7q can be seen in Spitz's nevus, gene amplifications (gains of not just an extra copy, but many extra copies) are not. Dr. Boris Bastian also reviewed the comparative genomic hybridization data and agrees with this interpretation of it.  The lesion is broadly transected, and may be considerably thicker than the 3.2 mm that I measured on the slide. Given the comparative genomic hybridization results and morphology, I believe that this lesion should be classified as a spitzoid melanoma of childhood, i.e., an emerging class of lesions that usually lack b-raf mutations (which are present in most melanomas) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. Most lesions of this type are well circumscribed and relatively narrow re-excision margins are adequate for local control. The value of sentinel lymph node biopsy seems even less than in adult melanoma, as the predictive value of nodal involvement for distant disease is less, and there is little evidence that completion lymphadenectomy has an effect on survival.	SPITZOID MELANOMA OF CHILDHOOD	173403	1752	\N	\N	11-88209	\N	SYNAT590	2010-2017	IP1071369	AirTable blocks_with_IP_info.csv
3580	Thomas_SK_MEL_23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1753	\N	\N	None	\N	SYNAT591	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
3455	KIT134	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1754	\N	\N	None	\N	SYNAT592	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3457	KIT191	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1755	\N	\N	None	\N	SYNAT593	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3460	KIT205	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1756	\N	\N	None	\N	SYNAT594	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3461	KIT206	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1757	\N	\N	None	\N	SYNAT595	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3462	KIT210	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1758	\N	\N	None	\N	SYNAT596	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3463	KIT217	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1759	\N	\N	None	\N	SYNAT597	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3464	KIT225	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1760	\N	\N	None	\N	SYNAT598	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3467	KIT244	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1761	\N	\N	None	\N	SYNAT599	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3468	KIT260	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1762	\N	\N	None	\N	SYNAT600	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3470	KIT273	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1763	\N	\N	None	\N	SYNAT601	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3472	KIT295	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1764	\N	\N	None	\N	SYNAT602	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
10572	SQ13-8208B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dr. Perry, Melanocytic Shwannoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1804	\N	\N	\N	\N	SYNX401	\N	\N	Consolidated_data_final.csv
2999	98-18400a	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1805	\N	\N	None	\N	SYNAT603	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1330	08-70283a	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1807	\N	\N	None	\N	SYNAT604	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1094	03-34051A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1808	\N	\N	03-34051	A1	SYNAT605	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1067	02-42436	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1809	\N	\N	02-42436	\N	SYNAT606	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
10804	Dummer-KF1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, H01.10457/II 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1939	\N	\N	\N	\N	SYNX536	\N	\N	Consolidated_data_final.csv
10805	Dummer-KF1-Met1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, 14.20/II 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1940	\N	\N	\N	\N	SYNX537	\N	\N	Consolidated_data_final.csv
10518	11-23878	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	Iwei CGH, Translocation 	CGH11-109 	Sections show a polypoid compound proliferation of enlarged epithelioid melanocytes distributed along a largely thinned epidermis. There are single melanocytes and nests distributed nearly confluently, and in the dermis below this there are partially-maturing nests and cords of similar melanocytes. In the middle of the proliferation, melanocytes in mitosis are easily found. In a recut section, mitotic figures are again apparent in the upper dermis.	Three outside slides, S11-03153 and one corresponding block.	\N	\N	\N	\N	The architectural features of this lesion favor a Spitz's nevus. The fact that there are dermal melanocytes in mitosis is concerning. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a moderate proliferation rate in the upper part of the lesion and a low one in the lower part. Array-based comparative genomic hybridization shows no chromosomal gains or losses. In the context of the findings noted above, I believe that this is best interpreted as a Spitz's nevus. The margins appear clear in the planes of section examined.	SPITZ'S NEVUS, COMPOUND	101625	1765	\N	\N	11-23878	A	SYNX362	\N	IP1013316	Consolidated_data_final.csv
1567	12-11041	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	from Swapna	Sections show a nodular pan-dermal and superficial subcutaneous proliferation of fusiform and slightly spindled cells with pale or amphophilic cytoplasm. The cells are distributed interstitially in a sclerotic reticular dermis, and extension into the subjacent subcutis in somewhat infiltrative fashion is noted. There is not maturation with descent in the dermis. In both the dermis and subcutis, a nested or fascicular configuration is apparent. With close scrutiny, occasional cells in mitosis can be found.	One outside slide, P-12-01072:A1-16, and one corresponding block, P-12-01072:A1.	HISTORY OF HURLER'S, STATUS POST BONE MARROW TRANSPLANT, NOW WITH A NODULAR LESION	\N	\N	\N	A SOX-10 immunostain shows diffuse immunopositivity, and this staining result indicates that this atypical proliferation is of melanocytic lineage. With that established, our differential diagnosis included a highly unconventional melanocytic nevus on one hand and spitzoid melanoma on the other. We included array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies, as per your request. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 1q, 5, 8, and 17q, and loss in chromosomes 9 and 12q was also documented. The documentation of multiple chromosomal aberrations confirms genomic instability, as is stereotypical of melanoma. The aCGH profile that we have documented is incompatible with any type of melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. This deeply invasive, thick tumor is non-ulcerated but demonstrates associated subcutaneous involvement. Further excision remains warranted to ensure that local eradication has been accomplished.	MELANOMA OF 6.5 MM IN THICKNESS, TRANSECTED AT THE SPECIMEN PERIPHERY	173676	1766	\N	\N	12-11041	\N	DP-09	PRKC Fused Cases	IP1096857	AirTable blocks_with_IP_info.csv
1635	12-55584	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. Overlying the lesion is irregular epidermal hyperplasia. There are confluent nests of large oval melanocytes that form sheets in some areas. Many mitotic figures are present superficially, and some in the lower portions of the lesion as well.	One outside slide, KA12-11802 (12-4953) and one corresponding block.	R/O SPITZ NEVUS/KERATOTIC NEVUS > VERRUCA VULGARIS	\N	\N	\N	The attached insurance information noted a request for comparative genomic hybridization which has now been performed, and shows multiple aberrations, with losses involving peri-centromeric areas of chromosomes 7q and 12q, and a peri-telomeric focus of 18q. The presence of multiple aberrations is worrisome, and is not in keeping with the diagnosis of a Spitz's nevus. As the aberrations are not typical of melanoma, I would consider this as equivalent to what has been reported in the literature as an atypical Spitz tumor. The vast majority of such cases have a favorable outcome, regardless of sentinel lymph node status. If a re-excision of this site shows a significant residuum, I would be interested in viewing the slides.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173305	1767	\N	\N	12-55584	\N	SYNAT607	2010-2017	IP1141397	AirTable blocks_with_IP_info.csv
1520	11-85416	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a compound proliferation of melanocytes mostly involving the junctional zone and a thickened papillary dermis.  Nests of, and increased numbers of single melanocytes are situated at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused by junctional nests, some of which have horizontally oriented spindled cells.  Toward the center of the lesion, smaller melanocytes reside in the papillary dermis. A focally dense lymphocytic infiltrate ascends to the junction.	One outside slide, M11-6000. One corresponding block received 11-21-11.	MELANOMA	\N	\N	\N	In addition to the findings noted below, levels show that the lesion is considerably thicker than in the initial sections, and has more confluence of junctional nests. A zone of paucicellular fibrosis is present beneath part of the lesion, consistent with a scar. Immunoperoxidase stained sections prepared in our laboratory show that a small minority of cells are p16 positive. This finding is less common in nevi than in melanoma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a very low proliferation rate, which in contrast is a reassuring finding. Similarly, only rare cells are positive in a phosphohistone H3 immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle).  Due to the difficult nature of this case, we obtained comparative genomic hybridization. This showed an isolated gain involving chromosome 7q. We have seen this aberration mainly in Spitz's nevi. While this is not a classic Spitz's nevus, the junctional component has some spitzoid features, and in this context I cannot interpret the current findings as supporting melanoma. Given the unusual nature of this lesion, I would still obtain a narrow re-excision of this site, however.	COMPOUND MELANOCYTIC NEVUS WITH SOME SPITZOID FEATURES	102538	1768	\N	\N	11-85416	\N	SYNAT608	2010-2017	IP1074864	AirTable blocks_with_IP_info.csv
1529	11-94134	0	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged epithelioid and slightly spindled melanocytes arrayed irregularly within the epidermis and dermis. The lesion shows reasonable lateral demarcation but is asymmetrical. Within the epidermis, enlarged melanocytes are present at both the epidermal-dermal junction and also above the junction, particularly toward one edge. In fibrotic dermis below this, partially maturing but enlarged epithelioid melanocytes are apparent, and occasional melanocytes in mitosis can be found. Some melanocytes are also multinucleate.	Two outside slides, EFG 296-11 (ML11157016:A,B) and one corresponding block (B).	9 X 6 MM GROWING LESION	\N	\N	\N	Our differential diagnosis included a highly unconventional Spitz nevus on one hand and nevoid melanoma on the other. As a certain diagnosis often cannot be rendered in this context based solely upon conventional microscopy, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a segmental gain in chromosome 7q with no other chromosomal gains or losses. We have identified gain in chromosome 7q in a small series of unconventional Spitz nevi. In contrast, gain in chromosome 7q as a monoaberration has not been documented in melanoma, in my experience. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, I believe this melanocytic proliferation represents an unconventional Spitz nevus.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, EXCISED IN THE AVAILABLE PLANES OF SECTION	173720	1769	\N	\N	11-94134	\N	SYNAT609	2010-2017	IP1083582	AirTable blocks_with_IP_info.csv
1546	12-2898	29	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes with a domed surface and a wedge shaped base. The overlying epidermis is slightly thickened, with a few discrete junctional nests. Within most of the dermal component, small fusiform melanocytes with lightly pigmented cytoplasm predominate. These cells have monomorphous oval, vesicular nuclei with small nucleoli. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. At the flanks of the lesion, smaller melanocytes are evident at the junction and in the superficial dermis. Some of the deeper melanocytes are peri-adnexal or bulge into a lymphatic vessel.	One outside slide, DPR-12-00019:A1, and one corresponding block.	NEW DARK BROWN IRREGULARLY PIGMENTED TENDER PAPULE", COMPARATIVE GENOMIC HYBRIDIZATION REQUESTED IN COVER LETTER	\N	\N	\N	Comparative genomic hybridization shows a gain involving chromosome 7, but no other aberrations. Gains of chromosome 7 are relatively common in melanoma. The lesion is not ulcerated, and hence is stage T3a in the 2009 AJCC classification. The configuration suggests that the final thickness will not be substantially greater than that seen here.	MELANOMA, AT LEAST 2.3 MM. IN THICKNESS	129522	1770	\N	\N	12-2898	\N	SYNAT610	2010-2017	IP1088714	AirTable blocks_with_IP_info.csv
10807	Dummer-KF2-Primary	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.19/D 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1942	\N	\N	\N	\N	SYNX539	\N	\N	Consolidated_data_final.csv
1548	12-4251	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a pedunculated segment of skin with a compound proliferation of large oval melanocytes. The junctional component is minor, and consists of increased numbers of single cells and small nests. Both the junctional and the dermal cells have abundant homogeneous-appearing pale eosinophilic cytoplasm with a ground-glass appearance, and large, pleomorphic, vesicular nuclei, some with enlarged nucleoli. Focally dense infiltrates of lymphocytes are present in many portions of the lesion.	One outside slide, S-12-784:1-1-2, and one corresponding block, 1A.	6 X 5 MM; RULE OUT DYSPLASTIC NEVUS	\N	\N	\N	There were some features in the hematoxylin and eosin stained sections suggesting a Spitz's nevus with a mutation in the BAP-1 gene. This mutation is often accompanied by loss of chromosome 3p or a segment thereof that can be found by comparative genomic hybridization. However, a BAP-1 immunoperoxidase stain shows no loss of nuclear staining in the large melanocytes, and comparative genomic hybridization shows no loss of chromosome 3p. However, there is a gain involving chromosome 1p, a small gain in 7p and a gain in 7q. Gains in 7q can be seen as isolated findings in some Spitz's nevi, but are also common findings in melanoma. Losses of 1p are typical of a variety of malignancies, including melanoma, but gains of 1p, as are present here, are unusual in melanoma. Given that three aberrations are evident, the lesion may have metastatic potential, but I am not convinced that an outright diagnosis of melanoma is appropriate. I believe that this lesion is equivalent to an atypical Spitz tumor, in which some metastatic potential is present, but not commensurate with lesional thickness (which in this case is around 2 mm.).	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH UNUSUAL GENOMIC ABERRATIONS	139523	1772	\N	\N	12-4251	\N	KF-01	Fusion RNA	IP1090067	AirTable blocks_with_IP_info.csv
1564	12-8171	82	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show a predominantly dermal proliferation of melanocytes. The overlying epidermis is slightly thickened, with a thick granular layer and compact hyperkeratosis. Within an area of fibrosis in the upper part of the lesion are small discrete aggregations of small, round melanocytes. These abut a larger population of large, oval melanocytes with abundant, pale cytoplasm and dusty appearing melanin, and monomorphous oval vesicular nuclei containing small nucleoli. There are many admixed melanophages. The enclosed immunoperoxidase stains show the melanocytes are strongly and uniformly Melan-A positive, and have (for a melanocytic neoplasm) a relatively high Ki-67 labelling rate (roughly 15-20%).	Three outside slides, W12-2042 / B, and one corresponding block.	1 CM BLUE-BLACK PAPULE; R/O MM	\N	\N	\N	While a combined deep penetrating nevus (with a minor component of conventional intradermal melanocytic nevus) is a plausible diagnosis based only on the morphology of the melanocytes, the lesion is in severely sun damaged skin and has a higher proliferation rate than is typical for such lesions (although this does not translate into a high mitotic rate). Comparative genomic hybridization shows numerous chromosomal aberrations including a rearrangement of 5q, a loss of 6q, a gain of 7q, a gain of 15q, a loss of 18q and a gain of 19. These findings are not compatible with a deep penetrating nevus, and include aberrations typical of melanoma.	MELANOMA, 3.3 MM. IN THICKNESS	423456	1773	\N	\N	12-8171	\N	SYNAT611	2010-2017	IP1093987	AirTable blocks_with_IP_info.csv
1566	12-10777	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	from Swapna	There is a compound proliferation of large oval, fusiform and polygonal melanocytes involving a segment of skin with a raised and slightly papillated surface. The junctional component is limited, consisting of increased numbers of single melanocytes and small nests of them, mostly at one edge of the specimen. Within the dermis are small aggregations of melanocytes with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular, heterochromatic nuclei, embedded in fibrotic stroma. Little mature with descent is evident. There are subepidermal fibrin deposits, with edema and extravasated erythrocytes.	One outside slide, 014855-AD, and one corresponding block.	PINK-CRUSTED PLAQUE; IMPRESSION OF RULE OUT SCC	\N	\N	\N	The differential diagnosis posed by these sections was that between a traumatized Spitz's nevus with unusual features (including striking nuclear pleomorphism) and melanoma. Comparative genomic hybridization shows chromosomal amplifications involving 5p, 7p, 12q and 22q; there is a probable gain involving 6p and one involving 8q as well. The number of aberrations is inconsistent with a Spitz's nevus, as are the multiple amplifications (gains of 11p and 7q can be seen as isolated phenomena in Spitz's nevi, but chromosomal amplifications are not generally found). The final thickness and AJCC stage will need to await complete removal of the remainder of the lesion. Any comments regarding treatment would be premature.	MELANOMA, AT LEAST 1.8 MM IN THICKNESS	173622	1774	\N	\N	12-10777	\N	DP-02	Possible TERT Fusion	IP1096593	AirTable blocks_with_IP_info.csv
10528	10_63051C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Normal (for #9) 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1775	\N	\N	\N	\N	SYNX372	\N	\N	Consolidated_data_final.csv
3326	DPN9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1777	\N	\N	None	\N	SYNAT612	2010-2017	\N	AirTable blocks_with_IP_info.csv
10531	DPN18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1778	\N	\N	\N	\N	SYNX375	\N	\N	Consolidated_data_final.csv
1449	11-21178	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed, somewhat papillated segment of skin with a proliferation of large oval melanocytes that extends from the junctional zone to the base of the specimen in the superficial reticular dermis. Large junctional and superficial dermal nests are present, composed of cells with large oval vesicular nuclei, small nucleoli and abundant amphophilic cytoplasm. The sizes of aggregations and of the cells that comprise them diminish toward the base of the specimen, where small nests are positioned between thickened collagen bundles. A focally dense lymphocytic infiltrate is evident. There are scattered mitotic figures.	Skin segment measuring 0.9 x 0.6 x 0.2 cm, bisected and entirely submitted.	7 X 6 MM PINK NODULE; SPITZ VS. JXG VS. MASTOCYTOMA	\N	\N	\N	The lesion is extensively transected at the base of the specimen. The majority of findings favor an inflamed Spitz's nevus. There are rare cases in which large nodular collections of more atypical-appearing cells are evident in the deep reticular dermis, and are only evident on reexcision. Comparative genomic hybridization shows no detectable chromosomal gains or losses. While the quality of the DNA that we extracted is not optimal, it is reasonable.  Most lesions of this type are well circumscribed. Hence, despite this result, I would still consider a slightly wider, but deeper (full thickness) reexcision to remove the remainder of the lesion and to make sure that a more atypical, deep component is not evident.	INFLAMED COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, PROBABLY AN UNUSUAL SPITZ'S NEVUS	107705	1779	\N	\N	11-21178	\N	SYNAT613	2010-2017	IP1010616	AirTable blocks_with_IP_info.csv
1666	13-212	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1780	\N	\N	13-212	\N	SYNAT614	2010-2017	\N	AirTable blocks_with_IP_info.csv
3466	KIT230	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1781	\N	\N	None	\N	SYNAT615	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3473	KIT297	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1782	\N	\N	None	\N	SYNAT616	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3474	KIT302	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1783	\N	\N	None	\N	SYNAT617	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3476	KIT316	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1784	\N	\N	None	\N	SYNAT618	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
11058	CP-4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2107	\N	\N	\N	\N	SYNX704	\N	\N	Consolidated_data_final.csv
1487	11-50270	19	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a domed proliferation of large oval and spindled melanocytes with oval vesicular nuclei and amphophilic cytoplasm involving the junctional zone of a thickened epidermis, and stratum spinosum above this, and the subjacent upper dermis. Nests predominate over single melanocytes along the epidermal-dermal junction. A few Kamino bodies are present. Clear suprabasilar scatter of single melanocytes is present within the epidermis. Melanocyte aggregations perhaps diminish in size with descent. There is a lymphohistiocytic infiltrate with admixed melanophages in the dermis. The dermal melanocytes include a few in mitosis. The enclosed immunoperoxidase stains show that most of the dermal melanocytes express HMB-45. When viewed at scanning magnification, the proliferation is asymmetrical. It also shows considerable scatter of melanocytes above the junction at its leading edges.	Three outside slides, WD11-7670. One corresponding block received 7-20-11.	DYSPLASTIC", SUBMITTED FOR COMPARATIVE GENOMIC HYBRIDIZATION	\N	\N	\N	This atypical melanocytic proliferation was evaluated by both immunohistochemistry and by molecular methods. Immunoperoxidase stained sections prepared in our laboratory show that while the intraepidermal component has only patchy expression of p16, the dermal component strongly expresses this determinant. A phosphohistone H3 immunoperoxidase stain (which labels melanocytes in mitosis) labels nuclei in the dermis, but these cells are mostly lymphocytes (that said, melanocytes in mitosis can be seen in conventional sections, so it is clear that cell proliferation was ongoing prior to biopsy). The aforementioned immunostaining results are inconclusive. We also completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH demonstrated gains in chromosomes 5p, 6, 7, 12, 21, and 22. A small segmental loss in chromosome 9q was also found. As you probably know, the identification of multiple chromosomal copy number aberrations indicates genomic instability and is stereotypical of melanoma. The finding of multiple genomic anomalies is incompatible with a diagnosis of melanocytic nevus.  In summary, the combination of results derived from conventional microscopy coupled with aCGH analysis points to interpretation as melanoma. This melanoma is non-ulcerated and shows Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished. This melanoma is of stage pT2a (2009 AJCC guidelines).	MELANOMA OF 1.4 MM IN THICKNESS	173507	1786	\N	\N	11-50270	\N	SYNAT619	2010-2017	IP1039709	AirTable blocks_with_IP_info.csv
1615	12-23578	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a zone of fibrosing inflammatory alterations beneath which is a proliferation of melanocytes with a wedge shaped configuration. Superficially, there are large ovoid melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei as well as prominent, central nucleoli. These cells are positioned just beneath the epidermis, and a few cells in mitosis are evident. Deeper and to the side in the dermis, small  melanocytes are apparent as maturing nests, cords, and syncytia.	Three outside slides, SROS12-3933:A1 through A3 (DRMC12-1872/MR:07670919), and three corresponding blocks.	EXCISION OF PATH DL12-16031, SPITZ NEOPLASM, R/O RESIDUAL, CHECK MARGINS	\N	\N	\N	The residuum seen here posed a microscopic differential diagnosis of a combined Spitz nevus on one hand and spitzoid melanoma arising in association with a congenital melanocytic nevus on the other. Per your request, we pursued array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a small gain in chromosome 7q with no other significant gains or losses. We have encountered this anomaly in a series of spitzoid tumors that either represent unconventional Spitz nevi or represent unclassifiable spitzoid tumors with indolent behavior. The molecular findings that we have identified do not point to interpretation as spitzoid melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of spitzoid melanoma. This unconventional melanocytic proliferation has been excised by means of this specimen.	RESIDUAL DESMOPLASTIC COMPOUND PROLIFERATION OF MELANOCYTES, EXCISED IN THE AVAILABLE PLANES OF SECTION	222596	1787	\N	\N	12-23578	\N	SYNAT620	2010-2017	IP1101847	AirTable blocks_with_IP_info.csv
1623	12-31421	60	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a slightly asymmetrical, broad, yet laterally demarcated compound proliferation of melanocytes. There are single melanocytes and nests distributed at the junction, and virtually all melanocytes are immediately at the junction. Some of the junctional nests centrally are large. Below the junction, striking lamellar fibroplasia is coupled with a patchy lymphohistiocytic infiltrate with admixed melanophages. Centrally, there are also some partially maturing but large dermal nests, and deep to this, modest elastosis is appreciable.	Three outside slides, D12-12414 and one corresponding block.	R/O LMN	\N	\N	\N	My differential diagnosis included an unconventional melanocytic nevus and nevoid melanoma, and after completion of molecular analysis, I believe the latter possibility represent the best interpretation for this atypical melanocytic tumor. Immunohistochemistry for p16 has been completed and demonstrates significant loss of expression, and thus an underlying anomaly in chromosome 9p was suspected. To more fully substantiate the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 5p, 5q, and 7q, as well as loss in chromosomes 5q  and 9. The identification of multiple copy number aberrations indicates genomic instability, as is stereotypical of malignancies such as melanoma. Additionally, the fact that chromosome 9 loss has been documented correlates with the loss of p16 expression that was documented immunohistochemically. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as nevoid melanoma. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.75 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	102537	1788	\N	\N	12-31421	\N	SYNAT621	2010-2017	IP1117239	AirTable blocks_with_IP_info.csv
1438	11-13661	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show an intradermal and superficial subcutaneous proliferation of plump spindled melanocytes distributed in wedge-shaped fashion within a skin segment that shows marked superficial elastosis. Cellularity is accentuated in the perifollicular adventitial dermis. Focal extension into fatty tissue is also apparent.	Two outside slides, AS11-9989:1 and 2, and two corresponding blocks.	PIGMENTED NODULE FOR 2 MONTHS; R/O MM, R/O BLUE NEVUS;" CGH PLEASE	\N	\N	\N	Our differential diagnosis included an atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other, and the latter possibility proves to represent the correct interpretation of this proliferation. To further assess the aforementioned differential diagnosis and screen this tissue for melanoma-associated genomic anomalies, we completed array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gains in chromosomes 1, 2, 6p, 7, and 8, as well as losses in chromosomes 6q, 11, and 22q. The identification of multiple chromosomal gains and losses decisively proves that this proliferation does not represent a melanocytic nevus but instead constitutes melanoma. Presuming this to be a primary lesion, the melanoma within this biopsy is non-ulcerated and focally invades the superficial subcutis (Clark's level V). If there is any history of melanoma, the possibility of a blue nevus-like metastasis s of melanoma could also be considered. Further excision is warranted to ensure that local eradication has been accomplished.  This report was reissued on March 29, 2011, after correcting a typographical error.	BLUE NEVUS-LIKE MELANOMA OF 2.9 MM IN THICKNESS	103362	1789	\N	\N	11-13661	\N	SYNAT622	2010-2017	IP1003098	AirTable blocks_with_IP_info.csv
10552	RC11-001	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1790	\N	\N	\N	\N	SYNX387	\N	\N	Consolidated_data_final.csv
10553	RC11-002	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1791	\N	\N	\N	\N	SYNX388	\N	\N	Consolidated_data_final.csv
10554	RC11-003	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1792	\N	\N	\N	\N	SYNX389	\N	\N	Consolidated_data_final.csv
10555	RC11-004	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1793	\N	\N	\N	\N	SYNX390	\N	\N	Consolidated_data_final.csv
10556	RC11-005	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1794	\N	\N	\N	\N	SYNX391	\N	\N	Consolidated_data_final.csv
10557	RC11-021	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1795	\N	\N	\N	\N	SYNX392	\N	\N	Consolidated_data_final.csv
10558	RC11-022	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1796	\N	\N	\N	\N	SYNX393	\N	\N	Consolidated_data_final.csv
10559	RC11-023	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1797	\N	\N	\N	\N	SYNX394	\N	\N	Consolidated_data_final.csv
1460	11-28912B	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a dome surfaced, wedge-based proliferation of large oval melanocytes with moderately enlarged oval vesicular nuclei and abundant pale, vacuolated cytoplasms, arranged as large nests and fascicles superficially and as smaller aggregations in the deep reticular dermis. Some nuclear pleomorphism is present. There are evenly distributed melanophages. Mitoses appear to be rare, and mostly superficial.	Two skin segments, one measuring 0.5 x 0.3 x 0.1 cm, intact, and the other measuring 0.7 x 0.6 x 0.1 cm, bisected, all entirely submitted in cassette B.	A) ? NEOPLASM, R/O DF, B) ? NEOPLASM; R/O ATYPICAL NEVUS, C) R/O VK VS. CONDYLOMA (-) HPV TYPING IF NEEDED	\N	\N	\N	The neoplasm extends to the base of the specimen in the deeper piece. This is an unusual lesion whose appearance is similar in some respects to that of blue nevus, clinically and histopathologically, but is genomically different. While most of the findings are reassuring, I would still consider a narrow re-excision as there are rare lesions in which the appearance that most of the lesion has been removed is deceptive.	DEEP PENETRATING NEVUS	173533	1669	\N	\N	11-28912	B	SYNAT623	Deep Penetrating Nevus	IP1018350	AirTable blocks_with_IP_info.csv
1475	11-38149	54	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show an area of inflamed granulation tissue with no evidence of residual melanocytic neoplasm.	Ellipse measuring 2.0 x 1.2 x 0.9 cm.  With the margin inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A and four sections in cassette B.	RE-EXC DEEP PENETRATING NEVUS	\N	\N	\N	None	HEALING BIOPSY SITE, WITH NO EVIDENCE OF A RESIDUAL DEEP PENETRATING NEVUS	173533	1669	\N	\N	11-38149	\N	SYNAT624	Deep Penetrating Nevus	IP1018350	AirTable blocks_with_IP_info.csv
1669	13-2939B	71	\N	\N	\N	T4b	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in contiguity with the epidermis. The melanocytes are pigmented and epithelioid or fusiform, and coalescing fascicles and sheets of cells are apparent and are accompanied by many melanophages. There is little diminishment in melanocyte size with descent in the dermis. Deep extension into the subcutis is present centrally. To the side of this, many similar epidermal melanocytes are apparent singly and in small nests and fascicles. A perijunctional lymphohistiocytic infiltrate with admixed melanophages is also noted.	Oriented oval excision, 1.5 x 1.5 x 1.2 cm, including a central 0.9 x 0.9 cm violaceous pink and raised area.  With the orienting sutured end arbitrarily designated 12 o'clock by the grosser, the 12 to 6 o'clock margin is inked blue and the 6 to 12 o'clock margin is inked yellow; entirely submitted with two sections each in A-C. HD/HD	MELANOMA	\N	\N	\N	This biopsy demonstrates a 'deep penetrating' melanoma with a nodular invasive component that extends into the upper subcutis. The invasive component has been fully excised, but flanking melanoma in situ is transected at the inked specimen periphery. With respect to staging, this melanoma exceeds 4 mm in thickness and shows focal associated ulceration. Therefore, it represents a melanoma of stage pT4b (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 8.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE INKED SPECIMEN MARGIN	172599	1810	\N	\N	13-2939	B	SYNAT625	Deep Penetrating Nevus	IP1187682	AirTable blocks_with_IP_info.csv
10580	L13-48798	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN (DPN like Melanoma)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1811	\N	\N	\N	\N	SYNX408	\N	\N	Consolidated_data_final.csv
1711	13-51115A	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of nested and solitary melanocytes arrayed irregularly and confluently within the epidermis and dermis. The constituent melanocytes display atypical nuclear features and have abundant vacuolated and heavily pigmented cytoplasm, and some melanocytes are scattered above the epidermal-dermal junction. In the dermis, there is a syncytial array of non-maturing melanocytes with associated early necrosis and many melanophages.	Skin segment measuring 0.8 x 0.6 x 0.3 cm, bisected and entirely submitted in A. PL/PL	A) HYPERKERATOTIC, PIGMENTED CHANGING PAPULE; R/O MM, B) SAME LESION, DEEP TO (A), CLINICALLY VISIBLE RESIDUAL PIGMENTED LESION REMOVED BY PUNCH; R/O MM	\N	\N	\N	\N	INVASIVE MELANOMA	173502	1812	\N	\N	13-51115	A	SYNAT626	2010-2017	IP380899	AirTable blocks_with_IP_info.csv
1506	11-73238A	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show skin in a polypoid configuration.  A compound proliferation of melanocytes composed of single cells and nests along the sides and bases of elongated rete ridges is present. Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the reticular dermis.	Skin segment measuring 0.9 x 0.7 x 0.4 cm, trisected and entirely submitted in cassette A.	A-B) NEOPLASM NOS, IRRITATED ACROCHORDON	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, POLYPOID	173530	1813	\N	\N	11-73238	A	SYNAT627	2010-2017	IP987085	AirTable blocks_with_IP_info.csv
1507	11-73999	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes.  A few small junctional nests of melanocytes are present at the periphery.  Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the reticular dermis with accentuation around adnexae. The overlying epidermis is papillated.	Skin segment measuring 1.3 x 1.1 x 0.3 cm, quadrisected and entirely submitted.	LARGE CONGENITAL NEVUS, RECENTLY CHANGING WITH IRREGULAR PIGMENT; R/O CONGENITAL NEVUS VS. MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173714	1814	\N	\N	11-73999	\N	SYNAT628	2010-2017	IP1063446	AirTable blocks_with_IP_info.csv
3302	DM65	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1815	\N	\N	None	\N	SYNAT629	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1715	13-59840	52	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a papillated segment of skin in which there is a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.	Multiple tissue fragments, 1.6 x 1.3 x 0.3 cm in aggregate, entirely submitted. RS/RS	R/O DYSPLASTIC NEVUS	\N	\N	\N	None	COMBINED MELANOCYTIC NEVUS, WITH SUPERFICIAL CONGENITAL AND DEEP PENETRATING NEVUS COMPONENTS	528599	1816	\N	\N	13-59840	\N	SYNAT630	2010-2017	IP352453	AirTable blocks_with_IP_info.csv
3554	Seider_Uveal	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1817	\N	\N	None	\N	SYNAT631	2010-2017	\N	AirTable blocks_with_IP_info.csv
3495	Luping_ROS_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1818	\N	\N	None	\N	SYNAT632	2010-2017	\N	AirTable blocks_with_IP_info.csv
3553	Seider_Roe	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1819	\N	\N	None	\N	SYNAT633	2010-2017	\N	AirTable blocks_with_IP_info.csv
10606	12-762B	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Iwei DPN (Control Normal Nevus)	\N	Sections show is a dome surfaced segment of skin with nests of small, round melanocytes in the dermis with increased numbers distributed around adnexal structures.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette B.	\N	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173312	1827	\N	\N	12-762	B	SYNX424	\N	IP1086578	Consolidated_data_final.csv
11059	CP-5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2108	\N	\N	\N	\N	SYNX705	\N	\N	Consolidated_data_final.csv
10599	11-51223	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	Iwei 7Q Gain	CGH11-215 	There is a broad and poorly circumscribed proliferation of melanocytes with a papillated surface. At the periphery, increased numbers of single melanocytes and small nests are present along and above the junction. Many of these cells are spindled, and some have large, hyperchromatic nuclei or pigmented dendrites. The overlying epidermis has pigmentation of its keratinocytes. Centrally, in the papillated part of the proliferation, there are large nests and fascicles of large fusiform melanocytes with lightly pigmented cytoplasm and oval, vesicular nuclei that extend from the junctional zone into the superficial reticular dermis. Some of the superficial nests are confluent and oddly shaped. A few mitotic figures are present among them. They are a few large Kamino bodies. Toward the base of the proliferation, somewhat smaller cells colonize adnexal structures. A perijunctional lymphohistiocytic infiltrate with admixed melanophages is also noted.	Four outside slides, SK11-11019 B and one corresponding block.	\N	\N	\N	\N	Our differential diagnosis included a peculiar pigmented spindle cell nevus on one hand and spitzoid melanoma on the other. To more comprehensively assess this differential diagnosis, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH demonstrated possible gain in chromosome 2q, gain in chromosome 5p, loss in terminal chromosome 5q, loss in 6q, gain in 7q, and segmental gain in 11q. As you know, the identification of multiple genomic gains and losses is indicative of genomic instability and is incompatible with a diagnosis of melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with low risk for widespread dissemination. In our experience, most tumors of this type are of very low grade.  With respect to staging parameters, this melanoma is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	CHILDHOOD-TYPE SPITZOID MELANOMA OF 1.3 MM IN THICKNESS	173305	1821	\N	\N	11-51223	A	SYNX418	\N	IP1040663	Consolidated_data_final.csv
10600	12-22542	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	Iwei 7Q Gain	CGH12-088 	Sections show acral skin with a broad-based pan-dermal and superficial subcutaneous proliferation of large oval melanocytes. The constituent cells are arranged as discrete nests and interconnecting fascicles within fibrotic stroma. The cells have abundant amphophilic cytoplasm and enlarged, oval vesicular nuclei. Scattered mitotic figures are evident. There is no significant intraepidermal component, nor do areas show significant pigmentation. The enclosed immunoperoxidase stains include an S100 preparation labeling nearly all of the constituent cells, paralleled by similar staining with Melan-A and HMB45. There is no loss of nuclear or cytoplasmic staining for p16 protein. A Ki-67 stain shows a low proliferative rate.	Ten outside slides, SV12-1858:B1 and B2, and one corresponding block (B2).	\N	\N	\N	\N	The configuration of this lesion is unusual (it is more bottom-heavy than most spitzoid proliferations). Comparative genomic hybridization shows a gain of part of chromosome 7q and a loss of part of that chromosome, and a gain of part of chromosome 11p and a loss of part of that chromosome, but no other aberrations. Spitz's nevi with chromosome 11p gains are likely to have a mutation involving h-ras, and to deeply infiltrate the reticular dermis as single cells, findings that are present here. Because of the presence of losses in both chromosomes as well as gains, I asked my colleague, Dr. Boris Bastian to review the findings as well, and he agrees with this interpretation. References:  van Engen-van Grunsven AC, van Dijk MC, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WA. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. Am J Surg Pathol. 2010 Oct;34(10):1436-41.  Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000 Sep;157(3):967-72.	SPITZ'S NEVUS, PREDOMINANTLY INTRADERMAL	672655	1822	\N	\N	12-22542	A	SYNX419	\N	IP1108360	Consolidated_data_final.csv
10601	12-42406	44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei 7Q Gain	CGH12-188 	Sections show a compound proliferation of melanocytes, many of which are large, and spindled to epithelioid, arrayed as nests and some single cells along the junctional zone, and as clusters and syncytia within the dermis. Some slightly smaller but similar melanocytes are also present, and many melanocytes are positioned between thickened/sclerotic collagen bundles. There is a patchy lymphocytic infiltrate. Occasional dermal mitotic figures are evident.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted.	\N	\N	\N	\N	ADDENDUM, July 19, 2012: As you know, our differential diagnosis included an unconventional desmoplastic Spitz nevus on one hand and spitzoid melanoma on the other. To more fully address that differential diagnosis, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 11p as well as focal gain and loss in chromosome 7q. The identification of 11p gain indicates a desmoplastic Spitz nevus with associated HRAS mutation (a reference regarding this entity is listed below). The additional identification of an anomaly involving chromosome 7 is meaningless in the context of 11p gain. In our prior evaluation of this tumor, p16 immunostaining was completed and a near-total loss of expression is apparent. This result implied that a genomic copy number anomaly involving chromosome 9p might be present. However, our aCGH analysis proves this is not the case. Rather, molecular assessment proves that a copy number anomaly involving chromosome 9 is not present.  A reexcision from this site has been received as our case 12-46583. Please refer to that case for additional information.  Reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF ENLARGED SPINDLED AND EPITHELIOID MELANOCYTES, CONSISTENT WITH AN UNCONVENTIONAL DESMOPLASTIC SPITZ NEVUS	17723	1823	\N	\N	12-42406	A	SYNX420	\N	IP1128224	Consolidated_data_final.csv
10602	12-55875	5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	Iwei 7Q Gain	CGH12-227 	There is a large, a pedunculated segment of skin with a proliferation of large, oval, fusiform and spindled cells throughout the dermis. The overlying epidermis is irregularly hyperplastic. The lesional melanocytes form closely apposed fascicles, and have homogeneous appearing eosinophilic cytoplasm, with adjacent cells delineated by clefts. Some cells have coarse chromatin, large, and sometimes multiple nucleoli. Scattered mitotic figures are present. Little diminution in cellularity is present toward the base of the specimen.	Three outside slides, SP12-11271 / A1-A3 (R12-15385 / A).  Three corresponding blocks received 7-30-12.	\N	\N	\N	\N	I note the considerations in Dr. Barnhill's report, and in large part agree. The extreme nuclear pleomorphism, with large bizarre nuclei, some containing macronucleoli and configuration of the lesion are findings by light microscopy against a conventional Spitz's nevus, or a well characterized variant. Morphologically, I favored designation as spitzoid melanoma of childhood. After discussion of the case with the child's dermatologist, Dr. Aimee Smidt, we have proceeded with comparative genomic hybridization. This showed multiple aberrations, consistent with melanoma. These included a set of aberrations involving chromosome 6p, with high level amplifications of the peri-telomeric and peri-centromeric areas, and a loss of the broader area in between them. Other losses include 8p, 11q and 19q, with a gain involving 19p.  The lesion is over 7 mm in thickness, which ordinarily would qualify this non-ulcerated neoplasm as stage T4 melanoma. While there is a propensity for lesions like this one to involve local lymph nodes, systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. This lessens the predictive value of sentinel lymph node biopsy and the therapeutic value of completion lymphadenectomy even when nodes are positive.	SPITZOID MELANOMA, CHILDHOOD TYPE	173507	1824	\N	\N	12-55875	A	SYNX421	\N	IP1141688	Consolidated_data_final.csv
10603	12-88454	67	f	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.5	Iwei 7Q Gain	CGH12-376 	Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. There are plump, oval melanocytes with moderate amounts of pale cytoplasm and monomorphous small nuclei arranged as nests along the dermo-epidermal junction, with large, confluent nests in the subjacent papillary dermis. Some pagetoid scatter of single melanocytes is present, much better seen in the Melan-A immunoperoxidase stain than in the hematoxylin and eosin stained sections.	Seven outside slides, DA12-04997 / A (A12-3268 / A1). One corresponding block received 11/27/12.	\N	\N	\N	\N	The pagetoid scatter (revealed in your Melan-A immunoperoxidase stain) and the confluence of nests in the superficial dermis are findings worrisome for melanoma. The mostly nested pattern seen here would be unusual for a dysplastic (Clark's) nevus in a patient of this age. On the other hand, immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) performed in our laboratory shows almost no labelling of the nuclei of dermal melanocytes with Ki-67. Because of these conflicting criteria, we obtained comparative genomic hybridization. This showed multiple chromosomal aberrations indicative of melanoma. The include gains involving chromosomes 1p, 6p and 7q, with a loss involving 9q. Several of these aberrations are typical ones seen in melanoma.  The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 0.6 MM. IN THICKNESS	173531	1825	\N	\N	12-88454	A	SYNX422	\N	IP1174271	Consolidated_data_final.csv
10604	12-98328	8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Iwei 7Q Gain	CGH13-007 	There is a broad-based, roughly wedge-shaped pan-dermal and superficial subcutaneous proliferation of large oval and fusiform melanocytes. The overlying epidermis is irregularly hyperplastic, with, in one focus, a subjacent area of inflamed fibrosing granulation tissue containing histiocytes with granular material in their cytoplasm (aluminum chloride residue). The subjacent melanocytic proliferation consists of thin fascicles of cells with abundant pale amphophilic cytoplasm and oval vesicular nuclei with variable chromatin (finely stippled in some cells, and with large nucleoli in others). An infiltrate of lymphocytes, plasma cells and eosinophils is present.	Three outside slides, D12-26205:1, 2, and 3, and three corresponding blocks.	\N	\N	\N	\N	An ALK stain was negative (performed as some spitzoid lesions with very long vertically oriented fascicles are ALK positive). Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively high proliferation rate in deep dermal melanocytes, with about 10% of nuclei positive in some aggregations). A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows scattered mitotic figures in both superficial and deep melanocytes. The proliferation rate and lack of maturation with descent are worrisome, raising the possibility of a spitzoid melanoma. Comparative genomic hybridization shows gains involving the distal portion of chromosome 7q and 11p. These two aberrations are found in a minority of Spitz's nevi, usually in isolation, but occasionally together. The deeply infiltrative pattern is one associated with 11p gain; we are in the process of analyzing the findings in Spitz's nevi with 7q gain, and those with both aberrations. Given this result, I would follow the site clinically.	COMPOUND SPITZ'S NEVUS	123746	1826	\N	\N	12-98328	A	SYNX423	\N	IP1176562	Consolidated_data_final.csv
10809	Dummer-KF2-Met1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS2014.15/7 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1944	\N	\N	\N	\N	SYNX541	\N	\N	Consolidated_data_final.csv
11157	SSCS03-014369	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	2204	\N	\N	\N	\N	SYNX801	\N	\N	Consolidated_data_final.csv
10610	13-47668	65	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	Iwei DPN  	\N	Sections show a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another more superficial component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm. Solar elastosis is present in the dermis.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. RS/RS	\N	\N	\N	\N	This melanocytic nevus shows features of both a conventional melanocytic nevus and a deep penetrating nevus.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	424655	1831	\N	\N	13-47668	A	SYNX428	\N	IP298118	Consolidated_data_final.csv
10613	13-47621	24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Iwei DPN  	\N	Sections show a compound proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There are melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. HD/HD	\N	\N	\N	\N	This neoplasm has features of both a superficial congenital melanocytic nevus and a deep penetrating nevus. There is no evidence of melanoma or atypicality.	COMBINED MELANOCYTIC NEVUS	528522	1833	\N	\N	13-47621	A	SYNX430	\N	IP1288923	Consolidated_data_final.csv
10615	13-37371	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	Iwei DPN  	\N	Sections show a compound proliferation of small melanocytes with ovoid nuclei, and slight diminishment in the size of melanocytes with descent in the dermis is appreciable.  Most of the dermal melanocytes are arrayed as syncytia. Some dermal melanocytes have ample, finely melanized cytoplasm and are slightly larger in size.  There are many surrounding melanophages in the dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	\N	\N	\N	\N	This biphasic melanocytic nevus includes the commingling of congenital melanocytic nevus with deep penetrating nevus.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	173688	1834	\N	\N	13-37371	A	SYNX431	\N	IP1278673	Consolidated_data_final.csv
10622	Acral-11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	_Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	1835	\N	\N	\N	\N	SYNX432	\N	\N	Consolidated_data_final.csv
10624	Acral-12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	_Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	1836	\N	\N	\N	\N	SYNX433	\N	\N	Consolidated_data_final.csv
10628	02-2599C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1837	\N	\N	02-2599	C	SYNX434	\N	IP307333	Consolidated_data_final.csv
10626	02-2599	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	757.33	\N	\N	Sections show a domed segment of skin, with a slightly hyperkeratotic\nepidermis above a proliferation of spindled cells and thin-walled\nblood vessels.  There are adipocytes within the core of the lesion.	Polypoid skin fragment, measuring 0.8 x 0.8 x 0.6 cm, trisected and\nentirely submitted.	\N	\N	\N	\N	This lesion displays adipocytes within its core, an alteration similar to that seen in nevus lipomatosus. This is probably a reflection of the hamartomatous nature of this lesion.	ACQUIRED DIGITAL FIBROKERATOMA	666689	1837	\N	\N	02-2599	A	SYNX434	\N	IP307333	Consolidated_data_final.csv
10638	T07-1120	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1838	\N	\N	\N	\N	SYNX435	\N	\N	Consolidated_data_final.csv
10639	T09-8069	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1839	\N	\N	\N	\N	SYNX436	\N	\N	Consolidated_data_final.csv
10640	T02-16195	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1840	\N	\N	\N	\N	SYNX437	\N	\N	Consolidated_data_final.csv
10641	T00-12011	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1841	\N	\N	\N	\N	SYNX438	\N	\N	Consolidated_data_final.csv
10642	T06-6855	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1842	\N	\N	\N	\N	SYNX439	\N	\N	Consolidated_data_final.csv
10643	12-18832AA	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.0	\N	\N	Sections show an intraepithelial proliferation of atypical keratinocytes confined largely to the interadnexal epidermis, with overlying parakeratosis.	Skin segment measuring 0.5 x 0.2 x 0.1 cm. Submitted intact.	\N	\N	\N	\N	Level sections show similar findings.	SOLAR KERATOSIS	100058	1843	\N	\N	12-18832	A	SYNX440	\N	IP1104649	Consolidated_data_final.csv
10644	CNS52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1844	\N	\N	\N	\N	SYNX441	\N	\N	Consolidated_data_final.csv
10645	CNS53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1845	\N	\N	\N	\N	SYNX442	\N	\N	Consolidated_data_final.csv
10646	CNS54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1846	\N	\N	\N	\N	SYNX443	\N	\N	Consolidated_data_final.csv
10647	CNS57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1847	\N	\N	\N	\N	SYNX444	\N	\N	Consolidated_data_final.csv
10649	BN-N1-Tert	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1848	\N	\N	\N	\N	SYNX445	\N	\N	Consolidated_data_final.csv
10650	BN-N2-Tert	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1849	\N	\N	\N	\N	SYNX446	\N	\N	Consolidated_data_final.csv
10651	BN-M1-Tert	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1850	\N	\N	\N	\N	SYNX447	\N	\N	Consolidated_data_final.csv
10654	12-12039B	35	f	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of melanocytes arranged singly and in small nests along the dermo-epidermal junction in a broad area. There is a small focus in which the melanocytes have abundant, pale amphophilic cytoplasm and enlarged nuclei, with pagetoid scatter in the epidermis and clusters of similar cells in the superficial dermis, accompanied there by fibrosis and a patchy lymphocytic infiltrate.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, quadrisected perpendicular to the long axis and entirely submitted in cassette B.	\N	\N	\N	\N	The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 0.35 MM. IN THICKNESS	176788	1851	\N	\N	12-12039	B	SYNX448	\N	IP1097855	Consolidated_data_final.csv
10656	99-29482	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of atypical melanocytes\narranged in a pagetoid pattern within the epidermis, and with similar\ncells in the deep reticular dermis.  There is confluence of\nmelanocytes at the junction.	Cylindrical skin segment plus fragment, measuring 0.4 cm in diameter\nand 0.7 cm in thickness in aggregate.	\N	\N	\N	\N	The neoplasm measures over 1 mm. in these sections.	MELANOMA, FINAL THICKNESS TO AWAIT COMPLETE EXCISION	173713	1852	\N	\N	99-29482	A	SYNX449	\N	IP205015	Consolidated_data_final.csv
10811	Dummer-KF3-Primary	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.16 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1945	\N	\N	\N	\N	SYNX542	\N	\N	Consolidated_data_final.csv
10812	Dummer-KF3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.16 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1946	\N	\N	\N	\N	SYNX543	\N	\N	Consolidated_data_final.csv
10658	99-885	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of atypical melanocytes\narranged in an irregular pattern within the epidermis, and with\nsimilar cells in the papillary dermis.  There are foci of pagetoid\nupward spread.  While some of the dermal cells are small, others have\nlarge nuclei and are different in appearance from their counterparts\nat the same level of the dermis.	Skin segment measuring 0.9 x 0.7 x 0.2 cm, trisected and entirely\nsubmitted.	\N	\N	\N	\N	\N	MELANOMA, 0.70 MM IN THICKNESS, INVOLVING ACRAL SKIN, EXTENDING TO THE PERIPHERAL MARGIN	323788	1854	\N	\N	99-885	A	SYNX451	\N	IP176418	Consolidated_data_final.csv
10659	98-37643	44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of atypical melanocytes\narranged in an irregular pattern within the epidermis, and with\nsimilar cells in the papillary dermis.  The pattern is predominantly\nnested, with striking irregularity among nests.	Cylindrical skin segment, 0.7 cm in diameter and 0.3 cm in thickness,\ntrisected and entirely submitted.	\N	\N	\N	\N	In light of the presence of some degree of epidermal hyperplasia, the microstage measurement listed above probably overestimates the prognostic risk of this lesion, as the measurement is inflated by the epidermal changes.	MELANOMA, 0.7 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173717	1855	\N	\N	98-37643	A	SYNX452	\N	IP175216	Consolidated_data_final.csv
11060	CP-6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2109	\N	\N	\N	\N	SYNX706	\N	\N	Consolidated_data_final.csv
11111	RPA08-0209	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2158	\N	\N	\N	\N	SYNX755	\N	\N	Consolidated_data_final.csv
10661	09-29997	53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Iwei Acral Melanoma	\N	Sections show distorted nail bed epithelium, containing a proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells in sheets in the dermis. Only scant melanin pigment is present. In the portion of epithelium, there is suprabasal scatter of melanocytes, and they may also be present in the overlying stratum corneum. The nail plate is markedly dystrophic.	Two cylindrical skin segments, one measuring 0.3 cm in diameter and 0.2 cm in thickness, inked blue, and the other measuring 0.3 cm in diameter and 0.1 cm in thickness, both submitted intact.	\N	\N	\N	\N	I have also had the opportunity to review the prior biopsy from this patient, and the current findings are now diagnostic for melanoma. The lineage of the neoplastic cells was confirmed in a Melan-A immunostain, as the tumor displays only scant pigment. With regard to the staging of subungual melanoma, Clark's levels are not reported, as the typical arrangement of papillary and reticular dermis is not present in the nail unit per se. The exception is for Clark's level V, which is assigned when periosteal involvement is present. That finding cannot be assessed in the current sections. There is no evidence of lymphovascular or perineural invasion in these sections. However, given the potentially large size of the area of involvement indicated in the clinical photographs we received previously, definitive assessment of all prognostic features should be deferred to the complete reexcision specimen.	SUBUNGUAL MELANOMA, AT LEAST 1 MM IN THICKNESS, EXTENDING TO THE PERIPHERY OF THE BIOPSY	252688	1857	\N	\N	09-29997	A	SYNX454	\N	IP310907	Consolidated_data_final.csv
10662	04-11158	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of strikingly atypical melanocytes arranged in an irregular and focally pagetoid pattern within the epidermis, and with sheets similar cells throughout the dermis.  Slightly smaller ones are present near one edge.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.3 cm in thickness.	\N	\N	\N	\N	This appears to be a primary melanoma of about 2 mm in thickness.  The final thickness measurement should be made after complete excision.  There may be cells of a pre-existent nevus as well (but I cannot distinguish them with certainty from small melanoma cells),	MELANOMA	173616	1858	\N	\N	04-11158	A	SYNX455	\N	IP427557	Consolidated_data_final.csv
10663	UM4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1859	\N	\N	\N	\N	SYNX456	\N	\N	Consolidated_data_final.csv
10664	UM5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1860	\N	\N	\N	\N	SYNX457	\N	\N	Consolidated_data_final.csv
10665	08-84352	36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	Ivanka Patient Melanoma	\N	Sections show an asymmetrical, compound melanocytic proliferation with a biphasic pattern. One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. Similar melanocytes are present in the subjacent dermis. There are mitotic figures within the epidermis, and within the perijunctional and deeper dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). This latter population is arrayed as nests and single cells along the sides and bases of elongate and focally fused rete ridges, with similar small melanocytes present within a fibrotic papillary dermis.	Skin segment measuring 1.4 x 0.9 x 0.2 cm, trisected and entirely submitted in cassette A.	\N	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level III/IV, abutting the reticular dermal interface. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is of course warranted to ensure that this lesion has been removed in its entirety.	MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE PERIPHERAL EDGE AND BASE OF THE SPECIMEN	123493	1861	\N	\N	08-84352	A	SYNX458	\N	IP792993	Consolidated_data_final.csv
10669	11-88792	56	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.7	Ivanka Patient Melanoma	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with numerous cells present above the basal layer.  There are similar melanocytes in the subjacent dermis and some of them surround eccrine ducts.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  These cells tend to mature with descent.	Skin segment, 1.5 x 1.0 x 0.1 cm, quadrisected, and entirely submitted.	\N	\N	\N	\N	Melanoma in situ extends along eccrine glands to the base of the specimen.  In terms of staging, this is a thin, non-ulcerated melanoma.  No dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.	MELANOMA, 0.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173710	1862	\N	\N	11-88792	A	SYNX459	\N	IP787073	Consolidated_data_final.csv
10674	13-74952	2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei DPN	CGH13-324 	There is a mostly intradermal proliferation of large, oval melanocytes with abundant pale cytoplasm and large, but monomorphous oval vesicular nuclei. The overlying epidermis is thinned, with much of the lesion in an expanded papillary dermis, surrounded by epithelial collarettes. There are patchy lymphocytic infiltrates throughout the lesion. There are scattered mitotic figures. There is limited maturation with descent.	One outside slide, DPR-13-8644 / A1, and one corresponding block.	\N	\N	\N	\N	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. To provide some context for the eventual findings, I performed a few immunostains. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows many nuclei with what appear to be mitotic figures in melanocytes in the lower half of the lesion. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. Comparative genomic hybridization shows gains involving chromosomes 12p and 15q. This is an unusual result. I shared the comparative genomic hybridization data with my colleagues, Drs. Boris Bastian and Iwei Yeh. They do not regard these aberrations as indicating melanoma, as more typical ones would. There may be a gene fusion mechanism in this case, as has been seen with other spitzoid lesions in studies from their lab.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have feature more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. If there are significant findings on re-excision, I would appreciate a chance to see the sections. Most lesions of this type are well circumscribed, and the re-excision should be deeper, but necessarily more than a few mms. wider that the prior biopsy site or an visible residuum.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR	173304	1863	\N	\N	13-74952	A	SYNX460	\N	IP1316957	Consolidated_data_final.csv
10813	Dummer-KF3-Met1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.17/I 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1947	\N	\N	\N	\N	SYNX544	\N	\N	Consolidated_data_final.csv
11052	UM15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2101	\N	\N	\N	\N	SYNX698	\N	\N	Consolidated_data_final.csv
10675	13-75067	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Iwei Translocation	CGH13-331 ETV6 Fusion	Sections show a compound, wedge-shaped proliferation of large oval melanocytes with  pleomorphic vesicular nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. Only a few junctional nests are present. The apex of the lesion is in the superficial subcutis dermis. There are evenly distributed melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. RS/RS	\N	\N	\N	\N	ADDENDUM, October  4, 2013: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: The overall findings are those of a so-called deep penetrating nevus. These are unusual melanocytic lesions with some features similar to those of blue nevus, but with a different genomic origin and the presence of some junctional nests. There are deep penetrating nevus-like melanomas, and in some controversies about the essential nature of this entity. Hence, I performed immunostaining. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a high proliferative rate in the lesional cells, with up to 30% of the cells in occasional nests having positively stained nuclei. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows only rare positive nuclei. A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product.  Given the unusual features in the hematoxylin and eosin-stained sections (the degree of confluence of dermal aggregations, and the degree of nuclear pleomorphism), as well as the high proliferative rate noted above, one would ideally achieve unequivocally clear margins around such a lesion. The current margins are less than 0.2 mm.  Following our discussion, and the history of brain tumor followed by radiation, I have requested a p53 immunoperoxidase stain, as some neoplasms due to radiation have p53 mutations that stabilize the protein, and lead to immunohistochemical positivity. The staining is negative.  Comparative genomic hybridization did not show chromosomal gains or losses, a finding that is strongly against melanoma.	DEEP PENETRATING NEVUS WITH SOME ATYPICAL FEATURES, WITH NO  ABERRATIONS SEEN WITH COMPARATIVE GENOMIC HYBRIDIZATION	173305	1864	\N	\N	13-75067	A	SYNX461	\N	IP1317072	Consolidated_data_final.csv
10676	Spitz_M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1865	\N	\N	\N	\N	SYNX462	\N	\N	Consolidated_data_final.csv
10677	Spitz_M2_(?)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1866	\N	\N	\N	\N	SYNX463	\N	\N	Consolidated_data_final.csv
10678	Spitz_N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1867	\N	\N	\N	\N	SYNX464	\N	\N	Consolidated_data_final.csv
10679	Spitz_N2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1868	\N	\N	\N	\N	SYNX465	\N	\N	Consolidated_data_final.csv
10680	Spitz_N3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1869	\N	\N	\N	\N	SYNX466	\N	\N	Consolidated_data_final.csv
10682	13-159	17	f	\N	\N	T3a	Primary	\N	\N	\N	\N	\N	\N	172.7	Iwei 7Q Gain	CGH13-016 	Sections show a dome-shaped segment of acral skin in which there is a compound proliferation of melanocytes, some of which are large and epithelioid, and the junctional component of which is arrayed with the lowermost sections of an epithelium that is slightly acanthotic and hyperkeratotic. Many of the lesional cells contain large nucleoli. In some areas within the dermis, the lesional cells are configured as confluence sheets without significant intervening stroma. The size of the melanocytes does not diminish with descent into the dermis.	Cylindrical skin segment, 0.9 cm in diameter and 0.5 cm in thickness, trisected and totally submitted.   CF/CF	\N	\N	\N	\N	Thank you also for informing me that the lesion has been present on the patient since age four and has grown steadily with the patient. However, the patient recently noted a more rapid rate of growth. My initial differential diagnosis included an unusual nevus with Spitzoid features and melanoma. To further evaluate for this differential diagnosis, I performed comparative genomic hybridization on this specimen. This is a molecular technique that evaluates for the presence of chromosomal gains or losses. It is based on the presence of chromosomal gains and losses in about 95% of melanomas, but with the exception of a gain of 11p, a lack of them in Spitz's nevi.  The comparative genomic hybridization has now been completed and it shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi.  In particular there is a loss of chromosome 6q, a gain of chromosome 7q, both a loss and a gain of chromosome 12p and a gain of chromosome 18q. The presence of multiple gains and losses supports the diagnosis of melanoma.  With regard to staging, the melanoma is between 2-4 millimeters in thickness and is not ulcerated. Therefore it should be classified as pT3a per the 2009 revision of the AJCC staging system for melanoma.  My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis and assessment.	MELANOMA, 3.1 MILLIMETERS IN THICKNESS, EXTENDING TO THE TISSUE EDGES	101721	1871	\N	\N	13-159	A	SYNX468	\N	IP1183551	Consolidated_data_final.csv
10683	12-43016	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH12-163 	There is a somewhat dome-shaped segment of skin that extends to the level of the superficial reticular dermis. There are large, compactly arranged nests of plump oval to slightly spindled melanocytes both at the junction and in the subjacent, fibrotic dermis. These cells have relatively monomorphous nuclei, diffuse hyperchromasia, and relatively abundant pale, somewhat fibrillar-appearing cytoplasm. There are areas in which some maturation and dispersion with descent appear to be present. The accompanying immunoperoxidase-stained sections show a very low proliferative rate amongst the dermal melanocytes with a Ki-67/Melan-A double stain, and HMB45 staining is limited to the junctional zone.	Seven outside slides, SH-12-22523:A.1-1 and A1, and one corresponding block, SH12-22523:A1.	\N	\N	\N	\N	The differential diagnosis included both an unusual nevus (probably the upper part of a superficial congenital nevus) and nevoid melanoma. The latter diagnosis is raised by the presence of very large nests, and the somewhat unusual cytologic features. Comparative genomic hybridization shows losses involving parts of chromosome 15 (discrete areas on both the short and long arms, but not the entire chromosome). This chromosome is not commonly lost in melanoma, and the meaning of this finding is not clear. I believe that the best interpretation is as a partially transformed lesion that is not diagnostic of melanoma, but should be completely excised.	COMPOUND PROLIFERATION OF MELANOCYTES WITH UNUSUAL FEATURES	321300	1872	\N	\N	12-43016	A	SYNX469	\N	IP1128829	Consolidated_data_final.csv
10684	13-34291	47	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.2	Iwei Translocation	CGH13-166 	Sections show an asymmetrical compound proliferation of melanocytes that is distinctly biphasic in its composition. One population consists of melanocytes with small amounts of amphophilic or vacuolated cytoplasm. These cells are distributed singly and in many nests within the epidermis and focally within adnexa, and maturing nests, cords, and syncytia of similar melanocytes can be seen in the dermis below this. The second population of larger epithelioid melanocytes has pale, ballooned, or finely pigmented cytoplasm. These cells are distributed erratically along the junction and in pagetoid fashion within adnexa, and several large nests of these melanocytes are present in the dermis as well. A patchy infiltrate of lymphocytes and melanophages is present in the dermis, concurrently. There is marked elastosis. In accompanying immunostains, the Ki-67 cell proliferation index is low.	Three outside slides, DN13-015188 and one corresponding block.	\N	\N	\N	\N	My differential diagnosis included both an atypical combined melanocytic nevus on one hand and nevoid (or deep penetrating) melanoma on the other. To more fully assess this differential diagnosis and to screen for genomic copy number anomalies, as can be seen with melanoma, we pursued array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss of chromosome 6q and gain in chromosome 15q. (The loss in chromosome 6q includes the location of the MYB gene that is assayed as part of standard fluorescence in situ hybridization copy number analysis of melanocytic tumors.) No other substantive chromosomal copy number gains or losses were noted. The identification of multiple copy number abnormalities suggests genomic instability, as is typical of malignancies such as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as nevoid melanoma. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration. Therefore, it represents melanoma of stage pT2a (2009 AJCC Guidelines). Further excision is warranted to ensure that local control has been established.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MELANOMA OF 1.7 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	120288	1873	\N	\N	13-34291	A	SYNX470	\N	IP1275593	Consolidated_data_final.csv
10686	Yurif_DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1875	\N	\N	\N	\N	SYNX472	\N	\N	Consolidated_data_final.csv
10689	DPN26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1876	\N	\N	\N	\N	SYNX473	\N	\N	Consolidated_data_final.csv
10713	MIN_7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma In Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1877	\N	\N	\N	\N	SYNX474	\N	\N	Consolidated_data_final.csv
10716	MIN_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma In Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1878	\N	\N	\N	\N	SYNX475	\N	\N	Consolidated_data_final.csv
10719	501_Mel	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1879	\N	\N	\N	\N	SYNX476	\N	\N	Consolidated_data_final.csv
10720	Sk_Mel_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1880	\N	\N	\N	\N	SYNX477	\N	\N	Consolidated_data_final.csv
10721	DPN24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1881	\N	\N	\N	\N	SYNX478	\N	\N	Consolidated_data_final.csv
10722	DPN28	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1882	\N	\N	\N	\N	SYNX479	\N	\N	Consolidated_data_final.csv
10723	DPN29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1883	\N	\N	\N	\N	SYNX480	\N	\N	Consolidated_data_final.csv
10724	DPN31	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1884	\N	\N	\N	\N	SYNX481	\N	\N	Consolidated_data_final.csv
10725	DPN33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1885	\N	\N	\N	\N	SYNX482	\N	\N	Consolidated_data_final.csv
10726	DPN40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1886	\N	\N	\N	\N	SYNX483	\N	\N	Consolidated_data_final.csv
10728	DPN41	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1887	\N	\N	\N	\N	SYNX484	\N	\N	Consolidated_data_final.csv
10729	DPN42	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1888	\N	\N	\N	\N	SYNX485	\N	\N	Consolidated_data_final.csv
10730	DPN44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1889	\N	\N	\N	\N	SYNX486	\N	\N	Consolidated_data_final.csv
10734	Birt_Hogg_Dube	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Metastatic Melanoma (KIT, NRAS, BRAF)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1893	\N	\N	\N	\N	SYNX490	\N	\N	Consolidated_data_final.csv
10735	13-1939	26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-027 NTRK3	There is a compound proliferation of large, oval melanocytes with abundant, pale slightly vacuolated amphophilic cytoplasm and large, vesicular nuclei with large central nucleoli. The lesion has a raised, slightly papillated surface, and a relatively thin epidermis. The lesional melanocytes are in closely apposed aggregations in the upper part of the lesion with a more dispersed pattern lower in it. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. The enclosed two-color immunostain shows that there is a low proliferation rate among the lesional melanocytes. A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product.	Six outside slides, S12-19782, S12-2604:C, and one corresponding block.	\N	\N	\N	\N	Comparative genomic hybridization shows an isolated loss of an interstitial area in chromosome 3p that contains the BAP-1 gene. Immunoperoxidase staining for BAP-1 shows loss of nuclear staining in the lesional melanocytes implying a mutation in the remaining allele; this aberration has been seen in a recently described subset of spitzoid lesions: 1: Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC. A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression. Am J Surg Pathol. 2012 Jun;36(6):818-30. PMID: 22367297.  2: Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, R¸tten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011 Aug 28;43(10):1018-21. doi: 10.1038/ng.910. PubMed PMID: 21874003.  I would look at the clinical images in paper #2 and biopsy any nevi similar to this one, or to those in the article. A family history of ocular or cutaneous melanoma, or synovial sarcoma should also be obtained. Most lesions of this type are spontaneous, however. A very narrow re-excision to prevent regrowth would be prudent. If there was a pre-operative photograph, we would greatly appreciate having it for our teaching collection.  To date, there is no link between tanning booth or UV exposure and nevi of this type.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES WITH A BAP-1 ABERRATION	173505	1894	\N	\N	13-1939	A	SYNX491	\N	IP1186681	Consolidated_data_final.csv
3589	UM26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2144	\N	\N	None	\N	SYNAT664	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
3578	TCR-Beta-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2145	\N	\N	None	\N	SYNAT665	2010-2017	\N	AirTable blocks_with_IP_info.csv
3579	TCR-Beta-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2146	\N	\N	None	\N	SYNAT666	2010-2017	\N	AirTable blocks_with_IP_info.csv
3257	CP1-80	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2147	\N	\N	None	\N	SYNAT667	2010-2017	\N	AirTable blocks_with_IP_info.csv
3256	CP1-40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2148	\N	\N	None	\N	SYNAT668	2010-2017	\N	AirTable blocks_with_IP_info.csv
3255	CP1-20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2149	\N	\N	None	\N	SYNAT669	2010-2017	\N	AirTable blocks_with_IP_info.csv
10736	13-51657	9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-268 MET	Sections show a domed compound proliferation of enlarged fusiform melanocytes with amphophilic cytoplasm. These cells are distributed singly and in nests and large fascicles within the epidermis, which is acanthotic, and limited scatter above the junction can be seen. Some large nests are accompanied by perijunctional edema, and some mitotic figures can be found within large junctional collections. In fibrotic dermis below this, there are much smaller nests and cords of similar melanocytes, but most of the dermis cannot be visualized because of the superficial nature of the biopsy.	Six outside slides, MS-13-0007857 A1. One corresponding block received 7-12-13.	\N	\N	\N	\N	ADDENDUM, August 9, 2013: As I reported previously, I am in general agreement with your suggested interpretation of this case. I favor the surface of a compound Spitz nevus, but some unconventional (or atypical) features are present, and the extent of subjacent dermal involvement cannot be evaluated because of the superficial nature of the biopsy. There are at least two ways to proceed in the management of this case. One is to complete conservative reexcision of this site and obtain any residuum for further histopathologic assessment. The other is to pursue comparative genomic hybridization (CGH) to screen this tumor for chromosomal copy number abnormalities, as can be found in association with spitzoid melanoma. (The latter option was selected, as is discussed further below.) Per a clinical request, we completed CGH analysis to screen for genomic copy number anomalies. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in distal chromosome 7q with no other chromosomal gains or losses. As background for understanding this result, please note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while most melanocytic nevi lack such aberrations. We have identified gain in chromosome 7q as a monoaberration in a subset of unconventional Spitz nevi.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of spitzoid melanoma. Rather, our analysis supports interpretation as an unconventional Spitz nevus. Given the complexity of this assessment, reexcision of this site would be reasonable to ensure local control and prevent persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, CONSISTENT WITH THE SURFACE OF AN UNCONVENTIONAL COMPOUND SPITZ NEVUS	173304	1895	\N	\N	13-51657	A	SYNX492	\N	IP1293660	Consolidated_data_final.csv
10737	13-89069	17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	Iwei DPN	CGH13-365 DPN-like Melanoma	Sections show a punch biopsy harboring a compound proliferation of heavily pigmented melanocytes that is biphasic in its composition. Deep within the specimen, there are dendritic and thin spindled melanocytes distributed interstitially amongst coarse collagenous stroma in concert with numerous melanophages, and this comprises one population of cells. In the upper dermis, the epidermis, and the perifollicular dermis, there is a second population of larger ovoid and fusiform melanocytes with abundant pale cytoplasm. These cells are also accompanied by many melanophages and have a slightly elevated cell proliferation index. Within the epidermis, scatter of some melanocytes above the junction can be seen.	Three outside slides, DP13-14246, and one corresponding block.	\N	\N	\N	\N	The histopathologic findings in this initial biopsy were worrisome for melanoma ex blue nevus. We completed comparative genomic hybridization (CGH) to screen for chromosomal copy number abnormalities, as can be seen in association with melanoma, and the results of this analysis are discussed in association with the specimen that follows.	BIPHASIC COMPOUND PROLIFERATION OF HEAVILY PIGMENTED MELANOCYTES, INCLUDING A COMPONENT OF BLUE NEVUS	173406	1896	\N	\N	13-89069	A	SYNX493	\N	IP1331074	Consolidated_data_final.csv
10738	11-1051A	30	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	Iwei Blue Nevus Melanoma	CGH11-018 	Sections show lactiferous ducts in fibrofatty tissue, with masses of plump oval melanocytes that have monomorphous, vesicular nuclei and inconspicuous cytoplasm in several areas. There are scattered melanophages in some areas, as well as clusters of bipolar, dendritic melanocytes in others. The most cellular areas of the proliferation have crowded, somewhat larger oval vesicular nuclei with many pyknotic cells amongst them. Mitotic figures are difficult to find.	Two outside slides, PC10-3033:A1,A2.	\N	\N	\N	\N	\N	MELANOMA, ARISING IN ASSOCIATION WITH A CELLULAR BLUE NEVUS	173504	1897	\N	\N	11-1051	A	SYNX494	\N	IP990488	Consolidated_data_final.csv
10739	11-5480	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	Iwei Blue Nevus Melanoma	CGH11-027 	Sections show segments of breast parenchyma, and within these segments there is a proliferation of plump spindled and slender dendritic melanocytes encompassed by a sclerotic fibrous matrix. In many areas, the proliferation consists of small dendritic melanocytes encompassed by this matrix and accompanied by an infiltrate of many melanophages. In other, more cellular foci, there are nodules composed of coalescing fascicles of plump spindled melanocytes with pale or faintly melanized cytoplasm. In these cellular areas, melanophages are few in number. Cells in mitosis are focally present but are not readily identifiable. The Ki-67 cell proliferation index is extremely low.	Twenty-seven outside slides, S10-8040:E1-E3,E5,E6,E8,E9,E13 and two corresponding blocks (E8,E9).	\N	\N	\N	\N	Based solely upon conventional microscopical assessment, I was agreement with the interpretation of Dr. Wick: I favored interpretation of this proliferation as a cellular blue nevus and was not convinced that a component of melanoma was present. However, given the diagnostic controversy that had surrounded this case, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block (from a hypercellular focus), aCGH analysis was completed and demonstrated gains in chromosomes 6p, 8q, and 17q as well as losses in chromosomes 6q, 9p, 11q, and 16q. The presence of multiple chromosomal gains and losses is not an alteration that is known to occur in cellular blue nevi (or even in so-called atypical cellular blue nevi) and suggests instead that a component of melanoma is present. In summary, based upon the combination of results derived from conventional microscopy and aCGH, I believe this breast lesion includes a component of blue nevus-like melanoma that developed within a background of cellular blue nevus. The component of melanoma is not obvious and fully distinctive microscopically, at least to my eye, and thus molecular assessment proved to be instrumental in rendering the above interpretation. This melanoma cannot be staged by conventional microscopical parameters.  I do not know the status of the final surgical margin for this case. The fact that this specimen is listed as a mastectomy specimen leads me to presume that complete excision has been achieved.	BLUE NEVUS-LIKE MELANOMA, ARISING WITHIN AN INTRAMAMMARY CELLULAR BLUE NEVUS	173505	1898	\N	\N	11-5480	A	SYNX495	\N	IP994917	Consolidated_data_final.csv
10742	09-33283	42	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.4	Ivanka Patient Melanoma  	\N	Sections show nodular aggregations of atypical, peripherally palisaded basaloid cells. Very focally, tiny angulate aggregations of similar cells are apparent in infiltrative array. There is enveloping inflamed cellular stroma.	Skin segment measuring 0.4 x 0.3 x 0.1 cm in cassette A.	\N	\N	\N	\N	\N	NODULAR BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173441	1899	\N	\N	09-33283	A	SYNX496	\N	IP834046	Consolidated_data_final.csv
10746	09-31895	80	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Ivanka Patient Melanoma  	\N	\N	Skin segment measuring 1.0 x 0.9 x 0.2 cm, trisected and entirely submitted.	\N	\N	\N	\N	This biopsy contains two populations of melanocytes within it, with one population representing superficially invasive melanoma and with the other population representing a longstanding melanocytic nevus. This is a non-ulcerated melanoma with associated Clark's level III invasion. There is no evidence of associated vascular or perineural invasion. Associated partial regression is apparent; in light of the associated regression, the microstage measurement listed above may underestimate the prognostic impact of this melanoma. Melanoma is transected at the periphery of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.55 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173649	1900	\N	\N	09-31895	A	SYNX497	\N	IP79298	Consolidated_data_final.csv
10751	R29032-05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1901	\N	\N	\N	\N	SYNX498	\N	\N	Consolidated_data_final.csv
10753	01-8297	34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	110.9	Iwei Pediatric Melanoma	\N	Sections show spongiosis with an altered cornified layer.	One outside slide, 01-04664 (01-0708).	\N	\N	\N	\N	3/15/2001:  A PAS-D stain confirms the presence of hyphae in the cornified layer.   3/12/2001:  I suspect dermatophytosis.	DERMATOPHYTOSIS	173610	1902	\N	\N	01-8297	A	SYNX499	\N	IP264700	Consolidated_data_final.csv
10755	8298-01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1903	\N	\N	\N	\N	SYNX500	\N	\N	Consolidated_data_final.csv
10814	Long-TN1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type"), Georgina Long, Australia, SP-12-18648, Nugent	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1948	\N	\N	\N	\N	SYNX545	\N	\N	Consolidated_data_final.csv
10816	Long-TN2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type"), Georgina Long, Australia, SP-12-13739, Phu	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1949	\N	\N	\N	\N	SYNX546	\N	\N	Consolidated_data_final.csv
10818	D326	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Blue Nevus-like Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1950	\N	\N	\N	\N	SYNX547	\N	\N	Consolidated_data_final.csv
10820	D366	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Blue Nevus-like Melanoma: S06-35322	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1951	\N	\N	\N	\N	SYNX548	\N	\N	Consolidated_data_final.csv
10831	13-67500AL	27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Dr. Schulman Xanthoma Disseminatum	\N	There is a massive polypoid segment of skin with a fibrotic dermis, within which there are aggregates of foamy histiocytes, as well as scattered giant cells, some of them Touton-type and some of them Langhans' type. There are focally dense lymphocytic infiltrates as well.	Five outside slides, S13-3960 / A1-A5, and one corresponding block (A1).	\N	\N	\N	\N	Immunoperoxidase studies performed in our laboratory show that the large pale cells are S100 negative, against an unusual presentation of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). The vacuolated cells are adipophilin positive, consistent with their being lipid-laden histiocytes. There are many admixed factor XIIIa-positive cells, some of them small and dendritic, but others large and more histiocytic-appearing. This mixture of cells is consistent with an adult analogue of juvenile xanthogranuloma, presenting as a particularly large lesion.	XANTHOGRANULOMA	100556	1961	\N	\N	13-67500	A	SYNX558	\N	IP1309505	Consolidated_data_final.csv
10757	08-53951	17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	Ivanka Patient Melanoma	\N	Sections show an asymmetrical, compound proliferation of melanocytes which is well-circumscribed. There is a slightly biphasic pattern, with larger atypical melanocytes with more abundant dusty cytoplasmic melanin within the epidermis arrayed irregularly as nests and single cells. Melanocytes are scattered above the basal layer in this zone as well. Similar melanocytes are present within the dermis as clusters which demonstrate deficient maturation with descent. Mitotic figures are evident within the epidermal component, but not within the dermal component in this area. At the periphery, there is also a compound proliferation of smaller and bland melanocytes, arrayed as small nests along the junction, and as nests and syncytia in the dermis. These melanocytes mature with descent. Some of them contain dusty cytoplasmic melanin, but less abundant than those in the aforementioned atypical zone. There is a patchy lymphocytic infiltrate, especially surrounding the population of larger atypical melanocytes.	Oriented ellipse, 1.4 x 0.8 x 0.3 cm, including a central multi-colored (dark brown, light brown, red) 0.7 x 0.7 cm papule.  With the orienting sutured tip placed to the left and designated tagged @ superior by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with three sections each in cassettes A and B, one tip returned to container.	\N	\N	\N	\N	Although nevi on the scalp and hairline on children can demonstrate unusual features, the findings in a portion of this lesion exceed what would be expected in that setting. These include a markedly irregular distribution of atypical melanocytes which appear morphologically distinct from those of the surrounding nevus, as well significant suprabasal scatter of melanocytes, and a lack of maturation of the dermal component in that area. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level III, with atypical melanocytes expanding the papillary dermis and abutting the reticular dermis. There are no other features which would have an impact on prognosis apart from those given above. Reexcision of this site with standard margins is of course warranted.	MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO PERIPHERAL EXCISION MARGINS	191323	1904	\N	\N	08-53951	A	SYNX501	\N	IP596372	Consolidated_data_final.csv
10761	13000212	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dr. A. Fouchardiere Project	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1905	\N	\N	\N	\N	SYNX502	\N	\N	Consolidated_data_final.csv
10762	8528-05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1906	\N	\N	\N	\N	SYNX503	\N	\N	Consolidated_data_final.csv
10763	1286184b	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1907	\N	\N	\N	\N	SYNX504	\N	\N	Consolidated_data_final.csv
10765	206436	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1908	\N	\N	\N	\N	SYNX505	\N	\N	Consolidated_data_final.csv
10766	35942-04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1909	\N	\N	\N	\N	SYNX506	\N	\N	Consolidated_data_final.csv
10767	15329-03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1910	\N	\N	\N	\N	SYNX507	\N	\N	Consolidated_data_final.csv
10768	Z1188-03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1911	\N	\N	\N	\N	SYNX508	\N	\N	Consolidated_data_final.csv
10769	1185-03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1912	\N	\N	\N	\N	SYNX509	\N	\N	Consolidated_data_final.csv
10770	14514-02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1913	\N	\N	\N	\N	SYNX510	\N	\N	Consolidated_data_final.csv
10771	15102-02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1914	\N	\N	\N	\N	SYNX511	\N	\N	Consolidated_data_final.csv
10772	9116-05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1915	\N	\N	\N	\N	SYNX512	\N	\N	Consolidated_data_final.csv
10773	24516-06	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1916	\N	\N	\N	\N	SYNX513	\N	\N	Consolidated_data_final.csv
10775	07-3078	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	232.6	Iwei Pediatric Melanoma (PMM)	\N	Sections show a melanocytic proliferation composed largely of single cells arrayed in near-continuous fashion within some parts of the lower epidermis, above a reticular dermis with considerable elastosis. Some single cells are scattered above the junction.	One outside slide, 07-139 and one corresponding block.	\N	\N	\N	\N	Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA IN SITU, TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	733602	1917	\N	\N	07-3078	A	SYNX514	\N	IP625607	Consolidated_data_final.csv
10776	B06-37358	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1918	\N	\N	\N	\N	SYNX515	\N	\N	Consolidated_data_final.csv
10777	21590	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1919	\N	\N	\N	\N	SYNX516	\N	\N	Consolidated_data_final.csv
10779	A2A79@	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1920	\N	\N	\N	\N	SYNX517	\N	\N	Consolidated_data_final.csv
10780	356A3-075	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1921	\N	\N	\N	\N	SYNX518	\N	\N	Consolidated_data_final.csv
10781	20847-09	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1922	\N	\N	\N	\N	SYNX519	\N	\N	Consolidated_data_final.csv
10782	525	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1923	\N	\N	\N	\N	SYNX520	\N	\N	Consolidated_data_final.csv
10783	PMM_23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1924	\N	\N	\N	\N	SYNX521	\N	\N	Consolidated_data_final.csv
10785	UM7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1925	\N	\N	\N	\N	SYNX522	\N	\N	Consolidated_data_final.csv
10786	UM8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1926	\N	\N	\N	\N	SYNX523	\N	\N	Consolidated_data_final.csv
10787	UM9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1927	\N	\N	\N	\N	SYNX524	\N	\N	Consolidated_data_final.csv
10788	UM10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1928	\N	\N	\N	\N	SYNX525	\N	\N	Consolidated_data_final.csv
10789	UM11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1929	\N	\N	\N	\N	SYNX526	\N	\N	Consolidated_data_final.csv
10790	Xanthoma_Disseminatum	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dr. Shulman Xanthoma Disseminatum	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1930	\N	\N	\N	\N	SYNX527	\N	\N	Consolidated_data_final.csv
10794	13-94981	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-392 	There is a relatively narrowly based, and somewhat wedge-shaped compound proliferation of melanocytes that mostly involves the junctional zone and superficial dermis. There are nests of large oval cells at the junction, with some confluence of them. Some of these have homogeneous, and some vacuolated cytoplasm with dusty melanin. There are pleomorphic, vesicular nuclei with large nucleoli. Nuclear maturation and dispersion are both evident with descent. There are focally dense lymphocytic infiltrates. A mitotic figure is present in the mid-dermal portion of the lesion, either in a melanocyte or in a stromal cell. The enclosed Mart-1 stained sections highlight that the lesion has an irregular lower contour. A gradient of HMB-45 staining is present, mostly at the junction.	Five outside slides, M13-32431 1A (SU-13-25161 A).  One corresponding block received 11-26-13.	\N	\N	\N	\N	This spitzoid proliferation has marked confluence of both junctional nests and dermal ones, and in the thinner sections, some pulverocytes.* It also has an uneven lower border. These findings raised the possibility of a spitzoid melanoma. Comparative genomic hybridization shows chromosomal amplifications involving areas on 7p (near the terminal end) and 7q. The latter includes part of the b-raf gene. The fusion partner for b-raf in this case may be MAD1L1, a gene that has been seen as a fusion partner in other such cases. My colleague, Dr. Iwei Yeh also reveiwed the comparative genomic hybridization data and agrees with this interpretation of it.  Spitzoid lesions with b-raf fusions lack b-raf mutations (i.e. the sequence of the gene is wild type, but there is a break in the gene and the chromosome is attached at the breakpoint to its fusion partner). This mechanism can occur in Spitz's nevi, atypical Spitz tumors and in melanoma. An overview of the subject of braf fusions is in the paper from our group referenced below. The absence of other abberations in this lesion, with the exception of a low level loss involving chromosome 14q is against an outright diagnosis of spitzoid melanoma.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have feature more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy.  Reference:  Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res. 2013 Nov;26(6):845-51. doi: 10.1111/pcmr.12148. Epub 2013 Aug 19. PubMed PMID: 23890088; PubMed Central PMCID: PMC3808507.   *This term is introduced in Massi G, LeBoit P. Histologic Diagnosis of Nevi and Melanoma, 2nd Edition, Springer-Verlag, Berlin Heidelberg, 2014 p. 57, and refers to cells with abundant, pale cytoplasm and dusty appearing melanin, deriving from the Latin term for dust	COMPOUND PROLIFERATION OF LARGE, ATYPICAL MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR	173530	1931	\N	\N	13-94981	A	SYNX528	\N	IP1336996	Consolidated_data_final.csv
10795	13-99411A	17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-399 	An asymmetrical polypoid compound proliferation of melanocytes is quite protuberant. Near the base of the polyp, a small junctional component that consists of single melanocytes and pigmented nests can be seen. In the dermis below this, a syncytial array of fusiform and epithelioid melanocytes with slightly enlarged nuclei can be seen. In some areas, the background stroma is collagenous and has a vaguely whorled configuration. Although the constituent melanocytes are enlarged, cells in mitosis are not easily found.	One outside slide, DPR-13-11019:A1 and one corresponding block.	\N	\N	\N	\N	To further assess this proliferation, limited immunoperoxidase staining was first completed as part of our assessment. CD34 staining demonstrates relatively diffuse fingerprint positivity, thereby corroborating that neural differentiation is present. An EMA immunostain proved to be completely negative, and thus there is not proof of perineurial differentiation (nevertheless, I suspect it may be present). Per the request of Dr. Vetto, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number abnormalities. as can be seen with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in in chromosome 9, loss of much of chromosome 7, and loss of distal chromosome 2. The identification of multiple chromosomal copy number abnormalities, with loss of chromosome 9 as the dominant finding, indicates that melanoma cannot be excluded from the differential diagnosis. However, based upon conventional microscopy, I cannot render a conclusive diagnosis of melanoma.  In short, this represents an ambiguous melanocytic tumor. If interpreted as melanoma, the tumor is 1.95 mm in thickness and is non-ulcerated.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL POLYPOID COMPOUND PROLIFERATION OF MELANOCYTES; GENOMIC LOSSES HAVE BEEN IDENTIFIED VIA COMPARATIVE GENOMIC HYBRIDIZATION	101406	1932	\N	\N	13-99411	A	SYNX529	\N	IP1341428	Consolidated_data_final.csv
10796	13-94484	3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-394 	Sections show melanocytes arrayed in compound fashion in a large polypoid skin segment. There are single melanocytes and large pale nests of melanocytes within the epidermis, and limited intraspinous scatter is noted. In the vast subjacent dermis in the center of the polyp, there is a large nodular population of melanocytes that is somewhat biphasic. There are smaller ovoid and fusiform melanocytes arrayed as nests, cords, fascicles, and syncytia, and there is also a large syncytial population of enlarged epithelioid melanocytes with amphophilic or pale cytoplasm. A patchy lymphohistiocytic infiltrate is noted as well.	Two outside slides, S13-5421. One corresponding block received 11-18-13.	\N	\N	\N	\N	This large polypoid tumor does not represent a variant of conventional Spitz nevus. Rather, our differential diagnosis includes an unusual combined melanocytic nevus or unconventional Spitz nevus, an 'atypical Spitz tumor' (a provisional diagnostic category), and childhood spitzoid melanoma. We completed BAP-1 immunoperoxidase staining as part of our evaluation, as BAP-1 loss (within chromosome 3p) can be detected in a subset of Spitz tumors with enlarged epithelioid melanocytes, similar to those seen here. The BAP-1 immunostain demonstrates preserved nuclear positivity throughout, thereby indicating that BAP-1 loss is not present. This is the type of challenging tumor for which array-based comparative genomic hybridization (aCGH) can be of value. This technique was applied, as per your approval. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in distal chromosome 7 with no other associated chromosomal gains or losses. Gain in chromosome 7q suggests a Spitz nevus with associated MET genetic fusion. MET immunostaining was additionally completed and demonstrates positivity, thereby corroborating the possibility suggested in the preceding sentence.  This is an unusual melanocytic tumor. I believe it is benign, but follow-up studies of tumors of this type have not been completed. Conservative complete reexcision of this site would be reasonable to consider to ensure complete tumor removal and prevent persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	POLYPOID COMPOUND PROLIFERATION OF ENLARGED EPITHELIOID MELANOCYTES, CONSISTENT WITH AN UNCONVENTIONAL POLYPOID SPITZ NEVUS	173707	1933	\N	\N	13-94484	A	SYNX530	\N	IP1336499	Consolidated_data_final.csv
10797	DM27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1934	\N	\N	\N	\N	SYNX531	\N	\N	Consolidated_data_final.csv
10823	11-2532	64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	Iwei Blue Nevus Like Melanoma	CGH11-023 	Sections show a cellular nodular proliferation of plump spindled melanocytes that spans the full reticular dermis and focally juts into the uppermost subcutis. The lesional melanocytes are slightly spindled and have cytoplasmic pigmentation that varies in degree. Centrally, the degree of cytoplasmic melanization is marked. Melanocytes in mitosis are easily found. In one of the two available sections, there is a central focus of degeneration that is colonized by many melanophages.	One outside slide, W11-270:A and one corresponding block.	\N	\N	\N	\N	Our differential diagnosis included so-called atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other, and the latter possibility proves to represent the correct interpretation for this atypical melanocytic proliferation. To further establish the diagnosis for this tumor, we employed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block aCGH analysis revealed loss in chromosome 3 (3p and 3q) as well as losses in distal chromosome 9q and chromosome 19p. The documentation of multiple chromosomal gains and losses supports interpretation as melanoma, and the documentation of chromosome 3 loss, in particular, has been associated with blue nevus-like melanoma. I also considered the possibility of a metastasis of melanoma in my differential diagnosis, but I view this as unlikely. If there is any history of melanoma in this patient, please keep me informed.  This melanoma is non-ulcerated and shows associated Clark's level V invasion. Further excision is warranted to ensure that local eradication has been accomplished.	BLUE NEVUS-LIKE MELANOMA OF 5.6 MM IN THICKNESS, PARTIALLY CAPTURED VIA BIOPSY	102499	1953	\N	\N	11-2532	A	SYNX550	\N	IP991969	Consolidated_data_final.csv
10824	AST-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dermpath - Atypical Spitz Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1954	\N	\N	\N	\N	SYNX551	\N	\N	Consolidated_data_final.csv
10825	08-18595B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	UCSF Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1955	\N	\N	08-18595	B	SYNX552	\N	IP711218	Consolidated_data_final.csv
10826	13-60273	60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	UCSF Wild Type Melanoma	\N	\N	Six slides, S13-16054:A3 through A8, and six corresponding blocks.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-16054:A of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal mutations.	MELANOMA, NO MUTATIONS DETECTED IN BRAF, KIT AND NRAS	173316	1956	\N	\N	13-60273	A	SYNX553	\N	IP841587	Consolidated_data_final.csv
10827	12-52454	89	\N	\N	\N	T4a	Primary	\N	\N	\N	\N	\N	\N	172.4	UCSF Wild Type Melanoma	\N	Sections show a dermal neoplasm comprised of markedly atypical pigmented and spindled melanocytes arranged as cellular fascicles.  Numerous mitotic figures are noted throughout the full thickness of the lesion.  The atypical melanocytes encircle small nerve twigs.	Two specimens received in the same container. The first specimen is a Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected. The second specimen is a 0.5 x 0.2 x 0.5 cm skin segment. A total of three pieces entirely submitted.   HD/HD	\N	\N	\N	\N	No connection to the epidermis is seen and as before a metastasis is possible.  Foci of perineural infiltration are identified.  If this is a primary lesion it would be a stage pT4a melanoma based on the 2009 AJCC melanoma staging system.	MELANOMA, APPROXIMATELY 5.0 MILLIMETERS IN THICKNESS, EXTENDING TO THE TISSUE EDGES	173410	1957	\N	\N	12-52454	A	SYNX554	\N	IP1032345	Consolidated_data_final.csv
10828	12-75125	26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	UCSF Wild Type Melanoma	\N	Sections show a neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a wedge-shaped configuration.  Some of the constituent melanocytes have abundant pale cytoplasm with dusty melanin and pleomorphic nuclei while others have abundant dull pink eosinophilic cytoplasm.  There are many admixed melanophages. In general, the size of the melanocytes does not diminish with descent into the dermis and many of the lesional melanocytes have prominent nucleoli.	Elliptical excision measuring 0.8 x 0.7 x 0.3 cm, including a central 0.5 x 0.4 cm pink tan area.  With the peripheral and deep margins inked blue, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with four sections.   HD/HD	\N	\N	\N	\N	My initial differential diagnosis included an unusual combined melanocytic nevus with features of a deep penetrating nevus and other features of a Spitz's nevus and melanoma. To further evaluate for this differential diagnosis, I initially performed a phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle). The stain showed only a few melanocytes in mitosis or near to mitosis, which was reassuring.  Nonetheless, as an additional diagnositic maneuver, I performed comparative genomic hybridization on this case after receiving authorization from the clinical team who had discussed the testing with the family. This is a technique that assesses chromosomal gains or losses, which are found in melanoma and not in nevi.  The comparative genomic hybridization showed losses involving portions of chromosome 9p and 10q. The presence of two chromosomal losses is abnormal and supportive of melanoma. The melanoma measures 2.6 millimeter in thickness and is present in the tip margin. Therefore, by conventional AJCC melanoma staging guidelines, this would be considered a pT3a melanoma. However, given the spitzoid morphology of many of the cells, it is possible that this melanoma would behave in a less aggressive fashion compared with a conventional melanoma of equivalent thickness. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this assessment.  This report was reissued on November 27, 2012 to add the patient's UCSF Medical Record number.	INTRADERMAL ATYPICAL MELANOCYTIC PROLIFERATION, GENOMICALLY CONSISTENT WITH MELANOMA	102735	1958	\N	\N	12-75125	A	SYNX555	\N	IP1160942	Consolidated_data_final.csv
10829	12-98235A	60	\N	\N	\N	T4b	Primary	\N	\N	\N	\N	\N	\N	172.2	UCSF Wild Type Melanoma	\N	There is an ulcerated, multi-nodular proliferation of large, atypical melanocytes in partial apposition to a thinned epidermis. The lesional melanocytes have variably pigmented cytoplasm, large, hyperchromatic nuclei and a high mitotic rate. Maturation with descent is faulty. A focally dense lymphocytic infiltrate with melanophages is present.	Nodular skin fragment measuring 1.5 x 1.2 x 0.8 cm.  With the base inked blue, the specimen is quadrisected and fragmented upon quadrisection, all entirely submitted with four sections and one fragment in cassette A.  PL/PL	\N	\N	\N	\N	The epidermal margin is clear by about 1 mm., and the deep margin by 1.7 mm. in most of the cross-sections, but margins cannot be evaluated in one cross section. Even though an intraepidermal component is not present, the multinodular configuration suggests are primary melanoma, rather than a metastasis to this site. Given the ulceration, this is a stage T4b lesion in the 2009 AJCC staging schema for melanoma.	MELANOMA, 5.5 MM. IN THICKNESS	102285	1959	\N	\N	12-98235	A	SYNX556	\N	IP1184052	Consolidated_data_final.csv
10830	13-3619B	72	t	\N	\N	T3b	Primary	None	\N	\N	\N	\N	\N	172.7	UCSF Wild Type Melanoma	\N	Sections show a proliferation of markedly atypical melanocytes arranged as large, irregular confluent nests at the dermo-epidermal junction and above it and as smaller irregular nest in the dermis.  Many of the melanocytes have ample cytoplasm that contains melanin pigment.  Numerous melanophages are also noted.  The epidermis has a papillated contour and shows ulceration.	Elliptical excision measuring 2.5 x 1.3 x 0.4 cm, including a central 1.4 x 0.9 cm brown black raised area.  With the peripheral and deep margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in cassettes A and B and three sections in cassette C.   HD/HD	\N	\N	\N	\N	Melanoma in situ is present 1-2 millimeters from the lateral margins.  This melanoma is ulcerated.  It should be regarded as a pT3b lesion.	MELANOMA, APPROXIMATELY 2.1 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED	173711	1960	\N	\N	13-3619	B	SYNX557	\N	IP1188362	Consolidated_data_final.csv
1723	13-98534	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	None	Block S13-23549:B.	MELANOMA SUBMITTED FOR BRAF MUTATION ANALYSIS	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-23549 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF revealed no mutation.	MELANOMA, NO BRAF MUTATION DETECTED	173405	2023	\N	\N	13-98534	\N	SYNAT634	Wild Type Melanoma	IP1340550	AirTable blocks_with_IP_info.csv
10981	SP-13-0185993A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2049	\N	\N	\N	\N	SYNX646	\N	\N	Consolidated_data_final.csv
10982	SP-13-0185992B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2050	\N	\N	\N	\N	SYNX647	\N	\N	Consolidated_data_final.csv
10832	13-19205	74	\N	\N	\N	T3b	Primary	\N	\N	\N	\N	\N	\N	172.5	UCSF Wild Type Melanoma	\N	Sections show a broad and poorly circumscribed proliferation of atypical epithelioid melanocytes.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The papillary and reticular dermis contains aggregates of similar cells.  The epidermis shows focal ulceration and there is an overlying hemorrhagic scale crust.	Skin segment measuring 1.4 x 1.1 x 0.4 cm, serially sectioned and entirely submitted with five sections. CF/CF	\N	\N	\N	\N	Invasive melanoma abuts the edge of the specimen.  Focal ulceration is also noted.  Based on the 2009 AJCC melanoma staging system, this is a pT3b lesion.	MELANOMA, APPROXIMATELY 2.1 MILLIMETERS IN THICKNESS	173502	1962	\N	\N	13-19205	A	SYNX559	\N	IP1203948	Consolidated_data_final.csv
10833	13-48330	82	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	UCSF Wild Type Melanoma	\N	Sections show dermal nodule composed of sheets and cords of melanocytes with atypical nuclei. There are scattered mitotic figures as well as areas of pigmentation. A surrounding sparse lymphoplasmacytic infiltrate is also present. A junctional melanocytic proliferation is not present. The dermis is altered by solar elastosis.	Cylindrical skin segment measuring 0.6 cm in diameter and 0.6 cm in thickness. The specimen is filtered, bisected, and entirely submitted. HD/HD	\N	\N	\N	\N	\N	METASTATIC MELANOMA	\N	1963	\N	\N	13-48330	A	SYNX560	\N	IP467959	Consolidated_data_final.csv
10834	13-11086	79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	UCSF Wild Type Melanoma	\N	\N	Twenty-three blocks, S13-1165:A1 through A23, received 2-20-13.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-1165 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal any mutations.	MELANOMA	173714	1964	\N	\N	13-11086	A	SYNX561	\N	IP1158926	Consolidated_data_final.csv
10835	13-15966	65	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.9	UCSF Wild Type Melanoma	\N	\N	Blocks S12-25910:A.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S12-25910 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, were performed on block (A2) and no mutations were detected. Because there was only a tiny focus from which pure populations of neoplastic cells could be microdissected, the risk of a false negative results is increased.	MELANOMA	222922	1965	\N	\N	13-15966	A	SYNX562	\N	IP1200709	Consolidated_data_final.csv
10836	13-39228	77	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	UCSF Wild Type Melanoma	\N	\N	Blocks S12-7524:A1 through A7.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S12-7524 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal any mutations.	MELANOMA, MUTATIONAL ANALYSIS FOR BRAF, NRAS, AND KIT DID NOT DETECT ANY MUTATIONS	173417	1966	\N	\N	13-39228	A	SYNX563	\N	IP1104118	Consolidated_data_final.csv
10837	13-45942	69	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	UCSF Wild Type Melanoma	\N	\N	Block S11-9752.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S11-9752 of UCSF Surgical Pathology. Sanger sequencing of exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots, did not yield any mutations.	METASTATIC MELANOMA, NO KIT MUTATIONS DETECTED	925	1967	\N	\N	13-45942	A	SYNX564	\N	IP1005877	Consolidated_data_final.csv
10838	13-49600	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.9	UCSF Wild Type Melanoma	\N	\N	Block S13-12304:G5.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-12304 of UCSF Surgical Pathology. No mutations were detected by Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes.	MELANOMA, NO MUTATIONS DETECTED IN BRAF, NRAS, AND KIT	666955	1968	\N	\N	13-49600	A	SYNX565	\N	IP61201	Consolidated_data_final.csv
10839	13-59640	69	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	UCSF Wild Type Melanoma	\N	\N	Block S13-14324:A1.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-14324 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF did not reveal mutations.	METASTATIC MELANOMA, NO MUTATION IN BRAF DETECTED	222922	1969	\N	\N	13-59640	A	SYNX566	\N	IP1276884	Consolidated_data_final.csv
10840	13-67817	71	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	UCSF Wild Type Melanoma	\N	\N	Blocks S13-8339:A and D.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-8339 of UCSF Surgical Pathology. I reviewed the sections, and marked them for microdissection. The results of Sanger sequencing are as follows:  BRAF exon 15: wild-type. NRAS exons 1 and 2: wild-type. KIT exons 11, 13, 17 and 18:  wild-type.	METASTATIC MELANOMA, WITH NO DETECTED MUTATIONS OF KIT, BRAF AND NRAS	176788	1970	\N	\N	13-67817	A	SYNX567	\N	IP1199676	Consolidated_data_final.csv
10841	SP-12-5612(1K)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1971	\N	\N	\N	\N	SYNX568	\N	\N	Consolidated_data_final.csv
10842	SP-13-14992(1A)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1972	\N	\N	\N	\N	SYNX569	\N	\N	Consolidated_data_final.csv
10843	SP-12-2294-2(2A)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1973	\N	\N	\N	\N	SYNX570	\N	\N	Consolidated_data_final.csv
10844	SP-13-17075(1B)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1974	\N	\N	\N	\N	SYNX571	\N	\N	Consolidated_data_final.csv
10845	SP-42-10361(1A)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1975	\N	\N	\N	\N	SYNX572	\N	\N	Consolidated_data_final.csv
10846	SP-13-1038(1A)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1976	\N	\N	\N	\N	SYNX573	\N	\N	Consolidated_data_final.csv
10847	S13-13286A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Translocation	NTRK3	\N	\N	\N	\N	\N	\N	\N	\N	\N	1977	\N	\N	\N	\N	SYNX574	\N	\N	Consolidated_data_final.csv
10849	S11-20884A-A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	DPN-like Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	1978	\N	\N	\N	\N	SYNX575	\N	\N	Consolidated_data_final.csv
10851	S12-6218A-D3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Blue Nevus Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1979	\N	\N	\N	\N	SYNX576	\N	\N	Consolidated_data_final.csv
10881	08-79358	61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Ivanka Patient Melanoma	\N	Sections show a well-circumscribed compound proliferation of melanocytes limited to the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges in some areas, and are accompanied by lamellar fibrosis. There is solar elastosis. There are zones within the epidermis characterized by cytoplasmic vacuolization of keratinocytes, coarse keratohyaline and trichohyaline-like granules, and hyperkeratosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in cassette A.	\N	\N	\N	\N	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE AND BASE OF THE SPECIMEN	139522	1996	\N	\N	08-79358	A	SYNX593	\N	IP172751	Consolidated_data_final.csv
11154	HAYS02-005731	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	98	\N	\N	\N	\N	\N	\N	\N	\N	\N	2201	\N	\N	\N	\N	SYNX798	\N	\N	Consolidated_data_final.csv
10885	09-45509	55	f	\N	1	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Ivanka Patient Melanoma	\N	Sections show sun damaged skin with a proliferation of melanocytes involving the superficial dermis. There are nests, cords and strands of small, round melanocytes that mature with descent, flanking a central focus in which large melanocytes with abundant, pale cytoplasm and dusty appearing melanin and large, pleomorphic vesicular nuclei are present in fibrotic stroma, with incomplete maturation toward the base of the lesion.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted.	\N	\N	\N	\N	The nevus extends to a peripheral edge, and the melanoma nearly to the base of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low (one mitotic figure identified; 1/mm2)* Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  * some studies have found that melanomas in which a mitotic figure is present in the dermis have a less favorable prognosis than do ones with without this finding.	MELANOMA, 0.9 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS	173688	1997	\N	\N	09-45509	A	SYNX594	\N	IP846272	Consolidated_data_final.csv
10889	DM50	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1998	\N	\N	\N	\N	SYNX595	\N	\N	Consolidated_data_final.csv
10890	DM56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1999	\N	\N	\N	\N	SYNX596	\N	\N	Consolidated_data_final.csv
1530	11-94204	46	\N	\N	\N	T2a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26321	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm.  These cells are irregularly distributed along the dermal-epidermal junction as mostly single cells with some present above the basal layer.  There are similar melanocytes arranged as expansile nests in the subjacent dermis. Melanocytes in mitosis are noted throughout the full thickness of this area.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Excision, 1.1 x 0.5 x 0.4 cm, peripheral and deep margins inked blue, serially sectioned perpendicular to the long axis and entirely submitted with five sections in one cassette.\n\n	NEW BUMP X 4 MONTHS TWO ADJACENT DARKLY PIGMENTED PAPULES IN 4 X 7 MM AREA; R/O MELANOMA	\N	\N	FFPE	The lesion is very narrowly excised and melanoma in present to within a millimeter of the peripheral margin.  This is non-ulcerated lesion.  No regression, lymphatic, or vascular invasion is noted.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.	MELANOMA, 1.1 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173509	2000	\N	\N	11-94204	\N	JJS5	Melanoma Evolution	IP1083652	AirTable blocks_with_IP_info.csv
10894	London-L10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2001	\N	\N	\N	\N	SYNX598	\N	\N	Consolidated_data_final.csv
10898	London-L12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2002	\N	\N	\N	\N	SYNX599	\N	\N	Consolidated_data_final.csv
10901	London-L16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2003	\N	\N	\N	\N	SYNX600	\N	\N	Consolidated_data_final.csv
10903	London-L16A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2004	\N	\N	\N	\N	SYNX601	\N	\N	Consolidated_data_final.csv
10906	London-L16B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2005	\N	\N	\N	\N	SYNX602	\N	\N	Consolidated_data_final.csv
10909	DM15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2006	\N	\N	\N	\N	SYNX603	\N	\N	Consolidated_data_final.csv
10910	DM19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2007	\N	\N	\N	\N	SYNX604	\N	\N	Consolidated_data_final.csv
10912	DM46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2008	\N	\N	\N	\N	SYNX605	\N	\N	Consolidated_data_final.csv
10913	140038340	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions (University Hospital Erlangen, Germany)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2009	\N	\N	\N	\N	SYNX606	\N	\N	Consolidated_data_final.csv
10914	140092090	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions (University Hospital Erlangen, Germany)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2010	\N	\N	\N	\N	SYNX607	\N	\N	Consolidated_data_final.csv
10915	UM13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2011	\N	\N	\N	\N	SYNX608	\N	\N	Consolidated_data_final.csv
10916	UM14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2012	\N	\N	\N	\N	SYNX609	\N	\N	Consolidated_data_final.csv
10917	UM16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2013	\N	\N	\N	\N	SYNX610	\N	\N	Consolidated_data_final.csv
10918	London-L17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2014	\N	\N	\N	\N	SYNX611	\N	\N	Consolidated_data_final.csv
10923	GAK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2015	\N	\N	\N	\N	SYNX612	\N	\N	Consolidated_data_final.csv
10924	Yurif	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2016	\N	\N	\N	\N	SYNX613	\N	\N	Consolidated_data_final.csv
10928	London-L18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2017	\N	\N	\N	\N	SYNX614	\N	\N	Consolidated_data_final.csv
10932	London-L21	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2018	\N	\N	\N	\N	SYNX615	\N	\N	Consolidated_data_final.csv
1746	14-16247	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a dome-surfaced compound proliferation of melanocytes featuring markedly elongated, jagged ridges and large oval and fusiform cells with variable amounts of amphophilic cytoplasm and large nuclei, amongst which mitotic figures can be discerned. Fewer of these, and some maturation are present at the base of the lesion, which is relatively flat, and beneath which is a dense lymphocytic infiltrate.	Two outside slides, SPS-14-7904:AI,AII and two corresponding blocks.	ATYPICAL COMPOUND MELANOCYTIC NEOPLASM WITH SPITZOID FEATURES	\N	\N	\N	The silhouette is that of a Spitz's nevus, but I am concerned about the crowding of nuclei and the presence of a focally high mitotic rate. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively high proliferation rate in the dermal component (about 10-15%). A p16 immunoperoxidase stain show a mosaic pattern of loss of that tumor suppressor gene product, an indeterminate pattern. Comparative genomic hybridization shows a gain involving chr. 2p, and a complex combination of gains and losses involving chr. 7q. The breakpoints suggest a gene fusion involving MET on chr. 7 and DTCN1 on chr. 2p, a combination that Dr. Iwei Yeh, who also viewed the comparative genomic hybridization data has previously noted. This may lead to upregulation of braf (near one of the other breakpoints on 7q), in the absence of braf mutation. While the absence of other chromosomal gains and losses is somewhat reassuring, it would be best to view this as a lesion with limited but non-zero metastatic potential, e.g. as an atypical Spitz. These are neoplasms that have feature more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR	173796	2019	\N	\N	14-16247	\N	SYNAT635	2010-2017	IP1366169	AirTable blocks_with_IP_info.csv
1705	13-35959	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	None	Block DL13-32481 (PL13-8590), received 5-28-13.	MELANOMA SUBMITTED FOR BRAF MUTATION ANALYSIS	\N	\N	\N	The histopathological diagnosis was established by our previous pathology report DL13-32481. Sanger sequencing of exon 15 of BRAF revealed no mutation.	MELANOMA, NO BRAF MUTATION DETECTED	333504	2020	\N	\N	13-35959	\N	SYNAT636	Wild Type Melanoma	IP1217226	AirTable blocks_with_IP_info.csv
1726	13-102610	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2021	\N	\N	13-102610	\N	SYNAT637	Wild Type Melanoma	\N	AirTable blocks_with_IP_info.csv
1725	13-99417	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.9	\N	\N	None	Eight slides/blocks S13-26334:A1 through A8.	MELANOMA SUBMITTED FOR KIT & BRAF MUTATION ANALYSIS	\N	\N	\N	Please refer to UCSF Surgical Pathology report S13-26334 for the histopathologic analysis regarding this tumor. Sanger sequencing of exon 15 of BRAF,  and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal any mutations.	MELANOMA, NO MUTATIONS DETECTED IN KIT OR BRAF	222922	2022	\N	\N	13-99417	\N	SYNAT638	Wild Type Melanoma	IP2344638	AirTable blocks_with_IP_info.csv
10983	SP-12-003309B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2051	\N	\N	\N	\N	SYNX648	\N	\N	Consolidated_data_final.csv
10984	SP-13-0212981A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2052	\N	\N	\N	\N	SYNX649	\N	\N	Consolidated_data_final.csv
10985	SP-13-0068754A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2053	\N	\N	\N	\N	SYNX650	\N	\N	Consolidated_data_final.csv
10986	SP-13-0068751C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2054	\N	\N	\N	\N	SYNX651	\N	\N	Consolidated_data_final.csv
10987	SP-07-0116602	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2055	\N	\N	\N	\N	SYNX652	\N	\N	Consolidated_data_final.csv
1703	13-32982A	54	\N	1.05	1	T2a	Primary	 Melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a segment of acral skin in which there is a scar. In addition, there is a biphasic proliferation of melanocytes. One population is composed of both spindled and epithelioid melanocytes, many of which contain dusty melanin within their cytoplasm.  These melanocytes are configured as single cells and nests along the dermo-epidermal junction and as nests, cords and single cells in the underlying dermis. The size of the melanocytes does not diminish with descent into the dermis. There is also a population of cytologically bland cells arranged as nests along the junction and as maturing nests cords and strands in the underlying dermis.	One elliptical excision and one tissue fragment received in one bottle. Ellipse, 2.7 x 1.2 x 0.4 cm, including a central 1.2 x 0.7 cm depressed grayish-brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections in A and six in B. Tissue fragment measuring 0.9 x 0.3 x 0.2 cm, submitted intact in B. CF/CF	5 X 5 MM MELANOMA, SEE DT13-25288	\N	\N	\N	It is now evident that this neoplasm represents a melanoma of 1.05 millimeters in thickness. A melanocytic nevus is also present intermingled with the melanoma, and thus the melanoma likely arose within the nevus. Given the thickness of the melanoma in combination with the proximity of it to the inked margin, a re-excision at this site is warranted. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: Excision Tumor site:  R. lateral foot Microscopic tumor type:  Melanoma Breslow thickness: 1.05 millimeters Ulceration: no Margins, peripheral and deep: 0.4 millimeters to the deep margin and 1.5 millimeters to the peripheral margins Mitotic index: < 1/mm2, although a dermal mitotic figure was identified in the initial biopsy of the melanoma (13-25288) Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2aNXMX  I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.  This report was reissued on May 28, 2013 to add the patient's UCSF Medical Record number.	SCAR, WITH RESIDUAL MELANOMA, 1.05 MILLIMETERS IN THICKNESS, ABUTTING THE INKED MARGINS	582753	1856	\N	\N	13-32982	A	SYNAT639	Wild Type Melanoma	IP1210033	AirTable blocks_with_IP_info.csv
10660	13-25288	54	\N	\N	\N	T1b	Primary	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a fragmented compound proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells in the dermis. There are also many melanophages and dilated lymphovascular spaces.	A skin segment and multiple tissue fragments received in one specimen bottle. The skin segment, 1.1 x 0.7 x 0.2 cm, serially sectioned perpendicular to the long axis and entirely submitted with five sections. The multiple tissue fragments, 1.0 x 0.5 x 0.1 cm in aggregate, entirely submitted. RS/RS	\N	\N	\N	\N	The tumor is sampled in a fragmented manner, and thus a meaningful estimate of thickness is not possible. It involves the dermis without further orientation. I identified a mitotic figure in routine sections. Occasional mitotic figures are also evident in a phosphohistone H3 immunostain, but such results are used for diagnostic purposes but not currently for staging purposes. There are also areas suspicious for lymphovascular invasion, but this could not be confirmed in  D2-40 immunoperoxidase stain. In short, definitive assessment of prognostic features should be deferred to the excision specimen. In these sections, there does not appear to be ulceration, and thus the staging is T1b preliminarily. This report was reissued on May 28, 2013 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA, INVOLVING ACRAL SKIN, FRAGMENTED	582753	1856	\N	\N	13-25288	A	SYNX453	\N	IP1210033	Consolidated_data_final.csv
1679	13-9916	82	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	None	Block DL13-9684:A (12-3263/PS12-4904:A), received 2-12-13.	MELANOMA SUBMITTED FOR BRAF & NRAS MUTATION ANALYSIS	\N	\N	\N	The histopathological diagnosis was established by pathology report PS12-4904 of Mills Peninsula Health Services. Sanger sequencing of exon 15 of BRAF and exons 1 and 2 of NRAS, which include the known mutational hotspots of these genes, was performed. No mutations were detected.	MELANOMA	173604	2024	\N	\N	13-9916	\N	SYNAT640	Wild Type Melanoma	IP1194427	AirTable blocks_with_IP_info.csv
1481	11-44609F	91	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a proliferation of spindled melanocytes with hyperchromatic nuclei, positioned between markedly thickened collagen bundles in the dermis in broad areas. Some multinucleate melanocytes are present. The cellularity of the lesion diminishes toward the deep reticular dermis. To the side of these changes, melanocytes with enlarged nuclei are present singly and in small nests in the basal layer of the epidermis in a poorly circumscribed pattern. Atypical keratinocytes thicken the epidermis, forming buds that protrude into the papillary dermis but mature toward a parakeratotic surface in diverse other foci. There is marked solar elastosis.	Ellipse, 5.7 x 2.5 x 0.8 cm, including a central 2.5 x 1.3 cm white-tan rough area and a marginal 1.2 x 0.7 cm pale-white area adjacent to one tip. The tip with adjacent pale-white area is placed to the left. With the far margin inked blue and the near margin inked yellow, the specimen is serially sectioned perpendicular to the long axis from left to right tips and entirely submitted with three  sections in cassette A, two sections each in cassettes B through H, and three sections each in cassettes I and J.	DS11-39631, RE-EXCISION OF MELANOMA	\N	\N	\N	An extensive area of melanoma in situ is present. The invasive melanoma is essentially entirely desmoplastic. Some studies have suggested that pure desmoplastic melanomas have a more favorable prognosis, vis a vis distant metastasis, especially to sentinel nodes than do melanomas in which only part of the invasive component is desmoplastic. Some perineural invasion is present, within 3 mm of the yellow inked margin in slide F (near 9 o'clock, with your suture designated as 12 o'clock). There is melanoma in situ and within 1 mm of the blue inked margin in slides F and G (near 3 o'clock, with your suture designated as 12 o'clock). Extensive solar keratosis is also evident. Several old scars are present in the dermis as well, one accounting for the pale area in the gross description.  Reference:  George E, McClain SE, Slingluff CL, Polissar NL, Patterson JW. Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis. J Cutan Pathol. 2009 Apr;36(4):425-32.	DESMOPLASTIC MELANOMA, 4.8 MM. IN THICKNESS	173316	2025	\N	\N	11-44609	F	SYNAT641	Wild Type Melanoma	IP1029070	AirTable blocks_with_IP_info.csv
1656	12-98575A1	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	\N	\N	Sections show pulmonary parenchyma with fascicles of spindled cells with large, hyperchromatic nuclei embedded in fibrotic stroma, with S100 and Sox-10 positivity in the immunoperoxidase stained sections.	Nine outside (unstained) slides, S12-27867:B1.	MELANOMA SUBMITTED FOR MOLECULAR TESTING	\N	\N	\N	No mutations were found in the oncogenes that we sequenced. The specific results are below: BRAF exon 15: wild-type. NRAS exons 1 and 2: wild-type. KIT exons 9, 11, 13, 17 and 18:  wild-type.	METASTATIC MELANOMA	666955	2026	\N	\N	12-98575	A1	SYNAT642	Wild Type Melanoma	IP824297	AirTable blocks_with_IP_info.csv
3297	DM60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2027	\N	\N	None	\N	SYNAT643	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3298	DM61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2028	\N	\N	None	\N	SYNAT644	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3299	DM62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2029	\N	\N	None	\N	SYNAT645	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3300	DM63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2030	\N	\N	None	\N	SYNAT646	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3303	DM66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2031	\N	\N	None	\N	SYNAT647	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3304	DM67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2032	\N	\N	None	\N	SYNAT648	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3306	DM69	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2033	\N	\N	None	\N	SYNAT649	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3307	DM70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2034	\N	\N	None	\N	SYNAT650	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3311	DM81	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2035	\N	\N	None	\N	SYNAT651	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3493	London-L3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2036	\N	\N	None	\N	SYNAT652	2010-2017	\N	AirTable blocks_with_IP_info.csv
10957	S12-27617B9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Melanoma and Metastasis Project (Lymph Node)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2037	\N	\N	\N	\N	SYNX634	\N	\N	Consolidated_data_final.csv
10958	S12-25164A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Melanoma and Metastasis Project (Lymph Node)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2038	\N	\N	\N	\N	SYNX635	\N	\N	Consolidated_data_final.csv
10959	S12-25164C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Melanoma and Metastasis Project (Lymph Node)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2039	\N	\N	\N	\N	SYNX636	\N	\N	Consolidated_data_final.csv
10960	London-L19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2040	\N	\N	\N	\N	SYNX637	\N	\N	Consolidated_data_final.csv
10963	London-L19E	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2041	\N	\N	\N	\N	SYNX638	\N	\N	Consolidated_data_final.csv
10966	London-L22	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2042	\N	\N	\N	\N	SYNX639	\N	\N	Consolidated_data_final.csv
10969	London-L23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2043	\N	\N	\N	\N	SYNX640	\N	\N	Consolidated_data_final.csv
10972	London-L23D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2044	\N	\N	\N	\N	SYNX641	\N	\N	Consolidated_data_final.csv
10974	London-L6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2045	\N	\N	\N	\N	SYNX642	\N	\N	Consolidated_data_final.csv
10977	XD-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Xanthoma Disseminatum Project	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2046	\N	\N	\N	\N	SYNX643	\N	\N	Consolidated_data_final.csv
10979	SP-13-006364	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2047	\N	\N	\N	\N	SYNX644	\N	\N	Consolidated_data_final.csv
11061	14-18	73	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	707.9	AGL Sample	13 Cycle Post Hybridization LM-PCR	Sections show a zone of ulceration, with necrosis and a fibrinopurulent exudate, as well as an adjacent proliferation of small vessels arrayed in inflamed stroma. There is hyperkeratotic debris with neutrophils and bacteria.	One hematoxylin and eosin-stained section prepared from outside block labeled 13-11325.	\N	\N	\N	\N	Thank you for sending the clinical image of this patient's lesion. I do not see evidence of a malignancy in this biopsy. There are some bacteria, but they are superficial and likely represent secondary impetiginization rather than a primary infection. The clinical and histopathologic findings seem to fit closest with those seen in erosive pustular dermatosis of the scalp.	ULCERATION WITH HYPERKERATOSIS AND GRANULATION TISSUE	100432	2110	\N	\N	14-18	A	SYNX707	\N	IP703498	Consolidated_data_final.csv
11062	14-19	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	AGL Sample	13 Cycle Post Hybridization LM-PCR	Sections show basilar pigmentation with prominent, enlarged single melanocytes along the dermo-epidermal junction. There is solar elastosis.	One hematoxylin and eosin-stained section prepared from outside block labeled 13-11407.	\N	\N	\N	\N	Level sections and a Sox-10 stain show a subtle proliferation of melanocytes with atypical nuclei above elastosis. While the melanocytic density is not very high, the findings are more consistent with early melanoma in situ than a solar lentigo. The proliferation extends to the specimen periphery. Additional treatment to ensure complete removal would be prudent. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation.	ATYPICAL INTRAEPIDERMAL MELANOCYTIC PROLIFERATION, CONSISTENT WITH SUBTLE MELANOMA IN SITU	173305	2111	\N	\N	14-19	A	SYNX708	\N	IP1349938	Consolidated_data_final.csv
11063	14-21	65	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	AGL Sample	13 Cycle Post Hybridization LM-PCR	An excisional specimen demonstrates a compound proliferation of melanocytes that is subtly biphasic in configuration. Centrally, hypocellular sclerotic scarring is noted, and this stems from prior biopsies in this vicinity. Above this, there is a broad and badly circumscribed intraepidermal population of enlarged melanocytes. These cells are distributed singly and in small nests in lentiginous fashion along the junction, and prominent scatter of melanocytes above the junction is also noted. In various areas in the dermis below this, maturing nests, cords, and small syncytia of smaller melanocytes are noted.	Eight outside slides, VS-13-8199 1A-1E.	\N	\N	\N	\N	I believe there are two populations of melanocytes within this specimen, with the badly circumscribed intraepidermal population of melanocytes representing melanoma in situ and with the smaller subjacent dermal melanocytes representing persistent melanocytic nevus. The component of melanoma in situ appears narrowly excised in the available planes of section. I do believe that reexcision of this site would be appropriate.	MELANOMA IN SITU, ARISING IN ASSOCIATION WITH A PERSISTENT ACRAL MELANOCYTIC NEVUS	173788	2112	\N	\N	14-21	A	SYNX709	\N	IP1349940	Consolidated_data_final.csv
3604	XD-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2113	\N	\N	None	\N	SYNAT653	2010-2017	\N	AirTable blocks_with_IP_info.csv
3605	XD-1.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2114	\N	\N	None	\N	SYNAT654	2010-2017	\N	AirTable blocks_with_IP_info.csv
3548	PMM-8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2115	\N	\N	None	\N	SYNAT655	2010-2017	\N	AirTable blocks_with_IP_info.csv
11067	Long-TN10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2116	\N	\N	\N	\N	SYNX713	\N	\N	Consolidated_data_final.csv
11069	Long-TN11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2117	\N	\N	\N	\N	SYNX714	\N	\N	Consolidated_data_final.csv
3381	JBP-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2118	\N	\N	None	\N	SYNAT656	2010-2017	\N	AirTable blocks_with_IP_info.csv
3383	JBP-3-MM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2119	\N	\N	None	\N	SYNAT657	2010-2017	\N	AirTable blocks_with_IP_info.csv
3382	JBP-3-Met1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2120	\N	\N	None	\N	SYNAT658	2010-2017	\N	AirTable blocks_with_IP_info.csv
11074	S12-15765B3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2121	\N	\N	\N	\N	SYNX718	\N	\N	Consolidated_data_final.csv
11075	S12-4365A8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2122	\N	\N	\N	\N	SYNX719	\N	\N	Consolidated_data_final.csv
11076	S12-4365A7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2123	\N	\N	\N	\N	SYNX720	\N	\N	Consolidated_data_final.csv
11077	S12-4365B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2124	\N	\N	\N	\N	SYNX721	\N	\N	Consolidated_data_final.csv
11078	S12-4365C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2125	\N	\N	\N	\N	SYNX722	\N	\N	Consolidated_data_final.csv
3550	S12-9606C4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2126	\N	S	12-9606	C4	SYNAT310	2010-2017	\N	AirTable blocks_with_IP_info.csv
11080	S12-9606EE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2127	\N	\N	\N	\N	SYNX724	\N	\N	Consolidated_data_final.csv
3549	S12-9606A2	69	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	698.3	\N	\N	Sections show verrucous epidermal hyperplasia, hypergranulosis and compact hyperkeratosis, and fibrosis of the papillary dermis. Some follicular infundibula are widened or cystically dilated.	One outside slide, G56860, 12-DM-590-1.	R/O VERRUCA	\N	\N	\N	The differential diagnosis includes a resolving keratoacanthoma that has been persistently rubbed.	PRURIGO NODULARIS-LIKE CHANGES	173665	2128	\N	S	12-9606	A2	SYNAT310	2010-2017	IP1095422	AirTable blocks_with_IP_info.csv
11082	ZS10-972C2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2129	\N	\N	\N	\N	SYNX726	\N	\N	Consolidated_data_final.csv
11083	ZS10-972A9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2130	\N	\N	\N	\N	SYNX727	\N	\N	Consolidated_data_final.csv
3384	JBP-7-Met	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2131	\N	\N	None	\N	SYNAT659	2010-2017	\N	AirTable blocks_with_IP_info.csv
11085	ZS10-1843A5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2132	\N	\N	\N	\N	SYNX729	\N	\N	Consolidated_data_final.csv
11086	ZS10-8439A4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal MM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2133	\N	\N	\N	\N	SYNX730	\N	\N	Consolidated_data_final.csv
11087	ZS10-1843A4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal MM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2134	\N	\N	\N	\N	SYNX731	\N	\N	Consolidated_data_final.csv
3612	ZS10-10558B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2135	\N	ZS	10-10558	B1	SYNAT660	2010-2017	\N	AirTable blocks_with_IP_info.csv
3611	ZS10-10558A10	82	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	Sections show an epidermis thickened by a sessile, papillated proliferation of basaloid and squamous keratinocytes with monomorphous nuclei.  Thick rete ridges enclose horn pseudocysts.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted.	1.0 CM GRAY BROWN FLAT PAPULE; SEB KER VS. PIGMENTED BCC	\N	\N	\N	\N	SEBORRHEIC KERATOSIS	173389	2136	\N	ZS	10-10558	A10	SYNAT660	2010-2017	IP644642	AirTable blocks_with_IP_info.csv
3613	ZS10-10558C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2137	\N	ZS	10-10558	C1	SYNAT660	2010-2017	\N	AirTable blocks_with_IP_info.csv
3610	ZS10-3560F1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2138	\N	ZS	10-3560	F1	SYNAT332	2010-2017	\N	AirTable blocks_with_IP_info.csv
11155	SRFS97-002805	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	2202	\N	\N	\N	\N	SYNX799	\N	\N	Consolidated_data_final.csv
11156	VALS03-019832	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	124	\N	\N	\N	\N	\N	\N	\N	\N	\N	2203	\N	\N	\N	\N	SYNX800	\N	\N	Consolidated_data_final.csv
3606	ZS10-3560A3	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.0	\N	\N	Sections show zones of the epidermis that contain a proliferation of keratinocytes with atypical nuclei, and parakeratosis containing inflammatory cells is present in the overlying cornified layer.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.1 cm in thickness.	H/O SCC, BCC, PERSISTENT SCALY PATCH, PRIOR TX X2 LN02	\N	\N	\N	\N	CRUSTED SOLAR KERATOSIS	123144	2139	\N	ZS	10-3560	A3	SYNAT332	2010-2017	IP773046	AirTable blocks_with_IP_info.csv
11093	ZS10-3560C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal MM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2140	\N	\N	\N	\N	SYNX737	\N	\N	Consolidated_data_final.csv
3586	UM23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2141	\N	\N	None	\N	SYNAT661	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
3587	UM24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2142	\N	\N	None	\N	SYNAT662	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
3588	UM25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2143	\N	\N	None	\N	SYNAT663	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
11112	RPA08-0315	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2159	\N	\N	\N	\N	SYNX756	\N	\N	Consolidated_data_final.csv
11113	NZM52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jillian Cell Lines	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2160	\N	\N	\N	\N	SYNX757	\N	\N	Consolidated_data_final.csv
11114	NZM40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jillian Cell Lines	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2161	\N	\N	\N	\N	SYNX758	\N	\N	Consolidated_data_final.csv
11115	NZM91	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jillian Cell Lines	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2162	\N	\N	\N	\N	SYNX759	\N	\N	Consolidated_data_final.csv
11116	SP-13-198211A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	DH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2163	\N	\N	\N	\N	SYNX760	\N	\N	Consolidated_data_final.csv
11117	RNS11P15316B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	DH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2164	\N	\N	\N	\N	SYNX761	\N	\N	Consolidated_data_final.csv
11118	9246581-A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	JG	\N	\N	\N	\N	\N	\N	\N	\N	\N	2165	\N	\N	\N	\N	SYNX762	\N	\N	Consolidated_data_final.csv
11119	9246581-A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	JG	\N	\N	\N	\N	\N	\N	\N	\N	\N	2166	\N	\N	\N	\N	SYNX763	\N	\N	Consolidated_data_final.csv
11120	DHM4855-14MP	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	MLH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2167	\N	\N	\N	\N	SYNX764	\N	\N	Consolidated_data_final.csv
11121	SNPN08289D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	MLH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2168	\N	\N	\N	\N	SYNX765	\N	\N	Consolidated_data_final.csv
11122	SP-10-143551E	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	JM	\N	\N	\N	\N	\N	\N	\N	\N	\N	2169	\N	\N	\N	\N	SYNX766	\N	\N	Consolidated_data_final.csv
11123	SP-10-143552A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	JM	\N	\N	\N	\N	\N	\N	\N	\N	\N	2170	\N	\N	\N	\N	SYNX767	\N	\N	Consolidated_data_final.csv
11124	04-SW-12-31366B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	AH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2171	\N	\N	\N	\N	SYNX768	\N	\N	Consolidated_data_final.csv
11125	04-SW-12-31366B6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	AH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2172	\N	\N	\N	\N	SYNX769	\N	\N	Consolidated_data_final.csv
11126	SP-13-63011A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	FN	\N	\N	\N	\N	\N	\N	\N	\N	\N	2173	\N	\N	\N	\N	SYNX770	\N	\N	Consolidated_data_final.csv
11127	SP-11-160493A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	FN	\N	\N	\N	\N	\N	\N	\N	\N	\N	2174	\N	\N	\N	\N	SYNX771	\N	\N	Consolidated_data_final.csv
11128	SP-13-87981B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	GJ	\N	\N	\N	\N	\N	\N	\N	\N	\N	2175	\N	\N	\N	\N	SYNX772	\N	\N	Consolidated_data_final.csv
11129	SP-11-40641B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	GJ	\N	\N	\N	\N	\N	\N	\N	\N	\N	2176	\N	\N	\N	\N	SYNX773	\N	\N	Consolidated_data_final.csv
11130	SP-14-125801B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	CG	\N	\N	\N	\N	\N	\N	\N	\N	\N	2177	\N	\N	\N	\N	SYNX774	\N	\N	Consolidated_data_final.csv
11131	SP-14-125802A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	CG	\N	\N	\N	\N	\N	\N	\N	\N	\N	2178	\N	\N	\N	\N	SYNX775	\N	\N	Consolidated_data_final.csv
11132	WCRS97-025628	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	17	\N	\N	\N	\N	\N	\N	\N	\N	\N	2179	\N	\N	\N	\N	SYNX776	\N	\N	Consolidated_data_final.csv
11133	SCHS10-026422	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	41	\N	\N	\N	\N	\N	\N	\N	\N	\N	2180	\N	\N	\N	\N	SYNX777	\N	\N	Consolidated_data_final.csv
11134	SROS12-001198	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	90	\N	\N	\N	\N	\N	\N	\N	\N	\N	2181	\N	\N	\N	\N	SYNX778	\N	\N	Consolidated_data_final.csv
11135	SROS09-001574	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	92	\N	\N	\N	\N	\N	\N	\N	\N	\N	2182	\N	\N	\N	\N	SYNX779	\N	\N	Consolidated_data_final.csv
11136	SCHS09-005840-B5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	93	\N	\N	\N	\N	\N	\N	\N	\N	\N	2183	\N	\N	\N	\N	SYNX780	\N	\N	Consolidated_data_final.csv
11137	SACS05-011507	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	99	\N	\N	\N	\N	\N	\N	\N	\N	\N	2184	\N	\N	\N	\N	SYNX781	\N	\N	Consolidated_data_final.csv
11138	FRSS09-009402-A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	105	\N	\N	\N	\N	\N	\N	\N	\N	\N	2185	\N	\N	\N	\N	SYNX782	\N	\N	Consolidated_data_final.csv
11139	RCHS07-000380-B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	28	\N	\N	\N	\N	\N	\N	\N	\N	\N	2186	\N	\N	\N	\N	SYNX783	\N	\N	Consolidated_data_final.csv
11140	SROS11-005030	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	30	\N	\N	\N	\N	\N	\N	\N	\N	\N	2187	\N	\N	\N	\N	SYNX784	\N	\N	Consolidated_data_final.csv
11141	VALS09-000266	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	2188	\N	\N	\N	\N	SYNX785	\N	\N	Consolidated_data_final.csv
11142	SFOS09-007093	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	18	\N	\N	\N	\N	\N	\N	\N	\N	\N	2189	\N	\N	\N	\N	SYNX786	\N	\N	Consolidated_data_final.csv
11143	FRSS09-008805	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	2190	\N	\N	\N	\N	SYNX787	\N	\N	Consolidated_data_final.csv
11144	RCHS06-004567	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	2191	\N	\N	\N	\N	SYNX788	\N	\N	Consolidated_data_final.csv
11145	VALS05-014946-E	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	2192	\N	\N	\N	\N	SYNX789	\N	\N	Consolidated_data_final.csv
11146	SCHS08-007754	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	2	\N	\N	\N	\N	\N	\N	\N	\N	\N	2193	\N	\N	\N	\N	SYNX790	\N	\N	Consolidated_data_final.csv
11147	SFOS12-018173	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	5	\N	\N	\N	\N	\N	\N	\N	\N	\N	2194	\N	\N	\N	\N	SYNX791	\N	\N	Consolidated_data_final.csv
11148	SROS00-001103	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	2195	\N	\N	\N	\N	SYNX792	\N	\N	Consolidated_data_final.csv
11149	MTZS94-007340	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	2196	\N	\N	\N	\N	SYNX793	\N	\N	Consolidated_data_final.csv
11150	SFOS94-003116	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	49	\N	\N	\N	\N	\N	\N	\N	\N	\N	2197	\N	\N	\N	\N	SYNX794	\N	\N	Consolidated_data_final.csv
11151	SACS93-027850	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	27	\N	\N	\N	\N	\N	\N	\N	\N	\N	2198	\N	\N	\N	\N	SYNX795	\N	\N	Consolidated_data_final.csv
11152	SCLS91-006557	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	2199	\N	\N	\N	\N	SYNX796	\N	\N	Consolidated_data_final.csv
11153	OAKS90-012369	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	9	\N	\N	\N	\N	\N	\N	\N	\N	\N	2200	\N	\N	\N	\N	SYNX797	\N	\N	Consolidated_data_final.csv
11158	RCHS01-003684	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	86	\N	\N	\N	\N	\N	\N	\N	\N	\N	2205	\N	\N	\N	\N	SYNX802	\N	\N	Consolidated_data_final.csv
11159	WCRS99-012800	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	111	\N	\N	\N	\N	\N	\N	\N	\N	\N	2206	\N	\N	\N	\N	SYNX803	\N	\N	Consolidated_data_final.csv
11160	HAYS90-005154	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	77	\N	\N	\N	\N	\N	\N	\N	\N	\N	2207	\N	\N	\N	\N	SYNX804	\N	\N	Consolidated_data_final.csv
11161	SFOS00-016989	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	69	\N	\N	\N	\N	\N	\N	\N	\N	\N	2208	\N	\N	\N	\N	SYNX805	\N	\N	Consolidated_data_final.csv
11162	VALS03-007457	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	117	\N	\N	\N	\N	\N	\N	\N	\N	\N	2209	\N	\N	\N	\N	SYNX806	\N	\N	Consolidated_data_final.csv
11163	SFO93-005184	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	103	\N	\N	\N	\N	\N	\N	\N	\N	\N	2210	\N	\N	\N	\N	SYNX807	\N	\N	Consolidated_data_final.csv
11164	DHM50691-14MP5C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2211	\N	\N	\N	\N	SYNX808	\N	\N	Consolidated_data_final.csv
11165	DHM50691-14MP3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2212	\N	\N	\N	\N	SYNX809	\N	\N	Consolidated_data_final.csv
11166	RNS14P13907B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2213	\N	\N	\N	\N	SYNX810	\N	\N	Consolidated_data_final.csv
11167	SP-10-197431A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2214	\N	\N	\N	\N	SYNX811	\N	\N	Consolidated_data_final.csv
11168	DHM57444-14MP	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2215	\N	\N	\N	\N	SYNX812	\N	\N	Consolidated_data_final.csv
11169	SP-12-177322A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2216	\N	\N	\N	\N	SYNX813	\N	\N	Consolidated_data_final.csv
11170	DHM94457-13SK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2217	\N	\N	\N	\N	SYNX814	\N	\N	Consolidated_data_final.csv
11171	DHM48742-12MPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2218	\N	\N	\N	\N	SYNX815	\N	\N	Consolidated_data_final.csv
11172	Laverty13-88354	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2219	\N	\N	\N	\N	SYNX816	\N	\N	Consolidated_data_final.csv
11173	ICPMR19684.13A11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2220	\N	\N	\N	\N	SYNX817	\N	\N	Consolidated_data_final.csv
11174	SP-13-15691B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2221	\N	\N	\N	\N	SYNX818	\N	\N	Consolidated_data_final.csv
11175	SP-13-15691D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2222	\N	\N	\N	\N	SYNX819	\N	\N	Consolidated_data_final.csv
11176	57059699	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2223	\N	\N	\N	\N	SYNX820	\N	\N	Consolidated_data_final.csv
11177	57269600	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2224	\N	\N	\N	\N	SYNX821	\N	\N	Consolidated_data_final.csv
11178	57213442	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2225	\N	\N	\N	\N	SYNX822	\N	\N	Consolidated_data_final.csv
11179	57346060	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2226	\N	\N	\N	\N	SYNX823	\N	\N	Consolidated_data_final.csv
11180	SROS10-009251	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	19	\N	\N	\N	\N	\N	\N	\N	\N	\N	2227	\N	\N	\N	\N	SYNX824	\N	\N	Consolidated_data_final.csv
11181	FRSS99-007026	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	32	\N	\N	\N	\N	\N	\N	\N	\N	\N	2228	\N	\N	\N	\N	SYNX825	\N	\N	Consolidated_data_final.csv
11182	SCLS04-001045	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	60	\N	\N	\N	\N	\N	\N	\N	\N	\N	2229	\N	\N	\N	\N	SYNX826	\N	\N	Consolidated_data_final.csv
11183	OAKS96-014392-G	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	74	\N	\N	\N	\N	\N	\N	\N	\N	\N	2230	\N	\N	\N	\N	SYNX827	\N	\N	Consolidated_data_final.csv
11184	OAKS96-022398	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	109	\N	\N	\N	\N	\N	\N	\N	\N	\N	2231	\N	\N	\N	\N	SYNX828	\N	\N	Consolidated_data_final.csv
11185	OAK84-008979-B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	112	\N	\N	\N	\N	\N	\N	\N	\N	\N	2232	\N	\N	\N	\N	SYNX829	\N	\N	Consolidated_data_final.csv
11186	ROSS09-022626-A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	115	\N	\N	\N	\N	\N	\N	\N	\N	\N	2233	\N	\N	\N	\N	SYNX830	\N	\N	Consolidated_data_final.csv
11187	SCHS11-018842-A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	119	\N	\N	\N	\N	\N	\N	\N	\N	\N	2234	\N	\N	\N	\N	SYNX831	\N	\N	Consolidated_data_final.csv
11188	SSCS03-004945	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	2235	\N	\N	\N	\N	SYNX832	\N	\N	Consolidated_data_final.csv
11189	WCRS02-022688	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	47	\N	\N	\N	\N	\N	\N	\N	\N	\N	2236	\N	\N	\N	\N	SYNX833	\N	\N	Consolidated_data_final.csv
11190	SACS02-020334	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	100	\N	\N	\N	\N	\N	\N	\N	\N	\N	2237	\N	\N	\N	\N	SYNX834	\N	\N	Consolidated_data_final.csv
11191	HAYS98-001046	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	75	\N	\N	\N	\N	\N	\N	\N	\N	\N	2238	\N	\N	\N	\N	SYNX835	\N	\N	Consolidated_data_final.csv
11192	SACS88-019073	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	64	\N	\N	\N	\N	\N	\N	\N	\N	\N	2239	\N	\N	\N	\N	SYNX836	\N	\N	Consolidated_data_final.csv
11193	SACS87-010145	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	50	\N	\N	\N	\N	\N	\N	\N	\N	\N	2240	\N	\N	\N	\N	SYNX837	\N	\N	Consolidated_data_final.csv
11194	STRS91-006237	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	39	\N	\N	\N	\N	\N	\N	\N	\N	\N	2241	\N	\N	\N	\N	SYNX838	\N	\N	Consolidated_data_final.csv
11195	SSCS92-009981	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	22	\N	\N	\N	\N	\N	\N	\N	\N	\N	2242	\N	\N	\N	\N	SYNX839	\N	\N	Consolidated_data_final.csv
1775	14-59304A	11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a compound proliferation of plump, oval to small round melanocytes, arrayed as a few small nests along the epidermal-dermal junction, and as nests, cords and strands that extend into the superficial reticular dermis and are distributed around adnexa.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A-B) R/O DN	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173416	2243	\N	\N	14-59304	A	SYNAT673	2010-2017	IP1409245	AirTable blocks_with_IP_info.csv
11198	13-48020	66	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Ellipse measuring 1.4 x 1.3 x 0.3 cm, including a central 1.1 x 1.0 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with five sections. HD/HD	\N	\N	\N	\N	Melanoma in situ is present < 2 millimeters from the edge of the specimen.  This is a non-ulcerated melanoma and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.  I have reviewed this case with Dr. McCalmont who concurs with the diagnosis.	MELANOMA, 0.75 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	2244	\N	\N	13-48020	A	SYNX841	\N	IP1289322	Consolidated_data_final.csv
11200	14-13499	84	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  Some bridging of rete is noted.  There are a few clusters similar melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected and entirely submitted. PL/PL	\N	\N	\N	\N	Melanoma in situ is present a fraction of a millimeter from the edge of the specimen.  I have examined additional sections and a Melan-A stain.  The immunostain highlights areas of increased confluence of junctional melanocytes as well as scattered melanocytes above the dermo-epidermal junction.  Within the fibrotic dermis a few nests of melanocytes are also present.  There is also a small population of bland dermal melanocytes that represent a melanocytic nevus.  This is a non-ulcerated melanoma and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.	MELANOMA, 0.62 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	2245	\N	\N	14-13499	A	SYNX842	\N	IP1363420	Consolidated_data_final.csv
11207	13-61146	26	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, surrounded by a lymphocytic infiltrate.  Laterally in the superficial dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords.	Ellipse, 1.0 x 0.7 x 0.4 cm, including a central 0.8 x 0.7 cm brown area. With the margins inked, the specimen is quadrisected perpendicular to the long axis and entirely submitted. PL/PL	\N	\N	\N	\N	This biopsy demonstrates a thin invasive melanoma that has developed in conjunction with a small congenital melanocytic nevus. With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its small invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Both the melanoma and the melanocytic nevus appear narrowly excised in the available sections.	MELANOMA OF 0.45 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173649	2248	\N	\N	13-61146	A	SYNX845	\N	IP1303150	Consolidated_data_final.csv
11210	57001550	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	uveal melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2249	\N	\N	\N	\N	SYNX846	\N	\N	Consolidated_data_final.csv
11211	57291680	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	uveal melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2250	\N	\N	\N	\N	SYNX847	\N	\N	Consolidated_data_final.csv
11220	UM33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Soyer Microbiopsy Study	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2251	\N	\N	\N	\N	SYNX848	\N	\N	Consolidated_data_final.csv
11221	UM35_A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2252	\N	\N	\N	\N	SYNX849	\N	\N	Consolidated_data_final.csv
11222	UM39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2253	\N	\N	\N	\N	SYNX850	\N	\N	Consolidated_data_final.csv
11223	UM40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2254	\N	\N	\N	\N	SYNX851	\N	\N	Consolidated_data_final.csv
11224	UM41	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2255	\N	\N	\N	\N	SYNX852	\N	\N	Consolidated_data_final.csv
11225	UM36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2256	\N	\N	\N	\N	SYNX853	\N	\N	Consolidated_data_final.csv
11226	UM37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2257	\N	\N	\N	\N	SYNX854	\N	\N	Consolidated_data_final.csv
11228	57715138	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma, left eye, s/p enucleation	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2258	\N	\N	\N	\N	SYNX855	\N	\N	Consolidated_data_final.csv
11230	332771	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma (choroidal melanoma, right eye)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2259	\N	\N	\N	\N	SYNX856	\N	\N	Consolidated_data_final.csv
11231	57723220	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma (choroidal melanoma, right eye)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2260	\N	\N	\N	\N	SYNX857	\N	\N	Consolidated_data_final.csv
11232	55875588	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2261	\N	\N	\N	\N	SYNX858	\N	\N	Consolidated_data_final.csv
11233	57714581	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma (choroidal lesion, left eye)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2262	\N	\N	\N	\N	SYNX859	\N	\N	Consolidated_data_final.csv
11234	UM47	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2263	\N	\N	\N	\N	SYNX860	\N	\N	Consolidated_data_final.csv
11236	Sample_KAM1-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2264	\N	\N	\N	\N	SYNX861	\N	\N	Consolidated_data_final.csv
11237	Sample_KAM106-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2265	\N	\N	\N	\N	SYNX862	\N	\N	Consolidated_data_final.csv
11238	Sample_KAM12-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2266	\N	\N	\N	\N	SYNX863	\N	\N	Consolidated_data_final.csv
11239	Sample_KAM121-T-B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2267	\N	\N	\N	\N	SYNX864	\N	\N	Consolidated_data_final.csv
11240	Sample_KAM20-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2268	\N	\N	\N	\N	SYNX865	\N	\N	Consolidated_data_final.csv
11241	Sample_KAM3-T-A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2269	\N	\N	\N	\N	SYNX866	\N	\N	Consolidated_data_final.csv
11242	Sample_KAM35-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2270	\N	\N	\N	\N	SYNX867	\N	\N	Consolidated_data_final.csv
11243	Sample_KAM38-T-B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2271	\N	\N	\N	\N	SYNX868	\N	\N	Consolidated_data_final.csv
11244	Sample_KAM53-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2272	\N	\N	\N	\N	SYNX869	\N	\N	Consolidated_data_final.csv
11245	Sample_KAM61-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2273	\N	\N	\N	\N	SYNX870	\N	\N	Consolidated_data_final.csv
11246	Sample_KAM7-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2274	\N	\N	\N	\N	SYNX871	\N	\N	Consolidated_data_final.csv
11247	Sample_KAM78-T-III	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2275	\N	\N	\N	\N	SYNX872	\N	\N	Consolidated_data_final.csv
11248	Sample_KAM82-T-B8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2276	\N	\N	\N	\N	SYNX873	\N	\N	Consolidated_data_final.csv
11249	Sample_KAM84-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2277	\N	\N	\N	\N	SYNX874	\N	\N	Consolidated_data_final.csv
11250	Sample_KAM94-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2278	\N	\N	\N	\N	SYNX875	\N	\N	Consolidated_data_final.csv
11251	Sample_KAM96-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2279	\N	\N	\N	\N	SYNX876	\N	\N	Consolidated_data_final.csv
\.


--
-- Data for Name: na_sl_link; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.na_sl_link (id, input_vol, input_amount, nucacid_id, sample_lib_id, date, sl_name, na_name) FROM stdin;
89770	\N	\N	29897	37066	\N	Kit_227_Acral_WT_ACACGA	Kit_227_Acral_WT_NA
90101	\N	\N	31223	37397	\N	NGS 1-10	NGS 1-10_NA
90151	\N	\N	28785	37447	\N	ChIP1_9	ChIP1_9_NA
90815	\N	\N	\N	38111	\N	RLP-111	RNA-165,RNA-208
89091	\N	\N	\N	36387	\N	AMLP-212	AM2 D-59,AM2 D-205
89092	\N	\N	\N	36388	\N	AMLP-228	AM2 D-206,AM2 D-252
89107	\N	\N	\N	36403	\N	AMLP-234	AM2 D-261,AM2 D-363
89445	\N	\N	\N	36741	\N	KAM111-tumor_kapa-NGv3-PE100-NGv3-ready	KAM111-T-A1,KAM111-T-A2
89600	\N	\N	\N	36896	\N	AMLP-199	AM2 D-24,AM2 D-225
89616	\N	\N	\N	36912	\N	AMLP-218	AM2 D-22,AM2 D-245
89617	\N	\N	\N	36913	\N	AMLP-219	AM2 D-23,AM2 D-246,AM2 D-254
89621	\N	\N	\N	36917	\N	AMLP-290	AM2 D-426,AM2 D-428
89632	\N	\N	\N	36928	\N	AMLP-245	AM2 D-410,AM2 D-411,AM2 D-360
89637	\N	\N	\N	36933	\N	AMLP-261	AM2 D-342,AM2 D-343
89649	\N	\N	\N	36945	\N	AMLP-200	AM2 D-26,AM2 D-226
89652	\N	\N	\N	36948	\N	AMLP-224	AM2 D-220,AM2 D-253
89656	\N	\N	\N	36952	\N	AMLP-217	AM2 D-21,AM2 D-244
89657	\N	\N	\N	36953	\N	AMLP-206	AM2 D-199,AM2 D-233
89659	\N	\N	\N	36955	\N	AMLP-220	AM2 D-247,AM2 D-251
89673	\N	\N	\N	36969	\N	AMLP-283	AM2 D-406,AM2 D-407
89694	\N	\N	\N	36990	\N	AMLP-248	AM2 D-320,AM2 D-361
89709	\N	\N	\N	37005	\N	AMLP-203	AM2 D-29,AM2 D-229
89710	\N	\N	\N	37006	\N	AMLP-202	AM2 D-28,AM2 D-228
89712	\N	\N	\N	37008	\N	AMLP-201	AM2 D-27,AM2 D-227
90215	\N	\N	\N	37511	\N	KAM111-tumor	KAM111-T-A1,KAM111-T-A2
90323	\N	\N	\N	37619	\N	2229_Normal	DNA-397,DNA-420
90325	\N	\N	\N	37621	\N	2222_Normal	DNA-388,DNA-423
90410	\N	\N	\N	37706	\N	1917_Mel	DNA-160,DNA-203
90411	\N	\N	\N	37707	\N	1955_Normal	DNA-198,DNA-241,DNA-256
90414	\N	\N	\N	37710	\N	1958_Normal	DNA-258,DNA-263
90415	\N	\N	\N	37711	\N	892_Mel	DNA-132,DNA-266
90416	\N	\N	\N	37712	\N	1927_MIS	DNA-170,DNA-213
90417	\N	\N	\N	37713	\N	1949_1956_Normal	DNA-236,DNA-192,DNA-201,DNA-244,DNA-255
90421	\N	\N	\N	37717	\N	1926_Mel	DNA-169,DNA-212
90423	\N	\N	\N	37719	\N	1919_Nevus	DNA-162,DNA-205
90426	\N	\N	\N	37722	\N	1918_MIS	DNA-161,DNA-204
90427	\N	\N	\N	37723	\N	1930_Normal	DNA-216,DNA-173
90429	\N	\N	\N	37725	\N	1922_Nevus	DNA-165,DNA-208
90432	\N	\N	\N	37728	\N	1954_MIS	DNA-197,DNA-233
90434	\N	\N	\N	37730	\N	894_Normal	DNA-131,DNA-267,DNA-270,DNA-271
90435	\N	\N	\N	37731	\N	1931_Mel	DNA-174,DNA-217
90436	\N	\N	\N	37732	\N	1928_Nevus	DNA-171,DNA-214
90439	\N	\N	\N	37735	\N	1933_Nevus	DNA-176,DNA-219,DNA-252
90442	\N	\N	\N	37738	\N	1951_Mel	DNA-194,DNA-238
90631	\N	\N	\N	37927	\N	RLP-92	RNA-155,RNA-150
90636	\N	\N	\N	37932	\N	RLP-89	RNA-152,RNA-147
90637	\N	\N	\N	37933	\N	RLP-90	RNA-153,RNA-148
90646	\N	\N	\N	37942	\N	RLP-91	RNA-154,RNA-149
90658	\N	\N	\N	37954	\N	DLP-123	DNA-153,DNA-148
90659	\N	\N	\N	37955	\N	DLP-124	DNA-158,DNA-154,DNA-149
90660	\N	\N	\N	37956	\N	DLP-126	DNA-159,DNA-156,DNA-151
90672	\N	\N	\N	37968	\N	DLP-122	DNA-157,DNA-152,DNA-147
90673	\N	\N	\N	37969	\N	DLP-125	DNA-155,DNA-150
90769	\N	\N	\N	38065	\N	RLP-118	RNA-187,RNA-230
90790	\N	\N	\N	38086	\N	RLP-107	RNA-160,RNA-203
90791	\N	\N	\N	38087	\N	RLP-115	RNA-174,RNA-217
90792	\N	\N	\N	38088	\N	RLP-110	RNA-207,RNA-245
90793	\N	\N	\N	38089	\N	RLP-119	RNA-188,RNA-231
90811	\N	\N	\N	38107	\N	RLP-114	RNA-171,RNA-214
90812	\N	\N	\N	38108	\N	RLP-121	RNA-234,RNA-247
90813	\N	\N	\N	38109	\N	RLP-113	RNA-170,RNA-213
90814	\N	\N	\N	38110	\N	RLP-108	RNA-161,RNA-204
90817	\N	\N	\N	38113	\N	RLP-112	RNA-169,RNA-212
90841	\N	\N	\N	38137	\N	RLP-109	RNA-162,RNA-205
90842	\N	\N	\N	38138	\N	RLP-123	RNA-199,RNA-242
90843	\N	\N	\N	38139	\N	RLP-116	RNA-175,RNA-218
90874	\N	\N	\N	38170	\N	RLP-117	RNA-176,RNA-219
90875	\N	\N	\N	38171	\N	RLP-120	RNA-197,RNA-233
90917	\N	\N	\N	38213	\N	DLP-128	DNA-277,DNA-291
90919	\N	\N	\N	38215	\N	DLP-129	DNA-276,DNA-313
90923	\N	\N	\N	38219	\N	DLP-135	DNA-316,DNA-317
90939	\N	\N	\N	38235	\N	AMLP-527	AM2 D-268,AM2 D-368
91845	\N	\N	\N	39141	\N	SGLP-0795	SND-11,SND-31
91846	\N	\N	\N	39142	\N	SGLP-0796	SND-12,SND-32
91847	\N	\N	\N	39143	\N	SGLP-0797	SND-16,SND-33
91850	\N	\N	\N	39146	\N	SGLP-0800	SND-08,SND-30,SND-36
91851	\N	\N	\N	39147	\N	SGLP-0801	SND-18,SND-37
91852	\N	\N	\N	39148	\N	SGLP-0802	SND-26,SND-38
91912	\N	\N	\N	39208	\N	AMLP-386	AM2 D-338,AM2 D-339
91951	\N	\N	\N	39247	\N	SGLP-0828	LN D-070,LN D-117
91952	\N	\N	\N	39248	\N	SGLP-0827	LN D-069,LN D-116
91953	\N	\N	\N	39249	\N	SGLP-0829	LN D-071,LN D-095,LN D-147
91954	\N	\N	\N	39250	\N	SGLP-0831	LN D-073,LN D-097,LN D-149
91955	\N	\N	\N	39251	\N	SGLP-0830	LN D-072,LN D-096,LN D-148
91956	\N	\N	\N	39252	\N	SGLP-0832	LN D-074,LN D-098,LN D-150
91957	\N	\N	\N	39253	\N	SGLP-0833	LN D-075,LN D-099,LN D-151
91958	\N	\N	\N	39254	\N	SGLP-0834	LN D-076,LN D-118
91959	\N	\N	\N	39255	\N	SGLP-0835	LN D-077,LN D-119
91960	\N	\N	\N	39256	\N	SGLP-0837	LN D-079,LN D-100
91961	\N	\N	\N	39257	\N	SGLP-0836	LN D-078,LN D-120
91962	\N	\N	\N	39258	\N	SGLP-0838	LN D-080,LN D-121
91963	\N	\N	\N	39259	\N	SGLP-0839	LN D-082,LN D-101,LN D-154
91964	\N	\N	\N	39260	\N	SGLP-0840	LN D-083,LN D-102,LN D-155
91965	\N	\N	\N	39261	\N	SGLP-0842	LN D-085,LN D-104,LN D-157
91966	\N	\N	\N	39262	\N	SGLP-0841	LN D-084,LN D-103,LN D-156
91967	\N	\N	\N	39263	\N	SGLP-0843	LN D-086,LN D-122
91968	\N	\N	\N	39264	\N	SGLP-0845	LN D-089,LN D-124
91970	\N	\N	\N	39266	\N	SGLP-0846	LN D-090,LN D-125
91971	\N	\N	\N	39267	\N	SGLP-0847	LN D-091,LN D-126
91972	\N	\N	\N	39268	\N	SGLP-0848	LN D-092,LN D-127,LN D-159
91973	\N	\N	\N	39269	\N	SGLP-0849	LN D-093,LN D-128,LN D-160
91974	\N	\N	\N	39270	\N	SGLP-0850	LN D-094,LN D-129
91975	\N	\N	\N	39271	\N	SGLP-0853	LN D-107,LN D-135
91976	\N	\N	\N	39272	\N	SGLP-0856	LN D-134,LN D-138
91977	\N	\N	\N	39273	\N	SGLP-0861	LN D-112,LN D-143
91978	\N	\N	\N	39274	\N	SGLP-0854	LN D-132,LN D-136
91979	\N	\N	\N	39275	\N	SGLP-0860	LN D-111,LN D-142
91980	\N	\N	\N	39276	\N	SGLP-0858	LN D-109,LN D-140
91981	\N	\N	\N	39277	\N	SGLP-0855	LN D-133,LN D-137
91982	\N	\N	\N	39278	\N	SGLP-0859	LN D-110,LN D-141
91983	\N	\N	\N	39279	\N	SGLP-0863	LN D-114,LN D-145
91984	\N	\N	\N	39280	\N	SGLP-0852	LN D-106,LN D-131,LN D-162
91985	\N	\N	\N	39281	\N	SGLP-0851	LN D-105,LN D-130,LN D-161
91986	\N	\N	\N	39282	\N	SGLP-0862	LN D-113,LN D-144,LN D-164
91987	\N	\N	\N	39283	\N	SGLP-0857	LN D-108,LN D-139
91988	\N	\N	\N	39284	\N	SGLP-0864	LN D-115,LN D-146
91989	\N	\N	\N	39285	\N	OMLP-022	OM-1D-2,OM-1D-3
91990	\N	\N	\N	39286	\N	OMLP-023	OM-4D-2,OM-4D-3
91991	\N	\N	\N	39287	\N	OMLP-026	OM-10D-2,OM-10D-3
91992	\N	\N	\N	39288	\N	OMLP-031	OM-25D,OM-25D-2
91993	\N	\N	\N	39289	\N	OMLP-029	OM-23D,OM-23D-2
91994	\N	\N	\N	39290	\N	OMLP-024	OM-5D-2,OM-5D-3
91996	\N	\N	\N	39292	\N	OMLP-033	OM-27D,OM-27D-2
91997	\N	\N	\N	39293	\N	OMLP-035	OM-29D,OM-29D-2
91998	\N	\N	\N	39294	\N	OMLP-030	OM-24D,OM-24D-2
91999	\N	\N	\N	39295	\N	OMLP-034	OM-28D,OM-28D-2
92000	\N	\N	\N	39296	\N	OMLP-028	OM-22D,OM-22D-2
92001	\N	\N	\N	39297	\N	OMLP-032	OM-26D,OM-26D-2
92002	\N	\N	\N	39298	\N	OMLP-025	OM-6D-2,OM-6D-3
92021	\N	\N	\N	39317	\N	OMLP-051	OM D-40.1,OM D-40.2
92045	\N	\N	\N	39341	\N	CCRLP-0001	MMD-09,MMD-55,MMD-69
92046	\N	\N	\N	39342	\N	CCRLP-0003	MMD-28,MMD-59
92049	\N	\N	\N	39345	\N	CCRLP-0024	MMD-05,MMD-54,MMD-68
92050	\N	\N	\N	39346	\N	CCRLP-0035	MMD-217,MMD-129
92051	\N	\N	\N	39347	\N	CCRLP-0019	MMD-40,MMD-56
92055	\N	\N	\N	39351	\N	CCRLP-0037	MMD-53,MMD-67
92056	\N	\N	\N	39352	\N	CCRLP-0008	MMD-33,MMD-62,MMD-106
92058	\N	\N	\N	39354	\N	CCRLP-0028	MMD-32,MMD-61
92060	\N	\N	\N	39356	\N	CCRLP-0051	MMD-73,MMD-74,MMD-75,MMD-93
92061	\N	\N	\N	39357	\N	CCRLP-0005	MMD-16,MMD-24
92062	\N	\N	\N	39358	\N	CCRLP-0034	MMD-173,MMD-315
92063	\N	\N	\N	39359	\N	CCRLP-0015	MMD-51,MMD-102
92064	\N	\N	\N	39360	\N	CCRLP-0007	MMD-19,MMD-25
92081	\N	\N	\N	39377	\N	CCRLP-0026	MMD-21,MMD-26,MMD-22,MMD-27
92111	\N	\N	\N	39407	\N	AMLP-416	AM2 D-356,AM2 D-506
92273	\N	\N	\N	39569	\N	JJS21_Mel	"21\n  MEL_RNA"
90620	\N	\N	31625	37916	\N	RLP-67	RNA-72
89012	\N	\N	27843	36308	\N	AMLP-57	AM2 D-102
89013	\N	\N	27842	36309	\N	AMLP-56	AM2 D-101
89014	\N	\N	27845	36310	\N	AMLP-59	AM2 D-104
89015	\N	\N	27847	36311	\N	AMLP-60	AM2 D-105
89016	\N	\N	27850	36312	\N	AMLP-62	AM2 D-108
89017	\N	\N	27851	36313	\N	AMLP-63	AM2 D-109
89018	\N	\N	27784	36314	\N	AMLP-32	AM2 D-43
89019	\N	\N	27821	36315	\N	AMLP-26	AM2 D-80
89020	\N	\N	27815	36316	\N	AMLP-23_1	AM2 D-74
89021	\N	\N	27787	36317	\N	AMLP-34	AM2 D-46
89022	\N	\N	27818	36318	\N	AMLP-24_1	AM2 D-77
89023	\N	\N	27798	36319	\N	AMLP-38	AM2 D-57
89024	\N	\N	27801	36320	\N	AMLP-40	AM2 D-60
89025	\N	\N	27828	36321	\N	AMLP-43	AM2 D-87
89026	\N	\N	27791	36322	\N	AMLP-35	AM2 D-50
89027	\N	\N	27822	36323	\N	AMLP-27	AM2 D-81
89028	\N	\N	27797	36324	\N	AMLP-37	AM2 D-56
89029	\N	\N	27786	36325	\N	AMLP-31	AM2 D-45
89030	\N	\N	27774	36326	\N	AMLP-20_1	AM2 D-33
89031	\N	\N	27826	36327	\N	AMLP-42	AM2 D-85
89032	\N	\N	27819	36328	\N	AMLP-25	AM2 D-78
89033	\N	\N	27794	36329	\N	AMLP-36	AM2 D-53
89034	\N	\N	27785	36330	\N	AMLP-33	AM2 D-44
89035	\N	\N	27799	36331	\N	AMLP-39	AM2 D-58
89036	\N	\N	27825	36332	\N	AMLP-28	AM2 D-84
89037	\N	\N	31581	36333	\N	RNA-23	RNA-23
89038	\N	\N	31568	36334	\N	RNA-10	RNA-10
89039	\N	\N	31577	36335	\N	RNA-19	RNA-19
89040	\N	\N	31578	36336	\N	RNA-20	RNA-20
89041	\N	\N	27853	36337	\N	AMLP-65	AM2 D-111
89042	\N	\N	27888	36338	\N	AMLP-100	AM2 D-146
89043	\N	\N	27911	36339	\N	AMLP-118	AM2 D-169
89044	\N	\N	27913	36340	\N	AMLP-120	AM2 D-171
89045	\N	\N	27858	36341	\N	AMLP-71	AM2 D-116
89046	\N	\N	27912	36342	\N	AMLP-119	AM2 D-170
89047	\N	\N	27861	36343	\N	AMLP-74	AM2 D-119
89048	\N	\N	27906	36344	\N	AMLP-115	AM2 D-164
89049	\N	\N	27915	36345	\N	AMLP-122	AM2 D-173
89050	\N	\N	27917	36346	\N	AMLP-124	AM2 D-175
89051	\N	\N	27897	36347	\N	AMLP-106	AM2 D-155
89052	\N	\N	27855	36348	\N	AMLP-67	AM2 D-113
89053	\N	\N	27873	36349	\N	AMLP-86	AM2 D-131
89054	\N	\N	27859	36350	\N	AMLP-72	AM2 D-117
89055	\N	\N	27881	36351	\N	AMLP-94	AM2 D-139
89056	\N	\N	27889	36352	\N	AMLP-101	AM2 D-147
89057	\N	\N	27884	36353	\N	AMLP-98	AM2 D-142
89058	\N	\N	27887	36354	\N	AMLP-70	AM2 D-145
89059	\N	\N	27860	36355	\N	AMLP-73	AM2 D-118
89060	\N	\N	27907	36356	\N	AMLP-116	AM2 D-165
89061	\N	\N	27866	36357	\N	AMLP-79	AM2 D-124
89062	\N	\N	31243	36358	\N	NMLP-005	NM D-05
89063	\N	\N	31285	36359	\N	NMLP-047	NM D-059
89064	\N	\N	31282	36360	\N	NMLP-044	NM D-054
89065	\N	\N	31244	36361	\N	NMLP-006	NM D-06
89066	\N	\N	31281	36362	\N	NMLP-043	NM D-053
89067	\N	\N	31921	36363	\N	SGLP-0361	SM D-06
89068	\N	\N	30083	36364	\N	SGLP-0419	LN D-028 (LN-028)
89069	\N	\N	30099	36365	\N	SGLP-0435	LN D-044 (LN-044)
89070	\N	\N	31616	36366	\N	RLP-58	RNA-58
89071	\N	\N	31615	36367	\N	RLP-57	RNA-57
89072	\N	\N	28804	36368	\N	SGLP-0472	CM D-18
89073	\N	\N	28809	36369	\N	SGLP-0476	CM D-23
89074	\N	\N	28817	36370	\N	SGLP-0483	CM D-31
89075	\N	\N	28828	36371	\N	SGLP-0494	CM D-42
89076	\N	\N	30421	36372	\N	SGLP-0551	MDD-78
89077	\N	\N	27744	36373	\N	AMLP-144	AM2 D-03
89078	\N	\N	27774	36374	\N	AMLP-154	AM2 D-33
89079	\N	\N	27927	36375	\N	AMLP-155	AM2 D-185
89080	\N	\N	27837	36376	\N	AMLP-158	AM2 D-96
89081	\N	\N	27925	36377	\N	AMLP-157	AM2 D-183
89082	\N	\N	27929	36378	\N	AMLP-159	AM2 D-187
89083	\N	\N	27910	36379	\N	AMLP-187	AM2 D-168
89084	\N	\N	27912	36380	\N	AMLP-190	AM2 D-170
89085	\N	\N	27911	36381	\N	AMLP-188	AM2 D-169
89086	\N	\N	27933	36382	\N	AMLP-189	AM2 D-191
89087	\N	\N	27774	36383	\N	AMLP-20_2	AM2 D-33
89088	\N	\N	27815	36384	\N	AMLP-23_2	AM2 D-74
89089	\N	\N	27818	36385	\N	AMLP-24_2	AM2 D-77
89090	\N	\N	27801	36386	\N	AMLP-213	AM2 D-60
89093	\N	\N	27946	36389	\N	AMLP-229	AM2 D-207
89094	\N	\N	27947	36390	\N	AMLP-230	AM2 D-208
89095	\N	\N	27933	36391	\N	AMLP-232	AM2 D-191
89096	\N	\N	29312	36392	\N	DLP-100	DNA-100
89097	\N	\N	31464	36393	\N	EXLP-02	PROG D-02
89098	\N	\N	31465	36394	\N	EXLP-03	PROG D-03
89099	\N	\N	31468	36395	\N	EXLP-06	PROG D-06
89100	\N	\N	31473	36396	\N	EXLP-08	PROG D-11
89101	\N	\N	31470	36397	\N	EXLP-07	PROG D-08
89102	\N	\N	29333	36398	\N	DLP-112	DNA-126
89103	\N	\N	29334	36399	\N	DLP-113	DNA-127
89104	\N	\N	31663	36400	\N	RLP-83	RNA-129
89105	\N	\N	31664	36401	\N	RLP-84	RNA-130
89106	\N	\N	27994	36402	\N	AMLP-233	AM2 D-260
89108	\N	\N	27998	36404	\N	AMLP-235	AM2 D-264
89109	\N	\N	27999	36405	\N	AMLP-236	AM2 D-265
89110	\N	\N	28034	36406	\N	AMLP-242	AM2 D-309
89111	\N	\N	28035	36407	\N	AMLP-243	AM2 D-310
89112	\N	\N	28040	36408	\N	AMLP-246	AM2 D-316
89113	\N	\N	28047	36409	\N	AMLP-251	AM2 D-323
89114	\N	\N	28053	36410	\N	AMLP-253	AM2 D-329
89115	\N	\N	28058	36411	\N	AMLP-258	AM2 D-334
89116	\N	\N	28065	36412	\N	AMLP-260	AM2 D-341
89117	\N	\N	28080	36413	\N	AMLP-294	AM2 D-358
89118	\N	\N	30740	36414	\N	CCRLP-0042	MMD-165
89119	\N	\N	30582	36415	\N	CCRLP-0040	MMD-02
89120	\N	\N	30756	36416	\N	CCRLP-0032	MMD-181
89121	\N	\N	31426	36417	\N	OMLP-001	OM-15D (P040_11D)
89122	\N	\N	29273	36418	\N	DLP-054_RE	DNA-54_REPEAT
89123	\N	\N	29271	36419	\N	DLP-053_RE	DNA-53_REPEAT
89124	\N	\N	29230	36420	\N	DLP-01_RE	DNA-01_REPEAT
89125	\N	\N	28040	36421	\N	AMLP-309	AM2 D-316
89126	\N	\N	28070	36422	\N	AMLP-328	AM2 D-348
89127	\N	\N	28177	36423	\N	AMLP-329	AM2 D-475
89128	\N	\N	27992	36424	\N	AMLP-333	AM2 D-258
89129	\N	\N	28077	36425	\N	AMLP-335	AM2 D-355
89130	\N	\N	27996	36426	\N	AMLP-334	AM2 D-262
89131	\N	\N	28184	36427	\N	AMLP-337	AM2 D-482 (P041_03C)
89132	\N	\N	28183	36428	\N	AMLP-336	AM2 D-481 (P041_03B)
89133	\N	\N	28185	36429	\N	AMLP-338	AM2 D-483 (P041_03D)
89134	\N	\N	30752	36430	\N	CCRLP-0055 (DO NOT USE)	MMD-177
89135	\N	\N	30675	36431	\N	CCRLP-0056 (DO NOT USE)	MMD-97
89136	\N	\N	30582	36432	\N	CCRLP-0057 (DO NOT USE)	MMD-02
89137	\N	\N	30740	36433	\N	CCRLP-0058 (DO NOT USE)	MMD-165
89138	\N	\N	28137	36434	\N	AMLP-351	AM2 D-431
89139	\N	\N	28100	36435	\N	AMLP-356	AM2 D-381
89140	\N	\N	28187	36436	\N	AMLP-358	AM2 D-485
89141	\N	\N	28137	36437	\N	AMLP-357	AM2 D-431
89142	\N	\N	28100	36438	\N	AMLP-359	AM2 D-381
89143	\N	\N	28187	36439	\N	AMLP-361	AM2 D-485
89144	\N	\N	28137	36440	\N	AMLP-360	AM2 D-431
89145	\N	\N	28186	36441	\N	AMLP-365	AM2 D-484
89146	\N	\N	28188	36442	\N	AMLP-368	AM2 D-486-1
89147	\N	\N	27998	36443	\N	AMLP-371	AM2 D-264
89148	\N	\N	27957	36444	\N	AMLP-370	AM2 D-219
89149	\N	\N	27957	36445	\N	AMLP-370-1	AM2 D-219
89150	\N	\N	27957	36446	\N	AMLP-370-2	AM2 D-219
89151	\N	\N	28192	36447	\N	AMLP-374	AM2 D-489
89152	\N	\N	28188	36448	\N	AMLP-375	AM2 D-486-1
89153	\N	\N	27864	36449	\N	AMLP-380	AM2 D-122
89154	\N	\N	28047	36450	\N	AMLP-382	AM2 D-323
89155	\N	\N	28070	36451	\N	AMLP-385	AM2 D-348
89156	\N	\N	28196	36452	\N	AMLP-393	AM2 D-493
89157	\N	\N	28197	36453	\N	AMLP-394	AM2 D-494
89158	\N	\N	28249	36454	\N	AMLP-425	AM2 R-227
89159	\N	\N	28250	36455	\N	AMLP-426	AM2 R-228
89160	\N	\N	28249	36456	\N	AMLP-428	AM2 R-227
89161	\N	\N	28290	36457	\N	AMLP-427	AM2 R-273
89162	\N	\N	28250	36458	\N	AMLP-429	AM2 R-228
89163	\N	\N	28249	36459	\N	AMLP-431	AM2 R-227
89164	\N	\N	28290	36460	\N	AMLP-430	AM2 R-273
89165	\N	\N	28250	36461	\N	AMLP-432	AM2 R-228
89166	\N	\N	28290	36462	\N	AMLP-433	AM2 R-273
89167	\N	\N	28290	36463	\N	AMLP-436	AM2 R-273
89168	\N	\N	28255	36464	\N	AMLP-441	AM2 R-237
89169	\N	\N	28291	36465	\N	AMLP-448	AM2 R-274
89170	\N	\N	28256	36466	\N	AMLP-442	AM2 R-238
89171	\N	\N	28306	36467	\N	AMLP-449	AM2 R-291
89172	\N	\N	28319	36468	\N	AMLP-452	AM2 R-310
89173	\N	\N	28288	36469	\N	AMLP-446	AM2 R-271
89174	\N	\N	28337	36470	\N	AMLP-459	AM2 R-329
89175	\N	\N	28289	36471	\N	AMLP-447	AM2 R-272
89176	\N	\N	28364	36472	\N	AMLP-467	AM2 R-363
89177	\N	\N	28349	36473	\N	AMLP-485	AM2 R-342
89178	\N	\N	28437	36474	\N	AMLP-489	AM2 R-472
89179	\N	\N	28448	36475	\N	AMLP-490	AM2 R-486-1
89180	\N	\N	28463	36476	\N	AMLP-494	AM2 R-501
89181	\N	\N	28466	36477	\N	AMLP-496	AM2 R-505
89182	\N	\N	28465	36478	\N	AMLP-495	AM2 R-504
89183	\N	\N	31492	36479	\N	EXLP-12	PROG R-04
89184	\N	\N	31494	36480	\N	EXLP-14	PROG R-06
89185	\N	\N	31493	36481	\N	EXLP-13	PROG R-05
89186	\N	\N	31496	36482	\N	EXLP-15	PROG R-08
89187	\N	\N	31498	36483	\N	EXLP-17	PROG R-10
89188	\N	\N	31497	36484	\N	EXLP-16	PROG R-09
89189	\N	\N	31500	36485	\N	EXLP-18	PROG R-12
89190	\N	\N	31501	36486	\N	EXLP-19	PROG R-13
89191	\N	\N	28252	36487	\N	AMLP-497	AM2 R-232
89192	\N	\N	28289	36488	\N	AMLP-504	AM2 R-272
89193	\N	\N	28306	36489	\N	AMLP-508	AM2 R-291
89194	\N	\N	28336	36490	\N	AMLP-510	AM2 R-328
89195	\N	\N	28481	36491	\N	AMLP-522	AM2 R-521
89196	\N	\N	28482	36492	\N	AMLP-523	AM2 R-522
89197	\N	\N	28476	36493	\N	AMLP-519	AM2 R-516
89198	\N	\N	28448	36494	\N	AMLP-516	AM2 R-486-1
89199	\N	\N	28256	36495	\N	AMLP-500	AM2 R-238
89200	\N	\N	28306	36496	\N	AMLP-509	AM2 R-291
89201	\N	\N	28364	36497	\N	AMLP-513	AM2 R-363
89202	\N	\N	28291	36498	\N	AMLP-506	AM2 R-274
89203	\N	\N	28291	36499	\N	AMLP-507	AM2 R-274
89204	\N	\N	28437	36500	\N	AMLP-515	AM2 R-472
89205	\N	\N	28475	36501	\N	AMLP-518	AM2 R-514
89206	\N	\N	28289	36502	\N	AMLP-505	AM2 R-272
89207	\N	\N	28288	36503	\N	AMLP-502	AM2 R-271
89208	\N	\N	28252	36504	\N	AMLP-498	AM2 R-232
89209	\N	\N	28288	36505	\N	AMLP-503	AM2 R-271
89210	\N	\N	28474	36506	\N	AMLP-517	AM2 R-513
89211	\N	\N	28485	36507	\N	AMLP-524	AM2 R-525
89212	\N	\N	28435	36508	\N	AMLP-514	AM2 R-470
89213	\N	\N	28337	36509	\N	AMLP-511	AM2 R-329
89214	\N	\N	28486	36510	\N	AMLP-525	AM2 R-526
89215	\N	\N	28477	36511	\N	AMLP-520	AM2 R-517
89216	\N	\N	28364	36512	\N	AMLP-512	AM2 R-363
89217	\N	\N	28278	36513	\N	AMLP-501	AM2 R-260
89218	\N	\N	28256	36514	\N	AMLP-499	AM2 R-238
89219	\N	\N	31667	36515	\N	RLP-127	RNA-133
89220	\N	\N	31830	36516	\N	RLP-149	RNA-366
89221	\N	\N	31831	36517	\N	RLP-150	RNA-369
89222	\N	\N	31847	36518	\N	RLP-167	RNA-402
89223	\N	\N	28217	36519	\N	AMLP-526	AM2 D-517
89224	\N	\N	28229	36520	\N	AMLP-536	AM2 D-531
89225	\N	\N	28428	36521	\N	AMLP-538	AM2 R-462
89226	\N	\N	28485	36522	\N	AMLP-547	AM2 R-525
89227	\N	\N	28474	36523	\N	AMLP-543	AM2 R-513
89228	\N	\N	28490	36524	\N	AMLP-550	AM2 R-532
89229	\N	\N	28429	36525	\N	AMLP-539	AM2 R-463
89230	\N	\N	28486	36526	\N	AMLP-548	AM2 R-526
89231	\N	\N	28491	36527	\N	AMLP-551	AM2 R-536
89232	\N	\N	28476	36528	\N	AMLP-545	AM2 R-516
89233	\N	\N	28477	36529	\N	AMLP-546	AM2 R-517
89234	\N	\N	28485	36530	\N	AMLP-568	AM2 R-525
89235	\N	\N	28252	36531	\N	AMLP-555	AM2 R-232
89236	\N	\N	28462	36532	\N	AMLP-565	AM2 R-500
89237	\N	\N	28485	36533	\N	AMLP-570	AM2 R-525
89238	\N	\N	28462	36534	\N	AMLP-564	AM2 R-500
89239	\N	\N	28486	36535	\N	AMLP-572	AM2 R-526
89240	\N	\N	28278	36536	\N	AMLP-557	AM2 R-260
89241	\N	\N	28485	36537	\N	AMLP-569	AM2 R-525
89242	\N	\N	28435	36538	\N	AMLP-561	AM2 R-470
89243	\N	\N	28486	36539	\N	AMLP-571	AM2 R-526
89244	\N	\N	28427	36540	\N	AMLP-582	AM2 R-461
89245	\N	\N	28337	36541	\N	AMLP-581	AM2 R-329
89246	\N	\N	27783	36542	\N	AGLP-04	AM2 D-42
89247	\N	\N	27781	36543	\N	AGLP-03	AM2 D-40
89248	\N	\N	31486	36544	\N	EXLP-28	PROG D-24
89249	\N	\N	31487	36545	\N	EXLP-29	PROG D-25
89250	\N	\N	31512	36546	\N	EXLP-37	PROG R-24
89789	\N	\N	28963	37085	\N	28_1	D28-1_NA
89251	\N	\N	29650	36547	\N	DPN_Conv_35	DPN_Conv_35_NA
89252	\N	\N	29707	36548	\N	HW_Acral_#8_Tumor	HW_Acral_#8_Tumor_NA
89253	\N	\N	28608	36549	\N	CGH11-224	CGH11-224_NA
89254	\N	\N	29898	36550	\N	KIT_230	KIT_230_NA
89255	\N	\N	29636	39693	\N	DPN_9_Normal	DPN_9_Normal_NA
89256	\N	\N	29105	36552	\N	DM45_2_Tumor	DM45_2_Tumor_NA
89257	\N	\N	29889	36553	\N	KIT_191	KIT_191_NA
89258	\N	\N	29031	36554	\N	DM_42_Normal	DM_42_Normal_NA
89259	\N	\N	27705	36555	\N	AM_14_Tumor	AM_14_Tumor_NA
89260	\N	\N	29110	36556	\N	DM77_2_Tumor	DM77_2_Tumor_NA
89261	\N	\N	29064	36557	\N	DM_101_Tumor	DM_101_Tumor_NA
89262	\N	\N	29652	36558	\N	DPN_MM 21	DPN_MM 21_NA
89263	\N	\N	31899	36559	\N	Seider_Roe	Seider_Roe_NA
89264	\N	\N	29719	36560	\N	Ivanka_10_2	Ivanka_10_2_NA
89265	\N	\N	29709	36561	\N	Ivanka_5_2	Ivanka_5_2_NA
89266	\N	\N	29058	36562	\N	DM_98_Tumor	DM_98_Tumor_NA
89267	\N	\N	29092	36563	\N	DM16_Normal	DM16_Normal_NA
89268	\N	\N	29069	36564	\N	DM-63-Tumor	DM-63-Tumor_NA
89269	\N	\N	29651	39707	\N	DPN_MM 20	DPN_MM 20_NA
89270	\N	\N	29065	36566	\N	DM_102_Tumor	DM_102_Tumor_NA
89271	\N	\N	29070	36567	\N	DM-66-Tumor	DM-66-Tumor_NA
89272	\N	\N	28541	36568	\N	BN_N1	BN_N1_NA
89273	\N	\N	28628	36569	\N	CGH12_040	CGH12_040_NA
89274	\N	\N	30569	36570	\N	MIN_4	MIN_4_NA
89275	\N	\N	29686	36571	\N	HW_8_Mucosal_Tumor	HW_8_Mucosal_Tumor_NA
89276	\N	\N	27703	36572	\N	AM_11_Tumor	AM_11_Tumor_NA
89277	\N	\N	29887	36573	\N	Kit_181_Muc BRAF	Kit_181_Muc BRAF_NA
89278	\N	\N	28540	36574	\N	BN_M2	BN_M2_NA
89279	\N	\N	29900	36575	\N	KIT_260	KIT_260_NA
89280	\N	\N	29026	36576	\N	DM_31_2_Tumor	DM_31_2_Tumor_NA
89281	\N	\N	29941	36577	\N	L2-Normal	L2-Normal_NA
89282	\N	\N	28630	36578	\N	CGH12_056	CGH12_056_NA
89283	\N	\N	28631	36579	\N	CGH12_058	CGH12_058_NA
89284	\N	\N	29044	36580	\N	DM_65_2_Tumor	DM_65_2_Tumor_NA
89285	\N	\N	29894	36581	\N	KIT_210	KIT_210_NA
89286	\N	\N	29653	36582	\N	DPN_MM 22	DPN_MM 22_NA
89287	\N	\N	29901	36583	\N	KIT_273	KIT_273_NA
89288	\N	\N	29013	39688	\N	DM_13_2_Tumor	DM_13_2_Tumor_NA
89289	\N	\N	29905	36585	\N	KIT_302	KIT_302_NA
89290	\N	\N	29683	36586	\N	G5 DP08-4205A Tumor	G5 DP08-4205A Tumor_NA
89291	\N	\N	29051	36587	\N	DM_94_Normal	DM_94_Normal_NA
89292	\N	\N	28646	36588	\N	CGH12-124	CGH12-124_NA
89293	\N	\N	31895	36589	\N	RPA_09_0209	RPA_09_0209_NA
89294	\N	\N	29681	36590	\N	G3 DP08-21965C Tumor	G3 DP08-21965C Tumor_NA
89295	\N	\N	31182	36591	\N	MS_1_Tumor	MS_1_Tumor_NA
89296	\N	\N	28538	36592	\N	bMV_10_0206	bMV_10_0206_NA
89297	\N	\N	29943	36593	\N	L3-Normal	L3-Normal_NA
89298	\N	\N	29048	36594	\N	DM_93_3_Tumor	DM_93_3_Tumor_NA
89299	\N	\N	27704	36595	\N	AM_13_Tumor	AM_13_Tumor_NA
89300	\N	\N	30312	36596	\N	Luping_ROS 1	Luping_ROS 1_NA
89301	\N	\N	29684	36597	\N	HW_2_Tumor Dissect	HW_2_Tumor Dissect_NA
89302	\N	\N	29038	36598	\N	DM_51_Tumor	DM_51_Tumor_NA
89303	\N	\N	28627	36599	\N	CGH12_039	CGH12_039_NA
89304	\N	\N	28634	36600	\N	CGH12_224	CGH12_224_NA
89305	\N	\N	29720	36601	\N	Ivanka_10_3	Ivanka_10_3_NA
89306	\N	\N	29003	36602	\N	DM_2	DM_2_NA
89307	\N	\N	29040	36603	\N	DM_58_Tumor	DM_58_Tumor_NA
89308	\N	\N	29682	36604	\N	G5 DP08-4205A Normal	G5 DP08-4205A Normal_NA
89309	\N	\N	27685	36605	\N	35_M	35_M_NA
89310	\N	\N	29066	36606	\N	DM-60-Tumor	DM-60-Tumor_NA
89311	\N	\N	29007	36607	\N	DM_6_Normal	DM_6_Normal_NA
89312	\N	\N	29072	36608	\N	DM-69-Tumor	DM-69-Tumor_NA
89313	\N	\N	29685	36609	\N	HW_3_Tumor	HW_3_Tumor_NA
89314	\N	\N	29036	36610	\N	DM_49_2_Tumor	DM_49_2_Tumor_NA
89315	\N	\N	28626	36611	\N	CGH12_026	CGH12_026_NA
89316	\N	\N	29886	36612	\N	KIT_134	KIT_134_NA
89317	\N	\N	29893	36613	\N	KIT_206	KIT_206_NA
89318	\N	\N	27662	36614	\N	22_Normal	22_Normal_NA
89319	\N	\N	29710	36615	\N	Ivanka_5_3	Ivanka_5_3_NA
89320	\N	\N	27661	36616	\N	22_Nevus	22_Nevus_NA
89321	\N	\N	29899	39692	\N	KIT_244	KIT_244_NA
89322	\N	\N	29033	36618	\N	DM_43_Normal	DM_43_Normal_NA
89323	\N	\N	29045	36619	\N	DM_68_Tumor	DM_68_Tumor_NA
89324	\N	\N	29062	36620	\N	DM_101_IS	DM_101_IS_NA
89325	\N	\N	29057	36621	\N	DM_98_2_Normal	DM_98_2_Normal_NA
89326	\N	\N	29068	36622	\N	DM-62-Tumor	DM-62-Tumor_NA
89327	\N	\N	28590	36623	\N	CGH11_410	CGH11_410_NA
89328	\N	\N	29073	36624	\N	DM-70-Tumor	DM-70-Tumor_NA
89329	\N	\N	29647	36625	\N	DPN_35	DPN_35_NA
89330	\N	\N	29104	36626	\N	DM37_1_Normal	DM37_1_Normal_NA
89331	\N	\N	29708	36627	\N	Ivanka_5_1	Ivanka_5_1_NA
89332	\N	\N	30566	36628	\N	MIN_1	MIN_1_NA
89333	\N	\N	29940	36629	\N	L2-HGD	L2-HGD_NA
89334	\N	\N	29667	36630	\N	DT10_63051C	DT10_63051C_NA
89335	\N	\N	29892	36631	\N	KIT_205	KIT_205_NA
89336	\N	\N	29046	36632	\N	DM_74_1_Tumor	DM_74_1_Tumor_NA
89337	\N	\N	30568	36633	\N	MIN_3	MIN_3_NA
89338	\N	\N	27701	36634	\N	AM_7_Tumor	AM_7_Tumor_NA
89339	\N	\N	28667	36635	\N	CGH14-059	CGH14-059_NA
89340	\N	\N	29027	36636	\N	DM_31_Normal	DM_31_Normal_NA
89341	\N	\N	29028	39689	\N	DM_36_2_Tumor	DM_36_2_Tumor_NA
89342	\N	\N	30570	36638	\N	MIN_5	MIN_5_NA
89343	\N	\N	32052	36639	\N	Thomas_SK_MEL_23	Thomas_SK_MEL_23_NA
89344	\N	\N	28542	36640	\N	BN_N2	BN_N2_NA
89345	\N	\N	29630	36641	\N	DPN_5_Normal	DPN_5_Normal_NA
89346	\N	\N	29115	36642	\N	DM93_2_Tumor	DM93_2_Tumor_NA
89347	\N	\N	29907	36643	\N	KIT_316	KIT_316_NA
89348	\N	\N	28580	36644	\N	CGH11_109	CGH11_109_NA
89349	\N	\N	29711	36645	\N	Ivanka_5_4	Ivanka_5_4_NA
89350	\N	\N	28606	36646	\N	CGH11-184	CGH11-184_NA
89351	\N	\N	29634	36647	\N	DPN_8_Normal	DPN_8_Normal_NA
89352	\N	\N	29037	36648	\N	DM_49_Normal	DM_49_Normal_NA
89353	\N	\N	29074	36649	\N	DM-81-Tumor	DM-81-Tumor_NA
89354	\N	\N	27659	39706	\N	22_IS	22_IS_NA
89355	\N	\N	31900	36651	\N	Seider_Uveal Melanoma	Seider_Uveal Melanoma_NA
89356	\N	\N	29644	36652	\N	DPN_18_Normal	DPN_18_Normal_NA
89357	\N	\N	29896	36653	\N	KIT_225	KIT_225_NA
89358	\N	\N	28774	36654	\N	CHG11-402	CHG11-402_NA
89359	\N	\N	29067	36655	\N	DM-61-Tumor	DM-61-Tumor_NA
89360	\N	\N	29039	36656	\N	DM_58_Normal	DM_58_Normal_NA
89361	\N	\N	29063	39694	\N	DM_101_Normal	DM_101_Normal_NA
89362	\N	\N	29106	36658	\N	DM45_Normal	DM45_Normal_NA
89363	\N	\N	27660	36659	\N	22_Melanoma	22_Melanoma_NA
89364	\N	\N	29042	36660	\N	DM_64_1_Normal	DM_64_1_Normal_NA
89365	\N	\N	29648	36661	\N	DPN_CNN 30	DPN_CNN 30_NA
89366	\N	\N	29071	36662	\N	DM-67-Tumor	DM-67-Tumor_NA
89367	\N	\N	29093	39687	\N	DM16_Tumor	DM16_Tumor_NA
89368	\N	\N	30567	36664	\N	MIN_2	MIN_2_NA
89369	\N	\N	30571	36665	\N	MIN_6	MIN_6_NA
89370	\N	\N	29047	36666	\N	DM_74_2_Tumor	DM_74_2_Tumor_NA
89371	\N	\N	29680	36667	\N	G3 DP08-21965C Normal	G3 DP08-21965C Normal_NA
89372	\N	\N	29721	36668	\N	Ivanka_10_4	Ivanka_10_4_NA
89373	\N	\N	29649	36669	\N	DPN_CNN 32	DPN_CNN 32_NA
89374	\N	\N	29718	36670	\N	Ivanka_10_1	Ivanka_10_1_NA
89375	\N	\N	29059	36671	\N	DM_99_Normal	DM_99_Normal_NA
89376	\N	\N	28539	36672	\N	BN_M1	BN_M1_NA
89377	\N	\N	27698	36673	\N	AF13_212	AF13_212_NA
89378	\N	\N	29111	36674	\N	DM77_Normal	DM77_Normal_NA
89379	\N	\N	29052	36675	\N	DM_94_Tumor	DM_94_Tumor_NA
89380	\N	\N	29722	36676	\N	Ivanka_10_5	Ivanka_10_5_NA
89381	\N	\N	28644	36677	\N	CGH12-104	CGH12-104_NA
89382	\N	\N	28629	36678	\N	CGH12_053	CGH12_053_NA
89383	\N	\N	29043	36679	\N	DM_64_Tumor	DM_64_Tumor_NA
89384	\N	\N	29895	36680	\N	KIT_217	KIT_217_NA
89385	\N	\N	29060	36681	\N	DM_99_Tumor	DM_99_Tumor_NA
89386	\N	\N	28958	36682	\N	12_M	D12_M_NA
89387	\N	\N	29904	36683	\N	KIT_297	KIT_297_NA
89388	\N	\N	29712	36684	\N	Ivanka_5_5	Ivanka_5_5_NA
89389	\N	\N	27687	36685	\N	49_M	49_M_NA
89390	\N	\N	29061	36686	\N	DM_100_Tumor_Pool	DM_100_Tumor_Pool_NA
89391	\N	\N	29903	36687	\N	KIT_295	KIT_295_NA
89392	\N	\N	28638	36688	\N	CGH12-043	CGH12-043_NA
89393	\N	\N	29029	36689	\N	DM_36_Normal	DM_36_Normal_NA
89394	\N	\N	28579	36690	\N	CGH11_091	CGH11_091_NA
89395	\N	\N	29041	36691	\N	DM_59_Tumor	DM_59_Tumor_NA
89396	\N	\N	28591	36692	\N	CGH11_424	CGH11_424_NA
89397	\N	\N	27702	36693	\N	AM_9_Tumor	AM_9_Tumor_NA
89398	\N	\N	28601	36694	\N	CGH11-115	CGH11-115_NA
89399	\N	\N	29942	36695	\N	L3-HGD	L3-HGD_NA
89400	\N	\N	27666	36696	\N	IYEH-01	22-104389A2-RNA
89401	\N	\N	27670	36697	\N	IYEH-02	22-104389C-RNA
89402	\N	\N	27672	36698	\N	IYEH-03	22-125373-RNA
89403	\N	\N	30009	36699	\N	LMM-04	LMM R-004
89404	\N	\N	30023	36700	\N	LMM-18	LMM R-018
89405	\N	\N	30015	36701	\N	LMM-10	LMM R-010
89406	\N	\N	30019	36702	\N	LMM-14	LMM R-014
89407	\N	\N	30012	36703	\N	LMM-07	LMM R-007
89408	\N	\N	30013	36704	\N	LMM-08	LMM R-008
89409	\N	\N	30016	36705	\N	LMM-11	LMM R-011
89410	\N	\N	30010	36706	\N	LMM-05	LMM R-005
89411	\N	\N	30018	36707	\N	LMM-13	LMM R-013
89412	\N	\N	30022	36708	\N	LMM-17	LMM R-017
89413	\N	\N	31484	36709	\N	EXLP-41	PROG D-22
89414	\N	\N	31487	36710	\N	EXLP-42	PROG D-25
89415	\N	\N	31512	36711	\N	EXLP-50	PROG R-24
89416	\N	\N	31506	36712	\N	EXLP-46	PROG R-18
89417	\N	\N	27670	36713	\N	IYEH-08	22-104389C-RNA
89418	\N	\N	27666	36714	\N	IYEH-07	22-104389A2-RNA
89419	\N	\N	29813	36715	\N	KALP-013	KA D-29
89420	\N	\N	29820	36716	\N	KALP-018	KA D-36
89421	\N	\N	29816	36717	\N	KALP-016	KA D-32
89422	\N	\N	29819	36718	\N	KALP-017	KA D-35
89423	\N	\N	29816	36719	\N	KALP-026	KA D-32
89424	\N	\N	31913	36720	\N	SKMEL28-1	SKMEL28-1_NA
89425	\N	\N	31912	36721	\N	SKMEL5-3	SKMEL5-3_NA
89426	\N	\N	31911	36722	\N	SKMEL5-2	SKMEL5-2_NA
89427	\N	\N	32053	36723	\N	Sk-Mel-23	Thomas_SK_Mel23
89428	\N	\N	31914	36724	\N	SKMEL28-2	SKMEL28-2_NA
89429	\N	\N	31910	36725	\N	SKMEL5-1	SKMEL5-1_NA
89430	\N	\N	31915	36726	\N	SKMEL28-3	SKMEL28-3_NA
89431	\N	\N	32224	36727	\N	UM_1	UM1_NA
89432	\N	\N	32225	36728	\N	UM_2	UM2_NA
89433	\N	\N	27693	36729	\N	1205LU-3_Unknown	1205LU-3_NA
89434	\N	\N	27691	36730	\N	1205lu-1_Unknown	1205lu-1_NA
89435	\N	\N	27692	36731	\N	1205lu-2_Unknown	1205lu-2_NA
89436	\N	\N	28623	36732	\N	CGH11-402	CGH11-402
89437	\N	\N	28616	36733	\N	CGH11-275	CGH11-275
89438	\N	\N	28622	36734	\N	CGH11-399	CGH11-399
89439	\N	\N	29002	36735	\N	DM1-Tert-Amplicon	DM_1_Tumor_NA
89440	\N	\N	29864	36736	\N	KAM111-normal	KAM111-N-A4
89441	\N	\N	29856	36737	\N	KAM93-normal	KAM93-N-B10
89442	\N	\N	29870	36738	\N	KAM123-T	KAM123-T
89443	\N	\N	29861	36739	\N	KAM100-normal_kapa-NGv3-PE100-NGv3-ready	KAM100-N
89444	\N	\N	29117	36740	\N	DM93_NFKBIE_Amplicon	DM93_NFKBIE_NA
89446	\N	\N	29842	36742	\N	KAM10-normal	KAM10-N-B7
89447	\N	\N	29862	36743	\N	KAM100-tumor_kapa-NGv3-PE100-NGv3-ready	KAM100-T-11
89448	\N	\N	29859	36744	\N	KAM99-normal_kapa-NGv3-PE100-NGv3-ready	KAM99-N
89449	\N	\N	29119	36745	\N	DM93_Tumor	DM93_Tumor_NA
89450	\N	\N	29856	36746	\N	KAM93-normal_kapa-NGv3-PE100-NGv3-ready	KAM93-N-B10
89451	\N	\N	29843	36747	\N	KAM10-Tumor_kapa-NGv3-PE100-NGv3-ready	KAM10-T
89452	\N	\N	29844	36748	\N	KAM12-T	KAM12-T
89453	\N	\N	29864	36749	\N	KAM111-normal_kapa-NGv3-PE100-NGv3-ready	KAM111-N-A4
89454	\N	\N	29861	36750	\N	KAM100-normal	KAM100-N
89455	\N	\N	29015	36751	\N	DM14-Tert-Amplicon	DM_14_Tumor_NA
89456	\N	\N	29012	36752	\N	DM11-Tert-Amplicon	DM_11_Tumor_NA
89457	\N	\N	29863	36753	\N	KAM102-T-B	KAM102-T-B
89458	\N	\N	29869	36754	\N	KAM122-T-A	KAM122-T-A
89459	\N	\N	29860	36755	\N	KAM99-tumor_kapa-NGv3-PE100-NGv3-ready	KAM99-T
89460	\N	\N	29857	36756	\N	KAM93-tumor_kapa-NGv3-PE100-NGv3-ready	KAM93-T
89461	\N	\N	29004	36757	\N	DM2-Tert-Amplicon	DM_2_Tumor_NA
89462	\N	\N	29107	36758	\N	DM45_NFKBIE_Amplicon	DM45_Tumor_NA
89463	\N	\N	29658	36759	\N	DPN54-Tumor	DPN54-Tumor_NA
89464	\N	\N	29867	36760	\N	KAM113-T-H	KAM113-T-H
89465	\N	\N	29859	36761	\N	KAM99-normal	KAM99-N
89466	\N	\N	29854	36762	\N	KAM75-T	KAM75-T
89467	\N	\N	29868	36763	\N	KAM116-T	KAM116-T
89468	\N	\N	29842	36764	\N	KAM10-normal_kapa-NGv3-PE100-NGv3-ready	KAM10-N-B7
89469	\N	\N	29114	36765	\N	DM79_NFKBIE_Amplicon	DM79_Tumor_NA
89470	\N	\N	29663	36766	\N	DPN59-Tumor	DPN59-Tumor_NA
89471	\N	\N	29009	36767	\N	DM8Tumor	DM_8_Tumor_NA
89472	\N	\N	27680	36768	\N	26	26_NA
89473	\N	\N	32232	36769	\N	VS-01	VS-01_NA
89474	\N	\N	32233	36770	\N	VS-02	VS-02_NA
89475	\N	\N	32234	36771	\N	VS-03	VS-03_NA
89476	\N	\N	32235	36772	\N	VS-04	VS-04_NA
89477	\N	\N	32236	36773	\N	VS-05	VS-05_NA
89478	\N	\N	32238	36774	\N	VS-07	VS-07_NA
89479	\N	\N	32239	36775	\N	VS-08	VS-08_NA
89480	\N	\N	32237	36776	\N	VS-06	VS-06_NA
89481	\N	\N	27780	36777	\N	AMLP-02	AM2 D-39
89482	\N	\N	27778	36778	\N	AMLP-01	AM2 D-37
89483	\N	\N	27780	36779	\N	AGLP-02	AM2 D-39
89484	\N	\N	27778	36780	\N	AGLP-01	AM2 D-37
89485	\N	\N	27781	36781	\N	AMLP-03	AM2 D-40
89486	\N	\N	27788	36782	\N	AMLP-05	AM2 D-47
89487	\N	\N	27800	36783	\N	AMLP-11	AM2 D-59
89488	\N	\N	27775	36784	\N	AMLP-21	AM2 D-34
89489	\N	\N	27807	36785	\N	AMLP-15	AM2 D-66
89490	\N	\N	27814	36786	\N	AMLP-18	AM2 D-73
89491	\N	\N	27792	36787	\N	AMLP-08	AM2 D-51
89492	\N	\N	27795	36788	\N	AMLP-10	AM2 D-54
89493	\N	\N	27806	36789	\N	AMLP-14	AM2 D-65
89494	\N	\N	27811	36790	\N	AMLP-17	AM2 D-70
89495	\N	\N	27783	36791	\N	AMLP-04	AM2 D-42
89496	\N	\N	27810	36792	\N	AMLP-16	AM2 D-69
89497	\N	\N	27802	36793	\N	AMLP-12	AM2 D-61
89498	\N	\N	27777	36794	\N	AMLP-22_1	AM2 D-36
89499	\N	\N	27789	36795	\N	AMLP-06	AM2 D-48
89500	\N	\N	27803	36796	\N	AMLP-13	AM2 D-62
89501	\N	\N	27790	36797	\N	AMLP-07	AM2 D-49
89502	\N	\N	27793	36798	\N	AMLP-09	AM2 D-52
89503	\N	\N	27777	36799	\N	AMLP-22_2	AM2 D-36
89504	\N	\N	27829	36800	\N	AMLP-44	AM2 D-88
89505	\N	\N	27831	36801	\N	AMLP-46	AM2 D-90
89506	\N	\N	27834	36802	\N	AMLP-49	AM2 D-93
89507	\N	\N	27886	36803	\N	AMLP-96	AM2 D-144
89508	\N	\N	27874	36804	\N	AMLP-87	AM2 D-132
89509	\N	\N	27854	36805	\N	AMLP-66	AM2 D-112
89510	\N	\N	27857	36806	\N	AMLP-69	AM2 D-115
89511	\N	\N	27864	36807	\N	AMLP-77	AM2 D-122
89512	\N	\N	27885	36808	\N	AMLP-99	AM2 D-143
89513	\N	\N	27862	36809	\N	AMLP-75	AM2 D-120
89514	\N	\N	27882	36810	\N	AMLP-95	AM2 D-140
89515	\N	\N	27905	36811	\N	AMLP-114	AM2 D-163
89516	\N	\N	27908	36812	\N	AMLP-117	AM2 D-166
89517	\N	\N	27898	36813	\N	AMLP-107	AM2 D-156
89518	\N	\N	27901	36814	\N	AMLP-110	AM2 D-159
89519	\N	\N	27883	36815	\N	AMLP-97	AM2 D-141
89520	\N	\N	27892	36816	\N	AMLP-102	AM2 D-150
89521	\N	\N	27900	36817	\N	AMLP-109	AM2 D-158
89522	\N	\N	27904	36818	\N	AMLP-113	AM2 D-162
89523	\N	\N	27782	36819	\N	AMLP-30	AM2 D-41
89524	\N	\N	27830	36820	\N	AMLP-45	AM2 D-89
89525	\N	\N	27827	36821	\N	AMLP-41	AM2 D-86
89526	\N	\N	27776	36822	\N	AMLP-125	AM2 D-35
89527	\N	\N	27774	36823	\N	AMLP-126	AM2 D-33
89528	\N	\N	27927	36824	\N	AMLP-127	AM2 D-185
89529	\N	\N	27926	36825	\N	AMLP-128	AM2 D-184
89530	\N	\N	27777	36826	\N	AMLP-130	AM2 D-36
89531	\N	\N	27925	36827	\N	AMLP-131	AM2 D-183
89532	\N	\N	27831	36828	\N	AMLP-132	AM2 D-90
89533	\N	\N	27839	36829	\N	AMLP-133	AM2 D-98
89534	\N	\N	27877	36830	\N	AMLP-135	AM2 D-135
89535	\N	\N	27904	36831	\N	AMLP-140	AM2 D-162
89536	\N	\N	27885	36832	\N	AMLP-137	AM2 D-143
89537	\N	\N	27908	36833	\N	AMLP-142	AM2 D-166
89538	\N	\N	27802	36834	\N	AMLP-150	AM2 D-61
89539	\N	\N	27810	36835	\N	AMLP-151	AM2 D-69
89540	\N	\N	27799	36836	\N	AMLP-149	AM2 D-58
89541	\N	\N	27921	36837	\N	AMLP-147	AM2 D-179
89542	\N	\N	27840	36838	\N	AMLP-55	AM2 D-99
89543	\N	\N	27771	36839	\N	AMLP-19_1	AM2 D-30
89544	\N	\N	27836	36840	\N	AMLP-51	AM2 D-95
89545	\N	\N	27838	36841	\N	AMLP-53	AM2 D-97
89546	\N	\N	27833	36842	\N	AMLP-48	AM2 D-92
89547	\N	\N	27871	36843	\N	AMLP-84	AM2 D-129
89548	\N	\N	27878	36844	\N	AMLP-90	AM2 D-136
89549	\N	\N	27776	36845	\N	AMLP-129	AM2 D-35
89550	\N	\N	27882	36846	\N	AMLP-136	AM2 D-140
89551	\N	\N	27898	36847	\N	AMLP-138	AM2 D-156
89552	\N	\N	27905	36848	\N	AMLP-143	AM2 D-163
89553	\N	\N	27770	36849	\N	AMLP-146	AM2 D-29
89554	\N	\N	27900	36850	\N	AMLP-139	AM2 D-158
89555	\N	\N	27796	36851	\N	AMLP-148	AM2 D-55
89556	\N	\N	27771	36852	\N	AMLP-19_2	AM2 D-30
89557	\N	\N	27869	36853	\N	AMLP-82	AM2 D-127
90654	\N	\N	29344	37950	\N	DLP-117	DNA-137
89558	\N	\N	27865	36854	\N	AMLP-78	AM2 D-123
89559	\N	\N	27926	36855	\N	AMLP-156	AM2 D-184
89560	\N	\N	27928	36856	\N	AMLP-160	AM2 D-186
89561	\N	\N	27857	36857	\N	AMLP-163	AM2 D-115
89562	\N	\N	27864	36858	\N	AMLP-168	AM2 D-122
89563	\N	\N	27865	36859	\N	AMLP-169	AM2 D-123
89564	\N	\N	27868	36860	\N	AMLP-172-81	AM2 D-126
89565	\N	\N	27926	36861	\N	AMLP-175	AM2 D-184
89566	\N	\N	27928	36862	\N	AMLP-176	AM2 D-186
89567	\N	\N	27934	36863	\N	AMLP-186	AM2 D-192
89568	\N	\N	27774	36864	\N	AMLP-195	AM2 D-33
89569	\N	\N	27837	36865	\N	AMLP-198	AM2 D-96
89570	\N	\N	27925	36866	\N	AMLP-197	AM2 D-183
89571	\N	\N	27927	36867	\N	AMLP-196	AM2 D-185
89572	\N	\N	27844	36868	\N	AMLP-58	AM2 D-103
89573	\N	\N	27849	36869	\N	AMLP-61	AM2 D-107
89574	\N	\N	27852	36870	\N	AMLP-64	AM2 D-110
89575	\N	\N	27916	36871	\N	AMLP-123	AM2 D-174
89576	\N	\N	27896	36872	\N	AMLP-105	AM2 D-154
89577	\N	\N	27907	36873	\N	AMLP-174	AM2 D-165
89578	\N	\N	27871	36874	\N	AMLP-178	AM2 D-129
89579	\N	\N	27872	36875	\N	AMLP-179	AM2 D-130
89580	\N	\N	27892	36876	\N	AMLP-181	AM2 D-150
89581	\N	\N	27878	36877	\N	AMLP-180	AM2 D-136
89582	\N	\N	27895	36878	\N	AMLP-184	AM2 D-153
89583	\N	\N	27896	36879	\N	AMLP-185	AM2 D-154
89584	\N	\N	27935	36880	\N	AMLP-191	AM2 D-193
89585	\N	\N	27916	36881	\N	AMLP-194	AM2 D-174
89586	\N	\N	27895	36882	\N	AMLP-104	AM2 D-153
89587	\N	\N	27872	36883	\N	AMLP-85	AM2 D-130
89588	\N	\N	27914	36884	\N	AMLP-121	AM2 D-172
89589	\N	\N	27875	36885	\N	AMLP-88	AM2 D-133
89590	\N	\N	27856	36886	\N	AMLP-68	AM2 D-114
89591	\N	\N	27903	36887	\N	AMLP-112	AM2 D-161
89592	\N	\N	27870	36888	\N	AMLP-83	AM2 D-128
89593	\N	\N	27880	36889	\N	AMLP-93	AM2 D-138
89594	\N	\N	27773	36890	\N	AMLP-153	AM2 D-32
89595	\N	\N	27856	36891	\N	AMLP-162	AM2 D-114
89596	\N	\N	27866	36892	\N	AMLP-170	AM2 D-124
89597	\N	\N	27906	36893	\N	AMLP-173	AM2 D-164
89598	\N	\N	27870	36894	\N	AMLP-177	AM2 D-128
89599	\N	\N	27936	36895	\N	AMLP-192	AM2 D-194
89601	\N	\N	27899	36897	\N	AMLP-108	AM2 D-157
89602	\N	\N	27879	36898	\N	AMLP-92	AM2 D-137
89603	\N	\N	27867	36899	\N	AMLP-80	AM2 D-125
89604	\N	\N	27863	36900	\N	AMLP-76-164	AM2 D-121
89605	\N	\N	27893	36901	\N	AMLP-103	AM2 D-151
89606	\N	\N	27876	36902	\N	AMLP-91	AM2 D-134
89607	\N	\N	27932	36903	\N	AMLP-165	AM2 D-190
89608	\N	\N	27867	36904	\N	AMLP-171	AM2 D-125
89609	\N	\N	27893	36905	\N	AMLP-182	AM2 D-151
89610	\N	\N	27921	36906	\N	AMLP-204	AM2 D-179
89611	\N	\N	27942	36907	\N	AMLP-210	AM2 D-202
89612	\N	\N	27916	36908	\N	AMLP-231	AM2 D-174
89613	\N	\N	27779	36909	\N	AMLP-29	AM2 D-38
89614	\N	\N	27943	36910	\N	AMLP-211	AM2 D-203
89615	\N	\N	27972	36911	\N	AMLP-214	AM2 D-238
89618	\N	\N	28092	36914	\N	AMLP-267	AM2 D-372
89619	\N	\N	28098	36915	\N	AMLP-269	AM2 D-379
89620	\N	\N	28130	36916	\N	AMLP-289	AM2 D-423
89622	\N	\N	28136	36918	\N	AMLP-291	AM2 D-430
89623	\N	\N	28025	36919	\N	AMLP-240	AM2 D-295
89624	\N	\N	28042	36920	\N	AMLP-247	AM2 D-318
89625	\N	\N	28122	36921	\N	AMLP-263	AM2 D-412
89626	\N	\N	28089	36922	\N	AMLP-264	AM2 D-369
89627	\N	\N	28090	36923	\N	AMLP-265	AM2 D-370
89628	\N	\N	28091	36924	\N	AMLP-266	AM2 D-371
89629	\N	\N	28097	36925	\N	AMLP-268	AM2 D-378
89630	\N	\N	28087	36926	\N	AMLP-238	AM2 D-367
89631	\N	\N	28033	36927	\N	AMLP-241	AM2 D-308
89633	\N	\N	28052	36929	\N	AMLP-252	AM2 D-328
89634	\N	\N	28056	36930	\N	AMLP-256	AM2 D-332
89635	\N	\N	28057	36931	\N	AMLP-257	AM2 D-333
89636	\N	\N	28064	36932	\N	AMLP-259	AM2 D-340
89638	\N	\N	28023	36934	\N	AMLP-237	AM2 D-293
89639	\N	\N	28139	36935	\N	AMLP-272	AM2 D-434
89640	\N	\N	28040	36936	\N	AMLP-295	AM2 D-316
89641	\N	\N	28041	36937	\N	AMLP-296	AM2 D-317
89642	\N	\N	28052	36938	\N	AMLP-298	AM2 D-328
89643	\N	\N	28085	36939	\N	AMLP-299	AM2 D-365
89644	\N	\N	28140	36940	\N	AMLP-273	AM2 D-435
89645	\N	\N	28141	36941	\N	AMLP-274	AM2 D-436
89646	\N	\N	28142	36942	\N	AMLP-275	AM2 D-437
89647	\N	\N	28110	36943	\N	AMLP-277	AM2 D-399
89648	\N	\N	28112	36944	\N	AMLP-279	AM2 D-401
89650	\N	\N	27955	36946	\N	AMLP-221	AM2 D-217
89651	\N	\N	27956	36947	\N	AMLP-222	AM2 D-218
89653	\N	\N	27959	36949	\N	AMLP-225	AM2 D-221
89654	\N	\N	27960	36950	\N	AMLP-226	AM2 D-222
89655	\N	\N	27961	36951	\N	AMLP-227	AM2 D-223
89658	\N	\N	27970	36954	\N	AMLP-208	AM2 D-236
89660	\N	\N	28085	36956	\N	AMLP-254	AM2 D-365
89661	\N	\N	28055	36957	\N	AMLP-255	AM2 D-331
89662	\N	\N	28069	36958	\N	AMLP-262	AM2 D-347
89663	\N	\N	28113	36959	\N	AMLP-280	AM2 D-402
89664	\N	\N	28116	36960	\N	AMLP-282	AM2 D-405
89665	\N	\N	28147	36961	\N	AMLP-293	AM2 D-443
89666	\N	\N	28146	36962	\N	AMLP-292	AM2 D-441
89667	\N	\N	28160	36963	\N	AMLP-312	AM2 D-457
89668	\N	\N	28167	36964	\N	AMLP-318	AM2 D-464
89669	\N	\N	28169	36965	\N	AMLP-320	AM2 D-466
89670	\N	\N	28055	36966	\N	AMLP-300	AM2 D-331
89671	\N	\N	28111	36967	\N	AMLP-278	AM2 D-400
89672	\N	\N	28115	36968	\N	AMLP-281	AM2 D-404
89674	\N	\N	28126	36970	\N	AMLP-285	AM2 D-419
89675	\N	\N	28128	36971	\N	AMLP-287	AM2 D-421
89676	\N	\N	28127	36972	\N	AMLP-286	AM2 D-420
89677	\N	\N	28129	36973	\N	AMLP-288	AM2 D-422
89678	\N	\N	28046	36974	\N	AMLP-250	AM2 D-322
89679	\N	\N	28158	36975	\N	AMLP-310	AM2 D-455
89680	\N	\N	28162	36976	\N	AMLP-314	AM2 D-459
89681	\N	\N	28164	36977	\N	AMLP-316	AM2 D-461
89682	\N	\N	28163	36978	\N	AMLP-315	AM2 D-460
89683	\N	\N	28171	36979	\N	AMLP-322	AM2 D-468
89684	\N	\N	28170	36980	\N	AMLP-321	AM2 D-467
89685	\N	\N	28172	36981	\N	AMLP-323	AM2 D-470
89686	\N	\N	28180	36982	\N	AMLP-331	AM2 D-478
89687	\N	\N	28069	36983	\N	AMLP-301	AM2 D-347
89688	\N	\N	27994	36984	\N	AMLP-324	AM2 D-260
89689	\N	\N	28173	36985	\N	AMLP-325	AM2 D-471
89690	\N	\N	28174	36986	\N	AMLP-326	AM2 D-472
89691	\N	\N	28176	36987	\N	AMLP-327	AM2 D-474
89692	\N	\N	28178	36988	\N	AMLP-330	AM2 D-476
89693	\N	\N	28182	36989	\N	AMLP-332	AM2 D-480
89695	\N	\N	28083	36991	\N	AMLP-249	AM2 D-362
89696	\N	\N	28150	36992	\N	AMLP-302	AM2 D-446
89697	\N	\N	28152	36993	\N	AMLP-303	AM2 D-448
89698	\N	\N	28155	36994	\N	AMLP-304	AM2 D-452
89699	\N	\N	28157	36995	\N	AMLP-307	AM2 D-454
89700	\N	\N	27902	36996	\N	AMLP-111	AM2 D-160
89701	\N	\N	27855	36997	\N	AMLP-161	AM2 D-113
89702	\N	\N	27937	36998	\N	AMLP-193	AM2 D-195
89703	\N	\N	28119	36999	\N	AMLP-284	AM2 D-408
89704	\N	\N	28156	37000	\N	AMLP-305-306	AM2 D-453
89705	\N	\N	28137	37001	\N	AMLP-348	AM2 D-431
89706	\N	\N	28100	37002	\N	AMLP-347	AM2 D-381
89707	\N	\N	28101	37003	\N	AMLP-367	AM2 D-382
89708	\N	\N	28188	37004	\N	AMLP-375-1	AM2 D-486-1
89711	\N	\N	28191	37007	\N	AMLP-373	AM2 D-488
89713	\N	\N	28187	37009	\N	AMLP-349-352	AM2 D-485
89714	\N	\N	28949	37010	\N	T12_12366	D6_NA
89715	\N	\N	28948	37011	\N	T12_6261B	D2_NA
89716	\N	\N	28947	37012	\N	T12_6261A	D1_NA
89717	\N	\N	28951	37013	\N	T12_12470D	D11_NA
89718	\N	\N	28950	37014	\N	T12_12467	D7_NA
89719	\N	\N	28959	37015	\N	T12_562	D13_NA
89720	\N	\N	28961	37016	\N	T12_12626	D20_NA
89721	\N	\N	28960	37017	\N	T12_12647	D15_NA
89722	\N	\N	27673	37018	\N	T12_13587_B2	23_NA
89723	\N	\N	27674	37019	\N	T12_18438A	24_NA
89724	\N	\N	28975	37020	\N	T12_13587_B2_0_75ug	D44_NA
89725	\N	\N	28967	37021	\N	T12-19187A	D31_NA
89726	\N	\N	28968	37022	\N	T12_22172_Norm	D35_NA
89727	\N	\N	27686	37023	\N	T12_21726A_Tumor	38_NA
89728	\N	\N	28970	37024	\N	T12_22901A_Norm	D39_NA
89729	\N	\N	27681	37025	\N	T12_13152_Tumor	27_NA
89730	\N	\N	28976	37026	\N	T12_13587_B2_0_5ug	D45_NA
89731	\N	\N	28969	37027	\N	T12_22172_Tumor	D36_NA
89732	\N	\N	28966	37028	\N	T12_19596	D29_NA
89733	\N	\N	28972	37029	\N	H12_22776_B5_Norm	D41_NA
89734	\N	\N	28973	37030	\N	Buffy_Coat	D43_NA_BC
89735	\N	\N	27682	37031	\N	T12_12750B	28_NA
89736	\N	\N	28977	37032	\N	T12_13587_B2_0_25ug	D46_NA
89737	\N	\N	28971	37033	\N	T12_22901A_Tumor	D40_NA
89738	\N	\N	28995	37034	\N	T12_22900	D71_NA
89739	\N	\N	28985	37035	\N	T12_22602B	D59_NA
89740	\N	\N	28988	37036	\N	T12_22720A1	D62_NA
89741	\N	\N	28990	37037	\N	T12_22884C	D65_NA
89742	\N	\N	28992	37038	\N	T12_22886	D67_NA
89743	\N	\N	28980	37039	\N	T12_22582A	D49_NA
89744	\N	\N	28981	37040	\N	T12_22587	D51_NA
89745	\N	\N	28984	37041	\N	T12_22602A	D58_NA
89746	\N	\N	28979	37042	\N	T12_22573	D48_NA
89747	\N	\N	28987	37043	\N	T12_22604	D61_NA
89748	\N	\N	28978	37044	\N	H12_22794A	D47_NA
89749	\N	\N	28994	37045	\N	T12_22898	D70_NA
89750	\N	\N	28996	37046	\N	T12_22597_700ng	D72_NA
89751	\N	\N	28993	37047	\N	T12_22894B	D68_NA
89752	\N	\N	28983	37048	\N	T12_22597_1000ng	D56_NA
89753	\N	\N	28974	37049	\N	H12_22775	D43_NA_SCC
89754	\N	\N	28986	37050	\N	T12_22603	D60_NA
89755	\N	\N	28998	37051	\N	T12_22597_250ng	D74_NA
89756	\N	\N	28982	37052	\N	T12_22592	D55_NA
89757	\N	\N	28997	37053	\N	T12_22597_500ng	D73_NA
89758	\N	\N	28999	37054	\N	T12_22597_100ng	D75_NA
89759	\N	\N	28989	37055	\N	T12_22868	D64_NA
89760	\N	\N	28991	37056	\N	T12_22884D	D66_NA
89761	\N	\N	32246	37057	\N	WP_11	WP_11_NA
89762	\N	\N	32247	37058	\N	WP_23	WP_23_NA
89763	\N	\N	32248	37059	\N	WP_29	WP_29_NA
89764	\N	\N	31457	37060	\N	PG_8	PG_8_NA
89765	\N	\N	29880	37061	\N	Kit_37_Acral_NRAS	Kit_37_Acral_NRAS_NA
89766	\N	\N	28535	37062	\N	Bivona_L4	Bivona_L4_NA
89767	\N	\N	28529	37063	\N	Bivona_L_1	Bivona_L_1_NA
89768	\N	\N	28533	37064	\N	Bivona_L2	Bivona_L2_NA
89769	\N	\N	29888	37065	\N	Kit_181_Muc_BRAF	Kit_181_Muc_BRAF_NA
89771	\N	\N	29883	37067	\N	Kit_62__Acral_NRAS	Kit_62__Acral_NRAS_NA
89772	\N	\N	28536	37068	\N	Bivona_L5	Bivona_L5_NA
89773	\N	\N	28537	37069	\N	Bivona_L6	Bivona_L6_NA
89774	\N	\N	28534	37070	\N	Bivona_L3	Bivona_L3_NA
89775	\N	\N	29885	37071	\N	Kit_118_Muc_NRAS	Kit_118_Muc_NRAS_NA
89776	\N	\N	29902	37072	\N	Kit_275_Muc_BRAF	Kit_275_Muc_BRAF_NA
89777	\N	\N	27656	37073	\N	21-3	21-3_NA
89778	\N	\N	27676	37074	\N	Ivanka_24-2_Tert	24-2_NA
89779	\N	\N	28964	37075	\N	28_2	D28-2_NA
89780	\N	\N	29877	37076	\N	Kit 262	Kit 262_NA
89781	\N	\N	28965	37077	\N	28_3	D28-3_NA
89782	\N	\N	27683	37078	\N	28_4	28-4_NA
89783	\N	\N	27678	39639	\N	24-4	24-4_NA
89784	\N	\N	28962	37080	\N	21-1	D21-1_NA
89785	\N	\N	27675	37081	\N	Ivanka_24-1_Tert	24-1_NA
89786	\N	\N	27684	37082	\N	28_5	28-5_NA
89787	\N	\N	27658	37083	\N	21_5	21-5_NA
89788	\N	\N	27677	37084	\N	24-3	24-3_NA
89790	\N	\N	27679	37086	\N	24_5_Norm	24-5_NA
89791	\N	\N	27655	37087	\N	21-2	21-2_NA
89792	\N	\N	27657	37088	\N	21-4	21-4_NA
89793	\N	\N	31202	37089	\N	N3_10	N3_10_NA
89794	\N	\N	31195	37090	\N	N3_3	N3_3_NA
89795	\N	\N	31206	37091	\N	N3_14	N3_14_NA
89796	\N	\N	31208	37092	\N	N3_16	N3_16_NA
89797	\N	\N	31207	37093	\N	N3_15	N3_15_NA
89798	\N	\N	31203	37094	\N	N3_11	N3_11_NA
89799	\N	\N	31193	37095	\N	N3_1	N3_1_NA
89800	\N	\N	31204	37096	\N	N3_12	N3_12_NA
89801	\N	\N	31196	37097	\N	N3_4	N3_4_NA
89802	\N	\N	31200	37098	\N	N3_8	N3_8_NA
89803	\N	\N	31194	37099	\N	N3_2	N3_2_NA
89804	\N	\N	31198	37100	\N	N3_6	N3_6_NA
89805	\N	\N	31201	39646	\N	N3_9	N3_9_NA
89806	\N	\N	31205	37102	\N	N3_13	N3_13_NA
89807	\N	\N	31197	37103	\N	N3_5	N3_5_NA
89808	\N	\N	31199	37104	\N	N3_7	N3_7_NA
89809	\N	\N	30333	37105	\N	MB_1454_Normal	MB_1454_Normal_NA
89810	\N	\N	30330	37106	\N	MB_1036_Normal	MB_1036_Normal_NA
89811	\N	\N	28532	37107	\N	Bivona_L_19	Bivona_L_19_NA
89812	\N	\N	30329	37108	\N	MB_1029_Tumor	MB_1029_Tumor_NA
89813	\N	\N	30326	37109	\N	MB_327_Tumor	MB_327_Tumor_NA
89814	\N	\N	30327	37110	\N	MB_760_Tumor	MB_760_Tumor_NA
89815	\N	\N	30332	37111	\N	MB_1418_Normal	MB_1418_Normal_NA
89816	\N	\N	29906	37112	\N	Kit_313_Mucosal	Kit_313_Mucosal_NA
89817	\N	\N	28530	37113	\N	Bivona__L_17	Bivona_L_17_NA
89818	\N	\N	29881	37114	\N	Kit_53_Acral_NRAS	Kit_53_Acral_NRAS_NA
89819	\N	\N	29897	37115	\N	Kit_227_Acral_WT_CACCTC	Kit_227_Acral_WT_NA
89820	\N	\N	30325	37116	\N	MB_161_Tumor	MB_161_Tumor_NA
89821	\N	\N	30331	39647	\N	MB_1046_Tumor	MB_1046_Tumor_NA
89822	\N	\N	30324	37118	\N	MB_161_Normal	MB_161_Normal_NA
89823	\N	\N	30328	37119	\N	MB_1028_Normal	MB_1028_Normal_NA
89824	\N	\N	28531	37120	\N	Bivona_L_18	Bivona_L_18_NA
89825	\N	\N	28501	37121	\N	BB008_CGH12-047	BB008_CGH12-047_NA
89826	\N	\N	28511	37122	\N	BB008_NB2107	BB008_NB2107_NA
89827	\N	\N	28512	37123	\N	BB008_WM3211	BB008_WM3211_NA
89828	\N	\N	28497	37124	\N	BB008_CGH10-013	BB008_CGH10-013_NA
89829	\N	\N	28509	37125	\N	BB008_LAL-L1	BB008_LAL-L1_NA
89830	\N	\N	28507	37126	\N	BB008_HW9TC	BB008_HW9TC_NA
89831	\N	\N	28506	37127	\N	BB008_HW9-NB	BB008_HW9-NB_NA
89832	\N	\N	28503	37128	\N	BB008_HW2TC	BB008_HW2TC_NA
89833	\N	\N	28502	37129	\N	BB008_HW2NC	BB008_HW2NC_NA
89834	\N	\N	28510	37130	\N	BB008_LAL-L2	BB008_LAL-L2_NA
89835	\N	\N	28505	37131	\N	BB008_HW8TC	BB008_HW8TC_NA
89836	\N	\N	28508	37132	\N	BB008_Kit 227 Acral WT	BB008_Kit 227 Acral WT_NA
89837	\N	\N	28499	39648	\N	BB008_CGH11-153	BB008_CGH11-153_NA
89838	\N	\N	28498	37134	\N	BB008_CGH11-036	BB008_CGH11-036_NA
89839	\N	\N	28500	37135	\N	BB008_CGH11-386	BB008_CGH11-386_NA
89840	\N	\N	28504	37136	\N	BB008_HW8NC	BB008_HW8NC_NA
89841	\N	\N	28513	37137	\N	BB09_Bivona_L7	BB09_Bivona_L7_NA
89842	\N	\N	28516	37138	\N	BB09_Bivona_L10	BB09_Bivona_L10_NA
89843	\N	\N	28524	37139	\N	BB09_HW3_T	BB09_HW3_T_NA
89844	\N	\N	28523	37140	\N	BB09_HW3_N	BB09_HW3_N_NA
89845	\N	\N	28520	37141	\N	BB09_CGH11_092	BB09_CGH11_092_NA
89846	\N	\N	28517	37142	\N	BB09_Bivona_L11	BB09_Bivona_L11_NA
89847	\N	\N	28515	37143	\N	BB09_Bivona_L9	BB09_Bivona_L9_NA
89848	\N	\N	28518	37144	\N	BB09_CGH11_029	BB09_CGH11_029_NA
89849	\N	\N	28528	39649	\N	BB09_HW6_TD	BB09_HW6_TD_NA
89850	\N	\N	28521	37146	\N	BB09_CGH11_125	BB09_CGH11_125_NA
89851	\N	\N	28519	37147	\N	BB09_CGH11_045	BB09_CGH11_045_NA
89852	\N	\N	28522	37148	\N	BB09_CGH11_194	BB09_CGH11_194_NA
89853	\N	\N	28525	37149	\N	BB09_HW4_N	BB09_HW4_N_NA
89854	\N	\N	28514	37150	\N	BB09_Bivona_L8	BB09_Bivona_L8_NA
89855	\N	\N	28526	37151	\N	BB09_HW4_T	BB09_HW4_T_NA
89856	\N	\N	28527	37152	\N	BB09_HW6_ND	BB09_HW6_ND_NA
89857	\N	\N	29625	37153	\N	DP12_200	DP12_200_NA
89858	\N	\N	29687	37154	\N	HW_A1_Cntl	HW_A1_Cntl_NA
89859	\N	\N	29693	37155	\N	HW_A4_Cntl	HW_A4_Cntl_NA
89860	\N	\N	29694	37156	\N	HW_A4_Tumor	HW_A4_Tumor_NA
89861	\N	\N	28576	37157	\N	CGH11_60	CGH11_60_NA
89862	\N	\N	28565	37158	\N	CGH10_16	CGH10_16_NA
89863	\N	\N	27700	37159	\N	ALK_Cntl	ALK_Cntl_NA
89864	\N	\N	28581	37160	\N	CGH11_252	CGH11_252_NA
89865	\N	\N	28566	37161	\N	CGH10_17	CGH10_17_NA
89866	\N	\N	29691	37162	\N	HW_A3_Cntl	HW_A3_Cntl_NA
89867	\N	\N	29688	37163	\N	HW_A1_Tumor	HW_A1_Tumor_NA
89868	\N	\N	29690	37164	\N	HW_A2_Tumor	HW_A2_Tumor_NA
89869	\N	\N	29692	37165	\N	HW_A3_Tumor	HW_A3_Tumor_NA
89870	\N	\N	28575	39650	\N	CGH11_035	CGH11_035_NA
89871	\N	\N	28588	37167	\N	CGH11_343	CGH11_343_NA
89872	\N	\N	29689	37168	\N	HW_A2_Cntl	HW_A2_Cntl_NA
89873	\N	\N	28957	37169	\N	D12_67298_Tumor	D12_67298_Tumor_NA
89874	\N	\N	30339	37170	\N	MB1423_Tumor	MB1423_Tumor_NA
89875	\N	\N	30337	37171	\N	MB1421_Norm	MB1421_Norm_NA
89876	\N	\N	28635	37172	\N	CGH12_317	CGH12_317_NA
89877	\N	\N	31896	37173	\N	S12_20321_A2_Tumor	S12_20321_A2_Tumor_NA
89878	\N	\N	29944	37174	\N	L11_96096_A2_Norm	L11_96096_A2_Norm_NA
89879	\N	\N	30340	39651	\N	MB1424 _Tumor	MB1424 _Tumor_NA
89880	\N	\N	28633	37176	\N	CGH12_161	CGH12_161_NA
89881	\N	\N	30342	37177	\N	MB1429_Tumor	MB1429_Tumor_NA
89882	\N	\N	28956	37178	\N	D12_67298_Norm	D12_67298_Norm_NA
89883	\N	\N	30341	37179	\N	MB1428_Norm	MB1428_Norm_NA
89884	\N	\N	28636	37180	\N	CGH12_343	CGH12_343_NA
89885	\N	\N	30335	37181	\N	MB1241_Norm	MB1241_Norm_NA
89886	\N	\N	28632	37182	\N	CGH12_135	CGH12_135_NA
89887	\N	\N	30338	37183	\N	MB1423_Norm	MB1423_Norm_NA
90655	\N	\N	29345	37951	\N	DLP-118	DNA-138
89888	\N	\N	30336	37184	\N	MB1242_Tumor	MB1242_Tumor_NA
89889	\N	\N	30334	37185	\N	MB_1609_Normal	MB_1609_Normal_NA
89890	\N	\N	29695	37186	\N	HW_A5_Cntl	HW_A5_Cntl_NA
89891	\N	\N	29701	37187	\N	HW_A8_Cntl	HW_A8_Cntl_NA
89892	\N	\N	29699	37188	\N	HW_A7 Cntl	HW_A7 Cntl_NA
89893	\N	\N	29700	37189	\N	HW_A7_Tumor	HW_A7_Tumor_NA
89894	\N	\N	32241	37190	\N	WM51	WM51_NA
89895	\N	\N	29698	37191	\N	HW_A6_Tumor	HW_A6_Tumor_NA
89896	\N	\N	29704	39652	\N	HW_A9_Tumor	HW_A9_Tumor_NA
89897	\N	\N	29697	37193	\N	HW_A6_Cntl	HW_A6_Cntl_NA
89898	\N	\N	29703	37194	\N	HW_A9_Cntl	HW_A9_Cntl_NA
89899	\N	\N	29696	37195	\N	HW_A5_Tumor	HW_A5_Tumor_NA
89900	\N	\N	29705	37196	\N	HW_A10_Cntl	HW_A10_Cntl_NA
89901	\N	\N	32245	37197	\N	WM3918	WM3918_NA
89902	\N	\N	30343	37198	\N	MB1617_Tumor	MB1617_Tumor_NA
89903	\N	\N	29702	37199	\N	HW_A8_Tumor	HW_A8_Tumor_NA
89904	\N	\N	29706	37200	\N	HW_A10_Tumor	HW_A10_Tumor_NA
89905	\N	\N	29116	37201	\N	DM93_CGN	DM93_CGN_NA
89906	\N	\N	29076	37202	\N	DM1_Tumor	DM1_Tumor_NA
89907	\N	\N	29118	37203	\N	DM93_Normal	DM93_Normal_NA
89908	\N	\N	29077	37204	\N	DM2_Normal	DM2_Normal_NA
89909	\N	\N	29086	39653	\N	DM12_Normal	DM12_Normal_NA
89910	\N	\N	29094	37206	\N	DM21_Normal	DM21_Normal_NA
89911	\N	\N	29080	37207	\N	DM5_Normal	DM5_Normal_NA
89912	\N	\N	29075	37208	\N	DM1_Normal	DM1_Normal_NA
89913	\N	\N	29079	37209	\N	DM5 _Tumor	DM5 _Tumor_NA
89914	\N	\N	29078	37210	\N	DM2_Tumor	DM2_Tumor_NA
89915	\N	\N	29088	37211	\N	DM13_Normal	DM13_Normal_NA
89916	\N	\N	29087	37212	\N	DM12_Tumor	DM12_Tumor_NA
89917	\N	\N	29095	37213	\N	DM21_Tumor	DM21_Tumor_NA
89918	\N	\N	29089	37214	\N	DM13_Tumor	DM13_Tumor_NA
89919	\N	\N	29082	37215	\N	DM7_Tumor	DM7_Tumor_NA
89920	\N	\N	29081	37216	\N	DM7_Normal	DM7_Normal_NA
89921	\N	\N	29083	37217	\N	DM8TumorCrest	DM8TumorCrest_NA
89922	\N	\N	32244	37218	\N	WM3912	WM3912_NA
89923	\N	\N	32243	37219	\N	WM3622	WM3622_NA
89924	\N	\N	28952	39654	\N	D12_54296_Norm	D12_54296_Norm_NA
89925	\N	\N	32240	37221	\N	WM8	WM8_NA
89926	\N	\N	28955	37222	\N	D12_54992_Tumor	D12_54992_Tumor_NA
89927	\N	\N	28577	37223	\N	CGH11_078	CGH11_078_NA
89928	\N	\N	28574	37224	\N	CGH11_020	CGH11_020_NA
89929	\N	\N	28568	37225	\N	CGH10_049	CGH10_049_NA
89930	\N	\N	28583	37226	\N	CGH11_283	CGH11_283_NA
89931	\N	\N	28954	37227	\N	D12_54992_Norm	D12_54992_Norm_NA
89932	\N	\N	32242	37228	\N	WM1963	WM1963_NA
89933	\N	\N	28569	37229	\N	CGH10_058	CGH10_058_NA
89934	\N	\N	28578	37230	\N	CGH11_080	CGH11_080_NA
89935	\N	\N	28953	37231	\N	D12_54296_Tumor	D12_54296_Tumor_NA
89936	\N	\N	28582	37232	\N	CGH11_281	CGH11_281_NA
89937	\N	\N	28567	37233	\N	CGH10_020	CGH10_020_NA
89938	\N	\N	29084	37234	\N	DM11_Normal	DM11_Normal_NA
89939	\N	\N	29100	39655	\N	DM29_2_Tumor	DM29_2_Tumor_NA
89940	\N	\N	29108	37236	\N	DM55 Normal	DM55 Normal_NA
89941	\N	\N	29113	37237	\N	DM79_Normal	DM79_Normal_NA
89942	\N	\N	29096	37238	\N	DM26_Normal	DM26_Normal_NA
89943	\N	\N	29112	37239	\N	DM79_2_Tumor	DM79_2_Tumor_NA
89944	\N	\N	29102	37240	\N	DM34_Normal	DM34_Normal_NA
89945	\N	\N	29103	37241	\N	DM34_Tumor	DM34_Tumor_NA
89946	\N	\N	29085	37242	\N	DM11_Tumor	DM11_Tumor_NA
89947	\N	\N	29097	37243	\N	DM26_Tumor	DM26_Tumor_NA
89948	\N	\N	29109	37244	\N	DM55_Tumor	DM55_Tumor_NA
89949	\N	\N	29101	37245	\N	DM29_Normal	DM29_Normal_NA
89950	\N	\N	29090	37246	\N	DM14_Normal	DM14_Normal_NA
89951	\N	\N	29098	37247	\N	DM28_Normal	DM28_Normal_NA
89952	\N	\N	29091	37248	\N	DM14_Tumor	DM14_Tumor_NA
89953	\N	\N	29099	37249	\N	DM28_Tumor	DM28_Tumor_NA
89954	\N	\N	28560	37250	\N	CGH_11_366	CGH_11_366_NA
89955	\N	\N	29005	37251	\N	DM_4_Normal	DM_4_Normal_NA
89956	\N	\N	29878	37252	\N	Kit_8	Kit_8_NA
89957	\N	\N	29053	39656	\N	DM_95_2_Tumor	DM_95_2_Tumor_NA
89958	\N	\N	28559	37254	\N	CGH_11_361	CGH_11_361_NA
89959	\N	\N	29882	37255	\N	Kit_55	Kit_55_NA
89960	\N	\N	28564	37256	\N	CGH_12_016	CGH_12_016_NA
89961	\N	\N	29006	37257	\N	DM_4_Tumor	DM_4_Tumor_NA
89962	\N	\N	29054	37258	\N	DM_95_Normal	DM_95_Normal_NA
89963	\N	\N	28562	37259	\N	CGH_11_388	CGH_11_388_NA
89964	\N	\N	28561	37260	\N	CGH_11_376	CGH_11_376_NA
89965	\N	\N	29056	37261	\N	DM_96_Normal	DM_96_Normal_NA
89966	\N	\N	29884	37262	\N	Kit_76	Kit_76_NA
89967	\N	\N	28563	37263	\N	CGH_11_422	CGH_11_422_NA
89968	\N	\N	29879	37264	\N	Kit_21	Kit_21_NA
89969	\N	\N	29055	37265	\N	DM_96_2_Tumor	DM_96_2_Tumor_NA
89970	\N	\N	29890	37266	\N	Kit_192	Kit_192_NA
89971	\N	\N	28885	37267	\N	CNS_39_Tumor	CNS_39_Tumor_NA
89972	\N	\N	28882	39657	\N	CNS_36_Tumor	CNS_36_Tumor_NA
89973	\N	\N	28876	37269	\N	CNS_30_Tumor	CNS_30_Tumor_NA
89974	\N	\N	28881	37270	\N	CNS_35_Tumor	CNS_35_Tumor_NA
89975	\N	\N	28878	37271	\N	CNS_33_Tumor	CNS_33_Tumor_NA
89976	\N	\N	28880	37272	\N	CNS_34_Tumor	CNS_34_Tumor_NA
89977	\N	\N	28886	37273	\N	CNS_40_Tumor	CNS_40_Tumor_NA
89978	\N	\N	28879	37274	\N	CNS_34_Normal	CNS_34_Normal_NA
89979	\N	\N	28887	37275	\N	CNS_41_Tumor	CNS_41_Tumor_NA
89980	\N	\N	28874	37276	\N	CNS_29_Normal	CNS_29_Normal_NA
89981	\N	\N	29891	37277	\N	Kit_203	Kit_203_NA
89982	\N	\N	28877	37278	\N	CNS_31_Tumor	CNS_31_Tumor_NA
89983	\N	\N	28883	37279	\N	CNS_37_Tumor	CNS_37_Tumor_NA
89984	\N	\N	28875	37280	\N	CNS_29_Tumor	CNS_29_Tumor_NA
89985	\N	\N	28884	37281	\N	CNS_38_Tumor	CNS_38_Tumor_NA
89986	\N	\N	29929	37282	\N	KR_177	KR_177_NA
89987	\N	\N	29934	39658	\N	KR_5233	KR_5233_NA
89988	\N	\N	29932	37284	\N	KR_2030	KR_2030_NA
89989	\N	\N	29933	37285	\N	KR_2064	KR_2064_NA
89990	\N	\N	29935	37286	\N	KR_RMK0091B	KR_RMK0091B_NA
89991	\N	\N	29930	37287	\N	KR_203	KR_203_NA
89992	\N	\N	29939	37288	\N	KR_RMK0194C	KR_RMK0194C_NA
89993	\N	\N	29926	37289	\N	KR_8	KR_8_NA
89994	\N	\N	29937	37290	\N	KR_RMK0162C	KR_RMK0162C_NA
89995	\N	\N	29928	37291	\N	KR_166	KR_166_NA
89996	\N	\N	29927	37292	\N	KR_150	KR_150_NA
89997	\N	\N	29936	37293	\N	KR_RMK0137C	KR_RMK0137C_NA
89998	\N	\N	27679	37294	\N	Ivanka_24_5_Norm	24-5_NA
89999	\N	\N	27658	37295	\N	Ivanka_21_5_Norm	21-5_NA
90000	\N	\N	29931	37296	\N	KR_229	KR_229_NA
90001	\N	\N	29938	37297	\N	KR_RMK0168C	KR_RMK0168C_NA
90002	\N	\N	29030	37298	\N	DM_37_Tumor	DM_37_Tumor_NA
90003	\N	\N	29022	37299	\N	DM_23_Normal	DM_23_Normal_NA
90004	\N	\N	29025	37300	\N	DM_25_Tumor	DM_25_Tumor_NA
90005	\N	\N	29011	37301	\N	DM_10_Tumor	DM_10_Tumor_NA
90006	\N	\N	29049	37302	\N	DM_93_cgn	DM_93_cgn_NA
90007	\N	\N	29020	37303	\N	DM_22_Normal	DM_22_Normal_NA
90008	\N	\N	29018	37304	\N	DM_18_Normal	DM_18_Normal_NA
90009	\N	\N	29021	37305	\N	DM_22_Tumor	DM_22_Tumor_NA
90010	\N	\N	29010	37306	\N	DM_10_Normal	DM_10_Normal_NA
90011	\N	\N	29024	37307	\N	DM_25_Normal	DM_25_Normal_NA
90012	\N	\N	29008	37308	\N	DM_6_Tumor	DM_6_Tumor_NA
90013	\N	\N	29017	37309	\N	DM_17_Tumor	DM_17_Tumor_NA
90014	\N	\N	29016	37310	\N	DM_17_Normal	DM_17_Normal_NA
90015	\N	\N	29050	37311	\N	DM_93_Normal	DM_93_Normal_NA
90016	\N	\N	29019	37312	\N	DM_18_Tumor	DM_18_Tumor_NA
90017	\N	\N	29023	39659	\N	DM_23_Tumor	DM_23_Tumor_NA
90018	\N	\N	31957	39660	\N	SM_11_Tumor	SM_11_Tumor_NA
90019	\N	\N	29034	37315	\N	DM_43_Tumor	DM_43_Tumor_NA
90020	\N	\N	31941	37316	\N	SM_1_Tumor	SM_1_Tumor_NA
90021	\N	\N	31953	37317	\N	SM_8_Tumor	SM_8_Tumor_NA
90022	\N	\N	29035	37318	\N	DM_48_Tumor	DM_48_Tumor_NA
90023	\N	\N	31948	37319	\N	SM_5_Tumor	SM_5_Tumor_NA
90024	\N	\N	31962	37320	\N	SM7_Tumor	SM7_Tumor_NA
90025	\N	\N	31945	37321	\N	SM_4_Normal	SM_4_Normal_NA
90026	\N	\N	31961	37322	\N	SM_18_Tumor	SM_18_Tumor_NA
90027	\N	\N	31959	37323	\N	SM_16_Normal	SM_16_Normal_NA
90028	\N	\N	31960	37324	\N	SM_16_Tumor	SM_16_Tumor_NA
90029	\N	\N	29032	37325	\N	DM_42_Tumor	DM_42_Tumor_NA
90030	\N	\N	31947	37326	\N	SM_5_Normal	SM_5_Normal_NA
90031	\N	\N	31958	37327	\N	SM_12_Tumor	SM_12_Tumor_NA
90032	\N	\N	31944	37328	\N	SM_3_Tumor	SM_3_Tumor_NA
90033	\N	\N	31946	37329	\N	SM_4_Tumor	SM_4_Tumor_NA
90034	\N	\N	28597	37330	\N	CGH11-087	CGH11-087_NA
90035	\N	\N	28589	37331	\N	CGH11_348	CGH11_348_NA
90036	\N	\N	28585	37332	\N	CGH11_305	CGH11_305_NA
90037	\N	\N	28596	37333	\N	CGH11-072	CGH11-072_NA
90038	\N	\N	28586	37334	\N	CGH11_310	CGH11_310_NA
90039	\N	\N	28571	37335	\N	CGH10-045	CGH10-045_NA
90040	\N	\N	28592	39661	\N	CGH11-011	CGH11-011_NA
90041	\N	\N	28603	37337	\N	CGH11-158	CGH11-158_NA
90042	\N	\N	28602	37338	\N	CGH11-147	CGH11-147_NA
90043	\N	\N	28605	37339	\N	CGH11-172	CGH11-172_NA
90044	\N	\N	28598	37340	\N	CGH11-089	CGH11-089_NA
90045	\N	\N	28584	37341	\N	CGH11_292	CGH11_292_NA
90046	\N	\N	28604	37342	\N	CGH11-166	CGH11-166_NA
90047	\N	\N	28587	37343	\N	CGH11_319	CGH11_319_NA
90048	\N	\N	28573	37344	\N	CGH10-062	CGH10-062_NA
90049	\N	\N	28570	37345	\N	CGH10-028	CGH10-028_NA
90050	\N	\N	28614	37346	\N	CGH11-259	CGH11-259_NA
90051	\N	\N	28572	37347	\N	CGH10-058	CGH10-058_NA
90052	\N	\N	28625	37348	\N	CGH11-409	CGH11-409_NA
90053	\N	\N	28619	37349	\N	CGH11-315	CGH11-315_NA
90054	\N	\N	28624	37350	\N	CGH11-404	CGH11-404_NA
90055	\N	\N	28620	37351	\N	CGH11-339	CGH11-339_NA
90056	\N	\N	28607	37352	\N	CGH11-194	CGH11-194_NA
90057	\N	\N	28613	37353	\N	CGH11-252	CGH11-252_NA
90058	\N	\N	28593	39662	\N	CGH11-035	CGH11-035_NA
90059	\N	\N	31956	37355	\N	SM_10_Tumor	SM_10_Tumor_NA
90060	\N	\N	31951	37356	\N	SM_7_Tumor	SM_7_Tumor_NA
90061	\N	\N	31952	37357	\N	SM_8_Normal	SM_8_Normal_NA
90062	\N	\N	31942	37358	\N	SM_2_Normal	SM_2_Normal_NA
90063	\N	\N	31949	37359	\N	SM_6_Tumor	SM_6_Tumor_NA
90064	\N	\N	31955	37360	\N	SM_9_Tumor	SM_9_Tumor_NA
90065	\N	\N	31954	39663	\N	SM_9_Normal	SM_9_Normal_NA
90066	\N	\N	31943	37362	\N	SM_2_Tumor	SM_2_Tumor_NA
90067	\N	\N	31950	37363	\N	SM_7_Normal	SM_7_Normal_NA
90068	\N	\N	28657	37364	\N	CGH13-034	CGH13-034_NA
90069	\N	\N	28658	37365	\N	CGH13-041	CGH13-041_NA
90070	\N	\N	28653	37366	\N	CGH13-003	CGH13-003_NA
90071	\N	\N	28652	37367	\N	CGH12-347	CGH12-347_NA
90072	\N	\N	28659	37368	\N	CGH13-044	CGH13-044_NA
90073	\N	\N	28661	37369	\N	CGH13-058	CGH13-058_NA
90074	\N	\N	28654	37370	\N	CGH13-009	CGH13-009_NA
90075	\N	\N	28655	37371	\N	CGH13-011	CGH13-011_NA
90076	\N	\N	28651	37372	\N	CGH12-345	CGH12-345_NA
90077	\N	\N	28776	37373	\N	CHG12-335	CHG12-335_NA
90078	\N	\N	28660	37374	\N	CGH13-046	CGH13-046_NA
90079	\N	\N	28656	37375	\N	CGH13-033	CGH13-033_NA
90080	\N	\N	29639	37376	\N	DPN_11_Tumor	DPN_11_Tumor_NA
90081	\N	\N	29638	37377	\N	DPN_10_Tumor	DPN_10_Tumor_NA
90082	\N	\N	29629	37378	\N	DPN_4_Tumor	DPN_4_Tumor_NA
90083	\N	\N	29635	37379	\N	DPN_8_Tumor	DPN_8_Tumor_NA
90084	\N	\N	29632	37380	\N	DPN_6_Tumor	DPN_6_Tumor_NA
90085	\N	\N	29640	37381	\N	DPN_12_Tumor	DPN_12_Tumor_NA
90086	\N	\N	29627	37382	\N	DPN_1_Tumor	DPN_1_Tumor_NA
90087	\N	\N	29631	37383	\N	DPN_5_Tumor	DPN_5_Tumor_NA
90656	\N	\N	29348	37952	\N	DLP-119	DNA-141
90088	\N	\N	29628	39664	\N	DPN_3_Tumor	DPN_3_Tumor_NA
90089	\N	\N	29637	37385	\N	DPN_9_Tumor	DPN_9_Tumor_NA
90090	\N	\N	29633	37386	\N	DPN_7_Tumor	DPN_7_Tumor_NA
90091	\N	\N	31215	37387	\N	NGS 1-1	NGS 1-1_NA
90092	\N	\N	31220	37388	\N	NGS 1-7	NGS 1-7_NA
90093	\N	\N	31225	37389	\N	NGS 1-14	NGS 1-14_NA
90094	\N	\N	31219	37390	\N	NGS 1-6	NGS 1-6_NA
90095	\N	\N	31222	37391	\N	NGS 1-9	NGS 1-9_NA
90096	\N	\N	31216	37392	\N	NGS 1-3	NGS 1-3_NA
90097	\N	\N	31221	37393	\N	NGS 1-8	NGS 1-8_NA
90098	\N	\N	31224	37394	\N	NGS 1-13	NGS 1-13_NA
90099	\N	\N	31218	37395	\N	NGS 1-5	NGS 1-5_NA
90100	\N	\N	31217	37396	\N	NGS 1-4	NGS 1-4_NA
90102	\N	\N	29641	37398	\N	DPN_14_Tumor	DPN_14_Tumor_NA
90103	\N	\N	28890	37399	\N	CNS_44_Tumor	CNS_44_Tumor_NA
90104	\N	\N	28892	37400	\N	CNS_49_Tumor	CNS_49_Tumor_NA
90105	\N	\N	29643	37401	\N	DPN_17_Tumor	DPN_17_Tumor_NA
90106	\N	\N	28893	37402	\N	CNS_50_Tumor	CNS_50_Tumor_NA
90107	\N	\N	29646	37403	\N	DPN_19_Tumor	DPN_19_Tumor_NA
90108	\N	\N	28891	37404	\N	CNS_48_Tumor	CNS_48_Tumor_NA
90109	\N	\N	28889	39685	\N	CNS_43_Tumor	CNS_43_Tumor_NA
90110	\N	\N	29645	37406	\N	DPN_18_Tumor	DPN_18_Tumor_NA
90111	\N	\N	28888	37407	\N	CNS_42_Tumor	CNS_42_Tumor_NA
90112	\N	\N	29642	37408	\N	DPN_16_Tumor	DPN_16_Tumor_NA
90113	\N	\N	29727	37409	\N	Ivanka_12_5	Ivanka_12_5_NA
90114	\N	\N	29723	37410	\N	Ivanka_12_1	Ivanka_12_1_NA
90115	\N	\N	29726	37411	\N	Ivanka_12_4	Ivanka_12_4_NA
90116	\N	\N	29715	37412	\N	Ivanka_9_3	Ivanka_9_3_NA
90117	\N	\N	29717	37413	\N	Ivanka_9_5	Ivanka_9_5_NA
90118	\N	\N	29725	37414	\N	Ivanka_12_3	Ivanka_12_3_NA
90119	\N	\N	29716	37415	\N	Ivanka_9_4	Ivanka_9_4_NA
90120	\N	\N	29724	37416	\N	Ivanka_12_2	Ivanka_12_2_NA
90121	\N	\N	29713	37417	\N	Ivanka_9_1	Ivanka_9_1_NA
90122	\N	\N	29714	37418	\N	Ivanka_9_2	Ivanka_9_2_NA
90123	\N	\N	29728	37419	\N	Ivanka_16_1	Ivanka_16_1_NA
90124	\N	\N	29732	37420	\N	Ivanka_16_5	Ivanka_16_5_NA
90125	\N	\N	29731	37421	\N	Ivanka_16_4	Ivanka_16_4_NA
90126	\N	\N	29738	37422	\N	Ivanka_22_1	Ivanka_22_1_NA
90127	\N	\N	29740	37423	\N	Ivanka_22_3	Ivanka_22_3_NA
90128	\N	\N	29741	37424	\N	Ivanka_22_4	Ivanka_22_4_NA
90129	\N	\N	29739	37425	\N	Ivanka_22_2	Ivanka_22_2_NA
90130	\N	\N	29742	37426	\N	Ivanka_22_5	Ivanka_22_5_NA
90131	\N	\N	29730	37427	\N	Ivanka_16_3	Ivanka_16_3_NA
90132	\N	\N	29729	39686	\N	Ivanka_16_2	Ivanka_16_2_NA
90133	\N	\N	27699	37429	\N	Algazi_Tumor	Algazi_Tumor_NA
90134	\N	\N	29734	37430	\N	Ivanka_20_2	Ivanka_20_2_NA
90135	\N	\N	29745	37431	\N	Ivanka_23_3	Ivanka_23_3_NA
90136	\N	\N	29744	37432	\N	Ivanka_23_2	Ivanka_23_2_NA
90137	\N	\N	29746	39690	\N	Ivanka_23_4	Ivanka_23_4_NA
90138	\N	\N	29737	37434	\N	Ivanka_20_5	Ivanka_20_5_NA
90139	\N	\N	29747	37435	\N	Ivanka_23_5	Ivanka_23_5_NA
90140	\N	\N	29733	37436	\N	Ivanka_20_1	Ivanka_20_1_NA
90141	\N	\N	29743	37437	\N	Ivanka_23_1	Ivanka_23_1_NA
90142	\N	\N	29736	37438	\N	Ivanka_20_4	Ivanka_20_4_NA
90143	\N	\N	29735	37439	\N	Ivanka_20_3	Ivanka_20_3_NA
90144	\N	\N	28609	37440	\N	CGH11-229	CGH11-229_NA
90145	\N	\N	28611	39691	\N	CGH11-232	CGH11-232_NA
90146	\N	\N	28610	37442	\N	CGH11-231	CGH11-231_NA
90147	\N	\N	28612	37443	\N	CGH11-237	CGH11-237_NA
90148	\N	\N	28775	37444	\N	CHG11-409	CHG11-409_NA
90149	\N	\N	28778	37445	\N	ChIP1_2	ChIP1_2_NA
90150	\N	\N	28777	37446	\N	ChIP1_1	ChIP1_1_NA
90152	\N	\N	28783	37448	\N	ChIP1_7	ChIP1_7_NA
90153	\N	\N	28779	37449	\N	ChIP1_3	ChIP1_3_NA
90154	\N	\N	28780	37450	\N	ChIP1_4	ChIP1_4_NA
90155	\N	\N	28782	37451	\N	ChIP1_6	ChIP1_6_NA
90156	\N	\N	28784	37452	\N	ChIP1_8	ChIP1_8_NA
90157	\N	\N	28781	37453	\N	ChIP1_5	ChIP1_5_NA
90158	\N	\N	28786	37454	\N	ChIP1_10	ChIP1_10_NA
90159	\N	\N	28787	37455	\N	ChIP1_11	ChIP1_11_NA
90160	\N	\N	28788	37456	\N	ChIP1_12	ChIP1_12_NA
90161	\N	\N	28595	37457	\N	CGH11-051	CGH11-051
90162	\N	\N	32250	37458	\N	WTMM-18-Tumor	WTMM-18-Tumor_NA
90163	\N	\N	32252	37459	\N	WTMM-20-Tumor	WTMM-20-Tumor_NA
90164	\N	\N	32253	37460	\N	WTMM-21-Tumor	WTMM-21-Tumor_NA
90165	\N	\N	32255	37461	\N	WTMM-23-Tumor	WTMM-23-Tumor_NA
90166	\N	\N	32249	37462	\N	WTMM-17-Tumor	WTMM-17-Tumor_NA
90167	\N	\N	32256	37463	\N	WTMM-24-Tumor	WTMM-24-Tumor_NA
90168	\N	\N	32251	37464	\N	WTMM-19-Tumor	WTMM-19-Tumor_NA
90169	\N	\N	32254	37465	\N	WTMM-22-Tumor	WTMM-22-Tumor_NA
90170	\N	\N	29774	37466	\N	XD-1-Tumor	K2_1_NA
90171	\N	\N	29778	37467	\N	Long-TN10-Tumor	K2_5
90172	\N	\N	29765	37468	\N	JBP-4-Met1	K1_14
90173	\N	\N	29770	37469	\N	JBP-7-Norm	K1_19
90174	\N	\N	29768	37470	\N	JBP-5-MM	K1_17
90175	\N	\N	29783	37471	\N	JBP-3-Met1	K2_10
90176	\N	\N	29772	37472	\N	JBP-7-Met	K1_21
90177	\N	\N	29779	37473	\N	Long-TN11-Normal	K2_6
90178	\N	\N	29769	37474	\N	JBP-5-Met	K1_18
90179	\N	\N	29777	37475	\N	Long-TN10-Normal	K2_4
90180	\N	\N	29773	37476	\N	JBP-9-Norm	K1_22
90181	\N	\N	29776	37477	\N	PMM-8-Tumor	K2_3_NA
90182	\N	\N	29784	37478	\N	JBP-3-Met2	K2_11_NA
90183	\N	\N	29000	37479	\N	JBP-4-Norm	D76_NA
90184	\N	\N	29782	37480	\N	JBP-3-MM	K2_9
90185	\N	\N	29767	37481	\N	JBP-5-Norm	K1_16
90186	\N	\N	29771	37482	\N	JBP-7-MM	K1_20
90187	\N	\N	29766	37483	\N	JBP-4-Met2	K1_15
90188	\N	\N	29781	37484	\N	JBP-3-Norm	K2_8
90189	\N	\N	29780	37485	\N	Long-TN11-Tumor	K2_7
90190	\N	\N	29764	37486	\N	JBP-4-MM	K1_13
90191	\N	\N	29775	37487	\N	XD-1-1-Tumor	K2_2_NA
90192	\N	\N	29749	37488	\N	JBP-9-MM	JBP-6-MM_NA
90193	\N	\N	29751	37489	\N	JBP-9-Met	JBP-9Met_NA
90194	\N	\N	29750	37490	\N	JBP-6-Norm	JBP-6-Norm_NA
90195	\N	\N	29749	37491	\N	JBP-6-MM	JBP-6-MM_NA
90196	\N	\N	29748	37492	\N	JBP-6-Met	JBP-6-Met_NA
90197	\N	\N	29753	37493	\N	JBP-11-Met	JBP-11Met
90198	\N	\N	32226	37494	\N	UM23	UM23_NA
90199	\N	\N	29754	37495	\N	JBP-11-MM	JBP-11MM
90200	\N	\N	29755	37496	\N	JBP-11-Norm	JBP-11Norm
90201	\N	\N	31212	37497	\N	CP1-20	NA_CP1-20_Tumor
90202	\N	\N	32050	37498	\N	TCR-Beta-1	TCR-Beta-1_NA
90203	\N	\N	31214	37499	\N	CP1-80	NA_CP1-80_Tumor
90204	\N	\N	31213	37500	\N	CP1-40	NA_CP1-40_Tumor
90205	\N	\N	31209	37501	\N	CP1-Norm	NA_CP1_Normal
90206	\N	\N	32051	37502	\N	TCR-Beta-2	TCR-Beta-2_NA
90207	\N	\N	31211	37503	\N	CP1-10	NA_CP1-10_Tumor
90208	\N	\N	32229	37504	\N	UM26	UM26_NA
90209	\N	\N	31210	37505	\N	CP1-5	NA_CP1-5_Tumor
90210	\N	\N	32228	37506	\N	UM25	UM25_NA
90211	\N	\N	32227	37507	\N	UM24	UM24_NA
90212	\N	\N	29860	37508	\N	KAM99-tumor	KAM99-T
90213	\N	\N	29841	37509	\N	KAM3-T-A	KAM3-T-A
90214	\N	\N	29857	37510	\N	KAM93-tumor	KAM93-T
90216	\N	\N	29843	37512	\N	KAM10-Tumor	KAM10-T
90217	\N	\N	29862	37513	\N	KAM100-tumor	KAM100-T-11
90218	\N	\N	29852	37514	\N	KAM65-T	KAM65-T
90219	\N	\N	29853	37515	\N	KAM71-T	KAM71-T
90220	\N	\N	29858	37516	\N	KAM95-T-B1	KAM95-T-B1
90221	\N	\N	29855	37517	\N	KAM79-T	KAM79-T
90222	\N	\N	29849	37518	\N	KAM43-T	KAM43-T
90223	\N	\N	29847	37519	\N	KAM34-T	KAM34-T
90224	\N	\N	29850	37520	\N	KAM48-T	KAM48-T
90225	\N	\N	29848	37521	\N	KAM37-T	KAM37-T
90226	\N	\N	29851	37522	\N	KAM62-T	KAM62-T
90227	\N	\N	29846	37523	\N	KAM26-T	KAM26-T
90228	\N	\N	29845	37524	\N	KAM14-T	KAM14-T
90229	\N	\N	32231	37525	\N	UM38-Tumor	UM38-Tumor_NA
90230	\N	\N	32230	37526	\N	UM38-Normal	UM38-Normal_NA
90231	\N	\N	29759	37527	\N	JBU8-Norm	JBU8-Norm
90232	\N	\N	29757	37528	\N	JBU7-Norm	JBU7-Norm
90233	\N	\N	29763	37529	\N	JBU11-Norm	JBU11-Norm
90234	\N	\N	29760	37530	\N	JBU10-MVP	JBU10-MVP
90235	\N	\N	29758	37531	\N	JBU8-MVP	JBU8-MVP
90236	\N	\N	29761	37532	\N	JBU10-Norm	JBU10-Norm
90237	\N	\N	29762	37533	\N	JBU11-MVP	JBU11-MVP
90238	\N	\N	29756	37534	\N	JBU7-MVP	JBU7-MVP
90239	\N	\N	29626	37535	\N	DPN49-Tumor	DPN 49
90240	\N	\N	29665	37536	\N	DPN61-Tumor	DPN61-Tumor_NA
90241	\N	\N	29664	37537	\N	DPN60-Tumor	DPN60-Tumor_NA
90242	\N	\N	29655	37538	\N	DPN51-Tumor	DPN51-Tumor_NA
90243	\N	\N	29656	37539	\N	DPN52-Tumor	DPN52-Tumor_NA
90244	\N	\N	29657	37540	\N	DPN53-Tumor	DPN53-Tumor_NA
90245	\N	\N	29661	37541	\N	DPN57-Tumor	DPN57-Tumor_NA
90246	\N	\N	29660	37542	\N	DPN56-Tumor	DPN56-Tumor_NA
90247	\N	\N	29654	37543	\N	DPN50-Tumor	DPN50-Tumor_NA
90248	\N	\N	29659	37544	\N	DPN55-Tumor	DPN55-Tumor_NA
90249	\N	\N	29666	37545	\N	DPN62-Tumor	DPN62-Tumor_NA
90250	\N	\N	29662	37546	\N	DPN58-Tumor	DPN58-Tumor_NA
90251	\N	\N	27706	37547	\N	AM-15-Tumor	AM-15-Tumor
90252	\N	\N	27722	37548	\N	AM-23-Tumor	AM-23-Tumor
90253	\N	\N	27728	37549	\N	AM-26-Tumor	AM-26-Tumor
90254	\N	\N	27714	37550	\N	AM-19-Tumor	AM-19-Tumor
90255	\N	\N	27726	37551	\N	AM-25-Tumor	AM-25-Tumor
90256	\N	\N	27716	37552	\N	AM-20-Tumor	AM-20-Tumor
90257	\N	\N	27710	37553	\N	AM-17-Tumor	AM-17-Tumor
90258	\N	\N	27712	37554	\N	AM-18-Tumor	AM-18-Tumor
90259	\N	\N	27724	37555	\N	AM-24-Tumor	AM-24-Tumor
90260	\N	\N	27718	37556	\N	AM-21-Tumor	AM-21-Tumor
90261	\N	\N	27708	37557	\N	AM-16-Tumor	AM-16-Tumor
90262	\N	\N	27720	37558	\N	AM-22-Tumor	AM-22-Tumor
90263	\N	\N	29876	37559	\N	KAM131-T	KAM131-T
90264	\N	\N	29871	37560	\N	KAM127-N	KAM127-N
90265	\N	\N	29873	37561	\N	KAM128-T	KAM128-T
90266	\N	\N	29874	37562	\N	KAM130-T	KAM130-T
90267	\N	\N	29875	37563	\N	KAM131-N	KAM131-N
90268	\N	\N	29872	37564	\N	KAM127-T	KAM127-T
90269	\N	\N	27730	37565	\N	AM-27-Tumor	AM-27-Tumor
90270	\N	\N	27740	37566	\N	AM-32-Tumor	AM-32-Tumor
90271	\N	\N	27736	37567	\N	AM-30-Tumor	AM-30-Tumor
90272	\N	\N	27732	37568	\N	AM-28-Tumor	AM-28-Tumor
90273	\N	\N	27738	37569	\N	AM-31-Tumor	AM-31-Tumor
90274	\N	\N	27734	37570	\N	AM-29-Tumor	AM-29-Tumor
90275	\N	\N	29626	37571	\N	DPN-49-Graz	DPN 49
90276	\N	\N	31883	37572	\N	Rob-T001-Mel	Rob-T001-Mel_NA
90277	\N	\N	31890	37573	\N	Rob-T008-Normal	Rob-T008-Normal_NA
90278	\N	\N	31892	37574	\N	Rob-T009-Normal	Rob-T009-Normal_NA
90279	\N	\N	31893	37575	\N	Rob-T010-Nev	Rob-T010-Nev_NA
90280	\N	\N	31887	37576	\N	Rob-T005-Nev	Rob-T005-Nev_NA
90281	\N	\N	31889	37577	\N	Rob-T008-Nev	Rob-T008-Nev_NA
90282	\N	\N	31894	37578	\N	Rob-T010-Normal	Rob-T010-Normal_NA
90283	\N	\N	31888	37579	\N	Rob-T005-Normal	Rob-T005-Normal_NA
90284	\N	\N	31885	37580	\N	Rob-T003-Mel	Rob-T003-Mel_NA
90285	\N	\N	31891	37581	\N	Rob-T009-Nev	Rob-T009-Nev_NA
90286	\N	\N	31884	37582	\N	Rob-T001-Normal	Rob-T001-Normal_NA
90287	\N	\N	31886	37583	\N	Rob-T003-Normal	Rob-T003-Normal_NA
90288	\N	\N	29588	37584	\N	2243_MIS	DNA-421
90289	\N	\N	29586	37585	\N	2242_Normal	DNA-419
90290	\N	\N	29577	37586	\N	2230_Mel	DNA-399
90291	\N	\N	29567	37587	\N	2220_MIS	DNA-385
90292	\N	\N	29551	37588	\N	2204_Mel	DNA-359
90293	\N	\N	29568	37589	\N	2221_Nevus	DNA-387
90294	\N	\N	29562	37590	\N	2215_Mel	DNA-377
90295	\N	\N	29531	37591	\N	2184_Mel	DNA-334
90296	\N	\N	29533	37592	\N	2186_Normal	DNA-336
90297	\N	\N	29530	37593	\N	2183_Normal	DNA-333
90298	\N	\N	29578	37594	\N	2231_MIS	DNA-401
90299	\N	\N	29527	37595	\N	2180_Mel1	DNA-330
90300	\N	\N	29561	37596	\N	2214_Normal	DNA-374
90301	\N	\N	29581	37597	\N	2234_Mel	DNA-404
90302	\N	\N	29565	37598	\N	2218_Normal	DNA-382
90303	\N	\N	29559	37599	\N	2212_MIS	DNA-372
90304	\N	\N	29580	37600	\N	2233_Normal	DNA-403
90305	\N	\N	29572	37601	\N	2225_Nevus	DNA-392
90306	\N	\N	29584	37602	\N	2237_MIS	DNA-417
90307	\N	\N	29537	37603	\N	2190_Mel	DNA-340
90308	\N	\N	29582	37604	\N	2235_Nevus	DNA-405
90309	\N	\N	29526	37605	\N	2244_Nevus	DNA-320
90310	\N	\N	29554	37606	\N	2207_MIS	DNA-364
90311	\N	\N	29528	37607	\N	2181_Mel2	DNA-331
90312	\N	\N	29555	37608	\N	2208_Nevus	DNA-365
90313	\N	\N	29541	37609	\N	2239_Nevus	DNA-346
90314	\N	\N	29560	37610	\N	2213_Nevus	DNA-373
90315	\N	\N	29535	37611	\N	2188_Nevus	DNA-338
90316	\N	\N	29571	37612	\N	2224_Mel2	DNA-391
90317	\N	\N	29557	37613	\N	2210_Normal	DNA-367
90318	\N	\N	29538	37614	\N	2191_Nevus	DNA-341
90319	\N	\N	29532	37615	\N	2185_Nevus	DNA-335
90320	\N	\N	29570	37616	\N	2223_Mel1	DNA-390
90321	\N	\N	29552	37617	\N	2205_Nevus	DNA-361
90322	\N	\N	29566	37618	\N	2219_Mel	DNA-383
90324	\N	\N	29556	37620	\N	2209_PRAME-positive_Nevus	DNA-366
90326	\N	\N	29540	37622	\N	2238_Mel	DNA-344
90327	\N	\N	29539	37623	\N	2192_Normal	DNA-342
90328	\N	\N	29549	37624	\N	2202_Nevus	DNA-357
90329	\N	\N	29558	37625	\N	2211_Mel	DNA-369
90330	\N	\N	29563	37626	\N	2216_Nevus	DNA-379
90331	\N	\N	29564	37627	\N	2217_Regressed-Area	DNA-381
90332	\N	\N	29536	37628	\N	2189_Normal	DNA-339
90333	\N	\N	29575	37629	\N	2228_Nevus	DNA-396
90334	\N	\N	29546	37630	\N	2199_Normal	DNA-353
90335	\N	\N	29545	37631	\N	2198_Nevus	DNA-351
90336	\N	\N	29550	37632	\N	2203_Normal	DNA-358
90337	\N	\N	29547	37633	\N	2200_Mel	DNA-355
90338	\N	\N	29529	37634	\N	2182_Nevus	DNA-332
90339	\N	\N	29585	37635	\N	2241_Normal	DNA-418
90340	\N	\N	29574	37636	\N	2227_Mel	DNA-394
90341	\N	\N	29589	37637	\N	2245_Normal	DNA-422
90342	\N	\N	29542	37638	\N	2240_Normal	DNA-347
90343	\N	\N	29544	37639	\N	2197_MIS	DNA-350
90344	\N	\N	29579	37640	\N	2232_Nevus	DNA-402
90345	\N	\N	29534	37641	\N	2187_Mel	DNA-337
90346	\N	\N	29548	37642	\N	2201_MIS	DNA-356
90347	\N	\N	29583	37643	\N	2236_Normal	DNA-407
90348	\N	\N	29543	37644	\N	2196_Mel	DNA-348
90349	\N	\N	31316	37645	\N	2046_Normal	NM D-091
90350	\N	\N	29591	37646	\N	2287_Mel	DNA-424
90351	\N	\N	29592	37647	\N	2288_Melanocytoma	DNA-425
90352	\N	\N	31315	37648	\N	2045_Mel	NM D-090
90353	\N	\N	29599	37649	\N	2295_MIS	DNA-432
90354	\N	\N	29598	37650	\N	2294_Mel	DNA-431
90355	\N	\N	29597	37651	\N	2293_Normal	DNA-430
90356	\N	\N	29596	37652	\N	2292_Mel	DNA-429
90357	\N	\N	29595	37653	\N	2291_Nevus	DNA-428
90358	\N	\N	29594	37654	\N	2290_Mel	DNA-427
90359	\N	\N	29593	37655	\N	2289_Normal	DNA-426
90360	\N	\N	31314	37656	\N	2044_Mel	NM D-089
90361	\N	\N	31313	37657	\N	2043_Mel	NM D-088
90362	\N	\N	31326	37658	\N	2270_Normal	NM D-101
90363	\N	\N	31325	37659	\N	2268_Met1-2269_Met2	NM D-100
90364	\N	\N	29615	37660	\N	2461_Normal	DNA-448
90365	\N	\N	29614	37661	\N	2460_Nevus	DNA-447
90366	\N	\N	29613	37662	\N	2459_MIS	DNA-446
90367	\N	\N	29612	37663	\N	2449_Normal	DNA-445
90368	\N	\N	29611	37664	\N	2448_Nevus	DNA-444
90369	\N	\N	29610	37665	\N	2447_Mel	DNA-443
90370	\N	\N	29609	37666	\N	2446_Normal	DNA-442
90371	\N	\N	29608	37667	\N	2445_Nevus	DNA-441
90372	\N	\N	29607	37668	\N	2444_MIS	DNA-440
90373	\N	\N	29606	37669	\N	2443_Mel	DNA-439
90374	\N	\N	29605	37670	\N	2301_Normal	DNA-438
90375	\N	\N	29604	37671	\N	2300_Nevus	DNA-437
90376	\N	\N	29603	37672	\N	2299_Mel	DNA-436
90377	\N	\N	29602	37673	\N	2298_Normal	DNA-435
90378	\N	\N	29601	37674	\N	2297_Mel	DNA-434
90379	\N	\N	29600	37675	\N	2296_Nevus	DNA-433
90380	\N	\N	29960	37676	\N	2450_Normal	LMM D-016
90381	\N	\N	29961	37677	\N	2451_MIS	LMM D-017
90382	\N	\N	29962	37678	\N	2452_Invasive	LMM D-018
90383	\N	\N	29959	37679	\N	2505_Normal	LMM D-015
90384	\N	\N	29958	37680	\N	2504_MIS	LMM D-014
90385	\N	\N	29957	37681	\N	2503_Invasive	LMM D-013
90386	\N	\N	29951	37682	\N	2497_Invasive	LMM D-007
90387	\N	\N	29950	37683	\N	2496_Normal	LMM D-006
90388	\N	\N	29949	37684	\N	2495_MIS	LMM D-005
90389	\N	\N	29948	37685	\N	2494_Invasive	LMM D-004
90390	\N	\N	31317	37686	\N	2047_Mel	NM D-092
90391	\N	\N	31324	37687	\N	2054_Normal	NM D-099
90392	\N	\N	31323	37688	\N	2053_Mel	NM D-098
90393	\N	\N	31322	37689	\N	2052_Mel	NM D-097
90394	\N	\N	31321	37690	\N	2051_Mel	NM D-096
90395	\N	\N	31320	37691	\N	2050_Normal	NM D-095
90396	\N	\N	31319	37692	\N	2049_Mel	NM D-094
90397	\N	\N	31318	37693	\N	2048_Mel	NM D-093
90398	\N	\N	29956	37694	\N	2502_Normal	LMM D-012
90399	\N	\N	29955	37695	\N	2501_MIS	LMM D-011
90400	\N	\N	29954	37696	\N	2500_Invasive	LMM D-010
90401	\N	\N	29953	37697	\N	2499_Normal_flag	LMM D-009
90402	\N	\N	29952	37698	\N	2498_MIS	LMM D-008
90403	\N	\N	27690	37699	\N	2466_Cell-Line	230 WT
90404	\N	\N	30314	37700	\N	2468_Melanoma-Cell-Line	M230 Imat A3
90405	\N	\N	30313	37701	\N	2467_Melanoma-Cell-Line	M230 Imat A2
90406	\N	\N	27689	37702	\N	2465_Cell-Line	144aI WT
90407	\N	\N	29352	37703	\N	2463_Melanoma-Cell-Line	DNA-144 Imat B15
90408	\N	\N	27669	37704	\N	2457_Tumor	22-104389C-DNA
90409	\N	\N	27665	37705	\N	2456_Tumor	22-104389A2-DNA
90412	\N	\N	29465	37708	\N	2036_Normal	DNA-259
90413	\N	\N	29407	37709	\N	1641_Mel	DNA-199
90418	\N	\N	29448	37714	\N	1953_Normal	DNA-240
90419	\N	\N	29340	37715	\N	893_Nevus	DNA-133
90420	\N	\N	29372	37716	\N	1921_Mel	DNA-164
90422	\N	\N	31312	37718	\N	2041_Normal	NM D-087
90424	\N	\N	29399	37720	\N	1948_Nevus	DNA-191
90425	\N	\N	29398	37721	\N	1947_Melanocytoma	DNA-190
90428	\N	\N	29403	37724	\N	1952_Nevus	DNA-195
90430	\N	\N	29397	37726	\N	1946_Normal	DNA-189
90431	\N	\N	29395	37727	\N	1944_Mel	DNA-187
90433	\N	\N	29383	37729	\N	1932_MIS	DNA-175
90437	\N	\N	31310	37733	\N	2039_Mel	NM D-085
90438	\N	\N	29396	37734	\N	1945_Nevus	DNA-188
90440	\N	\N	31311	37736	\N	2040_Mel	NM D-086
90441	\N	\N	31309	37737	\N	2038_Mel	NM D-084
90443	\N	\N	31599	37739	\N	VMRLP-41	RNA-41
90444	\N	\N	31601	37740	\N	VMRLP-43	RNA-43
90445	\N	\N	31600	37741	\N	VMRLP-42	RNA-42
90446	\N	\N	31602	37742	\N	VMRLP-44	RNA-44
90447	\N	\N	31603	37743	\N	VMRLP-45	RNA-45
90448	\N	\N	31604	37744	\N	VMRLP-46	RNA-46
90449	\N	\N	31605	37745	\N	VMRLP-47	RNA-47
90450	\N	\N	31607	37746	\N	VMRLP-49	RNA-49
90451	\N	\N	31606	37747	\N	VMRLP-48	RNA-48
90452	\N	\N	31608	37748	\N	VMRLP-50	RNA-50
90453	\N	\N	31609	37749	\N	VMRLP-51	RNA-51
90454	\N	\N	31610	37750	\N	VMRLP-52	RNA-52
90455	\N	\N	31613	37751	\N	VMRLP-55	RNA-55
90456	\N	\N	31611	37752	\N	VMRLP-53	RNA-53
90457	\N	\N	31612	37753	\N	VMRLP-54	RNA-54
90458	\N	\N	31617	37754	\N	VMRLP-59	RNA-59
90459	\N	\N	31618	37755	\N	VMRLP-60	RNA-60
90460	\N	\N	31614	37756	\N	VMRLP-56	RNA-56
90461	\N	\N	31619	37757	\N	VMRLP-61	RNA-61
90462	\N	\N	31621	37758	\N	VMRLP-63	RNA-63
90463	\N	\N	31620	37759	\N	VMRLP-62	RNA-62
90464	\N	\N	31624	37760	\N	RLP-66	RNA-66
90465	\N	\N	31623	37761	\N	RLP-65	RNA-65
90466	\N	\N	28903	37762	\N	CGP-600	D-NA-545
90467	\N	\N	28904	37763	\N	CGP-601	D-NA-546
90468	\N	\N	28905	37764	\N	CGP-602	D-NA-547
90469	\N	\N	28906	37765	\N	CGP-603	D-NA-548
90470	\N	\N	28907	37766	\N	CGP-604	D-NA-549
90471	\N	\N	28908	37767	\N	CGP-605	D-NA-550
90472	\N	\N	28910	37768	\N	CGP-607	D-NA-552
90473	\N	\N	28909	37769	\N	CGP-606	D-NA-551
90474	\N	\N	28911	37770	\N	CGP-608	D-NA-553
90475	\N	\N	28913	37771	\N	CGP-610	D-NA-555
90476	\N	\N	28912	37772	\N	CGP-609	D-NA-554
90477	\N	\N	28914	37773	\N	CGP-611	D-NA-556
90478	\N	\N	28915	37774	\N	CGP-612	D-NA-557
90479	\N	\N	28916	37775	\N	CGP-613	D-NA-558
90480	\N	\N	28917	37776	\N	CGP-614	D-NA-559
90481	\N	\N	28918	37777	\N	CGP-615	D-NA-560
90482	\N	\N	28919	37778	\N	CGP-616	D-NA-561
90483	\N	\N	28920	37779	\N	CGP-617	D-NA-562
90484	\N	\N	28921	37780	\N	CGP-618	D-NA-563
90485	\N	\N	28922	37781	\N	CGP-619	D-NA-564
90486	\N	\N	28923	37782	\N	CGP-620	D-NA-565
90487	\N	\N	28930	37783	\N	CGP-675	D-NA-620
90488	\N	\N	28931	37784	\N	CGP-676	D-NA-621
90489	\N	\N	28932	37785	\N	CGP-677	D-NA-622
90490	\N	\N	28933	37786	\N	CGP-678	D-NA-623
90491	\N	\N	28924	37787	\N	CGP-664	D-NA-585
90492	\N	\N	28925	37788	\N	CGP-665	D-NA-586
90493	\N	\N	28926	37789	\N	CGP-666	D-NA-587
90494	\N	\N	28927	37790	\N	CGP-667	D-NA-588
90495	\N	\N	28928	37791	\N	CGP-668	D-NA-589
90496	\N	\N	28929	37792	\N	CGP-669	D-NA-590
90497	\N	\N	28938	37793	\N	CGP-683	D-NA-628
90498	\N	\N	28939	37794	\N	CGP-684	D-NA-629
90499	\N	\N	28940	37795	\N	CGP-685	D-NA-630
90500	\N	\N	28941	37796	\N	CGP-686	D-NA-631
90501	\N	\N	28942	37797	\N	CGP-672	D-NA-645
90502	\N	\N	28943	37798	\N	CGP-673	D-NA-646
90503	\N	\N	28944	37799	\N	CGP-674	D-NA-647
90504	\N	\N	28934	37800	\N	CGP-679	D-NA-624
90505	\N	\N	28936	37801	\N	CGP-681	D-NA-626
90506	\N	\N	28935	37802	\N	CGP-680	D-NA-625
90507	\N	\N	28937	37803	\N	CGP-682	D-NA-627
90508	\N	\N	28895	37804	\N	CGP-583	D-NA-537
90509	\N	\N	28896	37805	\N	CGP-584	D-NA-538
90510	\N	\N	28896	37806	\N	CGP-999	D-NA-538
90511	\N	\N	28895	37807	\N	CGP-998	D-NA-537
90512	\N	\N	28897	37808	\N	CGP-585	D-NA-539
90513	\N	\N	28898	37809	\N	CGP-586	D-NA-540
90514	\N	\N	28899	37810	\N	CGP-587	D-NA-541
90515	\N	\N	28750	37811	\N	CGP-1481	CGP-1481_NA
90516	\N	\N	28751	37812	\N	CGP-1482	CGP-1482_NA
90517	\N	\N	28752	37813	\N	CGP-1483	CGP-1483_NA
90518	\N	\N	28759	37814	\N	CGP-1550	CGP-1550_NA
90519	\N	\N	28760	37815	\N	CGP-1551	CGP-1551_NA
90520	\N	\N	28761	37816	\N	CGP-1552	CGP-1552_NA
90521	\N	\N	28753	37817	\N	CGP-1544	CGP-1544_NA
90522	\N	\N	28754	37818	\N	CGP-1545	CGP-1545_NA
90523	\N	\N	28755	37819	\N	CGP-1546	CGP-1546_NA
90524	\N	\N	28756	37820	\N	CGP-1547	CGP-1547_NA
90525	\N	\N	28758	37821	\N	CGP-1549	CGP-1549_NA
90526	\N	\N	28757	37822	\N	CGP-1548	CGP-1548_NA
90527	\N	\N	28762	37823	\N	CGP-1553	CGP-1553_NA
90528	\N	\N	28763	37824	\N	CGP-1554	CGP-1554_NA
90529	\N	\N	28764	37825	\N	CGP-1555	CGP-1555_NA
90530	\N	\N	28765	37826	\N	CGP-1556	CGP-1556_NA
90531	\N	\N	28766	37827	\N	CGP-1557	CGP-1557_NA
90532	\N	\N	28767	37828	\N	CGP-1558	CGP-1558_NA
90533	\N	\N	28768	37829	\N	CGP-1559	CGP-1559_NA
90534	\N	\N	28770	37830	\N	CGP-1561	CGP-1561_NA
90535	\N	\N	28769	37831	\N	CGP-1560	CGP-1560_NA
90536	\N	\N	28771	37832	\N	CGP-1575	CGP-1575_NA
90537	\N	\N	28772	37833	\N	CGP-1576	CGP-1576_NA
90538	\N	\N	28773	37834	\N	CGP-1577	CGP-1577_NA
90539	\N	\N	29240	37835	\N	DLP-011	DNA-11
90540	\N	\N	29263	37836	\N	DLP-045	DNA-45
90541	\N	\N	29248	37837	\N	DLP-021	DNA-21
90542	\N	\N	29249	37838	\N	DLP-022	DNA-22
90543	\N	\N	29268	37839	\N	DLP-050	DNA-50
90544	\N	\N	29278	37840	\N	DLP-061	DNA-61
90545	\N	\N	29241	37841	\N	DLP-012	DNA-12
90546	\N	\N	29264	37842	\N	DLP-046	DNA-46
90547	\N	\N	29267	37843	\N	DLP-049	DNA-49
90548	\N	\N	29261	37844	\N	DLP-043	DNA-43
90549	\N	\N	29262	37845	\N	DLP-044	DNA-44
90550	\N	\N	29279	37846	\N	DLP-062	DNA-62
90551	\N	\N	29244	37847	\N	DLP-017	DNA-17
90552	\N	\N	29245	37848	\N	DLP-018	DNA-18
90553	\N	\N	29274	37849	\N	DLP-055	DNA-55
90554	\N	\N	29275	37850	\N	DLP-056	DNA-56
90555	\N	\N	29254	37851	\N	DLP-027	DNA-27
90556	\N	\N	29258	37852	\N	DLP-031	DNA-31
90557	\N	\N	29253	37853	\N	DLP-026	DNA-26
90558	\N	\N	29280	37854	\N	DLP-065	DNA-65
90559	\N	\N	29282	37855	\N	DLP-069	DNA-69
90560	\N	\N	29256	37856	\N	DLP-029	DNA-29
90561	\N	\N	28945	37857	\N	CGP-9023	D-NA-8691
90562	\N	\N	28946	37858	\N	CGP-9008	D-NA-8692
90563	\N	\N	29270	37859	\N	DLP-053	DNA-53
90564	\N	\N	29252	37860	\N	DLP-025	DNA-25
90565	\N	\N	29269	37861	\N	DLP-052	DNA-52
90566	\N	\N	29229	37862	\N	DLP-001	DNA-01
90567	\N	\N	29276	37863	\N	DLP-59	DNA-59
90568	\N	\N	29257	37864	\N	DLP-030	DNA-30
90569	\N	\N	29284	37865	\N	DLP-071	DNA-71
90570	\N	\N	29260	37866	\N	DLP-041	DNA-41
90571	\N	\N	29283	37867	\N	DLP-070	DNA-70
90572	\N	\N	29272	37868	\N	DLP-054	DNA-54
90573	\N	\N	29286	37869	\N	DLP-073	DNA-73
90574	\N	\N	29265	37870	\N	DLP-047	DNA-47
90575	\N	\N	29255	37871	\N	DLP-028	DNA-28
90576	\N	\N	29231	37872	\N	DLP-02	DNA-02
90577	\N	\N	29232	37873	\N	DLP-03	DNA-03
90578	\N	\N	29235	37874	\N	DLP-06	DNA-06
90579	\N	\N	29246	37875	\N	DLP-19	DNA-19
90580	\N	\N	29237	37876	\N	DLP-08	DNA-08
90581	\N	\N	29238	37877	\N	DLP-09	DNA-09
90582	\N	\N	29285	37878	\N	DLP-72	DNA-72
90583	\N	\N	29292	37879	\N	DLP-79	DNA-79
90584	\N	\N	29288	37880	\N	DLP-75	DNA-75
90585	\N	\N	29298	37881	\N	DLP-86	DNA-86
90586	\N	\N	29297	37882	\N	DLP-85	DNA-85
90587	\N	\N	29301	37883	\N	DLP-89	DNA-89
90588	\N	\N	29302	37884	\N	DLP-90	DNA-90
90589	\N	\N	29303	37885	\N	DLP-91	DNA-91
90590	\N	\N	29304	37886	\N	DLP-92	DNA-92
90591	\N	\N	29305	37887	\N	DLP-93	DNA-93
90592	\N	\N	29306	37888	\N	DLP-94	DNA-94
90593	\N	\N	29308	37889	\N	DLP-96	DNA-96
90594	\N	\N	29307	37890	\N	DLP-95	DNA-95
90595	\N	\N	31635	37891	\N	VMRLP-101	RNA-101 (Mel_1)
90596	\N	\N	31636	37892	\N	VMRLP-102	RNA-102 (Mel_2)
90597	\N	\N	31637	37893	\N	VMRLP-103	RNA-103 (Mel_3)
90598	\N	\N	31638	37894	\N	VMRLP-104	RNA-104 (Mel_4)
90599	\N	\N	31639	37895	\N	VMRLP-105	RNA-105 (Mel_5)
90600	\N	\N	31640	37896	\N	VMRLP-106	RNA-106 (Mel_6)
90601	\N	\N	29234	37897	\N	DLP-05	DNA-05
90602	\N	\N	29236	37898	\N	DLP-07	DNA-07
90603	\N	\N	29242	37899	\N	DLP-15	DNA-15
90604	\N	\N	29243	37900	\N	DLP-16	DNA-16
90605	\N	\N	29251	37901	\N	DLP-24	DNA-24
90606	\N	\N	29289	37902	\N	DLP-76	DNA-76
90607	\N	\N	29294	37903	\N	DLP-81	DNA-81
90608	\N	\N	29293	37904	\N	DLP-80	DNA-80
90609	\N	\N	29296	37905	\N	DLP-83	DNA-83
90610	\N	\N	29300	37906	\N	DLP-88	DNA-88
90611	\N	\N	29250	37907	\N	DLP-23	DNA-23
90612	\N	\N	29281	37908	\N	DLP-68	DNA-68
90613	\N	\N	29239	37909	\N	DLP-10	DNA-10
90614	\N	\N	29299	37910	\N	DLP-87	DNA-87
90615	\N	\N	29247	37911	\N	DLP-20	DNA-20
90616	\N	\N	29266	37912	\N	DLP-48	DNA-48
90617	\N	\N	29233	37913	\N	DLP-04	DNA-04
90618	\N	\N	29277	37914	\N	DLP-059_RE2	DNA-59_REPEAT
90619	\N	\N	29277	37915	\N	DLP-059_RE3	DNA-59_REPEAT
90621	\N	\N	31626	37917	\N	RLP-68	RNA-73
90622	\N	\N	31627	37918	\N	RLP-69	RNA-74
90623	\N	\N	31628	37919	\N	RLP-70	RNA-75
90624	\N	\N	31631	37920	\N	RLP-73	RNA-98
90625	\N	\N	31632	37921	\N	RLP-74	RNA-99
90626	\N	\N	31629	37922	\N	RLP-71	RNA-76
90627	\N	\N	31630	37923	\N	RLP-72	RNA-97
90628	\N	\N	31633	37924	\N	RLP-75	RNA-100
90629	\N	\N	31634	37925	\N	RLP-76	RNA-101
90630	\N	\N	31680	37926	\N	RLP-88	RNA-146
90632	\N	\N	31582	37928	\N	RLP-24	RNA-24
90633	\N	\N	31647	37929	\N	RLP-78	RNA-113
90634	\N	\N	31648	37930	\N	RLP-79	RNA-114
90635	\N	\N	31650	37931	\N	RLP-80	RNA-116
90638	\N	\N	31575	37934	\N	RLP-17	RNA-17
90639	\N	\N	31583	37935	\N	RLP-25	RNA-25
90640	\N	\N	31641	37936	\N	RLP-77	RNA-107
90641	\N	\N	31658	37937	\N	RLP-81	RNA-124
90642	\N	\N	31659	37938	\N	RLP-82	RNA-125
90643	\N	\N	31665	37939	\N	RLP-85	RNA-131
90644	\N	\N	31667	37940	\N	RLP-87	RNA-133
90645	\N	\N	31666	37941	\N	RLP-86	RNA-132
90647	\N	\N	31685	37943	\N	RLP-93	RNA-151
90648	\N	\N	29310	37944	\N	DLP-98	DNA-98
90649	\N	\N	29311	37945	\N	DLP-99	DNA-99
90650	\N	\N	29325	37946	\N	DLP-105	DNA-118
90651	\N	\N	29329	37947	\N	DLP-108	DNA-122
90652	\N	\N	29342	37948	\N	DLP-115	DNA-135
90653	\N	\N	29343	37949	\N	DLP-116	DNA-136
90657	\N	\N	29351	37953	\N	DLP-120	DNA-144
90661	\N	\N	29315	37957	\N	DLP-101	DNA-108
90662	\N	\N	29316	37958	\N	DLP-102	DNA-109
90663	\N	\N	29321	37959	\N	DLP-104	DNA-114
90664	\N	\N	29320	37960	\N	DLP-103	DNA-113
90665	\N	\N	29327	37961	\N	DLP-106	DNA-120
90666	\N	\N	29328	37962	\N	DLP-107	DNA-121
90667	\N	\N	29331	37963	\N	DLP-110	DNA-124
90668	\N	\N	29330	37964	\N	DLP-109	DNA-123
90669	\N	\N	29332	37965	\N	DLP-111	DNA-125
90670	\N	\N	29313	37966	\N	DLP-114	DNA-101
90671	\N	\N	29354	37967	\N	DLP-121	DNA-146
90674	\N	\N	28366	37970	\N	AMLP-469	AM2 R-371
90675	\N	\N	28375	37971	\N	AMLP-474	AM2 R-382
90676	\N	\N	28372	37972	\N	AMLP-471	AM2 R-379
90677	\N	\N	28373	37973	\N	AMLP-472	AM2 R-380
90678	\N	\N	28370	37974	\N	AMLP-470	AM2 R-375
90679	\N	\N	28393	37975	\N	AMLP-478	AM2 R-412
90680	\N	\N	28374	37976	\N	AMLP-473	AM2 R-381
90681	\N	\N	28365	37977	\N	AMLP-468	AM2 R-370
90682	\N	\N	28340	37978	\N	AMLP-461	AM2 R-333
90683	\N	\N	28341	37979	\N	AMLP-462	AM2 R-334
90684	\N	\N	28352	37980	\N	AMLP-465	AM2 R-347
90685	\N	\N	28386	37981	\N	AMLP-477	AM2 R-402
90686	\N	\N	28347	37982	\N	AMLP-464	AM2 R-340
90687	\N	\N	28384	37983	\N	AMLP-475	AM2 R-400
90688	\N	\N	28385	37984	\N	AMLP-476	AM2 R-401
90689	\N	\N	28343	37985	\N	AMLP-463	AM2 R-336
90690	\N	\N	28465	37986	\N	AMLP-541	AM2 R-504
90691	\N	\N	28466	37987	\N	AMLP-542	AM2 R-505
90692	\N	\N	28492	37988	\N	AMLP-552	AM2 R-537
90693	\N	\N	28492	37989	\N	AMLP-575	AM2 R-537
90694	\N	\N	28492	37990	\N	AMLP-576	AM2 R-537
90695	\N	\N	28466	37991	\N	AMLP-580	AM2 R-505
90696	\N	\N	28250	37992	\N	AMLP-435	AM2 R-228
90697	\N	\N	28249	37993	\N	AMLP-434	AM2 R-227
90698	\N	\N	28248	37994	\N	AMLP-437	AM2 R-226
90699	\N	\N	28251	37995	\N	AMLP-438	AM2 R-229
90700	\N	\N	28402	37996	\N	AMLP-486	AM2 R-426
90701	\N	\N	28400	37997	\N	AMLP-537	AM2 R-423
90702	\N	\N	28253	37998	\N	AMLP-440	AM2 R-233
90703	\N	\N	28252	37999	\N	AMLP-439	AM2 R-232
90704	\N	\N	28478	38000	\N	AMLP-521	AM2 R-518
90705	\N	\N	28252	38001	\N	AMLP-553	AM2 R-232
90706	\N	\N	28252	38002	\N	AMLP-554	AM2 R-232
90707	\N	\N	28260	38003	\N	AMLP-444	AM2 R-242
90708	\N	\N	28259	38004	\N	AMLP-443	AM2 R-241
90709	\N	\N	28419	38005	\N	AMLP-482	AM2 R-453
90710	\N	\N	28450	38006	\N	AMLP-491	AM2 R-487
90711	\N	\N	28454	38007	\N	AMLP-493	AM2 R-491
90712	\N	\N	28453	38008	\N	AMLP-492	AM2 R-490
90713	\N	\N	28463	38009	\N	AMLP-540	AM2 R-501
90714	\N	\N	28491	38010	\N	AMLP-574	AM2 R-536
90715	\N	\N	28476	38011	\N	AMLP-567	AM2 R-516
90716	\N	\N	28476	38012	\N	AMLP-566	AM2 R-516
90717	\N	\N	28491	38013	\N	AMLP-573	AM2 R-536
90718	\N	\N	28463	38014	\N	AMLP-577	AM2 R-501
90719	\N	\N	28477	38015	\N	AMLP-578	AM2 R-517
90720	\N	\N	28477	38016	\N	AMLP-579	AM2 R-517
90721	\N	\N	28278	38017	\N	AMLP-445	AM2 R-260
90722	\N	\N	28422	38018	\N	AMLP-484	AM2 R-456
90723	\N	\N	28421	38019	\N	AMLP-483	AM2 R-455
90724	\N	\N	28360	38020	\N	AMLP-466	AM2 R-356
90725	\N	\N	28434	38021	\N	AMLP-487	AM2 R-468
90726	\N	\N	28435	38022	\N	AMLP-488	AM2 R-470
90727	\N	\N	28435	38023	\N	AMLP-560	AM2 R-470
90728	\N	\N	28278	38024	\N	AMLP-556	AM2 R-260
90729	\N	\N	28328	38025	\N	AMLP-457	AM2 R-320
90730	\N	\N	28339	38026	\N	AMLP-460	AM2 R-331
90731	\N	\N	28336	38027	\N	AMLP-458	AM2 R-328
90732	\N	\N	28336	38028	\N	AMLP-558	AM2 R-328
90733	\N	\N	28459	38029	\N	AMLP-563	AM2 R-496
90734	\N	\N	28336	38030	\N	AMLP-559	AM2 R-328
90735	\N	\N	28459	38031	\N	AMLP-562	AM2 R-496
90736	\N	\N	28427	38032	\N	AMLP-584	AM2 R-461
90737	\N	\N	28398	38033	\N	AMLP-480	AM2 R-420
90738	\N	\N	28397	38034	\N	AMLP-479	AM2 R-419
90739	\N	\N	28399	38035	\N	AMLP-481	AM2 R-422
90740	\N	\N	28475	38036	\N	AMLP-544	AM2 R-514
90741	\N	\N	28474	38037	\N	AMLP-583	AM2 R-513
90742	\N	\N	28317	38038	\N	AMLP-450	AM2 R-308
90743	\N	\N	28322	38039	\N	AMLP-455	AM2 R-313
90744	\N	\N	28320	38040	\N	AMLP-453	AM2 R-311
90745	\N	\N	28321	38041	\N	AMLP-454	AM2 R-312
90746	\N	\N	28318	38042	\N	AMLP-451	AM2 R-309
90747	\N	\N	28326	38043	\N	AMLP-456	AM2 R-318
90748	\N	\N	28489	38044	\N	AMLP-549	AM2 R-531
90749	\N	\N	31504	38045	\N	EXLP-31	PROG R-16
90750	\N	\N	31505	38046	\N	EXLP-32	PROG R-17
90751	\N	\N	31508	38047	\N	EXLP-34	PROG R-20
90752	\N	\N	31506	38048	\N	EXLP-33	PROG R-18
90753	\N	\N	31510	38049	\N	EXLP-35	PROG R-22
90754	\N	\N	31511	38050	\N	EXLP-36	PROG R-23
90755	\N	\N	31513	38051	\N	EXLP-38	PROG R-25
90756	\N	\N	31514	38052	\N	EXLP-39	PROG R-26
90757	\N	\N	31514	38053	\N	EXLP-52	PROG R-26
90758	\N	\N	31513	38054	\N	EXLP-51	PROG R-25
90759	\N	\N	31511	38055	\N	EXLP-49	PROG R-23
90760	\N	\N	31510	38056	\N	EXLP-48	PROG R-22
90761	\N	\N	31508	38057	\N	EXLP-47	PROG R-20
90762	\N	\N	31505	38058	\N	EXLP-45	PROG R-17
90763	\N	\N	31504	38059	\N	EXLP-44	PROG R-16
90764	\N	\N	31514	38060	\N	EXLP-54	PROG R-26
90765	\N	\N	31510	38061	\N	EXLP-53	PROG R-22
90766	\N	\N	31770	38062	\N	RLP-126	RNA-266
90767	\N	\N	31771	38063	\N	RLP-124	RNA-268
90768	\N	\N	31729	38064	\N	RLP-125	RNA-195
90770	\N	\N	31871	38066	\N	RLP-242	RNA-437
90771	\N	\N	31870	38067	\N	RLP-241	RNA-436
90772	\N	\N	31867	38068	\N	RLP-239	RNA-433
90773	\N	\N	31881	38069	\N	RLP-249	RNA-447
90774	\N	\N	31880	38070	\N	RLP-248	RNA-446
90775	\N	\N	27664	38071	\N	IYEH-09	22-44183B-RNA
90776	\N	\N	31815	38072	\N	RLP-137	RNA-340
90777	\N	\N	31846	38073	\N	RLP-166	RNA-401
90778	\N	\N	31832	38074	\N	RLP-151	RNA-372
90779	\N	\N	31833	38075	\N	RLP-152	RNA-373
90780	\N	\N	31833	38076	\N	RLP-214	RNA-373
90781	\N	\N	31832	38077	\N	RLP-213	RNA-372
90782	\N	\N	31831	38078	\N	RLP-212	RNA-369
90783	\N	\N	31815	38079	\N	RLP-199	RNA-340
90784	\N	\N	31862	38080	\N	RLP-235	RNA-428
90785	\N	\N	31861	38081	\N	RLP-234	RNA-427
90786	\N	\N	31859	38082	\N	RLP-233	RNA-425
90787	\N	\N	31858	38083	\N	RLP-232	RNA-424
90788	\N	\N	31847	38084	\N	RLP-229	RNA-402
90789	\N	\N	31846	38085	\N	RLP-228	RNA-401
90794	\N	\N	31806	38090	\N	RLP-129	RNA-320
90795	\N	\N	31826	38091	\N	RLP-145	RNA-359
90796	\N	\N	31837	38092	\N	RLP-157	RNA-383
90797	\N	\N	31840	38093	\N	RLP-160	RNA-390
90798	\N	\N	31835	38094	\N	RLP-155	RNA-379
90799	\N	\N	31839	38095	\N	RLP-159	RNA-387
90800	\N	\N	31734	38096	\N	RLP-170	RNA-203
90801	\N	\N	31835	38097	\N	RLP-217	RNA-379
90802	\N	\N	31763	38098	\N	RLP-173	RNA-245
90803	\N	\N	31826	38099	\N	RLP-207	RNA-359
90804	\N	\N	31840	38100	\N	RLP-222	RNA-390
90805	\N	\N	31839	38101	\N	RLP-221	RNA-387
90806	\N	\N	31837	38102	\N	RLP-219	RNA-383
90807	\N	\N	31878	38103	\N	RLP-247	RNA-444
90808	\N	\N	31875	38104	\N	RLP-245	RNA-441
90809	\N	\N	31878	38105	\N	RLP-255	RNA-444
90810	\N	\N	31875	38106	\N	RLP-253	RNA-441
90816	\N	\N	31725	38112	\N	RLP-122	RNA-191
90818	\N	\N	31810	38114	\N	RLP-133	RNA-334
90819	\N	\N	31850	38115	\N	RLP-169	RNA-405
90820	\N	\N	31849	38116	\N	RLP-168	RNA-404
90821	\N	\N	31851	38117	\N	RLP-154	RNA-417
90822	\N	\N	31841	38118	\N	RLP-161	RNA-391
90823	\N	\N	31834	38119	\N	RLP-153	RNA-377
90824	\N	\N	31851	38120	\N	RLP-216	RNA-417
90825	\N	\N	31834	38121	\N	RLP-215	RNA-377
90826	\N	\N	31725	38122	\N	RLP-185	RNA-191
90827	\N	\N	31756	38123	\N	RLP-184	RNA-234
90828	\N	\N	31743	38124	\N	RLP-177	RNA-214
90829	\N	\N	31742	38125	\N	RLP-176	RNA-213
90830	\N	\N	31741	38126	\N	RLP-175	RNA-212
90831	\N	\N	31738	38127	\N	RLP-174	RNA-208
90832	\N	\N	31735	38128	\N	RLP-171	RNA-204
90833	\N	\N	31810	38129	\N	RLP-195	RNA-334
90834	\N	\N	31866	38130	\N	RLP-238	RNA-432
90835	\N	\N	31865	38131	\N	RLP-237	RNA-431
90836	\N	\N	31850	38132	\N	RLP-231	RNA-405
90837	\N	\N	31849	38133	\N	RLP-230	RNA-404
90838	\N	\N	31841	38134	\N	RLP-223	RNA-391
90839	\N	\N	31865	38135	\N	RLP-256	RNA-431
90840	\N	\N	31866	38136	\N	RLP-250	RNA-432
90844	\N	\N	31827	38140	\N	RLP-146	RNA-361
90845	\N	\N	31811	38141	\N	RLP-134	RNA-335
90846	\N	\N	31844	38142	\N	RLP-164	RNA-396
90847	\N	\N	31838	38143	\N	RLP-158	RNA-385
90848	\N	\N	31842	38144	\N	RLP-162	RNA-392
90849	\N	\N	31836	38145	\N	RLP-156	RNA-381
90850	\N	\N	31836	38146	\N	RLP-218	RNA-381
90851	\N	\N	31745	38147	\N	RLP-179	RNA-218
90852	\N	\N	31736	38148	\N	RLP-172	RNA-205
90853	\N	\N	31827	38149	\N	RLP-208	RNA-361
90854	\N	\N	31811	38150	\N	RLP-196	RNA-335
90855	\N	\N	31732	38151	\N	RLP-186	RNA-199
90856	\N	\N	31844	38152	\N	RLP-226	RNA-396
90857	\N	\N	31842	38153	\N	RLP-224	RNA-392
90858	\N	\N	31838	38154	\N	RLP-220	RNA-385
90859	\N	\N	31868	38155	\N	RLP-240	RNA-434
90860	\N	\N	31868	38156	\N	RLP-257	RNA-434
90861	\N	\N	31807	38157	\N	RLP-130	RNA-330
90862	\N	\N	31824	38158	\N	RLP-143	RNA-356
90863	\N	\N	31808	38159	\N	RLP-131	RNA-331
90864	\N	\N	31829	38160	\N	RLP-148	RNA-365
90865	\N	\N	31822	38161	\N	RLP-141	RNA-351
90866	\N	\N	31809	38162	\N	RLP-132	RNA-332
90867	\N	\N	31828	38163	\N	RLP-147	RNA-364
90868	\N	\N	31812	38164	\N	RLP-135	RNA-337
90869	\N	\N	31863	38165	\N	RLP-236	RNA-429
90870	\N	\N	31874	38166	\N	RLP-244	RNA-440
90871	\N	\N	31873	38167	\N	RLP-243	RNA-439
90872	\N	\N	31874	38168	\N	RLP-252	RNA-440
90873	\N	\N	31873	38169	\N	RLP-251	RNA-439
90876	\N	\N	31855	38172	\N	RLP-128	RNA-421
90877	\N	\N	31820	38173	\N	RLP-139	RNA-348
90878	\N	\N	31821	38174	\N	RLP-140	RNA-350
90879	\N	\N	31816	38175	\N	RLP-138	RNA-341
90880	\N	\N	31825	38176	\N	RLP-144	RNA-357
90881	\N	\N	31823	38177	\N	RLP-142	RNA-355
90882	\N	\N	31813	38178	\N	RLP-136	RNA-338
90883	\N	\N	31843	38179	\N	RLP-163	RNA-394
90884	\N	\N	31845	38180	\N	RLP-165	RNA-399
90885	\N	\N	31830	38181	\N	RLP-211	RNA-366
90886	\N	\N	31746	38182	\N	RLP-180	RNA-219
90887	\N	\N	31816	38183	\N	RLP-200	RNA-341
90888	\N	\N	31855	38184	\N	RLP-190	RNA-421
90889	\N	\N	31843	38185	\N	RLP-225	RNA-394
90890	\N	\N	31877	38186	\N	RLP-246	RNA-443
90891	\N	\N	31877	38187	\N	RLP-254	RNA-443
90892	\N	\N	29785	38188	\N	KALP-001	KA D-01
90893	\N	\N	29810	38189	\N	KALP-012	KA D-26
90894	\N	\N	29801	38190	\N	KALP-009	KA D-17
90895	\N	\N	29786	38191	\N	KALP-002	KA D-02
90896	\N	\N	29798	38192	\N	KALP-008	KA D-14
90897	\N	\N	29802	38193	\N	KALP-010	KA D-18
90898	\N	\N	29797	38194	\N	KALP-007	KA D-13
90899	\N	\N	29808	38195	\N	KALP-011	KA D-24
90900	\N	\N	29785	38196	\N	KALP-019	KA D-01
90901	\N	\N	29810	38197	\N	KALP-022	KA D-26
90902	\N	\N	29801	38198	\N	KALP-021	KA D-17
90903	\N	\N	29816	38199	\N	KALP-015	KA D-32
90904	\N	\N	29815	38200	\N	KALP-014	KA D-31
90905	\N	\N	29794	38201	\N	KALP-006	KA D-10
90906	\N	\N	29789	38202	\N	KALP-003	KA D-05
90907	\N	\N	29790	38203	\N	KALP-004	KA D-06
90908	\N	\N	29793	38204	\N	KALP-005	KA D-09
90909	\N	\N	29789	38205	\N	KALP-020	KA D-05
90910	\N	\N	29819	38206	\N	KALP-028	KA D-35
90911	\N	\N	29815	38207	\N	KALP-023	KA D-31
90912	\N	\N	29815	38208	\N	KALP-025	KA D-31
90913	\N	\N	29819	38209	\N	KALP-027	KA D-35
90914	\N	\N	29815	38210	\N	KALP-024	KA D-31
90915	\N	\N	29820	38211	\N	KALP-029	KA D-36
90916	\N	\N	29481	38212	\N	DLP-127	DNA-275
90918	\N	\N	29484	38214	\N	DLP-130	DNA-278
90920	\N	\N	29498	38216	\N	DLP-132	DNA-292
90921	\N	\N	29520	38217	\N	DLP-133	DNA-314
90922	\N	\N	29521	38218	\N	DLP-134	DNA-315
90924	\N	\N	29504	38220	\N	DLP-136	DNA-298
90925	\N	\N	29510	38221	\N	DLP-138	DNA-304
90926	\N	\N	29485	38222	\N	DLP-131	DNA-279
90927	\N	\N	29509	38223	\N	DLP-137	DNA-303
90928	\N	\N	29511	38224	\N	DLP-139	DNA-305
90929	\N	\N	29512	38225	\N	DLP-140	DNA-306
90930	\N	\N	31818	38226	\N	RLP-265	RNA-346
90931	\N	\N	31817	38227	\N	RLP-264	RNA-344
90932	\N	\N	31804	38228	\N	RLP-263	RNA-315
90933	\N	\N	31803	38229	\N	RLP-262	RNA-314
90934	\N	\N	31802	38230	\N	RLP-261	RNA-313
90935	\N	\N	31778	38231	\N	RLP-260	RNA-279
90936	\N	\N	31777	38232	\N	RLP-259	RNA-278
90937	\N	\N	31775	38233	\N	RLP-258	RNA-275
90938	\N	\N	28221	38234	\N	AMLP-531	AM2 D-521
90940	\N	\N	28228	38236	\N	AMLP-533	AM2 D-528
90941	\N	\N	28214	38237	\N	AMLP-528	AM2 D-513
90942	\N	\N	28226	38238	\N	AMLP-535	AM2 D-526
90943	\N	\N	28215	38239	\N	AMLP-529	AM2 D-514
90944	\N	\N	28222	38240	\N	AMLP-532	AM2 D-522
90945	\N	\N	28219	38241	\N	AMLP-530	AM2 D-519
90946	\N	\N	28225	38242	\N	AMLP-534	AM2 D-525
90947	\N	\N	31964	38243	\N	IRLP-002	SMPR4
90948	\N	\N	31963	38244	\N	IRLP-001	SMPR2
90949	\N	\N	31969	38245	\N	IRLP-007	SMPR55
90950	\N	\N	31968	38246	\N	IRLP-006	SMPR48
90951	\N	\N	31970	38247	\N	IRLP-008	SMPR56
90952	\N	\N	31972	38248	\N	IRLP-010	SMPR58B
90953	\N	\N	31965	38249	\N	IRLP-003	SMPR11
90954	\N	\N	31971	38250	\N	IRLP-009	SMPR58A
90955	\N	\N	31967	38251	\N	IRLP-005	SMPR20
90956	\N	\N	31966	38252	\N	IRLP-004	SMPR12
90957	\N	\N	32059	38253	\N	SGLP-0028	TPP 1_6
90958	\N	\N	32074	38254	\N	SGLP-0043	TPP 1_21
90959	\N	\N	32058	38255	\N	SGLP-0027	TPP 1_5
90960	\N	\N	32064	38256	\N	SGLP-0033	TPP 1_11
90961	\N	\N	32054	38257	\N	SGLP-0023	TPP 1_1
90962	\N	\N	32070	38258	\N	SGLP-0039	TPP 1_17
90963	\N	\N	32079	38259	\N	SGLP-0048	TPP 1_26
90964	\N	\N	32055	38260	\N	SGLP-0024	TPP 1_2
90965	\N	\N	32068	38261	\N	SGLP-0037	TPP 1_15
90966	\N	\N	32056	38262	\N	SGLP-0025	TPP 1_3
90967	\N	\N	32057	38263	\N	SGLP-0026	TPP 1_4
90968	\N	\N	32072	38264	\N	SGLP-0041	TPP 1_19
90969	\N	\N	32080	38265	\N	SGLP-0049	TPP 1_27
90970	\N	\N	32069	38266	\N	SGLP-0038	TPP 1_16
90971	\N	\N	32077	38267	\N	SGLP-0046	TPP 1_24
90972	\N	\N	32067	38268	\N	SGLP-0036	TPP 1_14
90973	\N	\N	32065	38269	\N	SGLP-0034	TPP 1_12
90974	\N	\N	32075	38270	\N	SGLP-0044	TPP 1_22
90975	\N	\N	32066	38271	\N	SGLP-0035	TPP 1_13
90976	\N	\N	32062	38272	\N	SGLP-0031	TPP 1_9
90977	\N	\N	32073	38273	\N	SGLP-0042	TPP 1_20
90978	\N	\N	32061	38274	\N	SGLP-0030	TPP 1_8
90979	\N	\N	32078	38275	\N	SGLP-0047	TPP 1_25
90980	\N	\N	32076	38276	\N	SGLP-0045	TPP 1_23
90981	\N	\N	28594	38277	\N	SGLP-0001	CGH11-045_NA
90982	\N	\N	28599	38278	\N	SGLP-0002	CGH11-092
90983	\N	\N	28615	38279	\N	SGLP-0003	CGH11-268
90984	\N	\N	28617	38280	\N	SGLP-0004	CGH11-282
90985	\N	\N	28618	38281	\N	SGLP-0005	CGH11-294
90986	\N	\N	28621	38282	\N	SGLP-0006	CGH11-386_DNA
90987	\N	\N	28622	38283	\N	SGLP-0007	CGH11-399
90988	\N	\N	28623	38284	\N	SGLP-0008	CGH11-402
90989	\N	\N	28639	38285	\N	SGLP-0009	CGH12-055
90990	\N	\N	28647	38286	\N	SGLP-0010	CGH12-191
90991	\N	\N	28648	38287	\N	SGLP-0011	CGH12-273
90992	\N	\N	28650	38288	\N	SGLP-0012	CGH12-301
90993	\N	\N	28662	38289	\N	SGLP-0013	CGH13-159
90994	\N	\N	28663	38290	\N	SGLP-0014	CGH13-321
90995	\N	\N	28664	38291	\N	SGLP-0015	CGH13-340
90996	\N	\N	28665	38292	\N	SGLP-0016	CGH14-032
90997	\N	\N	28669	38293	\N	SGLP-0017	CGH14-119
90998	\N	\N	28670	38294	\N	SGLP-0018	CGH14-144
90999	\N	\N	28673	38295	\N	SGLP-0019	CGH14-181
91000	\N	\N	28674	38296	\N	SGLP-0020	CGH14-286
91001	\N	\N	28675	38297	\N	SGLP-0021	CGH14-293
91002	\N	\N	28676	38298	\N	SGLP-0022	CGH14-328
91003	\N	\N	28679	38299	\N	SGLP-0050	CGH15-043
91004	\N	\N	28680	38300	\N	SGLP-0051	CGH15-064
91005	\N	\N	28681	38301	\N	SGLP-0052	CGH15-081
91006	\N	\N	28682	38302	\N	SGLP-0053	CGH15-082
91007	\N	\N	28683	38303	\N	SGLP-0054	CGH15-090
91008	\N	\N	28685	38304	\N	SGLP-0055	CGH15-115
91009	\N	\N	28686	38305	\N	SGLP-0056	CGH15-139
91010	\N	\N	28687	38306	\N	SGLP-0057	CGH15-151
91011	\N	\N	28688	38307	\N	SGLP-0058	CGH15-163
91012	\N	\N	28689	38308	\N	SGLP-0059	CGH15-176
91013	\N	\N	28690	38309	\N	SGLP-0060	CGH15-206
91014	\N	\N	28691	38310	\N	SGLP-0061	CGH15-210
91015	\N	\N	28692	38311	\N	SGLP-0062	CGH15-211
91016	\N	\N	28693	38312	\N	SGLP-0063	CGH15-246
91017	\N	\N	28695	38313	\N	SGLP-0064	CGH15-253
91018	\N	\N	28696	38314	\N	SGLP-0065	CGH15-263
91019	\N	\N	28697	38315	\N	SGLP-0066	CGH16-002
91020	\N	\N	28698	38316	\N	SGLP-0067	CGH16-023
91021	\N	\N	28699	38317	\N	SGLP-0068	CGH16-025
91022	\N	\N	28700	38318	\N	SGLP-0069	CGH16-032
91023	\N	\N	28701	38319	\N	SGLP-0070	CGH16-035
91024	\N	\N	28702	38320	\N	SGLP-0071	CGH16-038
91025	\N	\N	28703	38321	\N	SGLP-0072	CGH16-053
91026	\N	\N	28704	38322	\N	SGLP-0073	CGH16-054
91027	\N	\N	28705	38323	\N	SGLP-0074	CGH16-062
91028	\N	\N	28706	38324	\N	SGLP-0075	CGH16-071
91029	\N	\N	28707	38325	\N	SGLP-0076	CGH16-087
91030	\N	\N	28708	38326	\N	SGLP-0077	CGH16-089
91031	\N	\N	28709	38327	\N	SGLP-0078	CGH16-093
91032	\N	\N	28710	38328	\N	SGLP-0079	CGH16-097
91033	\N	\N	28711	38329	\N	SGLP-0080	CGH16-105
91034	\N	\N	28712	38330	\N	SGLP-0081	CGH16-117
91035	\N	\N	28713	38331	\N	SGLP-0082	CGH16-123
91036	\N	\N	28714	38332	\N	SGLP-0083	CGH16-130
91037	\N	\N	28715	38333	\N	SGLP-0084	CGH16-136
91038	\N	\N	28716	38334	\N	SGLP-0085	CGH16-172-2
91039	\N	\N	28717	38335	\N	SGLP-0086	CGH16-179
91040	\N	\N	28718	38336	\N	SGLP-0087	CGH16-198
91041	\N	\N	28720	38337	\N	SGLP-0088	CGH16-209
91042	\N	\N	28721	38338	\N	SGLP-0089	CGH16-215
91043	\N	\N	28722	38339	\N	SGLP-0090	CGH16-222
91044	\N	\N	28723	38340	\N	SGLP-0091	CGH16-250
91045	\N	\N	28724	38341	\N	SGLP-0092	CGH16-254
91046	\N	\N	28725	38342	\N	SGLP-0093	CGH17-001
91047	\N	\N	28726	38343	\N	SGLP-0094	CGH17-003
91048	\N	\N	28727	38344	\N	SGLP-0095	CGH17-008
91049	\N	\N	28728	38345	\N	SGLP-0096	CGH17-015
91050	\N	\N	32071	38346	\N	SGLP-0040	TPP 1_18
91051	\N	\N	32063	38347	\N	SGLP-0032	TPP 1_10
91052	\N	\N	32060	38348	\N	SGLP-0029	TPP 1_7
91053	\N	\N	32149	38349	\N	SGLP-0165	TPP 2_69
91054	\N	\N	32122	38350	\N	SGLP-0138	TPP 2_42
91055	\N	\N	32140	38351	\N	SGLP-0156	TPP 2_60
91056	\N	\N	32115	38352	\N	SGLP-0131	TPP 2_35
91057	\N	\N	32119	38353	\N	SGLP-0135	TPP 2_39
91058	\N	\N	32117	38354	\N	SGLP-0133	TPP 2_37
91059	\N	\N	32113	38355	\N	SGLP-0129	TPP 2_33
91060	\N	\N	32130	38356	\N	SGLP-0146	TPP 2_50
91061	\N	\N	32138	38357	\N	SGLP-0154	TPP 2_58
91062	\N	\N	32096	38358	\N	SGLP-0112	TPP 2_16
91063	\N	\N	32128	38359	\N	SGLP-0144	TPP 2_48
91064	\N	\N	32091	38360	\N	SGLP-0107	TPP 2_11
91065	\N	\N	32155	38361	\N	SGLP-0171	TPP 2_75
91066	\N	\N	32111	38362	\N	SGLP-0127	TPP 2_31
91067	\N	\N	32090	38363	\N	SGLP-0106	TPP 2_10
91068	\N	\N	32131	38364	\N	SGLP-0147	TPP 2_51
91069	\N	\N	32123	38365	\N	SGLP-0139	TPP 2_43
91070	\N	\N	32166	38366	\N	SGLP-0182	TPP 2_86
91071	\N	\N	32160	38367	\N	SGLP-0176	TPP 2_80
91072	\N	\N	32086	38368	\N	SGLP-0102	TPP 2_6
91073	\N	\N	32164	38369	\N	SGLP-0180	TPP 2_84
91074	\N	\N	32129	38370	\N	SGLP-0145	TPP 2_49
91075	\N	\N	32097	38371	\N	SGLP-0113	TPP 2_17
91076	\N	\N	32135	38372	\N	SGLP-0151	TPP 2_55
91077	\N	\N	32085	38373	\N	SGLP-0101	TPP 2_5
91078	\N	\N	32161	38374	\N	SGLP-0177	TPP 2_81
91079	\N	\N	32141	38375	\N	SGLP-0157	TPP 2_61
91080	\N	\N	32108	38376	\N	SGLP-0124	TPP 2_28
91081	\N	\N	32092	38377	\N	SGLP-0108	TPP 2_12
91082	\N	\N	32156	38378	\N	SGLP-0172	TPP 2_76
91083	\N	\N	32088	38379	\N	SGLP-0104	TPP 2_8
91084	\N	\N	32110	38380	\N	SGLP-0126	TPP 2_30
91085	\N	\N	32136	38381	\N	SGLP-0152	TPP 2_56
91086	\N	\N	32147	38382	\N	SGLP-0163	TPP 2_67
91087	\N	\N	32083	38383	\N	SGLP-0099	TPP 2_3
91088	\N	\N	32137	38384	\N	SGLP-0153	TPP 2_57
91089	\N	\N	32157	38385	\N	SGLP-0173	TPP 2_77
91090	\N	\N	32094	38386	\N	SGLP-0110	TPP 2_14
91091	\N	\N	32093	38387	\N	SGLP-0109	TPP 2_13
91092	\N	\N	32095	38388	\N	SGLP-0111	TPP 2_15
91093	\N	\N	32125	38389	\N	SGLP-0141	TPP 2_45
91094	\N	\N	32081	38390	\N	SGLP-0097	TPP 2_1
91095	\N	\N	32152	38391	\N	SGLP-0168	TPP 2_72
91096	\N	\N	32132	38392	\N	SGLP-0148	TPP 2_52
91097	\N	\N	32116	38393	\N	SGLP-0132	TPP 2_36
91098	\N	\N	32098	38394	\N	SGLP-0114	TPP 2_18
91099	\N	\N	32106	38395	\N	SGLP-0122	TPP 2_26
91100	\N	\N	32105	38396	\N	SGLP-0121	TPP 2_25
91101	\N	\N	32099	38397	\N	SGLP-0115	TPP 2_19
91102	\N	\N	32148	38398	\N	SGLP-0164	TPP 2_68
91103	\N	\N	32107	38399	\N	SGLP-0123	TPP 2_27
91104	\N	\N	32145	38400	\N	SGLP-0161	TPP 2_65
91105	\N	\N	32162	38401	\N	SGLP-0178	TPP 2_82
91106	\N	\N	32082	38402	\N	SGLP-0098	TPP 2_2
91107	\N	\N	32154	38403	\N	SGLP-0170	TPP 2_74
91108	\N	\N	32120	38404	\N	SGLP-0136	TPP 2_40
91109	\N	\N	32124	38405	\N	SGLP-0140	TPP 2_44
91110	\N	\N	32103	38406	\N	SGLP-0119	TPP 2_23
91111	\N	\N	32143	38407	\N	SGLP-0159	TPP 2_63
91112	\N	\N	32134	38408	\N	SGLP-0150	TPP 2_54
91113	\N	\N	32159	38409	\N	SGLP-0175	TPP 2_79
91114	\N	\N	32163	38410	\N	SGLP-0179	TPP 2_83
91115	\N	\N	32153	38411	\N	SGLP-0169	TPP 2_73
91116	\N	\N	32144	38412	\N	SGLP-0160	TPP 2_64
91117	\N	\N	32101	38413	\N	SGLP-0117	TPP 2_21
91118	\N	\N	32126	38414	\N	SGLP-0142	TPP 2_46
91119	\N	\N	32167	38415	\N	SGLP-0183	TPP 2_87
91120	\N	\N	32112	38416	\N	SGLP-0128	TPP 2_32
91121	\N	\N	32158	38417	\N	SGLP-0174	TPP 2_78
91122	\N	\N	32168	38418	\N	SGLP-0184	TPP 2_88
91123	\N	\N	32087	38419	\N	SGLP-0103	TPP 2_7
91124	\N	\N	32165	38420	\N	SGLP-0181	TPP 2_85
91125	\N	\N	32114	38421	\N	SGLP-0130	TPP 2_34
91126	\N	\N	32151	38422	\N	SGLP-0167	TPP 2_71
91127	\N	\N	32146	38423	\N	SGLP-0162	TPP 2_66
91128	\N	\N	32142	38424	\N	SGLP-0158	TPP 2_62
91129	\N	\N	32127	38425	\N	SGLP-0143	TPP 2_47
91130	\N	\N	32150	38426	\N	SGLP-0166	TPP 2_70
91131	\N	\N	32139	38427	\N	SGLP-0155	TPP 2_59
91132	\N	\N	32104	38428	\N	SGLP-0120	TPP 2_24
91133	\N	\N	32133	38429	\N	SGLP-0149	TPP 2_53
91134	\N	\N	32121	38430	\N	SGLP-0137	TPP 2_41
91135	\N	\N	32084	38431	\N	SGLP-0100	TPP 2_4
91136	\N	\N	32089	38432	\N	SGLP-0105	TPP 2_9
91137	\N	\N	32118	38433	\N	SGLP-0134	TPP 2_38
91138	\N	\N	32109	38434	\N	SGLP-0125	TPP 2_29
91139	\N	\N	30366	38435	\N	SGLP-0239	MDD-23
91140	\N	\N	30378	38436	\N	SGLP-0251	MDD-35
91141	\N	\N	30352	38437	\N	SGLP-0225	MDD-09
91142	\N	\N	30346	38438	\N	SGLP-0219	MDD-03
91143	\N	\N	30354	38439	\N	SGLP-0227	MDD-11
91144	\N	\N	30377	38440	\N	SGLP-0250	MDD-34
91145	\N	\N	30360	38441	\N	SGLP-0233	MDD-17
91146	\N	\N	30365	38442	\N	SGLP-0238	MDD-22
91147	\N	\N	30374	38443	\N	SGLP-0247	MDD-31
91148	\N	\N	30363	38444	\N	SGLP-0236	MDD-20
91149	\N	\N	30358	38445	\N	SGLP-0231	MDD-15
91150	\N	\N	30345	38446	\N	SGLP-0218	MDD-02
91151	\N	\N	30349	38447	\N	SGLP-0222	MDD-06
91152	\N	\N	30356	38448	\N	SGLP-0229	MDD-13
91153	\N	\N	30361	38449	\N	SGLP-0234	MDD-18
91154	\N	\N	30344	38450	\N	SGLP-0217	MDD-01
91155	\N	\N	30364	38451	\N	SGLP-0237	MDD-21
91156	\N	\N	30353	38452	\N	SGLP-0226	MDD-10
91157	\N	\N	30355	38453	\N	SGLP-0228	MDD-12
91158	\N	\N	29672	38454	\N	FKP-01	Fusion-01
91159	\N	\N	29673	38455	\N	FKP-02	Fusion-02
91160	\N	\N	29674	38456	\N	FKP-05	Fusion-05
91161	\N	\N	29676	38457	\N	FKP-08	Fusion-08
91162	\N	\N	29677	38458	\N	FKP-09	Fusion-09
91163	\N	\N	29678	38459	\N	FKP-10	Fusion-10
91164	\N	\N	29679	38460	\N	FKP-11	Fusion-11
91165	\N	\N	29675	38461	\N	FKP-06	Fusion-06
91166	\N	\N	28729	38462	\N	SGLP-0185	CGH17-017
91167	\N	\N	28730	38463	\N	SGLP-0186	CGH17-021
91168	\N	\N	28731	38464	\N	SGLP-0187	CGH17-024
91169	\N	\N	28732	38465	\N	SGLP-0188	CGH17-026
91170	\N	\N	28733	38466	\N	SGLP-0189	CGH17-031
91171	\N	\N	28734	38467	\N	SGLP-0190	CGH17-033
91172	\N	\N	28735	38468	\N	SGLP-0191	CGH17-039
91173	\N	\N	28736	38469	\N	SGLP-0192	CGH17-052
91174	\N	\N	28737	38470	\N	SGLP-0193	CGH17-058
91175	\N	\N	28738	38471	\N	SGLP-0194	CGH17-076
91176	\N	\N	28739	38472	\N	SGLP-0195	CGH17-083
91177	\N	\N	28740	38473	\N	SGLP-0196	CGH17-095
91178	\N	\N	28741	38474	\N	SGLP-0197	CGH17-097
91179	\N	\N	28742	38475	\N	SGLP-0198	CGH17-104
91180	\N	\N	29908	38476	\N	SGLP-0199	KIT-01
91181	\N	\N	29919	38477	\N	SGLP-0210	KIT-12
91182	\N	\N	29920	38478	\N	SGLP-0211	KIT-13
91183	\N	\N	29921	38479	\N	SGLP-0212	KIT-14
91184	\N	\N	29922	38480	\N	SGLP-0213	KIT-15
91185	\N	\N	29923	38481	\N	SGLP-0214	KIT-16
91186	\N	\N	29924	38482	\N	SGLP-0215	KIT-17
91187	\N	\N	29925	38483	\N	SGLP-0216	KIT-18
91188	\N	\N	29673	38484	\N	Nu-02	Fusion-02
91189	\N	\N	29672	38485	\N	Nu-01	Fusion-01
91190	\N	\N	29674	38486	\N	Nu-05	Fusion-05
91191	\N	\N	29675	38487	\N	Nu-06	Fusion-06
91192	\N	\N	29677	38488	\N	Nu-09	Fusion-09
91193	\N	\N	29676	38489	\N	Nu-08	Fusion-08
91194	\N	\N	29678	38490	\N	Nu-10	Fusion-10
91195	\N	\N	29679	38491	\N	Nu-11	Fusion-11
91196	\N	\N	32169	38492	\N	SGLP-0258	TPP_3-01
91197	\N	\N	32197	38493	\N	SGLP-0286	TPP_3-29
91198	\N	\N	32170	38494	\N	SGLP-0259	TPP_3-02
91199	\N	\N	32181	38495	\N	SGLP-0270	TPP_3-13
91200	\N	\N	32217	38496	\N	SGLP-0306	TPP_3-49
91201	\N	\N	32185	38497	\N	SGLP-0274	TPP_3-17
91202	\N	\N	32193	38498	\N	SGLP-0282	TPP_3-25
91203	\N	\N	32207	38499	\N	SGLP-0296	TPP_3-39
91204	\N	\N	32189	38500	\N	SGLP-0278	TPP_3-21
91205	\N	\N	32171	38501	\N	SGLP-0260	TPP_3-03
91206	\N	\N	32219	38502	\N	SGLP-0308	TPP_3-51
91207	\N	\N	32201	38503	\N	SGLP-0290	TPP_3-33
91208	\N	\N	32187	38504	\N	SGLP-0276	TPP_3-19
91209	\N	\N	32190	38505	\N	SGLP-0279	TPP_3-22
91210	\N	\N	32188	38506	\N	SGLP-0277	TPP_3-20
91211	\N	\N	32218	38507	\N	SGLP-0307	TPP_3-50
91212	\N	\N	32202	38508	\N	SGLP-0291	TPP_3-34
91213	\N	\N	32179	38509	\N	SGLP-0268	TPP_3-11
91214	\N	\N	32223	38510	\N	SGLP-0312	TPP_3-55
91215	\N	\N	32221	38511	\N	SGLP-0310	TPP_3-53
91216	\N	\N	32175	38512	\N	SGLP-0264	TPP_3-07
91217	\N	\N	32208	38513	\N	SGLP-0297	TPP_3-40
91218	\N	\N	32204	38514	\N	SGLP-0293	TPP_3-36
91219	\N	\N	32184	38515	\N	SGLP-0273	TPP_3-16
91220	\N	\N	32192	38516	\N	SGLP-0281	TPP_3-24
91221	\N	\N	32210	38517	\N	SGLP-0299	TPP_3-42
91222	\N	\N	32176	38518	\N	SGLP-0265	TPP_3-08
91223	\N	\N	32195	38519	\N	SGLP-0284	TPP_3-27
91224	\N	\N	32182	38520	\N	SGLP-0271	TPP_3-14
91225	\N	\N	32211	38521	\N	SGLP-0300	TPP_3-43
91226	\N	\N	32198	38522	\N	SGLP-0287	TPP_3-30
91227	\N	\N	32180	38523	\N	SGLP-0269	TPP_3-12
91228	\N	\N	32194	38524	\N	SGLP-0283	TPP_3-26
91229	\N	\N	32212	38525	\N	SGLP-0301	TPP_3-44
91230	\N	\N	30056	38526	\N	SGLP-0313	LN D-01 (LN-01)
91231	\N	\N	30065	38527	\N	SGLP-0322	LN D-10 (LN-10)
91232	\N	\N	30066	38528	\N	SGLP-0323	LN D-11 (LN-11)
91338	\N	\N	31174	38634	\N	MRLP-044	MR-044
91233	\N	\N	30067	38529	\N	SGLP-0324	LN D-12 (LN-12)
91234	\N	\N	30071	38530	\N	SGLP-0328	LN D-16 (LN-16)
91235	\N	\N	30068	38531	\N	SGLP-0325	LN D-13 (LN-13)
91236	\N	\N	30076	38532	\N	SGLP-0333	LN D-21 (LN-21)
91237	\N	\N	30072	38533	\N	SGLP-0329	LN D-17 (LN-17)
91238	\N	\N	30070	38534	\N	SGLP-0327	LN D-15 (LN-15)
91239	\N	\N	30074	38535	\N	SGLP-0331	LN D-19 (LN-19)
91240	\N	\N	32183	38536	\N	SGLP-0272	TPP_3-15
91241	\N	\N	32199	38537	\N	SGLP-0288	TPP_3-31
91242	\N	\N	30060	38538	\N	SGLP-0317	LN D-05 (LN-05)
91243	\N	\N	30075	38539	\N	SGLP-0332	LN D-20 (LN-20)
91244	\N	\N	32222	38540	\N	SGLP-0311	TPP_3-54
91245	\N	\N	30064	38541	\N	SGLP-0321	LN D-09 (LN-09)
91246	\N	\N	32215	38542	\N	SGLP-0304	TPP_3-47
91247	\N	\N	32174	38543	\N	SGLP-0263	TPP_3-06
91248	\N	\N	32191	38544	\N	SGLP-0280	TPP_3-23
91249	\N	\N	30069	38545	\N	SGLP-0326	LN D-14 (LN-14)
91250	\N	\N	30061	38546	\N	SGLP-0318	LN D-06 (LN-06)
91251	\N	\N	32213	38547	\N	SGLP-0302	TPP_3-45
91252	\N	\N	30059	38548	\N	SGLP-0316	LN D-04 (LN-04)
91253	\N	\N	32214	38549	\N	SGLP-0303	TPP_3-46
91254	\N	\N	32178	38550	\N	SGLP-0267	TPP_3-10
91255	\N	\N	30058	38551	\N	SGLP-0315	LN D-03 (LN-03)
91256	\N	\N	32203	38552	\N	SGLP-0292	TPP_3-35
91257	\N	\N	30057	38553	\N	SGLP-0314	LN D-02 (LN-02)
91258	\N	\N	32209	38554	\N	SGLP-0298	TPP_3-41
91259	\N	\N	30062	38555	\N	SGLP-0319	LN D-07 (LN-07)
91260	\N	\N	32220	38556	\N	SGLP-0309	TPP_3-52
91261	\N	\N	32196	38557	\N	SGLP-0285	TPP_3-28
91262	\N	\N	32206	38558	\N	SGLP-0295	TPP_3-38
91263	\N	\N	30073	38559	\N	SGLP-0330	LN D-18 (LN-18)
91264	\N	\N	30063	38560	\N	SGLP-0320	LN D-08 (LN-08)
91265	\N	\N	32216	38561	\N	SGLP-0305	TPP_3-48
91266	\N	\N	32186	38562	\N	SGLP-0275	TPP_3-18
91267	\N	\N	32205	38563	\N	SGLP-0294	TPP_3-37
91268	\N	\N	32173	38564	\N	SGLP-0262	TPP_3-05
91269	\N	\N	31241	38565	\N	NMLP-003	NM D-03
91270	\N	\N	31266	38566	\N	NMLP-028	NM D-037
91271	\N	\N	31245	38567	\N	NMLP-007	NM D-07
91272	\N	\N	31916	38568	\N	SGLP-0356	SM D-01
91273	\N	\N	31290	38569	\N	NMLP-052	NM D-065
91274	\N	\N	31277	38570	\N	NMLP-039	NM D-049
91275	\N	\N	31257	38571	\N	NMLP-019	NM D-19
91276	\N	\N	31264	38572	\N	NMLP-026	NM D-035
91277	\N	\N	31918	38573	\N	SGLP-0358	SM D-03
91278	\N	\N	31288	38574	\N	NMLP-050	NM D-063
91279	\N	\N	31251	38575	\N	NMLP-013	NM D-13
91280	\N	\N	31289	38576	\N	NMLP-051	NM D-064
91281	\N	\N	31260	38577	\N	NMLP-022	NM D-31
91282	\N	\N	31246	38578	\N	NMLP-008	NM D-08
91283	\N	\N	31270	38579	\N	NMLP-032	NM D-041
91284	\N	\N	31269	38580	\N	NMLP-031	NM D-040
91285	\N	\N	31267	38581	\N	NMLP-029	NM D-038
91286	\N	\N	31917	38582	\N	SGLP-0357	SM D-02
91287	\N	\N	31253	38583	\N	NMLP-015	NM D-15
91288	\N	\N	31919	38584	\N	SGLP-0359	SM D-04
91289	\N	\N	31263	38585	\N	NMLP-025	NM D-034
91290	\N	\N	31920	38586	\N	SGLP-0360	SM D-05
91291	\N	\N	31250	38587	\N	NMLP-012	NM D-12
91292	\N	\N	31268	38588	\N	NMLP-030	NM D-039
91293	\N	\N	31274	38589	\N	NMLP-036	NM D-046
91294	\N	\N	28745	38590	\N	SGLP-0353	CGH18-012-D
91295	\N	\N	28637	38591	\N	SGLP-0349	CGH12-039-D
91296	\N	\N	28684	38592	\N	SGLP-0354	CGH15-109-D
91297	\N	\N	31252	38593	\N	NMLP-014	NM D-14
91298	\N	\N	28640	38594	\N	SGLP-0348	CGH12-056-D
91299	\N	\N	31926	38595	\N	SGLP-0366	SM D-11
91300	\N	\N	31935	38596	\N	SGLP-0375	SM D-20
91301	\N	\N	28677	38597	\N	SGLP-0352	CGH14-341-D
91302	\N	\N	31928	38598	\N	SGLP-0368	SM D-13
91303	\N	\N	31929	38599	\N	SGLP-0369	SM D-14
91304	\N	\N	31934	38600	\N	SGLP-0374	SM D-19
91305	\N	\N	28600	38601	\N	SGLP-0347	CGH11-098-D
91306	\N	\N	31936	38602	\N	SGLP-0376	SM D-21
91307	\N	\N	31925	38603	\N	SGLP-0365	SM D-10
91308	\N	\N	28668	38604	\N	SGLP-0351	CGH14-083-D
91309	\N	\N	31924	38605	\N	SGLP-0364	SM D-09
91310	\N	\N	31932	38606	\N	SGLP-0372	SM D-17
91311	\N	\N	31937	38607	\N	SGLP-0377	SM D-22
91312	\N	\N	28643	38608	\N	SGLP-0350	CGH12-092-D
91313	\N	\N	31923	38609	\N	SGLP-0363	SM D-08
91314	\N	\N	31280	38610	\N	NMLP-042	NM D-052
91315	\N	\N	31939	38611	\N	SGLP-0379	SM D-24
91316	\N	\N	31930	38612	\N	SGLP-0370	SM D-15
91317	\N	\N	31931	38613	\N	SGLP-0371	SM D-16
91318	\N	\N	31271	38614	\N	NMLP-033	NM D-043
91319	\N	\N	31933	38615	\N	SGLP-0373	SM D-18
91320	\N	\N	31938	38616	\N	SGLP-0378	SM D-23
91321	\N	\N	31927	38617	\N	SGLP-0367	SM D-12
91322	\N	\N	31922	38618	\N	SGLP-0362	SM D-07
91323	\N	\N	28671	38619	\N	SGLP-0406	CGH14-145
91324	\N	\N	28743	38620	\N	SGLP-0409	CGH17-135
91325	\N	\N	28746	38621	\N	SGLP-0412	CGH18-137
91326	\N	\N	28744	38622	\N	SGLP-0411	CGH17-240
91327	\N	\N	28678	38623	\N	SGLP-0407	CGH14-348
91328	\N	\N	28649	38624	\N	SGLP-0405	CGH12-280
91329	\N	\N	28645	38625	\N	SGLP-0404	CGH12-109
91330	\N	\N	28747	38626	\N	SGLP-0410	CGH18-139
91331	\N	\N	28719	38627	\N	SGLP-0408	CGH16-200
91332	\N	\N	27901	38628	\N	AMLP-141	AM2 D-159
91333	\N	\N	31180	38629	\N	MRLP-050	MR-050
91334	\N	\N	31232	38630	\N	SGLP-0397	NLD-019
91335	\N	\N	31231	38631	\N	SGLP-0396	NLD-018
91336	\N	\N	28553	38632	\N	SGLP-0390	BND-011
91337	\N	\N	31227	38633	\N	SGLP-0392	NLD-014
91339	\N	\N	31175	38635	\N	MRLP-045	MR-045
91340	\N	\N	31176	38636	\N	MRLP-046	MR-046
91341	\N	\N	31173	38637	\N	MRLP-043	MR-043
91342	\N	\N	28554	38638	\N	SGLP-0391	BND-012
91343	\N	\N	28546	38639	\N	SGLP-0384	BND-004
91344	\N	\N	31235	38640	\N	SGLP-0400	NLD-022
91345	\N	\N	31230	38641	\N	SGLP-0395	NLD-017
91346	\N	\N	31238	38642	\N	SGLP-0403	NLD-025
91347	\N	\N	31172	38643	\N	MRLP-042	MR-042
91348	\N	\N	31179	38644	\N	MRLP-049	MR-049
91349	\N	\N	31234	38645	\N	SGLP-0399	NLD-021
91350	\N	\N	31171	38646	\N	MRLP-041	MR-041
91351	\N	\N	28551	38647	\N	SGLP-0389	BND-009
91352	\N	\N	31177	38648	\N	MRLP-047	MR-047
91353	\N	\N	28550	38649	\N	SGLP-0388	BND-008
91354	\N	\N	31229	38650	\N	SGLP-0394	NLD-016
91355	\N	\N	28544	38651	\N	SGLP-0382	BND-002
91356	\N	\N	31178	38652	\N	MRLP-048	MR-048
91357	\N	\N	28548	38653	\N	SGLP-0386	BND-006
91358	\N	\N	31237	38654	\N	SGLP-0402	NLD-024
91359	\N	\N	31236	38655	\N	SGLP-0401	NLD-023
91360	\N	\N	31228	38656	\N	SGLP-0393	NLD-015
91361	\N	\N	28543	38657	\N	SGLP-0381	BND-001
91362	\N	\N	31233	38658	\N	SGLP-0398	NLD-020
91363	\N	\N	28790	38659	\N	SGLP-0458	CM D-04
91364	\N	\N	28791	38660	\N	SGLP-0459	CM D-05
91365	\N	\N	28803	38661	\N	SGLP-0471	CM D-17
91366	\N	\N	28807	38662	\N	SGLP-0474	CM D-21
91367	\N	\N	28811	38663	\N	SGLP-0478	CM D-25
91368	\N	\N	28826	38664	\N	SGLP-0492	CM D-40
91369	\N	\N	28827	38665	\N	SGLP-0493	CM D-41
91370	\N	\N	28829	38666	\N	SGLP-0495	CM D-43
91371	\N	\N	31140	38667	\N	MRLP-001	MR-001
91372	\N	\N	31143	38668	\N	MRLP-004	MR-004
91373	\N	\N	31154	38669	\N	MRLP-021	MR-021
91374	\N	\N	31152	38670	\N	MRLP-017	MR-017
91375	\N	\N	31162	38671	\N	MRLP-032	MR-032
91376	\N	\N	31181	38672	\N	MRLP-051	MR-051
91377	\N	\N	31149	38673	\N	MRLP-011	MR-011
91378	\N	\N	28545	38674	\N	SGLP-0383	BND-003
91379	\N	\N	31155	38675	\N	MRLP-024	MR-024
91380	\N	\N	31148	38676	\N	MRLP-010	MR-010
91381	\N	\N	31150	38677	\N	MRLP-012	MR-012
91382	\N	\N	31142	38678	\N	MRLP-003	MR-003
91383	\N	\N	31164	38679	\N	MRLP-034	MR-034
91384	\N	\N	31144	38680	\N	MRLP-005	MR-005
91385	\N	\N	31146	38681	\N	MRLP-008	MR-008
91386	\N	\N	31166	38682	\N	MRLP-036	MR-036
91387	\N	\N	31156	38683	\N	MRLP-025	MR-025
91388	\N	\N	31151	38684	\N	MRLP-015	MR-015
91389	\N	\N	31165	38685	\N	MRLP-035	MR-035
91390	\N	\N	31145	38686	\N	MRLP-006	MR-006
91391	\N	\N	31169	38687	\N	MRLP-039	MR-039
91392	\N	\N	31141	38688	\N	MRLP-002	MR-002
91393	\N	\N	31159	38689	\N	MRLP-029	MR-029
91394	\N	\N	31153	38690	\N	MRLP-020	MR-020
91395	\N	\N	31147	38691	\N	MRLP-009	MR-009
91396	\N	\N	31168	38692	\N	MRLP-038	MR-038
91397	\N	\N	31163	38693	\N	MRLP-033	MR-033
91398	\N	\N	28813	38694	\N	SGLP-0480	CM D-27
91399	\N	\N	31139	38695	\N	MP41-YMR1	MP41-YM-R1-D
91400	\N	\N	31138	38696	\N	MP41	MP41-D
91401	\N	\N	30578	38697	\N	SGLP-0338	MM100513 (AMC-03)
91402	\N	\N	30319	38698	\N	SGLP-0343	M040418 (AMC-08)
91403	\N	\N	30576	38699	\N	SGLP-0336	MM100511 (AMC-03)
91404	\N	\N	30318	38700	\N	SGLP-0342	M040416 (AMC-08)
91405	\N	\N	30579	38701	\N	SGLP-0339	MM100916 (AMC-03)
91406	\N	\N	30320	38702	\N	SGLP-0344	M040419A (AMC-08)
91407	\N	\N	30580	38703	\N	SGLP-0345	MM160113 (AMC-12)
91408	\N	\N	30317	38704	\N	SGLP-0341	M040415 (AMC-08)
91409	\N	\N	30577	38705	\N	SGLP-0337	MM100512 (AMC-03)
91410	\N	\N	30322	38706	\N	SGLP-0346	M180322 (AMC-13)
91411	\N	\N	30315	38707	\N	SGLP-0340	M040204 (AMC-07)
91412	\N	\N	30323	38708	\N	SGLP-0334	MaMel  152aI (AMC-01)
91413	\N	\N	30321	38709	\N	SGLP-0335	M100118 (AMC-02)
91414	\N	\N	31905	38710	\N	SGLP-0450	SKMEL 1023A
91415	\N	\N	31906	38711	\N	SGLP-0451	SKMEL 1107B
91416	\N	\N	31908	38712	\N	SGLP-0453	SKMEL 1121B
91417	\N	\N	30565	38713	\N	SGLP-0454	Mel290
91418	\N	\N	31167	38714	\N	MRLP-037	MR-037
91419	\N	\N	31170	38715	\N	MRLP-040	MR-040
91420	\N	\N	31161	38716	\N	MRLP-031	MR-031
91421	\N	\N	31157	38717	\N	MRLP-026	MR-026
91422	\N	\N	31158	38718	\N	MRLP-027	MR-027
91423	\N	\N	31160	38719	\N	MRLP-030	MR-030
91424	\N	\N	30079	38720	\N	SGLP-0415	LN D-024 (LN-024)
91425	\N	\N	30091	38721	\N	SGLP-0427	LN D-036 (LN-036)
91426	\N	\N	30086	38722	\N	SGLP-0422	LN D-031 (LN-031)
91427	\N	\N	30077	38723	\N	SGLP-0413	LN D-022 (LN-022)
91428	\N	\N	30081	38724	\N	SGLP-0417	LN D-026 (LN-026)
91429	\N	\N	30080	38725	\N	SGLP-0416	LN D-025 (LN-025)
91430	\N	\N	30087	38726	\N	SGLP-0423	LN D-032 (LN-032)
91431	\N	\N	30084	38727	\N	SGLP-0420	LN D-029 (LN-029)
91432	\N	\N	30078	38728	\N	SGLP-0414	LN D-023 (LN-023)
91433	\N	\N	30082	38729	\N	SGLP-0418	LN D-027 (LN-027)
91434	\N	\N	30085	38730	\N	SGLP-0421	LN D-030 (LN-030)
91435	\N	\N	30090	38731	\N	SGLP-0426	LN D-035 (LN-035)
91436	\N	\N	30088	38732	\N	SGLP-0424	LN D-033 (LN-033)
91437	\N	\N	30089	38733	\N	SGLP-0425	LN D-034 (LN-034)
91438	\N	\N	30101	38734	\N	SGLP-0437	LN D-046 (LN-046)
91439	\N	\N	30097	38735	\N	SGLP-0433	LN D-042 LN-042)
91440	\N	\N	30094	38736	\N	SGLP-0430	LN D-039 (LN-039)
91441	\N	\N	30093	38737	\N	SGLP-0429	LN D-038 (LN-038)
91442	\N	\N	30100	38738	\N	SGLP-0436	LN D-045 (LN-045)
91443	\N	\N	30095	38739	\N	SGLP-0431	LN D-040 (LN-040)
91444	\N	\N	30098	38740	\N	SGLP-0434	LN D-043 (LN-043)
91445	\N	\N	30096	38741	\N	SGLP-0432	LN D-041 (LN-041)
91446	\N	\N	30102	38742	\N	SGLP-0438	LN D-047 (LN-047)
91447	\N	\N	30105	38743	\N	SGLP-0439	LN D-050 (LN-050)
91448	\N	\N	30113	38744	\N	SGLP-0441	LN D-058 (LN-058)
91449	\N	\N	30112	38745	\N	SGLP-0440	LN D-057 (LN-057)
91450	\N	\N	30114	38746	\N	SGLP-0442	LN D-059 (LN-059)
91451	\N	\N	30115	38747	\N	SGLP-0443	LN D-060 (LN-060)
91452	\N	\N	30117	38748	\N	SGLP-0444	LN D-062 (LN-062)
91453	\N	\N	30119	38749	\N	SGLP-0446	LN D-064 (LN-064)
91454	\N	\N	30118	38750	\N	SGLP-0445	LN D-063 (LN-063)
91455	\N	\N	30121	38751	\N	SGLP-0448	LN D-066 (LN-066)
91456	\N	\N	30120	38752	\N	SGLP-0447	LN D-065 (LN-065)
91457	\N	\N	30122	38753	\N	SGLP-0449	LN D-067 (LN-067)
91458	\N	\N	28872	38754	\N	SGLP-0455	CMD-01
91459	\N	\N	28873	38755	\N	SGLP-0456	CMD-02
91460	\N	\N	28789	38756	\N	SGLP-0457	CM D-03
91461	\N	\N	28792	38757	\N	SGLP-0460	CM D-06
91462	\N	\N	28793	38758	\N	SGLP-0461	CM D-07
91463	\N	\N	28794	38759	\N	SGLP-0462	CM D-08
91464	\N	\N	28796	38760	\N	SGLP-0464	CM D-10
91465	\N	\N	28795	38761	\N	SGLP-0463	CM D-09
91466	\N	\N	28797	38762	\N	SGLP-0465	CM D-11
91467	\N	\N	28799	38763	\N	SGLP-0467	CM D-13
91468	\N	\N	28798	38764	\N	SGLP-0466	CM D-12
91469	\N	\N	28800	38765	\N	SGLP-0468	CM D-14
91470	\N	\N	28801	38766	\N	SGLP-0469	CM D-15
91471	\N	\N	28802	38767	\N	SGLP-0470	CM D-16
91472	\N	\N	28805	38768	\N	SGLP-0473	CM D-19
91473	\N	\N	28808	38769	\N	SGLP-0475	CM D-22
91474	\N	\N	28810	38770	\N	SGLP-0477	CM D-24
91475	\N	\N	28821	38771	\N	SGLP-0487	CM D-35
91476	\N	\N	28820	38772	\N	SGLP-0486	CM D-34
91477	\N	\N	28822	38773	\N	SGLP-0488	CM D-36
91478	\N	\N	28825	38774	\N	SGLP-0491	CM D-39
91479	\N	\N	28830	38775	\N	SGLP-0496	CM D-44
91480	\N	\N	28831	38776	\N	SGLP-0497	CM D-45
91481	\N	\N	28832	38777	\N	SGLP-0498	CM D-46
91482	\N	\N	28833	38778	\N	SGLP-0499	CM D-47
91483	\N	\N	31239	38779	\N	NMLP-001	NM D-01
91484	\N	\N	31249	38780	\N	NMLP-011	NM D-11
91485	\N	\N	31287	38781	\N	NMLP-049	NM D-061
91486	\N	\N	31242	38782	\N	NMLP-004	NM D-04
91487	\N	\N	31248	38783	\N	NMLP-010	NM D-10
91488	\N	\N	28812	38784	\N	SGLP-0479	CM D-26
91489	\N	\N	28816	38785	\N	SGLP-0482	CM D-30
91490	\N	\N	28815	38786	\N	SGLP-0481	CM D-29
91491	\N	\N	28818	38787	\N	SGLP-0484	CM D-32
91492	\N	\N	28819	38788	\N	SGLP-0485	CM D-33
91493	\N	\N	30430	38789	\N	SGLP-0577	MDD-87
91494	\N	\N	30429	38790	\N	SGLP-0576	MDD-86
91495	\N	\N	30431	38791	\N	SGLP-0578	MDD-88
91496	\N	\N	30433	38792	\N	SGLP-0580	MDD-90
91497	\N	\N	30432	38793	\N	SGLP-0579	MDD-89
91498	\N	\N	30434	38794	\N	SGLP-0581	MDD-91
91499	\N	\N	30435	38795	\N	SGLP-0582	MDD-92
91500	\N	\N	28694	38796	\N	SGLP-0603	CGH15-249
91501	\N	\N	28666	38797	\N	SGLP-0602	CGH14-050
91502	\N	\N	28641	38798	\N	SGLP-0600	CGH12-058
91503	\N	\N	28672	38799	\N	SGLP-0604	CGH14-147
91504	\N	\N	28650	38800	\N	SGLP-0601	CGH12-301
91505	\N	\N	28642	38801	\N	SGLP-0605	CGH12-067
91506	\N	\N	28748	38802	\N	SGLP-0606	CGH19-097_1.00
91507	\N	\N	28749	38803	\N	SGLP-0607	CGH19-097_2
91508	\N	\N	31284	38804	\N	NMLP-046	NM D-058
91509	\N	\N	31262	38805	\N	NMLP-024	NM D-033
91510	\N	\N	31265	38806	\N	NMLP-027	NM D-036
91511	\N	\N	31259	38807	\N	NMLP-021	NM D-29
91512	\N	\N	31276	38808	\N	NMLP-038	NM D-048
91513	\N	\N	31273	38809	\N	NMLP-035	NM D-045
91514	\N	\N	31286	38810	\N	NMLP-048	NM D-060
91515	\N	\N	31261	38811	\N	NMLP-023	NM D-32
91516	\N	\N	31283	38812	\N	NMLP-045	NM D-055
91517	\N	\N	31258	38813	\N	NMLP-020	NM D-27
91518	\N	\N	31254	38814	\N	NMLP-016	NM D-16
91519	\N	\N	31275	38815	\N	NMLP-037	NM D-047
91520	\N	\N	31255	38816	\N	NMLP-017	NM D-17
91521	\N	\N	31279	38817	\N	NMLP-041	NM D-051
91522	\N	\N	31278	38818	\N	NMLP-040	NM D-050
91523	\N	\N	30381	38819	\N	SGLP-0254	MDD-38
91524	\N	\N	31256	38820	\N	NMLP-018	NM D-18
91525	\N	\N	28823	38821	\N	SGLP-0489	CM D-37
91526	\N	\N	31247	38822	\N	NMLP-009	NM D-09
91527	\N	\N	31272	38823	\N	NMLP-034	NM D-044
91528	\N	\N	30379	38824	\N	SGLP-0252	MDD-36
91529	\N	\N	30384	38825	\N	SGLP-0257	MDD-41
91530	\N	\N	30380	38826	\N	SGLP-0253	MDD-37
91531	\N	\N	30383	38827	\N	SGLP-0256	MDD-40
91532	\N	\N	30382	38828	\N	SGLP-0255	MDD-39
91533	\N	\N	28824	38829	\N	SGLP-0490	CM D-38
91534	\N	\N	28834	38830	\N	SGLP-0500	CM D-48
91535	\N	\N	28835	38831	\N	SGLP-0501	CM D-49
91536	\N	\N	28836	38832	\N	SGLP-0502	CM D-50
91537	\N	\N	28837	38833	\N	SGLP-0503	CM D-51
91538	\N	\N	28839	38834	\N	SGLP-0505	CM D-53
91539	\N	\N	28838	38835	\N	SGLP-0504	CM D-52
91540	\N	\N	28840	38836	\N	SGLP-0506	CM D-54
91541	\N	\N	28841	38837	\N	SGLP-0507	CM D-55
91542	\N	\N	28842	38838	\N	SGLP-0508	CM D-56
91543	\N	\N	28843	38839	\N	SGLP-0509	CM D-57
91544	\N	\N	28846	38840	\N	SGLP-0510	CM D-60
91545	\N	\N	28849	38841	\N	SGLP-0511	CM D-63
91546	\N	\N	28850	38842	\N	SGLP-0512	CM D-64
91547	\N	\N	28851	38843	\N	SGLP-0513	CM D-65
91548	\N	\N	28852	38844	\N	SGLP-0514	CM D-66
91549	\N	\N	30386	38845	\N	SGLP-0516	MDD-43
91550	\N	\N	30385	38846	\N	SGLP-0515	MDD-42
91551	\N	\N	30387	38847	\N	SGLP-0517	MDD-44
91552	\N	\N	30388	38848	\N	SGLP-0518	MDD-45
91553	\N	\N	30390	38849	\N	SGLP-0520	MDD-47
91554	\N	\N	30389	38850	\N	SGLP-0519	MDD-46
91555	\N	\N	30391	38851	\N	SGLP-0521	MDD-48
91556	\N	\N	30394	38852	\N	SGLP-0524	MDD-51
91557	\N	\N	30396	38853	\N	SGLP-0526	MDD-53
91558	\N	\N	30395	38854	\N	SGLP-0525	MDD-52
91559	\N	\N	30392	38855	\N	SGLP-0522	MDD-49
91560	\N	\N	30393	38856	\N	SGLP-0523	MDD-50
91561	\N	\N	30399	38857	\N	SGLP-0529	MDD-56
91562	\N	\N	30400	38858	\N	SGLP-0530	MDD-57
91563	\N	\N	30397	38859	\N	SGLP-0527	MDD-54
91564	\N	\N	30398	38860	\N	SGLP-0528	MDD-55
91565	\N	\N	30402	38861	\N	SGLP-0532	MDD-59
91566	\N	\N	30401	38862	\N	SGLP-0531	MDD-58
91567	\N	\N	30408	38863	\N	SGLP-0538	MDD-65
91568	\N	\N	30404	38864	\N	SGLP-0534	MDD-61
91569	\N	\N	30403	38865	\N	SGLP-0533	MDD-60
91570	\N	\N	30407	38866	\N	SGLP-0537	MDD-64
91571	\N	\N	30405	38867	\N	SGLP-0535	MDD-62
91572	\N	\N	30406	38868	\N	SGLP-0536	MDD-63
91573	\N	\N	30412	38869	\N	SGLP-0542	MDD-69
91574	\N	\N	30414	38870	\N	SGLP-0544	MDD-71
91575	\N	\N	30409	38871	\N	SGLP-0539	MDD-66
91576	\N	\N	30411	38872	\N	SGLP-0541	MDD-68
91577	\N	\N	30413	38873	\N	SGLP-0543	MDD-70
91578	\N	\N	30410	38874	\N	SGLP-0540	MDD-67
91579	\N	\N	30417	38875	\N	SGLP-0547	MDD-74
91580	\N	\N	30416	38876	\N	SGLP-0546	MDD-73
91581	\N	\N	30415	38877	\N	SGLP-0545	MDD-72
91582	\N	\N	30418	38878	\N	SGLP-0548	MDD-75
91583	\N	\N	30423	38879	\N	SGLP-0553	MDD-80
91584	\N	\N	30419	38880	\N	SGLP-0549	MDD-76
91585	\N	\N	30425	38881	\N	SGLP-0555	MDD-82
91586	\N	\N	30422	38882	\N	SGLP-0552	MDD-79
91587	\N	\N	30420	38883	\N	SGLP-0550	MDD-77
91588	\N	\N	30427	38884	\N	SGLP-0557	MDD-84
91589	\N	\N	30424	38885	\N	SGLP-0554	MDD-81
91590	\N	\N	30426	38886	\N	SGLP-0556	MDD-83
91591	\N	\N	30428	38887	\N	SGLP-0558	MDD-85
91592	\N	\N	28855	38888	\N	SGLP-0559	CM D-69
91593	\N	\N	28856	38889	\N	SGLP-0560	CM D-70
91594	\N	\N	28857	38890	\N	SGLP-0561	CM D-71
91595	\N	\N	28858	38891	\N	SGLP-0562	CM D-72
91596	\N	\N	28859	38892	\N	SGLP-0563	CM D-73
91597	\N	\N	28860	38893	\N	SGLP-0564	CM D-74
91598	\N	\N	28861	38894	\N	SGLP-0565	CM D-75
91599	\N	\N	28862	38895	\N	SGLP-0566	CM D-76
91600	\N	\N	28863	38896	\N	SGLP-0567	CM D-77
91601	\N	\N	28864	38897	\N	SGLP-0568	CM D-78
91602	\N	\N	28865	38898	\N	SGLP-0569	CM D-79
91603	\N	\N	28867	38899	\N	SGLP-0571	CM D-81
91604	\N	\N	28866	38900	\N	SGLP-0570	CM D-80
91605	\N	\N	28868	38901	\N	SGLP-0572	CM D-82
91606	\N	\N	28869	38902	\N	SGLP-0573	CM D-83
91607	\N	\N	28870	38903	\N	SGLP-0574	CM D-84
91608	\N	\N	28871	38904	\N	SGLP-0575	CM D-85
91609	\N	\N	32177	38905	\N	SGLP-0266	TPP_3-09
91610	\N	\N	32200	38906	\N	SGLP-0289	TPP_3-32
91611	\N	\N	32172	38907	\N	SGLP-0261	TPP_3-04
91612	\N	\N	28547	38908	\N	SGLP-0385	BND-005
91613	\N	\N	28549	38909	\N	SGLP-0387	BND-007
91614	\N	\N	30438	38910	\N	SGLP-0585	MDD-95
91615	\N	\N	30449	38911	\N	SGLP-0596	MDD-106
91616	\N	\N	30452	38912	\N	SGLP-0599	MDD-109
91617	\N	\N	30444	38913	\N	SGLP-0591	MDD-101
91618	\N	\N	30445	38914	\N	SGLP-0592	MDD-102
91619	\N	\N	30446	38915	\N	SGLP-0593	MDD-103
91620	\N	\N	30437	38916	\N	SGLP-0584	MDD-94
91621	\N	\N	30439	38917	\N	SGLP-0586	MDD-96
91622	\N	\N	30451	38918	\N	SGLP-0598	MDD-108
91623	\N	\N	30440	38919	\N	SGLP-0587	MDD-97
91624	\N	\N	30436	38920	\N	SGLP-0583	MDD-93
91625	\N	\N	30448	38921	\N	SGLP-0595	MDD-105
91626	\N	\N	30450	38922	\N	SGLP-0597	MDD-107
91627	\N	\N	30447	38923	\N	SGLP-0594	MDD-104
91628	\N	\N	30443	38924	\N	SGLP-0590	MDD-100
91629	\N	\N	30442	38925	\N	SGLP-0589	MDD-99
91630	\N	\N	30441	38926	\N	SGLP-0588	MDD-98
91631	\N	\N	31291	38927	\N	SGLP-0608	NM D-066
91632	\N	\N	31292	38928	\N	SGLP-0609	NM D-067
91633	\N	\N	31293	38929	\N	SGLP-0610	NM D-068
91634	\N	\N	31294	38930	\N	SGLP-0611	NM D-069
91635	\N	\N	31295	38931	\N	SGLP-0612	NM D-070
91636	\N	\N	31296	38932	\N	SGLP-0613	NM D-071
91637	\N	\N	31297	38933	\N	SGLP-0614	NM D-072
91638	\N	\N	31298	38934	\N	SGLP-0615	NM D-073
91639	\N	\N	31299	38935	\N	SGLP-0616	NM D-074
91640	\N	\N	31300	38936	\N	SGLP-0617	NM D-075
91641	\N	\N	31301	38937	\N	SGLP-0618	NM D-076
91642	\N	\N	31302	38938	\N	SGLP-0619	NM D-077
91643	\N	\N	31303	38939	\N	SGLP-0620	NM D-078
91644	\N	\N	31304	38940	\N	SGLP-0621	NM D-079
91645	\N	\N	31305	38941	\N	SGLP-0622	NM D-080
91646	\N	\N	31306	38942	\N	SGLP-0623	NM D-081
91647	\N	\N	31307	38943	\N	SGLP-0624	NM D-082
91648	\N	\N	31308	38944	\N	SGLP-0625	NM D-083
91649	\N	\N	30456	38945	\N	SGLP-0627	MDD-113
91650	\N	\N	30456	38946	\N	SGLP-0626	MDD-113
91651	\N	\N	30466	38947	\N	SGLP-0628	MDD-123
91652	\N	\N	30466	38948	\N	SGLP-0629	MDD-123
91653	\N	\N	30475	38949	\N	SGLP-0630	MDD-132
91654	\N	\N	30456	38950	\N	SGLP-0632	MDD-113
91655	\N	\N	30475	38951	\N	SGLP-0631	MDD-132
91656	\N	\N	30466	38952	\N	SGLP-0633	MDD-123
91657	\N	\N	30488	38953	\N	SGLP-0634	MDD-145
91658	\N	\N	30488	38954	\N	SGLP-0635	MDD-145
91659	\N	\N	30456	38955	\N	SGLP-0636	MDD-113
91660	\N	\N	30466	38956	\N	SGLP-0637	MDD-123
91661	\N	\N	30453	38957	\N	SGLP-0638	MDD-110
91662	\N	\N	30479	38958	\N	SGLP-0661	MDD-136
91663	\N	\N	30468	38959	\N	SGLP-0651	MDD-125
91664	\N	\N	30455	38960	\N	SGLP-0640	MDD-112
91665	\N	\N	30473	38961	\N	SGLP-0656	MDD-130
91666	\N	\N	30472	38962	\N	SGLP-0655	MDD-129
91667	\N	\N	30476	38963	\N	SGLP-0658	MDD-133
91668	\N	\N	30474	38964	\N	SGLP-0657	MDD-131
91669	\N	\N	30477	38965	\N	SGLP-0659	MDD-134
91670	\N	\N	30461	38966	\N	SGLP-0645	MDD-118
91671	\N	\N	30454	38967	\N	SGLP-0639	MDD-111
91672	\N	\N	30470	38968	\N	SGLP-0653	MDD-127
91673	\N	\N	30457	38969	\N	SGLP-0641	MDD-114
91674	\N	\N	30464	38970	\N	SGLP-0648	MDD-121
91675	\N	\N	30460	38971	\N	SGLP-0644	MDD-117
91676	\N	\N	30458	38972	\N	SGLP-0642	MDD-115
91677	\N	\N	30471	38973	\N	SGLP-0654	MDD-128
91678	\N	\N	30478	38974	\N	SGLP-0660	MDD-135
91679	\N	\N	30462	38975	\N	SGLP-0646	MDD-119
91680	\N	\N	30469	38976	\N	SGLP-0652	MDD-126
91681	\N	\N	30463	38977	\N	SGLP-0647	MDD-120
91682	\N	\N	30459	38978	\N	SGLP-0643	MDD-116
91683	\N	\N	30467	38979	\N	SGLP-0650	MDD-124
91684	\N	\N	30465	38980	\N	SGLP-0649	MDD-122
91685	\N	\N	30376	38981	\N	SGLP-0249	MDD-33
91686	\N	\N	30375	38982	\N	SGLP-0248	MDD-32
91687	\N	\N	30348	38983	\N	SGLP-0221	MDD-05
91688	\N	\N	30367	38984	\N	SGLP-0240	MDD-24
91689	\N	\N	30362	38985	\N	SGLP-0235	MDD-19
91690	\N	\N	30371	38986	\N	SGLP-0244	MDD-28
91691	\N	\N	30347	38987	\N	SGLP-0220	MDD-04
91692	\N	\N	30372	38988	\N	SGLP-0245	MDD-29
91693	\N	\N	30368	38989	\N	SGLP-0241	MDD-25
91694	\N	\N	30350	38990	\N	SGLP-0223	MDD-07
91695	\N	\N	30373	38991	\N	SGLP-0246	MDD-30
91696	\N	\N	30357	38992	\N	SGLP-0230	MDD-14
91697	\N	\N	30369	38993	\N	SGLP-0242	MDD-26
91698	\N	\N	30370	38994	\N	SGLP-0243	MDD-27
91699	\N	\N	30351	38995	\N	SGLP-0224	MDD-08
91700	\N	\N	30359	38996	\N	SGLP-0232	MDD-16
91701	\N	\N	29909	38997	\N	SGLP-0200	KIT-02
91702	\N	\N	29910	38998	\N	SGLP-0201	KIT-03
91703	\N	\N	29911	38999	\N	SGLP-0202	KIT-04
91704	\N	\N	29912	39000	\N	SGLP-0203	KIT-05
91705	\N	\N	29913	39001	\N	SGLP-0204	KIT-06
91706	\N	\N	29914	39002	\N	SGLP-0205	KIT-07
91707	\N	\N	29916	39003	\N	SGLP-0207	KIT-09
91708	\N	\N	29917	39004	\N	SGLP-0208	KIT-10
91709	\N	\N	29915	39005	\N	SGLP-0206	KIT-08
91710	\N	\N	29918	39006	\N	SGLP-0209	KIT-11
91711	\N	\N	31940	39007	\N	SGLP-0380	SM D-25
91712	\N	\N	30480	39008	\N	SGLP-0662	MDD-137
91713	\N	\N	30481	39009	\N	SGLP-0663	MDD-138
91714	\N	\N	30482	39010	\N	SGLP-0664	MDD-139
91715	\N	\N	30483	39011	\N	SGLP-0665	MDD-140
91716	\N	\N	30484	39012	\N	SGLP-0666	MDD-141
91717	\N	\N	30485	39013	\N	SGLP-0667	MDD-142
91718	\N	\N	30487	39014	\N	SGLP-0669	MDD-144
91719	\N	\N	30486	39015	\N	SGLP-0668	MDD-143
91720	\N	\N	30489	39016	\N	SGLP-0670	MDD-146
91721	\N	\N	30490	39017	\N	SGLP-0671	MDD-147
91722	\N	\N	30491	39018	\N	SGLP-0672	MDD-148
91723	\N	\N	30492	39019	\N	SGLP-0673	MDD-149
91724	\N	\N	30493	39020	\N	SGLP-0674	MDD-150
91725	\N	\N	30494	39021	\N	SGLP-0675	MDD-151
91726	\N	\N	30495	39022	\N	SGLP-0676	MDD-152
91727	\N	\N	30496	39023	\N	SGLP-0677	MDD-153
91728	\N	\N	30497	39024	\N	SGLP-0678	MDD-154
91729	\N	\N	30498	39025	\N	SGLP-0679	MDD-155
91730	\N	\N	30499	39026	\N	SGLP-0680	MDD-156
91731	\N	\N	30500	39027	\N	SGLP-0681	MDD-157
91732	\N	\N	30501	39028	\N	SGLP-0682	MDD-158
91733	\N	\N	30502	39029	\N	SGLP-0683	MDD-159
91734	\N	\N	30503	39030	\N	SGLP-0684	MDD-160
91735	\N	\N	30505	39031	\N	SGLP-0686	MDD-162
91736	\N	\N	30504	39032	\N	SGLP-0685	MDD-161
91737	\N	\N	30506	39033	\N	SGLP-0687	MDD-163
91738	\N	\N	30509	39034	\N	SGLP-0688	MDD-166
91739	\N	\N	30510	39035	\N	SGLP-0689	MDD-167
91740	\N	\N	30511	39036	\N	SGLP-0690	MDD-168
91741	\N	\N	30512	39037	\N	SGLP-0691	MDD-169
91742	\N	\N	30513	39038	\N	SGLP-0692	MDD-170
91743	\N	\N	30514	39039	\N	SGLP-0693	MDD-171
91744	\N	\N	30516	39040	\N	SGLP-0694	MDD-173
91745	\N	\N	30517	39041	\N	SGLP-0695	MDD-174
91746	\N	\N	30518	39042	\N	SGLP-0696	MDD-175
91747	\N	\N	30519	39043	\N	SGLP-0697	MDD-176
91748	\N	\N	30520	39044	\N	SGLP-0698	MDD-177
91749	\N	\N	30521	39045	\N	SGLP-0699	MDD-178
91750	\N	\N	30522	39046	\N	SGLP-0700	MDD-179
91751	\N	\N	30523	39047	\N	SGLP-0701	MDD-180
91752	\N	\N	30524	39048	\N	SGLP-0702	MDD-181
91753	\N	\N	30525	39049	\N	SGLP-0703	MDD-182
91754	\N	\N	30526	39050	\N	SGLP-0704	MDD-183
91755	\N	\N	30527	39051	\N	SGLP-0705	MDD-184
91756	\N	\N	30528	39052	\N	SGLP-0706	MDD-185
91757	\N	\N	30529	39053	\N	SGLP-0707	MDD-186
91758	\N	\N	30530	39054	\N	SGLP-0708	MDD-187
91759	\N	\N	30531	39055	\N	SGLP-0709	MDD-188
91760	\N	\N	30532	39056	\N	SGLP-0710	MDD-189
91761	\N	\N	30534	39057	\N	SGLP-0712	MDD-191
91762	\N	\N	30533	39058	\N	SGLP-0711	MDD-190
91763	\N	\N	30535	39059	\N	SGLP-0713	MDD-192
91764	\N	\N	30537	39060	\N	SGLP-0714	MDD-194
91765	\N	\N	30539	39061	\N	SGLP-0716	MDD-196
91766	\N	\N	30538	39062	\N	SGLP-0715	MDD-195
91767	\N	\N	30540	39063	\N	SGLP-0717	MDD-197
91768	\N	\N	30541	39064	\N	SGLP-0718	MDD-198
91769	\N	\N	30543	39065	\N	SGLP-0720	MDD-200
91770	\N	\N	30542	39066	\N	SGLP-0719	MDD-199
91771	\N	\N	30544	39067	\N	SGLP-0721	MDD-201
91772	\N	\N	30545	39068	\N	SGLP-0722	MDD-202
91773	\N	\N	30546	39069	\N	SGLP-0723	MDD-203
91774	\N	\N	30547	39070	\N	SGLP-0724	MDD-204
91775	\N	\N	30548	39071	\N	SGLP-0725	MDD-205
91776	\N	\N	30549	39072	\N	SGLP-0726	MDD-206
91777	\N	\N	30550	39073	\N	SGLP-0727	MDD-207
91778	\N	\N	30551	39074	\N	SGLP-0728	MDD-208
91779	\N	\N	30552	39075	\N	SGLP-0729	MDD-209
91780	\N	\N	30553	39076	\N	SGLP-0730	MDD-210
91781	\N	\N	30554	39077	\N	SGLP-0731	MDD-211
91782	\N	\N	30556	39078	\N	SGLP-0732	MDD-213
91783	\N	\N	30557	39079	\N	SGLP-0733	MDD-214
91784	\N	\N	30558	39080	\N	SGLP-0734	MDD-215
91785	\N	\N	30559	39081	\N	SGLP-0735	MDD-216
91786	\N	\N	30560	39082	\N	SGLP-0736	MDD-217
91787	\N	\N	30561	39083	\N	SGLP-0737	MDD-218
91788	\N	\N	30562	39084	\N	SGLP-0738	MDD-219
91789	\N	\N	30563	39085	\N	SGLP-0739	MDD-220
91790	\N	\N	30564	39086	\N	SGLP-0740	MDD-221
91791	\N	\N	31907	39087	\N	SGLP-0765	SKMel 1107B Dec2019 (MC-02)
91792	\N	\N	31909	39088	\N	SGLP-0766	SKMel 1121B Dec2019 (MC-03)
91793	\N	\N	30316	39089	\N	SGLP-0767	M040204 Dec2019 (AMC-07)
91794	\N	\N	29616	39090	\N	SGLP-0768	DNPD-01
91795	\N	\N	29617	39091	\N	SGLP-0769	DNPD-02
91796	\N	\N	29618	39092	\N	SGLP-0770	DNPD-03
91797	\N	\N	29620	39093	\N	SGLP-0772	DNPD-05
91798	\N	\N	29619	39094	\N	SGLP-0771	DNPD-04
91799	\N	\N	29621	39095	\N	SGLP-0773	DNPD-06
91800	\N	\N	29196	39096	\N	SGLP-0741	DN-055
91801	\N	\N	29198	39097	\N	SGLP-0742	DN-057
91802	\N	\N	29200	39098	\N	SGLP-0743	DN-059
91803	\N	\N	29201	39099	\N	SGLP-0744	DN-060
91804	\N	\N	29202	39100	\N	SGLP-0745	DN-061
91805	\N	\N	29204	39101	\N	SGLP-0747	DN-063
91806	\N	\N	29203	39102	\N	SGLP-0746	DN-062
91807	\N	\N	29205	39103	\N	SGLP-0748	DN-064
91808	\N	\N	29206	39104	\N	SGLP-0749	DN-065
91809	\N	\N	29207	39105	\N	SGLP-0750	DN-066
91810	\N	\N	29208	39106	\N	SGLP-0751	DN-067
91811	\N	\N	29210	39107	\N	SGLP-0752	DN-069
91812	\N	\N	29212	39108	\N	SGLP-0754	DN-071
91813	\N	\N	29211	39109	\N	SGLP-0753	DN-070
91814	\N	\N	29213	39110	\N	SGLP-0755	DN-072
91815	\N	\N	29217	39111	\N	SGLP-0757	DN-076
91816	\N	\N	29214	39112	\N	SGLP-0756	DN-073
91817	\N	\N	29219	39113	\N	SGLP-0758	DN-078
91818	\N	\N	29223	39114	\N	SGLP-0759	DN-082
91819	\N	\N	29224	39115	\N	SGLP-0760	DN-083
91820	\N	\N	29225	39116	\N	SGLP-0761	DN-084
91821	\N	\N	29226	39117	\N	SGLP-0762	DN-085
91822	\N	\N	29227	39118	\N	SGLP-0763	DN-086
91823	\N	\N	29228	39119	\N	SGLP-0764	DN-087
91824	\N	\N	31973	39120	\N	SGLP-0774	SND-01
91825	\N	\N	31974	39121	\N	SGLP-0775	SND-02
91826	\N	\N	31976	39122	\N	SGLP-0776	SND-04
91827	\N	\N	31977	39123	\N	SGLP-0777	SND-05
91828	\N	\N	31978	39124	\N	SGLP-0778	SND-06
91829	\N	\N	31979	39125	\N	SGLP-0779	SND-07
91830	\N	\N	31982	39126	\N	SGLP-0781	SND-10
91831	\N	\N	31981	39127	\N	SGLP-0780	SND-09
91832	\N	\N	31985	39128	\N	SGLP-0782	SND-13
91833	\N	\N	31986	39129	\N	SGLP-0783	SND-14
91834	\N	\N	31987	39130	\N	SGLP-0784	SND-15
91835	\N	\N	31989	39131	\N	SGLP-0785	SND-17
91836	\N	\N	31991	39132	\N	SGLP-0786	SND-19
91837	\N	\N	31992	39133	\N	SGLP-0787	SND-20
91838	\N	\N	31993	39134	\N	SGLP-0788	SND-21
91839	\N	\N	31994	39135	\N	SGLP-0789	SND-22
91840	\N	\N	31995	39136	\N	SGLP-0790	SND-23
91841	\N	\N	31996	39137	\N	SGLP-0791	SND-24
91842	\N	\N	31997	39138	\N	SGLP-0792	SND-25
91843	\N	\N	31999	39139	\N	SGLP-0793	SND-27
91844	\N	\N	32000	39140	\N	SGLP-0794	SND-28
91848	\N	\N	31897	39144	\N	SGLP-0798	SCH D-01
91849	\N	\N	31898	39145	\N	SGLP-0799	SCH R-01
91853	\N	\N	31622	39149	\N	RLP-64	RNA-64
91854	\N	\N	28183	39150	\N	AMLP-342	AM2 D-481 (P041_03B)
91855	\N	\N	28184	39151	\N	AMLP-343	AM2 D-482 (P041_03C)
91856	\N	\N	28185	39152	\N	AMLP-344	AM2 D-483 (P041_03D)
91857	\N	\N	31426	39153	\N	OMLP-002	OM-15D (P040_11D)
91858	\N	\N	31426	39154	\N	OMLP-003	OM-15D (P040_11D)
91859	\N	\N	28183	39155	\N	AMLP-339	AM2 D-481 (P041_03B)
91860	\N	\N	28184	39156	\N	AMLP-340	AM2 D-482 (P041_03C)
91861	\N	\N	28185	39157	\N	AMLP-341	AM2 D-483 (P041_03D)
91862	\N	\N	31293	39158	\N	NMLP-053	NM D-068
91863	\N	\N	28100	39159	\N	AMLP-353	AM2 D-381
91864	\N	\N	28137	39160	\N	AMLP-354	AM2 D-431
91865	\N	\N	28187	39161	\N	AMLP-355	AM2 D-485
91866	\N	\N	28100	39162	\N	AMLP-362	AM2 D-381
91867	\N	\N	28137	39163	\N	AMLP-363	AM2 D-431
91868	\N	\N	28187	39164	\N	AMLP-364	AM2 D-485
91869	\N	\N	28154	39165	\N	AMLP-372	AM2 D-451
91870	\N	\N	31397	39166	\N	OMLP-004	OM-1D (P040_09A)
91871	\N	\N	31407	39167	\N	OMLP-007	OM-5D (P040_09D)
91872	\N	\N	31403	39168	\N	OMLP-006	OM-4D (P040_09C)
91873	\N	\N	31401	39169	\N	OMLP-005	OM-3D (P040_09B)
91874	\N	\N	31414	39170	\N	OMLP-008	OM-8D (P040_11A)
91875	\N	\N	31417	39171	\N	OMLP-009	OM-10D (P040_11B)
91876	\N	\N	31421	39172	\N	OMLP-010	OM-11D (P040_11C)
91877	\N	\N	31411	39173	\N	OMLP-011	OM-6D
91878	\N	\N	31416	39174	\N	OMLP-012	OM-9D
91879	\N	\N	31423	39175	\N	OMLP-013	OM-12D
91880	\N	\N	31425	39176	\N	OMLP-015	OM-14D
91881	\N	\N	31424	39177	\N	OMLP-014	OM-13D
91882	\N	\N	31429	39178	\N	OMLP-016	OM-16D
91883	\N	\N	31430	39179	\N	OMLP-017	OM-17D
91884	\N	\N	31431	39180	\N	OMLP-018	OM-18D
91885	\N	\N	31433	39181	\N	OMLP-020	OM-18D3
91886	\N	\N	31432	39182	\N	OMLP-019	OM-18D2
91887	\N	\N	31434	39183	\N	OMLP-021	OM-18D4
91888	\N	\N	32012	39184	\N	SGLP-0803	SND-40
91889	\N	\N	32013	39185	\N	SGLP-0804	SND-41
91890	\N	\N	32014	39186	\N	SGLP-0805	SND-42
91891	\N	\N	27957	39187	\N	AMLP-370-3	AM2 D-219
91892	\N	\N	27931	39188	\N	AMLP-166	AM2 D-189
91893	\N	\N	27930	39189	\N	AMLP-167	AM2 D-188
91894	\N	\N	27779	39190	\N	AMLP-308	AM2 D-38
91895	\N	\N	27928	39191	\N	AMLP-345	AM2 D-186
91896	\N	\N	27921	39192	\N	AMLP-346	AM2 D-179
91897	\N	\N	28100	39193	\N	AMLP-350	AM2 D-381
91898	\N	\N	27780	39194	\N	AMLP-376	AM2 D-39
91899	\N	\N	27831	39195	\N	AMLP-377	AM2 D-90
91900	\N	\N	27838	39196	\N	AMLP-378	AM2 D-97
91901	\N	\N	27840	39197	\N	AMLP-379	AM2 D-99
91902	\N	\N	27895	39198	\N	AMLP-381	AM2 D-153
91903	\N	\N	28060	39199	\N	AMLP-383	AM2 D-336
91904	\N	\N	28167	39200	\N	AMLP-384	AM2 D-464
91905	\N	\N	28098	39201	\N	AMLP-387	AM2 D-379
91906	\N	\N	28092	39202	\N	AMLP-388	AM2 D-372
91907	\N	\N	28194	39203	\N	AMLP-391	AM2 D-491
91908	\N	\N	28101	39204	\N	AMLP-389	AM2 D-382
91909	\N	\N	28193	39205	\N	AMLP-390	AM2 D-490
91910	\N	\N	28199	39206	\N	AMLP-396	AM2 D-496
91911	\N	\N	28195	39207	\N	AMLP-392	AM2 D-492
91913	\N	\N	28198	39209	\N	AMLP-395	AM2 D-495
91914	\N	\N	27837	39210	\N	AMLP-52	AM2 D-96
91915	\N	\N	27877	39211	\N	AMLP-89	AM2 D-135
91916	\N	\N	27839	39212	\N	AMLP-54	AM2 D-98
91917	\N	\N	27832	39213	\N	AMLP-47	AM2 D-91
91918	\N	\N	27835	39214	\N	AMLP-50	AM2 D-94
91919	\N	\N	27769	39215	\N	AMLP-145	AM2 D-28
91920	\N	\N	28099	39216	\N	AMLP-270	AM2 D-380
91921	\N	\N	28143	39217	\N	AMLP-276	AM2 D-438
91922	\N	\N	27957	39218	\N	AMLP-223	AM2 D-219
91923	\N	\N	27975	39219	\N	AMLP-215	AM2 D-241
91924	\N	\N	27976	39220	\N	AMLP-216	AM2 D-242
91925	\N	\N	28166	39221	\N	AMLP-317	AM2 D-463
91926	\N	\N	28168	39222	\N	AMLP-319	AM2 D-465
91927	\N	\N	28047	39223	\N	AMLP-297	AM2 D-323
91928	\N	\N	28190	39224	\N	AMLP-366	AM2 D-487
91929	\N	\N	27956	39225	\N	AMLP-369	AM2 D-218
91930	\N	\N	30056	39226	\N	SGLP-0806	LN D-01 (LN-01)
91931	\N	\N	30057	39227	\N	SGLP-0807	LN D-02 (LN-02)
91932	\N	\N	30058	39228	\N	SGLP-0808	LN D-03 (LN-03)
91933	\N	\N	30059	39229	\N	SGLP-0809	LN D-04 (LN-04)
91934	\N	\N	30061	39230	\N	SGLP-0811	LN D-06 (LN-06)
91935	\N	\N	30060	39231	\N	SGLP-0810	LN D-05 (LN-05)
91936	\N	\N	30063	39232	\N	SGLP-0813	LN D-08 (LN-08)
91937	\N	\N	30062	39233	\N	SGLP-0812	LN D-07 (LN-07)
91938	\N	\N	30064	39234	\N	SGLP-0814	LN D-09 (LN-09)
91939	\N	\N	30065	39235	\N	SGLP-0815	LN D-10 (LN-10)
91940	\N	\N	30066	39236	\N	SGLP-0816	LN D-11 (LN-11)
91941	\N	\N	30067	39237	\N	SGLP-0817	LN D-12 (LN-12)
91942	\N	\N	30068	39238	\N	SGLP-0818	LN D-13 (LN-13)
91943	\N	\N	30069	39239	\N	SGLP-0819	LN D-14 (LN-14)
91944	\N	\N	30070	39240	\N	SGLP-0820	LN D-15 (LN-15)
91945	\N	\N	30071	39241	\N	SGLP-0821	LN D-16 (LN-16)
91946	\N	\N	30072	39242	\N	SGLP-0822	LN D-17 (LN-17)
91947	\N	\N	30073	39243	\N	SGLP-0823	LN D-18 (LN-18)
91948	\N	\N	30074	39244	\N	SGLP-0824	LN D-19 (LN-19)
91949	\N	\N	30076	39245	\N	SGLP-0826	LN D-21 (LN-21)
91950	\N	\N	30075	39246	\N	SGLP-0825	LN D-20 (LN-20)
91969	\N	\N	30176	39265	\N	SGLP-0844	LN D-123
91995	\N	\N	31427	39291	\N	OMLP-027	OM-15D-2
92003	\N	\N	31330	39299	\N	OMLP-036	OM D-31
92004	\N	\N	31331	39300	\N	OMLP-037	OM D-32
92005	\N	\N	31332	39301	\N	OMLP-038	OM D-33
92006	\N	\N	31334	39302	\N	OMLP-039	OM D-34
92007	\N	\N	31336	39303	\N	OMLP-040	OM D-36
92008	\N	\N	31337	39304	\N	OMLP-041	OM D-37
92009	\N	\N	31338	39305	\N	OMLP-042	OM D-38
92010	\N	\N	31339	39306	\N	OMLP-043	OM D-39
92011	\N	\N	31343	39307	\N	OMLP-045	OM D-42
92012	\N	\N	31342	39308	\N	OMLP-044	OM D-41
92013	\N	\N	31344	39309	\N	OMLP-046	OM D-43
92014	\N	\N	31348	39310	\N	OMLP-047	OM D-45
92015	\N	\N	31349	39311	\N	OMLP-048	OM D-46
92016	\N	\N	31350	39312	\N	OMLP-049	OM D-47
92017	\N	\N	31329	39313	\N	OMLP-050	OM D-30
92018	\N	\N	31345	39314	\N	OMLP-052	OM D-44.1
92019	\N	\N	31346	39315	\N	OMLP-053	OM D-44.2
92020	\N	\N	31347	39316	\N	OMLP-054	OM D-44.3
92022	\N	\N	31354	39318	\N	OMLP-055	OM D-51
92023	\N	\N	31356	39319	\N	OMLP-056	OM D-53
92024	\N	\N	31357	39320	\N	OMLP-057	OM D-54
92025	\N	\N	31358	39321	\N	OMLP-058	OM D-55
92026	\N	\N	31360	39322	\N	OMLP-059	OM D-57
92027	\N	\N	31361	39323	\N	OMLP-060	OM D-58.1
92028	\N	\N	31364	39324	\N	OMLP-062	OM D-59
92029	\N	\N	31362	39325	\N	OMLP-061	OM D-58.2
92030	\N	\N	31365	39326	\N	OMLP-063	OM D-60
92031	\N	\N	31366	39327	\N	OMLP-064	OM D-61
92032	\N	\N	31367	39328	\N	OMLP-065	OM D-62A
92033	\N	\N	31368	39329	\N	OMLP-066	OM D-62B
92034	\N	\N	31370	39330	\N	OMLP-068	OM D-64
92035	\N	\N	31369	39331	\N	OMLP-067	OM D-63
92036	\N	\N	31372	39332	\N	OMLP-069	OM D-66.1
92037	\N	\N	31374	39333	\N	OMLP-071	OM D-66.3
92038	\N	\N	31373	39334	\N	OMLP-070	OM D-66.2
92039	\N	\N	31376	39335	\N	OMLP-072	OM D-68.1
92040	\N	\N	31379	39336	\N	OMLP-073	OM D-69
92041	\N	\N	31380	39337	\N	OMLP-074	OM D-70
92042	\N	\N	31381	39338	\N	OMLP-075	OM D-71
92043	\N	\N	28138	39339	\N	AMLP-271	AM2 D-433
92044	\N	\N	30747	39340	\N	CCRLP-0002	MMD-172
92047	\N	\N	30600	39343	\N	CCRLP-0004	MMD-20
92048	\N	\N	30696	39344	\N	CCRLP-0038	MMD-119
92052	\N	\N	30654	39348	\N	CCRLP-0011	MMD-76
92053	\N	\N	30610	39349	\N	CCRLP-0025	MMD-30
92054	\N	\N	30650	39350	\N	CCRLP-0012	MMD-72
92057	\N	\N	30590	39353	\N	CCRLP-0013	MMD-10
92059	\N	\N	30618	39355	\N	CCRLP-0043	MMD-38
92065	\N	\N	30595	39361	\N	CCRLP-0027	MMD-15
92066	\N	\N	30584	39362	\N	CCRLP-0039	MMD-04
92067	\N	\N	30587	39363	\N	CCRLP-0029	MMD-07
92068	\N	\N	30738	39364	\N	CCRLP-0052	MMD-163
92069	\N	\N	30581	39365	\N	CCRLP-0054	MMD-01
92070	\N	\N	30592	39366	\N	CCRLP-0023	MMD-12
92071	\N	\N	30659	39367	\N	CCRLP-0010	MMD-81
92072	\N	\N	30638	39368	\N	CCRLP-0006	MMD-60
92073	\N	\N	30737	39369	\N	CCRLP-0020	MMD-162
92074	\N	\N	30752	39370	\N	CCRLP-0059	MMD-177
92075	\N	\N	30588	39371	\N	CCRLP-0022	MMD-08
92076	\N	\N	30583	39372	\N	CCRLP-0053	MMD-03
92077	\N	\N	30617	39373	\N	CCRLP-0021	MMD-37
92078	\N	\N	30621	39374	\N	CCRLP-0041	MMD-41
92079	\N	\N	30674	39375	\N	CCRLP-0031	MMD-96
92080	\N	\N	30669	39376	\N	CCRLP-0009	MMD-91
92082	\N	\N	30586	39378	\N	CCRLP-0044	MMD-06
92083	\N	\N	30675	39379	\N	CCRLP-0060	MMD-97
92084	\N	\N	30615	39380	\N	CCRLP-0030	MMD-35
92085	\N	\N	30740	39381	\N	CCRLP-0045	MMD-165
92086	\N	\N	30756	39382	\N	CCRLP-0046	MMD-181
92087	\N	\N	30582	39383	\N	CCRLP-0047	MMD-02
92088	\N	\N	30740	39384	\N	CCRLP-0048	MMD-165
92089	\N	\N	30756	39385	\N	CCRLP-0049	MMD-181
92090	\N	\N	30582	39386	\N	CCRLP-0050	MMD-02
92091	\N	\N	27894	39387	\N	AMLP-183	AM2 D-152
92092	\N	\N	28036	39388	\N	AMLP-244	AM2 D-311
92093	\N	\N	28150	39389	\N	AMLP-397	AM2 D-446
92094	\N	\N	28130	39390	\N	AMLP-407	AM2 D-423
92095	\N	\N	27872	39391	\N	AMLP-400	AM2 D-130
92096	\N	\N	28162	39392	\N	AMLP-403	AM2 D-459
92097	\N	\N	28129	39393	\N	AMLP-406	AM2 D-422
92098	\N	\N	28042	39394	\N	AMLP-404	AM2 D-318
92099	\N	\N	27916	39395	\N	AMLP-401	AM2 D-174
92100	\N	\N	28068	39396	\N	AMLP-405	AM2 D-345
92101	\N	\N	27777	39397	\N	AMLP-398	AM2 D-36
92102	\N	\N	27871	39398	\N	AMLP-399	AM2 D-129
92103	\N	\N	28160	39399	\N	AMLP-402	AM2 D-457
92104	\N	\N	28124	39400	\N	AMLP-408	AM2 D-414
92105	\N	\N	28025	39401	\N	AMLP-409	AM2 D-295
92106	\N	\N	28202	39402	\N	AMLP-411	AM2 D-500
92107	\N	\N	28201	39403	\N	AMLP-410	AM2 D-499
92108	\N	\N	28203	39404	\N	AMLP-412	AM2 D-501
92109	\N	\N	28204	39405	\N	AMLP-413	AM2 D-503
92110	\N	\N	28205	39406	\N	AMLP-414	AM2 D-504
92112	\N	\N	28206	39408	\N	AMLP-415	AM2 D-505
92113	\N	\N	28208	39409	\N	AMLP-417	AM2 D-507
92114	\N	\N	28210	39410	\N	AMLP-419	AM2 D-509
92115	\N	\N	28209	39411	\N	AMLP-418	AM2 D-508
92116	\N	\N	28211	39412	\N	AMLP-420	AM2 D-510
92117	\N	\N	28212	39413	\N	AMLP-421	AM2 D-511
92118	\N	\N	27774	39414	\N	AMLP-422	AM2 D-33
92119	\N	\N	27927	39415	\N	AMLP-423	AM2 D-185
92120	\N	\N	27925	39416	\N	AMLP-424	AM2 D-183
92121	\N	\N	27772	39417	\N	AMLP-152	AM2 D-31
92122	\N	\N	28024	39418	\N	AMLP-239	AM2 D-294
92123	\N	\N	27846	39419	\N	AMLP-207	AM2 D-104-1
92124	\N	\N	27971	39420	\N	AMLP-209	AM2 D-237
92125	\N	\N	28159	39421	\N	AMLP-311	AM2 D-456
92126	\N	\N	28161	39422	\N	AMLP-313	AM2 D-458
92127	\N	\N	27968	39423	\N	AMLP-205	AM2 D-232
92128	\N	\N	30572	39424	\N	U5LP-01	MM-1
92129	\N	\N	30573	39425	\N	U5LP-02	MM-2
92130	\N	\N	30574	39426	\N	U5LP-13	MM-3
92131	\N	\N	30575	39427	\N	U5LP-04	MM-4
92132	\N	\N	31460	39428	\N	U5LP-06	PM-2
92133	\N	\N	31191	39429	\N	U5LP-11	N-3
92134	\N	\N	31461	39430	\N	U5LP-03	PM-3
92135	\N	\N	31189	39431	\N	U5LP-09	N-1
92136	\N	\N	31192	39432	\N	U5LP-12	N-4
92137	\N	\N	31190	39433	\N	U5LP-10	N-2
92138	\N	\N	31462	39434	\N	U5LP-08	PM-4
92139	\N	\N	31459	39435	\N	U5LP-05	PM-1
92140	\N	\N	31561	39436	\N	RNA-03	RNA-03
92141	\N	\N	31562	39437	\N	RNA-04	RNA-04
92142	\N	\N	31565	39438	\N	RNA-07	RNA-07
92143	\N	\N	31570	39439	\N	RNA-12	RNA-12
92144	\N	\N	31571	39440	\N	RNA-13	RNA-13
92145	\N	\N	31563	39441	\N	RNA-05	RNA-05
92146	\N	\N	31569	39442	\N	RNA-11	RNA-11
92147	\N	\N	31572	39443	\N	RNA-14	RNA-14
92148	\N	\N	31580	39444	\N	RNA-22	RNA-22
92149	\N	\N	31559	39445	\N	RNA-01	RNA-01
92150	\N	\N	31560	39446	\N	RNA-02	RNA-02
92151	\N	\N	31579	39447	\N	RNA-21	RNA-21
92152	\N	\N	31573	39448	\N	RNA-15	RNA-15
92153	\N	\N	31564	39449	\N	RNA-06	RNA-06
92154	\N	\N	31567	39450	\N	RNA-09	RNA-09
92155	\N	\N	31574	39451	\N	RNA-16	RNA-16
92156	\N	\N	31566	39452	\N	RNA-08	RNA-08
92157	\N	\N	31576	39453	\N	RNA-18	RNA-18
92158	\N	\N	31590	39454	\N	RNA-32	RNA-32
92159	\N	\N	31595	39455	\N	RNA-37	RNA-37
92160	\N	\N	31594	39456	\N	RNA-36	RNA-36
92161	\N	\N	31587	39457	\N	RNA-29	RNA-29
92162	\N	\N	31592	39458	\N	RNA-34	RNA-34
92163	\N	\N	31584	39459	\N	RNA-26	RNA-26
92164	\N	\N	31589	39460	\N	RNA-31	RNA-31
92165	\N	\N	31591	39461	\N	RNA-33	RNA-33
92166	\N	\N	31597	39462	\N	RNA-39	RNA-39
92167	\N	\N	31588	39463	\N	RNA-30	RNA-30
92168	\N	\N	31596	39464	\N	RNA-38	RNA-38
92169	\N	\N	31586	39465	\N	RNA-28	RNA-28
92170	\N	\N	31593	39466	\N	RNA-35	RNA-35
92171	\N	\N	31585	39467	\N	RNA-27	RNA-27
92172	\N	\N	31598	39468	\N	RNA-40	RNA-40
92173	\N	\N	31463	39469	\N	EXLP-01	PROG D-01
92174	\N	\N	31466	39470	\N	EXLP-04	PROG D-04
92175	\N	\N	31467	39471	\N	EXLP-05	PROG D-05
92176	\N	\N	31474	39472	\N	EXLP-09	PROG D-12
92177	\N	\N	31475	39473	\N	EXLP-10	PROG D-13
92178	\N	\N	31476	39474	\N	EXLP-11	PROG D-14
92179	\N	\N	31480	39475	\N	EXLP-23	PROG D-18
92180	\N	\N	31482	39476	\N	EXLP-25	PROG D-20
92181	\N	\N	31477	39477	\N	EXLP-20	PROG D-15
92182	\N	\N	31479	39478	\N	EXLP-22	PROG D-17
92183	\N	\N	31479	39479	\N	EXLP-40	PROG D-17
92184	\N	\N	31481	39480	\N	EXLP-24	PROG D-19
92185	\N	\N	31485	39481	\N	EXLP-27	PROG D-23
92186	\N	\N	31478	39482	\N	EXLP-21	PROG D-16
92187	\N	\N	31484	39483	\N	EXLP-26	PROG D-22
92188	\N	\N	31488	39484	\N	EXLP-30	PROG D-26
92189	\N	\N	31488	39485	\N	EXLP-43	PROG D-26
92190	\N	\N	32257	39486	\N	XuRLP-001	Xu-1
92191	\N	\N	32258	39487	\N	XuRLP-002	Xu-2
92192	\N	\N	32260	39488	\N	XuRLP-004	Xu-4
92193	\N	\N	32259	39489	\N	XuRLP-003	Xu-3
92194	\N	\N	32261	39490	\N	XuRLP-005	Xu-5
92195	\N	\N	32263	39491	\N	XuRLP-007	Xu-7
92196	\N	\N	32262	39492	\N	XuRLP-006	Xu-6
92197	\N	\N	32264	39493	\N	XuRLP-008	Xu-8
92198	\N	\N	32267	39494	\N	XuRLP-011	Xu-11
92199	\N	\N	32268	39495	\N	XuRLP-012	Xu-12
92200	\N	\N	32266	39496	\N	XuRLP-010	Xu-10
92201	\N	\N	32265	39497	\N	XuRLP-009	Xu-9
92202	\N	\N	32270	39498	\N	XuRLP-014	Xu-14
92203	\N	\N	32269	39499	\N	XuRLP-013	Xu-13
92204	\N	\N	32271	39500	\N	XuRLP-015	Xu-015
92205	\N	\N	32272	39501	\N	XuRLP-016	Xu-016
92206	\N	\N	32273	39502	\N	XuRLP-017	Xu-017
92207	\N	\N	32275	39503	\N	XuRLP-019	Xu-019
92208	\N	\N	32274	39504	\N	XuRLP-018	Xu-018
92209	\N	\N	32276	39505	\N	XuRLP-020	Xu-020
92210	\N	\N	32280	39506	\N	XuRLP-024	Xu-024
92211	\N	\N	32277	39507	\N	XuRLP-021	Xu-021
92212	\N	\N	32279	39508	\N	XuRLP-023	Xu-023
92213	\N	\N	32278	39509	\N	XuRLP-022	Xu-022
92214	\N	\N	32284	39510	\N	XuRLP-028	Xu-028
92215	\N	\N	32281	39511	\N	XuRLP-025	Xu-025
92216	\N	\N	32283	39512	\N	XuRLP-027	Xu-027
92217	\N	\N	32282	39513	\N	XuRLP-026	Xu-026
92218	\N	\N	32285	39514	\N	XuRLP-029	Xu-029
92219	\N	\N	32288	39515	\N	XuRLP-032	Xu-032
92220	\N	\N	32287	39516	\N	XuRLP-031	Xu-031
92221	\N	\N	32286	39517	\N	XuRLP-030	Xu-030
92222	\N	\N	32292	39518	\N	XuRLP-036	Xu-036
92223	\N	\N	32291	39519	\N	XuRLP-035	Xu-035
92224	\N	\N	32290	39520	\N	XuRLP-034	Xu-034
92225	\N	\N	32289	39521	\N	XuRLP-033	Xu-033
92226	\N	\N	32296	39522	\N	XuRLP-040	Xu-040
92227	\N	\N	32295	39523	\N	XuRLP-039	Xu-039
92228	\N	\N	32293	39524	\N	XuRLP-037	Xu-037
92229	\N	\N	32294	39525	\N	XuRLP-038	Xu-038
92230	\N	\N	32297	39526	\N	XuRLP-041	Xu-041
92231	\N	\N	32299	39527	\N	XuRLP-043	Xu-043
92232	\N	\N	32298	39528	\N	XuRLP-042	Xu-042
92233	\N	\N	32300	39529	\N	XuRLP-044	Xu-044
92234	\N	\N	32303	39530	\N	XuRLP-047	Xu-047
92235	\N	\N	32304	39531	\N	XuRLP-048	Xu-048
92236	\N	\N	32302	39532	\N	XuRLP-046	Xu-046
92237	\N	\N	32301	39533	\N	XuRLP-045	Xu-045
92238	\N	\N	32308	39534	\N	XuRLP-052	Xu-052
92239	\N	\N	32307	39535	\N	XuRLP-051	Xu-051
92240	\N	\N	32306	39536	\N	XuRLP-050	Xu-050
92241	\N	\N	32305	39537	\N	XuRLP-049	Xu-049
92242	\N	\N	32309	39538	\N	XuRLP-053	Xu-053
92243	\N	\N	32311	39539	\N	XuRLP-055	Xu-055
92244	\N	\N	32312	39540	\N	XuRLP-056	Xu-056
92245	\N	\N	32310	39541	\N	XuRLP-054	Xu-054
92246	\N	\N	32314	39542	\N	XuRLP-058	Xu-058
92247	\N	\N	32315	39543	\N	XuRLP-059	Xu-059
92248	\N	\N	32313	39544	\N	XuRLP-057	Xu-057
92249	\N	\N	32316	39545	\N	XuRLP-060	Xu-060
92250	\N	\N	32318	39546	\N	XuRLP-062	Xu-062
92251	\N	\N	32320	39547	\N	XuRLP-064	Xu-064
92252	\N	\N	32319	39548	\N	XuRLP-063	Xu-063
92253	\N	\N	32317	39549	\N	XuRLP-061	Xu-061
92254	\N	\N	32333	39550	\N	JJS10_Mel	10 MEL_RNA
92255	\N	\N	32334	39551	\N	JJS10_Nev	10 NEV_RNA
92256	\N	\N	32335	39552	\N	JJS12_Mel	12 MEL_RNA
92257	\N	\N	32336	39553	\N	JJS12_Nev	12 NEV_RNA
92258	\N	\N	32326	39554	\N	JJS13_Mel	13 MEL_RNA
92259	\N	\N	32324	39555	\N	JJS13_Nev	13 NEV_RNA
92260	\N	\N	32328	39556	\N	JJS14_Mel	14 MEL_RNA
92261	\N	\N	32327	39557	\N	JJS14_Nev	14 NEV_RNA
92262	\N	\N	32330	39558	\N	JJS16_Mel	16 MEL_RNA
92263	\N	\N	32329	39559	\N	JJS16_Nev	16 NEV_RNA
92264	\N	\N	32332	39560	\N	JJS17_Mel	17 MEL_RNA
92265	\N	\N	32331	39561	\N	JJS17_Nev	17 NEV_RNA
92266	\N	\N	32337	39562	\N	JJS18_Mel	18 MEL_RNA
92267	\N	\N	32338	39563	\N	JJS18_Nev	18 NEV_RNA
92268	\N	\N	32339	39564	\N	JJS19_Mel	19 MEL_RNA
92269	\N	\N	32340	39565	\N	JJS19_Nev	19 NEV_RNA
92270	\N	\N	32321	39566	\N	JJS1_Nev	1 NEV_RNA
92271	\N	\N	32341	39567	\N	JJS20_Mel	20 MEL_RNA
92272	\N	\N	32342	39568	\N	JJS20_Nev	20 NEV_RNA
92274	\N	\N	32347	39570	\N	JJS21_Nev	21 NEV_RNA
92275	\N	\N	32348	39571	\N	JJS22_Mel	22 MEL_RNA
92276	\N	\N	32349	39572	\N	JJS22_Nev	22 NEV_RNA
92277	\N	\N	32350	39573	\N	JJS23_Mel	23 MEL_RNA
92278	\N	\N	32351	39574	\N	JJS23_Nev	23 NEV_RNA
92279	\N	\N	32352	39575	\N	JJS25_Mel	25 MEL_RNA
92280	\N	\N	32353	39576	\N	JJS25_Nev	25 NEV_RNA
92281	\N	\N	32354	39577	\N	JJS26_Mel	26 MEL_RNA
92282	\N	\N	32355	39578	\N	JJS26_Nev	26 NEV_RNA
92283	\N	\N	32356	39579	\N	JJS27_Mel	27 MEL_RNA
92284	\N	\N	32357	39580	\N	JJS27_Nev	27 NEV_RNA
92285	\N	\N	32358	39581	\N	JJS28_Mel	28 MEL_RNA
92286	\N	\N	32359	39582	\N	JJS28_Nev	28 NEV_RNA
92287	\N	\N	32323	39583	\N	JJS3_Mel1	3 MEL_RNA
92288	\N	\N	32343	39584	\N	JJS3_Nev	3 NEV_RNA
92289	\N	\N	32344	39585	\N	JJS5_Mel	5 MEL_RNA
92290	\N	\N	32345	39586	\N	JJS5_Nev	5 NEV_RNA
92291	\N	\N	32360	39587	\N	12-6261A	NA_12-6261A_Tumor
92292	\N	\N	32361	39588	\N	12-6261B	NA_12-6261B_Tumor
92293	\N	\N	32362	39589	\N	12-12366	NA_12-12366_Tumor
92294	\N	\N	32363	39590	\N	12-12467	NA_12-12467_Tumor
92295	\N	\N	32364	39591	\N	12-12470D	NA_12-12470D_Tumor
92296	\N	\N	32365	39592	\N	12-562	NA_12-562_Tumor
92297	\N	\N	32366	39593	\N	12-12647	NA_12-12647_Tumor
92298	\N	\N	32367	39594	\N	12-12626	NA_12-12626_Tumor
92299	\N	\N	32368	39595	\N	12-13587 B2	NA_12-13587_Tumor
92300	\N	\N	32369	39596	\N	12-18438A	NA_12-18438A_Tumor
92301	\N	\N	32370	39597	\N	12-13152 Tumor	NA_12-13152_Tumor
92302	\N	\N	32371	39598	\N	12-12750B	NA_12-12750B_Tumor
92303	\N	\N	32372	39599	\N	12-19596	NA_12-19596_Tumor
92304	\N	\N	32373	39600	\N	12-19187A	NA_12-19187A_Tumor
92305	\N	\N	32374	39601	\N	12-22172 Normal	NA_12-22172_Normal
92306	\N	\N	32375	39602	\N	12-22172 Tumor	NA_12-22172_Tumor
92307	\N	\N	32376	39603	\N	12-21726A Tumor	NA_12-21726A_Tumor
92308	\N	\N	32377	39604	\N	12-22901A Normal	NA_12-22901A_Normal
92309	\N	\N	32378	39605	\N	12-22901A Tumor	NA_12-22901A_Tumor
92310	\N	\N	32379	39606	\N	12-22776 B5 Normal	NA_12-22776_Normal
92311	\N	\N	32380	39607	\N	Buffy Coat	NA_BuffyCoat_Tumor
92312	\N	\N	32381	39608	\N	12-13587 B2_0_75ug	NA_12-13587B2_Tumor
92313	\N	\N	32381	39609	\N	12-13587_B2_0_5ug	NA_12-13587B2_Tumor
92314	\N	\N	32381	39610	\N	12-13587 B2_0_25ug	NA_12-13587B2_Tumor
92315	\N	\N	32382	39611	\N	Buffy Coa	NA_BuffyCoa_Tumor
92316	\N	\N	32383	39612	\N	12-22775	NA_12-22775_Tumor
92317	\N	\N	32384	39613	\N	12-22794A	NA_12-22794A_Tumor
92318	\N	\N	32385	39614	\N	12-22573	NA_12-22573_Tumor
92319	\N	\N	32386	39615	\N	12-22582A	NA_12-22582A_Tumor
92320	\N	\N	32387	39616	\N	12-22587	NA_12-22587_Tumor
92321	\N	\N	32388	39617	\N	12-22592	NA_12-22592_Tumor
92322	\N	\N	32389	39618	\N	12-22597	NA_12-22597_Tumor
92323	\N	\N	32390	39619	\N	12-22602A	NA_12-22602A_Tumor
92324	\N	\N	32391	39620	\N	12-22602B	NA_12-22602B_Tumor
92325	\N	\N	32392	39621	\N	12-22603	NA_12-22603_Tumor
92326	\N	\N	32393	39622	\N	12-22604	NA_12-22604_Tumor
92327	\N	\N	32394	39623	\N	12-22720A1	NA_12-22720A_Tumor
92328	\N	\N	32395	39624	\N	12-22868	NA_12-22868_Tumor
92329	\N	\N	32396	39625	\N	12-22884C	NA_12-22884C_Tumor
92330	\N	\N	32397	39626	\N	12-22884D	NA_12-22884D_Tumor
92331	\N	\N	32398	39627	\N	12-22886	NA_12-22886_Tumor
92332	\N	\N	32399	39628	\N	12-22894B	NA_12-22894B_Tumor
92333	\N	\N	32400	39629	\N	12-22898	NA_12-22898_Tumor
92334	\N	\N	32401	39630	\N	12-22900	NA_12-22900_Tumor
92335	\N	\N	32389	39631	\N	12-22597_700ng	NA_12-22597_Tumor
92336	\N	\N	32389	39632	\N	12-22597_500ng	NA_12-22597_Tumor
92337	\N	\N	32389	39633	\N	12-22597_250ng	NA_12-22597_Tumor
92338	\N	\N	32389	39634	\N	12-22597_100ng	NA_12-22597_Tumor
92339	\N	\N	32410	39635	\N	Kit_227_Acral_WT	NA_KIT227_Tumor
92340	\N	\N	32420	39636	\N	21-5	NA_10-41439_Normal
92341	\N	\N	32421	39637	\N	24-1	NA_11-23681_Melanoma
92342	\N	\N	32421	39638	\N	24-2	NA_11-23681_Melanoma
92343	\N	\N	32422	39639	\N	24-4	NA_11-23681_Nevus
92344	\N	\N	32423	39640	\N	24-5	NA_11-23681_Normal
92345	\N	\N	32424	39641	\N	28-1	NA_11-37533_Melanoma
92346	\N	\N	32424	39642	\N	28-2	NA_11-37533_Melanoma
92347	\N	\N	32425	39643	\N	28-3	NA_11-37533_Nevus
92348	\N	\N	32425	39644	\N	28-4	NA_11-37533_Nevus
92349	\N	\N	32426	39645	\N	28-5	NA_11-37533_Normal
92350	\N	\N	32436	39646	\N	N3_9	NA_HW6_Tumor
92351	\N	\N	32452	39647	\N	MB_1046_Tumor	NA_MB_1046_Tumor
92352	\N	\N	32467	39648	\N	BB008_CGH11-153	NA_11-34950_Tumor
92353	\N	\N	32436	39649	\N	BB09_HW6_TD	NA_HW6_Tumor
92354	\N	\N	32487	39650	\N	CGH11_035	NA_11-5482_Tumor
92355	\N	\N	32503	39651	\N	MB1424 _Tumor	NA_MB1424__Tumor
92356	\N	\N	32519	39652	\N	HW_A9_Tumor	NA_HWA9_Tumor
92357	\N	\N	32535	39653	\N	DM12_Normal	NA_DM12_Normal
92358	\N	\N	32551	39654	\N	D12_54296_Norm	NA_12-54296_Normal
92359	\N	\N	32567	39655	\N	DM29_2_Tumor	NA_DM29_Tumor
92360	\N	\N	32583	39656	\N	DM_95_2_Tumor	NA_DM95_Tumor
92361	\N	\N	32599	39657	\N	CNS_36_Tumor	NA_S05-41924_Tumor
92362	\N	\N	32615	39658	\N	KR_5233	NA_KR_5233_Tumor
92363	\N	\N	32630	39659	\N	DM_23_Tumor	NA_DM23_Tumor
92364	\N	\N	32644	39660	\N	SM_11_Tumor	NA_SM_11_Tumor
92365	\N	\N	32660	39661	\N	CGH11-011	NA_11-699_Tumor
92366	\N	\N	32487	39662	\N	CGH11-035	NA_11-5482_Tumor
92367	\N	\N	32676	39663	\N	SM_9_Normal	NA_07-14044A_Normal
92368	\N	\N	32692	39664	\N	DPN_3_Tumor	NA_11-26903_Tumor
92369	\N	\N	32702	39665	\N	WM3928 F	NA_K1_1_Tumor
92370	\N	\N	32703	39666	\N	C037	NA_K1_2_Tumor
92371	\N	\N	32704	39667	\N	C022	NA_K1_3_Tumor
92372	\N	\N	32705	39668	\N	L20-Mel	NA_London-L20_Melanoma
92373	\N	\N	32706	39669	\N	L20-NL	NA_London-L20_Normal
92374	\N	\N	32707	39670	\N	L20-Nevus-A	NA_London-L20_Nevus
92375	\N	\N	32708	39671	\N	L15-NL	NA_London-L15_Normal
92376	\N	\N	32709	39672	\N	L23C-Dysplastic	NA_London-L23C_Nevus
92377	\N	\N	32710	39673	\N	UM15	NA_K1_9_Tumor
92378	\N	\N	32711	39674	\N	UM19	NA_K1_10_Tumor
92379	\N	\N	32712	39675	\N	UM20	NA_K1_11_Tumor
92380	\N	\N	32713	39676	\N	CP-1	NA_K1_12_Tumor
92381	\N	\N	32714	39677	\N	CP-2	NA_K1_13_Tumor
92382	\N	\N	32715	39678	\N	CP-3	NA_K1_14_Tumor
92383	\N	\N	32716	39679	\N	CP-4	NA_K1_15_Tumor
92384	\N	\N	32717	39680	\N	CP-5	NA_K1_16_Tumor
92385	\N	\N	32718	39681	\N	CP-6	NA_K1_17_Tumor
92386	\N	\N	32719	39682	\N	14-18	NA_K1_18_Tumor
92387	\N	\N	32720	39683	\N	14-19	NA_K1_19_Tumor
92388	\N	\N	32721	39684	\N	14-21	NA_K1_20_Tumor
92389	\N	\N	32728	39685	\N	CNS_43_Tumor	NA_S11-032523A1_Tumor
92390	\N	\N	32739	39686	\N	Ivanka_16_2	NA_09-8165_Melanoma
92391	\N	\N	32751	39687	\N	DM16_Tumor	NA_DM16_Tumor
92392	\N	\N	32538	39688	\N	DM_13_2_Tumor	NA_DM13_Tumor
92393	\N	\N	32768	39689	\N	DM_36_2_Tumor	NA_DM36_Tumor
92394	\N	\N	32781	39690	\N	Ivanka_23_4	NA_10-73024_Nevus
92395	\N	\N	32801	39691	\N	CGH11-232	NA_11-52339_Tumor
92396	\N	\N	32817	39692	\N	KIT_244	NA_KIT244_Tumor
92397	\N	\N	32833	39693	\N	DPN_9_Normal	NA_DPN9_Normal
92398	\N	\N	32623	39694	\N	DM_101_Normal	NA_DM10_Normal
92399	\N	\N	32849	39695	\N	BS1	NA_11-13661_Tumor
92400	\N	\N	32850	39696	\N	BS2	NA_RC11-001_Tumor
92401	\N	\N	32851	39697	\N	BS3	NA_RC11-002_Tumor
92402	\N	\N	32852	39698	\N	BS4	NA_RC11-003_Tumor
92403	\N	\N	32853	39699	\N	BS5	NA_RC11-004_Tumor
92404	\N	\N	32854	39700	\N	BS6	NA_RC11-005_Tumor
92405	\N	\N	32855	39701	\N	BS7	NA_RC11-021_Tumor
92406	\N	\N	32856	39702	\N	BS8	NA_RC11-022_Tumor
92407	\N	\N	32857	39703	\N	BS9	NA_RC11-023_Tumor
92408	\N	\N	32858	39704	\N	BS10	NA_RC11-024_Tumor
92409	\N	\N	32859	39705	\N	BS11	NA_Kit298_Tumor
92410	\N	\N	32860	39706	\N	22_IS	NA_08-46462_Tumor
92411	\N	\N	32872	39707	\N	DPN_MM 20	NA_13-2939B_Tumor
92412	\N	\N	32626	39708	\N	DM_18_2_Tumor	NA_DM18_Tumor
92413	\N	\N	32885	39709	\N	CGH11-202	NA_11-41004_Tumor
92414	\N	\N	32886	39710	\N	CGH11-215	NA_11-51223_Tumor
92415	\N	\N	32887	39711	\N	CGH12-088	NA_12-22542_Tumor
92416	\N	\N	32888	39712	\N	CGH12-188	NA_12-42406_Tumor
92417	\N	\N	32889	39713	\N	CGH12-227	NA_12-55875_Tumor
92418	\N	\N	32890	39714	\N	CGH12-376	NA_12-88454_Tumor
92419	\N	\N	32891	39715	\N	CGH13-007	NA_12-98328_Tumor
92420	\N	\N	32892	39716	\N	DPN_CNN 23	NA_12-762B_Normal
92421	\N	\N	32893	39717	\N	DPN_CNN 25	NA_12-168B_Normal
92422	\N	\N	32894	39718	\N	DPN_CNN 26	NA_11-75173_Normal
92423	\N	\N	32895	39719	\N	DPN_CNN 27	NA_12-167B_Normal
92424	\N	\N	32896	39720	\N	DPN 34 pool	NA_13-47668_Tumor
92425	\N	\N	32896	39721	\N	DPN 34 Conv pool	NA_13-47668_Tumor
92426	\N	\N	32897	39722	\N	DPN 36 pool	NA_12-66661_Tumor
92427	\N	\N	32898	39723	\N	DPN 37 pool	NA_13-47621_Tumor
92428	\N	\N	32898	39724	\N	DPN Conv 37	NA_13-47621_Tumor
92429	\N	\N	32899	39725	\N	DPN 38	NA_13-37371_Tumor
92430	\N	\N	32899	39726	\N	DPN Conv 38	NA_13-37371_Tumor
92431	\N	\N	32559	39727	\N	DM11_Tert_Amplicon	NA_DM11_Tumor
92432	\N	\N	32561	39728	\N	DM14_Tert_Amplicon	NA_DM14_Tumor
92433	\N	\N	32788	39729	\N	MIN_1_Tert_Amplicon	NA_13-25110A1_Melanoma
92434	\N	\N	32790	39730	\N	MIN_3_Tert_Amplicon	NA_13-25110A1_Normal
92435	\N	\N	32793	39731	\N	MIN_6_Tert_Amplicon	NA_13-45163_Normal
92436	\N	\N	32900	39732	\N	Acral_11_Tumor	NA_Acral-11_Tumor
92437	\N	\N	32901	39733	\N	Acral_11_Cntl	NA_Acral-11_Normal
92438	\N	\N	32902	39734	\N	Acral_12_Tumor	NA_Acral-12_Tumor
92439	\N	\N	32903	39735	\N	Acral_12_Cntl	NA_Acral-12_Normal
92440	\N	\N	32904	39736	\N	Mucosal_02-2599_Primary A	NA_02-2599_Tumor
92441	\N	\N	32904	39737	\N	Mucosal_02-2599_Primary B	NA_02-2599_Tumor
92442	\N	\N	32905	39738	\N	Mucosal_02-2599_Control	NA_02-2599C_Tumor
92443	\N	\N	32904	39739	\N	Mucosal_02-2599_Met	NA_02-2599_Tumor
92444	\N	\N	32906	39740	\N	DM_48_Normal	NA_DM48_Normal
92445	\N	\N	32907	39741	\N	DM_59_Normal	NA_DM59_Normal
92446	\N	\N	32908	39742	\N	DM_68_Normal	NA_DM68_Normal
92447	\N	\N	32583	39743	\N	DM_95_Tert	NA_DM95_Tumor
92448	\N	\N	32743	39744	\N	Ivanka_22_Nevus_Tert	NA_08-46462_Nevus
92449	\N	\N	32909	39745	\N	Ivanka_22_IS_Tert	NA_08-46462_MIS
92450	\N	\N	32744	39746	\N	Ivanka_22_Normal_Tert	NA_08-46462_Normal
92451	\N	\N	32742	39747	\N	Ivanka_22_Mel_Tert	NA_08-46462_Melanoma
92452	\N	\N	32910	39748	\N	CNS20-Tumor	NA_T07-1120_Tumor
92453	\N	\N	32911	39749	\N	CNS21-Tumor	NA_T09-8069_Tumor
92454	\N	\N	32912	39750	\N	CNS22-Tumor	NA_T02-16195_Tumor
92455	\N	\N	32913	39751	\N	CNS23-Tumor	NA_T00-12011_Tumor
92456	\N	\N	32914	39752	\N	CNS24-Tumor	NA_T06-6855_Tumor
92457	\N	\N	32915	39753	\N	CNS51-Tumor	NA_12-18832AA_Tumor
92458	\N	\N	32916	39754	\N	CNS52-Tumor	NA_CNS52_Tumor
92459	\N	\N	32917	39755	\N	CNS53-Tumor	NA_CNS53_Tumor
92460	\N	\N	32918	39756	\N	CNS54-Tumor	NA_CNS54_Tumor
92461	\N	\N	32919	39757	\N	CNS57-Tumor	NA_CNS57_Tumor
92462	\N	\N	32920	39758	\N	CNS57-Normal	NA_CNS57_Normal
92463	\N	\N	32921	39759	\N	BN-N1-Tert	NA_BN-N1-Tert_Tumor
92464	\N	\N	32922	39760	\N	BN-N2-Tert	NA_BN-N2-Tert_Tumor
92465	\N	\N	32923	39761	\N	BN-M1-Tert	NA_BN-M1-Tert_Tumor
92466	\N	\N	32771	39762	\N	Ivanka-5-4-Tert	NA_08-43264_Nevus
92467	\N	\N	32733	39763	\N	Ivanka-9-1-Tert	NA_10-58663_Melanoma
92468	\N	\N	32924	39764	\N	AM_1_Tumor	NA_12-12039B_Tumor
92469	\N	\N	32925	39765	\N	AM_2_Tumor	NA_12-22776B3_Tumor
92470	\N	\N	32926	39766	\N	AM_3_Tumor	NA_99-29482_Tumor
92471	\N	\N	32927	39767	\N	AM_4_Tumor	NA_99-15313_Tumor
92472	\N	\N	32928	39768	\N	AM_5_Tumor	NA_99-885_Tumor
92473	\N	\N	32929	39769	\N	AM_6_Tumor	NA_98-37643_Tumor
92474	\N	\N	32930	39770	\N	AM_8_Tumor	NA_13-25288_Tumor
92475	\N	\N	32931	39771	\N	AM_10_Tumor	NA_09-29997_Tumor
92476	\N	\N	32932	39772	\N	AM_12_Tumor	NA_04-11158_Tumor
92477	\N	\N	32933	39773	\N	UM4	NA_UM4_Tumor
92478	\N	\N	32934	39774	\N	UM5	NA_UM5_Tumor
92479	\N	\N	32935	39775	\N	Ivanka_13_1	NA_08-84352_Melanoma
92480	\N	\N	32935	39776	\N	Ivanka_13_2	NA_08-84352_Melanoma
92481	\N	\N	32936	39777	\N	Ivanka_13_3	NA_08-84352_Nevus
92482	\N	\N	32937	39778	\N	Ivanka_13_5	NA_08-84352_Normal
92483	\N	\N	32938	39779	\N	Ivanka_25_1	NA_11-88792_Melanoma
92484	\N	\N	32938	39780	\N	Ivanka_25_2	NA_11-88792_Melanoma
92485	\N	\N	32939	39781	\N	Ivanka_25_3	NA_11-88792_Nevus
92486	\N	\N	32939	39782	\N	Ivanka_25_4	NA_11-88792_Nevus
92487	\N	\N	32940	39783	\N	Ivanka_25_5	NA_11-88792_Normal
92488	\N	\N	32941	39784	\N	CGH13_324	NA_13-74952_Tumor
92489	\N	\N	32942	39785	\N	CGH13_331	NA_13-75067_Tumor
92490	\N	\N	32943	39786	\N	Spitz_M1	NA_Spitz_M1_Tumor
92491	\N	\N	32944	39787	\N	Spitz_M2 (?)	NA_Spitz_M2_(?)_Tumor
92492	\N	\N	32945	39788	\N	Spitz_N1	NA_Spitz_N1_Tumor
92493	\N	\N	32946	39789	\N	Spitz_N2	NA_Spitz_N2_Tumor
92494	\N	\N	32947	39790	\N	Spitz_N3	NA_Spitz_N3_Tumor
92495	\N	\N	32948	39791	\N	BN_Normal	NA_BN_Normal
92496	\N	\N	32949	39792	\N	CGH13-016	NA_13-159_Tumor
92497	\N	\N	32950	39793	\N	CGH12_163	NA_12-43016_Tumor
92498	\N	\N	32951	39794	\N	CGH13_166	NA_13-34291_Tumor
92499	\N	\N	32952	39795	\N	GAK_DNA	NA_GAK_DNA_Tumor
92500	\N	\N	32953	39796	\N	Yurif_DNA	NA_Yurif_DNA_Tumor
92501	\N	\N	32900	39797	\N	Acral 11 Tumor	NA_Acral-11_Tumor
92502	\N	\N	32901	39798	\N	Acral 11 Cntl	NA_Acral-11_Normal
92503	\N	\N	32896	39799	\N	DPN 34	NA_13-47668_Tumor
92504	\N	\N	32896	39800	\N	DPN Conv 34	NA_13-47668_Tumor
92505	\N	\N	32898	39801	\N	DPN 37	NA_13-47621_Tumor
92506	\N	\N	32749	39802	\N	DM45 2 Tumor	NA_DM45_Tumor
92507	\N	\N	32765	39803	\N	DM58 Tumor	NA_DM58_Tumor
92508	\N	\N	32528	39804	\N	DM1_Tert_Amplicon	NA_DM1_Tumor
92509	\N	\N	32530	39805	\N	DM2_Tert_Amplicon	NA_DM2_Tumor
92510	\N	\N	32466	39806	\N	CGH10-013	NA_10-55707_Tumor
92511	\N	\N	32467	39807	\N	CGH11-153	NA_11-34950_Tumor
92512	\N	\N	32468	39808	\N	CGH11-036	NA_11-8228_Tumor
92513	\N	\N	32469	39809	\N	CGH11-386	NA_11-84681_Tumor
92514	\N	\N	32956	39810	\N	MIN_7_Normal	NA_MIN_7_Normal
92515	\N	\N	32957	39811	\N	MIN_7_Nevus	NA_MIN_7_Nevus
92516	\N	\N	32958	39812	\N	MIN_7_Melanoma	NA_MIN_7_Tumor
92517	\N	\N	32959	39813	\N	MIN_8_Normal	NA_MIN_8_Normal
92518	\N	\N	32960	39814	\N	MIN_8_Nevus	NA_MIN_8_Nevus
92519	\N	\N	32961	39815	\N	MIN_8_Melanoma	NA_MIN_8_Tumor
92520	\N	\N	32962	39816	\N	501_Mel	NA_501_Mel_Tumor
92521	\N	\N	32963	39817	\N	Sk_Mel_1	NA_Sk_Mel_1_Tumor
92522	\N	\N	32964	39818	\N	DPN_CNN 24	NA_DPN24_Tumor
92523	\N	\N	32965	39819	\N	DPN_CNN 28	NA_DPN28_Tumor
92524	\N	\N	32966	39820	\N	DPN_CNN 29	NA_DPN29_Tumor
92525	\N	\N	32967	39821	\N	DPN_CNN 31	NA_DPN31_Tumor
92526	\N	\N	32968	39822	\N	DPN_CNN 33	NA_DPN33_Tumor
92527	\N	\N	32969	39823	\N	DPN 40 A	NA_DPN40_Tumor
92528	\N	\N	32969	39824	\N	DPN 40 B	NA_DPN40_Tumor
92529	\N	\N	32970	39825	\N	DPN 41	NA_DPN41_Tumor
92530	\N	\N	32971	39826	\N	DPN42	NA_DPN42_Tumor
92531	\N	\N	32972	39827	\N	DPN44	NA_DPN44_Tumor
92532	\N	\N	32973	39828	\N	DPN 45	NA_DPN45_Tumor
92533	\N	\N	32974	39829	\N	DPN 46	NA_DPN46_Tumor
92534	\N	\N	32975	39830	\N	UM_6	NA_UM_6_Tumor
92535	\N	\N	32976	39831	\N	Birt_Hogg_Dube	NA_Birt_Hogg_Dube_Tumor
92536	\N	\N	32977	39832	\N	CGH13-027	NA_13-1939_Tumor
92537	\N	\N	32978	39833	\N	CGH13-268	NA_13-51657_Tumor
92538	\N	\N	32979	39834	\N	CGH13-365	NA_13-89069_Tumor
92539	\N	\N	32980	39835	\N	CGH11-018	NA_11-1051A_Tumor
92540	\N	\N	32981	39836	\N	CGH11-027	NA_11-5480_Tumor
92541	\N	\N	32982	39837	\N	Ivanka_23_Tumor	NA_10-73024_Tumor
92542	\N	\N	32782	39838	\N	Ivanka_23_Normal	NA_10-73024_Normal
92543	\N	\N	32983	39839	\N	Ivanka_2-1	NA_09-33283_Melanoma
92544	\N	\N	32983	39840	\N	Ivanka_2-2	NA_09-33283_Melanoma
92545	\N	\N	32984	39841	\N	Ivanka_2-3	NA_09-33283_Nevus
92546	\N	\N	32984	39842	\N	Ivanka_2-4	NA_09-33283_Nevus
92547	\N	\N	32985	39843	\N	Ivanka_3-1	NA_09-31895_Melanoma
92548	\N	\N	32985	39844	\N	Ivanka_3-2	NA_09-31895_Melanoma
92549	\N	\N	32986	39845	\N	Ivanka_3-3	NA_09-31895_Nevus
92550	\N	\N	32986	39846	\N	Ivanka_3-4	NA_09-31895_Nevus
92551	\N	\N	32987	39847	\N	Ivanka_3-5	NA_09-31895_Normal
92552	\N	\N	32988	39848	\N	PMM_1_Tumor	NA_R29032-05_Tumor
92553	\N	\N	32989	39849	\N	PMM_1_Normal	NA_R29032-05_Normal
92554	\N	\N	32990	39850	\N	PMM_3_A_Tumor	NA_01-8297_Tumor
92555	\N	\N	32991	39851	\N	PMM_3_A_Normal	NA_01-8297_Normal
92556	\N	\N	32992	39852	\N	PMM_3_B_Tumor	NA_8298-01_Tumor
92557	\N	\N	32993	39853	\N	PMM_3_B_Normal	NA_8298-01_Normal
92558	\N	\N	32994	39854	\N	Ivanka_11-1	NA_08-53951_Melanoma
92559	\N	\N	32994	39855	\N	Ivanka_11-2	NA_08-53951_Melanoma
92560	\N	\N	32995	39856	\N	Ivanka_11-3	NA_08-53951_Nevus
92561	\N	\N	32995	39857	\N	Ivanka_11-4	NA_08-53951_Nevus
92562	\N	\N	32997	39858	\N	PMM_5_Tumor	NA_8528-05_Tumor
92563	\N	\N	32998	39859	\N	PMM_6_Tumor	NA_1286184b_Tumor
92564	\N	\N	32999	39860	\N	PMM_6_Normal	NA_1286184b_Normal
92565	\N	\N	33000	39861	\N	PMM_7_Tumor	NA_206436_Tumor
92566	\N	\N	33001	39862	\N	PMM_8_Tumor	NA_35942-04_Tumor
92567	\N	\N	33002	39863	\N	PMM_8_Normal	NA_15329-03_Normal
92568	\N	\N	33003	39864	\N	PMM_10_Tumor	NA_Z1188-03_Tumor
92569	\N	\N	33004	39865	\N	PMM_10_Normal	NA_1185-03_Normal
92570	\N	\N	33005	39866	\N	PMM_12_Tumor	NA_14514-02_Tumor
92571	\N	\N	33006	39867	\N	PMM_12_Normal	NA_15102-02_Normal
92572	\N	\N	33007	39868	\N	PMM_13_Tumor	NA_9116-05_Tumor
92573	\N	\N	33008	39869	\N	PMM_14_Tumor	NA_24516-06_Tumor
92574	\N	\N	33009	39870	\N	PMM_14_Normal	NA_24516-06_Normal
92575	\N	\N	33010	39871	\N	PMM_15_Tumor	NA_07-3078_Tumor
92576	\N	\N	33011	39872	\N	PMM_17_Tumor	NA_B06-37358_Tumor
92577	\N	\N	33012	39873	\N	PMM_18_Tumor	NA_21590_Tumor
92578	\N	\N	33013	39874	\N	PMM_18_Normal	NA_21590_Normal
92579	\N	\N	33014	39875	\N	PMM_19_Tumor	NA_A2A79@_Tumor
92580	\N	\N	33015	39876	\N	PMM_20_Tumor	NA_356A3-075_Tumor
92581	\N	\N	33016	39877	\N	PMM_20_Normal	NA_20847-09_Normal
92582	\N	\N	33017	39878	\N	PMM_22_Tumor	NA_525_Tumor
92583	\N	\N	33018	39879	\N	PMM_23_Tumor	NA_PMM_23_Tumor
92584	\N	\N	33019	39880	\N	PMM_23_Normal	NA_PMM_23_Normal
92585	\N	\N	33020	39881	\N	UM7	NA_UM7_Tumor
92586	\N	\N	33021	39882	\N	UM8	NA_UM8_Tumor
92587	\N	\N	33022	39883	\N	UM9	NA_UM9_Tumor
92588	\N	\N	33023	39884	\N	UM10	NA_UM10_Tumor
92589	\N	\N	33024	39885	\N	UM11	NA_UM11_Tumor
92590	\N	\N	33025	39886	\N	Xanthoma_Disseminatum	NA_Xanthoma_Disseminatum_Tumor
92591	\N	\N	33026	39887	\N	CGH13-392	NA_13-94981_Tumor
92592	\N	\N	33027	39888	\N	CGH13-399	NA_13-99411A_Tumor
92593	\N	\N	33028	39889	\N	CGH13-394	NA_13-94484_Tumor
92594	\N	\N	33029	39890	\N	DM_27_Tumor	NA_DM27_Tumor
92595	\N	\N	33030	39891	\N	DM_32_Tumor	NA_DM32_Tumor
92596	\N	\N	33031	39892	\N	DM_35_Tumor	NA_DM35_Tumor
92597	\N	\N	33032	39893	\N	DM_40_Tumor	NA_DM40_Tumor
92598	\N	\N	33033	39894	\N	Dummer-KF1-Primary	NA_H01.10457/II_Primary
92599	\N	\N	33034	39895	\N	Dummer-KF1-Normal	NA_H01.10457/II_Normal
92600	\N	\N	33035	39896	\N	Dummer-KF1-Met1	NA_14.20/II_Met1
92601	\N	\N	33036	39897	\N	Dummer-KF1-Met2	NA_HS14.18/I_Met2
92602	\N	\N	33037	39898	\N	Dummer-KF2-Primary	NA_HS14.19/D_Primary
92603	\N	\N	33038	39899	\N	Dummer-KF2-Nevus	NA_HS14.19/D_Nevus
92604	\N	\N	33039	39900	\N	Dummer-KF2-Met1	NA_HS2014.15/7_Met1
92605	\N	\N	33040	39901	\N	Dummer-KF2-Normal	NA_HS2014.15/7_Normal
92606	\N	\N	33041	39902	\N	Dummer-KF3-Primary	NA_HS14.16_Primary
92607	\N	\N	33042	39903	\N	Dummer-KF3-Normal	NA_HS14.16_Normal
92608	\N	\N	33043	39904	\N	Dummer-KF3-Met1	NA_HS14.17/I_Met1
92609	\N	\N	33044	39905	\N	Long-TN1-Normal	NA_Long-TN1_Normal
92610	\N	\N	33045	39906	\N	Long-TN1-Tumor	NA_Long-TN1_Tumor
92611	\N	\N	33046	39907	\N	Long-TN2-Normal	NA_Long-TN2_Normal
92612	\N	\N	33047	39908	\N	Long-TN2-Tumor	NA_Long-TN2_Tumor
92613	\N	\N	33048	39909	\N	D326-1	NA_D326_Tumor
92614	\N	\N	33048	39910	\N	D326-2	NA_D326_Tumor
92615	\N	\N	33049	39911	\N	D366	NA_D366_Tumor
92616	\N	\N	33049	39912	\N	D366-A	NA_D366_Tumor
92617	\N	\N	33050	39913	\N	DPN 48	NA_DPN48_Tumor
92618	\N	\N	33051	39914	\N	CGH11-023	NA_11-2532_Tumor
92619	\N	\N	33052	39915	\N	AST-1-Tumor	NA_AST-1_Tumor
92620	\N	\N	33053	39916	\N	WTMM-1-Tumor	NA_08-18595B_Tumor
92621	\N	\N	33054	39917	\N	WTMM-2-Tumor	NA_13-60273_Tumor
92622	\N	\N	33055	39918	\N	WTMM-3-Tumor	NA_12-52454_Tumor
92623	\N	\N	33056	39919	\N	WTMM-4-Tumor	NA_12-75125_Tumor
92624	\N	\N	33057	39920	\N	WTMM-5-Tumor	NA_12-98235A_Tumor
92625	\N	\N	33058	39921	\N	WTMM-6-Tumor	NA_13-3619B_Tumor
92626	\N	\N	33059	39922	\N	XD-1-Normal	NA_13-67500AL_Normal
92627	\N	\N	33060	39923	\N	WTMM-8-Tumor	NA_13-19205_Tumor
92628	\N	\N	33061	39924	\N	WTMM-9-Tumor	NA_13-48330_Tumor
92629	\N	\N	33062	39925	\N	WTMM-10-Tumor	NA_13-11086_Tumor
92630	\N	\N	33063	39926	\N	WTMM-11-Tumor	NA_13-15966_Tumor
92631	\N	\N	33064	39927	\N	WTMM-12-Tumor	NA_13-39228_Tumor
92632	\N	\N	33065	39928	\N	WTMM-13-Tumor	NA_13-45942_Tumor
92633	\N	\N	33066	39929	\N	WTMM-14-Tumor	NA_13-49600_Tumor
92634	\N	\N	33067	39930	\N	WTMM-15-Tumor	NA_13-59640_Tumor
92635	\N	\N	33068	39931	\N	WTMM-16-Tumor	NA_13-67817_Tumor
92636	\N	\N	33069	39932	\N	Long-TN3-Normal	NA_SP-12-5612(1K)_Normal
92637	\N	\N	33070	39933	\N	Long-TN3-Tumor	NA_SP-13-14992(1A)_Tumor
92638	\N	\N	33071	39934	\N	Long-TN4-Normal	NA_SP-12-2294-2(2A)_Normal
92639	\N	\N	33072	39935	\N	Long-TN4-Tumor	NA_SP-13-17075(1B)_Tumor
92640	\N	\N	33073	39936	\N	Long-TN5-Normal	NA_SP-42-10361(1A)_Normal
92641	\N	\N	33074	39937	\N	Long-TN5-Tumor	NA_SP-13-1038(1A)_Tumor
92642	\N	\N	33075	39938	\N	AGL14-89-Tumor	NA_S13-13286A6_Tumor
92643	\N	\N	33076	39939	\N	AGL14-89-Normal	NA_S13-13286A6_Normal
92644	\N	\N	33077	39940	\N	AGL14-92-Tumor	NA_S11-20884A-A1_Tumor
92645	\N	\N	33078	39941	\N	AGL14-92-Normal	NA_S11-20884A-A1_Normal
92646	\N	\N	33079	39942	\N	AGL14-91-Tumor	NA_S12-6218A-D3_Tumor
92647	\N	\N	33080	39943	\N	AGL14-91-Normal	NA_S12-6218A-D3_Normal
92648	\N	\N	33081	39944	\N	AGL4-Tumor	NA_ZS06-11249A-C2_Tumor
92649	\N	\N	33082	39945	\N	AGL14-96-Tumor	NA_S12-26125A2_Tumor
92650	\N	\N	33083	39946	\N	AGL14-94-Tumor	NA_S12-28585A6_Tumor
92651	\N	\N	33084	39947	\N	AGL14-97-Tumor	NA_S11-2018B5_Tumor
92652	\N	\N	33085	39948	\N	AGL14-93-Tumor	NA_S13-11748F5_Tumor
92653	\N	\N	33086	39949	\N	AGL9-Tumor	NA_S12-7250E3_Tumor
92654	\N	\N	33087	39950	\N	AGL14-95-Tumor	NA_S13-3401B3_Tumor
92655	\N	\N	33088	39951	\N	AGL11-Tumor	NA_S13-12947A2_Tumor
92656	\N	\N	33089	39952	\N	AGL12-Tumor	NA_S13-18444A16_Tumor
92657	\N	\N	33090	39953	\N	AGL13-Tumor	NA_ZS07-1210F6_Tumor
92658	\N	\N	33091	39954	\N	AGL14-Tumor	NA_ZS10-11930B12_Tumor
92659	\N	\N	33092	39955	\N	AGL15-Tumor	NA_S12-28988_Tumor
92660	\N	\N	33093	39956	\N	AGL16-Tumor	NA_SSS13-1652B2_Tumor
92661	\N	\N	33094	39957	\N	AGL17-Tumor	NA_S13-5249_Tumor
92662	\N	\N	33095	39958	\N	L1-Normal	NA_London-L1_Normal
92663	\N	\N	33096	39959	\N	L1-DN	NA_London-L1_Nevus
92664	\N	\N	33097	39960	\N	L1-MIS	NA_London-L1_MIS
92665	\N	\N	33098	39961	\N	L1-INV	NA_London-L1_Melanoma
92666	\N	\N	33099	39962	\N	L14-Normal	NA_London-L14_Normal
92667	\N	\N	33100	39963	\N	L14-Nevus-A	NA_London-L14_Nevus
92668	\N	\N	33100	39964	\N	L14-Nevus-B	NA_London-L14_Nevus
92669	\N	\N	33101	39965	\N	L14-Mel-Comb	NA_London-L14_Melanoma
92670	\N	\N	33101	39966	\N	L14-Mel-S	NA_London-L14_Melanoma
92671	\N	\N	33101	39967	\N	L14-Mel-Deep	NA_London-L14_Melanoma
92672	\N	\N	33102	39968	\N	L14C-Normal	NA_London-L14C_Normal
92673	\N	\N	33103	39969	\N	L14C-HGD	NA_London-L14C_Intermediate
92674	\N	\N	33104	39970	\N	Ivanka-6-1	NA_08-79358_Melanoma
92675	\N	\N	33104	39971	\N	Ivanka-6-2	NA_08-79358_Melanoma
92676	\N	\N	33105	39972	\N	Ivanka-6-3	NA_08-79358_Nevus
92677	\N	\N	33106	39973	\N	Ivanka-6-5	NA_08-79358_Normal
92678	\N	\N	33107	39974	\N	Ivanka-27-1	NA_09-45509_Melanoma
92679	\N	\N	33107	39975	\N	Ivanka-27-2	NA_09-45509_Melanoma
92680	\N	\N	33108	39976	\N	Ivanka-27-3	NA_09-45509_Nevus
92681	\N	\N	33109	39977	\N	Ivanka-27-5	NA_09-45509_Normal
92682	\N	\N	33110	39978	\N	DM_50_Tumor	NA_DM50_Tumor
92683	\N	\N	33111	39979	\N	DM_56_Tumor	NA_DM56_Tumor
92684	\N	\N	33112	39980	\N	Ivanka-26-1	NA_11-94204_Melanoma
92685	\N	\N	33113	39981	\N	Ivanka-26-3	NA_11-94204_Nevus
92686	\N	\N	33114	39982	\N	Ivanka-26-5	NA_11-94204_Normal
92687	\N	\N	33115	39983	\N	L10-Normal	NA_London-L10_Normal
92688	\N	\N	33116	39984	\N	L10-MIS	NA_London-L10_MIS
92689	\N	\N	33117	39985	\N	L10-INV	NA_London-L10_Melanoma
92690	\N	\N	33118	39986	\N	L10-HGD	NA_London-L10_Intermediate
92691	\N	\N	33119	39987	\N	L12-Normal	NA_London-L12_Normal
92692	\N	\N	33120	39988	\N	L12-Nevus	NA_London-L12_Nevus
92693	\N	\N	33121	39989	\N	L12-HGD	NA_London-L12_Intermediate
92694	\N	\N	33122	39990	\N	L16-Nevus-A	NA_London-L16_Nevus
92695	\N	\N	33123	39991	\N	L16-Mel-Deep	NA_London-L16_Melanoma
92696	\N	\N	33124	39992	\N	L16A-Normal	NA_London-L16A_Normal
92697	\N	\N	33125	39993	\N	L16A-Nevus-B	NA_London-L16A_Nevus
92698	\N	\N	33126	39994	\N	L16A-Mel-Sup	NA_London-L16A_Melanoma
92699	\N	\N	33127	39995	\N	L16B-Lesion-A	NA_London-L16B_Intermediate
92700	\N	\N	33127	39996	\N	L16B-Lesion-B	NA_London-L16B_Intermediate
92701	\N	\N	33128	39997	\N	L16B-NL	NA_London-L16B_Normal
92702	\N	\N	33129	39998	\N	DM15 Tumor	NA_DM15_Tumor
92703	\N	\N	33130	39999	\N	DM19	NA_DM19_Tumor
92704	\N	\N	33130	40000	\N	DM19-2	NA_DM19_Tumor
92705	\N	\N	33131	40001	\N	DM_46_Tumor	NA_DM46_Tumor
92706	\N	\N	33132	40002	\N	Heinzerling-1-Tumor	NA_140038340_Tumor
92707	\N	\N	33133	40003	\N	Heinzerling-1-Normal	NA_140092090_Normal
92708	\N	\N	33134	40004	\N	UM13	NA_UM13_Tumor
92709	\N	\N	33135	40005	\N	UM14	NA_UM14_Tumor
92710	\N	\N	33136	40006	\N	UM16	NA_UM16_Tumor
92711	\N	\N	33137	40007	\N	L17-Normal	NA_London-L17_Normal
92712	\N	\N	33138	40008	\N	L17-Nevus-A	NA_London-L17_Nevus
92713	\N	\N	33138	40009	\N	L17-Nevus-B	NA_London-L17_Nevus
92714	\N	\N	33139	40010	\N	L17-Mel-S	NA_London-L17_Melanoma
92715	\N	\N	33139	40011	\N	L17-Mel-Deep	NA_London-L17_Melanoma
92716	\N	\N	33140	40012	\N	GAK	NA_GAK_Tumor
92717	\N	\N	33141	40013	\N	Yurif	NA_Yurif_Tumor
92718	\N	\N	32995	40014	\N	Ivanka-11-Nevus	NA_08-53951_Nevus
92719	\N	\N	33142	40015	\N	Ivanka-11-M1	NA_08-53951_M1
92720	\N	\N	33143	40016	\N	Ivanka-11-M2	NA_08-53951_M2
92721	\N	\N	33144	40017	\N	L18-Normal	NA_London-L18_Normal
92722	\N	\N	33145	40018	\N	L18-Nevus-A	NA_London-L18_Nevus
92723	\N	\N	33146	40019	\N	L18-Mel-S	NA_London-L18_Melanoma
92724	\N	\N	33146	40020	\N	L18-Mel-D	NA_London-L18_Melanoma
92725	\N	\N	33147	40021	\N	L21-MIS-Lesion-A	NA_London-L21_MIS
92726	\N	\N	33148	40022	\N	L21-LesionB	NA_London-L21_Intermediate
92727	\N	\N	33149	40023	\N	L21-NL	NA_London-L21_Normal
92728	\N	\N	33172	40024	\N	JBP-1-Norm	NA_S12-27617B9_Normal
92729	\N	\N	33173	40025	\N	JBP-1-MM	NA_S12-25164A_Tumor
92730	\N	\N	33174	40026	\N	JBP-1-Met	NA_S12-25164C1_Tumor
92731	\N	\N	33175	40027	\N	L19-Normal	NA_London-L19_Normal
92732	\N	\N	33176	40028	\N	L19-Nevus-A	NA_London-L19_Nevus
92733	\N	\N	33177	40029	\N	L19-Mel	NA_London-L19_Melanoma
92734	\N	\N	33178	40030	\N	L19E-NL	NA_London-L19E_Normal
92735	\N	\N	33179	40031	\N	L19E-Nevus	NA_London-L19E_Nevus
92736	\N	\N	33180	40032	\N	L19E-MM	NA_London-L19E_Melanoma
92737	\N	\N	33181	40033	\N	L22-MIS	NA_London-L22_MIS
92738	\N	\N	33182	40034	\N	L22-Melanoma	NA_London-L22_Melanoma
92739	\N	\N	33183	40035	\N	L22-NL	NA_London-L22_Normal
92740	\N	\N	33184	40036	\N	L23-MM-Deep	NA_London-L23_Melanoma
92741	\N	\N	33185	40037	\N	L23C-NL	NA_London-L23C_Normal
92742	\N	\N	33186	40038	\N	L23C-Mel-Sup	NA_London-L23C_Melanoma
92743	\N	\N	33187	40039	\N	L23D-NL	NA_London-L23D_Normal
92744	\N	\N	33188	40040	\N	L23D-HGD	NA_London-L23D_Intermediate
92745	\N	\N	33189	40041	\N	L6-Normal	NA_London-L6_Normal
92746	\N	\N	33190	40042	\N	L6-LGD-Super	NA_London-L6_Nevus
92747	\N	\N	33190	40043	\N	L6-LGD-Deep	NA_London-L6_Nevus
92748	\N	\N	33191	40044	\N	XD-2-Tumor	NA_XD-2_Tumor
92749	\N	\N	33192	40045	\N	XD-2-Normal	NA_XD-2_Normal
92750	\N	\N	33193	40046	\N	Long-TN6-Normal	NA_SP-13-006364_Normal
92751	\N	\N	33194	40047	\N	Long-TN6-Tumor	NA_SP-14-001249_Tumor
92752	\N	\N	33195	40048	\N	Long-TN7-Normal	NA_SP-13-0185993A_Normal
92753	\N	\N	33196	40049	\N	Long-TN7-Tumor	NA_SP-13-0185992B_Tumor
92754	\N	\N	33197	40050	\N	Long-TN8-Normal	NA_SP-12-003309B_Normal
92755	\N	\N	33198	40051	\N	Long-TN8-Tumor	NA_SP-13-0212981A_Tumor
92756	\N	\N	33199	40052	\N	Long-TN9-Normal	NA_SP-13-0068754A_Normal
92757	\N	\N	33200	40053	\N	Long-TN9-Tumor	NA_SP-13-0068751C_Tumor
92758	\N	\N	33205	40054	\N	Long-TN12-Normal	NA_SP-10-003167A_Normal
92759	\N	\N	33206	40055	\N	Long-TN12-Tumor	NA_SP-13-009897_Tumor
92760	\N	\N	33207	40056	\N	Long-TN13-Normal	NA_SP-12-0087723B_Normal
92761	\N	\N	33208	40057	\N	Long-TN13-Tumor	NA_SP-12-020017C_Tumor
92762	\N	\N	33209	40058	\N	Long-TN14-Normal	NA_SP-12-0032671A_Normal
92763	\N	\N	33210	40059	\N	Long-TN14-Tumor	NA_SP-13-006337A_Tumor
92764	\N	\N	33211	40060	\N	Long-TN15-Normal	NA_SP-12-0228802A_Normal
92765	\N	\N	33212	40061	\N	Long-TN15-Tumor	NA_SP-12-0228801A_Tumor
92766	\N	\N	33213	40062	\N	Long-TN16-Normal	NA_SP-12-0146612A_Normal
92767	\N	\N	33214	40063	\N	Long-TN16-Tumor	NA_SP-12-01466111A_Tumor
92768	\N	\N	33215	40064	\N	Long-TN17-Normal	NA_SP-10-004335_Normal
92769	\N	\N	33216	40065	\N	Long-TN17-Tumor	NA_SP-13-000848_Tumor
92770	\N	\N	33217	40066	\N	M230	NA_M230_Tumor
92771	\N	\N	33218	40067	\N	M257	NA_M257_Tumor
92772	\N	\N	33219	40068	\N	M285	NA_M285_Tumor
92773	\N	\N	33220	40069	\N	M368	NA_M368_Tumor
92774	\N	\N	33221	40070	\N	M375	NA_M375_Tumor
92775	\N	\N	33222	40071	\N	M418	NA_M418_Tumor
92776	\N	\N	33223	40072	\N	C8161	NA_C8161_Tumor
92777	\N	\N	33224	40073	\N	L4-Normal	NA_London-L4_Normal
92778	\N	\N	33225	40074	\N	L4-LGD	NA_London-L4_Nevus
92779	\N	\N	33226	40075	\N	L5-Normal	NA_London-L5_Normal
92780	\N	\N	33227	40076	\N	L5-LGD	NA_London-L5_Nevus
92781	\N	\N	33228	40077	\N	L8-Normal	NA_London-L8_Normal
92782	\N	\N	33229	40078	\N	L8-LGD	NA_London-L8_Nevus
92783	\N	\N	33230	40079	\N	L9-Normal	NA_London-L9_Normal
92784	\N	\N	33231	40080	\N	L9-HGD	NA_London-L9_Intermediate
92785	\N	\N	33232	40081	\N	L13-Normal	NA_London-L13_Normal
92786	\N	\N	33233	40082	\N	L13-Lesion-A	NA_London-L13_Intermediate
92787	\N	\N	33233	40083	\N	L13-Lesion-B	NA_London-L13_Intermediate
92788	\N	\N	33234	40084	\N	L15-DysPN	NA_London-L15_Nevus
92789	\N	\N	33235	40085	\N	L15-MM	NA_London-L15_Melanoma
92790	\N	\N	33236	40086	\N	1212	NA_1212_Tumor
92791	\N	\N	33237	40087	\N	1213	NA_1213_Tumor
92792	\N	\N	33238	40088	\N	1214	NA_1214_Tumor
92793	\N	\N	33239	40089	\N	3860	NA_3860_Tumor
92794	\N	\N	33240	40090	\N	UM17	NA_UM17_Tumor
92795	\N	\N	33241	40091	\N	JBP-2-Norm	NA_S12-23475A6_Normal
92796	\N	\N	33242	40092	\N	JBP-2-MM	NA_S12-23475A4_Tumor
92797	\N	\N	33243	40093	\N	JBP-2-Met	NA_S12-23475C1_Tumor
92798	\N	\N	33244	40094	\N	Long-TN18-Normal	NA_13-21725_Normal
92799	\N	\N	33245	40095	\N	Long-TN18-Tumor	NA_SP-14-68521D_Tumor
92800	\N	\N	33246	40096	\N	Long-TN19-Normal	NA_SP-13-208365A_Normal
92801	\N	\N	33247	40097	\N	Long-TN19-Tumor	NA_SP-14-36134A_Tumor
92802	\N	\N	33248	40098	\N	Long-TN20-Normal	NA_SP-14-73676A_Normal
92803	\N	\N	33249	40099	\N	Long-TN20-Tumor	NA_SP-14-73671M_Tumor
92804	\N	\N	33250	40100	\N	Long-TN21-Normal	NA_SP-14-7691A_Normal
92805	\N	\N	33251	40101	\N	Long-TN21-Tumor	NA_SP-14-7691A_Tumor
92806	\N	\N	33268	40102	\N	XD-1.1-Tumor	NA_XD-1.1_Tumor
92807	\N	\N	33303	40103	\N	ADM_1	NA_SMU10-0457_Tumor
92808	\N	\N	33304	40104	\N	ADM_2	NA_SMU10-0206_Tumor
92809	\N	\N	33305	40105	\N	ADM_3	NA_SMU10-0240_Tumor
92810	\N	\N	33306	40106	\N	ADM_4	NA_SCC10-0092_Tumor
92811	\N	\N	33307	40107	\N	ADM_5	NA_MASCRI-432_Tumor
92812	\N	\N	33308	40108	\N	ADM_6	NA_RPA08-0209_Tumor
92813	\N	\N	33309	40109	\N	ADM_7	NA_RPA08-0315_Tumor
92814	\N	\N	33310	40110	\N	NZM52	NA_NZM52_Tumor
92815	\N	\N	33311	40111	\N	NZM40	NA_NZM40_Tumor
92816	\N	\N	33312	40112	\N	NZM91	NA_NZM91_Tumor
92817	\N	\N	33313	40113	\N	Long-TN22-Tumor	NA_SP-13-198211A_Tumor
92818	\N	\N	33314	40114	\N	Long-TN22-Normal	NA_RNS11P15316B1_Normal
92819	\N	\N	33315	40115	\N	Long-TN23-Tumor	NA_9246581-A3_Tumor
92820	\N	\N	33316	40116	\N	Long-TN23-Normal	NA_9246581-A6_Normal
92821	\N	\N	33317	40117	\N	Long-TN24-Tumor	NA_DHM4855-14MP_Tumor
92822	\N	\N	33318	40118	\N	Long-TN24-Normal	NA_SNPN08289D_Normal
92823	\N	\N	33319	40119	\N	Long-TN25-Tumor	NA_SP-10-143551E_Tumor
92824	\N	\N	33320	40120	\N	Long-TN25-Normal	NA_SP-10-143552A_Normal
92825	\N	\N	33321	40121	\N	Long-TN26-Tumor	NA_04-SW-12-31366B1_Tumor
92826	\N	\N	33322	40122	\N	Long-TN26-Normal	NA_04-SW-12-31366B6_Normal
92827	\N	\N	33323	40123	\N	Long-TN27-Tumor	NA_SP-13-63011A_Tumor
92828	\N	\N	33324	40124	\N	Long-TN27-Normal	NA_SP-11-160493A_Normal
92829	\N	\N	33325	40125	\N	Long-TN28-Tumor	NA_SP-13-87981B_Tumor
92830	\N	\N	33326	40126	\N	Long-TN28-Normal	NA_SP-11-40641B_Normal
92831	\N	\N	33327	40127	\N	Long-TN29-Tumor	NA_SP-14-125801B_Tumor
92832	\N	\N	33328	40128	\N	Long-TN29-Normal	NA_SP-14-125802A_Normal
92833	\N	\N	33329	40129	\N	KAM17-T	NA_WCRS97-025628_Tumor
92834	\N	\N	33330	40130	\N	KAM41-T	NA_SCHS10-026422_Tumor
92835	\N	\N	33331	40131	\N	KAM90-T	NA_SROS12-001198_Tumor
92836	\N	\N	33332	40132	\N	KAM92-T	NA_SROS09-001574_Tumor
92837	\N	\N	33333	40133	\N	KAM93-T	NA_SCHS09-005840-B5_Tumor
92838	\N	\N	33334	40134	\N	KAM99-T	NA_SACS05-011507_Tumor
92839	\N	\N	33335	40135	\N	KAM105-T-A1	NA_FRSS09-009402-A1_Tumor
92840	\N	\N	33336	40136	\N	KAM28-T-B1	NA_RCHS07-000380-B1_Tumor
92841	\N	\N	33337	40137	\N	KAM30-T	NA_SROS11-005030_Tumor
92842	\N	\N	33338	40138	\N	KAM72-T	NA_VALS09-000266_Tumor
92843	\N	\N	33339	40139	\N	KAM18-T	NA_SFOS09-007093_Tumor
92844	\N	\N	33340	40140	\N	KAM63-T	NA_FRSS09-008805_Tumor
92845	\N	\N	33341	40141	\N	KAM70-T	NA_RCHS06-004567_Tumor
92846	\N	\N	33342	40142	\N	KAM54-T-E	NA_VALS05-014946-E_Tumor
92847	\N	\N	33343	40143	\N	KAM2-T	NA_SCHS08-007754_Tumor
92848	\N	\N	33344	40144	\N	KAM5-T	NA_SFOS12-018173_Tumor
92849	\N	\N	33345	40145	\N	KAM10-T	NA_SROS00-001103_Tumor
92850	\N	\N	33346	40146	\N	KAM45-T-D	NA_MTZS94-007340_Tumor
92851	\N	\N	33347	40147	\N	KAM49-T	NA_SFOS94-003116_Tumor
92852	\N	\N	33348	40148	\N	KAM27-T	NA_SACS93-027850_Tumor
92853	\N	\N	33349	40149	\N	KAM68-T	NA_SCLS91-006557_Tumor
92854	\N	\N	33350	40150	\N	KAM9-T-H	NA_OAKS90-012369_Tumor
92855	\N	\N	33351	40151	\N	KAM98-T-B	NA_HAYS02-005731_Tumor
92856	\N	\N	33352	40152	\N	KAM67-T	NA_SRFS97-002805_Tumor
92857	\N	\N	33353	40153	\N	KAM124-T-B	NA_VALS03-019832_Tumor
92858	\N	\N	33354	40154	\N	KAM58-T-GIV	NA_SSCS03-014369_Tumor
92859	\N	\N	33355	40155	\N	KAM86-T	NA_RCHS01-003684_Tumor
92860	\N	\N	33356	40156	\N	KAM111-T-A2	NA_WCRS99-012800_Tumor
92861	\N	\N	33357	40157	\N	KAM77-T	NA_HAYS90-005154_Tumor
92862	\N	\N	33358	40158	\N	KAM69-T	NA_SFOS00-016989_Tumor
92863	\N	\N	33359	40159	\N	KAM117-T-D	NA_VALS03-007457_Tumor
92864	\N	\N	33360	40160	\N	KAM103-T	NA_SFO93-005184_Tumor
92865	\N	\N	33361	40161	\N	Long-TN30-Tumor	NA_DHM50691-14MP5C_Tumor
92866	\N	\N	33362	40162	\N	Long-TN30-Normal	NA_DHM50691-14MP3_Normal
92867	\N	\N	33363	40163	\N	Long-TN31-Tumor	NA_RNS14P13907B1_Tumor
92868	\N	\N	33364	40164	\N	Long-TN31-Normal	NA_SP-10-197431A_Normal
92869	\N	\N	33365	40165	\N	Long-TN32-Tumor	NA_DHM57444-14MP_Tumor
92870	\N	\N	33366	40166	\N	Long-TN32-Normal	NA_SP-12-177322A_Normal
92871	\N	\N	33367	40167	\N	Long-TN33-Tumor	NA_DHM94457-13SK_Tumor
92872	\N	\N	33368	40168	\N	Long-TN33-Normal	NA_DHM48742-12MPE_Normal
92873	\N	\N	33369	40169	\N	Long-TN34-Tumor	NA_Laverty13-88354_Tumor
92874	\N	\N	33370	40170	\N	Long-TN34-Normal	NA_ICPMR19684.13A11_Normal
92875	\N	\N	33371	40171	\N	Long-TN35-Tumor	NA_SP-13-15691B_Tumor
92876	\N	\N	33372	40172	\N	Long-TN35-Normal	NA_SP-13-15691D_Normal
92877	\N	\N	33373	40173	\N	UM29	NA_57059699_Tumor
92878	\N	\N	33374	40174	\N	UM30	NA_57269600_Tumor
92879	\N	\N	33375	40175	\N	UM31	NA_57213442_Tumor
92880	\N	\N	33376	40176	\N	UM34	NA_57346060_Tumor
92881	\N	\N	33377	40177	\N	KAM19-T	NA_SROS10-009251_Tumor
92882	\N	\N	33378	40178	\N	KAM32-T	NA_FRSS99-007026_Tumor
92883	\N	\N	33379	40179	\N	KAM60-T-B	NA_SCLS04-001045_Tumor
92884	\N	\N	33380	40180	\N	KAM74-T-G	NA_OAKS96-014392-G_Tumor
92885	\N	\N	33381	40181	\N	KAM109-T	NA_OAKS96-022398_Tumor
92886	\N	\N	33382	40182	\N	KAM112-T-B	NA_OAK84-008979-B_Tumor
92887	\N	\N	33383	40183	\N	KAM115-T-A1	NA_ROSS09-022626-A1_Tumor
92888	\N	\N	33384	40184	\N	KAM119-T	NA_SCHS11-018842-A1_Tumor
92889	\N	\N	33385	40185	\N	KAM46-T	NA_SSCS03-004945_Tumor
92890	\N	\N	33386	40186	\N	KAM47-T	NA_WCRS02-022688_Tumor
92891	\N	\N	33387	40187	\N	KAM100-T-II	NA_SACS02-020334_Tumor
92892	\N	\N	33388	40188	\N	KAM75	NA_HAYS98-001046_Tumor
92893	\N	\N	33389	40189	\N	KAM64-T	NA_SACS88-019073_Tumor
92894	\N	\N	33390	40190	\N	KAM50-T	NA_SACS87-010145_Tumor
92895	\N	\N	33391	40191	\N	KAM39-T	NA_STRS91-006237_Tumor
92896	\N	\N	33392	40192	\N	KAM22-T	NA_SSCS92-009981_Tumor
92897	\N	\N	33393	40193	\N	T015-Normal	NA_14-59304A_Normal
92898	\N	\N	33394	40194	\N	T015-Nevus	NA_14-59304A_Nevus
92899	\N	\N	33395	40195	\N	T016-Normal	NA_13-48020_Normal
92900	\N	\N	33396	40196	\N	T016-Nevus	NA_13-48020_Nevus
92901	\N	\N	33397	40197	\N	T017-Normal	NA_14-13499_Normal
92902	\N	\N	33398	40198	\N	T017-Nevus	NA_14-13499_Nevus
92903	\N	\N	33399	40199	\N	T020-Normal	NA_13-64515B_Normal
92904	\N	\N	33400	40200	\N	T020-Nevus	NA_13-64515B_Nevus
92905	\N	\N	33401	40201	\N	T020-Melanoma	NA_13-64515B_Tumor
92906	\N	\N	33402	40202	\N	T021-Nevus	NA_14-22939_Nevus
92907	\N	\N	33403	40203	\N	T021-Melanoma	NA_14-22939_Tumor
92908	\N	\N	33404	40204	\N	T023-Normal	NA_13-61146_Normal
92909	\N	\N	33405	40205	\N	T023-Nevus	NA_13-61146_Nevus
92910	\N	\N	33406	40206	\N	T023-Melanoma	NA_13-61146_Tumor
92911	\N	\N	33407	40207	\N	UM27	NA_57001550_Tumor
92912	\N	\N	33408	40208	\N	UM28	NA_57291680_Tumor
92913	\N	\N	33409	40209	\N	736TP-FFPE-L3	NA_London-L3_Tumor
92914	\N	\N	33410	40210	\N	736TP-FFPE-L13	NA_London-L13_Tumor
92915	\N	\N	33409	40211	\N	736TP-MB-L3-L2	NA_London-L3_Tumor
92916	\N	\N	33409	40212	\N	736TP-MB-L3-L4	NA_London-L3_Tumor
92917	\N	\N	33409	40213	\N	736TP-MB-L3-P1	NA_London-L3_Tumor
92918	\N	\N	33409	40214	\N	736TP-MB-L3-P2	NA_London-L3_Tumor
92919	\N	\N	33410	40215	\N	736TP-MB-L13-L1	NA_London-L13_Tumor
92920	\N	\N	33410	40216	\N	736TP-MB-L13-P2	NA_London-L13_Tumor
92921	\N	\N	33411	40217	\N	UM33	NA_UM33_Tumor
92922	\N	\N	33412	40218	\N	UM35_A	NA_UM35_A_Tumor
92923	\N	\N	33413	40219	\N	UM39	NA_UM39_Tumor
92924	\N	\N	33414	40220	\N	UM40	NA_UM40_Tumor
92925	\N	\N	33415	40221	\N	UM41	NA_UM41_Tumor
92926	\N	\N	33416	40222	\N	UM36	NA_UM36_Tumor
92927	\N	\N	33417	40223	\N	UM37	NA_UM37_Tumor
92928	\N	\N	33410	40224	\N	736TP-F-L13	NA_London-L13_Tumor
92929	\N	\N	33418	40225	\N	UM41-A	NA_57715138_Tumor
92930	\N	\N	33418	40226	\N	UM41-B	NA_57715138_Tumor
92931	\N	\N	33419	40227	\N	UM42	NA_332771_Tumor
92932	\N	\N	33420	40228	\N	UM43	NA_57723220_Tumor
92933	\N	\N	33421	40229	\N	UM44	NA_55875588_Tumor
92934	\N	\N	33422	40230	\N	UM45	NA_57714581_Tumor
92935	\N	\N	33423	40231	\N	UM47-Tumor	NA_UM47_Tumor
92936	\N	\N	33424	40232	\N	UM47-Normal	NA_UM47_Normal
92937	\N	\N	33425	40233	\N	Sample_KAM1-T	NA_Sample_KAM1-T_Tumor
92938	\N	\N	33426	40234	\N	Sample_KAM106-T	NA_Sample_KAM106-T_Tumor
92939	\N	\N	33427	40235	\N	Sample_KAM12-T	NA_Sample_KAM12-T_Tumor
92940	\N	\N	33428	40236	\N	Sample_KAM121-T-B	NA_Sample_KAM121-T-B_Tumor
92941	\N	\N	33429	40237	\N	Sample_KAM20-T	NA_Sample_KAM20-T_Tumor
92942	\N	\N	33430	40238	\N	Sample_KAM3-T-A	NA_Sample_KAM3-T-A_Tumor
92943	\N	\N	33431	40239	\N	Sample_KAM35-T	NA_Sample_KAM35-T_Tumor
92944	\N	\N	33432	40240	\N	Sample_KAM38-T-B	NA_Sample_KAM38-T-B_Tumor
92945	\N	\N	33433	40241	\N	Sample_KAM53-T	NA_Sample_KAM53-T_Tumor
92946	\N	\N	33434	40242	\N	Sample_KAM61-T	NA_Sample_KAM61-T_Tumor
92947	\N	\N	33435	40243	\N	Sample_KAM7-T	NA_Sample_KAM7-T_Tumor
92948	\N	\N	33436	40244	\N	Sample_KAM78-T-III	NA_Sample_KAM78-T-III_Tumor
92949	\N	\N	33437	40245	\N	Sample_KAM82-T-B8	NA_Sample_KAM82-T-B8_Tumor
92950	\N	\N	33438	40246	\N	Sample_KAM84-T	NA_Sample_KAM84-T_Tumor
92951	\N	\N	33439	40247	\N	Sample_KAM94-T	NA_Sample_KAM94-T_Tumor
92952	\N	\N	33440	40248	\N	Sample_KAM96-T	NA_Sample_KAM96-T_Tumor
\.


--
-- Data for Name: nuc_acids; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.nuc_acids (nu_id, name, date, na_type, conc, vol_init, vol_remain, notes, method_id) FROM stdin;
27655	21-2_NA	2012-08-23 00:00:00-07	DNA	0.94	100	100	\N	\N
27656	21-3_NA	2012-08-23 00:00:00-07	DNA	1.35	100	100	\N	\N
27657	21-4_NA	2012-08-23 00:00:00-07	DNA	1.02	100	100	\N	\N
27658	21-5_NA	2013-03-18 00:00:00-07	DNA	1.19	200	200	\N	5
27659	22_IS_NA	\N	DNA	\N	\N	\N	\N	\N
27660	22_Melanoma_NA	\N	DNA	\N	\N	\N	\N	\N
27661	22_Nevus_NA	\N	DNA	\N	\N	\N	\N	\N
27662	22_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
27663	22-44183B-DNA	2023-07-24 00:00:00-07	DNA	0.71	190	190	\N	2
27664	22-44183B-RNA	2023-07-24 00:00:00-07	RNA	17.5	91	91	\N	1
27665	22-104389A2-DNA	2023-05-19 00:00:00-07	DNA	6.2	160	160	\N	6
27666	22-104389A2-RNA	2023-05-19 00:00:00-07	RNA	4.28	40	40	-80 BOX3	6
27667	22-104389A4-DNA	2023-06-05 00:00:00-07	DNA	0	200	200	\N	6
27668	22-104389A4-RNA	2023-06-05 00:00:00-07	RNA	0	46	46	\N	6
27669	22-104389C-DNA	2023-05-19 00:00:00-07	DNA	0.74	160	160	\N	6
27670	22-104389C-RNA	2023-05-19 00:00:00-07	RNA	2.53	40	40	-80 BOX3	6
27671	22-125373-DNA	2023-02-08 00:00:00-08	DNA	12.2	352	352	\N	2
27672	22-125373-RNA	2023-02-08 00:00:00-08	RNA	34.8	160	160	-80 BOX3	1
27673	23_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
27674	24_NA	2012-04-24 00:00:00-07	DNA	8	50	50	\N	\N
27675	24-1_NA	2012-08-23 00:00:00-07	DNA	38.33	100	100	\N	\N
27676	24-2_NA	2012-08-23 00:00:00-07	DNA	11.27	100	100	\N	\N
27677	24-3_NA	2012-08-23 00:00:00-07	DNA	1.89	100	100	\N	\N
27678	24-4_NA	2012-08-23 00:00:00-07	DNA	2.47	100	100	\N	\N
27679	24-5_NA	2013-03-21 00:00:00-07	DNA	0.84	200	200	\N	5
27680	26_NA	2012-04-24 00:00:00-07	DNA	2.58	50	50	\N	5
27681	27_NA	2012-04-24 00:00:00-07	DNA	11.08	50	50	\N	\N
27682	28_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
27683	28-4_NA	2012-08-23 00:00:00-07	DNA	1.17	100	100	\N	\N
27684	28-5_NA	2012-08-23 00:00:00-07	DNA	1.03	100	100	\N	\N
27685	35_M_NA	\N	DNA	\N	\N	\N	\N	\N
27686	38_NA	2012-04-25 00:00:00-07	DNA	3.14	50	50	\N	\N
27687	49_M_NA	\N	DNA	\N	\N	\N	\N	\N
27688	144 Imat B15-2	\N	DNA	18.8	100	100	MISC -20oC BOX; MK Cells for the Broad Institute	\N
27689	144aI WT	\N	DNA	206	15	15	\N	\N
27690	230 WT	\N	DNA	536	15	15	\N	\N
27691	1205lu-1_NA	\N	DNA	\N	\N	\N	\N	\N
27692	1205lu-2_NA	\N	DNA	\N	\N	\N	\N	\N
27693	1205LU-3_NA	\N	DNA	\N	\N	\N	\N	\N
27694	ACL01	2023-02-22 00:00:00-08	DNA	17.2	140	140	3mm punch biopsy	3
27695	ACL03	2023-02-22 00:00:00-08	DNA	16.1	140	140	3mm punch biopsy	3
27696	ACL05	2023-02-22 00:00:00-08	DNA	12.1	140	140	3mm punch biopsy	3
27697	ACL06	2023-02-22 00:00:00-08	DNA	20.3	140	140	3mm punch biopsy	3
27698	AF13_212_NA	2012-07-30 00:00:00-07	DNA	\N	\N	\N	\N	\N
27699	Algazi_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
27700	ALK_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
27701	AM_7_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27702	AM_9_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27703	AM_11_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27704	AM_13_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27705	AM_14_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27706	AM-15-Tumor	2015-02-25 00:00:00-08	DNA	4.31	48	48	\N	\N
27708	AM-16-Tumor	2015-02-25 00:00:00-08	DNA	45.3	48	48	\N	\N
27710	AM-17-Tumor	2015-02-25 00:00:00-08	DNA	43.6	48	48	\N	\N
27712	AM-18-Tumor	2015-02-25 00:00:00-08	DNA	1.09	48	48	\N	\N
27714	AM-19-Tumor	2015-02-25 00:00:00-08	DNA	12.9	48	48	\N	\N
27716	AM-20-Tumor	2015-02-25 00:00:00-08	DNA	1.82	48	48	\N	\N
27718	AM-21-Tumor	2015-02-25 00:00:00-08	DNA	1.08	48	48	\N	\N
27720	AM-22-Tumor	2015-02-25 00:00:00-08	DNA	2.5	48	48	\N	\N
27722	AM-23-Tumor	2015-02-25 00:00:00-08	DNA	4.39	48	48	\N	\N
27724	AM-24-Tumor	2015-02-25 00:00:00-08	DNA	1.47	48	48	\N	\N
27726	AM-25-Tumor	2015-02-25 00:00:00-08	DNA	1.77	48	48	\N	\N
27728	AM-26-Tumor	2015-02-25 00:00:00-08	DNA	2.81	48	48	\N	\N
27730	AM-27-Tumor	2015-02-25 00:00:00-08	DNA	48.6	48	48	\N	\N
27732	AM-28-Tumor	2015-02-25 00:00:00-08	DNA	1.47	48	48	\N	\N
27734	AM-29-Tumor	2015-02-25 00:00:00-08	DNA	28	48	48	\N	\N
27736	AM-30-Tumor	2015-02-25 00:00:00-08	DNA	5.06	48	48	\N	\N
27738	AM-31-Tumor	2015-02-25 00:00:00-08	DNA	1.52	48	48	\N	\N
27740	AM-32-Tumor	2015-02-25 00:00:00-08	DNA	2.6	48	48	\N	\N
27742	AM2 D-01	\N	DNA	0.39	90	90	\N	\N
27743	AM2 D-02	\N	DNA	0.12	90	90	\N	\N
27744	AM2 D-03	\N	DNA	0.76	90	90	\N	\N
28624	CGH11-404_NA	\N	DNA	\N	\N	\N	\N	\N
27745	AM2 D-04	\N	DNA	0	0	0	\N	\N
27746	AM2 D-05	\N	DNA	0	0	0	\N	\N
27747	AM2 D-06	\N	DNA	0	0	0	\N	\N
27748	AM2 D-07	\N	DNA	0	0	0	\N	\N
27749	AM2 D-08	\N	DNA	0	0	0	\N	\N
27750	AM2 D-09	\N	DNA	0	0	0	\N	\N
27751	AM2 D-10	\N	DNA	0	0	0	\N	\N
27752	AM2 D-11	\N	DNA	0	0	0	\N	\N
27753	AM2 D-12	\N	DNA	0	0	0	\N	\N
27754	AM2 D-13	\N	DNA	0	0	0	\N	\N
27755	AM2 D-14	\N	DNA	0.09	90	90	\N	\N
27756	AM2 D-15	\N	DNA	0.11	90	90	\N	\N
27757	AM2 D-16	\N	DNA	0.54	90	90	\N	\N
27758	AM2 D-17	\N	DNA	0.09	90	90	\N	\N
27759	AM2 D-18	\N	DNA	0.05	90	90	\N	\N
27760	AM2 D-19	\N	DNA	1.58	90	90	\N	\N
27761	AM2 D-20	\N	DNA	0.17	90	90	\N	\N
27762	AM2 D-21	\N	DNA	0.48	90	90	\N	\N
27763	AM2 D-22	\N	DNA	0.31	90	90	\N	\N
27764	AM2 D-23	\N	DNA	0.68	90	90	\N	\N
27765	AM2 D-24	\N	DNA	2.4	50	50	\N	\N
27766	AM2 D-25	\N	DNA	0.1	90	90	\N	\N
27767	AM2 D-26	\N	DNA	1.11	90	90	\N	\N
27768	AM2 D-27	\N	DNA	2.85	90	90	\N	\N
27769	AM2 D-28	\N	DNA	3.01	90	90	\N	\N
27770	AM2 D-29	\N	DNA	4.63	90	90	\N	\N
27771	AM2 D-30	\N	DNA	35.3	90	90	\N	\N
27772	AM2 D-31	\N	DNA	7.78	90	90	\N	\N
27773	AM2 D-32	\N	DNA	4	90	90	\N	\N
27774	AM2 D-33	\N	DNA	48.1	90	90	\N	\N
27775	AM2 D-34	\N	DNA	116	90	90	\N	\N
27776	AM2 D-35	\N	DNA	6.11	90	90	\N	\N
27777	AM2 D-36	\N	DNA	95.2	90	90	\N	\N
27778	AM2 D-37	2017-12-20 00:00:00-08	DNA	29	50	50	\N	\N
27779	AM2 D-38	2017-12-20 00:00:00-08	DNA	110	50	50	\N	\N
27780	AM2 D-39	2017-12-20 00:00:00-08	DNA	175.6	50	50	\N	\N
27781	AM2 D-40	2017-12-20 00:00:00-08	DNA	54.4	50	50	\N	\N
27782	AM2 D-41	2017-12-20 00:00:00-08	DNA	108	50	50	\N	\N
27783	AM2 D-42	2017-12-20 00:00:00-08	DNA	50.2	50	50	\N	\N
27784	AM2 D-43	2017-12-20 00:00:00-08	DNA	25.6	50	50	\N	\N
27785	AM2 D-44	2017-12-20 00:00:00-08	DNA	37.8	50	50	\N	\N
27786	AM2 D-45	\N	DNA	1.57	50	50	\N	\N
27787	AM2 D-46	\N	DNA	50.6	50	50	\N	\N
27788	AM2 D-47	\N	DNA	7.12	50	50	\N	\N
27789	AM2 D-48	\N	DNA	55.8	50	50	\N	\N
27790	AM2 D-49	\N	DNA	8.48	50	50	\N	\N
27791	AM2 D-50	\N	DNA	62.2	50	50	\N	\N
27792	AM2 D-51	\N	DNA	15.1	50	50	\N	\N
27793	AM2 D-52	\N	DNA	2.84	50	50	\N	\N
27794	AM2 D-53	\N	DNA	28.4	50	50	\N	\N
27795	AM2 D-54	\N	DNA	20	50	50	\N	\N
27796	AM2 D-55	\N	DNA	2.56	50	50	\N	\N
27797	AM2 D-56	\N	DNA	58	50	50	\N	\N
27798	AM2 D-57	\N	DNA	43.6	50	50	\N	\N
27799	AM2 D-58	\N	DNA	58	50	50	\N	\N
27800	AM2 D-59	\N	DNA	10.1	50	50	\N	\N
27801	AM2 D-60	\N	DNA	75.6	50	50	\N	\N
27802	AM2 D-61	\N	DNA	102	50	50	\N	\N
27803	AM2 D-62	\N	DNA	6.14	50	50	\N	\N
27804	AM2 D-63	\N	DNA	48.8	50	50	\N	\N
27805	AM2 D-64	\N	DNA	13.7	50	50	\N	\N
27806	AM2 D-65	\N	DNA	60.6	50	50	\N	\N
27807	AM2 D-66	\N	DNA	5.56	50	50	\N	\N
27808	AM2 D-67	\N	DNA	5.06	50	50	\N	\N
27809	AM2 D-68	\N	DNA	12.5	50	50	\N	\N
27810	AM2 D-69	\N	DNA	52.4	50	50	\N	\N
27811	AM2 D-70	\N	DNA	7.52	50	50	\N	\N
27812	AM2 D-71	\N	DNA	23.4	50	50	\N	\N
27813	AM2 D-72	\N	DNA	0	0	0	not circled on the slide image	\N
27814	AM2 D-73	\N	DNA	35.2	50	50	\N	\N
27815	AM2 D-74	\N	DNA	14.7	50	50	\N	\N
27816	AM2 D-75	\N	DNA	58.8	50	50	\N	\N
27817	AM2 D-76	\N	DNA	49.6	50	50	\N	\N
27818	AM2 D-77	\N	DNA	74.4	50	50	\N	\N
27819	AM2 D-78	\N	DNA	114	50	50	\N	\N
27820	AM2 D-79	\N	DNA	22.6	50	50	\N	\N
27821	AM2 D-80	\N	DNA	37.8	50	50	\N	\N
27822	AM2 D-81	\N	DNA	17.6	50	50	\N	\N
27823	AM2 D-82	\N	DNA	8.68	50	50	\N	\N
27824	AM2 D-83	\N	DNA	15.4	50	50	\N	\N
27825	AM2 D-84	\N	DNA	41.6	50	50	\N	\N
27826	AM2 D-85	\N	DNA	32.6	50	50	\N	\N
27827	AM2 D-86	\N	DNA	90	50	50	\N	\N
27828	AM2 D-87	\N	DNA	116	50	50	\N	\N
27829	AM2 D-88	\N	DNA	164.4	50	50	\N	\N
27830	AM2 D-89	\N	DNA	5.92	50	50	\N	\N
27831	AM2 D-90	\N	DNA	30.4	50	50	No DNA left over	\N
27832	AM2 D-91	\N	DNA	69.4	50	50	\N	\N
27833	AM2 D-92	\N	DNA	15.6	50	50	\N	\N
27834	AM2 D-93	\N	DNA	33.4	50	50	\N	\N
27835	AM2 D-94	\N	DNA	8.78	50	50	\N	\N
27836	AM2 D-95	\N	DNA	15.4	50	50	\N	\N
27837	AM2 D-96	\N	DNA	62.8	50	50	\N	\N
27838	AM2 D-97	\N	DNA	63.4	50	50	\N	\N
27839	AM2 D-98	\N	DNA	91.2	50	50	\N	\N
28625	CGH11-409_NA	\N	DNA	\N	\N	\N	\N	\N
27840	AM2 D-99	\N	DNA	32.2	50	50	\N	\N
27841	AM2 D-100	2018-07-30 00:00:00-07	DNA	0.5	50	50	Qubit conc. <0.50 ng/ul	4
27842	AM2 D-101	2018-07-30 00:00:00-07	DNA	5.72	50	50	\N	4
27843	AM2 D-102	2018-07-30 00:00:00-07	DNA	20	50	50	\N	4
27844	AM2 D-103	2018-07-30 00:00:00-07	DNA	43	50	50	\N	4
27845	AM2 D-104	2018-07-30 00:00:00-07	DNA	49.8	50	50	\N	4
27846	AM2 D-104-1	2020-03-07 00:00:00-08	DNA	8.47	96	96	\N	5
27847	AM2 D-105	2018-07-30 00:00:00-07	DNA	4.84	50	50	\N	4
27848	AM2 D-106	2018-07-30 00:00:00-07	DNA	0.11	50	50	\N	4
27849	AM2 D-107	2018-07-30 00:00:00-07	DNA	108	50	50	\N	4
27850	AM2 D-108	2018-07-30 00:00:00-07	DNA	0.83	50	50	\N	4
27851	AM2 D-109	2018-07-30 00:00:00-07	DNA	83	50	50	\N	4
27852	AM2 D-110	2018-07-30 00:00:00-07	DNA	30.4	50	50	\N	4
27853	AM2 D-111	2018-10-30 00:00:00-07	DNA	5.97	48	48	\N	5
27854	AM2 D-112	2018-10-30 00:00:00-07	DNA	24.3	48	48	\N	5
27855	AM2 D-113	2018-10-30 00:00:00-07	DNA	7.7	48	48	\N	5
27856	AM2 D-114	2018-10-30 00:00:00-07	DNA	4.07	48	48	\N	5
27857	AM2 D-115	2018-10-30 00:00:00-07	DNA	9.7	48	48	DNA sample missing	5
27858	AM2 D-116	2018-11-13 00:00:00-08	DNA	5.07	48	48	\N	5
27859	AM2 D-117	2018-11-13 00:00:00-08	DNA	11.4	48	48	\N	5
27860	AM2 D-118	2018-10-30 00:00:00-07	DNA	2.86	48	48	\N	5
27861	AM2 D-119	2018-11-13 00:00:00-08	DNA	6.84	48	48	\N	5
27862	AM2 D-120	2018-10-30 00:00:00-07	DNA	6.22	48	48	\N	5
27863	AM2 D-121	2018-10-30 00:00:00-07	DNA	3.04	48	48	\N	5
27864	AM2 D-122	2018-10-30 00:00:00-07	DNA	9.58	48	48	\N	5
27865	AM2 D-123	2018-10-30 00:00:00-07	DNA	6.74	48	48	\N	5
27866	AM2 D-124	2018-11-15 00:00:00-08	DNA	1.54	48	48	\N	5
27867	AM2 D-125	2018-10-30 00:00:00-07	DNA	4.03	48	48	\N	5
27868	AM2 D-126	2018-11-15 00:00:00-08	DNA	3.58	48	48	AMLP-172 sheared 268 ng	5
27869	AM2 D-127	2018-10-30 00:00:00-07	DNA	6.79	48	48	\N	5
27870	AM2 D-128	2018-10-30 00:00:00-07	DNA	5.69	48	48	\N	5
27871	AM2 D-129	2018-10-30 00:00:00-07	DNA	36.1	48	48	\N	5
27872	AM2 D-130	2018-10-30 00:00:00-07	DNA	48.4	48	48	\N	5
27873	AM2 D-131	2018-10-30 00:00:00-07	DNA	1.41	48	48	\N	5
27874	AM2 D-132	2018-10-30 00:00:00-07	DNA	3.86	48	48	\N	5
27875	AM2 D-133	2018-10-30 00:00:00-07	DNA	5.68	48	48	\N	5
27876	AM2 D-134	2018-10-30 00:00:00-07	DNA	1	48	48	\N	5
27877	AM2 D-135	2018-10-30 00:00:00-07	DNA	47.8	48	48	\N	5
27878	AM2 D-136	2018-10-30 00:00:00-07	DNA	3.88	48	48	AMLP-190 sheared 94 ng	5
27879	AM2 D-137	2018-10-30 00:00:00-07	DNA	2.6	48	48	\N	5
27880	AM2 D-138	2018-10-30 00:00:00-07	DNA	5.77	48	48	\N	5
27881	AM2 D-139	2018-10-30 00:00:00-07	DNA	2.24	48	48	\N	5
27882	AM2 D-140	2018-10-30 00:00:00-07	DNA	12.4	48	48	\N	5
27883	AM2 D-141	2018-10-30 00:00:00-07	DNA	45.1	48	48	\N	5
27884	AM2 D-142	2018-10-30 00:00:00-07	DNA	7.7	48	48	\N	5
27885	AM2 D-143	2018-10-30 00:00:00-07	DNA	38.7	48	48	\N	5
27886	AM2 D-144	2018-11-15 00:00:00-08	DNA	25.5	48	48	\N	5
27887	AM2 D-145	2018-11-13 00:00:00-08	DNA	13.2	48	48	\N	5
27888	AM2 D-146	2018-11-13 00:00:00-08	DNA	23.3	48	48	\N	5
27889	AM2 D-147	2018-11-13 00:00:00-08	DNA	49.5	48	48	\N	5
27890	AM2 D-148	2018-11-13 00:00:00-08	DNA	0	48	48	extracted DNA < 0.5 ng/ul	5
27891	AM2 D-149	2018-11-13 00:00:00-08	DNA	0	48	48	extracted DNA < 0.5 ng/ul	5
27892	AM2 D-150	2018-11-15 00:00:00-08	DNA	39.9	48	48	\N	5
27893	AM2 D-151	2018-11-13 00:00:00-08	DNA	1.13	48	48	AMLP-182 sheared 344 ng	5
27894	AM2 D-152	2018-11-13 00:00:00-08	DNA	0.32	48	48	\N	5
27895	AM2 D-153	2018-11-13 00:00:00-08	DNA	10.8	48	48	AMLP-184 sheared 333ng	5
27896	AM2 D-154	2018-11-13 00:00:00-08	DNA	1.91	48	48	AMLP-185 sheared sheared 325 ng	5
27897	AM2 D-155	2018-11-15 00:00:00-08	DNA	47.8	48	48	\N	5
27898	AM2 D-156	2018-11-15 00:00:00-08	DNA	22.2	48	48	\N	5
27899	AM2 D-157	2018-11-15 00:00:00-08	DNA	2.13	48	48	\N	5
27900	AM2 D-158	2018-11-15 00:00:00-08	DNA	21.1	48	48	\N	5
27901	AM2 D-159	2018-11-15 00:00:00-08	DNA	10.8	48	48	\N	5
27902	AM2 D-160	2018-11-15 00:00:00-08	DNA	2.11	48	48	\N	5
27903	AM2 D-161	2018-11-15 00:00:00-08	DNA	4.46	48	48	\N	5
27904	AM2 D-162	2018-11-15 00:00:00-08	DNA	29.6	48	48	\N	5
27905	AM2 D-163	2018-11-13 00:00:00-08	DNA	8.16	48	48	\N	5
27906	AM2 D-164	2018-11-13 00:00:00-08	DNA	4.67	48	48	\N	5
27907	AM2 D-165	2018-11-13 00:00:00-08	DNA	12.9	48	48	\N	5
27908	AM2 D-166	2018-11-13 00:00:00-08	DNA	38.6	48	48	\N	5
27909	AM2 D-167	2018-11-13 00:00:00-08	DNA	0.53	48	48	\N	5
27910	AM2 D-168	2018-11-13 00:00:00-08	DNA	0.45	48	48	\N	5
27911	AM2 D-169	2018-11-13 00:00:00-08	DNA	1.41	48	48	\N	5
27912	AM2 D-170	2018-11-13 00:00:00-08	DNA	0.68	48	48	\N	5
27913	AM2 D-171	2018-11-13 00:00:00-08	DNA	1.43	48	48	\N	5
27914	AM2 D-172	2018-11-13 00:00:00-08	DNA	2.88	48	48	\N	5
27915	AM2 D-173	2018-11-13 00:00:00-08	DNA	1.61	48	48	\N	5
27916	AM2 D-174	2018-11-13 00:00:00-08	DNA	33.6	48	48	\N	5
27917	AM2 D-175	2018-11-15 00:00:00-08	DNA	14	48	48	\N	5
27918	AM2 D-176	2019-11-18 00:00:00-08	DNA	0.3	96	96	\N	5
27919	AM2 D-177	2019-11-18 00:00:00-08	DNA	0.09	96	96	\N	5
27920	AM2 D-178	2019-11-18 00:00:00-08	DNA	0	96	96	\N	5
27921	AM2 D-179	2019-11-18 00:00:00-08	DNA	31.5	96	96	\N	5
27922	AM2 D-180	2019-11-18 00:00:00-08	DNA	0.58	96	96	\N	5
27923	AM2 D-181	2019-11-18 00:00:00-08	DNA	0.15	96	96	\N	5
27924	AM2 D-182	2019-11-18 00:00:00-08	DNA	2.65	96	96	\N	5
27925	AM2 D-183	2019-11-18 00:00:00-08	DNA	44	96	96	Has Melanin	5
27926	AM2 D-184	2019-11-18 00:00:00-08	DNA	21.9	96	96	\N	5
27927	AM2 D-185	2019-11-18 00:00:00-08	DNA	40.1	96	96	\N	5
27928	AM2 D-186	2020-01-19 00:00:00-08	DNA	52	96	96	\N	5
27929	AM2 D-187	2020-01-19 00:00:00-08	DNA	40.4	96	96	\N	5
27930	AM2 D-188	2020-01-23 00:00:00-08	DNA	0.56	96	96	\N	5
27931	AM2 D-189	2020-01-23 00:00:00-08	DNA	2.34	96	96	\N	5
27932	AM2 D-190	2020-01-23 00:00:00-08	DNA	2.78	96	96	\N	5
27933	AM2 D-191	2020-01-23 00:00:00-08	DNA	9.22	96	96	\N	5
27934	AM2 D-192	2020-01-23 00:00:00-08	DNA	8.09	96	96	\N	5
27935	AM2 D-193	2020-01-23 00:00:00-08	DNA	2.7	192	192	Combined Normal 1 and Normal 2	5
27936	AM2 D-194	2020-01-23 00:00:00-08	DNA	3.42	96	96	\N	5
27937	AM2 D-195	2020-01-23 00:00:00-08	DNA	2.37	96	96	\N	5
27938	AM2 D-196	2020-03-07 00:00:00-08	DNA	2.95	96	96	\N	5
27939	AM2 D-199	2020-03-07 00:00:00-08	DNA	1.56	96	96	\N	5
27940	AM2 D-200	2020-03-07 00:00:00-08	DNA	0.25	96	96	\N	5
27941	AM2 D-201	2020-03-07 00:00:00-08	DNA	0.06	96	96	\N	5
27942	AM2 D-202	2020-03-07 00:00:00-08	DNA	16.9	96	96	\N	5
27943	AM2 D-203	2020-03-07 00:00:00-08	DNA	12.19	192	192	\N	5
27944	AM2 D-205	2020-03-07 00:00:00-08	DNA	4.97	96	96	\N	5
27945	AM2 D-206	2020-03-07 00:00:00-08	DNA	0.57	96	96	\N	5
27946	AM2 D-207	2020-03-07 00:00:00-08	DNA	11.5	96	96	\N	5
27947	AM2 D-208	2020-03-07 00:00:00-08	DNA	4.76	96	96	\N	5
27948	AM2 D-210	2020-03-07 00:00:00-08	DNA	0.07	96	96	\N	5
27949	AM2 D-211	2020-03-07 00:00:00-08	DNA	1.28	96	96	\N	5
27950	AM2 D-212	2020-03-07 00:00:00-08	DNA	0.18	96	96	\N	5
27951	AM2 D-213	2020-03-07 00:00:00-08	DNA	1.11	96	96	\N	5
27952	AM2 D-214	2020-03-07 00:00:00-08	DNA	0.63	96	96	\N	5
27953	AM2 D-215	2020-03-07 00:00:00-08	DNA	40.1	96	96	\N	5
27954	AM2 D-216	2020-03-07 00:00:00-08	DNA	0.71	96	96	\N	5
27955	AM2 D-217	2020-03-07 00:00:00-08	DNA	0.7	96	96	\N	5
27956	AM2 D-218	2020-03-07 00:00:00-08	DNA	20.3	96	96	AMLP-222 (sheared 250 ng)	5
27957	AM2 D-219	2020-03-07 00:00:00-08	DNA	22	96	96	\N	5
27958	AM2 D-220	2020-03-07 00:00:00-08	DNA	0.62	96	96	\N	5
27959	AM2 D-221	2020-03-07 00:00:00-08	DNA	2.37	96	96	\N	5
27960	AM2 D-222	2020-03-07 00:00:00-08	DNA	6.75	96	96	\N	5
27961	AM2 D-223	2020-03-07 00:00:00-08	DNA	4.16	96	96	\N	5
27962	AM2 D-224	2020-03-07 00:00:00-08	DNA	11.9	96	96	\N	5
27963	AM2 D-225	2020-07-22 00:00:00-07	DNA	3.25	100	100	\N	6
27964	AM2 D-226	2020-07-22 00:00:00-07	DNA	0.68	100	100	\N	6
27965	AM2 D-227	2020-07-22 00:00:00-07	DNA	2.06	100	100	\N	6
27966	AM2 D-228	2020-07-22 00:00:00-07	DNA	1.63	100	100	\N	6
27967	AM2 D-229	2020-07-22 00:00:00-07	DNA	5.12	100	100	\N	6
27968	AM2 D-232	2020-07-22 00:00:00-07	DNA	5.25	100	100	\N	6
27969	AM2 D-233	2020-07-22 00:00:00-07	DNA	0.85	100	100	\N	6
27970	AM2 D-236	2020-07-22 00:00:00-07	DNA	0.72	100	100	\N	6
27971	AM2 D-237	2020-07-22 00:00:00-07	DNA	33	100	100	\N	6
27972	AM2 D-238	2020-07-22 00:00:00-07	DNA	2.89	100	100	\N	6
27973	AM2 D-239	2020-07-22 00:00:00-07	DNA	0.17	100	100	\N	6
27974	AM2 D-240	2020-07-22 00:00:00-07	DNA	0.2	100	100	\N	6
27975	AM2 D-241	2020-07-22 00:00:00-07	DNA	1.12	100	100	\N	6
27976	AM2 D-242	2020-07-22 00:00:00-07	DNA	32	100	100	\N	6
27977	AM2 D-243	2020-07-22 00:00:00-07	DNA	0.25	100	100	\N	6
27978	AM2 D-244	2020-07-22 00:00:00-07	DNA	1.47	100	100	\N	6
27979	AM2 D-245	2020-07-22 00:00:00-07	DNA	0.69	100	100	\N	6
27980	AM2 D-246	2020-07-22 00:00:00-07	DNA	0.37	100	100	\N	6
27981	AM2 D-247	2020-07-22 00:00:00-07	DNA	0.46	100	100	\N	6
27982	AM2 D-248	2020-07-22 00:00:00-07	DNA	0	100	100	\N	6
27983	AM2 D-249	2020-07-22 00:00:00-07	DNA	0.3	100	100	\N	6
27984	AM2 D-250	2020-07-22 00:00:00-07	DNA	0.38	100	100	\N	6
27985	AM2 D-251	2020-07-22 00:00:00-07	DNA	3.23	100	100	\N	6
27986	AM2 D-252	2020-07-22 00:00:00-07	DNA	0.64	100	100	\N	6
27987	AM2 D-253	2020-07-22 00:00:00-07	DNA	2.1	100	100	\N	6
27988	AM2 D-254	2020-07-22 00:00:00-07	DNA	0.62	100	100	\N	6
27989	AM2 D-255	2020-07-22 00:00:00-07	DNA	0.19	100	100	\N	6
27990	AM2 D-256	2020-11-10 00:00:00-08	DNA	0.1	96	96	\N	6
27991	AM2 D-257	2020-11-10 00:00:00-08	DNA	0.29	96	96	\N	6
27992	AM2 D-258	2020-11-10 00:00:00-08	DNA	0.21	96	96	\N	6
27993	AM2 D-259	2020-11-10 00:00:00-08	DNA	1.86	96	96	\N	6
27994	AM2 D-260	2020-11-10 00:00:00-08	DNA	5.11	96	96	\N	6
27995	AM2 D-261	2020-11-10 00:00:00-08	DNA	1.25	96	96	\N	6
27996	AM2 D-262	2020-11-10 00:00:00-08	DNA	0.44	96	96	\N	6
27997	AM2 D-263	2020-11-10 00:00:00-08	DNA	0.28	96	96	\N	6
27998	AM2 D-264	2020-11-10 00:00:00-08	DNA	4.07	96	96	\N	6
27999	AM2 D-265	2020-11-10 00:00:00-08	DNA	2.55	96	96	\N	6
28000	AM2 D-266	2020-11-10 00:00:00-08	DNA	0.62	96	96	\N	6
28001	AM2 D-268	2020-11-10 00:00:00-08	DNA	0.13	96	96	\N	6
28002	AM2 D-269	2020-11-10 00:00:00-08	DNA	12.6	96	96	\N	6
28003	AM2 D-270	2020-11-10 00:00:00-08	DNA	3.26	96	96	\N	6
28004	AM2 D-271	2020-11-10 00:00:00-08	DNA	0.37	96	96	\N	6
28005	AM2 D-272	2020-11-10 00:00:00-08	DNA	0.75	96	96	\N	6
28006	AM2 D-273	2020-11-10 00:00:00-08	DNA	0.67	96	96	\N	6
28007	AM2 D-274	2020-11-10 00:00:00-08	DNA	2.36	96	96	\N	6
28008	AM2 D-275	2020-11-10 00:00:00-08	DNA	0.38	96	96	\N	6
28009	AM2 D-276	2020-11-10 00:00:00-08	DNA	0.2	96	96	\N	6
28010	AM2 D-277	2020-11-10 00:00:00-08	DNA	0.13	96	96	\N	6
28011	AM2 D-278	2020-11-10 00:00:00-08	DNA	0	96	96	\N	6
28012	AM2 D-279	2020-11-10 00:00:00-08	DNA	0	96	96	\N	6
28013	AM2 D-280	2020-11-10 00:00:00-08	DNA	0	96	96	\N	6
28014	AM2 D-281	2020-12-28 00:00:00-08	DNA	0.59	96	96	\N	6
28015	AM2 D-282	2020-12-28 00:00:00-08	DNA	0	96	96	\N	6
28016	AM2 D-283	2020-12-28 00:00:00-08	DNA	0.26	96	96	\N	6
28017	AM2 D-284	2020-12-28 00:00:00-08	DNA	0.18	96	96	\N	6
28018	AM2 D-286	2020-12-28 00:00:00-08	DNA	0	96	96	\N	6
28019	AM2 D-287	2020-12-28 00:00:00-08	DNA	1.57	96	96	\N	6
28020	AM2 D-288	2020-12-28 00:00:00-08	DNA	0.2	96	96	\N	6
28021	AM2 D-289	2020-12-28 00:00:00-08	DNA	0.4	96	96	\N	6
28022	AM2 D-291	2020-12-28 00:00:00-08	DNA	0.57	96	96	\N	6
28023	AM2 D-293	2021-02-22 00:00:00-08	DNA	1.23	95	95	\N	2
28024	AM2 D-294	2020-12-28 00:00:00-08	DNA	11	96	96	\N	6
28025	AM2 D-295	2020-12-28 00:00:00-08	DNA	11.4	96	96	\N	6
28026	AM2 D-296	2020-12-28 00:00:00-08	DNA	0.81	96	96	\N	6
28027	AM2 D-297	2020-12-28 00:00:00-08	DNA	0.18	96	96	\N	6
28028	AM2 D-298	2020-12-28 00:00:00-08	DNA	0.83	96	96	\N	6
28029	AM2 D-299	2020-12-28 00:00:00-08	DNA	0.3	96	96	\N	6
28030	AM2 D-300	2020-12-28 00:00:00-08	DNA	0.13	96	96	\N	6
28031	AM2 D-303	2020-12-28 00:00:00-08	DNA	0.05	96	96	\N	6
28032	AM2 D-304	2020-12-28 00:00:00-08	DNA	0.26	96	96	\N	6
28033	AM2 D-308	2020-12-28 00:00:00-08	DNA	4	96	96	\N	6
28034	AM2 D-309	2020-12-28 00:00:00-08	DNA	4.23	96	96	\N	6
28035	AM2 D-310	2020-12-28 00:00:00-08	DNA	1.51	96	96	\N	6
28036	AM2 D-311	2020-12-28 00:00:00-08	DNA	2.17	96	96	\N	6
28037	AM2 D-312	2020-12-28 00:00:00-08	DNA	0.88	96	96	\N	6
28038	AM2 D-313	2020-12-28 00:00:00-08	DNA	1.09	96	96	\N	6
28039	AM2 D-314	2021-01-05 00:00:00-08	DNA	0	96	96	\N	6
28040	AM2 D-316	2021-01-05 00:00:00-08	DNA	9.53	96	96	\N	6
28041	AM2 D-317	2021-01-05 00:00:00-08	DNA	2.13	96	96	\N	6
28042	AM2 D-318	2021-01-05 00:00:00-08	DNA	10.7	96	96	\N	6
28043	AM2 D-319	2021-01-05 00:00:00-08	DNA	0.14	96	96	\N	6
28044	AM2 D-320	2021-01-05 00:00:00-08	DNA	0.52	96	96	\N	6
28045	AM2 D-321	\N	DNA	0	0	0	\N	\N
28046	AM2 D-322	2021-01-05 00:00:00-08	DNA	1.47	96	96	\N	6
28047	AM2 D-323	2021-01-05 00:00:00-08	DNA	33.3	96	96	\N	6
28048	AM2 D-324	2021-01-05 00:00:00-08	DNA	0.09	96	96	\N	6
28049	AM2 D-325	2021-01-05 00:00:00-08	DNA	0.09	96	96	\N	6
28050	AM2 D-326	2021-01-05 00:00:00-08	DNA	0	96	96	\N	6
28051	AM2 D-327	2021-01-05 00:00:00-08	DNA	0.11	96	96	\N	6
28052	AM2 D-328	2021-01-05 00:00:00-08	DNA	5.45	96	96	\N	6
28053	AM2 D-329	2021-01-05 00:00:00-08	DNA	2.64	96	96	\N	6
28054	AM2 D-330	2021-01-05 00:00:00-08	DNA	0	96	96	\N	6
28055	AM2 D-331	2021-01-05 00:00:00-08	DNA	42	96	96	\N	6
28056	AM2 D-332	2021-02-21 00:00:00-08	DNA	4.51	95	95	\N	2
28057	AM2 D-333	2021-01-05 00:00:00-08	DNA	2.76	96	96	\N	6
28058	AM2 D-334	2021-01-05 00:00:00-08	DNA	1.4	96	96	\N	6
28059	AM2 D-335	2021-01-05 00:00:00-08	DNA	0.75	96	96	\N	6
28060	AM2 D-336	2021-01-05 00:00:00-08	DNA	1.31	96	96	\N	6
28061	AM2 D-337	2021-01-05 00:00:00-08	DNA	0.28	96	96	\N	6
28062	AM2 D-338	2021-01-05 00:00:00-08	DNA	0.71	96	96	\N	6
28063	AM2 D-339	2021-01-05 00:00:00-08	DNA	0.58	96	96	\N	6
28064	AM2 D-340	2021-01-05 00:00:00-08	DNA	1.97	96	96	\N	6
28065	AM2 D-341	2021-02-22 00:00:00-08	DNA	1.57	95	95	\N	2
28066	AM2 D-342	2021-02-22 00:00:00-08	DNA	0.84	95	95	\N	2
28067	AM2 D-343	2021-02-22 00:00:00-08	DNA	1.13	95	95	\N	2
28068	AM2 D-345	2021-02-22 00:00:00-08	DNA	1	95	95	\N	2
28069	AM2 D-347	2021-02-22 00:00:00-08	DNA	5.87	95	95	AMLP-301 sheared 200 ng	2
28070	AM2 D-348	2021-02-22 00:00:00-08	DNA	3.24	95	95	\N	2
28071	AM2 D-349	2021-03-08 00:00:00-08	DNA	1.68	95	95	\N	2
28072	AM2 D-350	2021-03-08 00:00:00-08	DNA	0.46	95	95	\N	2
28073	AM2 D-351	2021-03-08 00:00:00-08	DNA	0.77	95	95	\N	2
28074	AM2 D-352	2021-03-08 00:00:00-08	DNA	0.3	95	95	\N	2
28075	AM2 D-353	2021-03-08 00:00:00-08	DNA	0.19	95	95	\N	2
28076	AM2 D-354	2021-03-08 00:00:00-08	DNA	0.74	95	95	\N	2
28077	AM2 D-355	2021-02-22 00:00:00-08	DNA	0.23	95	95	\N	2
28078	AM2 D-356	2021-02-22 00:00:00-08	DNA	0.26	95	95	\N	2
28079	AM2 D-357	2021-02-22 00:00:00-08	DNA	0.41	95	95	\N	2
28080	AM2 D-358	2021-02-22 00:00:00-08	DNA	1.21	95	95	DO NOT USE	2
28081	AM2 D-360	2021-03-09 00:00:00-08	DNA	1.2	95	95	45 min incubation at 72oC	2
28082	AM2 D-361	2021-03-09 00:00:00-08	DNA	0.77	95	95	45 min incubation at 72oC	2
28083	AM2 D-362	2021-03-09 00:00:00-08	DNA	1.22	95	95	45 min incubation at 72oC	2
28084	AM2 D-363	2021-03-09 00:00:00-08	DNA	0.65	95	95	45 min incubation at 72oC	2
28085	AM2 D-365	2021-03-09 00:00:00-08	DNA	35.3	95	95	45 min incubation at 72oC	2
28086	AM2 D-366	2021-03-09 00:00:00-08	DNA	1.44	95	95	45 min incubation at 72oC	2
28087	AM2 D-367	2021-03-09 00:00:00-08	DNA	15.4	95	95	45 min incubation at 72oC	2
28088	AM2 D-368	2021-03-09 00:00:00-08	DNA	1.65	95	95	45 min incubation at 72oC	2
28089	AM2 D-369	2021-02-27 00:00:00-08	DNA	3.07	95	95	45 min incubation at 72oC	2
28090	AM2 D-370	2021-02-27 00:00:00-08	DNA	2.83	95	95	45 min incubation at 72oC	2
28091	AM2 D-371	2021-02-27 00:00:00-08	DNA	7.46	95	95	45 min incubation at 72oC	2
28092	AM2 D-372	2021-02-11 00:00:00-08	DNA	10.5	95	95	30 min incubation at 72oC	2
28093	AM2 D-373	2021-02-14 00:00:00-08	DNA	18.6	95	95	45 min incubation at 72oC	2
28094	AM2 D-374	2021-02-11 00:00:00-08	DNA	14.8	95	95	60 min incubation at 72oC	2
28095	AM2 D-375	2021-02-14 00:00:00-08	DNA	25.5	95	95	75 min incubation at 72oC	2
28096	AM2 D-376	2020-02-17 00:00:00-08	DNA	38.1	88	88	\N	6
28097	AM2 D-378	2021-02-27 00:00:00-08	DNA	7.53	190	190	45 min incubation at 72oC	2
28098	AM2 D-379	2021-02-27 00:00:00-08	DNA	19.5	190	190	45 min incubation at 72oC	2
28099	AM2 D-380	2021-02-27 00:00:00-08	DNA	51	190	190	45 min incubation at 72oC	2
28100	AM2 D-381	2021-09-06 00:00:00-07	DNA	15.4	88	88	\N	2
28101	AM2 D-382	2021-09-06 00:00:00-07	DNA	5.31	88	88	\N	2
28102	AM2 D-383	2021-02-11 00:00:00-08	DNA	11.7	95	95	30 min incubation at 72oC	2
28103	AM2 D-384	2021-02-14 00:00:00-08	DNA	14.8	95	95	45 min incubation at 72oC	2
28104	AM2 D-385	2021-02-11 00:00:00-08	DNA	8.54	95	95	60 min incubation at 72oC	2
28105	AM2 D-386	2021-02-14 00:00:00-08	DNA	14.4	95	95	75 min incubation at 72oC	2
28106	AM2 D-387	2020-02-17 00:00:00-08	DNA	12.6	88	88	\N	6
28107	AM2 D-393	2021-03-01 00:00:00-08	DNA	0	95	95	45 min incubation at 72oC	2
28108	AM2 D-394	2021-03-01 00:00:00-08	DNA	0	95	95	45 min incubation at 72oC	2
28109	AM2 D-395	2021-03-01 00:00:00-08	DNA	0	95	95	45 min incubation at 72oC	2
28110	AM2 D-399	2021-02-27 00:00:00-08	DNA	1.67	190	190	45 min incubation at 72oC	2
28111	AM2 D-400	2021-02-27 00:00:00-08	DNA	3.84	95	95	45 min incubation at 72oC	2
28112	AM2 D-401	2021-03-01 00:00:00-08	DNA	36.3	190	190	45 min incubation at 72oC	2
28113	AM2 D-402	2021-02-27 00:00:00-08	DNA	40.2	95	95	45 min incubation at 72oC	2
28114	AM2 D-403	2021-03-01 00:00:00-08	DNA	0.56	95	95	45 min incubation at 72oC	2
28115	AM2 D-404	2021-03-01 00:00:00-08	DNA	0.89	95	95	45 min incubation at 72oC	2
28116	AM2 D-405	2021-03-01 00:00:00-08	DNA	4.46	95	95	45 min incubation at 72oC	2
28117	AM2 D-406	2021-03-01 00:00:00-08	DNA	1.03	95	95	45 min incubation at 72oC	2
28118	AM2 D-407	2021-03-01 00:00:00-08	DNA	0.78	95	95	45 min incubation at 72oC	2
28119	AM2 D-408	2021-03-01 00:00:00-08	DNA	0.96	95	95	45 min incubation at 72oC	2
28120	AM2 D-410	2021-02-04 00:00:00-08	DNA	0.84	95	95	\N	2
28121	AM2 D-411	2021-02-03 00:00:00-08	DNA	0.11	88	88	\N	6
28122	AM2 D-412	2021-02-04 00:00:00-08	DNA	51	95	95	\N	2
28123	AM2 D-413	2021-02-03 00:00:00-08	DNA	38.4	88	88	\N	6
28124	AM2 D-414	2021-02-04 00:00:00-08	DNA	7.3	88	88	\N	2
28125	AM2 D-415	2021-02-03 00:00:00-08	DNA	2.04	88	88	\N	6
28126	AM2 D-419	2021-03-01 00:00:00-08	DNA	3.96	95	95	45 min incubation at 72oC	2
28127	AM2 D-420	2021-03-01 00:00:00-08	DNA	2.25	95	95	45 min incubation at 72oC	2
28128	AM2 D-421	2021-03-01 00:00:00-08	DNA	1.86	95	95	45 min incubation at 72oC	2
28129	AM2 D-422	2021-03-01 00:00:00-08	DNA	35.9	190	190	45 min incubation at 72oC	2
28130	AM2 D-423	2021-03-01 00:00:00-08	DNA	11.1	190	190	45 min incubation at 72oC	2
28131	AM2 D-425	2021-02-11 00:00:00-08	DNA	1.19	95	95	30 min incubation at 72oC	2
28132	AM2 D-426	2021-02-14 00:00:00-08	DNA	2.19	95	95	45 min incubation at 72oC	2
28133	AM2 D-427	2021-02-11 00:00:00-08	DNA	1.18	95	95	60 min incubation at 72oC	2
28134	AM2 D-428	2021-02-14 00:00:00-08	DNA	1.8	95	95	75 min incubation at 72oC	2
28135	AM2 D-429	2020-02-17 00:00:00-08	DNA	1.1	88	88	\N	6
28136	AM2 D-430	2021-03-01 00:00:00-08	DNA	2.45	190	190	45 min incubation at 72oC	2
28137	AM2 D-431	2021-09-06 00:00:00-07	DNA	23.4	88	88	\N	2
28138	AM2 D-433	2021-02-27 00:00:00-08	DNA	6.74	95	95	45 min incubation at 72oC	2
28139	AM2 D-434	2021-02-27 00:00:00-08	DNA	1.08	95	95	45 min incubation at 72oC	2
28140	AM2 D-435	2021-02-27 00:00:00-08	DNA	2.51	95	95	45 min incubation at 72oC	2
28141	AM2 D-436	2021-02-27 00:00:00-08	DNA	1.74	95	95	45 min incubation at 72oC	2
28142	AM2 D-437	2021-02-27 00:00:00-08	DNA	1.08	190	190	45 min incubation at 72oC	2
28143	AM2 D-438	2021-02-27 00:00:00-08	DNA	12.8	95	95	45 min incubation at 72oC	2
28144	AM2 D-439	2021-03-09 00:00:00-08	DNA	0.16	95	95	45 min incubation at 72oC	2
28145	AM2 D-440	2021-03-09 00:00:00-08	DNA	0.18	95	95	45 min incubation at 72oC	2
28146	AM2 D-441	2021-03-09 00:00:00-08	DNA	7.43	95	95	45 min incubation at 72oC	2
28147	AM2 D-443	2021-03-09 00:00:00-08	DNA	1.22	95	95	45 min incubation at 72oC	2
28148	AM2 D-444	2021-03-09 00:00:00-08	DNA	0	95	95	45 min incubation at 72oC	2
28149	AM2 D-445	2021-03-22 00:00:00-07	DNA	3.59	95	95	45 min incubation at 72oC	2
28150	AM2 D-446	2021-03-22 00:00:00-07	DNA	6.14	95	95	45 min incubation at 72oC	2
28151	AM2 D-447	2021-03-22 00:00:00-07	DNA	0.61	95	95	45 min incubation at 72oC	2
28152	AM2 D-448	2021-03-22 00:00:00-07	DNA	2.62	95	95	45 min incubation at 72oC	2
28153	AM2 D-450	2021-03-22 00:00:00-07	DNA	1.44	95	95	45 min incubation at 72oC	2
28154	AM2 D-451	2021-03-22 00:00:00-07	DNA	1.06	95	95	45 min incubation at 72oC	2
28155	AM2 D-452	2021-03-22 00:00:00-07	DNA	1.89	95	95	45 min incubation at 72oC	2
28156	AM2 D-453	2021-04-15 00:00:00-07	DNA	0.73	380	380	45 min incubation at 72oC	2
28157	AM2 D-454	2021-05-06 00:00:00-07	DNA	2.4	95	95	45 min incubation at 72oC	2
28158	AM2 D-455	2021-05-18 00:00:00-07	DNA	1.68	95	95	45 min incubation at 72oC	2
28159	AM2 D-456	2021-05-18 00:00:00-07	DNA	2.95	95	95	45 min incubation at 72oC	2
28160	AM2 D-457	2021-05-18 00:00:00-07	DNA	10.2	95	95	45 min incubation at 72oC	2
28161	AM2 D-458	2021-05-18 00:00:00-07	DNA	6.65	95	95	45 min incubation at 72oC	2
28162	AM2 D-459	2021-05-18 00:00:00-07	DNA	19	95	95	45 min incubation at 72oC	2
28163	AM2 D-460	2021-05-18 00:00:00-07	DNA	9.94	95	95	45 min incubation at 72oC	2
28164	AM2 D-461	2021-05-18 00:00:00-07	DNA	7.76	95	95	45 min incubation at 72oC	2
28165	AM2 D-462	2021-05-18 00:00:00-07	DNA	1.73	95	95	45 min incubation at 72oC	2
28166	AM2 D-463	2021-05-18 00:00:00-07	DNA	2.6	95	95	45 min incubation at 72oC	2
28167	AM2 D-464	2021-05-18 00:00:00-07	DNA	5.47	95	95	45 min incubation at 72oC	2
28168	AM2 D-465	2021-05-18 00:00:00-07	DNA	6.25	95	95	45 min incubation at 72oC	2
28169	AM2 D-466	2021-05-18 00:00:00-07	DNA	1.25	95	95	45 min incubation at 72oC	2
28170	AM2 D-467	2021-05-25 00:00:00-07	DNA	0.55	190	190	45 min incubation at 72oC	2
28171	AM2 D-468	2021-05-25 00:00:00-07	DNA	7.74	95	95	45 min incubation at 72oC	2
28172	AM2 D-470	2021-05-25 00:00:00-07	DNA	1.85	190	190	45 min incubation at 72oC	2
28173	AM2 D-471	2021-05-25 00:00:00-07	DNA	1.05	95	95	45 min incubation at 72oC	2
28174	AM2 D-472	2021-05-25 00:00:00-07	DNA	1.58	95	95	45 min incubation at 72oC	2
28175	AM2 D-473	2021-05-25 00:00:00-07	DNA	0	0	0	45 min incubation at 72oC	2
28176	AM2 D-474	2021-05-25 00:00:00-07	DNA	1.37	95	95	45 min incubation at 72oC	2
28177	AM2 D-475	2021-05-25 00:00:00-07	DNA	2.78	95	95	45 min incubation at 72oC	2
28178	AM2 D-476	2021-05-25 00:00:00-07	DNA	1.27	95	95	45 min incubation at 72oC	2
28179	AM2 D-477	2021-05-25 00:00:00-07	DNA	0.27	95	95	45 min incubation at 72oC	2
28180	AM2 D-478	2021-05-25 00:00:00-07	DNA	5.19	95	95	45 min incubation at 72oC	2
28181	AM2 D-479	2021-05-25 00:00:00-07	DNA	0.48	95	95	45 min incubation at 72oC	2
28182	AM2 D-480	2021-05-25 00:00:00-07	DNA	0.64	95	95	45 min incubation at 72oC	2
28183	AM2 D-481 (P041_03B)	2021-07-29 00:00:00-07	DNA	1.09	48	48	DIN:2.4, 10 x (1-48 mm^2; 15 um)\n16 ng input	7
28184	AM2 D-482 (P041_03C)	2021-07-29 00:00:00-07	DNA	4.85	48	48	DIN:1.9, 10 x (1-48 mm^2; 15 um)\n90 ng input	7
28185	AM2 D-483 (P041_03D)	2021-07-29 00:00:00-07	DNA	2.21	48	48	DIN: 2.2, 10 x (1-48 mm^2; 15 um)\n40.0 ng input	7
28186	AM2 D-484	2021-09-06 00:00:00-07	DNA	0.44	88	88	\N	2
28187	AM2 D-485	2021-09-06 00:00:00-07	DNA	8.12	176	176	Has Melanin	2
28188	AM2 D-486-1	2021-09-06 00:00:00-07	DNA	9.07	88	88	Use this sample for LP	2
28189	AM2 D-486-2	2021-09-06 00:00:00-07	DNA	0.23	88	88	\N	2
28190	AM2 D-487	2021-09-10 00:00:00-07	DNA	1.61	88	88	\N	2
28191	AM2 D-488	2021-09-21 00:00:00-07	DNA	3.6	88	88	No DNA left over	2
28192	AM2 D-489	2021-09-21 00:00:00-07	DNA	22.4	88	88	\N	2
28193	AM2 D-490	2022-01-17 00:00:00-08	DNA	4.84	88	88	\N	2
28194	AM2 D-491	2022-01-17 00:00:00-08	DNA	11	88	88	\N	2
28195	AM2 D-492	2022-01-17 00:00:00-08	DNA	1.61	88	88	\N	2
28196	AM2 D-493	2022-01-17 00:00:00-08	DNA	1.31	88	88	\N	2
28197	AM2 D-494	2022-01-17 00:00:00-08	DNA	2.14	88	88	\N	2
28198	AM2 D-495	2022-01-17 00:00:00-08	DNA	1.36	88	88	\N	2
28199	AM2 D-496	2022-01-17 00:00:00-08	DNA	4.8	88	88	\N	2
28200	AM2 D-498	2022-05-16 00:00:00-07	DNA	0.14	88	88	\N	2
28201	AM2 D-499	2022-05-16 00:00:00-07	DNA	0.16	88	88	\N	2
28202	AM2 D-500	2022-05-16 00:00:00-07	DNA	4.65	88	88	\N	2
28203	AM2 D-501	2022-05-16 00:00:00-07	DNA	2.17	88	88	\N	2
28204	AM2 D-503	2022-05-16 00:00:00-07	DNA	10.2	88	88	\N	2
28205	AM2 D-504	2022-05-16 00:00:00-07	DNA	2.28	88	88	\N	2
28206	AM2 D-505	2022-05-16 00:00:00-07	DNA	3.25	88	88	\N	2
28207	AM2 D-506	2022-05-16 00:00:00-07	DNA	0.57	88	88	\N	2
28208	AM2 D-507	2022-05-16 00:00:00-07	DNA	2.24	88	88	\N	2
28209	AM2 D-508	2022-05-16 00:00:00-07	DNA	4.85	88	88	\N	2
28210	AM2 D-509	2022-05-16 00:00:00-07	DNA	2.39	88	88	\N	2
28211	AM2 D-510	2022-05-16 00:00:00-07	DNA	5.74	88	88	\N	2
28212	AM2 D-511	2022-05-16 00:00:00-07	DNA	1.73	88	88	\N	2
28213	AM2 D-512	2022-05-16 00:00:00-07	DNA	4.34	88	88	\N	2
28214	AM2 D-513	2023-02-08 00:00:00-08	DNA	6.47	180	180	\N	2
28215	AM2 D-514	2023-02-08 00:00:00-08	DNA	9.46	180	180	\N	2
28216	AM2 D-516	2023-02-08 00:00:00-08	DNA	5.72	180	180	\N	2
28217	AM2 D-517	2023-02-08 00:00:00-08	DNA	0.98	180	180	\N	2
28218	AM2 D-518	2023-02-08 00:00:00-08	DNA	2.56	80	80	\N	2
28219	AM2 D-519	2023-02-08 00:00:00-08	DNA	0.56	80	80	\N	2
28220	AM2 D-520	\N	DNA	0	0	0	\N	2
28626	CGH12_026_NA	\N	DNA	\N	\N	\N	\N	\N
28221	AM2 D-521	2023-02-08 00:00:00-08	DNA	2.54	180	180	\N	2
28222	AM2 D-522	2023-02-08 00:00:00-08	DNA	0.87	80	80	\N	2
28223	AM2 D-523	2023-02-08 00:00:00-08	DNA	8.63	180	180	\N	2
28224	AM2 D-524	2023-02-08 00:00:00-08	DNA	4.1	180	180	\N	2
28225	AM2 D-525	2023-02-08 00:00:00-08	DNA	1.51	180	180	\N	2
28226	AM2 D-526	2023-02-08 00:00:00-08	DNA	1.58	80	80	\N	2
28227	AM2 D-527	\N	DNA	0	0	0	\N	2
28228	AM2 D-528	2023-02-14 00:00:00-08	DNA	0.34	176	176	\N	2
28229	AM2 D-531	2023-02-14 00:00:00-08	DNA	3.76	88	88	\N	2
28230	AM2 D-532	2023-02-14 00:00:00-08	DNA	13.4	176	176	\N	2
28231	AM2 D-533	\N	DNA	0	0	0	\N	2
28232	AM2 D-534	\N	DNA	0	0	0	\N	2
28233	AM2 D-535	\N	DNA	0	0	0	\N	2
28234	AM2 D-536	2023-03-29 00:00:00-07	DNA	2.52	80	80	\N	2
28235	AM2 D-537	2023-03-29 00:00:00-07	DNA	6.92	80	80	\N	2
28236	AM2 D-538	2023-06-07 00:00:00-07	DNA	51	88	88	\N	6
28237	AM2 D-539	2023-06-07 00:00:00-07	DNA	12.5	88	88	\N	6
28238	AM2 D-540	2023-06-07 00:00:00-07	DNA	6.37	88	88	\N	6
28239	AM2 D-541	2023-06-07 00:00:00-07	DNA	33.6	88	88	\N	6
28240	AM2 D-544	2023-10-10 00:00:00-07	DNA	53	182	182	\N	2
28241	AM2 D-547	2023-10-10 00:00:00-07	DNA	0.35	182	182	\N	2
28242	AM2 D-550	2023-10-10 00:00:00-07	DNA	1.7	88	88	\N	2
28243	AM2 D-554	2023-10-10 00:00:00-07	DNA	1.94	200	200	\N	2
28244	AM2 D-557	2023-10-10 00:00:00-07	DNA	2.39	88	88	\N	2
28245	AM2 D-560	2023-10-10 00:00:00-07	DNA	0.63	88	88	\N	2
28246	AM2 D-563	2023-10-10 00:00:00-07	DNA	0.85	88	88	\N	2
28247	AM2 R-225	2020-07-25 00:00:00-07	RNA	11.8	20	20	\N	6
28248	AM2 R-226	2020-07-25 00:00:00-07	RNA	30.1	20	20	\N	6
28249	AM2 R-227	2020-07-25 00:00:00-07	RNA	74	20	20	DV200: 30-50	6
28250	AM2 R-228	2020-07-25 00:00:00-07	RNA	61	20	20	DV200: 50-70	6
28251	AM2 R-229	2020-07-25 00:00:00-07	RNA	91	20	20	\N	6
28252	AM2 R-232	2020-07-25 00:00:00-07	RNA	446	20	20	\N	6
28253	AM2 R-233	2020-07-25 00:00:00-07	RNA	33	20	20	\N	6
28254	AM2 R-236	2020-07-25 00:00:00-07	RNA	47.4	20	20	\N	6
28255	AM2 R-237	2020-07-25 00:00:00-07	RNA	956	20	20	\N	6
28256	AM2 R-238	2020-07-25 00:00:00-07	RNA	27.1	20	20	\N	6
28257	AM2 R-239	2020-07-25 00:00:00-07	RNA	5.22	20	20	\N	6
28258	AM2 R-240	2020-07-25 00:00:00-07	RNA	13.4	20	20	\N	6
28259	AM2 R-241	2020-07-25 00:00:00-07	RNA	23	20	20	\N	6
28260	AM2 R-242	2020-07-25 00:00:00-07	RNA	476	20	20	\N	6
28261	AM2 R-243	2020-07-25 00:00:00-07	RNA	5.58	20	20	\N	6
28262	AM2 R-244	2020-07-25 00:00:00-07	RNA	35.3	20	20	\N	6
28263	AM2 R-245	2020-07-25 00:00:00-07	RNA	55	20	20	\N	6
28264	AM2 R-246	2020-07-25 00:00:00-07	RNA	13.3	20	20	\N	6
28265	AM2 R-247	2020-07-25 00:00:00-07	RNA	5.67	20	20	\N	6
28266	AM2 R-248	2020-07-25 00:00:00-07	RNA	0	20	20	\N	6
28267	AM2 R-249	2020-07-25 00:00:00-07	RNA	14.8	20	20	\N	6
28268	AM2 R-250	2020-07-25 00:00:00-07	RNA	44.5	20	20	\N	6
28269	AM2 R-251	2020-07-25 00:00:00-07	RNA	29.8	20	20	\N	6
28270	AM2 R-252	2020-07-25 00:00:00-07	RNA	22.7	20	20	\N	6
28271	AM2 R-253	2020-07-25 00:00:00-07	RNA	24.8	20	20	\N	6
28272	AM2 R-254	2020-07-25 00:00:00-07	RNA	15.9	20	20	\N	6
28273	AM2 R-255	2020-07-25 00:00:00-07	RNA	0	20	20	\N	6
28274	AM2 R-256	2020-11-11 00:00:00-08	RNA	9.61	20	20	\N	6
28275	AM2 R-257	2020-11-11 00:00:00-08	RNA	69	20	20	\N	6
28276	AM2 R-258	2020-11-11 00:00:00-08	RNA	11.7	20	20	\N	6
28277	AM2 R-259	2020-11-11 00:00:00-08	RNA	32.9	20	20	\N	6
28278	AM2 R-260	2020-11-11 00:00:00-08	RNA	28.7	20	20	\N	6
28279	AM2 R-261	2020-11-11 00:00:00-08	RNA	0	20	20	\N	6
28280	AM2 R-262	2020-11-11 00:00:00-08	RNA	3.62	20	20	\N	6
28281	AM2 R-263	2020-11-11 00:00:00-08	RNA	5.68	20	20	\N	6
28282	AM2 R-264	2020-11-11 00:00:00-08	RNA	79	20	20	\N	6
28283	AM2 R-265	2020-11-11 00:00:00-08	RNA	7.29	20	20	\N	6
28284	AM2 R-266	2020-11-11 00:00:00-08	RNA	6.55	20	20	\N	6
28285	AM2 R-268	2020-11-11 00:00:00-08	RNA	10.3	20	20	\N	6
28286	AM2 R-269	2020-11-11 00:00:00-08	RNA	46.6	20	20	\N	6
28287	AM2 R-270	2020-11-11 00:00:00-08	RNA	69	20	20	\N	6
28288	AM2 R-271	2020-11-11 00:00:00-08	RNA	34.1	20	20	\N	6
28289	AM2 R-272	2020-11-11 00:00:00-08	RNA	28	20	20	\N	6
28290	AM2 R-273	2020-11-11 00:00:00-08	RNA	30.9	20	20	DV200: 50-70	6
28291	AM2 R-274	2020-11-11 00:00:00-08	RNA	31.3	20	20	\N	6
28292	AM2 R-275	2020-11-11 00:00:00-08	RNA	20.3	20	20	\N	6
28293	AM2 R-276	2020-11-11 00:00:00-08	RNA	10.4	20	20	\N	6
28294	AM2 R-277	2020-11-11 00:00:00-08	RNA	2.84	20	20	\N	6
28295	AM2 R-278	2020-11-11 00:00:00-08	RNA	0	20	20	\N	6
28296	AM2 R-279	2020-11-11 00:00:00-08	RNA	0	20	20	\N	6
28297	AM2 R-280	2020-11-11 00:00:00-08	RNA	5.35	20	20	\N	6
28298	AM2 R-281	2021-01-02 00:00:00-08	RNA	7.06	20	20	\N	6
28299	AM2 R-282	2021-01-02 00:00:00-08	RNA	2.4	20	20	\N	6
28300	AM2 R-283	2021-01-02 00:00:00-08	RNA	7.7	20	20	\N	6
28301	AM2 R-284	2021-01-02 00:00:00-08	RNA	2.99	20	20	\N	6
29093	DM16_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
28302	AM2 R-286	2021-01-02 00:00:00-08	RNA	6.99	20	20	\N	6
28303	AM2 R-287	2021-01-02 00:00:00-08	RNA	51	20	20	\N	6
28304	AM2 R-288	2021-01-02 00:00:00-08	RNA	21.3	20	20	\N	6
28305	AM2 R-289	2021-01-02 00:00:00-08	RNA	10.5	20	20	\N	6
28306	AM2 R-291	2021-01-02 00:00:00-08	RNA	55	20	20	\N	6
28307	AM2 R-293	2021-02-22 00:00:00-08	RNA	9.76	48	48	\N	1
28308	AM2 R-294	2021-01-02 00:00:00-08	RNA	0	20	20	\N	6
28309	AM2 R-295	2021-01-02 00:00:00-08	RNA	0	20	20	\N	6
28310	AM2 R-296	2021-01-02 00:00:00-08	RNA	28.7	20	20	\N	6
28311	AM2 R-297	2021-01-02 00:00:00-08	RNA	5.36	20	20	\N	6
28312	AM2 R-298	2021-01-02 00:00:00-08	RNA	38.7	20	20	\N	6
28313	AM2 R-299	2021-01-02 00:00:00-08	RNA	17.6	20	20	\N	6
28314	AM2 R-300	2021-01-02 00:00:00-08	RNA	9.51	20	20	\N	6
28315	AM2 R-303	2021-01-02 00:00:00-08	RNA	0	20	20	\N	6
28316	AM2 R-304	2021-01-02 00:00:00-08	RNA	2.51	20	20	\N	6
28317	AM2 R-308	2021-01-02 00:00:00-08	RNA	22.5	20	20	\N	6
28318	AM2 R-309	2021-01-02 00:00:00-08	RNA	58	20	20	\N	6
28319	AM2 R-310	2021-01-02 00:00:00-08	RNA	48.9	20	20	\N	6
28320	AM2 R-311	2021-01-02 00:00:00-08	RNA	52	20	20	\N	6
28321	AM2 R-312	2021-01-02 00:00:00-08	RNA	41.7	20	20	\N	6
28322	AM2 R-313	2021-01-02 00:00:00-08	RNA	17.4	20	20	\N	6
28323	AM2 R-314	2021-01-09 00:00:00-08	RNA	6.84	20	20	\N	6
28324	AM2 R-316	2021-01-09 00:00:00-08	RNA	28	20	20	\N	6
28325	AM2 R-317	2021-01-09 00:00:00-08	RNA	56	20	20	\N	6
28326	AM2 R-318	2021-01-09 00:00:00-08	RNA	25.7	20	20	\N	6
28327	AM2 R-319	2021-01-09 00:00:00-08	RNA	6.46	20	20	\N	6
28328	AM2 R-320	2021-01-09 00:00:00-08	RNA	22	20	20	\N	6
28329	AM2 R-321	\N	RNA	0	0	0	\N	\N
28330	AM2 R-322	2021-01-09 00:00:00-08	RNA	3.98	20	20	\N	6
28331	AM2 R-323	2021-01-09 00:00:00-08	RNA	17.8	20	20	\N	6
28332	AM2 R-324	2021-01-09 00:00:00-08	RNA	0	20	20	\N	6
28333	AM2 R-325	2021-01-09 00:00:00-08	RNA	0	20	20	\N	6
28334	AM2 R-326	2021-01-09 00:00:00-08	RNA	0	20	20	\N	6
28335	AM2 R-327	2021-01-09 00:00:00-08	RNA	5.03	20	20	\N	6
28336	AM2 R-328	2021-01-09 00:00:00-08	RNA	23.9	20	20	\N	6
28337	AM2 R-329	2021-01-09 00:00:00-08	RNA	14.9	20	20	\N	6
28338	AM2 R-330	2021-01-09 00:00:00-08	RNA	4.06	20	20	\N	6
28339	AM2 R-331	2021-01-09 00:00:00-08	RNA	93	20	20	\N	6
28340	AM2 R-333	2021-01-09 00:00:00-08	RNA	43.2	20	20	\N	6
28341	AM2 R-334	2021-01-09 00:00:00-08	RNA	31	20	20	\N	6
28342	AM2 R-335	2021-01-09 00:00:00-08	RNA	12.8	20	20	\N	6
28343	AM2 R-336	2021-01-09 00:00:00-08	RNA	20.1	20	20	\N	6
28344	AM2 R-337	2021-01-09 00:00:00-08	RNA	9.15	20	20	\N	6
28345	AM2 R-338	2021-01-09 00:00:00-08	RNA	8.8	20	20	\N	6
28346	AM2 R-339	2021-01-09 00:00:00-08	RNA	8.9	20	20	\N	6
28347	AM2 R-340	2021-01-09 00:00:00-08	RNA	19.7	20	20	\N	6
28348	AM2 R-341	2021-02-22 00:00:00-08	RNA	6.66	48	48	\N	1
28349	AM2 R-342	2021-02-22 00:00:00-08	RNA	2.3	48	48	\N	1
28350	AM2 R-343	2021-02-22 00:00:00-08	RNA	0	48	48	\N	1
28351	AM2 R-345	2021-02-22 00:00:00-08	RNA	4.45	48	48	\N	1
28352	AM2 R-347	2021-02-22 00:00:00-08	RNA	22.9	48	48	\N	1
28353	AM2 R-348	2021-02-22 00:00:00-08	RNA	18.6	48	48	\N	1
28354	AM2 R-350	2021-03-09 00:00:00-08	RNA	0	48	48	\N	1
28355	AM2 R-351	2021-03-09 00:00:00-08	RNA	0	48	48	\N	1
28356	AM2 R-352	2021-03-09 00:00:00-08	RNA	2	48	48	\N	1
28357	AM2 R-353	2021-03-09 00:00:00-08	RNA	2.1	48	48	\N	1
28358	AM2 R-354	2021-03-09 00:00:00-08	RNA	9.56	48	48	\N	1
28359	AM2 R-355	2021-02-22 00:00:00-08	RNA	5.83	48	48	\N	1
28360	AM2 R-356	2021-02-22 00:00:00-08	RNA	3.52	48	48	\N	1
28361	AM2 R-357	2021-02-22 00:00:00-08	RNA	7.59	48	48	\N	1
28362	AM2 R-358	2021-02-22 00:00:00-08	RNA	4.29	48	48	DO NOT USE	1
28363	AM2 R-361	2021-03-09 00:00:00-08	RNA	7.28	48	48	45 min incubation at 72oC	1
28364	AM2 R-363	2021-03-09 00:00:00-08	RNA	9.31	48	48	45 min incubation at 72oC	1
28365	AM2 R-370	2021-02-27 00:00:00-08	RNA	18.5	48	48	45 min incubation at 72oC	1
28366	AM2 R-371	2021-02-27 00:00:00-08	RNA	38.1	48	48	45 min incubation at 72oC	1
28367	AM2 R-372	2021-02-11 00:00:00-08	RNA	37.4	48	48	30 min incubation at 72oC	1
28368	AM2 R-373	2021-02-14 00:00:00-08	RNA	35.9	48	48	45 min incubation at 72oC	1
28369	AM2 R-374	2021-02-11 00:00:00-08	RNA	45.4	48	48	60 min incubation at 72oC	1
28370	AM2 R-375	2021-02-14 00:00:00-08	RNA	54	48	48	75 min incubation at 72oC	1
28371	AM2 R-376	2020-02-17 00:00:00-08	RNA	219	20	20	\N	6
28372	AM2 R-379	2021-02-27 00:00:00-08	RNA	20.5	144	144	45 min incubation at 72oC	1
28373	AM2 R-380	2021-02-27 00:00:00-08	RNA	46.9	96	96	45 min incubation at 72oC	1
28374	AM2 R-381	2021-09-06 00:00:00-07	RNA	27.4	48	48	\N	1
28375	AM2 R-382	2021-09-06 00:00:00-07	RNA	5.31	48	48	\N	1
28376	AM2 R-383	2021-02-11 00:00:00-08	RNA	46.7	48	48	30 min incubation at 72oC	1
28377	AM2 R-384	2021-02-14 00:00:00-08	RNA	45.1	48	48	45 min incubation at 72oC	1
28378	AM2 R-385	2021-02-11 00:00:00-08	RNA	44	48	48	60 min incubation at 72oC	1
28379	AM2 R-386	2021-02-14 00:00:00-08	RNA	46.3	48	48	75 min incubation at 72oC	1
28380	AM2 R-387	2020-02-17 00:00:00-08	RNA	81	20	20	\N	6
28381	AM2 R-393	2021-03-01 00:00:00-08	RNA	0	48	48	45 min incubation at 72oC	1
28382	AM2 R-394	2021-03-01 00:00:00-08	RNA	0	48	48	45 min incubation at 72oC	1
28383	AM2 R-395	2021-03-01 00:00:00-08	RNA	0	48	48	45 min incubation at 72oC	1
28384	AM2 R-400	2021-02-27 00:00:00-08	RNA	21.1	48	48	45 min incubation at 72oC	1
28385	AM2 R-401	2021-03-01 00:00:00-08	RNA	72	96	96	45 min incubation at 72oC	1
28386	AM2 R-402	2021-02-27 00:00:00-08	RNA	38.1	48	48	45 min incubation at 72oC	1
28387	AM2 R-403	2021-03-01 00:00:00-08	RNA	20	48	48	45 min incubation at 72oC	1
28388	AM2 R-404	2021-03-01 00:00:00-08	RNA	4.68	48	48	45 min incubation at 72oC	1
28389	AM2 R-405	2021-03-01 00:00:00-08	RNA	12.2	48	48	45 min incubation at 72oC	1
28390	AM2 R-408	2021-03-01 00:00:00-08	RNA	0	48	48	45 min incubation at 72oC	1
28391	AM2 R-410	2021-02-04 00:00:00-08	RNA	0	48	48	120 min incubation at 72oC	1
28392	AM2 R-411	2021-02-03 00:00:00-08	RNA	3.12	20	20	120 min incubation at 72oC	6
28393	AM2 R-412	2021-02-04 00:00:00-08	RNA	25	48	48	120 min incubation at 72oC	1
28394	AM2 R-413	2021-02-03 00:00:00-08	RNA	544	20	20	120 min incubation at 72oC	6
28395	AM2 R-414	2021-02-04 00:00:00-08	RNA	0	48	48	120 min incubation at 72oC	1
28396	AM2 R-415	2021-02-03 00:00:00-08	RNA	6.97	20	20	120 min incubation at 72oC	6
28397	AM2 R-419	2021-03-01 00:00:00-08	RNA	25.2	48	48	45 min incubation at 72oC	1
28398	AM2 R-420	2021-03-01 00:00:00-08	RNA	16.5	48	48	45 min incubation at 72oC	1
28399	AM2 R-422	2021-03-01 00:00:00-08	RNA	81	96	96	45 min incubation at 72oC	1
28400	AM2 R-423	2021-03-01 00:00:00-08	RNA	42.2	96	96	45 min incubation at 72oC	1
28401	AM2 R-425	2021-02-11 00:00:00-08	RNA	4.57	48	48	30 min incubation at 72oC	1
28402	AM2 R-426	2021-02-14 00:00:00-08	RNA	6.22	48	48	45 min incubation at 72oC	1
28403	AM2 R-427	2021-02-11 00:00:00-08	RNA	5.14	48	48	60 min incubation at 72oC	1
28404	AM2 R-428	2021-02-14 00:00:00-08	RNA	6.84	48	48	75 min incubation at 72oC	1
28405	AM2 R-429	2020-02-17 00:00:00-08	RNA	3.81	20	20	\N	6
28406	AM2 R-431	2021-09-06 00:00:00-07	RNA	15.9	48	48	\N	1
28407	AM2 R-433	2021-02-27 00:00:00-08	RNA	16.4	48	48	45 min incubation at 72oC	1
28408	AM2 R-434	2021-02-27 00:00:00-08	RNA	8.82	48	48	45 min incubation at 72oC	1
28409	AM2 R-435	2021-02-27 00:00:00-08	RNA	7.53	48	48	45 min incubation at 72oC	1
28410	AM2 R-436	2021-02-27 00:00:00-08	RNA	11.5	48	48	45 min incubation at 72oC	1
28411	AM2 R-438	2021-02-27 00:00:00-08	RNA	14.8	48	48	45 min incubation at 72oC	1
28412	AM2 R-445	2021-03-22 00:00:00-07	RNA	22.2	48	48	45 min incubation at 72oC	1
28413	AM2 R-446	2021-03-22 00:00:00-07	RNA	25.8	48	48	45 min incubation at 72oC	1
28414	AM2 R-447	2021-03-22 00:00:00-07	RNA	10.1	48	48	45 min incubation at 72oC	1
28415	AM2 R-448	2021-03-22 00:00:00-07	RNA	24.5	48	48	45 min incubation at 72oC	1
28416	AM2 R-450	2021-03-22 00:00:00-07	RNA	7.08	48	48	45 min incubation at 72oC	1
28417	AM2 R-451	2021-03-22 00:00:00-07	RNA	10.2	48	48	45 min incubation at 72oC	1
28418	AM2 R-452	2021-03-22 00:00:00-07	RNA	19.1	48	48	45 min incubation at 72oC	1
28419	AM2 R-453	2021-04-15 00:00:00-07	RNA	17.3	96	96	45 min incubation at 72oC	1
28420	AM2 R-454	2021-05-06 00:00:00-07	RNA	14.7	48	48	45 min incubation at 72oC	1
28421	AM2 R-455	2021-05-18 00:00:00-07	RNA	13.3	45	45	45 min incubation at 72oC	1
28422	AM2 R-456	2021-05-18 00:00:00-07	RNA	9.99	45	45	45 min incubation at 72oC	1
28423	AM2 R-457	2021-05-18 00:00:00-07	RNA	42.8	45	45	45 min incubation at 72oC	1
28424	AM2 R-458	2021-05-18 00:00:00-07	RNA	11.7	45	45	45 min incubation at 72oC	1
28425	AM2 R-459	2021-05-18 00:00:00-07	RNA	47.5	45	45	45 min incubation at 72oC	1
28426	AM2 R-460	2021-05-18 00:00:00-07	RNA	9.94	45	45	45 min incubation at 72oC	1
28427	AM2 R-461	2021-05-18 00:00:00-07	RNA	10.7	45	45	45 min incubation at 72oC	1
28428	AM2 R-462	2021-05-18 00:00:00-07	RNA	3.37	45	45	45 min incubation at 72oC	1
28429	AM2 R-463	2021-05-18 00:00:00-07	RNA	2.69	45	45	45 min incubation at 72oC	1
28430	AM2 R-464	2021-05-18 00:00:00-07	RNA	11.2	45	45	45 min incubation at 72oC	1
28431	AM2 R-465	2021-05-18 00:00:00-07	RNA	8.88	45	45	45 min incubation at 72oC	1
28432	AM2 R-466	2021-05-18 00:00:00-07	RNA	2.58	45	45	45 min incubation at 72oC	1
28433	AM2 R-467	2021-05-25 00:00:00-07	RNA	2.5	90	90	45 min incubation at 72oC	1
28434	AM2 R-468	2021-05-25 00:00:00-07	RNA	11.7	45	45	45 min incubation at 72oC	1
28435	AM2 R-470	2021-05-25 00:00:00-07	RNA	8.52	90	90	45 min incubation at 72oC	1
28436	AM2 R-471	2021-05-25 00:00:00-07	RNA	4.56	45	45	45 min incubation at 72oC	1
28437	AM2 R-472	2021-05-25 00:00:00-07	RNA	6.14	45	45	45 min incubation at 72oC	1
28438	AM2 R-473	2021-05-25 00:00:00-07	RNA	0	0	0	45 min incubation at 72oC	1
28439	AM2 R-474	2021-05-25 00:00:00-07	RNA	3.91	45	45	45 min incubation at 72oC	1
28440	AM2 R-475	2021-05-25 00:00:00-07	RNA	2.59	45	45	45 min incubation at 72oC	1
28441	AM2 R-476	2021-05-25 00:00:00-07	RNA	0	45	45	45 min incubation at 72oC	1
28442	AM2 R-477	2021-05-25 00:00:00-07	RNA	0	45	45	45 min incubation at 72oC	1
28443	AM2 R-478	2021-05-25 00:00:00-07	RNA	7.94	45	45	45 min incubation at 72oC	1
28444	AM2 R-479	2021-05-25 00:00:00-07	RNA	6.85	45	45	45 min incubation at 72oC	1
28445	AM2 R-480	2021-05-25 00:00:00-07	RNA	8.17	45	45	45 min incubation at 72oC	1
28446	AM2 R-484	2021-09-06 00:00:00-07	RNA	3.31	48	48	\N	1
28447	AM2 R-485	2021-09-06 00:00:00-07	RNA	0	48	48	\N	1
28448	AM2 R-486-1	2021-09-06 00:00:00-07	RNA	9.7	48	48	\N	1
28449	AM2 R-486-2	2021-09-06 00:00:00-07	RNA	4.66	48	48	\N	1
28450	AM2 R-487	2021-09-10 00:00:00-07	RNA	11.3	48	48	\N	1
28451	AM2 R-488	2021-09-21 00:00:00-07	RNA	19.6	48	48	\N	1
28452	AM2 R-489	2021-09-21 00:00:00-07	RNA	27.5	48	48	\N	1
28453	AM2 R-490	2022-01-17 00:00:00-08	RNA	10.9	48	48	\N	1
28454	AM2 R-491	2022-01-17 00:00:00-08	RNA	25.6	48	48	\N	1
28455	AM2 R-492	2022-01-17 00:00:00-08	RNA	3.13	48	48	\N	1
28456	AM2 R-493	2022-01-17 00:00:00-08	RNA	5.34	48	48	\N	1
28457	AM2 R-494	2022-01-17 00:00:00-08	RNA	4.21	48	48	\N	1
28458	AM2 R-495	2022-01-17 00:00:00-08	RNA	7	48	48	\N	1
28459	AM2 R-496	2022-01-17 00:00:00-08	RNA	7.75	48	48	\N	1
28460	AM2 R-498	2022-05-16 00:00:00-07	RNA	2.2	48	48	\N	1
28461	AM2 R-499	2022-05-16 00:00:00-07	RNA	2.4	48	48	\N	1
28462	AM2 R-500	2022-05-16 00:00:00-07	RNA	24.6	48	48	\N	1
28463	AM2 R-501	2022-05-16 00:00:00-07	RNA	9.23	48	48	\N	1
28464	AM2 R-503	2022-05-16 00:00:00-07	RNA	15.8	48	48	\N	1
28465	AM2 R-504	2022-05-16 00:00:00-07	RNA	8.31	48	48	\N	1
28466	AM2 R-505	2022-05-16 00:00:00-07	RNA	6.4	48	48	\N	1
28467	AM2 R-506	2022-05-16 00:00:00-07	RNA	5.41	48	48	\N	1
28468	AM2 R-507	2022-05-16 00:00:00-07	RNA	8.4	48	48	\N	1
28469	AM2 R-508	2022-05-16 00:00:00-07	RNA	10	48	48	\N	1
28470	AM2 R-509	2022-05-16 00:00:00-07	RNA	4.88	48	48	\N	1
28471	AM2 R-510	2022-05-16 00:00:00-07	RNA	11.5	48	48	\N	1
28472	AM2 R-511	2022-05-16 00:00:00-07	RNA	8.79	48	48	\N	1
28473	AM2 R-512	2022-05-16 00:00:00-07	RNA	12.4	48	48	\N	1
28474	AM2 R-513	2023-02-08 00:00:00-08	RNA	6.47	80	80	\N	1
28475	AM2 R-514	2023-02-08 00:00:00-08	RNA	9.46	80	80	\N	1
28476	AM2 R-516	2023-02-08 00:00:00-08	RNA	16.1	80	80	\N	1
28477	AM2 R-517	2023-02-08 00:00:00-08	RNA	8.66	80	80	\N	1
28478	AM2 R-518	2023-02-08 00:00:00-08	RNA	18.2	40	40	\N	1
28479	AM2 R-519	2023-02-08 00:00:00-08	RNA	6.52	40	40	\N	1
28480	AM2 R-520	\N	RNA	0	0	0	\N	1
28481	AM2 R-521	2023-02-08 00:00:00-08	RNA	21.7	80	80	\N	1
28482	AM2 R-522	2023-02-08 00:00:00-08	RNA	9.99	40	40	\N	1
28483	AM2 R-523	2023-02-08 00:00:00-08	RNA	0	80	80	\N	1
28484	AM2 R-524	2023-02-08 00:00:00-08	RNA	0	80	80	\N	1
28485	AM2 R-525	2023-02-08 00:00:00-08	RNA	13.3	80	80	\N	1
28486	AM2 R-526	2023-02-08 00:00:00-08	RNA	21.9	40	40	\N	1
28487	AM2 R-527	\N	RNA	0	0	0	\N	1
28488	AM2 R-528	2023-02-14 00:00:00-08	RNA	0.99	70	70	\N	1
28489	AM2 R-531	2023-02-14 00:00:00-08	RNA	15.8	40	40	\N	1
28490	AM2 R-532	2023-02-14 00:00:00-08	RNA	11.8	80	80	\N	1
28491	AM2 R-536	2023-03-29 00:00:00-07	RNA	5.64	40	40	\N	1
28492	AM2 R-537	2023-03-29 00:00:00-07	RNA	6.78	40	40	\N	1
28493	AM2 R-538	2023-06-07 00:00:00-07	RNA	83	18	18	\N	6
28494	AM2 R-539	2023-06-07 00:00:00-07	RNA	24.5	18	18	\N	6
28495	AM2 R-540	2023-06-07 00:00:00-07	RNA	8.41	18	18	\N	6
28496	AM2 R-541	2023-06-07 00:00:00-07	RNA	52	18	18	\N	6
28497	BB008_CGH10-013_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28498	BB008_CGH11-036_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28499	BB008_CGH11-153_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28500	BB008_CGH11-386_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28501	BB008_CGH12-047_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28502	BB008_HW2NC_NA	2012-09-20 00:00:00-07	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	5
28503	BB008_HW2TC_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28504	BB008_HW8NC_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28505	BB008_HW8TC_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28506	BB008_HW9-NB_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28507	BB008_HW9TC_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28508	BB008_Kit 227 Acral WT_NA	\N	DNA	\N	\N	\N	Alyssa Kit mutations.  Same template was used to go into BB007, BB004. Understanding run to run variation.  Influence of LM-PCR cycle reduction 	\N
28509	BB008_LAL-L1_NA	\N	DNA	\N	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N
28510	BB008_LAL-L2_NA	\N	DNA	\N	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N
28511	BB008_NB2107_NA	\N	DNA	\N	\N	\N	Cell Line DNA received from Patricia Brafford, Wistar Institute	\N
28512	BB008_WM3211_NA	\N	DNA	\N	\N	\N	Cell Line DNA received from Patricia Brafford, Wistar Institute	\N
28513	BB09_Bivona_L7_NA	2012-12-03 00:00:00-08	DNA	106	100	100	\N	\N
28514	BB09_Bivona_L8_NA	2012-12-03 00:00:00-08	DNA	44.8	100	100	\N	\N
28515	BB09_Bivona_L9_NA	2012-12-03 00:00:00-08	DNA	22.8	100	100	\N	\N
28516	BB09_Bivona_L10_NA	2012-12-03 00:00:00-08	DNA	42.3	100	100	\N	\N
28517	BB09_Bivona_L11_NA	2012-12-03 00:00:00-08	DNA	56.6	100	100	\N	\N
28518	BB09_CGH11_029_NA	2012-09-21 00:00:00-07	DNA	244	100	100	\N	5
28519	BB09_CGH11_045_NA	2012-09-21 00:00:00-07	DNA	254	100	100	\N	5
28520	BB09_CGH11_092_NA	2012-09-21 00:00:00-07	DNA	734	100	100	\N	5
28521	BB09_CGH11_125_NA	2012-09-21 00:00:00-07	DNA	136	100	100	\N	5
28522	BB09_CGH11_194_NA	2012-09-21 00:00:00-07	DNA	74	100	100	\N	5
28523	BB09_HW3_N_NA	\N	DNA	\N	\N	\N	\N	\N
28524	BB09_HW3_T_NA	\N	DNA	\N	\N	\N	\N	\N
28525	BB09_HW4_N_NA	\N	DNA	\N	\N	\N	\N	\N
28526	BB09_HW4_T_NA	\N	DNA	\N	\N	\N	\N	\N
28527	BB09_HW6_ND_NA	\N	DNA	\N	\N	\N	\N	\N
28528	BB09_HW6_TD_NA	\N	DNA	\N	\N	\N	\N	\N
28529	Bivona_L_1_NA	\N	DNA	\N	\N	\N	\N	\N
28530	Bivona_L_17_NA	\N	DNA	\N	\N	\N	 Patient Treated with EGFR TK1	\N
28531	Bivona_L_18_NA	\N	DNA	\N	\N	\N	 Patient Treated with EGFR TK1	\N
28532	Bivona_L_19_NA	\N	DNA	\N	\N	\N	 Patient Treated with EGFR TK1	\N
28533	Bivona_L2_NA	\N	DNA	\N	\N	\N	\N	\N
28534	Bivona_L3_NA	\N	DNA	\N	\N	\N	\N	\N
28535	Bivona_L4_NA	\N	DNA	\N	\N	\N	\N	\N
28536	Bivona_L5_NA	\N	DNA	\N	\N	\N	\N	\N
28537	Bivona_L6_NA	\N	DNA	\N	\N	\N	\N	\N
28538	bMV_10_0206_NA	\N	DNA	\N	\N	\N	\N	\N
28539	BN_M1_NA	\N	DNA	\N	\N	\N	\N	\N
28540	BN_M2_NA	\N	DNA	\N	\N	\N	\N	\N
28541	BN_N1_NA	\N	DNA	\N	\N	\N	\N	\N
28542	BN_N2_NA	\N	DNA	\N	\N	\N	\N	\N
28543	BND-001	2019-02-20 00:00:00-08	DNA	2.2	48	48	\N	5
28544	BND-002	2019-02-20 00:00:00-08	DNA	2.8	48	48	\N	5
28545	BND-003	2019-02-20 00:00:00-08	DNA	3.9	48	48	\N	5
28546	BND-004	2019-02-20 00:00:00-08	DNA	1.1	48	48	\N	5
28547	BND-005	2019-02-20 00:00:00-08	DNA	0.6	48	48	\N	5
28548	BND-006	2019-02-20 00:00:00-08	DNA	1.1	48	48	\N	5
28549	BND-007	2019-02-20 00:00:00-08	DNA	1.1	48	48	\N	5
28550	BND-008	2019-02-20 00:00:00-08	DNA	0.8	48	48	\N	5
28551	BND-009	2019-02-20 00:00:00-08	DNA	2	48	48	\N	5
28552	BND-010	2019-02-20 00:00:00-08	DNA	0.2	48	48	\N	5
28553	BND-011	2019-02-20 00:00:00-08	DNA	13.2	48	48	\N	5
28554	BND-012	2019-02-20 00:00:00-08	DNA	1.6	48	48	\N	5
28555	BTK01	2023-02-22 00:00:00-08	DNA	0.41	140	140	3mm punch biopsy	3
28556	BTK03	2023-02-22 00:00:00-08	DNA	17.2	140	140	3mm punch biopsy	3
28557	BTK05	2023-02-22 00:00:00-08	DNA	16.4	140	140	3mm punch biopsy	3
28558	BTK06	2023-02-22 00:00:00-08	DNA	0.55	140	140	3mm punch biopsy	3
28559	CGH_11_361_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28560	CGH_11_366_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28561	CGH_11_376_NA	\N	DNA	\N	\N	\N	BRAF	\N
28562	CGH_11_388_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28563	CGH_11_422_NA	\N	DNA	\N	\N	\N	BRAF	\N
28564	CGH_12_016_NA	\N	DNA	\N	\N	\N	BRAF	\N
28565	CGH10_16_NA	\N	DNA	\N	\N	\N	\N	\N
28566	CGH10_17_NA	\N	DNA	\N	\N	\N	\N	\N
28567	CGH10_020_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28568	CGH10_049_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28569	CGH10_058_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28570	CGH10-028_NA	\N	DNA	\N	\N	\N	\N	\N
28571	CGH10-045_NA	\N	DNA	\N	\N	\N	\N	\N
28572	CGH10-058_NA	\N	DNA	\N	\N	\N	\N	\N
28573	CGH10-062_NA	\N	DNA	\N	\N	\N	\N	\N
28574	CGH11_020_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28575	CGH11_035_NA	\N	DNA	\N	\N	\N	\N	\N
28576	CGH11_60_NA	\N	DNA	\N	\N	\N	\N	\N
28577	CGH11_078_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28578	CGH11_080_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28579	CGH11_091_NA	\N	DNA	\N	\N	\N	\N	\N
28580	CGH11_109_NA	\N	DNA	\N	\N	\N	\N	\N
28581	CGH11_252_NA	\N	DNA	\N	\N	\N	\N	\N
28582	CGH11_281_NA	\N	DNA	\N	\N	\N	BRAF	\N
28583	CGH11_283_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28584	CGH11_292_NA	\N	DNA	\N	\N	\N	\N	\N
28585	CGH11_305_NA	\N	DNA	\N	\N	\N	\N	\N
28586	CGH11_310_NA	\N	DNA	\N	\N	\N	\N	\N
28587	CGH11_319_NA	\N	DNA	\N	\N	\N	\N	\N
28588	CGH11_343_NA	\N	DNA	\N	\N	\N	\N	\N
28589	CGH11_348_NA	\N	DNA	\N	\N	\N	\N	\N
28590	CGH11_410_NA	\N	DNA	\N	\N	\N	\N	\N
28591	CGH11_424_NA	\N	DNA	\N	\N	\N	\N	\N
28592	CGH11-011_NA	\N	DNA	\N	\N	\N	\N	\N
28593	CGH11-035_NA	\N	DNA	\N	\N	\N	\N	\N
28594	CGH11-045_NA	2017-06-27 00:00:00-07	DNA	4.2	50	50	\N	\N
28595	CGH11-051	2013-07-30 00:00:00-07	DNA	133	100	100	\N	5
28596	CGH11-072_NA	\N	DNA	\N	\N	\N	\N	\N
28597	CGH11-087_NA	\N	DNA	\N	\N	\N	\N	\N
28598	CGH11-089_NA	\N	DNA	\N	\N	\N	\N	\N
28599	CGH11-092	2017-06-27 00:00:00-07	DNA	6.85	50	50	\N	\N
28600	CGH11-098-D	\N	DNA	10.3	50	50	DNA from Dermpath/Swapna	\N
28601	CGH11-115_NA	\N	DNA	\N	\N	\N	\N	\N
28602	CGH11-147_NA	\N	DNA	\N	\N	\N	\N	\N
28603	CGH11-158_NA	\N	DNA	\N	\N	\N	\N	\N
28604	CGH11-166_NA	\N	DNA	\N	\N	\N	\N	\N
28605	CGH11-172_NA	\N	DNA	\N	\N	\N	\N	\N
28606	CGH11-184_NA	\N	DNA	\N	\N	\N	\N	\N
28607	CGH11-194_NA	\N	DNA	\N	\N	\N	\N	\N
28608	CGH11-224_NA	\N	DNA	\N	\N	\N	\N	\N
28609	CGH11-229_NA	2013-07-10 00:00:00-07	DNA	204	100	100	\N	5
28610	CGH11-231_NA	2013-07-10 00:00:00-07	DNA	710	100	100	\N	5
28611	CGH11-232_NA	2013-07-10 00:00:00-07	DNA	139	100	100	\N	5
28612	CGH11-237_NA	2013-07-10 00:00:00-07	DNA	93.1	100	100	\N	5
28613	CGH11-252_NA	\N	DNA	\N	\N	\N	\N	\N
28614	CGH11-259_NA	2013-07-10 00:00:00-07	DNA	471	100	100	\N	5
28615	CGH11-268	2017-06-27 00:00:00-07	DNA	6.21	50	50	\N	5
28616	CGH11-275	\N	DNA	\N	\N	\N	\N	\N
28617	CGH11-282	2017-06-27 00:00:00-07	DNA	6.95	50	50	\N	5
28618	CGH11-294	2017-06-27 00:00:00-07	DNA	7.22	50	50	\N	5
28619	CGH11-315_NA	\N	DNA	\N	\N	\N	\N	\N
28620	CGH11-339_NA	\N	DNA	\N	\N	\N	\N	\N
28621	CGH11-386_DNA	2017-06-27 00:00:00-07	DNA	4.24	50	50	\N	\N
28622	CGH11-399	2017-06-27 00:00:00-07	DNA	2.59	50	50	\N	\N
28623	CGH11-402	2017-06-27 00:00:00-07	DNA	5.75	50	50	\N	\N
28627	CGH12_039_NA	2012-07-24 00:00:00-07	DNA	145	100	100	\N	\N
28628	CGH12_040_NA	2012-07-24 00:00:00-07	DNA	920	100	100	\N	\N
28629	CGH12_053_NA	2012-07-24 00:00:00-07	DNA	120	100	100	\N	\N
28630	CGH12_056_NA	2012-07-24 00:00:00-07	DNA	236	100	100	\N	\N
28631	CGH12_058_NA	\N	DNA	\N	\N	\N	\N	\N
28632	CGH12_135_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28633	CGH12_161_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28634	CGH12_224_NA	\N	DNA	\N	\N	\N	\N	\N
28635	CGH12_317_NA	\N	DNA	\N	\N	\N	NTRK3 | Barcode mismatch comment in note	\N
28636	CGH12_343_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28637	CGH12-039-D	\N	DNA	7.34	50	50	DNA from Dermpath/Swapna	\N
28638	CGH12-043_NA	\N	DNA	\N	\N	\N	\N	\N
28639	CGH12-055	2017-06-27 00:00:00-07	DNA	4.39	50	50	\N	\N
28640	CGH12-056-D	\N	DNA	6.14	50	50	DNA from Dermpath/Swapna	\N
28641	CGH12-058	\N	DNA	41.6	10	10	DNA from Dermpath/Swapna	\N
28642	CGH12-067	\N	DNA	29.52	10	10	DNA from Dermpath/Swapna	\N
28643	CGH12-092-D	\N	DNA	8.42	50	50	DNA from Dermpath/Swapna	\N
28644	CGH12-104_NA	\N	DNA	\N	\N	\N	\N	\N
28645	CGH12-109	\N	DNA	25	10	10	From Swapna	5
28646	CGH12-124_NA	\N	DNA	\N	\N	\N	\N	\N
28647	CGH12-191	2017-06-27 00:00:00-07	DNA	18.3	50	50	\N	\N
28648	CGH12-273	2017-06-27 00:00:00-07	DNA	6.43	50	50	\N	\N
28649	CGH12-280	\N	DNA	25	10	10	\N	5
28650	CGH12-301	\N	DNA	41.6	10	10	DNA from Dermpath/Swapna	\N
28651	CGH12-345_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28652	CGH12-347_NA	\N	DNA	\N	\N	\N	NTRK2	\N
28653	CGH13-003_NA	\N	DNA	\N	\N	\N	BRAF	\N
28654	CGH13-009_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28655	CGH13-011_NA	\N	DNA	\N	\N	\N	BRAF	\N
28656	CGH13-033_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28657	CGH13-034_NA	\N	DNA	\N	\N	\N	NTRK1?	\N
28658	CGH13-041_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28659	CGH13-044_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28660	CGH13-046_NA	\N	DNA	\N	\N	\N	BRAF	\N
28661	CGH13-058_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28662	CGH13-159	2017-06-27 00:00:00-07	DNA	5.16	50	50	\N	\N
28663	CGH13-321	2017-06-27 00:00:00-07	DNA	4.24	50	50	\N	\N
28664	CGH13-340	2017-06-27 00:00:00-07	DNA	8.27	50	50	\N	\N
28665	CGH14-032	2017-06-27 00:00:00-07	DNA	7.55	50	50	\N	\N
28666	CGH14-050	\N	DNA	31.6	10	10	DNA from Dermpath/Swapna	\N
28667	CGH14-059_NA	\N	DNA	\N	\N	\N	\N	\N
28668	CGH14-083-D	\N	DNA	5.02	50	50	DNA from Dermpath/Swapna	\N
28669	CGH14-119	2017-06-27 00:00:00-07	DNA	6.09	50	50	\N	\N
28670	CGH14-144	2017-06-27 00:00:00-07	DNA	5.86	50	50	\N	\N
28671	CGH14-145	\N	DNA	25	10	10	\N	5
28672	CGH14-147	\N	DNA	31.44	10	10	DNA from Dermpath/Swapna	\N
28673	CGH14-181	2017-06-27 00:00:00-07	DNA	10.8	50	50	\N	\N
28674	CGH14-286	2017-06-27 00:00:00-07	DNA	8.64	50	50	\N	\N
28675	CGH14-293	2017-06-27 00:00:00-07	DNA	9.5	50	50	\N	\N
28676	CGH14-328	2017-06-27 00:00:00-07	DNA	5.65	50	50	\N	\N
28677	CGH14-341-D	\N	DNA	1.89	50	50	DNA from Dermpath/Swapna	\N
28678	CGH14-348	\N	DNA	25	10	10	\N	5
28679	CGH15-043	2017-07-10 00:00:00-07	DNA	4.8	50	50	\N	\N
28680	CGH15-064	2017-07-10 00:00:00-07	DNA	6.8	50	50	\N	\N
28681	CGH15-081	2017-07-10 00:00:00-07	DNA	5.5	50	50	\N	\N
28682	CGH15-082	2017-07-10 00:00:00-07	DNA	4.8	50	50	\N	\N
28683	CGH15-090	2017-07-10 00:00:00-07	DNA	6.4	50	50	\N	\N
28684	CGH15-109-D	\N	DNA	7.88	50	50	DNA from Dermpath/Swapna	\N
28685	CGH15-115	2017-07-10 00:00:00-07	DNA	7.6	50	50	\N	\N
28686	CGH15-139	2017-07-10 00:00:00-07	DNA	3.7	50	50	\N	\N
28687	CGH15-151	2017-07-10 00:00:00-07	DNA	3.7	50	50	\N	\N
28688	CGH15-163	2017-07-10 00:00:00-07	DNA	6.1	50	50	\N	\N
28689	CGH15-176	2017-07-10 00:00:00-07	DNA	10.8	50	50	\N	\N
28690	CGH15-206	2017-07-10 00:00:00-07	DNA	5	50	50	\N	\N
28691	CGH15-210	2017-07-10 00:00:00-07	DNA	5.7	50	50	\N	\N
28692	CGH15-211	2017-07-10 00:00:00-07	DNA	17.6	50	50	\N	\N
28693	CGH15-246	2017-07-10 00:00:00-07	DNA	4.3	50	50	\N	\N
28694	CGH15-249	\N	DNA	28.96	10	10	DNA from Dermpath/Swapna	\N
28695	CGH15-253	2017-07-10 00:00:00-07	DNA	4.6	50	50	\N	\N
28696	CGH15-263	2017-07-10 00:00:00-07	DNA	5.9	50	50	\N	\N
28697	CGH16-002	2017-07-10 00:00:00-07	DNA	29.2	50	50	\N	\N
28698	CGH16-023	2017-07-10 00:00:00-07	DNA	7.5	50	50	\N	\N
28699	CGH16-025	2017-07-10 00:00:00-07	DNA	8.4	50	50	\N	\N
28700	CGH16-032	2017-07-10 00:00:00-07	DNA	12.8	50	50	\N	\N
28701	CGH16-035	2017-07-10 00:00:00-07	DNA	4.2	50	50	\N	\N
28702	CGH16-038	2017-07-10 00:00:00-07	DNA	26.6	50	50	\N	\N
28703	CGH16-053	2017-07-10 00:00:00-07	DNA	5.6	50	50	\N	\N
28704	CGH16-054	2017-07-10 00:00:00-07	DNA	6.1	50	50	\N	\N
28705	CGH16-062	2017-07-10 00:00:00-07	DNA	4.9	50	50	\N	\N
28706	CGH16-071	2017-07-10 00:00:00-07	DNA	4.7	50	50	\N	\N
28707	CGH16-087	2017-07-10 00:00:00-07	DNA	8.6	50	50	\N	\N
28708	CGH16-089	2017-07-10 00:00:00-07	DNA	3.9	50	50	\N	\N
28709	CGH16-093	2017-07-10 00:00:00-07	DNA	6.2	50	50	\N	\N
28710	CGH16-097	2017-07-10 00:00:00-07	DNA	8.1	50	50	\N	\N
28711	CGH16-105	2017-07-10 00:00:00-07	DNA	12.1	50	50	\N	\N
28712	CGH16-117	2017-07-10 00:00:00-07	DNA	24.4	50	50	\N	\N
28713	CGH16-123	2017-07-10 00:00:00-07	DNA	15.2	50	50	\N	\N
28714	CGH16-130	2017-07-10 00:00:00-07	DNA	6.2	50	50	\N	\N
28715	CGH16-136	2017-07-10 00:00:00-07	DNA	5.9	50	50	\N	\N
28716	CGH16-172-2	2017-07-10 00:00:00-07	DNA	6.1	50	50	\N	\N
29715	Ivanka_9_3_NA	\N	DNA	\N	\N	\N	\N	\N
28717	CGH16-179	2017-07-10 00:00:00-07	DNA	4	50	50	\N	\N
28718	CGH16-198	2017-07-10 00:00:00-07	DNA	6.5	50	50	\N	\N
28719	CGH16-200	\N	DNA	25	10	10	\N	5
28720	CGH16-209	2017-07-10 00:00:00-07	DNA	5	50	50	\N	\N
28721	CGH16-215	2017-07-10 00:00:00-07	DNA	6.6	50	50	\N	\N
28722	CGH16-222	2017-07-10 00:00:00-07	DNA	7.4	50	50	\N	\N
28723	CGH16-250	2017-07-10 00:00:00-07	DNA	3	50	50	\N	\N
28724	CGH16-254	2017-07-10 00:00:00-07	DNA	3.2	50	50	\N	\N
28725	CGH17-001	2017-07-10 00:00:00-07	DNA	3.9	50	50	\N	\N
28726	CGH17-003	2017-07-10 00:00:00-07	DNA	7.1	50	50	\N	\N
28727	CGH17-008	2017-07-10 00:00:00-07	DNA	6.6	50	50	\N	\N
28728	CGH17-015	2017-07-10 00:00:00-07	DNA	2.1	50	50	\N	\N
28729	CGH17-017	2017-07-10 00:00:00-07	DNA	2.4	50	50	\N	\N
28730	CGH17-021	2017-07-10 00:00:00-07	DNA	4	50	50	\N	\N
28731	CGH17-024	2017-07-10 00:00:00-07	DNA	4.2	50	50	\N	\N
28732	CGH17-026	2017-07-10 00:00:00-07	DNA	3.8	50	50	\N	\N
28733	CGH17-031	2017-07-10 00:00:00-07	DNA	5	50	50	\N	\N
28734	CGH17-033	2017-07-10 00:00:00-07	DNA	3.2	50	50	\N	\N
28735	CGH17-039	2017-07-10 00:00:00-07	DNA	3	50	50	\N	\N
28736	CGH17-052	2017-07-10 00:00:00-07	DNA	2.6	50	50	\N	\N
28737	CGH17-058	2017-07-10 00:00:00-07	DNA	4.3	50	50	\N	\N
28738	CGH17-076	2017-07-10 00:00:00-07	DNA	4.7	50	50	\N	\N
28739	CGH17-083	2017-07-10 00:00:00-07	DNA	4	50	50	\N	\N
28740	CGH17-095	2017-07-10 00:00:00-07	DNA	2.9	50	50	\N	\N
28741	CGH17-097	2017-07-10 00:00:00-07	DNA	2.1	50	50	\N	\N
28742	CGH17-104	2017-07-10 00:00:00-07	DNA	4.4	50	50	\N	\N
28743	CGH17-135	\N	DNA	25	10	10	\N	5
28744	CGH17-240	\N	DNA	25	10	10	\N	5
28745	CGH18-012-D	\N	DNA	6.78	50	50	DNA from Dermpath/Swapna	\N
28746	CGH18-137	\N	DNA	25	10	10	\N	5
28747	CGH18-139	\N	DNA	25	10	10	\N	5
28748	CGH19-097_1.00	\N	DNA	31.92	10	10	Atypical Spitz tumor-nodule	\N
28749	CGH19-097_2	2019-08-17 00:00:00-07	DNA	22.2	96	96	Atypical Spitz tumor-nodule	\N
28750	CGP-1481_NA	\N	DNA	\N	\N	\N	\N	\N
28751	CGP-1482_NA	\N	DNA	\N	\N	\N	\N	\N
28752	CGP-1483_NA	\N	DNA	\N	\N	\N	\N	\N
28753	CGP-1544_NA	\N	DNA	\N	\N	\N	\N	\N
28754	CGP-1545_NA	\N	DNA	\N	\N	\N	\N	\N
28755	CGP-1546_NA	\N	DNA	\N	\N	\N	\N	\N
28756	CGP-1547_NA	\N	DNA	\N	\N	\N	\N	\N
28757	CGP-1548_NA	\N	DNA	\N	\N	\N	\N	\N
28758	CGP-1549_NA	\N	DNA	\N	\N	\N	\N	\N
28759	CGP-1550_NA	\N	DNA	\N	\N	\N	\N	\N
28760	CGP-1551_NA	\N	DNA	\N	\N	\N	\N	\N
28761	CGP-1552_NA	\N	DNA	\N	\N	\N	\N	\N
28762	CGP-1553_NA	\N	DNA	\N	\N	\N	\N	\N
28763	CGP-1554_NA	\N	DNA	\N	\N	\N	\N	\N
28764	CGP-1555_NA	\N	DNA	\N	\N	\N	\N	\N
28765	CGP-1556_NA	\N	DNA	\N	\N	\N	\N	\N
28766	CGP-1557_NA	\N	DNA	\N	\N	\N	\N	\N
28767	CGP-1558_NA	\N	DNA	\N	\N	\N	\N	\N
28768	CGP-1559_NA	\N	DNA	\N	\N	\N	\N	\N
28769	CGP-1560_NA	\N	DNA	\N	\N	\N	\N	\N
28770	CGP-1561_NA	\N	DNA	\N	\N	\N	\N	\N
28771	CGP-1575_NA	\N	DNA	\N	\N	\N	\N	\N
28772	CGP-1576_NA	\N	DNA	\N	\N	\N	\N	\N
28773	CGP-1577_NA	\N	DNA	\N	\N	\N	\N	\N
28774	CHG11-402_NA	\N	DNA	\N	\N	\N	\N	\N
28775	CHG11-409_NA	2013-07-10 00:00:00-07	DNA	86.7	100	100	\N	\N
28776	CHG12-335_NA	\N	DNA	\N	\N	\N	BRAF	\N
28777	ChIP1_1_NA	\N	DNA	5.33	25	25	\N	\N
28778	ChIP1_2_NA	\N	DNA	0.31	25	25	\N	\N
28779	ChIP1_3_NA	\N	DNA	0.15	25	25	\N	\N
28780	ChIP1_4_NA	\N	DNA	7.72	25	25	\N	\N
28781	ChIP1_5_NA	\N	DNA	0.39	25	25	\N	\N
28782	ChIP1_6_NA	\N	DNA	0.21	25	25	\N	\N
28783	ChIP1_7_NA	\N	DNA	4.21	25	25	\N	\N
28784	ChIP1_8_NA	\N	DNA	0.33	25	25	\N	\N
28785	ChIP1_9_NA	\N	DNA	0.07	25	25	\N	\N
28786	ChIP1_10_NA	\N	DNA	6.39	25	25	\N	\N
28787	ChIP1_11_NA	\N	DNA	0.35	25	25	\N	\N
28788	ChIP1_12_NA	\N	DNA	0.14	25	25	\N	\N
28789	CM D-03	2019-05-17 00:00:00-07	DNA	2.6	48	48	\N	5
28790	CM D-04	2019-05-17 00:00:00-07	DNA	13.8	48	48	\N	5
28791	CM D-05	2019-05-17 00:00:00-07	DNA	7.47	48	48	\N	5
28792	CM D-06	2019-05-17 00:00:00-07	DNA	29	48	48	\N	5
28793	CM D-07	2019-05-17 00:00:00-07	DNA	9.2	48	48	\N	5
28794	CM D-08	2019-05-17 00:00:00-07	DNA	45.2	48	48	\N	5
28795	CM D-09	2019-05-17 00:00:00-07	DNA	3.74	48	48	\N	5
28796	CM D-10	2019-05-17 00:00:00-07	DNA	8.84	48	48	\N	5
28797	CM D-11	2019-05-17 00:00:00-07	DNA	2.94	48	48	\N	5
28798	CM D-12	2019-05-17 00:00:00-07	DNA	1	48	48	\N	5
28799	CM D-13	2019-05-17 00:00:00-07	DNA	14.9	48	48	\N	5
28800	CM D-14	2019-05-17 00:00:00-07	DNA	10.6	48	48	\N	5
28801	CM D-15	2019-05-17 00:00:00-07	DNA	2.74	48	48	\N	5
28802	CM D-16	2019-05-17 00:00:00-07	DNA	15.8	48	48	\N	5
28803	CM D-17	2019-05-17 00:00:00-07	DNA	9.32	48	48	\N	5
28804	CM D-18	2019-05-17 00:00:00-07	DNA	0.47	48	48	Not sufficient for LP	5
28805	CM D-19	2019-05-17 00:00:00-07	DNA	25.6	48	48	\N	5
28806	CM D-20	2019-05-17 00:00:00-07	DNA	0.06	48	48	Not sufficient for LP	5
28807	CM D-21	2019-05-17 00:00:00-07	DNA	1.15	48	48	\N	5
28808	CM D-22	2019-05-17 00:00:00-07	DNA	6.22	48	48	\N	5
28809	CM D-23	2019-05-17 00:00:00-07	DNA	9.66	48	48	\N	5
28810	CM D-24	2019-05-17 00:00:00-07	DNA	18.9	48	48	\N	5
28811	CM D-25	2019-05-19 00:00:00-07	DNA	48.2	48	48	\N	5
28812	CM D-26	2019-05-19 00:00:00-07	DNA	5.45	48	48	\N	5
28813	CM D-27	2019-05-19 00:00:00-07	DNA	15.9	48	48	\N	5
28814	CM D-28	2019-05-19 00:00:00-07	DNA	0.39	48	48	Not sufficient for LP	5
28815	CM D-29	2019-05-19 00:00:00-07	DNA	7.23	48	48	\N	5
28816	CM D-30	2019-05-19 00:00:00-07	DNA	17.3	48	48	\N	5
28817	CM D-31	2019-05-19 00:00:00-07	DNA	14.8	48	48	\N	5
28818	CM D-32	2019-05-19 00:00:00-07	DNA	38.8	48	48	\N	5
28819	CM D-33	2019-05-19 00:00:00-07	DNA	20.8	48	48	\N	5
28820	CM D-34	2019-05-19 00:00:00-07	DNA	26	48	48	\N	5
28821	CM D-35	2019-05-19 00:00:00-07	DNA	58	48	48	\N	5
28822	CM D-36	2019-05-19 00:00:00-07	DNA	4.58	48	48	\N	5
28823	CM D-37	2019-05-19 00:00:00-07	DNA	54	48	48	\N	5
28824	CM D-38	2019-05-19 00:00:00-07	DNA	36.6	48	48	\N	5
28825	CM D-39	2019-05-19 00:00:00-07	DNA	3.19	48	48	\N	5
28826	CM D-40	2019-05-19 00:00:00-07	DNA	15.1	48	48	\N	5
28827	CM D-41	2019-05-19 00:00:00-07	DNA	5.44	48	48	\N	5
28828	CM D-42	2019-05-19 00:00:00-07	DNA	5.84	48	48	\N	5
28829	CM D-43	2019-05-19 00:00:00-07	DNA	18.7	48	48	\N	5
28830	CM D-44	2019-05-19 00:00:00-07	DNA	0.88	48	48	\N	5
28831	CM D-45	2019-05-19 00:00:00-07	DNA	3.42	48	48	\N	5
28832	CM D-46	2019-05-19 00:00:00-07	DNA	2.81	48	48	\N	5
28833	CM D-47	2019-05-19 00:00:00-07	DNA	2.64	48	48	\N	5
28834	CM D-48	2019-05-19 00:00:00-07	DNA	4.91	48	48	\N	5
28835	CM D-49	2019-06-05 00:00:00-07	DNA	2.31	48	48	\N	5
28836	CM D-50	2019-06-05 00:00:00-07	DNA	3	48	48	\N	5
28837	CM D-51	2019-06-05 00:00:00-07	DNA	21.3	48	48	\N	5
28838	CM D-52	2019-06-05 00:00:00-07	DNA	9.89	48	48	\N	5
28839	CM D-53	2019-06-05 00:00:00-07	DNA	25.1	48	48	\N	5
28840	CM D-54	2019-06-05 00:00:00-07	DNA	2.41	48	48	\N	5
28841	CM D-55	2019-06-05 00:00:00-07	DNA	1.62	48	48	\N	5
28842	CM D-56	2019-06-05 00:00:00-07	DNA	41	48	48	\N	5
28843	CM D-57	2019-06-05 00:00:00-07	DNA	13.5	48	48	\N	5
28844	CM D-58	2019-06-05 00:00:00-07	DNA	0.68	48	48	Not sufficient for LP	5
28845	CM D-59	2019-06-05 00:00:00-07	DNA	0.33	48	48	Not sufficient for LP	5
28846	CM D-60	2019-06-05 00:00:00-07	DNA	2.33	48	48	\N	5
28847	CM D-61	2019-06-05 00:00:00-07	DNA	0.55	48	48	Not sufficient for LP	5
28848	CM D-62	2019-06-05 00:00:00-07	DNA	0.6	48	48	Not sufficient for LP	5
28849	CM D-63	2019-06-05 00:00:00-07	DNA	18	48	48	\N	5
28850	CM D-64	2019-06-05 00:00:00-07	DNA	4.63	48	48	\N	5
28851	CM D-65	2019-06-05 00:00:00-07	DNA	2.22	48	48	\N	5
28852	CM D-66	2019-06-05 00:00:00-07	DNA	2.4	48	48	\N	5
28853	CM D-67	2019-06-05 00:00:00-07	DNA	0.52	48	48	Not sufficient for LP	5
28854	CM D-68	2019-06-07 00:00:00-07	DNA	0	96	96	Not sufficient for LP	5
28855	CM D-69	2019-07-26 00:00:00-07	DNA	2.35	96	96	\N	5
28856	CM D-70	2019-07-26 00:00:00-07	DNA	4.52	96	96	\N	5
28857	CM D-71	2019-07-26 00:00:00-07	DNA	18	96	96	\N	5
28858	CM D-72	2019-07-26 00:00:00-07	DNA	0.5	96	96	\N	5
28859	CM D-73	2019-07-26 00:00:00-07	DNA	0.44	96	96	\N	5
28860	CM D-74	2019-07-26 00:00:00-07	DNA	0.19	96	96	\N	5
28861	CM D-75	2019-07-26 00:00:00-07	DNA	2.93	96	96	\N	5
28862	CM D-76	2019-07-26 00:00:00-07	DNA	1.12	96	96	\N	5
28863	CM D-77	2019-07-26 00:00:00-07	DNA	167	96	96	\N	5
28864	CM D-78	2019-07-26 00:00:00-07	DNA	51	96	96	\N	5
28865	CM D-79	2019-07-26 00:00:00-07	DNA	45	96	96	\N	5
28866	CM D-80	2019-07-26 00:00:00-07	DNA	5.07	96	96	\N	5
28867	CM D-81	2019-07-26 00:00:00-07	DNA	47.3	96	96	\N	5
28868	CM D-82	2019-07-26 00:00:00-07	DNA	1.2	96	96	\N	5
28869	CM D-83	2019-07-26 00:00:00-07	DNA	47.5	96	96	\N	5
28870	CM D-84	2019-07-26 00:00:00-07	DNA	0.38	96	96	\N	5
28871	CM D-85	2019-07-26 00:00:00-07	DNA	5.08	96	96	\N	5
28872	CMD-01	2019-05-17 00:00:00-07	DNA	11.5	48	48	\N	5
28873	CMD-02	2019-05-17 00:00:00-07	DNA	0.89	48	48	\N	5
28874	CNS_29_Normal_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28875	CNS_29_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28876	CNS_30_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28877	CNS_31_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28878	CNS_33_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28879	CNS_34_Normal_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28880	CNS_34_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28881	CNS_35_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28882	CNS_36_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28883	CNS_37_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28884	CNS_38_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28885	CNS_39_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28886	CNS_40_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28887	CNS_41_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28888	CNS_42_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28889	CNS_43_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28890	CNS_44_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28891	CNS_48_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28892	CNS_49_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28893	CNS_50_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28894	D-NA-536	\N	DNA	0	50	50	\N	5
28895	D-NA-537	\N	DNA	13.6	50	50	\N	5
28896	D-NA-538	\N	DNA	106	50	50	\N	5
28897	D-NA-539	\N	DNA	5.41	50	50	\N	5
28898	D-NA-540	\N	DNA	4.34	50	50	\N	5
28899	D-NA-541	\N	DNA	35.3	50	50	\N	5
28900	D-NA-542	\N	DNA	0.76	50	50	\N	5
28901	D-NA-543	\N	DNA	1.14	50	50	\N	5
28902	D-NA-544	\N	DNA	1.62	50	50	\N	5
28903	D-NA-545	\N	DNA	0	50	50	\N	5
28904	D-NA-546	\N	DNA	0	50	50	\N	5
28905	D-NA-547	\N	DNA	0.18	50	50	\N	5
28906	D-NA-548	\N	DNA	0.45	50	50	\N	5
28907	D-NA-549	\N	DNA	0.1	50	50	\N	5
28908	D-NA-550	\N	DNA	0.24	50	50	\N	5
28909	D-NA-551	2015-02-26 00:00:00-08	DNA	0.57	45	45	\N	5
28910	D-NA-552	2015-02-26 00:00:00-08	DNA	9.9	45	45	\N	5
28911	D-NA-553	2015-02-26 00:00:00-08	DNA	29.4	45	45	\N	5
28912	D-NA-554	2015-02-26 00:00:00-08	DNA	1.21	45	45	\N	5
28913	D-NA-555	2015-02-26 00:00:00-08	DNA	1.03	45	45	\N	5
28914	D-NA-556	2015-02-26 00:00:00-08	DNA	4.92	45	45	\N	5
28915	D-NA-557	2015-02-26 00:00:00-08	DNA	0.12	45	45	\N	5
28916	D-NA-558	2015-02-26 00:00:00-08	DNA	0.81	45	45	\N	5
28917	D-NA-559	2015-02-26 00:00:00-08	DNA	1.75	45	45	\N	5
28918	D-NA-560	2015-02-26 00:00:00-08	DNA	6.76	45	45	\N	5
28919	D-NA-561	2015-02-26 00:00:00-08	DNA	3.46	45	45	\N	5
28920	D-NA-562	2015-02-26 00:00:00-08	DNA	21.2	45	45	\N	5
28921	D-NA-563	2015-02-26 00:00:00-08	DNA	0.88	45	45	\N	5
28922	D-NA-564	2015-02-26 00:00:00-08	DNA	6.22	45	45	\N	5
28923	D-NA-565	2015-02-26 00:00:00-08	DNA	18.9	45	45	\N	5
28924	D-NA-585	2015-03-04 00:00:00-08	DNA	0.24	45	45	\N	5
28925	D-NA-586	2015-03-04 00:00:00-08	DNA	0.32	45	45	\N	5
28926	D-NA-587	2015-03-04 00:00:00-08	DNA	1.16	45	45	\N	5
28927	D-NA-588	2015-03-04 00:00:00-08	DNA	0.54	45	45	\N	5
28928	D-NA-589	2015-03-04 00:00:00-08	DNA	0.18	45	45	\N	5
28929	D-NA-590	2015-03-04 00:00:00-08	DNA	0.29	45	45	\N	5
28930	D-NA-620	2015-03-05 00:00:00-08	DNA	0.55	45	45	\N	5
28931	D-NA-621	2015-03-05 00:00:00-08	DNA	0.27	45	45	\N	5
28932	D-NA-622	2015-03-05 00:00:00-08	DNA	0.67	45	45	\N	5
28933	D-NA-623	2015-03-05 00:00:00-08	DNA	0.93	45	45	\N	5
28934	D-NA-624	2015-03-05 00:00:00-08	DNA	0.62	45	45	\N	5
28935	D-NA-625	2015-03-05 00:00:00-08	DNA	0.29	45	45	\N	5
28936	D-NA-626	2015-03-05 00:00:00-08	DNA	0.2	45	45	\N	5
28937	D-NA-627	2015-03-05 00:00:00-08	DNA	0.9	45	45	\N	5
28938	D-NA-628	2015-03-05 00:00:00-08	DNA	0.38	45	45	\N	5
28939	D-NA-629	2015-03-05 00:00:00-08	DNA	0.2	45	45	\N	5
28940	D-NA-630	2015-03-05 00:00:00-08	DNA	0.61	45	45	\N	5
28941	D-NA-631	2015-03-05 00:00:00-08	DNA	0.51	45	45	\N	5
28942	D-NA-645	2015-03-04 00:00:00-08	DNA	0.5	45	45	\N	5
28943	D-NA-646	2015-03-04 00:00:00-08	DNA	2.4	45	45	\N	5
28944	D-NA-647	2015-03-04 00:00:00-08	DNA	0.41	45	45	\N	5
28945	D-NA-8691	\N	DNA	5.32	100	100	\N	5
28946	D-NA-8692	\N	DNA	10.4	100	100	\N	5
28947	D1_NA	2012-04-11 00:00:00-07	DNA	10.24	50	50	\N	\N
28948	D2_NA	2012-04-11 00:00:00-07	DNA	4.2	50	50	\N	\N
28949	D6_NA	2012-04-11 00:00:00-07	DNA	20	50	50	\N	\N
28950	D7_NA	2012-04-11 00:00:00-07	DNA	20	50	50	\N	\N
28951	D11_NA	2012-04-11 00:00:00-07	DNA	9.6	50	50	\N	\N
28952	D12_54296_Norm_NA	\N	DNA	\N	\N	\N	Melanoma, Rt Inguinal Lymph node & Rt. Vulva	\N
28953	D12_54296_Tumor_NA	\N	DNA	\N	\N	\N	Melanoma, Rt Inguinal Lymph node & Rt. Vulva	\N
28954	D12_54992_Norm_NA	\N	DNA	\N	\N	\N	Melanoma, Lt groin sentinel lymph nodes	\N
28955	D12_54992_Tumor_NA	\N	DNA	\N	\N	\N	Melanoma, Lt groin sentinel lymph nodes	\N
28956	D12_67298_Norm_NA	\N	DNA	\N	\N	\N	lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation	\N
28957	D12_67298_Tumor_NA	\N	DNA	\N	\N	\N	lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation	\N
28958	D12_M_NA	\N	DNA	\N	\N	\N	\N	\N
28959	D13_NA	2012-04-11 00:00:00-07	DNA	20	50	50	\N	\N
28960	D15_NA	2012-04-11 00:00:00-07	DNA	6.6	50	50	\N	\N
28961	D20_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
28962	D21-1_NA	2012-08-23 00:00:00-07	DNA	1.38	100	100	\N	\N
28963	D28-1_NA	2012-08-23 00:00:00-07	DNA	3.55	100	100	\N	\N
28964	D28-2_NA	2012-08-23 00:00:00-07	DNA	5.98	100	100	\N	\N
28965	D28-3_NA	2012-08-23 00:00:00-07	DNA	0.31	100	100	\N	\N
28966	D29_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
28967	D31_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
28968	D35_NA	2012-04-25 00:00:00-07	DNA	7.42	50	50	\N	\N
28969	D36_NA	2012-04-25 00:00:00-07	DNA	20	50	50	\N	\N
28970	D39_NA	2012-04-25 00:00:00-07	DNA	9.94	50	50	\N	\N
28971	D40_NA	2012-04-25 00:00:00-07	DNA	20	50	50	\N	\N
28972	D41_NA	2012-04-25 00:00:00-07	DNA	20	50	50	\N	\N
28973	D43_NA_BC	\N	DNA	20	50	50	\N	\N
28974	D43_NA_SCC	\N	DNA	20	50	50	\N	\N
28975	D44_NA	\N	DNA	15	50	50	\N	\N
28976	D45_NA	\N	DNA	10	50	50	\N	\N
28977	D46_NA	\N	DNA	5	50	50	\N	\N
28978	D47_NA	\N	DNA	38.3	65	65	\N	\N
28979	D48_NA	\N	DNA	20.1	65	65	\N	\N
28980	D49_NA	2015-07-31 00:00:00-07	DNA	35.8	65	65	\N	\N
29716	Ivanka_9_4_NA	\N	DNA	\N	\N	\N	\N	\N
28981	D51_NA	2015-07-31 00:00:00-07	DNA	6.83	65	65	\N	\N
28982	D55_NA	2015-07-31 00:00:00-07	DNA	11.9	65	65	\N	\N
28983	D56_NA	2015-07-31 00:00:00-07	DNA	10.3	65	65	\N	\N
28984	D58_NA	2015-07-31 00:00:00-07	DNA	48.7	65	65	\N	\N
28985	D59_NA	2015-07-31 00:00:00-07	DNA	39	65	65	\N	\N
28986	D60_NA	2015-07-31 00:00:00-07	DNA	85.2	65	65	\N	\N
28987	D61_NA	2015-07-31 00:00:00-07	DNA	41.6	65	65	\N	\N
28988	D62_NA	2015-07-31 00:00:00-07	DNA	4.28	65	65	\N	\N
28989	D64_NA	2015-07-31 00:00:00-07	DNA	5.68	65	65	\N	\N
28990	D65_NA	2015-07-31 00:00:00-07	DNA	44.5	65	65	\N	\N
28991	D66_NA	2015-07-31 00:00:00-07	DNA	20.4	65	65	\N	\N
28992	D67_NA	2015-07-31 00:00:00-07	DNA	3.21	65	65	\N	\N
28993	D68_NA	2015-07-31 00:00:00-07	DNA	36.5	65	65	\N	\N
28994	D70_NA	2015-07-31 00:00:00-07	DNA	4.66	65	65	\N	\N
28995	D71_NA	2015-07-31 00:00:00-07	DNA	15.1	65	65	\N	\N
28996	D72_NA	2015-07-31 00:00:00-07	DNA	9.29	65	65	\N	\N
28997	D73_NA	2015-07-31 00:00:00-07	DNA	10	50	50	\N	\N
28998	D74_NA	2015-07-31 00:00:00-07	DNA	5	50	50	\N	\N
28999	D75_NA	2015-07-31 00:00:00-07	DNA	2	50	50	\N	\N
29000	D76_NA	2014-07-22 00:00:00-07	DNA	4.83	50	50	\N	\N
29001	DM_1_Normal_NA	\N	DNA	1.27	45	45	\N	\N
29002	DM_1_Tumor_NA	\N	DNA	60.8	10	10	\N	\N
29003	DM_2_NA	\N	DNA	\N	\N	\N	\N	\N
29004	DM_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29005	DM_4_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29006	DM_4_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29007	DM_6_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29008	DM_6_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29009	DM_8_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29010	DM_10_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29011	DM_10_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29012	DM_11_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29013	DM_13_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29014	DM_13_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29015	DM_14_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29016	DM_17_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29017	DM_17_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29018	DM_18_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29019	DM_18_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29020	DM_22_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29021	DM_22_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29022	DM_23_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29023	DM_23_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29024	DM_25_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29025	DM_25_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29026	DM_31_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29027	DM_31_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29028	DM_36_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29029	DM_36_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29030	DM_37_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29031	DM_42_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29032	DM_42_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29033	DM_43_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29034	DM_43_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29035	DM_48_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29036	DM_49_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29037	DM_49_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29038	DM_51_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29039	DM_58_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29040	DM_58_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29041	DM_59_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29042	DM_64_1_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29043	DM_64_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29044	DM_65_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29045	DM_68_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29046	DM_74_1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29047	DM_74_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29048	DM_93_3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29049	DM_93_cgn_NA	\N	DNA	\N	\N	\N	\N	\N
29050	DM_93_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29051	DM_94_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29052	DM_94_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29053	DM_95_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29054	DM_95_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29055	DM_96_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29056	DM_96_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29057	DM_98_2_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29058	DM_98_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29059	DM_99_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29060	DM_99_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29061	DM_100_Tumor_Pool_NA	\N	DNA	\N	\N	\N	\N	\N
29062	DM_101_IS_NA	\N	DNA	\N	\N	\N	\N	\N
29063	DM_101_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29064	DM_101_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29065	DM_102_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29066	DM-60-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29067	DM-61-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29068	DM-62-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29069	DM-63-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29070	DM-66-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29071	DM-67-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29072	DM-69-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29073	DM-70-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29074	DM-81-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29075	DM1_Normal_NA	2013-01-29 00:00:00-08	DNA	2.54	100	100	\N	5
29076	DM1_Tumor_NA	2013-01-29 00:00:00-08	DNA	121.6	100	100	\N	5
29077	DM2_Normal_NA	2013-01-29 00:00:00-08	DNA	10.56	100	100	\N	5
29078	DM2_Tumor_NA	2013-01-29 00:00:00-08	DNA	175	100	100	\N	5
29079	DM5 _Tumor_NA	2013-01-29 00:00:00-08	DNA	90.2	100	100	\N	5
29080	DM5_Normal_NA	2013-01-29 00:00:00-08	DNA	2.8	100	100	\N	5
29081	DM7_Normal_NA	2013-01-29 00:00:00-08	DNA	3.76	100	100	\N	5
29082	DM7_Tumor_NA	2013-01-29 00:00:00-08	DNA	34.2	100	100	\N	5
29083	DM8TumorCrest_NA	\N	DNA	\N	\N	\N	\N	\N
29084	DM11_Normal_NA	2013-01-29 00:00:00-08	DNA	2.88	100	100	\N	5
29085	DM11_Tumor_NA	2013-01-29 00:00:00-08	DNA	104	100	100	\N	5
29086	DM12_Normal_NA	2013-01-29 00:00:00-08	DNA	13.28	100	100	\N	5
29087	DM12_Tumor_NA	2013-01-29 00:00:00-08	DNA	30.2	100	100	\N	5
29088	DM13_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29089	DM13_Tumor_NA	2013-01-29 00:00:00-08	DNA	83.2	100	100	\N	5
29090	DM14_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29091	DM14_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29092	DM16_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29094	DM21_Normal_NA	2013-01-29 00:00:00-08	DNA	2.16	100	100	\N	5
29095	DM21_Tumor_NA	2013-01-29 00:00:00-08	DNA	15.66	100	100	\N	5
29096	DM26_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29097	DM26_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29098	DM28_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29099	DM28_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29100	DM29_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29101	DM29_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29102	DM34_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29103	DM34_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29104	DM37_1_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29105	DM45_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29106	DM45_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29107	DM45_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29108	DM55 Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29109	DM55_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29110	DM77_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29111	DM77_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29112	DM79_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29113	DM79_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29114	DM79_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29115	DM93_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29116	DM93_CGN_NA	2013-01-29 00:00:00-08	DNA	28	100	100	\N	5
29117	DM93_NFKBIE_NA	\N	DNA	\N	\N	\N	\N	\N
29118	DM93_Normal_NA	2013-01-29 00:00:00-08	DNA	14.64	100	100	\N	5
29119	DM93_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29120	DMS-001A	\N	DNA	19.9	48	48	\N	2
29121	DMS-001B	\N	DNA	21.4	48	48	\N	2
29122	DMS-001C	\N	DNA	16.3	48	48	\N	2
29123	DMS-002	\N	DNA	11.7	48	48	\N	2
29124	DMS-003	\N	DNA	14.7	48	48	\N	2
29125	DMS-004	\N	DNA	1.05	48	48	\N	2
29126	DMS-005	\N	DNA	2.88	48	48	\N	2
29127	DMS-006	\N	DNA	7.4	48	48	\N	2
29128	DMS-007	\N	DNA	19.5	48	48	\N	2
29129	DMS-008	\N	DNA	7.23	48	48	\N	2
29130	DMS-009	\N	DNA	1.21	48	48	\N	2
29131	DMS-010	\N	DNA	10.7	48	48	\N	2
29132	DMS-011	\N	DNA	0.12	48	48	\N	2
29133	DMS-012	\N	DNA	0.28	48	48	\N	2
29134	DMS-013	\N	DNA	6.83	48	48	\N	2
29135	DMS-014	\N	DNA	1.17	48	48	\N	2
29136	DMS-015	\N	DNA	1.8	48	48	\N	2
29137	DMS-016	\N	DNA	5.67	48	48	\N	2
29138	DMS-017	\N	DNA	4.13	48	48	\N	2
29139	DMS-018	\N	DNA	1.72	48	48	\N	2
29140	DMS-019	\N	DNA	12.5	48	48	\N	2
29141	DMS-020	\N	DNA	1.08	48	48	\N	2
29142	DMS-021	\N	DNA	2.13	48	48	\N	2
29143	DMS-022	\N	DNA	15.5	48	48	\N	2
29144	DMS-023	\N	DNA	8.09	48	48	\N	2
29145	DMS-024	\N	DNA	2.94	48	48	\N	2
29146	DMS-025	\N	DNA	9.7	48	48	\N	2
29147	DMS-026	\N	DNA	15.9	48	48	\N	2
29148	DMS-027	\N	DNA	0.38	48	48	\N	2
29149	DMS-028	\N	DNA	1.02	48	48	\N	2
29150	DMS-029	\N	DNA	0.24	48	48	\N	2
29151	DMS-030	\N	DNA	7.47	48	48	\N	2
29152	DMS-031	\N	DNA	0.16	48	48	\N	2
29153	DMS-032	\N	DNA	16.3	48	48	\N	2
29154	DMS-033	\N	DNA	16.4	48	48	\N	2
29155	DMS-034	\N	DNA	8.38	48	48	\N	2
29156	DMS-035	\N	DNA	0.6	48	48	\N	2
29157	DMS-035N	\N	DNA	0.1	48	48	\N	2
29158	DMS-036	\N	DNA	13.1	48	48	\N	2
29159	DMS-037	\N	DNA	0.74	48	48	\N	2
29160	DMS-037N	\N	DNA	0	48	48	\N	2
29161	DMS-038	\N	DNA	1.85	48	48	\N	2
29162	DMS-038N	\N	DNA	0.62	48	48	\N	2
29163	DMS-039	\N	DNA	5.25	48	48	\N	2
29164	DMS-039N	\N	DNA	0.34	48	48	\N	2
29165	DMS-040	\N	DNA	1.87	48	48	\N	2
29166	DMS-040N	\N	DNA	0.16	48	48	\N	2
29167	DMS-041	\N	DNA	4.57	48	48	\N	2
29168	DMS-042	\N	DNA	7.82	48	48	\N	2
29169	DMS-043	\N	DNA	7.2	48	48	\N	2
29170	DMS-044	\N	DNA	12.1	48	48	\N	2
29171	DMS-045	\N	DNA	20	48	48	\N	2
29172	DMS-046	\N	DNA	1.59	48	48	\N	2
29173	DMS-047	\N	DNA	6.88	48	48	\N	2
29174	DMS-048	\N	DNA	6.78	48	48	\N	2
29175	DMS-049	\N	DNA	16	48	48	\N	2
29176	DMS-050	\N	DNA	5.94	48	48	\N	2
29177	DMS-051	\N	DNA	0.56	48	48	\N	2
29178	DMS-052 A	\N	DNA	0.18	48	48	\N	2
29179	DMS-052 B	\N	DNA	0.53	48	48	\N	2
29180	DMS-053	\N	DNA	8.01	48	48	\N	2
29181	DMS-054	\N	DNA	4.32	48	48	\N	2
29182	DMS-055	\N	DNA	1.19	48	48	\N	2
29183	DMS-056	\N	DNA	5.67	48	48	\N	2
29184	DMS-057	\N	DNA	7.21	48	48	\N	2
29185	DMS-058	\N	DNA	15.8	48	48	\N	2
29186	DMS-059A	\N	DNA	1.99	48	48	\N	2
29187	DMS-059B	\N	DNA	3.06	48	48	\N	2
29188	DMS-060	\N	DNA	9.82	48	48	\N	2
29189	DMS-061	\N	DNA	1.42	48	48	\N	2
29190	DMS-062	\N	DNA	6.94	48	48	\N	2
29191	DMS-062N	\N	DNA	1.45	48	48	\N	2
29192	DMS-063	\N	DNA	0.99	48	48	\N	2
29193	DN-052	\N	DNA	0	0	0	\N	\N
29194	DN-053	\N	DNA	0.23	80	80	\N	5
29195	DN-054	\N	DNA	0.1	80	80	\N	5
29196	DN-055	\N	DNA	1.01	80	80	\N	5
29197	DN-056	\N	DNA	0.26	80	80	\N	5
29198	DN-057	\N	DNA	1.23	80	80	\N	5
29199	DN-058	\N	DNA	0.4	80	80	\N	5
29200	DN-059	\N	DNA	1.19	80	80	\N	5
29201	DN-060	\N	DNA	2.87	80	80	\N	5
29202	DN-061	\N	DNA	1.36	80	80	\N	5
29203	DN-062	\N	DNA	4.58	80	80	\N	5
29204	DN-063	\N	DNA	1.52	80	80	\N	5
29205	DN-064	\N	DNA	1.85	80	80	\N	5
29206	DN-065	\N	DNA	1.23	80	80	\N	5
29207	DN-066	\N	DNA	2.36	80	80	\N	5
29208	DN-067	\N	DNA	14.2	80	80	\N	5
29209	DN-068	\N	DNA	0.25	80	80	\N	5
29210	DN-069	\N	DNA	3.29	80	80	\N	5
29211	DN-070	\N	DNA	1.47	80	80	\N	5
29212	DN-071	\N	DNA	4.06	80	80	\N	5
29213	DN-072	\N	DNA	1.59	80	80	\N	5
29214	DN-073	\N	DNA	3.73	80	80	\N	5
29215	DN-074	\N	DNA	0	80	80	\N	5
29216	DN-075	\N	DNA	0	0	0	\N	\N
29217	DN-076	\N	DNA	1.02	80	80	\N	5
29218	DN-077	\N	DNA	0.09	80	80	\N	5
29219	DN-078	\N	DNA	0.52	80	80	\N	5
29220	DN-079	\N	DNA	0.07	80	80	\N	5
29221	DN-080	\N	DNA	0.1	80	80	\N	5
29222	DN-081	\N	DNA	0	0	0	\N	\N
29223	DN-082	\N	DNA	1.05	80	80	\N	5
29224	DN-083	\N	DNA	2.17	80	80	\N	5
29225	DN-084	\N	DNA	1.9	80	80	\N	5
29226	DN-085	\N	DNA	3.95	80	80	\N	5
29227	DN-086	\N	DNA	5.35	80	80	\N	5
29228	DN-087	\N	DNA	2.21	80	80	\N	5
29229	DNA-01	2019-04-05 00:00:00-07	DNA	2.88	18	18	\N	6
29230	DNA-01_REPEAT	\N	DNA	3.01	96	96	\N	6
29231	DNA-02	2019-05-22 00:00:00-07	DNA	3.9	96	96	\N	5
29232	DNA-03	2019-05-22 00:00:00-07	DNA	9.24	96	96	\N	5
29233	DNA-04	2019-05-22 00:00:00-07	DNA	0.39	48	48	\N	5
29234	DNA-05	2019-05-22 00:00:00-07	DNA	0.62	96	96	\N	5
29235	DNA-06	2019-05-22 00:00:00-07	DNA	3.5	96	96	\N	5
29236	DNA-07	2019-05-22 00:00:00-07	DNA	0.17	90	90	\N	5
29237	DNA-08	2019-05-22 00:00:00-07	DNA	0.48	48	48	\N	5
29238	DNA-09	2019-05-22 00:00:00-07	DNA	0.45	48	48	\N	5
29239	DNA-10	\N	DNA	0	48	48	\N	5
29240	DNA-11	\N	DNA	1.92	48	48	\N	6
29241	DNA-12	\N	DNA	6.54	48	48	\N	6
29242	DNA-15	2019-05-22 00:00:00-07	DNA	0.46	57	57	\N	5
29243	DNA-16	2019-05-22 00:00:00-07	DNA	0.55	57	57	\N	5
29244	DNA-17	\N	DNA	4.45	48	48	\N	6
29245	DNA-18	\N	DNA	19.1	48	48	\N	6
29246	DNA-19	2019-05-22 00:00:00-07	DNA	0.92	96	96	\N	5
29247	DNA-20	\N	DNA	0	0	0	\N	5
29248	DNA-21	\N	DNA	1.97	48	48	\N	6
29249	DNA-22	\N	DNA	11.1	48	48	\N	6
29250	DNA-23	2019-05-22 00:00:00-07	DNA	0.43	96	96	\N	5
29251	DNA-24	2019-05-22 00:00:00-07	DNA	1.42	48	48	\N	5
29252	DNA-25	\N	DNA	0.88	75	75	\N	6
29253	DNA-26	\N	DNA	2.14	91	91	\N	6
29254	DNA-27	\N	DNA	3.82	60	60	\N	6
29255	DNA-28	\N	DNA	23.5	85	85	\N	6
29256	DNA-29	\N	DNA	3.35	91	91	\N	6
29257	DNA-30	\N	DNA	2.55	48	48	\N	6
29258	DNA-31	\N	DNA	12.3	48	48	\N	6
29259	DNA-38	\N	DNA	0.35	48	48	\N	5
29260	DNA-41	\N	DNA	6.03	61	61	\N	6
29261	DNA-43	\N	DNA	1.92	48	48	\N	6
29262	DNA-44	\N	DNA	2.08	48	48	\N	6
29263	DNA-45	\N	DNA	5.39	48	48	\N	6
29264	DNA-46	\N	DNA	2.57	48	48	\N	6
29265	DNA-47	\N	DNA	4.14	48	48	\N	6
29266	DNA-48	2019-05-22 00:00:00-07	DNA	0.18	96	96	\N	5
29267	DNA-49	\N	DNA	14.5	48	48	\N	6
29268	DNA-50	\N	DNA	2.4	48	48	\N	6
29269	DNA-52	\N	DNA	2.01	48	48	\N	6
29270	DNA-53	\N	DNA	9.13	48	48	\N	6
29271	DNA-53_REPEAT	2019-05-22 00:00:00-07	DNA	5.45	96	96	\N	5
29272	DNA-54	\N	DNA	1.64	48	48	\N	6
29273	DNA-54_REPEAT	2019-05-22 00:00:00-07	DNA	1.08	96	96	\N	5
29274	DNA-55	\N	DNA	14.3	48	48	\N	6
29275	DNA-56	\N	DNA	19.7	48	48	\N	6
29276	DNA-59	2019-04-09 00:00:00-07	DNA	2.29	48	48	\N	6
29277	DNA-59_REPEAT	2019-05-22 00:00:00-07	DNA	1.08	96	96	\N	5
29278	DNA-61	\N	DNA	3.84	48	48	\N	6
29279	DNA-62	\N	DNA	1.56	48	48	\N	6
29280	DNA-65	\N	DNA	4.98	48	48	\N	6
29281	DNA-68	2019-05-22 00:00:00-07	DNA	0	48	48	\N	5
29282	DNA-69	\N	DNA	1.65	97	97	\N	6
29283	DNA-70	\N	DNA	0.55	91	91	\N	6
29284	DNA-71	2019-05-22 00:00:00-07	DNA	0.75	99	99	\N	6
29285	DNA-72	2019-05-22 00:00:00-07	DNA	0.35	96	96	\N	5
29286	DNA-73	\N	DNA	0.52	95	95	\N	6
29717	Ivanka_9_5_NA	\N	DNA	\N	\N	\N	\N	\N
29287	DNA-74	2019-05-22 00:00:00-07	DNA	0.28	48	48	\N	5
29288	DNA-75	2019-05-22 00:00:00-07	DNA	0.76	48	48	\N	5
29289	DNA-76	2019-05-22 00:00:00-07	DNA	0.79	48	48	\N	5
29290	DNA-77	\N	DNA	0.24	48	48	\N	5
29291	DNA-78	\N	DNA	0.18	48	48	\N	5
29292	DNA-79	2019-05-22 00:00:00-07	DNA	0.96	48	48	\N	5
29293	DNA-80	2019-05-22 00:00:00-07	DNA	1.57	48	48	\N	5
29294	DNA-81	2019-05-22 00:00:00-07	DNA	0.76	48	48	\N	5
29295	DNA-82	2019-05-22 00:00:00-07	DNA	0.52	48	48	\N	5
29296	DNA-83	2019-05-22 00:00:00-07	DNA	0.28	48	48	\N	5
29297	DNA-85	2019-05-22 00:00:00-07	DNA	1.22	96	96	\N	5
29298	DNA-86	2019-05-22 00:00:00-07	DNA	1.91	96	96	\N	5
29299	DNA-87	2019-05-22 00:00:00-07	DNA	0.16	96	96	\N	5
29300	DNA-88	\N	DNA	16.3	48	48	\N	5
29301	DNA-89	\N	DNA	9.25	48	48	\N	5
29302	DNA-90	\N	DNA	12	48	48	\N	5
29303	DNA-91	\N	DNA	2.25	48	48	\N	5
29304	DNA-92	\N	DNA	1.47	48	48	\N	5
29305	DNA-93	\N	DNA	1.45	48	48	\N	5
29306	DNA-94	2019-06-19 00:00:00-07	DNA	263	48	48	\N	5
29307	DNA-95	2019-06-19 00:00:00-07	DNA	20.6	48	48	\N	5
29308	DNA-96	2019-06-19 00:00:00-07	DNA	41.6	48	48	\N	5
29309	DNA-97	2020-07-29 00:00:00-07	DNA	0.08	96	96	\N	6
29310	DNA-98	2020-07-29 00:00:00-07	DNA	2.44	96	96	\N	6
29311	DNA-99	2020-07-29 00:00:00-07	DNA	0.87	96	96	\N	6
29312	DNA-100	2020-07-29 00:00:00-07	DNA	0	96	96	\N	6
29313	DNA-101	2020-07-29 00:00:00-07	DNA	2.28	96	96	\N	6
29314	DNA-107	2020-08-23 00:00:00-07	DNA	1.28	90	90	\N	6
29315	DNA-108	2020-08-23 00:00:00-07	DNA	14.6	90	90	\N	6
29316	DNA-109	2020-08-23 00:00:00-07	DNA	0.87	90	90	\N	6
29317	DNA-110	2020-08-23 00:00:00-07	DNA	0	90	90	\N	6
29318	DNA-111	2020-08-23 00:00:00-07	DNA	0.23	90	90	\N	6
29319	DNA-112	2020-08-23 00:00:00-07	DNA	0.27	90	90	\N	6
29320	DNA-113	2020-08-23 00:00:00-07	DNA	0.24	90	90	\N	6
29321	DNA-114	2020-08-23 00:00:00-07	DNA	0.22	90	90	\N	6
29322	DNA-115	2020-08-23 00:00:00-07	DNA	0	90	90	\N	6
29323	DNA-116	2020-08-23 00:00:00-07	DNA	0.2	90	90	\N	6
29324	DNA-117	2020-08-23 00:00:00-07	DNA	0	0	0	\N	6
29325	DNA-118	2020-08-23 00:00:00-07	DNA	1.16	90	90	\N	6
29326	DNA-119	2020-08-23 00:00:00-07	DNA	0.11	90	90	\N	6
29327	DNA-120	2020-08-23 00:00:00-07	DNA	10.3	90	90	\N	6
29328	DNA-121	2020-08-23 00:00:00-07	DNA	1.25	90	90	\N	6
29329	DNA-122	2020-08-23 00:00:00-07	DNA	4.71	90	90	\N	6
29330	DNA-123	2020-08-23 00:00:00-07	DNA	0.51	90	90	\N	6
29331	DNA-124	2020-08-23 00:00:00-07	DNA	0.47	90	90	\N	6
29332	DNA-125	2020-08-23 00:00:00-07	DNA	0.8	90	90	\N	6
29333	DNA-126	2020-08-23 00:00:00-07	DNA	0.33	90	90	\N	6
29334	DNA-127	2020-08-23 00:00:00-07	DNA	1.51	90	90	\N	6
29335	DNA-128	2020-08-23 00:00:00-07	DNA	0	90	90	DO NOT USE; WRONG TISSUE WAS MICRODISSECTED: 17-43707	6
29336	DNA-129	2020-08-23 00:00:00-07	DNA	0.41	90	90	\N	6
29337	DNA-130	2020-08-23 00:00:00-07	DNA	1.46	90	90	\N	6
29338	DNA-131	2020-08-23 00:00:00-07	DNA	0.06	90	90	\N	6
29339	DNA-132	2020-08-23 00:00:00-07	DNA	1.3	90	90	\N	6
29340	DNA-133	2020-08-23 00:00:00-07	DNA	7.04	90	90	\N	6
29341	DNA-134	2020-09-12 00:00:00-07	DNA	0.14	90	90	\N	6
29342	DNA-135	2020-09-12 00:00:00-07	DNA	1.23	90	90	\N	6
29343	DNA-136	2020-09-12 00:00:00-07	DNA	0.82	90	90	\N	6
29344	DNA-137	2020-09-12 00:00:00-07	DNA	3.58	90	90	\N	6
29345	DNA-138	2020-09-12 00:00:00-07	DNA	2.49	90	90	\N	6
29346	DNA-139	2020-09-12 00:00:00-07	DNA	0.62	90	90	\N	6
29347	DNA-140	2020-09-12 00:00:00-07	DNA	0.19	90	90	\N	6
29348	DNA-141	2020-09-12 00:00:00-07	DNA	1.07	90	90	\N	6
29349	DNA-142	2020-09-18 00:00:00-07	DNA	0	90	90	\N	6
29350	DNA-143	2020-09-18 00:00:00-07	DNA	0	90	90	\N	6
29351	DNA-144	2020-09-18 00:00:00-07	DNA	4.12	90	90	\N	6
29352	DNA-144 Imat B15	\N	DNA	59	230	230	MISC -20oC BOX; MK Cells for the Broad Institute	\N
29353	DNA-145	2020-09-18 00:00:00-07	DNA	0	90	90	\N	6
29354	DNA-146	2020-10-03 00:00:00-07	DNA	10.6	96	96	\N	6
29355	DNA-147	2020-10-03 00:00:00-07	DNA	0.41	96	96	\N	6
29356	DNA-148	2020-10-03 00:00:00-07	DNA	0.77	96	96	\N	6
29357	DNA-149	2020-10-03 00:00:00-07	DNA	0.28	96	96	\N	6
29358	DNA-150	2020-10-03 00:00:00-07	DNA	1.02	96	96	\N	6
29359	DNA-151	2020-10-03 00:00:00-07	DNA	1.08	96	96	\N	6
29360	DNA-152	2020-10-05 00:00:00-07	DNA	0.61	96	96	\N	6
29361	DNA-153	2020-10-05 00:00:00-07	DNA	1.07	96	96	\N	6
29362	DNA-154	2020-10-05 00:00:00-07	DNA	0.09	96	96	\N	6
29363	DNA-155	2020-10-05 00:00:00-07	DNA	1.31	96	96	\N	6
29364	DNA-156	2020-10-05 00:00:00-07	DNA	0.19	96	96	\N	6
29365	DNA-157	2020-10-07 00:00:00-07	DNA	0.25	96	96	\N	6
29366	DNA-158	2020-10-07 00:00:00-07	DNA	0.13	96	96	\N	6
29367	DNA-159	2020-10-07 00:00:00-07	DNA	0.85	96	96	\N	6
29368	DNA-160	2022-03-14 00:00:00-07	DNA	2.09	88	88	\N	2
29369	DNA-161	2022-03-14 00:00:00-07	DNA	1.16	88	88	\N	2
29370	DNA-162	2022-03-14 00:00:00-07	DNA	1.3	88	88	\N	2
29371	DNA-163	2022-03-14 00:00:00-07	DNA	0.12	88	88	\N	2
29372	DNA-164	2022-03-14 00:00:00-07	DNA	11.8	88	88	\N	2
29373	DNA-165	2022-03-14 00:00:00-07	DNA	0.85	88	88	\N	2
29374	DNA-166	2022-03-14 00:00:00-07	DNA	1.99	88	88	\N	2
29375	DNA-167	2022-03-14 00:00:00-07	DNA	0.36	88	88	\N	2
29376	DNA-168	2022-03-14 00:00:00-07	DNA	0.11	88	88	\N	2
29377	DNA-169	2022-03-14 00:00:00-07	DNA	1.51	88	88	\N	2
29378	DNA-170	2022-03-14 00:00:00-07	DNA	0.91	88	88	\N	2
29379	DNA-171	2022-03-14 00:00:00-07	DNA	0.43	88	88	\N	2
29380	DNA-172	2022-03-14 00:00:00-07	DNA	0.18	88	88	\N	2
29381	DNA-173	2022-03-14 00:00:00-07	DNA	0.72	88	88	\N	2
29382	DNA-174	2022-03-14 00:00:00-07	DNA	1.07	88	88	\N	2
29383	DNA-175	2022-03-14 00:00:00-07	DNA	2.12	88	88	\N	2
29384	DNA-176	2022-03-14 00:00:00-07	DNA	0.34	88	88	\N	2
29385	DNA-177	2022-03-14 00:00:00-07	DNA	0.32	88	88	\N	2
29386	DNA-178	2022-03-14 00:00:00-07	DNA	1.33	88	88	\N	2
29387	DNA-179	2022-03-14 00:00:00-07	DNA	0.15	88	88	\N	2
29388	DNA-180	2022-03-15 00:00:00-07	DNA	0.15	88	88	\N	2
29389	DNA-181	2022-03-15 00:00:00-07	DNA	0.91	88	88	\N	2
29390	DNA-182	2022-03-15 00:00:00-07	DNA	0.35	88	88	\N	2
29391	DNA-183	2022-03-15 00:00:00-07	DNA	0.38	88	88	\N	2
29392	DNA-184	2022-03-15 00:00:00-07	DNA	6.56	88	88	\N	2
29393	DNA-185	2022-03-15 00:00:00-07	DNA	0.2	88	88	\N	2
29394	DNA-186	2022-03-15 00:00:00-07	DNA	0.46	88	88	\N	2
29395	DNA-187	2022-03-15 00:00:00-07	DNA	13.5	88	88	\N	2
29396	DNA-188	2022-03-15 00:00:00-07	DNA	2.09	88	88	\N	2
29397	DNA-189	2022-03-15 00:00:00-07	DNA	2.44	88	88	\N	2
29398	DNA-190	2022-03-15 00:00:00-07	DNA	1.71	88	88	\N	2
29399	DNA-191	2022-03-15 00:00:00-07	DNA	1.71	88	88	\N	2
29400	DNA-192	2022-03-15 00:00:00-07	DNA	0.13	88	88	\N	2
29401	DNA-193	2022-03-15 00:00:00-07	DNA	0.2	88	88	\N	2
29402	DNA-194	2022-03-15 00:00:00-07	DNA	1	88	88	\N	2
29403	DNA-195	2022-03-15 00:00:00-07	DNA	6.47	88	88	\N	2
29404	DNA-196	2022-03-15 00:00:00-07	DNA	2.35	88	88	\N	2
29405	DNA-197	2022-03-15 00:00:00-07	DNA	0.75	88	88	\N	2
29406	DNA-198	2022-04-14 00:00:00-07	DNA	0.74	88	88	\N	2
29407	DNA-199	2022-04-21 00:00:00-07	DNA	2.5	88	88	\N	2
29408	DNA-200	2022-04-21 00:00:00-07	DNA	0.38	88	88	\N	2
29409	DNA-201	2022-04-14 00:00:00-07	DNA	0.56	88	88	\N	2
29410	DNA-202	2022-04-14 00:00:00-07	DNA	1.55	88	88	\N	2
29411	DNA-203	2022-04-18 00:00:00-07	DNA	3.69	88	88	\N	2
29412	DNA-204	2022-04-18 00:00:00-07	DNA	2.12	88	88	\N	2
29413	DNA-205	2022-04-18 00:00:00-07	DNA	1.97	88	88	\N	2
29414	DNA-206	2022-04-14 00:00:00-07	DNA	0.41	88	88	\N	2
29415	DNA-207	2022-04-18 00:00:00-07	DNA	14.1	88	88	\N	2
29416	DNA-208	2022-04-18 00:00:00-07	DNA	1.55	88	88	\N	2
29417	DNA-209	2022-04-18 00:00:00-07	DNA	1.91	88	88	\N	2
29418	DNA-210	2022-04-18 00:00:00-07	DNA	0.61	88	88	\N	2
29419	DNA-211	2022-04-14 00:00:00-07	DNA	0.22	88	88	\N	2
29420	DNA-212	2022-04-18 00:00:00-07	DNA	4.93	88	88	\N	2
29421	DNA-213	2022-04-18 00:00:00-07	DNA	2.12	88	88	\N	2
29422	DNA-214	2022-04-18 00:00:00-07	DNA	1.03	88	88	\N	2
29423	DNA-215	2022-04-14 00:00:00-07	DNA	0.34	88	88	\N	2
29424	DNA-216	2022-04-14 00:00:00-07	DNA	0.99	88	88	\N	2
29425	DNA-217	2022-04-18 00:00:00-07	DNA	0.75	88	88	\N	2
29426	DNA-218	2022-04-18 00:00:00-07	DNA	3.08	88	88	\N	2
29427	DNA-219	2022-04-18 00:00:00-07	DNA	0.64	88	88	\N	2
29428	DNA-220	2022-04-14 00:00:00-07	DNA	0.15	88	88	\N	2
29429	DNA-221	2022-04-18 00:00:00-07	DNA	1.76	88	88	\N	2
29430	DNA-222	2022-04-18 00:00:00-07	DNA	0.25	88	88	\N	2
29431	DNA-223	2022-04-14 00:00:00-07	DNA	0.29	88	88	\N	2
29432	DNA-224	2022-04-18 00:00:00-07	DNA	1.69	88	88	\N	2
29433	DNA-225	2022-04-18 00:00:00-07	DNA	0.48	88	88	\N	2
29434	DNA-226	2022-04-14 00:00:00-07	DNA	0.52	88	88	\N	2
29435	DNA-227	\N	DNA	0	0	0	\N	\N
29436	DNA-228	\N	DNA	0	0	0	\N	\N
29437	DNA-229	\N	DNA	0	0	0	\N	\N
29438	DNA-230	2022-04-18 00:00:00-07	DNA	10.1	88	88	\N	2
29439	DNA-231	2022-04-18 00:00:00-07	DNA	1.06	88	88	\N	2
29440	DNA-232	2022-04-14 00:00:00-07	DNA	1.54	88	88	\N	2
29441	DNA-233	2022-04-18 00:00:00-07	DNA	1.17	88	88	\N	2
29442	DNA-234	2022-04-18 00:00:00-07	DNA	2.95	88	88	5 sections/tube	2
29443	DNA-235	2022-04-21 00:00:00-07	DNA	4.97	88	88	\N	2
29444	DNA-236	2022-04-14 00:00:00-07	DNA	0.44	88	88	\N	2
29445	DNA-237	2022-04-14 00:00:00-07	DNA	0.65	88	88	10 sections/tube	2
29446	DNA-238	2022-04-21 00:00:00-07	DNA	1.4	88	88	\N	2
29447	DNA-239	\N	DNA	0	0	0	\N	\N
29448	DNA-240	2022-04-14 00:00:00-07	DNA	3.79	88	88	\N	2
29449	DNA-241	2022-04-14 00:00:00-07	DNA	0.73	88	88	\N	2
29450	DNA-242	2022-04-21 00:00:00-07	DNA	2.97	88	88	\N	2
29451	DNA-243	2022-04-21 00:00:00-07	DNA	0.52	88	88	\N	2
29452	DNA-244	2022-04-21 00:00:00-07	DNA	0.24	88	88	\N	2
29453	DNA-245	2022-04-18 00:00:00-07	DNA	13	88	88	6 sections/tube	2
29454	DNA-246	2022-04-18 00:00:00-07	DNA	1.11	88	88	6 sections/tube	2
29455	DNA-247	2022-04-18 00:00:00-07	DNA	3.7	88	88	5 sections/tube	2
29456	DNA-248	2022-04-14 00:00:00-07	DNA	0.48	88	88	10 sections/tube	2
29457	DNA-251	2022-05-13 00:00:00-07	DNA	0.65	88	88	\N	2
29458	DNA-252	2022-05-13 00:00:00-07	DNA	0.34	88	88	\N	2
29459	DNA-253	2022-05-13 00:00:00-07	DNA	0.16	88	88	\N	2
29460	DNA-254	2022-05-13 00:00:00-07	DNA	0.75	88	88	\N	2
29461	DNA-255	2022-05-13 00:00:00-07	DNA	0.28	88	88	\N	2
29462	DNA-256	2022-05-13 00:00:00-07	DNA	1.19	88	88	4 tissue sections/tube	2
29463	DNA-257	2022-05-13 00:00:00-07	DNA	0.47	88	88	2 tissue sections	2
29464	DNA-258	2022-05-13 00:00:00-07	DNA	0.93	88	88	6.5 tissue sections/tube	2
29465	DNA-259	2022-05-13 00:00:00-07	DNA	8.14	88	88	2.5 tissue sections/tube	2
29466	DNA-260	2022-05-13 00:00:00-07	DNA	1.29	88	88	\N	2
29467	DNA-261	2022-05-13 00:00:00-07	DNA	1.34	88	88	2.5 tissue sections/tube	2
29468	DNA-262	2022-05-13 00:00:00-07	DNA	1.28	88	88	2.5 tissue sections/tube	2
29469	DNA-263	2022-05-13 00:00:00-07	DNA	0.86	88	88	6.5 tissue sections/tube	2
29470	DNA-264	2022-05-13 00:00:00-07	DNA	7.36	88	88	2.5 tissue sections/tube	2
29471	DNA-265	2022-05-13 00:00:00-07	DNA	1.39	88	88	\N	2
29472	DNA-266	2022-05-25 00:00:00-07	DNA	16.2	88	88	\N	2
29473	DNA-267	2022-05-25 00:00:00-07	DNA	0.58	88	88	\N	2
29474	DNA-268	\N	DNA	0	0	0	NOT MICRODISSECTED NOR EXTRACTED	\N
29475	DNA-269	\N	DNA	0	0	0	NOT MICRODISSECTED NOR EXTRACTED	\N
29476	DNA-270	2022-06-06 00:00:00-07	DNA	0.03	90	90	\N	2
29477	DNA-271	2022-06-06 00:00:00-07	DNA	0.37	100	100	\N	2
29478	DNA-272	\N	DNA	0	0	0	\N	\N
29479	DNA-273	2022-08-25 00:00:00-07	DNA	0.15	88	88	\N	2
29480	DNA-274	2022-08-17 00:00:00-07	DNA	0	88	88	\N	2
29481	DNA-275	2022-08-25 00:00:00-07	DNA	3.04	88	88	\N	2
29482	DNA-276	2022-08-25 00:00:00-07	DNA	0.26	88	88	\N	2
29483	DNA-277	2022-08-17 00:00:00-07	DNA	0.47	88	88	\N	2
29484	DNA-278	2022-08-25 00:00:00-07	DNA	1.24	88	88	\N	2
29485	DNA-279	2022-08-25 00:00:00-07	DNA	2.33	88	88	\N	2
29486	DNA-280	2022-08-17 00:00:00-07	DNA	0.5	88	88	\N	2
29487	DNA-281	\N	DNA	0	0	0	\N	\N
29488	DNA-282	\N	DNA	0	0	0	\N	\N
29489	DNA-283	\N	DNA	0	0	0	\N	\N
29490	DNA-284	\N	DNA	0	0	0	\N	\N
29491	DNA-285	2022-08-25 00:00:00-07	DNA	0.49	88	88	\N	2
29492	DNA-286	2022-08-25 00:00:00-07	DNA	11.3	88	88	\N	2
29493	DNA-287	2022-08-17 00:00:00-07	DNA	0.64	88	88	\N	2
29494	DNA-288	2022-08-25 00:00:00-07	DNA	0.97	88	88	\N	2
29495	DNA-289	2022-08-25 00:00:00-07	DNA	0.19	88	88	\N	2
29496	DNA-290	2022-08-17 00:00:00-07	DNA	0.1	88	88	\N	2
29497	DNA-291	2022-08-17 00:00:00-07	DNA	0.41	88	88	\N	2
29498	DNA-292	2022-08-17 00:00:00-07	DNA	6.05	88	88	\N	2
29499	DNA-293	\N	DNA	0	0	0	\N	\N
29500	DNA-294	2022-08-25 00:00:00-07	DNA	3.58	88	88	\N	2
29501	DNA-295	2022-08-25 00:00:00-07	DNA	0.47	88	88	\N	2
29502	DNA-296	\N	DNA	0	0	0	\N	\N
29503	DNA-297	2022-08-17 00:00:00-07	DNA	0.24	88	88	5 sections/tube	2
29504	DNA-298	2022-08-26 00:00:00-07	DNA	7.91	88	88	5 sections/tube	2
29505	DNA-299	2022-08-26 00:00:00-07	DNA	26.7	88	88	5 sections/tube	2
29506	DNA-300	2022-08-26 00:00:00-07	DNA	0.1	88	88	\N	2
29507	DNA-301	2022-08-26 00:00:00-07	DNA	1.5	88	88	\N	2
29508	DNA-302	2022-08-17 00:00:00-07	DNA	3.89	88	88	\N	2
29509	DNA-303	2022-08-26 00:00:00-07	DNA	1.75	88	88	\N	2
29510	DNA-304	2022-08-26 00:00:00-07	DNA	0.76	88	88	\N	2
29511	DNA-305	2022-08-26 00:00:00-07	DNA	7.89	88	88	\N	2
29512	DNA-306	2022-08-26 00:00:00-07	DNA	3.77	88	88	\N	2
29513	DNA-307	2022-08-26 00:00:00-07	DNA	0.81	88	88	\N	2
29514	DNA-308	2022-08-17 00:00:00-07	DNA	0.43	88	88	5 sections/tube	2
29515	DNA-309	2022-08-26 00:00:00-07	DNA	7.3	88	88	5 sections/tube	2
29516	DNA-310	2022-08-26 00:00:00-07	DNA	26.4	88	88	5 sections/tube	2
29517	DNA-311	2022-08-25 00:00:00-07	DNA	0.05	88	88	\N	2
29518	DNA-312	\N	DNA	0	0	0	\N	\N
29519	DNA-313	2022-08-25 00:00:00-07	DNA	2.12	88	88	\N	2
29520	DNA-314	2022-08-26 00:00:00-07	DNA	0.97	88	88	\N	2
29521	DNA-315	2022-08-26 00:00:00-07	DNA	0.98	88	88	\N	2
29522	DNA-316	2022-08-17 00:00:00-07	DNA	0.3	88	88	5 sections/tube	2
29523	DNA-317	2022-08-17 00:00:00-07	DNA	0.56	88	88	5 sections/tube	2
29524	DNA-318	2022-11-22 00:00:00-08	DNA	0.3	88	88	\N	2
29525	DNA-319	2022-11-28 00:00:00-08	DNA	0.41	88	88	\N	2
29526	DNA-320	2022-12-09 00:00:00-08	DNA	1.6	88	88	\N	2
29527	DNA-330	2022-10-28 00:00:00-07	DNA	38.1	176	176	\N	2
29528	DNA-331	2022-10-28 00:00:00-07	DNA	36.6	176	176	\N	2
29529	DNA-332	2022-10-28 00:00:00-07	DNA	39.4	88	88	\N	2
29530	DNA-333	2022-11-03 00:00:00-07	DNA	8.2	176	176	\N	2
29531	DNA-334	2022-10-28 00:00:00-07	DNA	2.77	176	176	\N	2
29532	DNA-335	2022-10-28 00:00:00-07	DNA	6.31	88	88	\N	2
29533	DNA-336	2022-11-03 00:00:00-07	DNA	0.66	200	200	\N	2
29534	DNA-337	2022-10-28 00:00:00-07	DNA	20.9	88	88	\N	2
29535	DNA-338	2022-10-28 00:00:00-07	DNA	4.81	88	88	\N	2
29536	DNA-339	2022-10-28 00:00:00-07	DNA	1.74	88	88	\N	2
29537	DNA-340	2022-10-28 00:00:00-07	DNA	21.2	88	88	\N	2
29538	DNA-341	2022-10-31 00:00:00-07	DNA	7.44	88	88	\N	2
29539	DNA-342	2022-11-03 00:00:00-07	DNA	0.72	264	264	\N	2
29540	DNA-344	2022-12-09 00:00:00-08	DNA	21.7	176	176	\N	2
29541	DNA-346	2022-12-09 00:00:00-08	DNA	3.56	88	88	\N	2
29542	DNA-347	2022-12-09 00:00:00-08	DNA	5.46	88	88	\N	2
29543	DNA-348	2022-10-31 00:00:00-07	DNA	20.6	352	352	\N	2
29544	DNA-350	2022-10-31 00:00:00-07	DNA	4.79	176	176	\N	2
29545	DNA-351	2022-10-31 00:00:00-07	DNA	5.43	352	352	\N	2
29546	DNA-353	2022-11-03 00:00:00-07	DNA	2	176	176	\N	2
29547	DNA-355	2022-10-31 00:00:00-07	DNA	7.79	88	88	\N	2
29548	DNA-356	2022-11-10 00:00:00-08	DNA	16	88	88	\N	2
29549	DNA-357	2022-11-10 00:00:00-08	DNA	1.49	88	88	\N	2
29550	DNA-358	2022-11-03 00:00:00-07	DNA	3.23	100	100	\N	2
29551	DNA-359	2022-11-10 00:00:00-08	DNA	7.23	176	176	\N	2
29552	DNA-361	2022-11-10 00:00:00-08	DNA	1.63	176	176	\N	2
29553	DNA-363	2022-11-28 00:00:00-08	DNA	0.14	88	88	\N	2
29554	DNA-364	2022-11-10 00:00:00-08	DNA	10.5	176	176	\N	2
29555	DNA-365	2022-11-10 00:00:00-08	DNA	4.74	88	88	\N	2
29556	DNA-366	2022-11-10 00:00:00-08	DNA	3.24	88	88	\N	2
29557	DNA-367	2022-11-28 00:00:00-08	DNA	0.95	352	352	\N	2
29558	DNA-369	2022-11-14 00:00:00-08	DNA	8.74	264	264	\N	2
29559	DNA-372	2022-11-10 00:00:00-08	DNA	2.6	88	88	\N	2
29560	DNA-373	2022-11-10 00:00:00-08	DNA	2.91	88	88	\N	2
29561	DNA-374	2022-11-28 00:00:00-08	DNA	0.53	264	264	\N	2
29562	DNA-377	2022-11-14 00:00:00-08	DNA	19	264	264	\N	2
29563	DNA-379	2022-11-14 00:00:00-08	DNA	23.3	176	176	\N	2
29564	DNA-381	2022-11-14 00:00:00-08	DNA	10.8	88	88	\N	2
29565	DNA-382	2022-11-28 00:00:00-08	DNA	1.45	88	88	\N	2
29566	DNA-383	2022-11-14 00:00:00-08	DNA	7.58	176	176	\N	2
29567	DNA-385	2022-11-22 00:00:00-08	DNA	6.09	88	88	\N	2
29568	DNA-387	2022-11-22 00:00:00-08	DNA	7.53	88	88	\N	2
29569	DNA-388	2022-11-28 00:00:00-08	DNA	0.41	176	176	\N	2
29570	DNA-390	2022-11-22 00:00:00-08	DNA	3.61	88	88	\N	2
29571	DNA-391	2022-11-22 00:00:00-08	DNA	2.7	88	88	\N	2
29572	DNA-392	2022-11-22 00:00:00-08	DNA	9.28	88	88	\N	2
29573	DNA-393	2022-11-28 00:00:00-08	DNA	0.99	88	88	\N	2
29574	DNA-394	2022-11-22 00:00:00-08	DNA	32.6	176	176	\N	2
29575	DNA-396	2022-11-22 00:00:00-08	DNA	15.5	88	88	\N	2
29576	DNA-397	2022-11-28 00:00:00-08	DNA	0.17	352	352	\N	2
29577	DNA-399	2022-12-09 00:00:00-08	DNA	9.68	88	88	\N	2
29578	DNA-401	2022-12-09 00:00:00-08	DNA	8.78	88	88	\N	2
29579	DNA-402	2022-12-09 00:00:00-08	DNA	4.41	88	88	\N	2
29580	DNA-403	2022-12-09 00:00:00-08	DNA	20.4	176	176	\N	2
29581	DNA-404	2022-11-22 00:00:00-08	DNA	2.87	88	88	\N	2
29582	DNA-405	2022-11-22 00:00:00-08	DNA	4.33	176	176	\N	2
29583	DNA-407	2022-11-28 00:00:00-08	DNA	2.09	176	176	\N	2
29584	DNA-417	2022-11-14 00:00:00-08	DNA	11.2	88	88	\N	2
29585	DNA-418	2022-12-09 00:00:00-08	DNA	14.8	88	88	\N	2
29586	DNA-419	2022-12-09 00:00:00-08	DNA	50	176	176	\N	2
29587	DNA-420	2022-12-09 00:00:00-08	DNA	0.82	176	176	\N	2
29588	DNA-421	2022-12-09 00:00:00-08	DNA	11	88	88	\N	2
29589	DNA-422	2022-12-09 00:00:00-08	DNA	4.81	88	88	\N	2
29590	DNA-423	2022-12-09 00:00:00-08	DNA	1.11	88	88	\N	2
29591	DNA-424	2023-04-18 00:00:00-07	DNA	6.6	160	160	\N	2
29592	DNA-425	2023-04-18 00:00:00-07	DNA	25.2	160	160	\N	2
29593	DNA-426	2023-04-18 00:00:00-07	DNA	141	160	160	\N	2
29594	DNA-427	2023-04-20 00:00:00-07	DNA	11.3	160	160	\N	2
29595	DNA-428	2023-04-18 00:00:00-07	DNA	8.52	80	80	\N	2
29596	DNA-429	2023-04-20 00:00:00-07	DNA	24.5	160	160	\N	2
29597	DNA-430	2023-04-20 00:00:00-07	DNA	49.4	80	80	\N	2
29598	DNA-431	2023-04-20 00:00:00-07	DNA	8.54	80	80	\N	2
29599	DNA-432	2023-04-20 00:00:00-07	DNA	22.4	80	80	\N	2
29600	DNA-433	2023-04-20 00:00:00-07	DNA	2.55	80	80	\N	2
29601	DNA-434	2023-04-20 00:00:00-07	DNA	8.22	80	80	\N	2
29602	DNA-435	2023-04-20 00:00:00-07	DNA	3.57	80	80	\N	2
29603	DNA-436	2023-04-25 00:00:00-07	DNA	21.3	160	160	\N	2
29604	DNA-437	2023-04-25 00:00:00-07	DNA	19.3	80	80	\N	2
29605	DNA-438	2023-04-25 00:00:00-07	DNA	3.85	160	160	\N	2
29606	DNA-439	2023-06-05 00:00:00-07	DNA	20.7	198	198	\N	6
29607	DNA-440	2023-06-05 00:00:00-07	DNA	3.79	96	96	\N	6
29608	DNA-441	2023-06-05 00:00:00-07	DNA	3.06	96	96	\N	6
29609	DNA-442	2023-06-05 00:00:00-07	DNA	1.42	198	198	\N	6
29610	DNA-443	2023-06-06 00:00:00-07	DNA	2.39	200	200	\N	6
29611	DNA-444	2023-06-06 00:00:00-07	DNA	5.48	200	200	\N	6
29718	Ivanka_10_1_NA	\N	DNA	\N	\N	\N	\N	\N
29612	DNA-445	2023-06-06 00:00:00-07	DNA	0.09	200	200	\N	6
29613	DNA-446	2023-06-06 00:00:00-07	DNA	7.96	200	200	\N	6
29614	DNA-447	2023-06-06 00:00:00-07	DNA	2.41	100	100	\N	6
29615	DNA-448	2023-06-06 00:00:00-07	DNA	1.81	100	100	\N	6
29616	DNPD-01	2020-06-01 00:00:00-07	DNA	0.95	80	80	\N	5
29617	DNPD-02	2020-06-01 00:00:00-07	DNA	2.13	80	80	\N	5
29618	DNPD-03	2020-06-01 00:00:00-07	DNA	0.83	80	80	\N	5
29619	DNPD-04	2020-06-01 00:00:00-07	DNA	1.88	80	80	\N	5
29620	DNPD-05	2020-06-01 00:00:00-07	DNA	2.27	80	80	\N	5
29621	DNPD-06	2020-06-01 00:00:00-07	DNA	2.3	80	80	\N	5
29622	DNPD-07	2020-06-01 00:00:00-07	DNA	0	80	80	\N	5
29623	DNPD-08	2020-06-01 00:00:00-07	DNA	0.09	80	80	\N	5
29624	DNPD-09	2020-06-01 00:00:00-07	DNA	0.19	80	80	\N	5
29625	DP12_200_NA	\N	DNA	\N	\N	\N	\N	\N
29626	DPN 49	\N	DNA	6.89	48	48	Sent from Dr. Helmut Kerl, University of Graz, 'Cerebral meta'	\N
29627	DPN_1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29628	DPN_3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29629	DPN_4_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29630	DPN_5_Normal_NA	2013-08-06 00:00:00-07	DNA	9.28	100	100	\N	5
29631	DPN_5_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29632	DPN_6_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29633	DPN_7_Tumor_NA	2013-08-06 00:00:00-07	DNA	0.1	100	100	\N	5
29634	DPN_8_Normal_NA	2013-07-30 00:00:00-07	DNA	\N	\N	\N	\N	\N
29635	DPN_8_Tumor_NA	2013-07-30 00:00:00-07	DNA	\N	\N	\N	\N	\N
29636	DPN_9_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29637	DPN_9_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29638	DPN_10_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29639	DPN_11_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29640	DPN_12_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29641	DPN_14_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29642	DPN_16_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29643	DPN_17_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29644	DPN_18_Normal_NA	2013-07-30 00:00:00-07	DNA	\N	\N	\N	\N	\N
29645	DPN_18_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29646	DPN_19_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29647	DPN_35_NA	\N	DNA	\N	\N	\N	\N	\N
29648	DPN_CNN 30_NA	\N	DNA	\N	\N	\N	\N	\N
29649	DPN_CNN 32_NA	\N	DNA	\N	\N	\N	\N	\N
29650	DPN_Conv_35_NA	\N	DNA	\N	\N	\N	\N	\N
29651	DPN_MM 20_NA	\N	DNA	\N	\N	\N	\N	\N
29652	DPN_MM 21_NA	\N	DNA	\N	\N	\N	\N	\N
29653	DPN_MM 22_NA	\N	DNA	\N	\N	\N	\N	\N
29654	DPN50-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29655	DPN51-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29656	DPN52-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29657	DPN53-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29658	DPN54-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29659	DPN55-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29660	DPN56-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29661	DPN57-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29662	DPN58-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29663	DPN59-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29664	DPN60-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29665	DPN61-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29666	DPN62-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29667	DT10_63051C_NA	\N	DNA	\N	\N	\N	Ivanka Normal (for #9)	\N
29668	FAC01	2023-02-22 00:00:00-08	DNA	0.64	140	140	3mm punch biopsy	3
29669	FAC03	2023-02-22 00:00:00-08	DNA	24.8	140	140	3mm punch biopsy	3
29670	FAC05	2023-02-22 00:00:00-08	DNA	30.7	140	140	3mm punch biopsy	3
29671	FAC06	2023-02-22 00:00:00-08	DNA	23.8	140	140	3mm punch biopsy	3
29672	Fusion-01	\N	RNA	26.9	20	20	Fusion Gene: MET; Fusion Verified DNA: EPS15-MET; **Nanodrop was used to quantify	\N
29673	Fusion-02	\N	RNA	7.8	15	15	Fusion Gene: BRAF; Fusion Verified DNA: MAD1L-BRAF; **Nanodrop was used to quantify	\N
29674	Fusion-05	\N	RNA	161.6	20	20	Fusion Gene: MET; Fusion Verified DNA: ZKSCAN1-MET; **Nanodrop was used to quantify	\N
29675	Fusion-06	\N	RNA	13.8	20	20	Fusion Gene: PRKCA; Fusion Verified RNA: ATP2B4-PRKCA; **Nanodrop was used to quantify	\N
29676	Fusion-08	\N	RNA	17.2	20	20	Fusion Gene: NTRK3; Fusion Verified RNA: Myo5A-NTRK3; **Nanodrop was used to quantify	\N
29677	Fusion-09	\N	RNA	64.5	20	20	Fusion Gene: ROS1; Fusion Verified RNA: PWWP2A-ROS1; **Nanodrop was used to quantify	\N
29678	Fusion-10	\N	RNA	43.9	100	100	Fusion Gene: BRAF; Fusion Verified DNA: Cell line MA9254; **Nanodrop was used to quantify	\N
29679	Fusion-11	\N	RNA	536.5	20	20	Fusion Gene: ALK; Fusion Verified DNA: Lung cancer with ALK fusion; ; **Nanodrop was used to quantify	\N
29680	G3 DP08-21965C Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29681	G3 DP08-21965C Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29682	G5 DP08-4205A Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29683	G5 DP08-4205A Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29684	HW_2_Tumor Dissect_NA	\N	DNA	\N	\N	\N	\N	\N
29685	HW_3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29686	HW_8_Mucosal_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29687	HW_A1_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29688	HW_A1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29689	HW_A2_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29690	HW_A2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29691	HW_A3_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29692	HW_A3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29693	HW_A4_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29694	HW_A4_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29695	HW_A5_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29696	HW_A5_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29697	HW_A6_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29698	HW_A6_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29699	HW_A7 Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29700	HW_A7_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29701	HW_A8_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29702	HW_A8_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29703	HW_A9_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29704	HW_A9_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29705	HW_A10_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29706	HW_A10_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29707	HW_Acral_#8_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29708	Ivanka_5_1_NA	\N	DNA	\N	\N	\N	\N	\N
29709	Ivanka_5_2_NA	\N	DNA	\N	\N	\N	\N	\N
29710	Ivanka_5_3_NA	\N	DNA	\N	\N	\N	\N	\N
29711	Ivanka_5_4_NA	\N	DNA	\N	\N	\N	\N	\N
29712	Ivanka_5_5_NA	\N	DNA	\N	\N	\N	\N	\N
29713	Ivanka_9_1_NA	\N	DNA	\N	\N	\N	\N	\N
29714	Ivanka_9_2_NA	\N	DNA	\N	\N	\N	\N	\N
29719	Ivanka_10_2_NA	\N	DNA	\N	\N	\N	\N	\N
29720	Ivanka_10_3_NA	\N	DNA	\N	\N	\N	\N	\N
29721	Ivanka_10_4_NA	\N	DNA	\N	\N	\N	\N	\N
29722	Ivanka_10_5_NA	\N	DNA	\N	\N	\N	\N	\N
29723	Ivanka_12_1_NA	\N	DNA	\N	\N	\N	\N	\N
29724	Ivanka_12_2_NA	\N	DNA	\N	\N	\N	\N	\N
29725	Ivanka_12_3_NA	\N	DNA	\N	\N	\N	\N	\N
29726	Ivanka_12_4_NA	\N	DNA	\N	\N	\N	\N	\N
29727	Ivanka_12_5_NA	\N	DNA	\N	\N	\N	\N	\N
29728	Ivanka_16_1_NA	\N	DNA	\N	\N	\N	\N	\N
29729	Ivanka_16_2_NA	\N	DNA	\N	\N	\N	\N	\N
29730	Ivanka_16_3_NA	\N	DNA	\N	\N	\N	\N	\N
29731	Ivanka_16_4_NA	\N	DNA	\N	\N	\N	\N	\N
29732	Ivanka_16_5_NA	\N	DNA	\N	\N	\N	\N	\N
29733	Ivanka_20_1_NA	\N	DNA	\N	\N	\N	\N	\N
29734	Ivanka_20_2_NA	\N	DNA	\N	\N	\N	\N	\N
29735	Ivanka_20_3_NA	\N	DNA	\N	\N	\N	\N	\N
29736	Ivanka_20_4_NA	\N	DNA	\N	\N	\N	\N	\N
29737	Ivanka_20_5_NA	\N	DNA	\N	\N	\N	\N	\N
29738	Ivanka_22_1_NA	\N	DNA	\N	\N	\N	\N	\N
29739	Ivanka_22_2_NA	\N	DNA	\N	\N	\N	\N	\N
29740	Ivanka_22_3_NA	\N	DNA	\N	\N	\N	\N	\N
29741	Ivanka_22_4_NA	\N	DNA	\N	\N	\N	\N	\N
29742	Ivanka_22_5_NA	\N	DNA	\N	\N	\N	\N	\N
29743	Ivanka_23_1_NA	\N	DNA	\N	\N	\N	\N	\N
29744	Ivanka_23_2_NA	\N	DNA	\N	\N	\N	\N	\N
29745	Ivanka_23_3_NA	\N	DNA	\N	\N	\N	\N	\N
29746	Ivanka_23_4_NA	\N	DNA	\N	\N	\N	\N	\N
29747	Ivanka_23_5_NA	\N	DNA	\N	\N	\N	\N	\N
29748	JBP-6-Met_NA	\N	DNA	22.6	50	50	\N	\N
29749	JBP-6-MM_NA	\N	DNA	29.1	50	50	\N	\N
29750	JBP-6-Norm_NA	\N	DNA	10.2	50	50	\N	\N
29751	JBP-9Met_NA	\N	DNA	31.5	50	50	\N	\N
29752	JBP-9MM_NA	\N	DNA	1.9	50	50	\N	\N
29753	JBP-11Met	\N	DNA	29.4	50	50	\N	\N
29754	JBP-11MM	\N	DNA	25.1	50	50	\N	\N
29755	JBP-11Norm	\N	DNA	38.2	50	50	\N	\N
29756	JBU7-MVP	\N	DNA	41.5	50	50	\N	\N
29757	JBU7-Norm	\N	DNA	27	50	50	\N	\N
29758	JBU8-MVP	\N	DNA	33.4	50	50	\N	\N
29759	JBU8-Norm	\N	DNA	0.48	50	50	\N	\N
29760	JBU10-MVP	\N	DNA	31.2	50	50	\N	\N
29761	JBU10-Norm	\N	DNA	53	50	50	\N	\N
29762	JBU11-MVP	\N	DNA	35.4	50	50	\N	\N
29763	JBU11-Norm	\N	DNA	13.9	50	50	\N	\N
29764	K1_13	2014-07-22 00:00:00-07	DNA	1.71	50	50	\N	\N
29765	K1_14	2014-07-22 00:00:00-07	DNA	46.4	50	50	\N	\N
29766	K1_15	2014-07-22 00:00:00-07	DNA	47.5	50	50	\N	\N
29767	K1_16	2014-07-22 00:00:00-07	DNA	36.2	50	50	\N	\N
29768	K1_17	2014-07-22 00:00:00-07	DNA	39.3	50	50	\N	\N
29769	K1_18	2014-07-22 00:00:00-07	DNA	23.3	50	50	\N	\N
29770	K1_19	2014-07-22 00:00:00-07	DNA	43.2	50	50	\N	\N
29771	K1_20	2014-07-22 00:00:00-07	DNA	14.1	50	50	\N	\N
29772	K1_21	2014-07-22 00:00:00-07	DNA	38.9	50	50	\N	\N
29773	K1_22	2014-07-22 00:00:00-07	DNA	44.7	50	50	\N	\N
29774	K2_1_NA	2014-07-22 00:00:00-07	DNA	51	50	50	\N	\N
29775	K2_2_NA	2014-07-22 00:00:00-07	DNA	6.56	50	50	\N	\N
29776	K2_3_NA	2014-07-22 00:00:00-07	DNA	\N	50	50	\N	\N
29777	K2_4	2014-07-22 00:00:00-07	DNA	6.26	50	50	\N	\N
29778	K2_5	2014-07-22 00:00:00-07	DNA	11.2	50	50	\N	\N
29779	K2_6	2014-07-22 00:00:00-07	DNA	0.79	50	50	\N	\N
29780	K2_7	2014-07-22 00:00:00-07	DNA	41.8	50	50	\N	\N
29781	K2_8	2014-07-22 00:00:00-07	DNA	1.26	50	50	\N	\N
29782	K2_9	2014-07-22 00:00:00-07	DNA	54	50	50	\N	\N
29783	K2_10	2014-07-22 00:00:00-07	DNA	56	50	50	\N	\N
29784	K2_11_NA	2014-07-22 00:00:00-07	DNA	49.7	50	50	\N	\N
29785	KA D-01	2023-08-22 00:00:00-07	DNA	4	88	88	\N	2
29786	KA D-02	2023-08-17 00:00:00-07	DNA	5.98	88	88	\N	2
29787	KA D-03	2023-08-22 00:00:00-07	DNA	1.55	88	88	\N	2
29788	KA D-04	2023-08-17 00:00:00-07	DNA	1.6	88	88	\N	2
29789	KA D-05	2023-08-22 00:00:00-07	DNA	2.66	176	176	\N	2
29790	KA D-06	2023-08-17 00:00:00-07	DNA	3.51	352	352	\N	2
29791	KA D-07	2023-08-22 00:00:00-07	DNA	4.55	176	176	\N	2
29792	KA D-08	2023-08-17 00:00:00-07	DNA	\N	0	0	\N	2
29793	KA D-09	2023-08-22 00:00:00-07	DNA	1.43	176	176	\N	2
29794	KA D-10	2023-08-17 00:00:00-07	DNA	8.53	88	88	\N	2
29795	KA D-11	2023-08-22 00:00:00-07	DNA	1.38	176	176	\N	2
29796	KA D-12	2023-08-17 00:00:00-07	DNA	7.26	88	88	\N	2
29797	KA D-13	2023-08-22 00:00:00-07	DNA	2.6	176	176	\N	2
29798	KA D-14	2023-08-17 00:00:00-07	DNA	22.1	88	88	\N	2
29799	KA D-15	2023-08-22 00:00:00-07	DNA	2.23	88	88	\N	2
29800	KA D-16	2023-08-17 00:00:00-07	DNA	17.2	176	176	\N	2
29801	KA D-17	2023-08-22 00:00:00-07	DNA	3.44	176	176	\N	2
29802	KA D-18	2023-08-17 00:00:00-07	DNA	17.9	88	88	\N	2
29803	KA D-19	2023-08-17 00:00:00-07	DNA	17.4	88	88	\N	2
29804	KA D-20	2023-08-17 00:00:00-07	DNA	30.3	88	88	\N	2
29805	KA D-21	2023-08-17 00:00:00-07	DNA	11.2	88	88	\N	2
29806	KA D-22	2023-08-22 00:00:00-07	DNA	1.25	176	176	\N	2
29807	KA D-23	2023-08-17 00:00:00-07	DNA	7.79	88	88	\N	2
29808	KA D-24	2023-08-22 00:00:00-07	DNA	5.39	176	176	\N	2
29809	KA D-25	2023-08-17 00:00:00-07	DNA	\N	0	0	\N	2
29810	KA D-26	2023-08-21 00:00:00-07	DNA	32.4	176	176	\N	2
29811	KA D-27	2023-08-22 00:00:00-07	DNA	1.87	88	88	\N	2
29812	KA D-28	2023-08-21 00:00:00-07	DNA	4.89	88	88	\N	2
29813	KA D-29	2023-08-22 00:00:00-07	DNA	3.21	88	88	\N	2
29814	KA D-30	2023-08-21 00:00:00-07	DNA	20.7	88	88	\N	2
29815	KA D-31	2023-08-22 00:00:00-07	DNA	2.49	176	176	\N	2
29907	KIT_316_NA	\N	DNA	\N	\N	\N	\N	\N
29816	KA D-32	2023-08-21 00:00:00-07	DNA	17.2	176	176	\N	2
29817	KA D-33	2023-08-22 00:00:00-07	DNA	2.74	88	88	\N	2
29818	KA D-34	2023-08-21 00:00:00-07	DNA	9.52	88	88	\N	2
29819	KA D-35	2023-08-21 00:00:00-07	DNA	18.7	88	88	\N	2
29820	KA D-36	2023-08-22 00:00:00-07	DNA	7.18	176	176	\N	2
29821	KA R-02	2023-08-17 00:00:00-07	RNA	42.8	45	45	\N	1
29822	KA R-04	2023-08-17 00:00:00-07	RNA	6.22	45	45	\N	1
29823	KA R-06	2023-08-17 00:00:00-07	RNA	17.2	180	180	\N	1
29824	KA R-08	2023-08-17 00:00:00-07	RNA	0	45	45	\N	1
29825	KA R-10	2023-08-17 00:00:00-07	RNA	10.4	45	45	\N	1
29826	KA R-12	2023-08-17 00:00:00-07	RNA	20	45	45	\N	1
29827	KA R-14	2023-08-17 00:00:00-07	RNA	38.8	45	45	\N	1
29828	KA R-16	2023-08-17 00:00:00-07	RNA	30.5	90	90	\N	1
29829	KA R-18	2023-08-17 00:00:00-07	RNA	28.8	45	45	\N	1
29830	KA R-19	2023-08-17 00:00:00-07	RNA	45.4	45	45	\N	1
29831	KA R-20	2023-08-17 00:00:00-07	RNA	37.6	45	45	\N	1
29832	KA R-21	2023-08-17 00:00:00-07	RNA	45.8	45	45	\N	1
29833	KA R-23	2023-08-17 00:00:00-07	RNA	35.5	45	45	\N	1
29834	KA R-25	2023-08-17 00:00:00-07	RNA	49.7	45	45	\N	1
29835	KA R-26	2023-08-21 00:00:00-07	RNA	83	90	90	\N	1
29836	KA R-28	2023-08-21 00:00:00-07	RNA	37	45	45	\N	1
29837	KA R-30	2023-08-21 00:00:00-07	RNA	56	45	45	\N	1
29838	KA R-32	2023-08-21 00:00:00-07	RNA	48	45	45	\N	1
29839	KA R-34	2023-08-21 00:00:00-07	RNA	70	45	45	\N	1
29840	KA R-35	2023-08-21 00:00:00-07	RNA	128	45	45	\N	1
29841	KAM3-T-A	2014-08-13 00:00:00-07	DNA	0.07	50	50	\N	\N
29842	KAM10-N-B7	2014-10-21 00:00:00-07	DNA	4.39	50	50	\N	\N
29843	KAM10-T	2014-08-26 00:00:00-07	DNA	34.9	50	50	\N	\N
29844	KAM12-T	2014-08-13 00:00:00-07	DNA	1.03	50	50	\N	\N
29845	KAM14-T	2014-08-13 00:00:00-07	DNA	6.21	50	50	\N	\N
29846	KAM26-T	2014-08-22 00:00:00-07	DNA	3.02	50	50	\N	\N
29847	KAM34-T	2014-08-22 00:00:00-07	DNA	1.63	50	50	\N	\N
29848	KAM37-T	2014-08-26 00:00:00-07	DNA	3.27	50	50	\N	\N
29849	KAM43-T	2014-08-26 00:00:00-07	DNA	1.78	50	50	\N	\N
29850	KAM48-T	2014-08-27 00:00:00-07	DNA	15.7	50	50	\N	\N
29851	KAM62-T	2014-08-27 00:00:00-07	DNA	7.79	50	50	\N	\N
29852	KAM65-T	2014-08-27 00:00:00-07	DNA	7.01	50	50	\N	\N
29853	KAM71-T	2014-08-28 00:00:00-07	DNA	7.39	50	50	\N	\N
29854	KAM75-T	2014-09-02 00:00:00-07	DNA	24.9	50	50	\N	\N
29855	KAM79-T	2014-09-02 00:00:00-07	DNA	5.84	50	50	\N	\N
29856	KAM93-N-B10	2014-10-23 00:00:00-07	DNA	5.38	50	50	\N	\N
29857	KAM93-T	2014-09-10 00:00:00-07	DNA	14	55	55	\N	\N
29858	KAM95-T-B1	2014-11-06 00:00:00-08	DNA	5.2	50	50	\N	\N
29859	KAM99-N	2014-09-10 00:00:00-07	DNA	2.8	55	55	\N	\N
29860	KAM99-T	2014-09-10 00:00:00-07	DNA	27.6	50	50	\N	\N
29861	KAM100-N	2014-10-15 00:00:00-07	DNA	7.38	50	50	\N	\N
29862	KAM100-T-11	2014-10-15 00:00:00-07	DNA	13.7	50	50	\N	\N
29863	KAM102-T-B	2014-10-15 00:00:00-07	DNA	8.12	50	50	\N	\N
29864	KAM111-N-A4	2014-10-23 00:00:00-07	DNA	2.36	50	50	\N	\N
29865	KAM111-T-A1	2014-11-06 00:00:00-08	DNA	10.1	50	50	\N	\N
29866	KAM111-T-A2	2014-10-15 00:00:00-07	DNA	33.3	50	50	\N	\N
29867	KAM113-T-H	2014-10-15 00:00:00-07	DNA	2.87	50	50	\N	\N
29868	KAM116-T	2014-10-15 00:00:00-07	DNA	1.59	50	50	\N	\N
29869	KAM122-T-A	2014-10-21 00:00:00-07	DNA	1.64	50	50	\N	\N
29870	KAM123-T	2014-10-21 00:00:00-07	DNA	4.82	50	50	\N	\N
29871	KAM127-N	2015-07-06 00:00:00-07	DNA	43.9	48	48	\N	\N
29872	KAM127-T	2015-07-06 00:00:00-07	DNA	9.45	48	48	\N	\N
29873	KAM128-T	2015-07-06 00:00:00-07	DNA	0.59	48	48	\N	\N
29874	KAM130-T	2015-07-06 00:00:00-07	DNA	0.47	48	48	\N	\N
29875	KAM131-N	2015-07-06 00:00:00-07	DNA	0.88	48	48	\N	\N
29876	KAM131-T	2015-07-06 00:00:00-07	DNA	24	48	48	\N	\N
29877	Kit 262_NA	\N	DNA	\N	\N	\N	\N	\N
29878	Kit_8_NA	\N	DNA	\N	\N	\N	WT/Mucosal Oral	\N
29879	Kit_21_NA	\N	DNA	\N	\N	\N	BRAF/Mucosal Anal	\N
29880	Kit_37_Acral_NRAS_NA	\N	DNA	\N	\N	\N	\N	\N
29881	Kit_53_Acral_NRAS_NA	\N	DNA	\N	\N	\N	Melanoma, Heel	\N
29882	Kit_55_NA	\N	DNA	\N	\N	\N	WT/Mucosal Anal	\N
29883	Kit_62__Acral_NRAS_NA	\N	DNA	\N	\N	\N	\N	\N
29884	Kit_76_NA	\N	DNA	\N	\N	\N	WT/Mucosal Sinus	\N
29885	Kit_118_Muc_NRAS_NA	\N	DNA	\N	\N	\N	\N	\N
29886	KIT_134_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29887	Kit_181_Muc BRAF_NA	\N	DNA	\N	\N	\N	\N	\N
29888	Kit_181_Muc_BRAF_NA	\N	DNA	\N	\N	\N	\N	\N
29889	KIT_191_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29890	Kit_192_NA	\N	DNA	\N	\N	\N	Acral Mucosal	\N
29891	Kit_203_NA	\N	DNA	\N	\N	\N	Acral Mucosal	\N
29892	KIT_205_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29893	KIT_206_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29894	KIT_210_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29895	KIT_217_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29896	KIT_225_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29897	Kit_227_Acral_WT_NA	2012-07-31 00:00:00-07	DNA	70.5	45	45	Melanoma, vulva	\N
29898	KIT_230_NA	\N	DNA	\N	\N	\N	\N	\N
29899	KIT_244_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29900	KIT_260_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29901	KIT_273_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29902	Kit_275_Muc_BRAF_NA	\N	DNA	\N	\N	\N	\N	\N
29903	KIT_295_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29904	KIT_297_NA	\N	DNA	\N	\N	\N	\N	\N
29905	KIT_302_NA	\N	DNA	\N	\N	\N	\N	\N
29906	Kit_313_Mucosal_NA	\N	DNA	\N	\N	\N	Melanoma, Rectum	\N
29908	KIT-01	2017-11-07 00:00:00-08	DNA	0.21	90	90	\N	5
29909	KIT-02	2017-11-07 00:00:00-08	DNA	0.73	90	90	\N	5
29910	KIT-03	2017-11-07 00:00:00-08	DNA	1.09	90	90	\N	5
29911	KIT-04	2017-11-07 00:00:00-08	DNA	1.38	90	90	\N	5
29912	KIT-05	2017-11-07 00:00:00-08	DNA	0.81	90	90	\N	5
29913	KIT-06	2017-11-07 00:00:00-08	DNA	0.48	90	90	\N	5
29914	KIT-07	2017-11-15 00:00:00-08	DNA	1.97	30	30	\N	4
29915	KIT-08	2017-11-15 00:00:00-08	DNA	0.65	30	30	\N	4
29916	KIT-09	2017-11-15 00:00:00-08	DNA	1.36	30	30	\N	4
29917	KIT-10	2017-11-15 00:00:00-08	DNA	3.26	30	30	\N	4
29918	KIT-11	2017-11-07 00:00:00-08	DNA	3.86	15	15	\N	5
29919	KIT-12	2017-11-07 00:00:00-08	DNA	2.46	25	25	\N	5
29920	KIT-13	2018-01-26 00:00:00-08	DNA	1.69	50	50	\N	4
29921	KIT-14	2018-01-26 00:00:00-08	DNA	3.98	50	50	\N	4
29922	KIT-15	2018-01-26 00:00:00-08	DNA	1.85	50	50	\N	4
29923	KIT-16	2018-01-26 00:00:00-08	DNA	2.58	50	50	\N	4
29924	KIT-17	2018-01-26 00:00:00-08	DNA	3.98	50	50	\N	4
29925	KIT-18	2018-01-26 00:00:00-08	DNA	4.46	50	50	\N	4
29926	KR_8_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29927	KR_150_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29928	KR_166_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29929	KR_177_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29930	KR_203_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29931	KR_229_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29932	KR_2030_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29933	KR_2064_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29934	KR_5233_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29935	KR_RMK0091B_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29936	KR_RMK0137C_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29937	KR_RMK0162C_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29938	KR_RMK0168C_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29939	KR_RMK0194C_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29940	L2-HGD_NA	\N	DNA	\N	\N	\N	\N	\N
29941	L2-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29942	L3-HGD_NA	\N	DNA	\N	\N	\N	\N	\N
29943	L3-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29944	L11_96096_A2_Norm_NA	\N	DNA	\N	\N	\N	Metastatic Melanoma, Lymph Node, sentinel. Capsular nevus is present	\N
29945	LMM D-001	2023-04-18 00:00:00-07	DNA	1.46	80	80	\N	2
29946	LMM D-002	2023-04-18 00:00:00-07	DNA	0.72	80	80	\N	2
29947	LMM D-003	2023-04-18 00:00:00-07	DNA	0.32	80	80	\N	2
29948	LMM D-004	2023-04-18 00:00:00-07	DNA	20.4	80	80	\N	2
29949	LMM D-005	2023-04-18 00:00:00-07	DNA	4.6	80	80	\N	2
29950	LMM D-006	2023-04-18 00:00:00-07	DNA	6.68	80	80	\N	2
29951	LMM D-007	2023-04-20 00:00:00-07	DNA	6.99	80	80	\N	2
29952	LMM D-008	2023-04-20 00:00:00-07	DNA	7.3	80	80	\N	2
29953	LMM D-009	2023-04-20 00:00:00-07	DNA	4.12	80	80	\N	2
29954	LMM D-010	2023-04-20 00:00:00-07	DNA	24.5	80	80	\N	2
29955	LMM D-011	2023-04-20 00:00:00-07	DNA	26.3	80	80	\N	2
29956	LMM D-012	2023-04-20 00:00:00-07	DNA	13.5	80	80	\N	2
29957	LMM D-013	2023-04-18 00:00:00-07	DNA	27.7	80	80	\N	2
29958	LMM D-014	2023-04-18 00:00:00-07	DNA	8.56	80	80	\N	2
29959	LMM D-015	2023-04-18 00:00:00-07	DNA	5.34	80	80	\N	2
29960	LMM D-016	2023-05-19 00:00:00-07	DNA	0.93	170	170	\N	6
29961	LMM D-017	2023-05-19 00:00:00-07	DNA	2.08	80	80	\N	6
29962	LMM D-018	2023-05-19 00:00:00-07	DNA	2.26	80	80	\N	6
29963	LMM D-019	2023-05-19 00:00:00-07	DNA	2.24	80	80	\N	6
29964	LMM D-020	2023-05-19 00:00:00-07	DNA	0.18	80	80	\N	6
29965	LMM D-021	2023-05-19 00:00:00-07	DNA	0.2	80	80	\N	6
29966	LMM D-022	2023-06-07 00:00:00-07	DNA	0.74	88	88	\N	6
29967	LMM D-023	2023-06-07 00:00:00-07	DNA	0.08	88	88	\N	6
29968	LMM D-024	2023-06-07 00:00:00-07	DNA	1.03	88	88	\N	6
29969	LMM D-025	2023-08-25 00:00:00-07	DNA	3.12	88	88	\N	2
29970	LMM D-026	2023-08-25 00:00:00-07	DNA	1.01	88	88	\N	2
29971	LMM D-027	2023-08-28 00:00:00-07	DNA	0.13	88	88	\N	2
29972	LMM D-028	2023-08-25 00:00:00-07	DNA	0.7	88	88	\N	2
29973	LMM D-029	2023-08-25 00:00:00-07	DNA	2.07	88	88	\N	2
29974	LMM D-030	2023-08-28 00:00:00-07	DNA	0.14	88	88	\N	2
29975	LMM D-031	2023-08-25 00:00:00-07	DNA	31.6	88	88	\N	2
29976	LMM D-032	2023-08-25 00:00:00-07	DNA	3.08	88	88	\N	2
29977	LMM D-033	2023-08-28 00:00:00-07	DNA	5.48	88	88	\N	2
29978	LMM D-034	2023-08-25 00:00:00-07	DNA	3.61	88	88	\N	2
29979	LMM D-035	2023-08-25 00:00:00-07	DNA	3.71	88	88	\N	2
29980	LMM D-036	2023-08-28 00:00:00-07	DNA	0.26	88	88	\N	2
29981	LMM D-037	2023-08-25 00:00:00-07	DNA	0.32	88	88	\N	2
29982	LMM D-038	2023-08-25 00:00:00-07	DNA	0.87	88	88	\N	2
29983	LMM D-039	2023-08-28 00:00:00-07	DNA	0.11	88	88	\N	2
29984	LMM D-040	2023-08-25 00:00:00-07	DNA	1.39	88	88	\N	2
29985	LMM D-041	2023-08-25 00:00:00-07	DNA	1.9	88	88	\N	2
29986	LMM D-042	2023-08-28 00:00:00-07	DNA	0.36	88	88	\N	2
29987	LMM D-043	2023-08-25 00:00:00-07	DNA	12.7	88	88	\N	2
29988	LMM D-044	2023-08-25 00:00:00-07	DNA	8.03	88	88	\N	2
29989	LMM D-045	2023-08-28 00:00:00-07	DNA	5.15	88	88	\N	2
29990	LMM D-046	\N	DNA	\N	\N	\N	\N	2
29991	LMM D-047	\N	DNA	\N	\N	\N	\N	2
29992	LMM D-048	\N	DNA	\N	\N	\N	\N	2
29993	LMM D-049	\N	DNA	\N	\N	\N	\N	2
29994	LMM D-050	\N	DNA	\N	\N	\N	\N	2
29995	LMM D-051	\N	DNA	\N	\N	\N	\N	2
29996	LMM D-052	\N	DNA	\N	\N	\N	\N	2
29997	LMM D-053	\N	DNA	\N	\N	\N	\N	2
29998	LMM D-054	2023-10-10 00:00:00-07	DNA	0.82	210	210	\N	2
29999	LMM D-055	\N	DNA	\N	\N	\N	\N	2
30000	LMM D-056	\N	DNA	\N	\N	\N	\N	2
30001	LMM D-057	2023-10-10 00:00:00-07	DNA	1.61	88	88	\N	2
30002	LMM D-060	2023-10-10 00:00:00-07	DNA	2.95	88	88	\N	2
30003	LMM D-061	\N	DNA	\N	\N	\N	\N	\N
30004	LMM D-062	\N	DNA	\N	\N	\N	\N	\N
30005	LMM D-063	2023-10-10 00:00:00-07	DNA	5.69	88	88	\N	2
30006	LMM R-001	2023-04-18 00:00:00-07	RNA	3.28	45	45	\N	1
30007	LMM R-002	2023-04-18 00:00:00-07	RNA	1.16	40	40	\N	1
30008	LMM R-003	2023-04-18 00:00:00-07	RNA	0	45	45	\N	1
30009	LMM R-004	2023-04-18 00:00:00-07	RNA	18.7	45	45	\N	1
30010	LMM R-005	2023-04-18 00:00:00-07	RNA	7.57	45	45	\N	1
30011	LMM R-006	2023-04-18 00:00:00-07	RNA	7.36	45	45	\N	1
30012	LMM R-007	2023-04-20 00:00:00-07	RNA	2.65	45	45	\N	1
30013	LMM R-008	2023-04-20 00:00:00-07	RNA	2.3	45	45	\N	1
30014	LMM R-009	2023-04-20 00:00:00-07	RNA	5.21	45	45	\N	1
30015	LMM R-010	2023-04-20 00:00:00-07	RNA	2.65	45	45	\N	1
30016	LMM R-011	2023-04-20 00:00:00-07	RNA	2.4	45	45	\N	1
30017	LMM R-012	2023-04-20 00:00:00-07	RNA	2.1	45	45	\N	1
30018	LMM R-013	2023-04-18 00:00:00-07	RNA	19.2	45	45	\N	1
30019	LMM R-014	2023-04-18 00:00:00-07	RNA	2.58	45	45	\N	1
30020	LMM R-015	2023-04-18 00:00:00-07	RNA	2.3	45	45	\N	1
30021	LMM R-016	2023-05-19 00:00:00-07	RNA	3.03	18	18	\N	6
30022	LMM R-017	2023-05-19 00:00:00-07	RNA	3.12	18	18	\N	6
30023	LMM R-018	2023-05-19 00:00:00-07	RNA	3.93	18	18	\N	6
30024	LMM R-019	2023-05-19 00:00:00-07	RNA	53	18	18	\N	6
30025	LMM R-020	2023-05-19 00:00:00-07	RNA	4.44	18	18	\N	6
30026	LMM R-021	2023-05-19 00:00:00-07	RNA	3.35	18	18	\N	6
30027	LMM R-022	2023-06-07 00:00:00-07	RNA	5.44	18	18	\N	6
30028	LMM R-023	2023-06-07 00:00:00-07	RNA	1.44	18	18	\N	6
30029	LMM R-024	2023-06-07 00:00:00-07	RNA	23.1	18	18	\N	6
30030	LMM R-025	2023-08-25 00:00:00-07	RNA	12	45	45	\N	1
30031	LMM R-026	2023-08-25 00:00:00-07	RNA	4.2	45	45	\N	1
30032	LMM R-028	2023-08-25 00:00:00-07	RNA	1.75	35	35	\N	1
30033	LMM R-029	2023-08-25 00:00:00-07	RNA	3.91	45	45	\N	1
30034	LMM R-031	2023-08-25 00:00:00-07	RNA	36	45	45	\N	1
30035	LMM R-032	2023-08-25 00:00:00-07	RNA	4.84	45	45	\N	1
30036	LMM R-034	2023-08-25 00:00:00-07	RNA	3.84	45	45	\N	1
30037	LMM R-035	2023-08-25 00:00:00-07	RNA	5.53	45	45	\N	1
30038	LMM R-037	2023-08-25 00:00:00-07	RNA	1.06	35	35	\N	1
30039	LMM R-038	2023-08-25 00:00:00-07	RNA	3.92	45	45	\N	1
30040	LMM R-040	2023-08-25 00:00:00-07	RNA	2.3	45	45	\N	1
30041	LMM R-041	2023-08-25 00:00:00-07	RNA	7.67	45	45	\N	1
30042	LMM R-043	2023-08-25 00:00:00-07	RNA	19.8	45	45	\N	1
30043	LMM R-044	2023-08-25 00:00:00-07	RNA	17.6	45	45	\N	1
30044	LMM R-046	\N	RNA	8.8	45	45	\N	1
30045	LMM R-047	\N	RNA	10.7	45	45	\N	1
30046	LMM R-048	\N	RNA	0	45	45	\N	1
30047	LMM R-049	\N	RNA	11	45	45	\N	1
30048	LMM R-050	\N	RNA	7.19	45	45	\N	1
30049	LMM R-051	\N	RNA	0	45	45	\N	1
30050	LMM R-052	\N	RNA	13.8	45	45	\N	1
30051	LMM R-053	\N	RNA	4.6	45	45	\N	1
30052	LMM R-054	\N	RNA	0	45	45	\N	1
30053	LMM R-055	\N	RNA	5.46	45	45	\N	1
30054	LMM R-056	\N	RNA	2.1	45	45	\N	1
30055	LMM R-057	\N	RNA	0	45	45	\N	1
30056	LN D-01 (LN-01)	\N	DNA	98	50	50	\N	\N
30057	LN D-02 (LN-02)	\N	DNA	59.6	50	50	\N	\N
30058	LN D-03 (LN-03)	\N	DNA	106	50	50	\N	\N
30059	LN D-04 (LN-04)	\N	DNA	47.4	50	50	\N	\N
30060	LN D-05 (LN-05)	\N	DNA	15	50	50	\N	\N
30061	LN D-06 (LN-06)	\N	DNA	22.8	50	50	\N	\N
30062	LN D-07 (LN-07)	\N	DNA	85.8	50	50	\N	\N
30063	LN D-08 (LN-08)	\N	DNA	65.8	50	50	\N	\N
30064	LN D-09 (LN-09)	\N	DNA	29.8	50	50	\N	\N
30065	LN D-10 (LN-10)	\N	DNA	59	50	50	\N	\N
30066	LN D-11 (LN-11)	\N	DNA	23	50	50	\N	\N
30067	LN D-12 (LN-12)	\N	DNA	91.6	50	50	\N	\N
30068	LN D-13 (LN-13)	\N	DNA	100	50	50	\N	\N
30069	LN D-14 (LN-14)	\N	DNA	25.8	50	50	\N	\N
30070	LN D-15 (LN-15)	\N	DNA	36.6	50	50	\N	\N
30071	LN D-16 (LN-16)	\N	DNA	92.4	50	50	\N	\N
30072	LN D-17 (LN-17)	\N	DNA	49.8	50	50	\N	\N
30073	LN D-18 (LN-18)	\N	DNA	73.6	50	50	\N	\N
30074	LN D-19 (LN-19)	\N	DNA	17.6	50	50	\N	\N
30075	LN D-20 (LN-20)	\N	DNA	120	50	50	\N	\N
30076	LN D-21 (LN-21)	\N	DNA	35.2	50	50	\N	\N
30077	LN D-022 (LN-022)	2019-03-15 00:00:00-07	DNA	0.39	48	48	\N	5
30078	LN D-023 (LN-023)	2019-03-15 00:00:00-07	DNA	0.49	48	48	\N	5
30079	LN D-024 (LN-024)	2019-03-15 00:00:00-07	DNA	0.66	48	48	\N	5
30080	LN D-025 (LN-025)	2019-03-15 00:00:00-07	DNA	0.79	48	48	\N	5
30081	LN D-026 (LN-026)	2019-03-15 00:00:00-07	DNA	0.52	48	48	\N	5
30082	LN D-027 (LN-027)	2019-03-15 00:00:00-07	DNA	0.33	48	48	\N	5
30083	LN D-028 (LN-028)	2019-03-15 00:00:00-07	DNA	0.14	48	48	\N	5
30084	LN D-029 (LN-029)	2019-03-15 00:00:00-07	DNA	0.29	48	48	\N	5
30085	LN D-030 (LN-030)	2019-03-15 00:00:00-07	DNA	0.38	48	48	\N	5
30086	LN D-031 (LN-031)	2019-03-15 00:00:00-07	DNA	0.18	48	48	\N	5
30087	LN D-032 (LN-032)	2019-03-15 00:00:00-07	DNA	0.44	48	48	\N	5
30088	LN D-033 (LN-033)	2019-03-15 00:00:00-07	DNA	1.27	48	48	\N	5
30089	LN D-034 (LN-034)	2019-03-15 00:00:00-07	DNA	0.16	48	48	\N	5
30090	LN D-035 (LN-035)	2019-03-15 00:00:00-07	DNA	0.27	48	48	\N	5
30091	LN D-036 (LN-036)	2019-03-15 00:00:00-07	DNA	0.15	48	48	\N	5
30092	LN D-037 (LN-037)	2019-03-15 00:00:00-07	DNA	0.05	48	48	\N	5
30093	LN D-038 (LN-038)	2019-03-15 00:00:00-07	DNA	0.09	48	48	\N	5
30094	LN D-039 (LN-039)	2019-03-15 00:00:00-07	DNA	0.2	48	48	\N	5
30095	LN D-040 (LN-040)	2019-03-15 00:00:00-07	DNA	0.55	48	48	\N	5
30096	LN D-041 (LN-041)	2019-03-15 00:00:00-07	DNA	1.42	48	48	\N	5
30097	LN D-042 LN-042)	2019-03-15 00:00:00-07	DNA	0.12	48	48	\N	5
30098	LN D-043 (LN-043)	2019-03-15 00:00:00-07	DNA	0.58	48	48	\N	5
30099	LN D-044 (LN-044)	2019-03-15 00:00:00-07	DNA	0.63	48	48	\N	5
30100	LN D-045 (LN-045)	2019-03-15 00:00:00-07	DNA	1.52	48	48	\N	5
30101	LN D-046 (LN-046)	2019-03-15 00:00:00-07	DNA	0.25	48	48	\N	5
30102	LN D-047 (LN-047)	2019-03-15 00:00:00-07	DNA	0.27	48	48	\N	5
30103	LN D-048 (LN-048)	2019-03-29 00:00:00-07	DNA	1.3	48	48	\N	5
30104	LN D-049 (LN-049)	2019-03-29 00:00:00-07	DNA	0.63	48	48	\N	5
30105	LN D-050 (LN-050)	2019-03-29 00:00:00-07	DNA	2.09	48	48	\N	5
30106	LN D-051 (LN-051)	2019-03-29 00:00:00-07	DNA	0.46	48	48	\N	5
30107	LN D-052 (LN-052)	2019-03-29 00:00:00-07	DNA	0.18	48	48	\N	5
30108	LN D-053 (LN-053)	2019-03-29 00:00:00-07	DNA	0.78	48	48	\N	5
30109	LN D-054 (LN-054)	2019-04-24 00:00:00-07	DNA	0.09	48	48	\N	5
30110	LN D-055 (LN-055)	2019-04-24 00:00:00-07	DNA	0.44	48	48	\N	5
30111	LN D-056 (LN-056)	2019-04-24 00:00:00-07	DNA	0.62	48	48	\N	5
30112	LN D-057 (LN-057)	2019-04-24 00:00:00-07	DNA	2.75	48	48	\N	5
30113	LN D-058 (LN-058)	2019-04-24 00:00:00-07	DNA	1.2	48	48	\N	5
30114	LN D-059 (LN-059)	2019-04-24 00:00:00-07	DNA	0.98	48	48	\N	5
30115	LN D-060 (LN-060)	2019-04-24 00:00:00-07	DNA	2.65	48	48	\N	5
30116	LN D-061 (LN-061)	2019-04-24 00:00:00-07	DNA	0.51	48	48	\N	5
30117	LN D-062 (LN-062)	2019-04-24 00:00:00-07	DNA	2.24	48	48	\N	5
30118	LN D-063 (LN-063)	2019-04-24 00:00:00-07	DNA	1.49	48	48	\N	5
30119	LN D-064 (LN-064)	2019-04-24 00:00:00-07	DNA	2.31	48	48	\N	5
30120	LN D-065 (LN-065)	2019-04-24 00:00:00-07	DNA	1.36	48	48	\N	5
30121	LN D-066 (LN-066)	2019-04-24 00:00:00-07	DNA	0.98	48	48	\N	5
30122	LN D-067 (LN-067)	2019-04-24 00:00:00-07	DNA	1.68	48	48	\N	5
30123	LN D-068 (LN-068)	2019-04-24 00:00:00-07	DNA	0.4	48	48	\N	5
30124	LN D-069	2022-01-10 00:00:00-08	DNA	0.23	88	88	\N	2
30125	LN D-070	2022-01-10 00:00:00-08	DNA	0.16	88	88	\N	2
30126	LN D-071	2021-12-10 00:00:00-08	DNA	0.95	95	95	\N	2
30127	LN D-072	2021-12-10 00:00:00-08	DNA	1.62	95	95	\N	2
30128	LN D-073	2021-12-10 00:00:00-08	DNA	1.02	95	95	\N	2
30129	LN D-074	2021-12-10 00:00:00-08	DNA	1.16	95	95	\N	2
30130	LN D-075	2021-12-10 00:00:00-08	DNA	1.24	95	95	\N	2
30131	LN D-076	2022-01-13 00:00:00-08	DNA	0.94	88	88	\N	2
30132	LN D-077	2022-01-13 00:00:00-08	DNA	1.97	88	88	\N	2
30133	LN D-078	2022-01-13 00:00:00-08	DNA	0.84	88	88	\N	2
30134	LN D-079	2021-12-10 00:00:00-08	DNA	2.23	95	95	\N	2
30135	LN D-080	2022-01-10 00:00:00-08	DNA	1.37	88	88	\N	2
30136	LN D-082	2021-12-10 00:00:00-08	DNA	0.12	95	95	\N	2
30137	LN D-083	2021-12-10 00:00:00-08	DNA	0.74	95	95	\N	2
30138	LN D-084	2021-12-10 00:00:00-08	DNA	1.59	95	95	\N	2
30139	LN D-085	2021-12-10 00:00:00-08	DNA	0.71	95	95	\N	2
30140	LN D-086	2022-01-10 00:00:00-08	DNA	1.47	88	88	\N	2
30141	LN D-087	2022-01-13 00:00:00-08	DNA	1.83	88	88	\N	2
30142	LN D-089	2022-01-13 00:00:00-08	DNA	0.45	88	88	\N	2
30143	LN D-090	2022-01-13 00:00:00-08	DNA	0.62	88	88	\N	2
30144	LN D-091	2022-01-13 00:00:00-08	DNA	0.62	88	88	\N	2
30145	LN D-092	2022-01-10 00:00:00-08	DNA	0.16	88	88	\N	2
30146	LN D-093	2022-01-10 00:00:00-08	DNA	0.47	88	88	\N	2
30147	LN D-094	2022-01-13 00:00:00-08	DNA	2.07	88	88	\N	2
30148	LN D-095	2022-01-10 00:00:00-08	DNA	0.43	88	88	\N	2
30149	LN D-096	2022-01-10 00:00:00-08	DNA	0.8	88	88	\N	2
30150	LN D-097	2022-01-10 00:00:00-08	DNA	0.77	88	88	\N	2
30151	LN D-098	2022-01-10 00:00:00-08	DNA	0.65	88	88	\N	2
30152	LN D-099	2022-01-10 00:00:00-08	DNA	0.56	88	88	\N	2
30153	LN D-100	2022-01-10 00:00:00-08	DNA	0.99	88	88	\N	2
30154	LN D-101	2022-01-10 00:00:00-08	DNA	0.05	88	88	\N	2
30155	LN D-102	2022-01-10 00:00:00-08	DNA	0.47	88	88	\N	2
30156	LN D-103	2022-01-10 00:00:00-08	DNA	1.08	88	88	\N	2
30157	LN D-104	2022-01-10 00:00:00-08	DNA	0.42	88	88	\N	2
30158	LN D-105	2022-01-10 00:00:00-08	DNA	1.45	88	88	\N	2
30159	LN D-106	2022-01-10 00:00:00-08	DNA	0.93	88	88	\N	2
30160	LN D-107	2022-01-17 00:00:00-08	DNA	0.46	88	88	\N	2
30161	LN D-108	2022-01-10 00:00:00-08	DNA	0.43	88	88	\N	2
30162	LN D-109	2022-01-10 00:00:00-08	DNA	1.67	88	88	\N	2
30163	LN D-110	2022-01-17 00:00:00-08	DNA	1.64	88	88	\N	2
30164	LN D-111	2022-01-17 00:00:00-08	DNA	1.79	88	88	\N	2
30165	LN D-112	2022-01-10 00:00:00-08	DNA	0.84	88	88	\N	2
30166	LN D-113	2022-01-10 00:00:00-08	DNA	1.26	88	88	\N	2
30167	LN D-114	2022-01-10 00:00:00-08	DNA	1.58	88	88	\N	2
30168	LN D-115	2022-01-10 00:00:00-08	DNA	1.32	88	88	\N	2
30169	LN D-116	2022-01-13 00:00:00-08	DNA	0.27	88	88	\N	2
30170	LN D-117	2022-01-13 00:00:00-08	DNA	0.28	88	88	\N	2
30171	LN D-118	2022-01-20 00:00:00-08	DNA	0.41	88	88	\N	2
30172	LN D-119	2022-01-20 00:00:00-08	DNA	1.26	88	88	\N	2
30173	LN D-120	2022-01-20 00:00:00-08	DNA	0.72	88	88	\N	2
30174	LN D-121	2022-01-20 00:00:00-08	DNA	1.56	88	88	\N	2
30175	LN D-122	2022-01-24 00:00:00-08	DNA	2.3	88	88	\N	2
30176	LN D-123	2022-01-24 00:00:00-08	DNA	3.37	88	88	\N	2
30177	LN D-124	2022-01-20 00:00:00-08	DNA	0.67	88	88	\N	2
30178	LN D-125	2022-01-20 00:00:00-08	DNA	1.56	88	88	\N	2
30179	LN D-126	2022-01-20 00:00:00-08	DNA	0.27	88	88	\N	2
30180	LN D-127	2022-01-13 00:00:00-08	DNA	0.39	88	88	\N	2
30181	LN D-128	2022-01-13 00:00:00-08	DNA	1.05	88	88	\N	2
30182	LN D-129	2022-01-17 00:00:00-08	DNA	1.14	88	88	\N	2
30183	LN D-130	2022-01-24 00:00:00-08	DNA	2.77	88	88	\N	2
30184	LN D-131	2022-01-24 00:00:00-08	DNA	2.43	88	88	\N	2
30185	LN D-132	2022-01-17 00:00:00-08	DNA	0.82	88	88	\N	2
30186	LN D-133	2022-01-17 00:00:00-08	DNA	0.51	88	88	\N	2
30187	LN D-134	2022-01-17 00:00:00-08	DNA	0.61	88	88	\N	2
30188	LN D-135	2022-01-24 00:00:00-08	DNA	0.46	88	88	\N	2
30189	LN D-136	2022-01-24 00:00:00-08	DNA	2.79	88	88	\N	2
30190	LN D-137	2022-02-04 00:00:00-08	DNA	0.1	88	88	\N	2
30191	LN D-138	2022-02-04 00:00:00-08	DNA	0.93	88	88	\N	2
30192	LN D-139	2022-01-13 00:00:00-08	DNA	1.69	88	88	\N	2
30193	LN D-140	2022-01-13 00:00:00-08	DNA	4.63	88	88	\N	2
30194	LN D-141	2022-01-17 00:00:00-08	DNA	4.37	88	88	\N	2
30195	LN D-142	2022-01-17 00:00:00-08	DNA	5.9	88	88	\N	2
30196	LN D-143	2022-01-24 00:00:00-08	DNA	1.23	88	88	\N	2
30197	LN D-144	2022-01-24 00:00:00-08	DNA	1.02	88	88	\N	2
30198	LN D-145	2022-01-24 00:00:00-08	DNA	2.43	88	88	\N	2
30199	LN D-146	2022-01-24 00:00:00-08	DNA	2.25	88	88	\N	2
30200	LN D-147	2022-02-02 00:00:00-08	DNA	0.79	88	88	\N	2
30201	LN D-148	2022-02-02 00:00:00-08	DNA	1.43	88	88	\N	2
30202	LN D-149	2022-02-02 00:00:00-08	DNA	0.88	88	88	\N	2
30203	LN D-150	2022-02-02 00:00:00-08	DNA	0.81	88	88	\N	2
30204	LN D-151	2022-02-02 00:00:00-08	DNA	0.98	88	88	\N	2
30205	LN D-152	2022-02-02 00:00:00-08	DNA	1.22	88	88	\N	2
30206	LN D-153	2022-02-02 00:00:00-08	DNA	1.44	88	88	\N	2
30207	LN D-154	2022-02-02 00:00:00-08	DNA	0.26	88	88	\N	2
30208	LN D-155	2022-02-02 00:00:00-08	DNA	1.27	88	88	\N	2
30209	LN D-156	2022-02-02 00:00:00-08	DNA	1.61	88	88	\N	2
30210	LN D-157	2022-02-04 00:00:00-08	DNA	0.39	88	88	\N	2
30211	LN D-158	2022-02-04 00:00:00-08	DNA	1.38	88	88	\N	2
30212	LN D-159	2022-02-04 00:00:00-08	DNA	0.21	88	88	\N	2
30213	LN D-160	2022-02-04 00:00:00-08	DNA	0.42	88	88	\N	2
30214	LN D-161	2022-02-04 00:00:00-08	DNA	0.85	88	88	\N	2
30215	LN D-162	2022-02-04 00:00:00-08	DNA	0.85	88	88	\N	2
30216	LN D-163	2022-02-04 00:00:00-08	DNA	1.13	88	88	\N	2
30217	LN D-164	2022-02-22 00:00:00-08	DNA	0.56	88	88	\N	2
30218	LN R-069	2022-01-10 00:00:00-08	RNA	4.4	48	48	\N	1
30219	LN R-070	2022-01-10 00:00:00-08	RNA	2.4	48	48	\N	1
30220	LN R-071	2021-12-10 00:00:00-08	RNA	0	48	48	\N	1
30221	LN R-072	2021-12-10 00:00:00-08	RNA	2.3	48	48	\N	1
30222	LN R-073	2021-12-10 00:00:00-08	RNA	0	48	48	\N	1
30223	LN R-074	2021-12-10 00:00:00-08	RNA	2	48	48	\N	1
30224	LN R-075	2021-12-10 00:00:00-08	RNA	2.2	48	48	\N	1
30225	LN R-076	2022-01-13 00:00:00-08	RNA	2	48	48	\N	1
30226	LN R-077	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30227	LN R-078	2022-01-13 00:00:00-08	RNA	2.1	48	48	\N	1
30228	LN R-079	2021-12-10 00:00:00-08	RNA	2.2	48	48	\N	1
30229	LN R-080	2022-01-10 00:00:00-08	RNA	3.3	48	48	\N	1
30230	LN R-082	2021-12-10 00:00:00-08	RNA	0	48	48	\N	1
30231	LN R-083	2021-12-10 00:00:00-08	RNA	2.4	48	48	\N	1
30232	LN R-084	2021-12-10 00:00:00-08	RNA	2.85	48	48	\N	1
30233	LN R-085	2021-12-10 00:00:00-08	RNA	0	48	48	\N	1
30234	LN R-086	2022-01-10 00:00:00-08	RNA	2.87	48	48	\N	1
30235	LN R-087	2022-01-13 00:00:00-08	RNA	3.41	48	48	\N	1
30236	LN R-089	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30237	LN R-090	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30238	LN R-091	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30239	LN R-092	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30240	LN R-093	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
31891	Rob-T009-Nev_NA	\N	DNA	\N	\N	\N	\N	\N
30241	LN R-094	2022-01-13 00:00:00-08	RNA	2.74	48	48	\N	1
30242	LN R-095	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30243	LN R-096	2022-01-10 00:00:00-08	RNA	2.5	48	48	\N	1
30244	LN R-097	2022-01-10 00:00:00-08	RNA	2	48	48	\N	1
30245	LN R-098	2022-01-10 00:00:00-08	RNA	2.1	48	48	\N	1
30246	LN R-099	2022-01-10 00:00:00-08	RNA	2	48	48	\N	1
30247	LN R-100	2022-01-10 00:00:00-08	RNA	2.64	48	48	\N	1
30248	LN R-101	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30249	LN R-102	2022-01-10 00:00:00-08	RNA	3.17	48	48	\N	1
30250	LN R-103	2022-01-10 00:00:00-08	RNA	3.76	48	48	\N	1
30251	LN R-104	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30252	LN R-105	2022-01-10 00:00:00-08	RNA	2.78	48	48	\N	1
30253	LN R-106	2022-01-10 00:00:00-08	RNA	2.51	48	48	\N	1
30254	LN R-107	2022-01-17 00:00:00-08	RNA	0	48	48	\N	1
30255	LN R-108	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30256	LN R-109	2022-01-10 00:00:00-08	RNA	2.88	48	48	\N	1
30257	LN R-110	2022-01-17 00:00:00-08	RNA	3.13	48	48	\N	1
30258	LN R-111	2022-01-17 00:00:00-08	RNA	3.01	48	48	\N	1
30259	LN R-112	2022-01-10 00:00:00-08	RNA	2.2	48	48	\N	1
30260	LN R-113	2022-01-10 00:00:00-08	RNA	2.61	48	48	\N	1
30261	LN R-114	2022-01-10 00:00:00-08	RNA	5.66	48	48	\N	1
30262	LN R-115	2022-01-10 00:00:00-08	RNA	4.12	48	48	\N	1
30263	LN R-116	2022-01-13 00:00:00-08	RNA	4.7	48	48	\N	1
30264	LN R-117	2022-01-13 00:00:00-08	RNA	6.55	48	48	\N	1
30265	LN R-118	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30266	LN R-119	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30267	LN R-120	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30268	LN R-121	2022-01-20 00:00:00-08	RNA	3.07	48	48	\N	1
30269	LN R-122	2022-01-20 00:00:00-08	RNA	3.27	48	48	\N	1
30270	LN R-123	2022-01-20 00:00:00-08	RNA	4.59	48	48	\N	1
30271	LN R-124	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30272	LN R-125	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30273	LN R-126	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30274	LN R-127	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30275	LN R-128	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30276	LN R-129	2022-01-17 00:00:00-08	RNA	2.99	48	48	\N	1
30277	LN R-130	2022-01-24 00:00:00-08	RNA	0	48	48	\N	1
30278	LN R-131	2022-01-24 00:00:00-08	RNA	4.39	48	48	\N	1
30279	LN R-132	2022-01-17 00:00:00-08	RNA	0	48	48	\N	1
30280	LN R-133	2022-01-17 00:00:00-08	RNA	0	48	48	\N	1
30281	LN R-134	2022-01-17 00:00:00-08	RNA	0	48	48	\N	1
30282	LN R-135	2022-01-24 00:00:00-08	RNA	0	48	48	\N	1
30283	LN R-136	2022-01-24 00:00:00-08	RNA	2.5	48	48	\N	1
30284	LN R-137	2022-02-04 00:00:00-08	RNA	0	48	48	\N	1
30285	LN R-138	2022-02-04 00:00:00-08	RNA	0	48	48	\N	1
30286	LN R-139	2022-01-13 00:00:00-08	RNA	2	48	48	\N	1
30287	LN R-140	2022-01-13 00:00:00-08	RNA	5.93	48	48	\N	1
30288	LN R-141	2022-01-17 00:00:00-08	RNA	3.18	48	48	\N	1
30289	LN R-142	2022-01-17 00:00:00-08	RNA	3.32	48	48	\N	1
30290	LN R-143	2022-01-24 00:00:00-08	RNA	0	48	48	\N	1
30291	LN R-144	2022-01-24 00:00:00-08	RNA	2.4	48	48	\N	1
30292	LN R-145	2022-01-24 00:00:00-08	RNA	3.68	48	48	\N	1
30293	LN R-146	2022-01-24 00:00:00-08	RNA	2.61	48	48	\N	1
30294	LN R-147	2022-02-02 00:00:00-08	RNA	2.55	48	48	\N	1
30295	LN R-148	2022-02-02 00:00:00-08	RNA	4.26	48	48	\N	1
30296	LN R-149	2022-02-02 00:00:00-08	RNA	2.3	48	48	\N	1
30297	LN R-150	2022-02-02 00:00:00-08	RNA	2.59	48	48	\N	1
30298	LN R-151	2022-02-02 00:00:00-08	RNA	3.14	48	48	\N	1
30299	LN R-152	2022-02-02 00:00:00-08	RNA	3.73	48	48	\N	1
30300	LN R-153	2022-02-02 00:00:00-08	RNA	5.02	48	48	\N	1
30301	LN R-154	2022-02-02 00:00:00-08	RNA	0	48	48	\N	1
30302	LN R-155	2022-02-02 00:00:00-08	RNA	3.6	48	48	\N	1
30303	LN R-156	2022-02-02 00:00:00-08	RNA	4.73	48	48	\N	1
30304	LN R-157	2022-02-04 00:00:00-08	RNA	2	48	48	\N	1
30305	LN R-158	2022-02-04 00:00:00-08	RNA	3.51	48	48	\N	1
30306	LN R-159	2022-02-04 00:00:00-08	RNA	0	48	48	\N	1
30307	LN R-160	2022-02-04 00:00:00-08	RNA	0	48	48	\N	1
30308	LN R-161	2022-02-04 00:00:00-08	RNA	4.9	48	48	\N	1
30309	LN R-162	2022-02-04 00:00:00-08	RNA	3.15	48	48	\N	1
30310	LN R-163	2022-02-04 00:00:00-08	RNA	2.98	48	48	\N	1
30311	LN R-164	\N	RNA	0	0	0	\N	\N
30312	Luping_ROS 1_NA	\N	DNA	\N	\N	\N	\N	\N
30313	M230 Imat A2	\N	DNA	10.5	200	200	MISC -20oC BOX; MK Cells for the Broad Institute	\N
30314	M230 Imat A3	\N	DNA	18	200	200	MISC -20oC BOX; MK Cells for the Broad Institute	\N
30315	M040204 (AMC-07)	\N	DNA	15.2	50	50	\N	\N
30316	M040204 Dec2019 (AMC-07)	\N	DNA	40	10	10	\N	\N
30317	M040415 (AMC-08)	\N	DNA	16.5	50	50	\N	\N
30318	M040416 (AMC-08)	\N	DNA	21	50	50	\N	\N
30319	M040418 (AMC-08)	\N	DNA	16.2	50	50	\N	\N
30320	M040419A (AMC-08)	\N	DNA	14.1	50	50	\N	\N
30321	M100118 (AMC-02)	\N	DNA	9.3	50	50	\N	\N
30322	M180322 (AMC-13)	\N	DNA	9.88	50	50	\N	\N
30323	MaMel  152aI (AMC-01)	\N	DNA	15.1	50	50	\N	\N
30324	MB_161_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, FFPE	\N
30325	MB_161_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30326	MB_327_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30327	MB_760_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30328	MB_1028_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30329	MB_1029_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30330	MB_1036_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30331	MB_1046_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver,Frozen Tissue	\N
30332	MB_1418_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30333	MB_1454_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30334	MB_1609_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
30335	MB1241_Norm_NA	\N	DNA	\N	\N	\N	Acral Normal, Frozen Tissue DNA  Extracted by Denver	\N
30336	MB1242_Tumor_NA	\N	DNA	\N	\N	\N	Acral Tumor, Frozen Tissue DNA Extracted by Denver	\N
30337	MB1421_Norm_NA	\N	DNA	\N	\N	\N	Acral Normal, Thumb, Frozen Tissue DNA extracted by Denver	\N
30338	MB1423_Norm_NA	\N	DNA	\N	\N	\N	Acral Normal Heel, FFPE Extracted DNA by Denver	\N
30339	MB1423_Tumor_NA	\N	DNA	\N	\N	\N	Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver	\N
30340	MB1424 _Tumor_NA	\N	DNA	\N	\N	\N	Acral Tumor, Thumb, Frozen Tissue DNA extracted by Denver	\N
30341	MB1428_Norm_NA	\N	DNA	\N	\N	\N	Acral Normal, Heel Frozen Tissue DNA Extracted by Denver | Barcode mismatch comment in note	\N
30342	MB1429_Tumor_NA	\N	DNA	\N	\N	\N	Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver	\N
30343	MB1617_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
30344	MDD-01	\N	DNA	24.4	50	50	\N	5
30345	MDD-02	\N	DNA	31.2	50	50	\N	5
30346	MDD-03	\N	DNA	19.8	50	50	\N	5
30347	MDD-04	\N	DNA	2.46	50	50	\N	5
30348	MDD-05	\N	DNA	36.6	50	50	\N	5
30349	MDD-06	\N	DNA	25.6	50	50	\N	5
30350	MDD-07	\N	DNA	28.6	50	50	\N	5
30351	MDD-08	\N	DNA	86.6	50	50	\N	5
30352	MDD-09	\N	DNA	61	50	50	\N	5
30353	MDD-10	\N	DNA	77.6	50	50	\N	5
30354	MDD-11	\N	DNA	15.4	50	50	\N	5
30355	MDD-12	\N	DNA	32.4	50	50	\N	5
30356	MDD-13	\N	DNA	79.4	50	50	\N	5
30357	MDD-14	\N	DNA	346	50	50	\N	5
30358	MDD-15	\N	DNA	38.2	50	50	\N	5
30359	MDD-16	\N	DNA	39	50	50	\N	5
30360	MDD-17	\N	DNA	21.8	50	50	\N	5
30361	MDD-18	\N	DNA	23.4	50	50	\N	5
30362	MDD-19	\N	DNA	5.32	50	50	\N	5
30363	MDD-20	\N	DNA	9.9	50	50	\N	5
30364	MDD-21	\N	DNA	4.46	50	50	\N	5
30365	MDD-22	\N	DNA	9.38	50	50	\N	5
30366	MDD-23	\N	DNA	15.4	50	50	\N	5
30367	MDD-24	\N	DNA	7.84	50	50	\N	5
30368	MDD-25	\N	DNA	12.6	50	50	\N	5
30369	MDD-26	\N	DNA	73	50	50	\N	5
30370	MDD-27	\N	DNA	19.3	50	50	\N	5
30371	MDD-28	\N	DNA	17.7	50	50	\N	5
30372	MDD-29	\N	DNA	23.6	50	50	\N	5
30373	MDD-30	\N	DNA	32.6	50	50	\N	5
30374	MDD-31	\N	DNA	3.86	50	50	\N	5
30375	MDD-32	\N	DNA	78.4	50	50	\N	5
30376	MDD-33	\N	DNA	15.2	50	50	\N	5
30377	MDD-34	\N	DNA	4.62	50	50	\N	5
30378	MDD-35	\N	DNA	33.4	50	50	\N	5
30379	MDD-36	\N	DNA	29.2	50	50	\N	5
30380	MDD-37	\N	DNA	104	50	50	\N	5
30381	MDD-38	\N	DNA	28.8	50	50	\N	5
30382	MDD-39	\N	DNA	70	50	50	\N	5
30383	MDD-40	\N	DNA	1.45	50	50	\N	5
30384	MDD-41	\N	DNA	12.4	50	50	\N	5
30385	MDD-42	2019-07-08 00:00:00-07	DNA	22.7	96	96	\N	5
30386	MDD-43	2019-07-08 00:00:00-07	DNA	1.77	96	96	\N	5
30387	MDD-44	2019-07-08 00:00:00-07	DNA	27.1	96	96	\N	5
30388	MDD-45	2019-07-08 00:00:00-07	DNA	25.8	96	96	\N	5
30389	MDD-46	2019-07-08 00:00:00-07	DNA	6.88	96	96	\N	5
30390	MDD-47	2019-07-08 00:00:00-07	DNA	21.3	96	96	\N	5
30391	MDD-48	2019-07-08 00:00:00-07	DNA	21.7	96	96	\N	5
30392	MDD-49	2019-07-08 00:00:00-07	DNA	2.39	96	96	\N	5
30393	MDD-50	2019-07-08 00:00:00-07	DNA	2.4	96	96	\N	5
30394	MDD-51	2019-07-08 00:00:00-07	DNA	6.52	96	96	\N	5
30395	MDD-52	2019-07-08 00:00:00-07	DNA	9.74	96	96	\N	5
30396	MDD-53	2019-07-08 00:00:00-07	DNA	11.6	96	96	\N	5
30397	MDD-54	2019-07-08 00:00:00-07	DNA	22.2	96	96	\N	5
30398	MDD-55	2019-07-08 00:00:00-07	DNA	5.54	96	96	\N	5
30399	MDD-56	2019-07-08 00:00:00-07	DNA	1.79	96	96	\N	5
30400	MDD-57	2019-07-08 00:00:00-07	DNA	0.48	96	96	\N	5
30401	MDD-58	2019-07-08 00:00:00-07	DNA	11.7	96	96	\N	5
30402	MDD-59	2019-07-08 00:00:00-07	DNA	3.46	96	96	\N	5
30403	MDD-60	2019-07-08 00:00:00-07	DNA	2.94	96	96	\N	5
30404	MDD-61	2019-07-08 00:00:00-07	DNA	37.5	96	96	\N	5
30405	MDD-62	2019-07-08 00:00:00-07	DNA	28	96	96	\N	5
30406	MDD-63	2019-07-08 00:00:00-07	DNA	23.6	96	96	\N	5
30407	MDD-64	2019-07-16 00:00:00-07	DNA	14.5	96	96	\N	5
30408	MDD-65	2019-07-16 00:00:00-07	DNA	2.58	96	96	\N	5
30409	MDD-66	2019-07-16 00:00:00-07	DNA	11.1	96	96	\N	5
30410	MDD-67	2019-07-16 00:00:00-07	DNA	3.87	96	96	\N	5
30411	MDD-68	2019-07-16 00:00:00-07	DNA	15	96	96	\N	5
30412	MDD-69	2019-07-16 00:00:00-07	DNA	10.7	96	96	\N	5
30413	MDD-70	2019-07-16 00:00:00-07	DNA	38.8	96	96	\N	5
30414	MDD-71	2019-07-16 00:00:00-07	DNA	16.6	96	96	\N	5
30415	MDD-72	2019-07-16 00:00:00-07	DNA	28.4	96	96	\N	5
30416	MDD-73	2019-07-16 00:00:00-07	DNA	1.37	96	96	\N	5
30417	MDD-74	2019-07-16 00:00:00-07	DNA	5.4	96	96	\N	5
30418	MDD-75	2019-07-16 00:00:00-07	DNA	56	96	96	\N	5
30419	MDD-76	2019-07-16 00:00:00-07	DNA	32.7	96	96	\N	5
30420	MDD-77	2019-07-16 00:00:00-07	DNA	39.4	96	96	\N	5
30421	MDD-78	2019-07-16 00:00:00-07	DNA	3.36	96	96	\N	5
30422	MDD-79	2019-07-16 00:00:00-07	DNA	16.1	96	96	\N	5
30423	MDD-80	2019-07-16 00:00:00-07	DNA	1.34	96	96	\N	5
30424	MDD-81	2019-07-16 00:00:00-07	DNA	1.76	96	96	\N	5
30425	MDD-82	2019-07-16 00:00:00-07	DNA	53	96	96	\N	5
30426	MDD-83	2019-07-16 00:00:00-07	DNA	53	96	96	\N	5
30427	MDD-84	2019-07-16 00:00:00-07	DNA	9.55	96	96	\N	5
30428	MDD-85	2019-07-16 00:00:00-07	DNA	47.4	96	96	\N	5
30429	MDD-86	2019-07-16 00:00:00-07	DNA	41.1	96	96	\N	5
30430	MDD-87	2019-07-16 00:00:00-07	DNA	17	96	96	\N	5
30431	MDD-88	2019-07-23 00:00:00-07	DNA	59	96	96	\N	5
30432	MDD-89	2019-07-23 00:00:00-07	DNA	35.2	96	96	\N	5
30433	MDD-90	2019-07-23 00:00:00-07	DNA	4.81	96	96	\N	5
30434	MDD-91	2019-07-23 00:00:00-07	DNA	5.57	96	96	\N	5
30435	MDD-92	2019-07-23 00:00:00-07	DNA	44.5	96	96	\N	5
30436	MDD-93	2019-07-23 00:00:00-07	DNA	127	96	96	\N	5
30437	MDD-94	2019-07-23 00:00:00-07	DNA	26.5	96	96	\N	5
30438	MDD-95	2019-07-23 00:00:00-07	DNA	15.2	96	96	\N	5
30439	MDD-96	2019-07-23 00:00:00-07	DNA	25.1	96	96	\N	5
30440	MDD-97	2019-07-23 00:00:00-07	DNA	0.56	96	96	\N	5
30441	MDD-98	2019-07-23 00:00:00-07	DNA	5.37	96	96	\N	5
30442	MDD-99	2019-07-23 00:00:00-07	DNA	11.8	96	96	\N	5
30443	MDD-100	2019-07-23 00:00:00-07	DNA	10.2	96	96	\N	5
30444	MDD-101	2019-07-23 00:00:00-07	DNA	3.47	96	96	\N	5
30445	MDD-102	2019-07-23 00:00:00-07	DNA	18.6	96	96	\N	5
30446	MDD-103	2019-07-23 00:00:00-07	DNA	4.73	96	96	\N	5
30447	MDD-104	2019-07-23 00:00:00-07	DNA	19.9	96	96	\N	5
30448	MDD-105	2019-07-23 00:00:00-07	DNA	10.6	96	96	\N	5
30449	MDD-106	2019-07-23 00:00:00-07	DNA	1.14	96	96	\N	5
30450	MDD-107	2019-07-23 00:00:00-07	DNA	4.15	96	96	\N	5
30451	MDD-108	2019-07-23 00:00:00-07	DNA	37.5	96	96	\N	5
30452	MDD-109	2019-07-23 00:00:00-07	DNA	12.5	96	96	\N	5
30453	MDD-110	2019-10-05 00:00:00-07	DNA	2.09	96	96	\N	5
30454	MDD-111	2019-10-05 00:00:00-07	DNA	2.41	96	96	\N	5
30455	MDD-112	2019-10-05 00:00:00-07	DNA	5.47	96	96	\N	5
30456	MDD-113	2019-10-05 00:00:00-07	DNA	50	96	96	\N	5
30457	MDD-114	2019-10-05 00:00:00-07	DNA	3.04	96	96	\N	5
30458	MDD-115	2019-10-05 00:00:00-07	DNA	3.2	96	96	\N	5
30459	MDD-116	2019-10-05 00:00:00-07	DNA	2.73	96	96	\N	5
30460	MDD-117	2019-10-05 00:00:00-07	DNA	1.51	96	96	\N	5
30461	MDD-118	2019-10-05 00:00:00-07	DNA	1.59	96	96	\N	5
30462	MDD-119	2019-10-05 00:00:00-07	DNA	6.27	96	96	\N	5
30463	MDD-120	2019-10-05 00:00:00-07	DNA	10.6	96	96	\N	5
30464	MDD-121	2019-10-05 00:00:00-07	DNA	2.64	96	96	\N	5
30465	MDD-122	2019-10-05 00:00:00-07	DNA	6.77	96	96	\N	5
30466	MDD-123	2019-10-05 00:00:00-07	DNA	31.8	96	96	\N	5
30467	MDD-124	2019-10-05 00:00:00-07	DNA	2.79	96	96	\N	5
30468	MDD-125	2019-10-05 00:00:00-07	DNA	1.62	96	96	\N	5
30469	MDD-126	2019-10-05 00:00:00-07	DNA	11.1	96	96	\N	5
30470	MDD-127	2019-10-05 00:00:00-07	DNA	1.04	96	96	\N	5
30471	MDD-128	2019-10-05 00:00:00-07	DNA	6.15	96	96	\N	5
30472	MDD-129	2019-10-05 00:00:00-07	DNA	6.86	96	96	\N	5
30473	MDD-130	2019-10-05 00:00:00-07	DNA	2.73	96	96	\N	5
30474	MDD-131	2019-10-05 00:00:00-07	DNA	8.16	96	96	\N	5
30475	MDD-132	2019-10-05 00:00:00-07	DNA	15.9	96	96	\N	5
30476	MDD-133	2019-10-05 00:00:00-07	DNA	0.86	96	96	\N	5
30477	MDD-134	2019-10-08 00:00:00-07	DNA	5.51	96	96	\N	5
30478	MDD-135	2019-10-08 00:00:00-07	DNA	2.62	96	96	\N	5
30479	MDD-136	2019-10-08 00:00:00-07	DNA	8.14	96	96	\N	5
30480	MDD-137	2019-10-08 00:00:00-07	DNA	0.8	96	96	\N	5
30481	MDD-138	2019-10-08 00:00:00-07	DNA	9.05	96	96	\N	5
30482	MDD-139	2019-10-08 00:00:00-07	DNA	4.21	96	96	\N	5
30483	MDD-140	2019-10-08 00:00:00-07	DNA	3.81	96	96	\N	5
30484	MDD-141	2019-10-08 00:00:00-07	DNA	1.83	96	96	\N	5
30485	MDD-142	2019-10-08 00:00:00-07	DNA	2.3	96	96	\N	5
30486	MDD-143	2019-10-08 00:00:00-07	DNA	5.11	96	96	\N	5
30487	MDD-144	2019-10-08 00:00:00-07	DNA	1.29	96	96	\N	5
30488	MDD-145	2019-10-08 00:00:00-07	DNA	35.7	96	96	\N	5
30489	MDD-146	2019-10-08 00:00:00-07	DNA	1.79	96	96	\N	5
30490	MDD-147	2019-10-08 00:00:00-07	DNA	4.52	96	96	\N	5
30491	MDD-148	2019-10-08 00:00:00-07	DNA	3.87	96	96	\N	5
31892	Rob-T009-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
30492	MDD-149	2019-10-08 00:00:00-07	DNA	10.7	96	96	\N	5
30493	MDD-150	2019-10-12 00:00:00-07	DNA	2.61	96	96	\N	5
30494	MDD-151	2019-10-12 00:00:00-07	DNA	7.07	96	96	\N	5
30495	MDD-152	2019-10-12 00:00:00-07	DNA	0.98	96	96	\N	5
30496	MDD-153	2019-10-12 00:00:00-07	DNA	2.34	96	96	\N	5
30497	MDD-154	2019-10-12 00:00:00-07	DNA	1.37	96	96	\N	5
30498	MDD-155	2019-10-12 00:00:00-07	DNA	1.47	96	96	\N	5
30499	MDD-156	2019-10-12 00:00:00-07	DNA	2.79	96	96	\N	5
30500	MDD-157	2019-10-12 00:00:00-07	DNA	1.42	96	96	\N	5
30501	MDD-158	2019-10-12 00:00:00-07	DNA	3.16	96	96	\N	5
30502	MDD-159	2019-10-12 00:00:00-07	DNA	1.66	96	96	\N	5
30503	MDD-160	2019-10-12 00:00:00-07	DNA	1.63	96	96	\N	5
30504	MDD-161	2019-10-12 00:00:00-07	DNA	1.59	96	96	\N	5
30505	MDD-162	2019-10-12 00:00:00-07	DNA	3.33	96	96	\N	5
30506	MDD-163	2019-10-12 00:00:00-07	DNA	7.32	96	96	\N	5
30507	MDD-164	2019-10-12 00:00:00-07	DNA	0.24	96	96	\N	5
30508	MDD-165	2019-10-12 00:00:00-07	DNA	0	96	96	\N	5
30509	MDD-166	2019-10-12 00:00:00-07	DNA	6.45	96	96	\N	5
30510	MDD-167	2019-10-12 00:00:00-07	DNA	2.81	96	96	\N	5
30511	MDD-168	2019-10-12 00:00:00-07	DNA	0.51	96	96	\N	5
30512	MDD-169	2019-10-12 00:00:00-07	DNA	3.57	96	96	\N	5
30513	MDD-170	2019-10-12 00:00:00-07	DNA	1.66	96	96	\N	5
30514	MDD-171	2019-10-12 00:00:00-07	DNA	2.64	96	96	\N	5
30515	MDD-172	2019-10-12 00:00:00-07	DNA	0.38	96	96	\N	5
30516	MDD-173	2019-10-12 00:00:00-07	DNA	1.1	96	96	\N	5
30517	MDD-174	2019-10-26 00:00:00-07	DNA	4.72	96	96	\N	5
30518	MDD-175	2019-10-26 00:00:00-07	DNA	3.04	96	96	\N	5
30519	MDD-176	2019-10-26 00:00:00-07	DNA	0.77	96	96	\N	5
30520	MDD-177	2019-10-26 00:00:00-07	DNA	2.05	96	96	\N	5
30521	MDD-178	2019-10-26 00:00:00-07	DNA	4.32	96	96	\N	5
30522	MDD-179	2019-10-26 00:00:00-07	DNA	1.25	96	96	\N	5
30523	MDD-180	2019-10-26 00:00:00-07	DNA	8.58	96	96	\N	5
30524	MDD-181	2019-10-26 00:00:00-07	DNA	2.35	96	96	\N	5
30525	MDD-182	2019-10-26 00:00:00-07	DNA	2.53	96	96	\N	5
30526	MDD-183	2019-10-26 00:00:00-07	DNA	2.8	96	96	\N	5
30527	MDD-184	2019-10-26 00:00:00-07	DNA	4.67	96	96	\N	5
30528	MDD-185	2019-10-26 00:00:00-07	DNA	31.7	96	96	\N	5
30529	MDD-186	2019-10-26 00:00:00-07	DNA	6.81	96	96	\N	5
30530	MDD-187	2019-10-26 00:00:00-07	DNA	1.57	96	96	\N	5
30531	MDD-188	2019-10-26 00:00:00-07	DNA	2.66	96	96	\N	5
30532	MDD-189	2019-10-26 00:00:00-07	DNA	0.83	80	80	\N	5
30533	MDD-190	2019-10-26 00:00:00-07	DNA	2.57	80	80	\N	5
30534	MDD-191	2019-10-26 00:00:00-07	DNA	17	80	80	\N	5
30535	MDD-192	2019-10-26 00:00:00-07	DNA	0.75	80	80	\N	5
30536	MDD-193	2019-10-26 00:00:00-07	DNA	0.13	80	80	\N	5
30537	MDD-194	2019-10-26 00:00:00-07	DNA	1.33	80	80	\N	5
30538	MDD-195	2019-10-26 00:00:00-07	DNA	2.3	80	80	\N	5
30539	MDD-196	2019-10-26 00:00:00-07	DNA	4.07	80	80	\N	5
30540	MDD-197	2019-10-26 00:00:00-07	DNA	0.69	80	80	\N	5
30541	MDD-198	2019-10-30 00:00:00-07	DNA	34.3	80	80	\N	5
30542	MDD-199	2019-10-30 00:00:00-07	DNA	5.75	80	80	\N	5
30543	MDD-200	2019-10-30 00:00:00-07	DNA	1.47	80	80	\N	5
30544	MDD-201	2019-10-30 00:00:00-07	DNA	5.08	80	80	\N	5
30545	MDD-202	2019-10-30 00:00:00-07	DNA	9.08	80	80	\N	5
30546	MDD-203	2019-10-30 00:00:00-07	DNA	2.02	80	80	\N	5
30547	MDD-204	2019-10-30 00:00:00-07	DNA	13.3	80	80	\N	5
30548	MDD-205	2019-10-30 00:00:00-07	DNA	13.7	80	80	\N	5
30549	MDD-206	2019-10-30 00:00:00-07	DNA	6.52	80	80	\N	5
30550	MDD-207	2019-10-30 00:00:00-07	DNA	2.36	80	80	\N	5
30551	MDD-208	2019-10-30 00:00:00-07	DNA	2.68	80	80	\N	5
30552	MDD-209	2019-10-30 00:00:00-07	DNA	4.33	80	80	\N	5
30553	MDD-210	2019-10-30 00:00:00-07	DNA	2.28	80	80	\N	5
30554	MDD-211	2019-10-30 00:00:00-07	DNA	21.6	80	80	\N	5
30555	MDD-212	2019-10-30 00:00:00-07	DNA	0.12	80	80	\N	5
30556	MDD-213	2019-10-30 00:00:00-07	DNA	1.88	80	80	\N	5
30557	MDD-214	2019-10-30 00:00:00-07	DNA	6.22	80	80	\N	5
30558	MDD-215	2019-10-30 00:00:00-07	DNA	1.84	80	80	\N	5
30559	MDD-216	2019-10-30 00:00:00-07	DNA	1.97	80	80	\N	5
30560	MDD-217	2019-10-30 00:00:00-07	DNA	2.87	80	80	\N	5
30561	MDD-218	2019-10-30 00:00:00-07	DNA	13.4	80	80	\N	5
30562	MDD-219	2019-10-30 00:00:00-07	DNA	2.97	80	80	\N	5
30563	MDD-220	2019-10-30 00:00:00-07	DNA	0.93	80	80	\N	5
30564	MDD-221	2019-10-30 00:00:00-07	DNA	11.2	80	80	\N	5
30565	Mel290	\N	DNA	4.08	50	50	\N	\N
30566	MIN_1_NA	\N	DNA	\N	\N	\N	\N	\N
30567	MIN_2_NA	\N	DNA	\N	\N	\N	\N	\N
30568	MIN_3_NA	\N	DNA	\N	\N	\N	\N	\N
30569	MIN_4_NA	\N	DNA	\N	\N	\N	\N	\N
30570	MIN_5_NA	\N	DNA	\N	\N	\N	\N	\N
30571	MIN_6_NA	\N	DNA	\N	\N	\N	\N	\N
30572	MM-1	2019-04-01 00:00:00-07	DNA	8.83	20	20	\N	5
30573	MM-2	2019-04-01 00:00:00-07	DNA	42.6	42	42	\N	5
30574	MM-3	2019-04-01 00:00:00-07	DNA	1.17	48	48	\N	5
30575	MM-4	2019-04-01 00:00:00-07	DNA	31.5	80	80	\N	5
30576	MM100511 (AMC-03)	\N	DNA	24.8	50	50	\N	\N
30577	MM100512 (AMC-03)	\N	DNA	6.52	50	50	\N	\N
30578	MM100513 (AMC-03)	\N	DNA	15.8	50	50	\N	\N
30579	MM100916 (AMC-03)	\N	DNA	18.3	50	50	\N	\N
30580	MM160113 (AMC-12)	\N	DNA	12.8	50	50	\N	\N
30581	MMD-01	\N	DNA	25.3	88	88	\N	6
30582	MMD-02	\N	DNA	26.2	88	88	\N	6
30583	MMD-03	\N	DNA	11.7	88	88	\N	6
30584	MMD-04	\N	DNA	7.92	88	88	\N	6
30585	MMD-05	\N	DNA	0.27	88	88	\N	6
30586	MMD-06	\N	DNA	5.37	88	88	\N	6
30587	MMD-07	\N	DNA	2.02	88	88	\N	6
30588	MMD-08	\N	DNA	1.9	88	88	\N	6
30589	MMD-09	\N	DNA	0.18	88	88	\N	6
30590	MMD-10	\N	DNA	2.66	88	88	\N	6
30591	MMD-11	\N	DNA	1.45	88	88	\N	6
30592	MMD-12	\N	DNA	1.32	88	88	\N	6
30593	MMD-13	\N	DNA	1.31	88	88	\N	6
30594	MMD-14	\N	DNA	0.44	88	88	\N	6
30595	MMD-15	\N	DNA	0.77	88	88	\N	6
30596	MMD-16	\N	DNA	0.34	88	88	\N	6
30597	MMD-17	\N	DNA	0	88	88	\N	6
30598	MMD-18	\N	DNA	1.96	88	88	\N	6
30599	MMD-19	\N	DNA	0.45	88	88	\N	6
30600	MMD-20	\N	DNA	0.74	88	88	\N	6
30601	MMD-21	\N	DNA	0.24	88	88	\N	6
30602	MMD-22	\N	DNA	0.29	88	88	\N	6
30603	MMD-23	\N	DNA	1.72	88	88	\N	5
30604	MMD-24	\N	DNA	0.9	88	88	\N	5
30605	MMD-25	\N	DNA	1.79	88	88	\N	5
30606	MMD-26	\N	DNA	0.68	88	88	\N	5
30607	MMD-27	\N	DNA	0.74	88	88	\N	5
30608	MMD-28	\N	DNA	0.17	88	88	\N	6
30609	MMD-29	\N	DNA	0.15	88	88	\N	5
30610	MMD-30	\N	DNA	2.29	88	88	\N	6
30611	MMD-31	\N	DNA	0.12	88	88	\N	6
30612	MMD-32	\N	DNA	0.43	88	88	\N	6
30613	MMD-33	\N	DNA	0.14	88	88	\N	6
30614	MMD-34	\N	DNA	0.41	88	88	\N	5
30615	MMD-35	\N	DNA	5.41	88	88	\N	6
30616	MMD-36	\N	DNA	0.7	88	88	\N	5
30617	MMD-37	\N	DNA	5.84	88	88	\N	6
30618	MMD-38	\N	DNA	0.89	88	88	\N	6
30619	MMD-39	\N	DNA	0.86	88	88	\N	5
30620	MMD-40	\N	DNA	0.79	88	88	\N	6
30621	MMD-41	\N	DNA	5.24	88	88	\N	6
30622	MMD-42	\N	DNA	1.12	88	88	\N	6
30623	MMD-43	\N	DNA	0.17	88	88	\N	5
30624	MMD-44	\N	DNA	0.24	88	88	\N	6
30625	MMD-45	\N	DNA	0.84	88	88	\N	2
30626	MMD-46	\N	DNA	0.1	88	88	\N	6
30627	MMD-47	\N	DNA	0.08	88	88	\N	5
30628	MMD-48	\N	DNA	0.57	88	88	\N	6
30629	MMD-49	\N	DNA	4.66	88	88	\N	5
30630	MMD-50	\N	DNA	0.08	88	88	\N	6
30631	MMD-51	\N	DNA	0.42	88	88	\N	6
30632	MMD-52	\N	DNA	0.65	88	88	\N	5
30633	MMD-53	\N	DNA	0.51	88	88	\N	6
30634	MMD-54	\N	DNA	0.22	88	88	\N	6
30635	MMD-55	\N	DNA	0.23	88	88	\N	6
30636	MMD-56	\N	DNA	0.5	88	88	\N	6
30637	MMD-59	\N	DNA	0.52	88	88	\N	5
30638	MMD-60	\N	DNA	3.65	88	88	\N	5
30639	MMD-61	\N	DNA	2.45	88	88	\N	5
30640	MMD-62	\N	DNA	0.97	88	88	\N	5
30641	MMD-63	\N	DNA	0.89	88	88	\N	5
30642	MMD-64	\N	DNA	0.64	88	88	\N	5
30643	MMD-65	\N	DNA	7.28	88	88	\N	5
30644	MMD-66	\N	DNA	0.87	88	88	\N	5
30645	MMD-67	\N	DNA	1.01	88	88	\N	5
30646	MMD-68	\N	DNA	0.66	88	88	\N	5
30647	MMD-69	\N	DNA	0.66	88	88	\N	5
30648	MMD-70	\N	DNA	0.01	88	88	\N	6
30649	MMD-71	\N	DNA	0.08	88	88	\N	5
30650	MMD-72	\N	DNA	0.93	88	88	\N	6
30651	MMD-73	\N	DNA	21.9	88	88	\N	6
30652	MMD-74	\N	DNA	44	88	88	\N	2
30653	MMD-75	\N	DNA	35.8	88	88	\N	5
30654	MMD-76	\N	DNA	8.55	88	88	\N	6
30655	MMD-77	\N	DNA	1.2	88	88	\N	5
30656	MMD-78	\N	DNA	10.3	88	88	\N	6
30657	MMD-79	\N	DNA	13.6	88	88	\N	2
30658	MMD-80	\N	DNA	12.9	88	88	\N	5
30659	MMD-81	\N	DNA	3.68	88	88	\N	6
30660	MMD-82	\N	DNA	2.86	88	88	\N	5
30661	MMD-83	\N	DNA	11.3	88	88	\N	6
30662	MMD-84	\N	DNA	32.8	88	88	\N	2
30663	MMD-85	\N	DNA	21.9	88	88	\N	5
30664	MMD-86	\N	DNA	3.2	88	88	\N	6
30665	MMD-87	\N	DNA	1.08	88	88	\N	5
30666	MMD-88	\N	DNA	0.12	88	88	\N	6
30667	MMD-89	\N	DNA	2.69	88	88	\N	6
30668	MMD-90	\N	DNA	0.55	88	88	\N	6
30669	MMD-91	\N	DNA	0.66	88	88	\N	6
30670	MMD-92	\N	DNA	0.94	88	88	\N	5
30671	MMD-93	\N	DNA	16.6	88	88	\N	6
30672	MMD-94	\N	DNA	8.07	88	88	\N	6
30673	MMD-95	\N	DNA	11.6	88	88	\N	6
30674	MMD-96	\N	DNA	2.48	88	88	\N	6
30675	MMD-97	\N	DNA	42.6	88	88	\N	6
30676	MMD-98	\N	DNA	1.24	88	88	\N	6
30677	MMD-99	\N	DNA	0.88	88	88	\N	5
30678	MMD-100	\N	DNA	1.87	88	88	\N	6
30679	MMD-101	\N	DNA	1.2	88	88	\N	6
30680	MMD-102	\N	DNA	2.36	88	88	\N	5
30681	MMD-103	\N	DNA	2.33	88	88	\N	5
30682	MMD-104	\N	DNA	1.81	88	88	\N	5
30683	MMD-105	\N	DNA	0.13	88	88	\N	5
30684	MMD-106	\N	DNA	0.41	88	88	\N	5
30685	MMD-107	\N	DNA	0.14	88	88	\N	5
30686	MMD-108	\N	DNA	3.69	88	88	\N	5
30687	MMD-109	\N	DNA	0.14	88	88	\N	5
30688	MMD-111	\N	DNA	0.13	88	88	\N	5
30689	MMD-112	\N	DNA	0.21	88	88	\N	2
30690	MMD-113	\N	DNA	0.2	88	88	\N	5
30691	MMD-114	\N	DNA	0	88	88	\N	2
30692	MMD-115	\N	DNA	19.2	88	88	\N	2
30693	MMD-116	\N	DNA	1.2	88	88	\N	2
30694	MMD-117	\N	DNA	0.5	88	88	\N	5
30695	MMD-118	\N	DNA	0	88	88	\N	2
30696	MMD-119	\N	DNA	1.44	88	88	\N	2
30697	MMD-120	\N	DNA	17.4	88	88	\N	2
30698	MMD-121	\N	DNA	8.55	88	88	\N	2
30699	MMD-122	\N	DNA	0.19	88	88	\N	5
30700	MMD-123	\N	DNA	0.44	88	88	\N	2
30701	MMD-124	\N	DNA	1.9	88	88	\N	2
30702	MMD-125	\N	DNA	0.4	88	88	\N	5
30703	MMD-126	\N	DNA	2.16	88	88	\N	2
30704	MMD-127	\N	DNA	0.15	88	88	\N	5
30705	MMD-128	\N	DNA	0.09	88	88	\N	2
30706	MMD-129	\N	DNA	0.49	88	88	\N	2
30707	MMD-130	\N	DNA	1.88	88	88	\N	5
30708	MMD-131	\N	DNA	0.16	88	88	\N	2
30709	MMD-132	\N	DNA	0.56	88	88	\N	2
30710	MMD-133	\N	DNA	0.06	88	88	\N	5
30711	MMD-134	\N	DNA	2.03	88	88	\N	2
30712	MMD-135	\N	DNA	0.85	88	88	\N	5
30713	MMD-136	\N	DNA	0	88	88	\N	2
30714	MMD-137	\N	DNA	0.06	88	88	\N	5
30715	MMD-140	\N	DNA	0	88	88	\N	2
30716	MMD-141	\N	DNA	0.17	88	88	\N	2
30717	MMD-142	\N	DNA	0.05	88	88	\N	5
30718	MMD-143	\N	DNA	0.48	88	88	\N	2
30719	MMD-144	\N	DNA	0.14	88	88	\N	2
30720	MMD-145	\N	DNA	0.2	88	88	DNA ONLY	2
30721	MMD-146	\N	DNA	0.44	88	88	\N	5
30722	MMD-147	\N	DNA	0.09	88	88	DNA ONLY	2
30723	MMD-148	\N	DNA	0.14	88	88	\N	5
30724	MMD-149	\N	DNA	0.71	88	88	\N	2
30725	MMD-150	\N	DNA	0.44	88	88	\N	5
30726	MMD-151	\N	DNA	1.37	88	88	\N	2
30727	MMD-152	\N	DNA	0.11	88	88	DNA ONLY	2
30728	MMD-153	\N	DNA	0.13	88	88	\N	2
30729	MMD-154	\N	DNA	0.18	88	88	\N	5
30730	MMD-155	\N	DNA	0.07	88	88	\N	2
30731	MMD-156	\N	DNA	0.09	88	88	\N	5
30732	MMD-157	\N	DNA	9.52	88	88	\N	2
30733	MMD-158	\N	DNA	2.19	88	88	\N	2
30734	MMD-159	\N	DNA	0.07	88	88	\N	2
30735	MMD-160	\N	DNA	15.9	88	88	\N	2
30736	MMD-161	\N	DNA	0.52	88	88	\N	5
30737	MMD-162	\N	DNA	3.3	88	88	\N	2
30738	MMD-163	\N	DNA	9.84	88	88	\N	2
30739	MMD-164	\N	DNA	1.01	88	88	\N	5
30740	MMD-165	\N	DNA	17.4	88	88	\N	2
30741	MMD-166	\N	DNA	1.93	88	88	\N	5
30742	MMD-167	\N	DNA	0.6	88	88	\N	2
30743	MMD-168	\N	DNA	0.57	88	88	\N	5
30744	MMD-169	\N	DNA	0.23	88	88	\N	2
30745	MMD-170	\N	DNA	0.17	88	88	\N	2
30746	MMD-171	\N	DNA	0.11	88	88	\N	5
30747	MMD-172	\N	DNA	2.1	88	88	\N	2
30748	MMD-173	\N	DNA	0.59	88	88	\N	2
30749	MMD-174	\N	DNA	0.05	88	88	\N	5
30750	MMD-175	\N	DNA	5.42	88	88	\N	2
30751	MMD-176	\N	DNA	0.9	88	88	\N	5
30752	MMD-177	\N	DNA	30.5	88	88	\N	2
30753	MMD-178	\N	DNA	2.49	88	88	\N	2
30754	MMD-179	\N	DNA	0.74	88	88	\N	2
30755	MMD-180	\N	DNA	1.42	88	88	\N	5
30756	MMD-181	\N	DNA	14.7	88	88	\N	2
30757	MMD-182	\N	DNA	3.52	88	88	\N	2
30758	MMD-183	\N	DNA	0.64	88	88	\N	5
30759	MMD-184	\N	DNA	3.79	88	88	\N	2
30760	MMD-185	\N	DNA	0.29	88	88	\N	5
30761	MMD-186	\N	DNA	0.08	88	88	\N	2
30762	MMD-187	\N	DNA	0.26	88	88	\N	2
30763	MMD-188	\N	DNA	0	88	88	\N	5
30764	MMD-189	\N	DNA	0.23	88	88	DNA ONLY	2
30765	MMD-190	\N	DNA	0	88	88	DNA ONLY	2
30766	MMD-191	\N	DNA	0.93	88	88	\N	2
30767	MMD-192	\N	DNA	0.14	88	88	\N	2
30768	MMD-193	\N	DNA	0.14	88	88	DNA ONLY	2
30769	MMD-194	\N	DNA	0.14	88	88	DNA ONLY	2
30770	MMD-195	\N	DNA	0.13	88	88	\N	2
30771	MMD-196	\N	DNA	0.47	88	88	\N	2
30772	MMD-197	\N	DNA	0.28	88	88	\N	2
30773	MMD-198	\N	DNA	0.44	88	88	DNA ONLY	2
30774	MMD-199	\N	DNA	0.47	88	88	\N	5
30775	MMD-200	\N	DNA	1.35	88	88	\N	2
30776	MMD-201	\N	DNA	0.72	88	88	\N	2
30777	MMD-202	\N	DNA	0	88	88	DNA ONLY	2
30778	MMD-203	\N	DNA	0	88	88	\N	5
30779	MMD-204	\N	DNA	1.61	88	88	\N	2
30780	MMD-205	\N	DNA	0.06	88	88	\N	5
30781	MMD-206	\N	DNA	0.24	88	88	\N	2
30782	MMD-207	\N	DNA	0.25	88	88	DNA ONLY	2
30783	MMD-208	\N	DNA	0.18	88	88	\N	\N
30784	MMD-209	\N	DNA	0.34	88	88	DNA ONLY	2
30785	MMD-210	\N	DNA	0.13	88	88	\N	5
30786	MMD-211	\N	DNA	1.87	88	88	DNA ONLY	2
30787	MMD-212	\N	DNA	0.22	88	88	DNA ONLY	2
30788	MMD-213	\N	DNA	0.07	88	88	\N	2
30789	MMD-214	\N	DNA	0.15	88	88	\N	2
30790	MMD-215	\N	DNA	0.18	88	88	DNA ONLY	2
30791	MMD-216	\N	DNA	0.06	88	88	\N	2
30792	MMD-217	\N	DNA	3.21	88	88	DNA ONLY	2
30793	MMD-218	\N	DNA	0.45	88	88	DNA ONLY	2
30794	MMD-219	\N	DNA	0.3	88	88	DNA ONLY	2
30795	MMD-220	\N	DNA	0	88	88	DNA ONLY	2
30796	MMD-221	\N	DNA	0.16	88	88	\N	2
30797	MMD-222	\N	DNA	0	88	88	\N	2
30798	MMD-223	\N	DNA	1.79	88	88	\N	2
30799	MMD-224	\N	DNA	0.8	88	88	DNA ONLY	2
30800	MMD-225	\N	DNA	0.54	88	88	\N	2
30801	MMD-226	\N	DNA	0.34	88	88	DNA ONLY	2
30802	MMD-227	\N	DNA	0.13	88	88	\N	2
30803	MMD-228	\N	DNA	1.74	88	88	\N	2
30804	MMD-229	\N	DNA	0.05	88	88	DNA ONLY	2
30805	MMD-230	\N	DNA	0.63	88	88	\N	2
30806	MMD-231	\N	DNA	0.19	88	88	DNA ONLY	2
30807	MMD-232	\N	DNA	0.18	88	88	\N	2
30808	MMD-233	\N	DNA	0.18	88	88	DNA ONLY	2
30809	MMD-234	\N	DNA	0.51	88	88	\N	2
30810	MMD-235	\N	DNA	0.36	88	88	DNA ONLY	2
30811	MMD-236	\N	DNA	0.99	88	88	\N	2
30812	MMD-237	\N	DNA	0.28	88	88	\N	2
30813	MMD-238	\N	DNA	2.41	88	88	\N	2
30814	MMD-239	\N	DNA	1.34	88	88	DNA ONLY	2
30815	MMD-240	\N	DNA	0.68	88	88	\N	2
30816	MMD-241	\N	DNA	0.18	88	88	DNA ONLY	2
30817	MMD-242	\N	DNA	2.13	88	88	\N	2
30818	MMD-243	\N	DNA	0.89	88	88	DNA ONLY	2
30819	MMD-244	\N	DNA	1.26	88	88	\N	2
30820	MMD-245	\N	DNA	0	88	88	DNA ONLY	2
30821	MMD-246	\N	DNA	1.25	88	88	\N	2
30822	MMD-247	\N	DNA	0.24	88	88	DNA ONLY	2
30823	MMD-248	\N	DNA	0.12	88	88	\N	2
30824	MMD-249	\N	DNA	0.4	88	88	\N	2
30825	MMD-250	\N	DNA	0.07	88	88	DNA ONLY	2
30826	MMD-251	\N	DNA	1.99	88	88	\N	2
30827	MMD-252	\N	DNA	0.09	88	88	DNA ONLY	2
30828	MMD-253	\N	DNA	0	88	88	\N	2
30829	MMD-254	\N	DNA	0.07	88	88	DNA ONLY	2
30830	MMD-255	\N	DNA	0	88	88	\N	2
30831	MMD-256	\N	DNA	0.09	88	88	DNA ONLY	2
30832	MMD-257	\N	DNA	0	88	88	DNA ONLY	2
30833	MMD-258	\N	DNA	0.16	88	88	DNA ONLY	2
30834	MMD-259	\N	DNA	0.08	88	88	DNA ONLY	2
30835	MMD-260	\N	DNA	0.37	88	88	DNA ONLY	2
30836	MMD-261	\N	DNA	0.24	88	88	DNA ONLY	2
30837	MMD-262	\N	DNA	0.14	88	88	\N	2
30838	MMD-263	\N	DNA	0.23	88	88	DNA ONLY	2
30839	MMD-264	\N	DNA	0.1	88	88	DNA ONLY	2
30840	MMD-265	\N	DNA	0.07	88	88	DNA ONLY	2
30841	MMD-266	\N	DNA	0.11	88	88	DNA ONLY	2
30842	MMD-267	\N	DNA	0	88	88	\N	2
30843	MMD-268	\N	DNA	0.07	88	88	DNA ONLY	2
30844	MMD-269	\N	DNA	2.5	88	88	DNA ONLY	2
30845	MMD-270	\N	DNA	0.99	88	88	DNA ONLY	2
30846	MMD-271	\N	DNA	0.09	88	88	DNA ONLY	2
30847	MMD-272	\N	DNA	0.1	88	88	DNA ONLY	2
30848	MMD-273	\N	DNA	0.29	88	88	DNA ONLY	2
30849	MMD-274	\N	DNA	0	88	88	DNA ONLY	2
30850	MMD-275	\N	DNA	0	88	88	\N	2
30851	MMD-276	\N	DNA	0.85	88	88	DNA ONLY	2
30852	MMD-277	\N	DNA	0.89	88	88	DNA ONLY	2
30853	MMD-278	\N	DNA	0.24	88	88	DNA ONLY	2
30854	MMD-279	\N	DNA	0.19	88	88	\N	2
30855	MMD-280	\N	DNA	0.12	88	88	DNA ONLY	2
30856	MMD-281	\N	DNA	0.58	88	88	\N	2
30857	MMD-282	\N	DNA	0.06	88	88	\N	2
30858	MMD-283	\N	DNA	0.47	88	88	DNA ONLY	2
30859	MMD-284	\N	DNA	0.17	88	88	DNA ONLY	2
30860	MMD-285	\N	DNA	1.48	88	88	DNA ONLY	2
30861	MMD-286	\N	DNA	0.41	88	88	DNA ONLY	2
30862	MMD-287	\N	DNA	0.52	88	88	DNA ONLY	2
30863	MMD-288	\N	DNA	0.18	88	88	\N	2
30864	MMD-289	\N	DNA	0.2	88	88	DNA ONLY	2
30865	MMD-290	\N	DNA	0.08	88	88	DNA ONLY	2
30866	MMD-291	\N	DNA	0.15	88	88	DNA ONLY	2
30867	MMD-292	\N	DNA	1.57	88	88	DNA ONLY	2
30868	MMD-293	\N	DNA	0.07	88	88	\N	2
30869	MMD-294	\N	DNA	1.03	88	88	DNA ONLY	2
30870	MMD-295	\N	DNA	0.07	88	88	DNA ONLY	2
30871	MMD-296	\N	DNA	0.16	88	88	DNA ONLY	2
30872	MMD-297	\N	DNA	0.25	88	88	DNA ONLY	2
30873	MMD-298	\N	DNA	0.54	88	88	DNA ONLY	2
30874	MMD-299	\N	DNA	0	88	88	DNA ONLY	2
30875	MMD-300	\N	DNA	0.29	88	88	DNA ONLY	2
30876	MMD-301	\N	DNA	0	88	88	\N	2
30877	MMD-302	\N	DNA	1.46	88	88	\N	2
30878	MMD-303	\N	DNA	0.23	88	88	DNA ONLY	2
30879	MMD-304	\N	DNA	0.21	88	88	\N	2
30880	MMD-305	\N	DNA	4.36	88	88	\N	2
30881	MMD-306	\N	DNA	0.34	88	88	DNA ONLY	2
30882	MMD-307	\N	DNA	0.16	88	88	DNA ONLY	2
30883	MMD-308	\N	DNA	0.13	88	88	\N	2
30884	MMD-309	\N	DNA	0.35	88	88	DNA ONLY	2
30885	MMD-310	\N	DNA	0	88	88	DNA ONLY	2
30886	MMD-311	\N	DNA	0.39	88	88	DNA ONLY	2
30887	MMD-312	\N	DNA	0.31	88	88	DNA ONLY	2
30888	MMD-313	\N	DNA	0.1	88	88	\N	2
30889	MMD-314	\N	DNA	0	88	88	DNA ONLY	2
30890	MMD-315	\N	DNA	0.76	88	88	DNA ONLY	2
30891	MMD-316	\N	DNA	0.14	88	88	DNA ONLY	2
30892	MMD-317	\N	DNA	0.29	88	88	DNA ONLY	2
30893	MMD-318	\N	DNA	0.56	88	88	DNA ONLY	2
30894	MMD-319	\N	DNA	0.57	88	88	DNA ONLY	2
30895	MMD-320	\N	DNA	0	88	88	DNA ONLY	2
30896	MMD-321	\N	DNA	0.25	88	88	\N	2
30897	MMD-322	\N	DNA	0.25	88	88	DNA ONLY	2
30898	MMD-323	\N	DNA	0.21	88	88	\N	2
30899	MMD-324	\N	DNA	1.79	88	88	\N	2
30900	MMD-325	2021-09-23 00:00:00-07	DNA	0	88	88	DNA ONLY	2
30901	MMD-326	\N	DNA	0.2	88	88	\N	2
30902	MMD-327	2021-09-23 00:00:00-07	DNA	0.37	88	88	DNA ONLY	2
30903	MMD-328	\N	DNA	2.58	88	88	\N	2
30904	MMD-329	2021-09-23 00:00:00-07	DNA	0.98	88	88	DNA ONLY	2
30905	MMD-330	\N	DNA	1.01	88	88	\N	2
30906	MMD-331	2021-09-23 00:00:00-07	DNA	2.48	88	88	DNA ONLY	2
30907	MMD-332	\N	DNA	0.21	88	88	\N	2
30908	MMD-333	2021-09-23 00:00:00-07	DNA	1.29	88	88	DNA ONLY	2
30909	MMD-334	\N	DNA	1.4	88	88	\N	2
30910	MMD-335	\N	DNA	9.02	88	88	\N	2
30911	MMD-336	\N	DNA	0.41	88	88	\N	2
30912	MMD-337	2021-09-23 00:00:00-07	DNA	0.12	88	88	DNA ONLY	2
30913	MMD-338	\N	DNA	7.66	88	88	\N	2
30914	MMD-339	\N	DNA	0	88	88	DNA ONLY	2
30915	MMD-340	2021-09-23 00:00:00-07	DNA	11.8	88	88	\N	2
30916	MMD-341	2021-09-23 00:00:00-07	DNA	3.35	88	88	DNA ONLY	2
30917	MMD-342	2021-09-23 00:00:00-07	DNA	4.38	88	88	\N	2
30918	MMD-343	2021-09-23 00:00:00-07	DNA	2.22	88	88	DNA ONLY	2
30919	MMD-344	2021-09-23 00:00:00-07	DNA	6.94	88	88	\N	2
30920	MMD-345	2021-09-23 00:00:00-07	DNA	2.76	88	88	DNA ONLY	2
30921	MMD-346	2021-09-23 00:00:00-07	DNA	1.47	88	88	\N	2
30922	MMD-347	2021-09-23 00:00:00-07	DNA	1.85	88	88	\N	2
30923	MMD-348	2021-09-23 00:00:00-07	DNA	1.18	88	88	DNA ONLY	2
30924	MMD-349	2021-09-23 00:00:00-07	DNA	1.02	88	88	\N	2
30925	MMD-350	2021-09-23 00:00:00-07	DNA	1.57	88	88	\N	2
30926	MMD-351	2021-09-23 00:00:00-07	DNA	0.34	88	88	DNA ONLY	2
30927	MMD-352	2021-09-23 00:00:00-07	DNA	9.99	88	88	\N	2
30928	MMD-353	2021-09-23 00:00:00-07	DNA	0.65	88	88	DNA ONLY	2
30929	MMD-354	2021-09-23 00:00:00-07	DNA	0.68	88	88	\N	2
30930	MMD-355 (P041_01A)	2021-07-29 00:00:00-07	DNA	0.39	50	50	DIN:4.2, 5 x (1-48 mm^2; 10 um)\n	7
30931	MMD-356 (P041_01B)	2021-07-29 00:00:00-07	DNA	0	50	50	DIN:5.2, 5 x (1-48 mm^2; 10 um)\n	7
30932	MMD-357 (P041_01C)	2021-07-29 00:00:00-07	DNA	0.48	50	50	DIN:5.6, 5 x (1-48 mm^2; 10 um)\n	7
30933	MMD-358	2021-09-23 00:00:00-07	DNA	0.47	88	88	\N	2
30934	MMD-359 (P041_01D)	2021-07-29 00:00:00-07	DNA	0.97	50	50	DIN:UND, 5 x (1-48 mm^2; 10 um)\n	7
30935	MMD-360	2021-09-23 00:00:00-07	DNA	0.88	88	88	\N	2
30936	MMD-361 (P041_03A)	2021-07-29 00:00:00-07	DNA	1	50	50	DIN:4.8, 5 x (1-48 mm^2; 10 um)\n	7
30937	MMR-01	\N	RNA	570	25	25	\N	6
30938	MMR-02	\N	RNA	381	25	25	\N	6
30939	MMR-03	\N	RNA	0	25	25	\N	6
30940	MMR-04	\N	RNA	100	25	25	\N	6
30941	MMR-05	\N	RNA	7.86	25	25	\N	6
30942	MMR-06	\N	RNA	76	25	25	\N	6
30943	MMR-07	\N	RNA	63	25	25	\N	6
30944	MMR-08	\N	RNA	100	25	25	\N	6
30945	MMR-09	\N	RNA	4	25	25	\N	6
30946	MMR-10	\N	RNA	0	25	25	\N	6
30947	MMR-11	\N	RNA	52	25	25	\N	6
30948	MMR-12	\N	RNA	20.3	25	25	\N	6
30949	MMR-13	\N	RNA	20.5	25	25	\N	6
30950	MMR-14	\N	RNA	22.6	25	25	\N	6
30951	MMR-15	\N	RNA	16.1	25	25	\N	6
30952	MMR-16	\N	RNA	18	25	25	\N	6
30953	MMR-17	\N	RNA	0	25	25	\N	6
30954	MMR-18	\N	RNA	24.3	25	25	\N	6
30955	MMR-19	\N	RNA	30.7	25	25	\N	6
30956	MMR-20	\N	RNA	32.2	25	25	\N	6
30957	MMR-21	\N	RNA	17.6	25	25	\N	6
30958	MMR-22	\N	RNA	15.7	25	25	\N	6
30959	MMR-23	\N	RNA	0	0	0	\N	\N
30960	MMR-24	\N	RNA	0	0	0	\N	\N
30961	MMR-25	\N	RNA	0	0	0	\N	\N
30962	MMR-26	\N	RNA	0	0	0	\N	\N
30963	MMR-27	\N	RNA	0	0	0	\N	\N
30964	MMR-28	\N	RNA	14.3	25	25	\N	6
30965	MMR-29	\N	RNA	0	0	0	\N	\N
30966	MMR-30	\N	RNA	81	25	25	\N	6
30967	MMR-31	\N	RNA	5.46	25	25	\N	6
30968	MMR-32	\N	RNA	14.4	25	25	\N	6
30969	MMR-33	\N	RNA	14.2	25	25	\N	6
30970	MMR-34	\N	RNA	0	0	0	\N	\N
30971	MMR-35	\N	RNA	166	25	25	\N	6
30972	MMR-37	\N	RNA	265	25	25	\N	6
30973	MMR-38	\N	RNA	95	25	25	\N	6
30974	MMR-40	\N	RNA	0	25	25	\N	6
30975	MMR-41	\N	RNA	14.6	25	25	\N	6
30976	MMR-42	\N	RNA	54	25	25	\N	6
30977	MMR-44	\N	RNA	13.6	25	25	\N	6
30978	MMR-45	\N	RNA	7.7	50	50	\N	1
30979	MMR-46	\N	RNA	9.6	25	25	\N	6
30980	MMR-48	\N	RNA	21.8	25	25	\N	6
30981	MMR-50	\N	RNA	4.32	25	25	\N	6
30982	MMR-51	\N	RNA	15.6	25	25	\N	6
30983	MMR-53	\N	RNA	9.87	25	25	\N	6
30984	MMR-54	\N	RNA	6.22	25	25	\N	6
30985	MMR-55	\N	RNA	4.3	25	25	\N	6
30986	MMR-56	\N	RNA	0	25	25	\N	6
30987	MMR-70	\N	RNA	13.6	25	25	\N	6
30988	MMR-73	\N	RNA	346	25	25	\N	6
30989	MMR-74	\N	RNA	316	25	25	\N	6
30990	MMR-76	\N	RNA	0	25	25	\N	6
30991	MMR-78	\N	RNA	0	25	25	\N	6
30992	MMR-79	\N	RNA	0	50	50	\N	1
30993	MMR-81	\N	RNA	29.3	25	25	\N	6
30994	MMR-83	\N	RNA	0	25	25	\N	6
30995	MMR-84	\N	RNA	0	50	50	\N	1
30996	MMR-86	\N	RNA	64	25	25	\N	6
30997	MMR-88	\N	RNA	2.63	25	25	\N	6
30998	MMR-89	\N	RNA	36	25	25	\N	6
30999	MMR-90	\N	RNA	7.11	25	25	\N	6
31000	MMR-91	\N	RNA	44	25	25	\N	6
31001	MMR-93	\N	RNA	710	25	25	\N	6
31002	MMR-94	\N	RNA	0	25	25	\N	6
31003	MMR-95	\N	RNA	0	25	25	\N	6
31004	MMR-96	\N	RNA	183	25	25	\N	6
31005	MMR-97	\N	RNA	183	25	25	\N	6
31006	MMR-98	\N	RNA	42.5	25	25	\N	6
31007	MMR-100	\N	RNA	26.1	25	25	\N	6
31008	MMR-101	\N	RNA	27.2	25	25	\N	6
31009	MMR-112	\N	RNA	6.25	50	50	\N	1
31010	MMR-114	\N	RNA	0	50	50	\N	1
31011	MMR-115	\N	RNA	38.7	50	50	\N	1
31012	MMR-116	\N	RNA	64	50	50	\N	1
31013	MMR-118	\N	RNA	2	50	50	\N	1
31014	MMR-119	\N	RNA	13.9	50	50	\N	1
31015	MMR-120	\N	RNA	56	50	50	\N	1
31016	MMR-121	\N	RNA	37.3	50	50	\N	1
31017	MMR-123	\N	RNA	3.03	50	50	\N	1
31018	MMR-124	\N	RNA	15	50	50	\N	1
31019	MMR-126	\N	RNA	14	50	50	\N	1
31020	MMR-128	\N	RNA	0	50	50	\N	1
31021	MMR-129	\N	RNA	18.4	50	50	\N	1
31022	MMR-131	\N	RNA	3.45	50	50	\N	1
31023	MMR-132	\N	RNA	6.63	50	50	\N	1
31024	MMR-134	\N	RNA	12.4	50	50	\N	1
31025	MMR-136	\N	RNA	0	50	50	\N	1
31026	MMR-140	\N	RNA	0	50	50	\N	1
31027	MMR-141	\N	RNA	2.1	50	50	\N	1
31028	MMR-143	\N	RNA	5.32	50	50	\N	1
31029	MMR-144	\N	RNA	2.44	50	50	\N	1
31030	MMR-149	\N	RNA	6.94	50	50	\N	1
31031	MMR-151	\N	RNA	9.66	50	50	\N	1
31032	MMR-153	\N	RNA	2.2	50	50	\N	1
31033	MMR-155	\N	RNA	0	50	50	\N	1
31034	MMR-157	\N	RNA	45.5	50	50	\N	1
31893	Rob-T010-Nev_NA	\N	DNA	\N	\N	\N	\N	\N
31035	MMR-158	\N	RNA	29.8	50	50	\N	1
31036	MMR-159	\N	RNA	2.2	50	50	\N	1
31037	MMR-160	\N	RNA	50	50	50	\N	1
31038	MMR-162	\N	RNA	43.6	50	50	\N	1
31039	MMR-163	\N	RNA	44.9	50	50	\N	1
31040	MMR-165	\N	RNA	38.6	50	50	\N	1
31041	MMR-167	\N	RNA	13.6	50	50	\N	1
31042	MMR-169	\N	RNA	13.6	50	50	\N	1
31043	MMR-170	\N	RNA	4.34	50	50	\N	1
31044	MMR-172	\N	RNA	8.18	50	50	\N	1
31045	MMR-173	\N	RNA	9.34	50	50	\N	1
31046	MMR-175	\N	RNA	2.52	50	50	\N	1
31047	MMR-177	\N	RNA	254	50	50	\N	1
31048	MMR-178	\N	RNA	13.6	50	50	\N	1
31049	MMR-179	\N	RNA	3.33	50	50	\N	1
31050	MMR-181	\N	RNA	60	50	50	\N	1
31051	MMR-182	\N	RNA	54	50	50	\N	1
31052	MMR-184	\N	RNA	18.3	50	50	\N	1
31053	MMR-186	\N	RNA	0	50	50	\N	1
31054	MMR-187	\N	RNA	5.61	50	50	\N	1
31055	MMR-191	\N	RNA	33.4	50	50	\N	1
31056	MMR-192	\N	RNA	5.55	50	50	\N	1
31057	MMR-195	\N	RNA	0	0	0	\N	1
31058	MMR-196	\N	RNA	5.5	50	50	\N	1
31059	MMR-197	\N	RNA	0.28	50	50	\N	1
31060	MMR-200	\N	RNA	25.9	50	50	\N	1
31061	MMR-201	\N	RNA	10.1	50	50	\N	1
31062	MMR-204	\N	RNA	12.3	50	50	\N	1
31063	MMR-206	\N	RNA	2.4	50	50	\N	1
31064	MMR-208	\N	RNA	2.4	50	50	\N	\N
31065	MMR-213	\N	RNA	0	50	50	\N	1
31066	MMR-214	\N	RNA	4.61	50	50	\N	1
31067	MMR-216	\N	RNA	0	50	50	\N	1
31068	MMR-221	\N	RNA	2.86	50	50	\N	1
31069	MMR-223	\N	RNA	11.7	50	50	\N	1
31070	MMR-225	\N	RNA	3.11	50	50	\N	1
31071	MMR-227	\N	RNA	0	50	50	\N	1
31072	MMR-228	\N	RNA	0	50	50	\N	1
31073	MMR-230	\N	RNA	4.88	50	50	\N	1
31074	MMR-232	\N	RNA	0	50	50	\N	1
31075	MMR-234	\N	RNA	6.72	50	50	\N	1
31076	MMR-236	\N	RNA	10.8	50	50	\N	1
31077	MMR-237	\N	RNA	0	50	50	\N	1
31078	MMR-240	\N	RNA	7.67	50	50	\N	1
31079	MMR-242	\N	RNA	16.1	50	50	\N	1
31080	MMR-244	\N	RNA	4.6	50	50	\N	1
31081	MMR-246	\N	RNA	5.46	50	50	\N	1
31082	MMR-248	\N	RNA	0	50	50	\N	1
31083	MMR-249	\N	RNA	19.4	50	50	\N	1
31084	MMR-251	\N	RNA	5.39	50	50	\N	1
31085	MMR-253	\N	RNA	0	50	50	\N	1
31086	MMR-255	\N	RNA	2.55	50	50	\N	1
31087	MMR-262	\N	RNA	2.3	50	50	\N	1
31088	MMR-267	\N	RNA	0	25	25	\N	1
31089	MMR-275	\N	RNA	0	50	50	\N	1
31090	MMR-279	\N	RNA	2.95	50	50	\N	1
31091	MMR-288	\N	RNA	2	50	50	\N	1
31092	MMR-293	\N	RNA	0	50	50	\N	1
31093	MMR-301	\N	RNA	0	50	50	\N	1
31094	MMR-302	\N	RNA	18.3	50	50	\N	1
31095	MMR-304	\N	RNA	5.45	50	50	\N	1
31096	MMR-305	\N	RNA	2.2	50	50	\N	1
31097	MMR-308	\N	RNA	0.13	50	50	\N	1
31098	MMR-313	\N	RNA	0	50	50	\N	1
31099	MMR-321	\N	RNA	0	50	50	\N	1
31100	MMR-323	\N	RNA	2.6	50	50	\N	1
31101	MMR-324	\N	RNA	0	50	50	\N	1
31102	MMR-325	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31103	MMR-326	\N	RNA	2.94	50	50	\N	1
31104	MMR-327	2021-09-23 00:00:00-07	RNA	2.51	50	50	\N	1
31105	MMR-328	\N	RNA	0	50	50	\N	1
31106	MMR-329	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31107	MMR-330	\N	RNA	8.7	50	50	\N	1
31108	MMR-331	2021-09-23 00:00:00-07	RNA	7.04	50	50	\N	1
31109	MMR-332	\N	RNA	2	50	50	\N	1
31110	MMR-333	2021-09-23 00:00:00-07	RNA	5.6	50	50	\N	1
31111	MMR-334	\N	RNA	8.72	50	50	\N	1
31112	MMR-335	\N	RNA	68	50	50	\N	1
31113	MMR-336	\N	RNA	3.35	50	50	\N	1
31114	MMR-337	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31115	MMR-338	\N	RNA	42.1	50	50	\N	1
31116	MMR-340	2021-09-23 00:00:00-07	RNA	27.4	50	50	\N	1
31117	MMR-341	2021-09-23 00:00:00-07	RNA	9.46	50	50	\N	1
31118	MMR-342	2021-09-23 00:00:00-07	RNA	5.69	50	50	\N	1
31119	MMR-343	2021-09-23 00:00:00-07	RNA	2.3	50	50	\N	1
31120	MMR-344	2021-09-23 00:00:00-07	RNA	11.3	50	50	\N	1
31121	MMR-345	2021-09-23 00:00:00-07	RNA	6.56	50	50	\N	1
31122	MMR-346	2021-09-23 00:00:00-07	RNA	2.5	50	50	\N	1
31123	MMR-347	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31124	MMR-348	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31125	MMR-349	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31126	MMR-350	2021-09-23 00:00:00-07	RNA	2.4	50	50	\N	1
31127	MMR-351	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31894	Rob-T010-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31128	MMR-352	2021-09-23 00:00:00-07	RNA	5.8	50	50	\N	1
31129	MMR-353	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31130	MMR-354	2021-09-23 00:00:00-07	RNA	2.5	50	50	\N	1
31131	MMR-355	\N	RNA	0	0	0	\N	\N
31132	MMR-356	\N	RNA	0	0	0	\N	\N
31133	MMR-357	\N	RNA	0	0	0	\N	\N
31134	MMR-358	2021-09-23 00:00:00-07	RNA	2	50	50	\N	1
31135	MMR-359	\N	RNA	0	0	0	\N	\N
31136	MMR-360	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31137	MMR-361	\N	RNA	0	0	0	\N	\N
31138	MP41-D	\N	DNA	3.82	0	0	from human uveal melanoma cell line	\N
31139	MP41-YM-R1-D	\N	DNA	5.89	0	0	\N	\N
31140	MR-001	\N	DNA	58	48	48	\N	\N
31141	MR-002	\N	DNA	41.6	48	48	\N	\N
31142	MR-003	\N	DNA	21.7	48	48	\N	\N
31143	MR-004	\N	DNA	29.6	48	48	\N	\N
31144	MR-005	\N	DNA	16.8	48	48	\N	\N
31145	MR-006	\N	DNA	9.84	48	48	\N	\N
31146	MR-008	\N	DNA	12	48	48	\N	\N
31147	MR-009	\N	DNA	8.6	48	48	\N	\N
31148	MR-010	\N	DNA	8.87	48	48	\N	\N
31149	MR-011	\N	DNA	59	48	48	\N	\N
31150	MR-012	\N	DNA	31.1	48	48	\N	\N
31151	MR-015	\N	DNA	1.11	48	48	\N	\N
31152	MR-017	\N	DNA	53	48	48	\N	\N
31153	MR-020	\N	DNA	207	48	48	\N	\N
31154	MR-021	\N	DNA	11.5	48	48	\N	\N
31155	MR-024	\N	DNA	11.8	48	48	\N	\N
31156	MR-025	\N	DNA	6.4	48	48	\N	\N
31157	MR-026	\N	DNA	121	48	48	\N	\N
31158	MR-027	\N	DNA	1.01	48	48	\N	\N
31159	MR-029	\N	DNA	29.5	48	48	\N	\N
31160	MR-030	\N	DNA	13.7	48	48	\N	\N
31161	MR-031	\N	DNA	18.1	48	48	\N	\N
31162	MR-032	\N	DNA	11.5	48	48	\N	\N
31163	MR-033	\N	DNA	24.5	48	48	\N	\N
31164	MR-034	\N	DNA	46.2	48	48	\N	\N
31165	MR-035	\N	DNA	44.6	48	48	\N	\N
31166	MR-036	\N	DNA	5.41	48	48	\N	\N
31167	MR-037	\N	DNA	9.44	48	48	\N	\N
31168	MR-038	\N	DNA	14.4	48	48	\N	\N
31169	MR-039	\N	DNA	19.9	48	48	\N	\N
31170	MR-040	\N	DNA	34.6	48	48	\N	\N
31171	MR-041	\N	DNA	34.9	48	48	\N	\N
31172	MR-042	\N	DNA	6.61	48	48	\N	\N
31173	MR-043	\N	DNA	17.2	48	48	\N	\N
31174	MR-044	\N	DNA	18.1	48	48	\N	\N
31175	MR-045	\N	DNA	0.97	48	48	\N	\N
31176	MR-046	\N	DNA	19.2	48	48	\N	\N
31177	MR-047	\N	DNA	2.04	48	48	\N	\N
31178	MR-048	\N	DNA	37.8	48	48	\N	\N
31179	MR-049	\N	DNA	23.7	48	48	\N	\N
31180	MR-050	\N	DNA	20.2	48	48	\N	\N
31181	MR-051	\N	DNA	2.12	48	48	\N	\N
31182	MS_1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31183	MucM D-006	2023-10-10 00:00:00-07	DNA	45.5	88	88	\N	2
31184	MucM D-009	2023-10-10 00:00:00-07	DNA	12.3	200	200	\N	2
31185	MucM D-012	2023-10-10 00:00:00-07	DNA	37.3	88	88	\N	2
31186	MucM D-015	2023-10-10 00:00:00-07	DNA	10.6	88	88	\N	2
31187	MucM D-019	2023-10-10 00:00:00-07	DNA	0.7	116	116	\N	2
31188	MucM D-020	2023-10-10 00:00:00-07	DNA	1.06	430	430	\N	2
31189	N-1	2019-06-21 00:00:00-07	DNA	9.13	21	21	\N	5
31190	N-2	2019-07-01 00:00:00-07	DNA	2.32	48	48	\N	5
31191	N-3	2019-07-01 00:00:00-07	DNA	3.75	48	48	\N	5
31192	N-4	2019-07-01 00:00:00-07	DNA	16.3	33	33	\N	5
31193	N3_1_NA	\N	DNA	\N	\N	\N	\N	\N
31194	N3_2_NA	\N	DNA	\N	\N	\N	\N	\N
31195	N3_3_NA	\N	DNA	\N	\N	\N	\N	\N
31196	N3_4_NA	\N	DNA	\N	\N	\N	\N	\N
31197	N3_5_NA	\N	DNA	\N	\N	\N	\N	\N
31198	N3_6_NA	\N	DNA	\N	\N	\N	\N	\N
31199	N3_7_NA	\N	DNA	\N	\N	\N	\N	\N
31200	N3_8_NA	\N	DNA	\N	\N	\N	\N	\N
31201	N3_9_NA	\N	DNA	\N	\N	\N	\N	\N
31202	N3_10_NA	\N	DNA	\N	\N	\N	\N	\N
31203	N3_11_NA	\N	DNA	\N	\N	\N	\N	\N
31204	N3_12_NA	\N	DNA	\N	\N	\N	\N	\N
31205	N3_13_NA	\N	DNA	\N	\N	\N	\N	\N
31206	N3_14_NA	\N	DNA	\N	\N	\N	\N	\N
31207	N3_15_NA	\N	DNA	\N	\N	\N	\N	\N
31208	N3_16_NA	\N	DNA	\N	\N	\N	\N	\N
31209	NA_CP1_Normal	\N	DNA	\N	\N	\N	\N	\N
31210	NA_CP1-5_Tumor	\N	DNA	\N	\N	\N	\N	\N
31211	NA_CP1-10_Tumor	\N	DNA	\N	\N	\N	\N	\N
31212	NA_CP1-20_Tumor	\N	DNA	\N	\N	\N	\N	\N
31213	NA_CP1-40_Tumor	\N	DNA	\N	\N	\N	\N	\N
31214	NA_CP1-80_Tumor	\N	DNA	\N	\N	\N	\N	\N
31215	NGS 1-1_NA	\N	DNA	\N	\N	\N	\N	\N
31216	NGS 1-3_NA	\N	DNA	\N	\N	\N	\N	\N
31217	NGS 1-4_NA	\N	DNA	\N	\N	\N	\N	\N
31218	NGS 1-5_NA	\N	DNA	\N	\N	\N	\N	\N
31219	NGS 1-6_NA	\N	DNA	\N	\N	\N	\N	\N
31220	NGS 1-7_NA	\N	DNA	\N	\N	\N	\N	\N
31221	NGS 1-8_NA	\N	DNA	\N	\N	\N	\N	\N
31222	NGS 1-9_NA	\N	DNA	\N	\N	\N	\N	\N
31223	NGS 1-10_NA	\N	DNA	\N	\N	\N	\N	\N
31224	NGS 1-13_NA	\N	DNA	\N	\N	\N	\N	\N
31225	NGS 1-14_NA	\N	DNA	\N	\N	\N	\N	\N
31226	NLD-013	2019-02-20 00:00:00-08	DNA	0.09	48	48	Not enough for LP	5
31227	NLD-014	2019-02-20 00:00:00-08	DNA	12.6	48	48	\N	5
31228	NLD-015	2019-02-20 00:00:00-08	DNA	34.2	48	48	\N	5
31229	NLD-016	2019-02-20 00:00:00-08	DNA	6.1	48	48	\N	5
31230	NLD-017	2019-02-20 00:00:00-08	DNA	1.2	48	48	\N	5
31231	NLD-018	2019-02-20 00:00:00-08	DNA	0.8	48	48	\N	5
31232	NLD-019	2019-02-20 00:00:00-08	DNA	1.5	48	48	\N	5
31233	NLD-020	2019-02-20 00:00:00-08	DNA	0.9	48	48	\N	5
31234	NLD-021	2019-02-20 00:00:00-08	DNA	26.5	48	48	\N	5
31235	NLD-022	2019-02-20 00:00:00-08	DNA	1.7	48	48	\N	5
31236	NLD-023	2019-02-20 00:00:00-08	DNA	2.4	48	48	\N	5
31237	NLD-024	2019-02-20 00:00:00-08	DNA	1.7	48	48	\N	5
31238	NLD-025	2019-02-20 00:00:00-08	DNA	1.4	48	48	\N	5
31239	NM D-01	2018-11-15 00:00:00-08	DNA	21.7	48	48	\N	5
31240	NM D-02	2018-11-15 00:00:00-08	DNA	0.26	48	48	\N	5
31241	NM D-03	2018-11-15 00:00:00-08	DNA	19.2	48	48	\N	5
31242	NM D-04	2018-11-15 00:00:00-08	DNA	1.73	48	48	\N	5
31243	NM D-05	2018-11-15 00:00:00-08	DNA	30.6	48	48	\N	5
31244	NM D-06	2018-11-15 00:00:00-08	DNA	28.4	48	48	\N	5
31245	NM D-07	2018-11-15 00:00:00-08	DNA	37.9	48	48	\N	5
31246	NM D-08	2018-11-15 00:00:00-08	DNA	35	48	48	\N	5
31247	NM D-09	2018-11-15 00:00:00-08	DNA	26.9	48	48	\N	5
31248	NM D-10	2018-11-15 00:00:00-08	DNA	23.4	48	48	\N	5
31249	NM D-11	2018-11-15 00:00:00-08	DNA	36.8	48	48	\N	5
31250	NM D-12	2018-11-17 00:00:00-08	DNA	32.5	48	48	\N	5
31251	NM D-13	2018-11-17 00:00:00-08	DNA	9.95	48	48	\N	5
31252	NM D-14	2018-11-17 00:00:00-08	DNA	15.8	48	48	\N	5
31253	NM D-15	2018-11-17 00:00:00-08	DNA	5.52	48	48	\N	5
31254	NM D-16	2018-11-17 00:00:00-08	DNA	27.3	48	48	\N	5
31255	NM D-17	2018-11-17 00:00:00-08	DNA	25	48	48	\N	5
31256	NM D-18	2018-11-17 00:00:00-08	DNA	31.3	48	48	\N	5
31257	NM D-19	2018-11-17 00:00:00-08	DNA	43.7	48	48	\N	5
31258	NM D-27	2018-11-17 00:00:00-08	DNA	4.94	48	48	\N	5
31259	NM D-29	2018-11-17 00:00:00-08	DNA	1.84	48	48	\N	5
31260	NM D-31	2018-11-17 00:00:00-08	DNA	45	48	48	\N	5
31261	NM D-32	2018-11-17 00:00:00-08	DNA	45	48	48	\N	5
31262	NM D-033	2018-11-17 00:00:00-08	DNA	46.2	48	48	\N	5
31263	NM D-034	2018-11-17 00:00:00-08	DNA	49	48	48	\N	5
31264	NM D-035	2018-11-17 00:00:00-08	DNA	50	48	48	\N	5
31265	NM D-036	2018-11-17 00:00:00-08	DNA	26.2	48	48	\N	5
31266	NM D-037	2018-11-17 00:00:00-08	DNA	50	48	48	\N	5
31267	NM D-038	2018-11-17 00:00:00-08	DNA	38.2	48	48	\N	5
31268	NM D-039	2018-11-17 00:00:00-08	DNA	1.47	48	48	\N	5
31269	NM D-040	2018-11-17 00:00:00-08	DNA	17.9	48	48	\N	5
31270	NM D-041	2018-11-17 00:00:00-08	DNA	8.55	48	48	\N	5
31271	NM D-043	2018-11-17 00:00:00-08	DNA	0.82	48	48	\N	5
31272	NM D-044	2018-11-17 00:00:00-08	DNA	30.2	48	48	\N	5
31273	NM D-045	2018-11-17 00:00:00-08	DNA	11.6	48	48	\N	5
31274	NM D-046	2018-11-17 00:00:00-08	DNA	0.9	48	48	\N	5
31275	NM D-047	2018-11-17 00:00:00-08	DNA	17.4	48	48	\N	5
31276	NM D-048	2018-11-24 00:00:00-08	DNA	13.4	48	48	\N	5
31277	NM D-049	2018-11-24 00:00:00-08	DNA	15.4	48	48	\N	5
31278	NM D-050	2018-11-24 00:00:00-08	DNA	5.7	48	48	\N	5
31279	NM D-051	2018-11-24 00:00:00-08	DNA	1.94	48	48	\N	5
31280	NM D-052	2018-11-24 00:00:00-08	DNA	0.6	48	48	\N	5
31281	NM D-053	2018-11-24 00:00:00-08	DNA	2.67	48	48	\N	5
31282	NM D-054	2018-11-24 00:00:00-08	DNA	7.1	48	48	\N	5
31283	NM D-055	2018-11-24 00:00:00-08	DNA	27.8	48	48	\N	5
31284	NM D-058	2018-11-24 00:00:00-08	DNA	1.96	48	48	\N	5
31285	NM D-059	2018-11-24 00:00:00-08	DNA	16.1	48	48	\N	5
31286	NM D-060	2018-11-24 00:00:00-08	DNA	40.3	48	48	\N	5
31287	NM D-061	2018-11-24 00:00:00-08	DNA	0.55	48	48	\N	5
31288	NM D-063	2018-11-24 00:00:00-08	DNA	40	48	48	\N	5
31289	NM D-064	2018-11-24 00:00:00-08	DNA	43.4	48	48	\N	5
31290	NM D-065	2018-11-24 00:00:00-08	DNA	48.4	48	48	\N	5
31291	NM D-066	2019-09-23 00:00:00-07	DNA	52	96	96	\N	5
31292	NM D-067	2019-09-23 00:00:00-07	DNA	49.1	96	96	\N	5
31293	NM D-068	2019-09-23 00:00:00-07	DNA	21.2	96	96	250 ng of DNA per library prep.	5
31294	NM D-069	2019-09-23 00:00:00-07	DNA	4.77	96	96	\N	5
31295	NM D-070	2019-09-23 00:00:00-07	DNA	15.2	96	96	\N	5
31296	NM D-071	2019-09-23 00:00:00-07	DNA	29.9	96	96	\N	5
31297	NM D-072	2019-09-23 00:00:00-07	DNA	13.5	96	96	\N	5
31298	NM D-073	2019-09-23 00:00:00-07	DNA	3.92	96	96	\N	5
31299	NM D-074	2019-09-23 00:00:00-07	DNA	42.3	96	96	\N	5
31300	NM D-075	2019-09-23 00:00:00-07	DNA	33.3	96	96	\N	5
31301	NM D-076	2019-09-23 00:00:00-07	DNA	35.9	96	96	\N	5
31302	NM D-077	2019-09-23 00:00:00-07	DNA	14.3	96	96	\N	5
31303	NM D-078	2019-09-23 00:00:00-07	DNA	4.88	96	96	\N	5
31304	NM D-079	2019-09-23 00:00:00-07	DNA	2.78	96	96	\N	5
31305	NM D-080	2019-09-23 00:00:00-07	DNA	3.69	96	96	\N	5
31306	NM D-081	2019-09-23 00:00:00-07	DNA	8.23	96	96	\N	5
31307	NM D-082	2019-09-23 00:00:00-07	DNA	17.1	96	96	\N	5
31308	NM D-083	2019-09-23 00:00:00-07	DNA	6.51	96	96	\N	5
31309	NM D-084	2022-06-15 00:00:00-07	DNA	15.4	90	90	(NM_01-A), Region A below C.  GREEN = Normal, BLUE = Melanoma. Image in Nod Mel	2
31310	NM D-085	2022-06-15 00:00:00-07	DNA	14.5	90	90	(NM_01-B), Region B upper side of C. GREEN = Normal, BLUE = Melanoma	2
31311	NM D-086	2022-06-15 00:00:00-07	DNA	17.9	90	90	(NM_01-C), Center Region. GREEN = Normal, BLUE = Melanoma	2
31312	NM D-087	2022-06-15 00:00:00-07	DNA	1.37	90	90	(NM_01-N), Normal Region. GREEN = Normal, BLUE = Melanoma	2
31895	RPA_09_0209_NA	\N	DNA	\N	\N	\N	\N	\N
31313	NM D-088	2022-06-15 00:00:00-07	DNA	2.39	90	90	(NM_02-A), Region A below C.  GREEN = Normal, BLUE = Melanoma. Image in Nod Mel	2
31314	NM D-089	2022-06-15 00:00:00-07	DNA	1.65	90	90	(NM_02-B), Region B upper side of C. GREEN = Normal, BLUE = Melanoma	2
31315	NM D-090	2022-06-15 00:00:00-07	DNA	2.62	90	90	(NM_02-C), Center Region. GREEN = Normal, BLUE = Melanoma	2
31316	NM D-091	2022-06-15 00:00:00-07	DNA	1.13	90	90	(NM_02-N), Normal Region. GREEN = Normal, BLUE = Melanoma	2
31317	NM D-092	2022-06-15 00:00:00-07	DNA	4.4	90	90	(NM_03-A), Region A below C.  GREEN = Normal, BLUE = Melanoma. Image in Nod Mel	2
31318	NM D-093	2022-06-15 00:00:00-07	DNA	4.6	90	90	(NM_03-B), Region B upper side of C. GREEN = Normal, BLUE = Melanoma	2
31319	NM D-094	2022-06-15 00:00:00-07	DNA	6.6	90	90	(NM_03-C), Center Region. GREEN = Normal, BLUE = Melanoma	2
31320	NM D-095	2022-06-15 00:00:00-07	DNA	11.2	90	90	(NM_03-N), Normal Region. GREEN = Normal, BLUE = Melanoma	2
31321	NM D-096	2022-06-15 00:00:00-07	DNA	2.16	90	90	(NM_04-A), Region A below C.  GREEN = Normal, BLUE = Melanoma. Image in Nod Mel	2
31322	NM D-097	2022-06-15 00:00:00-07	DNA	1.53	90	90	(NM_04-B), Region B upper side of C. GREEN = Normal, BLUE = Melanoma	2
31323	NM D-098	2022-06-15 00:00:00-07	DNA	2.68	90	90	(NM_04-C), Center Region. GREEN = Normal, BLUE = Melanoma	2
31324	NM D-099	2022-06-15 00:00:00-07	DNA	0.82	90	90	(NM_04-N), Normal Region. GREEN = Normal, BLUE = Melanoma	2
31325	NM D-100	2023-03-29 00:00:00-07	DNA	11	180	180	\N	2
31326	NM D-101	2023-03-29 00:00:00-07	DNA	11.7	180	180	\N	2
31327	NM R-100	2023-03-29 00:00:00-07	RNA	11	90	90	\N	1
31328	NM R-101	2023-03-29 00:00:00-07	RNA	11.8	90	90	\N	1
31329	OM D-30	2022-02-22 00:00:00-08	DNA	0.25	88	88	\N	2
31330	OM D-31	2022-02-04 00:00:00-08	DNA	2.52	88	88	\N	2
31331	OM D-32	2022-02-04 00:00:00-08	DNA	4.55	88	88	\N	2
31332	OM D-33	2022-02-04 00:00:00-08	DNA	1.6	88	88	\N	2
31333	OM D-33A	2022-03-16 00:00:00-07	DNA	0.99	88	88	\N	2
31334	OM D-34	2022-02-04 00:00:00-08	DNA	5.17	88	88	\N	2
31335	OM D-35	2022-02-04 00:00:00-08	DNA	0.12	88	88	\N	2
31336	OM D-36	2022-02-04 00:00:00-08	DNA	10.2	88	88	\N	2
31337	OM D-37	2022-02-04 00:00:00-08	DNA	1.78	88	88	\N	2
31338	OM D-38	2022-02-04 00:00:00-08	DNA	0.89	88	88	\N	2
31339	OM D-39	2022-02-04 00:00:00-08	DNA	0.5	88	88	\N	2
31340	OM D-40.1	2022-02-22 00:00:00-08	DNA	1.69	88	88	\N	2
31341	OM D-40.2	2022-02-22 00:00:00-08	DNA	0.47	88	88	\N	2
31342	OM D-41	2022-02-04 00:00:00-08	DNA	8	88	88	\N	2
31343	OM D-42	2022-02-04 00:00:00-08	DNA	1.54	88	88	\N	2
31344	OM D-43	2022-02-04 00:00:00-08	DNA	1.14	88	88	\N	2
31345	OM D-44.1	2022-02-22 00:00:00-08	DNA	1.49	88	88	\N	2
31346	OM D-44.2	2022-02-22 00:00:00-08	DNA	1.44	88	88	\N	2
31347	OM D-44.3	2022-02-22 00:00:00-08	DNA	0.81	88	88	\N	2
31348	OM D-45	2022-02-04 00:00:00-08	DNA	46	88	88	\N	2
31349	OM D-46	2022-02-04 00:00:00-08	DNA	5.71	88	88	\N	2
31350	OM D-47	2022-02-04 00:00:00-08	DNA	7.1	88	88	\N	2
31351	OM D-48	2022-03-16 00:00:00-07	DNA	0.15	88	88	\N	2
31352	OM D-49	2022-03-16 00:00:00-07	DNA	0.1	88	88	\N	2
31353	OM D-50	2022-03-16 00:00:00-07	DNA	0.22	88	88	\N	2
31354	OM D-51	2022-03-16 00:00:00-07	DNA	1	88	88	\N	2
31355	OM D-52	2022-03-16 00:00:00-07	DNA	0.21	88	88	\N	2
31356	OM D-53	2022-03-16 00:00:00-07	DNA	1.77	88	88	\N	2
31357	OM D-54	2022-03-16 00:00:00-07	DNA	1.04	88	88	\N	2
31358	OM D-55	2022-03-16 00:00:00-07	DNA	0.84	88	88	\N	2
31359	OM D-56	2022-03-16 00:00:00-07	DNA	0.41	88	88	\N	2
31360	OM D-57	2022-03-16 00:00:00-07	DNA	2.4	88	88	\N	2
31361	OM D-58.1	2022-03-16 00:00:00-07	DNA	1.03	88	88	\N	2
31362	OM D-58.2	2022-03-16 00:00:00-07	DNA	0.66	88	88	\N	2
31363	OM D-58.3	2022-03-16 00:00:00-07	DNA	0.25	88	88	\N	2
31364	OM D-59	2022-03-16 00:00:00-07	DNA	2.11	88	88	\N	2
31365	OM D-60	2022-03-16 00:00:00-07	DNA	1.5	88	88	\N	2
31366	OM D-61	2022-03-17 00:00:00-07	DNA	0.81	88	88	\N	2
31367	OM D-62A	2022-03-17 00:00:00-07	DNA	1.23	88	88	\N	2
31368	OM D-62B	2022-03-17 00:00:00-07	DNA	3.1	88	88	\N	2
31369	OM D-63	2022-03-17 00:00:00-07	DNA	1.04	88	88	\N	2
31370	OM D-64	2022-03-17 00:00:00-07	DNA	0.5	88	88	\N	2
31371	OM D-65	2022-03-17 00:00:00-07	DNA	0.13	88	88	\N	2
31372	OM D-66.1	2022-03-17 00:00:00-07	DNA	4.08	88	88	\N	2
31373	OM D-66.2	2022-03-17 00:00:00-07	DNA	1.64	88	88	\N	2
31374	OM D-66.3	2022-03-17 00:00:00-07	DNA	3.71	88	88	\N	2
31375	OM D-67	2022-03-17 00:00:00-07	DNA	0.2	88	88	\N	2
31376	OM D-68.1	2022-03-17 00:00:00-07	DNA	0.48	88	88	\N	2
31377	OM D-68.2	2022-03-17 00:00:00-07	DNA	0.28	88	88	\N	2
31378	OM D-68.3	2022-03-17 00:00:00-07	DNA	0.31	88	88	\N	2
31379	OM D-69	2022-03-17 00:00:00-07	DNA	0.74	88	88	\N	2
31380	OM D-70	2022-03-17 00:00:00-07	DNA	1.12	88	88	\N	2
31381	OM D-71	2022-03-17 00:00:00-07	DNA	0.49	88	88	\N	2
31382	OM R-31	2022-02-04 00:00:00-08	RNA	14.3	46	46	\N	1
31383	OM R-32	2022-02-04 00:00:00-08	RNA	27.7	46	46	\N	1
31384	OM R-33	2022-02-04 00:00:00-08	RNA	22	46	46	\N	1
31385	OM R-34	2022-02-04 00:00:00-08	RNA	20.3	46	46	\N	1
31386	OM R-35	2022-02-04 00:00:00-08	RNA	3.77	46	46	\N	1
31387	OM R-36	2022-02-04 00:00:00-08	RNA	50	46	46	\N	1
31388	OM R-37	2022-02-04 00:00:00-08	RNA	17.6	46	46	\N	1
31389	OM R-38	2022-02-04 00:00:00-08	RNA	10.4	46	46	\N	1
31390	OM R-39	2022-02-04 00:00:00-08	RNA	14.7	46	46	\N	1
31391	OM R-41	2022-02-04 00:00:00-08	RNA	44.8	46	46	\N	1
31392	OM R-42	2022-02-04 00:00:00-08	RNA	33.11	46	46	\N	1
31393	OM R-43	2022-02-04 00:00:00-08	RNA	11.2	46	46	\N	1
31394	OM R-45	2022-02-04 00:00:00-08	RNA	62	46	46	\N	1
31395	OM R-46	2022-02-04 00:00:00-08	RNA	67	46	46	\N	1
31396	OM R-47	2022-02-04 00:00:00-08	RNA	0	46	46	\N	1
31397	OM-1D (P040_09A)	2021-06-07 00:00:00-07	DNA	1.8	52	52	DIN 4.1	7
31398	OM-1D-2	2022-01-05 00:00:00-08	DNA	1.49	88	88	\N	2
31399	OM-1D-3	2022-01-20 00:00:00-08	DNA	1.03	88	88	\N	2
31400	OM-1R (P040_05A)	2021-06-07 00:00:00-07	RNA	7.6	50	50	DV200 17%	7
31401	OM-3D (P040_09B)	2021-06-07 00:00:00-07	DNA	1.9	53	53	DIN 3.9	7
31402	OM-3R (P040_05B)	2021-06-07 00:00:00-07	RNA	8.4	50	50	DV200 14%	7
31403	OM-4D (P040_09C)	2021-06-07 00:00:00-07	DNA	0.4	51	51	DIN UND	7
31404	OM-4D-2	2022-01-05 00:00:00-08	DNA	0.43	88	88	\N	2
31405	OM-4D-3	2022-01-20 00:00:00-08	DNA	1.08	88	88	\N	2
31406	OM-4R (P040_05C)	2021-06-07 00:00:00-07	RNA	3	50	50	DV200 38%	7
31407	OM-5D (P040_09D)	2021-06-07 00:00:00-07	DNA	0.4	52	52	DIN 3.6	7
31408	OM-5D-2	2022-01-05 00:00:00-08	DNA	0.15	88	88	\N	2
31409	OM-5D-3	2022-01-20 00:00:00-08	DNA	0.36	88	88	\N	2
31410	OM-5R (P040_05D)	2021-06-07 00:00:00-07	RNA	1.7	50	50	DV200 26%	7
31411	OM-6D	2021-08-30 00:00:00-07	DNA	0.83	48	48	\N	7
31412	OM-6D-2	2022-01-05 00:00:00-08	DNA	0.64	88	88	\N	2
31413	OM-6D-3	2022-01-20 00:00:00-08	DNA	1.16	88	88	\N	2
31414	OM-8D (P040_11A)	2021-06-07 00:00:00-07	DNA	0.1	52	52	DIN 5.9	7
31415	OM-8R (P040_07A)	2021-06-07 00:00:00-07	RNA	0.7	51	51	DV200 46%	7
31416	OM-9D	2021-08-30 00:00:00-07	DNA	0.85	48	48	DO NOT use sequencing data.	7
31417	OM-10D (P040_11B)	2021-06-07 00:00:00-07	DNA	2	51	51	DIN 3.3	7
31418	OM-10D-2	2022-01-05 00:00:00-08	DNA	2.21	88	88	\N	2
31419	OM-10D-3	2022-01-20 00:00:00-08	DNA	1.65	88	88	\N	2
31420	OM-10R (P040_07B)	2021-06-07 00:00:00-07	RNA	11.6	50	50	DV200 22%	7
31421	OM-11D (P040_11C)	2021-06-07 00:00:00-07	DNA	0.1	51	51	DIN 3.6	7
31422	OM-11R (P040_07C)	2021-06-07 00:00:00-07	RNA	1.2	49	49	DV200 13%	7
31423	OM-12D	2021-08-30 00:00:00-07	DNA	0.56	48	48	\N	7
31424	OM-13D	2021-08-30 00:00:00-07	DNA	0.32	48	48	\N	7
31425	OM-14D	2021-08-30 00:00:00-07	DNA	0.07	48	48	\N	7
31426	OM-15D (P040_11D)	2021-06-07 00:00:00-07	DNA	10.9	51	51	DIN 2.4	7
31427	OM-15D-2	2022-01-05 00:00:00-08	DNA	27.2	88	88	\N	2
31428	OM-15R (P040_07D)	2021-06-07 00:00:00-07	RNA	21.7	50	50	DV200 58%	7
31429	OM-16D	2021-08-30 00:00:00-07	DNA	0.73	48	48	\N	7
31430	OM-17D	2021-08-30 00:00:00-07	DNA	2.53	48	48	\N	7
31431	OM-18D	2021-08-30 00:00:00-07	DNA	0.39	48	48	\N	7
31432	OM-18D2	2021-08-30 00:00:00-07	DNA	1.39	48	48	\N	7
31433	OM-18D3	2021-08-30 00:00:00-07	DNA	1.29	48	48	\N	7
31434	OM-18D4	2021-08-30 00:00:00-07	DNA	0.56	48	48	\N	7
31435	OM-22D	2022-01-05 00:00:00-08	DNA	1.04	88	88	\N	2
31436	OM-22D-2	2022-01-20 00:00:00-08	DNA	1.64	88	88	\N	2
31437	OM-23D	2022-01-05 00:00:00-08	DNA	0.74	88	88	\N	2
31438	OM-23D-2	2022-01-20 00:00:00-08	DNA	4.3	88	88	\N	2
31439	OM-24D	2022-01-05 00:00:00-08	DNA	0.61	88	88	\N	2
31440	OM-24D-2	2022-01-20 00:00:00-08	DNA	2.49	88	88	\N	2
31441	OM-25D	2022-01-05 00:00:00-08	DNA	1.12	88	88	\N	2
31442	OM-25D-2	2022-01-20 00:00:00-08	DNA	3.59	88	88	\N	2
31443	OM-26D	2022-01-05 00:00:00-08	DNA	0.34	88	88	\N	2
31444	OM-26D-2	2022-01-20 00:00:00-08	DNA	2.13	88	88	\N	2
31445	OM-27D	2022-01-05 00:00:00-08	DNA	1.17	88	88	\N	2
31446	OM-27D-2	2022-01-20 00:00:00-08	DNA	2.35	88	88	\N	2
31447	OM-28D	2022-01-05 00:00:00-08	DNA	1.76	88	88	\N	2
31448	OM-28D-2	2022-01-20 00:00:00-08	DNA	0.91	88	88	\N	2
31449	OM-29D	2022-01-05 00:00:00-08	DNA	1.03	88	88	\N	2
31450	OM-29D-2	2022-01-20 00:00:00-08	DNA	2.91	88	88	\N	2
31451	P57-A-1.0mm_NA	2023-06-07 00:00:00-07	DNA	0.78	48	48	1mm punch biopsy, Epidermis Only	3
31452	P57-A-2.0mm_NA	2023-06-07 00:00:00-07	DNA	23.7	48	48	1mm punch biopsy, possible dermis contamination	3
31453	P57-B-1.0mm_NA	2023-06-07 00:00:00-07	DNA	3.01	48	48	1mm punch biopsy, possible dermis contamination	3
31454	P57-B-2.0mm_NA	2023-06-07 00:00:00-07	DNA	2.93	48	48	2mm punch biopsy, Epidermis Only	3
31455	P57-Normal_NA_3423-Normal	2023-06-07 00:00:00-07	DNA	57	138	138	~20 ug tissue for Bulk LP	3
31456	P57-Normal_NA_3424-Normal	2023-06-07 00:00:00-07	DNA	34.1	138	138	~20 ug tissue for Bulk LP	3
31457	PG_8_NA	\N	DNA	\N	\N	\N	\N	\N
31458	PG8_NA	\N	DNA	\N	\N	\N	\N	\N
31459	PM-1	2019-04-01 00:00:00-07	DNA	19	35	35	\N	5
31460	PM-2	2019-04-01 00:00:00-07	DNA	18.8	35	35	\N	5
31461	PM-3	2019-04-01 00:00:00-07	DNA	20.4	36	36	\N	5
31462	PM-4	2019-04-01 00:00:00-07	DNA	38	41	41	\N	5
31463	PROG D-01	2020-07-28 00:00:00-07	DNA	0.83	100	100	\N	6
32553	NA_12-54992_Normal	\N	DNA	\N	\N	\N	\N	\N
31464	PROG D-02	2020-07-28 00:00:00-07	DNA	0.32	100	100	\N	6
31465	PROG D-03	2020-07-28 00:00:00-07	DNA	0.16	100	100	\N	6
31466	PROG D-04	2020-07-28 00:00:00-07	DNA	8.55	100	100	\N	6
31467	PROG D-05	2020-07-28 00:00:00-07	DNA	5.84	100	100	\N	6
31468	PROG D-06	2020-07-28 00:00:00-07	DNA	0.07	100	100	\N	6
31469	PROG D-07	2020-07-28 00:00:00-07	DNA	0	100	100	\N	6
31470	PROG D-08	2020-07-28 00:00:00-07	DNA	0.09	100	100	\N	6
31471	PROG D-09	2020-07-28 00:00:00-07	DNA	0	100	100	\N	6
31472	PROG D-10	2020-07-28 00:00:00-07	DNA	0	100	100	\N	6
31473	PROG D-11	2020-07-28 00:00:00-07	DNA	0.1	100	100	\N	6
31474	PROG D-12	2020-07-28 00:00:00-07	DNA	2.02	100	100	\N	6
31475	PROG D-13	2020-07-28 00:00:00-07	DNA	0.94	100	100	\N	6
31476	PROG D-14	2020-08-23 00:00:00-07	DNA	0.71	100	100	\N	6
31477	PROG D-15	2023-05-19 00:00:00-07	DNA	1.78	308	308	\N	6
31478	PROG D-16	2023-05-19 00:00:00-07	DNA	0.72	198	198	\N	6
31479	PROG D-17	2023-05-12 00:00:00-07	DNA	16.6	200	200	\N	6
31480	PROG D-18	2023-05-19 00:00:00-07	DNA	15.2	88	88	\N	6
31481	PROG D-19	2023-05-18 00:00:00-07	DNA	1.05	184	184	\N	6
31482	PROG D-20	2023-05-18 00:00:00-07	DNA	10.7	308	308	\N	6
31483	PROG D-21	2023-05-12 00:00:00-07	DNA	0.36	200	200	\N	6
31484	PROG D-22	2023-05-12 00:00:00-07	DNA	3.43	400	400	\N	6
31485	PROG D-23	2023-05-12 00:00:00-07	DNA	7.02	400	400	\N	6
31486	PROG D-24	2023-05-18 00:00:00-07	DNA	5.78	408	408	\N	6
31487	PROG D-25	2023-05-18 00:00:00-07	DNA	3.3	438	438	\N	6
31488	PROG D-26	2023-05-18 00:00:00-07	DNA	3.28	428	428	\N	6
31489	PROG R-01	2020-08-03 00:00:00-07	RNA	12.5	20	20	\N	6
31490	PROG R-02	2020-08-03 00:00:00-07	RNA	9.48	20	20	\N	6
31491	PROG R-03	2020-08-03 00:00:00-07	RNA	5.78	20	20	\N	6
31492	PROG R-04	2020-08-03 00:00:00-07	RNA	321	20	20	\N	6
31493	PROG R-05	2020-08-03 00:00:00-07	RNA	309	20	20	\N	6
31494	PROG R-06	2020-08-03 00:00:00-07	RNA	5.32	20	20	\N	6
31495	PROG R-07	2020-08-03 00:00:00-07	RNA	7.92	20	20	\N	6
31496	PROG R-08	2020-08-03 00:00:00-07	RNA	23.7	20	20	\N	6
31497	PROG R-09	2020-08-03 00:00:00-07	RNA	13.5	20	20	\N	6
31498	PROG R-10	2020-08-03 00:00:00-07	RNA	15.2	20	20	\N	6
31499	PROG R-11	2020-08-03 00:00:00-07	RNA	3.17	20	20	\N	6
31500	PROG R-12	2020-08-03 00:00:00-07	RNA	40.8	20	20	\N	6
31501	PROG R-13	2020-08-03 00:00:00-07	RNA	11.5	20	20	\N	6
31502	PROG R-14	2020-08-18 00:00:00-07	RNA	5.49	20	20	\N	6
31503	PROG R-15	2023-05-19 00:00:00-07	RNA	7.92	55	55	\N	6
31504	PROG R-16	2023-05-19 00:00:00-07	RNA	7.64	40	40	\N	6
31505	PROG R-17	2023-05-12 00:00:00-07	RNA	172.8	40	40	\N	6
31506	PROG R-18	2023-05-19 00:00:00-07	RNA	30.8	18	18	\N	6
31507	PROG R-19	2023-05-18 00:00:00-07	RNA	3.27	16	16	\N	6
31508	PROG R-20	2023-05-18 00:00:00-07	RNA	45.5	53	53	\N	6
31509	PROG R-21	2023-05-12 00:00:00-07	RNA	3.78	41	41	\N	6
31510	PROG R-22	2023-05-12 00:00:00-07	RNA	41.1	81	81	\N	6
31511	PROG R-23	2023-05-12 00:00:00-07	RNA	54	81	81	\N	6
31512	PROG R-24	2023-05-18 00:00:00-07	RNA	39.7	77	77	\N	6
31513	PROG R-25	2023-05-18 00:00:00-07	RNA	39.8	77	77	\N	6
31514	PROG R-26	2023-05-18 00:00:00-07	RNA	22.1	78	78	\N	6
31515	RMS-001A	\N	RNA	8.92	48	48	\N	1
31516	RMS-001B	\N	RNA	12.8	48	48	\N	1
31517	RMS-001C	\N	RNA	16	48	48	\N	1
31518	RMS-018	\N	RNA	5.12	48	48	\N	1
31519	RMS-019	\N	RNA	16	48	48	\N	1
31520	RMS-020	\N	RNA	2.82	48	48	\N	1
31521	RMS-021	\N	RNA	7.67	48	48	\N	1
31522	RMS-032	\N	RNA	4.82	48	48	\N	1
31523	RMS-033	\N	RNA	21.7	48	48	\N	1
31524	RMS-034	\N	RNA	12	48	48	\N	1
31525	RMS-035	\N	RNA	31.6	48	48	\N	1
31526	RMS-036	\N	RNA	29.4	48	48	\N	1
31527	RMS-037	\N	RNA	40	48	48	\N	1
31528	RMS-038	\N	RNA	8.59	48	48	\N	1
31529	RMS-038N	\N	RNA	20.9	48	48	\N	1
31530	RMS-039	\N	RNA	9.55	48	48	\N	1
31531	RMS-039N	\N	RNA	8.2	48	48	\N	1
31532	RMS-040	\N	RNA	32	48	48	\N	1
31533	RMS-040N	\N	RNA	5.35	48	48	\N	1
31534	RMS-041	\N	RNA	4.53	48	48	\N	1
31535	RMS-043	\N	RNA	4.48	48	48	\N	1
31536	RMS-044	\N	RNA	7.96	48	48	\N	1
31537	RMS-045	\N	RNA	15.8	48	48	\N	1
31538	RMS-046	\N	RNA	10	48	48	\N	1
31539	RMS-047	\N	RNA	6.03	48	48	\N	1
31540	RMS-048	\N	RNA	6.06	48	48	\N	1
31541	RMS-049	\N	RNA	12.8	48	48	\N	1
31542	RMS-050	\N	RNA	9.98	48	48	\N	1
31543	RMS-051	\N	RNA	23.2	48	48	\N	1
31544	RMS-052A	\N	RNA	8.1	48	48	\N	1
31545	RMS-052B	\N	RNA	10.3	48	48	\N	1
31546	RMS-053	\N	RNA	9.75	48	48	\N	1
31547	RMS-054	\N	RNA	24.9	48	48	\N	1
31548	RMS-055	\N	RNA	11.4	48	48	\N	1
31549	RMS-056	\N	RNA	6.1	48	48	\N	1
31550	RMS-057	\N	RNA	22.5	48	48	\N	1
31551	RMS-058	\N	RNA	8.67	48	48	\N	1
31552	RMS-059A	\N	RNA	7.94	48	48	\N	1
31553	RMS-059B	\N	RNA	12.9	48	48	\N	1
31554	RMS-060	\N	RNA	58	48	48	\N	1
31555	RMS-061	\N	RNA	16.9	48	48	\N	1
31556	RMS-062	\N	RNA	26.7	48	48	\N	1
31557	RMS-062N	\N	RNA	9.95	48	48	\N	1
31558	RMS-063	\N	RNA	8.38	48	48	\N	1
31559	RNA-01	\N	RNA	208	20	20	\N	6
31560	RNA-02	\N	RNA	86.4	20	20	\N	6
31561	RNA-03	\N	RNA	299	20	20	\N	6
31562	RNA-04	\N	RNA	9.6	20	20	\N	6
31563	RNA-05	\N	RNA	10.7	20	20	\N	6
31564	RNA-06	\N	RNA	64.4	20	20	\N	6
31565	RNA-07	\N	RNA	33.5	20	20	\N	6
31566	RNA-08	\N	RNA	15.6	20	20	\N	6
31567	RNA-09	\N	RNA	47	20	20	\N	6
31568	RNA-10	\N	RNA	38	20	20	\N	6
31569	RNA-11	\N	RNA	10	20	20	\N	6
31570	RNA-12	\N	RNA	33	20	20	\N	6
31571	RNA-13	\N	RNA	73.2	20	20	\N	6
31572	RNA-14	\N	RNA	834	20	20	\N	6
31573	RNA-15	\N	RNA	24.2	20	20	\N	6
31574	RNA-16	\N	RNA	54	20	20	\N	6
31575	RNA-17	\N	RNA	27	20	20	\N	6
31576	RNA-18	\N	RNA	61	20	20	\N	6
31577	RNA-19	\N	RNA	23	20	20	\N	6
31578	RNA-20	\N	RNA	14	20	20	\N	6
31579	RNA-21	\N	RNA	83	20	20	\N	6
31580	RNA-22	\N	RNA	135	20	20	\N	6
31581	RNA-23	\N	RNA	100	20	20	\N	6
31582	RNA-24	\N	RNA	63.5	20	20	\N	6
31583	RNA-25	\N	RNA	4.3	20	20	\N	6
31584	RNA-26	\N	RNA	81	20	20	\N	6
31585	RNA-27	\N	RNA	52	20	20	\N	6
31586	RNA-28	\N	RNA	223	20	20	\N	6
31587	RNA-29	\N	RNA	36	20	20	\N	6
31588	RNA-30	\N	RNA	163	20	20	\N	6
31589	RNA-31	\N	RNA	206	20	20	\N	6
31590	RNA-32	\N	RNA	15.5	20	20	\N	6
31591	RNA-33	\N	RNA	26	20	20	\N	6
31592	RNA-34	\N	RNA	22.4	20	20	\N	6
31593	RNA-35	\N	RNA	209	20	20	\N	6
31594	RNA-36	\N	RNA	50	20	20	\N	6
31595	RNA-37	\N	RNA	33.7	20	20	\N	6
31596	RNA-38	\N	RNA	48	20	20	\N	6
31597	RNA-39	\N	RNA	150	20	20	\N	6
31598	RNA-40	\N	RNA	228	20	20	\N	6
31599	RNA-41	\N	RNA	23.7	20	20	\N	6
31600	RNA-42	\N	RNA	5.3	20	20	\N	6
31601	RNA-43	\N	RNA	11.6	20	20	\N	6
31602	RNA-44	\N	RNA	57.3	20	20	\N	6
31603	RNA-45	\N	RNA	9.6	20	20	\N	6
31604	RNA-46	\N	RNA	3.5	20	20	\N	6
31605	RNA-47	\N	RNA	4.3	20	20	\N	6
31606	RNA-48	\N	RNA	23.5	20	20	\N	6
31607	RNA-49	\N	RNA	140	20	20	\N	6
31608	RNA-50	\N	RNA	61	20	20	\N	6
31609	RNA-51	\N	RNA	14	20	20	\N	6
31610	RNA-52	\N	RNA	15	20	20	\N	6
31611	RNA-53	\N	RNA	112	20	20	\N	6
31612	RNA-54	\N	RNA	10	20	20	\N	6
31613	RNA-55	\N	RNA	91	20	20	\N	6
31614	RNA-56	\N	RNA	167	20	20	\N	6
31615	RNA-57	\N	RNA	23.4	20	20	\N	6
31616	RNA-58	\N	RNA	1.5	20	20	\N	6
31617	RNA-59	\N	RNA	4.7	20	20	\N	6
31618	RNA-60	\N	RNA	1.6	20	20	\N	6
31619	RNA-61	\N	RNA	59	20	20	\N	6
31620	RNA-62	\N	RNA	52	20	20	\N	6
31621	RNA-63	\N	RNA	39	20	20	\N	6
31622	RNA-64	\N	RNA	10	20	20	\N	6
31623	RNA-65	\N	RNA	170	20	20	\N	6
31624	RNA-66	\N	RNA	171	20	20	\N	6
31625	RNA-72	\N	RNA	20.6	30	30	\N	6
31626	RNA-73	\N	RNA	4.2	30	30	\N	6
31627	RNA-74	\N	RNA	7.4	30	30	\N	6
31628	RNA-75	\N	RNA	6.6	30	30	\N	6
31629	RNA-76	\N	RNA	4	30	30	\N	6
31630	RNA-97	2020-08-03 00:00:00-07	RNA	2.3	20	20	\N	6
31631	RNA-98	2020-08-03 00:00:00-07	RNA	38.1	20	20	\N	6
31632	RNA-99	2020-08-03 00:00:00-07	RNA	5.27	20	20	\N	6
31633	RNA-100	2020-08-03 00:00:00-07	RNA	2.51	20	20	\N	6
31634	RNA-101	2020-08-03 00:00:00-07	RNA	37.8	20	20	\N	6
31635	RNA-101 (Mel_1)	\N	RNA	405	47	47	\N	6
31636	RNA-102 (Mel_2)	\N	RNA	485	47	47	\N	6
31637	RNA-103 (Mel_3)	\N	RNA	365	47	47	\N	6
31638	RNA-104 (Mel_4)	\N	RNA	380	47	47	\N	6
31639	RNA-105 (Mel_5)	\N	RNA	450	47	47	\N	6
31640	RNA-106 (Mel_6)	\N	RNA	410	47	47	\N	6
31641	RNA-107	2020-08-28 00:00:00-07	RNA	18.9	20	20	\N	6
31642	RNA-108	2020-08-28 00:00:00-07	RNA	124	20	20	\N	6
31643	RNA-109	2020-08-28 00:00:00-07	RNA	18.1	20	20	\N	6
32554	NA_12-54992_Tumor	\N	DNA	\N	\N	\N	\N	\N
31644	RNA-110	2020-08-28 00:00:00-07	RNA	0	20	20	\N	6
31645	RNA-111	2020-08-28 00:00:00-07	RNA	5.06	20	20	\N	6
31646	RNA-112	2020-08-28 00:00:00-07	RNA	10.3	20	20	\N	6
31647	RNA-113	2020-08-28 00:00:00-07	RNA	11	20	20	\N	6
31648	RNA-114	2020-08-28 00:00:00-07	RNA	8.83	20	20	\N	6
31649	RNA-115	2020-08-28 00:00:00-07	RNA	0	20	20	\N	6
31650	RNA-116	2020-08-28 00:00:00-07	RNA	8.39	20	20	\N	6
31651	RNA-117	2020-08-28 00:00:00-07	RNA	0	20	20	\N	6
31652	RNA-118	2020-08-28 00:00:00-07	RNA	8.74	20	20	\N	6
31653	RNA-119	2020-08-28 00:00:00-07	RNA	0	20	20	\N	6
31654	RNA-120	2020-08-28 00:00:00-07	RNA	25.1	20	20	\N	6
31655	RNA-121	2020-08-28 00:00:00-07	RNA	10.4	20	20	\N	6
31656	RNA-122	2020-08-28 00:00:00-07	RNA	32.4	20	20	\N	6
31657	RNA-123	2020-08-28 00:00:00-07	RNA	4.75	20	20	\N	6
31658	RNA-124	2020-08-28 00:00:00-07	RNA	5.62	20	20	\N	6
31659	RNA-125	2020-08-28 00:00:00-07	RNA	10.8	20	20	\N	6
31660	RNA-126	2020-08-28 00:00:00-07	RNA	3.26	20	20	\N	6
31661	RNA-127	2020-08-28 00:00:00-07	RNA	8.72	20	20	\N	6
31662	RNA-128	2020-08-28 00:00:00-07	RNA	2.2	20	20	DO NOT USE: DO NOT USE; WRONG TISSUE WAS MICRODISSECTED: 17-43707	6
31663	RNA-129	2020-08-28 00:00:00-07	RNA	11.5	20	20	\N	6
31664	RNA-130	2020-08-28 00:00:00-07	RNA	18.3	20	20	\N	6
31665	RNA-131	2020-08-28 00:00:00-07	RNA	2.1	20	20	\N	6
31666	RNA-132	2020-08-28 00:00:00-07	RNA	15.2	20	20	\N	6
31667	RNA-133	2020-08-28 00:00:00-07	RNA	57	20	20	\N	6
31668	RNA-134	2020-09-11 00:00:00-07	RNA	0	20	20	Third try, tissue failed to produce RNA	6
31669	RNA-135	2020-09-11 00:00:00-07	RNA	4.32	20	20	\N	6
31670	RNA-136	2020-09-11 00:00:00-07	RNA	4.19	20	20	\N	6
31671	RNA-137	2020-09-11 00:00:00-07	RNA	3.48	20	20	\N	6
31672	RNA-138	2020-09-11 00:00:00-07	RNA	0	20	20	\N	6
31673	RNA-139	2020-09-11 00:00:00-07	RNA	0	20	20	\N	6
31674	RNA-140	2020-09-11 00:00:00-07	RNA	0	20	20	\N	6
31675	RNA-141	2020-09-11 00:00:00-07	RNA	2.55	20	20	\N	6
31676	RNA-142	2020-09-22 00:00:00-07	RNA	0	20	20	\N	6
31677	RNA-143	2020-09-22 00:00:00-07	RNA	0	20	20	\N	6
31678	RNA-144	2020-09-22 00:00:00-07	RNA	4.18	20	20	\N	6
31679	RNA-145	2020-09-22 00:00:00-07	RNA	0	20	20	\N	6
31680	RNA-146	2020-10-03 00:00:00-07	RNA	17.4	20	20	\N	6
31681	RNA-147	2020-10-03 00:00:00-07	RNA	3.54	20	20	\N	6
31682	RNA-148	2020-10-03 00:00:00-07	RNA	6.11	20	20	\N	6
31683	RNA-149	2020-10-03 00:00:00-07	RNA	7.5	20	20	\N	6
31684	RNA-150	2020-10-03 00:00:00-07	RNA	8.6	20	20	\N	6
31685	RNA-151	2020-10-03 00:00:00-07	RNA	5.83	20	20	\N	6
31686	RNA-152	2020-10-05 00:00:00-07	RNA	3.44	20	20	\N	6
31687	RNA-153	2020-10-05 00:00:00-07	RNA	4.51	20	20	\N	6
31688	RNA-154	2020-10-05 00:00:00-07	RNA	2.57	20	20	\N	6
31689	RNA-155	2020-10-05 00:00:00-07	RNA	5.26	20	20	\N	6
31690	RNA-156	2020-10-05 00:00:00-07	RNA	0	20	20	\N	6
31691	RNA-157	2020-10-09 00:00:00-07	RNA	0	20	20	\N	6
31692	RNA-158	2020-10-09 00:00:00-07	RNA	0	20	20	\N	6
31693	RNA-159	2020-10-09 00:00:00-07	RNA	0	20	20	\N	6
31694	RNA-160	2022-03-14 00:00:00-07	RNA	16.1	48	48	\N	1
31695	RNA-161	2022-03-14 00:00:00-07	RNA	8.28	48	48	\N	1
31696	RNA-162	2022-03-14 00:00:00-07	RNA	5.33	48	48	\N	1
31697	RNA-163	2022-03-14 00:00:00-07	RNA	0	48	48	\N	1
31698	RNA-164	2022-03-14 00:00:00-07	RNA	35	48	48	\N	1
31699	RNA-165	2022-03-14 00:00:00-07	RNA	2.83	48	48	\N	1
31700	RNA-166	2022-03-14 00:00:00-07	RNA	23.6	48	48	\N	1
31701	RNA-167	2022-03-14 00:00:00-07	RNA	2.4	48	48	\N	1
31702	RNA-168	2022-03-14 00:00:00-07	RNA	0	48	48	\N	1
31703	RNA-169	2022-03-14 00:00:00-07	RNA	9.24	48	48	\N	1
31704	RNA-170	2022-03-14 00:00:00-07	RNA	7.32	48	48	\N	1
31705	RNA-171	2022-03-14 00:00:00-07	RNA	2	48	48	\N	1
31706	RNA-172	2022-03-14 00:00:00-07	RNA	0	48	48	\N	1
31707	RNA-173	2022-03-14 00:00:00-07	RNA	2.3	48	48	\N	1
31708	RNA-174	2022-03-14 00:00:00-07	RNA	10.3	48	48	\N	1
31709	RNA-175	2022-03-14 00:00:00-07	RNA	15.1	48	48	\N	1
31710	RNA-176	2022-03-14 00:00:00-07	RNA	2.93	48	48	\N	1
31711	RNA-177	2022-03-14 00:00:00-07	RNA	2	48	48	\N	1
31712	RNA-178	2022-03-14 00:00:00-07	RNA	10.3	48	48	\N	1
31713	RNA-179	2022-03-14 00:00:00-07	RNA	0	48	48	\N	1
31714	RNA-180	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31715	RNA-181	2022-03-15 00:00:00-07	RNA	5.22	48	48	\N	1
31716	RNA-182	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31717	RNA-183	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31718	RNA-184	2022-03-15 00:00:00-07	RNA	20.2	48	48	\N	1
31719	RNA-185	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31720	RNA-186	2022-03-15 00:00:00-07	RNA	2.2	48	48	\N	1
31721	RNA-187	2022-03-15 00:00:00-07	RNA	23	48	48	\N	1
31722	RNA-188	2022-03-15 00:00:00-07	RNA	7.06	48	48	\N	1
31723	RNA-189	2022-03-15 00:00:00-07	RNA	6.79	48	48	\N	1
32555	NA_WM3622_Tumor	\N	DNA	\N	\N	\N	\N	\N
31724	RNA-190	2022-03-15 00:00:00-07	RNA	5.22	48	48	\N	1
31725	RNA-191	2022-03-15 00:00:00-07	RNA	6.32	48	48	\N	1
31726	RNA-192	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31727	RNA-193	2022-03-15 00:00:00-07	RNA	3.85	48	48	\N	1
31728	RNA-194	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31729	RNA-195	2022-03-15 00:00:00-07	RNA	8.06	48	48	\N	1
31730	RNA-196	2022-03-15 00:00:00-07	RNA	6.99	48	48	\N	1
31731	RNA-197	2022-03-15 00:00:00-07	RNA	4.92	48	48	\N	1
31732	RNA-199	2022-04-21 00:00:00-07	RNA	12.4	48	48	\N	1
31733	RNA-200	2022-04-21 00:00:00-07	RNA	0	48	48	\N	1
31734	RNA-203	2022-04-18 00:00:00-07	RNA	32.7	48	48	\N	1
31735	RNA-204	2022-04-18 00:00:00-07	RNA	16	48	48	\N	1
31736	RNA-205	2022-04-18 00:00:00-07	RNA	16.6	48	48	\N	1
31737	RNA-207	2022-04-18 00:00:00-07	RNA	28.9	48	48	\N	1
31738	RNA-208	2022-04-18 00:00:00-07	RNA	8.15	48	48	\N	1
31739	RNA-209	2022-04-18 00:00:00-07	RNA	25.5	48	48	\N	1
31740	RNA-210	2022-04-18 00:00:00-07	RNA	4.44	48	48	\N	1
31741	RNA-212	2022-04-18 00:00:00-07	RNA	7.6	48	48	\N	1
31742	RNA-213	2022-04-18 00:00:00-07	RNA	12.4	48	48	\N	1
31743	RNA-214	2022-04-18 00:00:00-07	RNA	4.95	48	48	\N	1
31744	RNA-217	2022-04-18 00:00:00-07	RNA	9.21	48	48	\N	1
31745	RNA-218	2022-04-18 00:00:00-07	RNA	18.1	48	48	\N	1
31746	RNA-219	2022-04-18 00:00:00-07	RNA	3.35	48	48	\N	1
31747	RNA-221	2022-04-18 00:00:00-07	RNA	14.8	48	48	\N	1
31748	RNA-222	2022-04-18 00:00:00-07	RNA	2	48	48	\N	1
31749	RNA-224	2022-04-18 00:00:00-07	RNA	8.04	48	48	\N	1
31750	RNA-225	2022-04-18 00:00:00-07	RNA	0	48	48	\N	1
31751	RNA-227	\N	RNA	0	0	0	\N	\N
31752	RNA-228	\N	RNA	0	0	0	\N	\N
31753	RNA-230	2022-04-18 00:00:00-07	RNA	16.7	48	48	\N	1
31754	RNA-231	2022-04-18 00:00:00-07	RNA	4.25	48	48	\N	1
31755	RNA-233	2022-04-18 00:00:00-07	RNA	6.33	48	48	\N	1
31756	RNA-234	2022-04-18 00:00:00-07	RNA	7.7	48	48	5 sections/tube	1
31757	RNA-235	2022-04-21 00:00:00-07	RNA	6.27	48	48	\N	1
31758	RNA-238	2022-04-21 00:00:00-07	RNA	0	48	48	\N	1
31759	RNA-239	\N	RNA	0	0	0	\N	\N
31760	RNA-242	2022-04-21 00:00:00-07	RNA	8.98	48	48	\N	1
31761	RNA-243	2022-04-21 00:00:00-07	RNA	0	48	48	\N	1
31762	RNA-244	2022-04-21 00:00:00-07	RNA	0	48	48	\N	1
31763	RNA-245	2022-04-18 00:00:00-07	RNA	24.4	48	48	6 sections/tube	1
31764	RNA-246	2022-04-18 00:00:00-07	RNA	15.4	48	48	6 sections/tube	1
31765	RNA-247	2022-04-18 00:00:00-07	RNA	6.87	48	48	5 sections/tube	1
31766	RNA-251	2022-05-13 00:00:00-07	RNA	3.2	48	48	\N	1
31767	RNA-252	2022-05-13 00:00:00-07	RNA	2.61	48	48	\N	1
31768	RNA-253	2022-05-13 00:00:00-07	RNA	0	38	38	\N	1
31769	RNA-254	2022-05-13 00:00:00-07	RNA	1.14	38	38	\N	1
31770	RNA-266	2022-05-25 00:00:00-07	RNA	200	48	48	\N	1
31771	RNA-268	2022-05-25 00:00:00-07	RNA	268	36	36	\N	1
31772	RNA-269	2022-06-06 00:00:00-07	RNA	0	48	48	\N	1
31773	RNA-272	\N	RNA	0	0	0	\N	\N
31774	RNA-273	2022-08-25 00:00:00-07	RNA	7	45	45	\N	1
31775	RNA-275	2022-08-25 00:00:00-07	RNA	9.06	45	45	\N	1
31776	RNA-276	2022-08-25 00:00:00-07	RNA	1.02	38	38	\N	1
31777	RNA-278	2022-08-25 00:00:00-07	RNA	4.36	45	45	\N	1
31778	RNA-279	2022-08-25 00:00:00-07	RNA	6.77	45	45	\N	1
31779	RNA-281	\N	RNA	0	0	0	\N	\N
31780	RNA-282	\N	RNA	0	0	0	\N	\N
31781	RNA-283	\N	RNA	0	0	0	\N	\N
31782	RNA-284	\N	RNA	0	0	0	\N	\N
31783	RNA-285	2022-08-25 00:00:00-07	RNA	0	38	38	\N	1
31784	RNA-286	2022-08-25 00:00:00-07	RNA	25	45	45	\N	1
31785	RNA-288	2022-08-25 00:00:00-07	RNA	3.83	45	45	\N	1
31786	RNA-289	2022-08-25 00:00:00-07	RNA	0.52	38	38	\N	1
31787	RNA-294	2022-08-25 00:00:00-07	RNA	12.8	45	45	\N	1
31788	RNA-295	2022-08-25 00:00:00-07	RNA	2	45	45	\N	1
31789	RNA-298	2022-08-26 00:00:00-07	RNA	15.3	45	45	\N	1
31790	RNA-299	2022-08-26 00:00:00-07	RNA	30.5	45	45	\N	1
31791	RNA-300	2022-08-26 00:00:00-07	RNA	0	38	38	\N	1
31792	RNA-301	2022-08-26 00:00:00-07	RNA	0.55	38	38	\N	1
31793	RNA-303	2022-08-26 00:00:00-07	RNA	0.9	38	38	\N	1
31794	RNA-304	2022-08-26 00:00:00-07	RNA	0	38	38	\N	1
31795	RNA-305	2022-08-26 00:00:00-07	RNA	10.4	45	45	\N	1
31796	RNA-306	2022-08-26 00:00:00-07	RNA	5.7	45	45	\N	1
31797	RNA-307	2022-08-26 00:00:00-07	RNA	0.95	38	38	\N	1
31798	RNA-309	2022-08-26 00:00:00-07	RNA	12.9	45	45	\N	1
31799	RNA-310	2022-08-26 00:00:00-07	RNA	25	45	45	\N	1
31800	RNA-311	2022-08-25 00:00:00-07	RNA	1.22	38	38	\N	1
31801	RNA-312	\N	RNA	0	0	0	\N	\N
31802	RNA-313	2022-08-25 00:00:00-07	RNA	6.71	45	45	\N	1
31803	RNA-314	2022-08-26 00:00:00-07	RNA	4.73	45	45	\N	1
31804	RNA-315	2022-08-26 00:00:00-07	RNA	2.1	38	38	\N	1
31805	RNA-318	2022-11-22 00:00:00-08	RNA	0	0	0	\N	1
31806	RNA-320	2022-12-09 00:00:00-08	RNA	2.56	48	48	\N	1
31807	RNA-330	2022-10-28 00:00:00-07	RNA	46	80	80	\N	1
31808	RNA-331	2022-10-28 00:00:00-07	RNA	40.3	80	80	\N	1
31809	RNA-332	2022-10-28 00:00:00-07	RNA	25.4	45	45	\N	1
31810	RNA-334	2022-10-28 00:00:00-07	RNA	12.5	90	90	\N	1
31811	RNA-335	2022-10-28 00:00:00-07	RNA	20	45	45	\N	1
31812	RNA-337	2022-10-28 00:00:00-07	RNA	36.5	45	45	\N	1
31813	RNA-338	2022-10-28 00:00:00-07	RNA	8.11	45	45	\N	1
31814	RNA-339	2022-10-28 00:00:00-07	RNA	4.65	45	45	\N	1
31815	RNA-340	2022-10-28 00:00:00-07	RNA	22.3	45	45	\N	1
31816	RNA-341	2022-10-31 00:00:00-07	RNA	23.9	40	40	\N	1
31817	RNA-344	2022-12-09 00:00:00-08	RNA	5.92	96	96	\N	1
31818	RNA-346	2022-12-09 00:00:00-08	RNA	2.1	48	48	\N	1
31819	RNA-347	2022-12-09 00:00:00-08	RNA	4.91	48	48	\N	1
31820	RNA-348	2022-10-31 00:00:00-07	RNA	41.5	183	183	\N	1
31821	RNA-350	2022-10-31 00:00:00-07	RNA	16.7	95	95	\N	1
31822	RNA-351	2022-10-31 00:00:00-07	RNA	5.19	190	190	\N	1
31823	RNA-355	2022-10-31 00:00:00-07	RNA	12.4	52	52	\N	1
31824	RNA-356	2022-11-10 00:00:00-08	RNA	65	48	48	\N	1
31825	RNA-357	2022-11-10 00:00:00-08	RNA	5.12	48	48	\N	1
31826	RNA-359	2022-11-10 00:00:00-08	RNA	33.5	90	90	\N	1
31827	RNA-361	2022-11-10 00:00:00-08	RNA	9.09	90	90	\N	1
31828	RNA-364	2022-11-10 00:00:00-08	RNA	19	90	90	\N	1
31829	RNA-365	2022-11-10 00:00:00-08	RNA	3.71	48	48	\N	1
31830	RNA-366	2022-11-10 00:00:00-08	RNA	3.25	48	48	\N	1
31831	RNA-369	2022-11-14 00:00:00-08	RNA	18.5	135	135	\N	1
31832	RNA-372	2022-11-10 00:00:00-08	RNA	15	48	48	\N	1
31833	RNA-373	2022-11-10 00:00:00-08	RNA	9.27	48	48	\N	1
31834	RNA-377	2022-11-14 00:00:00-08	RNA	18.5	135	135	\N	1
31835	RNA-379	2022-11-14 00:00:00-08	RNA	22.7	84	84	\N	1
31836	RNA-381	2022-11-14 00:00:00-08	RNA	8.28	48	48	\N	1
31837	RNA-383	2022-11-14 00:00:00-08	RNA	5.05	84	84	\N	1
31838	RNA-385	2022-11-22 00:00:00-08	RNA	7.67	48	48	\N	1
31839	RNA-387	2022-11-22 00:00:00-08	RNA	5.24	48	48	\N	1
31840	RNA-390	2022-11-22 00:00:00-08	RNA	3.1	48	48	\N	1
31841	RNA-391	2022-11-22 00:00:00-08	RNA	4.45	48	48	\N	1
31842	RNA-392	2022-11-22 00:00:00-08	RNA	15.3	48	48	\N	1
31843	RNA-394	2022-11-22 00:00:00-08	RNA	37.9	96	96	\N	1
31844	RNA-396	2022-11-22 00:00:00-08	RNA	11.6	48	48	\N	1
31845	RNA-399	2022-12-09 00:00:00-08	RNA	3.32	48	48	\N	1
31846	RNA-401	2022-12-09 00:00:00-08	RNA	4.67	48	48	\N	1
31847	RNA-402	2022-12-09 00:00:00-08	RNA	2.2	48	48	\N	1
31848	RNA-403	2022-12-09 00:00:00-08	RNA	7.71	96	96	\N	1
31849	RNA-404	2022-11-22 00:00:00-08	RNA	3.57	48	48	\N	1
31850	RNA-405	2022-11-22 00:00:00-08	RNA	3.45	96	96	\N	1
31851	RNA-417	2022-11-14 00:00:00-08	RNA	13.4	48	48	\N	1
31852	RNA-418	2022-12-09 00:00:00-08	RNA	4.88	48	48	\N	1
31853	RNA-419	2022-12-09 00:00:00-08	RNA	16.3	96	96	\N	1
31854	RNA-420	2022-12-09 00:00:00-08	RNA	0.7	86	86	\N	1
31855	RNA-421	2022-12-09 00:00:00-08	RNA	3.56	96	96	\N	1
31856	RNA-422	2022-12-09 00:00:00-08	RNA	1.08	48	48	\N	1
31857	RNA-423	2022-12-09 00:00:00-08	RNA	0	48	48	\N	1
31858	RNA-424	2023-04-18 00:00:00-07	RNA	2.4	45	45	\N	1
31859	RNA-425	2023-04-18 00:00:00-07	RNA	4.36	45	45	\N	1
31860	RNA-426	2023-04-18 00:00:00-07	RNA	7.6	45	45	\N	1
31861	RNA-427	2023-04-20 00:00:00-07	RNA	1.64	80	80	\N	1
31862	RNA-428	2023-04-18 00:00:00-07	RNA	1.43	40	40	\N	1
31863	RNA-429	2023-04-20 00:00:00-07	RNA	2.5	80	80	\N	1
31864	RNA-430	2023-04-20 00:00:00-07	RNA	2.82	40	40	\N	1
31865	RNA-431	2023-04-20 00:00:00-07	RNA	3.02	45	45	\N	1
31866	RNA-432	2023-04-20 00:00:00-07	RNA	4.42	45	45	\N	1
31867	RNA-433	2023-04-20 00:00:00-07	RNA	0.4	35	35	\N	1
31868	RNA-434	2023-04-20 00:00:00-07	RNA	3.22	45	45	\N	1
31869	RNA-435	2023-04-20 00:00:00-07	RNA	1.47	40	40	\N	1
31870	RNA-436	2023-04-25 00:00:00-07	RNA	19.5	80	80	\N	1
31871	RNA-437	2023-04-25 00:00:00-07	RNA	13.6	40	40	\N	1
31872	RNA-438	2023-04-25 00:00:00-07	RNA	2.5	80	80	\N	1
31873	RNA-439	2023-06-05 00:00:00-07	RNA	38.1	51	51	\N	6
31874	RNA-440	2023-06-05 00:00:00-07	RNA	8.81	21	21	\N	6
31875	RNA-441	2023-06-05 00:00:00-07	RNA	8.3	21	21	\N	6
31876	RNA-442	2023-06-05 00:00:00-07	RNA	7.97	48	48	\N	6
31877	RNA-443	2023-06-06 00:00:00-07	RNA	10.1	41	41	\N	6
31878	RNA-444	2023-06-06 00:00:00-07	RNA	14.3	41	41	\N	6
31879	RNA-445	2023-06-06 00:00:00-07	RNA	48.2	36	36	\N	6
31880	RNA-446	2023-06-06 00:00:00-07	RNA	70	43	43	\N	6
31881	RNA-447	2023-06-06 00:00:00-07	RNA	13.5	20	20	\N	6
31882	RNA-448	2023-06-06 00:00:00-07	RNA	18.2	20	20	\N	6
31883	Rob-T001-Mel_NA	\N	DNA	\N	\N	\N	\N	\N
31884	Rob-T001-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31885	Rob-T003-Mel_NA	\N	DNA	\N	\N	\N	\N	\N
31886	Rob-T003-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31887	Rob-T005-Nev_NA	\N	DNA	\N	\N	\N	\N	\N
31888	Rob-T005-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31889	Rob-T008-Nev_NA	\N	DNA	\N	\N	\N	\N	\N
31890	Rob-T008-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31896	S12_20321_A2_Tumor_NA	\N	DNA	\N	\N	\N	Brain, right frontal, biopsy: Glioblastoma, WHO Grade IV 	\N
31897	SCH D-01	2020-11-23 00:00:00-08	DNA	12.2	88	88	SP13-6852-B2	6
31898	SCH R-01	2020-11-28 00:00:00-08	RNA	540	20	20	\N	6
31899	Seider_Roe_NA	\N	DNA	\N	\N	\N	\N	\N
31900	Seider_Uveal Melanoma_NA	\N	DNA	\N	\N	\N	\N	\N
31901	SHR01	2023-02-22 00:00:00-08	DNA	12.6	140	140	3mm punch biopsy	3
31902	SHR03	2023-02-22 00:00:00-08	DNA	10.6	140	140	3mm punch biopsy	3
31903	SHR05	2023-02-22 00:00:00-08	DNA	11.1	140	140	3mm punch biopsy	3
31904	SHR06	2023-02-22 00:00:00-08	DNA	0.38	140	140	3mm punch biopsy	3
31905	SKMEL 1023A	\N	DNA	116	10	10	\N	\N
31906	SKMEL 1107B	\N	DNA	118	10	10	\N	\N
31907	SKMel 1107B Dec2019 (MC-02)	\N	DNA	47.8	13	13	\N	\N
31908	SKMEL 1121B	\N	DNA	114	10	10	\N	\N
31909	SKMel 1121B Dec2019 (MC-03)	\N	DNA	26.4	33	33	\N	\N
31910	SKMEL5-1_NA	\N	DNA	\N	\N	\N	\N	\N
31911	SKMEL5-2_NA	\N	DNA	\N	\N	\N	\N	\N
31912	SKMEL5-3_NA	\N	DNA	\N	\N	\N	\N	\N
31913	SKMEL28-1_NA	\N	DNA	\N	\N	\N	\N	\N
31914	SKMEL28-2_NA	\N	DNA	\N	\N	\N	\N	\N
31915	SKMEL28-3_NA	\N	DNA	\N	\N	\N	\N	\N
31916	SM D-01	2018-12-12 00:00:00-08	DNA	1.36	48	48	\N	5
31917	SM D-02	2018-12-12 00:00:00-08	DNA	2.1	48	48	\N	5
31918	SM D-03	2018-12-12 00:00:00-08	DNA	8.67	48	48	\N	5
31919	SM D-04	2018-12-12 00:00:00-08	DNA	3.02	48	48	\N	5
31920	SM D-05	2018-12-12 00:00:00-08	DNA	2.6	48	48	\N	5
31921	SM D-06	2018-12-12 00:00:00-08	DNA	0.37	48	48	\N	5
31922	SM D-07	2018-12-12 00:00:00-08	DNA	2.08	48	48	\N	5
31923	SM D-08	2018-12-12 00:00:00-08	DNA	4.14	48	48	\N	5
31924	SM D-09	2018-12-12 00:00:00-08	DNA	0.92	48	48	\N	5
31925	SM D-10	2018-12-12 00:00:00-08	DNA	4.36	48	48	\N	5
31926	SM D-11	2018-12-12 00:00:00-08	DNA	1.4	48	48	\N	5
31927	SM D-12	2018-12-12 00:00:00-08	DNA	14.4	48	48	\N	5
31928	SM D-13	2018-12-12 00:00:00-08	DNA	9.44	48	48	\N	5
31929	SM D-14	2018-12-12 00:00:00-08	DNA	3.3	48	48	\N	5
31930	SM D-15	2018-12-12 00:00:00-08	DNA	8.61	48	48	\N	5
31931	SM D-16	2018-12-12 00:00:00-08	DNA	2.27	48	48	\N	5
31932	SM D-17	2018-12-12 00:00:00-08	DNA	6.84	48	48	\N	5
31933	SM D-18	2018-12-12 00:00:00-08	DNA	6.75	48	48	\N	5
31934	SM D-19	2018-12-12 00:00:00-08	DNA	1.22	48	48	\N	5
31935	SM D-20	2018-12-12 00:00:00-08	DNA	5.97	48	48	\N	5
31936	SM D-21	2018-12-12 00:00:00-08	DNA	0.77	48	48	\N	5
31937	SM D-22	2018-12-12 00:00:00-08	DNA	1.87	48	48	\N	5
31938	SM D-23	2018-12-12 00:00:00-08	DNA	0.83	48	48	\N	5
31939	SM D-24	2018-12-12 00:00:00-08	DNA	1.54	48	48	\N	5
31940	SM D-25	2018-12-12 00:00:00-08	DNA	2.36	48	48	\N	5
31941	SM_1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31942	SM_2_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31943	SM_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31944	SM_3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31945	SM_4_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31946	SM_4_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31947	SM_5_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31948	SM_5_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31949	SM_6_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31950	SM_7_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31951	SM_7_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31952	SM_8_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31953	SM_8_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31954	SM_9_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31955	SM_9_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31956	SM_10_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31957	SM_11_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31958	SM_12_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31959	SM_16_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31960	SM_16_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31961	SM_18_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31962	SM7_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31963	SMPR2	\N	RNA	8.8	20	20	\N	6
31964	SMPR4	\N	RNA	41.1	20	20	\N	6
31965	SMPR11	\N	RNA	205.8	20	20	\N	6
31966	SMPR12	\N	RNA	34.1	20	20	\N	6
31967	SMPR20	\N	RNA	24.7	20	20	\N	6
31968	SMPR48	\N	RNA	14.9	20	20	\N	6
31969	SMPR55	\N	RNA	77.2	20	20	\N	6
31970	SMPR56	\N	RNA	23.8	20	20	\N	6
31971	SMPR58A	\N	RNA	8.6	20	20	\N	6
31972	SMPR58B	\N	RNA	35.5	20	20	\N	6
31973	SND-01	2020-07-12 00:00:00-07	DNA	0.53	88	88	MAP2K1	6
31974	SND-02	2020-07-12 00:00:00-07	DNA	0.5	88	88	MAP2K1	6
31975	SND-03	2020-07-12 00:00:00-07	DNA	0.09	88	88	GNAQ	6
31976	SND-04	2020-07-12 00:00:00-07	DNA	0.68	88	88	GNAQ	6
31977	SND-05	2020-07-12 00:00:00-07	DNA	0.58	88	88	MAP2K1	6
31978	SND-06	2020-07-12 00:00:00-07	DNA	0.57	88	88	GNAQ	6
31979	SND-07	2020-07-12 00:00:00-07	DNA	3.19	88	88	MAP2K1	6
31980	SND-08	2020-07-12 00:00:00-07	DNA	0.22	88	88	GNAQ	6
31981	SND-09	2020-07-12 00:00:00-07	DNA	0.66	88	88	MAP2K1	6
31982	SND-10	2020-07-12 00:00:00-07	DNA	0.69	88	88	GNAQ	6
31983	SND-11	2020-07-12 00:00:00-07	DNA	0.37	88	88	MAP2K1	6
31984	SND-12	2020-07-12 00:00:00-07	DNA	0.44	88	88	MAP2K1	6
31985	SND-13	2020-07-12 00:00:00-07	DNA	0.92	88	88	GNAQ	6
31986	SND-14	2020-07-12 00:00:00-07	DNA	2.04	88	88	MAP2K1	6
31987	SND-15	2020-07-12 00:00:00-07	DNA	1.3	88	88	MAP2K1	6
31988	SND-16	2020-07-12 00:00:00-07	DNA	0.26	88	88	GNAQ	6
31989	SND-17	2020-07-12 00:00:00-07	DNA	2.18	88	88	MAP2K1	6
31990	SND-18	2020-07-12 00:00:00-07	DNA	0.24	88	88	MAP2K1	6
31991	SND-19	2020-07-12 00:00:00-07	DNA	0.88	88	88	MAP2K1	6
31992	SND-20	2020-11-23 00:00:00-08	DNA	1.08	88	88	\N	6
31993	SND-21	2020-11-23 00:00:00-08	DNA	2.09	88	88	\N	6
31994	SND-22	2020-11-23 00:00:00-08	DNA	1.16	88	88	\N	6
31995	SND-23	2020-11-23 00:00:00-08	DNA	1.53	88	88	\N	6
31996	SND-24	2020-11-23 00:00:00-08	DNA	0.55	88	88	\N	6
31997	SND-25	2020-11-23 00:00:00-08	DNA	0.64	88	88	\N	6
31998	SND-26	2020-11-23 00:00:00-08	DNA	0.18	88	88	\N	6
31999	SND-27	2020-11-23 00:00:00-08	DNA	3.84	88	88	\N	6
32000	SND-28	2020-11-23 00:00:00-08	DNA	3.63	88	88	\N	6
32001	SND-29	2020-11-23 00:00:00-08	DNA	0	88	88	\N	6
32002	SND-30	2020-11-23 00:00:00-08	DNA	0.11	88	88	\N	6
32003	SND-31	2020-11-23 00:00:00-08	DNA	0.15	88	88	\N	6
32004	SND-32	2020-11-23 00:00:00-08	DNA	0.05	88	88	\N	6
32005	SND-33	2020-11-23 00:00:00-08	DNA	0.26	88	88	\N	6
32006	SND-34	2020-11-23 00:00:00-08	DNA	0	88	88	\N	6
32007	SND-35	2020-12-03 00:00:00-08	DNA	0	88	88	\N	6
32008	SND-36	2020-12-03 00:00:00-08	DNA	0.15	88	88	\N	6
32009	SND-37	2020-12-03 00:00:00-08	DNA	0	88	88	\N	6
32010	SND-38	2020-12-03 00:00:00-08	DNA	0.32	88	88	\N	6
32011	SND-39	2021-08-30 00:00:00-07	DNA	0.57	48	48	\N	7
32012	SND-40	2021-08-30 00:00:00-07	DNA	0.74	48	48	\N	7
32013	SND-41	2021-08-30 00:00:00-07	DNA	1.5	48	48	\N	7
32014	SND-42	2021-08-30 00:00:00-07	DNA	2.14	48	48	\N	7
32015	SND-43	2021-08-30 00:00:00-07	DNA	0.17	48	48	\N	7
32016	SNR-01	2020-07-12 00:00:00-07	RNA	9.89	20	20	MAP2K1	6
32017	SNR-02	2020-07-12 00:00:00-07	RNA	8.04	20	20	MAP2K1	6
32018	SNR-03	2020-07-12 00:00:00-07	RNA	0	20	20	GNAQ	6
32019	SNR-04	2020-07-12 00:00:00-07	RNA	3.2	20	20	GNAQ	6
32020	SNR-05	2020-07-12 00:00:00-07	RNA	7.62	20	20	MAP2K1	6
32021	SNR-06	2020-07-12 00:00:00-07	RNA	3.17	20	20	GNAQ	6
32022	SNR-07	2020-07-12 00:00:00-07	RNA	19.8	20	20	MAP2K1	6
32023	SNR-08	2020-07-12 00:00:00-07	RNA	0	20	20	GNAQ	6
32024	SNR-09	2020-07-12 00:00:00-07	RNA	2.5	20	20	MAP2K1	6
32025	SNR-10	2020-07-12 00:00:00-07	RNA	5.79	20	20	GNAQ	6
32026	SNR-11	2020-07-12 00:00:00-07	RNA	3.09	20	20	MAP2K1	6
32027	SNR-12	2020-07-12 00:00:00-07	RNA	7.67	20	20	MAP2K1	6
32028	SNR-13	2020-07-12 00:00:00-07	RNA	7.3	20	20	GNAQ	6
32029	SNR-14	2020-07-12 00:00:00-07	RNA	20.5	20	20	MAP2K1	6
32030	SNR-15	2020-07-12 00:00:00-07	RNA	8.59	20	20	MAP2K1	6
32031	SNR-16	2020-07-12 00:00:00-07	RNA	0	20	20	GNAQ	6
32032	SNR-17	2020-07-12 00:00:00-07	RNA	20.2	20	20	MAP2K1	6
32033	SNR-18	2020-07-12 00:00:00-07	RNA	2.52	20	20	MAP2K1	6
32034	SNR-19	2020-07-12 00:00:00-07	RNA	0	20	20	MAP2K1	6
32035	SNR-20	2020-11-28 00:00:00-08	RNA	2.76	20	20	\N	6
32036	SNR-21	2020-11-28 00:00:00-08	RNA	2.9	20	20	\N	6
32037	SNR-22	2020-11-28 00:00:00-08	RNA	8.9	20	20	\N	6
32038	SNR-23	2020-11-28 00:00:00-08	RNA	11.3	20	20	\N	6
32039	SNR-24	2020-11-28 00:00:00-08	RNA	2.2	20	20	\N	6
32040	SNR-25	2020-11-28 00:00:00-08	RNA	6.75	20	20	\N	6
32041	SNR-26	2020-11-28 00:00:00-08	RNA	0	20	20	\N	6
32042	SNR-27	2020-11-28 00:00:00-08	RNA	14.3	20	20	\N	6
32043	SNR-28	2020-11-28 00:00:00-08	RNA	69	20	20	\N	6
32044	SNR-29	2020-11-28 00:00:00-08	RNA	0	20	20	\N	6
32045	SNR-30	2020-11-28 00:00:00-08	RNA	0	20	20	\N	6
32046	SNR-31	2020-11-28 00:00:00-08	RNA	2.3	20	20	\N	6
32047	SNR-32	2020-11-28 00:00:00-08	RNA	5.94	20	20	\N	6
32048	SNR-33	2020-11-28 00:00:00-08	RNA	2.59	20	20	\N	6
32049	SNR-34	2020-11-28 00:00:00-08	RNA	0	20	20	\N	6
32050	TCR-Beta-1_NA	\N	DNA	\N	\N	\N	\N	\N
32051	TCR-Beta-2_NA	\N	DNA	\N	\N	\N	\N	\N
32052	Thomas_SK_MEL_23_NA	\N	DNA	\N	\N	\N	\N	\N
32053	Thomas_SK_Mel23	2013-07-02 00:00:00-07	DNA	147	50	50	\N	\N
32054	TPP 1_1	\N	DNA	1.35	90	90	\N	\N
32055	TPP 1_2	\N	DNA	0.86	90	90	\N	\N
32056	TPP 1_3	\N	DNA	1.59	90	90	\N	\N
32057	TPP 1_4	\N	DNA	0.9	90	90	\N	\N
32058	TPP 1_5	\N	DNA	0.56	90	90	\N	\N
32059	TPP 1_6	\N	DNA	0.48	90	90	\N	\N
32060	TPP 1_7	\N	DNA	3.79	90	90	\N	\N
32061	TPP 1_8	\N	DNA	1.08	90	90	\N	\N
32062	TPP 1_9	\N	DNA	0.94	90	90	\N	\N
32063	TPP 1_10	\N	DNA	0.83	90	90	\N	\N
32064	TPP 1_11	\N	DNA	0.61	90	90	\N	\N
32065	TPP 1_12	\N	DNA	1.67	90	90	\N	\N
32066	TPP 1_13	\N	DNA	3.4	90	90	\N	\N
32067	TPP 1_14	\N	DNA	4.63	90	90	\N	\N
32068	TPP 1_15	\N	DNA	1.01	90	90	\N	\N
32069	TPP 1_16	\N	DNA	4.2	90	90	\N	\N
32070	TPP 1_17	\N	DNA	2.3	90	90	\N	\N
32071	TPP 1_18	\N	DNA	3.94	90	90	\N	\N
32072	TPP 1_19	\N	DNA	32.4	90	90	\N	\N
32073	TPP 1_20	\N	DNA	10.5	90	90	\N	\N
32074	TPP 1_21	\N	DNA	3.58	90	90	\N	\N
32075	TPP 1_22	\N	DNA	8.88	90	90	\N	\N
32076	TPP 1_23	\N	DNA	4.62	90	90	\N	\N
32077	TPP 1_24	\N	DNA	15	90	90	\N	\N
32078	TPP 1_25	\N	DNA	6.14	90	90	\N	\N
32079	TPP 1_26	\N	DNA	14.2	90	90	\N	\N
32080	TPP 1_27	\N	DNA	14.3	90	90	\N	\N
32081	TPP 2_1	2017-08-02 00:00:00-07	DNA	0.98	100	100	\N	\N
32082	TPP 2_2	2017-08-02 00:00:00-07	DNA	15.6	100	100	\N	\N
32083	TPP 2_3	2017-08-02 00:00:00-07	DNA	2.61	100	100	\N	\N
32084	TPP 2_4	2017-08-02 00:00:00-07	DNA	2.63	100	100	\N	\N
32085	TPP 2_5	2017-08-02 00:00:00-07	DNA	10.3	100	100	\N	\N
32086	TPP 2_6	2017-08-02 00:00:00-07	DNA	6.8	100	100	\N	\N
32087	TPP 2_7	2017-08-02 00:00:00-07	DNA	4.07	100	100	\N	\N
32088	TPP 2_8	2017-08-02 00:00:00-07	DNA	5.6	100	100	\N	\N
32089	TPP 2_9	2017-08-02 00:00:00-07	DNA	6.5	100	100	\N	\N
32090	TPP 2_10	2017-08-02 00:00:00-07	DNA	7.53	100	100	\N	\N
32091	TPP 2_11	2017-08-02 00:00:00-07	DNA	5.23	100	100	\N	\N
32092	TPP 2_12	2017-08-02 00:00:00-07	DNA	10.2	100	100	\N	\N
32093	TPP 2_13	2017-08-02 00:00:00-07	DNA	14.1	100	100	\N	\N
32094	TPP 2_14	2017-08-02 00:00:00-07	DNA	4.64	100	100	\N	\N
32095	TPP 2_15	2017-08-02 00:00:00-07	DNA	0.38	100	100	\N	\N
32096	TPP 2_16	2017-08-02 00:00:00-07	DNA	24.3	100	100	\N	\N
32097	TPP 2_17	2017-08-02 00:00:00-07	DNA	9.26	100	100	\N	\N
32098	TPP 2_18	2017-08-02 00:00:00-07	DNA	9.09	100	100	\N	\N
32099	TPP 2_19	2017-08-02 00:00:00-07	DNA	10.8	100	100	\N	\N
32100	TPP 2_20	2017-08-02 00:00:00-07	DNA	2.3	100	100	\N	\N
32101	TPP 2_21	2017-08-02 00:00:00-07	DNA	12.2	100	100	\N	\N
32102	TPP 2_22	2017-08-02 00:00:00-07	DNA	1.13	100	100	\N	\N
32103	TPP 2_23	2017-08-02 00:00:00-07	DNA	9.74	100	100	\N	\N
32104	TPP 2_24	2017-08-02 00:00:00-07	DNA	6.96	100	100	\N	\N
32105	TPP 2_25	2017-08-09 00:00:00-07	DNA	11	100	100	\N	\N
32106	TPP 2_26	2017-08-09 00:00:00-07	DNA	11	100	100	\N	\N
32107	TPP 2_27	2017-08-09 00:00:00-07	DNA	1.31	100	100	\N	\N
32108	TPP 2_28	2017-08-09 00:00:00-07	DNA	3.12	100	100	\N	\N
32109	TPP 2_29	2017-08-09 00:00:00-07	DNA	12	100	100	\N	\N
32110	TPP 2_30	2017-08-09 00:00:00-07	DNA	1.92	100	100	\N	\N
32111	TPP 2_31	2017-08-09 00:00:00-07	DNA	6.58	100	100	\N	\N
32112	TPP 2_32	2017-08-09 00:00:00-07	DNA	4.1	100	100	\N	\N
32113	TPP 2_33	2017-08-09 00:00:00-07	DNA	4.54	100	100	\N	\N
32114	TPP 2_34	2017-08-09 00:00:00-07	DNA	2.6	100	100	\N	\N
32115	TPP 2_35	2017-08-09 00:00:00-07	DNA	14.9	100	100	\N	\N
32116	TPP 2_36	2017-08-09 00:00:00-07	DNA	48.2	100	100	\N	\N
32117	TPP 2_37	2017-08-09 00:00:00-07	DNA	12.9	100	100	\N	\N
32118	TPP 2_38	2017-08-09 00:00:00-07	DNA	1.89	100	100	\N	\N
32119	TPP 2_39	2017-08-09 00:00:00-07	DNA	2.2	100	100	\N	\N
32120	TPP 2_40	2017-08-09 00:00:00-07	DNA	19.1	100	100	\N	\N
32121	TPP 2_41	2017-08-09 00:00:00-07	DNA	6.2	100	100	\N	\N
32122	TPP 2_42	2017-08-09 00:00:00-07	DNA	1.56	100	100	\N	\N
32123	TPP 2_43	2017-08-09 00:00:00-07	DNA	3.76	100	100	\N	\N
32124	TPP 2_44	2017-08-09 00:00:00-07	DNA	5.12	100	100	\N	\N
32125	TPP 2_45	2017-08-09 00:00:00-07	DNA	4.14	100	100	\N	\N
32126	TPP 2_46	2017-08-09 00:00:00-07	DNA	5.56	100	100	\N	\N
32127	TPP 2_47	2017-08-09 00:00:00-07	DNA	4.08	100	100	\N	\N
32128	TPP 2_48	2017-08-09 00:00:00-07	DNA	14	100	100	\N	\N
32129	TPP 2_49	2017-08-09 00:00:00-07	DNA	1.08	100	100	\N	\N
32130	TPP 2_50	2017-08-09 00:00:00-07	DNA	0.84	100	100	\N	\N
32131	TPP 2_51	2017-08-09 00:00:00-07	DNA	0.72	100	100	\N	\N
32132	TPP 2_52	2017-08-09 00:00:00-07	DNA	6.74	100	100	\N	\N
32133	TPP 2_53	2017-08-09 00:00:00-07	DNA	5.8	100	100	\N	\N
32134	TPP 2_54	2017-08-09 00:00:00-07	DNA	10	100	100	\N	\N
32135	TPP 2_55	\N	DNA	18.1	100	100	\N	\N
32136	TPP 2_56	\N	DNA	4.3	100	100	\N	\N
32137	TPP 2_57	\N	DNA	15	100	100	\N	\N
32138	TPP 2_58	\N	DNA	1.92	100	100	\N	\N
32139	TPP 2_59	\N	DNA	1.79	100	100	\N	\N
32140	TPP 2_60	\N	DNA	6.6	100	100	\N	\N
32141	TPP 2_61	\N	DNA	0.23	100	100	\N	\N
32142	TPP 2_62	\N	DNA	17.6	100	100	\N	\N
32143	TPP 2_63	\N	DNA	2.76	100	100	\N	\N
32144	TPP 2_64	\N	DNA	2.7	100	100	\N	\N
32145	TPP 2_65	\N	DNA	2.6	100	100	\N	\N
32146	TPP 2_66	\N	DNA	0.52	100	100	\N	\N
32147	TPP 2_67	\N	DNA	11.4	100	100	\N	\N
32148	TPP 2_68	\N	DNA	10.3	100	100	\N	\N
32149	TPP 2_69	\N	DNA	3.76	100	100	\N	\N
32150	TPP 2_70	\N	DNA	4.46	100	100	\N	\N
32151	TPP 2_71	\N	DNA	1.84	100	100	\N	\N
32152	TPP 2_72	\N	DNA	12.1	100	100	\N	\N
32153	TPP 2_73	\N	DNA	10	100	100	\N	\N
32154	TPP 2_74	\N	DNA	7.32	100	100	\N	\N
32155	TPP 2_75	\N	DNA	24.8	100	100	\N	\N
32156	TPP 2_76	\N	DNA	11.5	100	100	\N	\N
32157	TPP 2_77	\N	DNA	14.9	100	100	\N	\N
32158	TPP 2_78	\N	DNA	2.56	100	100	\N	\N
32159	TPP 2_79	\N	DNA	10.4	100	100	\N	\N
32160	TPP 2_80	\N	DNA	20.2	100	100	\N	\N
32161	TPP 2_81	\N	DNA	9.68	100	100	\N	\N
32162	TPP 2_82	\N	DNA	7.2	100	100	\N	\N
32163	TPP 2_83	\N	DNA	14.9	100	100	\N	\N
32164	TPP 2_84	\N	DNA	0.71	100	100	\N	\N
32165	TPP 2_85	\N	DNA	12.2	100	100	\N	\N
32166	TPP 2_86	\N	DNA	6.34	100	100	\N	\N
32167	TPP 2_87	\N	DNA	2.3	100	100	\N	\N
32168	TPP 2_88	\N	DNA	14	100	100	\N	\N
32169	TPP_3-01	\N	DNA	28.6	48	48	\N	\N
32170	TPP_3-02	\N	DNA	8.34	48	48	\N	\N
32171	TPP_3-03	\N	DNA	19	48	48	\N	\N
32172	TPP_3-04	\N	DNA	23.2	48	48	\N	\N
32173	TPP_3-05	\N	DNA	16.3	48	48	\N	\N
32174	TPP_3-06	\N	DNA	11.5	48	48	\N	\N
32175	TPP_3-07	\N	DNA	67.2	48	48	\N	\N
32176	TPP_3-08	\N	DNA	47.4	48	48	\N	\N
32177	TPP_3-09	\N	DNA	25.4	48	48	\N	\N
32178	TPP_3-10	\N	DNA	2.7	48	48	\N	\N
32179	TPP_3-11	\N	DNA	11.5	48	48	\N	\N
32180	TPP_3-12	\N	DNA	28.6	48	48	\N	\N
32181	TPP_3-13	\N	DNA	18.3	48	48	\N	\N
32182	TPP_3-14	\N	DNA	39.4	48	48	\N	\N
32183	TPP_3-15	\N	DNA	43.4	48	48	\N	\N
32184	TPP_3-16	\N	DNA	6.34	48	48	\N	\N
32185	TPP_3-17	\N	DNA	8.52	48	48	\N	\N
32186	TPP_3-18	\N	DNA	10.2	48	48	\N	\N
32187	TPP_3-19	\N	DNA	99.8	48	48	\N	\N
32188	TPP_3-20	\N	DNA	33.4	48	48	\N	\N
32189	TPP_3-21	\N	DNA	18.1	48	48	\N	\N
32190	TPP_3-22	\N	DNA	27.4	48	48	\N	\N
32191	TPP_3-23	\N	DNA	22.6	48	48	\N	\N
32192	TPP_3-24	\N	DNA	22.4	48	48	\N	\N
32193	TPP_3-25	\N	DNA	23.4	48	48	\N	\N
32194	TPP_3-26	\N	DNA	4.7	48	48	\N	\N
32195	TPP_3-27	\N	DNA	13.7	48	48	\N	\N
32196	TPP_3-28	\N	DNA	39.2	48	48	\N	\N
32197	TPP_3-29	\N	DNA	33.4	48	48	\N	\N
32198	TPP_3-30	\N	DNA	14.3	48	48	\N	\N
32199	TPP_3-31	\N	DNA	26.2	48	48	\N	\N
32200	TPP_3-32	\N	DNA	20.4	48	48	\N	\N
32201	TPP_3-33	\N	DNA	11.3	48	48	\N	\N
32202	TPP_3-34	\N	DNA	25.6	48	48	\N	\N
32203	TPP_3-35	\N	DNA	20	48	48	\N	\N
32204	TPP_3-36	\N	DNA	16.1	48	48	\N	\N
32205	TPP_3-37	\N	DNA	20.4	48	48	\N	\N
32206	TPP_3-38	\N	DNA	6.6	48	48	\N	\N
32207	TPP_3-39	\N	DNA	42.2	48	48	\N	\N
32208	TPP_3-40	\N	DNA	17.9	48	48	\N	\N
32209	TPP_3-41	\N	DNA	16.6	48	48	\N	\N
32210	TPP_3-42	\N	DNA	48.8	48	48	\N	\N
32211	TPP_3-43	\N	DNA	89.6	48	48	\N	\N
32212	TPP_3-44	\N	DNA	58.6	48	48	\N	\N
32213	TPP_3-45	\N	DNA	24	48	48	\N	\N
32214	TPP_3-46	\N	DNA	85.8	48	48	\N	\N
32215	TPP_3-47	\N	DNA	70.6	48	48	\N	\N
32216	TPP_3-48	\N	DNA	29.4	48	48	\N	\N
32217	TPP_3-49	\N	DNA	23.6	48	48	\N	\N
32218	TPP_3-50	\N	DNA	33.2	48	48	\N	\N
32219	TPP_3-51	\N	DNA	41.2	48	48	\N	\N
32220	TPP_3-52	\N	DNA	36.8	48	48	\N	\N
32221	TPP_3-53	\N	DNA	34.2	48	48	\N	\N
32222	TPP_3-54	\N	DNA	18.9	48	48	\N	\N
32223	TPP_3-55	\N	DNA	46.2	48	48	\N	\N
32224	UM1_NA	2013-08-30 00:00:00-07	DNA	0.99	45	45	Uveal Melanoma, Dr. Seider	\N
32225	UM2_NA	2013-09-03 00:00:00-07	DNA	0.34	45	45	Uveal Melanoma, Dr. Seider	\N
32226	UM23_NA	\N	DNA	\N	\N	\N	\N	\N
32227	UM24_NA	\N	DNA	\N	\N	\N	\N	\N
32228	UM25_NA	\N	DNA	\N	\N	\N	\N	\N
32229	UM26_NA	\N	DNA	\N	\N	\N	\N	\N
32230	UM38-Normal_NA	2014-12-10 00:00:00-08	DNA	14.3	45	45	\N	\N
32231	UM38-Tumor_NA	2014-12-10 00:00:00-08	DNA	68	45	45	\N	\N
32232	VS-01_NA	\N	RNA	\N	\N	\N	\N	\N
32233	VS-02_NA	\N	RNA	\N	\N	\N	\N	\N
32234	VS-03_NA	\N	RNA	\N	\N	\N	\N	\N
32235	VS-04_NA	\N	RNA	\N	\N	\N	\N	\N
32236	VS-05_NA	\N	RNA	\N	\N	\N	\N	\N
32237	VS-06_NA	\N	RNA	\N	\N	\N	\N	\N
32238	VS-07_NA	\N	RNA	\N	\N	\N	\N	\N
32239	VS-08_NA	\N	RNA	\N	\N	\N	\N	\N
32240	WM8_NA	2012-11-01 00:00:00-07	DNA	38.4	30	30	wt/wt	\N
32241	WM51_NA	2012-11-01 00:00:00-07	DNA	98.1	30	30	\N	\N
32242	WM1963_NA	2012-11-01 00:00:00-07	DNA	28.7	30	30	wt/wt	\N
32243	WM3622_NA	2012-11-01 00:00:00-07	DNA	17	30	30	wt/wt	\N
32244	WM3912_NA	\N	DNA	16.5	100	100	wt/wt	\N
32245	WM3918_NA	2012-11-01 00:00:00-07	DNA	52.7	30	30	\N	\N
32246	WP_11_NA	2012-06-01 00:00:00-07	DNA	454	50	50	\N	\N
32247	WP_23_NA	2012-06-01 00:00:00-07	DNA	179	50	50	\N	\N
32248	WP_29_NA	2012-06-01 00:00:00-07	DNA	394	50	50	\N	\N
32249	WTMM-17-Tumor_NA	2015-07-27 00:00:00-07	DNA	7.13	100	100	\N	\N
32250	WTMM-18-Tumor_NA	2015-07-27 00:00:00-07	DNA	4.16	100	100	\N	\N
32251	WTMM-19-Tumor_NA	2015-07-27 00:00:00-07	DNA	19.9	100	100	\N	\N
32252	WTMM-20-Tumor_NA	2015-07-27 00:00:00-07	DNA	40.4	100	100	\N	\N
32253	WTMM-21-Tumor_NA	2015-07-27 00:00:00-07	DNA	2.89	100	100	\N	\N
32254	WTMM-22-Tumor_NA	2015-07-27 00:00:00-07	DNA	2.63	100	100	\N	\N
32255	WTMM-23-Tumor_NA	2015-07-27 00:00:00-07	DNA	7.96	100	100	\N	\N
32256	WTMM-24-Tumor_NA	2015-07-27 00:00:00-07	DNA	9.93	100	100	\N	\N
32257	Xu-1	\N	RNA	200	10	10	\N	\N
32258	Xu-2	\N	RNA	200	10	10	\N	\N
32259	Xu-3	\N	RNA	200	10	10	\N	\N
32260	Xu-4	\N	RNA	200	10	10	\N	\N
32261	Xu-5	\N	RNA	200	10	10	\N	\N
32262	Xu-6	\N	RNA	200	10	10	\N	\N
32263	Xu-7	\N	RNA	200	10	10	\N	\N
32264	Xu-8	\N	RNA	200	10	10	\N	\N
32265	Xu-9	\N	RNA	200	10	10	\N	\N
32266	Xu-10	\N	RNA	200	10	10	\N	\N
32267	Xu-11	\N	RNA	200	10	10	\N	\N
32268	Xu-12	\N	RNA	200	10	10	\N	\N
32269	Xu-13	\N	RNA	200	10	10	\N	\N
32270	Xu-14	\N	RNA	200	10	10	\N	\N
32271	Xu-015	\N	RNA	200	10	10	\N	\N
32272	Xu-016	\N	RNA	200	10	10	\N	\N
32273	Xu-017	\N	RNA	200	10	10	\N	\N
32274	Xu-018	\N	RNA	200	10	10	\N	\N
32275	Xu-019	\N	RNA	200	10	10	\N	\N
32276	Xu-020	\N	RNA	200	10	10	\N	\N
32277	Xu-021	\N	RNA	200	10	10	\N	\N
32278	Xu-022	\N	RNA	200	10	10	\N	\N
32279	Xu-023	\N	RNA	200	10	10	\N	\N
32280	Xu-024	\N	RNA	200	10	10	\N	\N
32281	Xu-025	\N	RNA	200	10	10	\N	\N
32282	Xu-026	\N	RNA	200	10	10	\N	\N
32283	Xu-027	\N	RNA	200	10	10	\N	\N
32284	Xu-028	\N	RNA	200	10	10	\N	\N
32285	Xu-029	\N	RNA	200	10	10	\N	\N
32286	Xu-030	\N	RNA	200	10	10	\N	\N
32287	Xu-031	\N	RNA	200	10	10	\N	\N
32288	Xu-032	\N	RNA	130	10	10	\N	\N
32289	Xu-033	\N	RNA	200	10	10	\N	\N
32290	Xu-034	\N	RNA	200	10	10	\N	\N
32291	Xu-035	\N	RNA	200	10	10	\N	\N
32292	Xu-036	\N	RNA	200	10	10	\N	\N
32293	Xu-037	\N	RNA	200	10	10	\N	\N
32294	Xu-038	\N	RNA	200	10	10	\N	\N
32295	Xu-039	\N	RNA	200	10	10	\N	\N
32296	Xu-040	\N	RNA	200	10	10	\N	\N
32297	Xu-041	\N	RNA	200	10	10	\N	\N
32298	Xu-042	\N	RNA	200	10	10	\N	\N
32299	Xu-043	\N	RNA	200	10	10	\N	\N
32300	Xu-044	\N	RNA	200	10	10	\N	\N
32301	Xu-045	\N	RNA	200	10	10	\N	\N
32302	Xu-046	\N	RNA	200	10	10	\N	\N
32303	Xu-047	\N	RNA	200	10	10	\N	\N
32304	Xu-048	\N	RNA	200	10	10	\N	\N
32305	Xu-049	\N	RNA	200	10	10	\N	\N
32306	Xu-050	\N	RNA	200	10	10	\N	\N
32307	Xu-051	\N	RNA	200	10	10	\N	\N
32308	Xu-052	\N	RNA	200	10	10	\N	\N
32309	Xu-053	\N	RNA	200	10	10	\N	\N
32310	Xu-054	\N	RNA	200	10	10	\N	\N
32311	Xu-055	\N	RNA	165	10	10	\N	\N
32312	Xu-056	\N	RNA	113	10	10	\N	\N
32313	Xu-057	\N	RNA	94.3	10	10	\N	\N
32314	Xu-058	\N	RNA	119.1	10	10	\N	\N
32315	Xu-059	\N	RNA	201.9	10	10	\N	\N
32316	Xu-060	\N	RNA	150.5	10	10	\N	\N
32317	Xu-061	\N	RNA	179.2	10	10	\N	\N
32318	Xu-062	\N	RNA	76.7	10	10	\N	\N
32319	Xu-063	\N	RNA	129.5	10	10	\N	\N
32320	Xu-064	\N	RNA	21.2	25	25	\N	\N
32321	1 NEV_RNA	2016-08-30 00:00:00-07	RNA	19.5	50	50	\N	6
32322	1 MEL_RNA	2016-08-30 00:00:00-07	RNA	66	50	50	\N	6
32323	3 MEL_RNA	2016-08-30 00:00:00-07	RNA	17.1	50	50	\N	6
32324	13 NEV_RNA	2016-08-30 00:00:00-07	RNA	2	50	50	\N	6
32325	13 AMB_RNA	2016-08-30 00:00:00-07	RNA	8.1	50	50	\N	6
32326	13 MEL_RNA	2016-08-30 00:00:00-07	RNA	5	50	50	\N	6
32327	14 NEV_RNA	2016-08-30 00:00:00-07	RNA	19.2	50	50	\N	6
32328	14 MEL_RNA	2016-08-30 00:00:00-07	RNA	27.7	50	50	\N	6
32329	16 NEV_RNA	2016-08-30 00:00:00-07	RNA	0.1	50	50	\N	6
32330	16 MEL_RNA	2016-08-30 00:00:00-07	RNA	2.7	50	50	\N	6
32331	17 NEV_RNA	2016-08-30 00:00:00-07	RNA	0.1	50	50	\N	6
32332	17 MEL_RNA	2016-08-30 00:00:00-07	RNA	2	50	50	\N	6
32333	10 MEL_RNA	2015-03-17 00:00:00-07	RNA	29.5	50	50	\N	\N
32334	10 NEV_RNA	2015-03-17 00:00:00-07	RNA	6.17	50	50	\N	\N
32335	12 MEL_RNA	2015-03-17 00:00:00-07	RNA	5.55	50	50	\N	\N
32336	12 NEV_RNA	2015-03-17 00:00:00-07	RNA	3.35	50	50	\N	\N
32337	18 MEL_RNA	2015-03-17 00:00:00-07	RNA	4.32	50	50	\N	\N
32338	18 NEV_RNA	2015-03-17 00:00:00-07	RNA	6.04	50	50	\N	\N
32339	19 MEL_RNA	2015-03-17 00:00:00-07	RNA	3.34	38	38	\N	\N
32340	19 NEV_RNA	2015-03-17 00:00:00-07	RNA	0	38	38	\N	\N
32341	20 MEL_RNA	2015-03-17 00:00:00-07	RNA	3.79	50	50	\N	\N
32342	20 NEV_RNA	2015-03-17 00:00:00-07	RNA	0	38	38	\N	\N
32343	3 NEV_RNA	2015-03-17 00:00:00-07	RNA	2.59	38	38	\N	\N
32344	5 MEL_RNA	2015-03-17 00:00:00-07	RNA	11.2	38	38	\N	\N
32345	5 NEV_RNA	2015-03-17 00:00:00-07	RNA	4.98	38	38	\N	\N
32346	21\n  MEL_RNA	\N	RNA	\N	\N	\N	\N	\N
32347	21 NEV_RNA	\N	RNA	\N	\N	\N	\N	\N
32348	22 MEL_RNA	\N	RNA	\N	\N	\N	\N	\N
32349	22 NEV_RNA	\N	RNA	\N	\N	\N	\N	\N
32350	23 MEL_RNA	\N	RNA	\N	\N	\N	\N	\N
32351	23 NEV_RNA	\N	RNA	\N	\N	\N	\N	\N
32352	25 MEL_RNA	\N	RNA	\N	\N	\N	\N	\N
32353	25 NEV_RNA	\N	RNA	\N	\N	\N	\N	\N
32354	26 MEL_RNA	\N	RNA	\N	\N	\N	\N	\N
32355	26 NEV_RNA	\N	RNA	\N	\N	\N	\N	\N
32356	27 MEL_RNA	\N	RNA	\N	\N	\N	\N	\N
32357	27 NEV_RNA	\N	RNA	\N	\N	\N	\N	\N
32358	28 MEL_RNA	\N	RNA	\N	\N	\N	\N	\N
32359	28 NEV_RNA	\N	RNA	\N	\N	\N	\N	\N
32360	NA_12-6261A_Tumor	\N	DNA	512	\N	\N	Cheek	\N
32361	NA_12-6261B_Tumor	\N	DNA	210	\N	\N	Neck	\N
32362	NA_12-12366_Tumor	\N	DNA	1000	\N	\N	\N	\N
32363	NA_12-12467_Tumor	\N	DNA	1000	\N	\N	\N	\N
32364	NA_12-12470D_Tumor	\N	DNA	480	\N	\N	\N	\N
32365	NA_12-562_Tumor	\N	DNA	1000	\N	\N	\N	\N
32366	NA_12-12647_Tumor	\N	DNA	330	\N	\N	\N	\N
32367	NA_12-12626_Tumor	\N	DNA	1000	\N	\N	Right Arm	\N
32368	NA_12-13587_Tumor	\N	DNA	1000	\N	\N	\N	\N
32369	NA_12-18438A_Tumor	\N	DNA	400	\N	\N	\N	\N
32370	NA_12-13152_Tumor	\N	DNA	554	\N	\N	\N	\N
32371	NA_12-12750B_Tumor	\N	DNA	1000	\N	\N	Forehead	\N
32372	NA_12-19596_Tumor	\N	DNA	1000	\N	\N	\N	\N
32373	NA_12-19187A_Tumor	\N	DNA	1000	\N	\N	Shin	\N
32374	NA_12-22172_Normal	\N	DNA	371	\N	\N	\N	\N
32375	NA_12-22172_Tumor	\N	DNA	1000	\N	\N	\N	\N
32376	NA_12-21726A_Tumor	\N	DNA	157	\N	\N	\N	\N
32377	NA_12-22901A_Normal	\N	DNA	497	\N	\N	\N	\N
32378	NA_12-22901A_Tumor	\N	DNA	1000	\N	\N	\N	\N
32379	NA_12-22776_Normal	\N	DNA	1000	\N	\N	\N	\N
32380	NA_BuffyCoat_Tumor	\N	DNA	1000	\N	\N	\N	\N
32381	NA_12-13587B2_Tumor	\N	DNA	750	\N	\N	\N	\N
32382	NA_BuffyCoa_Tumor	\N	DNA	1000	\N	\N	Collaborated with Robert Nussbaum to get this blood	\N
32383	NA_12-22775_Tumor	\N	DNA	1000	\N	\N	\N	\N
32384	NA_12-22794A_Tumor	\N	DNA	1000	\N	\N	\N	\N
32385	NA_12-22573_Tumor	\N	DNA	1000	\N	\N	\N	\N
32386	NA_12-22582A_Tumor	\N	DNA	444	\N	\N	\N	\N
32387	NA_12-22587_Tumor	\N	DNA	773	\N	\N	\N	\N
32388	NA_12-22592_Tumor	\N	DNA	670	\N	\N	Scalp	\N
32389	NA_12-22597_Tumor	\N	DNA	1000	\N	\N	\N	\N
32390	NA_12-22602A_Tumor	\N	DNA	1000	\N	\N	\N	\N
32391	NA_12-22602B_Tumor	\N	DNA	1000	\N	\N	\N	\N
32392	NA_12-22603_Tumor	\N	DNA	1000	\N	\N	Forehead	\N
32393	NA_12-22604_Tumor	\N	DNA	278	\N	\N	\N	\N
32394	NA_12-22720A_Tumor	\N	DNA	370	\N	\N	Upper back	\N
32395	NA_12-22868_Tumor	\N	DNA	1000	\N	\N	\N	\N
32396	NA_12-22884C_Tumor	\N	DNA	1000	\N	\N	\N	\N
32397	NA_12-22884D_Tumor	\N	DNA	208	\N	\N	\N	\N
32398	NA_12-22886_Tumor	\N	DNA	1000	\N	\N	\N	\N
32399	NA_12-22894B_Tumor	\N	DNA	303	\N	\N	\N	\N
32400	NA_12-22898_Tumor	\N	DNA	981	\N	\N	\N	\N
32401	NA_12-22900_Tumor	\N	DNA	604	\N	\N	Eybrow	\N
32402	NA_WP11_Tumor	\N	DNA	100	\N	\N	\N	\N
32403	NA_WP23_Tumor	\N	DNA	100	\N	\N	\N	\N
32404	NA_WP29_Tumor	\N	DNA	100	\N	\N	\N	\N
32405	NA_PG8_Tumor	\N	DNA	100	\N	\N	\N	\N
32406	NA_KIT37_Tumor	\N	DNA	100	\N	\N	_Acral_NRAS	\N
32407	NA_KIT62_Tumor	\N	DNA	50	\N	\N	__Acral_NRAS	\N
32408	NA_KIT118_Tumor	\N	DNA	100	\N	\N	_Muc_NRAS	\N
32409	NA_KIT181_Tumor	\N	DNA	100	\N	\N	_Muc_BRAF	\N
32410	NA_KIT227_Tumor	\N	DNA	100	\N	\N	_Acral_WT	\N
32411	NA_KIT275_Tumor	\N	DNA	100	\N	\N	_Muc_BRAF	\N
32412	NA_Bivona-L1_Tumor	\N	DNA	100	\N	\N	\N	\N
32413	NA_Bivona-L2_Tumor	\N	DNA	100	\N	\N	\N	\N
32414	NA_Bivona-L3_Tumor	\N	DNA	100	\N	\N	\N	\N
32415	NA_Bivona-L4_Tumor	\N	DNA	100	\N	\N	\N	\N
32416	NA_Bivona-L5_Tumor	\N	DNA	100	\N	\N	\N	\N
32417	NA_Bivona-L6_Tumor	\N	DNA	100	\N	\N	\N	\N
32418	NA_10-41439_Melanoma	\N	DNA	62.5	\N	\N	\N	\N
32419	NA_10-41439_Nevus	\N	DNA	62.5	\N	\N	\N	\N
32420	NA_10-41439_Normal	\N	DNA	44.8	\N	\N	\N	\N
32421	NA_11-23681_Melanoma	\N	DNA	62.5	\N	\N	\N	\N
32422	NA_11-23681_Nevus	\N	DNA	62.5	\N	\N	\N	\N
32423	NA_11-23681_Normal	\N	DNA	33.04	\N	\N	\N	\N
32424	NA_11-37533_Melanoma	\N	DNA	33.88	\N	\N	\N	\N
32425	NA_11-37533_Nevus	\N	DNA	62.5	\N	\N	\N	\N
32426	NA_11-37533_Normal	\N	DNA	62.5	\N	\N	\N	\N
32427	NA_KIT262_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32428	NA_Dog12_Tumor	\N	DNA	45	\N	\N	sp-12-3436|mucosal melanoma +EIN	\N
32429	NA_Dog24_Tumor	\N	DNA	62.5	\N	\N	sp-07-8373|mucosal melanomas-non-pigmented	\N
32430	NA_Dog43_Tumor	\N	DNA	62.5	\N	\N	2990543-1|melanocytoma	\N
32431	NA_Dog55_Tumor	\N	DNA	62.5	\N	\N	3146318-1|acral melanoma	\N
32432	NA_HW3_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32433	NA_HW3_Normal	\N	DNA	62.5	\N	\N	\N	\N
32434	NA_HW4_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32435	NA_HW4_Normal	\N	DNA	62.50000000000001	\N	\N	\N	\N
32436	NA_HW6_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32437	NA_HW6_Normal	\N	DNA	62.5	\N	\N	\N	\N
32438	NA_10-86469_Tumor	\N	DNA	62.50000000000001	\N	\N	CGH11-029 Need to Get diagnosis from Iwei|NTRK3 Translocation case	\N
32439	NA_11-12273_Tumor	\N	DNA	62.5	\N	\N	CGH11-045 Need to Get diagnosis from Iwei|ROS1 Translocation case	\N
32440	NA_11-23710_Tumor	\N	DNA	62.5	\N	\N	CGH11-092 Need to Get diagnosis from Iwei|ROS1 Translocation case	\N
32441	NA_11-30426_Tumor	\N	DNA	62.5	\N	\N	CGH11-125 Need to Get diagnosis from Iwei|NTRK3 Translocation case	\N
32442	NA_11-31904_Tumor	\N	DNA	62.5	\N	\N	CGH11-194 Need to Get diagnosis from Iwei|BRAF Translocation case	\N
32443	NA_11-47644_Tumor	\N	DNA	60	\N	\N	CGH11-201 Need to Get diagnosis from Iwei|BRAF Translocation case	\N
32444	NA_MB_161_Tumor	\N	DNA	100	\N	\N	\N	\N
32445	NA_MB_161_Normal	\N	DNA	100	\N	\N	\N	\N
32446	NA_MB_327_Tumor	\N	DNA	100	\N	\N	\N	\N
32447	NA_MB_1454_Normal	\N	DNA	100	\N	\N	\N	\N
32448	NA_MB_760_Tumor	\N	DNA	100	\N	\N	\N	\N
32449	NA_MB_1418_Normal	\N	DNA	100	\N	\N	\N	\N
32450	NA_MB_1029_Tumor	\N	DNA	100	\N	\N	\N	\N
32451	NA_MB_1028_Normal	\N	DNA	100	\N	\N	\N	\N
32452	NA_MB_1046_Tumor	\N	DNA	100	\N	\N	\N	\N
32453	NA_MB_1036_Normal	\N	DNA	100	\N	\N	\N	\N
32454	NA_Bivona-L17_Tumor	\N	DNA	100	\N	\N	\N	\N
32455	NA_Bivona-L18_Tumor	\N	DNA	62.72	\N	\N	\N	\N
32456	NA_Bivona-L19_Tumor	\N	DNA	9.12	\N	\N	\N	\N
32457	NA_KIT53_Tumor	\N	DNA	100	\N	\N	_Acral_NRAS	\N
32458	NA_KIT313_Tumor	\N	DNA	100	\N	\N	_Mucosal	\N
32459	NA_HW2_Normal	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32460	NA_HW2_Tumor	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32461	NA_HW8_Normal	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32462	NA_HW8_Tumor	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32463	NA_HW9_Normal	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32464	NA_HW9_Tumor	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32465	NA_12-6981_Tumor	\N	DNA	100	\N	\N	CGH12-047 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32466	NA_10-55707_Tumor	\N	DNA	100	\N	\N	CGH10-013 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32467	NA_11-34950_Tumor	\N	DNA	100	\N	\N	CGH11-153 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32468	NA_11-8228_Tumor	\N	DNA	100	\N	\N	CGH11-036 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32469	NA_11-84681_Tumor	\N	DNA	100	\N	\N	CGH11-386 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32470	NA_WM3211_Tumor	\N	DNA	100	\N	\N	\N	\N
32471	NA_NB2107_Tumor	\N	DNA	100	\N	\N	\N	\N
32472	NA_London-L1_Tumor	\N	DNA	100	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N
32473	NA_London-L2_Tumor	\N	DNA	100	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N
32474	NA_Bivona-L7_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32475	NA_Bivona-L8_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32476	NA_Bivona-L9_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32477	NA_Bivona-L10_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32478	NA_Bivona-L11_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32479	NA_HWA1_Tumor	\N	DNA	100	\N	\N	Hong Wu	\N
32480	NA_HWA1_Normal	\N	DNA	34.3	\N	\N	Hong Wu	\N
32481	NA_HWA2_Tumor	\N	DNA	100	\N	\N	Hong Wu	\N
32482	NA_HWA2_Normal	\N	DNA	95.8	\N	\N	Hong Wu	\N
32483	NA_HWA3_Tumor	\N	DNA	100	\N	\N	Hong Wu	\N
32484	NA_HWA3_Normal	\N	DNA	67	\N	\N	Hong Wu	\N
32485	NA_HWA4_Tumor	\N	DNA	100	\N	\N	Hong Wu	\N
32486	NA_HWA4_Normal	\N	DNA	84.39999999999999	\N	\N	Hong Wu	\N
32487	NA_11-5482_Tumor	\N	DNA	100	\N	\N	CGH11-035 Iwei Translocation Case	\N
32488	NA_11-79158_Tumor	\N	DNA	100	\N	\N	CGH11-343 Iwei Translocation Case	\N
32489	NA_DP12-200_Tumor	\N	DNA	100	\N	\N	Dr. Lutzky's Case	\N
32490	NA_TissueCoreALKControl_Normal	\N	DNA	100	\N	\N	Tissue Core ALK | Barcode mismatch comment in note	\N
32491	NA_10-59344_Tumor	\N	DNA	74.30000000000001	\N	\N	CGH10-016 Iwei Translocation Case | Barcode mismatch comment in note	\N
32492	NA_11-16253_Tumor	\N	DNA	34	\N	\N	CGH11-060 Iwei Translocation Case	\N
32493	NA_11-61046_Tumor	\N	DNA	100	\N	\N	CGH11-252 Iwei Translocation Case	\N
32494	NA_10-56047_Tumor	\N	DNA	100	\N	\N	CGH10-017 Iwei Translocation Case	\N
32495	NA_12-67298_Tumor	\N	DNA	100	\N	\N	\N	\N
32496	NA_12-67298_Normal	\N	DNA	78.19999999999999	\N	\N	Less than 100 ng input for End Repair	\N
32497	NA_12-20321_Tumor	\N	DNA	100	\N	\N	\N	\N
32498	NA_11-96096_Normal	\N	DNA	100	\N	\N	\N	\N
32499	NA_MB1242_Tumor	\N	DNA	100	\N	\N	\N	\N
32500	NA_MB1241_Normal	\N	DNA	100	\N	\N	\N	\N
32501	NA_MB1423_Tumor	\N	DNA	100	\N	\N	\N	\N
32502	NA_MB1423_Normal	\N	DNA	100	\N	\N	\N	\N
32503	NA_MB1424__Tumor	\N	DNA	100	\N	\N	\N	\N
32504	NA_MB1421_Normal	\N	DNA	100	\N	\N	\N	\N
32505	NA_MB1429_Tumor	\N	DNA	100	\N	\N	\N	\N
32506	NA_MB1428_Normal	\N	DNA	100	\N	\N	\N	\N
32507	NA_12-71679_Tumor	\N	DNA	100	\N	\N	CGH12-317 	\N
32508	NA_12-80985B_Tumor	\N	DNA	74.55	\N	\N	CGH12-343 Less than 100 ng input for End Repair	\N
32509	NA_12-31996_Tumor	\N	DNA	100	\N	\N	CGH12-135 	\N
32510	NA_12-39632_Tumor	\N	DNA	30.3	\N	\N	CGH12-161 Less than 100 ng input for End Repair	\N
32511	NA_HWA5_Tumor	\N	DNA	100	\N	\N	\N	\N
32512	NA_HWA5_Normal	\N	DNA	82.60000000000002	\N	\N	\N	\N
32513	NA_HWA6_Tumor	\N	DNA	100	\N	\N	\N	\N
32514	NA_HWA6_Normal	\N	DNA	68.3	\N	\N	\N	\N
32515	NA_HWA7_Tumor	\N	DNA	86.49999999999999	\N	\N	\N	\N
32516	NA_HWA7_Normal	\N	DNA	100	\N	\N	\N	\N
32517	NA_HWA8_Tumor	\N	DNA	100	\N	\N	\N	\N
32518	NA_HWA8_Normal	\N	DNA	100	\N	\N	\N	\N
32519	NA_HWA9_Tumor	\N	DNA	100	\N	\N	\N	\N
32520	NA_HWA9_Normal	\N	DNA	100	\N	\N	\N	\N
32521	NA_HWA10_Tumor	\N	DNA	100	\N	\N	\N	\N
32522	NA_HWA10_Normal	\N	DNA	97.4	\N	\N	\N	\N
32523	NA_MB1617_Tumor	\N	DNA	100	\N	\N	\N	\N
32524	NA_MB1609_Normal	\N	DNA	32.09999999999999	\N	\N	\N	\N
32525	NA_WM51_Tumor	\N	DNA	100	\N	\N	Wistar	\N
32526	NA_wm3918_Tumor	\N	DNA	100	\N	\N	Wistar	\N
32527	NA_DM1_Normal	\N	DNA	34.3	\N	\N	\N	\N
32528	NA_DM1_Tumor	\N	DNA	100	\N	\N	\N	\N
32529	NA_DM2_Normal	\N	DNA	89.9	\N	\N	\N	\N
32530	NA_DM2_Tumor	\N	DNA	100	\N	\N	\N	\N
32531	NA_DM5_Normal	\N	DNA	32.59999999999999	\N	\N	\N	\N
32532	NA_DM5_Tumor	\N	DNA	38.3	\N	\N	\N	\N
32533	NA_DM7_Normal	\N	DNA	51.49999999999999	\N	\N	\N	\N
32534	NA_DM7_Tumor	\N	DNA	100	\N	\N	\N	\N
32535	NA_DM12_Normal	\N	DNA	100	\N	\N	\N	\N
32536	NA_DM12_Tumor	\N	DNA	100	\N	\N	\N	\N
32537	NA_DM13_Normal	\N	DNA	67.5	\N	\N	\N	\N
32538	NA_DM13_Tumor	\N	DNA	100	\N	\N	\N	\N
32539	NA_DM21_Normal	\N	DNA	39.6	\N	\N	\N	\N
32540	NA_DM21_Tumor	\N	DNA	16.4	\N	\N	\N	\N
32541	NA_DM93_Normal	\N	DNA	100	\N	\N	\N	\N
32542	NA_DM93_Tumor	\N	DNA	45.7	\N	\N	\N	\N
32543	NA_11-20375_Tumor	\N	DNA	\N	\N	\N	CGH11-078 Iwei Translocation Cases	\N
32544	NA_11-21491_Tumor	\N	DNA	\N	\N	\N	CGH11-080 Iwei Translocation Cases	\N
32545	NA_11-65778_Tumor	\N	DNA	\N	\N	\N	CGH11-281 Iwei Translocation Cases	\N
32546	NA_10-88482_Tumor	\N	DNA	\N	\N	\N	CGH10-058 Iwei Translocation Cases	\N
32547	NA_11-63178_Tumor	\N	DNA	\N	\N	\N	CGH11-283 Iwei Translocation Cases	\N
32548	NA_10-71761_Tumor	\N	DNA	\N	\N	\N	CGH10-020 Iwei Translocation Cases	\N
32549	NA_10-84478_Tumor	\N	DNA	\N	\N	\N	CGH10-049 Iwei Translocation Cases	\N
32550	NA_10-88475_Tumor	\N	DNA	\N	\N	\N	CGH11-020 Iwei Translocation Cases	\N
32551	NA_12-54296_Normal	\N	DNA	\N	\N	\N	\N	\N
32552	NA_12-54296_Tumor	\N	DNA	\N	\N	\N	\N	\N
32556	NA_WM1963_Tumor	\N	DNA	\N	\N	\N	\N	\N
32557	NA_WM8_Tumor	\N	DNA	\N	\N	\N	\N	\N
32558	NA_WM3912_Tumor	\N	DNA	\N	\N	\N	\N	\N
32559	NA_DM11_Tumor	\N	DNA	\N	\N	\N	\N	\N
32560	NA_DM11_Normal	\N	DNA	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	\N
32561	NA_DM14_Tumor	\N	DNA	\N	\N	\N	\N	\N
32562	NA_DM14_Normal	\N	DNA	\N	\N	\N	\N	\N
32563	NA_DM26_Tumor	\N	DNA	\N	\N	\N	\N	\N
32564	NA_DM26_Normal	\N	DNA	\N	\N	\N	\N	\N
32565	NA_DM28_Tumor	\N	DNA	\N	\N	\N	\N	\N
32566	NA_DM28_Normal	\N	DNA	\N	\N	\N	\N	\N
32567	NA_DM29_Tumor	\N	DNA	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	\N
32568	NA_DM29_Normal	\N	DNA	\N	\N	\N	\N	\N
32569	NA_DM34_Tumor	\N	DNA	\N	\N	\N	\N	\N
32570	NA_DM34_Normal	\N	DNA	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	\N
32571	NA_DM55_Tumor	\N	DNA	\N	\N	\N	\N	\N
32572	NA_DM55_Normal	\N	DNA	\N	\N	\N	\N	\N
32573	NA_DM79_Tumor	\N	DNA	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	\N
32574	NA_DM79_Normal	\N	DNA	\N	\N	\N	\N	\N
32575	NA_11-78845_Tumor	\N	DNA	100	\N	\N	CGH11-361 Iwei Translocation Project	\N
32576	NA_11-81405_Tumor	\N	DNA	12.4	\N	\N	CGH11-366 Iwei Translocation Project	\N
32577	NA_11-85075_Tumor	\N	DNA	84.3	\N	\N	CGH11-376 Iwei Translocation Project	\N
32578	NA_11-83908_Tumor	\N	DNA	69.4	\N	\N	CGH11-388 Iwei Translocation Project	\N
32579	NA_11-85859_Tumor	\N	DNA	100	\N	\N	CGH11-422 Iwei Translocation Project	\N
32580	NA_11-95663_Tumor	\N	DNA	94.6	\N	\N	CGH12-016 Iwei Translocation Project	\N
32581	NA_DM4_Tumor	\N	DNA	33.5	\N	\N	Hunter Dermoplastic Melanoma	\N
32582	NA_DM4_Normal	\N	DNA	97.8	\N	\N	Hunter Dermoplastic Melanoma	\N
32583	NA_DM95_Tumor	\N	DNA	73.6	\N	\N	Hunter Dermoplastic Melanoma	\N
32584	NA_DM95_Normal	\N	DNA	100	\N	\N	Hunter Dermoplastic Melanoma	\N
32585	NA_DM96_Tumor	\N	DNA	100	\N	\N	Hunter Dermoplastic Melanoma	\N
32586	NA_DM96_Normal	\N	DNA	29.5	\N	\N	Hunter Dermoplastic Melanoma	\N
32587	NA_KIT8_Tumor	\N	DNA	100	\N	\N	Alyssa Kit Mutations	\N
32588	NA_KIT21_Tumor	\N	DNA	100	\N	\N	Alyssa Kit Mutations	\N
32589	NA_KIT55_Tumor	\N	DNA	87	\N	\N	Alyssa Kit Mutations	\N
32590	NA_KIT76_Tumor	\N	DNA	100	\N	\N	Alyssa Kit Mutations	\N
32591	NA_W09-1121_Tumor	\N	DNA	85.9	\N	\N	N14_1	\N
32592	NA_W09-1121_Normal	\N	DNA	91.7	\N	\N	N14_2	\N
32593	NA_W10-143_Tumor	\N	DNA	100	\N	\N	N14_3	\N
32594	NA_S94-31062_Tumor	\N	DNA	100	\N	\N	N14_4	\N
32595	NA_S02-23636A02_Tumor	\N	DNA	100	\N	\N	N14_5	\N
32596	NA_S02-33818A03_Tumor	\N	DNA	100	\N	\N	N14_6	\N
32597	NA_S02-33818A03_Normal	\N	DNA	80.8	\N	\N	N14_7	\N
32598	NA_S05-7439A12_Tumor	\N	DNA	100	\N	\N	N14_8	\N
32599	NA_S05-41924_Tumor	\N	DNA	100	\N	\N	N14_9	\N
32600	NA_S06-47079A02_Tumor	\N	DNA	70.4	\N	\N	N14_10	\N
32601	NA_S08-4544A03_Tumor	\N	DNA	100	\N	\N	N14_11	\N
32602	NA_S10-26316A2_Tumor	\N	DNA	100	\N	\N	N14_12	\N
32603	NA_S10-44069A4_Tumor	\N	DNA	100	\N	\N	N14_13	\N
32604	NA_S11-38910A2_Tumor	\N	DNA	100	\N	\N	N14_14	\N
32605	NA_KIT192_Tumor	\N	DNA	100	\N	\N	N14_15	\N
32606	NA_KIT203_Tumor	\N	DNA	100	\N	\N	N14_16	\N
32607	NA_KR_166_Tumor	\N	DNA	53.90000000000001	\N	\N	blood derived.	\N
32608	NA_KR_2064_Tumor	\N	DNA	74.2	\N	\N	blood derived	\N
32609	NA_KR_2030_Tumor	\N	DNA	85.8	\N	\N	blood derived	\N
32610	NA_KR_177_Tumor	\N	DNA	100	\N	\N	blood derived	\N
32611	NA_KR_150_Tumor	\N	DNA	100	\N	\N	blood derived	\N
32612	NA_KR_229_Tumor	\N	DNA	54.1	\N	\N	blood derived	\N
32613	NA_KR_203_Tumor	\N	DNA	47.5	\N	\N	blood derived	\N
32614	NA_KR_8_Tumor	\N	DNA	88.6	\N	\N	blood derived	\N
32615	NA_KR_5233_Tumor	\N	DNA	100	\N	\N	blood	\N
32616	NA_KR_RMK0091B_Tumor	\N	DNA	100	\N	\N	skin	\N
32617	NA_KR_RMK0194C_Tumor	\N	DNA	100	\N	\N	Saliva-tube	\N
32618	NA_KR_RMK0137C_Tumor	\N	DNA	25	\N	\N	saliva | Barcode mismatch comment in note	\N
32619	NA_KR_RMK0162C_Tumor	\N	DNA	100	\N	\N	saliva | Barcode mismatch comment in note	\N
32620	NA_KR_RMK0168C_Tumor	\N	DNA	67.10000000000001	\N	\N	saliva	\N
32621	NA_11-23681A+C_Normal	\N	DNA	74.6	\N	\N	\N	\N
32622	NA_DM10_Tumor	\N	DNA	80.60000000000001	\N	\N	\N	\N
32623	NA_DM10_Normal	\N	DNA	97.8	\N	\N	\N	\N
32624	NA_DM17_Tumor	\N	DNA	100	\N	\N	\N	\N
32625	NA_DM17_Normal	\N	DNA	31.3	\N	\N	\N	\N
32626	NA_DM18_Tumor	\N	DNA	100	\N	\N	\N	\N
32627	NA_DM18_Normal	\N	DNA	100	\N	\N	\N	\N
32628	NA_DM22_Tumor	\N	DNA	100	\N	\N	\N	\N
32629	NA_DM22_Normal	\N	DNA	12	\N	\N	\N	\N
32630	NA_DM23_Tumor	\N	DNA	10.3	\N	\N	\N	\N
32631	NA_DM23_Normal	\N	DNA	30.8	\N	\N	\N	\N
32632	NA_DM25_Tumor	\N	DNA	24.5	\N	\N	\N	\N
32633	NA_DM25_Normal	\N	DNA	76.5	\N	\N	| Barcode mismatch comment in note	\N
32634	NA_DM6_Tumor	\N	DNA	90.1	\N	\N	| Barcode mismatch comment in note	\N
32635	NA_DM37_Tumor	\N	DNA	100	\N	\N	\N	\N
32636	NA_SM_1_Tumor	\N	DNA	100	\N	\N	\N	\N
32637	NA_SM_3_Tumor	\N	DNA	76.2	\N	\N	\N	\N
32638	NA_SM_4_Tumor	\N	DNA	95.20000000000002	\N	\N	\N	\N
32639	NA_SM_4_Normal	\N	DNA	23.3	\N	\N	\N	\N
32640	NA_SM_5_Tumor	\N	DNA	100	\N	\N	\N	\N
32641	NA_SM_5_Normal	\N	DNA	100	\N	\N	\N	\N
32642	NA_SM7_Tumor	\N	DNA	100	\N	\N	\N	\N
32643	NA_SM_8_Tumor	\N	DNA	98.4	\N	\N	\N	\N
32644	NA_SM_11_Tumor	\N	DNA	100	\N	\N	\N	\N
32645	NA_SM_12_Tumor	\N	DNA	39.6	\N	\N	\N	\N
32646	NA_SM_16_Tumor	\N	DNA	85.8	\N	\N	\N	\N
32647	NA_SM_16_Normal	\N	DNA	100	\N	\N	| Barcode mismatch comment in note	\N
32648	NA_SM_18_Tumor	\N	DNA	100	\N	\N	| Barcode mismatch comment in note	\N
32649	NA_DM42_Tumor	\N	DNA	100	\N	\N	\N	\N
32650	NA_DM43_Tumor	\N	DNA	91.8	\N	\N	\N	\N
32651	NA_DM48_Tumor	\N	DNA	44.79999999999998	\N	\N	\N	\N
32674	NA_07-04365_Normal	\N	DNA	35.5	\N	\N	\N	\N
32675	NA_07-14044A_Tumor	\N	DNA	68.9	\N	\N	\N	\N
32676	NA_07-14044A_Normal	\N	DNA	34.4	\N	\N	\N	\N
32652	NA_11-64496_Tumor	\N	DNA	100	\N	\N	CGH11-292 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32653	NA_11-71491_Tumor	\N	DNA	54.3	\N	\N	CGH11-305 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32654	NA_11-65756_Tumor	\N	DNA	54	\N	\N	CGH11-310 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32655	NA_11-74100_Tumor	\N	DNA	100	\N	\N	CGH11-319 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32656	NA_11-74517_Tumor	\N	DNA	60.2	\N	\N	CGH11-348 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32657	NA_10-74513_Tumor	\N	DNA	100	\N	\N	CGH10-028 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32658	NA_10-80009_Tumor	\N	DNA	100	\N	\N	CGH10-045 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32659	NA_10-91484_Tumor	\N	DNA	100	\N	\N	CGH10-062 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32660	NA_11-699_Tumor	\N	DNA	100	\N	\N	CGH11-011 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32661	NA_11-18560_Tumor	\N	DNA	100	\N	\N	CGH11-072 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32662	NA_11-20772_Tumor	\N	DNA	100	\N	\N	CGH11-087 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32663	NA_11-19877_Tumor	\N	DNA	100	\N	\N	CGH11-089 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32664	NA_11-35616_Tumor	\N	DNA	100	\N	\N	CGH11-147 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32665	NA_11-33856_Tumor	\N	DNA	100	\N	\N	CGH11-158 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32666	NA_11-38771_Tumor	\N	DNA	100	\N	\N	CGH11-166 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32667	NA_11-39639_Tumor	\N	DNA	100	\N	\N	CGH11-172 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32668	NA_08-27590_Tumor	\N	DNA	57.59999999999999	\N	\N	\N	\N
32669	NA_08-27590_Normal	\N	DNA	10.2	\N	\N	\N	\N
32670	NA_06-32942_Tumor	\N	DNA	69.80000000000001	\N	\N	\N	\N
32671	NA_06-52508_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32672	NA_06-52508_Normal	\N	DNA	39	\N	\N	\N	\N
32673	NA_07-04365_Tumor	\N	DNA	60.4	\N	\N	\N	\N
32677	NA_07-26247_Tumor	\N	DNA	71.7	\N	\N	\N	\N
32678	NA_09-37302_Tumor	\N	DNA	62.3	\N	\N	\N	\N
32679	NA_12-79358_Tumor	\N	DNA	100	\N	\N	Iwei, Translocation CGH BRAF	\N
32680	NA_12-81302_Tumor	\N	DNA	100	\N	\N	CGH12-345 Iwei, Translocation CGH NTRK1	\N
32681	NA_12-81749_Tumor	\N	DNA	88.5	\N	\N	CGH12-347 Iwei, Translocation CGH NTRK2	\N
32682	NA_12-97031_Tumor	\N	DNA	13.6	\N	\N	CGH13-003 Iwei, Translocation CGH BRAF	\N
32683	NA_12-98736_Tumor	\N	DNA	96.2	\N	\N	CGH13-009 Iwei, Translocation CGH NTRK1	\N
32684	NA_13-3874_Tumor	\N	DNA	100	\N	\N	CGH13-033 Iwei, Translocation CGH NTRK1	\N
32685	NA_13-3732_Tumor	\N	DNA	68.6	\N	\N	CGH13-034 Iwei, Translocation CGH NTRK1?	\N
32686	NA_13-3889_Tumor	\N	DNA	29.1	\N	\N	CGH13-041 Iwei, Translocation CGH NTRK3	\N
32687	NA_13-4090B_Tumor	\N	DNA	100	\N	\N	CGH13-044 Iwei, Translocation CGH NTRK3	\N
32688	NA_13-4136_Tumor	\N	DNA	71.1	\N	\N	CGH13-046 Iwei, Translocation CGH BRAF	\N
32689	NA_13-7186_Tumor	\N	DNA	100	\N	\N	CGH13-058 Iwei, Translocation CGH NTRK3	\N
32690	NA_13-25A_Tumor	\N	DNA	100	\N	\N	CGH13-011 Iwei, Translocation CGH BRAF	\N
32691	NA_11-71241_Tumor	\N	DNA	76.7	\N	\N	\N	\N
32692	NA_11-26903_Tumor	\N	DNA	77.6	\N	\N	\N	\N
32693	NA_11-28912B_Tumor	\N	DNA	99.7	\N	\N	\N	\N
32694	NA_11-5210D_Tumor	\N	DNA	62.60000000000001	\N	\N	\N	\N
32695	NA_10-83193_Tumor	\N	DNA	51	\N	\N	\N	\N
32696	NA_11-95856_Tumor	\N	DNA	76.10000000000001	\N	\N	\N	\N
32697	NA_10-23569A_Tumor	\N	DNA	77.39999999999999	\N	\N	\N	\N
32698	NA_09-92749_Tumor	\N	DNA	100	\N	\N	\N	\N
32699	NA_09-72944_Tumor	\N	DNA	53.2	\N	\N	\N	\N
32700	NA_10-46536_Tumor	\N	DNA	76	\N	\N	\N	\N
32701	NA_10-83613A_Tumor	\N	DNA	96.6	\N	\N	\N	\N
32702	NA_K1_1_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32703	NA_K1_2_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32704	NA_K1_3_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32705	NA_London-L20_Melanoma	\N	DNA	84.39999999999999	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32706	NA_London-L20_Normal	\N	DNA	39.52	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32707	NA_London-L20_Nevus	\N	DNA	17.172	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32708	NA_London-L15_Normal	\N	DNA	12.441	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32709	NA_London-L23C_Nevus	\N	DNA	4.968	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32710	NA_K1_9_Tumor	\N	DNA	5.236	\N	\N	\N	\N
32711	NA_K1_10_Tumor	\N	DNA	7.4	\N	\N	\N	\N
32712	NA_K1_11_Tumor	\N	DNA	1000	\N	\N	\N	\N
32713	NA_K1_12_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32714	NA_K1_13_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32715	NA_K1_14_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32716	NA_K1_15_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32717	NA_K1_16_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32718	NA_K1_17_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32719	NA_K1_18_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32720	NA_K1_19_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32721	NA_K1_20_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32722	NA_10-32987_Tumor	\N	DNA	75.1	\N	\N	\N	\N
32723	NA_06-08042_Tumor	\N	DNA	82.4	\N	\N	\N	\N
32724	NA_06-00911_Tumor	\N	DNA	74.2	\N	\N	\N	\N
32725	NA_06-21363_Tumor	\N	DNA	86.1	\N	\N	\N	\N
32726	NA_06-47334_Tumor	\N	DNA	75.3	\N	\N	\N	\N
32727	NA_S12-6332A5_Tumor	\N	DNA	100	\N	\N	\N	\N
32728	NA_S11-032523A1_Tumor	\N	DNA	97	\N	\N	\N	\N
32729	NA_S08-1463A2_Tumor	\N	DNA	100	\N	\N	\N	\N
32730	NA_S12-7093NG176-1_Tumor	\N	DNA	100	\N	\N	\N	\N
32731	NA_S10-7937B2_Tumor	\N	DNA	95.9	\N	\N	\N	\N
32732	NA_S11-21025B1_Tumor	\N	DNA	100	\N	\N	\N	\N
32733	NA_10-58663_Melanoma	\N	DNA	100	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32734	NA_10-58663_Nevus	\N	DNA	48.09999999999999	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32735	NA_10-58663_Normal	\N	DNA	11.3	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32736	NA_08-52519_Melanoma	\N	DNA	100	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32737	NA_08-52519_Nevus	\N	DNA	65.10000000000001	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32738	NA_08-52519_Normal	\N	DNA	17.6	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32739	NA_09-8165_Melanoma	\N	DNA	34.8	\N	\N	\N	\N
32740	NA_09-8165_Nevus	\N	DNA	11.4	\N	\N	\N	\N
32741	NA_09-8165_Normal	\N	DNA	20.7	\N	\N	\N	\N
32742	NA_08-46462_Melanoma	\N	DNA	94.9	\N	\N	\N	\N
32743	NA_08-46462_Nevus	\N	DNA	82.4	\N	\N	\N	\N
32744	NA_08-46462_Normal	\N	DNA	10.8	\N	\N	\N	\N
32745	NA_11-25808_Tumor	\N	DNA	45.09999999999999	\N	\N	CGH11-115 	\N
32746	NA_11-42027_Tumor	\N	DNA	100	\N	\N	CGH11-184 	\N
32747	NA_12-7775_Tumor	\N	DNA	100	\N	\N	CGH12-043 	\N
32748	NA_DM37_Normal	\N	DNA	62	\N	\N	\N	\N
32749	NA_DM45_Tumor	\N	DNA	31.6	\N	\N	\N	\N
32750	NA_DM45_Normal	\N	DNA	22	\N	\N	\N	\N
32751	NA_DM16_Tumor	\N	DNA	31.3	\N	\N	\N	\N
32752	NA_DM16_Normal	\N	DNA	100	\N	\N	\N	\N
32753	NA_DM77_Tumor	\N	DNA	57.2	\N	\N	\N	\N
32754	NA_DM77_Normal	\N	DNA	100	\N	\N	\N	\N
32755	NA_HWAcr_Tumor	\N	DNA	\N	\N	\N	\N	\N
32756	NA_DM94_Tumor	\N	DNA	69.6	\N	\N	\N	\N
32757	NA_DM94_Normal	\N	DNA	10.1	\N	\N	\N	\N
32758	NA_DM98_Tumor	\N	DNA	100	\N	\N	\N	\N
32759	NA_DM98_Normal	\N	DNA	89.59999999999997	\N	\N	\N	\N
32760	NA_DM99_Tumor	\N	DNA	12.6	\N	\N	\N	\N
32761	NA_DM99_Normal	\N	DNA	77.8	\N	\N	\N	\N
32762	NA_DM64_Tumor	\N	DNA	100	\N	\N	\N	\N
32763	NA_DM64_Normal	\N	DNA	35.8	\N	\N	\N	\N
32764	NA_DM51_Tumor	\N	DNA	100	\N	\N	\N	\N
32765	NA_DM58_Tumor	\N	DNA	100	\N	\N	\N	\N
32766	NA_DM59_Tumor	\N	DNA	100	\N	\N	\N	\N
32767	NA_DM31_Tumor	\N	DNA	16.2	\N	\N	\N	\N
32768	NA_DM36_Tumor	\N	DNA	28.6	\N	\N	\N	\N
32769	NA_DM74_Tumor	\N	DNA	12.2	\N	\N	\N	\N
32770	NA_08-43264_Melanoma	\N	DNA	21.6	\N	\N	\N	\N
32771	NA_08-43264_Nevus	\N	DNA	80.60000000000001	\N	\N	\N	\N
32772	NA_08-43264_Normal	\N	DNA	42.8	\N	\N	\N	\N
32773	NA_08-51219_Melanoma	\N	DNA	38.3	\N	\N	\N	\N
32774	NA_08-51219_Nevus	\N	DNA	100	\N	\N	\N	\N
32775	NA_08-51219_Normal	\N	DNA	21.4	\N	\N	\N	\N
32776	NA_S12-18826_Tumor	\N	DNA	40.7	\N	\N	\N	\N
32777	NA_11-81851_Melanoma	\N	DNA	100	\N	\N	\N	\N
32778	NA_11-81851_Nevus	\N	DNA	41.5	\N	\N	\N	\N
32779	NA_11-81851_Normal	\N	DNA	10.2	\N	\N	\N	\N
32780	NA_10-73024_Melanoma	\N	DNA	22.9	\N	\N	\N	\N
32781	NA_10-73024_Nevus	\N	DNA	11	\N	\N	\N	\N
32782	NA_10-73024_Normal	\N	DNA	10.1	\N	\N	\N	\N
32783	NA_12_M_Tumor	\N	DNA	75.7	\N	\N	\N	\N
32784	NA_35_M_Tumor	\N	DNA	100	\N	\N	\N	\N
32785	NA_49_M_Tumor	\N	DNA	100	\N	\N	\N	\N
32786	NA_10-0206_Tumor	\N	DNA	100	\N	\N	\N	\N
32787	NA_09-0209_Tumor	\N	DNA	100	\N	\N	\N	\N
32788	NA_13-25110A1_Melanoma	\N	DNA	46.7	\N	\N	\N	\N
32789	NA_13-25110A1_Nevus	\N	DNA	14.3	\N	\N	\N	\N
32790	NA_13-25110A1_Normal	\N	DNA	19	\N	\N	\N	\N
32791	NA_13-45163_Melanoma	\N	DNA	100	\N	\N	\N	\N
32792	NA_13-45163_Nevus	\N	DNA	30.9	\N	\N	\N	\N
32793	NA_13-45163_Normal	\N	DNA	100	\N	\N	\N	\N
32794	NA_DM49_Tumor	\N	DNA	26.9	\N	\N	\N	\N
32795	NA_DP08-21965C_Tumor	\N	DNA	14	\N	\N	\N	\N
32796	NA_DP08-21965C_Normal	\N	DNA	20.5	\N	\N	\N	\N
32797	NA_DP08-4205A_Tumor	\N	DNA	78.5	\N	\N	\N	\N
32798	NA_DP08-4205A_Normal	\N	DNA	76.30000000000001	\N	\N	\N	\N
32799	NA_11-50182_Tumor	\N	DNA	51.40000000000001	\N	\N	CGH11-229 	\N
32800	NA_11-51553_Tumor	\N	DNA	100	\N	\N	CGH11-231 	\N
32801	NA_11-52339_Tumor	\N	DNA	67.8	\N	\N	CGH11-232 	\N
32802	NA_11-55993_Tumor	\N	DNA	70.9	\N	\N	CGH11-237 	\N
32803	NA_11-57051_Tumor	\N	DNA	93.5	\N	\N	CGH11-259 	\N
32804	NA_11-71006_Tumor	\N	DNA	31.1	\N	\N	CGH11-315 	\N
32805	NA_11-76464_Tumor	\N	DNA	100	\N	\N	CGH11-339 	\N
32806	NA_11-88431_Tumor	\N	DNA	22	\N	\N	\N	\N
32807	NA_11-88432_Tumor	\N	DNA	65.5	\N	\N	CGH11-404 	\N
32808	NA_11-88209_Tumor	\N	DNA	100	\N	\N	CGH11-409 	\N
32809	NA_Thomas_SK_MEL_23_Tumor	\N	DNA	45.7	\N	\N	\N	\N
32810	NA_KIT134_Tumor	\N	DNA	96.9	\N	\N	Alyssa Acral Mucosal DNA	\N
32811	NA_KIT191_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32812	NA_KIT205_Tumor	\N	DNA	68.8	\N	\N	Alyssa Acral Mucosal DNA	\N
32813	NA_KIT206_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32814	NA_KIT210_Tumor	\N	DNA	65.19999999999999	\N	\N	Alyssa Acral Mucosal DNA	\N
32815	NA_KIT217_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32816	NA_KIT225_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32817	NA_KIT244_Tumor	\N	DNA	77.5	\N	\N	Alyssa Acral Mucosal DNA	\N
32818	NA_KIT260_Tumor	\N	DNA	89.39999999999999	\N	\N	Alyssa Acral Mucosal DNA	\N
32819	NA_KIT273_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32820	NA_KIT295_Tumor	\N	DNA	39.7	\N	\N	Alyssa Acral Mucosal DNA	\N
32821	NA_11-23878_Tumor	\N	DNA	100	\N	\N	CGH11-109 	\N
32822	NA_12-11041_Tumor	\N	DNA	100	\N	\N	CGH12-058 	\N
32823	NA_12-55584_Tumor	\N	DNA	100	\N	\N	CGH12-224 	\N
32824	NA_11-85416_Tumor	\N	DNA	93.2	\N	\N	CGH11-410 	\N
32825	NA_11-94134_Tumor	\N	DNA	100	\N	\N	CGH11-424 	\N
32826	NA_12-2898_Tumor	\N	DNA	89.5	\N	\N	CGH12-026 	\N
32827	NA_12-1782_Tumor	\N	DNA	82.90000000000003	\N	\N	CGH12-039 	\N
32828	NA_12-4251_Tumor	\N	DNA	100	\N	\N	CGH12-040 	\N
32829	NA_12-8171_Tumor	\N	DNA	100	\N	\N	CGH12-053 	\N
32830	NA_12-10777_Tumor	\N	DNA	78.3	\N	\N	CGH12-056 	\N
32831	NA_10_63051C_Normal	\N	DNA	100	\N	\N	\N	\N
32832	NA_DPN8_Normal	\N	DNA	67	\N	\N	\N	\N
32833	NA_DPN9_Normal	\N	DNA	22.6	\N	\N	\N	\N
32834	NA_DPN18_Normal	\N	DNA	10.1	\N	\N	\N	\N
32835	NA_11-21178_Tumor	\N	DNA	100	\N	\N	CGH11-091 	\N
32836	NA_13-212_Tumor	\N	DNA	71.4	\N	\N	\N	\N
32837	NA_KIT230_Tumor	\N	DNA	10.3	\N	\N	\N	\N
32838	NA_KIT297_Tumor	\N	DNA	100	\N	\N	\N	\N
32839	NA_KIT302_Tumor	\N	DNA	100	\N	\N	\N	\N
32840	NA_KIT316_Tumor	\N	DNA	100	\N	\N	\N	\N
32841	NA_DM6_Normal	\N	DNA	72	\N	\N	\N	\N
32842	NA_DM31_Normal	\N	DNA	40.3	\N	\N	\N	\N
32843	NA_DM36_Normal	\N	DNA	47.40000000000001	\N	\N	\N	\N
32844	NA_DM42_Normal	\N	DNA	35.2	\N	\N	\N	\N
32845	NA_DM68_Tumor	\N	DNA	10	\N	\N	\N	\N
32846	NA_11-50270_Tumor	\N	DNA	25.6	\N	\N	CGH11-224 	\N
32847	NA_12-23578_Tumor	\N	DNA	71.2	\N	\N	CGH12-104 	\N
32848	NA_12-31421_Tumor	\N	DNA	71.6	\N	\N	CGH12-124 	\N
32849	NA_11-13661_Tumor	\N	DNA	\N	\N	\N	CGH11-051 	\N
32850	NA_RC11-001_Tumor	\N	DNA	\N	\N	\N	\N	\N
32851	NA_RC11-002_Tumor	\N	DNA	\N	\N	\N	\N	\N
32852	NA_RC11-003_Tumor	\N	DNA	\N	\N	\N	\N	\N
32853	NA_RC11-004_Tumor	\N	DNA	\N	\N	\N	\N	\N
32854	NA_RC11-005_Tumor	\N	DNA	\N	\N	\N	\N	\N
32855	NA_RC11-021_Tumor	\N	DNA	\N	\N	\N	\N	\N
32856	NA_RC11-022_Tumor	\N	DNA	\N	\N	\N	\N	\N
32857	NA_RC11-023_Tumor	\N	DNA	\N	\N	\N	\N	\N
32858	NA_RC11-024_Tumor	\N	DNA	\N	\N	\N	\N	\N
32859	NA_Kit298_Tumor	\N	DNA	\N	\N	\N	\N	\N
32860	NA_08-46462_Tumor	\N	DNA	11.4	\N	\N	\N	\N
32861	NA_BN_N1_Tumor	\N	DNA	100	\N	\N	\N	\N
32862	NA_BN_N2_Tumor	\N	DNA	100	\N	\N	\N	\N
32863	NA_BN_M1_Tumor	\N	DNA	100	\N	\N	\N	\N
32864	NA_BN_M2_Tumor	\N	DNA	100	\N	\N	\N	\N
32865	NA_SQ13-8208B_Tumor	\N	DNA	27.1	\N	\N	\N	\N
32866	NA_98-18400a_Tumor	\N	DNA	100	\N	\N	\N	\N
32867	NA_12-11406A_Tumor	\N	DNA	67.4	\N	\N	\N	\N
32868	NA_08-70283a_Tumor	\N	DNA	100	\N	\N	\N	\N
32869	NA_03-34051A1_Tumor	\N	DNA	100	\N	\N	\N	\N
32870	NA_02-42436_Tumor	\N	DNA	100	\N	\N	\N	\N
32871	NA_11-38149_Normal	\N	DNA	10.5	\N	\N	\N	\N
32872	NA_13-2939B_Tumor	\N	DNA	74.2	\N	\N	\N	\N
32873	NA_L13-48798_Tumor	\N	DNA	100	\N	\N	\N	\N
32874	NA_13-51115A_Tumor	\N	DNA	100	\N	\N	\N	\N
32875	NA_11-73238A_Normal	\N	DNA	100	\N	\N	\N	\N
32876	NA_11-73999_Normal	\N	DNA	93.5	\N	\N	\N	\N
32877	NA_DM43_Normal	\N	DNA	100	\N	\N	\N	\N
32878	NA_DM49_Normal	\N	DNA	100	\N	\N	\N	\N
32879	NA_DM58_Normal	\N	DNA	100	\N	\N	\N	\N
32880	NA_DM65_Tumor	\N	DNA	60.09999999999999	\N	\N	\N	\N
32881	NA_13-59840_Tumor	\N	DNA	100	\N	\N	\N	\N
32882	NA_Seider_Uveal_Tumor	\N	DNA	44.3	\N	\N	\N	\N
32883	NA_Luping_ROS_1_Tumor	\N	DNA	55	\N	\N	\N	\N
32884	NA_Seider_Roe_Tumor	\N	DNA	35.4	\N	\N	\N	\N
32885	NA_11-41004_Tumor	\N	DNA	100	\N	\N	CGH11-202 	\N
32886	NA_11-51223_Tumor	\N	DNA	84	\N	\N	CGH11-215 	\N
32887	NA_12-22542_Tumor	\N	DNA	100	\N	\N	CGH12-088 	\N
32888	NA_12-42406_Tumor	\N	DNA	100	\N	\N	CGH12-188 	\N
32889	NA_12-55875_Tumor	\N	DNA	100	\N	\N	CGH12-227 	\N
32890	NA_12-88454_Tumor	\N	DNA	100	\N	\N	CGH12-376 	\N
32891	NA_12-98328_Tumor	\N	DNA	100	\N	\N	CGH13-007 	\N
32892	NA_12-762B_Normal	\N	DNA	2.35	\N	\N	\N	\N
32893	NA_12-168B_Normal	\N	DNA	2.86	\N	\N	\N	\N
32894	NA_11-75173_Normal	\N	DNA	3.46	\N	\N	\N	\N
32895	NA_12-167B_Normal	\N	DNA	5.04	\N	\N	\N	\N
32896	NA_13-47668_Tumor	\N	DNA	8.57	\N	\N	\N	\N
32897	NA_12-66661_Tumor	\N	DNA	3.75	\N	\N	\N	\N
32898	NA_13-47621_Tumor	\N	DNA	2.53	\N	\N	\N	\N
32899	NA_13-37371_Tumor	\N	DNA	4.49	\N	\N	\N	\N
32900	NA_Acral-11_Tumor	\N	DNA	\N	\N	\N	_Tumor	\N
32901	NA_Acral-11_Normal	\N	DNA	\N	\N	\N	_Cntl	\N
32902	NA_Acral-12_Tumor	\N	DNA	\N	\N	\N	_Tumor	\N
32903	NA_Acral-12_Normal	\N	DNA	\N	\N	\N	_Cntl	\N
32904	NA_02-2599_Tumor	\N	DNA	\N	\N	\N	\N	\N
32905	NA_02-2599C_Tumor	\N	DNA	\N	\N	\N	\N	\N
32906	NA_DM48_Normal	\N	DNA	\N	\N	\N	\N	\N
32907	NA_DM59_Normal	\N	DNA	\N	\N	\N	\N	\N
32908	NA_DM68_Normal	\N	DNA	\N	\N	\N	\N	\N
32909	NA_08-46462_MIS	\N	DNA	\N	\N	\N	\N	\N
32910	NA_T07-1120_Tumor	\N	DNA	5.1792	\N	\N	\N	\N
32911	NA_T09-8069_Tumor	\N	DNA	7.8214	\N	\N	\N	\N
32912	NA_T02-16195_Tumor	\N	DNA	15.959	\N	\N	\N	\N
32913	NA_T00-12011_Tumor	\N	DNA	8.9639	\N	\N	\N	\N
32914	NA_T06-6855_Tumor	\N	DNA	1.0365	\N	\N	\N	\N
32915	NA_12-18832AA_Tumor	\N	DNA	16.6144	\N	\N	\N	\N
32916	NA_CNS52_Tumor	\N	DNA	0.2966	\N	\N	\N	\N
32917	NA_CNS53_Tumor	\N	DNA	9.2806	\N	\N	\N	\N
32918	NA_CNS54_Tumor	\N	DNA	6.3439	\N	\N	\N	\N
32919	NA_CNS57_Tumor	\N	DNA	13.1388	\N	\N	\N	\N
32920	NA_CNS57_Normal	\N	DNA	13.2164	\N	\N	\N	\N
32921	NA_BN-N1-Tert_Tumor	\N	DNA	0.1454	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N
32922	NA_BN-N2-Tert_Tumor	\N	DNA	0.1761	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N
32923	NA_BN-M1-Tert_Tumor	\N	DNA	0.179	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N
32924	NA_12-12039B_Tumor	\N	DNA	\N	\N	\N	\N	\N
32925	NA_12-22776B3_Tumor	\N	DNA	\N	\N	\N	\N	\N
32926	NA_99-29482_Tumor	\N	DNA	\N	\N	\N	\N	\N
32927	NA_99-15313_Tumor	\N	DNA	\N	\N	\N	\N	\N
32928	NA_99-885_Tumor	\N	DNA	\N	\N	\N	\N	\N
32929	NA_98-37643_Tumor	\N	DNA	\N	\N	\N	\N	\N
32930	NA_13-25288_Tumor	\N	DNA	\N	\N	\N	\N	\N
32931	NA_09-29997_Tumor	\N	DNA	\N	\N	\N	\N	\N
32932	NA_04-11158_Tumor	\N	DNA	\N	\N	\N	\N	\N
32933	NA_UM4_Tumor	\N	DNA	\N	\N	\N	\N	\N
32934	NA_UM5_Tumor	\N	DNA	\N	\N	\N	\N	\N
32935	NA_08-84352_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32936	NA_08-84352_Nevus	\N	DNA	\N	\N	\N	\N	\N
32937	NA_08-84352_Normal	\N	DNA	\N	\N	\N	\N	\N
32938	NA_11-88792_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32939	NA_11-88792_Nevus	\N	DNA	\N	\N	\N	\N	\N
32940	NA_11-88792_Normal	\N	DNA	\N	\N	\N	\N	\N
32941	NA_13-74952_Tumor	\N	DNA	\N	\N	\N	CGH13-324 	\N
32942	NA_13-75067_Tumor	\N	DNA	\N	\N	\N	CGH13-331 ETV6 Fusion	\N
32943	NA_Spitz_M1_Tumor	\N	DNA	\N	\N	\N	\N	\N
32944	NA_Spitz_M2_(?)_Tumor	\N	DNA	\N	\N	\N	\N	\N
32945	NA_Spitz_N1_Tumor	\N	DNA	\N	\N	\N	\N	\N
32946	NA_Spitz_N2_Tumor	\N	DNA	\N	\N	\N	\N	\N
32947	NA_Spitz_N3_Tumor	\N	DNA	\N	\N	\N	\N	\N
32948	NA_BN_Normal	\N	DNA	\N	\N	\N	\N	\N
32949	NA_13-159_Tumor	\N	DNA	\N	\N	\N	CGH13-016 	\N
32950	NA_12-43016_Tumor	\N	DNA	\N	\N	\N	CGH12-163 	\N
32951	NA_13-34291_Tumor	\N	DNA	\N	\N	\N	CGH13-166 	\N
32952	NA_GAK_DNA_Tumor	\N	DNA	\N	\N	\N	\N	\N
32953	NA_Yurif_DNA_Tumor	\N	DNA	\N	\N	\N	\N	\N
32954	NA_DPN26_Tumor	\N	DNA	\N	\N	\N	\N	\N
32955	NA_11-73238A_Tumor	\N	DNA	100	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32956	NA_MIN_7_Normal	\N	DNA	\N	\N	\N	\N	\N
32957	NA_MIN_7_Nevus	\N	DNA	\N	\N	\N	\N	\N
32958	NA_MIN_7_Tumor	\N	DNA	\N	\N	\N	\N	\N
32959	NA_MIN_8_Normal	\N	DNA	\N	\N	\N	\N	\N
32960	NA_MIN_8_Nevus	\N	DNA	\N	\N	\N	\N	\N
32961	NA_MIN_8_Tumor	\N	DNA	\N	\N	\N	\N	\N
32962	NA_501_Mel_Tumor	\N	DNA	\N	\N	\N	\N	\N
32963	NA_Sk_Mel_1_Tumor	\N	DNA	\N	\N	\N	\N	\N
32964	NA_DPN24_Tumor	\N	DNA	\N	\N	\N	\N	\N
32965	NA_DPN28_Tumor	\N	DNA	\N	\N	\N	\N	\N
32966	NA_DPN29_Tumor	\N	DNA	\N	\N	\N	\N	\N
32967	NA_DPN31_Tumor	\N	DNA	\N	\N	\N	\N	\N
32968	NA_DPN33_Tumor	\N	DNA	\N	\N	\N	\N	\N
32969	NA_DPN40_Tumor	\N	DNA	\N	\N	\N	\N	\N
32970	NA_DPN41_Tumor	\N	DNA	\N	\N	\N	\N	\N
32971	NA_DPN42_Tumor	\N	DNA	\N	\N	\N	\N	\N
32972	NA_DPN44_Tumor	\N	DNA	\N	\N	\N	\N	\N
32973	NA_DPN45_Tumor	\N	DNA	\N	\N	\N	\N	\N
32974	NA_DPN46_Tumor	\N	DNA	\N	\N	\N	\N	\N
32975	NA_UM_6_Tumor	\N	DNA	\N	\N	\N	\N	\N
32976	NA_Birt_Hogg_Dube_Tumor	\N	DNA	\N	\N	\N	\N	\N
32977	NA_13-1939_Tumor	\N	DNA	\N	\N	\N	CGH13-027 NTRK3	\N
32978	NA_13-51657_Tumor	\N	DNA	\N	\N	\N	CGH13-268 MET	\N
32979	NA_13-89069_Tumor	\N	DNA	\N	\N	\N	CGH13-365 DPN-like Melanoma	\N
32980	NA_11-1051A_Tumor	\N	DNA	\N	\N	\N	CGH11-018 	\N
32981	NA_11-5480_Tumor	\N	DNA	\N	\N	\N	CGH11-027 	\N
32982	NA_10-73024_Tumor	\N	DNA	\N	\N	\N	\N	\N
32983	NA_09-33283_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32984	NA_09-33283_Nevus	\N	DNA	\N	\N	\N	\N	\N
32985	NA_09-31895_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32986	NA_09-31895_Nevus	\N	DNA	\N	\N	\N	\N	\N
32987	NA_09-31895_Normal	\N	DNA	\N	\N	\N	\N	\N
32988	NA_R29032-05_Tumor	\N	DNA	\N	\N	\N	\N	\N
32989	NA_R29032-05_Normal	\N	DNA	\N	\N	\N	\N	\N
32990	NA_01-8297_Tumor	\N	DNA	\N	\N	\N	\N	\N
32991	NA_01-8297_Normal	\N	DNA	\N	\N	\N	\N	\N
32992	NA_8298-01_Tumor	\N	DNA	\N	\N	\N	\N	\N
32993	NA_8298-01_Normal	\N	DNA	\N	\N	\N	\N	\N
32994	NA_08-53951_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32995	NA_08-53951_Nevus	\N	DNA	\N	\N	\N	\N	\N
32996	NA_13000212_Tumor	\N	DNA	\N	\N	\N	\N	\N
32997	NA_8528-05_Tumor	\N	DNA	\N	\N	\N	\N	\N
32998	NA_1286184b_Tumor	\N	DNA	\N	\N	\N	\N	\N
32999	NA_1286184b_Normal	\N	DNA	\N	\N	\N	\N	\N
33000	NA_206436_Tumor	\N	DNA	\N	\N	\N	\N	\N
33001	NA_35942-04_Tumor	\N	DNA	\N	\N	\N	\N	\N
33002	NA_15329-03_Normal	\N	DNA	\N	\N	\N	\N	\N
33003	NA_Z1188-03_Tumor	\N	DNA	\N	\N	\N	\N	\N
33004	NA_1185-03_Normal	\N	DNA	\N	\N	\N	\N	\N
33005	NA_14514-02_Tumor	\N	DNA	\N	\N	\N	\N	\N
33006	NA_15102-02_Normal	\N	DNA	\N	\N	\N	\N	\N
33007	NA_9116-05_Tumor	\N	DNA	\N	\N	\N	\N	\N
33008	NA_24516-06_Tumor	\N	DNA	\N	\N	\N	\N	\N
33009	NA_24516-06_Normal	\N	DNA	\N	\N	\N	\N	\N
33010	NA_07-3078_Tumor	\N	DNA	\N	\N	\N	\N	\N
33011	NA_B06-37358_Tumor	\N	DNA	\N	\N	\N	\N	\N
33012	NA_21590_Tumor	\N	DNA	\N	\N	\N	\N	\N
33013	NA_21590_Normal	\N	DNA	\N	\N	\N	\N	\N
33014	NA_A2A79@_Tumor	\N	DNA	\N	\N	\N	\N	\N
33015	NA_356A3-075_Tumor	\N	DNA	\N	\N	\N	\N	\N
33016	NA_20847-09_Normal	\N	DNA	\N	\N	\N	\N	\N
33017	NA_525_Tumor	\N	DNA	\N	\N	\N	\N	\N
33018	NA_PMM_23_Tumor	\N	DNA	\N	\N	\N	\N	\N
33019	NA_PMM_23_Normal	\N	DNA	\N	\N	\N	\N	\N
33020	NA_UM7_Tumor	\N	DNA	\N	\N	\N	\N	\N
33021	NA_UM8_Tumor	\N	DNA	\N	\N	\N	\N	\N
33022	NA_UM9_Tumor	\N	DNA	\N	\N	\N	\N	\N
33023	NA_UM10_Tumor	\N	DNA	\N	\N	\N	\N	\N
33024	NA_UM11_Tumor	\N	DNA	\N	\N	\N	\N	\N
33025	NA_Xanthoma_Disseminatum_Tumor	\N	DNA	\N	\N	\N	\N	\N
33026	NA_13-94981_Tumor	\N	DNA	\N	\N	\N	CGH13-392 	\N
33027	NA_13-99411A_Tumor	\N	DNA	\N	\N	\N	CGH13-399 	\N
33028	NA_13-94484_Tumor	\N	DNA	\N	\N	\N	CGH13-394 	\N
33029	NA_DM27_Tumor	\N	DNA	\N	\N	\N	\N	\N
33030	NA_DM32_Tumor	\N	DNA	\N	\N	\N	\N	\N
33031	NA_DM35_Tumor	\N	DNA	\N	\N	\N	\N	\N
33032	NA_DM40_Tumor	\N	DNA	\N	\N	\N	\N	\N
33033	NA_H01.10457/II_Primary	\N	DNA	\N	\N	\N	\N	\N
33034	NA_H01.10457/II_Normal	\N	DNA	\N	\N	\N	\N	\N
33035	NA_14.20/II_Met1	\N	DNA	\N	\N	\N	\N	\N
33036	NA_HS14.18/I_Met2	\N	DNA	\N	\N	\N	\N	\N
33037	NA_HS14.19/D_Primary	\N	DNA	\N	\N	\N	\N	\N
33038	NA_HS14.19/D_Nevus	\N	DNA	\N	\N	\N	\N	\N
33039	NA_HS2014.15/7_Met1	\N	DNA	\N	\N	\N	\N	\N
33040	NA_HS2014.15/7_Normal	\N	DNA	\N	\N	\N	\N	\N
33041	NA_HS14.16_Primary	\N	DNA	\N	\N	\N	\N	\N
33042	NA_HS14.16_Normal	\N	DNA	\N	\N	\N	\N	\N
33043	NA_HS14.17/I_Met1	\N	DNA	\N	\N	\N	\N	\N
33044	NA_Long-TN1_Normal	\N	DNA	\N	\N	\N	\N	\N
33045	NA_Long-TN1_Tumor	\N	DNA	\N	\N	\N	\N	\N
33046	NA_Long-TN2_Normal	\N	DNA	\N	\N	\N	\N	\N
33047	NA_Long-TN2_Tumor	\N	DNA	\N	\N	\N	\N	\N
33048	NA_D326_Tumor	\N	DNA	\N	\N	\N	\N	\N
33049	NA_D366_Tumor	\N	DNA	\N	\N	\N	\N	\N
33050	NA_DPN48_Tumor	\N	DNA	\N	\N	\N	\N	\N
33051	NA_11-2532_Tumor	\N	DNA	\N	\N	\N	CGH11-023 	\N
33052	NA_AST-1_Tumor	\N	DNA	\N	\N	\N	\N	\N
33053	NA_08-18595B_Tumor	\N	DNA	\N	\N	\N	\N	\N
33054	NA_13-60273_Tumor	\N	DNA	\N	\N	\N	\N	\N
33055	NA_12-52454_Tumor	\N	DNA	\N	\N	\N	\N	\N
33056	NA_12-75125_Tumor	\N	DNA	\N	\N	\N	\N	\N
33057	NA_12-98235A_Tumor	\N	DNA	\N	\N	\N	\N	\N
33058	NA_13-3619B_Tumor	\N	DNA	\N	\N	\N	\N	\N
33059	NA_13-67500AL_Normal	\N	DNA	\N	\N	\N	\N	\N
33060	NA_13-19205_Tumor	\N	DNA	\N	\N	\N	\N	\N
33061	NA_13-48330_Tumor	\N	DNA	\N	\N	\N	\N	\N
33062	NA_13-11086_Tumor	\N	DNA	\N	\N	\N	\N	\N
33063	NA_13-15966_Tumor	\N	DNA	\N	\N	\N	\N	\N
33064	NA_13-39228_Tumor	\N	DNA	\N	\N	\N	\N	\N
33065	NA_13-45942_Tumor	\N	DNA	\N	\N	\N	\N	\N
33066	NA_13-49600_Tumor	\N	DNA	\N	\N	\N	\N	\N
33067	NA_13-59640_Tumor	\N	DNA	\N	\N	\N	\N	\N
33068	NA_13-67817_Tumor	\N	DNA	\N	\N	\N	\N	\N
33069	NA_SP-12-5612(1K)_Normal	\N	DNA	\N	\N	\N	\N	\N
33070	NA_SP-13-14992(1A)_Tumor	\N	DNA	\N	\N	\N	\N	\N
33071	NA_SP-12-2294-2(2A)_Normal	\N	DNA	\N	\N	\N	\N	\N
33072	NA_SP-13-17075(1B)_Tumor	\N	DNA	\N	\N	\N	\N	\N
33073	NA_SP-42-10361(1A)_Normal	\N	DNA	\N	\N	\N	\N	\N
33074	NA_SP-13-1038(1A)_Tumor	\N	DNA	\N	\N	\N	\N	\N
33075	NA_S13-13286A6_Tumor	\N	DNA	98.55999999999996	\N	\N	NTRK3	\N
33076	NA_S13-13286A6_Normal	\N	DNA	99.22	\N	\N	MET	\N
33077	NA_S11-20884A-A1_Tumor	\N	DNA	102	\N	\N	DPN-like Melanoma	\N
33078	NA_S11-20884A-A1_Normal	\N	DNA	101.06	\N	\N	\N	\N
33079	NA_S12-6218A-D3_Tumor	\N	DNA	101.66	\N	\N	\N	\N
33080	NA_S12-6218A-D3_Normal	\N	DNA	100.8	\N	\N	\N	\N
33081	NA_ZS06-11249A-C2_Tumor	\N	DNA	99.45	\N	\N	\N	\N
33082	NA_S12-26125A2_Tumor	\N	DNA	100.54	\N	\N	\N	\N
33083	NA_S12-28585A6_Tumor	\N	DNA	99.12	\N	\N	\N	\N
33084	NA_S11-2018B5_Tumor	\N	DNA	100.25	\N	\N	\N	\N
33085	NA_S13-11748F5_Tumor	\N	DNA	101.8	\N	\N	\N	\N
33086	NA_S12-7250E3_Tumor	\N	DNA	98.7	\N	\N	\N	\N
33087	NA_S13-3401B3_Tumor	\N	DNA	102.3	\N	\N	\N	\N
33088	NA_S13-12947A2_Tumor	\N	DNA	97.8	\N	\N	\N	\N
33089	NA_S13-18444A16_Tumor	\N	DNA	98.56	\N	\N	\N	\N
33090	NA_ZS07-1210F6_Tumor	\N	DNA	100.75	\N	\N	\N	\N
33091	NA_ZS10-11930B12_Tumor	\N	DNA	99.6	\N	\N	\N	\N
33092	NA_S12-28988_Tumor	\N	DNA	100.38	\N	\N	\N	\N
33093	NA_SSS13-1652B2_Tumor	\N	DNA	102.06	\N	\N	\N	\N
33094	NA_S13-5249_Tumor	\N	DNA	99.75	\N	\N	\N	\N
33095	NA_London-L1_Normal	\N	DNA	46	\N	\N	\N	\N
33096	NA_London-L1_Nevus	\N	DNA	68.4	\N	\N	\N	\N
33097	NA_London-L1_MIS	\N	DNA	40	\N	\N	\N	\N
33098	NA_London-L1_Melanoma	\N	DNA	68.4	\N	\N	\N	\N
33099	NA_London-L14_Normal	\N	DNA	40	\N	\N	\N	\N
33100	NA_London-L14_Nevus	\N	DNA	59.6	\N	\N	\N	\N
33101	NA_London-L14_Melanoma	\N	DNA	52.40000000000001	\N	\N	\N	\N
33102	NA_London-L14C_Normal	\N	DNA	40	\N	\N	\N	\N
33103	NA_London-L14C_Intermediate	\N	DNA	49.6	\N	\N	\N	\N
33104	NA_08-79358_Melanoma	\N	DNA	70.4	\N	\N	\N	\N
33105	NA_08-79358_Nevus	\N	DNA	81.19999999999999	\N	\N	\N	\N
33106	NA_08-79358_Normal	\N	DNA	100.86	\N	\N	\N	\N
33107	NA_09-45509_Melanoma	\N	DNA	100.62	\N	\N	\N	\N
33108	NA_09-45509_Nevus	\N	DNA	76.8	\N	\N	\N	\N
33109	NA_09-45509_Normal	\N	DNA	47.2	\N	\N	\N	\N
33110	NA_DM50_Tumor	\N	DNA	98.81	\N	\N	\N	\N
33111	NA_DM56_Tumor	\N	DNA	60	\N	\N	\N	\N
33112	NA_11-94204_Melanoma	\N	DNA	98.91	\N	\N	\N	\N
33113	NA_11-94204_Nevus	\N	DNA	76	\N	\N	\N	\N
33114	NA_11-94204_Normal	\N	DNA	41.2	\N	\N	\N	\N
33115	NA_London-L10_Normal	\N	DNA	46.8	\N	\N	\N	\N
33116	NA_London-L10_MIS	\N	DNA	99.62	\N	\N	\N	\N
33117	NA_London-L10_Melanoma	\N	DNA	98.56	\N	\N	\N	\N
33118	NA_London-L10_Intermediate	\N	DNA	40	\N	\N	\N	\N
33119	NA_London-L12_Normal	\N	DNA	100.8	\N	\N	\N	\N
33120	NA_London-L12_Nevus	\N	DNA	98.28	\N	\N	\N	\N
33121	NA_London-L12_Intermediate	\N	DNA	99.28	\N	\N	\N	\N
33122	NA_London-L16_Nevus	\N	DNA	40	\N	\N	\N	\N
33123	NA_London-L16_Melanoma	\N	DNA	99.33	\N	\N	\N	\N
33124	NA_London-L16A_Normal	\N	DNA	71.2	\N	\N	\N	\N
33125	NA_London-L16A_Nevus	\N	DNA	40.4	\N	\N	\N	\N
33126	NA_London-L16A_Melanoma	\N	DNA	100	\N	\N	\N	\N
33127	NA_London-L16B_Intermediate	\N	DNA	97.2	\N	\N	\N	\N
33128	NA_London-L16B_Normal	\N	DNA	101.06	\N	\N	\N	\N
33129	NA_DM15_Tumor	\N	DNA	40	\N	\N	\N	\N
33130	NA_DM19_Tumor	\N	DNA	48	\N	\N	\N	\N
33131	NA_DM46_Tumor	\N	DNA	43.6	\N	\N	\N	\N
33132	NA_140038340_Tumor	\N	DNA	100.1	\N	\N	\N	\N
33133	NA_140092090_Normal	\N	DNA	50.4	\N	\N	\N	\N
33134	NA_UM13_Tumor	\N	DNA	50	\N	\N	\N	\N
33135	NA_UM14_Tumor	\N	DNA	62.39999999999999	\N	\N	\N	\N
33136	NA_UM16_Tumor	\N	DNA	48	\N	\N	\N	\N
33137	NA_London-L17_Normal	\N	DNA	42	\N	\N	\N	\N
33138	NA_London-L17_Nevus	\N	DNA	101.32	\N	\N	\N	\N
33139	NA_London-L17_Melanoma	\N	DNA	98.75	\N	\N	\N	\N
33140	NA_GAK_Tumor	\N	DNA	60.4	\N	\N	\N	\N
33141	NA_Yurif_Tumor	\N	DNA	69.6	\N	\N	\N	\N
33142	NA_08-53951_M1	\N	DNA	40.4	\N	\N	\N	\N
33143	NA_08-53951_M2	\N	DNA	40.8	\N	\N	\N	\N
33144	NA_London-L18_Normal	\N	DNA	43.99999999999999	\N	\N	\N	\N
33145	NA_London-L18_Nevus	\N	DNA	40	\N	\N	\N	\N
33146	NA_London-L18_Melanoma	\N	DNA	65.60000000000001	\N	\N	\N	\N
33147	NA_London-L21_MIS	\N	DNA	101.36	\N	\N	\N	\N
33148	NA_London-L21_Intermediate	\N	DNA	98.79	\N	\N	\N	\N
33149	NA_London-L21_Normal	\N	DNA	40.4	\N	\N	\N	\N
33150	NA_14-16247_Tumor	\N	DNA	100	\N	\N	CGH14-059 	\N
33151	NA_13-35959_Tumor	\N	DNA	100	\N	\N	\N	\N
33152	NA_13-102610_Tumor	\N	DNA	100	\N	\N	\N	\N
33153	NA_13-99417_Tumor	\N	DNA	100	\N	\N	\N	\N
33154	NA_13-98534_Tumor	\N	DNA	100	\N	\N	\N	\N
33155	NA_13-32982A_Tumor	\N	DNA	100	\N	\N	\N	\N
33156	NA_13-9916_Tumor	\N	DNA	100	\N	\N	\N	\N
33157	NA_11-44609F_Tumor	\N	DNA	100	\N	\N	\N	\N
33158	NA_12-98575A1_Tumor	\N	DNA	100	\N	\N	\N	\N
33159	NA_DM60_Tumor	\N	DNA	49.6	\N	\N	\N	\N
33160	NA_DM61_Tumor	\N	DNA	54	\N	\N	\N	\N
33161	NA_DM62_Tumor	\N	DNA	90	\N	\N	\N	\N
33162	NA_DM63_Tumor	\N	DNA	86.8	\N	\N	\N	\N
33163	NA_DM66_Tumor	\N	DNA	40	\N	\N	\N	\N
33164	NA_DM67_Tumor	\N	DNA	45.2	\N	\N	\N	\N
33165	NA_DM69_Tumor	\N	DNA	60	\N	\N	\N	\N
33166	NA_DM70_Tumor	\N	DNA	100	\N	\N	\N	\N
33167	NA_DM81_Tumor	\N	DNA	100	\N	\N	\N	\N
33168	NA_London-L2_Normal	\N	DNA	85.19999999999999	\N	\N	\N	\N
33169	NA_London-L2_Intermediate	\N	DNA	96.4	\N	\N	\N	\N
33170	NA_London-L3_Normal	\N	DNA	40	\N	\N	\N	\N
33171	NA_London-L3_Intermediate	\N	DNA	70	\N	\N	\N	\N
33172	NA_S12-27617B9_Normal	\N	DNA	100	\N	\N	\N	\N
33173	NA_S12-25164A_Tumor	\N	DNA	100	\N	\N	\N	\N
33174	NA_S12-25164C1_Tumor	\N	DNA	100	\N	\N	\N	\N
33175	NA_London-L19_Normal	\N	DNA	76.8	\N	\N	\N	\N
33176	NA_London-L19_Nevus	\N	DNA	47.59999999999999	\N	\N	\N	\N
33177	NA_London-L19_Melanoma	\N	DNA	100	\N	\N	\N	\N
33178	NA_London-L19E_Normal	\N	DNA	57.59999999999999	\N	\N	\N	\N
33179	NA_London-L19E_Nevus	\N	DNA	94	\N	\N	\N	\N
33180	NA_London-L19E_Melanoma	\N	DNA	100	\N	\N	\N	\N
33181	NA_London-L22_MIS	\N	DNA	68.4	\N	\N	\N	\N
33182	NA_London-L22_Melanoma	\N	DNA	92.4	\N	\N	\N	\N
33183	NA_London-L22_Normal	\N	DNA	89.60000000000001	\N	\N	\N	\N
33184	NA_London-L23_Melanoma	\N	DNA	100	\N	\N	\N	\N
33185	NA_London-L23C_Normal	\N	DNA	68	\N	\N	\N	\N
33186	NA_London-L23C_Melanoma	\N	DNA	100	\N	\N	\N	\N
33187	NA_London-L23D_Normal	\N	DNA	41.6	\N	\N	\N	\N
33188	NA_London-L23D_Intermediate	\N	DNA	47.2	\N	\N	\N	\N
33189	NA_London-L6_Normal	\N	DNA	100	\N	\N	\N	\N
33190	NA_London-L6_Nevus	\N	DNA	100	\N	\N	\N	\N
33191	NA_XD-2_Tumor	\N	DNA	100	\N	\N	\N	\N
33192	NA_XD-2_Normal	\N	DNA	100	\N	\N	\N	\N
33193	NA_SP-13-006364_Normal	\N	DNA	100	\N	\N	\N	\N
33194	NA_SP-14-001249_Tumor	\N	DNA	100	\N	\N	\N	\N
33195	NA_SP-13-0185993A_Normal	\N	DNA	100	\N	\N	\N	\N
33196	NA_SP-13-0185992B_Tumor	\N	DNA	100	\N	\N	\N	\N
33197	NA_SP-12-003309B_Normal	\N	DNA	100	\N	\N	\N	\N
33198	NA_SP-13-0212981A_Tumor	\N	DNA	100	\N	\N	\N	\N
33199	NA_SP-13-0068754A_Normal	\N	DNA	100	\N	\N	\N	\N
33200	NA_SP-13-0068751C_Tumor	\N	DNA	100	\N	\N	\N	\N
33201	NA_SP-07-0116602_Normal	\N	DNA	100	\N	\N	\N	\N
33202	NA_12GS-2466_Tumor	\N	DNA	100	\N	\N	\N	\N
33203	NA_SP-09-0150202A_Normal	\N	DNA	54	\N	\N	\N	\N
33204	NA_SP-13-006535C_Tumor	\N	DNA	100	\N	\N	\N	\N
33205	NA_SP-10-003167A_Normal	\N	DNA	67.6	\N	\N	\N	\N
33206	NA_SP-13-009897_Tumor	\N	DNA	100	\N	\N	\N	\N
33207	NA_SP-12-0087723B_Normal	\N	DNA	100	\N	\N	\N	\N
33208	NA_SP-12-020017C_Tumor	\N	DNA	100	\N	\N	\N	\N
33209	NA_SP-12-0032671A_Normal	\N	DNA	100	\N	\N	\N	\N
33210	NA_SP-13-006337A_Tumor	\N	DNA	100	\N	\N	\N	\N
33211	NA_SP-12-0228802A_Normal	\N	DNA	100	\N	\N	\N	\N
33212	NA_SP-12-0228801A_Tumor	\N	DNA	100	\N	\N	\N	\N
33213	NA_SP-12-0146612A_Normal	\N	DNA	100	\N	\N	\N	\N
33214	NA_SP-12-01466111A_Tumor	\N	DNA	100	\N	\N	\N	\N
33215	NA_SP-10-004335_Normal	\N	DNA	100	\N	\N	\N	\N
33216	NA_SP-13-000848_Tumor	\N	DNA	100	\N	\N	\N	\N
33217	NA_M230_Tumor	\N	DNA	100	\N	\N	\N	\N
33218	NA_M257_Tumor	\N	DNA	100	\N	\N	\N	\N
33219	NA_M285_Tumor	\N	DNA	100	\N	\N	\N	\N
33220	NA_M368_Tumor	\N	DNA	100	\N	\N	\N	\N
33221	NA_M375_Tumor	\N	DNA	100	\N	\N	\N	\N
33222	NA_M418_Tumor	\N	DNA	100	\N	\N	\N	\N
33223	NA_C8161_Tumor	\N	DNA	100	\N	\N	\N	\N
33224	NA_London-L4_Normal	\N	DNA	42.40000000000001	\N	\N	\N	\N
33225	NA_London-L4_Nevus	\N	DNA	53.6	\N	\N	\N	\N
33226	NA_London-L5_Normal	\N	DNA	40.4	\N	\N	\N	\N
33227	NA_London-L5_Nevus	\N	DNA	41.2	\N	\N	\N	\N
33228	NA_London-L8_Normal	\N	DNA	51.6	\N	\N	\N	\N
33229	NA_London-L8_Nevus	\N	DNA	40.4	\N	\N	\N	\N
33230	NA_London-L9_Normal	\N	DNA	40	\N	\N	\N	\N
33231	NA_London-L9_Intermediate	\N	DNA	94.8	\N	\N	\N	\N
33232	NA_London-L13_Normal	\N	DNA	64.80000000000001	\N	\N	\N	\N
33233	NA_London-L13_Intermediate	\N	DNA	64.4	\N	\N	\N	\N
33234	NA_London-L15_Nevus	\N	DNA	70.4	\N	\N	\N	\N
33235	NA_London-L15_Melanoma	\N	DNA	100	\N	\N	\N	\N
33236	NA_1212_Tumor	\N	DNA	\N	\N	\N	\N	\N
33237	NA_1213_Tumor	\N	DNA	\N	\N	\N	\N	\N
33238	NA_1214_Tumor	\N	DNA	\N	\N	\N	\N	\N
33239	NA_3860_Tumor	\N	DNA	\N	\N	\N	\N	\N
33240	NA_UM17_Tumor	\N	DNA	101.44	\N	\N	\N	\N
33241	NA_S12-23475A6_Normal	\N	DNA	99.36	\N	\N	\N	\N
33242	NA_S12-23475A4_Tumor	\N	DNA	101.06	\N	\N	\N	\N
33243	NA_S12-23475C1_Tumor	\N	DNA	99	\N	\N	\N	\N
33244	NA_13-21725_Normal	\N	DNA	99.12	\N	\N	\N	\N
33245	NA_SP-14-68521D_Tumor	\N	DNA	97.92	\N	\N	\N	\N
33246	NA_SP-13-208365A_Normal	\N	DNA	98.4	\N	\N	\N	\N
33247	NA_SP-14-36134A_Tumor	\N	DNA	102.27	\N	\N	\N	\N
33248	NA_SP-14-73676A_Normal	\N	DNA	97.2	\N	\N	\N	\N
33249	NA_SP-14-73671M_Tumor	\N	DNA	100.59	\N	\N	\N	\N
33250	NA_SP-14-7691A_Normal	\N	DNA	101.14	\N	\N	\N	\N
33251	NA_SP-14-7691A_Tumor	\N	DNA	102.17	\N	\N	\N	\N
33252	NA_WM3928F_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33253	NA_C037_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33254	NA_C022_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33255	NA_UM15_Tumor	\N	DNA	5.236	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33256	NA_UM19_Tumor	\N	DNA	7.4	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33257	NA_UM20_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33258	NA_CP-1_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33259	NA_CP-2_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33260	NA_CP-3_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33261	NA_CP-4_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33262	NA_CP-5_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33263	NA_CP-6_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33264	NA_14-18_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33265	NA_14-19_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33266	NA_14-21_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33267	NA_XD-1_Tumor	\N	DNA	250	\N	\N	\N	\N
33268	NA_XD-1.1_Tumor	\N	DNA	250	\N	\N	\N	\N
33269	NA_PMM-8_Tumor	\N	DNA	\N	\N	\N	\N	\N
33270	NA_Long-TN10_Normal	\N	DNA	250	\N	\N	\N	\N
33271	NA_Long-TN10_Tumor	\N	DNA	250	\N	\N	\N	\N
33272	NA_Long-TN11_Normal	\N	DNA	39.4	\N	\N	\N	\N
33273	NA_Long-TN11_Tumor	\N	DNA	250	\N	\N	\N	\N
33274	NA_JBP-3_Normal	\N	DNA	63	\N	\N	\N	\N
33275	NA_JBP-3-MM_Tumor	\N	DNA	250	\N	\N	\N	\N
33276	NA_JBP-3-Met1_Tumor	\N	DNA	250	\N	\N	\N	\N
33277	NA_S12-15765B3_Tumor	\N	DNA	250	\N	\N	\N	\N
33278	NA_S12-4365A8_Normal	\N	DNA	241.5	\N	\N	\N	\N
33279	NA_S12-4365A7_Tumor	\N	DNA	85.5	\N	\N	\N	\N
33280	NA_S12-4365B1_Tumor	\N	DNA	250	\N	\N	\N	\N
33281	NA_S12-4365C1_Tumor	\N	DNA	250	\N	\N	\N	\N
33282	NA_S12-9606C4_Normal	\N	DNA	250	\N	\N	\N	\N
33283	NA_S12-9606EE_Tumor	\N	DNA	250	\N	\N	\N	\N
33284	NA_S12-9606A2_Tumor	\N	DNA	250	\N	\N	\N	\N
33285	NA_ZS10-972C2_Normal	\N	DNA	250	\N	\N	\N	\N
33286	NA_ZS10-972A9_Tumor	\N	DNA	250	\N	\N	\N	\N
33287	NA_JBP-7-Met_Tumor	\N	DNA	250	\N	\N	\N	\N
33288	NA_ZS10-1843A5_Normal	\N	DNA	250	\N	\N	\N	\N
33289	NA_ZS10-8439A4_Tumor	\N	DNA	89.3	\N	\N	\N	\N
33290	NA_ZS10-1843A4_Tumor	\N	DNA	250	\N	\N	\N	\N
33291	NA_ZS10-10558B1_Normal	\N	DNA	250	\N	\N	\N	\N
33292	NA_ZS10-10558A10_Tumor	\N	DNA	250	\N	\N	\N	\N
33293	NA_ZS10-10558C1_Tumor	\N	DNA	250	\N	\N	\N	\N
33294	NA_ZS10-3560F1_Normal	\N	DNA	250	\N	\N	\N	\N
33295	NA_ZS10-3560A3_Tumor	\N	DNA	250	\N	\N	\N	\N
33296	NA_ZS10-3560C1_Tumor	\N	DNA	250	\N	\N	\N	\N
33297	NA_UM23_Tumor	\N	DNA	250	\N	\N	\N	\N
33298	NA_UM24_Tumor	\N	DNA	13.536	\N	\N	\N	\N
33299	NA_UM25_Tumor	\N	DNA	31.396	\N	\N	\N	\N
33300	NA_UM26_Tumor	\N	DNA	2.35	\N	\N	\N	\N
33301	NA_TCR-Beta-1_Tumor	\N	DNA	250	\N	\N	\N	\N
33302	NA_TCR-Beta-2_Tumor	\N	DNA	250	\N	\N	\N	\N
33303	NA_SMU10-0457_Tumor	\N	DNA	\N	\N	\N	\N	\N
33304	NA_SMU10-0206_Tumor	\N	DNA	\N	\N	\N	\N	\N
33305	NA_SMU10-0240_Tumor	\N	DNA	\N	\N	\N	\N	\N
33306	NA_SCC10-0092_Tumor	\N	DNA	\N	\N	\N	\N	\N
33307	NA_MASCRI-432_Tumor	\N	DNA	\N	\N	\N	\N	\N
33308	NA_RPA08-0209_Tumor	\N	DNA	\N	\N	\N	\N	\N
33309	NA_RPA08-0315_Tumor	\N	DNA	\N	\N	\N	\N	\N
33310	NA_NZM52_Tumor	\N	DNA	\N	\N	\N	\N	\N
33311	NA_NZM40_Tumor	\N	DNA	\N	\N	\N	\N	\N
33312	NA_NZM91_Tumor	\N	DNA	\N	\N	\N	\N	\N
33313	NA_SP-13-198211A_Tumor	\N	DNA	\N	\N	\N	DH	\N
33314	NA_RNS11P15316B1_Normal	\N	DNA	\N	\N	\N	DH	\N
33315	NA_9246581-A3_Tumor	\N	DNA	\N	\N	\N	JG	\N
33316	NA_9246581-A6_Normal	\N	DNA	\N	\N	\N	JG	\N
33317	NA_DHM4855-14MP_Tumor	\N	DNA	\N	\N	\N	MLH	\N
33318	NA_SNPN08289D_Normal	\N	DNA	\N	\N	\N	MLH	\N
33319	NA_SP-10-143551E_Tumor	\N	DNA	\N	\N	\N	JM	\N
33320	NA_SP-10-143552A_Normal	\N	DNA	\N	\N	\N	JM	\N
33321	NA_04-SW-12-31366B1_Tumor	\N	DNA	\N	\N	\N	AH	\N
33322	NA_04-SW-12-31366B6_Normal	\N	DNA	\N	\N	\N	AH	\N
33323	NA_SP-13-63011A_Tumor	\N	DNA	\N	\N	\N	FN	\N
33324	NA_SP-11-160493A_Normal	\N	DNA	\N	\N	\N	FN	\N
33325	NA_SP-13-87981B_Tumor	\N	DNA	\N	\N	\N	GJ	\N
33326	NA_SP-11-40641B_Normal	\N	DNA	\N	\N	\N	GJ	\N
33327	NA_SP-14-125801B_Tumor	\N	DNA	\N	\N	\N	CG	\N
33328	NA_SP-14-125802A_Normal	\N	DNA	\N	\N	\N	CG	\N
33329	NA_WCRS97-025628_Tumor	\N	DNA	184.5	\N	\N	17	\N
33330	NA_SCHS10-026422_Tumor	\N	DNA	190.35	\N	\N	41	\N
33331	NA_SROS12-001198_Tumor	\N	DNA	250	\N	\N	90	\N
33332	NA_SROS09-001574_Tumor	\N	DNA	250	\N	\N	92	\N
33333	NA_SCHS09-005840-B5_Tumor	\N	DNA	250	\N	\N	93	\N
33334	NA_SACS05-011507_Tumor	\N	DNA	250	\N	\N	99	\N
33335	NA_FRSS09-009402-A1_Tumor	\N	DNA	250	\N	\N	105	\N
33336	NA_RCHS07-000380-B1_Tumor	\N	DNA	250	\N	\N	28	\N
33337	NA_SROS11-005030_Tumor	\N	DNA	250	\N	\N	30	\N
33338	NA_VALS09-000266_Tumor	\N	DNA	250	\N	\N	72	\N
33339	NA_SFOS09-007093_Tumor	\N	DNA	250	\N	\N	18	\N
33340	NA_FRSS09-008805_Tumor	\N	DNA	250	\N	\N	63	\N
33341	NA_RCHS06-004567_Tumor	\N	DNA	250	\N	\N	70	\N
33342	NA_VALS05-014946-E_Tumor	\N	DNA	250	\N	\N	54	\N
33343	NA_SCHS08-007754_Tumor	\N	DNA	250	\N	\N	2	\N
33344	NA_SFOS12-018173_Tumor	\N	DNA	250	\N	\N	5	\N
33345	NA_SROS00-001103_Tumor	\N	DNA	250	\N	\N	10	\N
33346	NA_MTZS94-007340_Tumor	\N	DNA	250	\N	\N	45	\N
33347	NA_SFOS94-003116_Tumor	\N	DNA	250	\N	\N	49	\N
33348	NA_SACS93-027850_Tumor	\N	DNA	250	\N	\N	27	\N
33349	NA_SCLS91-006557_Tumor	\N	DNA	250	\N	\N	68	\N
33350	NA_OAKS90-012369_Tumor	\N	DNA	250	\N	\N	9	\N
33351	NA_HAYS02-005731_Tumor	\N	DNA	250	\N	\N	98	\N
33352	NA_SRFS97-002805_Tumor	\N	DNA	250	\N	\N	67	\N
33353	NA_VALS03-019832_Tumor	\N	DNA	250	\N	\N	124	\N
33354	NA_SSCS03-014369_Tumor	\N	DNA	250	\N	\N	58	\N
33355	NA_RCHS01-003684_Tumor	\N	DNA	250	\N	\N	86	\N
33356	NA_WCRS99-012800_Tumor	\N	DNA	250	\N	\N	111	\N
33357	NA_HAYS90-005154_Tumor	\N	DNA	250	\N	\N	77	\N
33358	NA_SFOS00-016989_Tumor	\N	DNA	250	\N	\N	69	\N
33359	NA_VALS03-007457_Tumor	\N	DNA	250	\N	\N	117	\N
33360	NA_SFO93-005184_Tumor	\N	DNA	250	\N	\N	103	\N
33361	NA_DHM50691-14MP5C_Tumor	\N	DNA	250	\N	\N	\N	\N
33362	NA_DHM50691-14MP3_Normal	\N	DNA	250	\N	\N	\N	\N
33363	NA_RNS14P13907B1_Tumor	\N	DNA	250	\N	\N	\N	\N
33364	NA_SP-10-197431A_Normal	\N	DNA	122.8	\N	\N	\N	\N
33365	NA_DHM57444-14MP_Tumor	\N	DNA	250	\N	\N	\N	\N
33366	NA_SP-12-177322A_Normal	\N	DNA	250	\N	\N	\N	\N
33367	NA_DHM94457-13SK_Tumor	\N	DNA	250	\N	\N	\N	\N
33368	NA_DHM48742-12MPE_Normal	\N	DNA	250	\N	\N	\N	\N
33369	NA_Laverty13-88354_Tumor	\N	DNA	250	\N	\N	\N	\N
33370	NA_ICPMR19684.13A11_Normal	\N	DNA	250	\N	\N	\N	\N
33371	NA_SP-13-15691B_Tumor	\N	DNA	250	\N	\N	\N	\N
33372	NA_SP-13-15691D_Normal	\N	DNA	250	\N	\N	\N	\N
33373	NA_57059699_Tumor	\N	DNA	250	\N	\N	\N	\N
33374	NA_57269600_Tumor	\N	DNA	250	\N	\N	\N	\N
33375	NA_57213442_Tumor	\N	DNA	174.8	\N	\N	\N	\N
33376	NA_57346060_Tumor	\N	DNA	250	\N	\N	\N	\N
33377	NA_SROS10-009251_Tumor	\N	DNA	110	\N	\N	19	\N
33378	NA_FRSS99-007026_Tumor	\N	DNA	100	\N	\N	32	\N
33379	NA_SCLS04-001045_Tumor	\N	DNA	84.80000000000001	\N	\N	60	\N
33380	NA_OAKS96-014392-G_Tumor	\N	DNA	108	\N	\N	74	\N
33381	NA_OAKS96-022398_Tumor	\N	DNA	80.39999999999999	\N	\N	109	\N
33382	NA_OAK84-008979-B_Tumor	\N	DNA	100.4	\N	\N	112	\N
33383	NA_ROSS09-022626-A1_Tumor	\N	DNA	105.2	\N	\N	115	\N
33384	NA_SCHS11-018842-A1_Tumor	\N	DNA	101.6	\N	\N	119	\N
33385	NA_SSCS03-004945_Tumor	\N	DNA	\N	\N	\N	46	\N
33386	NA_WCRS02-022688_Tumor	\N	DNA	\N	\N	\N	47	\N
33387	NA_SACS02-020334_Tumor	\N	DNA	\N	\N	\N	100	\N
33388	NA_HAYS98-001046_Tumor	\N	DNA	\N	\N	\N	75	\N
33389	NA_SACS88-019073_Tumor	\N	DNA	\N	\N	\N	64	\N
33390	NA_SACS87-010145_Tumor	\N	DNA	\N	\N	\N	50	\N
33391	NA_STRS91-006237_Tumor	\N	DNA	\N	\N	\N	39	\N
33392	NA_SSCS92-009981_Tumor	\N	DNA	\N	\N	\N	22	\N
33393	NA_14-59304A_Normal	\N	DNA	44.325	\N	\N	\N	\N
33394	NA_14-59304A_Nevus	\N	DNA	102.15	\N	\N	\N	\N
33395	NA_13-48020_Normal	\N	DNA	32.04	\N	\N	\N	\N
33396	NA_13-48020_Nevus	\N	DNA	110.4	\N	\N	\N	\N
33397	NA_14-13499_Normal	\N	DNA	31.59	\N	\N	\N	\N
33398	NA_14-13499_Nevus	\N	DNA	110.7	\N	\N	\N	\N
33399	NA_13-64515B_Normal	\N	DNA	66.15	\N	\N	\N	\N
33400	NA_13-64515B_Nevus	\N	DNA	16.875	\N	\N	\N	\N
33401	NA_13-64515B_Tumor	\N	DNA	40.095	\N	\N	\N	\N
33402	NA_14-22939_Nevus	\N	DNA	37.62	\N	\N	\N	\N
33403	NA_14-22939_Tumor	\N	DNA	13.59	\N	\N	\N	\N
33404	NA_13-61146_Normal	\N	DNA	23.895	\N	\N	\N	\N
33405	NA_13-61146_Nevus	\N	DNA	105.25	\N	\N	\N	\N
33406	NA_13-61146_Tumor	\N	DNA	118.35	\N	\N	\N	\N
33407	NA_57001550_Tumor	\N	DNA	15.525	\N	\N	\N	\N
33408	NA_57291680_Tumor	\N	DNA	17.1	\N	\N	\N	\N
33409	NA_London-L3_Tumor	\N	DNA	\N	\N	\N	\N	\N
33410	NA_London-L13_Tumor	\N	DNA	\N	\N	\N	\N	\N
33411	NA_UM33_Tumor	\N	DNA	\N	\N	\N	\N	\N
33412	NA_UM35_A_Tumor	\N	DNA	\N	\N	\N	\N	\N
33413	NA_UM39_Tumor	\N	DNA	\N	\N	\N	\N	\N
33414	NA_UM40_Tumor	\N	DNA	\N	\N	\N	\N	\N
33415	NA_UM41_Tumor	\N	DNA	\N	\N	\N	\N	\N
33416	NA_UM36_Tumor	\N	DNA	\N	\N	\N	\N	\N
33417	NA_UM37_Tumor	\N	DNA	\N	\N	\N	\N	\N
33418	NA_57715138_Tumor	\N	DNA	742.5	\N	\N	\N	\N
33419	NA_332771_Tumor	\N	DNA	688.5	\N	\N	\N	\N
33420	NA_57723220_Tumor	\N	DNA	2.79	\N	\N	\N	\N
33421	NA_55875588_Tumor	\N	DNA	3.15	\N	\N	\N	\N
33422	NA_57714581_Tumor	\N	DNA	7.92	\N	\N	\N	\N
33423	NA_UM47_Tumor	\N	DNA	1.11	\N	\N	\N	\N
33424	NA_UM47_Normal	\N	DNA	59	\N	\N	\N	\N
33425	NA_Sample_KAM1-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33426	NA_Sample_KAM106-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33427	NA_Sample_KAM12-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33428	NA_Sample_KAM121-T-B_Tumor	\N	DNA	\N	\N	\N	\N	\N
33429	NA_Sample_KAM20-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33430	NA_Sample_KAM3-T-A_Tumor	\N	DNA	\N	\N	\N	\N	\N
33431	NA_Sample_KAM35-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33432	NA_Sample_KAM38-T-B_Tumor	\N	DNA	\N	\N	\N	\N	\N
33433	NA_Sample_KAM53-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33434	NA_Sample_KAM61-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33435	NA_Sample_KAM7-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33436	NA_Sample_KAM78-T-III_Tumor	\N	DNA	\N	\N	\N	\N	\N
33437	NA_Sample_KAM82-T-B8_Tumor	\N	DNA	\N	\N	\N	\N	\N
33438	NA_Sample_KAM84-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33439	NA_Sample_KAM94-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33440	NA_Sample_KAM96-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
27711	AM-17-Tumor_RNA	2015-02-25 00:00:00-08	RNA	\N	16	16	\N	\N
27729	AM-26-Tumor_RNA	2015-02-25 00:00:00-08	RNA	55	16	16	\N	\N
27713	AM-18-Tumor_RNA	2015-02-25 00:00:00-08	RNA	29.7	16	16	\N	\N
27725	AM-24-Tumor_RNA	2015-02-25 00:00:00-08	RNA	33.8	16	16	\N	\N
27707	AM-15-Tumor_RNA	2015-02-25 00:00:00-08	RNA	35.1	16	16	\N	\N
27741	AM-32-Tumor_RNA	2015-02-25 00:00:00-08	RNA	43.5	16	16	\N	\N
27737	AM-30-Tumor_RNA	2015-02-25 00:00:00-08	RNA	39.6	16	16	\N	\N
27717	AM-20-Tumor_RNA	2015-02-25 00:00:00-08	RNA	49.7	16	16	\N	\N
27739	AM-31-Tumor_RNA	2015-02-25 00:00:00-08	RNA	75	16	16	\N	\N
27731	AM-27-Tumor_RNA	2015-02-25 00:00:00-08	RNA	\N	16	16	\N	\N
27723	AM-23-Tumor_RNA	2015-02-25 00:00:00-08	RNA	73	16	16	\N	\N
27715	AM-19-Tumor_RNA	2015-02-25 00:00:00-08	RNA	77	16	16	\N	\N
27733	AM-28-Tumor_RNA	2015-02-25 00:00:00-08	RNA	37	16	16	\N	\N
27719	AM-21-Tumor_RNA	2015-02-25 00:00:00-08	RNA	39.3	16	16	\N	\N
27727	AM-25-Tumor_RNA	2015-02-25 00:00:00-08	RNA	42	16	16	\N	\N
27721	AM-22-Tumor_RNA	2015-02-25 00:00:00-08	RNA	67	16	16	\N	\N
27709	AM-16-Tumor_RNA	2015-02-25 00:00:00-08	RNA	22.6	16	16	\N	\N
27735	AM-29-Tumor_RNA	2015-02-25 00:00:00-08	RNA	69	16	16	\N	\N
\.


--
-- Data for Name: patients; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.patients (pat_id, sex, dob, race, source, blocks_temp, notes, pa_id, date_added, pat_ip_id) FROM stdin;
AM2-127	\N	\N	Unknown	UCSF	\N	\N	97	\N	\N
KF-11	\N	\N	Unknown	\N	\N	\N	781	\N	\N
LN-089	M	\N	Unknown	UCSF	\N	\N	902	\N	\N
OM-09	F	\N	Unknown	UCSF	\N	LEFT LABIUM MAJUS	1270	\N	\N
UV-01	\N	\N	Unknown	UCSF	MP41	Cell culture DNA from Xu	1392	\N	\N
SYNX245	F	\N	\N	\N	08-27590	NaN	1648	\N	IP736231
SYNX403	F	\N	\N	\N	12-11406A	NaN	1806	\N	IP1097222
AM2-001	\N	\N	Unknown	Bolivia	86502d,86502c,86502b,86502f, 86502d, 86502c, 86502b, 86502f	\N	1	\N	\N
AM2-002	\N	\N	Unknown	Bolivia	78821-1b,"78821-1a\n",78821-1c,78821-2a,78821-2b, 78821-1a\n, 78821-1b, 78821-1c, 78821-2a, 78821-2b	\N	2	\N	\N
AM2-004	\N	\N	Unknown	Bolivia	534-1-11.1,534-1-11.3,534-1-11.2, 534-1-11.1, 534-1-11.3, 534-1-11.2	\N	3	\N	\N
CME-008	\N	\N	Asian	Taiwan	13-50059	\N	310	\N	\N
SYNX1	M	\N	\N	\N	12-6261A,12-6261B	Cheek	1404	\N	IP1092077
SYNX2	M	\N	\N	\N	12-12366	NaN	1405	\N	IP1098182
SYNX3	F	\N	\N	\N	12-12467	NaN	1406	\N	IP1098283
SYNX4	M	\N	\N	\N	12-12470D	NaN	1407	\N	IP192328
SYNX5	M	\N	\N	\N	12-562	NaN	1408	\N	IP1042076
SYNX6	M	\N	\N	\N	12-12647	NaN	1409	\N	IP858006
SYNX7	F	\N	\N	\N	12-12626	Right Arm	1410	\N	IP1098442
SYNX9	M	\N	\N	\N	12-18438A	NaN	1412	\N	IP1104255
SYNX10	M	\N	\N	\N	12-13152	NaN	1413	\N	IP1098968
SYNX11	M	\N	\N	\N	12-12750B	Forehead	1414	\N	IP114451
SYNX12	F	\N	\N	\N	12-19596	NaN	1415	\N	IP1105413
SYNX13	F	\N	\N	\N	12-19187A	Shin	1416	\N	IP1105004
SYNX14	F	\N	\N	\N	12-22172	NaN	1417	\N	IP1107990
SYNX15	F	\N	\N	\N	12-21726A	NaN	1418	\N	IP1107544
SYNX16	M	\N	\N	\N	12-22901A	NaN	1419	\N	IP1108719
SYNX20	M	\N	\N	\N	12-22775	NaN	1423	\N	IP249102
SYNX21	M	\N	\N	\N	12-22794A	NaN	1424	\N	IP454633
SYNX22	F	\N	\N	\N	12-22573	NaN	1425	\N	IP1108391
SYNX23	F	\N	\N	\N	12-22582A	NaN	1426	\N	IP1108400
SYNX24	F	\N	\N	\N	12-22587	NaN	1427	\N	IP1108405
SYNX25	M	\N	\N	\N	12-22592	Scalp	1428	\N	IP559886
SYNX26	M	\N	\N	\N	12-22597	NaN	1429	\N	IP575947
SYNX27	F	\N	\N	\N	12-22602B,12-22602A	NaN	1430	\N	IP1081809
SYNX28	F	\N	\N	\N	12-22603	Forehead	1431	\N	IP1108421
SYNX29	M	\N	\N	\N	12-22604	NaN	1432	\N	IP1108422
SYNX31	F	\N	\N	\N	12-22868	NaN	1434	\N	IP1108686
SYNX32	F	\N	\N	\N	12-22884D,12-22884C	NaN	1435	\N	IP1108702
SYNX33	F	\N	\N	\N	12-22886	NaN	1436	\N	IP337537
SYNX34	M	\N	\N	\N	12-22894B	NaN	1437	\N	IP1108712
SYNX35	F	\N	\N	\N	12-22898	NaN	1438	\N	IP445158
SYNX36	M	\N	\N	\N	12-22900	Eybrow	1439	\N	IP2427054
SYNX40	NaN	\N	\N	\N	PG8	NaN	1443	\N	\N
SYNX41	NaN	\N	\N	\N	KIT37	_Acral_NRAS	1444	\N	\N
SYNX42	NaN	\N	\N	\N	KIT62	__Acral_NRAS	1445	\N	\N
SYNX43	NaN	\N	\N	\N	KIT118	_Muc_NRAS	1446	\N	\N
SYNX44	NaN	\N	\N	\N	KIT181	_Muc_BRAF	1447	\N	\N
SYNX45	NaN	\N	\N	\N	KIT227	_Acral_WT	1448	\N	\N
SYNX46	NaN	\N	\N	\N	KIT275	_Muc_BRAF	1449	\N	\N
SYNX53	M	\N	\N	\N	10-41439	NaN	1456	\N	IP936014
SYNX55	F	\N	\N	\N	11-37533	NaN	1458	\N	IP1021763
SYNX56	NaN	\N	\N	\N	KIT262	NaN	1459	\N	\N
SYNX57	NaN	\N	\N	\N	Dog12	sp-12-3436|mucosal melanoma +EIN	1460	\N	\N
SYNX58	NaN	\N	\N	\N	Dog24	sp-07-8373|mucosal melanomas-non-pigmented	1461	\N	\N
SYNX59	NaN	\N	\N	\N	Dog43	2990543-1|melanocytoma	1462	\N	\N
SYNX60	NaN	\N	\N	\N	Dog55	3146318-1|acral melanoma	1463	\N	\N
SYNX64	M	\N	\N	\N	10-86469	CGH11-029 Need to Get diagnosis from Iwei|NTRK3 Translocation case	1467	\N	IP981048
SYNX65	M	\N	\N	\N	11-12273	CGH11-045 Need to Get diagnosis from Iwei|ROS1 Translocation case	1468	\N	IP1001710
SYNX66	F	\N	\N	\N	11-23710	CGH11-092 Need to Get diagnosis from Iwei|ROS1 Translocation case	1469	\N	IP1013148
SYNX67	F	\N	\N	\N	11-30426	CGH11-125 Need to Get diagnosis from Iwei|NTRK3 Translocation case	1470	\N	IP1019864
SYNX68	F	\N	\N	\N	11-31904	CGH11-194 Need to Get diagnosis from Iwei|BRAF Translocation case	1471	\N	IP1021342
SYNX69	F	\N	\N	\N	11-47644	CGH11-201 Need to Get diagnosis from Iwei|BRAF Translocation case	1472	\N	IP1037083
SYNX70	NaN	\N	\N	\N	MB_161	NaN	1473	\N	\N
SYNX71	NaN	\N	\N	\N	MB_327	NaN	1474	\N	\N
SYNX72	NaN	\N	\N	\N	MB_1454	NaN	1475	\N	\N
SYNX73	NaN	\N	\N	\N	MB_760	NaN	1476	\N	\N
SYNX74	NaN	\N	\N	\N	MB_1418	NaN	1477	\N	\N
SYNX75	NaN	\N	\N	\N	MB_1029	NaN	1478	\N	\N
SYNX76	NaN	\N	\N	\N	MB_1028	NaN	1479	\N	\N
SYNX77	NaN	\N	\N	\N	MB_1046	NaN	1480	\N	\N
SYNX78	NaN	\N	\N	\N	MB_1036	NaN	1481	\N	\N
SYNX79	NaN	\N	\N	\N	Bivona-L17	NaN	1482	\N	\N
SYNX80	NaN	\N	\N	\N	Bivona-L18	NaN	1483	\N	\N
SYNX81	NaN	\N	\N	\N	Bivona-L19	NaN	1484	\N	\N
SYNX83	NaN	\N	\N	\N	KIT313	_Mucosal	1486	\N	\N
SYNX174	NaN	\N	\N	\N	DM95	Hunter Dermoplastic Melanoma	1577	\N	\N
SYNX87	F	\N	\N	\N	12-6981	CGH12-047 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	1490	\N	IP1092797
SYNX88	F	\N	\N	\N	10-55707	CGH10-013 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	1491	\N	IP950283
SYNX89	F	\N	\N	\N	11-34950	CGH11-153 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	1492	\N	IP1024388
SYNX90	M	\N	\N	\N	11-8228	CGH11-036 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	1493	\N	IP997665
SYNX91	F	\N	\N	\N	11-84681	CGH11-386 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	1494	\N	IP1074129
SYNX92	NaN	\N	\N	\N	WM3211	NaN	1495	\N	\N
SYNX93	NaN	\N	\N	\N	NB2107	NaN	1496	\N	\N
SYNX95	NaN	\N	\N	\N	London-L2	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	1498	\N	\N
SYNX105	F	\N	\N	\N	11-5482	CGH11-035 Iwei Translocation Case	1508	\N	IP994919
SYNX106	M	\N	\N	\N	11-79158	CGH11-343 Iwei Translocation Case	1509	\N	IP1068606
SYNX108	NaN	\N	\N	\N	TissueCoreALKControl	Tissue Core ALK | Barcode mismatch comment in note	1511	\N	\N
SYNX109	F	\N	\N	\N	10-59344	CGH10-016 Iwei Translocation Case | Barcode mismatch comment in note	1512	\N	IP953920
SYNX110	F	\N	\N	\N	11-16253	CGH11-060 Iwei Translocation Case	1513	\N	IP1005690
SYNX111	F	\N	\N	\N	11-61046	CGH11-252 Iwei Translocation Case	1514	\N	IP1050489
SYNX112	F	\N	\N	\N	10-56047	CGH10-017 Iwei Translocation Case	1515	\N	IP950623
SYNX113	F	\N	\N	\N	12-67298	NaN	1516	\N	IP960004
SYNX115	F	\N	\N	\N	11-96096	NaN	1518	\N	IP1085544
SYNX116	NaN	\N	\N	\N	MB1242	NaN	1519	\N	\N
SYNX117	NaN	\N	\N	\N	MB1241	NaN	1520	\N	\N
SYNX118	NaN	\N	\N	\N	MB1423	NaN	1521	\N	\N
SYNX120	NaN	\N	\N	\N	MB1421	NaN	1523	\N	\N
SYNX121	NaN	\N	\N	\N	MB1429	NaN	1524	\N	\N
SYNX122	NaN	\N	\N	\N	MB1428	NaN	1525	\N	\N
SYNX123	F	\N	\N	\N	12-71679	CGH12-317 	1526	\N	IP1157496
SYNX124	M	\N	\N	\N	12-80985B	CGH12-343 Less than 100 ng input for End Repair	1527	\N	IP1166802
SYNX125	F	\N	\N	\N	12-31996	CGH12-135 	1528	\N	IP1148421
SYNX126	F	\N	\N	\N	12-39632	CGH12-161 Less than 100 ng input for End Repair	1529	\N	IP1125450
SYNX133	NaN	\N	\N	\N	MB1617	NaN	1536	\N	\N
SYNX134	NaN	\N	\N	\N	MB1609	NaN	1537	\N	\N
SYNX135	NaN	\N	\N	\N	WM51	Wistar	1538	\N	\N
SYNX137	NaN	\N	\N	\N	DM1	NaN	1540	\N	\N
SYNX138	NaN	\N	\N	\N	DM2	NaN	1541	\N	\N
SYNX139	NaN	\N	\N	\N	DM5	NaN	1542	\N	\N
SYNX140	NaN	\N	\N	\N	DM7	NaN	1543	\N	\N
SYNX141	NaN	\N	\N	\N	DM12	NaN	1544	\N	\N
SYNX142	NaN	\N	\N	\N	DM13	NaN	1545	\N	\N
SYNX143	NaN	\N	\N	\N	DM21	NaN	1546	\N	\N
SYNX144	NaN	\N	\N	\N	DM93	NaN	1547	\N	\N
SYNX145	F	\N	\N	\N	11-20375	CGH11-078 Iwei Translocation Cases	1548	\N	IP1009813
SYNX146	M	\N	\N	\N	11-21491	CGH11-080 Iwei Translocation Cases	1549	\N	IP1010929
SYNX147	F	\N	\N	\N	11-65778	CGH11-281 Iwei Translocation Cases	1550	\N	IP1055221
SYNX148	M	\N	\N	\N	10-88482	CGH10-058 Iwei Translocation Cases	1551	\N	IP983061
SYNX149	F	\N	\N	\N	11-63178	CGH11-283 Iwei Translocation Cases	1552	\N	IP1052621
SYNX150	F	\N	\N	\N	10-71761	CGH10-020 Iwei Translocation Cases	1553	\N	IP966340
SYNX151	F	\N	\N	\N	10-84478	CGH10-049 Iwei Translocation Cases	1554	\N	IP979057
SYNX152	F	\N	\N	\N	10-88475	CGH11-020 Iwei Translocation Cases	1555	\N	IP983054
SYNX153	F	\N	\N	\N	12-54296	NaN	1556	\N	IP1140109
SYNX154	F	\N	\N	\N	12-54992	NaN	1557	\N	IP1140805
SYNX155	NaN	\N	\N	\N	WM3622	NaN	1558	\N	\N
SYNX156	NaN	\N	\N	\N	WM1963	NaN	1559	\N	\N
SYNX157	NaN	\N	\N	\N	WM8	NaN	1560	\N	\N
SYNX158	NaN	\N	\N	\N	WM3912	NaN	1561	\N	\N
SYNX159	NaN	\N	\N	\N	DM11	NaN	1562	\N	\N
SYNX160	NaN	\N	\N	\N	DM14	NaN	1563	\N	\N
SYNX161	NaN	\N	\N	\N	DM26	NaN	1564	\N	\N
SYNX162	NaN	\N	\N	\N	DM28	NaN	1565	\N	\N
SYNX163	NaN	\N	\N	\N	DM29	Less than the optimal 100 ng input conc. For End Repair	1566	\N	\N
SYNX164	NaN	\N	\N	\N	DM34	NaN	1567	\N	\N
SYNX165	NaN	\N	\N	\N	DM55	NaN	1568	\N	\N
SYNX166	NaN	\N	\N	\N	DM79	Less than the optimal 100 ng input conc. For End Repair	1569	\N	\N
SYNX167	F	\N	\N	\N	11-78845	CGH11-361 Iwei Translocation Project	1570	\N	IP1068293
SYNX168	F	\N	\N	\N	11-81405	CGH11-366 Iwei Translocation Project	1571	\N	IP1070853
SYNX169	F	\N	\N	\N	11-85075	CGH11-376 Iwei Translocation Project	1572	\N	IP1074523
SYNX170	F	\N	\N	\N	11-83908	CGH11-388 Iwei Translocation Project	1573	\N	IP1073356
SYNX171	F	\N	\N	\N	11-85859	CGH11-422 Iwei Translocation Project	1574	\N	IP1075307
SYNX172	F	\N	\N	\N	11-95663	CGH12-016 Iwei Translocation Project	1575	\N	IP1085111
SYNX173	NaN	\N	\N	\N	DM4	Hunter Dermoplastic Melanoma	1576	\N	\N
SYNX175	NaN	\N	\N	\N	DM96	Hunter Dermoplastic Melanoma	1578	\N	\N
SYNX176	NaN	\N	\N	\N	KIT8	Alyssa Kit Mutations	1579	\N	\N
SYNX177	NaN	\N	\N	\N	KIT21	Alyssa Kit Mutations	1580	\N	\N
SYNX178	NaN	\N	\N	\N	KIT55	Alyssa Kit Mutations	1581	\N	\N
SYNX179	NaN	\N	\N	\N	KIT76	Alyssa Kit Mutations	1582	\N	\N
SYNX192	NaN	\N	\N	\N	KIT192	N14_15	1595	\N	\N
SYNX193	NaN	\N	\N	\N	KIT203	N14_16	1596	\N	\N
SYNX194	NaN	\N	\N	\N	KR_166	blood derived.	1597	\N	\N
SYNX195	NaN	\N	\N	\N	KR_2064	blood derived	1598	\N	\N
SYNX196	NaN	\N	\N	\N	KR_2030	blood derived	1599	\N	\N
SYNX197	NaN	\N	\N	\N	KR_177	blood derived	1600	\N	\N
SYNX198	NaN	\N	\N	\N	KR_150	blood derived	1601	\N	\N
SYNX199	NaN	\N	\N	\N	KR_229	blood derived	1602	\N	\N
SYNX200	NaN	\N	\N	\N	KR_203	blood derived	1603	\N	\N
SYNX201	NaN	\N	\N	\N	KR_8	blood derived	1604	\N	\N
SYNX202	NaN	\N	\N	\N	KR_5233	blood	1605	\N	\N
SYNX203	NaN	\N	\N	\N	KR_RMK0091B	skin	1606	\N	\N
SYNX204	NaN	\N	\N	\N	KR_RMK0194C	Saliva-tube	1607	\N	\N
SYNX205	NaN	\N	\N	\N	KR_RMK0137C	saliva | Barcode mismatch comment in note	1608	\N	\N
SYNX206	NaN	\N	\N	\N	KR_RMK0162C	saliva | Barcode mismatch comment in note	1609	\N	\N
SYNX207	NaN	\N	\N	\N	KR_RMK0168C	saliva	1610	\N	\N
SYNX208	NaN	\N	\N	\N	DM10	NaN	1611	\N	\N
SYNX209	NaN	\N	\N	\N	DM17	NaN	1612	\N	\N
SYNX210	NaN	\N	\N	\N	DM18	NaN	1613	\N	\N
SYNX211	NaN	\N	\N	\N	DM22	NaN	1614	\N	\N
SYNX212	NaN	\N	\N	\N	DM23	NaN	1615	\N	\N
SYNX213	NaN	\N	\N	\N	DM25	NaN	1616	\N	\N
SYNX214	NaN	\N	\N	\N	DM6	| Barcode mismatch comment in note	1617	\N	\N
SYNX215	NaN	\N	\N	\N	DM37	NaN	1618	\N	\N
SYNX217	NaN	\N	\N	\N	SM_3	NaN	1620	\N	\N
SYNX218	NaN	\N	\N	\N	SM_4	NaN	1621	\N	\N
SYNX219	NaN	\N	\N	\N	SM_5	NaN	1622	\N	\N
SYNX220	NaN	\N	\N	\N	SM7	NaN	1623	\N	\N
SYNX222	NaN	\N	\N	\N	SM_11	NaN	1625	\N	\N
SYNX223	NaN	\N	\N	\N	SM_12	NaN	1626	\N	\N
SYNX224	NaN	\N	\N	\N	SM_16	NaN	1627	\N	\N
SYNX226	NaN	\N	\N	\N	DM42	NaN	1629	\N	\N
SYNX227	NaN	\N	\N	\N	DM43	NaN	1630	\N	\N
SYNX228	NaN	\N	\N	\N	DM48	NaN	1631	\N	\N
SYNX229	F	\N	\N	\N	11-64496	CGH11-292 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1632	\N	IP1053939
SYNX230	F	\N	\N	\N	11-71491	CGH11-305 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1633	\N	IP1060934
SYNX231	M	\N	\N	\N	11-65756	CGH11-310 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1634	\N	IP1055199
SYNX232	M	\N	\N	\N	11-74100	CGH11-319 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1635	\N	IP1063547
SYNX270	F	\N	\N	\N	10-23569A	NaN	1673	\N	IP918142
SYNX271	M	\N	\N	\N	09-92749	NaN	1674	\N	IP893515
SYNX233	M	\N	\N	\N	11-74517	CGH11-348 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1636	\N	IP1063964
SYNX234	F	\N	\N	\N	10-74513	CGH10-028 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1637	\N	IP969092
SYNX235	M	\N	\N	\N	10-80009	CGH10-045 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1638	\N	IP974588
SYNX236	F	\N	\N	\N	10-91484	CGH10-062 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1639	\N	IP986063
SYNX293	M	\N	\N	\N	10-32987	NaN	1696	\N	IP927561
SYNX294	NaN	\N	\N	\N	06-08042	NaN	1697	\N	\N
SYNX237	F	\N	\N	\N	11-699	CGH11-011 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1640	\N	IP990136
SYNX238	M	\N	\N	\N	11-18560	CGH11-072 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1641	\N	IP1007998
SYNX239	F	\N	\N	\N	11-20772	CGH11-087 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1642	\N	IP1010210
SYNX240	F	\N	\N	\N	11-19877	CGH11-089 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1643	\N	IP1009315
SYNX241	F	\N	\N	\N	11-35616	CGH11-147 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1644	\N	IP1025054
SYNX242	M	\N	\N	\N	11-33856	CGH11-158 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1645	\N	IP1023294
SYNX243	F	\N	\N	\N	11-38771	CGH11-166 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1646	\N	IP1028210
SYNX244	M	\N	\N	\N	11-39639	CGH11-172 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1647	\N	IP1029078
SYNX246	F	\N	\N	\N	06-32942	NaN	1649	\N	IP578011
SYNX247	M	\N	\N	\N	06-52508	NaN	1650	\N	IP597577
SYNX248	NaN	\N	\N	\N	07-04365	NaN	1651	\N	\N
SYNX249	M	\N	\N	\N	07-14044A	NaN	1652	\N	IP636575
SYNX250	F	\N	\N	\N	07-26247	NaN	1653	\N	IP208441
SYNX251	M	\N	\N	\N	09-37302	NaN	1654	\N	IP838065
SYNX252	M	\N	\N	\N	12-79358	Iwei, Translocation CGH BRAF	1655	\N	IP1165175
SYNX253	F	\N	\N	\N	12-81302	CGH12-345 Iwei, Translocation CGH NTRK1	1656	\N	IP1167119
SYNX254	M	\N	\N	\N	12-81749	CGH12-347 Iwei, Translocation CGH NTRK2	1657	\N	IP1167566
SYNX255	F	\N	\N	\N	12-97031	CGH13-003 Iwei, Translocation CGH BRAF	1658	\N	IP1182848
SYNX256	M	\N	\N	\N	12-98736	CGH13-009 Iwei, Translocation CGH NTRK1	1659	\N	IP1184553
SYNX257	M	\N	\N	\N	13-3874	CGH13-033 Iwei, Translocation CGH NTRK1	1660	\N	IP1188617
SYNX258	F	\N	\N	\N	13-3732	CGH13-034 Iwei, Translocation CGH NTRK1?	1661	\N	IP1188475
SYNX259	F	\N	\N	\N	13-3889	CGH13-041 Iwei, Translocation CGH NTRK3	1662	\N	IP1188632
SYNX260	M	\N	\N	\N	13-4090B	CGH13-044 Iwei, Translocation CGH NTRK3	1663	\N	IP1188833
SYNX261	M	\N	\N	\N	13-4136	CGH13-046 Iwei, Translocation CGH BRAF	1664	\N	IP1179510
SYNX262	M	\N	\N	\N	13-7186	CGH13-058 Iwei, Translocation CGH NTRK3	1665	\N	IP1191929
SYNX263	F	\N	\N	\N	13-25A	CGH13-011 Iwei, Translocation CGH BRAF	1666	\N	IP1184767
SYNX264	F	\N	\N	\N	11-71241	NaN	1667	\N	IP1060684
SYNX265	M	\N	\N	\N	11-26903	NaN	1668	\N	IP1016341
SYNX267	M	\N	\N	\N	11-5210D	NaN	1670	\N	IP873475
SYNX268	F	\N	\N	\N	10-83193	NaN	1671	\N	IP977772
SYNX269	M	\N	\N	\N	11-95856	NaN	1672	\N	IP1085304
SYNX272	F	\N	\N	\N	09-72944	NaN	1675	\N	IP563362
SYNX273	F	\N	\N	\N	10-46536	NaN	1676	\N	IP941112
SYNX274	M	\N	\N	\N	10-83613A	NaN	1677	\N	IP978192
SYNX295	NaN	\N	\N	\N	06-00911	NaN	1698	\N	\N
SYNX296	F	\N	\N	\N	06-21363	NaN	1699	\N	IP566429
SYNX297	F	\N	\N	\N	06-47334	NaN	1700	\N	IP454219
SYNX304	F	\N	\N	\N	10-58663	13 Cycle Post Hybridization LM-PCR	1707	\N	IP953239
SYNX305	F	\N	\N	\N	08-52519	13 Cycle Post Hybridization LM-PCR	1708	\N	IP761160
SYNX306	M	\N	\N	\N	09-8165	NaN	1709	\N	IP458841
SYNX307	M	\N	\N	\N	08-46462	NaN	1710	\N	IP755103
SYNX308	F	\N	\N	\N	11-25808	CGH11-115 	1711	\N	IP1015246
SYNX309	M	\N	\N	\N	11-42027	CGH11-184 	1712	\N	IP940410
SYNX310	F	\N	\N	\N	12-7775	CGH12-043 	1713	\N	IP1093591
SYNX311	NaN	\N	\N	\N	DM45	NaN	1714	\N	\N
SYNX312	NaN	\N	\N	\N	DM16	NaN	1715	\N	\N
SYNX313	NaN	\N	\N	\N	DM77	NaN	1716	\N	\N
SYNX315	NaN	\N	\N	\N	DM94	NaN	1718	\N	\N
SYNX316	NaN	\N	\N	\N	DM98	NaN	1719	\N	\N
SYNX317	NaN	\N	\N	\N	DM99	NaN	1720	\N	\N
SYNX318	NaN	\N	\N	\N	DM64	NaN	1721	\N	\N
SYNX319	NaN	\N	\N	\N	DM51	NaN	1722	\N	\N
SYNX320	NaN	\N	\N	\N	DM58	NaN	1723	\N	\N
SYNX321	NaN	\N	\N	\N	DM59	NaN	1724	\N	\N
SYNX322	NaN	\N	\N	\N	DM31	NaN	1725	\N	\N
SYNX323	NaN	\N	\N	\N	DM36	NaN	1726	\N	\N
SYNX324	NaN	\N	\N	\N	DM74	NaN	1727	\N	\N
SYNX325	F	\N	\N	\N	08-43264	NaN	1728	\N	IP179649
SYNX326	M	\N	\N	\N	08-51219	NaN	1729	\N	IP754897
SYNX328	F	\N	\N	\N	11-81851	NaN	1731	\N	IP1071299
SYNX329	M	\N	\N	\N	10-73024	NaN	1732	\N	IP967603
SYNX331	NaN	\N	\N	\N	35_M	NaN	1734	\N	\N
SYNX332	NaN	\N	\N	\N	49_M	NaN	1735	\N	\N
SYNX333	NaN	\N	\N	\N	10-0206	NaN	1736	\N	\N
SYNX334	NaN	\N	\N	\N	09-0209	NaN	1737	\N	\N
SYNX335	F	\N	\N	\N	13-25110A1	NaN	1738	\N	IP1209855
SYNX336	F	\N	\N	\N	13-45163	NaN	1739	\N	IP468757
SYNX337	NaN	\N	\N	\N	DM49	NaN	1740	\N	\N
SYNX340	M	\N	\N	\N	11-50182	CGH11-229 	1743	\N	IP1039621
SYNX341	F	\N	\N	\N	11-51553	CGH11-231 	1744	\N	IP1040993
SYNX342	F	\N	\N	\N	11-52339	CGH11-232 	1745	\N	IP1041779
SYNX343	F	\N	\N	\N	11-55993	CGH11-237 	1746	\N	IP1045436
SYNX344	M	\N	\N	\N	11-57051	CGH11-259 	1747	\N	IP1046494
SYNX345	F	\N	\N	\N	11-71006	CGH11-315 	1748	\N	IP1060449
SYNX346	M	\N	\N	\N	11-76464	CGH11-339 	1749	\N	IP1065911
SYNX347	M	\N	\N	\N	11-88431	NaN	1750	\N	IP1077879
SYNX348	F	\N	\N	\N	11-88432	CGH11-404 	1751	\N	IP1077880
SYNX349	M	\N	\N	\N	11-88209	CGH11-409 	1752	\N	IP1071369
SYNX350	NaN	\N	\N	\N	Thomas_SK_MEL_23	NaN	1753	\N	\N
SYNX351	NaN	\N	\N	\N	KIT134	Alyssa Acral Mucosal DNA	1754	\N	\N
SYNX352	NaN	\N	\N	\N	KIT191	Alyssa Acral Mucosal DNA	1755	\N	\N
SYNX353	NaN	\N	\N	\N	KIT205	Alyssa Acral Mucosal DNA	1756	\N	\N
SYNX354	NaN	\N	\N	\N	KIT206	Alyssa Acral Mucosal DNA	1757	\N	\N
SYNX355	NaN	\N	\N	\N	KIT210	Alyssa Acral Mucosal DNA	1758	\N	\N
SYNX356	NaN	\N	\N	\N	KIT217	Alyssa Acral Mucosal DNA	1759	\N	\N
SYNX357	NaN	\N	\N	\N	KIT225	Alyssa Acral Mucosal DNA	1760	\N	\N
SYNX358	NaN	\N	\N	\N	KIT244	Alyssa Acral Mucosal DNA	1761	\N	\N
SYNX359	NaN	\N	\N	\N	KIT260	Alyssa Acral Mucosal DNA	1762	\N	\N
SYNX360	NaN	\N	\N	\N	KIT273	Alyssa Acral Mucosal DNA	1763	\N	\N
SYNX361	NaN	\N	\N	\N	KIT295	Alyssa Acral Mucosal DNA	1764	\N	\N
SYNX363	F	\N	\N	\N	12-11041	CGH12-058 	1766	\N	IP1096857
SYNX364	F	\N	\N	\N	12-55584	CGH12-224 	1767	\N	IP1141397
SYNX365	F	\N	\N	\N	11-85416	CGH11-410 	1768	\N	IP1074864
SYNX366	F	\N	\N	\N	11-94134	CGH11-424 	1769	\N	IP1083582
SYNX367	F	\N	\N	\N	12-2898	CGH12-026 	1770	\N	IP1088714
SYNX368	M	\N	\N	\N	12-1782	CGH12-039 	1771	\N	IP1087598
SYNX369	F	\N	\N	\N	12-4251	CGH12-040 	1772	\N	IP1090067
SYNX370	M	\N	\N	\N	12-8171	CGH12-053 	1773	\N	IP1093987
SYNX371	F	\N	\N	\N	12-10777	CGH12-056 	1774	\N	IP1096593
SYNX374	NaN	\N	\N	\N	DPN9	NaN	1777	\N	\N
SYNX376	F	\N	\N	\N	11-21178	CGH11-091 	1779	\N	IP1010616
SYNX377	M	\N	\N	\N	13-212	NaN	1780	\N	IP1184954
SYNX378	NaN	\N	\N	\N	KIT230	NaN	1781	\N	\N
SYNX379	NaN	\N	\N	\N	KIT297	NaN	1782	\N	\N
SYNX380	NaN	\N	\N	\N	KIT302	NaN	1783	\N	\N
SYNX381	NaN	\N	\N	\N	KIT316	NaN	1784	\N	\N
SYNX382	NaN	\N	\N	\N	DM68	NaN	1785	\N	\N
SYNX383	F	\N	\N	\N	11-50270	CGH11-224 	1786	\N	IP1039709
SYNX384	F	\N	\N	\N	12-23578	CGH12-104 	1787	\N	IP1101847
SYNX385	M	\N	\N	\N	12-31421	CGH12-124 	1788	\N	IP1117239
SYNX386	M	\N	\N	\N	11-13661	CGH11-051 	1789	\N	IP1003098
SYNX397	NaN	\N	\N	\N	BN_N1	NaN	1800	\N	\N
SYNX398	NaN	\N	\N	\N	BN_N2	NaN	1801	\N	\N
SYNX399	NaN	\N	\N	\N	BN_M1	NaN	1802	\N	\N
SYNX400	NaN	\N	\N	\N	BN_M2	NaN	1803	\N	\N
SYNX402	F	\N	\N	\N	98-18400a	NaN	1805	\N	IP155973
SYNX404	F	\N	\N	\N	08-70283a	NaN	1807	\N	IP778923
SYNX405	M	\N	\N	\N	03-34051A1	NaN	1808	\N	IP392364
SYNX406	F	\N	\N	\N	02-42436	NaN	1809	\N	IP347170
SYNX266	M	\N	\N	\N	11-28912B,11-38149	NaN	1669	\N	IP1018350
SYNX407	M	\N	\N	\N	13-2939B	NaN	1810	\N	IP1187682
SYNX409	M	\N	\N	\N	13-51115A	NaN	1812	\N	IP380899
SYNX410	F	\N	\N	\N	11-73238A	NaN	1813	\N	IP987085
SYNX411	F	\N	\N	\N	11-73999	NaN	1814	\N	IP1063446
SYNX412	NaN	\N	\N	\N	DM65	NaN	1815	\N	\N
SYNX413	M	\N	\N	\N	13-59840	NaN	1816	\N	IP352453
SYNX414	NaN	\N	\N	\N	Seider_Uveal	NaN	1817	\N	\N
SYNX415	NaN	\N	\N	\N	Luping_ROS_1	NaN	1818	\N	\N
SYNX416	NaN	\N	\N	\N	Seider_Roe	NaN	1819	\N	\N
SYNX467	NaN	\N	\N	\N	BN	NaN	1870	\N	\N
SYNX597	M	\N	\N	\N	11-94204	NaN	2000	\N	IP1083652
SYNX616	F	\N	\N	\N	14-16247	CGH14-059 	2019	\N	IP1366169
SYNX617	F	\N	\N	\N	13-35959	NaN	2020	\N	IP1217226
SYNX618	F	\N	\N	\N	13-102610	NaN	2021	\N	IP1138765
SYNX619	F	\N	\N	\N	13-99417	NaN	2022	\N	IP2344638
SYNX620	M	\N	\N	\N	13-98534	NaN	2023	\N	IP1340550
SYNX621	M	\N	\N	\N	13-9916	NaN	2024	\N	IP1194427
SYNX622	M	\N	\N	\N	11-44609F	NaN	2025	\N	IP1029070
SYNX623	F	\N	\N	\N	12-98575A1	NaN	2026	\N	IP824297
SYNX624	NaN	\N	\N	\N	DM60	NaN	2027	\N	\N
SYNX625	NaN	\N	\N	\N	DM61	NaN	2028	\N	\N
SYNX626	NaN	\N	\N	\N	DM62	NaN	2029	\N	\N
SYNX627	NaN	\N	\N	\N	DM63	NaN	2030	\N	\N
SYNX628	NaN	\N	\N	\N	DM66	NaN	2031	\N	\N
SYNX629	NaN	\N	\N	\N	DM67	NaN	2032	\N	\N
SYNX630	NaN	\N	\N	\N	DM69	NaN	2033	\N	\N
SYNX631	NaN	\N	\N	\N	DM70	NaN	2034	\N	\N
SYNX632	NaN	\N	\N	\N	DM81	NaN	2035	\N	\N
SYNX633	NaN	\N	\N	\N	London-L3	NaN	2036	\N	\N
SYNX710	NaN	\N	\N	\N	XD-1	NaN	2113	\N	\N
SYNX711	NaN	\N	\N	\N	XD-1.1	NaN	2114	\N	\N
SYNX712	NaN	\N	\N	\N	PMM-8	NaN	2115	\N	\N
SYNX715	NaN	\N	\N	\N	JBP-3	NaN	2118	\N	\N
SYNX716	NaN	\N	\N	\N	JBP-3-MM	NaN	2119	\N	\N
SYNX717	NaN	\N	\N	\N	JBP-3-Met1	NaN	2120	\N	\N
SYNX723	NaN	\N	\N	\N	S12-9606C4	NaN	2126	\N	\N
SYNX725	NaN	\N	\N	\N	S12-9606A2	NaN	2128	\N	\N
SYNX728	NaN	\N	\N	\N	JBP-7-Met	NaN	2131	\N	\N
SYNX732	NaN	\N	\N	\N	ZS10-10558B1	NaN	2135	\N	\N
SYNX733	NaN	\N	\N	\N	ZS10-10558A10	NaN	2136	\N	\N
SYNX734	NaN	\N	\N	\N	ZS10-10558C1	NaN	2137	\N	\N
SYNX735	NaN	\N	\N	\N	ZS10-3560F1	NaN	2138	\N	\N
SYNX736	NaN	\N	\N	\N	ZS10-3560A3	NaN	2139	\N	\N
SYNX738	NaN	\N	\N	\N	UM23	NaN	2141	\N	\N
SYNX739	NaN	\N	\N	\N	UM24	NaN	2142	\N	\N
SYNX740	NaN	\N	\N	\N	UM25	NaN	2143	\N	\N
SYNX741	NaN	\N	\N	\N	UM26	NaN	2144	\N	\N
SYNX742	NaN	\N	\N	\N	TCR-Beta-1	NaN	2145	\N	\N
SYNX743	NaN	\N	\N	\N	TCR-Beta-2	NaN	2146	\N	\N
SYNX744	NaN	\N	\N	\N	CP1-80	NaN	2147	\N	\N
SYNX745	NaN	\N	\N	\N	CP1-40	NaN	2148	\N	\N
SYNX746	NaN	\N	\N	\N	CP1-20	NaN	2149	\N	\N
SYNX747	NaN	\N	\N	\N	CP1-10	NaN	2150	\N	\N
SYNX748	NaN	\N	\N	\N	CP1-5	NaN	2151	\N	\N
SYNX749	NaN	\N	\N	\N	CP1	NaN	2152	\N	\N
SYNX840	M	\N	\N	\N	14-59304A	NaN	2243	\N	IP1409245
SYNX843	M	\N	\N	\N	13-64515B	NaN	2246	\N	IP1292049
SYNX844	M	\N	\N	\N	14-22939	NaN	2247	\N	IP1372863
SYNAT1	\N	\N	\N	\N	00-001103, 00-001103B7	\N	2826	\N	\N
SYNAT2	\N	\N	\N	\N	01-003845	\N	2895	\N	\N
SYNAT3	\N	\N	\N	\N	09-80101A-2	\N	2651	\N	\N
SYNAT4	\N	\N	\N	\N	02-000540	\N	2547	\N	\N
SYNAT5	\N	\N	\N	\N	02-5203B2, 02-5203G2	\N	2330	\N	\N
SYNAT6	\N	\N	\N	\N	02-008514	\N	2706	\N	\N
SYNAT7	\N	\N	\N	\N	02-012396A	\N	2754	\N	\N
SYNAT8	\N	\N	\N	\N	02-020334-11	\N	2784	\N	\N
SYNAT9	\N	\N	\N	\N	02-20629	\N	2844	\N	IP325354
SYNAT10	\N	\N	\N	\N	02-23636A-02	\N	2489	\N	\N
SYNAT11	\N	\N	\N	\N	02-33818A-03	\N	2384	\N	\N
SYNAT12	\N	\N	\N	\N	03-197B2	\N	2683	\N	IP358509
SYNAT13	\N	\N	\N	\N	03-1978B3	\N	2949	\N	\N
SYNAT14	\N	\N	\N	\N	03-007239	\N	2499	\N	\N
SYNAT16	\N	\N	\N	\N	04-003736A	\N	2530	\N	\N
SYNAT17	\N	\N	\N	\N	04-9498	\N	2617	\N	IP425897
SYNAT18	\N	\N	\N	\N	04-37400	\N	2326	\N	IP453803
SYNAT19	\N	\N	\N	\N	05-006815	\N	2364	\N	\N
SYNAT20	\N	\N	\N	\N	05-7439A12	\N	2548	\N	IP484151
SYNAT21	\N	\N	\N	\N	05-011507	\N	2631	\N	\N
SYNAT22	\N	\N	\N	\N	05-015408	\N	2659	\N	\N
SYNX488	NaN	\N	\N	\N	DPN46	NaN	1891	\N	\N
SYNAT15	\N	\N	\N	\N	05-29484F, 05-29484E, 05-29484A, 05-29484B, 05-29484C, 05-29484D	\N	2817	\N	IP504172
SYNAT23	\N	\N	\N	\N	05-41924	\N	2285	\N	\N
MD-103	\N	\N	Unknown	Madrid, Spain	06-11147 N1	\N	999	\N	\N
SYNAT24	\N	\N	\N	\N	06-018998	\N	2425	\N	\N
SYNAT25	\N	\N	\N	\N	08-51220	\N	2467	\N	IP759861
SYNAT26	\N	\N	\N	\N	08-51221	\N	2701	\N	\N
SYNAT27	\N	\N	\N	\N	06-47079A02	\N	2518	\N	IP586773
SYNAT28	\N	\N	\N	\N	08-51222	\N	2836	\N	IP759863
SYNAT29	\N	\N	\N	\N	07-1210F6	\N	2848	\N	IP614870
SYNAT30	\N	\N	\N	\N	07-011660-2	\N	2526	\N	\N
SYNAT31	\N	\N	\N	\N	07-012236B1	\N	2363	\N	\N
SYNAT32	\N	\N	\N	\N	07-13061	\N	2543	\N	IP504172
SYNAT33	\N	\N	\N	\N	07-20501	\N	2726	\N	\N
SYNAT34	\N	\N	\N	\N	07-41091A, 07-41091B	\N	2620	\N	IP659911
SYNAT35	\N	\N	\N	\N	08-51223	\N	2859	\N	IP692531
SYNAT36	\N	\N	\N	\N	08-1463A2	\N	2511	\N	IP475429
SYNAT37	\N	\N	\N	\N	08-4205A	\N	2802	\N	IP700910
SYNAT38	\N	\N	\N	\N	08-4544A03	\N	2487	\N	IP424543
SYNAT39	\N	\N	\N	\N	08-018003	\N	2602	\N	\N
SYNAT40	\N	\N	\N	\N	08-21965C	\N	2447	\N	IP730606
SYNAT41	\N	\N	\N	\N	08-43265	\N	2940	\N	\N
SYNAT42	\N	\N	\N	\N	08-43266	\N	2763	\N	IP751907
SYNAT43	\N	\N	\N	\N	08-43267	\N	2351	\N	IP751908
SYNAT44	\N	\N	\N	\N	08-43268	\N	2950	\N	\N
SYNAT45	\N	\N	\N	\N	08-65412A, 08-65412B	\N	2816	\N	IP504172
SYNAT46	\N	\N	\N	\N	09-1121	\N	2711	\N	\N
SYNAT47	\N	\N	\N	\N	09-005840	\N	2576	\N	\N
SYNAT48	\N	\N	\N	\N	09-008704	\N	2401	\N	\N
SYNAT49	\N	\N	\N	\N	09-015020-2A	\N	2353	\N	\N
SYNAT50	\N	\N	\N	\N	09-22513A	\N	2822	\N	IP823276
SYNAT51	\N	\N	\N	\N	09-36483	\N	2872	\N	IP757083
SYNAT52	\N	\N	\N	\N	10-143	\N	2359	\N	\N
SYNAT53	\N	\N	\N	\N	10-972A9, 10-972A17, 10-972C2	\N	2647	\N	IP895542
SYNAT54	\N	\N	\N	\N	10-1843A4, 10-1843A5	\N	2575	\N	IP896413
SYNAT55	\N	\N	\N	\N	10-4769A	\N	2637	\N	IP852443
SYNAT56	\N	\N	\N	\N	10-006275	\N	2728	\N	\N
SYNAT57	\N	\N	\N	\N	10-7937B2	\N	2296	\N	IP164592
SYNAT58	\N	\N	\N	\N	10-008371A1	\N	2290	\N	\N
SYNAT59	\N	\N	\N	\N	10-8439A4	\N	2580	\N	IP903012
SYNAT60	\N	\N	\N	\N	10-11930B12	\N	2550	\N	IP906503
SYNAT62	\N	\N	\N	\N	10-26316A2	\N	2924	\N	IP666578
SYNAT63	\N	\N	\N	\N	10-42241	\N	2796	\N	\N
SYNAT64	\N	\N	\N	\N	10-44069A4	\N	2853	\N	IP929046
SYNAT65	\N	\N	\N	\N	10-63051C	\N	2833	\N	IP953239
SYNAT66	\N	\N	\N	\N	11-21025B1	\N	2546	\N	\N
SYNAT67	\N	\N	\N	\N	11-032523A1	\N	2792	\N	IP939446
SYNAT68	\N	\N	\N	\N	11-38910A2	\N	2644	\N	IP1028349
SYNAT69	\N	\N	\N	\N	11-62022	\N	2791	\N	IP948784
SYNAT70	\N	\N	\N	\N	12_20321A2	\N	2951	\N	\N
SYNAT71	\N	\N	\N	\N	12_54296	\N	2761	\N	\N
SYNAT72	\N	\N	\N	\N	12-4365A8, 12-4365B1, 12-4365C1, 12-4365C2	\N	2929	\N	IP39574
SYNAT73	\N	\N	\N	\N	12-004374B	\N	2380	\N	IP222047
SYNAT74	\N	\N	\N	\N	12-7093NG176-1	\N	2923	\N	\N
SYNAT75	\N	\N	\N	\N	12-15765B3	\N	2333	\N	IP1101581
SYNAT76	\N	\N	\N	\N	12-18826	\N	2482	\N	IP535712
SYNAT77	\N	\N	\N	\N	12-19018B	\N	2453	\N	IP1104835
SYNAT78	\N	\N	\N	\N	12-21933I	\N	2470	\N	\N
SYNAT80	\N	\N	\N	\N	12-22720A1	\N	2565	\N	IP118827
SYNAT81	\N	\N	\N	\N	12-22776B5	\N	2880	\N	IP1096148
SYNAT82	\N	\N	\N	\N	Cell-Line_Xu-46	\N	2479	\N	\N
SYNAT83	\N	\N	\N	\N	Cell-Line_Xu-47	\N	2389	\N	\N
SYNAT84	\N	\N	\N	\N	14-159A2	\N	2558	\N	\N
SYNAT85	\N	\N	\N	\N	13-2054	\N	2493	\N	IP1186796
SYNAT86	\N	\N	\N	\N	13-61266A	\N	2283	\N	\N
SYNAT87	\N	\N	\N	\N	13-006535C	\N	2814	\N	IP1191278
SYNAT88	\N	\N	\N	\N	13-8208B	\N	2739	\N	IP1192951
SYNAT89	\N	\N	\N	\N	13-9682	\N	2318	\N	\N
SYNAT90	\N	\N	\N	\N	13-10776A1	\N	2943	\N	\N
SYNAT91	\N	\N	\N	\N	13-12947A2	\N	2444	\N	IP1197690
SYNAT92	\N	\N	\N	\N	13-62943	\N	2612	\N	\N
SYNAT93	\N	\N	\N	\N	13-17202A11, 13-17202C4	\N	2867	\N	\N
SYNAT94	\N	\N	\N	\N	13-18444A16	\N	2676	\N	IP1203187
SYNAT95	\N	\N	\N	\N	13-46194	\N	2729	\N	\N
SYNAT96	\N	\N	\N	\N	13-48798	\N	2704	\N	IP1290801
SYNAT97	\N	\N	\N	\N	13-69386B	\N	2926	\N	\N
SYNAT98	\N	\N	\N	\N	13-90988	\N	2343	\N	\N
SYNAT99	\N	\N	\N	\N	14-3598	\N	2625	\N	\N
SYNAT100	\N	\N	\N	\N	14-4989D3	\N	2748	\N	\N
SYNAT101	\N	\N	\N	\N	14-5893	\N	2866	\N	IP370740
SYNAT102	\N	\N	\N	\N	14-13830	\N	2435	\N	\N
SYNAT103	\N	\N	\N	\N	14-32353	\N	2553	\N	\N
SYNAT104	\N	\N	\N	\N	14-37911A	\N	2862	\N	\N
SYNAT105	\N	\N	\N	\N	14-58566	\N	2525	\N	\N
SYNAT106	\N	\N	\N	\N	14-40331B	\N	2640	\N	IP1380659
SYNAT107	\N	\N	\N	\N	14-44611	\N	2666	\N	IP1394545
SYNAT108	\N	\N	\N	\N	14-58579	\N	2750	\N	IP1408520
SYNAT109	\N	\N	\N	\N	14-53094\t	\N	2474	\N	IP1403032
SYNAT110	\N	\N	\N	\N	14-53375	\N	2403	\N	IP1403313
SYNAT112	\N	\N	\N	\N	Cell-Line_Xu-31	\N	2302	\N	\N
SYNAT113	\N	\N	\N	\N	14-58586	\N	2634	\N	IP1408527
SYNAT114	\N	\N	\N	\N	14-58667	\N	2348	\N	IP1304478
SYNAT121	\N	\N	\N	\N	14-62335	\N	2338	\N	IP1412277
SYNAT122	\N	\N	\N	\N	14-66686B	\N	2445	\N	\N
SYNAT123	\N	\N	\N	\N	14-74770	\N	2299	\N	IP1424729
SYNAT124	\N	\N	\N	\N	14-80165	\N	2430	\N	IP1430130
SYNAT125	\N	\N	\N	\N	14-83646	\N	2289	\N	\N
SYNAT126	\N	\N	\N	\N	14-88685	\N	2857	\N	\N
SYNAT127	\N	\N	\N	\N	14-94217A	\N	2646	\N	IP1444208
SYNAT128	\N	\N	\N	\N	14-99831	\N	2355	\N	\N
SYNAT129	\N	\N	\N	\N	14-102015A	\N	2881	\N	\N
SYNAT130	\N	\N	\N	\N	14-106005	\N	2689	\N	IP1456016
SYNAT131	\N	\N	\N	\N	14-113574	\N	2905	\N	IP1463605
SYNAT132	\N	\N	\N	\N	14-118975	\N	2503	\N	\N
SYNAT133	\N	\N	\N	\N	15-3641	\N	2484	\N	\N
SYNAT134	\N	\N	\N	\N	15-6952	\N	2604	\N	IP1477972
SYNAT135	\N	\N	\N	\N	15-8321	\N	2519	\N	IP1448202
SYNAT136	\N	\N	\N	\N	15-16543B	\N	2408	\N	\N
SYNAT137	\N	\N	\N	\N	15-45455F	\N	2738	\N	\N
SYNAT138	\N	\N	\N	\N	Cell-Line_Xu-32	\N	2639	\N	\N
SYNAT139	\N	\N	\N	\N	Cell-Line_Xu-33	\N	2409	\N	\N
SYNAT140	\N	\N	\N	\N	17-8769A	\N	2890	\N	IP1576568
SYNAT141	\N	\N	\N	\N	Cell-Line_Xu-34	\N	2896	\N	\N
SYNAT142	\N	\N	\N	\N	17-43707	\N	2362	\N	\N
SYNAT143	\N	\N	\N	\N	Cell-Line_Xu-35	\N	2304	\N	\N
SYNAT144	\N	\N	\N	\N	Cell-Line_Xu-36	\N	2345	\N	\N
SYNAT145	\N	\N	\N	\N	Cell-Line_Xu-37	\N	2439	\N	\N
SYNAT146	\N	\N	\N	\N	Cell-Line_Xu-38	\N	2865	\N	\N
SYNAT147	\N	\N	\N	\N	Cell-Line_Xu-39	\N	2831	\N	\N
SYNAT148	\N	\N	\N	\N	Cell-Line_Xu-40	\N	2421	\N	\N
SYNAT149	\N	\N	\N	\N	61000/00 (LN)	\N	2811	\N	\N
SYNAT150	\N	\N	\N	\N	19-94061	\N	2476	\N	IP370740
SYNAT151	\N	\N	\N	\N	Cell-Line_Xu-41	\N	2777	\N	\N
SYNAT152	\N	\N	\N	\N	Cell-Line_Xu-42	\N	2315	\N	\N
SYNAT153	\N	\N	\N	\N	Cell-Line_Xu-43	\N	2404	\N	\N
SYNAT154	\N	\N	\N	\N	21-3841E1	\N	2864	\N	IP1199808
SYNAT155	\N	\N	\N	\N	Cell-Line_Xu-44	\N	2752	\N	\N
SYNAT156	\N	\N	\N	\N	21-21314	\N	2561	\N	\N
SYNAT157	\N	\N	\N	\N	21-21324	\N	2757	\N	\N
SYNAT158	\N	\N	\N	\N	96-6536	\N	2716	\N	IP77652
SYNAT159	\N	\N	\N	\N	22-80980	\N	2572	\N	IP2482899
SYNAT160	\N	\N	\N	\N	22-83923A	\N	2632	\N	IP2060770
SYNAT161	\N	\N	\N	\N	AM2_D-72	\N	2892	\N	\N
SYNAT162	\N	\N	\N	\N	Cell-Line_Xu-45	\N	2512	\N	\N
SYNAT163	\N	\N	\N	\N	22-107614	\N	2350	\N	IP2509746
SYNAT164	\N	\N	\N	\N	22-115635C4	\N	2783	\N	IP908318
SYNAT165	\N	\N	\N	\N	22-152373	\N	2442	\N	\N
SYNAT166	\N	\N	\N	\N	91-017419	\N	2454	\N	\N
SYNAT167	\N	\N	\N	\N	23-18865	\N	2910	\N	IP2557030
SYNAT168	\N	\N	\N	\N	23-83099	\N	2655	\N	IP2621535
SYNAT169	\N	\N	\N	\N	23-97273	\N	2449	\N	IP2626851
SYNAT171	\N	\N	\N	\N	90-012097B	\N	2829	\N	\N
SYNAT172	\N	\N	\N	\N	35_M	\N	2941	\N	\N
SYNAT173	\N	\N	\N	\N	92-003527H	\N	2808	\N	\N
SYNAT174	\N	\N	\N	\N	94-016368	\N	2736	\N	\N
SYNAT175	\N	\N	\N	\N	94-31062  	\N	2418	\N	\N
SYNAT176	\N	\N	\N	\N	95-007992	\N	2522	\N	\N
SYNAT177	\N	\N	\N	\N	98-001046	\N	2376	\N	\N
SYNAT178	\N	\N	\N	\N	98-019394	\N	2710	\N	\N
SYNAT179	\N	\N	\N	\N	99-005681	\N	2373	\N	\N
SYNAT180	\N	\N	\N	\N	99-012800, 99-012800-2	\N	2868	\N	\N
SYNAT181	\N	\N	\N	\N	144 Imat B15	\N	2765	\N	\N
SYNAT182	\N	\N	\N	\N	144 Imat B15-2	\N	2606	\N	\N
SYNAT183	\N	\N	\N	\N	144aI WT	\N	2649	\N	\N
SYNAT184	\N	\N	\N	\N	230 WT	\N	2875	\N	\N
SYNAT185	\N	\N	\N	\N	1205lu-1	\N	2360	\N	\N
SYNAT186	\N	\N	\N	\N	1205lu-2	\N	2368	\N	\N
SYNAT187	\N	\N	\N	\N	1205LU-3	\N	2452	\N	\N
SYNAT188	\N	\N	\N	\N	Bivona L1	\N	2629	\N	\N
SYNAT189	\N	\N	\N	\N	Bivona L2	\N	2698	\N	\N
SYNAT190	\N	\N	\N	\N	Bivona L3	\N	2753	\N	\N
SYNAT191	\N	\N	\N	\N	Bivona L4	\N	2673	\N	\N
SYNAT192	\N	\N	\N	\N	Bivona L5	\N	2703	\N	\N
SYNAT193	\N	\N	\N	\N	Bivona L6	\N	2328	\N	\N
SYNAT194	\N	\N	\N	\N	Bivona L7	\N	2746	\N	\N
SYNAT195	\N	\N	\N	\N	Bivona L8	\N	2722	\N	\N
SYNAT196	\N	\N	\N	\N	Bivona L9	\N	2691	\N	\N
SYNAT197	\N	\N	\N	\N	Bivona L10	\N	2310	\N	\N
SYNAT198	\N	\N	\N	\N	Bivona L11	\N	2322	\N	\N
SYNAT199	\N	\N	\N	\N	Buffy Coat	\N	2437	\N	\N
SYNAT200	\N	\N	\N	\N	Cell-Line_Xu-1	\N	2481	\N	\N
SYNAT201	\N	\N	\N	\N	Cell-Line_Xu-2	\N	2730	\N	\N
SYNAT202	\N	\N	\N	\N	Cell-Line_Xu-3	\N	2925	\N	\N
SYNAT203	\N	\N	\N	\N	Cell-Line_Xu-4	\N	2641	\N	\N
SYNAT204	\N	\N	\N	\N	Cell-Line_Xu-5	\N	2434	\N	\N
SYNAT205	\N	\N	\N	\N	Cell-Line_Xu-6	\N	2480	\N	\N
SYNAT206	\N	\N	\N	\N	Cell-Line_Xu-7	\N	2461	\N	\N
SYNAT207	\N	\N	\N	\N	Cell-Line_Xu-8	\N	2549	\N	\N
SYNAT208	\N	\N	\N	\N	Cell-Line_Xu-9	\N	2803	\N	\N
SYNAT209	\N	\N	\N	\N	Cell-Line_Xu-10	\N	2325	\N	\N
SYNAT230	\N	\N	\N	\N	Cell-Line_Xu-48	\N	2715	\N	\N
SYNAT231	\N	\N	\N	\N	Cell-Line_Xu-49	\N	2615	\N	\N
SYNAT232	\N	\N	\N	\N	Cell-Line_Xu-50	\N	2719	\N	\N
SYNAT233	\N	\N	\N	\N	Cell-Line_Xu-51	\N	2663	\N	\N
SYNAT234	\N	\N	\N	\N	Cell-Line_Xu-52	\N	2498	\N	\N
SYNAT235	\N	\N	\N	\N	Cell-Line_Xu-53	\N	2672	\N	\N
SYNAT236	\N	\N	\N	\N	Cell-Line_Xu-54	\N	2907	\N	\N
SYNAT257	\N	\N	\N	\N	CGH14-147	\N	2441	\N	IP1393739
SYNAT258	\N	\N	\N	\N	CGH15-249	\N	2668	\N	IP1573327
SYNAT260	\N	\N	\N	\N	ct-H3K4	\N	2610	\N	\N
SYNAT261	\N	\N	\N	\N	ct-H3K27	\N	2496	\N	\N
SYNAT262	\N	\N	\N	\N	ct-Input	\N	2653	\N	\N
SYNAT265	\N	\N	\N	\N	DM100	\N	2507	\N	\N
SYNAT266	\N	\N	\N	\N	DM101	\N	2450	\N	\N
SYNAT267	\N	\N	\N	\N	DM102	\N	2650	\N	\N
SYNAT268	\N	\N	\N	\N	DP12-200 	\N	2410	\N	\N
SYNAT269	\N	\N	\N	\N	HW Acral #1 Cntl	\N	2904	\N	\N
SYNAT270	\N	\N	\N	\N	HW Acral #1 Tumor	\N	2879	\N	\N
SYNAT271	\N	\N	\N	\N	HW Acral #2 Cntl	\N	2292	\N	\N
SYNAT272	\N	\N	\N	\N	HW Acral #2 Tumor	\N	2697	\N	\N
SYNAT273	\N	\N	\N	\N	HW Acral #3 Cntl	\N	2695	\N	\N
SYNAT274	\N	\N	\N	\N	HW Acral #3 Tumor	\N	2465	\N	\N
SYNAT275	\N	\N	\N	\N	HW Acral #4 Cntl	\N	2733	\N	\N
SYNAT276	\N	\N	\N	\N	HW Acral #4 Tumor	\N	2483	\N	\N
SYNAT277	\N	\N	\N	\N	HW Acral #5 Cntl	\N	2818	\N	\N
SYNAT278	\N	\N	\N	\N	HW Acral #5 Tumor	\N	2621	\N	\N
SYNAT279	\N	\N	\N	\N	HW Acral #6 Cntl	\N	2335	\N	\N
SYNAT280	\N	\N	\N	\N	HW Acral #6 Tumor	\N	2681	\N	\N
SYNAT281	\N	\N	\N	\N	HW Acral #7 Cntl	\N	2806	\N	\N
SYNAT282	\N	\N	\N	\N	HW Acral #7 Tumor	\N	2774	\N	\N
SYNAT283	\N	\N	\N	\N	HW Acral #8 Cntl	\N	2494	\N	\N
SYNAT284	\N	\N	\N	\N	HW Acral #8 Tumor	\N	2287	\N	\N
SYNAT285	\N	\N	\N	\N	HW Acral #9 Cntl	\N	2515	\N	\N
SYNAT286	\N	\N	\N	\N	HW Acral #9 Tumor	\N	2595	\N	\N
SYNAT287	\N	\N	\N	\N	HW Acral #10 Cntl	\N	2440	\N	\N
SYNAT288	\N	\N	\N	\N	HW Acral #10 Tumor	\N	2524	\N	\N
SYNAT289	\N	\N	\N	\N	HW2- Normal Curls	\N	2500	\N	\N
SYNAT290	\N	\N	\N	\N	HW2- Tumor Dissect	\N	2605	\N	\N
SYNAT291	\N	\N	\N	\N	HW3-Normal	\N	2446	\N	\N
SYNAT292	\N	\N	\N	\N	HW3-Tumor	\N	2486	\N	\N
SYNAT293	\N	\N	\N	\N	HW4-Normal	\N	2545	\N	\N
SYNAT294	\N	\N	\N	\N	HW4-Tumor	\N	2952	\N	\N
SYNAT295	\N	\N	\N	\N	HW6-NormalDissect	\N	2899	\N	\N
SYNAT296	\N	\N	\N	\N	HW6-TumorDissect	\N	2433	\N	\N
SYNAT297	\N	\N	\N	\N	HW8- Normal Curls	\N	2563	\N	\N
SYNAT298	\N	\N	\N	\N	HW8- Tumor Curls	\N	2815	\N	\N
SYNAT299	\N	\N	\N	\N	HW9- Normal gDNA from Blood (129920)	\N	2768	\N	\N
SYNAT300	\N	\N	\N	\N	HW9- Tumor Curls	\N	2840	\N	\N
SYNAT301	\N	\N	\N	\N	LAL-L Cells	\N	2492	\N	\N
SYNAT302	\N	\N	\N	\N	M230 Imat A2	\N	2585	\N	\N
SYNAT303	\N	\N	\N	\N	M230 Imat A3	\N	2749	\N	\N
SYNAT304	\N	\N	\N	\N	MB1424	\N	2308	\N	\N
SYNAT305	\N	\N	\N	\N	P57	\N	2533	\N	\N
SYNAT306	\N	\N	\N	\N	P57-A-1.0mm	\N	2723	\N	\N
SYNAT307	\N	\N	\N	\N	P57-A-2.0mm	\N	2582	\N	\N
SYNAT308	\N	\N	\N	\N	P57-B-1.0mm	\N	2334	\N	\N
SYNAT309	\N	\N	\N	\N	P57-B-2.0mm	\N	2772	\N	\N
SYNAT311	\N	\N	\N	\N	sh-H3K4	\N	2947	\N	\N
SYNAT312	\N	\N	\N	\N	sh-H3K27	\N	2609	\N	\N
SYNAT313	\N	\N	\N	\N	sh-Input	\N	2937	\N	\N
SYNAT314	\N	\N	\N	\N	SKMEL5-1	\N	2460	\N	\N
SYNAT315	\N	\N	\N	\N	SKMEL5-2	\N	2485	\N	\N
SYNAT316	\N	\N	\N	\N	SKMEL5-3	\N	2654	\N	\N
SYNAT317	\N	\N	\N	\N	SKMEL28-1	\N	2374	\N	\N
SYNAT318	\N	\N	\N	\N	SKMEL28-2	\N	2339	\N	\N
SYNAT319	\N	\N	\N	\N	SKMEL28-3	\N	2764	\N	\N
SYNAT320	\N	\N	\N	\N	SM_2_Tumor	\N	2884	\N	\N
SYNAT321	\N	\N	\N	\N	SM_10_Tumor	\N	2448	\N	\N
SYNAT322	\N	\N	\N	\N	Thomas_SK_Mel23	\N	2312	\N	\N
SYNAT323	\N	\N	\N	\N	UCSF-23-041_Biopsy	\N	2874	\N	\N
SYNAT324	\N	\N	\N	\N	UM1_UvealMel	\N	2627	\N	\N
SYNAT325	\N	\N	\N	\N	UM2_UvealMel	\N	2349	\N	\N
SYNAT326	\N	\N	\N	\N	WM3918	\N	2787	\N	\N
SYNAT327	\N	\N	\N	\N	WP 11	\N	2601	\N	\N
SYNAT328	\N	\N	\N	\N	WP 23	\N	2931	\N	\N
SYNAT329	\N	\N	\N	\N	WP 29	\N	2383	\N	\N
SYNAT330	\N	\N	\N	\N	X06-6624A7, X06-6624D1	\N	2505	\N	IP227601
SYNAT330	\N	\N	\N	\N	X06-6624A7, X06-6624D1	\N	2758	\N	\N
SYNAT331	\N	\N	\N	\N	X98-1056, X98-1056A9	\N	2459	\N	IP138629
SYNAT331	\N	\N	\N	\N	X98-1056, X98-1056A9	\N	2648	\N	\N
SYNAT333	\N	\N	\N	\N	08-27590	\N	2938	\N	IP736231
SYNAT334	\N	\N	\N	\N	12-11406A	\N	2793	\N	\N
BN-003	F	\N	Unknown	UCSF	12-97918	blue nevus, cellular	107	\N	\N
DN-161	M	\N	Unknown	\N	19-15442	\N	636	\N	\N
DN-162	M	\N	Unknown	\N	19-37607D	\N	637	\N	\N
MD-171	\N	\N	Unknown	Madrid, Spain	03-17395J T2	\N	1048	\N	\N
MD-172	\N	\N	Unknown	Madrid, Spain	03-24659-2 T2	\N	1049	\N	\N
MD-173	\N	\N	Unknown	Madrid, Spain	03-08311E T2	\N	1050	\N	\N
MD-174	\N	\N	Unknown	Madrid, Spain	02-26442 T4	\N	1051	\N	\N
DP-05	F	\N	Unknown	UCSF	14-29390	\N	642	\N	\N
MD-175	\N	\N	Unknown	Madrid, Spain	02-20732 T2	\N	1052	\N	\N
DP-12	F	\N	Unknown	UCSF	15-101612	IntelliPath says its an "atypical Spitz tumor"	649	\N	\N
MD-177	\N	\N	Unknown	Madrid, Spain	02-28682 T4	\N	1054	\N	\N
DP-18	F	\N	Unknown	UCSF	11-63724	\N	655	\N	\N
DP-27	F	\N	Unknown	UCSF	13-32039	\N	664	\N	\N
LN-18	M	\N	Unknown	UCSF	18-15165	\N	838	\N	\N
MD-181	\N	\N	Unknown	Madrid, Spain	01-17200 T3	\N	1058	\N	\N
DPN-05	\N	\N	Unknown	UCSF	18-31431	\N	738	\N	\N
JJS6	M	\N	Unknown	UCSF	12-79097B	\N	745	\N	\N
KIT-11	\N	\N	Unknown	\N	12-169	\N	792	\N	\N
KF-10	\N	\N	Unknown	\N	Lung cancer with ALK fusion	\N	780	\N	\N
KIT-01	\N	\N	Unknown	\N	14-077	\N	782	\N	\N
KIT-02	\N	\N	Unknown	\N	13-207	\N	783	\N	\N
KIT-03	\N	\N	Unknown	\N	13-140	\N	784	\N	\N
KIT-04	\N	\N	Unknown	\N	13-129	\N	785	\N	\N
KIT-12	\N	\N	Unknown	\N	12-200	\N	793	\N	\N
MD-47	\N	\N	Unknown	Madrid, Spain	94-00669 N1	\N	953	\N	\N
MD-48	\N	\N	Unknown	Madrid, Spain	94-00143-2 N1	\N	954	\N	\N
MD-49	\N	\N	Unknown	Madrid, Spain	93-06269-4 N1	\N	955	\N	\N
MD-50	\N	\N	Unknown	Madrid, Spain	95-05959 M1	\N	956	\N	\N
SYNX18	NaN	\N	\N	\N	BuffyCoat	NaN	1421	\N	\N
SYNX128	NaN	\N	\N	\N	HWA6	NaN	1531	\N	\N
SYNX281	NaN	\N	\N	\N	K1_9	NaN	1684	\N	\N
SYNX373	NaN	\N	\N	\N	DPN8	NaN	1776	\N	\N
SYNX471	NaN	\N	\N	\N	GAK_DNA	NaN	1874	\N	\N
SYNAT61	\N	\N	\N	\N	12-6332A5	\N	2411	\N	IP1092148
SYNAT111	\N	\N	\N	\N	14-53894B	\N	2422	\N	IP1403832
SYNAT115	\N	\N	\N	\N	14-59332	\N	2909	\N	IP988413
SYNAT116	\N	\N	\N	\N	14-59956	\N	2531	\N	IP1409897
SYNAT117	\N	\N	\N	\N	14-61297	\N	2541	\N	IP1411239
SYNAT118	\N	\N	\N	\N	14-61299	\N	2357	\N	IP1411241
SYNAT119	\N	\N	\N	\N	14-61835	\N	2527	\N	IP1411777
SYNAT120	\N	\N	\N	\N	14-96795	\N	2539	\N	IP1069336
SYNAT170	\N	\N	\N	\N	23-107334C2	\N	2600	\N	IP2626851
SYNAT210	\N	\N	\N	\N	Cell-Line_Xu-11	\N	2927	\N	\N
SYNAT211	\N	\N	\N	\N	Cell-Line_Xu-12	\N	2420	\N	\N
SYNAT212	\N	\N	\N	\N	Cell-Line_Xu-13	\N	2458	\N	\N
SYNAT213	\N	\N	\N	\N	Cell-Line_Xu-14	\N	2395	\N	\N
SYNAT214	\N	\N	\N	\N	Cell-Line_Xu-15	\N	2870	\N	\N
SYNAT215	\N	\N	\N	\N	Cell-Line_Xu-16	\N	2630	\N	\N
SYNAT216	\N	\N	\N	\N	Cell-Line_Xu-17	\N	2438	\N	\N
SYNAT217	\N	\N	\N	\N	Cell-Line_Xu-18	\N	2377	\N	\N
SYNAT218	\N	\N	\N	\N	Cell-Line_Xu-19	\N	2662	\N	\N
SYNAT219	\N	\N	\N	\N	Cell-Line_Xu-20	\N	2352	\N	\N
SYNAT220	\N	\N	\N	\N	Cell-Line_Xu-21	\N	2535	\N	\N
SYNAT221	\N	\N	\N	\N	Cell-Line_Xu-22	\N	2388	\N	\N
SYNAT222	\N	\N	\N	\N	Cell-Line_Xu-23	\N	2930	\N	\N
SYNAT223	\N	\N	\N	\N	Cell-Line_Xu-24	\N	2491	\N	\N
SYNAT224	\N	\N	\N	\N	Cell-Line_Xu-25	\N	2589	\N	\N
SYNAT225	\N	\N	\N	\N	Cell-Line_Xu-26	\N	2324	\N	\N
SYNAT226	\N	\N	\N	\N	Cell-Line_Xu-27	\N	2633	\N	\N
SYNAT227	\N	\N	\N	\N	Cell-Line_Xu-28	\N	2497	\N	\N
SYNAT228	\N	\N	\N	\N	Cell-Line_Xu-29	\N	2856	\N	\N
SYNAT229	\N	\N	\N	\N	Cell-Line_Xu-30	\N	2281	\N	\N
SYNAT237	\N	\N	\N	\N	Cell-Line_Xu-55	\N	2946	\N	\N
SYNAT238	\N	\N	\N	\N	Cell-Line_Xu-56	\N	2850	\N	\N
SYNAT239	\N	\N	\N	\N	Cell-Line_Xu-57	\N	2845	\N	\N
SYNAT240	\N	\N	\N	\N	Cell-Line_Xu-58	\N	2900	\N	\N
SYNAT241	\N	\N	\N	\N	Cell-Line_Xu-59	\N	2912	\N	\N
SYNAT242	\N	\N	\N	\N	Cell-Line_Xu-60	\N	2878	\N	\N
SYNAT243	\N	\N	\N	\N	Cell-Line_Xu-61	\N	2457	\N	\N
SYNAT244	\N	\N	\N	\N	Cell-Line_Xu-62	\N	2544	\N	\N
SYNAT245	\N	\N	\N	\N	Cell-Line_Xu-63	\N	2775	\N	\N
SYNAT246	\N	\N	\N	\N	Cell-Line_Xu-64	\N	2466	\N	\N
SYNAT247	\N	\N	\N	\N	CGH12-067	\N	2789	\N	IP963226
SYNAT248	\N	\N	\N	\N	CGH12-146	\N	2877	\N	IP1121579
SYNAT249	\N	\N	\N	\N	CGH13-008	\N	2854	\N	IP1175438
SYNAT250	\N	\N	\N	\N	CGH13-010	\N	2337	\N	IP300725
SYNAT251	\N	\N	\N	\N	CGH13-014	\N	2771	\N	IP1185530
SYNAT252	\N	\N	\N	\N	CGH13-026	\N	2369	\N	IP1185221
SYNAT253	\N	\N	\N	\N	CGH13-034	\N	2780	\N	IP1188475
SYNAT254	\N	\N	\N	\N	CGH13-094	\N	2358	\N	IP1202986
SYNAT255	\N	\N	\N	\N	CGH14-050	\N	2828	\N	IP1365348
SYNAT256	\N	\N	\N	\N	PG_8	\N	2747	\N	\N
SYNAT259	\N	\N	\N	\N	CGH19-097	\N	2939	\N	IP2049186
SYNAT263	\N	\N	\N	\N	D12_M	\N	2508	\N	\N
SYNAT264	\N	\N	\N	\N	DM8	\N	2790	\N	\N
AM2-006	\N	\N	Unknown	Bolivia	86541-2b,86541-1g,86541-2a,86541-2c,86541-1f,86541-1E, 86541-1f, 86541-2b, 86541-1g, 86541-2a, 86541-2c, 86541-1E	\N	4	\N	\N
AM2-007	\N	\N	Unknown	Bolivia	"79447-a\n",79447-c,79447-d,79447-b, 79447-a\n, 79447-c, 79447-d, 79447-b	\N	5	\N	\N
AM2-008	\N	\N	Unknown	Bolivia	79049-1a,79049-1c,79049-2a,79049-2b,79049-1d,79049-1b, 79049-1a, 79049-1c, 79049-2a, 79049-2b, 79049-1d, 79049-1b	\N	6	\N	\N
AM2-012	\N	\N	Unknown	Bolivia	352-1-15.1,352-1-15.3,352-1-15.2, 352-1-15.1, 352-1-15.3, 352-1-15.2	\N	7	\N	\N
AM2-014	\N	\N	Unknown	Bolivia	2686-1-13.1,2686-1-13.2, 2686-1-13.1, 2686-1-13.2	\N	8	\N	\N
AM2-018	\N	\N	Unknown	Bolivia	1586-2-13-B,1586-2-13-A,1586-2-13-C, 1586-2-13-B, 1586-2-13-A, 1586-2-13-C	\N	9	\N	\N
AM2-019	\N	\N	Unknown	Bolivia	385/14	\N	10	\N	\N
AM2-022	\N	\N	Unknown	Bolivia	4070/3/13.1,4070/3/13.3,4070/2/13.1,4070/3/13.2,4070/2/13.3,4070/2/13.2, 4070/3/13.1, 4070/3/13.3, 4070/2/13.1, 4070/3/13.2, 4070/2/13.3, 4070/2/13.2	\N	11	\N	\N
AM2-027	\N	\N	Unknown	Chile	501950A3,501950C, 501950A3, 501950C	\N	12	\N	\N
AM2-029	\N	\N	Unknown	Chile	"610186B\n",610186D,610186A,610186C, 610186B\n, 610186D, 610186A, 610186C	\N	13	\N	\N
AM2-030	\N	\N	Unknown	Chile	604076	\N	14	\N	\N
AM2-039	\N	\N	Unknown	Chile	488836A	\N	15	\N	\N
AM2-040	\N	\N	Unknown	Zurich	H13.10897/11,B13.26332/1,H13.10897/2, H13.10897/11, B13.26332/1, H13.10897/2	\N	16	\N	\N
AM2-041	\N	\N	Unknown	Zurich	B06.41962/3,B14.2561/12,H13.21587/1,B06.41962/5, B06.41962/3, B14.2561/12, H13.21587/1, B06.41962/5	\N	17	\N	\N
AM2-042	\N	\N	Unknown	Zurich	B62056/15,H16.660,B15.28523/11, B62056/15, H16.660, B15.28523/11	Patient 3	18	\N	\N
AM2-043	\N	\N	Unknown	Zurich	H15.2058/1,H12.27716/7, H15.2058/1, H12.27716/7	\N	19	\N	\N
AM2-045	\N	\N	Unknown	Zurich	B2008.3067/5,H2007.215/5,H 2008.8956/1, B2008.3067/5, H2007.215/5, H 2008.8956/1	Patient 6	20	\N	\N
AM2-046	\N	\N	Unknown	Zurich	B2008.24393/1,H2007.4636/9,B2007.15494/1, B2008.24393/1, H2007.4636/9, B2007.15494/1	\N	21	\N	\N
AM2-048	\N	\N	Unknown	Zurich	H2007.358/3,H2007.358/1,B2007.998/2, H2007.358/3, H2007.358/1, B2007.998/2	Patient 9	22	\N	\N
AM2-049	\N	\N	Asian	Japan	K1-A,K1-B,K1-A.2,K1-D,K1-C, K1-A, K1-B, K1-A.2, K1-D, K1-C	Case K1	23	\N	\N
AM2-050	\N	\N	Asian	Japan	K2-A,K2-C,K2-D,K2-B, K2-A, K2-C, K2-D, K2-B	Case K2	24	\N	\N
AM2-051	\N	\N	Unknown	Bolivia	19111/14.5,19111/14.2,19111/14.4,"19111/14.1\n",19111/14.3, 19111/14.1\n, 19111/14.5, 19111/14.2, 19111/14.4, 19111/14.3	\N	25	\N	\N
AM2-053	\N	\N	Unknown	Bolivia	21159 A5,21159 G5,21159 A6,21159 G2, 21159 A5, 21159 G5, 21159 A6, 21159 G2	Sites of cancer are not sure, diagnosis are in Spanish.  See scanned file:  "AM2_051 to AM2_056" in "Materials came with the speciment" folder. 	26	\N	\N
AM2-055	\N	\N	Unknown	Bolivia	38637-16.3,38637-16.2,38637-16.1, 38637-16.3, 38637-16.2, 38637-16.1	Sites of cancer are not sure, diagnosis are in Spanish.  See scanned file:  "AM2_051 to AM2_056" in "Materials came with the speciment" folder. 	27	\N	\N
AM2-057	\N	\N	Unknown	Zurich	H13.5620/1,H09.22183/1, H13.5620/1, H09.22183/1	Patient 10	28	\N	\N
AM2-058	\N	\N	Unknown	Zurich	H18.7977,H16.5818/2,H15.5120/1, H18.7977, H16.5818/2, H15.5120/1	Patient 11	29	\N	\N
AM2-059	\N	\N	Unknown	Zurich	H14.26934/2,HS17.35/2, H14.26934/2, HS17.35/2	Patient 12	30	\N	\N
AM2-060	\N	\N	Unknown	Zurich	H15.19121/7,H16.872/2, H15.19121/7, H16.872/2	Patient 13	31	\N	\N
AM2-061	\N	\N	Asian	Japan	K3-D,K3-C,K3-A-B, K3-D, K3-C, K3-A-B	Case K3 (Sole)	32	\N	\N
AM2-062	\N	\N	Asian	Japan	K4-C,K4-D,K4-A,K4-C-2,K4-B, K4-C, K4-D, K4-A, K4-C-2, K4-B	Case K4 (Sole)	33	\N	\N
AM2-063	\N	\N	Asian	Japan	K5-A-B,K5-D, K5-A-B, K5-D	\N	34	\N	\N
AM2-065	\N	\N	Asian	Japan	K6-A-D,K6-B, K6-A-D, K6-B	\N	35	\N	\N
AM2-066	\N	\N	Asian	Japan	K7-D,K7-A,K7-B,K7-B-2, K7-D, K7-A, K7-B, K7-B-2	\N	36	\N	\N
AM2-067	\N	\N	Asian	Japan	K8-A,K8-B, K8-A, K8-B	\N	37	\N	\N
AM2-068	\N	\N	Asian	Japan	K9-D,K9-A-B,K9-C, K9-D, K9-A-B, K9-C	\N	38	\N	\N
AM2-069	\N	\N	Asian	Japan	K10-A,K10-C,K10-D,K10-B, K10-A, K10-C, K10-D, K10-B	\N	39	\N	\N
AM2-070	\N	\N	Asian	Japan	K11-D,K11-B,K11-A, K11-D, K11-B, K11-A	\N	40	\N	\N
AM2-071	\N	\N	Asian	Japan	K12-A,K12-B,K12-D, K12-A, K12-B, K12-D	\N	41	\N	\N
AM2-072	\N	\N	Asian	Japan	K13-D,K13-B,K13-A, K13-D, K13-B, K13-A	\N	42	\N	\N
AM2-073	\N	\N	Asian	Japan	K14-B,K14-D,K14-A, K14-B, K14-D, K14-A	\N	43	\N	\N
AM2-074	\N	\N	Asian	Japan	K15-A-B,K15-D, K15-A-B, K15-D	\N	44	\N	\N
AM2-075	\N	\N	Asian	Japan	K16-D,K16-A-B, K16-D, K16-A-B	\N	45	\N	\N
AM2-076	\N	\N	Asian	Japan	K17-A,K17-D,K17-B, K17-A, K17-D, K17-B	\N	46	\N	\N
AM2-077	\N	\N	Asian	Japan	K18-A-B	no area circled, confirmed with Iwei\n	47	\N	\N
AM2-078	\N	\N	Asian	Japan	K19-A-B	no area circled, confirmed with Iwei\n	48	\N	\N
AM2-079	\N	\N	Asian	Japan	K20-A-B	\N	49	\N	\N
AM2-080	\N	\N	Asian	Japan	K21-A-B	\N	50	\N	\N
AM2-081	\N	\N	Asian	Japan	K22-A-B,K22-D, K22-A-B, K22-D	\N	51	\N	\N
AM2-082	\N	\N	Asian	Japan	K23-D,K23-A-B, K23-D, K23-A-B	\N	52	\N	\N
AM2-083	\N	\N	Asian	Japan	K24-A-B	\N	53	\N	\N
AM2-084	\N	\N	Unknown	Zurich	H 2015.1871,B17.80125 ,B2015.54040, H 2015.1871, B17.80125 , B2015.54040	\N	54	\N	\N
AM2-085	\N	\N	Unknown	Zurich	H13.3143 ,B14. 951 , H13.3143 , B14. 951 	\N	55	\N	\N
AM2-086	\N	\N	Asian	Taiwan	15-29364A1,14-31886,13-30315A3, 15-29364A1, 14-31886, 13-30315A3	\N	56	\N	\N
AM2-087	\N	\N	Asian	Taiwan	10-22319,15-14674, 10-22319, 15-14674	\N	57	\N	\N
AM2-088	\N	\N	Asian	Taiwan	15-17010A1,15-17010A2,15-17010C1, 15-17010A1, 15-17010A2, 15-17010C1	\N	58	\N	\N
AM2-089	\N	\N	Asian	Taiwan	12-24502A1,12-24502B, 12-24502A1, 12-24502B	\N	59	\N	\N
AM2-090	\N	\N	Asian	Taiwan	12-24189A1,12-24455, 12-24189A1, 12-24455	\N	60	\N	\N
AM2-091	\N	\N	Asian	Taiwan	11-36301A5,11-35367,11-36301A1,11-36301C1, 11-36301A5, 11-35367, 11-36301A1, 11-36301C1	\N	61	\N	\N
AM2-092	\N	\N	Asian	Taiwan	10-38178A1,12-41833E1, 10-38178A1, 12-41833E1	\N	62	\N	\N
AM2-093	\N	\N	Asian	Taiwan	13-37513,10-22013, 13-37513, 10-22013	\N	63	\N	\N
MD-86	\N	\N	Unknown	Madrid, Spain	10-30525-4 M1	\N	987	\N	\N
AM2-094	\N	\N	Asian	Taiwan	10-18253B,10-17734,10-15411B,10-39146A1,10-39146A2, 10-18253B, 10-17734, 10-15411B, 10-39146A1, 10-39146A2	\N	64	\N	\N
AM2-095	\N	\N	Asian	Taiwan	10-14390,10-14100,10-15514A2,10-13619, 10-14390, 10-14100, 10-15514A2, 10-13619	\N	65	\N	\N
AM2-096	\N	\N	Asian	Taiwan	15-3736C5,15-18463,15-3736C1,15-3736A1, 15-3736C5, 15-18463, 15-3736C1, 15-3736A1	\N	66	\N	\N
AM2-097	\N	\N	Asian	Taiwan	23-6349A3,15-4505B,22-25497A1,22-44747A1,22-25497A2,22-44747A2,23-6349A2,15-4505A1,23-6349A1,15-4505C, 23-6349A3, 15-4505B, 22-25497A1, 22-44747A1, 22-25497A2, 22-44747A2, 23-6349A2, 15-4505A1, 23-6349A1, 15-4505C	\N	67	\N	\N
DN-060	M	\N	Unknown	\N	17-27000	\N	535	\N	\N
AM2-098	\N	\N	Asian	Taiwan	18-15332A1,18-15332A3,18-15332A2,18-15332A6,18-15332A5,19-23613C4,19-20141,18-15332A4, 18-15332A1, 18-15332A3, 18-15332A2, 18-15332A6, 18-15332A5, 19-23613C4, 19-20141, 18-15332A4	\N	68	\N	\N
AM2-099	\N	\N	Asian	Taiwan	16-9204,16-21256,14-37577A5,13-23696A5,14-35086A, 16-9204, 16-21256, 14-37577A5, 13-23696A5, 14-35086A	\N	69	\N	\N
AM2-100	\N	\N	Asian	Taiwan	17-21835A3,15-0176A1,15-00176S2,17-34742,14-51352,15-48543A1, 17-21835A3, 15-0176A1, 15-00176S2, 17-34742, 14-51352, 15-48543A1	\N	70	\N	\N
AM2-101	\N	\N	Asian	Taiwan	18-28886,19-6410A1,19-6410A2,15-26253A1,18-12734, 18-28886, 19-6410A1, 19-6410A2, 15-26253A1, 18-12734	\N	71	\N	\N
AM2-102	\N	\N	Asian	Taiwan	17-14203A1,17-14203A2,16-552A7,17-9337A2,19-19590,17-9337A1, 17-14203A1, 17-14203A2, 16-552A7, 17-9337A2, 19-19590, 17-9337A1	\N	72	\N	\N
AM2-103	\N	\N	Asian	Taiwan	17-21588,16-10035C,16-10035A3, 17-21588, 16-10035C, 16-10035A3	\N	73	\N	\N
AMC-07	\N	\N	Unknown	\N	M040204,M040204 Dec2019, M040204, M040204 Dec2019	\N	101	\N	\N
AM2-104	\N	\N	Asian	Taiwan	20-09338A1,18-22781A1, 20-09338A1, 18-22781A1	\N	74	\N	\N
AM2-105	\N	\N	Asian	Taiwan	18-35014A1,20-21458A1,18-35014B2,20-21458A2, 18-35014A1, 20-21458A1, 18-35014B2, 20-21458A2	\N	75	\N	\N
AM2-106	\N	\N	Asian	Taiwan	19-34937S1,19-34937A2, 19-34937S1, 19-34937A2	\N	76	\N	\N
AM2-107	\N	\N	Asian	Taiwan	19-43366G,19-43366F,19-43366A1, 19-43366G, 19-43366F, 19-43366A1	\N	77	\N	\N
AM2-108	\N	\N	Asian	Taiwan	19-44348A4,20-59076A1,19-44348A1, 19-44348A4, 20-59076A1, 19-44348A1	\N	78	\N	\N
AM2-109	\N	\N	Asian	Taiwan	19-44987A1,19-44987C1,20-33334A1, 19-44987A1, 19-44987C1, 20-33334A1	\N	79	\N	\N
AM2-110	\N	\N	Asian	Taiwan	19-52004A1,19-52004B1, 19-52004A1, 19-52004B1	\N	80	\N	\N
CCR-205	M	\N	White	\N	05-46869B	\N	185	\N	\N
AM2-111	\N	\N	Asian	Taiwan	20-28721A1,19-51759,21-961A,08-35719A1,21-26009A1,21-13227A, 20-28721A1, 19-51759, 21-961A, 08-35719A1, 21-26009A1, 21-13227A	\N	81	\N	\N
AM2-112	\N	\N	Asian	Taiwan	20-12501E1,20-12501A1, 20-12501E1, 20-12501A1	\N	82	\N	\N
AM2-113	\N	\N	Asian	Taiwan	16-35844B2,16-32182, 16-35844B2, 16-32182	\N	83	\N	\N
AM2-114	\N	\N	Asian	Taiwan	15-24753A1,20-26269A1, 15-24753A1, 20-26269A1	\N	84	\N	\N
AM2-115	\N	\N	Asian	Taiwan	21-108508B,21-108508A, 21-108508B, 21-108508A	\N	85	\N	\N
AM2-116	\N	\N	Asian	Taiwan	21-108509A,21-108509D,21-108509B,21-108509C,21-108509E, 21-108509A, 21-108509D, 21-108509B, 21-108509C, 21-108509E	\N	86	\N	\N
AM2-117	\N	\N	Asian	Taiwan	21-108510A,21-108510B,21-108510C, 21-108510A, 21-108510B, 21-108510C	\N	87	\N	\N
AM2-118	\N	\N	Asian	Taiwan	22-9055A1,22-9055C1,22-510407A1, 22-9055A1, 22-9055C1, 22-510407A1	\N	88	\N	\N
MD-92	\N	\N	Unknown	Madrid, Spain	14-04359A2 N1	\N	988	\N	\N
AM2-119	\N	\N	Unknown	UCSF	23-51956A3,23-51956B14,23-51956B16,23-51956B17, 23-51956A3, 23-51956B14, 23-51956B16, 23-51956B17	\N	89	\N	\N
AM2-120	\N	\N	Unknown	UCSF	18-51740B2,18-51740C6,18-51740C7, 18-51740B2, 18-51740C6, 18-51740C7	\N	90	\N	\N
AM2-121	\N	\N	Unknown	UCSF	21-4449B2,21-4449A3,21-4449A5, 21-4449B2, 21-4449A3, 21-4449A5	\N	91	\N	\N
AM2-122	\N	\N	Unknown	UCSF	19-360A2,19-360A1, 19-360A2, 19-360A1	\N	92	\N	\N
AM2-123	\N	\N	Unknown	UCSF	20-113547C2,20-113547A2,20-113547A3, 20-113547C2, 20-113547A2, 20-113547A3	\N	93	\N	\N
AM2-124	\N	\N	Unknown	UCSF	20-37211A,20-37211I, 20-37211A, 20-37211I	\N	94	\N	\N
AM2-125	\N	\N	Unknown	UCSF	20-83082A3,20-83082B, 20-83082A3, 20-83082B	\N	95	\N	\N
AM2-126	\N	\N	Unknown	UCSF	20-8536D,20-8536E, 20-8536D, 20-8536E	\N	96	\N	\N
AMC-01	\N	\N	Unknown	\N	MaMel 152aI	\N	98	\N	\N
AMC-02	\N	\N	Unknown	\N	M100118	\N	99	\N	\N
AMC-03	\N	\N	Unknown	\N	MM100511,MM100512,MM100513,MM100916, MM100511, MM100512, MM100513, MM100916	\N	100	\N	\N
AMC-08	\N	\N	Unknown	\N	M040415,M040416,M040419A,M040418, M040415, M040416, M040419A, M040418	\N	102	\N	\N
AMC-12	\N	\N	Unknown	\N	MM160113	\N	103	\N	\N
AMC-13	\N	\N	Unknown	\N	M180322	\N	104	\N	\N
BN-001	F	\N	Unknown	UCSF	12-37217	blue nevus, cellular	105	\N	\N
BN-002	F	\N	Unknown	UCSF	12-52736	blue nevus, cellular	106	\N	\N
BN-004	F	\N	Unknown	UCSF	12-6550	blue nevus, cellular	108	\N	\N
BN-005	F	\N	Unknown	UCSF	12-20144	blue nevus, cellular	109	\N	\N
BN-006	F	\N	Unknown	UCSF	12-32138	blue nevus, cellular	110	\N	\N
BN-007	F	\N	Unknown	UCSF	11-47908	blue nevus, cellular	111	\N	\N
BN-008	F	\N	Unknown	UCSF	11-59209	blue nevus, cellular	112	\N	\N
BN-009	M	\N	Unknown	UCSF	11-85008	blue nevus, cellular	113	\N	\N
BN-011	F	\N	Unknown	UCSF	11-19048	blue nevus, cellular	115	\N	\N
BN-012	F	\N	Unknown	UCSF	11-43354	blue nevus, cellular	116	\N	\N
CCGL-2973	M	\N	Unknown	UCSF	18-68921A,18-28169, 18-68921A, 18-28169	DermPath patient with multiple BCC	117	\N	\N
CCR-	M	\N	White	\N	04-15284	\N	118	\N	\N
CCR-001	F	\N	White	\N	99-3122A	\N	119	\N	\N
CCR-134	F	\N	White	\N	99-19410A,99-19410B, 99-19410A, 99-19410B	\N	166	\N	\N
CM-63	\N	\N	Unknown	Denmark	19Rig750007.05.07.03	\N	296	\N	\N
CM-69	\N	\N	Unknown	Denmark	19Rig750007.05.13.03,19Rig750007.05.13.09, 19Rig750007.05.13.03, 19Rig750007.05.13.09	\N	297	\N	\N
CCR-003	M	\N	White	\N	14-34758	\N	120	\N	\N
CCR-004	F	\N	White	\N	07-55149	\N	121	\N	\N
CCR-005	M	\N	White	\N	99-14477	\N	122	\N	\N
CCR-007	M	\N	White	\N	00-14127B	\N	123	\N	\N
CCR-008	M	\N	White	\N	02-7356,01-10896, 02-7356, 01-10896	\N	124	\N	\N
CCR-009	F	\N	White	\N	06-18321	\N	125	\N	\N
CM-70	\N	\N	Unknown	Denmark	19Rig750007.05.14.03	\N	298	\N	\N
CCR-010	M	\N	White	\N	05-19406	\N	126	\N	\N
CCR-011	M	\N	White	\N	08-48442,11-89154A7,11-89154A6, 11-89154A7, 11-89154A6, 08-48442	\N	127	\N	\N
CM-33	\N	\N	Unknown	Denmark	19Rig750007.03.04.02,19Rig750007.03.04.03, 19Rig750007.03.04.02, 19Rig750007.03.04.03	\N	273	\N	\N
CCR-014	M	\N	White	\N	09-90221	\N	128	\N	\N
CCR-015	F	\N	White	\N	08-51663	\N	129	\N	\N
CCR-020	M	\N	White	\N	08-44748	\N	130	\N	\N
CCR-034	F	\N	White	\N	12-85105A	\N	136	\N	\N
CCR-021	M	\N	White	\N	04-34117,07-85201, 04-34117, 07-85201	\N	131	\N	\N
CCR-024	M	\N	White	\N	06-8729	\N	132	\N	\N
CM-34	\N	\N	Unknown	Denmark	19Rig750007.03.05.02	\N	274	\N	\N
MD-93	\N	\N	Unknown	Madrid, Spain	14-17085A2 M1	\N	989	\N	\N
CCR-029	F	\N	White	\N	01-18107A	\N	133	\N	\N
CCR-031	M	\N	White	\N	09-16836	\N	134	\N	\N
CCR-032	F	\N	White	\N	07-28805	\N	135	\N	\N
CM-71	\N	\N	Unknown	Denmark	19Rig750007.05.15.03	\N	299	\N	\N
CM-72	\N	\N	Unknown	Denmark	19Rig750007.05.16.01	\N	300	\N	\N
CM-73	\N	\N	Unknown	Denmark	19Rig750007.06.01	\N	301	\N	\N
CM-76	\N	\N	Unknown	Denmark	19rig750007.02.11.01	\N	302	\N	\N
OM-34	F	\N	Unknown	UCSF	14-70636	\N	1292	\N	\N
CCR-035	F	\N	White	\N	09-48136A	\N	137	\N	\N
CCR-040	\N	\N	Unknown	\N	07-37378	\N	138	\N	\N
CCR-058	M	\N	White	\N	99-18307	\N	148	\N	\N
CCR-041	M	\N	White	\N	02-28807	\N	139	\N	\N
CCR-042	F	\N	White	\N	95-5908	\N	140	\N	\N
CCR-046	M	\N	White	\N	05-58791	\N	141	\N	\N
CCR-048	M	\N	White	\N	09-23922B,09-23922A, 09-23922B, 09-23922A	\N	142	\N	\N
CCR-049	M	\N	White	\N	98-11545	\N	143	\N	\N
CGH16-200	M	\N	Unknown	UCSF	16-83056	cases with MAP3K8 fusions	244	\N	\N
CCR-051	M	\N	White	\N	15-43069A	\N	144	\N	\N
CCR-054	M	\N	White	\N	13-32289A,13-32289B, 13-32289A, 13-32289B	\N	145	\N	\N
CCR-055	M	\N	White	\N	13-14077	\N	146	\N	\N
CCR-057	M	\N	White	\N	04-6689B	\N	147	\N	\N
CM-36	\N	\N	Unknown	Denmark	19Rig750007.03.07.03,19Rig750007.03.07.05, 19Rig750007.03.07.03, 19Rig750007.03.07.05	\N	275	\N	\N
MD-95	\N	\N	Unknown	Madrid, Spain	96-07395C M1	\N	991	\N	\N
CCR-066	F	\N	White	\N	09-31608	\N	149	\N	\N
CME-058	M	\N	Asian	Japan	20-00548-10	\N	360	\N	\N
CCR-067	F	\N	White	\N	08-25654	\N	150	\N	\N
CCR-097	M	\N	White	\N	11-80898	\N	155	\N	\N
CME-059	M	\N	Asian	Japan	20-01665-3	\N	361	\N	\N
SYNAT670	\N	\N	\N	\N	CP1-10	\N	2406	\N	\N
CCR-074	M	\N	White	\N	08-1851B,08-1851C,08-1851A, 08-1851B, 08-1851C, 08-1851A	\N	151	\N	\N
CCR-083	M	\N	White	\N	07-67657B,07-67657A, 07-67657B, 07-67657A	\N	152	\N	\N
CCR-086	M	\N	White	\N	01-16263	\N	153	\N	\N
CCR-090	F	\N	White	\N	03-57585E,03-57585C,03-57585A, 03-57585A, 03-57585C, 03-57585E	\N	154	\N	\N
CM-37	\N	\N	Unknown	Denmark	19Rig750007.03.08.05,19Rig750007.03.08.03, 19Rig750007.03.08.05, 19Rig750007.03.08.03	\N	276	\N	\N
CCR-099	M	\N	White	\N	11-37100B	\N	156	\N	\N
CCR-102	M	\N	White	\N	10-25517A,10-25517E,10-23548, 10-25517A, 10-25517E, 10-23548	\N	157	\N	\N
CCR-151	M	\N	White	\N	99-32835	\N	173	\N	\N
CCR-147	M	\N	White	\N	97-13166G	\N	171	\N	\N
CCR-107	F	\N	White	\N	08-8920B,08-8920A, 08-8920B, 08-8920A	\N	158	\N	\N
CCR-109	M	\N	White	\N	07-77608	\N	159	\N	\N
CCR-112	M	\N	White	\N	07-42908	\N	160	\N	\N
CCR-113	F	\N	White	\N	07-40241A	\N	161	\N	\N
CCR-217	M	\N	White	\N	98-16285A2	\N	195	\N	\N
MD-96	\N	\N	Unknown	Madrid, Spain	96-13701 M1	\N	992	\N	\N
CCR-114	F	\N	White	\N	07-7626	\N	162	\N	\N
CCR-124	F	\N	White	\N	98-13466	\N	163	\N	\N
CCR-125	M	\N	White	\N	98-6161B	\N	164	\N	\N
CCR-130	M	\N	White	\N	07-76799A	\N	165	\N	\N
CM-40	\N	\N	Unknown	Denmark	19Rig750007.03.11.02,19Rig750007.03.11.03, 19Rig750007.03.11.02, 19Rig750007.03.11.03	\N	277	\N	\N
CCR-146	F	\N	White	\N	98-10389	\N	170	\N	\N
SYNX119	NaN	\N	\N	\N	MB1424_	NaN	1522	\N	\N
CCR-141	F	\N	White	\N	05-37586A1,05-37586A3, 05-37586A1, 05-37586A3	\N	167	\N	\N
CCR-142	F	\N	White	\N	05-27460	\N	168	\N	\N
CCR-144	M	\N	White	\N	00-5989A2	\N	169	\N	\N
CGH17-135	F	\N	Unknown	UCSF	17-61001	cases with MAP3K8 fusions	245	\N	\N
MD-97	\N	\N	Unknown	Madrid, Spain	96-23601-4 M1	\N	993	\N	\N
CCR-148	F	\N	White	\N	05-5976C,05-5976A,05-5976B, 05-5976C, 05-5976A, 05-5976B	\N	172	\N	\N
CM-41	\N	\N	Unknown	Denmark	19Rig750007.03.12.02,19Rig750007.03.12.05,19Rig750007.03.12.03, 19Rig750007.03.12.02, 19Rig750007.03.12.05, 19Rig750007.03.12.03	\N	278	\N	\N
CCR-154	M	\N	White	\N	92-5109	\N	174	\N	\N
SYNAT420	\N	\N	\N	\N	MB1421	\N	2455	\N	\N
CCR-155	M	\N	White	\N	92-1608B,92-1608A, 92-1608B, 92-1608A	\N	175	\N	\N
CCR-157	F	\N	White	\N	10-43330	\N	176	\N	\N
CM-42	\N	\N	Unknown	Denmark	19Rig750007.04.01.03	\N	279	\N	\N
CM-43	\N	\N	Unknown	Denmark	19Rig750007.04.02.03	\N	280	\N	\N
CM-44	\N	\N	Unknown	Denmark	19Rig750007.04.03.03	\N	281	\N	\N
CM-45	\N	\N	Unknown	Denmark	19Rig750007.04.04.03	\N	282	\N	\N
CCR-158	M	\N	White	\N	04-12137A,04-12137D,04-12137E, 04-12137A, 04-12137D, 04-12137E	\N	177	\N	\N
CCR-159	F	\N	White	\N	03-29330B,03-29330A, 03-29330B, 03-29330A	\N	178	\N	\N
CM-46	\N	\N	Unknown	Denmark	19Rig750007.04.05.03	\N	283	\N	\N
CM-47	\N	\N	Unknown	Denmark	19Rig750007.04.06.03	\N	284	\N	\N
CM-48	\N	\N	Unknown	Denmark	19Rig750007.04.07.03,19Rig750007.04.07.09, 19Rig750007.04.07.03, 19Rig750007.04.07.09	\N	285	\N	\N
CCR-162	M	\N	White	\N	03-30961B,03-30961A, 03-30961B, 03-30961A	\N	179	\N	\N
CCR-163	F	\N	White	\N	99-23502C,99-23502A, 99-23502C, 99-23502A	\N	180	\N	\N
CCR-201	F	\N	White	\N	99-30301	\N	181	\N	\N
CCR-202	M	\N	White	\N	96-3842	\N	182	\N	\N
CM-50	\N	\N	Unknown	Denmark	19Rig750007.04.09.03	\N	286	\N	\N
CM-51	\N	\N	Unknown	Denmark	19Rig750007.04.10.03	\N	287	\N	\N
CM-53	\N	\N	Unknown	Denmark	19Rig750007.04.12.08,19Rig750007.04.12.03, 19Rig750007.04.12.08, 19Rig750007.04.12.03	\N	288	\N	\N
CCR-208	F	\N	White	\N	02-5600A	\N	188	\N	\N
CCR-203	M	\N	White	\N	04-38345	\N	183	\N	\N
CCR-204	F	\N	Unknown	\N	06-28087	\N	184	\N	\N
CCR-206	M	\N	White	\N	02-8746B,02-8746A, 02-8746B, 02-8746A	\N	186	\N	\N
CCR-207	F	\N	White	\N	04-59140B	\N	187	\N	\N
CCR-272	Unknown	\N	Unknown	\N	98-21806	\N	222	\N	\N
CCR-209	M	\N	White	\N	06-23240A,06-10811, 06-23240A, 06-10811	\N	189	\N	\N
CCR-211	M	\N	White	\N	03-47623B	\N	190	\N	\N
CCR-212	F	\N	White	\N	04-18467	\N	191	\N	\N
CM-54	\N	\N	Unknown	Denmark	19Rig750007.04.13.08,19Rig750007.04.13.03, 19Rig750007.04.13.08, 19Rig750007.04.13.03	\N	289	\N	\N
CM-56	\N	\N	Unknown	Denmark	19Rig750007.04.15.03	\N	290	\N	\N
CCR-219	F	\N	White	\N	06-4069	\N	196	\N	\N
CME-104	M	\N	Asian	Japan	17-08581-5	\N	406	\N	\N
CCR-213	M	\N	White	\N	05-66206A	\N	192	\N	\N
CCR-214	F	\N	White	\N	06-47809B	\N	193	\N	\N
CCR-215	M	\N	White	\N	96-18458E,96-18458C,96-18458F,96-18458A, 96-18458E, 96-18458C, 96-18458F, 96-18458A	\N	194	\N	\N
MD-98	\N	\N	Unknown	Madrid, Spain	98-23221F M1	\N	994	\N	\N
CCR-220	F	\N	White	\N	06-64692B	\N	197	\N	\N
CCR-221	F	\N	White	\N	06-5249	\N	198	\N	\N
CCR-222	M	\N	White	\N	02-17626	\N	199	\N	\N
CCR-224	F	\N	White	\N	05-28152B	\N	200	\N	\N
DN-089	M	\N	Unknown	\N	18-96989	\N	564	\N	\N
CM-14	\N	\N	Unknown	Denmark	19Rig750007.01.14.04	replacement for 19rig750007.02.02.04	258	\N	\N
MD-99	\N	\N	Unknown	Madrid, Spain	01-00467B N1	\N	995	\N	\N
CCR-225	F	\N	White	\N	06-70035C	\N	201	\N	\N
CCR-228	M	\N	White	\N	04-31313A	\N	202	\N	\N
CCR-231	M	\N	White	\N	04-28340	\N	203	\N	\N
CCR-233	F	\N	White	\N	06-68314	\N	204	\N	\N
CCR-234	M	\N	White	\N	03-44586	\N	205	\N	\N
CM-15	\N	\N	Unknown	Denmark	19Rig750007.01.15.03,19Rig750007.01.15.01, 19Rig750007.01.15.03, 19Rig750007.01.15.01	\N	259	\N	\N
CCR-235	M	\N	White	\N	06-65105	\N	206	\N	\N
DN-058	M	\N	Unknown	\N	17-26289G	\N	533	\N	\N
CCR-237	M	\N	White	\N	03-16497B,03-16497A, 03-16497B, 03-16497A	\N	207	\N	\N
CCR-238	F	\N	White	\N	04-25639B,04-25639A, 04-25639B, 04-25639A	\N	208	\N	\N
CGH12-109	F	\N	Unknown	UCSF	12-26470	cases with MAP3K8 fusions	240	\N	\N
CCR-240	F	\N	White	\N	03-39293	\N	209	\N	\N
CCR-241	F	\N	White	\N	02-20619B	\N	210	\N	\N
CCR-247	M	\N	White	\N	01-6748	\N	211	\N	\N
CCR-248	F	\N	White	\N	00-26584A1	\N	212	\N	\N
CCR-250	M	\N	White	\N	00-7684A2	\N	213	\N	\N
CGH12-280	F	\N	Unknown	UCSF	12-67286	cases with MAP3K8 fusions	241	\N	\N
CCR-256	M	\N	White	\N	05-27756A,05-27756B, 05-27756A, 05-27756B	\N	214	\N	\N
CCR-257	M	\N	White	\N	94-7602A	\N	215	\N	\N
CCR-258	F	\N	White	\N	96-12193	\N	216	\N	\N
CGH14-145	F	\N	Unknown	UCSF	14-48102	cases with MAP3K8 fusions	242	\N	\N
MD-100	\N	\N	Unknown	Madrid, Spain	00-27758D M1	\N	996	\N	\N
CM-57	\N	\N	Unknown	Denmark	19Rig750007.05.01.03,19Rig750007.05.01.04, 19Rig750007.05.01.03, 19Rig750007.05.01.04	\N	291	\N	\N
CM-58	\N	\N	Unknown	Denmark	19Rig750007.05.02.04,19Rig750007.05.02.03, 19Rig750007.05.02.04, 19Rig750007.05.02.03	\N	292	\N	\N
CM-60	\N	\N	Unknown	Denmark	19Rig750007.05.04.03	\N	293	\N	\N
CM-61	\N	\N	Unknown	Denmark	19Rig750007.05.05.03,19Rig750007.05.05.08, 19Rig750007.05.05.03, 19Rig750007.05.05.08	\N	294	\N	\N
CM-62	\N	\N	Unknown	Denmark	19Rig750007.05.06.04,19Rig750007.05.06.10,19Rig750007.05.06.03, 19Rig750007.05.06.10, 19Rig750007.05.06.03, 19Rig750007.05.06.04	\N	295	\N	\N
CCR-261	M	\N	White	\N	03-3075A,03-3075B, 03-3075A, 03-3075B	\N	217	\N	\N
CCR-263	M	\N	White	\N	04-50387	\N	218	\N	\N
CCR-264	M	\N	White	\N	04-14908,04-14908A, 04-14908, 04-14908A	\N	219	\N	\N
CCR-268	F	\N	White	\N	07-37090	\N	220	\N	\N
CCR-269	M	\N	White	\N	98-9595B	\N	221	\N	\N
CCR-273	F	\N	White	\N	06-17933A,06-17933B, 06-17933A, 06-17933B	\N	223	\N	\N
CCR-274	F	\N	White	\N	95-21392	\N	224	\N	\N
CCR-281	F	\N	White	\N	93-13675A,93-13675B, 93-13675A, 93-13675B	\N	225	\N	\N
CM-16	\N	\N	Unknown	Denmark	19Rig750007.01.16.03,19Rig750007.01.16.02, 19Rig750007.01.16.03, 19Rig750007.01.16.02	\N	260	\N	\N
CM-17	\N	\N	Unknown	Denmark	19rig750007.01.17.01	\N	261	\N	\N
CM-18	\N	\N	Unknown	Denmark	19rig75000701.18.02,19rig75000701.18.01, 19rig75000701.18.02, 19rig75000701.18.01	\N	262	\N	\N
CM-21	\N	\N	Unknown	Denmark	19Rig750007.02.02.04,19Rig750007.02.02.03, 19Rig750007.02.02.04, 19Rig750007.02.02.03	\N	263	\N	\N
CCR-282	M	\N	White	\N	01-11378A2	\N	226	\N	\N
CCR-287	M	\N	White	\N	98-1556	\N	227	\N	\N
CCR-290	F	\N	Unknown	\N	06-22923	\N	228	\N	\N
CCR-296	F	\N	White	\N	04-57347A	\N	229	\N	\N
CCR-298	M	\N	White	\N	03-24651	\N	230	\N	\N
CCR-300	F	\N	White	\N	99-4387	\N	231	\N	\N
CM-22	\N	\N	Unknown	Denmark	19Rig750007.02.03.03,19Rig750007.02.03.02, 19Rig750007.02.03.03, 19Rig750007.02.03.02	\N	264	\N	\N
CM-23	\N	\N	Unknown	Denmark	19Rig750007.02.04.02	\N	265	\N	\N
CM-24	\N	\N	Unknown	Denmark	19Rig750007.02.05.03	\N	266	\N	\N
CM-27	\N	\N	Unknown	Denmark	19Rig750007.02.08.02	\N	267	\N	\N
CCR-301	M	\N	White	\N	06-73878D,06-73878A,06-73878C, 06-73878D, 06-73878A, 06-73878C	\N	232	\N	\N
CCR-302	F	\N	White	\N	03-57215B,03-57215A, 03-57215B, 03-57215A	\N	233	\N	\N
CM-28	\N	\N	Unknown	Denmark	19Rig750007.02.09.03,19Rig750007.02.09.02, 19Rig750007.02.09.03, 19Rig750007.02.09.02	\N	268	\N	\N
CM-29	\N	\N	Unknown	Denmark	19Rig750007.02.10.02,19Rig750007.02.10.01, 19Rig750007.02.10.02, 19Rig750007.02.10.01	\N	269	\N	\N
CM-30	\N	\N	Unknown	Denmark	19Rig750007.03.01.03	\N	270	\N	\N
CCR-303	F	\N	Unknown	\N	06-21115A,06-21115B, 06-21115A, 06-21115B	\N	234	\N	\N
CCR-310	M	\N	Unknown	\N	06-11151F,06-11151D,06-11151C, 06-11151F, 06-11151D, 06-11151C	\N	235	\N	\N
CGH14-348	M	\N	Unknown	UCSF	14-96361	cases with MAP3K8 fusions	243	\N	\N
CCR-311	F	\N	White	\N	00-4845	\N	236	\N	\N
CCR-312	M	\N	White	\N	01-34127B,01-34127A, 01-34127B, 01-34127A	\N	237	\N	\N
CCR-313	F	\N	White	\N	00-556A,00-556B, 00-556A, 00-556B	\N	238	\N	\N
CCR-316	F	\N	White	\N	97-23367	\N	239	\N	\N
CM-31	\N	\N	Unknown	Denmark	19Rig750007.03.02.03,19Rig750007.03.02.05, 19Rig750007.03.02.03, 19Rig750007.03.02.05	\N	271	\N	\N
CGH17-240	M	\N	Unknown	UCSF	17-112474	\N	246	\N	\N
DN-059	F	\N	Unknown	\N	17-62813A	\N	534	\N	\N
CGH18-137	\N	\N	Unknown	UCSF	18-95536	already sequenced (BCB004, SGLP-0412 Mean target cov-140, leftover library 176ng)	247	\N	\N
CGH18-139	F	\N	Unknown	UCSF	18-95537	\N	248	\N	\N
CM-01	\N	\N	Unknown	Denmark	19Rig750007.01.01.02,19Rig750007.01.01.03, 19Rig750007.01.01.02, 19Rig750007.01.01.03	\N	249	\N	\N
CM-04	\N	\N	Unknown	Denmark	19Rig750007.01.04.02	\N	250	\N	\N
CM-05	\N	\N	Unknown	Denmark	19Rig750007.01.05.02,19Rig750007.01.05.03, 19Rig750007.01.05.02, 19Rig750007.01.05.03	\N	251	\N	\N
CM-07	\N	\N	Unknown	Denmark	19Rig750007.01.07.03,19Rig750007.01.07.02, 19Rig750007.01.07.03, 19Rig750007.01.07.02	\N	252	\N	\N
CM-08	\N	\N	Unknown	Denmark	19Rig750007.01.08.03,19Rig750007.01.08.05, 19Rig750007.01.08.03, 19Rig750007.01.08.05	\N	253	\N	\N
CM-10	\N	\N	Unknown	Denmark	19Rig750007.01.10.03	\N	254	\N	\N
CM-11	\N	\N	Unknown	Denmark	19Rig750007.01.11.02	\N	255	\N	\N
CM-12	\N	\N	Unknown	Denmark	19Rig750007.01.12.02	\N	256	\N	\N
CM-13	\N	\N	Unknown	Denmark	19Rig750007.01.13.04,19Rig750007.05.11.03,19Rig750007.01.13.03, 19Rig750007.01.13.04, 19Rig750007.05.11.03, 19Rig750007.01.13.03	\N	257	\N	\N
CM-32	\N	\N	Unknown	Denmark	19Rig750007.03.03.05,19Rig750007.03.03.03,19Rig750007.03.03.04, 19Rig750007.03.03.05, 19Rig750007.03.03.03, 19Rig750007.03.03.04	\N	272	\N	\N
MD-101	\N	\N	Unknown	Madrid, Spain	02-16797C M1	\N	997	\N	\N
CME-001	\N	\N	Asian	Taiwan	21-20305A1,21-13595A1,21-13595C1,21-09097A1, 21-20305A1, 21-13595A1, 21-13595C1, 21-09097A1	\N	303	\N	\N
CME-083	M	\N	Asian	Japan	15-08126-3	\N	385	\N	\N
MD-102	\N	\N	Unknown	Madrid, Spain	02-00594E M1	\N	998	\N	\N
CME-002	\N	\N	Asian	Taiwan	21-20002A1,21-20368A1,21-20368A3, 21-20002A1, 21-20368A1, 21-20368A3	\N	304	\N	\N
CME-003	\N	\N	Asian	Taiwan	20-52125A1,22-42722B1,20-54923B1, 20-52125A1, 22-42722B1, 20-54923B1	\N	305	\N	\N
CME-004	\N	\N	Asian	Taiwan	20-50565B1,20-56832A1,21-37814A1,19-25808,20-50565A1, 20-50565B1, 20-56832A1, 21-37814A1, 19-25808, 20-50565A1	\N	306	\N	\N
CME-105	F	\N	Asian	Japan	17-11446-5	\N	407	\N	\N
CME-009	\N	\N	Asian	Taiwan	14-31325	\N	311	\N	\N
CME-084	M	\N	Asian	Japan	15-08727-2	\N	386	\N	\N
MD-105	\N	\N	Unknown	Madrid, Spain	04-20471E M1	\N	1000	\N	\N
CME-013	\N	\N	Asian	Taiwan	15-36291	\N	315	\N	\N
CME-005	\N	\N	Asian	Taiwan	22-21012A3,21-30633A1,22-21012A5,22-21012A2,21-32669B1,22-21012A1,22-21012A4, 21-30633A1, 22-21012A3, 22-21012A5, 22-21012A2, 21-32669B1, 22-21012A1, 22-21012A4	\N	307	\N	\N
CME-006	\N	\N	Asian	Taiwan	13-32637	\N	308	\N	\N
CME-007	\N	\N	Asian	Taiwan	13-33924	\N	309	\N	\N
CME-010	\N	\N	Asian	Taiwan	16-32627A1	\N	312	\N	\N
CME-011	\N	\N	Asian	Taiwan	15-13150A1	\N	313	\N	\N
CME-012	\N	\N	Asian	Taiwan	15-36675	\N	314	\N	\N
CME-014	\N	\N	Asian	Taiwan	15-49595A1,15-49595, 15-49595, 15-49595A1	\N	316	\N	\N
CME-015	\N	\N	Asian	Taiwan	16-53749A2,16-53749A1, 16-53749A2, 16-53749A1	\N	317	\N	\N
CME-016	\N	\N	Asian	Taiwan	17-37055	\N	318	\N	\N
CME-078	F	\N	Asian	Japan	23-01329-1	\N	380	\N	\N
CME-017	\N	\N	Asian	Taiwan	17-55712A1,17-55712A2, 17-55712A1, 17-55712A2	\N	319	\N	\N
CME-018	\N	\N	Asian	Taiwan	18-05067	\N	320	\N	\N
CME-019	\N	\N	Asian	Taiwan	19-17484	\N	321	\N	\N
CME-020	\N	\N	Asian	Taiwan	19-33672A1	\N	322	\N	\N
CME-021	\N	\N	Asian	Taiwan	19-44938	\N	323	\N	\N
CME-022	\N	\N	Asian	Taiwan	20-7562\t	\N	324	\N	\N
CME-070	M	\N	Asian	Japan	21-09543-2,21-09543-1, 21-09543-2, 21-09543-1	\N	372	\N	\N
SYNAT421	\N	\N	\N	\N	MB1429	\N	2428	\N	\N
CME-023	\N	\N	Asian	Taiwan	20-13577A1	\N	325	\N	\N
CME-024	\N	\N	Asian	Taiwan	20-56532	\N	326	\N	\N
CME-025	\N	\N	Asian	Taiwan	21-20367A1	\N	327	\N	\N
CME-026	\N	\N	Asian	Taiwan	21-15959	\N	328	\N	\N
CME-027	\N	\N	Asian	Taiwan	21-17351	\N	329	\N	\N
CME-079	F	\N	Asian	Japan	15-05771-4	\N	381	\N	\N
MD-106	\N	\N	Unknown	Madrid, Spain	05-14728C M1	\N	1001	\N	\N
CME-028	\N	\N	Asian	Taiwan	20-24373A1	\N	330	\N	\N
CME-029	\N	\N	Asian	Taiwan	16-37564A1	\N	331	\N	\N
CME-030	\N	\N	Asian	Taiwan	18-31426A	\N	332	\N	\N
CME-031	\N	\N	Asian	Taiwan	21-21081	\N	333	\N	\N
CME-032	\N	\N	Asian	Taiwan	22-34951	\N	334	\N	\N
CME-101	F	\N	Asian	Japan	17-00731-3	\N	403	\N	\N
CME-102	M	\N	Asian	Japan	17-03472-1	\N	404	\N	\N
CME-033	\N	\N	Asian	Taiwan	22-21031A1	\N	335	\N	\N
CME-034	\N	\N	Asian	Taiwan	22-25709C1	\N	336	\N	\N
CME-035	\N	\N	Asian	Taiwan	23-09618	\N	337	\N	\N
CME-036	F	\N	Asian	Japan	23-02692-3	\N	338	\N	\N
CME-037	M	\N	Asian	Japan	23-03529-3	\N	339	\N	\N
CME-038	F	\N	Asian	Japan	23-04707-7	\N	340	\N	\N
CME-039	F	\N	Asian	Japan	23-05091-4	\N	341	\N	\N
CME-040	F	\N	Asian	Japan	23-04628-5	\N	342	\N	\N
CME-041	F	\N	Asian	Japan	23-05782-2	\N	343	\N	\N
CME-042	M	\N	Asian	Japan	23-06001-12	\N	344	\N	\N
CME-043	M	\N	Asian	Japan	23-07186-13	\N	345	\N	\N
CME-080	M	\N	Asian	Japan	15-06395-3	\N	382	\N	\N
MD-107	\N	\N	Unknown	Madrid, Spain	06-12646D M1	\N	1002	\N	\N
CME-044	F	\N	Asian	Japan	18-00447N1,18-00447-2, 18-00447N1, 18-00447-2	\N	346	\N	\N
CME-045	M	\N	Asian	Japan	18-02303-1	\N	347	\N	\N
CME-046	F	\N	Asian	Japan	18-08429-4	\N	348	\N	\N
CME-047	F	\N	Asian	Japan	18-09671N1,18-09671-4,20-00782N3, 18-09671N1, 18-09671-4, 20-00782N3	\N	349	\N	\N
CME-103	F	\N	Asian	Japan	17-09063-N1,17-09063-1, 17-09063-N1, 17-09063-1	\N	405	\N	\N
CME-048	M	\N	Asian	Japan	19-03736,19-01043N2,19-01043-1, 19-03736, 19-01043N2, 19-01043-1	\N	350	\N	\N
CME-049	F	\N	Asian	Japan	19-03114-6,19-03114N1, 19-03114-6, 19-03114N1	\N	351	\N	\N
CME-050	F	\N	Asian	Japan	19-03800-4	\N	352	\N	\N
CME-051	M	\N	Asian	Japan	20-02956-5,19-03361-3,20-00698, 20-02956-5, 19-03361-3, 20-00698	\N	353	\N	\N
CME-052	F	\N	Asian	Japan	19-05268N1,19-05268-9, 19-05268N1, 19-05268-9	\N	354	\N	\N
CME-053	F	\N	Asian	Japan	19-05094-9	\N	355	\N	\N
CME-054	M	\N	Asian	Japan	19-05307-8	\N	356	\N	\N
CME-055	M	\N	Asian	Japan	19-08527-2,19-08527N1, 19-08527-2, 19-08527N1	\N	357	\N	\N
CME-056	M	\N	Asian	Japan	19-09700-4	\N	358	\N	\N
CME-057	F	\N	Asian	Japan	20-01244-2	\N	359	\N	\N
CME-060	M	\N	Asian	Japan	20-03009N1,20-03009-7, 20-03009N1, 20-03009-7	\N	362	\N	\N
CME-061	M	\N	Asian	Japan	20-04152-8	\N	363	\N	\N
CME-062	M	\N	Asian	Japan	22-07164-1,20-04546-3,21-03240, 22-07164-1, 20-04546-3, 21-03240	\N	364	\N	\N
CME-063	F	\N	Asian	Japan	20-08679-5	\N	365	\N	\N
CME-064	M	\N	Asian	Japan	20-06242	\N	366	\N	\N
CME-081	F	\N	Asian	Japan	15-07035-1	\N	383	\N	\N
CME-082	F	\N	Asian	Japan	15-08075-5	\N	384	\N	\N
MD-108	\N	\N	Unknown	Madrid, Spain	03-19132B T1	Two tubes, one extracted on 10/12/2019	1003	\N	\N
CME-065	M	\N	Asian	Japan	21-04018,20-05671-2,22-03790, 21-04018, 20-05671-2, 22-03790	\N	367	\N	\N
CME-066	M	\N	Asian	Japan	23-03515-1,21-04690-3, 23-03515-1, 21-04690-3	\N	368	\N	\N
CME-067	M	\N	Asian	Japan	21-06796-5	\N	369	\N	\N
CME-068	M	\N	Asian	Japan	21-08944-3	\N	370	\N	\N
CME-069	F	\N	Asian	Japan	21-09119N2,21-09119-2,21-09119-4, 21-09119-4, 21-09119N2, 21-09119-2	\N	371	\N	\N
CME-071	M	\N	Asian	Japan	22-00847N5,21-09545-2, 22-00847N5, 21-09545-2	\N	373	\N	\N
CME-072	M	\N	Asian	Japan	22-00892-16	\N	374	\N	\N
CME-073	M	\N	Asian	Japan	22-01164-2	\N	375	\N	\N
CME-074	M	\N	Asian	Japan	22-04201N2,22-04201-6, 22-04201N2, 22-04201-6	\N	376	\N	\N
CME-075	M	\N	Asian	Japan	22-05287N2,22-05287-15, 22-05287N2, 22-05287-15	\N	377	\N	\N
CME-076	F	\N	Asian	Japan	22-06500-1	\N	378	\N	\N
CME-077	F	\N	Asian	Japan	23-01133	\N	379	\N	\N
CME-085	F	\N	Asian	Japan	15-10294-1	\N	387	\N	\N
CME-086	M	\N	Asian	Japan	15-11029-1	\N	388	\N	\N
CME-087	M	\N	Asian	Japan	16-00657-2	\N	389	\N	\N
CME-088	M	\N	Asian	Japan	16-03460-1	\N	390	\N	\N
CME-089	M	\N	Asian	Japan	17-00792,16-04805-2, 17-00792, 16-04805-2	\N	391	\N	\N
CME-090	F	\N	Asian	Japan	16-05265-2	\N	392	\N	\N
CME-091	M	\N	Asian	Japan	16-05548-2	\N	393	\N	\N
CME-092	M	\N	Asian	Japan	21-10478-2,16-05958-2, 21-10478-2, 16-05958-2	\N	394	\N	\N
CME-093	F	\N	Asian	Japan	16-06126-2	\N	395	\N	\N
CME-094	M	\N	Asian	Japan	16-06348-2	\N	396	\N	\N
CME-095	F	\N	Asian	Japan	16-06590-2	\N	397	\N	\N
CME-096	F	\N	Asian	Japan	16-06994-1	\N	398	\N	\N
CME-097	F	\N	Asian	Japan	16-09944-2	\N	399	\N	\N
CME-098	F	\N	Asian	Japan	16-10561-3	\N	400	\N	\N
CME-099	M	\N	Asian	Japan	16-10560-1	\N	401	\N	\N
CME-100	M	\N	Asian	Japan	17-00730-3	\N	402	\N	\N
CME-106	M	\N	Asian	Japan	17-10987-N2,17-10987-6, 17-10987-N2, 17-10987-6	\N	408	\N	\N
CME-107	M	\N	Asian	Japan	17-11087-5	\N	409	\N	\N
CME-108	F	\N	Asian	Japan	17-10231-5	\N	410	\N	\N
DMS-002	\N	\N	Unknown	UCSF	23-4594	\N	414	\N	\N
MD-112	\N	\N	Unknown	Madrid, Spain	95-14690F T1	\N	1004	\N	\N
MD-113	\N	\N	Unknown	Madrid, Spain	00-16651B T1	\N	1005	\N	\N
CS-01	M	\N	Unknown	UCSF	22-104389A4,22-104389A2,22-104389C,22-44813B, 22-104389A4, 22-104389A2, 22-104389C, 22-44813B	CS = Clinical Sample	411	\N	\N
CS-02	F	\N	Unknown	UCSF	22-125373	\N	412	\N	\N
DMS-029	\N	\N	Unknown	UCSF	22-91591	\N	441	\N	\N
DMS-001	\N	\N	Unknown	UCSF	23-7246A ,23-7246C,23-7246B, 23-7246A , 23-7246C, 23-7246B	\N	413	\N	\N
DMS-003	\N	\N	Unknown	UCSF	23-4595	\N	415	\N	\N
DMS-004	\N	\N	Unknown	UCSF	23-5236	\N	416	\N	\N
DMS-005	\N	\N	Unknown	UCSF	22-35051	\N	417	\N	\N
DMS-006	\N	\N	Unknown	UCSF	23-4742	\N	418	\N	\N
DMS-007	\N	\N	Unknown	UCSF	23-4604	\N	419	\N	\N
DMS-008	\N	\N	Unknown	UCSF	22-122015	\N	420	\N	\N
DMS-009	\N	\N	Unknown	UCSF	22-115763	\N	421	\N	\N
OM-35	F	\N	Unknown	UCSF	14-14773	\N	1293	\N	\N
SYNAT422	\N	\N	\N	\N	MB1428	\N	2396	\N	\N
DMS-010	\N	\N	Unknown	UCSF	22-59468	\N	422	\N	\N
DMS-011	\N	\N	Unknown	UCSF	23-5230	\N	423	\N	\N
DMS-012	\N	\N	Unknown	UCSF	22-114644	\N	424	\N	\N
DMS-013	\N	\N	Unknown	UCSF	22-127365	\N	425	\N	\N
DMS-014	\N	\N	Unknown	UCSF	22-127490	\N	426	\N	\N
DMS-015	\N	\N	Unknown	UCSF	22-128532	\N	427	\N	\N
DMS-016	\N	\N	Unknown	UCSF	22-128941	\N	428	\N	\N
DMS-017	\N	\N	Unknown	UCSF	22-83883	\N	429	\N	\N
DMS-018	\N	\N	Unknown	UCSF	23-293	\N	430	\N	\N
DMS-019	\N	\N	Unknown	UCSF	23-4720	\N	431	\N	\N
DMS-020	\N	\N	Unknown	UCSF	22-115140	\N	432	\N	\N
DMS-021	\N	\N	Unknown	UCSF	23-3020	\N	433	\N	\N
MD-114	\N	\N	Unknown	Madrid, Spain	99-13402-3 T1	\N	1006	\N	\N
MD-118	\N	\N	Unknown	Madrid, Spain	06-24998B T2	\N	1007	\N	\N
MD-119	\N	\N	Unknown	Madrid, Spain	00-23160D T1	\N	1008	\N	\N
DMS-022	\N	\N	Unknown	UCSF	22-8115	\N	434	\N	\N
DMS-023	\N	\N	Unknown	UCSF	22-81230	\N	435	\N	\N
DMS-024	\N	\N	Unknown	UCSF	22-83760	\N	436	\N	\N
DMS-025	\N	\N	Unknown	UCSF	22-854	\N	437	\N	\N
DMS-026	\N	\N	Unknown	UCSF	22-85528	\N	438	\N	\N
DMS-027	\N	\N	Unknown	UCSF	22-88969	\N	439	\N	\N
DMS-028	\N	\N	Unknown	UCSF	22-90430	\N	440	\N	\N
SYNAT461	\N	\N	\N	\N	DM96	\N	2608	\N	\N
DMS-030	\N	\N	Unknown	UCSF	22-94507	\N	442	\N	\N
DMS-031	\N	\N	Unknown	UCSF	22-95858	\N	443	\N	\N
DMS-032	\N	\N	Unknown	UCSF	22-99877	\N	444	\N	\N
MD-121	\N	\N	Unknown	Madrid, Spain	06-21073E T3	\N	1009	\N	\N
MD-122	\N	\N	Unknown	Madrid, Spain	06-20661-2 T1	\N	1010	\N	\N
DMS-033	\N	\N	Unknown	UCSF	19-111428	\N	445	\N	\N
DMS-034	\N	\N	Unknown	UCSF	20-103041	\N	446	\N	\N
DMS-035	\N	\N	Unknown	UCSF	20-14475	\N	447	\N	\N
DMS-036	\N	\N	Unknown	UCSF	20-23650	\N	448	\N	\N
DMS-056	\N	\N	Unknown	UCSF	22-51687	\N	468	\N	\N
DMS-037	\N	\N	Unknown	UCSF	20-31361	\N	449	\N	\N
DMS-038	\N	\N	Unknown	UCSF	20-35177	\N	450	\N	\N
MD-125	\N	\N	Unknown	Madrid, Spain	06-17562-2 T1	\N	1011	\N	\N
MD-127	\N	\N	Unknown	Madrid, Spain	06-15453C T1	\N	1012	\N	\N
DMS-039	\N	\N	Unknown	UCSF	20-43970	\N	451	\N	\N
DMS-040	\N	\N	Unknown	UCSF	20-5264	\N	452	\N	\N
DMS-041	\N	\N	Unknown	UCSF	20-57917	\N	453	\N	\N
DMS-042	\N	\N	Unknown	UCSF	20-64178	\N	454	\N	\N
DMS-054	\N	\N	Unknown	UCSF	22-46448	\N	466	\N	\N
DMS-043	\N	\N	Unknown	UCSF	23-7509	\N	455	\N	\N
DMS-044	\N	\N	Unknown	UCSF	23-14412	\N	456	\N	\N
DMS-045	\N	\N	Unknown	UCSF	23-37594	\N	457	\N	\N
DN-086	M	\N	Unknown	\N	16-118014	\N	561	\N	\N
DMS-046	\N	\N	Unknown	UCSF	23-42323	\N	458	\N	\N
DMS-047	\N	\N	Unknown	UCSF	17-102266	\N	459	\N	\N
DMS-048	\N	\N	Unknown	UCSF	17-113038	\N	460	\N	\N
DMS-055	\N	\N	Unknown	UCSF	22-47776	\N	467	\N	\N
DMS-049	\N	\N	Unknown	UCSF	17-130985	\N	461	\N	\N
DMS-050	\N	\N	Unknown	UCSF	17-48914	\N	462	\N	\N
DMS-051	\N	\N	Unknown	UCSF	17-75346	\N	463	\N	\N
MD-128	\N	\N	Unknown	Madrid, Spain	06-10522-2B T1	\N	1013	\N	\N
MD-130	\N	\N	Unknown	Madrid, Spain	06-01846D T1	\N	1014	\N	\N
MD-131	\N	\N	Unknown	Madrid, Spain	06-06053B T1	\N	1015	\N	\N
DMS-052	\N	\N	Unknown	UCSF	17-91856A,17-91856B, 17-91856A, 17-91856B	\N	464	\N	\N
DMS-053	\N	\N	Unknown	UCSF	17-94254	\N	465	\N	\N
OM-36	M	\N	Unknown	UCSF	15-30226	\N	1294	\N	\N
SYNAT462	\N	\N	\N	\N	KIT8	\N	2852	\N	\N
SYNAT463	\N	\N	\N	\N	KIT21	\N	2534	\N	\N
SYNAT464	\N	\N	\N	\N	KIT55	\N	2882	\N	\N
DMS-057	\N	\N	Unknown	UCSF	22-53879	\N	469	\N	\N
DMS-058	\N	\N	Unknown	UCSF	22-61674	\N	470	\N	\N
DMS-059	\N	\N	Unknown	UCSF	22-67443	\N	471	\N	\N
DMS-060	\N	\N	Unknown	UCSF	22-84696	\N	472	\N	\N
DMS-061	\N	\N	Unknown	UCSF	22-88291	\N	473	\N	\N
DMS-062	\N	\N	Unknown	UCSF	22-93578	\N	474	\N	\N
DMS-063	\N	\N	Unknown	UCSF	22-95643B,22-95643, 22-95643B, 22-95643	\N	475	\N	\N
DN-001	F	\N	Unknown	\N	16-119468	\N	476	\N	\N
DN-002	M	\N	Unknown	\N	17-20901	\N	477	\N	\N
DN-003	F	\N	Unknown	\N	17-35589	\N	478	\N	\N
DN-004	M	\N	Unknown	\N	17-21285	\N	479	\N	\N
DN-005	M	\N	Unknown	\N	16-125611	\N	480	\N	\N
DN-006	M	\N	Unknown	\N	16-126284A	\N	481	\N	\N
DN-007	F	\N	Unknown	\N	17-21066B	\N	482	\N	\N
DN-008	M	\N	Unknown	\N	16-125177	\N	483	\N	\N
OM-59	M	\N	Unknown	UCSF	16-76143	\N	1317	\N	\N
DN-009	M	\N	Unknown	\N	17-35916B	\N	484	\N	\N
DN-010	M	\N	Unknown	\N	17-62447A,17-62447B, 17-62447B, 17-62447A	\N	485	\N	\N
MD-132	\N	\N	Unknown	Madrid, Spain	96-24948 T1	\N	1016	\N	\N
MD-135	\N	\N	Unknown	Madrid, Spain	05-26408 T1	\N	1017	\N	\N
MD-137	\N	\N	Unknown	Madrid, Spain	05-24184C T1	\N	1018	\N	\N
DN-011	M	\N	Unknown	\N	17-21476B	\N	486	\N	\N
DN-012	M	\N	Unknown	\N	16-125754	\N	487	\N	\N
DN-013	M	\N	Unknown	\N	17-62828B,17-62828A, 17-62828B, 17-62828A	\N	488	\N	\N
DN-014	M	\N	Unknown	\N	16-98123	\N	489	\N	\N
OM-60	M	\N	Unknown	UCSF	16-108474	\N	1318	\N	\N
OM-61	F	\N	Unknown	UCSF	16-118278	\N	1319	\N	\N
DN-015	F	\N	Unknown	\N	17-34432D,17-34432B,17-34432C, 17-34432D, 17-34432B, 17-34432C	\N	490	\N	\N
DN-016	M	\N	Unknown	\N	17-35486A,17-35486B, 17-35486B, 17-35486A	\N	491	\N	\N
MD-138	\N	\N	Unknown	Madrid, Spain	05-26627-1B T1	\N	1019	\N	\N
MD-139	\N	\N	Unknown	Madrid, Spain	01-15780R T1	\N	1020	\N	\N
DN-017	M	\N	Unknown	\N	17-65201A	\N	492	\N	\N
DN-018	M	\N	Unknown	\N	17-35917B,17-35917A, 17-35917B, 17-35917A	\N	493	\N	\N
DN-019	M	\N	Unknown	\N	17-26400	\N	494	\N	\N
SYNAT465	\N	\N	\N	\N	KIT76	\N	2405	\N	\N
SYNX180	NaN	\N	\N	\N	W09-1121	N14_1	1583	\N	\N
DN-020	F	\N	Unknown	\N	17-62534	\N	495	\N	\N
DN-021	M	\N	Unknown	\N	16-126258A	\N	496	\N	\N
DN-022	M	\N	Unknown	\N	17-35859B,17-35859A,17-35859C, 17-35859C, 17-35859B, 17-35859A	\N	497	\N	\N
MD-140	\N	\N	Unknown	Madrid, Spain	05-20065-4 T1	\N	1021	\N	\N
MD-141	\N	\N	Unknown	Madrid, Spain	05-13894C T2	\N	1022	\N	\N
DN-023	F	\N	Unknown	\N	16-119063	\N	498	\N	\N
DN-024	M	\N	Unknown	\N	16-125609	\N	499	\N	\N
DN-025	F	\N	Unknown	\N	16-98528A	\N	500	\N	\N
DN-026	M	\N	Unknown	\N	16-97347	\N	501	\N	\N
DN-027	M	\N	Unknown	\N	16-117695A	\N	502	\N	\N
SYNX181	NaN	\N	\N	\N	W10-143	N14_3	1584	\N	\N
SYNX182	NaN	\N	\N	\N	S94-31062	N14_4	1585	\N	\N
SYNX183	NaN	\N	\N	\N	S02-23636A02	N14_5	1586	\N	\N
DN-028	F	\N	Unknown	\N	17-63837	\N	503	\N	\N
DN-029	F	\N	Unknown	\N	17-27830B	\N	504	\N	\N
DN-030	M	\N	Unknown	\N	16-98055B,16-98055A, 16-98055B, 16-98055A	\N	505	\N	\N
DN-031	M	\N	Unknown	\N	17-64032	\N	506	\N	\N
MD-142	\N	\N	Unknown	Madrid, Spain	05-17080 T2	\N	1023	\N	\N
DN-032	M	\N	Unknown	\N	17-27833	\N	507	\N	\N
DN-033	F	\N	Unknown	\N	16-98733	\N	508	\N	\N
DN-034	M	\N	Unknown	\N	17-26455B	\N	509	\N	\N
DN-035	F	\N	Unknown	\N	17-35502B,17-35502A, 17-35502B, 17-35502A	\N	510	\N	\N
DN-036	F	\N	Unknown	\N	17-34979	\N	511	\N	\N
DN-037	M	\N	Unknown	\N	17-63503	\N	512	\N	\N
DN-038	M	\N	Unknown	\N	17-2270A	\N	513	\N	\N
DN-039	M	\N	Unknown	\N	16-119311	\N	514	\N	\N
DN-103	M	\N	Unknown	\N	17-92405	\N	578	\N	\N
DN-040	M	\N	Unknown	\N	17-65020B	\N	515	\N	\N
DN-041	F	\N	Unknown	\N	17-65000	\N	516	\N	\N
DN-042	F	\N	Unknown	\N	17-28040A	\N	517	\N	\N
DN-043	F	\N	Unknown	\N	17-3739	\N	518	\N	\N
SYNX184	NaN	\N	\N	\N	S02-33818A03	N14_6	1587	\N	\N
DN-044	M	\N	Unknown	\N	17-62502A,17-62502B, 17-62502A, 17-62502B	\N	519	\N	\N
DN-045	F	\N	Unknown	\N	17-27410	\N	520	\N	\N
DN-046	M	\N	Unknown	\N	16-98043	\N	521	\N	\N
DN-047	M	\N	Unknown	\N	17-3829B	\N	522	\N	\N
MD-144	\N	\N	Unknown	Madrid, Spain	05-04841C T2	\N	1024	\N	\N
DN-048	M	\N	Unknown	\N	16-119467B,16-119467D,16-119467C, 16-119467B, 16-119467D, 16-119467C	\N	523	\N	\N
DN-056	F	\N	Unknown	\N	17-3731	\N	531	\N	\N
DN-049	F	\N	Unknown	\N	16-98328A	\N	524	\N	\N
DN-050	M	\N	Unknown	\N	17-26447	\N	525	\N	\N
DN-051	M	\N	Unknown	\N	17-26969	\N	526	\N	\N
DN-052	M	\N	Unknown	\N	17-34448	\N	527	\N	\N
DN-053	F	\N	Unknown	\N	17-34977	\N	528	\N	\N
MD-146	\N	\N	Unknown	Madrid, Spain	04-08148D T1	\N	1025	\N	\N
MD-147	\N	\N	Unknown	Madrid, Spain	04-22191D T1	\N	1026	\N	\N
MD-148	\N	\N	Unknown	Madrid, Spain	05-04949-1C T1	\N	1027	\N	\N
DN-054	M	\N	Unknown	\N	17-65263C	\N	529	\N	\N
DN-055	M	\N	Unknown	\N	17-26432A,17-26432B, 17-26432A, 17-26432B	\N	530	\N	\N
SYNX185	NaN	\N	\N	\N	S05-7439A12	N14_8	1588	\N	\N
SYNX186	NaN	\N	\N	\N	S05-41924	N14_9	1589	\N	\N
SYNX187	NaN	\N	\N	\N	S06-47079A02	N14_10	1590	\N	\N
DN-057	M	\N	Unknown	\N	17-21049	\N	532	\N	\N
MD-149	\N	\N	Unknown	Madrid, Spain	04-18775B T1	\N	1028	\N	\N
MD-150	\N	\N	Unknown	Madrid, Spain	04-14677 T1	\N	1029	\N	\N
MD-151	\N	\N	Unknown	Madrid, Spain	04-00122C T1	\N	1030	\N	\N
DN-061	F	\N	Unknown	\N	17-34464A,17-34464B, 17-34464A, 17-34464B	\N	536	\N	\N
DN-062	F	\N	Unknown	\N	17-65218B	\N	537	\N	\N
DN-063	M	\N	Unknown	\N	17-20908	\N	538	\N	\N
DN-064	M	\N	Unknown	\N	16-118019	\N	539	\N	\N
DN-065	M	\N	Unknown	\N	16-119333	\N	540	\N	\N
DN-066	M	\N	Unknown	\N	17-36682	\N	541	\N	\N
DN-067	F	\N	Unknown	\N	16-126879A	\N	542	\N	\N
DN-068	M	\N	Unknown	\N	16-125621	\N	543	\N	\N
DN-069	F	\N	Unknown	\N	17-20900B	\N	544	\N	\N
MD-152	\N	\N	Unknown	Madrid, Spain	04-11144C T1	\N	1031	\N	\N
MD-153	\N	\N	Unknown	Madrid, Spain	04-14508C T1	\N	1032	\N	\N
MD-154	\N	\N	Unknown	Madrid, Spain	04-15616C T2	\N	1033	\N	\N
MD-155	\N	\N	Unknown	Madrid, Spain	04-17745B T1	\N	1034	\N	\N
DN-070	M	\N	Unknown	\N	16-98735	\N	545	\N	\N
DN-071	M	\N	Unknown	\N	17-20501C	\N	546	\N	\N
DN-072	M	\N	Unknown	\N	17-63163	\N	547	\N	\N
DN-073	F	\N	Unknown	\N	17-27380	\N	548	\N	\N
DN-074	M	\N	Unknown	\N	17-62251	\N	549	\N	\N
DN-075	M	\N	Unknown	\N	16-98130	\N	550	\N	\N
DN-076	M	\N	Unknown	\N	17-65315B	\N	551	\N	\N
DN-077	M	\N	Unknown	\N	17-65160B	\N	552	\N	\N
DN-113	M	\N	Unknown	\N	18-121006	\N	588	\N	\N
DN-078	M	\N	Unknown	\N	16-48776B	\N	553	\N	\N
DN-079	F	\N	Unknown	\N	17-63890C	\N	554	\N	\N
DN-080	M	\N	Unknown	\N	17-2241	\N	555	\N	\N
SYNX188	NaN	\N	\N	\N	S08-4544A03	N14_11	1591	\N	\N
SYNX189	NaN	\N	\N	\N	S10-26316A2	N14_12	1592	\N	\N
SYNX190	NaN	\N	\N	\N	S10-44069A4	N14_13	1593	\N	\N
DN-081	M	\N	Unknown	\N	17-20497A	\N	556	\N	\N
DN-082	F	\N	Unknown	\N	17-27403	\N	557	\N	\N
DN-083	M	\N	Unknown	\N	17-48595B	\N	558	\N	\N
DN-084	M	\N	Unknown	\N	17-36614	\N	559	\N	\N
DN-085	F	\N	Unknown	\N	17-20244B	\N	560	\N	\N
MD-156	\N	\N	Unknown	Madrid, Spain	04-15689C T1	\N	1035	\N	\N
MD-157	\N	\N	Unknown	Madrid, Spain	04-13607 T1	\N	1036	\N	\N
DN-087	M	\N	Unknown	\N	16-126714	\N	562	\N	\N
DN-088	F	\N	Unknown	\N	16-12574	can't find patient age for tnis one, will look into intellipath later, double check this is not T16-125754	563	\N	\N
DN-090	F	\N	Unknown	\N	17-72585A,17-72585B,17-72585C, 17-72585A, 17-72585B, 17-72585C	\N	565	\N	\N
DN-091	M	\N	Unknown	\N	17-93945C	\N	566	\N	\N
DN-092	F	\N	Unknown	\N	17-82365B	\N	567	\N	\N
DN-093	M	\N	Unknown	\N	17-72429A	\N	568	\N	\N
DN-094	F	\N	Unknown	\N	18-119366A	\N	569	\N	\N
DN-114	M	\N	Unknown	\N	18-52908	\N	589	\N	\N
MD-158	\N	\N	Unknown	Madrid, Spain	04-13171C T1	\N	1037	\N	\N
DN-095	F	\N	Unknown	\N	17-91889	\N	570	\N	\N
DN-096	F	\N	Unknown	\N	18-96108	\N	571	\N	\N
DN-097	M	\N	Unknown	\N	18-121403A	\N	572	\N	\N
DN-098	F	\N	Unknown	\N	18-119369B	\N	573	\N	\N
SYNX191	NaN	\N	\N	\N	S11-38910A2	N14_14	1594	\N	\N
DN-099	M	\N	Unknown	\N	18-120593B	\N	574	\N	\N
DN-100	F	\N	Unknown	\N	18-90550	\N	575	\N	\N
DN-101	F	\N	Unknown	\N	17-72580	\N	576	\N	\N
DN-102	F	\N	Unknown	\N	17-72563	\N	577	\N	\N
MD-159	\N	\N	Unknown	Madrid, Spain	04-03547G T1	\N	1038	\N	\N
MD-161	\N	\N	Unknown	Madrid, Spain	04-03311H T2	\N	1039	\N	\N
MD-162	\N	\N	Unknown	Madrid, Spain	01-10208A T1	\N	1040	\N	\N
MD-163	\N	\N	Unknown	Madrid, Spain	04-02031D T1	\N	1041	\N	\N
DN-104	F	\N	Unknown	\N	17-85037	\N	579	\N	\N
DN-105	F	\N	Unknown	\N	17-74152D	\N	580	\N	\N
DN-125	M	\N	Unknown	\N	18-65038B	\N	600	\N	\N
SYNAT466	\N	\N	\N	\N	KIT192	\N	2307	\N	\N
DN-106	M	\N	Unknown	\N	17-74882B,17-74882A, 17-74882B, 17-74882A	\N	581	\N	\N
DN-107	F	\N	Unknown	\N	17-74282	\N	582	\N	\N
DN-108	F	\N	Unknown	\N	17-125335	\N	583	\N	\N
DN-109	M	\N	Unknown	\N	17-93961A	\N	584	\N	\N
DN-110	F	\N	Unknown	\N	18-54612	\N	585	\N	\N
DN-111	M	\N	Unknown	\N	18-121415	\N	586	\N	\N
DN-112	F	\N	Unknown	\N	17-112277	\N	587	\N	\N
DN-115	F	\N	Unknown	\N	17-92850	\N	590	\N	\N
DN-116	M	\N	Unknown	\N	18-120470	\N	591	\N	\N
DN-117	M	\N	Unknown	\N	18-120587	\N	592	\N	\N
DN-118	M	\N	Unknown	\N	17-82806	\N	593	\N	\N
DN-119	M	\N	Unknown	\N	17-81767B,17-81767C, 17-81767B, 17-81767C	\N	594	\N	\N
DN-120	M	\N	Unknown	\N	17-117666	\N	595	\N	\N
DN-121	F	\N	Unknown	\N	17-117775B	\N	596	\N	\N
DN-122	F	\N	Unknown	\N	17-49739B	\N	597	\N	\N
MD-165	\N	\N	Unknown	Madrid, Spain	03-22623A T1	\N	1042	\N	\N
MD-166	\N	\N	Unknown	Madrid, Spain	03-23238B T2	\N	1043	\N	\N
MD-167	\N	\N	Unknown	Madrid, Spain	99-19998 T2	\N	1044	\N	\N
DN-123	M	\N	Unknown	\N	17-81609B	\N	598	\N	\N
DN-124	M	\N	Unknown	\N	17-112631B	\N	599	\N	\N
SYNAT467	\N	\N	\N	\N	KIT203	\N	2537	\N	\N
SYNAT468	\N	\N	\N	\N	KR_166	\N	2830	\N	\N
SYNAT469	\N	\N	\N	\N	KR_2064	\N	2760	\N	\N
DN-126	M	\N	Unknown	\N	17-93920	\N	601	\N	\N
DN-127	M	\N	Unknown	\N	18-135600	\N	602	\N	\N
DN-128	M	\N	Unknown	\N	18-135492	\N	603	\N	\N
DN-129	F	\N	Unknown	\N	18-135488	\N	604	\N	\N
DN-130	M	\N	Unknown	\N	18-136721	\N	605	\N	\N
DN-131	M	\N	Unknown	\N	18-136716B	\N	606	\N	\N
DN-132	M	\N	Unknown	\N	18-136800A	\N	607	\N	\N
DN-133	F	\N	Unknown	\N	19-7686A	\N	608	\N	\N
DN-134	F	\N	Unknown	\N	18-135485	\N	609	\N	\N
DN-135	M	\N	Unknown	\N	18-136484	\N	610	\N	\N
SYNAT470	\N	\N	\N	\N	KR_2030	\N	2514	\N	\N
SYNAT471	\N	\N	\N	\N	KR_177	\N	2955	\N	\N
DN-136	M	\N	Unknown	\N	18-136800B	\N	611	\N	\N
DN-137	M	\N	Unknown	\N	18-137340A	\N	612	\N	\N
DN-138	M	\N	Unknown	\N	18-137854C	\N	613	\N	\N
DN-139	M	\N	Unknown	\N	18-137857	\N	614	\N	\N
DN-140	M	\N	Unknown	\N	18-137809B	\N	615	\N	\N
DN-141	M	\N	Unknown	\N	19-7126B	\N	616	\N	\N
DN-142	M	\N	Unknown	\N	19-7344	\N	617	\N	\N
DN-143	M	\N	Unknown	\N	19-7357A	\N	618	\N	\N
DN-144	M	\N	Unknown	\N	19-7357B	\N	619	\N	\N
DN-145	F	\N	Unknown	\N	19-7596C	\N	620	\N	\N
DN-146	F	\N	Unknown	\N	19-7600	\N	621	\N	\N
SYNAT472	\N	\N	\N	\N	KR_150	\N	2773	\N	\N
DN-147	M	\N	Unknown	\N	19-7601	\N	622	\N	\N
DN-148	M	\N	Unknown	\N	19-7669	\N	623	\N	\N
DN-149	M	\N	Unknown	\N	19-29433C	\N	624	\N	\N
DN-150	F	\N	Unknown	\N	19-15130	\N	625	\N	\N
DN-151	F	\N	Unknown	\N	19-37609	\N	626	\N	\N
KIT-13	\N	\N	Unknown	\N	11-072	\N	794	\N	\N
KIT-14	\N	\N	Unknown	\N	11-091	\N	795	\N	\N
DN-152	M	\N	Unknown	\N	19-29129	\N	627	\N	\N
DN-153	M	\N	Unknown	\N	19-30025B	\N	628	\N	\N
LN-13	M	\N	Unknown	UCSF	17-120276	\N	833	\N	\N
SYNAT473	\N	\N	\N	\N	KR_229	\N	2636	\N	\N
SYNAT474	\N	\N	\N	\N	KR_203	\N	2858	\N	\N
DN-154	M	\N	Unknown	\N	19-37607E	\N	629	\N	\N
DN-155	M	\N	Unknown	\N	19-38447	\N	630	\N	\N
DN-156	M	\N	Unknown	\N	19-15378	\N	631	\N	\N
DN-157	M	\N	Unknown	\N	19-37607F	\N	632	\N	\N
DN-158	M	\N	Unknown	\N	19-37409B	\N	633	\N	\N
DN-159	F	\N	Unknown	\N	19-30079A	\N	634	\N	\N
DN-160	M	\N	Unknown	\N	19-38090	\N	635	\N	\N
KIT-15	\N	\N	Unknown	\N	11-133	\N	796	\N	\N
MD-168	\N	\N	Unknown	Madrid, Spain	03-21273-1G T1	\N	1045	\N	\N
MD-169	\N	\N	Unknown	Madrid, Spain	03-19080C T1	\N	1046	\N	\N
MD-170	\N	\N	Unknown	Madrid, Spain	03-15183D T1	\N	1047	\N	\N
DP-11	F	\N	Unknown	UCSF	14-15427	Consultation; Diagnosis on IntelliPath: Atypical Melanocytic Proliferation	648	\N	\N
DP-01	F	\N	Unknown	UCSF	11-13665	\N	638	\N	\N
DP-04	F	\N	Unknown	UCSF	12-24226	\N	641	\N	\N
DP-06	F	\N	Unknown	UCSF	14-90528	\N	643	\N	\N
DP-07	M	\N	Unknown	UCSF	17-132120	\N	644	\N	\N
DP-08	M	\N	Unknown	UCSF	15-42060	\N	645	\N	\N
DP-10	F	\N	Unknown	UCSF	12-70514	Diagnosis on IntelliPath: Spitzoid Melanoma	647	\N	\N
MD-176	\N	\N	Unknown	Madrid, Spain	02-17209C T2	\N	1053	\N	\N
MD-197	\N	\N	Unknown	Madrid, Spain	92-03953C T2	\N	1074	\N	\N
MD-198	\N	\N	Unknown	Madrid, Spain	91-08026A T2	\N	1075	\N	\N
MD-199	\N	\N	Unknown	Madrid, Spain	95-14297-5 T2	\N	1076	\N	\N
MD-200	\N	\N	Unknown	Madrid, Spain	96-02480 T3	\N	1077	\N	\N
MD-201	\N	\N	Unknown	Madrid, Spain	95-16013B T3	\N	1078	\N	\N
MD-202	\N	\N	Unknown	Madrid, Spain	92-18572E T3	\N	1079	\N	\N
DP-13	M	\N	Unknown	UCSF	14-43805	Consultation. IntelliPath says its a "Spitzoid melanoma"	650	\N	\N
DP-14	M	\N	Unknown	UCSF	10-75211	IntelliPath says its a "melanocytic nevus"	651	\N	\N
DP-15	M	\N	Unknown	UCSF	19-44904	\N	652	\N	\N
DP-19	F	\N	Unknown	UCSF	11-65284	\N	656	\N	\N
DP-20	F	\N	Unknown	UCSF	11-66564	\N	657	\N	\N
MD-178	\N	\N	Unknown	Madrid, Spain	02-20495B T2	\N	1055	\N	\N
MD-179	\N	\N	Unknown	Madrid, Spain	01-26615B T2	\N	1056	\N	\N
MD-180	\N	\N	Unknown	Madrid, Spain	01-1112 T2	\N	1057	\N	\N
MD-203	\N	\N	Unknown	Madrid, Spain	87-14087B T2	\N	1080	\N	\N
MD-204	\N	\N	Unknown	Madrid, Spain	88-6851-2 T3	\N	1081	\N	\N
MD-205	\N	\N	Unknown	Madrid, Spain	92-14752-1 T2	\N	1082	\N	\N
DP-22	F	\N	Unknown	UCSF	11-87412	\N	659	\N	\N
DP-24	F	\N	Unknown	UCSF	12-9397B	\N	661	\N	\N
DP-25	M	\N	Unknown	UCSF	12-48249	\N	662	\N	\N
DP-26	M	\N	Unknown	UCSF	12-64897	\N	663	\N	\N
DP-28	F	\N	Unknown	UCSF	13-73582	\N	665	\N	\N
KIT-18	\N	\N	Unknown	\N	11-256	\N	799	\N	\N
DP-29	M	\N	Unknown	UCSF	13-75788B	\N	666	\N	\N
DP-30	M	\N	Unknown	UCSF	14-11769	\N	667	\N	\N
DP-31	F	\N	Unknown	UCSF	14-42631	\N	668	\N	\N
DP-32	F	\N	Unknown	UCSF	14-46549	\N	669	\N	\N
DP-33	M	\N	Unknown	UCSF	14-57552	\N	670	\N	\N
LN-19	F	\N	Unknown	UCSF	18-15028	\N	839	\N	\N
MD-182	\N	\N	Unknown	Madrid, Spain	00-24216D T4	\N	1059	\N	\N
DP-34	M	\N	Unknown	UCSF	14-83928	\N	671	\N	\N
MD-206	\N	\N	Unknown	Madrid, Spain	94-19725B T3	\N	1083	\N	\N
DP-35	M	\N	Unknown	UCSF	14-82758	\N	672	\N	\N
DP-36	F	\N	Unknown	UCSF	14-95595	\N	673	\N	\N
DP-37	M	\N	Unknown	UCSF	15-10108	\N	674	\N	\N
DP-38	F	\N	Unknown	UCSF	15-16907A	\N	675	\N	\N
DP-39	M	\N	Unknown	UCSF	15-25818	\N	676	\N	\N
MD-183	\N	\N	Unknown	Madrid, Spain	00-06521B T3	\N	1060	\N	\N
MD-184	\N	\N	Unknown	Madrid, Spain	00-12952-3 T2	\N	1061	\N	\N
MD-185	\N	\N	Unknown	Madrid, Spain	00-15364 T2	\N	1062	\N	\N
MD-186	\N	\N	Unknown	Madrid, Spain	99-15953D T2	\N	1063	\N	\N
MD-187	\N	\N	Unknown	Madrid, Spain	99-24969F T4	\N	1064	\N	\N
LN-09	F	\N	Unknown	UCSF	17-120790	\N	829	\N	\N
DP-40	F	\N	Unknown	UCSF	07-55184	\N	677	\N	\N
DP-41	F	\N	Unknown	UCSF	15-33496	\N	678	\N	\N
DP-42	F	\N	Unknown	UCSF	15-41815	\N	679	\N	\N
DP-43	F	\N	Unknown	UCSF	15-52489	\N	680	\N	\N
DP-44	F	\N	Unknown	UCSF	15-60391	\N	681	\N	\N
DP-45	F	\N	Unknown	UCSF	15-61456	\N	682	\N	\N
DP-46	F	\N	Unknown	UCSF	15-71393	\N	683	\N	\N
DP-47	F	\N	Unknown	UCSF	15-88900	\N	684	\N	\N
MD-188	\N	\N	Unknown	Madrid, Spain	99-09753 T2	\N	1065	\N	\N
DP-48	M	\N	Unknown	UCSF	15-92618	\N	685	\N	\N
DP-49	F	\N	Unknown	UCSF	15-87833	\N	686	\N	\N
DP-50	F	\N	Unknown	UCSF	15-110181	\N	687	\N	\N
DP-51	M	\N	Unknown	UCSF	15-116253	\N	688	\N	\N
DP-52	F	\N	Unknown	UCSF	15-117186	\N	689	\N	\N
DP-53	M	\N	Unknown	UCSF	15-123058	\N	690	\N	\N
LN-20	M	\N	Unknown	UCSF	18-15803	\N	840	\N	\N
MD-189	\N	\N	Unknown	Madrid, Spain	99-16706 T2	\N	1066	\N	\N
DP-54	F	\N	Unknown	UCSF	16-13909	\N	691	\N	\N
DP-55	F	\N	Unknown	UCSF	16-10466	\N	692	\N	\N
DP-56	M	\N	Unknown	UCSF	16-19895	\N	693	\N	\N
DP-57	F	\N	Unknown	UCSF	16-20360	\N	694	\N	\N
DP-58	M	\N	Unknown	UCSF	16-18320A	\N	695	\N	\N
DP-59	F	\N	Unknown	UCSF	16-25723	\N	696	\N	\N
DP-60	M	\N	Unknown	UCSF	16-30292	\N	697	\N	\N
DP-61	F	\N	Unknown	UCSF	16-26672	\N	698	\N	\N
MD-207	\N	\N	Unknown	Madrid, Spain	92-06469A T2	\N	1084	\N	\N
MD-208	\N	\N	Unknown	Madrid, Spain	94-01469-2 T3	\N	1085	\N	\N
DP-62	F	\N	Unknown	UCSF	16-31382	\N	699	\N	\N
DP-63	M	\N	Unknown	UCSF	16-41709	\N	700	\N	\N
DP-64	F	\N	Unknown	UCSF	16-42657	\N	701	\N	\N
DP-65	F	\N	Unknown	UCSF	16-27084	\N	702	\N	\N
DP-66	M	\N	Unknown	UCSF	16-19890	\N	703	\N	\N
DP-67	M	\N	Unknown	UCSF	16-42062	\N	704	\N	\N
DP-68	M	\N	Unknown	UCSF	16-55411	\N	705	\N	\N
MD-25	\N	\N	Unknown	Madrid, Spain	09-21320A3 N1-M1,09-21320 T2, 09-21320A3 N1-M1, 09-21320 T2	\N	931	\N	\N
DP-69	F	\N	Unknown	UCSF	16-56300	\N	706	\N	\N
DP-70	M	\N	Unknown	UCSF	16-42198	\N	707	\N	\N
DP-71	F	\N	Unknown	UCSF	16-63804	\N	708	\N	\N
DP-72	M	\N	Unknown	UCSF	16-77392	\N	709	\N	\N
DP-73	M	\N	Unknown	UCSF	16-80354	\N	710	\N	\N
DP-74	M	\N	Unknown	UCSF	16-89926	\N	711	\N	\N
DP-75	F	\N	Unknown	UCSF	16-90917	\N	712	\N	\N
DP-76	M	\N	Unknown	UCSF	16-94655	\N	713	\N	\N
DP-77	M	\N	Unknown	UCSF	16-96276	\N	714	\N	\N
DP-78	M	\N	Unknown	UCSF	16-105648	\N	715	\N	\N
DP-79	M	\N	Unknown	UCSF	16-97391	\N	716	\N	\N
DP-80	M	\N	Unknown	UCSF	16-127388	\N	717	\N	\N
KIT-06	\N	\N	Unknown	\N	13-074	\N	787	\N	\N
KIT-07	\N	\N	Unknown	\N	13-028	\N	788	\N	\N
DP-81	F	\N	Unknown	UCSF	16-92011	\N	718	\N	\N
DP-82	M	\N	Unknown	UCSF	16-125975	\N	719	\N	\N
DP-83	F	\N	Unknown	UCSF	17-2869	\N	720	\N	\N
DP-84	F	\N	Unknown	UCSF	17-2120	\N	721	\N	\N
DP-85	F	\N	Unknown	UCSF	17-6351	\N	722	\N	\N
DP-86	F	\N	Unknown	UCSF	17-6368	\N	723	\N	\N
DP-87	F	\N	Unknown	UCSF	17-8968	\N	724	\N	\N
DP-88	M	\N	Unknown	UCSF	17-9550	\N	725	\N	\N
DP-89	M	\N	Unknown	UCSF	17-10585	\N	726	\N	\N
DP-90	F	\N	Unknown	UCSF	17-14313	\N	727	\N	\N
DP-91	F	\N	Unknown	UCSF	17-26078	\N	728	\N	\N
DP-92	F	\N	Unknown	UCSF	17-29457B	\N	729	\N	\N
DP-93	F	\N	Unknown	UCSF	17-13205	\N	730	\N	\N
DP-94	F	\N	Unknown	UCSF	17-42757	\N	731	\N	\N
MD-26	\N	\N	Unknown	Madrid, Spain	10-10275D13 M1,10-10275 T2, 10-10275D13 M1, 10-10275 T2	\N	932	\N	\N
MD-27	\N	\N	Unknown	Madrid, Spain	11-03286-4 M1,11-03286 T3, 11-03286-4 M1, 11-03286 T3	\N	933	\N	\N
MD-28	\N	\N	Unknown	Madrid, Spain	11-27846 T3,11-27846-2 N1, 11-27846 T3, 11-27846-2 N1	\N	934	\N	\N
DP-95	F	\N	Unknown	UCSF	17-48219	\N	732	\N	\N
DP-96	F	\N	Unknown	UCSF	17-49361	\N	733	\N	\N
DP-97	F	\N	Unknown	UCSF	17-50829	\N	734	\N	\N
DPN-01	\N	\N	Unknown	UCSF	19-88385	\N	735	\N	\N
DPN-02	\N	\N	Unknown	UCSF	19-109646	\N	736	\N	\N
DPN-03	\N	\N	Unknown	UCSF	12-051311	\N	737	\N	\N
DPN-06	\N	\N	Unknown	UCSF	10-57426	\N	739	\N	\N
MD-209	\N	\N	Unknown	Madrid, Spain	86-04906-2 T2	\N	1086	\N	\N
MD-210	\N	\N	Unknown	Madrid, Spain	93-12428-1 T2	\N	1087	\N	\N
MD-211	\N	\N	Unknown	Madrid, Spain	91-09968E T3	\N	1088	\N	\N
MD-212	\N	\N	Unknown	Madrid, Spain	89-13569-1 T2	\N	1089	\N	\N
MD-213	\N	\N	Unknown	Madrid, Spain	94-18018-2 T3	\N	1090	\N	\N
JJS2	F	\N	Unknown	UCSF	11-29719	BAD SAMPLE	741	\N	\N
JJS4	F	\N	Unknown	UCSF	11-49127	BAD SAMPLE	743	\N	\N
JJS7	F	\N	Unknown	UCSF	12-12684	PMID: 29990500 case XX; RPA-297	746	\N	\N
MD-29	\N	\N	Unknown	Madrid, Spain	12-05858 T3,12-05858A3 M1, 12-05858 T3, 12-05858A3 M1	\N	935	\N	\N
MD-30	\N	\N	Unknown	Madrid, Spain	12-12352 T3	\N	936	\N	\N
JJS8	M	\N	Unknown	UCSF	12-21993I,12-21993C, 12-21993I, 12-21993C	PMID: 29990500 case XX; RPA-298	747	\N	\N
JJS9	M	\N	Unknown	UCSF	12-57797	\N	748	\N	\N
JJS10	M	\N	Unknown	UCSF	12-67568A,12-67568B, 12-67568A, 12-67568B	PMID: 29990500 case 74; RPA-295	749	\N	\N
MD-31	\N	\N	Unknown	Madrid, Spain	13-24372B CONSULTA,13-24372B T1,13-24372A T1, 13-24372B T1, 13-24372B CONSULTA, 13-24372A T1	\N	937	\N	\N
JJS11	F	\N	Unknown	UCSF	12-57349C,12-57349E, 12-57349C, 12-57349E	PMID: 29990500 case 57; RPA-330	750	\N	\N
JJS12	F	\N	Unknown	UCSF	12-93589A	PMID: 29990500 case 42; RPA-316	751	\N	\N
JJS13	M	\N	Unknown	UCSF	13-2138C	PMID: 29990500 case 64; RPA-331	752	\N	\N
JJS14	M	\N	Unknown	UCSF	13-98648	PMID: 29990500 case 54; RPA-299	753	\N	\N
MD-32	\N	\N	Unknown	Madrid, Spain	13-26846 T4,13-26846A1 N1, 13-26846 T4, 13-26846A1 N1	\N	938	\N	\N
MD-33	\N	\N	Unknown	Madrid, Spain	14-03473 T3	\N	939	\N	\N
MD-34	\N	\N	Unknown	Madrid, Spain	15-02416 T2	\N	940	\N	\N
JJS15	M	\N	Unknown	UCSF	14-2508	BAD SAMPLE	754	\N	\N
JJS16	F	\N	Unknown	UCSF	14-64047	PMID: 29990500 case 68; RPA-300	755	\N	\N
JJS17	M	\N	Unknown	UCSF	14-33100	PMID: 29990500 case 71; RPA-301	756	\N	\N
JJS18	M	\N	Unknown	UCSF	14-47962	PMID: 29990500 case 48; RPA-341	757	\N	\N
LN-10	M	\N	Unknown	UCSF	17-119451	\N	830	\N	\N
JJS19	F	\N	Unknown	UCSF	14-73175B	PMID: 29990500 case 51; RPA-302	758	\N	\N
MD-35	\N	\N	Unknown	Madrid, Spain	15-22166 T4	\N	941	\N	\N
MD-36	\N	\N	Unknown	Madrid, Spain	15-32174 T2	\N	942	\N	\N
MD-37	\N	\N	Unknown	Madrid, Spain	16-31317 T4	\N	943	\N	\N
MD-38	\N	\N	Unknown	Madrid, Spain	05-01411 T4,05-01411C N1, 05-01411 T4, 05-01411C N1	\N	944	\N	\N
JJS20	M	\N	Unknown	UCSF	14-78242	PMID: 29990500 case 60; RPA-303	759	\N	\N
JJS21	F	\N	Unknown	UCSF	15-98263	PMID: 29990500 case 75; RPA-565	760	\N	\N
JJS23	M	\N	Unknown	UCSF	15-50051	PMID: 29990500 case 77; RPA-567	761	\N	\N
LN-11	F	\N	Unknown	UCSF	17-120839	\N	831	\N	\N
MD-214	\N	\N	Unknown	Madrid, Spain	94-12246 T3	\N	1091	\N	\N
JJS24	M	\N	Unknown	UCSF	15-48134	PMID: 29990500 case 78; RPA-568	762	\N	\N
MD-39	\N	\N	Unknown	Madrid, Spain	06-08092 T3	\N	945	\N	\N
MD-40	\N	\N	Unknown	Madrid, Spain	05-12693C M1	\N	946	\N	\N
JJS25	M	\N	Unknown	UCSF	15-12964B	PMID: 29990500 case 79; RPA-569	763	\N	\N
JJS26	M	\N	Unknown	UCSF	15-14665B,15-14665C, 15-14665B, 15-14665C	PMID: 29990500 case 80; RPA-570	764	\N	\N
MD-215	\N	\N	Unknown	Madrid, Spain	94-23180 T4	\N	1092	\N	\N
JJS27	M	\N	Unknown	UCSF	15-85517	PMID: 29990500 case 81; RPA-571	765	\N	\N
MD-41	\N	\N	Unknown	Madrid, Spain	05-27343A M1	\N	947	\N	\N
MD-42	\N	\N	Unknown	Madrid, Spain	06-03046F N1	\N	948	\N	\N
MD-43	\N	\N	Unknown	Madrid, Spain	06-06325 M1	\N	949	\N	\N
JJS28	M	\N	Unknown	UCSF	15-21741	PMID: 29990500 case 82; RPA-572	766	\N	\N
KA-01	M	\N	Unknown	UCSF	21-89776B,21-89776A, 21-89776B, 21-89776A	\N	767	\N	\N
LN-12	F	\N	Unknown	UCSF	17-120280	\N	832	\N	\N
MD-216	\N	\N	Unknown	Madrid, Spain	94-08318-1 T2	\N	1093	\N	\N
KA-02	F	\N	Unknown	UCSF	20-91483B,20-91483A, 20-91483B, 20-91483A	\N	768	\N	\N
KA-03	F	\N	Unknown	UCSF	22-52528-1,22-52528-2, 22-52528-1, 22-52528-2	\N	769	\N	\N
KA-04	F	\N	Unknown	UCSF	22-105120-1,22-105120-2, 22-105120-1, 22-105120-2	\N	770	\N	\N
KIT-08	\N	\N	Unknown	\N	12-073	\N	789	\N	\N
MD-44	\N	\N	Unknown	Madrid, Spain	06-16008-1	\N	950	\N	\N
KA-05	F	\N	Unknown	UCSF	20-82651A,20-82651C,20-82651E,20-82651D,20-82651B, 20-82651A, 20-82651C, 20-82651E, 20-82651D, 20-82651B	\N	771	\N	\N
KA-06	M	\N	Unknown	UCSF	21-96446A2,21-96446A1, 21-96446A2, 21-96446A1	\N	772	\N	\N
KA-07	M	\N	Unknown	UCSF	20-104213B,20-104213A, 20-104213B, 20-104213A	\N	773	\N	\N
KA-08	M	\N	Unknown	UCSF	20-18514A,20-18514B, 20-18514B, 20-18514A	\N	774	\N	\N
KIT-09	\N	\N	Unknown	\N	12-095	\N	790	\N	\N
KIT-10	\N	\N	Unknown	\N	12-122	\N	791	\N	\N
MD-45	\N	\N	Unknown	Madrid, Spain	10-10942A2 M1	\N	951	\N	\N
MD-46	\N	\N	Unknown	Madrid, Spain	12-05089-3	\N	952	\N	\N
KA-09	F	\N	Unknown	UCSF	20-98774B,20-98774A,20-98774D, 20-98774B, 20-98774A, 20-98774D	\N	775	\N	\N
KIT-05	\N	\N	Unknown	\N	13-122	\N	786	\N	\N
KIT-16	\N	\N	Unknown	\N	11-154	\N	797	\N	\N
KIT-17	\N	\N	Unknown	\N	11-172	\N	798	\N	\N
MD-217	\N	\N	Unknown	Madrid, Spain	93-13951 T2	\N	1094	\N	\N
MD-218	\N	\N	Unknown	Madrid, Spain	89-10450-1 T2	\N	1095	\N	\N
LMM-01	\N	\N	Unknown	UCSF	"20-81257A\n",20-81257B, 20-81257A\n, 20-81257B	\N	800	\N	\N
SYNAT475	\N	\N	\N	\N	KR_8	\N	2679	\N	\N
LMM-02	\N	\N	Unknown	UCSF	21-7055B1,21-7055B6,21-7055B4, 21-7055B1, 21-7055B6, 21-7055B4	\N	801	\N	\N
LMM-03	\N	\N	Unknown	UCSF	21-457B,21-457C,21-35943A, 21-457B, 21-457C, 21-35943A	\N	802	\N	\N
LMM-17	\N	\N	Unknown	UCSF	22-7578,22-15594-4, 22-7578, 22-15594-4	\N	816	\N	\N
LMM-04	\N	\N	Unknown	UCSF	21-21304A10,21-21304A1,21-25546B2, 21-21304A10, 21-21304A1, 21-25546B2	\N	803	\N	\N
LMM-15	\N	\N	Unknown	UCSF	21-79845,22-76519A, 21-79845, 22-76519A	\N	814	\N	\N
LMM-16	\N	\N	Unknown	UCSF	22-102807-2,22-102807-4, 22-102807-2, 22-102807-4	\N	815	\N	\N
MD-51	\N	\N	Unknown	Madrid, Spain	89-10432A M1	\N	957	\N	\N
LMM-05	\N	\N	Unknown	UCSF	22-91699A7,22-91699A4,22-91699A1, 22-91699A7, 22-91699A4, 22-91699A1	\N	804	\N	\N
LMM-06	\N	\N	Unknown	UCSF	23-37003	\N	805	\N	\N
LMM-07	\N	\N	Unknown	UCSF	21-135927,22-29280, 21-135927, 22-29280	\N	806	\N	\N
MD-52	\N	\N	Unknown	Madrid, Spain	85-01186	\N	958	\N	\N
MD-53	\N	\N	Unknown	Madrid, Spain	95-01141-1 M1	\N	959	\N	\N
LMM-08	\N	\N	Unknown	UCSF	20-102366B1,20-102366B2,17-77365, 20-102366B1, 20-102366B2, 17-77365	\N	807	\N	\N
LMM-09	\N	\N	Unknown	UCSF	20-11796D,20-6751, 20-11796D, 20-6751	\N	808	\N	\N
LMM-10	\N	\N	Unknown	UCSF	18-83370A,19-75051,18-83370B, 18-83370B, 18-83370A, 19-75051	\N	809	\N	\N
MD-54	\N	\N	Unknown	Madrid, Spain	95-05724-1 M1	\N	960	\N	\N
MD-55	\N	\N	Unknown	Madrid, Spain	96-06832D M1	\N	961	\N	\N
LMM-11	\N	\N	Unknown	UCSF	18-12160E,18-12160F,18-12160D, 18-12160E, 18-12160F, 18-12160D	\N	810	\N	\N
LN-06	F	\N	Unknown	UCSF	17-119445	\N	826	\N	\N
MD-56	\N	\N	Unknown	Madrid, Spain	91-16318 M1	\N	962	\N	\N
SYNAT476	\N	\N	\N	\N	KR_5233	\N	2431	\N	\N
SYNAT477	\N	\N	\N	\N	KR_RMK0091B	\N	2298	\N	\N
LMM-12	\N	\N	Unknown	UCSF	21-83029B,21-83029A,22-94741, 21-83029B, 21-83029A, 22-94741	\N	811	\N	\N
LMM-13	\N	\N	Unknown	UCSF	21-62764	\N	812	\N	\N
LMM-14	\N	\N	Unknown	UCSF	20-18383B2,20-18383A1, 20-18383B2, 20-18383A1	\N	813	\N	\N
MD-57	\N	\N	Unknown	Madrid, Spain	96-18967-1 M1	\N	963	\N	\N
SYNX487	NaN	\N	\N	\N	DPN45	NaN	1890	\N	\N
LMM-18	\N	\N	Unknown	UCSF	16-74494,17-81380B, 16-74494, 17-81380B	\N	817	\N	\N
LMM-19	\N	\N	Unknown	UCSF	22-38234B,23-1012A2, 22-38234B, 23-1012A2	\N	818	\N	\N
LN-07	M	\N	Unknown	UCSF	17-119302B	\N	827	\N	\N
MD-58	\N	\N	Unknown	Madrid, Spain	97-01837E M1	\N	964	\N	\N
LN-08	F	\N	Unknown	UCSF	17-118980	\N	828	\N	\N
SYNAT478	\N	\N	\N	\N	KR_RMK0194C	\N	2834	\N	\N
SYNAT479	\N	\N	\N	\N	KR_RMK0137C	\N	2366	\N	\N
SYNAT480	\N	\N	\N	\N	KR_RMK0162C	\N	2587	\N	\N
LMM-20	\N	\N	Unknown	UCSF	17-111862B,17-111862A,17-122697A, 17-111862B, 17-111862A, 17-122697A	\N	819	\N	\N
LMM-21	\N	\N	Unknown	UCSF	23-12491,23-3314, 23-12491, 23-3314	\N	820	\N	\N
LN-01	M	\N	Unknown	\N	17-119570C	\N	821	\N	\N
LN-02	M	\N	Unknown	UCSF	17-118831C	\N	822	\N	\N
LN-03	M	\N	Unknown	UCSF	17-109907D	\N	823	\N	\N
LN-04	M	\N	Unknown	UCSF	17-120049C	\N	824	\N	\N
LN-05	F	\N	Unknown	UCSF	17-119013	\N	825	\N	\N
MD-59	\N	\N	Unknown	Madrid, Spain	98-02267-5 M1	\N	965	\N	\N
MD-60	\N	\N	Unknown	Madrid, Spain	98-03336-8 M1	\N	966	\N	\N
LN-14	M	\N	Unknown	UCSF	17-110828C	\N	834	\N	\N
LN-15	F	\N	Unknown	UCSF	17-118904B	\N	835	\N	\N
LN-16	M	\N	Unknown	UCSF	17-119079A	\N	836	\N	\N
LN-17	M	\N	Unknown	UCSF	17-99294B	\N	837	\N	\N
LN-21	M	\N	Unknown	UCSF	18-15487B	\N	841	\N	\N
LN-022	M	\N	Unknown	UCSF	17-111004B	Jessica assigned different Pat_ID to same sample. LN-022 = LN-045	842	\N	\N
LN-023	M	\N	Unknown	UCSF	17-112365B	\N	843	\N	\N
LN-024	M	\N	Unknown	UCSF	17-111571	\N	844	\N	\N
LN-025	F	\N	Unknown	UCSF	17-115572A	\N	845	\N	\N
LN-026	M	\N	Unknown	UCSF	17-115588	\N	846	\N	\N
LN-027	F	\N	Unknown	UCSF	17-115635	\N	847	\N	\N
LN-028	F	\N	Unknown	UCSF	17-111657A,17-111657B, 17-111657A, 17-111657B	\N	848	\N	\N
LN-030	M	\N	Unknown	UCSF	17-111279	\N	849	\N	\N
MD-61	\N	\N	Unknown	Madrid, Spain	98-05054 N1	\N	967	\N	\N
MD-62	\N	\N	Unknown	Madrid, Spain	99-16633E N1	\N	968	\N	\N
LN-031	F	\N	Unknown	UCSF	18-61924A	\N	850	\N	\N
LN-032	M	\N	Unknown	UCSF	18-18111A	Jessica assigned different Pat_ID to same sample. LN-032 = LN-056	851	\N	\N
LN-033	M	\N	Unknown	UCSF	17-112653	\N	852	\N	\N
LN-034	M	\N	Unknown	UCSF	17-115568B	\N	853	\N	\N
NL-019	F	\N	Unknown	UCSF	18-121973	\N	1181	\N	\N
LN-035	F	\N	Unknown	UCSF	17-114505	\N	854	\N	\N
LN-036	F	\N	Unknown	UCSF	17-115149A	\N	855	\N	\N
LN-037	M	\N	Unknown	UCSF	17-111038B	\N	856	\N	\N
LN-038	F	\N	Unknown	UCSF	17-115571D,17-115571C, 17-115571D, 17-115571C	\N	857	\N	\N
LN-040	M	\N	Unknown	UCSF	17-112365A	\N	858	\N	\N
LN-041	M	\N	Unknown	UCSF	17-112588B	\N	859	\N	\N
MD-63	\N	\N	Unknown	Madrid, Spain	99-27534 M1	\N	969	\N	\N
MD-64	\N	\N	Unknown	Madrid, Spain	00-09653C M1	\N	970	\N	\N
LN-042	M	\N	Unknown	UCSF	17-111040A	\N	860	\N	\N
LN-043	M	\N	Unknown	UCSF	18-27178B	Jessica assigned different Pat_ID to same sample. LN-043 = LN-050	861	\N	\N
LN-044	M	\N	Unknown	UCSF	18-35802B	\N	862	\N	\N
NL-020	M	\N	Unknown	UCSF	18-121986	\N	1182	\N	\N
LN-045	M	\N	Unknown	UCSF	17-111004A,17-111004C, 17-111004A, 17-111004C	Jessica assigned different Pat_ID to same sample. LN-022 = LN-045	863	\N	\N
SYNX130	NaN	\N	\N	\N	HWA8	NaN	1533	\N	\N
LN-047	F	\N	Unknown	UCSF	18-81165B	\N	864	\N	\N
LN-048	F	\N	Unknown	UCSF	18-136508B	\N	865	\N	\N
LN-049	F	\N	Unknown	UCSF	17-114552	\N	866	\N	\N
LN-050	M	\N	Unknown	UCSF	18-27178A	Jessica assigned different Pat_ID to same sample. LN-043 = LN-050	867	\N	\N
LN-051	M	\N	Unknown	UCSF	17-111324	\N	868	\N	\N
LN-052	F	\N	Unknown	UCSF	17-113511	\N	869	\N	\N
LN-053	F	\N	Unknown	UCSF	18-17957	\N	870	\N	\N
LN-054	F	\N	Unknown	UCSF	17-111704B,17-111704A, 17-111704B, 17-111704A	\N	871	\N	\N
OM-30	M	\N	Unknown	UCSF	11-48013	\N	1288	\N	\N
OM-31	F	\N	Unknown	UCSF	13-48	LEFT LATERAL PLANTAR FOOT	1289	\N	\N
LN-056	M	\N	Unknown	UCSF	18-18111C,18-18111B, 18-18111C, 18-18111B	Jessica assigned different Pat_ID to same sample. LN-032 = LN-056	872	\N	\N
LN-058	F	\N	Unknown	UCSF	18-57977B	\N	873	\N	\N
LN-059	F	\N	Unknown	UCSF	18-65460	\N	874	\N	\N
LN-060	M	\N	Unknown	UCSF	18-65957A	\N	875	\N	\N
MD-65	\N	\N	Unknown	Madrid, Spain	00-11793E M1	\N	971	\N	\N
MD-66	\N	\N	Unknown	Madrid, Spain	00-15034-1B M1	\N	972	\N	\N
MD-67	\N	\N	Unknown	Madrid, Spain	02-11468D M1	\N	973	\N	\N
MD-68	\N	\N	Unknown	Madrid, Spain	02-22843 M1	\N	974	\N	\N
MD-69	\N	\N	Unknown	Madrid, Spain	02-22662B M1	\N	975	\N	\N
MD-70	\N	\N	Unknown	Madrid, Spain	02-16325B M1	\N	976	\N	\N
LN-061	F	\N	Unknown	UCSF	18-19195A	\N	876	\N	\N
OM-32	F	\N	Unknown	UCSF	13-11936	\N	1290	\N	\N
LN-062	M	\N	Unknown	UCSF	18-44463C,18-44463B, 18-44463C, 18-44463B	\N	877	\N	\N
LN-064	M	\N	Unknown	UCSF	18-44464	\N	878	\N	\N
LN-065	F	\N	Unknown	UCSF	18-69862A,18-69862B, 18-69862A, 18-69862B	\N	879	\N	\N
LN-067	F	\N	Unknown	UCSF	18-76615	\N	880	\N	\N
MD-71	\N	\N	Unknown	Madrid, Spain	03-04925E M1	\N	977	\N	\N
LN-068	M	\N	Unknown	UCSF	18-44465	\N	881	\N	\N
LN-069	F	\N	Unknown	UCSF	21-52881	\N	882	\N	\N
SYNAT481	\N	\N	\N	\N	KR_RMK0168C	\N	2618	\N	\N
SYNX653	NaN	\N	\N	\N	12GS-2466	NaN	2056	\N	\N
SYNAT671	\N	\N	\N	\N	CP1-5	\N	2737	\N	\N
LN-070	F	\N	Unknown	UCSF	20-60575	\N	883	\N	\N
LN-071	M	\N	Unknown	UCSF	21-61821	\N	884	\N	\N
LN-072	F	\N	Unknown	UCSF	21-63579A	\N	885	\N	\N
LN-073	F	\N	Unknown	UCSF	21-59993A	\N	886	\N	\N
LN-074	F	\N	Unknown	UCSF	21-98047	\N	887	\N	\N
LN-075	F	\N	Unknown	UCSF	21-98013A	\N	888	\N	\N
LN-076	M	\N	Unknown	UCSF	21-62140A	\N	889	\N	\N
MD-72	\N	\N	Unknown	Madrid, Spain	03-16198-1C M1	\N	978	\N	\N
MD-73	\N	\N	Unknown	Madrid, Spain	04-00065-6 M1	\N	979	\N	\N
MD-74	\N	\N	Unknown	Madrid, Spain	04-01241G M1	\N	980	\N	\N
MD-75	\N	\N	Unknown	Madrid, Spain	04-21305-4 M1	\N	981	\N	\N
MD-77	\N	\N	Unknown	Madrid, Spain	05-21257 M1	\N	982	\N	\N
LN-077	M	\N	Unknown	UCSF	21-63575B	\N	890	\N	\N
SYNX654	NaN	\N	\N	\N	SP-09-0150202A	NaN	2057	\N	\N
LN-078	M	\N	Unknown	UCSF	21-61319	\N	891	\N	\N
LN-079	M	\N	Unknown	UCSF	21-96630	\N	892	\N	\N
LN-080	M	\N	Unknown	UCSF	21-110504	\N	893	\N	\N
LN-081	M	\N	Unknown	UCSF	21-110027B	\N	894	\N	\N
LN-082	M	\N	Unknown	UCSF	21-110012A	\N	895	\N	\N
LN-083	M	\N	Unknown	UCSF	21-110009A	\N	896	\N	\N
LN-084	M	\N	Unknown	UCSF	21-112103B	\N	897	\N	\N
LN-085	F	\N	Unknown	UCSF	21-112298	\N	898	\N	\N
MD-94	\N	\N	Unknown	Madrid, Spain	94-21132 M1	\N	990	\N	\N
MD-79	\N	\N	Unknown	Madrid, Spain	09-15598 M1	\N	983	\N	\N
MD-80	\N	\N	Unknown	Madrid, Spain	09-13370-2G N1,09-13370-1M N1, 09-13370-2G N1, 09-13370-1M N1	\N	984	\N	\N
MD-84	\N	\N	Unknown	Madrid, Spain	10-20397-3 M1	\N	985	\N	\N
MD-85	\N	\N	Unknown	Madrid, Spain	10-30890-5 N1	\N	986	\N	\N
LN-086	M	\N	Unknown	UCSF	21-112195B	Jessica assigned different Pat_ID to same sample. LN-086 = LN-087	899	\N	\N
SYNAT363	\N	\N	\N	\N	12-22597	\N	2794	\N	IP575947
LN-087	M	\N	Unknown	UCSF	21-112195D	Jessica assigned different Pat_ID to same sample. LN-086 = LN-087	900	\N	\N
LN-088	M	\N	Unknown	UCSF	21-112321A	\N	901	\N	\N
MC-01	\N	\N	Unknown	\N	SKMEL 1023A	\N	903	\N	\N
MC-02	\N	\N	Unknown	\N	SKMel 1107B Dec2019,SKMEL 1107B, SKMel 1107B Dec2019, SKMEL 1107B	\N	904	\N	\N
MC-03	\N	\N	Unknown	\N	SKMEL 1121B,SKMel 1121B Dec2019, SKMEL 1121B, SKMel 1121B Dec2019	\N	905	\N	\N
MC-04	\N	\N	Unknown	\N	Mel290	\N	906	\N	\N
MD-01	\N	\N	Unknown	Madrid, Spain	00-21551 T3	\N	907	\N	\N
MD-02	\N	\N	Unknown	Madrid, Spain	01-00027 T1	\N	908	\N	\N
MD-03	\N	\N	Unknown	Madrid, Spain	01-07957 T4	\N	909	\N	\N
MD-04	\N	\N	Unknown	Madrid, Spain	01-20248 T3	\N	910	\N	\N
MD-05	\N	\N	Unknown	Madrid, Spain	02-05776D T1,02-05776 T1, 02-05776D T1, 02-05776 T1	\N	911	\N	\N
MD-06	\N	\N	Unknown	Madrid, Spain	03-26518B M1,03-26518 T1, 03-26518B M1, 03-26518 T1	\N	912	\N	\N
MD-07	\N	\N	Unknown	Madrid, Spain	04-28824 T2	\N	913	\N	\N
MD-08	\N	\N	Unknown	Madrid, Spain	04-01809 T4,04-01809E T4, 04-01809 T4, 04-01809E T4	\N	914	\N	\N
MD-09	\N	\N	Unknown	Madrid, Spain	04-05355 T4,04-05355B T4, 04-05355 T4, 04-05355B T4	\N	915	\N	\N
MD-10	\N	\N	Unknown	Madrid, Spain	05-23001 T4,05-23001E T4, 05-23001 T4, 05-23001E T4	\N	916	\N	\N
SYNX131	NaN	\N	\N	\N	HWA9	NaN	1534	\N	\N
MD-11	\N	\N	Unknown	Madrid, Spain	05-14988B T3,05-14988 T3, 05-14988B T3, 05-14988 T3	\N	917	\N	\N
MD-12	\N	\N	Unknown	Madrid, Spain	05-29322B T3,05-29322 T3, 05-29322B T3, 05-29322 T3	\N	918	\N	\N
MD-13	\N	\N	Unknown	Madrid, Spain	06-05518 T4,06-05518B T4, 06-05518 T4, 06-05518B T4	\N	919	\N	\N
MD-14	\N	\N	Unknown	Madrid, Spain	06-01845E T4,06-01845 T4, 06-01845E T4, 06-01845 T4	\N	920	\N	\N
MD-15	\N	\N	Unknown	Madrid, Spain	06-04915 T2	\N	921	\N	\N
MD-16	\N	\N	Unknown	Madrid, Spain	06-14812D T2,06-14812E T2, 06-14812D T2, 06-14812E T2	\N	922	\N	\N
MD-17	\N	\N	Unknown	Madrid, Spain	06-17441 T2,06-17441-2 T2, 06-17441 T2, 06-17441-2 T2	\N	923	\N	\N
MD-18	\N	\N	Unknown	Madrid, Spain	06-25697-1 T1,06-25697 T1, 06-25697-1 T1, 06-25697 T1	\N	924	\N	\N
MD-19	\N	\N	Unknown	Madrid, Spain	06-23345 T1	\N	925	\N	\N
MD-20	\N	\N	Unknown	Madrid, Spain	06-27633 T1	\N	926	\N	\N
MD-21	\N	\N	Unknown	Madrid, Spain	06-23587 T1,06-23587B T1, 06-23587 T1, 06-23587B T1	\N	927	\N	\N
MD-22	\N	\N	Unknown	Madrid, Spain	06-16759A T1,06-16759 T1, 06-16759A T1, 06-16759 T1	\N	928	\N	\N
MD-23	\N	\N	Unknown	Madrid, Spain	07-25593 T2,07-25593-2 T2, 07-25593 T2, 07-25593-2 T2	\N	929	\N	\N
MD-24	\N	\N	Unknown	Madrid, Spain	08-21729 T2,08-21729-2 M1, 08-21729-2 M1, 08-21729 T2	\N	930	\N	\N
MD-190	\N	\N	Unknown	Madrid, Spain	98-21389A T2	\N	1067	\N	\N
MD-191	\N	\N	Unknown	Madrid, Spain	98-06203-3 T2	\N	1068	\N	\N
MD-192	\N	\N	Unknown	Madrid, Spain	97-8417 T2	\N	1069	\N	\N
MD-193	\N	\N	Unknown	Madrid, Spain	95-02325-1 T3	\N	1070	\N	\N
MD-194	\N	\N	Unknown	Madrid, Spain	90-07958-1 T2	\N	1071	\N	\N
MD-195	\N	\N	Unknown	Madrid, Spain	96-20650-1A T3	\N	1072	\N	\N
MD-196	\N	\N	Unknown	Madrid, Spain	93-21060-4 T2	\N	1073	\N	\N
ME-01	F	\N	Unknown	UCSF	16-109659A4	\N	1096	\N	\N
ME-02	M	\N	Unknown	UCSF	16-84820	\N	1097	\N	\N
ME-03	M	\N	Unknown	UCSF	17-26457	\N	1098	\N	\N
NM-58	\N	\N	Unknown	Greece	N-ID 2225	\N	1233	\N	\N
NM-59	\N	\N	Unknown	Greece	N-ID 1941	\N	1234	\N	\N
NM-60	\N	\N	Unknown	Greece	3188/18	\N	1235	\N	\N
ME-04	F	\N	Unknown	UCSF	16-106975	\N	1099	\N	\N
ME-05	M	\N	Unknown	UCSF	17-12444,17-99365, 17-12444, 17-99365	\N	1100	\N	\N
SYNAT395	\N	\N	\N	\N	MB_1036	\N	2669	\N	\N
SYNAT396	\N	\N	\N	\N	Bivona-L17	\N	2678	\N	\N
SYNAT397	\N	\N	\N	\N	Bivona-L18	\N	2286	\N	\N
ME-06	M	\N	Unknown	UCSF	17-88262,17-95052A, 17-88262, 17-95052A	\N	1101	\N	\N
ME-07	F	\N	Unknown	UCSF	16-107007	\N	1102	\N	\N
NM-61	\N	\N	Unknown	Greece	15356/1 (H08.15356/1 slide)	\N	1236	\N	\N
NM-63	\N	\N	Unknown	Greece	176323	\N	1237	\N	\N
ME-08	M	\N	Unknown	UCSF	16-88453A	\N	1103	\N	\N
ME-09	M	\N	Unknown	UCSF	16-110683	\N	1104	\N	\N
SYNAT398	\N	\N	\N	\N	Bivona-L19	\N	2416	\N	\N
SYNX82	NaN	\N	\N	\N	KIT53	_Acral_NRAS	1485	\N	\N
SYNAT399	\N	\N	\N	\N	KIT313	\N	2824	\N	\N
ME-10	F	\N	Unknown	UCSF	17-68446,06-72820A, 17-68446, 06-72820A	17-68446: 63 yrs old; T06-72820-A: 52 yrs old	1105	\N	\N
NM-64	\N	\N	Unknown	Greece	17-1468II-2	\N	1238	\N	\N
ME-11	M	\N	Unknown	UCSF	17-55182C,17-55182D, 17-55182C, 17-55182D	\N	1106	\N	\N
SYNAT672	\N	\N	\N	\N	CP1	\N	2839	\N	\N
ME-12	M	\N	Unknown	UCSF	17-33401C	\N	1107	\N	\N
ME-13	F	\N	Unknown	UCSF	17-130286	\N	1108	\N	\N
ME-14	F	\N	Unknown	UCSF	16-108259C,16-103438, 16-103438, 16-108259C	DROPPED CASE	1109	\N	\N
ME-37	M	\N	Unknown	UCSF	22-17043	\N	1132	\N	\N
NM-70	\N	\N	Unknown	Greece	46976B	\N	1244	\N	\N
SYNX84	NaN	\N	\N	\N	HW2	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	1487	\N	\N
ME-15	M	\N	Unknown	UCSF	16-99265,16-104614H, 16-99265, 16-104614H	16-99265 = Male, whereas T16-104614-H = Female	1110	\N	\N
ME-16	M	\N	Unknown	UCSF	17-83378B,17-83378C,17-83378D, 17-83378B, 17-83378C, 17-83378D	\N	1111	\N	\N
ME-17	M	\N	Unknown	UCSF	16-101803B	\N	1112	\N	\N
ME-18	M	\N	Unknown	UCSF	16-103071,16-105218C, 16-103071, 16-105218C	\N	1113	\N	\N
ME-19	M	\N	Unknown	UCSF	17-82793A,19-135629A, 17-82793A, 19-135629A	\N	1114	\N	\N
ME-20	M	\N	Unknown	UCSF	17-61310	\N	1115	\N	\N
NM-65	\N	\N	Unknown	Greece	17-1741I	\N	1239	\N	\N
ME-21	M	\N	Unknown	UCSF	17-56506	\N	1116	\N	\N
SYNX655	NaN	\N	\N	\N	SP-13-006535C	NaN	2058	\N	\N
ME-22	M	\N	Unknown	UCSF	17-43703	\N	1117	\N	\N
ME-23	F	\N	Unknown	UCSF	17-32863B	\N	1118	\N	\N
ME-24	M	\N	Unknown	UCSF	17-13334,17-27224, 17-13334, 17-27224	\N	1119	\N	\N
NM-66	\N	\N	Unknown	Greece	1135/19	\N	1240	\N	\N
NM-67	\N	\N	Unknown	Greece	59/15	\N	1241	\N	\N
ME-46	M	\N	Unknown	UCSF	17-89239A	\N	1141	\N	\N
ME-25	F	\N	Unknown	UCSF	17-31440	\N	1120	\N	\N
ME-26	F	\N	Unknown	UCSF	17-36409	\N	1121	\N	\N
ME-27	M	\N	Unknown	UCSF	17-61108	\N	1122	\N	\N
ME-28	M	\N	Unknown	UCSF	17-43712,17-62026B, 17-43712, 17-62026B	\N	1123	\N	\N
NM-68	\N	\N	Unknown	Greece	718/12a	\N	1242	\N	\N
NM-69	\N	\N	Unknown	Greece	115016	\N	1243	\N	\N
ME-29	M	\N	Unknown	UCSF	17-125030	\N	1124	\N	\N
ME-30	F	\N	Unknown	UCSF	19-4879	\N	1125	\N	\N
ME-31	M	\N	Unknown	UCSF	19-2118	\N	1126	\N	\N
ME-32	M	\N	Unknown	UCSF	19-488	\N	1127	\N	\N
ME-33	M	\N	Unknown	UCSF	16-1675	\N	1128	\N	\N
ME-34	M	\N	Unknown	UCSF	19-596B	\N	1129	\N	\N
ME-35	M	\N	Unknown	UCSF	19-2710	\N	1130	\N	\N
ME-36	M	\N	Unknown	UCSF	17-88895	\N	1131	\N	\N
NL-016	F	\N	Unknown	UCSF	19-2264A	\N	1178	\N	\N
ME-38	F	\N	Unknown	UCSF	18-97419C	\N	1133	\N	\N
ME-39	F	\N	Unknown	UCSF	17-51847B	\N	1134	\N	\N
ME-40	M	\N	Unknown	UCSF	17-100072A	\N	1135	\N	\N
ME-41	M	\N	Unknown	UCSF	17-23681	\N	1136	\N	\N
ME-62	M	\N	Unknown	UCSF	22-102809	\N	1157	\N	\N
NM-47	\N	\N	Unknown	Greece	B224228/2	\N	1224	\N	\N
ME-42	M	\N	Unknown	UCSF	16-109052C	\N	1137	\N	\N
ME-43	M	\N	Unknown	UCSF	17-38404A2	\N	1138	\N	\N
ME-44	M	\N	Unknown	UCSF	17-68780B,17-68780C,17-68780A, 17-68780B, 17-68780C, 17-68780A	EXCLUDE CASE	1139	\N	\N
ME-45	M	\N	Unknown	UCSF	14-50051	\N	1140	\N	\N
ME-47	M	\N	Unknown	UCSF	16-17132B	\N	1142	\N	\N
ME-48	M	\N	Unknown	UCSF	16-35900	\N	1143	\N	\N
ME-49	M	\N	Unknown	UCSF	18-139329	\N	1144	\N	\N
ME-50	M	\N	Unknown	UCSF	18-75585B	\N	1145	\N	\N
ME-51	F	\N	Unknown	UCSF	19-36210A	\N	1146	\N	\N
ME-52	M	\N	Unknown	UCSF	19-5916	\N	1147	\N	\N
ME-53	F	\N	Unknown	UCSF	20-31447	\N	1148	\N	\N
ME-54	M	\N	Unknown	UCSF	18-67239,20-43011, 18-67239, 20-43011	\N	1149	\N	\N
MP-01	\N	\N	Unknown	\N	05-605A2,02-49261, 05-605A2, 02-49261	08/11/22: Blocks do NOT match patient. Why is this?	1165	\N	\N
ME-55	M	\N	Unknown	UCSF	20-53075B	\N	1150	\N	\N
ME-56	F	\N	Unknown	UCSF	20-79197A	\N	1151	\N	\N
ME-57	M	\N	Unknown	UCSF	21-118604	\N	1152	\N	\N
ME-58	M	\N	Unknown	UCSF	21-131828	\N	1153	\N	\N
ME-63	M	\N	Unknown	UCSF	22-114059B,22-101809, 22-114059B, 22-101809	\N	1158	\N	\N
NM-48	\N	\N	Unknown	Greece	B205907 III	\N	1225	\N	\N
MucM-01	\N	\N	Unknown	UCSF	22-34510A3,22-34510B1, 22-34510B1, 22-34510A3	\N	1169	\N	\N
NL-018	M	\N	Unknown	UCSF	18-121971A	\N	1180	\N	\N
SYNX750	NaN	\N	\N	\N	SMU10-0457	NaN	2153	\N	\N
ME-59	M	\N	Unknown	UCSF	21-2141,21-16708A, 21-2141, 21-16708A	\N	1154	\N	\N
ME-60	M	\N	Unknown	UCSF	21-41149	\N	1155	\N	\N
ME-61	F	\N	Unknown	UCSF	21-1134A,21-44171, 21-1134A, 21-44171	\N	1156	\N	\N
ME-64	F	\N	Unknown	UCSF	23-11588A,23-2718 (block 1),23-2718 (block 2), 23-11588A, 23-2718 (block 1), 23-2718 (block 2)	\N	1159	\N	\N
ME-65	M	\N	Unknown	UCSF	22-80319A2,22-80319A1, 22-80319A2, 22-80319A1	\N	1160	\N	\N
ME-66	F	\N	Unknown	UCSF	22-104652	\N	1161	\N	\N
ME-67	F	\N	Unknown	UCSF	23-47967	\N	1162	\N	\N
ME-68	M	\N	Unknown	UCSF	23-47727,23-34755, 23-47727, 23-34755	\N	1163	\N	\N
ME-69	\N	\N	Unknown	UCSF	23-49347	\N	1164	\N	\N
MP-02	\N	\N	Unknown	\N	04-35102A,06-521B2, 04-35102A, 06-521B2	08/11/22: Blocks do NOT match patient. Why is this?	1166	\N	\N
MP-03	\N	\N	Unknown	\N	08-6790A,08-6790B,11-19653B2, 08-6790A, 08-6790B, 11-19653B2	08/11/22: Blocks do NOT match patient. Why is this?	1167	\N	\N
MP-04	\N	\N	Unknown	\N	96-14850,02-1274B1,96-4039A5,96-4039A7,96-4039, 96-14850, 02-1274B1, 96-4039A5, 96-4039A7, 96-4039	08/11/22: Blocks do NOT match patient. Why is this?	1168	\N	\N
MucM-02	\N	\N	Unknown	UCSF	20-10245F1,20-10245H3,20-10245D1, 20-10245F1, 20-10245H3, 20-10245D1	\N	1170	\N	\N
OM-17	F	\N	Unknown	Mexico	21-21316	\N	1278	\N	\N
MucM-03	\N	\N	Unknown	UCSF	17-33973D3,17-33973C4,17-33973A1, 17-33973D3, 17-33973C4, 17-33973A1	\N	1171	\N	\N
MucM-04	\N	\N	Unknown	UCSF	20-16903C4,20-16903A2,20-16903C1, 20-16903C4, 20-16903A2, 20-16903C1	\N	1172	\N	\N
NM-49	\N	\N	Unknown	Greece	B236709/ 1B	\N	1226	\N	\N
NM-50	\N	\N	Unknown	Greece	B206739	\N	1227	\N	\N
NM-51	\N	\N	Unknown	Greece	B215962	\N	1228	\N	\N
NM-52	\N	\N	Unknown	Greece	B167003/1B  I	\N	1229	\N	\N
SYNX85	NaN	\N	\N	\N	HW8	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	1488	\N	\N
SYNAT400	\N	\N	\N	\N	DM95	\N	2928	\N	\N
SYNX656	NaN	\N	\N	\N	SP-10-003167A	NaN	2059	\N	\N
MucM-05	\N	\N	Unknown	UCSF	13-17186A21,13-17186A20,13-17186A14,13-17186A16, 13-17186A21, 13-17186A20, 13-17186A14, 13-17186A16	\N	1173	\N	\N
MucM-06	\N	\N	Unknown	UCSF	14-12190L4,14-12190A1, 14-12190L4, 14-12190A1	\N	1174	\N	\N
NL-013	M	\N	Unknown	UCSF	12-16974B	\N	1175	\N	\N
NL-014	M	\N	Unknown	UCSF	18-129422	\N	1176	\N	\N
NL-015	M	\N	Unknown	UCSF	19-1978C	\N	1177	\N	\N
NM-53	\N	\N	Unknown	Greece	351/10 2 (HBD)	\N	1230	\N	\N
NM-54	\N	\N	Unknown	Greece	351/10 4 (HBD)	\N	1231	\N	\N
NL-017	F	\N	Unknown	UCSF	18-121943A	\N	1179	\N	\N
SYNX657	NaN	\N	\N	\N	SP-13-009897	NaN	2060	\N	\N
SYNX751	NaN	\N	\N	\N	SMU10-0206	NaN	2154	\N	\N
NL-021	M	\N	Unknown	UCSF	15-101715	\N	1183	\N	\N
NM-55	\N	\N	Unknown	Greece	467/10  1	\N	1232	\N	\N
NL-022	F	\N	Unknown	UCSF	11-91034,14-113821,19-28178,19-135490, 11-91034, 14-113821, 19-28178, 19-135490	\N	1184	\N	\N
NL-023	F	\N	Unknown	UCSF	18-34960	\N	1185	\N	\N
NL-024	F	\N	Unknown	UCSF	18-122476	\N	1186	\N	\N
SYNX658	NaN	\N	\N	\N	SP-12-0087723B	NaN	2061	\N	\N
SYNX752	NaN	\N	\N	\N	SMU10-0240	NaN	2155	\N	\N
NL-025	M	\N	Unknown	UCSF	18-122972	\N	1187	\N	\N
NM-001	\N	\N	Unknown	Greece	5890/08	\N	1188	\N	\N
NM-002	\N	\N	Unknown	Greece	1485/15 (1485/15 slide)	\N	1189	\N	\N
NM-003	\N	\N	Unknown	Greece	2997/11	\N	1190	\N	\N
NM-004	\N	\N	Unknown	Greece	5696/15	\N	1191	\N	\N
NM-005	\N	\N	Unknown	Greece	03B12175 (eppendorf)	\N	1192	\N	\N
NM-006	\N	\N	Unknown	Greece	07B2313 (eppendorf)	\N	1193	\N	\N
NM-007	\N	\N	Unknown	Greece	16B10343 (eppendorf)	\N	1194	\N	\N
NM-008	\N	\N	Unknown	Greece	14B13985 (eppendorf)	\N	1195	\N	\N
NM-009	\N	\N	Unknown	Greece	10B18943 (eppendorf)	\N	1196	\N	\N
NM-010	\N	\N	Unknown	Greece	08B9531 (eppendorf)	\N	1197	\N	\N
NM-011	\N	\N	Unknown	Greece	08B8345 (eppendorf)	\N	1198	\N	\N
NM-012	\N	\N	Unknown	Greece	10B339 (eppendorf)	\N	1199	\N	\N
NM-013	\N	\N	Unknown	Greece	10B7952 (eppendorf)	\N	1200	\N	\N
NM-014	\N	\N	Unknown	Greece	16B8849 (eppendorf)	\N	1201	\N	\N
NM-015	\N	\N	Unknown	Greece	14B1910 (eppendorf)	\N	1202	\N	\N
NM-016	\N	\N	Unknown	Greece	13B10486 (eppendorf)	\N	1203	\N	\N
NM-017	\N	\N	Unknown	Greece	11B9724 (eppendorf)	\N	1204	\N	\N
NM-018	\N	\N	Unknown	Greece	11B2562 (eppendorf)	\N	1205	\N	\N
NM-019	\N	\N	Unknown	Greece	11522/18	\N	1206	\N	\N
NM-027	\N	\N	Unknown	Greece	2065/12 (2065/117 slide)	\N	1207	\N	\N
NM-029	\N	\N	Unknown	Greece	16053/12 wy (16053/12 slide)	\N	1208	\N	\N
NM-031	\N	\N	Unknown	Greece	2227/14 4	\N	1209	\N	\N
NM-032	\N	\N	Unknown	Greece	150/17	\N	1210	\N	\N
NM-33	\N	\N	Unknown	Greece	4136/16	\N	1211	\N	\N
NM-34	\N	\N	Unknown	Greece	4449/16 (4449/16 3 slide)	\N	1212	\N	\N
NM-35	\N	\N	Unknown	Greece	1283/14	\N	1213	\N	\N
NM-36	\N	\N	Unknown	Greece	1205/17	\N	1214	\N	\N
NM-37	\N	\N	Unknown	Greece	1813/15 3	\N	1215	\N	\N
NM-38	\N	\N	Unknown	Greece	4890/15 8	\N	1216	\N	\N
NM-39	\N	\N	Unknown	Greece	6172.3 (14.6172.3 slide)	\N	1217	\N	\N
NM-40	\N	\N	Unknown	Greece	11649.2 (15.11649.2 slide)	\N	1218	\N	\N
NM-41	\N	\N	Unknown	Greece	5698.3 (14.5698.3 slide)	\N	1219	\N	\N
NM-43	\N	\N	Unknown	Greece	12410/09	\N	1220	\N	\N
NM-44	\N	\N	Unknown	Greece	17890/18 (HBD)	\N	1221	\N	\N
NM-45	\N	\N	Unknown	Greece	B246205/ 1BI	\N	1222	\N	\N
NM-46	\N	\N	Unknown	Greece	B247206/ 1Bl	\N	1223	\N	\N
NM-71	\N	\N	Unknown	Greece	6258/2015	\N	1245	\N	\N
NM-72	\N	\N	Unknown	Greece	21831/14	\N	1246	\N	\N
NM-73	\N	\N	Unknown	Greece	156/13	\N	1247	\N	\N
NM-74	\N	\N	Unknown	Greece	2017-19575	\N	1248	\N	\N
NM-75	\N	\N	Unknown	Greece	K3920/19 A1	\N	1249	\N	\N
NM-76	\N	\N	Unknown	Greece	10226 2	\N	1250	\N	\N
NM-77	\N	\N	Unknown	Greece	M32727/18 A1	\N	1251	\N	\N
NM-78	\N	\N	Unknown	Greece	M21326/18 A1	\N	1252	\N	\N
NM-79	\N	\N	Unknown	Greece	14531/14	\N	1253	\N	\N
NM-80	\N	\N	Unknown	Greece	8716/2016	\N	1254	\N	\N
NM-81	\N	\N	Unknown	Greece	M31513/18	\N	1255	\N	\N
NM-82	\N	\N	Unknown	Greece	2017-07184	\N	1256	\N	\N
NM-83	\N	\N	Unknown	Greece	15864 3	\N	1257	\N	\N
NM-84	F	\N	Unknown	UCSF	22-81852A,22-51092,22-81852B, 22-81852A, 22-51092, 22-81852B	\N	1258	\N	\N
NM-85	M	\N	Unknown	UCSF	20-106642A	\N	1259	\N	\N
OM-16	F	\N	Unknown	Mexico	21-21341	\N	1277	\N	\N
OM-18	F	\N	Unknown	Mexico	21-21315C	\N	1279	\N	\N
NM-86	M	\N	Unknown	UCSF	20-91914A	\N	1260	\N	\N
SYNX659	NaN	\N	\N	\N	SP-12-020017C	NaN	2062	\N	\N
NM-87	M	\N	Unknown	UCSF	20-60974B	\N	1261	\N	\N
OM-01	M	\N	Unknown	UCSF	07-74058A,07-74058B, 07-74058A, 07-74058B	RIGHT LOWER LIP, LATERAL	1262	\N	\N
OM-02	F	\N	Unknown	UCSF	08-16770	LEFT LABIA MINORA	1263	\N	\N
OM-03	F	\N	Unknown	UCSF	09-88536	LEFT LABIA	1264	\N	\N
OM-22	M	\N	Unknown	UCSF	18-00192	\N	1280	\N	\N
OM-04	F	\N	Unknown	UCSF	13-68674	RIGHT LABIA MINORA	1265	\N	\N
OM-33	F	\N	Unknown	UCSF	13-51506B,13-51506A, 13-51506B, 13-51506A	\N	1291	\N	\N
OM-05	M	\N	Unknown	UCSF	13-107061	LEFT INFERIOR VERMILLION LIP	1266	\N	\N
OM-06	F	\N	Unknown	UCSF	15-1495	LEFT LABIA MAJORA	1267	\N	\N
OM-07	F	\N	Unknown	UCSF	18-103965B	LEFT LOWER LIP	1268	\N	\N
OM-08	M	\N	Unknown	UCSF	18-91716	GLANS PENIS	1269	\N	\N
OM-10	M	\N	Unknown	Mexico	21-21342	BB21-21342	1271	\N	\N
OM-11	F	\N	Unknown	Mexico	21-21334	BB21-21334	1272	\N	\N
OM-12	F	\N	Unknown	Mexico	19-126110	\N	1273	\N	\N
OM-13	F	\N	Unknown	Mexico	21-21338	\N	1274	\N	\N
OM-14	F	\N	Unknown	Mexico	21-21336	\N	1275	\N	\N
OM-15	M	\N	Unknown	Mexico	21-21351	\N	1276	\N	\N
SYNAT335	\N	\N	\N	\N	DM28	\N	2521	\N	\N
OM-23	M	\N	Unknown	UCSF	19-72316	\N	1281	\N	\N
OM-24	M	\N	Unknown	UCSF	19-122139	\N	1282	\N	\N
OM-25	F	\N	Unknown	UCSF	20-16705	\N	1283	\N	\N
OM-26	M	\N	Unknown	UCSF	20-28273	\N	1284	\N	\N
OM-27	F	\N	Unknown	UCSF	21-59477	\N	1285	\N	\N
OM-28	M	\N	Unknown	UCSF	21-59483	\N	1286	\N	\N
OM-29	F	\N	Unknown	UCSF	21-93208	\N	1287	\N	\N
OM-37	F	\N	Unknown	UCSF	15-99261C	\N	1295	\N	\N
OM-38	F	\N	Unknown	UCSF	15-102731B	\N	1296	\N	\N
OM-39	M	\N	Unknown	UCSF	15-122774	\N	1297	\N	\N
OM-40	F	\N	Unknown	UCSF	16-2833	\N	1298	\N	\N
OM-41	M	\N	Unknown	UCSF	16-77557	\N	1299	\N	\N
OM-42	F	\N	Unknown	UCSF	17-70204	\N	1300	\N	\N
OM-43	M	\N	Unknown	UCSF	17-24139	\N	1301	\N	\N
OM-44	M	\N	Unknown	UCSF	17-116120	\N	1302	\N	\N
OM-45	M	\N	Unknown	UCSF	18-44728A	\N	1303	\N	\N
OM-46	M	\N	Unknown	UCSF	18-88579	\N	1304	\N	\N
OM-47	M	\N	Unknown	UCSF	18-90413	\N	1305	\N	\N
OM-48	F	\N	Unknown	UCSF	10-86269	\N	1306	\N	\N
OM-49	F	\N	Unknown	UCSF	13-55769	\N	1307	\N	\N
OM-50	F	\N	Unknown	UCSF	15-86891	\N	1308	\N	\N
OM-51	M	\N	Unknown	UCSF	15-43382	\N	1309	\N	\N
OM-52	F	\N	Unknown	UCSF	15-74487	\N	1310	\N	\N
OM-53	M	\N	Unknown	UCSF	15-96473	\N	1311	\N	\N
OM-54	F	\N	Unknown	UCSF	16-53528	\N	1312	\N	\N
OM-55	M	\N	Unknown	UCSF	16-55930	\N	1313	\N	\N
OM-56	F	\N	Unknown	UCSF	16-8674	\N	1314	\N	\N
OM-57	F	\N	Unknown	UCSF	16-37928A	\N	1315	\N	\N
OM-58	F	\N	Unknown	UCSF	16-44627	\N	1316	\N	\N
OM-62	F	\N	Unknown	UCSF	17-3165A,17-3165B, 17-3165A, 17-3165B	\N	1320	\N	\N
OM-63	M	\N	Unknown	UCSF	19-94975	\N	1321	\N	\N
OM-64	M	\N	Unknown	UCSF	16-24795	\N	1322	\N	\N
OM-65	F	\N	Unknown	UCSF	20-026598	\N	1323	\N	\N
OM-67	F	\N	Unknown	UCSF	14-01007	\N	1324	\N	\N
OM-68	F	\N	Unknown	UCSF	14-4953	\N	1325	\N	\N
OM-69	M	\N	Unknown	UCSF	15-122795	\N	1326	\N	\N
OM-70	F	\N	Unknown	UCSF	16-85059	\N	1327	\N	\N
OM-71	F	\N	Unknown	UCSF	17-91629	\N	1328	\N	\N
P_MEL202	\N	\N	Unknown	UCSF	MEL202_DMSO,MEL202_Vemu, MEL202_DMSO, MEL202_Vemu	melanoma cell line	1329	\N	\N
SM-008	F	\N	Unknown	UCSF	17-82364B	\N	1338	\N	\N
SCH-01	M	\N	Unknown	UCSF	20-30367	\N	1330	\N	\N
SM-001	F	\N	Unknown	UCSF	15-21302	SM-skin mole	1331	\N	\N
SM-002	M	\N	Unknown	UCSF	11-53065	\N	1332	\N	\N
SN-05	M	\N	Unknown	UCSF	15-102927	\N	1368	\N	\N
SM-003	F	\N	Unknown	UCSF	06-2345	\N	1333	\N	\N
SM-004	F	\N	Unknown	UCSF	16-33907	\N	1334	\N	\N
SM-005	F	\N	Unknown	UCSF	17-120984	\N	1335	\N	\N
SM-006	M	\N	Unknown	UCSF	12-51532	\N	1336	\N	\N
SM-007	F	\N	Unknown	UCSF	15-72350	\N	1337	\N	\N
SM-009	M	\N	Unknown	UCSF	17-90774B	\N	1339	\N	\N
SM-010	M	\N	Unknown	UCSF	17-106118C,17-106118B, 17-106118C, 17-106118B	\N	1340	\N	\N
SM-012	M	\N	Unknown	UCSF	17-115105	\N	1341	\N	\N
SN-06	M	\N	Unknown	UCSF	19-115700A	\N	1369	\N	\N
SYNX753	NaN	\N	\N	\N	SCC10-0092	NaN	2156	\N	\N
SM-013	F	\N	Unknown	UCSF	15-16261	\N	1342	\N	\N
SM-014	F	\N	Unknown	UCSF	15-118245A	\N	1343	\N	\N
SM-015	F	\N	Unknown	UCSF	17-10753	\N	1344	\N	\N
SM-016	M	\N	Unknown	UCSF	17-21788B	\N	1345	\N	\N
SYNAT337	\N	\N	\N	\N	12-22886	\N	2566	\N	IP337537
SM-017	M	\N	Unknown	UCSF	17-52720	\N	1346	\N	\N
SM-018	F	\N	Unknown	UCSF	17-120487A	\N	1347	\N	\N
SM-019	F	\N	Unknown	UCSF	18-24908	\N	1348	\N	\N
SYNX754	NaN	\N	\N	\N	MASCRI-432	NaN	2157	\N	\N
SM-020	F	\N	Unknown	UCSF	18-59376	\N	1349	\N	\N
SM-021	F	\N	Unknown	UCSF	18-76281	\N	1350	\N	\N
SM-022	M	\N	Unknown	UCSF	18-113402B	\N	1351	\N	\N
SM-023	M	\N	Unknown	UCSF	12-16974C	\N	1352	\N	\N
SM-024	F	\N	Unknown	UCSF	17-128346A	\N	1353	\N	\N
SM-025	F	\N	Unknown	UCSF	18-85718	\N	1354	\N	\N
SMP2	F	\N	Unknown	UCSF	14-39393	\N	1355	\N	\N
SN-07	F	\N	Unknown	UCSF	19-117270	\N	1370	\N	\N
SMP4	F	\N	Unknown	UCSF	14-59414	\N	1356	\N	\N
SMP11	F	\N	Unknown	UCSF	12-24027C	\N	1357	\N	\N
SMP12	F	\N	Unknown	UCSF	13-105024A	\N	1358	\N	\N
SMP20	M	\N	Unknown	UCSF	12-91942	\N	1359	\N	\N
SN-03	M	\N	Unknown	UCSF	19-104449D	\N	1366	\N	\N
SN-04	M	\N	Unknown	UCSF	19-103058B	\N	1367	\N	\N
SN-08	M	\N	Unknown	UCSF	19-97163	\N	1371	\N	\N
SN-19	F	\N	Unknown	UCSF	20-25263A	\N	1382	\N	\N
SYNX660	NaN	\N	\N	\N	SP-12-0032671A	NaN	2063	\N	\N
SMP48	M	\N	Unknown	UCSF	15-52921B	\N	1360	\N	\N
SMP55	M	\N	Unknown	UCSF	11-1044	\N	1361	\N	\N
SMP56	F	\N	Unknown	UCSF	11-7028	\N	1362	\N	\N
SMP58	M	\N	Unknown	UCSF	14-115431C,14-115431A, 14-115431C, 14-115431A	\N	1363	\N	\N
SN-01	M	\N	Unknown	UCSF	19-53945B	\N	1364	\N	\N
SN-02	M	\N	Unknown	UCSF	19-69103	\N	1365	\N	\N
SN-09	F	\N	Unknown	UCSF	19-59869A	\N	1372	\N	\N
SN-10	M	\N	Unknown	UCSF	19-43600A	\N	1373	\N	\N
SN-11	F	\N	Unknown	UCSF	19-79825	\N	1374	\N	\N
SN-12	M	\N	Unknown	UCSF	19-80535A	\N	1375	\N	\N
SN-13	M	\N	Unknown	UCSF	19-43600B	\N	1376	\N	\N
SN-14	F	\N	Unknown	UCSF	19-78038	\N	1377	\N	\N
SYNX63	NaN	\N	\N	\N	HW6	NaN	1466	\N	\N
SYNAT338	\N	\N	\N	\N	DM29	\N	2311	\N	\N
SN-15	F	\N	Unknown	UCSF	19-89855A	\N	1378	\N	\N
SN-16	F	\N	Unknown	UCSF	19-105255	\N	1379	\N	\N
SN-17	F	\N	Unknown	UCSF	19-21355B	\N	1380	\N	\N
SN-18	F	\N	Unknown	UCSF	19-9438B	\N	1381	\N	\N
SYNX661	NaN	\N	\N	\N	SP-13-006337A	NaN	2064	\N	\N
SYNX662	NaN	\N	\N	\N	SP-12-0228802A	NaN	2065	\N	\N
SN-20	F	\N	Unknown	UCSF	20-36120	\N	1383	\N	\N
SN-21	M	\N	Unknown	UCSF	20-92494	\N	1384	\N	\N
SN-22	M	\N	Unknown	UCSF	20-43801	\N	1385	\N	\N
SYNAT339	\N	\N	\N	\N	12-18438A	\N	2502	\N	IP1104255
SN-23	M	\N	Unknown	UCSF	19-117072A,19-117072A2, 19-117072A, 19-117072A2	\N	1386	\N	\N
SN-24	F	\N	Unknown	UCSF	20-36500A	\N	1387	\N	\N
SN-25	F	\N	Unknown	UCSF	20-48338A	\N	1388	\N	\N
SN-26	F	\N	Unknown	UCSF	20-48331	\N	1389	\N	\N
SYNX663	NaN	\N	\N	\N	SP-12-0228801A	NaN	2066	\N	\N
SYNX664	NaN	\N	\N	\N	SP-12-0146612A	NaN	2067	\N	\N
SN-27	F	\N	Unknown	UCSF	20-57308	\N	1390	\N	\N
SN-28	F	\N	Unknown	UCSF	20-34915	\N	1391	\N	\N
UV-02	\N	\N	Unknown	UCSF	MP41-YM-R1	Cell culture DNA from Xu	1393	\N	\N
VS-01	\N	\N	Unknown	UCSF	11-14908C	\N	1394	\N	\N
VS-02	\N	\N	Unknown	UCSF	20-30233,20-30233-2, 20-30233-2, 20-30233	\N	1395	\N	\N
VS-03	\N	\N	Unknown	UCSF	19-10031,19-10031-2, 19-10031, 19-10031-2	\N	1396	\N	\N
VS-04_JJS22	F	\N	Unknown	UCSF	15-22411	PMID: 29990500 case 76; RPA-566	1397	\N	\N
VS-05	\N	\N	Unknown	UCSF	22-75050A2	\N	1398	\N	\N
VS-06	\N	\N	Unknown	UCSF	22-124532-2	\N	1399	\N	\N
VS-07	\N	\N	Unknown	UCSF	22-119466	\N	1400	\N	\N
VS-08	\N	\N	Unknown	UCSF	22-73345B	\N	1401	\N	\N
SYNAT340	\N	\N	\N	\N	DM34	\N	2898	\N	\N
SYNAT341	\N	\N	\N	\N	DM55	\N	2624	\N	\N
WS-01	\N	\N	Unknown	Japan	11-1969-F,12-1450,12-3277,11-1973, 11-1969-F, 12-1450, 12-3277, 11-1973	\nChanged Pat_ID to WS-01; moved 11-1969 to WS-01 (04/06/23)\n	1402	\N	\N
WS-02	\N	\N	Unknown	Japan	07-1791,07-2104,07-2479-1 ,07-3001,07-2889-2,07-2889-1 ,07-1841,07-2479-2, 07-1791, 07-2104, 07-2479-1 , 07-3001, 07-2889-2, 07-2889-1 , 07-1841, 07-2479-2	Changed Pat_ID to WS-02 (04/06/23)	1403	\N	\N
SYNAT342	\N	\N	\N	\N	12-6261A, 12-6261B	\N	2569	\N	IP1092077
SYNAT343	\N	\N	\N	\N	12-12366	\N	2597	\N	\N
SYNAT344	\N	\N	\N	\N	12-12467	\N	2957	\N	IP1098283
SYNAT345	\N	\N	\N	\N	12-12470D	\N	2797	\N	IP192328
SYNAT346	\N	\N	\N	\N	12-562	\N	2720	\N	\N
SYNAT347	\N	\N	\N	\N	12-12647	\N	2379	\N	IP858006
SYNAT348	\N	\N	\N	\N	12-12626	\N	2356	\N	IP1098442
SYNAT349	\N	\N	\N	\N	DM79	\N	2693	\N	\N
SYNAT350	\N	\N	\N	\N	12-13152	\N	2320	\N	IP1098968
SYNAT351	\N	\N	\N	\N	12-12750B	\N	2920	\N	IP114451
SYNAT352	\N	\N	\N	\N	12-19596	\N	2667	\N	\N
SYNAT353	\N	\N	\N	\N	12-19187A	\N	2820	\N	IP1105004
SYNAT354	\N	\N	\N	\N	12-22172	\N	2849	\N	IP1107990
SYNAT355	\N	\N	\N	\N	12-21726A	\N	2769	\N	IP1107544
SYNAT356	\N	\N	\N	\N	12-22901A	\N	2584	\N	IP1108719
SYNAT357	\N	\N	\N	\N	12-13587B2	\N	2294	\N	IP502329
SYNX8	F	\N	\N	\N	12-13587B2,12-13587, 12-13587	NaN	1411	\N	IP502329
SYNX19	NaN	\N	\N	\N	BuffyCoa	Collaborated with Robert Nussbaum to get this blood	1422	\N	\N
SYNAT358	\N	\N	\N	\N	12-22775	\N	2288	\N	IP249102
SYNX549	NaN	\N	\N	\N	DPN48	NaN	1952	\N	\N
SYNX645	NaN	\N	\N	\N	SP-14-001249	NaN	2048	\N	\N
SYNAT359	\N	\N	\N	\N	12-22794A	\N	2319	\N	IP454633
SYNAT360	\N	\N	\N	\N	12-22573	\N	2776	\N	IP1108391
SYNAT79	\N	\N	\N	\N	12-22582C, 12-22582A	\N	2282	\N	IP1108400
SYNAT361	\N	\N	\N	\N	12-22587	\N	2564	\N	IP1108405
SYNAT362	\N	\N	\N	\N	12-22592	\N	2891	\N	\N
SYNAT364	\N	\N	\N	\N	12-22602B, 12-22602A	\N	2611	\N	IP1081809
SYNAT365	\N	\N	\N	\N	12-22603	\N	2935	\N	IP1108421
SYNAT366	\N	\N	\N	\N	12-22604	\N	2588	\N	IP1108422
SYNX30	F	\N	\N	\N	12-22720A	Upper back	1433	\N	IP118827
SYNAT367	\N	\N	\N	\N	12-22868	\N	2725	\N	IP1108686
SYNAT336	\N	\N	\N	\N	12-22884C, 12-22884D	\N	2756	\N	IP1108702
SYNAT368	\N	\N	\N	\N	12-22894B	\N	2390	\N	IP1108712
SYNAT369	\N	\N	\N	\N	12-22898	\N	2893	\N	IP445158
SYNAT370	\N	\N	\N	\N	12-22900	\N	2317	\N	IP2427054
SYNX37	NaN	\N	\N	\N	WP11	NaN	1440	\N	\N
SYNX38	NaN	\N	\N	\N	WP23	NaN	1441	\N	\N
SYNX39	NaN	\N	\N	\N	WP29	NaN	1442	\N	\N
SYNAT371	\N	\N	\N	\N	PG8	\N	2432	\N	\N
SYNAT372	\N	\N	\N	\N	KIT37	\N	2861	\N	\N
SYNAT373	\N	\N	\N	\N	KIT62	\N	2571	\N	\N
SYNAT374	\N	\N	\N	\N	KIT118	\N	2557	\N	\N
SYNAT375	\N	\N	\N	\N	KIT181	\N	2727	\N	\N
SYNAT376	\N	\N	\N	\N	KIT227	\N	2953	\N	\N
SYNAT377	\N	\N	\N	\N	KIT275	\N	2684	\N	\N
SYNX47	NaN	\N	\N	\N	Bivona-L1	NaN	1450	\N	\N
SYNX48	NaN	\N	\N	\N	Bivona-L2	NaN	1451	\N	\N
SYNX49	NaN	\N	\N	\N	Bivona-L3	NaN	1452	\N	\N
SYNX50	NaN	\N	\N	\N	Bivona-L4	NaN	1453	\N	\N
SYNX51	NaN	\N	\N	\N	Bivona-L5	NaN	1454	\N	\N
SYNX52	NaN	\N	\N	\N	Bivona-L6	NaN	1455	\N	\N
SYNAT378	\N	\N	\N	\N	10-41439	\N	2661	\N	IP936014
JJS3	F	\N	Unknown	UCSF	11-37533B,11-37533, 11-37533B, 11-37533	PMID: 29990500 case 22-2; RPA-329	742	\N	\N
SYNAT379	\N	\N	\N	\N	KIT262	\N	2798	\N	\N
SYNAT380	\N	\N	\N	\N	Dog12	\N	2475	\N	\N
SYNAT381	\N	\N	\N	\N	Dog24	\N	2813	\N	\N
SYNAT382	\N	\N	\N	\N	Dog43	\N	2592	\N	\N
SYNAT383	\N	\N	\N	\N	Dog55	\N	2755	\N	\N
SYNX61	NaN	\N	\N	\N	HW3	NaN	1464	\N	\N
SYNX62	NaN	\N	\N	\N	HW4	NaN	1465	\N	\N
SYNAT384	\N	\N	\N	\N	10-86469	\N	2782	\N	IP981048
SYNX665	NaN	\N	\N	\N	SP-12-01466111A	NaN	2068	\N	\N
SYNX666	NaN	\N	\N	\N	SP-10-004335	NaN	2069	\N	\N
SYNX667	NaN	\N	\N	\N	SP-13-000848	NaN	2070	\N	\N
SYNX668	NaN	\N	\N	\N	M230	NaN	2071	\N	\N
DP-16	M	\N	Unknown	UCSF	11-12273	\N	653	\N	\N
DP-17	F	\N	Unknown	UCSF	11-23710	\N	654	\N	\N
SYNAT385	\N	\N	\N	\N	11-30426	\N	2471	\N	IP1019864
KF-02	F	\N	Unknown	\N	11-31904	\N	777	\N	\N
SYNX577	NaN	\N	\N	\N	ZS06-11249A-C2	NaN	1980	\N	\N
SYNX578	NaN	\N	\N	\N	S12-26125A2	NaN	1981	\N	\N
SYNAT386	\N	\N	\N	\N	11-47644	\N	2788	\N	IP1037083
SYNAT387	\N	\N	\N	\N	MB_161	\N	2568	\N	\N
SYNAT388	\N	\N	\N	\N	MB_327	\N	2306	\N	\N
SYNAT389	\N	\N	\N	\N	MB_1454	\N	2280	\N	\N
SYNAT390	\N	\N	\N	\N	MB_760	\N	2365	\N	\N
SYNAT391	\N	\N	\N	\N	MB_1418	\N	2574	\N	\N
SYNAT392	\N	\N	\N	\N	MB_1029	\N	2567	\N	\N
SYNAT393	\N	\N	\N	\N	MB_1028	\N	2591	\N	\N
SYNAT394	\N	\N	\N	\N	MB_1046	\N	2759	\N	\N
SYNX17	M	\N	\N	\N	12-22776,12-22776B3, 12-22776, 12-22776B3	NaN	1420	\N	IP1096148
SYNX86	NaN	\N	\N	\N	HW9	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	1489	\N	\N
SYNAT401	\N	\N	\N	\N	12-6981	\N	2469	\N	IP1092797
SYNAT402	\N	\N	\N	\N	10-55707	\N	2642	\N	IP950283
SYNAT403	\N	\N	\N	\N	11-5210D	\N	2664	\N	IP873475
SYNAT404	\N	\N	\N	\N	11-34950	\N	2696	\N	IP1024388
SYNAT405	\N	\N	\N	\N	11-8228	\N	2932	\N	IP997665
SYNAT411	\N	\N	\N	\N	10-59344	\N	2342	\N	IP953920
SYNX669	NaN	\N	\N	\N	M257	NaN	2072	\N	\N
SYNX670	NaN	\N	\N	\N	M285	NaN	2073	\N	\N
DP-21	F	\N	Unknown	UCSF	11-84681	\N	658	\N	\N
SYNAT406	\N	\N	\N	\N	WM3211	\N	2751	\N	\N
SYNAT407	\N	\N	\N	\N	NB2107	\N	2801	\N	\N
SYNX94	NaN	\N	\N	\N	London-L1	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	1497	\N	\N
SYNAT408	\N	\N	\N	\N	London-L2	\N	2506	\N	\N
SYNX96	NaN	\N	\N	\N	Bivona-L7	N/A|Bivona Lung Cell Line	1499	\N	\N
SYNX97	NaN	\N	\N	\N	Bivona-L8	N/A|Bivona Lung Cell Line	1500	\N	\N
SYNX98	NaN	\N	\N	\N	Bivona-L9	N/A|Bivona Lung Cell Line	1501	\N	\N
SYNX99	NaN	\N	\N	\N	Bivona-L10	N/A|Bivona Lung Cell Line	1502	\N	\N
SYNX100	NaN	\N	\N	\N	Bivona-L11	N/A|Bivona Lung Cell Line	1503	\N	\N
SYNX101	NaN	\N	\N	\N	HWA1	Hong Wu	1504	\N	\N
SYNX102	NaN	\N	\N	\N	HWA2	Hong Wu	1505	\N	\N
SYNX103	NaN	\N	\N	\N	HWA3	Hong Wu	1506	\N	\N
SYNX104	NaN	\N	\N	\N	HWA4	Hong Wu	1507	\N	\N
KF-05	F	\N	Unknown	\N	11-5482	\N	778	\N	\N
SYNX425	M	\N	\N	\N	12-168B	NaN	1828	\N	IP1080712
SYNAT409	\N	\N	\N	\N	11-79158	\N	2809	\N	IP1068606
SYNX107	NaN	\N	\N	\N	DP12-200	Dr. Lutzky's Case	1510	\N	\N
SYNAT410	\N	\N	\N	\N	TissueCoreALKControl	\N	2520	\N	\N
SYNAT416	\N	\N	\N	\N	11-96096	\N	2745	\N	IP1085544
SYNAT412	\N	\N	\N	\N	11-16253	\N	2626	\N	IP1005690
KF-08	F	\N	Unknown	\N	11-61046	\N	779	\N	\N
SYNAT413	\N	\N	\N	\N	12-31996	\N	2699	\N	IP1148421
SYNAT414	\N	\N	\N	\N	10-56047	\N	2835	\N	IP950623
SYNAT415	\N	\N	\N	\N	12-67298	\N	2488	\N	IP960004
SYNX114	M	\N	\N	\N	12-20321	NaN	1517	\N	IP1102231
SYNAT417	\N	\N	\N	\N	MB1242	\N	2740	\N	\N
SYNAT418	\N	\N	\N	\N	MB1241	\N	2413	\N	\N
SYNAT419	\N	\N	\N	\N	MB1423	\N	2707	\N	\N
SYNAT423	\N	\N	\N	\N	12-71679	\N	2385	\N	IP1157496
SYNAT424	\N	\N	\N	\N	12-80985B	\N	2714	\N	IP1166802
SYNX579	NaN	\N	\N	\N	S12-28585A6	NaN	1982	\N	\N
SYNX580	NaN	\N	\N	\N	S11-2018B5	NaN	1983	\N	\N
SYNX581	NaN	\N	\N	\N	S13-11748F5	NaN	1984	\N	\N
SYNX582	NaN	\N	\N	\N	S12-7250E3	NaN	1985	\N	\N
SYNX583	NaN	\N	\N	\N	S13-3401B3	NaN	1986	\N	\N
SYNAT425	\N	\N	\N	\N	12-39632	\N	2677	\N	IP1125450
SYNX127	NaN	\N	\N	\N	HWA5	NaN	1530	\N	\N
SYNX129	NaN	\N	\N	\N	HWA7	NaN	1532	\N	\N
SYNX132	NaN	\N	\N	\N	HWA10	NaN	1535	\N	\N
SYNAT426	\N	\N	\N	\N	MB1617	\N	2397	\N	\N
SYNAT427	\N	\N	\N	\N	MB1609	\N	2443	\N	\N
SYNAT428	\N	\N	\N	\N	WM51	\N	2713	\N	\N
SYNX136	NaN	\N	\N	\N	wm3918	Wistar	1539	\N	\N
SYNAT429	\N	\N	\N	\N	DM1	\N	2398	\N	\N
SYNAT430	\N	\N	\N	\N	DM2	\N	2799	\N	\N
SYNAT431	\N	\N	\N	\N	DM5	\N	2619	\N	\N
SYNAT432	\N	\N	\N	\N	DM7	\N	2316	\N	\N
SYNAT433	\N	\N	\N	\N	DM12	\N	2327	\N	\N
SYNAT434	\N	\N	\N	\N	DM13	\N	2532	\N	\N
SYNAT435	\N	\N	\N	\N	DM21	\N	2386	\N	\N
SYNAT436	\N	\N	\N	\N	DM93	\N	2407	\N	\N
SYNX671	NaN	\N	\N	\N	M368	NaN	2074	\N	\N
SYNX672	NaN	\N	\N	\N	M375	NaN	2075	\N	\N
SYNX673	NaN	\N	\N	\N	M418	NaN	2076	\N	\N
SYNX674	NaN	\N	\N	\N	C8161	NaN	2077	\N	\N
SYNX675	NaN	\N	\N	\N	London-L4	NaN	2078	\N	\N
SYNX676	NaN	\N	\N	\N	London-L5	NaN	2079	\N	\N
SYNAT437	\N	\N	\N	\N	11-20375	\N	2464	\N	IP1009813
SYNAT438	\N	\N	\N	\N	11-21491	\N	2685	\N	IP1010929
SYNAT439	\N	\N	\N	\N	10-88475	\N	2542	\N	IP983054
SYNAT440	\N	\N	\N	\N	12-54296	\N	2901	\N	\N
SYNAT441	\N	\N	\N	\N	12-54992	\N	2897	\N	\N
SYNAT442	\N	\N	\N	\N	WM3622	\N	2578	\N	\N
SYNAT443	\N	\N	\N	\N	11-65778	\N	2616	\N	IP1055221
SYNAT504	\N	\N	\N	\N	10-23569A	\N	2883	\N	IP918142
SYNX677	NaN	\N	\N	\N	London-L8	NaN	2080	\N	\N
SYNX678	NaN	\N	\N	\N	London-L9	NaN	2081	\N	\N
SYNX679	NaN	\N	\N	\N	London-L13	NaN	2082	\N	\N
SYNAT444	\N	\N	\N	\N	10-88482	\N	2675	\N	IP983061
SYNAT445	\N	\N	\N	\N	11-63178	\N	2954	\N	IP1052621
SYNAT446	\N	\N	\N	\N	10-71761	\N	2717	\N	IP966340
SYNX489	NaN	\N	\N	\N	UM_6	NaN	1892	\N	\N
SYNAT447	\N	\N	\N	\N	10-84478	\N	2291	\N	IP979057
SYNAT448	\N	\N	\N	\N	WM1963	\N	2346	\N	\N
SYNAT449	\N	\N	\N	\N	WM8	\N	2323	\N	\N
SYNAT450	\N	\N	\N	\N	WM3912	\N	2607	\N	\N
SYNAT451	\N	\N	\N	\N	DM11	\N	2321	\N	\N
SYNAT452	\N	\N	\N	\N	DM14	\N	2838	\N	\N
SYNAT453	\N	\N	\N	\N	DM26	\N	2513	\N	\N
SYNAT454	\N	\N	\N	\N	11-78845	\N	2463	\N	IP1068293
SYNAT455	\N	\N	\N	\N	11-81405	\N	2478	\N	IP1070853
SYNAT456	\N	\N	\N	\N	11-85075	\N	2770	\N	IP1074523
SYNAT457	\N	\N	\N	\N	11-83908	\N	2354	\N	IP1073356
SYNAT458	\N	\N	\N	\N	11-85859	\N	2889	\N	IP1075307
SYNX584	NaN	\N	\N	\N	S13-12947A2	NaN	1987	\N	\N
SYNX585	NaN	\N	\N	\N	S13-18444A16	NaN	1988	\N	\N
SYNAT459	\N	\N	\N	\N	11-95663	\N	2510	\N	IP1085111
SYNAT460	\N	\N	\N	\N	DM4	\N	2680	\N	\N
JJS1	F	\N	Unknown	UCSF	11-23681C,11-23681,11-23681B,11-23681A, 11-23681C, 11-23681B, 11-23681A, 11-23681	PMID: 29990500 case 33 OR 33_2; RPA-294	740	\N	\N
BN-010	F	\N	Unknown	UCSF	10-83193	blue nevus, cellular	114	\N	\N
SYNX54	F	\N	\N	\N	11-23681,11-23681A+C, 11-23681A+C	NaN	1457	\N	IP1013119
SYNAT482	\N	\N	\N	\N	DM10	\N	2562	\N	\N
SYNAT483	\N	\N	\N	\N	DM17	\N	2847	\N	\N
SYNAT484	\N	\N	\N	\N	DM18	\N	2846	\N	\N
SYNAT485	\N	\N	\N	\N	DM22	\N	2468	\N	\N
SYNAT486	\N	\N	\N	\N	DM23	\N	2902	\N	\N
SYNAT487	\N	\N	\N	\N	DM25	\N	2347	\N	\N
SYNAT488	\N	\N	\N	\N	DM6	\N	2705	\N	\N
SYNAT489	\N	\N	\N	\N	DM37	\N	2367	\N	\N
SYNX216	NaN	\N	\N	\N	SM_1	NaN	1619	\N	\N
SYNAT490	\N	\N	\N	\N	SM_3	\N	2451	\N	\N
SYNAT491	\N	\N	\N	\N	SM_4	\N	2583	\N	\N
SYNAT492	\N	\N	\N	\N	SM_5	\N	2297	\N	\N
SYNAT493	\N	\N	\N	\N	SM7	\N	2419	\N	\N
SYNX221	NaN	\N	\N	\N	SM_8	NaN	1624	\N	\N
SYNAT494	\N	\N	\N	\N	SM_11	\N	2509	\N	\N
SYNAT495	\N	\N	\N	\N	SM_12	\N	2370	\N	\N
SYNAT496	\N	\N	\N	\N	SM_16	\N	2536	\N	\N
SYNX225	NaN	\N	\N	\N	SM_18	| Barcode mismatch comment in note	1628	\N	\N
SYNAT497	\N	\N	\N	\N	DM42	\N	2559	\N	\N
SYNAT498	\N	\N	\N	\N	DM43	\N	2623	\N	\N
SYNAT499	\N	\N	\N	\N	DM48	\N	2919	\N	\N
SYNAT505	\N	\N	\N	\N	09-92749	\N	2628	\N	IP893515
SYNX680	NaN	\N	\N	\N	1212	NaN	2083	\N	\N
SYNX681	NaN	\N	\N	\N	1213	NaN	2084	\N	\N
SYNX682	NaN	\N	\N	\N	1214	NaN	2085	\N	\N
SYNX683	NaN	\N	\N	\N	3860	NaN	2086	\N	\N
SYNX684	NaN	\N	\N	\N	UM17	NaN	2087	\N	\N
SYNAT500	\N	\N	\N	\N	11-64496	\N	2786	\N	IP1053939
SYNAT501	\N	\N	\N	\N	11-71491	\N	2686	\N	IP1060934
SYNX586	NaN	\N	\N	\N	ZS07-1210F6	NaN	1989	\N	\N
SYNX587	NaN	\N	\N	\N	ZS10-11930B12	NaN	1990	\N	\N
SYNX588	NaN	\N	\N	\N	S12-28988	NaN	1991	\N	\N
SYNX589	NaN	\N	\N	\N	SSS13-1652B2	NaN	1992	\N	\N
SYNX590	NaN	\N	\N	\N	S13-5249	NaN	1993	\N	\N
SYNAT502	\N	\N	\N	\N	11-65756	\N	2300	\N	IP1055199
SYNAT503	\N	\N	\N	\N	11-74100	\N	2581	\N	IP1063547
SYNX300	NaN	\N	\N	\N	S08-1463A2	NaN	1703	\N	\N
SYNX301	NaN	\N	\N	\N	S12-7093NG176-1	NaN	1704	\N	\N
SYNX302	NaN	\N	\N	\N	S10-7937B2	NaN	1705	\N	\N
SYNX303	NaN	\N	\N	\N	S11-21025B1	NaN	1706	\N	\N
SYNX685	NaN	\N	\N	\N	S12-23475A6	NaN	2088	\N	\N
SYNX686	NaN	\N	\N	\N	S12-23475A4	NaN	2089	\N	\N
SYNAT506	\N	\N	\N	\N	11-74517	\N	2819	\N	IP1063964
SYNAT507	\N	\N	\N	\N	11-18560	\N	2658	\N	IP1007998
SYNX450	F	\N	\N	\N	99-15313	NaN	1853	\N	IP190846
SYNAT508	\N	\N	\N	\N	10-74513	\N	2885	\N	IP969092
SYNAT509	\N	\N	\N	\N	10-80009	\N	2392	\N	IP974588
SYNAT510	\N	\N	\N	\N	10-91484	\N	2825	\N	IP986063
SYNX292	NaN	\N	\N	\N	K1_20	13 Cycle Post Hybridization LM-PCR	1695	\N	\N
SYNAT587	\N	\N	\N	\N	BN_M2	\N	2657	\N	\N
SYNAT511	\N	\N	\N	\N	10-32987	\N	2916	\N	IP927561
SYNAT512	\N	\N	\N	\N	06-08042	\N	2295	\N	IP553108
SYNAT513	\N	\N	\N	\N	11-699	\N	2906	\N	IP990136
SYNAT514	\N	\N	\N	\N	11-20772	\N	2551	\N	IP1010210
SYNAT515	\N	\N	\N	\N	11-19877	\N	2504	\N	IP1009315
SYNAT516	\N	\N	\N	\N	11-35616	\N	2613	\N	IP1025054
SYNAT517	\N	\N	\N	\N	11-33856	\N	2477	\N	IP1023294
SYNX538	NaN	\N	\N	\N	Dummer-KF1-Met2	NaN	1941	\N	\N
SYNX687	NaN	\N	\N	\N	S12-23475C1	NaN	2090	\N	\N
SYNX688	F	\N	\N	\N	13-21725	NaN	2091	\N	IP1175186
SYNAT518	\N	\N	\N	\N	11-38771	\N	2495	\N	IP1028210
SYNAT519	\N	\N	\N	\N	11-39639	\N	2305	\N	IP1029078
SYNX426	F	\N	\N	\N	11-75173	NaN	1829	\N	IP1064620
SYNAT520	\N	\N	\N	\N	06-32942	\N	2886	\N	IP578011
SYNAT521	\N	\N	\N	\N	06-52508	\N	2914	\N	IP597577
SYNX395	NaN	\N	\N	\N	RC11-024	NaN	1798	\N	\N
SYNX429	F	\N	\N	\N	12-66661	NaN	1832	\N	IP1152477
SYNAT522	\N	\N	\N	\N	07-04365	\N	2552	\N	IP617346
SYNAT523	\N	\N	\N	\N	07-14044A	\N	2810	\N	IP636575
SYNAT524	\N	\N	\N	\N	07-26247	\N	2426	\N	IP208441
SYNAT525	\N	\N	\N	\N	13-3732	\N	2622	\N	IP1188475
SYNX532	NaN	\N	\N	\N	DM32	NaN	1935	\N	\N
SYNAT526	\N	\N	\N	\N	09-37302	\N	2599	\N	IP838065
SYNAT527	\N	\N	\N	\N	12-79358	\N	2393	\N	IP1165175
SYNX540	NaN	\N	\N	\N	Dummer-KF2	NaN	1943	\N	\N
SYNAT528	\N	\N	\N	\N	12-81302	\N	2387	\N	IP1167119
SYNAT529	\N	\N	\N	\N	12-81749	\N	2313	\N	IP1167566
SYNAT530	\N	\N	\N	\N	12-97031	\N	2635	\N	IP1182848
SYNAT531	\N	\N	\N	\N	12-98736	\N	2743	\N	IP1184553
SYNAT532	\N	\N	\N	\N	13-3874	\N	2762	\N	IP1188617
SYNX427	F	\N	\N	\N	12-167B	NaN	1830	\N	IP671051
SYNX533	NaN	\N	\N	\N	DM35	NaN	1936	\N	\N
SYNAT533	\N	\N	\N	\N	13-3889	\N	2423	\N	IP1188632
SYNAT534	\N	\N	\N	\N	13-4090B	\N	2876	\N	IP1188833
SYNX689	NaN	\N	\N	\N	SP-14-68521D	NaN	2092	\N	\N
SYNAT535	\N	\N	\N	\N	13-4136	\N	2415	\N	IP1179510
SYNAT536	\N	\N	\N	\N	13-7186	\N	2570	\N	IP1191929
SYNAT537	\N	\N	\N	\N	13-25A	\N	2329	\N	IP1184767
SYNAT538	\N	\N	\N	\N	11-71241	\N	2638	\N	IP1060684
SYNAT539	\N	\N	\N	\N	11-26903	\N	2371	\N	IP1016341
SYNX534	NaN	\N	\N	\N	DM40	NaN	1937	\N	\N
SYNX591	NaN	\N	\N	\N	London-L14	NaN	1994	\N	\N
SYNAT540	\N	\N	\N	\N	11-95856	\N	2331	\N	IP1085304
SYNAT541	\N	\N	\N	\N	09-72944	\N	2402	\N	IP563362
SYNX690	NaN	\N	\N	\N	SP-13-208365A	NaN	2093	\N	\N
SYNX691	NaN	\N	\N	\N	SP-14-36134A	NaN	2094	\N	\N
SYNX692	NaN	\N	\N	\N	SP-14-73676A	NaN	2095	\N	\N
SYNAT542	\N	\N	\N	\N	10-46536	\N	2903	\N	IP941112
SYNAT543	\N	\N	\N	\N	10-83613A	\N	2863	\N	IP978192
SYNX275	NaN	\N	\N	\N	K1_1	13 Cycle Post Hybridization LM-PCR	1678	\N	\N
SYNX276	NaN	\N	\N	\N	K1_2	13 Cycle Post Hybridization LM-PCR	1679	\N	\N
SYNX277	NaN	\N	\N	\N	K1_3	13 Cycle Post Hybridization LM-PCR	1680	\N	\N
SYNX278	NaN	\N	\N	\N	London-L20	13 Cycle Post Hybridization LM-PCR	1681	\N	\N
SYNX279	NaN	\N	\N	\N	London-L15	13 Cycle Post Hybridization LM-PCR	1682	\N	\N
SYNX280	NaN	\N	\N	\N	London-L23C	13 Cycle Post Hybridization LM-PCR	1683	\N	\N
SYNX282	NaN	\N	\N	\N	K1_10	NaN	1685	\N	\N
SYNX283	NaN	\N	\N	\N	K1_11	NaN	1686	\N	\N
SYNX284	NaN	\N	\N	\N	K1_12	13 Cycle Post Hybridization LM-PCR	1687	\N	\N
SYNX285	NaN	\N	\N	\N	K1_13	13 Cycle Post Hybridization LM-PCR	1688	\N	\N
SYNX286	NaN	\N	\N	\N	K1_14	13 Cycle Post Hybridization LM-PCR	1689	\N	\N
SYNX287	NaN	\N	\N	\N	K1_15	13 Cycle Post Hybridization LM-PCR	1690	\N	\N
SYNX288	NaN	\N	\N	\N	K1_16	13 Cycle Post Hybridization LM-PCR	1691	\N	\N
SYNX289	NaN	\N	\N	\N	K1_17	13 Cycle Post Hybridization LM-PCR	1692	\N	\N
SYNX290	NaN	\N	\N	\N	K1_18	13 Cycle Post Hybridization LM-PCR	1693	\N	\N
SYNX291	NaN	\N	\N	\N	K1_19	13 Cycle Post Hybridization LM-PCR	1694	\N	\N
SYNAT544	\N	\N	\N	\N	06-00911	\N	2887	\N	IP545976
SYNX535	NaN	\N	\N	\N	Dummer-KF1-Primary	NaN	1938	\N	\N
SYNAT545	\N	\N	\N	\N	06-21363	\N	2944	\N	IP566429
SYNAT546	\N	\N	\N	\N	06-47334	\N	2656	\N	IP454219
SYNX298	NaN	\N	\N	\N	S12-6332A5	NaN	1701	\N	\N
SYNX299	NaN	\N	\N	\N	S11-032523A1	NaN	1702	\N	\N
SYNAT547	\N	\N	\N	\N	10-58663	\N	2922	\N	IP953239
SYNAT548	\N	\N	\N	\N	08-52519	\N	2344	\N	IP761160
SYNAT549	\N	\N	\N	\N	09-8165	\N	2702	\N	IP458841
SYNAT550	\N	\N	\N	\N	08-46462	\N	2412	\N	IP755103
DP-03	M	\N	Unknown	UCSF	12-1782	\N	640	\N	\N
SYNX592	NaN	\N	\N	\N	London-L14C	NaN	1995	\N	\N
SYNAT551	\N	\N	\N	\N	11-25808	\N	2821	\N	IP1015246
SYNAT552	\N	\N	\N	\N	11-42027	\N	2614	\N	\N
SYNX693	NaN	\N	\N	\N	SP-14-73671M	NaN	2096	\N	\N
SYNX694	NaN	\N	\N	\N	SP-14-7691A	NaN	2097	\N	\N
SYNX695	NaN	\N	\N	\N	WM3928F	13 Cycle Post Hybridization LM-PCR	2098	\N	\N
SYNX696	NaN	\N	\N	\N	C037	13 Cycle Post Hybridization LM-PCR	2099	\N	\N
SYNAT553	\N	\N	\N	\N	12-7775	\N	2586	\N	IP1093591
SYNAT554	\N	\N	\N	\N	DM45	\N	2700	\N	\N
SYNAT555	\N	\N	\N	\N	DM16	\N	2472	\N	\N
SYNAT556	\N	\N	\N	\N	DM77	\N	2682	\N	\N
SYNX314	NaN	\N	\N	\N	HWAcr	NaN	1717	\N	\N
SYNAT557	\N	\N	\N	\N	DM94	\N	2540	\N	\N
SYNAT558	\N	\N	\N	\N	DM98	\N	2436	\N	\N
SYNAT559	\N	\N	\N	\N	DM99	\N	2424	\N	\N
SYNAT560	\N	\N	\N	\N	DM64	\N	2554	\N	\N
SYNAT561	\N	\N	\N	\N	DM51	\N	2579	\N	\N
SYNAT562	\N	\N	\N	\N	DM58	\N	2314	\N	\N
SYNAT563	\N	\N	\N	\N	DM59	\N	2301	\N	\N
SYNAT564	\N	\N	\N	\N	DM31	\N	2671	\N	\N
SYNAT565	\N	\N	\N	\N	DM36	\N	2688	\N	\N
SYNAT566	\N	\N	\N	\N	DM74	\N	2918	\N	\N
SYNAT567	\N	\N	\N	\N	08-43264	\N	2735	\N	IP179649
SYNAT568	\N	\N	\N	\N	08-51219	\N	2779	\N	IP754897
SYNX327	NaN	\N	\N	\N	S12-18826	NaN	1730	\N	\N
SYNAT569	\N	\N	\N	\N	DM68	\N	2956	\N	\N
SYNAT570	\N	\N	\N	\N	11-81851	\N	2598	\N	IP1071299
SYNX697	NaN	\N	\N	\N	C022	13 Cycle Post Hybridization LM-PCR	2100	\N	\N
SYNX699	NaN	\N	\N	\N	UM19	13 Cycle Post Hybridization LM-PCR	2102	\N	\N
SYNX700	NaN	\N	\N	\N	UM20	13 Cycle Post Hybridization LM-PCR	2103	\N	\N
SYNX701	NaN	\N	\N	\N	CP-1	13 Cycle Post Hybridization LM-PCR	2104	\N	\N
SYNAT571	\N	\N	\N	\N	10-73024	\N	2361	\N	IP967603
SYNX330	NaN	\N	\N	\N	12_M	NaN	1733	\N	\N
SYNAT572	\N	\N	\N	\N	49_M	\N	2800	\N	\N
SYNAT573	\N	\N	\N	\N	10-0206	\N	2665	\N	IP894776
SYNAT574	\N	\N	\N	\N	09-0209	\N	2501	\N	\N
SYNAT575	\N	\N	\N	\N	13-25110A1	\N	2560	\N	IP1209855
SYNAT576	\N	\N	\N	\N	13-45163	\N	2804	\N	IP468757
SYNAT577	\N	\N	\N	\N	DM49	\N	2293	\N	\N
SYNX338	NaN	\N	\N	\N	DP08-21965C	NaN	1741	\N	\N
SYNX339	NaN	\N	\N	\N	DP08-4205A	NaN	1742	\N	\N
SYNAT578	\N	\N	\N	\N	11-50182	\N	2869	\N	IP1039621
SYNX396	NaN	\N	\N	\N	Kit298	NaN	1799	\N	\N
SYNAT579	\N	\N	\N	\N	BN_N1	\N	2341	\N	\N
SYNX854	NaN	\N	\N	\N	UM37	NaN	2257	\N	\N
SYNX417	M	\N	\N	\N	11-41004	CGH11-202 	1820	\N	IP1030443
SYNX702	NaN	\N	\N	\N	CP-2	13 Cycle Post Hybridization LM-PCR	2105	\N	\N
SYNX703	NaN	\N	\N	\N	CP-3	13 Cycle Post Hybridization LM-PCR	2106	\N	\N
SYNAT580	\N	\N	\N	\N	11-51553	\N	2805	\N	IP1040993
SYNAT581	\N	\N	\N	\N	11-52339	\N	2781	\N	IP1041779
SYNAT582	\N	\N	\N	\N	11-55993	\N	2908	\N	IP1045436
SYNAT583	\N	\N	\N	\N	11-57051	\N	2427	\N	IP1046494
SYNAT584	\N	\N	\N	\N	11-71006	\N	2742	\N	IP1060449
SYNAT585	\N	\N	\N	\N	BN_N2	\N	2284	\N	\N
SYNAT586	\N	\N	\N	\N	BN_M1	\N	2399	\N	\N
SYNAT588	\N	\N	\N	\N	11-76464	\N	2709	\N	IP1065911
DP-23	F	\N	Unknown	UCSF	11-88431	\N	660	\N	\N
SYNAT589	\N	\N	\N	\N	11-88432	\N	2860	\N	IP1077880
SYNAT590	\N	\N	\N	\N	11-88209	\N	2724	\N	IP1071369
SYNAT591	\N	\N	\N	\N	Thomas_SK_MEL_23	\N	2381	\N	\N
SYNAT592	\N	\N	\N	\N	KIT134	\N	2843	\N	\N
SYNAT593	\N	\N	\N	\N	KIT191	\N	2921	\N	\N
SYNAT594	\N	\N	\N	\N	KIT205	\N	2690	\N	\N
SYNAT595	\N	\N	\N	\N	KIT206	\N	2555	\N	\N
SYNAT596	\N	\N	\N	\N	KIT210	\N	2462	\N	\N
SYNAT597	\N	\N	\N	\N	KIT217	\N	2827	\N	\N
SYNAT598	\N	\N	\N	\N	KIT225	\N	2645	\N	\N
SYNAT599	\N	\N	\N	\N	KIT244	\N	2309	\N	\N
SYNAT600	\N	\N	\N	\N	KIT260	\N	2394	\N	\N
SYNAT601	\N	\N	\N	\N	KIT273	\N	2871	\N	\N
SYNAT602	\N	\N	\N	\N	KIT295	\N	2529	\N	\N
SYNX401	NaN	\N	\N	\N	SQ13-8208B	NaN	1804	\N	\N
SYNAT603	\N	\N	\N	\N	98-18400a	\N	2594	\N	\N
SYNAT604	\N	\N	\N	\N	08-70283a	\N	2456	\N	\N
SYNAT605	\N	\N	\N	\N	03-34051A1	\N	2807	\N	\N
SYNAT606	\N	\N	\N	\N	02-42436	\N	2573	\N	\N
SYNX536	NaN	\N	\N	\N	Dummer-KF1	NaN	1939	\N	\N
SYNX537	NaN	\N	\N	\N	Dummer-KF1-Met1	NaN	1940	\N	\N
SYNX362	F	\N	\N	\N	11-23878	CGH11-109 	1765	\N	IP1013316
DP-09	F	\N	Unknown	UCSF	12-11041	Consultation; Diagnosis on IntelliPath: Melanoma	646	\N	\N
SYNAT607	\N	\N	\N	\N	12-55584	\N	2556	\N	IP1141397
SYNAT608	\N	\N	\N	\N	11-85416	\N	2490	\N	IP1074864
SYNAT609	\N	\N	\N	\N	11-94134	\N	2596	\N	IP1083582
SYNAT610	\N	\N	\N	\N	12-2898	\N	2933	\N	IP1088714
SYNX539	NaN	\N	\N	\N	Dummer-KF2-Primary	NaN	1942	\N	\N
KF-01	F	\N	Unknown	\N	12-4251	\N	776	\N	\N
SYNAT611	\N	\N	\N	\N	12-8171	\N	2948	\N	IP1093987
DP-02	F	\N	Unknown	UCSF	12-10777	\N	639	\N	\N
SYNX372	NaN	\N	\N	\N	10_63051C	NaN	1775	\N	\N
SYNAT612	\N	\N	\N	\N	DPN9	\N	2590	\N	\N
SYNX375	NaN	\N	\N	\N	DPN18	NaN	1778	\N	\N
SYNAT613	\N	\N	\N	\N	11-21178	\N	2400	\N	IP1010616
SYNAT614	\N	\N	\N	\N	13-212	\N	2934	\N	\N
SYNAT615	\N	\N	\N	\N	KIT230	\N	2721	\N	\N
SYNAT616	\N	\N	\N	\N	KIT297	\N	2577	\N	\N
SYNAT617	\N	\N	\N	\N	KIT302	\N	2708	\N	\N
SYNAT618	\N	\N	\N	\N	KIT316	\N	2766	\N	\N
SYNX704	NaN	\N	\N	\N	CP-4	13 Cycle Post Hybridization LM-PCR	2107	\N	\N
SYNAT619	\N	\N	\N	\N	11-50270	\N	2936	\N	IP1039709
SYNAT620	\N	\N	\N	\N	12-23578	\N	2517	\N	IP1101847
SYNAT621	\N	\N	\N	\N	12-31421	\N	2894	\N	IP1117239
SYNAT622	\N	\N	\N	\N	11-13661	\N	2523	\N	IP1003098
SYNX387	NaN	\N	\N	\N	RC11-001	NaN	1790	\N	\N
SYNX388	NaN	\N	\N	\N	RC11-002	NaN	1791	\N	\N
SYNX389	NaN	\N	\N	\N	RC11-003	NaN	1792	\N	\N
SYNX390	NaN	\N	\N	\N	RC11-004	NaN	1793	\N	\N
SYNX391	NaN	\N	\N	\N	RC11-005	NaN	1794	\N	\N
SYNX392	NaN	\N	\N	\N	RC11-021	NaN	1795	\N	\N
SYNX393	NaN	\N	\N	\N	RC11-022	NaN	1796	\N	\N
SYNX394	NaN	\N	\N	\N	RC11-023	NaN	1797	\N	\N
SYNAT623	\N	\N	\N	\N	11-28912B	\N	2741	\N	IP1018350
SYNAT624	\N	\N	\N	\N	11-38149	\N	2336	\N	IP1018350
SYNAT625	\N	\N	\N	\N	13-2939B	\N	2718	\N	IP1187682
SYNX408	NaN	\N	\N	\N	L13-48798	NaN	1811	\N	\N
SYNAT626	\N	\N	\N	\N	13-51115A	\N	2429	\N	IP380899
SYNAT627	\N	\N	\N	\N	11-73238A	\N	2643	\N	IP987085
SYNAT628	\N	\N	\N	\N	11-73999	\N	2767	\N	IP1063446
SYNAT629	\N	\N	\N	\N	DM65	\N	2372	\N	\N
SYNAT630	\N	\N	\N	\N	13-59840	\N	2851	\N	IP352453
SYNAT631	\N	\N	\N	\N	Seider_Uveal	\N	2340	\N	\N
SYNAT632	\N	\N	\N	\N	Luping_ROS_1	\N	2915	\N	\N
SYNAT633	\N	\N	\N	\N	Seider_Roe	\N	2382	\N	\N
SYNX424	M	\N	\N	\N	12-762B	NaN	1827	\N	IP1086578
SYNX705	NaN	\N	\N	\N	CP-5	13 Cycle Post Hybridization LM-PCR	2108	\N	\N
SYNX418	F	\N	\N	\N	11-51223	CGH11-215 	1821	\N	IP1040663
SYNX419	M	\N	\N	\N	12-22542	CGH12-088 	1822	\N	IP1108360
SYNX420	M	\N	\N	\N	12-42406	CGH12-188 	1823	\N	IP1128224
SYNX421	M	\N	\N	\N	12-55875	CGH12-227 	1824	\N	IP1141688
SYNX422	M	\N	\N	\N	12-88454	CGH12-376 	1825	\N	IP1174271
SYNX423	M	\N	\N	\N	12-98328	CGH13-007 	1826	\N	IP1176562
SYNX541	NaN	\N	\N	\N	Dummer-KF2-Met1	NaN	1944	\N	\N
SYNX801	NaN	\N	\N	\N	SSCS03-014369	58	2204	\N	\N
SYNX428	F	\N	\N	\N	13-47668	NaN	1831	\N	IP298118
SYNX430	F	\N	\N	\N	13-47621	NaN	1833	\N	IP1288923
SYNX431	F	\N	\N	\N	13-37371	NaN	1834	\N	IP1278673
SYNX432	NaN	\N	\N	\N	Acral-11	_Tumor	1835	\N	\N
SYNX433	NaN	\N	\N	\N	Acral-12	_Tumor	1836	\N	\N
SYNX434	M	\N	\N	\N	02-2599C,02-2599, 02-2599C, 02-2599	NaN	1837	\N	IP307333
SYNX435	NaN	\N	\N	\N	T07-1120	NaN	1838	\N	\N
SYNX436	NaN	\N	\N	\N	T09-8069	NaN	1839	\N	\N
SYNX437	NaN	\N	\N	\N	T02-16195	NaN	1840	\N	\N
SYNX438	NaN	\N	\N	\N	T00-12011	NaN	1841	\N	\N
SYNX439	NaN	\N	\N	\N	T06-6855	NaN	1842	\N	\N
SYNX440	F	\N	\N	\N	12-18832AA	NaN	1843	\N	IP1104649
SYNX441	NaN	\N	\N	\N	CNS52	NaN	1844	\N	\N
SYNX442	NaN	\N	\N	\N	CNS53	NaN	1845	\N	\N
SYNX443	NaN	\N	\N	\N	CNS54	NaN	1846	\N	\N
SYNX444	NaN	\N	\N	\N	CNS57	NaN	1847	\N	\N
SYNX445	NaN	\N	\N	\N	BN-N1-Tert	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	1848	\N	\N
SYNX446	NaN	\N	\N	\N	BN-N2-Tert	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	1849	\N	\N
SYNX447	NaN	\N	\N	\N	BN-M1-Tert	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	1850	\N	\N
SYNX448	M	\N	\N	\N	12-12039B	NaN	1851	\N	IP1097855
SYNX449	?	\N	\N	\N	99-29482	NaN	1852	\N	IP205015
SYNX542	NaN	\N	\N	\N	Dummer-KF3-Primary	NaN	1945	\N	\N
SYNX543	NaN	\N	\N	\N	Dummer-KF3	NaN	1946	\N	\N
SYNX451	M	\N	\N	\N	99-885	NaN	1854	\N	IP176418
SYNX452	M	\N	\N	\N	98-37643	NaN	1855	\N	IP175216
SYNX706	NaN	\N	\N	\N	CP-6	13 Cycle Post Hybridization LM-PCR	2109	\N	\N
SYNX755	NaN	\N	\N	\N	RPA08-0209	NaN	2158	\N	\N
SYNX454	M	\N	\N	\N	09-29997	NaN	1857	\N	IP310907
SYNX455	F	\N	\N	\N	04-11158	NaN	1858	\N	IP427557
SYNX456	NaN	\N	\N	\N	UM4	NaN	1859	\N	\N
SYNX457	NaN	\N	\N	\N	UM5	NaN	1860	\N	\N
SYNX458	M	\N	\N	\N	08-84352	NaN	1861	\N	IP792993
SYNX459	M	\N	\N	\N	11-88792	NaN	1862	\N	IP787073
SYNX460	M	\N	\N	\N	13-74952	CGH13-324 	1863	\N	IP1316957
SYNX544	NaN	\N	\N	\N	Dummer-KF3-Met1	NaN	1947	\N	\N
SYNX698	NaN	\N	\N	\N	UM15	13 Cycle Post Hybridization LM-PCR	2101	\N	\N
SYNX461	M	\N	\N	\N	13-75067	CGH13-331 ETV6 Fusion	1864	\N	IP1317072
SYNX462	NaN	\N	\N	\N	Spitz_M1	NaN	1865	\N	\N
SYNX463	NaN	\N	\N	\N	Spitz_M2_(?)	NaN	1866	\N	\N
SYNX464	NaN	\N	\N	\N	Spitz_N1	NaN	1867	\N	\N
SYNX465	NaN	\N	\N	\N	Spitz_N2	NaN	1868	\N	\N
SYNX466	NaN	\N	\N	\N	Spitz_N3	NaN	1869	\N	\N
SYNX468	F	\N	\N	\N	13-159	CGH13-016 	1871	\N	IP1183551
SYNX469	F	\N	\N	\N	12-43016	CGH12-163 	1872	\N	IP1128829
SYNX470	M	\N	\N	\N	13-34291	CGH13-166 	1873	\N	IP1275593
SYNX472	NaN	\N	\N	\N	Yurif_DNA	NaN	1875	\N	\N
SYNX473	NaN	\N	\N	\N	DPN26	NaN	1876	\N	\N
SYNX474	NaN	\N	\N	\N	MIN_7	NaN	1877	\N	\N
SYNX475	NaN	\N	\N	\N	MIN_8	NaN	1878	\N	\N
SYNX476	NaN	\N	\N	\N	501_Mel	NaN	1879	\N	\N
SYNX477	NaN	\N	\N	\N	Sk_Mel_1	NaN	1880	\N	\N
SYNX478	NaN	\N	\N	\N	DPN24	NaN	1881	\N	\N
SYNX479	NaN	\N	\N	\N	DPN28	NaN	1882	\N	\N
SYNX480	NaN	\N	\N	\N	DPN29	NaN	1883	\N	\N
SYNX481	NaN	\N	\N	\N	DPN31	NaN	1884	\N	\N
SYNX482	NaN	\N	\N	\N	DPN33	NaN	1885	\N	\N
SYNX483	NaN	\N	\N	\N	DPN40	NaN	1886	\N	\N
SYNX484	NaN	\N	\N	\N	DPN41	NaN	1887	\N	\N
SYNX485	NaN	\N	\N	\N	DPN42	NaN	1888	\N	\N
SYNX486	NaN	\N	\N	\N	DPN44	NaN	1889	\N	\N
SYNX490	NaN	\N	\N	\N	Birt_Hogg_Dube	NaN	1893	\N	\N
SYNX491	F	\N	\N	\N	13-1939	CGH13-027 NTRK3	1894	\N	IP1186681
SYNAT664	\N	\N	\N	\N	UM26	\N	2812	\N	\N
SYNAT665	\N	\N	\N	\N	TCR-Beta-1	\N	2692	\N	\N
SYNAT666	\N	\N	\N	\N	TCR-Beta-2	\N	2913	\N	\N
SYNAT667	\N	\N	\N	\N	CP1-80	\N	2842	\N	\N
SYNAT668	\N	\N	\N	\N	CP1-40	\N	2712	\N	\N
SYNAT669	\N	\N	\N	\N	CP1-20	\N	2837	\N	\N
SYNX492	F	\N	\N	\N	13-51657	CGH13-268 MET	1895	\N	IP1293660
SYNX493	F	\N	\N	\N	13-89069	CGH13-365 DPN-like Melanoma	1896	\N	IP1331074
SYNX494	M	\N	\N	\N	11-1051A	CGH11-018 	1897	\N	IP990488
SYNX495	F	\N	\N	\N	11-5480	CGH11-027 	1898	\N	IP994917
SYNX496	M	\N	\N	\N	09-33283	NaN	1899	\N	IP834046
SYNX497	M	\N	\N	\N	09-31895	NaN	1900	\N	IP79298
SYNX498	NaN	\N	\N	\N	R29032-05	NaN	1901	\N	\N
SYNX499	F	\N	\N	\N	01-8297	NaN	1902	\N	IP264700
SYNX500	NaN	\N	\N	\N	8298-01	NaN	1903	\N	\N
SYNX545	NaN	\N	\N	\N	Long-TN1	NaN	1948	\N	\N
SYNX546	NaN	\N	\N	\N	Long-TN2	NaN	1949	\N	\N
SYNX547	NaN	\N	\N	\N	D326	NaN	1950	\N	\N
SYNX548	NaN	\N	\N	\N	D366	NaN	1951	\N	\N
SYNX558	M	\N	\N	\N	13-67500AL	NaN	1961	\N	IP1309505
SYNX501	F	\N	\N	\N	08-53951	NaN	1904	\N	IP596372
SYNX502	NaN	\N	\N	\N	13000212	NaN	1905	\N	\N
SYNX503	NaN	\N	\N	\N	8528-05	NaN	1906	\N	\N
SYNX504	NaN	\N	\N	\N	1286184b	NaN	1907	\N	\N
SYNX505	NaN	\N	\N	\N	206436	NaN	1908	\N	\N
SYNX506	NaN	\N	\N	\N	35942-04	NaN	1909	\N	\N
SYNX507	NaN	\N	\N	\N	15329-03	NaN	1910	\N	\N
SYNX508	NaN	\N	\N	\N	Z1188-03	NaN	1911	\N	\N
SYNX509	NaN	\N	\N	\N	1185-03	NaN	1912	\N	\N
SYNX510	NaN	\N	\N	\N	14514-02	NaN	1913	\N	\N
SYNX511	NaN	\N	\N	\N	15102-02	NaN	1914	\N	\N
SYNX512	NaN	\N	\N	\N	9116-05	NaN	1915	\N	\N
SYNX513	NaN	\N	\N	\N	24516-06	NaN	1916	\N	\N
SYNX514	F	\N	\N	\N	07-3078	NaN	1917	\N	IP625607
SYNX515	NaN	\N	\N	\N	B06-37358	NaN	1918	\N	\N
SYNX516	NaN	\N	\N	\N	21590	NaN	1919	\N	\N
SYNX517	NaN	\N	\N	\N	A2A79@	NaN	1920	\N	\N
SYNX518	NaN	\N	\N	\N	356A3-075	NaN	1921	\N	\N
SYNX519	NaN	\N	\N	\N	20847-09	NaN	1922	\N	\N
SYNX520	NaN	\N	\N	\N	525	NaN	1923	\N	\N
SYNX521	NaN	\N	\N	\N	PMM_23	NaN	1924	\N	\N
SYNX522	NaN	\N	\N	\N	UM7	NaN	1925	\N	\N
SYNX523	NaN	\N	\N	\N	UM8	NaN	1926	\N	\N
SYNX524	NaN	\N	\N	\N	UM9	NaN	1927	\N	\N
SYNX525	NaN	\N	\N	\N	UM10	NaN	1928	\N	\N
SYNX526	NaN	\N	\N	\N	UM11	NaN	1929	\N	\N
SYNX527	NaN	\N	\N	\N	Xanthoma_Disseminatum	NaN	1930	\N	\N
SYNX528	M	\N	\N	\N	13-94981	CGH13-392 	1931	\N	IP1336996
SYNX529	F	\N	\N	\N	13-99411A	CGH13-399 	1932	\N	IP1341428
SYNX530	F	\N	\N	\N	13-94484	CGH13-394 	1933	\N	IP1336499
SYNX531	NaN	\N	\N	\N	DM27	NaN	1934	\N	\N
SYNX550	F	\N	\N	\N	11-2532	CGH11-023 	1953	\N	IP991969
SYNX551	NaN	\N	\N	\N	AST-1	NaN	1954	\N	\N
SYNX552	M	\N	\N	\N	08-18595B	NaN	1955	\N	IP711218
SYNX553	M	\N	\N	\N	13-60273	NaN	1956	\N	IP841587
SYNX554	M	\N	\N	\N	12-52454	NaN	1957	\N	IP1032345
SYNX555	F	\N	\N	\N	12-75125	NaN	1958	\N	IP1160942
SYNX556	M	\N	\N	\N	12-98235A	NaN	1959	\N	IP1184052
SYNX557	M	\N	\N	\N	13-3619B	NaN	1960	\N	IP1188362
SYNAT634	\N	\N	\N	\N	13-98534	\N	2795	\N	IP1340550
SYNX646	NaN	\N	\N	\N	SP-13-0185993A	NaN	2049	\N	\N
SYNX647	NaN	\N	\N	\N	SP-13-0185992B	NaN	2050	\N	\N
SYNX559	F	\N	\N	\N	13-19205	NaN	1962	\N	IP1203948
SYNX560	F	\N	\N	\N	13-48330	NaN	1963	\N	IP467959
SYNX561	F	\N	\N	\N	13-11086	NaN	1964	\N	IP1158926
SYNX562	F	\N	\N	\N	13-15966	NaN	1965	\N	IP1200709
SYNX563	M	\N	\N	\N	13-39228	NaN	1966	\N	IP1104118
SYNX564	M	\N	\N	\N	13-45942	NaN	1967	\N	IP1005877
SYNX565	M	\N	\N	\N	13-49600	NaN	1968	\N	IP61201
SYNX566	F	\N	\N	\N	13-59640	NaN	1969	\N	IP1276884
SYNX567	M	\N	\N	\N	13-67817	NaN	1970	\N	IP1199676
SYNX568	NaN	\N	\N	\N	SP-12-5612(1K)	NaN	1971	\N	\N
SYNX569	NaN	\N	\N	\N	SP-13-14992(1A)	NaN	1972	\N	\N
SYNX570	NaN	\N	\N	\N	SP-12-2294-2(2A)	NaN	1973	\N	\N
SYNX571	NaN	\N	\N	\N	SP-13-17075(1B)	NaN	1974	\N	\N
SYNX572	NaN	\N	\N	\N	SP-42-10361(1A)	NaN	1975	\N	\N
SYNX573	NaN	\N	\N	\N	SP-13-1038(1A)	NaN	1976	\N	\N
SYNX574	NaN	\N	\N	\N	S13-13286A6	NTRK3	1977	\N	\N
SYNX575	NaN	\N	\N	\N	S11-20884A-A1	DPN-like Melanoma	1978	\N	\N
SYNX576	NaN	\N	\N	\N	S12-6218A-D3	NaN	1979	\N	\N
SYNX593	M	\N	\N	\N	08-79358	NaN	1996	\N	IP172751
SYNX798	NaN	\N	\N	\N	HAYS02-005731	98	2201	\N	\N
SYNX594	F	\N	\N	\N	09-45509	NaN	1997	\N	IP846272
SYNX595	NaN	\N	\N	\N	DM50	NaN	1998	\N	\N
SYNX596	NaN	\N	\N	\N	DM56	NaN	1999	\N	\N
JJS5	M	\N	Unknown	UCSF	11-94204	PMID: 29990500 case 27_2; RPA-315	744	\N	\N
SYNX598	NaN	\N	\N	\N	London-L10	NaN	2001	\N	\N
SYNX599	NaN	\N	\N	\N	London-L12	NaN	2002	\N	\N
SYNX600	NaN	\N	\N	\N	London-L16	NaN	2003	\N	\N
SYNX601	NaN	\N	\N	\N	London-L16A	NaN	2004	\N	\N
SYNX602	NaN	\N	\N	\N	London-L16B	NaN	2005	\N	\N
SYNX603	NaN	\N	\N	\N	DM15	NaN	2006	\N	\N
SYNX604	NaN	\N	\N	\N	DM19	NaN	2007	\N	\N
SYNX605	NaN	\N	\N	\N	DM46	NaN	2008	\N	\N
SYNX606	NaN	\N	\N	\N	140038340	NaN	2009	\N	\N
SYNX607	NaN	\N	\N	\N	140092090	NaN	2010	\N	\N
SYNX608	NaN	\N	\N	\N	UM13	NaN	2011	\N	\N
SYNX609	NaN	\N	\N	\N	UM14	NaN	2012	\N	\N
SYNX610	NaN	\N	\N	\N	UM16	NaN	2013	\N	\N
SYNX611	NaN	\N	\N	\N	London-L17	NaN	2014	\N	\N
SYNX612	NaN	\N	\N	\N	GAK	NaN	2015	\N	\N
SYNX613	NaN	\N	\N	\N	Yurif	NaN	2016	\N	\N
SYNX614	NaN	\N	\N	\N	London-L18	NaN	2017	\N	\N
SYNX615	NaN	\N	\N	\N	London-L21	NaN	2018	\N	\N
SYNAT635	\N	\N	\N	\N	14-16247	\N	2687	\N	IP1366169
SYNAT636	\N	\N	\N	\N	13-35959	\N	2417	\N	IP1217226
SYNAT637	\N	\N	\N	\N	13-102610	\N	2473	\N	\N
SYNAT638	\N	\N	\N	\N	13-99417	\N	2911	\N	IP2344638
SYNX648	NaN	\N	\N	\N	SP-12-003309B	NaN	2051	\N	\N
SYNX649	NaN	\N	\N	\N	SP-13-0212981A	NaN	2052	\N	\N
SYNX650	NaN	\N	\N	\N	SP-13-0068754A	NaN	2053	\N	\N
SYNX651	NaN	\N	\N	\N	SP-13-0068751C	NaN	2054	\N	\N
SYNX652	NaN	\N	\N	\N	SP-07-0116602	NaN	2055	\N	\N
SYNAT639	\N	\N	\N	\N	13-32982A	\N	2593	\N	IP1210033
SYNX453	M	\N	\N	\N	13-32982A,13-25288, 13-25288	NaN	1856	\N	IP1210033
SYNAT640	\N	\N	\N	\N	13-9916	\N	2528	\N	IP1194427
SYNAT641	\N	\N	\N	\N	11-44609F	\N	2652	\N	IP1029070
SYNAT642	\N	\N	\N	\N	12-98575A1	\N	2888	\N	IP824297
SYNAT643	\N	\N	\N	\N	DM60	\N	2734	\N	\N
SYNAT644	\N	\N	\N	\N	DM61	\N	2303	\N	\N
SYNAT645	\N	\N	\N	\N	DM62	\N	2945	\N	\N
SYNAT646	\N	\N	\N	\N	DM63	\N	2516	\N	\N
SYNAT647	\N	\N	\N	\N	DM66	\N	2375	\N	\N
SYNAT648	\N	\N	\N	\N	DM67	\N	2391	\N	\N
SYNAT649	\N	\N	\N	\N	DM69	\N	2785	\N	\N
SYNAT650	\N	\N	\N	\N	DM70	\N	2660	\N	\N
SYNAT651	\N	\N	\N	\N	DM81	\N	2378	\N	\N
SYNAT652	\N	\N	\N	\N	London-L3	\N	2841	\N	\N
SYNX634	NaN	\N	\N	\N	S12-27617B9	NaN	2037	\N	\N
SYNX635	NaN	\N	\N	\N	S12-25164A	NaN	2038	\N	\N
SYNX636	NaN	\N	\N	\N	S12-25164C1	NaN	2039	\N	\N
SYNX637	NaN	\N	\N	\N	London-L19	NaN	2040	\N	\N
SYNX638	NaN	\N	\N	\N	London-L19E	NaN	2041	\N	\N
SYNX639	NaN	\N	\N	\N	London-L22	NaN	2042	\N	\N
SYNX640	NaN	\N	\N	\N	London-L23	NaN	2043	\N	\N
SYNX641	NaN	\N	\N	\N	London-L23D	NaN	2044	\N	\N
SYNX642	NaN	\N	\N	\N	London-L6	NaN	2045	\N	\N
SYNX643	NaN	\N	\N	\N	XD-2	NaN	2046	\N	\N
SYNX644	NaN	\N	\N	\N	SP-13-006364	NaN	2047	\N	\N
SYNX707	F	\N	\N	\N	14-18	13 Cycle Post Hybridization LM-PCR	2110	\N	IP703498
SYNX708	F	\N	\N	\N	14-19	13 Cycle Post Hybridization LM-PCR	2111	\N	IP1349938
SYNX709	M	\N	\N	\N	14-21	13 Cycle Post Hybridization LM-PCR	2112	\N	IP1349940
SYNAT653	\N	\N	\N	\N	XD-1	\N	2855	\N	\N
SYNAT654	\N	\N	\N	\N	XD-1.1	\N	2778	\N	\N
SYNAT655	\N	\N	\N	\N	PMM-8	\N	2732	\N	\N
SYNX713	NaN	\N	\N	\N	Long-TN10	NaN	2116	\N	\N
SYNX714	NaN	\N	\N	\N	Long-TN11	NaN	2117	\N	\N
SYNAT656	\N	\N	\N	\N	JBP-3	\N	2832	\N	\N
SYNAT657	\N	\N	\N	\N	JBP-3-MM	\N	2670	\N	\N
SYNAT658	\N	\N	\N	\N	JBP-3-Met1	\N	2603	\N	\N
SYNX718	NaN	\N	\N	\N	S12-15765B3	NaN	2121	\N	\N
SYNX719	NaN	\N	\N	\N	S12-4365A8	NaN	2122	\N	\N
SYNX720	NaN	\N	\N	\N	S12-4365A7	NaN	2123	\N	\N
SYNX721	NaN	\N	\N	\N	S12-4365B1	NaN	2124	\N	\N
SYNX722	NaN	\N	\N	\N	S12-4365C1	NaN	2125	\N	\N
SYNX724	NaN	\N	\N	\N	S12-9606EE	NaN	2127	\N	\N
SYNAT310	\N	\N	\N	\N	S12-9606E4, S12-9606E9, S12-9606C4, S12-9606A2	\N	2538	\N	IP1095422
SYNAT310	\N	\N	\N	\N	S12-9606E4, S12-9606E9, S12-9606C4, S12-9606A2	\N	2674	\N	\N
SYNX726	NaN	\N	\N	\N	ZS10-972C2	NaN	2129	\N	\N
SYNX727	NaN	\N	\N	\N	ZS10-972A9	NaN	2130	\N	\N
SYNAT659	\N	\N	\N	\N	JBP-7-Met	\N	2414	\N	\N
SYNX729	NaN	\N	\N	\N	ZS10-1843A5	NaN	2132	\N	\N
SYNX730	NaN	\N	\N	\N	ZS10-8439A4	NaN	2133	\N	\N
SYNX731	NaN	\N	\N	\N	ZS10-1843A4	NaN	2134	\N	\N
SYNAT660	\N	\N	\N	\N	ZS10-10558B1, ZS10-10558A10, ZS10-10558C1	\N	2731	\N	IP644642
SYNAT660	\N	\N	\N	\N	ZS10-10558B1, ZS10-10558A10, ZS10-10558C1	\N	2823	\N	\N
SYNX799	NaN	\N	\N	\N	SRFS97-002805	67	2202	\N	\N
SYNX800	NaN	\N	\N	\N	VALS03-019832	124	2203	\N	\N
SYNAT332	\N	\N	\N	\N	ZS10-3560A4, ZS10-3560A10, ZS10-3560C1\n, ZS10-3560F1, ZS10-3560A3	\N	2744	\N	\N
SYNAT332	\N	\N	\N	\N	ZS10-3560A4, ZS10-3560A10, ZS10-3560C1\n, ZS10-3560F1, ZS10-3560A3	\N	2942	\N	IP773046
SYNX737	NaN	\N	\N	\N	ZS10-3560C1	NaN	2140	\N	\N
SYNAT661	\N	\N	\N	\N	UM23	\N	2694	\N	\N
SYNAT662	\N	\N	\N	\N	UM24	\N	2917	\N	\N
SYNAT663	\N	\N	\N	\N	UM25	\N	2873	\N	\N
SYNX756	NaN	\N	\N	\N	RPA08-0315	NaN	2159	\N	\N
SYNX757	NaN	\N	\N	\N	NZM52	NaN	2160	\N	\N
SYNX758	NaN	\N	\N	\N	NZM40	NaN	2161	\N	\N
SYNX759	NaN	\N	\N	\N	NZM91	NaN	2162	\N	\N
SYNX760	NaN	\N	\N	\N	SP-13-198211A	DH	2163	\N	\N
SYNX761	NaN	\N	\N	\N	RNS11P15316B1	DH	2164	\N	\N
SYNX762	NaN	\N	\N	\N	9246581-A3	JG	2165	\N	\N
SYNX763	NaN	\N	\N	\N	9246581-A6	JG	2166	\N	\N
SYNX764	NaN	\N	\N	\N	DHM4855-14MP	MLH	2167	\N	\N
SYNX765	NaN	\N	\N	\N	SNPN08289D	MLH	2168	\N	\N
SYNX766	NaN	\N	\N	\N	SP-10-143551E	JM	2169	\N	\N
SYNX767	NaN	\N	\N	\N	SP-10-143552A	JM	2170	\N	\N
SYNX768	NaN	\N	\N	\N	04-SW-12-31366B1	AH	2171	\N	\N
SYNX769	NaN	\N	\N	\N	04-SW-12-31366B6	AH	2172	\N	\N
SYNX770	NaN	\N	\N	\N	SP-13-63011A	FN	2173	\N	\N
SYNX771	NaN	\N	\N	\N	SP-11-160493A	FN	2174	\N	\N
SYNX772	NaN	\N	\N	\N	SP-13-87981B	GJ	2175	\N	\N
SYNX773	NaN	\N	\N	\N	SP-11-40641B	GJ	2176	\N	\N
SYNX774	NaN	\N	\N	\N	SP-14-125801B	CG	2177	\N	\N
SYNX775	NaN	\N	\N	\N	SP-14-125802A	CG	2178	\N	\N
SYNX776	NaN	\N	\N	\N	WCRS97-025628	17	2179	\N	\N
SYNX777	NaN	\N	\N	\N	SCHS10-026422	41	2180	\N	\N
SYNX778	NaN	\N	\N	\N	SROS12-001198	90	2181	\N	\N
SYNX779	NaN	\N	\N	\N	SROS09-001574	92	2182	\N	\N
SYNX780	NaN	\N	\N	\N	SCHS09-005840-B5	93	2183	\N	\N
SYNX781	NaN	\N	\N	\N	SACS05-011507	99	2184	\N	\N
SYNX782	NaN	\N	\N	\N	FRSS09-009402-A1	105	2185	\N	\N
SYNX783	NaN	\N	\N	\N	RCHS07-000380-B1	28	2186	\N	\N
SYNX784	NaN	\N	\N	\N	SROS11-005030	30	2187	\N	\N
SYNX785	NaN	\N	\N	\N	VALS09-000266	72	2188	\N	\N
SYNX786	NaN	\N	\N	\N	SFOS09-007093	18	2189	\N	\N
SYNX787	NaN	\N	\N	\N	FRSS09-008805	63	2190	\N	\N
SYNX788	NaN	\N	\N	\N	RCHS06-004567	70	2191	\N	\N
SYNX789	NaN	\N	\N	\N	VALS05-014946-E	54	2192	\N	\N
SYNX790	NaN	\N	\N	\N	SCHS08-007754	2	2193	\N	\N
SYNX791	NaN	\N	\N	\N	SFOS12-018173	5	2194	\N	\N
SYNX792	NaN	\N	\N	\N	SROS00-001103	10	2195	\N	\N
SYNX793	NaN	\N	\N	\N	MTZS94-007340	45	2196	\N	\N
SYNX794	NaN	\N	\N	\N	SFOS94-003116	49	2197	\N	\N
SYNX795	NaN	\N	\N	\N	SACS93-027850	27	2198	\N	\N
SYNX796	NaN	\N	\N	\N	SCLS91-006557	68	2199	\N	\N
SYNX797	NaN	\N	\N	\N	OAKS90-012369	9	2200	\N	\N
SYNX802	NaN	\N	\N	\N	RCHS01-003684	86	2205	\N	\N
SYNX803	NaN	\N	\N	\N	WCRS99-012800	111	2206	\N	\N
SYNX804	NaN	\N	\N	\N	HAYS90-005154	77	2207	\N	\N
SYNX805	NaN	\N	\N	\N	SFOS00-016989	69	2208	\N	\N
SYNX806	NaN	\N	\N	\N	VALS03-007457	117	2209	\N	\N
SYNX807	NaN	\N	\N	\N	SFO93-005184	103	2210	\N	\N
SYNX808	NaN	\N	\N	\N	DHM50691-14MP5C	NaN	2211	\N	\N
SYNX809	NaN	\N	\N	\N	DHM50691-14MP3	NaN	2212	\N	\N
SYNX810	NaN	\N	\N	\N	RNS14P13907B1	NaN	2213	\N	\N
SYNX811	NaN	\N	\N	\N	SP-10-197431A	NaN	2214	\N	\N
SYNX812	NaN	\N	\N	\N	DHM57444-14MP	NaN	2215	\N	\N
SYNX813	NaN	\N	\N	\N	SP-12-177322A	NaN	2216	\N	\N
SYNX814	NaN	\N	\N	\N	DHM94457-13SK	NaN	2217	\N	\N
SYNX815	NaN	\N	\N	\N	DHM48742-12MPE	NaN	2218	\N	\N
SYNX816	NaN	\N	\N	\N	Laverty13-88354	NaN	2219	\N	\N
SYNX817	NaN	\N	\N	\N	ICPMR19684.13A11	NaN	2220	\N	\N
SYNX818	NaN	\N	\N	\N	SP-13-15691B	NaN	2221	\N	\N
SYNX819	NaN	\N	\N	\N	SP-13-15691D	NaN	2222	\N	\N
SYNX820	NaN	\N	\N	\N	57059699	NaN	2223	\N	\N
SYNX821	NaN	\N	\N	\N	57269600	NaN	2224	\N	\N
SYNX822	NaN	\N	\N	\N	57213442	NaN	2225	\N	\N
SYNX823	NaN	\N	\N	\N	57346060	NaN	2226	\N	\N
SYNX824	NaN	\N	\N	\N	SROS10-009251	19	2227	\N	\N
SYNX825	NaN	\N	\N	\N	FRSS99-007026	32	2228	\N	\N
SYNX826	NaN	\N	\N	\N	SCLS04-001045	60	2229	\N	\N
SYNX827	NaN	\N	\N	\N	OAKS96-014392-G	74	2230	\N	\N
SYNX828	NaN	\N	\N	\N	OAKS96-022398	109	2231	\N	\N
SYNX829	NaN	\N	\N	\N	OAK84-008979-B	112	2232	\N	\N
SYNX830	NaN	\N	\N	\N	ROSS09-022626-A1	115	2233	\N	\N
SYNX831	NaN	\N	\N	\N	SCHS11-018842-A1	119	2234	\N	\N
SYNX832	NaN	\N	\N	\N	SSCS03-004945	46	2235	\N	\N
SYNX833	NaN	\N	\N	\N	WCRS02-022688	47	2236	\N	\N
SYNX834	NaN	\N	\N	\N	SACS02-020334	100	2237	\N	\N
SYNX835	NaN	\N	\N	\N	HAYS98-001046	75	2238	\N	\N
SYNX836	NaN	\N	\N	\N	SACS88-019073	64	2239	\N	\N
SYNX837	NaN	\N	\N	\N	SACS87-010145	50	2240	\N	\N
SYNX838	NaN	\N	\N	\N	STRS91-006237	39	2241	\N	\N
SYNX839	NaN	\N	\N	\N	SSCS92-009981	22	2242	\N	\N
SYNAT673	\N	\N	\N	\N	14-59304A	\N	2332	\N	IP1409245
SYNX841	F	\N	\N	\N	13-48020	NaN	2244	\N	IP1289322
SYNX842	F	\N	\N	\N	14-13499	NaN	2245	\N	IP1363420
SYNX845	F	\N	\N	\N	13-61146	NaN	2248	\N	IP1303150
SYNX846	NaN	\N	\N	\N	57001550	NaN	2249	\N	\N
SYNX847	NaN	\N	\N	\N	57291680	NaN	2250	\N	\N
SYNX848	NaN	\N	\N	\N	UM33	NaN	2251	\N	\N
SYNX849	NaN	\N	\N	\N	UM35_A	NaN	2252	\N	\N
SYNX850	NaN	\N	\N	\N	UM39	NaN	2253	\N	\N
SYNX851	NaN	\N	\N	\N	UM40	NaN	2254	\N	\N
SYNX852	NaN	\N	\N	\N	UM41	NaN	2255	\N	\N
SYNX853	NaN	\N	\N	\N	UM36	NaN	2256	\N	\N
SYNX855	NaN	\N	\N	\N	57715138	NaN	2258	\N	\N
SYNX856	NaN	\N	\N	\N	332771	NaN	2259	\N	\N
SYNX857	NaN	\N	\N	\N	57723220	NaN	2260	\N	\N
SYNX858	NaN	\N	\N	\N	55875588	NaN	2261	\N	\N
SYNX859	NaN	\N	\N	\N	57714581	NaN	2262	\N	\N
SYNX860	NaN	\N	\N	\N	UM47	NaN	2263	\N	\N
SYNX861	NaN	\N	\N	\N	Sample_KAM1-T	NaN	2264	\N	\N
SYNX862	NaN	\N	\N	\N	Sample_KAM106-T	NaN	2265	\N	\N
SYNX863	NaN	\N	\N	\N	Sample_KAM12-T	NaN	2266	\N	\N
SYNX864	NaN	\N	\N	\N	Sample_KAM121-T-B	NaN	2267	\N	\N
SYNX865	NaN	\N	\N	\N	Sample_KAM20-T	NaN	2268	\N	\N
SYNX866	NaN	\N	\N	\N	Sample_KAM3-T-A	NaN	2269	\N	\N
SYNX867	NaN	\N	\N	\N	Sample_KAM35-T	NaN	2270	\N	\N
SYNX868	NaN	\N	\N	\N	Sample_KAM38-T-B	NaN	2271	\N	\N
SYNX869	NaN	\N	\N	\N	Sample_KAM53-T	NaN	2272	\N	\N
SYNX870	NaN	\N	\N	\N	Sample_KAM61-T	NaN	2273	\N	\N
SYNX871	NaN	\N	\N	\N	Sample_KAM7-T	NaN	2274	\N	\N
SYNX872	NaN	\N	\N	\N	Sample_KAM78-T-III	NaN	2275	\N	\N
SYNX873	NaN	\N	\N	\N	Sample_KAM82-T-B8	NaN	2276	\N	\N
SYNX874	NaN	\N	\N	\N	Sample_KAM84-T	NaN	2277	\N	\N
SYNX875	NaN	\N	\N	\N	Sample_KAM94-T	NaN	2278	\N	\N
SYNX876	NaN	\N	\N	\N	Sample_KAM96-T	NaN	2279	\N	\N
\.


--
-- Data for Name: sample_lib; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.sample_lib (id, name, date, qubit, shear_volume, qpcr_conc, pcr_cycles, amount_in, amount_final, vol_init, vol_remain, notes, barcode_id, method_id) FROM stdin;
36308	AMLP-57	\N	NaN	13	0.5	NaN	250	\N	\N	\N	NaN	C10	\N
36309	AMLP-56	\N	NaN	44	1.1	NaN	250	\N	\N	\N	NaN	C9	\N
36310	AMLP-59	\N	NaN	5	0.4	NaN	250	\N	\N	\N	NaN	C12	\N
36311	AMLP-60	\N	NaN	52	0.4	NaN	250	\N	\N	\N	NaN	D1	\N
36312	AMLP-62	\N	NaN	302	0.5	NaN	250	\N	\N	\N	NaN	D3	\N
36313	AMLP-63	\N	NaN	3	1.1	NaN	250	\N	\N	\N	NaN	D4	\N
36314	AMLP-32	2018-06-21 00:00:00-07	2.7	14	0.7	NaN	350	\N	\N	\N	NaN	H10	\N
36315	AMLP-26	2018-05-08 00:00:00-07	6.9	7	0.1	NaN	250	\N	\N	\N	NaN	A2	\N
36316	AMLP-23_1	2018-05-08 00:00:00-07	2.9	17	1.3	NaN	250	\N	\N	\N	NaN	H11	\N
36317	AMLP-34	2018-06-21 00:00:00-07	2	7	1.5	NaN	350	\N	\N	\N	NaN	H12	\N
36318	AMLP-24_1	2018-05-08 00:00:00-07	1.9	3	0.6	NaN	250	\N	\N	\N	NaN	H12	\N
36319	AMLP-38	2018-06-21 00:00:00-07	4	8	0.6	NaN	350	\N	\N	\N	NaN	A12	\N
36320	AMLP-40	2018-06-21 00:00:00-07	5.7	5	1.7	NaN	350	\N	\N	\N	NaN	B2	\N
36321	AMLP-43	2018-07-23 00:00:00-07	6.1	0	1.38	NaN	NaN	\N	\N	\N	NaN	B6	\N
36322	AMLP-35	2018-06-21 00:00:00-07	4.3	6	0.2	NaN	350	\N	\N	\N	NaN	A9	\N
36323	AMLP-27	2018-05-08 00:00:00-07	3.2	14	1.1	NaN	250	\N	\N	\N	NaN	A3	\N
36324	AMLP-37	2018-06-21 00:00:00-07	2.5	6	0.6	NaN	350	\N	\N	\N	NaN	A11	\N
36325	AMLP-31	2018-06-21 00:00:00-07	1.8	215	0.8	NaN	338	\N	\N	\N	NaN	H9	\N
36326	AMLP-20_1	2018-05-08 00:00:00-07	5.5	5	1.2	NaN	250	\N	\N	\N	NaN	H8	\N
36327	AMLP-42	2018-07-23 00:00:00-07	1.2	0	0.1	NaN	NaN	\N	\N	\N	NaN	B5	\N
36328	AMLP-25	2018-05-08 00:00:00-07	2.9	2	1.1	NaN	250	\N	\N	\N	NaN	A1	\N
36329	AMLP-36	2018-06-21 00:00:00-07	7.7	12	0.4	NaN	350	\N	\N	\N	NaN	A10	\N
36330	AMLP-33	2018-06-21 00:00:00-07	3.1	9	0.9	NaN	350	\N	\N	\N	NaN	H11	\N
36331	AMLP-39	2018-06-21 00:00:00-07	3.3	6	1.1	NaN	350	\N	\N	\N	NaN	B1	\N
36332	AMLP-28	2018-05-07 00:00:00-07	1	6	0.4	NaN	250	\N	\N	\N	NaN	A4	\N
36333	RNA-23	2018-08-20 00:00:00-07	0.6	NaN	0.4	11	NaN	\N	\N	\N	RLP-23	E10	\N
36334	RNA-10	2018-08-20 00:00:00-07	1.9	NaN	1.2	11	NaN	\N	\N	\N	RLP-10	E11	\N
36335	RNA-19	2018-08-20 00:00:00-07	1.6	NaN	1.1	11	NaN	\N	\N	\N	RLP-19, Sample removed from study	D10	\N
36336	RNA-20	2018-08-20 00:00:00-07	2.8	NaN	1.4	11	NaN	\N	\N	\N	RLP-20, Sample removed from study	D12	\N
36337	AMLP-65	2018-11-27 00:00:00-08	5.33	48	1.95	4	286.6	\N	\N	\N	NaN	39	\N
36338	AMLP-100	2018-11-30 00:00:00-08	8.03	13	6.99	4	300	\N	\N	\N	NaN	26	\N
36339	AMLP-118	2018-12-07 00:00:00-08	NaN	48	0.11	4	67.7	\N	\N	\N	NaN	96	\N
36340	AMLP-120	2018-12-07 00:00:00-08	NaN	48	0.43	4	68.6	\N	\N	\N	NaN	2	\N
36341	AMLP-71	2018-11-27 00:00:00-08	3.88	48	0.99	4	243.4	\N	\N	\N	NaN	45	\N
36342	AMLP-119	2018-12-07 00:00:00-08	NaN	48	0.31	4	32.7	\N	\N	\N	NaN	1	\N
36343	AMLP-74	2018-11-27 00:00:00-08	5.06	44	1.49	4	300	\N	\N	\N	NaN	48	\N
36344	AMLP-115	2018-12-07 00:00:00-08	6.67	48	0.63	4	224.2	\N	\N	\N	NaN	93	\N
36345	AMLP-122	2018-12-07 00:00:00-08	NaN	48	0.46	4	77.3	\N	\N	\N	NaN	4	\N
36346	AMLP-124	2018-12-07 00:00:00-08	NaN	21	0.63	4	300	\N	\N	\N	NaN	6	\N
36347	AMLP-106	2018-11-30 00:00:00-08	23.7	6	9.76	4	300	\N	\N	\N	NaN	32	\N
36348	AMLP-67	2018-11-27 00:00:00-08	4.47	39	1.52	4	300	\N	\N	\N	NaN	41	\N
36349	AMLP-86	2018-11-27 00:00:00-08	1.48	48	0.91	4	67.7	\N	\N	\N	NaN	60	\N
36350	AMLP-72	2018-11-27 00:00:00-08	4.06	26	0.91	4	300	\N	\N	\N	NaN	46	\N
36351	AMLP-94	2018-11-30 00:00:00-08	2.59	48	1.81	4	107.5	\N	\N	\N	NaN	20	\N
36352	AMLP-101	2018-11-30 00:00:00-08	26.4	6	4.03	4	300	\N	\N	\N	NaN	27	\N
36353	AMLP-98	2018-11-30 00:00:00-08	18.5	39	8.4	4	300	\N	\N	\N	NaN	24	\N
36354	AMLP-70	2018-11-27 00:00:00-08	5.98	23	2.71	4	300	\N	\N	\N	NaN	44	\N
36355	AMLP-73	2018-11-27 00:00:00-08	2.17	48	0.49	4	137.3	\N	\N	\N	NaN	47	\N
36356	AMLP-116	2018-12-07 00:00:00-08	NaN	23	0.52	4	300	\N	\N	\N	NaN	94	\N
36357	AMLP-79	2018-11-27 00:00:00-08	2.79	48	1.08	4	73.9	\N	\N	\N	NaN	53	\N
36358	NMLP-005	2018-12-07 00:00:00-08	3.64	8	0.03	4	250	\N	\N	\N	NaN	4	\N
36359	NMLP-047	\N	NaN	16	0.03	4	250	\N	\N	\N	not enough LP\n	67	\N
36360	NMLP-044	\N	NaN	35	0.01	4	250	\N	\N	\N	Sample had high melanin	64	\N
36361	NMLP-006	2018-12-07 00:00:00-08	3.66	9	0.04	4	250	\N	\N	\N	NaN	5	\N
36362	NMLP-043	\N	NaN	48	0	4	128.2	\N	\N	\N	Sample had high melanin	63	\N
36363	SGLP-0361	2018-12-20 00:00:00-08	0	48	0	4	17.6	\N	\N	\N	NaN	78	\N
36364	SGLP-0419	2019-05-07 00:00:00-07	0.4	181	0.09	NaN	25.4	\N	\N	\N	Not enough LP	24	\N
36365	SGLP-0435	2019-05-07 00:00:00-07	0.43	48	0.05	NaN	30.4	\N	\N	\N	Not enough LP	39	\N
36366	RLP-58	2018-11-05 00:00:00-08	1.95	NaN	3.99	11	NaN	\N	\N	\N	RLP-58, Sample removed from study	82	\N
36367	RLP-57	2018-11-05 00:00:00-08	1.24	NaN	2.72	11	NaN	\N	\N	\N	RLP-57, Sample removed from study	81	\N
36368	SGLP-0472	2019-06-04 00:00:00-07	0.32	49	0.04	4	23	\N	\N	\N	Not enough LP	65	\N
36369	SGLP-0476	2019-06-04 00:00:00-07	9.94	26	0	4	250	\N	\N	\N	Not enough LP; High Melanin	69	\N
36370	SGLP-0483	2019-06-06 00:00:00-07	3.35	17	0.01	4	250	\N	\N	\N	Not enough LP; High Melanin	76	\N
36371	SGLP-0494	2019-06-06 00:00:00-07	1	43	0	4	250	\N	\N	\N	Not enough LP	87	\N
36372	SGLP-0551	2019-07-24 00:00:00-07	2.37	74	0	4	250	\N	\N	\N	Madrid Melanoma	68	\N
36373	AMLP-144	2019-12-03 00:00:00-08	1.74	0	0.59	4	NaN	\N	\N	\N	120s shear time; DNA repaired, combined with AM2 D-176 (area 1145 Mel1)	78	\N
36374	AMLP-154	2020-01-31 00:00:00-08	13.1	5	2.3	3	250	\N	\N	\N	120s shear time; DNA repaired	14	\N
36375	AMLP-155	2020-01-31 00:00:00-08	11.6	25	2.36	3	999	\N	\N	\N	120s shear time; DNA repaired	15	\N
36376	AMLP-158	2020-01-31 00:00:00-08	10.8	0	5.92	3	NaN	\N	\N	\N	120s shear time; DNA repaired	22	\N
36377	AMLP-157	2020-01-31 00:00:00-08	22.5	23	2.09	3	999	\N	\N	\N	120s shear time; DNA repaired	21	\N
36378	AMLP-159	2020-01-31 00:00:00-08	12.4	0	1.24	3	NaN	\N	\N	\N	120s shear time; DNA repaired	23	\N
36379	AMLP-187	2020-02-07 00:00:00-08	0.84	157	0.18	4	71	\N	\N	\N	NaN	109	\N
36380	AMLP-190	2020-02-07 00:00:00-08	0.47	48	0.11	4	32.7	\N	\N	\N	NaN	112	\N
36381	AMLP-188	2020-02-07 00:00:00-08	0.98	48	0.17	4	67.7	\N	\N	\N	NaN	110	\N
36382	AMLP-189	2020-02-07 00:00:00-08	4.27	72	1.23	4	666	\N	\N	\N	NaN	111	\N
36383	AMLP-20_2	2018-07-23 00:00:00-07	3.7	5	0.4	NaN	250	\N	\N	\N	NaN	A5	\N
36384	AMLP-23_2	2018-07-23 00:00:00-07	1.5	17	0.42	NaN	250	\N	\N	\N	NaN	A7	\N
36385	AMLP-24_2	2018-07-23 00:00:00-07	1.4	3	0.25	NaN	250	\N	\N	\N	NaN	A8	\N
36386	AMLP-213	2020-08-06 00:00:00-07	1.45	5	1.41	4	350	\N	\N	\N	NaN	148	\N
36387	AMLP-212	2020-08-06 00:00:00-07	1.89	NaN	0.79	4	NaN	\N	\N	\N	NaN	147	\N
36388	AMLP-228	2020-08-06 00:00:00-07	1.65	NaN	0.7	4	NaN	\N	\N	\N	NaN	163	\N
36389	AMLP-229	2020-08-06 00:00:00-07	4.03	29	1.7	4	333	\N	\N	\N	NaN	164	\N
36390	AMLP-230	2020-08-06 00:00:00-07	2.28	70	0.2	4	333	\N	\N	\N	NaN	165	\N
36391	AMLP-232	2020-08-06 00:00:00-07	4.46	72	2.8	4	666	\N	\N	\N	NaN	167	\N
36392	DLP-100	2020-08-02 00:00:00-07	0.28	NaN	0.19	4	NaN	\N	\N	\N	NaN	133	\N
36393	EXLP-02	2020-08-05 00:00:00-07	1.63	100	1.14	4	32	\N	\N	\N	NaN	122	\N
36394	EXLP-03	2020-08-05 00:00:00-07	0.65	99	0.35	4	16	\N	\N	\N	NaN	123	\N
36395	EXLP-06	2020-08-05 00:00:00-07	0.16	99	0.06	4	7	\N	\N	\N	NaN	126	\N
36396	EXLP-08	2020-08-05 00:00:00-07	0.55	105	0.43	4	10	\N	\N	\N	NaN	128	\N
36397	EXLP-07	2020-08-05 00:00:00-07	0.2	99	0.07	4	9	\N	\N	\N	NaN	127	\N
36398	DLP-112	2020-09-03 00:00:00-07	0.69	91	0.33	4	30	\N	\N	\N	Sample removed from study	190	\N
36399	DLP-113	2020-09-03 00:00:00-07	3.16	90	1.52	4	136	\N	\N	\N	Sample removed from study	191	\N
36400	RLP-83	2020-09-05 00:00:00-07	8.82	NaN	15.93	11	NaN	\N	\N	\N	Sample removed from study	174	\N
36401	RLP-84	2020-09-05 00:00:00-07	16.2	NaN	26.83	11	NaN	\N	\N	\N	Sample removed from study	175	\N
36402	AMLP-233	2020-12-05 00:00:00-08	3.19	96	1.23	4	490	\N	\N	\N	NaN	168	\N
36403	AMLP-234	2021-03-17 00:00:00-07	3.68	NaN	0.24	4	NaN	\N	\N	\N	NaN	97	\N
36404	AMLP-235	2021-03-17 00:00:00-07	5.36	96	0.25	4	390.7	\N	\N	\N	NaN	98	\N
36405	AMLP-236	2021-03-17 00:00:00-07	4.07	96	0.41	4	244.8	\N	\N	\N	NaN	99	\N
36406	AMLP-242	2021-03-17 00:00:00-07	5.68	79	0.4	4	333	\N	\N	\N	NaN	106	\N
36407	AMLP-243	2021-03-17 00:00:00-07	3.74	96	0.18	4	145	\N	\N	\N	NaN	107	\N
36408	AMLP-246	2021-03-17 00:00:00-07	5.02	35	0.2	4	333	\N	\N	\N	NaN	110	\N
36409	AMLP-251	2021-03-17 00:00:00-07	6.37	10	0.43	4	333	\N	\N	\N	NaN	117	\N
36410	AMLP-253	2021-03-17 00:00:00-07	5	96	0.22	4	253.4	\N	\N	\N	NaN	119	\N
36411	AMLP-258	2021-03-17 00:00:00-07	3.35	96	0.74	4	134.4	\N	\N	\N	NaN	124	\N
36412	AMLP-260	2021-03-17 00:00:00-07	3.17	95	0.49	4	149	\N	\N	\N	NaN	126	\N
36413	AMLP-294	2021-03-17 00:00:00-07	3.09	95	0.26	4	115	\N	\N	\N	DISCARD. DO NOT USE THIS LIBRARY. THE SAMPLE WAS POOLED WITH MEL1.	178	\N
36414	CCRLP-0042	2021-08-04 00:00:00-07	1.59	14	0.96	4	250	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	185	\N
36415	CCRLP-0040	2021-08-04 00:00:00-07	1.06	10	0.55	4	250	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	187	\N
36416	CCRLP-0032	2021-08-04 00:00:00-07	2.03	17	1.12	4	250	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	186	\N
36417	OMLP-001	2021-08-04 00:00:00-07	4.53	23	2.27	4	250	\N	\N	\N	DO NOT USE SEQUENCED DATA! Adapter Ligation: O/N (15 hrs) at 20oC	188	\N
36418	DLP-054_RE	2019-05-23 00:00:00-07	2.66	0	0.98	4	NaN	\N	\N	\N	NaN	76	\N
36419	DLP-053_RE	2019-05-23 00:00:00-07	3.95	0	1.19	4	NaN	\N	\N	\N	NaN	75	\N
36420	DLP-01_RE	2019-05-23 00:00:00-07	5.79	0	1.26	4	NaN	\N	\N	\N	NaN	1	\N
36421	AMLP-309	2021-05-13 00:00:00-07	3.53	35	0.9	4	333	\N	\N	\N	NaN	147	\N
36422	AMLP-328	2021-05-27 00:00:00-07	5.06	95	3.42	4	307	\N	\N	\N	NaN	158	\N
36423	AMLP-329	2021-05-27 00:00:00-07	5.41	95	4.61	4	264	\N	\N	\N	NaN	167	\N
36424	AMLP-333	2021-08-04 00:00:00-07	1.01	96	0.37	4	20	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	179	\N
36425	AMLP-335	2021-08-04 00:00:00-07	0.92	96	0.53	4	22	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	181	\N
36426	AMLP-334	2021-08-04 00:00:00-07	1	96	0.26	4	42	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	180	\N
36427	AMLP-337	2021-08-04 00:00:00-07	0.84	9	0.28	4	42	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	183	\N
36428	AMLP-336	2021-08-04 00:00:00-07	0.67	18	0.24	4	20	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	182	\N
36429	AMLP-338	2021-08-04 00:00:00-07	1.22	10	0.58	4	22	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	184	\N
36430	CCRLP-0055 (DO NOT USE)	2021-07-06 00:00:00-07	0	8	0	4	250	\N	\N	\N	Jessica practice LP	103	\N
36431	CCRLP-0056 (DO NOT USE)	2021-07-06 00:00:00-07	0	6	0	4	250	\N	\N	\N	Jessica practice LP	104	\N
36432	CCRLP-0057 (DO NOT USE)	2021-07-06 00:00:00-07	0	10	0	4	250	\N	\N	\N	Jessica practice LP	105	\N
36433	CCRLP-0058 (DO NOT USE)	2021-07-06 00:00:00-07	0	14	0	4	250	\N	\N	\N	Jessica practice LP	106	\N
36434	AMLP-351	2021-09-15 00:00:00-07	5.91	51	6.11	4	1200	\N	\N	\N	HyperPREP; Ligation: 60 min at 20 oC	98	\N
36435	AMLP-356	2021-09-15 00:00:00-07	11.9	78	12.03	4	1200	\N	\N	\N	HyperPLUS, Ligation: 15 min at 20 oC	116	\N
36436	AMLP-358	2021-09-15 00:00:00-07	1.29	148	0.4	4	1200	\N	\N	\N	HyperPLUS, Ligation: 15 min at 20 oC	118	\N
36437	AMLP-357	2021-09-15 00:00:00-07	9.93	51	10.03	4	1200	\N	\N	\N	HyperPLUS, Ligation: 15 min at 20 oC	117	\N
36438	AMLP-359	2021-09-15 00:00:00-07	12.5	78	12.03	4	1200	\N	\N	\N	HyperPLUS, Ligation: 60 min at 20 oC	116	\N
36439	AMLP-361	2021-09-15 00:00:00-07	1.54	148	0.56	4	1200	\N	\N	\N	HyperPLUS, Ligation: 60 min at 20 oC	118	\N
36440	AMLP-360	2021-09-15 00:00:00-07	10.3	51	10.97	4	1200	\N	\N	\N	HyperPLUS, Ligation: 60 min at 20 oC	117	\N
36441	AMLP-365	2021-09-18 00:00:00-07	0.75	88	0.36	4	38.7	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	102	\N
36442	AMLP-368	2021-09-18 00:00:00-07	3.22	37	1.31	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	105	\N
36443	AMLP-371	2021-09-18 00:00:00-07	1.44	96	0.54	4	390.7	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	108	\N
36444	AMLP-370	2021-09-18 00:00:00-07	1.94	27	0.34	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	107	\N
36445	AMLP-370-1	2021-09-27 00:00:00-07	5.16	27	2.66	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	107	\N
36446	AMLP-370-2	2021-09-27 00:00:00-07	5.74	27	2.66	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	107	\N
36447	AMLP-374	2021-09-27 00:00:00-07	4.93	15	2.32	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	108	\N
36448	AMLP-375	2021-09-27 00:00:00-07	4.97	37	2.74	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	105	\N
36449	AMLP-380	2022-01-26 00:00:00-08	0	31	0	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	129	\N
36450	AMLP-382	2022-01-26 00:00:00-08	7.99	10	6.74	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	131	\N
36451	AMLP-385	2022-01-26 00:00:00-08	0	95	0	4	307	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	134	\N
36452	AMLP-393	2022-01-26 00:00:00-08	1.45	88	0.93	4	115	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	144	\N
36453	AMLP-394	2022-01-26 00:00:00-08	2.85	88	1.2	4	188	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	145	\N
36454	AMLP-425	2023-01-10 00:00:00-08	0.65	NaN	0.98	8	NaN	\N	\N	\N	65oC X 1 min; 1.5 uM adapter; 8 cycles	100	\N
36455	AMLP-426	2023-01-10 00:00:00-08	1.05	NaN	1.5	8	NaN	\N	\N	\N	65oC X 1 min; 1.5 uM adapter; 8 cycles	101	\N
36456	AMLP-428	2023-01-10 00:00:00-08	0.58	NaN	0.71	8	NaN	\N	\N	\N	85oC X 3 min; 1.5 uM adapter; 8 cycles	103	\N
36457	AMLP-427	2023-01-10 00:00:00-08	0.16	NaN	0.13	8	NaN	\N	\N	\N	65oC X 1 min; 1.5 uM adapter; 8 cycles	102	\N
36458	AMLP-429	2023-01-10 00:00:00-08	0.62	NaN	0.92	8	NaN	\N	\N	\N	85oC X 3 min; 1.5 uM adapter; 8 cycles	106	\N
36459	AMLP-431	2023-01-10 00:00:00-08	0.62	NaN	0.94	8	NaN	\N	\N	\N	85oC x 6 min; 1.5 uM adapter; 8 cycles	113	\N
36460	AMLP-430	2023-01-10 00:00:00-08	0.16	NaN	0.14	8	NaN	\N	\N	\N	85oC X 3 min; 1.5 uM adapter; 8 cycles	112	\N
36461	AMLP-432	2023-01-10 00:00:00-08	0.59	NaN	0.89	8	NaN	\N	\N	\N	85oC x 6 min; 1.5 uM adapter; 8 cycles	114	\N
36462	AMLP-433	2023-01-10 00:00:00-08	0.17	NaN	0.22	8	NaN	\N	\N	\N	85oC x 6 min; 1.5 uM adapter; 8 cycles	115	\N
36463	AMLP-436	2023-01-13 00:00:00-08	0.28	NaN	0.36	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	121	\N
36464	AMLP-441	2023-01-20 00:00:00-08	1.63	NaN	2.43	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	126	\N
36465	AMLP-448	2023-01-20 00:00:00-08	0.41	NaN	0.57	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	133	\N
36466	AMLP-442	2023-01-20 00:00:00-08	0.33	NaN	0.41	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	127	\N
36467	AMLP-449	2023-01-20 00:00:00-08	0.29	NaN	0.29	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	134	\N
36468	AMLP-452	2023-01-20 00:00:00-08	1.32	NaN	1.96	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	137	\N
36469	AMLP-446	2023-01-20 00:00:00-08	0.17	NaN	0.18	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	131	\N
36470	AMLP-459	2023-01-20 00:00:00-08	0.91	NaN	1.27	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146	\N
36471	AMLP-447	2023-01-20 00:00:00-08	0.32	NaN	0.43	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	132	\N
36472	AMLP-467	2023-01-24 00:00:00-08	0.06	NaN	0.14	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	156	\N
36473	AMLP-485	2023-01-26 00:00:00-08	0.14	NaN	0.13	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	184	\N
36474	AMLP-489	2023-01-26 00:00:00-08	0.19	NaN	0.23	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	188	\N
36475	AMLP-490	2023-01-26 00:00:00-08	0.14	NaN	0.14	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	189	\N
36476	AMLP-494	2023-01-26 00:00:00-08	0.9	NaN	1.67	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	87	\N
36477	AMLP-496	2023-01-26 00:00:00-08	0.84	NaN	1.6	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	89	\N
36478	AMLP-495	2023-01-26 00:00:00-08	0.9	NaN	1.72	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	88	\N
36479	EXLP-12	2023-01-26 00:00:00-08	0.86	NaN	1.64	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	90	\N
36480	EXLP-14	2023-01-26 00:00:00-08	0.07	NaN	0.04	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	92	\N
36481	EXLP-13	2023-01-26 00:00:00-08	1.16	NaN	2.18	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	91	\N
36482	EXLP-15	2023-01-26 00:00:00-08	0.11	NaN	0.06	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	95	\N
36483	EXLP-17	2023-01-26 00:00:00-08	0.11	NaN	0.06	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	97	\N
36484	EXLP-16	2023-01-26 00:00:00-08	0.09	NaN	0.05	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	96	\N
36485	EXLP-18	2023-01-26 00:00:00-08	3.14	NaN	5.22	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	98	\N
36486	EXLP-19	2023-01-26 00:00:00-08	4.76	NaN	7.43	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	99	\N
36487	AMLP-497	2023-03-02 00:00:00-08	0.55	NaN	0.66	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	167	\N
36488	AMLP-504	2023-03-02 00:00:00-08	0.25	NaN	0.18	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	174	\N
36489	AMLP-508	2023-03-02 00:00:00-08	0.19	NaN	0.12	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	178	\N
36490	AMLP-510	2023-03-02 00:00:00-08	0.55	NaN	0.46	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	180	\N
39698	BS4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
36491	AMLP-522	2023-03-02 00:00:00-08	0.43	NaN	0.4	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	96	\N
36492	AMLP-523	2023-03-02 00:00:00-08	0.53	NaN	0.53	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	159	\N
36493	AMLP-519	2023-03-02 00:00:00-08	0.67	NaN	0.62	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	192	\N
36494	AMLP-516	2023-03-02 00:00:00-08	0.18	NaN	0.11	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	186	\N
36495	AMLP-500	2023-03-02 00:00:00-08	0.22	NaN	0.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	170	\N
36496	AMLP-509	2023-03-02 00:00:00-08	0.23	NaN	0.18	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	179	\N
36497	AMLP-513	2023-03-02 00:00:00-08	0.11	NaN	0.06	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	183	\N
36498	AMLP-506	2023-03-02 00:00:00-08	0.5	NaN	0.42	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	176	\N
36499	AMLP-507	2023-03-02 00:00:00-08	0.39	NaN	0.3	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	177	\N
36500	AMLP-515	2023-03-02 00:00:00-08	0.25	NaN	0.19	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	185	\N
36501	AMLP-518	2023-03-02 00:00:00-08	1.83	NaN	1.87	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	191	\N
36502	AMLP-505	2023-03-02 00:00:00-08	0.44	NaN	0.36	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	175	\N
36503	AMLP-502	2023-03-02 00:00:00-08	0.13	NaN	0.09	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	172	\N
36504	AMLP-498	2023-03-02 00:00:00-08	0.56	NaN	0.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	168	\N
36505	AMLP-503	2023-03-02 00:00:00-08	0.16	NaN	0.1	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	173	\N
36506	AMLP-517	2023-03-02 00:00:00-08	1.45	NaN	1.26	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	190	\N
36507	AMLP-524	2023-03-02 00:00:00-08	0.44	NaN	0.4	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	100	\N
36508	AMLP-514	2023-03-02 00:00:00-08	0.84	NaN	0.74	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	184	\N
36509	AMLP-511	2023-03-02 00:00:00-08	0.76	NaN	0.68	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	181	\N
36510	AMLP-525	2023-03-02 00:00:00-08	0.93	NaN	0.98	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	101	\N
36511	AMLP-520	2023-03-02 00:00:00-08	0.74	NaN	0.84	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	92	\N
36512	AMLP-512	2023-03-02 00:00:00-08	0.09	NaN	0.04	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	182	\N
36513	AMLP-501	2023-03-02 00:00:00-08	0.62	NaN	0.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	171	\N
36514	AMLP-499	2023-03-02 00:00:00-08	0.25	NaN	0.19	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	169	\N
36515	RLP-127	2023-03-03 00:00:00-08	0	NaN	0.01	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	123	\N
36516	RLP-149	2023-03-10 00:00:00-08	3.55	NaN	0.64	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146	\N
36517	RLP-150	2023-03-10 00:00:00-08	3.02	NaN	0.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	147	\N
36518	RLP-167	2023-03-10 00:00:00-08	0.99	NaN	0.95	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-29; Sequenced with RLP-229, BCB059	164	\N
36519	AMLP-526	2023-03-31 00:00:00-07	8.63	0	4.28	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	109	\N
36520	AMLP-536	2023-03-31 00:00:00-07	7.92	0	4.84	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	133	\N
36521	AMLP-538	2023-04-05 00:00:00-07	0.64	NaN	0.82	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	117	\N
36522	AMLP-547	2023-04-05 00:00:00-07	0.39	NaN	0.51	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	145	\N
36523	AMLP-543	2023-04-05 00:00:00-07	1.1	NaN	1.77	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	141	\N
36524	AMLP-550	2023-04-05 00:00:00-07	0.22	NaN	0.22	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	148	\N
36525	AMLP-539	2023-04-05 00:00:00-07	0.25	NaN	0.22	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	134	\N
36526	AMLP-548	2023-04-05 00:00:00-07	0.81	NaN	1.32	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146	\N
36527	AMLP-551	2023-04-05 00:00:00-07	1.04	NaN	1.46	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	149	\N
36528	AMLP-545	2023-04-05 00:00:00-07	0.56	NaN	0.77	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	143	\N
36529	AMLP-546	2023-04-05 00:00:00-07	0.93	NaN	1.29	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	144	\N
36530	AMLP-568	2023-04-21 00:00:00-07	0.5	NaN	0.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	145	\N
36531	AMLP-555	2023-04-21 00:00:00-07	0.47	NaN	0.49	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	124	\N
36532	AMLP-565	2023-04-21 00:00:00-07	0.44	NaN	0.53	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	127	\N
36533	AMLP-570	2023-04-21 00:00:00-07	0.51	NaN	0.61	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	145	\N
36534	AMLP-564	2023-04-21 00:00:00-07	0.44	NaN	0.52	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	127	\N
36535	AMLP-572	2023-04-21 00:00:00-07	0.92	NaN	0.96	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146	\N
36536	AMLP-557	2023-04-21 00:00:00-07	0.83	NaN	0.88	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	130	\N
36537	AMLP-569	2023-04-21 00:00:00-07	0.51	NaN	0.6	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	145	\N
36538	AMLP-561	2023-04-21 00:00:00-07	0.74	NaN	0.97	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	187	\N
36539	AMLP-571	2023-04-21 00:00:00-07	1.1	NaN	1.06	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146	\N
36540	AMLP-582	2023-04-28 00:00:00-07	1.65	NaN	2.33	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146	\N
36541	AMLP-581	2023-04-28 00:00:00-07	0.34	NaN	0.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146	\N
36542	AGLP-04	2018-04-26 00:00:00-07	1	5	0	NaN	250	\N	\N	\N	SureSelect Library Prep	NaN	\N
36543	AGLP-03	2018-04-26 00:00:00-07	96.6	5	257.7	NaN	250	\N	\N	\N	SureSelect Library Prep	NaN	\N
36544	EXLP-28	2023-05-25 00:00:00-07	7.78	43	3.26	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	159	\N
36545	EXLP-29	2023-05-25 00:00:00-07	3.88	76	0.55	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	160	\N
36546	EXLP-37	2023-05-29 00:00:00-07	0.65	NaN	0.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	168	\N
36547	DPN_Conv_35	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei DPN	L2DR05	\N
36548	HW_Acral_#8_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Hong Wu, FCCC, Dissect, Acral Melanoma, Dissect	L2DR07	\N
36549	CGH11-224	\N	NaN	Infinity	NaN	NaN	25.6	\N	\N	\N	Iwei CGH, 7Q Gain	L2DR11	\N
36550	KIT_230	\N	NaN	Infinity	NaN	NaN	10.3	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR15	\N
36552	DM45_2_Tumor	\N	NaN	Infinity	NaN	NaN	31.6	\N	\N	\N	NaN	L2DR07	\N
36553	KIT_191	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Acral melanoma, heel, WT	L2DR03	\N
36554	DM_42_Normal	\N	NaN	Infinity	NaN	NaN	35.2	\N	\N	\N	NaN	L2DR06	\N
36555	AM_14_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Acral Melanoma	L2DR07	\N
36556	DM77_2_Tumor	\N	NaN	Infinity	NaN	NaN	57.2	\N	\N	\N	NaN	L2DR11	\N
36557	DM_101_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR08	\N
36558	DPN_MM 21	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei DPN (DPN like Melanoma)	L2DR10	\N
36559	Seider_Roe	\N	NaN	Infinity	NaN	NaN	35.4	\N	\N	\N	Seider Uveal Melanoma	L2DR08	\N
36560	Ivanka_10_2	\N	13.4	Infinity	NaN	NaN	49	\N	\N	\N	Ivanka Patient Melanoma	L2DR02	\N
36561	Ivanka_5_2	\N	8.85	Infinity	NaN	NaN	65.1	\N	\N	\N	Ivanka Patient Melanoma	L2DR13	\N
36562	DM_98_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR12	\N
36563	DM16_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR10	\N
36564	DM-63-Tumor	\N	NaN	Infinity	NaN	NaN	86.8	\N	\N	\N	NaN	NextFlex 21	\N
36566	DM_102_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR02	\N
36567	DM-66-Tumor	\N	NaN	Infinity	NaN	NaN	40	\N	\N	\N	NaN	NextFlex 22	\N
36568	BN_N1	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hunter Blue Nevus (Melanoma in Nevus Project)	L2DR13	\N
36569	CGH12_040	\N	NaN	0	NaN	NaN	100	\N	\N	\N	Iwei CGH, 7Q Gain 	L2DR04	\N
36570	MIN_4	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR15	\N
36571	HW_8_Mucosal_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hong Wu	L2DR11	\N
36572	AM_11_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Acral Melanoma	L2DR05	\N
36573	Kit_181_Muc BRAF	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Alyssa Acral Mucosal, Mucosal, BRAF, glans penis	L2DR08	\N
36574	BN_M2	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hunter Blue Nevus (Melanoma in Nevus Project)	L2DR16	\N
36575	KIT_260	\N	NaN	Infinity	NaN	NaN	89.4	\N	\N	\N	Mucosal melanoma, perirectal, 	L2DR10	\N
36576	DM_31_2_Tumor	\N	NaN	Infinity	NaN	NaN	16.2	\N	\N	\N	NaN	L2DR08	\N
36577	L2-Normal	\N	NaN	Infinity	NaN	NaN	85.2	\N	\N	\N	Hunter Dysplastic Nevus	NextFlex 3	\N
36578	CGH12_056	\N	NaN	0	NaN	NaN	78.3	\N	\N	\N	Iwei CGH, 7Q Gain 	L2DR06	\N
36579	CGH12_058	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei CGH, Translocation FLT4	L2DR14	\N
36580	DM_65_2_Tumor	\N	NaN	Infinity	NaN	NaN	60.1	\N	\N	\N	NaN	L2DR01	\N
36581	KIT_210	\N	NaN	Infinity	NaN	NaN	65.2	\N	\N	\N	Mucosal melanoma, rectal, WT	L2DR06	\N
36582	DPN_MM 22	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei DPN (DPN like Melanoma)	L2DR11	\N
36583	KIT_273	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosal melanoma, duodenal, NRAS	L2DR11	\N
36585	KIT_302	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR01	\N
36586	G5 DP08-4205A Tumor	\N	NaN	Infinity	NaN	NaN	78.5	\N	\N	\N	Tumor	L2DR05	\N
36587	DM_94_Normal	\N	NaN	Infinity	NaN	NaN	10.1	\N	\N	\N	NaN	L2DR11	\N
36588	CGH12-124	\N	NaN	Infinity	NaN	NaN	71.6	\N	\N	\N	Iwei CGH, 7Q Gain	L2DR13	\N
36589	RPA_09_0209	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hunter, Desmoplastic Melanoma Amplicon Sequence	L2DR16	\N
36590	G3 DP08-21965C Tumor	\N	NaN	Infinity	NaN	NaN	14	\N	\N	\N	Tumor	L2DR03	\N
36591	MS_1_Tumor	\N	NaN	Infinity	NaN	NaN	27.1	\N	\N	\N	Dr. Perry, Melanocytic Shwannoma	L2DR08	\N
36592	bMV_10_0206	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hunter, Desmoplastic Melanoma Amplicon Sequence	L2DR15	\N
36593	L3-Normal	\N	NaN	Infinity	NaN	NaN	40	\N	\N	\N	Hunter Dysplastic Nevus	NextFlex 5	\N
36594	DM_93_3_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR02	\N
36595	AM_13_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Acral Melanoma	L2DR06	\N
36596	Luping_ROS 1	\N	NaN	Infinity	NaN	NaN	55	\N	\N	\N	Bivona Lab, ROS 1	L2DR07	\N
36597	HW_2_Tumor Dissect	\N	NaN	Infinity	NaN	NaN	11	\N	\N	\N	Hong Wu, Melanoma, Mucosal Melanoma, vulva	L2DR06	\N
36598	DM_51_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR04	\N
36599	CGH12_039	\N	NaN	1	NaN	NaN	82.9	\N	\N	\N	Iwei CGH, 7Q Gain 	L2DR03	\N
36600	CGH12_224	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei CGH, Translocation 	L2DR15	\N
36601	Ivanka_10_3	\N	14.7	Infinity	NaN	NaN	100	\N	\N	\N	Ivanka Patient Melanoma	L2DR03	\N
36602	DM_2	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hunter, Desmoplastic Melanoma Amplicon Sequence	L2DR14	\N
36603	DM_58_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR06	\N
36604	G5 DP08-4205A Normal	\N	NaN	Infinity	NaN	NaN	76.3	\N	\N	\N	Normal	L2DR06	\N
36605	35_M	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hunter, Desmoplastic Melanoma Amplicon Sequence	L2DR12	\N
36606	DM-60-Tumor	\N	NaN	Infinity	NaN	NaN	49.6	\N	\N	\N	NaN	NextFlex 18	\N
36607	DM_6_Normal	\N	NaN	Infinity	NaN	NaN	72	\N	\N	\N	NaN	L2DR03	\N
36608	DM-69-Tumor	\N	NaN	Infinity	NaN	NaN	60	\N	\N	\N	NaN	NextFlex 24	\N
36609	HW_3_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Hong Wu, Melanoma, Tumor Melanoma, nasal sinus	L2DR05	\N
36610	DM_49_2_Tumor	\N	NaN	Infinity	NaN	NaN	26.9	\N	\N	\N	NaN	L2DR02	\N
36611	CGH12_026	\N	NaN	Infinity	NaN	NaN	89.5	\N	\N	\N	Iwei CGH, 7Q Gain 	L2DR02	\N
36612	KIT_134	\N	NaN	Infinity	NaN	NaN	96.9	\N	\N	\N	Mucosal melanoma, rectal, WT	L2DR02	\N
36613	KIT_206	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosal melanoma, ?, WT	L2DR05	\N
36614	22_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13)	L2DR12	\N
36615	Ivanka_5_3	\N	7.88	Infinity	NaN	NaN	80.6	\N	\N	\N	Ivanka Patient Melanoma	L2DR14	\N
36616	22_Nevus	\N	NaN	Infinity	NaN	NaN	42.7	\N	\N	\N	Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13)	L2DR10	\N
36618	DM_43_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR14	\N
36619	DM_68_Tumor	\N	NaN	Infinity	NaN	NaN	10	\N	\N	\N	NaN	L2DR07	\N
36620	DM_101_IS	\N	NaN	Infinity	NaN	NaN	38	\N	\N	\N	NaN	L2DR10	\N
36621	DM_98_2_Normal	\N	NaN	Infinity	NaN	NaN	89.6	\N	\N	\N	NaN	L2DR13	\N
36622	DM-62-Tumor	\N	NaN	Infinity	NaN	NaN	90	\N	\N	\N	NaN	NextFlex 20	\N
36623	CGH11_410	\N	NaN	Infinity	NaN	NaN	93.2	\N	\N	\N	Iwei CGH, 7Q Gain 	L2DR16	\N
36624	DM-70-Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	NextFlex 1	\N
36625	DPN_35	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei DPN	L2DR04	\N
36626	DM37_1_Normal	\N	NaN	Infinity	NaN	NaN	62	\N	\N	\N	NaN	L2DR06	\N
36627	Ivanka_5_1	\N	2.24	Infinity	NaN	NaN	21.6	\N	\N	\N	Ivanka Patient Melanoma	L2DR12	\N
36628	MIN_1	\N	NaN	Infinity	NaN	NaN	46.7	\N	\N	\N	NaN	L2DR12	\N
36629	L2-HGD	\N	NaN	Infinity	NaN	NaN	96.4	\N	\N	\N	Hunter Dysplastic Nevus	NextFlex 4	\N
36630	DT10_63051C	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Ivanka Normal (for #9) 	L2DR07	\N
36631	KIT_205	\N	NaN	Infinity	NaN	NaN	68.8	\N	\N	\N	Acral melanoma, toe, WT	L2DR04	\N
36632	DM_74_1_Tumor	\N	NaN	Infinity	NaN	NaN	36.2	\N	\N	\N	NaN	L2DR01	\N
36633	MIN_3	\N	NaN	Infinity	NaN	NaN	19	\N	\N	\N	NaN	L2DR14	\N
36634	AM_7_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Acral Melanoma	L2DR03	\N
36635	CGH14-059	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Translocation	NextFlex 9	\N
36636	DM_31_Normal	\N	NaN	Infinity	NaN	NaN	40.3	\N	\N	\N	NaN	L2DR04	\N
36638	MIN_5	\N	NaN	Infinity	NaN	NaN	30.9	\N	\N	\N	NaN	L2DR16	\N
36639	Thomas_SK_MEL_23	\N	NaN	Infinity	NaN	NaN	45.7	\N	\N	\N	SKMEL23(Cell Line)	L2DR01	\N
36640	BN_N2	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hunter Blue Nevus (Melanoma in Nevus Project)	L2DR14	\N
36641	DPN_5_Normal	\N	NaN	1	NaN	NaN	10.5	\N	\N	\N	Iwei DPN	L2DR08	\N
36642	DM93_2_Tumor	\N	NaN	Infinity	NaN	NaN	10	\N	\N	\N	NaN	L2DR05	\N
36643	KIT_316	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR02	\N
36644	CGH11_109	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei CGH, Translocation 	L2DR13	\N
36645	Ivanka_5_4	\N	7.29	Infinity	NaN	NaN	93.6	\N	\N	\N	Ivanka Patient Melanoma	L2DR15	\N
36646	CGH11-184	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei, Translocation CGH, PDGFRB	L2DR03	\N
36647	DPN_8_Normal	\N	NaN	Infinity	NaN	NaN	67	\N	\N	\N	Iwei DPN	L2DR08	\N
36648	DM_49_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR15	\N
36649	DM-81-Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	NextFlex 2	\N
36651	Seider_Uveal Melanoma	\N	NaN	Infinity	NaN	NaN	44.3	\N	\N	\N	Seider Uveal Melanoma	L2DR06	\N
36652	DPN_18_Normal	\N	NaN	Infinity	NaN	NaN	10.1	\N	\N	\N	Iwei DPN	L2DR11	\N
36653	KIT_225	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosal melanoma, anal, 	L2DR08	\N
36654	CHG11-402	\N	NaN	Infinity	NaN	NaN	22	\N	\N	\N	Iwei 7Q Gain	L2DR14	\N
36655	DM-61-Tumor	\N	NaN	Infinity	NaN	NaN	54	\N	\N	\N	NaN	NextFlex 19	\N
36656	DM_58_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR16	\N
36658	DM45_Normal	\N	NaN	Infinity	NaN	NaN	22	\N	\N	\N	NaN	L2DR08	\N
36659	22_Melanoma	\N	NaN	Infinity	NaN	NaN	39.6	\N	\N	\N	Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13)	L2DR11	\N
36660	DM_64_1_Normal	\N	NaN	Infinity	NaN	NaN	35.8	\N	\N	\N	NaN	L2DR03	\N
36661	DPN_CNN 30	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei DPN (Control Normal Nevus)	L2DR12	\N
36662	DM-67-Tumor	\N	NaN	Infinity	NaN	NaN	45.2	\N	\N	\N	NaN	NextFlex 23	\N
36664	MIN_2	\N	NaN	Infinity	NaN	NaN	14.3	\N	\N	\N	NaN	L2DR13	\N
36665	MIN_6	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR01	\N
36666	DM_74_2_Tumor	\N	NaN	Infinity	NaN	NaN	12.2	\N	\N	\N	NaN	L2DR10	\N
36667	G3 DP08-21965C Normal	\N	NaN	Infinity	NaN	NaN	20.5	\N	\N	\N	Normal	L2DR04	\N
36668	Ivanka_10_4	\N	2.62	Infinity	NaN	NaN	11	\N	\N	\N	Ivanka Patient Melanoma	L2DR04	\N
36669	DPN_CNN 32	\N	NaN	Infinity	NaN	NaN	93.5	\N	\N	\N	Iwei DPN (Control Normal Nevus)	L2DR13	\N
36670	Ivanka_10_1	\N	6.68	Infinity	NaN	NaN	38.3	\N	\N	\N	Ivanka Patient Melanoma	L2DR01	\N
36671	DM_99_Normal	\N	NaN	Infinity	NaN	NaN	77.8	\N	\N	\N	NaN	L2DR15	\N
36672	BN_M1	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hunter Blue Nevus (Melanoma in Nevus Project)	L2DR15	\N
36673	AF13_212	\N	NaN	Infinity	NaN	NaN	71.4	\N	\N	\N	 A. Fouchardiere Project	L2DR13	\N
36674	DM77_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR12	\N
36675	DM_94_Tumor	\N	NaN	Infinity	NaN	NaN	69.6	\N	\N	\N	NaN	L2DR10	\N
36676	Ivanka_10_5	\N	2.86	Infinity	NaN	NaN	21.4	\N	\N	\N	Ivanka Patient Melanoma	L2DR05	\N
36677	CGH12-104	\N	NaN	Infinity	NaN	NaN	71.2	\N	\N	\N	Iwei CGH, 7Q Gain	L2DR12	\N
36678	CGH12_053	\N	NaN	1	NaN	NaN	100	\N	\N	\N	Iwei CGH, 7Q Gain 	L2DR05	\N
36679	DM_64_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR02	\N
36680	KIT_217	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosal melanoma, vaginal, WT	L2DR07	\N
36681	DM_99_Tumor	\N	NaN	Infinity	NaN	NaN	12.6	\N	\N	\N	NaN	L2DR14	\N
36682	12_M	\N	NaN	Infinity	NaN	NaN	75.7	\N	\N	\N	Hunter, Desmoplastic Melanoma Amplicon Sequence	L2DR11	\N
36683	KIT_297	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR16	\N
36684	Ivanka_5_5	\N	8.04	Infinity	NaN	NaN	42.8	\N	\N	\N	Ivanka Patient Melanoma	L2DR16	\N
36685	49_M	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hunter, Desmoplastic Melanoma Amplicon Sequence	L2DR13	\N
36686	DM_100_Tumor_Pool	\N	NaN	Infinity	NaN	NaN	10	\N	\N	\N	NaN	L2DR03	\N
36687	KIT_295	\N	NaN	Infinity	NaN	NaN	39.7	\N	\N	\N	Mucosal melanoma, oral, WT	L2DR12	\N
36688	CGH12-043	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei, Translocation CGH, MET	L2DR04	\N
36689	DM_36_Normal	\N	NaN	Infinity	NaN	NaN	47.4	\N	\N	\N	NaN	L2DR05	\N
36690	CGH11_091	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei CGH, Translocation	L2DR12	\N
36691	DM_59_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR07	\N
36692	CGH11_424	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei CGH, 7Q Gain 	L2DR01	\N
36693	AM_9_Tumor	\N	NaN	Infinity	NaN	NaN	67.4	\N	\N	\N	Iwei Acral Melanoma	L2DR04	\N
36694	CGH11-115	\N	NaN	Infinity	NaN	NaN	45.1	\N	\N	\N	Iwei, Translocation CGH, PDGFRB	L2DR02	\N
36695	L3-HGD	\N	NaN	Infinity	NaN	NaN	70	\N	\N	\N	Hunter Dysplastic Nevus	NextFlex 6	\N
36696	IYEH-01	2023-05-29 00:00:00-07	0.36	NaN	0.25	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	171	\N
36697	IYEH-02	2023-05-29 00:00:00-07	0.41	NaN	0.39	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	172	\N
36698	IYEH-03	2023-05-29 00:00:00-07	5.01	NaN	4.68	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	173	\N
36699	LMM-04	2023-05-29 00:00:00-07	0.67	NaN	0.66	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	174	\N
36700	LMM-18	2023-05-29 00:00:00-07	0.39	NaN	0.3	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	182	\N
36701	LMM-10	2023-05-29 00:00:00-07	4.53	NaN	4.6	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	178	\N
36702	LMM-14	2023-05-29 00:00:00-07	4.24	NaN	5.34	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	181	\N
36703	LMM-07	2023-05-29 00:00:00-07	2.38	NaN	2.26	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	176	\N
36704	LMM-08	2023-05-29 00:00:00-07	3.29	NaN	3.46	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	177	\N
36705	LMM-11	2023-05-29 00:00:00-07	3.66	NaN	4.98	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	179	\N
36706	LMM-05	2023-05-29 00:00:00-07	0.99	NaN	0.94	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	175	\N
36707	LMM-13	2023-05-29 00:00:00-07	10.5	NaN	10	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	180	\N
36708	LMM-17	2023-05-29 00:00:00-07	0.39	NaN	0.38	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	183	\N
36709	EXLP-41	2023-06-13 00:00:00-07	3.63	73	1	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	157	\N
36710	EXLP-42	2023-06-13 00:00:00-07	3.06	76	0.33	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	160	\N
36711	EXLP-50	2023-06-20 00:00:00-07	0.6	NaN	0.69	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	168	\N
36712	EXLP-46	2023-06-20 00:00:00-07	1.75	NaN	2.34	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	164	\N
36713	IYEH-08	2023-06-19 00:00:00-07	0.28	NaN	0.32	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	172	\N
36714	IYEH-07	2023-06-19 00:00:00-07	0.36	NaN	0.52	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	171	\N
36715	KALP-013	2023-09-06 00:00:00-07	6.28	78	2.47	4	250	\N	\N	\N	NaN	187	\N
36716	KALP-018	2023-09-06 00:00:00-07	2.11	35	1.49	4	250	\N	\N	\N	NaN	192	\N
36717	KALP-016	2023-09-06 00:00:00-07	4.39	15	1.51	4	250	\N	\N	\N	NaN	190	\N
36718	KALP-017	2023-09-06 00:00:00-07	2.31	13	0.84	4	250	\N	\N	\N	NaN	191	\N
36719	KALP-026	2023-09-15 00:00:00-07	11	15	3.22	4	250	\N	\N	\N	NaN	190	\N
36720	SKMEL28-1	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36721	SKMEL5-3	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36722	SKMEL5-2	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36723	Sk-Mel-23	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR01	\N
36724	SKMEL28-2	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36725	SKMEL5-1	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36726	SKMEL28-3	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39699	BS5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
36727	UM_1	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul\n	NaN	\N
36728	UM_2	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul\n	NaN	\N
36729	1205LU-3_Unknown	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	cell line: 1205Lu (RRID:CVCL_5239)	NaN	\N
36730	1205lu-1_Unknown	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	cell line: 1205Lu (RRID:CVCL_5239)	NaN	\N
36731	1205lu-2_Unknown	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	cell line: 1205Lu (RRID:CVCL_5239)	NaN	\N
36732	CGH11-402	2013-07-09 00:00:00-07	18.5	43	NaN	NaN	250	\N	\N	\N	Iwei 7Q gain, Swapna CGH screened, FFPE derived	L2DR14	\N
36733	CGH11-275	2013-07-09 00:00:00-07	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Iwei 7Q gain\n, Swapna CGH screened, FFPE derived; Not sequenced, <2 ul volume remaining\n\n	L2DR12	\N
36734	CGH11-399	2013-07-09 00:00:00-07	NaN	50	NaN	NaN	129.5	\N	\N	\N	Iwei 7Q gain\n, Swapna CGH screened, FFPE derived; Not sequenced, <2 ul volume remaining\n	L2DR15	\N
36735	DM1-Tert-Amplicon	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	Hunter Amplicon Sequencing\n; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul\n	NaN	\N
36736	KAM111-normal	2015-11-19 00:00:00-08	5.03	106	NaN	NaN	250	\N	\N	\N	NaN	E6	\N
36737	KAM93-normal	2015-11-19 00:00:00-08	3.32	46	NaN	NaN	250	\N	\N	\N	NaN	D5	\N
36738	KAM123-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36739	KAM100-normal_kapa-NGv3-PE100-NGv3-ready	\N	NaN	34	NaN	NaN	250	\N	\N	\N	NaN	NaN	\N
36740	DM93_NFKBIE_Amplicon	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Hunter Amplicon Sequencing\n; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul	NaN	\N
36741	KAM111-tumor_kapa-NGv3-PE100-NGv3-ready	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36742	KAM10-normal	2015-11-19 00:00:00-08	7.09	45	NaN	NaN	197.6	\N	\N	\N	NaN	E1	\N
36743	KAM100-tumor_kapa-NGv3-PE100-NGv3-ready	\N	NaN	18	NaN	NaN	250	\N	\N	\N	NaN	NaN	\N
36744	KAM99-normal_kapa-NGv3-PE100-NGv3-ready	\N	NaN	89	NaN	NaN	250	\N	\N	\N	NaN	NaN	\N
36745	DM93_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36746	KAM93-normal_kapa-NGv3-PE100-NGv3-ready	\N	NaN	46	NaN	NaN	250	\N	\N	\N	NaN	NaN	\N
36747	KAM10-Tumor_kapa-NGv3-PE100-NGv3-ready	\N	NaN	7	NaN	NaN	250	\N	\N	\N	NaN	NaN	\N
36748	KAM12-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36749	KAM111-normal_kapa-NGv3-PE100-NGv3-ready	\N	NaN	106	NaN	NaN	250	\N	\N	\N	NaN	NaN	\N
36750	KAM100-normal	2015-11-19 00:00:00-08	5.09	34	NaN	NaN	250	\N	\N	\N	NaN	D9	\N
36751	DM14-Tert-Amplicon	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Hunter DM Amplicon Sequencing; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul\n; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul\n\n"	NaN	\N
36752	DM11-Tert-Amplicon	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Hunter DM Amplicon Sequencing; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul\n; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul\n\n	NaN	\N
36753	KAM102-T-B	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36754	KAM122-T-A	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36755	KAM99-tumor_kapa-NGv3-PE100-NGv3-ready	\N	NaN	9	NaN	NaN	250	\N	\N	\N	NaN	NaN	\N
36756	KAM93-tumor_kapa-NGv3-PE100-NGv3-ready	\N	NaN	18	NaN	NaN	250	\N	\N	\N	NaN	NaN	\N
36757	DM2-Tert-Amplicon	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Hunter Amplicon Sequencing\n; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul	NaN	\N
36758	DM45_NFKBIE_Amplicon	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Hunter Amplicon Sequencing\n; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul	NaN	\N
36759	DPN54-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36760	KAM113-T-H	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36761	KAM99-normal	2015-11-19 00:00:00-08	2.15	89	NaN	NaN	250	\N	\N	\N	NaN	D7	\N
36762	KAM75-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36763	KAM116-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36764	KAM10-normal_kapa-NGv3-PE100-NGv3-ready	\N	NaN	45	NaN	NaN	197.6	\N	\N	\N	NaN	NaN	\N
36765	DM79_NFKBIE_Amplicon	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Hunter Amplicon Sequencing\n; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul	NaN	\N
36766	DPN59-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36767	DM8Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36768	26	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
36769	VS-01	2022-07-21 00:00:00-07	3.18	NaN	2.37	18	NaN	\N	\N	\N	SI-TS-A1	SI-TS-A1	\N
36770	VS-02	2022-07-21 00:00:00-07	2.4	NaN	1.98	16	NaN	\N	\N	\N	SI-TS-A2	SI-TS-A2	\N
36771	VS-03	2022-07-21 00:00:00-07	2.72	NaN	2.67	18	NaN	\N	\N	\N	SI-TS-A3	SI-TS-A3	\N
36772	VS-04	2022-07-21 00:00:00-07	2.82	NaN	2.54	18	NaN	\N	\N	\N	SI-TS-A4	SI-TS-A4	\N
36773	VS-05	2023-10-06 00:00:00-07	1.07	NaN	0.72	16	NaN	\N	\N	\N	LOT #: 164486	SI-TS-A5	\N
36774	VS-07	2023-10-06 00:00:00-07	1.02	NaN	0.57	15	NaN	\N	\N	\N	LOT #: 164486	SI-TS-A7	\N
36775	VS-08	2023-10-06 00:00:00-07	1.95	NaN	0.69	14	NaN	\N	\N	\N	LOT #: 164486	SI-TS-A8	\N
36776	VS-06	2023-10-06 00:00:00-07	1.8	NaN	1.23	14	NaN	\N	\N	\N	LOT #: 164486	SI-TS-A6	\N
36777	AMLP-02	2018-05-08 00:00:00-07	6.7	1	3	NaN	250	\N	\N	\N	NaN	G2	\N
36778	AMLP-01	2018-05-08 00:00:00-07	5.6	9	2.1	NaN	250	\N	\N	\N	NaN	G1	\N
36779	AGLP-02	2018-04-26 00:00:00-07	118	1	231.5	NaN	250	\N	\N	\N	SureSelect Library Prep	AGXTHS-02	\N
36780	AGLP-01	2018-04-26 00:00:00-07	90.4	9	167.2	NaN	250	\N	\N	\N	SureSelect Library Prep	AGXTHS-01	\N
36781	AMLP-03	2018-05-08 00:00:00-07	11	5	6.3	NaN	250	\N	\N	\N	NaN	G3	\N
39700	BS6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
36782	AMLP-05	2018-05-08 00:00:00-07	7.4	35	1.7	NaN	250	\N	\N	\N	NaN	G5	\N
36783	AMLP-11	2018-05-08 00:00:00-07	4.1	25	1.3	NaN	250	\N	\N	\N	NaN	G11	\N
36784	AMLP-21	2018-05-08 00:00:00-07	6.4	2	1.9	NaN	250	\N	\N	\N	NaN	H9	\N
36785	AMLP-15	2018-05-08 00:00:00-07	8.3	45	3	NaN	250	\N	\N	\N	NaN	H3	\N
36786	AMLP-18	2018-05-08 00:00:00-07	1.6	7	0.2	NaN	250	\N	\N	\N	NaN	H6	\N
36787	AMLP-08	2018-05-08 00:00:00-07	10.7	17	4.3	NaN	250	\N	\N	\N	NaN	G8	\N
36788	AMLP-10	2018-05-08 00:00:00-07	9.4	13	1.9	NaN	250	\N	\N	\N	NaN	G10	\N
36789	AMLP-14	2018-05-08 00:00:00-07	3	4	1.7	NaN	250	\N	\N	\N	NaN	H2	\N
36790	AMLP-17	2018-05-08 00:00:00-07	5.3	33	1.1	NaN	250	\N	\N	\N	NaN	H5	\N
36791	AMLP-04	2018-05-08 00:00:00-07	3.6	5	1.3	NaN	250	\N	\N	\N	NaN	G4	\N
36792	AMLP-16	2018-05-08 00:00:00-07	6.1	5	2.3	NaN	250	\N	\N	\N	NaN	H4	\N
36793	AMLP-12	2018-05-08 00:00:00-07	5	2	1	NaN	250	\N	\N	\N	NaN	G12	\N
36794	AMLP-22_1	2018-05-08 00:00:00-07	5.3	3	1.3	NaN	250	\N	\N	\N	NaN	H10	\N
36795	AMLP-06	2018-05-08 00:00:00-07	5	4	2	NaN	250	\N	\N	\N	NaN	G6	\N
36796	AMLP-13	2018-05-08 00:00:00-07	4.8	41	2	NaN	250	\N	\N	\N	NaN	H1	\N
36797	AMLP-07	2018-05-08 00:00:00-07	9.8	29	3.3	NaN	250	\N	\N	\N	NaN	G7	\N
36798	AMLP-09	2018-05-08 00:00:00-07	3.7	50	0.8	NaN	142	\N	\N	\N	NaN	G9	\N
36799	AMLP-22_2	2018-07-23 00:00:00-07	3.2	3	0.35	NaN	250	\N	\N	\N	NaN	A6	\N
36800	AMLP-44	2018-07-23 00:00:00-07	4.6	0	0.98	NaN	NaN	\N	\N	\N	NaN	B7	\N
36801	AMLP-46	2018-07-23 00:00:00-07	4.2	50	1.85	NaN	1520	\N	\N	\N	NaN	B9	\N
36802	AMLP-49	2018-07-23 00:00:00-07	2.9	0	0.8	NaN	NaN	\N	\N	\N	NaN	B12	\N
36803	AMLP-96	2018-11-30 00:00:00-08	7.55	12	6.63	4	300	\N	\N	\N	NaN	22	\N
36804	AMLP-87	2018-11-27 00:00:00-08	3.79	48	1.74	4	185.3	\N	\N	\N	NaN	61	\N
36805	AMLP-66	2018-11-27 00:00:00-08	6.3	12	2.26	4	300	\N	\N	\N	NaN	40	\N
36806	AMLP-69	2019-02-27 00:00:00-08	4.83	31	2.26	4	300	\N	\N	\N	repeated sequencing	43	\N
36807	AMLP-77	2019-02-27 00:00:00-08	5.89	31	2.06	4	300	\N	\N	\N	repeated sequencing	51	\N
36808	AMLP-99	2018-11-30 00:00:00-08	7.06	8	5.59	4	300	\N	\N	\N	NaN	25	\N
36809	AMLP-75	2018-11-27 00:00:00-08	4.85	48	2.14	4	298.6	\N	\N	\N	NaN	49	\N
36810	AMLP-95	2018-11-30 00:00:00-08	6.33	24	4.36	4	300	\N	\N	\N	NaN	21	\N
36811	AMLP-114	2018-11-30 00:00:00-08	7.91	37	5.7	4	300	\N	\N	\N	NaN	92	\N
36812	AMLP-117	2018-12-07 00:00:00-08	NaN	8	1.07	4	300	\N	\N	\N	repeated sequencing	95	\N
36813	AMLP-107	2018-11-30 00:00:00-08	6.33	14	3.78	4	300	\N	\N	\N	NaN	33	\N
36814	AMLP-110	2018-11-30 00:00:00-08	7.85	28	5.7	4	300	\N	\N	\N	re-LP on 2/27/19; repeated sequencing	36	\N
36815	AMLP-97	2018-11-30 00:00:00-08	1.44	7	1.08	4	300	\N	\N	\N	re-LP on 2/27/19; repeated sequencing	23	\N
36816	AMLP-102	2018-11-30 00:00:00-08	8.73	8	4.65	4	300	\N	\N	\N	NaN	28	\N
36817	AMLP-109	2018-11-30 00:00:00-08	6.63	14	3.92	4	300	\N	\N	\N	NaN	35	\N
36818	AMLP-113	2018-11-30 00:00:00-08	7.14	10	5.46	4	300	\N	\N	\N	NaN	91	\N
36819	AMLP-30	\N	NaN	3	9.3	NaN	350	\N	\N	\N	NaN	H8	\N
36820	AMLP-45	2018-07-23 00:00:00-07	4.4	0	2.17	NaN	NaN	\N	\N	\N	NaN	B8	\N
36821	AMLP-41	\N	NaN	4	3.2	NaN	350	\N	\N	\N	NaN	B3	\N
36822	AMLP-125	2019-06-04 00:00:00-07	5.62	41	1.91	4	250	\N	\N	\N	NaN	71	\N
36823	AMLP-126	2019-12-03 00:00:00-08	13.7	5	2.45	3	250	\N	\N	\N	120s shear time; DNA repaired	40	\N
36824	AMLP-127	2019-12-03 00:00:00-08	14.3	25	1.63	3	999	\N	\N	\N	120s shear time; DNA repaired	41	\N
36825	AMLP-128	2019-12-03 00:00:00-08	11.3	46	2.09	3	999	\N	\N	\N	120s shear time; DNA repaired	48	\N
36826	AMLP-130	2019-12-03 00:00:00-08	9.21	3	1.73	3	250	\N	\N	\N	120s shear time; DNA repaired	51	\N
36827	AMLP-131	2019-12-03 00:00:00-08	20.6	23	1.3	3	999	\N	\N	\N	120s shear time; DNA repaired	52	\N
36828	AMLP-132	2019-12-03 00:00:00-08	10.3	50	4.28	3	1520	\N	\N	\N	120s shear time; DNA repaired	53	\N
36829	AMLP-133	2019-12-03 00:00:00-08	7.94	0	2.97	3	NaN	\N	\N	\N	120s shear time; DNA repaired	54	\N
36830	AMLP-135	2019-12-03 00:00:00-08	18.8	6	2.42	3	300	\N	\N	\N	120s shear time; DNA repaired	56	\N
36831	AMLP-140	2019-12-03 00:00:00-08	11.8	10	4.02	3	300	\N	\N	\N	120s shear time; DNA repaired	74	\N
36832	AMLP-137	2019-12-03 00:00:00-08	14.8	8	4.8	3	300	\N	\N	\N	120s shear time; DNA repaired	67	\N
36833	AMLP-142	2019-12-03 00:00:00-08	13.5	8	3.52	3	300	\N	\N	\N	120s shear time; DNA repaired	76	\N
36834	AMLP-150	2019-12-03 00:00:00-08	24.4	2	1.63	3	250	\N	\N	\N	120s shear time; DNA repaired	84	\N
36835	AMLP-151	2019-12-03 00:00:00-08	17.6	5	4.89	3	250	\N	\N	\N	120s shear time; DNA repaired	85	\N
36836	AMLP-149	2019-12-03 00:00:00-08	9	6	2.34	3	350	\N	\N	\N	120s shear time; DNA repaired	83	\N
36837	AMLP-147	2019-12-03 00:00:00-08	9.9	32	2.49	3	999	\N	\N	\N	120s shear time; DNA repaired	81	\N
36838	AMLP-55	2018-07-23 00:00:00-07	8.3	0	2.82	NaN	NaN	\N	\N	\N	NaN	C6	\N
36839	AMLP-19_1	2018-05-08 00:00:00-07	5.4	7	1.1	NaN	250	\N	\N	\N	NaN	H7	\N
36840	AMLP-51	2018-07-23 00:00:00-07	5.1	0	3.09	NaN	NaN	\N	\N	\N	NaN	C2	\N
36841	AMLP-53	2018-07-23 00:00:00-07	4.6	11	1.91	NaN	666	\N	\N	\N	NaN	C4	\N
36842	AMLP-48	2018-07-23 00:00:00-07	4.8	0	2.13	NaN	NaN	\N	\N	\N	NaN	B11	\N
36843	AMLP-84	2019-02-27 00:00:00-08	6.99	8	2.3	4	300	\N	\N	\N	NaN	58	\N
36844	AMLP-90	2018-11-27 00:00:00-08	3.81	48	1.97	4	186.2	\N	\N	\N	NaN	64	\N
36845	AMLP-129	2019-12-03 00:00:00-08	5.28	41	1.77	4	250	\N	\N	\N	120s shear time; DNA repaired	50	\N
36846	AMLP-136	2019-12-03 00:00:00-08	5.79	24	3.14	4	300	\N	\N	\N	120s shear time; DNA repaired	66	\N
36847	AMLP-138	2019-12-03 00:00:00-08	11.5	14	5.48	4	300	\N	\N	\N	120s shear time; DNA repaired	70	\N
39701	BS7	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
36848	AMLP-143	2019-12-03 00:00:00-08	2.87	37	1.9	4	300	\N	\N	\N	120s shear time; DNA repaired	77	\N
36849	AMLP-146	2019-12-03 00:00:00-08	7.33	0	3.66	4	NaN	\N	\N	\N	120s shear time; DNA repaired. SGPC-20: 12 Cycles post Hyb, 43ng captured	80	\N
36850	AMLP-139	2019-12-03 00:00:00-08	11.4	14	5.82	4	300	\N	\N	\N	120s shear time; DNA repaired	73	\N
36851	AMLP-148	2019-12-03 00:00:00-08	6.3	0	3.79	4	NaN	\N	\N	\N	120s shear time; DNA repaired	82	\N
36852	AMLP-19_2	2018-07-23 00:00:00-07	5.2	7	0.9	NaN	250	\N	\N	\N	NaN	B4	\N
36853	AMLP-82	2018-11-27 00:00:00-08	4.67	44	0.92	4	300	\N	\N	\N	NaN	56	\N
36854	AMLP-78	2018-11-27 00:00:00-08	4.56	45	1.32	4	300	\N	\N	\N	NaN	52	\N
36855	AMLP-156	2020-01-31 00:00:00-08	11.7	46	1.75	3	999	\N	\N	\N	120s shear time; DNA repaired	16	\N
36856	AMLP-160	2020-01-31 00:00:00-08	15.6	19	2.21	3	999	\N	\N	\N	120s shear time; DNA repaired	24	\N
36857	AMLP-163	2020-01-31 00:00:00-08	4.91	31	1.87	4	300	\N	\N	\N	120s shear time; DNA repaired	27	\N
36858	AMLP-168	2020-01-31 00:00:00-08	6.4	31	1.16	4	300	\N	\N	\N	120s shear time; DNA repaired	79	\N
36859	AMLP-169	2020-01-31 00:00:00-08	8	45	1.76	4	300	\N	\N	\N	120s shear time; DNA repaired	80	\N
36860	AMLP-172-81	2020-01-31 00:00:00-08	6.29	48	1.57	4	171.8	\N	\N	\N	120s shear time; DNA repaired. Sequenced as: AMLP-172 (AMLP-172 captured 79 ng in AGEX-9; AMLP-81 captured 69 ng in AGEX-9). Same adapter #55	55	\N
36861	AMLP-175	2020-02-07 00:00:00-08	5.94	46	1.41	4	999	\N	\N	\N	NaN	97	\N
36862	AMLP-176	2020-02-07 00:00:00-08	7.13	19	1.45	4	999	\N	\N	\N	NaN	98	\N
36863	AMLP-186	2020-02-07 00:00:00-08	4.78	32	1.46	4	258	\N	\N	\N	NaN	108	\N
36864	AMLP-195	2020-02-07 00:00:00-08	5.94	5	2	4	250	\N	\N	\N	NaN	117	\N
36865	AMLP-198	2020-02-07 00:00:00-08	4.9	0	4.2	4	NaN	\N	\N	\N	NaN	120	\N
36866	AMLP-197	2020-02-07 00:00:00-08	8.05	23	2.65	4	999	\N	\N	\N	NaN	119	\N
36867	AMLP-196	2020-02-07 00:00:00-08	5.17	25	1.88	4	999	\N	\N	\N	NaN	118	\N
36868	AMLP-58	\N	NaN	6	4.3	NaN	250	\N	\N	\N	NaN	C11	\N
36869	AMLP-61	\N	2.8	2	4	NaN	250	\N	\N	\N	NaN	D2	\N
36870	AMLP-64	\N	NaN	8	1.7	NaN	250	\N	\N	\N	NaN	F4	\N
36871	AMLP-123	2018-12-07 00:00:00-08	NaN	9	0.67	4	300	\N	\N	\N	NaN	5	\N
36872	AMLP-105	2018-11-30 00:00:00-08	2.03	48	0.82	4	91.7	\N	\N	\N	NaN	31	\N
36873	AMLP-174	2020-01-31 00:00:00-08	6.3	23	4.58	4	300	\N	\N	\N	120s shear time; DNA repaired	94	\N
36874	AMLP-178	2020-02-07 00:00:00-08	7.15	8	2.6	4	300	\N	\N	\N	NaN	100	\N
36875	AMLP-179	2020-02-07 00:00:00-08	15.8	6	2.97	4	300	\N	\N	\N	NaN	101	\N
36876	AMLP-181	2020-02-07 00:00:00-08	7.91	8	2.38	4	300	\N	\N	\N	NaN	103	\N
36877	AMLP-180	2020-02-07 00:00:00-08	2.91	48	0.77	4	186.2	\N	\N	\N	NaN	102	\N
36878	AMLP-184	2020-02-07 00:00:00-08	5.88	28	1.31	4	300	\N	\N	\N	NaN	106	\N
36879	AMLP-185	2020-02-07 00:00:00-08	4.72	48	1.38	4	91.7	\N	\N	\N	NaN	107	\N
36880	AMLP-191	2020-02-07 00:00:00-08	7.57	96	1.71	4	259	\N	\N	\N	NaN	113	\N
36881	AMLP-194	2020-02-07 00:00:00-08	6.12	9	1.12	4	300	\N	\N	\N	NaN	116	\N
36882	AMLP-104	2018-11-30 00:00:00-08	5.85	28	2.78	4	300	\N	\N	\N	re-LP on 2/27/19; repeated sequencing	30	\N
36883	AMLP-85	2018-11-27 00:00:00-08	16.5	6	3.63	4	300	\N	\N	\N	NaN	59	\N
36884	AMLP-121	2018-12-07 00:00:00-08	NaN	48	0.54	4	138.2	\N	\N	\N	NaN	3	\N
36885	AMLP-88	2018-11-27 00:00:00-08	5.16	48	2	4	272.6	\N	\N	\N	NaN	62	\N
36886	AMLP-68	2018-11-27 00:00:00-08	2.64	48	1.09	4	195.4	\N	\N	\N	NaN	42	\N
36887	AMLP-112	2018-11-30 00:00:00-08	5.07	48	5.07	4	214.1	\N	\N	\N	NaN	38	\N
36888	AMLP-83	2018-11-27 00:00:00-08	4.08	48	1.52	4	273.1	\N	\N	\N	NaN	57	\N
36889	AMLP-93	2018-11-30 00:00:00-08	6.06	48	2.55	4	277	\N	\N	\N	NaN	19	\N
36890	AMLP-153	2020-01-31 00:00:00-08	6.98	0	2.3	4	NaN	\N	\N	\N	120s shear time; DNA repaired	11	\N
36891	AMLP-162	2020-01-31 00:00:00-08	2.98	48	1.14	4	195.4	\N	\N	\N	120s shear time; DNA repaired	26	\N
36892	AMLP-170	2020-01-31 00:00:00-08	9.06	48	2.38	4	73.9	\N	\N	\N	120s shear time; DNA repaired	81	\N
36893	AMLP-173	2020-01-31 00:00:00-08	6.56	48	3.4	4	224.2	\N	\N	\N	120s shear time; DNA repaired. Accidentally added an excess of 71 ng in the capture.	93	\N
36894	AMLP-177	2020-02-07 00:00:00-08	2.93	48	0.85	4	273.1	\N	\N	\N	NaN	99	\N
36895	AMLP-192	2020-02-07 00:00:00-08	7.27	96	1.98	4	328	\N	\N	\N	NaN	114	\N
36896	AMLP-199	2020-08-02 00:00:00-07	7.1	NaN	4.68	4	NaN	\N	\N	\N	Accidentally added an excess of 154 ng in the capture.	134	\N
36897	AMLP-108	2018-11-30 00:00:00-08	2.81	48	1.72	4	102.2	\N	\N	\N	NaN	34	\N
36898	AMLP-92	2018-11-30 00:00:00-08	2.68	48	1.34	4	124.8	\N	\N	\N	NaN	18	\N
36899	AMLP-80	2018-11-27 00:00:00-08	2.6	48	0.45	4	193.4	\N	\N	\N	NaN	54	\N
36900	AMLP-76-164	2018-11-27 00:00:00-08	3.19	48	1.22	4	145.9	\N	\N	\N	Sequenced as: AMLP-76. 120s shear time; DNA repaired (AMLP-164 captured 10ng, AGEX-12). (AMLP-76 captured 61.0 ng in AGEX-12). Same adapter #50. AMLP-164: 1/31/2020	50	\N
36901	AMLP-103	2018-11-30 00:00:00-08	1.28	48	0.51	4	54.2	\N	\N	\N	NaN	29	\N
36902	AMLP-91	2018-11-30 00:00:00-08	1.44	48	0.8	4	48	\N	\N	\N	NaN	17	\N
36903	AMLP-165	2020-01-31 00:00:00-08	5.76	0	1.77	4	NaN	\N	\N	\N	120s shear time; DNA repaired	73	\N
36904	AMLP-171	2020-01-31 00:00:00-08	4.54	48	0.81	4	193.4	\N	\N	\N	120s shear time; DNA repaired	86	\N
36905	AMLP-182	2020-02-07 00:00:00-08	5.98	48	1.2	4	54.2	\N	\N	\N	NaN	104	\N
36906	AMLP-204	2020-08-02 00:00:00-07	6.83	32	4.17	4	999	\N	\N	\N	NaN	139	\N
36907	AMLP-210	2020-08-06 00:00:00-07	3.2	20	1.54	4	333	\N	\N	\N	NaN	145	\N
36908	AMLP-231	2020-08-06 00:00:00-07	4.53	9	2.1	4	300	\N	\N	\N	NaN	166	\N
36909	AMLP-29	\N	NaN	3	2.6	NaN	350	\N	\N	\N	NaN	H7	\N
39702	BS8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
36910	AMLP-211	2020-08-06 00:00:00-07	6.01	27	3.98	4	333	\N	\N	\N	NaN	146	\N
36911	AMLP-214	2020-08-06 00:00:00-07	3.99	88	1.44	4	254	\N	\N	\N	NaN	149	\N
36912	AMLP-218	2020-08-06 00:00:00-07	3.54	NaN	2.3	4	NaN	\N	\N	\N	NaN	153	\N
36913	AMLP-219	2020-08-06 00:00:00-07	4	NaN	2.6	4	NaN	\N	\N	\N	NaN	154	\N
36914	AMLP-267	2021-03-17 00:00:00-07	9.81	32	2.72	4	333	\N	\N	\N	NaN	133	\N
36915	AMLP-269	2021-03-17 00:00:00-07	5.79	17	1.66	4	333	\N	\N	\N	NaN	135	\N
36916	AMLP-289	2021-03-17 00:00:00-07	6.57	30	2.49	4	333	\N	\N	\N	NaN	173	\N
36917	AMLP-290	2021-03-17 00:00:00-07	5.77	NaN	1.37	4	NaN	\N	\N	\N	NaN	174	\N
36918	AMLP-291	2021-03-17 00:00:00-07	5.17	136	1.63	4	333	\N	\N	\N	NaN	175	\N
36919	AMLP-240	2021-03-17 00:00:00-07	11.1	29	2.26	4	333	\N	\N	\N	NaN	103	\N
36920	AMLP-247	2021-03-17 00:00:00-07	6.8	31	1.59	4	333	\N	\N	\N	NaN	112	\N
36921	AMLP-263	2021-03-17 00:00:00-07	23.9	7	11.26	4	333	\N	\N	\N	NaN	129	\N
36922	AMLP-264	2021-03-17 00:00:00-07	6.56	95	1.57	4	291.7	\N	\N	\N	NaN	130	\N
36923	AMLP-265	2021-03-17 00:00:00-07	6.77	95	2.26	4	268.9	\N	\N	\N	NaN	131	\N
36924	AMLP-266	2021-03-17 00:00:00-07	7.95	45	3.52	4	333	\N	\N	\N	NaN	132	\N
36925	AMLP-268	2021-03-17 00:00:00-07	6.09	44	1.68	4	333	\N	\N	\N	NaN	134	\N
36926	AMLP-238	2021-03-17 00:00:00-07	6.64	22	1.28	4	333	\N	\N	\N	NaN	101	\N
36927	AMLP-241	2021-03-17 00:00:00-07	5.71	83	0.86	4	333	\N	\N	\N	NaN	104	\N
36928	AMLP-245	2021-03-17 00:00:00-07	4.36	NaN	0.33	4	NaN	\N	\N	\N	NaN	109	\N
36929	AMLP-252	2021-03-17 00:00:00-07	5.82	61	0.16	4	333	\N	\N	\N	NaN	118	\N
36930	AMLP-256	2021-03-17 00:00:00-07	5.49	74	1.05	4	333	\N	\N	\N	NaN	122	\N
36931	AMLP-257	2021-03-17 00:00:00-07	6.36	96	1.07	4	265	\N	\N	\N	NaN	123	\N
36932	AMLP-259	2021-03-17 00:00:00-07	5.4	96	1.26	4	189	\N	\N	\N	NaN	125	\N
36933	AMLP-261	2021-03-17 00:00:00-07	6.23	NaN	0.91	4	NaN	\N	\N	\N	NaN	127	\N
36934	AMLP-237	2021-03-17 00:00:00-07	3.2	95	0.39	4	116.9	\N	\N	\N	NaN	100	\N
36935	AMLP-272	2021-03-17 00:00:00-07	4.09	95	1.18	4	103	\N	\N	\N	NaN	145	\N
36936	AMLP-295	2021-04-07 00:00:00-07	5.38	35	1.25	4	333	\N	\N	\N	NaN	179	\N
36937	AMLP-296	2021-04-07 00:00:00-07	4.58	0	2.38	4	NaN	\N	\N	\N	NaN	180	\N
36938	AMLP-298	2021-04-07 00:00:00-07	3.96	61	0.97	4	333	\N	\N	\N	NaN	182	\N
36939	AMLP-299	2021-04-07 00:00:00-07	7.25	9	5.22	4	333	\N	\N	\N	NaN	183	\N
36940	AMLP-273	2021-03-17 00:00:00-07	6.15	95	1.78	4	238.5	\N	\N	\N	NaN	147	\N
36941	AMLP-274	2021-03-17 00:00:00-07	5.19	95	1.66	4	165.3	\N	\N	\N	NaN	148	\N
36942	AMLP-275	2021-03-17 00:00:00-07	8.54	190	1.77	4	205.2	\N	\N	\N	NaN	152	\N
36943	AMLP-277	2021-03-17 00:00:00-07	8.08	190	3.16	4	317	\N	\N	\N	NaN	160	\N
36944	AMLP-279	2021-03-17 00:00:00-07	7.03	9	2.43	4	333	\N	\N	\N	NaN	162	\N
36945	AMLP-200	2020-08-02 00:00:00-07	3.91	NaN	1.86	4	NaN	\N	\N	\N	NaN	135	\N
36946	AMLP-221	2020-08-06 00:00:00-07	1.28	96	0.8	4	67	\N	\N	\N	NaN	156	\N
36947	AMLP-222	2020-08-06 00:00:00-07	3.52	29	1.8	4	583	\N	\N	\N	NaN	157	\N
36948	AMLP-224	2020-08-06 00:00:00-07	4.28	NaN	1.6	4	NaN	\N	\N	\N	NaN	159	\N
36949	AMLP-225	2020-08-06 00:00:00-07	2.36	96	0.8	4	227	\N	\N	\N	NaN	160	\N
36950	AMLP-226	2020-08-06 00:00:00-07	3.31	49	1.2	4	333	\N	\N	\N	NaN	161	\N
36951	AMLP-227	2020-08-06 00:00:00-07	7.32	80	5.1	4	333	\N	\N	\N	NaN	162	\N
36952	AMLP-217	2020-08-06 00:00:00-07	3.99	NaN	2.8	4	NaN	\N	\N	\N	NaN	152	\N
36953	AMLP-206	2020-08-02 00:00:00-07	5.29	NaN	3.3	4	NaN	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 45 ng library	141	\N
36954	AMLP-208	2020-08-02 00:00:00-07	3.27	88	2.75	4	63	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 50 ng library	143	\N
36955	AMLP-220	2020-08-06 00:00:00-07	6.96	NaN	3.9	4	NaN	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 65 ng library	155	\N
36956	AMLP-254	2021-03-17 00:00:00-07	8.95	9	0.82	4	333	\N	\N	\N	NaN	120	\N
36957	AMLP-255	2021-03-17 00:00:00-07	9.19	8	1.19	4	333	\N	\N	\N	NaN	121	\N
36958	AMLP-262	2021-03-17 00:00:00-07	6.32	57	0.96	4	333	\N	\N	\N	NaN	128	\N
36959	AMLP-280	2021-03-17 00:00:00-07	7.14	8	3.23	4	333	\N	\N	\N	NaN	163	\N
36960	AMLP-282	2021-03-17 00:00:00-07	4.32	75	1.43	4	333	\N	\N	\N	NaN	165	\N
36961	AMLP-293	2021-03-17 00:00:00-07	3.25	95	1.19	4	115.9	\N	\N	\N	NaN	177	\N
36962	AMLP-292	2021-03-17 00:00:00-07	11.3	45	2.81	4	333	\N	\N	\N	NaN	176	\N
36963	AMLP-312	2021-05-20 00:00:00-07	10.2	33	3.17	4	333	\N	\N	\N	NaN	115	\N
36964	AMLP-318	2021-05-20 00:00:00-07	5.47	61	2.44	4	333	\N	\N	\N	NaN	145	\N
36965	AMLP-320	2021-05-20 00:00:00-07	1.25	95	2.28	4	118.8	\N	\N	\N	NaN	150	\N
36966	AMLP-300	2021-04-07 00:00:00-07	9.25	8	5.1	4	333	\N	\N	\N	70 ng in AGEX-22	184	\N
36967	AMLP-278	2021-03-17 00:00:00-07	5.44	87	1.64	4	333	\N	\N	\N	NaN	161	\N
36968	AMLP-281	2021-03-17 00:00:00-07	1.23	95	0.19	4	84.6	\N	\N	\N	NaN	164	\N
36969	AMLP-283	2021-03-17 00:00:00-07	2.49	NaN	0.68	4	NaN	\N	\N	\N	NaN	166	\N
36970	AMLP-285	2021-03-17 00:00:00-07	4.38	84	1.34	4	333	\N	\N	\N	NaN	169	\N
36971	AMLP-287	2021-03-17 00:00:00-07	2.91	95	0.75	4	177	\N	\N	\N	NaN	171	\N
36972	AMLP-286	2021-03-17 00:00:00-07	3.53	95	1.06	4	214	\N	\N	\N	NaN	170	\N
36973	AMLP-288	2021-03-17 00:00:00-07	5	9	1.39	4	333	\N	\N	\N	NaN	172	\N
36974	AMLP-250	2021-03-17 00:00:00-07	3.44	96	0.22	4	141.1	\N	\N	\N	NaN	116	\N
36975	AMLP-310	2021-05-20 00:00:00-07	1.68	95	1.68	4	159	\N	\N	\N	NaN	110	\N
36976	AMLP-314	2021-05-20 00:00:00-07	19	18	3.52	4	333	\N	\N	\N	NaN	135	\N
36977	AMLP-316	2021-05-20 00:00:00-07	7.76	43	2.66	4	333	\N	\N	\N	NaN	142	\N
36978	AMLP-315	2021-05-20 00:00:00-07	9.94	34	2.89	4	333	\N	\N	\N	NaN	141	\N
36979	AMLP-322	2021-05-27 00:00:00-07	4.3	43	2.46	4	333	\N	\N	\N	NaN	151	\N
36980	AMLP-321	2021-05-27 00:00:00-07	1.79	191	0.93	4	105	\N	\N	\N	NaN	105	\N
36981	AMLP-323	2021-05-27 00:00:00-07	4.36	180	1.87	4	333	\N	\N	\N	NaN	153	\N
36982	AMLP-331	2021-05-27 00:00:00-07	6.33	64	5.7	4	333	\N	\N	\N	NaN	180	\N
36983	AMLP-301	2021-04-07 00:00:00-07	4.59	57	3.03	4	333	\N	\N	\N	42 ng in AGEX-25	185	\N
36984	AMLP-324	2021-05-27 00:00:00-07	2.99	96	0.94	4	490	\N	\N	\N	NaN	154	\N
36985	AMLP-325	2021-05-27 00:00:00-07	1.76	95	0.88	4	100	\N	\N	\N	NaN	155	\N
36986	AMLP-326	2021-05-27 00:00:00-07	2.83	95	1.36	4	150	\N	\N	\N	NaN	156	\N
36987	AMLP-327	2021-05-27 00:00:00-07	2.55	95	1.42	4	130	\N	\N	\N	NaN	157	\N
36988	AMLP-330	2021-05-27 00:00:00-07	3.15	95	2.69	4	121	\N	\N	\N	NaN	179	\N
36989	AMLP-332	2021-05-27 00:00:00-07	0.98	95	0.38	4	61	\N	\N	\N	NaN	183	\N
36990	AMLP-248	2021-03-17 00:00:00-07	4.13	NaN	0.37	4	NaN	\N	\N	\N	NaN	113	\N
36991	AMLP-249	2021-03-17 00:00:00-07	2.95	95	0.27	4	115.9	\N	\N	\N	NaN	114	\N
36992	AMLP-302	2021-04-07 00:00:00-07	5.08	54	1.9	4	333	\N	\N	\N	NaN	186	\N
36993	AMLP-303	2021-05-13 00:00:00-07	4.97	95	1.67	4	249	\N	\N	\N	NaN	136	\N
36994	AMLP-304	2021-05-13 00:00:00-07	2.25	95	0.58	4	180	\N	\N	\N	NaN	137	\N
36995	AMLP-307	2021-05-13 00:00:00-07	2.93	95	0.73	4	228	\N	\N	\N	NaN	144	\N
36996	AMLP-111	2018-11-30 00:00:00-08	4.33	48	3.42	4	101.3	\N	\N	\N	NaN	37	\N
36997	AMLP-161	2020-01-31 00:00:00-08	5.58	39	2.26	4	300	\N	\N	\N	120s shear time; DNA repaired	25	\N
36998	AMLP-193	2020-02-07 00:00:00-08	4.5	96	1.4	4	228	\N	\N	\N	NaN	115	\N
36999	AMLP-284	2021-03-17 00:00:00-07	2.47	95	0.89	4	91.4	\N	\N	\N	NaN	168	\N
37000	AMLP-305-306	2021-05-13 00:00:00-07	3.2	380	1.75	4	278	\N	\N	\N	Merged AMLP-305 (91.7ng captured in AGEX-27), and AMLP-306 (83.4ng captured in AGEX-28; 302bp size) and submitted as AMLP-305 in BCB031. Same adapter #138.	138	\N
37001	AMLP-348	2021-09-15 00:00:00-07	5.09	51	4.7	4	1200	\N	\N	\N	HyperPREP; Ligation: 15 min at 20 oC	98	\N
37002	AMLP-347	2021-09-15 00:00:00-07	6.51	78	5.79	4	1200	\N	\N	\N	HyperPREP; Ligation: 15 min at 20 oC	97	\N
37003	AMLP-367	2021-09-18 00:00:00-07	6.8	63	5.32	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	104	\N
37004	AMLP-375-1	2021-09-27 00:00:00-07	2.2	37	4.52	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	105	\N
37005	AMLP-203	2020-08-02 00:00:00-07	9.32	NaN	6.67	4	NaN	\N	\N	\N	NaN	138	\N
37006	AMLP-202	2020-08-02 00:00:00-07	5.73	NaN	3.36	4	NaN	\N	\N	\N	NaN	137	\N
37007	AMLP-373	2021-09-27 00:00:00-07	3.79	50	2.46	4	180	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	108	\N
37008	AMLP-201	2020-08-02 00:00:00-07	9.49	NaN	5.61	4	NaN	\N	\N	\N	AGEX-30: 150ng, SSXTHS Hu All Exon V7	136	\N
37009	AMLP-349-352	2021-09-15 00:00:00-07	3.34	148	1.75	4	1200	\N	\N	\N	Sequenced as: AMLP-349; HyperPREP; Ligation: 60 min at 20 oC., HyperPREP; Ligation: 15 min at 20 oC. AMLP-349: capture 87.5 ng in AGEX-29. AMLP-352: capture 81.0 ng in AGEX-30.	99	\N
37010	T12_12366	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	None	NF-96-3	\N
37011	T12_6261B	2012-05-14 00:00:00-07	NaN	50	4.2	NaN	210	\N	\N	\N	None	NF-96-2	\N
37012	T12_6261A	2012-05-14 00:00:00-07	NaN	50	10.24	NaN	512	\N	\N	\N	None	NF-96-1	\N
37013	T12_12470D	2012-05-14 00:00:00-07	NaN	50	9.6	NaN	480	\N	\N	\N	None	NF-96-8	\N
37014	T12_12467	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	Hybridization Input DNA Manipulation	NF-96-4	\N
37015	T12_562	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	None	NF-96-10	\N
37016	T12_12626	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	Hybridization Input DNA Manipulation	NF-96-13	\N
37017	T12_12647	2012-05-14 00:00:00-07	NaN	50	6.6	NaN	330	\N	\N	\N	None	NF-96-12	\N
37018	T12_13587_B2	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	None	NF-96-14	\N
37019	T12_18438A	2012-05-14 00:00:00-07	NaN	50	8	NaN	400	\N	\N	\N	None	NF-96-15	\N
37020	T12_13587_B2_0_75ug	2012-05-14 00:00:00-07	NaN	50	15	NaN	750	\N	\N	\N	Diluted Input Library DNA, Samples 44-46 were dilutions made from sample 23 to test how the same template with varying input concentrations under the required 1 ug input effects sequencing. 	NF-96-29	\N
37021	T12-19187A	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	None	NF-96-20	\N
37022	T12_22172_Norm	\N	NaN	50	7.42	NaN	371	\N	\N	\N	 Normal Tumor Pair; Bowen's Disease,Left lateral back; SCC, in situ	NF-96-22	\N
37023	T12_21726A_Tumor	2012-05-14 00:00:00-07	NaN	50	3.14	NaN	157	\N	\N	\N	None; Dermatofibroma	NF-96-24	\N
37024	T12_22901A_Norm	2012-05-14 00:00:00-07	NaN	50	9.94	NaN	497	\N	\N	\N	Normal Tumor Pair; Melanocytic Nevus; Intradermal, forehead; PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	NF-96-25	\N
37025	T12_13152_Tumor	2012-05-14 00:00:00-07	NaN	50	11.08	NaN	554	\N	\N	\N	Hybridization Input DNA Manipulation	NF-96-17	\N
37026	T12_13587_B2_0_5ug	2012-05-14 00:00:00-07	NaN	50	10	NaN	500	\N	\N	\N	Diluted Input Library DNA, Samples 44-46 were dilutions made from sample 23 to test how the same template with varying input concentrations under the required 1 ug input effects sequencing. 	NF-96-30	\N
37027	T12_22172_Tumor	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	Normal Tumor Pair; Bowen's Disease,Left lateral back; SCC, in situ	NF-96-23	\N
37028	T12_19596	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	None	NF-96-19	\N
37029	H12_22776_B5_Norm	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	Melanoma, Acral; Biopsy site w/residual Acral,Toe web	NF-96-27	\N
37030	Buffy_Coat	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	Buffy Coat Derived DNA	NF-96-28	\N
37031	T12_12750B	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	None	NF-96-18	\N
37089	N3_10	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	73010|Normal Melanoma, Mucosal vulva	L2DR10	\N
37090	N3_3	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	2990543-1|melanocytoma	L2DR03	\N
37032	T12_13587_B2_0_25ug	2012-05-14 00:00:00-07	NaN	50	5	NaN	250	\N	\N	\N	Diluted Input Library DNA, Samples 44-46 were dilutions made from sample 23 to test how the same template with varying input concentrations under the required 1 ug input effects sequencing. 	NF-96-31	\N
37033	T12_22901A_Tumor	2012-05-14 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	Normal Tumor Pair; Melanocytic Nevus; Intradermal, forehead; PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)\n	NF-96-26	\N
37034	T12_22900	2012-06-08 00:00:00-07	NaN	40	12.08	NaN	604	\N	\N	\N	NaN	NF-96-57	\N
37035	T12_22602B	2012-06-08 00:00:00-07	NaN	26	20	NaN	1000	\N	\N	\N	NaN	NF-96-45	\N
37036	T12_22720A1	2012-06-08 00:00:00-07	NaN	86	7.4	NaN	370	\N	\N	\N	NaN	NF-96-49	\N
37037	T12_22884C	2012-06-08 00:00:00-07	NaN	22	20	NaN	1000	\N	\N	\N	NaN	NF-96-51	\N
37038	T12_22886	2012-06-08 00:00:00-07	NaN	312	20	NaN	1000	\N	\N	\N	NaN	NF-96-53	\N
37039	T12_22582A	2012-06-08 00:00:00-07	NaN	12	8.88	NaN	444	\N	\N	\N	NaN	NF-96-36	\N
37040	T12_22587	2012-06-08 00:00:00-07	NaN	113	15.46	NaN	773	\N	\N	\N	NaN	NF-96-40	\N
37041	T12_22602A	2012-06-08 00:00:00-07	NaN	21	20	NaN	1000	\N	\N	\N	NaN	NF-96-44	\N
37042	T12_22573	2012-06-08 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	NaN	NF-96-34	\N
37043	T12_22604	2012-06-08 00:00:00-07	NaN	7	5.56	NaN	278	\N	\N	\N	NaN	NF-96-47	\N
37044	H12_22794A	2012-06-08 00:00:00-07	NaN	26	20	NaN	1000	\N	\N	\N	NaN	NF-96-33	\N
37045	T12_22898	2012-06-08 00:00:00-07	NaN	211	19.62	NaN	981	\N	\N	\N	NaN	NF-96-56	\N
37046	T12_22597_700ng	2012-06-08 00:00:00-07	NaN	75	14	NaN	700	\N	\N	\N	Samples 73-76 were dilutions made from sample 58 to test how the same template with varying input concentrations ( under the required 1 ug input) effects sequencing. \n	NF-96-58	\N
37047	T12_22894B	2012-06-08 00:00:00-07	NaN	8	6.06	NaN	303	\N	\N	\N	NaN	NF-96-55	\N
37048	T12_22597_1000ng	2012-06-08 00:00:00-07	NaN	97	20	NaN	1000	\N	\N	\N	NaN	NF-96-43	\N
37049	H12_22775	2012-06-08 00:00:00-07	NaN	50	20	NaN	1000	\N	\N	\N	NaN	NF-96-32	\N
37050	T12_22603	2012-06-08 00:00:00-07	NaN	12	20	NaN	1000	\N	\N	\N	NaN	NF-96-46	\N
37051	T12_22597_250ng	2012-06-08 00:00:00-07	NaN	50	5	NaN	250	\N	\N	\N	Samples 73-76 were dilutions made from sample 58 to test how the same template with varying input concentrations ( under the required 1 ug input) effects sequencing. 	NF-96-60	\N
37052	T12_22592	2012-06-08 00:00:00-07	NaN	56	13.4	NaN	670	\N	\N	\N	NaN	NF-96-41	\N
37053	T12_22597_500ng	2012-06-08 00:00:00-07	NaN	50	10	NaN	500	\N	\N	\N	Samples 73-76 were dilutions made from sample 58 to test how the same template with varying input concentrations ( under the required 1 ug input) effects sequencing. 	NF-96-59	\N
37054	T12_22597_100ng	2012-06-08 00:00:00-07	NaN	50	2	NaN	100	\N	\N	\N	Samples 73-76 were dilutions made from sample 58 to test how the same template with varying input concentrations ( under the required 1 ug input) effects sequencing. 	NF-96-61	\N
37055	T12_22868	2012-06-08 00:00:00-07	NaN	176	20	NaN	1000	\N	\N	\N	NaN	NF-96-50	\N
37056	T12_22884D	2012-06-08 00:00:00-07	NaN	10	4.16	NaN	208	\N	\N	\N	NaN	NF-96-52	\N
37057	WP_11	\N	NaN	0	NaN	NaN	100	\N	\N	\N	Iwei Autopsy	L2DR01	\N
37058	WP_23	\N	NaN	1	NaN	NaN	100	\N	\N	\N	Iwei Autopsy	L2DR02	\N
37059	WP_29	\N	NaN	0	NaN	NaN	100	\N	\N	\N	Iwei Autopsy	L2DR03	\N
37060	PG_8	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR04	\N
37061	Kit_37_Acral_NRAS	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR05	\N
37062	Bivona_L4	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR14	\N
37063	Bivona_L_1	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR11	\N
37064	Bivona_L2	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR12	\N
37065	Kit_181_Muc_BRAF	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR08	\N
37067	Kit_62__Acral_NRAS	\N	NaN	Infinity	NaN	NaN	50	\N	\N	\N	NaN	L2DR06	\N
37068	Bivona_L5	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR15	\N
37069	Bivona_L6	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR16	\N
37070	Bivona_L3	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR13	\N
37071	Kit_118_Muc_NRAS	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR07	\N
37072	Kit_275_Muc_BRAF	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR10	\N
37073	21-3	\N	NaN	74	NaN	NaN	100	\N	\N	\N	RIGHT MID UPPER BACK	L2DR03	\N
37074	Ivanka_24-2_Tert	\N	NaN	9	NaN	NaN	100	\N	\N	\N	RIGHT GLUTEUS	L2DR07	\N
37075	28_2	\N	NaN	17	NaN	NaN	100	\N	\N	\N	LEFT POPLITEAL FOSSA	L2DR12	\N
37076	Kit 262	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Rectal	L2DR16	\N
37077	28_3	\N	NaN	120	NaN	NaN	37	\N	\N	\N	LEFT POPLITEAL FOSSA	L2DR13	\N
37078	28_4	\N	NaN	85	NaN	NaN	100	\N	\N	\N	LEFT POPLITEAL FOSSA	L2DR14	\N
37080	21-1	\N	NaN	72	NaN	NaN	100	\N	\N	\N	RIGHT MID UPPER BACK	L2DR01	\N
37081	Ivanka_24-1_Tert	\N	NaN	3	NaN	NaN	100	\N	\N	\N	RIGHT GLUTEUS	L2DR06	\N
37082	28_5	\N	NaN	97	NaN	NaN	100	\N	\N	\N	LEFT POPLITEAL FOSSA	L2DR15	\N
37083	21_5	\N	NaN	13	NaN	NaN	15.6	\N	\N	\N	Ivanka_21_5_Norm, RIGHT MID UPPER BACK	L2DR05	\N
37084	24-3	\N	NaN	53	NaN	NaN	100	\N	\N	\N	RIGHT GLUTEUS	L2DR08	\N
37085	28_1	\N	NaN	28	NaN	NaN	100	\N	\N	\N	LEFT POPLITEAL FOSSA	L2DR11	\N
37086	24_5_Norm	\N	NaN	14	NaN	NaN	12	\N	\N	\N	Ivanka_24_5_Norm, RIGHT GLUTEUS	L2DR10	\N
37087	21-2	\N	NaN	106	NaN	NaN	100	\N	\N	\N	RIGHT MID UPPER BACK	L2DR02	\N
37088	21-4	\N	NaN	98	NaN	NaN	100	\N	\N	\N	RIGHT MID UPPER BACK	L2DR04	\N
39703	BS9	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39704	BS10	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
39705	BS11	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 11	\N
39706	22_IS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37091	N3_14	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Need to Get diagnosis from Iwei|NTRK3 Translocation case	L2DR14	\N
37092	N3_16	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Need to Get diagnosis from Iwei|BRAF Translocation case	L2DR16	\N
37093	N3_15	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Need to Get diagnosis from Iwei|BRAF Translocation case	L2DR15	\N
37094	N3_11	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Need to Get diagnosis from Iwei|NTRK3 Translocation case	L2DR11	\N
37095	N3_1	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	sp-12-3436|mucosal melanoma +EIN	L2DR01	\N
37096	N3_12	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Need to Get diagnosis from Iwei|ROS1 Translocation case	L2DR12	\N
37097	N3_4	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	3146318-1|acral melanoma	L2DR04	\N
37098	N3_8	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	73005|Normal Melanoma, Mucosal nasal sinus	L2DR08	\N
37099	N3_2	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	sp-07-8373|mucosal melanomas-non-pigmented	L2DR02	\N
37100	N3_6	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	73003|Normal Melanoma, Mucosal nasal sinus	L2DR06	\N
37102	N3_13	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Need to Get diagnosis from Iwei|ROS1 Translocation case	L2DR13	\N
37103	N3_5	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	73001, 73002|TUMOR Mucosal Melanoma, nasal sinus	L2DR05	\N
37104	N3_7	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	73004|TUMOR Melanoma, Mucosal nasal sinus	L2DR07	\N
37105	MB_1454_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR04	\N
37106	MB_1036_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR10	\N
37107	Bivona_L_19	\N	NaN	Infinity	NaN	NaN	9.1	\N	\N	\N	NaN	L2DR13	\N
37108	MB_1029_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR07	\N
37109	MB_327_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR03	\N
37110	MB_760_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR05	\N
37111	MB_1418_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR06	\N
37112	Kit_313_Mucosal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR16	\N
37113	Bivona__L_17	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR11	\N
37114	Kit_53_Acral_NRAS	\N	63.4	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR15	\N
37115	Kit_227_Acral_WT_CACCTC	\N	100	1	NaN	NaN	100	\N	\N	\N	NaN	L2DR14	\N
37116	MB_161_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR01	\N
37118	MB_161_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR02	\N
37119	MB_1028_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR08	\N
37120	Bivona_L_18	\N	NaN	Infinity	NaN	NaN	62.7	\N	\N	\N	NaN	L2DR12	\N
37121	BB008_CGH12-047	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR07	\N
37122	BB008_NB2107	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR14	\N
37123	BB008_WM3211	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR13	\N
37124	BB008_CGH10-013	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR08	\N
37125	BB008_LAL-L1	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR15	\N
37126	BB008_HW9TC	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosla Melanoma, vulva, Hong Wu	L2DR06	\N
37127	BB008_HW9-NB	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosal Melanoma, Blood, Hong Wu	L2DR05	\N
37128	BB008_HW2TC	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosal Melanoma, vulva, Hong Wu	L2DR02	\N
37129	BB008_HW2NC	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosal Melanoma, vulva, Hong Wu	L2DR01	\N
37130	BB008_LAL-L2	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR16	\N
37131	BB008_HW8TC	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosal Melanoma, Urethra, Hong Wu	L2DR04	\N
37132	BB008_Kit 227 Acral WT	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR12	\N
37134	BB008_CGH11-036	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR10	\N
37135	BB008_CGH11-386	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR11	\N
37136	BB008_HW8NC	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Mucosal Melanoma, Urethra, Hong Wu	L2DR03	\N
37137	BB09_Bivona_L7	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	Unknown	L2DR01	\N
37138	BB09_Bivona_L10	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	Unknown	L2DR04	\N
37139	BB09_HW3_T	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	TUMOR Mucosal Melanoma, nasal sinus	L2DR05	\N
37140	BB09_HW3_N	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Normal Melanoma, Mucosal nasal sinus	L2DR06	\N
37141	BB09_CGH11_092	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	ROS1 Translocation case	L2DR13	\N
37142	BB09_Bivona_L11	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	Unknown	L2DR16	\N
37143	BB09_Bivona_L9	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	Unknown	L2DR03	\N
37144	BB09_CGH11_029	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NTRK3 Translocation case	L2DR11	\N
37146	BB09_CGH11_125	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NTRK3 Translocation case	L2DR14	\N
37147	BB09_CGH11_045	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	ROS1 Translocation case	L2DR12	\N
37148	BB09_CGH11_194	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	BRAF Translocation case	L2DR15	\N
37149	BB09_HW4_N	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Normal Melanoma, Mucosal nasal sinus	L2DR08	\N
37150	BB09_Bivona_L8	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	Unknown	L2DR02	\N
37151	BB09_HW4_T	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	TUMOR Melanoma, Mucosal nasal sinus	L2DR07	\N
37152	BB09_HW6_ND	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Normal Melanoma, Mucosal vulva	L2DR10	\N
37153	DP12_200	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Dr. Lutzky's Case	L2DR11	\N
37154	HW_A1_Cntl	\N	NaN	Infinity	NaN	NaN	34.3	\N	\N	\N	Hong Wu	L2DR02	\N
37155	HW_A4_Cntl	\N	NaN	Infinity	NaN	NaN	84.4	\N	\N	\N	Hong Wu	L2DR08	\N
37156	HW_A4_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hong Wu	L2DR07	\N
37157	CGH11_60	\N	NaN	Infinity	NaN	NaN	34	\N	\N	\N	Iwei Translocation Case	L2DR14	\N
37158	CGH10_16	\N	NaN	Infinity	NaN	NaN	74.3	\N	\N	\N	Iwei Translocation Case | Barcode mismatch comment in note	L2DR13	\N
37159	ALK_Cntl	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Tissue Core ALK | Barcode mismatch comment in note	L2DR12	\N
37160	CGH11_252	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Translocation Case	L2DR15	\N
37161	CGH10_17	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Translocation Case	L2DR16	\N
37162	HW_A3_Cntl	\N	NaN	Infinity	NaN	NaN	67	\N	\N	\N	Hong Wu	L2DR06	\N
37163	HW_A1_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hong Wu	L2DR01	\N
37164	HW_A2_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hong Wu	L2DR03	\N
37165	HW_A3_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Hong Wu	L2DR05	\N
37167	CGH11_343	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Translocation Case	L2DR10	\N
37168	HW_A2_Cntl	\N	NaN	Infinity	NaN	NaN	95.8	\N	\N	\N	Hong Wu	L2DR04	\N
37169	D12_67298_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation	L2DR01	\N
37170	MB1423_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver	L2DR07	\N
37171	MB1421_Norm	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Acral Normal, Thumb, Frozen Tissue DNA extracted by Denver	L2DR10	\N
37172	CGH12_317	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NTRK3 | Barcode mismatch comment in note	L2DR13	\N
37173	S12_20321_A2_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Brain, right frontal, biopsy: Glioblastoma, WHO Grade IV 	L2DR03	\N
37174	L11_96096_A2_Norm	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Metastatic Melanoma, Lymph Node, sentinel. Capsular nevus is present	L2DR04	\N
37176	CGH12_161	\N	NaN	Infinity	NaN	NaN	30.3	\N	\N	\N	NTRK1	L2DR16	\N
37177	MB1429_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver	L2DR11	\N
37178	D12_67298_Norm	\N	NaN	Infinity	NaN	NaN	78.2	\N	\N	\N	lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation	L2DR02	\N
37179	MB1428_Norm	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Acral Normal, Heel Frozen Tissue DNA Extracted by Denver | Barcode mismatch comment in note	L2DR13	\N
37180	CGH12_343	\N	NaN	Infinity	NaN	NaN	74.6	\N	\N	\N	NTRK3	L2DR14	\N
37181	MB1241_Norm	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Acral Normal, Frozen Tissue DNA  Extracted by Denver	L2DR06	\N
37182	CGH12_135	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NTRK1	L2DR15	\N
37183	MB1423_Norm	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Acral Normal Heel, FFPE Extracted DNA by Denver	L2DR08	\N
37184	MB1242_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Acral Tumor, Frozen Tissue DNA Extracted by Denver	L2DR05	\N
37185	MB_1609_Normal	\N	NaN	Infinity	NaN	NaN	32.1	\N	\N	\N	NaN	L2DR14	\N
37186	HW_A5_Cntl	\N	NaN	Infinity	NaN	NaN	82.6	\N	\N	\N	NaN	L2DR02	\N
37187	HW_A8_Cntl	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR08	\N
37188	HW_A7 Cntl	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR06	\N
37189	HW_A7_Tumor	\N	NaN	Infinity	NaN	NaN	86.5	\N	\N	\N	NaN	L2DR05	\N
37190	WM51	2013-03-25 00:00:00-07	NaN	1	NaN	NaN	100	\N	\N	\N	NaN	L2DR15	\N
37191	HW_A6_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR03	\N
37193	HW_A6_Cntl	\N	NaN	Infinity	NaN	NaN	68.3	\N	\N	\N	NaN	L2DR04	\N
37194	HW_A9_Cntl	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR10	\N
37195	HW_A5_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR01	\N
37196	HW_A10_Cntl	\N	NaN	Infinity	NaN	NaN	97.4	\N	\N	\N	NaN	L2DR12	\N
37197	WM3918	2013-03-25 00:00:00-07	NaN	2	NaN	NaN	100	\N	\N	\N	NaN	L2DR16	\N
37198	MB1617_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR13	\N
37199	HW_A8_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR07	\N
37200	HW_A10_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR11	\N
37201	DM93_CGN	\N	NaN	2	NaN	NaN	45.7	\N	\N	\N	NaN	L2DR16	\N
37202	DM1_Tumor	\N	NaN	1	NaN	NaN	100	\N	\N	\N	NaN	L2DR02	\N
37203	DM93_Normal	\N	NaN	7	NaN	NaN	100	\N	\N	\N	NaN	L2DR15	\N
37204	DM2_Normal	\N	NaN	9	NaN	NaN	89.9	\N	\N	\N	NaN	L2DR03	\N
37206	DM21_Normal	\N	NaN	18	NaN	NaN	39.6	\N	\N	\N	NaN	L2DR13	\N
37207	DM5_Normal	\N	NaN	12	NaN	NaN	32.6	\N	\N	\N	NaN	L2DR05	\N
37208	DM1_Normal	\N	NaN	14	NaN	NaN	34.3	\N	\N	\N	NaN	L2DR01	\N
37209	DM5 _Tumor	\N	NaN	0	NaN	NaN	38.3	\N	\N	\N	NaN	L2DR06	\N
37210	DM2_Tumor	\N	NaN	1	NaN	NaN	100	\N	\N	\N	NaN	L2DR04	\N
37211	DM13_Normal	\N	NaN	Infinity	NaN	NaN	67.5	\N	\N	\N	NaN	L2DR11	\N
37212	DM12_Tumor	\N	NaN	3	NaN	NaN	100	\N	\N	\N	NaN	L2DR10	\N
37213	DM21_Tumor	\N	NaN	1	NaN	NaN	16.4	\N	\N	\N	NaN	L2DR14	\N
37214	DM13_Tumor	\N	NaN	1	NaN	NaN	100	\N	\N	\N	NaN	L2DR12	\N
37215	DM7_Tumor	\N	NaN	3	NaN	NaN	100	\N	\N	\N	NaN	L2DR08	\N
37216	DM7_Normal	\N	NaN	14	NaN	NaN	51.5	\N	\N	\N	NaN	L2DR07	\N
37217	DM8TumorCrest	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37218	WM3912	2013-03-25 00:00:00-07	NaN	0	NaN	NaN	NaN	\N	\N	\N	Wistar, Fusion Project, Cell Line DNA	L2DR16	\N
37219	WM3622	2013-03-25 00:00:00-07	NaN	6	NaN	NaN	100	\N	\N	\N	Wistar, Fusion Project, Cell Line DNA	L2DR12	\N
37221	WM8	2013-03-25 00:00:00-07	NaN	0	NaN	NaN	NaN	\N	\N	\N	Wistar, Fusion Project, Cell Line DNA	L2DR15	\N
37222	D12_54992_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Swapna DNA, screened	L2DR13	\N
37223	CGH11_078	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Iwei Translocation Cases	L2DR01	\N
37224	CGH11_020	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Iwei Translocation Cases	L2DR08	\N
37225	CGH10_049	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Iwei Translocation Cases	L2DR07	\N
37226	CGH11_283	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Iwei Translocation Cases	L2DR05	\N
37227	D12_54992_Norm	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Swapna DNA, screened	L2DR11	\N
37228	WM1963	2013-03-25 00:00:00-07	NaN	3	NaN	NaN	100	\N	\N	\N	Wistar, Fusion Project, Cell Line DNA	L2DR14	\N
37229	CGH10_058	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Iwei Translocation Cases	L2DR04	\N
37230	CGH11_080	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Iwei Translocation Cases	L2DR02	\N
37231	D12_54296_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Swapna DNA, screened	L2DR10	\N
37232	CGH11_281	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Iwei Translocation Cases	L2DR03	\N
37233	CGH10_020	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Iwei Translocation Cases	L2DR06	\N
37234	DM11_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	L2DR02	\N
37236	DM55 Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR14	\N
37237	DM79_Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR16	\N
37238	DM26_Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR06	\N
37239	DM79_2_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	L2DR15	\N
37240	DM34_Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	L2DR12	\N
37241	DM34_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR11	\N
37242	DM11_Tumor	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR01	\N
37243	DM26_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR05	\N
37244	DM55_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR13	\N
37245	DM29_Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR10	\N
37246	DM14_Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR04	\N
37247	DM28_Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR08	\N
37248	DM14_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR03	\N
37249	DM28_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR07	\N
37250	CGH_11_366	\N	NaN	Infinity	NaN	NaN	12.4	\N	\N	\N	Iwei Translocation Project	L2DR02	\N
37251	DM_4_Normal	\N	NaN	Infinity	NaN	NaN	97.8	\N	\N	\N	NaN	L2DR08	\N
37252	Kit_8	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Alyssa Kit Mutations	L2DR12	\N
37254	CGH_11_361	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Translocation Project	L2DR01	\N
37255	Kit_55	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Alyssa Kit Mutations	L2DR15	\N
37256	CGH_12_016	\N	NaN	Infinity	NaN	NaN	94.6	\N	\N	\N	Iwei Translocation Project	L2DR06	\N
37257	DM_4_Tumor	\N	NaN	Infinity	NaN	NaN	33.5	\N	\N	\N	NaN	L2DR07	\N
37258	DM_95_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR10	\N
37259	CGH_11_388	\N	NaN	Infinity	NaN	NaN	69.4	\N	\N	\N	Iwei Translocation Project	L2DR04	\N
37260	CGH_11_376	\N	NaN	Infinity	NaN	NaN	84.3	\N	\N	\N	Iwei Translocation Project	L2DR03	\N
37261	DM_96_Normal	\N	NaN	Infinity	NaN	NaN	29.5	\N	\N	\N	NaN	L2DR13	\N
37262	Kit_76	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Alyssa Kit Mutations	L2DR16	\N
37263	CGH_11_422	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei Translocation Project	L2DR05	\N
37264	Kit_21	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Alyssa Kit Mutations	L2DR14	\N
37265	DM_96_2_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR11	\N
37266	Kit_192	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_15	L2DR15	\N
37267	CNS_39_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_12	L2DR12	\N
37269	CNS_30_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_3	L2DR03	\N
37270	CNS_35_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_8	L2DR08	\N
37271	CNS_33_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_5	L2DR05	\N
37272	CNS_34_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_6	L2DR06	\N
37273	CNS_40_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_13	L2DR13	\N
37274	CNS_34_Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_7	L2DR07	\N
37275	CNS_41_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_14	L2DR14	\N
37276	CNS_29_Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_2	L2DR02	\N
37277	Kit_203	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_16	L2DR16	\N
37278	CNS_31_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_4	L2DR04	\N
37279	CNS_37_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_10	L2DR10	\N
37280	CNS_29_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_1	L2DR01	\N
37281	CNS_38_Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	N14_11	L2DR11	\N
37282	KR_177	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	blood derived	L2DR04	\N
37284	KR_2030	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	blood derived	L2DR03	\N
37285	KR_2064	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	blood derived	L2DR02	\N
37286	KR_RMK0091B	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	skin	L2DR10	\N
37287	KR_203	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	blood derived	L2DR07	\N
37288	KR_RMK0194C	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	Saliva-tube	L2DR11	\N
37289	KR_8	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	blood derived	L2DR08	\N
37290	KR_RMK0162C	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	saliva | Barcode mismatch comment in note	L2DR12	\N
37291	KR_166	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	blood derived.	L2DR01	\N
37292	KR_150	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	blood derived	L2DR05	\N
37293	KR_RMK0137C	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	saliva | Barcode mismatch comment in note	L2DR13	\N
37294	Ivanka_24_5_Norm	\N	NaN	14	NaN	NaN	12	\N	\N	\N	Ivanka Normal Resequencing	L2DR16	\N
37295	Ivanka_21_5_Norm	\N	NaN	13	NaN	NaN	15.6	\N	\N	\N	Ivanka Normal Resequencing	L2DR15	\N
37296	KR_229	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	blood derived	L2DR06	\N
37297	KR_RMK0168C	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	saliva	L2DR14	\N
37298	DM_37_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR14	\N
37299	DM_23_Normal	\N	NaN	Infinity	NaN	NaN	30.8	\N	\N	\N	NaN	L2DR10	\N
37300	DM_25_Tumor	\N	NaN	Infinity	NaN	NaN	24.5	\N	\N	\N	NaN	L2DR11	\N
37301	DM_10_Tumor	\N	NaN	Infinity	NaN	NaN	80.6	\N	\N	\N	NaN	L2DR01	\N
37302	DM_93_cgn	\N	NaN	Infinity	NaN	NaN	45.7	\N	\N	\N	NaN	L2DR16	\N
37303	DM_22_Normal	\N	NaN	Infinity	NaN	NaN	12	\N	\N	\N	NaN	L2DR08	\N
37304	DM_18_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR06	\N
37305	DM_22_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR07	\N
37306	DM_10_Normal	\N	NaN	Infinity	NaN	NaN	97.8	\N	\N	\N	NaN	L2DR02	\N
37307	DM_25_Normal	\N	NaN	Infinity	NaN	NaN	76.5	\N	\N	\N	NaN	L2DR13	\N
37308	DM_6_Tumor	\N	NaN	Infinity	NaN	NaN	90.1	\N	\N	\N	NaN	L2DR12	\N
37309	DM_17_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR03	\N
37310	DM_17_Normal	\N	NaN	Infinity	NaN	NaN	31.3	\N	\N	\N	NaN	L2DR04	\N
37311	DM_93_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR15	\N
37312	DM_18_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR05	\N
37315	DM_43_Tumor	\N	NaN	Infinity	NaN	NaN	91.8	\N	\N	\N	NaN	L2DR15	\N
37316	SM_1_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Spitzoid Melanoma Maria	L2DR01	\N
37317	SM_8_Tumor	\N	NaN	Infinity	NaN	NaN	98.4	\N	\N	\N	Spitzoid Melanoma Maria	L2DR08	\N
37318	DM_48_Tumor	\N	NaN	Infinity	NaN	NaN	44.8	\N	\N	\N	NaN	L2DR16	\N
37319	SM_5_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Spitzoid Melanoma Maria	L2DR05	\N
37320	SM7_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Spitzoid Melanoma Maria	L2DR07	\N
37321	SM_4_Normal	\N	NaN	Infinity	NaN	NaN	23.3	\N	\N	\N	Spitzoid Melanoma Maria	L2DR04	\N
37322	SM_18_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Spitzoid Melanoma Maria	L2DR12	\N
37323	SM_16_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Spitzoid Melanoma Maria	L2DR13	\N
37324	SM_16_Tumor	\N	NaN	Infinity	NaN	NaN	85.8	\N	\N	\N	Spitzoid Melanoma Maria	L2DR11	\N
37325	DM_42_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR14	\N
37326	SM_5_Normal	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Spitzoid Melanoma Maria	L2DR06	\N
37327	SM_12_Tumor	\N	NaN	Infinity	NaN	NaN	39.6	\N	\N	\N	Spitzoid Melanoma Maria	L2DR10	\N
37328	SM_3_Tumor	\N	NaN	Infinity	NaN	NaN	76.2	\N	\N	\N	Spitzoid Melanoma Maria	L2DR02	\N
37329	SM_4_Tumor	\N	NaN	Infinity	NaN	NaN	95.2	\N	\N	\N	Spitzoid Melanoma Maria	L2DR03	\N
37330	CGH11-087	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR11	\N
37331	CGH11_348	\N	NaN	Infinity	NaN	NaN	60.2	\N	\N	\N	NTRK1 Iwei, Translocation	L2DR05	\N
37332	CGH11_305	\N	NaN	Infinity	NaN	NaN	54.3	\N	\N	\N	NTRK1 Iwei, Translocation	L2DR02	\N
37333	CGH11-072	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR10	\N
37334	CGH11_310	\N	NaN	Infinity	NaN	NaN	54	\N	\N	\N	ALK Iwei, Translocation	L2DR03	\N
37335	CGH10-045	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR07	\N
37337	CGH11-158	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR14	\N
37338	CGH11-147	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR12	\N
37339	CGH11-172	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR16	\N
37340	CGH11-089	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR13	\N
37341	CGH11_292	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	ALK Iwei, Translocation	L2DR01	\N
37342	CGH11-166	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR15	\N
37343	CGH11_319	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NTRK1 Iwei, Translocation	L2DR04	\N
39707	DPN_MM 20	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39708	DM_18_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
39709	CGH11-202	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-202 	L2DR04	\N
39710	CGH11-215	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-215 	L2DR05	\N
39711	CGH12-088	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-088 	L2DR06	\N
39712	CGH12-188	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-188 	L2DR07	\N
37344	CGH10-062	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR08	\N
37345	CGH10-028	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	 Iwei, 7QGain	L2DR06	\N
37346	CGH11-259	\N	20.3	0	NaN	NaN	93.5	\N	\N	\N	Iwei 7Q Gain	L2DR11	\N
37347	CGH10-058	\N	NaN	Infinity	NaN	NaN	120	\N	\N	\N	NaN	L2DR04	\N
37348	CGH11-409	\N	16	Infinity	NaN	NaN	100	\N	\N	\N	Iwei 7Q Gain	L2DR16	\N
37349	CGH11-315	\N	15.8	Infinity	NaN	NaN	31.1	\N	\N	\N	Iwei 7Q Gain	L2DR12	\N
37350	CGH11-404	\N	21.7	Infinity	NaN	NaN	65.5	\N	\N	\N	Iwei 7Q Gain	L2DR15	\N
37351	CGH11-339	\N	20.8	Infinity	NaN	NaN	100	\N	\N	\N	Iwei 7Q Gain	L2DR13	\N
37352	CGH11-194	\N	NaN	Infinity	NaN	NaN	120	\N	\N	\N	NaN	L2DR15	\N
37353	CGH11-252	\N	NaN	Infinity	NaN	NaN	120	\N	\N	\N	NaN	L2DR01	\N
37355	SM_10_Tumor	\N	NaN	Infinity	NaN	NaN	71.7	\N	\N	\N	Spitzoid Melanoma	L2DR10	\N
37356	SM_7_Tumor	\N	NaN	Infinity	NaN	NaN	62.5	\N	\N	\N	Spitzoid Melanoma	L2DR04	\N
37357	SM_8_Normal	\N	NaN	Infinity	NaN	NaN	35.5	\N	\N	\N	Spitzoid Melanoma	L2DR07	\N
37358	SM_2_Normal	\N	NaN	Infinity	NaN	NaN	10.2	\N	\N	\N	Spitzoid Melanoma	L2DR02	\N
37359	SM_6_Tumor	\N	NaN	Infinity	NaN	NaN	69.8	\N	\N	\N	Spitzoid Melanoma	L2DR03	\N
37360	SM_9_Tumor	\N	NaN	Infinity	NaN	NaN	68.9	\N	\N	\N	Spitzoid Melanoma	L2DR08	\N
37362	SM_2_Tumor	\N	NaN	Infinity	NaN	NaN	57.6	\N	\N	\N	Spitzoid Melanoma	L2DR01	\N
37363	SM_7_Normal	\N	NaN	Infinity	NaN	NaN	39	\N	\N	\N	Spitzoid Melanoma	L2DR05	\N
37364	CGH13-034	\N	NaN	Infinity	NaN	NaN	68.6	\N	\N	\N	Iwei, Translocation CGH NTRK1?	L2DR02	\N
37365	CGH13-041	\N	NaN	Infinity	NaN	NaN	29.1	\N	\N	\N	Iwei, Translocation CGH NTRK3	L2DR03	\N
37366	CGH13-003	\N	NaN	Infinity	NaN	NaN	13.6	\N	\N	\N	Iwei, Translocation CGH BRAF	L2DR15	\N
37367	CGH12-347	\N	NaN	Infinity	NaN	NaN	88.5	\N	\N	\N	Iwei, Translocation CGH NTRK2	L2DR14	\N
37368	CGH13-044	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei, Translocation CGH NTRK3	L2DR04	\N
37369	CGH13-058	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei, Translocation CGH NTRK3	L2DR06	\N
37370	CGH13-009	\N	NaN	Infinity	NaN	NaN	96.2	\N	\N	\N	Iwei, Translocation CGH NTRK1	L2DR16	\N
37371	CGH13-011	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei, Translocation CGH BRAF	L2DR07	\N
37372	CGH12-345	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei, Translocation CGH NTRK1	L2DR13	\N
37373	CHG12-335	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei, Translocation CGH BRAF	L2DR12	\N
37374	CGH13-046	\N	NaN	Infinity	NaN	NaN	71.1	\N	\N	\N	Iwei, Translocation CGH BRAF	L2DR05	\N
37375	CGH13-033	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei, Translocation CGH NTRK1	L2DR01	\N
37376	DPN_11_Tumor	\N	NaN	Infinity	NaN	NaN	76	\N	\N	\N	Iwei DPN	L2DR01	\N
37377	DPN_10_Tumor	\N	NaN	Infinity	NaN	NaN	53.2	\N	\N	\N	Iwei DPN	L2DR16	\N
37378	DPN_4_Tumor	\N	NaN	Infinity	NaN	NaN	99.7	\N	\N	\N	Iwei DPN	L2DR10	\N
37379	DPN_8_Tumor	\N	NaN	Infinity	NaN	NaN	77.4	\N	\N	\N	Iwei DPN	L2DR14	\N
37380	DPN_6_Tumor	\N	NaN	Infinity	NaN	NaN	51	\N	\N	\N	Iwei DPN	L2DR12	\N
37381	DPN_12_Tumor	\N	NaN	Infinity	NaN	NaN	96.6	\N	\N	\N	Iwei DPN	L2DR02	\N
37382	DPN_1_Tumor	\N	NaN	Infinity	NaN	NaN	76.7	\N	\N	\N	Iwei DPN	L2DR08	\N
37383	DPN_5_Tumor	\N	NaN	Infinity	NaN	NaN	62.6	\N	\N	\N	Iwei DPN	L2DR11	\N
37385	DPN_9_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Iwei DPN	L2DR15	\N
37386	DPN_7_Tumor	\N	NaN	746	NaN	NaN	76.1	\N	\N	\N	Iwei DPN	L2DR13	\N
37387	NGS 1-1	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR01	\N
37388	NGS 1-7	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR06	\N
37389	NGS 1-14	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR11	\N
37390	NGS 1-6	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR05	\N
37391	NGS 1-9	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR08	\N
37392	NGS 1-3	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR02	\N
37393	NGS 1-8	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR07	\N
37394	NGS 1-13	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR10	\N
37395	NGS 1-5	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR04	\N
37396	NGS 1-4	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR03	\N
37398	DPN_14_Tumor	\N	NaN	Infinity	NaN	NaN	75.1	\N	\N	\N	Iwei DPN	L2DR03	\N
37399	CNS_44_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR10	\N
37400	CNS_49_Tumor	\N	NaN	Infinity	NaN	NaN	95.9	\N	\N	\N	NaN	L2DR12	\N
37401	DPN_17_Tumor	\N	NaN	Infinity	NaN	NaN	74.2	\N	\N	\N	Iwei DPN	L2DR05	\N
37402	CNS_50_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR13	\N
37403	DPN_19_Tumor	\N	NaN	Infinity	NaN	NaN	75.3	\N	\N	\N	Iwei DPN	L2DR07	\N
37404	CNS_48_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR11	\N
37406	DPN_18_Tumor	\N	NaN	Infinity	NaN	NaN	86.1	\N	\N	\N	Iwei DPN	L2DR06	\N
37407	CNS_42_Tumor	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR08	\N
37408	DPN_16_Tumor	\N	NaN	Infinity	NaN	NaN	82.4	\N	\N	\N	Iwei DPN	L2DR04	\N
37409	Ivanka_12_5	\N	NaN	Infinity	NaN	NaN	17.6	\N	\N	\N	NaN	L2DR07	\N
37410	Ivanka_12_1	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR03	\N
37411	Ivanka_12_4	\N	NaN	Infinity	NaN	NaN	77.1	\N	\N	\N	NaN	L2DR06	\N
37412	Ivanka_9_3	\N	NaN	Infinity	NaN	NaN	48.1	\N	\N	\N	NaN	L2DR16	\N
37413	Ivanka_9_5	\N	NaN	Infinity	NaN	NaN	11.3	\N	\N	\N	NaN	L2DR02	\N
37414	Ivanka_12_3	\N	NaN	Infinity	NaN	NaN	65.1	\N	\N	\N	NaN	L2DR05	\N
37415	Ivanka_9_4	\N	NaN	Infinity	NaN	NaN	61.5	\N	\N	\N	NaN	L2DR01	\N
37416	Ivanka_12_2	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR04	\N
37417	Ivanka_9_1	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR14	\N
37418	Ivanka_9_2	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR15	\N
37419	Ivanka_16_1	\N	NaN	Infinity	NaN	NaN	34.8	\N	\N	\N	NaN	L2DR08	\N
37420	Ivanka_16_5	\N	NaN	Infinity	NaN	NaN	20.7	\N	\N	\N	NaN	L2DR12	\N
37421	Ivanka_16_4	\N	NaN	Infinity	NaN	NaN	19.1	\N	\N	\N	NaN	L2DR11	\N
37422	Ivanka_22_1	\N	NaN	Infinity	NaN	NaN	94.9	\N	\N	\N	NaN	L2DR13	\N
37423	Ivanka_22_3	\N	NaN	Infinity	NaN	NaN	82.4	\N	\N	\N	NaN	L2DR15	\N
37424	Ivanka_22_4	\N	NaN	Infinity	NaN	NaN	20.2	\N	\N	\N	NaN	L2DR16	\N
37425	Ivanka_22_2	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	NaN	L2DR14	\N
37426	Ivanka_22_5	\N	NaN	Infinity	NaN	NaN	10.8	\N	\N	\N	NaN	L2DR01	\N
37427	Ivanka_16_3	\N	NaN	Infinity	NaN	NaN	11.4	\N	\N	\N	NaN	L2DR10	\N
37429	Algazi_Tumor	\N	NaN	Infinity	NaN	NaN	40.7	\N	\N	\N	Alain Algazi	L2DR06	\N
37430	Ivanka_20_2	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Ivanka Patient Melanoma	L2DR02	\N
37431	Ivanka_23_3	\N	NaN	Infinity	NaN	NaN	11	\N	\N	\N	Ivanka Patient Melanoma	L2DR08	\N
37432	Ivanka_23_2	\N	NaN	Infinity	NaN	NaN	57.2	\N	\N	\N	Ivanka Patient Melanoma	L2DR07	\N
37434	Ivanka_20_5	\N	NaN	Infinity	NaN	NaN	10.2	\N	\N	\N	Ivanka Patient Melanoma	L2DR05	\N
37435	Ivanka_23_5	\N	NaN	Infinity	NaN	NaN	10.1	\N	\N	\N	Ivanka Patient Melanoma	L2DR10	\N
37436	Ivanka_20_1	\N	NaN	Infinity	NaN	NaN	100	\N	\N	\N	Ivanka Patient Melanoma	L2DR01	\N
37437	Ivanka_23_1	\N	NaN	Infinity	NaN	NaN	22.9	\N	\N	\N	Ivanka Patient Melanoma	L2DR06	\N
37438	Ivanka_20_4	\N	NaN	Infinity	NaN	NaN	61.2	\N	\N	\N	Ivanka Patient Melanoma	L2DR04	\N
37439	Ivanka_20_3	\N	NaN	Infinity	NaN	NaN	41.5	\N	\N	\N	Ivanka Patient Melanoma	L2DR03	\N
37440	CGH11-229	\N	1.64	0	NaN	NaN	51.4	\N	\N	\N	Iwei 7Q Gain	L2DR07	\N
37442	CGH11-231	\N	40.3	0	NaN	NaN	100	\N	\N	\N	Iwei 7Q Gain	L2DR08	\N
37443	CGH11-237	\N	28.5	1	NaN	NaN	70.9	\N	\N	\N	Iwei 7Q Gain	L2DR10	\N
37444	CHG11-409	2013-07-09 00:00:00-07	16	0	NaN	NaN	NaN	\N	\N	\N	Iwei 7Q gain, Swapna CGH screened, FFPE derived\n	L2DR16	\N
37445	ChIP1_2	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR02	\N
37446	ChIP1_1	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR01	\N
37448	ChIP1_7	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR07	\N
37449	ChIP1_3	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR03	\N
37450	ChIP1_4	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR04	\N
37451	ChIP1_6	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR06	\N
37452	ChIP1_8	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR08	\N
37453	ChIP1_5	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR05	\N
37454	ChIP1_10	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR10	\N
37455	ChIP1_11	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR11	\N
37456	ChIP1_12	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	L2DR12	\N
37457	CGH11-051	2013-07-31 00:00:00-07	39.4	0	NaN	NaN	NaN	\N	\N	\N	Iwei Translocation	NextFlex 1	\N
37458	WTMM-18-Tumor	\N	NaN	24	NaN	NaN	100	\N	\N	\N	UCSF Wild Type Melanoma	NextFlex 11	\N
37459	WTMM-20-Tumor	\N	NaN	2	NaN	NaN	100	\N	\N	\N	UCSF Wild Type Melanoma	NextFlex 13	\N
37460	WTMM-21-Tumor	\N	NaN	35	NaN	NaN	100	\N	\N	\N	UCSF Wild Type Melanoma	NextFlex 14	\N
37461	WTMM-23-Tumor	\N	NaN	13	NaN	NaN	100	\N	\N	\N	UCSF Wild Type Melanoma	NextFlex 16	\N
37462	WTMM-17-Tumor	\N	NaN	14	NaN	NaN	100	\N	\N	\N	UCSF Wild Type Melanoma	NextFlex 10	\N
37463	WTMM-24-Tumor	\N	NaN	10	NaN	NaN	100	\N	\N	\N	UCSF Wild Type Melanoma	NextFlex 17	\N
37464	WTMM-19-Tumor	\N	NaN	5	NaN	NaN	100	\N	\N	\N	UCSF Wild Type Melanoma	NextFlex 12	\N
37465	WTMM-22-Tumor	\N	NaN	38	NaN	NaN	100	\N	\N	\N	UCSF Wild Type Melanoma	NextFlex 15	\N
37466	XD-1-Tumor	2014-08-14 00:00:00-07	15.7	5	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 10	\N
37467	Long-TN10-Tumor	2014-08-14 00:00:00-07	1.39	22	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 14	\N
37468	JBP-4-Met1	2014-08-14 00:00:00-07	15.1	5	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 23	\N
37469	JBP-7-Norm	2014-08-14 00:00:00-07	19.1	6	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 4	\N
37470	JBP-5-MM	2014-08-14 00:00:00-07	18.9	6	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 2	\N
37471	JBP-3-Met1	2014-08-14 00:00:00-07	10	4	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 19	\N
37535	DPN49-Tumor	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37472	JBP-7-Met	2014-08-14 00:00:00-07	18.1	6	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 6	\N
37473	Long-TN11-Normal	2014-08-14 00:00:00-07	1.12	317	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 15	\N
37474	JBP-5-Met	2014-08-14 00:00:00-07	13.9	11	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 3	\N
37475	Long-TN10-Normal	2014-08-14 00:00:00-07	1.73	40	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 13	\N
37476	JBP-9-Norm	2014-08-14 00:00:00-07	9.94	6	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 7	\N
37477	PMM-8-Tumor	2014-08-14 00:00:00-07	1.02	Infinity	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 12	\N
37478	JBP-3-Met2	2014-08-14 00:00:00-07	9.29	5	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 20	\N
37479	JBP-4-Norm	2014-08-14 00:00:00-07	20.3	52	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 21	\N
37480	JBP-3-MM	2014-08-14 00:00:00-07	9.99	5	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 18	\N
37481	JBP-5-Norm	2014-08-14 00:00:00-07	19.3	7	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 1	\N
37482	JBP-7-MM	2014-08-14 00:00:00-07	17.2	18	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 5	\N
37483	JBP-4-Met2	2014-08-14 00:00:00-07	14.6	5	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 24	\N
37484	JBP-3-Norm	2014-08-14 00:00:00-07	2.98	198	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 17	\N
37485	Long-TN11-Tumor	2014-08-14 00:00:00-07	4.82	6	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 16	\N
37486	JBP-4-MM	2014-08-14 00:00:00-07	8.29	146	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 22	\N
37487	XD-1-1-Tumor	2014-08-14 00:00:00-07	8.79	38	NaN	6	250	\N	\N	\N	Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE	NextFlex 11	\N
37488	JBP-9-MM	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 11	\N
37489	JBP-9-Met	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 12	\N
37490	JBP-6-Norm	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 13	\N
37491	JBP-6-MM	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 14	\N
37492	JBP-6-Met	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 15	\N
37493	JBP-11-Met	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 18	\N
37494	UM23	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 19	\N
37495	JBP-11-MM	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 17	\N
37496	JBP-11-Norm	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 16	\N
37497	CP1-20	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 3	\N
37498	TCR-Beta-1	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 23	\N
37499	CP1-80	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 1	\N
37500	CP1-40	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 2	\N
37501	CP1-Norm	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 6	\N
37502	TCR-Beta-2	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 24	\N
37503	CP1-10	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 4	\N
37504	UM26	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 22	\N
37505	CP1-5	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 5	\N
37506	UM25	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 21	\N
37507	UM24	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NextFlex 20	\N
37508	KAM99-tumor	2015-11-19 00:00:00-08	4.41	9	NaN	4	250	\N	\N	\N	NaN	D8	\N
37509	KAM3-T-A	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37510	KAM93-tumor	2015-11-19 00:00:00-08	5.01	18	NaN	4	250	\N	\N	\N	NaN	D6	\N
37511	KAM111-tumor	2015-11-19 00:00:00-08	7.64	NaN	NaN	4	NaN	\N	\N	\N	NaN	E7	\N
37512	KAM10-Tumor	2015-11-19 00:00:00-08	3.74	7	NaN	4	250	\N	\N	\N	NaN	D4	\N
37513	KAM100-tumor	2015-11-19 00:00:00-08	6.58	18	NaN	4	250	\N	\N	\N	NaN	D3	\N
37514	KAM65-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37515	KAM71-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37516	KAM95-T-B1	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37517	KAM79-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37518	KAM43-T	\N	NaN	0	NaN	4	NaN	\N	\N	\N	NaN	NaN	\N
37519	KAM34-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37520	KAM48-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37521	KAM37-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37522	KAM62-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37523	KAM26-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37524	KAM14-T	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37525	UM38-Tumor	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37526	UM38-Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37527	JBU8-Norm	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37528	JBU7-Norm	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37529	JBU11-Norm	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37530	JBU10-MVP	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37531	JBU8-MVP	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37532	JBU10-Norm	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37533	JBU11-MVP	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37534	JBU7-MVP	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37536	DPN61-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37537	DPN60-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37538	DPN51-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37539	DPN52-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37540	DPN53-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37541	DPN57-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37542	DPN56-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37543	DPN50-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37544	DPN55-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37545	DPN62-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37546	DPN58-Tumor	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37547	AM-15-Tumor	\N	6.43	0	5.57	6	NaN	\N	\N	\N	NaN	A7	\N
37548	AM-23-Tumor	\N	7.2	0	9	6	NaN	\N	\N	\N	NaN	B3	\N
37549	AM-26-Tumor	\N	12.6	0	12.95	6	NaN	\N	\N	\N	NaN	B6	\N
37550	AM-19-Tumor	\N	14.5	0	15.91	6	NaN	\N	\N	\N	NaN	A11	\N
37551	AM-25-Tumor	\N	11.1	0	13.01	6	NaN	\N	\N	\N	NaN	B5	\N
37552	AM-20-Tumor	\N	6.1	0	7.22	6	NaN	\N	\N	\N	NaN	A12	\N
37553	AM-17-Tumor	\N	15.5	0	18.11	6	NaN	\N	\N	\N	NaN	A9	\N
37554	AM-18-Tumor	\N	1.54	0	1.29	6	NaN	\N	\N	\N	NaN	A10	\N
37555	AM-24-Tumor	\N	7.53	0	8.46	6	NaN	\N	\N	\N	NaN	B4	\N
37556	AM-21-Tumor	\N	3.67	0	3.89	6	NaN	\N	\N	\N	NaN	B1	\N
37557	AM-16-Tumor	\N	29.8	0	36.16	6	NaN	\N	\N	\N	NaN	A8	\N
37558	AM-22-Tumor	\N	8.99	0	10.38	6	NaN	\N	\N	\N	NaN	B2	\N
37559	KAM131-T	\N	17.7	0	19.72	6	NaN	\N	\N	\N	NaN	A5	\N
37560	KAM127-N	\N	23.6	0	26.13	6	NaN	\N	\N	\N	NaN	A2	\N
37561	KAM128-T	\N	1.93	0	1.5	6	NaN	\N	\N	\N	NaN	A3	\N
37562	KAM130-T	\N	1.2	0	1.04	6	NaN	\N	\N	\N	NaN	A4	\N
37563	KAM131-N	\N	4.27	0	4.54	6	NaN	\N	\N	\N	NaN	A6	\N
37564	KAM127-T	\N	20	0	21.73	6	NaN	\N	\N	\N	NaN	A1	\N
37565	AM-27-Tumor	\N	29.2	0	39.06	6	NaN	\N	\N	\N	NaN	B7	\N
37566	AM-32-Tumor	\N	10.4	0	10.5	6	NaN	\N	\N	\N	NaN	B12	\N
37567	AM-30-Tumor	\N	15.6	0	16.64	6	NaN	\N	\N	\N	NaN	B10	\N
37568	AM-28-Tumor	\N	3.49	0	3.37	6	NaN	\N	\N	\N	NaN	B8	\N
37569	AM-31-Tumor	\N	6.03	0	6.12	6	NaN	\N	\N	\N	NaN	B11	\N
37570	AM-29-Tumor	\N	10.4	0	11.23	6	NaN	\N	\N	\N	NaN	B9	\N
37571	DPN-49-Graz	\N	5.27	0	2.86	6	NaN	\N	\N	\N	NaN	C1	\N
37572	Rob-T001-Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C3	\N
37573	Rob-T008-Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C8	\N
37574	Rob-T009-Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C10	\N
37575	Rob-T010-Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	D1	\N
37576	Rob-T005-Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C7	\N
37577	Rob-T008-Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C9	\N
37578	Rob-T010-Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C12	\N
37579	Rob-T005-Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C6	\N
37580	Rob-T003-Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C5	\N
37581	Rob-T009-Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C11	\N
37582	Rob-T001-Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C2	\N
37583	Rob-T003-Normal	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	C4	\N
37584	2243_MIS	2023-04-06 00:00:00-07	NaN	23	NaN	NaN	250	\N	\N	\N	SM-MQTS9; GATK4-Mutect2/CNV pipeline	NaN	\N
37585	2242_Normal	2023-04-06 00:00:00-07	NaN	7	NaN	NaN	350	\N	\N	\N	SM-MQTTO; GATK4-Mutect2/CNV pipeline	NaN	\N
37586	2230_Mel	2023-04-06 00:00:00-07	NaN	26	NaN	NaN	250	\N	\N	\N	SM-MQTTS; GATK4-Mutect2/CNV pipeline	NaN	\N
37587	2220_MIS	2023-04-06 00:00:00-07	NaN	41	NaN	NaN	250	\N	\N	\N	SM-MQTTI; GATK4-Mutect2/CNV pipeline	NaN	\N
37588	2204_Mel	2023-04-06 00:00:00-07	NaN	35	NaN	NaN	250	\N	\N	\N	SM-MQTT1; GATK4-Mutect2/CNV pipeline	NaN	\N
37589	2221_Nevus	2023-04-06 00:00:00-07	NaN	33	NaN	NaN	250	\N	\N	\N	SM-MQTTJ; GATK4-Mutect2/CNV pipeline	NaN	\N
37590	2215_Mel	2023-04-06 00:00:00-07	NaN	13	NaN	NaN	250	\N	\N	\N	SM-MQTTC; GATK4-Mutect2/CNV pipeline	NaN	\N
37591	2184_Mel	2023-04-06 00:00:00-07	NaN	90	NaN	NaN	250	\N	\N	\N	SM-MQTSG; GATK4-Mutect2/CNV pipeline	NaN	\N
37592	2186_Normal	2023-04-06 00:00:00-07	NaN	176	NaN	NaN	116	\N	\N	\N	SM-MTN3L; GATK4-Mutect2/CNV pipeline	NaN	\N
37593	2183_Normal	2023-04-06 00:00:00-07	NaN	30	NaN	NaN	250	\N	\N	\N	SM-MQTSF; GATK4-Mutect2/CNV pipeline	NaN	\N
37594	2231_MIS	2023-04-06 00:00:00-07	NaN	28	NaN	NaN	250	\N	\N	\N	SM-MQTTT; GATK4-Mutect2/CNV pipeline	NaN	\N
37595	2180_Mel1	2023-04-06 00:00:00-07	NaN	9	NaN	NaN	350	\N	\N	\N	SM-MQTSC; GATK4-Mutect2/CNV pipeline	NaN	\N
37596	2214_Normal	2023-04-06 00:00:00-07	NaN	261	NaN	NaN	139	\N	\N	\N	SM-MQTTB; GATK4-Mutect2/CNV pipeline	NaN	\N
37597	2234_Mel	2023-04-06 00:00:00-07	NaN	88	NaN	NaN	252	\N	\N	\N	SM-MVZGV; GATK4-Mutect2/CNV pipeline	NaN	\N
37598	2218_Normal	2023-04-06 00:00:00-07	NaN	88	NaN	NaN	127	\N	\N	\N	SM-MQTTG; GATK4-Mutect2/CNV pipeline	NaN	\N
37599	2212_MIS	2023-04-06 00:00:00-07	NaN	88	NaN	NaN	228	\N	\N	\N	SM-MQTUT; GATK4-Mutect2/CNV pipeline	NaN	\N
37600	2233_Normal	2023-04-06 00:00:00-07	NaN	17	NaN	NaN	350	\N	\N	\N	SM-MQTTV; GATK4-Mutect2/CNV pipeline	NaN	\N
37601	2225_Nevus	2023-04-06 00:00:00-07	NaN	27	NaN	NaN	250	\N	\N	\N	SM-MQTTN; GATK4-Mutect2/CNV pipeline	NaN	\N
37602	2237_MIS	2023-04-06 00:00:00-07	NaN	22	NaN	NaN	250	\N	\N	\N	SM-MQTTD; GATK4-Mutect2/CNV pipeline	NaN	\N
37603	2190_Mel	2023-04-06 00:00:00-07	NaN	12	NaN	NaN	250	\N	\N	\N	SM-MQTSM; GATK4-Mutect2/CNV pipeline	NaN	\N
37604	2235_Nevus	2023-04-06 00:00:00-07	NaN	58	NaN	NaN	250	\N	\N	\N	SM-MW1V9; GATK4-Mutect2/CNV pipeline	NaN	\N
37605	2244_Nevus	2023-04-06 00:00:00-07	NaN	156	NaN	NaN	250	\N	\N	\N	SM-MQTSA; GATK4-Mutect2/CNV pipeline	NaN	\N
37606	2207_MIS	2023-04-06 00:00:00-07	NaN	24	NaN	NaN	250	\N	\N	\N	SM-MQTT4; GATK4-Mutect2/CNV pipeline	NaN	\N
37607	2181_Mel2	2023-04-06 00:00:00-07	NaN	10	NaN	NaN	350	\N	\N	\N	SM-MQTSD; GATK4-Mutect2/CNV pipeline	NaN	\N
37608	2208_Nevus	2023-04-06 00:00:00-07	NaN	53	NaN	NaN	250	\N	\N	\N	SM-MQTT5; GATK4-Mutect2/CNV pipeline	NaN	\N
37609	2239_Nevus	2023-04-06 00:00:00-07	NaN	70	NaN	NaN	250	\N	\N	\N	SM-MQTSQ; GATK4-Mutect2/CNV pipeline	NaN	\N
37610	2213_Nevus	2023-04-06 00:00:00-07	NaN	88	NaN	NaN	256	\N	\N	\N	SM-MQTTA; GATK4-Mutect2/CNV pipeline	NaN	\N
37611	2188_Nevus	2023-04-06 00:00:00-07	NaN	52	NaN	NaN	250	\N	\N	\N	SM-MQTUV; GATK4-Mutect2/CNV pipeline	NaN	\N
37612	2224_Mel2	2023-04-06 00:00:00-07	NaN	88	NaN	NaN	237	\N	\N	\N	SM-MQTTM; GATK4-Mutect2/CNV pipeline	NaN	\N
37613	2210_Normal	2023-04-06 00:00:00-07	NaN	264	NaN	NaN	250	\N	\N	\N	SM-MQTT7; GATK4-Mutect2/CNV pipeline	NaN	\N
37614	2191_Nevus	2023-04-06 00:00:00-07	NaN	34	NaN	NaN	250	\N	\N	\N	SM-MQTSN; GATK4-Mutect2/CNV pipeline	NaN	\N
37615	2185_Nevus	2023-04-06 00:00:00-07	NaN	32	NaN	NaN	200	\N	\N	\N	SM-MQTSH; GATK4-Mutect2/CNV pipeline	NaN	\N
37616	2223_Mel1	2023-04-06 00:00:00-07	NaN	69	NaN	NaN	250	\N	\N	\N	SM-MTMX4; GATK4-Mutect2/CNV pipeline	NaN	\N
37617	2205_Nevus	2023-04-06 00:00:00-07	NaN	153	NaN	NaN	250	\N	\N	\N	SM-MQTT2; GATK4-Mutect2/CNV pipeline	NaN	\N
37618	2219_Mel	2023-04-06 00:00:00-07	NaN	33	NaN	NaN	250	\N	\N	\N	SM-MQTTH; GATK4-Mutect2/CNV pipeline	NaN	\N
37619	2229_Normal	2023-04-06 00:00:00-07	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MQTTR; GATK4-Mutect2/CNV pipeline	NaN	\N
37620	2209_PRAME-positive_Nevus	2023-04-06 00:00:00-07	NaN	88	NaN	NaN	285	\N	\N	\N	SM-MQTT6; GATK4-Mutect2/CNV pipeline	NaN	\N
37621	2222_Normal	2023-04-06 00:00:00-07	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MTL7E; GATK4-Mutect2/CNV pipeline	NaN	\N
37622	2238_Mel	2023-04-06 00:00:00-07	NaN	12	NaN	NaN	250	\N	\N	\N	SM-MQTSP; GATK4-Mutect2/CNV pipeline	NaN	\N
37623	2192_Normal	2023-04-06 00:00:00-07	NaN	264	NaN	NaN	190	\N	\N	\N	SM-MQTSO; GATK4-Mutect2/CNV pipeline	NaN	\N
37624	2202_Nevus	2023-04-06 00:00:00-07	NaN	88	NaN	NaN	131	\N	\N	\N	SM-MQTSY; GATK4-Mutect2/CNV pipeline	NaN	\N
37625	2211_Mel	2023-04-06 00:00:00-07	NaN	29	NaN	NaN	250	\N	\N	\N	SM-MTKPX; GATK4-Mutect2/CNV pipeline	NaN	\N
37626	2216_Nevus	2023-04-06 00:00:00-07	NaN	11	NaN	NaN	250	\N	\N	\N	SM-MQTTE; GATK4-Mutect2/CNV pipeline	NaN	\N
37627	2217_Regressed-Area	2023-04-06 00:00:00-07	NaN	23	NaN	NaN	250	\N	\N	\N	SM-MQTTF; GATK4-Mutect2/CNV pipeline	NaN	\N
37628	2189_Normal	2023-04-06 00:00:00-07	NaN	88	NaN	NaN	153	\N	\N	\N	SM-MQTSL; GATK4-Mutect2/CNV pipeline	NaN	\N
37629	2228_Nevus	2023-04-06 00:00:00-07	NaN	16	NaN	NaN	250	\N	\N	\N	SM-MQTTQ; GATK4-Mutect2/CNV pipeline	NaN	\N
37630	2199_Normal	2023-04-06 00:00:00-07	NaN	125	NaN	NaN	250	\N	\N	\N	SM-MTLID; GATK4-Mutect2/CNV pipeline	NaN	\N
37631	2198_Nevus	2023-04-06 00:00:00-07	NaN	46	NaN	NaN	250	\N	\N	\N	SM-MQTSU; GATK4-Mutect2/CNV pipeline	NaN	\N
37632	2203_Normal	2023-04-06 00:00:00-07	NaN	77	NaN	NaN	250	\N	\N	\N	SM-MQTSZ; GATK4-Mutect2/CNV pipeline	NaN	\N
37633	2200_Mel	2023-04-06 00:00:00-07	NaN	32	NaN	NaN	250	\N	\N	\N	SM-MQTUU; GATK4-Mutect2/CNV pipeline	NaN	\N
37634	2182_Nevus	2023-04-06 00:00:00-07	NaN	9	NaN	NaN	350	\N	\N	\N	SM-MQTSE; GATK4-Mutect2/CNV pipeline	NaN	\N
37635	2241_Normal	2023-04-06 00:00:00-07	NaN	17	NaN	NaN	250	\N	\N	\N	SM-MQTT3; GATK4-Mutect2/CNV pipeline	NaN	\N
37636	2227_Mel	2023-04-06 00:00:00-07	NaN	11	NaN	NaN	350	\N	\N	\N	SM-MQTTP; GATK4-Mutect2/CNV pipeline	NaN	\N
37637	2245_Normal	2023-04-06 00:00:00-07	NaN	52	NaN	NaN	250	\N	\N	\N	SM-MQTSB; GATK4-Mutect2/CNV pipeline	NaN	\N
37638	2240_Normal	2023-04-06 00:00:00-07	NaN	46	NaN	NaN	250	\N	\N	\N	SM-MQTSR; GATK4-Mutect2/CNV pipeline	NaN	\N
37639	2197_MIS	2023-04-06 00:00:00-07	NaN	52	NaN	NaN	250	\N	\N	\N	SM-MQTST; GATK4-Mutect2/CNV pipeline	NaN	\N
37640	2232_Nevus	2023-04-06 00:00:00-07	NaN	57	NaN	NaN	250	\N	\N	\N	SM-MQTTU; GATK4-Mutect2/CNV pipeline	NaN	\N
37641	2187_Mel	2023-04-06 00:00:00-07	NaN	12	NaN	NaN	250	\N	\N	\N	SM-MTHZS; GATK4-Mutect2/CNV pipeline	NaN	\N
37642	2201_MIS	2023-04-06 00:00:00-07	NaN	16	NaN	NaN	250	\N	\N	\N	SM-MQTSX; GATK4-Mutect2/CNV pipeline	NaN	\N
37643	2236_Normal	2023-04-06 00:00:00-07	NaN	57	NaN	NaN	119	\N	\N	\N	SM-MW3G4; GATK4-Mutect2/CNV pipeline	NaN	\N
37644	2196_Mel	2023-04-06 00:00:00-07	NaN	12	NaN	NaN	250	\N	\N	\N	SM-MQTSS; GATK4-Mutect2/CNV pipeline	NaN	\N
37645	2046_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37646	2287_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37647	2288_Melanocytoma	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37648	2045_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37649	2295_MIS	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37650	2294_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37651	2293_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37652	2292_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37653	2291_Nevus	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37654	2290_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37655	2289_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37656	2044_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37657	2043_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37658	2270_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37659	2268_Met1-2269_Met2	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37660	2461_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37661	2460_Nevus	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37662	2459_MIS	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37663	2449_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37664	2448_Nevus	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37665	2447_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37666	2446_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37667	2445_Nevus	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37668	2444_MIS	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37669	2443_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37670	2301_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37671	2300_Nevus	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37672	2299_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37673	2298_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37674	2297_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37675	2296_Nevus	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37676	2450_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37677	2451_MIS	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37678	2452_Invasive	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37679	2505_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37680	2504_MIS	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37681	2503_Invasive	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37682	2497_Invasive	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37683	2496_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37684	2495_MIS	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37685	2494_Invasive	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37686	2047_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37687	2054_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37688	2053_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37689	2052_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37690	2051_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37691	2050_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37692	2049_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37693	2048_Mel	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37694	2502_Normal	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37695	2501_MIS	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37696	2500_Invasive	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37697	2499_Normal_flag	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37698	2498_MIS	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37699	2466_Cell-Line	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37700	2468_Melanoma-Cell-Line	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37701	2467_Melanoma-Cell-Line	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37702	2465_Cell-Line	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37703	2463_Melanoma-Cell-Line	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37704	2457_Tumor	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37705	2456_Tumor	\N	NaN	0	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37706	1917_Mel	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ7Q; GATK4-Mutect2/CNV pipeline	NaN	\N
37707	1955_Normal	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ88; GATK4-Mutect2/CNV pipeline	NaN	\N
37708	2036_Normal	2022-11-15 00:00:00-08	NaN	18	NaN	NaN	150	\N	\N	\N	SM-MRJ7U; GATK4-Mutect2/CNV pipeline	NaN	\N
37709	1641_Mel	2022-11-15 00:00:00-08	NaN	60	NaN	NaN	150	\N	\N	\N	SM-MRJ8C; GATK4-Mutect2/CNV pipeline	NaN	\N
37710	1958_Normal	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ7Z; GATK4-Mutect2/CNV pipeline	NaN	\N
37711	892_Mel	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ8I; GATK4-Mutect2/CNV pipeline	NaN	\N
37712	1927_MIS	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ7X; GATK4-Mutect2/CNV pipeline	NaN	\N
37713	1949_1956_Normal	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ8B; GATK4-Mutect2/CNV pipeline	NaN	\N
37714	1953_Normal	2022-11-15 00:00:00-08	NaN	40	NaN	NaN	150	\N	\N	\N	SM-MRJ8H; GATK4-Mutect2/CNV pipeline	NaN	\N
37715	893_Nevus	2022-11-15 00:00:00-08	NaN	21	NaN	NaN	150	\N	\N	\N	SM-MQT6A; GATK4-Mutect2/CNV pipeline	NaN	\N
37716	1921_Mel	2022-11-15 00:00:00-08	NaN	13	NaN	NaN	150	\N	\N	\N	SM-MRJ7V; GATK4-Mutect2/CNV pipeline	NaN	\N
37717	1926_Mel	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ7W; GATK4-Mutect2/CNV pipeline	NaN	\N
37718	2041_Normal	2022-11-15 00:00:00-08	NaN	109	NaN	NaN	150	\N	\N	\N	SM-MRJ5H; GATK4-Mutect2/CNV pipeline	NaN	\N
37719	1919_Nevus	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ7T; GATK4-Mutect2/CNV pipeline	NaN	\N
37720	1948_Nevus	2022-11-15 00:00:00-08	NaN	88	NaN	NaN	150	\N	\N	\N	SM-MRJ82; GATK4-Mutect2/CNV pipeline	NaN	\N
37721	1947_Melanocytoma	2022-11-15 00:00:00-08	NaN	88	NaN	NaN	150	\N	\N	\N	SM-MRJ81; GATK4-Mutect2/CNV pipeline	NaN	\N
37722	1918_MIS	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ7S; GATK4-Mutect2/CNV pipeline	NaN	\N
37723	1930_Normal	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ89; GATK4-Mutect2/CNV pipeline	NaN	\N
37724	1952_Nevus	2022-11-15 00:00:00-08	NaN	23	NaN	NaN	150	\N	\N	\N	SM-MRJ86; GATK4-Mutect2/CNV pipeline	NaN	\N
37725	1922_Nevus	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ87; GATK4-Mutect2/CNV pipeline	NaN	\N
37726	1946_Normal	2022-11-15 00:00:00-08	NaN	61	NaN	NaN	150	\N	\N	\N	SM-MRJ84; GATK4-Mutect2/CNV pipeline	NaN	\N
37727	1944_Mel	2022-11-15 00:00:00-08	NaN	11	NaN	NaN	150	\N	\N	\N	SM-MRJ8E; GATK4-Mutect2/CNV pipeline	NaN	\N
37728	1954_MIS	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ8F; GATK4-Mutect2/CNV pipeline	NaN	\N
37729	1932_MIS	2022-11-15 00:00:00-08	NaN	71	NaN	NaN	150	\N	\N	\N	SM-MRJ85; GATK4-Mutect2/CNV pipeline	NaN	\N
37730	894_Normal	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ5L; GATK4-Mutect2/CNV pipeline	NaN	\N
37731	1931_Mel	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ8G; GATK4-Mutect2/CNV pipeline	NaN	\N
37732	1928_Nevus	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ7Y; GATK4-Mutect2/CNV pipeline	NaN	\N
37733	2039_Mel	2022-11-15 00:00:00-08	NaN	10	NaN	NaN	150	\N	\N	\N	SM-MRJ5J; GATK4-Mutect2/CNV pipeline	NaN	\N
37734	1945_Nevus	2022-11-15 00:00:00-08	NaN	72	NaN	NaN	150	\N	\N	\N	SM-MRJ83; GATK4-Mutect2/CNV pipeline	NaN	\N
37735	1933_Nevus	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ8A; GATK4-Mutect2/CNV pipeline	NaN	\N
37736	2040_Mel	2022-11-15 00:00:00-08	NaN	8	NaN	NaN	150	\N	\N	\N	SM-MRJ5I; GATK4-Mutect2/CNV pipeline	NaN	\N
37737	2038_Mel	2022-11-15 00:00:00-08	NaN	10	NaN	NaN	150	\N	\N	\N	SM-MRJ5K; GATK4-Mutect2/CNV pipeline	NaN	\N
37738	1951_Mel	2022-11-15 00:00:00-08	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	SM-MRJ8D; GATK4-Mutect2/CNV pipeline	NaN	\N
37739	VMRLP-41	2018-11-05 00:00:00-08	14.6	NaN	32.89	11	NaN	\N	\N	\N	RLP-41	65	\N
37740	VMRLP-43	2018-11-05 00:00:00-08	13.1	NaN	26.38	11	NaN	\N	\N	\N	RLP-43	67	\N
37741	VMRLP-42	2018-11-05 00:00:00-08	8.93	NaN	18.31	11	NaN	\N	\N	\N	RLP-42	66	\N
37742	VMRLP-44	2018-11-05 00:00:00-08	10.7	NaN	21.58	11	NaN	\N	\N	\N	RLP-44	68	\N
37743	VMRLP-45	2018-11-05 00:00:00-08	8.67	NaN	18.61	11	NaN	\N	\N	\N	RLP-45	69	\N
37744	VMRLP-46	2018-11-05 00:00:00-08	7.79	NaN	16.53	11	NaN	\N	\N	\N	RLP-46	70	\N
37745	VMRLP-47	2018-11-05 00:00:00-08	4.98	NaN	11.48	11	NaN	\N	\N	\N	RLP-47	71	\N
37746	VMRLP-49	2018-11-05 00:00:00-08	23.7	NaN	47.7	11	NaN	\N	\N	\N	RLP-49	73	\N
37747	VMRLP-48	2018-11-05 00:00:00-08	8.29	NaN	18.01	11	NaN	\N	\N	\N	RLP-48	72	\N
37748	VMRLP-50	2018-11-05 00:00:00-08	4.55	NaN	9.05	11	NaN	\N	\N	\N	RLP-50	74	\N
37749	VMRLP-51	2018-11-05 00:00:00-08	15	NaN	30.39	11	NaN	\N	\N	\N	RLP-51	75	\N
37750	VMRLP-52	2018-11-05 00:00:00-08	18	NaN	39.94	11	NaN	\N	\N	\N	RLP-52	76	\N
37751	VMRLP-55	2018-11-05 00:00:00-08	17.3	NaN	39.67	11	NaN	\N	\N	\N	RLP-55, Sample removed from study	79	\N
37752	VMRLP-53	2018-11-05 00:00:00-08	22.7	NaN	54.77	11	NaN	\N	\N	\N	RLP-53	77	\N
37753	VMRLP-54	2018-11-05 00:00:00-08	14.7	NaN	33.88	11	NaN	\N	\N	\N	RLP-54	78	\N
37754	VMRLP-59	2018-11-05 00:00:00-08	7.13	NaN	14.45	11	NaN	\N	\N	\N	RLP-59	83	\N
37755	VMRLP-60	2018-11-05 00:00:00-08	5.39	NaN	10.64	11	NaN	\N	\N	\N	RLP-60	84	\N
37756	VMRLP-56	2018-11-05 00:00:00-08	14.8	NaN	32.57	11	NaN	\N	\N	\N	RLP-56, Sample removed from study	80	\N
37757	VMRLP-61	2018-11-05 00:00:00-08	23.6	NaN	51.79	11	NaN	\N	\N	\N	RLP-61	85	\N
37758	VMRLP-63	2018-11-05 00:00:00-08	14	NaN	32.35	11	NaN	\N	\N	\N	RLP-63	87	\N
37759	VMRLP-62	2018-11-05 00:00:00-08	12.8	NaN	28.64	11	NaN	\N	\N	\N	RLP-62	86	\N
37760	RLP-66	2018-11-05 00:00:00-08	1.57	NaN	3.28	11	NaN	\N	\N	\N	RLP-66, Sample removed from study	90	\N
37761	RLP-65	2018-11-05 00:00:00-08	10.2	NaN	21.66	11	NaN	\N	\N	\N	RLP-65, Sample removed from study	89	\N
37762	CGP-600	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37763	CGP-601	\N	2.61	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37764	CGP-602	\N	11.4	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37765	CGP-603	\N	4.72	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37766	CGP-604	\N	4.89	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37767	CGP-605	\N	11.5	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37768	CGP-607	\N	19.2	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 390	NaN	\N
37769	CGP-606	\N	3.53	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 143	NaN	\N
37770	CGP-608	\N	27.7	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 393	NaN	\N
37771	CGP-610	\N	0	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 385	NaN	\N
37772	CGP-609	\N	0	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 412	NaN	\N
37773	CGP-611	\N	2.71	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 450	NaN	\N
37774	CGP-612	\N	0	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 28	NaN	\N
37775	CGP-613	\N	0	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 227	NaN	\N
37776	CGP-614	\N	2.71	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 346	NaN	\N
37777	CGP-615	\N	0	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 519	NaN	\N
37778	CGP-616	\N	0	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 396	NaN	\N
37779	CGP-617	\N	3.34	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 473	NaN	\N
37780	CGP-618	\N	0	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 272	NaN	\N
37781	CGP-619	\N	0	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 370	NaN	\N
37782	CGP-620	\N	3.79	0	0	4	NaN	\N	\N	\N	Mean Target Coverage: 401	NaN	\N
37783	CGP-675	\N	11.8	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 228	NaN	\N
37784	CGP-676	\N	2.59	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 161	NaN	\N
37785	CGP-677	\N	17.1	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 279	NaN	\N
37786	CGP-678	\N	7.54	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 337	NaN	\N
37787	CGP-664	\N	0	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 99	NaN	\N
37788	CGP-665	\N	0	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 126	NaN	\N
37789	CGP-666	\N	0	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 274	NaN	\N
37790	CGP-667	\N	4.62	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 151	NaN	\N
37791	CGP-668	\N	3.35	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 47	NaN	\N
37792	CGP-669	\N	5.55	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 67	NaN	\N
37793	CGP-683	\N	3.2	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 311	NaN	\N
37794	CGP-684	\N	2	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 169	NaN	\N
37795	CGP-685	\N	8.13	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 358	NaN	\N
37796	CGP-686	\N	4.98	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 351	NaN	\N
37797	CGP-672	\N	0	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 18	NaN	\N
37798	CGP-673	\N	6.04	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 320	NaN	\N
37799	CGP-674	\N	4.32	0	0	5	NaN	\N	\N	\N	Mean Target Coverage: 164	NaN	\N
37800	CGP-679	\N	4.21	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37801	CGP-681	\N	4.58	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37802	CGP-680	\N	0	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37803	CGP-682	\N	7.79	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37804	CGP-583	\N	0	0	0	NaN	NaN	\N	\N	\N	JJS1_Nev_R1.fastq; JJS1_Nev_R2.fastq	NaN	\N
37805	CGP-584	\N	19.5	0	0	NaN	NaN	\N	\N	\N	1_MEL_R1.fastq; 1_MEL_R2.fastq	NaN	\N
37806	CGP-999	\N	0	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37807	CGP-998	\N	0	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37808	CGP-585	\N	66	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37809	CGP-586	\N	6.17	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37810	CGP-587	\N	29.5	0	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37811	CGP-1481	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37812	CGP-1482	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37813	CGP-1483	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37814	CGP-1550	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37815	CGP-1551	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37816	CGP-1552	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37817	CGP-1544	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37818	CGP-1545	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37819	CGP-1546	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37820	CGP-1547	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37821	CGP-1549	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37822	CGP-1548	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37823	CGP-1553	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37824	CGP-1554	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37825	CGP-1555	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37826	CGP-1556	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37827	CGP-1557	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37828	CGP-1558	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37829	CGP-1559	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37830	CGP-1561	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37831	CGP-1560	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37832	CGP-1575	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37833	CGP-1576	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37834	CGP-1577	\N	0	NaN	0	NaN	NaN	\N	\N	\N	NaN	NaN	\N
37835	DLP-011	2019-01-02 00:00:00-08	3.15	48	1.52	4	92.2	\N	\N	\N	NaN	7	\N
37836	DLP-045	2019-01-02 00:00:00-08	4.26	46	2.38	4	250	\N	\N	\N	NaN	67	\N
37837	DLP-021	2019-01-02 00:00:00-08	4.7	48	1.83	4	94.6	\N	\N	\N	Sample removed from study	13	\N
37838	DLP-022	2019-01-02 00:00:00-08	2.75	23	2.85	4	250	\N	\N	\N	Sample removed from study	14	\N
37839	DLP-050	2019-01-02 00:00:00-08	3.2	48	2.21	4	115.2	\N	\N	\N	NaN	72	\N
37840	DLP-061	2019-01-02 00:00:00-08	5.55	48	3.19	4	184.3	\N	\N	\N	NaN	79	\N
37841	DLP-012	2019-01-02 00:00:00-08	6.3	38	3.21	4	250	\N	\N	\N	NaN	8	\N
37842	DLP-046	2019-01-02 00:00:00-08	2.32	48	1.34	4	123.4	\N	\N	\N	NaN	68	\N
37843	DLP-049	2019-01-02 00:00:00-08	4.33	17	2.62	4	250	\N	\N	\N	NaN	71	\N
37844	DLP-043	2019-01-02 00:00:00-08	2.65	48	1.56	4	92.2	\N	\N	\N	NaN	65	\N
37845	DLP-044	2019-01-02 00:00:00-08	2.59	48	1.63	4	99.8	\N	\N	\N	NaN	66	\N
37846	DLP-062	2019-01-02 00:00:00-08	2.16	48	1.43	4	74.9	\N	\N	\N	NaN	80	\N
37847	DLP-017	2019-01-02 00:00:00-08	5.83	48	2.79	4	213.6	\N	\N	\N	NaN	9	\N
37848	DLP-018	2019-01-02 00:00:00-08	5.59	13	3.01	4	250	\N	\N	\N	NaN	10	\N
37849	DLP-055	2019-01-02 00:00:00-08	4.97	17	2.73	4	250	\N	\N	\N	Sample removed from study	73	\N
37850	DLP-056	2019-01-02 00:00:00-08	5.04	13	2.92	4	250	\N	\N	\N	Sample removed from study	74	\N
37851	DLP-027	2019-04-08 00:00:00-07	4.96	60	3.55	4	229	\N	\N	\N	NaN	15	\N
37852	DLP-031	2019-01-02 00:00:00-08	6.27	20	4.9	4	250	\N	\N	\N	NaN	10	\N
37853	DLP-026	2019-04-08 00:00:00-07	4.77	91	2.75	4	194.7	\N	\N	\N	NaN	14	\N
37854	DLP-065	2019-04-08 00:00:00-07	5.44	48	3.48	4	239	\N	\N	\N	Sample removed from study	67	\N
37855	DLP-069	2019-04-08 00:00:00-07	2.93	97	2.23	4	160.1	\N	\N	\N	NaN	71	\N
37856	DLP-029	2019-04-08 00:00:00-07	5.58	75	4.01	4	250	\N	\N	\N	NaN	63	\N
37857	CGP-9023	\N	NaN	0	13.23	NaN	NaN	\N	\N	\N	NaN	6	\N
37858	CGP-9008	\N	NaN	0	9.89	NaN	NaN	\N	\N	\N	NaN	87	\N
37859	DLP-053	2019-01-02 00:00:00-08	4.9	27	2.3	4	250	\N	\N	\N	NaN	75	\N
37860	DLP-025	2019-04-08 00:00:00-07	1.88	75	0.85	4	65.6	\N	\N	\N	NaN	13	\N
37861	DLP-052	2019-04-08 00:00:00-07	2.41	48	2	4	96.5	\N	\N	\N	NaN	65	\N
37862	DLP-001	2019-04-08 00:00:00-07	1.66	18	0.8	4	52	\N	\N	\N	NaN	7	\N
37863	DLP-59	2019-05-23 00:00:00-07	2.11	48	1.18	4	110	\N	\N	\N	NaN	66	\N
37864	DLP-030	2019-01-02 00:00:00-08	3.85	48	2.5	4	122.4	\N	\N	\N	NaN	9	\N
37865	DLP-071	2019-04-08 00:00:00-07	1.76	99	1.23	4	73.8	\N	\N	\N	NaN	73	\N
37866	DLP-041	2019-04-08 00:00:00-07	4.34	41	2.49	4	250	\N	\N	\N	NaN	64	\N
37867	DLP-070	2019-04-08 00:00:00-07	1.4	91	1.11	4	50.1	\N	\N	\N	NaN	72	\N
37868	DLP-054	2019-04-08 00:00:00-07	1.97	48	1.2	4	78.7	\N	\N	\N	NaN	76	\N
37869	DLP-073	2019-04-08 00:00:00-07	1.23	95	0.8	4	49.4	\N	\N	\N	NaN	77	\N
37870	DLP-047	2019-01-02 00:00:00-08	3.49	48	1.9	4	198.7	\N	\N	\N	NaN	69	\N
37871	DLP-028	2019-04-08 00:00:00-07	4.56	11	2.26	4	250	\N	\N	\N	NaN	16	\N
37872	DLP-02	2019-05-23 00:00:00-07	NaN	64	1.17	4	250	\N	\N	\N	NaN	1	\N
37873	DLP-03	2019-05-23 00:00:00-07	NaN	27	1.12	4	250	\N	\N	\N	NaN	3	\N
37874	DLP-06	2019-05-23 00:00:00-07	NaN	0	1.19	4	NaN	\N	\N	\N	NaN	5	\N
37875	DLP-19	2019-05-23 00:00:00-07	NaN	66	0.71	4	60.5	\N	\N	\N	Sample removed from study	11	\N
37876	DLP-08	2019-05-23 00:00:00-07	NaN	512	1.51	4	247.7	\N	\N	\N	NaN	59	\N
37877	DLP-09	2019-05-23 00:00:00-07	NaN	553	1.72	4	250	\N	\N	\N	NaN	60	\N
37878	DLP-72	2019-05-23 00:00:00-07	NaN	149	0.67	4	51.7	\N	\N	\N	Sample removed from study	74	\N
37879	DLP-79	2019-05-23 00:00:00-07	NaN	161	0.83	4	154.1	\N	\N	\N	NaN	86	\N
37880	DLP-75	2019-05-23 00:00:00-07	NaN	145	0.88	4	110.6	\N	\N	\N	NaN	84	\N
37881	DLP-86	2019-05-23 00:00:00-07	NaN	96	2.72	4	183.4	\N	\N	\N	NaN	96	\N
37882	DLP-85	2019-05-23 00:00:00-07	NaN	96	0.83	4	117.1	\N	\N	\N	Sample removed from study	94	\N
37883	DLP-89	2019-06-20 00:00:00-07	5.3	27	3.9	4	250	\N	\N	\N	NaN	33	\N
37884	DLP-90	2019-06-20 00:00:00-07	6.6	21	4.63	4	250	\N	\N	\N	NaN	34	\N
37885	DLP-91	2019-06-20 00:00:00-07	4.04	48	2.11	4	108	\N	\N	\N	NaN	35	\N
37886	DLP-92	2019-06-20 00:00:00-07	2.1	48	1.16	4	71	\N	\N	\N	NaN	36	\N
37887	DLP-93	2019-06-20 00:00:00-07	1.86	48	1.12	4	70	\N	\N	\N	NaN	37	\N
37888	DLP-94	2019-06-20 00:00:00-07	3.32	1	1.99	4	250	\N	\N	\N	NaN	38	\N
37889	DLP-96	2019-06-20 00:00:00-07	5.09	6	2.99	4	250	\N	\N	\N	NaN	40	\N
37890	DLP-95	2019-06-20 00:00:00-07	5.24	12	3.3	4	250	\N	\N	\N	NaN	39	\N
37891	VMRLP-101	2019-08-07 00:00:00-07	35.5	NaN	72.27	9	NaN	\N	\N	\N	cell culture	9	\N
37892	VMRLP-102	2019-08-07 00:00:00-07	32.9	NaN	74.49	9	NaN	\N	\N	\N	cell culture	10	\N
37893	VMRLP-103	2019-08-07 00:00:00-07	29.7	NaN	67.36	9	NaN	\N	\N	\N	cell culture	11	\N
37894	VMRLP-104	2019-08-07 00:00:00-07	29.8	NaN	63.85	9	NaN	\N	\N	\N	cell culture	12	\N
37895	VMRLP-105	2019-08-07 00:00:00-07	33.1	NaN	64.93	9	NaN	\N	\N	\N	cell culture	13	\N
37896	VMRLP-106	2019-08-07 00:00:00-07	36.5	NaN	66.91	9	NaN	\N	\N	\N	cell culture	14	\N
37897	DLP-05	2019-05-23 00:00:00-07	1.31	96	0.29	4	59.8	\N	\N	\N	NaN	4	\N
37898	DLP-07	2019-05-23 00:00:00-07	0.89	350	0.42	4	60.5	\N	\N	\N	NaN	6	\N
37899	DLP-15	2019-05-23 00:00:00-07	1.05	154	0.43	4	70.6	\N	\N	\N	NaN	61	\N
37900	DLP-16	2019-05-23 00:00:00-07	1.92	231	0.73	4	126.7	\N	\N	\N	NaN	62	\N
37901	DLP-24	2019-05-23 00:00:00-07	0.42	67	0.24	4	94.5	\N	\N	\N	NaN	69	\N
37902	DLP-76	2019-05-23 00:00:00-07	1.37	117	0.67	4	92.2	\N	\N	\N	NaN	85	\N
37903	DLP-81	2019-05-23 00:00:00-07	1.31	105	0.55	4	79.6	\N	\N	\N	Sample removed from study	92	\N
37904	DLP-80	2019-05-23 00:00:00-07	0.64	71	0.6	4	110.7	\N	\N	\N	NaN	87	\N
37905	DLP-83	2019-05-23 00:00:00-07	2.56	201	0.3	4	57.2	\N	\N	\N	Sample removed from study	93	\N
37906	DLP-88	2019-06-20 00:00:00-07	6.86	15	5.28	4	250	\N	\N	\N	NaN	32	\N
37907	DLP-23	2019-08-23 00:00:00-07	4.63	0	1.12	4	NaN	\N	\N	\N	NaN	13	\N
37908	DLP-68	2019-04-08 00:00:00-07	2.01	Infinity	0.6	4	72.1	\N	\N	\N	NaN	68	\N
37909	DLP-10	2019-04-08 00:00:00-07	0.82	Infinity	0.58	4	48	\N	\N	\N	NaN	8	\N
37910	DLP-87	2019-08-23 00:00:00-07	4.46	0	1.02	4	NaN	\N	\N	\N	NaN	95	\N
37911	DLP-20	2019-08-23 00:00:00-07	2.24	Infinity	0.54	4	66.2	\N	\N	\N	Sample removed from study	12	\N
37912	DLP-48	2019-01-02 00:00:00-08	0.63	0	0.46	4	NaN	\N	\N	\N	NaN	70	\N
37913	DLP-04	2019-08-23 00:00:00-07	1.54	0	0.31	4	NaN	\N	\N	\N	NaN	3	\N
37914	DLP-059_RE2	2019-05-24 00:00:00-07	1.95	0	0.6	4	NaN	\N	\N	\N	NaN	83	\N
37915	DLP-059_RE3	2019-08-23 00:00:00-07	1.16	0	0.19	4	NaN	\N	\N	\N	NaN	83	\N
37916	RLP-67	2020-08-15 00:00:00-07	17.1	NaN	28.6	11	NaN	\N	\N	\N	NaN	17	\N
37917	RLP-68	2020-08-15 00:00:00-07	7.47	NaN	13.02	11	NaN	\N	\N	\N	NaN	18	\N
37918	RLP-69	2020-08-15 00:00:00-07	8	NaN	13.11	11	NaN	\N	\N	\N	NaN	19	\N
37919	RLP-70	2020-08-15 00:00:00-07	9.38	NaN	15.04	11	NaN	\N	\N	\N	NaN	20	\N
37920	RLP-73	2020-08-15 00:00:00-07	8.29	NaN	14.11	11	NaN	\N	\N	\N	NaN	26	\N
37921	RLP-74	2020-08-15 00:00:00-07	8.18	NaN	12.54	11	NaN	\N	\N	\N	NaN	28	\N
37922	RLP-71	2020-08-15 00:00:00-07	4.18	NaN	6.01	11	NaN	\N	\N	\N	NaN	24	\N
37923	RLP-72	2020-08-15 00:00:00-07	2.47	NaN	3.75	11	NaN	\N	\N	\N	NaN	25	\N
37924	RLP-75	2020-08-15 00:00:00-07	2.31	NaN	3.85	11	NaN	\N	\N	\N	NaN	29	\N
37925	RLP-76	2020-08-15 00:00:00-07	10	NaN	18.59	11	NaN	\N	\N	\N	NaN	30	\N
37926	RLP-88	2020-10-13 00:00:00-07	9.19	NaN	21.22	11	NaN	\N	\N	\N	NaN	110	\N
37927	RLP-92	2020-10-13 00:00:00-07	1.96	NaN	3.21	11	NaN	\N	\N	\N	NaN	114	\N
37928	RLP-24	2018-08-20 00:00:00-07	1.2	NaN	0.8	11	NaN	\N	\N	\N	RLP-24	E11	\N
37929	RLP-78	2020-09-05 00:00:00-07	4.24	NaN	6.89	11	NaN	\N	\N	\N	NaN	169	\N
37930	RLP-79	2020-09-05 00:00:00-07	4.68	NaN	6.25	11	NaN	\N	\N	\N	NaN	170	\N
37931	RLP-80	2020-09-05 00:00:00-07	3.04	NaN	4.88	11	NaN	\N	\N	\N	NaN	171	\N
37932	RLP-89	2020-10-13 00:00:00-07	1.87	NaN	3.18	11	NaN	\N	\N	\N	NaN	111	\N
37933	RLP-90	2020-10-13 00:00:00-07	1.58	NaN	2.78	11	NaN	\N	\N	\N	NaN	112	\N
37934	RLP-17	2018-08-20 00:00:00-07	11.7	NaN	3.3	11	NaN	\N	\N	\N	RLP-17	B6	\N
37935	RLP-25	2018-09-27 00:00:00-07	4.8	NaN	7.9	11	NaN	\N	\N	\N	RLP-25	1	\N
37936	RLP-77	2020-09-05 00:00:00-07	12.9	NaN	19.04	11	NaN	\N	\N	\N	NaN	168	\N
37937	RLP-81	2020-09-05 00:00:00-07	4.49	NaN	6.82	11	NaN	\N	\N	\N	NaN	172	\N
37938	RLP-82	2020-09-05 00:00:00-07	8.39	NaN	15.82	11	NaN	\N	\N	\N	NaN	173	\N
37939	RLP-85	2020-09-05 00:00:00-07	11.7	NaN	20.36	11	NaN	\N	\N	\N	NaN	176	\N
37940	RLP-87	2020-09-05 00:00:00-07	18.1	NaN	32.5	11	NaN	\N	\N	\N	NaN	178	\N
37941	RLP-86	2020-09-05 00:00:00-07	15.3	NaN	25.94	11	NaN	\N	\N	\N	NaN	177	\N
37942	RLP-91	2020-10-13 00:00:00-07	3.63	NaN	7.1	11	NaN	\N	\N	\N	NaN	113	\N
37943	RLP-93	2020-10-13 00:00:00-07	3.49	NaN	6.97	11	NaN	\N	\N	\N	NaN	115	\N
37944	DLP-98	2020-08-02 00:00:00-07	6.84	0	5.61	4	NaN	\N	\N	\N	NaN	131	\N
37945	DLP-99	2020-08-02 00:00:00-07	2.57	0	2.53	4	NaN	\N	\N	\N	NaN	132	\N
37946	DLP-105	2020-09-03 00:00:00-07	3.48	90	1.57	4	104	\N	\N	\N	NaN	183	\N
37947	DLP-108	2020-09-03 00:00:00-07	4.73	71	1.82	4	333	\N	\N	\N	NaN	186	\N
37948	DLP-115	2020-09-28 00:00:00-07	2.47	90	0.72	4	111	\N	\N	\N	NaN	2	\N
37949	DLP-116	2020-09-28 00:00:00-07	1.91	89	0.7	4	73	\N	\N	\N	NaN	31	\N
37950	DLP-117	2020-09-28 00:00:00-07	5.71	70	2.42	4	250	\N	\N	\N	NaN	55	\N
37951	DLP-118	2020-09-28 00:00:00-07	6.06	90	2.99	4	224	\N	\N	\N	NaN	56	\N
37952	DLP-119	2020-09-28 00:00:00-07	1.58	90	0.62	4	96	\N	\N	\N	NaN	73	\N
37953	DLP-120	2020-09-28 00:00:00-07	3.75	61	1.97	4	250	\N	\N	\N	NaN	75	\N
37954	DLP-123	2020-10-10 00:00:00-07	3.38	NaN	1.52	4	NaN	\N	\N	\N	NaN	85	\N
37955	DLP-124	2020-10-10 00:00:00-07	1.42	NaN	0.7	4	NaN	\N	\N	\N	NaN	86	\N
37956	DLP-126	2020-10-10 00:00:00-07	3.83	NaN	3	4	NaN	\N	\N	\N	NaN	101	\N
37957	DLP-101	2020-09-03 00:00:00-07	5.17	23	1.78	4	333	\N	\N	\N	NaN	179	\N
37958	DLP-102	2020-09-03 00:00:00-07	2.93	90	1.25	4	78	\N	\N	\N	NaN	180	\N
37959	DLP-104	2020-09-03 00:00:00-07	0.7	90	0.3	4	19.8	\N	\N	\N	NaN	182	\N
37960	DLP-103	2020-09-03 00:00:00-07	0.83	90	0.35	4	21.6	\N	\N	\N	NaN	181	\N
37961	DLP-106	2020-09-03 00:00:00-07	5.29	32	2.56	4	333	\N	\N	\N	NaN	184	\N
37962	DLP-107	2020-09-03 00:00:00-07	2.44	90	1.48	4	112.5	\N	\N	\N	NaN	185	\N
37963	DLP-110	2020-09-03 00:00:00-07	1	90	0.47	4	42	\N	\N	\N	NaN	188	\N
37964	DLP-109	2020-09-03 00:00:00-07	0.99	90	0.41	4	46	\N	\N	\N	NaN	187	\N
37965	DLP-111	2020-09-03 00:00:00-07	2.08	90	0.85	4	72	\N	\N	\N	NaN	189	\N
37966	DLP-114	2020-09-03 00:00:00-07	6.01	90	3.22	4	205	\N	\N	\N	NaN	192	\N
37967	DLP-121	2020-10-10 00:00:00-07	4.05	24	2.82	4	250	\N	\N	\N	NaN	109	\N
37968	DLP-122	2020-10-10 00:00:00-07	2.77	NaN	1.52	4	NaN	\N	\N	\N	NaN	82	\N
37969	DLP-125	2020-10-10 00:00:00-07	5.78	NaN	5.17	4	NaN	\N	\N	\N	NaN	100	\N
37970	AMLP-469	2023-01-24 00:00:00-08	5.22	NaN	9.24	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	158	\N
37971	AMLP-474	2023-01-24 00:00:00-08	15.1	NaN	29.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	173	\N
37972	AMLP-471	2023-01-24 00:00:00-08	9.74	NaN	18.73	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	170	\N
37973	AMLP-472	2023-01-24 00:00:00-08	9.24	NaN	16.14	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	171	\N
37974	AMLP-470	2023-01-24 00:00:00-08	8.95	NaN	15.88	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	169	\N
37975	AMLP-478	2023-01-24 00:00:00-08	10.2	NaN	17.53	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	177	\N
37976	AMLP-473	2023-01-24 00:00:00-08	7.46	NaN	13.33	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	172	\N
37977	AMLP-468	2023-01-24 00:00:00-08	8.83	NaN	17.94	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	157	\N
37978	AMLP-461	2023-01-24 00:00:00-08	5.7	NaN	11.76	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	149	\N
37979	AMLP-462	2023-01-24 00:00:00-08	4.12	NaN	8.85	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	150	\N
37980	AMLP-465	2023-01-24 00:00:00-08	5.37	NaN	11.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	154	\N
37981	AMLP-477	2023-01-24 00:00:00-08	4.74	NaN	7.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	176	\N
37982	AMLP-464	2023-01-24 00:00:00-08	5.33	NaN	11.04	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	153	\N
37983	AMLP-475	2023-01-24 00:00:00-08	4.93	NaN	9.71	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	174	\N
37984	AMLP-476	2023-01-24 00:00:00-08	6.33	NaN	11.23	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	175	\N
37985	AMLP-463	2023-01-24 00:00:00-08	4.43	NaN	9.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	152	\N
37986	AMLP-541	2023-04-05 00:00:00-07	1.19	NaN	1.94	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	139	\N
37987	AMLP-542	2023-04-05 00:00:00-07	0.98	NaN	1.57	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-580 in BCB057	140	\N
37988	AMLP-552	2023-04-05 00:00:00-07	0.62	NaN	0.92	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	150	\N
37989	AMLP-575	2023-04-21 00:00:00-07	0.6	NaN	0.55	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-552 in BCB057	150	\N
37990	AMLP-576	2023-04-21 00:00:00-07	0.48	NaN	0.47	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-552 in BCB057	150	\N
37991	AMLP-580	2023-04-28 00:00:00-07	1.02	NaN	1.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	140	\N
37992	AMLP-435	2023-01-13 00:00:00-08	3.13	NaN	4.89	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	120	\N
37993	AMLP-434	2023-01-13 00:00:00-08	3.03	NaN	4.26	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	119	\N
37994	AMLP-437	2023-01-20 00:00:00-08	3.98	NaN	6.8	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	122	\N
37995	AMLP-438	2023-01-20 00:00:00-08	2.49	NaN	4.25	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	123	\N
37996	AMLP-486	2023-01-26 00:00:00-08	3.83	NaN	6.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	185	\N
37997	AMLP-537	2023-04-05 00:00:00-07	4.08	NaN	5.82	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	110	\N
37998	AMLP-440	2023-01-20 00:00:00-08	1.38	NaN	2.04	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	125	\N
37999	AMLP-439	2023-01-20 00:00:00-08	0.54	NaN	0.78	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	124	\N
38000	AMLP-521	2023-03-02 00:00:00-08	2.82	NaN	3.34	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	160	\N
38001	AMLP-553	2023-04-21 00:00:00-07	0.95	NaN	1.07	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles. Sequenced as AMLP-439	124	\N
38002	AMLP-554	2023-04-21 00:00:00-07	1.03	NaN	1.23	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles. Sequenced as AMLP-439	124	\N
38003	AMLP-444	2023-01-20 00:00:00-08	3.33	NaN	5.24	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	129	\N
38004	AMLP-443	2023-01-20 00:00:00-08	2.14	NaN	3.08	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	128	\N
38005	AMLP-482	2023-01-24 00:00:00-08	3.67	NaN	6.55	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	181	\N
38006	AMLP-491	2023-01-26 00:00:00-08	1.89	NaN	3.39	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	190	\N
38007	AMLP-493	2023-01-26 00:00:00-08	3.05	NaN	6.03	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	192	\N
38008	AMLP-492	2023-01-26 00:00:00-08	3.32	NaN	6.01	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	191	\N
38009	AMLP-540	2023-04-05 00:00:00-07	0.93	NaN	1.35	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-577 in BCB055	135	\N
38010	AMLP-574	2023-04-21 00:00:00-07	1.03	NaN	1.31	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-573 in BCB055	149	\N
38011	AMLP-567	2023-04-21 00:00:00-07	1.03	NaN	1.42	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-566 in BCB055	192	\N
38012	AMLP-566	2023-04-21 00:00:00-07	0.84	NaN	1.33	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	192	\N
38013	AMLP-573	2023-04-21 00:00:00-07	1.1	NaN	1.25	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	149	\N
38014	AMLP-577	2023-04-28 00:00:00-07	1.01	NaN	1.35	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	135	\N
38015	AMLP-578	2023-04-28 00:00:00-07	1.09	NaN	1.56	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	144	\N
38016	AMLP-579	2023-04-28 00:00:00-07	1.01	NaN	1.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-578 in BCB055	144	\N
38017	AMLP-445	2023-01-20 00:00:00-08	0.78	NaN	1.21	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	130	\N
38018	AMLP-484	2023-01-24 00:00:00-08	1.64	NaN	3.17	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	183	\N
38019	AMLP-483	2023-01-24 00:00:00-08	1.17	NaN	1.89	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	182	\N
38020	AMLP-466	2023-01-24 00:00:00-08	3.2	NaN	6.68	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	155	\N
38021	AMLP-487	2023-01-26 00:00:00-08	1.63	NaN	2.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	186	\N
38022	AMLP-488	2023-01-26 00:00:00-08	0.72	NaN	1.04	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	187	\N
38023	AMLP-560	2023-04-21 00:00:00-07	0.89	NaN	1.23	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-488 in BCB055	187	\N
38024	AMLP-556	2023-04-21 00:00:00-07	0.87	NaN	1.14	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-445 in BCB055	130	\N
38025	AMLP-457	2023-01-20 00:00:00-08	1.76	NaN	3	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	143	\N
38026	AMLP-460	2023-01-20 00:00:00-08	4.93	NaN	8.65	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	151	\N
38027	AMLP-458	2023-01-20 00:00:00-08	0.61	NaN	0.93	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	144	\N
38028	AMLP-558	2023-04-21 00:00:00-07	0.59	NaN	0.74	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-458 in BCB056	144	\N
38029	AMLP-563	2023-04-21 00:00:00-07	0.93	NaN	1.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-562 in BCB056	188	\N
38030	AMLP-559	2023-04-21 00:00:00-07	0.66	NaN	0.85	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-458 in BCB056	144	\N
38031	AMLP-562	2023-04-21 00:00:00-07	0.9	NaN	1.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	188	\N
38032	AMLP-584	2023-04-28 00:00:00-07	1.91	NaN	2.9	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146	\N
38033	AMLP-480	2023-01-24 00:00:00-08	1.16	NaN	1.74	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	179	\N
38034	AMLP-479	2023-01-24 00:00:00-08	1.22	NaN	1.94	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	178	\N
38035	AMLP-481	2023-01-24 00:00:00-08	1.52	NaN	2.57	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	180	\N
38036	AMLP-544	2023-04-05 00:00:00-07	1.49	NaN	2.55	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	142	\N
38037	AMLP-583	2023-04-28 00:00:00-07	1.64	NaN	2.33	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	141	\N
38038	AMLP-450	2023-01-20 00:00:00-08	2.64	NaN	4.71	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	135	\N
38039	AMLP-455	2023-01-20 00:00:00-08	3.15	NaN	5.86	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	140	\N
38040	AMLP-453	2023-01-20 00:00:00-08	1.33	NaN	2.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	138	\N
38041	AMLP-454	2023-01-20 00:00:00-08	1.37	NaN	2.71	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	139	\N
38042	AMLP-451	2023-01-20 00:00:00-08	1.16	NaN	1.81	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	136	\N
38043	AMLP-456	2023-01-20 00:00:00-08	2.24	NaN	4.06	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	141	\N
38044	AMLP-549	2023-04-05 00:00:00-07	1.31	NaN	2.03	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	147	\N
38045	EXLP-31	2023-05-29 00:00:00-07	0.66	NaN	0.52	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	162	\N
38046	EXLP-32	2023-05-29 00:00:00-07	0.63	NaN	0.66	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	163	\N
38047	EXLP-34	2023-05-29 00:00:00-07	1.41	NaN	1.23	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	165	\N
38048	EXLP-33	2023-05-29 00:00:00-07	2.4	NaN	2.86	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	164	\N
38049	EXLP-35	2023-05-29 00:00:00-07	0.38	NaN	0.26	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	166	\N
38050	EXLP-36	2023-05-29 00:00:00-07	0.74	NaN	0.78	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	167	\N
38051	EXLP-38	2023-05-29 00:00:00-07	0.63	NaN	0.53	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	169	\N
38052	EXLP-39	2023-05-29 00:00:00-07	0.21	NaN	0.13	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	170	\N
38053	EXLP-52	2023-06-19 00:00:00-07	0.24	NaN	0.27	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-39 in BCB058	170	\N
38054	EXLP-51	2023-06-19 00:00:00-07	0.63	NaN	0.77	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-38 in BCB058	169	\N
38055	EXLP-49	2023-06-20 00:00:00-07	0.76	NaN	0.88	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-36 in BCB058	167	\N
38056	EXLP-48	2023-06-20 00:00:00-07	0.36	NaN	0.35	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-35 in BCB058	166	\N
38057	EXLP-47	2023-06-20 00:00:00-07	1.15	NaN	1.43	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-34 in BCB058	165	\N
38058	EXLP-45	2023-06-20 00:00:00-07	0.54	NaN	0.71	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-32 in BCB058	163	\N
38059	EXLP-44	2023-06-19 00:00:00-07	0.67	NaN	0.81	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-44 in BCB058	162	\N
38060	EXLP-54	2023-06-30 00:00:00-07	0.25	NaN	0.16	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-39 in BCB058	170	\N
38061	EXLP-53	2023-06-30 00:00:00-07	0.36	NaN	0.31	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-35 in BCB058	166	\N
38062	RLP-126	2023-03-03 00:00:00-08	4.12	NaN	5.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	122	\N
38063	RLP-124	2023-03-03 00:00:00-08	5.79	NaN	6.28	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	168	\N
38064	RLP-125	2023-03-03 00:00:00-08	10.3	NaN	15.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	121	\N
38065	RLP-118	2023-03-03 00:00:00-08	2.71	NaN	2.9	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	111	\N
38066	RLP-242	2023-07-18 00:00:00-07	6.45	NaN	8.54	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	177	\N
38067	RLP-241	2023-07-18 00:00:00-07	6.44	NaN	7.35	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	176	\N
38068	RLP-239	2023-07-18 00:00:00-07	2.38	NaN	2.89	12	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 12 cycles	174	\N
38069	RLP-249	2023-07-25 00:00:00-07	3.27	NaN	4.78	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	184	\N
38070	RLP-248	2023-07-25 00:00:00-07	4.19	NaN	5.67	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	183	\N
38071	IYEH-09	2023-07-25 00:00:00-07	1.27	NaN	1.56	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	185	\N
38072	RLP-137	2023-03-08 00:00:00-08	1.53	NaN	1.77	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles. KAPAEX-29; Sequenced with RLP-199, BCB059	133	\N
38073	RLP-166	2023-03-10 00:00:00-08	1.26	NaN	1.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-29; Sequenced with RLP-228, BCB059	163	\N
38074	RLP-151	2023-03-10 00:00:00-08	2.01	NaN	0.73	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles;  KAPAEX-29; Sequenced with RLP-213, BCB059	148	\N
38075	RLP-152	2023-03-10 00:00:00-08	2.83	NaN	0.37	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-29; Sequenced with RLP-214, BCB059	149	\N
38076	RLP-214	2023-07-05 00:00:00-07	2.85	NaN	2.6	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	149	\N
38077	RLP-213	2023-07-05 00:00:00-07	2.28	NaN	2.16	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	148	\N
38078	RLP-212	2023-07-05 00:00:00-07	3.57	NaN	3.16	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	147	\N
38079	RLP-199	2023-07-05 00:00:00-07	1.33	NaN	1.26	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	133	\N
38080	RLP-235	2023-07-11 00:00:00-07	2.77	NaN	2.99	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	170	\N
38081	RLP-234	2023-07-11 00:00:00-07	5.67	NaN	5.76	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	169	\N
38082	RLP-233	2023-07-11 00:00:00-07	5.77	NaN	6.21	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	168	\N
38083	RLP-232	2023-07-11 00:00:00-07	5.77	NaN	5.45	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	167	\N
38084	RLP-229	2023-07-11 00:00:00-07	1.96	NaN	2.29	10	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 10 cycles	164	\N
38085	RLP-228	2023-07-11 00:00:00-07	2.33	NaN	2.52	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	163	\N
38086	RLP-107	2023-03-03 00:00:00-08	1.11	NaN	1.18	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	169	\N
38087	RLP-115	2023-03-03 00:00:00-08	1.47	NaN	1.8	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	167	\N
38088	RLP-110	2023-03-03 00:00:00-08	1.13	NaN	1.25	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-30; Sequenced with RLP-173, BCB062	100	\N
38089	RLP-119	2023-03-03 00:00:00-08	2.32	NaN	1.87	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	112	\N
38090	RLP-129	2023-03-08 00:00:00-08	1.86	NaN	1.76	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	125	\N
38091	RLP-145	2023-03-08 00:00:00-08	0.86	NaN	0.93	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-30; Sequenced with RLP-207, BCB062	142	\N
38092	RLP-157	2023-03-10 00:00:00-08	0.51	NaN	0.56	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-219, BCB062	154	\N
38093	RLP-160	2023-03-10 00:00:00-08	0.42	NaN	0.39	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-222, BCB062	157	\N
38094	RLP-155	2023-03-10 00:00:00-08	0.8	NaN	0.96	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-217, BCB062	152	\N
38095	RLP-159	2023-03-10 00:00:00-08	0.68	NaN	0.71	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-221, BCB062	156	\N
38096	RLP-170	2023-06-30 00:00:00-07	0.64	NaN	0.62	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	97	\N
38097	RLP-217	2023-07-05 00:00:00-07	0.88	NaN	0.7	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	152	\N
38098	RLP-173	2023-06-30 00:00:00-07	0.48	NaN	0.37	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	100	\N
38099	RLP-207	2023-07-05 00:00:00-07	0.83	NaN	0.83	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	142	\N
38100	RLP-222	2023-07-11 00:00:00-07	1.35	NaN	1.29	10	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 10 cycles	157	\N
38101	RLP-221	2023-07-11 00:00:00-07	1.18	NaN	1.16	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	156	\N
38102	RLP-219	2023-07-11 00:00:00-07	1.1	NaN	1.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	154	\N
38103	RLP-247	2023-07-18 00:00:00-07	1.02	NaN	1.14	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; ; KAPAEX-30; Sequenced with RLP-255, BCB062	182	\N
38104	RLP-245	2023-07-18 00:00:00-07	1.4	NaN	1.78	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-253, BCB062	180	\N
38105	RLP-255	2023-08-04 00:00:00-07	1.06	NaN	0.72	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	182	\N
38106	RLP-253	2023-08-04 00:00:00-07	1.18	NaN	0.68	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	180	\N
38107	RLP-114	2023-03-03 00:00:00-08	0.57	NaN	0.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-177, BCB063	104	\N
38108	RLP-121	2023-03-03 00:00:00-08	0.33	NaN	0.28	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-184, BCB063	114	\N
38109	RLP-113	2023-03-03 00:00:00-08	0.51	NaN	0.46	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-176, BCB063	103	\N
38110	RLP-108	2023-03-03 00:00:00-08	0.66	NaN	0.67	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-171, BCB063	98	\N
38111	RLP-111	2023-03-03 00:00:00-08	0.52	NaN	0.54	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-174, BCB063	101	\N
38112	RLP-122	2023-03-03 00:00:00-08	0.33	NaN	0.31	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-185, BCB063	115	\N
38113	RLP-112	2023-03-03 00:00:00-08	0.39	NaN	0.43	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-175, BCB063	102	\N
38114	RLP-133	2023-03-08 00:00:00-08	0.41	NaN	0.42	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-195, BCB063	129	\N
38115	RLP-169	2023-03-10 00:00:00-08	0.47	NaN	0.61	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-231, BCB063	166	\N
38116	RLP-168	2023-03-10 00:00:00-08	0.34	NaN	0.36	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; ; KAPAEX-31; Sequenced with RLP-230, BCB063	165	\N
38117	RLP-154	2023-03-10 00:00:00-08	0.62	NaN	0.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-216, BCB063	151	\N
38118	RLP-161	2023-03-10 00:00:00-08	0.42	NaN	0.43	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-223, BCB063	158	\N
38119	RLP-153	2023-03-10 00:00:00-08	0.58	NaN	0.48	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-215, BCB063	150	\N
38120	RLP-216	2023-07-05 00:00:00-07	0.67	NaN	0.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	151	\N
38121	RLP-215	2023-07-05 00:00:00-07	0.59	NaN	0.45	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	150	\N
38122	RLP-185	2023-06-30 00:00:00-07	0.24	NaN	0.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	115	\N
38123	RLP-184	2023-06-30 00:00:00-07	0.16	NaN	0.09	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	114	\N
38124	RLP-177	2023-06-30 00:00:00-07	0.52	NaN	0.49	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	104	\N
38125	RLP-176	2023-06-30 00:00:00-07	0.37	NaN	0.3	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	103	\N
38126	RLP-175	2023-06-30 00:00:00-07	0.09	NaN	0.02	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	102	\N
38127	RLP-174	2023-06-30 00:00:00-07	0.44	NaN	0.39	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	101	\N
38128	RLP-171	2023-06-30 00:00:00-07	0.45	NaN	0.37	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	98	\N
38129	RLP-195	2023-07-05 00:00:00-07	0.48	NaN	0.39	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	129	\N
38130	RLP-238	2023-07-18 00:00:00-07	0.75	NaN	0.76	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-250, BCB063	173	\N
38131	RLP-237	2023-07-18 00:00:00-07	0.57	NaN	0.62	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-256, BCB063	172	\N
38132	RLP-231	2023-07-11 00:00:00-07	0.67	NaN	0.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	166	\N
38133	RLP-230	2023-07-11 00:00:00-07	0.57	NaN	0.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	165	\N
38134	RLP-223	2023-07-11 00:00:00-07	0.67	NaN	0.55	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	158	\N
38135	RLP-256	2023-08-04 00:00:00-07	0.28	NaN	0.18	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	172	\N
38136	RLP-250	2023-08-04 00:00:00-07	0.61	NaN	0.38	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	173	\N
38137	RLP-109	2023-03-03 00:00:00-08	0.77	NaN	0.9	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	170	\N
38138	RLP-123	2023-03-03 00:00:00-08	0.92	NaN	0.89	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-186, BCB059	119	\N
38139	RLP-116	2023-03-03 00:00:00-08	0.81	NaN	0.93	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-179, BCB059	109	\N
38140	RLP-146	2023-03-08 00:00:00-08	0.77	NaN	0.76	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-208, BCB059	143	\N
38141	RLP-134	2023-03-08 00:00:00-08	0.63	NaN	0.72	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-196, BCB059	130	\N
38142	RLP-164	2023-03-10 00:00:00-08	0.56	NaN	0.51	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-226, BCB059	161	\N
38143	RLP-158	2023-03-10 00:00:00-08	0.51	NaN	0.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-220, BCB059	155	\N
38144	RLP-162	2023-03-10 00:00:00-08	0.55	NaN	0.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-224, BCB059	159	\N
38145	RLP-156	2023-03-10 00:00:00-08	0.59	NaN	0.68	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-218, BCB059	153	\N
38146	RLP-218	2023-07-05 00:00:00-07	0.72	NaN	0.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	153	\N
38147	RLP-179	2023-06-30 00:00:00-07	0.47	NaN	0.42	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	109	\N
38148	RLP-172	2023-06-30 00:00:00-07	0.77	NaN	0.64	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	99	\N
38149	RLP-208	2023-07-05 00:00:00-07	0.76	NaN	0.79	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	143	\N
38150	RLP-196	2023-07-05 00:00:00-07	0.61	NaN	0.56	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	130	\N
38151	RLP-186	2023-07-05 00:00:00-07	0.68	NaN	0.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	119	\N
38152	RLP-226	2023-07-11 00:00:00-07	0.95	NaN	0.84	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	161	\N
38153	RLP-224	2023-07-11 00:00:00-07	0.87	NaN	0.67	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	159	\N
38154	RLP-220	2023-07-11 00:00:00-07	0.92	NaN	0.87	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	155	\N
38155	RLP-240	2023-07-18 00:00:00-07	0.58	NaN	0.6	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-257, BCB059	175	\N
38156	RLP-257	2023-08-04 00:00:00-07	1.02	NaN	0.81	10	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 10 cycles; 1 hr adapter ligation at 20oC	175	\N
38157	RLP-130	2023-03-08 00:00:00-08	5.31	NaN	5.99	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	126	\N
38158	RLP-143	2023-03-08 00:00:00-08	2.83	NaN	3.11	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	140	\N
38159	RLP-131	2023-03-08 00:00:00-08	5.98	NaN	6.4	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	127	\N
38160	RLP-148	2023-03-08 00:00:00-08	3.21	NaN	3.21	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	145	\N
38161	RLP-141	2023-03-08 00:00:00-08	2.6	NaN	3.28	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	137	\N
38162	RLP-132	2023-03-08 00:00:00-08	4.02	NaN	4.49	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	128	\N
38163	RLP-147	2023-03-08 00:00:00-08	4.5	NaN	4.99	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	144	\N
38164	RLP-135	2023-03-08 00:00:00-08	2.93	NaN	3.54	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	131	\N
38165	RLP-236	2023-07-18 00:00:00-07	6.59	NaN	9.37	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	171	\N
38166	RLP-244	2023-07-18 00:00:00-07	1.26	NaN	1.55	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-33; Sequenced with RLP-252, BCB061	179	\N
38167	RLP-243	2023-07-18 00:00:00-07	1.53	NaN	1.94	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-33; Sequenced with RLP-251, BCB061	178	\N
38168	RLP-252	2023-08-04 00:00:00-07	1.27	NaN	0.98	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	179	\N
38169	RLP-251	2023-08-04 00:00:00-07	1.72	NaN	1.17	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	178	\N
38170	RLP-117	2023-03-03 00:00:00-08	0.92	NaN	1.38	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-180, BCB064	110	\N
38171	RLP-120	2023-03-03 00:00:00-08	2.16	NaN	2.26	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	113	\N
38172	RLP-128	2023-03-08 00:00:00-08	1.39	NaN	1.52	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-190, BCB064	124	\N
38173	RLP-139	2023-03-08 00:00:00-08	2.41	NaN	2.76	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	135	\N
38174	RLP-140	2023-03-08 00:00:00-08	2.1	NaN	2.19	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	136	\N
38175	RLP-138	2023-03-08 00:00:00-08	1.33	NaN	1.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-200, BCB064	134	\N
38176	RLP-144	2023-03-08 00:00:00-08	2.6	NaN	2.38	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	141	\N
38177	RLP-142	2023-03-08 00:00:00-08	2.01	NaN	2.03	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	139	\N
38178	RLP-136	2023-03-08 00:00:00-08	2.59	NaN	2.74	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	132	\N
38179	RLP-163	2023-03-10 00:00:00-08	0.83	NaN	0.93	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-225, BCB064	160	\N
38180	RLP-165	2023-03-10 00:00:00-08	1.76	NaN	2.4	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	162	\N
38181	RLP-211	2023-07-05 00:00:00-07	2.24	NaN	2.17	8	NaN	\N	\N	\N	NaN	146	\N
38182	RLP-180	2023-06-30 00:00:00-07	0.73	NaN	0.72	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	110	\N
38183	RLP-200	2023-07-05 00:00:00-07	1.04	NaN	1.06	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	134	\N
38184	RLP-190	2023-07-05 00:00:00-07	0.96	NaN	0.98	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	124	\N
38185	RLP-225	2023-07-11 00:00:00-07	1.38	NaN	1.25	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	160	\N
38186	RLP-246	2023-07-18 00:00:00-07	1.39	NaN	1.73	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-254, BCB064	181	\N
38187	RLP-254	2023-08-04 00:00:00-07	1.23	NaN	0.69	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	181	\N
38188	KALP-001	2023-09-06 00:00:00-07	0.98	63	1.77	4	250	\N	\N	\N	NaN	126	\N
39713	CGH12-227	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-227 	L2DR08	\N
38189	KALP-012	2023-09-06 00:00:00-07	3.96	8	1.81	4	250	\N	\N	\N	NaN	186	\N
38190	KALP-009	2023-09-06 00:00:00-07	4.09	73	1.82	4	250	\N	\N	\N	NaN	140	\N
38191	KALP-002	2023-09-06 00:00:00-07	6.79	42	3.57	4	250	\N	\N	\N	NaN	128	\N
38192	KALP-008	2023-09-06 00:00:00-07	8.19	11	4.97	4	250	\N	\N	\N	NaN	139	\N
38193	KALP-010	2023-09-06 00:00:00-07	6.22	14	3.52	4	250	\N	\N	\N	NaN	141	\N
38194	KALP-007	2023-09-06 00:00:00-07	6.34	96	3.25	4	250	\N	\N	\N	NaN	138	\N
38195	KALP-011	2023-09-06 00:00:00-07	5.19	46	3.14	4	250	\N	\N	\N	NaN	142	\N
38196	KALP-019	2023-09-15 00:00:00-07	4.9	63	2.36	4	250	\N	\N	\N	Captured as KALP-001 in KAPAEX-35 and sequenced in BCB065.	126	\N
38197	KALP-022	2023-09-15 00:00:00-07	12.1	8	6.18	4	250	\N	\N	\N	Captured as KALP-012 in KAPAEX-35 and sequenced in BCB065.	186	\N
38198	KALP-021	2023-09-15 00:00:00-07	10.6	73	4	4	250	\N	\N	\N	Captured as KALP-009 in KAPAEX-35 and sequenced in BCB065.	140	\N
38199	KALP-015	2023-09-06 00:00:00-07	18.1	15	5.18	4	250	\N	\N	\N	NaN	189	\N
38200	KALP-014	2023-09-06 00:00:00-07	0.75	100	0.33	4	250	\N	\N	\N	NaN	188	\N
38201	KALP-006	2023-09-06 00:00:00-07	7.26	29	3.72	4	250	\N	\N	\N	NaN	137	\N
38202	KALP-003	2023-09-06 00:00:00-07	5.27	94	2.12	4	250	\N	\N	\N	NaN	131	\N
38203	KALP-004	2023-09-06 00:00:00-07	7.33	71	2.69	4	250	\N	\N	\N	NaN	132	\N
38204	KALP-005	2023-09-06 00:00:00-07	6.43	175	2.49	4	250	\N	\N	\N	NaN	136	\N
38205	KALP-020	2023-09-15 00:00:00-07	7.3	94	3.59	4	250	\N	\N	\N	Captured as KALP-003 in KAPAEX-36 and sequenced in BCB066.	131	\N
38206	KALP-028	2023-09-15 00:00:00-07	12	13	3.55	4	250	\N	\N	\N	Captured as KALP-027 in KAPAEX-36 and sequenced in BCB066.	191	\N
38207	KALP-023	2023-09-15 00:00:00-07	1.36	100	0.27	4	250	\N	\N	\N	Captured as KALP-014 in KAPAEX-36 and sequenced in BCB066.	188	\N
38208	KALP-025	2023-09-15 00:00:00-07	1.37	100	0.27	4	250	\N	\N	\N	Captured as KALP-014 in KAPAEX-36 and sequenced in BCB066.	188	\N
38209	KALP-027	2023-09-15 00:00:00-07	14.1	13	3.55	4	250	\N	\N	\N	NaN	191	\N
38210	KALP-024	2023-09-15 00:00:00-07	1.53	100	0.27	4	250	\N	\N	\N	Captured as KALP-014 in KAPAEX-36 and sequenced in BCB066.	188	\N
38211	KALP-029	2023-09-15 00:00:00-07	12.2	35	5.85	4	250	\N	\N	\N	NaN	192	\N
38212	DLP-127	2022-10-04 00:00:00-07	3.45	0	1.75	4	NaN	\N	\N	\N	NaN	153	\N
38213	DLP-128	2022-10-04 00:00:00-07	1.42	NaN	0.97	4	NaN	\N	\N	\N	NaN	154	\N
38214	DLP-130	2022-10-04 00:00:00-07	1.98	0	1.42	4	NaN	\N	\N	\N	NaN	156	\N
38215	DLP-129	2022-10-04 00:00:00-07	2.86	NaN	1.59	4	NaN	\N	\N	\N	NaN	155	\N
38216	DLP-132	2022-10-04 00:00:00-07	0.78	0	0.63	4	NaN	\N	\N	\N	NaN	158	\N
38217	DLP-133	2022-10-04 00:00:00-07	2.18	0	1.26	4	NaN	\N	\N	\N	NaN	159	\N
38218	DLP-134	2022-10-04 00:00:00-07	2.4	0	1.22	4	NaN	\N	\N	\N	NaN	160	\N
38219	DLP-135	2022-10-04 00:00:00-07	0.95	NaN	0.53	4	NaN	\N	\N	\N	NaN	161	\N
38220	DLP-136	2022-10-04 00:00:00-07	4.61	0	1.97	4	NaN	\N	\N	\N	NaN	162	\N
38221	DLP-138	2022-10-04 00:00:00-07	1.76	0	1.05	4	NaN	\N	\N	\N	NaN	164	\N
38222	DLP-131	2022-10-04 00:00:00-07	3.69	0	2.48	4	NaN	\N	\N	\N	NaN	157	\N
38223	DLP-137	2022-10-04 00:00:00-07	4.01	0	2.7	4	NaN	\N	\N	\N	NaN	163	\N
38224	DLP-139	2022-10-04 00:00:00-07	5.18	0	3.44	4	NaN	\N	\N	\N	NaN	165	\N
38225	DLP-140	2022-10-04 00:00:00-07	4.46	0	2.76	4	NaN	\N	\N	\N	NaN	166	\N
38226	RLP-265	2023-08-29 00:00:00-07	2.21	NaN	2.62	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	180	\N
38227	RLP-264	2023-08-29 00:00:00-07	2.34	NaN	2.72	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	179	\N
38228	RLP-263	2023-08-29 00:00:00-07	0.38	NaN	0.36	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	178	\N
38229	RLP-262	2023-08-29 00:00:00-07	0.72	NaN	0.76	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	177	\N
38230	RLP-261	2023-08-29 00:00:00-07	0.92	NaN	0.98	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	176	\N
38231	RLP-260	2023-08-29 00:00:00-07	1.61	NaN	2.05	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	175	\N
38232	RLP-259	2023-08-29 00:00:00-07	1.18	NaN	1.4	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	174	\N
38233	RLP-258	2023-08-29 00:00:00-07	0.71	NaN	0.8	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC	173	\N
38234	AMLP-531	2023-03-31 00:00:00-07	7.38	0	3.88	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	128	\N
38235	AMLP-527	2023-03-31 00:00:00-07	9.04	NaN	7.77	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	102	\N
38236	AMLP-533	2023-03-31 00:00:00-07	2	0	1.15	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	130	\N
38237	AMLP-528	2023-03-31 00:00:00-07	7.53	0	6.49	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	111	\N
38238	AMLP-535	2023-03-31 00:00:00-07	4.48	0	2.34	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	132	\N
38239	AMLP-529	2023-03-31 00:00:00-07	4.41	0	3.27	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	115	\N
38240	AMLP-532	2023-03-31 00:00:00-07	2.5	0	1.57	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	129	\N
38241	AMLP-530	2023-03-31 00:00:00-07	1.61	0	0.86	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	126	\N
38242	AMLP-534	2023-03-31 00:00:00-07	4.8	0	2.5	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	131	\N
38243	IRLP-002	2019-01-08 00:00:00-08	9.64	NaN	16.1	11	NaN	\N	\N	\N	NaN	33	\N
38244	IRLP-001	2019-01-08 00:00:00-08	8.61	NaN	15.84	11	NaN	\N	\N	\N	NaN	32	\N
38245	IRLP-007	2019-01-08 00:00:00-08	7.32	NaN	13.74	11	NaN	\N	\N	\N	NaN	39	\N
38246	IRLP-006	2019-01-08 00:00:00-08	5.42	NaN	8.93	11	NaN	\N	\N	\N	NaN	37	\N
38247	IRLP-008	2019-01-08 00:00:00-08	3.24	NaN	4.88	11	NaN	\N	\N	\N	NaN	40	\N
38248	IRLP-010	2019-01-08 00:00:00-08	3.15	NaN	5.26	11	NaN	\N	\N	\N	NaN	42	\N
38249	IRLP-003	2019-01-08 00:00:00-08	1.36	NaN	2.36	11	NaN	\N	\N	\N	NaN	34	\N
38250	IRLP-009	2019-01-08 00:00:00-08	1.74	NaN	3.42	11	NaN	\N	\N	\N	NaN	41	\N
38251	IRLP-005	2019-01-08 00:00:00-08	1.74	NaN	2.85	11	NaN	\N	\N	\N	NaN	36	\N
38252	IRLP-004	2019-01-08 00:00:00-08	1.47	NaN	2.51	11	NaN	\N	\N	\N	NaN	35	\N
38253	SGLP-0028	2017-07-11 00:00:00-07	0.9	100	0.3	NaN	48.1	\N	\N	\N	NaN	C4	\N
38254	SGLP-0043	2017-07-11 00:00:00-07	6.94	100	4.08	NaN	358	\N	\N	\N	NaN	D7	\N
38255	SGLP-0027	2017-07-11 00:00:00-07	2.3	100	1.3	NaN	56.1	\N	\N	\N	NaN	C3	\N
38256	SGLP-0033	2017-07-11 00:00:00-07	2.1	100	0.99	NaN	61.4	\N	\N	\N	NaN	C9	\N
38257	SGLP-0023	2017-07-11 00:00:00-07	4.1	100	1.8	NaN	135	\N	\N	\N	NaN	B11	\N
38258	SGLP-0039	2017-07-11 00:00:00-07	5.36	100	2.88	NaN	230	\N	\N	\N	NaN	D3	\N
38259	SGLP-0048	2017-07-11 00:00:00-07	10.8	100	7.81	NaN	1420	\N	\N	\N	NaN	D12	\N
38260	SGLP-0024	2017-07-11 00:00:00-07	3.3	100	1.8	NaN	85.6	\N	\N	\N	NaN	B12	\N
38261	SGLP-0037	2017-07-11 00:00:00-07	1.14	100	0.35	NaN	101	\N	\N	\N	NaN	D1	\N
38262	SGLP-0025	2017-07-11 00:00:00-07	4.3	100	2.1	NaN	159	\N	\N	\N	NaN	C1	\N
38263	SGLP-0026	2017-07-11 00:00:00-07	2.1	100	0.9	NaN	90.3	\N	\N	\N	NaN	C2	\N
38264	SGLP-0041	2017-07-11 00:00:00-07	11	100	7.05	NaN	3240	\N	\N	\N	NaN	D5	\N
38265	SGLP-0049	2017-07-11 00:00:00-07	11.1	100	9.91	NaN	1430	\N	\N	\N	NaN	E1	\N
38266	SGLP-0038	2017-07-11 00:00:00-07	8.2	100	4.58	NaN	420	\N	\N	\N	NaN	D2	\N
38267	SGLP-0046	2017-07-11 00:00:00-07	9.82	100	7.63	NaN	1500	\N	\N	\N	NaN	D10	\N
38268	SGLP-0036	2017-07-11 00:00:00-07	8.46	100	5.1	NaN	463	\N	\N	\N	NaN	C12	\N
38269	SGLP-0034	2017-07-11 00:00:00-07	5.44	100	3.08	NaN	167	\N	\N	\N	NaN	C10	\N
38270	SGLP-0044	2017-07-11 00:00:00-07	8.68	100	7.58	NaN	888	\N	\N	\N	NaN	D8	\N
38271	SGLP-0035	2017-07-11 00:00:00-07	6.3	100	3.08	NaN	340	\N	\N	\N	NaN	C11	\N
38272	SGLP-0031	2017-07-11 00:00:00-07	3.16	100	1.58	NaN	94.1	\N	\N	\N	NaN	C7	\N
38273	SGLP-0042	2017-07-11 00:00:00-07	11.5	100	8.12	NaN	1050	\N	\N	\N	NaN	D6	\N
38274	SGLP-0030	2017-07-11 00:00:00-07	3.4	100	1.77	NaN	108	\N	\N	\N	NaN	C6	\N
38275	SGLP-0047	2017-07-11 00:00:00-07	8.96	100	6.09	NaN	614	\N	\N	\N	NaN	D11	\N
38276	SGLP-0045	2017-07-11 00:00:00-07	9.76	100	7.68	NaN	462	\N	\N	\N	NaN	D9	\N
38277	SGLP-0001	2017-07-06 00:00:00-07	3.3	50	6.91	NaN	210	\N	\N	\N	NaN	A1	\N
38278	SGLP-0002	2017-07-06 00:00:00-07	4.07	36	8.3	NaN	250	\N	\N	\N	NaN	A2	\N
38279	SGLP-0003	2017-07-06 00:00:00-07	4.13	40	7.26	NaN	250	\N	\N	\N	NaN	A3	\N
38280	SGLP-0004	2017-07-06 00:00:00-07	4.75	36	10.87	NaN	250	\N	\N	\N	NaN	A4	\N
38281	SGLP-0005	2017-07-06 00:00:00-07	4.73	35	9.63	NaN	250	\N	\N	\N	NaN	A5	\N
38282	SGLP-0006	2017-07-06 00:00:00-07	3.94	50	7.18	NaN	212	\N	\N	\N	NaN	A6	\N
38283	SGLP-0007	2017-07-06 00:00:00-07	2.32	50	3.92	NaN	129.5	\N	\N	\N	NaN	A7	\N
38284	SGLP-0008	2017-07-06 00:00:00-07	4.1	43	7.68	NaN	250	\N	\N	\N	NaN	A8	\N
38285	SGLP-0009	2017-07-06 00:00:00-07	1.9	50	2.85	NaN	219.5	\N	\N	\N	NaN	A9	\N
38286	SGLP-0010	2017-07-06 00:00:00-07	2.99	14	6.3	NaN	250	\N	\N	\N	NaN	A10	\N
38287	SGLP-0011	2017-07-06 00:00:00-07	4.81	39	10.64	NaN	250	\N	\N	\N	NaN	A11	\N
38288	SGLP-0012	2017-07-06 00:00:00-07	3.56	6	7.85	NaN	250	\N	\N	\N	NaN	A12	\N
38289	SGLP-0013	2017-07-06 00:00:00-07	3.26	48	6.13	NaN	250	\N	\N	\N	NaN	B1	\N
38290	SGLP-0014	2017-07-06 00:00:00-07	2.95	50	5.53	NaN	212	\N	\N	\N	NaN	B2	\N
38291	SGLP-0015	2017-07-06 00:00:00-07	1.7	30	2.46	NaN	250	\N	\N	\N	NaN	B3	\N
38292	SGLP-0016	2017-07-06 00:00:00-07	2.49	33	4.15	NaN	250	\N	\N	\N	NaN	B4	\N
38293	SGLP-0017	2017-07-06 00:00:00-07	3.77	41	9.6	NaN	250	\N	\N	\N	NaN	B5	\N
38294	SGLP-0018	2017-07-06 00:00:00-07	3.11	43	7.29	NaN	250	\N	\N	\N	NaN	B6	\N
38295	SGLP-0019	2017-07-06 00:00:00-07	3.71	23	9.17	NaN	250	\N	\N	\N	NaN	B7	\N
38296	SGLP-0020	2017-07-06 00:00:00-07	2.85	29	5.96	NaN	250	\N	\N	\N	NaN	B8	\N
38297	SGLP-0021	2017-07-06 00:00:00-07	2.49	26	4.97	NaN	250	\N	\N	\N	NaN	B9	\N
38298	SGLP-0022	2017-07-06 00:00:00-07	3.75	44	7.88	NaN	250	\N	\N	\N	NaN	B10	\N
38299	SGLP-0050	2017-07-17 00:00:00-07	7.36	50	4.53	NaN	238	\N	\N	\N	NaN	E5	\N
38300	SGLP-0051	2017-07-17 00:00:00-07	9.5	37	7.18	NaN	250	\N	\N	\N	NaN	E6	\N
38301	SGLP-0052	2017-07-17 00:00:00-07	6.46	45	4.58	NaN	250	\N	\N	\N	NaN	E7	\N
38302	SGLP-0053	2017-07-17 00:00:00-07	2.84	50	1.05	NaN	242	\N	\N	\N	NaN	E8	\N
38303	SGLP-0054	2017-07-17 00:00:00-07	8.52	39	5.74	NaN	250	\N	\N	\N	NaN	E9	\N
38304	SGLP-0055	2017-07-17 00:00:00-07	9.48	33	9.62	NaN	250	\N	\N	\N	NaN	E10	\N
38305	SGLP-0056	2017-07-17 00:00:00-07	5.18	50	2.97	NaN	185	\N	\N	\N	NaN	E11	\N
38306	SGLP-0057	2017-07-17 00:00:00-07	10.2	50	7.16	NaN	185.5	\N	\N	\N	NaN	E12	\N
38307	SGLP-0058	2017-07-17 00:00:00-07	8.68	41	6.55	NaN	250	\N	\N	\N	NaN	F1	\N
38308	SGLP-0059	2017-07-17 00:00:00-07	6.2	23	5.25	NaN	250	\N	\N	\N	NaN	F2	\N
38309	SGLP-0060	2017-07-17 00:00:00-07	6.46	50	3.01	NaN	248	\N	\N	\N	NaN	F3	\N
38310	SGLP-0061	2017-07-17 00:00:00-07	6.18	44	4.89	NaN	250	\N	\N	\N	NaN	F4	\N
38311	SGLP-0062	2017-07-17 00:00:00-07	5.34	14	4.63	NaN	250	\N	\N	\N	NaN	F5	\N
38312	SGLP-0063	2017-07-17 00:00:00-07	8.34	50	5.2	NaN	213	\N	\N	\N	NaN	F6	\N
38313	SGLP-0064	2017-07-17 00:00:00-07	7.46	50	7.11	NaN	232	\N	\N	\N	NaN	F7	\N
38314	SGLP-0065	2017-07-17 00:00:00-07	8.46	42	7.28	NaN	250	\N	\N	\N	NaN	F8	\N
38315	SGLP-0066	2017-07-17 00:00:00-07	7.86	9	6.22	NaN	250	\N	\N	\N	NaN	F9	\N
38316	SGLP-0067	2017-07-17 00:00:00-07	9.2	33	8.13	NaN	250	\N	\N	\N	NaN	F10	\N
38317	SGLP-0068	2017-07-17 00:00:00-07	7.96	30	5.97	NaN	250	\N	\N	\N	NaN	F11	\N
38318	SGLP-0069	2017-07-17 00:00:00-07	9.52	20	8.59	NaN	250	\N	\N	\N	NaN	F12	\N
38319	SGLP-0070	2017-07-17 00:00:00-07	4.46	50	2.87	NaN	208	\N	\N	\N	NaN	G1	\N
38320	SGLP-0071	2017-07-17 00:00:00-07	15.1	9	13.66	NaN	250	\N	\N	\N	NaN	G2	\N
38321	SGLP-0072	2017-07-17 00:00:00-07	10.5	45	9.29	NaN	250	\N	\N	\N	NaN	G3	\N
38322	SGLP-0073	2017-07-17 00:00:00-07	11.7	41	10.2	NaN	250	\N	\N	\N	NaN	G4	\N
38323	SGLP-0074	2017-07-17 00:00:00-07	7	50	4.52	NaN	245	\N	\N	\N	NaN	G5	\N
38324	SGLP-0075	2017-07-17 00:00:00-07	7.26	50	5.23	NaN	233	\N	\N	\N	NaN	G6	\N
38325	SGLP-0076	2017-07-17 00:00:00-07	6.94	29	5.13	NaN	250	\N	\N	\N	NaN	G7	\N
38326	SGLP-0077	2017-07-17 00:00:00-07	7.22	50	4.53	NaN	195.5	\N	\N	\N	NaN	G8	\N
38327	SGLP-0078	2017-07-17 00:00:00-07	5.22	40	3.79	NaN	250	\N	\N	\N	NaN	G9	\N
38328	SGLP-0079	2017-07-17 00:00:00-07	5.9	31	2.32	NaN	250	\N	\N	\N	NaN	G10	\N
38329	SGLP-0080	2017-07-24 00:00:00-07	5.54	21	5.2	NaN	250	\N	\N	\N	NaN	G11	\N
38330	SGLP-0081	2017-07-24 00:00:00-07	8.82	10	9.98	NaN	250	\N	\N	\N	NaN	G12	\N
38331	SGLP-0082	2017-07-24 00:00:00-07	5.82	16	6.08	NaN	250	\N	\N	\N	NaN	H1	\N
38332	SGLP-0083	2017-07-24 00:00:00-07	4.2	40	3.72	NaN	250	\N	\N	\N	NaN	H2	\N
38333	SGLP-0084	2017-07-24 00:00:00-07	6.54	42	5.79	NaN	250	\N	\N	\N	NaN	H3	\N
38334	SGLP-0085	2017-07-24 00:00:00-07	4.78	41	5.13	NaN	250	\N	\N	\N	NaN	H4	\N
38335	SGLP-0086	2017-07-24 00:00:00-07	6.22	51	5.46	NaN	202	\N	\N	\N	NaN	H5	\N
38336	SGLP-0087	2017-07-24 00:00:00-07	6.02	38	6.94	NaN	250	\N	\N	\N	NaN	H6	\N
38337	SGLP-0088	2017-07-24 00:00:00-07	4.42	50	4.07	NaN	250	\N	\N	\N	NaN	H7	\N
38338	SGLP-0089	2017-07-24 00:00:00-07	8.5	38	8.66	NaN	250	\N	\N	\N	NaN	H8	\N
38339	SGLP-0090	2017-07-24 00:00:00-07	7.14	34	6.47	NaN	250	\N	\N	\N	NaN	H9	\N
38340	SGLP-0091	2017-07-24 00:00:00-07	7.82	50	6.73	NaN	149	\N	\N	\N	NaN	H10	\N
38341	SGLP-0092	2017-07-24 00:00:00-07	5.8	51	4.29	NaN	162	\N	\N	\N	NaN	H11	\N
38342	SGLP-0093	2017-07-24 00:00:00-07	5.36	51	4.94	NaN	197	\N	\N	\N	NaN	H12	\N
38343	SGLP-0094	2017-07-24 00:00:00-07	3.56	35	3.92	NaN	250	\N	\N	\N	NaN	E4	\N
38344	SGLP-0095	2017-07-24 00:00:00-07	8.9	38	10.37	NaN	250	\N	\N	\N	NaN	E2	\N
38345	SGLP-0096	2017-07-24 00:00:00-07	4.22	50	1.94	NaN	106	\N	\N	\N	NaN	E3	\N
38346	SGLP-0040	2017-07-11 00:00:00-07	3.36	100	1.08	4	394	\N	\N	\N	NaN	D4	\N
38347	SGLP-0032	2017-07-11 00:00:00-07	2.94	100	1.34	4	82.6	\N	\N	\N	NaN	C8	\N
38348	SGLP-0029	2017-07-11 00:00:00-07	9.26	100	5	4	379	\N	\N	\N	NaN	C5	\N
38349	SGLP-0165	2017-08-28 00:00:00-07	4.2	66	2.4	NaN	250	\N	\N	\N	NaN	G4	\N
38350	SGLP-0138	2017-08-22 00:00:00-07	8.3	100	5	NaN	156	\N	\N	\N	NaN	D8	\N
38351	SGLP-0156	2017-08-28 00:00:00-07	5.5	38	3.6	NaN	250	\N	\N	\N	NaN	F7	\N
38352	SGLP-0131	2017-08-22 00:00:00-07	10.4	17	7.9	NaN	250	\N	\N	\N	NaN	D1	\N
38353	SGLP-0135	2017-08-22 00:00:00-07	4.6	100	1.7	NaN	220	\N	\N	\N	NaN	D5	\N
38354	SGLP-0133	2017-08-22 00:00:00-07	7.4	19	4.8	NaN	250	\N	\N	\N	NaN	D3	\N
38355	SGLP-0129	2017-08-22 00:00:00-07	6.3	55	2.6	NaN	250	\N	\N	\N	NaN	C11	\N
38356	SGLP-0146	2017-08-22 00:00:00-07	1.3	100	0.4	NaN	83.6	\N	\N	\N	NaN	E4	\N
38357	SGLP-0154	2017-08-28 00:00:00-07	3.4	100	1.3	NaN	192	\N	\N	\N	NaN	F5	\N
38358	SGLP-0112	2017-08-15 00:00:00-07	3.9	10	1.6	NaN	250	\N	\N	\N	NaN	B4	\N
38359	SGLP-0144	2017-08-22 00:00:00-07	6.4	18	2.9	NaN	250	\N	\N	\N	NaN	E2	\N
38360	SGLP-0107	2017-08-15 00:00:00-07	6.7	48	3	NaN	250	\N	\N	\N	NaN	A11	\N
38361	SGLP-0171	2017-08-28 00:00:00-07	7.5	10	5	NaN	250	\N	\N	\N	NaN	G10	\N
38362	SGLP-0127	2017-08-22 00:00:00-07	8.5	38	4	NaN	250	\N	\N	\N	NaN	C9	\N
38363	SGLP-0106	2017-08-15 00:00:00-07	6.2	33	3.7	NaN	250	\N	\N	\N	NaN	A10	\N
38364	SGLP-0147	2017-08-22 00:00:00-07	0.7	100	0.3	NaN	71.8	\N	\N	\N	NaN	E5	\N
38365	SGLP-0139	2017-08-22 00:00:00-07	6	66	4.3	NaN	250	\N	\N	\N	NaN	D9	\N
38366	SGLP-0182	2017-08-28 00:00:00-07	5.8	39	5.5	NaN	250	\N	\N	\N	NaN	H9	\N
38367	SGLP-0176	2017-08-28 00:00:00-07	5.2	12	2.7	NaN	250	\N	\N	\N	NaN	H3	\N
38368	SGLP-0102	2017-08-15 00:00:00-07	9.9	37	5.3	NaN	250	\N	\N	\N	NaN	A6	\N
38369	SGLP-0180	2017-08-28 00:00:00-07	0.6	100	0.2	NaN	71	\N	\N	\N	NaN	H7	\N
38370	SGLP-0145	2017-08-22 00:00:00-07	1.2	100	0.3	NaN	108	\N	\N	\N	NaN	E3	\N
38371	SGLP-0113	2017-08-15 00:00:00-07	6.6	27	2.9	NaN	250	\N	\N	\N	NaN	B5	\N
38372	SGLP-0151	2017-08-22 00:00:00-07	10.7	14	5.8	NaN	250	\N	\N	\N	NaN	E9	\N
38373	SGLP-0101	2017-08-15 00:00:00-07	8.5	24	4.4	NaN	250	\N	\N	\N	NaN	A5	\N
38374	SGLP-0177	2017-08-28 00:00:00-07	6.4	26	4.3	NaN	250	\N	\N	\N	NaN	H4	\N
38375	SGLP-0157	2017-08-28 00:00:00-07	0.4	100	0.1	NaN	23	\N	\N	\N	NaN	F8	\N
38376	SGLP-0124	2017-08-15 00:00:00-07	5	80	2.8	NaN	250	\N	\N	\N	NaN	C4	\N
38377	SGLP-0108	2017-08-15 00:00:00-07	6	25	2.5	NaN	250	\N	\N	\N	NaN	A12	\N
38378	SGLP-0172	2017-08-28 00:00:00-07	5	22	2.6	NaN	250	\N	\N	\N	NaN	G11	\N
38379	SGLP-0104	2017-08-15 00:00:00-07	6.5	45	3	NaN	250	\N	\N	\N	NaN	A8	\N
38380	SGLP-0126	2017-08-15 00:00:00-07	1.3	100	0.3	NaN	192	\N	\N	\N	NaN	C6	\N
38381	SGLP-0152	2017-08-22 00:00:00-07	8.3	58	5.2	NaN	250	\N	\N	\N	NaN	E10	\N
38382	SGLP-0163	2017-08-28 00:00:00-07	6.6	22	4.1	NaN	250	\N	\N	\N	NaN	G2	\N
38383	SGLP-0099	2017-08-15 00:00:00-07	4.2	96	1.7	NaN	250	\N	\N	\N	NaN	A3	\N
38384	SGLP-0153	2017-08-22 00:00:00-07	6.9	17	4.4	NaN	250	\N	\N	\N	NaN	E11	\N
38385	SGLP-0173	2017-08-28 00:00:00-07	6	17	3.3	NaN	250	\N	\N	\N	NaN	G12	\N
38386	SGLP-0110	2017-08-15 00:00:00-07	4.2	54	1.9	NaN	250	\N	\N	\N	NaN	B2	\N
38387	SGLP-0109	2017-08-15 00:00:00-07	4.9	18	2.5	NaN	250	\N	\N	\N	NaN	B1	\N
38388	SGLP-0111	2017-08-15 00:00:00-07	0.6	100	0.2	NaN	37.5	\N	\N	\N	NaN	B3	\N
38389	SGLP-0141	2017-08-22 00:00:00-07	6	60	3.7	NaN	250	\N	\N	\N	NaN	D11	\N
38390	SGLP-0097	2017-08-15 00:00:00-07	2.4	100	0.8	NaN	97.8	\N	\N	\N	NaN	A1	\N
38391	SGLP-0168	2017-08-28 00:00:00-07	6	21	3.4	NaN	250	\N	\N	\N	NaN	G7	\N
38392	SGLP-0148	2017-08-22 00:00:00-07	7.1	37	5.2	NaN	250	\N	\N	\N	NaN	E6	\N
38393	SGLP-0132	2017-08-22 00:00:00-07	7.5	5	4.6	NaN	250	\N	\N	\N	NaN	D2	\N
38394	SGLP-0114	2017-08-15 00:00:00-07	4.8	28	2.1	NaN	250	\N	\N	\N	NaN	B6	\N
38395	SGLP-0122	2017-08-15 00:00:00-07	5.6	23	3.2	NaN	250	\N	\N	\N	NaN	C2	\N
38396	SGLP-0121	2017-08-15 00:00:00-07	5.5	23	3.2	NaN	250	\N	\N	\N	NaN	C1	\N
38397	SGLP-0115	2017-08-15 00:00:00-07	4.7	23	1.5	NaN	250	\N	\N	\N	NaN	B7	\N
38398	SGLP-0164	2017-08-28 00:00:00-07	6.4	24	4.1	NaN	250	\N	\N	\N	NaN	G3	\N
38399	SGLP-0123	2017-08-15 00:00:00-07	0.9	100	0.2	NaN	131	\N	\N	\N	NaN	C3	\N
38400	SGLP-0161	2017-08-28 00:00:00-07	3.6	96	1.3	NaN	250	\N	\N	\N	NaN	F12	\N
38401	SGLP-0178	2017-08-28 00:00:00-07	3.5	35	1.4	NaN	250	\N	\N	\N	NaN	H5	\N
38402	SGLP-0098	2017-08-15 00:00:00-07	6.3	16	2.6	NaN	250	\N	\N	\N	NaN	A2	\N
38403	SGLP-0170	2017-08-28 00:00:00-07	3.9	34	2.8	NaN	250	\N	\N	\N	NaN	G9	\N
38404	SGLP-0136	2017-08-22 00:00:00-07	8.3	13	4.9	NaN	250	\N	\N	\N	NaN	D6	\N
38405	SGLP-0140	2017-08-22 00:00:00-07	8.3	49	5.5	NaN	250	\N	\N	\N	NaN	D10	\N
38406	SGLP-0119	2017-08-15 00:00:00-07	5.5	26	2.8	NaN	250	\N	\N	\N	NaN	B11	\N
38407	SGLP-0159	2017-08-28 00:00:00-07	2.7	91	0.7	NaN	250	\N	\N	\N	NaN	F10	\N
38408	SGLP-0150	2017-08-22 00:00:00-07	10.4	25	4.9	NaN	250	\N	\N	\N	NaN	E8	\N
38409	SGLP-0175	2017-08-28 00:00:00-07	5.1	24	3	NaN	250	\N	\N	\N	NaN	H2	\N
38410	SGLP-0179	2017-08-28 00:00:00-07	7.1	17	4.9	NaN	250	\N	\N	\N	NaN	H6	\N
38411	SGLP-0169	2017-08-28 00:00:00-07	5	25	2.7	NaN	250	\N	\N	\N	NaN	G8	\N
38412	SGLP-0160	2017-08-28 00:00:00-07	2.2	93	0.5	NaN	250	\N	\N	\N	NaN	F11	\N
38413	SGLP-0117	2017-08-15 00:00:00-07	4.6	20	2.6	NaN	250	\N	\N	\N	NaN	B9	\N
38414	SGLP-0142	2017-08-22 00:00:00-07	8.6	45	6.5	NaN	250	\N	\N	\N	NaN	D12	\N
38415	SGLP-0183	2017-08-28 00:00:00-07	2.8	100	1.7	4	230	\N	\N	\N	NaN	H10	\N
38416	SGLP-0128	2017-08-22 00:00:00-07	5.8	61	3.2	4	250	\N	\N	\N	NaN	C10	\N
38417	SGLP-0174	2017-08-28 00:00:00-07	3.4	98	2.3	4	250	\N	\N	\N	NaN	H1	\N
38418	SGLP-0184	2017-08-28 00:00:00-07	5.7	18	3.6	4	250	\N	\N	\N	NaN	H11	\N
38419	SGLP-0103	2017-08-15 00:00:00-07	5.5	61	2.17	4	250	\N	\N	\N	NaN	A7	\N
38420	SGLP-0181	2017-08-28 00:00:00-07	5.5	20	2.3	4	250	\N	\N	\N	NaN	H8	\N
38421	SGLP-0130	2017-08-22 00:00:00-07	4.5	96	2.8	4	250	\N	\N	\N	NaN	C12	\N
38422	SGLP-0167	2017-08-28 00:00:00-07	1.3	100	0.3	4	184	\N	\N	\N	NaN	G6	\N
38423	SGLP-0162	2017-08-28 00:00:00-07	1	100	0.6	4	51.8	\N	\N	\N	NaN	G1	\N
38424	SGLP-0158	2017-08-28 00:00:00-07	4.5	14	2.2	4	250	\N	\N	\N	NaN	F9	\N
38425	SGLP-0143	2017-08-22 00:00:00-07	4.9	61	1.3	4	250	\N	\N	\N	NaN	E1	\N
38426	SGLP-0166	2017-08-28 00:00:00-07	2.8	56	0.9	4	250	\N	\N	\N	NaN	G5	\N
38427	SGLP-0155	2017-08-28 00:00:00-07	3.1	100	1.5	4	179	\N	\N	\N	NaN	F6	\N
38428	SGLP-0120	2017-08-15 00:00:00-07	5.3	36	3.06	4	250	\N	\N	\N	NaN	B12	\N
38429	SGLP-0149	2017-08-22 00:00:00-07	5.3	43	2.7	4	250	\N	\N	\N	NaN	E7	\N
38430	SGLP-0137	2017-08-22 00:00:00-07	2.6	40	1.3	4	250	\N	\N	\N	NaN	D7	\N
38431	SGLP-0100	2017-08-15 00:00:00-07	4.9	95	2.1	4	250	\N	\N	\N	NaN	A4	\N
38432	SGLP-0105	2017-08-15 00:00:00-07	5.1	38	1.84	4	250	\N	\N	\N	NaN	A9	\N
38433	SGLP-0134	2017-08-22 00:00:00-07	4.2	100	2.3	4	189	\N	\N	\N	Barcode overlap	D4	\N
38434	SGLP-0125	2017-08-15 00:00:00-07	5.9	21	3.88	4	250	\N	\N	\N	Barcode overlap	C5	\N
38435	SGLP-0239	\N	4.2	16	1.5	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C7	\N
38436	SGLP-0251	\N	6.6	7	1.7	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	D7	\N
38437	SGLP-0225	\N	3.1	4	0.4	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A9	\N
38438	SGLP-0219	\N	3.7	13	0.8	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A3	\N
38439	SGLP-0227	\N	3	16	0.6	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A11	\N
38440	SGLP-0250	\N	5	50	1.3	4	231	\N	\N	\N	Capture hyb at 65c for 4 hours. 	D6	\N
38441	SGLP-0233	\N	3.1	11	0.6	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C1	\N
38442	SGLP-0238	\N	2	27	0.6	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C6	\N
38443	SGLP-0247	\N	4.2	50	2.1	4	193	\N	\N	\N	Capture hyb at 65c for 4 hours. 	D3	\N
38444	SGLP-0236	\N	3.7	25	1.4	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C4	\N
38445	SGLP-0231	\N	3.4	7	0.7	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	B3	\N
38446	SGLP-0218	\N	2.5	8	0.5	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A2	\N
38447	SGLP-0222	\N	3.4	10	0.9	4	250	\N	\N	\N	Madrid Melanoma, Capture hyb at 65c for 4 hours. 	A6	\N
38448	SGLP-0229	\N	5	3	1.2	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	B1	\N
38449	SGLP-0234	\N	3.8	11	1.4	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C2	\N
38450	SGLP-0217	\N	2.7	10	0.9	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A1	\N
38451	SGLP-0237	\N	6	50	1.8	4	223	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C5	\N
38452	SGLP-0226	\N	3.4	3	0.6	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A10	\N
38453	SGLP-0228	\N	4	8	0.9	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A12	\N
39714	CGH12-376	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-376 	L2DR09	\N
38454	FKP-01	2018-03-05 00:00:00-08	NaN	NaN	112.22	4	NaN	\N	\N	\N	KAPA RNA LP Kit, Capture hyb at 65c for 4 hours. \n	B5	\N
38455	FKP-02	2018-03-05 00:00:00-08	NaN	NaN	28.73	4	NaN	\N	\N	\N	KAPA RNA LP Kit, Capture hyb at 65c for 4 hours. \n	B6	\N
38456	FKP-05	2018-03-05 00:00:00-08	NaN	NaN	413.29	4	NaN	\N	\N	\N	KAPA RNA LP Kit, Capture hyb at 65c for 4 hours. \n	B7	\N
38457	FKP-08	2018-03-05 00:00:00-08	NaN	NaN	491.3	4	NaN	\N	\N	\N	KAPA RNA LP Kit, Capture hyb at 65c for 4 hours. \n	B9	\N
38458	FKP-09	2018-03-05 00:00:00-08	NaN	NaN	1062.35	4	NaN	\N	\N	\N	KAPA RNA LP Kit, Capture hyb at 65c for 4 hours. \n	B10	\N
38459	FKP-10	2018-03-05 00:00:00-08	NaN	NaN	3337.2	4	NaN	\N	\N	\N	KAPA RNA LP Kit, Capture hyb at 65c for 4 hours. \n	B11	\N
38460	FKP-11	2018-03-05 00:00:00-08	NaN	NaN	863.29	4	NaN	\N	\N	\N	KAPA RNA LP Kit, Capture hyb at 65c for 4 hours. \n	B12	\N
38461	FKP-06	2018-03-05 00:00:00-08	NaN	NaN	1033.36	4	NaN	\N	\N	\N	KAPA RNA LP Kit, Capture hyb at 65c for 4 hours. \n	B8	\N
38462	SGLP-0185	2018-03-20 00:00:00-07	4.2	50	1.3	NaN	119	\N	\N	\N	Capture hyb at 65c for 4 hours. 	F5	\N
38463	SGLP-0186	2018-03-20 00:00:00-07	2.7	50	1	NaN	199	\N	\N	\N	Capture hyb at 65c for 4 hours. 	F6	\N
38464	SGLP-0187	2018-03-20 00:00:00-07	3	50	1.1	NaN	208	\N	\N	\N	Capture hyb at 65c for 4 hours. 	F7	\N
38465	SGLP-0188	2018-03-20 00:00:00-07	2.6	50	0.9	NaN	189	\N	\N	\N	Capture hyb at 65c for 4 hours. 	F8	\N
38466	SGLP-0189	2018-03-20 00:00:00-07	3.8	50	2.3	NaN	249	\N	\N	\N	Capture hyb at 65c for 4 hours. 	F9	\N
38467	SGLP-0190	2018-03-20 00:00:00-07	2.3	50	0.6	NaN	159	\N	\N	\N	Capture hyb at 65c for 4 hours. 	F10	\N
38468	SGLP-0191	2018-03-20 00:00:00-07	2	50	0.8	NaN	150	\N	\N	\N	Capture hyb at 65c for 4 hours. 	F11	\N
38469	SGLP-0192	2018-03-20 00:00:00-07	5.5	50	2.4	NaN	129	\N	\N	\N	Capture hyb at 65c for 4 hours. 	F12	\N
38470	SGLP-0193	2018-03-20 00:00:00-07	3.4	50	1.1	NaN	215	\N	\N	\N	Capture hyb at 65c for 4 hours. 	G1	\N
38471	SGLP-0194	2018-03-20 00:00:00-07	2	50	0.5	NaN	235	\N	\N	\N	Capture hyb at 65c for 4 hours. 	G2	\N
38472	SGLP-0195	2018-03-20 00:00:00-07	2.6	50	1.3	NaN	201	\N	\N	\N	Capture hyb at 65c for 4 hours. 	G3	\N
38473	SGLP-0196	2018-03-20 00:00:00-07	1.5	49	0.4	NaN	143	\N	\N	\N	Capture hyb at 65c for 4 hours. 	G4	\N
38474	SGLP-0197	2018-03-20 00:00:00-07	3.3	50	1.2	NaN	106	\N	\N	\N	Capture hyb at 65c for 4 hours. 	G5	\N
38475	SGLP-0198	2018-03-20 00:00:00-07	3	50	1.4	NaN	220	\N	\N	\N	Capture hyb at 65c for 4 hours. 	G6	\N
38476	SGLP-0199	2018-03-20 00:00:00-07	1.2	90	0.3	4	19	\N	\N	\N	KIT mutant DNA samples, Capture hyb at 65c for 4 hours. 	G7	\N
38477	SGLP-0210	2018-03-20 00:00:00-07	1.3	25	0.1	4	62	\N	\N	\N	KIT mutant DNA samples, Capture hyb at 65c for 4 hours. 	H6	\N
38478	SGLP-0211	2018-03-20 00:00:00-07	4.9	50	1	4	85	\N	\N	\N	KIT mutant DNA samples, Capture hyb at 65c for 4 hours. 	H7	\N
38479	SGLP-0212	2018-03-20 00:00:00-07	10.5	50	2.4	4	199	\N	\N	\N	KIT mutant DNA samples, Capture hyb at 65c for 4 hours. 	H8	\N
38480	SGLP-0213	2018-03-20 00:00:00-07	3.7	50	0.7	4	93	\N	\N	\N	KIT mutant DNA samples, Capture hyb at 65c for 4 hours. 	H9	\N
38481	SGLP-0214	2018-03-20 00:00:00-07	4.7	50	1.4	4	129	\N	\N	\N	KIT mutant DNA samples, Capture hyb at 65c for 4 hours. 	H10	\N
38482	SGLP-0215	2018-03-20 00:00:00-07	5.8	50	2.2	4	199	\N	\N	\N	KIT mutant DNA samples, Capture hyb at 65c for 4 hours. 	H11	\N
38483	SGLP-0216	2018-03-20 00:00:00-07	4.6	50	1.6	4	223	\N	\N	\N	KIT mutant DNA samples, Capture hyb at 65c for 4 hours. 	H12	\N
38484	Nu-02	\N	NaN	NaN	3.1	NaN	NaN	\N	\N	\N	NuGen LP Kit, Spiked after capture clean up, NuGen B01, AGCTAGTG\n\n	B01	\N
38485	Nu-01	\N	NaN	NaN	0.9	NaN	NaN	\N	\N	\N	NuGen LP Kit, Spiked after capture clean up, NuGen A01 adapter, CACGTCTA\n\n	A01	\N
38486	Nu-05	\N	NaN	NaN	1.6	NaN	NaN	\N	\N	\N	NuGen LP Kit, Spiked after capture clean up, NuGen C01, ACTATCGC\n\n	C01	\N
38487	Nu-06	\N	NaN	NaN	2.8	NaN	NaN	\N	\N	\N	NuGen LP Kit, Spiked after capture clean up, NuGen D01, GCGTATCA\n\n	D01	\N
38488	Nu-09	\N	NaN	NaN	3.8	NaN	NaN	\N	\N	\N	NuGen LP Kit, Spiked after capture clean up, NuGen F01, CGTCCATT\n\n	F01	\N
38489	Nu-08	\N	NaN	NaN	3.7	NaN	NaN	\N	\N	\N	NuGen LP Kit, Spiked after capture clean up, NuGen E01, ACTCTCCA\n\n	E01	\N
38490	Nu-10	\N	NaN	NaN	11.2	NaN	NaN	\N	\N	\N	NuGen LP Kit, Spiked after capture clean up, NuGen G01, AGCCGTAA\n\n	G01	\N
38491	Nu-11	\N	NaN	NaN	2.1	NaN	NaN	\N	\N	\N	NuGen LP Kit, Spiked after capture clean up, NuGen H01, GAGTAGAG. Lung cancer with ALK fusion\n\n	H01	\N
38492	SGLP-0258	\N	NaN	9	1.5	4	250	\N	\N	\N	NaN	A1	\N
38493	SGLP-0286	\N	NaN	7	2.1	4	250	\N	\N	\N	NaN	C5	\N
38494	SGLP-0259	\N	NaN	30	2.2	4	250	\N	\N	\N	NaN	A2	\N
38495	SGLP-0270	\N	NaN	14	2.9	4	250	\N	\N	\N	NaN	B1	\N
38496	SGLP-0306	\N	NaN	11	1.5	4	250	\N	\N	\N	NaN	E1	\N
38497	SGLP-0274	\N	NaN	29	2	4	250	\N	\N	\N	NaN	B5	\N
38498	SGLP-0282	\N	NaN	11	3.3	4	250	\N	\N	\N	NaN	C1	\N
38499	SGLP-0296	\N	NaN	6	0.3	4	250	\N	\N	\N	NaN	D3	\N
38500	SGLP-0278	\N	NaN	14	3.2	4	250	\N	\N	\N	NaN	B9	\N
38501	SGLP-0260	\N	NaN	13	2.8	4	250	\N	\N	\N	NaN	A3	\N
38502	SGLP-0308	\N	NaN	6	1.3	4	250	\N	\N	\N	NaN	E3	\N
38503	SGLP-0290	\N	NaN	22	1.6	4	250	\N	\N	\N	NaN	C9	\N
38504	SGLP-0276	\N	NaN	3	2.3	4	250	\N	\N	\N	NaN	B7	\N
38505	SGLP-0279	\N	NaN	9	3.5	4	250	\N	\N	\N	NaN	B10	\N
38506	SGLP-0277	\N	NaN	7	2.5	4	250	\N	\N	\N	NaN	B8	\N
38507	SGLP-0307	\N	NaN	8	1.4	4	250	\N	\N	\N	NaN	E2	\N
38508	SGLP-0291	\N	NaN	10	2	4	250	\N	\N	\N	NaN	C10	\N
38509	SGLP-0268	\N	NaN	22	3.3	4	250	\N	\N	\N	NaN	A11	\N
38510	SGLP-0312	\N	NaN	5	1.2	4	250	\N	\N	\N	NaN	E7	\N
38511	SGLP-0310	\N	NaN	7	0.2	4	250	\N	\N	\N	NaN	E5	\N
38512	SGLP-0264	\N	NaN	4	0.6	4	250	\N	\N	\N	NaN	A7	\N
38513	SGLP-0297	\N	NaN	14	1	4	250	\N	\N	\N	NaN	D4	\N
38514	SGLP-0293	\N	NaN	16	1.7	4	250	\N	\N	\N	NaN	C12	\N
38515	SGLP-0273	\N	NaN	39	2.4	4	250	\N	\N	\N	NaN	B4	\N
38516	SGLP-0281	\N	NaN	11	2	4	250	\N	\N	\N	NaN	B12	\N
38517	SGLP-0299	\N	NaN	5	1	4	250	\N	\N	\N	NaN	D6	\N
38518	SGLP-0265	\N	NaN	5	2.8	4	250	\N	\N	\N	NaN	A8	\N
38519	SGLP-0284	\N	NaN	18	2.4	4	250	\N	\N	\N	NaN	C3	\N
38520	SGLP-0271	\N	NaN	6	2.7	4	250	\N	\N	\N	NaN	B2	\N
38521	SGLP-0300	\N	NaN	3	1.1	4	250	\N	\N	\N	NaN	D7	\N
38522	SGLP-0287	\N	NaN	17	2.1	4	250	\N	\N	\N	NaN	C6	\N
38523	SGLP-0269	\N	NaN	9	2.4	4	250	\N	\N	\N	NaN	A12	\N
38524	SGLP-0283	\N	NaN	48	4.5	4	226	\N	\N	\N	NaN	C2	\N
38525	SGLP-0301	\N	NaN	4	0.8	4	250	\N	\N	\N	NaN	D8	\N
38526	SGLP-0313	\N	6.3	0	3.5	4	NaN	\N	\N	\N	NaN	NaN	\N
38527	SGLP-0322	\N	4.1	0	2	4	NaN	\N	\N	\N	NaN	NaN	\N
38528	SGLP-0323	\N	3.9	0	2.2	4	NaN	\N	\N	\N	NaN	NaN	\N
38529	SGLP-0324	\N	4.2	0	2.3	4	NaN	\N	\N	\N	NaN	NaN	\N
38530	SGLP-0328	\N	5	0	2.7	4	NaN	\N	\N	\N	NaN	NaN	\N
38531	SGLP-0325	\N	5.6	0	2.4	4	NaN	\N	\N	\N	NaN	NaN	\N
38532	SGLP-0333	\N	9.2	0	7.3	4	NaN	\N	\N	\N	NaN	NaN	\N
38533	SGLP-0329	\N	4.1	0	2.7	4	NaN	\N	\N	\N	NaN	NaN	\N
38534	SGLP-0327	\N	4.8	0	2.7	4	NaN	\N	\N	\N	NaN	NaN	\N
38535	SGLP-0331	\N	6.3	0	4.7	4	NaN	\N	\N	\N	NaN	NaN	\N
38536	SGLP-0272	\N	4.8	6	2.09	4	250	\N	\N	\N	NaN	B3	\N
38537	SGLP-0288	\N	5.4	10	1.48	4	250	\N	\N	\N	NaN	C7	\N
38538	SGLP-0317	\N	5	17	2.28	4	250	\N	\N	\N	Reseqencing of Previous LN	F1	\N
38539	SGLP-0332	\N	7	2	5.22	4	250	\N	\N	\N	Reseqencing of Previous LN	G4	\N
38540	SGLP-0311	\N	3.6	13	1.18	4	250	\N	\N	\N	NaN	E6	\N
38541	SGLP-0321	\N	5.4	8	2.61	4	250	\N	\N	\N	Reseqencing of Previous LN	F5	\N
38542	SGLP-0304	\N	4	4	1.12	4	250	\N	\N	\N	NaN	D11	\N
38543	SGLP-0263	\N	3.5	22	1.35	4	250	\N	\N	\N	NaN	A6	\N
38544	SGLP-0280	\N	4	11	1.76	4	250	\N	\N	\N	NaN	B11	\N
38545	SGLP-0326	\N	1.7	10	2.21	4	250	\N	\N	\N	Reseqencing of Previous LN	F10	\N
38546	SGLP-0318	\N	5.5	11	3	4	250	\N	\N	\N	Reseqencing of Previous LN	F2	\N
38547	SGLP-0302	\N	3.8	10	0.65	4	250	\N	\N	\N	NaN	D9	\N
38548	SGLP-0316	\N	4.3	5	2.09	4	250	\N	\N	\N	Reseqencing of Previous LN	E12	\N
38549	SGLP-0303	\N	3.9	3	1.05	4	250	\N	\N	\N	NaN	D10	\N
38550	SGLP-0267	\N	3.1	48	1.26	4	130	\N	\N	\N	NaN	A10	\N
38551	SGLP-0315	\N	6	2	3.54	4	250	\N	\N	\N	Reseqencing of Previous LN	E11	\N
38552	SGLP-0292	\N	5.3	13	1.55	4	250	\N	\N	\N	NaN	C11	\N
38553	SGLP-0314	\N	4.7	4	2.31	4	250	\N	\N	\N	Reseqencing of Previous LN	E10	\N
38554	SGLP-0298	\N	5	15	2.02	4	250	\N	\N	\N	NaN	D5	\N
38555	SGLP-0319	\N	4.4	3	2.29	4	250	\N	\N	\N	Reseqencing of Previous LN	F3	\N
38556	SGLP-0309	\N	2.1	7	0.4	4	250	\N	\N	\N	NaN	E4	\N
38557	SGLP-0285	\N	3.3	6	2.48	4	250	\N	\N	\N	NaN	C4	\N
38558	SGLP-0295	\N	2.9	38	0.6	4	250	\N	\N	\N	NaN	D2	\N
38559	SGLP-0330	\N	6.2	3	4.53	4	250	\N	\N	\N	Reseqencing of Previous LN	G2	\N
38560	SGLP-0320	\N	5.6	4	2.68	4	250	\N	\N	\N	Reseqencing of Previous LN	F4	\N
38561	SGLP-0305	\N	4.8	9	1.43	4	250	\N	\N	\N	NaN	D12	\N
38562	SGLP-0275	\N	5.9	25	2.85	4	250	\N	\N	\N	NaN	B6	\N
38563	SGLP-0294	\N	3.3	12	0.61	4	250	\N	\N	\N	NaN	D1	\N
38564	SGLP-0262	\N	4	15	1.55	4	250	\N	\N	\N	NaN	A5	\N
38565	NMLP-003	2018-12-07 00:00:00-08	4.43	13	1.94	4	250	\N	\N	\N	NaN	2	\N
38566	NMLP-028	2018-12-11 00:00:00-08	11.6	5	4.98	4	250	\N	\N	\N	NaN	48	\N
38567	NMLP-007	2018-12-07 00:00:00-08	4.48	7	0.42	4	250	\N	\N	\N	NaN	6	\N
38568	SGLP-0356	2018-12-20 00:00:00-08	1.36	48	0.77	4	65.3	\N	\N	\N	Nevus from Iwei	73	\N
38569	NMLP-052	\N	8.63	5	2.79	4	250	\N	\N	\N	NaN	72	\N
38570	NMLP-039	2018-12-11 00:00:00-08	3.92	16	1.48	4	250	\N	\N	\N	NaN	59	\N
38571	NMLP-019	2018-12-11 00:00:00-08	10.2	6	0.58	4	250	\N	\N	\N	NaN	39	\N
38572	NMLP-026	2018-12-11 00:00:00-08	9.14	5	2.89	4	250	\N	\N	\N	NaN	46	\N
38573	SGLP-0358	2018-12-20 00:00:00-08	8.67	29	1.96	4	250	\N	\N	\N	Nevus from Iwei	75	\N
38574	NMLP-050	\N	8.63	6	0.46	4	250	\N	\N	\N	NaN	70	\N
38575	NMLP-013	2018-12-07 00:00:00-08	3.65	25	1.45	4	250	\N	\N	\N	NaN	12	\N
38576	NMLP-051	\N	5.67	6	0.47	4	250	\N	\N	\N	NaN	71	\N
38577	NMLP-022	2018-12-11 00:00:00-08	9.17	6	3.33	4	250	\N	\N	\N	NaN	52	\N
38578	NMLP-008	2018-12-07 00:00:00-08	5.7	7	0.75	4	250	\N	\N	\N	NaN	7	\N
38579	NMLP-032	2018-12-11 00:00:00-08	3.89	29	0.94	4	250	\N	\N	\N	NaN	52	\N
38580	NMLP-031	2018-12-11 00:00:00-08	6.62	14	3.63	4	250	\N	\N	\N	NaN	51	\N
38581	NMLP-029	2018-12-11 00:00:00-08	2.33	7	0.64	4	250	\N	\N	\N	NaN	49	\N
38582	SGLP-0357	2018-12-20 00:00:00-08	2.1	48	0.63	4	100.8	\N	\N	\N	Nevus from Iwei	74	\N
38583	NMLP-015	2018-12-07 00:00:00-08	3.58	45	0.35	4	250	\N	\N	\N	NaN	14	\N
38584	SGLP-0359	2018-12-20 00:00:00-08	3.02	48	1.54	4	145	\N	\N	\N	Nevus from Iwei	76	\N
38585	NMLP-025	2018-12-11 00:00:00-08	13.6	5	5.29	4	250	\N	\N	\N	NaN	45	\N
38586	SGLP-0360	2018-12-20 00:00:00-08	2.6	48	0.73	4	124.8	\N	\N	\N	Nevus from Iwei	77	\N
38587	NMLP-012	2018-12-07 00:00:00-08	3.09	8	0.38	4	250	\N	\N	\N	NaN	11	\N
38588	NMLP-030	2018-12-11 00:00:00-08	1.25	48	0.28	4	70.6	\N	\N	\N	NaN	50	\N
38589	NMLP-036	2018-12-11 00:00:00-08	0.63	48	0.11	4	43.1	\N	\N	\N	NaN	56	\N
38590	SGLP-0353	2018-10-13 00:00:00-07	1.34	37	2.58	4	250	\N	\N	\N	DNA from Dermpath/Swapna	36	\N
38591	SGLP-0349	2018-10-13 00:00:00-07	2.71	34	1.62	4	250	\N	\N	\N	DNA from Dermpath/Swapna	32	\N
38592	SGLP-0354	2018-10-13 00:00:00-07	1.89	32	3.43	4	250	\N	\N	\N	DNA from Dermpath/Swapna	37	\N
38593	NMLP-014	2018-12-07 00:00:00-08	3.25	16	0.12	4	250	\N	\N	\N	NaN	13	\N
38594	SGLP-0348	2018-10-13 00:00:00-07	1.97	41	2.07	4	250	\N	\N	\N	DNA from Dermpath/Swapna	31	\N
38595	SGLP-0366	2018-12-20 00:00:00-08	1.4	48	1.3	4	67.2	\N	\N	\N	Nevus from Iwei	83	\N
38596	SGLP-0375	2018-12-20 00:00:00-08	5.97	42	3.95	4	250	\N	\N	\N	Nevus from Iwei	92	\N
38597	SGLP-0352	2018-10-13 00:00:00-07	0.59	50	0.94	4	94.5	\N	\N	\N	DNA from Dermpath/Swapna	35	\N
38598	SGLP-0368	2018-12-20 00:00:00-08	9.44	26	3.29	4	250	\N	\N	\N	Nevus from Iwei	85	\N
38599	SGLP-0369	2018-12-20 00:00:00-08	3.3	48	2.69	4	159.8	\N	\N	\N	Nevus from Iwei	86	\N
38600	SGLP-0374	2018-12-20 00:00:00-08	1.22	48	0.91	4	58.6	\N	\N	\N	Nevus from Iwei	91	\N
38601	SGLP-0347	2018-10-13 00:00:00-07	1.92	24	4.17	4	250	\N	\N	\N	DNA from Dermpath/Swapna	30	\N
38602	SGLP-0376	2018-12-20 00:00:00-08	0.77	48	0.28	4	36.9	\N	\N	\N	Nevus from Iwei	93	\N
38603	SGLP-0365	2018-12-20 00:00:00-08	4.36	48	2.89	4	209.3	\N	\N	\N	Nevus from Iwei	82	\N
38604	SGLP-0351	2018-10-13 00:00:00-07	1.53	50	2.89	4	250	\N	\N	\N	DNA from Dermpath/Swapna	34	\N
38605	SGLP-0364	2018-12-20 00:00:00-08	0.92	48	0.85	4	44	\N	\N	\N	Nevus from Iwei	81	\N
38606	SGLP-0372	2018-12-20 00:00:00-08	6.84	37	1.9	4	250	\N	\N	\N	Nevus from Iwei	89	\N
38607	SGLP-0377	2018-12-20 00:00:00-08	1.87	48	2.02	4	89.8	\N	\N	\N	Nevus from Iwei	94	\N
38608	SGLP-0350	2018-10-13 00:00:00-07	2.06	30	4.26	4	250	\N	\N	\N	DNA from Dermpath/Swapna	33	\N
38609	SGLP-0363	2018-12-20 00:00:00-08	4.14	48	4.28	4	198.7	\N	\N	\N	Nevus from Iwei; NEED TO RE-SEQUENCE	80	\N
38610	NMLP-042	\N	0.3	48	0.15	4	28.9	\N	\N	\N	NaN	62	\N
38611	SGLP-0379	2018-12-20 00:00:00-08	1.54	48	0.7	4	73.9	\N	\N	\N	Nevus from Iwei	96	\N
38612	SGLP-0370	2018-12-20 00:00:00-08	8.61	29	4.22	4	250	\N	\N	\N	Nevus from Iwei; NEED TO RE-SEQUENCE	87	\N
38613	SGLP-0371	2018-12-20 00:00:00-08	2.27	48	0.46	4	109	\N	\N	\N	Nevus from Iwei	88	\N
38614	NMLP-033	2018-12-11 00:00:00-08	0.94	48	0.19	4	39.4	\N	\N	\N	NaN	53	\N
38615	SGLP-0373	2018-12-20 00:00:00-08	6.75	37	1.63	4	250	\N	\N	\N	Nevus from Iwei	90	\N
38616	SGLP-0378	2018-12-20 00:00:00-08	0.83	48	0.29	4	39.7	\N	\N	\N	Nevus from Iwei	95	\N
38617	SGLP-0367	2018-12-20 00:00:00-08	14.4	17	3.56	4	250	\N	\N	\N	Nevus from Iwei	84	\N
38618	SGLP-0362	2018-12-20 00:00:00-08	2.08	48	0.99	4	99.8	\N	\N	\N	Nevus from Iwei	79	\N
38619	SGLP-0406	2019-02-27 00:00:00-08	25	10	4.55	4	250	\N	\N	\N	cases with MAP3K8 fusions	18	\N
38620	SGLP-0409	2019-02-27 00:00:00-08	25	10	7.49	4	250	\N	\N	\N	cases with MAP3K8 fusions	21	\N
38621	SGLP-0412	2019-02-27 00:00:00-08	25	10	3.68	4	250	\N	\N	\N	NaN	24	\N
38622	SGLP-0411	2019-02-27 00:00:00-08	25	10	6.03	4	250	\N	\N	\N	NaN	23	\N
38623	SGLP-0407	2019-02-27 00:00:00-08	25	10	2.59	4	250	\N	\N	\N	cases with MAP3K8 fusions	19	\N
38624	SGLP-0405	2019-02-27 00:00:00-08	25	10	5.39	4	250	\N	\N	\N	cases with MAP3K8 fusions	16	\N
38625	SGLP-0404	2019-02-27 00:00:00-08	25	10	9.77	4	250	\N	\N	\N	cases with MAP3K8 fusions	15	\N
38626	SGLP-0410	2019-02-27 00:00:00-08	25	10	12.08	4	250	\N	\N	\N	NaN	22	\N
38627	SGLP-0408	2019-02-27 00:00:00-08	25	10	4.59	4	250	\N	\N	\N	cases with MAP3K8 fusions	20	\N
38628	AMLP-141	2019-12-03 00:00:00-08	3.68	28	2.1	4	300	\N	\N	\N	120s shear time; DNA repaired	75	\N
38629	MRLP-050	2019-02-13 00:00:00-08	20.2	12	3.11	4	250	\N	\N	\N	NaN	67	\N
38630	SGLP-0397	2019-02-21 00:00:00-08	1.51	48	0.39	4	72.5	\N	\N	\N	NaN	85	\N
38631	SGLP-0396	2019-02-21 00:00:00-08	0.75	45	0.18	4	36.1	\N	\N	\N	NaN	84	\N
38632	SGLP-0390	2019-02-21 00:00:00-08	13.2	19	1.42	4	250	\N	\N	\N	NaN	74	\N
38633	SGLP-0392	2019-02-21 00:00:00-08	12.6	20	3.08	4	250	\N	\N	\N	NaN	80	\N
38634	MRLP-044	2019-02-13 00:00:00-08	18.1	14	2.15	4	250	\N	\N	\N	NaN	61	\N
38635	MRLP-045	2019-02-13 00:00:00-08	0.97	48	0.28	4	46.6	\N	\N	\N	NaN	62	\N
38636	MRLP-046	2019-02-13 00:00:00-08	19.2	13	0.91	4	250	\N	\N	\N	NaN	63	\N
38637	MRLP-043	2019-02-13 00:00:00-08	17.2	15	2.68	4	250	\N	\N	\N	NaN	60	\N
38638	SGLP-0391	2019-02-21 00:00:00-08	1.59	48	0.55	4	76.3	\N	\N	\N	NaN	79	\N
38639	SGLP-0384	2019-02-21 00:00:00-08	1.14	50	0.81	4	54.7	\N	\N	\N	NaN	72	\N
38640	SGLP-0400	2019-02-21 00:00:00-08	1.65	47	1.31	4	79.2	\N	\N	\N	NaN	88	\N
38641	SGLP-0395	2019-02-21 00:00:00-08	1.23	49	0.42	4	59	\N	\N	\N	NaN	83	\N
38642	SGLP-0403	2019-02-21 00:00:00-08	1.37	47	2.1	4	65.8	\N	\N	\N	NaN	91	\N
38643	MRLP-042	2019-02-13 00:00:00-08	6.61	38	0.83	4	250	\N	\N	\N	NaN	59	\N
38644	MRLP-049	2019-02-13 00:00:00-08	23.7	11	1.55	4	250	\N	\N	\N	NaN	66	\N
38645	SGLP-0399	2019-02-21 00:00:00-08	26.5	9	0.95	4	250	\N	\N	\N	NaN	87	\N
38646	MRLP-041	2019-02-13 00:00:00-08	34.9	7	3.29	4	250	\N	\N	\N	NaN	58	\N
38647	SGLP-0389	2019-02-21 00:00:00-08	1.96	47	0.47	4	94.1	\N	\N	\N	NaN	73	\N
38648	MRLP-047	2019-02-13 00:00:00-08	2.04	48	0.67	4	97.9	\N	\N	\N	NaN	64	\N
38649	SGLP-0388	2019-02-21 00:00:00-08	0.78	47	0.38	4	37.6	\N	\N	\N	NaN	76	\N
38650	SGLP-0394	2019-02-21 00:00:00-08	6.1	41	7.83	4	250	\N	\N	\N	NaN	82	\N
38651	SGLP-0382	2019-02-21 00:00:00-08	2.81	48	1.56	4	134.9	\N	\N	\N	NaN	70	\N
38652	MRLP-048	2019-02-13 00:00:00-08	37.8	7	2	4	250	\N	\N	\N	NaN	65	\N
38653	SGLP-0386	2019-02-21 00:00:00-08	1.13	49	0.38	4	54.2	\N	\N	\N	NaN	74	\N
38654	SGLP-0402	2019-02-21 00:00:00-08	1.74	49	2.91	4	83.5	\N	\N	\N	NaN	90	\N
38655	SGLP-0401	2019-02-21 00:00:00-08	2.41	48	1.74	4	115.7	\N	\N	\N	NaN	89	\N
38656	SGLP-0393	2019-02-21 00:00:00-08	34.2	7	5.74	4	250	\N	\N	\N	NaN	81	\N
38657	SGLP-0381	2019-02-21 00:00:00-08	2.2	48	1.05	4	105.6	\N	\N	\N	NaN	69	\N
38658	SGLP-0398	2019-02-21 00:00:00-08	0.93	50	0.34	4	44.6	\N	\N	\N	NaN	86	\N
38659	SGLP-0458	2019-06-04 00:00:00-07	8.29	18	2.3	4	250	\N	\N	\N	NaN	15	\N
38660	SGLP-0459	2019-06-04 00:00:00-07	10.2	33	3.56	4	250	\N	\N	\N	NaN	16	\N
38661	SGLP-0471	2019-06-04 00:00:00-07	4.74	27	3.03	4	250	\N	\N	\N	NaN	64	\N
38662	SGLP-0474	2019-06-04 00:00:00-07	0.77	48	0.13	4	55	\N	\N	\N	NaN	67	\N
38663	SGLP-0478	2019-06-06 00:00:00-07	7.49	5	4.4	4	250	\N	\N	\N	NaN	71	\N
38664	SGLP-0492	2019-06-06 00:00:00-07	2.99	17	1.47	4	250	\N	\N	\N	NaN	85	\N
38665	SGLP-0493	2019-06-06 00:00:00-07	3.6	46	2.08	4	250	\N	\N	\N	NaN	86	\N
38666	SGLP-0495	2019-06-06 00:00:00-07	5.74	13	2.84	4	250	\N	\N	\N	NaN	88	\N
38667	MRLP-001	2019-02-08 00:00:00-08	58	4	3.87	4	250	\N	\N	\N	NaN	25	\N
38668	MRLP-004	2019-02-08 00:00:00-08	29.6	8	0.68	4	250	\N	\N	\N	NaN	28	\N
38669	MRLP-021	2019-02-08 00:00:00-08	11.5	22	2.17	4	250	\N	\N	\N	NaN	39	\N
38670	MRLP-017	2019-02-08 00:00:00-08	53	5	1.04	4	250	\N	\N	\N	NaN	37	\N
38671	MRLP-032	2019-02-13 00:00:00-08	11.5	22	2.53	4	250	\N	\N	\N	NaN	49	\N
38672	MRLP-051	2019-02-13 00:00:00-08	2.12	48	0.4	4	101.8	\N	\N	\N	NaN	68	\N
38673	MRLP-011	2019-02-08 00:00:00-08	59	4	1.76	4	250	\N	\N	\N	NaN	34	\N
38674	SGLP-0383	2019-02-21 00:00:00-08	3.85	47	0.43	4	184.8	\N	\N	\N	NaN	71	\N
38675	MRLP-024	2019-02-08 00:00:00-08	11.8	21	1.26	4	250	\N	\N	\N	NaN	40	\N
38676	MRLP-010	2019-02-08 00:00:00-08	8.87	28	0.62	4	250	\N	\N	\N	NaN	33	\N
38677	MRLP-012	2019-02-08 00:00:00-08	31.1	8	0.27	4	250	\N	\N	\N	NaN	35	\N
38678	MRLP-003	2019-02-08 00:00:00-08	21.7	12	0.53	4	250	\N	\N	\N	NaN	27	\N
38679	MRLP-034	2019-02-13 00:00:00-08	46.2	5	2.88	4	250	\N	\N	\N	NaN	51	\N
38680	MRLP-005	2019-02-08 00:00:00-08	16.8	15	0.96	4	250	\N	\N	\N	NaN	29	\N
38681	MRLP-008	2019-02-08 00:00:00-08	12	21	0.55	4	250	\N	\N	\N	NaN	31	\N
38682	MRLP-036	2019-02-13 00:00:00-08	5.41	46	0.76	4	250	\N	\N	\N	NaN	53	\N
38683	MRLP-025	2019-02-08 00:00:00-08	6.4	39	0.36	4	250	\N	\N	\N	NaN	41	\N
38684	MRLP-015	2019-02-08 00:00:00-08	1.11	48	1.34	4	53.3	\N	\N	\N	NaN	36	\N
38685	MRLP-035	2019-02-13 00:00:00-08	44.6	6	4.17	4	250	\N	\N	\N	NaN	52	\N
38686	MRLP-006	2019-02-08 00:00:00-08	9.84	25	1.16	4	250	\N	\N	\N	NaN	30	\N
38687	MRLP-039	2019-02-13 00:00:00-08	19.9	13	0.65	4	250	\N	\N	\N	NaN	56	\N
38688	MRLP-002	2019-02-08 00:00:00-08	41.6	6	2.09	4	250	\N	\N	\N	NaN	26	\N
38689	MRLP-029	2019-02-08 00:00:00-08	29.5	8	1.18	4	250	\N	\N	\N	NaN	44	\N
38690	MRLP-020	2019-02-08 00:00:00-08	207	1	1.39	4	250	\N	\N	\N	NaN	38	\N
38691	MRLP-009	2019-02-08 00:00:00-08	8.6	29	4.48	4	250	\N	\N	\N	NaN	32	\N
38692	MRLP-038	2019-02-13 00:00:00-08	14.4	17	0.82	4	250	\N	\N	\N	NaN	55	\N
38693	MRLP-033	2019-02-13 00:00:00-08	24.5	10	1.47	4	250	\N	\N	\N	NaN	50	\N
38694	SGLP-0480	2019-06-06 00:00:00-07	7.98	16	6.5	4	250	\N	\N	\N	NaN	73	\N
38695	MP41-YMR1	2019-01-03 00:00:00-08	9.14	42	6.03	NaN	250	\N	\N	\N	4/25/23: deleted -LP from the LP_ID	74	\N
38696	MP41	2019-01-03 00:00:00-08	13	65	10.89	NaN	250	\N	\N	\N	4/25/23: deleted -LP from the LP_ID	73	\N
38697	SGLP-0338	2018-10-13 00:00:00-07	2.71	16	7.5	4	250	\N	\N	\N	Acral Melanoma Cell Line	21	\N
38698	SGLP-0343	2018-10-13 00:00:00-07	3.28	15	9.66	4	250	\N	\N	\N	Acral Melanoma Cell Line	26	\N
38699	SGLP-0336	2018-10-13 00:00:00-07	2.41	10	4.37	4	250	\N	\N	\N	Acral Melanoma Cell Line	19	\N
38700	SGLP-0342	2018-10-13 00:00:00-07	3.21	12	9.75	4	250	\N	\N	\N	Acral Melanoma Cell Line	25	\N
38701	SGLP-0339	2018-10-13 00:00:00-07	3.2	14	8.25	4	250	\N	\N	\N	Acral Melanoma Cell Line	22	\N
38702	SGLP-0344	2018-10-13 00:00:00-07	4.06	18	8.58	4	250	\N	\N	\N	Acral Melanoma Cell Line	27	\N
38703	SGLP-0345	2018-10-13 00:00:00-07	1.79	20	4.31	4	250	\N	\N	\N	Acral Melanoma Cell Line	28	\N
38704	SGLP-0341	2018-10-13 00:00:00-07	2.14	15	1.6	4	250	\N	\N	\N	Acral Melanoma Cell Line	24	\N
38705	SGLP-0337	2018-10-13 00:00:00-07	2.87	38	7.24	4	250	\N	\N	\N	Acral Melanoma Cell Line	20	\N
38706	SGLP-0346	2018-10-13 00:00:00-07	2.56	25	4.73	4	250	\N	\N	\N	Acral Melanoma Cell Line	29	\N
38707	SGLP-0340	2018-10-13 00:00:00-07	2.69	16	0.37	4	250	\N	\N	\N	Acral Melanoma Cell Line	23	\N
38708	SGLP-0334	2018-10-13 00:00:00-07	3.02	17	6.16	4	250	\N	\N	\N	Acral Melanoma Cell Line	17	\N
38709	SGLP-0335	2018-10-13 00:00:00-07	2.31	27	3.96	4	250	\N	\N	\N	Acral Melanoma Cell Line; NEED TO RE SEQUENCE	18	\N
38710	SGLP-0450	2019-05-14 00:00:00-07	10.4	2	8.91	4	250	\N	\N	\N	Acral Melanoma Cell Line	52	\N
38711	SGLP-0451	2019-05-14 00:00:00-07	17.7	2	13.59	4	250	\N	\N	\N	Acral Melanoma Cell Line	53	\N
38712	SGLP-0453	2019-05-14 00:00:00-07	20.3	2	17.72	4	250	\N	\N	\N	Acral Melanoma Cell Line	55	\N
38713	SGLP-0454	2019-05-14 00:00:00-07	7.9	61	7.93	4	250	\N	\N	\N	Acral Melanoma Cell Line	56	\N
38714	MRLP-037	2019-02-13 00:00:00-08	9.44	26	3.56	4	250	\N	\N	\N	NaN	54	\N
38715	MRLP-040	2019-02-13 00:00:00-08	34.6	7	3.13	4	250	\N	\N	\N	NaN	57	\N
38716	MRLP-031	2019-02-08 00:00:00-08	18.1	14	4.1	4	250	\N	\N	\N	NaN	46	\N
38717	MRLP-026	2019-02-08 00:00:00-08	121	2	4.35	4	250	\N	\N	\N	NaN	52	\N
38718	MRLP-027	2019-02-08 00:00:00-08	1.01	48	3.29	4	48.5	\N	\N	\N	NaN	43	\N
38719	MRLP-030	2019-02-08 00:00:00-08	13.7	18	4.91	4	250	\N	\N	\N	NaN	45	\N
38720	SGLP-0415	2019-05-07 00:00:00-07	1.67	197	0.32	4	130.1	\N	\N	\N	NaN	19	\N
38721	SGLP-0427	2019-05-07 00:00:00-07	1.5	406	0.39	4	61	\N	\N	\N	NaN	32	\N
38722	SGLP-0422	2019-05-07 00:00:00-07	0.73	218	0.15	4	39.2	\N	\N	\N	NaN	27	\N
38723	SGLP-0413	2019-05-07 00:00:00-07	1.09	172	0.2	4	67.2	\N	\N	\N	NaN	17	\N
38724	SGLP-0417	2019-05-07 00:00:00-07	2.41	249	0.8	4	129.6	\N	\N	\N	NaN	21	\N
38725	SGLP-0416	2019-05-07 00:00:00-07	2.51	224	0.91	4	176.6	\N	\N	\N	NaN	20	\N
38726	SGLP-0423	2019-05-07 00:00:00-07	2.72	323	0.6	4	142.1	\N	\N	\N	NaN	28	\N
38727	SGLP-0420	2019-05-07 00:00:00-07	0.85	161	0.24	4	46.6	\N	\N	\N	NaN	25	\N
38728	SGLP-0414	2019-05-07 00:00:00-07	1.04	125	0.17	4	61.4	\N	\N	\N	NaN	18	\N
38729	SGLP-0418	2019-05-07 00:00:00-07	0.96	199	0.27	4	65.8	\N	\N	\N	NaN	22	\N
38730	SGLP-0421	2019-05-07 00:00:00-07	1.15	162	0.29	4	61.4	\N	\N	\N	NaN	26	\N
38731	SGLP-0426	2019-05-07 00:00:00-07	1.59	388	0.35	4	104.6	\N	\N	\N	NaN	31	\N
38732	SGLP-0424	2019-05-07 00:00:00-07	2.71	48	0.61	4	61	\N	\N	\N	NaN	29	\N
38733	SGLP-0425	2019-05-07 00:00:00-07	2.32	825	0.72	4	132	\N	\N	\N	NaN	30	\N
38734	SGLP-0437	2019-05-07 00:00:00-07	3.36	640	0.59	4	159.4	\N	\N	\N	NaN	41	\N
38735	SGLP-0433	2019-05-07 00:00:00-07	2.2	680	0.57	4	81.6	\N	\N	\N	NaN	37	\N
38736	SGLP-0430	2019-05-07 00:00:00-07	1.94	475	0.55	4	95	\N	\N	\N	NaN	34	\N
38737	SGLP-0429	2019-05-07 00:00:00-07	1.38	859	0.34	4	77.3	\N	\N	\N	NaN	33	\N
38738	SGLP-0436	2019-05-07 00:00:00-07	5.53	164	1.29	4	250	\N	\N	\N	NaN	40	\N
38739	SGLP-0431	2019-05-07 00:00:00-07	1.68	153	0.38	4	85	\N	\N	\N	NaN	35	\N
38740	SGLP-0434	2019-05-07 00:00:00-07	5.01	428	2	4	250	\N	\N	\N	NaN	38	\N
38741	SGLP-0432	2019-05-07 00:00:00-07	5.65	176	2.11	4	250	\N	\N	\N	NaN	36	\N
38742	SGLP-0438	2019-05-14 00:00:00-07	2.13	436	0.9	4	117.6	\N	\N	\N	NaN	2	\N
38743	SGLP-0439	2019-05-14 00:00:00-07	3.28	48	2	4	100.3	\N	\N	\N	NaN	4	\N
38744	SGLP-0441	2019-05-14 00:00:00-07	1.46	48	0.93	4	57.6	\N	\N	\N	repeat qPCR	6	\N
38745	SGLP-0440	2019-05-14 00:00:00-07	3.07	48	1.8	4	132	\N	\N	\N	NaN	5	\N
38746	SGLP-0442	2019-05-14 00:00:00-07	1	48	0.4	4	46.9	\N	\N	\N	NaN	11	\N
38747	SGLP-0443	2019-05-14 00:00:00-07	2.49	48	1	4	127.2	\N	\N	\N	NaN	12	\N
38748	SGLP-0444	2019-05-14 00:00:00-07	2.23	48	1.2	4	107.5	\N	\N	\N	NaN	52	\N
38749	SGLP-0446	2019-05-14 00:00:00-07	2.39	48	1.2	4	110.9	\N	\N	\N	NaN	45	\N
38750	SGLP-0445	2019-05-14 00:00:00-07	1.97	48	1.1	4	71.5	\N	\N	\N	NaN	44	\N
38751	SGLP-0448	2019-05-14 00:00:00-07	1.21	48	0.7	4	47	\N	\N	\N	NaN	49	\N
38752	SGLP-0447	2019-05-14 00:00:00-07	1.52	48	1	4	65.3	\N	\N	\N	NaN	46	\N
38753	SGLP-0449	2019-05-14 00:00:00-07	2.61	48	1.5	4	80.6	\N	\N	\N	NaN	50	\N
38754	SGLP-0455	2019-06-04 00:00:00-07	4.26	22	0.69	4	250	\N	\N	\N	NaN	7	\N
38755	SGLP-0456	2019-06-04 00:00:00-07	0.94	48	0.15	4	43	\N	\N	\N	NaN	13	\N
38756	SGLP-0457	2019-06-04 00:00:00-07	4	48	1.51	4	125	\N	\N	\N	NaN	14	\N
38757	SGLP-0460	2019-06-04 00:00:00-07	3.21	9	0.38	4	250	\N	\N	\N	NaN	43	\N
38758	SGLP-0461	2019-06-04 00:00:00-07	27	27	0.58	4	250	\N	\N	\N	NaN	47	\N
38759	SGLP-0462	2019-06-04 00:00:00-07	4.79	6	2.23	4	250	\N	\N	\N	NaN	48	\N
38760	SGLP-0464	2019-06-04 00:00:00-07	5.91	28	1.69	4	250	\N	\N	\N	NaN	57	\N
38761	SGLP-0463	2019-06-04 00:00:00-07	3.03	48	0.66	4	180	\N	\N	\N	NaN	51	\N
38762	SGLP-0465	2019-06-04 00:00:00-07	2.89	48	1.36	4	141	\N	\N	\N	NaN	58	\N
38763	SGLP-0467	2019-06-04 00:00:00-07	4.76	17	3.02	4	250	\N	\N	\N	NaN	60	\N
38764	SGLP-0466	2019-06-04 00:00:00-07	1.31	48	0.5	4	48	\N	\N	\N	NaN	59	\N
38765	SGLP-0468	2019-06-04 00:00:00-07	3.46	24	1.17	4	250	\N	\N	\N	NaN	61	\N
38766	SGLP-0469	2019-06-04 00:00:00-07	1.73	48	0.63	4	132	\N	\N	\N	NaN	62	\N
38767	SGLP-0470	2019-06-04 00:00:00-07	4.91	16	1.65	4	250	\N	\N	\N	NaN	63	\N
38768	SGLP-0473	2019-06-04 00:00:00-07	3.48	10	1.23	4	250	\N	\N	\N	NaN	66	\N
38769	SGLP-0475	2019-06-04 00:00:00-07	5.66	40	1.85	4	250	\N	\N	\N	NaN	68	\N
38770	SGLP-0477	2019-06-04 00:00:00-07	5.29	13	1.55	4	250	\N	\N	\N	NaN	70	\N
38771	SGLP-0487	2019-06-06 00:00:00-07	4.55	4	1.51	4	250	\N	\N	\N	NaN	80	\N
38772	SGLP-0486	2019-06-06 00:00:00-07	6.61	10	3.36	4	250	\N	\N	\N	NaN	79	\N
38773	SGLP-0488	2019-06-06 00:00:00-07	2.84	48	0.49	4	220	\N	\N	\N	NaN	81	\N
38774	SGLP-0491	2019-06-06 00:00:00-07	2.52	48	0.71	4	153	\N	\N	\N	NaN	84	\N
38775	SGLP-0496	2019-06-06 00:00:00-07	1	48	0.34	4	42	\N	\N	\N	NaN	89	\N
38776	SGLP-0497	2019-06-06 00:00:00-07	2.89	48	0.76	4	164	\N	\N	\N	NaN	90	\N
38777	SGLP-0498	2019-06-06 00:00:00-07	3.59	48	1.58	4	135	\N	\N	\N	NaN	91	\N
38778	SGLP-0499	2019-06-06 00:00:00-07	4.28	48	2.1	4	127	\N	\N	\N	NaN	92	\N
38779	NMLP-001	2018-12-07 00:00:00-08	3.43	12	2.15	4	250	\N	\N	\N	NM from Greece	1	\N
38780	NMLP-011	2018-12-07 00:00:00-08	5.32	7	1.8	4	250	\N	\N	\N	NaN	10	\N
38781	NMLP-049	\N	0.53	48	0.88	4	26.5	\N	\N	\N	NaN	69	\N
38782	NMLP-004	2018-12-07 00:00:00-08	1.2	48	1.36	4	83	\N	\N	\N	NaN	3	\N
38783	NMLP-010	2018-12-07 00:00:00-08	2.65	11	1.21	4	250	\N	\N	\N	NaN	9	\N
38784	SGLP-0479	2019-06-06 00:00:00-07	8.35	46	5.09	4	250	\N	\N	\N	NaN	72	\N
38785	SGLP-0482	2019-06-06 00:00:00-07	5.05	14	2.38	4	250	\N	\N	\N	NaN	75	\N
38786	SGLP-0481	2019-06-06 00:00:00-07	7.03	35	4.52	4	250	\N	\N	\N	NaN	74	\N
38787	SGLP-0484	2019-06-06 00:00:00-07	6.55	6	3.22	4	250	\N	\N	\N	NaN	77	\N
38788	SGLP-0485	2019-06-06 00:00:00-07	8.44	12	5.65	4	250	\N	\N	\N	NaN	78	\N
38789	SGLP-0577	2019-08-05 00:00:00-07	NaN	15	0.98	4	250	\N	\N	\N	Madrid Melanoma	90	\N
38790	SGLP-0576	2019-08-05 00:00:00-07	NaN	6	0.37	4	250	\N	\N	\N	Madrid Melanoma	89	\N
38791	SGLP-0578	2019-08-05 00:00:00-07	NaN	4	1.76	4	250	\N	\N	\N	Madrid Melanoma	91	\N
38792	SGLP-0580	2019-08-05 00:00:00-07	NaN	48	1.4	4	231	\N	\N	\N	Madrid Melanoma	94	\N
38793	SGLP-0579	2019-08-05 00:00:00-07	NaN	7	0.8	4	250	\N	\N	\N	Madrid Melanoma	92	\N
38794	SGLP-0581	2019-08-05 00:00:00-07	NaN	45	0.6	4	250	\N	\N	\N	Madrid Melanoma	95	\N
38795	SGLP-0582	2019-08-05 00:00:00-07	NaN	6	1.6	4	250	\N	\N	\N	Madrid Melanoma	96	\N
38796	SGLP-0603	2019-08-13 00:00:00-07	NaN	9	4.82	4	250	\N	\N	\N	NRAS sequencing	35	\N
38797	SGLP-0602	2019-08-13 00:00:00-07	NaN	8	2.71	4	250	\N	\N	\N	PRKC fused cases	34	\N
38798	SGLP-0600	2019-08-13 00:00:00-07	NaN	6	5.49	4	250	\N	\N	\N	PRKC fused cases	32	\N
38799	SGLP-0604	2019-08-13 00:00:00-07	NaN	8	5.07	4	250	\N	\N	\N	NRAS sequencing	36	\N
38800	SGLP-0601	2019-08-13 00:00:00-07	NaN	6	3.51	4	250	\N	\N	\N	PRKC fused cases	33	\N
38801	SGLP-0605	2019-08-13 00:00:00-07	NaN	8	3.84	4	250	\N	\N	\N	NRAS sequencing	37	\N
38802	SGLP-0606	2019-08-13 00:00:00-07	NaN	8	3.27	4	250	\N	\N	\N	Atypical Spitz tumor-nodule	38	\N
38803	SGLP-0607	2019-08-13 00:00:00-07	4.76	11	1.54	4	250	\N	\N	\N	Atypical Spitz tumor-nevus	39	\N
38804	NMLP-046	\N	1.37	48	0.33	4	94.1	\N	\N	\N	NaN	66	\N
38805	NMLP-024	2018-12-11 00:00:00-08	25.3	5	4.34	4	250	\N	\N	\N	NaN	44	\N
38806	NMLP-027	2018-12-11 00:00:00-08	4.1	10	0.34	4	250	\N	\N	\N	NaN	47	\N
38807	NMLP-021	2018-12-11 00:00:00-08	2.49	48	1.23	4	88.3	\N	\N	\N	NaN	41	\N
38808	NMLP-038	2018-12-11 00:00:00-08	2.44	19	0.44	4	250	\N	\N	\N	NaN	58	\N
38809	NMLP-035	2018-12-11 00:00:00-08	4.06	22	0.94	4	250	\N	\N	\N	NaN	55	\N
38810	NMLP-048	\N	3.88	6	0.86	4	250	\N	\N	\N	NaN	68	\N
38811	NMLP-023	2018-12-11 00:00:00-08	6.69	6	4.1	4	250	\N	\N	\N	NaN	43	\N
38812	NMLP-045	\N	2.65	9	0.56	4	250	\N	\N	\N	NaN	65	\N
38813	NMLP-020	2018-12-11 00:00:00-08	6.73	48	5.01	4	237.1	\N	\N	\N	NaN	40	\N
38814	NMLP-016	2018-12-11 00:00:00-08	4.42	9	1.83	4	250	\N	\N	\N	NaN	15	\N
38815	NMLP-037	2018-12-11 00:00:00-08	1.98	14	0.42	4	250	\N	\N	\N	NaN	57	\N
38816	NMLP-017	2018-12-11 00:00:00-08	5.35	10	1.93	4	250	\N	\N	\N	NaN	16	\N
38817	NMLP-041	\N	1.57	48	0.32	4	93.1	\N	\N	\N	NaN	61	\N
38818	NMLP-040	\N	2.56	44	0.47	4	250	\N	\N	\N	NEED TO RE SEQUENCE	60	\N
38819	SGLP-0254	\N	1.4	9	0.2	4	250	\N	\N	\N	Madrid Melanoma	D10	\N
38820	NMLP-018	2018-12-11 00:00:00-08	6.21	8	2.56	4	250	\N	\N	\N	NaN	17	\N
38821	SGLP-0489	2019-06-06 00:00:00-07	3.88	5	0.14	4	250	\N	\N	\N	NaN	82	\N
38822	NMLP-009	2018-12-07 00:00:00-08	1.71	9	0.38	4	250	\N	\N	\N	NaN	8	\N
38823	NMLP-034	2018-12-11 00:00:00-08	2.74	8	0.25	4	250	\N	\N	\N	NaN	54	\N
38824	SGLP-0252	\N	4.2	9	1.7	4	250	\N	\N	\N	Madrid Melanoma	D8	\N
38825	SGLP-0257	\N	5.3	20	2.9	4	250	\N	\N	\N	Madrid Melanoma	E1	\N
38826	SGLP-0253	\N	5.7	2	2.2	4	250	\N	\N	\N	Madrid Melanoma	D9	\N
38827	SGLP-0256	\N	4.4	50	1.9	4	72.5	\N	\N	\N	Madrid Melanoma	D12	\N
38828	SGLP-0255	\N	3.3	4	1.4	4	250	\N	\N	\N	Madrid Melanoma	D11	\N
38829	SGLP-0490	2019-06-06 00:00:00-07	2.5	7	0.4	4	250	\N	\N	\N	NaN	83	\N
38830	SGLP-0500	2019-06-06 00:00:00-07	10.4	48	5.73	4	236	\N	\N	\N	NaN	93	\N
38831	SGLP-0501	2019-06-20 00:00:00-07	3.65	48	1.64	4	110.9	\N	\N	\N	NaN	17	\N
38832	SGLP-0502	2019-06-20 00:00:00-07	3.47	48	1.03	4	144	\N	\N	\N	NaN	18	\N
38833	SGLP-0503	2019-06-20 00:00:00-07	4.8	12	1.49	4	250	\N	\N	\N	NaN	19	\N
38834	SGLP-0505	2019-06-20 00:00:00-07	4.79	10	1.56	4	250	\N	\N	\N	NaN	21	\N
38835	SGLP-0504	2019-06-20 00:00:00-07	6.33	25	3.58	4	250	\N	\N	\N	NaN	20	\N
38836	SGLP-0506	2019-06-20 00:00:00-07	3.04	48	1.06	4	115.7	\N	\N	\N	NaN	22	\N
38837	SGLP-0507	2019-06-20 00:00:00-07	2.05	48	0.66	4	77.8	\N	\N	\N	NaN	23	\N
38838	SGLP-0508	2019-06-20 00:00:00-07	9.08	6	5.73	4	250	\N	\N	\N	NaN	24	\N
38839	SGLP-0509	2019-06-20 00:00:00-07	11	19	10.3	4	250	\N	\N	\N	NaN	25	\N
38840	SGLP-0510	2019-06-20 00:00:00-07	2.7	48	1.36	4	111.8	\N	\N	\N	NaN	26	\N
38841	SGLP-0511	2019-06-20 00:00:00-07	6.62	14	4.15	4	250	\N	\N	\N	NaN	27	\N
38842	SGLP-0512	2019-06-20 00:00:00-07	5.77	48	2.18	4	222.2	\N	\N	\N	NaN	28	\N
38843	SGLP-0513	2019-06-20 00:00:00-07	2.23	48	0.97	4	106.6	\N	\N	\N	NaN	29	\N
38844	SGLP-0514	2019-06-20 00:00:00-07	2.37	48	1.22	4	115.2	\N	\N	\N	NaN	31	\N
38845	SGLP-0516	2019-07-15 00:00:00-07	3.52	96	0.88	4	170	\N	\N	\N	Madrid Melanoma; 05-27343-A M1	33	\N
38846	SGLP-0515	2019-07-15 00:00:00-07	2.12	11	0.24	4	250	\N	\N	\N	Madrid Melanoma; 05-12693-C M1	32	\N
38847	SGLP-0517	2019-07-15 00:00:00-07	3.1	9	0.66	4	250	\N	\N	\N	Madrid Melanoma; 06-03046-F N1	34	\N
38848	SGLP-0518	2019-07-15 00:00:00-07	2.86	10	0.49	4	250	\N	\N	\N	Madrid Melanoma; 06-06325 M1	35	\N
38849	SGLP-0520	2019-07-15 00:00:00-07	5.11	12	0.01	4	250	\N	\N	\N	Madrid Melanoma; 10-10942-A2 M1	37	\N
38850	SGLP-0519	2019-07-15 00:00:00-07	4.87	36	1.28	4	250	\N	\N	\N	Madrid Melanoma	36	\N
38851	SGLP-0521	2019-07-15 00:00:00-07	1.89	12	0.43	4	250	\N	\N	\N	Madrid Melanoma	38	\N
38852	SGLP-0524	2019-07-15 00:00:00-07	3.28	38	0.32	4	250	\N	\N	\N	Madrid Melanoma	41	\N
38853	SGLP-0526	2019-07-15 00:00:00-07	2.57	22	0.24	4	250	\N	\N	\N	Madrid Melanoma	43	\N
38854	SGLP-0525	2019-07-15 00:00:00-07	3.87	26	0.62	4	250	\N	\N	\N	Madrid Melanoma; Need to resequence due to barcode error	52	\N
38855	SGLP-0522	2019-07-15 00:00:00-07	3.17	96	0.27	4	229	\N	\N	\N	Madrid Melanoma	39	\N
38856	SGLP-0523	2019-07-15 00:00:00-07	3.03	96	0.18	4	230	\N	\N	\N	Madrid Melanoma	40	\N
38857	SGLP-0529	2019-07-15 00:00:00-07	2.54	96	0.43	4	172	\N	\N	\N	Madrid Melanoma	46	\N
38858	SGLP-0530	2019-07-15 00:00:00-07	1.05	95	0.28	4	46	\N	\N	\N	Madrid Melanoma	47	\N
38859	SGLP-0527	2019-07-15 00:00:00-07	2.37	11	0.29	4	250	\N	\N	\N	Madrid Melanoma	44	\N
38860	SGLP-0528	2019-07-15 00:00:00-07	4.14	45	0.74	4	250	\N	\N	\N	Madrid Melanoma	45	\N
38861	SGLP-0532	2019-07-15 00:00:00-07	3.84	72	0.8	4	250	\N	\N	\N	Madrid Melanoma	49	\N
38862	SGLP-0531	2019-07-15 00:00:00-07	3.78	21	0.8	4	250	\N	\N	\N	Madrid Melanoma	48	\N
38863	SGLP-0538	2019-07-24 00:00:00-07	2.23	96	0.31	4	248	\N	\N	\N	Madrid Melanoma	55	\N
38864	SGLP-0534	2019-07-15 00:00:00-07	2.61	7	0.4	4	250	\N	\N	\N	Madrid Melanoma	51	\N
38865	SGLP-0533	2019-07-15 00:00:00-07	3.56	85	0.56	4	250	\N	\N	\N	Madrid Melanoma	50	\N
38866	SGLP-0537	2019-07-24 00:00:00-07	2.8	17	0.43	4	250	\N	\N	\N	Madrid Melanoma	54	\N
38867	SGLP-0535	2019-07-24 00:00:00-07	0.14	9	0.16	4	250	\N	\N	\N	Madrid Melanoma; Need to resequence due to barcode error	52	\N
38868	SGLP-0536	2019-07-24 00:00:00-07	4.11	11	0.56	4	250	\N	\N	\N	Madrid Melanoma	53	\N
38869	SGLP-0542	2019-07-24 00:00:00-07	2.86	23	0.82	4	250	\N	\N	\N	Madrid Melanoma	59	\N
38870	SGLP-0544	2019-07-24 00:00:00-07	5.11	15	0.9	4	250	\N	\N	\N	Madrid Melanoma	61	\N
38871	SGLP-0539	2019-07-24 00:00:00-07	2.12	23	0.67	4	250	\N	\N	\N	Madrid Melanoma	56	\N
38872	SGLP-0541	2019-07-24 00:00:00-07	3.1	17	0.83	4	250	\N	\N	\N	Madrid Melanoma	58	\N
38873	SGLP-0543	2019-07-24 00:00:00-07	4.87	6	0.2	4	250	\N	\N	\N	Madrid Melanoma	60	\N
38874	SGLP-0540	2019-07-24 00:00:00-07	3.52	65	0.77	4	250	\N	\N	\N	Madrid Melanoma	57	\N
38875	SGLP-0547	2019-07-24 00:00:00-07	3.03	46	0.67	4	250	\N	\N	\N	Madrid Melanoma	64	\N
38876	SGLP-0546	2019-07-24 00:00:00-07	3.17	96	0.72	4	132	\N	\N	\N	Madrid Melanoma	63	\N
38877	SGLP-0545	2019-07-24 00:00:00-07	1.89	9	0.83	4	250	\N	\N	\N	Madrid Melanoma	62	\N
38878	SGLP-0548	2019-07-24 00:00:00-07	3.28	4	0.51	4	250	\N	\N	\N	Madrid Melanoma	65	\N
38879	SGLP-0553	2019-07-24 00:00:00-07	2.54	96	0.2	4	129	\N	\N	\N	Madrid Melanoma	70	\N
38880	SGLP-0549	2019-07-24 00:00:00-07	3.87	8	0.72	4	250	\N	\N	\N	Madrid Melanoma	66	\N
38881	SGLP-0555	2019-07-24 00:00:00-07	3.78	5	0.43	4	250	\N	\N	\N	Madrid Melanoma	72	\N
38882	SGLP-0552	2019-07-24 00:00:00-07	4.14	16	0.79	4	250	\N	\N	\N	Madrid Melanoma	69	\N
38883	SGLP-0550	2019-07-24 00:00:00-07	2.57	6	0.29	4	250	\N	\N	\N	Madrid Melanoma	67	\N
38884	SGLP-0557	2019-07-24 00:00:00-07	3.56	26	0.29	4	250	\N	\N	\N	Madrid Melanoma	77	\N
38885	SGLP-0554	2019-07-24 00:00:00-07	1.05	96	1.16	4	169	\N	\N	\N	Madrid Melanoma	71	\N
38886	SGLP-0556	2019-07-24 00:00:00-07	3.84	5	0.89	4	250	\N	\N	\N	Madrid Melanoma	76	\N
38887	SGLP-0558	2019-07-24 00:00:00-07	2.61	5	0.39	4	250	\N	\N	\N	Madrid Melanoma	78	\N
38888	SGLP-0559	2019-08-05 00:00:00-07	NaN	96	0.79	4	226	\N	\N	\N	NaN	1	\N
38889	SGLP-0560	2019-08-05 00:00:00-07	NaN	55	0.79	4	250	\N	\N	\N	NaN	3	\N
38890	SGLP-0561	2019-08-05 00:00:00-07	NaN	14	0.76	4	250	\N	\N	\N	NaN	4	\N
38891	SGLP-0562	2019-08-05 00:00:00-07	NaN	97	0.29	4	48	\N	\N	\N	NaN	5	\N
38892	SGLP-0563	2019-08-05 00:00:00-07	NaN	95	0.15	4	42	\N	\N	\N	NaN	6	\N
38893	SGLP-0564	2019-08-05 00:00:00-07	NaN	93	0.09	4	18	\N	\N	\N	NaN	7	\N
38894	SGLP-0565	2019-08-05 00:00:00-07	NaN	85	1.26	4	250	\N	\N	\N	NaN	8	\N
38895	SGLP-0566	2019-08-05 00:00:00-07	NaN	96	0.88	4	108	\N	\N	\N	NaN	79	\N
38896	SGLP-0567	2019-08-05 00:00:00-07	NaN	1	1.59	4	250	\N	\N	\N	NaN	80	\N
38897	SGLP-0568	2019-08-05 00:00:00-07	NaN	5	0.62	4	250	\N	\N	\N	NaN	81	\N
38898	SGLP-0569	2019-08-05 00:00:00-07	NaN	6	2.45	4	250	\N	\N	\N	NaN	82	\N
38899	SGLP-0571	2019-08-05 00:00:00-07	NaN	5	2.98	4	250	\N	\N	\N	NaN	84	\N
38900	SGLP-0570	2019-08-05 00:00:00-07	NaN	49	2.59	4	250	\N	\N	\N	NaN	83	\N
38901	SGLP-0572	2019-08-05 00:00:00-07	NaN	96	1.1	4	115	\N	\N	\N	NaN	85	\N
38902	SGLP-0573	2019-08-05 00:00:00-07	NaN	5	0.87	4	250	\N	\N	\N	NaN	86	\N
38903	SGLP-0574	2019-08-05 00:00:00-07	NaN	47	0.37	4	18	\N	\N	\N	NaN	87	\N
38904	SGLP-0575	2019-08-05 00:00:00-07	NaN	48	1.09	4	244	\N	\N	\N	NaN	88	\N
38905	SGLP-0266	\N	4.4	10	1.47	4	250	\N	\N	\N	Barcode overlap	A9	\N
38906	SGLP-0289	\N	5.6	12	1.45	4	250	\N	\N	\N	Barcode overlap	C8	\N
38907	SGLP-0261	\N	5	11	2.61	4	250	\N	\N	\N	Barcode overlap	A4	\N
38908	SGLP-0385	2019-02-21 00:00:00-08	0.66	45	0.17	4	26.7	\N	\N	\N	Blue Nevus	73	\N
38909	SGLP-0387	2019-02-21 00:00:00-08	0.84	49	0.15	4	53.8	\N	\N	\N	Blue Nevus	75	\N
38910	SGLP-0585	2019-08-13 00:00:00-07	NaN	16	2.35	4	250	\N	\N	\N	Madrid Melanoma	17	\N
38911	SGLP-0596	2019-08-13 00:00:00-07	NaN	96	0.79	4	109	\N	\N	\N	Madrid Melanoma	28	\N
38912	SGLP-0599	2019-08-13 00:00:00-07	NaN	20	1.75	4	250	\N	\N	\N	Madrid Melanoma	31	\N
38913	SGLP-0591	2019-08-13 00:00:00-07	NaN	72	0.4	4	250	\N	\N	\N	Madrid Melanoma	23	\N
38914	SGLP-0592	2019-08-13 00:00:00-07	NaN	13	0.72	4	250	\N	\N	\N	Madrid Melanoma	24	\N
38915	SGLP-0593	2019-08-13 00:00:00-07	NaN	53	1.38	4	250	\N	\N	\N	Madrid Melanoma	25	\N
38916	SGLP-0584	2019-08-13 00:00:00-07	NaN	9	2.04	4	250	\N	\N	\N	Madrid Melanoma	16	\N
38917	SGLP-0586	2019-08-13 00:00:00-07	NaN	10	0.1	4	250	\N	\N	\N	Madrid Melanoma	18	\N
38918	SGLP-0598	2019-08-13 00:00:00-07	NaN	7	1.04	4	250	\N	\N	\N	Madrid Melanoma	30	\N
38919	SGLP-0587	2019-08-13 00:00:00-07	NaN	95	0.21	4	53	\N	\N	\N	Madrid Melanoma	19	\N
38920	SGLP-0583	2019-08-13 00:00:00-07	NaN	2	2.31	4	250	\N	\N	\N	Madrid Melanoma	15	\N
38921	SGLP-0595	2019-08-13 00:00:00-07	NaN	24	1.66	4	250	\N	\N	\N	Madrid Melanoma	27	\N
38922	SGLP-0597	2019-08-13 00:00:00-07	NaN	60	0.55	4	250	\N	\N	\N	Madrid Melanoma	29	\N
38923	SGLP-0594	2019-08-13 00:00:00-07	NaN	13	1.2	4	250	\N	\N	\N	Madrid Melanoma	26	\N
38924	SGLP-0590	2019-08-13 00:00:00-07	NaN	25	0.41	4	250	\N	\N	\N	Madrid Melanoma	22	\N
38925	SGLP-0589	2019-08-13 00:00:00-07	NaN	21	0.8	4	250	\N	\N	\N	Madrid Melanoma	21	\N
38926	SGLP-0588	2019-08-13 00:00:00-07	NaN	47	0.35	4	250	\N	\N	\N	Madrid Melanoma	20	\N
38927	SGLP-0608	2019-09-24 00:00:00-07	6.47	5	3.8	4	250	\N	\N	\N	NaN	32	\N
38928	SGLP-0609	2019-09-24 00:00:00-07	4.48	5	1.5	4	250	\N	\N	\N	NaN	33	\N
38929	SGLP-0610	2019-09-24 00:00:00-07	3.9	12	1.4	4	250	\N	\N	\N	NaN	34	\N
38930	SGLP-0611	2019-09-24 00:00:00-07	5.18	52	1.3	4	250	\N	\N	\N	NaN	35	\N
38931	SGLP-0612	2019-09-24 00:00:00-07	2.16	16	0.5	4	250	\N	\N	\N	NaN	36	\N
38932	SGLP-0613	2019-09-24 00:00:00-07	3.69	8	1.3	4	250	\N	\N	\N	NaN	37	\N
38933	SGLP-0614	2019-09-24 00:00:00-07	3.04	19	1.2	4	250	\N	\N	\N	NaN	39	\N
38934	SGLP-0615	2019-09-24 00:00:00-07	5.61	64	1.9	4	250	\N	\N	\N	NaN	40	\N
38935	SGLP-0616	2019-09-24 00:00:00-07	3.01	6	0.6	4	250	\N	\N	\N	NaN	41	\N
38936	SGLP-0617	2019-09-24 00:00:00-07	7.58	8	4.9	4	250	\N	\N	\N	NaN	43	\N
38937	SGLP-0618	2019-09-24 00:00:00-07	3.5	7	1	4	250	\N	\N	\N	NaN	44	\N
38938	SGLP-0619	2019-09-24 00:00:00-07	5.31	17	2.2	4	250	\N	\N	\N	NaN	45	\N
38939	SGLP-0620	2019-09-24 00:00:00-07	3.7	51	1.2	4	250	\N	\N	\N	NaN	46	\N
38940	SGLP-0621	2019-09-24 00:00:00-07	5.41	90	1.6	4	250	\N	\N	\N	NaN	47	\N
38941	SGLP-0622	2019-09-24 00:00:00-07	5.47	68	2.9	4	250	\N	\N	\N	NaN	48	\N
38942	SGLP-0623	2019-09-24 00:00:00-07	4.98	30	1.4	4	250	\N	\N	\N	NaN	50	\N
38943	SGLP-0624	2019-09-24 00:00:00-07	3.05	15	0.5	4	250	\N	\N	\N	NaN	51	\N
38944	SGLP-0625	2019-09-24 00:00:00-07	4.35	38	0.7	4	250	\N	\N	\N	NaN	52	\N
38945	SGLP-0627	2019-10-16 00:00:00-07	4.38	58	2.19	4	2900	\N	\N	\N	Madrid Melanoma; 200ng; repair	80	\N
38946	SGLP-0626	2019-10-16 00:00:00-07	3.73	58	1.46	4	2900	\N	\N	\N	Madrid Melanoma; 200ng; No repair	79	\N
38947	SGLP-0628	2019-10-16 00:00:00-07	2.8	63	1.04	4	2000	\N	\N	\N	Madrid Melanoma; 250ng; No repair	81	\N
38948	SGLP-0629	2019-10-16 00:00:00-07	2.84	63	1.31	4	2000	\N	\N	\N	Madrid Melanoma; 250 ng; repair	86	\N
38949	SGLP-0630	2019-10-16 00:00:00-07	5.35	0	1.73	4	NaN	\N	\N	\N	Madrid Melanoma; 500ng; No repair	88	\N
38950	SGLP-0632	2019-10-16 00:00:00-07	9.07	58	2.73	4	2900	\N	\N	\N	Madrid Melanoma; 500ng; No repair; 4 Cycles\n	90	\N
38951	SGLP-0631	2019-10-16 00:00:00-07	5.62	0	2.53	4	NaN	\N	\N	\N	Madrid Melanoma; 500ng; repair	89	\N
38952	SGLP-0633	2019-10-16 00:00:00-07	5.88	63	1.68	4	2000	\N	\N	\N	Madrid Melanoma; 500ng; No repair; 4 Cycles	93	\N
38953	SGLP-0634	2019-10-16 00:00:00-07	13.7	14	0.79	4	500	\N	\N	\N	Madrid Melanoma; 500ng; No repair; 4 Cycles	95	\N
38954	SGLP-0635	2019-10-16 00:00:00-07	28.7	14	0.51	4	500	\N	\N	\N	Madrid Melanoma; 1000ng; No repair; 4 Cycles	96	\N
38955	SGLP-0636	2019-10-16 00:00:00-07	16.1	58	2.09	3	2900	\N	\N	\N	Madrid Melanoma; 1000ng; No repair; 3 Cycles	91	\N
38956	SGLP-0637	2019-10-16 00:00:00-07	10.2	63	1.27	3	2000	\N	\N	\N	Madrid Melanoma; 1000ng; No repair; 3 Cycles	94	\N
38957	SGLP-0638	2019-11-07 00:00:00-08	3.94	96	1	4	201	\N	\N	\N	Madrid Melanoma; 100s shear time	53	\N
38958	SGLP-0661	2019-11-07 00:00:00-08	8.24	61	2	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	7	\N
38959	SGLP-0651	2019-11-07 00:00:00-08	0.99	96	0.04	4	156	\N	\N	\N	Madrid Melanoma; 100s shear time	67	\N
38960	SGLP-0640	2019-11-07 00:00:00-08	7.75	91	1.44	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	55	\N
38961	SGLP-0656	2019-11-07 00:00:00-08	2.39	96	0.23	4	262	\N	\N	\N	Madrid Melanoma; 100s shear time	74	\N
38962	SGLP-0655	2019-11-07 00:00:00-08	7.14	73	1.46	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	72	\N
38963	SGLP-0658	2019-11-07 00:00:00-08	1.39	97	0.42	4	83	\N	\N	\N	Madrid Melanoma; 100s shear time	77	\N
38964	SGLP-0657	2019-11-07 00:00:00-08	6.66	61	1.32	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	76	\N
38965	SGLP-0659	2019-11-07 00:00:00-08	6.51	91	1.04	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	78	\N
38966	SGLP-0645	2019-11-07 00:00:00-08	2.73	96	0.88	4	153	\N	\N	\N	Madrid Melanoma; 100s shear time	60	\N
38967	SGLP-0639	2019-11-07 00:00:00-08	3.22	96	0.32	4	231	\N	\N	\N	Madrid Melanoma; 100s shear time	54	\N
38968	SGLP-0653	2019-11-07 00:00:00-08	1.42	96	0.33	4	100	\N	\N	\N	Madrid Melanoma; 100s shear time	69	\N
38969	SGLP-0641	2019-11-07 00:00:00-08	4.32	96	0.76	4	292	\N	\N	\N	Madrid Melanoma; 100s shear time	56	\N
38970	SGLP-0648	2019-11-07 00:00:00-08	2.78	96	0.45	4	253	\N	\N	\N	Madrid Melanoma; 100s shear time	64	\N
38971	SGLP-0644	2019-11-07 00:00:00-08	1.85	96	0.19	4	145	\N	\N	\N	Madrid Melanoma; 100s shear time	59	\N
38972	SGLP-0642	2019-11-07 00:00:00-08	4.65	96	0.83	4	307	\N	\N	\N	Madrid Melanoma; 100s shear time	57	\N
38973	SGLP-0654	2019-11-07 00:00:00-08	5.46	81	0.7	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	70	\N
38974	SGLP-0660	2019-11-07 00:00:00-08	4.12	96	0.64	4	252	\N	\N	\N	Madrid Melanoma; 100s shear time	5	\N
38975	SGLP-0646	2019-11-07 00:00:00-08	7.14	80	1.12	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	13	\N
38976	SGLP-0652	2019-11-07 00:00:00-08	5.42	45	1.5	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	68	\N
38977	SGLP-0647	2019-11-07 00:00:00-08	7.04	47	1.21	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	14	\N
38978	SGLP-0643	2019-11-07 00:00:00-08	3.51	96	0.98	4	262	\N	\N	\N	Madrid Melanoma; 100s shear time	11	\N
38979	SGLP-0650	2019-11-07 00:00:00-08	3.46	96	0.8	4	268	\N	\N	\N	Madrid Melanoma; 100s shear time	66	\N
38980	SGLP-0649	2019-11-07 00:00:00-08	4.66	74	0.56	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	65	\N
38981	SGLP-0249	\N	4.1	16	1.2	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	D5	\N
38982	SGLP-0248	\N	4.5	3	2.6	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	D4	\N
38983	SGLP-0221	\N	2	7	0.4	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A5	\N
38984	SGLP-0240	\N	4	32	1.3	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C8	\N
38985	SGLP-0235	\N	2.2	47	0.7	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C3	\N
38986	SGLP-0244	\N	4.5	14	1.7	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C12	\N
38987	SGLP-0220	\N	2.9	50	0.9	4	123	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A4	\N
38988	SGLP-0245	\N	5.8	11	3.3	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	D1	\N
38989	SGLP-0241	\N	3.5	20	1.7	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C9	\N
38990	SGLP-0223	\N	2.1	9	0.4	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A7	\N
38991	SGLP-0246	\N	5.3	8	2.5	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	D2	\N
38992	SGLP-0230	\N	3.4	1	1.4	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	B2	\N
38993	SGLP-0242	\N	4.5	3	1.6	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C10	\N
38994	SGLP-0243	\N	5.5	13	3	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	C11	\N
38995	SGLP-0224	\N	3.2	3	1.3	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	A8	\N
38996	SGLP-0232	\N	3.3	6	1.2	4	250	\N	\N	\N	Capture hyb at 65c for 4 hours. 	B4	\N
38997	SGLP-0200	2018-03-20 00:00:00-07	3.2	89	1.1	4	65	\N	\N	\N	KIT mutant DNA samples	G8	\N
38998	SGLP-0201	2018-03-20 00:00:00-07	5	90	1.3	4	98.1	\N	\N	\N	KIT mutant DNA samples	G9	\N
38999	SGLP-0202	2018-03-20 00:00:00-07	7.3	90	2	4	124.2	\N	\N	\N	KIT mutant DNA samples	G10	\N
39000	SGLP-0203	2018-03-20 00:00:00-07	3.8	90	0.8	4	72.8	\N	\N	\N	KIT mutant DNA samples	G11	\N
39001	SGLP-0204	2018-03-20 00:00:00-07	1.7	90	0.4	4	43.3	\N	\N	\N	KIT mutant DNA samples	G12	\N
39002	SGLP-0205	2018-03-20 00:00:00-07	4.6	30	1.1	4	59.1	\N	\N	\N	KIT mutant DNA samples	H1	\N
39003	SGLP-0207	2018-03-20 00:00:00-07	2.3	30	0.8	4	40.8	\N	\N	\N	KIT mutant DNA samples	H3	\N
39004	SGLP-0208	2018-03-20 00:00:00-07	3.3	30	1	4	97.8	\N	\N	\N	KIT mutant DNA samples	H4	\N
39005	SGLP-0206	2018-03-20 00:00:00-07	1.3	30	0.4	4	19.6	\N	\N	\N	KIT mutant DNA samples	H2	\N
39006	SGLP-0209	2018-03-20 00:00:00-07	1.6	15	0.3	4	57.9	\N	\N	\N	KIT mutant DNA samples	H5	\N
39007	SGLP-0380	2018-12-20 00:00:00-08	2.36	48	4.8	4	113.3	\N	\N	\N	Nevus from Iwei	38	\N
39008	SGLP-0662	2020-05-30 00:00:00-07	1.64	96	0.41	4	77	\N	\N	\N	Madrid Melanoma; 100s shear time	121	\N
39009	SGLP-0663	2020-05-30 00:00:00-07	7.04	55	1.91	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	122	\N
39010	SGLP-0664	2020-05-30 00:00:00-07	6.4	96	0.88	4	404	\N	\N	\N	Madrid Melanoma; 100s shear time	123	\N
39011	SGLP-0665	2020-05-30 00:00:00-07	7.05	96	1.28	4	366	\N	\N	\N	Madrid Melanoma; 100s shear time	124	\N
39012	SGLP-0666	2020-05-30 00:00:00-07	3	96	0.71	4	176	\N	\N	\N	Madrid Melanoma; 100s shear time	125	\N
39013	SGLP-0667	2020-05-30 00:00:00-07	3.52	96	0.65	4	221	\N	\N	\N	Madrid Melanoma; 100s shear time	126	\N
39014	SGLP-0669	2020-05-30 00:00:00-07	2.05	96	0.5	4	124	\N	\N	\N	Madrid Melanoma; 100s shear time	128	\N
39015	SGLP-0668	2020-05-30 00:00:00-07	6.74	96	0.78	4	491	\N	\N	\N	Madrid Melanoma; 100s shear time	127	\N
39016	SGLP-0670	2020-05-30 00:00:00-07	2.2	96	0.39	4	172	\N	\N	\N	Madrid Melanoma; 100s shear time	129	\N
39017	SGLP-0671	2020-05-30 00:00:00-07	4.7	96	1.32	4	434	\N	\N	\N	Madrid Melanoma; 100s shear time	130	\N
39018	SGLP-0672	2020-05-30 00:00:00-07	6.03	96	1.62	4	372	\N	\N	\N	Madrid Melanoma; 100s shear time	131	\N
39019	SGLP-0673	2020-05-30 00:00:00-07	4.27	47	0.41	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	132	\N
39020	SGLP-0674	2020-05-30 00:00:00-07	1.83	96	0.24	4	251	\N	\N	\N	Madrid Melanoma; 100s shear time	133	\N
39021	SGLP-0675	2020-05-30 00:00:00-07	5.88	71	1.16	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	134	\N
39022	SGLP-0676	2020-05-30 00:00:00-07	1.37	96	0.38	4	94	\N	\N	\N	Madrid Melanoma; 100s shear time	135	\N
39023	SGLP-0677	2020-05-30 00:00:00-07	3.9	96	0.82	4	225	\N	\N	\N	Madrid Melanoma; 100s shear time	136	\N
39024	SGLP-0678	2020-05-30 00:00:00-07	1.57	96	0.35	4	132	\N	\N	\N	Madrid Melanoma; 100s shear time	137	\N
39025	SGLP-0679	2020-05-30 00:00:00-07	3.13	96	0.77	4	141	\N	\N	\N	Madrid Melanoma; 100s shear time	138	\N
39026	SGLP-0680	2020-05-30 00:00:00-07	4.3	96	0.94	4	268	\N	\N	\N	Madrid Melanoma; 100s shear time	139	\N
39715	CGH13-007	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-007 	L2DR10	\N
39027	SGLP-0681	2020-05-30 00:00:00-07	3.59	96	0.8	4	136	\N	\N	\N	Madrid Melanoma; 100s shear time	140	\N
39028	SGLP-0682	2020-05-30 00:00:00-07	4.9	96	0.83	4	303	\N	\N	\N	Madrid Melanoma; 100s shear time	141	\N
39029	SGLP-0683	2020-05-30 00:00:00-07	2.85	96	0.82	4	159	\N	\N	\N	Madrid Melanoma; 100s shear time	142	\N
39030	SGLP-0684	2020-05-30 00:00:00-07	1.7	96	0.18	4	156	\N	\N	\N	Madrid Melanoma; 100s shear time	143	\N
39031	SGLP-0686	2020-05-31 00:00:00-07	6.29	96	1.55	4	320	\N	\N	\N	Madrid Melanoma; 100s shear time	145	\N
39032	SGLP-0685	2020-05-30 00:00:00-07	2.44	96	0.41	4	153	\N	\N	\N	Madrid Melanoma; 100s shear time	144	\N
39033	SGLP-0687	2020-05-31 00:00:00-07	6.08	68	1.51	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	146	\N
39034	SGLP-0688	2020-05-31 00:00:00-07	5.53	78	2.55	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	147	\N
39035	SGLP-0689	2020-05-31 00:00:00-07	5.67	96	1.92	4	270	\N	\N	\N	Madrid Melanoma; 100s shear time	148	\N
39036	SGLP-0690	2020-05-31 00:00:00-07	1.7	97	0.42	4	49	\N	\N	\N	Madrid Melanoma; 100s shear time	149	\N
39037	SGLP-0691	2020-05-31 00:00:00-07	3.73	96	0.25	4	343	\N	\N	\N	Madrid Melanoma; 100s shear time	150	\N
39038	SGLP-0692	2020-05-31 00:00:00-07	2.07	96	0.53	4	159	\N	\N	\N	Madrid Melanoma; 100s shear time	151	\N
39039	SGLP-0693	2020-05-31 00:00:00-07	4.79	96	1.11	4	253	\N	\N	\N	Madrid Melanoma; 100s shear time	152	\N
39040	SGLP-0694	2020-05-31 00:00:00-07	1.07	96	0.4	4	106	\N	\N	\N	Madrid Melanoma; 100s shear time	153	\N
39041	SGLP-0695	2020-05-31 00:00:00-07	3.49	96	0.4	4	453	\N	\N	\N	Madrid Melanoma; 100s shear time	154	\N
39042	SGLP-0696	2020-05-31 00:00:00-07	2.81	96	0.8	4	292	\N	\N	\N	Madrid Melanoma; 100s shear time	155	\N
39043	SGLP-0697	2020-05-31 00:00:00-07	0.52	96	0.1	4	74	\N	\N	\N	Madrid Melanoma; 100s shear time	156	\N
39044	SGLP-0698	2020-05-31 00:00:00-07	0.65	96	0.09	4	197	\N	\N	\N	Madrid Melanoma; 100s shear time	157	\N
39045	SGLP-0699	2020-05-31 00:00:00-07	6.78	96	1.49	4	415	\N	\N	\N	Madrid Melanoma; 100s shear time	158	\N
39046	SGLP-0700	2020-05-31 00:00:00-07	2.14	96	0.62	4	120	\N	\N	\N	Madrid Melanoma; 100s shear time	159	\N
39047	SGLP-0701	2020-05-31 00:00:00-07	8.3	58	2.48	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	160	\N
39048	SGLP-0702	2020-05-31 00:00:00-07	2.62	96	2.13	4	226	\N	\N	\N	Madrid Melanoma; 100s shear time	161	\N
39049	SGLP-0703	2020-05-31 00:00:00-07	3.51	96	0.49	4	243	\N	\N	\N	Madrid Melanoma; 100s shear time	162	\N
39050	SGLP-0704	2020-05-31 00:00:00-07	2.17	96	0.6	4	269	\N	\N	\N	Madrid Melanoma; 100s shear time	163	\N
39051	SGLP-0705	2020-05-31 00:00:00-07	4.19	96	1.64	4	448	\N	\N	\N	Madrid Melanoma; 100s shear time	164	\N
39052	SGLP-0706	2020-05-31 00:00:00-07	3.92	16	1.02	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	165	\N
39053	SGLP-0707	2020-05-31 00:00:00-07	3.28	73	0.47	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	166	\N
39054	SGLP-0708	2020-05-31 00:00:00-07	1.71	96	0.53	4	151	\N	\N	\N	Madrid Melanoma; 100s shear time	167	\N
39055	SGLP-0709	2020-05-31 00:00:00-07	2.4	96	0.63	4	255	\N	\N	\N	Madrid Melanoma; 100s shear time	168	\N
39056	SGLP-0710	2020-06-06 00:00:00-07	1.66	80	0.74	4	66	\N	\N	\N	Madrid Melanoma; 100s shear time	169	\N
39057	SGLP-0712	2020-06-06 00:00:00-07	4.97	29	2.1	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	171	\N
39058	SGLP-0711	2020-06-06 00:00:00-07	3.56	80	1.12	4	206	\N	\N	\N	Madrid Melanoma; 100s shear time	170	\N
39059	SGLP-0713	2020-06-06 00:00:00-07	0.12	80	0.02	4	60	\N	\N	\N	Madrid Melanoma; 100s shear time	172	\N
39060	SGLP-0714	2020-06-06 00:00:00-07	2.01	80	0.71	4	106	\N	\N	\N	Madrid Melanoma; 100s shear time	173	\N
39061	SGLP-0716	2020-06-06 00:00:00-07	3.4	80	0.75	4	326	\N	\N	\N	Madrid Melanoma; 100s shear time	175	\N
39062	SGLP-0715	2020-06-06 00:00:00-07	1.43	80	0.1	4	184	\N	\N	\N	Madrid Melanoma; 100s shear time	174	\N
39063	SGLP-0717	2020-06-06 00:00:00-07	0.82	80	0.16	4	55	\N	\N	\N	Madrid Melanoma; 100s shear time	176	\N
39064	SGLP-0718	2020-06-06 00:00:00-07	5.45	15	2.44	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	177	\N
39065	SGLP-0720	2020-06-06 00:00:00-07	2.58	80	0.95	4	118	\N	\N	\N	Madrid Melanoma; 100s shear time	179	\N
39066	SGLP-0719	2020-06-06 00:00:00-07	4.13	80	0.71	4	460	\N	\N	\N	Madrid Melanoma; 100s shear time	178	\N
39067	SGLP-0721	2020-06-06 00:00:00-07	4.68	80	0.7	4	406	\N	\N	\N	Madrid Melanoma; 100s shear time	180	\N
39068	SGLP-0722	2020-06-06 00:00:00-07	4.84	55	0.82	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	181	\N
39069	SGLP-0723	2020-06-06 00:00:00-07	1.67	80	0.36	4	162	\N	\N	\N	Madrid Melanoma; 100s shear time	182	\N
39070	SGLP-0724	2020-06-06 00:00:00-07	5.76	38	1.62	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	183	\N
39071	SGLP-0725	2020-06-06 00:00:00-07	3.56	36	0.51	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	184	\N
39072	SGLP-0726	2020-06-06 00:00:00-07	5.12	77	0.56	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	185	\N
39073	SGLP-0727	2020-06-06 00:00:00-07	3.19	80	0.84	4	189	\N	\N	\N	Madrid Melanoma; 100s shear time	186	\N
39074	SGLP-0728	2020-06-06 00:00:00-07	2.55	80	0.72	4	214	\N	\N	\N	Madrid Melanoma; 100s shear time	187	\N
39075	SGLP-0729	2020-06-06 00:00:00-07	4.02	80	0.66	4	346	\N	\N	\N	Madrid Melanoma; 100s shear time	188	\N
39076	SGLP-0730	2020-06-06 00:00:00-07	2.57	80	0.5	4	182	\N	\N	\N	Madrid Melanoma; 100s shear time	189	\N
39077	SGLP-0731	2020-06-06 00:00:00-07	4.45	23	1.1	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	190	\N
39078	SGLP-0732	2020-06-06 00:00:00-07	1.13	80	0.1	4	150	\N	\N	\N	Madrid Melanoma; 100s shear time	191	\N
39079	SGLP-0733	2020-06-06 00:00:00-07	6.75	80	1.1	4	498	\N	\N	\N	Madrid Melanoma; 100s shear time	192	\N
39080	SGLP-0734	2020-06-11 00:00:00-07	1.62	80	0.32	4	147	\N	\N	\N	Madrid Melanoma; 100s shear time	97	\N
39081	SGLP-0735	2020-06-11 00:00:00-07	2.52	80	0.48	4	158	\N	\N	\N	Madrid Melanoma; 100s shear time	98	\N
39082	SGLP-0736	2020-06-11 00:00:00-07	2.31	80	0.48	4	230	\N	\N	\N	Madrid Melanoma; 100s shear time	99	\N
39083	SGLP-0737	2020-06-11 00:00:00-07	4.61	37	0.03	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	100	\N
39084	SGLP-0738	2020-06-11 00:00:00-07	3.24	80	0.68	4	238	\N	\N	\N	Madrid Melanoma; 100s shear time	101	\N
39085	SGLP-0739	2020-06-11 00:00:00-07	1.19	80	0.38	4	74	\N	\N	\N	Madrid Melanoma; 100s shear time	102	\N
39086	SGLP-0740	2020-06-11 00:00:00-07	3.27	45	0.95	4	500	\N	\N	\N	Madrid Melanoma; 100s shear time	103	\N
39087	SGLP-0765	2020-06-18 00:00:00-07	12.5	5	12.23	4	250	\N	\N	\N	MK cell culture: 12.2019 batch	20	\N
39088	SGLP-0766	2020-06-18 00:00:00-07	8	9	8.2	4	250	\N	\N	\N	MK cell culture: 12.2019 batch	21	\N
39089	SGLP-0767	2020-06-18 00:00:00-07	11.2	6	12.4	4	250	\N	\N	\N	NaN	22	\N
39090	SGLP-0768	2020-06-18 00:00:00-07	2.05	0	1.1	4	NaN	\N	\N	\N	NaN	23	\N
39091	SGLP-0769	2020-06-18 00:00:00-07	7.12	0	5	4	NaN	\N	\N	\N	NaN	27	\N
39092	SGLP-0770	2020-06-18 00:00:00-07	1.85	0	1.1	4	NaN	\N	\N	\N	NaN	28	\N
39093	SGLP-0772	2020-06-18 00:00:00-07	6.83	0	6.1	4	NaN	\N	\N	\N	NaN	30	\N
39094	SGLP-0771	2020-06-18 00:00:00-07	2.54	0	0.8	4	NaN	\N	\N	\N	NaN	29	\N
39095	SGLP-0773	2020-06-18 00:00:00-07	3.81	0	2.2	4	NaN	\N	\N	\N	NaN	31	\N
39096	SGLP-0741	2020-06-11 00:00:00-07	2.96	0	2.15	4	NaN	\N	\N	\N	NaN	104	\N
39097	SGLP-0742	2020-06-11 00:00:00-07	2.7	0	1.57	4	NaN	\N	\N	\N	NaN	105	\N
39098	SGLP-0743	2020-06-11 00:00:00-07	1.64	0	0.73	4	NaN	\N	\N	\N	NaN	106	\N
39099	SGLP-0744	2020-06-11 00:00:00-07	6.15	0	3.95	4	NaN	\N	\N	\N	NaN	107	\N
39100	SGLP-0745	2020-06-11 00:00:00-07	3.09	0	0.2	4	NaN	\N	\N	\N	NaN	108	\N
39101	SGLP-0747	2020-06-11 00:00:00-07	4.37	0	2.92	4	NaN	\N	\N	\N	NaN	110	\N
39102	SGLP-0746	2020-06-11 00:00:00-07	7.29	0	4.53	4	NaN	\N	\N	\N	NaN	109	\N
39103	SGLP-0748	2020-06-11 00:00:00-07	4.04	0	2.42	4	NaN	\N	\N	\N	NaN	111	\N
39104	SGLP-0749	2020-06-11 00:00:00-07	2.65	0	1.8	4	NaN	\N	\N	\N	NaN	112	\N
39105	SGLP-0750	2020-06-11 00:00:00-07	4.74	0	2.82	4	NaN	\N	\N	\N	NaN	113	\N
39106	SGLP-0751	2020-06-11 00:00:00-07	4.96	0	2.46	4	NaN	\N	\N	\N	NaN	114	\N
39107	SGLP-0752	2020-06-11 00:00:00-07	5.5	0	2.11	4	NaN	\N	\N	\N	NaN	115	\N
39108	SGLP-0754	2020-06-11 00:00:00-07	8.64	0	4.33	4	NaN	\N	\N	\N	NaN	117	\N
39109	SGLP-0753	2020-06-11 00:00:00-07	4.68	0	2.91	4	NaN	\N	\N	\N	NaN	116	\N
39110	SGLP-0755	2020-06-11 00:00:00-07	3.66	0	2.24	4	NaN	\N	\N	\N	NaN	118	\N
39111	SGLP-0757	2020-06-11 00:00:00-07	0.28	0	0.13	4	NaN	\N	\N	\N	NaN	120	\N
39112	SGLP-0756	2020-06-11 00:00:00-07	8.06	0	4.91	4	NaN	\N	\N	\N	NaN	119	\N
39113	SGLP-0758	\N	1.45	0	0.8	4	NaN	\N	\N	\N	NaN	5	\N
39114	SGLP-0759	\N	1.1	0	0.35	4	NaN	\N	\N	\N	NaN	6	\N
39115	SGLP-0760	\N	1.91	0	0.82	4	NaN	\N	\N	\N	NaN	15	\N
39116	SGLP-0761	\N	4.18	0	1.74	4	NaN	\N	\N	\N	NaN	16	\N
39117	SGLP-0762	\N	6.41	0	2.58	4	NaN	\N	\N	\N	NaN	17	\N
39118	SGLP-0763	\N	5.17	0	0.9	4	NaN	\N	\N	\N	NaN	18	\N
39119	SGLP-0764	\N	2.18	0	0.39	4	NaN	\N	\N	\N	NaN	19	\N
39120	SGLP-0774	2020-11-18 00:00:00-08	1.54	89	0.81	4	47	\N	\N	\N	NaN	97	\N
39121	SGLP-0775	2020-11-18 00:00:00-08	1.85	88	1.02	4	44	\N	\N	\N	NaN	98	\N
39122	SGLP-0776	2020-11-18 00:00:00-08	2.42	88	1.72	4	60	\N	\N	\N	NaN	99	\N
39123	SGLP-0777	2020-11-18 00:00:00-08	1.91	88	1.12	4	51	\N	\N	\N	NaN	100	\N
39124	SGLP-0778	2020-11-18 00:00:00-08	3.15	88	2.29	4	50	\N	\N	\N	NaN	101	\N
39125	SGLP-0779	2020-11-18 00:00:00-08	9.19	78	6.45	4	250	\N	\N	\N	NaN	102	\N
39126	SGLP-0781	2020-11-18 00:00:00-08	2.83	88	2.02	4	61	\N	\N	\N	NaN	104	\N
39127	SGLP-0780	2020-11-18 00:00:00-08	1.16	88	0.53	4	58	\N	\N	\N	NaN	103	\N
39128	SGLP-0782	2020-11-18 00:00:00-08	3.59	88	2.5	4	81	\N	\N	\N	NaN	105	\N
39129	SGLP-0783	2020-11-18 00:00:00-08	7.38	88	5.15	4	180	\N	\N	\N	NaN	106	\N
39130	SGLP-0784	2020-11-18 00:00:00-08	5.01	88	3.53	4	114	\N	\N	\N	NaN	107	\N
39131	SGLP-0785	2020-11-18 00:00:00-08	6.62	88	4.59	4	192	\N	\N	\N	NaN	108	\N
39132	SGLP-0786	2020-11-18 00:00:00-08	2.59	88	1.18	4	77	\N	\N	\N	NaN	109	\N
39133	SGLP-0787	2020-11-25 00:00:00-08	2.39	88	1.68	4	95	\N	\N	\N	NaN	110	\N
39134	SGLP-0788	2020-11-25 00:00:00-08	7.08	88	5.7	4	184	\N	\N	\N	NaN	111	\N
39135	SGLP-0789	2020-11-25 00:00:00-08	3.83	88	3.02	4	102	\N	\N	\N	NaN	112	\N
39136	SGLP-0790	2020-11-25 00:00:00-08	4.99	88	3.44	4	135	\N	\N	\N	NaN	113	\N
39137	SGLP-0791	2020-11-25 00:00:00-08	1.79	87	1.45	4	48	\N	\N	\N	NaN	114	\N
39138	SGLP-0792	2020-11-25 00:00:00-08	1.25	88	0.85	4	56	\N	\N	\N	NaN	115	\N
39139	SGLP-0793	2020-11-25 00:00:00-08	8.9	65	7.52	4	250	\N	\N	\N	NaN	116	\N
39140	SGLP-0794	2020-11-25 00:00:00-08	7.36	69	4.85	4	250	\N	\N	\N	NaN	117	\N
39141	SGLP-0795	2020-11-25 00:00:00-08	2.24	NaN	1.76	4	NaN	\N	\N	\N	NaN	118	\N
39142	SGLP-0796	2020-11-25 00:00:00-08	2.22	NaN	1.85	4	NaN	\N	\N	\N	NaN	119	\N
39143	SGLP-0797	2020-11-25 00:00:00-08	1.58	NaN	1.11	4	NaN	\N	\N	\N	NaN	120	\N
39144	SGLP-0798	2020-11-25 00:00:00-08	12.5	20	9.19	4	250	\N	\N	\N	Seattle Children's Hospital	121	\N
39145	SGLP-0799	2020-12-02 00:00:00-08	31.7	NaN	57.03	11	NaN	\N	\N	\N	Seattle Children's Hospital	122	\N
39146	SGLP-0800	2020-12-05 00:00:00-08	1.5	NaN	1.14	4	NaN	\N	\N	\N	NaN	123	\N
39147	SGLP-0801	2020-12-05 00:00:00-08	0.66	NaN	0.36	4	NaN	\N	\N	\N	NaN	124	\N
39148	SGLP-0802	2020-12-05 00:00:00-08	1.49	NaN	1.3	4	NaN	\N	\N	\N	NaN	125	\N
39149	RLP-64	2018-11-05 00:00:00-08	13.9	NaN	30.9	11	NaN	\N	\N	\N	RLP-64	88	\N
39150	AMLP-342	2021-08-06 00:00:00-07	0.42	18	0.08	4	20	\N	\N	\N	HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. Used 16 ng DNA.	189	\N
39151	AMLP-343	2021-08-06 00:00:00-07	1.58	9	0.28	4	42	\N	\N	\N	HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. Used 90 ng of DNA.	190	\N
39152	AMLP-344	2021-08-06 00:00:00-07	1.62	10	0.88	4	22	\N	\N	\N	HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. Used 40 ng of DNA.	191	\N
39153	OMLP-002	2021-08-06 00:00:00-07	3.93	23	1.91	4	250	\N	\N	\N	DO NOT USE SEQUENCED DATA! Purigen, HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. SGPC-21: xx Cycles post Hyb, XXng captured	167	\N
39154	OMLP-003	2021-08-06 00:00:00-07	2.88	23	0.89	4	250	\N	\N	\N	DO NOT USE SEQUENCED DATA! HyperPrep, NEBRepair, Ligation: 17 hrs,16oC.	153	\N
39155	AMLP-339	2021-08-06 00:00:00-07	0.41	18	0.13	4	20	\N	\N	\N	HyperPREP, Ligation: 17 hrs,16oC.	136	\N
39156	AMLP-340	2021-08-06 00:00:00-07	1.11	9	0.22	4	42	\N	\N	\N	HyperPREP, Ligation: 17 hrs,16oC.	137	\N
39157	AMLP-341	2021-08-06 00:00:00-07	1.51	10	0.71	4	22	\N	\N	\N	HyperPREP, Ligation: 17 hrs,16oC.	138	\N
39158	NMLP-053	2021-09-08 00:00:00-07	1.83	12	0.31	4	250	\N	\N	\N	KAPA HyperPLUS, 10 min Frag at 37oC, 30 min ligation at 20oC	154	\N
39159	AMLP-353	2021-09-16 00:00:00-07	7.18	78	6.73	4	1200	\N	\N	\N	HyperPREP; Ligation: O/N (23hrs) at 4 oC	97	\N
39160	AMLP-354	2021-09-16 00:00:00-07	6.04	51	6.25	4	1200	\N	\N	\N	HyperPREP; Ligation: O/N (23hrs) at 4 oC	98	\N
39161	AMLP-355	2021-09-16 00:00:00-07	1.31	148	0.56	4	1200	\N	\N	\N	HyperPREP; Ligation: O/N (23hrs) at 4 oC	99	\N
39162	AMLP-362	2021-09-16 00:00:00-07	9.63	78	9.69	4	1200	\N	\N	\N	HyperPLUS, Ligation: O/N at 4 oC	116	\N
39163	AMLP-363	2021-09-16 00:00:00-07	9.82	51	10.56	4	1200	\N	\N	\N	HyperPLUS, Ligation: O/N at 4 oC	117	\N
39164	AMLP-364	2021-09-16 00:00:00-07	1.36	148	0.68	4	1200	\N	\N	\N	HyperPLUS, Ligation: O/N at 4 oC	118	\N
39165	AMLP-372	2021-09-18 00:00:00-07	1.25	95	0.54	4	100.7	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	109	\N
39166	OMLP-004	2021-09-22 00:00:00-07	0.24	0	0.1	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	119	\N
39167	OMLP-007	2021-09-22 00:00:00-07	0.07	0	0.01	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	122	\N
39168	OMLP-006	2021-09-22 00:00:00-07	0.07	0	0.01	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	121	\N
39169	OMLP-005	2021-09-22 00:00:00-07	0.27	0	0.12	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	120	\N
39170	OMLP-008	2021-09-22 00:00:00-07	0	0	0	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	123	\N
39171	OMLP-009	2021-09-22 00:00:00-07	0.13	0	0.04	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	124	\N
39172	OMLP-010	2021-09-22 00:00:00-07	0	0	0	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	125	\N
39173	OMLP-011	2021-09-22 00:00:00-07	0.09	0	0.02	4	NaN	\N	\N	\N	DO NOT USE SEQUENCED DATA! HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	126	\N
39174	OMLP-012	2021-09-22 00:00:00-07	0.28	0	0.17	4	NaN	\N	\N	\N	DO NOT USE SEQUENCED DATA! HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	127	\N
39175	OMLP-013	2021-09-22 00:00:00-07	0	0	0	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	128	\N
39176	OMLP-015	2021-09-22 00:00:00-07	0.06	0	0	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	130	\N
39177	OMLP-014	2021-09-22 00:00:00-07	0.13	0	0.03	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	129	\N
39178	OMLP-016	2021-09-22 00:00:00-07	0.09	0	0.02	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	131	\N
39179	OMLP-017	2021-09-22 00:00:00-07	0.26	0	0.04	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	132	\N
39180	OMLP-018	2021-09-22 00:00:00-07	0	0	0	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	133	\N
39181	OMLP-020	2021-09-22 00:00:00-07	0.06	0	0	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	135	\N
39182	OMLP-019	2021-09-22 00:00:00-07	0	0	0.01	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	134	\N
39183	OMLP-021	2021-09-22 00:00:00-07	0.06	0	0	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	139	\N
39184	SGLP-0803	2021-09-22 00:00:00-07	0.11	48	0.04	4	35.6	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	140	\N
39185	SGLP-0804	2021-09-22 00:00:00-07	0.24	48	0.12	4	72	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	141	\N
39186	SGLP-0805	2021-09-22 00:00:00-07	0.34	48	0.22	4	103	\N	\N	\N	HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.	142	\N
39187	AMLP-370-3	2021-09-27 00:00:00-07	5.69	27	3.99	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	107	\N
39188	AMLP-166	2020-01-31 00:00:00-08	2.35	0	0.52	4	NaN	\N	\N	\N	120s shear time; DNA repaired	75	\N
39189	AMLP-167	2020-01-31 00:00:00-08	0.76	0	0.29	4	NaN	\N	\N	\N	120s shear time; DNA repaired	78	\N
39190	AMLP-308	2021-05-13 00:00:00-07	5.26	3	3.52	4	350	\N	\N	\N	Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	146	\N
39191	AMLP-345	2021-09-08 00:00:00-07	4.45	19	1.34	4	999	\N	\N	\N	KAPA HyperPLUS, 10 min Frag at 37oC, 60 min ligation at 20oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	155	\N
39192	AMLP-346	2021-09-08 00:00:00-07	2.47	32	0.91	4	999	\N	\N	\N	KAPA HyperPLUS, 10 min Frag at 37oC, 120 min ligation at 20oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	156	\N
39193	AMLP-350	2021-09-15 00:00:00-07	6.24	78	5.56	4	1200	\N	\N	\N	HyperPREP; Ligation: 60 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	97	\N
39194	AMLP-376	2022-01-26 00:00:00-08	5.87	1	6.09	4	250	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	100	\N
39463	RNA-30	2018-09-27 00:00:00-07	5.2	NaN	10.5	11	NaN	\N	\N	\N	RLP-30	6	\N
39195	AMLP-377	2022-01-26 00:00:00-08	6.12	50	8.15	4	1520	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	101	\N
39196	AMLP-378	2022-01-26 00:00:00-08	7.33	11	8.7	4	666	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	127	\N
39197	AMLP-379	2022-01-26 00:00:00-08	6.02	0	7.44	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	128	\N
39198	AMLP-381	2022-01-26 00:00:00-08	6.35	28	3.63	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	130	\N
39199	AMLP-383	2022-01-26 00:00:00-08	2.58	88	2.5	4	115	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	132	\N
39200	AMLP-384	2022-01-26 00:00:00-08	3.83	61	5.31	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	133	\N
39201	AMLP-387	2022-01-26 00:00:00-08	5.54	17	7.72	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	136	\N
39202	AMLP-388	2022-01-26 00:00:00-08	7.73	32	8.82	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	137	\N
39203	AMLP-391	2022-01-26 00:00:00-08	8.39	30	9.31	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	141	\N
39204	AMLP-389	2022-01-26 00:00:00-08	5.32	63	6.19	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	138	\N
39205	AMLP-390	2022-01-26 00:00:00-08	5.12	69	3.79	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	140	\N
39206	AMLP-396	2022-01-26 00:00:00-08	5.49	69	4.67	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	148	\N
39207	AMLP-392	2022-01-26 00:00:00-08	1.99	88	1.12	4	142	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	142	\N
39208	AMLP-386	2022-01-26 00:00:00-08	3.61	NaN	2.58	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	135	\N
39209	AMLP-395	2022-01-26 00:00:00-08	2.35	88	1.2	4	120	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	147	\N
39210	AMLP-52	2018-07-23 00:00:00-07	4.1	0	2.28	NaN	NaN	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 30ng captured	C3	\N
39211	AMLP-89	2019-02-27 00:00:00-08	8.57	6	2.61	4	300	\N	\N	\N	repeated sequencing. SGPC-20: 12 Cycles post Hyb, 50ng captured	63	\N
39212	AMLP-54	2018-07-23 00:00:00-07	8.4	0	3.68	NaN	NaN	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured	C5	\N
39213	AMLP-47	2018-07-23 00:00:00-07	5.4	0	1.7	NaN	NaN	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 35ng captured	B10	\N
39214	AMLP-50	2018-07-23 00:00:00-07	5.8	0	4.3	NaN	NaN	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured	C1	\N
39215	AMLP-145	2019-12-03 00:00:00-08	4.87	90	1.81	4	271	\N	\N	\N	120s shear time; DNA repaired	79	\N
39216	AMLP-270	2021-03-17 00:00:00-07	7	7	2.87	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 40ng captured	139	\N
39217	AMLP-276	2021-03-17 00:00:00-07	8.28	26	4.72	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 40ng captured	159	\N
39218	AMLP-223	2020-08-06 00:00:00-07	5.31	27	3.5	4	583	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured	158	\N
39219	AMLP-215	2020-08-06 00:00:00-07	2.82	88	2.93	4	99	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 43ng captured	150	\N
39220	AMLP-216	2020-08-06 00:00:00-07	15.4	10	13.54	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured	151	\N
39221	AMLP-317	2021-05-20 00:00:00-07	2.6	95	3.98	4	247	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 44ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	143	\N
39222	AMLP-319	2021-05-20 00:00:00-07	6.25	53	3.09	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 31ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	149	\N
39223	AMLP-297	2021-04-07 00:00:00-07	7.51	10	4.22	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	181	\N
39224	AMLP-366	2021-09-18 00:00:00-07	2.76	88	1.51	4	141.7	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. SGPC-20: 12 Cycles post Hyb, 25ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	103	\N
39225	AMLP-369	2021-09-18 00:00:00-07	5.59	29	2.88	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. SGPC-20: 12 Cycles post Hyb, 50ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	106	\N
39226	SGLP-0806	2021-11-02 00:00:00-07	7.39	0	5.89	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	105	\N
39227	SGLP-0807	2021-11-02 00:00:00-07	6.28	4	4.62	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	106	\N
39228	SGLP-0808	2021-11-02 00:00:00-07	7.63	2	5.91	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	108	\N
39229	SGLP-0809	2021-11-02 00:00:00-07	6.7	5	4.86	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	109	\N
39230	SGLP-0811	2021-11-02 00:00:00-07	6.37	11	5.24	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	111	\N
39231	SGLP-0810	2021-11-02 00:00:00-07	5.69	17	3.73	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	110	\N
39232	SGLP-0813	2021-11-02 00:00:00-07	7.55	4	5.78	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	113	\N
39233	SGLP-0812	2021-11-02 00:00:00-07	6.05	3	4.98	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	112	\N
39234	SGLP-0814	2021-11-02 00:00:00-07	8.76	8	8.72	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	114	\N
39235	SGLP-0815	2021-11-02 00:00:00-07	6.93	0	4.55	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	115	\N
39236	SGLP-0816	2021-11-02 00:00:00-07	7.61	0	6.06	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	116	\N
39237	SGLP-0817	2021-11-02 00:00:00-07	6.5	0	4.55	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	117	\N
39238	SGLP-0818	2021-11-02 00:00:00-07	6.26	0	3.44	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	118	\N
39239	SGLP-0819	2021-11-02 00:00:00-07	8.89	10	5.42	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	119	\N
39240	SGLP-0820	2021-11-02 00:00:00-07	6.31	0	4.72	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	120	\N
39241	SGLP-0821	2021-11-02 00:00:00-07	6.23	0	5.8	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	121	\N
39242	SGLP-0822	2021-11-02 00:00:00-07	6.8	0	11.23	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	122	\N
39243	SGLP-0823	2021-11-02 00:00:00-07	7.5	3	6.54	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	123	\N
39244	SGLP-0824	2021-11-02 00:00:00-07	7.41	0	7.93	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	124	\N
39245	SGLP-0826	2021-11-02 00:00:00-07	8.44	0	10.01	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	126	\N
39246	SGLP-0825	2021-11-02 00:00:00-07	10.9	2	10.67	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	125	\N
39247	SGLP-0828	2022-02-08 00:00:00-08	0.9	NaN	0.12	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	174	\N
39248	SGLP-0827	2022-02-08 00:00:00-08	1.14	NaN	0.38	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	173	\N
39249	SGLP-0829	2022-02-08 00:00:00-08	3.7	NaN	0.59	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	175	\N
39250	SGLP-0831	2022-02-08 00:00:00-08	4.19	NaN	0.55	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	177	\N
39251	SGLP-0830	2022-02-08 00:00:00-08	3.61	NaN	0.44	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	176	\N
39252	SGLP-0832	2022-02-08 00:00:00-08	4.67	NaN	0.86	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	178	\N
39253	SGLP-0833	2022-02-08 00:00:00-08	4.22	NaN	0.65	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	179	\N
39254	SGLP-0834	2022-02-08 00:00:00-08	2.41	NaN	0.54	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	180	\N
39255	SGLP-0835	2022-02-24 00:00:00-08	6.44	NaN	4.15	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	127	\N
39256	SGLP-0837	2022-02-24 00:00:00-08	5.75	NaN	5.43	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	129	\N
39257	SGLP-0836	2022-02-24 00:00:00-08	5.21	NaN	3	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	128	\N
39258	SGLP-0838	2022-02-24 00:00:00-08	13.4	NaN	9.52	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	130	\N
39259	SGLP-0839	2022-02-24 00:00:00-08	1.18	NaN	0.85	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	131	\N
39260	SGLP-0840	2022-02-24 00:00:00-08	6.58	NaN	5.13	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	132	\N
39261	SGLP-0842	2022-02-24 00:00:00-08	3.25	NaN	2.38	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	134	\N
39262	SGLP-0841	2022-02-24 00:00:00-08	4.98	NaN	4.11	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	133	\N
39263	SGLP-0843	2022-02-24 00:00:00-08	5.86	NaN	3.41	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	135	\N
39264	SGLP-0845	2022-02-24 00:00:00-08	2.2	NaN	0.74	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	137	\N
39265	SGLP-0844	2022-02-24 00:00:00-08	5.39	0	2.63	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	136	\N
39266	SGLP-0846	2022-02-24 00:00:00-08	3.95	NaN	1.68	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	138	\N
39267	SGLP-0847	2022-02-24 00:00:00-08	1.91	NaN	0.65	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	139	\N
39268	SGLP-0848	2022-02-24 00:00:00-08	0.91	NaN	0.35	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	140	\N
39269	SGLP-0849	2022-02-24 00:00:00-08	2.32	NaN	0.75	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	141	\N
39270	SGLP-0850	2022-03-07 00:00:00-08	5.73	NaN	4.11	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	142	\N
39271	SGLP-0853	2022-03-07 00:00:00-08	2.95	NaN	2.64	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	145	\N
39272	SGLP-0856	2022-03-07 00:00:00-08	5.37	NaN	6.35	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	148	\N
39273	SGLP-0861	2022-03-07 00:00:00-08	8.47	NaN	9.32	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	153	\N
39274	SGLP-0854	2022-03-07 00:00:00-08	7.99	NaN	7.68	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	146	\N
39275	SGLP-0860	2022-03-07 00:00:00-08	7.72	NaN	7.66	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	152	\N
39276	SGLP-0858	2022-03-07 00:00:00-08	6.18	NaN	7.51	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	150	\N
39277	SGLP-0855	2022-03-07 00:00:00-08	2.38	NaN	2.87	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	147	\N
39278	SGLP-0859	2022-03-07 00:00:00-08	8.21	NaN	8.9	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	151	\N
39279	SGLP-0863	2022-03-07 00:00:00-08	6.86	NaN	7.24	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	155	\N
39280	SGLP-0852	2022-03-07 00:00:00-08	9.55	NaN	11.47	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	144	\N
39281	SGLP-0851	2022-03-07 00:00:00-08	6.64	NaN	6.78	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	143	\N
39282	SGLP-0862	2022-03-07 00:00:00-08	6.6	NaN	7.89	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	154	\N
39283	SGLP-0857	2022-03-07 00:00:00-08	6.16	NaN	7.71	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	149	\N
39284	SGLP-0864	2022-03-07 00:00:00-08	6.7	NaN	7.86	4	NaN	\N	\N	\N	HyperPREP; Ligation: 30min, 20oC.	156	\N
39285	OMLP-022	2022-01-28 00:00:00-08	5.65	NaN	4.96	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	159	\N
39286	OMLP-023	2022-01-28 00:00:00-08	4.35	NaN	3.61	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	160	\N
39287	OMLP-026	2022-01-28 00:00:00-08	5.8	NaN	4.8	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	163	\N
39288	OMLP-031	2022-01-28 00:00:00-08	7.63	NaN	5.74	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	168	\N
39289	OMLP-029	2022-01-28 00:00:00-08	8.08	NaN	5.1	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	166	\N
39290	OMLP-024	2022-01-28 00:00:00-08	1.4	NaN	3.46	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	161	\N
39291	OMLP-027	2022-01-28 00:00:00-08	6.74	9	5.71	4	250	\N	\N	\N	Ligation: 30min, 20oC.	164	\N
39292	OMLP-033	2022-01-28 00:00:00-08	8.95	NaN	6.17	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	170	\N
39293	OMLP-035	2022-01-28 00:00:00-08	5.44	NaN	4.41	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	172	\N
39294	OMLP-030	2022-01-28 00:00:00-08	10.5	NaN	8.41	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	167	\N
39609	12-13587_B2_0_5ug	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	30	\N
39295	OMLP-034	2022-01-28 00:00:00-08	14.8	NaN	10	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	171	\N
39296	OMLP-028	2022-01-28 00:00:00-08	5.8	NaN	3.52	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	165	\N
39297	OMLP-032	2022-01-28 00:00:00-08	2.84	NaN	1.37	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	169	\N
39298	OMLP-025	2022-01-28 00:00:00-08	7.69	NaN	6.93	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	162	\N
39299	OMLP-036	2022-02-21 00:00:00-08	4.34	0	2.14	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	182	\N
39300	OMLP-037	2022-02-21 00:00:00-08	4.73	0	2.17	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	183	\N
39301	OMLP-038	2022-02-21 00:00:00-08	3.14	0	0.98	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	184	\N
39302	OMLP-039	2022-02-21 00:00:00-08	6.88	0	3.65	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	185	\N
39303	OMLP-040	2022-02-21 00:00:00-08	4.48	0	1.77	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	186	\N
39304	OMLP-041	2022-02-21 00:00:00-08	3.72	0	1.45	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	187	\N
39305	OMLP-042	2022-02-21 00:00:00-08	1.68	0	0.79	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	188	\N
39306	OMLP-043	2022-02-21 00:00:00-08	1.14	0	0.44	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	189	\N
39307	OMLP-045	2022-02-21 00:00:00-08	2.89	0	1.16	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	191	\N
39308	OMLP-044	2022-02-21 00:00:00-08	5.42	0	3.2	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	190	\N
39309	OMLP-046	2022-02-21 00:00:00-08	2.65	0	0.88	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	192	\N
39310	OMLP-047	2022-02-21 00:00:00-08	6.99	0	4.26	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	104	\N
39311	OMLP-048	2022-02-21 00:00:00-08	5.28	0	3.03	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	105	\N
39312	OMLP-049	2022-02-21 00:00:00-08	4.35	0	2.98	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	111	\N
39313	OMLP-050	2022-03-07 00:00:00-08	0.22	0	0.12	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	88	\N
39314	OMLP-052	2022-03-07 00:00:00-08	2.38	0	1.41	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	90	\N
39315	OMLP-053	2022-03-07 00:00:00-08	2.14	0	1.31	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	91	\N
39316	OMLP-054	2022-03-07 00:00:00-08	1.49	0	0.86	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	93	\N
39317	OMLP-051	2022-03-07 00:00:00-08	2.73	NaN	1.65	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	89	\N
39318	OMLP-055	2022-03-24 00:00:00-07	1.82	0	0.52	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	1	\N
39319	OMLP-056	2022-03-24 00:00:00-07	3.22	0	1.66	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	38	\N
39320	OMLP-057	2022-03-24 00:00:00-07	1.93	0	1.18	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	84	\N
39321	OMLP-058	2022-03-24 00:00:00-07	1.88	0	1.01	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	87	\N
39322	OMLP-059	2022-03-24 00:00:00-07	5.12	0	3.4	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	94	\N
39323	OMLP-060	2022-03-24 00:00:00-07	2.2	0	0.97	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	95	\N
39324	OMLP-062	2022-03-24 00:00:00-07	4.34	0	2.85	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	100	\N
39325	OMLP-061	2022-03-24 00:00:00-07	1	0	0.47	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	96	\N
39326	OMLP-063	2022-03-24 00:00:00-07	3	0	2.95	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	101	\N
39327	OMLP-064	2022-03-24 00:00:00-07	1.73	0	1.19	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	102	\N
39328	OMLP-065	2022-03-24 00:00:00-07	2.03	0	1.12	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	103	\N
39329	OMLP-066	2022-03-24 00:00:00-07	4.84	0	3.29	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	106	\N
39330	OMLP-068	2022-03-24 00:00:00-07	1.17	0	0.65	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	113	\N
39331	OMLP-067	2022-03-24 00:00:00-07	2.38	0	1.67	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	112	\N
39332	OMLP-069	2022-03-24 00:00:00-07	3.64	0	3	4	NaN	\N	\N	\N	Ligation: 30min, 20oC. 3/31/22 CHANGED PAT ID TO OM-01	114	\N
39333	OMLP-071	2022-03-24 00:00:00-07	4.82	0	2.62	4	NaN	\N	\N	\N	Ligation: 30min, 20oC. 3/31/22 CHANGED PAT ID TO OM-01	119	\N
39334	OMLP-070	2022-03-24 00:00:00-07	3.31	0	1.78	4	NaN	\N	\N	\N	Ligation: 30min, 20oC. 3/31/22 CHANGED PAT ID TO OM-01	115	\N
39335	OMLP-072	2022-03-24 00:00:00-07	0.79	0	0.27	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	120	\N
39336	OMLP-073	2022-03-24 00:00:00-07	1.51	0	0.96	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	157	\N
39337	OMLP-074	2022-03-24 00:00:00-07	1.84	0	1.01	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	158	\N
39338	OMLP-075	2022-03-24 00:00:00-07	1.39	0	0.69	4	NaN	\N	\N	\N	Ligation: 30min, 20oC.	181	\N
39339	AMLP-271	2021-03-17 00:00:00-07	9.16	49	3.21	4	333	\N	\N	\N	SGPC-22: 12 Cycles post Hyb, 49ng captured	140	\N
39340	CCRLP-0002	2021-10-16 00:00:00-07	1.87	88	1.32	4	185	\N	\N	\N	HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC. 	108	\N
39341	CCRLP-0001	2021-10-16 00:00:00-07	1.23	NaN	0.41	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC. 	107	\N
39342	CCRLP-0003	2021-10-16 00:00:00-07	0.76	NaN	0.19	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC. 	116	\N
39343	CCRLP-0004	2021-10-16 00:00:00-07	0.97	88	0.31	4	65	\N	\N	\N	HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC. 	117	\N
39344	CCRLP-0038	2021-11-02 00:00:00-07	2.26	174	1.22	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	149	\N
39345	CCRLP-0024	2021-11-02 00:00:00-07	2.25	NaN	1.08	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	136	\N
39346	CCRLP-0035	2021-11-02 00:00:00-07	3.77	NaN	1.06	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	147	\N
39347	CCRLP-0019	2021-10-22 00:00:00-07	1.68	NaN	0.34	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	129	\N
39348	CCRLP-0011	2021-10-22 00:00:00-07	1.34	0	0.08	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	124	\N
39349	CCRLP-0025	2021-11-02 00:00:00-07	4.24	88	1.66	4	202	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	137	\N
39350	CCRLP-0012	2021-10-22 00:00:00-07	2.95	88	1.78	4	82	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	125	\N
39351	CCRLP-0037	2021-11-02 00:00:00-07	3.94	NaN	2.41	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	148	\N
39352	CCRLP-0008	2021-10-16 00:00:00-07	1.89	NaN	1.56	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC. 	121	\N
39353	CCRLP-0013	2021-10-22 00:00:00-07	2.39	88	0.74	4	234	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	126	\N
39354	CCRLP-0028	2021-11-02 00:00:00-07	3.82	NaN	1.22	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	140	\N
39355	CCRLP-0043	2021-11-02 00:00:00-07	2.22	88	0.92	4	79	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	152	\N
39356	CCRLP-0051	2021-11-02 00:00:00-07	5.26	NaN	1.29	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	97	\N
39357	CCRLP-0005	2021-10-16 00:00:00-07	2.15	NaN	1.04	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC. 	118	\N
39358	CCRLP-0034	2021-11-02 00:00:00-07	2.87	NaN	1.15	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	186	\N
39359	CCRLP-0015	2021-10-22 00:00:00-07	4.94	NaN	1.48	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	127	\N
39360	CCRLP-0007	2021-10-16 00:00:00-07	2.12	NaN	3.85	4	NaN	\N	\N	\N	HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC. 	120	\N
39361	CCRLP-0027	2021-11-02 00:00:00-07	2.33	88	1.36	4	68	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	139	\N
39362	CCRLP-0039	2021-11-02 00:00:00-07	6.48	32	4.25	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	150	\N
39363	CCRLP-0029	2021-11-02 00:00:00-07	4.28	88	1.96	4	178	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	141	\N
39364	CCRLP-0052	2021-11-02 00:00:00-07	4.04	25	1.38	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	98	\N
39365	CCRLP-0054	2021-11-02 00:00:00-07	3.14	10	0.68	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	102	\N
39366	CCRLP-0023	2021-11-02 00:00:00-07	3.19	176	2.19	4	232	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	134	\N
39367	CCRLP-0010	2021-10-22 00:00:00-07	4.98	68	1.99	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	123	\N
39368	CCRLP-0006	2021-10-16 00:00:00-07	5.3	68	3.77	4	250	\N	\N	\N	HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC. 	119	\N
39369	CCRLP-0020	2021-10-22 00:00:00-07	2.77	76	1.51	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	130	\N
39370	CCRLP-0059	2021-11-02 00:00:00-07	2.27	8	0.69	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	103	\N
39371	CCRLP-0022	2021-11-02 00:00:00-07	5.08	88	2.7	4	167	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	132	\N
39372	CCRLP-0053	2021-11-02 00:00:00-07	3.89	21	1.44	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	99	\N
39373	CCRLP-0021	2021-11-02 00:00:00-07	7.48	43	5.2	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	131	\N
39374	CCRLP-0041	2021-11-02 00:00:00-07	6.57	0	2.92	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	187	\N
39375	CCRLP-0031	2021-11-02 00:00:00-07	4.99	88	1.79	4	218	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	143	\N
39376	CCRLP-0009	2021-10-22 00:00:00-07	1.11	88	1.23	4	58	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	122	\N
39377	CCRLP-0026	2021-11-02 00:00:00-07	4	NaN	1.58	4	NaN	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	138	\N
39378	CCRLP-0044	2021-11-02 00:00:00-07	5.68	47	1.97	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	153	\N
39379	CCRLP-0060	2021-11-02 00:00:00-07	3.95	6	1.89	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	104	\N
39380	CCRLP-0030	2021-11-02 00:00:00-07	6.09	46	4.11	4	250	\N	\N	\N	HyperPREP; Ligation: 20min, 20oC.	142	\N
39381	CCRLP-0045	2021-08-06 00:00:00-07	2.87	14	1.78	4	250	\N	\N	\N	HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 66ng captured	192	\N
39382	CCRLP-0046	2021-08-06 00:00:00-07	3.16	17	1.85	4	250	\N	\N	\N	HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 67ng captured	157	\N
39383	CCRLP-0047	2021-08-06 00:00:00-07	1.81	10	1.02	4	250	\N	\N	\N	HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 36ng captured	158	\N
39384	CCRLP-0048	2021-08-06 00:00:00-07	1.54	14	0.79	4	250	\N	\N	\N	HyperPrep, Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 20ng captured	144	\N
39385	CCRLP-0049	2021-08-06 00:00:00-07	1.58	17	0.82	4	250	\N	\N	\N	HyperPrep, Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 21ng captured	146	\N
39386	CCRLP-0050	2021-08-06 00:00:00-07	1.04	10	0.39	4	250	\N	\N	\N	HyperPrep, Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 7ng captured	151	\N
39387	AMLP-183	2020-02-07 00:00:00-08	1.83	263	0.53	4	84	\N	\N	\N	NaN	105	\N
39388	AMLP-244	2021-03-17 00:00:00-07	5.5	96	0.41	4	208	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 20.5ng captured	108	\N
39389	AMLP-397	2022-04-27 00:00:00-07	3.73	54	2.9	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. 	106	\N
39390	AMLP-407	2022-04-27 00:00:00-07	8.81	30	8.93	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	126	\N
39391	AMLP-400	2022-04-27 00:00:00-07	19.6	6	7.44	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	114	\N
39392	AMLP-403	2022-04-27 00:00:00-07	6.56	18	5.95	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	122	\N
39393	AMLP-406	2022-04-27 00:00:00-07	8.58	9	7.32	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	125	\N
39394	AMLP-404	2022-04-27 00:00:00-07	8.81	31	6.34	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	123	\N
39395	AMLP-401	2022-04-27 00:00:00-07	6.49	9	2.9	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	120	\N
39396	AMLP-405	2022-04-27 00:00:00-07	3.16	0	3.93	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	124	\N
39397	AMLP-398	2022-04-27 00:00:00-07	5.72	3	4.06	4	250	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	112	\N
39398	AMLP-399	2022-04-27 00:00:00-07	10.9	8	5.93	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	113	\N
39399	AMLP-402	2022-04-27 00:00:00-07	7.88	33	6.6	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	121	\N
39400	AMLP-408	2022-04-27 00:00:00-07	9.75	0	10.55	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	127	\N
39401	AMLP-409	2022-05-20 00:00:00-07	13.4	29	10.92	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	129	\N
39610	12-13587 B2_0_25ug	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	31	\N
39402	AMLP-411	2022-05-20 00:00:00-07	5.48	72	2.64	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	136	\N
39403	AMLP-410	2022-05-20 00:00:00-07	0.43	90	0.21	4	14	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	134	\N
39404	AMLP-412	2022-05-20 00:00:00-07	4.31	88	2.34	4	191	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	137	\N
39405	AMLP-413	2022-05-20 00:00:00-07	6.16	33	4.56	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	138	\N
39406	AMLP-414	2022-05-20 00:00:00-07	3.7	88	1.7	4	201	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	139	\N
39407	AMLP-416	2022-05-20 00:00:00-07	2.77	NaN	2.91	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	151	\N
39408	AMLP-415	2022-05-20 00:00:00-07	5.73	88	3.2	4	286	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	146	\N
39409	AMLP-417	2022-05-20 00:00:00-07	4.12	88	3.2	4	197	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	154	\N
39410	AMLP-419	2022-05-20 00:00:00-07	6.08	88	5.49	4	210	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	156	\N
39411	AMLP-418	2022-05-20 00:00:00-07	6.1	69	4.92	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	155	\N
39412	AMLP-420	2022-05-20 00:00:00-07	5.15	58	3.67	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	157	\N
39413	AMLP-421	2022-05-20 00:00:00-07	2.4	88	1.27	4	152	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	158	\N
39414	AMLP-422	2022-05-31 00:00:00-07	6.67	5	4.77	4	250	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	167	\N
39415	AMLP-423	2022-05-31 00:00:00-07	6.77	25	4.74	4	999	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	181	\N
39416	AMLP-424	2022-05-31 00:00:00-07	7.84	23	3.02	4	999	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	189	\N
39417	AMLP-152	2020-01-31 00:00:00-08	13.6	0	3.47	4	NaN	\N	\N	\N	120s shear time; DNA repaired. SGPC-24: 12 Cycles post Hyb, 60ng captured	7	\N
39418	AMLP-239	2021-03-17 00:00:00-07	8.39	30	2.83	4	333	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 45ng captured	102	\N
39419	AMLP-207	2020-08-02 00:00:00-07	8.63	39	6.76	4	333	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 100 ng library. SGPC-24: 12 Cycles post Hyb, 50ng captured	142	\N
39420	AMLP-209	2020-08-02 00:00:00-07	7.1	10	5.9	4	333	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 100 ng library. SGPC-24: 12 Cycles post Hyb, 50ng captured	144	\N
39421	AMLP-311	2021-05-20 00:00:00-07	2.95	95	3.61	4	280	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 25ng captured	111	\N
39422	AMLP-313	2021-05-20 00:00:00-07	6.65	50	3.64	4	333	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 32ng captured	133	\N
39423	AMLP-205	2020-08-02 00:00:00-07	8.06	63	4.19	4	333	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 50ng captured	140	\N
39424	U5LP-01	2019-07-02 00:00:00-07	4.05	0	1.02	4	NaN	\N	\N	\N	NaN	1	\N
39425	U5LP-02	2019-07-02 00:00:00-07	5.61	0	2.7	4	NaN	\N	\N	\N	NaN	3	\N
39426	U5LP-13	2019-07-02 00:00:00-07	0.48	0	0.05	4	NaN	\N	\N	\N	NaN	49	\N
39427	U5LP-04	2019-07-11 00:00:00-07	1.03	0	1.21	4	NaN	\N	\N	\N	NaN	9	\N
39428	U5LP-06	2019-07-02 00:00:00-07	3.7	0	1.05	4	NaN	\N	\N	\N	NaN	12	\N
39429	U5LP-11	2019-07-02 00:00:00-07	3.01	0	1.27	4	NaN	\N	\N	\N	NaN	45	\N
39430	U5LP-03	2019-07-02 00:00:00-07	5.3	0	2.17	4	NaN	\N	\N	\N	NaN	8	\N
39431	U5LP-09	2019-07-02 00:00:00-07	5.54	0	1.66	4	NaN	\N	\N	\N	NaN	43	\N
39432	U5LP-12	2019-07-02 00:00:00-07	3.16	0	1.33	4	NaN	\N	\N	\N	NaN	46	\N
39433	U5LP-10	2019-07-02 00:00:00-07	2.91	0	1.66	4	NaN	\N	\N	\N	NaN	44	\N
39434	U5LP-08	2019-07-16 00:00:00-07	2.37	0	0.46	4	NaN	\N	\N	\N	NaN	42	\N
39435	U5LP-05	2019-07-11 00:00:00-07	3.17	0	0.6	4	NaN	\N	\N	\N	NaN	10	\N
39436	RNA-03	2018-08-20 00:00:00-07	21.6	NaN	16.4	11	NaN	\N	\N	\N	RLP-03	D9	\N
39437	RNA-04	2018-08-20 00:00:00-07	2.8	NaN	2.6	11	NaN	\N	\N	\N	RLP-04	D10	\N
39438	RNA-07	2018-08-20 00:00:00-07	4.8	NaN	2.1	11	NaN	\N	\N	\N	RLP-07	UN	\N
39439	RNA-12	2018-08-20 00:00:00-07	12.3	NaN	11.7	11	NaN	\N	\N	\N	RLP-12	H9	\N
39440	RNA-13	2018-08-20 00:00:00-07	18.2	NaN	17.9	11	NaN	\N	\N	\N	RLP-13	A3	\N
39441	RNA-05	2018-08-20 00:00:00-07	3.2	NaN	2.2	11	NaN	\N	\N	\N	RLP-05	D11	\N
39442	RNA-11	2018-08-20 00:00:00-07	13.3	NaN	11.5	11	NaN	\N	\N	\N	RLP-11	H8	\N
39443	RNA-14	2018-08-20 00:00:00-07	27	NaN	23.4	11	NaN	\N	\N	\N	RLP-14	A5	\N
39444	RNA-22	2018-08-20 00:00:00-07	19.7	NaN	24.2	11	NaN	\N	\N	\N	RLP-22, Sample removed from study	E9	\N
39445	RNA-01	2018-08-20 00:00:00-07	13.6	NaN	8.9	11	NaN	\N	\N	\N	RLP-01	B7	\N
39446	RNA-02	2018-08-20 00:00:00-07	13.1	NaN	7.8	11	NaN	\N	\N	\N	RLP-02	D8	\N
39447	RNA-21	2018-08-20 00:00:00-07	8.1	NaN	5.3	11	NaN	\N	\N	\N	RLP-21, Sample removed from study	UN	\N
39448	RNA-15	2018-08-20 00:00:00-07	10.2	NaN	7.3	11	NaN	\N	\N	\N	RLP-15	B4	\N
39449	RNA-06	2018-08-20 00:00:00-07	9.1	NaN	4.4	11	NaN	\N	\N	\N	RLP-06	D12	\N
39450	RNA-09	2018-08-20 00:00:00-07	12.1	NaN	7.4	11	NaN	\N	\N	\N	RLP-09	E10	\N
39451	RNA-16	2018-08-20 00:00:00-07	11	NaN	7.3	11	NaN	\N	\N	\N	RLP-16	B5	\N
39452	RNA-08	2018-08-20 00:00:00-07	6.5	NaN	4.2	11	NaN	\N	\N	\N	RLP-08	E9	\N
39453	RNA-18	2018-08-20 00:00:00-07	20.4	NaN	13	11	NaN	\N	\N	\N	RLP-18	D9	\N
39454	RNA-32	2018-09-27 00:00:00-07	4.8	NaN	10.7	11	NaN	\N	\N	\N	RLP-32	8	\N
39455	RNA-37	2018-09-27 00:00:00-07	7.4	NaN	19	11	NaN	\N	\N	\N	RLP-37	13	\N
39456	RNA-36	2018-09-27 00:00:00-07	9.1	NaN	18.5	11	NaN	\N	\N	\N	RLP-36	12	\N
39457	RNA-29	2018-09-27 00:00:00-07	17.8	NaN	37.8	11	NaN	\N	\N	\N	RLP-29	5	\N
39458	RNA-34	2018-09-27 00:00:00-07	7.4	NaN	11.8	11	NaN	\N	\N	\N	RLP-34	10	\N
39459	RNA-26	2018-09-27 00:00:00-07	6.6	NaN	11	11	NaN	\N	\N	\N	RLP-26	2	\N
39460	RNA-31	2018-09-27 00:00:00-07	14.3	NaN	31.3	11	NaN	\N	\N	\N	RLP-31	7	\N
39461	RNA-33	2018-09-27 00:00:00-07	5.7	NaN	9.7	11	NaN	\N	\N	\N	RLP-33	9	\N
39462	RNA-39	2018-09-27 00:00:00-07	8.5	NaN	17.6	11	NaN	\N	\N	\N	RLP-39, Sample removed from study	15	\N
39464	RNA-38	2018-09-27 00:00:00-07	9.8	NaN	18.3	11	NaN	\N	\N	\N	RLP-38, Sample removed from study	14	\N
39465	RNA-28	2018-09-27 00:00:00-07	17.3	NaN	33.8	11	NaN	\N	\N	\N	RLP-28	4	\N
39466	RNA-35	2018-09-27 00:00:00-07	4.8	NaN	8.8	11	NaN	\N	\N	\N	RLP-35	11	\N
39467	RNA-27	2018-09-27 00:00:00-07	10.2	NaN	19.1	11	NaN	\N	\N	\N	RLP-27	3	\N
39468	RNA-40	2018-09-27 00:00:00-07	9.1	NaN	16.9	11	NaN	\N	\N	\N	RLP-40, Sample removed from study	16	\N
39469	EXLP-01	2020-08-05 00:00:00-07	3.84	100	3.07	4	83	\N	\N	\N	Whole Genome Sequencing (WGS)	121	\N
39470	EXLP-04	2020-08-05 00:00:00-07	9.71	39	7.06	4	333	\N	\N	\N	Whole Genome Sequencing (WGS)	124	\N
39471	EXLP-05	2020-08-05 00:00:00-07	7.84	57	4.29	4	333	\N	\N	\N	Whole Genome Sequencing (WGS)	125	\N
39472	EXLP-09	2020-08-05 00:00:00-07	9.04	100	7.58	4	202	\N	\N	\N	Whole Genome Sequencing (WGS)	129	\N
39473	EXLP-10	2020-08-05 00:00:00-07	3.31	100	2.92	4	94	\N	\N	\N	Whole Genome Sequencing (WGS)	130	\N
39474	EXLP-11	2020-09-03 00:00:00-07	2.65	99	1.53	4	71	\N	\N	\N	Whole Genome Sequencing (WGS)	128	\N
39475	EXLP-23	2023-05-25 00:00:00-07	8.15	16	4.7	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	154	\N
39476	EXLP-25	2023-05-25 00:00:00-07	7.12	23	3.79	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	156	\N
39477	EXLP-20	2023-05-25 00:00:00-07	5.53	140	2	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	151	\N
39478	EXLP-22	2023-05-25 00:00:00-07	5.41	15	2.31	4	250	\N	\N	\N	1 hr adapter ligation at 20oC. Merged with EXLP-40 for sequencing (17.5 ng each)	153	\N
39479	EXLP-40	2023-06-13 00:00:00-07	4.28	15	1.45	4	250	\N	\N	\N	1 hr adapter ligation at 20oC. Merged with EXLP-22 for sequencing (17.5 ng each)	153	\N
39480	EXLP-24	2023-05-25 00:00:00-07	5.02	184	2.76	4	193	\N	\N	\N	1 hr adapter ligation at 20oC	155	\N
39481	EXLP-27	2023-05-25 00:00:00-07	8.22	36	6.85	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	158	\N
39482	EXLP-21	2023-05-25 00:00:00-07	3.69	199	1.52	4	143	\N	\N	\N	1 hr adapter ligation at 20oC	152	\N
39483	EXLP-26	2023-05-25 00:00:00-07	4.76	73	1.59	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	157	\N
39484	EXLP-30	2023-05-25 00:00:00-07	4.73	76	1.17	4	250	\N	\N	\N	1 hr adapter ligation at 20oC	161	\N
39485	EXLP-43	2023-06-13 00:00:00-07	3.51	76	1.03	4	250	\N	\N	\N	1 hr adapter ligation at 20oC. Sequenced as EXLP-30	161	\N
39486	XuRLP-001	2019-01-07 00:00:00-08	89.03	NaN	46.2	NaN	NaN	\N	\N	\N	NaN	18	\N
39487	XuRLP-002	2019-01-07 00:00:00-08	82.66	NaN	42.7	NaN	NaN	\N	\N	\N	NaN	19	\N
39488	XuRLP-004	2019-01-07 00:00:00-08	105.74	NaN	40	NaN	NaN	\N	\N	\N	NaN	21	\N
39489	XuRLP-003	2019-01-07 00:00:00-08	90.55	NaN	40.5	NaN	NaN	\N	\N	\N	NaN	20	\N
39490	XuRLP-005	2019-01-07 00:00:00-08	106.46	NaN	43.8	NaN	NaN	\N	\N	\N	NaN	22	\N
39491	XuRLP-007	2019-01-07 00:00:00-08	99.85	NaN	43.8	NaN	NaN	\N	\N	\N	NaN	24	\N
39492	XuRLP-006	2019-01-07 00:00:00-08	114.27	NaN	44	NaN	NaN	\N	\N	\N	NaN	23	\N
39493	XuRLP-008	2019-01-07 00:00:00-08	71.75	NaN	31.2	NaN	NaN	\N	\N	\N	NaN	25	\N
39494	XuRLP-011	2019-01-07 00:00:00-08	91.47	NaN	46.9	NaN	NaN	\N	\N	\N	NaN	28	\N
39495	XuRLP-012	2019-01-07 00:00:00-08	96.54	NaN	43.9	NaN	NaN	\N	\N	\N	NaN	29	\N
39496	XuRLP-010	2019-01-07 00:00:00-08	98.51	NaN	48.9	NaN	NaN	\N	\N	\N	NaN	27	\N
39497	XuRLP-009	2019-01-07 00:00:00-08	107.18	NaN	45.5	NaN	NaN	\N	\N	\N	NaN	26	\N
39498	XuRLP-014	2019-01-07 00:00:00-08	74.71	NaN	32.9	NaN	NaN	\N	\N	\N	NaN	31	\N
39499	XuRLP-013	2019-01-07 00:00:00-08	111.98	NaN	44.4	NaN	NaN	\N	\N	\N	NaN	30	\N
39500	XuRLP-015	2019-01-10 00:00:00-08	106.46	NaN	42.8	NaN	NaN	\N	\N	\N	NaN	43	\N
39501	XuRLP-016	2019-01-10 00:00:00-08	118.99	NaN	42.3	NaN	NaN	\N	\N	\N	NaN	44	\N
39502	XuRLP-017	2019-01-10 00:00:00-08	92.08	NaN	37	NaN	NaN	\N	\N	\N	NaN	45	\N
39503	XuRLP-019	2019-01-10 00:00:00-08	118.59	NaN	43.9	NaN	NaN	\N	\N	\N	NaN	47	\N
39504	XuRLP-018	2019-01-10 00:00:00-08	111.23	NaN	40.7	NaN	NaN	\N	\N	\N	NaN	46	\N
39505	XuRLP-020	2019-01-10 00:00:00-08	124.74	NaN	43.2	NaN	NaN	\N	\N	\N	NaN	48	\N
39506	XuRLP-024	2019-01-10 00:00:00-08	103.97	NaN	43.4	NaN	NaN	\N	\N	\N	NaN	52	\N
39507	XuRLP-021	2019-01-10 00:00:00-08	117	NaN	42.6	NaN	NaN	\N	\N	\N	NaN	49	\N
39508	XuRLP-023	2019-01-10 00:00:00-08	104.68	NaN	40.3	NaN	NaN	\N	\N	\N	NaN	51	\N
39509	XuRLP-022	2019-01-10 00:00:00-08	109.74	NaN	43.7	NaN	NaN	\N	\N	\N	NaN	50	\N
39510	XuRLP-028	2019-01-10 00:00:00-08	110.85	NaN	43.6	NaN	NaN	\N	\N	\N	NaN	56	\N
39511	XuRLP-025	2019-01-10 00:00:00-08	105.38	NaN	47.6	NaN	NaN	\N	\N	\N	NaN	53	\N
39512	XuRLP-027	2019-01-10 00:00:00-08	113.5	NaN	44.5	NaN	NaN	\N	\N	\N	NaN	55	\N
39513	XuRLP-026	2019-01-10 00:00:00-08	117.79	NaN	47.2	NaN	NaN	\N	\N	\N	NaN	54	\N
39514	XuRLP-029	2019-01-10 00:00:00-08	121.83	NaN	46.1	NaN	NaN	\N	\N	\N	NaN	57	\N
39515	XuRLP-032	2019-01-10 00:00:00-08	123.9	NaN	43.6	NaN	NaN	\N	\N	\N	NaN	60	\N
39516	XuRLP-031	2019-01-10 00:00:00-08	113.12	NaN	45.2	NaN	NaN	\N	\N	\N	NaN	59	\N
39517	XuRLP-030	2019-01-10 00:00:00-08	107.54	NaN	46.2	NaN	NaN	\N	\N	\N	NaN	58	\N
39518	XuRLP-036	2019-01-10 00:00:00-08	118.99	NaN	43.6	NaN	NaN	\N	\N	\N	NaN	64	\N
39519	XuRLP-035	2019-01-10 00:00:00-08	105.03	NaN	45	NaN	NaN	\N	\N	\N	NaN	63	\N
39520	XuRLP-034	2019-01-10 00:00:00-08	108.27	NaN	42.3	NaN	NaN	\N	\N	\N	NaN	62	\N
39521	XuRLP-033	2019-01-10 00:00:00-08	106.82	NaN	41.9	NaN	NaN	\N	\N	\N	NaN	61	\N
39522	XuRLP-040	2019-01-10 00:00:00-08	123.07	NaN	40.4	NaN	NaN	\N	\N	\N	NaN	94	\N
39523	XuRLP-039	2019-01-10 00:00:00-08	126.01	NaN	47.4	NaN	NaN	\N	\N	\N	NaN	93	\N
39524	XuRLP-037	2019-01-10 00:00:00-08	109.37	NaN	44.3	NaN	NaN	\N	\N	\N	NaN	91	\N
39525	XuRLP-038	2019-01-10 00:00:00-08	111.98	NaN	46.5	NaN	NaN	\N	\N	\N	NaN	92	\N
39526	XuRLP-041	2019-01-24 00:00:00-08	86.37	NaN	48.3	NaN	NaN	\N	\N	\N	NaN	95	\N
39527	XuRLP-043	2019-01-24 00:00:00-08	63.97	NaN	43.4	NaN	NaN	\N	\N	\N	NaN	1	\N
39528	XuRLP-042	2019-01-24 00:00:00-08	75.72	NaN	45.7	NaN	NaN	\N	\N	\N	NaN	96	\N
39529	XuRLP-044	2019-01-24 00:00:00-08	78.32	NaN	46.3	NaN	NaN	\N	\N	\N	NaN	2	\N
39530	XuRLP-047	2019-01-24 00:00:00-08	65.72	NaN	45.8	NaN	NaN	\N	\N	\N	NaN	5	\N
39531	XuRLP-048	2019-01-24 00:00:00-08	77.53	NaN	43.5	NaN	NaN	\N	\N	\N	NaN	6	\N
39532	XuRLP-046	2019-01-24 00:00:00-08	73.96	NaN	44.4	NaN	NaN	\N	\N	\N	NaN	4	\N
39533	XuRLP-045	2019-01-24 00:00:00-08	72.48	NaN	42.1	NaN	NaN	\N	\N	\N	NaN	3	\N
39534	XuRLP-052	2019-01-24 00:00:00-08	62.48	NaN	40.8	NaN	NaN	\N	\N	\N	NaN	10	\N
39535	XuRLP-051	2019-01-24 00:00:00-08	59	NaN	37.6	NaN	NaN	\N	\N	\N	NaN	9	\N
39536	XuRLP-050	2019-01-24 00:00:00-08	46.12	NaN	32.7	NaN	NaN	\N	\N	\N	NaN	8	\N
39537	XuRLP-049	2019-01-24 00:00:00-08	59.2	NaN	45	NaN	NaN	\N	\N	\N	NaN	7	\N
39538	XuRLP-053	2019-01-24 00:00:00-08	66.39	NaN	44.8	NaN	NaN	\N	\N	\N	NaN	11	\N
39539	XuRLP-055	2019-01-24 00:00:00-08	78.59	NaN	47.4	NaN	NaN	\N	\N	\N	NaN	13	\N
39540	XuRLP-056	2019-01-24 00:00:00-08	64.19	NaN	37.2	NaN	NaN	\N	\N	\N	NaN	14	\N
39541	XuRLP-054	2019-01-24 00:00:00-08	76.24	NaN	44.5	NaN	NaN	\N	\N	\N	NaN	12	\N
39542	XuRLP-058	2019-01-24 00:00:00-08	32.26	NaN	24.5	NaN	NaN	\N	\N	\N	NaN	16	\N
39543	XuRLP-059	2019-01-24 00:00:00-08	30.26	NaN	22.5	NaN	NaN	\N	\N	\N	NaN	17	\N
39544	XuRLP-057	2019-01-24 00:00:00-08	41.55	NaN	25.5	NaN	NaN	\N	\N	\N	NaN	15	\N
39545	XuRLP-060	2019-01-24 00:00:00-08	38.7	NaN	19.3	NaN	NaN	\N	\N	\N	NaN	81	\N
39546	XuRLP-062	2019-01-24 00:00:00-08	69.37	NaN	38.8	NaN	NaN	\N	\N	\N	NaN	88	\N
39547	XuRLP-064	2019-01-24 00:00:00-08	44	NaN	33.5	NaN	NaN	\N	\N	\N	NaN	90	\N
39548	XuRLP-063	2019-01-24 00:00:00-08	63.76	NaN	41.5	NaN	NaN	\N	\N	\N	NaN	89	\N
39549	XuRLP-061	2019-01-24 00:00:00-08	62.27	NaN	42.8	NaN	NaN	\N	\N	\N	NaN	82	\N
39550	JJS10_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39551	JJS10_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39552	JJS12_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39553	JJS12_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39554	JJS13_Mel	\N	7.89	NaN	8.6	NaN	NaN	\N	\N	\N	NaN	H6	\N
39555	JJS13_Nev	\N	11.8	NaN	13.74	NaN	NaN	\N	\N	\N	NaN	H4	\N
39556	JJS14_Mel	\N	27.4	NaN	33.52	NaN	NaN	\N	\N	\N	NaN	H8	\N
39557	JJS14_Nev	\N	26	NaN	32.21	NaN	NaN	\N	\N	\N	NaN	H7	\N
39558	JJS16_Mel	\N	5.32	NaN	7.84	NaN	NaN	\N	\N	\N	NaN	H10	\N
39559	JJS16_Nev	\N	6.59	NaN	9.38	NaN	NaN	\N	\N	\N	NaN	H9	\N
39560	JJS17_Mel	\N	9.34	NaN	14.29	NaN	NaN	\N	\N	\N	NaN	H12	\N
39561	JJS17_Nev	\N	5.91	NaN	8.32	NaN	NaN	\N	\N	\N	NaN	H11	\N
39562	JJS18_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39563	JJS18_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39564	JJS19_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39565	JJS19_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39566	JJS1_Nev	\N	7.33	NaN	8.27	NaN	NaN	\N	\N	\N	NaN	H1	\N
39567	JJS20_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39568	JJS20_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39569	JJS21_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39570	JJS21_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39571	JJS22_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39572	JJS22_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39573	JJS23_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39574	JJS23_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39575	JJS25_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39576	JJS25_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39577	JJS26_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39578	JJS26_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39579	JJS27_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39580	JJS27_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39581	JJS28_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39582	JJS28_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39583	JJS3_Mel1	\N	8.09	NaN	9.79	NaN	NaN	\N	\N	\N	NaN	H3	\N
39584	JJS3_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39585	JJS5_Mel	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39586	JJS5_Nev	\N	NaN	NaN	NaN	NaN	NaN	\N	\N	\N	NaN	NaN	\N
39587	12-6261A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Cheek	1	\N
39588	12-6261B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Neck	2	\N
39589	12-12366	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	3	\N
39590	12-12467	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	4	\N
39591	12-12470D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	8	\N
39592	12-562	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	10	\N
39593	12-12647	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	12	\N
39594	12-12626	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Right Arm	13	\N
39595	12-13587 B2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	14	\N
39596	12-18438A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	15	\N
39597	12-13152 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	17	\N
39598	12-12750B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Forehead	18	\N
39599	12-19596	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	19	\N
39600	12-19187A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Shin	20	\N
39601	12-22172 Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	22	\N
39602	12-22172 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	23	\N
39603	12-21726A Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	24	\N
39604	12-22901A Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	25	\N
39605	12-22901A Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	26	\N
39606	12-22776 B5 Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	27	\N
39607	Buffy Coat	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	28	\N
39608	12-13587 B2_0_75ug	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	29	\N
39611	Buffy Coa	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Collaborated with Robert Nussbaum to get this blood	28	\N
39612	12-22775	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	32	\N
39613	12-22794A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	33	\N
39614	12-22573	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	34	\N
39615	12-22582A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	36	\N
39616	12-22587	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	40	\N
39617	12-22592	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Scalp	41	\N
39618	12-22597	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	43	\N
39619	12-22602A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	44	\N
39620	12-22602B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	45	\N
39621	12-22603	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Forehead	46	\N
39622	12-22604	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	47	\N
39623	12-22720A1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Upper back	49	\N
39624	12-22868	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	50	\N
39625	12-22884C	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	51	\N
39626	12-22884D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	52	\N
39627	12-22886	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	53	\N
39628	12-22894B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	55	\N
39629	12-22898	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	56	\N
39630	12-22900	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Eybrow	57	\N
39631	12-22597_700ng	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	58	\N
39632	12-22597_500ng	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	59	\N
39633	12-22597_250ng	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	60	\N
39634	12-22597_100ng	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	61	\N
39635	Kit_227_Acral_WT	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Acral_WT	L2DR09	\N
39636	21-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
39637	24-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
39638	24-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
39639	24-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39640	24-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
39641	28-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
39642	28-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
39643	28-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
39644	28-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
39645	28-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
39646	N3_9	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39647	MB_1046_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39648	BB008_CGH11-153	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-153 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	L2DR09	\N
39649	BB09_HW6_TD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39650	CGH11_035	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-035 Iwei Translocation Case	L2DR09	\N
39651	MB1424 _Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39652	HW_A9_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39653	DM12_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39654	D12_54296_Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39655	DM29_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	L2DR09	\N
39656	DM_95_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Dermoplastic Melanoma	L2DR09	\N
39657	CNS_36_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_9	L2DR09	\N
39658	KR_5233	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood	L2DR09	\N
39659	DM_23_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39660	SM_11_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39661	CGH11-011	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-011 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR09	\N
39662	CGH11-035	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-035 MET	L2DR09	\N
39663	SM_9_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39664	DPN_3_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39665	WM3928 F	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 14	\N
39666	C037	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 15	\N
39667	C022	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 16	\N
39668	L20-Mel	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 17	\N
39669	L20-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 18	\N
39670	L20-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 19	\N
39671	L15-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 20	\N
39672	L23C-Dysplastic	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 21	\N
39673	UM15	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39674	UM19	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
39675	UM20	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
39676	CP-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 1	\N
39677	CP-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 2	\N
39678	CP-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 3	\N
39679	CP-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 4	\N
39680	CP-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 5	\N
39681	CP-6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 6	\N
39682	14-18	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 7	\N
39683	14-19	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 8	\N
39684	14-21	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 9	\N
39685	CNS_43_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39686	Ivanka_16_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39687	DM16_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39688	DM_13_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39689	DM_36_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39690	Ivanka_23_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39691	CGH11-232	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-232 	L2DR09	\N
39692	KIT_244	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR09	\N
39693	DPN_9_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39694	DM_101_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39695	BS1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-051 	 NextFlex 1	\N
39696	BS2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 2	\N
39697	BS3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
39716	DPN_CNN 23	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
39717	DPN_CNN 25	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
39718	DPN_CNN 26	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
39719	DPN_CNN 27	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
39720	DPN 34 pool	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
39721	DPN 34 Conv pool	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
39722	DPN 36 pool	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
39723	DPN 37 pool	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
39724	DPN Conv 37	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39725	DPN 38	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
39726	DPN Conv 38	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
39727	DM11_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
39728	DM14_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
39729	MIN_1_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
39730	MIN_3_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
39731	MIN_6_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
39732	Acral_11_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Tumor	L2DR01	\N
39733	Acral_11_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Cntl	L2DR02	\N
39734	Acral_12_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Tumor	L2DR03	\N
39735	Acral_12_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Cntl	L2DR04	\N
39736	Mucosal_02-2599_Primary A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
39737	Mucosal_02-2599_Primary B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
39738	Mucosal_02-2599_Control	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
39739	Mucosal_02-2599_Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
39740	DM_48_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39741	DM_59_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
39742	DM_68_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
39743	DM_95_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
39744	Ivanka_22_Nevus_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
39745	Ivanka_22_IS_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
39746	Ivanka_22_Normal_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
39747	Ivanka_22_Mel_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
39748	CNS20-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
39749	CNS21-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
39750	CNS22-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
39751	CNS23-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
39752	CNS24-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
39753	CNS51-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
39754	CNS52-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
39755	CNS53-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
39756	CNS54-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39757	CNS57-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
39758	CNS57-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
39759	BN-N1-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	L2DR12	\N
39760	BN-N2-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	L2DR13	\N
39761	BN-M1-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	L2DR14	\N
39762	Ivanka-5-4-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Ivanka Patient Melanoma  	L2DR15	\N
39763	Ivanka-9-1-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Ivanka Patient Melanoma  	L2DR16	\N
39764	AM_1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
39765	AM_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
39766	AM_3_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
39767	AM_4_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
39768	AM_5_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
39769	AM_6_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
39770	AM_8_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
39771	AM_10_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
39772	AM_12_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
39773	UM4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
39774	UM5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
39775	Ivanka_13_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 1	\N
39776	Ivanka_13_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 2	\N
39777	Ivanka_13_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
39778	Ivanka_13_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
39779	Ivanka_25_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
39780	Ivanka_25_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
39781	Ivanka_25_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
39782	Ivanka_25_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
39783	Ivanka_25_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39784	CGH13_324	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-324 	 NextFlex 10	\N
39785	CGH13_331	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-331 ETV6 Fusion	 NextFlex 11	\N
39786	Spitz_M1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 2	\N
39787	Spitz_M2 (?)	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
39788	Spitz_N1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
39789	Spitz_N2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
39790	Spitz_N3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
39791	BN_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
39792	CGH13-016	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-016 	 NextFlex 8	\N
39793	CGH12_163	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-163 	 NextFlex 9	\N
39794	CGH13_166	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-166 	 NextFlex 10	\N
39795	GAK_DNA	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 11	\N
39796	Yurif_DNA	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 12	\N
39797	Acral 11 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Tumor	L2DR01	\N
39798	Acral 11 Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Cntl	L2DR02	\N
39799	DPN 34	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
39800	DPN Conv 34	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
39801	DPN 37	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
39802	DM45 2 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
39803	DM58 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
39804	DM1_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Amplicon Sequencing	L2DR12	\N
39805	DM2_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Amplicon Sequencing	L2DR13	\N
39806	CGH10-013	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-013 13 Cycle Post Hybridization LM-PCR	N5_8 (BB008)	\N
39807	CGH11-153	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-153 13 Cycle Post Hybridization LM-PCR	N5_9 (BB008)	\N
39808	CGH11-036	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-036 13 Cycle Post Hybridization LM-PCR	N5_10 (BB008)	\N
39809	CGH11-386	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-386 13 Cycle Post Hybridization LM-PCR	N5_11 (BB008)	\N
39810	MIN_7_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
39811	MIN_7_Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
39812	MIN_7_Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
39813	MIN_8_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
39814	MIN_8_Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
39815	MIN_8_Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
39816	501_Mel	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39817	Sk_Mel_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
39818	DPN_CNN 24	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
39819	DPN_CNN 28	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
39820	DPN_CNN 29	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
39821	DPN_CNN 31	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
39822	DPN_CNN 33	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
39823	DPN 40 A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
39824	DPN 40 B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
39825	DPN 41	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
39826	DPN42	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
39827	DPN44	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
39828	DPN 45	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
39829	DPN 46	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39830	UM_6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
39831	Birt_Hogg_Dube	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
39832	CGH13-027	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-027 NTRK3	 NextFlex 1	\N
39833	CGH13-268	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-268 MET	 NextFlex 2	\N
39834	CGH13-365	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-365 DPN-like Melanoma	 NextFlex 3	\N
39835	CGH11-018	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-018 	 NextFlex 4	\N
39836	CGH11-027	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-027 	 NextFlex 5	\N
39837	Ivanka_23_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
39838	Ivanka_23_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
39839	Ivanka_2-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NexFlex 8	\N
39840	Ivanka_2-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39841	Ivanka_2-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
39842	Ivanka_2-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
39843	Ivanka_3-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
39844	Ivanka_3-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
39845	Ivanka_3-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
39846	Ivanka_3-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
39847	Ivanka_3-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
39848	PMM_1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
39849	PMM_1_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
39850	PMM_3_A_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
39851	PMM_3_A_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
39852	PMM_3_B_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
39853	PMM_3_B_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39854	Ivanka_11-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
39855	Ivanka_11-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
39856	Ivanka_11-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
39857	Ivanka_11-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
39858	PMM_5_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
39859	PMM_6_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39860	PMM_6_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
39861	PMM_7_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
39862	PMM_8_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
39863	PMM_8_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
39864	PMM_10_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
39865	PMM_10_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
39866	PMM_12_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
39867	PMM_12_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
39868	PMM_13_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
39869	PMM_14_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
39870	PMM_14_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
39871	PMM_15_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
39872	PMM_17_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39873	PMM_18_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
39874	PMM_18_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
39875	PMM_19_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 1	\N
39876	PMM_20_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 2	\N
39877	PMM_20_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
39878	PMM_22_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
39879	PMM_23_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
39880	PMM_23_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
39881	UM7	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
39882	UM8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
39883	UM9	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
39884	UM10	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
39885	UM11	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
39886	Xanthoma_Disseminatum	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
39887	CGH13-392	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-392 	 NextFlex 10	\N
39888	CGH13-399	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-399 	NextFlex 11	\N
39889	CGH13-394	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-394 	NextFlex 12	\N
39890	DM_27_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
39891	DM_32_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
39892	DM_35_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
39893	DM_40_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39894	Dummer-KF1-Primary	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
39895	Dummer-KF1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
39896	Dummer-KF1-Met1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
39897	Dummer-KF1-Met2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
39898	Dummer-KF2-Primary	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
39899	Dummer-KF2-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
39900	Dummer-KF2-Met1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39901	Dummer-KF2-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
39902	Dummer-KF3-Primary	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
39903	Dummer-KF3-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
39904	Dummer-KF3-Met1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
39905	Long-TN1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
39906	Long-TN1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
39907	Long-TN2-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
39908	Long-TN2-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
39909	D326-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
39910	D326-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
39911	D366	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
39912	D366-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
39913	DPN 48	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39914	CGH11-023	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-023 	NextFlex 23	\N
39915	AST-1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
39916	WTMM-1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
39917	WTMM-2-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
39918	WTMM-3-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
39919	WTMM-4-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
39920	WTMM-5-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
39921	WTMM-6-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39922	XD-1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
39923	WTMM-8-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
39924	WTMM-9-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
39925	WTMM-10-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
39926	WTMM-11-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
39927	WTMM-12-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
39928	WTMM-13-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
39929	WTMM-14-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
39930	WTMM-15-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
39931	WTMM-16-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
39932	Long-TN3-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
39933	Long-TN3-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
39934	Long-TN4-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39935	Long-TN4-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
39936	Long-TN5-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
39937	Long-TN5-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
39938	AGL14-89-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NTRK3	 NextFlex 5	\N
39939	AGL14-89-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	MET	 NextFlex 6	\N
39940	AGL14-92-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	DPN-like Melanoma	 NextFlex 7	\N
39941	AGL14-92-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
39942	AGL14-91-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39943	AGL14-91-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
39944	AGL4-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
39945	AGL14-96-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
39946	AGL14-94-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
39947	AGL14-97-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
39948	AGL14-93-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
39949	AGL9-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
39950	AGL14-95-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
39951	AGL11-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
39952	AGL12-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
39953	AGL13-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
39954	AGL14-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
39955	AGL15-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39956	AGL16-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
39957	AGL17-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
39958	L1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
39959	L1-DN	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
39960	L1-MIS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
39961	L1-INV	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39962	L14-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
39963	L14-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
39964	L14-Nevus-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
39965	L14-Mel-Comb	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
39966	L14-Mel-S	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
39967	L14-Mel-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
39968	L14C-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
39969	L14C-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
39970	Ivanka-6-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
39971	Ivanka-6-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
39972	Ivanka-6-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
39973	Ivanka-6-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
39974	Ivanka-27-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39975	Ivanka-27-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
39976	Ivanka-27-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
39977	Ivanka-27-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
39978	DM_50_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
39979	DM_56_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
39980	Ivanka-26-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
39981	Ivanka-26-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
39982	Ivanka-26-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
39983	L10-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
39984	L10-MIS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
39985	L10-INV	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
39986	L10-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
39987	L12-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
39988	L12-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
39989	L12-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
39990	L16-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
39991	L16-Mel-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
39992	L16A-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
39993	L16A-Nevus-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
39994	L16A-Mel-Sup	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
39995	L16B-Lesion-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
39996	L16B-Lesion-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
39997	L16B-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
39998	DM15 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
39999	DM19	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
40000	DM19-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
40001	DM_46_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
40002	Heinzerling-1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	TTAGGC	\N
40003	Heinzerling-1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	ACTTGA	\N
40004	UM13	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	GATCAG	\N
40005	UM14	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	TAGCTT	\N
40006	UM16	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	GGCTAC	\N
40007	L17-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
40008	L17-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
40009	L17-Nevus-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
40010	L17-Mel-S	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
40011	L17-Mel-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
40012	GAK	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
40013	Yurif	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
40014	Ivanka-11-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
40015	Ivanka-11-M1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
40016	Ivanka-11-M2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
40017	L18-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
40018	L18-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
40019	L18-Mel-S	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
40020	L18-Mel-D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
40021	L21-MIS-Lesion-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
40022	L21-LesionB	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
40023	L21-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
40024	JBP-1-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 10	\N
40025	JBP-1-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
40026	JBP-1-Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
40027	L19-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
40028	L19-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
40029	L19-Mel	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
40030	L19E-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
40031	L19E-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
40032	L19E-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
40033	L22-MIS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
40034	L22-Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
40035	L22-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
40036	L23-MM-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
40037	L23C-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
40038	L23C-Mel-Sup	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
40039	L23D-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
40040	L23D-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
40041	L6-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
40042	L6-LGD-Super	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
40043	L6-LGD-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
40044	XD-2-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
40045	XD-2-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
40046	Long-TN6-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
40047	Long-TN6-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
40048	Long-TN7-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
40049	Long-TN7-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
40050	Long-TN8-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
40051	Long-TN8-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
40052	Long-TN9-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
40053	Long-TN9-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
40054	Long-TN12-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
40055	Long-TN12-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
40056	Long-TN13-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
40057	Long-TN13-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
40058	Long-TN14-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
40059	Long-TN14-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
40060	Long-TN15-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
40061	Long-TN15-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
40062	Long-TN16-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
40063	Long-TN16-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
40064	Long-TN17-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
40065	Long-TN17-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
40066	M230	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
40067	M257	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
40068	M285	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
40069	M368	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
40070	M375	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
40071	M418	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
40072	C8161	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
40073	L4-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
40074	L4-LGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
40075	L5-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
40076	L5-LGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
40077	L8-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
40078	L8-LGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
40079	L9-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
40080	L9-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
40081	L13-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
40082	L13-Lesion-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
40083	L13-Lesion-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
40084	L15-DysPN	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
40085	L15-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
40086	1212	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
40087	1213	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
40088	1214	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 3	\N
40089	3860	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 4	\N
40090	UM17	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
40091	JBP-2-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
40092	JBP-2-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
40093	JBP-2-Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
40094	Long-TN18-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
40095	Long-TN18-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
40096	Long-TN19-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
40097	Long-TN19-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
40098	Long-TN20-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
40099	Long-TN20-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
40100	Long-TN21-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
40101	Long-TN21-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
40102	XD-1.1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
40103	ADM_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	807	\N
40104	ADM_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	808	\N
40105	ADM_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	809	\N
40106	ADM_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	812	\N
40107	ADM_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	813	\N
40108	ADM_6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	814	\N
40109	ADM_7	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	815	\N
40110	NZM52	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	816	\N
40111	NZM40	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	817	\N
40112	NZM91	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	818	\N
40113	Long-TN22-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	DH	NaN	\N
40114	Long-TN22-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	DH	NaN	\N
40115	Long-TN23-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	JG	NaN	\N
40116	Long-TN23-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	JG	NaN	\N
40117	Long-TN24-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	MLH	NaN	\N
40118	Long-TN24-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	MLH	NaN	\N
40119	Long-TN25-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	JM	NaN	\N
40120	Long-TN25-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	JM	NaN	\N
40121	Long-TN26-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	AH	NaN	\N
40122	Long-TN26-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	AH	NaN	\N
40123	Long-TN27-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	FN	NaN	\N
40124	Long-TN27-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	FN	NaN	\N
40125	Long-TN28-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	GJ	NaN	\N
40126	Long-TN28-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	GJ	NaN	\N
40127	Long-TN29-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CG	NaN	\N
40128	Long-TN29-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CG	NaN	\N
40129	KAM17-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	17	Dual_AD707 Duplex	\N
40130	KAM41-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	41	Dual_AD708 Duplex	\N
40131	KAM90-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	90	Dual_AD709 Duplex	\N
40132	KAM92-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	92	Dual_AD710 Duplex	\N
40133	KAM93-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	93	Dual_AD711 Duplex	\N
40134	KAM99-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	99	Dual_AD712 Duplex	\N
40135	KAM105-T-A1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	105	Dual_AD801 Duplex	\N
40136	KAM28-T-B1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	28	Dual_AD802 Duplex	\N
40137	KAM30-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	30	Dual_AD803 Duplex	\N
40138	KAM72-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	72	Dual_AD804 Duplex	\N
40139	KAM18-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	18	Dual_AD805 Duplex	\N
40140	KAM63-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	63	Dual_AD806 Duplex	\N
40141	KAM70-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	70	Dual_AD807 Duplex	\N
40142	KAM54-T-E	\N	NaN	\N	\N	\N	\N	\N	\N	\N	54	Dual_AD808 Duplex	\N
40143	KAM2-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	2	Dual_AD809 Duplex	\N
40144	KAM5-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	5	Dual_AD812 Duplex	\N
40145	KAM10-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	10	Dual_AD824 Duplex	\N
40146	KAM45-T-D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	45	Dual_AD826 Duplex	\N
40147	KAM49-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	49	Dual_AD827 Duplex	\N
40148	KAM27-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	27	Dual_AD828 Duplex	\N
40149	KAM68-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	68	Dual_AD829 Duplex	\N
40150	KAM9-T-H	\N	NaN	\N	\N	\N	\N	\N	\N	\N	9	Dual_AD830 Duplex	\N
40151	KAM98-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	98	Dual_AD832 Duplex	\N
40152	KAM67-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	67	Dual_AD833 Duplex	\N
40153	KAM124-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	124	Dual_AD887 Duplex	\N
40154	KAM58-T-GIV	\N	NaN	\N	\N	\N	\N	\N	\N	\N	58	Dual_AD836 Duplex	\N
40155	KAM86-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	86	Dual_AD837 Duplex	\N
40156	KAM111-T-A2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	111	Dual_AD838 Duplex	\N
40157	KAM77-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	77	Dual_AD840 Duplex	\N
40158	KAM69-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	69	Dual_AD841 Duplex	\N
40159	KAM117-T-D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	117	Dual_AD882 Duplex	\N
40160	KAM103-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	103	Dual_AD843 Duplex	\N
40161	Long-TN30-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD810 Duplex	\N
40162	Long-TN30-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD504 Duplex	\N
40163	Long-TN31-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD856 Duplex	\N
40164	Long-TN31-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD857 Duplex	\N
40165	Long-TN32-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD858 Duplex	\N
40166	Long-TN32-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD859 Duplex	\N
40167	Long-TN33-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD860 Duplex	\N
40168	Long-TN33-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD861 Duplex	\N
40169	Long-TN34-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD862 Duplex	\N
40170	Long-TN34-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD863 Duplex	\N
40171	Long-TN35-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD864 Duplex	\N
40172	Long-TN35-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD865 Duplex	\N
40173	UM29	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD868 Duplex	\N
40174	UM30	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD869 Duplex	\N
40175	UM31	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD870 Duplex	\N
40176	UM34	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD871 Duplex	\N
40177	KAM19-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	19	AD501	\N
40178	KAM32-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	32	AD503	\N
40179	KAM60-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	60	AD505	\N
40180	KAM74-T-G	\N	NaN	\N	\N	\N	\N	\N	\N	\N	74	AD506	\N
40181	KAM109-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	109	AD507	\N
40182	KAM112-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	112	AD508	\N
40183	KAM115-T-A1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	115	AD703	\N
40184	KAM119-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	119	AD704	\N
40185	KAM46-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	46	AD819	\N
40186	KAM47-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	47	AD821	\N
40187	KAM100-T-II	\N	NaN	\N	\N	\N	\N	\N	\N	\N	100	AD822 	\N
40188	KAM75	\N	NaN	\N	\N	\N	\N	\N	\N	\N	75	AD825 	\N
40189	KAM64-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	64	AD831 	\N
40190	KAM50-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	50	AD834 	\N
40191	KAM39-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	39	AD820 	\N
40192	KAM22-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	22	AD853 	\N
40193	T015-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD816	\N
40194	T015-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD817	\N
40195	T016-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD818	\N
40196	T016-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD866	\N
40197	T017-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD819	\N
40198	T017-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD821	\N
40199	T020-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD822	\N
40200	T020-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD824	\N
40201	T020-Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD825	\N
40202	T021-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD826	\N
40203	T021-Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD827	\N
40204	T023-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD828	\N
40205	T023-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD829	\N
40206	T023-Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD830 	\N
40207	UM27	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD831	\N
40208	UM28	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD834	\N
40209	736TP-FFPE-L3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD861 	\N
40210	736TP-FFPE-L13	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD862 	\N
40211	736TP-MB-L3-L2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD863 	\N
40212	736TP-MB-L3-L4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD864 	\N
40213	736TP-MB-L3-P1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD865 	\N
40214	736TP-MB-L3-P2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD868 	\N
40215	736TP-MB-L13-L1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD869 	\N
40216	736TP-MB-L13-P2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD870 	\N
40217	UM33	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD871 	\N
40218	UM35_A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD872 	\N
40219	UM39	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD873 	\N
40220	UM40	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD874 	\N
40221	UM41	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD875 	\N
40222	UM36	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD847 	\N
40223	UM37	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD848 	\N
40224	736TP-F-L13	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD878 	\N
40225	UM41-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40226	UM41-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40227	UM42	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40228	UM43	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40229	UM44	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40230	UM45	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40231	UM47-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40232	UM47-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40233	Sample_KAM1-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40234	Sample_KAM106-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40235	Sample_KAM12-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40236	Sample_KAM121-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40237	Sample_KAM20-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40238	Sample_KAM3-T-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40239	Sample_KAM35-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40240	Sample_KAM38-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40241	Sample_KAM53-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40242	Sample_KAM61-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40243	Sample_KAM7-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40244	Sample_KAM78-T-III	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40245	Sample_KAM82-T-B8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40246	Sample_KAM84-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40247	Sample_KAM94-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
40248	Sample_KAM96-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
\.


--
-- Name: area_na_link_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.area_na_link_id_seq', 128773, true);


--
-- Name: block_area_link_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.block_area_link_id_seq', 59793, true);


--
-- Name: na_sl_link_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.na_sl_link_id_seq', 92952, true);


--
-- Name: nuc_acids_nu_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.nuc_acids_nu_id_seq', 33440, true);


--
-- Name: patients_pa_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.patients_pa_id_seq', 2957, true);


--
-- Name: sample_lib_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.sample_lib_id_seq', 40248, true);


--
-- Name: area_na_link area_na_link_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.area_na_link
    ADD CONSTRAINT area_na_link_pkey PRIMARY KEY (id);


--
-- Name: block_area_link block_area_link_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.block_area_link
    ADD CONSTRAINT block_area_link_pkey PRIMARY KEY (id);


--
-- Name: na_sl_link na_sl_link_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.na_sl_link
    ADD CONSTRAINT na_sl_link_pkey PRIMARY KEY (id);


--
-- Name: nuc_acids nuc_acids_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.nuc_acids
    ADD CONSTRAINT nuc_acids_pkey PRIMARY KEY (nu_id);


--
-- Name: patients patients_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.patients
    ADD CONSTRAINT patients_pkey PRIMARY KEY (pa_id);


--
-- Name: sample_lib sample_lib_name_key; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.sample_lib
    ADD CONSTRAINT sample_lib_name_key UNIQUE (name);


--
-- Name: sample_lib sample_lib_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.sample_lib
    ADD CONSTRAINT sample_lib_pkey PRIMARY KEY (id);


--
-- PostgreSQL database dump complete
--

